PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Kumbrink, J; Soni, S; Laumbacher, B; Loesch, B; Kirsch, KH				Kumbrink, Joerg; Soni, Shefali; Laumbacher, Barbara; Loesch, Barbara; Kirsch, Kathrin H.			Identification of Novel Crk-associated Substrate (p130(Cas)) Variants with Functionally Distinct Focal Adhesion Kinase Binding Activities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cancer biology; cell migration; cell signaling; PTK2 protein tyrosine kinase 2 (PTK2) (focal adhesion kinase) (FAK); signal transduction; SH3 domain binding; alternative splice variants; N-terminal SH3 domain extensions; exon 1; p130Cas	BREAST-CANCER CELLS; P130CAS LOCALIZATION; GENE-EXPRESSION; RESISTANCE; DOMAIN; CAS; TRANSFORMATION; ORGANIZATION; SEQUENCES; DYNAMICS	Background: The tumor promoter p130(Cas) utilizes its SH3 domain to control cell adhesion and migration. Results: We identified N-terminal extended p130(Cas) variants with enhanced SH3 domain binding activity which modulates cell migration and invasion. Conclusion: Naturally occurring p130(Cas) variants exhibit differential biological activities. Significance: Knowledge on these variants may explain how p130(Cas) controls cellular programs and drives carcinogenesis. Elevated levels of p130(Cas) (Crk-associated substrate)/BCAR1 (breast cancer antiestrogen resistance 1 gene) are associated with aggressiveness of breast tumors. Following phosphorylation of its substrate domain, p130(Cas) promotes the integration of protein complexes involved in multiple signaling pathways and mediates cell proliferation, adhesion, and migration. In addition to the known BCAR1-1A (wild-type) and 1C variants, we identified four novel BCAR1 mRNA variants, generated by alternative first exon usage (1B, 1B1, 1D, and 1E). Exons 1A and 1C encode for four amino acids (aa), whereas 1D and 1E encode for 22 aa and 1B1 encodes for 50 aa. Exon 1B is non-coding, resulting in a truncated p130(Cas) protein (Cas1B). BCAR1-1A, 1B1, and variant 1C mRNAs were ubiquitously expressed in cell lines and a survey of human tissues, whereas 1B, 1D, and 1E expression was more restricted. Reconstitution of all isoforms except for 1B in p130(Cas)-deficient murine fibroblasts induced lamellipodia formation and membrane ruffling, which was unrelated to the substrate domain phosphorylation status. The longer isoforms exhibited increased binding to focal adhesion kinase (FAK), a molecule important for migration and adhesion. The shorter 1B isoform exhibited diminished FAK binding activity and significantly reduced migration and invasion. In contrast, the longest variant 1B1 established the most efficient FAK binding and greatly enhanced migration. Our results indicate that the p130(Cas) exon 1 variants display altered functional properties. The truncated variant 1B and the longer isoform 1B1 may contribute to the diverse effects of p130(Cas) on cell biology and therefore will be the target of future studies.	[Kumbrink, Joerg; Soni, Shefali; Kirsch, Kathrin H.] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA; [Laumbacher, Barbara] Immunotherapy Res Ctr, D-80336 Munich, Germany; [Loesch, Barbara] Immunis eV, D-80336 Munich, Germany	Boston University	Kirsch, KH (corresponding author), Boston Univ, Sch Med, Dept Biochem, 72 E Concord St, Boston, MA 02118 USA.	kirschk@bu.edu		Kirsch, Kathrin/0000-0003-1532-1715	Public Health Service Grant from NCI, National Institutes of Health [CA106468]; Susan G. Komen for the Cure Breast Cancer Foundation Grant [KG101208]; NATIONAL CANCER INSTITUTE [R01CA106468] Funding Source: NIH RePORTER	Public Health Service Grant from NCI, National Institutes of Health; Susan G. Komen for the Cure Breast Cancer Foundation Grant(Susan G. Komen Breast Cancer Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Public Health Service Grant CA106468 from the NCI, National Institutes of Health (to K. H. K.) and Susan G. Komen for the Cure Breast Cancer Foundation Grant KG101208.	Akagi T, 2002, MOL CELL BIOL, V22, P7015, DOI 10.1128/MCB.22.20.7015-7023.2002; Bouton AH, 2001, ONCOGENE, V20, P6448, DOI 10.1038/sj.onc.1204785; Cabodi S, 2010, NAT REV CANCER, V10, P858, DOI 10.1038/nrc2967; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chen CH, 2013, CARDIOVASC RES, V100, P461, DOI 10.1093/cvr/cvt207; Deramaudt T. B, 2014, PLOS ONE, V9; Donato DM, 2010, J BIOL CHEM, V285, P20769, DOI 10.1074/jbc.M109.091207; DORSSERS LCJ, 1993, MOL ENDOCRINOL, V7, P870, DOI 10.1210/me.7.7.870; Dorssers LCJ, 2001, DRUGS, V61, P1721, DOI 10.2165/00003495-200161120-00004; Fernandez IE, 2012, LANCET, V380, P680, DOI 10.1016/S0140-6736(12)61144-1; Fujita-Becker S, 2006, J BIOL CHEM, V281, P36102, DOI 10.1074/jbc.M605171200; Gould CM, 2010, NUCLEIC ACIDS RES, V38, pD167, DOI 10.1093/nar/gkp1016; Graham LJ, 1998, BIOCHEM BIOPH RES CO, V249, P537, DOI 10.1006/bbrc.1998.9177; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harte MT, 2000, BBA-MOL CELL RES, V1499, P34, DOI 10.1016/S0167-4889(00)00104-X; Honda H, 1998, NAT GENET, V19, P361, DOI 10.1038/1246; Huang JH, 2002, J BIOL CHEM, V277, P27265, DOI 10.1074/jbc.M203063200; Janostiak R, 2014, CELL MOL LIFE SCI, V71, P727, DOI 10.1007/s00018-013-1450-x; Kirsch KH, 1998, J BIOL CHEM, V273, P25673, DOI 10.1074/jbc.273.40.25673; Kogerman P, 2002, ONCOGENE, V21, P6007, DOI 10.1038/sj.onc.1205865; Kos M, 2001, MOL ENDOCRINOL, V15, P2057, DOI 10.1210/me.15.12.2057; Kumbrink J, 2011, BREAST CANC CURRENT, P37; Kumbrink J, 2013, INT J BIOCHEM CELL B, V45, P531, DOI 10.1016/j.biocel.2012.12.017; Kumbrink J, 2012, NEOPLASIA, V14, P108, DOI 10.1593/neo.111760; Kumbrink J, 2010, J CELL BIOCHEM, V111, P207, DOI 10.1002/jcb.22690; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Tu L, 2012, AM J RESP CRIT CARE, V186, P666, DOI 10.1164/rccm.201202-0309OC; Makkinje A, 2009, CELL SIGNAL, V21, P1423, DOI 10.1016/j.cellsig.2009.05.006; Meenderink LM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013412; Nakamoto T, 1997, MOL CELL BIOL, V17, P3884, DOI 10.1128/MCB.17.7.3884; Nikonova AS, 2014, IUBMB LIFE, V66, P387, DOI 10.1002/iub.1282; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Parsons JT, 2000, ONCOGENE, V19, P5606, DOI 10.1038/sj.onc.1203877; POLTE TR, 1995, P NATL ACAD SCI USA, V92, P10678, DOI 10.1073/pnas.92.23.10678; Sayers EW, 2010, NUCLEIC ACIDS RES, V38, pD5, DOI 10.1093/nar/gkp967; Soni S, 2009, J CELL BIOCHEM, V107, P364, DOI 10.1002/jcb.22136; Streb JW, 2004, J BIOL CHEM, V279, P56014, DOI 10.1074/jbc.M408828200; Ta HQ, 2008, CANCER RES, V68, P8796, DOI 10.1158/0008-5472.CAN-08-2426; Thierry-Mieg D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s12; Tikhmyanova N, 2010, CELL MOL LIFE SCI, V67, P1025, DOI 10.1007/s00018-009-0213-1; Vancheri C, 2013, EUR RESPIR REV, V22, P265, DOI 10.1183/09059180.00003613; Wang HZ, 2009, ENDOCRINOLOGY, V150, P3301, DOI 10.1210/en.2008-1812; Zhao YS, 2013, CARCINOGENESIS, V34, P2880, DOI 10.1093/carcin/bgt238	43	4	4	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2015	290	19					12247	12255		10.1074/jbc.M115.649947	http://dx.doi.org/10.1074/jbc.M115.649947			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH9XA	25805500	Green Published, hybrid			2022-12-26	WOS:000354388600035
J	Hardy, AB; Prentice, KJ; Froese, S; Liu, Y; Andrews, GK; Wheeler, MB				Hardy, Alexandre B.; Prentice, Kacey J.; Froese, Sean; Liu, Ying; Andrews, Glen K.; Wheeler, Michael B.			Zip4 Mediated Zinc Influx Stimulates Insulin Secretion in Pancreatic Beta Cells	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; GLUCOSE-HOMEOSTASIS; TRANSPORTER ZNT8; ACRODERMATITIS-ENTEROPATHICA; RISK LOCI; EXPRESSION; MICE; BIOSYNTHESIS; FAMILY; METALLOTHIONEIN	Zinc has an important role in normal pancreatic beta cell physiology as it regulates gene transcription, insulin crystallization and secretion, and cell survival. Nevertheless, little is known about how zinc is transported through the plasma membrane of beta cells and which of the class of zinc influx transporters (Zip) is involved. Zip4 was previously shown to be expressed in human and mouse beta cells; however, its function there is still unknown. Therefore, the aim of this study was to define the zinc transport role of Zip4 in beta cells. To investigate this, Zip4 was over-expressed in MIN6 beta cells using a pCMV6-Zip4GFP plasmid. Organelle staining combined with confocal microscopy showed that Zip4 exhibits a widespread localization in MIN6 cells. Time-lapse zinc imaging experiments showed that Zip4 increases cytoplasmic zinc levels. This resulted in increased granular zinc content and glucose-stimulated insulin secretion. Interestingly, it is unlikely that the increased glucose stimulated insulin secretion was triggered by a modulation of mitochondrial function, as mitochondrial membrane potential remained unchanged. To define the role of Zip4 in-vivo, we generated a beta cell-specific knockout mouse model (Zip4BK0). Deletion of the Zip4 gene was confirmed in Zip4BKO islets by FOR, RT-PCR, and immuno-histochemistry. Zip4BKO mice showed slightly improved glucose homeostasis but no change in insulin secretion during an oral glucose tolerance test. While Zip4 was not found to be essential for proper glucose homeostasis and insulin secretion in vivo in mice, this study also found that Zip4 mediates increases in cytoplasmic and granular zinc pools and stimulates glucose dependant insulin secretion in-vitro.	[Hardy, Alexandre B.; Prentice, Kacey J.; Froese, Sean; Liu, Ying; Wheeler, Michael B.] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Andrews, Glen K.] Univ Kansas, Med Ctr, Kansas City, KS 66103 USA	University of Toronto; University of Kansas; University of Kansas Medical Center	Wheeler, MB (corresponding author), Univ Toronto, Dept Physiol, Toronto, ON, Canada.	michael.wheeler@utoronto.ca	; Liu, Ying/H-6045-2018	Wheeler, Michael B./0000-0002-7480-7267; Liu, Ying/0000-0001-7710-0809	Canadian Institutes of Health Research (CIHR) [MOP-102588]; CIHR doctoral research award; Ontario Graduate Scholarship; Banting and Best Postdoctoral fellowship	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR doctoral research award(Canadian Institutes of Health Research (CIHR)); Ontario Graduate Scholarship(Ontario Graduate Scholarship); Banting and Best Postdoctoral fellowship	This work was supported by a grant from the Canadian Institutes of Health Research (CIHR; MOP-102588) to M.B. Wheeler. K.J. Prentice was supported by a CIHR doctoral research award. S. Froese was supported by an Ontario Graduate Scholarship and Y. Liu was supported by a Banting and Best Postdoctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellomo EA, 2011, J BIOL CHEM, V286, P25778, DOI 10.1074/jbc.M111.246082; Chimienti F, 2004, DIABETES, V53, P2330, DOI 10.2337/diabetes.53.9.2330; Chimienti F, 2006, J CELL SCI, V119, P4199, DOI 10.1242/jcs.03164; Dineley KE, 2003, J NEUROCHEM, V85, P563, DOI 10.1046/j.1471-4159.2003.01678.x; Dodson G, 1998, CURR OPIN STRUC BIOL, V8, P189, DOI 10.1016/S0959-440X(98)80037-7; Dufner-Beattie J, 2003, J BIOL CHEM, V278, P33474, DOI 10.1074/jbc.M305000200; Dufner-Beattie J, 2004, J BIOL CHEM, V279, P49082, DOI 10.1074/jbc.M409962200; Eide DJ, 2006, BBA-MOL CELL RES, V1763, P711, DOI 10.1016/j.bbamcr.2006.03.005; EMDIN SO, 1980, DIABETOLOGIA, V19, P174, DOI 10.1007/BF00275265; Formigare A, 2007, COMP BIOCHEM PHYS C, V146, P443, DOI 10.1016/j.cbpc.2007.07.010; Gee KR, 2002, CELL CALCIUM, V31, P245, DOI 10.1016/S0143-4160(02)00053-2; Geiser J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002766; Goodge KA, 2000, SEMIN CELL DEV BIOL, V11, P235, DOI 10.1006/scdb.2000.0172; Gyulkhandanyan AV, 2008, J BIOL CHEM, V283, P10184, DOI 10.1074/jbc.M707005200; Gyulkhandanyan AV, 2006, J BIOL CHEM, V281, P9361, DOI 10.1074/jbc.M508542200; Hardy AB, 2012, AM J PHYSIOL-ENDOC M, V302, pE1084, DOI 10.1152/ajpendo.00448.2011; Hardy AB, 2009, J BIOL CHEM, V284, P30441, DOI 10.1074/jbc.M109.040659; Huang ZL, 2006, DEV BIOL, V295, P571, DOI 10.1016/j.ydbio.2006.03.045; Jeong J, 2013, MOL ASPECTS MED, V34, P612, DOI 10.1016/j.mam.2012.05.011; Kambe T, 2009, MOL CELL BIOL, V29, P129, DOI 10.1128/MCB.00963-08; Kim BE, 2004, J BIOL CHEM, V279, P4523, DOI 10.1074/jbc.M310799200; Kim BJ, 2000, DIABETES, V49, P367, DOI 10.2337/diabetes.49.3.367; Lee SC, 2009, J ENDOCRINOL, V203, P33, DOI 10.1677/JOE-09-0117; Lemaire K, 2009, P NATL ACAD SCI USA, V106, P14872, DOI 10.1073/pnas.0906587106; Liuzzi JP, 2004, P NATL ACAD SCI USA, V101, P14355, DOI 10.1073/pnas.0406216101; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Nicolson TJ, 2009, DIABETES, V58, P2070, DOI 10.2337/db09-0551; Qian WJ, 2000, ANAL CHEM, V72, P711, DOI 10.1021/ac991085t; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Steiner DF, 1996, DIABETES METAB, V22, P94; Steinthorsdottir V, 2007, NAT GENET, V39, P770, DOI 10.1038/ng2043; Wang K, 2002, AM J HUM GENET, V71, P66, DOI 10.1086/341125; Weaver BP, 2007, BIOL CHEM, V388, P1301, DOI 10.1515/BC.2007.149; Wijesekara N, 2010, DIABETOLOGIA, V53, P1656, DOI 10.1007/s00125-010-1733-9; Wijesekara N, 2009, DIABETES OBES METAB, V11, P202, DOI 10.1111/j.1463-1326.2009.01110.x; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	39	32	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0119136	10.1371/journal.pone.0119136	http://dx.doi.org/10.1371/journal.pone.0119136			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25806541	Green Published, gold, Green Submitted			2022-12-26	WOS:000351880000019
J	De Felice, A; Scattoni, ML; Ricceri, L; Calamandrei, G				De Felice, Alessia; Scattoni, Maria Luisa; Ricceri, Laura; Calamandrei, Gemma			Prenatal Exposure to a Common Organophosphate Insecticide Delays Motor Development in a Mouse Model of Idiopathic Autism	PLOS ONE			English	Article							T PLUS TF/J; BTBR-T+TF/J MICE; ULTRASONIC VOCALIZATION; CHLORPYRIFOS EXPOSURE; NEUROBEHAVIORAL DEVELOPMENT; BEHAVIORAL PHENOTYPES; PESTICIDE EXPOSURE; UNUSUAL REPERTOIRE; NEONATAL EXPOSURE; CRITICAL PERIODS	Autism spectrum disorders are characterized by impaired social and communicative skills and repetitive behaviors. Emerging evidence supported the hypothesis that these neurodevelopmental disorders may result from a combination of genetic susceptibility and exposure to environmental toxins in early developmental phases. This study assessed the effects of prenatal exposure to chlorpyrifos (CPF), a widely diffused organophosphate insecticide endowed with developmental neurotoxicity at sub-toxic doses, in the BTBR T+tf/J mouse strain, a validated model of idiopathic autism that displays several behavioral traits relevant to the autism spectrum. To this aim, pregnant BTBR mice were administered from gestational day 14 to 17 with either vehicle or CPF at a dose of 6 mg/kg/bw by oral gavages. Offspring of both sexes underwent assessment of early developmental milestones, including somatic growth, motor behavior and ultrasound vocalization. To evaluate the potential long-term effects of CPF, two different social behavior patterns typically altered in the BTBR strain (free social interaction with a same-sex companion in females, or interaction with a sexually receptive female in males) were also examined in the two sexes at adulthood. Our findings indicate significant effects of CPF on somatic growth and neonatal motor patterns. CPF treated pups showed reduced weight gain, delayed motor maturation (i.e., persistency of immature patterns such as pivoting at the expenses of coordinated locomotion) and a trend to enhanced ultrasound vocalization. At adulthood, CPF associated alterations were found in males only: the altered pattern of investigation of a sexual partner, previously described in BTBR mice, was enhanced in CPF males, and associated to increased ultrasonic vocalization rate. These findings strengthen the need of future studies to evaluate the role of environmental chemicals in the etiology of neurodevelopment disorders.	[De Felice, Alessia; Scattoni, Maria Luisa; Ricceri, Laura; Calamandrei, Gemma] Ist Super Sanita, Dept Cell Biol & Neurosci, Sect Neurotoxicol & Neuroendocrinol, Rome, Italy; [De Felice, Alessia] Univ Roma La Sapienza, Dept Physiol & Pharmacol Vittorio Erspamer, I-00185 Rome, Italy	Istituto Superiore di Sanita (ISS); Sapienza University Rome	Calamandrei, G (corresponding author), Ist Super Sanita, Dept Cell Biol & Neurosci, Sect Neurotoxicol & Neuroendocrinol, Rome, Italy.	gemma.calamandrei@iss.it	Scattoni, Maria Luisa/K-4116-2016; Ricceri, Laura/N-9168-2017	Scattoni, Maria Luisa/0000-0002-6659-0280; Ricceri, Laura/0000-0001-9850-2284; Calamandrei, Gemma/0000-0003-3762-3132	Italian Ministry of Health Grant; ISS/Ministry of Health; Ministry of Health	Italian Ministry of Health Grant(Ministry of Health, Italy); ISS/Ministry of Health; Ministry of Health	This work was supported by the Italian Ministry of Health Grant, Young Researcher 2008, GR3-"Non-invasive tools for early detection of Autism Spectrum Disorders" and by ISS/Ministry of Health Grant 5%3A "Role of neuroendocrine mechanisms in the etiology of neurodevelopmental disorders", funder: Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346; Aldridge JE, 2004, ENVIRON HEALTH PERSP, V112, P148, DOI 10.1289/ehp.6713; ALTMAN J, 1975, ANIM BEHAV, V23, P896, DOI 10.1016/0003-3472(75)90114-1; Amodeo DA, 2012, BEHAV BRAIN RES, V227, P64, DOI 10.1016/j.bbr.2011.10.032; Atladottir HO, 2010, J AUTISM DEV DISORD, V40, P1423, DOI 10.1007/s10803-010-1006-y; Bhat AN, 2012, INFANT BEHAV DEV, V35, P838, DOI 10.1016/j.infbeh.2012.07.019; Bolivar VJ, 2007, BEHAV BRAIN RES, V176, P21, DOI 10.1016/j.bbr.2006.09.007; Branchi I, 2004, DEV PSYCHOBIOL, V44, P37, DOI 10.1002/dev.10150; Branchi I, 2001, BEHAV BRAIN RES, V125, P49, DOI 10.1016/S0166-4328(01)00277-7; Brunelli SA, 2007, BEHAV BRAIN RES, V182, P193, DOI 10.1016/j.bbr.2007.04.014; Cazalets JR, 2000, J NEUROPHYSIOL, V83, P2468, DOI 10.1152/jn.2000.83.4.2468; Chadman KK, 2008, AUTISM RES, V1, P147, DOI 10.1002/aur.22; CHESS S, 1971, J AUTISM CHILD SCHIZ, V1, P33, DOI 10.1007/BF01537741; CHESS S, 1977, J AUTISM CHILD SCHIZ, V7, P69, DOI 10.1007/BF01531116; CIRULLI F, 1994, NEUROTOXICOLOGY, V15, P819; Cusco I, 2009, HUM MOL GENET, V18, P1795, DOI 10.1093/hmg/ddp092; Dam K, 2000, DEV BRAIN RES, V121, P179, DOI 10.1016/S0165-3806(00)00044-4; De Filippis B, 2010, GENES BRAIN BEHAV, V9, P213, DOI 10.1111/j.1601-183X.2009.00551.x; Dierssen M, 2002, PHARMACOL BIOCHEM BE, V73, P19, DOI 10.1016/S0091-3057(02)00792-X; Eaton DL, 2008, CRIT REV TOXICOL, V38, P1, DOI 10.1080/10408440802272158 ; Engel SM, 2011, ENVIRON HEALTH PERSP, V119, P1182, DOI 10.1289/ehp.1003183; Eskenazi B, 2007, ENVIRON HEALTH PERSP, V115, P792, DOI 10.1289/ehp.9828; Esposito G, 2011, BRAIN DEV-JPN, V33, P367, DOI 10.1016/j.braindev.2010.07.006; FOX WM, 1965, ANIM BEHAV, V13, P234, DOI 10.1016/0003-3472(65)90041-2; Gould GG, 2011, J NEUROCHEM, V116, P291, DOI 10.1111/j.1471-4159.2010.07104.x; Grandjean P, 2006, LANCET, V368, P2167, DOI 10.1016/S0140-6736(06)69665-7; Grandjean P, 2014, LANCET NEUROL, V13, P330, DOI 10.1016/S1474-4422(13)70278-3; Hallmayer J, 2011, ARCH GEN PSYCHIAT, V68, P1095, DOI 10.1001/archgenpsychiatry.2011.76; HOFER MA, 1978, DEV PSYCHOBIOL, V11, P495, DOI 10.1002/dev.420110513; Holy TE, 2005, PLOS BIOL, V3, P2177, DOI 10.1371/journal.pbio.0030386; Jones-Davis DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061829; Laviola G, 2006, PSYCHOPHARMACOLOGY, V187, P331, DOI 10.1007/s00213-006-0426-z; Leary MR, 1996, MENT RETARD, V34, P39; Leonard HC, 2014, AUTISM, V18, P281, DOI 10.1177/1362361312470037; Levitt P, 2009, J CLIN INVEST, V119, P747, DOI 10.1172/JCI37934; McFarlane HG, 2008, GENES BRAIN BEHAV, V7, P152, DOI 10.1111/j.1601-183X.2007.00330.x; MEDNICK SA, 1988, ARCH GEN PSYCHIAT, V45, P189, DOI 10.1001/archpsyc.1988.01800260109013; Moreira EG, 2010, TOXICOL APPL PHARM, V245, P310, DOI 10.1016/j.taap.2010.03.015; Moy SS, 2007, BEHAV BRAIN RES, V176, P4, DOI 10.1016/j.bbr.2006.07.030; Mullen BR, 2013, ASN NEURO, V5, P27, DOI 10.1042/AN20120060; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Pearson BL, 2011, GENES BRAIN BEHAV, V10, P228, DOI 10.1111/j.1601-183X.2010.00659.x; Pearson BL, 2012, BEHAV BRAIN RES, V233, P99, DOI 10.1016/j.bbr.2012.04.040; Persico AM, 2006, TRENDS NEUROSCI, V29, P349, DOI 10.1016/j.tins.2006.05.010; Pessah IN, 2008, NEUROTOXICOLOGY, V29, P532, DOI 10.1016/j.neuro.2008.02.006; Picker JD, 2006, NEUROREPORT, V17, P541, DOI 10.1097/01.wnr.0000208995.38695.2f; Rauh V, 2011, ENVIRON HEALTH PERSP, V119, P1196, DOI 10.1289/ehp.1003160; Ricceri L, 2003, TOXICOL APPL PHARM, V191, P189, DOI 10.1016/S0041-008X(03)00229-1; Ricceri L, 2006, TOXICOL SCI, V93, P105, DOI 10.1093/toxsci/kfl032; Romano E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064407; Rossignol DA, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.4; Roullet FI, 2011, BEHAV BRAIN RES, V216, P19, DOI 10.1016/j.bbr.2010.06.004; Rugh R, 1990, MOUSE ITS REPROD DEV; Santos M, 2007, GENES BRAIN BEHAV, V6, P277, DOI 10.1111/j.1601-183X.2006.00258.x; Saunders M, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-S1-S5; Scattoni ML, 2011, GENES BRAIN BEHAV, V10, P44, DOI 10.1111/j.1601-183X.2010.00623.x; Scattoni ML, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003067; Schwartzer JJ, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.16; Shelton JF, 2012, ENVIRON HEALTH PERSP, V120, P944, DOI 10.1289/ehp.1104553; Shu WG, 2005, P NATL ACAD SCI USA, V102, P9643, DOI 10.1073/pnas.0503739102; Silverman JL, 2010, NEUROSCIENCE, V171, P1197, DOI 10.1016/j.neuroscience.2010.09.059; Slotkin TA, 2007, REPROD TOXICOL, V23, P421, DOI 10.1016/j.reprotox.2006.07.010; SPEAR LP, 1986, PSYCHOPHARMACOLOGY, V90, P106; Tait S, 2009, ENVIRON HEALTH PERSP, V117, P112, DOI 10.1289/ehp.11696; Timofeeva OA, 2008, NEUROTOXICOL TERATOL, V30, P38, DOI 10.1016/j.ntt.2007.10.002; Venerosi A, 2012, NEUROTOXICOLOGY, V33, P1420, DOI 10.1016/j.neuro.2012.08.009; Venerosi A, 2008, NEUROTOXICOL TERATOL, V30, P468, DOI 10.1016/j.ntt.2008.07.002; Venerosi A, 2006, NEUROTOXICOL TERATOL, V28, P466, DOI 10.1016/j.ntt.2006.05.003; Venerosi A, 2010, PSYCHOPHARMACOLOGY, V208, P99, DOI 10.1007/s00213-009-1713-2; Venerosi A, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-12; Whyatt RM, 2004, ENVIRON HEALTH PERSP, V112, P1125, DOI 10.1289/ehp.6641; Wohr M, 2008, BEHAV NEUROSCI, V122, P310, DOI 10.1037/0735-7044.122.2.310; Wohr M, 2011, SOC NEUROSCI-UK, V6, P76, DOI 10.1080/17470911003765560; Woods R, 2012, HUM MOL GENET, V21, P2399, DOI 10.1093/hmg/dds046; Yang M, 2007, FRONT BEHAV NEUROSCI, V1, DOI [10.3389/neuro.08/001.2007, 10.3389/neuro.08.001.2007]; Yang M, 2007, INT J DEV NEUROSCI, V25, P515, DOI 10.1016/j.ijdevneu.2007.09.008; Yang M, 2012, PHYSIOL BEHAV, V107, P649, DOI 10.1016/j.physbeh.2011.12.025; Young JG, 2005, NEUROTOXICOLOGY, V26, P199, DOI 10.1016/j.neuro.2004.10.004; Zimmerberg B, 2003, DEV PSYCHOBIOL, V42, P52, DOI 10.1002/dev.10086	79	36	36	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0121663	10.1371/journal.pone.0121663	http://dx.doi.org/10.1371/journal.pone.0121663			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH2XV	25803479	gold, Green Published, Green Submitted			2022-12-26	WOS:000353889600169
J	He, Q; Sun, XX; Chu, C; Jiang, Q; Zhu, HF; He, Y; Yue, TT; Wang, RB; Lei, P; Shen, GX				He, Qi; Sun, Xiaoxu; Chu, Chong; Jiang, Qing; Zhu, Huifen; He, Yong; Yue, Tingting; Wang, Ruibo; Lei, Ping; Shen, Guanxin			Endocytosis of a Functionally Enhanced GFP-Tagged Transferrin Receptor in CHO Cells	PLOS ONE			English	Article							MEDIATED ENDOCYTOSIS; THERAPEUTIC AGENTS; TARGETED DELIVERY; DRUG-DELIVERY; CANCER; PATHWAY; GENE; COMPLEX; ANTIGEN; GROWTH	The endocytosis of transferrin receptor (TfR) has served as a model to study the receptor-targeted cargo delivery system for cancer therapy for many years. To accurately evaluate and optically measure this TfR targeting delivery in vitro, a CHO cell line with enhanced green fluorescent protein (EGFP)-tagged human TfR was established. A chimera of the hTfR and EGFP was engineered by fusing EGFP to the amino terminus of hTfR. Data were provided to demonstrate that hTfR-EGFP chimera was predominantly localized on the plasma membrane with some intracellular fluorescent structures on CHO cells and the EGFP moiety did not affect the endocytosis property of hTfR. Receptor internalization occurred similarly to that of HepG2 cells expressing wild-type hTfR. The internalization percentage of this chimeric receptor was about 81 +/- 3% of wild type. Time-dependent co-localization of hTfR-EGFP and PE-conjugated anti-hTfR mAb in living cells demonstrated the trafficking of mAb-receptor complexes through the endosomes followed by segregation of part of the mAb and receptor at the late stages of endocytosis. The CHO-hTfR cells preferentially took up anti-hTfR mAb conjugated nanoparticles. This CHO-hTfR cell line makes it feasible for accurate evaluation and visualization of intracellular trafficking of therapeutic agents conjugated with transferrin or Abs targeting the hTfRs.	[He, Qi; Sun, Xiaoxu; Chu, Chong; Jiang, Qing; Zhu, Huifen; Lei, Ping; Shen, Guanxin] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Immunol, Wuhan 430074, Hubei, Peoples R China; [Sun, Xiaoxu] Zhengzhou Univ, Affiliated Hosp 1, Dept Clin Lab, Zhengzhou 450052, Henan, Peoples R China; [He, Yong] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Nucl Med,Hubei Prov Key Lab Mol Imaging, Wuhan 430074, Hubei, Peoples R China; [Yue, Tingting; Wang, Ruibo] Beijing Pushikang Pharmaceut Technol Co Ltd, Beijing, Peoples R China	Huazhong University of Science & Technology; Zhengzhou University; Huazhong University of Science & Technology	Lei, P (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Immunol, Wuhan 430074, Hubei, Peoples R China.	adaleip@sina.com	shen, Guanxin/F-7441-2011	, Qi/0000-0002-1827-2456	Hi-Tech Research and Development Program of China [2012AA02A306]	Hi-Tech Research and Development Program of China(National High Technology Research and Development Program of China)	This study was supported by Hi-Tech Research and Development Program of China (No. 2012AA02A306). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Daniels TR, 2006, CLIN IMMUNOL, V121, P144, DOI 10.1016/j.clim.2006.06.010; Daniels TR, 2006, CLIN IMMUNOL, V121, P159, DOI 10.1016/j.clim.2006.06.006; Daniels TR, 2012, BBA-GEN SUBJECTS, V1820, P291, DOI 10.1016/j.bbagen.2011.07.016; Haldar S, 2007, J PHYS CHEM B, V111, P14436, DOI 10.1021/jp076797z; Hong Y, 2013, CANCER IMMUNOL IMMUN, V62, P447, DOI 10.1007/s00262-012-1337-y; Lepelletier Y, 2007, CANCER RES, V67, P1145, DOI 10.1158/0008-5472.CAN-06-1962; Levy JE, 1999, NAT GENET, V21, P396, DOI 10.1038/7727; Li JA, 2010, CELL IMMUNOL, V263, P154, DOI 10.1016/j.cellimm.2010.03.008; Lin QY, 2014, PHARM RES-DORDR, V31, P1438, DOI 10.1007/s11095-013-1046-z; Liu YQ, 2009, MOL THER, V17, P269, DOI 10.1038/mt.2008.266; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; MILLER YE, 1983, AM J HUM GENET, V35, P573; Moura IC, 2004, BLOOD, V103, P1838, DOI 10.1182/blood-2003-07-2440; Navaroli DM, 2012, P NATL ACAD SCI USA, V109, pE471, DOI 10.1073/pnas.1115495109; Lei P, 2007, ACTA PHARMACOL SIN, V28, P1659, DOI 10.1111/j.1745-7254.2007.00623.x; Pirollo KF, 2006, HUM GENE THER, V17, P117, DOI 10.1089/hum.2006.17.117; Qian ZM, 2002, PHARMACOL REV, V54, P561, DOI 10.1124/pr.54.4.561; SELIGMAN PA, 1986, AM J HUM GENET, V38, P540; Shen X, 2008, INT IMMUNOPHARMACOL, V8, P1813, DOI 10.1016/j.intimp.2008.08.022; Steere AN, 2012, BIOCHEMISTRY-US, V51, P2113, DOI 10.1021/bi3001038; VANRENSWOUDE J, 1982, P NATL ACAD SCI-BIOL, V79, P6186; Wei ML, 1998, J CELL BIOL, V140, P565, DOI 10.1083/jcb.140.3.565; Xu L, 2002, MOL CANCER THER, V1, P337; Xu L, 2001, MOL MED, V7, P723, DOI 10.1007/BF03401962; Ye Q, 2006, CANCER IMMUNOL IMMUN, V55, P1111, DOI 10.1007/s00262-005-0105-7; Yu W, 2004, GENE THER, V11, P1434, DOI 10.1038/sj.gt.3302304; Zhang ZH, 2010, SMALL, V6, P430, DOI 10.1002/smll.200901515; Zhang ZH, 2009, ANGEW CHEM INT EDIT, V48, P9171, DOI 10.1002/anie.200903112	28	3	4	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0122452	10.1371/journal.pone.0122452	http://dx.doi.org/10.1371/journal.pone.0122452			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803700	Green Published, gold, Green Submitted			2022-12-26	WOS:000353889600199
J	Zuckerman, DM; Boucher, LE; Xie, K; Engelhardt, H; Bosch, J; Hoiczyk, E				Zuckerman, David M.; Boucher, Lauren E.; Xie, Kefang; Engelhardt, Harald; Bosch, Juergen; Hoiczyk, Egbert			The Bactofilin Cytoskeleton Protein BacM of Myxococcus xanthus Forms an Extended beta-Sheet Structure Likely Mediated by Hydrophobic Interactions	PLOS ONE			English	Article							3D STRUCTURE PREDICTION; BACTERIAL CYTOSKELETON; CELL-SHAPE; MOLECULAR-DYNAMICS; CRYSTAL-STRUCTURE; I-TASSER; HELIX; INTERMEDIATE; FILAMENT; TUBULIN	Bactofilins are novel cytoskeleton proteins that are widespread in Gram-negative bacteria. Myxococcus xanthus, an important predatory soil bacterium, possesses four bactofilins of which one, BacM (Mxan_7475) plays an important role in cell shape maintenance. Electron and fluorescence light microscopy, as well as studies using over-expressed, purified BacM, indicate that this protein polymerizes in vivo and in vitro into similar to 3 nm wide filaments that further associate into higher ordered fibers of about 10 nm. Here we use a multipronged approach combining secondary structure determination, molecular modeling, biochemistry, and genetics to identify and characterize critical molecular elements that enable BacM to polymerize. Our results indicate that the bactofilin-determining domain DUF583 folds into an extended beta-sheet structure, and we hypothesize a left-handed beta-helix with polymerization into 3 nm filaments primarily via patches of hydrophobic amino acid residues. These patches form the interface allowing head-to-tail polymerization during filament formation. Biochemical analyses of these processes show that folding and polymerization occur across a wide variety of conditions and even in the presence of chaotropic agents such as one molar urea. Together, these data suggest that bactofilins are comprised of a structure unique to cytoskeleton proteins, which enables robust polymerization.	[Zuckerman, David M.; Xie, Kefang; Hoiczyk, Egbert] Johns Hopkins Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA; [Boucher, Lauren E.; Bosch, Juergen] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biochem & Mol Biol, Baltimore, MD USA; [Boucher, Lauren E.; Bosch, Juergen] Johns Hopkins Malaria Res Inst, Baltimore, MD USA; [Engelhardt, Harald] Max Planck Inst Biochem, Dept Biol Struct, D-82152 Martinsried, Germany	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Max Planck Society	Hoiczyk, E (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA.	ehoiczy1@jhu.edu	Bosch, Jurgen/E-9370-2011	Bosch, Jurgen/0000-0002-2624-4105; Boucher, Lauren/0000-0003-3152-6155	National Institute of General Medical Sciences [GM85024, T32GM080189]; National Institute of Allergy and Infectious Diseases [T32AI007417]; Johns Hopkins Malaria Research Institute; Bloomberg Family Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085024, T32GM080189] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Johns Hopkins Malaria Research Institute; Bloomberg Family Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was funded by a grant from the National Institute of General Medical Sciences to E.H. (GM85024), postdoctoral fellowships from the National Institute of Allergy and Infectious Diseases to D.M.Z. and K.X. (T32AI007417), pre-doctoral funding from the National Institute of General Medical Sciences to L.E.B. (T32GM080189), and a pre-doctoral fellowship from the Johns Hopkins Malaria Research Institute, and support to J.B. from the Bloomberg Family Foundation and the Johns Hopkins Malaria Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARRONDO JLR, 1993, PROG BIOPHYS MOL BIO, V59, P23, DOI 10.1016/0079-6107(93)90006-6; Ausmees N, 2003, CELL, V115, P705, DOI 10.1016/S0092-8674(03)00935-8; Bagchi S, 2008, MOL MICROBIOL, V70, P1037, DOI 10.1111/j.1365-2958.2008.06473.x; Barth A, 2002, Q REV BIOPHYS, V35, P369, DOI 10.1017/S0033583502003815; Biegert A, 2008, BIOINFORMATICS, V24, P807, DOI 10.1093/bioinformatics/btn039; BORK P, 1992, P NATL ACAD SCI USA, V89, P7290, DOI 10.1073/pnas.89.16.7290; Bosch J, 2006, P NATL ACAD SCI USA, V103, P4852, DOI 10.1073/pnas.0510907103; Bosch J, 2007, J MOL BIOL, V372, P77, DOI 10.1016/j.jmb.2007.06.016; Bryan AW, 2011, P NATL ACAD SCI USA, V108, P11099, DOI 10.1073/pnas.1017504108; Bulyha I, 2013, DEV CELL, V25, P119, DOI 10.1016/j.devcel.2013.02.017; Cabeen MT, 2010, ANNU REV GENET, V44, P365, DOI 10.1146/annurev-genet-102108-134845; Celler K, 2013, J BACTERIOL, V195, P1627, DOI 10.1128/JB.02194-12; Cheng JL, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-18; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Erickson HP, 2010, MICROBIOL MOL BIOL R, V74, P504, DOI 10.1128/MMBR.00021-10; Fenton AK, 2010, FEMS MICROBIOL LETT, V313, P89, DOI 10.1111/j.1574-6968.2010.02125.x; Fiuza M, 2010, J BIOL CHEM, V285, P29387, DOI 10.1074/jbc.M110.154427; Freund C., 2008, V186, P407, DOI 10.1007/978-3-540-72843-6_17; Gauthier SY, 1998, EUR J BIOCHEM, V258, P445, DOI 10.1046/j.1432-1327.1998.2580445.x; Gerdes K, 2010, CELL, V141, P927, DOI 10.1016/j.cell.2010.05.033; Gitai Z, 2007, CURR OPIN CELL BIOL, V19, P5, DOI 10.1016/j.ceb.2006.12.010; Goldman RD, 2012, J STRUCT BIOL, V177, P14, DOI 10.1016/j.jsb.2011.11.017; Govaerts C, 2004, P NATL ACAD SCI USA, V101, P8342, DOI 10.1073/pnas.0402254101; Graumann PL, 2009, CELL MOTIL CYTOSKEL, V66, P909, DOI 10.1002/cm.20381; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Hay NA, 1999, J BACTERIOL, V181, P2008, DOI 10.1128/JB.181.7.2008-2016.1999; Huang YJP, 2014, PROTEINS, V82, P43, DOI 10.1002/prot.24488; Iengar P, 2006, STRUCTURE, V14, P529, DOI 10.1016/j.str.2005.11.021; Ingerson-Mahar M, 2012, FEMS MICROBIOL REV, V36, P256, DOI 10.1111/j.1574-6976.2011.00316.x; Jenkins J, 2001, PROG BIOPHYS MOL BIO, V77, P111, DOI 10.1016/S0079-6107(01)00013-X; Jones LJF, 2001, CELL, V104, P913, DOI 10.1016/S0092-8674(01)00287-2; KAISER D, 1979, P NATL ACAD SCI USA, V76, P5952, DOI 10.1073/pnas.76.11.5952; Kajava AV, 2006, ADV PROTEIN CHEM, V73, P55, DOI 10.1016/S0065-3233(06)73003-0; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; Koch MK, 2011, MOL MICROBIOL, V80, P1031, DOI 10.1111/j.1365-2958.2011.07629.x; Kozakov D, 2013, PROTEINS, V81, P2159, DOI 10.1002/prot.24403; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kuhn J, 2010, EMBO J, V29, P327, DOI 10.1038/emboj.2009.358; Langedijk JPM, 2006, J MOL BIOL, V360, P907, DOI 10.1016/j.jmb.2006.05.042; Lin L, 2013, CYTOSKELETON, V70, P409, DOI 10.1002/cm.21126; Lowe J, 1998, NATURE, V391, P203, DOI 10.1038/34472; Lowe J, 2009, INT J BIOCHEM CELL B, V41, P323, DOI 10.1016/j.biocel.2008.08.010; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; Merlino A, 2006, PROTEINS, V63, P918, DOI 10.1002/prot.20941; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; Nogales E, 2003, CURR OPIN STRUC BIOL, V13, P256, DOI 10.1016/S0959-440X(03)00029-0; Nogales E, 1998, NAT STRUCT BIOL, V5, P451, DOI 10.1038/nsb0698-451; Ojeda-Lopez MA, 2014, NAT MATER, V13, P195, DOI 10.1038/nmat3858; Popp D, 2011, MOL MICROBIOL, V80, P300, DOI 10.1111/j.1365-2958.2011.07599.x; Rath A, 2005, BIOPOLYMERS, V80, P179, DOI 10.1002/bip.20227; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Ruzin S.E., 1999, PLANT MICROTECHNIQUE; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Schuler B, 1999, J BIOL CHEM, V274, P18589, DOI 10.1074/jbc.274.26.18589; Shih YL, 2006, MICROBIOL MOL BIOL R, V70, P729, DOI 10.1128/MMBR.00017-06; Specht M, 2011, J BACTERIOL, V193, P4523, DOI 10.1128/JB.00231-11; Stork M, 2005, BIOPHYS J, V88, P2442, DOI 10.1529/biophysj.104.052415; Sycuro LK, 2010, CELL, V141, P822, DOI 10.1016/j.cell.2010.03.046; Teixido-Travesa N, 2012, J CELL SCI, V125, P4445, DOI 10.1242/jcs.106971; Thanbichler M, 2008, NAT REV MICROBIOL, V6, P28, DOI 10.1038/nrmicro1795; van den Ent F, 2001, NATURE, V413, P39, DOI 10.1038/35092500; Waidner B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000669; Wang Z, 2010, BIOINFORMATICS, V26, P882, DOI 10.1093/bioinformatics/btq058; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; WILLIAMSON MP, 1994, BIOCHEM J, V297, P249, DOI 10.1042/bj2970249; Xu D, 2012, PROTEINS, V80, P1715, DOI 10.1002/prot.24065; Yeh TY, 2013, EMBO J, V32, P1023, DOI 10.1038/emboj.2013.30; Zandomeneghi G, 2004, PROTEIN SCI, V13, P3314, DOI 10.1110/ps.041024904; Zeth K, 2000, STRUCTURE, V8, P981, DOI 10.1016/S0969-2126(00)00189-1; Zhang JF, 2010, PROTEINS, V78, P1137, DOI 10.1002/prot.22634; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zheng J, 2007, BIOCHEMISTRY-US, V46, P1205, DOI 10.1021/bi061674a	73	13	13	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0121074	10.1371/journal.pone.0121074	http://dx.doi.org/10.1371/journal.pone.0121074			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803609	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000353889600121
J	Binder, E; Natarajan, D; Cooper, J; Kronfli, R; Cananzi, M; Delalande, JM; McCann, C; Burns, AJ; Thapar, N				Binder, Ellen; Natarajan, Dipa; Cooper, Julie; Kronfli, Rania; Cananzi, Mara; Delalande, Jean-Marie; McCann, Conor; Burns, Alan J.; Thapar, Nikhil			Enteric Neurospheres Are Not Specific to Neural Crest Cultures: Implications for Neural Stem Cell Therapies	PLOS ONE			English	Article							SYSTEM PROGENITOR CELLS; TYROSINE KINASE RET; NERVOUS-SYSTEM; HIRSCHSPRUNGS-DISEASE; FOLLOW-UP; RECEPTOR; COLON; AGANGLIONOSIS; NEUROPATHIES; NEURONS	Objectives Enteric neural stem cells provide hope of curative treatment for enteric neuropathies. Current protocols for their harvesting from humans focus on the generation of 'neurospheres' from cultures of dissociated gut tissue. The study aims to better understand the derivation, generation and composition of enteric neurospheres. Design Gut tissue was obtained from Wnt1-Cre; Rosa26(Yfp/Yfp) transgenic mice (constitutively labeled neural crest cells) and paediatric patients. Gut cells were cultured either unsorted (mixed neural crest/non-neural crest), or following FACS selection into neural crest (murine-YFP+ve/human-p75+ve) or non-neural crest (YFP-ve/p75-ve) populations. Cultures and resultant neurospheres were characterized using immunolabelling in vitro and following transplantation in vivo. Results Cultures of (i) unsorted, (ii) neural crest, and (iii) non-neural crest cell populations generated neurospheres similar in numbers, size and morphology. Unsorted neurospheres were highly heterogeneous for neural crest content. Neural crest-derived (YFP+ve/p75+ve) neurospheres contained only neural derivatives (neurons and glia) and were devoid of non-neural cells (i.e. negative for SMA, c-Kit), with the converse true for non-neural crest-derived (YFP-ve/p75-ve) 'neurospheres'. Under differentiation conditions only YFP+ve cells gave rise to neural derivatives. Both YFP+ve and YFP-ve cells displayed proliferation and spread upon transplantation in vivo, but YFP-ve cells did not locate or integrate within the host ENS. Conclusions Spherical accumulations of cells, so-called 'neurospheres' forming in cultures of dissociated gut contain variable proportions of neural crest-derived cells. If they are to be used for ENS cell replacement therapy then improved protocols for their generation, including cell selection, should be sought in order to avoid inadvertent transplantation of non-therapeutic, nonENS cells.	[Binder, Ellen; Natarajan, Dipa; Cooper, Julie; Kronfli, Rania; Cananzi, Mara; Delalande, Jean-Marie; McCann, Conor; Burns, Alan J.; Thapar, Nikhil] UCL Inst Child Hlth, Stem Cells & Regenerat Med, London, England; [Burns, Alan J.] Erasmus MC, Dept Clin Genet, Rotterdam, Netherlands; [Thapar, Nikhil] Great Ormond St Hosp Sick Children, Dept Gastroenterol, London WC1N 3JH, England	University of London; University College London; Erasmus University Rotterdam; Erasmus MC; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust	Burns, AJ (corresponding author), UCL Inst Child Hlth, Stem Cells & Regenerat Med, London, England.	alan.burns@ucl.ac.uk; n.thapar@ucl.ac.uk	Burns, Alan/AAC-1266-2022; cananzi, mara/AAS-8540-2020; Burns, Alan J/C-4988-2008	Cananzi, Mara/0000-0002-7177-2847; Burns, Alan/0000-0002-1725-1071; McCann, Conor/0000-0002-9324-5984	Great Ormond Street Hospital Children's Charity [W1018C, V1222]; Medical Research Council [G0800973]; MRC [G0800973] Funding Source: UKRI	Great Ormond Street Hospital Children's Charity; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Great Ormond Street Hospital Children's Charity, W1018C (NT and AJB); Great Ormond Street Hospital Children's Charity, V1222 (NT); and Medical Research Council, G0800973 (NT and AJB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almond S, 2007, GUT, V56, P489, DOI 10.1136/gut.2006.094565; Amiel J, 2008, J MED GENET, V45, P1, DOI 10.1136/jmg.2007.053959; Barlow A, 2003, NEURON, V40, P905, DOI 10.1016/S0896-6273(03)00730-X; BAYNASH AG, 1994, CELL, V79, P1277, DOI 10.1016/0092-8674(94)90018-3; Becker L, 2012, AM J PHYSIOL-GASTR L, V302, pG958, DOI 10.1152/ajpgi.00511.2011; Bixby S, 2002, NEURON, V35, P643, DOI 10.1016/S0896-6273(02)00825-5; Boeckxstaens GE, 2014, LANCET, V383, P83, DOI 10.1016/S0140-6736(13)60651-0; Bondurand N, 2003, DEVELOPMENT, V130, P6387, DOI 10.1242/dev.00857; Burns AJ, 2004, NEUROGASTROENT MOTIL, V16, P3, DOI 10.1111/j.1743-3150.2004.00466.x; Burns AJ, 2014, NAT REV GASTRO HEPAT, V11, P317, DOI 10.1038/nrgastro.2013.226; Caldwell C, 2007, J PEDIATR GASTR NUTR, V44, P15; Catto-Smith AG, 2007, J GASTROEN HEPATOL, V22, P2273, DOI 10.1111/j.1440-1746.2006.04750.x; Conway SJ, 2007, J PEDIATR SURG, V42, P1429, DOI 10.1016/j.jpedsurg.2007.03.046; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; Druckenbrod NR, 2005, DEV BIOL, V287, P125, DOI 10.1016/j.ydbio.2005.08.040; Gershon MD, 2007, GUT, V56, P459, DOI 10.1136/gut.2006.107748; Hanani M, 2003, J COMP NEUROL, V462, P315, DOI 10.1002/cne.10721; Heanue TA, 2007, NAT REV NEUROSCI, V8, P466, DOI 10.1038/nrn2137; Hetz S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093605; Hotta R, 2013, J CLIN INVEST, V123, P1182, DOI 10.1172/JCI65963; Hotta Ryo, 2011, J Pediatr Gastroenterol Nutr, V53 Suppl 2, pS43; Howe Steven J, 2012, Methods Mol Biol, V891, P85, DOI 10.1007/978-1-61779-873-3_5; Jiang XB, 2000, DEVELOPMENT, V127, P1607; Kalcheim C, 1999, NEURAL CREST; Knowles CH, 2013, NAT REV GASTRO HEPAT, V10, P206, DOI 10.1038/nrgastro.2013.18; Laranjeira C, 2011, J CLIN INVEST, V121, P3412, DOI 10.1172/JCI58200; Lindley RM, 2008, GASTROENTEROLOGY, V135, P205, DOI 10.1053/j.gastro.2008.03.035; Liu MT, 2009, J NEUROSCI, V29, P9683, DOI 10.1523/JNEUROSCI.1145-09.2009; Ludman L, 2002, ARCH DIS CHILD, V86, P348, DOI 10.1136/adc.86.5.348; Matsuda Y, 2013, WORLD J GASTROENTERO, V19, P42, DOI 10.3748/wjg.v19.i1.42; McKeown SJ, 2013, WIRES DEV BIOL, V2, P113, DOI 10.1002/wdev.57; Metzger M, 2009, GASTROENTEROLOGY, V136, P2214, DOI 10.1053/j.gastro.2009.02.048; Mifflin RC, 2011, AM J PHYSIOL-GASTR L, V300, pG684, DOI 10.1152/ajpgi.00474.2010; Nagoshi N, 2008, CELL STEM CELL, V2, P392, DOI 10.1016/j.stem.2008.03.005; Natarajan D, 2002, DEVELOPMENT, V129, P5151; Nunes MC, 2003, NAT MED, V9, P439, DOI 10.1038/nm837; Pallari HM, 2011, MOL BIOL CELL, V22, P1539, DOI 10.1091/mbc.E10-07-0568; Panza E, 2012, PROG NEUROBIOL, V96, P176, DOI 10.1016/j.pneurobio.2012.01.001; Prato AP, 2008, PEDIATR SURG INT, V24, P175, DOI 10.1007/s00383-007-2089-1; Rauch U, 2006, INT J COLORECTAL DIS, V21, P554, DOI 10.1007/s00384-005-0051-z; Rodrigues DM, 2011, NEUROGASTROENT MOTIL, V23, pe44, DOI 10.1111/j.1365-2982.2010.01626.x; Rothman TP, 1996, DEV BIOL, V178, P498, DOI 10.1006/dbio.1996.0234; Sanchez MP, 1996, NATURE, V382, P70, DOI 10.1038/382070a0; Sasselli V, 2012, DEV BIOL, V366, P64, DOI 10.1016/j.ydbio.2012.01.012; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Thapar N, 2007, J PEDIATR GASTR NUTR, V45, pS110, DOI 10.1097/MPG.0b013e31812e667c; Theocharatos S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054809; Tsai YH, 2011, NEUROGASTROENT MOTIL, V23, P362, DOI 10.1111/j.1365-2982.2010.01656.x; Tsuji H, 1999, J PEDIATR SURG, V34, P158, DOI 10.1016/S0022-3468(99)90248-8; Wallace AS, 2005, CELL TISSUE RES, V319, P367, DOI 10.1007/s00441-004-1023-2; Zani A, 2014, GUT, V63, P300, DOI 10.1136/gutjnl-2012-303735; Zufferey R, 1999, J VIROL, V73, P2886, DOI 10.1128/JVI.73.4.2886-2892.1999	52	35	37	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0119467	10.1371/journal.pone.0119467	http://dx.doi.org/10.1371/journal.pone.0119467			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799576	Green Published, Green Submitted, gold			2022-12-26	WOS:000351987300052
J	Liu, JX; Li, YZ; Verheyden, B; Chen, SG; Chen, ZH; Gai, YQ; Liu, JZ; Gao, JY; Xie, Q; Yuan, M; Li, Q; Li, L; Aubert, AE				Liu, Jiexin; Li, Yongzhi; Verheyden, Bart; Chen, Shanguang; Chen, Zhanghuang; Gai, Yuqing; Liu, Jianzhong; Gao, Jianyi; Xie, Qiong; Yuan, Ming; Li, Qin; Li, Li; Aubert, Andre E.			Is Autonomic Modulation Different between European and Chinese Astronauts?	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; POSTSPACEFLIGHT ORTHOSTATIC HYPOTENSION; CENTRAL VENOUS-PRESSURE; BAROREFLEX SENSITIVITY; CARDIOVASCULAR ADAPTATION; ARTERIAL-PRESSURE; BLOOD-VOLUME; MICROGRAVITY; RESPONSES; HUMANS	Purpose The objective was to investigate autonomic control in groups of European and Chinese astronauts and to identify similarities and differences. Methods Beat-to-beat heart rate and finger blood pressure, brachial blood pressure, and respiratory frequency were measured from 10 astronauts (five European taking part in three different space missions and five Chinese astronauts taking part in two different space missions). Data recording was performed in the supine and standing positions at least 10 days before launch, and 1, 3, and 10 days after return. Cross-correlation analysis of heart rate and systolic pressure was used to assess cardiac baroreflex modulation. A fixed breathing protocol was performed to measure respiratory sinus arrhythmia and low-frequency power of systolic blood pressure variability. Results Although baseline cardiovascular parameters before spaceflight were similar in all astronauts in the supine position, a significant increase in sympathetic activity and a decrease in vagal modulation occurred in the European astronauts when standing; spaceflight resulted in a remarkable vagal decrease in European astronauts only. Similar baseline supine and standing values for heart rate, mean arterial pressure, and respiratory frequency were shown in both groups. Standing autonomic control was based on a balance of higher vagal and sympathetic modulation in European astronauts. Conclusion Post-spaceflight orthostatic tachycardia was observed in all European astronauts, whereas post-spaceflight orthostatic tachycardia was significantly reduced in Chinese astronauts. The basis for orthostatic intolerance is not apparent; however, many possibilities can be considered and need to be further investigated, such as genetic diversities between races, astronaut selection, training, and nutrition, etc.	[Liu, Jiexin; Li, Qin; Li, Li] China Capital Med Univ, Dept Cardiol, Beijing Friendship Hosp, Beijing, Peoples R China; [Liu, Jiexin; Verheyden, Bart; Aubert, Andre E.] Katholieke Univ Leuven, Univ Hosp Gasthuisberg, Dept Cardiol, Leuven, Belgium; [Li, Yongzhi; Chen, Shanguang; Chen, Zhanghuang; Gai, Yuqing; Liu, Jianzhong; Gao, Jianyi; Xie, Qiong; Yuan, Ming] China Astronaut Ctr, Beijing, Peoples R China	Capital Medical University; KU Leuven; University Hospital Leuven	Liu, JX (corresponding author), China Capital Med Univ, Dept Cardiol, Beijing Friendship Hosp, Beijing, Peoples R China.	jiexinliu@hotmail.com; accsmfa@gmail.com	Ghiami, Zeinab/G-5492-2016		Belgian Federal Office of Scientific Affairs, Belgian-China cooperation; bilateral agreements Belgium-China from the Belgian Federal Office of Scientific Affairs; Belgian Federal Office of Scientific Affairs	Belgian Federal Office of Scientific Affairs, Belgian-China cooperation; bilateral agreements Belgium-China from the Belgian Federal Office of Scientific Affairs; Belgian Federal Office of Scientific Affairs	This work was funded by grants from the Belgian Federal Office of Scientific Affairs, Belgian-China cooperation (www.belspo.be). Jiexin Liu is supported from bilateral agreements Belgium-China from the Belgian Federal Office of Scientific Affairs. Bart Verheyden is supported as a post-doctoral researcher from ESA-PRODEX grants from the Belgian Federal Office of Scientific Affairs.	ARAI Y, 1989, AM J PHYSIOL, V256, pH132, DOI 10.1152/ajpheart.1989.256.1.H132; Arvedsen SK, 2012, AM J PHYSIOL-REG I, V302, pR984, DOI 10.1152/ajpregu.00036.2011; Aubert AE, 2005, ACTA CARDIOL, V60, P129, DOI 10.2143/AC.60.2.2005024; Aubert AE, 1999, COMPUT METH PROG BIO, V60, P197, DOI 10.1016/S0169-2607(99)00017-6; Aubert AE, 2010, AM J PHYSIOL-HEART C, V298, pH202, DOI 10.1152/ajpheart.00865.2009; Baevsky RM, 2007, J APPL PHYSIOL, V103, P156, DOI 10.1152/japplphysiol.00137.2007; Beckers F, 2006, WILEY ENCY BIOMEDICA; Beckers Frank, 2004, J Clin Monit Comput, V18, P131, DOI 10.1023/B:JOCM.0000032745.15545.78; Beckers F, 2009, ACTA ASTRONAUT, V65, P804, DOI 10.1016/j.actaastro.2009.03.004; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Buckey JC, 1996, J APPL PHYSIOL, V81, P19, DOI 10.1152/jappl.1996.81.1.19; Buckey JC, 1996, J APPL PHYSIOL, V81, P7, DOI 10.1152/jappl.1996.81.1.7; CHARLES JB, 1991, J CLIN PHARMACOL, V31, P1010, DOI 10.1002/j.1552-4604.1991.tb03665.x; Cintron N M, 1990, Physiologist, V33, pS16; Cooke WH, 2000, J APPL PHYSIOL, V89, P1039; Cox JF, 2002, J PHYSIOL-LONDON, V538, P309, DOI 10.1113/jphysiol.2001.012574; Delp MD, 2007, J APPL PHYSIOL, V102, P836, DOI 10.1152/japplphysiol.01347.2006; Deurenberg P, 2003, EUR J CLIN NUTR, V57, P405, DOI 10.1038/sj.ejcn.1601569; Deurenberg P, 2003, ASIA PAC J CLIN NUTR, V12, P261; Deurenberg P, 2002, Obes Rev, V3, P141, DOI 10.1046/j.1467-789X.2002.00065.x; Deurenberg-Yap M, 2000, INT J OBESITY, V24, P1011, DOI 10.1038/sj.ijo.0801353; Di Rienzo M, 2008, J APPL PHYSIOL, V105, P1569, DOI 10.1152/japplphysiol.90625.2008; ELLIOTT AR, 1994, J APPL PHYSIOL, V77, P2005, DOI 10.1152/jappl.1994.77.4.2005; Ertl AC, 2002, J PHYSIOL-LONDON, V538, P321, DOI 10.1113/jphysiol.2001.012576; FRITSCH JM, 1992, J APPL PHYSIOL, V73, P664, DOI 10.1152/jappl.1992.73.2.664; FRITSCHYELLE JM, 1994, J APPL PHYSIOL, V77, P1776, DOI 10.1152/jappl.1994.77.4.1776; FritschYelle JM, 1996, J APPL PHYSIOL, V81, P2134, DOI 10.1152/jappl.1996.81.5.2134; Fu Q, 2002, J PHYSIOL-LONDON, V544, P653, DOI 10.1113/jphysiol.2002.025098; Fu Q, 2010, J AM COLL CARDIOL, V55, P2858, DOI 10.1016/j.jacc.2010.02.043; FURLAN R, 1993, CARDIOVASC RES, V27, P482, DOI 10.1093/cvr/27.3.482; Gharib C, 2002, B ACAD NAT MED PARIS, V186, P733, DOI 10.1016/S0001-4079(19)34294-3; Hargens AR, 1996, MED SCI SPORT EXER, V28, P977, DOI 10.1097/00005768-199608000-00007; Hepburn H, 2005, EUR J APPL PHYSIOL, V94, P681, DOI 10.1007/s00421-005-1355-y; Kajiura M, 2008, CLIN PHYSIOL FUNCT I, V28, P174, DOI 10.1111/j.1475-097X.2008.00790.x; Koenig SC, 1998, AM J PHYSIOL-REG I, V275, pR1343, DOI 10.1152/ajpregu.1998.275.4.R1343; LEACH CS, 1988, ACTA ASTRONAUT, V17, P161, DOI 10.1016/0094-5765(88)90017-3; Leach CS, 1996, J APPL PHYSIOL, V81, P105, DOI 10.1152/jappl.1996.81.1.105; Levine BD, 2002, J PHYSIOL-LONDON, V538, P331, DOI 10.1113/jphysiol.2001.012575; Meck JV, 2004, AM J PHYSIOL-HEART C, V286, pH1486, DOI 10.1152/ajpheart.00740.2003; NORSK P, 1995, J APPL PHYSIOL, V78, P2253, DOI 10.1152/jappl.1995.78.6.2253; Norsk P, 2006, HYPERTENSION, V47, P69, DOI 10.1161/01.HYP.0000194332.98674.57; Perhonen MA, 2001, J APPL PHYSIOL, V91, P645, DOI 10.1152/jappl.2001.91.2.645; PRISK GK, 1993, J APPL PHYSIOL, V75, P15, DOI 10.1152/jappl.1993.75.1.15; Reed KE, 2006, APPL PHYSIOL NUTR ME, V31, P277, DOI 10.1139/H05-015; Sigaudo-Roussel D, 2002, EUR J APPL PHYSIOL, V86, P258, DOI 10.1007/s00421-001-0551-7; Singh RB, 2001, BIOMED PHARMACOTHER, V55, p115S; TANAKA H, 1994, EUR HEART J, V15, P1011, DOI 10.1093/oxfordjournals.eurheartj.a060622; Tsuji H, 1996, J AM COLL CARDIOL, V28, P1539, DOI 10.1016/S0735-1097(96)00342-7; Tuday EC, 2007, J APPL PHYSIOL, V102, P853, DOI 10.1152/japplphysiol.00950.2006; Verheyden B, 2007, ACTA PHYSIOL, V191, P297, DOI 10.1111/j.1748-1716.2007.01744.x; Verheyden B, 2006, EUR HEART J, V27, P191; Verheyden B, 2010, J APPL PHYSIOL, V108, P646, DOI 10.1152/japplphysiol.00883.2009; Verheyden B, 2009, RESP PHYSIOL NEUROBI, V169, pS13, DOI 10.1016/j.resp.2009.03.008; Videbaek R, 1997, J APPL PHYSIOL, V83, P1862, DOI 10.1152/jappl.1997.83.6.1862; Vorobiev D, 1995, ACTA ASTRONAUT, V36, P733, DOI 10.1016/0094-5765(95)00164-6; Waters WW, 2002, J APPL PHYSIOL, V92, P586, DOI 10.1152/japplphysiol.00544.2001; Westerhof BE, 2004, J HYPERTENS, V22, P1371, DOI 10.1097/01.hjh.0000125439.28861.ed; White RJ, 1998, J APPL PHYSIOL, V85, P738, DOI 10.1152/jappl.1998.85.2.738; White RJ, 2001, NATURE, V409, P1115, DOI 10.1038/35059243; Yang XS, 2010, AM J HYPERTENS, V23, P655, DOI 10.1038/ajh.2010.30	60	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120920	10.1371/journal.pone.0120920	http://dx.doi.org/10.1371/journal.pone.0120920			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799561	gold, Green Published, Green Submitted			2022-12-26	WOS:000351987300192
J	McAllister, SC; Schleiss, MR; Arbefeville, S; Steiner, ME; Hanson, RS; Pollock, C; Ferrieri, P				McAllister, Shane C.; Schleiss, Mark R.; Arbefeville, Sophie; Steiner, Marie E.; Hanson, Ryan S.; Pollock, Catherine; Ferrieri, Patricia			Epidemic 2014 Enterovirus D68 Cross-Reacts with Human Rhinovirus on a Respiratory Molecular Diagnostic Platform	PLOS ONE			English	Article							ILLNESS	Enterovirus D68 (EV-D68) is an emerging virus known to cause sporadic disease and occasional epidemics of severe lower respiratory tract infection. However, the true prevalence of infection with EV-D68 is unknown, due in part to the lack of a rapid and specific nucleic acid amplification test as well as the infrequency with which respiratory samples are analyzed by enterovirus surveillance programs. During the 2014 EV-D68 epidemic in the United States, we noted an increased frequency of "low-positive" results for human rhinovirus (HRV) detected in respiratory tract samples using the GenMark Diagnostics eSensor respiratory viral panel, a multiplex PCR assay able to detect 14 known respiratory viruses but not enteroviruses. We simultaneously noted markedly increased admissions to our Pediatric Intensive Care Unit for severe lower respiratory tract infections in patients both with and without a history of reactive airway disease. Accordingly, we hypothesized that these "low-positive" RVP results were due to EV-D68 rather than rhinovirus infection. Sequencing of the picornavirus 5' untranslated region (5'-UTR) of 49 samples positive for HRV by the GenMark RVP revealed that 33 (67.3%) were in fact EV-D68. Notably, the mean intensity of the HRV RVP result was significantly lower in the sequence-identified EV-D68 samples (20.3 nA) compared to HRV (129.7 nA). Using a cut-off of 40 nA for the differentiation of EV-D68 from HRV resulted in 94% sensitivity and 88% specificity. The robust diagnostic characteristics of our data suggest that the cross-reactivity of EV-D68 and HRV on the GenMark Diagnostics eSensor RVP platform may be an important factor to consider in making accurate molecular diagnosis of EV-D68 at institutions utilizing this system or other molecular respiratory platforms that may also cross-react.	[McAllister, Shane C.; Schleiss, Mark R.; Hanson, Ryan S.; Pollock, Catherine; Ferrieri, Patricia] Univ Minnesota, Sch Med, Div Pediat Infect Dis & Immunol, Minneapolis, MN 55455 USA; [McAllister, Shane C.; Schleiss, Mark R.; Hanson, Ryan S.; Pollock, Catherine] Univ Minnesota, Sch Med, Ctr Infect Dis & Microbiol Translat Res, Minneapolis, MN 55455 USA; [Arbefeville, Sophie; Ferrieri, Patricia] Univ Minnesota, Sch Med, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [Steiner, Marie E.] Univ Minnesota, Sch Med, Div Pediat Hematol & Oncol, Minneapolis, MN 55455 USA; [Steiner, Marie E.] Univ Minnesota, Sch Med, Div Pediat Crit Care, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	McAllister, SC (corresponding author), Univ Minnesota, Sch Med, Div Pediat Infect Dis & Immunol, Minneapolis, MN 55455 USA.	smcallis@umn.edu	Schleiss, Mark/ABI-8450-2020; Arbefeville, Sophie S./AAG-9460-2020	Schleiss, Mark/0000-0002-2108-9433; 	NICHD [K12 HD068322]; University of Minnesota; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD068322] Funding Source: NIH RePORTER	NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); University of Minnesota(University of Minnesota System); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was funded by the grant K12 HD068322 from NICHD and the University of Minnesota. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blomqvist S, 2002, J CLIN MICROBIOL, V40, P4218, DOI 10.1128/JCM.40.11.4218-4223.2002; de Almeida MB, 2010, EMERG INFECT DIS, V16, P996, DOI 10.3201/eid1606.100063; Ikeda T, 2012, MICROBIOL IMMUNOL, V56, P139, DOI 10.1111/j.1348-0421.2012.00411.x; Imamura T, 2014, INFLUENZA OTHER RESP, V8, P21, DOI 10.1111/irv.12206; Imamura T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074221; Imamura Tadatsugu, 2011, Morbidity and Mortality Weekly Report, V60, P1301; Jacobson LM, 2012, PEDIATR INFECT DIS J, V31, P309, DOI 10.1097/INF.0b013e3182443eaf; Jaramillo-Gutierrez G, 2013, J VIROL METHODS, V190, P53, DOI 10.1016/j.jviromet.2013.02.010; Kaida A, 2011, EMERG INFECT DIS, V17, P1494, DOI 10.3201/eid1708.110028; Khetsuriani N, 2006, MMWR SURVEILL SUMM, V55, P1, DOI DOI 10.1016/j.alit.2017.04.003; Lauinger IL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036005; Linsuwanon P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035190; Meijer A, 2012, VIROLOGY, V423, P49, DOI 10.1016/j.virol.2011.11.021; Midgley Claire M, 2014, MMWR Morb Mortal Wkly Rep, V63, P798; Oberste MS, 2004, J GEN VIROL, V85, P2577, DOI 10.1099/vir.0.79925-0; PELLETIER J, 1988, NATURE, V334, P320, DOI 10.1038/334320a0; Piralla A, 2014, J MED VIROL, V86, P1590, DOI 10.1002/jmv.23821; Rahamat-Langendoen J, 2011, J CLIN VIROL, V52, P103, DOI 10.1016/j.jcv.2011.06.019; SCHIEBLE JH, 1967, AM J EPIDEMIOL, V85, P297, DOI 10.1093/oxfordjournals.aje.a120693; Smura T, 2010, J MED VIROL, V82, P1940, DOI 10.1002/jmv.21894	20	31	31	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0118529	10.1371/journal.pone.0118529	http://dx.doi.org/10.1371/journal.pone.0118529			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799541	Green Published, Green Submitted, gold			2022-12-26	WOS:000351987300011
J	Wong, YL; Lautenschlager, I; Dombrowsky, H; Zitta, K; Bein, B; Krause, T; Goldmann, T; Frerichs, I; Steinfath, M; Weiler, N; Albrecht, M				Wong, Yuk Lung; Lautenschlaeger, Ingmar; Dombrowsky, Heike; Zitta, Karina; Bein, Berthold; Krause, Thorsten; Goldmann, Torsten; Frerichs, Inez; Steinfath, Markus; Weiler, Norbert; Albrecht, Martin			Hydroxyethyl Starch (HES 130/0.4) Impairs Intestinal Barrier Integrity and Metabolic Function: Findings from a Mouse Model of the Isolated Perfused Small Intestine	PLOS ONE			English	Article							INFLAMMATORY RESPONSE; FLUID RESUSCITATION; CAPILLARY-PERMEABILITY; VASCULAR-PERMEABILITY; PROTECTIVE ROLES; INTENSIVE-CARE; SEPSIS; RATS; ISCHEMIA; DEPOSITS	Background The application of hydroxyethyl starch (HES) for volume resuscitation is controversially discussed and clinical studies have suggested adverse effects of HES substitution, leading to increased patient mortality. Although, the intestine is of high clinical relevance and plays a crucial role in sepsis and inflammation, information about the effects of HES on intestinal function and barrier integrity is very scarce. We therefore evaluated the effects of clinically relevant concentrations of HES on intestinal function and barrier integrity employing an isolated perfused model of the mouse small intestine. Methods An isolated perfused model of the mouse small intestine was established and intestines were vascularly perfused with a modified Krebs-Henseleit buffer containing 3% Albumin (N=7) or 3% HES (130/0.4; N=7). Intestinal metabolic function (galactose uptake, lactate-topyruvate ratio), edema formation (wet-to-dry weight ratio), morphology (histological and electron microscopical analysis), fluid shifts within the vascular, lymphatic and luminal compartments, as well as endothelial and epithelial barrier permeability (FITC-dextran translocation) were evaluated in both groups. Results Compared to the Albumin group, HES perfusion did not significantly change the wet-to-dry weight ratio and lactate-to-pyruvate ratio. However, perfusing the small intestine with 3% HES resulted in a significant loss of vascular fluid (p<0.01), an increased fluid accumulation in the intestinal lumen (p<0.001), an enhanced translocation of FITC-dextran from the vascular to the luminal compartment (p<0.001) and a significantly impaired intestinal galactose uptake (p<0.001). Morphologically, these findings were associated with an aggregation of intracellular vacuoles within the intestinal epithelial cells and enlarged intercellular spaces. Conclusion A vascular perfusion with 3% HES impairs the endothelial and epithelial barrier integrity as well as metabolic function of the small intestine.	[Wong, Yuk Lung; Lautenschlaeger, Ingmar; Zitta, Karina; Bein, Berthold; Frerichs, Inez; Steinfath, Markus; Weiler, Norbert; Albrecht, Martin] Univ Med Ctr Schleswig Holstein, Dept Anesthesiol & Intens Care Med, Kiel, Germany; [Wong, Yuk Lung; Lautenschlaeger, Ingmar; Dombrowsky, Heike] Leibniz Ctr Med & Biosci, Res Ctr Borstel, Div Barrier Integr, Borstel, Germany; [Krause, Thorsten] Leibniz Ctr Med & Biosci, Res Ctr Borstel, Div Mucosal Immunol & Diagnost, Borstel, Germany; [Goldmann, Torsten] Leibniz Ctr Med & Biosci, Res Ctr Borstel, Div Clin & Expt Pathol, Borstel, Germany	University of Kiel; Schleswig Holstein University Hospital; Forschungszentrum Borstel; Forschungszentrum Borstel; Forschungszentrum Borstel	Albrecht, M (corresponding author), Univ Med Ctr Schleswig Holstein, Dept Anesthesiol & Intens Care Med, Kiel, Germany.	martin.albrecht@uksh.de	Albrecht, Martin/AAW-9303-2021; Frerichs, I./AAT-3685-2021; Goldmann, Torsten/E-5906-2010	Albrecht, Martin/0000-0003-2580-768X; Frerichs, I./0000-0002-7712-6539; Goldmann, Torsten/0000-0002-1621-560X				Blikslager AT, 2000, AM J PHYSIOL-GASTR L, V278, pG207, DOI 10.1152/ajpgi.2000.278.2.G207; BYE WA, 1984, GASTROENTEROLOGY, V86, P789; Feng XM, 2007, ANN CLIN LAB SCI, V37, P49; Feng XM, 2007, CLIN CHIM ACTA, V376, P60, DOI 10.1016/j.cca.2006.07.008; Finfer S, 2010, CRIT CARE, V14, DOI 10.1186/cc9293; Gao Xin-yue, 2006, Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, V18, P146; Haase N, 2012, CRIT CARE, V16, DOI 10.1186/cc11200; HULSTROM D, 1979, J PATHOL, V129, P125, DOI 10.1002/path.1711290304; Jacob M, 2006, ANESTHESIOLOGY, V104, P1223, DOI 10.1097/00000542-200606000-00018; Jacob M, 2009, TRANSPLANTATION, V87, P956, DOI 10.1097/TP.0b013e31819c83b5; JURECKA W, 1993, ARCH DERMATOL RES, V285, P13, DOI 10.1007/BF00370817; Kimberger O, 2009, ANESTHESIOLOGY, V110, P496, DOI 10.1097/ALN.0b013e31819841f6; Lautenschlager I, 2010, AM J PHYSIOL-GASTR L, V298, pG304, DOI 10.1152/ajpgi.00313.2009; Li XI, 2013, TRANSPL P, V45, P2491, DOI 10.1016/j.transproceed.2013.02.133; Lobo SM, 2008, BRAZ J MED BIOL RES, V41, P634, DOI 10.1590/S0100-879X2008000700014; Lv R, 2005, ANN CLIN LAB SCI, V35, P174; MCMANUS JFA, 1948, STAIN TECHNOL, V23, P99, DOI 10.3109/10520294809106232; MONCHIK GJ, 1971, SURGERY, V70, P693; Myburgh JA, 2012, NEW ENGL J MED, V367, P1901, DOI 10.1056/NEJMoa1209759; PARTH E, 1992, EUR SURG RES, V24, P13, DOI 10.1159/000129184; Perner A, 2012, NEW ENGL J MED, V367, P124, DOI 10.1056/NEJMoa1204242; Podolsky DK, 1999, AM J PHYSIOL-GASTR L, V277, pG495, DOI 10.1152/ajpgi.1999.277.3.G495; Rochwerg B, 2014, ANN INTERN MED, V161, P347, DOI 10.7326/M14-0178; Sirtl C, 1999, BRIT J ANAESTH, V82, P510, DOI 10.1093/bja/82.4.510; Stander S, 2001, CELL TISSUE RES, V304, P261, DOI 10.1007/s004410000324; Sun ZW, 1998, DIGEST SURG, V15, P386, DOI 10.1159/000018651; Sun ZW, 1997, SCAND J GASTROENTERO, V32, P995, DOI 10.3109/00365529709011216; Tian J, 2004, ANESTH ANALG, V98, P768; Wang PF, 2009, INFLAMMATION, V32, P71, DOI 10.1007/s10753-009-9105-7; Wiedermann CJ, 2014, INTENS CARE MED, V40, P160, DOI 10.1007/s00134-013-3156-9; Wright EM, 2003, BEST PRACT RES CL GA, V17, P943, DOI 10.1016/S1521-6918(03)00107-0	31	11	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121497	10.1371/journal.pone.0121497	http://dx.doi.org/10.1371/journal.pone.0121497			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799493	Green Published, gold			2022-12-26	WOS:000351987300260
J	Feldmann, EA; De Bona, P; Galletto, R				Feldmann, Erik A.; De Bona, Paolo; Galletto, Roberto			The Wrapping Loop and Rap1 C-terminal (RCT) Domain of Yeast Rap1 Modulate Access to Different DNA Binding Modes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPRESSOR ACTIVATOR PROTEIN-1; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTIONAL ACTIVATION; TELOMERE STRUCTURE; LAMM EQUATION; FACTOR TUF; SEQUENCES; INTERACTS; SILENCER; COMPLEX	Budding yeast Rap1 is a specific double-stranded DNA-binding protein involved in repression and activation of gene transcription and in the establishment of the nucleoprotein complex formed at telomeres. The DNA-binding domain (DBD) of Rap1 forms a high affinity complex with DNA where both Myb-like domains bind to the recognition site. However, we recently showed that the DBD can also access an alternative, lower affinity DNA-binding mode where a single Myb-like domain binds. This results in Rap1-DNA complexes with stoichiometry higher than previously anticipated. In this work, we show that the ability of the DBD to form higher stoichiometry complexes on DNA is maintained also in larger Rap1 constructs. This indicates that transition between at least two DNA-binding modes is a general property of the protein and not a specific feature of the DBD in isolation. The transition between binding modes is modulated by the C-terminal wrapping loop within the DBD, consistent with the proposed model in which the transient opening of this region allows a switch between binding modes. Finally, we provide evidence that the Rap1 C terminus interacts with the DNA-binding domain, suggesting a complex network of interactions that couples changes in conformation of the protein to the binding of its DNA recognition sequence.	[Feldmann, Erik A.; De Bona, Paolo; Galletto, Roberto] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA	Washington University (WUSTL)	Galletto, R (corresponding author), Washington Univ, Sch Med, Dept Biochem & Mol Biophys, 660 S Euclid Ave,Box 8231, St Louis, MO 63110 USA.	galletto@biochem.wustl.edu	Regan, Clinton/E-6250-2012	Galletto, Roberto/0000-0001-6435-122X	National Institutes of Health [GM098509]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098509] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM098509 (to R. G.).	Balbo Andrea, 2007, Curr Protoc Immunol, VChapter 18, DOI 10.1002/0471142735.im1808s79; BUCHMAN AR, 1988, MOL CELL BIOL, V8, P210, DOI 10.1128/MCB.8.1.210; CONRAD MN, 1990, CELL, V63, P739, DOI 10.1016/0092-8674(90)90140-A; Dam J, 2005, BIOPHYS J, V89, P619, DOI 10.1529/biophysj.105.059568; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; de Lange T, 2009, SCIENCE, V326, P948, DOI 10.1126/science.1170633; Feldmann EA, 2014, BIOCHEMISTRY-US, V53, P7471, DOI 10.1021/bi501049b; FREEMAN K, 1995, GENETICS, V141, P1253; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; GRAHAM IR, 1994, NUCLEIC ACIDS RES, V22, P124, DOI 10.1093/nar/22.2.124; HARDY CFJ, 1992, MOL CELL BIOL, V12, P1209, DOI 10.1128/MCB.12.3.1209; Konig P, 1996, CELL, V85, P125, DOI 10.1016/S0092-8674(00)81088-0; KURTZ S, 1991, GENE DEV, V5, P616, DOI 10.1101/gad.5.4.616; KYRION G, 1993, GENE DEV, V7, P1146, DOI 10.1101/gad.7.7a.1146; KYRION G, 1992, MOL CELL BIOL, V12, P5159, DOI 10.1128/MCB.12.11.5159; Lieb JD, 2001, NAT GENET, V28, P327, DOI 10.1038/ng569; Lopez MC, 1998, P NATL ACAD SCI USA, V95, P14112, DOI 10.1073/pnas.95.24.14112; LUSTIG AJ, 1990, SCIENCE, V250, P549, DOI 10.1126/science.2237406; Matot B, 2012, NUCLEIC ACIDS RES, V40, P3197, DOI 10.1093/nar/gkr1166; Mizuno T, 2004, YEAST, V21, P851, DOI 10.1002/yea.1123; Moretti P, 2001, MOL CELL BIOL, V21, P8082, DOI 10.1128/MCB.21.23.8082-8094.2001; MORETTI P, 1994, GENE DEV, V8, P2257, DOI 10.1101/gad.8.19.2257; Morse RH, 2000, TRENDS GENET, V16, P51, DOI 10.1016/S0168-9525(99)01936-8; Mukherjee S, 2004, NAT GENET, V36, P1331, DOI 10.1038/ng1473; MULLER T, 1994, J STRUCT BIOL, V113, P1, DOI 10.1006/jsbi.1994.1027; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; PALLADINO F, 1993, CELL, V75, P543, DOI 10.1016/0092-8674(93)90388-7; Schuck P, 1998, BIOPHYS J, V75, P1503, DOI 10.1016/S0006-3495(98)74069-X; Schuck P, 2003, ANAL BIOCHEM, V320, P104, DOI 10.1016/S0003-2697(03)00289-6; SHORE D, 1987, CELL, V51, P721, DOI 10.1016/0092-8674(87)90095-X; Taylor HOB, 2000, J MOL BIOL, V303, P693, DOI 10.1006/jmbi.2000.4161; VIGNAIS ML, 1990, J BIOL CHEM, V265, P14669; VIGNAIS ML, 1989, J BIOL CHEM, V264, P8463; Wahlin J, 2000, NUCLEIC ACIDS RES, V28, P2292, DOI 10.1093/nar/28.12.2292; WANG SS, 1990, MOL CELL BIOL, V10, P4415, DOI 10.1128/MCB.10.8.4415; Wotton D, 1997, GENE DEV, V11, P748, DOI 10.1101/gad.11.6.748; WRIGHT JH, 1995, NUCLEIC ACIDS RES, V23, P1454, DOI 10.1093/nar/23.9.1454	38	10	10	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2015	290	18					11455	11466		10.1074/jbc.M115.637678	http://dx.doi.org/10.1074/jbc.M115.637678			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH0OA	25805496	hybrid, Green Published			2022-12-26	WOS:000353719400022
J	Aerts, L; Cavanagh, MH; Dubois, J; Carbonneau, J; Rheaume, C; Lavigne, S; Couture, C; Hamelin, ME; Boivin, G				Aerts, Laetitia; Cavanagh, Marie-Helene; Dubois, Julia; Carbonneau, Julie; Rheaume, Chantal; Lavigne, Sophie; Couture, Christian; Hamelin, Marie-Eve; Boivin, Guy			Effect of In Vitro Syncytium Formation on the Severity of Human Metapneumovirus Disease in a Murine Model	PLOS ONE			English	Article							HUMAN KIDNEY-CELLS; MEMBRANE-FUSION; YOUNG-CHILDREN; F-PROTEIN; MOLECULAR CHARACTERIZATION; GENETIC-VARIABILITY; BALB/C MICE; LOW-PH; VIRUS; INFECTION	Human metapneumovirus (HMPV) is an important cause of acute respiratory tract infections (ARTI) in children, elderly individuals and immunocompromised patients. In vitro, different HMPV strains can induce variable cytopathic effects ranging from large multinucleated syncytia to focal cell rounding. In this study, we investigated the impact of different in vitro phenotypes of two HMPV strains on viral replication and disease severity in a BALB/c mouse model. We first generated two recombinant GFP-expressing HMPV viruses: C-85473, a syncytium-inducing strain (rC-85473) belonging to the A1 subtype and CAN98-75, a focal cell rounding-inducing strain (rCAN98-75) of the B2 subtype. We subsequently exchanged the F genes of both strains to create the chimeric viruses rC-85473_F and rCAN98-75_F. We demonstrated that the F protein was the sole protein responsible for the syncytium phenotype and that viruses carrying a syncytium-inducing F protein replicated to significantly higher titers in vitro. In vivo, however, the virulence and replicative capacity of the different HMPV strains did not appear to be solely dependent on the F gene but also on the viral background, with the strains containing the C-85473 background inducing more weight loss as well as increased lung viral titers, pro-inflammatory cytokines and inflammation than strains containing the CAN98-75 background. In conclusion, the F protein is the main determinant of syncytium formation and replication kinetics in vitro, although it is not the only factor implicated in HMPV disease severity in mice.	[Aerts, Laetitia; Cavanagh, Marie-Helene; Dubois, Julia; Carbonneau, Julie; Rheaume, Chantal; Hamelin, Marie-Eve; Boivin, Guy] Ctr Hosp Univ Quebec, Ctr Rech Infectiol, Quebec City, PQ, Canada; [Aerts, Laetitia; Cavanagh, Marie-Helene; Dubois, Julia; Carbonneau, Julie; Rheaume, Chantal; Lavigne, Sophie; Couture, Christian; Hamelin, Marie-Eve; Boivin, Guy] Univ Laval, Quebec City, PQ, Canada; [Lavigne, Sophie; Couture, Christian] Inst Univ Cardiol & Pneumol Quebec, Anatomopathol Cytol, Quebec City, PQ, Canada	Laval University; Laval University	Boivin, G (corresponding author), Ctr Hosp Univ Quebec, Ctr Rech Infectiol, Quebec City, PQ, Canada.	Guy.Boivin@crchul.ulaval.ca	Dubois, Julia/AAH-5914-2019	Dubois, Julia/0000-0002-9777-2968; Hamelin, Marie-Eve/0000-0002-7568-5097; Boivin, Guy/0000-0003-3027-4662	Canadian Institutes of Health Research [273261]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by a grant from the Canadian Institutes of Health Research to GB (273261). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agapov E, 2006, J INFECT DIS, V193, P396, DOI 10.1086/499310; Bao XY, 2008, J VIROL, V82, P8224, DOI 10.1128/JVI.02584-07; Bao XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062568; Bao XY, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000077; Chang A, 2012, J VIROL, V86, P9843, DOI 10.1128/JVI.00639-12; Chang A, 2012, VIRUSES-BASEL, V4, P613, DOI 10.3390/v4040613; Cox RG, 2013, VIRUSES-BASEL, V5, P192, DOI 10.3390/v5010192; de Graaf M, 2007, J VIROL METHODS, V143, P169, DOI 10.1016/j.jviromet.2007.03.005; Deffrasnes C, 2008, ANTIMICROB AGENTS CH, V52, P279, DOI 10.1128/AAC.00793-07; Fang Y, 2011, J VIROL METHODS, V173, P251, DOI 10.1016/j.jviromet.2011.02.013; Feuillet F, 2012, J CLIN VIROL, V53, P97, DOI 10.1016/j.jcv.2011.10.002; Fonteh PN, 2011, J INORG BIOCHEM, V105, P1173, DOI 10.1016/j.jinorgbio.2011.05.011; Goutagny N, 2010, J IMMUNOL, V184, P1168, DOI 10.4049/jimmunol.0902750; Hamelin ME, 2006, J INFECT DIS, V193, P1634, DOI 10.1086/504262; Hamelin ME, 2005, J VIROL, V79, P8894, DOI 10.1128/JVI.79.14.8894-8903.2005; Herd KA, 2010, J GEN VIROL, V91, P1302, DOI 10.1099/vir.0.015396-0; Herfst S, 2004, J VIROL, V78, P8264, DOI 10.1128/JVI.78.15.8264-8270.2004; Herfst S, 2008, J VIROL, V82, P8891, DOI 10.1128/JVI.00472-08; Huck B, 2006, EMERG INFECT DIS, V12, P147, DOI 10.3201/eid1201.050772; Huck B, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-6; Kahn JS, 2006, CLIN MICROBIOL REV, V19, P546, DOI 10.1128/CMR.00014-06; Karron RA, 1997, P NATL ACAD SCI USA, V94, P13961, DOI 10.1073/pnas.94.25.13961; Kolli D, 2011, J IMMUNOL, V187, P47, DOI 10.4049/jimmunol.1002589; Lamb RA, 2007, CURR OPIN STRUC BIOL, V17, P427, DOI 10.1016/j.sbi.2007.08.016; Mas V, 2011, J VIROL, V85, P12650, DOI 10.1128/JVI.05485-11; Papenburg J, 2013, J CLIN VIROL, V58, P541, DOI 10.1016/j.jcv.2013.08.029; Papenburg J, 2012, J INFECT DIS, V206, P178, DOI 10.1093/infdis/jis333; Papenburg J, 2010, REV MED VIROL, V20, P245, DOI 10.1002/rmv.651; Pitoiset C, 2010, J MED VIROL, V82, P1782, DOI 10.1002/jmv.21884; Ren JP, 2012, J VIROL, V86, P13049, DOI 10.1128/JVI.01248-12; Roussy JF, 2014, J CLIN VIROL, V60, P133, DOI 10.1016/j.jcv.2014.03.001; Schowalter RM, 2006, J VIROL, V80, P10931, DOI 10.1128/JVI.01287-06; Sharma BN, 2014, ANTIMICROB AGENTS CH, V58, P279, DOI 10.1128/AAC.01800-13; Sharma BN, 2011, ANTIVIR RES, V92, P115, DOI 10.1016/j.antiviral.2011.07.012; Sloots TP, 2006, EMERG INFECT DIS, V12, P1263, DOI 10.3201/eid1708.051239; Tian D., 2012, PLOS ONE, V7, DOI DOI 10.1371/JOURNAL.PONE.0031965; van den Hoogen BG, 2014, J GEN VIROL, V95, P1625, DOI 10.1099/vir.0.066100-0; van den Hoogen BG, 2004, EMERG INFECT DIS, V10, P658, DOI 10.3201/eid1004.030393; Vicente D, 2006, CLIN INFECT DIS, V42, pE111, DOI 10.1086/504378; Xiao NG, 2010, PEDIATR INFECT DIS J, V29, P131, DOI 10.1097/INF.0b013e3181b56009	40	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0120283	10.1371/journal.pone.0120283	http://dx.doi.org/10.1371/journal.pone.0120283			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803584	Green Submitted, Green Published, gold			2022-12-26	WOS:000353889600065
J	Asciutto, G; Dias, NV; Edsfeldt, A; Nitulescu, M; Persson, A; Nilsson, M; Duner, P; Nilsson, J; Goncalves, I				Asciutto, Giuseppe; Dias, Nuno V.; Edsfeldt, Andreas; Nitulescu, Mihaela; Persson, Ana; Nilsson, Marie; Duner, Pontus; Nilsson, Jan; Goncalves, Isabel			Low Elastin Content of Carotid Plaques Is Associated with Increased Risk of Ipsilateral Stroke	PLOS ONE			English	Article							MUSCLE-CELL PROLIFERATION; MATRIX METALLOPROTEINASES; ENDARTERECTOMY; ARTERIES; STABILITY; MIGRATION; STENOSIS; DEATH; AGE	Objectives Atherosclerotic plaques with a low content of connective tissue proteins are believed to have an increased risk of rupture and to give rise to clinical events. The aim of the present study was to investigate if the content of elastin, collagen and of the matrix metalloproteinase (MMP) -1, -3, -9 and -12 in plaques removed at surgery can be associated with the occurrence of ipsilateral symptoms. Methods The atherosclerotic plaques of 221 patients undergoing carotid endarterectomy were analyzed and their composition was related to the incidence of preoperative, intraoperative and postoperative neurological events. Results Elastin, collagen and MMP-12 contents were lower in males and diabetic patients. Elastin (P .010), MMP-3 (P .008) and MMP-9 (P < .0001) were lower, while MMP-1 (P .004) and MMP-9 (P .002) were higher in plaques of patients with preoperative symptoms, even after correction for the time between the occurrence of symptoms and surgery. Elastin and MMP-12 decreased (r = -0.17, P .009 and r = -.288, P <.0001 respectively) while MMP-1 (r = 0.17, P .012) and MMP-9 (r = .21 P <.0001) increased with age. After a mean follow-up time of 39.6 +/- 16.6 months, 7.7% of patients had suffered one or multiple ipsilateral neurological events. Patients with plaque elastin levels lower than the median (52 mg/g) had increased post-operative incidence of ipsilateral stroke (P for trend 0.009 using Log Rank Chi-square test). This finding was confirmed when controlling for age, gender, hypertension, diabetes, smoking, pre-operative symptoms and statin usage in a Cox Proportional Hazard model (hazard ratio 7.38, 95% C.I. 1.50-36.31). Conclusions These observations support the concept that elastin may be important for plaque stability, and suggest that a low plaque content of elastin is associated with a higher risk for ipsilateral stroke.	[Asciutto, Giuseppe; Dias, Nuno V.] Skane Univ Hosp, Vasc Ctr Malmo Lund, Malmo, Sweden; [Edsfeldt, Andreas; Nitulescu, Mihaela; Persson, Ana; Nilsson, Marie; Duner, Pontus; Nilsson, Jan; Goncalves, Isabel] Lund Univ, Clin Res Ctr, Dept Clin Sci Malmo, Expt Cardiovasc Res Unit, Malmo, Sweden; [Edsfeldt, Andreas; Persson, Ana; Nilsson, Marie; Goncalves, Isabel] Skane Univ Hosp, Dept Cardiol, Malmo, Sweden	Lund University; Skane University Hospital; Lund University; Lund University; Skane University Hospital	Asciutto, G (corresponding author), Skane Univ Hosp, Vasc Ctr Malmo Lund, Malmo, Sweden.	giuseppe.asciutto@med.lu.se	Goncalves, Isabel/AAD-4654-2022; Goncalves, Isabel/AAC-6632-2022	Goncalves, Isabel/0000-0002-2935-0181; Duner, Pontus/0000-0003-4171-5646; Dias, Nuno/0000-0002-6907-6148	Swedish Research Council [2010-2932]; Marianne and Marcus Wallenberg Foundation (MMW) [2010.0040]; Swedish Heart and Lung Foundation [20110355]; Swedish Foundation for Strategic Research [RBa08-0075]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Marianne and Marcus Wallenberg Foundation (MMW); Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research)	This work was supported by the Swedish Research Council (JN, IG) (2010-2932 http://www.vr.se/), the Marianne and Marcus Wallenberg Foundation (JN, IG) (MMW 2010.0040 https://www.wallenberg.com/mmw/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.-The Swedish Heart and Lung Foundation (JN, IG) 20110355 http://hjart-lungfonden.se/-The Swedish Foundation for Strategic Research (JN) RBa08-0075 http://www.stratresearch.se/	Asciutto G, 2012, INT ANGIOL, V31, P361; Bond M, 2006, CARDIOVASC RES, V69, P198, DOI 10.1016/j.cardiores.2005.08.020; de Borst GJ, 2007, EUR J VASC ENDOVASC, V33, P657, DOI 10.1016/j.ejvs.2007.01.010; Edsfeldt A, 2014, ARTERIOSCL THROM VAS, V34, P2143, DOI 10.1161/ATVBAHA.114.303414; Endarterectomy for asymptomatic carotid artery stenosis, 1995, JAMA J AM MED ASS, V273, P1421; Farrell B, 1998, LANCET, V351, P1379, DOI 10.1016/s0140-6736(97)09292-1; Goncalves I, 2004, STROKE, V35, P2795, DOI 10.1161/01.STR.0000147038.12073.59; Goncalves I, 2003, STROKE, V34, P616, DOI 10.1161/01.STR.0000058157.69113.F6; Greenwald SE, 2007, J PATHOL, V211, P157, DOI 10.1002/path.2101; Grujic Vera, 2005, Med Pregl, V58, P292, DOI 10.2298/MPNS0506292G; Hansen F, 1996, EUR J VASC ENDOVASC, V12, P331, DOI 10.1016/S1078-5884(96)80252-8; Hellings WE, 2007, J VASC SURG, V46, P1147, DOI 10.1016/j.jvs.2007.08.018; Hellings WE, 2007, J VASC SURG, V45, P289, DOI 10.1016/j.jvs.2006.09.051; Johnson JL, 2005, P NATL ACAD SCI USA, V102, P15575, DOI 10.1073/pnas.0506201102; Johnson TW, 2005, ARTERIOSCL THROM VAS, V25, P754, DOI 10.1161/01.ATV.0000157582.33180.a9; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; McEniery CM, 2007, CLIN EXP PHARMACOL P, V34, P665, DOI 10.1111/j.1440-1681.2007.04657.x; Newby AC, 2006, CARDIOVASC RES, V69, P614, DOI 10.1016/j.cardiores.2005.08.002; Newby AC, 2005, CIRC RES, V97, P958, DOI 10.1161/01.RES.0000193565.23357.c0; Newby AC, 2005, CARDIOVASC RES, V67, P4, DOI 10.1016/j.cardiores.2005.04.024; Niciforovic-Surkovic Olja, 2005, Med Pregl, V58, P52, DOI 10.2298/MPNS0502052N; North American Symptomatic Carotid Endarterectomy Trial (NASCET) Investigators, 1991, STROKE A JOURNAL OF, V22, P816; Payne RA, 2010, HYPERTENSION, V55, P9, DOI 10.1161/HYPERTENSIONAHA.107.090464; Peeters W, 2009, ARTERIOSCL THROM VAS, V29, P128, DOI 10.1161/ATVBAHA.108.173658; Rattik S, 2014, ARTERIOSCLER THROMB; Sala-Newby GB, 2005, FEBS LETT, V579, P6493, DOI 10.1016/j.febslet.2005.10.026; Traylor M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004469; Vitale C, 2009, NAT REV CARDIOL, V6, P532, DOI 10.1038/nrcardio.2009.105	28	11	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0121086	10.1371/journal.pone.0121086	http://dx.doi.org/10.1371/journal.pone.0121086			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803692	Green Published, Green Submitted, gold			2022-12-26	WOS:000353889600122
J	Graham, SF; Chevallier, OP; Elliott, CT; Holscher, C; Johnston, J; McGuinness, B; Kehoe, PG; Passmore, AP; Green, BD				Graham, Stewart F.; Chevallier, Olivier P.; Elliott, Christopher T.; Hoelscher, Christian; Johnston, Janet; McGuinness, Bernadette; Kehoe, Patrick G.; Passmore, Anthony Peter; Green, Brian D.			Untargeted Metabolomic Analysis of Human Plasma Indicates Differentially Affected Polyamine and L-Arginine Metabolism in Mild Cognitive Impairment Subjects Converting to Alzheimer's Disease	PLOS ONE			English	Article							MOUSE MODEL; DEMENTIA; PROGRESSION; DEPOSITION; DIAGNOSIS; ARGINASE; DEFICITS; HEALTH; TISSUE; URINE	This study combined high resolution mass spectrometry (HRMS), advanced chemometrics and pathway enrichment analysis to analyse the blood metabolome of patients attending the memory clinic: cases of mild cognitive impairment (MCI; n = 16), cases of MCI who upon subsequent follow-up developed Alzheimer's disease (MCI_AD; n = 19), and healthy agematched controls (Ctrl; n = 37). Plasma was extracted in acetonitrile and applied to an Acquity UPLC HILIC (1.7 mu m x 2.1 x 100 mm) column coupled to a Xevo G2 QT of mass spectrometer using a previously optimised method. Data comprising 6751 spectral features were used to build an OPLS-DA statistical model capable of accurately distinguishing Ctrl, MCI and MCI_AD. The model accurately distinguished (R2 = 99.1%; Q2 = 97%) those MCI patients who later went on to develop AD. S-plots were used to shortlist ions of interest which were responsible for explaining the maximum amount of variation between patient groups. Metabolite database searching and pathway enrichment analysis indicated disturbances in 22 biochemical pathways, and excitingly it discovered two interlinked areas of metabolism (polyamine metabolism and L-Arginine metabolism) were differentially disrupted in this well-defined clinical cohort. The optimised untargeted HRMS methods described herein not only demonstrate that it is possible to distinguish these pathologies in human blood but also that MCI patients 'at risk' from AD could be predicted up to 2 years earlier than conventional clinical diagnosis. Blood-based metabolite profiling of plasma from memory clinic patients is a novel and feasible approach in improving MCI and AD diagnosis and, refining clinical trials through better patient stratification.	[Graham, Stewart F.; Chevallier, Olivier P.; Elliott, Christopher T.; Green, Brian D.] Queens Univ Belfast, Inst Global Food Secur, Adv Asset Technol Ctr, Belfast BT9 5AG, Antrim, North Ireland; [Graham, Stewart F.] William Beaumont Res Inst, Royal Oak, MI 48073 USA; [Hoelscher, Christian] Univ Lancaster, Div Biomed Sci & Life Sci, Lancaster LA1 4YG, England; [Johnston, Janet; McGuinness, Bernadette; Passmore, Anthony Peter] Queens Univ Belfast, Ctr Publ Hlth, Ageing Grp, Belfast BT12 6BA, Antrim, North Ireland; [Kehoe, Patrick G.] Univ Bristol, Frenchay Hosp, Sch Clin Sci, Dementia Res Grp,Inst Clin Neurosci, Bristol BS16 1LE, Avon, England	Queens University Belfast; Lancaster University; Queens University Belfast; University of Bristol	Graham, SF (corresponding author), Queens Univ Belfast, Inst Global Food Secur, Adv Asset Technol Ctr, Stranmillis Rd, Belfast BT9 5AG, Antrim, North Ireland.	stewart.graham@beaumont.edu	Chevallier, Olivier P/I-6550-2015; Graham, Stewart/AAE-9772-2020; McGuinness, Bernadette/AAH-2755-2021; Kehoe, Patrick/P-8760-2018	Chevallier, Olivier P/0000-0002-3786-4318; McGuinness, Bernadette/0000-0002-7028-5633; Kehoe, Patrick/0000-0002-7542-1139; Graham, Stewart/0000-0003-1001-0002; Holscher, Christian/0000-0002-8159-3260	Alzheimer's Research, UK [ARUK-NCH2012B-5, ARUK-PPG2011B-8, ARUK-Network2012-11]; Invest Northern Ireland [INI-PoC406]; European Regional Development Fund (ERDF); Alzheimers Research UK [ARUK-NCG2012B-5] Funding Source: researchfish	Alzheimer's Research, UK(Alzheimer's Research UK (ARUK)); Invest Northern Ireland; European Regional Development Fund (ERDF)(European Commission); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK))	Metabolomics studies into Alzheimer's disease are supported by grants from Alzheimer's Research, UK [ARUK-NCH2012B-5; grant ARUK-PPG2011B-8 and ARUK-Network2012-11] (SG CH BMG PK APP BG), and by Proof of Concept grant from Invest Northern Ireland [INI-PoC406] (SG APP BG). The authors also gratefully acknowledge assistance from the European Regional Development Fund (ERDF) supporting the Advanced ASSET Centre, (CE BG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker-Catania SG, 2006, J NEUROSCI RES, V84, P735, DOI 10.1002/jnr.20964; Beckonert O, 2007, NAT PROTOC, V2, P2692, DOI 10.1038/nprot.2007.376; Brandt J, 2009, NEUROPSYCHOLOGY, V23, P607, DOI 10.1037/a0015851; Crane PK, 2013, NEW ENGL J MED, V369, P540, DOI [10.1056/NEJMoa1215740, 10.1056/NEJMc1311765]; Dubois B, 2007, LANCET NEUROL, V6, P734, DOI 10.1016/S1474-4422(07)70178-3; Esch F, 1998, J NEUROSCI, V18, P4083; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gamba P, 2012, ANN NY ACAD SCI, V1259, P54, DOI 10.1111/j.1749-6632.2012.06513.x; Graham SF, 2013, METABOLOMICS, V9, P974, DOI 10.1007/s11306-013-0516-y; Graham SF, 2013, ANAL CHEM, V85, P1803, DOI 10.1021/ac303163f; Ibanez C, 2013, J CHROMATOGR A, V1302, P65, DOI 10.1016/j.chroma.2013.06.005; Inoue K, 2013, SCI REP-UK, V3, DOI 10.1038/srep02364; Jones L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013950; Kaddurah-Daouk R, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.18; Kloppenborg RP, 2008, EUR J PHARMACOL, V585, P97, DOI 10.1016/j.ejphar.2008.02.049; Knight WD, 2011, BRAIN, V134, P293, DOI 10.1093/brain/awq310; Lalande J, 2014, J ALZHEIMERS DIS, V39, P121, DOI 10.3233/JAD-130023; Leoutsakos JMS, 2012, INT J GERIATR PSYCH, V27, P364, DOI 10.1002/gps.2723; Li L, 2007, BRAIN RES REV, V56, P384, DOI 10.1016/j.brainresrev.2007.09.001; Lopez OL, 2007, ARCH NEUROL-CHICAGO, V64, P416, DOI 10.1001/archneur.64.3.416; LOWE SL, 1988, BRAIN, V111, P785, DOI 10.1093/brain/111.4.785; Makitie LT, 2010, BRAIN PATHOL, V20, P571, DOI 10.1111/j.1750-3639.2009.00334.x; Maxwell AJ, 2000, CARDIOVASC DRUG THER, V14, P309, DOI 10.1023/A:1007886725480; McGeer PL, 1996, NEUROLOGY, V47, P425, DOI 10.1212/WNL.47.2.425; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Melnikova T, 2006, NEUROSCIENCE, V141, P1149, DOI 10.1016/j.neuroscience.2006.05.001; Mioshi E, 2006, INT J GERIATR PSYCH, V21, P1078, DOI 10.1002/gps.1610; Mitchell AJ, 2009, ACTA PSYCHIAT SCAND, V119, P252, DOI 10.1111/j.1600-0447.2008.01326.x; Monge-Argiles JA, 2011, NEUROCHEM RES, V36, P986, DOI 10.1007/s11064-011-0438-x; Motsinger-Reif AA, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-28; Nordlund A, 2010, J NEUROL NEUROSUR PS, V81, P541, DOI 10.1136/jnnp.2008.171066; Oresic M, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.55; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; ROSSOR MN, 1982, BRAIN, V105, P313, DOI 10.1093/brain/105.2.313; Salek RM, 2010, NEUROCHEM INT, V56, P937, DOI 10.1016/j.neuint.2010.04.001; Summers MJ, 2012, NEUROPSYCHOLOGY, V26, P498, DOI 10.1037/a0028576; Trushina E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063644; Tsang TM, 2009, NEUROCHEM RES, V34, P1261, DOI 10.1007/s11064-008-9904-5; Vural H, 2009, BIOL TRACE ELEM RES, V129, P58, DOI 10.1007/s12011-008-8291-8; Wallace HM, 2003, BIOCHEM J, V376, P1, DOI 10.1042/BJ20031327; Want EJ, 2010, NAT PROTOC, V5, P1005, DOI 10.1038/nprot.2010.50; Winblad B, 2004, J INTERN MED, V256, P240, DOI 10.1111/j.1365-2796.2004.01380.x; Xiang ZM, 2002, GENE EXPRESSION, V10, P271, DOI 10.3727/000000002783992352; Yatin SM, 1999, NEUROBIOL AGING, V20, P325; Yatin SM, 2001, J NEUROSCI RES, V63, P395, DOI 10.1002/1097-4547(20010301)63:5<395::AID-JNR1034>3.0.CO;2-Q; Zhang AH, 2014, MOL BIOSYST, V10, P2160, DOI 10.1039/c4mb00222a	47	112	115	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0119452	10.1371/journal.pone.0119452	http://dx.doi.org/10.1371/journal.pone.0119452			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH2XV	25803028	gold, Green Published, Green Submitted			2022-12-26	WOS:000353889600027
J	Petrov, P; Syrjanen, R; Smith, J; Gutowska, MW; Uchida, T; Vainio, O; Burt, DW				Petrov, Petar; Syrjanen, Riikka; Smith, Jacqueline; Gutowska, Maria Weronika; Uchida, Tatsuya; Vainio, Olli; Burt, David W.			Characterization of the Avian Trojan Gene Family Reveals Contrasting Evolutionary Constraints	PLOS ONE			English	Article							POSITIVE DARWINIAN SELECTION; SEQUENCE ALIGNMENT EDITOR; MAXIMUM-LIKELIHOOD; PROTEIN; CONVERSION; COMPLEX; RECEPTOR; SYSTEM; INTERLEUKIN-2; COEVOLUTION	"Trojan" is a leukocyte-specific, cell surface protein originally identified in the chicken. Its molecular function has been hypothesized to be related to anti-apoptosis and the proliferation of immune cells. The Trojan gene has been localized onto the Z sex chromosome. The adjacent two genes also show significant homology to Trojan, suggesting the existence of a novel gene/protein family. Here, we characterize this Trojan family, identify homologues in other species and predict evolutionary constraints on these genes. The two Trojan-related proteins in chicken were predicted as a receptor-type tyrosine phosphatase and a transmembrane protein, bearing a cytoplasmic immuno-receptor tyrosine-based activation motif. We identified the Trojan gene family in ten other bird species and found related genes in three reptiles and a fish species. The phylogenetic analysis of the homologues revealed a gradual diversification among the family members. Evolutionary analyzes of the avian genes predicted that the extracellular regions of the proteins have been subjected to positive selection. Such selection was possibly a response to evolving interacting partners or to pathogen challenges. We also observed an almost complete lack of intracellular positively selected sites, suggesting a conserved signaling mechanism of the molecules. Therefore, the contrasting patterns of selection likely correlate with the interaction and signaling potential of the molecules.	[Petrov, Petar; Syrjanen, Riikka; Uchida, Tatsuya; Vainio, Olli] Univ Oulu, Inst Diagnost, Dept Med Microbiol & Immunol, Oulu, Finland; [Petrov, Petar; Syrjanen, Riikka; Vainio, Olli] Oulu Univ Hosp, Nordlab Oulu, Oulu, Finland; [Petrov, Petar; Syrjanen, Riikka; Uchida, Tatsuya; Vainio, Olli] Oulu Univ Hosp, Med Res Ctr Oulu, Oulu, Finland; [Petrov, Petar; Syrjanen, Riikka; Uchida, Tatsuya; Vainio, Olli] Univ Oulu, Oulu, Finland; [Smith, Jacqueline; Gutowska, Maria Weronika; Burt, David W.] Univ Edinburgh, Div Genet & Genom, Roslin Inst, Roslin, Midlothian, Scotland; [Smith, Jacqueline; Gutowska, Maria Weronika; Burt, David W.] Univ Edinburgh, R D SVS, Roslin, Midlothian, Scotland	University of Oulu; University of Oulu; University of Oulu; University of Oulu; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh	Petrov, P (corresponding author), Univ Oulu, Inst Diagnost, Dept Med Microbiol & Immunol, Oulu, Finland.	petar.petrov@oulu.fi; dave.burt@roslin.ed.ac.uk	Petrov, Petar/D-8067-2019; Petrov, Petar/AAN-3817-2021; Burt, David W/C-7802-2013; Smith, Jacqueline/C-7719-2013	Petrov, Petar/0000-0001-5551-8032; Burt, David W/0000-0002-9991-1028; Smith, Jacqueline/0000-0002-2813-7872	Finnish Cultural Foundation; Central Fund [00110693]; Oulu University Hospital [K32737]; Biotechnology and Biological Sciences Research Council [1064919] Funding Source: researchfish	Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Central Fund; Oulu University Hospital; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Finnish Cultural Foundation (https://www.skr.fi/en), Central Fund (grant number 00110693); and Oulu University Hospital (http://www.ppshp.fi/) (VTR funding, project number K32737). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amemiya CT, 2013, NATURE, V496, P311, DOI 10.1038/nature12027; Bezbradica JS, 2012, CURR OPIN IMMUNOL, V24, P58, DOI 10.1016/j.coi.2011.12.010; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Bond CS, 2009, ACTA CRYSTALLOGR D, V65, P510, DOI 10.1107/S0907444909007835; Brown C, 2002, EMBED SYST PROGRAM, V15, P55; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Dinkel H, 2014, NUCLEIC ACIDS RES, V42, pD259, DOI 10.1093/nar/gkt1047; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Fares MA, 2006, BIOINFORMATICS, V22, P2821, DOI 10.1093/bioinformatics/btl493; Filip LC, 2004, MOL BIOL EVOL, V21, P1504, DOI 10.1093/molbev/msh111; Fornuskova A, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-194; Gloor GB, 2005, BIOCHEMISTRY-US, V44, P7156, DOI 10.1021/bi050293e; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Gremme G, 2013, IEEE ACM T COMPUT BI, V10, P645, DOI 10.1109/TCBB.2013.68; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Huang YH, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-149; Hughes A. L., 1998, FRONT BIOSCI, V3, P509; HUGHES AL, 1988, NATURE, V335, P167, DOI 10.1038/335167a0; Hughes AL, 1998, ANNU REV GENET, V32, P415, DOI 10.1146/annurev.genet.32.1.415; Jarvis ED, SCIENCE IN PRESS; Jiggins FM, 2007, J EVOLUTION BIOL, V20, P965, DOI 10.1111/j.1420-9101.2007.01305.x; Kunstman KJ, 2003, J VIROL, V77, P12310, DOI 10.1128/JVI.77.22.12310-12318.2003; Medzhitov R, 1998, SEMIN IMMUNOL, V10, P351, DOI 10.1006/smim.1998.0136; Medzhitov R, 1998, CURR OPIN IMMUNOL, V10, P12, DOI 10.1016/S0952-7915(98)80024-1; Meszaros B, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000376; Minezaki Y, 2007, J MOL BIOL, V368, P902, DOI 10.1016/j.jmb.2007.02.033; O'Connell MJ, 2005, J MOL EVOL, V61, P608, DOI 10.1007/s00239-004-0313-3; Okonechnikov K, 2012, BIOINFORMATICS, V28, P1166, DOI 10.1093/bioinformatics/bts091; Ortiz M, 2009, MOL BIOL EVOL, V26, P2865, DOI 10.1093/molbev/msp197; Petrov P, 2010, MOL IMMUNOL, V47, P1522, DOI 10.1016/j.molimm.2010.01.017; Prugnolle F, 2005, CURR BIOL, V15, P1022, DOI 10.1016/j.cub.2005.04.050; SAWYER S, 1989, MOL BIOL EVOL, V6, P526; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shields DC, 2000, GENE, V246, P239, DOI 10.1016/S0378-1119(00)00072-X; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sigalov A, 2004, BIOCHEMISTRY-US, V43, P2049, DOI 10.1021/bi035900h; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; TANAKA T, 1989, MOL BIOL EVOL, V6, P447; Travers SAA, 2007, MOL BIOL EVOL, V24, P1032, DOI 10.1093/molbev/msm022; Vamathevan JJ, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-273; Wang XQ, 2005, SCIENCE, V310, P1159, DOI 10.1126/science.1117893; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zelus D, 2000, J MOL EVOL, V51, P234, DOI 10.1007/s002390010085	44	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0121672	10.1371/journal.pone.0121672	http://dx.doi.org/10.1371/journal.pone.0121672			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803627	Green Published, gold, Green Submitted			2022-12-26	WOS:000353889600170
J	Rodriguez-Garcia, J; Gamino-Iriarte, A; Rodea-Montero, ER				Rodriguez-Garcia, Judith; Gamino-Iriarte, Astrid; Rafael Rodea-Montero, Edel			Nutritional Status and Nosocomial Infections among Adult Elective Surgery Patients in a Mexican Tertiary Care Hospital	PLOS ONE			English	Article							BODY-MASS-INDEX; LENGTH-OF-STAY; SURGICAL-PATIENTS; OBESITY PARADOX; ADVERSE EVENTS; COMPLICATIONS; ACCUMULATION; PREDICTORS; OUTCOMES; IMPACT	Background Controversy exists as to whether obesity constitutes a risk-factor or a protective-factor for the development of nosocomial Infection (NI). According to the obesity-paradox, there is evidence that moderate obesity is a protective-factor. In Mexico few studies have focused on the nutritional status (NS) distribution in the hospital setting. Objectives The aim of this study was to estimate the distribution of NS and the prevalence of nosocomial infection NI among adult elective surgery (ES) patients and to compare the clinical and anthropometric characteristics and length of stays (LOS) between obese and non-obese patients and between patients with and without NI. Methods We conducted a cross-sectional study with a sample (n = 82) adult ES patients (21-59 years old) who were recruited from a tertiary-care hospital. The prevalences of each NS category and NI were estimated, the assessments were compared between groups (Mann-Whitney, Chi-squared or the Fisher's-exact-test), and the association between preoperative risk-factors and NI was evaluated using odds ratios. Results The distribution of subjects by NS category was: underweight (3.66%), normal-weight (28.05%), overweight (35.36%), and obese (32.93%). The prevalence of NI was 14.63%. The LOS was longer (p<0.001) for the patients who developed NI. The percentages of NI were: 33.3% in underweight, 18.52% in obese, 17.39% in normal-weight, and 6.90% in overweight patients. Conclusion The prevalence of overweight and obesity in adult ES patients is high. The highest prevalence of NI occurred in the underweight and obese patients. The presence of NI considerably increased the LOS, resulting in higher medical care costs.	[Rodriguez-Garcia, Judith; Gamino-Iriarte, Astrid] Hosp Reg Alta Especialidad Bajio, Dept Nutr, Leon 37660, Guanajuato, Spain; [Rafael Rodea-Montero, Edel] Hosp Reg Alta Especialidad Bajio, Dept Res, Leon 37660, Guanajuato, Spain		Rodea-Montero, ER (corresponding author), Hosp Reg Alta Especialidad Bajio, Dept Res, Blvd Milenio 130, Leon 37660, Guanajuato, Spain.	edel.rodea@hraeb.gob.mx	Rodea-Montero, Edel Rafael/F-8479-2011	Rodea-Montero, Edel Rafael/0000-0003-4287-9626; Rodriguez-Garcia, Judith/0000-0002-7425-093X				Almeida AI, 2013, BRIT J NUTR, V109, P322, DOI 10.1017/S0007114512001134; Angeles-Garay Ulises, 2009, Rev Med Inst Mex Seguro Soc, V47, P387; Bamgbade OA, 2007, WORLD J SURG, V31, P556, DOI 10.1007/s00268-006-0305-0; Bibbo Christopher, 2010, Clin Podiatr Med Surg, V27, P485, DOI 10.1016/j.cpm.2010.06.001; Canturk Z, 2003, OBES RES, V11, P769, DOI 10.1038/oby.2003.107; Cheadle William G, 2006, Surg Infect (Larchmt), V7 Suppl 1, pS7, DOI 10.1089/sur.2006.7.s-7; Childers DK, 2010, INT J OBESITY, V34, P1231, DOI 10.1038/ijo.2010.71; CHOBAN PS, 1995, AM SURGEON, V61, P1001; CHUMLEA WMC, 1994, J AM DIET ASSOC, V94, P1385, DOI 10.1016/0002-8223(94)92540-2; Cove ME, 2012, J CARDIOTHOR VASC AN, V26, P1094, DOI 10.1053/j.jvca.2012.04.021; Curat CA, 2006, DIABETOLOGIA, V49, P744, DOI 10.1007/s00125-006-0173-z; De la Garza M, 2013, SEMIN COLON RECTAL S, V24, P96, DOI 10.1053/j.scrs.2013.02.008; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Dindo D, 2003, LANCET, V361, P2032, DOI 10.1016/S0140-6736(03)13640-9; Ducel G, 2002, WHO PREVENTION HOSP; ERBAYDAR S, 1995, J HOSP INFECT, V30, P149, DOI 10.1016/0195-6701(95)90155-8; Fischer SP, 2010, MILLERS ANESTHESIA, P1002; Font-Vizcarra L, 2011, INT J ARTIF ORGANS, V34, P876, DOI 10.5301/ijao.5000025; Fowler VG, 2005, CIRCULATION, V112, pI358, DOI 10.1161/CIRCULATIONAHA.104.525790; FRISANCHO AR, 1974, AM J CLIN NUTR, V27, P1052, DOI 10.1093/ajcn/27.8.1052; GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3; Gawande AA, 1999, SURGERY, V126, P66, DOI 10.1067/msy.1999.98664; Giles KA, 2010, J VASC SURG, V52, P1471, DOI 10.1016/j.jvs.2010.07.013; Gutierrez JP., 2012, RESULTADOS NACL; Javer AR, 2010, OTOLARYNG CLIN N AM, V43, P827, DOI 10.1016/j.otc.2010.04.021; Kable AK, 2002, INT J QUAL HEALTH C, V14, P269, DOI 10.1093/intqhc/14.4.269; Kanellakis S, 2010, MATURITAS, V65, P64, DOI 10.1016/j.maturitas.2009.10.012; Kaye KS, 2011, J AM GERIATR SOC, V59, P622, DOI 10.1111/j.1532-5415.2010.03289.x; Lohman T. G., 1998, ANTROPOMETRIC STANDA; Mullen JT, 2009, ANN SURG, V250, P166, DOI 10.1097/SLA.0b013e3181ad8935; Paillaud E, 2005, AGE AGEING, V34, P619, DOI 10.1093/ageing/afi197; Pessaux P, 2003, ARCH SURG-CHICAGO, V138, P314, DOI 10.1001/archsurg.138.3.314; Petrosillo N, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-34; R Development Core Team, 2006, R LANG ENV STAT COMP; Rosenthal VD, 2013, INFECT CONT HOSP EP, V34, P597, DOI 10.1086/670626; Rovera F, 2007, SURG ONCOL, V16, pS121, DOI 10.1016/j.suronc.2007.10.029; Silber JH, 2003, HEALTH SERV RES, V38, P867, DOI 10.1111/1475-6773.00150; Silber JH, 1999, HEALTH SERV RES, V34, P349; Suttajit M, 2007, ASIA PAC J CLIN NUTR, V16, P318; Thomas AM, 2006, NURS CLIN N AM, V41, P455, DOI 10.1016/j.cnur.2006.05.002; Waisbren E, 2010, J AM COLL SURGEONS, V210, P381, DOI 10.1016/j.jamcollsurg.2010.01.004; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Weiser TG, 2008, LANCET, V372, P139, DOI 10.1016/S0140-6736(08)60878-8; World Health Organization Expert Committee, 1995, WHO TECHN REP SER	44	3	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0118980	10.1371/journal.pone.0118980	http://dx.doi.org/10.1371/journal.pone.0118980			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH2XV	25803860	Green Submitted, Green Published, gold			2022-12-26	WOS:000353889600012
J	Roelke, DL; Spatharis, S				Roelke, Daniel L.; Spatharis, Sofie			Phytoplankton Succession in Recurrently Fluctuating Environments	PLOS ONE			English	Article							FRESH-WATER INFLOW; NUTRIENT LIMITATION; SEASONAL-CHANGES; P-LIMITATION; COASTAL; DYNAMICS; PLANKTON; BAY; BIOMASS; VARIABILITY	Coastal marine systems are affected by seasonal variations in biogeochemical and physical processes, sometimes leading to alternating periods of reproductive growth limitation within an annual cycle. Transitions between these periods can be sudden or gradual. Human activities, such as reservoir construction and interbasin water transfers, influence these processes and can affect the type of transition between resource loading conditions. How such human activities might influence phytoplankton succession is largely unknown. Here, we employ a multispecies, multi-nutrient model to explore how nutrient loading switching mode might affect phytoplankton succession. The model is based on the Monod-relationship, predicting an instantaneous reproductive growth rate from ambient inorganic nutrient concentrations whereas the limiting nutrient at any given time was determined by Liebig's Law of the Minimum. When these relationships are combined with population loss factors, such as hydraulic displacement of cells associated with inflows, a characterization of a species' niche can be achieved through application of the R* conceptual model, thus enabling an ecological interpretation of modeling results. We found that the mode of reversal in resource supply concentrations had a profound effect. When resource supply reversals were sudden, as expected in systems influenced by pulsed inflows or wind-driven mixing events, phytoplankton were characterized by alternating succession dynamics, a phenomenon documented in inland water bodies of temperate latitudes. When resource supply reversals were gradual, as expected in systems influenced by seasonally developing wet and dry seasons, or annually occurring periods of upwelling, phytoplankton dynamics were characterized by mirror-image succession patterns. This phenomenon has not been reported previously in plankton systems but has been observed in some terrestrial plant systems. These findings suggest that a transition from alternating to "mirror-image" succession patterns might arise with continued coastal zone development, with crucial implications for ecosystems dependent on time-sensitive processes, e.g., spawning events and migration patterns.	[Roelke, Daniel L.] Texas A&M Univ, Dept Wildlife & Fisheries Sci, College Stn, TX 77843 USA; [Roelke, Daniel L.] Texas A&M Univ, Dept Oceanog, College Stn, TX 77843 USA; [Spatharis, Sofie] Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Glasgow, Lanark, Scotland	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; University of Glasgow	Roelke, DL (corresponding author), Texas A&M Univ, Dept Wildlife & Fisheries Sci, 2258 TAMUS, College Stn, TX 77843 USA.	droelke@tamu.edu	Roelke, Daniel L/B-5766-2008; Spatharis, Sofie/I-9193-2019	Roelke, Daniel L/0000-0002-3166-3793; Spatharis, Sofie/0000-0003-1030-9821				Abe T, 2003, FOREST ECOL MANAG, V175, P153, DOI 10.1016/S0378-1127(02)00129-9; Al-Mufti MM, 1997, J ECOL, V65, P759; Anabalon V, 2014, PROG OCEANOGR, V120, P320, DOI 10.1016/j.pocean.2013.10.015; Barbosa AB, 2010, ESTUAR COAST, V33, P324, DOI 10.1007/s12237-009-9200-x; Calic M, 2013, ENVIRON MONIT ASSESS, V185, P7543, DOI 10.1007/s10661-013-3118-2; CARACO N, 1988, CAN J FISH AQUAT SCI, V45, P381; Chen XY, 2013, DEEP-SEA RES PT I, V73, P17, DOI 10.1016/j.dsr.2012.11.011; Davis SE, 2001, ESTUAR COAST SHELF S, V52, P753, DOI 10.1006/ecss.2001.0755; DEBAAR HJW, 1994, PROG OCEANOGR, V33, P347, DOI 10.1016/0079-6611(94)90022-1; Domingues RB, 2005, ESTUAR COAST SHELF S, V64, P249, DOI 10.1016/j.ecss.2005.02.017; FISHER TR, 1992, MAR ECOL PROG SER, V82, P51, DOI 10.3354/meps082051; Grover J. P., 1997, RESOURCE COMPETITION; Grover JP, 1999, ARCH HYDROBIOL, V145, P1; Hu S, 2011, MAR ECOL PROG SER, V427, P29, DOI 10.3354/meps09043; Huisman J, 2001, AM NAT, V157, P488, DOI 10.1086/319929; Huisman J, 1999, NATURE, V402, P407, DOI 10.1038/46540; Huisman J, 2001, ECOL LETT, V4, P408, DOI 10.1046/j.1461-0248.2001.00256.x; Interlandi SJ, 2001, ECOLOGY, V82, P1270, DOI 10.2307/2679988; Lares ML, 2009, ARCH ENVIRON CON TOX, V56, P707, DOI 10.1007/s00244-008-9210-x; LEON JA, 1975, J THEOR BIOL, V50, P185, DOI 10.1016/0022-5193(75)90032-6; Litchman E, 2008, ANNU REV ECOL EVOL S, V39, P615, DOI 10.1146/annurev.ecolsys.39.110707.173549; Magilligan FJ, 2005, GEOMORPHOLOGY, V71, P61, DOI 10.1016/j.geomorph.2004.08.017; McLusky D.S., 2004, ESTUARINE ECOSYSTEM; MONOD J, 1950, ANN I PASTEUR PARIS, V79, P390; Morse RE, 2014, MAR ECOL PROG SER, V503, P59, DOI 10.3354/meps10743; Nadia TD, 2012, FLORA, V207, P682, DOI 10.1016/j.flora.2012.06.020; PAERL HW, 1988, LIMNOL OCEANOGR, V33, P823, DOI 10.4319/lo.1988.33.4_part_2.0823; Philippart CJM, 2000, LIMNOL OCEANOGR, V45, P131, DOI 10.4319/lo.2000.45.1.0131; Pilkaityte R, 2007, BOREAL ENVIRON RES, V12, P551; Poff NL, 2007, P NATL ACAD SCI USA, V104, P5732, DOI 10.1073/pnas.0609812104; Pulina S, 2012, PLANT BIOSYST, V146, P259, DOI 10.1080/11263504.2012.717545; Reynolds CS, 2006, ECOL BIODIVERS CONS, P1, DOI 10.2277/ 0521605199; Roelke D, 2004, HYDROBIOLOGIA, V513, P205, DOI 10.1023/B:hydr.0000018185.41861.07; Roelke DL, 2008, AM NAT, V171, P162, DOI 10.1086/524955; Roelke DL, 2007, FRESHWATER BIOL, V52, P399, DOI 10.1111/j.1365-2427.2006.01703.x; Roelke DL, 2013, MAR ECOL PROG SER, V477, P61, DOI 10.3354/meps10182; Roelke DL, 1997, ESTUARIES, V20, P725, DOI 10.2307/1352247; Roelke DL, PLOS IN PRESS; Roy ED, 2013, SCI TOTAL ENVIRON, V458, P374, DOI 10.1016/j.scitotenv.2013.04.046; Russell MJ, 2006, ESTUAR COAST SHELF S, V68, P231, DOI 10.1016/j.ecss.2006.02.005; Sommer U., 1989, P57; SOMMER U, 1986, ARCH HYDROBIOL, V106, P433; SOMMER U, 1984, LIMNOL OCEANOGR, V29, P633, DOI 10.4319/lo.1984.29.3.0633; Sommer U, 1989, SUCCESSION PLANKTON; Spatharis S, 2008, J EXP MAR BIOL ECOL, V362, P55, DOI 10.1016/j.jembe.2008.06.003; Sterner RW, 2008, INT REV HYDROBIOL, V93, P433, DOI 10.1002/iroh.200811068; Tamminen T, 2007, MAR ECOL PROG SER, V340, P121, DOI 10.3354/meps340121; Tamvakis A, 2012, ESTUAR COAST SHELF S, V115, P210, DOI 10.1016/j.ecss.2012.09.003; Tilman D., 1982, Monographs in Population Biology, pi; Vincent TLS, 1996, AM NAT, V148, P1038, DOI 10.1086/285970; WEBB KL, 1988, CAN J FISH AQUAT SCI, V45, P380; Wollast R, 1983, MAJOR BIOGEO CHEM CY, P21; Yamamoto T, 2004, ECOL MODEL, V171, P247, DOI 10.1016/j.ecolmodel.2003.08.011; Yin KD, 2004, CONT SHELF RES, V24, P1895, DOI 10.1016/j.csr.2004.06.014; Yin KD, 2002, MAR ECOL PROG SER, V245, P111, DOI 10.3354/meps245111; Zhou WH, 2014, ENVIRON MONIT ASSESS, V186, P1705, DOI 10.1007/s10661-013-3487-6	56	18	18	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0121392	10.1371/journal.pone.0121392	http://dx.doi.org/10.1371/journal.pone.0121392			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803437	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000353889600155
J	Song, ZX; Wang, LQ; Liu, YP; Xiao, W				Song, Zixun; Wang, Lianqing; Liu, Yaping; Xiao, Wei			A Novel Nonsense Mutation in the MIP Gene Linked to Congenital Posterior Polar Cataracts in a Chinese Family	PLOS ONE			English	Article							MAJOR INTRINSIC PROTEIN; AUTOSOMAL-DOMINANT CATARACT; SPLICE-SITE MUTATION; AQUAPORIN WATER CHANNELS; NUCLEAR CATARACT; LENS; UNDERLIES; MEMBRANE; PORE	Purpose To detect the causative mutation for congenital posterior polar cataracts in a five-generation Chinese family and further explore the potential pathogenesis of this disease. Methods Coding exons, with flanking sequences of five candidate genes, were screened using direct DNA sequencing. The identified mutations were confirmed by restriction fragment length polymorphism (RFLP) analysis. A full-length wild-type or an Y219* mutant aquaporin0 (AQP0) fused with an N-terminal FLAG tag, was transfected into HEK293T cells. For co-localization studies, FLAG-WT-AQP0 and Myc-Y219*-AQP0 constructs were co-transfected. Quantitative real-time RT-PCR, western blotting and immunofluorescence studies were performed to determine protein expression levels and sub-cellular localization, respectively. Results We identified a novel nonsense mutation in MIP (c.657 C>G; p.Y219*) (major intrinsic protein gene) that segregates with congenital posterior polar cataract in a Chinese family. This mutation altered a highly conserved tyrosine to a stop codon (Y219*) within AQP0. When FLAG-WT-AQP0 and FLAG-Y219*-AQP0 expression constructs were singly transfected into HEK 293T cells, mRNA expression showed no significant difference between the wildtype and the mutant, while Y219*-AQP0 protein expression was significantly lower than that of wild-type AQP0. Wild-type AQP0 predominantly localized to the plasma membrane, while the mutated protein was abundant within the cytoplasm of HEK293T cells. However, when FLAG-WT-AQP0 and Myc-MU-AQP0were co-expressed, both proteins showed high fluorescence in the cytoplasm. Conclusions The novel nonsense mutation in the MIP gene (c.657 C>G) identified in a Chinese family may cause posterior polar cataracts. The dominant negative effect of the mutated protein on the wild-type protein interfered with the trafficking of wild-type protein to the cell membrane and both the mutant and wild-type protein were trapped in the cytoplasm. Consequently, both wild-type and mutant protein lost their function as a water channel on the cell membrane, and may result in a cataract phenotype. Our data also expands the spectrum of known MIP mutations.	[Song, Zixun; Xiao, Wei] China Med Univ, Shengjing Hosp, Dept Ophthalmol, Shenyang 110004, Liaoning, Peoples R China; [Wang, Lianqing; Liu, Yaping] Chinese Acad Med Sci, Inst Basic Med Sci, Dept Med Genet, Beijing 100005, Peoples R China; [Wang, Lianqing; Liu, Yaping] Peking Union Med Coll, Beijing 100005, Peoples R China	China Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Xiao, W (corresponding author), China Med Univ, Shengjing Hosp, Dept Ophthalmol, Shenyang 110004, Liaoning, Peoples R China.	xiaow@sj-hospital.org	Xiao, Wei/M-3847-2018; Wang, Lianqing/AAX-5278-2020	Xiao, Wei/0000-0001-5924-434X; Wang, Lianqing/0000-0002-7161-4718; song, zixun/0000-0002-6819-8178; Song, Zixun/0000-0003-0241-8518	National Natural Science Foundation of China [30973276]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 30973276). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agre P, 2002, J PHYSIOL-LONDON, V542, P3, DOI 10.1113/jphysiol.2002.020818; Berry V, 2000, NAT GENET, V25, P15, DOI 10.1038/75538; Borgnia M, 1999, ANNU REV BIOCHEM, V68, P425, DOI 10.1146/annurev.biochem.68.1.425; Buck TM, 2007, NAT STRUCT MOL BIOL, V14, P762, DOI 10.1038/nsmb1275; Cheng AC, 1997, NATURE, V387, P627, DOI 10.1038/42517; Chepelinsky Ana B, 2009, Handb Exp Pharmacol, P265, DOI 10.1007/978-3-540-79885-9_14; Francis P, 2000, BRIT J OPHTHALMOL, V84, P1376, DOI 10.1136/bjo.84.12.1376; Francis P, 2000, HUM MOL GENET, V9, P2329, DOI 10.1093/oxfordjournals.hmg.a018925; Geyer DD, 2006, AM J OPHTHALMOL, V141, P761, DOI 10.1016/j.ajo.2005.11.008; Gogate P, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000177; Golestaneh N, 2008, MOL VIS, V14, P1006; Gonen T, 2004, NATURE, V429, P193, DOI 10.1038/nature02503; Gu F, 2007, MOL VIS, V13, P1651; Hejtmancik JF, 2008, SEMIN CELL DEV BIOL, V19, P134, DOI 10.1016/j.semcdb.2007.10.003; Ionides A, 1999, BRIT J OPHTHALMOL, V83, P802, DOI 10.1136/bjo.83.7.802; Jiang J, 2009, MOL VIS, V15, P38; Kumar GS, 2013, EXP EYE RES, V110, P136, DOI 10.1016/j.exer.2012.10.010; Lin H, 2007, MOL VIS, V13, P1822; Mathias RT, 2007, J MEMBRANE BIOL, V216, P1, DOI 10.1007/s00232-007-9019-y; Murata K, 2000, NATURE, V407, P599, DOI 10.1038/35036519; Nemeth-Cahalan KL, 2000, J BIOL CHEM, V275, P6777, DOI 10.1074/jbc.275.10.6777; Pitonzo D, 2006, BBA-BIOMEMBRANES, V1758, P976, DOI 10.1016/j.bbamem.2006.04.021; Reis LM, 2013, HUM GENET, V132, P761, DOI 10.1007/s00439-013-1289-0; Ren G, 2001, P NATL ACAD SCI USA, V98, P1398, DOI 10.1073/pnas.041489198; Schey KL, 2000, INVEST OPHTH VIS SCI, V41, P175; Shiels A, 2001, PHYSIOL GENOMICS, V7, P179, DOI 10.1152/physiolgenomics.00078.2001; Shiels A, 2007, AM J HUM GENET, V81, P596, DOI 10.1086/519980; Shiels A, 2010, MOL VIS, V16, P2007; Tan FG, 2004, INVEST OPHTH VIS SCI, V45, P863, DOI 10.1167/iovs.03-0708; Varadaraj K, 2008, EXP EYE RES, V87, P9, DOI 10.1016/j.exer.2008.04.001; Verdin H, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/1750-1172-9-26; Walz T, 1997, NATURE, V387, P624, DOI 10.1038/42512; Wang KJ, 2011, MOL VIS, V17, P70; Wang W, 2010, MOL VIS, V16, P534; Xiao Xueshan, 2011, Mol Vis, V17, P2049; Yang GX, 2011, MOL VIS, V17, P1320; Yang ZF, 2012, MOL VIS, V18, P1283; Yu YB, 2014, BMC MED GENET, V15, DOI 10.1186/1471-2350-15-6; Zeng L, 2013, MOL VIS, V19, P2244	39	13	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0119296	10.1371/journal.pone.0119296	http://dx.doi.org/10.1371/journal.pone.0119296			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803033	Green Submitted, Green Published, gold			2022-12-26	WOS:000353889600020
J	Tiso, M; Schechter, AN				Tiso, Mauro; Schechter, Alan N.			Nitrate Reduction to Nitrite, Nitric Oxide and Ammonia by Gut Bacteria under Physiological Conditions	PLOS ONE			English	Article							DIETARY NITRATE; ESCHERICHIA-COLI; LACTOBACILLUS-PLANTARUM; NO; RESPIRATION; REDUCTASES; REGULATOR; TRANSPORT; PATHWAYS; FEATURES	The biological nitrogen cycle involves step-wise reduction of nitrogen oxides to ammonium salts and oxidation of ammonia back to nitrites and nitrates by plants and bacteria. Neither process has been thought to have relevance to mammalian physiology; however in recent years the salivary bacterial reduction of nitrate to nitrite has been recognized as an important metabolic conversion in humans. Several enteric bacteria have also shown the ability of catalytic reduction of nitrate to ammonia via nitrite during dissimilatory respiration; however, the importance of this pathway in bacterial species colonizing the human intestine has been little studied. We measured nitrite, nitric oxide (NO) and ammonia formation in cultures of Escherichia coli, Lactobacillus and Bifidobacterium species grown at different sodium nitrate concentrations and oxygen levels. We found that the presence of 5 mM nitrate provided a growth benefit and induced both nitrite and ammonia generation in E. coli and L. plantarum bacteria grown at oxygen concentrations compatible with the content in the gastrointestinal tract. Nitrite and ammonia accumulated in the growth medium when at least 2.5 mM nitrate was present. Time-course curves suggest that nitrate is first converted to nitrite and subsequently to ammonia. Strains of L. rhamnosus, L. acidophilus and B. longum infantis grown with nitrate produced minor changes in nitrite or ammonia levels in the cultures. However, when supplied with exogenous nitrite, NO gas was readily produced independently of added nitrate. Bacterial production of lactic acid causes medium acidification that in turn generates NO by non-enzymatic nitrite reduction. In contrast, nitrite was converted to NO by E. coli cultures even at neutral pH. We suggest that the bacterial nitrate reduction to ammonia, as well as the related NO formation in the gut, could be an important aspect of the overall mammalian nitrate/nitrite/NO metabolism and is yet another way in which the microbiome links diet and health.	[Tiso, Mauro; Schechter, Alan N.] NIDDK, Mol Med Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Schechter, AN (corresponding author), NIDDK, Mol Med Branch, NIH, Bethesda, MD 20892 USA.	alans@intra.niddk.nih.gov			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK025093] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Auron A, 2012, PEDIATR NEPHROL, V27, P207, DOI 10.1007/s00467-011-1838-5; BARTHOLOMEW B, 1984, FOOD CHEM TOXICOL, V22, P789, DOI 10.1016/0278-6915(84)90116-9; Brooijmans RJW, 2009, APPL ENVIRON MICROB, V75, P3580, DOI 10.1128/AEM.00147-09; Bueno E, 2012, ANTIOXID REDOX SIGN, V16, P819, DOI 10.1089/ars.2011.4051; Carlstrom M, 2010, P NATL ACAD SCI USA, V107, P17716, DOI 10.1073/pnas.1008872107; Castiglione N, 2012, ANTIOXID REDOX SIGN, V17, P684, DOI 10.1089/ars.2011.4196; Cole J, 1996, FEMS MICROBIOL LETT, V136, P1; COLE JA, 1982, BIOCHEM SOC T, V10, P476, DOI 10.1042/bst0100476; Corker H, 2003, J BIOL CHEM, V278, P31584, DOI 10.1074/jbc.M303282200; Espey MG, 2013, FREE RADICAL BIO MED, V55, P130, DOI 10.1016/j.freeradbiomed.2012.10.554; Flint HJ, 2010, MICROBIOL-SGM, V156, P3203, DOI 10.1099/mic.0.045443-0; Gates AJ, 2003, FEMS MICROBIOL LETT, V220, P261, DOI 10.1016/S0378-1097(03)00122-8; Govoni M, 2008, NITRIC OXIDE-BIOL CH, V19, P333, DOI 10.1016/j.niox.2008.08.003; GREEN LC, 1981, SCIENCE, V212, P56, DOI 10.1126/science.6451927; Hadjihambi A, 2014, EXPERT OPIN PHARMACO, V15, P1685, DOI 10.1517/14656566.2014.931372; He GL, 1999, P NATL ACAD SCI USA, V96, P4586, DOI 10.1073/pnas.96.8.4586; Ignarro LJ, 2000, NITRIC OXIDE BIOL PA; JI XB, 1989, BIOCHEM ARCH, V5, P61; JI XB, 1988, BIOCHEM BIOPH RES CO, V157, P106, DOI 10.1016/S0006-291X(88)80018-4; Jia W, 2005, BIOCHEM SOC T, V33, P159, DOI 10.1042/BST0330159; JONES GA, 1972, CAN J MICROBIOL, V18, P1784, DOI 10.1139/m72-279; Jones JA, 2013, J PARENTERAL; Jones SA, 2007, INFECT IMMUN, V75, P4891, DOI 10.1128/IAI.00484-07; Kundra A, 2005, CLIN BIOCHEM, V38, P696, DOI 10.1016/j.clinbiochem.2005.04.013; Leser TD, 2009, ENVIRON MICROBIOL, V11, P2194, DOI 10.1111/j.1462-2920.2009.01941.x; Lidder S, 2013, BRIT J CLIN PHARMACO, V75, P677, DOI 10.1111/j.1365-2125.2012.04420.x; Lundberg JO, 2004, NAT REV MICROBIOL, V2, P593, DOI 10.1038/nrmicro929; Lundberg JO, 2008, NAT REV DRUG DISCOV, V7, DOI [10.1038/nrd2466, 10.1038/nrd2466-c2]; MacArthur PH, 2007, J CHROMATOGR B, V851, P93, DOI 10.1016/j.jchromb.2006.12.012; Marteyn B, 2011, CELL MICROBIOL, V13, P171, DOI 10.1111/j.1462-5822.2010.01549.x; McKnight GM, 1999, BRIT J NUTR, V81, P349, DOI 10.1017/S000711459900063X; Nathan S., 2013, NITRITE NITRATE HUMA, P1; O'Hara AM, 2006, EMBO REP, V7, P688, DOI 10.1038/sj.embor.7400731; Patil DH, 1987, GUT; Raat NJH, 2009, FREE RADICAL BIO MED, V47, P510, DOI 10.1016/j.freeradbiomed.2009.05.015; Schreiber F, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-24; Sears CL, 2005, ANAEROBE, V11, P247, DOI 10.1016/j.anaerobe.2005.05.001; Siezen RJ, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-S1-S3; Simon J, 2002, FEMS MICROBIOL REV, V26, P285, DOI 10.1111/j.1574-6976.2002.tb00616.x; Sindelar JJ, 2012, NITRIC OXIDE-BIOL CH, V26, P259, DOI 10.1016/j.niox.2012.03.011; Sobko T, 2005, NITRIC OXIDE-BIOL CH, V13, P272, DOI 10.1016/j.niox.2005.08.002; Sobko T, 2006, FREE RADICAL BIO MED, V41, P985, DOI 10.1016/j.freeradbiomed.2006.06.020; Sparacino-Watkins C, 2014, CHEM SOC REV, V43, P676, DOI 10.1039/c3cs60249d; STEWART V, 1994, ANTON LEEUW INT J G, V66, P37, DOI 10.1007/BF00871631; Strauss Edna, 2003, Ann Hepatol, V2, P41; TANNENBAUM SR, 1978, SCIENCE, V200, P1487, DOI 10.1126/science.663630; Tiso M, 2012, BIOCHEMISTRY-US, V51, P5285, DOI 10.1021/bi300570v; Unden G, 1997, BBA-BIOENERGETICS, V1320, P217, DOI 10.1016/S0005-2728(97)00034-0; van Faassen EE, 2009, MED RES REV, V29, P683, DOI 10.1002/med.20151; Vermeiren J, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/284718; VINCE A, 1974, J MED MICROBIOL, V7, P163, DOI 10.1099/00222615-7-2-163; VINCE A, 1973, GUT, V14, P171, DOI 10.1136/gut.14.3.171; WAGNER DA, 1983, CANCER RES, V43, P1921; Weitzberg E, 2013, ANNU REV NUTR, V33, P129, DOI 10.1146/annurev-nutr-071812-161159; Winter SE, 2013, SCIENCE, V339, P708, DOI 10.1126/science.1232467; WOLF G, 1990, INT J FOOD MICROBIOL, V10, P323, DOI 10.1016/0168-1605(90)90079-K; Xu J, 2001, APPL MICROBIOL BIOT, V56, P504, DOI 10.1007/s002530100616	57	157	164	4	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0119712	10.1371/journal.pone.0119712	http://dx.doi.org/10.1371/journal.pone.0119712			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803049	gold, Green Submitted, Green Published			2022-12-26	WOS:000353889600041
J	Turner, NA; Sartain, SE; Hui, SK; Moake, JL				Turner, Nancy A.; Sartain, Sarah E.; Hui, Shiu-Ki; Moake, Joel L.			Regulatory Components of the Alternative Complement Pathway in Endothelial Cell Cytoplasm, Factor H and Factor I, Are Not Packaged in Weibel-Palade Bodies	PLOS ONE			English	Article							VON-WILLEBRAND-FACTOR; VONWILLEBRAND-FACTOR; COLOCALIZATION; MICROSCOPY; SECRETION; PROTEIN; SURFACE; GUIDE	It was recently reported that factor H, a regulatory component of the alternative complement pathway, is stored with von Willebrand factor (VWF) in the Weibel-Palade bodies of endothelial cells. If this were to be the case, it would have therapeutic importance for patients with the atypical hemolytic-uremic syndrome that can be caused either by a heterozygous defect in the factor H gene or by the presence of an autoantibody against factor H. The in vivo Weibel-Palade body secretagogue, des-amino-D-arginine vasopressin (DDAVP), would be expected to increase transiently the circulating factor H levels, in addition to increasing the circulating levels of VWF. We describe experiments demonstrating that factor H is released from endothelial cell cytoplasm without a secondary storage site. These experiments showed that factor H is not stored with VWF in endothelial cell Weibel-Palade bodies, and is not secreted in response in vitro in response to the Weibel-Palade body secretagogue, histamine. Furthermore, the in vivo Weibel-Palade body secretagogue, DDAVP does not increase the circulating factor H levels concomitantly with DDAVP-induced increased VWF. Factor I, a regulatory component of the alternative complement pathway that is functionally related to factor H, is also located in endothelial cell cytoplasm, and is also not present in endothelial cell Weibel-Palade bodies. Our data demonstrate that the factor H and factor I regulatory proteins of the alternative complement pathway are not stored in Weibel-Palade bodies. DDAVP induces the secretion into human plasma of VWF -but not factor H.	[Turner, Nancy A.; Moake, Joel L.] Rice Univ, Dept Bioengn, Houston, TX 77005 USA; [Sartain, Sarah E.] Texas Childrens Canc & Hematol Ctr, Dept Pediat, Hematol Oncol Sect, Houston, TX USA; [Sartain, Sarah E.; Hui, Shiu-Ki; Moake, Joel L.] Baylor Coll Med, Houston, TX 77030 USA; [Hui, Shiu-Ki] Texas Childrens Hosp, Div Transfus Med & Coagulat, Houston, TX 77030 USA	Rice University; Texas Children's Cancer Center; Baylor College of Medicine; Baylor College of Medicine	Turner, NA (corresponding author), Rice Univ, Dept Bioengn, Houston, TX 77005 USA.	nturner@rice.edu			Mary R. Gibson Foundation [R02230-778000]; Mabel and the Everett Hinkson Memorial Fund [G82567-778000]	Mary R. Gibson Foundation; Mabel and the Everett Hinkson Memorial Fund	This work was supported by the Mary R. Gibson Foundation (R02230-778000) and the Mabel and the Everett Hinkson Memorial Fund (G82567-778000). JLM received the funding from these organizations. Neither of these organizations have websites. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Comeau JWD, 2006, BIOPHYS J, V91, P4611, DOI 10.1529/biophysj.106.089441; Dong JF, 2002, BLOOD, V100, P4033, DOI 10.1182/blood-2002-05-1401; Dunn KW, 2011, AM J PHYSIOL-CELL PH, V300, pC723, DOI 10.1152/ajpcell.00462.2010; Fu J, 2005, J BIOL CHEM, V280, P3178, DOI 10.1074/jbc.M410044200; HAMILTON KK, 1987, J CLIN INVEST, V79, P600, DOI 10.1172/JCI112853; Hannah MJ, 2005, J BIOL CHEM, V280, P22827, DOI 10.1074/jbc.M412547200; HATTORI R, 1989, J BIOL CHEM, V264, P7768; Huang J, 2009, BLOOD, V113, P1589, DOI 10.1182/blood-2008-05-158584; Huang RH, 2008, P NATL ACAD SCI USA, V105, P482, DOI 10.1073/pnas.0710079105; Kask L, 2004, PROTEIN SCI, V13, P1356, DOI 10.1110/ps.03516504; Kaufmann JE, 2000, J CLIN INVEST, V106, P107, DOI 10.1172/JCI9516; Licht C, 2009, BLOOD, V114, P4538, DOI 10.1182/blood-2009-03-205096; Liu ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071366; Liu ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034280; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; Mannucci PM, 1997, BLOOD, V90, P2515, DOI 10.1182/blood.V90.7.2515.2515_2515_2521; Rayes J, 2014, BLOOD, V123, P121, DOI 10.1182/blood-2013-04-495853; RUGGERI ZM, 1993, FASEB J, V7, P308, DOI 10.1096/fasebj.7.2.8440408; Turner NA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059372; Turner NA, 2009, BLOOD, V114, P5102, DOI 10.1182/blood-2009-07-231597; Wagener FADTG, 1997, P SOC EXP BIOL MED, V216, P456; Yee A, 2014, SEMIN THROMB HEMOST, V40, P17, DOI 10.1055/s-0033-1363155; Zinchuk V, 2009, PROG HISTOCHEM CYTO, V44, P125, DOI 10.1016/j.proghi.2009.03.001	24	10	10	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0121994	10.1371/journal.pone.0121994	http://dx.doi.org/10.1371/journal.pone.0121994			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803806	Green Submitted, Green Published, gold			2022-12-26	WOS:000353889600186
J	Dent, KA; Christie, KJ; Bye, N; Basrai, HS; Turbic, A; Habgood, M; Cate, HS; Turnley, AM				Dent, Krista A.; Christie, Kimberly J.; Bye, Nicole; Basrai, Harleen S.; Turbic, Alisa; Habgood, Mark; Cate, Holly S.; Turnley, Ann M.			Oligodendrocyte Birth and Death following Traumatic Brain Injury in Adult Mice	PLOS ONE			English	Article							CONTROLLED CORTICAL IMPACT; WHITE-MATTER; PRECURSOR CELLS; AMYLOID-BETA; PROGENITORS; ASTROCYTES; EXPRESSION; AXONS; PROLIFERATION; REMYELINATION	Oligodendrocytes are responsible for producing and maintaining myelin throughout the CNS. One of the pathological features observed following traumatic brain injury (TBI) is the progressive demyelination and degeneration of axons within white matter tracts. While the effect of TBI on axonal health has been well documented, there is limited information regarding the response of oligodendrocytes within these areas. The aim of this study was to characterize the response of both mature oligodendrocytes and immature proliferative oligodendrocyte lineage cells across a 3 month timecourse following TBI. A computer-controlled cortical impact model was used to produce a focal lesion in the left motor cortex of adult mice. Immunohistochemical analyses were performed at 48 hours, 7 days, 2 weeks, 5 weeks and 3 months following injury to assess the prevalence of mature CC-1(+) oligodendrocyte cell death, immature Olig2(+) cell proliferation and longer term survival in the corpus callosum and external capsule. Decreased CC-1 immunoreactivity was observed in white matter adjacent to the site of injury from 2 days to 2 weeks post TBI, with ongoing mature oligodendrocyte apoptosis after this time. Conversely, proliferation of Olig2(+) cells was observed as early as 48 hours post TBI and significant numbers of these cells and their progeny survived and remained in the external capsule within the injured hemisphere until at least 3 months post injury. These findings demonstrate that immature oligodendrocyte lineage cells respond to TBI by replacing oligodendrocytes lost due to damage and that this process occurs for months after injury.	[Dent, Krista A.; Christie, Kimberly J.; Bye, Nicole; Basrai, Harleen S.; Turbic, Alisa; Cate, Holly S.; Turnley, Ann M.] Univ Melbourne, Dept Anat & Neurosci, Parkville, Vic 3052, Australia; [Habgood, Mark] Univ Melbourne, Dept Pharmacol & Therapeut, Parkville, Vic 3052, Australia	University of Melbourne; University of Melbourne	Turnley, AM (corresponding author), Univ Melbourne, Dept Anat & Neurosci, Parkville, Vic 3052, Australia.	turnley@unimelb.edu.au		Cate, Holly/0000-0001-6392-9640; Turbic, Alisa/0000-0002-9703-2484	National Health and Medical Research Council of Australia (NHMRC) [GNT 1045125, 628344]; Stem Cells Australia (SCA)	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Stem Cells Australia (SCA)	This work was supported by National Health and Medical Research Council of Australia (NHMRC) (www.NHMRC.gov.au), Project grant #GNT 1045125 to AMT, Research Fellowship # 628344 to AMT, and Stem Cells Australia (SCA) (www.stemcellsaustralia.edu.au) to AMT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bradl M, 2010, ACTA NEUROPATHOL, V119, P37, DOI 10.1007/s00401-009-0601-5; Bramlett HM, 2002, ACTA NEUROPATHOL, V103, P607, DOI 10.1007/s00401-001-0510-8; Buffo A, 2005, P NATL ACAD SCI USA, V102, P18183, DOI 10.1073/pnas.0506535102; Caprariello AV, 2012, ANN NEUROL, V72, P395, DOI 10.1002/ana.23606; Carbonnel WS, 1999, ACTA NEUROPATHOL, V98, P396, DOI 10.1007/s004010051100; Chen XH, 2004, AM J PATHOL, V165, P357, DOI 10.1016/S0002-9440(10)63303-2; Connor JR, 1996, GLIA, V17, P83, DOI 10.1002/(SICI)1098-1136(199606)17:2<83::AID-GLIA1>3.0.CO;2-7; Conti AC, 1998, J NEUROSCI, V18, P5663; Dewar D, 2003, J CEREBR BLOOD F MET, V23, P263, DOI 10.1097/01.WCB.0000053472.41007.F9; Dimou L, 2008, J NEUROSCI, V28, P10434, DOI 10.1523/JNEUROSCI.2831-08.2008; Dong HX, 2003, J NEUROSCI, V23, P8682; Eghwrudjakpor P O, 2010, Niger J Med, V19, P14; Ek CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012021; Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6; Flygt J, 2013, EUR J NEUROSCI, V38, P2153, DOI 10.1111/ejn.12179; FOKSEANG J, 1995, DEV BIOL, V171, P1, DOI 10.1006/dbio.1995.1255; Foote AK, 2005, BRAIN, V128, P528, DOI 10.1093/brain/awh417; Hampton DW, 2004, NEUROSCIENCE, V127, P813, DOI 10.1016/j.neuroscience.2004.05.028; Horiuchi M, 2006, J BIOL CHEM, V281, P20095, DOI 10.1074/jbc.M603179200; Hughes EG, 2013, NAT NEUROSCI, V16, P668, DOI 10.1038/nn.3390; Johnson S.C., 1994, NEUROPSYCHOLOGY, V8, P307, DOI [DOI 10.1037/0894-4105.8.3.301, 10.1037/0894-4105.8.3.301]; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Jurewicz A, 2005, BRAIN, V128, P2675, DOI 10.1093/brain/awh627; Kang SH, 2010, NEURON, V68, P668, DOI 10.1016/j.neuron.2010.09.009; Keirstead HS, 1997, J NEUROPATH EXP NEUR, V56, P1191, DOI 10.1097/00005072-199711000-00003; Kernie SG, 2001, J NEUROSCI RES, V66, P317, DOI 10.1002/jnr.10013; KIDD GJ, 1990, J NEUROSCI RES, V26, P409, DOI 10.1002/jnr.490260403; Lau LT, 2001, J NEUROTRAUM, V18, P351, DOI 10.1089/08977150151071035; LEVIN HS, 1990, J NEUROSURG, V73, P77, DOI 10.3171/jns.1990.73.1.0077; LEVINE JM, 1994, J NEUROSCI, V14, P4716; Levine JM, 1999, EXP NEUROL, V160, P333, DOI 10.1006/exnr.1999.7224; Lindner M, 2008, NEUROPATH APPL NEURO, V34, P105, DOI 10.1111/j.1365-2990.2007.00879.x; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Lotocki G, 2011, NEUROSCI LETT, V499, P143, DOI 10.1016/j.neulet.2011.05.056; Mason JL, 2004, AM J PATHOL, V164, P1673, DOI 10.1016/S0002-9440(10)63726-1; Matute C, 2007, J NEUROSCI, V27, P9525, DOI 10.1523/JNEUROSCI.0579-07.2007; McDonald JW, 1998, NAT MED, V4, P291, DOI 10.1038/nm0398-291; McGavern DB, 1999, EXP NEUROL, V158, P171, DOI 10.1006/exnr.1999.7082; MCPHILEMY K, 1990, J NEUROCYTOL, V19, P494, DOI 10.1007/BF01257239; MCPHILEMY K, 1991, NEUROPATH APPL NEURO, V17, P275, DOI 10.1111/j.1365-2990.1991.tb00725.x; McTigue DM, 2001, J NEUROSCI, V21, P3392, DOI 10.1523/JNEUROSCI.21-10-03392.2001; Menn B, 2006, J NEUROSCI, V26, P7907, DOI 10.1523/JNEUROSCI.1299-06.2006; Moore N, 2011, J ONCOL, V2011, DOI 10.1155/2011/396076; Onyszchuk G, 2007, J NEUROSCI METH, V160, P187, DOI 10.1016/j.jneumeth.2006.09.007; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; Patel JR, 2011, FEBS LETT, V585, P3730, DOI 10.1016/j.febslet.2011.04.037; Smith DH, 2003, J NEUROSURG, V98, P1072, DOI 10.3171/jns.2003.98.5.1072; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Stone JR, 2004, EXP NEUROL, V190, P59, DOI 10.1016/j.expneurol.2004.05.022; Thorburne SK, 1996, J NEUROCHEM, V67, P1014; Tyurin VA, 2000, J NEUROCHEM, V75, P2178, DOI 10.1046/j.1471-4159.2000.0752178.x; Young KM, 2013, NEURON, V77, P873, DOI 10.1016/j.neuron.2013.01.006; Zhao JW, 2009, EUR J NEUROSCI, V29, P1853, DOI 10.1111/j.1460-9568.2009.06736.x; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	54	41	44	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121541	10.1371/journal.pone.0121541	http://dx.doi.org/10.1371/journal.pone.0121541			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798924	Green Published, gold			2022-12-26	WOS:000351987300265
J	Jin, Y; Shao, CH; Li, J; Fan, H; Bai, YY; Wang, Y				Jin, Yan; Shao, Chunhong; Li, Jian; Fan, Hui; Bai, Yuanyuan; Wang, Yong			Outbreak of Multidrug Resistant NDM-1-Producing Klebsiella pneumoniae from a Neonatal Unit in Shandong Province, China	PLOS ONE			English	Article							BETA-LACTAMASE PRODUCTION; MOLECULAR EPIDEMIOLOGY; CARBAPENEM; OMPK36; SUSCEPTIBILITY; STRAINS; GENE	Despite worldwide dissemination of New Delhi metallo-beta-lactamase1 (blaNDM-1), outbreaks remain uncommon in China. In this study, we describe the characteristics of the outbreak-related blaNDM-1-producing K. pneumonia isolates in a neonatal unit in Shandong province, China. We recovered 21 non-repetitive carbapenem-resistant K. pneumoniae isolates with a positively modified Hodge test (MHT) or EDTA synergistic test from patients and environmental samples in Shandong provincial hospital. Pulsed-field gel electrophoresis (PFGE) and multilocus sequence typing (MLST) data show K. pneumoniae isolates from 19 patients were clonally related and belong to the clonal groups ST20 and ST17. We note two outbreaks, the first caused by ST20 during August 2012 involving four patients, and the second caused by ST20 and ST17 during January 2012 and September 2013 involving fourteen patients. We found the bed railing of one patient was the source of the outbreak. We verified the presence of the blaNDM-1 gene in 21 K. pneumoniae isolates. The genes blaCTX-M-15, blaCTX-M-14, blaDHA-1, blaTEM-1 and Class I integron were also present in 18 (85.7%), 3 (14.3%), 18 (85.7%), 19 (90.5%) and 19 (90.5%) isolates, respectively. We also found an isolate with both blaNDM-1 and blaIMP-4. All of the isolates exhibited a multidrug-resistance phenotype. The beta-lactam resistance of 20 isolates was transferable via conjugation. In addition, we show the resistance of 21 K. pneumoniae isolates to carbapenem is not related to lack of outer-membrane proteins OmpK35 and OmpK36 nor overpression of efflux pumps. This study provides the first report confirming blaNDM-1-producing K. pneumoniae ST20 and ST17 were associated with outbreak. Early detection of resistance genes is an effective strategy in preventing and controlling infection by limiting the dissemination of these organisms.	[Jin, Yan; Shao, Chunhong; Fan, Hui; Bai, Yuanyuan; Wang, Yong] Shandong Univ, Dept Microbiol, Prov Hosp, Clin Lab, Jinan 250100, Peoples R China; [Li, Jian] Jinan Ctr Dis Control & Prevent, Jinan, Peoples R China	Shandong University	Wang, Y (corresponding author), Shandong Univ, Dept Microbiol, Prov Hosp, Clin Lab, Jinan 250100, Peoples R China.	wangyongsdsl@163.com			Shandong province of Science and Technology Development Program of China [2012G0021844]; National Natural Science Foundation of China [81401696]; Shandong Provincial Natural Science Foundation of China [ZR2011HM019]; Shandong Provincial Awards Foundation [BS2011SW035]; Construction Program of Shandong	Shandong province of Science and Technology Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Provincial Natural Science Foundation of China(Natural Science Foundation of Shandong Province); Shandong Provincial Awards Foundation; Construction Program of Shandong	This study was supported by the Shandong province of Science and Technology Development Program of China (grant 2012G0021844) whose role was the study design and decision to publish; the National Natural Science Foundation of China (no. 81401696) whose role was data collection and analysis; the Shandong Provincial Natural Science Foundation of China (ZR2011HM019) whose role was data collection and analysis; the Shandong Provincial Awards Foundation for Young Scientists (BS2011SW035) whose role was data collection and analysis; and the Construction Program of Shandong key clinical specialty whose role was the contribution of equipment.	Anonymous, 2010, Morbidity and Mortality Weekly Report, V59, P750; Borer A, 2009, INFECT CONT HOSP EP, V30, P972, DOI 10.1086/605922; Chen LR, 2009, DIAGN MICR INFEC DIS, V65, P163, DOI 10.1016/j.diagmicrobio.2009.07.002; Clinical and Laboratory Standards Institute, 2013, M100S23 CLSI; Domenech-Sanchez A, 1999, J BACTERIOL, V181, P2726; Dortet L, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/249856; Doumith M, 2009, J ANTIMICROB CHEMOTH, V63, P659, DOI 10.1093/jac/dkp029; Fang H, 2008, J CLIN MICROBIOL, V46, P707, DOI 10.1128/JCM.01943-07; Fluit AC, 1999, EUR J CLIN MICROBIOL, V18, P761, DOI 10.1007/s100960050398; Goldstein C, 2001, ANTIMICROB AGENTS CH, V45, P723, DOI 10.1128/AAC.45.3.723-726.2001; Hemandez-Alles S, 1999, MICROBIOLOGY, V145, P673; Ho PL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017989; Hu FP, 2012, J MED MICROBIOL, V61, P132, DOI 10.1099/jmm.0.036483-0; KADO CI, 1981, J BACTERIOL, V145, P1365, DOI 10.1128/JB.145.3.1365-1373.1981; Landman D, 2009, J MED MICROBIOL, V58, P1303, DOI 10.1099/jmm.0.012575-0; Lee K, 2001, CLIN MICROBIOL INFEC, V7, P88, DOI 10.1046/j.1469-0691.2001.00204.x; Mavroidi A, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-105; Peirano G, 2012, J ANTIMICROB CHEMOTH, V67, P1114, DOI 10.1093/jac/dks026; Perez-Perez FJ, 2002, J CLIN MICROBIOL, V40, P2153, DOI 10.1128/JCM.40.6.2153-2162.2002; Queenan AM, 2007, CLIN MICROBIOL REV, V20, P440, DOI 10.1128/CMR.00001-07; Shi WF, 2013, BRAZ J MICROBIOL, V44, P435, DOI 10.1590/S1517-83822013000200015; Steinmann J, 2011, EURO SURVEILL, V16; Struelens MJ, 2010, EUROSURVEILLANCE, V15, P9; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Wang XD, 2009, J MED MICROBIOL, V58, P1196, DOI 10.1099/jmm.0.008094-0; Yong D, 2009, ANTIMICROB AGENTS CH, V53, P5046, DOI 10.1128/AAC.00774-09	27	47	71	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0119571	10.1371/journal.pone.0119571	http://dx.doi.org/10.1371/journal.pone.0119571			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799421	Green Published, Green Submitted, gold			2022-12-26	WOS:000351987300060
J	Liang, M; Yang, XM; Li, H; Su, SY; Yi, HL; Chai, LJ; Deng, XX				Liang, Mei; Yang, Xiaoming; Li, Hang; Su, Shiying; Yi, Hualin; Chai, Lijun; Deng, Xiuxin			De Novo Transcriptome Assembly of Pummelo and Molecular Marker Development	PLOS ONE			English	Article							SSR MARKERS; GENETIC DIVERSITY; CITRUS; ANNOTATION; DISCOVERY; ORIGIN; OSBECK; TOOL; EST; GENERATION	Pummelo (Citrus grandis) is an important fruit crop worldwide because of its nutritional value. To accelerate the pummelo breeding program, it is essential to obtain extensive genetic information and develop relative molecular markers. Here, we obtained a 12-Gb transcriptome dataset of pummelo through a mixture of RNA from seven tissues using Illumina pair-end sequencing, assembled into 57,212 unigenes with an average length of 1010 bp. The annotation and classification results showed that a total of 39,584 unigenes had similar hits to the known proteins of four public databases, and 31,501 were classified into 55 Gene Ontology (GO) functional sub-categories. The search for putative molecular markers among 57,212 unigenes identified 10,276 simple sequence repeats (SSRs) and 64,720 single nucleotide polymorphisms (SNPs). High-quality primers of 1174 SSR loci were designed, of which 88.16% were localized to nine chromosomes of sweet orange. Of 100 SSR primers that were randomly selected for testing, 87 successfully amplified clear banding patterns. Of these primers, 29 with a mean PIC (polymorphic information content) value of 0.52 were effectively applied for phylogenetic analysis. Of the 20 SNP primers, 14 primers, including 54 potential SNPs, yielded target amplifications, and 46 loci were verified via Sanger sequencing. This new dataset will be a valuable resource for molecular biology studies of pummelo and provides reliable information regarding SNP and SSR marker development, thus expediting the breeding program of pummelo.	[Liang, Mei; Yang, Xiaoming; Li, Hang; Su, Shiying; Yi, Hualin; Chai, Lijun; Deng, Xiuxin] Huazhong Agr Univ, MOA, Key Lab Hort Crop Biol & Genet Improvement Cent R, Key Lab Hort Plant Biol,Minist Educ, Wuhan 430070, Hubei, Peoples R China	Huazhong Agricultural University	Chai, LJ (corresponding author), Huazhong Agr Univ, MOA, Key Lab Hort Crop Biol & Genet Improvement Cent R, Key Lab Hort Plant Biol,Minist Educ, Wuhan 430070, Hubei, Peoples R China.	chailijun@mail.hzau.edu.cn	su, shiying/HDO-2892-2022	Liang, Mei/0000-0002-4877-2443; Xiuxin, Deng/0000-0003-4490-4514	Ministry of Science & Technology of China [2011CB100600]; National Natural Science Foundation of China [31301760, 31460507, 31330066, 31221062]; Ministry of Education Innovation Team [IRT13065]; Fundamental Research Funds for the Central Universities [2013QC037]	Ministry of Science & Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education Innovation Team; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This research was financially supported by the Ministry of Science & Technology of China (no. 2011CB100600), the National Natural Science Foundation of China (nos. 31301760, 31460507, 31330066, 31221062), the Ministry of Education Innovation Team (IRT13065), and the Fundamental Research Funds for the Central Universities (2013QC037). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barakat A, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-51; Barrett H. C., 1976, Systematic Botany, V1, P105, DOI 10.2307/2418763; Biswas MK, 2012, MOL BIOL REP, V39, P7221, DOI 10.1007/s11033-012-1553-8; Blanca J, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-104; Chai LJ, 2013, SCI HORTIC-AMSTERDAM, V155, P85, DOI 10.1016/j.scienta.2013.02.024; Chai LJ, 2011, PLANT CELL TISS ORG, V104, P1, DOI 10.1007/s11240-010-9793-6; Chen CX, 2006, THEOR APPL GENET, V112, P1248, DOI 10.1007/s00122-006-0226-1; Cheng YunJiang, 2003, Plant Molecular Biology Reporter, V21, p177a, DOI 10.1007/BF02774246; Collins LJ, 2008, GENOME INFORM SER, V21, P3; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cui J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092502; Dong SB, 2014, GENE, V544, P220, DOI 10.1016/j.gene.2014.04.031; Du F, 2015, PLANT MOL BIOL REP, V33, P281, DOI 10.1007/s11105-014-0746-9; Emrich SJ, 2007, GENOME RES, V17, P69, DOI 10.1101/gr.5145806; Fanciullino AL, 2007, J AGR FOOD CHEM, V55, P7405, DOI 10.1021/jf070711h; Feldmeyer B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-317; Feng C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-19; Fox SE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096855; Fu N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057686; Fullwood MJ, 2009, GENOME RES, V19, P521, DOI 10.1101/gr.074906.107; Gan XC, 2011, NATURE, V477, P419, DOI 10.1038/nature10414; Gao ZX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042637; Garcia-Lor A, 2013, ANN BOT-LONDON, V111, P1, DOI 10.1093/aob/mcs227; Garcia-Lor A, 2012, MOL GENET GENOMICS, V287, P77, DOI 10.1007/s00438-011-0658-4; Garg R, 2011, DNA RES, V18, P53, DOI 10.1093/dnares/dsq028; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hamon P, 2003, GENETIC DIVERSITY CU; Iorizzo M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-389; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Jayaprakasha GK, 2008, LWT-FOOD SCI TECHNOL, V41, P376, DOI 10.1016/j.lwt.2007.03.017; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kao TH, 2004, PLANT CELL, V16, pS72, DOI 10.1105/tpc.016154; Krost C, 2012, GENE, V498, P223, DOI 10.1016/j.gene.2012.01.078; Li DJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-192; Li HY, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-9; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Liang C, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-146; Liu FL, 2014, J APPL PHYCOL, V26, P1519, DOI 10.1007/s10811-013-0140-2; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Liu Y, 2004, ZHONGGUO NONGYE KEXU, V38, P2308; [LIU Yongzhong 刘永忠], 2006, [华中农业大学学报, Journal of Huazhong Agricultural University], V25, P300; Liu ZP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083549; Luro F, 2011, PLANT GENET RESOUR-C, V9, P218, DOI 10.1017/S1479262111000189; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Mokbel MS, 2006, FOOD CHEM, V94, P529, DOI 10.1016/j.foodchem.2004.11.042; Munoz-Merida A, 2013, DNA RES, V20, P93, DOI 10.1093/dnares/dss036; Nicolosi E, 2000, THEOR APPL GENET, V100, P1155, DOI 10.1007/s001220051419; Nunez-Acuna G, 2014, COMP BIOCHEM PHYS D, V10, P9, DOI 10.1016/j.cbd.2014.01.003; Ollitrault P, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-13; Peng J. H., 2005, Functional & Integrative Genomics, V5, P80, DOI 10.1007/s10142-004-0128-8; Pichaiyongvongdeeand S., 2009, Kasetsart Journal, Natural Sciences, V43, P458; Reis-Filho JS, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2431; Roberts A, 2011, BIOINFORMATICS, V27, P2325, DOI 10.1093/bioinformatics/btr355; Rohlf FJ, 1998, NTSYS PC NUMERICAL T; Rosenkranz R, 2008, GENOMICS, V92, P187, DOI 10.1016/j.ygeno.2008.05.011; Ruiz C, 2000, EUPHYTICA, V112, P89, DOI 10.1023/A:1003992719598; Salgado LR, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-236; Sassa H, 2010, SEX PLANT REPROD, V23, P39, DOI 10.1007/s00497-009-0111-6; SCORA RW, 1975, B TORREY BOT CLUB, V102, P369, DOI 10.2307/2484763; Shi CY, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-131; Su CL, 2011, PLANT CELL PHYSIOL, V52, P1501, DOI 10.1093/pcp/pcr097; Varshney RK, 2009, TRENDS BIOTECHNOL, V27, P522, DOI 10.1016/j.tibtech.2009.05.006; Wang SF, 2012, PLANT CELL REP, V31, P1437, DOI 10.1007/s00299-012-1259-3; Wang Y, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-836; Wang ZY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-726; Wei WL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-451; Wu B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094506; Wu CS, 2014, GENOME RES, V24, P25, DOI 10.1101/gr.159483.113; Xu Q, 2013, NAT GENET, V45, P59, DOI 10.1038/ng.2472; Yamamoto M, 2006, J JPN SOC HORTIC SCI, V75, P372, DOI 10.2503/jjshs.75.372; Yates SA, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-453; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yu KQ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-10; Yu Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087218; Zenoni S, 2010, PLANT PHYSIOL, V152, P1787, DOI 10.1104/pp.109.149716; Zhang JA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-90; Zhang MX, 2011, FOOD CHEM, V129, P1530, DOI 10.1016/j.foodchem.2011.05.136	77	21	25	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120615	10.1371/journal.pone.0120615	http://dx.doi.org/10.1371/journal.pone.0120615			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799271	gold, Green Submitted, Green Published			2022-12-26	WOS:000351987300158
J	Mellenius, H; Ehrenberg, M				Mellenius, Harriet; Ehrenberg, Mans			DNA Template Dependent Accuracy Variation of Nucleotide Selection in Transcription	PLOS ONE			English	Article							RNA-POLYMERASE-II; TRIGGER LOOP; FIDELITY; MODEL; ELONGATION; RECOGNITION; TRANSLATION; MECHANISM; ERRORS	It has been commonly assumed that the effect of erroneous transcription of DNA genes into messenger RNAs on peptide sequence errors are masked by much more frequent errors of mRNA translation to protein. We present a theoretical model of transcriptional accuracy. It uses experimentally estimated standard free energies of double-stranded DNA and RNA/DNA hybrids and predicts a DNA template dependent transcriptional accuracy variation spanning several orders of magnitude. The model also identifies high-error as well a high-accuracy transcription motifs. The source of the large accuracy span is the context dependent variation of the stacking free energy of pairs of correct and incorrect base pairs in the ever moving transcription bubble. Our model predictions have direct experimental support from recent single molecule based identifications of transcriptional errors in the C. elegans transcriptome. Our conclusions challenge the general view that amino acid substitution errors in proteins are mainly caused by translational errors. It suggests instead that transcriptional error hotspots are the dominating source of peptide sequence errors in some DNA template contexts, while mRNA translation is the major cause of protein errors in other contexts.	[Mellenius, Harriet; Ehrenberg, Mans] Uppsala Univ, Dept Cell & Mol Biol, Biomed Ctr, S-75124 Uppsala, Sweden	Uppsala University	Ehrenberg, M (corresponding author), Uppsala Univ, Dept Cell & Mol Biol, Biomed Ctr, Box 596, S-75124 Uppsala, Sweden.	ehrenberg@xray.bmc.uu.se			Vinnova; Knut and Alice Wallenberg Foundation; Swedish Research Council	Vinnova(Vinnova); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by grants from Vinnova, Knut and Alice Wallenberg Foundation and the Swedish Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alic N, 2007, P NATL ACAD SCI USA, V104, P10400, DOI 10.1073/pnas.0704116104; Bai L, 2004, J MOL BIOL, V344, P335, DOI 10.1016/j.jmb.2004.08.107; Bai L, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.068103; BLANK A, 1986, BIOCHEMISTRY-US, V25, P5920, DOI 10.1021/bi00368a013; Bochkareva A, 2012, EMBO J, V31, P630, DOI 10.1038/emboj.2011.432; BORUKHOV S, 1993, CELL, V72, P459, DOI 10.1016/0092-8674(93)90121-6; BOUADLOUN F, 1983, EMBO J, V2, P1351, DOI 10.1002/j.1460-2075.1983.tb01591.x; Bremer H., 1987, ESCHERICHIA COLI SAL, V2, P1527, DOI [10.1046/j.1365-2486.2000.06017.x, DOI 10.1046/J.1365-2486.2000.06017.X]; Buckstein MH, 2008, J BACTERIOL, V190, P718, DOI 10.1128/JB.01020-07; EHRENBERG M, 1984, Q REV BIOPHYS, V17, P45, DOI 10.1017/S0033583500005254; EHRENBERG M, 1980, BIOPHYS J, V31, P333, DOI 10.1016/S0006-3495(80)85063-6; ERIE DA, 1993, SCIENCE, V262, P867, DOI 10.1126/science.8235608; Fersht A., 1999, STRUCTURE MECH PROTE, P153; Fersht A., 1999, STRUCTURE MECH PROTE, P103; Gout JF, 2013, P NATL ACAD SCI USA, V110, P18584, DOI 10.1073/pnas.1309843110; Guajardo R, 1997, J MOL BIOL, V265, P8, DOI 10.1006/jmbi.1996.0707; HOPFIELD JJ, 1976, P NATL ACAD SCI USA, V73, P1164, DOI 10.1073/pnas.73.4.1164; HOPFIELD JJ, 1974, P NATL ACAD SCI USA, V71, P4135, DOI 10.1073/pnas.71.10.4135; Imashimizu M, 2013, NUCLEIC ACIDS RES, V41, P9090, DOI 10.1093/nar/gkt698; Itzkovitz S, 2007, GENOME RES, V17, P405, DOI 10.1101/gr.5987307; Jeon C, 1996, P NATL ACAD SCI USA, V93, P13677, DOI 10.1073/pnas.93.24.13677; Johansson M, 2008, CURR OPIN MICROBIOL, V11, P141, DOI 10.1016/j.mib.2008.02.015; Johansson M, 2012, P NATL ACAD SCI USA, V109, P131, DOI 10.1073/pnas.1116480109; Keseler IM, 2013, NUCLEIC ACIDS RES, V41, pD605, DOI 10.1093/nar/gks1027; Korzheva N, 2000, SCIENCE, V289, P619, DOI 10.1126/science.289.5479.619; Kramer EB, 2007, RNA, V13, P87, DOI 10.1261/rna.294907; Larson MH, 2012, P NATL ACAD SCI USA, V109, P6555, DOI 10.1073/pnas.1200939109; Mellenius Harriet, 2013, NATO Advanced Study Institute on Biophysics and Structure to Counter Threats and Challenges. Proceedings, P39, DOI 10.1007/978-94-007-4923-8_3; Miropolskaya N, 2014, NUCLEIC ACIDS RES, V42, P544, DOI 10.1093/nar/gkt877; Nedialkov YA, 2003, J BIOL CHEM, V278, P18303, DOI 10.1074/jbc.M301103200; NINIO J, 1975, BIOCHIMIE, V57, P587, DOI 10.1016/S0300-9084(75)80139-8; NINIO J, 1991, BIOCHIMIE, V73, P1517, DOI 10.1016/0300-9084(91)90186-5; Nudler E, 1997, CELL, V89, P33, DOI 10.1016/S0092-8674(00)80180-4; Ogle JM, 2001, SCIENCE, V292, P897, DOI 10.1126/science.1060612; ORLOVA M, 1995, P NATL ACAD SCI USA, V92, P4596, DOI 10.1073/pnas.92.10.4596; SantaLucia J, 1998, P NATL ACAD SCI USA, V95, P1460, DOI 10.1073/pnas.95.4.1460; Satpati P, 2014, BIOCHEMISTRY-US, V53, P1714, DOI 10.1021/bi5000355; Sosunova E, 2013, J BIOL CHEM, V288, P6688, DOI 10.1074/jbc.M112.424002; SPRINGGATE CF, 1975, J MOL BIOL, V97, P577, DOI 10.1016/S0022-2836(75)80060-X; SUGIMOTO N, 1995, BIOCHEMISTRY-US, V34, P11211, DOI 10.1021/bi00035a029; Wang D, 2009, SCIENCE, V324, P1203, DOI 10.1126/science.1168729; Watkins NE, 2011, NUCLEIC ACIDS RES, V39, P1894, DOI 10.1093/nar/gkq905; YAGER TD, 1991, BIOCHEMISTRY-US, V30, P1097, DOI 10.1021/bi00218a032; Zenkin N, 2006, SCIENCE, V313, P518, DOI 10.1126/science.1127422	44	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0119588	10.1371/journal.pone.0119588	http://dx.doi.org/10.1371/journal.pone.0119588			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799551	Green Published, Green Submitted, gold			2022-12-26	WOS:000351987300062
J	Teixeira, AS; Monteiro, PT; Carrico, JA; Ramirez, M; Francisco, AP				Teixeira, Andreia Sofia; Monteiro, Pedro T.; Carrico, Joao A.; Ramirez, Mario; Francisco, Alexandre P.			Not Seeing the Forest for the Trees: Size of the Minimum Spanning Trees (MSTs) Forest and Branch Significance in MST-Based Phylogenetic Analysis	PLOS ONE			English	Article							RECOMBINATION; EVOLUTION; GENOME	Trees, including minimum spanning trees (MSTs), are commonly used in phylogenetic studies. But, for the research community, it may be unclear that the presented tree is just a hypothesis, chosen from among many possible alternatives. In this scenario, it is important to quantify our confidence in both the trees and the branches/edges included in such trees. In this paper, we address this problem for MSTs by introducing a new edge betweenness metric for undirected and weighted graphs. This spanning edge betweenness metric is defined as the fraction of equivalent MSTs where a given edge is present. The metric provides a per edge statistic that is similar to that of the bootstrap approach frequently used in phylogenetics to support the grouping of taxa. We provide methods for the exact computation of this metric based on the well known Kirchhoff's matrix tree theorem. Moreover, we implement and make available a module for the PHYLOViZ software and evaluate the proposed metric concerning both effectiveness and computational performance. Analysis of trees generated using multilocus sequence typing data (MLST) and the goeBURST algorithm revealed that the space of possible MSTs in real data sets is extremely large. Selection of the edge to be represented using bootstrap could lead to unreliable results since alternative edges are present in the same fraction of equivalent MSTs. The choice of the MST to be presented, results from criteria implemented in the algorithm that must be based in biologically plausible models.	[Teixeira, Andreia Sofia; Monteiro, Pedro T.; Carrico, Joao A.; Francisco, Alexandre P.] INESC ID Lisboa, Lisbon, Portugal; [Teixeira, Andreia Sofia; Monteiro, Pedro T.; Francisco, Alexandre P.] Univ Lisbon, Inst Super Tecn, P-1699 Lisbon, Portugal; [Teixeira, Andreia Sofia; Carrico, Joao A.; Ramirez, Mario] Univ Lisbon, Fac Med, Inst Mol Med, Inst Microbiol, P-1699 Lisbon, Portugal	INESC-ID; Universidade de Lisboa; Universidade de Lisboa; Instituto Superior Tecnico; Universidade de Lisboa	Francisco, AP (corresponding author), INESC ID Lisboa, Lisbon, Portugal.	aplf@tecnico.pt	Monteiro, Pedro T./E-5113-2010; Carriço, Joao André/A-7367-2008; Francisco, Alexandre/B-9429-2009; Ramirez, Mario/B-4993-2008; Teixeira, Andreia Sofia Monteiro/N-1702-2018	Monteiro, Pedro T./0000-0002-7934-5495; Carriço, Joao André/0000-0002-5274-2722; Francisco, Alexandre/0000-0003-4852-1641; Ramirez, Mario/0000-0002-4084-6233; Teixeira, Andreia Sofia Monteiro/0000-0002-2758-1891	FCT-Fundacao para a Ciencia e Tecnologia [NETDYN PTDC/EIA-CCO/118533/2010, DATASTORM EXCL/EEI-ESS/0257/2012, UID/CEC/50021/2013]; Fundação para a Ciência e a Tecnologia [EXCL/EEI-ESS/0257/2012, PTDC/EIA-CCO/118533/2010] Funding Source: FCT	FCT-Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and Technology); Fundação para a Ciência e a Tecnologia	AST, PTM, JAC and APF were partly supported by national funds through FCT-Fundacao para a Ciencia e Tecnologia (http://www.fct.pt/), under project/grants NETDYN PTDC/EIA-CCO/118533/2010, DATASTORM EXCL/EEI-ESS/0257/2012 and UID/CEC/50021/2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borgatti S.P., 2006, SOC NETWORKS, V28, P466, DOI DOI 10.1016/J.S0CNET.2005.11.005; Broder AZ, 1997, J ALGORITHM, V24, P171, DOI 10.1006/jagm.1996.0851; Cormen TH, 2001, INTRODUCTION TO ALGO; Costa LD, 2007, ADV PHYS, V56, P167, DOI 10.1080/00018730601170527; Darwin C, 1861, ALBEMARLE STREET; Edmonds Jack, 1971, MATH PROGRAM, V1, P127, DOI [10.1007/BF01584082, DOI 10.1007/BF01584082]; Eppstein D, 1995, TECHNICAL REPORT 95; EXCOFFIER L, 1994, GENETICS, V136, P343; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Felsenstein J., 2004, INFERRING PHYLOGENIE; Flannery B. P., 1992, NUMERICAL RECIPES IN; Francisco AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-87; Francisco AP, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-152; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; GAVRIL F, 1987, J ALGORITHM, V8, P592, DOI 10.1016/0196-6774(87)90053-8; GEORGE A, 1988, SIAM J SCI STAT COMP, V9, P849, DOI 10.1137/0909057; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Harris J, 2008, COMBINATORICS AND GR; Kasner E, 2001, MATHEMATICS AND THE; Kirchhoff G., 1847, ANN PHYS CHEM, V72, P497, DOI [DOI 10.1002/ANDP.18471481202, 10.1002/andp.18471481202]; Kohl TA, 2014, J CLIN MICROBIOL, V52, P2479, DOI 10.1128/JCM.00567-14; Kong Y, 2013, GENOME BIOL EVOL, V5, P1611, DOI 10.1093/gbe/evt116; Kruskal J.B., 1956, P AM MATH SOC, V7, P48, DOI [10.1090/S0002-9939-1956-0078686-7, DOI 10.1090/S0002-9939-1956-0078686-7, 10.2307/2033241]; LEWIN M, 1982, MATH Z, V181, P55, DOI 10.1007/BF01214981; Maiden MCJ, 2013, NAT REV MICROBIOL, V11, P728, DOI 10.1038/nrmicro3093; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Muzzi A, 2011, INT J MED MICROBIOL, V301, P619, DOI 10.1016/j.ijmm.2011.09.008; Papadimitriou C.H., 1998, COMBINATORIAL OPTIMI, VUnabridged edition; Pearson T, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-78; Salipante SJ, 2011, J CLIN MICROBIOL, V49, P3568, DOI 10.1128/JCM.00919-11; Smith JM, 2000, BIOESSAYS, V22, P1115, DOI 10.1002/1521-1878(200012)22:12&lt;1115::AID-BIES9&gt;3.0.CO;2-R; SNEATH P. H., 1973, NUMERICAL TAXONOMY T; TUTTE WT, 1965, J RES NATL BUR STAND, VB 69, P1, DOI 10.6028/jres.069B.001; Whitney H, 1935, AM J MATH, V57, P509, DOI 10.2307/2371182; Wilson DJ, 2009, MOL BIOL EVOL, V26, P385, DOI 10.1093/molbev/msn264	35	11	11	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0119315	10.1371/journal.pone.0119315	http://dx.doi.org/10.1371/journal.pone.0119315			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799056	Green Published, Green Submitted, gold			2022-12-26	WOS:000351987300036
J	Tseng, HL; Yang, SC; Yang, SH; Shieh, KR				Tseng, Huey-Ling; Yang, Shu-Chuan; Yang, Shih-Hsien; Shieh, Kun-Ruey			Hepatic Circadian-Clock System Altered by Insulin Resistance, Diabetes and Insulin Sensitizer in Mice	PLOS ONE			English	Article							ACTIVATED RECEPTOR-ALPHA; SUPRACHIASMATIC NUCLEUS; GENE-EXPRESSION; RHYTHMIC EXPRESSION; PERIPHERAL-TISSUES; METABOLIC SYNDROME; STREPTOZOTOCIN; LIVER; MOUSE; TRANSCRIPTION	Circadian rhythms are intrinsic rhythms that are coordinated with the rotation of the Earth and are also generated by a set of circadian-clock genes at the intracellular level. Growing evidence suggests a strong link between circadian rhythms and energy metabolism; however, the fundamental mechanisms remain unclear. In the present study, neonatal streptozotocin (STZ)-treated mice were used to model the molecular and physiological progress from insulin resistance to diabetes. Two-day-old male C57BL/6 mice received a single injection of STZ and were tested for non-obese, hyperglycemic and hyperinsulinemic conditions in the early stage, insulin resistance in the middle stage, and diabetes in the late stage. Gene expression levels of the hepatic circadian-clock system were examined by real-time quantitative PCR. Most of the components of the hepatic circadian-clock gene expression system, such as the mRNAs of Bmal1 (brain and muscle Arnt-like protein-1), Per2 (period 2) and Cry1 (cryptochrome 1), were elevated, and circadian patterns were retained in the early and middle stages of insulin-resistant conditions. The insulin sensitizer, rosiglitazone, returns the physiological and molecular changes associated with the diabetic phenotype to normal levels through peroxisome proliferator-activated receptor gamma (PPAR gamma) rather than PPAR alpha. Early and chronic treatment with rosiglitazone has been shown to be effective to counter the diabetic condition. Over time, this effect acts to attenuate the increased gene expression levels of the hepatic circadian-clock system and delay the severity of diabetic conditions. Together, these results support an essential role for the hepatic circadian-clock system in the coordinated regulation and/or response of metabolic pathways.	[Tseng, Huey-Ling; Yang, Shih-Hsien; Shieh, Kun-Ruey] Tzu Chi Univ, Inst Med Sci, Sch Med, Hualien, Taiwan; [Tseng, Huey-Ling; Yang, Shih-Hsien; Shieh, Kun-Ruey] Tzu Chi Univ, Sch Med, Dept Physiol, Hualien, Taiwan; [Yang, Shu-Chuan] Tzu Chi Coll Technol, Gen Educ Ctr, Hualien, Taiwan; [Yang, Shih-Hsien] Buddhist Tzu Chi Gen Hosp, Dept Rehabil Med, Hualien, Taiwan	Tzu Chi University; Tzu Chi University; Tzu Chi University of Science & Technology; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital	Shieh, KR (corresponding author), Tzu Chi Univ, Inst Med Sci, Sch Med, Hualien, Taiwan.	krshieh@mail.tcu.edu.tw			Ministry of Science and Technology in Taiwan [99-2320-B-320-011-MY3, 103-2410-H-277-001]; Tzu Chi Foundation [TCIRP98002-04, TCRPP99014, TCRPP100020, TCRPP103015, TCMRC-P-103007]; Tzu Chi General Hospital [TCRD102-25]	Ministry of Science and Technology in Taiwan(Ministry of Science and Technology, Taiwan); Tzu Chi Foundation; Tzu Chi General Hospital	Funding: This study was supported in part by the Ministry of Science and Technology in Taiwan (99-2320-B-320-011-MY3 to KRS and 103-2410-H-277-001 to SCY), the Tzu Chi Foundation (TCIRP98002-04, TCRPP99014, TCRPP100020, TCRPP103015 and TCMRC-P-103007 to KRS) and Tzu Chi General Hospital (TCRD102-25). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attia RR, 2010, J BIOL CHEM, V285, P2375, DOI 10.1074/jbc.M109.039081; Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; Bodosi B, 2004, AM J PHYSIOL-REG I, V287, pR1071, DOI 10.1152/ajpregu.00294.2004; BONNERWEIR S, 1981, DIABETES, V30, P64, DOI 10.2337/diabetes.30.1.64; Bugianesi E, 2005, HEPATOLOGY, V42, P987, DOI 10.1002/hep.20920; Bunger MK, 2005, GENESIS, V41, P122, DOI 10.1002/gene.20102; Burcelin R, 2008, ENDOCRINOLOGY, V149, P443, DOI 10.1210/en.2007-1507; Canaple L, 2006, MOL ENDOCRINOL, V20, P1715, DOI 10.1210/me.2006-0052; CANDELA S, 1979, EXPERIENTIA, V35, P1256, DOI 10.1007/BF01963323; Coomans CP, 2013, DIABETES, V62, P1102, DOI 10.2337/db12-0507; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; Das Sidhartha, 2007, Metabolic Syndrome and Related Disorders, V5, P136, DOI 10.1089/met.2006.0024; DEBOER SF, 1987, PHYSIOL BEHAV, V40, P323, DOI 10.1016/0031-9384(87)90054-0; Diano S, 2011, NAT MED, V17, P1121, DOI 10.1038/nm.2421; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Eckel-Mahan KL, 2013, CELL, V155, P1464, DOI 10.1016/j.cell.2013.11.034; Froy O, 2010, ENDOCR REV, V31, P1, DOI 10.1210/er.2009-0014; Gavrilova O, 2003, J BIOL CHEM, V278, P34268, DOI 10.1074/jbc.M300043200; Gomez-Abellan P, 2008, INT J OBESITY, V32, P121, DOI 10.1038/sj.ijo.0803689; Green CB, 2008, CELL, V134, P728, DOI 10.1016/j.cell.2008.08.022; Herichova I, 2005, MOL CELL BIOCHEM, V270, P223, DOI 10.1007/s11010-005-5323-y; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Herzig S, 2003, NATURE, V426, P190, DOI 10.1038/nature02110; Hofmann K, 2013, HORM METAB RES, V45, P629, DOI 10.1055/s-0033-1343462; Hsieh MC, 2010, INT J OBESITY, V34, P227, DOI 10.1038/ijo.2009.228; Jin J, 2013, J NEUROCHEM, V125, P410, DOI 10.1111/jnc.12190; Kataoka M, 2013, BIOCHEM BIOPH RES CO, V430, P1103, DOI 10.1016/j.bbrc.2012.12.030; Kohsaka A, 2007, CELL METAB, V6, P414, DOI 10.1016/j.cmet.2007.09.006; Kondratov RV, 2006, GENE DEV, V20, P1868, DOI 10.1101/gad.1432206; Kuriyama K, 2004, FEBS LETT, V572, P206, DOI 10.1016/j.febslet.2004.07.036; la Fleur SE, 1999, J NEUROENDOCRINOL, V11, P643; Lahouaoui H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101584; Lamia KA, 2008, P NATL ACAD SCI USA, V105, P15172, DOI 10.1073/pnas.0806717105; Lauro D, 1998, NAT GENET, V20, P294, DOI 10.1038/3112; Lemberger T, 1996, J BIOL CHEM, V271, P1764, DOI 10.1074/jbc.271.3.1764; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Marcheva B, 2010, NATURE, V466, P627, DOI 10.1038/nature09253; Michael MD, 2000, MOL CELL, V6, P87, DOI 10.1016/S1097-2765(00)00010-1; NELSON W, 1979, CHRONOBIOLOGIA, V6, P305; Oishi K, 2004, BIOCHEM BIOPH RES CO, V317, P330, DOI 10.1016/j.bbrc.2004.03.055; Oishi K, 1998, BIOCHEM BIOPH RES CO, V253, P199, DOI 10.1006/bbrc.1998.9779; Oishi K, 2012, CHRONOBIOL INT, V29, P799, DOI 10.3109/07420528.2012.699127; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Pittas AG, 2004, J CLIN ENDOCR METAB, V89, P447, DOI 10.1210/jc.2003-031005; Ramsey KM, 2007, ANNU REV NUTR, V27, P219, DOI 10.1146/annurev.nutr.27.061406.093546; Rudic RD, 2004, PLOS BIOL, V2, P1893, DOI 10.1371/journal.pbio.0020377; Ruiter M, 2003, DIABETES, V52, P1709, DOI 10.2337/diabetes.52.7.1709; Rutter J, 2001, SCIENCE, V293, P510, DOI 10.1126/science.1060698; Sato M, 2014, CELL REP, V8, P392, DOI 10.1016/j.celrep.2014.06.015; Scott EM, 2008, INT J OBESITY, V32, P658, DOI 10.1038/sj.ijo.0803778; Shieh KR, 2005, J BIOMED SCI, V12, P209, DOI 10.1007/s11373-004-8176-6; Tsatsoulis A, 2013, METABOLISM, V62, P622, DOI 10.1016/j.metabol.2012.11.004; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Ueda HR, 2002, NATURE, V418, P534, DOI 10.1038/nature00906; Vu-Dac N, 1998, J BIOL CHEM, V273, P25713, DOI 10.1074/jbc.273.40.25713; Wu PF, 2001, BIOCHEM BIOPH RES CO, V287, P391, DOI 10.1006/bbrc.2001.5608; Yamajuku D, 2012, SCI REP-UK, V2, DOI 10.1038/srep00439; Yang GR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038117; Yang SC, 2013, CHRONOBIOL INT, V30, P796, DOI 10.3109/07420528.2013.766204; Yang SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017057; Zhang EE, 2010, NAT MED, V16, P1152, DOI 10.1038/nm.2214	61	16	17	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120380	10.1371/journal.pone.0120380	http://dx.doi.org/10.1371/journal.pone.0120380			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799429	Green Published, Green Submitted, gold			2022-12-26	WOS:000351987300139
J	Wittkopf, N; Pickert, G; Billmeier, U; Mahapatro, M; Wirtz, S; Martini, E; Leppkes, M; Neurath, MF; Becker, C				Wittkopf, Nadine; Pickert, Geethanjali; Billmeier, Ulrike; Mahapatro, Mousumi; Wirtz, Stefan; Martini, Eva; Leppkes, Moritz; Neurath, Markus Friedrich; Becker, Christoph			Activation of Intestinal Epithelial Stat3 Orchestrates Tissue Defense during Gastrointestinal Infection	PLOS ONE			English	Article							ESCHERICHIA-COLI; IN-VITRO; CELLS; EXPRESSION; DISEASE; COLONIZATION; SIGNALS; LOCI	Gastrointestinal infections with EHEC and EPEC are responsible for outbreaks of diarrheal diseases and represent a global health problem. Innate first-line-defense mechanisms such as production of mucus and antimicrobial peptides by intestinal epithelial cells are of utmost importance for host control of gastrointestinal infections. For the first time, we directly demonstrate a critical role for Stat3 activation in intestinal epithelial cells upon infection of mice with Citrobacter rodentium - a murine pathogen that mimics human infections with attaching and effacing Escherichia coli. C. rodentium induced transcription of IL-6 and IL-22 in gut samples of mice and was associated with activation of the transcription factor Stat3 in intestinal epithelial cells. C. rodentium infection induced expression of several antimicrobial peptides such as RegIII. and Pla2g2a in the intestine which was critically dependent on Stat3 activation. Consequently, mice with specific deletion of Stat3 in intestinal epithelial cells showed increased susceptibility to C. rodentium infection as indicated by high bacterial load, severe gut inflammation, pronounced intestinal epithelial cell death and dissemination of bacteria to distant organs. Together, our data implicate an essential role for Stat3 activation in intestinal epithelial cells during C. rodentium infection. Stat3 concerts the host response to bacterial infection by controlling bacterial growth and suppression of apoptosis to maintain intestinal epithelial barrier function.	[Wittkopf, Nadine; Billmeier, Ulrike; Mahapatro, Mousumi; Wirtz, Stefan; Martini, Eva; Leppkes, Moritz; Neurath, Markus Friedrich; Becker, Christoph] Univ Erlangen Nurnberg, Dept Med 1, D-91052 Erlangen, Germany; [Pickert, Geethanjali] Johannes Gutenberg Univ Mainz, Inst Translat Immunol, D-55131 Mainz, Germany	University of Erlangen Nuremberg; Johannes Gutenberg University of Mainz	Becker, C (corresponding author), Univ Erlangen Nurnberg, Dept Med 1, D-91052 Erlangen, Germany.	christoph.becker@uk-erlangen.de	Leppkes, Moritz/ABG-7617-2020; Leppkes, Moritz/N-2932-2017; Becker, Christoph/L-2996-2016; Becker, Christoph/A-6694-2008	Leppkes, Moritz/0000-0003-2311-090X; Wirtz, Stefan/0000-0001-6936-7431; Becker, Christoph/0000-0002-1388-1041	Interdisciplinary Center for Clinical Research (IZKF) of the University Erlangen-Nuremberg; European Community's 7th Framework Program (acronym BTCure); DFG [SFB796, SPP1656, KFO257, BE3686/2]	Interdisciplinary Center for Clinical Research (IZKF) of the University Erlangen-Nuremberg; European Community's 7th Framework Program (acronym BTCure); DFG(German Research Foundation (DFG))	The research leading to these results has received funding from the Interdisciplinary Center for Clinical Research (IZKF) of the University Erlangen-Nuremberg, the European Community's 7th Framework Program (acronym BTCure), and the DFG (SFB796, SPP1656, clinical research unit KFO257). NW was further supported by DFG grant BE3686/2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Becker C, 2003, J CLIN INVEST, V112, P693, DOI 10.1172/JCI200317464; Behnsen J, 2014, IMMUNITY, V40, P262, DOI 10.1016/j.immuni.2014.01.003; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; Cella M, 2009, NATURE, V457, P722, DOI 10.1038/nature07537; Clarke SC, 2003, CLIN MICROBIOL REV, V16, P365, DOI 10.1128/CMR.16.3.365-378.2003; Eckmann L, 2006, ANN NY ACAD SCI, V1072, P28, DOI 10.1196/annals.1326.008; EISENHAUER PB, 1992, INFECT IMMUN, V60, P3556, DOI 10.1128/IAI.60.9.3556-3565.1992; Elphick DA, 2005, GUT, V54, P1802, DOI 10.1136/gut.2005.068601; Flynn AN, 2008, MICROB PATHOGENESIS, V45, P98, DOI 10.1016/j.micpath.2007.12.004; Franke A, 2008, NAT GENET, V40, P713, DOI 10.1038/ng.148; Graham AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017171; Iimura M, 2005, J IMMUNOL, V174, P4901, DOI 10.4049/jimmunol.174.8.4901; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Kosek M, 2003, B WORLD HEALTH ORGAN, V81, P197; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Mudter J, 2005, AM J GASTROENTEROL, V100, P64, DOI 10.1111/j.1572-0241.2005.40615.x; Neufert C, 2010, CELL CYCLE, V9, P652, DOI 10.4161/cc.9.4.10615; Neurath MF, 2010, GASTROENTEROLOGY, V139, P1837, DOI 10.1053/j.gastro.2010.10.007; O'Neil DA, 1999, J IMMUNOL, V163, P6718; Pickert G, 2009, J EXP MED, V206, P1465, DOI 10.1084/jem.20082683; Rasband W., 2006, IMAGEJ; Riedel CU, 2007, APPL ENVIRON MICROB, V73, P7092, DOI 10.1128/AEM.01394-07; Robert Koch-Institut, 2011, ABSCHLIESSENDE DARST; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Satoh-Takayama N, 2008, IMMUNITY, V29, P958, DOI 10.1016/j.immuni.2008.11.001; Sawa S, 2011, NAT IMMUNOL, V12, P320, DOI 10.1038/ni.2002; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Wehkamp J, 2005, P NATL ACAD SCI USA, V102, P18129, DOI 10.1073/pnas.0505256102; Wittkopf N, 2014, J GASTROENTEROL, V49, P375, DOI 10.1007/s00535-013-0929-4; Wong CS, 2000, NEW ENGL J MED, V342, P1930, DOI 10.1056/NEJM200006293422601; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720; Zindl CL, 2013, P NATL ACAD SCI USA, V110, P12768, DOI 10.1073/pnas.1300318110	33	36	36	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0118401	10.1371/journal.pone.0118401	http://dx.doi.org/10.1371/journal.pone.0118401			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799189	gold, Green Published, Green Submitted			2022-12-26	WOS:000351987300007
J	Ogren, JI; Yi, A; Mamaev, S; Li, H; Spudich, JL; Rothschild, KJ				Ogren, John I.; Yi, Adrian; Mamaev, Sergey; Li, Hai; Spudich, John L.; Rothschild, Kenneth J.			Proton Transfers in a Channelrhodopsin-1 Studied by Fourier Transform Infrared (FTIR) Difference Spectroscopy and Site-directed Mutagenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SCHIFF-BASE COUNTERION; BACTERIORHODOPSIN PHOTOCYCLE; VIBRATIONAL SPECTROSCOPY; SENSORY RHODOPSIN; CONFORMATIONAL-CHANGES; RETINAL CHROMOPHORE; STRUCTURAL-CHANGES; PHOTOACTIVE SITE; NEURAL CIRCUITRY; RESONANCE RAMAN	Channelrhodopsin-1 from the alga Chlamydomonas augustae (CaChR1) is a low-efficiency light-activated cation channel that exhibits properties useful for optogenetic applications such as a slow light inactivation and a red-shifted visible absorption maximum as compared with the more extensively studied channelrhodopsin-2 from Chlamydomonas reinhardtii (CrChR2). Previously, both resonance Raman and low-temperature FTIR difference spectroscopy revealed that unlike CrChR2, CaChR1 under our conditions exhibits an almost pure all-trans retinal composition in the unphotolyzed ground state and undergoes an all-trans to 13-cis isomerization during the primary photo-transition typical of other microbial rhodopsins such as bacteriorhodopsin (BR). Here, we apply static and rapid-scan FTIR difference spectroscopy along with site-directed mutagenesis to characterize the proton transfer events occurring upon the formation of the long-lived conducting P-2(380) state of CaChR1. Assignment of carboxylic C = O stretch bands indicates that Asp-299 (homolog to Asp-212 in BR) becomes protonated and Asp-169 (homolog to Asp-85 in BR) undergoes a net change in hydrogen bonding relative to the unphotolyzed ground state of CaChR1. These data along with earlier FTIR measurements on the CaChR1 -> P1 transition are consistent with a two-step proton relay mechanism that transfers a proton from Glu-169 to Asp-299 during the primary phototransition and from the Schiff base to Glu-169 during P-2(380) formation. The unusual charge neutrality of both Schiff base counterions in the P-2(380) conducting state suggests that these residues may function as part of a cation selective filter in the open channel state of CaChR1 as well as other low-efficiency ChRs.	[Ogren, John I.; Yi, Adrian; Mamaev, Sergey; Rothschild, Kenneth J.] Boston Univ, Photon Ctr, Mol Biophys Lab, Boston, MA 02215 USA; [Ogren, John I.; Yi, Adrian; Mamaev, Sergey; Rothschild, Kenneth J.] Boston Univ, Dept Phys, Boston, MA 02215 USA; [Li, Hai; Spudich, John L.] Univ Texas Houston, Hlth Sci Ctr, Ctr Membrane Biol, Dept Biochem & Mol Biol, Houston, TX 77030 USA	Boston University; Boston University; University of Texas System; University of Texas Health Science Center Houston	Rothschild, KJ (corresponding author), Boston Univ, Dept Phys, 590 Commonwealth Ave, Boston, MA 02215 USA.	kjr@bu.edu	Regan, Clinton/E-6250-2012; Rothschild, Kenneth J/P-6177-2018	Rothschild, Kenneth J/0000-0002-2847-6671	National Science Foundation [CBET-1264434]; National Institutes of Health [5R01EY21022, R01GM027750]; Robert A. Welch Foundation [AU-0009]; NATIONAL EYE INSTITUTE [R01EY021022] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM027750] Funding Source: NIH RePORTER; Div Of Chem, Bioeng, Env, & Transp Sys [1264434] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Div Of Chem, Bioeng, Env, & Transp Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This work was supported by National Science Foundation Grant CBET-1264434 and National Institutes of Health Grants 5R01EY21022 (to K. J. R.) and R01GM027750 (to J. L. S.). This work was also supported by the Hermann Eye Fund and Endowed Chair AU-0009 from the Robert A. Welch Foundation (to J. L. S.).	Arenkiel BR, 2007, NEURON, V54, P205, DOI 10.1016/j.neuron.2007.03.005; Bergo V, 2004, BIOCHEMISTRY-US, V43, P9075, DOI 10.1021/bi0361968; Bergo V, 2003, J BIOL CHEM, V278, P36556, DOI 10.1074/jbc.M303719200; Bergo V, 2002, PHOTOCHEM PHOTOBIOL, V76, P341, DOI 10.1562/0031-8655(2002)076<0341:AFTISO>2.0.CO;2; Bergo VB, 2006, J BIOL CHEM, V281, P15208, DOI 10.1074/jbc.M600033200; BOUSCHE O, 1992, PHOTOCHEM PHOTOBIOL, V56, P1085, DOI 10.1111/j.1751-1097.1992.tb09732.x; BOUSCHE O, 1991, J BIOL CHEM, V266, P11063; BRAIMAN MS, 1988, BIOCHEMISTRY-US, V27, P8516, DOI 10.1021/bi00423a002; BROWN LS, 1995, J BIOL CHEM, V270, P27122, DOI 10.1074/jbc.270.45.27122; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; FAHMY K, 1993, BIOCHEMISTRY-US, V32, P5862, DOI 10.1021/bi00073a020; Gradinaru V, 2009, SCIENCE, V324, P354, DOI 10.1126/science.1167093; Hendler RW, 2011, APPL SPECTROSC, V65, P1029, DOI 10.1366/11-06302; HIRAYMA J, 1995, FEBS LETT, V364, P168, DOI 10.1016/0014-5793(95)00381-I; HONIG B, 1979, J AM CHEM SOC, V101, P7084, DOI 10.1021/ja00517a060; Hou SY, 2012, PHOTOCHEM PHOTOBIOL, V88, P119, DOI 10.1111/j.1751-1097.2011.01027.x; Ito S, 2014, J AM CHEM SOC, V136, P3475, DOI 10.1021/ja410836g; Kato HE, 2012, NATURE, V482, P369, DOI 10.1038/nature10870; Kokaia M, 2011, DRUG TODAY, V47, P53, DOI 10.1358/dot.2011.47.1.1543306; Kraj JM, 2008, BIOCHEMISTRY-US, V47, P3447, DOI 10.1021/bi7018964; Lanyi JK, 2006, BBA-BIOENERGETICS, V1757, P1012, DOI 10.1016/j.bbabio.2005.11.003; Li H, 2014, BIOPHYS J, V106, P1607, DOI 10.1016/j.bpj.2014.03.002; Lorenz-Fonfria VA, 2014, J CHEM PHYS, V141, DOI 10.1063/1.4895796; Luecke H, 2000, J MOL BIOL, V300, P1237, DOI 10.1006/jmbi.2000.3884; Luecke H, 1999, J MOL BIOL, V291, P899, DOI 10.1006/jmbi.1999.3027; MAEDA A, 1992, BIOCHEMISTRY-US, V31, P4684, DOI 10.1021/bi00134a022; Muders V, 2014, FEBS LETT, V588, P2301, DOI 10.1016/j.febslet.2014.05.019; Nack M, 2009, FEBS LETT, V583, P3676, DOI 10.1016/j.febslet.2009.10.052; Neumann-Verhoefen MK, 2013, J AM CHEM SOC, V135, P6968, DOI 10.1021/ja400554y; Ogren JI, 2015, BIOCHEMISTRY-US, V54, P377, DOI 10.1021/bi501243y; Ogren JI, 2014, BIOCHEMISTRY-US, V53, P3961, DOI 10.1021/bi500445c; Rath P, 1996, BIOCHEMISTRY-US, V35, P6690, DOI 10.1021/bi9600355; RATH P, 1993, J BIOL CHEM, V268, P17742; ROEPE P, 1987, BIOCHEMISTRY-US, V26, P6696, DOI 10.1021/bi00395a020; ROEPE PD, 1988, J BIOL CHEM, V263, P5110; ROTHSCHILD KJ, 1990, J BIOL CHEM, V265, P16985; Sineshchekov OA, 2002, P NATL ACAD SCI USA, V99, P8689, DOI 10.1073/pnas.122243399; Sineshchekov OA, 2013, BIOPHYS J, V104, P807, DOI 10.1016/j.bpj.2013.01.002; SMITH SO, 1987, J PHYS CHEM-US, V91, P804, DOI 10.1021/j100288a011; Spudich JL, 2014, BBA-BIOENERGETICS, V1837, P546, DOI 10.1016/j.bbabio.2013.06.006; Zhang F, 2011, CELL, V147, P1446, DOI 10.1016/j.cell.2011.12.004	41	20	20	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2015	290	20					12719	12730		10.1074/jbc.M114.634840	http://dx.doi.org/10.1074/jbc.M114.634840			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI2IF	25802337	Green Published, hybrid			2022-12-26	WOS:000354569000024
J	Andersson, LE; Valtat, B; Bagge, A; Sharoyko, VV; Nicholls, DG; Ravassard, P; Scharfmann, R; Spegel, P; Mulder, H				Andersson, Lotta E.; Valtat, Berengere; Bagge, Annika; Sharoyko, Vladimir V.; Nicholls, David G.; Ravassard, Philippe; Scharfmann, Raphael; Spegel, Peter; Mulder, Hindrik			Characterization of Stimulus-Secretion Coupling in the Human Pancreatic EndoC-beta H1 Beta Cell Line	PLOS ONE			English	Article							SENSITIVE K+ CHANNEL; INSULIN-SECRETION; INS-1 832/13; MITOCHONDRIAL BIOENERGETICS; GLUCOSE; ISLETS; OSCILLATIONS; PYRUVATE; IDENTIFICATION; SECRETAGOGUES	Aims/Hypothesis Studies on beta cell metabolism are often conducted in rodent beta cell lines due to the lack of stable human beta cell lines. Recently, a human cell line, EndoC-beta H1, was generated. Here we investigate stimulus-secretion coupling in this cell line, and compare it with that in the rat beta cell line, INS-1 832/13, and human islets. Methods Cells were exposed to glucose and pyruvate. Insulin secretion and content (radioimmunoassay), gene expression (Gene Chip array), metabolite levels (GC/MS), respiration (Seahorse XF24 Extracellular Flux Analyzer), glucose utilization (radiometric), lactate release (enzymatic colorimetric), ATP levels (enzymatic bioluminescence) and plasma membrane potential and cytoplasmic Ca2+ responses (microfluorometry) were measured. Metabolite levels, respiration and insulin secretion were examined in human islets. Results Glucose increased insulin release, glucose utilization, raised ATP production and respiratory rates in both lines, and pyruvate increased insulin secretion and respiration. EndoC-beta H1 cells exhibited higher insulin secretion, while plasma membrane depolarization was attenuated, and neither glucose nor pyruvate induced oscillations in intracellular calcium concentration or plasma membrane potential. Metabolite profiling revealed that glycolytic and TCA-cycle intermediate levels increased in response to glucose in both cell lines, but responses were weaker in EndoC-beta H1 cells, similar to those observed in human islets. Respiration in EndoC-beta H1 cells was more similar to that in human islets than in INS-1 832/13 cells. Conclusions/Interpretation Functions associated with early stimulus-secretion coupling, with the exception of plasma membrane potential and Ca2+ oscillations, were similar in the two cell lines; insulin secretion, respiration and metabolite responses were similar in EndoC-beta H1 cells and human islets. While both cell lines are suitable in vitro models, with the caveat of replicating key findings in isolated islets, EndoC-beta H1 cells have the advantage of carrying the human genome, allowing studies of human genetic variants, epigenetics and regulatory RNA molecules.	[Andersson, Lotta E.; Valtat, Berengere; Bagge, Annika; Sharoyko, Vladimir V.; Nicholls, David G.; Spegel, Peter; Mulder, Hindrik] Lund Univ, CRC, Ctr Diabet, Dept Clin Sci,Unit Mol Metab, Malmo, Sweden; [Nicholls, David G.] Buck Inst Res Aging, Novato, CA USA; [Ravassard, Philippe] Univ Paris 06, Ctr Rech Inst Cerveau & Moelle Epiniere CRICM, Biotechnol & Biotherapy Team, UMRS 975, Paris, France; [Scharfmann, Raphael] Univ Paris 05, Sorbonne Paris Cite, Fac Med, Cochin Inst,INSERM,U1016, Paris, France	Lund University; Buck Institute for Research on Aging; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Andersson, LE (corresponding author), Lund Univ, CRC, Ctr Diabet, Dept Clin Sci,Unit Mol Metab, Malmo, Sweden.	lotta.andersson@med.lu.se	Bagge, Annika/A-4151-2015; scharfmann, raphael/L-3296-2017; Sharoyko, Vladimir/J-3625-2014; Spégel, Peter/G-9947-2018	Bagge, Annika/0000-0002-3897-9512; Sharoyko, Vladimir/0000-0002-3717-0471; Spégel, Peter/0000-0002-6092-2387; ravassard, philippe/0000-0002-0393-9262; Mulder, Hindrik/0000-0002-6593-8417; Scharfmann, Raphael/0000-0001-7619-337X	Crafoordska foundation; Knut and Alice Wallenberg foundation; Lars Hiertas Minne foundation; Soderberg foundation; O.E. och Edla Johansson foundation; Albert Pahlsson foundation; Swedish Research Council [VR 14196-12-5]	Crafoordska foundation; Knut and Alice Wallenberg foundation(Knut & Alice Wallenberg Foundation); Lars Hiertas Minne foundation; Soderberg foundation; O.E. och Edla Johansson foundation; Albert Pahlsson foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission)	This study was funded by research grants from the Crafoordska (www.crafoord.se), Knut and Alice Wallenberg (www.wallenberg.com/kaw), Lars Hiertas Minne (www.larshiertasminne.se), Soderberg (www.torstensoderbergsstiftelse.se), O.E. och Edla Johansson (www.stiftelsen.rago.se), and Albert Pahlsson foundations, and the Swedish Research Council (VR 14196-12-5, www.vr.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antinozzi PA, 2002, J BIOL CHEM, V277, P11746, DOI 10.1074/jbc.M108462200; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Brissova M, 2005, J HISTOCHEM CYTOCHEM, V53, P1087, DOI 10.1369/jhc.5C6684.2005; Casimir M, 2009, BIOCHEM J, V424, P459, DOI 10.1042/BJ20090729; Danielsson APH, 2010, ANAL BIOCHEM, V404, P30, DOI 10.1016/j.ab.2010.04.013; de la Tour DD, 2001, MOL ENDOCRINOL, V15, P476; DEVOS A, 1995, J CLIN INVEST, V96, P2489, DOI 10.1172/JCI118308; ELAYAT AA, 1995, J ANAT, V186, P629; Fernandez C, 2008, J PROTEOME RES, V7, P400, DOI 10.1021/pr070547d; Ferrannini E, 2010, CELL METAB, V11, P349, DOI 10.1016/j.cmet.2010.04.009; Goehring I, 2012, J BIOL CHEM, V287, P15706, DOI 10.1074/jbc.M111.314567; Gohring I, 2014, J BIOL CHEM, V289, P3786, DOI 10.1074/jbc.M113.507335; Gullberg J, 2004, ANAL BIOCHEM, V331, P283, DOI 10.1016/j.ab.2004.04.037; Henquin JC, 2009, DIABETOLOGIA, V52, P739, DOI 10.1007/s00125-009-1314-y; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; International Diabetes Federation, 2013, IDF DIABETES ATLAS; Ishihara H, 1999, J CLIN INVEST, V104, P1621, DOI 10.1172/JCI7515; Jitrapakdee S, 2010, DIABETOLOGIA, V53, P1019, DOI 10.1007/s00125-010-1685-0; Kanatsuna N, 2013, J BIOL CHEM, V288, P29013, DOI 10.1074/jbc.M113.478222; KINDMARK H, 1994, DIABETOLOGIA, V37, P1121, DOI 10.1007/s001250050225; KLEIBER M, 1947, PHYSIOL REV, V27, P511, DOI 10.1152/physrev.1947.27.4.511; Krus U, 2010, BIOCHEM J, V429, P205, DOI 10.1042/BJ20100142; MacDonald MJ, 2007, J BIOL CHEM, V282, P6043, DOI 10.1074/jbc.M606652200; Maechler P, 2001, NATURE, V414, P807, DOI 10.1038/414807a; Malmgren S, 2013, J BIOL CHEM, V288, P11973, DOI 10.1074/jbc.M112.422527; Malmgren S, 2009, J BIOL CHEM, V284, P32395, DOI 10.1074/jbc.M109.026708; Marmol P, 2009, J BIOL CHEM, V284, P515, DOI 10.1074/jbc.M806729200; Martin F, 1996, CELL CALCIUM, V20, P409, DOI 10.1016/S0143-4160(96)90003-2; MISLER S, 1992, DIABETES, V41, P1221, DOI 10.2337/diabetes.41.10.1221; Nagy KA, 2005, J EXP BIOL, V208, P1621, DOI 10.1242/jeb.01553; Nicholls DG, 2006, J BIOL CHEM, V281, P14864, DOI 10.1074/jbc.M510916200; Otonkoski T, 2007, AM J HUM GENET, V81, P467, DOI 10.1086/520960; Pullen TJ, 2010, ISLETS, V2, P89, DOI 10.4161/isl.2.2.11025; Ravassard P, 2011, J CLIN INVEST, V121, P3589, DOI 10.1172/JCI58447; Rolland JF, 2002, DIABETES, V51, P376, DOI 10.2337/diabetes.51.2.376; Scharfmann R, 2014, J CLIN INVEST, V124, P2087, DOI 10.1172/JCI72674; Scharfmann R, 2013, STEM CELL TRANSL MED, V2, P61, DOI 10.5966/sctm.2012-0120; Skelly RH, 1998, BIOCHEM J, V331, P553, DOI 10.1042/bj3310553; Spegel P, 2013, BIOCHEM J, V450, P595, DOI 10.1042/BJ20121349; Spegel P, 2011, BIOCHEM J, V435, P277, DOI 10.1042/BJ20100655; Tarasov A, 2004, DIABETES, V53, pS113, DOI 10.2337/diabetes.53.suppl_3.S113; Thorrez L, 2011, GENOME RES, V21, P95, DOI 10.1101/gr.109173.110; Trygg J, 2002, J CHEMOMETR, V16, P119, DOI 10.1002/cem.695; Wiederkehr A, 2012, MOL CELL ENDOCRINOL, V353, P128, DOI 10.1016/j.mce.2011.07.016; Wierup N, 2002, REGUL PEPTIDES, V107, P63, DOI 10.1016/S0167-0115(02)00067-8; Wiklund S, 2008, ANAL CHEM, V80, P115, DOI 10.1021/ac0713510; Wikstrom JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033023	47	48	48	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0120879	10.1371/journal.pone.0120879	http://dx.doi.org/10.1371/journal.pone.0120879			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803449	Green Published, gold, Green Submitted			2022-12-26	WOS:000353889600106
J	Tovar-Herrera, OE; Batista-Garcia, RA; Sanchez-Carbente, MD; Iracheta-Cardenas, MM; Arevalo-Nino, K; Folch-Mallol, JL				Eduardo Tovar-Herrera, Omar; Alberto Batista-Garcia, Ramon; del Rayo Sanchez-Carbente, Maria; Magdalena Iracheta-Cardenas, Maria; Arevalo-Nino, Katiushka; Luis Folch-Mallol, Jorge			A Novel Expansin Protein from the White-Rot Fungus Schizophyllum commune	PLOS ONE			English	Article							BACTERIAL EXPANSIN; ENZYMATIC-HYDROLYSIS; BACILLUS-SUBTILIS; CRYSTAL-STRUCTURE; SWOLLENIN; CELLULOSE; CHITIN; SACCHARIFICATION; SUPERFAMILY; EXPRESSION	A novel expansin protein (ScExlx1) was found, cloned and expressed from the Basidiomycete fungus Schizophylum commune. This protein showed the canonical features of plant expansins. ScExlx1 showed the ability to form "bubbles" in cotton fibers, reduce the size of avicel particles and enhance reducing sugar liberation from cotton fibers pretreated with the protein and then treated with cellulases. ScExlx1 was able to bind cellulose, birchwood xylan and chitin and this property was not affected by different sodium chloride concentrations. A novel property of ScExlx1 is its capacity to enhance reducing sugars (N-acetyl glucosamine) liberation from pretreated chitin and further added with chitinase, which has not been reported for any expansin or expansin-like protein. To the best of our knowledge, this is the first report of a bona fide fungal expansin found in a basidiomycete and we could express the bioactive protein in Pichia pastoris.	[Eduardo Tovar-Herrera, Omar; Magdalena Iracheta-Cardenas, Maria; Arevalo-Nino, Katiushka] Univ Autonoma Nuevo Leon, Fac Ciencias Biol, Inst Biotecnol, San Nicolas De Los Garza, Nuevo Leon, Mexico; [Alberto Batista-Garcia, Ramon; del Rayo Sanchez-Carbente, Maria; Luis Folch-Mallol, Jorge] Univ Autonoma Estado Morelos, Ctr Invest Biotecnol, Cuernavaca, Morelos, Mexico; [Alberto Batista-Garcia, Ramon] Univ Autonoma Estado Morelos, Fac Ciencias, Cuernavaca, Morelos, Mexico	Universidad Autonoma de Nuevo Leon; Universidad Autonoma del Estado de Morelos; Universidad Autonoma del Estado de Morelos	Arevalo-Nino, K (corresponding author), Univ Autonoma Nuevo Leon, Fac Ciencias Biol, Inst Biotecnol, San Nicolas De Los Garza, Nuevo Leon, Mexico.	katiushka.arevalonn@uanl.edu.mx; jordi@uaem.mx		Batista-Garcia, Ramon Alberto/0000-0002-1032-0767; Folch-Mallol, Jorge/0000-0002-1860-8175; Sanchez, Maria del Rayo/0000-0001-9586-3033	National Council for Science and Technology (CONACyT) from the Mexican government [CB-153789-Q, PAICYT-UANLCN-1008-11]; CONACyT; Europe Molecular Biology Organization in the Environmental Research Institute, University College Cork, Cork (Ireland) [EMBO: ASTF503-2013]	National Council for Science and Technology (CONACyT) from the Mexican government; CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Europe Molecular Biology Organization in the Environmental Research Institute, University College Cork, Cork (Ireland)	This work was funded by grant CB-153789-Q and PAICYT-UANLCN-1008-11 from the National Council for Science and Technology (CONACyT) from the Mexican government: http://www.conacyt.gob.mx. RAB-G and OET-H received a scholarship from CONACyT. The in silico analyses were performed during RAB-G's research stay funded by the Europe Molecular Biology Organization (EMBO: ASTF503-2013) in the Environmental Research Institute, University College Cork, Cork (Ireland). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen XA, 2010, APPL ENVIRON MICROB, V76, P2556, DOI 10.1128/AEM.02499-09; Cosgrove DJ, 1997, P NATL ACAD SCI USA, V94, P6559, DOI 10.1073/pnas.94.12.6559; Cosgrove DJ, 2000, NATURE, V407, P321, DOI 10.1038/35030000; DEREEPER A, 2008, NUCL ACIDS RES, V36; Dereeper A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-8; Dumetz AC, 2007, PROTEIN SCI, V16, P1867, DOI 10.1110/ps.072957907; Dutta PK, 2004, J SCI IND RES INDIA, V63, P20; Ferre F, 2005, NUCL ACIDS RES, V33; Georgelis N, 2014, CARBOHYD POLYM, V100, P17, DOI 10.1016/j.carbpol.2013.04.094; Georgelis N, 2011, J BIOL CHEM, V286, P16814, DOI 10.1074/jbc.M111.225037; Gourlay K, 2013, BIORESOURCE TECHNOL, V142, P498, DOI 10.1016/j.biortech.2013.05.053; Hamby SE, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-500; HOAGLIN DC, 1978, AM STAT, V32, P17, DOI 10.2307/2683469; Jager G, 2011, BIOTECHNOL BIOFUELS, V4, DOI 10.1186/1754-6834-4-33; Kang K, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-42; Kano R, 2002, J CLIN MICROBIOL, V40, P3535, DOI 10.1128/JCM.40.9.3535-3537.2002; Kende H, 2004, PLANT MOL BIOL, V55, P311, DOI 10.1007/s11103-004-0158-6; Kerff F, 2008, P NATL ACAD SCI USA, V105, P16876, DOI 10.1073/pnas.0809382105; Kim ES, 2009, BIOTECHNOL BIOENG, V102, P1342, DOI 10.1002/bit.22193; Kim IJ, 2013, APPL MICROBIOL BIOT, V97, P5381, DOI 10.1007/s00253-012-4412-6; Kim IJ, 2013, BIOTECHNOL BIOENG, V110, P401, DOI 10.1002/bit.24719; Lee HJ, 2013, BIORESOURCE TECHNOL, V149, P516, DOI 10.1016/j.biortech.2013.09.086; Lee HJ, 2010, MOL CELLS, V29, P379, DOI 10.1007/s10059-010-0033-z; Ohm RA, 2010, NAT BIOTECHNOL, V28, P957, DOI 10.1038/nbt.1643; Olarte-Lozano M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095638; Park BK, 2010, INT J MOL SCI, V11, P5153, DOI 10.3390/ijms11125152; Pastor N, 2014, ELECT ANAL BACTERIAL, P1; Pazzagli L, 2006, CELL BIOCHEM BIOPHYS, V44, P512, DOI 10.1385/CBB:44:3:512; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Premamalini T, 2011, CASE REP INFECT DIS, V2011, DOI 10.1155/2011/821259; Quiroz-Castaneda RE, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-8; Quiroz-Castaneda RE, 2009, ELECTRON J BIOTECHN, V12, DOI 10.2225/vol12-issue4-fulltext-3; Saloheimo M, 2002, EUR J BIOCHEM, V269, P4202, DOI 10.1046/j.1432-1033.2002.03095.x; Sampedro J, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-242; Simpson FR, 1939, EUGEN REV, V30, P298; Tanaka H, 2008, J VET MED SCI, V70, P1257, DOI 10.1292/jvms.70.1257; Von Hippel P. H., 1969, STRUCTURE STABILITY, P417; Wang MH, 2010, APPL BIOCHEM BIOTECH, V162, P2027, DOI 10.1007/s12010-010-8978-0; Yao Q, 2008, BIOSCI BIOTECH BIOCH, V72, P2799, DOI 10.1271/bbb.80124; Yennawar NH, 2006, P NATL ACAD SCI USA, V103, P14664, DOI 10.1073/pnas.0605979103; Zhang Y, 2013, SEGMENT ASSEMBLY STR, P2; Zhao Y, 2010, MAR DRUGS, V8, P24, DOI 10.3390/md8010024	43	26	28	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0122296	10.1371/journal.pone.0122296	http://dx.doi.org/10.1371/journal.pone.0122296			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803865	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000353889600194
J	Li, P; Shi, J; He, Q; Hu, Q; Wang, YY; Zhang, LJ; Chan, WT; Chen, WX				Li, Pu; Shi, Jing; He, Qiao; Hu, Qin; Wang, Yun Ying; Zhang, Li Jun; Chan, Wai Ting; Chen, Wei-Xian			Streptococcus pneumoniae Induces Autophagy through the Inhibition of the PI3K-I/Akt/mTOR Pathway and ROS Hypergeneration in A549 Cells	PLOS ONE			English	Article							EPITHELIAL-CELLS; TUBERCULOSIS; CLEARANCE; INFECTION; VIRULENCE; PROTECTS; DEFENSE; PMV158; DEATH	The present study focused on the action mechanism of S. pneumoniae (Sp) in inducing autophagy in human alveolar epithelial cells. Sp, a gram-positive extracellular bacterium, activates autophagy with considerably increased microtuble-associated protein light chain 3 (LC3) punctation in A549 cells. The accumulation of typical autophagosomes and conjugation of LC3 to phosphatidylethanolamine were observed in Sp-infected cells as an indication of autophagy. Using the pneumolysin (PLY) mutant, we successfully demonstrated that PLY is involved in initiating autophagy without affecting the expression levels of PI3K-III and Beclin1. PLY-mediated autophagy depends on the inhibition of the phosphoinositide 3-kinase/Akt/mammalian target of rapamycin (PI3K/Akt/mTOR) pathway. Furthermore, Sp could also lead to the reactive oxygen species (ROS) hypergeneration in A549 cells. Taken together, Sp infection-induced autophagy is PLY-mediated through ROS hypergeneration and mTOR inhibition. PI3K-I and rapamycin (autophagy inducers) enhanced bacterial clearance, whereas wortmannin (autophagy inhibitor) and acetylcysteine (ROS inhibitor) reduced intracellular bacteria clearance. Thus, Sp-induced autophagy represents a hostprotective mechanism, providing new insight into the pathogenesis of respiratory tract Sp infection.	[Li, Pu; He, Qiao; Hu, Qin; Wang, Yun Ying; Zhang, Li Jun; Chen, Wei-Xian] Chongqing Med Univ, Hosp 2, Dept Lab Med, Chongqing, Peoples R China; [Shi, Jing] Chongqing Med Univ, Hosp 1, Dept Lab Med, Chongqing, Peoples R China; [Chan, Wai Ting] CSIC, Ctr Invest Biol, Madrid, Spain	Chongqing Medical University; Chongqing Medical University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	Chen, WX (corresponding author), Chongqing Med Univ, Hosp 2, Dept Lab Med, Chongqing, Peoples R China.	chenweixian75@163.com			National Natural Science Foundation of China [81171628]; Spanish Ministry of Economy and Competitivity [CSD2008/00013]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Spanish Ministry of Economy and Competitivity(Spanish Government)	This project was supported by research grants from National Natural Science Foundation of China (no. 81171628). Author WTC was supported by the Spanish Ministry of Economy and Competitivity, grant CSD2008/00013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbuti G, 2010, FEMS IMMUNOL MED MIC, V60, P57, DOI 10.1111/j.1574-695X.2010.00716.x; BERRY AM, 1989, INFECT IMMUN, V57, P2037, DOI 10.1128/IAI.57.7.2037-2042.1989; Burghardt Robert C, 2006, Curr Protoc Microbiol, VChapter 2, DOI 10.1002/9780471729259.mc02b01s03; Byun YJ, 2009, NEUROSCI LETT, V461, P131, DOI 10.1016/j.neulet.2009.06.011; Castillo EF, 2012, P NATL ACAD SCI USA, V109, pE3168, DOI 10.1073/pnas.1210500109; Cho SH, 2004, FEBS LETT, V560, P7, DOI 10.1016/S0014-5793(04)00112-7; Choi AMK, 2013, NEW ENGL J MED, V368, P1845, DOI 10.1056/NEJMc1303158; Choy A, 2013, TRENDS MICROBIOL, V21, P451, DOI 10.1016/j.tim.2013.06.009; Codogno P, 2012, NAT REV MOL CELL BIO, V13, P7, DOI 10.1038/nrm3249; Conway KL, 2013, GASTROENTEROLOGY, V145, P1347, DOI 10.1053/j.gastro.2013.08.035; Deretic V, 2013, NAT REV IMMUNOL, V13, P722, DOI 10.1038/nri3532; Deretic V, 2011, IMMUNOL REV, V240, P92, DOI 10.1111/j.1600-065X.2010.00995.x; Eddens T, 2012, CURR OPIN IMMUNOL, V24, P424, DOI 10.1016/j.coi.2012.07.005; Gradstedt H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065626; Guo XG, 2013, BIOCHEM BIOPH RES CO, V432, P308, DOI 10.1016/j.bbrc.2013.01.111; Haspel JA, 2011, AM J RESP CRIT CARE, V184, P1237, DOI 10.1164/rccm.201106-0966CI; Huang J, 2011, ANTIOXID REDOX SIGN, V14, P2215, DOI 10.1089/ars.2010.3554; Huang J, 2009, P NATL ACAD SCI USA, V106, P6226, DOI 10.1073/pnas.0811045106; Ichimura Y, 2004, J BIOL CHEM, V279, P40584, DOI 10.1074/jbc.M405860200; Juncadella IJ, 2013, NATURE, V493, P547, DOI 10.1038/nature11714; Junkins RD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072263; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Kuster GM, 2005, CIRCULATION, V111, P1192, DOI 10.1161/01.CIR.0000157148.59308.F5; Luttge M, 2012, CELL MICROBIOL, V14, P210, DOI 10.1111/j.1462-5822.2011.01712.x; Martner A, 2008, INFECT IMMUN, V76, P4079, DOI 10.1128/IAI.01747-07; McCullers JA, 2006, CLIN MICROBIOL REV, V19, P571, DOI 10.1128/CMR.00058-05; Mitchell AM, 2010, CLIN MICROBIOL INFEC, V16, P411, DOI 10.1111/j.1469-0691.2010.03183.x; Molloy S, 2011, NAT REV MICROBIOL, V9, DOI 10.1038/nrmicro2497; Mostowy S, 2013, CELL MICROBIOL, V15, P395, DOI 10.1111/cmi.12063; Nair RR, 2009, MOL CANCER THER, V8, P2441, DOI 10.1158/1535-7163.MCT-09-0113; Nakagawa I, 2004, SCIENCE, V306, P1037, DOI 10.1126/science.1103966; Nieto C, 2003, PLASMID, V49, P281, DOI 10.1016/S0147-619X(03)00020-9; O'Farrell F, 2013, FEBS J, V280, P6322, DOI 10.1111/febs.12486; Patel AS, 2013, AM J RESP CELL MOL, V48, P1, DOI 10.1165/rcmb.2012-0282TR; Patel KK, 2013, ANNU REV PHYSIOL, V75, P241, DOI 10.1146/annurev-physiol-030212-183658; Petiot A, 2000, J BIOL CHEM, V275, P992, DOI 10.1074/jbc.275.2.992; PRIEBE SD, 1989, J BACTERIOL, V171, P4778, DOI 10.1128/jb.171.9.4778-4784.1989; Proud D, 2011, IMMUNOL REV, V242, P186, DOI 10.1111/j.1600-065X.2011.01033.x; Puleston DJ, 2014, IMMUNOLOGY, V141, P1, DOI 10.1111/imm.12165; Shin JH, 2012, BIOL PHARM BULL, V35, P1069, DOI 10.1248/bpb.b12-00009; Shoji-Kawata S, 2013, NATURE, V494, P201, DOI 10.1038/nature11866; van der Poll T, 2009, LANCET, V374, P1543, DOI 10.1016/S0140-6736(09)61114-4; Wileman T, 2013, ESSAYS BIOCHEM, V55, P153, DOI [10.1042/bse0550153, 10.1042/BSE0550153]; Yang F, 2012, J PHARMACOL SCI, V119, P214, DOI 10.1254/jphs.11235FP; Young AJ, 2006, MED SCI SPORT EXER, V38, P1, DOI 10.1249/01.mss.0000196708.08925.8b; Yuan H, 2009, AM J PHYSIOL-HEART C, V296, pH470, DOI 10.1152/ajpheart.01051.2008; Yuan KF, 2012, J CELL SCI, V125, P507, DOI 10.1242/jcs.094573; Zhang HY, 2009, TOXICOL SCI, V110, P376, DOI 10.1093/toxsci/kfp101	48	53	59	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0122753	10.1371/journal.pone.0122753	http://dx.doi.org/10.1371/journal.pone.0122753			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803050	gold, Green Published, Green Submitted			2022-12-26	WOS:000353889600209
J	Martinez-Balleste, A; Martorell, C				Martinez-Balleste, Andrea; Martorell, Carlos			Effects of Harvest on the Sustainability and Leaf Productivity of Populations of Two Palm Species in Maya Homegardens	PLOS ONE			English	Article							INTEGRAL PROJECTION MODELS; UNDERSTORY PALM; SABAL PALM; DEFOLIATION; GROWTH; IMPACT; REPRODUCTION; DEMOGRAPHY; ARECACEAE; PATTERNS	Traditional management practices are usually thought to be sustainable. The Maya manage Sabal (Arecaceae) palms in homegardens, using their leaves for thatching. The sustainability of such production systems depends on the long-term persistence of palm populations, whereas resource availability also depends on the number of leaves on individual palms. We examined how leaf harvest affects Sabal yapa and S. mexicana population growth rates (lambda) and leaf production, comparing traditional and alternative harvest regimes in terms of sustainability and productivity. Demographic, harvest and leaf production data were recorded for three years in two homegardens. We used general integral projection models linked to leaf-production models to describe population dynamics and productivity. Harvest had no effect on S. yapa's vital rates or on lambda, but it changed the growth rate of individuals of S. mexicana, with a negligible impact on lambda. Homegardens affected lambda values, reflecting the species' ecological affinities. S. mexicana, introduced from mesic forests, required watering and shade; therefore, its population declined rapidly in the homegarden that lacked both water and shade. The lambda of the xerophilic S. yapa was slightly larger without watering than with watering. Palms usually compensated for leaf extraction, causing the number of leaves harvested per individual to increase with harvest intensity. Nevertheless, traditional management is relatively mild, allowing standing leaves to accumulate but reducing the homegarden's yield. Apparently, the Maya do not seek to maximize annual production but to ensure the availability of large numbers of leaves in homegardens. These leaves may then be used when the entire roof of a hut needs to be replaced every few years.	[Martinez-Balleste, Andrea] Univ Nacl Autonoma Mexico, Inst Biol, Jardin Bot, Mexico City 04510, DF, Mexico; [Martorell, Carlos] Univ Nacl Autonoma Mexico, Fac Ciencias, Dept Ecol & Recursos Nat, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Martorell, C (corresponding author), Univ Nacl Autonoma Mexico, Fac Ciencias, Dept Ecol & Recursos Nat, Mexico City 04510, DF, Mexico.	martorell@ciencias.unam.mx	Martorell, Carlos/A-2265-2008; Ballesté, Andrea Martínez/G-1323-2019	Martorell, Carlos/0000-0002-0758-3953; Ballesté, Andrea Martínez/0000-0002-5287-1057	Comision Nacional para el Conocimiento y Uso de la Biodiversidad [M111]; Consejo Nacional de Ciencia y Tecnologia [31846 B]	Comision Nacional para el Conocimiento y Uso de la Biodiversidad; Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	Comision Nacional para el Conocimiento y Uso de la Biodiversidad (Project M111) (http://www.conabio.gob.mx/), Consejo Nacional de Ciencia y Tecnologia (Project 31846 B)(http://www.conacyt.mx/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, ARBOLES TROPICALES M; Anten NPR, 2003, ECOLOGY, V84, P2905, DOI 10.1890/02-0454; ARAUS JL, 1994, AM J BOT, V81, P726, DOI 10.2307/2445651; Beck H. T., 1990, USEFUL PALMS WORLD; CABALLERO J, 1994, THESIS U CALIFORNIA; Caswell, 2000, MATRIX POPULATION MO; CHAZDON RL, 1986, AM NAT, V127, P9, DOI 10.1086/284464; Easterling MR, 2000, ECOLOGY, V81, P694, DOI 10.1890/0012-9658(2000)081[0694:SSSAAN]2.0.CO;2; Ellner SP, 2006, AM NAT, V167, P410, DOI 10.1086/499438; Ellner SP, 2007, J MATH BIOL, V54, P227, DOI 10.1007/s00285-006-0044-8; Endress BA, 2004, CONSERV BIOL, V18, P822, DOI 10.1111/j.1523-1739.2004.00073.x; Endress BA, 2006, FOREST ECOL MANAG, V234, P181, DOI 10.1016/j.foreco.2006.07.020; Flores CF, 2000, ECON BOT, V54, P267, DOI 10.1007/BF02864781; Freckleton RP, 2003, J APPL ECOL, V40, P846, DOI 10.1046/j.1365-2664.2003.00842.x; JOHNSON DV, 1996, PALMS THEIR CONSERVA; Joyal E, 1996, ECON BOT, V50, P446, DOI 10.1007/BF02866527; Kumar BM, 2004, AGROFOREST SYST, V61-2, P135, DOI 10.1023/B:AGFO.0000028995.13227.ca; Lopez-Toledo L, 2012, J ECOL, V100, P1245, DOI 10.1111/j.1365-2745.2012.01992.x; Martinez-Balleste A, 2005, ECOL SOC, V10; Martinez-Balleste A, 2008, FOREST ECOL MANAG, V256, P1320, DOI 10.1016/j.foreco.2008.06.029; Martinez-Balleste A, 2006, ECOL SOC, V11; MENDOZA A, 1987, J ECOL, V75, P545, DOI 10.2307/2260433; Navarro JA, 2011, TROP CONSERV SCI, V4, P25, DOI 10.1177/194008291100400104; OYAMA K, 1990, BIOTROPICA, V22, P119, DOI 10.2307/2388403; Pamponet TC, 2013, EXP AGR, V49, P435, DOI 10.1017/S0014479713000148; Pulido MT, 2006, FOREST ECOL MANAG, V222, P399, DOI 10.1016/j.foreco.2005.10.043; Pulido MT, 2008, CURR TOP ETHNOBOT, V661, P1; Quero H., 1992, PALMAS SILVESTRES PE; Ramula S, 2009, J APPL ECOL, V46, P1048, DOI 10.1111/j.1365-2664.2009.01706.x; REICH PB, 1992, ECOL MONOGR, V62, P365, DOI 10.2307/2937116; Rodriguez-Buritica S, 2005, FOREST ECOL MANAG, V211, P329, DOI 10.1016/j.foreco.2005.02.052; Soemarwoto O., 1987, Agroforestry: a decade of development., P157; Svenning JC, 2001, BOT REV, V67, P1, DOI 10.1007/BF02857848; Ticktin T, 2004, J APPL ECOL, V41, P11, DOI 10.1111/j.1365-2664.2004.00859.x; VAZQUEZYANES C, 1993, ANNU REV ECOL SYST, V24, P69, DOI 10.1146/annurev.es.24.110193.000441; Zuidema P.A., 2000, DEMOGRAPHY EXPLOITED, P109	36	10	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0120666	10.1371/journal.pone.0120666	http://dx.doi.org/10.1371/journal.pone.0120666			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803029	Green Submitted, gold, Green Published			2022-12-26	WOS:000353889600090
J	Peng, MK; Chen, GM; Lix, LM; McAlister, FA; Tu, K; Campbell, NR; Hemmelgarn, BR; Svenson, LW; Quan, H				Peng, Mingkai; Chen, Guanmin; Lix, Lisa M.; McAlister, Finlay A.; Tu, Karen; Campbell, Norm R.; Hemmelgarn, Brenda R.; Svenson, Lawrence W.; Quan, Hude		Hypertension Outcomes Surveillance	Refining Hypertension Surveillance to Account for Potentially Misclassified Cases	PLOS ONE			English	Article							ADMINISTRATIVE DATA; BLOOD-PRESSURE; HEART-FAILURE; PREVALENCE; RISK; VALIDATION; ALGORITHMS; VALIDITY; OUTCOMES; CANADA	Administrative health data have been used in hypertension surveillance using the 1H2P method: the International Classification of Disease (ICD) hypertension diagnosis codes were recorded in at least 1 hospitalization or 2 physician claims within 2 year-period. Accumulation of false positive cases over time using the 1H2P method could result in the overestimation of hypertension prevalence. In this study, we developed and validated a new reclassification method to define hypertension cases using regularized logistic regression with the age, sex, hypertension and comorbidities in physician claims, and diagnosis of hypertension in hospital discharge data as independent variables. A Bayesian method was then used to adjust the prevalence estimated from the reclassification method. We evaluated the hypertension prevalence in data from Alberta, Canada using the currently accepted 1H2P method and these newly developed methods. The reclassification method with Bayesian adjustment produced similar prevalence estimates as the 1H2P method. This supports the continued use of the 1H2P method as a simple and practical way to conduct hypertension surveillance using administrative health data.	[Peng, Mingkai; Chen, Guanmin; Campbell, Norm R.; Hemmelgarn, Brenda R.; Quan, Hude] Univ Calgary, Fac Med, Dept Community Hlth Sci, Calgary, AB, Canada; [Lix, Lisa M.] Univ Manitoba, Dept Community Hlth Sci, Winnipeg, MB R3T 2N2, Canada; [McAlister, Finlay A.] Univ Alberta, Dept Med, Edmonton, AB, Canada; [Tu, Karen] Univ Toronto, Inst Clin Evaluat Sci, Toronto, ON, Canada; [Tu, Karen] Univ Toronto, Dept Family & Community Med, Toronto, ON M5S 1A1, Canada; [Campbell, Norm R.; Hemmelgarn, Brenda R.] Univ Calgary, Dept Med, Calgary, AB, Canada; [Svenson, Lawrence W.] Alberta Hlth, Surveillance & Assessment Branch, Edmonton, AB, Canada	University of Calgary; University of Manitoba; University of Alberta; University of Toronto; University of Toronto; University of Calgary; Alberta Health Services (AHS)	Quan, H (corresponding author), Univ Calgary, Fac Med, Dept Community Hlth Sci, Calgary, AB, Canada.	hquan@ucalgary.ca	Chen, Guanmin/AAN-4510-2020; McAlister, Finlay/C-4151-2013	McAlister, Finlay/0000-0001-7435-3341; Tu, Karen/0000-0003-0883-4934; Quan, Hude/0000-0002-7848-7256	Canadian Institutes of Health Research (CIHR) [125977]; Alberta Innovates [201300672] Funding Source: researchfish	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Alberta Innovates	This project was funded by Canadian Institutes of Health Research (CIHR, funding reference number: 125977). The CIHR had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	[Anonymous], 2014, R LANG ENV STAT COMP; Atwood KM, 2013, CAN J CARDIOL, V29, P606, DOI 10.1016/j.cjca.2012.11.019; Austin PC, 2013, J CLIN EPIDEMIOL, V66, P398, DOI 10.1016/j.jclinepi.2012.11.008; Bernatsky S, 2011, RHEUMATOL INT, V31, P549, DOI 10.1007/s00296-010-1591-2; Blais C, 2014, CAN J PUBLIC HEALTH, V105, pE79, DOI 10.17269/cjph.105.4123; CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Haider AW, 1997, HYPERTENSION, V30, P1020, DOI 10.1161/01.HYP.30.5.1020; Hastie T., 2009, THE ELEMENTS OF STAT, DOI DOI 10.1007/B94608; Hennessy DA, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-99; JOSEPH L, 1995, AM J EPIDEMIOL, V141, P263, DOI 10.1093/oxfordjournals.aje.a117428; Kadhim-Saleh A, 2013, J AM BOARD FAM MED, V26, P159, DOI 10.3122/jabfm.2013.02.120183; KANNEL WB, 1970, J AMER MED ASSOC, V214, P301, DOI 10.1001/jama.214.2.301; Kannel WB, 1996, JAMA-J AM MED ASSOC, V275, P1571, DOI 10.1001/jama.275.20.1571; Kannel WB, 2008, JAMA-J AM MED ASSOC, V300, P2545, DOI 10.1001/jama.2008.759; Ladouceur M, 2007, BIOMETRICS, V63, P272, DOI 10.1111/j.1541-0420.2006.00665.x; Levy D, 1996, JAMA-J AM MED ASSOC, V275, P1557, DOI 10.1001/jama.275.20.1557; Lix LM, 2008, J CLIN EPIDEMIOL, V61, P1250, DOI 10.1016/j.jclinepi.2008.02.002; Padwal RS, 2009, CAN J CARDIOL, V25, P279, DOI 10.1016/S0828-282X(09)70491-X; Public Health Agency of Canada, 2011, CAN CHRON DIS SURV S; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Quan HD, 2013, CAN J CARDIOL, V29, P592, DOI 10.1016/j.cjca.2012.12.016; Quan HD, 2009, HYPERTENSION, V54, P1423, DOI 10.1161/HYPERTENSIONAHA.109.139279; Robitaille C, 2012, CAN MED ASSOC J, V184, pE49, DOI 10.1503/cmaj.101863; So L, 2010, HEALTH INFORM J, V16, P101, DOI 10.1177/1460458210364784; Tu K, 2008, CAN MED ASSOC J, V178, P1429, DOI 10.1503/cmaj.071283; Tu Karen, 2007, Open Med, V1, pe18	29	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0119186	10.1371/journal.pone.0119186	http://dx.doi.org/10.1371/journal.pone.0119186			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803682	Green Published, Green Submitted, gold			2022-12-26	WOS:000353889600017
J	Rabello, LSCF; Silva, JRL; Azevedo, LCP; Souza, I; Torres, VBL; Rosolem, MM; Lisboa, T; Soares, M; Salluh, JIF				Rabello, Ligia S. C. F.; Silva, Jose R. L.; Azevedo, Luciano C. P.; Souza, Ivens; Torres, Viviane B. L.; Rosolem, Maria M.; Lisboa, Thiago; Soares, Marcio; Salluh, Jorge I. F.			Clinical Outcomes and Microbiological Characteristics of Severe Pneumonia in Cancer Patients: A Prospective Cohort Study	PLOS ONE			English	Article							CARE-ASSOCIATED PNEUMONIA; COMMUNITY-ACQUIRED PNEUMONIA; CRITICALLY-ILL PATIENTS; INTENSIVE-CARE; HOSPITALIZED-PATIENTS; RESISTANT PATHOGENS; ANTIBIOTIC-THERAPY; SEPTIC SHOCK; EPIDEMIOLOGY; SEPSIS	Introduction Pneumonia is the most frequent type of infection in cancer patients and a frequent cause of ICU admission. The primary aims of this study were to describe the clinical and microbiological characteristics and outcomes in critically ill cancer patients with severe pneumonia. Methods Prospective cohort study in 325 adult cancer patients admitted to three ICUs with severe pneumonia not acquired in the hospital setting. Demographic, clinical and microbiological data were collected. Results There were 229 (71%) patients with solid tumors and 96 (29%) patients with hematological malignancies. 75% of all patients were in septic shock and 81% needed invasive mechanical ventilation. ICU and hospital mortality rates were 45.8% and 64.9%. Microbiological confirmation was present in 169 (52%) with a predominance of Gram negative bacteria [99 (58.6%)]. The most frequent pathogens were methicillin-sensitive S. aureus [42 (24.9%)], P. aeruginosa [41(24.3%)] and S. pneumonia [21 (12.4%)]. A relatively low incidence of MR [23 (13.6%)] was observed. Adequate antibiotics were prescribed for most patients [136 (80.5%)]. In multivariate analysis, septic shock at ICU admission [OR 5.52 (1.92-15.84)], the use of invasive MV [OR 12.74 (3.60-45.07)] and poor Performance Status [OR 3.00 (1.07-8.42)] were associated with increased hospital mortality. Conclusions Severe pneumonia is associated with high mortality rates in cancer patients. A relatively low rate of MR pathogens is observed and severity of illness and organ dysfunction seems to be the best predictors of outcome in this population.	[Rabello, Ligia S. C. F.; Silva, Jose R. L.; Torres, Viviane B. L.; Soares, Marcio; Salluh, Jorge I. F.] Univ Fed Rio de Janeiro, Postgrad Program Internal Med, Rio De Janeiro, Brazil; [Azevedo, Luciano C. P.; Souza, Ivens] Hosp Sirio Libanes, Intens Care Unit, Sao Paulo, Brazil; [Rosolem, Maria M.] Hosp Barra Dor, Intens Care Unit, Rio De Janeiro, Brazil; [Lisboa, Thiago] Santa Casa Misericordia Porto Alegre, Intens Care Unit, Porto Alegre, RS, Brazil; [Soares, Marcio; Salluh, Jorge I. F.] DOr Inst Res & Educ, Rio De Janeiro, Brazil; [Soares, Marcio; Salluh, Jorge I. F.] Inst Nacl Canc, Postgrad Program, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Hospital Sirio Libanes; IDOR - Instituto D'Or de Ensino e Pesquisa; National Cancer Institute (Inca)	Salluh, JIF (corresponding author), Univ Fed Rio de Janeiro, Postgrad Program Internal Med, Rio De Janeiro, Brazil.	jorgesalluh@gmail.com	Lisboa, Thiago/W-2973-2019; Lapa e Silva, Jose R./AAS-4793-2020; Salluh, Jorge/AAF-2682-2021; Soares, Marcio/B-3083-2013; dantas, vicente c souza/L-2648-2013; Azevedo, Luciano CP/H-2652-2012	Lisboa, Thiago/0000-0003-4306-2212; Lapa e Silva, Jose R./0000-0003-3116-0253; Salluh, Jorge/0000-0002-8164-1453; Soares, Marcio/0000-0003-2503-6088; Azevedo, Luciano CP/0000-0001-6759-3910	National Council for Scientific and Technological Development (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Instituto Nacional de Cancer	National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Instituto Nacional de Cancer	The present work was supported by grants from the National Council for Scientific and Technological Development (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) and departmental funds from the Instituto Nacional de Cancer. Jorge Salluh is an academic editor of this Journal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrie C, 2013, CRIT CARE, V17, DOI 10.1186/cc13095; Aliberti S, 2012, CLIN INFECT DIS, V54, P470, DOI 10.1093/cid/cir840; [Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; Azoulay E, 2011, ANN INTENSIVE CARE, V1, DOI 10.1186/2110-5820-1-5; Benoit DD, 2003, CRIT CARE MED, V31, P104, DOI 10.1097/00003246-200301000-00017; Carratala J, 2007, ARCH INTERN MED, V167, P1393, DOI 10.1001/archinte.167.13.1393; Chalmers JD, 2011, CLIN INFECT DIS, V53, P107, DOI 10.1093/cid/cir274; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cockerill FR, 2010, PERFORMANCE STANDARD; de Montmollin E, 2013, SHOCK, V39, P250, DOI 10.1097/SHK.0b013e3182866d32; Dellinger RP, 2013, CRIT CARE MED, V41, P637, DOI [DOI 10.1097/CCM.0b013e31827e83af, DOI 10.1007/s00134-015-3827-9]; Ewig S, 2011, EUR RESPIR J, V38, P755, DOI 10.1183/09031936.00070011; Garcia-Vidal C, 2011, CLIN MICROBIOL INFEC, V17, P1659, DOI 10.1111/j.1469-0691.2011.03484.x; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Jung JY, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-61; Kollef MH, 2005, CHEST, V128, P3854, DOI 10.1378/chest.128.6.3854; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Levy MM, 2012, LANCET INFECT DIS, V12, P919, DOI 10.1016/S1473-3099(12)70239-6; Levy MM, 2001, INTENS CARE MED, V29, P530, DOI DOI 10.1007/S00134-003-1662-X; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Mandell LA, 2004, INFECT DIS CLIN N AM, V18, P761, DOI 10.1016/j.idc.2004.08.003; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Micek ST, 2007, ANTIMICROB AGENTS CH, V51, P3568, DOI 10.1128/AAC.00851-07; NIEDERMAN MS, 1993, AM REV RESPIR DIS, V148, P1418, DOI 10.1164/ajrccm/148.5.1418; Park HK, 2010, RESP MED, V104, P1729, DOI 10.1016/j.rmed.2010.06.009; Polverino E, 2013, THORAX, V68, P1007, DOI 10.1136/thoraxjnl-2013-203828; Rello J, 2010, CHEST, V137, P1138, DOI 10.1378/chest.09-2175; Rello J, 2008, CRIT CARE, V12, DOI 10.1186/cc7025; Rosolem MM, 2012, J CRIT CARE, V27, P301, DOI 10.1016/j.jcrc.2011.06.014; Shindo Y, 2009, CHEST, V135, P633, DOI 10.1378/chest.08-1357; Shorr AF, 2012, CLIN INFECT DIS, V54, P193, DOI 10.1093/cid/cir813; Soares M, 2005, INTENS CARE MED, V31, P408, DOI 10.1007/s00134-005-2554-z; Soares M, 2010, CRIT CARE MED, V38, P9, DOI 10.1097/CCM.0b013e3181c0349e; Taccone FS, 2009, CRIT CARE, V13, DOI 10.1186/cc7713; Vandijck DM, 2008, INTENS CARE MED, V34, P847, DOI 10.1007/s00134-008-1002-2; Venditti M, 2009, ANN INTERN MED, V150, P19, DOI 10.7326/0003-4819-150-1-200901060-00005; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Welte T, 2009, SEMIN RESP CRIT CARE, V30, P127, DOI 10.1055/s-0029-1202941	38	31	31	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0120544	10.1371/journal.pone.0120544	http://dx.doi.org/10.1371/journal.pone.0120544			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803690	gold, Green Published, Green Submitted			2022-12-26	WOS:000353889600080
J	Schilling, K; Krause, F				Schilling, Kristian; Krause, Frank			Analysis of Antibody Aggregate Content at Extremely High Concentrations Using Sedimentation Velocity with a Novel Interference Optics	PLOS ONE			English	Article							SIZE-DISTRIBUTION ANALYSIS; ANALYTICAL ULTRACENTRIFUGATION; TRACER SEDIMENTATION; SELF-ASSOCIATION; PROTEINS; SYSTEMS; MACROMOLECULES; COEFFICIENTS; EQUILIBRIUM; STRATEGIES	Monoclonal antibodies represent the most important group of protein-based biopharmaceuticals. During formulation, manufacturing, or storage, antibodies may suffer post-translational modifications altering their physical and chemical properties. Such induced conformational changes may lead to the formation of aggregates, which can not only reduce their efficiency but also be immunogenic. Therefore, it is essential to monitor the amount of size variants to ensure consistency and quality of pharmaceutical antibodies. In many cases, antibodies are formulated at very high concentrations > 50 g/L, mostly along with high amounts of sugarbased excipients. As a consequence, all routine aggregation analysis methods, such as size-exclusion chromatography, cannot monitor the size distribution at those original conditions, but only after dilution and usually under completely different solvent conditions. In contrast, sedimentation velocity (SV) allows to analyze samples directly in the product formulation, both with limited sample-matrix interactions and minimal dilution. One prerequisite for the analysis of highly concentrated samples is the detection of steep concentration gradients with sufficient resolution: Commercially available ultracentrifuges are not able to resolve such steep interference profiles. With the development of our Advanced Interference Detection Array (AIDA), it has become possible to register interferograms of solutions as highly concentrated as 150 g/L. The other major difficulty encountered at high protein concentrations is the pronounced non-ideal sedimentation behavior resulting from repulsive intermolecular interactions, for which a comprehensive theoretical modelling has not yet been achieved. Here, we report the first SV analysis of highly concentrated antibodies up to 147 g/L employing the unique AIDA ultracentrifuge. By developing a consistent experimental design and data fit approach, we were able to provide a reliable estimation of the minimum content of soluble aggregates in the original formulations of two antibodies. Limitations of the procedure are discussed.	[Schilling, Kristian; Krause, Frank] Nanolyt Gesell Kolloidanalyt, Potsdam, Germany		Krause, F (corresponding author), Nanolyt Gesell Kolloidanalyt, Potsdam, Germany.	krause@nanolytics.de			Nanolytics	Nanolytics	Sanofi-Aventis Deutschland GmbH ordered and paid for some of the experiments used for this study as part of the analytical services offered by Nanolytics. Kristian Schilling is the owner and CEO of Nanolytics, while Frank Krause is employed as Head Life Science at Nanolytics. Nanolytics provided support in the form of salaries for authors KS and FK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Arthur KK, 2009, J PHARM SCI-US, V98, P3522, DOI 10.1002/jps.21654; Berkowitz SA, 2012, NAT REV DRUG DISCOV, V11, P527, DOI 10.1038/nrd3746; Brown PH, 2009, EUR BIOPHYS J BIOPHY, V38, P1079, DOI 10.1007/s00249-009-0514-1; Brown Patrick H, 2008, Curr Protoc Immunol, VChapter 18, DOI 10.1002/0471142735.im1815s81; Cole JL, 2011, BIOPHYS CHEM, V159, P120, DOI 10.1016/j.bpc.2011.05.014; CORREIA JJ, 1976, BIOPHYS CHEM, V5, P255, DOI 10.1016/0301-4622(76)80038-5; Demeler B, 1997, BIOPHYS J, V72, P397, DOI 10.1016/S0006-3495(97)78680-6; den Engelsman J, 2011, PHARM RES-DORDR, V28, P920, DOI 10.1007/s11095-010-0297-1; Fujita H, 1962, MATH THEORY SEDIMENT; Gabrielson JP, 2011, METHODS, V54, P83, DOI 10.1016/j.ymeth.2010.12.030; Gabrielson JP, 2010, ANAL BIOCHEM, V396, P231, DOI 10.1016/j.ab.2009.09.036; Gabrielson JP, 2009, J PHARM SCI-US, V98, P50, DOI 10.1002/jps.21403; GRALEN N, 1944, THESIS U UPPSALA; Harding SE, 2010, BIOCHEM SOC T, V38, P901, DOI 10.1042/BST0380901; Harrington WF, 1952, J AM CHEM SOC, V75, P3533; Janado M, 1972, J BIOCH, V2, P257; JOHNSTON JP, 1946, T FARADAY SOC, V42, P789, DOI 10.1039/tf9464200789; Joubert MK, 2011, J BIOL CHEM, V286, P25118, DOI 10.1074/jbc.M110.160457; Kingsbury JS, 2008, J BIOL CHEM, V283, P11887, DOI 10.1074/jbc.M709638200; Kingsbury JS, 2012, ANAL BIOCHEM, V425, P151, DOI 10.1016/j.ab.2012.03.016; Krayukhina E, 2013, J BIOSCI BIOENG, V115, P104, DOI 10.1016/j.jbiosc.2012.07.021; Kroe RR, 2009, ANAL BIOCHEM, V390, P1, DOI 10.1016/j.ab.2008.11.033; LLOYD PH, 1974, OPTICAL METHODS ULTR; Pekar A, 2007, ANAL BIOCHEM, V367, P225, DOI 10.1016/j.ab.2007.04.035; Philo JS, 2009, CURR PHARM BIOTECHNO, V10, P359, DOI 10.2174/138920109788488815; Reichert JM, 2013, MABS-AUSTIN, V5, P513, DOI 10.4161/mabs.24990; Rivas G, 1999, BIOCHEMISTRY-US, V38, P9379, DOI 10.1021/bi990355z; Rommer P, 2014, CLIN EXP IMMUNOL, V175, P333, DOI [10.1111/cei.12260, DOI 10.1111/CEI.12260]; ROSENBERG L, 1970, J BIOL CHEM, V245, P4112; Rowe A. J., 1992, ANAL ULTRACENTRIFUGA, P394, DOI DOI 10.1007/S00249-009-0425-1; ROWE AJ, 1977, BIOPOLYMERS, V16, P2595, DOI 10.1002/bip.1977.360161202; Schachman H.K., 1959, ULTRACENTRIFUGATION; Schuck P, 2002, BIOPHYS J, V82, P1096, DOI 10.1016/S0006-3495(02)75469-6; Schuck P, 2003, ANAL BIOCHEM, V320, P104, DOI 10.1016/S0003-2697(03)00289-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shire SJ, 2004, J PHARM SCI-US, V93, P1390, DOI 10.1002/jps.20079; Sliwkowski MX, 2013, SCIENCE, V341, P1192, DOI 10.1126/science.1241145; Stafford WF, 2004, BIOPHYS CHEM, V108, P231, DOI 10.1016/j.bpc.2003.10.028; Steyrleuthner R, 2012, J AM CHEM SOC, V134, P18303, DOI 10.1021/ja306844f; Svensson H., 1954, OPT ACTA, V1, P25; TRAUTMAN R, 1954, J CHEM PHYS, V22, P555, DOI 10.1063/1.1740106; Zhao HY, 2011, BIOPHYS J, V100, P2309, DOI 10.1016/j.bpj.2011.03.004	42	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0120820	10.1371/journal.pone.0120820	http://dx.doi.org/10.1371/journal.pone.0120820			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803582	Green Published, gold, Green Submitted			2022-12-26	WOS:000353889600100
J	Adams, C; Adams, NE; Traub, RD; Whittington, MA				Adams, Christopher; Adams, Natalie E.; Traub, Roger D.; Whittington, Miles A.			Electrographic Waveform Structure Predicts Laminar Focus Location in a Model of Temporal Lobe Seizures In Vitro	PLOS ONE			English	Article							EPILEPTIFORM DISCHARGES; CA2-CA3 REGION; GUINEA-PIG; PROPAGATION; SPREAD; MOUSE; HIPPOCAMPUS; INITIATION; SLICES; CORTEX	Temporal lobe epilepsy is the most common form of partial-onset epilepsy and accounts for the majority of adult epilepsy cases in most countries. A critical role for the hippocampus (and to some extent amygdala) in the pathology of these epilepsies is clear, with selective removal of these regions almost as effective as temporal lobectomy in reducing subsequent seizure risk. However, there is debate about whether hippocampus is 'victim' or 'perpetrator': The structure is ideally placed to 'broadcast' epileptiform activity to a great many other brain regions, but removal often leaves epileptiform events still occurring in cortex, particularly in adjacent areas, and recruitment of the hippocampus into seizure-like activity has been shown to be difficult in clinically-relevant models. Using a very simple model of acute epileptiform activity with known, single primary pathology (GABAA Receptor partial blockade), we track the onset and propagation of epileptiform events in hippocampus, parahippocampal areas and neocortex. In this model the hippocampus acts as a potential seizure focus for the majority of observed events. Events with hippocampal focus were far more readily propagated throughout parahippocampal areas and into neocortex than vice versa. The electrographic signature of events of hippocampal origin was significantly different to those of primary neocortical origin - a consequence of differential laminar activation. These data confirm the critical role of the hippocampus in epileptiform activity generation in the temporal lobe and suggest the morphology of non-invasive electrical recording of neocortical interictal events may be useful in confirming this role.	[Adams, Christopher] Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Adams, Natalie E.; Whittington, Miles A.] Univ York, Hull York Med Sch, York YO10 5DD, N Yorkshire, England; [Traub, Roger D.] IBM TJ Watson Res Ctr, Dept Phys Sci, New York, NY USA; [Traub, Roger D.] Columbia Univ, Dept Neurol, New York, NY USA	Newcastle University - UK; University of Hull; University of York - UK; International Business Machines (IBM); Columbia University	Whittington, MA (corresponding author), Univ York, Hull York Med Sch, York YO10 5DD, N Yorkshire, England.	Miles.whittington@hyms.ac.uk		Whittington, Miles Adrian/0000-0002-0247-1362	Wellcome Trust; Wolfson Foundation; NSF [DMS-1042134]; IBM TJ Watson Research Center	Wellcome Trust(Wellcome TrustEuropean Commission); Wolfson Foundation; NSF(National Science Foundation (NSF)); IBM TJ Watson Research Center(International Business Machines (IBM))	This study was supported by the Wellcome Trust, The Wolfson Foundation, NSF (DMS-1042134). IBM TJ Watson Research Center provided support in the form of salaries for author RT, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section.	Akman O, 2010, NEUROSCI LETT, V479, P74, DOI 10.1016/j.neulet.2010.05.034; Ang CW, 2006, J NEUROSCI, V26, P11850, DOI 10.1523/JNEUROSCI.2354-06.2006; AVOLI M, 1988, NEUROSCI LETT, V94, P327, DOI 10.1016/0304-3940(88)90039-0; Barbarosie M, 1997, J NEUROSCI, V17, P9308; Biagini G, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00130; Boido D, 2014, CEREB CORTEX, V24, P163, DOI 10.1093/cercor/bhs298; Bonilha L, 2012, EPILEPSIA, V53, P1, DOI 10.1111/j.1528-1167.2011.03298.x; Borbely S, 2006, BRAIN RES BULL, V69, P161, DOI 10.1016/j.brainresbull.2005.11.018; Catenoix H, 2011, CLIN NEUROPHYSIOL, V122, P2488, DOI 10.1016/j.clinph.2011.05.007; COLOM LV, 1994, J NEUROPHYSIOL, V71, P1574, DOI 10.1152/jn.1994.71.4.1574; de la Prida LM, 2002, BRAIN RES, V940, P27, DOI 10.1016/S0006-8993(02)02564-7; Dyhrfjeld-Johnsen J, 2007, J NEUROPHYSIOL, V97, P1566, DOI 10.1152/jn.00950.2006; Fang QQ, 2009, I S BIOMED IMAGING, P1142, DOI 10.1109/ISBI.2009.5193259; Federico P, 1996, J NEUROPHYSIOL, V76, P3471, DOI 10.1152/jn.1996.76.5.3471; Ferrea E, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00080; FISHER RS, 1977, ELECTROEN CLIN NEURO, V42, P608, DOI 10.1016/0013-4694(77)90279-6; Fukumoto SI, 2002, PSYCHIAT CLIN NEUROS, V56, P561, DOI 10.1046/j.1440-1819.2002.01055.x; GJERSTAD L, 1981, ACTA PHYSIOL SCAND, V113, P245, DOI 10.1111/j.1748-1716.1981.tb06890.x; Gloveli T, 2005, P NATL ACAD SCI USA, V102, P13295, DOI 10.1073/pnas.0506259102; GRISSMER S, 1994, MOL PHARMACOL, V45, P1227; Holtkamp M, 2011, NEUROBIOL DIS, V43, P220, DOI 10.1016/j.nbd.2011.03.014; Kibler AB, 2011, EPILEPSIA, V52, P1590, DOI 10.1111/j.1528-1167.2011.03125.x; KNOWLES WD, 1987, NEUROSCIENCE, V21, P441, DOI 10.1016/0306-4522(87)90134-5; LAMBERT JDC, 1990, J NEUROPHYSIOL, V64, P119, DOI 10.1152/jn.1990.64.1.119; Lefort S, 2009, NEURON, V61, P301, DOI 10.1016/j.neuron.2008.12.020; Sekino Y, 1997, J NEUROPHYSIOL, V78, P1662, DOI 10.1152/jn.1997.78.3.1662; Smith SJM, 2005, J NEUROL NEUROSUR PS, V76, P2, DOI 10.1136/jnnp.2005.069245; SPENCER SS, 1990, NEUROLOGY, V40, P74, DOI 10.1212/WNL.40.1.74; SPENCER SS, 1987, EPILEPSIA, V28, P479, DOI 10.1111/j.1528-1157.1987.tb03676.x; STRINGER JL, 1990, EPILEPSY RES, V7, P197, DOI 10.1016/0920-1211(90)90015-N; TRAUB RD, 1987, NEUROSCIENCE, V21, P457, DOI 10.1016/0306-4522(87)90135-7; TRAUB RD, 1993, J PHYSIOL-LONDON, V472, P267, DOI 10.1113/jphysiol.1993.sp019946; TRAUB RD, 1994, J PHYSIOL-LONDON, V478, P379, DOI 10.1113/jphysiol.1994.sp020259; TSAI ML, 1993, ELECTROEN CLIN NEURO, V87, P25, DOI 10.1016/0013-4694(93)90171-Q; Tsau Y, 1999, J NEUROPHYSIOL, V82, P1965, DOI 10.1152/jn.1999.82.4.1965; van Groen T, 2003, HIPPOCAMPUS, V13, P133, DOI 10.1002/hipo.10037; WADMAN WJ, 1993, NEUROSCIENCE, V52, P255, DOI 10.1016/0306-4522(93)90154-8; WIESER HG, 1988, EPILEPSIA, V29, pS100, DOI 10.1111/j.1528-1157.1988.tb05793.x; Wong R K, 1986, Adv Neurol, V44, P583	39	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121676	10.1371/journal.pone.0121676	http://dx.doi.org/10.1371/journal.pone.0121676			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799020	Green Published, Green Submitted, gold			2022-12-26	WOS:000351987300285
J	Bekelis, K; Missios, S; Wong, K; MacKenzie, TA				Bekelis, Kimon; Missios, Symeon; Wong, Kendrew; MacKenzie, Todd A.			The Practice of Cranial Neurosurgery and the Malpractice Liability Environment in the United States	PLOS ONE			English	Article							ADVERSE EVENTS; CLAIMS; LITIGATION; CRISIS; RISK; NEGLIGENCE; PHYSICIANS; MEDICINE; ACCESS	Object The potential imbalance between malpractice liability cost and quality of care has been an issue of debate. We investigated the association of malpractice liability with unfavorable outcomes and increased hospitalization charges in cranial neurosurgery. Methods We performed a retrospective cohort study involving patients who underwent cranial neurosurgical procedures from 2005-2010, and were registered in the National Inpatient Sample (NIS) database. We used data from the National Practitioner Data Bank (NPDB) from 2005 to 2010 to create measures of volume and size of malpractice claim payments. The association of the latter with the state-level mortality, length of stay (LOS), unfavorable discharge, and hospitalization charges for cranial neurosurgery was investigated. Results During the study period, there were 189,103 patients (mean age 46.4 years, with 48.3% females) who underwent cranial neurosurgical procedures, and were registered in NIS. In a multivariable regression, higher number of claims per physician in a state was associated with increased In-transformed hospitalization charges (beta 0.18; 95% CI, 0.17 to 0.19). On the contrary, there was no association with mortality (OR 1.00; 95% CI, 0.94 to 1.06). We observed a small association with unfavorable discharge (OR 1.09; 95% CI, 1.06 to 1.13), and LOS (beta 0.01; 95% CI, 0.002 to 0.03). The size of the awarded claims demonstrated similar relationships. The average claims payment size (ln-transformed) (Pearson's rho=0.435, P=0.01) demonstrated a positive correlation with the risk-adjusted hospitalization charges but did not demonstrate a correlation with mortality, unfavorable discharge, or LOS. Conclusions In the present national study, aggressive malpractice environment was not correlated with mortality but was associated with higher hospitalization charges after cranial neurosurgery. In view of the association of malpractice with the economics of healthcare, further research on its impact is necessary.	[Bekelis, Kimon] Dartmouth Hitchcock Med Ctr, Sect Neurosurg, Lebanon, NH 03766 USA; [Missios, Symeon] Cleveland Clin Fdn, Dept Neurosurg, Cleveland, OH 44195 USA; [Wong, Kendrew; MacKenzie, Todd A.] Dartmouth Inst Hlth Policy & Clin Practice, Lebanon, NH USA; [MacKenzie, Todd A.] Geisel Sch Med Dartmouth, Hanover, NH USA	Dartmouth College; Cleveland Clinic Foundation; Dartmouth College; Dartmouth College	Bekelis, K (corresponding author), Dartmouth Hitchcock Med Ctr, Sect Neurosurg, Lebanon, NH 03766 USA.	kbekelis@gmail.com	Bekelis, Kimon/Y-3402-2019					Baicker K, 2007, HEALTH AFFAIR, V26, P841, DOI 10.1377/hlthaff.26.3.841; Bishop TF, 2011, JAMA-J AM MED ASSOC, V305, P2427, DOI 10.1001/jama.2011.813; BRENNAN TA, 1991, NEW ENGL J MED, V324, P370, DOI 10.1056/NEJM199102073240604; Brennan TA, 1996, NEW ENGL J MED, V335, P1963, DOI 10.1056/NEJM199612263352606; California Medical Association, 1977, REP MED INS FEAS STU; Chandra A, 2005, HLTH AFF MILLWOOD S, pW5; CHARLSON ME, 1987, ARCH INTERN MED, V147, P2155, DOI 10.1001/archinte.147.12.2155; Dranove D, 2005, HEALTH AFFAIR, V24, P802, DOI 10.1377/hlthaff.24.3.802; Eloy JA, 2014, J NEUROSURG, V120, P185, DOI 10.3171/2013.8.JNS13584; Emery E, 2014, WORLD NEUROSURG, V81, P218, DOI 10.1016/j.wneu.2013.01.029; General Accounting Office, 2000, MAJ IMPR NEED ENH DA; Jena AB, 2011, NEW ENGL J MED, V365, P629, DOI 10.1056/NEJMsa1012370; Kane C.K., 2010, POLICY RES PERSPECTI; LOCALIO AR, 1991, NEW ENGL J MED, V325, P245, DOI 10.1056/NEJM199107253250405; Mello MM, 2005, ANN SURG, V242, P621, DOI 10.1097/01.sla.0000182957.54783.9a; Mello MM, 2003, NEW ENGL J MED, V348, P2281, DOI 10.1056/NEJMp030064; Mukherjee S, 2014, ANN ROY COLL SURG, V96, P266, DOI 10.1308/003588414X13814021679834; Nahed BV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039237; ROMANO PS, 1993, J CLIN EPIDEMIOL, V46, P1075, DOI 10.1016/0895-4356(93)90103-8; Rovit RL, 2007, J NEUROSURG, V106, P1108, DOI 10.3171/jns.2007.106.6.1108; Seabury SA, 2013, HEALTH AFFAIR, V32, P111, DOI 10.1377/hlthaff.2012.0967; Steiner Claudia, 2002, Eff Clin Pract, V5, P143; Studdert DM, 2006, NEW ENGL J MED, V354, P2024, DOI 10.1056/NEJMsa054479; Studdert DM, 2005, JAMA-J AM MED ASSOC, V293, P2609, DOI 10.1001/jama.293.21.2609	24	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121191	10.1371/journal.pone.0121191	http://dx.doi.org/10.1371/journal.pone.0121191			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE6ZS	25798994	gold, Green Published, Green Submitted			2022-12-26	WOS:000351987300225
J	Chai, J; Feng, XC; Zhang, LJ; Chen, S; Cheng, Y; He, XC; Yang, YX; He, Y; Wang, HZ; Wang, RQ; Chen, WS				Chai, Jin; Feng, Xinchan; Zhang, Liangjun; Chen, Sheng; Cheng, Ying; He, Xiaochong; Yang, Yingxue; He, Yu; Wang, Huaizhi; Wang, Rongquan; Chen, Wensheng			Hepatic Expression of Detoxification Enzymes Is Decreased in Human Obstructive Cholestasis Due to Gallstone Biliary Obstruction	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; BILE-ACID; DOWN-REGULATION; RECEPTOR REGULATION; ADAPTIVE RESPONSE; NUCLEAR RECEPTORS; UP-REGULATION; LIVER-INJURY; OST-BETA; TRANSPORTER	Background & Aims Levels of bile acid metabolic enzymes and membrane transporters have been reported to change in cholestasis. These alterations (e.g. CYP7A1 repression and MRP4 induction) are thought to be adaptive responses that attenuate cholestatic liver injury. However, the molecular mechanisms of these adaptive responses in human obstructive cholestasis due to gallstone biliary obstruction remain unclear. Methods We collected liver samples from cholestatic patients with biliary obstruction due to gallstones and from control patients without liver disease (n = 22 per group). The expression levels of bile acid synthetic and detoxification enzymes, membrane transporters, and the related nuclear receptors and transcriptional factors were measured. Results The levels of bile acid synthetic enzymes, CYP7B1 and CYP8B1, and the detoxification enzyme CYP2B6 were increased in cholestatic livers by 2.4-fold, 2.8-fold, and 1.9-fold, respectively (p< 0.05). Conversely, the expression levels of liver detoxification enzymes, UGT2B4/7, SULT2A1, GSTA1-4, and GSTM1-4, were reduced by approximately 50% (p< 0.05) in human obstructive cholestasis. The levels of membrane transporters, OST beta and OCT1, were increased 10.4-fold and 1.8-fold, respectively, (p< 0.05), whereas those of OST alpha, ABCG2 and ABCG8 were all decreased by approximately 40%, (p< 0.05) in human cholestatic livers. Hepatic nuclear receptors, VDR, HNF4 alpha, RXR alpha and RAR alpha, were induced (approximately 2.0-fold, (p< 0.05) whereas FXR levels were markedly reduced to 44% of control, (p< 0.05) in human obstructive cholestasis. There was a significantly positive correlation between the reduction in FXR mRNA and UGT2B4/7, SULT2A1, GSTA1, ABCG2/8 mRNA levels in livers of obstructive cholestatic patients (p< 0.05). Conclusions The levels of hepatic detoxification enzymes were significantly decreased in human obstructive cholestasis, and these decreases were positively associated with a marked reduction of FXR levels. These findings are consistent with impaired detoxification ability in human obstructive cholestasis.	[Chai, Jin; Feng, Xinchan; Zhang, Liangjun; Cheng, Ying; Wang, Rongquan; Chen, Wensheng] Third Mil Med Univ, Southwest Hosp, Dept Gastroenterol, Chongqing, Peoples R China; [Chen, Sheng] Third Mil Med Univ, Southwest Hosp, Dept Pediat, Chongqing, Peoples R China; [He, Xiaochong] Third Mil Med Univ, Sch Nursing, Chongqing, Peoples R China; [Yang, Yingxue] Sichuan Univ, Dept Gastroenterol, West China Hosp, Chengdu 610064, Sichuan, Peoples R China; [He, Yu; Wang, Huaizhi] Third Mil Med Univ, Inst Hepatobiliary Surg, Southwest Hosp, Chongqing, Peoples R China	Army Medical University; Army Medical University; Army Medical University; Sichuan University; Army Medical University	Chen, WS (corresponding author), Third Mil Med Univ, Southwest Hosp, Dept Gastroenterol, Chongqing, Peoples R China.	wenshengchen@hotmail.com	Zhang, Liang/GWM-6088-2022	Chen, Sheng/0000-0003-3526-7808; Chai, Jin/0000-0002-8543-4566; Wang, Rongquan/0000-0001-5307-0086	National Natural Science Foundation of China [81370560, 81100280, 81470880]; Scholarship Foundation of China Scholarship Council (CSC) [201307610015]; Third Military Medical University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scholarship Foundation of China Scholarship Council (CSC); Third Military Medical University	Funding: This study was supported by National Natural Science Foundation of China (81370560, 81100280, and 81470880), Scholarship Foundation of China Scholarship Council (CSC No. 201307610015) and Third Military Medical University (2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleksunes LM, 2008, TOXICOL APPL PHARM, V226, P74, DOI 10.1016/j.taap.2007.08.022; Anakk S, 2011, J CLIN INVEST, V121, P86, DOI 10.1172/JCI42846; Ballatori N, 2009, FRONT BIOSCI-LANDMRK, V14, P2829, DOI 10.2741/3416; Blazquez AG, 2012, MOL PHARMACOL, V81, P273, DOI 10.1124/mol.111.075143; Bohan A, 2003, J BIOL CHEM, V278, P36688, DOI 10.1074/jbc.M304011200; Boyer JL, 2006, AM J PHYSIOL-GASTR L, V290, pG1124, DOI 10.1152/ajpgi.00539.2005; Boyer JL, 2005, GASTROENTEROLOGY, V129, P735, DOI 10.1053/j.gastro.2005.06.053; Chai J, 2012, HEPATOLOGY, V55, P1485, DOI 10.1002/hep.24801; Chai J, 2011, J GASTROINTEST SURG, V15, P996, DOI 10.1007/s11605-011-1473-2; Chatterjee B, 2005, METHOD ENZYMOL, V400, P165, DOI 10.1016/S0076-6879(05)00010-8; Chen WS, 2007, AM J PHYSIOL-GASTR L, V292, pG1221, DOI 10.1152/ajpgi.00191.2006; Denk GU, 2004, HEPATOLOGY, V39, P1382, DOI 10.1002/hep.20176; Ghonem NS, 2014, HEPATOLOGY, V59, P1030, DOI 10.1002/hep.26894; Jin HE, 2009, PHARM RES-DORDR, V26, P549, DOI 10.1007/s11095-008-9770-5; Jonker JW, 2012, J STEROID BIOCHEM, V130, P147, DOI 10.1016/j.jsbmb.2011.06.012; Kazgan N, 2014, GASTROENTEROLOGY, V146, P1006, DOI 10.1053/j.gastro.2013.12.029; Kir S, 2011, SCIENCE, V331, P1621, DOI 10.1126/science.1198363; Lorbek G, 2012, FEBS J, V279, P1516, DOI 10.1111/j.1742-4658.2011.08432.x; Mennone A, 2006, HEPATOLOGY, V43, P1013, DOI 10.1002/hep.21158; Modica S, 2012, GASTROENTEROLOGY, V142, P355, DOI 10.1053/j.gastro.2011.10.028; Nies AT, 2009, HEPATOLOGY, V50, P1227, DOI 10.1002/hep.23103; Park YJ, 2008, HEPATOLOGY, V47, P1578, DOI 10.1002/hep.22196; Plosch T, 2006, AM J PHYSIOL-GASTR L, V291, pG414, DOI 10.1152/ajpgi.00557.2005; Schaap FG, 2009, HEPATOLOGY, V49, P1228, DOI 10.1002/hep.22771; Soroka CJ, 2011, AM J PHYSIOL-GASTR L, V301, pG574, DOI 10.1152/ajpgi.00141.2011; Soroka CJ, 2010, HEPATOLOGY, V51, P181, DOI 10.1002/hep.23265; Trauner M, 2005, J CLIN GASTROENTEROL, V39, pS111, DOI 10.1097/01.mcg.0000155551.37266.26; Trauner M, 1998, NEW ENGL J MED, V339, P1217, DOI 10.1056/NEJM199810223391707; Triantis V, 2010, HEPATOLOGY, V52, P656, DOI 10.1002/hep.23708; Trottier J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022094; Wagner M, 2005, HEPATOLOGY, V42, P420, DOI 10.1002/hep.20784; Wagner Martin, 2005, Ann Hepatol, V4, P77; Wagner M, 2010, SEMIN LIVER DIS, V30, P160, DOI 10.1055/s-0030-1253225; Wagner M, 2009, J HEPATOL, V51, P565, DOI 10.1016/j.jhep.2009.05.012; Xu SH, 2010, AM J PHYSIOL-GASTR L, V299, pG126, DOI 10.1152/ajpgi.00522.2010; Zollner G, 2003, J HEPATOL, V38, P717, DOI 10.1016/S0168-8278(03)00096-5; Zollner G, 2007, LIVER INT, V27, P920, DOI 10.1111/j.1478-3231.2007.01506.x; Zollner G, 2006, MOL PHARMACEUT, V3, P231, DOI 10.1021/mp060010s	38	31	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120055	10.1371/journal.pone.0120055	http://dx.doi.org/10.1371/journal.pone.0120055			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798860	gold, Green Submitted, Green Published			2022-12-26	WOS:000351987300104
J	Dincel, GC; Kul, O				Dincel, Gungor Cagdas; Kul, Oguz			Increased Expressions of ADAMTS-13, Neuronal Nitric Oxide Synthase, and Neurofilament Correlate with Severity of Neuropathology in Border Disease Virus-Infected Small Ruminants	PLOS ONE			English	Article							VON-WILLEBRAND-FACTOR; CENTRAL-NERVOUS-SYSTEM; BLOOD-BRAIN-BARRIER; SHEAR-STRESS; CUB-DOMAIN; CELLS; FAMILY; NEUROTOXICITY; ASSOCIATION; THROMBOSIS	Border Disease (BD), caused by Pestivirus from the family Flaviviridae, leads to serious reproductive losses and brain anomalies such as hydranencephaly and cerebellar hypoplasia in aborted fetuses and neonatal lambs. In this report it is aimed to investigate the expression of neuronal nitric oxide synthase (nNOS), A Disintegrin And Metalloprotease with Thrombospondin type I repeats-13 (ADAMTS-13), and neurofilament (NF) in the brain tissue in small ruminants infected with Border Disease Virus (BDV) and to identify any correlation between hypomyelinogenesis and BD neuropathology. Results of the study revealed that the levels of ADAMTS-13 (p<0.05), nNOS (p<0.05), and NF (p<0.05) were remarkably higher in BDV-infected brain tissue than in the uninfected control. It was suggested that L-arginine-NO synthase pathway is activated after infection by BDV and that the expression of NF and nNOS is associated with the severity of BD. A few studies have focused on ADAMTS-13 expression in the central nervous system, and its function continues to remain unclear. The most prominent finding from our study was that ADAMTS-13, which contain two CUB domains, has two CUB domains and its high expression levels are probably associated with the development of the central nervous system (CNS). The results also clearly indicate that the interaction of ADAMTS-13 and NO may play an important role in the regulation and protection of the CNS microenvironment in neurodegenerative diseases. In addition, NF expression might indicate the progress of the disease. To the best of the authors' knowledge, this is the first report on ADAMTS-13 expression in the CNS of BDV-infected small ruminants.	[Dincel, Gungor Cagdas] Univ Gumushane, Siran Mustafa Beyaz Vocat Sch, Lab & Vet Hlth Program, Gumushane, Turkey; [Kul, Oguz] Kirikkale Univ, Fac Vet Med, Dept Pathol, Kirikkale, Turkey	Gumushane University; Kirikkale University	Dincel, GC (corresponding author), Univ Gumushane, Siran Mustafa Beyaz Vocat Sch, Lab & Vet Hlth Program, Gumushane, Turkey.	gcdincel@yahoo.com.tr	DİNÇEL, Güngör Çağdaş/H-7026-2018; DINCEL, Gungor Cagdas/AAF-3830-2020	DİNÇEL, Güngör Çağdaş/0000-0002-6985-3197; DINCEL, Gungor Cagdas/0000-0002-6985-3197; KUL, Oguz/0000-0002-1282-650X				Aitken ID, 2007, DIS SHEEP, P119; Al-Chalabi A, 2003, BIOESSAYS, V25, P346, DOI 10.1002/bies.10251; Apte SS, 2004, INT J BIOCHEM CELL B, V36, P981, DOI 10.1016/j.biocel.2004.01.014; BARLOW RM, 1986, VET REC, V118, P321, DOI 10.1136/vr.118.12.321; BOJE KM, 1992, BRAIN RES, V587, P250, DOI 10.1016/0006-8993(92)91004-X; BORK P, 1993, J MOL BIOL, V231, P539, DOI 10.1006/jmbi.1993.1305; Calabrese V, 2007, NAT REV NEUROSCI, V8, P766, DOI 10.1038/nrn2214; Chauhan AK, 2006, J EXP MED, V203, P767, DOI 10.1084/jem.20051732; Corson MA, 1996, CIRC RES, V79, P984, DOI 10.1161/01.RES.79.5.984; DAWSON VL, 1991, P NATL ACAD SCI USA, V88, P6368, DOI 10.1073/pnas.88.14.6368; Dincel GC, 2012, 27 WORLD BUIATR C OR, P73; Dong JF, 2002, BLOOD, V100, P4033, DOI 10.1182/blood-2002-05-1401; Frentzou GA, 2012, J MOL NEUROSCI, V46, P343, DOI 10.1007/s12031-011-9591-6; Gu CH, 2002, J BIOL CHEM, V277, P18069, DOI 10.1074/jbc.M201681200; Heinonen TYK, 2009, ANN MED, V41, P2, DOI 10.1080/07853890802301975; Jones GC, 2005, ARTHRITIS RES THER, V7, P160, DOI 10.1186/ar1783; Konstantopoulos K, 1997, BIORHEOLOGY, V34, P57, DOI 10.1016/S0006-355X(97)00004-8; Kul O, 2008, VET PATHOL, V45, P191, DOI 10.1354/vp.45-2-191; Liu H, 2011, P NATL ACAD SCI USA, V108, P1379, DOI 10.1073/pnas.1017228108; Liu Quan, 2011, Open Neurol J, V5, P58, DOI 10.2174/1874205X01105010058; MOLLER JR, 1993, J NEUROCHEM, V61, P1808, DOI 10.1111/j.1471-4159.1993.tb09820.x; Muroi C, 2014, J THROMB HAEMOST, V12, P505, DOI 10.1111/jth.12511; Norgren N, 2003, BRAIN RES, V987, P25, DOI 10.1016/S0006-8993(03)03219-0; Noubade R, 2008, AM J PATHOL, V173, P892, DOI 10.2353/ajpath.2008.080001; Oguzoglu T. C., 2012, ANIM HLTH PROD HYG, V1, P1; Sadler JE, 2002, P NATL ACAD SCI USA, V99, P11552, DOI 10.1073/pnas.192448999; Shang DZ, 2006, BLOOD, V108, P2207, DOI 10.1182/blood-2006-02-002139; Shelat SG, 2005, SEMIN THROMB HEMOST, V31, P659, DOI 10.1055/s-2005-925472; Tang BL, 2001, INT J BIOCHEM CELL B, V33, P33, DOI 10.1016/S1357-2725(00)00061-3; Tauchi R, 2012, NEUROSCI LETT, V517, P1, DOI 10.1016/j.neulet.2012.03.002; Toplu N, 2011, VET PATHOL, V48, P576, DOI 10.1177/0300985810371309; Tsai HM, 2012, ASAIO J, V58, P163, DOI 10.1097/MAT.0b013e31824363e7; Tsai HM, 2003, SEMIN THROMB HEMOST, V29, P479; Tu CF, 2008, J BIOL CHEM, V283, P12478, DOI 10.1074/jbc.M705872200; Vincentelli A, 2003, NEW ENGL J MED, V349, P343, DOI 10.1056/NEJMoa022831; Zhou WH, 2005, LAB INVEST, V85, P780, DOI 10.1038/labinvest.3700275; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	38	12	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120005	10.1371/journal.pone.0120005	http://dx.doi.org/10.1371/journal.pone.0120005			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799514	Green Published, gold, Green Submitted			2022-12-26	WOS:000351987300101
J	Furman, R; Danhart, EM; NandyMazumdar, M; Yuan, CH; Foster, MP; Artsimovitch, I				Furman, Ran; Danhart, Eric M.; NandyMazumdar, Monali; Yuan, Chunhua; Foster, Mark P.; Artsimovitch, Irina			pH Dependence of the Stress Regulator DksA	PLOS ONE			English	Article							COILED-COIL TIP; RNA-POLYMERASE; ESCHERICHIA-COLI; TRANSCRIPTION FACTOR; SECONDARY CHANNEL; TRIGGER LOOP; DIFFERENTIAL REGULATION; ACID RESISTANCE; BINDING-SITE; GRE-FACTOR	DksA controls transcription of genes associated with diverse stress responses, such as amino acid and carbon starvation, oxidative stress, and iron starvation. DksA binds within the secondary channel of RNA polymerase, extending its long coiled-coil domain towards the active site. The cellular expression of DksA remains constant due to a negative feedback autoregulation, raising the question of whether DksA activity is directly modulated during stress. Here, we show that Escherichia coli DksA is essential for survival in acidic conditions and that, while its cellular levels do not change significantly, DksA activity and binding to RNA polymerase are increased at lower pH, with a concomitant decrease in its stability. NMR data reveal pH-dependent structural changes centered at the interface of the N and C-terminal regions of DksA. Consistently, we show that a partial deletion of the N-terminal region and substitutions of a histidine 39 residue at the domain interface abolish pH sensitivity in vitro. Together, these data suggest that DksA responds to changes in pH by shifting between alternate conformations, in which competing interactions between the Nand C-terminal regions modify the protein activity.	[Furman, Ran; NandyMazumdar, Monali; Artsimovitch, Irina] Ohio State Univ, Dept Microbiol, Columbus, OH 43210 USA; [Furman, Ran; Danhart, Eric M.; NandyMazumdar, Monali; Foster, Mark P.; Artsimovitch, Irina] Ohio State Univ, Ctr RNA Biol, Columbus, OH 43210 USA; [Danhart, Eric M.; Foster, Mark P.] Ohio State Univ, Dept Chem & Biochem, Columbus, OH 43210 USA; [Yuan, Chunhua] Ohio State Univ, Campus Chem Instrument Ctr, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Artsimovitch, I (corresponding author), Ohio State Univ, Dept Microbiol, 484 W 12th Ave, Columbus, OH 43210 USA.	artsimovitch.1@osu.edu	NandyMazumdar, Monali/GLS-8973-2022; Artsimovitch, Irina/L-3467-2019; NandyMazumdar, Monali/AAQ-2420-2021; Foster, Mark P/F-6332-2012	Foster, Mark P/0000-0001-9645-7491	National Science Foundation [MCB-0949569]; National Institutes of Health [R01 GM077234, R01 GM67153, 3T32GM008512-14S1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077234, T32GM008512, R01GM067153] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by grant MCB-0949569 National Science Foundation (http://www.nsf.gov/); R01 GM077234 National Institutes of Health (http://www.nih.gov/); R01 GM67153 National Institutes of Health (http://www.nih.gov/); 3T32GM008512-14S1 National Institutes of Health (http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg A, 2008, MOL MICROBIOL, V67, P1223, DOI 10.1111/j.1365-2958.2008.06115.x; Aberg A, 2009, J BACTERIOL, V191, P3226, DOI 10.1128/JB.01410-08; Artsimovitch I, 2000, J BACTERIOL, V182, P6027, DOI 10.1128/JB.182.21.6027-6035.2000; Belogurov GA, 2007, MOL CELL, V26, P117, DOI 10.1016/j.molcel.2007.02.021; Bernardo LMD, 2006, MOL MICROBIOL, V60, P749, DOI 10.1111/j.1365-2958.2006.05129.x; Blaby-Haas CE, 2011, MOL MICROBIOL, V79, P700, DOI 10.1111/j.1365-2958.2010.07475.x; Blankschien MD, 2009, EMBO J, V28, P1720, DOI 10.1038/emboj.2009.126; BUC H, 1985, BIOCHEMISTRY-US, V24, P2712, DOI 10.1021/bi00332a018; Chandrangsu P, 2011, MOL MICROBIOL, V80, P1337, DOI 10.1111/j.1365-2958.2011.07649.x; Costanzo A, 2008, MOL MICROBIOL, V67, P619, DOI 10.1111/j.1365-2958.2007.06072.x; De Biase D, 1999, MOL MICROBIOL, V32, P1198, DOI 10.1046/j.1365-2958.1999.01430.x; Foster JW, 2004, NAT REV MICROBIOL, V2, P898, DOI 10.1038/nrmicro1021; Furman R, 2013, FEBS LETT, V587, P614, DOI 10.1016/j.febslet.2013.01.073; Furman R, 2013, J MOL BIOL, V425, P82, DOI 10.1016/j.jmb.2012.11.008; Furman R, 2012, NUCLEIC ACIDS RES, V40, P3392, DOI 10.1093/nar/gkr1273; Garrett DS, 1997, BIOCHEMISTRY-US, V36, P4393, DOI 10.1021/bi970221q; Gopalkrishnan S, 2014, MOL MICROBIOL, V93, P479, DOI 10.1111/mmi.12674; Greenfield NJ, 2006, NAT PROTOC, V1, P2527, DOI 10.1038/nprot.2006.204; Henard CA, 2014, MOL MICROBIOL, V91, P790, DOI 10.1111/mmi.12498; Jishage M, 2002, GENE DEV, V16, P1260, DOI 10.1101/gad.227902; Jude F, 2003, J BACTERIOL, V185, P3558, DOI 10.1128/JB.185.12.3558-3566.2003; Kanjee U, 2011, EMBO J, V30, P931, DOI 10.1038/emboj.2011.5; Lamour V, 2006, J MOL BIOL, V356, P179, DOI 10.1016/j.jmb.2005.10.083; Laptenko O, 2003, EMBO J, V22, P6322, DOI 10.1093/emboj/cdg610; Laptenko O, 2006, EMBO J, V25, P2131, DOI 10.1038/sj.emboj.7601094; Lavinder JJ, 2009, J AM CHEM SOC, V131, P3794, DOI 10.1021/ja8049063; Lee JH, 2012, J MOL BIOL, V416, P503, DOI 10.1016/j.jmb.2011.12.028; Lemke JJ, 2009, MOL MICROBIOL, V74, P1368, DOI 10.1111/j.1365-2958.2009.06939.x; Lennon CW, 2012, GENE DEV, V26, P2634, DOI 10.1101/gad.204693.112; Lennon CW, 2009, J BACTERIOL, V191, P5854, DOI 10.1128/JB.00621-09; Lyzen R, 2009, NUCLEIC ACIDS RES, V37, P6655, DOI 10.1093/nar/gkp676; Magnusson LU, 2007, J BACTERIOL, V189, P5193, DOI 10.1128/JB.00330-07; Magnusson LU, 2003, J BIOL CHEM, V278, P968, DOI 10.1074/jbc.M209881200; Mechold U, 2013, NUCLEIC ACIDS RES, V41, P6175, DOI 10.1093/nar/gkt302; Mogull SA, 2001, INFECT IMMUN, V69, P5742, DOI 10.1128/IAI.69.9.5742-5751.2001; Nichols RJ, 2011, CELL, V144, P143, DOI 10.1016/j.cell.2010.11.052; Paul BJ, 2005, P NATL ACAD SCI USA, V102, P7823, DOI 10.1073/pnas.0501170102; Paul BJ, 2004, CELL, V118, P311, DOI 10.1016/j.cell.2004.07.009; Perederina A, 2004, CELL, V118, P297, DOI 10.1016/j.cell.2004.06.030; Potrykus K, 2008, ANNU REV MICROBIOL, V62, P35, DOI 10.1146/annurev.micro.62.081307.162903; Rich AM, 2012, J AM CHEM SOC, V134, P10405, DOI 10.1021/ja211417g; Richard H, 2004, J BACTERIOL, V186, P6032, DOI 10.1128/jb.186.18.6032-6041.2004; Roghanian M, 2011, NUCLEIC ACIDS RES, V39, P4352, DOI 10.1093/nar/gkq1359; Ross W, 2013, MOL CELL, V50, P420, DOI 10.1016/j.molcel.2013.03.021; Ruan WJ, 2011, J BIOL CHEM, V286, P18701, DOI 10.1074/jbc.M111.222273; Rutherford ST, 2007, J MOL BIOL, V366, P1243, DOI 10.1016/j.jmb.2006.12.013; Tehranchi AK, 2010, CELL, V141, P595, DOI 10.1016/j.cell.2010.03.036; Vassylyeva MN, 2007, EMBO REP, V8, P1038, DOI 10.1038/sj.embor.7401079; Vedadi M, 2006, P NATL ACAD SCI USA, V103, P15835, DOI 10.1073/pnas.0605224103; Vinella D, 2012, J BACTERIOL, V194, P261, DOI 10.1128/JB.06238-11; Webb C, 1999, MOL MICROBIOL, V34, P112, DOI 10.1046/j.1365-2958.1999.01581.x; Zuo YH, 2013, MOL CELL, V50, P430, DOI 10.1016/j.molcel.2013.03.020	52	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120746	10.1371/journal.pone.0120746	http://dx.doi.org/10.1371/journal.pone.0120746			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799498	Green Submitted, Green Published, gold			2022-12-26	WOS:000351987300170
J	Glennie, R; Buckland, ST; Thomas, L				Glennie, Richard; Buckland, Stephen T.; Thomas, Len			The Effect of Animal Movement on Line Transect Estimates of Abundance	PLOS ONE			English	Article							RESPONSIVE MOVEMENT; BIAS; POPULATION; MODELS; STRIP	Line transect sampling is a distance sampling method for estimating the abundance of wild animal populations. One key assumption of this method is that all animals are detected at their initial location. Animal movement independent of the transect and observer can thus cause substantial bias. We present an analytic expression for this bias when detection within the transect is certain (strip transect sampling) and use simulation to quantify bias when detection falls off with distance from the line (line transect sampling). We also explore the non-linear relationship between bias, detection, and animal movement by varying detectability and movement type. We consider animals that move in randomly orientated straight lines, which provides an upper bound on bias, and animals that are constrained to a home range of random radius. We find that bias is reduced when animal movement is constrained, and bias is considerably smaller in line transect sampling than strip transect sampling provided that mean animal speed is less than observer speed. By contrast, when mean animal speed exceeds observer speed the bias in line transect sampling becomes comparable with, and may exceed, that of strip transect sampling. Bias from independent animal movement is reduced by the observer searching further perpendicular to the transect, searching a shorter distance ahead and by ignoring animals that may overtake the observer from behind. However, when animals move in response to the observer, the standard practice of searching further ahead should continue as the bias from responsive movement is often greater than that from independent movement.	[Glennie, Richard; Buckland, Stephen T.; Thomas, Len] Univ St Andrews, Ctr Res Ecol & Environm Modelling, St Andrews, Fife, Scotland	University of St Andrews	Glennie, R (corresponding author), Univ St Andrews, Ctr Res Ecol & Environm Modelling, St Andrews, Fife, Scotland.	rg374@st-andrews.ac.uk	Buckland, Stephen T/A-1998-2012	Glennie, Richard/0000-0003-3806-4280; Thomas, Len/0000-0002-7436-067X; Buckland, Stephen/0000-0002-9939-709X	University of St Andrews; Carnegie Trust for the Universities of Scotland	University of St Andrews(Deutsche KrebshilfeHelmholtz Association); Carnegie Trust for the Universities of Scotland	This work was supported by the University of St Andrews (http://www.st-andrews.ac.uk/; RG, STB, LT) and by a summer scholarship and PhD grant from The Carnegie Trust for the Universities of Scotland (http://www.carnegie-trust.org/) to RG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borchers D, 2010, J AGR BIOL ENVIR ST, V15, P346, DOI 10.1007/s13253-010-0021-y; Borchers DL, 2006, BIOMETRICS, V62, P372, DOI 10.1111/j.1541-0420.2005.00493.x; Buckland S., 2004, ADV DISTANCE SAMPLIN; Buckland S.T., 2001, pi; BUCKLAND ST, 1992, BIOMETRICS, V48, P901, DOI 10.2307/2532356; Buckland ST, 2010, BIOMETRICS, V66, P169, DOI 10.1111/j.1541-0420.2009.01239.x; BURNHAM KP, 1985, J WILDLIFE MANAGE, V49, P1012, DOI 10.2307/3801387; BURNHAM KP, 1980, WILDLIFE MONOGR, P7; Canadas A., 2006, Journal of Cetacean Research and Management, V8, P13; Certain G, 2008, REMOTE SENS ENVIRON, V112, P3314, DOI 10.1016/j.rse.2008.01.019; GRANHOLM SL, 1983, CONDOR, V85, P243, DOI 10.2307/1367261; Gurarie E, 2013, THEOR ECOL-NETH, V6, P189, DOI 10.1007/s12080-012-0170-4; HAYES RJ, 1983, BIOMETRICS, V39, P29, DOI 10.2307/2530804; Hiby A.R., 1986, International Whaling Commission Report of the Commission, V36, P497; Hiby A.R., 1982, International Whaling Commission Report of the Commission, V32, P791; Hutchinson JMC, 2007, BIOL REV, V82, P335, DOI 10.1111/j.1469-185X.2007.00014.x; Marques TA, 2004, BIOMETRICS, V60, P757, DOI 10.1111/j.0006-341X.2004.00226.x; Marsden SJ, 1999, IBIS, V141, P377; Palka DL, 2001, CAN J FISH AQUAT SCI, V58, P777, DOI 10.1139/cjfas-58-4-777; Schweder T., 1990, International Whaling Commission Report of the Commission, V40, P349; Schweder T., 1977, RECENT DEV STAT, P221; SKELLAM JG, 1958, BIOMETRICS, V14, P385, DOI 10.2307/2527881; SMITH GEJ, 1979, BIOMETRICS, V35, P323, DOI 10.2307/2529953; SPEAR L, 1992, AUK, V109, P385, DOI 10.2307/4088211; Strindberg S, 2004, ADVANCED DISTANCE SAMPLING: ESTIMATING ABUNDANCE OF BIOLOGICAL POPULATIONS, P190; Thomas L, 2010, J APPL ECOL, V47, P5, DOI 10.1111/j.1365-2664.2009.01737.x; TURNOCK BJ, 1991, BIOMETRICS, V47, P701, DOI 10.2307/2532156; WATSON RA, 1995, ECOL MODEL, V77, P205, DOI 10.1016/0304-3800(93)E0085-H; Yapp W. B., 1956, Bird Study, V3, P93	29	28	31	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121333	10.1371/journal.pone.0121333	http://dx.doi.org/10.1371/journal.pone.0121333			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799206	Green Published, gold, Green Submitted			2022-12-26	WOS:000351987300237
J	Hayward, MR; AbuOun, M; Woodward, MJ; Jansen, VAA				Hayward, Matthew R.; AbuOun, Manal; Woodward, Martin J.; Jansen, Vincent A. A.			Temperature and Oxygen Dependent Metabolite Utilization by Salmonella enterica Serovars Derby and Mbandaka	PLOS ONE			English	Article							IDENTIFICATION; TYPHIMURIUM; GROWTH; PERSISTENCE; BACTERIA; CATTLE; FEED	Salmonella enterica is a zoonotic pathogen of clinical and veterinary significance, with over 2500 serovars. In previous work we compared two serovars displaying host associations inferred from isolation statistics. Here, to validate genome sequence data and to expand on the role of environmental metabolite constitution in host range determination we use a phenotypic microarray approach to assess the ability of these serovars to metabolise similar to 500 substrates at 25 degrees C with oxygen (aerobic conditions) to represent the ex vivo environment and at 37 degrees C with and without oxygen (aerobic/anaerobic conditions) to represent the in vivo environment. A total of 26 substrates elicited a significant difference in the rate of metabolism of which only one, D-galactonic acid-g-lactone, could be explained by the presence (S. Mbandaka) or the absence (S. Derby) of metabolic genes. We find that S. Mbandaka respires more efficiently at ambient temperatures and under aerobic conditions on 18 substrates including: glucosominic acid, saccharic acid, trehalose, fumaric acid, maltotriose, N-acetyl-Dglucosamine, N-acetyl-beta-D-mannosamine, fucose, L-serine and dihydroxy-acetone; whereas S. Derby is more metabolically competent anaerobically at 37 degrees C for dipeptides, glutamine-glutamine, alanine-lysine, asparagine-glutamine and nitrogen sources glycine and nitrite. We conclude that the specific phenotype cannot be reliably predicted from the presence of metabolic genes directly relating to the metabolic pathways under study.	[Hayward, Matthew R.] European Mol Biol Lab, Dept Struct & Computat Biol, D-69117 Heidelberg, Germany; [Hayward, Matthew R.; AbuOun, Manal] Anim Hlth & Vet Labs Agcy, Dept Bacteriol, Addlestone KT15 3NB, Surrey, England; [Hayward, Matthew R.; Jansen, Vincent A. A.] Royal Holloway Univ London, Sch Biol Sci, Egham TW20 0EX, Surrey, England; [Woodward, Martin J.] Univ Reading, Dept Food & Nutr Sci, Reading RG6 6AP, Berks, England	European Molecular Biology Laboratory (EMBL); Veterinary Laboratories Agency; University of London; Royal Holloway University London; University of Reading	Hayward, MR (corresponding author), European Mol Biol Lab, Dept Struct & Computat Biol, Meyerhofstr 1, D-69117 Heidelberg, Germany.	hayward@embl.de		Jansen, Vincent A.A./0000-0002-6518-2090	Engineering and Physical Sciences Research Council (EPSRC); Animal Health and Veterinary Laboratories Agency (AHVLA); Biotechnology and Biological Sciences Research Council (BBSRC) partners of the ERASysBio+ initiative under the EU ERA-NET Plus scheme in FP7 [BB/I004548/1]; BBSRC [BB/I004548/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I004548/1] Funding Source: researchfish	Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Animal Health and Veterinary Laboratories Agency (AHVLA); Biotechnology and Biological Sciences Research Council (BBSRC) partners of the ERASysBio+ initiative under the EU ERA-NET Plus scheme in FP7(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Engineering and Physical Sciences Research Council (EPSRC), www.epsrc.ac.uk, 4 year studentship awarded to MRH. Animal Health and Veterinary Laboratories Agency (AHVLA), http://www.defra.gov.uk/ahvla-en/, seedcorn internal investment fund to MRH. Biotechnology and Biological Sciences Research Council (BBSRC) partners of the ERASysBio+ initiative supported under the EU ERA-NET Plus scheme in FP7, www.bbsrc.ac.uk, BB/I004548/1 to VAAJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbuOun M, 2009, J BIOL CHEM, V284, P29480, DOI 10.1074/jbc.M109.005868; AGUILERA A, 1988, BIOTECHNOL BIOENG, V32, P240, DOI 10.1002/bit.260320215; AHVLA, 2011, SALM LIV PROD ANN RE; Anjum MF, 2005, INFECT IMMUN, V73, P7894, DOI 10.1128/IAI.73.12.7894-7905.2005; Azelis, 2013, AZ AN NUTR; Baumler AJ, 1998, INFECT IMMUN, V66, P4579; BLASER MJ, 1982, REV INFECT DIS, V4, P1096; Buddruhs N, 2012, PACKAGE OPM; CDC PHLIS, 2009, SALM ANN SURV; Center for Disease Control and Prevention (CDC), 2011, NAT ENT DIS SURV SAL; Chang DE, 2002, MOL MICROBIOL, V45, P289, DOI 10.1046/j.1365-2958.2002.03001.x; Davies R H, 1999, Vet Rec, V145, P655; Davis MA, 2003, VET MICROBIOL, V95, P199, DOI 10.1016/S0378-1135(03)00159-7; Grimont, 2007, ANTIGENIC FORMULAE S; Hald T, 2006, FOODBORNE PATHOG DIS, V3, P422, DOI 10.1089/fpd.2006.3.422; Hayward MR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107857; Hayward MR, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-365; JONES PW, 1982, J HYG-CAMBRIDGE, V88, P255, DOI 10.1017/S002217240007011X; Joshi T, 2010, IEEE INT C BIOINFORM, P203, DOI 10.1109/BIBM.2010.5706563; Kahm M, 2012, PACKAGE GROFIT; Kingsley RA, 2003, INFECT IMMUN, V71, P629, DOI 10.1128/IAI.71.2.629-640.2003; Kraatz M, 2011, ISOLATION LACTIC ACI; Lu SW, 2003, INFECT IMMUN, V71, P6734, DOI 10.1128/IAI.71.12.6734-6741.2003; Mappley LJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-454; Ogata H., 1999, NUCLEIC ACIDS RES, V27, P29, DOI DOI 10.1093/nar/27.1.29; Pan ZS, 2009, MICROBIOL-SGM, V155, P3200, DOI 10.1099/mic.0.029405-0; Papadopoulou C, 2009, VET REC, V165, P681; Purvis GM, 2005, VET REC, V157, P165, DOI 10.1136/vr.157.6.165; R Core Team, 2012, R LANG ENV STAT COMP; Rabsch W, 2001, MICROBES INFECT, V3, P237, DOI 10.1016/S1286-4579(01)01375-2; Rolfe MD, 2012, J BACTERIOL, V194, P686, DOI 10.1128/JB.06112-11; Sambrook J., 2002, MOL CLONING LAB MANU; Schikora A, 2012, TRENDS PLANT SCI, V17, P245, DOI 10.1016/j.tplants.2012.03.007; Schikora A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002279; Storz G, 2011, MOL CELL, V43, P880, DOI 10.1016/j.molcel.2011.08.022; van Asselt ED, 2009, POULTRY SCI, V88, P2695, DOI 10.3382/ps.2009-00074; Wierup M, 2010, ACTA VET SCAND, V52, DOI 10.1186/1751-0147-52-15; Wilkins W, 2010, CAN J VET RES, V74, P81	38	6	7	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120450	10.1371/journal.pone.0120450	http://dx.doi.org/10.1371/journal.pone.0120450			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798944	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000351987300145
J	Hernandez-Aceituno, J; Acosta, L; Pineiro, JD				Hernandez-Aceituno, Javier; Acosta, Leopoldo; Pineiro, Jose D.			Application of Time Dependent Probabilistic Collision State Checkers in Highly Dynamic Environments	PLOS ONE			English	Article							MOTION; AVOIDANCE	When computing the trajectory of an autonomous vehicle, inevitable collision states must be avoided at all costs, so no harm comes to the device or pedestrians around it. In dynamic environments, considering collisions as binary events is risky and inefficient, as the future position of moving obstacles is unknown. We introduce a time-dependent probabilistic collision state checker system, which traces a safe route with a minimum collision probability for a robot. We apply a sequential Bayesian model to calculate approximate predictions of the movement patterns of the obstacles, and define a time-dependent variation of the Dijkstra algorithm to compute statistically safe trajectories through a crowded area. We prove the efficiency of our methods through experimentation, using a self-guided robotic device.	[Hernandez-Aceituno, Javier; Acosta, Leopoldo; Pineiro, Jose D.] Univ La Laguna, Dept Ingn Informat & Sistemas, E-38207 San Cristobal la Laguna, Canary Islands, Spain	Universidad de la Laguna	Hernandez-Aceituno, J (corresponding author), Univ La Laguna, Dept Ingn Informat & Sistemas, E-38207 San Cristobal la Laguna, Canary Islands, Spain.	javier@isaatc.ull.es	Hernández-Aceituno, Javier/AAA-7186-2019; Piñeiro, Jose/ABG-9470-2021; Acosta, Leopoldo/I-5110-2015; Piñeiro, Jose D/G-2370-2010	Hernández-Aceituno, Javier/0000-0001-8885-0605; Acosta, Leopoldo/0000-0001-9428-4507; Piñeiro, Jose D/0000-0003-0213-0004	Spanish Ministry of Economy and Competitiveness under Project STIRPE [DPI2013-46897-C2-1-R]; Spanish Ministry of Science and Innovation under the "Formacion de Profesorado Universitario" [FPU2012-3568]	Spanish Ministry of Economy and Competitiveness under Project STIRPE; Spanish Ministry of Science and Innovation under the "Formacion de Profesorado Universitario"	The authors gratefully acknowledge the contribution of the Spanish Ministry of Economy and Competitiveness (www.mineco.gob.es) under Project STIRPE DPI2013-46897-C2-1-R. JHA's research was supported by the Spanish Ministry of Science and Innovation (www.micinn.es), under the "Formacion de Profesorado Universitario" grant FPU2012-3568. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Mora J, 2012, IEEE INT CONF ROBOT, P360, DOI 10.1109/ICRA.2012.6225166; Althoff D, 2010, IEEE INT CONF ROBOT, P1492, DOI 10.1109/ROBOT.2010.5509369; Bautin A, 2010, IEEE INT CONF ROBOT, P4022, DOI 10.1109/ROBOT.2010.5509233; Benenson R, 2008, 2008 10TH INTERNATIONAL CONFERENCE ON CONTROL AUTOMATION ROBOTICS & VISION: ICARV 2008, VOLS 1-4, P515, DOI 10.1109/ICARCV.2008.4795572; Blackmore L, 2011, IEEE T ROBOT, V27, P1080, DOI 10.1109/TRO.2011.2161160; Bouraine S, 2011, IEEE INT C INT ROBOT, P2985, DOI 10.1109/IROS.2011.6048569; Brock O, 1999, ICRA '99: IEEE INTERNATIONAL CONFERENCE ON ROBOTICS AND AUTOMATION, VOLS 1-4, PROCEEDINGS, P341, DOI 10.1109/ROBOT.1999.770002; Caron F, 2007, IEEE T SIGNAL PROCES, V55, P2703, DOI 10.1109/TSP.2007.893914; Du Toit NE, 2012, IEEE T ROBOT, V28, P101, DOI 10.1109/TRO.2011.2166435; Du Toit NE, 2011, IEEE T ROBOT, V27, P809, DOI 10.1109/TRO.2011.2116190; DUBINS LE, 1957, AM J MATH, V79, P497, DOI 10.2307/2372560; Fox D, 1997, IEEE ROBOT AUTOM MAG, V4, P23, DOI 10.1109/100.580977; Fraichard T, 2003, IROS 2003: PROCEEDINGS OF THE 2003 IEEE/RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, VOLS 1-4, P388; Fraichard T, 2007, IEEE INT CONF ROBOT, P1140, DOI 10.1109/ROBOT.2007.363138; Fulgenzi C, 2008, 2008 IEEE/RSJ INTERNATIONAL CONFERENCE ON ROBOTS AND INTELLIGENT SYSTEMS, VOLS 1-3, CONFERENCE PROCEEDINGS, P1056, DOI 10.1109/IROS.2008.4650959; Guibas L., 1983, 24th Annual Symposium on Foundations of Computer Science, P100, DOI 10.1109/SFCS.1983.1; Henry P, 2010, IEEE INT CONF ROBOT, P981, DOI 10.1109/ROBOT.2010.5509772; Kim S., 2013, ALGORITHMIC FDN ROBO, P609; Koenig S, 2005, IEEE T ROBOT, V21, P354, DOI 10.1109/TRO.2004.838026; Luber M, 2012, IEEE INT C INT ROBOT, P902, DOI 10.1109/IROS.2012.6385716; Martinez-Gomez L, 2008, 2008 IEEE/RSJ INTERNATIONAL CONFERENCE ON ROBOTS AND INTELLIGENT SYSTEMS, VOLS 1-3, CONFERENCE PROCEEDINGS, P234, DOI 10.1109/IROS.2008.4650640; Miura J., 1999, IEEE SMC'99 Conference Proceedings. 1999 IEEE International Conference on Systems, Man, and Cybernetics (Cat. No.99CH37028), P692, DOI 10.1109/ICSMC.1999.812488; Miura J., 2000, Proceedings 2000 ICRA. Millennium Conference. IEEE International Conference on Robotics and Automation. Symposia Proceedings (Cat. No.00CH37065), P2258, DOI 10.1109/ROBOT.2000.846363; Oriolo G, 1997, J ROBOTIC SYST, V14, P179, DOI 10.1002/(SICI)1097-4563(199703)14:3<179::AID-ROB3>3.0.CO;2-O; Parthasarathi R, 2007, IEEE INT CONF ROBOT, P3068, DOI 10.1109/ROBOT.2007.363938; Patil S, 2012, IEEE INT CONF ROBOT, P3238, DOI 10.1109/ICRA.2012.6224727; Plagemann C, 2006, INT JOINT C ART INT, V20; van den Berg J, 2012, IEEE INT CONF ROBOT, P346, DOI 10.1109/ICRA.2012.6224648; ZHU QM, 1990, IEEE INTERNATIONAL CONFERENCE ON SYSTEMS ENGINEERING /, P216, DOI 10.1109/ICSYSE.1990.203136; Ziebart BD, 2009, 2009 IEEE-RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, P3931, DOI 10.1109/IROS.2009.5354147	30	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0119930	10.1371/journal.pone.0119930	http://dx.doi.org/10.1371/journal.pone.0119930			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799557	Green Published, gold			2022-12-26	WOS:000351987300092
J	Hu, SS; Hosey, KL; Derbigny, WA				Hu, Sishun; Hosey, Kristen L.; Derbigny, Wilbert A.			Analyses of the Pathways Involved in Early- and Late-Phase Induction of IFN-Beta during C. muridarum Infection of Oviduct Epithelial Cells	PLOS ONE			English	Article							NF-KAPPA-B; ALPHA/BETA-INTERFERON GENES; CHLAMYDIA-PNEUMONIAE; POSITIVE FEEDBACK; GAMMA; RECOGNITION; ACTIVATION; RNA; SECRETION; PROTEIN	We previously reported that the IFN-beta secreted by Chlamydia muridarum-infected murine oviduct epithelial cells (OE cells) was mostly dependent on the TLR3 signaling pathway. To further characterize the mechanisms of IFN-beta synthesis during Chlamydia infection of OE cells in vitro, we utilized specific inhibitory drugs to clarify the roles of IRF3 and NF-kappa B on both early-and late-phase C. muridarum infections. Our results showed that the pathways involved in the early-phase of IFN-beta production were distinct from that in the late-phase of IFN-beta production. Disruption of IRF3 activation using an inhibitor of TBK-1 at early-phase Chlamydia infection had a significant impact on the overall synthesis of IFN-beta; however, disruption of IRF3 activation at late times during infection had no effect. Interestingly, inhibition of NF-kappa B early during Chlamydia infection also had a negative effect on IFN-beta production; however, its impact was not significant. Our data show that the transcription factor IRF7 was induced late during Chlamydia infection, which is indicative of a positive feedback mechanism of IFN-beta synthesis late during infection. In contrast, IRF7 appears to play little or no role in the early synthesis of IFN-beta during Chlamydia infection. Finally, we demonstrate that antibiotics that target chlamydial DNA replication are much more effective at reducing IFN-beta synthesis during infection versus antibiotics that target chlamydial transcription. These results provide evidence that early-and late-phase IFN-beta production have distinct signaling pathways in Chlamydia-infected OE cells, and suggest that Chlamydia DNA replication might provide a link to the currently unknown chlamydial PAMP for TLR3.	[Hu, Sishun; Hosey, Kristen L.; Derbigny, Wilbert A.] Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA; [Hu, Sishun] Huazhong Agr Univ, Coll Vet Med, Wuhan, Peoples R China	Indiana University System; Indiana University Bloomington; Huazhong Agricultural University	Derbigny, WA (corresponding author), Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA.	wderbign@iupui.edu			National Institutes of Health [1K22AI072072-01A1, R25GM079657-04]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI104944] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM079657] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health (http://nih.gov/) grants 1K22AI072072-01A1 (WAD and KLH) and R25GM079657-04 (KLH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarskog NK, 2009, J NEUROIMMUNOL, V212, P148, DOI 10.1016/j.jneuroim.2009.04.012; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Aubry C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033299; Barker JR, 2013, MBIO, V4, DOI 10.1128/mBio.00018-13; Bhat N, 2013, EUR J IMMUNOL; Buss C, 2010, J IMMUNOL, V184, P3072, DOI 10.4049/jimmunol.0902947; Chen S, 2008, J IMMUNOL, V181, P7186, DOI 10.4049/jimmunol.181.10.7186; Clark K, 2009, J BIOL CHEM, V284, P14136, DOI 10.1074/jbc.M109.000414; Conzelmann KK, 2005, J VIROL, V79, P5241, DOI 10.1128/JVI.79.9.5241-5248.2005; Derbigny WA, 2005, J IMMUNOL, V175, P6065, DOI 10.4049/jimmunol.175.9.6065; Derbigny WA, 2007, INFECT IMMUN, V75, P1280, DOI 10.1128/IAI.01525-06; Derbigny WA, 2012, INFECT IMMUN, V80, P254, DOI 10.1128/IAI.05549-11; Derbigny WA, 2010, J IMMUNOL, V185, P6689, DOI 10.4049/jimmunol.1001548; Devitt A, 1996, INFECT IMMUN, V64, P3951, DOI 10.1128/IAI.64.10.3951-3956.1996; Dragan AI, 2008, J MOL BIOL, V384, P335, DOI 10.1016/j.jmb.2008.09.015; Feldman RI, 2005, J BIOL CHEM, V280, P19867, DOI 10.1074/jbc.M501367200; Francois-Newton V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022200; Gautier G, 2005, J EXP MED, V201, P1435, DOI 10.1084/jem.20041964; Hacker Hans, 2006, Sci STKE, V2006, pre13, DOI 10.1126/stke.3572006re13; HARTMANN G, 1967, BIOCHIM BIOPHYS ACTA, V145, P843, DOI 10.1016/0005-2787(67)90147-5; Honda K, 2005, INT IMMUNOL, V17, P1367, DOI 10.1093/intimm/dxh318; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Hosey KL, 2014, ROLE STAT1 CHL UNPUB; Johnson RM, 2004, INFECT IMMUN, V72, P3951, DOI 10.1128/IAI.72.7.3951-3960.2004; Kagnoff MF, 1997, J CLIN INVEST, V100, P6, DOI 10.1172/JCI119522; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kylaniemi MK, 2009, MICROB PATHOGENESIS, V46, P235, DOI 10.1016/j.micpath.2009.01.006; Lad SP, 2005, J IMMUNOL, V174, P7186, DOI 10.4049/jimmunol.174.11.7186; Le Bon A, 2002, CURR OPIN IMMUNOL, V14, P432, DOI 10.1016/S0952-7915(02)00354-0; Levy DE, 2002, J INTERF CYTOK RES, V22, P87, DOI 10.1089/107999002753452692; Liao JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026463; Lin RT, 2000, MOL CELL BIOL, V20, P6342, DOI 10.1128/MCB.20.17.6342-6353.2000; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marie I, 1998, EMBO J, V17, P6660, DOI 10.1093/emboj/17.22.6660; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Nagarajan UM, 2005, J IMMUNOL, V175, P450, DOI 10.4049/jimmunol.175.1.450; NEWHALL WJ, 1986, J CLIN MICROBIOL, V23, P333, DOI 10.1128/JCM.23.2.333-338.1986; Panne D, 2008, CURR OPIN STRUC BIOL, V18, P236, DOI 10.1016/j.sbi.2007.12.002; Prantner D, 2010, J IMMUNOL, V184, P2551, DOI 10.4049/jimmunol.0903704; Rasmussen SJ, 1997, J CLIN INVEST, V99, P77, DOI 10.1172/JCI119136; Rodel J, 2001, FEMS IMMUNOL MED MIC, V32, P9; Rodel J, 1998, INFECT IMMUN, V66, P4491; Rothenfusser S, 2005, J IMMUNOL, V175, P5260, DOI 10.4049/jimmunol.175.8.5260; Rothfuchs AG, 2004, J IMMUNOL, V172, P6345, DOI 10.4049/jimmunol.172.10.6345; Rothfuchs AG, 2001, J IMMUNOL, V167, P6453, DOI 10.4049/jimmunol.167.11.6453; Rothfuchs AG, 2006, J IMMUNOL, V176, P6982, DOI 10.4049/jimmunol.176.11.6982; Royer PJ, 2013, INFECT IMMUN, V81, P4299, DOI 10.1128/IAI.00477-13; Rozen S, 2000, Methods Mol Biol, V132, P365; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Sato M, 1998, FEBS LETT, V441, P106, DOI 10.1016/S0014-5793(98)01514-2; SCHACHTER J, 1980, ANNU REV MICROBIOL, V34, P285, DOI 10.1146/annurev.mi.34.100180.001441; Schachter J, 1980, CHLAMYDIAE MANUAL CL, P357; Schaefer TM, 2005, J IMMUNOL, V174, P992, DOI 10.4049/jimmunol.174.2.992; SEIBERT G, 1983, EUR J CLIN MICROBIOL, V2, P548, DOI 10.1007/BF02016563; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Shin HM, 2004, FEBS LETT, V571, P50, DOI 10.1016/j.febslet.2004.06.056; Su H, 1998, J EXP MED, V188, P809, DOI 10.1084/jem.188.5.809; Suchland RJ, 2009, ANTIMICROB AGENTS CH, V53, P4604, DOI 10.1128/AAC.00477-09; Suchland RJ, 2003, ANTIMICROB AGENTS CH, V47, P636, DOI 10.1128/AAC.47.2.636-642.2003; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; tenOever BR, 2004, J VIROL, V78, P10636, DOI 10.1128/JVI.78.19.10636-10649.2004; Witte CE, 2013, MBIO, V4, DOI 10.1128/mBio.00282-13; Yuhas Y, 2011, ANTIMICROB AGENTS CH, V55, P5541, DOI 10.1128/AAC.05149-11	64	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0119235	10.1371/journal.pone.0119235	http://dx.doi.org/10.1371/journal.pone.0119235			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798928	Green Published, gold			2022-12-26	WOS:000351987300035
J	Zhang, JQ; Li, SH; Liu, F; Zhou, LP; Shao, NS; Zhao, XH				Zhang, Jinqiang; Li, Shaohua; Liu, Fang; Zhou, Lanping; Shao, Ningsheng; Zhao, Xiaohang			SELEX Aptamer Used as a Probe to Detect Circulating Tumor Cells in Peripheral Blood of Pancreatic Cancer Patients	PLOS ONE			English	Article							BREAST-CANCER; HNRNP A1; SURVIVAL; TISSUE; GENE	Many studies have shown that the quantity and dynamics of circulating tumor cells (CTCs) in peripheral blood of patients afflicted with solid tumours have great relevance in therapeutic efficacy and prognosis. Different methods based on various strategies have been developed to isolate and identify CTCs, but their efficacy needs to be improved because of the rarity and complexity of CTCs. This study was designed to examine the possibility of using a SELEX aptamer (BC-15) as a probe to identify rare CTCs out of background nucleated cells. Aptamer BC-15 was selected from a random oligonucleotide library screened against human breast cancer tissue. Fluorescence staining showed that BC-15 had a high affinity for nuclei of human cancer cell lines of various origins as well as CTCs isolated from pancreatic cancer patients, whereas its binding capacity for non-tumor breast epithelial cells and leukocytes was almost undetectable. BC-15(+)/CD45(-) cells in cancer patient blood were also found to be cytokeratins 18-positive and aneuploid by immunofluorescence staining and fluorescent in situ hybridization, respectively. Finally, the aptamer method was compared with the well-established anti-cytokeratin method using 15 pancreatic cancer patient blood samples, and enumeration indicated no difference between these two methods. Our study establishes a novel way to identify CTCs by using a synthetic aptamer probe. This new approach is comparable with the anti-cytokeratin-based CTC identification method.	[Zhang, Jinqiang; Liu, Fang; Zhou, Lanping; Zhao, Xiaohang] Chinese Acad Med Sci, State Key Lab Mol Oncol, Canc Inst & Hosp, Beijing 100730, Peoples R China; [Zhang, Jinqiang; Liu, Fang; Zhou, Lanping; Zhao, Xiaohang] Peking Union Med Coll, Beijing 100021, Peoples R China; [Li, Shaohua; Shao, Ningsheng] Beijing Inst Basic Med Sci, Dept Biochem & Mol Biol, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Academy of Military Medical Sciences - China	Zhao, XH (corresponding author), Chinese Acad Med Sci, State Key Lab Mol Oncol, Canc Inst & Hosp, Beijing 100730, Peoples R China.	zhaoxh@cicams.ac.cn	LI, SHAOHUA/E-2733-2015		High-tech R D Program [2012AA020206, 2012AA02A503]; State Key Projects for Basic Research [2011CB910703]; NSFC of China [30700992, 81372591, 81321091]	High-tech R D Program; State Key Projects for Basic Research; NSFC of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants of the High-tech R & D Program (No. 2012AA020206 and 2012AA02A503), State Key Projects for Basic Research (2011CB910703) and NSFC (30700992, 81372591, 81321091) of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allard WJ, 2004, CLIN CANCER RES, V10, P6897, DOI 10.1158/1078-0432.CCR-04-0378; Balic M, 2012, EXPERT REV MOL DIAGN, V12, P303, DOI [10.1586/ERM.12.12, 10.1586/erm.12.12]; Bridonneau P, 1999, ANTISENSE NUCLEIC A, V9, P1, DOI 10.1089/oli.1.1999.9.1; Cristofanilli M, 2004, NEW ENGL J MED, V351, P781, DOI 10.1056/NEJMoa040766; Fehm T, 2002, CLIN CANCER RES, V8, P2073; Greene BT, 2012, FRONT ONCOL, V2, P1, DOI 10.3389/fonc.2012.00069; Ksiazkiewicz M, 2012, PATHOBIOLOGY, V79, P195, DOI 10.1159/000337106; Kunii T, 2011, ANALYST, V136, P1310, DOI 10.1039/c0an00962h; Li SH, 2009, J PATHOL, V218, P327, DOI 10.1002/path.2543; Meng S, 2006, P NATL ACAD SCI USA, V103, P17361, DOI 10.1073/pnas.0608113103; Molnar B, 2001, CLIN CANCER RES, V7, P4080; Moreno JG, 2005, UROLOGY, V65, P713, DOI 10.1016/j.urology.2004.11.006; Pantel K, 2008, NAT REV CANCER, V8, P329, DOI 10.1038/nrc2375; Patry C, 2003, CANCER RES, V63, P7679; Song KM, 2012, SENSORS-BASEL, V12, P612, DOI 10.3390/s120100612; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Ushigome M, 2005, INT J ONCOL, V26, P635; Wu C, 2009, J THORAC ONCOL, V4, P30, DOI 10.1097/JTO.0b013e3181914125; Yan-Sanders Y, 2002, CANCER LETT, V183, P215, DOI 10.1016/S0304-3835(02)00168-4; Ye M, 2012, INT J MOL SCI, V13, P3341, DOI 10.3390/ijms13033341; Yu M, 2013, SCIENCE, V339, P580, DOI 10.1126/science.1228522; Zerbe LK, 2004, MOL CARCINOGEN, V41, P187, DOI 10.1002/mc.20053; Zippelius A, 2000, ANN NY ACAD SCI, V906, P110	23	28	31	2	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121920	10.1371/journal.pone.0121920	http://dx.doi.org/10.1371/journal.pone.0121920			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799539	Green Submitted, Green Published, gold			2022-12-26	WOS:000351987300301
J	Yi, SY; Chhoun, P; Suong, S; Thin, K; Brody, C; Tuot, S				Yi, Siyan; Chhoun, Pheak; Suong, Samedy; Thin, Kouland; Brody, Carinne; Tuot, Sovannary			AIDS-Related Stigma and Mental Disorders among People Living with HIV: A Cross-Sectional Study in Cambodia	PLOS ONE			English	Article							AFRICAN-AMERICAN MEN; PERCEIVED DISCRIMINATION; PSYCHIATRIC-DISORDERS; MAJOR DEPRESSION; SOUTH-AFRICA; ANTIRETROVIRAL THERAPY; INFECTED INDIVIDUALS; INTERNALIZED STIGMA; TREATMENT ADHERENCE; PROTECTIVE FACTORS	Background AIDS-related stigma and mental disorders are the most common conditions in people living with HIV (PLHIV). We therefore conducted this study to examine the association of AIDS-related stigma and discrimination with mental disorders among PLHIV in Cambodia. Methods A two-stage cluster sampling method was used to select 1,003 adult PLHIV from six provinces. The People Living with HIV Stigma Index was used to measure stigma and discrimination, and a short version of general health questionnaire (GHQ-12) was used to measure mental disorders. Multivariate logistic regression analysis was conducted. Results The reported experiences of discrimination in communities in the past 12 months ranged from 0.8% for reports of being denied health services to 42.3% for being aware of being gossiped about. Internal stigma was also common ranging from 2.8% for avoiding going to a local clinic and/or hospital to 59.6% for deciding not to have (more) children. The proportions of PLHIV who reported fear of stigma and discrimination ranged from 13.9% for fear of being physically assaulted to 34.5% for fear of being gossiped about. The mean score of GHQ-12 was 3.2 (SD = 2.4). After controlling for several potential confounders, higher levels of mental disorders (GHQ-12 >= 4) remained significantly associated with higher levels of experiences of stigma and discrimination in family and communities (AOR = 1.9, 95% CI = 1.4-2.6), higher levels of internal stigma (AOR = 1.7, 95% CI = 1.2-2.3), and higher levels of fear of stigma and discrimination in family and communities (AOR = 1.5, 95% CI = 1.1-2.2). Conclusions AIDS-related stigma and discrimination among PLHIV in Cambodia are common and may have potential impacts on their mental health conditions. These findings indicate a need for community-based interventions to reduce stigma and discrimination in the general public and to help PLHIV to cope with this situation.	[Yi, Siyan; Chhoun, Pheak; Suong, Samedy; Thin, Kouland; Tuot, Sovannary] KHANA, Res Dept, Phnom Penh, Cambodia; [Yi, Siyan; Brody, Carinne] Touro Univ Calif, Coll Educ & Hlth Sci, Publ Hlth Program, Vallejo, CA USA	Touro University California	Yi, SY (corresponding author), KHANA, Res Dept, Phnom Penh, Cambodia.	siyan@doctor.com	Chhoun, Pheak/AAR-3361-2021	Chhoun, Pheak/0000-0001-6369-0190; Brody, Carinne/0000-0001-9376-5528				Adewuya AO, 2007, J PSYCHOSOM RES, V63, P203, DOI 10.1016/j.jpsychores.2007.03.006; Akena D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048671; Bjelland I, 2008, SOC SCI MED, V66, P1334, DOI 10.1016/j.socscimed.2007.12.019; Bogart LM, 2011, CULT DIVERS ETHN MIN, V17, P295, DOI 10.1037/a0024056; Bogart LM, 2010, ANN BEHAV MED, V40, P184, DOI 10.1007/s12160-010-9200-x; Bouhnik AD, 2005, ANTIVIR THER, V10, P53; Chibanda D, 2014, JAIDS-J ACQ IMM DEF, V67, pS54, DOI 10.1097/QAI.0000000000000258; Cook JA, 2004, AM J PUBLIC HEALTH, V94, P1133, DOI 10.2105/AJPH.94.7.1133; Cruess DG, 2005, AM J PSYCHIAT, V162, P2125, DOI 10.1176/appi.ajp.162.11.2125; dos Santos MML, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-80; Earnshaw VA, 2013, AM PSYCHOL, V68, P225, DOI 10.1037/a0032705; Fields EL, 2013, AM J PUBLIC HEALTH, V103, P875, DOI 10.2105/AJPH.2012.300951; Freeman M, 2007, AIDS CARE, V19, P1201, DOI 10.1080/09540120701426482; Freeman M, 2008, S AFR J PSYCHOL, V38, P489, DOI 10.1177/008124630803800304; Goldberg D.P., 1988, USERS GUIDE GEN HLTH; Goldberg D.P, 1972, DETECTION PSYCHIAT I; Goldberg DP, 1998, PSYCHOL MED, V28, P915, DOI 10.1017/S0033291798006874; Grossman CI, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.3.18881; Hatzenbuehler ML, 2009, PSYCHOL SCI, V20, P1282, DOI 10.1111/j.1467-9280.2009.02441.x; Horberg MA, 2008, JAIDS-J ACQ IMM DEF, V47, P384, DOI 10.1097/QAI.0b013e318160d53e; International Parenthood Federation (IPF) Global Network of People Living with HIV (GNP+) International Community of Women Living with HIV (ICW) UNAIDS, 2008, PEOPL LIV HIV STIGM; Jackson J.S., 2006, SOCIAL STRUCTURE AGI; Joska JA, 2014, AIDS BEHAV, V18, P1492, DOI 10.1007/s10461-014-0709-z; Kaharuza FM, 2006, AIDS BEHAV, V10, pS105, DOI 10.1007/s10461-006-9142-2; Katz IT, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.3.18640; Kim YJ, 2013, PSYCHIAT INVEST, V10, P352, DOI 10.4306/pi.2013.10.4.352; Kinyanda E, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-205; Li L, 2009, AIDS CARE, V21, P1007, DOI 10.1080/09540120802614358; Logie C, 2013, AIDS PATIENT CARE ST, V27, P114, DOI 10.1089/apc.2012.0296; Mogga S, 2006, BRIT J PSYCHIAT, V189, P241, DOI 10.1192/bjp.bp.105.013417; Myer L, 2008, AIDS PATIENT CARE ST, V22, P147, DOI 10.1089/apc.2007.0102; Naar-King S, 2007, AIDS PATIENT CARE ST, V21, pS40, DOI 10.1089/apc.2007.9988; Nachega Jean B, 2012, J Int Assoc Physicians AIDS Care (Chic), V11, P172, DOI 10.1177/1545109712436723; Nakasujja N, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-44; Nakimuli-Mpungu E, 2011, NEUROBEHAV HIV MED, V3, P19, DOI DOI 10.2147/NBHIV.S13277; National Institute of Public Health National Institute of Statistics and ORC Macro, 2010, CAMB DEM HLTH SURV 2; Olley BO, 2006, J PSYCHOSOM RES, V61, P479, DOI 10.1016/j.jpsychores.2006.03.010; Olley BO, 2004, AIDS PATIENT CARE ST, V18, P481, DOI 10.1089/1087291041703700; Pascoe EA, 2009, PSYCHOL BULL, V135, P531, DOI 10.1037/a0016059; Pence BW, 2009, J ANTIMICROB CHEMOTH, V63, P636, DOI 10.1093/jac/dkp006; Petrushkin H, 2005, PSYCHIATR BULL, V29, P455, DOI 10.1192/pb.29.12.455; Rao D, 2007, AIDS CARE, V19, P28, DOI 10.1080/09540120600652303; Sidibe M, 2013, J INT AIDS SOC, V16, DOI [10.7448/IAS.16.3.18893, 10.7448/IAS.17.3.19151]; Simbayi LC, 2007, SOC SCI MED, V64, P1823, DOI 10.1016/j.socscimed.2007.01.006; Sopheab H, 2013, MIDTERM REV SUSTAINA; Springer SA, 2012, AIDS BEHAV, V16, P2119, DOI 10.1007/s10461-012-0212-3; Stangl AL, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.3.18734; Steward WT, 2008, SOC SCI MED, V67, P1225, DOI 10.1016/j.socscimed.2008.05.032; Steward Wayne T, 2013, J Int Assoc Provid AIDS Care, V12, P103, DOI 10.1177/1545109711432315; Steward WT, 2011, PSYCHOL HEALTH MED, V16, P74, DOI 10.1080/13548506.2010.521568; Su XY, 2013, AIDS CARE, V25, P239, DOI 10.1080/09540121.2012.701713; Treisman G, 2007, CLIN INFECT DIS, V45, pS313, DOI 10.1086/522556; Tsai AC, 2013, ANN BEHAV MED, V46, P285, DOI 10.1007/s12160-013-9514-6; Turan JM, 2011, AIDS BEHAV, V15, P1111, DOI 10.1007/s10461-010-9798-5; UNAIDS, 2011, PEOPL LIV HIV STIGM; Valdiserri RO, 2002, AM J PUBLIC HEALTH, V92, P341, DOI 10.2105/AJPH.92.3.341; Wang B, 2012, SOC SCI MED, V74, P1435, DOI 10.1016/j.socscimed.2012.01.007; Williams DR, 2009, J BEHAV MED, V32, P20, DOI 10.1007/s10865-008-9185-0; Yi S, 2014, THE SUSTAINABLE ACTI; Yu XN, 2009, AIDS CARE, V21, P645, DOI 10.1080/09540120802459770; Zulkefly N. S., 2010, GLOBAL J HLTH SCI, V2, P73	61	36	38	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0121461	10.1371/journal.pone.0121461	http://dx.doi.org/10.1371/journal.pone.0121461			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE5MO	25806534	Green Published, Green Submitted, gold			2022-12-26	WOS:000351880000155
J	Abbas, MM; Mohie-Eldin, MM; El-Manzalawy, Y				Abbas, Mostafa M.; Mohie-Eldin, Mostafa M.; El-Manzalawy, Yasser			Assessing the Effects of Data Selection and Representation on the Development of Reliable E. coli Sigma 70 Promoter Region Predictors	PLOS ONE			English	Article							ESCHERICHIA-COLI; TRANSCRIPTION INITIATION; DNA-SEQUENCE; RECOGNITION; STABILITY; CURVE; SITES; ANNOTATION; ACCURACY; GENOMES	As the number of sequenced bacterial genomes increases, the need for rapid and reliable tools for the annotation of functional elements (e.g., transcriptional regulatory elements) becomes more desirable. Promoters are the key regulatory elements, which recruit the transcriptional machinery through binding to a variety of regulatory proteins (known as sigma factors). The identification of the promoter regions is very challenging because these regions do not adhere to specific sequence patterns or motifs and are difficult to determine experimentally. Machine learning represents a promising and cost-effective approach for computational identification of prokaryotic promoter regions. However, the quality of the predictors depends on several factors including: i) training data; ii) data representation; iii) classification algorithms; iv) evaluation procedures. In this work, we create several variants of E. coli promoter data sets and utilize them to experimentally examine the effect of these factors on the predictive performance of E. coli sigma(70) promoter models. Our results suggest that under some combinations of the first three criteria, a prediction model might perform very well on cross-validation experiments while its performance on independent test data is drastically very poor. This emphasizes the importance of evaluating promoter region predictors using independent test data, which corrects for the over-optimistic performance that might be estimated using the cross-validation procedure. Our analysis of the tested models shows that good prediction models often perform well despite how the non-promoter data was obtained. On the other hand, poor prediction models seems to be more sensitive to the choice of non-promoter sequences. Interestingly, the best performing sequence-based classifiers outperform the best performing structure-based classifiers on both cross-validation and independent test performance evaluation experiments. Finally, we propose a meta-predictor method combining two top performing sequence-based and structure-based classifiers and compare its performance with some of the state-of-the-art E. coli s70 promoter prediction methods.	[Abbas, Mostafa M.] Qatar Univ, Coll Engn, KINDI Ctr Comp Res, Doha, Qatar; [Mohie-Eldin, Mostafa M.] Al Azhar Univ, Fac Sci, Dept Math, Cairo, Egypt; [El-Manzalawy, Yasser] Al Azhar Univ, Syst & Comp Engn, Cairo, Egypt; [El-Manzalawy, Yasser] Penn State Univ, Coll Informat Sci, University Pk, PA 16802 USA	Qatar University; Egyptian Knowledge Bank (EKB); Al Azhar University; Egyptian Knowledge Bank (EKB); Al Azhar University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	El-Manzalawy, Y (corresponding author), Al Azhar Univ, Syst & Comp Engn, Cairo, Egypt.	yme2@psu.edu	El-Manzalawy, Yasser/ABE-3489-2020		NPRP from the Qatar National Research Fund [4-1454-1-233]	NPRP from the Qatar National Research Fund(Qatar National Research Fund (QNRF))	This publication was made possible by NPRP grant No. 4-1454-1-233 from the Qatar National Research Fund (a member of Qatar Foundation). The statements made herein are solely the responsibility of the authors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldi P, 2000, BIOINFORMATICS, V16, P412, DOI 10.1093/bioinformatics/16.5.412; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Blake RD, 1998, NUCLEIC ACIDS RES, V26, P3323, DOI 10.1093/nar/26.14.3323; Bockhorst J, 2003, BIOINFORMATICS, V19, pi34, DOI 10.1093/bioinformatics/btg1003; Bradley AP, 1997, PATTERN RECOGN, V30, P1145, DOI 10.1016/S0031-3203(96)00142-2; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; BRESLAUER KJ, 1986, P NATL ACAD SCI USA, V83, P3746, DOI 10.1073/pnas.83.11.3746; Burden S, 2005, BIOINFORMATICS, V21, P601, DOI 10.1093/bioinformatics/bti047; Chen W, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/623149; Chen W, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1450; Cherkassky V, 1997, IEEE Trans Neural Netw, V8, P1564, DOI 10.1109/TNN.1997.641482; Silva SDE, 2011, J THEOR BIOL, V287, P92, DOI 10.1016/j.jtbi.2011.07.017; Silva SDE, 2011, GENET MOL BIOL, V34, P353, DOI 10.1590/S1415-47572011000200031; DEMELER B, 1991, NUCLEIC ACIDS RES, V19, P1593, DOI 10.1093/nar/19.7.1593; Demsar J, 2006, J MACH LEARN RES, V7, P1; DU YH, 2008, 7 AS PAC C MED BIOL, V19, P608; ElHassan MA, 1996, J MOL BIOL, V259, P95, DOI 10.1006/jmbi.1996.0304; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Fletez-Brant C, 2013, NUCLEIC ACIDS RES, V41, pW544, DOI 10.1093/nar/gkt519; Gama-Castro S, 2011, NUCLEIC ACIDS RES, V39, pD98, DOI 10.1093/nar/gkq1110; Gan YL, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-4; Gordon J, 2005, LECT NOTES COMPUT SC, V3578, P448; Gordon JJ, 2006, BIOINFORMATICS, V22, P142, DOI 10.1093/bioinformatics/bti771; Gordon L, 2003, BIOINFORMATICS, V19, P1964, DOI 10.1093/bioinformatics/btg265; Guo SH, 2014, BIOINFORMATICS, V30, P1522, DOI 10.1093/bioinformatics/btu083; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; HO PS, 1986, EMBO J, V5, P2737, DOI 10.1002/j.1460-2075.1986.tb04558.x; Huerta AM, 2003, J MOL BIOL, V333, P261, DOI 10.1016/j.jmb.2003.07.017; IVANOV VI, 1995, J MOL BIOL, V245, P228, DOI 10.1006/jmbi.1994.0019; Kanhere A, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-1; Li DR, 2012, BIOTECHNIQUES, V52, P173, DOI 10.2144/000113821; Li QZ, 2006, J THEOR BIOL, V242, P135, DOI 10.1016/j.jtbi.2006.02.007; Lin H, 2011, THEOR BIOSCI, V130, P91, DOI 10.1007/s12064-010-0114-8; Maetschke S., 2006, P 2006 WORKSH INT SY, P9; MAHADEVAN I, 1994, NUCLEIC ACIDS RES, V22, P2158, DOI 10.1093/nar/22.11.2158; Mann S, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1024; Manzalawy EL- Y, 2015, GENNOTATE GENOME ANN; MCCLURE WR, 1985, ANNU REV BIOCHEM, V54, P171, DOI 10.1146/annurev.bi.54.070185.001131; MITCHELL T, 1989, ANNU REV COMPUT SCI, V4, P417; Ohler U, 2001, Bioinformatics, V17 Suppl 1, pS199; Olson WK, 1998, P NATL ACAD SCI USA, V95, P11163, DOI 10.1073/pnas.95.19.11163; ORNSTEIN RL, 1978, BIOPOLYMERS, V17, P2341, DOI 10.1002/bip.1978.360171005; Paget MSB, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-1-203; Pedersen A G, 1996, Proc Int Conf Intell Syst Mol Biol, V4, P182; Polat K, 2007, APPL MATH COMPUT, V190, P1574, DOI 10.1016/j.amc.2007.02.033; RABINER LR, 1989, P IEEE, V77, P257, DOI 10.1109/5.18626; Rangannan V, 2007, J BIOSCIENCES, V32, P851, DOI 10.1007/s12038-007-0085-1; Rani TS, 2007, BIOINFORMATICS, V23, P582, DOI 10.1093/bioinformatics/btl670; Rani T. Sobha, 2009, In Silico Biology, V9, pS1, DOI 10.3233/ISB-2009-0388; REZNIKOFF WS, 1985, ANNU REV GENET, V19, P355, DOI 10.1146/annurev.ge.19.120185.002035; Salgado H, 2013, NUCLEIC ACIDS RES, V41, pD203, DOI 10.1093/nar/gks1201; Sharma CM, 2010, NATURE, V464, P250, DOI 10.1038/nature08756; SIVOLOB AV, 1995, J MOL BIOL, V247, P918, DOI 10.1006/jmbi.1994.0190; Song K, 2012, NUCLEIC ACIDS RES, V40, P963, DOI 10.1093/nar/gkr795; Sonnenburg S, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S10-S7; Sugimoto N, 1996, NUCLEIC ACIDS RES, V24, P4501, DOI 10.1093/nar/24.22.4501; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Tjaden B, 2002, NUCLEIC ACIDS RES, V30, P3732, DOI 10.1093/nar/gkf505; Towsey M, 2007, GENOME INFORM SER, V19, P178; Towsey MW, 2006, INT J NEURAL SYST, V16, P363, DOI 10.1142/S0129065706000767; Vanet A, 1999, RES MICROBIOL, V150, P779, DOI 10.1016/S0923-2508(99)00115-1; Wang HQ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-248; Wozniak M, 2013, STUDIES COMPUTATIONA, V519; Yegnanarayana B., 2009, ARTIFICIAL NEURAL NE; Zhang R, 2014, CURR GENOMICS, V15, P78, DOI 10.2174/1389202915999140328162433; Zhou JD, 2013, NUCLEIC ACIDS RES, V41, pD613, DOI 10.1093/nar/gks1235; Zhou X, 2013, J THEOR BIOL, V319, P1, DOI 10.1016/j.jtbi.2012.11.024	68	6	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0119721	10.1371/journal.pone.0119721	http://dx.doi.org/10.1371/journal.pone.0119721			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803493	Green Published, gold, Green Submitted			2022-12-26	WOS:000353889600043
J	Brown, HL; Reuter, M; Hanman, K; Betts, RP; van Vliet, AHM				Brown, Helen L.; Reuter, Mark; Hanman, Kate; Betts, Roy P.; van Vliet, Arnoud H. M.			Prevention of Biofilm Formation and Removal of Existing Biofilms by Extracellular DNases of Campylobacter jejuni	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS; NATURAL TRANSFORMATION; VIBRIO-CHOLERAE; IN-VITRO; BACTERIAL; SEQUENCE; NUCLEASES; REVEALS; EXPRESSION; NUTRIENT	The fastidious nature of the foodborne bacterial pathogen Campylobacter jejuni contrasts with its ability to survive in the food chain. The formation of biofilms, or the integration into existing biofilms by C. jejuni, is thought to contribute to food chain survival. As extracellular DNA (eDNA) has previously been proposed to play a role in C. jejuni biofilms, we have investigated the role of extracellular DNases (eDNases) produced by C. jejuni in biofilm formation. A search of 2791 C. jejuni genomes highlighted that almost half of C. jejuni genomes contains at least one eDNase gene, but only a minority of isolates contains two or three of these eDNase genes, such as C. jejuni strain RM1221 which contains the cje0256, cje0566and cje1441eDNase genes. Strain RM1221 did not form biofilms, whereas the eDNase-negative strains NCTC 11168 and 81116 did. Incubation of pre-formed biofilms of NCTC 11168 with live C. jejuni RM1221 or with spent medium from a RM1221 culture resulted in removal of the biofilm. Inactivation of the cje1441 eDNase gene in strain RM1221 restored biofilm formation, and made the mutant unable to degrade biofilms of strain NCTC 11168. Finally, C. jejuni strain RM1221 was able to degrade genomic DNA from C. jejuni NCTC 11168, 81116 and RM1221, whereas strain NCTC 11168 and the RM1221 cje1441 mutant were unable to do so. This was mirrored by an absence of eDNA in overnight cultures of C. jejuni RM1221. This suggests that the activity of eDNases in C. jejuni affects biofilm formation and is not conducive to a biofilm lifestyle. These eDNases do however have a potential role in controlling biofilm formation by C. jejuni strains in food chain relevant environments.	[Brown, Helen L.; Reuter, Mark; Hanman, Kate; van Vliet, Arnoud H. M.] Inst Food Res, Norwich NR4 7UA, Norfolk, England; [Betts, Roy P.] Campden BRI, Chipping Campden GL55 6LD, Glos, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Quadram Institute; University of East Anglia	van Vliet, AHM (corresponding author), Inst Food Res, Norwich Res Pk,Colney Lane, Norwich NR4 7UA, Norfolk, England.	arnoud.vanvliet@ifr.ac.uk	Brown, Helen Louise/F-6565-2014	Brown, Helen Louise/0000-0001-7418-5536; van Vliet, Arnoud/0000-0003-0203-1305	Biotechnology and Biological Sciences Research Council (BBSRC) via BBSRC Institute Strategic Programme [BB/J004529/1]; BBSRC CASE studentship [BB/I15321/1]; Campden BRI; BBSRC [BBS/E/F/00044403] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/F/00044403, 1042596] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC) via BBSRC Institute Strategic Programme(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC CASE studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Campden BRI; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study is supported by the Biotechnology and Biological Sciences Research Council (BBSRC) via the BBSRC Institute Strategic Programme (BB/J004529/1) and a BBSRC CASE studentship (BB/I15321/1) with CASE funding from Campden BRI. The inclusion of Roy P Betts as author has raised concern that the funder must have had some role in the design, data collection, analysis or preparation of the manuscript for publication. The authors want to stress that this is not the case. A CASE PhD studentships are a UK-specific type of studentship, where academic and industrial partners collaborate and where the student has access to training opportunities at the industrial (CASE) partner. Author Roy P Betts contributed to the manuscript by critical analysis of data, suggestions for further research and by assistance with writing of the manuscript, and general supervisory assistance to the first author (who is a PhD student). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balamurugan S, 2011, FOOD MICROBIOL, V28, P1003, DOI 10.1016/j.fm.2011.01.012; Beenken KE, 2012, INFECT IMMUN, V80, P1634, DOI 10.1128/IAI.06134-11; Berends ETM, 2010, J INNATE IMMUN, V2, P576, DOI 10.1159/000319909; Bleumink-Pluym NMC, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003393; Bronowski C, 2014, FEMS MICROBIOL LETT, V356, P8, DOI 10.1111/1574-6968.12488; Brown HL, 2014, APPL ENVIRON MICROB, V80, P7053, DOI 10.1128/AEM.02614-14; Clark CG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095349; Cody AJ, 2013, J CLIN MICROBIOL, V51, P2526, DOI 10.1128/JCM.00066-13; Colles FM, 2012, MICROBIOL-SGM, V158, P2695, DOI 10.1099/mic.0.062000-0; Conover MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016861; Derre-Bobillot A, 2013, MOL MICROBIOL, V89, P518, DOI 10.1111/mmi.12295; Dingle KE, 2001, J CLIN MICROBIOL, V39, P14, DOI 10.1128/JCM.39.1.14-23.2001; Dominiak DM, 2011, ENVIRON MICROBIOL, V13, P710, DOI 10.1111/j.1462-2920.2010.02375.x; Donahue JP, 2000, MOL MICROBIOL, V37, P1066, DOI 10.1046/j.1365-2958.2000.02036.x; Donlan RM, 2002, EMERG INFECT DIS, V8, P881, DOI 10.3201/eid0809.020063; Finkel SE, 2001, J BACTERIOL, V183, P6288, DOI 10.1128/JB.183.21.6288-6293.2001; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; FOCARETA T, 1991, MOL MICROBIOL, V5, P2547, DOI 10.1111/j.1365-2958.1991.tb02101.x; Fouts DE, 2005, PLOS BIOL, V3, P72, DOI 10.1371/journal.pbio.0030015; Frirdich E, 2014, J BIOL CHEM, V289, P8007, DOI 10.1074/jbc.M113.491829; Gaasbeek EJ, 2010, J BACTERIOL, V192, P936, DOI 10.1128/JB.00867-09; Gaasbeek EJ, 2009, J BACTERIOL, V191, P2296, DOI 10.1128/JB.01430-08; Gillespie JJ, 2011, INFECT IMMUN, V79, P4286, DOI 10.1128/IAI.00207-11; Godeke J, 2011, APPL ENVIRON MICROB, V77, P5342, DOI 10.1128/AEM.00643-11; Golden NJ, 2002, INFECT IMMUN, V70, P1761, DOI 10.1128/IAI.70.4.1761-1771.2002; Grande R, 2011, J APPL MICROBIOL, V110, P490, DOI 10.1111/j.1365-2672.2010.04911.x; Gunther NW, 2009, FOOD MICROBIOL, V26, P44, DOI 10.1016/j.fm.2008.07.012; Guyard-Nicodeme M, 2013, INT J FOOD MICROBIOL, V164, P7, DOI 10.1016/j.ijfoodmicro.2013.03.009; Harmsen M, 2010, APPL ENVIRON MICROB, V76, P2271, DOI 10.1128/AEM.02361-09; Hymes SR, 2013, J INFECT DIS, V207, P1491, DOI 10.1093/infdis/jit047; JACKSON ME, 1985, EMBO J, V4, P2377, DOI 10.1002/j.1460-2075.1985.tb03942.x; Jakubovics NS, 2013, LETT APPL MICROBIOL, V57, P467, DOI 10.1111/lam.12134; Jolley KA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-595; Jones EA, 2013, J INNATE IMMUN, V5, P24, DOI 10.1159/000339961; Joshua GWP, 2006, MICROBIOL-SGM, V152, P387, DOI 10.1099/mic.0.28358-0; Kalmokoff M, 2006, J BACTERIOL, V188, P4312, DOI 10.1128/JB.01975-05; Kiedrowski MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026714; Konstan MW, 2012, J CYST FIBROS, V11, P78, DOI 10.1016/j.jcf.2011.10.003; Kruczkiewicz P, 2013, BIOINFORMATICS 2013: PROCEEDINGS OF THE INTERNATIONAL CONFERENCE ON BIOINFORMATICS MODELS, METHODS AND ALGORITHMS, P316; Lambert C, 2013, FEMS MICROBIOL LETT, V340, P109, DOI 10.1111/1574-6968.12075; Mann EE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005822; Manning G, 2001, APPL ENVIRON MICROB, V67, P1185, DOI 10.1128/AEM.67.3.1185-1189.2001; McCrate OA, 2013, J MOL BIOL, V425, P4286, DOI 10.1016/j.jmb.2013.06.022; Miller WG, 2000, APPL ENVIRON MICROB, V66, P5426, DOI 10.1128/AEM.66.12.5426-5436.2000; Mulcahy H, 2010, ENVIRON MICROBIOL, V12, P1621, DOI 10.1111/j.1462-2920.2010.02208.x; Nguyen MH, 2014, J BIOSCI BIOENG; Novotny LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067629; Oh E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087312; Pammi M, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-257; Parker CT, 2006, J CLIN MICROBIOL, V44, P4125, DOI 10.1128/JCM.01231-06; Parkhill J, 2000, NATURE, V403, P665, DOI 10.1038/35001088; Pemberton JM, 1997, FEMS MICROBIOL LETT, V152, P1, DOI 10.1016/S0378-1097(97)00186-9; Reuter M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054390; Reuter M, 2010, APPL ENVIRON MICROB, V76, P2122, DOI 10.1128/AEM.01878-09; Richards VP, 2013, INFECT GENET EVOL, V14, P200, DOI 10.1016/j.meegid.2012.12.010; Riyapa D, 2012, INFECT IMMUN, V80, P3921, DOI 10.1128/IAI.00806-12; Seper A, 2011, MOL MICROBIOL, V82, P1015, DOI 10.1111/j.1365-2958.2011.07867.x; Sheppard SK, 2013, MOL ECOL, V22, P1051, DOI 10.1111/mec.12162; Sulaeman S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046402; Svensson SL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106063; Svensson SL, 2009, MOL MICROBIOL, V71, P253, DOI 10.1111/j.1365-2958.2008.06534.x; Swartjes JJTM, 2013, ADV FUNCT MATER, V23, P2843, DOI 10.1002/adfm.201202927; Tam CC, 2012, GUT, V61, P69, DOI 10.1136/gut.2011.238386; Teh AHT, 2014, APPL ENVIRON MICROB, V80, P5154, DOI 10.1128/AEM.01493-14; Teh KH, 2010, INT J FOOD MICROBIOL, V143, P118, DOI 10.1016/j.ijfoodmicro.2010.07.037; Thornton RB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053837; Van Vliet AHM, 1998, METHOD MICROBIOL, V27, P407; Wang H, 2014, CURR MICROBIOL, V68, P262, DOI 10.1007/s00284-013-0468-5; Whitchurch CB, 2002, SCIENCE, V295, P1487, DOI 10.1126/science.295.5559.1487; WORRALL AF, 1990, J BIOL CHEM, V265, P21889; Zautner AE, 2014, EUR J CLIN MICROBIOL, V33, P1019, DOI 10.1007/s10096-013-2040-4; Zhao JQ, 2013, MICROBIOL-SGM, V159, P633, DOI 10.1099/mic.0.063784-0; Zweig M, 2014, ENVIRON MICROBIOL, V16, P1040, DOI 10.1111/1462-2920.12291	73	32	33	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0121680	10.1371/journal.pone.0121680	http://dx.doi.org/10.1371/journal.pone.0121680			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803828	Green Accepted, Green Published, gold			2022-12-26	WOS:000353889600172
J	Cimini, G; Castellano, C; Sanchez, A				Cimini, Giulio; Castellano, Claudio; Sanchez, Angel			Dynamics to Equilibrium in Network Games: Individual Behavior and Global Response	PLOS ONE			English	Article								Various social contexts can be depicted as games of strategic interactions on networks, where an individual's welfare depends on both her and her partners' actions. Whereas much attention has been devoted to Bayes-Nash equilibria in such games, here we look at strategic interactions from an evolutionary perspective. To this end, we present the results of a numerical simulations program for these games, which allows us to find out whether Nash equilibria are accessible by adaptation of player strategies, and in general to identify the attractors of the evolution. Simulations allow us to go beyond a global characterization of the cooperativeness at equilibrium and probe into individual behavior. We find that when players imitate each other, evolution does not reach Nash equilibria and, worse, leads to very unfavorable states in terms of welfare. On the contrary, when players update their behavior rationally, they self-organize into a rich variety of Nash equilibria, where individual behavior and payoffs are shaped by the nature of the game, the social network's structure and the players' position within the network. Our results allow to assess the validity of mean-field approaches we use to describe the dynamics of these games. Interestingly, our dynamically-found equilibria generally do not coincide with (but show qualitatively the same features of) those resulting from theoretical predictions in the context of one-shot games under incomplete information.	[Cimini, Giulio; Sanchez, Angel] Univ Carlos III Madrid, Dept Matemat, GISC, Leganes, Spain; [Cimini, Giulio; Castellano, Claudio] Univ Roma La Sapienza, Ist Sistemi Complessi ISC CNR UoS, I-00185 Rome, Italy; [Sanchez, Angel] Univ Zaragoza, Inst Biocomputac & Fis Sistemas Complejos BIFI, Zaragoza, Spain	Universidad Carlos III de Madrid; Consiglio Nazionale delle Ricerche (CNR); Istituto dei Sistemi Complessi (ISC-CNR); Sapienza University Rome; University of Zaragoza	Cimini, G (corresponding author), Univ Carlos III Madrid, Dept Matemat, GISC, Leganes, Spain.	giulio.cimini@roma1.infn.it	Castellano, Claudio/B-6946-2008; Cimini, Giulio/I-7413-2019; Cimini, Giulio/HGC-2758-2022	Castellano, Claudio/0000-0002-3773-3801; Cimini, Giulio/0000-0001-5698-8597; 	Swiss Natural Science Fundation [PBFRP2\_145872]; Ministerio de Economia y Competitividad (MINECO, Spain) through grant PRODIEVO	Swiss Natural Science Fundation; Ministerio de Economia y Competitividad (MINECO, Spain) through grant PRODIEVO	G. Cimini acknowledges the Swiss Natural Science Fundation (grant no PBFRP2\_145872). A. Sanchez acknowledges support from Ministerio de Economia y Competitividad (MINECO, Spain) through grant PRODIEVO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; BLUME LE, 1993, GAME ECON BEHAV, V5, P387, DOI 10.1006/game.1993.1023; Boncinelli L, 2012, GAME ECON BEHAV, V75, P538, DOI 10.1016/j.geb.2012.03.001; Bramoulle Y, 2007, J ECON THEORY, V135, P478, DOI 10.1016/j.jet.2006.06.006; BULOW JI, 1985, J POLIT ECON, V93, P488, DOI 10.1086/261312; CARLSSON H, 1993, ECONOMETRICA, V61, P989, DOI 10.2307/2951491; Catanzaro M, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.027103; Cimini G, 2014, EVOLUTIONARY NETWORK; Coleman J. S., 1966, MED INNOVATION DIFFU; Conley TG, 2010, AM ECON REV, V100, P35, DOI 10.1257/aer.100.1.35; Dorogovtsev SN, 2008, REV MOD PHYS, V80, P1275, DOI 10.1103/RevModPhys.80.1275; ERDOS P, 1960, B INT STATIST INST, V38, P343; FOSTER AD, 1995, J POLIT ECON, V103, P1176, DOI 10.1086/601447; Galeotti A, 2010, REV ECON STUD, V77, P218, DOI 10.1111/j.1467-937X.2009.00570.x; Gintis H, 2009, GAME THEORY EVOLVING: A PROBLEM-CENTERED INTRODUCTION TO MODELING STRATEGIC INTERACTION, SECOND EDITION, P1; Glaeser EL, 1996, Q J ECON, V111, P507, DOI 10.2307/2946686; Goyal Sanjeev, 2007, CONNECTIONS INTRO EC; Granovetter M, 1994, GETTING JOB STUDY CO; HELBING D, 1992, PHYSICA A, V181, P29, DOI 10.1016/0378-4371(92)90195-V; Hofbauer J, 1998, EVOLUTIONARY GAMES P; Jackson MO, 2008, SOCIAL AND ECONOMIC NETWORKS, P1; Katz E., 1955, PERSONAL INFLUENCE P; MATSUI A, 1992, J ECON THEORY, V57, P343, DOI 10.1016/0022-0531(92)90040-O; Morris S., 2003, ADV EC ECONOMETRICS, P56; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200; Perc M, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0997; Roca CP, 2009, PHYS LIFE REV, V6, P208, DOI 10.1016/j.plrev.2009.08.001; Szabo G, 2007, PHYS REP, V446, P97, DOI 10.1016/j.physrep.2007.04.004; Topa G, 2001, REV ECON STUD, V68, P261, DOI 10.1111/1467-937X.00169; Vega-Redondo F., 2007, ECONOMETRIC SOC MONO; Weber S, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.046111	32	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0120343	10.1371/journal.pone.0120343	http://dx.doi.org/10.1371/journal.pone.0120343			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH2XV	25803275	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000353889600070
J	de Sant'Anna, JR; Franco, CCD; Mathias, PCD; de Castro-Prado, MAA				de Sant'Anna, Juliane Rocha; da Silva Franco, Claudineia Conationi; de Freitas Mathias, Paulo Cezar; Alves de Castro-Prado, Marialba Avezum			Assessment of In Vivo and In Vitro Genotoxicity of Glibenclamide in Eukaryotic Cells	PLOS ONE			English	Article							FUNGUS ASPERGILLUS-NIDULANS; MITOTIC CROSSING-OVER; MOLECULAR-MECHANISMS; GENETIC TOXICOLOGY; DIPLOID STRAINS; CANCER-RISK; RECOMBINATION; CHANNELS; MICRONUCLEUS; APOPTOSIS	Glibenclamide is an oral hypoglycemic drug commonly prescribed for the treatment of type 2 diabetes mellitus, whose anti-tumor activity has been recently described in several human cancer cells. The mutagenic potential of such an antidiabetic drug and its recombinogenic activity in eukaryotic cells were evaluated, the latter for the first time. The mutagenic potential of glibenclamide in therapeutically plasma (0.6 mu M) and higher concentrations (10 mu M, 100 mu M, 240 mu M and 480 mu M) was assessed by the in vitro mammalian cell micronucleus test in human lymphocytes. Since the loss of heterozygosity arising from allelic recombination is an important biologically significant consequence of oxidative damage, the glibenclamide recombinogenic activity at 1 mu M, 10 mu M and 100 mu M concentrations was evaluated by the in vivo homozygotization assay. Glibenclamide failed to alter the frequency of micronuclei between 0.6 mu M and 480 mu M concentrations and the cytokinesis block proliferation index between 0.6 mu M and 240 mu M concentrations. On the other hand, glibenclamide changed the cell-proliferation kinetics when used at 480 mu M. In the homozygotization assay, the homozygotization indices for the analyzed markers were lower than 2.0 and demonstrated the lack of recombinogenic activity of glibenclamide. Data in the current study demonstrate that glibenclamide, in current experimental conditions, is devoid of significant genotoxic effects. This fact encourages further investigations on the use of this antidiabetic agent as a chemotherapeutic drug.	[de Sant'Anna, Juliane Rocha; Alves de Castro-Prado, Marialba Avezum] Univ Estadual Maringa, Dept Biotecnol Genet & Biol Celular, Lab Genet Microorganismos & Mutagenese, Maringa, Parana, Brazil; [da Silva Franco, Claudineia Conationi; de Freitas Mathias, Paulo Cezar] Univ Estadual Maringa, Dept Biotecnol Genet & Biol Celular, Lab Biol Celular & Secrecao, Maringa, Parana, Brazil	Universidade Estadual de Maringa; Universidade Estadual de Maringa	de Castro-Prado, MAA (corresponding author), Univ Estadual Maringa, Dept Biotecnol Genet & Biol Celular, Lab Genet Microorganismos & Mutagenese, Maringa, Parana, Brazil.	maacprado@uem.br	DE FREITAS MATHIAS, PAULO CEZAR/AAQ-9682-2021; de Freitas Mathias, Paulo Cezar PCFM/O-6056-2015	de Freitas Mathias, Paulo Cezar PCFM/0000-0001-6994-4585	Coordenacao de Aperfeicoamento de pessoal de Nivel Superior (CAPES)	Coordenacao de Aperfeicoamento de pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was funded by Coordenacao de Aperfeicoamento de pessoal de Nivel Superior (CAPES). The funder (CAPES) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, GUID TEST CHEM HLTH; Bo S, 2013, EUR J ENDOCRINOL, V169, P117, DOI 10.1530/EJE-13-0299; BREEN AP, 1995, FREE RADICAL BIO MED, V18, P1033, DOI 10.1016/0891-5849(94)00209-3; Burgos L, 2014, ECOTOX ENVIRON SAFE, V100, P282, DOI 10.1016/j.ecoenv.2013.10.022; Cardoso RA, 2010, GENET MOL RES, V9, P231, DOI 10.4238/vol9-1gmr688; Casorelli I, 2012, INT J ENV RES PUB HE, V9, P2636, DOI 10.3390/ijerph9082636; Chandrasekaran CV, 2009, FOOD CHEM TOXICOL, V47, P1892, DOI 10.1016/j.fct.2009.05.006; Cocca C, 2005, ONCOL RES, V15, P301, DOI 10.3727/096504005776404526; Dertinger SD, 2014, TOXICOL SCI, V140, P307, DOI 10.1093/toxsci/kfu078; ETCHEBERRIGARAY R, 1990, MEMBRANE BIOCHEM, V9, P215, DOI 10.3109/09687689009025842; Fenech M, 2011, MUTAGENESIS, V26, P125, DOI 10.1093/mutage/geq052; Fenech M, 2007, NAT PROTOC, V2, P1084, DOI 10.1038/nprot.2007.77; Flores-Murrieta Francisco J, 2007, Proc West Pharmacol Soc, V50, P64; Fuhlendorff J, 1998, DIABETES, V47, P345, DOI 10.2337/diabetes.47.3.345; Graf U, 1998, MUTAT RES-FUND MOL M, V402, P203, DOI 10.1016/S0027-5107(97)00298-4; Hambrock A, 2006, J PHARMACOL EXP THER, V316, P1031, DOI 10.1124/jpet.105.097501; Husgen U, 1999, J PHYTOPATHOL, V147, P591, DOI 10.1046/j.1439-0434.1999.00432.x; Juttner F, 2007, APPL ENVIRON MICROB, V73, P4395, DOI 10.1128/AEM.02250-06; Kim JA, 1999, BIOCHEM BIOPH RES CO, V261, P682, DOI 10.1006/bbrc.1999.1108; Kirsch-Volders M, 2011, ARCH TOXICOL, V85, P873, DOI 10.1007/s00204-011-0691-4; LaRocque JR, 2011, P NATL ACAD SCI USA, V108, P11971, DOI 10.1073/pnas.1104421108; Lebovitz HE, 2004, MED CLIN N AM, V88, P847, DOI 10.1016/j.mcna.2004.05.002; Lorge E, 2008, MUTAT RES-GEN TOX EN, V655, P1, DOI 10.1016/j.mrgentox.2008.06.003; Miyamoto CT, 2007, FOOD CHEM TOXICOL, V45, P1091, DOI 10.1016/j.fct.2006.12.018; Momota H, 2013, NEURO-ONCOLOGY, V15, P1445, DOI 10.1093/neuonc/not036; Monami M, 2007, DIABETES-METAB RES, V23, P479, DOI 10.1002/dmrr.736; Monami M, 2009, ACTA DIABETOL, V46, P279, DOI 10.1007/s00592-008-0083-2; Nichols CG, 2006, NATURE, V440, P470, DOI 10.1038/nature04711; Nunez M, 2013, BMC PHARMACOL TOXICO, V14, DOI 10.1186/2050-6511-14-6; Ouadid-Ahidouch H, 2008, J MEMBRANE BIOL, V221, P1, DOI 10.1007/s00232-007-9080-6; PIRES LTD, 1994, REV BRAS GENET, V17, P371; Qian X, 2008, BIOCHEM PHARMACOL, V76, P1705, DOI 10.1016/j.bcp.2008.09.009; Sant'Anna JR, 2013, EXP BIOL MED, V238, P803, DOI 10.1177/1535370213480744; Sawada F, 2008, METABOLISM, V57, P1038, DOI 10.1016/j.metabol.2008.01.038; Spaans VM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093451; Steinemann D, 2010, HAEMATOL-HEMATOL J, V95, P320, DOI 10.3324/haematol.2009.010355; Stewart DR, 2012, GENE CHROMOSOME CANC, V51, P429, DOI 10.1002/gcc.21928; Swerdlow AJ, 2011, J CLIN ONCOL, V29, P4096, DOI 10.1200/JCO.2011.34.8268; Tice RR, 2000, ENVIRON MOL MUTAGEN, V35, P206, DOI 10.1002/(SICI)1098-2280(2000)35:3<206::AID-EM8>3.0.CO;2-J; Turner DR, 2003, MUTAT RES-FUND MOL M, V522, P21, DOI 10.1016/S0027-5107(02)00194-X; Vlastos D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069494; Wondergem R, 1998, J MEMBRANE BIOL, V161, P257, DOI 10.1007/s002329900332; Yang XL, 2010, DIABETES RES CLIN PR, V90, P343, DOI 10.1016/j.diabres.2010.08.022; Yasukagawa T, 2012, FEBS LETT, V586, P1504, DOI 10.1016/j.febslet.2012.04.007; Zucchi TD, 2005, J ENVIRON MONITOR, V7, P598, DOI 10.1039/b500219b	45	13	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0120675	10.1371/journal.pone.0120675	http://dx.doi.org/10.1371/journal.pone.0120675			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803314	Green Published, gold, Green Submitted			2022-12-26	WOS:000353889600091
J	El-Ashram, S; Sun, XM; Yin, Q; Liu, XY; Suo, X				El-Ashram, Saeed; Sun, Ximeng; Yin, Qing; Liu, Xianyong; Suo, Xun			Exploring Early and Late Toxoplasma gondii Strain RH Infection by Two-Dimensional Immunoblots of Chicken Immunoglobulin G and M Profiles	PLOS ONE			English	Article							ANTIGENS; ANTIBODIES; ELECTROPHORESIS; PREVALENCE; DIAGNOSIS; PROTEOMICS; PROTEINS; HUMANS; BRAZIL	Toxoplasma gondii is an intracellular apicomplexan parasite infecting warm-blooded vertebrate hosts, with only early infection stage being contained with drugs. But diagnosis differencing early and late infection was not available. In the present investigation, 2-dimensional immunobloting was used to explore early and late infections in chickens. The protein expression of T. gondii was determined by image analysis of the tachyzoites proteome separated by standard-one and conventional two-dimentional gel polyacrylamide electrophoresis (2D-PAGE). Pooled gels were prepared from tachyzoites of T. gondii. A representative gel spanning a pH range of 3-10 of the tachyzoite proteome consisted of 1306 distinct polypeptide spots. Two-dimensional electrophoresis (2-DE) combined with 2-DE immunoblotting was used to resolve and compare immunoglobulins (Igs) M & G patterns against Toxoplasma gondii strain RH (mouse virulent strain). Total tachyzoite proteins of T. gondii were separated by two-dimensional gel electrophoresis and analyzed by Western blotting for their reactivity with the 7 and 56 days post-infection (dpi) SPF chicken antisera. Different antigenic determinant patterns were detected during analysis with M and G immunoglobulins. Of the total number of polypeptide spots analyzed (1306 differentially expressed protein spots), 6.97% were identified as having shared antigenic polypeptide spots on immunoblot profiles with IgG and IgM antibodies regardless the time after infection. Furthermore, some of the immunoreactive polypeptide spots seemed to be related to the stage of infection. Interestingly, we found natural antibodies to toxoplasmic antigens, in addition to the highly conserved antigenic determinants that reacted with non-specific secondary antibody; goat anti-chicken IgG antibodies conjugated with horseradish peroxidase. In conclusion, unique reactive polypeptide spots are promising candidates for designation of molecular markers to discriminate early and late chicken infection.	[El-Ashram, Saeed; Sun, Ximeng; Yin, Qing; Liu, Xianyong; Suo, Xun] China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China; [El-Ashram, Saeed; Sun, Ximeng; Yin, Qing; Liu, Xianyong; Suo, Xun] China Agr Univ, Natl Anim Protozoa Lab, Beijing 100193, Peoples R China; [El-Ashram, Saeed; Sun, Ximeng; Yin, Qing; Liu, Xianyong; Suo, Xun] China Agr Univ, Coll Vet Med, Beijing 100193, Peoples R China; [Liu, Xianyong; Suo, Xun] Minist Agr, Key Lab Anim Epidemiol & Zoonosis, Beijing, Peoples R China; [El-Ashram, Saeed] Kafr El Sheikh Univ, Fac Sci, Kafr Al Sheikh, Egypt	China Agricultural University; China Agricultural University; China Agricultural University; Ministry of Agriculture & Rural Affairs; Egyptian Knowledge Bank (EKB); Kafrelsheikh University	Suo, X (corresponding author), China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China.	suoxun@cau.edu.cn	Sun, Ximeng/AAA-8449-2022; El-Ashram, Saeed/AAC-6060-2021	El-Ashram, Saeed/0000-0003-0389-1980; LIU, XIANYONG/0000-0001-9425-6784	Special Fund for Agro-scientific Research in the Public Interest [201303042]	Special Fund for Agro-scientific Research in the Public Interest	This research was supported by the Special Fund for Agro-scientific Research in the Public Interest (Grant No. 201303042). Additionally, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERKELMAN T, 1998, 2D ELECTROPHORESIS U; BIANCIFIORI F, 1986, COMP IMMUNOL MICROB, V9, P337, DOI 10.1016/0147-9571(86)90046-9; Carter N, 2006, PROTEIN DETECTION GE; Choi SH, 2010, KOREAN J PARASITOL, V48, P195, DOI 10.3347/kjp.2010.48.3.195; CHUMPITAZI BFF, 1995, J CLIN MICROBIOL, V33, P1479, DOI 10.1128/JCM.33.6.1479-1485.1995; Cohen AM, 2002, INT J PARASITOL, V32, P39, DOI 10.1016/S0020-7519(01)00308-3; da Silva DS, 2003, J PARASITOL, V89, P394, DOI 10.1645/0022-3395(2003)089[0394:POTGIC]2.0.CO;2; de Camargo M C, 1995, Rev Soc Bras Med Trop, V28, P211, DOI 10.1590/S0037-86821995000300008; de Jong BG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072276; De Meuter F, 1975, Zentralbl Bakteriol Orig A, V233, P421; DESMONTS G, 1980, J CLIN MICROBIOL, V11, P562, DOI 10.1128/JCM.11.6.562-568.1980; Devada K, 1998, J PARASITOL, V84, P621, DOI 10.2307/3284735; Dlugonska H, 2001, PARASITOL RES, V87, P634, DOI 10.1007/s004360000367; Dubey JP, 2010, ZOONOSES PUBLIC HLTH, V57, P60, DOI 10.1111/j.1863-2378.2009.01274.x; Dubey JP, 2002, VET PARASITOL, V106, P121, DOI 10.1016/S0304-4017(02)00034-1; Dubey JP, 2002, INT J PARASITOL, V32, P99, DOI 10.1016/S0020-7519(01)00364-2; DZBENSKI TH, 1976, INFECT IMMUN, V14, P1196, DOI 10.1128/IAI.14.5.1196-1201.1976; El-Massry A, 2000, J PARASITOL, V86, P627, DOI 10.1645/0022-3395(2000)086[0627:POTGAI]2.0.CO;2; Geissler S, 1999, FEMS IMMUNOL MED MIC, V25, P299, DOI 10.1111/j.1574-695X.1999.tb01355.x; HUSKINSON J, 1989, J CLIN MICROBIOL, V27, P2031, DOI 10.1128/JCM.27.9.2031-2038.1989; Jefferies JR, 2000, ELECTROPHORESIS, V21, P3724, DOI 10.1002/1522-2683(200011)21:17&lt;3724::AID-ELPS3724&gt;3.0.CO;2-K; Jerome ME, 1998, INFECT IMMUN, V66, P4838, DOI 10.1128/IAI.66.10.4838-4844.1998; Kaneto CN, 1997, VET PARASITOL, V69, P203, DOI 10.1016/S0304-4017(96)01126-0; Kasuga-Aoki H, 2000, PARASITOLOGY, V121, P671, DOI 10.1017/S0031182000006892; Kirinoki Masashi, 1998, Parasitology International, V47, P21, DOI 10.1016/S1383-5769(97)00043-3; Klade CS, 2002, CURR OPIN MOL THER, V4, P216; KONISHI E, 1991, PARASITOLOGY, V102, P157, DOI 10.1017/S0031182000062430; Lee Eung-Goo, 2004, J Vet Sci, V5, P139; LONGENECKER BM, 1980, IMMUNOGENETICS, V11, P293, DOI 10.1007/BF01567795; Ma GY, 2009, EXP PARASITOL, V122, P41, DOI 10.1016/j.exppara.2009.01.011; MOROZOV V A, 1986, Byulleten' Eksperimental'noi Biologii i Meditsiny, V102, P620; PARTANEN P, 1984, J CLIN MICROBIOL, V20, P133, DOI 10.1128/JCM.20.1.133-135.1984; REMINGTON JS, 1985, J INFECT DIS, V152, P1020, DOI 10.1093/infdis/152.5.1020; RUIZ A, 1980, AM J TROP MED HYG, V29, P1161, DOI 10.4269/ajtmh.1980.29.1161; Shin YS, 2005, VET PARASITOL, V134, P41, DOI 10.1016/j.vetpar.2005.06.021; SULZER AJ, 1971, EXP PARASITOL, V29, P197, DOI 10.1016/0014-4894(71)90024-5; Sun Y, 2011, POULTRY SCI, V90, P2263, DOI 10.3382/ps.2011-01613; Tenter AM, 2000, INT J PARASITOL, V30, P1217, DOI 10.1016/S0020-7519(00)00124-7; TOWBIN H, 1984, J IMMUNOL METHODS, V72, P313, DOI 10.1016/0022-1759(84)90001-2; WARE PL, 1987, INFECT IMMUN, V55, P778, DOI 10.1128/IAI.55.3.778-783.1987; Yan C, 2010, VET PARASITOL, V173, P179, DOI 10.1016/j.vetpar.2010.07.011	41	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0121647	10.1371/journal.pone.0121647	http://dx.doi.org/10.1371/journal.pone.0121647			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803039	Green Published, gold			2022-12-26	WOS:000353889600167
J	Holloway, TM; Bloemberg, D; da Silva, ML; Simpson, JA; Quadrilatero, J; Spriet, LL				Holloway, Tanya M.; Bloemberg, Darin; da Silva, Mayne L.; Simpson, Jeremy A.; Quadrilatero, Joe; Spriet, Lawrence L.			High Intensity Interval and Endurance Training Have Opposing Effects on Markers of Heart Failure and Cardiac Remodeling in Hypertensive Rats	PLOS ONE			English	Article							HUMAN SKELETAL-MUSCLE; LEFT-VENTRICULAR MASS; DIASTOLIC DYSFUNCTION; SPRINT INTERVAL; DIABETIC CARDIOMYOPATHY; NATRIURETIC PEPTIDE; BLOOD-PRESSURE; NITRIC-OXIDE; EXERCISE; HYPERTROPHY	There has been re-emerging interest and significant work dedicated to investigating the metabolic effects of high intensity interval training (HIIT) in recent years. HIIT is considered to be a time efficient alternative to classic endurance training (ET) that elicits similar metabolic responses in skeletal muscle. However, there is a lack of information on the impact of HIIT on cardiac muscle in disease. Therefore, we determined the efficacy of ET and HIIT to alter cardiac muscle characteristics involved in the development of diastolic dysfunction, such as ventricular hypertrophy, fibrosis and angiogenesis, in a well-established rodent model of hypertension-induced heart failure before the development of overt heart failure. ET decreased left ventricle fibrosis by similar to 40% (P < 0.05), and promoted a 20% (P<0.05) increase in the left ventricular capillary/fibre ratio, an increase in endothelial nitric oxide synthase protein (P<0.05), and a decrease in hypoxia inducible factor 1 alpha protein content (P<0.05). In contrast, HIIT did not decrease existing fibrosis, and HIIT animals displayed a 20% increase in left ventricular mass (P<0.05) and a 20% decrease in cross sectional area (P<0.05). HIIT also increased brain natriuretic peptide by 50% (P<0.05), in the absence of concomitant angiogenesis, strongly suggesting pathological cardiac remodeling. The current data support the longstanding belief in the effectiveness of ET in hypertension. However, HIIT promoted a pathological adaptation in the left ventricle in the presence of hypertension, highlighting the need for further research on the widespread effects of HIIT in the presence of disease.	[Holloway, Tanya M.; da Silva, Mayne L.; Simpson, Jeremy A.; Spriet, Lawrence L.] Univ Guelph, Dept Human Hlth & Nutr Sci, Guelph, ON N1G 2W1, Canada; [Bloemberg, Darin; Quadrilatero, Joe] Univ Waterloo, Dept Kinesiol, Waterloo, ON N2L 3G1, Canada	University of Guelph; University of Waterloo	Holloway, TM (corresponding author), Univ Guelph, Dept Human Hlth & Nutr Sci, Guelph, ON N1G 2W1, Canada.	thollowa@uoguelph.ca			Natural Science and Engineering Research Council of Canada [2320]	Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by Natural Science and Engineering Research Council of Canada Grant Number 2320 (http://www.nserc-crsng.gc.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beaudoin MS, 2014, J PHYSIOL-LONDON, V592, P2519, DOI 10.1113/jphysiol.2013.270538; Blair SN, 2009, BRIT J SPORT MED, V43, P1; Bloemberg D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035273; BLOMQVIST CG, 1983, ANNU REV PHYSIOL, V45, P169, DOI 10.1146/annurev.ph.45.030183.001125; Borlaug BA, 2006, TRENDS CARDIOVAS MED, V16, P273, DOI 10.1016/j.tcm.2006.05.003; Boule NG, 2001, JAMA-J AM MED ASSOC, V286, P1218, DOI 10.1001/jama.286.10.1218; Brown DW, 2000, AM HEART J, V140, P848, DOI 10.1067/mhj.2000.111112; Burgomaster KA, 2005, J APPL PHYSIOL, V98, P1985, DOI 10.1152/japplphysiol.01095.2004; Burgomaster KA, 2008, J PHYSIOL-LONDON, V586, P151, DOI 10.1113/jphysiol.2007.142109; Cebasek V, 2004, EUR J HISTOCHEM, V48, P151; CLAUSEN JP, 1977, PHYSIOL REV, V57, P779, DOI 10.1152/physrev.1977.57.4.779; CRISMAN RP, 1985, MICROVASC RES, V30, P185, DOI 10.1016/0026-2862(85)90049-4; DAHL LK, 1969, CIRC RES, V24, pI21; Daussin FN, 2008, AM J PHYSIOL-REG I, V295, pR264, DOI 10.1152/ajpregu.00875.2007; DREXLER H, 1992, AM J CARDIOL, V69, P1596, DOI 10.1016/0002-9149(92)90710-G; Ennezat PV, 2001, J AM COLL CARDIOL, V38, P194, DOI 10.1016/S0735-1097(01)01321-3; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Galasso G, 2010, EUR J HEART FAIL, V12, P1290, DOI 10.1093/eurjhf/hfq102; Gibala MJ, 2009, J APPL PHYSIOL, V106, P929, DOI 10.1152/japplphysiol.90880.2008; Gillen JB, 2014, APPL PHYSIOL NUTR ME, V39, P409, DOI 10.1139/apnm-2013-0187; Gist NH, 2014, SPORTS MED, V44, P269, DOI 10.1007/s40279-013-0115-0; GROSSMAN W, 1975, J CLIN INVEST, V56, P56, DOI 10.1172/JCI108079; GROSSMAN W, 1980, FED PROC, V39, P148; Haider AW, 1998, J AM COLL CARDIOL, V32, P1454, DOI 10.1016/S0735-1097(98)00407-0; Helgerud J, 2007, MED SCI SPORT EXER, V39, P665, DOI 10.1249/mss.0b013e3180304570; Hink U, 2001, CIRC RES, V88, pE14; Holloszy J O, 1973, Exerc Sport Sci Rev, V1, P45; Kass DA, 2004, CIRC RES, V94, P1533, DOI 10.1161/01.RES.0000129254.25507.d6; Kehat I, 2010, CIRCULATION, V122, P2727, DOI 10.1161/CIRCULATIONAHA.110.942268; Kjaer A, 2004, EUR J HEART FAIL, V6, P29, DOI 10.1016/S1388-9842(03)00035-7; Kraljevic J, 2013, CARDIOVASC RES, V99, P55, DOI 10.1093/cvr/cvt080; Kregel KC, 2006, RESOURCE BOOK DESIGN; LEVY D, 1990, NEW ENGL J MED, V322, P1561, DOI 10.1056/NEJM199005313222203; Li HG, 2006, J AM COLL CARDIOL, V47, P2536, DOI 10.1016/j.jacc.2006.01.071; Linz W, 1999, CARDIOVASC RES, V43, P549, DOI 10.1016/S0008-6363(99)00091-7; LITWIN SE, 1993, J AM COLL CARDIOL, V22, pA49, DOI 10.1016/0735-1097(93)90463-B; Lundby C, 2006, EUR J APPL PHYSIOL, V96, P363, DOI 10.1007/s00421-005-0085-5; Macpherson REK, 2011, MED SCI SPORT EXER, V43, P115, DOI 10.1249/MSS.0b013e3181e5eacd; Matsuhisa S, 2008, AM J PHYSIOL-HEART C, V294, pH2473, DOI 10.1152/ajpheart.91533.2007; McMullen JR, 2007, CLIN EXP PHARMACOL P, V34, P255, DOI 10.1111/j.1440-1681.2007.04585.x; Miyachi M, 2009, HYPERTENSION, V53, P701, DOI 10.1161/HYPERTENSIONAHA.108.127290; Moraes-Teixeira JD, 2010, EXP MOL PATHOL, V89, P351, DOI 10.1016/j.yexmp.2010.08.004; Mori J, 2014, CIRC-HEART FAIL, V7, P327, DOI 10.1161/CIRCHEARTFAILURE.113.000672; MUKOYAMA M, 1990, NEW ENGL J MED, V323, P757; Olenich SA, 2013, J PHYSIOL-LONDON, V591, P5157, DOI 10.1113/jphysiol.2013.254979; Pederson BA, 2005, J BIOL CHEM, V280, P17260, DOI 10.1074/jbc.M410448200; Pena LL, 2003, CIRCULATION, V107, P1210, DOI 10.1161/01.CIR.0000055013.92097.40; Pereira F, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/752817; PFEFFER MA, 1984, HYPERTENSION, V6, P475, DOI 10.1161/01.HYP.6.4.475; Pinho CA, 2012, LIFE SCI, V90, P553, DOI 10.1016/j.lfs.2012.01.018; Reiser PJ, 2001, AM J PHYSIOL-HEART C, V280, pH1814, DOI 10.1152/ajpheart.2001.280.4.H1814; Rengo G, 2013, AGING CLIN EXP RES, V25, P487, DOI 10.1007/s40520-013-0117-7; Rimbaud S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026391; SALTIN B, 1980, FED PROC, V39, P1506; Sanada S, 2003, HYPERTENSION, V41, P963, DOI 10.1161/01.HYP.0000062881.36813.7A; Sano M, 2007, NATURE, V446, P444, DOI 10.1038/nature05602; Semenza GL, 2000, J APPL PHYSIOL, V88, P1474, DOI 10.1152/jappl.2000.88.4.1474; Shiojima I, 2006, GENE DEV, V20, P3347, DOI 10.1101/gad.1492806; Skelly LE, 2014, APPL PHYSIOL NUTR ME, V39, P845, DOI 10.1139/apnm-2013-0562; Smith AC, 2007, AM J PHYSIOL-ENDOC M, V293, pE172, DOI 10.1152/ajpendo.00677.2006; Srere PA, 1969, METHODS ENZYMOLOGY; Whelton SP, 2002, ANN INTERN MED, V136, P493, DOI 10.7326/0003-4819-136-7-200204020-00006; Willis MS, 2009, CIRC RES, V105, P80, DOI 10.1161/CIRCRESAHA.109.194928; Yang L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096892; YASUE H, 1994, CIRCULATION, V90, P195, DOI 10.1161/01.CIR.90.1.195	65	36	42	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0121138	10.1371/journal.pone.0121138	http://dx.doi.org/10.1371/journal.pone.0121138			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803693	Green Submitted, gold, Green Published			2022-12-26	WOS:000353889600129
J	Lee, C; Harper, M; Fryer, D				Lee, Christopher; Harper, Marc; Fryer, Dashiell			The Art of War: Beyond Memory-one Strategies in Population Games	PLOS ONE			English	Article							ITERATED PRISONERS-DILEMMA; TIT-FOR-TAT; REGULAR LATTICES; LOSE-SHIFT; WIN-STAY; COOPERATION; EXTORTION; EVOLUTION	We show that the history of play in a population game contains exploitable information that can be successfully used by sophisticated strategies to defeat memory-one opponents, including zero determinant strategies. The history allows a player to label opponents by their strategies, enabling a player to determine the population distribution and to act differentially based on the opponent's strategy in each pairwise interaction. For the Prisoner's Dilemma, these advantages lead to the natural formation of cooperative coalitions among similarly behaving players and eventually to unilateral defection against opposing player types. We show analytically and empirically that optimal play in population games depends strongly on the population distribution. For example, the optimal strategy for a minority player type against a resident TFT population is ALLC, while for a majority player type the optimal strategy versus TFT players is ALLD. Such behaviors are not accessible to memory-one strategies. Drawing inspiration from Sun Tzu's the Art of War, we implemented a non-memoryone strategy for population games based on techniques from machine learning and statistical inference that can exploit the history of play in this manner. Via simulation we find that this strategy is essentially uninvadable and can successfully invade (significantly more likely than a neutral mutant) essentially all known memory-one strategies for the Prisoner's Dilemma, including ALLC (always cooperate), ALLD (always defect), tit-for-tat (TFT), winstay- lose-shift (WSLS), and zero determinant (ZD) strategies, including extortionate and generous strategies.	[Lee, Christopher; Harper, Marc] Univ Calif Los Angeles, Inst Genom & Prote, Los Angeles, CA 90095 USA; [Lee, Christopher] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90024 USA; [Lee, Christopher] Univ Calif Los Angeles, Dept Comp Sci, Los Angeles, CA 90024 USA; [Lee, Christopher] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA; [Fryer, Dashiell] Pomona Coll, Dept Math, Claremont, CA 91711 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Claremont Colleges; Pomona College	Lee, C (corresponding author), Univ Calif Los Angeles, Inst Genom & Prote, Los Angeles, CA 90095 USA.	leec@chem.ucla.edu		, Dashiell/0000-0002-8515-1400	Office of Science (BER), U. S. Department of Energy [DE-FC02-02ER63421]	Office of Science (BER), U. S. Department of Energy(United States Department of Energy (DOE))	This work was supported by the Office of Science (BER), U. S. Department of Energy, Cooperative Agreement No. DE-FC02-02ER63421. There were no other funding sources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adami C, 2014, EVOLUTIONARY GAME TH; Adami C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3193; Akin E, 2012, STABLE COOPERATIVE S; [Anonymous], 1965, PRISONERS DILEMMA ST; Axelrod R., 2006, EVOLUTION COOPERATIO; Fischer I, 2013, P NATL ACAD SCI USA, V110, P10229, DOI 10.1073/pnas.1308221110; Hilbe C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077886; Hilbe C, 2013, P NATL ACAD SCI USA, V110, P6913, DOI 10.1073/pnas.1214834110; Imhof LA, 2007, J THEOR BIOL, V247, P574, DOI 10.1016/j.jtbi.2007.03.027; Lee C, 2011, INFORMATION, V2, P17, DOI 10.3390/info2010017; Moran P., 1962, STAT PROCESSES EVOLU; NOWAK M, 1993, NATURE, V364, P56, DOI 10.1038/364056a0; NOWAK M, 1990, THEOR POPUL BIOL, V38, P93, DOI 10.1016/0040-5809(90)90005-G; Nowak MA, 2004, NATURE, V428, P646, DOI 10.1038/nature02414; Nowak MA, 2006, EVOLUTIONARY DYNAMIC; Press WH, 2012, P NATL ACAD SCI USA, V109, P10409, DOI 10.1073/pnas.1206569109; RABINER LR, 1989, P IEEE, V77, P257, DOI 10.1109/5.18626; Roemheld L, 2013, EVOLUTIONARY EXTORTI; Stewart AJ, 2014, ARXIV14026628; Stewart AJ, 2013, P NATL ACAD SCI USA, V110, P15348, DOI 10.1073/pnas.1306246110; Stewart AJ, 2012, P NATL ACAD SCI USA, V109, P10134, DOI 10.1073/pnas.1208087109; van Veelen M, 2012, P NATL ACAD SCI USA, V109, P9929, DOI 10.1073/pnas.1206694109; Wang J, 2013, COMMUN THEOR PHYS, V59, P257, DOI 10.1088/0253-6102/59/3/02; Wang J, 2012, CHINESE SCI BULL, V57, P724, DOI 10.1007/s11434-011-4890-4	24	7	7	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0120625	10.1371/journal.pone.0120625	http://dx.doi.org/10.1371/journal.pone.0120625			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803576	Green Published, gold, Green Submitted			2022-12-26	WOS:000353889600086
J	Lu, LL; Xu, LJ; Guo, YC; Zhang, DY; Qi, TT; Jin, L; Gu, GF; Xu, L; Xiao, M				Lu, Lili; Xu, Lijuan; Guo, Yuchuan; Zhang, Dayu; Qi, Tingting; Jin, Lan; Gu, Guofeng; Xu, Li; Xiao, Min			Glycosylation of Phenolic Compounds by the Site-Mutated beta-Galactosidase from Lactobacillus bulgaricus L3	PLOS ONE			English	Article							XANTHOMONAS-CAMPESTRIS WU-9701; ENZYMATIC-SYNTHESIS; CAFFEIC ACID; GLUCOSYLATION; GLYCOSIDASE; GLUCOSIDES; EUGENOL	beta-Galactosidases can transfer the galactosyl from lactose or galactoside donors to various acceptors and thus are especially useful for the synthesis of important glycosides. However, these enzymes have limitations in the glycosylation of phenolic compounds that have many physiological functions. In this work, the beta-galactosidase from Lactobacillus bulgaricus L3 was subjected to site-saturation mutagenesis at the W980 residue. The recombinant pET-21b plasmid carrying the enzyme gene was used as the template for mutation. The mutant plasmids were transformed into Escherichia coli cells for screening. One recombinant mutant, W980F, exhibited increased yield of glycoside when using hydroquinone as the screening acceptor. The enzyme was purified and the effects of the mutation on enzyme properties were determined in detail. It showed improved transglycosylation activity on novel phenolic acceptors besides hydroquinone. The yields of the glycosides produced from phenol, hydroquinone, and catechol were increased by 7.6% to 53.1%. Moreover, it generated 32.3% glycosides from the pyrogallol that could not be glycosylated by the wildtype enzyme. Chemical structures of these glycoside products were further determined by MS and NMR analysis. Thus, a series of novel phenolic galactosides were achieved by beta-galactosidase for the first time. This was a breakthrough in the enzymatic galactosylation of the challenging phenolic compounds of great values.	[Lu, Lili; Xu, Lijuan; Guo, Yuchuan; Zhang, Dayu; Qi, Tingting; Jin, Lan; Gu, Guofeng; Xu, Li; Xiao, Min] Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Peoples R China; [Lu, Lili; Xu, Lijuan; Guo, Yuchuan; Zhang, Dayu; Qi, Tingting; Jin, Lan; Gu, Guofeng; Xu, Li; Xiao, Min] Shandong Univ, Natl Glycoengn Res Ctr, Jinan 250100, Peoples R China	Shandong University; Shandong University	Xiao, M (corresponding author), Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Peoples R China.	minxiao@sdu.edu.cn			Major State Basic Research Development Program of China (973 Program) [2012CB822102]; National High Technology Research and Development Program of China (863 Program) [2012AA021501, 2012AA021504]; National Natural Science Foundation of China [31000035]; Science and Technology Development Project of Shandong Province [2011GSF12104]; Independent Innovation Foundation of Shandong University [2012TS014]	Major State Basic Research Development Program of China (973 Program)(National Basic Research Program of China); National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Development Project of Shandong Province; Independent Innovation Foundation of Shandong University	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was supported by Major State Basic Research Development Program of China (973 Program) (No. 2012CB822102), National High Technology Research and Development Program of China (863 Program) (No. 2012AA021501, No. 2012AA021504), National Natural Science Foundation of China (No. 31000035), Science and Technology Development Project of Shandong Province (No. 2011GSF12104), and Independent Innovation Foundation of Shandong University (No. 2012TS014).	Bras NF, 2010, J CHEM THEORY COMPUT, V6, P421, DOI 10.1021/ct900530f; Chen C, 2012, PHARM BIOL, V50, P727, DOI 10.3109/13880209.2011.624104; Higashiyama T, 2004, CARBOHYD RES, V339, P1603, DOI 10.1016/j.carres.2004.04.005; Kim GE, 2010, J AGR FOOD CHEM, V58, P9492, DOI 10.1021/jf101748j; Kishore D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040708; Lim EK, 2003, BIOCHEM J, V373, P987, DOI 10.1042/BJ20021453; Lu LL, 2012, BIORESOURCE TECHNOL, V116, P327, DOI 10.1016/j.biortech.2012.03.108; Lu LL, 2012, FOOD CHEM, V134, P269, DOI 10.1016/j.foodchem.2012.02.134; Lu LL, 2010, FOOD CHEM, V121, P1283, DOI 10.1016/j.foodchem.2010.01.050; Naidu P. V. S., 2012, International Journal of Pharmacy and Biomedical Sciences, V3, P24; NISHIMURA T, 1995, J FERMENT BIOENG, V80, P18, DOI 10.1016/0922-338X(95)98170-P; Oliveira C, 2011, BIOTECHNOL ADV, V29, P600, DOI 10.1016/j.biotechadv.2011.03.008; Panesar P. S., 2010, Enzyme Research, V2010, P473137, DOI 10.4061/2010/473137; Park AR, 2010, APPL MICROBIOL BIOT, V85, P1279, DOI 10.1007/s00253-009-2356-2; Gonzalez CP, 2013, CARBOHYD RES, V368, P104, DOI 10.1016/j.carres.2012.12.009; Prodanovic R, 2005, J MOL CATAL B-ENZYM, V35, P142, DOI 10.1016/j.molcatb.2005.06.011; Sato T, 2003, J BIOSCI BIOENG, V96, P199, DOI 10.1263/jbb.96.199; Sato T, 2000, J BIOSCI BIOENG, V90, P625, DOI 10.1016/S1389-1723(00)90007-0; Shimizu R, 2006, BIOSCI BIOTECH BIOCH, V70, P940, DOI 10.1271/bbb.70.940; Torres P, 2011, ADV SYNTH CATAL, V353, P1077, DOI 10.1002/adsc.201000968; Tran V, 2010, PROTEIN ENG DES SEL, V23, P43, DOI 10.1093/protein/gzp068; van Rantwijk F, 1999, J MOL CATAL B-ENZYM, V6, P511, DOI 10.1016/S1381-1177(99)00042-9; [杨亚波 Yang Yabo], 2002, [中国药科大学学报, Journal of China Pharmaceutical University], V33, P526; Yoon JH, 1996, CARBOHYD RES, V292, P153; Zhang P, 2013, APPL MICROBIOL BIOT, V97, P1043, DOI 10.1007/s00253-012-4351-2	26	10	10	4	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0121445	10.1371/journal.pone.0121445	http://dx.doi.org/10.1371/journal.pone.0121445			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803778	gold, Green Published, Green Submitted			2022-12-26	WOS:000353889600158
J	Nonnekes, J; de Kam, D; Nijhuis, LBO; van Geel, K; Bloem, BR; Geurts, A; Weerdesteyn, V				Nonnekes, Jorik; de Kam, Digna; Nijhuis, Lars B. Oude; van Geel, Karin; Bloem, Bastiaan R.; Geurts, Alexander; Weerdesteyn, Vivian			StartReact Effects Support Different Pathophysiological Mechanisms Underlying Freezing of Gait and Postural Instability in Parkinson's Disease	PLOS ONE			English	Article							SPASTIC PARAPLEGIA; BALANCE IMPAIRMENT; RESPONSES; STARTLE; FALLS; PERTURBATIONS; CONTRIBUTES; MOVEMENTS; BACKWARD; DISTINCT	Introduction The pathophysiology underlying postural instability in Parkinson's disease is poorly understood. The frequent co-existence with freezing of gait raises the possibility of shared pathophysiology. There is evidence that dysfunction of brainstem structures contribute to freezing of gait. Here, we evaluated whether dysfunction of these structures contributes to postural instability as well. Brainstem function was assessed by studying the StartReact effect (acceleration of latencies by a startling acoustic stimulus (SAS)). Methods We included 25 patients, divided in two different ways: 1) those with postural instability (HY = 3, n = 11) versus those without (HY<3, n = 14); and 2) those with freezing (n = 11) versus those without freezing (n = 14). We also tested 15 matched healthy controls. We tested postural responses by translating a balance platform in the forward direction, resulting in backward balance perturbations. In 25% of trials, the start of the balance perturbation was accompanied by a SAS. Results The amplitude of automatic postural responses and length of the first balance correcting step were smaller in patients with postural instability compared to patients without postural instability, but did not differ between freezers and non-freezers. In contrast, the StartReact effect was intact in patients with postural instability but was attenuated in freezers. Discussion We suggest that the mechanisms underlying freezing of gait and postural instability in Parkinson's disease are at least partly different. Underscaling of automatic postural responses and balance-correcting steps both contribute to postural instability. The attenuated StartReact effect was seen only in freezers and likely reflects inadequate representation of motor programs at upper brainstem level.	[Nonnekes, Jorik; de Kam, Digna; van Geel, Karin; Geurts, Alexander; Weerdesteyn, Vivian] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Dept Rehabil, NL-6525 ED Nijmegen, Netherlands; [Nijhuis, Lars B. Oude; Bloem, Bastiaan R.] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Dept Neurol, NL-6525 ED Nijmegen, Netherlands; [Geurts, Alexander; Weerdesteyn, Vivian] Sint Maartensklin Res Dev & Educ, Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Sint Maartens Clinic	Nonnekes, J (corresponding author), Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Dept Rehabil, NL-6525 ED Nijmegen, Netherlands.	jorik.nonnekes@radboudumc.nl	de Kam, Digna/AAI-1945-2019; Weerdesteyn, Vivian/A-9599-2014; Bloem, Bastiaan/H-8013-2014; Geurts, Alexander/H-8032-2014; Nonnekes, Jorik/P-6648-2015	de Kam, Digna/0000-0001-6383-0106; Weerdesteyn, Vivian/0000-0003-4327-7600; Bloem, Bastiaan/0000-0002-6371-3337; Geurts, Alexander/0000-0001-7478-1119; Nonnekes, Jorik/0000-0003-2434-1427	Radboud University Medical Centre Research Grant; Dutch Parkinson Verening; Netherlands Organization for Scientific Research Veni Research Grant [916.10.106]	Radboud University Medical Centre Research Grant; Dutch Parkinson Verening; Netherlands Organization for Scientific Research Veni Research Grant	This research was funded by Radboud University Medical Centre Research Grant to JH Nonnekes, a grant from the Dutch Parkinson Verening to LB. Oude Nijhuis, and Netherlands Organization for Scientific Research Veni Research Grant 916.10.106 to V. Weerdesteyn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alibiglou L, 2012, J PHYSIOL-LONDON, V590, DOI 10.1113/jphysiol.2011.219592; Bloem BR, 1996, MOVEMENT DISORD, V11, P509, DOI 10.1002/mds.870110506; Bloem BR, 2004, MOVEMENT DISORD, V19, P871, DOI 10.1002/mds.20115; Bohnen NI, 2009, NEUROLOGY, V73, P1670, DOI 10.1212/WNL.0b013e3181c1ded6; Campbell AD, 2013, J NEUROPHYSIOL, V110, P2236, DOI 10.1152/jn.00766.2012; Campbell AD, 2012, J NEUROPHYSIOL, V108, P2946, DOI 10.1152/jn.01157.2011; Campbell AD, 2012, THESIS U BRIT COLUMB; Carlsen AN, 2004, J MOTOR BEHAV, V36, P253, DOI 10.3200/JMBR.36.3.253-264; Carlsen AN, 2007, EXP BRAIN RES, V176, P199, DOI 10.1007/s00221-006-0610-8; Carpenter MG, 2004, J NEUROL NEUROSUR PS, V75, P1245, DOI 10.1136/jnnp.2003.021147; Chung KA, 2010, NEUROLOGY, V75, P1263, DOI 10.1212/WNL.0b013e3181f6128c; DAVIS RB, 1991, HUM MOVEMENT SCI, V10, P575, DOI 10.1016/0167-9457(91)90046-Z; de Kam D, 2014, J NEUROL, V261, P2330, DOI 10.1007/s00415-014-7496-3; Demirci M, 1997, ANN NEUROL, V41, P781, DOI 10.1002/ana.410410614; Ferraye MU, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091183; Fisher KM, 2013, J NEUROL, V260, P3182, DOI 10.1007/s00415-013-7178-6; Giladi N, 2001, NEUROLOGY, V56, P1712, DOI 10.1212/WNL.56.12.1712; Goetz CG, 2008, MOVEMENT DISORD, V23, P2129, DOI 10.1002/mds.22340; Grimbergen YA SA, PARKINSONS DISEASE N, P361; Hass CJ, 2008, NAT CLIN PRACT NEURO, V4, P530, DOI 10.1038/ncpneuro0912; Hermens H.J., 1999, ROESSINGH RES DEV, V8, P11; Honeycutt CF, 2015, CLIN NEUROPHYSIOL, V126, P160, DOI 10.1016/j.clinph.2014.05.025; Honeycutt CF, 2013, J NEUROPHYSIOL, V110, P1476, DOI 10.1152/jn.00866.2012; Honeycutt CF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043097; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Jacobs JV, 2007, J NEURAL TRANSM, V114, P1339, DOI 10.1007/s00702-007-0657-0; Jacobs JV, 2006, NEUROSCIENCE, V141, P999, DOI 10.1016/j.neuroscience.2006.04.014; Jorgensen LM, 2005, J NEUROL SCI, V237, P25, DOI 10.1016/j.jns.2005.05.002; Karachi C, 2010, J CLIN INVEST, V120, P2745, DOI 10.1172/JCI42642; King LA, 2008, ARCH PHYS MED REHAB, V89, P492, DOI 10.1016/j.apmr.2007.11.017; King LA, 2010, ARCH PHYS MED REHAB, V91, P1332, DOI 10.1016/j.apmr.2010.05.013; MacKinnon CD, 2007, J NEUROPHYSIOL, V97, P4368, DOI 10.1152/jn.01136.2006; Maetzler W, 2013, MOVEMENT DISORD, V28, P1576, DOI 10.1002/mds.25682; Marinovic W, 2014, EXP BRAIN RES, V232, P3797, DOI 10.1007/s00221-014-4074-y; Maslovat D, 2012, NEUROSCI LETT, V513, P243, DOI 10.1016/j.neulet.2012.02.052; Muller MLTM, 2013, BRAIN, V136, P3282, DOI 10.1093/brain/awt247; Nachev P, 2008, NAT REV NEUROSCI, V9, P856, DOI 10.1038/nrn2478; Nieuwboer A, 2009, GAIT POSTURE, V30, P459, DOI 10.1016/j.gaitpost.2009.07.108; Nonnekes J, 2013, NEUROSCIENCE, V245, P109, DOI 10.1016/j.neuroscience.2013.04.036; Nonnekes J, 2015, J PARKINSON DIS, V5, P43, DOI 10.3233/JPD-140514; Nonnekes J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107731; Nonnekes J, 2014, J NEUROL, V261, P943, DOI 10.1007/s00415-014-7304-0; Nonnekes J, 2014, J NEUROSCI, V34, P275, DOI 10.1523/JNEUROSCI.2948-13.2014; Nonnekes J, 2013, EXPERT REV NEUROTHER, V13, P1303, DOI 10.1586/14737175.2013.839231; Nonnekes J, 2013, J NEUROL, V260, P2387, DOI 10.1007/s00415-013-7002-3; Nutt JG, 2011, LANCET NEUROL, V10, P734, DOI 10.1016/S1474-4422(11)70143-0; POLO JM, 1993, J NEUROL NEUROSUR PS, V56, P175, DOI 10.1136/jnnp.56.2.175; Quant S, 2004, EXP BRAIN RES, V155, P393, DOI 10.1007/s00221-003-1744-6; Reynolds RF, 2007, J PHYSIOL-LONDON, V583, P1107, DOI 10.1113/jphysiol.2007.136192; Rochester L, 2012, BRAIN, V135, P2779, DOI 10.1093/brain/aws207; Rodriguez-Oroz MC, 2009, LANCET NEUROL, V8, P1128, DOI 10.1016/S1474-4422(09)70293-5; Rogers MW, 2011, J NEUROPHYSIOL, V106, P915, DOI 10.1152/jn.00005.2010; Smulders K, 2014, GAIT POSTURE, V39, P700, DOI 10.1016/j.gaitpost.2013.10.003; Snijders AH, 2012, TACKLING FREEZING GA, P196; Snijders AH, 2012, PARKINSONISM RELAT D, V18, P149, DOI 10.1016/j.parkreldis.2011.09.006; St George RJ, 2012, J NEUROSURG, V116, P1347, DOI 10.3171/2012.2.JNS11847; Stapley PJ, 2009, J NEUROPHYSIOL, V101, P1334, DOI 10.1152/jn.91013.2008; Taube W, 2006, J APPL PHYSIOL, V101, P420, DOI 10.1152/japplphysiol.01447.2005; Thevathasan W, 2011, BRAIN, V134, P2085, DOI 10.1093/brain/awr131; Tresch UA, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12025; Valls-Sole J, 2008, EXP BRAIN RES, V187, P497, DOI 10.1007/s00221-008-1402-0; Weerdesteyn V, 2012, GAIT POSTURE, V35, P462, DOI 10.1016/j.gaitpost.2011.11.008	62	22	22	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0122064	10.1371/journal.pone.0122064	http://dx.doi.org/10.1371/journal.pone.0122064			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803045	Green Published, Green Submitted, gold			2022-12-26	WOS:000353889600188
J	Nunez, A; Dulude, D; Jbel, M; Rokeach, LA				Nunez, Andres; Dulude, Dominic; Jbel, Mehdi; Rokeach, Luis A.			Calnexin Is Essential for Survival under Nitrogen Starvation and Stationary Phase in Schizosaccharomyces pombe	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; FISSION YEAST; SACCHAROMYCES-CEREVISIAE; INDUCED APOPTOSIS; QUALITY-CONTROL; S-POMBE; AUTOPHAGY; PROTEIN; VIABILITY; PATHWAY	Cell fate is determined by the balance of conserved molecular mechanisms regulating death (apoptosis) and survival (autophagy). Autophagy is a process by which cells recycle their organelles and macromolecules through degradation within the vacuole in yeast and plants, and lysosome in metazoa. In the yeast Schizosaccharomyces pombe, autophagy is strongly induced under nitrogen starvation and in aging cells. Previously, we demonstrated that calnexin (Cnx1p), a highly conserved transmembrane chaperone of the endoplasmic reticulum (ER), regulates apoptosis under ER stress or inositol starvation. Moreover, we showed that in stationary phase, Cnx1p is cleaved into two moieties, L_Cnx1p and S_Cnx1p. Here, we show that the processing of Cnx1p is regulated by autophagy, induced by nitrogen starvation or cell aging. The cleavage of Cnx1p involves two vacuolar proteases: Isp6, which is essential for autophagy, and its paralogue Psp3. Blocking autophagy through the knockout of autophagy-related genes (atg) results in inhibition of both, the cleavage and the trafficking of Cnx1p from the ER to the vacuole. We demonstrate that Cnx1p is required for cell survival under nitrogen-starvation and in chronological aging cultures. The death of the mini_cnx1 mutant (overlapping S_cnx1p) cells is accompanied by accumulation of high levels of reactive-oxygen species (ROS), a slowdown in endocytosis and severe cell-wall defects. Moreover, mutant cells expressing only S_Cnx1p showed cell wall defects. Co-expressing mutant overlapping the L_Cnx1p and S_Cnx1p cleavage products reverses the death, ROS phenotype and cell wall defect to wild-type levels. As it is involved in both apoptosis and autophagy, Cnx1p could be a nexus for the crosstalk between these pro-death and pro-survival mechanisms. Ours, and observations in mammalian systems, suggest that the multiple roles of calnexin depend on its sub-cellular localization and on its cleavage. The use of S. pombe should assist in further shedding light on the multiple roles of calnexin.	[Nunez, Andres; Dulude, Dominic; Jbel, Mehdi; Rokeach, Luis A.] Univ Montreal, Dept Biochem & Mol Med, Montreal, PQ, Canada	Universite de Montreal	Rokeach, LA (corresponding author), Univ Montreal, Dept Biochem & Mol Med, Montreal, PQ, Canada.	luis.rokeach@umontreal.ca	Nunez-Hernandez, Andres/AAZ-3900-2020	Nunez-Hernandez, Andres/0000-0002-0781-0001	Canadian Institutes for Health Research (CIHR) [GI MOP 89702, MOP-119481]; National Sciences and Engineering Council of Canada [171325]; "FundacionSeneca - Agencia de Ciencia y Tecnologia de la Region de Murcia" within the Program "Plan de Ciencia, Tecnologia e Innovacion de la Region de Murcia	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); National Sciences and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); "FundacionSeneca - Agencia de Ciencia y Tecnologia de la Region de Murcia" within the Program "Plan de Ciencia, Tecnologia e Innovacion de la Region de Murcia	This work was funded by Canadian Institutes for Health Research (CIHR) grants GI MOP 89702, MOP-119481 http://www.cihr-irsc.gc.ca/e/193.html National Sciences and Engineering Council of Canada 171325 to LAR. ANH was a postdoctoral fellow funded by "FundacionSeneca - Agencia de Ciencia y Tecnologia de la Region de Murcia" within the Program "Plan de Ciencia, Tecnologia e Innovacion de la Region de Murcia (2011-2014) http://fseneca.es. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-390; Arlia-Ciommo A, 2014, MICROB CELL, V1, P163, DOI 10.15698/mic2014.06.152; BASI G, 1993, GENE, V123, P131, DOI 10.1016/0378-1119(93)90552-E; Bernales S, 2006, PLOS BIOL, V4, P2311, DOI 10.1371/journal.pbio.0040423; Brown MK, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00263; Chevet E, 2001, CURR OPIN STRUC BIOL, V11, P120, DOI 10.1016/S0959-440X(00)00168-8; de Leon N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071510; Delom F, 2007, CELL DEATH DIFFER, V14, P586, DOI 10.1038/sj.cdd.4402012; Delom F, 2006, BIOCHEM BIOPH RES CO, V341, P39, DOI 10.1016/j.bbrc.2005.12.149; Eisler H, 2004, EXP CELL RES, V300, P345, DOI 10.1016/j.yexcr.2004.07.025; Elagoz A, 1999, J CELL SCI, V112, P4449; Farrugia G, 2012, FRONT ONCOL, V2, P1, DOI 10.3389/fonc.2012.00064; Forsburg SL, 1997, GENE, V191, P191, DOI 10.1016/S0378-1119(97)00058-9; Free SJ, 2013, ADV GENET, V81, P33, DOI 10.1016/B978-0-12-407677-8.00002-6; Guerin R, 2008, MOL BIOL CELL, V19, P4404, DOI 10.1091/mbc.E08-02-0188; Guerin R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006244; Hajjar F, 2007, YEAST, V24, P89, DOI 10.1002/yea.1440; Hamasaki M, 2005, TRAFFIC, V6, P56, DOI 10.1111/j.1600-0854.2004.00245.x; He H, 2013, J ETHNOPHARMACOL, V148, P544, DOI 10.1016/j.jep.2013.04.051; Hecht Karen A, 2014, Cell Logist, V4, pe28023; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; HIRSCH HH, 1992, EUR J BIOCHEM, V203, P641, DOI 10.1111/j.1432-1033.1992.tb16594.x; Hughes AL, 2005, CELL, V120, P831, DOI 10.1016/j.cell.2005.01.012; Idiris A, 2006, YEAST, V23, P83, DOI 10.1002/yea.1342; JANNATIPOUR M, 1995, J BIOL CHEM, V270, P4845, DOI 10.1074/jbc.270.9.4845; Jiang N, 2007, NAT IMMUNOL, V8, P1114, DOI 10.1038/ni1501; Jones EW, 2002, METHOD ENZYMOL, V351, P127; Journo D, 2009, J BIOL CHEM, V284, P35885, DOI 10.1074/jbc.M109.048140; Kohda TA, 2007, GENES CELLS, V12, P155, DOI 10.1111/j.1365-2443.2007.01041.x; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Ladds G, 1998, SEMIN CELL DEV BIOL, V9, P111, DOI 10.1006/scdb.1997.0215; Ladds G, 2000, MOL MICROBIOL, V38, P839, DOI 10.1046/j.1365-2958.2000.02180.x; Lakkaraju AKK, 2013, MOL CELL, V51, P386, DOI 10.1016/j.molcel.2013.07.009; Lakkaraju AKK, 2012, EMBO J, V31, P1823, DOI 10.1038/emboj.2012.15; Lynes EM, 2013, J CELL SCI, V126, P3893, DOI 10.1242/jcs.125856; Madeo F, 1997, J CELL BIOL, V139, P729, DOI 10.1083/jcb.139.3.729; Madeo F, 1999, J CELL BIOL, V145, P757, DOI 10.1083/jcb.145.4.757; Marechal A, 2004, BIOCHEM J, V380, P441, DOI 10.1042/BJ20031546; Marino G, 2014, NAT REV MOL CELL BIO, V15, P81, DOI 10.1038/nrm3735; Matynia A, 2002, J CELL SCI, V115, P421; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Mukaiyama H, 2011, APPL MICROBIOL BIOT, V90, P203, DOI 10.1007/s00253-010-3031-3; Mukaiyama H, 2010, FEBS LETT, V584, P1327, DOI 10.1016/j.febslet.2009.12.037; Mukaiyama H, 2009, MICROBIOL-SGM, V155, P3816, DOI 10.1099/mic.0.034389-0; Munoz AJ, 2012, FEMS YEAST RES, V12, P249, DOI 10.1111/j.1567-1364.2011.00781.x; Myhill N, 2008, MOL BIOL CELL, V19, P2777, DOI 10.1091/mbc.E07-10-0995; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nakashima A, 2006, CURR GENET, V49, P403, DOI 10.1007/s00294-006-0067-0; NEBES VL, 1991, J BIOL CHEM, V266, P22851; OKAZAKI K, 1990, NUCLEIC ACIDS RES, V18, P6485, DOI 10.1093/nar/18.22.6485; Perrone GG, 2008, BBA-MOL CELL RES, V1783, P1354, DOI 10.1016/j.bbamcr.2008.01.023; Reggiori F, 2013, GENETICS, V194, P341, DOI 10.1534/genetics.112.149013; Roux AE, 2006, AGING CELL, V5, P345, DOI 10.1111/j.1474-9726.2006.00225.x; Roux AE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000408; Rubinsztein DC, 2012, CURR BIOL, V22, pR29, DOI 10.1016/j.cub.2011.11.034; Rubinsztein DC, 2011, CELL, V146, P682, DOI 10.1016/j.cell.2011.07.030; Rutkevich LA, 2011, CURR OPIN CELL BIOL, V23, P157, DOI 10.1016/j.ceb.2010.10.011; SATO S, 1994, CURR GENET, V26, P31, DOI 10.1007/BF00326301; SATO T, 1994, INT IMMUNOL, V6, P665, DOI 10.1093/intimm/6.4.665; Schuck S, 2014, J CELL SCI, V127, P4078, DOI 10.1242/jcs.154716; Shi JM, 2013, BIOCHEM PHARMACOL, V85, P913, DOI 10.1016/j.bcp.2013.01.009; Simons JF, 1998, EMBO J, V17, P396, DOI 10.1093/emboj/17.2.396; Tabuchi M, 1997, J BACTERIOL, V179, P4179, DOI 10.1128/jb.179.13.4179-4189.1997; TAKEGAWA K, 1995, J CELL SCI, V108, P3745; Takizawa T, 2004, J BIOCHEM, V136, P399, DOI 10.1093/jb/mvh133; Tomassini B, 2004, FASEB J, V18, P1553, DOI 10.1096/fj.04-1675fje; Torgler CN, 1997, CELL DEATH DIFFER, V4, P263, DOI 10.1038/sj.cdd.4400239; Trancikova A, 2004, FEMS YEAST RES, V5, P149, DOI 10.1016/j.femsyr.2004.06.014; Wang Z, 2001, MOL CELL BIOL, V21, P5742, DOI 10.1128/MCB.21.17.5742-5752.2001; Weinberger M, 2010, AGING-US, V2, P709, DOI 10.18632/aging.100215; Weisman R, 2001, J BIOL CHEM, V276, P7027, DOI 10.1074/jbc.M010446200; Wilk S, 2010, MOL GENET GENOMICS, V284, P217, DOI 10.1007/s00438-010-0563-2; Wood V, 2012, NUCLEIC ACIDS RES, V40, pD695, DOI 10.1093/nar/gkr853; Xue Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090496; Zuin A, 2010, EMBO J, V29, P981, DOI 10.1038/emboj.2009.407; Zuppini A, 2002, BIOCHEMISTRY-US, V41, P2850, DOI 10.1021/bi015967+	77	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0121059	10.1371/journal.pone.0121059	http://dx.doi.org/10.1371/journal.pone.0121059			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803873	Green Published, Green Submitted, gold			2022-12-26	WOS:000353889600117
J	Persson, LJP; Aanerud, M; Hiemstra, PS; Michelsen, AE; Ueland, T; Hardie, JA; Aukrust, P; Bakke, PS; Eagan, TML				Persson, Louise J. P.; Aanerud, Marianne; Hiemstra, Pieter S.; Michelsen, Annika E.; Ueland, Thor; Hardie, Jon A.; Aukrust, Pal; Bakke, Per S.; Eagan, Tomas M. L.			Vitamin D, Vitamin D Binding Protein, and Longitudinal Outcomes in COPD	PLOS ONE			English	Article							SERUM 25-HYDROXYVITAMIN D; 3RD NATIONAL-HEALTH; D DEFICIENCY; LUNG-FUNCTION; EXACERBATIONS; RISK; ASSOCIATION; DISEASE; PREVALENCE; MECHANISMS	Background Associations between Vitamin D3 [25(OH) D], vitamin D binding protein (VDBP) and chronic obstructive pulmonary disease (COPD) are previously reported. We aimed to further investigate these associations on longitudinal outcomes. Methods 426 COPD patients from western Norway, GOLD stage II-IV, aged 40-76, were followed every six-month from 2006 through 2009 with spirometry, bioelectrical impedance measurements and registration of exacerbation frequency. Serum 25(OH) D and VDBP levels were determined at study-entry by high-performance liquid chromatography coupled with mass spectrometry and enzyme immunoassays respectively. Yearly change in lung function and body composition was assessed by generalized estimating equations (GEE), yearly exacerbation rate by negative binomial regression models, and 5 years all-cause mortality by Cox proportional-hazard regression. Results 1/3 of the patients had vitamin D deficiency (<20ng/mL) and a greater decline in both FEV1 and FVC, compared to patients with normal levels; for FEV1 this difference only reached statistical significance in the 28 patients with the lowest levels (<10ng/mL, p = 0.01). Neither 25(OH) D nor VDBP levels predicted exacerbation rate, change in fat free mass index or risk of death. Conclusion Severe vitamin D deficiency may affect decline in lung function parameters in COPD. Neither 25(OH) D nor VDBP levels did otherwise predict markers of disease progression.	[Persson, Louise J. P.; Eagan, Tomas M. L.] Haukeland Hosp, Dept Thorac Med, N-5021 Bergen, Norway; [Aanerud, Marianne] Haukeland Hosp, Dept Med, N-5021 Bergen, Norway; [Hiemstra, Pieter S.] Leiden Univ, Med Ctr, Dept Pulmonol, Leiden, Netherlands; [Michelsen, Annika E.; Ueland, Thor; Aukrust, Pal] Oslo Univ Hosp, Rikshosp, Internal Med Res Inst, Oslo, Norway; [Aukrust, Pal] Oslo Univ Hosp, Rikshosp, Sect Clin Immunol & Infect Dis, Oslo, Norway; [Ueland, Thor; Aukrust, Pal] Univ Oslo, KG Jebsen Inflammatory Res Ctr, Oslo, Norway; [Ueland, Thor; Aukrust, Pal] Univ Oslo, Inst Clin Med, Oslo, Norway; [Hardie, Jon A.; Bakke, Per S.; Eagan, Tomas M. L.] Univ Bergen, Dept Clin Sci, Bergen, Norway	University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo; University of Oslo; University of Bergen	Persson, LJP (corresponding author), Haukeland Hosp, Dept Thorac Med, N-5021 Bergen, Norway.	louise.persson@med.uib.no	Eagan, Tomas ML/P-3554-2014; Eagan, Tomas Mikal/AHC-9127-2022; Hiemstra, Pieter S/K-8587-2018; /V-8478-2019	Eagan, Tomas ML/0000-0001-8725-9960; Hiemstra, Pieter S/0000-0002-0238-5982; 	Bergen Medical Research Foundation	Bergen Medical Research Foundation	Funding for the Vitamin D measurements was provided from an unrestricted grant from the Bergen Medical Research Foundation received by TMLE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afzal S, 2014, THORAX, V69, P24, DOI 10.1136/thoraxjnl-2013-203682; Baeke F, 2011, J IMMUNOL, V186, P132, DOI 10.4049/jimmunol.1000695; Baeke F, 2010, CURR OPIN PHARMACOL, V10, P482, DOI 10.1016/j.coph.2010.04.001; Bakke PS, 2011, EUR RESPIR J, V37, P255, DOI 10.1183/09031936.00091709; Bischoff-Ferrari HA, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3692; Black PN, 2005, CHEST, V128, P3792, DOI 10.1378/chest.128.6.3792; Calverley PMA, 2007, NEW ENGL J MED, V356, P775, DOI 10.1056/NEJMoa063070; Chalmers JD, 2013, THORAX, V68, P39, DOI 10.1136/thoraxjnl-2012-202125; Decramer M, 2008, COPD, V5, P235, DOI 10.1080/15412550802237531; Dimeloe S, 2012, THORAX, V67, P574, DOI 10.1136/thoraxjnl-2011-200651; Durup D, 2012, J CLIN ENDOCR METAB, V97, P2644, DOI 10.1210/jc.2012-1176; Eagan TML, 2010, EUR RESPIR J, V35, P540, DOI 10.1183/09031936.00088209; Gardiner JC, 2009, STAT MED, V28, P221, DOI 10.1002/sim.3478; Ginde AA, 2009, ARCH INTERN MED, V169, P384, DOI 10.1001/archinternmed.2008.560; Grimnes G, 2010, EUR J ENDOCRINOL, V163, P339, DOI 10.1530/EJE-10-0150; Holmgaard DB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053670; Hurst JR, 2010, NEW ENGL J MED, V363, P1128, DOI 10.1056/NEJMoa0909883; Janssens W, 2010, THORAX, V65, P215, DOI 10.1136/thx.2009.120659; Kongsbak M, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00148; Kunisaki KM, 2011, EUR RESPIR J, V37, P238, DOI 10.1183/09031936.00146509; Kunisaki KM, 2012, AM J RESP CRIT CARE, V185, P286, DOI 10.1164/rccm.201109-1644OC; Lange NE, 2012, AM J RESP CRIT CARE, V186, P616, DOI 10.1164/rccm.201110-1868OC; Lehouck A, 2012, ANN INTERN MED, V156, P105, DOI 10.7326/0003-4819-156-2-201201170-00004; Liu XD, 2014, AM J RESP CELL MOL, V50, P40, DOI 10.1165/rcmb.2013-0211OC; Mannino DM, 2007, LANCET, V370, P765, DOI 10.1016/S0140-6736(07)61380-4; Melamed ML, 2008, ARCH INTERN MED, V168, P1629, DOI 10.1001/archinte.168.15.1629; Persson LJP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038934; Powe CE, 2014, NEW ENGL J MED, V370, P880, DOI 10.1056/NEJMc1315850; Puhan MA, 2014, CHEST, V145, P37, DOI 10.1378/chest.13-1296; Quint JK, 2012, BMC PULM MED, V12, DOI 10.1186/1471-2466-12-28; Romme EAPM, 2013, ANN MED, V45, P91, DOI 10.3109/07853890.2012.671536; Schutz Y, 2002, INT J OBESITY, V26, pS3, DOI 10.1038/sj.ijo.0802122; Suissa S, 2006, AM J RESP CRIT CARE, V173, P842, DOI 10.1164/rccm.200508-1338PP; Tashkin DP, 2008, NEW ENGL J MED, V359, P1543, DOI 10.1056/NEJMoa0805800; Wagner PD, 2008, EUR RESPIR J, V31, P492, DOI 10.1183/09031936.00074807; Wood AM, 2011, THORAX, V66, P205, DOI 10.1136/thx.2010.140921; Yuk JM, 2009, CELL HOST MICROBE, V6, P231, DOI 10.1016/j.chom.2009.08.004; Zhang JH, 2004, J BIOL CHEM, V279, P53282, DOI 10.1074/jbc.M411462200; Zosky GR, 2011, AM J RESP CRIT CARE, V183, P1336, DOI 10.1164/rccm.201010-1596OC	39	21	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0121622	10.1371/journal.pone.0121622	http://dx.doi.org/10.1371/journal.pone.0121622			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803709	Green Submitted, Green Published, gold			2022-12-26	WOS:000353889600164
J	Wang, HD; Huang, CY; Dong, JR; Yao, YF; Xie, ZY; Liu, XY; Zhang, WJ; Fang, F; Chen, Z				Wang, Huadong; Huang, Chaoyang; Dong, Jinrong; Yao, Yanfeng; Xie, Zhenyuan; Liu, Xueying; Zhang, Wenjie; Fang, Fang; Chen, Ze			Complete Protection of Mice against Lethal Murine Cytomegalovirus Challenge by Immunization with DNA Vaccines Encoding Envelope Glycoprotein Complex III Antigens gH, gL and gO	PLOS ONE			English	Article							NEUTRALIZING ANTIBODIES; INFECTION; CELLS; DISEASE; FUSION; SPREAD; GENES; GH/GL	Human cytomegalovirus infects the majority of humanity which may lead to severe morbidity and mortality in newborns and immunocompromised adults. Humoral and cellular immunity are critical for controlling CMV infection. HCMV envelope glycoprotein complexes (gC I, II, III) represent major antigenic targets of antiviral immune responses. The gCIII complex is comprised of three glycoproteins, gH, gL, and gO. In the present study, DNA vaccines expressing the murine cytomegalovirus homologs of the gH, gL, and gO proteins were evaluated for protection against lethal MCMV infection in the mouse model. The results demonstrated that gH, gL, or gO single gene immunization could not yet offer good protection, whereas co-vaccination strategy apparently showed effects superior to separate immunization. Twice immunization with gH/gL/gO pDNAs could provide mice complete protection against lethal salivary gland-derived MCMV (SG-MCMV) challenge, while thrice immunization with pgH/pgL, pgH/pgO or pgL/pgO could not provide full protection. Co-vaccination with gH, gL and gO pDNAs elicited robust neutralizing antibody and cellular immune responses. Moreover, full protection was also achieved by simply passive immunization with anti-gH/gL/gO sera. These data demonstrated that gCIII complex antigens had fine immunogenicity and might be a promising candidate for the development of HCMV vaccines.	[Wang, Huadong; Huang, Chaoyang; Fang, Fang; Chen, Ze] Hunan Normal Univ, Coll Life Sci, Changsha 410081, Hunan, Peoples R China; [Wang, Huadong; Yao, Yanfeng] Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan 430071, Hubei, Peoples R China; [Dong, Jinrong; Liu, Xueying; Chen, Ze] Shanghai Inst Biol Prod, Shanghai 200052, Peoples R China; [Xie, Zhenyuan] Xie Tu Community Med Serv Ctr, Shanghai 200030, Peoples R China; [Zhang, Wenjie] Shanghai Jiaotong Univ Med, Xinhua Hosp, Shanghai 200092, Peoples R China	Hunan Normal University; Chinese Academy of Sciences; Wuhan Institute of Virology, CAS; Shanghai Jiao Tong University	Chen, Z (corresponding author), Hunan Normal Univ, Coll Life Sci, Changsha 410081, Hunan, Peoples R China.	chenze2005@hotmail.com			Innovation Platform Open Funds for Universities in Hunan Province [09K022, 11K010]; Cooperative Innovation Center of Engineering and New Products for Developmental Biology of Hunan Province [20134486]	Innovation Platform Open Funds for Universities in Hunan Province; Cooperative Innovation Center of Engineering and New Products for Developmental Biology of Hunan Province	This study was supported by the following research funds: The Innovation Platform Open Funds for Universities in Hunan Province (09K022 and 11K010) and the Cooperative Innovation Center of Engineering and New Products for Developmental Biology of Hunan Province (20134486). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler SP, 2009, J CLIN VIROL, V46, pS54, DOI 10.1016/j.jcv.2009.08.017; Aihara H, 1998, NAT BIOTECHNOL, V16, P867, DOI 10.1038/nbt0998-867; Arvin AM, 2004, CLIN INFECT DIS, V39, P233, DOI 10.1086/421999; Bowman JJ, 2011, J VIROL, V85, P2089, DOI 10.1128/JVI.01970-10; Britt WJ, 1996, INTERVIROLOGY, V39, P401, DOI 10.1159/000150510; Brune W, 2001, CURR PROTOC IMMUNOL, V19; Cui XH, 2013, J VIROL METHODS, V192, P44, DOI 10.1016/j.jviromet.2013.04.015; Dasari V, 2013, EXPERT REV VACCINES, V12, P661, DOI [10.1586/erv.13.46, 10.1586/ERV.13.46]; Dempsey AF, 2012, VACCINE, V30, P4060, DOI 10.1016/j.vaccine.2012.04.011; Fouts AE, 2012, J VIROL, V86, P7444, DOI 10.1128/JVI.00467-12; FOWLER KB, 1992, NEW ENGL J MED, V326, P663, DOI 10.1056/NEJM199203053261003; Geoffroy F, 1996, VACCINE, V14, P1686, DOI 10.1016/S0264-410X(96)00116-8; Griffiths P, 2013, VACCINE, V31, pB197, DOI 10.1016/j.vaccine.2012.10.074; Griffiths PD, 2002, J ANTIMICROB CHEMOTH, V49, P243, DOI 10.1093/jac/49.2.243; Hashimoto K, 2013, VACCINE, V31, P3199, DOI 10.1016/j.vaccine.2013.04.078; Heldwein EE, 2008, CELL MOL LIFE SCI, V65, P1653, DOI 10.1007/s00018-008-7570-z; Hobom U, 2000, J VIROL, V74, P7720, DOI 10.1128/JVI.74.17.7720-7729.2000; KEAY S, 1991, J VIROL, V65, P5124, DOI 10.1128/JVI.65.9.5124-5128.1991; Khanna R, 2006, TRENDS MOL MED, V12, P26, DOI 10.1016/j.molmed.2005.11.006; Klein M, 1999, J VIROL, V73, P878, DOI 10.1128/JVI.73.2.878-886.1999; Lazzarotto T, 2011, EXPERT REV ANTI-INFE, V9, P841, DOI [10.1586/eri.11.109, 10.1586/ERI.11.109]; Loomis RJ, 2013, VACCINE, V31, P919, DOI 10.1016/j.vaccine.2012.12.009; Morello CS, 2007, J VIROL, V81, P7766, DOI 10.1128/JVI.00633-07; Nigro G, 2005, NEW ENGL J MED, V353, P1350, DOI 10.1056/NEJMoa043337; Pass RF, 2009, NEW ENGL J MED, V360, P1191, DOI 10.1056/NEJMoa0804749; Qureshi MH, 2005, VIRUS RES, V114, P35, DOI 10.1016/j.virusres.2005.05.008; Shen SY, 2007, VACCINE, V25, P3319, DOI 10.1016/j.vaccine.2007.01.011; Sung H, 2010, EXPERT REV VACCINES, V9, P1303, DOI [10.1586/erv.10.125, 10.1586/ERV.10.125]; Tandon R, 2012, TRENDS MICROBIOL, V20, P392, DOI 10.1016/j.tim.2012.04.008; Theiler RN, 2002, J VIROL, V76, P2890, DOI 10.1128/JVI.76.6.2890-2898.2002; Vanarsdall AL, 2008, J VIROL, V82, P11837, DOI 10.1128/JVI.01623-08; Wang D, 2005, P NATL ACAD SCI USA, V102, P18153, DOI 10.1073/pnas.0509201102; Wang Huadong, 2013, Virologica Sinica, V28, P174, DOI 10.1007/s12250-013-3330-9; Wille PT, 2010, J VIROL, V84, P2585, DOI 10.1128/JVI.02249-09; Wussow F, 2013, J VIROL, V87, P1322, DOI 10.1128/JVI.01669-12; XW, 2005, NATURE MED, V11, P515; Zhong J, 2007, EXPERT REV ANTI-INFE, V5, P449, DOI 10.1586/14787210.5.3.449	37	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0119964	10.1371/journal.pone.0119964	http://dx.doi.org/10.1371/journal.pone.0119964			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803721	Green Published, gold, Green Submitted			2022-12-26	WOS:000353889600052
J	Wu, L; Zhou, ZY; Zhang, CG; Chai, J; Zhou, Q; Wang, L; Hirnerova, E; Mrvkova, M; Novak, O; Guo, GQ				Wu, Lei; Zhou, Zhao-Yang; Zhang, Chun-Guang; Chai, Juan; Zhou, Qin; Wang, Li; Hirnerova, Eva; Mrvkova, Michaela; Novak, Ondrej; Guo, Guang-Qin			Functional Roles of Three Cutin Biosynthetic Acyltransferases in Cytokinin Responses and Skotomorphogenesis	PLOS ONE			English	Article							SIGNAL-TRANSDUCTION; ARABIDOPSIS-THALIANA; ETHYLENE BIOSYNTHESIS; HYPOCOTYL ELONGATION; GENE; REGULATORS; RECEPTOR; ROOT; EXPRESSION; OVEREXPRESSION	Cytokinins (CKs) regulate plant development and growth via a two-component signaling pathway. By forward genetic screening, we isolated an Arabidopsis mutant named grow fast on cytokinins 1 (gfc1), whose seedlings grew larger aerial parts on MS medium with CK. gfc1 is allelic to a previously reported cutin mutant defective in cuticular ridges (dcr). GFC1/DCR encodes a soluble BAHD acyltransferase (a name based on the first four enzymes characterized in this family: Benzylalcohol O-acetyltransferase, Anthocyanin O-hydroxycinnamoyltransferase, anthranilate N-hydroxycinnamoyl/benzoyltransferase and Deacetylvindoline 4-O-acetyltransferase) with diacylglycerol acyltransferase (DGAT) activity in vitro and is necessary for normal cuticle formation on epidermis in vivo. Here we show that gfc1 was a CK-insensitive mutant, as revealed by its low regeneration frequency in vitro and resistance to CK in adventitious root formation and dark-grown hypocotyl inhibition assays. In addition, gfc1 had de-etiolated phenotypes in darkness and was therefore defective in skotomorphogenesis. The background expression levels of most type-A Arabidopsis Response Regulator (ARR) genes were higher in the gfc1 mutant. The gfc1-associated phenotypes were also observed in the cutin-deficient glycerol-3-phosphate acyltransferase 4/8 (gpat4/8) double mutant [defective in glycerol-3-phosphate (G3P) acyltransferase enzymes GPAT4 and GPAT8, which redundantly catalyze the acylation of G3P by hydroxyl fatty acid (OH-FA)], but not in the cutin- deficient mutant cytochrome p450, family 86, subfamily A, polypeptide 2/aberrant induction of type three 1 (cyp86A2/att1), which affects the biosynthesis of some OH-FAs. Our results indicate that some acyltransferases associated with cutin formation are involved in CK responses and skotomorphogenesis in Arabidopsis.	[Wu, Lei; Zhou, Zhao-Yang; Zhang, Chun-Guang; Chai, Juan; Zhou, Qin; Wang, Li; Guo, Guang-Qin] Lanzhou Univ, Sch Life Sci, MOE Key Lab Cell Act & Stress Adaptat, Lanzhou 730000, Peoples R China; [Zhang, Chun-Guang] Hebei Normal Univ, Lab Mol & Cell Biol, Shijiazhuang, Peoples R China; [Hirnerova, Eva; Mrvkova, Michaela; Novak, Ondrej] Palacky Univ, Inst Expt Bot ASCR, Ctr Reg Hana Biotechnol & Agr Res, Lab Growth Regulators, CR-77147 Olomouc, Czech Republic; [Hirnerova, Eva; Mrvkova, Michaela; Novak, Ondrej] Palacky Univ, Fac Sci, CR-77147 Olomouc, Czech Republic	Lanzhou University; Hebei Normal University; Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences; Palacky University Olomouc; Palacky University Olomouc	Guo, GQ (corresponding author), Lanzhou Univ, Sch Life Sci, MOE Key Lab Cell Act & Stress Adaptat, Lanzhou 730000, Peoples R China.	gqguo@lzu.edu.cn	NOVAK, Ondrej/F-7031-2014	NOVAK, Ondrej/0000-0003-3452-0154; Wu, Lei/0000-0002-1067-3095	Chinese National Science Foundation [31371431, 31030045]; Czech Ministry of Education grant from the National Program for Sustainability I [LO1204]	Chinese National Science Foundation(National Natural Science Foundation of China (NSFC)); Czech Ministry of Education grant from the National Program for Sustainability I	This work was supported by grants from the Chinese National Science Foundation (31371431 and 31030045) and the Czech Ministry of Education grant from the National Program for Sustainability I (LO1204). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Beisson F, 2012, CURR OPIN PLANT BIOL, V15, P329, DOI 10.1016/j.pbi.2012.03.003; CARY AJ, 1995, PLANT PHYSIOL, V107, P1075, DOI 10.1104/pp.107.4.1075; Catterou M, 2002, PLANT J, V30, P273, DOI 10.1046/j.1365-313X.2002.01286.x; Chae HS, 2003, PLANT CELL, V15, P545, DOI 10.1105/tpc.006882; CHORY J, 1994, PLANT PHYSIOL, V104, P339, DOI 10.1104/pp.104.2.339; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Colon-Carmona A, 1999, PLANT J, V20, P503, DOI 10.1046/j.1365-313x.1999.00620.x; D'Agostino IB, 2000, PLANT PHYSIOL, V124, P1706, DOI 10.1104/pp.124.4.1706; D'Agostino IB, 1999, CURR OPIN PLANT BIOL, V2, P359, DOI 10.1016/S1369-5266(99)00005-9; D'Auria JC, 2006, CURR OPIN PLANT BIOL, V9, P331, DOI 10.1016/j.pbi.2006.03.016; Dello Ioio R, 2007, CURR BIOL, V17, P678, DOI 10.1016/j.cub.2007.02.047; Dobrev PI, 2002, J CHROMATOGR A, V950, P21, DOI 10.1016/S0021-9673(02)00024-9; DOLAN L, 1993, DEVELOPMENT, V119, P71; Donnelly PM, 1999, DEV BIOL, V215, P407, DOI 10.1006/dbio.1999.9443; El-Showk S, 2013, DEVELOPMENT, V140, P1373, DOI 10.1242/dev.086371; GUZMAN P, 1990, PLANT CELL, V2, P513, DOI 10.1105/tpc.2.6.513; Haberer G, 2002, PLANT PHYSIOL, V128, P354, DOI 10.1104/pp.010773; Heyl A, 2003, CURR OPIN PLANT BIOL, V6, P480, DOI 10.1016/S1369-5266(03)00087-6; Higuchi M, 2004, P NATL ACAD SCI USA, V101, P8821, DOI 10.1073/pnas.0402887101; Hosoda K, 2002, PLANT CELL, V14, P2015, DOI 10.1105/tpc.002733; Hoyerova K, 2006, PHYTOCHEMISTRY, V67, P1151, DOI 10.1016/j.phytochem.2006.03.010; Hwang D, 2002, PLANT PHYSIOL, V129, P500, DOI 10.1104/pp.005504; Hwang I, 2001, NATURE, V413, P383, DOI 10.1038/35096500; Inagaki S, 2006, PLANT CELL, V18, P879, DOI 10.1105/tpc.105.036798; Inoue T, 2001, NATURE, V409, P1060, DOI 10.1038/35059117; Ishida K, 2008, PLANT CELL PHYSIOL, V49, P47, DOI 10.1093/pcp/pcm165; JEFFERSON RA, 1987, EMBO J, V6, P3901; Kakimoto T, 2003, ANNU REV PLANT BIOL, V54, P605, DOI 10.1146/annurev.arplant.54.031902.134802; Kamada-Nobusada T, 2009, PHYTOCHEMISTRY, V70, P444, DOI 10.1016/j.phytochem.2009.02.007; Kiba T, 2004, PLANT CELL PHYSIOL, V45, P1063, DOI 10.1093/pcp/pch128; Kiba T, 2003, PLANT CELL PHYSIOL, V44, P868, DOI 10.1093/pcp/pcg108; Kurdyukov S, 2006, PLANT CELL, V18, P321, DOI 10.1105/tpc.105.036079; Kuroha T, 2002, J EXP BOT, V53, P2193, DOI 10.1093/jxb/erf077; Laxmi A, 2006, PLANT MOL BIOL, V62, P409, DOI 10.1007/s11103-006-9032-z; Lee DJ, 2007, MOL GENET GENOMICS, V277, P115, DOI 10.1007/s00438-006-0177-x; Li YH, 2007, P NATL ACAD SCI USA, V104, P18339, DOI 10.1073/pnas.0706984104; Li-Beisson Yonghua, 2010, Arabidopsis Book, V8, pe0133, DOI [10.1199/tab.0133, 10.1199/tab.0161]; Li-Beisson Y, 2009, P NATL ACAD SCI USA, V106, P22008, DOI 10.1073/pnas.0909090106; Lochmanova G, 2008, J EXP BOT, V59, P3705, DOI 10.1093/jxb/ern220; Lohrmann J, 2001, MOL GENET GENOMICS, V265, P2, DOI 10.1007/s004380000400; MacGregor DR, 2008, PLANT CELL, V20, P2643, DOI 10.1105/tpc.107.055475; Mason MG, 2005, PLANT CELL, V17, P3007, DOI 10.1105/tpc.105.035451; MILLER CO, 1956, J AM CHEM SOC, V78, P1375, DOI 10.1021/ja01588a032; Mok DWS, 2001, ANNU REV PLANT PHYS, V52, P89, DOI 10.1146/annurev.arplant.52.1.89; Mok MC., 1994, CYTOKININS CHEM ACTI, P155, DOI DOI 10.1201/9781351071284; Molina I, 2008, PLANT J, V53, P437, DOI 10.1111/j.1365-313X.2007.03348.x; Osakabe Y, 2002, BIOCHEM BIOPH RES CO, V293, P806, DOI 10.1016/S0006-291X(02)00286-3; Panikashvili D, 2009, PLANT PHYSIOL, V151, P1773, DOI 10.1104/pp.109.143388; Pils B, 2009, PLANT PHYSIOL, V151, P782, DOI 10.1104/pp.109.139188; Piotrowska A, 2011, PHYTOCHEMISTRY, V72, P2097, DOI 10.1016/j.phytochem.2011.08.012; Rani SH, 2010, J BIOL CHEM, V285, P38337, DOI 10.1074/jbc.M110.133116; Ren B, 2009, CELL RES, V19, P1178, DOI 10.1038/cr.2009.88; Saibo NJM, 2007, PLANTA, V225, P831, DOI 10.1007/s00425-006-0395-9; Sakai H, 2000, PLANT J, V24, P703, DOI 10.1046/j.1365-313x.2000.00909.x; Sakakibara H, 2006, ANNU REV PLANT BIOL, V57, P431, DOI 10.1146/annurev.arplant.57.032905.105231; SU WP, 1995, PLANT PHYSIOL, V108, P1423, DOI 10.1104/pp.108.4.1423; Suzuki T, 2001, PLANT CELL PHYSIOL, V42, P107, DOI 10.1093/pcp/pce037; Svacinova J, 2012, PLANT METHODS, V8, DOI 10.1186/1746-4811-8-17; To JPC, 2008, TRENDS PLANT SCI, V13, P85, DOI 10.1016/j.tplants.2007.11.005; To JPC, 2004, PLANT CELL, V16, P658, DOI 10.1105/tpc.018978; Ueguchi C, 2001, PLANT CELL PHYSIOL, V42, P751, DOI 10.1093/pcp/pce094; Vogel JP, 1998, P NATL ACAD SCI USA, V95, P4766, DOI 10.1073/pnas.95.8.4766; Wellesen K, 2001, P NATL ACAD SCI USA, V98, P9694, DOI 10.1073/pnas.171285998; Werner T, 2003, PLANT CELL, V15, P2532, DOI 10.1105/tpc.014928; Xiao FM, 2004, EMBO J, V23, P2903, DOI 10.1038/sj.emboj.7600290; Yamada H, 2001, PLANT CELL PHYSIOL, V42, P1017, DOI 10.1093/pcp/pce127; Yang WL, 2010, P NATL ACAD SCI USA, V107, P12040, DOI 10.1073/pnas.0914149107; Yeats TH, 2013, PLANT PHYSIOL, V163, P5, DOI 10.1104/pp.113.222737; Zeier J, 2013, PLANT CELL ENVIRON, V36, P2085, DOI 10.1111/pce.12122; Zhang ZJ, 2009, PLANT PHYSIOL, V150, P365, DOI 10.1104/pp.109.135830	71	5	5	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0121943	10.1371/journal.pone.0121943	http://dx.doi.org/10.1371/journal.pone.0121943			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803274	gold, Green Published, Green Submitted			2022-12-26	WOS:000353889600182
J	Zhang, ML; Kong, XP; Xu, XB; Li, CL; Tian, HY; Ding, ZJ				Zhang, Maolin; Kong, Xiangpei; Xu, Xiangbo; Li, Cuiling; Tian, Huiyu; Ding, Zhaojun			Comparative Transcriptome Profiling of the Maize Primary, Crown and Seminal Root in Response to Salinity Stress	PLOS ONE			English	Article							NA+/H+ ANTIPORTER SOS1; LOB DOMAIN PROTEIN; ABIOTIC STRESS; SALT-STRESS; ZEA-MAYS; INCREASED TOLERANCE; AUXIN BIOSYNTHESIS; GENE-EXPRESSION; COLD TOLERANCE; DROUGHT	Soil salinity is a major constraint to crop growth and yield. The primary and lateral roots of Arabidopsis thaliana are known to respond differentially to a number of environmental stresses, including salinity. Although the maize root system as a whole is known to be sensitive to salinity, whether or not different structural root systems show differential growth responses to salinity stress has not yet been investigated. The maize primary root (PR) was more tolerant of salinity stress than either the crown root (CR) or the seminal root (SR). To understand the molecular mechanism of these differential growth responses, RNA-Seq analysis was conducted on cDNA prepared from the PR, CR and SR of plants either non-stressed or exposed to 100 mM NaCl for 24 h. A set of 444 genes were shown to be regulated by salinity stress, and the transcription pattern of a number of genes associated with the plant salinity stress response differed markedly between the various types of root. The pattern of transcription of the salinity-regulated genes was shown to be very diverse in the various root types. The differential transcription of these genes such as transcription factors, and the accumulation of compatible solutes such as soluble sugars probably underlie the differential growth responses to salinity stress of the three types of roots in maize.	[Zhang, Maolin; Kong, Xiangpei; Li, Cuiling; Tian, Huiyu; Ding, Zhaojun] Shandong Univ, Coll Life Sci, Key Lab Plant Cell Engn & Germplasm Innovat, Jinan 250100, Peoples R China; [Xu, Xiangbo] Shandong Acad Agr Sci, Natl Maize Improvement Subctr, Maize Inst, Natl Engn Lab Wheat & Maize, Jinan 250000, Shandong, Peoples R China	Shandong University; Shandong Academy of Agricultural Sciences	Ding, ZJ (corresponding author), Shandong Univ, Coll Life Sci, Key Lab Plant Cell Engn & Germplasm Innovat, Jinan 250100, Peoples R China.	dingzhaojun@sdu.edu.cn			National Natural Science Foundation of China [31222005, 31270327]; "1000-talents Plan" from China [11200095551303]; China Postdoctoral Science Foundation [2014T70631, 2013M540543]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); "1000-talents Plan" from China; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	Z.D. was supported by Grants from the National Natural Science Foundation of China (No. 31222005 and No. 31270327) and the "1000-talents Plan" from China for young researchers (11200095551303). X.K. was supported by the China Postdoctoral Science Foundation (No. 2014T70631 and No. 2013M540543). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal PK, 2006, PLANT CELL REP, V25, P1263, DOI 10.1007/s00299-006-0204-8; Akhtar M, 2012, J GENET, V91, P385, DOI 10.1007/s12041-012-0201-3; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Benjamini Y, 2001, ANN STAT, V29, P1165; Bowers EM, 2007, BBA-PROTEINS PROTEOM, V1774, P1500, DOI 10.1016/j.bbapap.2007.10.007; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Deak KI, 2005, PLANT J, V43, P17, DOI 10.1111/j.1365-313X.2005.02425.x; Deng XM, 2013, PHYSIOL PLANTARUM, V149, P367, DOI 10.1111/ppl.12046; Ding ZJ, 2013, TRENDS PLANT SCI, V18, P533, DOI 10.1016/j.tplants.2013.08.009; Dinneny JR, 2008, SCIENCE, V320, P942, DOI 10.1126/science.1153795; Duan LN, 2013, PLANT CELL, V25, P324, DOI 10.1105/tpc.112.107227; Fukaki H, 2009, PLANT MOL BIOL, V69, P437, DOI 10.1007/s11103-008-9417-2; Galvan-Ampudia CS, 2011, CURR OPIN PLANT BIOL, V14, P296, DOI 10.1016/j.pbi.2011.03.019; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; Griffiths J.W.R., 1983, ABSTR APPL ANAL, V130, P3, DOI DOI 10.1371/J0URNAL.P0NE.0054002; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; HENRISSAT B, 1993, BIOCHEM J, V293, P781, DOI 10.1042/bj2930781; Hochholdinger F, 2004, TRENDS PLANT SCI, V9, P42, DOI 10.1016/j.tplants.2003.11.003; Hong JH, 2013, PLANT CELL REP, V32, P971, DOI 10.1007/s00299-013-1439-9; Hong JK, 2002, PHYSIOL PLANTARUM, V114, P549, DOI 10.1034/j.1399-3054.2002.1140407.x; Ji XY, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-151; Jiang Y, 2007, J EXP BOT, V58, P3591, DOI 10.1093/jxb/erm207; KISHOR PBK, 1995, PLANT PHYSIOL, V108, P1387, DOI 10.1104/pp.108.4.1387; Kong XP, 2011, PLANT CELL ENVIRON, V34, P1291, DOI 10.1111/j.1365-3040.2011.02329.x; Lee SH, 2007, J PLANT PHYSIOL, V164, P1626, DOI 10.1016/j.jplph.2007.01.003; Liu JP, 1997, PLANT PHYSIOL, V114, P591, DOI 10.1104/pp.114.2.591; Long RC, 2013, PLANT CELL REP, V32, P1289, DOI 10.1007/s00299-013-1443-0; Majer C, 2012, PHILOS T R SOC B, V367, P1542, DOI 10.1098/rstb.2011.0238; Mao XG, 2012, J EXP BOT, V63, P2933, DOI 10.1093/jxb/err462; McLoughlin F, 2012, PLANT J, V72, P436, DOI 10.1111/j.1365-313X.2012.05089.x; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nakashima K, 2012, BBA-GENE REGUL MECH, V1819, P97, DOI 10.1016/j.bbagrm.2011.10.005; Oh SJ, 2005, PLANT PHYSIOL, V138, P341, DOI 10.1104/pp.104.059147; Olias R, 2009, PLANT CELL ENVIRON, V32, P904, DOI 10.1111/j.1365-3040.2009.01971.x; Orman-Ligeza B, 2013, TRENDS PLANT SCI, V18, P464, DOI 10.1016/j.tplants.2013.04.010; Rakwal R, 2001, GENE, V263, P189, DOI 10.1016/S0378-1119(00)00573-4; Rodriguez HG, 1997, PLANT PHYSIOL, V113, P881, DOI 10.1104/pp.113.3.881; Rosquete MR, 2013, CURR BIOL, V23, P817, DOI 10.1016/j.cub.2013.03.064; Roychoudhry S, 2013, CURR BIOL, V23, P1497, DOI 10.1016/j.cub.2013.06.034; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Scarpeci TE, 2013, PLANT MOL BIOL, V83, P265, DOI 10.1007/s11103-013-0090-8; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Seki M, 2007, CURR OPIN PLANT BIOL, V10, P296, DOI 10.1016/j.pbi.2007.04.014; Shi HZ, 2000, P NATL ACAD SCI USA, V97, P6896, DOI 10.1073/pnas.120170197; Shi HZ, 2002, PLANT CELL, V14, P465, DOI 10.1105/tpc.010371; Sun FF, 2008, PLANT PHYSIOL, V146, P178, DOI 10.1104/pp.107.109413; Swarup R, 2007, PLANT CELL, V19, P2186, DOI 10.1105/tpc.107.052100; Takasaki H, 2010, MOL GENET GENOMICS, V284, P173, DOI 10.1007/s00438-010-0557-0; Taramino G, 2007, PLANT J, V50, P649, DOI 10.1111/j.1365-313X.2007.03075.x; Umezawa T, 2006, PLANT J, V46, P171, DOI 10.1111/j.1365-313X.2006.02683.X; Vidal EA, 2013, P NATL ACAD SCI USA, V110, P12840, DOI 10.1073/pnas.1310937110; Woll K, 2005, PLANT PHYSIOL, V139, P1255, DOI 10.1104/pp.105.067330; Xiong LM, 2002, PLANT CELL, V14, pS165, DOI 10.1105/tpc.000596; Yang ZB, 2014, PLANT CELL, V26, P2889, DOI 10.1105/tpc.114.127993; Zhao J, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-110; Zhao YK, 2011, NEW PHYTOL, V189, P1122, DOI 10.1111/j.1469-8137.2010.03545.x; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329; Zhu JK, 2001, TRENDS PLANT SCI, V6, P66, DOI 10.1016/S1360-1385(00)01838-0	59	24	24	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0121222	10.1371/journal.pone.0121222	http://dx.doi.org/10.1371/journal.pone.0121222			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803026	Green Published, Green Submitted, gold			2022-12-26	WOS:000353889600139
J	Dervaux, J; Mejean, A; Brunet, P				Dervaux, Julien; Mejean, Annick; Brunet, Philippe			Irreversible Collective Migration of Cyanobacteria in Eutrophic Conditions	PLOS ONE			English	Article							VERTICAL MIGRATION; BUOYANCY; BLOOMS; METALS; LIGHT	In response to natural or anthropocentric pollutions coupled to global climate changes, microorganisms from aquatic environments can suddenly accumulate on water surface. These dense suspensions, known as blooms, are harmful to ecosystems and significantly degrade the quality of water resources. In order to determine the physico-chemical parameters involved in their formation and quantitatively predict their appearance, we successfully reproduced irreversible cyanobacterial blooms in vitro. By combining chemical, biochemical and hydrodynamic evidences, we identify a mechanism, unrelated to the presence of internal gas vesicles, allowing the sudden collective upward migration in test tubes of several cyanobacterial strains (Microcystis aeruginosa PCC 7005, Microcystis aeruginosa PCC 7806 and Synechocystis sp. PCC 6803). The final state consists in a foamy layer of biomass at the air-liquid interface, in which micro-organisms remain alive for weeks, the medium lying below being almost completely depleted of cyanobacteria. These "laboratory blooms" start with the aggregation of cells at high ionic force in cyanobacterial strains that produce anionic extracellular polymeric substances (EPS). Under appropriate conditions of nutrients and light intensity, the high photosynthetic activity within cell clusters leads the dissolved oxygen (DO) to supersaturate and to nucleate into bubbles. Trapped within the EPS, these bubbles grow until their buoyancy pulls the biomass towards the free surface. By investigating a wide range of spatially homogeneous environmental conditions (illumination, salinity, cell and nutrient concentration) we identify species-dependent thresholds and time-scales for bloom formation. We conclude on the relevance of such results for cyanobacterial bloom formation in the environment and we propose an efficient method for biomass harvesting in bioreactors.	[Dervaux, Julien; Mejean, Annick] Univ Paris 07, Lab Interdisciplinaire Energies Demain, Paris, France; [Brunet, Philippe] Univ Paris 07, Lab Mat & Syst Complexes, Paris, France	UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Dervaux, J (corresponding author), Univ Paris 07, Lab Interdisciplinaire Energies Demain, Paris, France.	dervauxjulien@wanadoo.fr			program Emergence(s) of the City of Paris	program Emergence(s) of the City of Paris	This project is funded by the program Emergence(s) of the City of Paris. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartram J., 1999, TOXIC CYANOBACTERIA, P179; BOOKER MJ, 1976, LIMNOL OCEANOGR, V21, P915, DOI 10.4319/lo.1976.21.6.0915; Briand E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029981; Cerantola S, 2000, FEMS MICROBIOL LETT, V185, P243, DOI 10.1016/S0378-1097(00)00099-9; Chaffin J.D., 2013, ADV MICROBIOLOGY, V3, P16, DOI [10.4236/aim.2013.36A003, DOI 10.4236/AIM.2013.36A003]; Chen M, 2014, SCI REP-UK, V4, DOI 10.1038/srep03998; Chorus I, 2000, MONITORING BATHING W; Coates RC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085140; De Philippis R, 1998, APPL ENVIRON MICROB, V64, P1130; De Philippis R, 1998, FEMS MICROBIOL REV, V22, P151, DOI 10.1016/S0168-6445(98)00012-6; Deacon Walsby AE, 1990, BRIT PHYCOL J, V25, P133, DOI [10.1080/00071619000650121, DOI 10.1080/00071619000650121]; Dickson A.G., 1994, HDB METH AN VAR PAR; Flewelling LJ, 2005, NATURE, V435, P755, DOI 10.1038/nature435755a; FOGG GE, 1969, PROC R SOC SER B-BIO, V173, P175, DOI 10.1098/rspb.1969.0045; FOY R H, 1976, British Phycological Journal, V11, P151; Garcia-Dominguez M, 2000, J BACTERIOL, V182, P1507, DOI 10.1128/JB.182.6.1507-1514.2000; HALLEGRAEFF GM, 1993, PHYCOLOGIA, V32, P79, DOI 10.2216/i0031-8884-32-2-79.1; Huisman J, 2004, ECOLOGY, V85, P2960, DOI 10.1890/03-0763; Jacoby JM, 2000, CAN J FISH AQUAT SCI, V57, P231, DOI 10.1139/cjfas-57-1-231; Jittawuttipoka T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055564; KLEMER AR, 1982, SCIENCE, V215, P1629, DOI 10.1126/science.215.4540.1629; Klemer AR, 1996, J PHYCOL, V32, P47, DOI 10.1111/j.0022-3646.1996.00047.x; KROMKAMP J, 1989, J GEN MICROBIOL, V135, P1933; KROMKAMP J, 1990, J PLANKTON RES, V12, P161, DOI 10.1093/plankt/12.1.161; Lehmann H, 1971, BERICHTE DTSCH BOTAN, V84, P615; Micheletti E, 2008, J APPL MICROBIOL, V105, P88, DOI 10.1111/j.1365-2672.2008.03728.x; Myers JA, 2013, BMC BIOPHYS, V6, DOI 10.1186/2046-1682-6-4; Paerl H W, 2001, ScientificWorldJournal, V1, P76; Paerl HW, 2008, SCIENCE, V320, P57, DOI 10.1126/science.1155398; Paerl HW, 2013, MICROB ECOL, V65, P995, DOI 10.1007/s00248-012-0159-y; PAERL HW, 1982, LIMNOL OCEANOGR, V27, P212, DOI 10.4319/lo.1982.27.2.0212; PAERL HW, 1988, LIMNOL OCEANOGR, V33, P823, DOI 10.4319/lo.1988.33.4_part_2.0823; Parker DL, 2000, J APPL PHYCOL, V12, P219, DOI 10.1023/A:1008195312218; Parmar A, 2011, BIORESOURCE TECHNOL, V102, P10163, DOI 10.1016/j.biortech.2011.08.030; Pereira S, 2011, MICROBIOL-SGM, V157, P451, DOI 10.1099/mic.0.041038-0; Reynolds CS, 2002, J PLANKTON RES, V24, P417, DOI 10.1093/plankt/24.5.417; REYNOLDS CS, 1975, BIOL REV, V50, P437, DOI 10.1111/j.1469-185X.1975.tb01060.x; Reynolds CS, 2006, ECOL BIODIVERS CONS, P1, DOI 10.2277/ 0521605199; SCHINDLER DW, 1974, SCIENCE, V184, P897, DOI 10.1126/science.184.4139.897; Schulze H., 1882, J PRAKT CHEM, V25, DOI [10.1002/prac.18820250142, DOI 10.1002/PRAC.18820250142]; Sivonen Kaarina, 1996, Phycologia, V35, P12, DOI 10.2216/i0031-8884-35-6S-12.1; Smith VH, 2009, TRENDS ECOL EVOL, V24, P201, DOI 10.1016/j.tree.2008.11.009; THOMAS RH, 1985, J GEN MICROBIOL, V131, P799; Tonk L, 2007, AQUAT MICROB ECOL, V46, P117, DOI 10.3354/ame046117; Visser PM, 1997, HYDROBIOLOGIA, V349, P99, DOI 10.1023/A:1003001713560; Visser PM., 2005, HARMFUL CYANOBACTERI, V3; WALSBY AE, 1994, MICROBIOL REV, V58, P94, DOI 10.1128/MMBR.58.1.94-144.1994; WALSBY AE, 1980, BRIT PHYCOL J, V15, P311, DOI 10.1080/00071618000650321; WEITKAMP DE, 1980, T AM FISH SOC, V109, P659, DOI 10.1577/1548-8659(1980)109&lt;659:ARODGS&gt;2.0.CO;2; Yang S., 2007, LIFE SCI J, V4, P28; Yang XE, 2008, J ZHEJIANG UNIV-SC B, V9, P197, DOI 10.1631/jzus.B0710626	51	26	27	3	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120906	10.1371/journal.pone.0120906	http://dx.doi.org/10.1371/journal.pone.0120906			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799424	Green Published, gold			2022-12-26	WOS:000351987300190
J	Herrmann, L; Wiegmann, C; Arsalan-Werner, A; Hilbrich, I; Jager, C; Flach, K; Suttkus, A; Lachmann, I; Arendt, T; Holzer, M				Herrmann, Lydia; Wiegmann, Caspar; Arsalan-Werner, Annika; Hilbrich, Isabel; Jaeger, Carsten; Flach, Katharina; Suttkus, Anne; Lachmann, Ingolf; Arendt, Thomas; Holzer, Max			Hook Proteins: Association with Alzheimer Pathology and Regulatory Role of Hook3 in Amyloid Beta Generation	PLOS ONE			English	Article							ENDOCYTIC TRAFFICKING; DOWN-SYNDROME; UP-REGULATION; TAU; DISEASE; DYSFUNCTION; NEURONS; TRANSPORT; NEURODEGENERATION; PATHOGENESIS	Defects in intracellular transport are implicated in the pathogenesis of Alzheimer's disease (AD). Hook proteins are a family of cytoplasmic linker proteins that participate in endosomal transport. In this study we show that Hook1 and Hook3 are expressed in neurons while Hook2 is predominantly expressed in astrocytes. Furthermore, Hook proteins are associated with pathological hallmarks in AD; Hook1 and Hook3 are localized to tau aggregates and Hook2 to glial components within amyloid plaques. Additionally, the expression of Hook3 is reduced in AD. Modelling of Hook3 deficiency in cultured cells leads to slowing of endosomal transport and increases beta-amyloid production. We propose that Hook3 plays a role in pathogenic events exacerbating AD.	[Herrmann, Lydia; Wiegmann, Caspar; Arsalan-Werner, Annika; Hilbrich, Isabel; Jaeger, Carsten; Flach, Katharina; Suttkus, Anne; Arendt, Thomas; Holzer, Max] Univ Leipzig, Paul Flechsig Inst Brain Res, Dept Mol & Cellular Mech Neurodegenerat, D-04109 Leipzig, Germany; [Lachmann, Ingolf] AJ Roboscreen GmbH, Leipzig, Germany	Leipzig University	Holzer, M (corresponding author), Univ Leipzig, Paul Flechsig Inst Brain Res, Dept Mol & Cellular Mech Neurodegenerat, D-04109 Leipzig, Germany.	max.holzer@medizin.uni-leipzig.de	Arendt, Thomas/C-8747-2012; Arsalan-Werner, Annika/AAA-6310-2019; Holzer, Max/A-1729-2008	Holzer, Max/0000-0003-1754-9932; Arendt, Thomas/0000-0003-4553-1625	EU funds (EFRE) of the Sachsische AufbauBank (SAB) [100111005]; German Research Foundation (DFG); University of Leipzig within the program of Open Access Publishing	EU funds (EFRE) of the Sachsische AufbauBank (SAB); German Research Foundation (DFG)(German Research Foundation (DFG)); University of Leipzig within the program of Open Access Publishing	http://www.dfg.de (HO2368/4-1), http://www.alzheimer-forschung.de (#06825), EU funds (EFRE) of the Sachsische AufbauBank (SAB, 100111005). We acknowledge support from the German Research Foundation (DFG) and University of Leipzig within the program of Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen OM, 2005, P NATL ACAD SCI USA, V102, P13461, DOI 10.1073/pnas.0503689102; Bielska E, 2014, J CELL BIOL, V204, P989, DOI 10.1083/jcb.201309022; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Cataldo AM, 2000, AM J PATHOL, V157, P277, DOI 10.1016/S0002-9440(10)64538-5; Cataldo AM, 1997, J NEUROSCI, V17, P6142; Cataldo AM, 1996, J NEUROSCI, V16, P186; Chia PZC, 2013, TRAFFIC, V14, P997, DOI 10.1111/tra.12088; Dai JP, 2002, BRAIN RES, V948, P138, DOI 10.1016/S0006-8993(02)03152-9; Ding QX, 2006, NEUROCHEM RES, V31, P705, DOI 10.1007/s11064-006-9071-5; Ding QX, 2005, J NEUROSCI, V25, P9171, DOI 10.1523/JNEUROSCI.3040-05.2005; Dodson SE, 2008, J NEUROSCI, V28, P12877, DOI 10.1523/JNEUROSCI.4582-08.2008; Eckermann K, 2007, J BIOL CHEM, V282, P31755, DOI 10.1074/jbc.M705282200; Flach K, 2014, BBA-MOL BASIS DIS, V1842, P1527, DOI 10.1016/j.bbadis.2014.05.029; Flach K, 2012, J BIOL CHEM, V287, P43223, DOI 10.1074/jbc.M112.396176; Fu MM, 2014, TRENDS CELL BIOL, V24, P564, DOI 10.1016/j.tcb.2014.05.002; Ginsberg SD, 2010, J ALZHEIMERS DIS, V22, P631, DOI 10.3233/JAD-2010-101080; Ginsberg SD, 2010, BIOL PSYCHIAT, V68, P885, DOI 10.1016/j.biopsych.2010.05.030; GOEDERT M, 1989, EMBO J, V8, P393, DOI 10.1002/j.1460-2075.1989.tb03390.x; Grbovic OM, 2003, J BIOL CHEM, V278, P31261, DOI 10.1074/jbc.M304122200; GREENBERG SG, 1990, P NATL ACAD SCI USA, V87, P5827, DOI 10.1073/pnas.87.15.5827; Guthrie CR, 2011, HUM MOL GENET, V20, P1989, DOI 10.1093/hmg/ddr079; Guthrie CR, 2009, HUM MOL GENET, V18, P1825, DOI 10.1093/hmg/ddp099; Holzer M, 2002, ACTA NEUROPATHOL, V104, P471, DOI 10.1007/s00401-002-0581-1; Ingelsson M, 2006, ACTA NEUROPATHOL, V112, P439, DOI 10.1007/s00401-006-0095-3; Jiang Y, 2010, P NATL ACAD SCI USA, V107, P1630, DOI 10.1073/pnas.0908953107; Kaether C, 2000, MOL BIOL CELL, V11, P1213, DOI 10.1091/mbc.11.4.1213; KHATOON S, 1994, FEBS LETT, V351, P80, DOI 10.1016/0014-5793(94)00829-9; Kimura N, 2009, J BIOL CHEM, V284, P31291, DOI 10.1074/jbc.M109.012625; Kramer H, 1999, GENETICS, V151, P675; Kramer H, 1996, J CELL BIOL, V133, P1205, DOI 10.1083/jcb.133.6.1205; Lee E, 2002, P NATL ACAD SCI USA, V99, P161, DOI 10.1073/pnas.012607799; Lewis J, 2000, NAT GENET, V25, P402, DOI 10.1038/78078; Maldonado-Baez Lymarie, 2013, Bioarchitecture, V3, P141, DOI 10.4161/bioa.26638; Moynihan KL, 2009, MOL BIOL CELL, V20, P4790, DOI 10.1091/mbc.E09-07-0560; Muhammad A, 2008, P NATL ACAD SCI USA, V105, P7327, DOI 10.1073/pnas.0802545105; Narayanan R, 2000, J NEUROBIOL, V45, P105, DOI 10.1002/1097-4695(20001105)45:2<105::AID-NEU5>3.0.CO;2-X; NILSSON E, 1990, NEUROBIOL AGING, V11, P425, DOI 10.1016/0197-4580(90)90009-O; Nixon RA, 2005, NEUROBIOL AGING, V26, P373, DOI 10.1016/j.neurobiolaging.2004.09.018; Nixon RA, 2000, ANN NY ACAD SCI, V924, P117; Nixon RA, 2006, ALZHEIMER'S DISEASE: A CENTURY OF SCIENTIFIC AND CLINICAL RESEARCH, P277; Rao MV, 2008, J NEUROSCI, V28, P12241, DOI 10.1523/JNEUROSCI.4119-08.2008; Sano H, 2007, J BIOL CHEM, V282, P7973, DOI 10.1074/jbc.M611537200; Shan X, 2006, NEUROBIOL AGING, V27, P657, DOI 10.1016/j.neurobiolaging.2005.03.022; Shotland Y, 2003, MOL MICROBIOL, V49, P1565, DOI 10.1046/j.1365-2958.2003.03668.x; Stokin GB, 2005, SCIENCE, V307, P1282, DOI 10.1126/science.1105681; Sunio A, 1999, MOL BIOL CELL, V10, P847, DOI 10.1091/mbc.10.4.847; Szebenyi G, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-19; Szebenyi G, 2007, TRAFFIC, V8, P32, DOI 10.1111/j.1600-0854.2006.00511.x; TERRY RD, 1964, AM J PATHOL, V44, P269; Tucker KL, 2001, NAT NEUROSCI, V4, P29, DOI 10.1038/82868; Walenta JH, 2001, J CELL BIOL, V152, P923, DOI 10.1083/jcb.152.5.923; Xu L, 2008, MOL BIOL CELL, V19, P5059, DOI 10.1091/mbc.E08-05-0473; YAGISHITA S, 1979, VIRCHOWS ARCH A, V382, P217, DOI 10.1007/BF01102876	53	17	17	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0119423	10.1371/journal.pone.0119423	http://dx.doi.org/10.1371/journal.pone.0119423			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799409	gold, Green Submitted, Green Published			2022-12-26	WOS:000351987300049
J	Kumari, R; Nambiar, M; Shanbagh, S; Raghavan, SC				Kumari, Rupa; Nambiar, Mridula; Shanbagh, Shaika; Raghavan, Sathees C.			Detection of G-Quadruplex DNA Using Primer Extension as a Tool	PLOS ONE			English	Article							MAJOR BREAKPOINT REGION; CHROMOSOMAL TRANSLOCATIONS; THERMOCOCCUS-LITORALIS; STABILITY; POLYMERASE; FRAGILITY; SEQUENCE; CANCER	DNA sequence and structure play a key role in imparting fragility to different regions of the genome. Recent studies have shown that non-B DNA structures play a key role in causing genomic instability, apart from their physiological roles at telomeres and promoters. Structures such as G-quadruplexes, cruciforms, and triplexes have been implicated in making DNA susceptible to breakage, resulting in genomic rearrangements. Hence, techniques that aid in the easy identification of such non-B DNA motifs will prove to be very useful in determining factors responsible for genomic instability. In this study, we provide evidence for the use of primer extension as a sensitive and specific tool to detect such altered DNA structures. We have used the G-quadruplex motif, recently characterized at the BCL2 major breakpoint region as a proof of principle to demonstrate the advantages of the technique. Our results show that pause sites corresponding to the non-B DNA are specific, since they are absent when the G-quadruplex motif is mutated and their positions change in tandem with that of the primers. The efficiency of primer extension pause sites varied according to the concentration of monovalant cations tested, which support G-quadruplex formation. Overall, our results demonstrate that primer extension is a strong in vitro tool to detect non-B DNA structures such as G-quadruplex on a plasmid DNA, which can be further adapted to identify non-B DNA structures, even at the genomic level.	[Kumari, Rupa; Nambiar, Mridula; Shanbagh, Shaika; Raghavan, Sathees C.] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Raghavan, SC (corresponding author), Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India.	sathees@biochem.iisc.ernet.in			CSIR, India [37(1400)/10/EMR-II:2010]	CSIR, India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by grants from CSIR, India [37(1400)/10/EMR-II:2010] to SCR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacolla A, 2004, J BIOL CHEM, V279, P47411, DOI 10.1074/jbc.R400028200; Bergoglio V, 2013, J CELL BIOL, V201, P395, DOI 10.1083/jcb.201207066; Bochman ML, 2012, NAT REV GENET, V13, P770, DOI 10.1038/nrg3296; FRY M, 1994, P NATL ACAD SCI USA, V91, P4950, DOI 10.1073/pnas.91.11.4950; Gopalakrishnan V, 2012, FUTURE ONCOL, V8, P1121, DOI [10.2217/FON.12.107, 10.2217/fon.12.107]; Han HY, 2000, TRENDS PHARMACOL SCI, V21, P136, DOI 10.1016/S0165-6147(00)01457-7; Han YJ, 2008, MOL CELL BIOL, V28, P863, DOI 10.1128/MCB.00960-07; Hegde ML, 2006, ARCH BIOCHEM BIOPHYS, V449, P143, DOI 10.1016/j.abb.2006.02.018; Huppert JL, 2007, NUCLEIC ACIDS RES, V35, P406, DOI 10.1093/nar/gkl1057; Katapadi VK, 2012, GENOMICS, V100, P72, DOI 10.1016/j.ygeno.2012.05.008; Kejnovska I, 2001, BBA-GEN SUBJECTS, V1527, P73, DOI 10.1016/S0304-4165(01)00150-7; KONG HM, 1993, J BIOL CHEM, V268, P1965; KORSMEYER SJ, 1992, ANNU REV IMMUNOL, V10, P785, DOI 10.1146/annurev.immunol.10.1.785; Kypr J, 2009, NUCLEIC ACIDS RES, V37, P1713, DOI 10.1093/nar/gkp026; Lam EYN, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2792; LUSTIG AJ, 1992, NUCLEIC ACIDS RES, V20, P3021, DOI 10.1093/nar/20.12.3021; MATTILA P, 1991, NUCLEIC ACIDS RES, V19, P4967, DOI 10.1093/nar/19.18.4967; Nambiar M, 2013, MOL CELL BIOL, V33, P4266, DOI 10.1128/MCB.00540-13; Nambiar M, 2013, CELL MOL LIFE SCI, V70, P1381, DOI 10.1007/s00018-012-1135-x; Nambiar M, 2011, NUCLEIC ACIDS RES, V39, P5813, DOI 10.1093/nar/gkr223; Nambiar M, 2011, NUCLEIC ACIDS RES, V39, P936, DOI 10.1093/nar/gkq824; Nambiar M, 2008, BBA-REV CANCER, V1786, P139, DOI 10.1016/j.bbcan.2008.07.005; Nilsen Timothy W, 2013, Cold Spring Harb Protoc, V2013, P1182, DOI 10.1101/pdb.prot079400; Qin Y, 2008, BIOCHIMIE, V90, P1149, DOI 10.1016/j.biochi.2008.02.020; RABBITTS TH, 1994, NATURE, V372, P143, DOI 10.1038/372143a0; Raghavan SC, 2007, FRONT BIOSCI, V12, P4402, DOI 10.2741/2397; Raghavan SC, 2005, MOL CELL BIOL, V25, P5904, DOI 10.1128/MCB.25.14.5904-5919.2005; Raghavan SC, 2004, NATURE, V428, P88, DOI 10.1038/nature02355; Rich A, 2003, NAT REV GENET, V4, P566, DOI 10.1038/nrg1115; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Siddiqui-Jain A, 2002, P NATL ACAD SCI USA, V99, P11593, DOI 10.1073/pnas.182256799; SINDEN R. R., 1994, DNA STRUCTURE FUNCTI; Srivastava M, 2012, CELL, V151, P1474, DOI 10.1016/j.cell.2012.11.054; Vasudevaraju P, 2012, J PHARM BIOALLIED SC, V4, P112, DOI 10.4103/0975-7406.94811; Zhao JH, 2010, CELL MOL LIFE SCI, V67, P43, DOI 10.1007/s00018-009-0131-2	35	15	15	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0119722	10.1371/journal.pone.0119722	http://dx.doi.org/10.1371/journal.pone.0119722			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799152	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000351987300077
J	Ma, JL; Xin, Q; Wang, XJ; Gao, M; Wang, YT; Liu, J				Ma, Jinling; Xin, Qian; Wang, Xiujie; Gao, Meng; Wang, Yutang; Liu, Jie			Prediction of Perioperative Cardiac Events through Preoperative NT-pro-BNP and cTnI after Emergent Non-Cardiac Surgery in Elderly Patients	PLOS ONE			English	Article							BRAIN NATRIURETIC PEPTIDE; ELECTIVE VASCULAR-SURGERY; C-REACTIVE PROTEIN; RISK-ASSESSMENT; TROPONIN-T; INCREMENTAL VALUE; PROGNOSTIC VALUE; TERM MORTALITY; STRATIFICATION; MARKER	Objectives Clinical risk stratification has an important function in preoperative evaluation of patients at risk for cardiac events prior to non-cardiac surgery. The aim of this study was to determine whether the combined measurement of pre-operative N-terminal pro-brain natriuretic peptide (NT-pro-BNP) and cardiac troponin I (cTnI) could provide useful prognostic information about postoperative major adverse cardiac events (MACE) within 30 days in patients aged over 60 years undergoing emergent non-cardiac surgery. Methods The study group comprised 2519 patients aged over 60 years that were undergoing emergent non-cardiac surgery between December 2007 and December 2013. NT-pro-BNP and cTnI were measured during hospital admission. The patients were monitored for MACE (cardiac death, non-fatal myocardial infarction, or cardiac arrest) during the 30-day postoperative follow-up period. Results MACE occurred in 251 patients (10.0%). Preoperative NT-pro-BNP and cTNI level were significantly higher in the individuals that experienced MACE than in those who did not (P < 0.001). The confounding factors of age, sex, co-morbidities and preoperative medications were adjusted in a multivariate logistic regression analysis. This analysis showed that preoperative NT-proBNP level > 917 pg/mL (OR 4.81, 95% CI 3.446-6.722, P < 0.001) and cTnI >= 0.07 ng/mL (OR 8.74, 95% CI 5.881-12.987, P < 0.001) remained significantly and independently associated with MACE after the adjustment of the confounding factors. Kaplan-Meier event-free survival curves demonstrated that patients with preoperative simultaneous NT-proBNP level > 917 pg/mL and cTnT >= 0.07 ng/mL had worse event-free survival than individual assessments of either biomarker. Conclusion Preoperative plasma NT-proBNP and cTnI are both independently associated with an increased risk of MACE in elderly patients after emergent non-cardiac surgery. The combination of these biomarkers provides better prognostic information than using either biomarker separately.	[Ma, Jinling; Gao, Meng; Wang, Yutang] Chinese Peoples Liberat Army Gen Hosp, Dept Geriatr Cardiol, Beijing 100853, Peoples R China; [Xin, Qian] Chinese Peoples Liberat Army Gen Hosp, Dept Cardiol, Beijing 100853, Peoples R China; [Wang, Xiujie] Zhaoyuan Peoples Hosp, Dept Radiol, Yantai, Shandong, Peoples R China; [Liu, Jie] Chinese Peoples Liberat Army Gen Hosp, Emergency Dept, Beijing 100853, Peoples R China	Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital	Ma, JL (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Geriatr Cardiol, Beijing 100853, Peoples R China.	majinling1@163.com						American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, 2009, J Am Coll Cardiol, V54, pe13, DOI 10.1016/j.jacc.2009.07.010; Ausset S, 2008, EUR J ANAESTH, V25, P158, DOI 10.1017/S0265021507001202; Biccard BM, 2012, ANAESTHESIA, V67, P389, DOI 10.1111/j.1365-2044.2011.07020.x; Borges FK, 2013, ARQ BRAS CARDIOL, V100, P561, DOI 10.5935/abc.20130090; Cardinale D, 2007, CIRCULATION, V115, P1339, DOI 10.1161/CIRCULATIONAHA.106.647008; Choi JH, 2010, HEART, V96, P56, DOI 10.1136/hrt.2009.181388; Chong CP, 2010, AM J CARDIOL, V106, P865, DOI 10.1016/j.amjcard.2010.05.012; Chong CP, 2009, AGE AGEING, V38, P168, DOI 10.1093/ageing/afn231; Clerico A, 2014, CLIN CHEM LAB MED, V52, P959, DOI 10.1515/cclm-2013-0900; Clerico A, 2014, J AM COLL CARDIOL, V63, P181, DOI 10.1016/j.jacc.2013.09.015; Daban JL, 2009, AGE AGEING, V38, P488, DOI 10.1093/ageing/afp040; DeFilippi C, 2008, AM J CARDIOL, V101, p82A, DOI 10.1016/j.amjcard.2007.11.029; Farzi S, 2013, BRIT J ANAESTH, V110, P554, DOI 10.1093/bja/aes454; Feringa HHH, 2007, HEART, V93, P226, DOI 10.1136/hrt.2006.093716; Feringa HHH, 2006, AM J CARDIOL, V98, P111, DOI 10.1016/j.amjcard.2006.01.058; Goei D, 2008, AM J CARDIOL, V101, P122, DOI 10.1016/j.amjcard.2007.07.058; Goei D, 2011, AM J CARDIOL, V107, P609, DOI 10.1016/j.amjcard.2010.10.021; Goei D, 2009, CORONARY ARTERY DIS, V20, P219, DOI 10.1097/MCA.0b013e3283219e47; Karakas M, 2013, EUR HEART J, V34, P796, DOI 10.1093/eurheartj/eht014; Karthikeyan G, 2009, J AM COLL CARDIOL, V54, P1599, DOI 10.1016/j.jacc.2009.06.028; Latini R, 2007, CIRCULATION, V116, P1242, DOI 10.1161/CIRCULATIONAHA.106.655076; Mahla E, 2007, ANESTHESIOLOGY, V106, P1088, DOI 10.1097/01.anes.0000267591.34626.b0; McFalls EO, 2008, EUR HEART J, V29, P394, DOI 10.1093/eurheartj/ehm620; Nakagawa Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092314; Omland T, 2009, NEW ENGL J MED, V361, P2538, DOI 10.1056/NEJMoa0805299; Oscarsson A, 2009, BRIT J ANAESTH, V103, P206, DOI 10.1093/bja/aep139; Owens CD, 2007, J VASC SURG, V45, P2, DOI 10.1016/j.jvs.2006.08.048; Poldermans D, 2008, J AM COLL CARDIOL, V51, P1913, DOI 10.1016/j.jacc.2008.03.005; Poldermans D, 2009, EUR HEART J, V30, P2769, DOI 10.1093/eurheartj/ehp337; Rajagopalan S, 2011, EUR J VASC ENDOVASC, V41, P657, DOI 10.1016/j.ejvs.2010.12.017; Rittoo D, 2014, J AM COLL CARDIOL, V63, P2411, DOI 10.1016/j.jacc.2014.03.027; Rodseth RN, 2008, ANAESTHESIA, V63, P1226, DOI 10.1111/j.1365-2044.2008.05574.x; Rodseth RN, 2014, J AM COLL CARDIOL, V63, P170, DOI 10.1016/j.jacc.2013.08.1630; Rodseth RN, 2011, J AM COLL CARDIOL, V58, P522, DOI 10.1016/j.jacc.2011.04.018; Schouten O, 2008, EUR HEART J, V29, P283, DOI 10.1093/eurheartj/ehm521; Schutt RC, 2009, AM J CARDIOL, V104, P137, DOI 10.1016/j.amjcard.2009.03.005; Sun JZ, 2007, AM HEART J, V154, P1021, DOI 10.1016/j.ahj.2007.07.025; Thygesen K, 2007, J AM COLL CARDIOL, V50, P2173, DOI 10.1016/j.jacc.2007.09.011; Weber M, 2013, EUR HEART J, V34, P853, DOI 10.1093/eurheartj/ehs445; Yeh HM, 2005, BRIT J SURG, V92, P1041, DOI 10.1002/bjs.4947; Yun KH, 2008, CIRC J, V72, P195, DOI 10.1253/circj.72.195	41	16	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121306	10.1371/journal.pone.0121306	http://dx.doi.org/10.1371/journal.pone.0121306			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799524	Green Published, Green Submitted, gold			2022-12-26	WOS:000351987300231
J	Marchesin, V; Montagnac, G; Chavrier, P				Marchesin, Valentina; Montagnac, Guillaume; Chavrier, Philippe			ARF6 Promotes the Formation of Rac1 and WAVE-Dependent Ventral F-Actin Rosettes in Breast Cancer Cells in Response to Epidermal Growth Factor	PLOS ONE			English	Article							TUMOR-CELLS; DOWNSTREAM ACTIVATION; INVADOPODIA FORMATION; INVASIVE ACTIVITIES; N-WASP; MEMBRANE; COMPLEX; MIGRATION; PATHWAY; ROLES	Coordination between actin cytoskeleton assembly and localized polarization of intracellular trafficking routes is crucial for cancer cell migration. ARF6 has been implicated in the endocytic recycling of surface receptors and membrane components and in actin cytoskeleton remodeling. Here we show that overexpression of an ARF6 fast-cyclingmutant inMDA-MB231 breast cancer-derived cells to mimick ARF6 hyperactivation observed in invasive breast tumors induced a striking rearrangement of the actin cytoskeleton at the ventral cell surface. This phenotype consisted in the formation of dynamic actin-based podosome rosette-like structures expanding outward as wave positive for F-actin and actin cytoskeleton regulatory components including cortactin, Arp2/3 and SCAR/WAVE complexes and upstream Rac1 regulator. Ventral rosette-like structures were similarly induced in MDA-MB-231 cells in response to epidermal growth factor (EGF) stimulation and to Rac1 hyperactivation. In addition, interference with ARF6 expression attenuated activation and plasma membrane targeting of Rac1 in response to EGF treatment. Our data suggest a role for ARF6 in linking EGF-receptor signaling to Rac1 recruitment and activation at the plasma membrane to promote breast cancer cell directed migration.	[Marchesin, Valentina; Montagnac, Guillaume; Chavrier, Philippe] Inst Curie, Res Ctr, F-75005 Paris, France; [Marchesin, Valentina; Montagnac, Guillaume; Chavrier, Philippe] CNRS, Membrane & Cytoskeleton Dynam, F-75005 Paris, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS)	Chavrier, P (corresponding author), Inst Curie, Res Ctr, F-75005 Paris, France.	philippe.chavrier@curie.fr	CHAVRIER, Philippe/AAG-2645-2020; CHAVRIER, Philippe/B-4707-2010	CHAVRIER, Philippe/0000-0002-7351-733X; CHAVRIER, Philippe/0000-0002-7351-733X	Domaine d'Interet Majeur de la Region Ile-de-France; Ligue Nationale contre le Cancer; Fondation ARC pour la Recherche contre le cancer [SL220100601356, SLR20130607099]; Institut National du Cancer [2012-1-PLBIO-02-IC-1]; Institut Curie and Centre National pour la Recherche Scientifique	Domaine d'Interet Majeur de la Region Ile-de-France(Region Ile-de-France); Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); Fondation ARC pour la Recherche contre le cancer; Institut National du Cancer(Institut National du Cancer (INCA) France); Institut Curie and Centre National pour la Recherche Scientifique	V.M. was supported by fellowships from Domaine d'Interet Majeur de la Region Ile-de-France and Ligue Nationale contre le Cancer. Funding for this work was provided by grants from Fondation ARC pour la Recherche contre le cancer [SL220100601356] and [SLR20130607099] and Institut National du Cancer [2012-1-PLBIO-02-IC-1] to P.C. and core funding from Institut Curie and Centre National pour la Recherche Scientifique. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albiges-Rizo C, 2009, J CELL SCI, V122, P3037, DOI 10.1242/jcs.052704; Artym VV, 2006, CANCER RES, V66, P3034, DOI 10.1158/0008-5472.CAN-05-2177; Bretschneider T, 2004, CURR BIOL, V14, P1, DOI 10.1016/j.cub.2003.12.005; Buccione R, 2004, NAT REV MOL CELL BIO, V5, P647, DOI 10.1038/nrm1436; Campellone KG, 2010, NAT REV MOL CELL BIO, V11, P237, DOI 10.1038/nrm2867; Case LB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026631; Caviston JP, 2014, CYTOSKELETON, V71, P380, DOI 10.1002/cm.21181; Chan AY, 1998, J CELL SCI, V111, P199; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; DesMarais V, 2009, CELL MOTIL CYTOSKEL, V66, P303, DOI 10.1002/cm.20361; Donaldson JG, 2011, NAT REV MOL CELL BIO, V12, P362, DOI 10.1038/nrm3117; Goley ED, 2006, NAT REV MOL CELL BIO, V7, P713, DOI 10.1038/nrm2026; Hashimoto S, 2004, P NATL ACAD SCI USA, V101, P6647, DOI 10.1073/pnas.0401753101; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Hu B, 2009, CANCER RES, V69, P794, DOI 10.1158/0008-5472.CAN-08-2110; Humphreys D, 2013, P NATL ACAD SCI USA, V110, P16880, DOI 10.1073/pnas.1311680110; Klein S, 2006, J BIOL CHEM, V281, P12352, DOI 10.1074/jbc.M601021200; Koo TH, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-29; Li M, 2006, CANCER RES, V66, P1583, DOI 10.1158/0008-5472.CAN-05-2424; Lizarraga F, 2009, CANCER RES, V69, P2792, DOI 10.1158/0008-5472.CAN-08-3709; Lorenz M, 2004, CURR BIOL, V14, P697, DOI 10.1016/j.cub.2004.04.008; MacGrath SM, 2012, J CELL SCI, V125, P1621, DOI 10.1242/jcs.093781; Mader CC, 2011, CANCER RES, V71, P1730, DOI 10.1158/0008-5472.CAN-10-1432; Magkou C, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2103; MARCHISIO PC, 1984, J CELL BIOL, V99, P1696, DOI 10.1083/jcb.99.5.1696; Miki H, 2000, NATURE, V408, P732, DOI 10.1038/35047107; Miki H, 1998, EMBO J, V17, P6932, DOI 10.1093/emboj/17.23.6932; Montagnac G, 2009, CURR BIOL, V19, P184, DOI 10.1016/j.cub.2008.12.043; Monteiro P, 2013, J CELL BIOL, V203, P1063, DOI 10.1083/jcb.201306162; Morishige M, 2008, NAT CELL BIOL, V10, P85, DOI 10.1038/ncb1672; Nurnberg A, 2011, NAT REV CANCER, V11, P177, DOI 10.1038/nrc3003; Onodera Y, 2005, EMBO J, V24, P963, DOI 10.1038/sj.emboj.7600588; Orth JD, 2006, CANCER RES, V66, P3603, DOI 10.1158/0008-5472.CAN-05-2916; Palacios F, 2002, NAT CELL BIOL, V4, P929, DOI 10.1038/ncb881; Palacios F, 2003, J BIOL CHEM, V278, P17395, DOI 10.1074/jbc.M300998200; Palamidessi A, 2008, CELL, V134, P135, DOI 10.1016/j.cell.2008.05.034; Poincloux R, 2009, J CELL SCI, V122, P3015, DOI 10.1242/jcs.034561; Sakurai-Yageta M, 2008, J CELL BIOL, V181, P985, DOI 10.1083/jcb.200709076; Santy LC, 2001, J CELL BIOL, V154, P599, DOI 10.1083/jcb.200104019; Santy LC, 2005, CURR BIOL, V15, P1749, DOI 10.1016/j.cub.2005.08.052; Santy LC, 2002, J BIOL CHEM, V277, P40185, DOI 10.1074/jbc.C200481200; Schnelzer A, 2000, ONCOGENE, V19, P3013, DOI 10.1038/sj.onc.1203621; Soderling SH, 2006, BIOCHEM SOC T, V34, P73, DOI 10.1042/BST0340073; Suetsugu S, 2003, DEV CELL, V5, P595, DOI 10.1016/S1534-5807(03)00297-1; Tague SE, 2004, P NATL ACAD SCI USA, V101, P9671, DOI 10.1073/pnas.0403531101; TARONE G, 1985, EXP CELL RES, V159, P141, DOI 10.1016/S0014-4827(85)80044-6; Wang WG, 2007, NAT REV CANCER, V7, P429, DOI 10.1038/nrc2148; Weiner OD, 2007, PLOS BIOL, V5, P2053, DOI 10.1371/journal.pbio.0050221; Wertheimer E, 2012, CELL SIGNAL, V24, P353, DOI 10.1016/j.cellsig.2011.08.011; Yamaguchi H, 2005, J CELL BIOL, V168, P441, DOI 10.1083/jcb.200407076; Yan C, 2003, EMBO J, V22, P3602, DOI 10.1093/emboj/cdg350	51	22	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121747	10.1371/journal.pone.0121747	http://dx.doi.org/10.1371/journal.pone.0121747			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799492	gold, Green Submitted, Green Published			2022-12-26	WOS:000351987300290
J	Ni, HM; Sheng, XH; Cui, X; Gu, MC; Liu, YH; Qi, XL; Xing, SH; Guo, Y				Ni, Hemin; Sheng, Xihui; Cui, Xu; Gu, Meichao; Liu, Yunhai; Qi, Xiaolong; Xing, Shuhan; Guo, Yong			Epidermal Growth Factor-Mediated Mitogen-Activated Protein Kinase3/1 Pathway Is Conducive to In Vitro Maturation of Sheep Oocytes	PLOS ONE			English	Article							OVARIAN GRANULOSA-CELLS; MOUSE OOCYTES; MEIOTIC MATURATION; CUMULUS CELLS; CYCLIC-GMP; DEVELOPMENTAL COMPETENCE; EMBRYONIC-DEVELOPMENT; DEPENDENT ACTIVATION; MEIOSIS RESUMPTION; BOVINE OOCYTES	Epidermal growth factor (EGF) has been shown to facilitate the in vitro maturation of sheep oocytes, and enhance embryo's capability for further development. However, such kind of molecular mechanism has not yet been elucidated. In the present study, we investigated the effect of EGF-mediated mitogen-activated protein kinases 3 and 1 (MAPK3/1) pathway on in vitro maturation of sheep oocytes. U0126, a specific inhibitor of MEK (MAPK kinase), was added into the maturation culture medium to block the EGF-mediated MAPK3/1 pathway with different doses. Then, the nuclear maturation of sheep oocytes was examined. Additionally, the effect of EGF-mediated MAPK3/1 on cytoplasmic maturation was examined though in vitro fertilization and embryonic development. The rate of germinal vesicle breakdown (GVBD) after 6 h of culture with 10(-4) mol/l of U0126 (50.4%) was significantly decreased compared with control (67.2%, p < 0.05), and the first polation body (PB1) extrusion rate after 22 h of culture in drug treatment was also significantly inhibited compared with control (28.6% vs. 48.4%, p < 0.05). However, 10(-6) mol/l U0126 had slight effect on oocyte nuclear maturation. The normal distribution rate of a-tubulin in the oocytes after 22 h of in vitro maturation was significantly decreased in the 10(-4) mol/l U0126 group (54%) compared with control (68%, p < 0.05). After in vitro fertilization, the cleavage rate in drug treatments (56.8% in 10(-6) mol/l U0126 group and 42.6% in 10(-4) mol/l U0126 group) was significantly decreased compared with control (72.3%, p < 0.01). The blastocyst rate in 10(-4) mol/l U0126 group (17.6%) was also significantly decreased compared with control (29.9%, p < 0.05). Collectively, these results suggest that EGF-mediated MAPK3/1 pathway is conducive to in vitro maturation of sheep oocytes.	[Ni, Hemin; Sheng, Xihui; Cui, Xu; Gu, Meichao; Liu, Yunhai; Qi, Xiaolong; Xing, Shuhan; Guo, Yong] Beijing Agr Univ, Anim Sci & Technol Coll, Beijing 100094, Peoples R China	Beijing University of Agriculture	Guo, Y (corresponding author), Beijing Agr Univ, Anim Sci & Technol Coll, Beijing 100094, Peoples R China.	y63guo@126.com			National Natural Science Foundation of China [31272526, 31402049]; Project of Construction of Innovative Teams and Teacher Career Development for Universities and Colleges Under Beijing Municipality [PXM2013_014207_000067]; science and technology project of Beijing Municipal Commission of Education [PXM 2014_014207_000001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Project of Construction of Innovative Teams and Teacher Career Development for Universities and Colleges Under Beijing Municipality; science and technology project of Beijing Municipal Commission of Education	This work was supported by grants from the National Natural Science Foundation of China (Grant No. 31272526, Grant No. 31402049), the Project of Construction of Innovative Teams and Teacher Career Development for Universities and Colleges Under Beijing Municipality (Grant No. PXM2013_014207_000067), and the science and technology project of Beijing Municipal Commission of Education (Grant No. PXM 2014_014207_000001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes FL, 1995, HUM REPROD, V10, P3243, DOI 10.1093/oxfordjournals.humrep.a135896; Chen J, 2013, NAT CELL BIOL, V15, P1415, DOI 10.1038/ncb2873; Choi TS, 1996, P NATL ACAD SCI USA, V93, P7032, DOI 10.1073/pnas.93.14.7032; Conti M, 2012, MOL CELL ENDOCRINOL, V356, P65, DOI 10.1016/j.mce.2011.11.002; Dedieu T, 1996, MOL REPROD DEV, V45, P351; Fan HY, 2009, SCIENCE, V324, P938, DOI 10.1126/science.1171396; Fan HY, 2003, BIOL REPROD, V68, P968, DOI 10.1095/biolreprod.102.008839; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; FERRELL JE, 1991, MOL CELL BIOL, V11, P1965, DOI 10.1128/MCB.11.4.1965; Fissore RA, 1996, BIOL REPROD, V55, P1261, DOI 10.1095/biolreprod55.6.1261; Gordo AC, 2001, MOL REPROD DEV, V59, P106, DOI 10.1002/mrd.1012; Grazul-Bilska AT, 2003, THERIOGENOLOGY, V59, P1449, DOI 10.1016/S0093-691X(02)01192-5; Guler A, 2000, THERIOGENOLOGY, V54, P209, DOI 10.1016/S0093-691X(00)00342-3; Hsieh M, 2007, MOL CELL BIOL, V27, P1914, DOI 10.1128/MCB.01919-06; INOUE M, 1995, ZYGOTE, V3, P265, DOI 10.1017/S0967199400002665; Kawamura K, 2011, HUM REPROD, V26, P3094, DOI 10.1093/humrep/der282; Kelly JM, 2008, REPROD FERT DEVELOP, V20, P570, DOI 10.1071/RD07220; Kim DH, 2004, J ASSIST REPROD GEN, V21, P233, DOI 10.1023/B:JARG.0000042008.83699.cc; Kondoh E, 2006, DEV BIOL, V293, P228, DOI 10.1016/j.ydbio.2006.02.005; Lee SE, 2007, MOL REPROD DEV, V74, P904, DOI 10.1002/mrd.20695; Li M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103347; Lu Q, 2001, BIOL REPROD, V64, P1444, DOI 10.1095/biolreprod64.5.1444; MARTINO A, 1994, THERIOGENOLOGY, V42, P859, DOI 10.1016/0093-691X(94)90454-Q; Mermillod P, 1999, J REPROD FERTIL, P449; Miyara F, 2003, HUM REPROD, V18, P1494, DOI 10.1093/humrep/deg272; MORGAN PM, 1991, BIOL REPROD, V45, P89, DOI 10.1095/biolreprod45.1.89; Norris RP, 2010, REPRODUCTION, V140, P655, DOI 10.1530/REP-10-0288; Norris RP, 2009, DEVELOPMENT, V136, P1869, DOI 10.1242/dev.035238; Park JY, 2004, SCIENCE, V303, P682, DOI 10.1126/science.1092463; Philipova R, 2005, DEVELOPMENT, V132, P579, DOI 10.1242/dev.01607; Phillips KP, 2002, DEV BIOL, V247, P210, DOI 10.1006/dbio.2002.0680; Richards JS, 2001, MOL ENDOCRINOL, V15, P209, DOI 10.1210/me.15.2.209; Robinson JW, 2012, DEV BIOL, V366, P308, DOI 10.1016/j.ydbio.2012.04.019; Sakaguchi M, 2000, THERIOGENOLOGY, V54, P1327, DOI 10.1016/S0093-691X(00)00439-8; Shabankareh HK, 2010, FERTIL STERIL, V94, P335, DOI 10.1016/j.fertnstert.2009.01.160; Su YQ, 2003, DEV BIOL, V263, P126, DOI 10.1016/S0012-1606(03)00437-8; Su YQ, 2002, ENDOCRINOLOGY, V143, P2221, DOI 10.1210/en.143.6.2221; Sun QY, 2001, BIOL REPROD, V64, P879, DOI 10.1095/biolreprod64.3.879; Trounson A, 2001, REPRODUCTION, V121, P51, DOI 10.1530/rep.0.1210051; Tsuji T, 2012, MOL REPROD DEV, V79, P795, DOI 10.1002/mrd.22114; Vaccari S, 2009, BIOL REPROD, V81, P595, DOI 10.1095/biolreprod.109.077768; VERLHAC MH, 1993, DEV BIOL, V158, P330, DOI 10.1006/dbio.1993.1192; Wang YK, 2013, ENDOCRINOLOGY, V154, P3401, DOI 10.1210/en.2013-1133; Zhang MJ, 2012, CELL MOL LIFE SCI, V69, P1279, DOI 10.1007/s00018-011-0867-3; Zhang MJ, 2010, SCIENCE, V330, P366, DOI 10.1126/science.1193573	45	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120418	10.1371/journal.pone.0120418	http://dx.doi.org/10.1371/journal.pone.0120418			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799554	Green Published, Green Submitted, gold			2022-12-26	WOS:000351987300141
J	Redondo, LM; Carrasco, JMD; Redondo, EA; Delgado, F; Miyakawa, MEF				Redondo, Leandro M.; Diaz Carrasco, Juan M.; Redondo, Enzo A.; Delgado, Fernando; Fernandez Miyakawa, Mariano E.			Clostridium perfringens Type E Virulence Traits Involved in Gut Colonization	PLOS ONE			English	Article							BINARY TOXIN; NECROTIC ENTERITIS; IOTA TOXIN; PURIFICATION; STRAINS; IDENTIFICATION; BACTERIOCINS; ADHERENCE; PROTEINS; RECEPTOR	Clostridium perfringens type E disease in ruminants has been characterized by hemorrhagic enteritis or sudden death. Although type E isolates are defined by the production of alpha and iota toxin, little is known about the pathogenesis of C. perfringens type E infections. Thus far, the role of iota toxin as a virulence factor is unknown. In this report, iota toxin showed positive effects on adherence and colonization of C. perfringens type E while having negative effect on the adherence of type A cells. In-vitro and in-vivo models suggest that toxinotype E would be particularly adapted to exploit the changes induced by iota toxin in the surface of epithelial cells. In addition, type E strains produce metabolites that affected the growth of potential intra-specific competitors. These results suggest that the alteration of the enterocyte morphology induced by iota toxin concomitantly with the specific increase of type E cell adhesion and the strong intra-specific growth inhibition of other strains could be competitive traits inherent to type E isolates that improve its fitness within the bovine gut environment.	[Redondo, Leandro M.; Diaz Carrasco, Juan M.; Redondo, Enzo A.; Delgado, Fernando; Fernandez Miyakawa, Mariano E.] Ctr Nacl Invest Agrpecuarias, Inst Nacl Tecnol Agrpecuarias, Inst Patobiol, Buenos Aires, DF, Argentina; [Redondo, Leandro M.; Diaz Carrasco, Juan M.; Redondo, Enzo A.; Fernandez Miyakawa, Mariano E.] Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina	Instituto Nacional de Tecnologia Agropecuaria (INTA); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Miyakawa, MEF (corresponding author), Ctr Nacl Invest Agrpecuarias, Inst Nacl Tecnol Agrpecuarias, Inst Patobiol, Buenos Aires, DF, Argentina.	fernandezmiyakawa.m@inta.gob.ar	Carrasco, Juan Diaz/AAO-2693-2020	Redondo, Leandro/0000-0001-6785-2812; Fernandez Miyakawa, Mariano Enrique/0000-0001-5251-4685	Instituto Nacional de Tecnologia Agropecuaria [INTA AESA-203941]; ANPCyT PICT [08/0861]; Consejo Nacional de Investigaciones Cientificas y Tecnologicas-Argentina	Instituto Nacional de Tecnologia Agropecuaria; ANPCyT PICT(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnologicas-Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	Funding for this work came from Instituto Nacional de Tecnologia Agropecuaria Grant INTA AESA-203941 and to MFM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Additonal support was provided by the Consejo Nacional de Investigaciones Cientificas y Tecnologicas-Argentina.	[Anonymous], 2014, TOXINS, DOI DOI 10.3390/T0XINS6092626; Barbara AJ, 2008, VET MICROBIOL, V126, P377, DOI 10.1016/j.vetmic.2007.07.019; Barth H, 2004, MICROBIOL MOL BIOL R, V68, P373, DOI 10.1128/MMBR.68.3.373-402.2004; BASKERVILLE M, 1980, VET REC, V107, P18, DOI 10.1136/vr.107.1.18; Carman R, 1989, MICROB ECOL HEALTH D, V2, P69; HART BARRY, 1967, AUST VET J, V43, P360, DOI 10.1111/j.1751-0813.1967.tb04882.x; Jost BH, 2006, VET MICROBIOL, V116, P158, DOI 10.1016/j.vetmic.2006.03.025; Kerr B, 2002, NATURE, V418, P171, DOI 10.1038/nature00823; Kim HY, 2013, ANAEROBE, V22, P141, DOI 10.1016/j.anaerobe.2013.06.009; KOKAIKUN JF, 1994, J CLIN MICROBIOL, V32, P2533, DOI 10.1128/JCM.32.10.2533-2539.1994; Lenski RE, 2002, P NATL ACAD SCI USA, V99, P556, DOI 10.1073/pnas.022641999; Li JH, 2007, INFECT IMMUN, V75, P1811, DOI 10.1128/IAI.01981-06; Li JH, 2014, INFECT IMMUN, V82, P4620, DOI 10.1128/IAI.02322-14; Li JH, 2006, APPL ENVIRON MICROB, V72, P4561, DOI 10.1128/AEM.00177-06; MAHONY DE, 1974, APPL MICROBIOL, V28, P172, DOI 10.1128/AEM.28.2.172-176.1974; Majeed H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063837; MARSHALL RS, 1965, APPL MICROBIOL, V13, P559, DOI 10.1128/AEM.13.4.559-563.1965; Martin TG, 2010, ANAEROBE, V16, P533, DOI 10.1016/j.anaerobe.2010.07.003; McClane BA, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 4, THIRD EDITION, P698, DOI 10.1007/0-387-30744-3_22; Meer RR, 1997, AM J VET RES, V58, P702; Miyamoto K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020376; OHISHI I, 1980, INFECT IMMUN, V30, P668; Papatheodorou P, 2012, INFECT IMMUN, V80, P1418, DOI 10.1128/IAI.06378-11; Papatheodorou P, 2011, P NATL ACAD SCI USA, V108, P16422, DOI 10.1073/pnas.1109772108; Parma YR, 2011, TOXICON, V58, P380, DOI 10.1016/j.toxicon.2011.07.009; POPOFF MR, 1989, INFECT IMMUN, V57, P2462, DOI 10.1128/IAI.57.8.2462-2469.1989; Redondo LM, 2013, ANAEROBE, V20, P1, DOI 10.1016/j.anaerobe.2013.01.001; Riley MA, 2002, ANNU REV MICROBIOL, V56, P117, DOI 10.1146/annurev.micro.56.012302.161024; Riley MA, 1999, TRENDS MICROBIOL, V7, P129, DOI 10.1016/S0966-842X(99)01459-6; Rupnik M, 2003, ANAEROBE, V9, P289, DOI 10.1016/j.anaerobe.2003.09.002; Schwan C, 2014, P NATL ACAD SCI USA, V111, P2313, DOI 10.1073/pnas.1311589111; Schwan C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000626; SIMPSON LL, 1987, INFECT IMMUN, V55, P118, DOI 10.1128/IAI.55.1.118-122.1987; Sipos W, 2003, J VET MED B, V50, P360, DOI 10.1046/j.1439-0450.2003.00690.x; Songer JG, 2004, ANAEROBE, V10, P239, DOI 10.1016/j.anaerobe.2004.05.001; Songer JG, 1996, CLIN MICROBIOL REV, V9, P216, DOI 10.1128/CMR.9.2.216; STILES BG, 1986, INFECT IMMUN, V54, P683, DOI 10.1128/IAI.54.3.683-688.1986; Timbermont L, 2014, VET RES, V45, DOI 10.1186/1297-9716-45-40; Timbermont L, 2009, VET MICROBIOL, V137, P388, DOI 10.1016/j.vetmic.2009.01.017; WATSON GN, 1985, J HYG-CAMBRIDGE, V94, P69, DOI 10.1017/S0022172400061143	40	12	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121305	10.1371/journal.pone.0121305	http://dx.doi.org/10.1371/journal.pone.0121305			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799452	Green Published, Green Submitted, gold			2022-12-26	WOS:000351987300230
J	Ross, KA; Gashugi, E; Gafasi, A; Wuest, A; Schmid, M				Ross, Kelly Ann; Gashugi, Elisee; Gafasi, Augustin; Wueest, Alfred; Schmid, Martin			Characterisation of the Subaquatic Groundwater Discharge That Maintains the Permanent Stratification within Lake Kivu; East Africa	PLOS ONE			English	Article							LATE PLEISTOCENE; WATER; HOLOCENE	Warm and cold subaquatic groundwater discharge into Lake Kivu forms the large-scale density gradients presently observed in the lake. This structure is pertinent to maintaining the stratification that locks the high volume of gases in the deepwater. Our research presents the first characterisation of these inflows. Temperature and conductivity profiling was conducted from January 2010 to March 2013 to map the locations of groundwater discharge. Water samples were obtained within the lake at the locations of the greatest temperature anomalies observed from the background lake-profile. The isotopic and chemical signatures of the groundwater were applied to assess how these inflows contribute to the overall stratification. It is inferred that Lake Kivu's deepwater has not been completely recharged by the groundwater inflows since its turnover that is speculated to have occurred within the last similar to 1000 yrs. Given a recent salinity increase in the lake constrained to within months of seismic activity measured beneath the basin, it is plausible that increased hydrothermal-groundwater inflows into the deep basin are correlated with episodic geologic events. These results invalidate the simple two-component end-member mixing regime that has been postulated up to now, and indicate the importance of monitoring this potentially explosive lake.	[Ross, Kelly Ann; Wueest, Alfred; Schmid, Martin] Eawag, Dept Surface Waters Res & Management, Swiss Fed Inst Aquat Sci & Technol, Kastanienbaum, Switzerland; [Ross, Kelly Ann] ETH, Inst Biogeochem & Pollutant Dynam, Swiss Fed Inst Technol, Zurich, Switzerland; [Gashugi, Elisee; Gafasi, Augustin] UR CST, Dept Chem, Kigali, Rwanda; [Wueest, Alfred] Ecole Polytech Fed Lausanne, Lab Phys Aquat Syst, CH-1015 Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Schmid, M (corresponding author), Eawag, Dept Surface Waters Res & Management, Swiss Fed Inst Aquat Sci & Technol, Kastanienbaum, Switzerland.	martin.schmid@eawag.ch	Wuest, Alfred/L-2607-2014; Schmid, Martin/C-3953-2009	Wuest, Alfred/0000-0001-7984-0368; Schmid, Martin/0000-0001-8699-5691	Swiss National Science Foundation; Swiss Agency for the Development and Cooperation [IZ70Z0 123923]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Agency for the Development and Cooperation	This project was financially supported by the Swiss National Science Foundation and the Swiss Agency for the Development and Cooperation under grant IZ70Z0 123923. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaberg AA, 2013, THESIS U MINNESOTA E; Anderson EI, 2008, WATER RESOUR RES, V44, DOI 10.1029/2008WR006925; Ayenew Tenalem, 2008, Lakes & Reservoirs Research and Management, V13, P181, DOI 10.1111/j.1440-1770.2008.00368.x; Bhattarai S, 2012, MICROB ECOL, V64, P291, DOI 10.1007/s00248-012-0034-x; Borges AV, 2012, AQUAT ECOL SER, V5, P47, DOI 10.1007/978-94-007-4243-7_4; Borges AV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109500; BUTTERFIELD DA, 1990, J GEOPHYS RES-SOLID, V95, P12895, DOI 10.1029/JB095iB08p12895; CHEN CTA, 1986, LIMNOL OCEANOGR, V31, P657, DOI 10.4319/lo.1986.31.3.0657; Chiodini G, 2012, B VOLCANOL, V74, P861, DOI 10.1007/s00445-011-0573-x; d'Oreye N, 2011, GEOPHYS J INT, V184, P934, DOI 10.1111/j.1365-246X.2010.04899.x; DEGENS ET, 1973, MINER DEPOSITA, V8, P388; Degens ET, 1973, GEOL RUNDSCH, V62, P245, DOI DOI 10.1007/BF01826830; Freeze R. A., 1977, GROUNDWATER; Gafasi A, 2013, THESIS U RWANDA; HABERYAN KA, 1987, PALAEOGEOGR PALAEOCL, V61, P169, DOI 10.1016/0031-0182(87)90048-4; Holz M, 2000, PHYS CHEM CHEM PHYS, V2, P4740, DOI 10.1039/b005319h; Katsev S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109084; Lorke A, 2004, LIMNOL OCEANOGR, V49, P778, DOI 10.4319/lo.2004.49.3.0778; Morgan LA, 2003, J VOLCANOL GEOTH RES, V122, P221, DOI 10.1016/S0377-0273(02)00503-6; Muvundja FA, 2014, LIMNOLOGICA, V47, P21, DOI 10.1016/j.limno.2014.02.003; Muvundja FA, 2009, J GREAT LAKES RES, V35, P406, DOI 10.1016/j.jglr.2009.06.002; Ohsawa Shinji, 2002, Limnology, V3, P169, DOI 10.1007/s102010200020; Ojiambo SB, 2003, APPL GEOCHEM, V18, P1789, DOI 10.1016/S0883-2927(03)00104-5; Pasche N, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2011JG001690; Pasche N, 2010, J PALEOLIMNOL, V44, P931, DOI 10.1007/s10933-010-9465-x; Pasche N, 2009, LIMNOL OCEANOGR, V54, P1863, DOI 10.4319/lo.2009.54.6.1863; Ross KA, 2015, J PALEOLIMN IN PRESS; Ross KA, 2014, GEOMORPHOLOGY, V221, P274, DOI 10.1016/j.geomorph.2014.05.010; Schmid M, 2005, GEOCHEM GEOPHY GEOSY, V6, DOI 10.1029/2004GC000892; Schmid M, 2012, AQUAT ECOL SER, V5, P13, DOI 10.1007/978-94-007-4243-7_2; Schmid M, 2012, J LIMNOL, V71, P330, DOI 10.4081/jlimnol.2012.e35; Schmid M, 2010, LIMNOL OCEANOGR, V55, P225, DOI 10.4319/lo.2010.55.1.0225; Sommer T, 2014, GEOPHYS RES LETT, V41, P5114, DOI 10.1002/2014GL060716; Stoffers P., 1978, INT ASS SEDIMENTOL S, V2, P43; Takano B, 2008, J VOLCANOL GEOTH RES, V178, P145, DOI 10.1016/j.jvolgeores.2008.06.038; Tassi F, 2009, GEOCHEM GEOPHY GEOSY, V10, DOI 10.1029/2008GC002191; Tierney JE, 2013, NATURE, V493, P389, DOI 10.1038/nature11785; Wauthier C, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2011JB008257; Wessel P, 1991, EOS T AM GEOPHYS UN, V72, P445, DOI [10.1029/90EO00319, DOI 10.1029/90EO00319, DOI 10.1029/90E000319]; WUEST A, 1996, LIMNOLOGY CLIMATOLOG, P183; Wuest A., 2009, MODELLING REINJECTIO	41	22	23	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121217	10.1371/journal.pone.0121217	http://dx.doi.org/10.1371/journal.pone.0121217			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799098	Green Published, Green Submitted, gold			2022-12-26	WOS:000351987300226
J	Silinski, A; Heuner, M; Schoelynck, J; Puijalon, S; Schroder, U; Fuchs, E; Troch, P; Bouma, TJ; Meire, P; Temmerman, S				Silinski, Alexandra; Heuner, Maike; Schoelynck, Jonas; Puijalon, Sara; Schroeder, Uwe; Fuchs, Elmar; Troch, Peter; Bouma, Tjeerd J.; Meire, Patrick; Temmerman, Stijn			Effects of Wind Waves versus Ship Waves on Tidal Marsh Plants: A Flume Study on Different Life Stages of Scirpus maritimus	PLOS ONE			English	Article							SALT-MARSH; RELATIVE IMPORTANCE; VEGETATION; DISTURBANCE; FEEDBACKS; STIFFNESS; SEDIMENT; SHIFTS; DRAG; FACE	Recent research indicates that many ecosystems, including intertidal marshes, follow the alternative stable states theory. This theory implies that thresholds of environmental factors can mark a limit between two opposing stable ecosystem states, e. g. vegetated marshes and bare mudflats. While elevation relative to mean sea level is considered as the overall threshold condition for colonization of mudflats by vegetation, little is known about the individual driving mechanisms, in particular the impact of waves, and more specifically of wave period. We studied the impact of different wave regimes on plants in a full scale flume experiment. Seedlings and adult shoots of the pioneer Scirpus maritimus were subjected to two wave periods at two water levels. Drag forces acting on, and sediment scouring occurring around the plants were quantified, as these are the two main mechanisms determining plant establishment and survival. Depending on life stage, two distinct survival strategies emerge: seedlings present a stress avoidance strategy by being extremely flexible, thus limiting the drag forces and thereby the risk of breaking. Adult shoots present a stress tolerance strategy by having stiffer stems, which gives them a higher resistance to breaking. These strategies work well under natural, short period wind wave conditions. For long period waves, however, caused e. g. by ships, these survival strategies have a high chance to fail as the flexibility of seedlings and stiffness of adults lead to plant tissue failure and extreme drag forces respectively. This results in both cases in strongly bent plant stems, potentially limiting their survival.	[Silinski, Alexandra; Schoelynck, Jonas; Meire, Patrick; Temmerman, Stijn] Univ Antwerp, Dept Biol, Ecosyst Management Res Grp, B-2020 Antwerp, Belgium; [Heuner, Maike; Schroeder, Uwe; Fuchs, Elmar] Fed Inst Hydrol, Koblenz, Germany; [Puijalon, Sara] Univ Lyon 1, CNRS, ENTPE, UMR 5023,LEHNA, F-69622 Villeurbanne, France; [Troch, Peter] Univ Ghent, Dept Civil Engn, B-9000 Ghent, Belgium; [Bouma, Tjeerd J.] Royal Netherlands Inst Sea Res, Yerseke, Netherlands	University of Antwerp; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Ghent University; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ)	Silinski, A (corresponding author), Univ Antwerp, Dept Biol, Ecosyst Management Res Grp, B-2020 Antwerp, Belgium.	Alexandra.Silinski@uantwerpen.be	Temmerman, Stijn/C-5521-2009; Troch, Peter/L-2463-2017; Puijalon, Sara/ABA-6520-2020	Troch, Peter/0000-0003-3274-0874; Puijalon, Sara/0000-0002-1942-7958; Bouma, Tjeerd/0000-0001-7824-7546; Schoelynck, Jonas/0000-0003-0166-280X; Temmerman, Stijn/0000-0003-3346-9115	Research Foundation Flanders (FWO) [11E0914N]; FWO Scientific Research Community on "The functioning of river ecosystems through plant-flow-soil interactions" [WO.027.11N]; Port of Antwerp; KLIWAS (Impacts of climate change on waterways and navigation-Searching for options of adaptation)	Research Foundation Flanders (FWO)(FWO); FWO Scientific Research Community on "The functioning of river ecosystems through plant-flow-soil interactions"(FWO); Port of Antwerp; KLIWAS (Impacts of climate change on waterways and navigation-Searching for options of adaptation)	This work was supported by a personal grant of Research Foundation Flanders (FWO, www.fwo.be/), grant number 11E0914N (AS); FWO Scientific Research Community on "The functioning of river ecosystems through plant-flow-soil interactions", grant number WO.027.11N (AS and MH); Port of Antwerp (www.portofantwerp.com) (AS); and KLIWAS (Impacts of climate change on waterways and navigation-Searching for options of adaptation, www.kliwas.de/KLIWAS/EN/) (MH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augustin LN, 2009, COAST ENG, V56, P332, DOI 10.1016/j.coastaleng.2008.09.004; Bal KD, 2011, FUNCT ECOL, V25, P1197, DOI 10.1111/j.1365-2435.2011.01909.x; Balke T, 2013, BIOGEOSCIENCES, V10, P5411, DOI 10.5194/bg-10-5411-2013; Balke T, 2014, J ECOL, V102, P700, DOI 10.1111/1365-2745.12241; Balke T, 2013, J APPL ECOL, V50, P740, DOI 10.1111/1365-2664.12067; Balke T, 2011, MAR ECOL PROG SER, V440, P1, DOI 10.3354/meps09364; Barbier EB, 2008, SCIENCE, V319, P321, DOI 10.1126/science.1150349; Barbier EB, 2011, ECOL MONOGR, V81, P169, DOI 10.1890/10-1510.1; Bouma TJ, 2013, GEOMORPHOLOGY, V180, P57, DOI 10.1016/j.geomorph.2012.09.005; Bouma TJ, 2009, MAR ECOL PROG SER, V388, P293, DOI 10.3354/meps08130; Bouma TJ, 2009, OIKOS, V118, P260, DOI 10.1111/j.1600-0706.2008.16892.x; Bouma TJ, 2005, ECOLOGY, V86, P2187, DOI 10.1890/04-1588; Callaghan DP, 2010, ESTUAR COAST SHELF S, V89, P73, DOI 10.1016/j.ecss.2010.05.013; Curtiss GM, 2009, MAR GEOL, V259, P73, DOI 10.1016/j.margeo.2008.12.009; Da Lio C, 2013, PHILOS T R SOC A, V371, DOI 10.1098/rsta.2012.0367; Denny MW, 2006, AQUAT ECOL, V40, P439, DOI 10.1007/s10452-004-5409-8; Fagherazzi S, 2012, REV GEOPHYS, V50, DOI 10.1029/2011RG000359; Francalanci S, 2013, GEOMORPHOLOGY, V195, P53, DOI 10.1016/j.geomorph.2013.04.026; Friess DA, 2012, BIOL REV, V87, P346, DOI 10.1111/j.1469-185X.2011.00198.x; Hamann E, 2013, ANN BOT-LONDON, V112, P1869, DOI 10.1093/aob/mct221; Henry PY, 2013, COAST ENG, V78, P13, DOI 10.1016/j.coastaleng.2013.03.004; Houser C, 2010, J COASTAL RES, V26, P230, DOI 10.2112/08-1084.1; Kirwan ML, 2013, NATURE, V504, P53, DOI 10.1038/nature12856; Kirwan ML, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL045489; Marani M, 2010, J GEOPHYS RES-EARTH, V115, DOI 10.1029/2009JF001600; Marani M, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030178; Mariotti G, 2010, J GEOPHYS RES-EARTH, V115, DOI 10.1029/2009JF001326; McConchie J.A., 2003, J HYDROL, V42, P163; Miler O, 2014, AQUAT SCI, V76, P465, DOI 10.1007/s00027-014-0347-6; Moller I, 2006, ESTUAR COAST SHELF S, V69, P337, DOI 10.1016/j.ecss.2006.05.003; Puijalon S, 2011, NEW PHYTOL, V191, P1141, DOI 10.1111/j.1469-8137.2011.03763.x; Pujol D, 2012, CONT SHELF RES, V49, P1, DOI 10.1016/j.csr.2012.09.004; Sand-Jensen K, 2003, FRESHWATER BIOL, V48, P271, DOI 10.1046/j.1365-2427.2003.00998.x; Temmerman S, 2013, NATURE, V504, P79, DOI 10.1038/nature12859; Temmerman S, 2012, GLOBAL PLANET CHANGE, V92-93, P267, DOI 10.1016/j.gloplacha.2012.06.001; Umeda S, 2011, J COASTAL RES, P845; van de Koppel J, 2005, AM NAT, V165, pE1; van Wesenbeeck BK, 2008, ECOSYSTEMS, V11, P1133, DOI 10.1007/s10021-008-9184-6; Wang C, 2013, J GEOPHYS RES-EARTH, V118, P229, DOI 10.1029/2012JF002474	39	50	55	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0118687	10.1371/journal.pone.0118687	http://dx.doi.org/10.1371/journal.pone.0118687			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799017	Green Published, Green Submitted, gold			2022-12-26	WOS:000351987300015
J	Voolstra, O; Spat, P; Oberegelsbacher, C; Claussen, B; Pfannstiel, J; Huber, A				Voolstra, Olaf; Spaet, Philipp; Oberegelsbacher, Claudia; Claussen, Bjoern; Pfannstiel, Jens; Huber, Armin			Light-Dependent Phosphorylation of the Drosophila Inactivation No Afterpotential D (INAD) Scaffolding Protein at Thr170 and Ser174 by Eye-Specific Protein Kinase C	PLOS ONE			English	Article							PDZ-DOMAIN PROTEIN; TRP CA2+ CHANNEL; SIGNALING COMPLEX; GENE; LOCALIZATION; POLYPEPTIDES; TERMINATION; REQUIRES; BINDING; NORPA	Drosophila inactivation no afterpotential D (INAD) is a PDZ domain-containing scaffolding protein that tethers components of the phototransduction cascade to form a supramolecular signaling complex. Here, we report the identification of eight INAD phosphorylation sites using a mass spectrometry approach. PDZ1, PDZ2, and PDZ4 each harbor one phosphorylation site, three phosphorylation sites are located in the linker region between PDZ1 and 2, one site is located between PDZ2 and PDZ3, and one site is located in the N-terminal region. Using a phosphospecific antibody, we found that INAD phosphorylated at Thr170/Ser174 was located within the rhabdomeres of the photoreceptor cells, suggesting that INAD becomes phosphorylated in this cellular compartment. INAD phosphorylation at Thr170/ Ser174 depends on light, the phototransduction cascade, and on eye-Protein kinase C that is attached to INAD via one of its PDZ domains.	[Voolstra, Olaf; Spaet, Philipp; Oberegelsbacher, Claudia; Claussen, Bjoern; Huber, Armin] Univ Hohenheim, Inst Physiol, Dept Biosensor, Stuttgart, Germany; [Pfannstiel, Jens; Huber, Armin] Univ Hohenheim, Mass Spectrometry Core Facil, Stuttgart, Germany	University Hohenheim; University Hohenheim	Voolstra, O (corresponding author), Univ Hohenheim, Inst Physiol, Dept Biosensor, Stuttgart, Germany.	voolstra@uni-hohenheim.de	Huber, Armin/GYU-6322-2022	Huber, Armin/0000-0003-3977-089X	Deutsche Forschungsgemeinschaft [VO 1741/1-1]; German-Israeli-Foundation for Research and Development (G.I.F. grant) [I-1001-96.13]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German-Israeli-Foundation for Research and Development (G.I.F. grant)	Funding was provided by Deutsche Forschungsgemeinschaft (VO 1741/1-1) to OV; German-Israeli-Foundation for Research and Development (G.I.F. grant I-1001-96.13) to OV, AH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamski FM, 1998, J BIOL CHEM, V273, P17713, DOI 10.1074/jbc.273.28.17713; BLOOMQUIST BT, 1988, CELL, V54, P723, DOI 10.1016/S0092-8674(88)80017-5; Chevesich J, 1997, NEURON, V18, P95, DOI 10.1016/S0896-6273(01)80049-0; Huang JH, 2010, CURR BIOL, V20, P189, DOI 10.1016/j.cub.2009.12.019; Huber A, 1998, FEBS LETT, V425, P317, DOI 10.1016/S0014-5793(98)00248-8; Huber A, 1996, EMBO J, V15, P7036, DOI 10.1002/j.1460-2075.1996.tb01095.x; Kimple ME, 2001, EMBO J, V20, P4414, DOI 10.1093/emboj/20.16.4414; Liu CH, 2007, J NEUROSCI, V27, P604, DOI 10.1523/JNEUROSCI.4099-06.2007; Liu MY, 2000, J BIOL CHEM, V275, P12194, DOI 10.1074/jbc.275.16.12194; Liu W, 2011, CELL, V145, P1088, DOI 10.1016/j.cell.2011.05.015; MATSUMOTO H, 1982, SCIENCE, V217, P839, DOI 10.1126/science.7100927; Matsumoto H, 1999, Novartis Found Symp, V224, P225; MATSUMOTO H, 1984, SCIENCE, V223, P184, DOI 10.1126/science.6419348; Matsumoto H, 1999, NOVART FDN SYMP, V224, P244; Mecklenburg KL, 2010, J NEUROSCI, V30, P1238, DOI 10.1523/JNEUROSCI.4464-09.2010; Meyer NE, 2008, FLY, V2, P36, DOI 10.4161/fly.5773; Mishra P, 2007, CELL, V131, P80, DOI 10.1016/j.cell.2007.07.037; OTOUSA JE, 1985, CELL, V40, P839, DOI 10.1016/0092-8674(85)90343-5; Pak W.L., 1979, P67; Peng L, 2008, J NEUROCHEM, V104, P1526, DOI 10.1111/j.1471-4159.2007.05096.x; SCOTT K, 1995, NEURON, V15, P919, DOI 10.1016/0896-6273(95)90182-5; Shieh BH, 1996, NEURON, V16, P991, DOI 10.1016/S0896-6273(00)80122-1; SMITH DP, 1991, SCIENCE, V254, P1478, DOI 10.1126/science.1962207; Tsunoda S, 1997, NATURE, V388, P243, DOI 10.1038/40805; van Huizen R, 1998, EMBO J, V17, P2285, DOI 10.1093/emboj/17.8.2285; Venkatachalam K, 2010, J NEUROSCI, V30, P11337, DOI 10.1523/JNEUROSCI.2709-10.2010; Voolstra O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073787; Voolstra O, 2010, J BIOL CHEM, V285, P14275, DOI 10.1074/jbc.M110.102053; Wes PD, 1999, NAT NEUROSCI, V2, P447, DOI 10.1038/8116; Xu XZS, 1998, J CELL BIOL, V142, P545, DOI 10.1083/jcb.142.2.545; Yoon J, 2000, J NEUROSCI, V20, P649, DOI 10.1523/JNEUROSCI.20-02-00649.2000	31	4	4	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0122039	10.1371/journal.pone.0122039	http://dx.doi.org/10.1371/journal.pone.0122039			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799587	Green Published, Green Submitted, gold			2022-12-26	WOS:000351987300312
J	Zhang, Y; Li, HB; Lang, X; Zhuo, CJ; Qin, W; Zhang, Q				Zhang, Yang; Li, Huabing; Lang, Xu; Zhuo, Chuanjun; Qin, Wen; Zhang, Quan			Abnormality of the Corpus Callosum in Coalmine Gas Explosion-Related Posttraumatic Stress Disorder	PLOS ONE			English	Article							STRUCTURAL BRAIN ABNORMALITIES; WHITE-MATTER INTEGRITY; PTSD; TRAUMA; VOLUME; METAANALYSIS; CONNECTIVITY; MALTREATMENT; DEPRESSION; PLASTICITY	Abnormal corpus callosum (CC) has been reported in childhood trauma-related posttraumatic stress disorder (PTSD); however, the nature of white matter (WM) integrity alterations in the CC of young adult-onset PTSD patients is unknown. In this study, 14 victims of a coal mine gas explosion with PTSD and 23 matched coal miners without experiencing the coal mine explosion were enrolled. The differences in fractional anisotropy (FA) within 7 sub-regions of the CC were compared between the two groups. Compared to the controls, PTSD coal miners exhibited significantly reduced FA values in the anterior sub-regions of the CC (P < 0.05, Bonferroni-corrected), which mainly interconnect the bilateral frontal cortices. Our findings indicated that the anterior part of the CC was more severely impaired than the posterior part in young adult-onset PTSD, which suggested the patterns of CC impairment may depend on the developmental stage of the structure when the PTSD occurs.	[Zhang, Yang; Lang, Xu; Qin, Wen; Zhang, Quan] Tianjin Med Univ, Gen Hosp, Dept Radiol, Tianjin 300052, Peoples R China; [Zhang, Yang; Lang, Xu; Qin, Wen; Zhang, Quan] Tianjin Med Univ, Gen Hosp, Tianjin Key Lab Funct Imaging, Tianjin 300052, Peoples R China; [Li, Huabing] Gen Hosp, Jinmei Grp, Dept Radiol, Jincheng 048006, Shanxi, Peoples R China; [Zhuo, Chuanjun] Anning Hosp Tianjin City, Dept Psychiat, Tianjin 300300, Peoples R China	Tianjin Medical University; Tianjin Medical University; Shanxi Medical University	Qin, W (corresponding author), Tianjin Med Univ, Gen Hosp, Dept Radiol, Tianjin 300052, Peoples R China.	wayne009007@126.com; zhangquan0912@163.com	QIN, WEN/F-3783-2015	QIN, WEN/0000-0002-9121-8296	National Basic Research Program of China (973 program) [2010CB732506]; International Cooperation and Exchanges NSFC [81061120533]; National Key Clinical Program on Radiology	National Basic Research Program of China (973 program)(National Basic Research Program of China); International Cooperation and Exchanges NSFC; National Key Clinical Program on Radiology	This work was supported by the National Basic Research Program of China (973 program, No. 2010CB732506), the International Cooperation and Exchanges NSFC (No. 81061120533), and the National Key Clinical Program on Radiology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe O, 2006, PSYCHIAT RES-NEUROIM, V146, P231, DOI 10.1016/j.pscychresns.2006.01.004; Association A.P., 2000, DIAGN STAT MAN MENT, VFourth; Bartzokis G, 2001, ARCH GEN PSYCHIAT, V58, P461, DOI 10.1001/archpsyc.58.5.461; Boulanger JJ, 2014, NEUROSCIENCE, V269, P343, DOI 10.1016/j.neuroscience.2014.03.063; Campbell DG, 2007, J GEN INTERN MED, V22, P711, DOI 10.1007/s11606-006-0101-4; CHANG KH, 1992, RADIOLOGY, V184, P117, DOI 10.1148/radiology.184.1.1609067; Clark DL, 1999, BRAIN BEHAV INTRO BE, P119; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Daniels JK, 2013, DEPRESS ANXIETY, V30, P207, DOI 10.1002/da.22044; De Bellis MD, 1999, BIOL PSYCHIAT, V45, P1271, DOI 10.1016/S0006-3223(99)00045-1; De Bellis MD, 2002, BIOL PSYCHIAT, V52, P1066, DOI 10.1016/S0006-3223(02)01459-2; de Kloet CS, 2006, J PSYCHIATR RES, V40, P550, DOI 10.1016/j.jpsychires.2005.08.002; Filipovic BR, 2011, CENT EUR NEUROSURG, V72, P133, DOI 10.1055/s-0030-1253349; Fuster JM, 2002, J NEUROCYTOL, V31, P373, DOI 10.1023/A:1024190429920; Geuze E, 2008, NEUROIMAGE, V41, P675, DOI 10.1016/j.neuroimage.2008.03.007; HAMILTON M, 1959, BRIT J MED PSYCHOL, V32, P50, DOI 10.1111/j.2044-8341.1959.tb00467.x; HAMILTON M, 1967, BRIT J SOC CLIN PSYC, V6, P278; Hughes KC, 2011, EXPERT REV NEUROTHER, V11, P275, DOI 10.1586/ERN.10.198; INNOCETI GM, 1974, EXP BRAIN RES, V19, P447; Jackowski AP, 2008, PSYCHIAT RES-NEUROIM, V162, P256, DOI 10.1016/j.pscychresns.2007.08.006; Jang SH, 2011, NEUROREHABILITATION, V29, P339, DOI 10.3233/NRE-2011-0710; Karl A, 2006, NEUROSCI BIOBEHAV R, V30, P1004, DOI 10.1016/j.neubiorev.2006.03.004; Kim MJ, 2005, NEUROREPORT, V16, P1049, DOI 10.1097/00001756-200507130-00004; Kim SJ, 2006, NEUROPSYCHOBIOLOGY, V54, P120, DOI 10.1159/000098262; Kroes MCW, 2011, J PSYCHIATR NEUROSCI, V36, P256, DOI 10.1503/jpn.100077; Kuhn S, 2013, BIOL PSYCHIAT, V73, P70, DOI 10.1016/j.biopsych.2012.06.029; Kuo JR, 2012, ARCH GEN PSYCHIAT, V69, P1080, DOI 10.1001/archgenpsychiatry.2012.73; Liberzon I, 2007, PROG BRAIN RES, V167, P151, DOI 10.1016/S0079-6123(07)67011-3; Lu SJ, 2013, AUST NZ J PSYCHIAT, V47, P1183, DOI 10.1177/0004867413508454; Nathan PJ, 2011, CURR OPIN PHARMACOL, V11, P540, DOI 10.1016/j.coph.2011.06.008; Oosthuizen Frasia, 2005, Neuropsychiatr Dis Treat, V1, P109, DOI 10.2147/nedt.1.2.109.61049; PUJOL J, 1993, ANN NEUROL, V34, P71, DOI 10.1002/ana.410340113; Pupo MC, 2011, PSYCHIAT RES, V185, P157, DOI 10.1016/j.psychres.2009.11.006; Saar-Ashkenazy R, 2014, J TRAUMA STRESS, V27, P18, DOI 10.1002/jts.21887; Schuff N, 2011, NEUROIMAGE, V54, pS62, DOI 10.1016/j.neuroimage.2010.05.024; Sripada RK, 2012, J PSYCHIATR NEUROSCI, V37, P241, DOI 10.1503/jpn.110069; Teicher MH, 2010, AM J PSYCHIAT, V167, P1464, DOI 10.1176/appi.ajp.2010.10010030; Teicher MH, 2004, BIOL PSYCHIAT, V56, P80, DOI 10.1016/j.biopsych.2004.03.016; Teicher MH, 2003, NEUROSCI BIOBEHAV R, V27, P33, DOI 10.1016/S0149-7634(03)00007-1; Teicher MH, 2002, PSYCHIAT CLIN N AM, V25, P397, DOI 10.1016/S0193-953X(01)00003-X; Vos SB, 2011, NEUROIMAGE, V55, P1566, DOI 10.1016/j.neuroimage.2011.01.048; Wang HH, 2010, J PSYCHIATR RES, V44, P385, DOI 10.1016/j.jpsychires.2009.10.001; WITELSON SF, 1989, BRAIN, V112, P799, DOI 10.1093/brain/112.3.799; Woon FL, 2010, PROG NEURO-PSYCHOPH, V34, P1181, DOI 10.1016/j.pnpbp.2010.06.016; YAZGAN MY, 1995, NEUROPSYCHOLOGIA, V33, P769, DOI 10.1016/0028-3932(95)00018-X; Yehuda R, 2007, NEURON, V56, P19, DOI 10.1016/j.neuron.2007.09.006; Zhang L, 2011, J AFFECT DISORDERS, V133, P294, DOI 10.1016/j.jad.2011.03.040	47	8	9	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121095	10.1371/journal.pone.0121095	http://dx.doi.org/10.1371/journal.pone.0121095			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE6ZS	25799310	gold, Green Published, Green Submitted			2022-12-26	WOS:000351987300208
J	Zhu, YH; He, ZJ; Chen, SJ				Zhu, Yuhong; He, Zhaojian; Chen, Shi-Jie			TBI Server: A Web Server for Predicting Ion Effects in RNA Folding	PLOS ONE			English	Article							TERTIARY STRUCTURE; HELIX STABILITY; BINDING; POLYELECTROLYTE; DEPENDENCE; VALENCE; CHAIN; SIZE	Background Metal ions play a critical role in the stabilization of RNA structures. Therefore, accurate prediction of the ion effects in RNA folding can have a far-reaching impact on our understanding of RNA structure and function. Multivalent ions, especially Mg2+, are essential for RNA tertiary structure formation. These ions can possibly become strongly correlated in the close vicinity of RNA surface. Most of the currently available software packages, which have widespread success in predicting ion effects in biomolecular systems, however, do not explicitly account for the ion correlation effect. Therefore, it is important to develop a software package/web server for the prediction of ion electrostatics in RNA folding by including ion correlation effects. Results The TBI web server http://rna.physics.missouri.edu/tbi_index.html provides predictions for the total electrostatic free energy, the different free energy components, and the mean number and the most probable distributions of the bound ions. A novel feature of the TBI server is its ability to account for ion correlation and ion distribution fluctuation effects. Conclusions By accounting for the ion correlation and fluctuation effects, the TBI server is a unique online tool for computing ion-mediated electrostatic properties for given RNA structures. The results can provide important data for in-depth analysis for ion effects in RNA folding including the ion-dependence of folding stability, ion uptake in the folding process, and the interplay between the different energetic components.	[Zhu, Yuhong; He, Zhaojian; Chen, Shi-Jie] Univ Missouri, Dept Phys, Dept Biochem, Columbia, MO 65211 USA; [Zhu, Yuhong; He, Zhaojian; Chen, Shi-Jie] Univ Missouri, Inst Informat, Columbia, MO 65211 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Chen, SJ (corresponding author), Univ Missouri, Dept Phys, Dept Biochem, Columbia, MO 65211 USA.	chenshi@missouri.edu		Chen, Shi-Jie/0000-0002-8093-7244	National Institutes of Health [GM063732]; National Science Foundation [MCB0920411]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063732] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by National Institutes of Health grant GM063732 and National Science Foundation grant MCB0920411. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker N, 2000, J COMPUT CHEM, V21, P1343, DOI 10.1002/1096-987X(20001130)21:15<1343::AID-JCC2>3.0.CO;2-K; Bowman JC, 2012, CURR OPIN STRUC BIOL, V22, P262, DOI 10.1016/j.sbi.2012.04.006; Chen AA, 2009, METHOD ENZYMOL, V469, P411, DOI 10.1016/S0076-6879(09)69020-0; Draper DE, 2005, ANNU REV BIOPH BIOM, V34, P221, DOI 10.1146/annurev.biophys.34.040204.144511; Draper DE, 2004, RNA, V10, P335, DOI 10.1261/rna.5205404; Fiore JL, 2012, J MOL BIOL, V423, P198, DOI 10.1016/j.jmb.2012.07.006; Grilley D, 2007, BIOCHEMISTRY-US, V46, P10266, DOI 10.1021/bi062284r; Ha BY, 2003, MACROMOLECULES, V36, P9658, DOI 10.1021/ma021226k; Harris RC, 2014, J CHEM PHYS, V140, DOI 10.1063/1.4864460; He ZJ, 2014, PHYS CHEM CHEM PHYS, V16, P6367, DOI 10.1039/c3cp53655f; He ZJ, 2012, J CHEM THEORY COMPUT, V8, P2095, DOI 10.1021/ct300227a; Holland JA, 1999, RNA, V5, P257, DOI 10.1017/S1355838299981360; Hou TJ, 2011, J CHEM INF MODEL, V51, P69, DOI 10.1021/ci100275a; Kirmizialtin S, 2012, BIOPHYS J, V102, P819, DOI 10.1016/j.bpj.2012.01.013; Leipply D, 2010, BIOCHEMISTRY-US, V49, P1843, DOI 10.1021/bi902036j; Leipply D, 2009, METHOD ENZYMOL, V469, P433, DOI 10.1016/S0076-6879(09)69021-2; Li L, 2012, BMC BIOPHYS, V5, DOI 10.1186/2046-1682-5-9; Li PTX, 2009, J MOL BIOL, V386, P1343, DOI 10.1016/j.jmb.2009.01.023; Misra VK, 2003, BIOPOLYMERS, V69, P118, DOI 10.1002/bip.10353; Misra VK, 2002, J MOL BIOL, V317, P507, DOI 10.1006/jmbi.2002.5422; Moghaddam S, 2009, J MOL BIOL, V393, P753, DOI 10.1016/j.jmb.2009.08.044; Qiu XY, 2013, BIOPHYS J, V105, P984, DOI 10.1016/j.bpj.2013.07.004; Qiu XY, 2010, P NATL ACAD SCI USA, V107, P21482, DOI 10.1073/pnas.1003374107; Schroeder R, 2004, NAT REV MOL CELL BIO, V5, P908, DOI 10.1038/nrm1497; Tan ZJ, 2008, BIOPHYS J, V94, P3137, DOI 10.1529/biophysj.107.122366; Tan ZJ, 2007, BIOPHYS J, V92, P3615, DOI 10.1529/biophysj.106.100388; Tan ZJ, 2011, METAL IONS LIFE SCI, V9, P101, DOI 10.1039/978184973251200101; Tan ZJ, 2011, BIOPHYS J, V101, P176, DOI 10.1016/j.bpj.2011.05.050; Tan ZJ, 2010, BIOPHYS J, V99, P1565, DOI 10.1016/j.bpj.2010.06.029; Tan ZJ, 2006, BIOPHYS J, V90, P1175, DOI 10.1529/biophysj.105.070904; Tan ZJ, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1842059; Woodson SA, 2005, CURR OPIN CHEM BIOL, V9, P104, DOI 10.1016/j.cbpa.2005.02.004; Xu XJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107504; Zhou HX, 2010, BIOPHYS J, V98, pL15, DOI 10.1016/j.bpj.2009.11.029; Zhu YH, 2014, J CHEM PHYS, V141, DOI 10.1063/1.4890656	35	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0119705	10.1371/journal.pone.0119705	http://dx.doi.org/10.1371/journal.pone.0119705			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798933	Green Published, Green Submitted, gold			2022-12-26	WOS:000351987300075
J	Binda, C; Robinson, RM; del Campo, JSM; Keul, ND; Rodriguez, PJ; Robinson, HH; Mattevi, A; Sobrado, P				Binda, Claudia; Robinson, Reeder M.; del Campo, Julia S. Martin; Keul, Nicholas D.; Rodriguez, Pedro J.; Robinson, Howard H.; Mattevi, Andrea; Sobrado, Pablo			An Unprecedented NADPH Domain Conformation in Lysine Monooxygenase NbtG Provides Insights into Uncoupling of Oxygen Consumption from Substrate Hydroxylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORNITHINE-HYDROXYLASE; PSEUDOMONAS-AERUGINOSA; PHENYLACETONE MONOOXYGENASE; CYCLOHEXANONE MONOOXYGENASE; KINETIC MECHANISM; FLAVIN; IDENTIFICATION; BIOSYNTHESIS; SELECTIVITY; PROTEINS	N-Hydroxylating monooxygenases are involved in the biosynthesis of iron-chelating hydroxamate-containing siderophores that play a role in microbial virulence. These flavoenzymes catalyze the NADPH- and oxygen-dependent hydroxylation of amines such as those found on the side chains of lysine and ornithine. In this work we report the biochemical and structural characterization of Nocardia farcinica Lys monooxygenase (NbtG), which has similar biochemical properties to mycobacterial homologs. NbtG is also active on D-Lys, although it binds L-Lys with a higher affinity. Differently from the ornithine monooxygenases PvdA, SidA, andKtzI, NbtG can use both NADH and NADPH and is highly uncoupled, producing more superoxide and hydrogen peroxide than hydroxylated Lys. The crystal structure of NbtG solved at 2.4 angstrom resolution revealed an unexpected protein conformation with a 30 degrees rotation of the NAD(P)H domain with respect to the flavin adenine dinucleotide (FAD) domain that precludes binding of the nicotinamide cofactor. This "occluded" structure may explain the biochemical properties of NbtG, specifically with regard to the substantial uncoupling and limited stabilization of the C4a-hydroperoxyflavin intermediate. Biological implications of these findings are discussed.	[Binda, Claudia; Mattevi, Andrea] Univ Pavia, Dept Biol & Biotechnol, I-27100 Pavia, Italy; [Robinson, Reeder M.; del Campo, Julia S. Martin; Keul, Nicholas D.; Rodriguez, Pedro J.; Sobrado, Pablo] Virginia Tech, Dept Biochem, Blacksburg, VA 24061 USA; [Robinson, Howard H.] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA	University of Pavia; Virginia Polytechnic Institute & State University; United States Department of Energy (DOE); Brookhaven National Laboratory	Mattevi, A (corresponding author), Univ Pavia, Dept Biol & Biotechnol, I-27100 Pavia, Italy.	andrea.mattevi@unipv.it; psobrado@vt.edu	Mattevi, Andrea/R-4469-2019; mattevi, andrea/K-5464-2012	Mattevi, Andrea/0000-0002-9523-7128; mattevi, andrea/0000-0002-9523-7128; S. Martin del Campo, Julia/0000-0001-8914-2504; Keul, Nicholas/0000-0002-5302-006X; Binda, Claudia/0000-0003-2038-9845	BioStruct-X program [5275]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR012408] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103473] Funding Source: NIH RePORTER; Direct For Biological Sciences [1021384] Funding Source: National Science Foundation	BioStruct-X program; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank the European Synchrotron Radiation Facility (ESRF) and the Swiss Light Source (SLS) for providing beam time and assistance and the BioStruct-X program (project 5275) for funding synchrotron trips. We thank the anonymous reviewers for suggestions.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alfieri A, 2008, P NATL ACAD SCI USA, V105, P6572, DOI 10.1073/pnas.0800859105; Barona-Gomez F, 2004, J AM CHEM SOC, V126, P16282, DOI 10.1021/ja045774k; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; BEATY NB, 1981, J BIOL CHEM, V256, P4619; Chocklett SW, 2010, BIOCHEMISTRY-US, V49, P6777, DOI 10.1021/bi100291n; CSAKY TZ, 1948, ACTA CHEM SCAND, V2, P450, DOI 10.3891/acta.chem.scand.02-0450; De Voss JJ, 2000, P NATL ACAD SCI USA, V97, P1252, DOI 10.1073/pnas.97.3.1252; Dhatwalia R, 2012, J AM CHEM SOC, V134, P18132, DOI 10.1021/ja308188z; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Dudek HM, 2010, APPL MICROBIOL BIOT, V88, P1135, DOI 10.1007/s00253-010-2769-y; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fox Brian G, 2009, Curr Protoc Protein Sci, VChapter 5, DOI 10.1002/0471140864.ps0523s56; Franceschini S, 2012, BIOCHEMISTRY-US, V51, P7043, DOI 10.1021/bi301072w; Goldschmidt L, 2007, PROTEIN SCI, V16, P1569, DOI 10.1110/ps.072914007; Hayward S, 1998, PROTEINS, V30, P144, DOI 10.1002/(SICI)1097-0134(19980201)30:2<144::AID-PROT4>3.0.CO;2-N; Heemstra JR, 2009, J AM CHEM SOC, V131, P15317, DOI 10.1021/ja9056008; Hissen AHT, 2005, INFECT IMMUN, V73, P5493, DOI 10.1128/IAI.73.9.5493-5503.2005; Hoshino Y, 2011, J BACTERIOL, V193, P441, DOI 10.1128/JB.00897-10; JEONG SS, 1994, ANAL BIOCHEM, V221, P273, DOI 10.1006/abio.1994.1411; Kang HY, 1996, J BACTERIOL, V178, P4877, DOI 10.1128/jb.178.16.4877-4884.1996; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Lynch D, 2001, J BACTERIOL, V183, P2576, DOI 10.1128/JB.183.8.2576-2585.2001; MACHEROUX P, 1993, EUR J BIOCHEM, V213, P995, DOI 10.1111/j.1432-1033.1993.tb17846.x; Malito E, 2004, P NATL ACAD SCI USA, V101, P13157, DOI 10.1073/pnas.0404538101; Mayfield JA, 2010, J BIOL CHEM, V285, P30375, DOI 10.1074/jbc.M110.157578; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Meneely KM, 2007, BIOCHEMISTRY-US, V46, P11930, DOI 10.1021/bi700932q; Meneely KM, 2009, BIOCHEMISTRY-US, V48, P4371, DOI 10.1021/bi900442z; Mirza IA, 2009, J AM CHEM SOC, V131, P8848, DOI 10.1021/ja9010578; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Olucha J, 2011, BIOORG CHEM, V39, P171, DOI 10.1016/j.bioorg.2011.07.006; Olucha J, 2011, J BIOL CHEM, V286, P31789, DOI 10.1074/jbc.M111.265876; Orru R, 2011, J BIOL CHEM, V286, P29284, DOI 10.1074/jbc.M111.255075; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Pazmino DET, 2008, BIOCHEMISTRY-US, V47, P4082, DOI 10.1021/bi702296k; Plattner H J, 1989, Biol Met, V2, P1, DOI 10.1007/BF01116193; Robinson R, 2014, BBA-PROTEINS PROTEOM, V1844, P778, DOI 10.1016/j.bbapap.2014.02.005; Robinson R, 2011, BIOCHEMISTRY-US, V50, P8489, DOI 10.1021/bi200933h; Robinson RM, 2014, ARCH BIOCHEM BIOPHYS, V550, P58, DOI 10.1016/j.abb.2014.04.006; Romero E, 2012, BBA-PROTEINS PROTEOM, V1824, P850, DOI 10.1016/j.bbapap.2012.03.004; Setser JW, 2014, BIOCHEMISTRY-US, V53, P6063, DOI 10.1021/bi500655q; Sheng DW, 2001, BIOCHEMISTRY-US, V40, P11156, DOI 10.1021/bi011153h; Takase H, 2000, INFECT IMMUN, V68, P1834, DOI 10.1128/IAI.68.4.1834-1839.2000; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	45	32	32	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2015	290	20					12676	12688		10.1074/jbc.M114.629485	http://dx.doi.org/10.1074/jbc.M114.629485			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI2IF	25802330	Green Published, hybrid, Green Submitted			2022-12-26	WOS:000354569000021
J	Wright, DS; Pierotti, MER; Rundle, HD; McKinnon, JS				Wright, Daniel Shane; Pierotti, Michele E. R.; Rundle, Howard D.; McKinnon, Jeffrey S.			Conspicuous Female Ornamentation and Tests of Male Mate Preference in Threespine Sticklebacks (Gasterosteus aculeatus)	PLOS ONE			English	Article							RED THROAT COLORATION; SEXUAL SELECTION; 3-SPINED STICKLEBACK; MALE CHOICE; PATTERN; MAINTENANCE; POPULATIONS; SPECIATION; EVOLUTION; BEHAVIOR	Sexual selection drives the evolution of exaggerated male ornaments in many animal species. Female ornamentation is now acknowledged also to be common but is generally less well understood. One example is the recently documented red female throat coloration in some threespine stickleback (Gasterosteus aculeatus) populations. Although female sticklebacks often exhibit a preference for red male throat coloration, the possibility of sexual selection on female coloration has been little studied. Using sequential and simultaneous mate choice trials, we examined male mate preferences for female throat color, as well as pelvic spine color and standard length, using wild-captured threespine sticklebacks from the Little Campbell River, British Columbia. In a multivariate analysis, we found no evidence for a population-level mate preference in males, suggesting the absence of directional sexual selection on these traits arising from male mate choice. Significant variation was detected among males in their preference functions, but this appeared to arise from differences in their mean responsiveness across mating trials and not from variation in the strength (i.e., slope) of their preference, suggesting the absence of individual-level preferences as well. When presented with conspecific intruder males, male response decreased as intruder red throat coloration increased, suggesting that males can discriminate color and other aspects of phenotype in our experiment and that males may use these traits in intrasexual interactions. The results presented here are the first to explicitly address male preference for female throat color in threespine sticklebacks.	[Wright, Daniel Shane; Pierotti, Michele E. R.; McKinnon, Jeffrey S.] E Carolina Univ, Dept Biol & Ctr Biodivers, Greenville, NC USA; [Rundle, Howard D.] Univ Ottawa, Dept Biol, Ottawa, ON, Canada	University of North Carolina; East Carolina University; University of Ottawa	Wright, DS (corresponding author), Univ Groningen, Behav Biol Res Grp, Groningen Inst Evolutionary Life Sci, Groningen, Netherlands.	d.s.wright@rug.nl	Wright, Shane/AAE-7523-2020; Pierotti, Michele E R/E-7563-2011	Wright, Shane/0000-0002-4066-6718; Pierotti, Michele E R/0000-0003-2837-6192; Rundle, Howard/0000-0002-8288-8888				Amundsen T, 2000, TRENDS ECOL EVOL, V15, P149, DOI 10.1016/S0169-5347(99)01800-5; Amundsen T, 2001, P NATL ACAD SCI USA, V98, P13155, DOI 10.1073/pnas.211439298; Amundsen Trond, 2006, P280; Andersson Malte, 1994; [Anonymous], 2006, SAS MIXED MODELS; Bakker TC, 1993, POSITIVE GENETIC COR; BAKKER TCM, 1994, BEHAV ECOL, V5, P74, DOI 10.1093/beheco/5.1.74; BATEMAN AJ, 1948, HEREDITY, V2, P349, DOI 10.1038/hdy.1948.21; Baube CL, 2008, ETHOLOGY, V114, P1122, DOI 10.1111/j.1439-0310.2008.01564.x; Bell M.A., 1994, EVOLUTIONARY BIOL TH; Berglund A, 2001, ANIM BEHAV, V61, P345, DOI 10.1006/anbe.2000.1599; BISAZZA A, 1989, ETHOLOGY, V83, P335, DOI 10.1111/j.1439-0310.1989.tb00541.x; Clutton-Brock T, 2007, SCIENCE, V318, P1882, DOI 10.1126/science.1133311; Clutton-Brock T, 2009, ANIM BEHAV, V77, P3, DOI 10.1016/j.anbehav.2008.08.026; COTE IM, 1989, ANIM BEHAV, V38, P78, DOI 10.1016/S0003-3472(89)80067-3; Dalton BE, 2010, J EXP BIOL, V213, P2243, DOI 10.1242/jeb.037671; Delcourt M, 2010, EVOLUTION, V64, P2758, DOI 10.1111/j.1558-5646.2010.01031.x; Dingemanse NJ, 2009, P R SOC B, V276, P1285, DOI 10.1098/rspb.2008.1555; Dosen LD, 2004, ETHOLOGY, V110, P245, DOI 10.1111/j.1439-0310.2004.00965.x; Edward DA, 2011, TRENDS ECOL EVOL, V26, P647, DOI 10.1016/j.tree.2011.07.012; Endler JA, 2005, BIOL J LINN SOC, V86, P405, DOI 10.1111/j.1095-8312.2005.00540.x; Foote CJ, 2004, ANIM BEHAV, V67, P69, DOI 10.1016/j.anbehav.2003.02.004; Gray SM, 2007, TRENDS ECOL EVOL, V22, P71, DOI 10.1016/j.tree.2006.10.005; Griggio M, 2005, ANIM BEHAV, V69, P1243, DOI 10.1016/j.anbehav.2004.10.004; Hendry AP, 2009, J FISH BIOL, V75, P2000, DOI 10.1111/j.1095-8649.2009.02419.x; Hine E, 2006, GENETICS, V173, P1135, DOI 10.1534/genetics.105.054627; Hodgson A, 2013, EVOL ECOL RES, V15, P199; Kirkpatrick M, 2004, GENETICS, V168, P2295, DOI 10.1534/genetics.104.029181; Kokko H, 2012, ECOL LETT, V15, P1340, DOI 10.1111/j.1461-0248.2012.01859.x; KYNARD BE, 1978, BEHAVIOUR, V67, P178, DOI 10.1163/156853978X00323; LANDE R, 1980, EVOLUTION, V34, P292, DOI [10.2307/2407393, 10.1111/j.1558-5646.1980.tb04817.x]; LeBas NR, 2003, P ROY SOC B-BIOL SCI, V270, P2159, DOI 10.1098/rspb.2003.2482; Martin JGA, 2011, METHODS ECOL EVOL, V2, P362, DOI 10.1111/j.2041-210X.2010.00084.x; McGuigan K, 2008, AM NAT, V172, P194, DOI 10.1086/588075; Mckinnon JS, 2000, BEHAVIOUR, V137, P947, DOI 10.1163/156853900502556; McKinnon JS, 2002, TRENDS ECOL EVOL, V17, P480, DOI 10.1016/S0169-5347(02)02579-X; McPhail J.D., 1994, P399; Meyer K, 2005, PHILOS T R SOC B, V360, P1443, DOI 10.1098/rstb.2005.1681; MILINSKI M, 1990, NATURE, V344, P330, DOI 10.1038/344330a0; MILINSKI M, 1992, P ROY SOC B-BIOL SCI, V250, P229, DOI 10.1098/rspb.1992.0153; MORI S, 1993, BEHAVIOUR, V126, P97, DOI 10.1163/156853993X00362; Nordeide JT, 2006, J EVOLUTION BIOL, V19, P431, DOI 10.1111/j.1420-9101.2005.01018.x; Nordeide JT, 2002, CAN J ZOOL, V80, P1344, DOI 10.1139/Z02-116; NUTTALL DB, 1993, ETHOLOGY, V95, P247, DOI 10.1111/j.1439-0310.1993.tb00474.x; Ostlund-Nilsson S., 2010, BIOL 3 SPINED STICKL; Pauers MJ, 2012, CURR ZOOL, V58, P475, DOI 10.1093/czoolo/58.3.475; Pauers MJ, 2004, P ROY SOC B-BIOL SCI, V271, pS444, DOI 10.1098/rsbl.2004.0215; Pelkwijk J. J.ter, 1937, Zeitschrift fuer Tierpsychologie Berlin, V1, P193; Pierotti MER, 2009, EVOLUTION, V63, P2372, DOI 10.1111/j.1558-5646.2009.00716.x; Pike TW, 2011, FUNCT ECOL, V25, P297, DOI 10.1111/j.1365-2435.2010.01781.x; Rick IP, 2008, BEHAV ECOL SOCIOBIOL, V62, P439, DOI 10.1007/s00265-007-0471-6; Rick IP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025554; Rick IP, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-189; ROWLAND WJ, 1982, ANIM BEHAV, V30, P1093, DOI 10.1016/S0003-3472(82)80199-1; ROWLAND WJ, 1991, ANIM BEHAV, V42, P243, DOI 10.1016/S0003-3472(05)80555-X; Rush VN, 2003, BEHAVIOUR, V140, P1003, DOI 10.1163/156853903322589614; SARGENT RC, 1986, ANIM BEHAV, V34, P545, DOI 10.1016/S0003-3472(86)80123-3; Stoddard MC, 2008, AM NAT, V171, P755, DOI 10.1086/587526; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; von Hippel FA, 1999, ENVIRON BIOL FISH, V55, P237, DOI 10.1023/A:1007572620424; Wagner WE, 1998, ANIM BEHAV, V55, P1029, DOI 10.1006/anbe.1997.0635; Weiss SL, 2002, ETHOLOGY, V108, P793, DOI 10.1046/j.1439-0310.2002.00819.x; Weiss SL, 2009, BEHAV ECOL; Wolf WL, 2004, ANIM BEHAV, V67, P93, DOI 10.1016/j.anbehav.2003.02.009; WOOTTON RJ, 1973, J FISH BIOL, V5, P683, DOI 10.1111/j.1095-8649.1973.tb04504.x; Yong LX, 2013, EVOL ECOL RES, V15, P453	66	14	14	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0120723	10.1371/journal.pone.0120723	http://dx.doi.org/10.1371/journal.pone.0120723			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE5MO	25806520	gold, Green Published, Green Submitted			2022-12-26	WOS:000351880000099
J	Conen, A; Frei, R; Adler, H; Dangel, M; Fux, CA; Widmer, AF				Conen, Anna; Frei, Reno; Adler, Hildegard; Dangel, Marc; Fux, Christoph A.; Widmer, Andreas F.			Microbiological Screening Is Necessary to Distinguish Carriers of Plasmid-Mediated AmpC Beta-Lactamase-Producing Enterobacteriaceae and Extended-Spectrum Beta-Lactamase (ESBL)-Producing Enterobacteriaceae because of Clinical Similarity	PLOS ONE			English	Article							RESISTANT ESCHERICHIA-COLI; BLOOD-STREAM INFECTIONS; KLEBSIELLA-PNEUMONIAE; BACTEREMIA; PREVALENCE; COMMUNITY; DISSEMINATION; EPIDEMIOLOGY; BROILERS; FEATURES	Objectives Plasmid-mediated AmpC beta-lactamase-producing (pAmpC) Enterobacteriaceae are increasing worldwide, difficult to identify and often confounded with extended-spectrum betalactamase (ESBL) producers. The low prevalence precludes routine universal admission screening. Therefore, we evaluated potential risk factors for carriage of pAmpC-producing Enterobacteriaceae that would allow targeted screening to improve yield and reduce cost. Patients and methods We performed a case control study at a tertiary care center from 1/2006 to 12/2010. Cases were adult patients in whom pAmpC-producing Enterobacteriaceae were isolated; controls were chosen among carriers of ESBL-producing Enterobacteriaceae. Both infected and colonized patients were included. Results Over five years, we identified 40 pAmpC producers in 39 patients among 16,247 screened consecutive isolates of Enterobacteriaceae. The pAmpC prevalence was low (0.25%), but more than 30% of pAmpC carriers received incorrect empirical antibiotic treatment. When compared with 39 ESBL controls, pAmpC carriage was associated with clinically confirmed infections in 74% (versus 51%) (p=0.035), mainly of the urinary tract, previous antibiotic exposure in 63% (versus 36%) (p=0.035) and carriage of a nasogastric tube in 23% (versus 0%) (p=0.002). In the multivariate regression analysis only clinically confirmed infections remained significantly associated with pAmpC carriage ( OR 1.44 ( 95% CI 1.15-2.57)). No other clinical and blood test-associated risk factor allowed discrimination of pAmpC-carrying patients from ESBL controls. The type of acquisition-nosocomial versus community-acquired-was also non-informative for resistance type, as 46% of pAmpC-and 44% of ESBL-producing Enterobacteriaceae were community-acquired. Conclusions This study could not identify a clinical profile that would allow targeted screening for pAmpC-producing Enterobacteriaceae when compared to ESBL carriers. Because empiric antimicrobial therapy was inappropriate in more than 30%, rapid identification of pAmpC carriers is needed. New microbiological methods are therefore required to simplify rapid and reliable detection of pAmpC carriers.	[Conen, Anna; Fux, Christoph A.] Kantonsspital Aarau, Div Infect Dis & Hosp Epidemiol, Aarau, Switzerland; [Frei, Reno; Adler, Hildegard] Univ Basel Hosp, Div Clin Microbiol, CH-4031 Basel, Switzerland; [Frei, Reno; Dangel, Marc; Widmer, Andreas F.] Univ Basel Hosp, Div Infect Dis & Hosp Epidemiol, CH-4031 Basel, Switzerland	Kantonsspital Aarau AG (KSA); University of Basel; University of Basel	Widmer, AF (corresponding author), Univ Basel Hosp, Div Infect Dis & Hosp Epidemiol, CH-4031 Basel, Switzerland.	andreas.widmer@usb.ch			Merck Sharp Dome; Gilead; Bristol-Myers-Squibb; VIIV	Merck Sharp Dome; Gilead(Gilead Sciences); Bristol-Myers-Squibb(Bristol-Myers Squibb); VIIV	AC received unrestricted travel grants from Merck Sharp & Dome, Gilead, Bristol-Myers-Squibb and VIIV. RF, HA, CAF, MD and AFW have no conflicts of interest. This does not alter the authors' adherence to PLOS One policies on sharing data and materials.	Adler H, 2008, J ANTIMICROB CHEMOTH, V61, P457, DOI 10.1093/jac/dkm472; Alvarez M, 2004, ANTIMICROB AGENTS CH, V48, P533, DOI 10.1128/AAC.48.2.533-537.2004; Cheong HS, 2013, INFECTION, V41, P287, DOI 10.1007/s15010-012-0341-7; CHOW JW, 1991, ANN INTERN MED, V115, P585, DOI 10.7326/0003-4819-115-8-585; Clinical and Laboratory Standards Institute (CLSI), 2014, CLIN LAB STANDARDS I; Coque TM, 2008, EUROSURVEILLANCE B E, V13; Dierikx C, 2013, J ANTIMICROB CHEMOTH, V68, P60, DOI 10.1093/jac/dks349; Ding H, 2008, EUR J CLIN MICROBIOL, V27, P915, DOI 10.1007/s10096-008-0532-4; Doi Y, 2012, DIAGN MICR INFEC DIS, V74, P34, DOI 10.1016/j.diagmicrobio.2012.05.020; Endimiani A, 2012, ANTIMICROB AGENTS CH, V56, P4556, DOI 10.1128/AAC.00389-12; Endimiani A, 2012, DIAGN MICR INFEC DIS, V73, P31, DOI 10.1016/j.diagmicrobio.2012.01.004; Fam N, 2013, LIFE SCI J, V10, P2294; Friedman ND, 2002, ANN INTERN MED, V137, P791, DOI 10.7326/0003-4819-137-10-200211190-00007; Friese A, 2013, BERL MUNCH TIERARZTL, V126, P175, DOI 10.2376/0005-9366-126-175; GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3; Giske CG, EUCAST 2013; Gray JT, 2004, ANTIMICROB AGENTS CH, V48, P3179, DOI 10.1128/AAC.48.8.3179-3181.2004; Hidron AI, 2008, INFECT CONT HOSP EP, V29, P996, DOI 10.1086/591861; Jacoby GA, 2009, CLIN MICROBIOL REV, V22, P161, DOI 10.1128/CMR.00036-08; Kohner PC, 2009, J CLIN MICROBIOL, V47, P2419, DOI 10.1128/JCM.00508-09; Lautenbach E, 2001, CLIN INFECT DIS, V32, P1162, DOI 10.1086/319757; Lee CH, 2010, ANTIMICROB AGENTS CH, V54, P5395, DOI 10.1128/AAC.00083-10; Matsumura Y, 2013, CLIN MICROBIOL INFEC, V19, P161, DOI 10.1111/j.1469-0691.2012.03762.x; MCCABE WR, 1962, ARCH INTERN MED, V110, P856, DOI 10.1001/archinte.1962.03620240038007; Migliavacca R, 2007, NEW MICROBIOL, V30, P295; Moland ES, 2006, J CLIN MICROBIOL, V44, P3318, DOI 10.1128/JCM.00756-06; Munier GK, 2010, J CLIN MICROBIOL, V48, P673, DOI 10.1128/JCM.01544-09; Pai H, 2004, ANTIMICROB AGENTS CH, V48, P3720, DOI 10.1128/AAC.48.10.3720-3728.2004; Park YS, 2009, INT J ANTIMICROB AG, V34, P38, DOI 10.1016/j.ijantimicag.2009.01.009; Paterson DL, 2004, CLIN INFECT DIS, V39, P31, DOI 10.1086/420816; Peleg AY, 2010, NEW ENGL J MED, V362, P1804, DOI 10.1056/NEJMra0904124; Perez-Perez FJ, 2002, J CLIN MICROBIOL, V40, P2153, DOI 10.1128/JCM.40.6.2153-2162.2002; Philippon A, 2002, ANTIMICROB AGENTS CH, V46, P1, DOI 10.1128/AAC.46.1.1-11.2002; Pitout JDD, 2003, J CLIN MICROBIOL, V41, P4578, DOI 10.1128/JCM.41.10.4578-4582.2003; Pitout JDD, 2013, CURR PHARM DESIGN, V19, P257, DOI 10.2174/138161213804070348; Rand KH, 2011, AM J CLIN PATHOL, V135, P572, DOI 10.1309/AJCP7VD0NMAMQCWA; Reich F, 2013, EMERG INFECT DIS, V19, P1253, DOI 10.3201/eid1908.120879; Reuland EA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091396; Robberts FJL, 2009, J CLIN MICROBIOL, V47, P358, DOI 10.1128/JCM.01687-08; Rodriguez-Bano J, 2012, J INFECTION, V64, P176, DOI 10.1016/j.jinf.2011.11.016; Seiffert SN, 2013, J ANTIMICROB CHEMOTH, V68, P2249, DOI 10.1093/jac/dkt208; Trivedi GR, 2013, INT J BIOL MED RES, V4, P3475; Tschudin-Sutter S, 2012, CLIN INFECT DIS, V55, P1505, DOI 10.1093/cid/cis770; Walsh TR, 2011, LANCET INFECT DIS, V11, P355, DOI 10.1016/S1473-3099(11)70059-7	44	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0120688	10.1371/journal.pone.0120688	http://dx.doi.org/10.1371/journal.pone.0120688			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803720	gold, Green Published, Green Submitted			2022-12-26	WOS:000353889600094
J	Kim, ES; Sonstegard, TS; da Silva, MVGB; Gasbarre, LC; Van Tassell, CP				Kim, Eui-Soo; Sonstegard, Tad S.; da Silva, Marcos V. G. B.; Gasbarre, Louis C.; Van Tassell, Curtis P.			Genome-Wide Scan of Gastrointestinal Nematode Resistance in Closed Angus Population Selected for Minimized Influence of MHC	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; LINKAGE DISEQUILIBRIUM; NATURAL-SELECTION; HAEMONCHUS-CONTORTUS; GENETIC-CONTROL; SHEEP; INFECTION; CATTLE; QUANTIFICATION; SUSCEPTIBILITY	Genetic markers associated with parasite indicator traits are ideal targets for study of marker assisted selection aimed at controlling infections that reduce herd use of anthelminthics. For this study, we collected gastrointestinal (GI) nematode fecal egg count (FEC) data from post-weaning animals of an Angus resource population challenged to a 26 week natural exposure on pasture. In all, data from 487 animals was collected over a 16 year period between 1992 and 2007, most of which were selected for a specific DRB1 allele to reduce the influence of potential allelic variant effects of the MHC locus. A genome-wide association study (GWAS) based on BovineSNP50 genotypes revealed six genomic regions located on bovine Chromosomes 3, 5, 8, 15 and 27; which were significantly associated (-log(10) p=4.3) with Box-Cox transformed mean FEC (BC-MFEC). DAVID analysis of the genes within the significant genomic regions suggested a correlation between our results and annotation for genes involved in inflammatory response to infection. Furthermore, ROH and selection signature analyses provided strong evidence that the genomic regions associated BC-MFEC have not been affected by local autozygosity or recent experimental selection. These findings provide useful information for parasite resistance prediction for young grazing cattle and suggest new candidate gene targets for development of disease-modifying therapies or future studies of host response to GI parasite infection.	[Kim, Eui-Soo; Sonstegard, Tad S.; Gasbarre, Louis C.; Van Tassell, Curtis P.] ARS, Anim Genom & Improvement Lab, USDA, Beltsville, MD 20705 USA; [da Silva, Marcos V. G. B.] Empresa Brasileira Pesquisa Agr, Embrapa Gado Leite, Juiz De Fora, Brazil	United States Department of Agriculture (USDA); Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)	Sonstegard, TS (corresponding author), ARS, Anim Genom & Improvement Lab, USDA, Beltsville, MD 20705 USA.	tad.sonstegard@ars.usda.gov	Van Tassell, Curtis P./O-4247-2019; Silva, Marcos Vinicius Gualberto Barbosa/AAS-1837-2020	Van Tassell, Curtis P./0000-0002-8416-2087; Silva, Marcos Vinicius Gualberto Barbosa/0000-0001-5449-1413	USDA-ARS [1265-31000-093-00, 104-00]; TS trust agreement with Merial-Igenity [1265-32000-084-01T]; Next-Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea [PJ008196]	USDA-ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); TS trust agreement with Merial-Igenity; Next-Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea	This work was supported in part by Projects 1265-31000-093-00 and 104-00 from USDA-ARS, and a TS trust agreement with Merial-Igenity (1265-32000-084-01T). TSS, LCG and CVT received the funding. ESK was partially supported by a grant from the Next-Generation BioGreen 21 Program (No. PJ008196), Rural Development Administration, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akey J, 2001, EUR J HUM GENET, V9, P291, DOI 10.1038/sj.ejhg.5200619; Bamshad M, 2003, NAT REV GENET, V4, P99, DOI 10.1038/nrg999; BARGER IA, 1993, VET PARASITOL, V46, P23, DOI 10.1016/0304-4017(93)90045-O; BARTON NH, 1995, GENETICS, V140, P821; Bisset SA, 1997, VET PARASITOL, V70, P255, DOI 10.1016/S0304-4017(96)01148-X; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Charlesworth D, 2009, NAT REV GENET, V10, P783, DOI 10.1038/nrg2664; Chun S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002240; CHURCHILL GA, 1994, GENETICS, V138, P963; Coppieters W, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-96; Crawford AM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-178; da Silva Marcos Vinicius Gualberto Barbosa, 2011, Front Genet, V2, P112, DOI 10.3389/fgene.2011.00112; Davies G, 2006, HEREDITY, V96, P252, DOI 10.1038/sj.hdy.6800788; Dominik S, 2005, GENET SEL EVOL, V37, pS83, DOI 10.1051/gse:2004027; Fernando R. L., 2008, ANIMAL BREEDING GENE; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; GASBARRE LC, 1986, VET PARASITOL, V20, P133, DOI 10.1016/0304-4017(86)90097-X; GASBARRE LC, 1990, VET PARASITOL, V37, P257, DOI 10.1016/0304-4017(90)90009-Z; GASBARRE LC, 1999, BREEDING DIS RESISTA, P129; Gasbarre LC, 2014, VET PARASITOL, V204, P3, DOI 10.1016/j.vetpar.2014.03.017; Grapes L, 2004, GENETICS, V166, P1561, DOI 10.1534/genetics.166.3.1561; Heitner S, UCSC COW GENOME BROW; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ingham A, 2008, INT J PARASITOL, V38, P431, DOI 10.1016/j.ijpara.2007.07.012; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Keller MC, 2012, PLOS GENET, V8, P425, DOI 10.1371/journal.pgen.1002656; Keller MC, 2011, GENETICS, V189, P237, DOI 10.1534/genetics.111.130922; Kim ES, 2009, ANIM GENET, V40, P279, DOI 10.1111/j.1365-2052.2008.01831.x; Kim ES, 2014, ANIM GENET, V45, P117, DOI 10.1111/age.12101; Kim ES, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080813; Knight JC, 2009, Human Genetic Diversity: Functional Consequences for Health and Disease, P1, DOI 10.1093/acprof:oso/9780199227693.001.0001; LEIGHTON EA, 1989, J PARASITOL, V75, P498, DOI 10.2307/3282895; Li RW, 2007, VET PARASITOL, V145, P100, DOI 10.1016/j.vetpar.2006.11.015; Loyacano AF, 2002, VET PARASITOL, V107, P227, DOI 10.1016/S0304-4017(02)00130-9; Luikart G, 2008, BIOL LETTERS, V4, P228, DOI 10.1098/rsbl.2007.0633; Lynn DJ, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.55; Marshall K, 2009, ANIM GENET, V40, P262, DOI 10.1111/j.1365-2052.2008.01836.x; Matukumalli LK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005350; McQuillan R, 2008, AM J HUM GENET, V83, P359, DOI 10.1016/j.ajhg.2008.08.007; Mcrae KM, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-637; Miller JE, 2006, VET PARASITOL, V140, P83, DOI 10.1016/j.vetpar.2006.02.043; Mitreva M, 2007, VET PARASITOL, V148, P31, DOI 10.1016/j.vetpar.2007.05.008; Morris CA, 2005, NEW ZEAL J AGR RES, V48, P1, DOI 10.1080/00288233.2005.9513625; Nielsen R, 2007, NAT REV GENET, V8, P857, DOI 10.1038/nrg2187; Riggio V, 2013, HEREDITY, V110, P420, DOI 10.1038/hdy.2012.90; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Salle G, 2012, J ANIM SCI, V90, P4690, DOI 10.2527/jas.2012-5121; Sayers G., 2005, Animal Health Research Reviews, V6, P159, DOI 10.1079/AHR2005108; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Sonstegard TS, 2001, VET PARASITOL, V101, P387, DOI 10.1016/S0304-4017(01)00563-5; Stear MJ, 2007, PARASITOLOGY, V134, P139, DOI 10.1017/S0031182006001557; Thermeau T., 2009, PACKAGE KINSHIP R R; University of Maryland Center for Bioinformatics and Computational Biology College Park MD USA, 2009, BOS TAUR GEN ASS; VanRaden PM, 2009, J DAIRY SCI, V92, P16, DOI 10.3168/jds.2008-1514; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Wolstenholme AJ, 2004, TRENDS PARASITOL, V20, P469, DOI 10.1016/j.pt.2004.07.010; Worthylake RA, 2001, CURR OPIN CELL BIOL, V13, P569, DOI 10.1016/S0955-0674(00)00253-2; Zhao HH, 2007, GENETICS, V175, P1975, DOI 10.1534/genetics.106.066480; Zhu JF, 2006, CELL RES, V16, P3, DOI 10.1038/sj.cr.7310002; Zimin AV, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r42	62	12	12	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0119380	10.1371/journal.pone.0119380	http://dx.doi.org/10.1371/journal.pone.0119380			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803687	Green Published, gold, Green Submitted			2022-12-26	WOS:000353889600024
J	Marcantonio, M; Rizzoli, A; Metz, M; Rosa, R; Marini, G; Chadwick, E; Neteler, M				Marcantonio, Matteo; Rizzoli, Annapaola; Metz, Markus; Rosa, Roberto; Marini, Giovanni; Chadwick, Elizabeth; Neteler, Markus			Identifying the Environmental Conditions Favouring West Nile Virus Outbreaks in Europe	PLOS ONE			English	Article							CULEX-PIPIENS DIPTERA; LAND-USE; MODEL SELECTION; MOSQUITO VECTORS; CLIMATE-CHANGE; RISK; LANDSCAPE; EPIDEMIOLOGY; CULICIDAE; TRANSMISSION	West Nile Virus (WNV) is a globally important mosquito borne virus, with significant implications for human and animal health. The emergence and spread of new lineages, and increased pathogenicity, is the cause of escalating public health concern. Pinpointing the environmental conditions that favour WNV circulation and transmission to humans is challenging, due both to the complexity of its biological cycle, and the under-diagnosis and reporting of epidemiological data. Here, we used remote sensing and GIS to enable collation of multiple types of environmental data over a continental spatial scale, in order to model annual West Nile Fever (WNF) incidence across Europe and neighbouring countries. Multimodel selection and inference were used to gain a consensus from multiple linear mixed models. Climate and landscape were key predictors of WNF outbreaks (specifically, high precipitation in late winter/early spring, high summer temperatures, summer drought, occurrence of irrigated croplands and highly fragmented forests). Identification of the environmental conditions associated with WNF outbreaks is key to enabling public health bodies to properly focus surveillance and mitigation of West Nile virus impact, but more work needs to be done to enable accurate predictions of WNF risk.	[Marcantonio, Matteo; Rizzoli, Annapaola; Metz, Markus; Rosa, Roberto; Marini, Giovanni; Neteler, Markus] Fdn Edmund Mach, Res & Innovat Ctr, Dept Biodivers & Mol Ecol, San Michele All Adige, Italy; [Chadwick, Elizabeth] Cardiff Univ, Sch Biosci, Cardiff CF10 3AX, S Glam, Wales	Fondazione Edmund Mach; Cardiff University	Marcantonio, M (corresponding author), Fdn Edmund Mach, Res & Innovat Ctr, Dept Biodivers & Mol Ecol, San Michele All Adige, Italy.	marcantoniomatteo@gmail.com	Marini, Giovanni/C-3808-2018; Rosà, Roberto/AAB-4479-2021; Neteler, Markus/C-6328-2008; Rizzoli, Annapaola/J-2439-2012; Rosa, Roberto/B-8562-2011; Chadwick, Elizabeth/G-1793-2010; marcantonio, matteo/B-3140-2013	Marini, Giovanni/0000-0001-9721-7211; Rosà, Roberto/0000-0002-8655-2230; Neteler, Markus/0000-0003-1916-1966; Rizzoli, Annapaola/0000-0003-3997-6783; Rosa, Roberto/0000-0002-8655-2230; Chadwick, Elizabeth/0000-0002-6662-6343; 	7th Framework Programme: European West Nile collaborative research project [261391]; Autonomous Province of Trento (Italy), Research funds for Grandi Progetti, Project LExEM (Laboratory of excellence for epidemiology and modeling)	7th Framework Programme: European West Nile collaborative research project; Autonomous Province of Trento (Italy), Research funds for Grandi Progetti, Project LExEM (Laboratory of excellence for epidemiology and modeling)	This work was funded by the 7th Framework Programme: European West Nile collaborative research project (Grant agreement no. 261391; http://www.eurowestnile.org/) and by the Autonomous Province of Trento (Italy), Research funds for Grandi Progetti, Project LExEM (Laboratory of excellence for epidemiology and modeling, http://www.lexem.eu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharonson-Raz K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113149; Allan BF, 2009, OECOLOGIA, V158, P699, DOI 10.1007/s00442-008-1169-9; Tran A, 2014, INT J HEALTH GEOGR, V13, DOI 10.1186/1476-072X-13-26; [Anonymous], 1992, BIOL MOSQUITOES DEV; Arnold Carrie, 2012, Lancet Neurol, V11, P1023, DOI 10.1016/S1474-4422(12)70278-8; Artsob H, 2009, ZOONOSES PUBLIC HLTH, V56, P357, DOI 10.1111/j.1863-2378.2008.01207.x; Bakonyi T, 2013, VET MICROBIOL, V165, P61, DOI 10.1016/j.vetmic.2013.03.005; Barton K., 2013, MUMLN MULTIMODEL INF; Barzon L, 2013, VIRUSES-BASEL, V5, P2825, DOI 10.3390/v5112825; Becker N, 2010, MOSQUITOES AND THEIR CONTROL, SECOND EDITION, P3, DOI 10.1007/978-3-540-92874-4_1; Bowden SE, 2011, AM J TROP MED HYG, V84, P234, DOI 10.4269/ajtmh.2011.10-0134; Bradley CA, 2008, ECOL APPL, V18, P1083, DOI 10.1890/07-0822.1; Bradley CA, 2007, TRENDS ECOL EVOL, V22, P95, DOI 10.1016/j.tree.2006.11.001; Brown H, 2008, VECTOR-BORNE ZOONOT, V8, P197, DOI 10.1089/vbz.2007.0154; Brown HE, 2008, EMERG INFECT DIS, V14, P1539, DOI 10.3201/eid1410.071396; Buckland ST, 1997, BIOMETRICS, V53, P603, DOI 10.2307/2533961; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Calcagno V, 2010, J STAT SOFTW, V34, P1; Calzolari M, 2013, VET ITAL, V49, P315; Campbell GL, 2002, LANCET INFECT DIS, V2, P519, DOI 10.1016/S1473-3099(02)00368-7; Chase JM, 2003, ECOL LETT, V6, P1017, DOI 10.1046/j.1461-0248.2003.00533.x; Chuang TW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046882; Chuang TW, 2012, AM J TROP MED HYG, V86, P724, DOI 10.4269/ajtmh.2012.11-0515; Coker R, 2011, LANCET INFECT DIS, V11, P326, DOI 10.1016/S1473-3099(10)70312-1; Colborn JM, 2013, J AM MOSQUITO CONTR, V29, P123, DOI 10.2987/13-6326r.1; Dauphin G, 2004, COMP IMMUNOL MICROB, V27, P343, DOI 10.1016/j.cimid.2004.03.009; Deichmeister JM, 2011, J VECTOR ECOL, V36, P75, DOI 10.1111/j.1948-7134.2011.00143.x; Dobson A, 2001, PHILOS T R SOC B, V356, P1001, DOI 10.1098/rstb.2001.0900; Dohm DJ, 2002, J MED ENTOMOL, V39, P221, DOI 10.1603/0022-2585-39.1.221; Dowling Z, 2013, J MED ENTOMOL, V50, P764, DOI 10.1603/ME12250; ECDC, 2014, W NIL FEV MAPS; Eisen L, 2013, J MED ENTOMOL, V50, P221, DOI 10.1603/ME12228; Ellis EC, 2008, FRONT ECOL ENVIRON, V6, P439, DOI 10.1890/070062; Elvidge CD, 1997, GLOBAL CHANGE BIOL, V3, P387, DOI 10.1046/j.1365-2486.1997.00115.x; Epstein PR, 2001, MICROBES INFECT, V3, P747, DOI 10.1016/S1286-4579(01)01429-0; Gardner AM, 2014, VECTOR-BORNE ZOONOT, V14, P338, DOI 10.1089/vbz.2013.1477; Gibbs SEJ, 2006, VECTOR-BORNE ZOONOT, V6, P73, DOI 10.1089/vbz.2006.6.73; Gomes B, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-93; Gomes B, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-262; Gomez A, 2008, EMERG INFECT DIS, V14, P962, DOI 10.3201/eid1406.070352; Hair F., 1995, MULTIVARIATE DATA AN, V4th; Harrigan RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015437; IPCC (Intergovernmental Panel on Climate Change), 2013, CLIMATE CHANGE 2013; Iyer AV, 2013, INT J ENV RES PUB HE, V10, P4200, DOI 10.3390/ijerph10094200; Jimenez-Clavero Miguel A., 2012, Frontiers in Genetics, V3, P105, DOI 10.3389/fgene.2012.00105; Johnson BJ, 2012, URBAN ECOSYST, V15, P513, DOI 10.1007/s11252-012-0248-1; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; Karesh WB, 2012, LANCET, V380, P1936, DOI 10.1016/S0140-6736(12)61678-X; Kilpatrick AM, 2006, P ROY SOC B-BIOL SCI, V273, P2327, DOI 10.1098/rspb.2006.3575; Kilpatrick AM, 2011, SCIENCE, V334, P323, DOI 10.1126/science.1201010; Kilpatrick AM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000092; Kwan JL, 2012, EMERG INFECT DIS, V18, P1298, DOI 10.3201/eid1808.111558; LaBeaud AD, 2008, GEOSPATIAL HEALTH, V2, P215, DOI 10.4081/gh.2008.245; Landesman WJ, 2007, VECTOR-BORNE ZOONOT, V7, P337, DOI 10.1089/vbz.2006.0590; Liu H, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-66; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Martin-Acebes Miguel A, 2012, World J Virol, V1, P51, DOI 10.5501/wjv.v1.i2.51; May FJ, 2011, J VIROL, V85, P2964, DOI 10.1128/JVI.01963-10; Metz M, 2014, REMOTE SENS-BASEL, V6, P3822, DOI 10.3390/rs6053822; Morin CW, 2013, P NATL ACAD SCI USA, V110, P15620, DOI 10.1073/pnas.1307135110; Moudy RM, 2007, AM J TROP MED HYG, V77, P365, DOI 10.4269/ajtmh.2007.77.365; Mulatti P, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-26; Murray KO, 2011, EPIDEMIOL INFECT, V139, P807, DOI 10.1017/S0950268811000185; Neteler M, 2012, ENVIRON MODELL SOFTW, V31, P124, DOI 10.1016/j.envsoft.2011.11.014; Osorio HC, 2013, MED VET ENTOMOL; Ozdenerol E, 2013, INT J ENV RES PUB HE, V10, P5399, DOI 10.3390/ijerph10115399; Papa A, 2013, J CLIN VIROL, V58, P351, DOI 10.1016/j.jcv.2013.02.020; Patrice B, GLOBCOVER PRODUCTS D; Patz JA, 2004, ENVIRON HEALTH PERSP, V112, P1092, DOI 10.1289/ehp.6877; Paz S, 2013, INT J ENV RES PUB HE, V10, P3543, DOI 10.3390/ijerph10083543; Paz S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056398; Pecoraro HL, 2007, J VECTOR ECOL, V32, P22, DOI 10.3376/1081-1710(2007)32[22:CALCFP]2.0.CO;2; Perez-Rodriguez A, 2013, GLOBAL CHANGE BIOL, V19, P3245, DOI 10.1111/gcb.12226; Petersen LR, 2002, ANN INTERN MED, V137, P173, DOI 10.7326/0003-4819-137-3-200208060-00009; Petersen LR, 2013, JAMA-J AM MED ASSOC, V310, P308, DOI 10.1001/jama.2013.8042; Petersen LR, 2012, NEW ENGL J MED, V367, P1281, DOI 10.1056/NEJMp1210537; PIELOU EC, 1966, J THEOR BIOL, V13, P131, DOI 10.1016/0022-5193(66)90013-0; Platonov AE, 2008, PARASITOL RES, V103, pS45, DOI 10.1007/s00436-008-1050-0; Popovic N, 2013, EUROSURVEILLANCE, V18, P18, DOI 10.2807/1560-7917.ES2013.18.43.20613; Pradier S, 2008, VECTOR-BORNE ZOONOT, V8, P253, DOI 10.1089/vbz.2007.0178; R Development Core Team, 2012, R LANG ENV STAT COMP; Reisen WK, 2013, VIRUSES-BASEL, V5, P2079, DOI 10.3390/v5092079; Reiter P., 2010, EUROSURVEILLANCE; Roerink GJ, 2000, INT J REMOTE SENS, V21, P1911, DOI 10.1080/014311600209814; Rosa R, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-269; Sambri V, 2013, CLIN MICROBIOL INFEC, V19, P699, DOI 10.1111/1469-0691.12211; Schoning JM, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054253, 10.1371/journal.pone.0060336]; Semenza JC, 2013, NAT CLIM CHANGE, V3, P432, DOI 10.1038/nclimate1867; Shaman J, 2005, J MED ENTOMOL, V42, P134, DOI 10.1603/0022-2585(2005)042[0134:DAAETO]2.0.CO;2; Shaman J, 2010, INT J ENV RES PUB HE, V7, P494, DOI 10.3390/ijerph7020494; Small C, 2011, REMOTE SENS ENVIRON, V115, P269, DOI 10.1016/j.rse.2010.08.021; Smithburn KC., 1940, AM J TROP MED HYG, V1, P471, DOI 10.4269/ajtmh.1940.s1-20.471; Soverow JE, 2009, ENVIRON HEALTH PERSP, V117, P1049, DOI 10.1289/ehp.0800487; Stephenson TS, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009127; Tsai TF, 1998, LANCET, V352, P767, DOI 10.1016/S0140-6736(98)03538-7; Valiakos G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096935; Warner RD, 2006, ANN EPIDEMIOL, V16, P749, DOI 10.1016/j.annepidem.2006.04.006; Young SG, 2013, APPL GEOGR, V45, P241, DOI 10.1016/j.apgeog.2013.09.022; Zhuo L, 2009, INT J REMOTE SENS, V30, P1003, DOI 10.1080/01431160802430693; Zuur Alain F., 2009, P1	100	56	56	4	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0121158	10.1371/journal.pone.0121158	http://dx.doi.org/10.1371/journal.pone.0121158			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803814	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000353889600130
J	Parajuli, RP; Umezaki, M; Fujiwara, T; Watanabe, C				Parajuli, Rajendra Prasad; Umezaki, Masahiro; Fujiwara, Takeo; Watanabe, Chiho			Association of Cord Blood Levels of Lead, Arsenic, and Zinc and Home Environment with Children Neurodevelopment at 36 Months Living in Chitwan Valley, Nepal	PLOS ONE			English	Article							EARLY COGNITIVE-DEVELOPMENT; PRENATAL EXPOSURE; MOTOR DEVELOPMENT; EARLY-CHILDHOOD; BIRTH COHORT; NEUROPSYCHOLOGICAL DEVELOPMENT; NEUROBEHAVIORAL DEVELOPMENT; PSYCHOMOTOR DEVELOPMENT; INTELLECTUAL FUNCTION; MENTAL-DEVELOPMENT	Background Inconsistent results continue to be reported from studies linking low-level prenatal lead exposure and child development. Because of limited earlier epidemiological studies with birth cohort follow up design, it still remains inconclusive that either the associations of cord blood level of toxic, and essential elements, and postnatal raising environment on neurodevelopment of children remains constant throughout childhood or change over time. Aims This study aims to investigate the influence of in utero toxic [lead (Pb) and arsenic (As)] and essential elements [zinc (Zn)] levels on neurodevelopment of 36 months children in Chitwan valley, Nepal taking the postnatal environment into account. Study Designs and Subjects In this birth cohort study, participants (N= 100 mother-infants' pairs) were recruited in Chitwan district, Nepal. We measured Pb, As and Zn concentrations in cord blood. Postnatal raising environment (i.e., Home score or home environment hereafter) was evaluated using Home Observation for Measurement of Environment (HOME) scale. Neurodevelopment of children at 36 months of age (n=70) were assessed using Bayley Scale of Infant Development, Second Edition (BSID II). Multivariate regression was performed (n=70) to see the association of in utero toxic and essential elements level and home environment with neurodevelopment score adjusted for covariates. Results Cord blood levels of Pb, As and Zn were not associated with any BSID II cluster scores of 36 months children. The children with relatively superior HOME score and concurrent nutritional status (weight at 36 months) showed better cognitive development (i.e., MDI scores) and motor functions than their counterparts, respectively. Conclusion In this general population in Nepal, prenatal Pb, As and Zn levels are not important determinants of the neurodevelopment of 36-month-old children while a consistent beneficial effect of a stimulating home environment on neurodevelopmental indicators is continued.	[Parajuli, Rajendra Prasad; Umezaki, Masahiro; Watanabe, Chiho] Univ Tokyo, Grad Sch Med, Dept Human Ecol, Bunkyo Ku, Tokyo 1130033, Japan; [Parajuli, Rajendra Prasad] IICRD, Victoria, BC V8W 3S2, Canada; [Parajuli, Rajendra Prasad] McGill Univ, Fac Agr & Environm Sci, Basu Lab, Montreal, PQ H9X 3V9, Canada; [Fujiwara, Takeo] Natl Res Inst Child Hlth & Dev, Dept Social Med, Tokyo 1578535, Japan	University of Tokyo; McGill University; National Center for Child Health & Development - Japan	Parajuli, RP (corresponding author), Univ Tokyo, Grad Sch Med, Dept Human Ecol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	rp.parajuli@mcgill.ca	Parajuli, Rajendra P/B-8410-2008	Parajuli, Rajendra P/0000-0002-4899-7212	Ministry of Education, Culture, Sports, Science and Technology (MEXT); Japan Society for the Promotion of Science (JSPS) (KAKENHI) [20310146]	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS) (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was funded by Grant-in-Aid for Scientific Research by Ministry of Education, Culture, Sports, Science and Technology (MEXT) and the Japan Society for the Promotion of Science (JSPS) (KAKENHI project number: 20310146).	Al-Saleh I, 2009, J ENVIRON PATHOL TOX, V28, P283, DOI 10.1615/JEnvironPatholToxicolOncol.v28.i4.40; Austin AMB, 2006, J RES CHILD EDUC, V20, P255, DOI 10.1080/02568540609594566; Badr Zahr LK, 2001, APPL NURS RES, V14, P125; Baker-Henningham H, 2009, J NUTR, V139, P1765, DOI 10.3945/jn.109.106294; Bayley N, 1993, BAYLEY SCALES INFANT; BELLINGER D, 1987, NEW ENGL J MED, V316, P1037, DOI 10.1056/NEJM198704233161701; Black MM, 2004, AM J CLIN NUTR, V80, P903, DOI 10.1093/ajcn/80.4.903; Black MM, 2004, PEDIATRICS, V113, P1297, DOI 10.1542/peds.113.5.1297; Black MM, 2000, J APPL DEV PSYCHOL, V21, P655, DOI 10.1016/S0193-3973(00)00059-9; Bulas D, 2005, SEMIN PERINATOL, V29, P58, DOI 10.1053/j.semperi.2005.02.009; Calderon J, 2001, ENVIRON RES, V85, P69, DOI 10.1006/enrs.2000.4106; Caldwell B., 1984, HOME OBSERVATION MEA; CDC, 2014, IMP MIL YOUR CHILD 3; Claus Henn B, 2011, ENV HLTH PERSPECT, V120; Concha G, 1998, INT ARCH OCC ENV HEA, V71, P42, DOI 10.1007/s004200050248; Dakeishi Miwako, 2006, Environ Health, V5, P31, DOI 10.1186/1476-069X-5-31; DIETRICH KN, 1990, ENVIRON HEALTH PERSP, V89, P13, DOI 10.2307/3430891; DREHER MC, 1994, PEDIATRICS, V93, P254; Eskenazi B, 2006, PEDIATRICS, V118, P233, DOI 10.1542/peds.2005-3117; Factor-Litvak P, 1999, ENVIRON HEALTH PERSP, V107, P9, DOI 10.2307/3434284; Hamadani JD, 2011, INT J EPIDEMIOL, V40, P1593, DOI 10.1093/ije/dyr176; Hamadani JD, 2010, INT J EPIDEMIOL, V39, P1206, DOI 10.1093/ije/dyp369; Hamadani JD, 2010, FOOD NUTR BULL, V31, pS198, DOI 10.1177/15648265100312S212; Henn BC, 2012, ENVIRON HEALTH PERSP, V120, P126, DOI 10.1289/ehp.1003300; Hu H, 2006, ENVIRON HEALTH PERSP, V114, P1730, DOI 10.1289/ehp.9067; Hutton JL, 1997, ARCH DIS CHILD-FETAL, V76, pF75, DOI 10.1136/fn.76.2.F75; Janssen AJWM, 2008, DEV MED CHILD NEUROL, V50, P926, DOI 10.1111/j.1469-8749.2008.03108.x; Jedrychowski W, 2007, ENVIRON INT, V33, P1057, DOI 10.1016/j.envint.2007.06.001; Jedrychowski W, 2010, PEDIAT ALLERG IMM-UK, V21, P550, DOI 10.1111/j.1399-3038.2009.00905.x; Jedrychowski W, 2009, EARLY HUM DEV, V85, P503, DOI 10.1016/j.earlhumdev.2009.04.006; Jedrychowski W, 2009, NEUROEPIDEMIOLOGY, V32, P270, DOI 10.1159/000203075; Koller K, 2004, ENVIRON HEALTH PERSP, V112, P987, DOI 10.1289/ehp.6941; LOZOFF B, 1995, INT J BEHAV DEV, V18, P277, DOI 10.1177/016502549501800206; Parajuli RP, 2014, NEUROTOXICOL TERATOL, V41, P89, DOI 10.1016/j.ntt.2013.12.006; Parajuli RP, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-56; Parajuli RP, 2013, ENVIRON RES, V121, P45, DOI 10.1016/j.envres.2012.10.010; Parajuli RP, 2012, BIOL TRACE ELEM RES; Parajuli RP, 2014, J TRACE ELEMENTS MED; Rauh VA, 2006, PEDIATRICS, V118, pE1845, DOI 10.1542/peds.2006-0338; Ribas-Fito N, 2003, PEDIATRICS, V111, pE580, DOI 10.1542/peds.111.5.e580; Rocha-Amador D, 2007, CAD SAUDE PUBLICA, V23, pS579, DOI 10.1590/S0102-311X2007001600018; Sandstead HH, 1998, AM J CLIN NUTR, V68, p470S, DOI 10.1093/ajcn/68.2.470S; Surkan PJ, 2008, NEUROTOXICOLOGY, V29, P278, DOI 10.1016/j.neuro.2007.11.006; Tamura T, 2003, AM J CLIN NUTR, V77, P1512, DOI 10.1093/ajcn/77.6.1512; Taneja S, 2005, J PEDIATR-US, V146, P506, DOI 10.1016/j.jpeds.2004.10.061; Tellez-Rojo MM, 2006, PEDIATRICS, V118, pE323, DOI 10.1542/peds.2005-3123; Tian LL, 2009, BIOL TRACE ELEM RES, V132, P51, DOI 10.1007/s12011-009-8391-0; Tofail F, 2009, ENVIRON HEALTH PERSP, V117, P288, DOI 10.1289/ehp.11670; Torres-Sanchez L, 2007, ENVIRON HEALTH PERSP, V115, P435, DOI 10.1289/ehp.9566; Torres-Sanchez L, 2009, NEUROTOXICOLOGY, V30, P1162, DOI 10.1016/j.neuro.2009.08.010; von Ehrenstein OS, 2007, EPIDEMIOLOGY, V18, P44, DOI 10.1097/01.ede.0000248900.65613.a9; Walkowiak J, 2001, LANCET, V358, P1602, DOI 10.1016/S0140-6736(01)06654-5; WANG JD, 1989, AM J IND MED, V15, P111, DOI 10.1002/ajim.4700150112; Wasserman GA, 2004, ENVIRON HEALTH PERSP, V112, P1329, DOI 10.1289/ehp.6964; WIGG NR, 1988, J EPIDEMIOL COMMUN H, V42, P213, DOI 10.1136/jech.42.3.213; Wright RO, 2006, NEUROTOXICOLOGY, V27, P210, DOI 10.1016/j.neuro.2005.10.001; Wu YT, 2008, J PEDIATR PSYCHOL, V33, P102, DOI 10.1093/jpepsy/jsm067	57	15	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0120992	10.1371/journal.pone.0120992	http://dx.doi.org/10.1371/journal.pone.0120992			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH2XV	25803364	Green Published, Green Submitted, gold			2022-12-26	WOS:000353889600112
J	Pennington, DL; Durazzo, TC; Schmidt, TP; Abe, C; Mon, A; Meyerhoff, DJ				Pennington, David L.; Durazzo, Timothy C.; Schmidt, Thomas P.; Abe, Christoph; Mon, Anderson; Meyerhoff, Dieter J.			Alcohol Use Disorder with and without Stimulant Use: Brain Morphometry and Its Associations with Cigarette Smoking, Cognition, and Inhibitory Control	PLOS ONE			English	Article							NATIONAL EPIDEMIOLOGIC SURVEY; MEDIAL ORBITOFRONTAL CORTEX; DSM-IV ALCOHOL; GRAY-MATTER; MAGNETIC-RESONANCE; NEUROCOGNITIVE RECOVERY; CORTICAL THICKNESS; UNITED-STATES; REWARD SYSTEM; SURFACE-AREA	Objective Little is known about the effects of polysubstance use and cigarette smoking on brain morphometry. This study examined neocortical brain morphometric differences between abstinent polysubstance dependent and alcohol-only dependent treatment seekers (ALC) as well as light drinking controls (CON), the associations of cigarette smoking in these polysubstance users (PSU), and morphometric relationships to cognition and inhibitory control. Methods All participants completed extensive neuropsychological assessments and 4 Tesla brain magnetic resonance imaging. PSU and ALC were abstinent for one month at the time of study. Parcellated morphological data (volume, surface area, thickness) were obtained with FreeSurfer methodology for the following bilateral components: dorso-prefrontal cortex (DPFC), anterior cingulate cortex (ACC), orbitofrontal cortex (OFC), and insula. Regional group differences were examined and structural data correlated with domains of cognition and inhibitory control. Results PSU had significantly smaller left OFC volume and surface area and trends to smaller right DPFC volume and surface area compared to CON; PSU did not differ significantly from ALC on these measures. PSU, however, had significantly thinner right ACC than ALC. Smoking PSU had significantly larger right OFC surface area than non-smoking PSU. No significant relationships between morphometry and quantity/frequency of substance use, alcohol use, or age of onset of heavy drinking were observed. PSU exhibited distinct relationships between brain structure and processing speed, cognitive efficiency, working memory and inhibitory control that were not observed in ALC or CON. Conclusion Polysubstance users have unique morphometric abnormalities and structure-function relationships when compared to individuals dependent only on alcohol and light drinking controls. Chronic cigarette smoking is associated with structural brain irregularities in polysubstance users. Further elucidation of these distinctive characteristics could help inform the development of targeted and thus potentially more effective treatments in this large but understudied population.	[Pennington, David L.] Vet Adm Med Ctr, Addict Res Program, San Francisco, CA 94121 USA; [Pennington, David L.] Northern Calif Inst Res & Educ, San Francisco, CA USA; [Durazzo, Timothy C.; Schmidt, Thomas P.; Meyerhoff, Dieter J.] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA; [Durazzo, Timothy C.; Meyerhoff, Dieter J.] Vet Adm Med Ctr, Ctr Imaging Neurodegenerat Dis, San Francisco, CA 94121 USA; [Abe, Christoph] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Mon, Anderson] Koforidua Polytech, Sch Appl Sci & Stat, Koforidua, Ghana	US Department of Veterans Affairs; Veterans Health Administration (VHA); Northern California Institute for Research & Education; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); Karolinska Institutet	Pennington, DL (corresponding author), Vet Adm Med Ctr, Addict Res Program, San Francisco, CA 94121 USA.	david.pennington2@va.gov	meyerhoff, dieter/A-7659-2017	meyerhoff, dieter/0000-0002-2433-7826; Abe, Christoph/0000-0002-1680-8480	National Institutes of Health (NIH) [AA10788, DA025202, DA24136]; Department of Defense [W81XWH-05-2-0094]; Mental Illness Research and Education Clinical Center of the US Veterans Health Administration; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA010788] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K01DA024136, R21DA025202] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Mental Illness Research and Education Clinical Center of the US Veterans Health Administration; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This project was supported by grants from the National Institutes of Health (NIH) AA10788 and DA025202 to DJM, NIH DA24136 and Department of Defense W81XWH-05-2-0094 to TCD, and the Mental Illness Research and Education Clinical Center of the US Veterans Health Administration. This material is also the result of work supported with resources and the use of facilities at the Veterans Administration Medical Center, San Francisco, California. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alia-Klein N, 2011, ARCH GEN PSYCHIAT, V68, P283, DOI 10.1001/archgenpsychiatry.2011.10; Almeida OP, 2008, AM J GERIAT PSYCHIAT, V16, P92, DOI 10.1097/JGP.0b013e318157cad2; Bechara A, 2007, IOWA GAMBLING TASK P; Beck AT, 1978, DEPRESSION INVENTORY; Brady KT, 2011, PHARMACOL BIOCHEM BE, V99, P285, DOI 10.1016/j.pbb.2011.04.017; Brody AL, 2004, BIOL PSYCHIAT, V55, P77, DOI 10.1016/S0006-3223(03)00610-3; Buckner RL, 2004, NEUROIMAGE, V23, P724, DOI 10.1016/j.neuroimage.2004.06.018; Buelow MT, 2009, NEUROPSYCHOL REV, V19, P102, DOI 10.1007/s11065-009-9083-4; Cadet JL, 2014, ACTA NEUROPATHOL, V127, P91, DOI 10.1007/s00401-013-1221-7; Cantrell H, 2008, ALCOHOL CLIN EXP RES, V32, P1398, DOI 10.1111/j.1530-0277.2008.00714.x; Clark KH, 2013, NEUROTOX RES, V23, P174, DOI 10.1007/s12640-012-9334-7; Cohen J.E., 1988, STAT POWER ANAL BEHA; Connor JP, 2014, CURR OPIN PSYCHIATR, V27, P269, DOI 10.1097/YCO.0000000000000069; Duka T, 2011, BIOL PSYCHIAT, V70, P545, DOI 10.1016/j.biopsych.2011.04.006; Durazzo TC, 2004, ALCOHOL CLIN EXP RES, V28, P1849, DOI 10.1097/01.ALC.0000148112.92525.AC; Durazzo TC, 2007, ALCOHOL ALCOHOLISM, V42, P174, DOI 10.1093/alcalc/agm020; Durazzo TC, 2007, ALCOHOL CLIN EXP RES, V31, P1114, DOI 10.1111/j.1530-0277.2007.00398.x; Durazzo TC, 2007, FRONT BIOSCI-LANDMRK, V12, P4079, DOI 10.2741/2373; Durazzo TC, 2007, DRUG ALCOHOL DEPEN, V87, P76, DOI 10.1016/j.drugalcdep.2006.08.003; Durazzo TC, 2015, ADDICT BIOL, V20, P956, DOI 10.1111/adb.12180; Durazzo TC, 2014, ALCOHOL CLIN EXP RES, V38, P2816, DOI 10.1111/acer.12552; Durazzo TC, 2014, ADDICT BIOL, V19, P132, DOI 10.1111/j.1369-1600.2012.00492.x; Durazzo TC, 2013, DRUG ALCOHOL DEPEN, V133, P704, DOI 10.1016/j.drugalcdep.2013.08.020; Durazzo TC, 2013, ADDICT BIOL, V18, P379, DOI 10.1111/j.1369-1600.2011.00407.x; Durazzo TC, 2011, ALCOHOL CLIN EXP RES, V35, P1187, DOI 10.1111/j.1530-0277.2011.01452.x; Durazzo TC, 2010, INT J ENV RES PUB HE, V7, P3760, DOI 10.3390/ijerph7103760; Durazzo TC, 2010, ALCOHOL ALCOHOLISM, V45, P507, DOI 10.1093/alcalc/agq057; Ersche KD, 2013, CURR OPIN NEUROBIOL, V23, P615, DOI 10.1016/j.conb.2013.02.017; Ersche KD, 2012, SCIENCE, V335, P601, DOI 10.1126/science.1214463; Ersche KD, 2011, BRAIN, V134, P2013, DOI 10.1093/brain/awr138; Eyler LT, 2011, CEREB CORTEX, V21, P2313, DOI 10.1093/cercor/bhr013; Fagerstrom K.O., 1991, ENT-EAR NOSE THROAT, V69, P763; Fein G, 2002, DRUG ALCOHOL DEPEN, V68, P87, DOI 10.1016/S0376-8716(02)00110-2; First M.B., 2016, STRUCTURED CLIN INTE; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Franklin TR, 2002, BIOL PSYCHIAT, V51, P134, DOI 10.1016/S0006-3223(01)01269-0; Gallinat J, 2006, EUR J NEUROSCI, V24, P1744, DOI 10.1111/j.1460-9568.2006.05050.x; Garavan H, 2013, CURR OPIN NEUROBIOL, V23, P668, DOI 10.1016/j.conb.2013.01.029; Gazdzinski S, 2005, ALCOHOL CLIN EXP RES, V29, P1484, DOI 10.1097/01.alc.0000175018.72488.61; Gazdzinski S, 2008, ALCOHOL, V42, P67, DOI 10.1016/j.alcohol.2008.01.002; Gazdzinski S, 2008, PSYCHIAT RES-NEUROIM, V162, P133, DOI 10.1016/j.pscychresns.2007.04.003; Glass JM, 2009, ADDICTION, V104, P38, DOI 10.1111/j.1360-0443.2008.02415.x; GLENN SW, 1992, J STUD ALCOHOL, V53, P546, DOI 10.15288/jsa.1992.53.546; Grodin EN, 2013, NEUROIMAGE-CLIN, V2, P469, DOI 10.1016/j.nicl.2013.03.013; Gruber SA, 2007, NEUROPSYCHOL REV, V17, P299, DOI 10.1007/s11065-007-9041-y; Hanlon CA, 2013, NEUROSCI BIOBEHAV R, V37, P2037, DOI 10.1016/j.neubiorev.2013.04.007; Hasin DS, 2007, ARCH GEN PSYCHIAT, V64, P830, DOI 10.1001/archpsyc.64.7.830; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; HOFMAN MA, 1989, PROG NEUROBIOL, V32, P137, DOI 10.1016/0301-0082(89)90013-0; IBM, 2012, SPSS STAT WIND VERS; Kalivas PW, 2005, AM J PSYCHIAT, V162, P1403, DOI 10.1176/appi.ajp.162.8.1403; Koob GF, 2009, NEUROPHARMACOLOGY, V56, P18, DOI 10.1016/j.neuropharm.2008.07.043; Kuhn S, 2012, BRAIN STRUCT FUNCT, V217, P517, DOI 10.1007/s00429-011-0346-5; Kuhn S, 2010, BIOL PSYCHIAT, V68, P1061, DOI 10.1016/j.biopsych.2010.08.004; Lawyer Glenn, 2010, BMC Pharmacology, V10, P5, DOI 10.1186/1471-2210-10-5; Lejuez CW, 2002, J EXP PSYCHOL-APPL, V8, P75, DOI 10.1037//1076-898X.8.2.75; Liao YH, 2012, ADDICT BIOL, V17, P977, DOI 10.1111/j.1369-1600.2010.00250.x; Licata SC, 2010, ANN NY ACAD SCI, V1187, P148, DOI 10.1111/j.1749-6632.2009.05143.x; Liu X, 1998, NEUROPSYCHOPHARMACOL, V18, P243; Mackey S, 2013, NEUROSCI BIOBEHAV R, V37, P300, DOI 10.1016/j.neubiorev.2012.12.003; Makris N, 2008, NEURON, V60, P174, DOI 10.1016/j.neuron.2008.08.011; Makris N, 2008, BIOL PSYCHIAT, V64, P192, DOI 10.1016/j.biopsych.2008.01.018; Makris N, 2007, CEREB CORTEX, V17, P1364, DOI 10.1093/cercor/bhl047; Matochik JA, 2003, NEUROIMAGE, V19, P1095, DOI 10.1016/S1053-8119(03)00244-1; MCLELLAN AT, 1992, J SUBST ABUSE TREAT, V9, P199, DOI 10.1016/0740-5472(92)90062-S; Mertens JR, 2003, ARCH INTERN MED, V163, P2511, DOI 10.1001/archinte.163.20.2511; Mertens JR, 2005, ALCOHOL CLIN EXP RES, V29, P989, DOI 10.1097/01.ALC.0000167958.68586.3D; Mon A, 2009, ALCOHOL CLIN EXP RES, V33, P1314, DOI 10.1111/j.1530-0277.2009.00960.x; Moreno-Lopez L, 2012, DRUG ALCOHOL DEPEN, V125, P208, DOI 10.1016/j.drugalcdep.2012.02.012; Moss HB, 2010, ALCOHOL CLIN EXP RES, V34, P1073, DOI 10.1111/j.1530-0277.2010.01183.x; Nakama H, 2011, ADDICTION, V106, P1474, DOI 10.1111/j.1360-0443.2011.03433.x; Nixon SJ, 1998, ALCOHOL CLIN EXP RES, V22, P1414, DOI 10.1111/j.1530-0277.1998.tb03929.x; NIXON SJ, 1995, ALCOHOL CLIN EXP RES, V19, P577, DOI 10.1111/j.1530-0277.1995.tb01551.x; O'Neill J, 2001, ADDICT BIOL, V6, P347, DOI 10.1080/13556210020077073; Parekh RS, 2001, CURR OPIN NEPHROL HY, V10, P385, DOI 10.1097/00041552-200105000-00014; Patkar AA, 2006, AM J DRUG ALCOHOL AB, V32, P135, DOI 10.1080/00952990500479209; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; Pennington DL, 2013, ALCOHOL CLIN EXP RES, V37, P1220, DOI 10.1111/acer.12089; PFEFFERBAUM A, 1995, ALCOHOL CLIN EXP RES, V19, P1177, DOI 10.1111/j.1530-0277.1995.tb01598.x; Porrino LJ, 2007, PROG NEURO-PSYCHOPH, V31, P1593, DOI 10.1016/j.pnpbp.2007.08.040; Rando K, 2011, AM J PSYCHIAT, V168, P183, DOI 10.1176/appi.ajp.2010.10020233; Rogers RD, 2001, CURR OPIN NEUROBIOL, V11, P250, DOI 10.1016/S0959-4388(00)00204-X; Rourke S. B., 2009, NEUROPSYCHOLOGICAL A, P398; Sankoh AJ, 1997, STAT MED, V16, P2529, DOI 10.1002/(SICI)1097-0258(19971130)16:22<2529::AID-SIM692>3.0.CO;2-J; Schwartz DL, 2010, NEUROIMAGE, V50, P1392, DOI 10.1016/j.neuroimage.2010.01.056; SKINNER HA, 1982, J STUD ALCOHOL, V43, P1157, DOI 10.15288/jsa.1982.43.1157; Smith SS, 1991, ADDICTIVE DRUG SURVE; SOBELL LC, 1990, BEHAV ASSESS, V12, P77; SOBELL LC, 1988, BRIT J ADDICT, V83, P393; Sofuoglu M, 2013, NEUROPHARMACOLOGY, V64, P452, DOI 10.1016/j.neuropharm.2012.06.021; Spielberger C. D., 1977, SELF EVALUATION QUES; Spielberger CD, 1999, STAXI 2 STATE TRAIT; Spronk DB, 2013, NEUROSCI BIOBEHAV R, V37, P1838, DOI 10.1016/j.neubiorev.2013.07.003; Stark M J, 1993, J Subst Abuse, V5, P175, DOI 10.1016/0899-3289(93)90060-O; Stinson FS, 2005, DRUG ALCOHOL DEPEN, V80, P105, DOI 10.1016/j.drugalcdep.2005.03.009; Swan GE, 2007, NEUROPSYCHOL REV, V17, P259, DOI 10.1007/s11065-007-9035-9; Tanabe J, 2013, AM J NEURORADIOL, V34, P1150, DOI 10.3174/ajnr.A3347; Tanabe J, 2009, BIOL PSYCHIAT, V65, P160, DOI 10.1016/j.biopsych.2008.07.030; Vocci FJ, 2008, EXP CLIN PSYCHOPHARM, V16, P484, DOI 10.1037/a0014101; Volkow ND, 2004, NEUROPHARMACOLOGY, V47, P3, DOI 10.1016/j.neuropharm.2004.07.019; Volkow Nora D, 2012, Annu Rev Pharmacol Toxicol, V52, P321, DOI 10.1146/annurev-pharmtox-010611-134625; Volkow ND, 2012, SCIENCE, V335, P546, DOI 10.1126/science.1218170; Winkler AM, 2010, NEUROIMAGE, V53, P1135, DOI 10.1016/j.neuroimage.2009.12.028; Yu R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021255	105	28	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0122505	10.1371/journal.pone.0122505	http://dx.doi.org/10.1371/journal.pone.0122505			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH2XV	25803861	Green Published, gold, Green Submitted			2022-12-26	WOS:000353889600201
J	Alig, SK; Stampnik, Y; Pircher, J; Rotter, R; Gaitzsch, E; Ribeiro, A; Wornle, M; Krotz, F; Mannell, H				Alig, Stefan K.; Stampnik, Yvonn; Pircher, Joachim; Rotter, Raffaela; Gaitzsch, Erik; Ribeiro, Andrea; Woernle, Markus; Kroetz, Florian; Mannell, Hanna			The Tyrosine Phosphatase SHP-1 Regulates Hypoxia Inducible Factor-1 alpha (HIF-1 alpha) Protein Levels in Endothelial Cells under Hypoxia	PLOS ONE			English	Article							FOCAL CEREBRAL-ISCHEMIA; GROWTH-FACTOR GENE; TRANSCRIPTIONAL REGULATION; SIGNAL-TRANSDUCTION; IN-VITRO; OXYGEN; ACTIVATION; ANGIOGENESIS; INHIBITION; DELIVERY	Introduction The tyrosine phosphatase SHP-1 negatively influences endothelial function, such as VEGF signaling and reactive oxygen species (ROS) formation, and has been shown to influence angiogenesis during tissue ischemia. In ischemic tissues, hypoxia induced angiogenesis is crucial for restoring oxygen supply. However, the exact mechanism how SHP-1 affects endothelial function during ischemia or hypoxia remains unclear. We performed in vitro endothelial cell culture experiments to characterize the role of SHP-1 during hypoxia. Results SHP-1 knock-down by specific antisense oligodesoxynucleotides (AS-Odn) increased cell growth as well as VEGF synthesis and secretion during 24 hours of hypoxia compared to control AS-Odn. This was prevented by HIF-1 alpha inhibition (echinomycin and apigenin). SHP1 knock-down as well as overexpression of a catalytically inactive SHP-1 (SHP-1 CS) further enhanced HIF-1 alpha protein levels, whereas overexpression of a constitutively active SHP-1 (SHP-1 E74A) resulted in decreased HIF-1 alpha levels during hypoxia, compared to wildtype SHP-1. Proteasome inhibition (MG132) returned HIF-1 alpha levels to control or wildtype levels respectively in these cells. SHP-1 silencing did not alter HIF-1 alpha mRNA levels. Finally, under hypoxic conditions SHP-1 knock-down enhanced intracellular endothelial reactive oxygen species (ROS) formation, as measured by oxidation of H-2-DCF and DHE fluorescence. Conclusions SHP-1 decreases half-life of HIF-1 alpha under hypoxic conditions resulting in decreased cell growth due to diminished VEGF synthesis and secretion. The regulatory effect of SHP-1 on HIF-1 alpha stability may be mediated by inhibition of endothelial ROS formation stabilizing HIF-1 alpha protein. These findings highlight the importance of SHP-1 in hypoxic signaling and its potential as therapeutic target in ischemic diseases.	[Alig, Stefan K.; Stampnik, Yvonn; Pircher, Joachim; Rotter, Raffaela; Gaitzsch, Erik; Mannell, Hanna] Univ Munich, Walter Brendel Ctr Expt Med, Munich, Germany; [Alig, Stefan K.] Univ Munich, Dept Internal Med 3, Munich, Germany; [Pircher, Joachim] Univ Munich, Dept Internal Med 1, Munich, Germany; [Ribeiro, Andrea; Woernle, Markus] Univ Munich, Dept Internal Med 4, Munich, Germany; [Kroetz, Florian] Starnberg Community Hosp, Intervent Cardiol, Starnberg, Germany	University of Munich; University of Munich; University of Munich; University of Munich	Mannell, H (corresponding author), Univ Munich, Walter Brendel Ctr Expt Med, Munich, Germany.	hanna.mannell@lrz.uni-muenchen.de	Mannell, Hanna/AAD-4282-2020	Alig, Stefan Karl Christian/0000-0001-6825-702X	Friedrich-Baur-Stiftung, Germany	Friedrich-Baur-Stiftung, Germany	This work was supported by a grant from the Friedrich-Baur-Stiftung, Germany (HM, http://www.klinikum.uni-muenchen.de/Friedrich-Baur-Institut/de/institut/friedrich_baur_stiftung/) and contains parts of the doctoral thesis of SA submitted to the medical faculty of the Ludwigs-Maximilians-University Munich, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADES EW, 1992, J INVEST DERMATOL, V99, P683, DOI 10.1111/1523-1747.ep12613748; Beamer CA, 2006, J NEUROSCI RES, V83, P1220, DOI 10.1002/jnr.20825; Brahimi-Horn MC, 2009, J CELL SCI, V122, P1055, DOI 10.1242/jcs.035022; Chandel NS, 2000, J BIOL CHEM, V275, P25130, DOI 10.1074/jbc.M001914200; Chandel NS, 1998, P NATL ACAD SCI USA, V95, P11715, DOI 10.1073/pnas.95.20.11715; Chao S-C, 2013, EVID-BASED COMPL ALT, V2013, DOI [10.1155/2013/817674, DOI 10.1155/2013/817674]; Cho SW, 2008, BIOCHEM BIOPH RES CO, V376, P158, DOI 10.1016/j.bbrc.2008.08.123; Craggs G, 2001, J BIOL CHEM, V276, P23719, DOI 10.1074/jbc.M102846200; Ferrara N, 1997, ENDOCR REV, V18, P4, DOI 10.1210/er.18.1.4; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Fraisl P, 2009, DEV CELL, V16, P167, DOI 10.1016/j.devcel.2009.01.003; Gerber HP, 1997, J BIOL CHEM, V272, P23659, DOI 10.1074/jbc.272.38.23659; Kallio PJ, 1998, EMBO J, V17, P6573, DOI 10.1093/emboj/17.22.6573; Kim D, 2013, J CONTROL RELEASE, V168, P125, DOI 10.1016/j.jconrel.2013.02.031; Klimova T, 2008, CELL DEATH DIFFER, V15, P660, DOI 10.1038/sj.cdd.4402307; Koch E, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/279781; Kong DH, 2005, CANCER RES, V65, P9047, DOI 10.1158/0008-5472.CAN-05-1235; Krotz F, 2003, MOL THER, V7, P700, DOI 10.1016/S1525-0016(03)00065-0; Krotz F, 2005, J AM COLL CARDIOL, V45, P1700, DOI 10.1016/j.jacc.2005.02.039; Krotz F, 2003, J VASC RES, V40, P425, DOI 10.1159/000073901; Lee HY, 2011, CARCINOGENESIS, V32, P703, DOI 10.1093/carcin/bgr034; Lee S, 2007, CELL, V130, P691, DOI 10.1016/j.cell.2007.06.054; Lopez-Ruiz P, 2011, ANTI-CANCER AGENT ME, V11, P89, DOI 10.2174/187152011794941154; Mannell H, 2008, J VASC RES, V45, P153, DOI 10.1159/000110081; Mannell H, 2010, CELL SIGNAL, V22, P88, DOI 10.1016/j.cellsig.2009.09.015; Mei S, 2012, J PATHOL, V226, P519, DOI 10.1002/path.3006; Mirzoeva S, 2008, MOL CARCINOGEN, V47, P686, DOI 10.1002/mc.20421; Moon EJ, 2010, P NATL ACAD SCI USA, V107, P20477, DOI 10.1073/pnas.1006646107; Nishi K, 2008, ANTIOXID REDOX SIGN, V10, P983, DOI 10.1089/ars.2007.1825; Pages G, 2005, CARDIOVASC RES, V65, P564, DOI 10.1016/j.cardiores.2004.09.032; Patten DA, 2010, MOL BIOL CELL, V21, P3247, DOI 10.1091/mbc.E10-01-0025; Rhim T, 2013, J CONTROL RELEASE, V172, P484, DOI 10.1016/j.jconrel.2013.05.021; Semenza GL, 2000, J APPL PHYSIOL, V88, P1474, DOI 10.1152/jappl.2000.88.4.1474; Semenza GL, 2002, BIOCHEM PHARMACOL, V64, P993, DOI 10.1016/S0006-2952(02)01168-1; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Sowter HM, 2003, CANCER RES, V63, P6130; Sugano M, 2005, FASEB J, V19, P2054, DOI 10.1096/fj.05-4020fje; Sugano M, 2007, ATHEROSCLEROSIS, V191, P33, DOI 10.1016/j.atherosclerosis.2006.04.021; Tang N, 2004, CANCER CELL, V6, P485, DOI 10.1016/j.ccr.2004.09.026; Waltenberger J, 1996, CIRCULATION, V94, P1647, DOI 10.1161/01.CIR.94.7.1647; Wishcamper CA, 2003, BRAIN RES, V974, P88, DOI 10.1016/S0006-8993(03)02564-2; Won YW, 2013, J CONTROL RELEASE, V165, P22, DOI 10.1016/j.jconrel.2012.10.014	42	12	15	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121113	10.1371/journal.pone.0121113	http://dx.doi.org/10.1371/journal.pone.0121113			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799543	gold, Green Submitted, Green Published			2022-12-26	WOS:000351987300211
J	Bach, EC; Halmos, KC; Smith, BN				Bach, Eva C.; Halmos, Katalin Cs.; Smith, Bret N.			Enhanced NMDA Receptor-Mediated Modulation of Excitatory Neurotransmission in the Dorsal Vagal Complex of Streptozotocin-Treated, Chronically Hyperglycemic Mice	PLOS ONE			English	Article							NUCLEUS-TRACTUS-SOLITARII; MOTOR NUCLEUS; GLUTAMATE RELEASE; SYNAPTIC-TRANSMISSION; TONIC FACILITATION; NERVOUS-SYSTEM; RAT NUCLEUS; NEURONS; GLUCOSE; PLASTICITY	A variety of metabolic disorders, including complications experienced by diabetic patients, have been linked to altered neural activity in the dorsal vagal complex. This study tested the hypothesis that augmentation of N-Methyl-D-Aspartate (NMDA) receptor-mediated responses in the vagal complex contributes to increased glutamate release in the dorsal motor nucleus of the vagus nerve (DMV) in mice with streptozotocin-induced chronic hyperglycemia (i.e., hyperglycemic mice), a model of type 1 diabetes. Antagonism of NMDA receptors with AP-5 (100 mu M) suppressed sEPSC frequency in vagal motor neurons recorded in vitro, confirming that constitutively active NMDA receptors regulate glutamate release in the DMV. There was a greater relative effect of NMDA receptor antagonism in hyperglycemic mice, suggesting that augmented NMDA effects occur in neurons presynaptic to the DMV. Effects of NMDA receptor blockade on mEPSC frequency were equivalent in control and diabetic mice, suggesting that differential effects on glutamate release were due to altered NMDA function in the soma-dendritic membrane of intact afferent neurons. Application of NMDA (300 mu M) resulted in greater inward current and current density in NTS neurons recorded from hyperglycemic than control mice, particularly in glutamatergic NTS neurons identified by single-cell RT-PCR for VGLUT2. Overall expression of NR1 protein and message in the dorsal vagal complex were not different between the two groups. Enhanced postsynaptic NMDA responsiveness of glutamatergic NTS neurons is consistent with tonically-increased glutamate release in the DMV in mice with chronic hyperglycemia. Functional augmentation of NMDA-mediated responses may serve as a physiological counter-regulatory mechanism to control pathological disturbances of homeostatic autonomic function in type 1 diabetes.	[Bach, Eva C.; Halmos, Katalin Cs.; Smith, Bret N.] Univ Kentucky, Coll Med, Dept Physiol, Lexington, KY 40506 USA	University of Kentucky	Smith, BN (corresponding author), Univ Kentucky, Coll Med, Dept Physiol, Lexington, KY 40506 USA.	bret.smith@uky.edu			BNS: National Institute of Child Health and Development [R21 HD079256]; BNS: National Institute of Diabetes and Digestive and Kidney Diseases [R01 DK056132, R01 DK080901]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R21HD079256] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080901, R01DK056132] Funding Source: NIH RePORTER	BNS: National Institute of Child Health and Development; BNS: National Institute of Diabetes and Digestive and Kidney Diseases; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The work was supported by the following: BNS: National Institute of Child Health and Development R21 HD079256 www.nichd.nih.gov; BNS: National Institute of Diabetes and Digestive and Kidney Diseases R01 DK056132 www.niddk.nih.gov; and BNS: National Institute of Diabetes and Digestive and Kidney Diseases R01 DK080901 www.niddk.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahren B, 1996, DIABETOLOGIA, V39, P383, DOI 10.1007/BF00400669; AOKI C, 1994, J NEUROSCI, V14, P5202; Babic T, 2012, NEUROGASTROENT MOTIL, V24, pe476, DOI 10.1111/j.1365-2982.2012.01987.x; Bach EC, 2012, J NEUROPHYSIOL, V108, P1484, DOI 10.1152/jn.01036.2011; Balfour RH, 2006, J PHYSIOL-LONDON, V570, P469, DOI 10.1113/jphysiol.2005.098822; Balfour RH, 2007, J PHYSIOL-LONDON, V579, P691, DOI 10.1113/jphysiol.2006.126094; Berretta N, 1996, NEUROSCIENCE, V75, P339, DOI 10.1016/0306-4522(96)00301-6; Blake CB, 2012, AM J PHYSIOL-REG I, V303, pR807, DOI 10.1152/ajpregu.00276.2012; Browning KN, 2007, J NEUROSCI, V27, P8979, DOI 10.1523/JNEUROSCI.1105-07.2007; Browning KN, 2011, AUTON NEUROSCI-BASIC, V161, P6, DOI 10.1016/j.autneu.2010.11.001; Carnethon MR, 2003, DIABETES CARE, V26, P3035, DOI 10.2337/diacare.26.11.3035; Chen CY, 1998, AM J PHYSIOL-HEART C, V275, pH1695, DOI 10.1152/ajpheart.1998.275.5.H1695; Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; Davis SF, 2004, BRAIN RES, V1017, P208, DOI 10.1016/j.brainres.2004.05.049; Davis SF, 2003, J NEUROSCI, V23, P3844; de Vries MG, 2003, DIABETES, V52, P2767, DOI 10.2337/diabetes.52.11.2767; Derbenev AV, 2006, J NEUROSCI, V26, P9666, DOI 10.1523/JNEUROSCI.1591-06.2006; Ferreira M, 2001, J PHYSIOL-LONDON, V536, P141, DOI 10.1111/j.1469-7793.2001.t01-1-00141.x; Gao H, 2009, BRAIN RES, V1291, P40, DOI 10.1016/j.brainres.2009.07.024; Glatzer NR, 2007, J NEUROPHYSIOL, V98, P1591, DOI 10.1152/jn.00336.2007; Glatzer NR, 2005, J NEUROPHYSIOL, V93, P2530, DOI 10.1152/jn.00429.2004; Glitsch M, 1999, J NEUROSCI, V19, P511; Goebel-Goody SM, 2009, NEUROSCIENCE, V158, P1446, DOI 10.1016/j.neuroscience.2008.11.006; GROSS PM, 1990, AM J PHYSIOL, V259, pR1131, DOI 10.1152/ajpregu.1990.259.6.R1131; Horvath TL, 2005, CELL METAB, V1, P279, DOI 10.1016/j.cmet.2005.03.003; Iwai T, 2009, NEUROSCI RES, V64, P67, DOI 10.1016/j.neures.2009.01.013; Kalappa BI, 2011, AM J PHYSIOL-CELL PH, V301, pC347, DOI 10.1152/ajpcell.00473.2010; KALIA M, 1980, J COMP NEUROL, V193, P435, DOI 10.1002/cne.901930210; KALIA M, 1980, J COMP NEUROL, V193, P467, DOI 10.1002/cne.901930211; Kraska A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046196; Lam CKL, 2011, DIABETES, V60, P107, DOI 10.2337/db10-0994; Li SP, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-58; Lin LH, 2006, J CHEM NEUROANAT, V32, P54, DOI 10.1016/j.jchemneu.2006.04.004; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; MERCHENTHALER I, 1991, NEUROSCIENCE, V44, P655, DOI 10.1016/0306-4522(91)90085-3; Neff RA, 1998, CIRC RES, V83, P1241, DOI 10.1161/01.RES.83.12.1241; PAGANI FD, 1985, AM J PHYSIOL, V249, pG73, DOI 10.1152/ajpgi.1985.249.1.G73; Paoletti P, 2013, NAT REV NEUROSCI, V14, P383, DOI 10.1038/nrn3504; Pocai A, 2005, CELL METAB, V1, P53, DOI 10.1016/j.cmet.2004.11.001; Rai S, 2014, PHARMACOL BIOCHEM BE, V117, P104, DOI 10.1016/j.pbb.2013.11.035; RITTER RC, 1981, SCIENCE, V213, P451, DOI 10.1126/science.6264602; Ritter RC, 2011, PHYSIOL BEHAV, V105, P94, DOI 10.1016/j.physbeh.2011.02.042; Ritter S, 2000, BRAIN RES, V856, P37, DOI 10.1016/S0006-8993(99)02327-6; SALTZMAN MB, 1983, YALE J BIOL MED, V56, P179; Santos TD, 2012, PHYSIOL BEHAV, V107, P401, DOI 10.1016/j.physbeh.2012.06.019; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; Seagard JL, 1999, J PHYSIOL-LONDON, V520, P243, DOI 10.1111/j.1469-7793.1999.00243.x; Smith BN, 1998, J PHYSIOL-LONDON, V512, P149, DOI 10.1111/j.1469-7793.1998.149bf.x; Travagli RA, 2007, J PHYSIOL-LONDON, V582, P471, DOI 10.1113/jphysiol.2007.137091; Travagli RA, 2006, ANNU REV PHYSIOL, V68, P279, DOI 10.1146/annurev.physiol.68.040504.094635; TRAVAGLI RA, 1991, AM J PHYSIOL, V260, pG531, DOI 10.1152/ajpgi.1991.260.3.G531; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Trudeau F, 2004, EUR J PHARMACOL, V490, P177, DOI 10.1016/j.ejphar.2004.02.055; Undeland KA, 1998, SCAND J GASTROENTERO, V33, P236; Wan SX, 2008, AM J PHYSIOL-GASTR L, V294, pG757, DOI 10.1152/ajpgi.00576.2007; WANG YT, 1994, NATURE, V369, P233, DOI 10.1038/369233a0; Williams KW, 2007, ENDOCRINOLOGY, V148, P1868, DOI 10.1210/en.2006-1098; Yang J, 2006, J NEUROSCI, V26, P406, DOI 10.1523/JNEUROSCI.4413-05.2006; Yu XM, 1997, SCIENCE, V275, P674, DOI 10.1126/science.275.5300.674; Zsombok A, 2011, J NEUROSCI, V31, P14024, DOI 10.1523/JNEUROSCI.2081-11.2011	61	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121022	10.1371/journal.pone.0121022	http://dx.doi.org/10.1371/journal.pone.0121022			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799386	gold, Green Published, Green Submitted			2022-12-26	WOS:000351987300199
J	Czemmel, S; Galarneau, ER; Travadon, R; McElrone, AJ; Cramer, GR; Baumgartner, K				Czemmel, Stefan; Galarneau, Erin R.; Travadon, Renaud; McElrone, Andrew J.; Cramer, Grant R.; Baumgartner, Kendra			Genes Expressed in Grapevine Leaves Reveal Latent Wood Infection by the Fungal Pathogen Neofusicoccum parvum	PLOS ONE			English	Article							CV CABERNET-SAUVIGNON; ESCA DISEASE; EUTYPA-LATA; PLANT; BOTRYOSPHAERIACEAE; TRANSCRIPTOME; TRUNK; XYLEM; INOCULATION; ENDOPHYTES	Some pathogenic species of the Botryosphaeriaceae have a latent phase, colonizing woody tissues while perennial hosts show no apparent symptoms until conditions for disease development become favorable. Detection of these pathogens is often limited to the later pathogenic phase. The latent phase is poorly characterized, despite the need for non-destructive detection tools and effective quarantine strategies, which would benefit from identification of host-based markers in leaves. Neofusicoccum parvum infects the wood of grapevines and other horticultural crops, killing the fruit-bearing shoots. We used light microscopy and high-resolution computed tomography (HRCT) to examine the spatiotemporal relationship between pathogen colonization and anatomical changes in stem sections. To identify differentially-expressed grape genes, leaves from inoculated and noninoculated plants were examined using RNA-Seq. The latent phase occurred between 0 and 1.5 months post-inoculation (MPI), during which time the pathogen did not spread significantly beyond the inoculation site nor were there differences in lesion lengths between inoculated and non-inoculated plants. The pathogenic phase occurred between 1.5 and 2 MPI, when recovery beyond the inoculation site increased and lesion lengths of inoculated plants tripled. By 2 MPI, inoculated plants also had decreased starch content in xylem fibers and rays, and increased levels of gel-occluded xylem vessels, the latter of which HRCT revealed at a higher frequency than microscopy. RNA-Seq and screening of 21 grape expression datasets identified 20 candidate genes that were transcriptionally-activated by infection during the latent phase, and confirmed that the four best candidates (galactinol synthase, abscisic acid-induced wheat plasma membrane polypeptide-19 ortholog, embryonic cell protein 63, BURP domain-containing protein) were not affected by a range of common foliar and wood pathogens or abiotic stresses. Assuming such host responses are consistent among cultivars, and do not cross react with other trunk/foliar pathogens, these grape genes may serve as host-based markers of the latent phase of N. parvum infection.	[Czemmel, Stefan; Cramer, Grant R.] Univ Nevada, Dept Biochem & Mol Biol, Reno, NV 89557 USA; [Galarneau, Erin R.; McElrone, Andrew J.; Baumgartner, Kendra] USDA ARS, Davis, CA 94710 USA; [Travadon, Renaud] Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA	Nevada System of Higher Education (NSHE); University of Nevada Reno; United States Department of Agriculture (USDA); University of California System; University of California Davis	Baumgartner, K (corresponding author), USDA ARS, Davis, CA 94710 USA.	kbaumgartner@ucdavis.edu	Cramer, Grant R/E-1815-2011	Travadon, Renaud/0000-0001-6062-1755; McElrone, Andrew/0000-0001-9466-4761	United States Department of Agriculture, National Institute of Food and Agriculture, Specialty Crop Research Initiative [2012-51181-19954]; ARS [ARS-0426234] Funding Source: Federal RePORTER	United States Department of Agriculture, National Institute of Food and Agriculture, Specialty Crop Research Initiative; ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This research was funded by grant 2012-51181-19954 to Baumgartner and Cramer from the United States Department of Agriculture, National Institute of Food and Agriculture, Specialty Crop Research Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahimera N, 2003, PLANT DIS, V87, P846, DOI 10.1094/PDIS.2003.87.7.846; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Berger S, 2007, J EXP BOT, V58, P4019, DOI 10.1093/jxb/erm298; Bertsch C, 2013, PLANT PATHOL, V62, P243, DOI 10.1111/j.1365-3059.2012.02674.x; Blanco-Ulate B, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00339-13; Bogs J, 2005, PLANT PHYSIOL, V139, P652, DOI 10.1104/pp.105.064238; Brodersen CR, 2011, NEW PHYTOL, V191, P1168, DOI 10.1111/j.1469-8137.2011.03754.x; Brunner E, 2002, NONPARAMETRIC ANAL L; Camps C, 2010, J EXP BOT, V61, P1719, DOI 10.1093/jxb/erq040; Christen D, 2007, ENVIRON EXP BOT, V60, P504, DOI 10.1016/j.envexpbot.2007.02.003; De Vos M, 2005, MOL PLANT MICROBE IN, V18, P923, DOI 10.1094/MPMI-18-0923; Downey MO, 2003, AUST J GRAPE WINE R, V9, P110, DOI 10.1111/j.1755-0238.2003.tb00261.x; Fasoli M, 2012, PLANT CELL, V24, P3489, DOI 10.1105/tpc.112.100230; Fung RWM, 2008, PLANT PHYSIOL, V146, P236, DOI 10.1104/pp.107.108712; Gambino G, 2008, PHYTOCHEM ANALYSIS, V19, P520, DOI 10.1002/pca.1078; HammondKosack KE, 1996, PLANT CELL, V8, P1773, DOI 10.1105/tpc.8.10.1773; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Letousey P, 2010, PHYTOPATHOLOGY, V100, P424, DOI 10.1094/PHYTO-100-5-0424; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lima MRM, 2010, J EXP BOT, V61, P4033, DOI 10.1093/jxb/erq214; Liu GT, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-174; Luini E, 2010, PHYSIOL MOL PLANT P, V74, P403, DOI 10.1016/j.pmpp.2010.06.007; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Magnin-Robert M, 2011, FUNCT PLANT BIOL, V38, P856, DOI 10.1071/FP11083; Martin JA, 2005, PHYTOCHEMISTRY, V66, P2458, DOI 10.1016/j.phytochem.2005.08.004; Martinelli F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038039; McElrone AJ, 2013, JOVE-J VIS EXP, DOI 10.3791/50162; MUNKVOLD GP, 1994, PHYTOPATHOLOGY, V84, P186, DOI 10.1094/Phyto-84-186; Pontin MA, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-224; Pouzoulet J, 2013, PHYTOPATHOL MEDITERR, V52, P313; Ramirez-Suero M, 2014, PROTOPLASMA, V251, P1417, DOI 10.1007/s00709-014-0643-y; Rolshausen PE, 2008, PHYTOPATHOLOGY, V98, P222, DOI 10.1094/PHYTO-98-2-0222; Rolshausen PE, 2005, PLANT DIS, V89, P734, DOI 10.1094/PD-89-0734; Rolshausen PE, 2010, AM J ENOL VITICULT, V61, P113; Rudelle J, 2005, FUNCT PLANT BIOL, V32, P537, DOI 10.1071/FP05012; Ruiz E, 2002, J PHYTOPATHOL, V150, P76, DOI 10.1046/j.1439-0434.2002.00720.x; Saikkonen K, 1998, ANNU REV ECOL SYST, V29, P319, DOI 10.1146/annurev.ecolsys.29.1.319; Shah DA, 2004, PHYTOPATHOLOGY, V94, P33, DOI 10.1094/PHYTO.2004.94.1.33; Siebert J.B., 2001, WINES VINES, V4, P50; Slippers Bernard, 2007, Fungal Biology Reviews, V21, P90, DOI 10.1016/j.fbr.2007.06.002; Spagnolo A, 2014, PHYTOPATHOLOGY, V104, P1021, DOI 10.1094/PHYTO-01-14-0007-R; Sun Q, 2006, AM J BOT, V93, P1567, DOI 10.3732/ajb.93.11.1567; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Travadon R, 2013, PLANT DIS, V97, P1529, DOI 10.1094/PDIS-05-13-0525-RE; Urbez-Torres JR, 2010, PLANT DIS, V94, P717, DOI 10.1094/PDIS-94-6-0717; Urbez-Torres JR, 2011, PHYTOPATHOL MEDITERR, V50, pS5; van der Laan MJ, 2003, J STAT PLAN INFER, V117, P275, DOI 10.1016/S0378-3758(02)00388-9; VERAESTRELLA R, 1994, PLANT PHYSIOL, V106, P97, DOI 10.1104/pp.106.1.97; Voegele RT, 2001, P NATL ACAD SCI USA, V98, P8133, DOI 10.1073/pnas.131186798; Weber EA, 2007, AM J ENOL VITICULT, V58, P61; Wilcox WW, 1964, FPL056 USDA FOR SERV; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134	53	37	37	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121828	10.1371/journal.pone.0121828	http://dx.doi.org/10.1371/journal.pone.0121828			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798871	Green Published, Green Submitted, gold			2022-12-26	WOS:000351987300294
J	De Baetselier, I; Menten, J; Cuylaerts, V; Ahmed, K; Deese, J; Van Damme, L; Crucitti, T				De Baetselier, Irith; Menten, Joris; Cuylaerts, Vicky; Ahmed, Khatija; Deese, Jennifer; Van Damme, Lut; Crucitti, Tania			Prevalence and Incidence Estimation of HSV-2 by Two IgG ELISA Methods among South African Women at High Risk of HIV	PLOS ONE			English	Article							SIMPLEX-VIRUS TYPE-2; LINKED IMMUNOSORBENT ASSAYS; ENZYME IMMUNOASSAYS; SEROLOGICAL ASSAYS; MALE CIRCUMCISION; ANTIBODIES; PERFORMANCE; INFECTION; FOCUS; HERPESELECT	Introduction Previous comparison studies of the Kalon and HerpeSelect 2 ELISA IgG assays on sub-Saharan samples have found differences in the sensitivity and specificity of these assays. Using longitudinal samples from an HIV prevention study, we compared both assays and determined the HSV-2 prevalence and incidence in a South African young female population at elevated risk of acquiring HIV. Methods Samples at baseline were tested in both assays using the manufacturers' guidelines (cut-off > 1.10). When non-reactive in one assay, the final visit samples were tested to determine the incidence rate. Using correlation and regression analyses, the intra-and inter-assay variabilities were assessed. Results The prevalence rate was 41.1% and 44.9% for Kalon and HerpeSelect using the manufacturer guidelines, respectively. Agreement between the two tests were high (kappa = 0.92). The original optical density values of both assays were highly correlated (R = 0.94), but the calibrator and correspondingly cut-off index values differed between the assays. Lowering the index value cut-off for the Kalon assay by 40% (to 0.66) resulted in a HSV-2 prevalence of 43.2%, and increased agreement between the assays (to kappa = 0.96). The incidence rate was 16.3/100 Person Years using the lower cut-off for the Kalon assay. Discussion In this longitudinal study, we showed that the performance of the two assays was very similar. After lowering the cut-off for the Kalon assay to 0.66 early infections were detected without impairing its specificity. The prevalence and incidence rates are in line with previously described rates for sub-Saharan African cohorts.	[De Baetselier, Irith; Menten, Joris; Cuylaerts, Vicky; Crucitti, Tania] Inst Trop Med, B-2000 Antwerp, Belgium; [Ahmed, Khatija] Setshaba Res Ctr, Pretoria, South Africa; [Deese, Jennifer; Van Damme, Lut] FHI 360, Durham, NC USA; [Van Damme, Lut] Bill & Melinda Gates Fdn, Seattle, WA USA	Institute of Tropical Medicine (ITM); FHI 360; Bill & Melinda Gates Foundation	De Baetselier, I (corresponding author), Inst Trop Med, B-2000 Antwerp, Belgium.	idebaetselier@itg.be	Crucitti, Tania/AAH-1902-2021; Crucitti, Tania/AEQ-9792-2022; Crucitti, Tania/AAB-9967-2019	Crucitti, Tania/0000-0002-2235-6038; Crucitti, Tania/0000-0002-2235-6038; deese, jennifer/0000-0003-1535-1076; ahmed, khatija/0000-0003-0309-1641	United States Agency for International Development (USAID): Contraceptive and Reproductive Health Technologies and Research Utilization Program; Bill and Melinda Gates Foundation;  [GHOA000900016-00]	United States Agency for International Development (USAID): Contraceptive and Reproductive Health Technologies and Research Utilization Program(United States Agency for International Development (USAID)); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); 	Funding: This work was made possible by grants funded by the United States Agency for International Development (USAID): the Contraceptive and Reproductive Health Technologies and Research Utilization Program, and the Preventive Technologies Agreement No GHOA000900016-00. Early support was also provided by the Bill and Melinda Gates Foundation. Gilead Sciences, Inc. donated TDF-FTF and placebo. Views expressed in this publication do not necessarily reflect those of FHI 360 or the agencies funding the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson NW, 2014, J CLIN MICROBIOL, V52, P2, DOI 10.1128/JCM.01966-13; Arvaja M, 1999, SEX TRANSM INFECT, V75, P168, DOI 10.1136/sti.75.3.168; Ashley-Morrow R, 2004, CLIN MICROBIOL INFEC, V10, P530, DOI 10.1111/j.1469-0691.2004.00836.x; Ashley-Morrow R, 2003, SEX TRANSM DIS, V30, P310, DOI 10.1097/00007435-200304000-00007; Biraro S, 2011, SEX TRANSM DIS, V38, P140, DOI 10.1097/OLQ.0b013e3181f0bafb; Cherpes TL, 2003, J CLIN MICROBIOL, V41, P671, DOI 10.1128/JCM.41.2.671-674.2003; Chohan V, 2009, SEX TRANSM INFECT, V85, P489, DOI 10.1136/sti.2009.036103; Delany-Moretlwe S, 2010, SEX TRANSM INFECT, V86, P46, DOI 10.1136/sti.2009.036541; Eis-Hubinger A, 1999, J CLIN MICROBIOL, V37, P1242; Gamiel JL, 2008, CLIN VACCINE IMMUNOL, V15, P888, DOI 10.1128/CVI.00453-07; Gupta R, 2007, LANCET, V370, P2127, DOI 10.1016/S0140-6736(07)61908-4; Hogrefe W, 2002, J CLIN MICROBIOL, V40, P3635, DOI 10.1128/JCM.40.10.3635-3640.2002; Kapiga SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068825; Laeyendecker O, 2004, J CLIN MICROBIOL, V42, P1794, DOI 10.1128/JCM.42.4.1794-1796.2004; LeGoff J, 2008, J CLIN MICROBIOL, V46, P1914, DOI 10.1128/JCM.02332-07; Lingappa J, 2010, INT J STD AIDS, V21, P611, DOI 10.1258/ijsa.2009.008477; Looker KJ, 2008, B WORLD HEALTH ORGAN, V86, P805, DOI 10.2471/BLT.07.046128; Luseno WK, 2014, J PRIM PREV, V35, P181, DOI 10.1007/s10935-014-0343-6; Masese L, 2014, J INFECT DIS, V209, P1023, DOI 10.1093/infdis/jit634; Meque I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089705; Morrow RA, 2006, J CLIN VIROL, V36, P141, DOI 10.1016/j.jcv.2006.02.006; Muiru AN, 2013, J INFECT DIS, V208, P1093, DOI 10.1093/infdis/jit303; Mujugira A, 2011, SEX TRANSM INFECT, V87, P238, DOI 10.1136/sti.2010.047415; Nascimento MC, 2007, J CLIN MICROBIOL, V45, P2309, DOI 10.1128/JCM.00144-07; Ng'ayo MO, 2010, J VIROL METHODS, V163, P276, DOI 10.1016/j.jviromet.2009.10.009; Ramjee G, 2005, JAIDS-J ACQ IMM DEF, V39, P333, DOI 10.1097/01.qai.0000144445.44518.ea; Rollenhagen C, 2014, MUCOSAL IMMUNOL, V7, P1165, DOI 10.1038/mi.2014.3; SAFRIN S, 1992, J CLIN MICROBIOL, V30, P1312, DOI 10.1128/JCM.30.5.1312-1314.1992; Smith JS, 2009, SEX TRANSM INFECT, V85, P92, DOI 10.1136/sti.2008.031815; Tobian AAR, 2013, AIDS, V27, P147, DOI 10.1097/QAD.0b013e32835aa181; Tobian AAR, 2012, J INFECT DIS, V205, P486, DOI 10.1093/infdis/jir767; Van Damme L, 2012, NEW ENGL J MED, V367, P411, DOI 10.1056/NEJMoa1202614; Van Dyck E, 2004, J CLIN MICROBIOL, V42, P2961, DOI 10.1128/JCM.42.7.2961-2965.2004	33	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120207	10.1371/journal.pone.0120207	http://dx.doi.org/10.1371/journal.pone.0120207			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799522	Green Published, Green Submitted, gold			2022-12-26	WOS:000351987300111
J	Dutta, N; Lashmit, P; Yuan, JX; Meier, J; Stinski, MF				Dutta, Nirmal; Lashmit, Philip; Yuan, Jinxiang; Meier, Jeffery; Stinski, Mark F.			The Human Cytomegalovirus UL133-138 Gene Locus Attenuates the Lytic Viral Cycle in Fibroblasts	PLOS ONE			English	Article							IE86 PROTEIN; EXPRESSION; PROMOTER; ACCUMULATION; REQUIREMENT; ACTIVATION; ENHANCER	The genomes of HCMV clinical strains (e.g. FIX, TR, PH, etc) contain a 15 kb region that encodes 20 putative ORFs. The region, termed ULb', is lost after serial passage of virus in human foreskin fibroblast (HFF) cell culture. Compared to clinical strains, laboratory strains replicate faster and to higher titers of infectious virus. We made recombinant viruses with 22, 14, or 7 ORFs deleted from the ULb' region using FIX and TR as model clinical strains. We also introduced a stop codon into single ORFs between UL133 and UL138 to prevent protein expression. All deletions within ULb' and all stop codon mutants within the UL133 to UL138 region increased to varying degrees, viral major immediate early RNA and protein, DNA, and cell-free infectious virus compared to the wild type viruses. The wild type viral proteins slowed down the viral replication process along with cell-free infectious virus release from human fibroblast cells.	[Dutta, Nirmal; Yuan, Jinxiang; Meier, Jeffery] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; [Lashmit, Philip] Univ Iowa, Ctr Biocatalysis & Bioproc, Iowa City, IA USA; [Meier, Jeffery] Iowa Vet Affairs Healthcare Syst, Iowa City, IA USA; [Stinski, Mark F.] Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System; University of Iowa	Stinski, MF (corresponding author), Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA.	mark-stinski@uiowa.edu		Meier, Jeffery/0000-0001-9491-1697	Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development [1BX001107-01 (JLM and JY)]; National Institutes of Health [AI-13562]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI013562, R01AI013562] Funding Source: NIH RePORTER	Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development 1BX001107-01 (JLM and JY) and by grant AI-13562 from the National Institutes of Health (MFS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boeckh M, 2011, J CLIN INVEST, V121, P1673, DOI 10.1172/JCI45449; Bughio F, 2013, J VIROL, V87, P3062, DOI 10.1128/JVI.02510-12; Cha TA, 1996, J VIROL, V70, P78, DOI 10.1128/JVI.70.1.78-83.1996; Compton T, 2003, J VIROL, V77, P4588, DOI 10.1128/JVI.77.8.4588-4596.2003; Du GX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081583; Du GX, 2011, J VIROL, V85, P804, DOI 10.1128/JVI.01173-10; Goodrum F, 2007, BLOOD, V110, P937, DOI 10.1182/blood-2007-01-070078; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; Grainger L, 2010, J VIROL, V84, P9472, DOI 10.1128/JVI.00855-10; Homer EG, 1999, J VIROL, V73, P8512, DOI 10.1128/JVI.73.10.8512-8518.1999; Isomura H, 2008, J VIROL, V82, P1638, DOI 10.1128/JVI.01917-07; Isomura H, 2008, J VIROL, V82, P849, DOI 10.1128/JVI.01593-07; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; Liu XQ, 2010, J VIROL, V84, P8495, DOI 10.1128/JVI.00416-10; Meier JL, 2006, CYTOMEGALOVIRUSES: MOLECULAR BIOLOGY AND IMMUNOLOGY, P151; Meier JL, 2002, J VIROL, V76, P313, DOI 10.1128/JVI.76.1.313-326.2002; Mocarski E., 2007, FIELDS VIROLOGY; Montag C, 2011, J VIROL, V85, P11409, DOI 10.1128/JVI.05028-11; Murphy E, 2003, P NATL ACAD SCI USA, V100, P14976, DOI 10.1073/pnas.2136652100; Petrik DT, 2006, J VIROL, V80, P3872, DOI 10.1128/JVI.80.8.3872-3883.2006; Petrik DT, 2007, J VIROL, V81, P5807, DOI 10.1128/JVI.02437-06; Petrucelli A, 2012, J VIROL, V86, P8653, DOI 10.1128/JVI.00465-12; Petrucelli A, 2009, J VIROL, V83, P5615, DOI 10.1128/JVI.01989-08; Sanchez V, 2004, J VIROL, V78, P11219, DOI 10.1128/JVI.78.20.11219-11232.2004; STENBERG RM, 1984, J VIROL, V49, P190, DOI 10.1128/JVI.49.1.190-199.1984; Stern-Ginossar N, 2012, SCIENCE, V338, P1088, DOI 10.1126/science.1227919; Stinski MF, 2008, CURR TOP MICROBIOL, V325, P133; STINSKI MF, 1976, J VIROL, V19, P594, DOI 10.1128/JVI.19.2.594-609.1976; Umashankar M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002444; Wang WJ, 2005, J VIROL, V79, P2115, DOI 10.1128/JVI.79.4.2115-2123.2005	31	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120946	10.1371/journal.pone.0120946	http://dx.doi.org/10.1371/journal.pone.0120946			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799165	Green Submitted, Green Published, gold			2022-12-26	WOS:000351987300197
J	Enzi, B; Lissek, S; Edel, MA; Tegenthoff, M; Nicolas, V; Scherbaum, N; Juckel, G; Roser, P				Enzi, Bjoern; Lissek, Silke; Edel, Marc-Andreas; Tegenthoff, Martin; Nicolas, Volkmar; Scherbaum, Norbert; Juckel, Georg; Roser, Patrik			Alterations of Monetary Reward and Punishment Processing in Chronic Cannabis Users: An fMRI Study	PLOS ONE			English	Article							DOPAMINE RELEASE; ENDOCANNABINOID SYSTEM; PREFRONTAL CORTEX; DORSAL STRIATUM; HUMAN BRAIN; ANTICIPATION; INVOLVEMENT; DYSFUNCTION; DEPENDENCE; INSIGHTS	Alterations in reward and punishment processing have been reported in adults suffering from long-term cannabis use. However, previous findings regarding the chronic effects of cannabis on reward and punishment processing have been inconsistent. In the present study, we used functional magnetic resonance imaging (fMRI) to reveal the neural correlates of reward and punishment processing in long-term cannabis users (n = 15) and in healthy control subjects (n = 15) with no history of drug abuse. For this purpose, we used the well-established Monetary Incentive Delay (MID) task, a reliable experimental paradigm that allows the differentiation between anticipatory and consummatory aspects of reward and punishment processing. Regarding the gain anticipation period, no significant group differences were observed. In the left caudate and the left inferior frontal gyrus, cannabis users were -in contrast to healthy controls - not able to differentiate between the conditions feedback of reward and control. In addition, cannabis users showed stronger activations in the left caudate and the bilateral inferior frontal gyrus following feedback of no punishment as compared to healthy controls. We interpreted these deficits in dorsal striatal functioning as altered stimulus-reward or action-contingent learning in cannabis users. In addition, the enhanced lateral prefrontal activation in cannabis users that is related to non-punishing feedback may reflect a deficit in emotion regulation or cognitive reappraisal in these subjects.	[Enzi, Bjoern; Edel, Marc-Andreas; Juckel, Georg; Roser, Patrik] Ruhr Univ Bochum, Dept Psychiat Psychotherapy & Prevent Med, LWL Univ Hosp, Bochum, Germany; [Lissek, Silke; Tegenthoff, Martin] Ruhr Univ Bochum, BG Univ Hosp Bergmannsheil, Dept Neurol, Bochum, Germany; [Nicolas, Volkmar] Ruhr Univ Bochum, BG Univ Hosp Bergmannsheil, Dept Radiol, Bochum, Germany; [Scherbaum, Norbert] Univ Duisburg Essen, LVR Hosp, Dept Addict Behav & Addict Med, Essen, Germany	Ruhr University Bochum; Ruhr University Bochum; Ruhr University Bochum; University of Duisburg Essen	Enzi, B (corresponding author), Ruhr Univ Bochum, Dept Psychiat Psychotherapy & Prevent Med, LWL Univ Hosp, Univ Str 150, Bochum, Germany.	bjoern.enzi@wkp-lwl.org		Lissek, Silke/0000-0001-8208-8584	Medical Faculty of the Ruhr-University Bochum [FoRUM F622-2008]	Medical Faculty of the Ruhr-University Bochum	This work was supported by a research grant of the Medical Faculty of the Ruhr-University Bochum to P.R. (FoRUM F622-2008; www.rub.de). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balleine BW, 2007, J NEUROSCI, V27, P8161, DOI 10.1523/JNEUROSCI.1554-07.2007; Barkus E, 2011, J PSYCHOPHARMACOL, V25, P1462, DOI 10.1177/0269881110382465; Blum K, 2000, J PSYCHOACTIVE DRUGS, V32, P1, DOI [10.1080/02791072, DOI 10.1080/02791072, DOI 10.1080/02791072.2000.10736099]; Bossong MG, 2009, NEUROPSYCHOPHARMACOL, V34, P759, DOI 10.1038/npp.2008.138; Enzi B, 2012, EXP NEUROL, V235, P256, DOI 10.1016/j.expneurol.2012.02.003; Friston KJ, 1998, NEUROIMAGE, V7, P30, DOI 10.1006/nimg.1997.0306; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Gardner EL, 2005, PHARMACOL BIOCHEM BE, V81, P263, DOI 10.1016/j.pbb.2005.01.032; Glascher J, 2009, NEUROINFORMATICS, V7, P73, DOI 10.1007/s12021-008-9042-x; Glass M, 1997, NEUROSCIENCE, V77, P299, DOI 10.1016/S0306-4522(96)00428-9; Haber SN, 2010, NEUROPSYCHOPHARMACOL, V35, P4, DOI 10.1038/npp.2009.129; Heinz A, 1999, NERVENARZT, V70, P391, DOI 10.1007/s001150050454; Horder J, 2010, INT J NEUROPSYCHOPH, V13, P1103, DOI 10.1017/S1461145710000453; Knutson B, 2003, NEUROIMAGE, V18, P263, DOI 10.1016/S1053-8119(02)00057-5; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; Knutson B, 2001, NEUROREPORT, V12, P3683, DOI 10.1097/00001756-200112040-00016; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Maldonado R, 2006, TRENDS NEUROSCI, V29, P225, DOI 10.1016/j.tins.2006.01.008; Nadulski T, 2005, J ANAL TOXICOL, V29, P782, DOI 10.1093/jat/29.8.782; Nestor L, 2010, NEUROIMAGE, V49, P1133, DOI 10.1016/j.neuroimage.2009.07.022; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; O'Doherty JP, 2004, CURR OPIN NEUROBIOL, V14, P769, DOI 10.1016/j.conb.2004.10.016; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; Perkonigg A, 2008, ADDICTION, V103, P439, DOI 10.1111/j.1360-0443.2007.02064.x; Pertwee RG, 2008, BRIT J PHARMACOL, V153, P199, DOI 10.1038/sj.bjp.0707442; Petrides M, 2005, PHILOS T ROY SOC B, V360, P781, DOI 10.1098/rstb.2005.1631; Phillips M, 2008, MOL PSYCHIATR, V13, P833, DOI 10.1038/mp.2008.65; Ray RD, 2012, NEUROSCI BIOBEHAV R, V36, P479, DOI 10.1016/j.neubiorev.2011.08.005; Schlagenhauf F, 2009, BIOL PSYCHIAT, V65, P1032, DOI 10.1016/j.biopsych.2008.12.016; Sim-Selley Laura J., 2003, Critical Reviews in Neurobiology, V15, P91, DOI 10.1615/CritRevNeurobiol.v15.i2.10; Solinas M, 2006, J NEUROCHEM, V98, P408, DOI 10.1111/j.1471-4159.2006.03880.x; Stokes PRA, 2009, NEUROIMAGE, V48, P186, DOI 10.1016/j.neuroimage.2009.06.029; Stoy M, 2012, J PSYCHOPHARMACOL, V26, P677, DOI 10.1177/0269881111416686; Szabo B, 2005, HANDB EXP PHARMACOL, V168, P327; Tanda G, 2003, PSYCHOPHARMACOLOGY, V169, P115, DOI 10.1007/s00213-003-1485-z; van Hell HH, 2012, PSYCHOPHARMACOLOGY, V219, P981, DOI 10.1007/s00213-011-2428-8; van Hell HH, 2010, EUR NEUROPSYCHOPHARM, V20, P153, DOI 10.1016/j.euroneuro.2009.11.010; Volkow ND, 2011, P NATL ACAD SCI USA, V108, P15037, DOI 10.1073/pnas.1010654108; Wrase J, 2007, NEUROIMAGE, V36, P1253, DOI 10.1016/j.neuroimage.2007.04.001; Wrase J, 2007, NEUROIMAGE, V35, P787, DOI 10.1016/j.neuroimage.2006.11.043	40	25	25	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0119150	10.1371/journal.pone.0119150	http://dx.doi.org/10.1371/journal.pone.0119150			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799565	Green Published, Green Submitted, gold			2022-12-26	WOS:000351987300032
J	Fang, Y; Nakashima, R; Matsumiya, K; Kuriki, I; Shioiri, S				Fang, Yu; Nakashima, Ryoichi; Matsumiya, Kazumichi; Kuriki, Ichiro; Shioiri, Satoshi			Eye-Head Coordination for Visual Cognitive Processing	PLOS ONE			English	Article							GAZE SHIFTS; MOVEMENTS; ATTENTION; AMPLITUDE; DYNAMICS; SEARCH; ROLES; SPACE; BODY	We investigated coordinated movements between the eyes and head ("eye-head coordination") in relation to vision for action. Several studies have measured eye and head movements during a single gaze shift, focusing on the mechanisms of motor control during eyehead coordination. However, in everyday life, gaze shifts occur sequentially and are accompanied by movements of the head and body. Under such conditions, visual cognitive processing influences eye movements and might also influence eye-head coordination because sequential gaze shifts include cycles of visual processing (fixation) and data acquisition (gaze shifts). In the present study, we examined how the eyes and head move in coordination during visual search in a large visual field. Subjects moved their eyes, head, and body without restriction inside a 360 degrees visual display system. We found patterns of eye-head coordination that differed those observed in single gaze-shift studies. First, we frequently observed multiple saccades during one continuous head movement, and the contribution of head movement to gaze shifts increased as the number of saccades increased. This relationship between head movements and sequential gaze shifts suggests eye-head coordination over several saccade-fixation sequences; this could be related to cognitive processing because saccade-fixation cycles are the result of visual cognitive processing. Second, distribution bias of eye position during gaze fixation was highly correlated with head orientation. The distribution peak of eye position was biased in the same direction as head orientation. This influence of head orientation suggests that eye-head coordination is involved in gaze fixation, when the visual system processes retinal information. This further supports the role of eye-head coordination in visual cognitive processing.	[Fang, Yu; Matsumiya, Kazumichi; Kuriki, Ichiro; Shioiri, Satoshi] Tohoku Univ, Grad Sch Informat Sci, Sendai, Miyagi 980, Japan; [Nakashima, Ryoichi; Matsumiya, Kazumichi; Kuriki, Ichiro; Shioiri, Satoshi] Tohoku Univ, Elect Commun Res Inst, Sendai, Miyagi 980, Japan; [Fang, Yu; Nakashima, Ryoichi; Matsumiya, Kazumichi; Kuriki, Ichiro; Shioiri, Satoshi] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Tokyo, Japan	Tohoku University; Tohoku University; Japan Science & Technology Agency (JST)	Fang, Y (corresponding author), Tohoku Univ, Grad Sch Informat Sci, Sendai, Miyagi 980, Japan.	fangyork@riec.tohoku.ac.jp	Kuriki, Ichiro/C-7225-2011; Matsumiya, Kazumichi/T-1995-2019; Fang, Yu/F-3296-2017; Shioiri, Satoshi/B-9625-2008	Kuriki, Ichiro/0000-0001-9981-9339; Matsumiya, Kazumichi/0000-0003-3744-6762; Fang, Yu/0000-0003-1289-2504; Shioiri, Satoshi/0000-0003-2149-6132	Core Research for Evolutional Science and Technology (CREST) Program of the Japan Science and Technology Agency (JST); Cooperative Research Project of the Research Institute of Electrical Communication (RIEC) at Tohoku University; Grants-in-Aid for Scientific Research [25780441] Funding Source: KAKEN	Core Research for Evolutional Science and Technology (CREST) Program of the Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Cooperative Research Project of the Research Institute of Electrical Communication (RIEC) at Tohoku University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was partially supported by the Core Research for Evolutional Science and Technology (CREST) Program of the Japan Science and Technology Agency (JST) to SS, and by the Cooperative Research Project of the Research Institute of Electrical Communication (RIEC) at Tohoku University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AFANADOR AJ, 1986, AM J OPTOM PHYS OPT, V63, P187; [Anonymous], HEAD NECK SENSORY MO; BALLARD DH, 1992, PHILOS T R SOC B, V337, P331, DOI 10.1098/rstb.1992.0111; BARNES GR, 1979, J PHYSIOL-LONDON, V287, P127, DOI 10.1113/jphysiol.1979.sp012650; Bergeron A, 2002, J NEUROPHYSIOL, V88, P1726, DOI 10.1152/jn.2002.88.4.1726; Bergeron A, 2003, NAT NEUROSCI, V6, P404, DOI 10.1038/nn1027; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Colby CL, 1999, ANNU REV NEUROSCI, V22, P319, DOI 10.1146/annurev.neuro.22.1.319; Dubrovsky AS, 2002, J NEUROPHYSIOL, V87, P859, DOI 10.1152/jn.00447.2001; Fang Y, 2013, AS PAC C VIS APCV201; Freedman EG, 2008, EXP BRAIN RES, V190, P369, DOI 10.1007/s00221-008-1504-8; Freedman EG, 1997, J NEUROPHYSIOL, V77, P2328, DOI 10.1152/jn.1997.77.5.2328; FULLER JH, 1992, EXP BRAIN RES, V92, P152; Goldring JE, 1996, EXP BRAIN RES, V111, P68; Goossens HHLM, 1997, EXP BRAIN RES, V114, P542, DOI 10.1007/PL00005663; Graziano MSA, 2002, ATTENTION PERFORM, V19, P136; GUITTON D, 1992, TRENDS NEUROSCI, V15, P174, DOI 10.1016/0166-2236(92)90169-9; Henderson JM, 2003, TRENDS COGN SCI, V7, P498, DOI 10.1016/j.tics.2003.09.006; Itti L, 1998, IEEE T PATTERN ANAL, V20, P1254, DOI 10.1109/34.730558; LAND MF, 1992, NATURE, V359, P318, DOI 10.1038/359318a0; Land MF, 2004, EXP BRAIN RES, V159, P151, DOI 10.1007/s00221-004-1951-9; Lee C, 1999, VISION RES, V39, P3761, DOI 10.1016/S0042-6989(99)00111-X; Liversedge SP, 2000, TRENDS COGN SCI, V4, P6, DOI 10.1016/S1364-6613(99)01418-7; Matsumiya K, 2014, CURR BIOL, V24, P165, DOI 10.1016/j.cub.2013.11.034; Milner A. D., 1995, VISUAL BRAIN ACTION; Nakashima R, 2013, INT JOINT WORKSH ADV; Nakashima R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092284; Nakashima R, 2013, ATTEN PERCEPT PSYCHO, V75, P299, DOI 10.3758/s13414-012-0402-0; Nakayama K, 2011, VISION RES, V51, P1526, DOI 10.1016/j.visres.2010.09.003; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Prinz W., 2002, ATTENTION PERFORMANC; Proudlock FA, 2003, INVEST OPHTH VIS SCI, V44, P2991, DOI 10.1167/iovs.02-1315; Rizzolatti G, 1997, SCIENCE, V277, P190, DOI 10.1126/science.277.5323.190; Scotto Di Cesare C, 2013, VISION RES, V78, P1, DOI 10.1016/j.visres.2012.11.011; Seo H, 2002, VISION RES, V42, P1325, DOI 10.1016/S0042-6989(02)00063-9; SHIOIRI S, 1989, PERCEPTION, V18, P347, DOI 10.1068/p180347; Stahl JS, 2001, EXP BRAIN RES, V136, P200, DOI 10.1007/s002210000593; Stahl JS, 1999, EXP BRAIN RES, V126, P41, DOI 10.1007/s002210050715; Thumser ZC, 2008, EXP BRAIN RES, V191, P419, DOI 10.1007/s00221-008-1534-2; Tsuchiai T, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00207; TWEED D, 1995, J NEUROPHYSIOL, V73, P766, DOI 10.1152/jn.1995.73.2.766; VOLLE M, 1993, EXP BRAIN RES, V94, P463; Wolfe JM, 2011, ATTEN PERCEPT PSYCHO, V73, P1650, DOI 10.3758/s13414-011-0153-3; Yarbus A.L., 1967, EYE MOVEMENTS VISION, DOI 10.1007/978-1-4899-5379-7; ZANGEMEISTER WH, 1981, EXP NEUROL, V71, P76, DOI 10.1016/0014-4886(81)90072-8	46	43	44	5	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121035	10.1371/journal.pone.0121035	http://dx.doi.org/10.1371/journal.pone.0121035			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE6ZS	25799510	Green Published, gold			2022-12-26	WOS:000351987300201
J	Guildea, C; Hitchen, Y; Duffy, R; Dias, PJ; Ledger, JM; Snow, M; Kennington, WJ				Guildea, Clodagh; Hitchen, Yvette; Duffy, Rodney; Dias, P. Joana; Ledger, Jason M.; Snow, Michael; Kennington, W. Jason			Introgression Threatens the Survival of the Critically Endangered Freshwater Crayfish Cherax tenuimanus (Decapoda: Parastacidae) in the Wild	PLOS ONE			English	Article							ERICHSON DECAPODA; HAIRY MARRON; HYBRIDIZATION; EXTINCTION; INFERENCE; SOFTWARE; LOCI	Hybridization and genetic introgression following the introduction of exotic species can pose a significant threat to the survival of geographically restricted species. A remnant population of the critically endangered freshwater crayfish Cherax tenuimanus in the upper reaches of the Margaret River in southwestern Australia is under threat following the introduction and spread of its congener Cherax cainii. Here, we examine the extent of hybridization and introgression between the two species using twelve polymorphic microsatellite loci. Our study reveals there are three times more C. cainii than C. tenuimanus at our study site in the upper reaches of the Margaret River. There is also evidence of hybridization and introgression between C. tenuimanus and C. cainii at this site, with F-1, F-2 and backcrossed individuals identified. While interbreeding was confirmed in this study, our simulations suggest that the levels of introgression are much lower than would be expected under random mating, indicating partial reproductive barriers exist. Nevertheless, it is apparent that hybridization and introgression with C. cainii pose a serious threat to C. tenuimanus and their survival in the wild will require active adaptive management and continued genetic monitoring to evaluate management effectiveness.	[Guildea, Clodagh; Dias, P. Joana; Kennington, W. Jason] Univ Western Australia, Sch Anim Biol, Ctr Evolutionary Biol, Crawley, WA 6009, Australia; [Hitchen, Yvette] Helix Mol Solut, Leederville, WA 6903, Australia; [Duffy, Rodney; Dias, P. Joana; Snow, Michael] Govt Western Australia, Western Australian Fisheries & Marine Res Labs, Dept Fisheries, North Beach, WA 6920, Australia; [Ledger, Jason M.] Univ Western Australia, Sch Anim Biol, Crawley, WA 6009, Australia	University of Western Australia; Government of Western Australia; Western Australian Fisheries & Marine Research Laboratories; University of Western Australia	Kennington, WJ (corresponding author), Univ Western Australia, Sch Anim Biol, Ctr Evolutionary Biol, Crawley, WA 6009, Australia.	jason.kennington@uwa.edu.au	Kennington, Winn J/H-5182-2014; Dias, Patrícia/HGT-6805-2022	Kennington, Winn J/0000-0001-6100-6543; 	University of Western Australia; Western Australian Department of Fisheries	University of Western Australia; Western Australian Department of Fisheries	Financial support for this project was provided by The University of Western Australia and the Western Australian Department of Fisheries. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allendorf FW., 2009, CONSERV GENET; Anderson EC, 2002, GENETICS, V160, P1217; Austin CM, 1996, AUST J ZOOL, V44, P223, DOI 10.1071/ZO9960223; Austin CM, 2002, INVERTEBR SYST, V16, P357, DOI 10.1071/IT01010; Balloux F, 2001, J HERED, V92, P301, DOI 10.1093/jhered/92.3.301; Binks RM, 2007, CONSERV GENET, V8, P1421, DOI 10.1007/s10592-007-9293-3; Bunn JJS, 2004, INVESTIGATION REPLAC; Bunn John J.S., 2008, Freshwater Crayfish, V16, P113; de Graaf M, 2009, CRUSTACEANA, V82, P1469, DOI 10.1163/156854009X463937; Ellegren H, 2000, TRENDS GENET, V16, P551, DOI 10.1016/S0168-9525(00)02139-9; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2003, GENETICS, V164, P1567; Goudet J, 2002, MOL ECOL, V11, P1103, DOI 10.1046/j.1365-294X.2002.01496.x; Goudet J, 2002, FSTAT PROGRAM ESTIMA, DOI DOI 10.1093/OXFORDJOURNALS.JHERED.A111627; Hardig TM, 2005, CASTANEA, V70, P246, DOI 10.2179/0008-7475(2005)070[0246:MEOHBL]2.0.CO;2; Hausdorf B, 2011, EVOLUTION, V65, P923, DOI 10.1111/j.1558-5646.2011.01231.x; Homyack JA, 2008, AM MIDL NAT, V159, P504, DOI 10.1674/0003-0031(2008)159[504:CLLCLR]2.0.CO;2; Imgrund JA, 1998, POPULATION GENETIC A; Kennington WJ, 2014, CONSERV GENET RESOUR, V6, P337, DOI 10.1007/s12686-013-0088-1; Kennington WJ, 2012, MOL ECOL, V21, P3489, DOI 10.1111/j.1365-294X.2012.05636.x; Lawrence C, 2007, IMPROVED PERFORMANCE, V17, P40; Levin DA, 2002, AM SCI, V90, P254; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Mooney HA, 2001, P NATL ACAD SCI USA, V98, P5446, DOI 10.1073/pnas.091093398; Perry WL, 2001, CONSERV BIOL, V15, P1656, DOI 10.1046/j.1523-1739.2001.00019.x; Perry WL, 2002, SYST BIOL, V51, P255, DOI 10.1080/10635150252899761; Pritchard JK, 2000, GENETICS, V155, P945; Rhymer JM, 1996, ANNU REV ECOL SYST, V27, P83, DOI 10.1146/annurev.ecolsys.27.1.83; Smith G., 1912, P ZOOL SOC LOND, V1912, P144, DOI [10. 1111/j. 1469-7998. 1912. tb07010. x, DOI 10.1111/J.1469-7998.1912.TB07010.X]; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; WRIGHT S, 1951, ANN EUGENIC, V15, P323; Young KA, 2004, ECOLOGY, V85, P134, DOI 10.1890/02-0402; [No title captured]	34	2	2	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121075	10.1371/journal.pone.0121075	http://dx.doi.org/10.1371/journal.pone.0121075			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799102	gold, Green Submitted, Green Published			2022-12-26	WOS:000351987300206
J	Huang, B; Lucas, T; Kueppers, C; Dong, XM; Krause, M; Bepperling, A; Buchner, J; Voshol, H; Weiss, A; Gerrits, B; Kochanek, S				Huang, Bin; Lucas, Tanja; Kueppers, Claudia; Dong, Xiaomin; Krause, Maike; Bepperling, Alexander; Buchner, Johannes; Voshol, Hans; Weiss, Andreas; Gerrits, Bertran; Kochanek, Stefan			Scalable Production in Human Cells and Biochemical Characterization of Full-Length Normal and Mutant Huntingtin	PLOS ONE			English	Article							NEURONAL INTRANUCLEAR INCLUSIONS; POSTTRANSLATIONAL MODIFICATIONS; NEUROLOGICAL PHENOTYPE; STATISTICAL-MODEL; GEL-FILTRATION; NUCLEAR ENTRY; HELPER VIRUS; CAG REPEATS; WILD-TYPE; KNOCK-IN	Huntingtin (Htt) is a 350 kD intracellular protein, ubiquitously expressed and mainly localized in the cytoplasm. Huntington's disease (HD) is caused by a CAG triplet amplification in exon 1 of the corresponding gene resulting in a polyglutamine (polyQ) expansion at the N-terminus of Htt. Production of full-length Htt has been difficult in the past and so far a scalable system or process has not been established for recombinant production of Htt in human cells. The ability to produce Htt in milligram quantities would be a prerequisite for many biochemical and biophysical studies aiming in a better understanding of Htt function under physiological conditions and in case of mutation and disease. For scalable production of full-length normal (17Q) and mutant (46Q and 128Q) Htt we have established two different systems, the first based on doxycycline-inducible Htt expression in stable cell lines, the second on "gutless" adenovirus mediated gene transfer. Purified material has then been used for biochemical characterization of full-length Htt. Posttranslational modifications (PTMs) were determined and several new phosphorylation sites were identified. Nearly all PTMs in full-length Htt localized to areas outside of predicted alpha-solenoid protein regions. In all detected N-terminal peptides methionine as the first amino acid was missing and the second, alanine, was found to be acetylated. Differences in secondary structure between normal and mutant Htt, a helix-rich protein, were not observed in our study. Purified Htt tends to form dimers and higher order oligomers, thus resembling the situation observed with N-terminal fragments, although the mechanism of oligomer formation may be different.	[Huang, Bin; Lucas, Tanja; Kueppers, Claudia; Dong, Xiaomin; Kochanek, Stefan] Univ Ulm, Dept Gene Therapy, D-89069 Ulm, Germany; [Krause, Maike; Bepperling, Alexander; Buchner, Johannes] Tech Univ Munich, Dept Biotechnol, Ctr Integrated Prot Sci Munich, Garching, Germany; [Voshol, Hans; Weiss, Andreas; Gerrits, Bertran] Novartis Inst Biomed Res, Basel, Switzerland	Ulm University; Technical University of Munich; Novartis	Kochanek, S (corresponding author), Univ Ulm, Dept Gene Therapy, D-89069 Ulm, Germany.	stefan.kochanek@uni-ulm.de	Buchner, Johannes/A-2651-2010	Buchner, Johannes/0000-0003-1282-7737; Krause, Maike/0000-0003-4068-8172	CDHI Foundation	CDHI Foundation	Funding by the CDHI Foundation (http://chdifoundation.org/) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiken CT, 2009, J BIOL CHEM, V284, P29427, DOI 10.1074/jbc.M109.013193; ANDRADE MA, 1995, NAT GENET, V11, P115, DOI 10.1038/ng1095-115; Anne SL, 2007, J NEUROSCI, V27, P7318, DOI 10.1523/JNEUROSCI.1831-07.2007; Atwal RS, 2007, HUM MOL GENET, V16, P2600, DOI 10.1093/hmg/ddm217; Bates G, 2002, HUNTINGTONS DISEASE; Borrell-Pages M, 2006, CELL MOL LIFE SCI, V63, P2642, DOI 10.1007/s00018-006-6242-0; Caviston JP, 2009, TRENDS CELL BIOL, V19, P147, DOI 10.1016/j.tcb.2009.01.005; Chook YM, 1999, NATURE, V399, P230, DOI 10.1038/20375; Colin E, 2008, EMBO J, V27, P2124, DOI 10.1038/emboj.2008.133; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; del Toro D, 2009, MOL BIOL CELL, V20, P1478, DOI 10.1091/mbc.E08-07-0726; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; DIFIGLIA M, 1995, NEURON, V14, P1075, DOI 10.1016/0896-6273(95)90346-1; Dong GF, 2012, PROTEOMICS, V12, P2060, DOI 10.1002/pmic.201100380; Dyer RB, 2001, NAT GENET, V29, P270, DOI 10.1038/ng745; Ehrnhoefer DE, 2011, NEUROSCIENTIST, V17, P475, DOI 10.1177/1073858410390378; Erickson HP, 2009, BIOL PROCED ONLINE, V11, P32, DOI 10.1007/s12575-009-9008-x; Fournier D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079894; Gauthier LR, 2004, CELL, V118, P127, DOI 10.1016/j.cell.2004.06.018; Goldenberg SJ, 2004, CELL, V119, P517, DOI 10.1016/j.cell.2004.10.019; GOSSEN M, 1995, SCIENCE, V268, P1766, DOI 10.1126/science.7792603; Groves MR, 1999, CELL, V96, P99, DOI 10.1016/S0092-8674(00)80963-0; Groves MR, 1999, CURR OPIN STRUC BIOL, V9, P383, DOI 10.1016/S0959-440X(99)80052-9; Gunawardena S, 2003, NEURON, V40, P25, DOI 10.1016/S0896-6273(03)00594-4; Harjes P, 2003, TRENDS BIOCHEM SCI, V28, P425, DOI 10.1016/S0968-0004(03)00168-3; Harper PS, 1991, HUNTINGTONS DISEASE; Hilditch-Maguire P, 2000, HUM MOL GENET, V9, P2789, DOI 10.1093/hmg/9.19.2789; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Huang B, 2007, HUM GENE THER, V18, P303, DOI 10.1089/hum.2006.160; Humbert S, 2002, DEV CELL, V2, P831, DOI 10.1016/S1534-5807(02)00188-0; Ishiguro H, 2001, J NEUROSCI RES, V65, P289, DOI 10.1002/jnr.1153; Kegel KB, 2005, J BIOL CHEM, V280, P36464, DOI 10.1074/jbc.M503672200; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kreppel F, 2002, HUM GENE THER, V13, P1151, DOI 10.1089/104303402320138934; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Li SH, 2004, NEUROSCIENTIST, V10, P467, DOI 10.1177/1073858404266777; Li W, 2006, J BIOL CHEM, V281, P15916, DOI 10.1074/jbc.M511007200; Lin CH, 2001, HUM MOL GENET, V10, P137, DOI 10.1093/hmg/10.2.137; Luo SQ, 2005, J CELL BIOL, V169, P647, DOI 10.1083/jcb.200412071; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; McMahon HT, 2004, CURR OPIN CELL BIOL, V16, P379, DOI 10.1016/j.ceb.2004.06.009; Mochel F, 2011, J CLIN INVEST, V121, P493, DOI 10.1172/JCI45691; Moritz A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000998; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Ordway JM, 1997, CELL, V91, P753, DOI 10.1016/S0092-8674(00)80464-X; Pal A, 2006, J CELL BIOL, V172, P605, DOI 10.1083/jcb.200509091; Palidwor GA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000304; Palmer D, 2003, MOL THER, V8, P846, DOI 10.1016/j.ymthe.2003.08.014; Parks RJ, 1996, P NATL ACAD SCI USA, V93, P13565, DOI 10.1073/pnas.93.24.13565; Phanstiel DH, 2011, NAT METHODS, V8, P821, DOI [10.1038/NMETH.1699, 10.1038/nmeth.1699]; Potter Nicholas T, 2004, Genet Med, V6, P61, DOI 10.1097/01.GIM.0000106165.74751.15; Rangone H, 2004, EUR J NEUROSCI, V19, P273, DOI 10.1111/j.0953-816X.2003.03131.x; Rohrbough J, 2005, NAT REV NEUROSCI, V6, P139, DOI 10.1038/nrn1608; Ross CA, 2011, LANCET NEUROL, V10, P83, DOI 10.1016/S1474-4422(10)70245-3; ROST B, 1994, COMPUT APPL BIOSCI, V10, P53; Rubinsztein DC, 1996, AM J HUM GENET, V59, P16; Sambrook J., 2001, MOL CLONING LAB MANU; Schiedner G, 1998, NAT GENET, V18, P180, DOI 10.1038/ng0298-180; Schilling B, 2006, J BIOL CHEM, V281, P23686, DOI 10.1074/jbc.M513507200; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Semaka A, 2014, CLIN GENET, V85, P303, DOI 10.1111/cge.12324; Seong IS, 2010, HUM MOL GENET, V19, P573, DOI 10.1093/hmg/ddp524; Shaw G, 2002, FASEB J, V16, P869, DOI 10.1096/fj.01-0995fje; SIEGEL LM, 1966, BIOCHIM BIOPHYS ACTA, V112, P346, DOI 10.1016/0926-6585(66)90333-5; Sivanandam VN, 2011, J AM CHEM SOC, V133, P4558, DOI 10.1021/ja110715f; Starheim KK, 2012, TRENDS BIOCHEM SCI, V37, P152, DOI 10.1016/j.tibs.2012.02.003; Suopanki J, 2006, J NEUROCHEM, V96, P870, DOI 10.1111/j.1471-4159.2005.03620.x; Takano H, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-15; Tartari M, 2008, MOL BIOL EVOL, V25, P330, DOI 10.1093/molbev/msm258; Thakur AK, 2009, NAT STRUCT MOL BIOL, V16, P380, DOI 10.1038/nsmb.1570; Velier J, 1998, EXP NEUROL, V152, P34, DOI 10.1006/exnr.1998.6832; Vetter IR, 1999, CELL, V97, P635, DOI 10.1016/S0092-8674(00)80774-6; Walker FO, 2007, SEMIN NEUROL, V27, P143, DOI 10.1055/s-2007-971176; Warby SC, 2005, HUM MOL GENET, V14, P1569, DOI 10.1093/hmg/ddi165; Warby SC, 2008, HUM MOL GENET, V17, P2390, DOI 10.1093/hmg/ddn139; Wetzel R, 2014, HUNTINGTONS DISEASE; Wetzel R, 2012, J MOL BIOL, V421, P466, DOI 10.1016/j.jmb.2012.01.030; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Wittig I, 2007, MOL CELL PROTEOMICS, V6, P1215, DOI 10.1074/mcp.M700076-MCP200; Wu LG, 2004, TRENDS NEUROSCI, V27, P548, DOI 10.1016/j.tins.2004.07.001; Xia QW, 2008, J PROTEOME RES, V7, P2845, DOI 10.1021/pr8000496; Yanai A, 2006, NAT NEUROSCI, V9, P824, DOI 10.1038/nn1702; Zala D, 2008, HUM MOL GENET, V17, P3837, DOI 10.1093/hmg/ddn281; Zuccato C, 2003, NAT GENET, V35, P76, DOI 10.1038/ng1219; Zuccato C, 2001, SCIENCE, V293, P493, DOI 10.1126/science.1059581; Zuccato C., 2014, HUNTINGTONS DIS, P243	88	24	25	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121055	10.1371/journal.pone.0121055	http://dx.doi.org/10.1371/journal.pone.0121055			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799558	Green Published, gold			2022-12-26	WOS:000351987300202
J	Jeong, WK; Kim, TY; Sohn, JH; Kim, Y; Kim, J				Jeong, Woo Kyoung; Kim, Tae Yeob; Sohn, Joo Hyun; Kim, Yongsoo; Kim, Jinoo			Severe Portal Hypertension in Cirrhosis: Evaluation of Perfusion Parameters with Contrast-Enhanced Ultrasonography	PLOS ONE			English	Article							DEGUM MULTICENTER TRIAL; TRANSIT-TIME ANALYSIS; FOCAL LIVER-LESIONS; VEIN WAVE-FORM; HEPATITIS-C; HEPATOCELLULAR-CARCINOMA; HEPATOPULMONARY SYNDROME; DOPPLER SONOGRAPHY; ULTRASOUND CEUS; DAMPING INDEX	Objective To investigate the role of contrast-enhanced ultrasonography (CEUS) and Doppler ultrasonography (DUS) in the diagnosis of severe portal hypertension (PH) in patients with liver cirrhosis (LC). Methods Patients with PH scheduled to receive hepatic venous pressure gradient (HVPG) measurement were recruited for this study. Hepatic DUS and CEUS were performed successively. Several Doppler and CEUS parameters were explored for correlation with HVPG values and their association with severe PH (>= 12 mmHg of HVPG). Comparison of the parameters between the severe and non-severe PH groups and their correlation with HVPG values was evaluated. A receiver operating characteristic (ROC) curve analysis was also performed to investigate the performance in order to diagnose severe PH. Results Fifty-three consecutive patients were enrolled in this study. Among them, 43 patients did not have significant ascites. Compared with the non-severe PH group, portal venous velocity and intrahepatic transit time (ITT) were significantly reduced in the severe PH group (all p<0.05). Difference between inspiratory and expiratory hepatic venous damping indices (.HVDI), hepatic venous arrival time (HVAT) and ITT moderately correlated with HVPG (r = -0.358, -0.338, and -0.613, respectively). Areas under the curves for severe PH were 0.94 of ITT and 0.72 of HVAT, respectively (all p<0.05). ITT under 6 seconds indicated severe PH with a sensitivity of 92% and a specificity of 89%. Conclusions Hepatic CEUS may be more useful in estimating the HVPG value and determining the presence of severe PH compared to DUS, and ITT was the most accurate parameter to diagnose severe PH.	[Jeong, Woo Kyoung] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Radiol, Seoul, South Korea; [Jeong, Woo Kyoung] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Ctr Imaging Sci, Seoul, South Korea; [Kim, Tae Yeob; Sohn, Joo Hyun] Hanyang Univ, Dept Internal Med, Guri Hosp, Coll Med, Guri Si, Gyeonggi Do, South Korea; [Kim, Yongsoo] Hanyang Univ, Dept Radiol, Guri Hosp, Coll Med, Guri Si, Gyeonggi Do, South Korea; [Kim, Jinoo] Ajou Univ, Dept Radiol, Ajou Univ Hosp, Coll Med, Suwon, Gyeonggi Do, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Hanyang University; Hanyang University; Ajou University; Ajou University Hospital	Sohn, JH (corresponding author), Hanyang Univ, Dept Internal Med, Guri Hosp, Coll Med, Guri Si, Gyeonggi Do, South Korea.	sonjh@hanyang.ac.kr	Jeong, Woo Kyoung/ABE-7025-2021	Jeong, Woo Kyoung/0000-0002-0676-2116; Kim, Jinoo/0000-0001-7238-2528				Albrecht T, 1999, LANCET, V353, P1579, DOI 10.1016/S0140-6736(98)06373-9; Baik SK, 2006, RADIOLOGY, V240, P574, DOI 10.1148/radiol.2402051142; Bendtsen F, 1999, LANCET, V354, P598, DOI 10.1016/S0140-6736(05)77953-8; Berzigottil A, 2012, ULTRASCHALL MED, V33, P8, DOI 10.1055/s-0031-1299145; Blomley MJK, 2003, GUT, V52, P1188, DOI 10.1136/gut.52.8.1188; D'Amico G, 2006, GASTROENTEROLOGY, V131, P1611, DOI 10.1053/j.gastro.2006.09.013; Gines P, 2010, J HEPATOL, V53, P397, DOI 10.1016/j.jhep.2010.05.004; Kim MY, 2007, LIVER INT, V27, P1103, DOI 10.1111/j.1478-3231.2007.01526.x; Kim Moon Young, 2010, Korean J Hepatol, V16, P347, DOI 10.3350/kjhep.2010.16.4.347; Kim MY, 2012, HEPATOLOGY; Kim SY, 2011, J ULTRAS MED, V30, P455, DOI 10.7863/jum.2011.30.4.455; Lassau N, 2011, RADIOLOGY, V258, P291, DOI 10.1148/radiol.10091870; Li N, 2010, ULTRASOUND MED BIOL, V36, P1066, DOI 10.1016/j.ultrasmedbio.2010.04.012; Lim AKP, 2005, AM J ROENTGENOL, V184, P1848, DOI 10.2214/ajr.184.6.01841848; Lim AKP, 2005, GUT, V54, P128, DOI 10.1136/gut.2003.030965; Orlacchio A, 2011, ULTRASOUND MED BIOL, V37, P1, DOI 10.1016/j.ultrasmedbio.2010.10.012; Ridolfi F, 2012, WORLD J GASTROENTERO, V18, P5225, DOI 10.3748/wjg.v18.i37.5225; Rockey DC, 2001, SEMIN LIVER DIS, V21, P337, DOI 10.1055/s-2001-17551; Rodriguez-Roisin R, 2008, NEW ENGL J MED, V358, P2378, DOI 10.1056/NEJMra0707185; Schenk P, 2002, GUT, V51, P853, DOI 10.1136/gut.51.6.853; Schneider AW, 1999, J HEPATOL, V30, P876, DOI 10.1016/S0168-8278(99)80142-1; Seitz K, 2010, ULTRASCHALL MED, V31, P492, DOI 10.1055/s-0029-1245591; Staub F, 2009, EUR RADIOL, V19, P1991, DOI 10.1007/s00330-009-1313-x; Strobel D, 2008, ULTRASCHALL MED, V29, P499, DOI 10.1055/s-2008-1027806; Strobel D, 2009, ULTRASCHALL MED, V30, P376, DOI 10.1055/s-0028-1109672; Sugimoto H, 2002, J HEPATOL, V37, P578, DOI 10.1016/S0168-8278(02)00264-7; Tang A, 2011, ULTRASOUND MED BIOL, V37, P1963, DOI 10.1016/j.ultrasmedbio.2011.09.010; Taourel P, 1998, HEPATOLOGY, V28, P932, DOI 10.1002/hep.510280406; Zhang CX, 2011, J ULTRAS MED, V30, P205, DOI 10.7863/jum.2011.30.2.205; Zhang L, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-84; Zhou JH, 2011, RADIOLOGY, V259, P406, DOI 10.1148/radiol.10101339	31	25	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121601	10.1371/journal.pone.0121601	http://dx.doi.org/10.1371/journal.pone.0121601			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798930	Green Published, Green Submitted, gold			2022-12-26	WOS:000351987300275
J	Kappen, JH; Medina-Gomez, C; van Hagen, PM; Stolk, L; Estrada, K; Rivadeneira, F; Uitterlinden, AG; Stanford, MR; Ben-Chetrit, E; Wallace, GR; Soylu, M; van Laar, JAM				Kappen, Jasper H.; Medina-Gomez, Carolina; van Hagen, P. Martin; Stolk, Lisette; Estrada, Karol; Rivadeneira, Fernando; Uitterlinden, Andre G.; Stanford, Miles R.; Ben-Chetrit, Eldat; Wallace, Graham R.; Soylu, Merih; van Laar, Jan A. M.			Genome-Wide Association Study in an Admixed Case Series Reveals IL12A as a New Candidate in Behcet Disease	PLOS ONE			English	Article							SUSCEPTIBILITY LOCI; IL23R-IL12RB2; POLYMORPHISM; METAANALYSIS; POPULATIONS; CHINESE; STAT4; SNPS	Introduction The etiology of Behcet's disease (BD) is unknown, but widely considered an excessive T-cell mediated inflammatory response in a genetically susceptible host. Recent genomewide association studies (GWAS) have shown limited number of novel loci-associations. The rarity and unequal distribution of the disease prevalence amongst different ethnic backgrounds have hampered the use of GWAS in cohorts of mixed ethnicity and sufficient sample size. However, novel statistical approaches have now enabled GWAS in admixed cohorts. Methods We ran a GWAS on 336 BD cases and 5,843 controls. The cases consisted of Western Europeans, Middle Eastern and Turkish individuals. Participants from the Generation R study, a multiethnic birth cohort in Rotterdam, The Netherlands were used as controls. All samples were genotyped and data was combined. Linear regression models were corrected for population stratification using Genomic Principal Components and Linear Mixed Modelling. Meta-analysis was performed on selected results previously published. Results We identified SNPs associated at genome-wide significant level mapping to the 6p21.33 (HLA) region. In addition to this known signal two potential novel associations on chromosomes 6 and 18 were identified, yet with low minor allele frequencies. Extended meta-analysis reveal a GWS association with the IL12A variant rs17810546 on chromosome 3. Discussion We demonstrate that new statistical techniques enable GWAS analyses in a limited sized cohort of mixed ethnicity. After implementation, we confirmed the central role of the HLA region in the disease and identified new regions of interest. Moreover, we validated the association of a variant in the IL2A gene by meta-analysis with previous work. These findings enhance our knowledge of genetic associations and BD, and provide further justification for pursuing collective initiatives in genetic studies given the low prevalence of this and other rare diseases.	[Kappen, Jasper H.; van Hagen, P. Martin; van Laar, Jan A. M.] Erasmus MC, Immunol Sect, Internal Med, Rotterdam, Netherlands; [Medina-Gomez, Carolina; van Hagen, P. Martin; Stolk, Lisette; Estrada, Karol; Rivadeneira, Fernando; Uitterlinden, Andre G.] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands; [van Hagen, P. Martin; van Laar, Jan A. M.] Erasmus MC, Dept Immunol, Rotterdam, Netherlands; [Medina-Gomez, Carolina; Rivadeneira, Fernando] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Medina-Gomez, Carolina; Rivadeneira, Fernando] Erasmus M Med Ctr C, Generat Study Grp R, Rotterdam, Netherlands; [Stanford, Miles R.] Kings Coll London, Dept Ophthalmol, London WC2R 2LS, England; [Wallace, Graham R.] Univ Birmingham, Ctr Translat Inflammat, Birmingham, W Midlands, England; [Ben-Chetrit, Eldat] Hadassah Hebrew Univ Med Ctr, Dept Med, Jerusalem, Israel; [Soylu, Merih] Cukurova Univ, Sch Med, Dept Ophthalmol, Adana, Turkey	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of London; King's College London; University of Birmingham; Hebrew University of Jerusalem; Cukurova University	Kappen, JH (corresponding author), Erasmus MC, Immunol Sect, Internal Med, Rotterdam, Netherlands.	j.Kappen@erasmusmc.nl	Medina-Gomez, Carolina/I-1725-2019; Rivadeneira, Fernando/O-5385-2015	Medina-Gomez, Carolina/0000-0001-7999-5538; Rivadeneira, Fernando/0000-0001-9435-9441; Wallace, Graham/0000-0003-2054-0509	Vereniging Trustfonds Erasmus Universiteit Rotterdam; De Landelijke Stichting voor Blinden en Slechtzienden; Stichting Janivo; Stichting Mitialto; Actelion	Vereniging Trustfonds Erasmus Universiteit Rotterdam; De Landelijke Stichting voor Blinden en Slechtzienden; Stichting Janivo; Stichting Mitialto; Actelion	Financial support provided by; Vereniging Trustfonds Erasmus Universiteit Rotterdam, De Landelijke Stichting voor Blinden en Slechtzienden, Stichting Janivo, Stichting Mitialto, dr N. Nobel and Actelion made this study possible. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altenburg A, 2012, OPHTHALMOLOGE, V109, P531, DOI 10.1007/s00347-012-2601-4; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Baranathan V, 2007, ANN RHEUM DIS, V66, P1531, DOI 10.1136/ard.2007.073866; Coram MA, 2013, AM J HUM GENET, V92, P904, DOI 10.1016/j.ajhg.2013.04.025; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Gul A, 2000, ANN RHEUM DIS, V59, P622, DOI 10.1136/ard.59.8.622; Gul A, 2001, CLIN EXP RHEUMATOL, V19, pS6; Hou SP, 2012, ARTHRITIS RHEUM-US, V64, P4104, DOI 10.1002/art.37708; Hu K, 2010, HUM IMMUNOL, V71, P723, DOI 10.1016/j.humimm.2010.04.007; Jaddoe VWV, 2012, EUR J EPIDEMIOL, V27, P739, DOI 10.1007/s10654-012-9735-1; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Kappen JH, 2009, RHEUMATOLOGY, V48, P1375, DOI 10.1093/rheumatology/kep292; Kirino Y, 2013, NAT GENET, V45, P202, DOI 10.1038/ng.2520; Lee YJ, 2012, ANN RHEUMATIC DIS; Lee YJ, 2013, ANN RHEUM DIS, V72, P1510, DOI 10.1136/annrheumdis-2011-200288; McCarthy MI, 2008, HUM MOL GENET, V17, pR156, DOI 10.1093/hmg/ddn289; Mizuki N, 2010, NAT GENET, V42, P703, DOI 10.1038/ng.624; Morris AP, 2011, GENET EPIDEMIOL, V35, P809, DOI 10.1002/gepi.20630; Naib OKD, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00342; Ortiz-Fernandez L, 2014, ANN RHEUMATIC DIS; Plomin R, 2014, MOL PSYCHIAT; Price AL, 2010, NAT REV GENET, V11, P459, DOI 10.1038/nrg2813; Remmers EF, 2010, NAT GENET, V42, P698, DOI 10.1038/ng.625; Sakane T, 1999, NEW ENGL J MED, V341, P1284, DOI 10.1056/NEJM199910213411707; SILMAN AJ, 1990, LANCET, V335, P1078; Thornton T, 2012, AM J HUM GENET, V91, P122, DOI 10.1016/j.ajhg.2012.05.024; Touma Z, 2010, ARCH MED RES, V41, P142, DOI 10.1016/j.arcmed.2010.02.002; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Xavier JM, 2012, ARTHRITIS RHEUM-US, V64, P2761, DOI 10.1002/art.34437; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yazici H, 2007, NAT CLIN PRACT RHEUM, V3, P148, DOI 10.1038/ncprheum0436; Zaitlen N, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003520	32	53	54	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0119085	10.1371/journal.pone.0119085	http://dx.doi.org/10.1371/journal.pone.0119085			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799145	Green Published, Green Submitted, gold			2022-12-26	WOS:000351987300027
J	Mathias, D; Mitchel, REJ; Barclay, M; Wyatt, H; Bugden, M; Priest, ND; Whitman, SC; Scholz, M; Hildebrandt, G; Kamprad, M; Glasow, A				Mathias, Daniel; Mitchel, Ronald E. J.; Barclay, Mirela; Wyatt, Heather; Bugden, Michelle; Priest, Nicholas D.; Whitman, Stewart C.; Scholz, Markus; Hildebrandt, Guido; Kamprad, Manja; Glasow, Annegret			Low-Dose Irradiation Affects Expression of Inflammatory Markers in the Heart of ApoE (-/-) Mice	PLOS ONE			English	Article							INTERCELLULAR-ADHESION MOLECULE-1; ACTIVATED ENDOTHELIAL-CELLS; INDUCED MYOCARDIAL FIBROSIS; ATOMIC-BOMB SURVIVORS; IONIZING-RADIATION; APOE(-/-) MICE; IN-VITRO; UP-REGULATION; VASCULAR ENDOTHELIUM; HODGKIN LYMPHOMA	Epidemiological studies indicate long-term risks of ionizing radiation on the heart, even at moderate doses. In this study, we investigated the inflammatory, thrombotic and fibrotic late responses of the heart after low-dose irradiation (IR) with specific emphasize on the dose rate. Hypercholesterolemic ApoE-deficient mice were sacrificed 3 and 6 months after total body irradiation (TBI) with 0.025, 0.05, 0.1, 0.5 or 2 Gy at low (1 mGy/min) or high dose rate (150 mGy/min). The expression of inflammatory and thrombotic markers was quantified in frozen heart sections (CD31, E-selectin, thrombomodulin, ICAM-1, VCAM-1, collagen IV, Thy-1, and CD45) and in plasma samples (IL6, KC, MCP-1, TNF alpha, INF gamma, IL-1 beta, TGF beta, INF gamma, IL-10, sICAM-1, sE-selectin, sVCAM-1 and fibrinogen) by fluorescence analysis and ELISA. We found that even very low irradiation doses induced adaptive late responses, such as increases of capillary density and changes in collagen IV and Thy-1 levels indicating compensatory regulation. Slight decreases of ICAM-1 levels and reduction of Thy 1 expression at 0.025-0.5 Gy indicate anti-inflammatory effects, whereas at the highest dose (2 Gy) increased VCAM-1 levels on the endocardium may represent a switch to a pro-inflammatory response. Plasma samples partially confirmed this pattern, showing a decrease of proinflammatory markers (sVCAM, sICAM) at 0.025-2.0 Gy. In contrast, an enhancement of MCP-1, TNF alpha and fibrinogen at 0.05-2.0 Gy indicated a proinflammatory and prothrombotic systemic response. Multivariate analysis also revealed significant age-dependent increases (KC, MCP-1, fibrinogen) and decreases (sICAM, sVCAM, sE-selectin) of plasma markers. This paper represents local and systemic effects of low-dose irradiation, including also age-and dose rate-dependent responses in the ApoE(-/-) mouse model. These insights in the multiple inflammatory/thrombotic effects caused by low-dose irradiation might facilitate an individual evaluation and intervention of radiation related, long-term side effects but also give important implications for low dose anti-inflammatory radiotherapy.	[Mathias, Daniel; Glasow, Annegret] Univ Leipzig, Dept Radiat Therapy, D-04109 Leipzig, Germany; [Mitchel, Ronald E. J.; Wyatt, Heather; Bugden, Michelle; Priest, Nicholas D.] Canadian Nucl Labs, Radiol Protect Res & Instrumentat Branch, Chalk River, ON, Canada; [Barclay, Mirela; Whitman, Stewart C.] Univ Ottawa, Dept Pathol & Lab Med, Ottawa, ON, Canada; [Barclay, Mirela; Whitman, Stewart C.] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON, Canada; [Barclay, Mirela; Whitman, Stewart C.] Univ Ottawa, Inst Heart, Vasc Biol Grp, Ottawa, ON, Canada; [Scholz, Markus] Univ Leipzig, Inst Med Informat Stat & Epidemiol, D-04109 Leipzig, Germany; [Hildebrandt, Guido] Univ Rostock, Dept Radiotherapy & Radiat Oncol, D-18055 Rostock, Germany; [Kamprad, Manja] Univ Leipzig, Inst Clin Immunol & Transfus Med, D-04109 Leipzig, Germany	Leipzig University; Atomic Energy of Canada Limited; University of Ottawa; University of Ottawa; University of Ottawa; University of Ottawa Heart Institute; Leipzig University; University of Rostock; Leipzig University	Glasow, A (corresponding author), Univ Leipzig, Dept Radiat Therapy, D-04109 Leipzig, Germany.	Annegret.Glasow@medizin.uni-leipzig.de			European commission [FI6R036465]	European commission(European CommissionEuropean Commission Joint Research Centre)	The project was funded by European commission grant FI6R036465, NOTE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu-Velez AM, 2012, N AM J MED SCI, V4, P1, DOI 10.4103/1947-2714.92892; Baker JE, 2011, ANTIOXID REDOX SIGN, V15, P1945, DOI 10.1089/ars.2010.3742; Baker JE, 2009, INT J RADIAT BIOL, V85, P1089, DOI 10.3109/09553000903264473; Baluna RG, 2006, RADIAT RES, V166, P819, DOI 10.1667/RR0380.1; Blankenberg S, 2001, CIRCULATION, V104, P1336, DOI 10.1161/hc3701.095949; Boerma M, 2011, CARDIOL RES PRACT, V2011, DOI 10.4061/2011/858262; BURCH GE, 1968, ARCH INTERN MED, V121, P230, DOI 10.1001/archinte.121.3.230; Corrado E, 2010, J ATHEROSCLER THROMB, V17, P1, DOI 10.5551/jat.2600; EGHBALI M, 1989, J MOL CELL CARDIOL, V21, P103, DOI 10.1016/0022-2828(89)91498-3; FAJARDO LF, 1971, RADIOLOGY, V101, P429, DOI 10.1148/101.2.429; FAJARDO LF, 1973, LAB INVEST, V29, P244; FAJARDO LF, 1988, PATHOL ANNU, V23, P297; Gabriels K, 2012, RADIOTHER ONCOL, V105, P358, DOI 10.1016/j.radonc.2012.08.002; Galper SL, 2011, BLOOD, V117, P412, DOI 10.1182/blood-2010-06-291328; Gaugler MH, 1997, INT J RADIAT BIOL, V72, P201, DOI 10.1080/095530097143428; Gaugler MH, 2004, J THROMB HAEMOST, V2, P2020, DOI 10.1111/j.1538-7836.2004.00951.x; GOMEZREINO JJ, 1993, CLIN EXP IMMUNOL, V93, P103; Gyenes G, 1998, ACTA ONCOL, V37, P241, DOI 10.1080/028418698429522; Haeryfar SMM, 2004, J IMMUNOL, V173, P3581, DOI 10.4049/jimmunol.173.6.3581; Hallahan D, 1995, BIOCHEM BIOPH RES CO, V217, P784, DOI 10.1006/bbrc.1995.2841; Hallahan D, 1996, CANCER RES, V56, P5150; Hauer-Jensen M, 2004, CRIT CARE MED, V32, pS325, DOI 10.1097/01.CCM.0000126358.15697.75; Hayashi T, 2012, FASEB J, V26, P4765, DOI 10.1096/fj.12-215228; Heckmann M, 1998, EXP CELL RES, V238, P148, DOI 10.1006/excr.1997.3826; Heidenreich PA, 2009, HEART, V95, P252, DOI 10.1136/hrt.2008.149088; Hildebrandt G, 2002, INT J RADIAT BIOL, V78, P315, DOI 10.1080/09553000110106027; Hildebrandt G, 1998, INT J RADIAT BIOL, V74, P367, DOI 10.1080/095530098141500; Hoving S, 2012, RADIOTHER ONCOL, V105, P365, DOI 10.1016/j.radonc.2012.11.001; Hudon-David F, 2007, J MOL CELL CARDIOL, V42, P991, DOI 10.1016/j.yjmcc.2007.02.009; Ishii Y, 1999, EUR RESPIR J, V13, P733, DOI 10.1034/j.1399-3003.1999.13d06.x; Jurcut R, 2009, HELL J CARDIOL, V50, P538; Jurisic G, 2010, EXP CELL RES, V316, P2982, DOI 10.1016/j.yexcr.2010.06.013; Kaczmarek A, 2004, STRUCT CHEM, V15, P517, DOI 10.1023/B:STUC.0000037910.26456.59; Kern PM, 2000, RADIOTHER ONCOL, V54, P273, DOI 10.1016/S0167-8140(00)00141-9; Krabbe KS, 2004, EXP GERONTOL, V39, P687, DOI 10.1016/j.exger.2004.01.009; LAUK S, 1985, INT J RADIAT ONCOL, V11, P801, DOI 10.1016/0360-3016(85)90314-1; LAUK S, 1990, INT J RADIAT BIOL, V57, P1017, DOI 10.1080/09553009014551131; Leda M, 2009, DEV CELL, V16, P233, DOI 10.1016/j.devcel.2008.12.007; Lee Peter J, 2005, Cardiol Rev, V13, P80, DOI 10.1097/01.crd.0000131188.41589.c5; LEINONEN A, 1994, J BIOL CHEM, V269, P26172; MARIYAMA M, 1994, J BIOL CHEM, V269, P23013; Matsuda Y, 2001, BONE MARROW TRANSPL, V27, P977, DOI 10.1038/sj.bmt.1703026; Meir KS, 2004, ARTERIOSCL THROM VAS, V24, P1006, DOI 10.1161/01.ATV.0000128849.12617.f4; Mertens A, 2001, FASEB J, V15, P2073, DOI 10.1096/fj.01-0273rev; Miles EA, 2008, ATHEROSCLEROSIS, V196, P298, DOI 10.1016/j.atherosclerosis.2006.11.002; MILLER GG, 1988, RADIAT RES, V115, P515, DOI 10.2307/3577301; MINER JH, 1994, J CELL BIOL, V127, P879, DOI 10.1083/jcb.127.3.879; Mitchel REJ, 2013, RADIAT RES, V179, P190, DOI 10.1667/RR3140.1; Mitchel REJ, 2011, RADIAT RES, V175, P665, DOI 10.1667/RR2176.1; Molla M, 2003, INT J RADIAT ONCOL, V57, P264, DOI 10.1016/S0360-3016(03)00523-6; Moriconi F, 2009, STRAHLENTHER ONKOL, V185, P460, DOI 10.1007/s00066-009-1964-1; Mulrooney DA, 2012, PEDIATR BLOOD CANCER, V59, P285, DOI 10.1002/pbc.24082; Patties I, 2015, STRAHLENTHER ONKOL, V191, P172, DOI 10.1007/s00066-014-0745-7; Patties I, 2014, RADIAT ENVIRON BIOPH, V53, P117, DOI 10.1007/s00411-013-0492-7; Quarmby S, 2000, ANTICANCER RES, V20, P3375; Quarmby S, 1999, ARTERIOSCL THROM VAS, V19, P588, DOI 10.1161/01.ATV.19.3.588; Quarmby S, 1999, INT J CANCER, V82, P385, DOI 10.1002/(SICI)1097-0215(19990730)82:3<385::AID-IJC12>3.0.CO;2-5; Ramirez G, 2011, LAB INVEST, V91, P1206, DOI 10.1038/labinvest.2011.80; Richter KK, 1997, RADIOTHER ONCOL, V44, P65, DOI 10.1016/S0167-8140(97)00063-7; Roedel F, 2002, INT J RADIAT BIOL, V78, P711, DOI 10.1080/09553000210137671; Ross CC, 2008, RADIAT RES, V169, P408, DOI 10.1667/RR1148.1; Sakata R, 2012, MATURITAS, V72, P99, DOI 10.1016/j.maturitas.2012.02.009; Schubert K, 2011, EUR J IMMUNOL, V41, P645, DOI 10.1002/eji.201041117; Schultz-Hector S, 2007, INT J RADIAT ONCOL, V67, P10, DOI 10.1016/j.ijrobp.2006.08.071; Seemann I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068922; Seemann I, 2012, RADIOTHER ONCOL, V103, P143, DOI 10.1016/j.radonc.2011.10.011; Stec JJ, 2000, CIRCULATION, V102, P1634, DOI 10.1161/01.CIR.102.14.1634; Stewart FA, 2006, AM J PATHOL, V168, P649, DOI 10.2353/ajpath.2006.050409; STEWART JR, 1984, PROG CARDIOVASC DIS, V27, P173; STEWART JR, 1995, INT J RADIAT ONCOL, V31, P1205, DOI 10.1016/0360-3016(94)00656-6; Takahashi I, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000654; Van de Wouwer M, 2004, CRIT CARE MED, V32, pS254, DOI 10.1097/01.CCM.0000128036.64448.9e; Walther M, 1999, INT J RADIAT BIOL, V75, P1317; Wang JR, 2002, AM J PATHOL, V160, P2063, DOI 10.1016/S0002-9440(10)61156-X; Weintraub NL, 2010, J AM COLL CARDIOL, V55, P1237, DOI 10.1016/j.jacc.2009.11.053; Wetzel A, 2004, J IMMUNOL, V172, P3850, DOI 10.4049/jimmunol.172.6.3850; Wetzel A, 2006, J INVEST DERMATOL, V126, P441, DOI 10.1038/sj.jid.5700072; Yamanishi A, 1998, PATHOL RES PRACT, V194, P413, DOI 10.1016/S0344-0338(98)80032-0; Zeisberg M, 2001, AM J PATHOL, V159, P1313, DOI 10.1016/S0002-9440(10)62518-7; ZHOU QS, 1992, THROMB RES, V68, P109, DOI 10.1016/0049-3848(92)90026-7; ZHOU QS, 1992, RADIAT RES, V131, P285, DOI 10.2307/3578417	81	28	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0119661	10.1371/journal.pone.0119661	http://dx.doi.org/10.1371/journal.pone.0119661			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799423	Green Published, gold			2022-12-26	WOS:000351987300069
J	Mueller, EA; Schlievert, PM				Mueller, Elizabeth A.; Schlievert, Patrick M.			Non-Aqueous Glycerol Monolaurate Gel Exhibits Antibacterial and Anti-Biofilm Activity against Gram-Positive and Gram-Negative Pathogens	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; SURGICAL-SITE INFECTIONS; IN-VITRO; PREVENTION; ANTIBIOTICS	Background Skin and surgical infections due to Staphylococcus aureus, Pseudomonas aeruginosa, and Acinetobacter baumannii are causes of patient morbidity and increased healthcare costs. These organisms grow planktonically and as biofilms, and many strains exhibit antibiotic resistance. This study examines the antibacterial and anti-biofilm activity of glycerol monolaurate (GML), as solubilized in a non-aqueous vehicle (5% GML Gel), as a novel, broadlyactive topical antimicrobial. The FDA has designated GML as generally recognized as safe for human use, and the compound is commonly used in the cosmetic and food industries. Methods In vitro, bacterial strains in broths and biofilms were exposed to GML Gel, and effects on bacterial colony-forming units (CFUs) were assessed. In vivo, subcutaneous incisions were made in New Zealand white rabbits; the incisions were closed with four sutures. Bacterial strains were painted onto the incision sites, and then GML Gel or placebo was liberally applied to cover the sites completely. Rabbits were allowed to awaken and were examined for CFUs as a function of exposure time. Results In vitro, GML Gel was bactericidal for all broth culture and biofilm organisms in <1 hour and <4 hour, respectively; no CFUs were detected after the entire 24 h test period. In vivo, GML Gel inhibited bacterial growth in the surgical incision sites, compared to no growth inhibition in controls. GML Gel significantly reduced inflammation, as viewed by lack of redness in and below the incision sites. Conclusions Our findings suggest that 5% GML Gel is useful as a potent topical antibacterial and anti-inflammatory agent for prevention of infections.	[Mueller, Elizabeth A.; Schlievert, Patrick M.] Univ Iowa, Dept Microbiol, Carver Coll Med, Iowa City, IA 52242 USA	University of Iowa	Schlievert, PM (corresponding author), Univ Iowa, Dept Microbiol, Carver Coll Med, Iowa City, IA 52242 USA.	patrick-schlievert@uiowa.edu		Schlievert, Patrick/0000-0001-8314-9369; Mueller, Elizabeth A/0000-0001-5482-6551	University of Iowa; American Society for Microbiology; University of Iowa, Microbiology Department, Stinski Fellowship	University of Iowa; American Society for Microbiology; University of Iowa, Microbiology Department, Stinski Fellowship	Funding: This research was supported by University of Iowa start-up funds for Patrick M. Schlievert. Elizabeth A. Mueller was supported by fellowships from the American Society for Microbiology and the University of Iowa, Microbiology Department, Stinski Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bratzler DW, 2006, CLIN INFECT DIS, V43, P322, DOI 10.1086/505220; Cardo D, 2004, AM J INFECT CONTROL, V32, P470, DOI 10.1016/j.ajic.2004.10.001; Church D, 2006, CLIN MICROBIOL REV, V19, P403, DOI 10.1128/CMR.19.2.403-434.2006; Grimble SAJ, 2001, EUR J VASC ENDOVASC, V22, P215, DOI 10.1053/ejvs.2001.1436; Hess DJ, 2012, J SURG RES, V177, P334, DOI 10.1016/j.jss.2012.04.040; Hidron AI, 2008, INFECT CONT HOSP EP, V29, P996, DOI 10.1086/591861; Kirkland KB, 1999, INFECT CONT HOSP EP, V20, P725, DOI 10.1086/501572; Kluytmans J, 1997, CLIN MICROBIOL REV, V10, P505, DOI 10.1128/CMR.10.3.505; Kwasny Steven M, 2010, Curr Protoc Pharmacol, VChapter 13, DOI 10.1002/0471141755.ph13a08s50; Li QS, 2009, NATURE, V458, P1034, DOI 10.1038/nature07831; Lin YC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007499; Martone WJ, 2001, CLIN INFECT DIS, V33, pS67, DOI 10.1086/321859; McConnell MJ, 2013, FEMS MICROBIOL REV, V37, P130, DOI 10.1111/j.1574-6976.2012.00344.x; Moran GJ, 2006, NEW ENGL J MED, V355, P666, DOI 10.1056/NEJMoa055356; Park JH, 2012, FEMS MICROBIOL LETT, V335, P31, DOI 10.1111/j.1574-6968.2012.02635.x; Peterson ML, 2006, BIOCHEMISTRY-US, V45, P2387, DOI 10.1021/bi051992u; PRUITT BA, 1984, AM J MED, V76, P146, DOI 10.1016/0002-9343(84)90334-6; Schlievert PM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040350; SCHLIEVERT PM, 1992, ANTIMICROB AGENTS CH, V36, P626, DOI 10.1128/AAC.36.3.626; Schlievert PM, 2008, ANTIMICROBIAL AGENTS; Strandberg KL, 2010, ANTIMICROB AGENTS CH, V54, P597, DOI 10.1128/AAC.01151-09; Strateva T, 2011, ANN MICROBIOL, V61, P717, DOI 10.1007/s13213-011-0273-y; Trinh JV, 2009, INFECT CONT HOSP EP, V30, P440, DOI 10.1086/596612; Xiong YH, 2013, COLLOID SURFACE B, V112, P435, DOI 10.1016/j.colsurfb.2013.07.060	25	20	22	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120280	10.1371/journal.pone.0120280	http://dx.doi.org/10.1371/journal.pone.0120280			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799455	Green Submitted, Green Published, gold			2022-12-26	WOS:000351987300120
J	Tai, CL; Lee, PY; Hsieh, PH				Tai, Ching-Lung; Lee, Po-Yi; Hsieh, Pang-Hsing			Preliminary Biomechanical Study of Different Acetabular Reinforcement Devices for Acetabular Reconstruction	PLOS ONE			English	Article							TOTAL HIP-ARTHROPLASTY; DISTAL FEMUR FRACTURES; PELVIC DISCONTINUITY; BONE LOSS; STRUCTURAL ALLOGRAFT; POLYAXIAL LOCKING; FOLLOW-UP; REVISION; FIXATION; RING	Background Acetabular reinforcement devices (ARDs) are frequently used as load-sharing devices to allow allograft incorporation in revision hip arthroplasty with massive acetabular bone loss. The key to a successful reconstruction is robust fixation of the device to the host acetabulum. Interlocking fixation is expected to improve the initial stability of the postoperative construct. However, all commercially available ARDs are designed with non-locking fixation. This study investigates the efficacy of standard ARDs modified with locking screw mechanisms for improving stability in acetabular reconstruction. Methods Three types of ARDs were examined to evaluate the postoperative compression and angular stability: i) standard commercial ARDs, ii) standard ARDs modified with monoaxial and iii) standard ARDs modified with polyaxial locking screw mechanisms. All ARDs were implanted into osteomized synthetic pelvis with pelvic discontinuity. Axial compression and torsion tests were then performed using a servohydraulic material testing machine that measured load (angle) versus displacement (torque). Initial stability was compared among the groups. Results Equipping ARDs with interlocking mechanisms effectively improved the initial stability at the device/bone interface compared to standard non-locked ARDs. In both compression and torsion experiments, the monoaxial interlocking construct demonstrated the highest construct stiffness (672.6 +/- 84.1 N/mm in compression and 13.3 +/- 1.0 N.m/degree in torsion), whereas the non-locked construct had the lowest construct stiffness (381.4 +/- 117.2 N/mm in compression and 6.9 +/- 2.1 N.m/degree in torsion) (P < 0.05). Conclusions Our study demonstrates the potential benefit of adding a locking mechanism to an ARD. Polyaxial ARDs provide the surgeon with more flexibility in placing the screws at the cost of reduced mechanical performance. This in vitro study provides a preliminary evaluation of biomechanical performance for ARDs with or without interlocking mechanisms, actual clinical trial deserves to be further investigated in future studies.	[Tai, Ching-Lung; Lee, Po-Yi] Chang Gung Univ, Grad Inst Med Mechatron, Dept Mech Engn, Taoyuan, Taiwan; [Hsieh, Pang-Hsing] Chang Gung Univ, Dept Orthoped Surg, Chang Gung Mem Hosp, Coll Med, Taoyuan, Taiwan	Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University	Hsieh, PH (corresponding author), Chang Gung Univ, Dept Orthoped Surg, Chang Gung Mem Hosp, Coll Med, Taoyuan, Taiwan.	hsiehph@adm.cgmh.org.tw		Tai, Ching-Lung/0000-0002-9084-4885	Chang Gung Memorial Hospital [CMRPG3A1011, CMRPG3A1012]	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	This research was supported by a research grant (CMRPG3A1011, CMRPG3A1012) from Chang Gung Memorial Hospital (https://www.cgmh.org.tw/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abolghasemian M, 2014, BONE JOINT J, V96B, P319, DOI 10.1302/0301-620X.96B3.32850; Barwar N, 2014, CHIN J TRAUMATOL, V17, P88, DOI 10.3760/cma.j.issn.1008-1275.2014.02.006; Boscainos PJ, 2007, CLIN ORTHOP RELAT R, P159, DOI 10.1097/BLO.0b013e3181560c6c; DeBoer DK, 2007, J BONE JOINT SURG AM, V89A, P835, DOI 10.2106/JBJS.F.00313; Doht S, 2014, SCI WORLD J, DOI 10.1155/2014/648787; Duffy GP, 2007, J ARTHROPLASTY, V22, P711, DOI 10.1016/j.arth.2006.12.108; Garbuz D, 1996, J BONE JOINT SURG AM, V78A, P693, DOI 10.2106/00004623-199605000-00008; Gerber A, 2003, J BONE JOINT SURG AM, V85A, P2358, DOI 10.2106/00004623-200312000-00013; Gililland JM, 2013, J ARTHROPLASTY, V28, P178, DOI 10.1016/j.arth.2012.04.031; Gill TJ, 2000, J ARTHROPLASTY, V15, P1, DOI 10.1016/S0883-5403(00)90973-2; Gravius S, 2009, ORTHOPADE, V38, P729, DOI 10.1007/s00132-009-1428-4; Gross AE, 2006, J ARTHROPLASTY, V21, P117, DOI 10.1016/j.arth.2005.11.006; Hugate RR, 2009, J ARTHROPLASTY, V24, P806, DOI 10.1016/j.arth.2008.04.019; Kawanabe K, 2011, J ARTHROPLASTY, V26, P1061, DOI 10.1016/j.arth.2011.04.019; Kerboull M, 2000, CLIN ORTHOP RELAT R, P155; Milne LP, 2014, J ARTHROPLASTY, V29, P1043, DOI 10.1016/j.arth.2013.11.007; Otto RJ, 2009, J ORTHOP TRAUMA, V23, P645, DOI 10.1097/BOT.0b013e3181a567c8; Petrie J, 2013, BONE JOINT J, V95B, P109, DOI 10.1302/0301-620X.95B11.32764; Pieringer H, 2006, J ARTHROPLASTY, V21, P489, DOI 10.1016/j.arth.2005.02.016; Regis D, 2008, J ARTHROPLASTY, V23, P826, DOI 10.1016/j.arth.2007.06.017; Shinar AA, 1997, J BONE JOINT SURG AM, V79A, P159, DOI 10.2106/00004623-199702000-00001; Stiehl JB, 2000, J ARTHROPLASTY, V15, P849, DOI 10.1054/arth.2000.9320; Tsukada S, 2013, INT ORTHOP, V37, P2451, DOI 10.1007/s00264-013-2109-9; Udomkiat P, 2001, J ARTHROPLASTY, V16, P961, DOI 10.1054/arth.2001.27669; Wilkens KJ, 2008, J ORTHOP TRAUMA, V22, P624, DOI 10.1097/BOT.0b013e31818896b3; Winter E, 2001, J BONE JOINT SURG AM, V83A, P862, DOI 10.2106/00004623-200106000-00007; Zettl R, 2011, INT ORTHOP, V35, P1245, DOI 10.1007/s00264-011-1220-z	27	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121588	10.1371/journal.pone.0121588	http://dx.doi.org/10.1371/journal.pone.0121588			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799569	Green Published, gold, Green Submitted			2022-12-26	WOS:000351987300272
J	Teillard, F; Jiguet, F; Tichit, M				Teillard, Felix; Jiguet, Frederic; Tichit, Muriel			The Response of Farmland Bird Communities to Agricultural Intensity as Influenced by Its Spatial Aggregation	PLOS ONE			English	Article							AGRI-ENVIRONMENT SCHEMES; LAND-USE INTENSITY; LANDSCAPE COMPLEXITY; BIODIVERSITY GAIN; POPULATION TRENDS; GRASSLAND; HABITAT; INTENSIFICATION; CONSERVATION; MANAGEMENT	The shape of the relationship between biodiversity and agricultural intensity determines the range of intensities that should be targeted by conservation policies to obtain the greatest environmental benefits. Although preliminary evidence of this relationship exists, the influence of the spatial arrangement of intensity on biodiversity remains untested. We conducted a nationwide study linking agricultural intensity and its spatial arrangement to a farmland bird community of 22 species. Intensity was described with a continuous indicator based on Input Cost per hectare, which was relevant for both livestock and crop production. We used the French Breeding Bird Survey to compute several descriptors of the farmland bird community along the intensity gradient and tested for the significance of an interaction effect between intensity and its spatial aggregation on these descriptors. We found that the bird community was comprised of both winner and loser species with regard to intensity. The community composition descriptors (trophic level, specialisation, and specialisation for grassland indices) displayed non-linear relationships to intensity, with steeper slopes in the lower intensity range. We found a significant interaction effect between intensity and its spatial aggregation on the grassland specialisation index of the bird community; the effect of agricultural intensity was strengthened by its spatial aggregation. We suggest that an opportunity to improve the effectiveness of conservation policies exists by targeting measures in areas where intensity is moderate to low and aggregated. The effect of the aggregation of agricultural intensity on biodiversity should be considered in other scales and taxa when developing optimal policy targeting and intensity allocation strategies.	[Teillard, Felix; Tichit, Muriel] INRA AgroParisTech, UMR SAD APT 1048, Paris, France; [Jiguet, Frederic] MNHN CNRS UPMC, UMR CRBPO 7204, Paris, France	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite	Teillard, F (corresponding author), INRA AgroParisTech, UMR SAD APT 1048, Paris, France.	teillard@agroparistech.fr			Agence Nationale de la Recherche (The French National Research Agency) under the SYSTERRA program [NR-08-STRA-007]; European Union by the European Commission [235175 TRUSTEE (ANR-13-RURA-0001-01)]	Agence Nationale de la Recherche (The French National Research Agency) under the SYSTERRA program(French National Research Agency (ANR)); European Union by the European Commission	Felix Teillard received financial support from the Agence Nationale de la Recherche (The French National Research Agency) under the SYSTERRA program (Ecosystems and Sustainable Development, project NR-08-STRA-007, FARMBIRD -Coviability models of FARMing and BIRD biodiversity). Frederic Jiguet and Muriel Tichit received funding from the European Union by the European Commission within the Seventh Framework Programme in the frame of RURAGRI ERA-NET under Grant Agreement no 235175 TRUSTEE (ANR-13-RURA-0001-01). The authors only are responsible for any omissions or deficiencies. Neither the TRUSTEE project and any of its partner organizations, nor any organization of the European Union or European Commission are accountable for the content of this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, DEV HIGH NATURE VALU; [Anonymous], 1994, NATURE FARMING LOW I; Atkinson PW, 2005, J APPL ECOL, V42, P932, DOI 10.1111/j.1365-2664.2005.01070.x; Attwood SJ, 2008, GLOBAL ECOL BIOGEOGR, V17, P585, DOI 10.1111/j.1466-8238.2008.00399.x; Bakker JP, 1999, TRENDS ECOL EVOL, V14, P63, DOI 10.1016/S0169-5347(98)01544-4; Batary P, 2007, DIVERS DISTRIB, V13, P196, DOI 10.1111/j.1472-4642.2006.00309.x; Batary P, 2011, P ROY SOC B-BIOL SCI, V278, P1894, DOI 10.1098/rspb.2010.1923; Batary P, 2010, BIOL CONSERV, V143, P2020, DOI 10.1016/j.biocon.2010.05.005; Benton TG, 2003, TRENDS ECOL EVOL, V18, P182, DOI 10.1016/S0169-5347(03)00011-9; Bibby C. J., 2000, BIRD CENSUS TECHNIQU, DOI [10.1016/B978-0-12-095830-6.50010-9, DOI 10.1016/B978-0-12-095830-6.50010-9]; Bignal EM, 1996, J APPL ECOL, V33, P413, DOI 10.2307/2404973; Billeter R, 2008, J APPL ECOL, V45, P141, DOI 10.1111/j.1365-2664.2007.01393.x; Bleken MA, 2005, AMBIO, V34, P598, DOI 10.1639/0044-7447(2005)034[0598:HNCODP]2.0.CO;2; BLOMQVIST D, 1995, IBIS, V137, P550, DOI 10.1111/j.1474-919X.1995.tb03266.x; Boxall A.B.A., 2002, REV VET MED ENV; Bradbury RB, 2006, BIOL CONSERV, V129, P530, DOI 10.1016/j.biocon.2005.11.020; Brotons L, 2005, BIOL CONSERV, V124, P407, DOI 10.1016/j.biocon.2005.01.046; BWPi, 2006, BIRDS W PAL INT; Chamberlain DE, 2000, J APPL ECOL, V37, P771, DOI 10.1046/j.1365-2664.2000.00548.x; Cliff A. D., 1981, SPATIAL PROCESSES MO; Concepcion ED, 2008, LANDSCAPE ECOL, V23, P135, DOI 10.1007/s10980-007-9150-2; Crawley M.J., 2007, R BOOK; Dalgaard T, 1998, NUTR CYCL AGROECOSYS, V52, P277, DOI 10.1023/A:1009790722044; Devictor V, 2008, OIKOS, V117, P507, DOI 10.1111/j.2008.0030-1299.16215.x; Devictor V, 2007, AGR ECOSYST ENVIRON, V120, P179, DOI 10.1016/j.agee.2006.08.013; Dietrich JP, 2012, ECOL MODEL, V232, P109, DOI 10.1016/j.ecolmodel.2012.03.002; Donald PF, 2006, AGR ECOSYST ENVIRON, V116, P189, DOI 10.1016/j.agee.2006.02.007; Donald PF, 2001, P ROY SOC B-BIOL SCI, V268, P25, DOI 10.1098/rspb.2000.1325; Donald PF, 2006, J APPL ECOL, V43, P209, DOI 10.1111/j.1365-2664.2006.01146.x; Doxa A, 2010, J APPL ECOL, V47, P1348, DOI 10.1111/j.1365-2664.2010.01869.x; DUNNING JB, 1992, OIKOS, V65, P169, DOI 10.2307/3544901; Ekroos J, 2010, J APPL ECOL, V47, P459, DOI 10.1111/j.1365-2664.2009.01767.x; Erb KH, 2013, CURR OPIN ENV SUST, V5, P464, DOI 10.1016/j.cosust.2013.07.010; Fahrig L, 2011, ECOL LETT, V14, P101, DOI 10.1111/j.1461-0248.2010.01559.x; Filippi-Codaccioni O, 2010, BIOL CONSERV, V143, P883, DOI 10.1016/j.biocon.2009.12.035; Fischer J, 2011, SCIENCE, V334, P593, DOI 10.1126/science.334.6056.593-a; FREEMARK K, 1995, AGR ECOSYST ENVIRON, V52, P67, DOI 10.1016/0167-8809(94)00534-L; Fuller RJ, 1995, CONSERV BIOL, V9, P1425, DOI 10.1046/j.1523-1739.1995.09061425.x; Gabriel D, 2010, ECOL LETT, V13, P858, DOI 10.1111/j.1461-0248.2010.01481.x; Gabriel D, 2009, J APPL ECOL, V46, P323, DOI 10.1111/j.1365-2664.2009.01624.x; GEISSER S, 1975, J AM STAT ASSOC, V70, P320, DOI 10.2307/2285815; Gillings S, 2005, P ROY SOC B-BIOL SCI, V272, P733, DOI 10.1098/rspb.2004.3010; Green RE, 2005, SCIENCE, V307, P550, DOI 10.1126/science.1106049; Gregory RD, 2004, IBIS, V146, P1, DOI 10.1111/j.1474-919X.2004.00358.x; Guisan A, 2002, ECOL MODEL, V157, P89, DOI 10.1016/S0304-3800(02)00204-1; Haddad NM, 2000, OECOLOGIA, V124, P73, DOI 10.1007/s004420050026; Hallmann CA, 2014, NATURE; Herzog F, 2006, EUR J AGRON, V24, P165, DOI 10.1016/j.eja.2005.07.006; Hulme MF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054597; Ilbery B, 2011, AREA, V43, P31, DOI 10.1111/j.1475-4762.2010.00953.x; Jiguet F, 2006, ECOL LETT, V9, P1321, DOI 10.1111/j.1461-0248.2006.00986.x; Jiguet F, 2012, ACTA OECOL, V44, P58, DOI 10.1016/j.actao.2011.05.003; Jiguet F, 2011, CURR ZOOL, V57, P406, DOI 10.1093/czoolo/57.3.406; Jiguet F, 2010, P ROY SOC B-BIOL SCI, V277, P3601, DOI 10.1098/rspb.2010.0796; Julliard R, 2006, ECOL LETT, V9, P1237, DOI 10.1111/j.1461-0248.2006.00977.x; Klatzmann J, 1995, TECHNICAL REPORT; Kleijn D, 2003, J APPL ECOL, V40, P947, DOI 10.1111/j.1365-2664.2003.00868.x; Kleijn D, 2006, ECOL LETT, V9, P243, DOI 10.1111/j.1461-0248.2005.00869.x; Kleijn D, 2009, P R SOC B, V276, P903, DOI 10.1098/rspb.2008.1509; Kohler F, 2007, BIOL CONSERV, V135, P302, DOI 10.1016/j.biocon.2006.10.037; LEGENDRE P, 1989, VEGETATIO, V80, P107, DOI 10.1007/BF00048036; Merckx T, 2009, AGR ECOSYST ENVIRON, V130, P177, DOI 10.1016/j.agee.2009.01.006; Netting R. M., 1993, SMALLHOLDERS HOUSEHO, DOI DOI 10.1111/j.1558-5646.2009.00817.x; Neumann K, 2009, LANDSCAPE ECOL, V24, P1207, DOI 10.1007/s10980-009-9357-5; OPDAM P, 1991, LANDSCAPE ECOL, V5, P93, DOI 10.1007/BF00124663; Perfecto I, 2002, CONSERV BIOL, V16, P174, DOI 10.1046/j.1523-1739.2002.99536.x; Perfecto I., 2009, NATURES MATRIX LINKI; Phalan B, 2011, SCIENCE, V333, P1289, DOI 10.1126/science.1208742; Phalan B, 2011, FOOD POLICY, V36, pS62, DOI 10.1016/j.foodpol.2010.11.008; Pointereau P., 2010, ANAL SPATIAL TEMPORA; Prince K, 2012, AGR ECOSYST ENVIRON, V149, P74, DOI 10.1016/j.agee.2011.11.021; Reif J, 2010, BIRD STUDY, V57, P197, DOI 10.1080/00063650903477046; Robinson RA, 2002, J APPL ECOL, V39, P157, DOI 10.1046/j.1365-2664.2002.00695.x; Roschewitz I, 2005, J APPL ECOL, V42, P873, DOI 10.1111/j.1365-2664.2005.01072.x; Rundlof M, 2008, BIOL CONSERV, V141, P417, DOI 10.1016/j.biocon.2007.10.011; Shriar AJ, 2000, AGROFOREST SYST, V49, P301, DOI 10.1023/A:1006316131781; Siriwardena GM, 2008, IBIS, V150, P585, DOI 10.1111/j.1474-919X.2008.00828.x; Soderstrom B, 2000, CONSERV BIOL, V14, P522, DOI 10.1046/j.1523-1739.2000.98564.x; Stoate C, 2001, J ENVIRON MANAGE, V63, P337, DOI 10.1006/jema.2001.0473; Stoate C, 2009, J ENVIRON MANAGE, V91, P22, DOI 10.1016/j.jenvman.2009.07.005; Sutcliffe OL, 2003, LANDSCAPE URBAN PLAN, V63, P15, DOI 10.1016/S0169-2046(02)00153-6; Teillard F, 2012, AGR ECOSYST ENVIRON, V149, P135, DOI 10.1016/j.agee.2011.12.018; Teillard F, 2014, BIOL CONSERV, V176, P243, DOI 10.1016/j.biocon.2014.06.001; Temme AJAM, 2011, AGR ECOSYST ENVIRON, V140, P46, DOI 10.1016/j.agee.2010.11.010; Tscharntke T, 2005, ECOL LETT, V8, P857, DOI 10.1111/j.1461-0248.2005.00782.x; TURNER BL, 1978, PROF GEOGR, V30, P297, DOI 10.1111/j.0033-0124.1978.00297.x; Uthes S, 2010, ENVIRON MANAGE, V46, P494, DOI 10.1007/s00267-010-9518-y; Vandermeer J, 2007, CONSERV BIOL, V21, P274, DOI 10.1111/j.1523-1739.2006.00582.x; Verhulst J, 2007, J APPL ECOL, V44, P70, DOI 10.1111/j.1365-2664.2006.01238.x; Vickery JA, 2001, J APPL ECOL, V38, P647, DOI 10.1046/j.1365-2664.2001.00626.x; Vorisek P., 2010, LOWLAND FARMLAND BIR; Whittingham MJ, 2007, J APPL ECOL, V44, P1, DOI 10.1111/j.1365-2664.2006.01263.x; Wilson A, 2007, BIOL CONSERV, V136, P128, DOI 10.1016/j.biocon.2006.11.010; Woodhouse SP, 2005, AGR ECOSYST ENVIRON, V107, P331, DOI 10.1016/j.agee.2004.12.006; Zuur A.F., 2007, ANAL ECOLOGICAL DATA, P672, DOI DOI 10.1007/978-0-387-45972-1	95	26	28	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0119674	10.1371/journal.pone.0119674	http://dx.doi.org/10.1371/journal.pone.0119674			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799552	gold, Green Submitted, Green Published			2022-12-26	WOS:000351987300071
J	Thumbi, SM; Njenga, MK; Marsh, TL; Noh, S; Otiang, E; Munyua, P; Ochieng, L; Ogola, E; Yoder, J; Audi, A; Montgomery, JM; Bigogo, G; Breiman, RF; Palmer, GH; McElwain, TF				Thumbi, S. M.; Njenga, M. Kariuki; Marsh, Thomas L.; Noh, Susan; Otiang, Elkanah; Munyua, Peninah; Ochieng, Linus; Ogola, Eric; Yoder, Jonathan; Audi, Allan; Montgomery, Joel M.; Bigogo, Godfrey; Breiman, Robert F.; Palmer, Guy H.; McElwain, Terry F.			Linking Human Health and Livestock Health: A "One-Health" Platform for Integrated Analysis of Human Health, Livestock Health, and Economic Welfare in Livestock Dependent Communities	PLOS ONE			English	Article							DEMOGRAPHIC SURVEILLANCE; NUTRITION; DETERMINANTS; MALNUTRITION; INFECTIONS; MORBIDITY; IMMUNITY; DISEASES; POVERTY; GROWTH	Background For most rural households in sub-Saharan Africa, healthy livestock play a key role in averting the burden associated with zoonotic diseases, and in meeting household nutritional and socio-economic needs. However, there is limited understanding of the complex nutritional, socio-economic, and zoonotic pathways that link livestock health to human health and welfare. Here we describe a platform for integrated human health, animal health and economic welfare analysis designed to address this challenge. We provide baseline epidemiological data on disease syndromes in humans and the animals they keep, and provide examples of relationships between human health, animal health and household socio-economic status. Method We designed a study to obtain syndromic disease data in animals along with economic and behavioral information for 1500 rural households in Western Kenya already participating in a human syndromic disease surveillance study. Data collection started in February 2013, and each household is visited bi-weekly and data on four human syndromes (fever, jaundice, diarrhea and respiratory illness) and nine animal syndromes (death, respiratory, reproductive, musculoskeletal, nervous, urogenital, digestive, udder disorders, and skin disorders in cattle, sheep, goats and chickens) are collected. Additionally, data from a comprehensive socio-economic survey is collected every 3 months in each of the study households. Findings Data from the first year of study showed 93% of the households owned at least one form of livestock (55%, 19%, 41% and 88% own cattle, sheep, goats and chickens respectively). Digestive disorders, mainly diarrhea episodes, were the most common syndromes observed in cattle, goats and sheep, accounting for 56% of all livestock syndromes, followed by respiratory illnesses (18%). In humans, respiratory illnesses accounted for 54% of all illnesses reported, followed by acute febrile illnesses (40%) and diarrhea illnesses (5%). While controlling for household size, the incidence of human illness increased 1.31-fold for every 10 cases of animal illness or death observed (95% CI 1.16-1.49). Access and utilization of animal source foods such as milk and eggs were positively associated with the number of cattle and chickens owned by the household. Additionally, health care seeking was correlated with household incomes and wealth, which were in turn correlated with livestock herd size. Conclusion This study platform provides a unique longitudinal dataset that allows for the determination and quantification of linkages between human and animal health, including the impact of healthy animals on human disease averted, malnutrition, household educational attainment, and income levels.	[Thumbi, S. M.; Marsh, Thomas L.; Noh, Susan; Yoder, Jonathan; Palmer, Guy H.; McElwain, Terry F.] Washington State Univ, Paul G Allen Sch Global Anim Hlth, Pullman, WA 99164 USA; [Thumbi, S. M.; Otiang, Elkanah; Ochieng, Linus; Ogola, Eric; Audi, Allan; Bigogo, Godfrey] Kenya Govt Med Res Ctr, Ctr Global Hlth Res, Kisumu, Kenya; [Njenga, M. Kariuki; Munyua, Peninah; Montgomery, Joel M.] Ctr Dis Control & Prevent, Nairobi, Kenya; [Marsh, Thomas L.; Yoder, Jonathan] Washington State Univ, Sch Econ Sci, Pullman, WA 99164 USA; [Noh, Susan] ARS, Anim Dis Res Unit, USDA, Pullman, WA USA; [Breiman, Robert F.] Emory Univ, Atlanta, GA 30322 USA	Washington State University; Kenya Medical Research Institute; Washington State University; United States Department of Agriculture (USDA); Emory University	Thumbi, SM (corresponding author), Washington State Univ, Paul G Allen Sch Global Anim Hlth, Pullman, WA 99164 USA.	thumbi.mwangi@wsu.edu	Yoder, Jonathan K/F-4840-2011; Munyua, Peninah/AAA-5922-2021; Bigogo, Godfrey/W-3591-2019; Mwangi, Thumbi/L-2216-2019	Mwangi, Thumbi/0000-0002-5754-0556; Yoder, Jonathan/0000-0002-9049-9591; Audi, Allan/0000-0003-1683-554X	Paul G. Allen School for Global Animal Health	Paul G. Allen School for Global Animal Health	The study was funded through the Paul G. Allen School for Global Animal Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aanensen DM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006968; Adazu K, 2005, AM J TROP MED HYG, V73, P1151, DOI 10.4269/ajtmh.2005.73.1151; [Anonymous], 2014, R LANG ENV STAT COMP; Argent J, 2014, J EC BEHAV ORG; Bhaskaram P, 2002, NUTR REV, V60, pS40, DOI 10.1301/00296640260130722; Bradford GE, 1999, LIVEST PROD SCI, V59, P95, DOI 10.1016/S0301-6226(99)00019-6; Darapheak Chau, 2013, Int Arch Med, V6, P29, DOI 10.1186/1755-7682-6-29; Eshitera EE, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-234; Feikin DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016085; Feikin DR, 2010, INT J EPIDEMIOL, V39, P450, DOI 10.1093/ije/dyp374; Grace D, 2014, ONDERSTEPOORT J VET, V81, DOI 10.4102/ojvr.v81i2.725; Hughes S, 2006, PARASITE IMMUNOL, V28, P577, DOI 10.1111/j.1365-3024.2006.00897.x; Jin MC, 2014, SOC SCI MED, V105, P16, DOI 10.1016/j.socscimed.2014.01.001; Knobel DL, 2013, AM J TROP MED HYG, V88, P513, DOI 10.4269/ajtmh.12-0169; Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2; Kristjanson P, 2004, 14 FAO, P23; Lannotti L, 2014, AM J PHYS ANTHR; Mableson HE, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002800; Madden M., 2012, PEW INTERNET REP, P1; Marmot M, 2008, LANCET, V372, P1661, DOI 10.1016/S0140-6736(08)61690-6; Mazet JAK, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000190; Morse SS, 2012, LANCET, V380, P1956, DOI 10.1016/S0140-6736(12)61684-5; Murphy SP, 2003, J NUTR, P3932; Narrod C, 2012, ECOHEALTH, V9, P150, DOI 10.1007/s10393-012-0747-9; Nicholson CF, 2003, 2003 AAEA ANN M MONT; Njuki J, 2013, LIVESTOCK OWNERSHIP; Odhiambo FO, 2012, INT J EPIDEMIOL, V41, P977, DOI 10.1093/ije/dys108; Okwi PO, 2007, P NATL ACAD SCI USA, V104, P16769, DOI 10.1073/pnas.0611107104; Perry B, 2009, PHILOS T R SOC B, V364, P2643, DOI 10.1098/rstb.2009.0097; Randolph TF, 2007, J ANIM SCI, V85, P2788, DOI 10.2527/jas.2007-0467; SIGMAN M, 1989, J PEDIATR-US, V115, P357, DOI 10.1016/S0022-3476(89)80832-7; Singer M, 2012, ANN ANTHROPL PRACT, V36, P328, DOI 10.1111/napa.12007; Staal S., 2009, TARGETING STRATEGIC; Thornton P.K., 2002, MAPPING POVERTY LIVE; von Wissmann B, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000941; Whaley SE, 2003, J NUTR, V133, p3965S, DOI 10.1093/jn/133.11.3965S; Zinsstag J, 2005, LANCET, V366, P2142, DOI 10.1016/S0140-6736(05)67731-8	37	49	49	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120761	10.1371/journal.pone.0120761	http://dx.doi.org/10.1371/journal.pone.0120761			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE6ZS	25798951	Green Published, gold, Green Submitted			2022-12-26	WOS:000351987300174
J	Woltje, K; Jabs, M; Fischer, A				Woeltje, Kerstin; Jabs, Markus; Fischer, Andreas			Serum Induces Transcription of Hey1 and Hey2 Genes by Alk1 but Not Notch Signaling in Endothelial Cells	PLOS ONE			English	Article							EXPRESSION; ANGIOGENESIS; INHIBITION; SEGMENTATION; ACTIVATION; BMP9	The transcriptional repressors Hey1 and Hey2 are primary target genes of Notch signaling in the cardiovascular system and induction of Hey gene expression is often interpreted as activation of Notch signaling. Here we report that treatment of primary human endothelial cells with serum or fresh growth medium led to a strong wave of Hey1 and Hey2 transcription lasting for approximately three hours. Transcription of other Notch target genes (Hes1, Hes5, ephrinB2, Dll4) was however not induced by serum in endothelial cells. Gamma secretase inhibition or expression of dominant-negative MAML1 did not prevent the induction of Hey genes indicating that canonical Notch signaling is dispensable. Pretreatment with soluble BMP receptor Alk1, but not Alk3, abolished Hey gene induction by serum. Consequently, the Alk1 ligand BMP9 stimulated Hey gene induction in endothelial cells. Several other cell types however did not show such a strong BMP signaling and consequently only a very mild induction of Hey genes. Taken together, the experiments revealed that bone morphogenic proteins within the serum of cell culture medium are potent inducers of endothelial Hey1 and Hey2 gene expression within the first few hours after medium change.	[Woeltje, Kerstin; Jabs, Markus; Fischer, Andreas] German Canc Res Ctr DKFZ ZMBH Alliance, Vasc Signaling & Canc A270, D-69120 Heidelberg, Germany; [Fischer, Andreas] Heidelberg Univ, Med Fac Mannheim CBTM, Vasc Biol & Tumor Angiogenesis, D-68167 Mannheim, Germany; [Fischer, Andreas] Heidelberg Univ, Dept Med & Clin Chem 1, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Fischer, A (corresponding author), German Canc Res Ctr DKFZ ZMBH Alliance, Vasc Signaling & Canc A270, D-69120 Heidelberg, Germany.	a.fischer@dkfz-heidelberg.de			Deutsche Forschungsgemeinschaft [SFB-TR23]; Deutsche Krebshilfe; Helmholtz Association	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Krebshilfe(Deutsche Krebshilfe); Helmholtz Association(Helmholtz Association)	This work was supported by grants from the Deutsche Forschungsgemeinschaft (SFB-TR23), the Deutsche Krebshilfe and the Helmholtz Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam MG, 2013, CIRC RES, V113, P1206, DOI 10.1161/CIRCRESAHA.113.301686; Beets K, 2013, TRENDS GENET, V29, P140, DOI 10.1016/j.tig.2012.11.008; Dahlqvist C, 2003, DEVELOPMENT, V130, P6089, DOI 10.1242/dev.00834; Fischer A, 2004, GENE DEV, V18, P901, DOI 10.1101/gad.291004; Fischer A, 2007, NUCLEIC ACIDS RES, V35, P4583, DOI 10.1093/nar/gkm477; Guruharsha KG, 2012, NAT REV GENET, V13, P654, DOI 10.1038/nrg3272; Heisig J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002728; Herrera B, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-20; Hirata H, 2002, SCIENCE, V298, P840, DOI 10.1126/science.1074560; Imayoshi I, 2013, SCIENCE, V342, P1203, DOI 10.1126/science.1242366; Iso T, 2006, BIOCHEM BIOPH RES CO, V341, P708, DOI 10.1016/j.bbrc.2006.01.020; Itoh F, 2004, EMBO J, V23, P541, DOI 10.1038/sj.emboj.7600065; Jakobsson L, 2010, NAT CELL BIOL, V12, P943, DOI 10.1038/ncb2103; Kobayashi T, 2009, GENE DEV, V23, P1870, DOI 10.1101/gad.1823109; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Larrivee B, 2012, DEV CELL, V22, P489, DOI 10.1016/j.devcel.2012.02.005; Leimeister C, 2000, DEV BIOL, V227, P91, DOI 10.1006/dbio.2000.9884; Leimeister C, 1999, MECH DEVELOP, V85, P173, DOI 10.1016/S0925-4773(99)00080-5; Li FF, 2011, DEV CELL, V20, P291, DOI 10.1016/j.devcel.2011.01.011; Lu FM, 1996, P NATL ACAD SCI USA, V93, P5663, DOI 10.1073/pnas.93.11.5663; Miyazono K, 2010, J BIOCHEM, V147, P35, DOI 10.1093/jb/mvp148; Morikawa M, 2011, NUCLEIC ACIDS RES, V39, P8712, DOI 10.1093/nar/gkr572; Moya IM, 2012, DEV CELL, V22, P501, DOI 10.1016/j.devcel.2012.01.007; Nakagawa O, 2000, P NATL ACAD SCI USA, V97, P13655, DOI 10.1073/pnas.250485597; Nakajima M, 2000, J NEUROSCI RES, V62, P311, DOI 10.1002/1097-4547(20001015)62:2<311::AID-JNR16>3.0.CO;2-G; Ntziachristos P, 2014, CANCER CELL, V25, P318, DOI 10.1016/j.ccr.2014.02.018; Oh SP, 2000, P NATL ACAD SCI USA, V97, P2626, DOI 10.1073/pnas.97.6.2626; Penton AL, 2012, SEMIN CELL DEV BIOL, V23, P450, DOI 10.1016/j.semcdb.2012.01.010; Phng LK, 2009, DEV CELL, V16, P196, DOI 10.1016/j.devcel.2009.01.015; Pourquie O, 2011, CELL, V145, P650, DOI 10.1016/j.cell.2011.05.011; Ricard N, 2012, BLOOD, V119, P6162, DOI 10.1182/blood-2012-01-407593; Weng AP, 2003, MOL CELL BIOL, V23, P655, DOI 10.1128/MCB.23.2.655-664.2003; Wiese C, 2010, PEDIATR CARDIOL, V31, P363, DOI 10.1007/s00246-009-9609-9; Wrighton KH, 2009, J BIOL CHEM, V284, P9755, DOI 10.1074/jbc.M809223200; Yoshiura S, 2007, P NATL ACAD SCI USA, V104, P11292, DOI 10.1073/pnas.0701837104; Yu PB, 2008, NAT MED, V14, P1363, DOI 10.1038/nm.1888	36	28	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120547	10.1371/journal.pone.0120547	http://dx.doi.org/10.1371/journal.pone.0120547			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799559	Green Published, gold, Green Submitted			2022-12-26	WOS:000351987300152
J	Wu, J; Yin, HD; Zhu, JH; Buckanovich, RJ; Thorpe, JD; Dai, JL; Urban, N; Lubman, DM				Wu, Jing; Yin, Haidi; Zhu, Jianhui; Buckanovich, Ronald J.; Thorpe, Jason D.; Dai, Jianliang; Urban, Nicole; Lubman, David M.			Validation of LRG1 as a Potential Biomarker for Detection of Epithelial Ovarian Cancer by a Blinded Study	PLOS ONE			English	Article							SERUM; ASSAY; LUNG; GLYCOPROTEINS; PROSTATE; ANTIGEN; MARKERS; PROTEIN	Background Leucine-rich alpha-2-glycoprotein (LRG1) was found to be differentially expressed in sera from patients with Epithelial Ovarian Cancer (EOC). The aim of this study is to investigate the performance of LRG1 for detection of EOC, including early stage EOC, and to evaluate if LRG1 can complement CA125 in order to improve EOC detection using two independent blinded sample sets. Methods and Results Serum LRG1 and CA125 were measured by immunoassays. All assays were performed blinded to clinical data. Using the two independent sample sets (156 participants for sample set 1, and 233 for sample set 2), LRG1 was differentially expressed in EOC cases as compared to healthy, surgical, and benign controls, and its performance was not affected by the conditions of blood collection. The areas under the ROC curve (AUC) for LRG1 in differentiating EOC cases from non-cases were 0.797 and 0.786 for sample set 1 and 2. For differentiating EOC cases from healthy controls, the AUC values for LRG1 were 0.792 and 0.794. At a fixed specificity of 95%, LRG1 detects 52%, and 53.5% of EOC cases from healthy controls for sample set 1 and 2. When combining LRG1 and CA125, the AUC value increased to 0.927, which was improved compared to CA125 (AUC=0.916) (p=0.008) alone in distinguishing EOC cases from non-cases. More importantly, LRG1 also showed potential performance in differentiating early stage EOC from non-cases with an AUC of 0.715 for sample set 1, and 0.690 for sample set 2. The combination of LRG1 and CA125 resulted in an AUC of 0.838, which outperforms CA125 (AUC=0.785) (p=0.018) in detecting early stage EOC cases from non-cases using the larger sample set. Conclusions LRG1 could be a useful biomarker alone or in combination with CA125 for the diagnosis of ovarian cancer.	[Wu, Jing; Yin, Haidi; Zhu, Jianhui; Lubman, David M.] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA; [Buckanovich, Ronald J.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Thorpe, Jason D.; Urban, Nicole] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Dai, Jianliang] Univ Texas MD Anderson Canc Ctr, Biostat, Houston, TX 77030 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Fred Hutchinson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Lubman, DM (corresponding author), Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA.	dmlubman@umich.edu	wu, jing/C-4576-2015; Yin, Haidi/AAG-2024-2022; Yin, Haidi/AAG-1625-2022; Zhu, Jianhui/H-4665-2011	Yin, Haidi/0000-0002-1595-3950; Zhu, Jianhui/0000-0002-0051-7777	DOD ovarian cancer research program [W81XWH-10-1-0233]; National Cancer Institute [P50CA083636, U01CA152637]; NATIONAL CANCER INSTITUTE [P30CA016672, P50CA083636, U01CA152637] Funding Source: NIH RePORTER	DOD ovarian cancer research program; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by W81XWH-10-1-0233 DOD ovarian cancer research program (http://cdmrp.army.mil/ocrp/default.shtml) to DML, and P50CA083636 and U01CA152637 National Cancer Institute (http://www.cancer.gov/researchandfunding) to NU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amonkar SD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004599; BAST RC, 1981, J CLIN INVEST, V68, P1331, DOI 10.1172/JCI110380; Buys SS, 2011, JAMA-J AM MED ASSOC, V305, P2295, DOI 10.1001/jama.2011.766; Cramer DW, 2011, CANCER PREV RES, V4, P365, DOI 10.1158/1940-6207.CAPR-10-0195; Dorigo O, 2011, CANCER PREV RES, V4, P1356, DOI 10.1158/1940-6207.CAPR-11-0378; Fassl S, 2003, ONCOGENE, V22, P8343, DOI 10.1038/sj.onc.1207047; Gorelik E, 2005, CANCER EPIDEM BIOMAR, V14, P981, DOI 10.1158/1055-9965.EPI-04-0404; Guechot J, 1996, CLIN CHEM, V42, P558; Guppy AE, 2002, ONCOLOGIST, V7, P437, DOI 10.1634/theoncologist.7-5-437; Hellstrom I, 2003, CANCER RES, V63, P3695; Hellstrom Ingegerd, 2011, Expert Opin Med Diagn, V5, P227, DOI 10.1517/17530059.2011.559459; Holschneider CH, 2000, SEMIN SURG ONCOL, V19, P3, DOI 10.1002/1098-2388(200007/08)19:1<3::AID-SSU2>3.0.CO;2-S; JACOBS I, 1989, HUM REPROD, V4, P1; Kaku Tsunehisa, 2003, Medical Electron Microscopy, V36, P9, DOI 10.1007/s007950300002; Kobel M, 2008, PLOS MED, V5, P1749, DOI 10.1371/journal.pmed.0050232; Nolen BM, 2013, MOL DIAGN THER, V17, P139, DOI 10.1007/s40291-013-0027-6; Nolenu BM, 2012, FUTURE ONCOL, V8, P55, DOI [10.2217/fon.11.135, 10.2217/FON.11.135]; Okano T, 2006, PROTEOMICS, V6, P3938, DOI 10.1002/pmic.200500883; Palmer C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002633; Partridge E, 2009, OBSTET GYNECOL, V113, P775, DOI 10.1097/AOG.0b013e31819cda77; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Skates SJ, 2004, J CLIN ONCOL, V22, P4059, DOI 10.1200/JCO.2004.03.091; Smith CR, 2014, CLIN PROTEOM, V11, DOI 10.1186/1559-0275-11-23; Thorpe JD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001281; WOOLAS RP, 1993, JNCI-J NATL CANCER I, V85, P1748, DOI 10.1093/jnci/85.21.1748; Wu J, 2013, J PROTEOME RES, V12, P3342, DOI 10.1021/pr400169n; Wu J, 2012, J PROTEOME RES, V11, P4541, DOI 10.1021/pr300330z; Yu KH, 2005, J PROTEOME RES, V4, P1742, DOI 10.1021/pr050174l; Yurkovetsky Z, 2010, J CLIN ONCOL, V28, P2159, DOI 10.1200/JCO.2008.19.2484; Zhang Z, 2004, CANCER RES, V64, P5882, DOI 10.1158/0008-5472.CAN-04-0746	30	18	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121112	10.1371/journal.pone.0121112	http://dx.doi.org/10.1371/journal.pone.0121112			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799488	Green Submitted, Green Published, gold			2022-12-26	WOS:000351987300210
J	Mangalam, M; Desai, N; Singh, M				Mangalam, Madhur; Desai, Nisarg; Singh, Mewa			Division of Labor in Hand Usage Is Associated with Higher Hand Performance in Free-Ranging Bonnet Macaques, Macaca radiate	PLOS ONE			English	Article							MONKEYS CEBUS-APELLA; CHIMPANZEES PAN-TROGLODYTES; COORDINATED-BIMANUAL TASKS; PRIMARY MOTOR CORTEX; CAPUCHIN MONKEYS; MANUAL LATERALITY; HANDEDNESS; PREFERENCES; ASYMMETRIES; SPECIALIZATION	A practical approach to understanding lateral asymmetries in body, brain, and cognition would be to examine the performance advantages/disadvantages associated with the corresponding functions and behavior. In the present study, we examined whether the division of labor in hand usage, marked by the preferential usage of the two hands across manual operations requiring maneuvering in three-dimensional space (e.g., reaching for food, grooming, and hitting an opponent) and those requiring physical strength (e.g., climbing), is associated with higher hand performance in free-ranging bonnet macaques, Macaca radiate. We determined the extent to which the macaques exhibit laterality in hand usage in an experimental unimanual and a bimanual food-reaching task, and the extent to which manual laterality is associated with hand performance in an experimental hand-performance-differentiation task. We observed negative relationships between (a) the latency in food extraction by the preferred hand in the hand-performance-differentiation task (wherein, lower latency implies higher performance), the preferred hand determined using the bimanual food-reaching task, and the normalized difference between the performance of the two hands, and (b) the normalized difference between the performance of the two hands and the absolute difference between the laterality in hand usage in the unimanual and the bimanual food-reaching tasks (wherein, lesser difference implies higher manual specialization). Collectively, these observations demonstrate that the division of labor between the two hands is associated with higher hand performance.	[Mangalam, Madhur] Univ Georgia, Dept Psychol, Athens, GA 30602 USA; [Desai, Nisarg] Indian Inst Sci Educ & Res Pune, Pune, Maharashtra, India; [Singh, Mewa] Univ Mysore, Biopsychol Lab, Mysore, Karnataka, India; [Singh, Mewa] Univ Mysore, Inst Excellence, Mysore, Karnataka, India; [Singh, Mewa] Indian Inst Sci, Jawaharlal Nehru Ctr Adv Sci Res, Evolutionary & Organismal Biol Unit, Bangalore 560012, Karnataka, India	University System of Georgia; University of Georgia; Indian Institute of Science Education & Research (IISER) Pune; University of Mysore; University of Mysore; Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR); Indian Institute of Science (IISC) - Bangalore	Singh, M (corresponding author), Univ Mysore, Biopsychol Lab, Mysore, Karnataka, India.	mewasinghltm@gmail.com			Department of Science and Technology (DST), Government of India Ramanna Fellowship	Department of Science and Technology (DST), Government of India Ramanna Fellowship	This study was supported by a Department of Science and Technology (DST), Government of India Ramanna Fellowship to MS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew Richard J., 2002, P94, DOI 10.1017/CBO9780511546372.005; Bradshaw JL., 1993, EVOLUTION LATERAL AS; FAGOT J, 1991, PSYCHOL BULL, V109, P76, DOI 10.1037/0033-2909.109.1.76; FRAGASZY DM, 1990, J COMP PSYCHOL, V104, P275, DOI 10.1037/0735-7036.104.3.275; Geschwind N., 1987, CEREBRAL LATERALIZAT; GLEZER II, 1987, BEHAV BRAIN SCI, V10, P273, DOI 10.1017/S0140525X00047798; Hollo G, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-22; Hopkins W D, 1997, Laterality, V2, P267, DOI 10.1080/135765097397486; Hopkins WD, 2004, BEHAV NEUROSCI, V118, P1176, DOI 10.1037/0735-7044.118.6.1176; HOPKINS WD, 1995, J COMP PSYCHOL, V109, P291, DOI 10.1037/0735-7036.109.3.291; Hopkins WD, 1994, AM J PRIMATOL, V27, P395; Hopkins WD, 2007, INT J PRIMATOL, V28, P1315, DOI 10.1007/s10764-007-9221-x; Hopkins WD, 2007, CEREB CORTEX, V17, P1750, DOI 10.1093/cercor/bhl085; Hopkins WD, 2007, CEREB CORTEX, V17, P1757, DOI 10.1093/cercor/bhl086; Lilak AL, 2008, AM J PRIMATOL, V70, P254, DOI 10.1002/ajp.20485; MACNEILAGE PF, 1987, BEHAV BRAIN SCI, V10, P247, DOI 10.1017/S0140525X00047695; Mangalam M, 2014, AM J PRIMATOL, V76, P576, DOI 10.1002/ajp.22250; Meguerditchian A, 2010, AM J PHYS ANTHROPOL, V141, P638, DOI 10.1002/ajpa.21244; Meunier H, 2007, AM J PRIMATOL, V69, P1064, DOI 10.1002/ajp.20437; Milliken GW, 2005, J COMP PSYCHOL, V119, P430, DOI 10.1037/0735-7036.119.4.430; Phillips KA, 2005, BEHAV NEUROSCI, V119, P1701, DOI 10.1037/0735-7044.119.6.1701; Phillips KA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000792; Phillips KA, 2007, NEUROPSYCHOLOGIA, V45, P2398, DOI 10.1016/j.neuropsychologia.2007.02.021; Phillips KA, 2007, NEUROPSYCHOLOGIA, V45, P2333, DOI 10.1016/j.neuropsychologia.2007.02.010; Spinozzi G, 1998, J COMP PSYCHOL, V112, P183, DOI 10.1037/0735-7036.112.2.183; Spinozzi G, 2007, AM J PRIMATOL, V69, P336, DOI 10.1002/ajp.20352; Spinozzi G, 2002, INT J PRIMATOL, V23, P621, DOI 10.1023/A:1014977818853; Vauclair J, 2005, COGNITIVE BRAIN RES, V25, P210, DOI 10.1016/j.cogbrainres.2005.05.012; Ward J. P., 1993, PRIMATE LATERALITY C, DOI 10.1007/978-1-4612-4370-0; Zhao DP, 2012, AM J PHYS ANTHROPOL, V148, P36, DOI 10.1002/ajpa.22038; Zhao DP, 2010, BEHAV BRAIN RES, V208, P85, DOI 10.1016/j.bbr.2009.11.011	31	6	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0119337	10.1371/journal.pone.0119337	http://dx.doi.org/10.1371/journal.pone.0119337			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25806511	gold, Green Submitted, Green Published, Green Accepted			2022-12-26	WOS:000351880000027
J	Martin-Alonso, A; Abreu-Yanes, E; Feliu, C; Mas-Coma, S; Bargues, MD; Valladares, B; Foronda, P				Martin-Alonso, Aaron; Abreu-Yanes, Estefania; Feliu, Carlos; Mas-Coma, Santiago; Dolores Bargues, Maria; Valladares, Basilio; Foronda, Pilar			Intermediate Hosts of Angiostrongylus cantonensis in Tenerife, Spain	PLOS ONE			English	Article							ISOTHERMAL AMPLIFICATION LAMP; EOSINOPHILIC MENINGITIS; INFECTION; NEMATODA	The nematode Angiostrongylus cantonensis is the causative agent of human angiostrongyliasis, the main clinical manifestation of which is eosinophilic meningitis. Although this parasite has been found recently in its definitive rat host in Tenerife (Canary Islands, Spain), showing a widespread distribution over the north-east part of the island, there are no available data regarding which snail and/or slug species are acting as intermediate hosts on this island. Consequently, the objective of this work was to determine the possible role of three mollusc species, Plutonia lamarckii, Cornu aspersum and Theba pisana, as intermediate hosts of Angiostrongylus cantonensis in Tenerife. Between 2011 and 2014, 233 molluscs were collected from five biotopes where rats had been found previously to harbor either adult worms or antibodies against Angiostrongylus cantonensis, and the identification was carried out on the basis of morphological features and a LAMP technique. The prevalence of Angiostrongylus cantonensis larvae in the mollusc samples, based on morphological identification, was 19.3%, whereas 59 out of the 98 individuals (60.2%) analyzed by LAMP were positive. Positive results were obtained for the three mollusc species analyzed and two of the positive samples, both obtained from Plutonia lamarckii, were confirmed as positive by 18S rRNA and ITS1 PCR. Sequence analysis of 18S rRNA PCR products showed 100% similarity with previously published Angiostrongylus cantonensis sequences. These results may be relevant from a public health point of view, since all the biotopes from which the samples were obtained were in inhabited areas or areas with human activity, but it is also important from the perspective of a possible transmission to other accidental hosts, such as dogs and horses, animals that are present in some of the areas analyzed.	[Martin-Alonso, Aaron; Abreu-Yanes, Estefania; Valladares, Basilio; Foronda, Pilar] Univ La Laguna, Inst Univ Enfermedades Trop & Salud Publ Canarias, E-38207 San Cristobal la Laguna, Islas Canarias, Spain; [Feliu, Carlos] Univ Barcelona, Dept Microbiol & Parasitol, Barcelona, Cataluna, Spain; [Mas-Coma, Santiago; Dolores Bargues, Maria] Univ Valencia, Fac Farm, Dept Parasitol, E-46100 Burjassot, Spain	Universidad de la Laguna; University of Barcelona; University of Valencia	Martin-Alonso, A (corresponding author), Univ La Laguna, Inst Univ Enfermedades Trop & Salud Publ Canarias, E-38207 San Cristobal la Laguna, Islas Canarias, Spain.	amalonso@ull.edu.es	Foronda, Pilar/H-4680-2015; Bargues, Maria Dolores/L-8259-2014		projects Red de Investigacion Cooperativa en Enfermedades Tropicales-RICET [RD12/0018/0013]; Agencia Canaria de Investigacion, Innovacion y Sociedad de la Informacion; Generalitat de Catalunya [2014SGR 1241];  [CGL 200907759BOS]	projects Red de Investigacion Cooperativa en Enfermedades Tropicales-RICET; Agencia Canaria de Investigacion, Innovacion y Sociedad de la Informacion; Generalitat de Catalunya(Generalitat de Catalunya); 	This work was supported by projects Red de Investigacion Cooperativa en Enfermedades Tropicales-RICET (RD12/0018/0013), CGL 200907759BOS and 2014SGR 1241 (Generalitat de Catalunya). A.M-A was supported by a PhD grant from Agencia Canaria de Investigacion, Innovacion y Sociedad de la Informacion. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alicata J. E., 1965, Advances in Parasitology, V3, P223; ASH LR, 1970, J PARASITOL, V56, P249, DOI 10.2307/3277651; BOWDEN DK, 1981, AM J TROP MED HYG, V30, P1141, DOI 10.4269/ajtmh.1981.30.1141; Carreno RA, 2003, J PARASITOL, V89, P965, DOI 10.1645/GE-76R; Chen DX, 2011, PARASITOL RES, V109, P305, DOI 10.1007/s00436-011-2255-1; Chen R, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-204; Chotmongkol Verajit, 2002, Southeast Asian Journal of Tropical Medicine and Public Health, V33, P231; Cowie Robert H, 2013, Hawaii J Med Public Health, V72, P70; Cowie Robert H, 2013, Hawaii J Med Public Health, V72, P6; Delgado JD, 2001, ECOGRAPHY, V24, P539, DOI 10.1034/j.1600-0587.2001.d01-209.x; Eamsobhana P., 2006, RAT LUNGWORM PARASTR; Eamsobhana P, 2009, INT J INFECT DIS, V13, P425, DOI 10.1016/j.ijid.2008.09.021; Foronda P, 2010, ACTA TROP, V114, P123, DOI 10.1016/j.actatropica.2010.02.004; Groh K., 2004, LISTA ESPECIES SILVE, P149; Hausdorf B, 2002, ZOOL J LINN SOC-LOND, V134, P347, DOI 10.1046/j.1096-3642.2002.00010.x; JOHNSON MS, 1988, HEREDITY, V61, P133, DOI 10.1038/hdy.1988.98; Kim JR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094969; KLIKS MM, 1992, SOC SCI MED, V34, P199, DOI 10.1016/0277-9536(92)90097-A; Liu CY, 2011, MOL CELL PROBE, V25, P164, DOI 10.1016/j.mcp.2011.04.002; Lpez C, 2015, CORAL REEFS, V34, P631, DOI 10.1007/s00338-015-1260-8; Lunn JA, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-70; Martin-Alonso A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027747; Nicolai A, 2010, THESIS U SHEFFIELD; Prociv P, 2001, Southeast Asian J Trop Med Public Health, V32 Suppl 2, P126; Qvarnstrom Y, 2007, APPL ENVIRON MICROB, V73, P1415, DOI 10.1128/AEM.01968-06; Qvarnstrom Yvonne, 2013, Hawaii J Med Public Health, V72, P63; Qvarnstrom Y, 2010, APPL ENVIRON MICROB, V76, P5287, DOI 10.1128/AEM.00546-10; Slom TJ, 2002, NEW ENGL J MED, V346, P668, DOI 10.1056/NEJMoa012462; Teem John L, 2013, Hawaii J Med Public Health, V72, P11; Thekisoe OMM, 2007, ACTA TROP, V102, P182, DOI 10.1016/j.actatropica.2007.05.004; Wang QP, 2008, LANCET INFECT DIS, V8, P621, DOI 10.1016/S1473-3099(08)70229-9; YEN CM, 1990, J TROP MED HYG, V93, P347; YII CY, 1976, AM J TROP MED HYG, V25, P233, DOI 10.4269/ajtmh.1976.25.233	33	21	21	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0120686	10.1371/journal.pone.0120686	http://dx.doi.org/10.1371/journal.pone.0120686			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803658	gold, Green Published, Green Submitted			2022-12-26	WOS:000353889600093
J	Sala, C; Mattiuz, G; Pietrobono, S; Chicca, A; Conticello, SG				Sala, Cesare; Mattiuz, Giorgio; Pietrobono, Silvia; Chicca, Andrea; Conticello, Silvestro G.			Splice Variants of Activation Induced Deaminase (AID) Do Not Affect the Efficiency of Class Switch Recombination in Murine CH12F3 Cells	PLOS ONE			English	Article							INDUCED-CYTIDINE-DEAMINASE; CHRONIC LYMPHOCYTIC-LEUKEMIA; SOMATIC HYPERMUTATION; B-CELLS; ANTIBODY DIVERSIFICATION; HIGH EXPRESSION; ISOTYPE SWITCH; MESSENGER-RNA; C-MYC; GENE	Activation Induced Deaminase (AID) triggers the antigen-driven antibody diversification processes through its ability to edit DNA. AID dependent DNA damage is also the cause of genetic alterations often found in mature B cell tumors. A number of splice variants of AID have been identified, for which a role in the modulation of its activity has been hypothesized. We have thus tested two of these splice variants, which we find catalytically inactive, for their ability to modulate the activity of endogenous AID in CH12F3 cells, a murine lymphoma cell line in which Class Switch Recombination (CSR) can be induced. In contrast to full-length AID, neither these splice variants or a catalytically impaired AID mutant affect the efficiency of Class Switch Recombination. Thus, while a role for these splice variants at the RNA level remains possible, it is unlikely that they exert any regulatory effect on the function of AID.	[Sala, Cesare; Mattiuz, Giorgio; Pietrobono, Silvia; Chicca, Andrea; Conticello, Silvestro G.] Ist Toscano Tumori, Core Res Lab, Florence, Italy; [Pietrobono, Silvia] Univ Siena, Dept Med Biotechnol, I-53100 Siena, Italy; [Conticello, Silvestro G.] Univ Careggi, Dept Oncol, Azienda Osped, Florence, Italy	ISPRO Istituto per lo studio, la prevenzione e la rete oncologica; University of Siena; University of Florence; Azienda Ospedaliero Universitaria Careggi	Conticello, SG (corresponding author), Ist Toscano Tumori, Core Res Lab, Florence, Italy.	silvo.conticello@ittumori.it	Chicca, Andrea/AAP-7156-2020; Pietrobono, Silvia S/K-3932-2016; Conticello, Silvestro/G-9113-2011	Pietrobono, Silvia S/0000-0002-5544-7286; Conticello, Silvestro/0000-0002-4244-1846; Mattiuz, Giorgio/0000-0002-9668-1706; Chicca, Andrea/0000-0001-9593-636X	Istituto Toscano Tumori; Italian Ministry of Health [GR-2008-1141464]	Istituto Toscano Tumori; Italian Ministry of Health(Ministry of Health, Italy)	This work was supported by an institutional grant from the Istituto Toscano Tumori (http://www.ittumori.it), and by a grant of the Italian Ministry of Health (www.salute.gov.it; GR-2008-1141464). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albesiano E, 2003, BLOOD, V102, P3333, DOI 10.1182/blood-2003-05-1585; Arakawa H, 2002, SCIENCE, V295, P1301, DOI 10.1126/science.1067308; Babbage G, 2004, BLOOD, V103, P2795, DOI 10.1182/blood-2003-05-1632; Basu U, 2005, NATURE, V438, P508, DOI 10.1038/nature04255; Brar SS, 2004, J BIOL CHEM, V279, P26395, DOI 10.1074/jbc.M403503200; Conticello SG, 2008, MOL CELL, V31, P474, DOI 10.1016/j.molcel.2008.07.009; Dorsett Y, 2007, J EXP MED, V204, P2225, DOI 10.1084/jem.20070884; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; Ellyard JI, 2011, EUR J IMMUNOL, V41, P485, DOI 10.1002/eji.201041011; Forconi F, 2004, BLOOD, V104, P3312, DOI 10.1182/blood-2004-03-0950; Greeve J, 2003, BLOOD, V101, P3574, DOI 10.1182/blood-2002-08-2424; Heintel D, 2004, LEUKEMIA, V18, P756, DOI 10.1038/sj.leu.2403294; Iacobucci I, 2010, LEUKEMIA, V24, P66, DOI 10.1038/leu.2009.197; Ito S, 2004, P NATL ACAD SCI USA, V101, P1975, DOI 10.1073/pnas.0307335101; Kotani A, 2007, P NATL ACAD SCI USA, V104, P1616, DOI 10.1073/pnas.0610732104; Liu M, 2008, NATURE, V451, P841, DOI 10.1038/nature06547; Marantidou F, 2010, BLOOD CELL MOL DIS, V44, P262, DOI 10.1016/j.bcmd.2009.12.005; McBride KM, 2006, P NATL ACAD SCI USA, V103, P8798, DOI 10.1073/pnas.0603272103; McBride KM, 2004, J EXP MED, V199, P1235, DOI 10.1084/jem.20040373; McCarthy H, 2003, BLOOD, V101, P4903, DOI 10.1182/blood-2002-09-2906; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Nakamura M, 1996, INT IMMUNOL, V8, P193, DOI 10.1093/intimm/8.2.193; Neuberger MS, 2008, IMMUNOL CELL BIOL, V86, P124, DOI 10.1038/sj.icb.7100160; Noguchi E, 2001, J ALLERGY CLIN IMMUN, V108, P382, DOI 10.1067/mai.2001.117456; Okazaki Il-mi, 2007, Adv Immunol, V94, P245, DOI 10.1016/S0065-2776(06)94008-5; Oppezzo P, 2003, BLOOD, V101, P4029, DOI 10.1182/blood-2002-10-3175; Orthwein A, 2010, J EXP MED, V207, P2751, DOI 10.1084/jem.20101321; Palacios F, 2010, BLOOD, V115, P4488, DOI 10.1182/blood-2009-12-257758; Parsa JY, 2007, MOL IMMUNOL, V44, P567, DOI 10.1016/j.molimm.2006.02.003; Pasqualucci L, 2006, P NATL ACAD SCI USA, V103, P395, DOI 10.1073/pnas.0509969103; Pasqualucci L, 2001, NATURE, V412, P341, DOI 10.1038/35085588; Patenaude AM, 2009, NAT STRUCT MOL BIOL, V16, P517, DOI 10.1038/nsmb.1598; Petersen-Mahrt SK, 2002, NATURE, V418, P99, DOI 10.1038/nature00862; Ramiro AR, 2004, CELL, V118, P431, DOI 10.1016/j.cell.2004.08.006; Rebhandl S, 2014, EUR J IMMUNOL, V44, P2175, DOI 10.1002/eji.201343853; Robbiani DF, 2013, ANNU REV PATHOL-MECH, V8, P79, DOI 10.1146/annurev-pathol-020712-164004; Robbiani DF, 2008, CELL, V135, P1028, DOI 10.1016/j.cell.2008.09.062; Ta VT, 2003, NAT IMMUNOL, V4, P843, DOI 10.1038/ni964; Tran TH, 2010, NAT IMMUNOL, V11, P148, DOI 10.1038/ni.1829; Uchimura Y, 2011, J EXP MED, V208, P2385, DOI 10.1084/jem.20110856; van Maldegem F, 2010, J IMMUNOL, V184, P2487, DOI 10.4049/jimmunol.0903102; van Maldegem F, 2009, BLOOD, V113, P1862, DOI 10.1182/blood-2008-08-175265; Wang CL, 2004, P NATL ACAD SCI USA, V101, P7352, DOI 10.1073/pnas.0402009101; Wu XS, 2008, BLOOD, V112, P4675, DOI 10.1182/blood-2008-03-145995; Yadav A, 2006, MOL IMMUNOL, V43, P529, DOI 10.1016/j.molimm.2005.05.007	45	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0121719	10.1371/journal.pone.0121719	http://dx.doi.org/10.1371/journal.pone.0121719			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803053	Green Published, Green Submitted, gold			2022-12-26	WOS:000353889600174
J	Van Sambeek, L; Cowley, ES; Newman, DK; Kato, R				Van Sambeek, Lindsey; Cowley, Elise S.; Newman, Dianne K.; Kato, Roberta			Sputum Glucose and Glycemic Control in Cystic Fibrosis-Related Diabetes: A Cross-Sectional Study	PLOS ONE			English	Article							PULMONARY-FUNCTION; LUNG-FUNCTION; HYPERGLYCEMIA; BACTERIAL	Cystic fibrosis-related diabetes affects up to half of cystic fibrosis patients and is associated with increased mortality and more frequent pulmonary exacerbations. However, it is unclear to what degree good glycemic control might mitigate these risks and clinical outcomes have not previously been studied in relation to glucose from the lower airways, the site of infection and CF disease progression. We initially hypothesized that diabetic cystic fibrosis patients with glycosylated hemoglobin (HbA(1c)) > 6.5% have worse pulmonary function, longer and more frequent exacerbations and also higher sputum glucose levels than patients with HbA(1c) <= 6.5% or cystic fibrosis patients without diabetes. To test this, we analyzed spontaneously expectorated sputum samples from 88 cystic fibrosis patients. The median sputum glucose concentration was 0.70 mM (mean, 4.75 mM; range, 0-64.6 mM). Sputum glucose was not correlated with age, sex, body mass index, diabetes diagnosis, glycemic control, exacerbation frequency or length, or pulmonary function. Surprisingly, sputum glucose was highest in subjects with normal glucose tolerance, suggesting the dynamics of glycemic control, sputum glucose and pulmonary infections are more complex than previously thought. Two-year mean HbA(1c) was positively correlated with the length of exacerbation admission (p < 0.01), and negatively correlated with measures of pulmonary function (p < 0.01). While total number of hospitalizations for exacerbations were not significantly different, subjects with an HbA(1c) > 6.5% were hospitalized on average 6 days longer than those with HbA(1c) <= 6.5% (p < 0.01). Current clinical care guidelines for cystic fibrosis-related diabetes target HbA(1c) <= 7% to limit long-term microvascular damage, but more stringent glycemic control (HbA(1c) <= 6.5%) may further reduce the short-term pulmonary complications.	[Van Sambeek, Lindsey; Cowley, Elise S.; Newman, Dianne K.] CALTECH, Pasadena, CA 91125 USA; [Van Sambeek, Lindsey; Cowley, Elise S.; Kato, Roberta] Childrens Hosp Los Angeles, Pediat Pulmonol, Los Angeles, CA 90027 USA	California Institute of Technology; Children's Hospital Los Angeles	Van Sambeek, L (corresponding author), CALTECH, Pasadena, CA 91125 USA.	lindseyv@gmail.com			Heart, Lung and Blood Institute of the National Institutes of Health [R01HL117328]; Del E. Webb Grant Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL117328] Funding Source: NIH RePORTER	Heart, Lung and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Del E. Webb Grant Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work is supported by the Heart, Lung and Blood Institute of the National Institutes of Health (www.nhlbi.nih.gov), grant number R01HL117328 and the Del E. Webb Grant Foundation (www.dewf.org). DKN is an Investigator of the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, HEALTH TECHNOL ASSES, V16, P1, DOI 10.3310/hta16240; Baker EH, 2007, J APPL PHYSIOL, V102, P1969, DOI 10.1152/japplphysiol.01425.2006; Bazerbachi F, 2014, CLEV CLIN J MED, V81, P146, DOI 10.3949/ccjm.81a.13147; Brennan AL, 2007, J CYST FIBROS, V6, P101, DOI 10.1016/j.jcf.2006.03.009; Brennan Amanda L, 2004, J Cyst Fibros, V3, P209, DOI 10.1016/j.jcf.2004.08.001; Flume PA, 2009, RESP CARE, V54, P618, DOI 10.4187/aarc0443; Garnett JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076283; Hunt WR, 2014, AM J PHYSIOL-LUNG C, V306, pL43, DOI 10.1152/ajplung.00224.2013; Hunter RC, 2013, MBIO, V4, DOI 10.1128/mBio.00557-13; LANNG S, 1994, ACTA PAEDIATR, V83, P849, DOI 10.1111/j.1651-2227.1994.tb13156.x; Milla CE, 2000, AM J RESP CRIT CARE, V162, P891, DOI 10.1164/ajrccm.162.3.9904075; Moran A, 2010, DIABETES CARE, V33, P2697, DOI 10.2337/dc10-1768; Palmer KL, 2007, J BACTERIOL, V189, P8079, DOI 10.1128/JB.01138-07; Parkins MD, 2012, CHEST, V141, DOI [10.1378/chest.11-2552, DOI 10.1378/CHEST.11-2552]; Philips BJ, 2003, INTENS CARE MED, V29, P2204, DOI 10.1007/s00134-003-1961-2; Reid DW, 2009, AM J PHYSIOL-LUNG C, V297, pL795, DOI 10.1152/ajplung.00132.2009; Rosenecker JHR, 2011, EUR J MED RES, V27, P345; Sanders DB, 2010, AM J RESP CRIT CARE, V182, P627, DOI 10.1164/rccm.200909-1421OC; Sims EJ, 2005, DIABETES CARE, V28, P1581, DOI 10.2337/diacare.28.7.1581; Singh Suchita, 2013, J Allergy (Cairo), V2013, P627384, DOI 10.1155/2013/627384; Stallings VA, 2008, J AM DIET ASSOC, V108, P832, DOI 10.1016/j.jada.2008.02.020	21	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0119938	10.1371/journal.pone.0119938	http://dx.doi.org/10.1371/journal.pone.0119938			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803537	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000353889600050
J	Xie, SM; Zuo, NM; Shang, LQ; Song, M; Fan, LZ; Jiang, TZ				Xie, Sangma; Zuo, Nianming; Shang, Liqing; Song, Ming; Fan, Lingzhong; Jiang, Tianzi			How Does B-Value Affect HARDI Reconstruction Using Clinical Diffusion MRI Data?	PLOS ONE			English	Article							HUMAN CONNECTOME PROJECT; ORIENTATION DISTRIBUTION FUNCTION; ANGULAR-RESOLUTION; SPHERICAL DECONVOLUTION; FIBER ORIENTATIONS; BRAIN; TRACTOGRAPHY; CONNECTIVITY; ACQUISITION	Background A number of imaging factors can affect the orientation distribution function (ODF) reconstruction in high angular resolution diffusion imaging (HARDI). The aim of this study was to investigate the effect of the b-value on the HARDI reconstruction and to seek for the appropriate b-value for ODF reconstruction from clinical HARDI data. Methods Diffusion MRI data with various b-values were collected on a GE 3T MRI scanner. To reconstruct the diffusion ODF and fiber ODF, decomposition-based spherical polar Fourier imaging and deconvolution-based constrained spherical deconvolution approaches were applied separately. The full width at half maximum (FWHM) of the ODF and the angular difference of the peaks extracted from ODF were measured to investigate the effect of b-value on the ODF reconstruction. Visual inspection of the ODF was used to evaluate the reconstructions. Results The FWHM of the ODFs in the corpus callosum, which was chosen as the region of interest (ROI), decreased with increasing b-values. The differences in the FWHM for the diffusion ODF and the fiber ODF between the b-values of 2000 s/mm(2) and 2500 s/mm(2) were not significant. The angular differences of the ODF between 2000 s/mm(2) and 2500 s/mm(2) were lowest in both single-directional and two-directional situations. The ODFs became sharper and crossing-fiber situations were detected with an increase in b-value. B = 2000 s/mm(2) and above revealed most of the two-way or three-way crossing-fiber structures. Conclusions Considering both the signal-to-noise ratio and the acquisition time, b = 2000 s/mm(2) is the basic requirement for ODF reconstruction using current HARDI methods on clinical data. This study can provide a useful reference for researchers and clinicians attempting to set appropriate scan protocols for specific HARDI experiments.	[Xie, Sangma; Zuo, Nianming; Song, Ming; Fan, Lingzhong; Jiang, Tianzi] Chinese Acad Sci, Inst Automat, Brainnetome Ctr, Beijing, Peoples R China; [Xie, Sangma; Zuo, Nianming; Song, Ming; Jiang, Tianzi] Chinese Acad Sci, Inst Automat, Natl Lab Pattern Recognit, Beijing, Peoples R China; [Shang, Liqing; Jiang, Tianzi] Univ Elect Sci & Technol China, Sch Life Sci & Technol, Minist Educ, Key Lab NeuroInformat, Chengdu 610054, Peoples R China; [Jiang, Tianzi] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia; [Jiang, Tianzi] Chinese Acad Sci, Inst Automat, CAS Ctr Excellence Brain Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Automation, CAS; Chinese Academy of Sciences; Institute of Automation, CAS; University of Electronic Science & Technology of China; University of Queensland; Chinese Academy of Sciences; Institute of Automation, CAS	Jiang, TZ (corresponding author), Chinese Acad Sci, Inst Automat, Brainnetome Ctr, Beijing, Peoples R China.	jiangtz@nlpr.ia.ac.cn	Jiang, Tianzi/I-4256-2012	Jiang, Tianzi/0000-0001-9531-291X	National Key Basic Research and Development Program (973) [2011CB707800]; Natural Science Foundation of China [81000634]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDB02030300]	National Key Basic Research and Development Program (973)(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by the National Key Basic Research and Development Program (973) (grant no. 2011CB707800), the Natural Science Foundation of China (grant no. 81000634), the Strategic Priority Research Program of the Chinese Academy of Sciences (grant no. XDB02030300). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aganj I, 2010, MAGN RESON MED, V64, P554, DOI 10.1002/mrm.22365; Alexander DC, 2005, NEUROIMAGE, V27, P357, DOI 10.1016/j.neuroimage.2005.04.008; Assaf Y, 2004, MAGN RESON MED, V52, P965, DOI 10.1002/mrm.20274; Assaf Y, 2013, NEUROIMAGE, V80, P273, DOI 10.1016/j.neuroimage.2013.05.055; Assemlal HE, 2009, MED IMAGE ANAL, V13, P715, DOI 10.1016/j.media.2009.06.004; Basser PJ, 2002, NMR BIOMED, V15, P456, DOI 10.1002/nbm.783; Bullmore ET, 2012, NAT REV NEUROSCI, V13, P336, DOI 10.1038/nrn3214; Cheng JA, 2010, LECT NOTES COMPUT SC, V6361, P648; Cho KH, 2008, NEUROIMAGE, V42, P262, DOI 10.1016/j.neuroimage.2008.03.053; Dell'Acqua F, 2007, IEEE T BIO-MED ENG, V54, P462, DOI 10.1109/TBME.2006.888830; Descoteaux M, 2007, MAGN RESON MED, V58, P497, DOI 10.1002/mrm.21277; Descoteaux M, 2009, IEEE T MED IMAGING, V28, P269, DOI 10.1109/TMI.2008.2004424; Dietrich O, 2007, J MAGN RESON IMAGING, V26, P375, DOI 10.1002/jmri.20969; Gong GL, 2009, CEREB CORTEX, V19, P524, DOI 10.1093/cercor/bhn102; Griffa A, 2013, NEUROIMAGE, V80, P515, DOI 10.1016/j.neuroimage.2013.04.056; He Y, 2007, CEREB CORTEX, V17, P2407, DOI 10.1093/cercor/bhl149; Hess CP, 2006, MAGN RESON MED, V56, P104, DOI 10.1002/mrm.20931; Hosey T, 2005, MAGN RESON MED, V54, P1480, DOI 10.1002/mrm.20723; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Jiang TZ, 2013, NEUROIMAGE, V80, P263, DOI 10.1016/j.neuroimage.2013.04.002; Jones DK, 2010, DIFFUSION MRI THEORY; Kuo LW, 2008, NEUROIMAGE, V41, P7, DOI 10.1016/j.neuroimage.2008.02.016; Ozarslan E, 2006, NEUROIMAGE, V31, P1086, DOI 10.1016/j.neuroimage.2006.01.024; Parker GD, 2013, NEUROIMAGE, V65, P433, DOI 10.1016/j.neuroimage.2012.10.022; Prckovska V, 2008, LECT NOTES COMPUT SC, V5242, P9, DOI 10.1007/978-3-540-85990-1_2; Setsompop K, 2013, NEUROIMAGE, V80, P220, DOI 10.1016/j.neuroimage.2013.05.078; Smith SM, 2012, NEUROIMAGE, V62, P1257, DOI 10.1016/j.neuroimage.2012.01.022; Sotiropoulos SN, 2013, NEUROIMAGE, V80, P125, DOI 10.1016/j.neuroimage.2013.05.057; Sporns O, 2011, ANN NY ACAD SCI, V1224, P109, DOI 10.1111/j.1749-6632.2010.05888.x; Tournier JD, 2007, NEUROIMAGE, V35, P1459, DOI 10.1016/j.neuroimage.2007.02.016; Tournier JD, 2013, NMR BIOMED, V26, P1775, DOI 10.1002/nbm.3017; Tournier JD, 2012, INT J IMAG SYST TECH, V22, P53, DOI 10.1002/ima.22005; Tournier JD, 2004, NEUROIMAGE, V23, P1176, DOI 10.1016/j.neuroimage.2004.07.037; Tristan-Vega A, 2010, NEUROIMAGE, V49, P1301, DOI 10.1016/j.neuroimage.2009.09.070; Tuch DS, 2004, MAGN RESON MED, V52, P1358, DOI 10.1002/mrm.20279; Van Essen DC, 2013, NEUROIMAGE, V80, P62, DOI 10.1016/j.neuroimage.2013.05.041; Wedeen VJ, 2008, NEUROIMAGE, V41, P1267, DOI 10.1016/j.neuroimage.2008.03.036; Wedeen VJ, 2005, MAGN RESON MED, V54, P1377, DOI 10.1002/mrm.20642	38	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0120773	10.1371/journal.pone.0120773	http://dx.doi.org/10.1371/journal.pone.0120773			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803023	Green Published, gold, Green Submitted			2022-12-26	WOS:000353889600097
J	Brooks, A; Shoup, D; Kustigian, L; Puchalla, J; Carr, CM; Rye, HS				Brooks, Arielle; Shoup, Daniel; Kustigian, Lauren; Puchalla, Jason; Carr, Chavela M.; Rye, Hays S.			Single Particle Fluorescence Burst Analysis of Epsin Induced Membrane Fission	PLOS ONE			English	Article							DOMAIN-CONTAINING PROTEINS; ANALYSIS SPECTROSCOPY; DISTINCT STEPS; VESICLE; DYNAMIN; SCISSION; RECRUITMENT; CURVATURE; FUSION	Vital cellular processes, from cell growth to synaptic transmission, rely on membrane-bounded carriers and vesicles to transport molecular cargo to and from specific intracellular compartments throughout the cell. Compartment-specific proteins are required for the final step, membrane fission, which releases the transport carrier from the intracellular compartment. The role of fission proteins, especially at intracellular locations and in non-neuronal cells, while informed by the dynamin-1 paradigm, remains to be resolved. In this study, we introduce a highly sensitive approach for the identification and analysis of membrane fission machinery, called burst analysis spectroscopy (BAS). BAS is a single particle, free-solution approach, well suited for quantitative measurements of membrane dynamics. Here, we use BAS to analyze membrane fission induced by the potent, fission-active ENTH domain of epsin. Using this method, we obtained temperature-dependent, time-resolved measurements of liposome size and concentration changes, even at sub-micromolar concentration of the epsin ENTH domain. We also uncovered, at 37 degrees C, fission activity for the full-length epsin protein, supporting the argument that the membrane-fission activity observed with the ENTH domain represents a native function of the full-length epsin protein.	[Brooks, Arielle; Shoup, Daniel; Kustigian, Lauren; Carr, Chavela M.; Rye, Hays S.] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA; [Puchalla, Jason] Princeton Univ, Dept Phys, Princeton, NJ 08544 USA	Texas A&M University System; Texas A&M University College Station; Princeton University	Rye, HS (corresponding author), Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA.	haysrye@tamu.edu		Rye, Hays/0000-0002-9420-3137	NIH [2RO1GM065421]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065421, R01GM114405] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH http://www.nigms.nih.gov/Pages/default.aspx 2RO1GM065421. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck R, 2011, J CELL BIOL, V194, P765, DOI 10.1083/jcb.201011027; Boucrot E, 2012, CELL, V149, P124, DOI 10.1016/j.cell.2012.01.047; Campelo F, 2012, ANNU REV BIOCHEM, V81, P407, DOI 10.1146/annurev-biochem-051710-094912; Carr CM, 2010, CURR OPIN CELL BIOL, V22, P488, DOI 10.1016/j.ceb.2010.04.006; Chen H, 1998, NATURE, V394, P793, DOI 10.1038/29555; Chen ZM, 2014, J AM CHEM SOC, V136, P4557, DOI 10.1021/ja411607b; Chernomordik LV, 2008, NAT STRUCT MOL BIOL, V15, P675, DOI 10.1038/nsmb.1455; Daumke O, 2014, CELL, V156, P882, DOI 10.1016/j.cell.2014.02.017; Ford MGJ, 2002, NATURE, V419, P361, DOI 10.1038/nature01020; HOPE MJ, 1989, J ELECTRON MICR TECH, V13, P277, DOI 10.1002/jemt.1060130403; Hurley JH, 2010, NAT REV MOL CELL BIO, V11, P556, DOI 10.1038/nrm2937; Krantz KC, 2013, J BIOL CHEM, V288, P26721, DOI 10.1074/jbc.M113.491753; Lee MCS, 2005, CELL, V122, P605, DOI 10.1016/j.cell.2005.07.025; Legendre-Guillemin V, 2004, J CELL SCI, V117, P9, DOI 10.1242/jcs.00928; Loerke D, 2009, PLOS BIOL, V7, P628, DOI 10.1371/journal.pbio.1000057; Massol RH, 2006, P NATL ACAD SCI USA, V103, P10265, DOI 10.1073/pnas.0603369103; Meinecke M, 2013, J BIOL CHEM, V288, P6651, DOI 10.1074/jbc.M112.444869; Merrifield CJ, 2005, CELL, V121, P593, DOI 10.1016/j.cell.2005.03.015; Mills IG, 2003, J CELL BIOL, V160, P213, DOI 10.1083/jcb.200208023; Neumann S, 2013, J BIOL CHEM, V288, P25119, DOI 10.1074/jbc.M113.490474; Pucadyil TJ, 2008, CELL, V135, P1263, DOI 10.1016/j.cell.2008.11.020; Puchalla J, 2008, P NATL ACAD SCI USA, V105, P14400, DOI 10.1073/pnas.0805969105; Rao YJ, 2010, P NATL ACAD SCI USA, V107, P8213, DOI 10.1073/pnas.1003478107; Roux A, 2006, NATURE, V441, P528, DOI 10.1038/nature04718; Shorter J, 2008, EMBO J, V27, P2712, DOI 10.1038/emboj.2008.194; Simpson F, 1999, NAT CELL BIOL, V1, P119, DOI 10.1038/10091; Taylor MJ, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000604; WANG LH, 1995, J BIOL CHEM, V270, P10079, DOI 10.1074/jbc.270.17.10079; Wickner W, 2008, NAT STRUCT MOL BIOL, V15, P658, DOI 10.1038/nsmb.1451	29	3	3	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0119563	10.1371/journal.pone.0119563	http://dx.doi.org/10.1371/journal.pone.0119563			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799353	Green Published, gold, Green Submitted			2022-12-26	WOS:000351987300059
J	Fortrie, G; Stads, S; Aarnoudse, AJH; Zietse, R; Betjes, MG				Fortrie, Gijs; Stads, Susanne; Aarnoudse, Albert-Jan H.; Zietse, Robert; Betjes, Michiel G.			Long-Term Sequelae of Severe Acute Kidney Injury in the Critically Ill Patient without Comorbidity: A Retrospective Cohort Study	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; REPLACEMENT THERAPY; HOSPITAL DISCHARGE; SERUM CREATININE; MORTALITY; AKI; RIFLE; CARE; OUTCOMES; PROGNOSIS	Background and Objectives Acute kidney injury (AKI) necessitating renal replacement therapy (RRT) is associated with high mortality and increased risk for end stage renal disease. However, it is unknown if this applies to patients with a preliminary unremarkable medical history. The purpose of this study was to describe overall and renal survival in critically ill patients with AKI necessitating RRT stratified by the presence of comorbidity. Design, Setting, Participants, and Measurements A retrospective cohort study was performed, between 1994 and 2010, including all adult critically ill patients with AKI necessitating RRT, stratified by the presence of comorbidity. Logistic regression, survival curve and cox proportional hazards analyses were used to evaluate overall and renal survival. Standardized mortality rate (SMR) analysis was performed to compare long-term survival to the predicted survival in the Dutch population. Results Of the 1067 patients included only 96(9.0%) had no comorbidity. Hospital mortality was 56.6% versus 43.8% in patients with and without comorbidity, respectively. In those who survived hospitalization 10-year survival was 45.0% and 86.0%, respectively. Adjusted for age, sex and year of treatment, absence of comorbidity was not associated with hospital mortality (OR=0.74, 95%-CI=0.47-1.15), while absence of comorbidity was associated with better long-term survival (adjusted HR=0.28, 95%-CI=0.14-0.58). Compared to the Dutch population, patients without comorbidity had a similar mortality risk (SMR=1.6, 95%-CI=0.73.2), while this was increased in patients with comorbidity (SMR=4.8, 95%-CI=4.1-5.5). Regarding chronic dialysis dependency, 10-year renal survival rates were 76.0% and 92.9% in patients with and without comorbidity, respectively. Absence of comorbidity was associated with better renal survival (adjusted HR=0.24, 95%-CI=0.07-0.76). Conclusions While hospital mortality remains excessively high, the absence of comorbidity in critically ill patients with RRT-requiring AKI is associated with a relative good long-term prognosis in those who survive hospitalization.	[Fortrie, Gijs; Aarnoudse, Albert-Jan H.; Zietse, Robert; Betjes, Michiel G.] Erasmus MC, Dept Internal Med, Div Nephrol, Rotterdam, Netherlands; [Stads, Susanne] Erasmus MC, Dept Intens Care, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Fortrie, G (corresponding author), Erasmus MC, Dept Internal Med, Div Nephrol, Rotterdam, Netherlands.	g.fortrie@erasmusmc.nl		Betjes, Michiel/0000-0001-9435-6208				Aldawood A, 2010, SAUDI J KIDNEY DIS T, V21, P1106; Bagshaw SM, 2008, NEPHROL DIAL TRANSPL, V23, P1569, DOI 10.1093/ndt/gfn009; Bagshaw SM, 2005, CRIT CARE, V9, pR700, DOI 10.1186/cc3879; Carl DE, 2010, HEMODIAL INT, V14, P11, DOI 10.1111/j.1542-4758.2009.00407.x; Cerda J, 2007, NEPHROL DIAL TRANSPL, V22, P2781, DOI 10.1093/ndt/gfm395; Chawla LS, 2012, KIDNEY INT, V82, P516, DOI 10.1038/ki.2012.208; Coca SG, 2012, KIDNEY INT, V81, P442, DOI 10.1038/ki.2011.379; Coca SG, 2009, AM J KIDNEY DIS, V53, P961, DOI 10.1053/j.ajkd.2008.11.034; Cohen SD, 2012, CURR OPIN CRIT CARE, V18, P623, DOI 10.1097/MCC.0b013e328358d3f5; Cruz DN, 2007, CLIN J AM SOC NEPHRO, V2, P418, DOI 10.2215/CJN.03361006; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Fortrie G, 2013, J CRIT CARE, V28, P126, DOI 10.1016/j.jcrc.2012.10.013; Garzotto F, 2011, BLOOD PURIFICAT, V31, P159, DOI 10.1159/000322161; Goldstein SL, 2010, CLIN J AM SOC NEPHRO, V5, P943, DOI 10.2215/CJN.07201009; Hoste EAJ, 2006, CRIT CARE, V10, DOI 10.1186/cc4915; Hsu CY, 2007, KIDNEY INT, V72, P208, DOI 10.1038/sj.ki.5002297; Hsu CY, 2012, J AM SOC NEPHROL, V23, P967, DOI 10.1681/ASN.2012030222; James MT, 2014, CLIN J AM SOC NEPHRO, V9, P435, DOI 10.2215/CJN.00500114; Joannidis M, 2009, INTENS CARE MED, V35, P1692, DOI 10.1007/s00134-009-1530-4; Kellum JA, 2012, JAMA-J AM MED ASSOC, V307, P2265, DOI 10.1001/jama.2012.4315; Korkeila M, 2000, INTENS CARE MED, V26, P1824, DOI 10.1007/s001340000726; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Morgera S, 2002, AM J KIDNEY DIS, V40, P275, DOI 10.1053/ajkd.2002.34505; Ostermann M, 2011, QJM-INT J MED, V104, P237, DOI 10.1093/qjmed/hcq185; Ostermann M, 2009, CRIT CARE, V13, DOI 10.1186/cc8154; Ostermann M, 2008, CRIT CARE, V12, DOI 10.1186/cc7123; Rifkin DE, 2012, J AM SOC NEPHROL, V23, P979, DOI 10.1681/ASN.2011121185; Schiffl H, 2006, NEPHROL DIAL TRANSPL, V21, P1248, DOI 10.1093/ndt/gfk069; Schiffl H, 2008, NEPHROL DIAL TRANSPL, V23, P2235, DOI 10.1093/ndt/gfn182; Stads S, 2013, CLIN J AM SOC NEPHRO, V8, P1284, DOI 10.2215/CJN.06650712; Susantitaphong P, 2013, CLIN J AM SOC NEPHRO, V8, P1482, DOI 10.2215/CJN.00710113; Thakar CV, 2009, CRIT CARE MED, V37, P2552, DOI 10.1097/CCM.0b013e3181a5906f; Uchino S, 2005, JAMA-J AM MED ASSOC, V294, P813, DOI 10.1001/jama.294.7.813; Waikar SS, 2006, J AM SOC NEPHROL, V17, P1143, DOI 10.1681/ASN.2005091017; Wald Ron, 2006, Hemodial Int, V10, P82, DOI 10.1111/j.1542-4758.2006.01179.x; Xue JL, 2006, J AM SOC NEPHROL, V17, P1135, DOI 10.1681/ASN.2005060668; Ympa YP, 2005, AM J MED, V118, P827, DOI 10.1016/j.amjmed.2005.01.069	37	11	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121482	10.1371/journal.pone.0121482	http://dx.doi.org/10.1371/journal.pone.0121482			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799318	Green Published, gold, Green Submitted			2022-12-26	WOS:000351987300258
J	Hidalgo-de-Quintana, J; Schwarz, N; Meschede, IP; Stern-Schneider, G; Powner, MB; Morrison, EE; Futter, CE; Wolfrum, U; Cheetham, ME; van der Spuy, J				Hidalgo-de-Quintana, Juan; Schwarz, Nele; Meschede, Ingrid P.; Stern-Schneider, Gabriele; Powner, Michael B.; Morrison, Ewan E.; Futter, Clare E.; Wolfrum, Uwe; Cheetham, Michael E.; van der Spuy, Jacqueline			The Leber Congenital Amaurosis Protein AIPL1 and EB Proteins Co-Localize at the Photoreceptor Cilium	PLOS ONE			English	Article							PEPTIDYLPROLYL ISOMERASE DOMAIN; END BINDING-PROTEINS; GLUCOCORTICOID-RECEPTOR; IMMUNOPHILIN FKBP52; DYNEIN INTERACTION; NUCLEAR TRANSLOCATION; MICROTUBULE DYNAMICS; CYTOPLASMIC DYNEIN; REGIONS; ROD	Purpose The aim of this study was to investigate the interaction and co-localization of novel interacting proteins with the Leber congenital amaurosis (LCA) associated protein aryl hydrocarbon receptor interacting protein-like 1 (AIPL1). Methods The CytoTrapXR yeast two-hybrid system was used to screen a bovine retinal cDNA library. A novel interaction between AIPL1 and members of the family of EB proteins was confirmed by directed yeast two-hybrid analysis and co-immunoprecipitation assays. The localization of AIPL1 and the EB proteins in cultured cells and in retinal cryosections was examined by immunofluorescence microscopy and cryo-immunogold electron microscopy. Results Yeast two-hybrid (Y2H) analysis identified the interaction between AIPL1 and the EB proteins, EB1 and EB3. EB1 and EB3 were specifically co-immunoprecipitated with AIPL1 from SK-N-SH neuroblastoma cells. In directed 1: 1 Y2H analysis, the interaction of EB1 with AIPL1 harbouring the LCA-causing mutations A197P, C239R and W278X was severely compromised. Immunofluorescent confocal microscopy revealed that AIPL1 did not co-localize with endogenous EB1 at the tips of microtubules, endogenous EB1 at the microtubule organising centre following disruption of the microtubule network, or with endogenous beta-tubulin. Moreover, AIPL1 did not localize to primary cilia in ARPE-19 cells, whereas EB1 co-localized with the centrosomal marker pericentrin at the base of primary cilia. However, both AIPL1 and the EB proteins, EB1 and EB3, co-localized with centrin-3 in the connecting cilium of photoreceptor cells. Cryo-immunogold electron microscopy confirmed the co-localization of AIPL1 and EB1 in the connecting cilia in human retinal photoreceptors. Conclusions AIPL1 and the EB proteins, EB1 and EB3, localize at the connecting cilia of retinal photoreceptor cells, but do not co-localize in the cellular microtubule network or in primary cilia in non-retinal cells. These findings suggest that AIPL1 function in these cells is not related to the role of EB proteins in microtubule dynamics or primary ciliogenesis, but that their association may be related to a specific role in the specialized cilia apparatus of retinal photoreceptors.	[Hidalgo-de-Quintana, Juan; Schwarz, Nele; Cheetham, Michael E.; van der Spuy, Jacqueline] UCL Inst Ophthalmol, Dept Ocular Biol & Therapeut, London, England; [Meschede, Ingrid P.; Powner, Michael B.; Futter, Clare E.] UCL Inst Ophthalmol, Dept Cell Biol, London, England; [Stern-Schneider, Gabriele; Wolfrum, Uwe] Johannes Gutenberg Univ Mainz, Inst Zool, Cell & Matrix Biol, Mainz, Germany; [Morrison, Ewan E.] St James Univ Hosp, Leeds Inst Mol Med, Sect Ophthalmol & Neurosci, Leeds, W Yorkshire, England	University of London; University College London; University of London; University College London; Johannes Gutenberg University of Mainz; Saint James's University Hospital; University of Leeds	van der Spuy, J (corresponding author), UCL Inst Ophthalmol, Dept Ocular Biol & Therapeut, London, England.	j.spuy@ucl.ac.uk	Powner, Michael/CAG-7455-2022	van der Spuy, Jacqueline/0000-0001-5906-2116; Powner, Michael/0000-0003-4913-1004; Futter, Clare/0000-0001-5559-9389; Cheetham, Michael/0000-0001-6429-654X	Action Medical Research [SP4014]; Wellcome Trust [GR077929MA]; European Community [241955]	Action Medical Research; Wellcome Trust(Wellcome TrustEuropean Commission); European Community(European Commission)	This work was supported by grants from Action Medical Research (www.action.org.uk) (SP4014) (MEC and JvdS), the Wellcome Trust (www.wellcome.ac.uk) (GR077929MA) (MEC and JvdS), and the European Community's Seventh Framework Programme FP7/2009 "SYSCILIA" under grant agreement number 241955 (http://cordis.europa.eu/fp7/home_en.html) (UW).	Aguila M, 2014, HUM MOL GENET, V23, P2164, DOI 10.1093/hmg/ddt613; Akhmanova A, 2008, NAT REV MOL CELL BIO, V9, P309, DOI 10.1038/nrm2369; Berrueta L, 1999, CURR BIOL, V9, P425, DOI 10.1016/S0960-9822(99)80190-0; Bett JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030866; Bjelic S, 2012, J STRUCT BIOL, V177, P160, DOI 10.1016/j.jsb.2011.11.010; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bu W, 2003, J BIOL CHEM, V278, P49721, DOI 10.1074/jbc.M306194200; Bu W, 2001, ONCOGENE, V20, P3185, DOI 10.1038/sj.onc.1204429; Chambraud B, 2007, FASEB J, V21, P2787, DOI 10.1096/fj.06-7667com; CZAR MJ, 1994, MOL ENDOCRINOL, V8, P1731, DOI 10.1210/me.8.12.1731; De Groot CO, 2010, J BIOL CHEM, V285, P5802, DOI 10.1074/jbc.M109.068130; Evans RJ, 2010, HUM MOL GENET, V19, P1358, DOI 10.1093/hmg/ddq012; Galigniana MD, 2010, MOL CELL BIOL, V30, P1285, DOI 10.1128/MCB.01190-09; Galigniana MD, 2004, J BIOL CHEM, V279, P22483, DOI 10.1074/jbc.M402223200; Galigniana MD, 2002, BIOCHEMISTRY-US, V41, P13602, DOI 10.1021/bi020399z; Galigniana MD, 2001, J BIOL CHEM, V276, P14884, DOI 10.1074/jbc.M010809200; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Hayashi I, 2003, J BIOL CHEM, V278, P36430, DOI 10.1074/jbc.M305773200; Hidalgo-De-Quintana J, 2008, INVEST OPHTH VIS SCI, V49, P2878, DOI 10.1167/iovs.07-1576; Honnappa S, 2005, EMBO J, V24, P261, DOI 10.1038/sj.emboj.7600529; Honnappa S, 2009, CELL, V138, P366, DOI 10.1016/j.cell.2009.04.065; Kazlauskas A, 2002, J BIOL CHEM, V277, P11795, DOI 10.1074/jbc.M200053200; Kolandaivelu S, 2009, J BIOL CHEM, V284, P30853, DOI 10.1074/jbc.M109.036780; Komarova Y, 2009, J CELL BIOL, V184, P691, DOI 10.1083/jcb.200807179; Larkins CE, 2011, MOL BIOL CELL, V22, P4694, DOI 10.1091/mbc.E10-12-0994; Li J, 2013, BIOCHEMISTRY-US, V52, P2089, DOI 10.1021/bi301648q; Liu Q, 2007, MOL CELL PROTEOMICS, V6, P1299, DOI 10.1074/mcp.M700054-MCP200; Liu XQ, 2004, P NATL ACAD SCI USA, V101, P13903, DOI 10.1073/pnas.0405160101; Mimori-Kiyosue Y, 2000, CURR BIOL, V10, P865, DOI 10.1016/S0960-9822(00)00600-X; Pazour GJ, 2005, J CELL BIOL, V170, P103, DOI 10.1083/jcb.200504008; PERROTAPPLANAT M, 1995, J CELL SCI, V108, P2037; Ramamurthy V, 2004, P NATL ACAD SCI USA, V101, P13897, DOI 10.1073/pnas.0404197101; Riggs DL, 2007, MOL CELL BIOL, V27, P8658, DOI 10.1128/MCB.00985-07; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Schmitt A, 2001, EXP EYE RES, V73, P837, DOI 10.1006/exer.2001.1086; Schroder JM, 2007, CURR BIOL, V17, P1134, DOI 10.1016/j.cub.2007.05.055; Schroder JM, 2011, J CELL SCI, V124, P2539, DOI 10.1242/jcs.085852; Silverstein AM, 1999, J BIOL CHEM, V274, P36980, DOI 10.1074/jbc.274.52.36980; SLOT JW, 1991, J CELL BIOL, V113, P123, DOI 10.1083/jcb.113.1.123; Sohocki MM, 2000, NAT GENET, V24, P79, DOI 10.1038/71732; Stone EM, 2007, AM J OPHTHALMOL, V144, P791, DOI 10.1016/j.ajo.2007.08.022; Tan MH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032330; Tirnauer JS, 2000, J CELL BIOL, V149, P761, DOI 10.1083/jcb.149.4.761; Trojan P, 2008, PROG RETIN EYE RES, V27, P237, DOI 10.1016/j.preteyeres.2008.01.003; van der Spuy J, 2004, J BIOL CHEM, V279, P48038, DOI 10.1074/jbc.M407871200; van der Spuy J, 2003, INVEST OPHTH VIS SCI, V44, P5396, DOI 10.1167/iovs.03-0686; van der Spuy J, 2002, HUM MOL GENET, V11, P823, DOI 10.1093/hmg/11.7.823; Vaughan KT, 2005, J CELL BIOL, V171, P197, DOI 10.1083/jcb.200509150; Vitre B, 2008, NAT CELL BIOL, V10, P415, DOI 10.1038/ncb1703; Wochnik GM, 2005, J BIOL CHEM, V280, P4609, DOI 10.1074/jbc.M407498200; WOLFRUM U, 1991, CELL TISSUE RES, V263, P399, DOI 10.1007/BF00318782	51	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121440	10.1371/journal.pone.0121440	http://dx.doi.org/10.1371/journal.pone.0121440			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799540	Green Accepted, Green Published, gold			2022-12-26	WOS:000351987300251
J	Osteikoetxea, X; Balogh, A; Szabo-Taylor, K; Nemeth, A; Szabo, TG; Paloczi, K; Sodar, B; Kittel, A; Gyorgy, B; Pallinger, E; Matko, J; Buzas, EI				Osteikoetxea, Xabier; Balogh, Andrea; Szabo-Taylor, Katalin; Nemeth, Andrea; Szabo, Tames Geza; Paloczi, Krisztina; Sodar, Barbara; Kittel, Agnes; Gyoergy, Bence; Pallinger, Eva; Matko, Janos; Buzas, Edit Iran			Improved Characterization of EV Preparations Based on Protein to Lipid Ratio and Lipid Properties	PLOS ONE			English	Article							EXTRACELLULAR VESICLES; MEMBRANE-VESICLES; APOPTOTIC BODIES; EMERGING ROLE; EXOSOMES; MICROVESICLES; STANDARDIZATION; MICROPARTICLES	In recent years the study of extracellular vesicles has gathered much scientific and clinical interest. As the field is expanding, it is becoming clear that better methods for characterization and quantification of extracellular vesicles as well as better standards to compare studies are warranted. The goal of the present work was to find improved parameters to characterize extracellular vesicle preparations. Here we introduce a simple 96 well plate-based total lipid assay for determination of lipid content and protein to lipid ratios of extracellular vesicle preparations from various myeloid and lymphoid cell lines as well as blood plasma. These preparations included apoptotic bodies, microvesicles/microparticles, and exosomes isolated by size-based fractionation. We also investigated lipid bilayer order of extracellular vesicle subpopulations using Di-4-ANEPPDHQ lipid probe, and lipid composition using affinity reagents to clustered cholesterol (monoclonal anti-cholesterol antibody) and ganglioside GM1 (cholera toxin subunit B). We have consistently found different protein to lipid ratios characteristic for the investigated extracellular vesicle subpopulations which were substantially altered in the case of vesicular damage or protein contamination. Spectral ratiometric imaging and flow cytometric analysis also revealed marked differences between the various vesicle populations in their lipid order and their clustered membrane cholesterol and GM1 content. Our study introduces for the first time a simple and readily available lipid assay to complement the widely used protein assays in order to better characterize extracellular vesicle preparations. Besides differentiating extracellular vesicle subpopulations, the novel parameters introduced in this work (protein to lipid ratio, lipid bilayer order, and lipid composition), may prove useful for quality control of extracellular vesicle related basic and clinical studies.	[Osteikoetxea, Xabier; Szabo-Taylor, Katalin; Nemeth, Andrea; Szabo, Tames Geza; Paloczi, Krisztina; Sodar, Barbara; Gyoergy, Bence; Pallinger, Eva; Buzas, Edit Iran] Semmelweis Univ, Dept Genet Cell & Immunobiol, H-1085 Budapest, Hungary; [Balogh, Andrea; Matko, Janos] Eotvos Lorand Univ, Dept Immunol, Budapest, Hungary; [Kittel, Agnes] Hungarian Acad Sci, Inst Expt Med, Budapest, Hungary; [Gyoergy, Bence] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA	Semmelweis University; Eotvos Lorand University; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Buzas, EI (corresponding author), Semmelweis Univ, Dept Genet Cell & Immunobiol, H-1085 Budapest, Hungary.	edit.buzas@gmail.com	Osteikoetxea, Xabier/K-3067-2019; Szabo, Tamas Geza/E-9722-2011	Szabo, Tamas Geza/0000-0001-9745-6255; Osteikoetxea, Xabier/0000-0003-3628-0174; Paloczi, Krisztina/0000-0001-7065-3582	OTKA [84043]; DYNANO [FP7-PEOPLE-2011-ITN-PITN-GA-2011-289033]; BMBS COST Action [BM1202 ME HAD]	OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); DYNANO; BMBS COST Action(European Cooperation in Science and Technology (COST))	This work was supported by OTKA 84043 (http://www.otka.hu/) FP7-PEOPLE-2011-ITN-PITN-GA-2011-289033 "DYNANO"(http://www.dynano.eu/) BMBS COST Action BM1202 ME HAD (http://www.mehad-cost.eu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aatonen MT, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.24692; Adami C, 2001, GLIA, V33, P131, DOI 10.1002/1098-1136(200102)33:2<131::AID-GLIA1012>3.0.CO;2-D; Al-Nedawi K, 2009, CELL CYCLE, V8, P2014, DOI 10.4161/cc.8.13.8988; Bilyy RO, 2012, J BIOL CHEM, V287, P496, DOI 10.1074/jbc.M111.273144; Biro A, 2007, J LIPID RES, V48, P19, DOI 10.1194/jlr.M600158-JLR200; Bissig C, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a016816; Booth AM, 2006, J CELL BIOL, V172, P923, DOI 10.1083/jcb.200508014; Buzas EI, 2014, NAT REV RHEUMATOL, V10, P356, DOI 10.1038/nrrheum.2014.19; Chabrol E, 1937, PRESS MED, V45, P1713; Crescitelli R, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.20677; de Gassart A, 2003, BLOOD, V102, P4336, DOI 10.1182/blood-2003-03-0871; Dean WL, 2009, THROMB HAEMOSTASIS, V102, P711, DOI 10.1160/TH09-04-243; Gyorgy B, 2014, THROMB RES, V133, P285, DOI 10.1016/j.thromres.2013.11.010; Gyorgy B, 2011, CELL MOL LIFE SCI, V68, P2667, DOI 10.1007/s00018-011-0689-3; Gyorgy B, 2011, BLOOD, V117, pE39, DOI 10.1182/blood-2010-09-307595; HOLMGREN J, 1975, P NATL ACAD SCI USA, V72, P2520, DOI 10.1073/pnas.72.7.2520; Kahlert C, 2014, J BIOL CHEM, V289, P3869, DOI 10.1074/jbc.C113.532267; Kasal A, 2010, STEROID ANALYSIS: SECOND EDITION, P27, DOI 10.1023/b135931_2; Lacroix R, 2013, J THROMB HAEMOST, V11, P1190, DOI 10.1111/jth.12207; Lacroix R, 2012, J THROMB HAEMOST, V10, P437, DOI 10.1111/j.1538-7836.2011.04610.x; Llorente A, 2013, BBA-MOL CELL BIOL L, V1831, P1302, DOI 10.1016/j.bbalip.2013.04.011; McMahon A, 2013, LIPIDS, V48, P513, DOI 10.1007/s11745-013-3755-9; Momen-Heravi F, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00354; Owen DM, 2012, NAT PROTOC, V7, P24, DOI 10.1038/nprot.2011.419; Record M, 2014, BBA-MOL CELL BIOL L, V1841, P108, DOI 10.1016/j.bbalip.2013.10.004; Szabo GT, 2014, CELL MOL LIFE SCI, V71, P4055, DOI 10.1007/s00018-014-1618-z; Tan SS, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.22614; Thery Clotilde, 2011, F1000 Biol Rep, V3, P15, DOI 10.3410/B3-15; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Turiak L, 2011, J PROTEOMICS, V74, P2025, DOI 10.1016/j.jprot.2011.05.023; van der Pol E, 2012, PHARMACOL REV, V64, P676, DOI 10.1124/pr.112.005983; Varga Z, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.23298	32	114	115	4	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121184	10.1371/journal.pone.0121184	http://dx.doi.org/10.1371/journal.pone.0121184			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798862	Green Accepted, gold, Green Published, Green Submitted			2022-12-26	WOS:000351987300224
J	Saint-Marcoux, D; Proust, H; Dolan, L; Langdale, JA				Saint-Marcoux, Denis; Proust, Helene; Dolan, Liam; Langdale, Jane A.			Identification of Reference Genes for Real-Time Quantitative PCR Experiments in the Liverwort Marchantia polymorpha	PLOS ONE			English	Article							AGROBACTERIUM-MEDIATED TRANSFORMATION; CANDIDATE REFERENCE GENES; EXPRESSION ANALYSIS; BRASSICA-NAPUS; NORMALIZATION; VALIDATION; SELECTION; PUBLICATION; ARABIDOPSIS; INTEGRITY	Real-time quantitative polymerase chain reaction (qPCR) has become widely used as a method to compare gene transcript levels across different conditions. However, selection of suitable reference genes to normalize qPCR data is required for accurate transcript level analysis. Recently, Marchantia polymorpha has been adopted as a model for the study of liverwort development and land plant evolution. Identification of appropriate reference genes has therefore become a necessity for gene expression studies. In this study, transcript levels of eleven candidate reference genes have been analyzed across a range of biological contexts that encompass abiotic stress, hormone treatment and different developmental stages. The consistency of transcript levels was assessed using both geNorm and NormFinder algorithms, and a consensus ranking of the different candidate genes was then obtained. MpAPT and MpACT showed relatively constant transcript levels across all conditions tested whereas the transcript levels of other candidate genes were clearly influenced by experimental conditions. By analyzing transcript levels of phosphate and nitrate starvation reporter genes, we confirmed that MpAPT and MpACT are suitable reference genes in M. polymorpha and also demonstrated that normalization with an inappropriate gene can lead to erroneous analysis of qPCR data.	[Saint-Marcoux, Denis; Proust, Helene; Dolan, Liam; Langdale, Jane A.] Univ Oxford, Dept Plant Sci, Oxford, England	University of Oxford	Proust, H (corresponding author), Univ Oxford, Dept Plant Sci, Oxford, England.	helene.proust@plants.ox.ac.uk	Langdale, Jane A./AAE-8343-2019	Dolan, Liam/0000-0003-1206-7096; Saint-Marcoux, Denis/0000-0002-0830-7096; Langdale, Jane/0000-0001-7648-3924	ERC [EVO500]; Biotechnology and Biological Sciences Research Council [BB/M020517/1] Funding Source: researchfish; BBSRC [BB/M020517/1] Funding Source: UKRI	ERC(European Research Council (ERC)European Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by ERC Advanced Investigator grants to JAL (EDIP) and LD (EVO500). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amil-Ruiz F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070603; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Borowski JM, 2014, PLANTA, V239, P1187, DOI 10.1007/s00425-014-2041-2; Bowman JL, 2007, CELL, V129, P229, DOI 10.1016/j.cell.2007.04.004; Bustin SA, 2010, METHODS, V50, P217, DOI 10.1016/j.ymeth.2009.12.006; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Derveaux S, 2010, METHODS, V50, P227, DOI 10.1016/j.ymeth.2009.11.001; FREDERICQ H, 1966, NATURWISSENSCHAFTEN, V53, P337, DOI 10.1007/BF00631208; Gutierrez L, 2008, PLANT BIOTECHNOL J, V6, P609, DOI 10.1111/j.1467-7652.2008.00346.x; Hong SY, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-112; Hruz T, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-156; Ishizaki K, 2008, PLANT CELL PHYSIOL, V49, P1084, DOI 10.1093/pcp/pcn085; Ishizaki K, 2013, PLANT CELL, V25, P4075, DOI 10.1105/tpc.113.117051; Ishizaki K, 2013, SCI REP-UK, V3, DOI 10.1038/srep01532; Ishizaki K, 2012, J PLANT RES, V125, P643, DOI 10.1007/s10265-012-0477-7; JOHNSON G. M. et al., 1957, Plant and Soil, V8, P337, DOI 10.1007/BF01666323; Kubota A, 2013, BIOSCI BIOTECH BIOCH, V77, P167, DOI 10.1271/bbb.120700; Le Bail A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070998; Le Bail A, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-75; Manoli A, 2012, J PLANT PHYSIOL, V169, P807, DOI 10.1016/j.jplph.2012.01.019; Moura Jullyana Cristina Magalhaes Silva, 2012, BMC Res Notes, V5, P634, DOI 10.1186/1756-0500-5-634; Orsel M, 2002, PLANT PHYSIOL, V129, P886, DOI 10.1104/pp.005280; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Qiu YL, 2006, P NATL ACAD SCI USA, V103, P15511, DOI 10.1073/pnas.0603335103; Remans T, 2014, PLANT CELL, V26, P3829, DOI 10.1105/tpc.114.130641; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Shin H, 2004, PLANT J, V39, P629, DOI 10.1111/j.1365-313X.2004.02161.x; TAREN NIINA, 1958, BRYOL OGIST, V61, P191; Tougane K, 2010, PLANT PHYSIOL, V152, P1529, DOI 10.1104/pp.110.153387; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang HL, 2014, PHYSIOL PLANTARUM, V152, P529, DOI 10.1111/ppl.12206; Wang Z, 2014, MOL GENET GENOMICS, V289, P1023, DOI 10.1007/s00438-014-0853-1; Wann FB, 1925, AM J BOT, V12, P307, DOI 10.2307/2435337; Wickett NJ, 2014, P NATL ACAD SCI USA, V111, pE4859, DOI 10.1073/pnas.1323926111; Yang HL, 2014, GENE, V538, P113, DOI 10.1016/j.gene.2013.12.057	39	41	42	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0118678	10.1371/journal.pone.0118678	http://dx.doi.org/10.1371/journal.pone.0118678			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798897	gold, Green Published, Green Submitted			2022-12-26	WOS:000351987300014
J	Schmitz, S; Werling, D; Allenspach, K				Schmitz, Silke; Werling, Dirk; Allenspach, Karin			Effects of Ex-Vivo and In-Vivo Treatment with Probiotics on the Inflammasome in Dogs with Chronic Enteropathy	PLOS ONE			English	Article							INTERLEUKIN-1 RECEPTOR ANTAGONIST; TUMOR-NECROSIS-FACTOR; CROHNS-DISEASE; ACCURATE NORMALIZATION; CONVERTING-ENZYME; EXPRESSION; CYTOKINE; ACTIVATION; CELLS; RNA	Inflammasomes coordinate the maturation of IL-1 beta and IL-18 in response to danger signals. They are vital for maintenance of intestinal homeostasis and have been linked to chronic intestinal inflammation in humans. Probiotics have been advocated as treatment in intestinal inflammation. So far, no study has investigated the role of the inflammasome in canine chronic enteropathy (CE). In this study the intestinal expression of inflammasome components was assessed in CE dogs compared to controls, when treated with probiotic Enterococcus faecium (EF) ex-vivo and in-vivo. RNA extraction from endoscopic biopsies and reverse-transcriptase quantitative PCR was performed for NLRP3, casp-1, IL-1 beta and IL-18. Immunohistochemistry was performed to investigate protein expression in tissues. Gene expression of casp-1 and NLRP3 was lower in CE samples than controls. Ex-vivo treatment with EF reduced NLRP3 expression in control samples. Treatment of CE dogs with EF alongside dietary intervention had no effect on gene expression. In contrast, IL-1 beta protein expression in CE decreased with dietary treatment (but not with probiotics). The results of this study suggest that the inflammasome or its components may be partially involved in the inflammatory process seen in CE, but distinct from intestinal inflammation in humans.	[Schmitz, Silke; Allenspach, Karin] Univ London, Royal Vet Coll, Dept Vet Sci & Serv, N Mymms, England; [Werling, Dirk] Univ London, Royal Vet Coll, Dept Pathol & Pathogen Biol, N Mymms, England	University of London; University of London Royal Veterinary College; University of London; University of London Royal Veterinary College	Schmitz, S (corresponding author), Univ Giessen, Small Anim Hosp, Dept Internal Med, D-35390 Giessen, Germany.	Silke.Schmitz@vetmed.uni-giessen.de	Schmitz, Silke Salavati nee/AAZ-6935-2020; Werling, Dirk/F-5555-2013	Werling, Dirk/0000-0001-5411-4044; Salavati, Silke/0000-0003-1084-7013	Biotechnology and Biological Sciences Research Council (BBSRC) CASE Studentship; Protexin Veterinary Ltd. (Somerset, UK)	Biotechnology and Biological Sciences Research Council (BBSRC) CASE Studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Protexin Veterinary Ltd. (Somerset, UK)	This study was funded through a Biotechnology and Biological Sciences Research Council (BBSRC) CASE Studentship with Protexin Veterinary Ltd. (Somerset, UK) (KA, DW). The BBSRC had no role in study design, data collection, analysis, decision to publish, or preparation of the manuscript. Protexin Ltd. was informed about the study design, data collection, and analysis and gave consent to that. They had no role in decision to publish or preparation of the manuscript.	Allenspach K, 2007, J VET INTERN MED, V21, P700, DOI 10.1892/0891-6640(2007)21[700:CEIDEO]2.0.CO;2; Bauer C, 2012, DIGEST DIS, V30, P82, DOI 10.1159/000341681; Bauer C, 2010, GUT, V59, P1192, DOI 10.1136/gut.2009.197822; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cayrol C, 2009, P NATL ACAD SCI USA, V106, P9021, DOI 10.1073/pnas.0812690106; Daig R, 2000, GUT, V46, P350, DOI 10.1136/gut.46.3.350; Eckhart L, 2009, BIOCHEM BIOPH RES CO, V384, P226, DOI 10.1016/j.bbrc.2009.04.092; FAO/WHO, 2001, HEALTH AND NUTRITION; Hirota SA, 2011, INFLAMM BOWEL DIS, V17, P1359, DOI 10.1002/ibd.21478; Kanneganti TD, 2006, NATURE, V440, P233, DOI 10.1038/nature04517; Kanneganti TD, 2006, J BIOL CHEM, V281, P36560, DOI 10.1074/jbc.M607594200; Maeda S, 2012, VET J, V194, P66, DOI 10.1016/j.tvjl.2012.02.026; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Martinon F, 2007, CELL DEATH DIFFER, V14, P10, DOI 10.1038/sj.cdd.4402038; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; McAlindon ME, 1998, GUT, V42, P214, DOI 10.1136/gut.42.2.214; MCCABE RP, 1993, CLIN IMMUNOL IMMUNOP, V66, P52, DOI 10.1006/clin.1993.1007; Miao EA, 2011, IMMUNOL REV, V243, P206, DOI 10.1111/j.1600-065X.2011.01044.x; Monteleone G, 1999, J IMMUNOL, V163, P143; OLSON AD, 1993, J PEDIATR GASTR NUTR, V16, P241, DOI 10.1097/00005176-199304000-00003; Pages F, 2001, EUR CYTOKINE NETW, V12, P97; Peters IR, 2007, VET IMMUNOL IMMUNOP, V117, P55, DOI 10.1016/j.vetimm.2007.01.011; Peters IR, 2005, J VET INTERN MED, V19, P644, DOI 10.1892/0891-6640(2005)19[644:CMQIDM]2.0.CO;2; Pizarro TT, 1999, J IMMUNOL, V162, P6829; Sanders ME, 2013, GUT, V62, P787, DOI 10.1136/gutjnl-2012-302504; Sauter SN, 2005, DOMEST ANIM ENDOCRIN, V29, P605, DOI 10.1016/j.domaniend.2005.04.006; Schmitz S, 2012, VET IMMUNOL IMMUNOP, V146, P87, DOI 10.1016/j.vetimm.2012.01.013; Shida K, 2011, GUT MICROBES, V2, P109, DOI 10.4161/gmic.2.2.15661; Simpson KW, 2011, VET CLIN N AM-SMALL, V41, P381, DOI 10.1016/j.cvsm.2011.02.003; STEVENS C, 1992, DIGEST DIS SCI, V37, P818, DOI 10.1007/BF01300378; Tamura K, 2002, J GASTROENTEROL, V37, P111, DOI 10.1007/BF03326428; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Villani AC, 2009, NAT GENET, V41, P71, DOI 10.1038/ng.285; Waterhouse CCM, 1999, CELL IMMUNOL, V193, P1, DOI 10.1006/cimm.1999.1468; Werts C, 2006, CELL DEATH DIFFER, V13, P798, DOI 10.1038/sj.cdd.4401890; Zaki MH, 2011, TRENDS IMMUNOL, V32, P171, DOI 10.1016/j.it.2011.02.002; Zaki MH, 2010, IMMUNITY, V32, P379, DOI 10.1016/j.immuni.2010.03.003	38	25	25	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120779	10.1371/journal.pone.0120779	http://dx.doi.org/10.1371/journal.pone.0120779			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799280	Green Published, Green Accepted, gold			2022-12-26	WOS:000351987300177
J	Shibata, ACE; Maebashi, HK; Nakahata, Y; Nabekura, J; Murakoshi, H				Shibata, Akihiro C. E.; Maebashi, Hiroshi K.; Nakahata, Yoshihisa; Nabekura, Junichi; Murakoshi, Hideji			Development of a Molecularly Evolved, Highly Sensitive CaMKII FRET Sensor with Improved Expression Pattern	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; SINGLE DENDRITIC SPINES; LONG-TERM POTENTIATION; RESONANCE ENERGY-TRANSFER; KINASE-II; RAT FOREBRAIN; DYNAMIC-RANGE; ACTIVATION; GTPASES; VISUALIZATION	Genetically encoded fluorescence resonance energy transfer (FRET) biosensors have been successfully used to visualize protein activity in living cells. The sensitivity and accuracy of FRET measurements directly depend on biosensor folding efficiency, expression pattern, sensitivity, and dynamic range. Here, to improve the folding efficiency of the Ca2+/calmodulin-dependent protein kinase II alpha (CaMKII alpha) FRET biosensor, we amplified the association domain of the CaMKII alpha gene using error-prone polymerase chain reaction (PCR) and fused it to the N-terminus of mCherry in a bacterial expression vector. We also created an Escherichia coli expression library based on a previously reported fluorescent protein folding reporter method, and found a bright red fluorescent colony that contained the association domain with four mutations (F394L, I419V, A430T, and I434T). In vitro assays using the purified mutant protein confirmed improved folding kinetics of the downstream fluorescent protein, but not of the association domain itself. Furthermore, we introduced these mutations into the previously reported CaMKIIa FRET sensor and monitored its Ca2+/calmodulin-dependent activation in HeLa cells using 2-photon fluorescence lifetime imaging microscopy (2pFLIM), and found that the expression pattern and signal reproducibility of the mutant sensor were greatly improved without affecting the autophosphorylation function and incorporation into oligomeric CaMKIIa. We believe that our improved CaMKIIa FRET sensor would be useful in various types of cells and tissues, providing data with high accuracy and reproducibility. In addition, the method described here may also be applicable for improving the performance of all currently available FRET sensors.	[Shibata, Akihiro C. E.; Maebashi, Hiroshi K.; Murakoshi, Hideji] Natl Inst Physiol Sci, Support Ctr Brain Res, Okazaki, Aichi 444, Japan; [Nakahata, Yoshihisa; Nabekura, Junichi] Natl Inst Physiol Sci, Div Homeostat Dev, Okazaki, Aichi 444, Japan; [Nabekura, Junichi; Murakoshi, Hideji] Grad Univ Adv Studies, Dept Physiol Sci, Okazaki, Aichi, Japan; [Shibata, Akihiro C. E.] Okazaki Inst Integrat Biosci, Okazaki, Aichi, Japan; [Nabekura, Junichi] Japan Sci & Technol Agcy JST, Core Res Evolut Sci & Technol, Kawaguchi, Saitama, Japan; [Murakoshi, Hideji] Japan Sci & Technol Agcy JST, Precursory Res Embryon Sci & Technol, Kawaguchi, Saitama, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Graduate University for Advanced Studies - Japan; National Institutes of Natural Sciences (NINS) - Japan; Okazaki Institute for Integrative Bioscience (OIIB); Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST)	Murakoshi, H (corresponding author), Natl Inst Physiol Sci, Support Ctr Brain Res, Okazaki, Aichi 444, Japan.	murakosh@nips.ac.jp	Murakoshi, Hideji/W-9266-2018	Shibata, Akihiro/0000-0003-1394-7220; Nakahata, Yoshihisa/0000-0003-3403-4527	MEXT/Japan Society for the Promotion of Sciences (JSPS) [24115520]; Okazaki ORION project; Mochida Memorial Foundation; JST Precursory Research for Embryonic Science and Technology (PREST) Program; Grants-in-Aid for Scientific Research [14J30003] Funding Source: KAKEN	MEXT/Japan Society for the Promotion of Sciences (JSPS); Okazaki ORION project; Mochida Memorial Foundation; JST Precursory Research for Embryonic Science and Technology (PREST) Program; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grant-in-Aid for Scientific Research on Innovative Areas (Grant No. 24115520) from MEXT/Japan Society for the Promotion of Sciences (JSPS) (to HM), the Okazaki ORION project (to HM), the Mochida Memorial Foundation, and the JST Precursory Research for Embryonic Science and Technology (PREST) Program (to HM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brewer GJ, 1997, J NEUROSCI METH, V71, P143, DOI 10.1016/S0165-0270(96)00136-7; Chao LH, 2011, CELL, V146, P732, DOI 10.1016/j.cell.2011.07.038; Cheng DM, 2006, MOL CELL PROTEOMICS, V5, P1158, DOI 10.1074/mcp.D500009-MCP200; Coultrap SJ, 2012, TRENDS NEUROSCI, V35, P607, DOI 10.1016/j.tins.2012.05.003; Dobson CM, 2004, SEMIN CELL DEV BIOL, V15, P3, DOI 10.1016/j.semcdb.2003.12.008; Elsasser S, 2005, METHOD ENZYMOL, V398, P353, DOI 10.1016/S0076-6879(05)98029-4; FUKUNAGA K, 1993, J BIOL CHEM, V268, P7863; Kiyokawa E, 2011, ANNU REV PHARMACOL, V51, P337, DOI 10.1146/annurev-pharmtox-010510-100234; Komatsu N, 2011, MOL BIOL CELL, V22, P4647, DOI 10.1091/mbc.E11-01-0072; Kotera I, 2010, ACS CHEM BIOL, V5, P215, DOI 10.1021/cb900263z; Kwok S, 2008, BIOCHEM BIOPH RES CO, V369, P519, DOI 10.1016/j.bbrc.2008.02.070; Lam AJ, 2012, NAT METHODS, V9, P1005, DOI [10.1038/NMETH.2171, 10.1038/nmeth.2171]; Lee SJR, 2009, NATURE, V458, P299, DOI 10.1038/nature07842; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; Lisman J, 2012, NAT REV NEUROSCI, V13, P169, DOI 10.1038/nrn3192; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; MCGUINNESS TL, 1985, J BIOL CHEM, V260, P1696; MILLER SG, 1985, J BIOL CHEM, V260, P9039; Miyawaki A, 2011, ANNU REV BIOCHEM, V80, P357, DOI 10.1146/annurev-biochem-072909-094736; Mower AF, 2011, P NATL ACAD SCI USA, V108, P21241, DOI 10.1073/pnas.1108261109; Murakoshi H, 2011, NATURE, V472, P100, DOI 10.1038/nature09823; Murakoshi H, 2008, BRAIN CELL BIOL, V36, P31, DOI 10.1007/s11068-008-9024-9; Otmakhov N, 2012, J NEUROSCI METH, V203, P106, DOI 10.1016/j.jneumeth.2011.09.022; Ouyang Y, 1997, J NEUROSCI, V17, P5416; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Raman R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014377; Reid BG, 1997, BIOCHEMISTRY-US, V36, P6786, DOI 10.1021/bi970281w; Shaner NC, 2013, NAT METHODS, V10, P407, DOI [10.1038/NMETH.2413, 10.1038/nmeth.2413]; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Takao K, 2005, J NEUROSCI, V25, P3107, DOI 10.1523/JNEUROSCI.0085-05.2005; Tramier M, 2006, MICROSC RES TECHNIQ, V69, P933, DOI 10.1002/jemt.20370; Waldo GS, 1999, NAT BIOTECHNOL, V17, P691, DOI 10.1038/10904; Yasuda R, 2006, NAT NEUROSCI, V9, P283, DOI 10.1038/nn1635; Yasuda R, 2012, COLD SPRING HARB PER, V4, P1121; Zhabotinsky AM, 2000, BIOPHYS J, V79, P2211, DOI 10.1016/S0006-3495(00)76469-1	37	7	7	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121109	10.1371/journal.pone.0121109	http://dx.doi.org/10.1371/journal.pone.0121109			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799407	Green Submitted, Green Published, gold			2022-12-26	WOS:000351987300209
J	Didiasova, M; Zakrzewicz, D; Magdolen, V; Nagaraj, C; Balint, Z; Rohde, M; Preissner, KT; Wygrecka, M				Didiasova, Miroslava; Zakrzewicz, Dariusz; Magdolen, Viktor; Nagaraj, Chandran; Balint, Zoltan; Rohde, Manfred; Preissner, Klaus T.; Wygrecka, Malgorzata			STIM1/ORAI1-mediated Ca2+ Influx Regulates Enolase-1 Exteriorization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						calcium; cancer; inflammation; membrane trafficking; stromal interaction molecule 1 (STIM1); enolase-1	MATRIX-DEGRADING PROTEASES; ALPHA-ENOLASE; PLASMINOGEN BINDING; CAVEOLIN-1 EXPRESSION; CELL-ADHESION; CANCER CELLS; TUMOR-GROWTH; RECEPTOR; ACTIVATION; GENE	Background: Cell surface-associated enolase-1 regulates plasmin formation and thus pericellular proteolysis. Results: STIM1/ORAI1-mediated Ca2+ influx controls enolase-1 exteriorization in cancer cells. Conclusion: Extracellular enolase-1 regulates migratory and invasive properties of cancer cells. Significance: Enhanced exteriorization of enolase-1 may aggravate the malignant behavior of cancer cells and thus contribute to metastasis formation. Tumor cells use broad spectrum proteolytic activity of plasmin to invade tissue and form metastatic foci. Cell surface-associated enolase-1 (ENO-1) enhances plasmin formation and thus participates in the regulation of pericellular proteolysis. Although increased levels of cell surface bound ENO-1 have been described in different types of cancer, the molecular mechanism responsible for ENO-1 exteriorization remains elusive. In the present study, increased ENO-1 protein levels were found in ductal breast carcinoma and on the cell surface of highly metastatic breast cancer cell line MDA-MB-231. Elevated cell surface-associated ENO-1 expression correlated with augmented MDA-MB-231 cell migratory and invasive properties. Exposure of MDA-MB-231 cells to LPS potentiated translocation of ENO-1 to the cell surface and its release into the extracellular space in the form of exosomes. These effects were independent of de novo protein synthesis and did not require the classical endoplasmic reticulum/Golgi pathway. LPS-triggered ENO-1 exteriorization was suppressed by pretreatment of MDA-MB-231 cells with the Ca2+ chelator BAPTA or an inhibitor of endoplasmic reticulum Ca2+-ATPase pump, cyclopiazonic acid. In line with these observations, the stromal interaction molecule (STIM) 1 and the calcium release-activated calcium modulator (ORAI) 1-mediated store-operated Ca2+ entry were found to regulate LPS-induced ENO-1 exteriorization. Pharmacological blockage or knockdown of STIM1 or ORAI1 reduced ENO-1-dependent migration of MDA-MB-231 cells. Collectively, our results demonstrate the pivotal role of store-operated Ca2+ channel-mediated Ca2+ influx in the regulation of ENO-1 exteriorization and thus in the modulation of cancer cell migratory and invasive properties.	[Didiasova, Miroslava; Zakrzewicz, Dariusz; Preissner, Klaus T.; Wygrecka, Malgorzata] Univ Giessen, Lung Ctr, Dept Biochem, D-35392 Giessen, Germany; [Magdolen, Viktor] Tech Univ Munich, Dept Obstet & Gynecol, Clin Res Unit, D-81675 Munich, Germany; [Nagaraj, Chandran; Balint, Zoltan] Ludwig Boltzmann Inst Lung Vasc Res, A-8010 Graz, Austria; [Rohde, Manfred] Helmholtz Ctr Infect Res, Cent Facil Microscopy, D-38124 Braunschweig, Germany	Justus Liebig University Giessen; Technical University of Munich; Ludwig Boltzmann Institute; Helmholtz Association; Helmholtz-Center for Infection Research	Wygrecka, M (corresponding author), Univ Giessen, Lung Ctr, Dept Biochem, Friedrichstr 24, D-35392 Giessen, Germany.	malgorzata.wygrecka@innere.med.uni-giessen.de	Bálint, Zoltán/AAJ-3080-2020; Chandran, Nagaraj/AAP-2007-2020; Wygrecka, Malgorzata/AAZ-3679-2020	Chandran, Nagaraj/0000-0003-3825-8587; Wygrecka, Malgorzata/0000-0002-3656-2932; Zakrzewicz, Dariusz/0000-0003-3292-9706; Balint, Zoltan/0000-0001-8598-2784	University Medical Center Giessen; University Medical Center Marburg; Deutsche Forschungsgemeinschaft [WY119/1-1, Sonderforschungsbereich-Transregio 84]; Excellence Cluster Cardiopulmonary System; Deutsches Zentrum fur Lungenforschung	University Medical Center Giessen; University Medical Center Marburg; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Excellence Cluster Cardiopulmonary System(German Research Foundation (DFG)); Deutsches Zentrum fur Lungenforschung	This work was supported by the University Medical Center Giessen and Marburg (to M. W.), Deutsche Forschungsgemeinschaft Grant WY119/1-1 (to M. W. and K. T. P.), Sonderforschungsbereich-Transregio 84 Project A2 (to M. W. and K. T. P.), the Excellence Cluster Cardiopulmonary System (to M. W. and D. Z.), and the Deutsches Zentrum fur Lungenforschung.	Altenberg B, 2004, GENOMICS, V84, P1014, DOI 10.1016/j.ygeno.2004.08.010; Andreasen PA, 2000, CELL MOL LIFE SCI, V57, P25, DOI 10.1007/s000180050497; Andronicos NM, 2001, BRIT J CANCER, V85, P909, DOI 10.1054/bjoc.2001.2022; Balint Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063776; Bonapace L, 2014, NATURE, V515, DOI 10.1038/nature13862; Capello M, 2011, FEBS J, V278, P1064, DOI 10.1111/j.1742-4658.2011.08025.x; Cappello P, 2009, INT J CANCER, V125, P639, DOI 10.1002/ijc.24355; Chang GC, 2006, CLIN CANCER RES, V12, P5746, DOI 10.1158/1078-0432.CCR-06-0324; Chen YF, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-23; DANCONA GG, 1977, CYTOGENET CELL GENET, V18, P327, DOI 10.1159/000130779; Das R, 2009, CIRC RES, V105, P167, DOI 10.1161/CIRCRESAHA.109.200311; Del Pozo JL, 2010, PANCREATOLOGY, V10, P114, DOI 10.1159/000299987; Diaz-Ramos A, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/156795; Didiasova M, 2014, INT J MOL SCI, V15, P21229, DOI 10.3390/ijms151121229; ELLIS V, 1991, J BIOL CHEM, V266, P12752; Fang WB, 2012, J BIOL CHEM, V287, P36593, DOI 10.1074/jbc.M112.365999; Gandhirajan RK, 2013, J CLIN INVEST, V123, P887, DOI 10.1172/JCI65647; Goetz JG, 2008, CANCER METAST REV, V27, P715, DOI 10.1007/s10555-008-9160-9; GONZALEZGRONOW M, 1991, ARCH BIOCHEM BIOPHYS, V286, P625, DOI 10.1016/0003-9861(91)90090-6; Grivennikov SI, 2011, ANN RHEUM DIS, V70, pI104, DOI 10.1136/ard.2010.140145; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HALL SW, 1991, J BIOL CHEM, V266, P12329; He P, 2007, CANCER SCI, V98, P1234, DOI 10.1111/j.1349-7006.2007.00509.x; Hsiao KC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069354; Hsu RYC, 2011, CANCER RES, V71, P1989, DOI 10.1158/0008-5472.CAN-10-2833; Jakowlew SB, 2006, CANCER METAST REV, V25, P435, DOI 10.1007/s10555-006-9006-2; Johnsen M, 1998, CURR OPIN CELL BIOL, V10, P667, DOI 10.1016/S0955-0674(98)80044-6; Li GL, 2013, J EXP CLIN CANC RES, V32, DOI 10.1186/1756-9966-32-20; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Lund LR, 1999, EMBO J, V18, P4645, DOI 10.1093/emboj/18.17.4645; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Matrisian LM, 1999, CURR BIOL, V9, pR776, DOI 10.1016/S0960-9822(00)80011-1; McDonald B, 2009, INT J CANCER, V125, P1298, DOI 10.1002/ijc.24409; MILES LA, 1991, BIOCHEMISTRY-US, V30, P1682, DOI 10.1021/bi00220a034; Pei ZY, 2008, CELL IMMUNOL, V254, P20, DOI 10.1016/j.cellimm.2008.06.007; Peinado H, 2011, SEMIN CANCER BIOL, V21, P139, DOI 10.1016/j.semcancer.2011.01.002; Perera PY, 2001, J IMMUNOL, V166, P574, DOI 10.4049/jimmunol.166.1.574; Pidgeon GP, 1999, BRIT J CANCER, V81, P1311, DOI 10.1038/sj.bjc.6694369; Plow EF, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/141806; Plow EF, 2009, BLOOD, V113, P5371, DOI 10.1182/blood-2009-03-208546; PLOW EF, 1986, J CELL BIOL, V103, P2411, DOI 10.1083/jcb.103.6.2411; RAY RB, 1995, CANCER RES, V55, P3747; REDLITZ A, 1995, EUR J BIOCHEM, V227, P407, DOI 10.1111/j.1432-1033.1995.tb20403.x; ROBBINS KC, 1967, J BIOL CHEM, V242, P2333; Semenza GL, 1996, J BIOL CHEM, V271, P32529, DOI 10.1074/jbc.271.51.32529; Senetta R, 2013, J CELL MOL MED, V17, P325, DOI 10.1111/jcmm.12030; Seweryn E, 2009, Z NATURFORSCH C, V64, P754; Stamenkovic I, 2000, SEMIN CANCER BIOL, V10, P415, DOI 10.1006/scbi.2000.0379; Sun RJ, 2012, CELL BIOL INT, V36, P475, DOI 10.1042/CBI20110535; Szkaradkiewicz A, 2009, ARCH IMMUNOL THER EX, V57, P291, DOI 10.1007/s00005-009-0031-z; Tiruppathi C, 2008, J BIOL CHEM, V283, P4210, DOI 10.1074/jbc.M703153200; Urbanelli L, 2013, GENES-BASEL, V4, P152, DOI 10.3390/genes4020152; Valapala M, 2011, J BIOL CHEM, V286, P30911, DOI 10.1074/jbc.M111.271155; Werb Z, 1999, APMIS, V107, P11, DOI 10.1111/j.1699-0463.1999.tb01521.x; Wygrecka M, 2009, BLOOD, V113, P5588, DOI 10.1182/blood-2008-08-170837; Yang SY, 2009, CANCER CELL, V15, P124, DOI 10.1016/j.ccr.2008.12.019; Yang XY, 2012, BIOCHEM BIOPH RES CO, V426, P334, DOI 10.1016/j.bbrc.2012.08.079; Zakrzewicz D, 2014, BIOCHEM J, V460, P295, DOI 10.1042/BJ20130945; Zhang F, 2010, ACTA PHARMACOL SIN, V31, P111, DOI 10.1038/aps.2009.178; Zhu H, 2008, J PHARMACOL SCI, V106, P287, DOI 10.1254/jphs.FP0071192	60	29	32	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2015	290	19					11983	11999		10.1074/jbc.M114.598425	http://dx.doi.org/10.1074/jbc.M114.598425			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH9XA	25805497	Green Published, hybrid			2022-12-26	WOS:000354388600015
J	Daniels, BC; Nemenman, I				Daniels, Bryan C.; Nemenman, Ilya			Efficient Inference of Parsimonious Phenomenological Models of Cellular Dynamics Using S-Systems and Alternating Regression	PLOS ONE			English	Article								The nonlinearity of dynamics in systems biology makes it hard to infer them from experimental data. Simple linear models are computationally efficient, but cannot incorporate these important nonlinearities. An adaptive method based on the S-system formalism, which is a sensible representation of nonlinear mass-action kinetics typically found in cellular dynamics, maintains the efficiency of linear regression. We combine this approach with adaptive model selection to obtain efficient and parsimonious representations of cellular dynamics. The approach is tested by inferring the dynamics of yeast glycolysis from simulated data. With little computing time, it produces dynamical models with high predictive power and with structural complexity adapted to the difficulty of the inference problem.	[Daniels, Bryan C.] Univ Wisconsin, Wisconsin Inst Discovery, Ctr Complex & Collect Computat, Madison, WI 53715 USA; [Nemenman, Ilya] Emory Univ, Dept Phys, Atlanta, GA 30322 USA; [Nemenman, Ilya] Emory Univ, Dept Biol, Atlanta, GA 30322 USA	University of Wisconsin System; University of Wisconsin Madison; Emory University; Emory University	Daniels, BC (corresponding author), Univ Wisconsin, Wisconsin Inst Discovery, Ctr Complex & Collect Computat, Madison, WI 53715 USA.	bdaniels@discovery.wisc.edu; ilya.nemenman@emory.edu	Daniels, Bryan/G-3615-2012	Daniels, Bryan/0000-0002-5870-1059	James S. McDonnell foundation [220020321]; John Templeton Foundation; Los Alamos National Laboratory Directed Research and Development Program; NSF [0904863]	James S. McDonnell foundation; John Templeton Foundation; Los Alamos National Laboratory Directed Research and Development Program(United States Department of Energy (DOE)Los Alamos National Laboratory); NSF(National Science Foundation (NSF))	This research was supported in part by the James S. McDonnell foundation Grant No. 220020321 (IN), a grant from the John Templeton Foundation for the study of complexity (BCD), the Los Alamos National Laboratory Directed Research and Development Program (IN and BD), and NSF Grant No. 0904863 (BD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balasubramanian V, 1997, NEURAL COMPUT, V9, P349, DOI 10.1162/neco.1997.9.2.349; Chou IC, 2006, THEOR BIOL MED MODEL, V3, DOI 10.1186/1742-4682-3-25; Crutchfield J. P., 1987, Complex Systems, V1, P417; Daniels B, 2014, PREPRINT; Gutenkunst RN, 2007, PLOS COMPUT BIOL, V3, P1871, DOI 10.1371/journal.pcbi.0030189; Hastie T., 2009, UNSUPERVISED LEARNIN; Lillacci G, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000696; MACKAY DJC, 1992, NEURAL COMPUT, V4, P415, DOI [10.1162/neco.1992.4.3.415, 10.1162/neco.1992.4.3.448]; Nemenman I, 2005, NEURAL COMPUT, V17, P2006, DOI 10.1162/0899766054322982; Neuert G, 2013, SCIENCE, V339, P584, DOI 10.1126/science.1231456; NOVICK A, 1950, SCIENCE, V112, P715, DOI 10.1126/science.112.2920.715; Oates CJ, 2014, BIOINFORMATICS, V30, pI468, DOI 10.1093/bioinformatics/btu452; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Ruoff P, 2003, BIOPHYS CHEM, V106, P179, DOI 10.1016/S0301-4622(03)00191-1; Savageau M, 1987, MATH BIOSCIENCES, P115; Savageau MA, 2002, MATH BIOSCI, V180, P237, DOI 10.1016/S0025-5564(02)00113-X; Schmidt M, 2009, SCIENCE, V324, P81, DOI 10.1126/science.1165893; Schmidt MD, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/5/055011; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Wang WX, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.154101; Wiggins CH, 2003, EXP MECH, V43, P361, DOI 10.1007/BF02410536	21	37	38	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0119821	10.1371/journal.pone.0119821	http://dx.doi.org/10.1371/journal.pone.0119821			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25806510	Green Published, Green Submitted, gold			2022-12-26	WOS:000351880000043
J	Nakano, H; Mizuno, N; Tosa, Y; Yoshida, K; Park, P; Takumi, S				Nakano, Hiroki; Mizuno, Nobuyuki; Tosa, Yukio; Yoshida, Kentaro; Park, Pyoyun; Takumi, Shigeo			Accelerated Senescence and Enhanced Disease Resistance in Hybrid Chlorosis Lines Derived from Interspecific Crosses between Tetraploid Wheat and Aegilops tauschii	PLOS ONE			English	Article							WRKY TRANSCRIPTION FACTORS; MITOTIC CELL-DIVISION; ARABIDOPSIS-THALIANA; ANEUPLOID ANALYSES; NATURAL VARIATION; LEAF SENESCENCE; F-1 HYBRID; GENE; NECROSIS; FITNESS	Hybrid chlorosis, a type of hybrid incompatibility, has frequently been reported in inter-and intraspecific crosses of allopolyploid wheat. In a previous study, we reported some types of growth abnormalities such as hybrid necrosis and observed hybrid chlorosis with mild or severe abnormalities in wheat triploids obtained in crosses between tetraploid wheat cultivar Langdon and four Ae. tauschii accessions and in their derived synthetic hexaploids. However, the molecular mechanisms underlying hybrid chlorosis are not well understood. Here, we compared cytology and gene expression in leaves to characterize the abnormal growth in wheat synthetics showing mild and severe chlorosis. In addition, we compared disease resistance to wheat blast fungus. In total 55 and 105 genes related to carbohydrate metabolism and 53 and 89 genes for defense responses were markedly up-regulated in the mild and severe chlorosis lines, respectively. Abnormal chloroplasts formed in the mesophyll cells before the leaves yellowed in the hybrid chlorosis lines. The plants with mild chlorosis showed increased resistance to wheat blast and powdery mildew fungi, although significant differences only in two, third internode length and maturation time, out of the examined agricultural traits were found between the wild type and plants showing mild chlorosis. These observations suggest that senescence might be accelerated in hybrid chlorosis lines of wheat synthetics. Moreover, in wheat synthetics showing mild chlorosis, the negative effects on biomass can be minimized, and they may show substantial fitness under pathogenpolluted conditions.	[Nakano, Hiroki; Mizuno, Nobuyuki; Yoshida, Kentaro; Takumi, Shigeo] Kobe Univ, Grad Sch Agr Sci, Lab Plant Genet, Kobe, Hyogo 657, Japan; [Tosa, Yukio] Kobe Univ, Grad Sch Agr Sci, Plant Pathol Lab, Kobe, Hyogo 657, Japan; [Park, Pyoyun] Kobe Univ, Grad Sch Agr Sci, Lab Stress Cytol, Kobe, Hyogo 657, Japan	Kobe University; Kobe University; Kobe University	Takumi, S (corresponding author), Kobe Univ, Grad Sch Agr Sci, Lab Plant Genet, Kobe, Hyogo 657, Japan.	takumi@kobe-u.ac.jp		Yoshida, Kentaro/0000-0002-3614-1759	Ministry of Education, Culture, Sports, Science and Technology of Japan [23658010, 25292008]; Japan Society for the Promotion of Science for Young Scientists	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan (Grant-in-Aid for Challenging Exploratory Research No. 23658010 and Grant-in-Aid for Scientific Research (B) No. 25292008) to ST, and by a Research Fellowship from the Japan Society for the Promotion of Science for Young Scientists to NM.	Abreu ME, 2009, J EXP BOT, V60, P1261, DOI 10.1093/jxb/ern363; Alcazar R, 2009, P NATL ACAD SCI USA, V106, P334, DOI 10.1073/pnas.0811734106; Alcazar R, 2010, NAT GENET, V42, P1135, DOI 10.1038/ng.704; Austin JR, 2006, PLANT CELL, V18, P1693, DOI 10.1105/tpc.105.039859; Berkman PJ, 2011, PLANT BIOTECHNOL J, V9, P768, DOI 10.1111/j.1467-7652.2010.00587.x; Bomblies K, 2007, PLOS BIOL, V5, P1962, DOI 10.1371/journal.pbio.0050236; Bomblies K, 2007, NAT REV GENET, V8, P382, DOI 10.1038/nrg2082; Brodersen P, 2002, GENE DEV, V16, P490, DOI 10.1101/gad.218202; Chen C, 2013, MOL PLANT, V6, P716, DOI 10.1093/mp/sss146; Chuma I, 2010, PHYTOPATHOLOGY, V100, P436, DOI 10.1094/PHYTO-100-5-0436; Comai L, 2005, NAT REV GENET, V6, P836, DOI 10.1038/nrg1711; Hatano H, 2012, NEW PHYTOL, V194, P1143, DOI 10.1111/j.1469-8137.2012.04125.x; HERMSEN JGT, 1972, EUPHYTICA, V21, P204, DOI 10.1007/BF00036760; Hyon GS, 2012, J GEN PLANT PATHOL, V78, P237, DOI 10.1007/s10327-012-0386-6; Ishihama N, 2012, CURR OPIN PLANT BIOL, V15, P431, DOI 10.1016/j.pbi.2012.02.003; Jeuken MJW, 2009, PLANT CELL, V21, P3368, DOI 10.1105/tpc.109.070334; Masaru IJC, 2012, DNA RES, V19, P487, DOI 10.1093/dnares/dss028; Kajimura T, 2011, BREEDING SCI, V61, P130, DOI 10.1270/jsbbs.61.130; Kajimura T, 2010, PLANT PHYSIOL BIOCH, V48, P851, DOI 10.1016/j.plaphy.2010.08.014; Kawaura K, 2008, FUNCT INTEGR GENOMIC, V8, P277, DOI 10.1007/s10142-008-0076-9; KIHARA H., 1949, Hereditas, P307; Kofler R, 2007, BIOINFORMATICS, V23, P1683, DOI 10.1093/bioinformatics/btm157; Krattinger SG, 2009, SCIENCE, V323, P1360, DOI 10.1126/science.1166453; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; Liang CZ, 2014, P NATL ACAD SCI USA, V111, P10013, DOI 10.1073/pnas.1321568111; Lorrain S, 2003, TRENDS PLANT SCI, V8, P263, DOI 10.1016/S1360-1385(03)00108-0; Matsuoka Y, 2004, THEOR APPL GENET, V109, P1710, DOI 10.1007/s00122-004-1806-6; Matsuoka Y, 2007, THEOR APPL GENET, V115, P509, DOI 10.1007/s00122-007-0584-3; Matsuoka Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068310; Matsuoka Y, 2011, PLANT CELL PHYSIOL, V52, P750, DOI 10.1093/pcp/pcr018; Mizuno N, 2011, PLANT J, V68, P114, DOI 10.1111/j.1365-313X.2011.04667.x; Mizuno N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011326; MORI N, 1992, JPN J GENET, V67, P371, DOI 10.1266/jjg.67.371; Murakami J, 2000, PHYTOPATHOLOGY, V90, P1060, DOI 10.1094/PHYTO.2000.90.10.1060; NISHIKAWA K, 1962, JPN J GENET, V37, P227, DOI 10.1266/jjg.37.227; NISHIKAWA K., 1962, SEIKEN ZIHO, V14, P45; Nishikawa K, 1960, SEIKEN ZIHO, V11, P21; Pandey SP, 2009, PLANT PHYSIOL, V150, P1648, DOI 10.1104/pp.109.138990; Rieseberg LH, 2007, SCIENCE, V317, P910, DOI 10.1126/science.1137729; Rospert S, 2002, CELL MOL LIFE SCI, V59, P1632, DOI 10.1007/PL00012490; Rushton PJ, 2010, TRENDS PLANT SCI, V15, P247, DOI 10.1016/j.tplants.2010.02.006; Shimono M, 2007, PLANT CELL, V19, P2064, DOI 10.1105/tpc.106.046250; Tian D, 2003, NATURE, V423, P74, DOI 10.1038/nature01588; Todesco M, 2010, NATURE, V465, P632, DOI 10.1038/nature09083; Traw MB, 2007, EVOLUTION, V61, P2444, DOI 10.1111/j.1558-5646.2007.00211.x; Tsunewaki K., 1970, Seiken Ziho, P67; TSUNEWAKI K, 1992, GENOME, V35, P594, DOI 10.1139/g92-089; Tsunewaki K, 2004, GENES GENET SYST, V79, P95, DOI 10.1266/ggs.79.95; TSUNEWAKI K, 1961, WHEAT INFORM SERV, V12, P1; Uauy C, 2006, SCIENCE, V314, P1298, DOI 10.1126/science.1133649; van Hulten M, 2006, P NATL ACAD SCI USA, V103, P5602, DOI 10.1073/pnas.0510213103; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Yamamoto E, 2010, MOL GENET GENOMICS, V283, P305, DOI 10.1007/s00438-010-0514-y; Zhou Y, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-132	54	13	13	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0121583	10.1371/journal.pone.0121583	http://dx.doi.org/10.1371/journal.pone.0121583			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25806790	Green Published, Green Submitted, gold			2022-12-26	WOS:000351880000164
J	Ding, J; Huang, F; Wu, GY; Han, T; Xu, FQ; Weng, D; Wu, CL; Zhang, XD; Yao, YQ; Zhu, XM				Ding, Jie; Huang, Fei; Wu, Gaoyi; Han, Tao; Xu, Fuqiang; Weng, Dan; Wu, Chengli; Zhang, Xiaodong; Yao, Yuanqing; Zhu, Xiaoming			MiR-519d-3p Suppresses Invasion and Migration of Trophoblast Cells via Targeting MMP-2	PLOS ONE			English	Article							MATRIX METALLOPROTEINASES; SEVERE PREECLAMPSIA; EXPRESSION; MICRORNA; PROLIFERATION; ANGIOGENESIS; INNATE; C19MC	Our study was approved by the Medical Ethics Committee of Tang Du Hospital, Fourth Military Medical University and complied strictly with national ethical guidelines. Preeclampsia (PE) is a specific clinical disorder characterized by gestational hypertension and proteinuria and is a leading cause of maternal and perinatal mortality worldwide. The miR-519d-3p is upregulated in the maternal plasma of patients with PE which indicates a possible association between this microRNA and the pathogenesis of PE. No studies to date have addressed the effect of miR-519d-3p on the invasion and migration of trophoblast cells. In our study, we found that miR-519d-3p expression was elevated in placental samples from patients with PE. In vitro, overexpression of miR-519d-3p significantly inhibited trophoblast cell migration and invasion, whereas transfection of a miR-519d-3p inhibitor enhanced trophoblast cell migration and invasion. Luciferase assays confirmed that matrix metalloproteinase-2 (MMP-2) is a direct target of miR-519d-3p. Quantitative real-time PCR and western blot assays showed that overexpression of miR-519d-3p downregulated MMP-2 mRNA and protein expression. Knockdown of MMP-2 using a siRNA attenuated the increased trophoblast migration and invasion promoted by the miR-519d-3p inhibitor. In placentas from patients with PE or normal pregnancies, a negative correlation between the expression of MMP-2 and miR-519d-3p was observed using the Pearson correlation and linear regression analysis. Our present findings suggest that upregulation of miR-519d-3p may contribute to the development of PE by inhibiting trophoblast cell migration and invasion via targeting MMP-2; miR-519d-3p may represent a potential predictive and therapeutic target for PE.	[Ding, Jie; Weng, Dan; Wu, Chengli; Yao, Yuanqing; Zhu, Xiaoming] Fourth Mil Med Univ, Tangdu Hosp, Dept Obstet & Gynecol, Xian 710038, Peoples R China; [Ding, Jie] Mil Med Sci, Affiliated Hosp, Hosp Chinese Peoples Liberat Army 307, Beijing 100071, Peoples R China; [Huang, Fei] PLA Navy Gen Hosp, Dept Stomatol, Beijing 100048, Peoples R China; [Wu, Gaoyi] Jinan Gen Mil Hosp, Dept Stomatol, Jinan 250000, Peoples R China; [Han, Tao] Peoples Liberat Army Gen Hosp, Hainan Branch, Dept Orthoped, Hainan 572013, Peoples R China; [Xu, Fuqiang] Shijingshan Hosp, Dept Gynecol & Obstet, Beijing 100043, Peoples R China; [Zhang, Xiaodong] Nankai Univ, Coll Life Sci, Inst Mol Biol,Minist Educ, Dept Canc Res,Key Lab Mol Microbiol & Technol, Tianjin 300071, Peoples R China; [Yao, Yuanqing] Peoples Liberat Army Gen Hosp, Dept Obstet & Gynecol, Beijing 100853, Peoples R China	Air Force Military Medical University; Sixth Medical Center of Chinese PLA General Hospital; Chinese People's Liberation Army General Hospital; Nankai University; Chinese People's Liberation Army General Hospital	Zhang, XD (corresponding author), Nankai Univ, Coll Life Sci, Inst Mol Biol,Minist Educ, Dept Canc Res,Key Lab Mol Microbiol & Technol, Tianjin 300071, Peoples R China.	xiaodongzhang@hotmail.com; rao_yu_zxm@hotmail.com; xiaomingzhu1981@hotmail.com	xu, fuqiang/AAI-1571-2019	YAO, YUANQING/0000-0001-5942-4121	Natural Science Foundation of China [81471474, 31000660, 31301127]; Postdoctoral Science Foundation of China [2014T70964, 2013M532203, 2012M521869]; Tangdu Hospital Reserve Personnel Fund	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Postdoctoral Science Foundation of China(China Postdoctoral Science Foundation); Tangdu Hospital Reserve Personnel Fund	This work was supported by grants from the Natural Science Foundation of China (81471474, 31000660, 31301127), Postdoctoral Science Foundation of China (2014T70964, 2013M532203, 2012M521869) and the Tangdu Hospital Reserve Personnel Fund (Xiao-ming Zhu). The authors gratefully acknowledge the assistance and cooperation of the staffs of the Department of Obstetrics and Gynaecology, Tangdu hospital, 2nd Affiliated Hospital of Forth Military Medical University and thank all study participants for their support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038875; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chaiworapongsa T, 2014, NAT REV NEPHROL, V10, P531, DOI 10.1038/nrneph.2014.103; Chaiworapongsa T, 2014, NAT REV NEPHROL, V10, P466, DOI 10.1038/nrneph.2014.102; Cristino AS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6529; Donker RB, 2012, MOL HUM REPROD, V18, P417, DOI 10.1093/molehr/gas013; Fornari F, 2012, J PATHOL, V227, P275, DOI 10.1002/path.3995; Goel A, 2013, CURR OPIN NEPHROL HY, V22, P643, DOI 10.1097/MNH.0b013e328365ad98; Hou YY, 2011, CANCER LETT, V307, P182, DOI 10.1016/j.canlet.2011.04.002; Hromadnikova I, 2013, MEDIAT INFLAMM, V2013, DOI DOI 10.1155/2013/186041; Hsu P, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00125; Hu YL, 2009, CLIN CHEM LAB MED, V47, P923, DOI 10.1515/CCLM.2009.228; Knoefler Martin, 2013, Frontiers in Genetics, V4, P190, DOI 10.3389/fgene.2013.00190; Li HL, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/970265; Li PF, 2013, CLIN SCI, V124, P27, DOI 10.1042/CS20120121; Lockwood CJ, 2014, AM J PATHOL, V184, P2549, DOI 10.1016/j.ajpath.2014.05.025; Luo LL, 2012, J CELL SCI, V125, P3124, DOI 10.1242/jcs.096412; Martinelli R, 2010, OBESITY, V18, P2170, DOI 10.1038/oby.2009.474; Matsubara K, 2010, J OBSTET GYNAECOL RE, V36, P239, DOI 10.1111/j.1447-0756.2009.01128.x; Morales-Prieto DM, 2012, PLACENTA, V33, P725, DOI 10.1016/j.placenta.2012.05.009; Myers JE, 2005, HYPERTENS PREGNANCY, V24, P103, DOI 10.1081/PRG-200059836; Noguer-Dance M, 2010, HUM MOL GENET, V19, P3566, DOI 10.1093/hmg/ddq272; Pang YX, 2014, ONCOTARGETS THER, V7, P587, DOI 10.2147/OTT.S60289; Perez-Sepulveda A, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00244; Sankaralingam Sowndramalingam, 2006, Expert Reviews in Molecular Medicine, V8, P1, DOI 10.1017/S1462399406010465; Santamaria X, 2014, FERTIL STERIL, V101, P1545, DOI 10.1016/j.fertnstert.2014.04.044; Tsai HC, 2014, ONCOTARGET, V5, P3800, DOI 10.18632/oncotarget.1998; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Wang YP, 2012, FEBS J, V279, P4510, DOI 10.1111/febs.12037; Zhu XM, 2009, AM J OBSTET GYNECOL, V200, P661, DOI [DOI 10.1016/J.AJ0G.2008.12.045, DOI 10.1016/J.AJOG.2008.12.045]	30	62	65	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0120321	10.1371/journal.pone.0120321	http://dx.doi.org/10.1371/journal.pone.0120321			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803859	Green Submitted, Green Published, gold			2022-12-26	WOS:000353889600068
J	Enioutina, EY; Myers, EJ; Tvrdik, P; Hoidal, JR; Rogers, SW; Gahring, LC				Enioutina, Elena Y.; Myers, Elizabeth J.; Tvrdik, Petr; Hoidal, John R.; Rogers, Scott W.; Gahring, Lorise C.			The Nicotinic Receptor Alph alpha 7 Impacts the Mouse Lung Response to LPS through Multiple Mechanisms	PLOS ONE			English	Article							ACETYLCHOLINE; EXPRESSION; ACTIVATION; ALPHA7; CELLS; ALPHA-7-NACHR; HYALURONAN; ADHESION; INJURY; CD44	The nicotinic acetylcholine receptor alpha7 (alpha 7) is expressed by neuronal and non-neuronal cells throughout the body. We examined the mechanisms of the lung inflammatory response to intranasal (i.n.) lipopolysaccharide (LPS) regulated by alpha 7. This was done in mice using homologous recombination to introduce a point mutation in the alpha 7 receptor that replaces the glutamate residue 260 that lines the pore with alanine (alpha 7(E260A)), which has been implicated in controlling the exceptional calcium ion conductance of this receptor. The alpha 7(E260A) mice exhibit normal inflammatory cell recruitment to the blood in response to i.n. LPS administration. This differs from the alpha 7knock-out (alpha 7(KO)) in which upstream signaling to initiate the recruitment to the blood following i.n. LPS is significantly impaired. While hematopoietic cells are recruited to the bloodstream in the alpha 7(E260A) mouse, they fail to be recruited efficiently into both the interstitium and alveolar spaces of the lung. Bone marrow reconstitution experiments demonstrate that the responsiveness of both CD45(+) and CD45(-) cells of the alpha 7(E260A) mouse are impaired. The expression of several pro-inflammatory cytokine and chemokine RNAs including TNF alpha, IL-1 alpha, Ccl2 and Cxcl10 are decreased in the alpha 7(E260A) mouse. However, there is a substantial increase in IL-13 expression by CD45(-) lung interstitial cells in the alpha 7(E260A) mouse. Our results support the conclusion that alpha 7 functional pleiotropy contributes to modulating the tissue response to an inflammatory insult through impacting upon a variety of mechanisms reflecting the individual cell composition of the lung.	[Enioutina, Elena Y.; Myers, Elizabeth J.; Rogers, Scott W.] Vet Affairs Med Ctr, GRECC, Salt Lake City, UT 84148 USA; [Enioutina, Elena Y.; Myers, Elizabeth J.; Gahring, Lorise C.] Univ Utah, Sch Med, Dept Internal Med, Div Geriatr, Salt Lake City, UT 84132 USA; [Enioutina, Elena Y.; Gahring, Lorise C.] Univ Utah, Sch Med, Div Microbiol & Immunol, Dept Pathol, Salt Lake City, UT 84132 USA; [Tvrdik, Petr] Univ Utah, Sch Med, Dept Human Genet, Salt Lake City, UT 84132 USA; [Hoidal, John R.] Univ Utah, Sch Med, Div Pulm Med, Dept Internal Med, Salt Lake City, UT 84132 USA; [Hoidal, John R.] Vet Affairs Med Ctr, Salt Lake City, UT 84148 USA; [Rogers, Scott W.] Univ Utah, Sch Med, Dept Neurobiol & Anat, Salt Lake City, UT 84132 USA	Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; US Department of Veterans Affairs; Veterans Health Administration (VHA); Utah System of Higher Education; University of Utah	Gahring, LC (corresponding author), Univ Utah, Sch Med, Dept Internal Med, Div Geriatr, Salt Lake City, UT 84132 USA.	Lorise.Gahring@hsc.utah.edu	Tvrdik, Petr/AAK-4398-2021; Enioutina, Elena/AAV-1745-2021	Tvrdik, Petr/0000-0002-8750-9672	Veterans Administration Merit Grant [1BX001798]; National Institutes of Health [R01DA025057]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA025057] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001798] Funding Source: NIH RePORTER	Veterans Administration Merit Grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by a Veterans Administration Merit Grant 1BX001798, and a National Institutes of Health grant R01DA025057. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal NR, 2014, AM J PHYSIOL-LUNG C, V306, pL709, DOI 10.1152/ajplung.00341.2013; Albuquerque EX, 2009, PHYSIOL REV, V89, P73, DOI 10.1152/physrev.00015.2008; Araz O, 2013, MULTIDISCIP RESP MED, V8, DOI 10.1186/2049-6958-8-74; BERTRAND D, 1993, P NATL ACAD SCI USA, V90, P6971, DOI 10.1073/pnas.90.15.6971; Brown KC, 2013, J BIOL CHEM, V288, P33049, DOI 10.1074/jbc.M113.501601; Corringer P J, 1999, Novartis Found Symp, V225, P215; Corringer PJ, 1999, NEURON, V22, P831, DOI 10.1016/S0896-6273(00)80741-2; Corringer PJ, 1999, NOVART FDN SYMP, V225, P224; Eddins D, 2002, AM J PHYSIOL-CELL PH, V282, pC796, DOI 10.1152/ajpcell.00453.2001; Engleka KA, 2005, DEV BIOL, V280, P396, DOI 10.1016/j.ydbio.2005.02.002; Gahring LC, 2005, AAPS J, V7, pE885, DOI 10.1208/aapsj070486; Gahring LC, 2003, J NEUROCHEM, V87, P1125, DOI 10.1046/j.1471-4159.2003.02074.x; Gahring LC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057481; Gahring LC, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-38; Gundavarapu S, 2012, J ALLERGY CLIN IMMUN, V130, P770, DOI 10.1016/j.jaci.2012.04.002; Horiguchi K, 2009, J NEUROSCI RES, V87, P2740, DOI 10.1002/jnr.22102; Improgo MR, 2011, BIOCHEM PHARMACOL, V82, P1015, DOI 10.1016/j.bcp.2011.05.020; Ji WJ, 2014, J IMMUNOL METHODS, V403, P7, DOI 10.1016/j.jim.2013.11.012; Kasahara K, 2012, AM J PHYSIOL-LUNG C, V303, pL834, DOI 10.1152/ajplung.00031.2012; Kurzen H, 2007, HORM METAB RES, V39, P125, DOI 10.1055/s-2007-961816; Lavezzi AM, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-11; Lesley J, 2000, J BIOL CHEM, V275, P26967; Maouche K, 2013, P NATL ACAD SCI USA, V110, P4099, DOI 10.1073/pnas.1216939110; Maouche K, 2009, AM J PATHOL, V175, P1868, DOI 10.2353/ajpath.2009.090212; Martelli D, 2014, AUTON NEUROSCI-BASIC, V182, P65, DOI 10.1016/j.autneu.2013.12.007; Morrison TB, 1998, BIOTECHNIQUES, V24, P954; Nandi A, 2004, IMMUNITY, V20, P455, DOI 10.1016/S1074-7613(04)00077-9; Osborne-Hereford AV, 2008, J NEUROIMMUNOL, V193, P130, DOI 10.1016/j.jneuroim.2007.10.029; Papke RL, 2014, BIOCHEM PHARMACOL, V89, P1, DOI 10.1016/j.bcp.2014.01.029; Pavlov VA, 2005, BRAIN BEHAV IMMUN, V19, P493, DOI 10.1016/j.bbi.2005.03.015; Pavlov VA, 2012, NAT REV ENDOCRINOL, V8, P743, DOI 10.1038/nrendo.2012.189; Rogers SW, 2012, BRAIN BEHAV, V2, P628, DOI 10.1002/brb3.84; Rogers SW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036467; Rogers SW, 2012, AM J MED GENET A, V158A, P1135, DOI 10.1002/ajmg.a.35372; Rosas-Ballina M, 2009, J INTERN MED, V265, P663, DOI 10.1111/j.1365-2796.2009.02098.x; Schneider C, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004053; Sekhon HS, 1999, J CLIN INVEST, V103, P637, DOI 10.1172/JCI5232; Siegelman MH, 1999, J LEUKOCYTE BIOL, V66, P315, DOI 10.1002/jlb.66.2.315; Su X, 2007, AM J RESP CELL MOL, V37, P186, DOI 10.1165/rcmb.2006-0240OC; Van Dyken SJ, 2013, ANNU REV IMMUNOL, V31, P317, DOI 10.1146/annurev-immunol-032712-095906; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Wang Y, 2001, MOL PHARMACOL, V60, P1201, DOI 10.1124/mol.60.6.1201; Zia S, 1997, RES COMMUN MOL PATH, V97, P243	43	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0121128	10.1371/journal.pone.0121128	http://dx.doi.org/10.1371/journal.pone.0121128			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803612	Green Published, gold, Green Submitted			2022-12-26	WOS:000353889600128
J	Kazemzadeh, F; Wong, A; Behr, BB; Hajian, AR				Kazemzadeh, Farnoud; Wong, Alexander; Behr, Bradford B.; Hajian, Arsen R.			Depth Profilometry via Multiplexed Optical High-Coherence Interferometry	PLOS ONE			English	Article							PHOTOTHERMAL RADIOMETRY; HUMAN TEETH; SUPERRESOLUTION; INTERFERENCE; LUMINESCENCE; SYSTEM; LIGHT	Depth Profilometry involves the measurement of the depth profile of objects, and has significant potential for various industrial applications that benefit from non-destructive subsurface profiling such as defect detection, corrosion assessment, and dental assessment to name a few. In this study, we investigate the feasibility of depth profilometry using an Multiplexed Optical High-coherence Interferometry MOHI instrument. The MOHI instrument utilizes the spatial coherence of a laser and the interferometric properties of light to probe the reflectivity as a function of depth of a sample. The axial and lateral resolutions, as well as imaging depth, are decoupled in the MOHI instrument. The MOHI instrument is capable of multiplexing interferometric measurements into 480 one-dimensional interferograms at a location on the sample and is built with axial and lateral resolutions of 40 mu m at a maximum imaging depth of 700 mu m. Preliminary results, where a piece of sand-blasted aluminum, an NBK7 glass piece, and an optical phantom were successfully probed using the MOHI instrument to produce depth profiles, demonstrate the feasibility of such an instrument for performing depth profilometry.	[Kazemzadeh, Farnoud; Wong, Alexander; Behr, Bradford B.; Hajian, Arsen R.] Univ Waterloo, Dept Syst Design Engn, Waterloo, ON N2L 3G1, Canada; [Behr, Bradford B.; Hajian, Arsen R.] Tornado Spectral Syst, Toronto, ON, Canada	University of Waterloo	Kazemzadeh, F (corresponding author), Univ Waterloo, Dept Syst Design Engn, Waterloo, ON N2L 3G1, Canada.	fkazemzadeh@uwaterloo.ca	Wong, Alexander/GZM-2929-2022	Wong, Alexander/0000-0002-5295-2797	Natural Sciences and Engineering Research Council of Canada; Canada Research Chairs Program; Ontario Ministry of Economic Development and Innovation; Thunder Bay Regional Research Institute	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Research Chairs Program(Canada Research Chairs); Ontario Ministry of Economic Development and Innovation; Thunder Bay Regional Research Institute	This work was supported by the Natural Sciences and Engineering Research Council of Canada, Canada Research Chairs Program, the Ontario Ministry of Economic Development and Innovation, and the Thunder Bay Regional Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Born M, 2011, PRINCIPLES OPTICS; Bouchard JP, 2010, OPT EXPRESS, V18, P11495, DOI 10.1364/OE.18.011495; Drexler W, 2008, BIOL MED PHYS BIOMED, P1, DOI 10.1007/978-3-540-77550-8; Fan Y, 2004, J ACOUST SOC AM, V116, P3523, DOI 10.1121/1.1819393; Goodman J. W., 2005, INTRO FOURIER OPTICS; Greivenkamp JE, 1995, HDB OPTICS INTERFERE; Gross P, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2712943; Hunt BR, 1995, INT J IMAG SYST TECH, V6, P297, DOI 10.1002/ima.1850060403; HUNT BR, 1992, ASTR SOC P, V25, P196; Hunt BR, 1996, INTERNATIONAL CONFERENCE ON IMAGE PROCESSING, PROCEEDINGS - VOL III, P109, DOI 10.1109/ICIP.1996.560381; Jacques V, 2005, EUR PHYS J D, V35, P561, DOI 10.1140/epjd/e2005-00201-y; Jeon RJ, 2004, J BIOMED OPT, V9, P804, DOI 10.1117/1.1755234; Jeon RJ, 2003, REV SCI INSTRUM, V74, P380, DOI 10.1063/1.1516242; Kazemzadeh F, 2011, THESIS U WATERLOO; Kazemzadeh F, 2011, PROC SPIE, V7907, DOI 10.1117/12.873892; Koch P, 2004, OPT LETT, V29, P1644, DOI 10.1364/OL.29.001644; Lu CD, 2014, BIOMED OPT EXPRESS, V5, P293, DOI 10.1364/BOE.5.000293; Mandelis A, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.205208; MISSIROLI GF, 1981, J PHYS E SCI INSTRUM, V14, P649, DOI 10.1088/0022-3735/14/6/001; Nicolaides L, 2001, P SPIE, V4249, P1605; Nyquist H., 1928, T AM I ELECT ING, V47, P617, DOI [10.1109/T-AIEE.1928.5055024, DOI 10.1109/T-AIEE.1928.5055024]; SEMENTILLI PJ, 1993, J OPT SOC AM A, V10, P2265, DOI 10.1364/JOSAA.10.002265; Shannon C. E., 1949, MATH THEORY COMMUNIC; Shaughnessy D, 2003, REV SCI INSTRUM, V74, P529, DOI 10.1063/1.1516243; Wax A, 2002, J OPT SOC AM A, V19, P737, DOI 10.1364/JOSAA.19.000737	25	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0121066	10.1371/journal.pone.0121066	http://dx.doi.org/10.1371/journal.pone.0121066			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803289	Green Published, gold, Green Submitted			2022-12-26	WOS:000353889600119
J	Vortmeier, G; DeLuca, SH; Els-Heindl, S; Chollet, C; Scheidt, HA; Beck-Sickinger, AG; Meiler, J; Huster, D				Vortmeier, Gerrit; DeLuca, Stephanie H.; Els-Heindl, Sylvia; Chollet, Constance; Scheidt, Holger A.; Beck-Sickinger, Annette G.; Meiler, Jens; Huster, Daniel			Integrating Solid-State NMR and Computational Modeling to Investigate the Structure and Dynamics of Membrane-Associated Ghrelin	PLOS ONE			English	Article							POLYPROLINE-II HELIX; CHEMICAL-SHIFT PREDICTION; PROTEIN SECONDARY STRUCTURE; NUCLEAR-MAGNETIC-RESONANCE; HORMONE-RELEASING PEPTIDE; DES-ACYL-GHRELIN; PLASMA GHRELIN; LIPID MODIFICATIONS; CS-ROSETTA; GH RELEASE	The peptide hormone ghrelin activates the growth hormone secretagogue receptor 1a, also known as the ghrelin receptor. This 28-residue peptide is acylated at Ser3 and is the only peptide hormone in the human body that is lipid-modified by an octanoyl group. Little is known about the structure and dynamics of membrane-associated ghrelin. We carried out solid-state NMR studies of ghrelin in lipid vesicles, followed by computational modeling of the peptide using Rosetta. Isotropic chemical shift data of isotopically labeled ghrelin provide information about the peptide's secondary structure. Spin diffusion experiments indicate that ghrelin binds to membranes via its lipidated Ser3. Further, Phe4, as well as electrostatics involving the peptide's positively charged residues and lipid polar head-groups, contribute to the binding energy. Other than the lipid anchor, ghrelin is highly flexible and mobile at the membrane surface. This observation is supported by our predicted model ensemble, which is in good agreement with experimentally determined chemical shifts. In the final ensemble of models, residues 8-17 form an a-helix, while residues 21-23 and 2627 often adopt a polyproline II helical conformation. These helices appear to assist the peptide in forming an amphipathic conformation so that it can bind to the membrane.	[Vortmeier, Gerrit; Scheidt, Holger A.; Huster, Daniel] Univ Leipzig, Inst Med Phys & Biophys, D-04109 Leipzig, Germany; [DeLuca, Stephanie H.; Meiler, Jens] Vanderbilt Univ, Struct Biol Ctr, Nashville, TN 37232 USA; [Els-Heindl, Sylvia; Chollet, Constance; Beck-Sickinger, Annette G.] Univ Leipzig, Inst Biochem, D-04109 Leipzig, Germany	Leipzig University; Vanderbilt University; Leipzig University	Huster, D (corresponding author), Univ Leipzig, Inst Med Phys & Biophys, D-04109 Leipzig, Germany.	daniel.huster@medizin.uni-leipzig.de		Meiler, Jens/0000-0001-8945-193X	Europaischer Sozialfonds [ESF 22117016]; U.S. National Institutes of Health (NIH) [F31-GM100742]; NIH [R01 GM080403]; NSF [CHE 1305874]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK058404, R01DK097376] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM100742, R01GM080403] Funding Source: NIH RePORTER; Direct For Mathematical & Physical Scien [1305874] Funding Source: National Science Foundation; Office Of Internatl Science &Engineering [1157751] Funding Source: National Science Foundation	Europaischer Sozialfonds(European Commission); U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Office Of Internatl Science &Engineering(National Science Foundation (NSF)NSF - Office of the Director (OD))	This study was supported by the Europaischer Sozialfonds (ESF 22117016) and the U.S. National Institutes of Health (NIH) F31-GM100742. Work in the Meiler laboratory was supported through NIH (R01 GM080403) and NSF (CHE 1305874). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei AA, 2013, J MOL BIOL, V425, P2100, DOI 10.1016/j.jmb.2013.03.018; AKMAN MS, 1993, ENDOCRINOLOGY, V132, P1286, DOI 10.1210/en.132.3.1286; Barre P, 2003, BIOCHEMISTRY-US, V42, P8377, DOI 10.1021/bi034239e; Barth P, 2007, P NATL ACAD SCI USA, V104, P15682, DOI 10.1073/pnas.0702515104; Bednarek MA, 2000, J MED CHEM, V43, P4370, DOI 10.1021/jm0001727; Beevers AJ, 2006, J BIOMOL STRUCT DYN, V23, P357, DOI 10.1080/07391102.2006.10531231; BenTal N, 1996, BIOPHYS J, V71, P561, DOI 10.1016/S0006-3495(96)79280-9; Bernado P, 2005, J AM CHEM SOC, V127, P17968, DOI 10.1021/ja055538p; Blanch EW, 2000, J MOL BIOL, V301, P553, DOI 10.1006/jmbi.2000.3981; Boomsma W, 2014, P NATL ACAD SCI USA, V111, P13852, DOI 10.1073/pnas.1404948111; Brunsveld L, 2009, BBA-BIOMEMBRANES, V1788, P273, DOI 10.1016/j.bbamem.2008.08.006; Buser CA, 1998, METH MOL B, V84, P267; Camilloni C, 2013, J PHYS CHEM B, V117, P1838, DOI 10.1021/jp3106666; Camilloni C, 2012, BIOCHEMISTRY-US, V51, P2224, DOI 10.1021/bi3001825; CASEY PJ, 1995, SCIENCE, V268, P221, DOI 10.1126/science.7716512; Chellgren BW, 2004, BIOCHEMISTRY-US, V43, P5864, DOI 10.1021/bi049922v; CHENG K, 1989, ENDOCRINOLOGY, V124, P2791; Cook GA, 2013, BIOCHEMISTRY-US, V52, P5295, DOI 10.1021/bi4006623; Cubellis MV, 2005, PROTEINS, V58, P880, DOI 10.1002/prot.20327; Czinki E, 2007, J AM CHEM SOC, V129, P1568, DOI 10.1021/ja065461k; Dastmalchi S, 2004, J STRUCT BIOL, V146, P261, DOI 10.1016/j.jsb.2004.01.004; Date Y, 2002, DIABETES, V51, P124, DOI 10.2337/diabetes.51.1.124; De Ricco R, 2013, PEPTIDES, V43, P62, DOI 10.1016/j.peptides.2013.02.021; Dehlin E, 2008, PEPTIDES, V29, P904, DOI 10.1016/j.peptides.2008.02.001; DeLuca SH, 2013, BIOPOLYMERS, V99, P314, DOI 10.1002/bip.22162; Eker F, 2004, BIOCHEMISTRY-US, V43, P6893, DOI 10.1021/bi049542+; Elipe MVS, 2001, BIOPOLYMERS, V59, P489, DOI 10.1002/1097-0282(200112)59:7<489::AID-BIP1054>3.0.CO;2-S; Els S, 2010, METHOD ENZYMOL, V485, P103, DOI [10.1016/S0076-6879(10)85006-2, 10.1016/B978-0-12-381296-4.00006-3]; English PJ, 2002, J CLIN ENDOCR METAB, V87, P2984, DOI 10.1210/jc.87.6.2984; Filigheddu N, 2007, MOL BIOL CELL, V18, P986, DOI 10.1091/mbc.E06-05-0402; Foroutan A, 2011, J PHYS CHEM B, V115, P3622, DOI 10.1021/jp1101253; Gront D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023294; Grossauer J, 2010, BIOORGAN MED CHEM, V18, P5483, DOI 10.1016/j.bmc.2010.06.062; Gutierrez JA, 2008, P NATL ACAD SCI USA, V105, P6320, DOI 10.1073/pnas.0800708105; Han B, 2011, J BIOMOL NMR, V50, P43, DOI 10.1007/s10858-011-9478-4; Hansen TK, 2002, CLIN ENDOCRINOL, V56, P203, DOI 10.1046/j.0300-0664.2001.01456.x; Heppner KM, 2012, ENDOCRINOLOGY, V153, P4687, DOI 10.1210/en.2012-1194; Hicks JM, 2004, PROTEINS, V55, P330, DOI 10.1002/prot.10630; HOPE MJ, 1985, BIOCHIM BIOPHYS ACTA, V812, P55, DOI 10.1016/0005-2736(85)90521-8; Huster D, 2005, PROG NUCL MAG RES SP, V46, P79, DOI 10.1016/j.pnmrs.2005.01.001; Huster D, 1998, BIOCHEMISTRY-US, V37, P17299, DOI 10.1021/bi980078g; Huster D, 2003, J AM CHEM SOC, V125, P4070, DOI 10.1021/ja0289245; Huster D, 2002, J AM CHEM SOC, V124, P874, DOI 10.1021/ja017001r; Huster D, 2001, BIOCHEMISTRY-US, V40, P7662, DOI 10.1021/bi0027231; Huster D, 2001, ANGEW CHEM INT EDIT, V40, P1056, DOI 10.1002/1521-3773(20010316)40:6<1056::AID-ANIE10560>3.0.CO;2-7; Jao CC, 2004, P NATL ACAD SCI USA, V101, P8331, DOI 10.1073/pnas.0400553101; Jensen MR, 2010, J AM CHEM SOC, V132, P1270, DOI 10.1021/ja909973n; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Karplus K, 1998, BIOINFORMATICS, V14, P846, DOI 10.1093/bioinformatics/14.10.846; Kaufmann KW, 2010, BIOCHEMISTRY-US, V49, P2987, DOI 10.1021/bi902153g; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Kukic P, 2014, J MOL BIOL, V426, P1826, DOI 10.1016/j.jmb.2014.02.002; Kukol A, 2007, VITAM HORM, P1; Kumashiro KK, 1998, J AM CHEM SOC, V120, P5043, DOI 10.1021/ja972655e; Lam SL, 2003, BIOPOLYMERS, V69, P270, DOI 10.1002/bip.10354; Lange OF, 2012, P NATL ACAD SCI USA, V109, P10873, DOI 10.1073/pnas.1203013109; Lange OF, 2012, PROTEINS, V80, P884, DOI 10.1002/prot.23245; le Roux CW, 2005, J CLIN ENDOCR METAB, V90, P1068, DOI 10.1210/jc.2004-1216; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; LEE CWB, 1989, BIOPHYS J, V55, P355, DOI 10.1016/S0006-3495(89)82812-7; Lin YZ, 2004, HYPERTENSION, V43, P977, DOI 10.1161/01.HYP.0000122803.91559.55; Ma K, 2001, BIOCHEMISTRY-US, V40, P3427, DOI 10.1021/bi0022792; Martin-Pastor M, 2010, BIOORGAN MED CHEM, V18, P1583, DOI 10.1016/j.bmc.2010.01.004; Matsumoto M, 2001, BIOCHEM BIOPH RES CO, V287, P142, DOI 10.1006/bbrc.2001.5553; Meiler J, 2003, P NATL ACAD SCI USA, V100, P12105, DOI 10.1073/pnas.1831973100; Meiler J, 2003, J BIOMOL NMR, V26, P25, DOI 10.1023/A:1023060720156; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; Mukrasch MD, 2007, J AM CHEM SOC, V129, P5235, DOI 10.1021/ja0690159; MUNOWITZ MG, 1981, J AM CHEM SOC, V103, P2529, DOI 10.1021/ja00400a007; Murray D, 1997, STRUCTURE, V5, P985, DOI 10.1016/S0969-2126(97)00251-7; Neal S, 2003, J BIOMOL NMR, V26, P215, DOI 10.1023/A:1023812930288; Ohgusu H, 2009, BIOCHEM BIOPH RES CO, V386, P153, DOI 10.1016/j.bbrc.2009.06.001; Poykko SM, 2003, DIABETES, V52, P2546, DOI 10.2337/diabetes.52.10.2546; Raman S, 2010, SCIENCE, V327, P1014, DOI 10.1126/science.1183649; Rath A, 2005, BIOPOLYMERS, V80, P179, DOI 10.1002/bip.20227; Reuther G, 2006, J AM CHEM SOC, V128, P13840, DOI 10.1021/ja063635s; Reuther G, 2006, ANGEW CHEM INT EDIT, V45, P5387, DOI 10.1002/anie.200504266; Rohl CA, 2005, METHOD ENZYMOL, V394, P244, DOI 10.1016/S0076-6879(05)94009-3; Rohl CA, 2011, METHOD ENZYMOL, V383, P66; SARGENT DF, 1986, P NATL ACAD SCI USA, V83, P5774, DOI 10.1073/pnas.83.16.5774; Sgourakis NG, 2011, J AM CHEM SOC, V133, P6288, DOI 10.1021/ja111318m; Shen Y, 2008, P NATL ACAD SCI USA, V105, P4685, DOI 10.1073/pnas.0800256105; Shen Y, 2010, J BIOMOL NMR, V48, P13, DOI 10.1007/s10858-010-9433-9; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Shen Y, 2009, J BIOMOL NMR, V43, P63, DOI 10.1007/s10858-008-9288-5; Shiiya T, 2002, J CLIN ENDOCR METAB, V87, P240, DOI 10.1210/jc.87.1.240; Simons KT, 1997, J MOL BIOL, V268, P209, DOI 10.1006/jmbi.1997.0959; Skora L, 2012, PROTEIN SCI, V21, P1948, DOI 10.1002/pro.2170; Staes E, 2010, BBA-BIOMEMBRANES, V1798, P2102, DOI 10.1016/j.bbamem.2010.07.002; Stapley BJ, 1999, PROTEIN SCI, V8, P587; SZEVERENYI NM, 1982, J MAGN RESON, V47, P462, DOI 10.1016/0022-2364(82)90213-X; Tanford C, 1980, THE HYDROPHOBIC EFFE; Torsello A, 2002, ENDOCRINOLOGY, V143, P1968, DOI 10.1210/en.143.5.1968; Tschop M, 2001, DIABETES, V50, P707, DOI 10.2337/diabetes.50.4.707; UDENFRIEND S, 1972, SCIENCE, V178, P871, DOI 10.1126/science.178.4063.871; Ukkola O, 2011, MOL CELL ENDOCRINOL, V340, P26, DOI 10.1016/j.mce.2011.02.009; Vernon R, 2013, J BIOMOL NMR, V57, P117, DOI 10.1007/s10858-013-9772-4; Vogel A, 2005, J AM CHEM SOC, V127, P12263, DOI 10.1021/ja051856c; Vogel A, 2009, ANGEW CHEM INT EDIT, V48, P8784, DOI 10.1002/anie.200903396; Wimley WC, 1996, NAT STRUCT BIOL, V3, P842, DOI 10.1038/nsb1096-842; Wishart DS, 1997, J BIOMOL NMR, V10, P329, DOI 10.1023/A:1018373822088; Wren AM, 2011, J CLIN ENDOCR METAB, V86, P5992; Yang J, 2008, CELL, V132, P387, DOI 10.1016/j.cell.2008.01.017; Yarov-Yarovoy V, 2006, PROTEINS, V62, P1010, DOI 10.1002/prot.20817	105	13	13	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0122444	10.1371/journal.pone.0122444	http://dx.doi.org/10.1371/journal.pone.0122444			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803439	Green Published, Green Submitted, gold			2022-12-26	WOS:000353889600197
J	Yang, JC; Liu, L; Sheikhahmadi, A; Wang, YF; Li, CC; Jiao, HC; Lin, H; Song, ZG				Yang, Jiachang; Liu, Lei; Sheikhahmadi, Ardashir; Wang, Yufeng; Li, Congcong; Jiao, Hongchao; Lin, Hai; Song, Zhigang			Effects of Corticosterone and Dietary Energy on Immune Function of Broiler Chickens	PLOS ONE			English	Article							GALLUS-GALLUS-DOMESTICUS; TOLL-LIKE RECEPTORS; DEOXYRIBONUCLEIC-ACID DEGRADATION; TRANSPORTER EXPRESSION; ENDOGENOUS GLUCOCORTICOIDS; STRESS HORMONES; GENE-EXPRESSION; TRADE-OFFS; SEA BASS; PERFORMANCE	An experiment was conducted to investigate the effects of dietary energy level on the performance and immune function of stressed broiler chickens (Gallus gallus domesticus). A total of 96 three-day-old male broiler chickens (Ross x Ross) were divided into two groups. One group received a high energy (HE) diet and the other group received a low energy (LE) diet for 7 days. At 5 days of age, the chickens from each group were further divided into two subgroups and received one of the following two treatments for 3 days: (1) subcutaneous injection of corticosterone, twice per day (CORT group; 2 mg of CORT/kg BW in corn oil) and (2) subcutaneous injection of corn oil, twice per day (Control/Sham treatment group). At 10 days of age, samples of blood, duodenum, jejunum, and ileum were obtained. Compared with the other three groups, the LE group treated with CORT had the lowest average daily gain (ADG) and the poorest feed conversion ratio (FCR, P < 0.05). Furthermore, CORT treatment decreased the relative weight (RW) of the bursa independent of the dietary energy level, but it decreased the RW of the thymus only in the chickens fed the LE diet. By contrast, CORT administration decreased the RW of the spleen only in the chickens fed the HE diet (P < 0.05). The plasma total protein, albumin, tumor necrosis factor alpha, interleukin 2 and immunoglobulin G (IgG) levels were affected by the CORT treatment (P < 0.05); however, these factors were not significantly affected by the dietary energy level. Toll-like receptor-5 mRNA level was down-regulated by CORT injection in the duodenum and ileum (P < 0.05) and showed a trend of down-regulation in the jejunum (P=0.0846). The present study showed that CORT treatment induced immunosuppressive effects on the innate immune system of broiler chickens, which were ameliorated by consumption of higher dietary energy.	[Yang, Jiachang; Liu, Lei; Jiao, Hongchao; Lin, Hai; Song, Zhigang] Shandong Agr Univ, Dept Anim Sci, Tai An 271018, Shandong, Peoples R China; [Sheikhahmadi, Ardashir] Univ Kurdistan, Fac Agr, Dept Anim Sci, Sanandaj 6617715175, Iran; [Wang, Yufeng; Li, Congcong] Katholieke Univ Leuven, Dept Biosyst, Lab Livestock Physiol, B-3001 Leuven, Belgium	Shandong Agricultural University; University of Kurdistan; KU Leuven	Song, ZG (corresponding author), Shandong Agr Univ, Dept Anim Sci, Tai An 271018, Shandong, Peoples R China.	zhigangs@sdau.edu.cn	Sheikhahmadi, Ardashir/AAK-8201-2021	Sheikhahmadi, Ardashir/0000-0002-8427-2825; Song, Zhigang/0000-0003-1525-5797	National Natural Science Foundation of China [31172226]; Shandong Modern Agricultural Technology and Industry System [SDAIT-13-011-08]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Modern Agricultural Technology and Industry System	This work was supported by the National Natural Science Foundation of China (31172226) and Shandong Modern Agricultural Technology and Industry System (SDAIT-13-011-08).	ANDUS T, 1988, EUR J IMMUNOL, V18, P739, DOI 10.1002/eji.1830180513; Bocker U, 2003, INT J COLORECTAL DIS, V18, P25, DOI 10.1007/s00384-002-0415-6; Cario E, 2007, GASTROENTEROLOGY, V132, P1359, DOI 10.1053/j.gastro.2007.02.056; Close B, 1997, LAB ANIM-UK, V31, P1, DOI 10.1258/002367797780600297; Collier SD, 1998, TOXICOL APPL PHARM, V148, P176, DOI 10.1006/taap.1997.8324; COMPTON MM, 1990, POULTRY SCI, V69, P1292, DOI 10.3382/ps.0691292; COMPTON MM, 1991, POULTRY SCI, V70, P521, DOI 10.3382/ps.0700521; d'Orbcastel ER, 2010, AQUAT LIVING RESOUR, V23, P109, DOI 10.1051/alr/2009056; Dong H, 2007, COMP BIOCHEM PHYS A, V147, P189, DOI 10.1016/j.cbpa.2006.12.034; Elenkov IJ, 1999, TRENDS ENDOCRIN MET, V10, P359, DOI 10.1016/S1043-2760(99)00188-5; Elenkov IJ, 2002, ANN NY ACAD SCI, V966, P290, DOI 10.1111/j.1749-6632.2002.tb04229.x; Feo P De, 1992, AM J PHYSIOL, V263, P794; Ferro PJ, 2004, EPIDEMIOL INFECT, V132, P1029, DOI 10.1017/S0950268804002687; Freeman CM, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-13; French SS, 2007, AM NAT, V170, P79, DOI 10.1086/518569; Fuku A, 2001, J BIOL CHEM, V276, P47143, DOI 10.1074/jbc.M103902200; Galyean ML, 1999, J ANIM SCI, V77, P1120; HAJDUCH E, 1995, ENDOCRINOLOGY, V136, P4782, DOI 10.1210/en.136.11.4782; Homma T, 2004, AM J RESP CELL MOL, V31, P463, DOI 10.1165/rcmb.2004-0161OC; Hu XF, 2010, POULTRY SCI, V89, P1967, DOI 10.3382/ps.2009-00547; Humphrey BD, 2006, COMP BIOCHEM PHYS A, V143, P218, DOI 10.1016/j.cbpa.2005.11.019; Humphrey BD, 2004, COMP BIOCHEM PHYS A, V138, P515, DOI 10.1016/j.cbpb.2004.06.016; Korver DR, 1997, J NUTR, V127, P2039, DOI 10.1093/jn/127.10.2039; Korver DR, 1997, THESIS U CALIFORNIA; KRUPPA G, 1992, J IMMUNOL, V148, P3152; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lochmiller RL, 2000, OIKOS, V88, P87, DOI 10.1034/j.1600-0706.2000.880110.x; MacRedmond RE, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-84; Martin LB, 2003, P ROY SOC B-BIOL SCI, V270, P153, DOI 10.1098/rspb.2002.2185; Maurice D, 2007, J ANIM PHYSIOL AN N, V91, P355, DOI 10.1111/j.1439-0396.2006.00662.x; Mirzaaghatabar F, 2011, FOOD AGR IMMUNOL, V22, P93, DOI 10.1080/09540105.2010.530249; Ortega-Cava CF, 2003, J IMMUNOL, V170, P3977, DOI 10.4049/jimmunol.170.8.3977; Parkin J, 2001, LANCET, V357, P1777, DOI 10.1016/S0140-6736(00)04904-7; Parmentier HK, 2002, BRIT POULTRY SCI, V43, P533, DOI 10.1080/0007166022000004444; Paspatis M, 2003, AQUACULTURE, V216, P103, DOI 10.1016/S0044-8486(02)00417-9; Pazirandeh A, 2002, FASEB J, V16, P727, DOI 10.1096/fj.01-0891fje; Post J, 2003, POULTRY SCI, V82, P1313, DOI 10.1093/ps/82.8.1313; Reichardt HM, 2000, MOL CELL BIOL, V20, P9009, DOI 10.1128/MCB.20.23.9009-9017.2000; Ren T, 2006, PLOS PATHOG, V2, P175, DOI 10.1371/journal.ppat.0020018; Rozkova D, 2006, CLIN IMMUNOL, V120, P260, DOI 10.1016/j.clim.2006.04.567; SCHAUMBURG BP, 1971, BIOCHIM BIOPHYS ACTA, V237, P494, DOI 10.1016/0304-4165(71)90269-8; SHERIDAN JF, 1994, CLIN MICROBIOL REV, V7, P200, DOI 10.1128/CMR.7.2.200-212.1994; Shibata M, 2009, J INVEST DERMATOL, V129, P375, DOI 10.1038/jid.2008.237; Sijben JWC, 2000, POULTRY SCI, V79, P1106, DOI 10.1093/ps/79.8.1106; Song ZG, 2011, J MOL ENDOCRINOL, V46, P217, DOI 10.1530/JME-10-0162; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Van Hunsel F, 1998, PSYCHOL MED, V28, P301, DOI 10.1017/S0033291797006351; Vijay-Kumar M, 2007, J CLIN INVEST, V117, P3909, DOI 10.1172/JCI33084; Wang Y, 2014, ANIMAL, V8, P610, DOI 10.1017/S175173111400007X; Wang YF, 2012, COMP BIOCHEM PHYS A, V163, P246, DOI 10.1016/j.cbpa.2012.08.009; Weinstein SP, 1998, METABOLISM, V47, P3, DOI 10.1016/S0026-0495(98)90184-6; Whithey TR, 2006, LIVEST SCI, V101, P1, DOI 10.1016/j.livprodsci.2005.04.011; Zulkifli I, 2004, APPL ANIM BEHAV SCI, V88, P77, DOI 10.1016/j.applanim.2004.02.014	54	34	34	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0119750	10.1371/journal.pone.0119750	http://dx.doi.org/10.1371/journal.pone.0119750			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803644	Green Published, gold, Green Submitted			2022-12-26	WOS:000353889600044
J	Zhou, YS; Liu, YJ; Li, KN; Zhang, R; Qiu, FJ; Zhao, N; Xu, Y				Zhou, Yuanshuai; Liu, Yongjing; Li, Kening; Zhang, Rui; Qiu, Fujun; Zhao, Ning; Xu, Yan			ICan: An Integrated Co-Alteration Network to Identify Ovarian Cancer-Related Genes	PLOS ONE			English	Article							CANONICAL CORRELATION-ANALYSIS; NUMBER ALTERATIONS; EXPRESSION; PATHWAYS; KNOWLEDGEBASE; COEXPRESSION; MUTATIONS; PACKAGE; POOR	Background Over the last decade, an increasing number of integrative studies on cancer-related genes have been published. Integrative analyses aim to overcome the limitation of a single data type, and provide a more complete view of carcinogenesis. The vast majority of these studies used sample-matched data of gene expression and copy number to investigate the impact of copy number alteration on gene expression, and to predict and prioritize candidate oncogenes and tumor suppressor genes. However, correlations between genes were neglected in these studies. Our work aimed to evaluate the co-alteration of copy number, methylation and expression, allowing us to identify cancer-related genes and essential functional modules in cancer. Results We built the Integrated Co-alteration network (ICan) based on multi-omics data, and analyzed the network to uncover cancer-related genes. After comparison with random networks, we identified 155 ovarian cancer-related genes, including well-known (TP53, BRCA1, RB1 and PTEN) and also novel cancer-related genes, such as PDPN and EphA2. We compared the results with a conventional method: CNAmet, and obtained a significantly better area under the curve value (ICan: 0.8179, CNAmet: 0.5183). Conclusion In this paper, we describe a framework to find cancer-related genes based on an Integrated Co-alteration network. Our results proved that ICan could precisely identify candidate cancer genes and provide increased mechanistic understanding of carcinogenesis. This work suggested a new research direction for biological network analyses involving multiomics data.	[Zhou, Yuanshuai; Liu, Yongjing; Li, Kening; Zhang, Rui; Qiu, Fujun; Zhao, Ning; Xu, Yan] Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin 150081, Peoples R China	Harbin Medical University	Xu, Y (corresponding author), Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin 150081, Peoples R China.	xuyan@ems.hrbmu.edu.cn		Zhao, Ning/0000-0002-6660-5606	National Natural Science Foundation of China [81372492]; Scientific Research Fund of Heilongjiang Provincial Education Department [12541278]; Natural Science Foundation of Heilongjiang Province [D201116]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Fund of Heilongjiang Provincial Education Department; Natural Science Foundation of Heilongjiang Province(Natural Science Foundation of Heilongjiang Province)	This work was supported in part by the National Natural Science Foundation of China (Grant No. 81372492), and in part by Scientific Research Fund of Heilongjiang Provincial Education Department (No. 12541278) and the Natural Science Foundation of Heilongjiang Province (Grant No. D201116). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akavia UD, 2010, CELL, V143, P1005, DOI 10.1016/j.cell.2010.11.013; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bashashati A, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-12-r124; Becker KG, 2004, NAT GENET, V36, P431, DOI 10.1038/ng0504-431; Bicciato S, 2009, NUCLEIC ACIDS RES, V37, P5057, DOI 10.1093/nar/gkp520; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Chow LML, 2011, CANCER CELL, V19, P305, DOI 10.1016/j.ccr.2011.01.039; Davoli T, 2013, CELL, V155, P948, DOI 10.1016/j.cell.2013.10.011; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Garbade KD, 1975, 2 METHODS EXAMINING, V19; Gu YY, 2010, MOL CANCER THER, V9, P2186, DOI 10.1158/1535-7163.MCT-10-0022; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hardle W, 2012, APPL MULTIVARIATE ST, Vxvii; Herath NI, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-144; Hong SJ, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt145; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang N, 2012, BRIEF BIOINFORM, V13, P305, DOI 10.1093/bib/bbr056; Johnson RA, 2002, APPL MULTIVARIATE ST, Vxviii; Jorgensen JT, 2011, DRUG DISCOV TODAY, V16, P891, DOI 10.1016/j.drudis.2011.09.010; Kohler S, 2008, AM J HUM GENET, V82, P949, DOI 10.1016/j.ajhg.2008.02.013; Levidou G, 2012, INT J GYNECOL PATHOL, V31, P319, DOI 10.1097/PGP.0b013e31823ef92e; Lin DD, 2013, BMC BIOINFORMATICS, V14, DOI [10.1186/1471-2105-14-245, 10.1186/1471-2105-14-S16-S3]; Louhimo R, 2011, BIOINFORMATICS, V27, P887, DOI 10.1093/bioinformatics/btr019; Matthews L, 2009, NUCLEIC ACIDS RES, V37, pD619, DOI 10.1093/nar/gkn863; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Miyazaki T, 2003, INT J CANCER, V103, P657, DOI 10.1002/ijc.10860; OBRIEN PC, 1984, J AM STAT ASSOC, V79, P231, DOI 10.2307/2288368; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Reedijk M, 2005, CANCER RES, V65, P8530, DOI 10.1158/0008-5472.CAN-05-1069; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Salari K, 2010, BIOINFORMATICS, V26, P414, DOI 10.1093/bioinformatics/btp702; Schaefer CF, 2009, NUCLEIC ACIDS RES, V37, pD674, DOI 10.1093/nar/gkn653; Shindo K, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-168; Soneson C, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-191; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Willner J, 2007, HUM PATHOL, V38, P607, DOI 10.1016/j.humpath.2006.10.007; Wu GM, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r53; Xiao X, 2014, GYNECOL ONCOL, V132, P506, DOI 10.1016/j.ygyno.2013.12.003; Xu JZ, 2006, BIOINFORMATICS, V22, P2800, DOI 10.1093/bioinformatics/btl467; Yang YI, 2014, CANCER RES, V74, P2258, DOI 10.1158/0008-5472.CAN-13-2459; Yu W, 2010, BIOINFORMATICS, V26, P145, DOI 10.1093/bioinformatics/btp618; Zelinski DP, 2001, CANCER RES, V61, P2301; Zhang YA, 2011, CANCER LETT, V303, P47, DOI 10.1016/j.canlet.2011.01.011	45	163	168	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0116095	10.1371/journal.pone.0116095	http://dx.doi.org/10.1371/journal.pone.0116095			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803614	Green Published, Green Submitted, gold			2022-12-26	WOS:000353889600002
J	Barbar, F; Werenkraut, V; Morales, JM; Lambertucci, SA				Barbar, Facundo; Werenkraut, Victoria; Manuel Morales, Juan; Agustin Lambertucci, Sergio			Emerging Ecosystems Change the Spatial Distribution of Top Carnivores Even in Poorly Populated Areas	PLOS ONE			English	Article							BIOTIC HOMOGENIZATION; ENVIRONMENTAL-CHANGE; BIRD COMMUNITIES; HABITAT USE; CONSERVATION; BIODIVERSITY; RAPTORS; URBANIZATION; ABUNDANCE; MANAGEMENT	Humans affect biological diversity and species distribution patterns by modifying resource availability and generating novel environments where generalist species benefit and specialist species are rare. In particular, cities create local homogenization while roads fragment habitat, although both processes can increase food availability for some species that may be able to take advantage of this new source. We studied space use by birds of prey in relation to human construction, hypothesizing that these birds would be affected even in poorly populated areas. We worked in Northwestern Patagonia, Argentina, which is experiencing a high population growth, but still having very large unpopulated areas. We related the presence of raptors with different sources of human disturbance and found that both the abundance and richness of these birds were positively associated with anthropogenic environments. These results are driven mostly by a strong association between the medium-sized generalist species and these novel environments (mainly roads and cities). This may create an imbalance in intra-guild competitive abilities, modifying the normal structures of top carnivore hierarchies. Indeed, the structure of raptor communities seems to be changing, even in poorly populated areas, with anthropogenic constructions seemingly producing changes in wild areas more promptly than thought, a cause for concern in ecosystems conservation issues.	[Barbar, Facundo; Werenkraut, Victoria; Manuel Morales, Juan; Agustin Lambertucci, Sergio] Univ Nacl Comahue, CONICET, INIBIOMA, Lab Ecotono, San Carlos De Bariloche, Rio Negro, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad Nacional del Comahue	Barbar, F (corresponding author), Univ Nacl Comahue, CONICET, INIBIOMA, Lab Ecotono, San Carlos De Bariloche, Rio Negro, Argentina.	facundo.barbar@gmail.com	Morales, Juan/B-6316-2009	Morales, Juan/0000-0001-7269-7490; LAMBERTUCCI, SERGIO/0000-0002-2624-2185; Werenkraut, Victoria/0000-0003-2417-3953	CONICET [PIP 0095]; ANPCYT-FONCYT Argentina [PICT1156/2010]	CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); ANPCYT-FONCYT Argentina(ANPCyTFONCyT)	This study was supported by funding from CONICET-PIP 0095, SAL, and PICT1156/2010 ANPCYT-FONCYT Argentina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbosa AM, 2010, ANIM CONSERV, V13, P446, DOI 10.1111/j.1469-1795.2010.00402.x; Bellati Javier, 2000, Ornitologia Neotropical, V11, P207; Bellocq MI, 2008, ANN ZOOL FENN, V45, P128, DOI 10.5735/086.045.0204; Branton M, 2011, CONSERV BIOL, V25, P9, DOI 10.1111/j.1523-1739.2010.01606.x; Burton AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038007; Cabrera A.L, 1976, REGIONES FITOGEOGR F; Caro TM, 1999, CONSERV BIOL, V13, P805, DOI 10.1046/j.1523-1739.1999.98338.x; Carrete M, 2010, ANIM CONSERV, V13, P390, DOI 10.1111/j.1469-1795.2010.00352.x; Carrete M, 2009, BIOL CONSERV, V142, P2002, DOI 10.1016/j.biocon.2009.02.012; Censos IN de E y, 2008, EST POBL TOT DEP AN; Chace JF, 2006, LANDSCAPE URBAN PLAN, V74, P46, DOI 10.1016/j.landurbplan.2004.08.007; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Clavel J, 2011, FRONT ECOL ENVIRON, V9, P222, DOI 10.1890/080216; Devictor V, 2008, GLOBAL ECOL BIOGEOGR, V17, P252, DOI 10.1111/j.1466-8238.2007.00364.x; Didham RK, 2005, TRENDS ECOL EVOL, V20, P470, DOI 10.1016/j.tree.2005.07.006; DONAZAR JA, 1993, J RAPTOR RES, V27, P106; Ferguson-Lees J, 2001, RAPTORS WORLD; FISKE I, 2010, UNMARKED MODELS DATA; Forman RTT, 1998, ANN REV ECOL SYST; Fuller M.R., 1981, Studies in Avian Biology, P235; Gaston KJ, 2005, PROG PHYS GEOG, V29, P239, DOI 10.1191/0309133305pp445pr; Gelman A., 2003, BAYESIAN DATA ANAL; Grimm NB, 2008, SCIENCE, V319, P756, DOI 10.1126/science.1150195; Hobbs RJ, 2006, GLOBAL ECOL BIOGEOGR, V15, P1, DOI 10.1111/j.1466-822x.2006.00212.x; Julliard R, 2004, P ROY SOC B-BIOL SCI, V271, pS490, DOI 10.1098/rsbl.2004.0229; Julliard R, 2006, ECOL LETT, V9, P1237, DOI 10.1111/j.1461-0248.2006.00977.x; Kennedy C, 2007, J IND ECOL, V11, P43, DOI 10.1162/jie.2007.1107; Lambertucci SA, 2014, BIOL CONSERV, V170, P145, DOI 10.1016/j.biocon.2013.12.041; Lambertucci Sergio A., 2007, Hornero, V22, P149; Lambertucci SA, 2009, BIODIVERS CONSERV, V18, P2063, DOI 10.1007/s10531-008-9573-3; Lepczyk CA, 2008, CONSERV BIOL, V22, P405, DOI 10.1111/j.1523-1739.2008.00881.x; Luck GW, 2007, BIOL REV, V82, P607, DOI 10.1111/j.1469-185X.2007.00028.x; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; MacKenzie D. I., 2017, OCCUPANCY ESTIMATION; McCullagh P, 1989, GEN LINEAR MODELS; MCDONNELL MJ, 1993, HUMANS AS COMPONENTS OF ECOSYSTEMS, P175; McGranahan G, 2003, ANNU REV ENV RESOUR, V28, P243, DOI 10.1146/annurev.energy.28.050302.105541; McKinney ML, 2006, BIOL CONSERV, V127, P247, DOI 10.1016/j.biocon.2005.09.005; McKinney ML, 2002, BIOSCIENCE, V52, P883, DOI 10.1641/0006-3568(2002)052[0883:UBAC]2.0.CO;2; Meunier FD, 1999, CAN J ZOOL, V77, P108, DOI 10.1139/cjz-77-1-108; Meunier FD, 2000, BIOL CONSERV, V92, P291, DOI 10.1016/S0006-3207(99)00094-4; Olden JD, 2004, TRENDS ECOL EVOL, V19, P18, DOI 10.1016/j.tree.2003.09.010; Olden JD, 2006, J BIOGEOGR, V33, P2027, DOI 10.1111/j.1365-2699.2006.01572.x; Oro D, 2013, ECOL LETT, V16, P1501, DOI 10.1111/ele.12187; Paruelo Jose M., 1998, Ecologia Austral, V8, P85; Pauchard A, 2006, BIOL CONSERV, V127, P272, DOI 10.1016/j.biocon.2005.05.015; Pautasso M, 2011, GLOBAL ECOL BIOGEOGR, V20, P426, DOI 10.1111/j.1466-8238.2010.00616.x; Preisser EL, 2005, ECOLOGY, V86, P501, DOI 10.1890/04-0719; R Development Core Team, 2012, R LANG ENV STAT COMP; Rodriguez-Estrella R, 1998, CONSERV BIOL, V12, P921, DOI 10.1046/j.1523-1739.1998.97044.x; Rooney TP, 2004, CONSERV BIOL, V18, P787, DOI 10.1111/j.1523-1739.2004.00515.x; Royle J. A., 2004, Animal Biodiversity and Conservation, V27, P375; Royle J. A., 2008, HIERARCHICAL MODELIN; Royle JA, 2004, BIOMETRICS, V60, P108, DOI 10.1111/j.0006-341X.2004.00142.x; Royle JA, 2005, OIKOS, V110, P353, DOI 10.1111/j.0030-1299.2005.13534.x; Sax DF, 2003, TRENDS ECOL EVOL, V18, P561, DOI 10.1016/S0169-5347(03)00224-6; Schielzeth H, 2010, METHODS ECOL EVOL, V1, P103, DOI 10.1111/j.2041-210X.2010.00012.x; Seastedt TR, 2008, FRONT ECOL ENVIRON, V6, P547, DOI 10.1890/070046; Seiler A, 2001, INTRODUTORY RES ESSA, V9, P1; Selva N, 2007, P ROY SOC B-BIOL SCI, V274, P1101, DOI 10.1098/rspb.2006.0232; Sergio F, 2006, J APPL ECOL, V43, P1049, DOI 10.1111/j.1365-2664.2006.01218.x; Sergio F, 2008, ANNU REV ECOL EVOL S, V39, P1, DOI 10.1146/annurev.ecolsys.39.110707.173545; Shochat E, 2006, TRENDS ECOL EVOL, V21, P186, DOI 10.1016/j.tree.2005.11.019; Speziale KL, 2008, BIOL CONSERV, V141, P1765, DOI 10.1016/j.biocon.2008.04.017; Speziale KL, 2013, J RAPTOR RES, V47, P133, DOI 10.3356/JRR-12-00003.1; Sturtz S, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i03; Tryjanowski P, 2013, CONSERV LETT; Tuomainen U, 2011, BIOL REV, V86, P640, DOI 10.1111/j.1469-185X.2010.00164.x; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Wilson EE, 2011, TRENDS ECOL EVOL, V26, P129, DOI 10.1016/j.tree.2010.12.011; Zipkin EF, 2009, J APPL ECOL, V46, P815, DOI 10.1111/j.1365-2664.2009.01664.x	71	15	16	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0118851	10.1371/journal.pone.0118851	http://dx.doi.org/10.1371/journal.pone.0118851			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799547	Green Submitted, Green Published, gold			2022-12-26	WOS:000351987300021
J	Gnyawali, SC; Barki, KG; Mathew-Steiner, SS; Dixith, S; Vanzant, D; Kim, J; Dickerson, JL; Datta, S; Powell, H; Roy, S; Bergdall, V; Sen, CK				Gnyawali, Surya C.; Barki, Kasturi G.; Mathew-Steiner, Shomita S.; Dixith, Sriteja; Vanzant, Daniel; Kim, Jayne; Dickerson, Jennifer L.; Datta, Soma; Powell, Heather; Roy, Sashwati; Bergdall, Valerie; Sen, Chandan K.			High-Resolution Harmonics Ultrasound Imaging for Non-Invasive Characterization of Wound Healing in a Pre-Clinical Swine Model	PLOS ONE			English	Article							SHEAR-WAVE ELASTOGRAPHY; VON-WILLEBRAND-FACTOR; DOPPLER-ECHOCARDIOGRAPHY; SKIN WOUNDS; ANGIOGENESIS; BREAST; GROWTH; MECHANISMS; EXPRESSION; PERFUSION	This work represents the first study employing non-invasive high-resolution harmonic ultrasound imaging to longitudinally characterize skin wound healing. Burn wounds (day 0-42), on the dorsum of a domestic Yorkshire white pig were studied non-invasively using tandem digital planimetry, laser speckle imaging and dual mode (B and Doppler) ultrasound imaging. Wound depth, as measured by B-mode imaging, progressively increased until day 21 and decreased thereafter. Initially, blood flow at the wound edge increased up to day 14 and subsequently regressed to baseline levels by day 21, when the wound was more than 90% closed. Coinciding with regression of blood flow at the wound edge, there was an increase in blood flow in the wound bed. This was observed to regress by day 42. Such changes in wound angiogenesis were corroborated histologically. Gated Doppler imaging quantitated the pulse pressure of the primary feeder artery supplying the wound site. This pulse pressure markedly increased with a bimodal pattern following wounding connecting it to the induction of wound angiogenesis. Finally, ultrasound elastography measured tissue stiffness and visualized growth of new tissue over time. These studies have elegantly captured the physiological sequence of events during the process of wound healing, much of which is anticipated based on certain dynamics in play, to provide the framework for future studies on molecular mechanisms driving these processes. We conclude that the tandem use of non-invasive imaging technologies has the power to provide unprecedented insight into the dynamics of the healing skin tissue.	[Gnyawali, Surya C.; Barki, Kasturi G.; Mathew-Steiner, Shomita S.; Dixith, Sriteja; Vanzant, Daniel; Dickerson, Jennifer L.; Datta, Soma; Roy, Sashwati; Sen, Chandan K.] Ohio State Univ, Davis Heart & Lung Res Inst, Comprehens Wound Ctr, Ctr Regenerat Med, Columbus, OH 43210 USA; [Gnyawali, Surya C.; Barki, Kasturi G.; Mathew-Steiner, Shomita S.; Dixith, Sriteja; Vanzant, Daniel; Dickerson, Jennifer L.; Datta, Soma; Roy, Sashwati; Sen, Chandan K.] Ohio State Univ, Davis Heart & Lung Res Inst, Comprehens Wound Ctr, Ctr Cell Based Therapies, Columbus, OH 43210 USA; [Bergdall, Valerie] Ohio State Univ, Vet Prevent Med, Columbus, OH 43210 USA; [Kim, Jayne; Powell, Heather] Ohio State Univ, Dept Biomed Engn, Columbus, OH 43210 USA; [Powell, Heather] Ohio State Univ, Dept Mat Sci & Engn, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Sen, CK (corresponding author), Ohio State Univ, Davis Heart & Lung Res Inst, Comprehens Wound Ctr, Ctr Regenerat Med, Columbus, OH 43210 USA.	chandan.sen@osumc.edu	Gnyawali, Surya/AAC-3082-2020; MATHEW-STEINER, SHOMITA S/AAE-8041-2022; Gnyawali, Surya/HGB-8982-2022; Roy, sashwati/E-3990-2011; Gnyawali, Surya/AAC-3082-2020	Gnyawali, Surya/0000-0001-8980-4889; Gnyawali, Surya/0000-0002-4214-8068; Mathew-Steiner, Shomita/0000-0002-7730-9140; Powell, Heather/0000-0002-6845-8101	National Institutes of Health (NIH) National Institute of Nursing Research [NR013898]; National Institutes of Health (NIH) National Institute of General Medical Sciences [GM077185, GM069589, GM108014]; U.S. Department of Defense (DoD) [DoD W81XWH-11-2-0142]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069589, R01GM108014, R01GM077185] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR013898, R01NR015676] Funding Source: NIH RePORTER	National Institutes of Health (NIH) National Institute of Nursing Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); National Institutes of Health (NIH) National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); U.S. Department of Defense (DoD)(United States Department of Defense); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	Grants from the National Institutes of Health (NIH - www.nih.gov) include the following: National Institute of Nursing Research NR013898 (CS); National Institute of General Medical Sciences GM077185 (CS), GM069589 (CS), GM108014 (CS); Grant from U.S. Department of Defense (DoD www.defense.gov): DoD W81XWH-11-2-0142 (CS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; Badeer H S, 1985, Physiologist, V28, P41; BATTEGAY EJ, 1995, J MOL MED, V73, P333; Berg WA, 2012, RADIOLOGY, V262, P435, DOI 10.1148/radiol.11110640; Boerckel JD, 2011, P NATL ACAD SCI USA, V108, pE674, DOI 10.1073/pnas.1107019108; Brigham Peter A., 1996, Journal of Burn Care and Rehabilitation, V17, P95, DOI 10.1097/00004630-199603000-00003; Broughton G, 2006, PLAST RECONSTR SURG, V117, p12S, DOI 10.1097/01.prs.0000225430.42531.c2; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Christoforidis JB, 2013, CLIN OPHTHALMOL, V7, P185, DOI 10.2147/OPTH.S40537; Cosgrove DO, 2012, EUR RADIOL, V22, P1023, DOI 10.1007/s00330-011-2340-y; Coutts L, 2013, SKIN RES TECHNOL, V19, pE37, DOI 10.1111/j.1600-0846.2011.00604.x; DASTOUS FT, 1986, ULTRASOUND MED BIOL, V12, P795, DOI 10.1016/0301-5629(86)90077-3; Davis Kathryn E, 2013, J Diabetes Sci Technol, V7, P1161; Davis SC, 2008, REV SCI INSTRUM, V79, DOI 10.1063/1.2919131; Elgharably H, 2013, WOUND REPAIR REGEN, V21, P473, DOI 10.1111/wrr.12039; Fonseca Jorge, 2012, Arq. Gastroenterol., V49, P82, DOI 10.1590/S0004-28032012000100014; Forrester KR, 2004, IEEE T BIO-MED ENG, V51, P2074, DOI 10.1109/TBME.2004.834259; Gennisson J-L, 2013, Diagn Interv Imaging, V94, P487, DOI 10.1016/j.diii.2013.01.022; Gupta R, 2009, CIRC RES, V105, P724, DOI 10.1161/CIRCRESAHA.109.200386; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Hoefer IE, 2013, CARDIOVASC RES, V99, P276, DOI 10.1093/cvr/cvt089; Hunt T K, 2000, Adv Skin Wound Care, V13, P6; INGBER DE, 1989, CELL, V58, P803, DOI 10.1016/0092-8674(89)90928-8; INGBER DE, 1989, J CELL BIOL, V109, P317, DOI 10.1083/jcb.109.1.317; JAFFE EA, 1974, P NATL ACAD SCI USA, V71, P1906, DOI 10.1073/pnas.71.5.1906; Krouskop TA, 1998, ULTRASONIC IMAGING, V20, P260, DOI 10.1177/016173469802000403; Lau JCM, 2005, BURNS, V31, P445, DOI 10.1016/j.burns.2004.07.016; Lehoux S, 2006, J INTERN MED, V259, P381, DOI 10.1111/j.1365-2796.2006.01624.x; Limbourg A, 2009, NAT PROTOC, V4, P1737, DOI 10.1038/nprot.2009.185; Little C, 2009, J Wound Care, V18, P250; Madri JA, 1997, TRANSPL IMMUNOL, V5, P179, DOI 10.1016/S0966-3274(97)80035-4; Manduca A, 2001, MED IMAGE ANAL, V5, P237, DOI 10.1016/S1361-8415(00)00039-6; MARAGOUDAKIS ME, 1993, KIDNEY INT, V43, P147, DOI 10.1038/ki.1993.24; Martin K., 2010, DIAGNOSTIC ULTRASOUN; Maurice RL, 2005, PHYS MED BIOL, V50, P1611, DOI 10.1088/0031-9155/50/7/020; Monstrey S, 2008, BURNS, V34, P761, DOI 10.1016/j.burns.2008.01.009; Muller AM, 2002, RESPIRATION, V69, P526, DOI 10.1159/000066471; MULVANY MJ, 1990, PHYSIOL REV, V70, P921, DOI 10.1152/physrev.1990.70.4.921; Ommen SR, 2000, CIRCULATION, V102, P1788; Ommen SR, 2000, MAYO CLIN PROC, V75, P24, DOI 10.4065/75.1.24; Peeters W, 2012, SKIN RES TECHNOL, V18, P188, DOI 10.1111/j.1600-0846.2011.00552.x; Pourageaud F, 1997, AM J PHYSIOL-HEART C, V273, pH1699, DOI 10.1152/ajpheart.1997.273.4.H1699; Ramasastry SS, 2005, CLIN PLAST SURG, V32, P195, DOI 10.1016/j.cps.2004.12.001; Rege A, 2012, ANGIOGENESIS, V15, P87, DOI 10.1007/s10456-011-9245-x; RESNICK N, 1995, FASEB J, V9, P874, DOI 10.1096/fasebj.9.10.7615157; Roy S, 2014, J PATHOL, V233, P331, DOI 10.1002/path.4360; Roy S, 2011, WOUND REPAIR REGEN, V19, P753, DOI 10.1111/j.1524-475X.2011.00740.x; Roy S, 2009, PHYSIOL GENOMICS, V37, P211, DOI 10.1152/physiolgenomics.90362.2008; RUBANYI GM, 1990, BLOOD VESSELS, V27, P246; SCHOTT RJ, 1993, CARDIOVASC RES, V27, P1155, DOI 10.1093/cvr/27.7.1155; Sen CK, 2009, WOUND REPAIR REGEN, V17, P763, DOI 10.1111/j.1524-475X.2009.00543.x; Stewart CJ, 2006, SKIN RES TECHNOL, V12, P247, DOI 10.1111/j.0909-752X.2006.00157.x; Stewart DJ, 2009, MOL THER, V17, P1109, DOI 10.1038/mt.2009.70; Swift ME, 1999, LAB INVEST, V79, P1479; Velnar T, 2009, J INT MED RES, V37, P1528, DOI 10.1177/147323000903700531; Witte MB, 1997, SURG CLIN N AM, V77, P509, DOI 10.1016/S0039-6109(05)70566-1; Yamamoto K, 1998, BLOOD, V92, P2791, DOI 10.1182/blood.V92.8.2791.420k24_2791_2801	57	27	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0122327	10.1371/journal.pone.0122327	http://dx.doi.org/10.1371/journal.pone.0122327			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799513	Green Published, Green Submitted, gold			2022-12-26	WOS:000351987300331
J	Gustafson, MP; Lin, Y; Maas, ML; Van Keulen, VP; Johnston, PB; Peikert, T; Gastineau, DA; Dietz, AB				Gustafson, Michael P.; Lin, Yi; Maas, Mary L.; Van Keulen, Virginia P.; Johnston, Patrick B.; Peikert, Tobias; Gastineau, Dennis A.; Dietz, Allan B.			A Method for Identification and Analysis of Non-Overlapping Myeloid Immunophenotypes in Humans	PLOS ONE			English	Article							SUPPRESSOR-CELLS; HUMAN BASOPHILS; CD14(+)HLA-DRLO/NEG MONOCYTES; GRANULOCYTES; NEUTROPHILS; CANCER; BLOOD; EXPRESSION	The development of flow cytometric biomarkers in human studies and clinical trials has been slowed by inconsistent sample processing, use of cell surface markers, and reporting of immunophenotypes. Additionally, the function(s) of distinct cell types as biomarkers cannot be accurately defined without the proper identification of homogeneous populations. As such, we developed a method for the identification and analysis of human leukocyte populations by the use of eight 10-color flow cytometric protocols in combination with novel software analyses. This method utilizes un-manipulated biological sample preparation that allows for the direct quantitation of leukocytes and non-overlapping immunophenotypes. We specifically designed myeloid protocols that enable us to define distinct phenotypes that include mature monocytes, granulocytes, circulating dendritic cells, immature myeloid cells, and myeloid derived suppressor cells (MDSCs). We also identified CD123 as an additional distinguishing marker for the phenotypic characterization of immature LIN-CD33(+)HLA-DR-MDSCs. Our approach permits the comprehensive analysis of all peripheral blood leukocytes and yields data that is highly amenable for standardization across inter-laboratory comparisons for human studies.	[Gustafson, Michael P.; Maas, Mary L.; Gastineau, Dennis A.; Dietz, Allan B.] Mayo Clin, Dept Lab Med & Pathol, Div Transfus Med, Human Cellular Therapy Lab, Rochester, MN 55905 USA; [Lin, Yi; Johnston, Patrick B.; Gastineau, Dennis A.] Mayo Clin, Div Hematol, Dept Med, Rochester, MN USA; [Van Keulen, Virginia P.] Mayo Clin, Dept Immunol, Rochester, MN USA; [Peikert, Tobias] Mayo Clin, Pulm & Crit Care Med, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Dietz, AB (corresponding author), Mayo Clin, Dept Lab Med & Pathol, Div Transfus Med, Human Cellular Therapy Lab, Rochester, MN 55905 USA.	dietz.allan@mayo.edu	Gustafson, Michael P./H-4056-2011; Dietz, Allan B/H-7414-2015; Lin, Yi/K-1510-2013; Dietz, Allan/AAI-6976-2021	Gustafson, Michael P./0000-0002-5514-7072; Dietz, Allan B/0000-0003-3410-9621; Dietz, Allan/0000-0003-3410-9621; Lin, Yi/0000-0002-1556-6416	Henry J. Predolin Foundation; University of Iowa/Mayo Clinic Lymphoma Specialized Program of Research Excellence (SPORE) [CA090628]; Mayo Clinic Cancer Center; Mayo Clinic Center for Individualized Medicine; Mayo Clinic Center for Regenerative Medicine; NATIONAL CANCER INSTITUTE [K12CA090628, K23CA159391] Funding Source: NIH RePORTER	Henry J. Predolin Foundation; University of Iowa/Mayo Clinic Lymphoma Specialized Program of Research Excellence (SPORE); Mayo Clinic Cancer Center; Mayo Clinic Center for Individualized Medicine; Mayo Clinic Center for Regenerative Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported by the Henry J. Predolin Foundation, University of Iowa/Mayo Clinic Lymphoma Specialized Program of Research Excellence (SPORE, number CA090628), Mayo Clinic Cancer Center, the Mayo Clinic Center for Individualized Medicine and the Mayo Clinic Center for Regenerative Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almand B, 2001, J IMMUNOL, V166, P678, DOI 10.4049/jimmunol.166.1.678; Brandau S, 2013, SEMIN CANCER BIOL, V23, P171, DOI 10.1016/j.semcancer.2013.02.007; Brandau S, 2013, SEMIN IMMUNOPATHOL, V35, P163, DOI 10.1007/s00281-012-0344-6; Buhring HJ, 1999, BLOOD, V94, P2343; Chavan R, 2014, CANCER IMMUNOL RES, V2, P241, DOI 10.1158/2326-6066.CIR-13-0094; De Palma M, 2013, CANCER CELL, V23, P277, DOI 10.1016/j.ccr.2013.02.013; Duffy A, 2013, CANCER IMMUNOL IMMUN, V62, P299, DOI 10.1007/s00262-012-1332-3; Dumitru CA, 2012, CANCER IMMUNOL IMMUN, V61, P1155, DOI 10.1007/s00262-012-1294-5; Gabrilovich DI, 2007, CANCER RES, V67, P425, DOI 10.1158/0008-5472.CAN-06-3037; Gabrilovich DI, 2012, NAT REV IMMUNOL, V12, P253, DOI 10.1038/nri3175; Gustafson MP, 2013, J IMMUNOTHER CANCER, V1, DOI 10.1186/2051-1426-1-7; Gustafson' MP, 2014, J IMMUNOTHER CANCER, V2, DOI 10.1186/2051-1426-2-18; Gustafson MP, 2012, BRIT J HAEMATOL, V156, P674, DOI 10.1111/j.1365-2141.2011.08902.x; Gustafson MP, 2010, NEURO-ONCOLOGY, V12, P631, DOI 10.1093/neuonc/noq001; Laborde RR, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00147; Lee JA, 2008, CYTOM PART A, V73A, P926, DOI 10.1002/cyto.a.20623; Lin Y, 2011, BLOOD, V117, P872, DOI 10.1182/blood-2010-05-283820; MacDonald KPA, 2002, BLOOD, V100, P4512, DOI 10.1182/blood-2001-11-0097; Meknache N, 2009, J IMMUNOL, V182, P2542, DOI 10.4049/jimmunol.0801665; Munder M, 2005, BLOOD, V105, P2549, DOI 10.1182/blood-2004-07-2521; Nakayama F, 2001, J BIOL CHEM, V276, P16100, DOI 10.1074/jbc.M007272200; Poschke I, 2012, CLIN IMMUNOL, V144, P250, DOI 10.1016/j.clim.2012.06.003; Robbins SH, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r17; Talmadge JE, 2013, NAT REV CANCER, V13, P739, DOI 10.1038/nrc3581; Toba K, 1999, CYTOMETRY, V35, P249, DOI 10.1002/(SICI)1097-0320(19990301)35:3<249::AID-CYTO8>3.3.CO;2-F; Vantourout P, 2013, NAT REV IMMUNOL, V13, P88, DOI 10.1038/nri3384; Vuk-Pavlovic S, 2010, PROSTATE, V70, P443, DOI 10.1002/pros.21078; Wagner C, 2003, SHOCK, V19, P5, DOI 10.1097/00024382-200301000-00002; Ziegler-Heitbrock L, 2010, BLOOD, V116, pE74, DOI 10.1182/blood-2010-02-258558	29	76	77	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121546	10.1371/journal.pone.0121546	http://dx.doi.org/10.1371/journal.pone.0121546			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799053	Green Published, Green Submitted, gold			2022-12-26	WOS:000351987300266
J	Leibold, S; Hammerschmidt, M				Leibold, Sandra; Hammerschmidt, Matthias			Long-Term Hyperphagia and Caloric Restriction Caused by Low- or High-Density Husbandry Have Differential Effects on Zebrafish Postembryonic Development, Somatic Growth, Fat Accumulation and Reproduction	PLOS ONE			English	Article							MELANOCYTE-STIMULATING HORMONE; DIET-INDUCED OBESITY; CORTICOTROPIN-RELEASING HORMONE; NON-SHIVERING THERMOGENESIS; FASTING-INDUCED SUPPRESSION; BETA-ENDORPHIN-LIKE; ENERGY DENSITY; NEUROPEPTIDE-Y; ADIPOSE-TISSUE; ANIMAL-MODELS	In recent years, the zebrafish (Danio rerio) has emerged as an alternative vertebrate model for energy homeostasis and metabolic diseases, including obesity and anorexia. It has been shown that diet-induced obesity (DIO) in zebrafish shares multiple pathophysiological features with obesity in mammals. However, a systematic and comprehensive analysis of the different pathways of energy expenditure in obese and starved fish had been missing thus far. Here, we carry out long-term ad libitum feeding (hyperphagia) and caloric restriction studies induced by low-or high-density husbandry, respectively, to investigate the impact of caloric intake on the timing of scale formation, a crucial step of postembryonic development and metamorphosis, and on somatic growth, body weight, fat storage and female reproduction. We show that all of them are positively affected by increased caloric intake, that middle-aged fish develop severe DIO, and that the body mass index (BMI) displays a strict linear correlation with whole-body triglyceride levels in adult zebrafish. Interestingly, juvenile fish are largely resistant to DIO, while BMI and triglyceride values drop in aged fish, pointing to aging-associated anorexic effects. Histological analyses further indicate that increased fat storage in white adipose tissue involves both hyperplasia and hypertrophy of adipocytes. Furthermore, in ovaries, caloric intake primarily affects the rate of oocyte growth, rather than total oocyte numbers. Finally, comparing the different pathways of energy expenditure with each other, we demonstrate that they are differentially affected by caloric restriction / high-density husbandry. In juvenile fish, scale formation is prioritized over somatic growth, while in sexually mature adults, female reproduction is prioritized over somatic growth, and somatic growth over fat storage. Our data will serve as a template for future functional studies to dissect the neuroendocrine regulators of energy homeostasis mediating differential energy allocation.	[Leibold, Sandra; Hammerschmidt, Matthias] Univ Cologne, Inst Dev Biol, D-50931 Cologne, Germany; [Leibold, Sandra; Hammerschmidt, Matthias] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50931 Cologne, Germany; [Hammerschmidt, Matthias] Univ Cologne, CMMC, D-50931 Cologne, Germany	University of Cologne; University of Cologne; University of Cologne	Hammerschmidt, M (corresponding author), Univ Cologne, Inst Dev Biol, D-50931 Cologne, Germany.	mhammers@uni-koeln.de			German Research Foundation (DFG; CECAD); European Union (Seventh Framework Programme, Integrated Project ZF-HEALTH, EC Grant) [HEATH-F4-2010-242048]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063904] Funding Source: NIH RePORTER	German Research Foundation (DFG; CECAD)(German Research Foundation (DFG)); European Union (Seventh Framework Programme, Integrated Project ZF-HEALTH, EC Grant); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Work was supported by the German Research Foundation (DFG; CECAD) and the European Union (Seventh Framework Programme, Integrated Project ZF-HEALTH, EC Grant agreement HEATH-F4-2010-242048). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS EF, 1987, ACTA ENDOCRINOL-COP, V115, P149, DOI 10.1530/acta.0.1150149; Ali S, 2014, GERONTOLOGY, V60, P294, DOI 10.1159/000356760; Almind K, 2004, DIABETES, V53, P3274, DOI 10.2337/diabetes.53.12.3274; ANGEL A, 1974, J LIPID RES, V15, P491; Arble DM, 2009, OBESITY, V17, P2100, DOI 10.1038/oby.2009.264; Balen Adam H, 2007, Hum Fertil (Camb), V10, P195, DOI 10.1080/14647270701731290; Belgardt BF, 2010, P NATL ACAD SCI USA, V107, P6028, DOI 10.1073/pnas.1001796107; Bessesen DH, 2008, J CLIN ENDOCR METAB, V93, P2027, DOI 10.1210/jc.2008-0520; Biga PR, 2006, AM J PHYSIOL-REG I, V291, pR1327, DOI 10.1152/ajpregu.00905.2005; BOISSONNEAULT GA, 1978, P SOC EXP BIOL MED, V157, P402, DOI 10.3181/00379727-157-40063; Brand M., 2002, ZEBRAFISH PRACTICAL; Bray GA, 1998, AM J CLIN NUTR, V68, P1157, DOI 10.1093/ajcn/68.6.1157; Bray George A., 1997, Human Reproduction (Oxford), V12, P26; BRAZEAU P, 1973, SCIENCE, V179, P77, DOI 10.1126/science.179.4068.77; Broberger C, 1998, P NATL ACAD SCI USA, V95, P15043, DOI 10.1073/pnas.95.25.15043; BRONSON FH, 1984, BIOL REPROD, V31, P83, DOI 10.1095/biolreprod31.1.83; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Carroll KK, 1998, LIPIDS, V33, P1055, DOI 10.1007/s11745-998-0305-8; Casper RC, 2008, PSYCHOPHARMACOLOGY, V199, P313, DOI 10.1007/s00213-008-1102-2; Chapman IM, 2007, CLIN GERIATR MED, V23, P735, DOI 10.1016/j.cger.2007.06.001; Chu CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036474; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Collins S, 2004, PHYSIOL BEHAV, V81, P243, DOI 10.1016/j.physbeh.2004.02.006; Cone RD, 2005, NAT NEUROSCI, V8, P571, DOI 10.1038/nn1455; Danielsen ET, 2013, CURR TOP DEV BIOL, V105, P37, DOI 10.1016/B978-0-12-396968-2.00002-6; DeLaurier A, 2010, GENESIS, V48, P505, DOI 10.1002/dvg.20639; Desai M, 2013, CURR DIABETES REP, V13, P27, DOI 10.1007/s11892-012-0344-x; Deshpande P.A., 2013, INT J CURR RES, V5, P1565; DESPRES JP, 1989, CLIN INVEST MED, V12, P374; Farooqi IS, 2003, NEW ENGL J MED, V348, P1085, DOI 10.1056/NEJMoa022050; FEINGOLD KR, 1984, DIABETOLOGIA, V26, P234; Fekete C, 2000, NEUROSCI LETT, V289, P152, DOI 10.1016/S0304-3940(00)01256-8; Fekete C, 2002, ENDOCRINOLOGY, V143, P3846, DOI 10.1210/en.2002-220338; Fekete C, 2000, J NEUROSCI, V20, P1550; FENTON PF, 1953, J NUTR, V49, P319, DOI 10.1093/jn/49.2.319; Fernald RD, 1999, FRONT NEUROENDOCRIN, V20, P224, DOI 10.1006/frne.1999.0181; Filby AL, 2010, PHYSIOL BEHAV, V101, P576, DOI 10.1016/j.physbeh.2010.09.004; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Flynn EJ, 2009, J LIPID RES, V50, P1641, DOI 10.1194/jlr.M800590-JLR200; GANTZ I, 1993, J BIOL CHEM, V268, P15174; GANTZ I, 1993, J BIOL CHEM, V268, P8246; Gardner DS, 2009, PHILOS T R SOC B, V364, P3419, DOI 10.1098/rstb.2009.0121; Girardet C, 2014, BBA-MOL BASIS DIS, V1842, P482, DOI 10.1016/j.bbadis.2013.05.004; Goolish EM, 1998, PROG FISH CULT, V60, P127, DOI 10.1577/1548-8640(1998)060&lt;0127:CVRFRO&gt;2.0.CO;2; Gorissen M, 2009, J ENDOCRINOL, V201, P329, DOI 10.1677/JOE-09-0034; Guh DP, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-88; Han JC, 2010, LANCET, V375, P1737, DOI 10.1016/S0140-6736(10)60171-7; Hariri N, 2010, NUTR RES REV, V23, P270, DOI 10.1017/S0954422410000168; Hasty AH, 2001, J BIOL CHEM, V276, P37402, DOI 10.1074/jbc.M010176200; Hasumura T, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-73; Heinrichs SC, 1999, NEUROPEPTIDES, V33, P350, DOI 10.1054/npep.1999.0047; Heisler LK, 2006, NEURON, V51, P239, DOI 10.1016/j.neuron.2006.06.004; HERBERG L, 1974, J LIPID RES, V15, P580; Hill JO, 2000, J NUTR, V130, p284S, DOI 10.1093/jn/130.2.284S; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; HUMMEL KP, 1966, SCIENCE, V153, P1127, DOI 10.1126/science.153.3740.1127; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; Imrie D, 2010, DEV DYNAM, V239, P3013, DOI 10.1002/dvdy.22443; INGALLS AM, 1950, J HERED, V41, P317, DOI 10.1093/oxfordjournals.jhered.a106073; Irani BG, 2005, BIOCHEM BIOPH RES CO, V326, P638, DOI 10.1016/j.bbrc.2004.11.084; Israel D, 2010, TRENDS ENDOCRIN MET, V21, P10, DOI 10.1016/j.tem.2009.07.004; Israel DD, 2012, ENDOCRINOLOGY, V153, P2408, DOI 10.1210/en.2011-1822; Jensen TK, 2004, FERTIL STERIL, V82, P863, DOI 10.1016/j.fertnstert.2004.03.056; Jo J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000324; Jones KS, 2008, NUTR METAB, V5, DOI 10.1186/1743-7075-5-23; Jungheim ES, 2010, ENDOCRINOLOGY, V151, P4039, DOI 10.1210/en.2010-0098; Kaplowitz PB, 2008, PEDIATRICS, V121, pS208, DOI 10.1542/peds.2007-1813F; Karanth S, 2013, DIS MODEL MECH, V6, P1365, DOI 10.1242/dmm.013425; Kim MS, 2000, J CLIN INVEST, V105, P1005, DOI 10.1172/JCI8857; Kishi S, 2003, EXP GERONTOL, V38, P777, DOI 10.1016/S0531-5565(03)00108-6; Klapper W, 1998, FEBS LETT, V434, P409, DOI 10.1016/S0014-5793(98)01020-5; KRAUSE BR, 1984, J LIPID RES, V25, P97; Lai Shih-Wei, 2001, Yale Journal of Biology and Medicine, V74, P205; Lawrence C, 2012, LAB ANIMAL, V41, P158, DOI 10.1038/laban0612-158; Lessman CA, 2009, GEN COMP ENDOCR, V161, P53, DOI 10.1016/j.ygcen.2008.11.004; Levine JA, 2002, BEST PRACT RES CL EN, V16, P679, DOI 10.1053/beem.2002.0227; LIOTTA AS, 1980, P NATL ACAD SCI-BIOL, V77, P1880, DOI 10.1073/pnas.77.4.1880; LIOTTA AS, 1984, J NEUROSCI, V4, P956; Liu HY, 2003, J NEUROSCI, V23, P7143, DOI 10.1523/JNEUROSCI.23-18-07143.2003; Lohr H, 2011, ANNU REV PHYSIOL, V73, P183, DOI 10.1146/annurev-physiol-012110-142320; Lu XY, 2003, J NEUROSCI, V23, P7863; Lucas J, 2014, J FISH BIOL, V84, P1171, DOI 10.1111/jfb.12306; MABEE TM, 1976, SURGERY, V79, P460; Martinelli CE, 2011, J CLIN ENDOCR METAB, V96, pE181, DOI 10.1210/jc.2010-1369; McMenamin SK, 2013, ENDOCRINOLOGY, V154, P1476, DOI 10.1210/en.2012-1734; McMenamin SK, 2013, CURR TOP DEV BIOL, V103, P127, DOI 10.1016/B978-0-12-385979-2.00005-8; MCMURRAY RG, 1995, INT J OBESITY, V19, P881; MCNAB BK, 1963, AM NAT, V97, P133, DOI 10.1086/282264; Meguro S, 2013, NUTR METAB, V10, DOI 10.1186/1743-7075-10-61; Michalakis K, 2013, METABOLISM, V62, P1341, DOI 10.1016/j.metabol.2013.05.019; MIETTINEN TA, 1971, CIRCULATION, V44, P842, DOI 10.1161/01.CIR.44.5.842; Mukhi S, 2007, GEN COMP ENDOCR, V150, P486, DOI 10.1016/j.ygcen.2006.11.013; NIIMI M, 1989, PEPTIDES, V10, P605, DOI 10.1016/0196-9781(89)90150-2; NISHINA PM, 1994, METABOLISM, V43, P549, DOI 10.1016/0026-0495(94)90194-5; Nishio SI, 2008, DEV DYNAM, V237, P1682, DOI 10.1002/dvdy.21559; Oka Takehiko, 2010, BMC Physiol, V10, P21, DOI 10.1186/1472-6793-10-21; Parichy DM, 2009, DEV DYNAM, V238, P2975, DOI 10.1002/dvdy.22113; Parichy DM, 2003, DEV BIOL, V256, P242, DOI 10.1016/S0012-1606(03)00015-0; Pasquali R, 2003, HUM REPROD UPDATE, V9, P359, DOI 10.1093/humupd/dmg024; Patino R, 2002, FISH PHYSIOL BIOCHEM, V26, P57, DOI 10.1023/A:1023311613987; Pavlidis M, 2013, ZEBRAFISH, V10, P524, DOI 10.1089/zeb.2012.0819; Poppitt SD, 1996, APPETITE, V26, P153, DOI 10.1006/appe.1996.0013; Power D. M., 2008, P607; Raguso CA, 2006, CLIN NUTR, V25, P573, DOI 10.1016/j.clnu.2005.10.013; Ramsay JM, 2006, AQUACULTURE, V258, P565, DOI 10.1016/j.aquaculture.2006.04.020; RIVEST S, 1989, AM J PHYSIOL, V257, pR1417, DOI 10.1152/ajpregu.1989.257.6.R1417; Roa J, 2012, ENDOCRINOLOGY, V153, P5587, DOI 10.1210/en.2012-1470; Rolls BJ, 1999, AM J CLIN NUTR, V69, P863; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Sarkar S, 2002, BRAIN RES, V945, P50, DOI 10.1016/S0006-8993(02)02619-7; Schlegel A, 2007, PLOS GENET, V3, P2037, DOI 10.1371/journal.pgen.0030199; Schrauwen P, 2000, BRIT J NUTR, V84, P417, DOI 10.1017/S0007114500001720; Scully T, 2014, NATURE, V508, pS50, DOI 10.1038/508S50a; Seli E, 2014, MOL ENDOCRINOL, V28, P790, DOI 10.1210/me.2013-1413; SELMAN K, 1993, J MORPHOL, V218, P203, DOI 10.1002/jmor.1052180209; Seth A, 2013, DIS MODEL MECH, V6, P1080, DOI 10.1242/dmm.011346; SHAH M, 1988, EUR J CLIN NUTR, V42, P455; Sharma AM, 2005, ACTA DIABETOL, V42, pS3, DOI 10.1007/s00592-005-0175-1; Sire JY, 2004, INT J DEV BIOL, V48, P233, DOI 10.1387/ijdb.15272389; Sire JY, 1997, J ANAT, V190, P545, DOI 10.1046/j.1469-7580.1997.19040545.x; Smith JV, 2004, CURR OPIN CLIN NUTR, V7, P615, DOI 10.1097/00075197-200411000-00005; Soenen S, 2013, J AM MED DIR ASSOC, V14, P642, DOI 10.1016/j.jamda.2013.02.004; Song Y, 2003, ENDOCRINE, V22, P257, DOI 10.1385/ENDO:22:3:257; Song Y, 2007, FASEB J, V21, P2042, DOI 10.1096/fj.06-7503com; SPADY DK, 1983, J LIPID RES, V24, P303; Speakman J, 2007, OBES REV, V8, P55, DOI 10.1111/j.1467-789X.2007.00319.x; STEINBERG MD, 1962, J PEDIATR-US, V61, P299, DOI 10.1016/S0022-3476(62)80282-0; Stuart JA, 1999, BBA-BIOENERGETICS, V1413, P50, DOI 10.1016/S0005-2728(99)00081-X; Stubbs RJ, 2004, PHYSIOL BEHAV, V81, P755, DOI 10.1016/j.physbeh.2004.04.027; SURWIT RS, 1988, DIABETES, V37, P1163, DOI 10.2337/diabetes.37.9.1163; Tainaka T, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-88; TANNENBAUM GS, 1984, ENDOCRINOLOGY, V115, P1952, DOI 10.1210/endo-115-5-1952; Tao YX, 2010, METHOD ENZYMOL, V484, P267, DOI [10.1016/S0076-6879(10)84014-5, 10.1016/B978-0-12-381298-8.00014-9]; Tchkonia T, 2010, AGING CELL, V9, P667, DOI 10.1111/j.1474-9726.2010.00608.x; TRAYHURN P, 1978, PFLUG ARCH EUR J PHY, V373, P189, DOI 10.1007/BF00584859; TRAYHURN P, 1979, PFLUG ARCH EUR J PHY, V380, P227, DOI 10.1007/BF00582901; Tsai SB, 2007, AGING CELL, V6, P209, DOI 10.1111/j.1474-9726.2007.00278.x; Tseng YC, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0018180, 10.1371/journal.pone.0024057]; TULLIS A, 1991, J EXP BIOL, V161, P383; Turley ML, 1998, EUR J CLIN NUTR, V52, P728, DOI 10.1038/sj.ejcn.1600634; Ussher JR, 2010, DIABETES, V59, P2453, DOI 10.2337/db09-1293; Varga ZM, 2011, METHOD CELL BIOL, V104, P453, DOI 10.1016/B978-0-12-374814-0.00024-0; Vella KR, 2011, CELL METAB, V14, P780, DOI 10.1016/j.cmet.2011.10.009; Vijgen GHEJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017247; Visser M, 2003, J APPL PHYSIOL, V94, P2368, DOI 10.1152/japplphysiol.00124.2002; Warne JP, 2013, TRENDS ENDOCRIN MET, V24, P68, DOI 10.1016/j.tem.2012.10.005; Watanobe H, 1999, BIOCHEM BIOPH RES CO, V257, P860, DOI 10.1006/bbrc.1999.0547; WEST DB, 1992, AM J PHYSIOL, V262, pR1025, DOI 10.1152/ajpregu.1992.262.6.R1025; Wu KK, 2005, ATHEROSCLEROSIS, V181, P251, DOI 10.1016/j.atherosclerosis.2005.01.029; Yang ZY, 2013, MATERN CHILD NUTR, V9, P105, DOI 10.1111/mcn.12010; Yaswen L, 1999, NAT MED, V5, P1066, DOI 10.1038/12506; Yoshizaki G, 2002, FISH PHYSIOL BIOCHEM, V26, P3, DOI 10.1023/A:1023388317621; Zhang C, 2012, CELL METAB, V15, P256, DOI 10.1016/j.cmet.2011.12.014	153	26	27	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120776	10.1371/journal.pone.0120776	http://dx.doi.org/10.1371/journal.pone.0120776			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799180	Green Published, Green Submitted, gold			2022-12-26	WOS:000351987300176
J	Lin, JC; Peng, YJ; Wang, SY; Young, TH; Salter, DM; Lee, HS				Lin, Jung-Chun; Peng, Yi-Jen; Wang, Shih-Yu; Young, Ton-Ho; Salter, Donald M.; Lee, Herng-Sheng			Role of the Sympathetic Nervous System in Carbon Tetrachloride-Induced Hepatotoxicity and Systemic Inflammation	PLOS ONE			English	Article							INDUCED LIVER-INJURY; CHEMICAL SYMPATHECTOMY; LIPID-PEROXIDATION; HEPATIC STEATOSIS; INDUCED APOPTOSIS; IMMUNE-RESPONSES; OXIDATIVE STRESS; GENE-EXPRESSION; KUPFFER CELLS; DENERVATION	Carbon tetrachloride (CCl4) is widely used as an animal model of hepatotoxicity and the mechanisms have been arduously studied, however, the contribution of the sympathetic nervous system (SNS) in CCl4-induced acute hepatotoxicity remains controversial. It is also known that either CCl4 or SNS can affect systemic inflammatory responses. The aim of this study was to establish the effect of chemical sympathectomy with 6-hydroxydopamine (6-OHDA) in a mouse model of CCl4-induced acute hepatotoxicity and systemic inflammatory response. Mice exposed to CCl4 or vehicle were pretreated with 6-OHDA or saline. The serum levels of aminotransferases and alkaline phosphatase in the CCl4-poisoning mice with sympathetic denervation were significantly lower than those without sympathetic denervation. With sympathetic denervation, hepatocellular necrosis and fat infiltration induced by CCl4 were greatly decreased. Sympathetic denervation significantly attenuated CCl4-induced lipid peroxidation in liver and serum. Acute CCl4 intoxication showed increased expression of inflammatory cytokines/chemokines [eotaxin-2/CCL24, Fas ligand, interleukin (IL)-1 alpha, IL-6, IL-12p40p70, monocyte chemoattractant protein-1 (MCP-1/CCL2), and tumor necrosis factor-alpha (TNF-alpha)], as well as decreased expression of granulocyte colony-stimulating factor and keratinocyte-derived chemokine. The overexpressed levels of IL-1 alpha, IL-6, IL-12p40p70, MCP-1/CCL2, and TNF-alpha were attenuated by sympathetic denervation. Pretreatment with dexamethasone significantly reduced CCl4-induced hepatic injury. Collectively, this study demonstrates that the SNS plays an important role in CCl4-induced acute hepatotoxicity and systemic inflammation and the effect may be connected with chemicalor drug-induced hepatotoxicity and circulating immune response.	[Lin, Jung-Chun; Peng, Yi-Jen; Lee, Herng-Sheng] Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan; [Lin, Jung-Chun] Triserv Gen Hosp, Natl Def Med Ctr, Dept Internal Med, Div Gastroenterol & Hepatol, Taipei, Taiwan; [Peng, Yi-Jen; Wang, Shih-Yu; Lee, Herng-Sheng] Triserv Gen Hosp, Natl Def Med Ctr, Dept Pathol, Taipei, Taiwan; [Wang, Shih-Yu; Lee, Herng-Sheng] Kaohsiung Vet Gen Hosp, Dept Pathol & Lab Med, Kaohsiung, Taiwan; [Young, Ton-Ho] Fu Jen Catholic Univ, Cardinal Tien Hosp, Dept Internal Med, Div Gastroenterol, Taipei 231, Taiwan; [Salter, Donald M.] Univ Edinburgh, MRC IGMM, Ctr Mol Med, Edinburgh, Midlothian, Scotland	National Defense Medical Center; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital; Kaohsiung Veterans General Hospital; Fu Jen Catholic University; University of Edinburgh	Lee, HS (corresponding author), Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan.	herngsheng131419@gmail.com	Peng, Yi-Jen/X-9124-2019	Peng, Yi-Jen/0000-0003-4630-2103	National Science Council, Taiwan [NSC100-2320-B-016-006-MY3]; Department of Medical Research of Cardinal Tien Hospital, Taiwan [CTH-103-1-2C04]; National Defense Medical Center, Tri-Service General Hospital, Taiwan [TSGH-C102-069, TSGH-C103-078, TSGH-C103-080, TSGH-C104-175]; Ministry of National Defense Medical Affairs Bureau [MAB-103-066, MAB-104-089]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Department of Medical Research of Cardinal Tien Hospital, Taiwan; National Defense Medical Center, Tri-Service General Hospital, Taiwan; Ministry of National Defense Medical Affairs Bureau	This study was supported in part by grants from the National Science Council, Taiwan (NSC100-2320-B-016-006-MY3); Department of Medical Research of Cardinal Tien Hospital, Taiwan (CTH-103-1-2C04); National Defense Medical Center, Tri-Service General Hospital, Taiwan (TSGH-C102-069, TSGH-C103-078, TSGH-C103-080, and TSGH-C104-175); and Ministry of National Defense Medical Affairs Bureau (MAB-103-066 and MAB-104-089). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aninat C, 2008, CRIT CARE MED, V36, P848, DOI 10.1097/CCM.0B013E31816532BE; ARMBRUST T, 1995, BIOCHEM BIOPH RES CO, V207, P637, DOI 10.1006/bbrc.1995.1235; Boll M, 2001, Z NATURFORSCH C, V56, P111; Cailotto C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005650; Callahan TA, 2002, BRAIN BEHAV IMMUN, V16, P764, DOI 10.1016/S0889-1591(02)00029-6; CALVERT DN, 1960, AM J PHYSIOL, V198, P669, DOI 10.1152/ajplegacy.1960.198.3.669; Chan CC, 2014, J GASTROEN HEPATOL, V29, P603, DOI 10.1111/jgh.12366; Chida Y, 2005, GUT, V54, P994, DOI 10.1136/gut.2004.058818; Dubuisson L, 2002, HEPATOLOGY, V35, P325, DOI 10.1053/jhep.2002.31166; Duval C, 2010, DIABETES, V59, P3181, DOI 10.2337/db10-0224; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gewiese-Rabsch J, 2010, BBA-MOL BASIS DIS, V1802, P1054, DOI 10.1016/j.bbadis.2010.07.023; Grebe KM, 2010, J IMMUNOL, V184, P540, DOI 10.4049/jimmunol.0903395; Grebe KM, 2009, P NATL ACAD SCI USA, V106, P5300, DOI 10.1073/pnas.0808851106; HAGLUND O, 1991, J NUTR, V121, P165, DOI 10.1093/jn/121.2.165; Hamasaki K, 2001, J GASTROENTEROL, V36, P111, DOI 10.1007/s005350170139; Hasko G, 1998, BIOCHEM PHARMACOL, V56, P1079, DOI 10.1016/S0006-2952(98)00153-1; Hiramoto T, 2008, GASTROENTEROLOGY, V134, P2122, DOI 10.1053/j.gastro.2008.03.005; HOLMIN T, 1984, EUR SURG RES, V16, P288, DOI 10.1159/000128421; ISHII K, 1992, J AUTONOM NERV SYST, V39, P13, DOI 10.1016/0165-1838(92)90246-D; Jaruga B, 2003, J IMMUNOL, V171, P3233, DOI 10.4049/jimmunol.171.6.3233; Jensen KJ, 2013, COMPR PHYSIOL, V3, P655, DOI 10.1002/cphy.c120018; Joers V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104850; JUDAH JD, 1959, FED PROC, V18, P1013; Kaiser JP, 2012, INT J TOXICOL, V31, P551, DOI 10.1177/1091581812466418; Kamari Y, 2011, J HEPATOL, V55, P1086, DOI 10.1016/j.jhep.2011.01.048; KAMINSKI NE, 1989, FUND APPL TOXICOL, V12, P117, DOI 10.1016/0272-0590(89)90067-5; Knockaert L, 2012, LAB INVEST, V92, P396, DOI 10.1038/labinvest.2011.193; Kremer M, 2010, HEPATOLOGY, V51, P130, DOI 10.1002/hep.23292; KRUSZEWSKA B, 1995, J IMMUNOL, V155, P4613; Kulcsar-Gergely J, 1973, Toxicology, V1, P125, DOI 10.1016/0300-483X(73)90024-3; LARSON RE, 1964, P SOC EXP BIOL MED, V116, P557; Leifeld L, 2002, HEPATOLOGY, V36, P1001, DOI 10.1053/jhep.2002.35532; Lentsch AB, 1999, HEPATOLOGY, V30, P1448, DOI 10.1002/hep.510300615; Leo NA, 1998, NEUROIMMUNOMODULAT, V5, P22, DOI 10.1159/000026323; Letteron P, 1996, J HEPATOL, V24, P200, DOI 10.1016/S0168-8278(96)80030-4; Li JJ, 2011, EUR J PHARMACOL, V671, P120, DOI 10.1016/j.ejphar.2011.09.174; LIBBY P, 1986, J CLIN INVEST, V78, P1432, DOI 10.1172/JCI112732; Liu C, 2010, LAB INVEST, V90, P1805, DOI 10.1038/labinvest.2010.123; Manibusan MK, 2007, J ENVIRON SCI HEAL C, V25, P185, DOI 10.1080/10590500701569398; Nishida K, 1998, TOXICOL LETT, V95, P141, DOI 10.1016/S0378-4274(98)00030-7; Obuchowicz Rafal, 2002, Folia Med Cracov, V43, P95; Pan XY, 2007, J BIOL CHEM, V282, P17078, DOI 10.1074/jbc.M701742200; PENCIL SD, 1984, BIOCHEM PHARMACOL, V33, P2419, DOI 10.1016/0006-2952(84)90713-5; Pessayre D, 2012, DRUG METAB REV, V44, P34, DOI 10.3109/03602532.2011.604086; POLI G, 1985, LIFE SCI, V36, P533, DOI 10.1016/0024-3205(85)90634-4; Poniachik J, 2006, CYTOKINE, V33, P252, DOI 10.1016/j.cyto.2006.02.006; Pritchard MT, 2010, J HEPATOL, V53, P655, DOI 10.1016/j.jhep.2010.04.017; Proctor WR, 2013, HEPATOLOGY, V57, P2026, DOI 10.1002/hep.26196; RECKNAGE RO, 1967, PHARMACOL REV, V19, P145; Sakurai T, 2008, CANCER CELL, V14, P156, DOI 10.1016/j.ccr.2008.06.016; Sato A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092515; Sato Y, 2003, J HEPATOL, V39, P47, DOI 10.1016/S0168-8278(03)00146-6; SMIALOWICZ RJ, 1991, FUND APPL TOXICOL, V17, P186, DOI 10.1016/0272-0590(91)90250-8; Teixeira-Clerc F, 2010, HEPATOLOGY, V52, P1046, DOI 10.1002/hep.23779; Tiegs G, 1999, J NEUROIMMUNOL, V96, P131, DOI 10.1016/S0165-5728(99)00014-4; Tseng CK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086557; Vanden Berghe Tom, 2004, Methods Mol Med, V98, P101; Wang MF, 2013, AM J PHYSIOL-REG I, V305, pR900, DOI 10.1152/ajpregu.00120.2013; Weber LWD, 2003, CRIT REV TOXICOL, V33, P105, DOI 10.1080/713611034; Wen Tao, 2006, Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, V18, P417; WHEATLEY AM, 1993, J AUTON PHARMACOL, V13, P15, DOI 10.1111/j.1474-8673.1993.tb00395.x; Xia F, 2006, HEPATOL RES, V36, P259, DOI 10.1016/j.hepres.2006.08.009; Xie WD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058639; Yamaji K, 2008, TOXICOL APPL PHARM, V226, P38, DOI 10.1016/j.taap.2007.08.014; Zamara E, 2007, J HEPATOL, V46, P230, DOI 10.1016/j.jhep.2006.09.007; Zapater P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043371; Zhang H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046574; Zhu RZ, 2010, WORLD J GASTROENTERO, V16, P2771, DOI 10.3748/wjg.v16.i22.2771; Zhu RZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071612	71	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121365	10.1371/journal.pone.0121365	http://dx.doi.org/10.1371/journal.pone.0121365			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799095	Green Published, gold, Green Submitted			2022-12-26	WOS:000351987300246
J	Lin, XL; Jia, JS; Du, T; Li, W; Wang, XY; Wei, JQ; Lin, X; Zeng, H; Yao, LP; Chen, XB; Zhuang, JS; Weng, J; Liu, Y; Lin, JH; Wu, QH; Wang, WS; Yao, KT; Xu, K; Xiao, D				Lin, Xiaolin; Jia, Junshuang; Du, Tao; Li, Wei; Wang, Xiaoyan; Wei, Jieqiong; Lin, Xia; Zeng, Hui; Yao, Longping; Chen, Xuebing; Zhuang, Jingshen; Weng, Jie; Liu, Yu; Lin, Jihong; Wu, Qinghong; Wang, Wanshan; Yao, Kaitai; Xu, Kang; Xiao, Dong			Overexpression of miR-155 in the Liver of Transgenic Mice Alters the Expression Profiling of Hepatic Genes Associated with Lipid Metabolism	PLOS ONE			English	Article							DECREASES BLOOD-LIPIDS; APOLIPOPROTEIN A-IV; IN-VIVO; BIOLUMINESCENCE; MOUSE; MICRORNAS; DIFFERENTIATION; TUMORIGENESIS; GENERATION; STEATOSIS	Hepatic expression profiling has revealed miRNA changes in liver diseases, while hepatic miR-155 expression was increased in murine non-alcoholic fatty liver disease, suggesting that miR-155 might regulate the biological process of lipid metabolism. To illustrate the effects of miR-155 gain of function in transgenic mouse liver on lipid metabolism, transgenic mice (i.e., Rm155LG mice) for the conditional overexpression of mouse miR-155 transgene mediated by Cre/lox P system were firstly generated around the world in this study. Rm155LG mice were further crossed to Alb-Cre mice to realize the liver-specific overexpression of miR-155 transgene in Rm155LG/Alb-Cre double transgenic mice which showed the unaltered body weight, liver weight, epididymal fat pad weight and gross morphology and appearance of liver. Furthermore, liver-specific overexpression of miR-155 transgene resulted in significantly reduced levels of serum total cholesterol, triglycerides (TG) and high-density lipoprotein (HDL), as well as remarkably decreased contents of hepatic lipid, TG, HDL and free fatty acid in Rm155LG/Alb-Cre transgenic mice. More importantly, microarray data revealed a general downward trend in the expression profile of hepatic genes with functions typically associated with fatty acid, cholesterol and triglyceride metabolism, which is likely at least partially responsible for serum cholesterol and triglyceride lowering observed in Rm155LG/Alb-Cre mice. In this study, we demonstrated that hepatic overexpression of miR-155 alleviated nonalcoholic fatty liver induced by a high-fat diet. Additionally, carboxylesterase 3/triacylglycerol hydrolase (Ces3/TGH) was identified as a direct miR-155 target gene that is potentially responsible for the partial liver phenotypes observed in Rm155LG/Alb-Cre mice. Taken together, these data from miR-155 gain of function study suggest, for what we believe is the first time, the altered lipid metabolism and provide new insights into the metabolic state of the liver in Rm155LG/Alb-Cre mice.	[Lin, Xiaolin; Jia, Junshuang; Li, Wei; Wang, Xiaoyan; Wei, Jieqiong; Lin, Xia; Weng, Jie; Liu, Yu; Yao, Kaitai; Xiao, Dong] Southern Med Univ, Canc Res Inst, Guangzhou, Guangdong, Peoples R China; [Lin, Jihong; Wu, Qinghong; Wang, Wanshan; Xiao, Dong] Southern Med Univ, Inst Comparat Med, Guangzhou, Guangdong, Peoples R China; [Lin, Jihong; Wu, Qinghong; Wang, Wanshan; Xiao, Dong] Southern Med Univ, Lab Anim Ctr, Guangzhou, Guangdong, Peoples R China; [Xu, Kang] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Gen Surg, Guangzhou 510275, Guangdong, Peoples R China; [Du, Tao] Guangzhou Med Univ, Affiliated Hosp 2, Dept Endocrinol, Guangzhou, Guangdong, Peoples R China; [Zeng, Hui] Southern Med Univ, Nanfang Hosp, Dept Med Imaging Ctr, Guangzhou, Guangdong, Peoples R China; [Yao, Longping] Southern Med Univ, Zhujiang Hosp, Guangzhou, Guangdong, Peoples R China; [Chen, Xuebing; Zhuang, Jingshen] Southern Med Univ, Sch Tradit Chinese Med, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Southern Medical University - China; Southern Medical University - China; Sun Yat Sen University; Guangzhou Medical University; Southern Medical University - China; Southern Medical University - China; Southern Medical University - China	Yao, KT (corresponding author), Southern Med Univ, Canc Res Inst, Guangzhou, Guangdong, Peoples R China.	Ktyao@fimmu.com; xukang1995@yahoo.com; Xiao_d@hotmail.com	lin, xiaolin/AAO-4758-2020		National Natural Science Foundation of China [81172587, 81372896, 81100573]; Natural Science Foundation of Guangdong Province of China [9151063101000015, S2012010009212]; Science and Technology Planning Project of Guangdong Province of China [2009B060300008, 2013B060300013, 2011B060300028, 2012B040304010]; Fundamental Research Funds for the Central Universities of China [10ykpy21]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province of China(National Natural Science Foundation of Guangdong Province); Science and Technology Planning Project of Guangdong Province of China; Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China (Grant No. 81172587 and 81372896, to D. Xiao; Grant No. 81100573, to T. Du), the Natural Science Foundation of Guangdong Province of China (Grant No. 9151063101000015, to J. -S. Jia; Grant No. S2012010009212, to K. Xu), the Science and Technology Planning Project of Guangdong Province of China (Grant No. 2009B060300008 and 2013B060300013, to D. Xiao; Grant No. 2011B060300028 and 2012B040304010, to W. -S. Wang), and Fundamental Research Funds for the Central Universities of China (Grant No. 10ykpy21, to K Xu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, MANIPULATING MOUSE E, DOI [10.1007/978-1-60327-019-9_13, DOI 10.1007/978-1-60327-019-9_13]; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bie JH, 2013, ARTERIOSCL THROM VAS, V33, P1795, DOI 10.1161/ATVBAHA.113.301634; Cao YA, 2005, TRANSPLANTATION, V80, P134, DOI 10.1097/01.TP.0000164347.50559.A3; Chen HC, 2009, BRIT J CANCER, V100, P1002, DOI 10.1038/sj.bjc.6604948; Chen T, 2011, INT J CARDIOL, V147, P446, DOI 10.1016/j.ijcard.2010.10.133; Chen Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2742; Cohen RD, 1997, J CLIN INVEST, V99, P1906, DOI 10.1172/JCI119358; Costinean S, 2006, P NATL ACAD SCI USA, V103, P7024, DOI 10.1073/pnas.0602266103; Dawson PA, 2006, PHYSIOL GENOMICS, V26, P116, DOI 10.1152/physiolgenomics.00300.2005; Dolinsky VW, 2001, BBA-MOL CELL BIOL L, V1532, P162, DOI 10.1016/S1388-1981(01)00133-0; Du T, 2014, BIOTECHNOL LETT, V36, P9, DOI 10.1007/s10529-013-1327-y; Miquilena-Colina ME, 2011, GUT, V60, P1394, DOI 10.1136/gut.2010.222844; Faraoni I, 2009, BBA-MOL BASIS DIS, V1792, P497, DOI 10.1016/j.bbadis.2009.02.013; Hui ABY, 2010, CLIN CANCER RES, V16, P1129, DOI 10.1158/1078-0432.CCR-09-2166; Kloting N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004699; Koonen DPY, 2007, DIABETES, V56, P2863, DOI 10.2337/db07-0907; Kornfeld JW, 2013, NATURE, V494, P111, DOI 10.1038/nature11793; Lian JH, 2012, HEPATOLOGY, V56, P2154, DOI 10.1002/hep.25881; Liao CP, 2007, CANCER RES, V67, P7525, DOI 10.1158/0008-5472.CAN-07-0668; Liu SH, 2011, BIOCHEM BIOPH RES CO, V414, P618, DOI 10.1016/j.bbrc.2011.09.131; Lyons SK, 2006, CANCER RES, V66, P4701, DOI 10.1158/0008-5472.CAN-05-3598; Lyons SK, 2003, CANCER RES, V63, P7042; Lyons SK, 2005, J PATHOL, V205, P194, DOI 10.1002/path.1697; Miller AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072324; Pogribny IP, 2010, LAB INVEST, V90, P1437, DOI 10.1038/labinvest.2010.113; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; Skarn M, 2012, STEM CELLS DEV, V21, P873, DOI 10.1089/scd.2010.0503; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Tili E, 2009, INT REV IMMUNOL, V28, P264, DOI 10.1080/08830180903093796; Vooijs M, 2002, CANCER RES, V62, P1862; Voshol PJ, 2003, ENDOCRINOLOGY, V144, P3456, DOI 10.1210/en.2002-0036; Wei EH, 2007, J LIPID RES, V48, P2597, DOI 10.1194/jlr.M700320-JLR200; Wei EH, 2010, CELL METAB, V11, P183, DOI 10.1016/j.cmet.2010.02.005; Weinstock PH, 1997, J LIPID RES, V38, P1782; Woolfenden S, 2009, GENESIS, V47, P659, DOI 10.1002/dvg.20545; Zhang N, 2009, CLIN CANCER RES, V15, P4915, DOI 10.1158/1078-0432.CCR-08-2256; Zheng L, 2008, TRANSGENIC RES, V17, P741, DOI 10.1007/s11248-007-9160-5; Zheng L, 2007, J LEUKOCYTE BIOL, V82, P1247, DOI 10.1189/jlb.0307141; Zhou J, 2008, GASTROENTEROLOGY, V134, P556, DOI 10.1053/j.gastro.2007.11.037; Zhu HX, 2005, GENESIS, V42, P86, DOI 10.1002/gene.20129	42	49	53	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0118417	10.1371/journal.pone.0118417	http://dx.doi.org/10.1371/journal.pone.0118417			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799309	Green Submitted, Green Published, gold			2022-12-26	WOS:000351987300008
J	Meza-Parral, Y; Pineda, E				Meza-Parral, Yocoyani; Pineda, Eduardo			Amphibian Diversity and Threatened Species in a Severely Transformed Neotropical Region in Mexico	PLOS ONE			English	Article							TROPICAL FOREST; VERACRUZ; HABITAT	Many regions around the world concentrate a large number of highly endangered species that have very restricted distributions. The mountainous region of central Veracruz, Mexico, is considered a priority area for amphibian conservation because of its high level of endemism and the number of threatened species. The original tropical montane cloud forest in the region has been dramatically reduced and fragmented and is now mainly confined to ravines and hillsides. We evaluated the current situation of amphibian diversity in the cloud forest fragments of this region by analyzing species richness and abundance, comparing assemblage structure and species composition, examining the distribution and abundance of threatened species, and identifying the local and landscape variables associated with the observed amphibian diversity. From June to October 2012 we sampled ten forest fragments, investing 944 person-hours of sampling effort. A total of 895 amphibians belonging to 16 species were recorded. Notable differences in species richness, abundance, and assemblage structure between forest fragments were observed. Species composition between pairs of fragments differed by an average of 53%, with the majority (58%) resulting from species replacement and the rest (42%) explained by differences in species richness. Half of the species detected are under threat of extinction according to the International Union for Conservation of Nature, and although their distribution and abundance varied markedly, there were also ubiquitous and abundant species, along with rare species of restricted distribution. The evident heterogeneity of the ten study sites indicates that to conserve amphibians in a mountainous region such as this one it is necessary to protect groups of fragments which represent the variability of the system. Both individually and together cloud forest fragments are very important to conservation because each remnant is inhabited by several threatened species, some of them at imminent risk of extinction.	[Meza-Parral, Yocoyani; Pineda, Eduardo] Inst Ecol AC, Red Biol & Conservac Vertebrados, Xalapa, Veracruz, Mexico	Instituto de Ecologia - Mexico	Pineda, E (corresponding author), Inst Ecol AC, Red Biol & Conservac Vertebrados, Xalapa, Veracruz, Mexico.	eduardo.pineda@inecol.mx	Meza-Parral, Yocoyani/AAX-7113-2021; Pineda, Eduardo/N-5254-2014	Pineda, Eduardo/0000-0002-1997-9576; Meza-Parral, Yocoyani/0000-0002-1911-6527	CONACyT (Consejo Nacional de Ciencia y Tecnologia) [262668]; CONABIO (Comision Nacional para el Conocimiento y Uso de la Biodiversidad) [JF212]	CONACyT (Consejo Nacional de Ciencia y Tecnologia)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); CONABIO (Comision Nacional para el Conocimiento y Uso de la Biodiversidad)	YMP was supported by CONACyT (Consejo Nacional de Ciencia y Tecnologia) grant 262668. The CONABIO (Comision Nacional para el Conocimiento y Uso de la Biodiversidad) supported this study (Project JF212). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carvalho JC, 2012, GLOBAL ECOL BIOGEOGR, V21, P760, DOI 10.1111/j.1466-8238.2011.00694.x; Castillo-Campos G, 2011, BIODIVERSIDAD VERACR, P163; Colwell RK, 2012, J PLANT ECOL, V5, P3, DOI 10.1093/jpe/rtr044; CONABIO, 2010, EL BOSQUE MESOFILO D, P197; Crump M.L., 1994, MEASURING MONITORING, P84, DOI DOI 10.1007/S10682-018-9929-4; Gascon C., 2007, Amphibian conservation action plan. Proceedings IUCN/SSC Amphibian Conservation Summit 2005; Gascon C, 1999, BIOL CONSERV, V91, P223, DOI 10.1016/S0006-3207(99)00080-4; Halffter Gonzalo, 2005, Acta Zool. Mex, V21, P133; HALFFTER Gonzalo, 2011, Acta Zool. Mex, V27, P177; IUCN (International Union for Conservation of Nature), 2013, THE IUCN RED LIST OF; Joppa LN, 2013, SCIENCE, V341, P1100, DOI 10.1126/science.1241706; Korhonen L, 2006, SILVA FENN, V40, P577, DOI 10.14214/sf.315; McDiarmid R.W., 1994, MEASURING MONITORING, P289; Murrieta-Galindo R, 2013, AGROFOREST SYST, V87, P767, DOI 10.1007/s10457-013-9595-z; Ochoa-Ochoa L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006878; Ochoa-Ochoa LM, 2011, BIOL CONSERV, V144, P2710, DOI 10.1016/j.biocon.2011.07.032; Parra-Olea G, 2010, ZOOTAXA, P57; Pineda E, 2004, BIOL CONSERV, V117, P499, DOI 10.1016/j.biocon.2003.08.009; Rasband W.S., 1997, IMAGE J; Ricketts TH, 2005, P NATL ACAD SCI USA, V102, P18497, DOI 10.1073/pnas.0509060102; Rodriguez-Mendoza C, 2010, BIOL LETTERS, V6, P781, DOI 10.1098/rsbl.2010.0334; Soto E, 1990, ATLAS CLIMATICO DEL; Stuart S., 2008, THREATENED AMPHIBIAN, P758; Suaz-Ortuno I, 2008, CONSERV BIOL, V22, P362, DOI 10.1111/j.1523-1739.2008.00883.x; Tobar SLC, 2012, THESIS; Urbina-Cardona JN, 2006, BIOL CONSERV, V132, P61, DOI 10.1016/j.biocon.2006.03.014; Wake David B., 1992, Tulane Studies in Zoology and Botany Supplementary Publication, V1, P303; Wanger TC, 2010, CONSERV BIOL, V24, P795, DOI 10.1111/j.1523-1739.2009.01434.x; Welsh HH, 2001, CONSERV BIOL, V15, P558, DOI 10.1046/j.1523-1739.2001.015003558.x; Whitfield SM, 2007, P NATL ACAD SCI USA, V104, P8352, DOI 10.1073/pnas.0611256104	30	16	16	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121652	10.1371/journal.pone.0121652	http://dx.doi.org/10.1371/journal.pone.0121652			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799369	Green Published, Green Submitted, gold			2022-12-26	WOS:000351987300279
J	Miyakawa, H; Sato, M; Colbourne, JK; Iguchi, T				Miyakawa, Hitoshi; Sato, Masanao; Colbourne, John K.; Iguchi, Taisen			Ionotropic Glutamate Receptors Mediate Inducible Defense in the Water Flea Daphnia pulex	PLOS ONE			English	Article							JUVENILE-HORMONE BIOSYNTHESIS; PREDATOR-INDUCED POLYPHENISM; EXPRESSION; INSECTS; MK-801	Phenotypic plasticity is the ability held in many organisms to produce different phenotypes with a given genome in response to environmental stimuli, such as temperature, nutrition and various biological interactions. It seems likely that environmental signals induce a variety of mechanistic responses that influence ontogenetic processes. Inducible defenses, in which prey animals alter their morphology, behavior and/or other traits to help protect against direct or latent predation threats, are among the most striking examples of phenotypic plasticity. The freshwater microcrustacean Daphnia pulex forms tooth-like defensive structures, "neckteeth," in response to chemical cues or signals, referred to as "kairomones," in this case released from phantom midge larvae, a predator of D. pulex. To identify factors involved in the reception and/or transmission of a kairomone, we used microarray analysis to identify genes up-regulated following a short period of exposure to the midge kairomone. In addition to identifying differentially expressed genes of unknown function, we also found significant up-regulation of genes encoding ionotropic glutamate receptors, which are known to be involved in neurotransmission in many animal species. Specific antagonists of these receptors strongly inhibit the formation of neckteeth in D. pulex, although agonists did not induce neckteeth by themselves, indicating that ionotropic glutamate receptors are necessary but not sufficient for early steps of neckteeth formation in D. pulex. Moreover, using co-exposure of D. pulex to antagonists and juvenile hormone (JH), which physiologically mediates neckteeth formation, we found evidence suggesting that the inhibitory effect of antagonists is not due to direct inhibition of JH synthesis/secretion. Our findings not only provide a candidate molecule required for the inducible defense response in D. pulex, but also will contribute to the understanding of complex mechanisms underlying the recognition of environmental changes, which form the basis of phenotypic plasticity.	[Miyakawa, Hitoshi; Sato, Masanao; Iguchi, Taisen] Natl Inst Basic Biol, Okazaki, Aichi 444, Japan; [Miyakawa, Hitoshi; Sato, Masanao; Iguchi, Taisen] Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Okazaki, Aichi 4448787, Japan; [Sato, Masanao; Iguchi, Taisen] SOKENDAI, Fac Life Sci, Dept Basic Biol, Okazaki, Aichi, Japan; [Colbourne, John K.] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); National Institutes of Natural Sciences (NINS) - Japan; Okazaki Institute for Integrative Bioscience (OIIB); Graduate University for Advanced Studies - Japan; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Okazaki Institute for Integrative Bioscience (OIIB); University of Birmingham	Miyakawa, H (corresponding author), Natl Inst Basic Biol, 5-1 Higashiyama, Okazaki, Aichi 444, Japan.	h-miya@nibb.ac.jp	Colbourne, John K/L-7748-2014; Iguchi, Taisen/AAL-4225-2021	Colbourne, John K/0000-0002-6966-2972; Sato, Masanao/0000-0003-3790-8218	Ministry of Education, Culture, Sports, Science and Technology of Japan [24370029]; Grants-in-Aid for Scientific Research [26840122] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Support was provided to TI by Grants-in-Aid for Scientific Research (B) (No. 24370029) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (http://www.jsps.go.jp/english/e-grants/index.html). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER FR, 1990, TRENDS ECOL EVOL, V5, P407, DOI 10.1016/0169-5347(90)90025-9; Barry MJ, 2002, PHYSIOL BIOCHEM ZOOL, V75, P179, DOI 10.1086/339389; Beaton MJ, 1997, LIMNOL OCEANOGR, V42, P346, DOI 10.4319/lo.1997.42.2.0346; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Chiang AS, 2002, P NATL ACAD SCI USA, V99, P37, DOI 10.1073/pnas.012318899; Chiang AS, 2002, INSECT BIOCHEM MOLEC, V32, P669, DOI 10.1016/S0965-1748(01)00146-1; Colbourne JK, 2011, SCIENCE, V331, P555, DOI 10.1126/science.1197761; Dingledine R, 1999, PHARMACOL REV, V51, P7; Dudley AM, 2002, P NATL ACAD SCI USA, V99, P7554, DOI 10.1073/pnas.112683499; Geister TL, 2008, J EXP BIOL, V211, P1587, DOI 10.1242/jeb.016725; Gilbert S. F., 2009, ECOLOGICAL DEV BIOL; Gotoh H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021139; Hepp Y, 2013, J COMP NEUROL, V521, P2279, DOI 10.1002/cne.23285; Hiruta C, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-96; Huang JH, 2011, DEVELOPMENT, V138, P2283, DOI 10.1242/dev.057687; Imai M, 2009, J EXP ZOOL PART A, V311A, P788, DOI 10.1002/jez.565; Kato Y, 2011, DEV GENES EVOL, V220, P337, DOI 10.1007/s00427-011-0353-9; KRUEGER DA, 1981, LIMNOL OCEANOGR, V26, P219, DOI 10.4319/lo.1981.26.2.0219; Lee HK, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-269; Miyakawa H, 2014, DAPHNIA BIOL MATH PE, P245; Miyakawa H, 2014, CURR OPIN INSECT SCI, V1, P81, DOI 10.1016/j.cois.2014.04.006; Miyakawa H, 2013, J EXP ZOOL PART A, V319, P440, DOI 10.1002/jez.1807; Miyakawa H, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-45; Naraki Y, 2013, ZOOL SCI, V30, P619, DOI 10.2108/zsj.30.619; Nijhout H.F., 1994, INSECT HORMONES; Nijhout HF, 1999, BIOSCIENCE, V49, P181, DOI 10.2307/1313508; Pener MP, 1998, J INSECT PHYSIOL, V44, P365, DOI 10.1016/S0022-1910(97)00169-8; Pigliucci Massimo, 2010, P355; R Core Team, 2021, R LANGUAGE ENV STAT; RANDLE JCR, 1992, EUR J PHARMACOL, V215, P237, DOI 10.1016/0014-2999(92)90033-Z; Sato M, 2007, PLANT J, V49, P565, DOI 10.1111/j.1365-313X.2006.02972.x; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Tollrian Ralph, 1999, P177; Weiss LC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036879; West-Eberhard Mary Jane, 2003, pi; WONG EHF, 1986, P NATL ACAD SCI USA, V83, P7104, DOI 10.1073/pnas.83.18.7104; Yanai H., 2004, STATCEL USEFUL ADD I	38	16	16	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121324	10.1371/journal.pone.0121324	http://dx.doi.org/10.1371/journal.pone.0121324			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799112	Green Published, gold, Green Submitted			2022-12-26	WOS:000351987300236
J	Saffarini, CM; McDonnell-Clark, EV; Amin, A; Huse, SM; Boekelheide, K				Saffarini, Camelia M.; McDonnell-Clark, Elizabeth V.; Amin, Ali; Huse, Susan M.; Boekelheide, Kim			Developmental Exposure to Estrogen Alters Differentiation and Epigenetic Programming in a Human Fetal Prostate Xenograft Model	PLOS ONE			English	Article							INCREASES SUSCEPTIBILITY; CANCER PROGRESSION; DNA METHYLATION; RECEPTOR-BETA; CARCINOGENESIS; MOUSE; ESTRADIOL; PACKAGE; STROMA; RAT	Prostate cancer is the most frequent non-cutaneous malignancy in men. There is strong evidence in rodents that neonatal estrogen exposure plays a role in the development of this disease. However, there is little information regarding the effects of estrogen in human fetal prostate tissue. This study explored early life estrogen exposure, with and without a secondary estrogen and testosterone treatment in a human fetal prostate xenograft model. Histopathological lesions, proliferation, and serum hormone levels were evaluated at 7, 30, 90, and 200-day time-points after xenografting. The expression of 40 key genes involved in prostatic glandular and stromal growth, cell-cycle progression, apoptosis, hormone receptors and tumor suppressors was evaluated using a custom PCR array. Epigenome-wide analysis of DNA methylation was performed on whole tissue, and laser capture-microdissection (LCM) isolated epithelial and stromal compartments of 200-day prostate xenografts. Combined initial plus secondary estrogenic exposures had the most severe tissue changes as revealed by the presence of hyperplastic glands at day 200. Gene expression changes corresponded with the cellular events in the KEGG prostate cancer pathway, indicating that initial plus secondary exposure to estrogen altered the PI3K-Akt signaling pathway, ultimately resulting in apoptosis inhibition and an increase in cell cycle progression. DNA methylation revealed that differentially methylated CpG sites significantly predominate in the stromal compartment as a result of estrogen-treatment, thereby providing new targets for future investigation. By using human fetal prostate tissue and eliminating the need for species extrapolation, this study provides novel insights into the gene expression and epigenetic effects related to prostate carcinogenesis following early life estrogen exposure.	[Saffarini, Camelia M.; McDonnell-Clark, Elizabeth V.; Amin, Ali; Huse, Susan M.; Boekelheide, Kim] Brown Univ, Dept Pathol & Lab Med, Providence, RI 02912 USA; [Amin, Ali] Rhode Isl Hosp, Dept Pathol & Lab Med, Providence, RI USA	Brown University; Lifespan Health Rhode Island; Rhode Island Hospital	Boekelheide, K (corresponding author), Brown Univ, Dept Pathol & Lab Med, Providence, RI 02912 USA.	kim_boekelheide@brown.edu			United States Environmental Protection Agency [RD-83459401]; National Institute of Environmental Health Sciences [5P20ES018169-02]; Training grant in Environmental Pathology [T32-ES007272]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P20ES018169, T32ES007272] Funding Source: NIH RePORTER	United States Environmental Protection Agency(United States Environmental Protection Agency); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Training grant in Environmental Pathology; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by United States Environmental Protection Agency RD-83459401, National Institute of Environmental Health Sciences 5P20ES018169-02, and Training grant in Environmental Pathology T32-ES007272. CMS and KB are the authors who received this funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbassi-Ghanavati M, 2009, OBSTET GYNECOL, V114, P1326, DOI 10.1097/AOG.0b013e3181c2bde8; Aksglaede L, 2006, HUM REPROD UPDATE, V12, P341, DOI 10.1093/humupd/dml018; Anderson PD, 2012, J CLIN INVEST, V122, P1907, DOI 10.1172/JCI58540; Arbab I. A., 2012, EVID-BASED COMPL ALT, V2012, DOI DOI 10.1155/2012/856029; Arredouani MS, 2009, CLIN CANCER RES, V15, P5794, DOI 10.1158/1078-0432.CCR-09-0911; Aryee MJ, 2014, BIOINFORMATICS, V30, P1363, DOI 10.1093/bioinformatics/btu049; Bjerke GA, 2013, ONCOGENE; Brett A, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-3; Carruba G, 2007, J CELL BIOCHEM, V102, P899, DOI 10.1002/jcb.21529; Coffey D S, 1980, Prog Clin Biol Res, V37, P379; Crews D, 2006, ENDOCRINOLOGY, V147, pS4, DOI 10.1210/en.2005-1122; Cunha GR, 2002, DIFFERENTIATION, V70, P473, DOI 10.1046/j.1432-0436.2002.700902.x; Cunha GR, 2003, INT J CANCER, V107, P1, DOI 10.1002/ijc.11335; Damber JE, 2008, LANCET, V371, P1710, DOI 10.1016/S0140-6736(08)60729-1; De Paepe ME, 2012, EXP LUNG RES, V38, P43, DOI 10.3109/01902148.2011.641139; Dey P, 2013, J MOL ENDOCRINOL, V51, pT61, DOI 10.1530/JME-13-0150; Ekbom A, 1998, SEMIN CANCER BIOL, V8, P237, DOI 10.1006/scbi.1998.0073; Farnsworth WE, 1999, PROSTATE, V38, P60; Franco OE, 2012, ADV PHARMACOL, V65, P267, DOI 10.1016/B978-0-12-397927-8.00009-9; Gann Peter H, 2002, Rev Urol, V4 Suppl 5, pS3; Gathirua-Mwangi WG, 2013, EUR J CANC PREV; Gilmore W, 1997, J IMMUNOL, V158, P446; Halvorsen OJ, 2007, CLIN CANCER RES, V13, P892, DOI 10.1158/1078-0432.CCR-06-1207; Harmelin A, 2005, LAB ANIM-UK, V39, P215, DOI 10.1258/0023677053739756; Hayward SW, 1996, ANN NY ACAD SCI, V784, P50, DOI 10.1111/j.1749-6632.1996.tb16227.x; Ho SM, 2006, CANCER RES, V66, P5624, DOI 10.1158/0008-5472.CAN-06-0516; Huang DW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r183; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2013, NUCL ACIDS RES; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kim JW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048455; Kohl M, 2007, FUNCTIONS ANAL REAL; Leek JT, 2012, BIOINFORMATICS, V28, P882, DOI 10.1093/bioinformatics/bts034; Li LC, 2004, BBA-REV CANCER, V1704, P87, DOI 10.1016/j.bbcan.2004.06.001; Li LC, 2005, JNCI-J NATL CANCER I, V97, P103, DOI 10.1093/jnci/dji010; Liu Y, 2013, J APPL GENETICS; Maksimovic J, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r44; McLachlan JA, 2001, APMIS, V109, P263, DOI 10.1034/j.1600-0463.2001.d01-119.x; MCNEAL JE, 1988, AM J SURG PATHOL, V12, P619, DOI 10.1097/00000478-198808000-00003; Nash AF, 2000, ENDOCR-RELAT CANCER, V7, P37, DOI 10.1677/erc.0.0070037; Nelles JL, 2011, EXPERT REV ENDOCRINO, V6, P437, DOI 10.1586/EEM.11.20; Pettersson K, 2001, ANNU REV PHYSIOL, V63, P165, DOI 10.1146/annurev.physiol.63.1.165; Pflieger-Bruss S, 2004, ANDROLOGIA, V36, P337, DOI 10.1111/j.1439-0272.2004.00641.x; Prins GS, 2008, ENDOCR-RELAT CANCER, V15, P649, DOI 10.1677/ERC-08-0043; Prins GS, 2008, BASIC CLIN PHARMACOL, V102, P134, DOI 10.1111/j.1742-7843.2007.00166.x; Prins GS, 2007, REPROD TOXICOL, V23, P374, DOI 10.1016/j.reprotox.2006.10.001; Prins GS, 2001, REPROD FERT DEVELOP, V13, P241, DOI 10.1071/RD00107; PRINS GS, 1992, ENDOCRINOLOGY, V130, P2401, DOI 10.1210/en.130.4.2401; RAO GN, 1987, FUND APPL TOXICOL, V9, P329, DOI 10.1016/0272-0590(87)90055-8; Ricke EA, 2012, CARCINOGENESIS, V33, P1391, DOI 10.1093/carcin/bgs153; Ricke WA, 2006, INT J CANCER, V118, P2123, DOI 10.1002/ijc.21614; Risbridger GP, 2005, CELL TISSUE RES, V322, P173, DOI 10.1007/s00441-005-1121-9; Saffarini CM, 2013, PROSTATE, V73, P1761, DOI 10.1002/pros.22713; Sanchez-Chapado M, 2003, PROSTATE, V54, P238, DOI 10.1002/pros.10177; Shappell SB, 2004, CANCER RES, V64, P2270, DOI 10.1158/0008-5472.CAN-03-0946; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; van der Heul-Nieuwenhuijsen L, 2009, PROSTATE, V69, P1538, DOI 10.1002/pros.20996; van der Heul-Nieuwenhuijsen L, 2009, BJU INT, V103, P1574, DOI 10.1111/j.1464-410X.2009.08351.x; van Leenders GJLH, 2003, AM J PATHOL, V162, P1529, DOI 10.1016/S0002-9440(10)64286-1; Wang D, 2012, BIOINFORMATICS, V28, P729, DOI 10.1093/bioinformatics/bts013; Wang YH, 2000, CANCER RES, V60, P6008; Wang YZ, 2005, PROSTATE, V64, P149, DOI 10.1002/pros.20225; XIA T, 1990, Pediatric Pathology, V10, P527	65	14	14	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0122290	10.1371/journal.pone.0122290	http://dx.doi.org/10.1371/journal.pone.0122290			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799167	gold, Green Submitted, Green Published			2022-12-26	WOS:000351987300327
J	Shing, CM; Fassett, RG; Peake, JM; Coombes, JS				Shing, Cecilia M.; Fassett, Robert G.; Peake, Jonathan M.; Coombes, Jeff S.			Voluntary Exercise Decreases Atherosclerosis in Nephrectomised ApoE Knockout Mice	PLOS ONE			English	Article							E-DEFICIENT MICE; RENIN-ANGIOTENSIN SYSTEM; CHRONIC KIDNEY-DISEASE; CHRONIC-RENAL-FAILURE; ENDOTHELIAL DYSFUNCTION; APOLIPOPROTEIN; CYTOKINES; PLAQUE; ATHEROGENESIS; EPIDEMIOLOGY	Cardiovascular disease is the main cause of morbidity and mortality in patients with kidney disease. The effectiveness of exercise for cardiovascular disease that is accelerated by the presence of chronic kidney disease remains unknown. The present study utilized apolipoprotein E knockout mice with 5/6 nephrectomy as a model of combined kidney disease and cardiovascular disease to investigate the effect of exercise on aortic plaque formation, vascular function and systemic inflammation. Animals were randomly assigned to nephrectomy or control and then to either voluntary wheel running exercise or sedentary. Following 12-weeks, aortic plaque area was significantly (p< 0.05, d= 1.2) lower in exercising nephrectomised mice compared to sedentary nephrectomised mice. There was a strong, negative correlation between average distance run each week and plaque area in nephrectomised and control mice (r=-0.76, p= 0.048 and r=-0.73, p= 0.062; respectively). In vitro aortic contraction and endothelial-independent and endothelial-dependent relaxation were not influenced by exercise (p>0.05). Nephrectomy increased IL-6 and TNF-alpha concentrations compared with control mice (p< 0.001 and p< 0.05, respectively), while levels of IL-10, MCP-1 and MIP-1 alpha were not significantly influenced by nephrectomy or voluntary exercise (p> 0.05). Exercise was an effective non-pharmacologic approach to slow cardiovascular disease in the presence of kidney disease in the apolipoprotein E knockout mouse.	[Shing, Cecilia M.] Univ Tasmania, Sch Hlth Sci, Launceston, Tas 7250, Australia; [Fassett, Robert G.; Coombes, Jeff S.] Univ Queensland, Sch Human Movement Studies, Brisbane, Qld, Australia; [Peake, Jonathan M.] Queensland Univ Technol, Sch Biomed Sci, Brisbane, Qld 4001, Australia	University of Tasmania; University of Queensland; Queensland University of Technology (QUT)	Shing, CM (corresponding author), Univ Tasmania, Sch Hlth Sci, Launceston, Tas 7250, Australia.	Cecilia.shing@utas.edu.au	Fassett, Robert/R-3495-2019; Coombes, Jeff/F-1764-2010; Peake, Jonathan/F-4114-2010; Kitic, Cecilia/D-1131-2018	Coombes, Jeff/0000-0002-6990-3596; Peake, Jonathan/0000-0002-8218-0038; Kitic, Cecilia/0000-0001-9866-5665				Ajijola OA, 2009, ANTIOXID REDOX SIGN, V11, P15, DOI 10.1089/ars.2008.2092; Balarini CM, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-220; Boor P, 2009, METABOLISM, V58, P1669, DOI 10.1016/j.metabol.2009.05.025; Bro S, 2003, J AM SOC NEPHROL, V14, P2466, DOI 10.1097/01.ASN.0000088024.72216.2E; Bro S, 2007, ARTERIOSCL THROM VAS, V27, P1080, DOI 10.1161/ATVBAHA.107.139634; Buzello M, 2003, J AM SOC NEPHROL, V14, P311, DOI 10.1097/01.ASN.0000045048.71975.FC; Caravaca F, 2014, NEFROLOGIA, V34, P469, DOI 10.3265/Nefrologia.pre2014.Apr.12277; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cook MD, 2013, BRAIN BEHAV IMMUN, V33, P46, DOI 10.1016/j.bbi.2013.05.005; Crauwels HM, 2003, CARDIOVASC RES, V59, P189, DOI 10.1016/S0008-6363(03)00353-5; Fischer CP, 2006, EXERC IMMUNOL REV, V12, P6; Fukao K, 2010, J ATHEROSCLER THROMB, V17, P1226, DOI 10.5551/jat.4788; GAGNON RF, 1983, UROL RES, V11, P11, DOI 10.1007/BF00272702; Hilberg T, 2008, HAMOSTASEOLOGIE, V28, P9; Hobo A, 2009, J CLIN INVEST, V119, P1616, DOI 10.1172/JCI37249; Kadoglou NPE, 2011, J VASC RES, V48, P347, DOI 10.1159/000321174; Keppler A, 2007, KIDNEY INT, V71, P74, DOI 10.1038/sj.ki.5001988; Kim YJ, 2008, PFLUG ARCH EUR J PHY, V455, P1081, DOI 10.1007/s00424-007-0356-6; Komura N, 2010, CARDIOVASC RES, V86, P471, DOI 10.1093/cvr/cvp415; Laufs U, 2005, ARTERIOSCL THROM VAS, V25, P809, DOI 10.1161/01.ATV.0000158311.24443.af; Levin A, 2003, SEMIN DIALYSIS, V16, P101, DOI 10.1046/j.1525-139X.2003.16025.x; Massy ZA, 2005, J AM SOC NEPHROL, V16, P109, DOI 10.1681/ASN.2004060495; Meyrelles SS, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-211; Okabe T, 2007, CARDIOVASC RES, V74, P537, DOI 10.1016/j.cardiores.2007.02.019; Peake JM, 2005, EUR J APPL PHYSIOL, V95, P514, DOI 10.1007/s00421-005-0035-2; Pedersen BK, 2000, IMMUNOL CELL BIOL, V78, P532, DOI 10.1046/j.1440-1711.2000.00962.x; Pelisek J, 2010, EUR J VASC ENDOVASC, V39, P11, DOI 10.1016/j.ejvs.2009.09.024; Pellegrin M, 2009, MED SCI SPORT EXER, V41, P2128, DOI 10.1249/MSS.0b013e3181a8d530; PLUMP AS, 1992, CELL, V71, P343, DOI 10.1016/0092-8674(92)90362-G; Ronco C, 2009, BLOOD PURIFICAT, V27, P114, DOI 10.1159/000167018; Rosner MH, 2012, SEMIN NEPHROL, V32, P70, DOI 10.1016/j.semnephrol.2011.11.010; Rugale C, 2013, AM J NEPHROL, V38, P168, DOI 10.1159/000353931; Shah P K, 1998, Vasc Med, V3, P199, DOI 10.1177/1358836X9800300304; Shon SM, 2011, ATHEROSCLEROSIS, V216, P67, DOI 10.1016/j.atherosclerosis.2011.01.036; Simolin MA, 2009, BMC CARDIOVASC DISOR, V9, DOI 10.1186/1471-2261-9-10; Tonelli M, 2005, KIDNEY INT, V68, P237, DOI 10.1111/j.1523-1755.2005.00398.x; Torres PAU, 2012, KIDNEY INT, V82, P19, DOI 10.1038/ki.2012.69; Wilcox CS, 2012, HYPERTENSION, V59, P375, DOI 10.1161/HYPERTENSIONAHA.111.187310; Zuo ML, 2013, AM J KIDNEY DIS, V62, P939, DOI 10.1053/j.ajkd.2013.05.016	39	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120287	10.1371/journal.pone.0120287	http://dx.doi.org/10.1371/journal.pone.0120287			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799529	Green Published, Green Submitted, gold			2022-12-26	WOS:000351987300121
J	Gorospe, KD; Karl, SA				Gorospe, Kelvin D.; Karl, Stephen A.			Depth as an Organizing Force in Pocillopora damicornis: Intra-Reef Genetic Architecture	PLOS ONE			English	Article							LOCAL ADAPTATION; MANTEL TEST; MULTIVARIATE-ANALYSIS; SPATIAL-PATTERNS; LARVAL BEHAVIOR; PLANULA LARVAE; CORAL-REEFS; POPULATION; SPECIATION; DISPERSAL	Relative to terrestrial plants, and despite similarities in life history characteristics, the potential for corals to exhibit intra-reef local adaptation in the form of genetic differentiation along an environmental gradient has received little attention. The potential for natural selection to act on such small scales is likely increased by the ability of coral larval dispersal and settlement to be influenced by environmental cues. Here, we combine genetic, spatial, and environmental data for a single patch reef in K ne'ohe Bay, O'ahu, Hawai'i, USA in a landscape genetics framework to uncover environmental drivers of intra-reef genetic structuring. The genetic dataset consists of near-exhaustive sampling (n = 2352) of the coral, Pocillopora damicornis at our study site and six microsatellite genotypes. In addition, three environmental parameters - depth and two depth-independent temperature indices - were collected on a 4 m grid across 85 locations throughout the reef. We use ordinary kriging to spatially interpolate our environmental data and estimate the three environmental parameters for each colony. Partial Mantel tests indicate a significant correlation between genetic relatedness and depth while controlling for space. These results are also supported by multi-model inference. Furthermore, spatial Principle Component Analysis indicates a statistically significant genetic cline along a depth gradient. Binning the genetic dataset based on size-class revealed that the correlation between genetic relatedness and depth was significant for new recruits and increased for larger size classes, suggesting a possible role of larval habitat selection as well as selective mortality in structuring intra-reef genetic diversity. That both pre- and post-recruitment processes may be involved points to the adaptive role of larval habitat selection in increasing adult survival. The conservation importance of uncovering intra-reef patterns of genetic diversity is discussed.	[Gorospe, Kelvin D.; Karl, Stephen A.] Univ Hawaii Mnoa, Hawaii Inst Marine Biol, Kneohe, HI USA		Karl, SA (corresponding author), 1510 Thurston Ave 4, Honolulu, HI USA.	skarl@hawaii.edu			National Science Foundation [OCE 06-27299]; Arcadia Wildlife, Inc.; National Science Foundation Graduate Research Fellowship Program; University of Hawaii Edmondson Research Grant; National Science Foundation, Hawaii EPSCoR Program [EPS-0903833]; EPSCoR [0903833] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Arcadia Wildlife, Inc.; National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF)); University of Hawaii Edmondson Research Grant; National Science Foundation, Hawaii EPSCoR Program; EPSCoR(National Science Foundation (NSF)NSF - Office of the Director (OD))	Funding was provided to SAK by the National Science Foundation Grant OCE 06-27299 and Arcadia Wildlife, Inc. and to KDG by the National Science Foundation Graduate Research Fellowship Program and the University of Hawaii Edmondson Research Grant and by the National Science Foundation, Hawaii EPSCoR Program EPS-0903833. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H., 1973, P 2 INT S INF THEOR, P267, DOI 10.1007/978-1-4612-1694-0; Anderson MJ, 2001, AUST NZ J STAT, V43, P75, DOI 10.1111/1467-842X.00156; Anderson TJC, 2000, MOL BIOL EVOL, V17, P1467, DOI 10.1093/oxfordjournals.molbev.a026247; Baird AH, 2003, MAR ECOL PROG SER, V252, P289, DOI 10.3354/meps252289; Barshis DJ, 2010, MOL ECOL, V19, P1705, DOI 10.1111/j.1365-294X.2010.04574.x; Barton K, 2020, MUMIN MULTIMODEL INF; Baums IB, 2008, MOL ECOL, V17, P2796, DOI 10.1111/j.1365-294X.2008.03787.x; Bird CE, 2011, INTEGR COMP BIOL, V51, P466, DOI 10.1093/icb/icr050; Bird CE, 2011, MOL ECOL, V20, P2128, DOI 10.1111/j.1365-294X.2011.05081.x; Bongaerts P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010871; Bowen BW, 2013, TRENDS ECOL EVOL, V28, P359, DOI 10.1016/j.tree.2013.01.018; Brown BE, 1997, CORAL REEFS, V16, pS129, DOI 10.1007/s003380050249; Burnham KP, 2001, WILDLIFE RES, V28, P111, DOI 10.1071/WR99107; Carlon DB, 2002, EVOLUTION, V56, P2227; Castellano S, 2002, EVOLUTION, V56, P1871; Conover DO, 2006, J FISH BIOL, V69, P21, DOI 10.1111/j.1095-8649.2006.01274.x; Costantini F, 2011, CORAL REEFS, V30, P991, DOI 10.1007/s00338-011-0771-1; D'Croz L, 2004, CORAL REEFS, V23, P473, DOI 10.1007/s00338-004-0397-7; Dray S, 2006, ECOL MODEL, V196, P483, DOI 10.1016/j.ecolmodel.2006.02.015; Dunne RP, 1996, MAR ECOL PROG SER, V144, P109, DOI 10.3354/meps144109; EXCOFFIER L, 1992, GENETICS, V131, P479; Flot JF, 2007, GENE, V401, P80, DOI 10.1016/j.gene.2007.07.006; Gleason DF, 2011, J EXP MAR BIOL ECOL, V408, P42, DOI 10.1016/j.jembe.2011.07.025; GLEASON DF, 1995, MAR BIOL, V123, P693, DOI 10.1007/BF00349112; GOREAU TF, 1959, ECOLOGY, V40, P67, DOI 10.2307/1929924; Gorospe KD, 2013, MOL ECOL, V22, P3721, DOI 10.1111/mec.12335; Gorospe Kelvin D., 2011, Journal of Marine Biology, V2011, P1; Griffith DA, 2006, ECOLOGY, V87, P2603, DOI 10.1890/0012-9658(2006)87[2603:SMIETF]2.0.CO;2; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Hardy OJ, 1999, HEREDITY, V83, P145, DOI 10.1046/j.1365-2540.1999.00558.x; HARRIOTT VJ, 1985, MAR ECOL PROG SER, V21, P81, DOI 10.3354/meps021081; Hellberg ME, 2009, ANNU REV ECOL EVOL S, V40, P291, DOI 10.1146/annurev.ecolsys.110308.120223; HUGHES TP, 1987, AM NAT, V129, P818, DOI 10.1086/284677; HURLBUT CJ, 1993, MAR BIOL, V115, P253, DOI 10.1007/BF00346342; Isomura N, 2001, CORAL REEFS, V20, P309, DOI 10.1007/s003380100180; JOHNSON MS, 1984, EVOLUTION, V38, P1371, DOI 10.1111/j.1558-5646.1984.tb05658.x; JOHNSON MS, 1982, MAR BIOL, V70, P157, DOI 10.1007/BF00397680; Jombart T, 2008, HEREDITY, V101, P92, DOI 10.1038/hdy.2008.34; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Jones RJ, 1998, PLANT CELL ENVIRON, V21, P1219, DOI 10.1046/j.1365-3040.1998.00345.x; Jorgensen HBH, 2005, MOL ECOL, V14, P3219, DOI 10.1111/j.1365-294X.2005.02658.x; Kalisz S, 2001, EVOLUTION, V55, P1560, DOI 10.1111/j.0014-3820.2001.tb00675.x; Kawecki TJ, 2004, ECOL LETT, V7, P1225, DOI 10.1111/j.1461-0248.2004.00684.x; Knight TM, 2004, EVOL ECOL RES, V6, P103; Legendre P, 2010, MOL ECOL RESOUR, V10, P831, DOI 10.1111/j.1755-0998.2010.02866.x; Leimu R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004010; Levin LA, 2006, INTEGR COMP BIOL, V46, P282, DOI 10.1093/icb/icj024; Linhart YB, 1996, ANNU REV ECOL SYST, V27, P237, DOI 10.1146/annurev.ecolsys.27.1.237; MANTEL N, 1967, CANCER RES, V27, P209; Marshall DJ, 2010, ECOL LETT, V13, P128, DOI 10.1111/j.1461-0248.2009.01408.x; Mayr E, 1942, SYSTEMATICS ORIGIN S; McEdward L., 1995, ECOLOGY MARINE INVER; McIntire EJB, 2009, ECOLOGY, V90, P46, DOI 10.1890/07-2096.1; Meirmans PG, 2004, MOL ECOL NOTES, V4, P792, DOI 10.1111/j.1471-8286.2004.00770.x; Meyer E, 2009, MAR ECOL PROG SER, V392, P81, DOI 10.3354/meps08208; Mundy CN, 1998, J EXP MAR BIOL ECOL, V223, P235, DOI 10.1016/S0022-0981(97)00167-6; Nosil P, 2005, EVOLUTION, V59, P705; Nosil P, 2008, MOL ECOL, V17, P2103, DOI 10.1111/j.1365-294X.2008.03715.x; Oetjen K, 2007, MOL ECOL, V16, P5156, DOI 10.1111/j.1365-294X.2007.03577.x; Pebesma EJ, 1998, COMPUT GEOSCI-UK, V24, P17, DOI 10.1016/S0098-3004(97)00082-4; Raimondi PT, 2000, ECOLOGY, V81, P3193, DOI 10.1890/0012-9658(2000)081[3193:TCOCLB]2.0.CO;2; Raufaste N, 2001, EVOLUTION, V55, P1703, DOI 10.1111/j.0014-3820.2001.tb00689.x; RICHMOND RH, 1987, B MAR SCI, V41, P594; Rocha LA, 2008, J FISH BIOL, V72, P1101, DOI 10.1111/j.1095-8649.2007.01770.x; Rocha LA, 2005, P ROY SOC B-BIOL SCI, V272, P573, DOI 10.1098/2004.3005; Sanford E, 2011, ANNU REV MAR SCI, V3, P509, DOI 10.1146/annurev-marine-120709-142756; Schoville SD, 2012, ANNU REV ECOL EVOL S, V43, P23, DOI 10.1146/annurev-ecolsys-110411-160248; Selkoe KA, 2010, MOL ECOL, V19, P3708, DOI 10.1111/j.1365-294X.2010.04658.x; Sherman CDH, 2008, EVOLUTION, V62, P1373, DOI 10.1111/j.1558-5646.2008.00375.x; Smith DB, 2007, CORAL REEFS, P26559; Smith-Keune C, 2006, CORAL REEFS, V25, P493, DOI 10.1007/s00338-006-0129-2; SMOUSE PE, 1986, SYST ZOOL, V35, P627, DOI 10.2307/2413122; Sotka EE, 2005, ECOL LETT, V8, P448, DOI 10.1111/j.1461-0248.2004.00719.x; Stake JL, 2003, J EXP MAR BIOL ECOL, V288, P181, DOI 10.1016/S0022-0981(03)00018-2; Storfer A, 2007, HEREDITY, V98, P128, DOI 10.1038/sj.hdy.6800917; Thioulouse J, 1995, ENVIRON ECOL STAT, V2, P1, DOI 10.1007/BF00452928; TONSOR SJ, 1993, EVOLUTION, V47, P833, DOI [10.2307/2410187, 10.1111/j.1558-5646.1993.tb01237.x]; Toonen RJ, 2001, EVOLUTION, V55, P2439; Toonen RJ, 2011, CRUSTACEAN ISS, V19, P75; Van Kleunen M, 2001, ECOLOGY, V82, P3309, DOI 10.1890/0012-9658(2001)082[3309:AEOPFR]2.0.CO;2; Vekemans X, 2004, MOL ECOL, V13, P921, DOI 10.1046/j.1365-294X.2004.02076.x; Vermeij MJA, 2007, EVOL ECOL, V21, P27, DOI 10.1007/s10682-006-9122-z; Warner ME, 1999, P NATL ACAD SCI USA, V96, P8007, DOI 10.1073/pnas.96.14.8007; Zepp RG, 2008, LIMNOL OCEANOGR, V53, P1909, DOI 10.4319/lo.2008.53.5.1909	84	15	15	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0122127	10.1371/journal.pone.0122127	http://dx.doi.org/10.1371/journal.pone.0122127			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25806798	Green Published, gold			2022-12-26	WOS:000351880000204
J	Hasni, I; Yaakoubi, H; Hamdani, S; Tajmir-Riahi, HA; Carpentier, R				Hasni, Imed; Yaakoubi, Hnia; Hamdani, Saber; Tajmir-Riahi, Heidar-Ali; Carpentier, Robert			Mechanism of Interaction of Al3+ with the Proteins Composition of Photosystem II	PLOS ONE			English	Article							PHOTOSYNTHETIC OXYGEN EVOLUTION; MANGANESE-STABILIZING PROTEIN; LIGHT-HARVESTING COMPLEX; WATER-OXIDIZING COMPLEX; TRANSFORM INFRARED-SPECTROSCOPY; CHLOROPHYLL FLUORESCENCE; EXTRINSIC POLYPEPTIDES; THYLAKOID MEMBRANES; SECONDARY STRUCTURE; ELECTRON-TRANSPORT	The inhibitory effect of Al3+on photosystem II (PSII) electron transport was investigated using several biophysical and biochemical techniques such as oxygen evolution, chlorophyll fluorescence induction and emission, SDS-polyacrylamide and native green gel electrophoresis, and FTIR spectroscopy. In order to understand the mechanism of its inhibitory action, we have analyzed the interaction of this toxic cation with proteins subunits of PSII submembrane fractions isolated from spinach. Our results show that Al (3+), especially above 3 mM, strongly inhibits oxygen evolution and affects the advancement of the S states of the Mn4O5Ca cluster. This inhibition was due to the release of the extrinsic polypeptides and the disorganization of the Mn4O5Ca cluster associated with the oxygen evolving complex (OEC) of PSII. This fact was accompanied by a significant decline of maximum quantum yield of PSII (F-v/F-m) together with a strong damping of the chlorophyll a fluorescence induction. The energy transfer from light harvesting antenna to reaction centers of PSII was impaired following the alteration of the light harvesting complex of photosystem II (LHCII). The latter result was revealed by the drop of chlorophyll fluorescence emission spectra at low temperature (77 K), increase of F-0 and confirmed by the native green gel electrophoresis. FTIR measurements indicated that the interaction of Al (3+) with the intrinsic and extrinsic polypeptides of PSII induces major alterations of the protein secondary structure leading to conformational changes. This was reflected by a major reduction of alpha-helix with an increase of beta-sheet and random coil structures in Al (3+)-PSII complexes. These structural changes are closely related with the functional alteration of PSII activity revealed by the inhibition of the electron transport chain of PSII.	[Hasni, Imed; Yaakoubi, Hnia; Tajmir-Riahi, Heidar-Ali; Carpentier, Robert] Univ Quebec Trois Rivieres, Dept Chem Biochem & Phys, Res Grp Plant Biol, Trois Rivieres, PQ GA9 5H7, Canada; [Hamdani, Saber] Chinese Acad Sci, Plant Syst Biol Grp, Partner Inst Computat Biol, Shanghai, Peoples R China	University of Quebec; University of Quebec Trois Rivieres; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Carpentier, R (corresponding author), Univ Quebec Trois Rivieres, Dept Chem Biochem & Phys, Res Grp Plant Biol, Trois Rivieres, PQ GA9 5H7, Canada.	Robert.Carpentier@uqtr.ca			Natural Sciences and Engineering Research Council of Canada [RGPIN-2014-03911]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by the Natural Sciences and Engineering Research Council of Canada RGPIN-2014-03911 www.nserc.ca to RC. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMED A, 1995, FEBS LETT, V363, P65, DOI 10.1016/0014-5793(95)00282-E; Ali NA, 2006, PHOTOSYNTH RES, V89, P81, DOI 10.1007/s11120-006-9085-5; ALLEN KD, 1991, ANAL BIOCHEM, V194, P214, DOI 10.1016/0003-2697(91)90170-X; Babani F, 1996, J PLANT PHYSIOL, V148, P555, DOI 10.1016/S0176-1617(96)80075-7; Ballottari M, 2012, BBA-BIOENERGETICS, V1817, P143, DOI 10.1016/j.bbabio.2011.06.005; Barber J, 2006, BIOCHEM SOC T, V34, P619, DOI 10.1042/BST0340619; Barber J, 1999, TRENDS BIOCHEM SCI, V24, P43, DOI 10.1016/S0968-0004(98)01348-6; Barra M, 2005, PHOTOSYNTH RES, V84, P231, DOI 10.1007/s11120-004-7158-x; Barros T, 2009, EMBO J, V28, P298, DOI 10.1038/emboj.2008.276; Beauchemkin R, 2007, BBA-BIOENERGETICS, V1767, P905, DOI 10.1016/j.bbabio.2007.04.001; BERNIER M, 1995, FEBS LETT, V360, P251, DOI 10.1016/0014-5793(95)00101-E; BERTHOLD DA, 1981, FEBS LETT, V134, P231, DOI 10.1016/0014-5793(81)80608-4; Blankenship R. E., 2002, MOLECULAR MECHANISMS; Boisvert S, 2007, BIOMETALS, V20, P879, DOI 10.1007/s10534-007-9081-z; Boisvert S, 2006, FEBS J, V273, P4770, DOI 10.1111/j.1742-4658.2006.05475.x; Boucher N, 1999, PHOTOSYNTH RES, V59, P167, DOI 10.1023/A:1006194621553; BREDENKAMP GJ, 1990, PHOTOSYNTH RES, V23, P111, DOI 10.1007/BF00030071; Bricker T.M., 2011, BIOCHIM BIOPHYS ACTA, V1817, P121, DOI [DOI 10.1016/J.BBABI0.2011.07.006, 10.1016/j.bbabio.2011.07.006]; Bricker TM, 2005, ADV PHOTO RESPIRAT, V22, P95; BRICKER TM, 1992, BIOCHEMISTRY-US, V31, P4623, DOI 10.1021/bi00134a012; BRICKER TM, 1996, OXYGENIC PHOTOSYNTHE, P113; BURNAP RL, 1992, BIOCHEMISTRY-US, V31, P7404, DOI 10.1021/bi00147a027; Carpentier R., 2002, HDB PLANT CROP PHYSL, P764; Chen LS, 2005, ANN BOT-LONDON, V96, P35, DOI 10.1093/aob/mci145; DEBUS RJ, 1992, BIOCHIM BIOPHYS ACTA, V1102, P269, DOI 10.1016/0005-2728(92)90133-M; Dekker JP, 2005, BBA-BIOENERGETICS, V1706, P12, DOI 10.1016/j.bbabio.2004.09.009; DelasRivas J, 1997, BIOCHEMISTRY-US, V36, P8897, DOI 10.1021/bi970684w; Dewez D, 2005, AQUAT TOXICOL, V74, P150, DOI 10.1016/j.aquatox.2005.05.007; Enami I, 2008, PHOTOSYNTH RES, V98, P349, DOI 10.1007/s11120-008-9343-9; Fagioni M, 2009, J PROTEOME RES, V8, P310, DOI 10.1021/pr800507x; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; GHANOTAKIS DF, 1985, FEBS LETT, V192, P1, DOI 10.1016/0014-5793(85)80030-2; GOVINDJEE, 1995, AUST J PLANT PHYSIOL, V22, P131, DOI 10.1071/PP9950131; Hamdani S, 2009, BBA-BIOENERGETICS, V1787, P1223, DOI 10.1016/j.bbabio.2009.05.009; Hankamer B, 1997, EUR J BIOCHEM, V243, P422, DOI 10.1111/j.1432-1033.1997.0422a.x; Hasni I, 2013, PHOTOCHEM PHOTOBIOL, V89, P1135, DOI 10.1111/php.12116; HE WZ, 1991, BIOCHEMISTRY-US, V30, P4552, DOI 10.1021/bi00232a027; JACKSON M, 1991, BIOCHEMISTRY-US, V30, P9681, DOI 10.1021/bi00104a016; Janik E, 2010, PLANT CELL PHYSIOL, V51, P1330, DOI 10.1093/pcp/pcq093; JEGERSCHOLD C, 1995, BIOCHEMISTRY-US, V34, P12747, DOI 10.1021/bi00039a034; Jegerschold C, 1999, BIOCHEMISTRY-US, V38, P12439, DOI 10.1021/bi990236j; Jiang HX, 2008, TREE PHYSIOL, V28, P1863, DOI 10.1093/treephys/28.12.1863; Jin SH, 2011, RUSS J PLANT PHYSL+, V58, P560, DOI 10.1134/S102144371103006X; Joly D, 2005, PHOTOSYNTH RES, V84, P107, DOI 10.1007/s11120-004-7763-8; Kochian LV, 2005, PLANT SOIL, V274, P175, DOI 10.1007/s11104-004-1158-7; KOCHIAN LV, 1995, ANNU REV PLANT PHYS, V46, P237, DOI 10.1146/annurev.pp.46.060195.001321; Kochubey SM, 2010, PHOTOSYNTH RES, V106, P239, DOI 10.1007/s11120-010-9599-8; KOK B, 1970, PHOTOCHEM PHOTOBIOL, V11, P457, DOI 10.1111/j.1751-1097.1970.tb06017.x; KRAUSE GH, 1991, ANNU REV PLANT PHYS, V42, P313, DOI 10.1146/annurev.pp.42.060191.001525; KRIEGER A, 1993, BIOCHIM BIOPHYS ACTA, V1144, P411, DOI 10.1016/0005-2728(93)90128-3; KRIMM S, 1986, ADV PROTEIN CHEM, V38, P181, DOI 10.1016/S0065-3233(08)60528-8; Kruger GHJ, 1997, PHYSIOL PLANTARUM, V101, P265, DOI 10.1034/j.1399-3054.1997.1010203.x; Kupper H, 2002, J PHYCOL, V38, P429, DOI 10.1046/j.1529-8817.2002.01148.x; KUWABARA T, 1982, PLANT CELL PHYSIOL, V23, P533, DOI 10.1093/oxfordjournals.pcp.a076378; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lazar D, 2006, FUNCT PLANT BIOL, V33, P9, DOI 10.1071/FP05095; Lazarova D, 2014, BIOL PLANTARUM, V58, P319, DOI 10.1007/s10535-014-0402-0; Li Z, 2012, PLANT CELL PHYSIOL, V53, P1295, DOI 10.1093/pcp/pcs076; Liu ZF, 2004, NATURE, V428, P287, DOI 10.1038/nature02373; Loll B, 2005, NATURE, V438, P1040, DOI 10.1038/nature04224; Lucinski R, 2006, ACTA BIOCHIM POL, V53, P693; Mallick N, 2003, ECOTOX ENVIRON SAFE, V55, P64, DOI 10.1016/S0147-6513(02)00122-7; Messinger J, 1997, BIOCHEMISTRY-US, V36, P6862, DOI 10.1021/bi962653r; Mihailovic N, 2008, PHOTOSYNTHETICA, V46, P476, DOI 10.1007/s11099-008-0082-0; MIYAO M, 1987, BIOCHIM BIOPHYS ACTA, V890, P151, DOI 10.1016/0005-2728(87)90016-8; Moustakas M, 1996, PLANT PHYSIOL BIOCH, V34, P553; Msilini N, 2011, PHOTOSYNTH RES, V107, P247, DOI 10.1007/s11120-011-9628-2; MURATA N, 1984, BIOCHIM BIOPHYS ACTA, V765, P363, DOI 10.1016/0005-2728(84)90177-4; Nahar S, 1997, J INORG BIOCHEM, V65, P245, DOI 10.1016/S0162-0134(96)00138-9; Nahar S, 1996, J COLLOID INTERF SCI, V178, P648, DOI 10.1006/jcis.1996.0162; Najafpour MM, 2012, INT J HYDROGEN ENERG, V37, P8753, DOI 10.1016/j.ijhydene.2012.02.075; Najafpour MM, 2012, BBA-BIOENERGETICS, V1817, P1110, DOI 10.1016/j.bbabio.2012.04.002; NAKATANI HY, 1984, BIOCHEM BIOPH RES CO, V120, P299, DOI 10.1016/0006-291X(84)91448-7; NANBA O, 1987, P NATL ACAD SCI USA, V84, P109, DOI 10.1073/pnas.84.1.109; NEDUNCHEZHIAN N, 1991, PHYSIOL PLANTARUM, V81, P558; Nelson N, 2006, ANNU REV PLANT BIOL, V57, P521, DOI 10.1146/annurev.arplant.57.032905.105350; Peixoto PHP, 2002, J PLANT NUTR, V25, P821, DOI 10.1081/PLN-120002962; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Pospisil P, 2003, BIOPHYS J, V84, P1370, DOI 10.1016/S0006-3495(03)74952-2; Putrenko II, 1999, BIOCHEMISTRY-US, V38, P10632, DOI 10.1021/bi990518j; Rajagopal S, 2002, J PHOTOCH PHOTOBIO B, V67, P194, DOI 10.1016/S1011-1344(02)00326-3; Ralph PJ, 1998, ENVIRON POLLUT, V103, P91, DOI 10.1016/S0269-7491(98)00121-3; RASHID A, 1994, FEBS LETT, V350, P296, DOI 10.1016/0014-5793(94)00789-6; RASHID A, 1991, PHOTOSYNTH RES, V30, P123, DOI 10.1007/BF00042010; RENGER G, 1993, Z NATURFORSCH C, V48, P234; Renger G, 2008, PHOTOSYNTH RES, V98, P53, DOI 10.1007/s11120-008-9345-7; Reyes-Diaz M, 2010, J AM SOC HORTIC SCI, V135, P212, DOI 10.21273/JASHS.135.3.212; Roose JL, 2007, PHOTOSYNTH RES, V92, P369, DOI 10.1007/s11120-006-9117-1; Roose JL, 2010, BIOCHEMISTRY-US, V49, P6042, DOI 10.1021/bi100303f; RUTHERFORD AW, 1989, TRENDS BIOCHEM SCI, V14, P227, DOI 10.1016/0968-0004(89)90032-7; SANDUSKY PO, 1986, BIOCHIM BIOPHYS ACTA, V849, P85, DOI 10.1016/0005-2728(86)90099-X; Seidler A, 1996, BBA-BIOENERGETICS, V1277, P35, DOI 10.1016/S0005-2728(96)00102-8; Sersen F, 1997, J PLANT PHYSIOL, V151, P299, DOI 10.1016/S0176-1617(97)80256-8; Shen J.R., 2008, PHOTOSYNTHETIC PROTE, P83, DOI [10.1002/9783527623464.ch4, DOI 10.1002/9783527623464.CH4]; SHEN JR, 1993, BIOCHEMISTRY-US, V32, P1825, DOI 10.1021/bi00058a017; Shevela DN, 2006, BBA-BIOENERGETICS, V1757, P253, DOI 10.1016/j.bbabio.2006.04.004; Siffel P, 2000, PHOTOSYNTH RES, V65, P219, DOI 10.1023/A:1010730103382; Sigfridsson KGV, 2004, BBA-BIOENERGETICS, V1659, P19, DOI 10.1016/j.bbabio.2004.07.003; Silva S, 2012, PLANT PHYSIOL BIOCH, V54, P105, DOI 10.1016/j.plaphy.2012.02.004; Sproviero EM, 2008, J AM CHEM SOC, V130, P3428, DOI 10.1021/ja076130q; Suorsa M, 2007, PHOTOSYNTH RES, V93, P89, DOI 10.1007/s11120-007-9154-4; SUREWICZ WK, 1988, BIOCHIM BIOPHYS ACTA, V952, P115, DOI 10.1016/0167-4838(88)90107-0; SUSI H, 1986, METHOD ENZYMOL, V130, P290; Tang YL, 2005, PLANT PHYSIOL BIOCH, V43, P193, DOI 10.1016/j.plaphy.2004.12.009; TREWHELLA J, 1989, BIOCHEMISTRY-US, V28, P1294, DOI 10.1021/bi00429a052; van Gorkom HJ, 2005, ADV PHOTO RESPIRAT, V22, P307; VANDENBUSSCHE G, 1992, EUR J BIOCHEM, V203, P201, DOI 10.1111/j.1432-1033.1992.tb19848.x; Wyman AJ, 2005, PHOTOSYNTH RES, V85, P359, DOI 10.1007/s11120-005-7385-9; Yruela I, 2000, PHYSIOL PLANTARUM, V110, P551, DOI 10.1034/j.1399-3054.2000.1100419.x; Zeinalov Yuzeir, 2002, Bulgarian Journal of Plant Physiology, V28, P57; Zhu XG, 2005, PLANTA, V223, P114, DOI 10.1007/s00425-005-0064-4	111	15	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0120876	10.1371/journal.pone.0120876	http://dx.doi.org/10.1371/journal.pone.0120876			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25806795	gold, Green Published, Green Submitted			2022-12-26	WOS:000351880000108
J	Willaert, W; De Vos, M; Van Hoof, T; Delrue, L; Pattyn, P; D'Herde, K				Willaert, Wouter; De Vos, Marie; Van Hoof, Tom; Delrue, Louke; Pattyn, Piet; D'Herde, Katharina			Understanding Thiel Embalming in Pig Kidneys to Develop a New Circulation Model	PLOS ONE			English	Article							HUMAN CADAVERS; PRESERVATION; FORMALIN; ANATOMY	The quality of tissue preservation in Thiel embalmed bodiesvaries. Research on the administered embalming volume and its vascular distribution may elucidate one of the mechanisms of tissue preservation and allow for new applications of Thiel embalming. Vascular embalming with (group 1, n = 15) or without (group 2, n = 20) contrast agent was initiated in pig kidneys. The distribution of Thiel embalming solution in group 1 was visualized using computed tomography. The kidneys in both groups were then immersed in concentrated salt solutions to reduce their weight and volume. Afterwards, to mimic a lifelike circulation in the vessels, group 2 underwent pump-driven reperfusion for 120 minutes with either paraffinum perliquidum or diluted polyethylene glycol. The circulation was imaged with computed tomography. All of the kidneys were adequately preserved. The embalming solution spread diffusely in the kidney, but fluid accumulation was present. Subsequent immersion in concentrated salt solutions reduced weight (P < 0.01) and volume (P < 0.01). Reperfusion for 120 minutes was established in group 2. Paraffinum perliquidum filled both major vessels and renal tissue, whereas diluted polyethylene glycol spread widely in the kidney. There were no increases in weight (P = 0.26) and volume (P = 0.79); and pressure further decreased (P = 0.032) after more than 60 minutes of reperfusion with paraffinum perliquidum, whereas there were increases in weight (P = 0.005), volume (P = 0.032) and pressure (P < 0.0001) after reperfusion with diluted polyethylene glycol. Arterial embalming of kidneys results in successful preservation due to complete parenchymatous spreading. More research is needed to determine whether other factors affect embalming quality. Dehydration is an effective method to regain the organs' initial status. Prolonged vascular reperfusion with paraffinum perliquidum can be established in this model without increases in weight, volume and pressure.	[Willaert, Wouter; De Vos, Marie; Pattyn, Piet] Ghent Univ Hosp, Dept Gastrointestinal Surg, Ghent, Belgium; [Van Hoof, Tom; D'Herde, Katharina] Ghent Univ Hosp, Dept Basic Med Sci, Ghent, Belgium; [Delrue, Louke] Ghent Univ Hosp, Dept Radiol & Med Imaging, Ghent, Belgium	Ghent University; Ghent University Hospital; Ghent University; Ghent University Hospital; Ghent University; Ghent University Hospital	Willaert, W (corresponding author), Ghent Univ Hosp, Dept Gastrointestinal Surg, Ghent, Belgium.	wouter.willaert@ugent.be	D'Herde, Katharina/AAM-4570-2020	D'Herde, Katharina/0000-0001-6591-0476				Benkhadra M, 2011, SURG RADIOL ANAT, V33, P359, DOI 10.1007/s00276-010-0705-6; Benkhadra M, 2009, SURG RADIOL ANAT, V31, P531, DOI 10.1007/s00276-009-0477-z; Eisma R, 2013, CLIN ANAT, V26, P564, DOI 10.1002/ca.22222; Eisma R, 2011, SURG-J R COLL SURG E, V9, P142, DOI 10.1016/j.surge.2010.09.001; Eisma R, 2013, MINIM INVASIV THER, V22, P291, DOI 10.3109/13645706.2013.769451; Giger U, 2008, SURG ENDOSC, V22, P901, DOI 10.1007/s00464-007-9502-7; Grabherr S, 2006, AJR, V187, P515; Groscurth P, 2001, ANAT REC, V265, P254, DOI 10.1002/ar.10030; Holzle F, 2012, CLIN IMPLANT DENT R, V14, P121, DOI 10.1111/j.1708-8208.2009.00230.x; KASSER U, 1988, BIORHEOLOGY, V25, P727; KERCKAERT I, 2008, ANATOMY, V2, P28, DOI DOI 10.2399/ANA.08.028; Munirama S, 2012, ANAESTHESIA, V67, P721, DOI 10.1111/j.1365-2044.2012.07086.x; Rai BP, 2012, ANAT SCI EDUC, V5, P182, DOI 10.1002/ase.1267; THIEL W, 1992, ANN ANAT, V174, P185, DOI 10.1016/S0940-9602(11)80346-8; Thiel W, 2002, ANN ANAT, V184, P267, DOI 10.1016/S0940-9602(02)80121-2; Willaert W, 2014, EUR SURG RES, V52, P8, DOI 10.1159/000357818; Willaert W, 2015, INDIAN J SURG, V77, pS712, DOI 10.1007/s12262-013-0961-x; Wolff KD, 2008, MICROSURG, V28, P273, DOI 10.1002/micr.20484	18	3	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0120114	10.1371/journal.pone.0120114	http://dx.doi.org/10.1371/journal.pone.0120114			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25806527	Green Published, Green Submitted, gold			2022-12-26	WOS:000351880000067
J	Balvan, J; Krizova, A; Gumulec, J; Raudenska, M; Sladek, Z; Sedlackova, M; Babula, P; Sztalmachova, M; Kizek, R; Chmelik, R; Masarik, M				Balvan, Jan; Krizova, Aneta; Gumulec, Jaromir; Raudenska, Martina; Sladek, Zbysek; Sedlackova, Miroslava; Babula, Petr; Sztalmachova, Marketa; Kizek, Rene; Chmelik, Radim; Masarik, Michal			Multimodal Holographic Microscopy: Distinction between Apoptosis and Oncosis	PLOS ONE			English	Article							CELL-DEATH; DIGITAL HOLOGRAPHY; NECROSIS; INTERFEROMETRY; EXPOSURE; SYSTEM	Identification of specific cell death is of a great value for many scientists. Predominant types of cell death can be detected by flow-cytometry (FCM). Nevertheless, the absence of cellular morphology analysis leads to the misclassification of cell death type due to underestimated oncosis. However, the definition of the oncosis is important because of its potential reversibility. Therefore, FCM analysis of cell death using annexin V/propidium iodide assay was compared with holographic microscopy coupled with fluorescence detection - "Multimodal holographic microscopy (MHM)". The aim was to highlight FCM limitations and to point out MHM advantages. It was shown that the annexin V+/PI-phenotype is not specific of early apoptotic cells, as previously believed, and that morphological criteria have to be necessarily combined with annexin V/PI for the cell death type to be ascertained precisely. MHM makes it possible to distinguish oncosis clearly from apoptosis and to stratify the progression of oncosis.	[Balvan, Jan; Gumulec, Jaromir; Raudenska, Martina; Sztalmachova, Marketa; Masarik, Michal] Masaryk Univ, Fac Med, Dept Pathol Physiol, Brno, Czech Republic; [Balvan, Jan; Krizova, Aneta; Gumulec, Jaromir; Raudenska, Martina; Sztalmachova, Marketa; Kizek, Rene; Chmelik, Radim; Masarik, Michal] Brno Univ Technol, Cent European Inst Technol, CS-61090 Brno, Czech Republic; [Krizova, Aneta] TESCAN Brno Sro, Brno, Czech Republic; [Sladek, Zbysek] Mendel Univ Brno, Dept Morphol Physiol & Anim Genet, Brno, Czech Republic; [Sedlackova, Miroslava] Masaryk Univ, Dept Histol & Embryol, Fac Med, Brno, Czech Republic; [Babula, Petr] Masaryk Univ, Dept Physiol, Fac Med, Brno, Czech Republic; [Kizek, Rene] Mendel Univ Brno, Dept Chem & Biochem, Brno, Czech Republic; [Chmelik, Radim] Brno Univ Technol, Fac Mech Engn, Inst Engn Phys, CS-61090 Brno, Czech Republic	Masaryk University Brno; Brno University of Technology; Mendel University in Brno; Masaryk University Brno; Masaryk University Brno; Mendel University in Brno; Brno University of Technology	Masarik, M (corresponding author), Masaryk Univ, Fac Med, Dept Pathol Physiol, Brno, Czech Republic.	masarik@med.muni.cz	Gumulec, Jaromir/D-7638-2012; Křížová, Aneta/ABC-9504-2021; Sztalmachová, Markéta/F-4144-2012; Sládek, Zbyšek/J-2703-2018; Raudenska, Martina/F-9187-2012; Babula, Petr/AAL-6510-2020; Chmelik, Radim/D-7616-2012; Balvan, Jan/I-2945-2012; Masarik, Michal/D-9920-2012; Křížová, Aneta/G-8475-2014	Gumulec, Jaromir/0000-0002-9658-3444; Křížová, Aneta/0000-0002-9919-6204; Raudenska, Martina/0000-0001-8258-6671; Chmelik, Radim/0000-0001-5410-4794; Masarik, Michal/0000-0003-1172-7195; Sladek, Zbysek/0000-0002-9268-4811; Kizek, Rene/0000-0002-0467-6169	CEITEC [CZ.1.05/1.1.00/02.0068]; project for conceptual development of research organization (Faculty of Medicine, Masaryk university) [ROZV/24/LF5/2014]; CEITEC Central European Institute of Technology under CEITEC-open access project [LM2011020]; Ministry of Education, Youth and Sports of the Czech Republic	CEITEC; project for conceptual development of research organization (Faculty of Medicine, Masaryk university); CEITEC Central European Institute of Technology under CEITEC-open access project; Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic)	The financial support from CEITEC CZ.1.05/1.1.00/02.0068 and project for conceptual development of research organization (Faculty of Medicine, Masaryk university - ROZV/24/LF5/2014) is greatly acknowledged. Part of the work was carried out with the support of core facilities of CEITEC Central European Institute of Technology under CEITEC-open access project, ID number LM2011020, funded by the Ministry of Education, Youth and Sports of the Czech Republic under the activity "Projects of major infrastructures for research, development and innovations". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARER R, 1957, J OPT SOC AM, V47, P545, DOI 10.1364/JOSA.47.000545; Boss D, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.3.036007; Buja LM, 1998, CIRCULATION, V98, P1355, DOI 10.1161/01.CIR.98.14.1355; Carl D, 2004, APPL OPTICS, V43, P6536, DOI 10.1364/AO.43.006536; Chanan-Khan Asher, 2004, J Support Oncol, V2, P251; Chmelik R, 2014, PROG OPTICS, V59, P267, DOI 10.1016/B978-0-444-63379-8.00005-2; Cuche E, 1999, OPT LETT, V24, P291, DOI 10.1364/OL.24.000291; DAVIES HG, 1952, NATURE, V169, P541, DOI 10.1038/169541a0; Dubois F, 1999, APPL OPTICS, V38, P7085, DOI 10.1364/AO.38.007085; DUNN GA, 1993, SYM SOC EXP BIOL, V47, P91; Edinger AL, 2004, CURR OPIN CELL BIOL, V16, P663, DOI 10.1016/j.ceb.2004.09.011; Freude B, 1998, BASIC RES CARDIOL, V93, P85, DOI 10.1007/s003950050066; Ghiglia D.C., 1998, 2 DIMENSIONAL PHASE, V1st; Girshovitz P, 2012, BIOMED OPT EXPRESS, V3, P1757, DOI 10.1364/BOE.3.001757; GOLDSTEIN RM, 1988, RADIO SCI, V23, P713, DOI 10.1029/RS023i004p00713; Gonzalez VM, 2001, MOL PHARMACOL, V59, P657, DOI 10.1124/mol.59.4.657; GRASLKRAUPP B, 1995, HEPATOLOGY, V21, P1465, DOI 10.1016/0270-9139(95)90071-3; Gumulec J, 2014, INT J ONCOL, V44, P923, DOI 10.3892/ijo.2013.2223; HAANEN C, 1995, MEDIAT INFLAMM, V4, P5, DOI 10.1155/S0962935195000020; Hinson Jack A, 2010, Handb Exp Pharmacol, P369, DOI 10.1007/978-3-642-00663-0_12; Hoffman RM, 2006, NAT PROTOC, V1, P775, DOI 10.1038/nprot.2006.109; Holubova M, 2014, METALLOMICS, V6, P1240, DOI 10.1039/c4mt00065j; Janeckova H, 2009, ANTICANCER RES, V29, P2339; Jolly PD, 1997, BIOL REPROD, V56, P837, DOI 10.1095/biolreprod56.4.837; Kolman P, 2010, OPT EXPRESS, V18, P21990, DOI 10.1364/OE.18.021990; KREIS T, 1986, J OPT SOC AM A, V3, P847, DOI 10.1364/JOSAA.3.000847; Krysko O, 2004, APOPTOSIS, V9, P495, DOI 10.1023/B:APPT.0000031452.75162.75; Lecoeur H, 2001, CYTOMETRY, V44, P65, DOI 10.1002/1097-0320(20010501)44:1<65::AID-CYTO1083>3.0.CO;2-Q; Mahdi Eamon J., 2014, J MICROSCOPY ULTRAST, V2, P20; Masarik M, 2012, INTEGR BIOL-UK, V4, P672, DOI 10.1039/c2ib00157h; Popescu G., 2011, QUANTITATIVE PHASE I; Popescu G, 2008, AM J PHYSIOL-CELL PH, V295, pC538, DOI 10.1152/ajpcell.00121.2008; Rappaz B, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3147385; Rappaz B, 2009, BLOOD CELL MOL DIS, V42, P228, DOI 10.1016/j.bcmd.2009.01.018; Rock KL, 2008, ANNU REV PATHOL-MECH, V3, P99, DOI 10.1146/annurev.pathmechdis.3.121806.151456; Shaked NT, 2011, QUANTITATIVE ANAL BI; Shin D, 2010, OPT LETT, V35, P4066, DOI 10.1364/OL.35.004066; Slaby T, 2013, OPT EXPRESS, V21, P14747, DOI 10.1364/OE.21.014747; Trump BF, 1997, TOXICOL PATHOL, V25, P82, DOI 10.1177/019262339702500116; Wang Z., 2011, J BIOMED OPT, V16; Weerasinghe P, 2012, EXP MOL PATHOL, V93, P302, DOI 10.1016/j.yexmp.2012.09.018; Wlodkowic D, 2010, CYTOM PART A, V77A, P591, DOI 10.1002/cyto.a.20889; Xu L, 2000, OPT ENG, V39, P3214, DOI 10.1117/1.1327503; Yamamoto N, 2004, CANCER RES, V64, P4251, DOI 10.1158/0008-5472.CAN-04-0643; Zhang T, 1998, OPT LETT, V23, P1221, DOI 10.1364/OL.23.001221; Zhu JB, 2003, ACTA HAEMATOL-BASEL, V110, P1, DOI 10.1159/000072407; Zikmund T, 2014, J MICROSC-OXFORD, V256, P117, DOI 10.1111/jmi.12165	47	36	36	1	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0121674	10.1371/journal.pone.0121674	http://dx.doi.org/10.1371/journal.pone.0121674			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803711	Green Published, gold, Green Submitted			2022-12-26	WOS:000353889600171
J	Dellaca, RL; Aliverti, A; Lo Mauro, A; Lutchen, KR; Pedotti, A; Suki, B				Dellaca, Raffaele L.; Aliverti, Andrea; Lo Mauro, Antonella; Lutchen, Kenneth R.; Pedotti, Antonio; Suki, Bela			Correlated Variability in the Breathing Pattern and End-Expiratory Lung Volumes in Conscious Humans	PLOS ONE			English	Article							OPTOELECTRONIC PLETHYSMOGRAPHY; ANESTHETIZED RATS; HUMAN RESPIRATION; INPUT IMPEDANCE; TIDAL VOLUME; CHEST-WALL; MECHANICS; EXERCISE; INFANTS; AIRWAY	In order to characterize the variability and correlation properties of spontaneous breathing in humans, the breathing pattern of 16 seated healthy subjects was studied during 40 min of quiet breathing using opto-electronic plethysmography, a contactless technology that measures total and compartmental chest wall volumes without interfering with the subjects breathing. From these signals, tidal volume (V-T), respiratory time (T-TOT) and the other breathing pattern parameters were computed breath-by-breath together with the end-expiratory total and compartmental (pulmonary rib cage and abdomen) chest wall volume changes. The correlation properties of these variables were quantified by detrended fluctuation analysis, computing the scaling exponenta. V-T, T-TOT and the other breathing pattern variables showed a values between 0.60 (for minute ventilation) to 0.71 (for respiratory rate), all significantly lower than the ones obtained for end-expiratory volumes, that ranged between 1.05 (for rib cage) and 1.13 (for abdomen) with no significant differences between compartments. The much stronger long-range correlations of the end expiratory volumes were interpreted by a neuromechanical network model consisting of five neuron groups in the brain respiratory center coupled with the mechanical properties of the respiratory system modeled as a simple Kelvin body. The model-based a for V-T is 0.57, similar to the experimental data. While the a for T-TOT was slightly lower than the experimental values, the model correctly predicted a for end-expiratory lung volumes (1.045). In conclusion, we propose that the correlations in the timing and amplitude of the physiological variables originate from the brain with the exception of end-expiratory lung volume, which shows the strongest correlations largely due to the contribution of the viscoelastic properties of the tissues. This cycle-by-cycle variability may have a significant impact on the functioning of adherent cells in the respiratory system.	[Dellaca, Raffaele L.; Aliverti, Andrea; Lo Mauro, Antonella; Pedotti, Antonio] Politecn Milano Univ, DEIB, Milan, Italy; [Lutchen, Kenneth R.; Suki, Bela] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA	Polytechnic University of Milan; Boston University	Dellaca, RL (corresponding author), Politecn Milano Univ, DEIB, Milan, Italy.	raffaele.dellaca@polimi.it	Dellaca', Raffaele/AAF-7078-2019; Andrea, Aliverti/A-3901-2015	Dellaca', Raffaele/0000-0002-3672-4591; Andrea, Aliverti/0000-0002-2950-0231; LoMauro, Antonella/0000-0002-1408-6971	NIH [HL-098976]; Italian Ministry of Health 'Ricerca Corrente IRCCS' program-Fondazione don Gnocchi IRCCS; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098976] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Italian Ministry of Health 'Ricerca Corrente IRCCS' program-Fondazione don Gnocchi IRCCS; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was funded by NIH HL-098976 and Italian Ministry of Health 'Ricerca Corrente IRCCS' program-Fondazione don Gnocchi IRCCS.	Aliverti A, 2000, AM J RESP CRIT CARE, V161, P1546, DOI 10.1164/ajrccm.161.5.9903024; Aliverti A, 1997, J APPL PHYSIOL, V83, P1256, DOI 10.1152/jappl.1997.83.4.1256; Aliverti A, 2001, ANN BIOMED ENG, V29, P60, DOI 10.1114/1.1332084; Arold SP, 2003, AM J PHYSIOL-LUNG C, V285, pL370, DOI 10.1152/ajplung.00036.2003; Arold SP, 2009, AM J PHYSIOL-LUNG C, V296, pL574, DOI 10.1152/ajplung.90454.2008; BARNAS GM, 1993, J APPL PHYSIOL, V74, P2286, DOI 10.1152/jappl.1993.74.5.2286; BOTROS SM, 1990, BIOL CYBERN, V63, P143, DOI 10.1007/BF00203037; Brack T, 2002, AM J RESP CRIT CARE, V165, P1260, DOI 10.1164/rccm.2201018; Cala SJ, 1996, J APPL PHYSIOL, V81, P2680, DOI 10.1152/jappl.1996.81.6.2680; Campana LM, 2013, RESP PHYSIOL NEUROBI, V186, P290, DOI 10.1016/j.resp.2013.02.026; Cernelc M, 2002, J APPL PHYSIOL, V92, P1817, DOI 10.1152/japplphysiol.00675.2001; Dellaca RL, 2001, CRIT CARE MED, V29, P1807, DOI 10.1097/00003246-200109000-00026; Fadel PJ, 2004, J APPL PHYSIOL, V97, P2056, DOI 10.1152/japplphysiol.00657.2004; Frey U, 1998, J APPL PHYSIOL, V85, P789, DOI 10.1152/jappl.1998.85.3.789; Fung Y.C., 1993, BIOMECHANICS MECH PR; Glass L, 2001, NATURE, V410, P277, DOI 10.1038/35065745; HANTOS Z, 1992, J APPL PHYSIOL, V72, P168, DOI 10.1152/jappl.1992.72.1.168; HLASTALA MP, 1973, J APPL PHYSIOL, V34, P670, DOI 10.1152/jappl.1973.34.5.670; HOOP B, 1995, CHAOS, V5, P609, DOI 10.1063/1.166130; Iscoe S, 1998, PROG NEUROBIOL, V56, P433, DOI 10.1016/S0301-0082(98)00046-X; Kenyon CM, 1997, J APPL PHYSIOL, V83, P1242, DOI 10.1152/jappl.1997.83.4.1242; NAVAJAS D, 1990, J APPL PHYSIOL, V69, P1372, DOI 10.1152/jappl.1990.69.4.1372; Peng CK, 2002, ANN BIOMED ENG, V30, P683, DOI 10.1114/1.1481053; PENG CK, 1995, CHAOS, V5, P82, DOI 10.1063/1.166141; SUKI B, 1993, J APPL PHYSIOL, V74, P2574, DOI 10.1152/jappl.1993.74.5.2574; SUKI B, 1994, J APPL PHYSIOL, V76, P2749, DOI 10.1152/jappl.1994.76.6.2749; Zhang XB, 2000, AM J PHYSIOL-REG I, V278, pR1446, DOI 10.1152/ajpregu.2000.278.6.R1446; Zhang XB, 2000, ANN BIOMED ENG, V28, P94, DOI 10.1114/1.257	28	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0116317	10.1371/journal.pone.0116317	http://dx.doi.org/10.1371/journal.pone.0116317			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803710	Green Published, gold, Green Submitted			2022-12-26	WOS:000353889600003
J	Liu, LM; Liang, DY; Ye, CG; Tu, WJ; Zhu, T				Liu, Liang Ming; Liang, Dong Yu; Ye, Chang Gen; Tu, Wen Juan; Zhu, Tong			The UII/UT System Mediates Upregulation of Proinflammatory Cytokines through p38 MAPK and NF-kappa B Pathways in LPS-Stimulated Kupffer Cells	PLOS ONE			English	Article							ACUTE LIVER-FAILURE; RECEPTOR 4 ANTAGONIST; UROTENSIN-II; D-GALACTOSAMINE; EXPRESSION; INJURY; MACROPHAGES; RATS; INFLAMMATION; MECHANISMS	The urotensin II (UII)/UII receptor (UT) system is closely related to immune inflammation. In acute liver failure (ALF), the UII/UT system can promote the production and release of proinflammatory cytokines, inducing an inflammatory injury response in liver tissue. However, the mechanism by which the hepatic UII/UT system promotes proinflammatory cytokine production and release is not clear. To solve this problem, we used primary Kupffer cells (KCs) as the model system in the current study. The results showed that after lipopolysaccharide (LPS) stimulation, KCs showed significantly increased expression and release of UII/UT and proinflammatory cytokines tumor necrosis factor alpha (TNF-alpha) and interleukin 1 beta (IL-1 beta). Pretreatment with urantide, which is a UT receptor antagonist, significantly inhibited the LPS-stimulated expression and release of UII/UT, TNF-alpha, and IL-1 beta by KCs. In addition, LPS stimulation induced nuclear p38 mitogen-activated protein kinase (MAPK) protein phosphorylation and expression of the nuclear nuclear factor kappa B (NF-kappa B) p65 subunit in KCs and enhanced the binding activity of NF-kappa B to DNA molecules, whereas urantide pretreatment significantly inhibited the LPS-stimulated nuclear expression and activity of these molecules in KCs. Therefore, our conclusion is that the UII/UT system mediates LPS-stimulated production and release of proinflammatory cytokine by KCs, and this mediating effect at least partially relies on the inflammatory signaling pathway molecules p38 MAPK and NF-kappa B.	[Liu, Liang Ming; Liang, Dong Yu; Ye, Chang Gen; Tu, Wen Juan; Zhu, Tong] Shanghai Jiao Tong Univ, Songjiang Hosp, Peoples Hosp 1, Dept Hepatol, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Liu, LM (corresponding author), Shanghai Jiao Tong Univ, Songjiang Hosp, Peoples Hosp 1, Dept Hepatol, Shanghai 200030, Peoples R China.	liuliangming@hotmail.com	叶, 长根/GPW-6602-2022; liang, dy/GZA-4770-2022	叶, 长根/0000-0001-5750-7660; 	National Natural Science Foundation of China [81070357, 30660066]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The work was supported by grants from National Natural Science Foundation of China (No. 81070357, No. 30660066) (http://www.nsfc.gov.cn/Portal0/default152.htm). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DH, 2010, TOXICOL SCI, V115, P307, DOI 10.1093/toxsci/kfq009; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Bernal W, 2010, LANCET, V376, P190, DOI 10.1016/S0140-6736(10)60274-7; Birker-Robaczewska M, 2003, J RECEPT SIG TRANSD, V23, P289, DOI 10.1081/RRS-120026972; Boivin S, 2006, BIOCHEMISTRY-US, V45, P5993, DOI 10.1021/bi060190b; Chatenet David, 2012, Front Endocrinol (Lausanne), V3, P174, DOI 10.3389/fendo.2012.00174; Chen Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044890; Cirillo P, 2008, J THROMB HAEMOST, V6, P726, DOI 10.1111/j.1538-7836.2008.02923.x; Coulouarn Y, 1998, P NATL ACAD SCI USA, V95, P15803, DOI 10.1073/pnas.95.26.15803; Dai HY, 2007, REGUL PEPTIDES, V140, P88, DOI 10.1016/j.regpep.2006.11.015; Desai N, 2008, CARDIOL REV, V16, P142, DOI 10.1097/CRD.0b013e31815c8048; Fukuda T, 2006, LIFE SCI, V79, P822, DOI 10.1016/j.lfs.2006.03.025; Hoesel B, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-86; Hsieh YC, 2007, MOL IMMUNOL, V44, P2165, DOI 10.1016/j.molimm.2006.11.019; Johns DG, 2004, N-S ARCH PHARMACOL, V370, P238, DOI 10.1007/s00210-004-0980-z; Kitazawa T, 2010, J GASTROEN HEPATOL, V25, P1009, DOI 10.1111/j.1440-1746.2009.06145.x; Kitazawa T, 2009, J GASTROEN HEPATOL, V24, P1089, DOI 10.1111/j.1440-1746.2008.05770.x; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; Leifeld L, 2010, DIGEST DIS SCI, V55, P1458, DOI 10.1007/s10620-009-0875-4; Liang DY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064895; Liu C, 2010, LAB INVEST, V90, P1805, DOI 10.1038/labinvest.2010.123; Movita D, 2012, J LEUKOCYTE BIOL, V92, P723, DOI 10.1189/jlb.1111566; Nothacker HP, 1999, NAT CELL BIOL, V1, P383, DOI 10.1038/14081; Patacchini R, 2003, BRIT J PHARMACOL, V140, P1155, DOI 10.1038/sj.bjp.0705555; Ross B, 2010, AM J PHYSIOL-REG I, V298, pR1156, DOI 10.1152/ajpregu.00706.2009; Segain JP, 2007, J IMMUNOL, V179, P901, DOI 10.4049/jimmunol.179.2.901; Vaudry H, 2010, ANN NY ACAD SCI, V1200, P53, DOI 10.1111/j.1749-6632.2010.05514.x; Vollmar B, 2009, PHYSIOL REV, V89, P1269, DOI 10.1152/physrev.00027.2008; Watanabe T, 2005, HYPERTENSION, V46, P738, DOI 10.1161/01.HYP.0000184226.99196.b5; Wu ZG, 2010, LIVER INT, V30, P782, DOI 10.1111/j.1478-3231.2010.02262.x; Yang Q, 2012, IMMUNOL LETT, V147, P1, DOI 10.1016/j.imlet.2012.07.002; Zarubin T, 2005, CELL RES, V15, P11, DOI 10.1038/sj.cr.7290257; Zhao J, 2014, EXP THER MED, V7, P1647, DOI 10.3892/etm.2014.1654	33	30	39	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0121383	10.1371/journal.pone.0121383	http://dx.doi.org/10.1371/journal.pone.0121383			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803040	Green Published, Green Submitted, gold			2022-12-26	WOS:000353889600153
J	Mulcahy, EM; Hudson, JB; Beggs, SA; Reid, DW; Roddam, LF; Cooley, MA				Mulcahy, Emily M.; Hudson, Jo B.; Beggs, Sean A.; Reid, David W.; Roddam, Louise F.; Cooley, Margaret A.			High Peripheral Blood Th17 Percent Associated with Poor Lung Function in Cystic Fibrosis	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; T-CELLS; PSEUDOMONAS-AERUGINOSA; CYTOKINE PROFILE; IMMUNE-RESPONSE; INFECTION; DISEASE; LYMPHOCYTES; SECRETION; DYSREGULATION	People with cystic fibrosis (CF) have been reported to make lung T cell responses that are biased towards T helper (Th) 2 or Th17. We hypothesized that CF-related T cell regulatory defects could be detected by analyzing CD4(+) lymphocyte subsets in peripheral blood. Peripheral blood mononuclear cells from 42 CF patients (6 months-53 years old) and 78 healthy controls (2-61 years old) were analyzed for Th1 (IFN-gamma(+)), Th2 (IL-4(+)), Th17 (IL-17(+)), Treg (FOXP3(+)), IL-10(+) and TGF-beta(+) CD4(+) cells. We observed higher proportions of Treg, IL-10(+) and TGF-beta(+) CD4(+) cells in CF adults (>= 18 years old), but not children/adolescents, compared with controls. Within the CF group, high TGF-beta(+)% was associated with chronic Pseudomonas aeruginosa lung infection (p < 0.006). We observed no significant differences between control and CF groups in the proportions of Th1, Th2 or Th17 cells, and no association within the CF group of any subset with sex, CFTR genotype, or clinical exacerbation. However, high Th17% was strongly associated with poor lung function (FEV1 % predicted) (p = 0.0008), and this association was strongest when both lung function testing and blood sampling were performed within one week. Our results are consistent with reports of CF as a Th17 disease and suggest that peripheral blood Th17 levels may be a surrogate marker of lung function in CF.	[Mulcahy, Emily M.; Hudson, Jo B.; Beggs, Sean A.; Reid, David W.; Roddam, Louise F.; Cooley, Margaret A.] Univ Tasmania, Sch Med, Hobart, Tas, Australia; [Beggs, Sean A.; Reid, David W.] Royal Hobart Hosp, Hobart, Tas, Australia	University of Tasmania; Royal Hobart Hospital	Cooley, MA (corresponding author), Univ Tasmania, Sch Med, Hobart, Tas, Australia.	Margaret.Cooley@utas.edu.au	Reid, David W/Y-2343-2018; Reid, David W/B-3263-2011; Roddam, Louise F/C-2408-2019	Reid, David W/0000-0001-9517-8212; Roddam, Louise F/0000-0002-4152-0681	Royal Hobart Hospital Research Foundation; Clifford Craig Medical Research Foundation; School of Medicine, University of Tasmania; Dr Leon Wescombe Cystic Fibrosis Research Fund	Royal Hobart Hospital Research Foundation; Clifford Craig Medical Research Foundation; School of Medicine, University of Tasmania; Dr Leon Wescombe Cystic Fibrosis Research Fund	Royal Hobart Hospital Research Foundation, Clifford Craig Medical Research Foundation, and the School of Medicine, University of Tasmania. The Dr Leon Wescombe Cystic Fibrosis Research Fund provided a scholarship for EM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allard JB, 2006, J IMMUNOL, V177, P5186, DOI 10.4049/jimmunol.177.8.5186; Anil N, 2014, IMMUNOL INVEST, V43, P535, DOI 10.3109/08820139.2014.888447; Australian Cystic Fibrosis Data Registry, 2012, AUSTR CYST FIBR DAT; Bernardi DM, 2013, J PEDIAT-BRAZIL, V89, P40, DOI 10.1016/j.jped.2013.02.007; Brazova J, 2005, CLIN IMMUNOL, V115, P210, DOI 10.1016/j.clim.2005.01.013; BRETT MM, 1992, ARCH DIS CHILD, V67, P1086, DOI 10.1136/adc.67.9.1086; Chan YR, 2013, J ALLERGY CLIN IMMUN, V131, P1117, DOI 10.1016/j.jaci.2012.05.036; Dosanjh AK, 1998, J INTERF CYTOK RES, V18, P851, DOI 10.1089/jir.1998.18.851; Dubin PJ, 2007, INFLAMM RES, V56, P221, DOI 10.1007/s00011-007-6187-2; Fazekas de St Groth B, 2011, METHODS MOL BIOL, V707, P263, DOI 10.1007/978-1-61737-979-6_17; Gratz IK, 2013, J IMMUNOL, V190, P4483, DOI 10.4049/jimmunol.1300212; Hartl D, 2006, J ALLERGY CLIN IMMUN, V117, P204, DOI 10.1016/j.jaci.2005.09.023; Hausler M, 2002, RESP MED, V96, P87, DOI 10.1053/rmed.2001.1217; Himmel ME, 2013, J IMMUNOL, V190, P2001, DOI 10.4049/jimmunol.1201379; Holt PG, 2011, ALLERGY, V66, P13, DOI 10.1111/j.1398-9995.2011.02623.x; Hovhannisyan Z, 2011, GASTROENTEROLOGY, V140, P957, DOI 10.1053/j.gastro.2010.12.002; Vargas-Rojas MI, 2011, RESP MED, V105, P1648, DOI 10.1016/j.rmed.2011.05.017; Knutsen AP, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/843763; Kushwah R, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-138; Lee RJ, 2014, CELL CALCIUM, V55, P325, DOI 10.1016/j.ceca.2014.02.001; MCDONALD TV, 1992, J BIOL CHEM, V267, P3242; McLoughlin RM, 2012, CLIN EXP ALLERGY, V42, P392, DOI 10.1111/j.1365-2222.2011.03882.x; Moser C, 2000, APMIS, V108, P329, DOI 10.1034/j.1600-0463.2000.d01-64.x; Moss RB, 2000, CLIN EXP IMMUNOL, V120, P518, DOI 10.1046/j.1365-2249.2000.01232.x; Mueller C, 2011, AM J RESP CELL MOL, V44, P922, DOI 10.1165/rcmb.2010-0224OC; Noack M, 2014, AUTOIMMUN REV, V13, P668, DOI 10.1016/j.autrev.2013.12.004; Rosenfeld M, 2001, J PEDIATR-US, V139, P359, DOI 10.1067/mpd.2001.117288; Schadenberg AWL, 2011, EUR J IMMUNOL, V41, P1132, DOI 10.1002/eji.201040363; Skov M, 1999, PEDIATR PULM, V27, P74, DOI 10.1002/(SICI)1099-0496(199902)27:2<74::AID-PPUL2>3.0.CO;2-L; Smith DJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109891; Tan HL, 2011, AM J RESP CRIT CARE, V184, P252, DOI 10.1164/rccm.201102-0236OC; Tang XX, 2012, J CELL PHYSIOL, V227, P3887, DOI 10.1002/jcp.24101; Tiringer K, 2013, AM J RESP CRIT CARE, V187, P621, DOI 10.1164/rccm.201206-1150OC; Walter GJ, 2013, ARTHRITIS RHEUM-US, V65, P627, DOI 10.1002/art.37832; Way EE, 2013, EUR J IMMUNOL, V43, P3116, DOI 10.1002/eji.201343713	35	23	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0120912	10.1371/journal.pone.0120912	http://dx.doi.org/10.1371/journal.pone.0120912			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803862	Green Submitted, Green Published, gold			2022-12-26	WOS:000353889600110
J	Ajona, D; Razquin, C; Pastor, MD; Pajares, MJ; Garcia, J; Cardenal, F; Fleischhacker, M; Lozano, MD; Zulueta, JJ; Schmidt, B; Nadal, E; Paz-Ares, L; Montuenga, LM; Pio, R				Ajona, Daniel; Razquin, Cristina; Dolores Pastor, Maria; Jose Pajares, Maria; Garcia, Javier; Cardenal, Felipe; Fleischhacker, Michael; Dolores Lozano, Maria; Zulueta, Javier J.; Schmidt, Bernd; Nadal, Ernest; Paz-Ares, Luis; Montuenga, Luis M.; Pio, Ruben			Elevated Levels of the Complement Activation Product C4d in Bronchial Fluids for the Diagnosis of Lung Cancer	PLOS ONE			English	Article							BRONCHOALVEOLAR LAVAGE; FACTOR-H; CYTOLOGICAL FLUID; TUMOR-MARKERS; BIOMARKER; BIOPSY; CELLS; GLYCOPROTEINS; BRONCHOSCOPY; METHYLATION	Molecular markers in bronchial fluids may contribute to the diagnosis of lung cancer. We previously observed a significant increase of C4d-containing complement degradation fragments in bronchoalveolar lavage (BAL) supernatants from lung cancer patients in a cohort of 50 cases and 22 controls (CUN cohort). The present study was designed to determine the diagnostic performance of these complement fragments (hereinafter jointly referred as C4d) in bronchial fluids. C4d levels were determined in BAL supernatants from two independent cohorts: the CU cohort (25 cases and 26 controls) and the HUVR cohort (60 cases and 98 controls). A series of spontaneous sputum samples from 68 patients with lung cancer and 10 controls was also used (LCCCIO cohort). Total protein content, complement C4, complement C5a, and CYFRA 21-1 were also measured in all cohorts. C4d levels were significantly increased in BAL samples from lung cancer patients. The area under the ROC curve was 0.82 (95% CI = 0.71-0.94) and 0.67 (95% CI = 0.58-0.76) for the CU and HUVR cohorts, respectively. In addition, unlike the other markers, C4d levels in BAL samples were highly consistent across the CUN, CU and HUVR cohorts. Interestingly, C4d test markedly increased the sensitivity of bronchoscopy in the two cohorts in which cytological data were available (CUN and HUVR cohorts). Finally, in the LCCCIO cohort, C4d levels were higher in sputum supernatants from patients with lung cancer (area under the ROC curve: 0.7; 95% CI = 0.56-0.83). In conclusion, C4d is consistently elevated in bronchial fluids from lung cancer patients and may be used to improve the diagnosis of the disease.	[Ajona, Daniel; Razquin, Cristina; Jose Pajares, Maria; Montuenga, Luis M.; Pio, Ruben] Ctr Appl Med Res CIMA, Program Solid Tumors & Biomarkers, Pamplona, Spain; [Dolores Pastor, Maria; Paz-Ares, Luis] Univ Seville, CSIC, Lab Oncol Mol & Nuevas Terapias, Inst Biomed Sevilla IBiS,Hosp Univ Virgen Rocio, Seville, Spain; [Jose Pajares, Maria; Montuenga, Luis M.] Univ Navarra, Sch Med, Dept Histol & Pathol, E-31080 Pamplona, Spain; [Garcia, Javier; Zulueta, Javier J.] Univ Navarra Clin, Dept Pulm Med, Pamplona, Spain; [Cardenal, Felipe; Nadal, Ernest] Catalan Inst Oncol IDIBELL, Dept Med Oncol, Barcelona, Spain; [Fleischhacker, Michael; Schmidt, Bernd] Univ Klinikum Halle, Mol Biol Lab, Saale, Germany; [Dolores Lozano, Maria] Univ Navarra Clin, Dept Pathol, Pamplona, Spain; [Pio, Ruben] Univ Navarra, Sch Sci, Dept Biochem & Genet, E-31080 Pamplona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; University of Navarra; University of Navarra; Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Navarra; University of Navarra	Ajona, D (corresponding author), Ctr Appl Med Res CIMA, Program Solid Tumors & Biomarkers, Pamplona, Spain.	dajonama@unav.es	Zulueta, Javier J/GXZ-5810-2022; Montuenga, Luis M/AAF-7783-2020; Zulueta, Javier J/H-5127-2011; Razquin, Cristina/H-2366-2017; Pio, Ruben/F-5353-2017; Paz-Ares, Luis/AAH-2750-2019; Lozano, Maria D/ABD-9613-2020; Ajona, Daniel/L-5669-2014	Montuenga, Luis M/0000-0002-8739-1387; Zulueta, Javier J/0000-0003-3182-3555; Razquin, Cristina/0000-0003-3480-2645; Pio, Ruben/0000-0002-6831-6111; Lozano, Maria D/0000-0002-6796-9380; GARCIA LOPEZ, JOSE JAVIER/0000-0002-4387-4221; Ajona, Daniel/0000-0001-5517-9165; Nadal, Ernest/0000-0002-9674-5554; Pastor, Maria Dolores/0000-0003-2736-0447	UTE project CIMA; Spanish Government (Red Tematica de Investigacion Cooperativa en Cancer) [RD12/0036/0028, RD12/0036/0040, RD12/0036/0045, RD12/0036/0062]; Fondo de Investigacion Sanitaria-Fondo Europeo de Desarrollo Regional (FEDER) [PI08/1156, CD09/00148, PI10/01652, PI10/00166, PI11/00618, PI11/02688, PI13/00806, PI14/01686]; European Community [HEALTH-F2-2010-258677-CURELUNG]	UTE project CIMA; Spanish Government (Red Tematica de Investigacion Cooperativa en Cancer); Fondo de Investigacion Sanitaria-Fondo Europeo de Desarrollo Regional (FEDER); European Community(European Commission)	This work was supported by "UTE project CIMA", the Spanish Government (Red Tematica de Investigacion Cooperativa en Cancer RD12/0036/0028, RD12/0036/0040, RD12/0036/0045, and RD12/0036/0062; and Fondo de Investigacion Sanitaria-Fondo Europeo de Desarrollo Regional (FEDER) PI08/1156, CD09/00148, PI10/01652, PI10/00166, PI11/00618, PI11/02688, PI13/00806, and PI14/01686), and the European Community's Seventh Framework Programme (HEALTH-F2-2010-258677-CURELUNG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajona D, 2004, CANCER RES, V64, P6310, DOI 10.1158/0008-5472.CAN-03-2328; Ajona D, 2007, J IMMUNOL, V178, P5991, DOI 10.4049/jimmunol.178.9.5991; Ajona D, 2013, JNCI-J NATL CANCER I, V105, P1385, DOI 10.1093/jnci/djt205; Boeri M, 2011, P NATL ACAD SCI USA, V108, P3713, DOI 10.1073/pnas.1100048108; Chapman CJ, 2013, CANCER EPIDEM BIOMAR, V22, P2161, DOI [10.1158/1055-9965.EPI-13-0621, DOI 10.1158/1055-9965.EPI-13-0621]; COOPER KM, 1981, CLIN EXP IMMUNOL, V45, P18; Coronell JAL, 2012, J PROTEOMICS, V76, P102, DOI 10.1016/j.jprot.2012.07.022; Corrales L, 2012, J IMMUNOL, V189, P4674, DOI 10.4049/jimmunol.1201654; Dietrich D, 2012, INT J ONCOL, V40, P825, DOI 10.3892/ijo.2011.1264; Edelman MJ, 2012, J THORAC ONCOL, V7, P649, DOI 10.1097/JTO.0b013e31824a8db0; Finn OJ, 2005, NEW ENGL J MED, V353, P1288, DOI 10.1056/NEJMe058157; Gal P, 2002, IMMUNOBIOLOGY, V205, P383, DOI 10.1078/0171-2985-00140; Goebell PJ, 2008, WORLD J UROL, V26, P5, DOI 10.1007/s00345-008-0240-9; Hong YJ, 2011, J THORAC ONCOL, V6, P1330, DOI 10.1097/JTO.0b013e31822462b1; Hur J, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-392; Kim H, 2004, J CLIN ONCOL, V22, P2363, DOI 10.1200/JCO.2004.10.077; Li J, 2013, INT J CANCER, V132, P1098, DOI 10.1002/ijc.27757; Li QK, 2013, J PROTEOME RES, V12, P3689, DOI 10.1021/pr400274w; Li XJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007013; Maeda H, 2003, INT IMMUNOPHARMACOL, V3, P319, DOI 10.1016/S1567-5769(02)00271-0; Mazzone P, 2002, CLIN CHEST MED, V23, P137, DOI 10.1016/S0272-5231(03)00065-0; Mountain CF, 1997, CHEST, V111, P1710, DOI 10.1378/chest.111.6.1710; Okroj M, 2008, MOL IMMUNOL, V45, P169, DOI 10.1016/j.molimm.2007.04.025; Pio R, 2010, CANCER EPIDEM BIOMAR, V19, P2665, DOI 10.1158/1055-9965.EPI-10-0467; Postmus PE, 2005, CHEST, V128, P16, DOI 10.1378/chest.128.1.16; Schreiber G, 2003, CHEST, V123, p115S, DOI 10.1378/chest.123.1_suppl.115S; Sen S, 2001, LUNG CANCER, V33, P41, DOI 10.1016/S0169-5002(01)00193-3; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Siegel R, 2012, CA-CANCER J CLIN, V62, P220, DOI 10.3322/caac.21149; Topaloglu O, 2004, CLIN CANCER RES, V10, P2284, DOI 10.1158/1078-0432.CCR-1111-3; Travis W, 2004, WHO CLASSIFICATION T; Turner NC, 2012, LANCET ONCOL, V13, pE178, DOI 10.1016/S1470-2045(11)70335-7; Varsano S, 1998, CLIN EXP IMMUNOL, V113, P173; VARSANO S, 1995, AM J RESP CRIT CARE, V152, P1087, DOI 10.1164/ajrccm.152.3.7545058; Villanueva J, 2006, J CLIN INVEST, V116, P271, DOI 10.1172/JCI26022	35	19	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0119878	10.1371/journal.pone.0119878	http://dx.doi.org/10.1371/journal.pone.0119878			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799154	Green Submitted, Green Published, gold			2022-12-26	WOS:000351987300087
J	Basnet, S; Sharma, A; Mathisen, M; Shrestha, PS; Ghimire, RK; Shrestha, DM; Valentiner-Branth, P; Sommerfelt, H; Strand, TA				Basnet, Sudha; Sharma, Arun; Mathisen, Maria; Shrestha, Prakash Sunder; Ghimire, Ram Kumar; Shrestha, Dhiraj Man; Valentiner-Branth, Palle; Sommerfelt, Halvor; Strand, Tor A.			Predictors of Duration and Treatment Failure of Severe Pneumonia in Hospitalized Young Nepalese Children	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; CHILDHOOD PNEUMONIA; PULSE OXIMETRY; RISK-FACTORS; OXYGEN; MORTALITY	Background Pneumonia in young children is still the most frequent cause of death in developing countries. We aimed to identify predictors for recovery and treatment failure in children hospitalized with severe pneumonia. Methods We enrolled 610 Nepalese children, aged 2 - 35 months from February 2006 to June 2008. Study participants were provided with standard treatment for pneumonia and followed up until discharge. Three multiple regression models representing clinical variables, clinical and radiological combined and all variables, including C-reactive protein (CRP) and viral etiology were used to assess the associations. Results The median age of study participants was 6 months with 493 (82%) infants and 367 (61%) males. The median time (IQR) till recovery was 49 (31, 87) hours and treatment failure was experienced by 209 (35%) of the children. Younger age, hypoxia on admission and radiographic pneumonia were independent predictors for both prolonged recovery and risk of treatment failure. While wasting and presence of any danger sign also predicted slower recovery, Parainfluenza type 1 isolated from the nasopharynx was associated with earlier resolution of illness. Gender, being breastfed, stunting, high fever, elevated CRP, presence of other viruses and supplementation with oral zinc did not show any significant association with these outcomes. Conclusion Age, hypoxia and consolidation on chest radiograph were significant predictors for time till recovery and treatment failure in children with severe pneumonia. While chest radiograph is not always needed, detection and treatment of hypoxia is a crucial step to guide the management of hospitalized children with pneumonia.	[Basnet, Sudha; Sharma, Arun; Shrestha, Prakash Sunder] Tribhuvan Univ, Inst Med, Dept Child Hlth, Kathmandu, Nepal; [Basnet, Sudha; Sommerfelt, Halvor; Strand, Tor A.] Univ Bergen, Ctr Int Hlth, Bergen, Norway; [Basnet, Sudha; Sommerfelt, Halvor; Strand, Tor A.] Univ Bergen, Ctr Intervent Sci Maternal & Child Hlth, Bergen, Norway; [Mathisen, Maria] Univ Hosp North Norway, Dept Microbiol & Infect Control, Tromso, Norway; [Ghimire, Ram Kumar] Tribhuvan Univ, Inst Med, Dept Radiol, Kathmandu, Nepal; [Shrestha, Dhiraj Man] Kathmandu Univ, Kathmandu Med Coll, Dept Radiol, Kathmandu, Nepal; [Shrestha, Dhiraj Man] Kathmandu Univ, Teaching Hosp, Kathmandu, Nepal; [Valentiner-Branth, Palle] Statens Serum Inst, Dept Infect Dis Epidemiol, Div Natl Hlth Surveillance & Res, DK-2300 Copenhagen, Denmark; [Sommerfelt, Halvor] Norwegian Inst Publ Hlth, Dept Int Publ Hlth, Oslo, Norway; [Strand, Tor A.] Innlandet Hosp Trust, Div Med Serv, Lillehammer, Norway	Tribhuvan University; Institute of Medicine (IoM) - Nepal; University of Bergen; University of Bergen; UiT The Arctic University of Tromso; University Hospital of North Norway; Tribhuvan University; Institute of Medicine (IoM) - Nepal; Kathmandu University; Kathmandu University; Statens Serum Institut; Norwegian Institute of Public Health (NIPH); Innlandet Hospital Trust	Basnet, S (corresponding author), Tribhuvan Univ, Inst Med, Dept Child Hlth, Kathmandu, Nepal.	sudhacbasnet@gmail.com	Strand, Tor/D-9836-2016; Sommerfelt, Halvor/ABD-3552-2020	Strand, Tor/0000-0002-4038-151X; Sommerfelt, Halvor/0000-0002-5670-9786	European Commission (EU-INCO-DC) [INCO-FP6-003740]; Meltzer Foundation in Bergen, Norway; Danish Council of Developmental Research [91128]; Research Council of Norway (RCN) [151054, 172226]; South-Eastern Norway Regional Health Authority [2012090]	European Commission (EU-INCO-DC)(European CommissionEuropean Commission Joint Research Centre); Meltzer Foundation in Bergen, Norway; Danish Council of Developmental Research; Research Council of Norway (RCN)(Research Council of Norway); South-Eastern Norway Regional Health Authority	This study was funded by grants from the European Commission (EU-INCO-DC contract number INCO-FP6-003740), the Meltzer Foundation in Bergen, Norway, the Danish Council of Developmental Research (project number: 91128), the Research Council of Norway (RCN project numbers: 151054 and 172226) and a grant from the South-Eastern Norway Regional Health Authority (grant number: 2012090) The sponsors of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report. The corresponding author had full access to all the data in the study and took the final decision to submit this report for publication.	Asghar R, 2008, BMJ-BRIT MED J, V336, P80, DOI 10.1136/bmj.39421.435949.BE; Basnet S, 2012, PEDIATRICS, V129, P701, DOI 10.1542/peds.2010-3091; Bharti B, 2008, INDIAN PEDIATR, V45, P893; Bradley JS, 2011, CLIN INFECT DIS, V53, pE25, DOI [10.1093/cid/cir531, 10.1093/cid/cir625]; Cherian T, 2005, B WORLD HEALTH ORGAN, V83, P353; Djelantik IGG, 2003, J TROP PEDIATRICS, V49, P327, DOI 10.1093/tropej/49.6.327; Duke T, 2008, LANCET, V372, P1328, DOI 10.1016/S0140-6736(08)61164-2; Fu LY, 2006, PEDIATRICS, V118, pE1822, DOI 10.1542/peds.2005-2673; Ginsburg AS, 2014, TROP MED INT HEALTH, V19, P537, DOI 10.1111/tmi.12291; Ginsburg AS, 2012, J TROP PEDIATRICS, V58, P389, DOI 10.1093/tropej/fmr103; Harris M, 2011, THORAX, V66, pII1, DOI 10.1136/thoraxjnl-2011-200598; Hosmer D.W., 2005, APPL LOGISTIC REGRES; Jackson S, 2013, CROAT MED J, V54, P110, DOI 10.3325/cmj.2013.54.110; Lupisan SP, 2007, TROP MED INT HEALTH, V12, P962, DOI 10.1111/j.1365-3156.2007.01872.x; Mathisen M, 2011, PEDIATR INFECT DIS J, V30, P1032, DOI 10.1097/INF.0b013e31822f845f; Mower WR, 1997, PEDIATRICS, V99, P681, DOI 10.1542/peds.99.5.681; Patel A, 2008, INT J TUBERC LUNG D, V12, P1320; Reed C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0027793; Rudan I, 2013, J GLOB HEALTH, V3, DOI [10.7189/jogh.03.010101, 10.7189/jogh.03.010401]; Rudan I, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001099; Sigauque B, 2009, J TROP PEDIATRICS, V55, P379, DOI 10.1093/tropej/fmp030; Walker CLF, 2013, LANCET, V381, P1405, DOI 10.1016/S0140-6736(13)60222-6; World Health Organization, 2014, INTEGRATED MANAGEMEN; World Health Organization, 2013, GUIDELINES MANAGEMEN; World Health Organization (WHO), 2005, POCK BOOK HOSP CAR C	25	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0122052	10.1371/journal.pone.0122052	http://dx.doi.org/10.1371/journal.pone.0122052			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798907	Green Published, Green Submitted, gold			2022-12-26	WOS:000351987300314
J	Chia, MY; Hu, AYC; Tseng, YF; Weng, TC; Lai, CC; Lin, JY; Chen, PL; Wang, YF; Chao, SR; Chang, JY; Hwang, YS; Yeh, CT; Yu, CP; Chen, YC; Su, IJ; Lee, MS				Chia, Min-Yuan; Hu, Alan Yung-Chih; Tseng, Yu-Fen; Weng, Tsai-Chuan; Lai, Chia-Chun; Lin, Jun-Yang; Chen, Po-Ling; Wang, Ya-Fang; Chao, Sin-Ru; Chang, Jui-Yuan; Hwang, Yi-Shiuh; Yeh, Chia-Tsui; Yu, Cheng-Ping; Chen, Yee-Chun; Su, Ih-Jen; Lee, Min-Shi			Evaluation of MDCK Cell-Derived Influenza H7N9 Vaccine Candidates in Ferrets	PLOS ONE			English	Article							H5N1 INFLUENZA; WHOLE-VIRUS; CLINICAL-TRIAL; IMMUNIZATION; PROTECTION; IMMUNOGENICITY; TRANSMISSION; CHALLENGE; A(H7N9); TAIWAN	Avian-origin influenza A (H7N9) viruses emerged as human pathogens in China in early 2013 and have killed >100 persons. Influenza vaccines are mainly manufactured using egg-based technology which could not meet the surging demand during influenza pandemics. In this study, we evaluated cell-based influenza H7N9 vaccines in ferrets. An egg-derived influenza H7N9 reassortant vaccine virus was adapted in MDCK cells. Influenza H7N9 whole virus vaccine antigen was manufactured using a microcarrier-based culture system. Immunogenicity and protection of the vaccine candidates with three different formulations (300 mu g aluminum hydroxide, 1.5 mu g HA, and 1.5 mu g HA plus 300 mu g aluminum hydroxide) were evaluated in ferrets. In ferrets receiving two doses of vaccination, geometric mean titers of hemagglutination (HA) inhibition and neutralizing antibodies were <10 and <40 for the control group (adjuvant only), 17 and 80 for the unadjuvanted (HA only) group, and 190 and 640 for the adjuvanted group (HA plus adjuvant), respectively. After challenge with wild-type influenza H7N9 viruses, virus titers in respiratory tracts of the adjuvanted group were significantly lower than that in the control, and unadjuvanted groups. MDCK cell-derived influenza H7N9 whole virus vaccine candidate is immunogenic and protective in ferrets and clinical development is highly warranted.	[Chia, Min-Yuan; Hu, Alan Yung-Chih; Tseng, Yu-Fen; Weng, Tsai-Chuan; Lai, Chia-Chun; Lin, Jun-Yang; Chen, Po-Ling; Wang, Ya-Fang; Chao, Sin-Ru; Chang, Jui-Yuan; Hwang, Yi-Shiuh; Chen, Yee-Chun; Su, Ih-Jen; Lee, Min-Shi] Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Zhunan, Taiwan; [Yeh, Chia-Tsui; Yu, Cheng-Ping] Natl Def Med Ctr, Inst Prevent Med, Taipei, Taiwan	National Health Research Institutes - Taiwan; National Defense Medical Center	Lee, MS (corresponding author), Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Zhunan, Taiwan.	minshi@nhri.org.tw	Chen, Yee-Chun/AGW-7535-2022; Lee, Min-Shi/E-3992-2010; Su, Ih-Jen/B-2655-2010; Lin, Chun-Yang/AAH-1897-2020; Hu, Alan Yung-Chih/G-3708-2011	Chen, Yee-Chun/0000-0002-1816-9010; Lin, Chun-Yang/0000-0002-3064-0178; Yu, Cheng-Ping/0000-0002-0693-5056; Chen, Po-Ling/0000-0002-7179-6144	Ministry of Health and Welfare, Taiwan [MOHW102-TD-B-111-V002]; National Health Research Institutes, Taiwan	Ministry of Health and Welfare, Taiwan; National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan)	This study was funded by the Ministry of Health and Welfare, Taiwan (grant no. MOHW102-TD-B-111-V002) and National Health Research Institutes, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bart SA, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008761; Baz M, 2013, VIRUS RES, V178, P78, DOI 10.1016/j.virusres.2013.05.006; Belser JA, 2013, NATURE, V501, P556, DOI 10.1038/nature12391; Chang SY, 2013, LANCET, V381, P1621, DOI 10.1016/S0140-6736(13)60943-5; Chia MY, 2014, PLOS NEGLECT TROP D, P8; Cox RJ, 2009, VACCINE, V27, P1889, DOI 10.1016/j.vaccine.2009.01.116; Cox RJ, 2009, INFLUENZA OTHER RESP, V3, P107, DOI 10.1111/j.1750-2659.2009.00082.x; European Union Committee of Experts on Rare Diseases, 2013, EUROSURVEILLANCE, P18; Fries LF, 2013, NEW ENGL J MED, V369, P2564, DOI 10.1056/NEJMc1313186; Govorkova EA, 2006, J INFECT DIS, V194, P159, DOI 10.1086/505225; Hehme N, 2004, VIRUS RES, V103, P163, DOI 10.1016/j.virusres.2004.02.029; Hehme N, 2002, MED MICROBIOL IMMUN, V191, P203, DOI 10.1007/s00430-002-0147-9; Horby P, 2013, NATURE, V496, P399, DOI 10.1038/496399a; Hu AYC, 2008, VACCINE, V26, P5736, DOI 10.1016/j.vaccine.2008.08.015; Hu AYC, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0014578, 10.1371/journal.pone.0029229]; Kreijtz JHCM, 2015, J INFECT DIS, V211, P791, DOI 10.1093/infdis/jiu528; Lee MS, 2012, TRENDS MICROBIOL, V20, P103, DOI 10.1016/j.tim.2011.12.002; Middleton D, 2009, J VIROL, V83, P7770, DOI 10.1128/JVI.00241-09; Mulligan MJ, 2014, JAMA-J AM MED ASSOC, V312, P1409, DOI 10.1001/jama.2014.12854; Nicholson KG, 2001, LANCET, V357, P1937, DOI 10.1016/S0140-6736(00)05066-2; Osterholm MT, 2013, JAMA-J AM MED ASSOC, V309, P2557, DOI 10.1001/jama.2013.6589; Pan SC, 2013, J MICROBIOL IMMUNOL, V46, P448, DOI 10.1016/j.jmii.2012.08.002; Partridge J, 2010, VACCINE, V28, P4709, DOI 10.1016/j.vaccine.2010.04.083; Smith GE, 2013, VACCINE, V31, P4305, DOI 10.1016/j.vaccine.2013.07.043; The Lancet Infectious Diseases, 2013, LANCET INFECT DIS; van der Velden MVW, 2014, J INFECT DIS, V209, P12, DOI 10.1093/infdis/jit498; van der Velden MVW, 2012, VACCINE, V30, P6127, DOI 10.1016/j.vaccine.2012.07.077; WOOD JM, 1977, J BIOL STAND, V5, P237, DOI 10.1016/S0092-1157(77)80008-5; World Health Organization, 2002, WHO MAN AN INFL DIAG; World Health Organization, 2014, WHO RISK ASS HUM INF; Zhu H, 2013, SCIENCE, V341, P183, DOI 10.1126/science.1239844; Zhu HC, 2010, VIROLOGY, V401, P1, DOI 10.1016/j.virol.2010.02.024	32	25	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120793	10.1371/journal.pone.0120793	http://dx.doi.org/10.1371/journal.pone.0120793			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799397	gold, Green Published, Green Submitted			2022-12-26	WOS:000351987300178
J	Iqbal, MUN; Khan, TA; Maqbool, SA				Iqbal, Mehr un Nisa; Khan, Taseer Ahmed; Maqbool, Syed Amir			Vitamin D Receptor Cdx-2 Polymorphism and Premenopausal Breast Cancer Risk in Southern Pakistani Patients	PLOS ONE			English	Article							HOMEODOMAIN PROTEIN CDX2; INTESTINAL METAPLASIA; GENE POLYMORPHISMS; PROSTATE-CANCER; GASTRIC-CARCINOMA; ESTROGEN-RECEPTOR; ENDOCRINE THERAPY; BRCA2 MUTATIONS; OVARIAN-CANCER; EXPRESSION	Background Vitamin D3 is a secoster oid that exerts its effect by binding to its nuclear receptor called vitamin D receptor (VDR), inducing apoptosis and thereby inhibiting cell proliferation in cancer cells. The VDR receptor, located in the nucleus, is known to regulate the functions of over 200 genes. Various allelic forms of hVDR have been discovered that increase susceptibility to various cancers. The VDR-Cdx2 polymorphism, located in the promoter region of exon 1e in the VDR gene, influences the functional activity of the receptor, since the hVDR lacks consensus TATA and CAAT boxes. The current investigation examines the association between VDR-Cdx2 polymorphism and breast cancer in premenopausal females from Southern Pakistan. Methods We conducted a case control study on 264 subjects (103 cases and 161 controls) who were recruited from a tertiary hospital located in Karachi, Pakistan. Genomic DNA was extracted from peripheral blood using a commercial kit method, and the VDR-Cdx2 polymorphism was genotyped using tetraprimer amplification refractory mutation system polymerase chain reaction (T-ARMS-PCR) method. Pearson chi square test was used to assess the association between VDR-Cdx2 genotype and breast cancer while genotype distribution in controls was evaluated by Hardy-Weinberg equilibrium (HWE). Breast cancer risk was calculated using odds ratios and 95% confidence intervals. Results The genotype distribution in the control group was in HWE (p > 0.05) for the VDR-Cdx2 polymorphism. A non-significant association was observed between VDR cdx2 polymorphism and breast cancer, however the GG genotype was at risk (OR = 1.832, 95% CI = 0.695-4.828) of developing breast cancer. Conclusion The GG genotype of Cdx2-VDR gene polymorphism may increase the risk of developing breast cancer in young female patients in South Pakistan. Further investigations examining additional single nucleotide polymorphisms (SNPs) in VDR are required to assess their relationships with breast cancer.	[Iqbal, Mehr un Nisa; Khan, Taseer Ahmed] Univ Karachi, Dept Physiol, Karachi, Pakistan; [Maqbool, Syed Amir] Karachi Inst Radiotherapy & Nucl Med, Dept Clin Oncol, Karachi, Pakistan	University of Karachi	Khan, TA (corresponding author), Univ Karachi, Dept Physiol, Karachi, Pakistan.	taseer2@yahoo.com	Khan, Taseer Ahmed/AAP-4917-2020	Khan, Taseer Ahmed/0000-0003-3844-4750				Abbas S, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1994; Almeida R, 2003, J PATHOL, V199, P36, DOI 10.1002/path.1246; Amir E, 2010, JNCI-J NATL CANCER I, V102, P680, DOI 10.1093/jnci/djq088; Anderson LN, 2011, CANCER EPIDEM BIOMAR, V20, P1708, DOI 10.1158/1055-9965.EPI-11-0300; Arai H, 2001, J BONE MINER RES, V16, P1256, DOI 10.1359/jbmr.2001.16.7.1256; Bai YH, 2012, WORLD J GASTROENTERO, V18, P1672, DOI 10.3748/wjg.v18.i14.1672; Bai YQ, 2002, CANCER LETT, V176, P47, DOI 10.1016/S0304-3835(01)00753-4; Berclaz G, 2004, ANN ONCOL, V15, P875, DOI 10.1093/annonc/mdh222; Bertone-Johnson ER, 2009, ANN EPIDEMIOL, V19, P462, DOI 10.1016/j.annepidem.2009.01.003; Bonhomme C, 2003, GUT, V52, P1465, DOI 10.1136/gut.52.10.1465; Boyd NF, 2010, JNCI-J NATL CANCER I, V102, P1224, DOI 10.1093/jnci/djq239; Brown MA, 2001, J BONE MINER RES, V16, P758, DOI 10.1359/jbmr.2001.16.4.758; Campbell MJ, 2000, ONCOGENE, V19, P5091, DOI 10.1038/sj.onc.1203888; Chen L, 2009, CANCER EPIDEM BIOMAR, V18, P2874, DOI 10.1158/1055-9965.EPI-09-0544; Chen WY, 2005, CANCER EPIDEM BIOMAR, V14, P2335, DOI 10.1158/1055-9965.EPI-05-0283; Cheung KL, 2007, BREAST, V16, P327, DOI 10.1016/j.breast.2007.03.004; Chung M, 2011, ANN INTERN MED, V155, P827, DOI 10.7326/0003-4819-155-12-201112200-00005; Dalessandri KM, 2012, J AM COLL SURGEONS, V215, P652, DOI 10.1016/j.jamcollsurg.2012.06.413; Deeb KK, 2007, NAT REV CANCER, V7, P684, DOI 10.1038/nrc2196; Engel LS, 2012, CANCER EPIDEM BIOMAR, V21, P1856, DOI 10.1158/1055-9965.EPI-12-0551; Fang Y, 2003, J BONE MINER RES, V18, P1632, DOI 10.1359/jbmr.2003.18.9.1632; Gonzalez-Sancho JM, 1998, FEBS LETT, V426, P225, DOI 10.1016/S0014-5793(98)00348-2; Guy M, 2004, CLIN CANCER RES, V10, P5472, DOI 10.1158/1078-0432.CCR-04-0206; Hanif M, 2009, ASIAN PAC J CANCER P, V10, P227; Hankinson SE, 2008, ADV EXP MED BIOL, V617, P161, DOI 10.1007/978-0-387-69080-3_15; Harris TJR, 2010, NAT REV CLIN ONCOL, V7, P251, DOI 10.1038/nrclinonc.2010.41; HORWITZ KB, 1975, SCIENCE, V189, P726, DOI 10.1126/science.168640; Imtiaz Saba, 2012, Indian J Endocrinol Metab, V16, P409, DOI 10.4103/2230-8210.95684; Jiao ZJ, 2013, TUMOR BIOL, V34, P1225, DOI 10.1007/s13277-013-0665-7; John EM, 2005, CANCER RES, V65, P5470, DOI 10.1158/0008-5472.CAN-04-3134; Kang JM, 2011, J KOREAN MED SCI, V26, P647, DOI 10.3346/jkms.2011.26.5.647; Krishnan AV, 2010, J STEROID BIOCHEM, V121, P343, DOI 10.1016/j.jsbmb.2010.02.009; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Liede A, 2002, AM J HUM GENET, V71, P595, DOI 10.1086/342506; Lopes N, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-483; Malik Fraz A, 2008, Int Semin Surg Oncol, V5, P21, DOI 10.1186/1477-7800-5-21; Marozik P, 2013, MED KAUMAS, V49, P20; Matsumoto H, 1999, ONCOL REP, V6, P349; McCullough ML, 2009, ANNU REV NUTR, V29, P111, DOI 10.1146/annurev-nutr-080508-141248; Miyamoto K, 1997, MOL ENDOCRINOL, V11, P1165, DOI 10.1210/me.11.8.1165; Mondul AM, 2012, CANCER EPIDEM BIOMAR, V21, P1222, DOI 10.1158/1055-9965.EPI-12-0439; Mutoh H, 2004, CANCER RES, V64, P7740, DOI 10.1158/0008-5472.CAN-04-1617; Pakistan Medical Research Council, 1977, PMRC MON, V1; Plum LA, 2010, NAT REV DRUG DISCOV, V9, P941, DOI 10.1038/nrd3318; Qin R, 2012, WORLD J GASTROENTERO, V18, P3296, DOI 10.3748/wjg.v18.i25.3296; Rashid MU, 2006, INT J CANCER, V119, P2832, DOI 10.1002/ijc.22269; Rollison DE, 2012, BREAST CANCER RES TR, V132, P683, DOI 10.1007/s10549-011-1885-4; Shahbazi S, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0393-7; Sillanpaa P, 2004, PHARMACOGENETICS, V14, P239, DOI 10.1097/01.fpc.0000114724.42625.70; Silva ID, 2008, PLOS MED, V5, P1372, DOI 10.1371/journal.pmed.0050193; Tang CB, 2009, BREAST CANCER RES TR, V117, P391, DOI 10.1007/s10549-008-0262-4; Touvier M, 2011, CANCER EPIDEM BIOMAR, V20, P1003, DOI 10.1158/1055-9965.EPI-10-1141; Townsend K, 2005, CLIN CANCER RES, V11, P3579, DOI 10.1158/1078-0432.CCR-04-2359; Trabert B, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1833; Uitterlinden AG, 2004, GENE, V338, P143, DOI 10.1016/j.gene.2004.05.014; Wacholder S, 2010, NEW ENGL J MED, V362, P986, DOI 10.1056/NEJMoa0907727; Yamamoto H, 1999, J BONE MINER RES, V14, P240, DOI 10.1359/jbmr.1999.14.2.240; Yang BH, 2014, META GENE, V2, P41, DOI 10.1016/j.mgene.2013.09.008; Yao S, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3162; Yin M, 2009, INT J CLIN EXP MED, V2, P159; Zaman Khalil, 2012, Rev Med Suisse, V8, P1101; Zhang K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096125; Zhou ZC, 2013, TUMOR BIOL, V34, P3437, DOI 10.1007/s13277-013-0919-4; Zinser GM, 2004, CARCINOGENESIS, V25, P2361, DOI 10.1093/carcin/bgh271; Zinser GM, 2002, CARCINOGENESIS, V23, P2103, DOI 10.1093/carcin/23.12.2103; Zmuda JM, 2000, EPIDEMIOL REV, V22, P203, DOI 10.1093/oxfordjournals.epirev.a018033	66	16	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0122657	10.1371/journal.pone.0122657	http://dx.doi.org/10.1371/journal.pone.0122657			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799416	Green Submitted, Green Published, gold			2022-12-26	WOS:000351987300339
J	Teplenin, A; Krasheninnikova, A; Agladze, N; Sidoruk, K; Agapova, O; Agapov, I; Bogush, V; Agladze, K				Teplenin, Alexander; Krasheninnikova, Anna; Agladze, Nadezhda; Sidoruk, Konstantin; Agapova, Olga; Agapov, Igor; Bogush, Vladimir; Agladze, Konstantin			Functional Analysis of the Engineered Cardiac Tissue Grown on Recombinant Spidroin Fiber Meshes	PLOS ONE			English	Article							SPIDER SILK; IN-VIVO; BIOMATERIALS; FIBROIN; POLYMERS; BLENDS; ANALOG; MODEL	In the present study, we examined the ability of the recombinant spidroin to serve as a substrate for the cardiac tissue engineering. For this purpose, isolated neonatal rat cardiomyocytes were seeded on the electrospun spidroin fiber matrices and cultured to form the confluent cardiac monolayers. Besides the adhesion assay and immunostaining analysis, we tested the ability of the cultured cardiomyocytes to form a functional cardiac syncytium by studying excitation propagation in the cultured tissue with the aid of optical mapping. It was demonstrated that recombinant spidroin fiber meshes are directly suitable for the adherence and growth of the cardiomyocytes without additional coating with the attachment factors, such as fibronectin.	[Teplenin, Alexander; Krasheninnikova, Anna; Agladze, Nadezhda; Agladze, Konstantin] Moscow Inst Phys & Technol, Dolgoprudnyi 141700, Moscow Region, Russia; [Sidoruk, Konstantin; Bogush, Vladimir] State Res Inst Genet & Select Ind Microorganisms, Moscow 117545, Russia; [Agapova, Olga; Agapov, Igor] Shumakov Res Ctr Transplantol & Artificial Organs, Moscow 123182, Russia	Moscow Institute of Physics & Technology; National Research Centre - Kurchatov Institute; Institute of Genetics & Selection of Industrial Microorganisms; V.I. Shumakov Federal Research Center of Transplantology & Artificial Organs	Agladze, K (corresponding author), Moscow Inst Phys & Technol, Inst Pereulok 9, Dolgoprudnyi 141700, Moscow Region, Russia.	agladze@yahoo.com	Agladze, Konstantin/J-6142-2012; Agladze, Konstantin/X-5496-2019; Bogush, Vladimir G/H-8182-2017; Сидорук, Константин/CAH-4222-2022; Agapova, Olga/AAH-7477-2020; Agapov, Igor/D-9450-2014	Agladze, Konstantin/0000-0002-9258-436X; Agladze, Konstantin/0000-0002-9258-436X; Сидорук, Константин/0000-0001-8952-5409; Agapova, Olga/0000-0002-4507-1852; Agapov, Igor/0000-0002-0273-4601; Bogush, vladimir/0000-0002-5969-3855; Nikitina, Anna/0000-0002-6462-7027; Teplenin, Alexander/0000-0001-7841-376X	Russian Government Program "5 TOP-100"; MIPT	Russian Government Program "5 TOP-100"; MIPT	The work was in part funded by the Russian Government Program "5 TOP-100" and research grant from MIPT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agladze K, 2007, AM J PHYSIOL-HEART C, V293, pH503, DOI 10.1152/ajpheart.01060.2006; Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8; Barczyk M, 2010, CELL TISSUE RES, V339, P269, DOI 10.1007/s00441-009-0834-6; Bhatia SK, 2010, BIOTECHNOL J, V5, P1309, DOI 10.1002/biot.201000230; Bogush VG, 2011, DOKL BIOCHEM BIOPHYS, V441, P276, DOI 10.1134/S1607672911060093; Bogush V. G., 2006, Biotekhnologiya, P3; Bursac N, 2002, CIRC RES, V91, pE45, DOI 10.1161/01.RES.0000047530.88338.EB; Chi NH, 2013, CARBOHYD POLYM, V92, P591, DOI 10.1016/j.carbpol.2012.09.012; Christman KL, 2006, J AM COLL CARDIOL, V48, P907, DOI 10.1016/j.jacc.2006.06.005; Gomes S, 2011, SOFT MATTER, V7, P4964, DOI 10.1039/c1sm05024a; Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0; Hofer M, 2012, BIOMATERIALS, V33, P1554, DOI 10.1016/j.biomaterials.2011.10.053; Kundu B, 2014, INT J BIOL MACROMOL, V70, P70, DOI 10.1016/j.ijbiomac.2014.06.022; Kundu B, 2013, ADV DRUG DELIVER REV, V65, P457, DOI 10.1016/j.addr.2012.09.043; Lammel A, 2011, BIOMATERIALS, V32, P2233, DOI 10.1016/j.biomaterials.2010.11.060; Leal-Egana A, 2012, J MATER CHEM, V22, P14330, DOI 10.1039/c2jm31174g; Lu BY, 2010, BURNS, V36, P891, DOI 10.1016/j.burns.2009.12.001; Moisenovich MM, 2011, J BIOMED MATER RES A, V96A, P125, DOI 10.1002/jbm.a.32968; Moisenovich MM, 2012, BIOMATERIALS, V33, P3887, DOI 10.1016/j.biomaterials.2012.02.013; Morgan AW, 2008, BIOMATERIALS, V29, P2556, DOI 10.1016/j.biomaterials.2008.02.007; Orlova Y, 2011, BIOMATERIALS, V32, P5615, DOI 10.1016/j.biomaterials.2011.04.042; Patra C, 2012, BIOMATERIALS, V33, P2673, DOI 10.1016/j.biomaterials.2011.12.036; Piruzian ES, 2003, MOL BIOL+, V37, P554, DOI 10.1023/A:1025187311024; Rammensee S, 2006, APPL PHYS A-MATER, V82, P261, DOI 10.1007/s00339-005-3431-x; Sapir Y, 2011, BIOMATERIALS, V32, P1838, DOI 10.1016/j.biomaterials.2010.11.008; Sionkowska A, 2011, PROG POLYM SCI, V36, P1254, DOI 10.1016/j.progpolymsci.2011.05.003; Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013; Widhe M, 2010, BIOMATERIALS, V31, P9575, DOI 10.1016/j.biomaterials.2010.08.061	28	16	18	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121155	10.1371/journal.pone.0121155	http://dx.doi.org/10.1371/journal.pone.0121155			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799394	gold, Green Submitted, Green Published			2022-12-26	WOS:000351987300219
J	Wang, LL; Zhao, GX; Li, M; Zhang, MT; Zhang, LF; Zhang, XF; An, LZ; Xu, SJ				Wang, Lilong; Zhao, Guanxiang; Li, Meng; Zhang, Mingting; Zhang, Lifang; Zhang, Xinfang; An, Lizhe; Xu, Shijian			C:N:P Stoichiometry and Leaf Traits of Halophytes in an Arid Saline Environment, Northwest China	PLOS ONE			English	Article							PHOSPHORUS STOICHIOMETRY; BIOLOGICAL STOICHIOMETRY; NITROGEN; DESERT; SOIL; TOLERANCE; AREA; PATTERNS; GROWTH; TERRESTRIAL	Salinization is an important and increasingly prevalent issue which has broad and profound effects on plant survival and distribution pattern. To understand the patterns and potential drivers of leaf traits in saline environments, we determined the soil properties, leaf morphological traits (specific leaf area, SLA, and leaf dry matter content, LDMC), leaf chemical traits (leaf carbon, C, nitrogen, N, and phosphorus, P, stoichiometry) based on 142 observations collected from 23 sites in an arid saline environment, which is a vulnerable ecosystem in northwest China. We also explored the relationships among leaf traits, the responses of leaf traits, and plant functional groups (herb, woody, and succulent woody) to various saline environments. The arid desert halophytes were characterized by lower leaf C and SLA levels, higher N, but stable P and N: P. The leaf morphological traits were correlated significantly with the C, N, and P contents across all observations, but they differed within each functional group. Succulent woody plants had the lowest leaf C and highest leaf N levels among the three functional groups. The growth of halophytes might be more limited by N rather than P in the study area. GLM analysis demonstrated that the soil available nutrients and plant functional groups, but not salinity, were potential drivers of leaf C: N: P stoichiometry in halophytes, whereas species differences accounted for the largest contributions to leaf morphological variations. Our study provides baseline information to facilitate the management and restoration of arid saline desert ecosystem.	[Wang, Lilong; Zhao, Guanxiang; Li, Meng; Zhang, Mingting; Zhang, Lifang; Zhang, Xinfang; An, Lizhe; Xu, Shijian] Lanzhou Univ, Sch Life Sci, MOE Key Lab Cell Activ & Stress Adaptat, Lanzhou 730000, Peoples R China	Lanzhou University	Xu, SJ (corresponding author), Lanzhou Univ, Sch Life Sci, MOE Key Lab Cell Activ & Stress Adaptat, Lanzhou 730000, Peoples R China.	xushijian@lzu.edu.cn			State Key Basic Research and Development Plan [2013CB429904]; National Natural Science Foundation of China [31170371, 40871041]; Gansu Province Science and Technology Support Plan [2009GS03292]	State Key Basic Research and Development Plan; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Gansu Province Science and Technology Support Plan	This research was funded jointly by grants from the State Key Basic Research and Development Plan (2013CB429904), National Natural Science Foundation of China (31170371, 40871041), and Gansu Province Science and Technology Support Plan (2009GS03292). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058179; Bazihizina N, 2012, PLANT SOIL, V354, P1, DOI 10.1007/s11104-012-1193-8; Canadell J, 1996, Oecologia, V108, P583, DOI 10.1007/BF00329030; Chaves MM, 2009, ANN BOT-LONDON, V103, P551, DOI 10.1093/aob/mcn125; Ding H, 2001, ARID ZONE RES, V18, P6; Dodd GL, 1999, AM J BOT, V86, P1146, DOI 10.2307/2656978; Drenovsky RE, 2004, PLANT SOIL, V259, P59, DOI 10.1023/B:PLSO.0000020945.09809.3d; Eallonardo AS, 2013, J VEG SCI, V24, P365, DOI 10.1111/j.1654-1103.2012.01470.x; Elser JJ, 2010, NEW PHYTOL, V186, P593, DOI 10.1111/j.1469-8137.2010.03214.x; Elser JJ, 2000, NATURE, V408, P578, DOI 10.1038/35046058; Elser JJ, 2000, ECOL LETT, V3, P540, DOI 10.1046/j.1461-0248.2000.00185.x; Flowers TJ, 2008, NEW PHYTOL, V179, P945, DOI 10.1111/j.1469-8137.2008.02531.x; Glenn EP, 1999, CRIT REV PLANT SCI, V18, P227, DOI 10.1016/S0735-2689(99)00388-3; Han WX, 2005, NEW PHYTOL, V168, P377, DOI 10.1111/j.1469-8137.2005.01530.x; He JS, 2008, OECOLOGIA, V155, P301, DOI 10.1007/s00442-007-0912-y; He JS, 2006, OECOLOGIA, V149, P115, DOI 10.1007/s00442-006-0425-0; He JS, 2010, J PLANT RES, V123, P551, DOI 10.1007/s10265-009-0294-9; He YB, 2012, GEODERMA, V185, P12, DOI 10.1016/j.geoderma.2012.03.022; Kang HZ, 2011, FOREST ECOL MANAG, V261, P195, DOI 10.1016/j.foreco.2010.10.004; Kuo S., 1996, Methods of soil analysis. Part 3 - chemical methods., P869; Li Yu-lin, 2010, Huanjing Kexue, V31, P1716; Lu XT, 2012, OECOLOGIA, V168, P301, DOI 10.1007/s00442-011-2097-7; Mansour MMF, 2000, BIOL PLANTARUM, V43, P491, DOI 10.1023/A:1002873531707; Martinez Beltran J., 2005, International salinity forum - managing saline soils and water: science, technology and social issues. Oral Presentation Abstracts, Riverside Convention Center, Riverside, California, USA, 25-28 April 2005, P311; MCCREE KJ, 1986, AUST J PLANT PHYSIOL, V13, P33, DOI 10.1071/PP9860033; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; MURPHY J, 1962, ANAL CHIM ACTA, V26, P31; Naz N, 2013, J BIOL RES-THESSALON, V19, P150; Osnas JLD, 2013, SCIENCE, V340, P741, DOI 10.1126/science.1231574; Penuelas J, 2012, GLOBAL CHANGE BIOL, V18, P3, DOI 10.1111/j.1365-2486.2011.02568.x; Perez-Harguindeguy N, 2013, AUST J BOT, V61, P167, DOI 10.1071/BT12225; Pessarakli M, 2012, INT J AGRONOMY, V2012, P9; Poorter H, 1999, NEW PHYTOL, V143, P163, DOI 10.1046/j.1469-8137.1999.00428.x; Rahnama A, 2010, FUNCT PLANT BIOL, V37, P255, DOI 10.1071/FP09148; Reich PB, 2004, P NATL ACAD SCI USA, V101, P11001, DOI 10.1073/pnas.0403588101; Rhoades J., 1999, SOIL USE MANAGE, V57th, DOI DOI 10.1111/sum.12554; Setia R, 2013, SCI TOTAL ENVIRON, V465, P267, DOI 10.1016/j.scitotenv.2012.08.028; Shabala S, 2012, PLANT STRESS PHYSL C; Shipley B, 2005, FUNCT ECOL, V19, P602, DOI 10.1111/j.1365-2435.2005.01008.x; SHIPLEY B, 1995, FUNCT ECOL, V9, P312, DOI 10.2307/2390579; Simoes MP, 2011, AQUAT BOT, V94, P119, DOI 10.1016/j.aquabot.2011.01.001; Song ZL, 2014, PLANT SOIL, V380, P165, DOI 10.1007/s11104-014-2084-y; Song ZL, 2011, CLEAN-SOIL AIR WATER, V39, P212, DOI 10.1002/clen.201000053; Sterner R.W., 2002, ECOLOGICAL STOICHIOM; Suter M, 2013, PERSPECT PLANT ECOL, V15, P217, DOI 10.1016/j.ppees.2013.05.001; Tilman D, 2002, NATURE, V418, P671, DOI 10.1038/nature01014; Vendramini F, 2002, NEW PHYTOL, V154, P147, DOI 10.1046/j.1469-8137.2002.00357.x; VITOUSEK PM, 1991, BIOGEOCHEMISTRY, V13, P87; Vitousek PM, 2012, ECOLOGICAL APPL, V20, P5; Wang YG, 2008, ENVIRON MONIT ASSESS, V140, P291, DOI 10.1007/s10661-007-9867-z; Wang YG, 2013, CATENA, V100, P50, DOI 10.1016/j.catena.2012.08.005; Westoby M, 2002, ANNU REV ECOL SYST, V33, P125, DOI 10.1146/annurev.ecolsys.33.010802.150452; WHITFORD WG, 1987, P S STRAT CLASS MAN; Willert D. J., 1992, LIFE STRATEGIES SUCC; Wilson PJ, 1999, NEW PHYTOL, V143, P155, DOI 10.1046/j.1469-8137.1999.00427.x; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; Wright IJ, 2000, FUNCT ECOL, V14, P97, DOI 10.1046/j.1365-2435.2000.00393.x; Wu TG, 2012, BIOCHEM SYST ECOL, V44, P255, DOI 10.1016/j.bse.2012.06.002; Yang CW, 2008, PHOTOSYNTHETICA, V46, P107, DOI [10.1007/s11099-008-0018-8, 10.1007/s11099-008-0047-3]; Yang YL, 2013, PLANT CELL TISS ORG, V112, P33, DOI 10.1007/s11240-012-0209-7; [殷密英 YIN Miying], 2007, [南水北调与水利科技, South-to-North Water Transfers and Water Science & Technology], V5, P72; Yuan ZY, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1346; Zhan XiaoYun, 2013, Journal of Resources and Ecology, V4, P125, DOI 10.5814/j.issn.1674-764x.2013.02.004; Zhao KF, 1999, CHINESE B BOT, V16, P201; Zhao N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095196	65	35	59	12	107	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0119935	10.1371/journal.pone.0119935	http://dx.doi.org/10.1371/journal.pone.0119935			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798853	gold, Green Submitted, Green Published			2022-12-26	WOS:000351987300094
J	Campbell, MT; Proctor, CA; Dou, YC; Schmitz, AJ; Phansak, P; Kruger, GR; Zhang, C; Walia, H				Campbell, Malachy T.; Proctor, Christopher A.; Dou, Yongchao; Schmitz, Aaron J.; Phansak, Piyaporn; Kruger, Greg R.; Zhang, Chi; Walia, Harkamal			Genetic and Molecular Characterization of Submergence Response Identifies Subtol6 as a Major Submergence Tolerance Locus in Maize	PLOS ONE			English	Article							CBF2 TRANSCRIPTIONAL ACTIVATOR; ANAEROBIC PRIMARY METABOLISM; ORGAN-SPECIFIC ANALYSIS; END RULE PATHWAY; LEAF SENESCENCE; FLOODING TOLERANCE; WATERLOGGING TOLERANCE; ZEA-NICARAGUENSIS; COLD-ACCLIMATION; WHEAT SEEDLINGS	Maize is highly sensitive to short term flooding and submergence. Early season flooding reduces germination, survival and growth rate of maize seedlings. We aimed to discover genetic variation for submergence tolerance in maize and elucidate the genetic basis of submergence tolerance through transcriptional profiling and linkage analysis of contrasting genotypes. A diverse set of maize nested association mapping (NAM) founder lines were screened, and two highly tolerant (Mo18W and M162W) and sensitive (B97 and B73) genotypes were identified. Tolerant lines exhibited delayed senescence and lower oxidative stress levels compared to sensitive lines. Transcriptome analysis was performed on these inbreds to provide genome level insights into the molecular responses to submergence. Tolerant lines had higher transcript abundance of several fermentation-related genes and an unannotated Pyrophosphate-Dependent Fructose-6-Phosphate 1-Phosphotransferase gene during submergence. A coexpression network enriched for CBF (C-REPEAT/DRE BINDING FACTOR: C-REPEAT/DRE BINDING FACTOR) genes, was induced by submergence in all four inbreds, but was more activated in the tolerant Mo18W. A recombinant inbred line (RIL) population derived from Mo18W and B73 was screened for submergence tolerance. A major QTL named Subtol6 was mapped to chromosome 6 that explains 22% of the phenotypic variation within the RIL population. We identified two candidate genes (HE-MOGLOBIN2 and RAV1) underlying Subtol6 based on contrasting expression patterns observed in B73 and Mo18W. Sources of tolerance identified in this study (Subtol6) can be useful to increase survival rate during flooding events that are predicted to increase in frequency with climate change.	[Campbell, Malachy T.; Proctor, Christopher A.; Schmitz, Aaron J.; Phansak, Piyaporn; Kruger, Greg R.; Walia, Harkamal] Univ Nebraska, Dept Agron & Hort, Lincoln, NE 68588 USA; [Dou, Yongchao; Zhang, Chi] Univ Nebraska, Sch Biol Sci, Lincoln, NE USA; [Phansak, Piyaporn] Nakhon Phanom Univ, Muang Dist, Thailand	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; Nakhon Phanom University	Walia, H (corresponding author), Univ Nebraska, Dept Agron & Hort, Lincoln, NE 68588 USA.	hwalia2@unl.edu	Proctor, Christopher/AAG-9910-2020; Zhang, Chi/C-4996-2009	Proctor, Christopher/0000-0003-0291-6103; Zhang, Chi/0000-0002-1827-8137; Schmitz, Aaron/0000-0002-8077-6751; Campbell, Malachy/0000-0002-8257-3595	Life Sciences Competition award, University of Nebraska, Lincoln	Life Sciences Competition award, University of Nebraska, Lincoln	Support was provided by the Life Sciences Competition award to HW and CZ (2011-2013), University of Nebraska, Lincoln. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abiko T, 2012, PLANT CELL ENVIRON, V35, P1618, DOI 10.1111/j.1365-3040.2012.02513.x; Alexa A, 2010, TOPGO TOPGO ENRICHME; Anders S., 2010, HTSEQ ANAL HIGH THRO; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Ay N, 2009, PLANT J, V58, P333, DOI [10.1111/j.0960-7412.2009.03782.x, 10.1111/j.1365-313X.2008.03782.x]; Bailey-Serres J, 2012, PLANT PHYSIOL, V160, P1698, DOI 10.1104/pp.112.208173; Bailey-Serres J, 2012, TRENDS PLANT SCI, V17, P129, DOI 10.1016/j.tplants.2011.12.004; Blokhina OB, 2001, J EXP BOT, V52, P1179, DOI 10.1093/jexbot/52.359.1179; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Cox MCH, 2003, PLANT PHYSIOL, V132, P282, DOI 10.1104/pp.102.014548; Fowler S, 2002, PLANT CELL, V14, P1675, DOI 10.1105/tpc.003483; Fukao T, 2004, TRENDS PLANT SCI, V9, P449, DOI 10.1016/j.tplants.2004.07.005; Fukao T, 2008, P NATL ACAD SCI USA, V105, P16814, DOI 10.1073/pnas.0807821105; Furukawa T, 2010, DNA REPAIR, V9, P940, DOI 10.1016/j.dnarep.2010.06.006; Gadjev I, 2006, PLANT PHYSIOL, V141, P436, DOI 10.1104/pp.106.078717; Geigenberger P, 2003, CURR OPIN PLANT BIOL, V6, P247, DOI 10.1016/S1369-5266(03)00038-4; Gibbs DJ, 2011, NATURE, V479, P415, DOI 10.1038/nature10534; Gibbs J, 2000, J EXP BOT, V51, P785, DOI 10.1093/jexbot/51.345.785; Guo XM, 2012, PLANT PHYSIOL, V158, P917, DOI 10.1104/pp.111.191163; Hattori Y, 2009, NATURE, V460, P1026, DOI 10.1038/nature08258; Hoagland D.I., 1950, CALIF AGR EXP STAT, V347, P1; Huang SL, 2014, PLANT PHYSIOL, V165, P810, DOI 10.1104/pp.114.239335; Jung KH, 2010, PLANT PHYSIOL, V152, P1674, DOI 10.1104/pp.109.152157; Khandelwal A, 2008, PLANT PHYSIOL, V148, P2050, DOI 10.1104/pp.108.128488; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee SC, 2011, NEW PHYTOL, V190, P457, DOI 10.1111/j.1469-8137.2010.03590.x; Lenaz G, 2001, IUBMB LIFE, V52, P159, DOI 10.1080/15216540152845957; Li GJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002767; Li SJ, 2011, PLANTA, V233, P1237, DOI 10.1007/s00425-011-1375-2; Licausi F, 2011, NATURE, V479, P419, DOI 10.1038/nature10536; Licausi F, 2010, PLANT J, V62, P302, DOI 10.1111/j.1365-313X.2010.04149.x; Liu ZJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039786; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Manac'h-Little N, 2005, PLANT PHYSIOL BIOCH, V43, P485, DOI 10.1016/j.plaphy.2005.03.012; Mano Y, 2005, EUPHYTICA, V142, P33, DOI 10.1007/s10681-005-0449-2; Mano Y, 2013, ANN BOT-LONDON, V112, P1125, DOI 10.1093/aob/mct160; McMullen MD, 2009, SCIENCE, V325, P737, DOI 10.1126/science.1174320; MERTENS E, 1991, FEBS LETT, V285, P1, DOI 10.1016/0014-5793(91)80711-B; MERTENS E, 1990, PLANT PHYSIOL, V93, P584, DOI 10.1104/pp.93.2.584; Miao Y, 2004, PLANT MOL BIOL, V55, P853, DOI 10.1007/s11103-005-2142-1; Miao Y, 2007, PLANT CELL, V19, P819, DOI 10.1105/tpc.106.042705; Mustroph A, 2006, PLANTA, V225, P103, DOI 10.1007/s00425-006-0333-x; Mustroph A, 2006, PLANTA, V225, P139, DOI 10.1007/s00425-006-0336-7; Mustroph A, 2010, PLANT PHYSIOL, V152, P1484, DOI 10.1104/pp.109.151845; Nakano T, 2006, PLANT PHYSIOL, V140, P411, DOI 10.1104/pp.105.073783; Novillo F, 2007, P NATL ACAD SCI USA, V104, P21002, DOI 10.1073/pnas.0705639105; Osman KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079305; Perazzolli M, 2004, PLANT CELL, V16, P2785, DOI 10.1105/tpc.104.025379; Perez-Rodriguez P, 2010, NUCLEIC ACIDS RES, V38, pD822, DOI 10.1093/nar/gkp805; Placido DF, 2013, PLANT PHYSIOL, V161, P1806, DOI 10.1104/pp.113.214262; Plaxton WC, 1996, ANNU REV PLANT PHYS, V47, P185, DOI 10.1146/annurev.arplant.47.1.185; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; Qiu FZ, 2007, ANN BOT-LONDON, V99, P1067, DOI 10.1093/aob/mcm055; R Core Team, 2020, R LANG ENV STAT COMP; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rosenzweig C, 2002, GLOBAL ENVIRON CHANG, V12, P197, DOI 10.1016/S0959-3780(02)00008-0; Saab IN, 1996, PLANT PHYSIOL, V112, P385, DOI 10.1104/pp.112.1.385; Sachs MM, 1996, J EXP BOT, V47, P1, DOI 10.1093/jxb/47.1.1; Schmitz AJ, 2013, NEW PHYTOL, V198, P1060, DOI 10.1111/nph.12202; Seo PJ, 2011, PLANT SIGNAL BEHAV, V6, P1564, DOI 10.4161/psb.6.10.17003; Sharabi-Schwager M, 2010, PLANT BIOLOGY, V12, P630, DOI 10.1111/j.1438-8677.2009.00255.x; Sharabi-Schwager M, 2010, J EXP BOT, V61, P261, DOI 10.1093/jxb/erp300; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Sowa AW, 1998, P NATL ACAD SCI USA, V95, P10317, DOI 10.1073/pnas.95.17.10317; Swarts K, 2014, PLANT GENOME-US, V7, DOI 10.3835/plantgenome2014.05.0023; Tang WH, 2005, SCI CHINA SER C, V48, P337, DOI 10.1360/062004-27; Thirunavukkarasu N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070433; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; van Veen H, 2013, PLANT CELL, V25, P4691, DOI 10.1105/tpc.113.119016; Woo HR, 2010, J EXP BOT, V61, P3947, DOI 10.1093/jxb/erq206; Xu K, 2006, NATURE, V442, P705, DOI 10.1038/nature04920; Yoshiyama K, 2009, P NATL ACAD SCI USA, V106, P12843, DOI 10.1073/pnas.0810304106; Zaidi PH, 2004, FIELD CROP RES, V90, P189, DOI 10.1016/j.fcr.2004.03.002; Zarka DG, 2003, PLANT PHYSIOL, V133, P910, DOI 10.1104/pp.103.027169	78	44	45	3	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0120385	10.1371/journal.pone.0120385	http://dx.doi.org/10.1371/journal.pone.0120385			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25806518	Green Published, Green Submitted, gold			2022-12-26	WOS:000351880000075
J	Belser, EH; Cohen, BS; Keeler, SP; Killmaster, CH; Bowers, JW; Miller, KV				Belser, Emily H.; Cohen, Bradley S.; Keeler, Shamus P.; Killmaster, Charles H.; Bowers, John W.; Miller, Karl V.			Epethelial Presence of Trueperella pyogenes Predicts Site-Level Presence of Cranial Abscess Disease in White-Tailed Deer (Odocoileus virginianus)	PLOS ONE			English	Article							INTRACRANIAL ABSCESSATION; ACTINOMYCES-PYOGENES	Cranial/intracranial abscess disease is an emerging source of significant mortality for male white-tailed deer (Odocoileus virginianus). Most cases of cranial/intracranial abscess disease are associated with infection by the opportunistic pathogen Trueperella pyogenes although the relationship between the prevalence of the bacteria and occurrence of disease is speculative. We examined 5,612 hunter-harvested deer from 29 sites across all physiographic provinces in Georgia for evidence of cranial abscess disease and sampled the forehead, lingual, and nasal surfaces from 692 deer. We used polymerase chain reaction (PCR) to determine presence of T. pyogenes from these samples. We found T. pyogenes prevalence at a site was a predictor for the occurrence of cranial abscess disease. Prevalence of T. pyogenes did not differ between samples from the nose or tongue although prevalence along the forehead was greater for males than females (p = 0.04), particularly at sites with high occurrence of this disease. Socio-sexual behaviors, bacterial prevalence, or physiological characteristics may predispose male deer to intracranial/cranial abscess disease. Determination of factors that affect T. pyogenes prevalence among sites may help explain the occurrence of this disease among populations.	[Belser, Emily H.; Cohen, Bradley S.; Miller, Karl V.] Univ Georgia, Warnell Sch Forestry & Nat Resources, Athens, GA 30602 USA; [Keeler, Shamus P.] Univ Georgia, Coll Vet Med, Southeastern Cooperat Wildlife Dis Study, Athens, GA 30602 USA; [Killmaster, Charles H.; Bowers, John W.] Georgia Dept Nat Resources, Wildlife Div, Social Circle, GA USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Cohen, BS (corresponding author), Univ Georgia, Warnell Sch Forestry & Nat Resources, Athens, GA 30602 USA.	bscohen3@gmail.com	Keeler, Shamus/ABC-1774-2020	Keeler, Shamus/0000-0002-1301-0852	Georgia Wildlife Resources Division through the Federal Aid in Wildlife Restoration Act	Georgia Wildlife Resources Division through the Federal Aid in Wildlife Restoration Act	Funding for this project was provided by the Georgia Wildlife Resources Division through the Federal Aid in Wildlife Restoration Act. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H., 1973, P 2 INT S INF THEOR, P267, DOI 10.1007/978-1-4612-1694-0; Bates D., 2011, PACKAGE LME4 LINEAR, V1; Baumann CD, 2001, J WILDLIFE DIS, V37, P661, DOI 10.7589/0090-3558-37.4.661; Billington SJ, 1997, J BACTERIOL, V179, P6100, DOI 10.1128/jb.179.19.6100-6106.1997; Cohen BS, J WILDL DIS IN PRESS; DAVIDSON WR, 1990, J WILDLIFE DIS, V26, P460, DOI 10.7589/0090-3558-26.4.460; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; FORAND KJ, 1989, AM MIDL NAT, V122, P357, DOI 10.2307/2425923; Grogan LF, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004015; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; HURVICH CM, 1989, BIOMETRIKA, V76, P297, DOI 10.2307/2336663; Jost BH, 2005, ANTON LEEUW INT J G, V88, P87, DOI 10.1007/s10482-005-2316-5; Karns GR, 2009, J WILDLIFE DIS, V45, P196, DOI 10.7589/0090-3558-45.1.196; MADSEN M, 1992, VET MICROBIOL, V30, P243, DOI 10.1016/0378-1135(92)90118-D; Marchinton R.L., 1984, P129; Moore R, 2010, PATHOGENESIS BACTERI, P113; SEVERINGHAUS CW, 1949, J WILDLIFE MANAGE, V13, P195, DOI 10.2307/3796089; Tremblay A, 2011, LMERCONVENIENCEFUNCT; Turner MM, 2013, INFECT ECOL EPIDEMIO, V3, P10; Yassin AF, 2011, INT J SYST EVOL MICR, V61, P1265, DOI 10.1099/ijs.0.020032-0	20	12	13	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0120028	10.1371/journal.pone.0120028	http://dx.doi.org/10.1371/journal.pone.0120028			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803047	Green Published, Green Submitted, gold			2022-12-26	WOS:000353889600055
J	Cerda-Olmedo, G; Mena-Duran, AV; Monsalve, V; Oltra, E				Cerda-Olmedo, German; Vicente Mena-Duran, Armando; Monsalve, Vicente; Oltra, Elisa			Identification of a MicroRNA Signature for the Diagnosis of Fibromyalgia	PLOS ONE			English	Article							CHRONIC-FATIGUE-SYNDROME; BLOOD MONONUCLEAR-CELLS; DIFFERENTIAL EXPRESSION; IMPACT QUESTIONNAIRE; RNA VIRUSES; CONTAMINATION; INFECTION; XMRV; SEQUENCES; PROTECTS	Background Diagnosis of fibromyalgia (FM), a chronic musculoskeletal pain syndrome characterized by generalized body pain, hyperalgesia and other functional and emotional comorbidities, is a challenging process hindered by symptom heterogeneity and clinical overlap with other disorders. No objective diagnostic method exists at present. The aim of this study was to identify changes in miRNA expression profiles (miRNome) of these patients for the development of a quantitative diagnostic method of FM. In addition, knowledge of FM patient miRNomes should lead to a deeper understanding of the etiology and/or symptom severity of this complex disease. Methods Genome-wide expression profiling of miRNAs was assessed in Peripheral Blood Mononuclear Cells (PBMCs) of FM patients (N=11) and population-age-matched controls (N=10) using human v16-miRbase 3D-Gene microarrays (Toray Industries, Japan). Selected miRNAs from the screen were further validated by RT-qPCR. Participating patients were long term sufferers (over 10 years) diagnosed by more than one specialist under 1990 American College of Rheumatology criteria. Results Microarray analysis of FM patient PBMCs evidenced a marked downregulation of hsa-miR223-3p, hsa-miR451a, hsa-miR338-3p, hsa-miR143-3p, hsa-miR145-5p and hsa-miR21-5p (4-fold or more). All but the mildest inhibited miRNA, hsa-miR-21-5p, were validated by RT-qPCR. Globally, 20% of the miRNAs analyzed (233/1212) showed downregulation of at least 2-fold in patients. This might indicate a general de-regulation of the miRNA synthetic pathway in FM. No significant correlations between miRNA inhibition and FM cardinal symptoms could be identified. However, the patient with the lowest score for mental fatigue coincided with the mildest inhibition in four of the five miRNAs associated with the FM-group. Conclusions We propose a signature of five strikingly downregulated miRNAs (hsa-miR223-3p, hsa-miR451a, hsa-miR338-3p, hsa-miR143-3p and hsa-miR145-5p) to be used as biomarkers of FM. Validation in larger study groups is required before the results can be transferred to the clinic.	[Cerda-Olmedo, German; Vicente Mena-Duran, Armando; Monsalve, Vicente; Oltra, Elisa] Univ Catolica Valencia San Vicente Martir, Fac Med, Valencia, Spain; [Cerda-Olmedo, German] Catedra Umivale Innovac & Invest Patol Trabajo, Valencia, Spain; [Oltra, Elisa] Univ Catolica Valencia San Vicente Martir, Inst Valenciano Patol, Ctr Invest Principe Felipe, Valencia, Spain	Universidad Catolica de Valencia San Vicente Martir; Prince Felipe Research Center; Universidad Catolica de Valencia San Vicente Martir	Oltra, E (corresponding author), Univ Catolica Valencia San Vicente Martir, Fac Med, Valencia, Spain.	elisa.oltra@ucv.es	Oltra, Elisa/I-3642-2015	Oltra, Elisa/0000-0003-0598-2907; Cerda Olmedo, German/0000-0003-4466-4151	Fundacion Universidad Catolica de Valencia "San Vicente Martir" (UCV) Research Grant Program [2011-011-02, 2011-011-04, 2012-011-008]; Fundacion Catedra Umivale at the UCV; 3D-Gene International Competition Award (Toray Industries, Japan)	Fundacion Universidad Catolica de Valencia "San Vicente Martir" (UCV) Research Grant Program; Fundacion Catedra Umivale at the UCV; 3D-Gene International Competition Award (Toray Industries, Japan)	The study was funded by the Fundacion Universidad Catolica de Valencia "San Vicente Martir" (UCV) Research Grant Program (2011-011-02, 2011-011-04 and 2012-011-008) the Fundacion Catedra Umivale at the UCV and the 3D-Gene International Competition Award to EO (Toray Industries, Japan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behm FG, 2012, BMC CLIN PATHOL, V12, DOI 10.1186/1472-6890-12-25; Bhalala OG, 2012, J NEUROSCI, V32, P17935, DOI 10.1523/JNEUROSCI.3860-12.2012; Bjersing JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078762; Bjersing JL, 2014, RHEUMATOL INT; Brenu EW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102783; Buller B, 2010, FEBS J, V277, P4299, DOI 10.1111/j.1742-4658.2010.07818.x; BURCKHARDT CS, 1991, J RHEUMATOL, V18, P728; Buskila D, 2008, AUTOIMMUN REV, V8, P41, DOI 10.1016/j.autrev.2008.07.023; Buyukkose M, 2009, CLIN RHEUMATOL, V28, P305, DOI 10.1007/s10067-008-1044-4; Carvalho LSC, 2008, CLIN EXP IMMUNOL, V154, P346, DOI 10.1111/j.1365-2249.2008.03787.x; Chavali V, 2014, CELL BIOCHEM BIOPHYS, V68, P25, DOI 10.1007/s12013-013-9679-4; Clauw DJ, 2014, JAMA-J AM MED ASSOC, V311, P1547, DOI 10.1001/jama.2014.3266; Dahan D, 2014, AM J PHYSIOL-CELL PH, V307, pC1093, DOI 10.1152/ajpcell.00250.2014; DEFREITAS E, 1991, P NATL ACAD SCI USA, V88, P2922, DOI 10.1073/pnas.88.7.2922; Delviks-Frankenberry K, 2012, CURR OPIN VIROL, V2, P499, DOI 10.1016/j.coviro.2012.06.009; Demettre E, 2002, J BIOL CHEM, V277, P35746, DOI 10.1074/jbc.M201263200; Dwivedi Y, 2014, DIALOGUES CLIN NEURO, V16, P43; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Emde A, 2014, EMBO J, V33, P1428, DOI 10.15252/embj.201488142; Fan HX, 2014, WORLD J GASTROENTERO, V20, P13477, DOI 10.3748/wjg.v20.i37.13477; Fan HM, 2014, J PSYCHIATR RES, V59, P45, DOI 10.1016/j.jpsychires.2014.08.007; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Haliloglu S, 2014, Z RHEUMATOL, V73, P742, DOI 10.1007/s00393-013-1330-7; HERNANZ W, 1994, J RHEUMATOL, V21, P2122; Jahan Firdous, 2012, Oman Med J, V27, P192, DOI 10.5001/omj.2012.44; Jones GT, 2015, ARTHRITIS RHEUMATOL, V67, P568, DOI 10.1002/art.38905; Kaufmann I, 2007, NEUROIMMUNOMODULAT, V14, P272, DOI 10.1159/000115041; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Landis CA, 2004, BRAIN BEHAV IMMUN, V18, P304, DOI 10.1016/j.bbi.2003.11.001; Lo SC, 2012, P NATL ACAD SCI USA, V109, P346, DOI 10.1073/pnas.1119641109; Lo SC, 2010, P NATL ACAD SCI USA, V107, P19132, DOI 10.1073/pnas.1015107107; Lo SC, 2010, P NATL ACAD SCI USA, V107, P15874, DOI 10.1073/pnas.1006901107; Lombardi VC, 2009, SCIENCE, V326, P585, DOI 10.1126/science.1179052; Mohammad A, 2012, J CLIN GASTROENTEROL, V46, P407, DOI 10.1097/MCG.0b013e3182485528; Murata K, 2014, ARTHRITIS RHEUMATOL, V66, P549, DOI 10.1002/art.38269; O'Connor RM, 2013, INT J NEUROPSYCHOPH, V16, P1885, DOI 10.1017/S1461145713000448; Oakes B, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-109; Oltra E, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-332; R Core Team, 2021, R LANGUAGE ENV STAT; Rahman S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034490; Rivera J, 2004, CLIN EXP RHEUMATOL, V22, P554; Sadegh MK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035882; SMETS EMA, 1995, J PSYCHOSOM RES, V39, P315, DOI 10.1016/0022-3999(94)00125-O; Smith RA, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-112; Strickland IT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023423; Sturgill J, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/938576; Suk JH, 2012, EXP CLIN ENDOCR DIAB, V120, P401, DOI 10.1055/s-0032-1309008; Sun GH, 2012, NUCLEIC ACIDS RES, V40, P2181, DOI 10.1093/nar/gkr961; Swaminathan G, 2013, PHYSIOL GENOMICS, V45, P1035, DOI 10.1152/physiolgenomics.00112.2013; tenOever BR, 2013, NAT REV MICROBIOL, V11, P169, DOI 10.1038/nrmicro2971; Terrier O, 2013, J GEN VIROL, V94, P985, DOI 10.1099/vir.0.049528-0; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203; Xiao CC, 2009, CELL, V136, P26, DOI 10.1016/j.cell.2008.12.027; Yao YX, 2009, J GEN VIROL, V90, P1551, DOI 10.1099/vir.0.009902-0; Zhang L, 2012, GLIA, V60, P1888, DOI 10.1002/glia.22404	56	34	36	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0121903	10.1371/journal.pone.0121903	http://dx.doi.org/10.1371/journal.pone.0121903			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803872	Green Submitted, gold, Green Published			2022-12-26	WOS:000353889600180
J	Drake, LY; Iijima, K; Hara, K; Kobayashi, T; Kephart, GM; Kita, H				Drake, Li Yin; Iijima, Koji; Hara, Kenichiro; Kobayashi, Takao; Kephart, Gail M.; Kita, Hirohito			B Cells Play Key Roles in Th2-Type Airway Immune Responses in Mice Exposed to Natural Airborne Allergens	PLOS ONE			English	Article							DEFICIENT MICE; IN-VIVO; DENDRITIC CELLS; ASTHMA; HYPERRESPONSIVENESS; SENSITIZATION; INFLAMMATION; EXPANSION; EFFECTOR; INNATE	Humans are frequently exposed to various airborne allergens. In addition to producing antibodies, B cells participate in immune responses via various mechanisms. The roles of B cells in allergic airway inflammation and asthma have been controversial. We examined the functional importance of B cells in a mouse model of asthma, in which mice were exposed repeatedly to common airborne allergens. Naive wild-type BALB/c mice or B cell-deficient JH(-/-) mice were exposed intranasally to a cocktail of allergen extracts, including Alternaria, Aspergillus, and house dust mite, every other day for two weeks. Ovalbumin was included in the cocktail to monitor the T cell immune response. Airway inflammation, lung pathology, and airway reactivity were analyzed. The airway exposure of naive wild type mice to airborne allergens induced robust eosinophilic airway inflammation, increased the levels of Th2 cytokines and chemokines in the lung, and increased the reactivity to inhaled methacholine. These pathological changes and immune responses were attenuated in B cell-deficient JH(-/-) mice. The allergen-induced expansion of CD4(+) T cells was impaired in the lungs and draining lymph nodes of JH(-/-) mice. Furthermore, lymphocytes from JH(-/-) mice failed to produce Th2 cytokines in response to ovalbumin re-stimulation in vitro. Our results suggest that B cells are required for the optimal development of Th2-type immune responses and airway inflammation when exposed to common airborne allergens. The therapeutic targeting of B cells may be beneficial to treat asthma in certain patients.	[Drake, Li Yin; Iijima, Koji; Hara, Kenichiro; Kobayashi, Takao; Kephart, Gail M.; Kita, Hirohito] Mayo Clin, Dept Internal Med, Div Allerg Dis, Rochester, MN 55905 USA; [Kita, Hirohito] Mayo Clin, Dept Immunol, Rochester, MN USA	Mayo Clinic; Mayo Clinic	Kita, H (corresponding author), Mayo Clin, Dept Internal Med, Div Allerg Dis, Rochester, MN 55905 USA.	kita.hirohito@mayo.edu			National Institute of Health [R01AI34486, R01AI49235]; Mayo Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL117823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI034486, R01AI049235] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the National Institute of Health, R01AI34486 and R01AI49235, and by Mayo Foundation. They provided funds to perform research that is described in the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnaboldi PM, 2005, J IMMUNOL, V175, P1276, DOI 10.4049/jimmunol.175.2.1276; Bradley LM, 2002, EUR J IMMUNOL, V32, P2338, DOI 10.1002/1521-4141(200208)32:8<2338::AID-IMMU2338>3.0.CO;2-R; Calderon MA, 2012, J ALLERGY CLIN IMMUN, V129, P929, DOI 10.1016/j.jaci.2011.11.019; Corry DB, 1998, MOL MED, V4, P344, DOI 10.1007/BF03401741; Crawford A, 2006, J IMMUNOL, V176, P3498, DOI 10.4049/jimmunol.176.6.3498; Dwyer DF, 2014, J IMMUNOL, V193, P529, DOI 10.4049/jimmunol.1303247; Ghosh S, 2012, J IMMUNOL, V189, P1322, DOI 10.4049/jimmunol.1200138; Hall LR, 1999, J IMMUNOL, V163, P4970; Hamelmann E, 1999, AM J RESP CELL MOL, V21, P480, DOI 10.1165/ajrcmb.21.4.3659; Hamelmann E, 1997, P NATL ACAD SCI USA, V94, P1350, DOI 10.1073/pnas.94.4.1350; Hernandez HJ, 1997, J IMMUNOL, V158, P4832; Holgate ST, 2012, NAT MED, V18, P673, DOI 10.1038/nm.2731; Iijima K, 2014, J IMMUNOL, V193, P1549, DOI 10.4049/jimmunol.1302984; Kim HY, 2010, NAT IMMUNOL, V11, P577, DOI 10.1038/ni.1892; Knutsen AP, 2012, J ALLERGY CLIN IMMUN, V129, P280, DOI 10.1016/j.jaci.2011.12.970; Kobayashi T, 2003, J IMMUNOL, V170, P5756, DOI 10.4049/jimmunol.170.11.5756; Kobayashi T, 2009, J IMMUNOL, V182, P2502, DOI 10.4049/jimmunol.0802773; Korsgren M, 1997, J EXP MED, V185, P885, DOI 10.1084/jem.185.5.885; Licona-Limon P, 2013, NAT IMMUNOL, V14, P536, DOI 10.1038/ni.2617; Lindell DM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003129; Linton PJ, 2003, J EXP MED, V197, P875, DOI 10.1084/jem.20021290; Liu Q, 2007, J IMMUNOL, V179, P3821, DOI 10.4049/jimmunol.179.6.3821; Lund FE, 2010, NAT REV IMMUNOL, V10, P236, DOI 10.1038/nri2729; MacLean JA, 1999, AM J RESP CELL MOL, V20, P379, DOI 10.1165/ajrcmb.20.3.3291; Morgan WJ, 2004, NEW ENGL J MED, V351, P1068, DOI 10.1056/NEJMoa032097; Oshiba A, 1996, J CLIN INVEST, V97, P1398, DOI 10.1172/JCI118560; Porter PC, 2011, TRENDS IMMUNOL, V32, P43, DOI 10.1016/j.it.2010.11.007; Rosenberg HF, 2007, J ALLERGY CLIN IMMUN, V119, P1303, DOI 10.1016/j.jaci.2007.03.048; Salo PM, 2008, J ALLERGY CLIN IMMUN, V121, P678, DOI 10.1016/j.jaci.2007.12.1164; Simpson A, 2010, AM J RESP CRIT CARE, V181, P1200, DOI 10.1164/rccm.200907-1101OC; SPORIK R, 1990, NEW ENGL J MED, V323, P502, DOI 10.1056/NEJM199008233230802; Tjota MY, 2014, J ALLERGY CLIN IMMUN, V134, P706, DOI 10.1016/j.jaci.2014.06.013; Wojciechowski W, 2009, IMMUNITY, V30, P421, DOI 10.1016/j.immuni.2009.01.006	33	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0121660	10.1371/journal.pone.0121660	http://dx.doi.org/10.1371/journal.pone.0121660			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803300	gold, Green Submitted, Green Published			2022-12-26	WOS:000353889600168
J	Engjom, T; Erchinger, F; Laerum, BN; Tjora, E; Gilja, OH; Dimcevski, G				Engjom, Trond; Erchinger, Friedemann; Laerum, Birger N.; Tjora, Erling; Gilja, Odd H.; Dimcevski, Georg			Ultrasound Echo-Intensity Predicts Severe Pancreatic Affection in Cystic Fibrosis Patients	PLOS ONE			English	Article							FECAL ELASTASE-1; GENE; IDENTIFICATION; ADULTS; DIAGNOSIS; SYSTEM; LIVER; CT	Background Pancreatic destruction affects the majority of patients with cystic fibrosis. We aimed to relate ultrasound findings to exocrine pancreatic function and cystic fibrosis genotype. Methods Patients with cystic fibrosis and a matched group of healthy controls were included. We performed transabdominal ultrasound, and recorded echo intensities of the pancreas and parenchymal characteristics according to endoscopic ultrasound based Rosemont criteria. Results We included 39 patients and 29 healthy controls. The cystic fibrosis patients were grouped according to exocrine pancreatic function; Cystic fibrosis, insufficient (n = 20) and sufficient ( n = 19). Echo intensity measures and visual score demonstrated hyper-echogenicity in the pancreas insufficient group compared to the pancreas sufficient groups (p<0.001). Ductal and parenchymal changes were not prevalent in any of the groups. Conclusion The hyper-echoic pancreas was the most frequent ultrasonographic finding in exocrine pancreas insufficient cystic fibrosis patients. Pancreatic echo levels correlated to pancreatic phenotype.	[Engjom, Trond; Erchinger, Friedemann; Gilja, Odd H.; Dimcevski, Georg] Univ Bergen, Dept Clin Med, Bergen, Norway; [Engjom, Trond; Gilja, Odd H.; Dimcevski, Georg] Haukeland Hosp, Dept Med, N-5021 Bergen, Norway; [Erchinger, Friedemann] Voss Hosp, Dept Med, Voss, Norway; [Laerum, Birger N.] Haukeland Hosp, Dept Thorac Med, N-5021 Bergen, Norway; [Laerum, Birger N.] Univ Bergen, Dept Clin Sci, Bergen, Norway; [Tjora, Erling] Haukeland Hosp, Dept Paediat, N-5021 Bergen, Norway; [Gilja, Odd H.] Haukeland Hosp, Natl Ctr Ultrasound Gastroenterol, N-5021 Bergen, Norway	University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital; University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital	Engjom, T (corresponding author), Univ Bergen, Dept Clin Med, Bergen, Norway.	trond.engjom@helse-bergen.no	Dimcevski, Georg/F-2860-2018	Dimcevski, Georg/0000-0003-2864-5129	Norwegian gastroenterology assosciation; Norwegian cystic fibrosis Foundation	Norwegian gastroenterology assosciation; Norwegian cystic fibrosis Foundation	This work was supported by the Norwegian gastroenterology assosciation (http://legeforeningen.no/Fagmed/Norsk-gastroenterologisk-forening/) through limited grants for TE, FE, and GD, and the Norwegian cystic fibrosis Foundation (http://www.cfnorge.no/) through a grant for TE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augarten A, 2008, EUR J GASTROEN HEPAT, V20, P164, DOI 10.1097/MEG.0b013e3282f36d04; Berrocal T, 2005, AM J ROENTGENOL, V184, P1305, DOI 10.2214/ajr.184.4.01841305; Borowitz D, 2004, J PEDIATR-US, V145, P322, DOI 10.1016/j.jpeds.2004.04.049; Chaudry G, 2006, PEDIATR RADIOL, V36, P233, DOI 10.1007/s00247-005-0049-2; Debray D, 2011, J CYST FIBROS, V10, pS29, DOI 10.1016/S1569-1993(11)60006-4; Dietrich CF, 2002, J ULTRAS MED, V21, P409, DOI 10.7863/jum.2002.21.4.409; Dorlochter L, 2002, EUR J NUTR, V41, P148, DOI 10.1007/s00394-002-0369-z; DURIE PR, 1989, J ROY SOC MED, V82, P2; Erchinger F, 2011, IMAGING MED, V3, P411; Erchinger F, 2013, PANCREAS, V42, P1101, DOI 10.1097/MPA.0b013e3182847a86; Farrell PM, 2008, J PEDIATR-US, V153, pS4, DOI 10.1016/j.jpeds.2008.05.005; Feigelson J, 2000, J PEDIATR GASTR NUTR, V30, P145, DOI 10.1097/00005176-200002000-00010; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; KOPELMAN H, 1988, GASTROENTEROLOGY, V95, P349, DOI 10.1016/0016-5085(88)90490-8; KOPITO LE, 1976, PEDIATR RES, V10, P742, DOI 10.1203/00006450-197610080-00010; LIU P, 1986, J CAN ASSOC RADIOL, V37, P279; MURAYAMA S, 1990, PEDIATR RADIOL, V20, P536, DOI 10.1007/BF02011384; O'Sullivan BP, 2009, LANCET, V373, P1891, DOI 10.1016/S0140-6736(09)60327-5; Ooi CY, 2012, J CYST FIBROS, V11, P355, DOI 10.1016/j.jcf.2012.05.001; Ooi CY, 2011, GASTROENTEROLOGY, V140, P153, DOI 10.1053/j.gastro.2010.09.046; RIORDAN JR, 1989, SCIENCE, V245, P1066; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; Sequeiros IM, 2010, BRIT J RADIOL, V83, P921, DOI 10.1259/bjr/24009651; Soyer P, 1999, RADIOLOGY, V210, P611, DOI 10.1148/radiology.210.3.r99mr08611; Stevens T, 2008, GASTROINTEST ENDOSC, V67, P458, DOI 10.1016/j.gie.2007.07.028; von Volkmann HL, 2013, MED ULTRASON, V15, P16, DOI 10.11152/mu.2013.2066.151.hlv1qmu2; WILSONSHARP RC, 1984, ARCH DIS CHILD, V59, P923, DOI 10.1136/adc.59.10.923; WORTHEN NJ, 1982, AM J ROENTGENOL, V139, P1095, DOI 10.2214/ajr.139.6.1095	28	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0121121	10.1371/journal.pone.0121121	http://dx.doi.org/10.1371/journal.pone.0121121			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803445	Green Published, gold			2022-12-26	WOS:000353889600127
J	Huang, XD; Cui, XH				Huang, Xiaodong; Cui, Xiaohua			The Functions of Atrial Strands Interdigitating with and Penetrating into Sinoatrial Node: A Theoretical Study of the Problem	PLOS ONE			English	Article							MATHEMATICAL-MODEL; PACEMAKER SYNCHRONIZATION; GLOBAL BIFURCATIONS; NONLINEAR DYNAMICS; PHASE LOCKING; MECHANISMS; ENTRAINMENT; PROPAGATION; GENERATION; MEMBRANE	The sinoatrial node (SAN)-atrium system is closely involved with the activity of heart beating. The impulse propagation and phase-locking behaviors of this system are of theoretical interest. Some experiments have revealed that atrial strands (ASs) interdigitate with and penetrate into the SAN, whereby the SAN-atrium system works as a complex network. In this study, the functions of ASs are numerically investigated using realistic cardiac models. The results indicate that the ASs penetrating into the central region of the SAN play a major role in propagating excitation into the atrium. This is because the threshold SAN-AS coupling for an AS to function as an alternative path for propagation is lower at the center than at the periphery. However, ASs penetrating into the peripheral region have a great effect in terms of enlarging the 1:1 entrainment range of the SAN because the automaticity of the SAN is evidently reduced by ASs. Moreover, an analytical formula for approximating the enlargement of the 1:1 range is derived.	[Huang, Xiaodong] S China Univ Technol, Dept Phys, Guangzhou 510641, Guangdong, Peoples R China; [Cui, Xiaohua] Beijing Normal Univ, Sch Syst Sci, Beijing 100875, Peoples R China	South China University of Technology; Beijing Normal University	Huang, XD (corresponding author), S China Univ Technol, Dept Phys, Guangzhou 510641, Guangdong, Peoples R China.	schuangxd@scut.edu.cn			National Natural Science Foundation of China [11205062]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by the National Natural Science Foundation of China under Grants of No. 11205062. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANUMONWO JMB, 1991, CIRC RES, V68, P1138, DOI 10.1161/01.RES.68.4.1138; Arnold, 1965, AMS TRANSLATIONS, V46, P213, DOI 10.1090/trans2/046/11; Aslanidi OV, 2009, BIOPHYS J, V96, P798, DOI 10.1016/j.bpj.2008.09.057; Boyett MR, 2000, CARDIOVASC RES, V47, P658, DOI 10.1016/S0008-6363(00)00135-8; BRISTOW DG, 1982, AM J PHYSIOL, V243, pH207, DOI 10.1152/ajpheart.1982.243.2.H207; CAI DM, 1993, PHYS REV LETT, V71, P2501, DOI 10.1103/PhysRevLett.71.2501; Coster ACF, 2003, ANN BIOMED ENG, V31, P271, DOI 10.1114/1.1553455; CRANEFIELD PF, 1973, CIRCULATION, V47, P190, DOI 10.1161/01.CIR.47.1.190; Croisier H, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.016209; Dobrzynski H, 2005, CIRCULATION, V111, P846, DOI 10.1161/01.CIR.0000152100.04087.DB; EARM YE, 1990, PROC R SOC SER B-BIO, V240, P83, DOI 10.1098/rspb.1990.0028; GLASS L, 1994, PHYS REV E, V50, P5077, DOI 10.1103/PhysRevE.50.5077; GLASS L, 1984, PHYS REV A, V29, P1348, DOI 10.1103/PhysRevA.29.1348; GLASS L, 1987, PROC R SOC LON SER-A, V413, P9, DOI 10.1098/rspa.1987.0097; Glass L, 1991, CHAOS, V1, P13, DOI 10.1063/1.165810; GUEVARA MR, 1987, BIOPHYS J, V52, P165, DOI 10.1016/S0006-3495(87)83204-6; GUEVARA MR, 1990, AM J PHYSIOL, V258, pH734, DOI 10.1152/ajpheart.1990.258.3.H734; GUEVARA MR, 1982, J MATH BIOL, V14, P1, DOI 10.1007/BF02154750; GUEVARA MR, 1990, ANN NY ACAD SCI, V591, P11; Guevara MR, 1982, SCIENCE, V214, P1350; Huang XD, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.061917; JALIFE J, 1984, J PHYSIOL-LONDON, V356, P221, DOI 10.1113/jphysiol.1984.sp015461; JOYNER RW, 1986, BIOPHYS J, V50, P1157, DOI 10.1016/S0006-3495(86)83559-7; KEENER JP, 1984, J MATH BIOL, V21, P175, DOI 10.1007/BF00277669; Kleber AG, 2004, PHYSIOL REV, V84, P431, DOI 10.1152/physrev.00025.2003; Kongas O, 1999, CHAOS SOLITON FRACT, V10, P119, DOI 10.1016/S0960-0779(98)00056-3; KOWTHA VC, 1994, PROG BIOPHYS MOL BIO, V61, P255, DOI 10.1016/0079-6107(94)90002-7; LUO CH, 1991, CIRC RES, V68, P1501, DOI 10.1161/01.RES.68.6.1501; Maltsev VA, 2014, J PHARMACOL SCI, V125, P6, DOI 10.1254/jphs.13R04CR; MICHAELS DC, 1984, CIRC RES, V55, P89, DOI 10.1161/01.RES.55.1.89; MICHAELS DC, 1989, CIRC RES, V65, P1350, DOI 10.1161/01.RES.65.5.1350; MICHAELS DC, 1986, CIRC RES, V58, P706, DOI 10.1161/01.RES.58.5.706; MICHAELS DC, 1987, CIRC RES, V61, P704, DOI 10.1161/01.RES.61.5.704; MOE GK, 1977, CIRCULATION, V56, P968, DOI 10.1161/01.CIR.56.6.968; MOORE JW, 1974, J THEOR BIOL, V45, P249, DOI 10.1016/0022-5193(74)90054-X; Oren RV, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001041; PARLITZ U, 1987, PHYS REV A, V36, P1428, DOI 10.1103/PhysRevA.36.1428; RUSH S, 1978, IEEE T BIO-MED ENG, V25, P389, DOI 10.1109/TBME.1978.326270; Sato D, 2006, CIRC RES, V99, P520, DOI 10.1161/01.RES.0000240542.03986.e7; TENVELDE I, 1995, CIRC RES, V76, P802, DOI 10.1161/01.RES.76.5.802; Verheijck EE, 1998, J GEN PHYSIOL, V111, P95, DOI 10.1085/jgp.111.1.95; WINFREE AT, 1987, TIME BREAKS DOWN; Winslow R. L., 1994, Proceedings Supercomputing '94 (Cat. No.94CH34819), P560, DOI 10.1109/SUPERC.1994.344320; Winslow R.L., 1994, P COMPUTERS CARDIOLO, P649; Winslow RL., 1995, IEEE 17 ANN C MONTR, V1, P3; Wu TJ, 1998, CIRC RES, V83, P448, DOI 10.1161/01.RES.83.4.448; ZENG WZ, 1990, J THEOR BIOL, V145, P225, DOI 10.1016/S0022-5193(05)80128-6; Zhang H, 2001, CIRCULATION, V103, P584, DOI 10.1161/01.CIR.103.4.584; Zhang H, 2000, AM J PHYSIOL-HEART C, V279, pH397, DOI 10.1152/ajpheart.2000.279.1.H397	49	6	6	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0118623	10.1371/journal.pone.0118623	http://dx.doi.org/10.1371/journal.pone.0118623			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803434	Green Published, gold, Green Submitted			2022-12-26	WOS:000353889600008
J	Shida-Sakazume, T; Endo-Sakamoto, Y; Unozawa, M; Fukumoto, C; Shimada, K; Kasamatsu, A; Ogawara, K; Yokoe, H; Shiiba, M; Tanzawa, H; Uzawa, K				Shida-Sakazume, Tomomi; Endo-Sakamoto, Yosuke; Unozawa, Motoharu; Fukumoto, Chonji; Shimada, Ken; Kasamatsu, Atsushi; Ogawara, Katsunori; Yokoe, Hidetaka; Shiiba, Masashi; Tanzawa, Hideki; Uzawa, Katsuhiro			Lysophosphatidylcholine Acyltransferase1 Overexpression Promotes Oral Squamous Cell Carcinoma Progression via Enhanced Biosynthesis of Platelet-Activating Factor	PLOS ONE			English	Article							FACTOR-KAPPA-B; FACTOR-RECEPTOR; FACTOR PAF; ACYL-COA; 1 LPCAT1; EXPRESSION; GROWTH; CANCER; PROLIFERATION; METASTASIS	Background The relevance of lysophosphatidylcholine acyltransferase1 (LPCAT1), a cytosolic enzyme in the remodeling pathway of phosphatidylcholine metabolism, in oral squamous cell carcinoma (OSCC) is unknown. We investigated LPCAT1 expression and its functional mechanism in OSCCs. Methods We analyzed LPCAT1 mRNA and protein expression levels in OSCC-derived cell lines. Immunohistochemistry was performed to identify correlations between LPCAT1 expression levels and primary OSCCs clinicopathological status. We established LPCAT1 knockdown models of the OSCC-derived cell lines (SAS, Ca9-22) for functional analysis and examined the association between LPCAT1 expression and the platelet-activating factor (PAF) concentration and PAF-receptor (PAFR) expression. Results LPCAT1 mRNA and protein were up-regulated significantly (p<0.05) in OSCC-derived cell lines compared with human normal oral keratinocytes. Immunohistochemistry showed significantly (p<0.05) elevated LPCAT1 expression in primary OSCCs compared with normal counterparts and a strong correlation between LPCAT1-positive OSCCs and tumoral size and regional lymph node metastasis. In LPCAT1 knockdown cells, cellular proliferation and invasiveness decreased significantly (p<0.05); cellular migration was inhibited compared with control cells. Down-regulation of LPCAT1 resulted in a decreased intercellular PAF concentration and PAFR expression. Conclusion LPCAT1 was overexpressed in OSCCs and correlated with cellular invasiveness and migration. LPCAT1 may contribute to tumoral growth and metastasis in oral cancer.	[Shida-Sakazume, Tomomi; Unozawa, Motoharu; Fukumoto, Chonji; Tanzawa, Hideki; Uzawa, Katsuhiro] Chiba Univ, Grad Sch Med, Dept Oral Sci, Chiba, Japan; [Endo-Sakamoto, Yosuke; Shimada, Ken; Kasamatsu, Atsushi; Ogawara, Katsunori; Tanzawa, Hideki; Uzawa, Katsuhiro] Chiba Univ Hosp, Dept Dent & Oral Maxillofacial Surg, Chiba, Japan; [Yokoe, Hidetaka] Natl Def Med Coll, Dept Oral, Saitama, Japan; [Yokoe, Hidetaka] Natl Def Med Coll, Maxillofacial Surg Res Inst, Saitama, Japan; [Shiiba, Masashi] Chiba Univ, Grad Sch Med, Dept Med Oncol, Chiba, Japan	Chiba University; Chiba University; National Defense Medical College - Japan; National Defense Medical College - Japan; Chiba University	Uzawa, K (corresponding author), Chiba Univ, Grad Sch Med, Dept Oral Sci, Chiba, Japan.	uzawak@faculty.chiba-u.jp		Fukumoto, Chonji/0000-0002-5160-6892; Uzawa, Katsuhiro/0000-0002-7036-0859				Agarwal A, 2005, ONCOGENE, V24, P1021, DOI 10.1038/sj.onc.1208296; Bussolati B, 2000, AM J PATHOL, V157, P1713, DOI 10.1016/S0002-9440(10)64808-0; de Oliveira SI, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-200; Endo Y, 2004, INT J CANCER, V110, P225, DOI 10.1002/ijc.20118; Fletcher JI, 2010, NAT REV CANCER, V10, P147, DOI 10.1038/nrc2789; Grupp K, 2013, MOL ONCOL, V7, P1001, DOI 10.1016/j.molonc.2013.07.009; Harayama T, 2008, J BIOL CHEM, V283, P11097, DOI 10.1074/jbc.M708909200; Ishii S, 2004, J IMMUNOL, V172, P7095, DOI 10.4049/jimmunol.172.11.7095; Iyoda M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014082; Kasamatsu A, 2005, INT J MOL MED, V16, P269; Kim HA, 2012, FEBS LETT, V586, P4296, DOI 10.1016/j.febslet.2012.10.034; Ko HM, 2002, CANCER RES, V62, P1809; Kouzu Y, 2006, BRIT J CANCER, V94, P717, DOI 10.1038/sj.bjc.6602991; Lombardi DP, 1999, CANCER RES, V59, P5724; Lukashova V, 2003, J IMMUNOL, V171, P3794, DOI 10.4049/jimmunol.171.7.3794; Mansilla F, 2009, J MOL MED, V87, P85, DOI 10.1007/s00109-008-0409-0; Marques SA, 2002, J PHARMACOL EXP THER, V300, P1026, DOI 10.1124/jpet.300.3.1026; Mathonnet M, 2006, WORLD J GASTROENTERO, V12, P2773, DOI 10.3748/wjg.v12.i17.2773; Melnikova V, 2007, CANCER METAST REV, V26, P359, DOI 10.1007/s10555-007-9092-9; Melnikova VO, 2008, CANCER MICROENVIRON, V1, P103, DOI 10.1007/s12307-008-0002-7; Morita Y, 2013, J HEPATOL, V59, P292, DOI 10.1016/j.jhep.2013.02.030; Nakanishi H, 2006, J BIOL CHEM, V281, P20140, DOI 10.1074/jbc.M600225200; Onda T, 2007, CANCER RES, V67, P9643, DOI 10.1158/0008-5472.CAN-07-1911; Onuchic AC, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/175408; Renteria LS, 2013, CELL PROLIFERAT, V46, P563, DOI 10.1111/cpr.12052; Sahu RP, 2014, JSM CELL, V2, P1008; Sakuma K, 2010, J CANCER RES CLIN, V136, P553, DOI 10.1007/s00432-009-0689-y; Shimada K, 2005, BRIT J CANCER, V92, P1915, DOI 10.1038/sj.bjc.6602594; Shindou H, 2005, J IMMUNOL, V175, P1177, DOI 10.4049/jimmunol.175.2.1177; Shindou H, 2000, BIOCHEM BIOPH RES CO, V271, P812, DOI 10.1006/bbrc.2000.2723; Shindou H, 2009, J BIOL CHEM, V284, P1, DOI 10.1074/jbc.R800046200; Taheri F, 2007, INVEST OPHTH VIS SCI, V48, P1931, DOI 10.1167/iovs.06-1008; Tsoupras A. B., 2009, Infectious Disorders - Drug Targets, V9, P390; Verburg FA, 2010, HORM METAB RES, V42, P736, DOI 10.1055/s-0030-1254132; Vlachostergios PJ, 2013, J CELL COMMUN SIGNAL, V7, P235, DOI 10.1007/s12079-013-0198-2; Vladslava OM, 2009, J BIOL CHEM, V281, P2911; Xu B, 2013, BRIT J CANCER, V109, P1279, DOI 10.1038/bjc.2013.480; Yamamoto A, 2013, J CANCER RES CLIN, V139, P533, DOI 10.1007/s00432-012-1356-2; Yamano Y, 2008, INT J ONCOL, V32, P1001; Yost CC, 2010, BIOCHIMIE, V92, P692, DOI 10.1016/j.biochi.2010.02.011; Zhang LF, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-74; Zhou WL, 2007, AM J PHYSIOL-HEART C, V292, pH2773, DOI 10.1152/ajpheart.01018.2006; Zhou XC, 2012, EXP MOL PATHOL, V92, P105, DOI 10.1016/j.yexmp.2011.11.001	43	35	36	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0120143	10.1371/journal.pone.0120143	http://dx.doi.org/10.1371/journal.pone.0120143			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803864	gold, Green Published, Green Submitted			2022-12-26	WOS:000353889600061
J	Singh, PK; Ghosh, D; Tewari, D; Mohite, GM; Carvalho, E; Jha, NN; Jacob, RS; Sahay, S; Banerjee, R; Bera, AK; Maji, SK				Singh, Pradeep K.; Ghosh, Dhiman; Tewari, Debanjan; Mohite, Ganesh M.; Carvalho, Edmund; Jha, Narendra Nath; Jacob, Reeba S.; Sahay, Shruti; Banerjee, Rinti; Bera, Amal K.; Maji, Samir K.			Cytotoxic Helix-Rich Oligomer Formation by Melittin and Pancreatic Polypeptide	PLOS ONE			English	Article							ALPHA-SYNUCLEIN AGGREGATION; SOLUBLE AMYLOID OLIGOMERS; ALZHEIMERS-DISEASE; CELL-SURFACE; PROTEIN AGGREGATION; FLUORESCENT-PROBE; COMMON MECHANISM; NILE RED; FIBRILS; BINDING	Conversion of amyloid fibrils by many peptides/proteins involves cytotoxic helix-rich oligomers. However, their toxicity and biophysical studies remain largely unknown due to their highly dynamic nature. To address this, we chose two helical peptides (melittin, Mel and pancreatic polypeptide, PP) and studied their aggregation and toxicity. Mel converted its random coil structure to oligomeric helical structure upon binding to heparin; however, PP remained as helix after oligomerization. Interestingly, similar to Parkinson's associated asynuclein (AS) oligomers, Mel and PP also showed tinctorial properties, higher hydrophobic surface exposure, cellular toxicity and membrane pore formation after oligomerization in the presence of heparin. We suggest that helix-rich oligomers with exposed hydrophobic surface are highly cytotoxic to cells irrespective of their disease association. Moreover as Mel and PP (in the presence of heparin) instantly self-assemble into stable helix-rich amyloidogenic oligomers; they could be represented as models for understanding the biophysical and cytotoxic properties of helix-rich intermediates in detail.	[Singh, Pradeep K.; Ghosh, Dhiman; Mohite, Ganesh M.; Carvalho, Edmund; Jha, Narendra Nath; Jacob, Reeba S.; Sahay, Shruti; Banerjee, Rinti; Maji, Samir K.] IIT, Dept Biosci & Bioengn, Bombay, Maharashtra, India; [Tewari, Debanjan; Bera, Amal K.] IIT, Dept Biotechnol, Madras, Tamil Nadu, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras	Maji, SK (corresponding author), IIT, Dept Biosci & Bioengn, Bombay, Maharashtra, India.	samirmaji@iitb.ac.in	Carvalho, Edmund/AAH-6114-2020; Maji, Samir K. K./B-9640-2019; JHA, NARENDRA NATH/ABI-3727-2020	Maji, Samir K. K./0000-0002-9110-1565; JHA, NARENDRA NATH/0000-0002-1734-7663; kumbara, arya/0000-0002-0395-1245; Jacob, Reeba/0000-0002-0676-834X; Singh, Pradeep/0000-0002-4625-9873; Bera, Amal Kanti/0000-0003-0362-5578; Tewari, Debanjan/0000-0001-5937-139X	Council of Scientific and Industrial Research, India [37 (1404)/10/EMR-11]; Department of Science and Technology, India [SR/FR/LS-032/2009]; Department of Biotechnology, India [BT/PR14344Med/30/501/2010, BT/PR13359/BRB/10/752/2009]; Council of Scientific and Industrial Research, India	Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India); Department of Science and Technology, India(Department of Science & Technology (India)); Department of Biotechnology, India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India)	This work was financially supported from the Council of Scientific and Industrial Research (37 (1404)/10/EMR-11), India; Department of Science and Technology (SR/FR/LS-032/2009), India and Department of Biotechnology (BT/PR14344Med/30/501/2010 and BT/PR13359/BRB/10/752/2009), India. PKS is thankful to the Council of Scientific and Industrial Research, India for his research fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedini A, 2009, PROTEIN ENG DES SEL, V22, P453, DOI 10.1093/protein/gzp036; Abedini A, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/1/015005; Anderson VL, 2010, P NATL ACAD SCI USA, V107, P18850, DOI 10.1073/pnas.1012336107; Anoop A, 2014, J BIOL CHEM, V289, P16884, DOI 10.1074/jbc.M114.548354; Batterham RL, 2003, J CLIN ENDOCR METAB, V88, P3989, DOI 10.1210/jc.2003-030630; BEHL C, 1994, CELL, V77, P817, DOI 10.1016/0092-8674(94)90131-7; Bitan G, 2003, P NATL ACAD SCI USA, V100, P330, DOI 10.1073/pnas.222681699; Bolognesi B, 2010, ACS CHEM BIOL, V5, P735, DOI 10.1021/cb1001203; Bouchard M, 2000, PROTEIN SCI, V9, P1960, DOI 10.1110/ps.9.10.1960; Bram Yaron, 2014, Sci Rep, V4, P4267, DOI 10.1038/srep04267; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Campioni S, 2010, NAT CHEM BIOL, V6, P140, DOI [10.1038/NCHEMBIO.283, 10.1038/nchembio.283]; CAVARI S, 1993, FEBS LETT, V323, P155, DOI 10.1016/0014-5793(93)81469-G; Chimon S, 2007, NAT STRUCT MOL BIOL, V14, P1157, DOI 10.1038/nsmb1345; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; DABAN JR, 1991, ANAL BIOCHEM, V199, P162, DOI 10.1016/0003-2697(91)90084-7; De Felice FG, 2004, FASEB J, V18, P1366, DOI 10.1096/fj.04-1764com; De Jong KL, 2006, BIOPHYS J, V91, P1905, DOI 10.1529/biophysj.105.077438; Gehlert DR, 1998, P SOC EXP BIOL MED, V218, P7; Ghosh D, 2014, BIOCHEMISTRY-US, V53, P6419, DOI 10.1021/bi5010365; Ghosh D, 2014, LANGMUIR, V30, P3775, DOI 10.1021/la404739f; Ghosh D, 2013, BIOCHEMISTRY-US, V52, P6925, DOI 10.1021/bi400999d; Goedert M, 1996, NATURE, V383, P550, DOI 10.1038/383550a0; Goldberg MS, 2000, NAT CELL BIOL, V2, pE115, DOI 10.1038/35017124; HABERMAN.E, 1972, SCIENCE, V177, P314, DOI 10.1126/science.177.4046.314; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Harper JD, 1997, CHEM BIOL, V4, P119, DOI 10.1016/S1074-5521(97)90255-6; Hileman RE, 1998, BIOESSAYS, V20, P156, DOI 10.1002/(SICI)1521-1878(199802)20:2<156::AID-BIES8>3.3.CO;2-#; Jha NN, 2013, BIOCHEMISTRY-US, V52, P8800, DOI 10.1021/bi401398k; Karpinar DP, 2009, EMBO J, V28, P3256, DOI 10.1038/emboj.2009.257; Kayed R, 2004, J BIOL CHEM, V279, P46363, DOI 10.1074/jbc.C400260200; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kayed R, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-18; Kirkitadze MD, 2001, J MOL BIOL, V312, P1103, DOI 10.1006/jmbi.2001.4970; Kirkitadze MD, 2002, J NEUROSCI RES, V69, P567, DOI 10.1002/jnr.10328; Klocek G, 2008, BIOCHEMISTRY-US, V47, P2841, DOI 10.1021/bi702258z; Klocek G, 2009, BIOCHEMISTRY-US, V48, P2586, DOI 10.1021/bi802127h; Klunk WE, 1999, METHOD ENZYMOL, V309, P285; Krishnan R, 2012, P NATL ACAD SCI USA, V109, P11172, DOI 10.1073/pnas.1209527109; Ladokhin AS, 1999, J MOL BIOL, V285, P1363, DOI 10.1006/jmbi.1998.2346; Lashuel HA, 2006, Q REV BIOPHYS, V39, P167, DOI 10.1017/S0033583506004422; LeVine H, 1999, METHOD ENZYMOL, V309, P274; Maji SK, 2008, PLOS BIOL, V6, P240, DOI 10.1371/journal.pbio.0060017; Maji SK, 2009, FEBS LETT, V583, P2610, DOI 10.1016/j.febslet.2009.07.003; Maji SK, 2009, SCIENCE, V325, P328, DOI 10.1126/science.1173155; Naik RJ, 2013, BBA-BIOMEMBRANES, V1828, P1484, DOI 10.1016/j.bbamem.2013.02.010; Prangkio P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047261; Quist A, 2005, P NATL ACAD SCI USA, V102, P10427, DOI 10.1073/pnas.0502066102; Ranganathan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031924; SACKETT DL, 1987, ANAL BIOCHEM, V167, P228, DOI 10.1016/0003-2697(87)90157-6; Singh PK, 2013, ACS CHEM NEUROSCI, V4, P393, DOI 10.1021/cn3001203; Singh PK, 2012, CELL BIOCHEM BIOPHYS, V64, P29, DOI 10.1007/s12013-012-9364-z; Suk JY, 2006, BIOCHEMISTRY-US, V45, P2234, DOI 10.1021/bi0519295; Tartaglia GG, 2008, CHEM SOC REV, V37, P1395, DOI 10.1039/b706784b; TERWILLIGER TC, 1982, BIOPHYS J, V37, P353, DOI 10.1016/S0006-3495(82)84683-3; Uversky VN, 2004, BBA-PROTEINS PROTEOM, V1698, P131, DOI 10.1016/j.bbapap.2003.12.008; Vieira MNN, 2007, J NEUROCHEM, V103, P736, DOI 10.1111/j.1471-4159.2007.04809.x; Volles MJ, 2007, J MOL BIOL, V366, P1510, DOI 10.1016/j.jmb.2006.12.044; Volles MJ, 2003, BIOCHEMISTRY-US, V42, P7871, DOI 10.1021/bi030086j; Walsh DM, 1997, J BIOL CHEM, V272, P22364, DOI 10.1074/jbc.272.35.22364; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; WILCOX W, 1992, PROTEIN SCI, V1, P641, DOI 10.1002/pro.5560010510; Winner B, 2011, P NATL ACAD SCI USA, V108, P4194, DOI 10.1073/pnas.1100976108	63	5	5	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0120346	10.1371/journal.pone.0120346	http://dx.doi.org/10.1371/journal.pone.0120346			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803428	Green Submitted, Green Published, gold			2022-12-26	WOS:000353889600071
J	Tsai, ML; Mao, CT; Chen, DY; Hsieh, IC; Wen, MS; Chen, TH				Tsai, Ming-Lung; Mao, Chun-Tai; Chen, Dong-Yi; Hsieh, I-Chang; Wen, Ming-Shien; Chen, Tien-Hsing			Short- and Long-Term Major Cardiovascular Adverse Events in Carotid Artery Interventions: A Nationwide Population-Based Cohort Study in Taiwan	PLOS ONE			English	Article							HEART-DISEASE; ENDARTERECTOMY; METAANALYSIS; ANGIOPLASTY; ASSOCIATION; PREVENTION; INFARCTION; STENOSIS; PATIENT; STROKE	Introduction Carotid artery stenosis is one of the leading causes of ischemic stroke. Carotid artery stenting has become well-established as an effective treatment option for carotid artery stenosis. For this study, we aimed to determine the efficacy and safety of carotid stenting in a population-based large cohort of patients by analyzing the Taiwan National Healthcare Insurance (NHI) database. Methods 2,849 patients who received carotid artery stents in the NHI database from 2004 to 2010 were identified. We analyzed the risk factors of outcomes including major adverse cardiovascular events including death, acute myocardial infarction, and cerebral vascular accidents at 30 days, 1 year, and overall period and further evaluated cause of death after carotid artery stenting. Results The periprocedural stroke rate was 2.7% and the recurrent stroke rate for the overall followup period was 20.3%. Male, diabetes mellitus, and heart failure were significant risk factors for overall recurrent stroke (Hazard Ratio (HR) = 1.35, p = 0.006; HR = 1.23, p = 0.014; HR = 1.61, p < 0.001, respectively). The periprocedural acute myocardial infarction rate was 0.3%. Age and Diabetes mellitus were the significant factors to predict periprocedural myocardial infarction (HR = 3.06, p = 0.019; HR = 1.68, p < 0.001, respectively). Periprocedural and overall mortality rates were 1.9% and 17.3%, respectively. The most significant periprocedural mortality risk factor was acute renal failure. Age, diabetes mellitus, acute or chronic renal failure, heart failure, liver disease, and malignancy were factors correlated to the overall period mortality. Conclusion Periprocedural acute renal failure significantly increased the mortality rate and the number of major adverse cardiovascular events, and the predict power persisted more than one year after the procedure. Age and diabetes mellitus were significant risk factors to predict acute myocardial infarction after carotid artery stenting.	[Tsai, Ming-Lung; Chen, Dong-Yi; Hsieh, I-Chang; Wen, Ming-Shien; Chen, Tien-Hsing] Chang Gung Mem Hosp, Dept Internal Med, Div Cardiol, Taipei 10591, Taiwan; [Mao, Chun-Tai] Chang Gung Mem Hosp, Heart Failure Ctr, Dept Internal Med, Div Cardiol, Keelung, Taiwan; [Tsai, Ming-Lung; Mao, Chun-Tai; Chen, Dong-Yi; Hsieh, I-Chang; Wen, Ming-Shien; Chen, Tien-Hsing] Chang Gung Univ, Coll Med, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University	Chen, TH (corresponding author), Chang Gung Mem Hosp, Dept Internal Med, Div Cardiol, 199 Tung Hwa N Rd, Taipei 10591, Taiwan.	skyheart0826@gmail.com						Adams RJ, 2008, STROKE, V39, P1647, DOI 10.1161/STROKEAHA.107.189063; BABA S, 1994, CIRCULATION, V89, P109, DOI 10.1161/01.CIR.89.1.109; Barnett HJM, 1998, NEW ENGL J MED, V339, P1415, DOI 10.1056/NEJM199811123392002; Barrett BJ, 2006, NEW ENGL J MED, V354, P379, DOI 10.1056/NEJMcp050801; Bates ER, 2007, J AM COLL CARDIOL, V49, P126, DOI 10.1016/j.jacc.2006.10.021; Bersin RM, 2012, CATHETER CARDIO INTE, V80, P1072, DOI 10.1002/ccd.24433; Bonati LH, 2010, LANCET, V376, P1062, DOI 10.1016/S0140-6736(10)61009-4; Brott TG, 2010, NEW ENGL J MED, V363, P11, DOI 10.1056/NEJMoa0912321; Brown MM, 2001, LANCET, V357, P1729; Chambless LE, 1997, AM J EPIDEMIOL, V146, P483, DOI 10.1093/oxfordjournals.aje.a009302; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Ederle J, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000515.pub3; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Fabian Bernhard, 1998, DIABETES CARE, V7:1, P21; Graner M, 2006, AM J CARDIOL, V97, P624, DOI 10.1016/j.amjcard.2005.09.098; Hofmann R, 2005, HEART, V91, P1438, DOI 10.1136/hrt.2004.050906; Mak KH, 2003, EUR HEART J, V24, P151, DOI 10.1016/S0195-668X(02)00423-2; Mao CT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111130; Mas JL, 2008, LANCET NEUROL, V7, P885, DOI 10.1016/S1474-4422(08)70195-9; MAYBERG MR, 1991, JAMA-J AM MED ASSOC, V266, P3289, DOI 10.1001/jama.266.23.3289; Mohammed Nazar M A, 2013, Heart Views, V14, P106, DOI 10.4103/1995-705X.125926; Mozes G, 2004, J VASC SURG, V39, P958, DOI 10.1016/j.jvs.2003.12.037; Narula A, 2014, EUR HEART J, V35, P1533, DOI 10.1093/eurheartj/ehu063; PARFREY PS, 1993, AM J KIDNEY DIS, V21, P77, DOI 10.1016/S0272-6386(12)80726-8; PRATI P, 1992, STROKE, V23, P1705, DOI 10.1161/01.STR.23.12.1705; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Ricci S, 1991, Epidemiol Prev, V13, P173; Rihal CS, 2002, CIRCULATION, V105, P2259, DOI 10.1161/01.CIR.0000016043.87291.33; Sasayama S, 2008, CIRCULATION, V118, P2669, DOI 10.1161/CIRCULATIONAHA.108.837054; Sheffet AJ, 2010, INT J STROKE, V5, P40, DOI 10.1111/j.1747-4949.2009.00405.x; TAYLOR DW, 1991, NEW ENGL J MED, V325, P445; Vernino S, 2003, STROKE, V34, P1828, DOI 10.1161/01.STR.0000080534.98416.A0; White CJ, 2013, CATHETER CARDIO INTE, V82, P715, DOI 10.1002/ccd.24984; White RA, 2005, J VASC SURG, V42, P213, DOI 10.1016/j.jvs.2005.04.023; Wholey MH, 2000, CATHETER CARDIO INTE, V50, P160, DOI 10.1002/(SICI)1522-726X(200006)50:2<160::AID-CCD2>3.0.CO;2-E; Wu CY, 2012, JAMA-J AM MED ASSOC, V308, P1906, DOI 10.1001/2012.jama.11975; Wu CY, 2010, GASTROENTEROLOGY, V139, P1165, DOI 10.1053/j.gastro.2010.06.067	37	15	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0121016	10.1371/journal.pone.0121016	http://dx.doi.org/10.1371/journal.pone.0121016			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803550	gold, Green Published, Green Submitted			2022-12-26	WOS:000353889600113
J	Wrycza, TF; Missov, TI; Baudisch, A				Wrycza, Tomasz F.; Missov, Trifon I.; Baudisch, Annette			Quantifying the Shape of Aging	PLOS ONE			English	Article							LIFE EXPECTANCY; NATURAL-POPULATIONS; MORTALITY; AGE; SENESCENCE; EVOLUTION; INEQUALITY; DEATH; PACE	In Biodemography, aging is typically measured and compared based on aging rates. We argue that this approach may be misleading, because it confounds the time aspect with the mere change aspect of aging. To disentangle these aspects, here we utilize a time-standardized framework and, instead of aging rates, suggest the shape of aging as a novel and valuable alternative concept for comparative aging research. The concept of shape captures the direction and degree of change in the force of mortality over age, which-on a demographic level-reflects aging. We 1) provide a list of shape properties that are desirable from a theoretical perspective, 2) suggest several demographically meaningful and non-parametric candidate measures to quantify shape, and 3) evaluate performance of these measures based on the list of properties as well as based on an illustrative analysis of a simple dataset. The shape measures suggested here aim to provide a general means to classify aging patterns independent of any particular mortality model and independent of any species-specific time-scale. Thereby they support systematic comparative aging research across different species or between populations of the same species under different conditions and constitute an extension of the toolbox available to comparative research in Biodemography.	[Wrycza, Tomasz F.; Missov, Trifon I.; Baudisch, Annette] Max Planck Inst Demog Res, Rostock, Germany; [Missov, Trifon I.] Univ Rostock, Inst Sociol & Demog, D-18055 Rostock, Germany; [Baudisch, Annette] Univ Southern Denmark, Max Planck Odense Ctr Biodemog Aging, Odense, Denmark	Max Planck Society; University of Rostock; University of Southern Denmark	Wrycza, TF (corresponding author), Max Planck Inst Demog Res, Rostock, Germany.	wrycza@demogr.mpg.de	Andersen, Mette Adalheidur/D-5608-2017; Missov, Trifon I./AAE-6540-2020; Baudisch, Annette/ABA-2290-2020	Missov, Trifon I./0000-0002-7312-4261; Baudisch, Annette/0000-0002-4202-089X				Baudisch A, 2008, DEMOGR RES MONOGR, P1, DOI 10.1007/978-3-540-76656-8; Baudisch A, 2013, J ECOL, V101, P596, DOI 10.1111/1365-2745.12084; Baudisch A, 2012, SCIENCE, V338, P618, DOI 10.1126/science.1226467; Baudisch A, 2011, METHODS ECOL EVOL, V2, P375, DOI 10.1111/j.2041-210X.2010.00087.x; Bronikowski AM, 2011, SCIENCE, V331, P1325, DOI 10.1126/science.1201571; Carey J. R., 2003, LONGEVITY BIOL DEMOG, DOI [10.1515/9780691224084, DOI 10.1515/9780691224084]; Cheung SLK, 2005, DEMOGRAPHY, V42, P243, DOI 10.1353/dem.2005.0012; Comfort A., 1979, BIOL SENESCENCE; Deevey E. S., 1950, SCI AM, V182, P58, DOI [10.1038/scientificamerican0450-58, DOI 10.1038/SCIENTIFICAMERICAN0450-58]; DEEVEY ES, 1947, Q REV BIOL, V22, P283, DOI 10.1086/395888; DEMETRIUS L, 1974, P NATL ACAD SCI USA, V71, P4645, DOI 10.1073/pnas.71.12.4645; DEMETRIUS L, 1979, DEMOGRAPHY, V16, P329, DOI 10.2307/2061146; DEMETRIUS L, 1978, NATURE, V275, P213, DOI 10.1038/275213a0; EAKIN T, 1994, B MATH BIOL, V56, P1121, DOI 10.1016/S0092-8240(05)80334-9; Economos A C, 1982, Arch Gerontol Geriatr, V1, P3; Edwards RD, 2005, POPUL DEV REV, V31, P645, DOI 10.1111/j.1728-4457.2005.00092.x; Edwards R, 2011, TLS-TIMES LIT SUPPL, P24; FINCH CE, 1990, SCIENCE, V249, P902, DOI 10.1126/science.2392680; FUKUI HH, 1993, EXP GERONTOL, V28, P585, DOI 10.1016/0531-5565(93)90048-I; Gems D, 2002, AGING CELL, V1, P1, DOI 10.1046/j.1474-9728.2002.00003.x; Gillespie DOS, 2014, TULJAPURKAR SD 2014; Gompertz B., 1825, PHILOS T ROYAL SOC L, V115, P515, DOI [DOI 10.1098/RSTL.1825.0026, 10.1098/rstl.1825.0026]; HAKKERT R, 1987, DEMOGRAPHY, V24, P615, DOI 10.2307/2061396; Hanada K., 1983, J JPN STATIST SOC, V13, P95; Hawkes K, 2012, EVOLUTION, V66, P103, DOI 10.1111/j.1558-5646.2011.01414.x; Jones OR, 2014, NATURE, V505, P169, DOI 10.1038/nature12789; Kannisto V., 2001, POPULATION ENGLISH S, P159; Kendall M.G., 1966, ADV THEORY STAT; Keyfitz N, 1977, APPL MATH DEMOGRAPH; Makeham W.M., 1860, J I ACTUAR, V8, P301, DOI DOI 10.1017/S204616580000126X; Oeppen J, 2002, SCIENCE, V296, P1029, DOI 10.1126/science.1069675; Pearl R, 1935, Q REV BIOL, V10, P60, DOI 10.1086/394476; Pearl R., 1928, RATE LIVING; PROMISLOW DEL, 1991, EVOLUTION, V45, P1869, DOI 10.1111/j.1558-5646.1991.tb02693.x; Reznick D, 2001, EXP GERONTOL, V36, P791, DOI 10.1016/S0531-5565(00)00241-2; Ricklefs RE, 1998, AM NAT, V152, P24, DOI 10.1086/286147; Shkolnikov V.M., 2003, DEMOGR RES, V8, P305, DOI [DOI 10.4054/DEMRES.2003.8.11, 10.4054/DemRes.2003.8.11]; Stearns SC, 2000, P NATL ACAD SCI USA, V97, P3309, DOI 10.1073/pnas.060289597; Vaupel JW, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000128; Vaupel JW, 2010, DEMOGR RES, V22, P1143, DOI 10.4054/DemRes.2010.22.36; Vaupel JW, 2004, THEOR POPUL BIOL, V65, P339, DOI 10.1016/j.tpb.2003.12.003; Vaupel JW, 2003, DEMOGRAPHY, V40, P201, DOI 10.1353/dem.2003.0018; VAUPEL JW, 1986, POP STUD-J DEMOG, V40, P147, DOI 10.1080/0032472031000141896; Wachter K.W, 1997, ZEUS SALMON; Wilmoth JR, 1999, DEMOGRAPHY, V36, P475, DOI 10.2307/2648085; Wrycza TF, 2014, DEMOGR RES, V30, P1571, DOI 10.4054/DemRes.2014.30.57; Wrycza TF, 2014, DEMOGR RES, V30, P1405, DOI 10.4054/DemRes.2014.30.50; Wrycza TF, 2012, DEMOGR RES, V27, P365, DOI 10.4054/DemRes.2012.27.13	48	39	39	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0119163	10.1371/journal.pone.0119163	http://dx.doi.org/10.1371/journal.pone.0119163			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH2XV	25803427	Green Submitted, Green Published, gold			2022-12-26	WOS:000353889600015
J	Derlindati, E; Dei Cas, A; Montanini, B; Spigoni, V; Curella, V; Aldigeri, R; Ardigo, D; Zavaroni, I; Bonadonna, RC				Derlindati, Eleonora; Dei Cas, Alessandra; Montanini, Barbara; Spigoni, Valentina; Curella, Valentina; Aldigeri, Raffaella; Ardigo, Diego; Zavaroni, Ivana; Bonadonna, Riccardo C.			Transcriptomic Analysis of Human Polarized Macrophages: More than One Role of Alternative Activation?	PLOS ONE			English	Article							GENE-EXPRESSION; PPAR-GAMMA; SIGNALING PATHWAY; WNT5B; ADIPOGENESIS; INFLAMMATION; DIFFERENTIATION; PHAGOCYTOSIS; RECEPTORS; IL-10	Background Macrophages are a heterogeneous cell population which in response to the cytokine milieu polarize in either classically activated macrophages (M1) or alternatively activated macrophages (M2). This plasticity makes macrophages essential in regulating inflammation, immune response and tissue remodeling and a novel therapeutic target in inflammatory diseases such as atherosclerosis. The aim of the study was to describe the transcriptomic profiles of differently polarized human macrophages to generate new hypotheses on the biological function of the different macrophage subtypes. Methods and Results Polarization of circulating monocytes/macrophages of blood donors was induced in vitro by IFN-gamma and LPS (M1), by IL-4 (M2a), and by IL-10 (M2c). Unstimulated cells (RM) served as time controls. Gene expression profile of M1, M2a, M2c and RM was assessed at 6, 12 and 24h after polarization with Whole Human Genome Agilent Microarray technique. When compared to RM, M1 significantly upregulated pathways involved in immunity and inflammation, whereas M2a did the opposite. Conversely, decreased and increased expression of mitochondrial metabolism, consistent with insulin resistant and insulin sensitive patterns, was seen in M1 and M2a, respectively. The time sequence in the expression of some pathways appeared to have some specific bearing on M1 function. Finally, canonical and non-canonical Wnt genes and gene groups, promoting inflammation and tissue remodeling, were upregulated in M2a compared to RM. Conclusion Our data in in vitro polarized human macrophages: 1. confirm and extend known inflammatory and anti-inflammatory gene expression patterns; 2. demonstrate changes in mitochondrial metabolism associated to insulin resistance and insulin sensitivity in M1 and M2a, respectively; 3. highlight the potential relevance of gene expression timing in M1 function; 4. unveil enhanced expression of Wnt pathways in M2a suggesting a potential dual (pro-inflammatory and anti-inflammatory) role of M2a in inflammatory diseases.	[Derlindati, Eleonora; Curella, Valentina; Aldigeri, Raffaella; Ardigo, Diego; Zavaroni, Ivana] Univ Parma, Unit Diabet & Metab, Dept Clin & Expt Med, I-43100 Parma, Italy; [Derlindati, Eleonora; Dei Cas, Alessandra; Spigoni, Valentina; Curella, Valentina; Aldigeri, Raffaella; Ardigo, Diego; Zavaroni, Ivana; Bonadonna, Riccardo C.] AOUI Parma, Parma, Italy; [Dei Cas, Alessandra; Spigoni, Valentina; Bonadonna, Riccardo C.] Univ Parma, Div Endocrinol, Dept Clin & Expt Med, I-43100 Parma, Italy; [Montanini, Barbara] Univ Parma, Dept Life Sci, Lab Funct Genom & Prot Engn, Biochem & Mol Biol Unit, I-43100 Parma, Italy	University of Parma; University Hospital of Parma; University of Parma; University Hospital of Parma; University of Parma; University Hospital of Parma; University of Parma	Derlindati, E (corresponding author), Univ Parma, Unit Diabet & Metab, Dept Clin & Expt Med, I-43100 Parma, Italy.	eleonora.derlindati@unipr.it	ARDIGO, DIEGO/AAD-5928-2022	Dei Cas, Alessandra/0000-0002-8666-4849; Aldigeri, Raffaella/0000-0003-2350-1222; Montanini, Barbara/0000-0002-5419-7975; Spigoni, Valentina/0000-0001-5716-1671; Bonadonna, Riccardo/0000-0002-9809-1005	European Community [FP6-IST-2004-027106]; University of Parma; Regione Emilia Romagna; Ricerca Regione-Universita, Strategic Programme "A tailored approach to the immune-monitoring and clinical management of viral and autoimmune diseases"	European Community(European Commission); University of Parma; Regione Emilia Romagna(Regione Emilia Romagna); Ricerca Regione-Universita, Strategic Programme "A tailored approach to the immune-monitoring and clinical management of viral and autoimmune diseases"	This work was supported by a grant from the European Community [FP6-IST-2004-027106] and by Local Funds for research "FIL" from the University of Parma of RCB, IZ and ADC. Work conducted by BM was supported by a grant from the Regione Emilia Romagna, Ricerca Regione-Universita 2010-2012, Strategic Programme "A tailored approach to the immune-monitoring and clinical management of viral and autoimmune diseases."	Bergenfelz C, 2012, J IMMUNOL, V188, P5448, DOI 10.4049/jimmunol.1103378; Beyer M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045466; Bilkovski R, 2011, INT J OBESITY, V35, P1450, DOI 10.1038/ijo.2011.6; Biswas SK, 2012, CELL METAB, V15, P432, DOI 10.1016/j.cmet.2011.11.013; Bouhlel MA, 2007, CELL METAB, V6, P137, DOI 10.1016/j.cmet.2007.06.010; Bowdish DME, 2007, MICROBES INFECT, V9, P1680, DOI 10.1016/j.micinf.2007.09.002; Cao YX, 2007, ARTHRITIS RHEUM-US, V56, P861, DOI 10.1002/art.22422; Chang YH, 2011, INT J OBES LOND, V36, P993; Chawla A, 2011, NAT REV IMMUNOL, V11, P738, DOI 10.1038/nri3071; Cho HH, 2006, TISSUE ENG, V12, P111, DOI 10.1089/ten.2006.12.111; Cosin-Roger J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078128; Derlindati E, 2012, FOOD FUNCT, V3, P1144, DOI 10.1039/c2fo30127j; Dobrovolskaia MA, 2002, MICROBES INFECT, V4, P903, DOI 10.1016/S1286-4579(02)01613-1; Ernst J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-191; Garcia-Jimenez C, 2014, J MOL ENDOCRINOL, V52, pR51, DOI 10.1530/JME-13-0152; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Han MS, 2013, SCIENCE, V339, P218, DOI 10.1126/science.1227568; Kanazawa A, 2005, BIOCHEM BIOPH RES CO, V330, P505, DOI 10.1016/j.bbrc.2005.03.007; Kanazawa A, 2004, AM J HUM GENET, V75, P832, DOI 10.1086/425340; Kang J, 2012, J BIOL CHEM, V287, P14502, DOI 10.1074/jbc.M111.329003; Krausgruber T, 2011, NAT IMMUNOL, V12, P231, DOI 10.1038/ni.1990; Lang R, 2002, J IMMUNOL, V169, P2253, DOI 10.4049/jimmunol.169.5.2253; Leitinger N, 2013, ARTERIOSCL THROM VAS, V33, P1120, DOI 10.1161/ATVBAHA.112.300173; Liang HY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0063983, 10.1371/journal.pone.0074121]; Lumeng CN, 2008, DIABETES, V57, P3239, DOI 10.2337/db08-0872; Madiraju AK, 2014, NATURE, V510, P542, DOI 10.1038/nature13270; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Mantovani A, 2009, ARTERIOSCL THROM VAS, V29, P1419, DOI 10.1161/ATVBAHA.108.180497; Marinou K, 2012, TRENDS ENDOCRIN MET, V23, P628, DOI 10.1016/j.tem.2012.06.001; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Martinez FO, 2013, BLOOD, V121, pE57, DOI 10.1182/blood-2012-06-436212; Martinez FO, 2011, EUR J IMMUNOL, V41, P1531, DOI 10.1002/eji.201141670; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; McNelis JC, 2014, IMMUNITY, V41, P36, DOI 10.1016/j.immuni.2014.05.010; Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984; Mills CD, 2000, J IMMUNOL, V164, P6166, DOI 10.4049/jimmunol.164.12.6166; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Ojalvo LS, 2010, J IMMUNOL, V184, P702, DOI 10.4049/jimmunol.0902360; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Ouchi N, 2010, SCIENCE, V329, P454, DOI 10.1126/science.1188280; Polakis P, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008052; Qatanani M, 2013, DIABETES, V62, P855, DOI 10.2337/db12-0399; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Saito R, 2012, NAT METHODS, V9, P1069, DOI [10.1038/nmeth.2212, 10.1038/NMETH.2212]; Salpea KD, 2009, NUTR METAB CARDIOVAS, V19, P140, DOI 10.1016/j.numecd.2008.02.009; Satoh T, 2010, NAT IMMUNOL, V11, P936, DOI 10.1038/ni.1920; Schmittgen TD, 2000, ANAL BIOCHEM, V285, P194, DOI 10.1006/abio.2000.4753; Sica A., 2010, Experimental Oncology, V32, P153; Sugiyama S, 2005, BIOCHEM BIOPH RES CO, V337, P271, DOI 10.1016/j.bbrc.2005.09.050; Takeshige K, 2002, MASUI, V51, P50; Tiemessen MM, 2007, P NATL ACAD SCI USA, V104, P19446, DOI 10.1073/pnas.0706832104; van Tienen FHJ, 2009, BIOCHEM BIOPH RES CO, V387, P207, DOI 10.1016/j.bbrc.2009.07.004; Varin A, 2009, IMMUNOBIOLOGY, V214, P630, DOI 10.1016/j.imbio.2008.11.009; Williams L, 2002, J LEUKOCYTE BIOL, V72, P800; Xue J, 2014, IMMUNITY, V40, P274, DOI 10.1016/j.immuni.2014.01.006; Zizzo G, 2013, J IMMUNOL, V190, P5237, DOI 10.4049/jimmunol.1203017	56	46	47	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0119751	10.1371/journal.pone.0119751	http://dx.doi.org/10.1371/journal.pone.0119751			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799240	gold, Green Submitted, Green Published			2022-12-26	WOS:000351987300078
J	Gao, CT; Li, SS; Zhao, TS; Chen, J; Ren, H; Zhang, H; Wang, XC; Lang, MX; Liu, JC; Gao, S; Zhao, X; Sheng, J; Yuan, ZN; Hao, JH				Gao, Chuntao; Li, Shasha; Zhao, Tiansuo; Chen, Jing; Ren, He; Zhang, Huan; Wang, Xiuchao; Lang, Mingxiao; Liu, Jingcheng; Gao, Song; Zhao, Xiao; Sheng, Jun; Yuan, Zhanna; Hao, Jihui			SCF, Regulated by HIF-1 alpha, Promotes Pancreatic Ductal Adenocarcinoma Cell Progression	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR; EXPRESSION; CANCER; CARCINOMA; KIT; FACTOR-1-ALPHA; METASTASIS; GROWTH; VEGF	Stem cell factor (SCF) and hypoxia-inducible factor-1 alpha (HIF-1 alpha) both have important functions in pancreatic ductal adenocarcinoma (PDAC). This study aims to analyze the expression and clinicopathological significance of SCF and HIF-1 alpha in PDAC specimens and explore the molecular mechanism at PDAC cells in vitro and in vivo. We showed that the expression of SCF was significantly correlated with HIF-1 alpha expression via Western blot, PCR, chromatin immunoprecipitation (ChIP) assay, and luciferase assay analysis. The SCF level was also correlated with lymph node metastasis and the pathological tumor node metastasis (pTNM) stage in PDAC samples. The SCF higher-expression group had significantly lower survival rates than the SCF lower-expression group (p<0.05). Hypoxia up-regulated the expression of SCF through the hypoxia-inducible factor (HIF)-1 alpha in PDAC cells at the protein and RNA levels. When HIF-1 alpha was knocked down by RNA interference, the SCF level decreased significantly. Additionally, ChIP and luciferase results demonstrated that HIF-1 alpha can directly bind to the hypoxia response element (HRE) region of the SCF promoter and activate the SCF transcription under hypoxia. The results of colony formation, cell scratch, and transwell migration assay showed that SCF promoted the proliferation and invasion of PANC-1 cells under hypoxia. Furthermore, the down-regulated ability of cell proliferation and invasion following HIF-1 alpha knockdown was rescued by adding exogenous SCF under hypoxia in vitro. Finally, when the HIF-1 alpha expression was inhibited by digoxin, the tumor volume and the SCF level decreased, thereby proving the relationship between HIF-1 alpha and SCF in vivo. In conclusion, SCF is an important factor for the growth of PDAC. In our experiments, we proved that SCF, a downstream gene of HIF-1 alpha, can promote the development of PDAC under hypoxia. Thus, SCF might be a potential therapeutic target for PDAC.	[Gao, Chuntao; Li, Shasha; Zhao, Tiansuo; Chen, Jing; Ren, He; Zhang, Huan; Wang, Xiuchao; Lang, Mingxiao; Liu, Jingcheng; Gao, Song; Zhao, Xiao; Sheng, Jun; Yuan, Zhanna; Hao, Jihui] Tianjin Med Univ, Canc Inst & Hosp, Key Lab Canc Prevent & Therapy, Natl Clin Res Ctr Canc,Dept Pancreat Canc, Tianjin 300060, Peoples R China	Tianjin Medical University	Hao, JH (corresponding author), Tianjin Med Univ, Canc Inst & Hosp, Key Lab Canc Prevent & Therapy, Natl Clin Res Ctr Canc,Dept Pancreat Canc, Tianjin 300060, Peoples R China.	haojihui@tjmuch.com			National Natural Science Foundation of China [81302082, 81272685, 31301151, 81172355]; Key Program of Natural Science Foundation of Tianjin [11JCZDJC18400, 13YCYBYC37400]; Major Anticancer Technologies R & D Program of Tianjin [12ZCDZSY16700]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Program of Natural Science Foundation of Tianjin; Major Anticancer Technologies R & D Program of Tianjin	This work was supported by grants as follows: National Natural Science Foundation of China (grant No. 81302082, 81272685, 31301151, 81172355); Key Program of Natural Science Foundation of Tianjin (grant No. 11JCZDJC18400, 13YCYBYC37400); Major Anticancer Technologies R & D Program of Tianjin (grant No. 12ZCDZSY16700). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amsterdam A, 2014, ACTA HISTOCHEM, V116, P197, DOI 10.1016/j.acthis.2013.07.002; Arko L, 2010, PHARMACOL THERAPEUT, V128, P1, DOI 10.1016/j.pharmthera.2010.04.015; Bai CG, 2012, WORLD J GASTROENTERO, V18, P2929, DOI 10.3748/wjg.v18.i23.2929; Chaturvedi P, 2013, J CLIN INVEST, V123, P189, DOI 10.1172/JCI64993; Fujisawa T, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-37; Gibbs BF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022502; Gu Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025984; Han ZB, 2008, CARCINOGENESIS, V29, P1853, DOI 10.1093/carcin/bgn066; Heissig B, 2003, THROMB HAEMOSTASIS, V90, P570, DOI 10.1160/TH03-03-0188; Hoffmann AC, 2008, NEOPLASIA, V10, P674, DOI 10.1593/neo.08292; Knaup KX, 2009, MOL CANCER RES, V7, P88, DOI 10.1158/1541-7786.MCR-08-0288; Krock Bryan L, 2011, Genes Cancer, V2, P1117, DOI 10.1177/1947601911423654; Lennartsson J, 2005, STEM CELLS, V23, P16, DOI 10.1634/stemcells.2004-0117; Miyake K, 2008, PANCREAS, V36, pE1, DOI 10.1097/MPA.0b013e31815f2c2a; Miyake K, 2012, EXP CELL RES, V318, P1554, DOI 10.1016/j.yexcr.2012.03.013; Nogueira V, 2008, CANCER CELL, V14, P458, DOI 10.1016/j.ccr.2008.11.003; Pedersen M, 2008, BIOCHEM BIOPH RES CO, V377, P98, DOI 10.1016/j.bbrc.2008.09.102; Schallier D, 2009, ANTICANCER RES, V29, P5225; Seenath MM, 2008, BRIT J CANCER, V99, P459, DOI 10.1038/sj.bjc.6604474; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Talaiezadeh A, 2012, WSPOLCZESNA ONKOL, V16, P306, DOI 10.5114/wo.2012.30058; Torres C, 2014, PANCREAS, V43, P1042, DOI 10.1097/MPA.0000000000000155; Wang XC, 2014, CARCINOGENESIS, V35, P2283, DOI 10.1093/carcin/bgu162; Zhang H, 2012, ONCOGENE, V31, P1757, DOI 10.1038/onc.2011.365; Zhang M, 2011, CANCER LETT, V303, P108, DOI 10.1016/j.canlet.2011.01.017; Zhu ZN, 2012, ONCOL REP, V27, P1567, DOI 10.3892/or.2012.1697	26	61	61	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121338	10.1371/journal.pone.0121338	http://dx.doi.org/10.1371/journal.pone.0121338			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799412	Green Published, gold, Green Submitted			2022-12-26	WOS:000351987300239
J	Hayakawa, Y; Aoyama, T; Yokoyama, C; Okamoto, C; Komaki, H; Minatoguchi, S; Iwasa, M; Yamada, Y; Kawamura, I; Kawasaki, M; Nishigaki, K; Mikami, A; Suzuki, F; Minatoguchi, S				Hayakawa, Yuka; Aoyama, Takuma; Yokoyama, Chiharu; Okamoto, Chihiro; Komaki, Hisaaki; Minatoguchi, Shingo; Iwasa, Masamitsu; Yamada, Yoshihisa; Kawamura, Itta; Kawasaki, Masanori; Nishigaki, Kazuhiko; Mikami, Atsushi; Suzuki, Fumiaki; Minatoguchi, Shinya			High Salt Intake Damages the Heart through Activation of Cardiac (Pro) Renin Receptors Even at an Early Stage of Hypertension	PLOS ONE			English	Article							ANGIOTENSIN-II; DIABETIC-NEPHROPATHY; NONPROTEOLYTIC ACTIVATION; BLOOD-PRESSURE; MUSCLE-CELLS; PRORENIN; RATS; FIBROSIS; HYPERTROPHY; EXPRESSION	Objective It has not yet been fully elucidated whether cardiac tissue levels of prorenin, renin and (P) RR are activated in hypertension with a high salt intake. We hypothesized that a high salt intake activates the cardiac tissue renin angiotensin system and prorenin-(pro) renin receptor system, and damages the heart at an early stage of hypertension. Methods Wistar Kyoto rats (WKY) and spontaneously hypertensive rats (SHR) received regular (normal-salt diet, 0.9%) and high-salt (8.9%) chow for 6 weeks from 6 to 12 weeks of age. The systolic blood pressure, plasma renin activity (PRA) and plasma angiotensin II concentration were measured, and the protein expressions of prorenin, (pro) renin receptor, angiotensinogen, angiotensin II AT1 receptor, ERK1/2, TGF-beta, p38MAPK and HSP27 in the myocardium were investigated. The cardiac function was assessed by echocardiography, and histological analysis of the myocardium was performed. Results The high-salt diet significantly increased the systolic blood pressure, and significantly reduced the PRA and plasma angiotensin II concentration both in the WKYs and SHRs. Cardiac expressions of prorenin, renin, (P) RR, angiotensinogen, angiotensin II AT1 receptor, phosphorylated (p)-ERK1/2, p-p38MAPK, TGF-beta and p-HSP27 were significantly increased by the high salt diet both in the WKYs and SHRs. The high-salt diet significantly increased the interventricular septum thickness and cardiomyocyte size, and accelerated cardiac interstitial and perivascular fibrosis both in the WKYs and SHRs. On the other hand, dilatation of left ventricular end-diastolic dimension and impairment of left ventricular fractional shortening was shown only in salt loaded SHRs. Conclusion The high-salt diet markedly accelerated cardiac damage through the stimulation of cardiac (P)RR and angiotensin II AT1 receptor by increasing tissue prorenin, renin and angiotensinogen and the activation of ERK1/2, TGF-beta, p38MAPK and HSP27 under higher blood pressure.	[Hayakawa, Yuka; Aoyama, Takuma; Yokoyama, Chiharu; Okamoto, Chihiro; Komaki, Hisaaki; Minatoguchi, Shingo; Iwasa, Masamitsu; Yamada, Yoshihisa; Kawamura, Itta; Kawasaki, Masanori; Nishigaki, Kazuhiko; Mikami, Atsushi; Minatoguchi, Shinya] Gifu Univ, Grad Sch Med, Dept Cardiol, Gifu, Japan; [Suzuki, Fumiaki] Gifu Univ, Dept Life Sci, Gifu, Japan	Gifu University; Gifu University	Minatoguchi, S (corresponding author), Gifu Univ, Grad Sch Med, Dept Cardiol, Gifu, Japan.	minatos@gifu-u.ac.jp			Gifu University Graduate School of Medicine	Gifu University Graduate School of Medicine	The funding of this study was provided from Gifu University Graduate School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Coelho MS, 2006, NUTR METAB CARDIOVAS, V16, P148, DOI 10.1016/j.numecd.2005.09.001; Danilczyk U, 2004, NAT MED, V10, P1193; DENTON D, 1995, NAT MED, V1, P1009, DOI 10.1038/nm1095-1009; Dunser AH, 2005, HYPERTENSION, V46, P1069; Ferreira DN, 2010, J NUTR, V140, P1742, DOI 10.3945/jn.109.117473; Fujii K, 1999, HYPERTENS RES-CLIN E, V22, P181, DOI 10.1291/hypres.22.181; Morales MG, 2012, INT J BIOCHEM CELL B, V44, P1993, DOI 10.1016/j.biocel.2012.07.028; Gerc Vjekoslav, 2010, Med Arh, V64, P295; Gurley SB, 2007, SEMIN NEPHROL, V27, P144, DOI 10.1016/j.semnephrol.2007.01.009; Hall John E., 2011, GUYTON HALL TXB MED, P213; Hodge G, 2002, ACTA PHYSIOL SCAND, V174, P209, DOI 10.1046/j.1365-201x.2002.00937.x; Huang Y, 2007, KIDNEY INT, V72, P45, DOI 10.1038/sj.ki.5002243; Ichihara A, 2006, HYPERTENSION, V47, P894, DOI 10.1161/01.HYP.0000215838.48170.0b; Ichihara A, 2004, J CLIN INVEST, V114, P1128, DOI 10.1172/JCI200421398; Kang JJ, 2008, HYPERTENSION, V51, P1597, DOI 10.1161/HYPERTENSIONAHA.107.107268; Katayama IA, 2014, J NUTR, V144, P1571, DOI 10.3945/jn.114.192054; Li WC, 2014, HYPERTENSION, V63, P316, DOI 10.1161/HYPERTENSIONAHA.113.02041; Price DA, 1999, J AM SOC NEPHROL, V10, P2382; RIBEIRO AB, 1985, DRUGS, V30, P6, DOI 10.2165/00003495-198500301-00003; Sakoda M, 2007, HYPERTENS RES, V30, P1139, DOI 10.1291/hypres.30.1139; Saris JJ, 2006, HYPERTENSION, V48, P564, DOI 10.1161/01.HYP.0000240064.19301.1b; Schnermann J., 2008, KIDNEY PHYSL PATHOPH, P589; Schroten NF, 2012, HEART FAIL REV, V17, P191, DOI 10.1007/s10741-011-9262-2; Susic D, 2008, AM J PHYSIOL-HEART C, V295, pH1117, DOI 10.1152/ajpheart.00055.2008; Varagic J, 2006, AM J PHYSIOL-HEART C, V290, pH1503, DOI 10.1152/ajpheart.00970.2005	25	32	35	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120453	10.1371/journal.pone.0120453	http://dx.doi.org/10.1371/journal.pone.0120453			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799069	Green Published, Green Submitted, gold			2022-12-26	WOS:000351987300146
J	Israel-Assayag, E; Beaulieu, MJ; Cormier, Y				Israel-Assayag, Evelyne; Beaulieu, Marie-Josee; Cormier, Yvon			ASM-024, a Piperazinium Compound, Promotes the In Vitro Relaxation of beta 2-Adrenoreceptor Desensitized Tracheas	PLOS ONE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTORS; SMOOTH-MUSCLE; AIRWAY; MECHANISMS; CELLS	Inhaled beta 2-adrenoreceptor agonists are widely used in asthma and chronic obstructive pulmonary disease (COPD) for bronchoconstriction relief. beta 2-adrenoreceptor agonists relax airway smooth muscle cells via cyclic adenosine monophosphate (cAMP) mediated pathways. However, prolonged stimulation induces functional desensitization of the beta 2-adrenoreceptors (beta 2-AR), potentially leading to reduced clinical efficacy with chronic or prolonged administration. ASM-024, a small synthetic molecule in clinical stage development, has shown activity at the level of nicotinic receptors and possibly at the muscarinic level and presents anti-inflammatory and bronchodilator properties. Aerosolized ASM-024 reduces airway resistance in mice and promotes in-vitro relaxation of tracheal and bronchial preparations from animal and human tissues. ASM-024 increased in vitro relaxation response to maximally effective concentration of short-acting beta-2 agonists in dog and human bronchi. Although the precise mechanisms by which ASM-024 promotes airway smooth muscle (ASM) relaxation remain unclear, we hypothesized that ASM-024 will attenuate and/or abrogate agonist-induced contraction and remain effective despite beta 2-AR tachyphylaxis. beta 2-AR tachyphylaxis was induced with salbutamol, salmeterol and formoterol on guinea pig tracheas. The addition of ASM-024 relaxed concentration-dependently intact or beta 2-AR desensitized tracheal rings precontracted with methacholine. ASM-024 did not induce any elevation of intracellular cAMP in isolated smooth muscle cells; moreover, blockade of the cAMP pathway with an adenylate cyclase inhibitor had no significant effect on ASM-024-induced guinea pig trachea relaxation. Collectively, these findings show that ASM-024 elicits relaxation of beta 2-AR desensitized tracheal preparations and suggest that ASM-024 mediates smooth muscle relaxation through a different target and signaling pathway than beta 2-adrenergic receptor agonists. These findings suggest ASM-024 could potentially provide clinical benefit when used adjunctively with inhaled beta 2-adrenoreceptor agonists in those patients exhibiting a reduced response to their chronic use.	[Israel-Assayag, Evelyne; Beaulieu, Marie-Josee; Cormier, Yvon] IUCPQ, Quebec City, PQ, Canada; [Israel-Assayag, Evelyne; Cormier, Yvon] Asmacure Ltee, Quebec City, PQ, Canada	Laval University	Cormier, Y (corresponding author), IUCPQ, Quebec City, PQ, Canada.	yvon.cormier@med.ulaval.ca			Asmacure Ltee, 2600 boul. Laurier, Suite 880, Quebec, QC	Asmacure Ltee, 2600 boul. Laurier, Suite 880, Quebec, QC	Funding: Supported by grants from Asmacure Ltee, 2600 boul. Laurier, Suite 880, Quebec, QC. G1V 4W2. The funder provided support in the form of salaries for authors YC & EIA, but had no additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Assayag EI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086091; Barnes PJ, 2011, J BIOL CHEM, V286, P32899, DOI 10.1074/jbc.R110.206466; Buccafusco JJ, 2009, J PHARMACOL EXP THER, V328, P364, DOI 10.1124/jpet.108.145292; Cazzola M, 2012, PHARMACOL REV, V64, P450, DOI 10.1124/pr.111.004580; Cooper PR, 2011, BRIT J PHARMACOL, V163, P521, DOI 10.1111/j.1476-5381.2011.01257.x; Dajas-Bailador FA, 2002, J NEUROCHEM, V81, P606, DOI 10.1046/j.1471-4159.2002.00846.x; Dorion G, 2005, AM J PHYSIOL-LUNG C, V288, pL1139, DOI 10.1152/ajplung.00406.2004; Duringer C, 2009, BRIT J PHARMACOL, V158, P169, DOI 10.1111/j.1476-5381.2009.00262.x; Jyang Y, 2014, CELLULAR PHYSL BIOCH, V33, P389, DOI [10.1159/000356678, DOI 10.1159/000356678]; Kotlikoff MI, 1996, ANNU REV PHYSIOL, V58, P115, DOI 10.1146/annurev.ph.58.030196.000555; Lin RJ, 2006, J PHARMACOL EXP THER, V316, P709, DOI 10.1124/jpet.105.092171; Lipworth BJ, 1997, DRUG SAFETY, V16, P295, DOI 10.2165/00002018-199716050-00002; LOHSE MJ, 1990, J BIOL CHEM, V265, P3202; Papke RL, 2014, J PHARMACOL EXP THER, V350, P665, DOI 10.1124/jpet.114.215236; Stokes C., 2013, NEUR M PLANN; Townsend Elizabeth A, 2012, J Allergy (Cairo), V2012, P321949, DOI 10.1155/2012/321949; Wessler I, 2008, BRIT J PHARMACOL, V154, P1558, DOI 10.1038/bjp.2008.185	17	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120095	10.1371/journal.pone.0120095	http://dx.doi.org/10.1371/journal.pone.0120095			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799096	Green Published, Green Submitted, gold			2022-12-26	WOS:000351987300106
J	Jeong, KH; Nam, JH; Jin, BK; Kim, SR				Jeong, Kyoung Hoon; Nam, Jin Han; Jin, Byung Kwan; Kim, Sang Ryong			Activation of CNTF/CNTFR alpha Signaling Pathway by hRheb(S16H) Transduction of Dopaminergic Neurons In Vivo	PLOS ONE			English	Article							NEUROTROPHIC FACTOR CNTF; DIFFERENTIAL REGULATION; EXPRESSION; DISEASE; DEGENERATION; PROTECTS	Ciliary neurotrophic factor (CNTF) is one of representative neurotrophic factors for the survival of dopaminergic neurons. Its effects are primarily mediated via CNTF receptor a (CNTFR alpha). It is still unclear whether the levels of CNTFR alpha change in the substantia nigra of Parkinson's disease (PD) patients, but CNTF expression shows the remarkable decrease in dopaminergic neurons in the substantia nigra pars compacta (SNpc), suggesting that the support of CNTF/CNTFR alpha signaling pathway may be a useful neuroprotective strategy for the nigrostriatal dopaminergic projection in the adult brain. Here, we report that transduction of rat SNpc dopaminergic neurons by adeno-associated virus with a gene encoding human ras homolog enriched in brain (hRheb), with an S16H mutation [hRheb(S16H)], significantly upregulated the levels of both CNTF and CNTFR alpha in dopaminergic neurons. Moreover, the hRheb(S16H)-activated CNTF/CNTFR alpha signaling pathway was protective against 1-methyl-4-phenylpyridinium-induced neurotoxicity in the nigrostriatal dopaminergic projections. These results suggest that activation of CNTF/CNTFR alpha signaling pathway by specific gene delivery such as hRheb(S16H) may have therapeutic potential in the treatment of PD.	[Jeong, Kyoung Hoon; Kim, Sang Ryong] Kyungpook Natl Univ, Sch Life Sci, Inst Life Sci & Biotechnol, Taegu, South Korea; [Jeong, Kyoung Hoon; Kim, Sang Ryong] Kyungpook Natl Univ, Plus KNU Creat BioRes Grp BK21, Inst Life Sci & Biotechnol, Taegu, South Korea; [Kim, Sang Ryong] Kyungpook Natl Univ, Inst Life Sci & Biotechnol, Taegu, South Korea; [Nam, Jin Han; Jin, Byung Kwan] Kyung Hee Univ, Neurodegenerat Control Res Ctr, Sch Med, Seoul, South Korea; [Jin, Byung Kwan] Kyung Hee Univ, Dept Biochem & Mol Biol, Sch Med, Seoul, South Korea; [Kim, Sang Ryong] Kyungpook Natl Univ, Brain Sci & Engn Inst, Taegu, South Korea	Kyungpook National University; Kyungpook National University; Kyungpook National University; Kyung Hee University; Kyung Hee University; Kyungpook National University	Kim, SR (corresponding author), Kyungpook Natl Univ, Sch Life Sci, Inst Life Sci & Biotechnol, Taegu, South Korea.	srk75@knu.ac.kr	Core, Vector/CAF-4832-2022	Nam, Jinhan/0000-0003-4153-3711	National Research Foundation of Korea (NRF) grant - Korea government [2008-0061888, 2012R1A1A1039140]	National Research Foundation of Korea (NRF) grant - Korea government	This research was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (No. 2008-0061888 and 2012R1A1A1039140). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chauhan NB, 2001, J CHEM NEUROANAT, V21, P277, DOI 10.1016/S0891-0618(01)00115-6; Chlocco MJ, 2007, PARKINSONISM RELAT D, V13, pS321, DOI 10.1016/S1353-8020(08)70024-5; Choi SH, 2003, J NEUROSCI, V23, P5877; DAVIS S, 1993, SCIENCE, V260, P1805, DOI 10.1126/science.8390097; Emerich DF, 2006, CURR GENE THER, V6, P147, DOI 10.2174/156652306775515547; HAGG T, 1993, P NATL ACAD SCI USA, V90, P6315, DOI 10.1073/pnas.90.13.6315; HENDERSON JT, 1994, MOL BRAIN RES, V22, P151, DOI 10.1016/0169-328X(94)90043-4; Ip Nancy Y., 1992, Progress in Growth Factor Research, V4, P139, DOI 10.1016/0955-2235(92)90028-G; Jeong HK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013756; Karassek S, 2010, J BIOL CHEM, V285, P33979, DOI 10.1074/jbc.M109.095968; Kim SR, 2012, MOL THER, V20, P275, DOI 10.1038/mt.2011.213; Kim SR, 2011, ANN NEUROL, V70, P110, DOI 10.1002/ana.22383; Lee MY, 1997, J NEUROSCI, V17, P1137; Leem E, 2014, J NUTR BIOCHEM, V25, P801, DOI 10.1016/j.jnutbio.2014.03.006; Lin TN, 1998, MOL BRAIN RES, V55, P71, DOI 10.1016/S0169-328X(97)00367-7; Long X, 2005, CURR BIOL, V15, P702, DOI 10.1016/j.cub.2005.02.053; Manning BD, 2003, TRENDS BIOCHEM SCI, V28, P573, DOI 10.1016/j.tibs.2003.09.003; Nam JH, 2015, MOL NEUROBIOL, V51, P487, DOI 10.1007/s12035-014-8729-2; Park ES, 2012, BRAIN RES BULL, V89, P92, DOI 10.1016/j.brainresbull.2012.07.001; Park KK, 2008, SCIENCE, V322, P963, DOI 10.1126/science.1161566; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Siegel GJ, 2000, BRAIN RES REV, V33, P199, DOI 10.1016/S0165-0173(00)00030-8; Sleeman M W, 2000, Pharm Acta Helv, V74, P265, DOI 10.1016/S0031-6865(99)00050-3; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Yokota H, 2005, NEUROSCI LETT, V377, P170, DOI 10.1016/j.neulet.2004.11.093	25	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121803	10.1371/journal.pone.0121803	http://dx.doi.org/10.1371/journal.pone.0121803			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799580	Green Published, Green Submitted, gold			2022-12-26	WOS:000351987300292
J	Powell, PO; Sullivan, MA; Sheehy, JJ; Schulz, BL; Warren, FJ; Gilbert, RG				Powell, Prudence O.; Sullivan, Mitchell A.; Sheehy, Joshua J.; Schulz, Benjamin L.; Warren, Frederick J.; Gilbert, Robert G.			Acid Hydrolysis and Molecular Density of Phytoglycogen and Liver Glycogen Helps Understand the Bonding in Glycogen a (Composite) Particles	PLOS ONE			English	Article							SIZE-EXCLUSION CHROMATOGRAPHY; PLANT STARCH GRANULE; PHYSICAL CONSTRAINTS; METABOLISM; AMYLOPECTIN; EXTRACTION; SEPARATION; ALPHA; RICE; POLYSACCHARIDES	Phytoglycogen (from certain mutant plants) and animal glycogen are highly branched glucose polymers with similarities in structural features and molecular size range. Both appear to form composite a particles from smaller beta particles. The molecular size distribution of liver glycogen is bimodal, with distinct a and beta components, while that of phytoglycogen is monomodal. This study aims to enhance our understanding of the nature of the link between liver-glycogen beta particles resulting in the formation of large a particles. It examines the time evolution of the size distribution of these molecules during acid hydrolysis, and the size dependence of the molecular density of both glucans. The monomodal distribution of phytoglycogen decreases uniformly in time with hydrolysis, while with glycogen, the large particles degrade significantly more quickly. The size dependence of the molecular density shows qualitatively different shapes for these two types of molecules. The data, combined with a quantitative model for the evolution of the distribution during degradation, suggest that the bonding between beta into a particles is different between phytoglycogen and liver glycogen, with the formation of a glycosidic linkage for phytoglycogen and a covalent or strong non-covalent linkage, most probably involving a protein, for glycogen as most likely. This finding is of importance for diabetes, where a-particle structure is impaired.	[Powell, Prudence O.; Sullivan, Mitchell A.; Sheehy, Joshua J.; Gilbert, Robert G.] Huazhong Univ Sci & Technol, Tongji Sch Pharm, Wuhan 430074, Hubei, Peoples R China; [Powell, Prudence O.; Sullivan, Mitchell A.; Sheehy, Joshua J.; Warren, Frederick J.; Gilbert, Robert G.] Univ Queensland, Queensland Alliance Agr & Food Innovat, Ctr Nutr & Food Sci, Brisbane, Qld, Australia; [Schulz, Benjamin L.] Univ Queensland, Fac Sci, Sch Chem & Mol Biosci, Brisbane, Qld, Australia	Huazhong University of Science & Technology; University of Queensland; University of Queensland	Gilbert, RG (corresponding author), Huazhong Univ Sci & Technol, Tongji Sch Pharm, Wuhan 430074, Hubei, Peoples R China.	b.gilbert@uq.edu.au	Warren, Frederick/AAN-5233-2020; Sullivan, Mitchell/Y-5727-2018; Schulz, Benjamin L/B-3911-2009; Gilbert, Robert G/C-5660-2009	Warren, Frederick/0000-0002-2512-4670; Sullivan, Mitchell/0000-0001-9913-4030; Schulz, Benjamin L/0000-0002-4823-7758; Gilbert, Robert G/0000-0001-6988-114X; Sheehy, Joshua/0000-0002-8661-1923	Australian Research Council Discovery grant [DP130102461]; Thousand-Talents Program of the Chinese Foreign Experts Bureau	Australian Research Council Discovery grant(Australian Research Council); Thousand-Talents Program of the Chinese Foreign Experts Bureau	This work was funded by the Australian Research Council Discovery grant, DP130102461, and the Thousand-Talents Program of the Chinese Foreign Experts Bureau. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ball S, 1996, CELL, V86, P349, DOI 10.1016/S0092-8674(00)80107-5; Ball SG, 2003, ANNU REV PLANT BIOL, V54, P207, DOI 10.1146/annurev.arplant.54.031902.134927; BARBER AA, 1967, J BIOL CHEM, V242, P4040; CHEE NP, 1977, FEBS LETT, V73, P164, DOI 10.1016/0014-5793(77)80972-1; Ciric J, 2012, ANAL CHEM, V84, P10463, DOI 10.1021/ac302704q; DEAPODACA MAO, 1992, J INHERIT METAB DIS, V15, P213, DOI 10.1007/BF01799633; Fernandez C, 2011, INT J BIOL MACROMOL, V49, P458, DOI 10.1016/j.ijbiomac.2011.05.016; Gaborieau M, 2007, MACROMOL THEOR SIMUL, V16, P13, DOI 10.1002/mats.200600046; Graham TE, 2010, ACTA PHYSIOL, V199, P489, DOI 10.1111/j.1748-1716.2010.02131.x; GUNJASMITH Z, 1970, FEBS LETT, V12, P101, DOI 10.1016/0014-5793(70)80573-7; Huang L, 2011, CARBOHYD POLYM, V83, P1665, DOI 10.1016/j.carbpol.2010.10.030; Konkolewicz D, 2007, J POLYM SCI POL CHEM, V45, P3112, DOI 10.1002/pola.22059; Konkolewicz D, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.238301; Kubo A, 2010, J AGR FOOD CHEM, V58, P4463, DOI 10.1021/jf904074k; LAWRENCE L, 1951, J AM CHEM SOC, V73, P3973, DOI 10.1021/ja01152a123; LICHTI G, 1977, J POLYM SCI POL CHEM, V15, P1957, DOI 10.1002/pol.1977.170150816; MARSHALL JJ, 1974, ARCH BIOCHEM BIOPHYS, V161, P234, DOI 10.1016/0003-9861(74)90256-2; Melendez R, 1997, J MOL EVOL, V45, P446, DOI 10.1007/PL00006249; Melendez R, 1998, BIOPHYS J, V75, P106, DOI 10.1016/S0006-3495(98)77498-3; Melendez R, 1999, BIOPHYS J, V77, P1327, DOI 10.1016/S0006-3495(99)76982-1; MELENDEZHEVIA E, 1993, BIOCHEM J, V295, P477, DOI 10.1042/bj2950477; MEYER F, 1970, J BIOL CHEM, V245, P6642; MORDOH J, 1965, P NATL ACAD SCI USA, V53, P86, DOI 10.1073/pnas.53.1.86; ORRELL SA, 1964, J BIOL CHEM, V239, P4021; Orzechowski S, 2008, ACTA BIOCHIM POL, V55, P435, DOI 10.18388/abp.2008_3049; Powell PO, 2014, CARBOHYD POLYM, V101, P423, DOI 10.1016/j.carbpol.2013.09.061; Putaux JL, 1999, INT J BIOL MACROMOL, V26, P145, DOI 10.1016/S0141-8130(99)00076-8; Radzicka A, 1996, J AM CHEM SOC, V118, P6105, DOI 10.1021/ja954077c; Roach PJ, 2012, BIOCHEM J, V441, P763, DOI 10.1042/BJ20111416; Rolland-Sabate A, 2008, BIOMACROMOLECULES, V9, P1719, DOI 10.1021/bm7013119; Rybicka KK, 1996, TISSUE CELL, V28, P253, DOI 10.1016/S0040-8166(96)80013-9; Ryu JH, 2009, INT J BIOL MACROMOL, V45, P478, DOI 10.1016/j.ijbiomac.2009.08.006; Stapleton D, 2010, PROTEOMICS, V10, P2320, DOI 10.1002/pmic.200900628; Sullivan MA, 2015, CARBOHYD POLYM, V118, P9, DOI 10.1016/j.carbpol.2014.11.005; Sullivan MA, 2014, J CHROMATOGR A, V1332, P21, DOI 10.1016/j.chroma.2014.01.053; Sullivan MA, 2014, BIOMACROMOLECULES, V15, P660, DOI 10.1021/bm401714v; Sullivan MA, 2012, BIOMACROMOLECULES, V13, P3805, DOI 10.1021/bm3012727; Sullivan MA, 2011, BIOMACROMOLECULES, V12, P1983, DOI 10.1021/bm2006054; Sullivan MA, 2010, BIOMACROMOLECULES, V11, P1094, DOI 10.1021/bm100074p; Syahariza ZA, 2010, CARBOHYD POLYM, V82, P14, DOI 10.1016/j.carbpol.2010.04.014; Vilaplana F, 2010, J SEP SCI, V33, P3537, DOI 10.1002/jssc.201000525; Wattebled F, 2005, PLANT PHYSIOL, V138, P184, DOI 10.1104/pp.105.059295; Wong KS, 2003, J CEREAL SCI, V37, P139, DOI 10.1006/jcrs.2002.0485; Zeeman SC, 2010, ANNU REV PLANT BIOL, V61, P209, DOI 10.1146/annurev-arplant-042809-112301	44	36	36	4	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121337	10.1371/journal.pone.0121337	http://dx.doi.org/10.1371/journal.pone.0121337			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799321	gold, Green Published			2022-12-26	WOS:000351987300238
J	Wang, KX; Xu, LL; Rui, YF; Huang, S; Lin, SE; Xiong, JH; Li, YH; Lee, WYW; Li, G				Wang, Kui-Xing; Xu, Liang-Liang; Rui, Yun-Feng; Huang, Shuo; Lin, Si-En; Xiong, Jiang-Hui; Li, Ying-Hui; Lee, Wayne Yuk-Wai; Li, Gang			The Effects of Secretion Factors from Umbilical Cord Derived Mesenchymal Stem Cells on Osteogenic Differentiation of Mesenchymal Stem Cells	PLOS ONE			English	Article							STROMAL CELLS; BONE REGENERATION; TISSUE; MARROW; REPAIR; MECHANISMS; OSTEOBLAST; SCAFFOLDS; PHOSPHATE; CARTILAGE	Factors synthesized by mesenchymal stem cells (MSCs) contain various growth factors, cytokines, exosomes and microRNAs, which may affect the differentiation abilities of MSCs. In the present study, we investigated the effects of secretion factors of human umbilical cord derived mesenchymal stem cells (hUCMSCs) on osteogenesis of human bone marrow derived MSCs (hBMSCs). The results showed that 20 mu g/ml hUCMSCs secretion factors could initiate osteogenic differentiation of hBMSCs without osteogenic induction medium (OIM), and the amount of calcium deposit (stained by Alizarin Red) was significantly increased after the hUCMSCs secretion factors treatment. Real time quantitative reverse transcription-polymerase chain reaction (real time qRT-PCR) demonstrated that the expression of osteogenesis-related genes including ALP, BMP2, OCN, Osterix, Col1 alpha and Runx2 were significantly up-regulated following hUCMSCs secretion factors treatment. In addition, we found that 10 mu g hUCMSCs secretion factors together with 2x10(5) hBMSCs in the HA/TCP scaffolds promoted ectopic bone formation in nude mice. Local application of 10 mu g hUCMSCs secretion factors with 50 mu l 2% hyaluronic acid hydrogel and 1x10(5) rat bone marrow derived MSCs (rBMSCs) also significantly enhanced the bone repair of rat calvarial bone critical defect model at both 4 weeks and 8 weeks. Moreover, the group that received the hUCMSCs secretion factors treatment had more cartilage and bone regeneration in the defect areas than those in the control group. Taken together, these findings suggested that hUCMSCs secretion factors can initiate osteogenesis of bone marrow MSCs and promote bone repair. Our study indicates that hUCMSCs secretion factors may be potential sources for promoting bone regeneration.	[Wang, Kui-Xing; Li, Gang] Chinese Univ Hong Kong, Fac Med, Sch Biomed Sci, Minist Educ,Key Lab Regenerat Med, Hong Kong, Hong Kong, Peoples R China; [Wang, Kui-Xing; Xu, Liang-Liang; Lee, Wayne Yuk-Wai; Li, Gang] Chinese Univ Hong Kong, Prince Wales Hosp, Li Ka Shing Inst Hlth Sci, Stem Cells & Regenerat Med Lab, Hong Kong, Hong Kong, Peoples R China; [Xu, Liang-Liang; Huang, Shuo; Lin, Si-En; Lee, Wayne Yuk-Wai; Li, Gang] Chinese Univ Hong Kong, Prince Wales Hosp, Fac Med, Dept Orthopaed & Traumatol, Hong Kong, Hong Kong, Peoples R China; [Xu, Liang-Liang; Huang, Shuo; Lin, Si-En; Lee, Wayne Yuk-Wai; Li, Gang] Chinese Univ Hong Kong, Fac Med, Lui Che Woo Inst Innovat Med, Hong Kong, Hong Kong, Peoples R China; [Rui, Yun-Feng; Li, Gang] Southeast Univ, Sch Med, Zhongda Hosp, Dept Orthopaed, Nanjing, Jiangsu, Peoples R China; [Xiong, Jiang-Hui; Li, Ying-Hui] Chinese Univ Hong Kong, Shenzhen Res Inst, CUHK ACC Space Med Ctr Hlth Maintenance Musculosk, Shenzhen, Peoples R China; [Xiong, Jiang-Hui; Li, Ying-Hui] Astronaut Res & Training Ctr China ACC, State Key Lab Space Med Fundamentat & Applicat, Beijing 100094, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Southeast University - China; Chinese University of Hong Kong, Shenzhen	Li, G (corresponding author), Chinese Univ Hong Kong, Fac Med, Sch Biomed Sci, Minist Educ,Key Lab Regenerat Med, Hong Kong, Hong Kong, Peoples R China.	gangli@cuhk.edu.hk	Lin, Sien/J-7773-2018; Liangliang, XU/K-9185-2019; Lee, Wayne YW/H-8298-2013; Li, Gang/J-7830-2018	Lin, Sien/0000-0002-7292-7062; Liangliang, XU/0000-0002-5249-7480; Lee, Wayne YW/0000-0002-0486-360X; Li, Gang/0000-0002-3981-2239	National Natural Science Foundation of China (NSFC) [81172177, 81371946]; Hong Kong Government Research Grant Council, General Research Fund [CUHK471110, CUHK470813]; National Basic Science and Development Programme (973 Programme) [2012CB518105]; SMART program	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Hong Kong Government Research Grant Council, General Research Fund; National Basic Science and Development Programme (973 Programme)(National Basic Research Program of China); SMART program	This work is supported by a grant from National Natural Science Foundation of China (NSFC No. 81172177, 81371946) and Hong Kong Government Research Grant Council, General Research Fund (CUHK471110 and CUHK470813) to Gang Li. This work was also supported in part by the National Basic Science and Development Programme (973 Programme, 2012CB518105) and SMART program seed funding to Gang Li, Lui Che Woo Institute of Innovation Medicine, The Chinese University of Hong Kong. This research work was made possible by resources donated by Lui Che Woo Foundation Limited. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amable PR, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt442; Ando Y, 2014, BONE, V61, P82, DOI 10.1016/j.bone.2013.12.029; Baek WY, 2009, J BONE MINER RES, V24, P1055, DOI [10.1359/JBMR.081248, 10.1359/jbmr.081248]; Baksh D, 2007, STEM CELLS, V25, P1384, DOI 10.1634/stemcells.2006-0709; Bian LM, 2013, BIOMATERIALS, V34, P413, DOI 10.1016/j.biomaterials.2012.09.052; BRUDER SP, 1994, J CELL BIOCHEM, V56, P283, DOI 10.1002/jcb.240560303; Byeon YE, 2010, CYTOTHERAPY, V12, P626, DOI 10.3109/14653249.2010.481665; Cameron JA, 2013, CURR TOP MICROBIOL, V367, P113, DOI 10.1007/82_2012_291; Can A, 2007, STEM CELLS, V25, P2886, DOI 10.1634/stemcells.2007-0417; Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886; Carlin R, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-8; Chen DF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052948; Ducy P, 2000, SCIENCE, V289, P1501, DOI 10.1126/science.289.5484.1501; Fong CY, 2011, STEM CELL REV REP, V7, P1, DOI 10.1007/s12015-010-9166-x; Gnecchi M, 2005, NAT MED, V11, P367, DOI 10.1038/nm0405-367; Hendijani F, 2014, CELL TISSUE BANK; Hou TY, 2009, TISSUE ENG PT A, V15, P2325, DOI 10.1089/ten.tea.2008.0402; Hsieh JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072604; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Jochmann K, 2014, MATRIX BIOL, V35, P239, DOI 10.1016/j.matbio.2014.04.001; Khan SN, 2004, EXPERT OPIN BIOL TH, V4, P741; Kinnaird T, 2004, CIRCULATION, V109, P1543, DOI 10.1161/01.CIR.0000124062.31102.57; Komori T, 2003, J BONE MINER METAB, V21, P193, DOI 10.1007/s00774-002-0408-0; Krampera M, 2006, BONE, V39, P678, DOI 10.1016/j.bone.2006.04.020; Lai RC, 2011, REGEN MED, V6, P481, DOI [10.2217/RME.11.35, 10.2217/rme.11.35]; Liu DD, 2013, J CELL BIOCHEM, V114, P1105, DOI 10.1002/jcb.24451; Liu Y, 2011, NAT MED, V17, P1594, DOI 10.1038/nm.2542; Majore I, 2011, STEM CELL REV REP, V7, P17, DOI 10.1007/s12015-010-9165-y; Patel AN, 2013, CELL TRANSPLANT, V22, P513, DOI 10.3727/096368912X655064; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Spicer PP, 2012, NAT PROTOC, V7, P1918, DOI 10.1038/nprot.2012.113; Staines KA, 2013, J ENDOCRINOL, V219, pR1, DOI 10.1530/JOE-13-0276; Sze SK, 2007, MOL CELL PROTEOMICS, V6, P1680, DOI 10.1074/mcp.M600393-MCP200; Thein-Han W, 2011, TISSUE ENG PT A, V17, P2943, DOI 10.1089/ten.tea.2010.0674; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Timmers L, 2011, STEM CELL RES, V6, P206, DOI 10.1016/j.scr.2011.01.001; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Wang HS, 2004, STEM CELLS, V22, P1330, DOI 10.1634/stemcells.2004-0013; Wang LM, 2010, TISSUE ENG PT A, V16, P1937, DOI 10.1089/ten.TEA.2009.0706; Wang LM, 2011, J TISSUE ENG REGEN M, V5, P712, DOI 10.1002/term.370; Wang LM, 2009, J TISSUE ENG REGEN M, V3, P398, DOI 10.1002/term.176; Xu LL, 2012, INT J BIOCHEM CELL B, V44, P612, DOI 10.1016/j.biocel.2011.12.018; Zhao L, 2010, BIOMATERIALS, V31, P3848, DOI 10.1016/j.biomaterials.2010.01.093	43	52	57	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120593	10.1371/journal.pone.0120593	http://dx.doi.org/10.1371/journal.pone.0120593			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799169	Green Published, gold, Green Submitted			2022-12-26	WOS:000351987300157
J	Yaya, Y; Data, T; Lindtjorn, B				Yaya, Yaliso; Data, Tadesse; Lindtjorn, Bernt			Maternal Mortality in Rural South Ethiopia: Outcomes of Community-Based Birth Registration by Health Extension Workers	PLOS ONE			English	Article							OPTIONS	Introduction Rural communities in low-income countries lack vital registrations to track birth outcomes. We aimed to examine the feasibility of community-based birth registration and measure maternal mortality ratio (MMR) in rural south Ethiopia. Methods In 2010, health extension workers (HEWs) registered births and maternal deaths among 421,639 people in three districts (Derashe, Bonke, and Arba Minch Zuria). One nurse-supervisor per district provided administrative and technical support to HEWs. The primary outcomes were the feasibility of registration of a high proportion of births and measuring MMR. The secondary outcome was the proportion of skilled birth attendance. We validated the completeness of the registry and the MMR by conducting a house-to-house survey in 15 randomly selected villages in Bonke. Results We registered 10,987 births (81.4% of expected 13,492 births) with annual crude birth rate of 32 per 1,000 population. The validation study showed that, of 2,401 births occurred in the surveyed households within eight months of the initiation of the registry, 71.6% (1,718) were registered with similar MMRs (474 vs. 439) between the registered and unregistered births. Overall, we recorded 53 maternal deaths; MMR was 489 per 100,000 live births and 83% (44 of 53 maternal deaths) occurred at home. Ninety percent (9,863 births) were at home, 4% (430) at health posts, 2.5% (282) at health centres, and 3.5% (412) in hospitals. MMR increased if: the male partners were illiterate (609 vs. 346; p=0.051) and the villages had no road access (946 vs. 410; p= 0.039). The validation helped to increase the registration coverage by 10% through feedback discussions. Conclusion It is possible to obtain a high-coverage birth registration and measure MMR in rural communities where a functional system of community health workers exists. The MMR was high in rural south Ethiopia and most births and maternal deaths occurred at home.	[Yaya, Yaliso; Lindtjorn, Bernt] Univ Bergen, Ctr Int Hlth, Bergen, Norway; [Yaya, Yaliso] Arba Minch Coll Hlth Sci, Arba Minch, Ethiopia; [Data, Tadesse] Gamo Gofa Zone Hlth Dept, Arba Minch, Ethiopia	University of Bergen	Yaya, Y (corresponding author), Univ Bergen, Ctr Int Hlth, Bergen, Norway.	yalisoyaya@gmail.com	Lindtjorn, Bernt/K-9465-2018	Lindtjorn, Bernt/0000-0002-6267-6984	Centre for International Health (CIH), University of Bergen, Norway	Centre for International Health (CIH), University of Bergen, Norway	This study was funded by the Centre for International Health (CIH), University of Bergen, Norway. The funders have no role in data acquisition, analysis, writing, and decision to submit for publication. The views expressed are that of the authors and do not necessarily express the policies of the funders and the institutions of the authors.	AbouZahr C, 2007, LANCET, V370, P1791, DOI 10.1016/S0140-6736(07)61310-5; Alkire S, 2011, PROCEEDINGS OF GERMA; Berhane Y, 2000, ACTA OBSTET GYN SCAN, V79, P968, DOI 10.1034/j.1600-0412.2000.079011968.x; Bhutta ZA, 2010, LANCET, V375, P2032, DOI 10.1016/S0140-6736(10)60678-2; Campbell C, 2005, B WORLD HEALTH ORGAN, V83, P462; CSA-Ethiopia, 2014, ETHIOPIA MINI DEMOGR; CSA-Ethiopia, 2010, STATISTICAL TABLES F; CSA-Ethiopia ICF-International, 2012, ETHIOPIA DEMOGRAPHIC; FMOH-Ethiopia, 2010, HEALTH SECTOR DEVELO; Gaym Asheber, 2012, Ethiop Med J, V50, P209; Girma M, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-459; GRAHAM W, 1989, STUD FAMILY PLANN, V20, P125, DOI 10.2307/1966567; Graham WJ, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-12; Graham WJ, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1001003; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; Jamison DT, 2013, LANCET, V382, P1898, DOI 10.1016/S0140-6736(13)62105-4; Koblinsky M, 2010, ETHIOPIAN JOURNAL OF, P24; KWAST BE, 1986, STUD FAMILY PLANN, V17, P288, DOI 10.2307/1966906; Major B, 1999, J PERS SOC PSYCHOL, V77, P735, DOI 10.1037/0022-3514.77.4.735; Menendez C, 2008, PLOS MED, V5, P220, DOI 10.1371/journal.pmed.0050044; Mersha A, 1996, Indian J Public Health, V40, P30; Samia ZG, 2011, SOURCE OF VITAL STAT; SHIFERAW T, 1993, ETHIOPIAN MED J, V31, P239; Songane FF, 2002, SOC SCI MED, V54, P23, DOI 10.1016/S0277-9536(01)00004-1; UNICEF, 2013, EVERY CHILDS BIRTH R; WHO, 2004, BEYOND THE NUMBERS R; WHO, 2013, MATERNAL DEATH SURVE; WHO U. UNFPA The World Bank, 2012, TRENDS MAT MORT 1990; WHO UNICEF UNFPA, WORLD BANK TRENDS IN; World-Bank Crude Birth Rate in Ethiopia, 2010, WORLD BANK CRUDE BIR; Yaya Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096294; Yaya Y, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-136	32	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0119321	10.1371/journal.pone.0119321	http://dx.doi.org/10.1371/journal.pone.0119321			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE6ZS	25799229	Green Published, gold, Green Submitted			2022-12-26	WOS:000351987300038
J	Yu, XD; Lin, M; Ye, F; Ouyang, H; Chen, Y; Zhou, CW; Su, ZH				Yu, Xiaoduo; Lin, Meng; Ye, Feng; Ouyang, Han; Chen, Yan; Zhou, Chunwu; Su, Zihua			Comparison of Contrast-Enhanced Isotropic 3D-GRE-T1WI Sequence versus Conventional Non-Isotropic Sequence on Preoperative Staging of Cervical Cancer	PLOS ONE			English	Article							TURBO SPIN-ECHO; 3.0 T; IMAGE QUALITY; 3D; CARCINOMA; 2D; EXPERIENCE; ACCURACY; MRI; CT	Purpose To compare contrast-enhanced isotropic 3D-GRE-T1WI sequence vs. conventional non-isotropic sequence in terms of image quality, estimated signal-to-noise ratio (eSNR), relative tumor contrast and performance of cervical cancer staging. Methods This retrospective study was approved by the institutional review board, and informed consent was waived. Seventy-one patients (47 +/- 9.4 years), with pathologically-confirmed cervical cancer underwent axial contrast-enhanced 1mm(3) isotropic 3D-GRE-T1WI sequence (herein referred to Isotropy), and 3-mm-thick non-isotropic sagittal and coronal sequences. Image quality score, eSNR and relative contrast between tumor to myometrium, gluteal muscle, and fat respectively, were compared between 3-mm-thick reconstructed images from Isotropy and directly scanned non-isotropic images by paired t-test. Difference in tumor staging obtained from Isotropy and combined Three-planes including reconstructed axial images, directly scanned sagittal and coronal sequence were compared by McNemar test. Results Both sequences showed similar image quality. Reconstructed images demonstrated higher eSNR, equal or lower relative tumor contrast compared with non-isotropic images. Compared with performing diagnosis on Three-planes, both reviewers showed higher accuracy when diagnosing vaginal invasion on Isotropy (p = 0.039 and 0.003, respectively). Conclusion Compared with non-isotropic sequence, 3.0T MR isotropic 3D-GRE-T1WI sequence exhibited better eSNR, providing more reliable clinical information for preoperative staging of cervical cancer.	[Yu, Xiaoduo; Lin, Meng; Ye, Feng; Ouyang, Han; Chen, Yan; Zhou, Chunwu] Chinese Acad Med Sci, Peking Union Med Coll, Canc Inst & Hosp, Dept Diagnost Radiol, Beijing 100730, Peoples R China; [Su, Zihua] GE Healthcare, Life Sci, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Peking Union Medical College; General Electric	Ouyang, H (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll, Canc Inst & Hosp, Dept Diagnost Radiol, Beijing 100730, Peoples R China.	houybj@126.com			Life Science, GE Healthcare	Life Science, GE Healthcare	The authors received no specific funding for this work. Life Science, GE Healthcare provided support in the form of a salary for author ZS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Akita A, 2011, EUR RADIOL, V21, P1850, DOI 10.1007/s00330-011-2122-6; Balleyguier C, 2011, EUR RADIOL, V21, P1102, DOI 10.1007/s00330-010-1998-x; Choi HJ, 2006, CANCER-AM CANCER SOC, V106, P914, DOI 10.1002/cncr.21641; Hecht EM, 2011, AM J ROENTGENOL, V197, pW346, DOI 10.2214/AJR.10.5914; Heverhagen JT, 2007, RADIOLOGY, V245, P638, DOI 10.1148/radiol.2453062151; Hori M, 2013, EUR RADIOL, V23, P2296, DOI 10.1007/s00330-013-2815-0; Hori M, 2011, RADIOLOGY, V258, P154, DOI 10.1148/radiol.10100866; Hricak H, 2007, RADIOLOGY, V245, P491, DOI 10.1148/radiol.2452061983; de la Pena MJ, 2008, GYNECOL ONCOL, V110, pS49, DOI 10.1016/j.ygyno.2008.05.030; Kim H, 2010, RADIOLOGY, V254, P485, DOI 10.1148/radiol.09090587; KIM SH, 1990, RADIOLOGY, V175, P45, DOI 10.1148/radiology.175.1.2315503; Komada Tomohiro, 2008, Magn Reson Med Sci, V7, P13, DOI 10.2463/mrms.7.13; Maffei E, 2011, INSIGHTS IMAGING, V2, P39, DOI 10.1007/s13244-010-0056-1; Meindl T, 2009, EUR RADIOL, V19, P713, DOI 10.1007/s00330-008-1175-7; Moraal B, 2010, RADIOLOGY, V255, P154, DOI 10.1148/radiol.09090814; Nicolet V, 2000, RADIOGRAPHICS, V20, P1539, DOI 10.1148/radiographics.20.6.g00nv111539; Pecorelli S, 2009, INT J GYNECOL OBSTET, V105, P103, DOI 10.1016/j.ijgo.2009.02.012; Puls R, 2007, J MAGN RESON IMAGING, V25, P1174, DOI 10.1002/jmri.20936; Ristow O, 2009, EUR RADIOL, V19, P1263, DOI 10.1007/s00330-008-1260-y; Rosenkrantz AB, 2010, AM J ROENTGENOL, V194, P634, DOI 10.2214/AJR.09.2994; Rosenkrantz AB, 2010, AM J ROENTGENOL, V194, P446, DOI 10.2214/AJR.09.3217; Sala E, 2007, AM J ROENTGENOL, V188, P1577, DOI 10.2214/AJR.06.1196; Scheidler J, 1998, RADIOLOGY, V206, P125, DOI 10.1148/radiology.206.1.9423661; Stevens KJ, 2008, RADIOLOGY, V249, P1026, DOI 10.1148/radiol.2493080227; Takeda T, 2008, ACTA RADIOL, V49, P1167, DOI 10.1080/02841850802477924; TOGASHI K, 1989, RADIOLOGY, V171, P245, DOI 10.1148/radiology.171.1.2928532; Van Hoe L, 1999, RADIOLOGY, V213, P608, DOI 10.1148/radiology.213.2.r99oc23608; Van Vierzen PBJ, 1998, CLIN RADIOL, V53, P183, DOI 10.1016/S0009-9260(98)80098-6	28	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0122053	10.1371/journal.pone.0122053	http://dx.doi.org/10.1371/journal.pone.0122053			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799021	Green Submitted, gold, Green Published			2022-12-26	WOS:000351987300315
J	Zhang, SH; Shi, YH; Cheng, NN; Du, HQ; Fan, WN; Wang, CZ				Zhang, Senhao; Shi, Yinghua; Cheng, Ningning; Du, Hongqi; Fan, Wenna; Wang, Chengzhang			De Novo Characterization of Fall Dormant and Nondormant Alfalfa (Medicago sativa L.) Leaf Transcriptome and Identification of Candidate Genes Related to Fall Dormancy	PLOS ONE			English	Article							ABSCISIC-ACID; SEED DORMANCY; SSR-MARKERS; SIGNAL-TRANSDUCTION; HORMONAL-REGULATION; GIBBERELLIC-ACID; COLD-RESISTANCE; RNA-SEQ; ANNOTATION; METABOLISM	Alfalfa (Medicago sativa L.) is one of the most widely cultivated perennial forage legumes worldwide. Fall dormancy is an adaptive character related to the biomass production and winter survival in alfalfa. The physiological, biochemical and molecular mechanisms causing fall dormancy and the related genes have not been well studied. In this study, we sequenced two standard varieties of alfalfa (dormant and non-dormant) at two time points and generated approximately 160 million high quality paired-end sequence reads using sequencing by synthesis (SBS) technology. The de novo transcriptome assembly generated a set of 192,875 transcripts with an average length of 856 bp representing about 165.1 Mb of the alfalfa leaf transcriptome. After assembly, 111,062 (57.6%) transcripts were annotated against the NCBI non-redundant database. A total of 30,165 (15.6%) transcripts were mapped to 323 Kyoto Encyclopedia of Genes and Genomes pathways. We also identified 41,973 simple sequence repeats, which can be used to generate markers for alfalfa, and 1,541 transcription factors were identified across 1,350 transcripts. Gene expression between dormant and non-dormant alfalfa at different time points were performed, and we identified several differentially expressed genes potentially related to fall dormancy. The Gene Ontology and pathways information were also identified. We sequenced and assembled the leaf transcriptome of alfalfa related to fall dormancy, and also identified some genes of interest involved in the fall dormancy mechanism. Thus, our research focused on studying fall dormancy in alfalfa through transcriptome sequencing. The sequencing and gene expression data generated in this study may be used further to elucidate the complete mechanisms governing fall dormancy in alfalfa.	[Zhang, Senhao; Shi, Yinghua; Cheng, Ningning; Du, Hongqi; Fan, Wenna; Wang, Chengzhang] Henan Agr Univ, Coll Anim Sci & Vet Med, Zhengzhou 450002, Henan, Peoples R China	Henan Agricultural University	Wang, CZ (corresponding author), Henan Agr Univ, Coll Anim Sci & Vet Med, Zhengzhou 450002, Henan, Peoples R China.	wangcz@henau.edu.cn		Zhang, Senhao/0000-0002-9231-9750	National Natural Science Foundation of China [31172261]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors gratefully thank the National Natural Science Foundation of China for financial support grant 31172261. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Andrews S, FASTQC QUALITY CONTR; [Anonymous], 2014, PLOS ONE, DOI DOI 10.1371/J0URNAL.P0NE.0114612; Ariss JJ, 2007, CROP SCI, V47, P2274, DOI 10.2135/cropsci2006.12.0782; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bielenberg DG, 2008, TREE GENET GENOMES, V4, P495, DOI 10.1007/s11295-007-0126-9; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brewer MS, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0068005, 10.1371/journal.pone.0079935]; BULA RJ, 1954, AGRON J, V46, P397, DOI 10.2134/agronj1954.00021962004600090001x; Busov VB, 2004, PLANTA, V218, P916, DOI 10.1007/s00425-003-1175-4; CASTONGUAY Y, 1995, CROP SCI, V35, P509, DOI 10.2135/cropsci1995.0011183X003500020038x; Chagne D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092644; Champagne CEM, 2007, PLANT CELL, V19, P3369, DOI 10.1105/tpc.107.052886; Chen M, 2004, ANNU REV GENET, V38, P87, DOI 10.1146/annurev.genet.38.072902.092259; Cunningham SM, 2001, CROP SCI, V41, P1091, DOI 10.2135/cropsci2001.4141091x; Cunningham SM, 1998, J PLANT PHYSIOL, V153, P220, DOI 10.1016/S0176-1617(98)80069-2; Dien BS, 2006, BIOMASS BIOENERG, V30, P880, DOI 10.1016/j.biombioe.2006.02.004; Eddy Sean R, 2009, Genome Inform, V23, P205; Fan WenNa, 2014, Acta Prataculturae Sinica, V23, P177; Flajoulot S, 2005, THEOR APPL GENET, V111, P1420, DOI 10.1007/s00122-005-0074-4; Garg R, 2011, PLANT PHYSIOL, V156, P1661, DOI 10.1104/pp.111.178616; Garg R, 2011, DNA RES, V18, P53, DOI 10.1093/dnares/dsq028; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Han Y., 2011, BMC GENOMICS, V12, P350, DOI DOI 10.1186/1471-2164-12-350; HEINRICHS D. H., 1960, CANADIAN JOUR PLANT SCI, V40, P638; Horvath D, 2009, PLANT SCI, V177, P523, DOI 10.1016/j.plantsci.2009.09.002; Horvath DP, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-536; Horvath DP, 2003, TRENDS PLANT SCI, V8, P534, DOI 10.1016/j.tplants.2003.09.013; Huang HH, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-648; Iorizzo M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-389; Kepczynski J, 1997, PHYSIOL PLANTARUM, V101, P720, DOI 10.1034/j.1399-3054.1997.1010407.x; Koornneef M, 2002, CURR OPIN PLANT BIOL, V5, P33, DOI 10.1016/S1369-5266(01)00219-9; Kuhn N, 2009, J PLANT PHYSIOL, V166, P1172, DOI 10.1016/j.jplph.2009.01.005; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; LARSEN K. L., 1963, CROP SCI, V3, P234, DOI 10.2135/cropsci1963.0011183X000300030018x; LATCHMAN DS, 1993, INT J EXP PATHOL, V74, P417; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li XH, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-568; Libault M, 2009, PLANT PHYSIOL, V151, P991, DOI 10.1104/pp.109.144105; Liu XD, 2013, P NATL ACAD SCI USA, V110, P15485, DOI 10.1073/pnas.1304651110; Lu MW, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-651; Ma KY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039727; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; McKenzie J. S., 1988, Alfalfa and alfalfa improvement, P259; Millar AA, 2006, PLANT J, V45, P942, DOI 10.1111/j.1365-313X.2006.02659.x; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Morozova O, 2009, ANNU REV GENOM HUM G, V10, P135, DOI 10.1146/annurev-genom-082908-145957; Mullineaux P, 2002, CURR OPIN PLANT BIOL, V5, P43, DOI 10.1016/S1369-5266(01)00226-6; Nakasugi K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059534; Nemri A, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00098; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Parra G, 2007, BIOINFORMATICS, V23, P1061, DOI 10.1093/bioinformatics/btm071; Perez-Rodriguez P, 2010, NUCLEIC ACIDS RES, V38, pD822, DOI 10.1093/nar/gkp805; PERRY TO, 1971, SCIENCE, V171, P29, DOI 10.1126/science.171.3966.29; Postnikova OA, 2013, PLANT CELL PHYSIOL, V54, P1041, DOI 10.1093/pcp/pct056; R Development Core Team, 2012, R LANG ENV STAT COMP; Riechmann JL, 1998, BIOL CHEM, V379, P633; RIKIN A, 1975, J EXP BOT, V26, P175, DOI 10.1093/jxb/26.2.175; Rohde A, 2000, FOR SCI, V64, P89; Rohde A, 2007, TRENDS PLANT SCI, V12, P217, DOI 10.1016/j.tplants.2007.03.012; Samac DA, 2006, CHEM IND-SER, V112, P79; Schwab PM, 1996, CROP SCI, V36, P418, DOI 10.2135/cropsci1996.0011183X003600020034x; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sharopova N, 2002, PLANT MOL BIOL, V48, P463, DOI 10.1023/A:1014868625533; Shi CY, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-131; SMITH D., 1961, Canadian Journal of Plant Science, V41, P244; Smith H, 2000, NATURE, V407, P585, DOI 10.1038/35036500; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; STOUT DG, 1989, CAN J PLANT SCI, V69, P491, DOI 10.4141/cjps89-060; Sun LB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050676; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Teuber L., 1998, STANDARD TESTS CHARA, pA; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; Tiwari SB, 2003, PLANT CELL, V15, P533, DOI 10.1105/tpc.008417; Toth G, 2000, GENOME RES, V10, P967, DOI 10.1101/gr.10.7.967; Umylny B, 2012, TAG BASED NEXT GENER, P449; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; VANCE CP, 1979, PLANT PHYSIOL, V64, P1, DOI 10.1104/pp.64.1.1; Victoria FC, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-15; Vinogradov AE, 2003, NUCLEIC ACIDS RES, V31, P1838, DOI 10.1093/nar/gkg296; VOLENEC JJ, 1991, PLANT PHYSIOL, V96, P786, DOI 10.1104/pp.96.3.786; WALDMAN M, 1975, J EXP BOT, V26, P853, DOI 10.1093/jxb/26.6.853; Wang CZ, 2008, J PLANT NUTR, V31, P1257, DOI 10.1080/01904160802135027; Wang CZ, 2009, AGRON J, V101, P1146, DOI 10.2134/agronj2009.0026; Wang XW, 2004, THEOR APPL GENET, V109, P352, DOI 10.1007/s00122-004-1634-8; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Xie C, 2011, NUCLEIC ACIDS RES, V39, pW316, DOI 10.1093/nar/gkr483; Yang SS, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-199; Yuegao H., 2009, ALFALFA MANAGEMENT G, P1; Zenser N, 2001, P NATL ACAD SCI USA, V98, P11795, DOI 10.1073/pnas.211312798; Zhang JH, 2006, FIELD CROP RES, V97, P111, DOI 10.1016/j.fcr.2005.08.018; Zhang LG, 2004, P NATL ACAD SCI USA, V101, P16855, DOI 10.1073/pnas.0407821101	95	34	36	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0122170	10.1371/journal.pone.0122170	http://dx.doi.org/10.1371/journal.pone.0122170			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799491	gold, Green Published, Green Submitted			2022-12-26	WOS:000351987300320
J	Banerjee, A; Adolph, RS; Gopalakrishnapai, J; Kleinboelting, S; Emmerich, C; Steegborn, C; Visweswariah, SS				Banerjee, Arka; Adolph, Ramona S.; Gopalakrishnapai, Jayashree; Kleinboelting, Silke; Emmerich, Christiane; Steegborn, Clemens; Visweswariah, Sandhya S.			A Universal Stress Protein (USP) in Mycobacteria Binds cAMP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC-AMP; RECEPTOR PROTEIN; MOLECULAR-REPLACEMENT; NUCLEOTIDE CYCLASES; TUBERCULOSIS H37RV; ADENYLYL CYCLASES; GAF DOMAINS; IDENTIFICATION; SMEGMATIS; TOOLS	Mycobacteria are endowed with rich and diverse machinery for the synthesis, utilization, and degradation of cAMP. The actions of cyclic nucleotides are generally mediated by binding of cAMP to conserved and well characterized cyclic nucleotide binding domains or structurally distinct cGMP-specific and -regulated cyclic nucleotide phosphodiesterase, adenylyl cyclase, and E. coli transcription factor FhlA (GAF) domain-containing proteins. Proteins with cyclic nucleotide binding and GAF domains can be identified in the genome of mycobacterial species, and some of them have been characterized. Here, we show that a significant fraction of intracellular cAMP is bound to protein in mycobacterial species, and by using affinity chromatography techniques, we identify specific universal stress proteins (USP) as abundantly expressed cAMP-binding proteins in slow growing as well as fast growing mycobacteria. We have characterized the biochemical and thermodynamic parameters for binding of cAMP, and we show that these USPs bind cAMP with a higher affinity than ATP, an established ligand for other USPs. We determined the structure of the USP MSMEG_3811 bound to cAMP, and we confirmed through structure-guided mutagenesis, the residues important for cAMP binding. This family of USPs is conserved in all mycobacteria, and we suggest that they serve as "sinks" for cAMP, making this second messenger available for downstream effectors as and when ATP levels are altered in the cell.	[Banerjee, Arka; Gopalakrishnapai, Jayashree; Visweswariah, Sandhya S.] Indian Inst Sci, Dept Mol Reprod Dev & Genet, Bangalore 560012, Karnataka, India; [Adolph, Ramona S.; Kleinboelting, Silke; Emmerich, Christiane; Steegborn, Clemens] Univ Bayreuth, Dept Biochem, D-95440 Bayreuth, Germany	Indian Institute of Science (IISC) - Bangalore; University of Bayreuth	Visweswariah, SS (corresponding author), Indian Inst Sci, Dept Mol Reprod Dev & Genet, Bangalore 560012, Karnataka, India.	sandhya@mrdg.iisc.ernet.in	Visweswariah, Sandhya/Q-7500-2019; Banerjee, Arka/ABE-7498-2020	Visweswariah, Sandhya/0000-0003-2786-7344; Banerjee, Arka/0000-0001-8387-1271; Adolph, Ramona S./0000-0001-5143-5977	Council for Scientific and Industrial Research, Government of India; Deutsche Forschungsgemeinschaft [STE1701/11-1]; Department of Biotechnology, an Intensive Research in High Priority Areas grant; JC Bose Fellowship from the Department of Science	Council for Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Department of Biotechnology, an Intensive Research in High Priority Areas grant; JC Bose Fellowship from the Department of Science	Supported by a senior research fellowship from the Council for Scientific and Industrial Research, Government of India.; Supported by Grant STE1701/11-1 from the Deutsche Forschungsgemeinschaft.; Supported by the Department of Biotechnology, an Intensive Research in High Priority Areas grant, and a JC Bose Fellowship from the Department of Science.	Antoni FA, 2000, FRONT NEUROENDOCRIN, V21, P103, DOI 10.1006/frne.1999.0193; Aravind L, 2002, PROTEINS, V48, P1, DOI 10.1002/prot.10064; Bahk YY, 2004, PROTEOMICS, V4, P3299, DOI 10.1002/pmic.200400980; Bai G, 2011, CELL MICROBIOL, V13, P349, DOI 10.1111/j.1462-5822.2010.01562.x; Bai GC, 2009, FEMS IMMUNOL MED MIC, V55, P68, DOI 10.1111/j.1574-695X.2008.00500.x; Bertinetti Daniela, 2009, BMC Chem Biol, V9, P3, DOI 10.1186/1472-6769-9-3; Biswas KH, 2008, BIOCHEMISTRY-US, V47, P3534, DOI 10.1021/bi702025w; Bond CS, 2003, BIOINFORMATICS, V19, P311, DOI 10.1093/bioinformatics/19.2.311; Borland G, 2009, BRIT J PHARMACOL, V158, P70, DOI 10.1111/j.1476-5381.2008.00087.x; Corrigan RM, 2013, P NATL ACAD SCI USA, V110, P9084, DOI 10.1073/pnas.1300595110; Dass BKM, 2008, J BACTERIOL, V190, P3824, DOI 10.1128/JB.00138-08; de Souza GA, 2011, J PROTEOMICS, V75, P502, DOI 10.1016/j.jprot.2011.08.016; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FSIHI H, 1995, MOL MICROBIOL, V16, P909, DOI 10.1111/j.1365-2958.1995.tb02317.x; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Gronenborn AM, 2009, CURR OPIN STRUC BIOL, V19, P39, DOI 10.1016/j.sbi.2008.12.002; Gu S, 2003, MOL CELL PROTEOMICS, V2, P1284, DOI 10.1074/mcp.M300060-MCP200; Harman JG, 2001, BBA-PROTEIN STRUCT M, V1547, P1, DOI 10.1016/S0167-4838(01)00187-X; Heikaus CC, 2009, STRUCTURE, V17, P1551, DOI 10.1016/j.str.2009.07.019; Hingley-Wilson SM, 2010, TUBERCULOSIS, V90, P236, DOI 10.1016/j.tube.2010.03.013; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kannan N, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-12-r264; Kantardjieff KA, 2003, PROTEIN SCI, V12, P1865, DOI 10.1110/ps.0350503; KOLB A, 1993, ANNU REV BIOCHEM, V62, P749, DOI 10.1146/annurev.bi.62.070193.003533; Kvint K, 2003, CURR OPIN MICROBIOL, V6, P140, DOI 10.1016/S1369-5274(03)00025-0; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Laxman S, 2007, MOL INTERV, V7, P203, DOI 10.1124/mi.7.4.7; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; LOWRIE DB, 1975, NATURE, V254, P600, DOI 10.1038/254600a0; Malen H, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-132; Martinez Sergio E, 2002, Mol Interv, V2, P317, DOI 10.1124/mi.2.5.317; Mattow J, 2003, ELECTROPHORESIS, V24, P3405, DOI 10.1002/elps.200305601; McCue LA, 2000, GENOME RES, V10, P204, DOI 10.1101/gr.10.2.204; McDonough KA, 2012, NAT REV MICROBIOL, V10, P27, DOI 10.1038/nrmicro2688; Mueller U, 2012, J SYNCHROTRON RADIAT, V19, P442, DOI 10.1107/S0909049512006395; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nambi S, 2013, J BIOL CHEM, V288, P14114, DOI 10.1074/jbc.M113.463992; Nambi S, 2010, J BIOL CHEM, V285, P24313, DOI 10.1074/jbc.M110.118398; Ntolosi BA, 2001, TUBERCULOSIS, V81, P279, DOI 10.1054/tube.2001.0302; O'Toole R, 2003, RES MICROBIOL, V154, P387, DOI 10.1016/S0923-2508(03)00081-0; PADH H, 1976, INDIAN J BIOCHEM BIO, V13, P413; Podobnik M, 2014, J BIOL CHEM, V289, P16588, DOI 10.1074/jbc.M114.560086; Rehmann H, 2007, NAT REV MOL CELL BIO, V8, P63, DOI 10.1038/nrm2082; Rosenkrands I, 2000, ELECTROPHORESIS, V21, P935, DOI 10.1002/(SICI)1522-2683(20000301)21:5<935::AID-ELPS935>3.3.CO;2-G; Sanchez J, 2008, CELL MOL LIFE SCI, V65, P1347, DOI 10.1007/s00018-008-7496-5; SCHOMAKER V, 1968, ACTA CRYSTALL B-STRU, VB 24, P63, DOI 10.1107/S0567740868001718; Schubert OT, 2013, CELL HOST MICROBE, V13, P602, DOI 10.1016/j.chom.2013.04.008; SHAH S, 1991, J BACTERIOL, V173, P3238, DOI 10.1128/JB.173.10.3238-3242.1991; Sharma R, 2014, BIOCHEMISTRY-US, V53, P7765, DOI 10.1021/bi500924v; Shenoy AR, 2004, COMP FUNCT GENOM, V5, P17, DOI 10.1002/cfg.349; Shenoy AR, 2003, ANAL BIOCHEM, V319, P335, DOI 10.1016/S0003-2697(03)00286-0; Shenoy AR, 2006, FEBS LETT, V580, P3344, DOI 10.1016/j.febslet.2006.05.034; Shenoy AR, 2006, TRENDS MICROBIOL, V14, P543, DOI 10.1016/j.tim.2006.10.005; Stapleton M, 2010, J BIOL CHEM, V285, P7016, DOI 10.1074/jbc.M109.047720; Steegborn C, 2014, BBA-MOL BASIS DIS, V1842, P2535, DOI 10.1016/j.bbadis.2014.08.012; Stivala A, 2011, BIOINFORMATICS, V27, P3315, DOI 10.1093/bioinformatics/btr575; Talaat AM, 2004, P NATL ACAD SCI USA, V101, P4602, DOI 10.1073/pnas.0306023101; Taylor SS, 2008, BBA-PROTEINS PROTEOM, V1784, P16, DOI 10.1016/j.bbapap.2007.10.002; Tkaczuk KL, 2013, EVOL APPL, V6, P434, DOI 10.1111/eva.12057; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Weiglmeier PR, 2010, TOXINS, V2, P2213, DOI 10.3390/toxins2092213; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zarembinski TI, 1998, P NATL ACAD SCI USA, V95, P15189, DOI 10.1073/pnas.95.26.15189; Zoraghi R, 2004, MOL PHARMACOL, V65, P267, DOI 10.1124/mol.65.2.267	65	20	21	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2015	290	20					12731	12743		10.1074/jbc.M115.644856	http://dx.doi.org/10.1074/jbc.M115.644856			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI2IF	25802331	hybrid, Green Published			2022-12-26	WOS:000354569000025
J	Song, JJ; Jiao, YM; Zhang, T; Zhang, YH; Huang, XJ; Li, HJ; Wu, H				Song, Jingjing; Jiao, Yanmei; Zhang, Tong; Zhang, Yonghong; Huang, Xiaojie; Li, Hongjun; Wu, Hao			Longitudinal Changes in Plasma Caspase-1 and Caspase-3 during the First 2 Years of HIV-1 Infection in CD4(Low) and CD4(High) Patient Groups	PLOS ONE			English	Article							RAPID DISEASE PROGRESSION; CELLS; SEROCONVERSION; VIREMIA; DEATH	Over 95% of CD4 cell death occurs by Caspase-1-mediated pyroptosis during HIV infection. Caspase-3-mediated apoptosis accounts for the death in a small proportion of infected CD4 cells. To date, there have been no reports on the dynamics of Caspase-1 and Caspase-3 and their relationship with disease progression in acute HIV-1 infection. In this study, two distinct HIV-1 patient groups were enrolled. The CD4(High) group maintained a CD4 level above450 cells/mu l while CD4 levels in the CD4(Low) group dropped below 250 cells/mu l within 2 years after infection. Blood samples were collected at 1, 2, 3, 4, 6, 12 and 24 months after HIV infection. Plasma Caspase-1 and Caspase-3 levels in the two patients groups were determined by a single-step ELISA using commercially available monoclonal antibodies. The results showed that Caspase-1 and Caspase-3 levels in the CD4(High) group increased rapidly and then decreased within a short time during early HIV-1 infection. In contrast, Caspase-1 and Caspase-3 levels in the CD4(Low) group were obviously increased after 1 year of HIV-1 infection.	[Song, Jingjing; Jiao, Yanmei; Zhang, Tong; Zhang, Yonghong; Huang, Xiaojie; Li, Hongjun; Wu, Hao] Capital Med Univ, Beijing Youan Hosp, Beijing 100069, Peoples R China	Capital Medical University	Li, HJ (corresponding author), Capital Med Univ, Beijing Youan Hosp, Beijing 100069, Peoples R China.	lihongjun00113@126.com; whdoc900@gmail.com	Zhang, Tong/HGC-1090-2022		National 12th Five-Year Major Projects of China [2012ZX10001-003, 2012ZX10001-006]; High-level health personnel training program of Beijing health system [2013-3-072]; Capital Medical University based-clinical cooperation projects [14JL70]; Development and Application Research of Beijing AIDS Clinical Data and Sample Repository [D131100005313005]	National 12th Five-Year Major Projects of China; High-level health personnel training program of Beijing health system; Capital Medical University based-clinical cooperation projects; Development and Application Research of Beijing AIDS Clinical Data and Sample Repository	This study was supported in part by the National 12th Five-Year Major Projects of China (2012ZX10001-003, 2012ZX10001-006), High-level health personnel training program of Beijing health system (2013-3-072), Capital Medical University based-clinical cooperation projects (14JL70), Development and Application Research of Beijing AIDS Clinical Data and Sample Repository (D131100005313005).	Bosinger SE, 2009, J CLIN INVEST, V119, P3556, DOI 10.1172/JCI40115; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Cohen MS, 2011, NEW ENGL J MED, V364, P1943, DOI 10.1056/NEJMra1011874; Cox AL, 2014, NATURE, V505, P492, DOI 10.1038/505492a; Dillon SM, 2012, J IMMUNOL, V189, P885, DOI 10.4049/jimmunol.1200681; Doitsh G, 2014, NATURE, V505, P509, DOI 10.1038/nature12940; Doitsh G, 2010, CELL, V143, P789, DOI 10.1016/j.cell.2010.11.001; Fiebig EW, 2003, AIDS, V17, P1871, DOI 10.1097/00002030-200309050-00005; Gaiha GD, 2014, SCIENCE, V343, P383, DOI 10.1126/science.1250175; Huang XJ, 2013, JAIDS-J ACQ IMM DEF, V62, P441, DOI 10.1097/QAI.0b013e31827f5c9a; Huang XJ, 2012, JAIDS-J ACQ IMM DEF, V61, P448, DOI 10.1097/QAI.0b013e31827146e0; Jacquelin B, 2009, J CLIN INVEST, V119, P3544, DOI 10.1172/JCI40093; Jiao YM, 2012, VIRAL IMMUNOL, V25, P333, DOI 10.1089/vim.2012.0011; Jiao YM, 2012, VIRAL IMMUNOL, V25, P262, DOI 10.1089/vim.2012.0035; Monroe KM, 2014, SCIENCE, V343, P428, DOI 10.1126/science.1243640; Sabado RL, 2010, BLOOD, V116, P3839, DOI 10.1182/blood-2010-03-273763; Stacey AR, 2009, J VIROL, V83, P3719, DOI 10.1128/JVI.01844-08; Steele AK, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-14; Yang X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049526	19	17	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0121011	10.1371/journal.pone.0121011	http://dx.doi.org/10.1371/journal.pone.0121011			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25806508	gold, Green Submitted, Green Published			2022-12-26	WOS:000351880000123
J	Correa, APD; Antunes, CF; Figueira, FR; de Castro, MA; Ribeiro, JP; Schaan, BD				dos Santos Correa, Ana Paula; Antunes, Cristiano Fetter; Figueira, Franciele Ramos; de Castro, Marina Axmann; Ribeiro, Jorge Pinto; Schaan, Beatriz D'Agord			Effect of Acute Inspiratory Muscle Exercise on Blood Flow of Resting and Exercising Limbs and Glucose Levels in Type 2 Diabetes	PLOS ONE			English	Article							FUNCTION-TESTS; RESPONSES; VASODILATION; INTENSITY; CAPACITY; WORK; HYPERGLYCEMIA; VOLUME	To evaluate the effects of inspiratory loading on blood flow of resting and exercising limbs in patients with diabetic autonomic neuropathy. Ten diabetic patients without cardiovascular autonomic neuropathy (DM), 10 patients with cardiovascular autonomic neuropathy (DM-CAN) and 10 healthy controls (C) were randomly assigned to inspiratory muscle load of 60% or 2% of maximal inspiratory pressure (PImax) for approximately 5 min, while resting calf blood flow (CBF) and exercising forearm blood flow (FBF) were measured. Reactive hyperemia was also evaluated. From the 20 diabetic patients initially allocated, 6 wore a continuous glucose monitoring system to evaluate the glucose levels during these two sessions (2%, placebo or 60%, inspiratory muscle metaboreflex). Mean age was 58 +/- 8 years, and mean HbA1c, 7.8% (62 mmol/mol) (DM and DM-CAN). A PImax of 60% caused reduction of CBF in DM-CAN and DM (P<0.001), but not in C, whereas calf vascular resistance (CVR) increased in DM-CAN and DM (P<0.001), but not in C. The increase in FBF during forearm exercise was blunted during 60% of PImax in DM-CAN and DM, and augmented in C (P<0.001). Glucose levels decreased by 40 +/- 18.8% (P<0.001) at 60%, but not at 2%, of PImax. A negative correlation was observed between reactive hyperemia and changes in CVR (Beta coefficient = -0.44, P = 0.034). Inspiratory muscle loading caused an exacerbation of the inspiratory muscle metaboreflex in patients with diabetes, regardless of the presence of neuropathy, but influenced by endothelial dysfunction. High-intensity exercise that recruits the diaphragm can abruptly reduce glucose levels.	[dos Santos Correa, Ana Paula; Antunes, Cristiano Fetter; Figueira, Franciele Ramos; Ribeiro, Jorge Pinto; Schaan, Beatriz D'Agord] Hosp Clin Porto Alegre, Exercise Pathophysiol Res Lab, Porto Alegre, RS, Brazil; [dos Santos Correa, Ana Paula] Univ Sydney, Fac Hlth Sci, Lidcombe, NSW, Australia; [Figueira, Franciele Ramos; Schaan, Beatriz D'Agord] Univ Fed Rio Grande do Sul, Postgrad Program Endocrinol, Porto Alegre, RS, Brazil; [Figueira, Franciele Ramos; Schaan, Beatriz D'Agord] Univ Fed Rio Grande do Sul, Dept Internal Med, Porto Alegre, RS, Brazil; [de Castro, Marina Axmann] Univ Fed Rio Grande do Sul, Postgrad Program Pneumol Sci, Porto Alegre, RS, Brazil; [Ribeiro, Jorge Pinto] Univ Fed Rio Grande do Sul, Postgrad Program Cardiol, Porto Alegre, RS, Brazil	University of Sydney; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul	Schaan, BD (corresponding author), Hosp Clin Porto Alegre, Exercise Pathophysiol Res Lab, Porto Alegre, RS, Brazil.	beatrizschaan@gmail.com	Schaan, Beatriz D./I-7518-2017	Schaan, Beatriz D./0000-0002-2128-8387	Coordination for the Improvement of Higher Education Personnel (CAPES), Brazil; Fundo de Incentivo a Pesquisa do Hospital de Clinicas de Porto Alegre (FIPE - HCPA)	Coordination for the Improvement of Higher Education Personnel (CAPES), Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundo de Incentivo a Pesquisa do Hospital de Clinicas de Porto Alegre (FIPE - HCPA)	A.P.S. Correa was supported by a grant from the Coordination for the Improvement of Higher Education Personnel (CAPES), Brazil. This study was supported by Fundo de Incentivo a Pesquisa do Hospital de Clinicas de Porto Alegre (FIPE - HCPA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldrich TK, 2002, AM J RESP CRIT CARE, V166, P548, DOI 10.1164/rccm.166.4.518; [Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; Bhandari A, 2000, MED SCI SPORT EXER, V32, P1406, DOI 10.1097/00005768-200008000-00008; Borghi-Silva A, 2008, AM J PHYSIOL-HEART C, V294, pH2465, DOI 10.1152/ajpheart.91520.2007; Callegaro CC, 2011, RESP PHYSIOL NEUROBI, V177, P24, DOI 10.1016/j.resp.2011.03.001; Chiappa GR, 2008, J AM COLL CARDIOL, V51, P1663, DOI 10.1016/j.jacc.2007.12.045; Correa APS, 2011, MED SCI SPORT EXER, V43, P1135, DOI 10.1249/MSS.0b013e31820a7c12; Dall'Ago P, 2006, J AM COLL CARDIOL, V47, P757, DOI 10.1016/j.jacc.2005.09.052; Dempsey JA, 2008, MED SCI SPORT EXER, V40, P457, DOI [10.1249/mss.0b013e31815f8957, 10.1249/MSS.0b013e31815f8957]; Dempsey JA, 2006, RESP PHYSIOL NEUROBI, V151, P242, DOI 10.1016/j.resp.2005.12.015; Estacio RO, 1998, DIABETES CARE, V21, P291, DOI 10.2337/diacare.21.2.291; EWING DJ, 1980, ANN INTERN MED, V92, P308, DOI 10.7326/0003-4819-92-2-308; EWING DJ, 1985, DIABETES CARE, V8, P491, DOI 10.2337/diacare.8.5.491; Figueira FR, 2010, PLOS ONE, V8; Guazzi M, 2006, AM J PHYSIOL-HEART C, V291, pH921, DOI 10.1152/ajpheart.00986.2005; HAMILTON AL, 1995, AM J RESP CRIT CARE, V152, P2021, DOI 10.1164/ajrccm.152.6.8520771; Harms CA, 2000, J APPL PHYSIOL, V89, P131, DOI 10.1152/jappl.2000.89.1.131; Ivy JL, 1986, EXERCISE SPORT SCI R, V15, P29; Kabitz HJ, 2008, DIABETOLOGIA, V51, P191, DOI 10.1007/s00125-007-0856-0; KAHN JK, 1986, DIABETES CARE, V9, P389, DOI 10.2337/diacare.9.4.389; Kaijser L, 1991, Clin Auton Res, V1, P239, DOI 10.1007/BF01824993; Kaminski DM, 2011, CLIN AUTON RES, V21, P29, DOI 10.1007/s10286-010-0087-1; Kingwell BA, 2003, DIABETES CARE, V26, P899, DOI 10.2337/diacare.26.3.899; KJAER M, 1990, J APPL PHYSIOL, V68, P2067, DOI 10.1152/jappl.1990.68.5.2067; Little JP, 2011, J APPL PHYSIOL, V111, P1554, DOI 10.1152/japplphysiol.00921.2011; MCVEIGH GE, 1992, DIABETOLOGIA, V35, P771; Neder JA, 1999, BRAZ J MED BIOL RES, V32, P719, DOI 10.1590/S0100-879X1999000600007; Neumann C, 1997, BRAZ J MED BIOL RES, V30, P197, DOI 10.1590/S0100-879X1997000200007; QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693; Roseguini BT, 2008, MED SCI SPORT EXER, V40, P9, DOI 10.1249/mss.0b013e3181590bd9; Sheel AW, 2001, J PHYSIOL-LONDON, V537, P277, DOI 10.1111/j.1469-7793.2001.0277k.x; St Croix CM, 2000, J PHYSIOL-LONDON, V529, P493, DOI 10.1111/j.1469-7793.2000.00493.x; Thaning P, 2011, DIABETES CARE, V34, P1186, DOI 10.2337/dc10-2129; Thaning P, 2010, DIABETES, V59, P182, DOI 10.2337/db09-1068; Umpierre D, 2009, EUR J CARDIOV PREV R, V16, P53, DOI 10.1097/HJR.0b013e32831c8489; da Silva AMV, 2010, CLINICS, V65, P1139, DOI 10.1590/S1807-59322010001100015; Vinik AI, 2003, DIABETES CARE, V26, P1553, DOI 10.2337/diacare.26.5.1553; Wei M, 2000, ANN INTERN MED, V132, P605, DOI 10.7326/0003-4819-132-8-200004180-00002; Williams SB, 1998, CIRCULATION, V97, P1695, DOI 10.1161/01.CIR.97.17.1695	39	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0121384	10.1371/journal.pone.0121384	http://dx.doi.org/10.1371/journal.pone.0121384			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803283	Green Submitted, Green Published, gold			2022-12-26	WOS:000353889600154
J	Lin, ML; Li, ZJ; Liu, JS; Gozlan, RE; Lek, S; Zhang, TL; Ye, SW; Li, W; Yuan, J				Lin, Mingli; Li, Zhongjie; Liu, Jiashou; Gozlan, Rodolphe E.; Lek, Sovan; Zhang, Tanglin; Ye, Shaowen; Li, Wei; Yuan, Jing			Maintaining Economic Value of Ecosystem Services Whilst Reducing Environmental Cost: A Way to Achieve Freshwater Restoration in China	PLOS ONE			English	Article							NUTRIENT CONTROL; YANGTZE-RIVER; MIDDLE REACH; BOTTOM-UP; LAKE; FISH; COMMUNITY; BIOMANIPULATION	Freshwater fisheries are central to food security in China and this remains one of the most important priorities for the growing human population. Thus, combining ecosystem restoration with economics is pivotal in setting successful conservation in China. Here, we have developed a practical management model that combines fishery improvement with conservation. For six years, a ban on fertilizer and a reduction of planktivorous fish stocking along with the introduction of both mandarin fish Siniperca chuatsi and Chinese mitten crab Eriocheir sinensis was apparent in Wuhu Lake, a highly eutrophic lake located in the middle reaches of the Yangtze River. Annual fish yield decreased slightly after the change in management, whereas fisheries income increased 2.6 times. Mandarin fish and Chinese mitten crab accounted for only 16% of total fisheries production but for 48% of total fisheries income. During this six year period, water clarity increased significantly from 61 cm to 111 cm. Total nitrogen, total phosphorus and chlorophyll decreased significantly from 1.14 to 0.84 mg/L, 0.077 to 0.045 mg/L, and 21.45 to 11.59 mu g/L respectively, and macrophyte coverage increased by about 30%. Our results showed that the ecological status of shallow lakes could be rapidly reversed from eutrophic to oligotrophic using simple biomanipulation, whilst maintaining fisheries economic value. It also offers a better approach to shallow fisheries lake management in Asia where traditionally the stocking of Chinese carp and use of fertilizers is still popular.	[Lin, Mingli; Li, Zhongjie; Liu, Jiashou; Zhang, Tanglin; Ye, Shaowen; Li, Wei; Yuan, Jing] Chinese Acad Sci, Inst Hydrobiol, State Key Lab Freshwater Ecol & Biotechnol, Wuhan, Peoples R China; [Lin, Mingli] Chinese Acad Sci, Sanya Inst Deep Sea Sci & Engn, Sanya, Peoples R China; [Gozlan, Rodolphe E.] UPMC, Museum Natl Hist Nat, IRD,UMR207, CNRS,MNHN 7208, Paris, France; [Lek, Sovan] Univ Toulouse 3, CNRS, EDB, UMR 5174, F-31062 Toulouse, France	Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Chinese Academy of Sciences; Institute of Deep-Sea Science & Engineering, CAS; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Ecole Nationale Formation Agronomique (ENSFEA)	Liu, JS (corresponding author), Chinese Acad Sci, Inst Hydrobiol, State Key Lab Freshwater Ecol & Biotechnol, Wuhan, Peoples R China.	jsliu@ihb.ac.cn		Ye, Shaowen/0000-0003-3932-8401	State Key Laboratory of Freshwater Ecology and Biotechnology [2011FBZ28]; Agro-scientific Research in the Public Interest in China [201303056]; "Hundred Talents Program" of the Chinese Academy of Sciences [SIDSSE-BR-315 201201, Y410012]; Knowledge Innovation Program of the Chinese Academy of Sciences [SIDSSE-316 201210]; Science and Technology Cooperation Project of Sanya City and Chinese Academy of Sciences [2013YD75]	State Key Laboratory of Freshwater Ecology and Biotechnology(Chinese Academy of Sciences); Agro-scientific Research in the Public Interest in China; "Hundred Talents Program" of the Chinese Academy of Sciences(Chinese Academy of Sciences); Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of SciencesKnowledge Innovation Program of the Chinese Academy of Sciences); Science and Technology Cooperation Project of Sanya City and Chinese Academy of Sciences	This research was funded by the State Key Laboratory of Freshwater Ecology and Biotechnology (No. 2011FBZ28) and Agro-scientific Research in the Public Interest in China (No. 201303056). The data analysis and writing of the manuscript were partly supported by "Hundred Talents Program" of the Chinese Academy of Sciences (SIDSSE-BR-315 201201, Y410012), Knowledge Innovation Program of the Chinese Academy of Sciences (SIDSSE-316 201210), and Science and Technology Cooperation Project of Sanya City and Chinese Academy of Sciences (2013YD75). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beklioglu M, 2003, HYDROBIOLOGIA, V490, P93, DOI 10.1023/A:1023466629489; Bornette G, 2011, AQUAT SCI, V73, P1, DOI 10.1007/s00027-010-0162-7; CARPENTER SR, 1985, BIOSCIENCE, V35, P634, DOI 10.2307/1309989; CARPENTER SR, 1987, ECOLOGY, V68, P1863, DOI 10.2307/1939878; Carpenter SR, 2009, TROPHIC CASCADES, P1; Chen H., 1989, ACTA HYDROBIOL, V13, P359; Cui YB, 2005, FISHERY RESOURCES CO, P313; De Leo G.A., 1997, CONSERV ECOL, V1, P3, DOI [10.5751/ES-00022-010103, DOI 10.5751/ES-00022-010103]; FAO, 2014, STAT WORLDS FISH AQ; FBMA (Fisheries Bureau of the Ministry of Agriculture), 2010, CHIN FISH STAT YB; Gozlan RE, 2008, FISH FISH, V9, P106, DOI 10.1111/j.1467-2979.2007.00267.x; He BW., 1992, CULTIVATION CHINESE, P381; Holling C.S., 1973, Annual Rev Ecol Syst, V4, P1, DOI 10.1146/annurev.es.04.110173.000245; Huang X., 1999, STANDARD METHODS OBS; HUNTER MD, 1992, ECOLOGY, V73, P724; Ings TC, 2009, J ANIM ECOL, V78, P253, DOI 10.1111/j.1365-2656.2008.01460.x; Jeppesen E, 2007, HYDROBIOLOGIA, V581, P269, DOI 10.1007/s10750-006-0507-3; [姜加虎 Jiang Jiahu], 2006, [生态环境, Ecology and Environment], V15, P424; [金刚 Jin Gang], 2003, [湖泊科学, Scientia Limnologica Sinica], V15, P69; Jin XC, 2005, SCI CHINA SER C, V48, P948, DOI 10.1360/062005-286; Lammens EHRR, 1999, HYDROBIOLOGIA, V395, P191, DOI 10.1023/A:1017053719871; LAMPERT W, 1993, LIMNOOKOLOGIE; Lathrop RC, 2002, FRESHWATER BIOL, V47, P2410, DOI 10.1046/j.1365-2427.2002.01011.x; Li X, 1997, RESOURCES ENV YANGTZ, V6, P7; Liu J, 1998, J FISH BIOL, V53, P1071, DOI 10.1111/j.1095-8649.1998.tb00464.x; Liu JS, 2000, COMP BIOCHEM PHYS A, V127, P131, DOI 10.1016/S1095-6433(00)00246-4; LORENZEN CJ, 1967, LIMNOL OCEANOGR, V12, P343, DOI 10.4319/lo.1967.12.2.0343; MCQUEEN DJ, 1989, ECOL MONOGR, V59, P289, DOI 10.2307/1942603; Mehner T, 2001, INT REV HYDROBIOL, V86, P253, DOI 10.1002/1522-2632(200104)86:2<253::AID-IROH253>3.0.CO;2-5; PAINE RT, 1969, ECOLOGY, V50, P950, DOI 10.2307/1936888; Parkos JJ, 2003, CAN J FISH AQUAT SCI, V60, P182, DOI 10.1139/F03-011; Polis GA, 2000, TRENDS ECOL EVOL, V15, P473, DOI 10.1016/S0169-5347(00)01971-6; Sun G., 1999, J NE NORMAL U NATURA, V19, P74; TRFfS Computing, 2011, R LANG ENV STAT COMP, DOI [10.1016/j.neuroimage.2011.01.013, DOI 10.1016/J.NEUROIMAGE.2011.01.013]; Wang HZ, 2006, AQUACULTURE, V255, P456, DOI 10.1016/j.aquaculture.2006.01.005; Wang SM, LAKES OF CHINA; Xia W., 2007, RESERV FISH, V27, P38; Xie S, 2001, J APPL ICHTHYOL, V17, P89, DOI 10.1046/j.1439-0426.2001.00248.x; Xie SG, 2000, ENVIRON BIOL FISH, V57, P179, DOI 10.1023/A:1007541031222; Ye SW, 2006, AQUAT LIVING RESOUR, V19, P349, DOI 10.1051/alr:2007005; Zhao Y., 2015, FRESHWATER FISHERIES	41	15	16	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0120298	10.1371/journal.pone.0120298	http://dx.doi.org/10.1371/journal.pone.0120298			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803696	Green Submitted, Green Published, gold			2022-12-26	WOS:000353889600066
J	Lin, WL; Lin, YS; Shi, GY; Chang, CF; Wu, HL				Lin, Wei-Ling; Lin, Yi-Shiuan; Shi, Guey-Yueh; Chang, Chuan-Fa; Wu, Hua-Lin			Lewis(y) Promotes Migration of Oral Cancer Cells by Glycosylation of Epidermal Growth Factor Receptor	PLOS ONE			English	Article							Y ANTIGEN; ERBB RECEPTORS; TUMOR-GROWTH; RMG-1 CELLS; EXPRESSION; CARCINOMA; CAVITY; GENE; ACTIVATION; TONGUE	Aberrant glycosylation changes normal cellular functions and represents a specific hallmark of cancer. Lewis(y) (Le(y)) carbohydrate upregulation has been reported in a variety of cancers, including oral squamous cell carcinoma (OSCC). A high level of Le(y) expression is related to poor prognosis of patients with oral cancer. However, it is unclear how Ley mediates oral cancer progression. In this study, the role of Le(y) in OSCC was explored. Our data showed that Le(y) was upregulated in HSC-3 and OC-2 OSCC cell lines. Particularly, glycosylation of epidermal growth factor receptor (EGFR) with Le(y) was found in OC-2 cells, and this modification was absent upon inhibition of Le(y) synthesis. The absence of Le(y) glycosylation of EGFR weakened phosphorylation of AKT and ERK in response to epidermal growth factor (EGF). Additionally, EGF-triggered cell migration was reduced, but cell proliferation was not affected. Le(y) modification stabilized EGFR upon ligand activation. Conversely, absence of Le(y) glycosylation accelerated EGFR degradation. In summary, these results indicate that increased expression of Le(y) in OSCC cells is able to promote cell migration by modifying EGFR which in turn stabilizes EGFR expression and downstream signaling. Targeting Le(y) on EGFR could have a potential therapeutic effect on oral cancer.	[Lin, Wei-Ling; Lin, Yi-Shiuan; Shi, Guey-Yueh; Wu, Hua-Lin] Natl Cheng Kung Univ, Dept Biochem & Mol Biol, Tainan 70101, Taiwan; [Lin, Wei-Ling; Lin, Yi-Shiuan; Shi, Guey-Yueh; Wu, Hua-Lin] Natl Cheng Kung Univ, Cardiovasc Res Ctr, Tainan 70101, Taiwan; [Chang, Chuan-Fa] Natl Cheng Kung Univ, Dept Med Lab Sci & Biotechnol, Tainan 70101, Taiwan	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University	Chang, CF (corresponding author), Natl Cheng Kung Univ, Dept Med Lab Sci & Biotechnol, Tainan 70101, Taiwan.	affa@mail.ncku.edu.tw; halnwu@mail.ncku.edu.tw	Lin, Wei-Ling/AAH-2429-2019; Lin, Wei-Ling/GQP-6706-2022	Chang, Chuan-fa/0000-0003-2404-1248	National Science Council, Taiwan [NSC 99-2320-B-006-008-MY3, NSC 99-2628-B-006-003-MY3, NSC 100-2325-B-006-003-MY3]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	Funding: This work was supported by National Science Council, Taiwan [(NSC 99-2320-B-006-008-MY3 (received by HLW), NSC 99-2628-B-006-003-MY3 (received by GYS), and NSC 100-2325-B-006-003-MY3 (received by GYS)] (URL: http://www.most.gov.tw/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bishayee S, 2000, BIOCHEM PHARMACOL, V60, P1217, DOI 10.1016/S0006-2952(00)00425-1; Boulougouris P, 2001, ANTICANCER RES, V21, P2769; Bundgaard T, 1996, HEAD NECK-J SCI SPEC, V18, P142, DOI 10.1002/(SICI)1097-0347(199603/04)18:2<142::AID-HED6>3.0.CO;2-1; Dabelsteen E, 2005, J DENT RES, V84, P21, DOI 10.1177/154405910508400103; Dabelsteen E, 1996, J PATHOL, V179, P358; de Vries T, 2001, GLYCOBIOLOGY, V11, p119R, DOI 10.1093/glycob/11.10.119R; Dettke M, 2000, J LEUKOCYTE BIOL, V68, P511; Dietrich EM, 2012, HIPPOKRATIA, V16, P196; Farhan H, 2006, J PHARMACOL EXP THER, V319, P1459, DOI 10.1124/jpet.106.107318; Gao LL, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-15; Gao S, 2010, MED ONCOL, V27, P960, DOI 10.1007/s12032-009-9317-6; Garcia-Vallejo JJ, 2008, MOL IMMUNOL, V45, P2359, DOI 10.1016/j.molimm.2007.11.001; GARRIGUES J, 1994, J CELL BIOL, V125, P129, DOI 10.1083/jcb.125.1.129; Harandi A, 2009, J ONCOLOGY, V2009, P1; Huang SF, 2009, HEAD NECK-J SCI SPEC, V31, P1068, DOI 10.1002/hed.21067; KIM YS, 1986, CANCER RES, V46, P5985; Klinger M, 2004, CANCER RES, V64, P1087, DOI 10.1158/0008-5472.CAN-03-2435; Le Roy C, 2005, NAT REV MOL CELL BIO, V6, P112, DOI 10.1038/nrm1571; Lee YR, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-9; Liu JJ, 2010, ONCOL REP, V23, P833, DOI 10.3892/or_00000705; Liu JJ, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-154; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Madjd Z, 2005, BREAST CANCER RES, V7, pR780, DOI 10.1186/bcr1305; Mitsudomi T, 2010, FEBS J, V277, P301, DOI 10.1111/j.1742-4658.2009.07448.x; Ogden GR, 2005, ALCOHOL, V35, P169, DOI 10.1016/j.alcohol.2005.04.002; REICHARD KW, 1993, J SURG ONCOL, V54, P239, DOI 10.1002/jso.2930540410; Saleh MN, 2000, J CLIN ONCOL, V18, P2282, DOI 10.1200/JCO.2000.18.11.2282; Warnakulasuriya S, 2005, ORAL ONCOL, V41, P244, DOI 10.1016/j.oraloncology.2004.08.010; Westwood JA, 2009, J IMMUNOTHER, V32, P292, DOI 10.1097/CJI.0b013e31819b7c8e; WONG DYK, 1990, J ORAL MAXIL SURG, V48, P385, DOI 10.1016/0278-2391(90)90436-6; Wu MH, 2009, MOL CANCER RES, V7, P311, DOI 10.1158/1541-7786.MCR-08-0297; Xie X, 1999, LARYNGOSCOPE, V109, P1474, DOI 10.1097/00005537-199909000-00022; Yan LM, 2010, BIOCHIMIE, V92, P852, DOI 10.1016/j.biochi.2010.02.012; YANG CY, 1994, J DENT RES, V73, P1407, DOI 10.1177/00220345940730080301; Zhang F, 2011, INT J MOL SCI, V12, P7323, DOI 10.3390/ijms12117323; Zhang ZB, 2008, BBA-MOL CELL RES, V1783, P287, DOI 10.1016/j.bbamcr.2007.10.007	36	23	24	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120162	10.1371/journal.pone.0120162	http://dx.doi.org/10.1371/journal.pone.0120162			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799278	gold, Green Published			2022-12-26	WOS:000351987300108
J	Lorenz, FKM; Wilde, S; Voigt, K; Kieback, E; Mosetter, B; Schendel, DJ; Uckert, W				Lorenz, Felix K. M.; Wilde, Susanne; Voigt, Katrin; Kieback, Elisa; Mosetter, Barbara; Schendel, Dolores J.; Uckert, Wolfgang			Codon Optimization of the Human Papillomavirus E7 Oncogene Induces a CD8(+) T Cell Response to a Cryptic Epitope Not Harbored by Wild-Type E7	PLOS ONE			English	Article							ANTIGEN-PRESENTING CELLS; ANTITUMOR-ACTIVITY; HUMAN-LYMPHOCYTES; MHC; GENE; EXPRESSION; PEPTIDES; RECEPTORS; EXPANSION; PRODUCTS	Codon optimization of nucleotide sequences is a widely used method to achieve high levels of transgene expression for basic and clinical research. Until now, immunological side effects have not been described. To trigger T cell responses against human papillomavirus, we incubated T cells with dendritic cells that were pulsed with RNA encoding the codon-optimized E7 oncogene. All T cell receptors isolated from responding T cell clones recognized target cells expressing the codon-optimized E7 gene but not the wild type E7 sequence. Epitope mapping revealed recognition of a cryptic epitope from the +3 alternative reading frame of codon-optimized E7, which is not encoded by the wild type E7 sequence. The introduction of a stop codon into the +3 alternative reading frame protected the transgene product from recognition by T cell receptor gene-modified T cells. This is the first experimental study demonstrating that codon optimization can render a transgene artificially immunogenic through generation of a dominant cryptic epitope. This finding may be of great importance for the clinical field of gene therapy to avoid rejection of gene-corrected cells and for the design of DNA-and RNA-based vaccines, where codon optimization may artificially add a strong immunogenic component to the vaccine.	[Lorenz, Felix K. M.; Voigt, Katrin; Uckert, Wolfgang] Max Delbruck Ctr Mol Med, Berlin, Germany; [Wilde, Susanne; Mosetter, Barbara; Schendel, Dolores J.] Helmholtz Zentrum Munchen, Inst Mol Immunol, Munich, Germany; [Kieback, Elisa; Uckert, Wolfgang] Humboldt Univ, Inst Biol, D-10099 Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Humboldt University of Berlin	Uckert, W (corresponding author), Max Delbruck Ctr Mol Med, Berlin, Germany.	wuckert@mdc-berlin.de		Lorenz, Felix/0000-0001-7826-0839	ATTRACT Marie Curie early research fellowship within the EU 7th framework program; Wilhelm-Sander-Stiftung [2011.116.1]; SFB (Sonderforschungsbereich/Collaborative Research Center) TR36 from the Deutsche Forschungsgemeinschaft	ATTRACT Marie Curie early research fellowship within the EU 7th framework program; Wilhelm-Sander-Stiftung; SFB (Sonderforschungsbereich/Collaborative Research Center) TR36 from the Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was supported by the ATTRACT Marie Curie early research fellowship within the EU 7th framework program held by FKML and grants from the Wilhelm-Sander-Stiftung (2011.116.1) and the SFB (Sonderforschungsbereich/Collaborative Research Center) TR36 from the Deutsche Forschungsgemeinschaft (WU, EK, KV, DJS, SW and BM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagarazzi ML, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004414; Benteyn D, 2013, MOL THER ACID, V1, P1; Bodles-Brakhop AM, 2009, MOL THER, V17, P585, DOI 10.1038/mt.2009.5; Britten CM, 2002, J IMMUNOL METHODS, V259, P95, DOI 10.1016/S0022-1759(01)00499-9; Brochet X, 2008, NUCLEIC ACIDS RES, V36, pW503, DOI 10.1093/nar/gkn316; BRUCE AG, 1986, P NATL ACAD SCI USA, V83, P5062, DOI 10.1073/pnas.83.14.5062; Burdek M, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-90; Bullock BTNJ, 1996, J EXP MED, P184; Carbonaro DA, 2014, MOL THER, V22, P607, DOI 10.1038/mt.2013.265; Cheever MA, 2009, CLIN CANCER RES, V15, P5323, DOI 10.1158/1078-0432.CCR-09-0737; Cid-Arregui A, 2003, J VIROL, V77; Cohen CJ, 2006, CANCER RES, V66, P8878, DOI 10.1158/0008-5472.CAN-06-1450; Deml L, 2001, J VIROL, V75, P10991, DOI 10.1128/JVI.75.22.10991-11001.2001; Engels B, 2003, HUM GENE THER, V14, P1155, DOI 10.1089/104303403322167993; Engels B, 2013, CANCER CELL, V23, P516, DOI 10.1016/j.ccr.2013.03.018; Fath S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017596; Gan LL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108892; Gurunathan S, 2000, ANNU REV IMMUNOL, V18, P927, DOI 10.1146/annurev.immunol.18.1.927; Ho O, 2006, J IMMUNOL, V177, P8283, DOI 10.4049/jimmunol.177.12.8283; Huston MW, 2011, MOL THER, V19, P1867, DOI 10.1038/mt.2011.127; JARDETZKY TS, 1991, NATURE, V353, P326, DOI 10.1038/353326a0; Javorovic M, 2008, J IMMUNOTHER, V31, P52, DOI 10.1097/CJI.0b013e31815a1202; Kammertoens T, 2013, CANCER CELL, V23, P429, DOI 10.1016/j.ccr.2013.04.004; Kedl RM, 2000, J EXP MED, V192, P1105, DOI 10.1084/jem.192.8.1105; Kieback E, 2008, P NATL ACAD SCI USA, V105, P623, DOI 10.1073/pnas.0710198105; Kwak K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060507; Lee S, 2012, P NATL ACAD SCI, V109; Leisegang M, 2008, J MOL MED, V86, P573, DOI 10.1007/s00109-008-0317-3; Leisegang M, 2010, J CLIN INVEST, V120, P3869, DOI 10.1172/JCI43437; Li CW, 2009, P NATL ACAD SCI USA, V106, P10770, DOI 10.1073/pnas.0902269106; Lin CT, 2006, J BIOMED SCI, V13, P481, DOI 10.1007/s11373-006-9086-6; LOZZIO CB, 1975, BLOOD, V45, P321, DOI 10.1182/blood.V45.3.321.321; Nathwani AC, 2011, N ENGL J MED, V365; Nielsen M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000796; Plotkin JB, 2011, NAT REV GENET, V12, P32, DOI 10.1038/nrg2899; Sack BK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037671; Saeterdal I, 2001, P NATL ACAD SCI USA, V98, P13255, DOI 10.1073/pnas.231326898; Scholten KBJ, 2006, CLIN IMMUNOL, V119, P135, DOI 10.1016/j.clim.2005.12.009; SEEDORF K, 1985, VIROLOGY, V145, P181, DOI 10.1016/0042-6822(85)90214-4; Shiver JW, 2002, NATURE, V415, P331, DOI 10.1038/415331a; Starck SR, 2011, CELL MOL LIFE SCI, V68, P1471, DOI 10.1007/s00018-011-0655-0; STEINLE A, 1995, J EXP MED, V181, P503, DOI 10.1084/jem.181.2.503; Suhoski MM, 2007, MOL THER, V15, P981, DOI 10.1038/mt.sj.6300134; Tindle RW, 2002, NAT REV CANCER, V2, P59, DOI 10.1038/nrc700; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Wang SX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028757; Wilde S, 2009, BLOOD, V114, P2131, DOI 10.1182/blood-2009-03-209387; Wolfl M, 2007, BLOOD, V110, P201, DOI 10.1182/blood-2006-11-056168; Yewdell JW, 1996, J IMMUNOL, V157, P1823; ZUCKERKANDL E, 1965, J THEOR BIOL, V8, P357, DOI 10.1016/0022-5193(65)90083-4; ZURHAUSEN H, 1976, CANCER RES, V36, P794	51	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121633	10.1371/journal.pone.0121633	http://dx.doi.org/10.1371/journal.pone.0121633			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799237	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000351987300278
J	Mora, DJ; Fortunato, LR; Andrade-Silva, LE; Ferreira-Paim, K; Rocha, IH; Vasconcelos, RR; Silva-Teixeira, DN; Nascentes, GAN; Silva-Vergara, ML				Mora, Delio Jose; Fortunato, Laila Rigolin; Andrade-Silva, Leonardo Euripedes; Ferreira-Paim, Kennio; Rocha, Ivonete Helena; Vasconcelos, Rakel Rocha; Silva-Teixeira, David Nascimento; Nogueira Nascentes, Gabriel Antonio; Silva-Vergara, Mario Leon			Cytokine Profiles at Admission Can Be Related to Outcome in AIDS Patients with Cryptococcal Meningitis	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; CENTRAL-NERVOUS-SYSTEM; CEREBROSPINAL-FLUID; INTERFERON-GAMMA; INFECTED PATIENTS; IMMUNE-RESPONSE; AMPHOTERICIN-B; T-LYMPHOCYTES; NEOFORMANS; CELLS	Cryptococcal meningitis (CM) remains as common life-threatening AIDS-defining illness mainly in resource-limited settings. Previous reports suggested that baseline cytokine profiles can be associated to fungal burden and clinical outcome. This study aimed to evaluate the baseline cytokine profiles in AIDS patients with CM and its relation with the outcome at weeks 2 and 10. Thirty AIDS patients with CM diagnosed by cerebrospinal fluid (CSF) Cryptococcus neoformans positive culture, India ink stain and cryptococcal antigen test were prospectively evaluated. As controls, 56 HIV-infected patients without CM and 48 non-HIV individuals were included. Baseline CSF and sera levels of IL-2, IL-4, IL-8, IL-10, IL-12p40, IL-17A, INF-gamma and TNF-alpha were measured by ELISA. Of 30 CM patients, 24 (80%) were male, median age of 38.1. The baseline CSF high fungal burden and positive blood culture were associated with a positive CSF culture at week 2 (p = 0.043 and 0.029). Most CSF and sera cytokines presented higher levels in CM patients than control subjects (p < 0.05). CSF levels of IL-8, IL-12p40, IL-17A, TNF-alpha, INF-gamma and sera TNF-alpha were significantly higher among survivors at weeks 2 and 10 (p < 0.05). Patients with increased intracranial pression exhibited CSF IL-10 high levels and poor outcome at week 10 (p = 0.032). Otherwise, baseline CSF log10 IFN-gamma and IL-17A were negatively correlated with fungal burden (r = -0.47 and -0.50; p = 0.0175 and 0.0094, respectively). The mortality rate was 33% (10/30) at week 2 and 57% (17/30) at week 10. The severity of CM and the advanced immunodeficiency at admission were related to a poor outcome in these patients. Otherwise, the predominant Th1 cytokines profile among survivors confirms its pivotal role to infection control and would be a prognostic marker in cryptococcal meningitis.	[Mora, Delio Jose; Fortunato, Laila Rigolin; Andrade-Silva, Leonardo Euripedes; Ferreira-Paim, Kennio; Rocha, Ivonete Helena; Vasconcelos, Rakel Rocha; Silva-Teixeira, David Nascimento; Silva-Vergara, Mario Leon] Triangulo Mineiro Fed Univ, Infect Dis Unit, Dept Internal Med, Uberaba, MG, Brazil; [Nogueira Nascentes, Gabriel Antonio] Fed Inst Triangulo Mineiro, Uberaba, MG, Brazil	Universidade Federal do Triangulo Mineiro; Instituto Federal do Triangulo Mineiro (IFTM); Universidade Federal do Triangulo Mineiro	Mora, DJ (corresponding author), Triangulo Mineiro Fed Univ, Infect Dis Unit, Dept Internal Med, Uberaba, MG, Brazil.	delioj@gmail.com; marioleon.dip@mednet.com.br	Ferreira-Paim, Kennio/A-8194-2013; Mora, Delio José/G-1614-2012; andrade-silva, leonardo/AAA-4356-2020	Ferreira-Paim, Kennio/0000-0002-6035-8392; andrade-silva, leonardo/0000-0002-0485-229X	Fundacao de Amparo a Pesquisa de Minas Gerais (FAPEMIG) [BPD-00507-13]	Fundacao de Amparo a Pesquisa de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	Funding: This work was supported by Fundacao de Amparo a Pesquisa de Minas Gerais (FAPEMIG) - grant # BPD-00507-13. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altfeld M, 2000, J ACQ IMMUN DEF SYND, V23, P287; Anekthananon T, 2011, INT J STD AIDS, V22, P665, DOI 10.1258/ijsa.2011.010538; Antinori S, 2013, ISRN AIDS, V25; Bicanic T, 2007, CLIN INFECT DIS, V45, P76, DOI 10.1086/518607; Bicanic T, 2009, CLIN INFECT DIS, V49, P702, DOI 10.1086/604716; Boulware DR, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000384; Brizendine KD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060431; Brouwer AE, 2004, LANCET, V363, P1764, DOI 10.1016/S0140-6736(04)16301-0; Buchanan KL, 2000, INFECT IMMUN, V68, P456, DOI 10.1128/IAI.68.2.456-462.2000; Cachay ER, 2010, AIDS RES THER, V7, DOI 10.1186/1742-6405-7-29; Lindenberg ADC, 2008, REV INST MED TROP SP, V50, P75, DOI 10.1590/S0036-46652008000200002; Chaka W, 1997, J INFECT DIS, V176, P1633, DOI 10.1086/517344; Chuang YM, 2010, EPIDEMIOL INFECT, V138, P1036, DOI 10.1017/S0950268809990926; CLEMONS KV, 1994, ANTIMICROB AGENTS CH, V38, P460, DOI 10.1128/AAC.38.3.460; Clemons KV, 2001, ANTIMICROB AGENTS CH, V45, P686, DOI 10.1128/AAC.45.3.686-689.2001; Dammert P, 2008, J INFECTION, V57, P260, DOI 10.1016/j.jinf.2008.06.020; Dromer F, 2007, PLOS MED, V4, P297, DOI 10.1371/journal.pmed.0040021; EDWARDS VE, 1970, J NEUROL NEUROSUR PS, V33, P415, DOI 10.1136/jnnp.33.4.415; Ellerbroek PM, 2004, CURR MED CHEM, V11, P253, DOI 10.2174/0929867043456188; Hernandez Y, 2005, J IMMUNOL, V174, P1027, DOI 10.4049/jimmunol.174.2.1027; Jarvis JN, 2014, CLIN INFECT DIS, V58, P736, DOI 10.1093/cid/cit794; Jarvis JN, 2013, J INFECT DIS, V207, P1817, DOI 10.1093/infdis/jit099; Jarvis JN, 2012, AIDS, V26, P1105, DOI 10.1097/QAD.0b013e3283536a93; Kambugu A, 2008, CLIN INFECT DIS, V46, P1694, DOI 10.1086/587667; Kawakami K, 2004, JPN J INFECT DIS, V57, P137; Kawakami K, 1996, CLIN EXP IMMUNOL, V104, P208, DOI 10.1046/j.1365-2249.1996.14723.x; Kedzierska Katherine, 2001, Antiviral Chemistry and Chemotherapy, V12, P133; Kozakiewicz L, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003472; KWONCHUNG KJ, 1982, J CLIN MICROBIOL, V15, P535, DOI 10.1128/JCM.15.3.535-537.1982; Lawn SD, 2010, CURR OPIN HIV AIDS, V5, P18, DOI 10.1097/COH.0b013e328333850f; Lindell DM, 2005, J IMMUNOL, V174, P7920, DOI 10.4049/jimmunol.174.12.7920; Lipovsky MM, 1998, J INFECT DIS, V177, P260, DOI 10.1086/517368; Lortholary O, 2005, CLIN MICROBIOL INFEC, V11, P296, DOI 10.1111/j.1469-0691.2005.01074.x; Lortholary O, 2001, J INFECT DIS, V183, P294, DOI 10.1086/317937; Loyse A, 2010, AIDS, V24, P405, DOI 10.1097/QAD.0b013e328333c005; Lutz JE, 2000, J ANTIMICROB CHEMOTH, V46, P437, DOI 10.1093/jac/46.3.437; Mao LY, 2013, EPILEPSIA, V54, pe142, DOI 10.1111/epi.12337; Maxeiner HG, 2014, CYTOKINE, V69, P62, DOI 10.1016/j.cyto.2014.05.008; McClelland EE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063632; Meyer W, 2003, EMERG INFECT DIS, V9, P189; Mora DJ, 2012, MYCOPATHOLOGIA, V173, P321, DOI 10.1007/s11046-011-9504-9; Mosser DM, 2008, IMMUNOL REV, V226, P205, DOI 10.1111/j.1600-065X.2008.00706.x; Naranbhai V, 2014, AIDS, V28, P657, DOI 10.1097/QAD.0000000000000200; Netea MG, 2004, CLIN INFECT DIS, V39, pE83, DOI 10.1086/425121; Nussbaum JC, 2010, CLIN INFECT DIS, V50, P338, DOI 10.1086/649861; Osakwe Chukwunomso E, 2010, Roum Arch Microbiol Immunol, V69, P24; Pappas PG, 2004, J INFECT DIS, V189, P2185, DOI 10.1086/420829; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Pietrella D, 2001, J INFECT DIS, V183, P51, DOI 10.1086/317648; Pyrgos V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056269; Robertson EJ, 2014, J INFECT DIS, V209, P74, DOI 10.1093/infdis/jit435; Rudner XL, 2007, INFECT IMMUN, V75, P3055, DOI 10.1128/IAI.01329-06; Siddiqui AA, 2005, J IMMUNOL, V174, P1746, DOI 10.4049/jimmunol.174.3.1746; Singh N, 2006, TRANSPL IMMUNOL, V16, P69, DOI 10.1016/j.trim.2006.03.009; Srikanth P, 2000, INT J STD AIDS, V11, P49, DOI 10.1258/0956462001914904; Stacey AR, 2009, J VIROL, V83, P3719, DOI 10.1128/JVI.01844-08; Stenzel W, 2009, AM J PATHOL, V174, P486, DOI 10.2353/ajpath.2009.080598; Uicker WC, 2005, MED MYCOL, V43, P27, DOI 10.1080/13693780410001731510; Vecchiarelli A, 2007, CRIT REV IMMUNOL, V27, P547, DOI 10.1615/CritRevImmunol.v27.i6.50; Vidal JE, 2013, BRAZ J INFECT DIS, V17, P353, DOI 10.1016/j.bjid.2012.10.020; Voelz K, 2009, INFECT IMMUN, V77, P3450, DOI 10.1128/IAI.00297-09; Wijewardana I, 2011, J INFECTION, V63, P484, DOI 10.1016/j.jinf.2011.09.002; Wirleitner B, 2003, CURR MED CHEM, V10, P1581, DOI 10.2174/0929867033457179; Wormley FL, 2007, INFECT IMMUN, V75, P1453, DOI 10.1128/IAI.00274-06; Wozniak KL, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-65; Wozniak KL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017204; Zhang YM, 2009, AM J PATHOL, V175, P2489, DOI 10.2353/ajpath.2009.090530; Zhou Q, 2007, J IMMUNOL, V178, P5753, DOI 10.4049/jimmunol.178.9.5753	68	31	31	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120297	10.1371/journal.pone.0120297	http://dx.doi.org/10.1371/journal.pone.0120297			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799044	gold, Green Published, Green Submitted			2022-12-26	WOS:000351987300125
J	Pattison, JM; Wright, JB; Cole, MD				Pattison, Jillian M.; Wright, Jason B.; Cole, Michael D.			Retroviruses Hijack Chromatin Loops to Drive Oncogene Expression and Highlight the Chromatin Architecture around Proto-Oncogenic Loci	PLOS ONE			English	Article							LEUKEMIA-VIRUS INTEGRATION; MYELOMA CELL-LINES; CYCLIN D1; CANCER; OVEREXPRESSION; REGION; GENES; BCL-1; IDENTIFICATION; TRANSLOCATION	The majority of the genome consists of intergenic and non-coding DNA sequences shown to play a major role in different gene regulatory networks. However, the specific potency of these distal elements as well as how these regions exert function across large genomic distances remains unclear. To address these unresolved issues, we closely examined the chromatin architecture around proto-oncogenic loci in the mouse and human genomes to demonstrate a functional role for chromatin looping in distal gene regulation. Using cell culture models, we show that tumorigenic retroviral integration sites within the mouse genome occur near existing large chromatin loops and that this chromatin architecture is maintained within the human genome as well. Significantly, as mutagenesis screens are not feasible in humans, we demonstrate a way to leverage existing screens in mice to identify disease relevant human enhancers and expose novel disease mechanisms. For instance, we characterize the epigenetic landscape upstream of the human Cyclin D1 locus to find multiple distal interactions that contribute to the complex cis-regulation of this cell cycle gene. Furthermore, we characterize a novel distal interaction upstream of the Cyclin D1 gene which provides mechanistic evidence for the abundant overexpression of Cyclin D1 occurring in multiple myeloma cells harboring a pathogenic translocation event. Through use of mapped retroviral integrations and translocation breakpoints, our studies highlight the importance of chromatin looping in oncogene expression, elucidate the epigenetic mechanisms crucial for distal cis-regulation, and in one particular instance, explain how a translocation event drives tumorigenesis through upregulation of a proto-oncogene.	[Pattison, Jillian M.; Wright, Jason B.; Cole, Michael D.] Norris Cotton Canc Ctr, Geisel Sch Med Dartmouth, Dept Genet, Lebanon, NH 03766 USA; [Cole, Michael D.] Norris Cotton Canc Ctr, Geisel Sch Med Dartmouth, Dept Pharmacol & Toxicol, Lebanon, NH USA	Dartmouth College; Norris Cotton Cancer Center; Dartmouth College; Norris Cotton Cancer Center	Cole, MD (corresponding author), Norris Cotton Canc Ctr, Geisel Sch Med Dartmouth, Dept Genet, Lebanon, NH 03766 USA.	Michael.D.Cole@dartmouth.edu			National Cancer Institute [R01CA080320]; National Institutes of Health Training Grant Award [T32GM8704-12S1]; NATIONAL CANCER INSTITUTE [P30CA023108, R01CA080320] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008704] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health Training Grant Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding: National Cancer Institute R01CA080320 to MDC and National Institutes of Health Training Grant Award T32GM8704-12S1 supporting JMP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARTKOVA J, 1994, J PATHOL, V172, P237, DOI 10.1002/path.1711720303; Bergsagel PL, 1996, P NATL ACAD SCI USA, V93, P13931, DOI 10.1073/pnas.93.24.13931; Cattoglio C, 2010, BLOOD, V116, P5507, DOI 10.1182/blood-2010-05-283523; Chesi M, 1996, BLOOD, V88, P674, DOI 10.1182/blood.V88.2.674.bloodjournal882674; De Rijck J, 2013, CELL REP, V5, P886, DOI 10.1016/j.celrep.2013.09.040; Duan H, 2008, ONCOGENE, V27, P6720, DOI 10.1038/onc.2008.286; Felice B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004571; French JD, 2013, AM J HUM GENET, V92, P489, DOI 10.1016/j.ajhg.2013.01.002; GAZDAR AF, 1986, BLOOD, V67, P1542; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Hwang HC, 2002, P NATL ACAD SCI USA, V99, P11293, DOI 10.1073/pnas.162356099; Janssen JWG, 2000, BLOOD, V95, P2691; Johansson FK, 2004, P NATL ACAD SCI USA, V101, P11334, DOI 10.1073/pnas.0402716101; KATAGIRI S, 1985, INT J CANCER, V36, P241, DOI 10.1002/ijc.2910360217; KOMATSU H, 1994, BLOOD, V84, P1226; Li JY, 1999, NAT GENET, V23, P348, DOI 10.1038/15531; Liu LZ, 1999, J IMMUNOL, V163, P868; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Lund AH, 2002, NAT GENET, V32, P160, DOI 10.1038/ng956; MEEKER TC, 1989, BLOOD, V74, P1801; Miele A, 2006, CURR PROTOC MOL BIOL; Mitchell RS, 2004, PLOS BIOL, V2, P1127, DOI 10.1371/journal.pbio.0020234; Otsuki T, 2000, GENE FUNCTION DIS, V1, P48; RIMOKH R, 1993, BLOOD, V81, P3063; Ronchetti D, 1999, BLOOD, V93, P1330, DOI 10.1182/blood.V93.4.1330.404k04_1330_1337; ROSENBERG CL, 1991, P NATL ACAD SCI USA, V88, P9638, DOI 10.1073/pnas.88.21.9638; Schodel J, 2012, NAT GENET, V44, P420, DOI 10.1038/ng.2204; Soverini S, 2003, BLOOD, V102, P1588, DOI 10.1182/blood-2002-12-3789; Specht K, 2002, CLIN CANCER RES, V8, P2902; Stadhouders R, 2012, EMBO J, V31, P986, DOI 10.1038/emboj.2011.450; Suzuki T, 2002, NAT GENET, V32, P166, DOI 10.1038/ng949; TSUJIMOTO Y, 1984, SCIENCE, V224, P1403, DOI 10.1126/science.6610211; TSUJIMOTO Y, 1985, NATURE, V315, P340, DOI 10.1038/315340a0; Uchimaru K, 1997, BLOOD, V89, P965, DOI 10.1182/blood.V89.3.965; Vaandrager JW, 1997, BLOOD, V89, P349, DOI 10.1182/blood.V89.1.349.349_349_349; WITHERS DA, 1991, MOL CELL BIOL, V11, P4846, DOI 10.1128/MCB.11.10.4846; Wright JB, 2010, MOL CELL BIOL, V30, P1411, DOI 10.1128/MCB.01384-09; Wu XL, 2003, SCIENCE, V300, P1749, DOI 10.1126/science.1083413; Zhang JF, 2012, J VIROL, V86, P10524, DOI 10.1128/JVI.01077-12	40	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120256	10.1371/journal.pone.0120256	http://dx.doi.org/10.1371/journal.pone.0120256			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799187	Green Published, gold, Green Submitted			2022-12-26	WOS:000351987300117
J	Nguyen, T; Ruan, Z; Oruganty, K; Kannan, N				Tuan Nguyen; Ruan, Zheng; Oruganty, Krishnadev; Kannan, Natarajan			Co-Conserved MAPK Features Couple D-Domain Docking Groove to Distal Allosteric Sites via the C-Terminal Flanking Tail	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; CRYSTAL-STRUCTURE; P38; MECHANISMS; P38-ALPHA; RECEPTOR; COMPLEX; MUTANTS; LOOP; ERK2	Mitogen activated protein kinases (MAPKs) form a closely related family of kinases that control critical pathways associated with cell growth and survival. Although MAPKs have been extensively characterized at the biochemical, cellular, and structural level, an integrated evolutionary understanding of how MAPKs differ from other closely related protein kinases is currently lacking. Here, we perform statistical sequence comparisons of MAPKs and related protein kinases to identify sequence and structural features associated with MAPK functional divergence. We show, for the first time, that virtually all MAPK-distinguishing sequence features, including an unappreciated short insert segment in the beta 4-beta 5 loop, physically couple distal functional sites in the kinase domain to the D-domain peptide docking groove via the C-terminal flanking tail (C-tail). The coupling mediated by MAPK-specific residues confers an allosteric regulatory mechanism unique to MAPKs. In particular, the regulatory alpha C-helix conformation is controlled by a MAPK-conserved salt bridge interaction between an arginine in the aC-helix and an acidic residue in the C-tail. The salt-bridge interaction is modulated in unique ways in individual sub-families to achieve regulatory specificity. Our study is consistent with a model in which the C-tail co-evolved with the D-domain docking site to allosterically control MAPK activity. Our study provides testable mechanistic hypotheses for biochemical characterization of MAPK-conserved residues and new avenues for the design of allosteric MAPK inhibitors.	[Tuan Nguyen; Oruganty, Krishnadev; Kannan, Natarajan] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA; [Ruan, Zheng; Kannan, Natarajan] Univ Georgia, Inst Bioinformat, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Kannan, N (corresponding author), Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA.	kannan@bmb.uga.edu	Oruganty, KrishnaDev/N-9465-2017	Oruganty, KrishnaDev/0000-0003-0866-6862; Ruan, Zheng/0000-0002-4412-4916	National Science Foundation [MCB-1149106]; American Cancer Society [RSG-10-188-01-TBE]; Georgia Cancer Coalition	National Science Foundation(National Science Foundation (NSF)); American Cancer Society(American Cancer Society); Georgia Cancer Coalition	National Science Foundation Grant MCB-1149106 (to N.K.) http://www.nsf.gov/funding/, American Cancer Society Grant RSG-10-188-01-TBE (to N.K.) http://www.cancer.org/research/applyforaresearchgrant/, Georgia Cancer Coalition (to N.K.) http://gra.org/page/1036/gra_cancer_scientists.html.	Bakan A, 2011, BIOINFORMATICS, V27, P1575, DOI 10.1093/bioinformatics/btr168; Bellon S, 1999, STRUCTURE, V7, P1057, DOI 10.1016/S0969-2126(99)80173-7; Bhattacharyya RP, 2006, SCIENCE, V311, P822, DOI 10.1126/science.1120941; Bubici C, 2014, BRIT J PHARMACOL, V171, P24, DOI 10.1111/bph.12432; Canagarajah BJ, 1997, CELL, V90, P859, DOI 10.1016/S0092-8674(00)80351-7; Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10; Chen Z, 2001, CHEM REV, V101, P2449, DOI 10.1021/cr000241p; Cheng M, 1996, J BIOL CHEM, V271, P8951, DOI 10.1074/jbc.271.15.8951; De Nicola GF, 2013, NAT STRUCT MOL BIOL, V20, P1182, DOI 10.1038/nsmb.2668; Diskin R, 2004, J BIOL CHEM, V279, P47040, DOI 10.1074/jbc.M404595200; Diskin R, 2007, J MOL BIOL, V365, P66, DOI 10.1016/j.jmb.2006.08.043; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Elkins JM, 2013, J MED CHEM, V56, P4413, DOI 10.1021/jm4000837; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; Glatz G, 2013, J BIOL CHEM, V288, P8596, DOI 10.1074/jbc.M113.452235; Gogl G, 2013, ACTA CRYSTALLOGR D, V69, P486, DOI 10.1107/S0907444912051062; Hu JC, 2013, CELL, V154, P1036, DOI 10.1016/j.cell.2013.07.046; Hubbard SR, 2004, NAT REV MOL CELL BIO, V5, P464, DOI 10.1038/nrm1399; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Huse M, 1999, CELL, V96, P425, DOI 10.1016/S0092-8674(00)80555-3; Ishitani T, 2013, CELL SIGNAL, V25, P190, DOI 10.1016/j.cellsig.2012.09.017; Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2; Jura N, 2011, MOL CELL, V42, P9, DOI 10.1016/j.molcel.2011.03.004; Kannan N, 2005, J MOL BIOL, V351, P956, DOI 10.1016/j.jmb.2005.06.057; Kannan N, 2004, PROTEIN SCI, V13, P2059, DOI 10.1110/ps.04637904; Kannan N, 2007, PLOS BIOL, V5, P467, DOI 10.1371/journal.pbio.0050017; Kannan N, 2007, P NATL ACAD SCI USA, V104, P1272, DOI 10.1073/pnas.0610251104; Khokhlatchev AV, 1998, CELL, V93, P605, DOI 10.1016/S0092-8674(00)81189-7; Kumar S, 2003, NAT REV DRUG DISCOV, V2, P717, DOI 10.1038/nrd1177; Laughlin JD, 2012, STRUCTURE, V20, P2174, DOI 10.1016/j.str.2012.09.021; Lee T, 2004, MOL CELL, V14, P43, DOI 10.1016/S1097-2765(04)00161-3; Li M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026999; Ma W, 2014, STRUCTURE, V18, P1502; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Mirza A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014310; Mittelstadt PR, 2005, NEW TRICKS FOR AN OL, P1189; Neuwald AF, 2003, GENOME RES, V13, P673, DOI 10.1101/gr.862303; Neuwald AF, 2007, TRENDS BIOCHEM SCI, V32, P487, DOI 10.1016/j.tibs.2007.08.009; Neuwald AF, 2011, STAT APPL GENET MOL, V10, DOI 10.2202/1544-6115.1666; Neuwald AF, 2009, BIOINFORMATICS, V25, P1869, DOI 10.1093/bioinformatics/btp342; Niefind K, 2007, J MOL BIOL, V370, P427, DOI 10.1016/j.jmb.2007.04.068; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Oruganty K, 2012, P NATL ACAD SCI USA, P1; Oruganty K, 2012, PHILOS T R SOC B, V367, P2529, DOI 10.1098/rstb.2012.0015; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Roskoski R, 2012, PHARMACOL RES, V66, P105, DOI 10.1016/j.phrs.2012.04.005; Russo AA, 1996, NATURE, V382, P325, DOI 10.1038/382325a0; Saklatvala J, 2004, CURR OPIN PHARMACOL, V4, P372, DOI 10.1016/j.coph.2004.03.009; Salvador JM, 2005, NAT IMMUNOL, V6, P390, DOI 10.1038/ni1177; Sanz V, 2000, FEBS LETT, V474, P169, DOI 10.1016/S0014-5793(00)01598-2; Shi ZS, 2006, CURR OPIN STRUC BIOL, V16, P686, DOI 10.1016/j.sbi.2006.10.011; Takahashi R, 2013, CANCER SCI, V104, P337, DOI 10.1111/cas.12080; Talevich E, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-117; Talevich E, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-321; Tanoue T, 2000, NAT CELL BIOL, V2, P110, DOI 10.1038/35000065; Taylor SS, 2011, TRENDS BIOCHEM SCI, V36, P65, DOI 10.1016/j.tibs.2010.09.006; ter Haar E, 2007, J BIOL CHEM, V282, P9733, DOI 10.1074/jbc.M611165200; Tokunaga Y, 2014, NAT STRUCT MOL BIOL, V21, P704, DOI 10.1038/nsmb.2861; Tzarum N, 2011, J MOL BIOL, V405, P1154, DOI 10.1016/j.jmb.2010.11.023; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Wang C, 2014, STRUCTURE, V20, P791; Wang ZL, 1997, P NATL ACAD SCI USA, V94, P2327, DOI 10.1073/pnas.94.6.2327; Webster RR, 2008, PLACENTA, V29, P985, DOI 10.1016/j.placenta.2008.09.003; Webster RP, 2007, PROTEOM CLIN APPL, V1, P1147, DOI 10.1002/prca.200700128; Webster RP, 2006, PROTEOMICS, V6, P4838, DOI 10.1002/pmic.200600176; Wilson KP, 1996, J BIOL CHEM, V271, P27696, DOI 10.1074/jbc.271.44.27696; Xie XL, 1998, STRUCTURE, V6, P983, DOI 10.1016/S0969-2126(98)00100-2; Yan CL, 2011, J PHYS CHEM B, V115, P1491, DOI 10.1021/jp1073522; ZERVOS AS, 1995, P NATL ACAD SCI USA, V92, P10531, DOI 10.1073/pnas.92.23.10531; ZHANG FM, 1994, NATURE, V367, P704, DOI 10.1038/367704a0; Zhang J, 2012, ACTA CRYSTALLOGR F, V68, P1434, DOI 10.1107/S1744309112042972; Zhang YY, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.203786; Zhou TJ, 2006, STRUCTURE, V14, P1011, DOI 10.1016/j.str.2006.04.006	75	10	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0119636	10.1371/journal.pone.0119636	http://dx.doi.org/10.1371/journal.pone.0119636			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799139	Green Published, gold, Green Submitted			2022-12-26	WOS:000351987300066
J	Zeng, Z; Leng, TD; Feng, XC; Sun, HW; Inoue, K; Zhu, L; Xiong, ZG				Zeng, Zhao; Leng, Tiandong; Feng, Xuechao; Sun, Huawei; Inoue, Koichi; Zhu, Li; Xiong, Zhi-Gang			Silencing TRPM7 in Mouse Cortical Astrocytes Impairs Cell Proliferation and Migration via ERK and JNK Signaling Pathways	PLOS ONE			English	Article							INDUCED ACTIVATION; CHANNEL; PROTEIN; KINASE; CATION; DIFFERENTIATION; INHIBITION; EXPRESSION; APOPTOSIS; GENES	Transient receptor potential melastatin 7 (TRPM7), a non-selective cation channel, is highly expressed expressed in the brain and plays a critical role in ischemic neuronal death. Astrocyte, the most abundant cell type in central nervous system (CNS), exerts many essential functions in the physiological and pathological conditions. Here we investigated the expression and functions of the TRPM7 channel in mouse cortical astrocytes. Using reverse transcription (RT)-PCR, immunostaining, western blot and patch clamp recording, we showed that functional TRPM7 channel is expressed in cultured mouse cortical astrocytes. Knocking down TRPM7 with specific siRNA impairs the proliferation and migration of astrocytes by 40.2% +/- 3.9% and 40.1% +/- 11.5%, respectively. Consistently, inhibition of TRPM7 with 2-aminoethoxydiphenyl borate (2-APB) also decreases astrocyte proliferation and migration by 46.1% +/- 2.5% and 64.2% +/- 2.4%. MAPKs and Akt signaling pathways have been shown to be implicated in TRPM7-mediated responses including cell proliferation and migration. Our data show that suppression of TRPM7 in astrocytes reduces the phosphorylation of extracellular signal-regulated kinases (ERK) and c-Jun N-terminal kinases (JNK), but not p38 mitogen-activated protein kinase and Akt. In addition, TRPM7, as a cation channel, has been involved in the Ca2+ and Mg2+ homeostasis in several types of cells. In our study, we found that silencing TRPM7 decreases the intracellular basal Mg2+ concentration without affecting Ca2+ concentration in astrocytes. However, an addition of Mg2+ to the growth medium could not rescue the impaired proliferation of astrocytes. Together, our data suggest that TRPM7 channel may play a critical role in the proliferation and migration of astrocytes via the ERK and JNK pathways.	[Zeng, Zhao; Zhu, Li] Soochow Univ, Jiangsu Key Lab Prevent & Translat Med Geriatr Di, MOH Key Lab Thrombosis & Hemostasis, Cyrus Tang Hematol Ctr,Collaborat Innovat Ctr Hem, Suzhou, Jiangsu, Peoples R China; [Leng, Tiandong; Inoue, Koichi; Xiong, Zhi-Gang] Morehouse Sch Med, Neurosci Inst, Atlanta, GA 30310 USA; [Feng, Xuechao] NE Normal Univ, Membrane Channel Res Lab, Changchun, Peoples R China; [Feng, Xuechao] NE Normal Univ, Key Lab Appl Stat MOE, Changchun, Peoples R China; [Sun, Huawei] Sun Yat Sen Univ, Dept Cardiol, Guangzhou, Guangdong, Peoples R China	Soochow University - China; Morehouse School of Medicine; Northeast Normal University - China; Northeast Normal University - China; Sun Yat Sen University	Zhu, L (corresponding author), Soochow Univ, Jiangsu Key Lab Prevent & Translat Med Geriatr Di, MOH Key Lab Thrombosis & Hemostasis, Cyrus Tang Hematol Ctr,Collaborat Innovat Ctr Hem, Suzhou, Jiangsu, Peoples R China.	lizhusong@yahoo.com; zxiong@msm.edu		feng, xuechao/0000-0003-2444-3757	National Institutes Health [R01NS047506, R01NS066027]; Minority Health and Health Disparities [S21MD000101, U54NS083932]; American Heart Association [0840132N]; Alzheimer's Association [IIRG-10-173350]; Jiangsu Province's Key Discipline of Medicine [XK201118]; Priority Academic Program Development of Jiangsu Higher Education Institutions of China; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047506, U54NS083932, R01NS066027] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [S21MD000101] Funding Source: NIH RePORTER	National Institutes Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Minority Health and Health Disparities; American Heart Association(American Heart Association); Alzheimer's Association(Alzheimer's Association); Jiangsu Province's Key Discipline of Medicine; Priority Academic Program Development of Jiangsu Higher Education Institutions of China; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by National Institutes Health [grant R01NS047506 and R01NS066027 to Z.G.X.]; Minority Health and Health Disparities [grant S21MD000101 and U54NS083932]; American Heart Association [grant 0840132N to Z.G.X.]; Alzheimer's Association [grant IIRG-10-173350 to Z.G.X.]; Jiangsu Province's Key Discipline of Medicine [grant XK201118 to L.Z.], and the Priority Academic Program Development of Jiangsu Higher Education Institutions of China [to L.Z.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts M, 2003, CELL, V115, P863, DOI 10.1016/S0092-8674(03)01017-1; Aarts MM, 2005, NEUROSCIENTIST, V11, P116, DOI 10.1177/1073858404272966; Akita T, 2011, J PHYSIOL-LONDON, V589, P3909, DOI 10.1113/jphysiol.2011.208173; Babu AN, 1999, BRAIN RES BULL, V50, P59, DOI 10.1016/S0361-9230(99)00091-X; Baldoli E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059891; Baldoli E, 2012, ANGIOGENESIS, V15, P47, DOI 10.1007/s10456-011-9242-0; Barreto GE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027881; Bates-Withers C, 2011, ADV EXP MED BIOL, V704, P173, DOI 10.1007/978-94-007-0265-3_9; Butenko O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039959; Chen KH, 2014, J CELL PHYSIOL, V229, P60, DOI 10.1002/jcp.24417; Cheng PP, 2013, INT J DEV NEUROSCI, V31, P783, DOI 10.1016/j.ijdevneu.2013.09.008; Clapham DE, 2001, NAT REV NEUROSCI, V2, P387, DOI 10.1038/35077544; Clark K, 2008, FEBS LETT, V582, P2993, DOI 10.1016/j.febslet.2008.07.043; Clark MA, 2008, BRAIN RES BULL, V75, P101, DOI 10.1016/j.brainresbull.2007.07.028; Clark MA, 2012, NEUROCHEM RES, V37, P1475, DOI 10.1007/s11064-012-0738-9; Colangelo AM, 2014, NEUROSCI LETT; Dong YS, 2001, GLIA, V36, P180, DOI 10.1002/glia.1107; Dorovkov MV, 2004, J BIOL CHEM, V279, P50643, DOI 10.1074/jbc.C400441200; Fang L, 2013, TOXICOL APPL PHARM, V272, P713, DOI 10.1016/j.taap.2013.08.009; Fonfria E, 2006, J RECEPT SIG TRANSD, V26, P159, DOI 10.1080/10799890600637506; Ghabriel MN, 2006, ACTA NEUROCHIR SUPPL, V96, P402; Hamby ME, 2010, NEUROTHERAPEUTICS, V7, P494, DOI 10.1016/j.nurt.2010.07.003; Hermosura MC, 2007, BBA-MOL BASIS DIS, V1772, P822, DOI 10.1016/j.bbadis.2007.02.008; Inoue K, 2010, J BIOL CHEM, V285, P7430, DOI 10.1074/jbc.M109.040485; Inoue K, 2009, CARDIOVASC RES, V83, P547, DOI 10.1093/cvr/cvp153; Jiang J, 2007, CANCER RES, V67, P10929, DOI 10.1158/0008-5472.CAN-07-1121; Jiang XP, 2003, J BIOL CHEM, V278, P42867, DOI 10.1074/jbc.M304487200; Jin J, 2008, SCIENCE, V322, P756, DOI 10.1126/science.1163493; Kunert-Keil C, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-159; Landman N, 2006, P NATL ACAD SCI USA, V103, P19524, DOI 10.1073/pnas.0604954103; Leng T, 2014, PROG NEUROBIOL; Leng TD, 2014, CNS NEUROSCI THER; Li W, 2014, MOL BRAIN, V7, DOI 10.1186/s13041-014-0065-y; Liu H, 2012, LIFE SCI, V90, P612, DOI 10.1016/j.lfs.2012.02.012; Liu ML, 2014, CELL SIGNAL, V26, P2773, DOI 10.1016/j.cellsig.2014.08.020; Malarkey EB, 2008, GLIA, V56, P821, DOI 10.1002/glia.20656; MONTGOMERY DL, 1994, VET PATHOL, V31, P145, DOI 10.1177/030098589403100201; Nadler MJS, 2001, NATURE, V411, P590, DOI 10.1038/35079092; Nunez-Villena F, 2011, ANTIOXID REDOX SIGN, V15, P2425, DOI 10.1089/ars.2010.3825; Runnels LW, 2011, CURR PHARM BIOTECHNO, V12, P42; Runnels LW, 2001, SCIENCE, V291, P1043, DOI 10.1126/science.1058519; Sahni J, 2008, CELL METAB, V8, P84, DOI 10.1016/j.cmet.2008.06.002; Schildge S, 2013, JOVE-J VIS EXP, DOI 10.3791/50079; Schilling T, 2014, J CELL SCI; Schmitz C, 2003, CELL, V114, P191, DOI 10.1016/S0092-8674(03)00556-7; Scimemi A, 2013, J PHYSIOL-LONDON, V591, P9, DOI 10.1113/jphysiol.2012.237883; Shibasaki K, 2013, BIOCHEM BIOPH RES CO, V441, P327, DOI 10.1016/j.bbrc.2013.10.046; Shigetomi E, 2012, NAT NEUROSCI, V15, P70, DOI 10.1038/nn.3000; Shirakawa H, 2010, J NEUROSCI, V30, P13116, DOI 10.1523/JNEUROSCI.1890-10.2010; Siddiqui T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106087; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Song XY, 2005, GLIA, V49, P418, DOI 10.1002/glia.20128; Su LT, 2011, BIOCHEM J, V434, P513, DOI 10.1042/BJ20101678; Su LT, 2010, J MOL BIOL, V396, P858, DOI 10.1016/j.jmb.2010.01.014; Su LT, 2006, J BIOL CHEM, V281, P11260, DOI 10.1074/jbc.M512885200; Sun HS, 2009, NAT NEUROSCI, V12, P1300, DOI 10.1038/nn.2395; Sun HW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079540; Sun YY, 2014, BBA-MOL CELL RES, V1843, P1839, DOI 10.1016/j.bbamcr.2014.04.019; Yee NS, 2011, DIS MODEL MECH, V4, P240, DOI 10.1242/dmm.004564; Yu MZ, 2013, INFLAMM RES, V62, P961, DOI 10.1007/s00011-013-0653-9; Zhang L, 2007, EUR J PHARMACOL, V564, P18, DOI 10.1016/j.ejphar.2007.01.089; Zhang Z, 2012, CIRC RES, V111, P1137, DOI 10.1161/CIRCRESAHA.112.273755	62	42	43	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0119912	10.1371/journal.pone.0119912	http://dx.doi.org/10.1371/journal.pone.0119912			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799367	Green Submitted, Green Published, gold			2022-12-26	WOS:000351987300089
J	Cai, RQ; Xue, WL; Liu, SS; Petersen, RB; Huang, K; Zheng, L				Cai, Ruiqi; Xue, Weili; Liu, Shanshan; Petersen, Robert B.; Huang, Kun; Zheng, Ling			Overexpression of glyceraldehyde 3-phosphate dehydrogenase prevents neurovascular degeneration after retinal injury	FASEB JOURNAL			English	Article						I/R injury; energy failure; necroptosis; DNA damage	ISCHEMIA-REPERFUSION INJURY; NITRIC-OXIDE SYNTHASE; DIABETIC-RETINOPATHY; PROGRAMMED NECROSIS; ENERGY-METABOLISM; GANGLION-CELLS; IN-VITRO; APOPTOSIS; PROTEIN; DAMAGE	Ischemia and reperfusion (I/R) injury is a common cause of many vascular and neuronal diseases. Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) has been found down-regulated or dysfunctional in several tissues upon I/R injury. To investigate the role of GAPDH in retinal I/R injury-induced neurovascular degeneration, the injured retinas of GAPDH transgenic (Tg) mice and wild-type (WT) littermates were analyzed. I/R injury induced neurovascular degeneration, energy failure, DNA damage, and necroptosis in the retinas of WT mice. In contrast, the GAPDH Tg mice showed resistance to all of these injury-induced abnormalities. In addition, I/R-induced effects were further examined in a neuroblastoma cell line and an endothelial cell line, which were transfected with a vector encoding human GAPDH or a control vector. After I/R challenge, energy failure, DNA damage, and elevation of receptor-interacting serine/threonine-protein kinase (RIP) 1/3 were observed in the cells transfected with the control vector. However, overexpression of GAPDH in these cells prevented the injury-induced RIP3 up-regulation by restoring energy production and preventing DNA damage. Together, the protective role of GAPDH in retinal neurovascular degeneration after I/R injury provides a better understanding of the underlying mechanism of I/R injury and a potential therapeutic target to attenuate I/R injuryrelated diseases.	[Cai, Ruiqi; Xue, Weili; Liu, Shanshan; Zheng, Ling] Wuhan Univ, Coll Life Sci, Wuhan 430072, Peoples R China; [Petersen, Robert B.] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Petersen, Robert B.] Case Western Reserve Univ, Dept Neurosci, Cleveland, OH 44106 USA; [Petersen, Robert B.] Case Western Reserve Univ, Dept Neurol, Cleveland, OH 44106 USA; [Huang, Kun] Huazhong Univ Sci & Technol, Tongji Sch Pharm, Wuhan 430074, Hubei, Peoples R China	Wuhan University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Huazhong University of Science & Technology	Zheng, L (corresponding author), Wuhan Univ, Coll Life Sci, Wuhan 430072, Peoples R China.	lzheng217@hotmail.com		Liu, Shanshan/0000-0002-7301-5196; Zheng, Ling/0000-0002-6545-4180; Huang, Kun/0000-0002-0808-2325	National Basic Research Program of China [2012CB524901]; Natural Science Foundation of China [31471208, 31271370, 81100687]; Fundamental Research Funding of Central University	National Basic Research Program of China(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funding of Central University	This work was supported by the National Basic Research Program of China (2012CB524901), the Natural Science Foundation of China (number 31471208, 31271370, and 81100687), and the Fundamental Research Funding of Central University. R.C. performed experiments, analyzed data, and wrote the manuscript; W.X. performed experiments and analyzed data; S.L. genotyped the mice; R.B.P. provided critical discussions and edited the manuscript; K.H. analyzed data and edited the manuscript; and L.Z. designed the experiments, supervised the project, and wrote the manuscript. The authors declare no conflicts of interest.	Azam S, 2008, J BIOL CHEM, V283, P30632, DOI 10.1074/jbc.M801401200; Berg J. M., 2002, BIOCHEMISTRY-US, P443; Brownlee M, 2005, DIABETES, V54, P1615, DOI 10.2337/diabetes.54.6.1615; Campello L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074439; Carden DL, 2000, J PATHOL, V190, P255, DOI 10.1002/(SICI)1096-9896(200002)190:3<255::AID-PATH526>3.0.CO;2-6; Carujo S, 2006, ONCOGENE, V25, P4033, DOI 10.1038/sj.onc.1209433; Casson RJ, 2004, ARCH OPHTHALMOL-CHIC, V122, P361, DOI 10.1001/archopht.122.3.361; Castilho MS, 2003, BIOCHEMISTRY-US, V42, P7143, DOI 10.1021/bi0206107; Chang B, 2013, INVEST OPHTH VIS SCI, V54, P4974, DOI 10.1167/iovs.13-12289; Chen H, 2014, J PHYSIOL-LONDON, V592, P505, DOI 10.1113/jphysiol.2013.266411; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Cohen Jeffrey E, 2006, Heart Lung Circ, V15, P119, DOI 10.1016/j.hlc.2005.12.004; Colell A, 2007, CELL, V129, P983, DOI 10.1016/j.cell.2007.03.045; Cuzzocrea S, 2001, PHARMACOL REV, V53, P135; D'Amours D, 2001, J CELL SCI, V114, P3771; Ding Y, 2014, INT J OBESITY, V38, P198, DOI 10.1038/ijo.2013.98; Du XL, 2003, J CLIN INVEST, V112, P1049, DOI 10.1172/JCI200318127; Dvoriantchikova G, 2014, EXP EYE RES, V123, P1, DOI 10.1016/j.exer.2014.04.009; Dvoriantchikova G, 2010, MOL VIS, V16, P2882; Eltzschig HK, 2011, NAT MED, V17, P1391, DOI 10.1038/nm.2507; HOYER S, 1986, NEUROBIOL AGING, V7, P23, DOI 10.1016/0197-4580(86)90022-9; Huang J, 2015, EPIGENETICS-US, V10, P62, DOI 10.4161/15592294.2014.990780; JENNINGS RB, 1991, ANNU REV MED, V42, P225, DOI 10.1146/annurev.med.42.1.225; Jiang M, 2010, AM J PATHOL, V176, P1181, DOI 10.2353/ajpath.2010.090594; Kaja S, 2003, INVEST OPHTH VIS SCI, V44, P3155, DOI 10.1167/iovs.02-1204; Kanwar M, 2009, DIABETES, V58, P227, DOI 10.2337/db08-1025; Kern TS, 2001, DIABETES, V50, P1636, DOI 10.2337/diabetes.50.7.1636; Li CZ, 2012, INVEST OPHTH VIS SCI, V53, P3241, DOI 10.1167/iovs.11-8406; Manning NW, 2014, STROKE, V45, P640, DOI 10.1161/STROKEAHA.113.003798; MEYERSIEGLER K, 1991, P NATL ACAD SCI USA, V88, P8460, DOI 10.1073/pnas.88.19.8460; Neufeld AH, 2002, EXP EYE RES, V75, P521, DOI 10.1006/exer.2002.2042; Neufeld AH, 1999, P NATL ACAD SCI USA, V96, P9944, DOI 10.1073/pnas.96.17.9944; Newton K, 2014, SCIENCE, V343, P1357, DOI 10.1126/science.1249361; Osborne NN, 2004, PROG RETIN EYE RES, V23, P91, DOI 10.1016/j.preteyeres.2003.12.001; Sen N, 2008, NAT CELL BIOL, V10, P866, DOI 10.1038/ncb1747; Tian H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116453; TOKUNAGA K, 1987, CANCER RES, V47, P5616; Tsujimoto Y, 1997, CELL DEATH DIFFER, V4, P429, DOI 10.1038/sj.cdd.4400262; VanGuilder HD, 2008, EUR J NEUROSCI, V28, P1, DOI 10.1111/j.1460-9568.2008.06322.x; Wang LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023194; Winkler BS, 1997, INVEST OPHTH VIS SCI, V38, P62; Yang YH, 2004, J BIOL CHEM, V279, P38820, DOI 10.1074/jbc.M401663200; Yogalingam G, 2013, J BIOL CHEM, V288, P18947, DOI 10.1074/jbc.M113.466870; Yoo MH, 2004, INVEST OPHTH VIS SCI, V45, P1523, DOI 10.1167/iovs.03-1315; Yoshizawa K, 2012, J TOXICOL PATHOL, V25, P27, DOI 10.1293/tox.25.27; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308; Zhao XL, 2014, J PROTEOME RES, V13, P2175, DOI 10.1021/pr500040a; Zheng L, 2007, DIABETOLOGIA, V50, P1987, DOI 10.1007/s00125-007-0734-9; Zheng L, 2007, INVEST OPHTH VIS SCI, V48, P361, DOI 10.1167/iovs.06-0510; Zheng L, 2009, PROTEOMICS, V9, P1869, DOI 10.1002/pmic.200701071; Zhou Y, 2008, MOL CANCER RES, V6, P1375, DOI 10.1158/1541-7786.MCR-07-2170	51	23	24	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2015	29	7					2749	2758		10.1096/fj.14-265801	http://dx.doi.org/10.1096/fj.14-265801			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CL3OI	25805836				2022-12-26	WOS:000356859100007
J	Tanida, T; Matsuda, KI; Yamada, S; Hashimoto, T; Kawata, M				Tanida, Takashi; Matsuda, Ken Ichi; Yamada, Shunji; Hashimoto, Takashi; Kawata, Mitsuhiro			Estrogen-related Receptor Reduces the Subnuclear Mobility of Estrogen Receptor and Suppresses Estrogen-dependent Cellular Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Breast Cancer; Estrogen Receptor; Fluorescence Recovery after Photobleaching (FRAP); Fluorescence Resonance Energy Transfer (FRET); Transcription; Estrogen-related Receptor (ERR); Live-cell Imaging	ORPHAN NUCLEAR RECEPTORS; STEROID-HORMONE RECEPTOR; BREAST-CANCER CELLS; ALPHA ERR-ALPHA; INTRANUCLEAR MOBILITY; TRANSCRIPTIONAL REGULATION; GLUCOCORTICOID-RECEPTOR; ANDROGEN RECEPTOR; BINDING DOMAIN; LIVING CELLS	Background: The role of orphan nuclear receptor ERR in estrogen-related pathophysiology is poorly understood. Results: ERR repressed the transactivity of ER and proliferation of MCF-7 breast carcinoma cells through reduction of the intranuclear mobility of ER. Conclusion: ERR affects ER dynamics and function. Significance: Regulation of ERR will provide a potential therapeutic approach for estrogen-related cancer. Estrogen-related receptor (ERR) is a member of the nuclear receptor superfamily that has strong homology with estrogen receptor (ER) . ERR has three subtypes (, , and ) expressed in estrogen-sensitive organs, including ovary, breast, and brain. No endogenous ligands of ERRs have been identified, but these receptors share a common DNA element with ER and control estrogen-mediated gene transcription. Recent evidence suggests a role of ERRs in estrogen-related pathophysiology, but the detailed mechanisms of ERR functions in estrogen-related tissues are unclear. Using live-cell imaging with fluorescent protein labeling, we found that only ERR among the ERRs exhibits a punctate intranuclear pattern overlapping with ER following 17-estradiol (E-2)-stimulation. Fluorescence recovery after photobleaching showed significant reduction of the mobility of ligand-activated ER with co-expression of ERR. Fluorescence resonance energy transfer revealed that ERR directly interacts with ER. The N-terminal domain of ERR was identified as the region that interacts with ER. We also found a correlation between punctate cluster formation of ER and interaction between the receptors. Expression of ERR significantly repressed ER-mediated transactivity, whereas that of other ERR subtypes had no effect on the transactivity of ER. Consistent with this finding, E-2-stimulated proliferation of MCF-7 breast carcinoma cells and bcl-2 expression was significantly inhibited by expression of ERR. These results provide strong evidence for a suppressive effect of ERR on estrogen signaling through reduction of the intranuclear mobility of ER. The findings further suggest a unique inhibitory role for ERR in estrogen-dependent cellular function such as cancer cell proliferation.	[Tanida, Takashi; Matsuda, Ken Ichi; Yamada, Shunji; Hashimoto, Takashi; Kawata, Mitsuhiro] Kyoto Prefectural Univ Med, Dept Anat & Neurobiol, Kamigyo Ku, Kyoto 6028566, Japan	Kyoto Prefectural University of Medicine	Tanida, T (corresponding author), Kyoto Prefectural Univ Med, Dept Anat & Neurobiol, Kamigyo Ku, 465 Kajii Cho,Kawara Machi Hirokoji, Kyoto 6028566, Japan.	t-tanida@koto.kpu-m.ac.jp		Tanida, Takashi/0000-0002-0864-2433	Ministry of Education, Culture, Sports, Science and Technology of Japan [24791116, 26860852, 24300128]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-aid for Young Scientists (B) 24791116 and 26860852 (to T. T.) and for Scientific Research (B) 24300128 (to M. K.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Alaynick WA, 2007, CELL METAB, V6, P13, DOI 10.1016/j.cmet.2007.06.007; ALEXANDER RB, 1987, ENDOCRINOLOGY, V120, P1851, DOI 10.1210/endo-120-5-1851; Ariazi EA, 2002, CANCER RES, V62, P6510; Barbieri RL, 2008, J CLIN ENDOCR METAB, V93, P2439, DOI 10.1210/jc.2008-0752; BARRACK ER, 1987, J STEROID BIOCHEM, V27, P115, DOI 10.1016/0022-4731(87)90302-5; Beato M, 1996, STEROIDS, V61, P240, DOI 10.1016/0039-128X(96)00030-X; Bombail V, 2010, MOL CELL ENDOCRINOL, V314, P53, DOI 10.1016/j.mce.2009.09.007; Bombail V, 2008, HUM REPROD, V23, P2782, DOI 10.1093/humrep/den298; Bookout AL, 2006, CELL, V126, P789, DOI 10.1016/j.cell.2006.06.049; Brazda P, 2011, J CELL SCI, V124, P3631, DOI 10.1242/jcs.086082; Chen S, 2001, J BIOL CHEM, V276, P28465, DOI 10.1074/jbc.M102638200; Deblois G, 2013, NAT REV CANCER, V13, P27, DOI 10.1038/nrc3396; Dong S, 2004, MOL CELL BIOL, V24, P4465, DOI 10.1128/MCB.24.10.4465-4475.2004; Dufour CR, 2007, CELL METAB, V5, P345, DOI 10.1016/j.cmet.2007.03.007; Eudy JD, 1998, GENOMICS, V50, P382, DOI 10.1006/geno.1998.5345; GIGUERE V, 1988, NATURE, V331, P91, DOI 10.1038/331091a0; Giguere V, 2008, ENDOCR REV, V29, P677, DOI 10.1210/er.2008-0017; Hall JM, 2005, MOL INTERV, V5, P343, DOI 10.1124/mi.5.6.7; Hashimoto T, 2012, J CELL BIOCHEM, V113, P3039, DOI 10.1002/jcb.24182; Heckler MM, 2015, CELL CYCLE, V14, P31, DOI 10.4161/15384101.2014.972886; Heery DM, 2001, J BIOL CHEM, V276, P6695, DOI 10.1074/jbc.M009404200; Hentschke M, 2002, EUR J BIOCHEM, V269, P4086, DOI 10.1046/j.1432-1033.2002.03102.x; Hong H, 1999, J BIOL CHEM, V274, P22618, DOI 10.1074/jbc.274.32.22618; Horard B, 2004, J MOL ENDOCRINOL, V33, P493, DOI 10.1677/jme.1.01538; Htun H, 1999, MOL BIOL CELL, V10, P471, DOI 10.1091/mbc.10.2.471; Huss JM, 2007, CELL METAB, V6, P25, DOI 10.1016/j.cmet.2007.06.005; Ijichi N, 2011, J STEROID BIOCHEM, V123, P1, DOI 10.1016/j.jsbmb.2010.09.002; Kaku N, 2008, ENDOCRINOLOGY, V149, P3960, DOI 10.1210/en.2008-0137; Kanaujiya JK, 2013, PROTEOMICS, V13, P2100, DOI 10.1002/pmic.201200534; Karimi P, 2013, CANCER INVEST, V31, P600, DOI 10.3109/07357907.2013.845672; Kawata M, 1995, NEUROSCI RES, V24, P1, DOI 10.1016/0168-0102(96)81278-8; Knower KC, 2013, BREAST CANCER RES TR, V142, P211, DOI 10.1007/s10549-013-2716-6; Kuiper GGJM, 1997, FEBS LETT, V410, P87, DOI 10.1016/S0014-5793(97)00413-4; Kumar R, 2003, MOL ENDOCRINOL, V17, P1, DOI 10.1210/me.2002-0258; LaBarge S, 2014, FASEB J, V28, P1082, DOI 10.1096/fj.13-229211; Lavinsky RM, 1998, P NATL ACAD SCI USA, V95, P2920, DOI 10.1073/pnas.95.6.2920; Lim CS, 1999, MOL ENDOCRINOL, V13, P366, DOI 10.1210/me.13.3.366; Lin CC, 2006, CARCINOGENESIS, V27, P131, DOI 10.1093/carcin/bgi199; Lu DS, 2001, CANCER RES, V61, P6755; Luo JM, 2003, MOL CELL BIOL, V23, P7947, DOI 10.1128/MCB.23.22.7947-7956.2003; Luo JM, 1997, NATURE, V388, P778, DOI 10.1038/42022; Maruyama K, 1998, BIOCHEM BIOPH RES CO, V246, P142, DOI 10.1006/bbrc.1998.8590; Matsuda K, 2008, J CELL BIOCHEM, V103, P136, DOI 10.1002/jcb.21393; Matsuda KI, 2002, MOL ENDOCRINOL, V16, P2215, DOI 10.1210/me.2002-0110; Mohseni M, 2014, P NATL ACAD SCI USA, V111, P17606, DOI 10.1073/pnas.1408650111; Monroe DG, 2005, MOL ENDOCRINOL, V19, P1555, DOI 10.1210/me.2004-0381; Muyan M, 2012, J MOL ENDOCRINOL, V49, P249, DOI 10.1530/JME-12-0097; Nishi M, 1999, EUR J NEUROSCI, V11, P1927, DOI 10.1046/j.1460-9568.1999.00616.x; Nishi M, 2004, J NEUROSCI, V24, P4918, DOI 10.1523/JNEUROSCI.5495-03.2004; Ochiai I, 2004, MOL ENDOCRINOL, V18, P26, DOI 10.1210/me.2002-0262; Oftedal BE, 2005, ANN NY ACAD SCI, V1040, P420, DOI 10.1196/annals.1327.079; Pettersson K, 1996, MECH DEVELOP, V54, P211, DOI 10.1016/0925-4773(95)00479-3; Pfaff DW, 1997, P NATL ACAD SCI USA, V94, P14213, DOI 10.1073/pnas.94.26.14213; Powell E, 2008, P NATL ACAD SCI USA, V105, P19012, DOI 10.1073/pnas.0807274105; Prufer K, 2008, EXP CELL RES, V314, P2652, DOI 10.1016/j.yexcr.2008.05.005; Schreiber SN, 2003, J BIOL CHEM, V278, P9013, DOI 10.1074/jbc.M212923200; SEKIGUCHI M, 1979, BIOMEDICINE, V30, P245; Sem DS, 1997, J BIOL CHEM, V272, P18038, DOI 10.1074/jbc.272.29.18038; Sengupta D, 2014, BRIT J CANCER, V110, P2144, DOI 10.1038/bjc.2014.53; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Stenoien DL, 2001, NAT CELL BIOL, V3, P15, DOI 10.1038/35050515; Stenoien DL, 2000, MOL ENDOCRINOL, V14, P518, DOI 10.1210/me.14.4.518; Sun PM, 2005, J MOL MED, V83, P457, DOI 10.1007/s00109-005-0639-3; Suzuki T, 2004, CANCER RES, V64, P4670, DOI 10.1158/0008-5472.CAN-04-0250; Tremblay GB, 2001, GENE DEV, V15, P833, DOI 10.1101/gad.873401; Watanabe A, 2006, J CLIN ENDOCR METAB, V91, P1573, DOI 10.1210/jc.2005-1990; Yoo YA, 2008, BBA-MOL CELL RES, V1783, P438, DOI 10.1016/j.bbamcr.2007.12.001; Yu S, 2008, ONCOGENE, V27, P3313, DOI 10.1038/sj.onc.1210986; Zhang X, 1998, MOL ENDOCRINOL, V12, P513, DOI 10.1210/me.12.4.513; Zhou W, 2006, J CLIN ENDOCR METAB, V91, P569, DOI 10.1210/jc.2004-1957	70	30	30	3	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2015	290	19					12332	12345		10.1074/jbc.M114.619098	http://dx.doi.org/10.1074/jbc.M114.619098			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH9XA	25805499	hybrid, Green Published			2022-12-26	WOS:000354388600042
J	Damm, P; Bender, A; Bergmann, G				Damm, Philipp; Bender, Alwina; Bergmann, Georg			Postoperative Changes in In Vivo Measured Friction in Total Hip Joint Prosthesis during Walking	PLOS ONE			English	Article							TELEMETRY SYSTEM; CONTACT FORCES; PART 1; LUBRICATION; WEAR; ARTHROPLASTY; REPLACEMENTS; IMPLANTS; TRIBOLOGY; SIMULATOR	Loosening of the artificial cup and inlay is the most common reasons for total hip replacement failures. Polyethylene wear and aseptic loosening are frequent reasons. Furthermore, over the past few decades, the population of patients receiving total hip replacements has become younger and more active. Hence, a higher level of activity may include an increased risk of implant loosening as a result of friction-induced wear. In this study, an instrumented hip implant was used to measure the contact forces and friction moments in vivo during walking. Subsequently, the three-dimensional coefficient of friction in vivo was calculated over the whole gait cycle. Measurements were collected from ten subjects at several time points between three and twelve months postoperative. No significant change in the average resultant contact force was observed between three and twelve months postoperative. In contrast, a significant decrease of up to 47% was observed in the friction moment. The coefficient of friction also decreased over postoperative time on average. These changes may be caused by 'running-in' effects of the gliding components or by the improved lubricating properties of the synovia. Because the walking velocity and contact forces were found to be nearly constant during the observed period, the decrease in friction moment suggests an increase in fluid viscosity. The peak values of the contact force individually varied by 32%-44%. The friction moment individually differed much more, by 110%129% at three and up to 451% at twelve months postoperative. The maximum coefficient of friction showed the highest individual variability, about 100% at three and up to 914% at twelve months after surgery. These individual variations in the friction parameters were most likely due to different 'running-in' effects that were influenced by the individual activity levels and synovia properties.	[Damm, Philipp; Bender, Alwina; Bergmann, Georg] Charite, Julius Wolff Inst, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Damm, P (corresponding author), Charite, Julius Wolff Inst, D-13353 Berlin, Germany.	Philipp.Damm@charite.de		Damm, Philipp/0000-0001-8471-7284; Bender, Alwina/0000-0002-4444-6309	German Research Society [SFB760, BE 804/19-1]	German Research Society(German Research Foundation (DFG))	Support was provided by the German Research Society (SFB760 and BE 804/19-1) [http://www.dfg.de] and Deutsche Arthrose-Hilfe e.V. [http://www.arthrose.de]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affatato S, 2008, MED ENG PHYS, V30, P1305, DOI 10.1016/j.medengphy.2008.07.006; Balazs E., 1974, DISORDERS KNEE, P63; Bender A, 2011, COMPUT METHOD BIOMEC, P1, DOI [10.1080/10255842.2011.560841, DOI 10.1080/10255842.2011.560841]; Bergen H., 2010, ANN REPORT 2010 NORW; BERGMANN G, 1989, Z ORTHOP GRENZGEB, V127, P672, DOI 10.1055/s-2008-1040311; Bergmann G, 2001, J BIOMECH, V34, P421, DOI 10.1016/S0021-9290(00)00188-3; Bergmann G, 2004, LANGENBECK ARCH SURG, V389, P53, DOI 10.1007/s00423-003-0434-y; Brand RA, 1982, IOVA ORTHOP J, V2, P43; Brockett C., 2006, J BIOMEDICAL MAT R B, V81B, P508, DOI DOI 10.1002/JBMB; Chatterji U, 2004, ANZ J SURG, V74, P446, DOI 10.1111/j.1445-1433.2004.03028.x; CJRR, 2008, CJRP REP TOT HIP TOT; CURTIS MJ, 1992, J BONE JOINT SURG BR, V74, P372, DOI 10.1302/0301-620X.74B3.1587880; Damm P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078373; Damm P, 2013, CLIN BIOMECH, V28, P530, DOI 10.1016/j.clinbiomech.2012.12.003; Damm P, 2010, MED ENG PHYS, V32, P95, DOI 10.1016/j.medengphy.2009.10.003; David D, 2013, AUSTR ORTHOPAEDIC AS; Fam H, 2007, BIORHEOLOGY, V44, P59; Fialho JC, 2007, J BIOMECH, V40, P2358, DOI 10.1016/j.jbiomech.2006.12.005; Fisher J, 1991, Proc Inst Mech Eng H, V205, P73, DOI 10.1243/PIME_PROC_1991_205_271_02; Flugsrud GB, 2007, ACTA ORTHOP, V78, P99, DOI 10.1080/17453670610013493; Garellick G, 2011, SWEDISH HIP ARTHROPL; GRAICHEN F, 1994, BIOMED TECH, V39, P251, DOI 10.1515/bmte.1994.39.10.251; Graichen F, 2007, IEEE T BIO-MED ENG, V54, P253, DOI 10.1109/TBME.2006.886857; Hall RM, 1997, BRIT J RHEUMATOL, V36, P20; Hall RM, 1997, BIOMATERIALS, V18, P1017, DOI 10.1016/S0142-9612(97)00034-3; Havelin LI, 2009, ACTA ORTHOP, V80, P393, DOI 10.3109/17453670903039544; Huch K, 2005, ANN RHEUM DIS, V64, P1715, DOI 10.1136/ard.2004.033266; Jalali-Vahid D, 2001, J BIOMECH, V34, P261, DOI 10.1016/S0021-9290(00)00181-0; Jin ZM, 2006, CURR ORTHOPAED, V20, P32, DOI 10.1016/j.cuor.2005.09.005; Li S, 1999, J ORTHOP RES, V17, P891, DOI 10.1002/jor.1100170614; Liao YS, 2003, BIOMATERIALS, V24, P3047, DOI 10.1061/S01429612(03)00148-0; Malchau H. P., 2000, PROGNOSIS TOTAL HIP; Mattei L, 2011, TRIBOL INT, V44, P532, DOI 10.1016/j.triboint.2010.06.010; PAUL JP, 1976, PROC R SOC SER B-BIO, V192, P163, DOI 10.1098/rspb.1976.0004; Saikko V, 1992, Proc Inst Mech Eng H, V206, P201, DOI 10.1243/PIME_PROC_1992_206_292_02; Scholes SC, 2006, P I MECH ENG H, V220, P687, DOI 10.1243/09544119JEIM21; Scholes SC, 2000, PHYS MED BIOL, V45, P3721, DOI 10.1088/0031-9155/45/12/315; Scholes SC, 2000, WEAR, V241, P209, DOI 10.1016/S0043-1648(00)00377-X; Scholes SC, 2000, P I MECH ENG H, V214, P49, DOI 10.1243/0954411001535237; Stansfield BW, 2003, J BIOMECH, V36, P929, DOI 10.1016/S0021-9290(03)00072-1; Taylor SJG, 1997, J BIOMECH, V30, P225, DOI 10.1016/S0021-9290(96)00141-8; Unsworth A, 2006, P I MECH ENG J-J ENG, V220, P711, DOI 10.1243/13506501JET84; UNSWORTH A, 1978, PHYS MED BIOL, V23, P253, DOI 10.1088/0031-9155/23/2/004; Williams S, 2006, J BIOMECH, V39, P2274, DOI 10.1016/j.jbiomech.2005.07.011; Wu G, 2002, J BIOMECH, V35, P543, DOI 10.1016/S0021-9290(01)00222-6; Xiong DS, 2001, WEAR, V250, P242, DOI 10.1016/S0043-1648(01)00647-0	46	21	21	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0120438	10.1371/journal.pone.0120438	http://dx.doi.org/10.1371/journal.pone.0120438			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25806805	Green Published, gold, Green Submitted			2022-12-26	WOS:000351880000076
J	Atroshi, I; Zhou, C; Joud, A; Petersson, IF; Englund, M				Atroshi, Isam; Zhou, Caddie; Joud, Anna; Petersson, Ingemar F.; Englund, Martin			Sickness Absence from Work among Persons with New Physician-Diagnosed Carpal Tunnel Syndrome: A Population-Based Matched-Cohort Study	PLOS ONE			English	Article							GENERAL-POPULATION; RETURN; SURGERY; RELEASE; TIME	Background Carpal tunnel syndrome is common among employed persons. Data on sickness absence from work in relation to carpal tunnel syndrome have been usually based on self-report and derived from clinical or occupational populations. We aimed to determine sickness absence among persons with physician-diagnosed carpal tunnel syndrome as compared to the general population. Methods In Skane region in Sweden we identified all subjects, aged 17-57 years, with new physician-made diagnosis of carpal tunnel syndrome during 5 years (2004-2008). For each subject we randomly sampled, from the general population, 4 matched reference subjects without carpal tunnel syndrome; the two cohorts comprised 5456 and 21,667 subjects, respectively (73% women; mean age 43 years). We retrieved social insurance register data on all sickness absence periods longer than 2 weeks from 12 months before to 24 months after diagnosis. Of those with carpal tunnel syndrome 2111 women (53%) and 710 men (48%) underwent surgery within 24 months of diagnosis. We compared all-cause sickness absence and analyzed sickness absence in conjunction with diagnosis and surgery. Results Mean number of all-cause sickness absence days per each 30-day period from 12 months before to 24 months after diagnosis was significantly higher in the carpal tunnel syndrome than in the reference cohort. A new sickness absence period longer than 2 weeks in conjunction with diagnosis was recorded in 12% of the women (n = 492) and 11% of the men (n = 170) and with surgery in 53% (n = 1121) and 58% (n = 408) of the surgically treated, respectively; median duration in conjunction with surgery was 35 days (IQR 27-45) for women and 41 days (IQR 28-50) for men. Conclusions Persons with physician-diagnosed carpal tunnel syndrome have substantially more sickness absence from work than age and sex-matched persons from the general population from1 year before to 2 years after diagnosis. Gender differences were small.	[Atroshi, Isam; Zhou, Caddie; Joud, Anna; Petersson, Ingemar F.; Englund, Martin] Lund Univ, Dept Clin Sci Lund, Orthoped, Lund, Sweden; [Atroshi, Isam] Hassleholm Hosp, Dept Orthoped Hassleholm Kristianstad, Hassleholm, Sweden; [Joud, Anna; Petersson, Ingemar F.; Englund, Martin] Skane Univ Hosp Lund, Epidemiol & Register Ctr South, Lund, Sweden; [Joud, Anna] Lund Univ, Dept Lab Med, Div Occupat & Environm Med, Lund, Sweden; [Englund, Martin] Boston Univ, Sch Med, Clin Epidemiol Res & Training Unit, Boston, MA 02118 USA	Lund University; Lund University; Skane University Hospital; Lund University; Boston University	Atroshi, I (corresponding author), Lund Univ, Dept Clin Sci Lund, Orthoped, Lund, Sweden.	Isam.Atroshi@med.lu.se	Jöud, Anna/AAA-3277-2022; Englund, Martin/J-7245-2012	Englund, Martin/0000-0003-3320-2437; Petersson, Ingemar/0000-0001-9139-1892	Swedish Research Council; Region Skane; Medical Faculty at Lund University, Sweden	Swedish Research Council(Swedish Research CouncilEuropean Commission); Region Skane; Medical Faculty at Lund University, Sweden	The study was supported by the Swedish Research Council, Region Skane, and Medical Faculty at Lund University, Sweden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abasolo L, 2007, ARTHRIT RHEUM-ARTHR, V57, P335, DOI 10.1002/art.22529; Atroshi I, 2006, BRIT MED J, V332, P1473, DOI 10.1136/bmj.38863.632789.1F; Atroshi I, 1999, JAMA-J AM MED ASSOC, V282, P153, DOI 10.1001/jama.282.2.153; Atroshi I, 2011, ARCH INTERN MED, V171, P943, DOI 10.1001/archinternmed.2011.203; Carmona L, 1998, ARTHRIT CARE RES, V11, P298, DOI 10.1002/art.1790110411; Chaise F, 2004, J HAND SURG-BRIT EUR, V29B, P568, DOI 10.1016/j.jhsb.2004.05.005; De Kesel R, 2008, OCCUP MED-OXFORD, V58, P187, DOI 10.1093/occmed/kqn034; Gelfman R, 2009, NEUROLOGY, V72, P33, DOI 10.1212/01.wnl.0000338533.88960.b9; Gimeno D, 2005, OCCUP ENVIRON MED, V62, DOI 10.1136/oem.2004.016931; Grovle L, 2012, J CLIN EPIDEMIOL, V65, P212, DOI 10.1016/j.jclinepi.2011.05.009; Katz JN, 2005, AM J IND MED, V47, P120, DOI 10.1002/ajim.20127; Parot-Schinkel E, 2011, ARCH PHYS MED REHAB, V92, P1863, DOI 10.1016/j.apmr.2011.06.001; Ratzon N, 2006, OCCUP MED-OXFORD, V56, P46, DOI 10.1093/occmed/kqi194; Sanati KA, 2011, J OCCUP REHABIL, V21, P474, DOI 10.1007/s10926-011-9310-8	14	14	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0119795	10.1371/journal.pone.0119795	http://dx.doi.org/10.1371/journal.pone.0119795			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803841	gold, Green Published, Green Submitted			2022-12-26	WOS:000353889600046
J	Iglesias, JM; Cairney, CJ; Ferrier, RK; McDonald, L; Soady, K; Kendrick, H; Pringle, MA; Morgan, RO; Martin, F; Smalley, MJ; Blyth, K; Stein, T				Iglesias, Juan Manuel; Cairney, Claire J.; Ferrier, Roderick K.; McDonald, Laura; Soady, Kelly; Kendrick, Howard; Pringle, Marie-Anne; Morgan, Reginald O.; Martin, Finian; Smalley, Matthew J.; Blyth, Karen; Stein, Torsten			Annexin A8 Identifies a Subpopulation of Transiently Quiescent c-Kit Positive Luminal Progenitor Cells of the Ductal Mammary Epithelium	PLOS ONE			English	Article							TRANSCRIPTOME ANALYSIS; NUCLEAR-LOCALIZATION; GLAND DEVELOPMENT; BINDING PROTEINS; DOWN-REGULATION; VIII GENE; CYCLIN-E; EXPRESSION; GROWTH; INVOLUTION	We have previously shown that Annexin A8 (ANXA8) is strongly associated with the basal-like subgroup of breast cancers, including BRCA1-associated breast cancers, and poor prognosis; while in the mouse mammary gland AnxA8 mRNA is expressed in low-proliferative isolated pubertal mouse mammary ductal epithelium and after enforced involution, but not in isolated highly proliferative terminal end buds (TEB) or during pregnancy. To better understand ANXA8's association with this breast cancer subgroup we established ANXA8's cellular distribution in the mammary gland and ANXA8's effect on cell proliferation. We show that ANXA8 expression in the mouse mammary gland was strong during pre-puberty before the expansion of the rudimentary ductal network and was limited to a distinct subpopulation of ductal luminal epithelial cells but was not detected in TEB or in alveoli during pregnancy. Similarly, during late involution its expression was found in the surviving ductal epithelium, but not in the apoptotic alveoli. Double-immunofluorescence (IF) showed that ANXA8 positive (+ve) cells were ER-alpha negative (-ve) and mostly quiescent, as defined by lack of Ki67 expression during puberty and mid-pregnancy, but not terminally differentiated with similar to 15% of ANXA8 +ve cells re-entering the cell cycle at the start of pregnancy (day 4.5). RT-PCR on RNA from FACS-sorted cells and double-IF showed that ANXA8+ve cells were a subpopulation of c-kit +ve luminal progenitor cells, which have recently been identified as the cells of origin of basal-like breast cancers. Over expression of ANXA8 in the mammary epithelial cell line Kim-2 led to a G(0)/G(1) arrest and suppressed Ki67 expression, indicating cell cycle exit. Our data therefore identify ANXA8 as a potential mediator of quiescence in the normal mouse mammary ductal epithelium, while its expression in basallike breast cancers may be linked to ANXA8' s association with their specific cells of origin.	[Iglesias, Juan Manuel; Cairney, Claire J.; Ferrier, Roderick K.; Pringle, Marie-Anne; Stein, Torsten] Univ Glasgow, Coll Med Vet & Life Sci, Inst Canc Sci, Glasgow, Lanark, Scotland; [Iglesias, Juan Manuel] Synpr Ltd, Edinburgh, Midlothian, Scotland; [McDonald, Laura; Blyth, Karen] CRUK Beatson Inst, Glasgow, Lanark, Scotland; [Soady, Kelly] Univ Oxford, Weatherall Inst Mol Med, Mol Haematol Unit, Med Res Council, Oxford, England; [Kendrick, Howard; Smalley, Matthew J.] Cardiff Univ, Cardiff Sch Biosci, European Canc Stem Cell Res Inst, Cardiff CF10 3AX, S Glam, Wales; [Pringle, Marie-Anne] Univ Glasgow, Inst Mol Cell & Syst Biol, Glasgow, Lanark, Scotland; [Morgan, Reginald O.] Univ Oviedo, Dept Biochem & Mol Biol, Oviedo, Spain; [Morgan, Reginald O.] Univ Oviedo, Inst Biotechnol Asturias IUBA, Oviedo, Spain; [Martin, Finian] Univ Coll Dublin, Conway Inst, Dublin 2, Ireland; [Martin, Finian] Univ Coll Dublin, Sch Biomol & Biomed Sci, Dublin 2, Ireland	University of Glasgow; Beatson Institute; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Oxford; Cardiff University; University of Glasgow; University of Oviedo; University of Oviedo; University College Dublin; University College Dublin	Stein, T (corresponding author), Univ Glasgow, Coll Med Vet & Life Sci, Inst Canc Sci, Glasgow, Lanark, Scotland.	Torsten.Stein@glasgow.ac.uk	Smalley, Matthew J/M-7000-2015; Morgan, Reginald O./Q-6447-2019; Stein, Torsten/G-1147-2012	Smalley, Matthew J/0000-0001-9540-1146; Blyth, Karen/0000-0002-9304-439X; Morgan, Reginald O./0000-0002-2059-792X; PRINGLE, MARIE ANNE/0000-0002-1358-4610; Cairney, Claire/0000-0001-6531-245X; Stein, Torsten/0000-0002-9946-1549	Breakthrough Breast Cancer grant [BGU05/06]; Breast Cancer Campaign grant [2012NovPR006]; Ministerio de Ciencia e Innovacion, Spain [BFU2007-67876]; FEDER; Synpromics Ltd.; Cancer Research UK [22311, 15938] Funding Source: researchfish; Breast Cancer Campaign [2012NovPR006] Funding Source: researchfish	Breakthrough Breast Cancer grant; Breast Cancer Campaign grant; Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); FEDER(European Commission); Synpromics Ltd.; Cancer Research UK(Cancer Research UK); Breast Cancer Campaign	The work was funded by a Breakthrough Breast Cancer grant (BGU05/06) and Breast Cancer Campaign grant (2012NovPR006) to TS. ROM was funded by grant BFU2007-67876 from the Ministerio de Ciencia e Innovacion, Spain, and co-financed by FEDER. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Synpromics Ltd. provided support in the form of a salary for author JMI but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Adachi K, 2004, ONCOGENE, V23, P7791, DOI 10.1038/sj.onc.1208067; Alldridge LC, 2003, EXP CELL RES, V290, P93, DOI 10.1016/S0014-4827(03)00310-0; Ang EZF, 2009, MOL CANCER RES, V7, P266, DOI 10.1158/1541-7786.MCR-08-0147; Bohn OL, 2010, INT J CLIN EXP PATHO, V3, P600; Bornkamm GW, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni137; Bostrom Pia, 2009, BMC Res Notes, V2, P140, DOI 10.1186/1756-0500-2-140; CHANG KS, 1992, BLOOD, V79, P1802; Chao A, 2006, INT J CANCER, V119, P91, DOI 10.1002/ijc.21813; Chiang YP, 1999, MOL CELL BIOCHEM, V199, P139, DOI 10.1023/A:1006942128672; Clarkson RWE, 2004, BREAST CANCER RES, V6, pR92, DOI 10.1186/bcr754; Cruz AC, 2004, J BIOL CHEM, V279, P5612, DOI 10.1074/jbc.M312323200; de Graauw M, 2010, P NATL ACAD SCI USA, V107, P6340, DOI 10.1073/pnas.0913360107; Fatimathas L, 2010, HISTOL HISTOPATHOL, V25, P527, DOI 10.14670/HH-25.527; Goebeler V, 2006, FEBS LETT, V580, P2430, DOI 10.1016/j.febslet.2006.03.076; Goebeler V, 2008, MOL BIOL CELL, V19, P5267, DOI 10.1091/mbc.E08-04-0383; Gonzalo DH, 2013, J PATHOL, V230, P420, DOI 10.1002/path.4200; Gordon KE, 2000, BREAST CANCER RES, V2, P222, DOI 10.1186/bcr57; HAUPTMANN R, 1989, EUR J BIOCHEM, V185, P63, DOI 10.1111/j.1432-1033.1989.tb15082.x; Hayes MJ, 2006, EMBO J, V25, P1816, DOI 10.1038/sj.emboj.7601078; Hayes MJ, 2009, J BIOL CHEM, V284, P10202, DOI 10.1074/jbc.M807043200; Hayes MJ, 2004, TRAFFIC, V5, P571, DOI 10.1111/j.1600-0854.2004.00210.x; HU ZB, 1993, LEUKEMIA RES, V17, P949, DOI 10.1016/0145-2126(93)90042-J; Humphreys RC, 1996, DEVELOPMENT, V122, P4013; Humphreys RC, 1999, J MAMMARY GLAND BIOL, V4, P213, DOI 10.1023/A:1018733426625; Inokuchi J, 2009, INT J CANCER, V124, P68, DOI 10.1002/ijc.23928; Jaeger J, 2007, CLIN CANCER RES, V13, P806, DOI 10.1158/1078-0432.CCR-06-1820; Karanjawala ZE, 2008, AM J SURG PATHOL, V32, P188, DOI 10.1097/PAS.0b013e31815701f3; Kawaguchi N, 2007, J CELL SCI, V120, P943, DOI 10.1242/jcs.03403; Kendrick H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-591; Lee MJ, 2009, GASTROENTEROLOGY, V137, P1138, DOI 10.1053/j.gastro.2009.04.015; Lim E, 2009, NAT MED, V15, P907, DOI 10.1038/nm.2000; Lin CY, 2008, J SURG ONCOL, V97, P544, DOI 10.1002/jso.20992; LIU JH, 1994, LEUKEMIA LYMPHOMA, V13, P381, DOI 10.3109/10428199409049626; Liu J, 2007, MOL CELL BIOCHEM, V303, P211, DOI 10.1007/s11010-007-9477-7; Ma YH, 2002, ARCH BIOCHEM BIOPHYS, V399, P212, DOI 10.1006/abbi.2002.2761; McBryan J, 2007, ONCOGENE, V26, P6406, DOI 10.1038/sj.onc.1210468; Molyneux G, 2010, CELL STEM CELL, V7, P403, DOI 10.1016/j.stem.2010.07.010; Monastyrskaya K, 2009, J BIOL CHEM, V284, P17227, DOI 10.1074/jbc.M109.004457; Morgan RO, 2006, BBA-MOL CELL RES, V1763, P1238, DOI 10.1016/j.bbamcr.2006.09.028; Morgan RO, 2004, BBA-MOL CELL RES, V1742, P133, DOI 10.1016/j.bbamcr.2004.09.010; Moss SE, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-4-219; Nakayama H, 2012, MOL BIOL CELL; Osada M, 2006, BIOCHEM BIOPH RES CO, V339, P1120, DOI 10.1016/j.bbrc.2005.11.118; Payton JE, 2009, J CLIN INVEST, V119, P1714, DOI 10.1172/JCI38248; Pece S, 2010, CELL, V140, P62, DOI 10.1016/j.cell.2009.12.007; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Piestun D, 2006, BIOCHEM BIOPH RES CO, V343, P279, DOI 10.1016/j.bbrc.2006.02.152; Poeter M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4738; Raynal P, 1997, BIOCHEM J, V322, P365, DOI 10.1042/bj3220365; Regan JL, 2012, ONCOGENE, V31, P869, DOI 10.1038/onc.2011.289; Rescher U, 2004, J CELL SCI, V117, P2631, DOI 10.1242/jcs.01245; Rick M, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-25; Runkel F, 2006, J MOL HISTOL, V37, P353, DOI 10.1007/s10735-006-9063-4; SARKAR A, 1994, BLOOD, V84, P279; SCHLAEPFER DD, 1990, J CELL BIOL, V111, P229, DOI 10.1083/jcb.111.1.229; Sgambato A, 1996, CANCER RES, V56, P1389; Sgambato A, 1997, CELL GROWTH DIFFER, V8, P393; Singhal S, 2003, CLIN CANCER RES, V9, P3080; Smalley MJ, 2010, METHODS MOL BIOL, V633, P139, DOI 10.1007/978-1-59745-019-5_11; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Stein T, 2005, CLIN CANCER RES, V11, P6872, DOI 10.1158/1078-0432.CCR-05-0547; Stein T, 2004, BREAST CANCER RES, V6, pR75, DOI 10.1186/bcr753; Stein T, 2007, J MAMMARY GLAND BIOL, V12, P25, DOI 10.1007/s10911-007-9035-7; THEOBALD J, 1994, BBA-MOL CELL RES, V1223, P383, DOI 10.1016/0167-4889(94)90099-X; Tomas A, 2004, J CELL BIOL, V165, P813, DOI 10.1083/jcb.200311054; Uddin M, 2015, GENET MED, V17, P747, DOI 10.1038/gim.2014.178; Wang S, 2006, ONCOGENE, V25, P3346, DOI 10.1038/sj.onc.1209357; Wansbury O, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2928; White AH, 2002, J BONE MINER RES, V17, P1851, DOI 10.1359/jbmr.2002.17.10.1851	69	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0119718	10.1371/journal.pone.0119718	http://dx.doi.org/10.1371/journal.pone.0119718			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803307	Green Published, Green Accepted, gold			2022-12-26	WOS:000353889600042
J	Luo, JF; Wu, B; Zhao, QH; Guo, QH; Meng, HJ; Yu, LR; Zheng, L; Hong, Z; Ding, D				Luo, Jianfeng; Wu, Bei; Zhao, Qianhua; Guo, Qihao; Meng, Haijiao; Yu, Lirong; Zheng, Li; Hong, Zhen; Ding, Ding			Association between Tooth Loss and Cognitive Function among 3063 Chinese Older Adults: A Community-Based Study	PLOS ONE			English	Article							REPORTED ORAL-HEALTH; C-REACTIVE PROTEIN; DENTAL-HEALTH; PERIODONTAL INFECTIONS; ALZHEIMERS-DISEASE; PROSPECTIVE COHORT; BRAIN-ABSCESS; DEMENTIA; IMPAIRMENT; PREVALENCE	Background Oral health has been found to be associated with cognitive function in basic research and epidemiology studies. Most of these studies had no comprehensive clinical diagnosis on cognitive function. This study firstly reported the association between tooth loss and cognitive function among Chinese older population. Methods The study included 3,063 community dwelling older adults aged 60 or above from the Shanghai Aging Study. Number of teeth missing was obtained from self-reporting questionnaire and confirmed by trained interviewers. Participants were diagnosed as "dementia", "mild cognitive impairment (MCI)", or "cognitive normal" by neurologists using DSM-IV and Petersen criteria. Multivariate logistic regression model was applied to examine the association between number of teeth missing and cognitive function. Results The study participants had an average of 10.2 teeth lost. Individuals with dementia lost 18.7 teeth on average, much higher than those with MCI (11.8) and cognitive normal (9.3) (p<0.001). After adjusted for sex, age, education year, living alone, body mass index, cigarette smoking, alcohol drinking, anxiety, depression, heart disease, hypertension, diabetes, and APOE-epsilon 4, tooth loss of > 16 were significantly associated with dementia with an OR of 1.56 (95%CI 1.12-2.18). Conclusion Having over 16 missing teeth was associated with severe cognitive impairment among Chinese older adults. Poor oral health might be considered as a related factor of neurodegenerative symptom among older Chinese population.	[Luo, Jianfeng] Fudan Univ, Sch Publ Hlth, Dept Hlth Stat & Social Med, Key Lab Publ Hlth Safety,Minist Educ, Shanghai 200433, Peoples R China; [Wu, Bei] Duke Univ, Sch Nursing, Durham, NC 27708 USA; [Wu, Bei] Duke Univ, Global Hlth Inst, Durham, NC USA; [Luo, Jianfeng; Zhao, Qianhua; Guo, Qihao; Meng, Haijiao; Yu, Lirong; Zheng, Li; Hong, Zhen; Ding, Ding] Fudan Univ, Huashan Hosp, WHO, Collaborating Ctr Res & Training Neurosci,Inst Ne, Shanghai 200433, Peoples R China; [Wu, Bei] Shanghai Univ, Sch Sociol & Polit Sci, Shanghai, Peoples R China	Fudan University; Duke University; Duke University; Fudan University; World Health Organization; Shanghai University	Wu, B (corresponding author), Duke Univ, Sch Nursing, Durham, NC 27708 USA.	bei.wu@duke.edu; dding99@yahoo.com	Luo, jian/HGE-7331-2022; Wu, Bei/X-2404-2019	Wu, Bei/0000-0002-6891-244X	Science & Technology Committee, Shanghai, China [09DZ1950400]	Science & Technology Committee, Shanghai, China	This work was supported by the Science & Technology Committee, Shanghai, China (09DZ1950400). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN WC, 1990, J PERIODONTOL, V61, P243, DOI 10.1902/jop.1990.61.4.243; Ando Y, 1997, J DENT HLTH, V47, P6; ANDREWS M, 1990, General Dentistry, V38, P224; Association AP, 1994, DIAGN STAT MAN MENT, V4th; Batty GD, 2013, EUR PSYCHIAT, V28, P49, DOI 10.1016/j.eurpsy.2011.07.005; Bretz WA, 2005, J AM GERIATR SOC, V53, P1532, DOI 10.1111/j.1532-5415.2005.53468.x; Chan KY, 2013, LANCET, V381, P2016, DOI 10.1016/S0140-6736(13)60221-4; Cheng Hong, 2009, Shanghai Kou Qiang Yi Xue, V18, P561; Ding D, 2015, ALZHEIMERS DEMENT, V11, P300, DOI 10.1016/j.jalz.2013.11.002; Ding D, 2014, NEUROEPIDEMIOLOGY, V43, P114, DOI 10.1159/000366163; DOUGLASS CW, 1991, J PUBLIC HEALTH DENT, V51, P220, DOI 10.1111/j.1752-7325.1991.tb02218.x; Dye BA, 2007, VITAL HLTH STAT, V2007, P1; EBERSOLE J L, 1990, Critical Reviews in Oral Biology and Medicine, V1, P283; Ebersole JL, 1997, CLIN EXP IMMUNOL, V107, P347, DOI 10.1111/j.1365-2249.1997.270-ce1162.x; Elter JR, 2004, J PERIODONTOL, V75, P782, DOI 10.1902/jop.2004.75.6.782; Gatz Margaret, 2006, Alzheimers Dement, V2, P110, DOI 10.1016/j.jalz.2006.01.002; Grabe HJ, 2009, J CLIN PERIODONTOL, V36, P550, DOI 10.1111/j.1600-051X.2009.01426.x; Hibberd CE, 2012, J CAN DENT ASSOC, V78; Kaye EK, 2010, J AM GERIATR SOC, V58, P713, DOI 10.1111/j.1532-5415.2010.02788.x; Kim JM, 2007, INT J GERIATR PSYCH, V22, P850, DOI 10.1002/gps.1750; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; Lexomboon D, 2012, J AM GERIATR SOC, V60, P1951, DOI 10.1111/j.1532-5415.2012.04154.x; Lim WS, 2007, CLIN MED RES, V5, P61, DOI 10.3121/cmr.2007.693; Loos BG, 2005, J PERIODONTOL, V76, P2106, DOI 10.1902/jop.2005.76.11-S.2106; Mayeux R, 2003, ARCH NEUROL-CHICAGO, V60, P161, DOI 10.1001/archneur.60.2.161; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Noack B, 2001, J PERIODONTOL, V72, P1221, DOI 10.1902/jop.2000.72.9.1221; Okamoto N, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-77; Paganini-Hill A, 2012, J AM GERIATR SOC, V60, P1556, DOI 10.1111/j.1532-5415.2012.04064.x; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Pitiphat W, 2002, J PUBLIC HEALTH DENT, V62, P122, DOI 10.1111/j.1752-7325.2002.tb03432.x; Reyes-Ortiz CA, 2013, COLOMB MEDICA, V44, P139; Riviere GR, 2002, ORAL MICROBIOL IMMUN, V17, P113, DOI 10.1046/j.0902-0055.2001.00100.x; SAAL CJ, 1988, J AM DENT ASSOC, V117, P453, DOI 10.1016/S0002-8177(88)73017-2; Saito Y, 2013, ANN GEN PSYCHIATR, V12, DOI 10.1186/1744-859X-12-20; Saxe SR, 1999, J AM DENT ASSOC, V130, P191, DOI 10.14219/jada.archive.1999.0168; Smirnov DA, 2009, NATURE, V459, P587, DOI 10.1038/nature07940; Stein PS, 2007, J AM DENT ASSOC, V138, P1314, DOI 10.14219/jada.archive.2007.0046; Stewart R, 2008, PSYCHOSOM MED, V70, P936, DOI 10.1097/PSY.0b013e3181870aec; Stewart R, 2007, J AM GERIATR SOC, V55, P1410, DOI 10.1111/j.1532-5415.2007.01298.x; Stewart R, 2013, J AM GERIATR SOC, V61, P177, DOI 10.1111/jgs.12094; Tucker KL, 2005, AM J CLIN NUTR, V82, P627; United Nations, 2007, WORLD POP PROSP 2006; World Health Organization, 2006, GLOB DAT BOD MASS IN; Wu B, 2007, AM J PUBLIC HEALTH, V97, P2216, DOI 10.2105/AJPH.2007.109934; Wu B, 2007, J PUBLIC HEALTH DENT, V67, P185, DOI 10.1111/j.1752-7325.2007.00038.x; Wu B, 2011, J AGING HEALTH, V23, P267, DOI 10.1177/0898264310382135; Yamamoto T, 2012, PSYCHOSOM MED, V74, P241, DOI 10.1097/PSY.0b013e318246dffb; Yang M Y, 2001, Shanghai Kou Qiang Yi Xue, V10, P263; Yu SB, 2012, CHINESE MED J-PEKING, V125, P4368, DOI 10.3760/cma.j.issn.0366-6999.2012.24.009; Zhang BS, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-74; ZHANG MY, 1990, ANN NEUROL, V27, P428, DOI 10.1002/ana.410270412; Zhang ZX, 2005, ARCH NEUROL-CHICAGO, V62, P447, DOI 10.1001/archneur.62.3.447; ZUNG WWK, 1971, PSYCHOSOMATICS, V12, P371	54	46	53	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0120986	10.1371/journal.pone.0120986	http://dx.doi.org/10.1371/journal.pone.0120986			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH2XV	25803052	Green Published, gold, Green Submitted			2022-12-26	WOS:000353889600111
J	Schmuch, J; Beckert, S; Brandt, S; Lohr, G; Hermann, F; Schmidt, TJ; Beikler, T; Hensel, A				Schmuch, Jana; Beckert, Sabine; Brandt, Simone; Loehr, Gesine; Hermann, Fabian; Schmidt, Thomas J.; Beikler, Thomas; Hensel, Andreas			Extract from Rumex acetosa L. for Prophylaxis of Periodontitis: Inhibition of Bacterial In Vitro Adhesion and of Gingipains of Porphyromonas gingivalis by Epicatechin-3-O-(4 beta -> 8)-Epicatechin-3-O-Gallate (Procyanidin-B2-Di-Gallate)	PLOS ONE			English	Article							HELICOBACTER-PYLORI; CYSTEINE PROTEINASE; ARG-GINGIPAIN; EPITHELIAL-CELLS; GROWTH; HOST; POLYSACCHARIDES; PURIFICATION; COMPONENTS; COMPLEXES	Background The aerial parts of Rumex acetosa L. have been used in traditional European medicine for inflammatory diseases of the mouth epithelial tissue. The following study aimed to investigate the influence of a proanthocyanidin-enriched extract from R. acetosa extract against the adhesion of Porphyromonas gingivalis (P. gingivalis), a pathogen strongly involved in chronic and aggressive periodontitis. A further goal was to define the bioactive lead structures responsible for a potential antiadhesive activity and to characterize the underlying molecular mechanisms of the antiadhesive effects. Methodology An extract of R. acetosa (RA1) with a defined mixture of flavan-3-ols, oligomeric proanthocyanidins and flavonoids, was used. Its impact on P. gingivalis adhesion to KB cells was studied by flow cytometry, confocal laser scanning microscopy and in situ adhesion assay using murine buccal tissue. RA1 and its compounds 1 to 15 were further investigated for additional effects on gingipain activity, hemagglutination and gene expression by RT-PCR. Principal Findings RA1 (5 to 15 mu g/mL) reduced P. gingivalis adhesion in a dose-dependent manner to about 90%. Galloylated proanthocyanidins were confirmed to be responsible for this antiadhesive effect with epicatechin-3-O-gallate-(4 beta,8)-epicatechin-3'-O-gallate (syn. procyanidin B2-di-gallate) being the lead compound. Ungalloylated flavan-3-ols and oligomeric proanthocyanidins were inactive. RA1 and the galloylated proanthocyanidins strongly interact with the bacterial virulence factor Arg-gingipain, while the corresponding Lys-gingipain was hardly influenced. RA1 inhibited also hemagglutination. In silico docking studies indicated that epicatechin-3-O-gallate-(4 beta,8)-epicatechin-3'-O-gallate interacts with the active side of Arg-gingipain and hemaglutinin from P. gingivalis; the galloylation of the molecule seems to be responsible for fixation of the ligand to the protein. In conclusion, the proanthocyanidin- enriched extract RA1 and its main active constituent procyanidin B2-di-gallate protect cells from P. gingivalis infection by inhibiting bacterial adhesion to the host cell. RA1 and procyanidin B2-di-gallate appear to be promising candidates for future cytoprotective preparations for oral mouth care products.	[Schmuch, Jana; Beckert, Sabine; Brandt, Simone; Loehr, Gesine; Hermann, Fabian; Schmidt, Thomas J.; Hensel, Andreas] Univ Munster, Inst Pharmaceut Biol & Phytochem, D-48149 Munster, Germany; [Beikler, Thomas] Univ Dusseldorf, Dept Operat Dent, Dusseldorf, Germany	University of Munster; Heinrich Heine University Dusseldorf	Hensel, A (corresponding author), Univ Munster, Inst Pharmaceut Biol & Phytochem, D-48149 Munster, Germany.	ahensel@uni-muenster.de	Schmidt, Thomas J/M-1678-2016	Schmidt, Thomas J/0000-0003-2634-9705	European Union (ZIEL2.NRW program) [w1006sb014, 300262502]; University of Munster; University of Dusseldorf	European Union (ZIEL2.NRW program); University of Munster; University of Dusseldorf	The present study was funded in part by the European Union (ZIEL2.NRW program) with fundings to AH (grant no. w1006sb014) and TB (grant no. 300262502). The remaining shares have been financed by intramural annual budgets of University of Munster to AH and from University of Dusseldorf to TB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano A, 2004, J PERIODONTAL RES, V39, P136, DOI 10.1111/j.1600-0765.2004.00719.x; Amano A, 2003, J PERIODONTOL, V74, P90, DOI 10.1902/jop.2003.74.1.90; Amano A, 2010, PERIODONTOL 2000, V52, P84, DOI 10.1111/j.1600-0757.2009.00309.x; Atanasova KR, 2014, MOL ORAL MICROBIOL, V29, P55, DOI 10.1111/omi.12047; Beikler T, 2004, J PERIODONTOL, V75, P169, DOI 10.1902/jop.2004.75.1.169; Beikler T, 2011, PERIODONTOL 2000, V55, P87, DOI 10.1111/j.1600-0757.2010.00360.x; Benakanakere M, 2012, FRONT ORAL BIOL, V15, P41, DOI 10.1159/000329670; Bicker J, 2009, FITOTERAPIA, V80, P483, DOI 10.1016/j.fitote.2009.08.015; Bodet C, 2007, EUR J ORAL SCI, V115, P64, DOI 10.1111/j.1600-0722.2007.00415.x; Bonifait L, 2011, J CAN DENT ASSOC, V76; Canon F, 2009, ANAL BIOANAL CHEM, V395, P2535, DOI 10.1007/s00216-009-3180-3; Chen T, 2001, INFECT IMMUN, V69, P3048, DOI 10.1128/IAI.69.5.3048-3056.2001; CHEN ZX, 1992, J BIOL CHEM, V267, P18896; Curtis MA, 2002, INFECT IMMUN, V70, P6968, DOI 10.1128/IAI.70.12.6968-6975.2002; Cutler Christopher W., 1995, Trends in Microbiology, V3, P45, DOI 10.1016/S0966-842X(00)88874-5; Darveau RP, 1997, PERIODONTOL 2000, V14, P12, DOI 10.1111/j.1600-0757.1997.tb00190.x; Derksen A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110089; Eichinger A, 1999, EMBO J, V18, P5453, DOI 10.1093/emboj/18.20.5453; Feghali K, 2012, J AGR FOOD CHEM, V60, P5728, DOI 10.1021/jf203304v; Feldman M, 2012, J APPL MICROBIOL, V113, P438, DOI 10.1111/j.1365-2672.2012.05329.x; Fitzpatrick RE, 2009, FUTURE MICROBIOL, V4, P471, DOI 10.2217/FMB.09.18; Ganuelas LA, 2013, EUR J MICROBIOL IMMU, V3, P152, DOI 10.1556/EuJMI.3.2013.3.2; Gescher K, 2011, ANTIVIR RES, V89, P9, DOI 10.1016/j.antiviral.2010.10.007; HAFFAJEE AD, 1991, J CLIN PERIODONTOL, V18, P744, DOI 10.1111/j.1600-051X.1991.tb00066.x; Hajishengallis G, 2012, NAT REV MICROBIOL, V10, P717, DOI 10.1038/nrmicro2873; Hajishengallis G, 2011, CELL HOST MICROBE, V10, P497, DOI 10.1016/j.chom.2011.10.006; Han YW, 2000, INFECT IMMUN, V68, P3140, DOI 10.1128/IAI.68.6.3140-3146.2000; HANAZAWA S, 1995, INFECT IMMUN, V63, P2374, DOI 10.1128/IAI.63.6.2374-2377.1995; Heitz-Mayfield LJA, 2002, J CLIN PERIODONTOL, V29, P92, DOI 10.1034/j.1600-051X.29.s3.5.x; Huard-Delcourt A, 1998, EUR J ORAL SCI, V106, P938, DOI 10.1046/j.0909-8836.1998.eos106506.x; International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use, 1994, ICH HARM TRIP GUID V; Kadowaki T, 2004, MOL PHARMACOL, V66, P1599, DOI 10.1124/mol.104.004366; Kadowaki T, 1998, J BIOL CHEM, V273, P29072, DOI 10.1074/jbc.273.44.29072; Keijser BJF, 2008, J DENT RES, V87, P1016, DOI 10.1177/154405910808701104; Kesavalu L, 2002, ORAL MICROBIOL IMMUN, V17, P177, DOI 10.1034/j.1399-302X.2002.170307.x; Koziel J, 2014, CURR RHEUMATOL REP, V16, DOI 10.1007/s11926-014-0408-9; Kushiyama M, 2009, J PERIODONTOL, V80, P372, DOI 10.1902/jop.2009.080510 ; Labrecque J, 2006, J ANTIMICROB CHEMOTH, V58, P439, DOI 10.1093/jac/dkl220; LANTZ MS, 1991, J BACTERIOL, V173, P4263, DOI 10.1128/JB.173.14.4263-4270.1991; Lee JH, 2006, CARBOHYD RES, V341, P1154, DOI 10.1016/j.carres.2006.03.032; Lengsfeld C, 2004, PLANTA MED, V70, P620, DOI 10.1055/s-2004-827184; Lengsfeld C, 2004, J AGR FOOD CHEM, V52, P1495, DOI 10.1021/jf030666n; Lohr G, 2011, J CLIN PERIODONTOL, V38, P457, DOI 10.1111/j.1600-051X.2010.01654.x; Machtei EE, 1997, J CLIN PERIODONTOL, V24, P102, DOI 10.1111/j.1600-051X.1997.tb00474.x; Mayeaux EJ, 2008, J LOW GENIT TRACT DI, V12, P185, DOI 10.1097/LGT.0b013e31815dd4b4; Messing J, 2014, MOLECULES, V19, P3696, DOI 10.3390/molecules19033696; Messing J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084836; Miyachi K, 2007, J DENT RES, V86, P446, DOI 10.1177/154405910708600511; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nakayama K, 1996, J BACTERIOL, V178, P2818, DOI 10.1128/jb.178.10.2818-2824.1996; Niehues M, 2010, MOL NUTR FOOD RES, V54, P1851, DOI 10.1002/mnfr.201000021; NILIUS AM, 1993, J DENT RES, V72, P1027, DOI 10.1177/00220345930720060601; OKUDA K, 1986, INFECT IMMUN, V54, P659, DOI 10.1128/IAI.54.3.659-665.1986; Palaska I, 2013, EUR J PHARMACOL, V720, P77, DOI 10.1016/j.ejphar.2013.10.047; Petrelli A, 2009, EXPERT OPIN PHARMACO, V10, P589, DOI [10.1517/14656560902781907, 10.1517/14656560902781907 ]; Pike RN, 1996, J BACTERIOL, V178, P2876, DOI 10.1128/jb.178.10.2876-2882.1996; Potempa Jan, 2007, Curr Protoc Protein Sci, VChapter 21, DOI 10.1002/0471140864.ps2120s49; Rescala B, 2010, J PERIODONTOL, V81, P1308, DOI 10.1902/jop.2010.090643; SCHROEDER DD, 1968, J BIOL CHEM, V243, P2943; Scragg MA, 2002, INFECT IMMUN, V70, P5740, DOI 10.1128/IAI.70.10.5740-5750.2002; SHAW ELLIOTT, 1965, BIOCHEMISTRY, V4, P2219, DOI 10.1021/bi00886a039; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; Teles R, 2013, PERIODONTOL 2000, V62, P95, DOI 10.1111/prd.12010; Travis J, 2000, BBA-PROTEIN STRUCT M, V1477, P35, DOI 10.1016/S0167-4838(99)00278-2; Umeda M, 1996, J PERIODONTOL, V67, P422, DOI 10.1902/jop.1996.67.4.422; Weinberg A, 1997, INFECT IMMUN, V65, P313, DOI 10.1128/IAI.65.1.313-316.1997; Wittschier N, 2007, J PHARM PHARMACOL, V59, P777, DOI 10.1211/jpp.59.6.0004; Wittschier N, 2009, J ETHNOPHARMACOL, V125, P218, DOI 10.1016/j.jep.2009.07.009; Yao ES, 1996, ORAL MICROBIOL IMMUN, V11, P35, DOI 10.1111/j.1399-302X.1996.tb00334.x; Yokoyama Kyosuke, 2007, J Oral Sci, V49, P201, DOI 10.2334/josnusd.49.201	70	20	23	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0120130	10.1371/journal.pone.0120130	http://dx.doi.org/10.1371/journal.pone.0120130			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803708	Green Submitted, Green Published, gold			2022-12-26	WOS:000353889600059
J	Zhang, JH; Jiang, KW; Lv, L; Wang, H; Shen, ZL; Gao, ZD; Wang, B; Yang, Y; Ye, YJ; Wang, S				Zhang, Jizhun; Jiang, Kewei; Lv, Liang; Wang, Hui; Shen, Zhanlong; Gao, Zhidong; Wang, Bo; Yang, Yang; Ye, Yingjiang; Wang, Shan			Use of Genome-Wide Association Studies for Cancer Research and Drug Repositioning	PLOS ONE			English	Article							CHROMATIN MARKS; RESOURCE; TARGETS; IDENTIFICATION; VARIANTS; GENETICS; DATABASE; CATALOG; TRAITS; GWAS	Although genome-wide association studies have identified many risk loci associated with colorectal cancer, the molecular basis of these associations are still unclear. We aimed to infer biological insights and highlight candidate genes of interest within GWAS risk loci. We used an in silico pipeline based on functional annotation, quantitative trait loci mapping of cis-acting gene, PubMed text-mining, protein-protein interaction studies, genetic overlaps with cancer somatic mutations and knockout mouse phenotypes, and functional enrichment analysis to prioritize the candidate genes at the colorectal cancer risk loci. Based on these analyses, we observed that these genes were the targets of approved therapies for colorectal cancer, and suggested that drugs approved for other indications may be repurposed for the treatment of colorectal cancer. This study highlights the use of publicly available data as a cost effective solution to derive biological insights, and provides an empirical evidence that the molecular basis of colorectal cancer can provide important leads for the discovery of new drugs.	[Zhang, Jizhun; Jiang, Kewei; Lv, Liang; Shen, Zhanlong; Gao, Zhidong; Wang, Bo; Yang, Yang; Ye, Yingjiang; Wang, Shan] Peking Univ, Peoples Hosp, Dept Surg Gastroenterol, Beijing 100044, Peoples R China; [Wang, Hui] Peking Univ, Peoples Hosp, Dept Clin Lab, Beijing 100044, Peoples R China	Peking University; Peking University	Ye, YJ (corresponding author), Peking Univ, Peoples Hosp, Dept Surg Gastroenterol, Beijing 100044, Peoples R China.	yeyingjiang2007@gmail.com; wangshan1953@163.com		Gao, Zhidong/0000-0002-8415-7587	National Key Technology Support Program [2104000032]; National Natural Science Foundation of China [81372290, 81372291]	National Key Technology Support Program(National Key Technology R&D Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Key Technology Support Program (Grant number: 2104000032), National Natural Science Foundation of China (Item number: 81372290) and National Natural Science Foundation of China (Item number: 81372291).	Benson AB, 2014, J NATL COMPR CANC NE, V12, P1028, DOI 10.6004/jnccn.2014.0099; Brown CD, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003649; Cao C, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-S4-S5; Cheung VG, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000480; Closa A, 2014, CARCINOGENESIS, V35, P2039, DOI 10.1093/carcin/bgu092; Cookson W, 2009, NAT REV GENET, V10, P184, DOI 10.1038/nrg2537; Cowley MJ, 2012, NUCLEIC ACIDS RES, V40, pD862, DOI 10.1093/nar/gkr967; Csermely P, 2013, PHARMACOL THERAPEUT, V138, P333, DOI 10.1016/j.pharmthera.2013.01.016; Edwards SL, 2013, AM J HUM GENET, V93, P779, DOI 10.1016/j.ajhg.2013.10.012; Eppig JT, 2012, NUCLEIC ACIDS RES, V40, pD881, DOI 10.1093/nar/gkr974; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Hiersche M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071775; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Liu X, 2011, EXPERT OPIN THER TAR, V15, P903, DOI 10.1517/14728222.2011.586635; Okada Y, 2014, NATURE, V506, P376, DOI 10.1038/nature12873; Raychaudhuri S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000534; Rossin EJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001273; Sanseau P, 2012, NAT BIOTECHNOL, V30, P317, DOI 10.1038/nbt.2151; Trynka G, 2013, CURR OPIN GENET DEV, V23, P635, DOI 10.1016/j.gde.2013.10.009; Trynka G, 2013, NAT GENET, V45, P124, DOI 10.1038/ng.2504; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang ZY, 2013, NAT BIOTECHNOL, V31, P1080, DOI 10.1038/nbt.2758; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pD901, DOI 10.1093/nar/gkm958	25	15	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0116477	10.1371/journal.pone.0116477	http://dx.doi.org/10.1371/journal.pone.0116477			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803826	Green Submitted, Green Published, gold			2022-12-26	WOS:000353889600004
J	Baeza, JA; Hemphill, CA; Ritson-Williams, R				Baeza, J. Antonio; Hemphill, Carrie A.; Ritson-Williams, Raphael			The Sexual and Mating System of the Shrimp Odontonia katoi (Palaemonidae, Pontoniinae), a Symbiotic Guest of the Ascidian Polycarpa aurata in the Coral Triangle	PLOS ONE			English	Article							PROTANDRIC SIMULTANEOUS HERMAPHRODITISM; SOCIAL MONOGAMY; SEA-ANEMONE; INACHUS-PHALANGIUM; SNAPPING SHRIMP; LIFE-HISTORY; PINNA-CARNEA; DECAPODA; LYSMATA; CRAB	Theory predicts that monogamy is adaptive in symbiotic crustaceans inhabiting relatively small and morphologically simple hosts in tropical environments where predation risk away from hosts is high. We tested this prediction in the shrimp Odontonia katoi, which inhabits the atrial chamber of the ascidian Polycarpa aurata in the Coral Triangle. Preliminary observations in O. katoi indicated that males were smaller than females, which is suggestive of sex change (protandry) in some symbiotic organisms. Thus, we first investigated the sexual system of O. katoi to determine if this shrimp was sequentially hermaphroditic. Morphological identification and size frequency distributions indicated that the population comprised males that, on average, were smaller than females. Gonad dissections demonstrated the absence of transitional individuals. Thus, O. katoi is a gonochoric species with reverse sexual dimorphism. The population distribution of O. katoi in its ascidian host did not differ significantly from a random distribution and shrimps inhabiting the same host individual as pairs were found with a frequency similar to that expected by chance alone. This is in contrast to that reported for other socially monogamous crustaceans in which pairs of heterosexual conspecifics are found in host individuals more frequently than expected by chance alone. Thus, the available information argues against monogamy in O. katoi. Furthermore, that a high frequency of solitary females were found brooding embryos and that the sex ratio was skewed toward females suggests that males might be roaming among hosts in search of receptive females in O. katoi. Symbiotic crustaceans can be used as a model system to understand the adaptive value of sexual and mating systems inmarine invertebrates.	[Baeza, J. Antonio; Hemphill, Carrie A.] Clemson Univ, Dept Biol Sci, Clemson, SC 29634 USA; [Baeza, J. Antonio] Smithsonian Inst, Smithsonian Marine Stn Ft Pierce, Ft Pierce, FL USA; [Baeza, J. Antonio] Univ Catolica Norte, Dept Biol Marina, Coquimbo, Chile; [Ritson-Williams, Raphael] Univ Hawaii Manoa, Hawaii Inst Marine Biol, Honolulu, HI 96822 USA	Clemson University; Smithsonian Institution; Smithsonian National Museum of Natural History; Universidad Catolica del Norte; University of Hawaii System; University of Hawaii Manoa	Baeza, JA (corresponding author), Clemson Univ, Dept Biol Sci, Clemson, SC 29634 USA.	baeza.antonio@gmail.com		Baeza, Juan Antonio/0000-0002-2573-6773	National Geographic Explorers Grant [8580-08]	National Geographic Explorers Grant(National Geographic Society)	This work was supported by the National Geographic Explorers Grant Number 8580-08 (JAB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS J, 1985, CRUSTACEANA, V48, P188, DOI 10.1163/156854085X00882; Baeza JA, 2011, INVERTEBR BIOL, V130, P351, DOI 10.1111/j.1744-7410.2011.00244.x; Baeza JA, 2011, J EXP MAR BIOL ECOL, V407, P41, DOI 10.1016/j.jembe.2011.07.011; Baeza JA, 2010, INVERTEBR BIOL, V129, P266, DOI 10.1111/j.1744-7410.2010.00200.x; Baeza JA, 2010, NATURWISSENSCHAFTEN, V97, P729, DOI 10.1007/s00114-010-0689-4; Aucoin S, 2010, SYMBIOSIS, V50, P135, DOI 10.1007/s13199-010-0050-x; Baeza JA, 2013, J ZOOL, V289, P172, DOI 10.1111/j.1469-7998.2012.00974.x; Baeza JA, 2010, BIOL BULL-US, V219, P151, DOI 10.1086/BBLv219n2p151; Baeza JA, 2008, MAR BIOL, V153, P387, DOI 10.1007/s00227-007-0815-9; Baeza JA, 2013, MOL PHYLOGENET EVOL, V69, P46, DOI 10.1016/j.ympev.2013.05.013; Baeza J. Antonio, 2009, Smithsonian Contributions to the Marine Sciences, P95; Baeza JA, 2000, J MAR BIOL ASSOC UK, V80, P639, DOI 10.1017/S0025315400002460; Baeza JA, 2003, MAR BIOL, V142, P93, DOI 10.1007/s00227-002-0927-1; Baeza JA, 2007, REPROD SOCIAL BEHAV, P245; Baeza JA, 2004, J MAR BIOL ASSOC UK, V81, P69; Baeza Juan A., 1999, Revista de Biologia Marina y Oceanografia, V34, P303; Barki A, 1997, AGGRESSIVE BEHAV, V23, P81; Bauer R. T., 2004, ANIM NAT HIST SER; BAUER RT, 1986, J CRUSTACEAN BIOL, V6, P313, DOI 10.2307/1548173; Bauer RT, 1998, MAR BIOL, V132, P223, DOI 10.1007/s002270050388; Bergstrom BI, 2000, ADV MAR BIOL, V38, P55, DOI 10.1016/S0065-2881(00)38003-8; Bracken Heather D., 2009, Crustacean Issues, V18, P281; Braga AA, 2009, J CRUSTACEAN BIOL, V29, P34, DOI 10.1651/08.3015.1; Bruce A. J., 2000, Beagle, V16, P91; CASTRO P, 1988, SYMBIOSIS, V5, P161; COURTNEY L A, 1981, Northeast Gulf Science, V5, P49; De Bary A., 1879, ERSCHEINUNG SYMBIOSE; De Bruyn C, 2010, MAR ECOL PROG SER, V398, P183, DOI 10.3354/meps08315; DIESEL R, 1986, ETHOLOGY, V72, P311; Duffy JE, 1998, B MAR SCI, V63, P387; ELLIOT JM, 1983, SOME METHODS STAT AN; Espinoza-Fuenzalida NL, 2008, MAR BIOL, V155, P623, DOI 10.1007/s00227-008-1059-z; Fiedler G. Curt, 1998, Pacific Science, V52, P161; Fransen CHJM, 2006, ZOOSYSTEMA, V28, P713; Fransen CHJM, 2002, ZOOLOGISCHE VERHANDE, V336, P1, DOI DOI 10.1163/156854008784513483; Gavio MA, 2006, J CRUSTACEAN BIOL, V26, P295, DOI 10.1651/C-2619.1; Hartnoll R.G., 1982, P111; HARTNOLL RG, 1978, CRUSTACEANA, V34, P281, DOI 10.1163/156854078X00844; Hipeau-Jacquotte R, 1973, TETHYS S, V5, P95; Hufnagl M, 2010, MAR BIOL, V157, P2097, DOI 10.1007/s00227-010-1477-6; Jensen GC, 2011, CRUSTACEANA, V84, P1181, DOI 10.1163/156854011X587487; KNOWLTON N, 1980, EVOLUTION, V34, P161, DOI 10.1111/j.1558-5646.1980.tb04802.x; KNOWLTON N, 1983, B MAR SCI, V33, P353; Li CP, 2011, ZOOL ANZ, V250, P270, DOI 10.1016/j.jcz.2011.04.003; Morrison CL, 2004, MOL PHYLOGENET EVOL, V30, P563, DOI 10.1016/S1055-7903(03)00252-5; NAKASHIMA Y, 1987, J ETHOL, V5, P145, DOI 10.1007/BF02349947; NIZINSKI MS, 1989, B MAR SCI, V45, P174; OMORI K, 1994, J CRUSTACEAN BIOL, V14, P132, DOI 10.2307/1549060; Onaga H, 2012, J CRUSTACEAN BIOL, V32, P383, DOI 10.1163/193724012X626520; Rahman N, 2003, ETHOLOGY, V109, P457, DOI 10.1046/j.1439-0310.2003.00885.x; Rahman N, 2002, BEHAVIOUR, V139, P1443, DOI 10.1163/15685390260514717; RANDALL JOHN E., 1967, STUD TROP OCEANOGR INST MAR SCI UNIV MIAMI, V5, P665; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Ross D.M., 1983, P163; SAS, 2004, SAS STAT SOFTW; Schatte J, 2006, HELGOLAND MAR RES, V60, P70, DOI 10.1007/s10152-005-0013-4; SHUSTER SM, 2003, MG BEH ECOL, pR7; Smith DC, 1987, BIOL SYMBIOSIS; Sokal R. R, 1981, BIOMETRY; Thiel M, 2003, J ZOOL, V261, P353, DOI 10.1017/S0952836903004333; Vermeij G.J., 1983, P311; WELLS HARRY W., 1961, BULL MAR SCI GULF AND CARIBBEAN, V11, P267; WICKLER W, 1981, Z TIERPSYCHOL, V57, P215; WIRTZ P, 1983, Z TIERPSYCHOL, V62, P209	64	20	21	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121120	10.1371/journal.pone.0121120	http://dx.doi.org/10.1371/journal.pone.0121120			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799577	Green Submitted, Green Published, gold			2022-12-26	WOS:000351987300212
J	Carvalho, CG; Silveira, RD; Neto, EC; Procianoy, RS				Carvalho, Clarissa Gutierrez; Silveira, Rita de Cassia; Camargo Neto, Eurico; Procianoy, Renato Soibelmann			Plasma Cytokine Levels Fall in Preterm Newborn Infants on Nasal CPAP with Early Respiratory Distress	PLOS ONE			English	Article							IMMEDIATE POSTNATAL-PERIOD; POSITIVE AIRWAY PRESSURE; C-REACTIVE PROTEIN; EXPIRATORY PRESSURE; LUNG INJURY; INFLAMMATION; BIRTH; INTERLEUKIN-6; FLUID; VENTILATION	Introduction Early nCPAP seems to prevent ventilator-induced lung injury in humans, although the pathophysiological mechanisms underlying this beneficial effect have not been clarified yet. Objective To evaluate plasma levels IL-1 beta, IL-6, IL-8, IL-10, and TNF-alpha immediately before the start of nCPAP and 2 hours later in preterm infants. Methods Prospective cohort including preterm infants with 28 to 35 weeks gestational age with moderate respiratory distress requiring nCPAP. Extreme preemies, newborns with malformations, congenital infections, sepsis, surfactant treatment, and receiving ventilatory support in the delivery room were excluded. Blood samples were collected right before and 2 hours after the start of nCPAP. Results 23 preterm infants (birth weight 1851 +/- 403 grams; GA 32.3 +/- 1.7 weeks) were treated with nCPAP. IL-1 beta, IL-10, TNF-alpha levels were similar, IL-8 levels were reduced in 18/23 preterm infants and a significant decrease in IL-6 levels was observed after 2 hours of nCPAP. All newborns whosemothers received antenatal steroids had lower cytokine levels at the onset of nCPAP than those whosemothers didn't receive it; this effect was not sustained after 2 hours of nCPAP. Conclusion Early use nCPAP is not associated with rising of plasma pro-inflammatory cytokines and it seems to be a less harmful respiratory strategy for preterm with moderate respiratory distress.	[Procianoy, Renato Soibelmann] Univ Fed Rio Grande do Sul, Dept Pediat, Porto Alegre, RS, Brazil; Hosp Clin Porto Alegre, Newborn Sect, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul	Procianoy, RS (corresponding author), Univ Fed Rio Grande do Sul, Dept Pediat, Porto Alegre, RS, Brazil.	rprocianoy@gmail.com	CG, Carvalho/V-9991-2019; Carvalho, Clarissa Gutierrez/HCG-9064-2022; Procianoy, Renato/I-5133-2014	Procianoy, Renato/0000-0001-8297-4164; SILVEIRA, RITA DE CASSIA/0000-0002-2982-2652	Pro-Reitoria de Pos Graduacao da Universidade Federal do Rio Grande do Sul and Fundo de Pesquisa do Hospital de Clinicas de Porto Alegre	Pro-Reitoria de Pos Graduacao da Universidade Federal do Rio Grande do Sul and Fundo de Pesquisa do Hospital de Clinicas de Porto Alegre	The study was supported by the authors' institutional research grants: Pro-Reitoria de Pos Graduacao da Universidade Federal do Rio Grande do Sul and Fundo de Pesquisa do Hospital de Clinicas de Porto Alegre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beresford MW, 2002, PEDIATR RES, V52, P973, DOI 10.1203/01.PDR.0000036626.67304.65; Bohrer B, 2010, J PEDIATR-US, V156, P16, DOI 10.1016/j.jpeds.2009.07.027; Caldas JPS, 2012, J PEDIAT-BRAZIL, V88, P61, DOI 10.2223/JPED.2158; Chiesa C, 2003, CLIN CHEM, V49, P60, DOI 10.1373/49.1.60; Chiesa C, 2001, CLIN CHEM, V47, P1016; Dembinski J, 2003, CYTOKINE, V21, P200, DOI 10.1016/S1043-4666(02)00498-2; DREYFUSS D, 1988, AM REV RESPIR DIS, V137, P1159, DOI 10.1164/ajrccm/137.5.1159; Dudley DJ, 1997, J REPROD IMMUNOL, V33, P147, DOI 10.1016/S0165-0378(97)00020-X; Finer NN, 2010, NEW ENGL J MED, V362, P1970, DOI 10.1056/NEJMoa0911783; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Hillman NH, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-124; Hotoura E, 2012, INFLAMMATION, V35, P1094, DOI 10.1007/s10753-011-9416-3; Jobe AH, 2002, PEDIATR RES, V52, P387, DOI 10.1203/01.PDR.0000025341.25481.42; Jonsson B, 2000, ACTA PAEDIATR, V89, P1375, DOI 10.1080/080352500300002606; Lista G, 2006, PEDIATR PULM, V41, P357, DOI 10.1002/ppul.20363; Lista G, 2010, ARCH DIS CHILD-FETAL, V95, pF85, DOI 10.1136/adc.2009.169219; Lusyati Setyadewi, 2013, BMC Res Notes, V6, P547, DOI 10.1186/1756-0500-6-547; Marchini G, 2000, ACTA PAEDIATR, V89, P1082, DOI 10.1080/713794557; MARKOS J, 1993, J APPL PHYSIOL, V74, P2627, DOI 10.1152/jappl.1993.74.6.2627; Morley CJ, 2008, NEW ENGL J MED, V358, P700, DOI 10.1056/NEJMoa072788; Mulrooney N, 2005, AM J RESP CRIT CARE, V171, P488, DOI 10.1164/rccm.200406-774OC; Naik AS, 2001, AM J RESP CRIT CARE, V164, P494, DOI 10.1164/ajrccm.164.3.2010127; Polglase GR, 2009, PEDIATR RES, V65, P67, DOI 10.1203/PDR.0b013e318189487e; Procianoy Renato S., 2004, J. Pediatr. (Rio J.), V80, P407, DOI 10.2223/JPED.1226; Sandri F, 2010, PEDIATRICS, V125, pE1402, DOI 10.1542/peds.2009-2131; Wright CJ, 2011, PEDIATRICS, V128, P111, DOI 10.1542/peds.2010-3875; Yoon BH, 2000, AM J OBSTET GYNECOL, V183, P1124, DOI 10.1067/mob.2000.109035	27	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120486	10.1371/journal.pone.0120486	http://dx.doi.org/10.1371/journal.pone.0120486			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799377	Green Published, Green Submitted, gold			2022-12-26	WOS:000351987300149
J	Charney, ND; Kubel, JE; Eiseman, CS				Charney, Noah D.; Kubel, Jacob E.; Eiseman, Charles S.			Temporally Adaptive Sampling: A Case Study in Rare Species Survey Design with Marbled Salamanders (Ambystoma opacum)	PLOS ONE			English	Article							DECLINING AMPHIBIAN POPULATIONS; ESTIMATING SITE OCCUPANCY; INTERANNUAL VARIABILITY; NATURAL FLUCTUATIONS; HUMAN IMPACTS; LANDSCAPE; DYNAMICS; ECOLOGY; CONSERVATION; PERSISTENCE	Improving detection rates for elusive species with clumped distributions is often accomplished through adaptive sampling designs. This approach can be extended to include species with temporally variable detection probabilities. By concentrating survey effort in years when the focal species are most abundant or visible, overall detection rates can be improved. This requires either long-term monitoring at a few locations where the species are known to occur or models capable of predicting population trends using climatic and demographic data. For marbled salamanders (Ambystoma opacum) in Massachusetts, we demonstrate that annual variation in detection probability of larvae is regionally correlated. In our data, the difference in survey success between years was far more important than the difference among the three survey methods we employed: diurnal surveys, nocturnal surveys, and dipnet surveys. Based on these data, we simulate future surveys to locate unknown populations under a temporally adaptive sampling framework. In the simulations, when pond dynamics are correlated over the focal region, the temporally adaptive design improved mean survey success by as much as 26% over a non-adaptive sampling design. Employing a temporally adaptive strategy costs very little, is simple, and has the potential to substantially improve the efficient use of scarce conservation funds.	[Charney, Noah D.] Bryn Mawr Coll, Dept Biol, Bryn Mawr, PA 19010 USA; [Kubel, Jacob E.] Div Fisheries & Wildlife, Nat Heritage Endangered Species Program, Westborough, MA USA	Bryn Mawr College	Charney, ND (corresponding author), Bryn Mawr Coll, Dept Biol, Bryn Mawr, PA 19010 USA.	noah@alumni.amherst.edu	Eiseman, Charles/AAM-9224-2020	Eiseman, Charles/0000-0001-5496-9114	Natural Heritage and Endangered Species Program of the Massachusetts Division of Fisheries and Wildlife; National Science Foundation Graduate Research Fellowship Program; Switzer Environmental Fellowship Program	Natural Heritage and Endangered Species Program of the Massachusetts Division of Fisheries and Wildlife; National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF)); Switzer Environmental Fellowship Program	Funding for this research was provided by the Natural Heritage and Endangered Species Program of the Massachusetts Division of Fisheries and Wildlife (www.mass.gov), the National Science Foundation Graduate Research Fellowship Program (www.nsf.gov), and the Switzer Environmental Fellowship Program (www.switzernetwork.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey LL, 2007, ECOL APPL, V17, P281, DOI 10.1890/1051-0761(2007)017[0281:SDTIOS]2.0.CO;2; Bailey LL, 2004, J WILDLIFE MANAGE, V68, P14, DOI 10.2193/0022-541X(2004)068[0014:SATVID]2.0.CO;2; Bevelhimer MS, 2008, SOUTHEAST NAT, V7, P311, DOI 10.1656/1528-7092(2008)7[311:ASOLAC]2.0.CO;2; BROWN JH, 1990, OIKOS, V59, P290, DOI 10.2307/3545139; Buech Richard R., 2002, Herpetological Review, V33, P182; Buech Richard R., 2002, Herpetological Review, V33, P275; Charney ND, 2009, J WILDLIFE MANAGE, V73, P1245, DOI 10.2193/2008-096; Cyr H, 1997, OIKOS, V79, P549, DOI 10.2307/3546899; Field SA, 2005, J WILDLIFE MANAGE, V69, P473, DOI 10.2193/0022-541X(2005)069[0473:OAOMEU]2.0.CO;2; FRANCIS RICC, 1984, NEW ZEAL J MAR FRESH, V18, P59, DOI 10.1080/00288330.1984.9516030; Fraser EFC, 1993, P ROY SOC LOND B BIO, V252, P135; Fronzuto J, 2000, J HERPETOL, V34, P146, DOI 10.2307/1565252; Gamble LR, 2007, BIOL CONSERV, V139, P247, DOI 10.1016/j.biocon.2007.07.001; Gamble LR, 2006, WETLANDS, V26, P298, DOI 10.1672/0277-5212(2006)26[298:LORBZF]2.0.CO;2; Gamble LR, 2004, THESIS U MASSACHUUSE; Gillman MP, 1998, BOT J LINN SOC, V126, P65, DOI 10.1006/bojl.1997.0144; GOODSON NJ, 1991, J WILDLIFE MANAGE, V55, P214, DOI 10.2307/3809142; Greenberg CH, 2005, HERPETOLOGICA, V61, P20, DOI 10.1655/04-32; Gu WD, 2004, BIOL CONSERV, V116, P195, DOI 10.1016/S0006-3207(03)00190-3; HANSKI I, 1991, BIOL J LINN SOC, V42, P17, DOI 10.1111/j.1095-8312.1991.tb00549.x; Jenkins Christopher L., 2002, Herpetological Review, V33, P33; KELLY D, 1994, TRENDS ECOL EVOL, V9, P465, DOI 10.1016/0169-5347(94)90310-7; Mackenzie DI, 2005, J APPL ECOL, V42, P1105, DOI 10.1111/j.1365-2664.2005.01098.x; MacKenzie DI, 2005, ECOLOGY, V86, P1101, DOI 10.1890/04-1060; MacKenzie DI, 2003, ECOLOGY, V84, P2200, DOI 10.1890/02-3090; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Mazerolle MJ, 2005, ECOL APPL, V15, P824, DOI 10.1890/04-0502; Mehta SV, 2007, ECOL ECON, V61, P237, DOI 10.1016/j.ecolecon.2006.10.024; Paradis A, 2008, MITIG ADAPT STRAT GL, V13, P541, DOI 10.1007/s11027-007-9127-0; PECHMANN JHK, 1994, HERPETOLOGICA, V50, P65; PECHMANN JHK, 1991, SCIENCE, V253, P892, DOI 10.1126/science.253.5022.892; Pollock KH, 2002, ENVIRONMETRICS, V13, P105, DOI 10.1002/env.514; R Core Team, 2020, R LANG ENV STAT COMP; Royle JA, 2005, OIKOS, V110, P353, DOI 10.1111/j.0030-1299.2005.13534.x; Sakai S, 1999, AM J BOT, V86, P1414, DOI 10.2307/2656924; STEINHORST RK, 1989, BIOMETRICS, V45, P415, DOI 10.2307/2531486; Taylor BE, 2006, CONSERV BIOL, V20, P792, DOI 10.1111/j.1523-1739.2005.00321.x; Taylor BE, 1997, HERPETOLOGICA, V53, P132; Therneau T, 2009, SURVIVAL SURVIVAL AN; Thompson S.K., 1996, ADAPTIVE SAMPLING; THOMPSON SK, 1990, J AM STAT ASSOC, V85, P1050, DOI 10.2307/2289601; Thompson WL, 2004, SAMPLING RARE ELUSIV; Turk P, 2005, ENVIRON ECOL STAT, V12, P55, DOI 10.1007/s10651-005-6818-0; Van Buskirk J, 2005, ECOLOGY, V86, P1936, DOI 10.1890/04-1237; van Zwieten PAM, 2002, FISH RES, V54, P329, DOI 10.1016/S0165-7836(01)00267-3; Willson John D., 2004, Herpetological Review, V35, P148; Wing SR, 2003, ESTUAR COAST SHELF S, V57, P859, DOI 10.1016/S0272-7714(02)00416-X	47	3	3	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120714	10.1371/journal.pone.0120714	http://dx.doi.org/10.1371/journal.pone.0120714			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799224	Green Published, gold, Green Submitted			2022-12-26	WOS:000351987300167
J	Choi, SM; Choi, DK; Kim, TH; Jeong, BC; Il Seo, S; Jeon, SS; Lee, HM; Choi, HY; Jeon, HG				Choi, See Min; Choi, Don Kyoung; Kim, Tae Heon; Jeong, Byong Chang; Il Seo, Seong; Jeon, Seong Soo; Lee, Hyun Moo; Choi, Han-Yong; Jeon, Hwang Gyun			A Comparison of Radiologic Tumor Volume and Pathologic Tumor Volume in Renal Cell Carcinoma (RCC)	PLOS ONE			English	Article							PARTIAL NEPHRECTOMY; RADIOGRAPHIC SIZE; KIDNEY VOLUME; MASS; CT; DIFFERENTIATION; TREAT	Objective To investigate the difference between preoperative radiologic tumor volume (RTV) and postoperative pathologic tumor volume (PTV) in patients who received nephrectomy for renal cell carcinoma (RCC). Materials and Methods We reviewed 482 patients who underwent preoperative computed tomography (CT) within 4 weeks before radical or partial nephrectomy for renal cell carcinoma. RTV measured by a three dimensional rendering program was compared with PTV (pi/6xheightxlengthxwidth) measured in surgical specimen according to pathologic tumor size and histologic subtype. Correlation of the inter-quartile range (IQR) of the RTV and Fuhrman nuclear grade was also investigated. Results There was a significant positive linear correlation between RTV and PTV (p<0.001, r = 0.911), and the mean RTV and mean PTV were not significantly different (79.0 vs 76.9cm(3), p = 0.393). For pathologic tumor size (PTS) <4cm, the mean RTV was larger than the mean PTV (10.9 vs 7.1cm(3), p<0.001). For a PTS of 4-7cm, the mean RTV was larger than the mean PTV (56.0 vs 44.7cm(3), p<0.001). However, for a PTS >= 7cm, there was no statistical difference between RTV and PTV (p>0.05). Among patients with clear cell RCC, the mean RTV was significantly larger than the mean PTV (p = 0.042), not for non-clear cell group (p = 0.055). As the quartile of the RTV increased, the Fuhrman grade also increased (p<0.001). Conclusions RTV was correlated with PTV and pathologic grade. RTV was larger than the PTV for a tumor size 7 cm or less or in clear cell RCC. RTV may be useful to measure tumor burden preoperatively.	[Choi, See Min] Gyeongsang Natl Univ, Gyeongsang Natl Univ Hosp, Sch Med, Dept Urol, Jinju, South Korea; [Choi, Don Kyoung; Kim, Tae Heon; Jeong, Byong Chang; Il Seo, Seong; Jeon, Seong Soo; Lee, Hyun Moo; Choi, Han-Yong] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Urol, Seoul, South Korea; [Jeon, Hwang Gyun] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Samsung Biomed Res Inst,Dept Urol, Seoul, South Korea	Gyeongsang National University; Gyeongsang National University Hospital; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Jeon, HG (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Samsung Biomed Res Inst,Dept Urol, Seoul, South Korea.	hwanggyun.jeon@samsung.com	Choi, See Min/G-8227-2014	Choi, See Min/0000-0002-6599-2640	Samsung Biomedical Research Institute [SMR113101]	Samsung Biomedical Research Institute(Samsung)	This study was supported by Samsung Biomedical Research Institute grant [#SMR113101]. HGJ received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aertsen M, 2013, EUR RADIOL, V23, P280, DOI 10.1007/s00330-012-2582-3; Alasker A, 2013, CURR UROL REP, V14, P13, DOI 10.1007/s11934-012-0296-3; Alicioglu B, 2009, J BUON, V14, P235; Ates F, 2010, INT UROL NEPHROL, V42, P861, DOI 10.1007/s11255-010-9707-x; Choi JY, 2010, KOREAN J UROL, V51, P161, DOI 10.4111/kju.2010.51.3.161; Choi YA, 2013, RADIOLOGY, V266, P514, DOI 10.1148/radiol.12120110; Gong IH, 2012, J UROLOGY, V187, P344, DOI 10.1016/j.juro.2011.09.005; Herr HW, 2001, UROLOGY, V58, P157, DOI 10.1016/S0090-4295(01)01173-6; Jeffery NN, 2011, BMC UROL, V11, DOI 10.1186/1471-2490-11-2; Jeon HG, 2012, BJU INT, V109, P1468, DOI 10.1111/j.1464-410X.2011.10531.x; Jorns J, 2012, BJU INT, V110, P956, DOI 10.1111/j.1464-410X.2012.10937.x; Kathrins M, 2013, CURR OPIN UROL, V23, P389, DOI 10.1097/MOU.0b013e328363212b; Kim JK, 2002, AM J ROENTGENOL, V178, DOI 10.2214/ajr.178.6.1781499; Kurta JM, 2009, BJU INT, V103, P24, DOI 10.1111/j.1464-410X.2008.07941.x; Lam JS, 2005, CANCER-AM CANCER SOC, V103, P2517, DOI 10.1002/cncr.21127; Lee SE, 2010, WORLD J UROL, V28, P263, DOI 10.1007/s00345-010-0511-0; Levey AS, 2007, CLIN CHEM, V53, P766, DOI 10.1373/clinchem.2006.077180; Mucksavage P, 2011, BJU INT, V108, pE232, DOI 10.1111/j.1464-410X.2010.09977.x; Reiner CS, 2013, INVEST RADIOL, V48, P183, DOI 10.1097/RLI.0b013e31827c63a3; Schlomer B, 2006, UROLOGY, V68, P292, DOI 10.1016/j.urology.2006.03.004; Secil M, 2012, DIAGN INTERV RADIOL, V18, P480, DOI 10.4261/1305-3825.DIR.5346-11.1; Thiel DD, 2013, SCAND J UROL, V47, P472, DOI 10.3109/21681805.2013.814071; Zhang J, 2007, RADIOLOGY, V244, P494, DOI 10.1148/radiol.2442060927	23	24	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0122019	10.1371/journal.pone.0122019	http://dx.doi.org/10.1371/journal.pone.0122019			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799553	gold, Green Published, Green Submitted			2022-12-26	WOS:000351987300311
J	Doi, H; Uchii, K; Takahara, T; Matsuhashi, S; Yamanaka, H; Minamoto, T				Doi, Hideyuki; Uchii, Kimiko; Takahara, Teruhiko; Matsuhashi, Saeko; Yamanaka, Hiroki; Minamoto, Toshifumi			Use of Droplet Digital PCR for Estimation of Fish Abundance and Biomass in Environmental DNA Surveys	PLOS ONE			English	Article							REAL-TIME PCR; WATER SAMPLES; COPY NUMBER; QUANTIFICATION; BIODIVERSITY; QUANTITATION; EDNA	An environmental DNA (eDNA) analysis method has been recently developed to estimate the distribution of aquatic animals by quantifying the number of target DNA copies with quantitative real-time PCR (qPCR). A new quantitative PCR technology, droplet digital PCR (ddPCR), partitions PCR reactions into thousands of droplets and detects the amplification in each droplet, thereby allowing direct quantification of target DNA. We evaluated the quantification accuracy of qPCR and ddPCR to estimate species abundance and biomass by using eDNA in mesocosm experiments involving different numbers of common carp. We found that ddPCR quantified the concentration of carp eDNA along with carp abundance and biomass more accurately than qPCR, especially at low eDNA concentrations. In addition, errors in the analysis were smaller in ddPCR than in qPCR. Thus, ddPCR is better suited to measure eDNA concentration in water, and it provides more accurate results for the abundance and biomass of the target species than qPCR. We also found that the relationship between carp abundance and eDNA concentration was stronger than that between biomass and eDNA by using both ddPCR and qPCR; this suggests that abundance can be better estimated by the analysis of eDNA for species with fewer variations in body mass.	[Doi, Hideyuki; Uchii, Kimiko; Matsuhashi, Saeko] Hiroshima Univ, Inst Sustainable Sci & Dev, Higashihiroshima 724, Japan; [Uchii, Kimiko] Osaka Ohtani Univ, Fac Pharm, Tondabayashi, Japan; [Takahara, Teruhiko] Hiroshima Univ, Grad Sch Integrated Arts & Sci, Higashihiroshima 724, Japan; [Yamanaka, Hiroki] Ryukoku Univ, Fac Sci & Technol, Dept Environm Solut Technol, Otsu, Shiga 52021, Japan; [Minamoto, Toshifumi] Kobe Univ, Grad Sch Human Dev & Environm, Kobe, Hyogo 657, Japan	Hiroshima University; Hiroshima University; Ryukoku University; Kobe University	Doi, H (corresponding author), Hiroshima Univ, Inst Sustainable Sci & Dev, Higashihiroshima 724, Japan.	hideyuki.doi@icloud.com	Uchii, Kimiko/J-8236-2019; Minamoto, Toshifumi/C-6453-2009	Uchii, Kimiko/0000-0002-1375-3875; Minamoto, Toshifumi/0000-0002-5379-1622	Environment Research and Technology Development Fund of the Ministry of the Environment, Japan, JST-CREST [4RF-1302]; Industry-University Collaboration Grant for Young Scientists in Hiroshima University; Grants-in-Aid for Scientific Research [26881007] Funding Source: KAKEN	Environment Research and Technology Development Fund of the Ministry of the Environment, Japan, JST-CREST; Industry-University Collaboration Grant for Young Scientists in Hiroshima University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the Environment Research and Technology Development Fund (4RF-1302) of the Ministry of the Environment, Japan, JST-CREST. Additional funding was provided in part by the Industry-University Collaboration Grant for Young Scientists in Hiroshima University to Teruhiko Takahara. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, R LANG ENV STAT COMP; Barnes MA, 2014, ENVIRON SCI TECHNOL, V48, P1819, DOI 10.1021/es404734p; Dejean T, 2012, J APPL ECOL, V49, P953, DOI 10.1111/j.1365-2664.2012.02171.x; Eichmiller JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112611; Ficetola GF, 2008, BIOL LETTERS, V4, P423, DOI 10.1098/rsbl.2008.0118; Goldberg CS, 2013, FRESHW SCI, V32, P792, DOI 10.1899/13-046.1; Goldberg CS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022746; Hayden RT, 2013, J CLIN MICROBIOL, V51, P540, DOI 10.1128/JCM.02620-12; Hindson BJ, 2011, ANAL CHEM, V83, P8604, DOI 10.1021/ac202028g; Hindson CM, 2013, NAT METHODS, V10, P1003, DOI 10.1038/nmeth.2633; Hoshino T, 2012, SYST APPL MICROBIOL, V35, P390, DOI 10.1016/j.syapm.2012.06.006; Jane SF, 2015, MOL ECOL RESOUR, V15, P216, DOI 10.1111/1755-0998.12285; Kelly RP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086175; Kim TG, 2014, APPL MICROBIOL BIOT, V98, P6105, DOI 10.1007/s00253-014-5794-4; Machler E, 2014, FRESHW SCI, V33, P1174, DOI 10.1086/678128; Minamoto T, 2012, LIMNOLOGY, V13, P193, DOI 10.1007/s10201-011-0362-4; Miotke L, 2014, ANAL CHEM, V86, P2618, DOI 10.1021/ac403843j; Nathan LM, 2014, ENVIRON SCI TECHNOL, V48, P12800, DOI 10.1021/es5034052; Norton SE, 2013, CLIN BIOCHEM, V46, P1561, DOI 10.1016/j.clinbiochem.2013.06.002; Pilliod DS, 2013, CAN J FISH AQUAT SCI, V70, P1123, DOI 10.1139/cjfas-2013-0047; Strain MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055943; Taberlet P, 2012, MOL ECOL, V21, P2045, DOI 10.1111/j.1365-294X.2012.05470.x; Takahara T, 2015, BIOL CONSERV, V183, P64, DOI 10.1016/j.biocon.2014.11.014; Takahara T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056584; Takahara T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035868; Thomsen PF, 2015, BIOL CONSERV, V183, P4, DOI 10.1016/j.biocon.2014.11.019; Thomsen PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041732; Thomsen PF, 2012, MOL ECOL, V21, P2565, DOI 10.1111/j.1365-294X.2011.05418.x; Treguier A, 2014, J APPL ECOL, V51, P871, DOI 10.1111/1365-2664.12262; Turner CR, 2014, METHODS ECOL EVOL, V5, P676, DOI 10.1111/2041-210X.12206	30	140	153	7	176	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0122763	10.1371/journal.pone.0122763	http://dx.doi.org/10.1371/journal.pone.0122763			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799582	Green Published, Green Submitted, gold			2022-12-26	WOS:000351987300342
J	Maawy, AA; Hiroshima, Y; Zhang, Y; Heim, R; Makings, L; Garcia-Guzman, M; Luiken, GA; Kobayashi, H; Hoffman, RM; Bouvet, M				Maawy, Ali A.; Hiroshima, Yukihiko; Zhang, Yong; Heim, Roger; Makings, Lew; Garcia-Guzman, Miguel; Luiken, George A.; Kobayashi, Hisataka; Hoffman, Robert M.; Bouvet, Michael			Near Infra-Red Photoimmunotherapy with Anti-CEA-IR700 Results in Extensive Tumor Lysis and a Significant Decrease in Tumor Burden in Orthotopic Mouse Models of Pancreatic Cancer	PLOS ONE			English	Article							FLUORESCENCE-GUIDED SURGERY; ANTI-CEA ANTIBODY; HUMAN COLON-CANCER; IMAGING-SYSTEM; NUDE-MICE; PATIENT; RESECTION; SURVIVAL; GROWTH	Photoimmunotherapy (PIT) of cancer utilizes tumor-specific monoclonal antibodies conjugated to a photosensitizer phthalocyanine dye IR700 which becomes cytotoxic upon irradiation with near infrared light. In this study, we aimed to evaluate the efficacy of PIT on human pancreatic cancer cells in vitro and in vivo in an orthotopic nude mouse model. The binding capacity of anti-CEA antibody to BxPC-3 human pancreatic cancer cells was determined by FACS analysis. An in vitro cytotoxicity assay was used to determine cell death following treatment with PIT. For in vivo determination of PIT efficacy, nude mice were orthotopically implanted with BxPC-3 pancreatic tumors expressing green fluorescent protein (GFP). After tumor engraftment, the mice were divided into two groups: (1) treatment with anti-CEA-IR700 + 690 nm laser and (2) treatment with 690 nm laser only. Anti-CEA-IR700 (100 mu g) was administered to group (1) via tail vein injection 24 hours prior to therapy. Tumors were then surgically exposed and treated with phototherapy at an intensity of 150 mW/cm(2) for 30 minutes. Whole body imaging was done subsequently for 5 weeks using an OV-100 small animal imaging system. Anti-CEA-IR700 antibody bound to the BxPC3 cells to a high degree as shown by FACS analysis. Anti-CEA-IR700 caused extensive cancer cell killing after light activation compared to control cells in cytotoxicity assays. In the orthotopic models of pancreatic cancer, the anti-CEA-IR700 group had significantly smaller tumors than the control after 5 weeks (p<0.001). There was no significant difference in the body weights of mice in the anti-CEA-IR700 and control groups indicating that PIT was well tolerated by the mice.	[Maawy, Ali A.; Hiroshima, Yukihiko; Hoffman, Robert M.; Bouvet, Michael] Univ Calif San Diego, Dept Surg, San Diego, CA 92103 USA; [Hiroshima, Yukihiko; Zhang, Yong; Hoffman, Robert M.] AntiCancer Inc, San Diego, CA USA; [Hiroshima, Yukihiko] Yokohama City Univ, Dept Surg, Yokohama, Kanagawa 232, Japan; [Heim, Roger; Makings, Lew; Garcia-Guzman, Miguel] Aspyrian Therapeut, San Diego, CA USA; [Luiken, George A.] OncoFluor Inc, San Diego, CA USA; [Kobayashi, Hisataka] NIH, Bethesda, MD 20892 USA; [Bouvet, Michael] VA Healthcare Syst, Surg Serv, San Diego, CA USA	University of California System; University of California San Diego; Anti Cancer Inc; Yokohama City University; National Institutes of Health (NIH) - USA	Bouvet, M (corresponding author), Univ Calif San Diego, Dept Surg, San Diego, CA 92103 USA.	mbouvet@ucsd.edu			National Cancer Institute [CA142669, CA132971]; AntiCancer, Inc.; Aspyrian Therapeutics; NATIONAL CANCER INSTITUTE [R01CA142669, ZIABC011513, R01CA132971] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); AntiCancer, Inc.(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); Aspyrian Therapeutics; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the National Cancer Institute CA142669 and CA132971 (to M.B. and AntiCancer, Inc). AntiCancer, Inc. and Aspyrian Therapeutics provided support in the form of salaries for authors YZ, RH, LM, and MG-G but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bouvet M, 2000, AM J SURG, V180, P13, DOI 10.1016/S0002-9610(00)00405-0; Bouvet M, 2000, CLIN EXP METASTAS, V18, P213, DOI 10.1023/A:1006767405609; Bouvet M, 2002, CANCER RES, V62, P1534; Cao HST, 2012, HEPATO-GASTROENTEROL, V59, P1994, DOI 10.5754/hge11836; FU XY, 1992, P NATL ACAD SCI USA, V89, P5645, DOI 10.1073/pnas.89.12.5645; FURUKAWA T, 1993, CANCER RES, V53, P3070; Hiroshima Y, 2014, J LAPAROENDOSC ADV S, V24, P241, DOI 10.1089/lap.2013.0418; Hiroshima Y, 2014, J SURG RES, V187, P510, DOI 10.1016/j.jss.2013.11.1083; Kaushal S, 2008, J GASTROINTEST SURG, V12, P1938, DOI 10.1007/s11605-008-0581-0; Maawy AA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097965; Maawy AA, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.12.126016; Metildi CA, 2014, J AM COLL SURGEONS, V219, P132, DOI 10.1016/j.jamcollsurg.2014.02.021; Metildi CA, 2014, J SURG ONCOL, V109, P451, DOI 10.1002/jso.23507; Metildi CA, 2014, ANN SURG ONCOL, V21, P1405, DOI 10.1245/s10434-014-3495-y; Metildi CA, 2012, J AM COLL SURGEONS, V214, P997, DOI 10.1016/j.jamcollsurg.2012.02.009; Mitsunaga M, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-345; Mitsunaga M, 2012, BIOCONJUGATE CHEM, V23, P604, DOI 10.1021/bc200648m; Mitsunaga M, 2011, NAT MED, V17, P1685, DOI 10.1038/nm.2554; Nakajima T, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-389; Nakajima T, 2013, THERANOSTICS, V3, P357, DOI 10.7150/thno.5908; Ryan DP, 2014, NEW ENGL J MED, V371, P1039, DOI 10.1056/NEJMra1404198; Sato K, 2014, MOL ONCOL, V8, P620, DOI 10.1016/j.molonc.2014.01.006; Yamauchi K, 2006, CANCER RES, V66, P4208, DOI 10.1158/0008-5472.CAN-05-3927	23	44	52	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121989	10.1371/journal.pone.0121989	http://dx.doi.org/10.1371/journal.pone.0121989			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799218	Green Published, gold, Green Submitted			2022-12-26	WOS:000351987300307
J	Posnack, NG; Idrees, R; Ding, H; Jaimes, R; Stybayeva, G; Karabekian, Z; Laflamme, MA; Sarvazyan, N				Posnack, Nikki Gillum; Idrees, Rabia; Ding, Hao; Jaimes, Rafael, III; Stybayeva, Gulnaz; Karabekian, Zaruhi; Laflamme, Michael A.; Sarvazyan, Narine			Exposure to Phthalates Affects Calcium Handling and Intercellular Connectivity of Human Stem Cell-Derived Cardiomyocytes	PLOS ONE			English	Article							DI(2-ETHYLHEXYL) PHTHALATE; SARCOPLASMIC-RETICULUM; PPAR-ALPHA; SPECIES-DIFFERENCES; HEART; GAP; COMMUNICATION; METABOLITES; INFANTS; MOUSE	Background The pervasive nature of plastics has raised concerns about the impact of continuous exposure to plastic additives on human health. Of particular concern is the use of phthalates in the production of flexible polyvinyl chloride (PVC) products. Di-2-ethylhexyl-phthalate (DEHP) is a commonly used phthalate ester plasticizer that imparts flexibility and elasticity to PVC products. Recent epidemiological studies have reported correlations between urinary phthalate concentrations and cardiovascular disease, including an increased risk of high blood pressure and coronary risk. Yet, there is little direct evidence linking phthalate exposure to adverse effects in human cells, including cardiomyocytes. Methods and Results The effect of DEHP on calcium handling was examined using monolayers of gCAMP3 human embryonic stem cell-derived cardiomyocytes, which contain an endogenous calcium sensor. Cardiomyocytes were exposed to DEHP (5-50 mu g/mL), and calcium transients were recorded using a Zeiss confocal imaging system. DEHP exposure (24-72 hr) had a negative chronotropic and inotropic effect on cardiomyocytes, increased the minimum threshold voltage required for external pacing, and modified connexin-43 expression. Application of Wy-14,643 (100 mu M), an agonist for the peroxisome proliferator-activated receptor alpha, did not replicate DEHP's effects on calcium transient morphology or spontaneous beating rate. Conclusions Phthalates can affect the normal physiology of human cardiomyocytes, including DEHP elicited perturbations in cardiac calcium handling and intercellular connectivity. Our findings call for additional studies to clarify the extent by which phthalate exposure can alter cardiac function, particularly in vulnerable patient populations who are at risk for high phthalate exposure.	[Posnack, Nikki Gillum; Idrees, Rabia; Ding, Hao; Karabekian, Zaruhi; Sarvazyan, Narine] George Washington Univ, Dept Physiol & Pharmacol, Washington, DC 20052 USA; [Jaimes, Rafael, III] George Washington Univ, Dept Elect & Comp Engn, Washington, DC USA; [Stybayeva, Gulnaz] Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA; [Laflamme, Michael A.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA	George Washington University; George Washington University; University of California System; University of California Davis; University of Washington; University of Washington Seattle	Posnack, NG (corresponding author), George Washington Univ, Dept Physiol & Pharmacol, Washington, DC 20052 USA.	ngillum@gwu.edu	Laflamme, Michael/AAV-6791-2021; Posnack, Nikki/F-1170-2013; Karabekian, Zaruhi Zara/GVS-1416-2022	Laflamme, Michael/0000-0001-5908-880X; Posnack, Nikki/0000-0002-3880-7200; Karabekian, Zaruhi Zara/0000-0002-8693-7288; Jaimes, Rafael/0000-0002-5493-0399; Sarvazyan, Narine/0000-0002-2002-5630	National Institutes of Health [K99ES023477, R01HL095828, R01HL117991, P01HL09374]; National Science Foundation (Eager award) [CBET 1231549]; American Heart Association (National) [SDG 5680036]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL122882, R01HL095828, R01HL117991, F32HL009374] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [K99ES023477] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (Eager award)(National Science Foundation (NSF)); American Heart Association (National)(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Funding was provided by the National Institutes of Health (K99ES023477, R01HL095828, R01HL117991, P01HL09374), National Science Foundation (Eager award: CBET 1231549), and American Heart Association (National SDG 5680036). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baartscheer A, 2003, CARDIOVASC RES, V58, P99, DOI 10.1016/S0008-6363(02)00854-4; Berman T, 2009, ENVIRON INT, V35, P353, DOI 10.1016/j.envint.2008.08.010; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Bers DM, 2002, CIRC RES, V90, P14, DOI 10.1161/res.90.1.14; Bers DM, 2000, CIRC RES, V87, P275, DOI 10.1161/01.RES.87.4.275; Bers DM, 2008, ANNU REV PHYSIOL, V70, P23, DOI 10.1146/annurev.physiol.70.113006.100455; Braam SR, 2010, STEM CELL RES, V4, P155, DOI 10.1016/j.scr.2010.04.008; Chong JJH, 2014, NATURE, V510, P273, DOI 10.1038/nature13233; Chung CS, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.158; Colon I, 2000, ENVIRON HEALTH PERSP, V108, P895, DOI 10.2307/3434999; Dolnikov K, 2006, STEM CELLS, V24, P236, DOI 10.1634/stemcells.2005-0036; Domeier TL, 2009, J PHYSIOL-LONDON, V587, P5197, DOI 10.1113/jphysiol.2009.177576; Duty SM, 2003, ENVIRON HEALTH PERSP, V111, P1164, DOI 10.1289/ehp.5756; Eisner DA, 2000, CIRC RES, V87, P1087, DOI 10.1161/01.RES.87.12.1087; Environmental Protection Agency (n.d.), 2 ETH PHTHAL DEHP RE; FDA, 2002, SAF ASS 2 ETH PHTHAL; Feige JN, 2010, ENVIRON HEALTH PERSP, V118, P234, DOI 10.1289/ehp.0901217; Gillum N, 2009, TOXICOL APPL PHARM, V236, P25, DOI 10.1016/j.taap.2008.12.027; Glukhov AV, 2015, EUR HEART J, V36, P686, DOI 10.1093/eurheartj/eht452; Gonzalez FJ, 2008, TOXICOLOGY, V246, P2, DOI 10.1016/j.tox.2007.09.030; Gutstein DE, 2001, CIRC RES, V88, P333, DOI 10.1161/01.RES.88.3.333; Gyorke S, 2004, BIOL RES, V37, P603, DOI 10.4067/s0716-97602004000400014; Hauser R, 2006, EPIDEMIOLOGY, V17, P682, DOI 10.1097/01.ede.0000235996.89953.d7; Huber WW, 1996, CRIT REV TOXICOL, V26, P365, DOI 10.3109/10408449609048302; Inoue K, 2005, CLIN CHIM ACTA, V358, P159, DOI 10.1016/j.cccn.2005.02.019; Isenberg JS, 2000, TOXICOL SCI, V56, P73, DOI 10.1093/toxsci/56.1.73; Jaeger R J, 1973, Environ Health Perspect, V3, P95, DOI 10.2307/3428035; James D, 2006, DEV BIOL, V295, P90, DOI 10.1016/j.ydbio.2006.03.026; JANUARY CT, 1988, PHARMACOL REV, V40, P219; Joensen UN, 2012, ENVIRON HEALTH PERSP, V120, P1397, DOI 10.1289/ehp.1205113; Jonsson MKB, 2011, ASSAY DRUG DEV TECHN, V9, P589, DOI 10.1089/adt.2011.0396; Kalyanasundaram A, 2012, AM J PHYSIOL-HEART C, V302, pH253, DOI 10.1152/ajpheart.00578.2011; Kamendulis LM, 2002, J TOXICOL ENV HEAL A, V65, P569, DOI 10.1080/152873902317349736; Kang KS, 2002, J TOXICOL ENV HEAL A, V65, P447, DOI 10.1080/15287390252808109; Karle VA, 1997, CRIT CARE MED, V25, P696, DOI 10.1097/00003246-199704000-00023; Klaunig JE, 2003, CRIT REV TOXICOL, V33, P655, DOI 10.1080/713608372; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Lapinskas PJ, 2005, TOXICOLOGY, V207, P149, DOI 10.1016/j.tox.2004.09.008; Latini G, 2003, ENVIRON HEALTH PERSP, V111, P1783, DOI 10.1289/ehp.6202; Latini G, 2003, BIOL NEONATE, V83, P22, DOI 10.1159/000067012; Lee YK, 2011, STEM CELL REV REP, V7, P976, DOI 10.1007/s12015-011-9273-3; Li LX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062526; Li S, 2013, J PHYSIOL-LONDON, V591, P5279, DOI 10.1113/jphysiol.2013.256495; Liu J, 2007, STEM CELLS, V25, P3038, DOI 10.1634/stemcells.2007-0549; Lockyer P, 2010, MOL ENDOCRINOL, V24, P1111, DOI 10.1210/me.2009-0374; LOISELLE DS, 1979, AM J PHYSIOL, V237, pH90, DOI 10.1152/ajpheart.1979.237.1.H90; Louch WE, 2012, PHYSIOLOGY, V27, P308, DOI 10.1152/physiol.00021.2012; Ma JY, 2011, AM J PHYSIOL-HEART C, V301, pH2006, DOI 10.1152/ajpheart.00694.2011; Meeker JD, 2009, ENVIRON HEALTH PERSP, V117, P1587, DOI 10.1289/ehp.0800522; Olson EN, 2004, NAT MED, V10, P467, DOI 10.1038/nm0504-467; Pakalin S, 2008, BIS 2 ETHYLHEXY PHTH; Pieske B, 1996, J CLIN INVEST, V98, P764, DOI 10.1172/JCI118849; Pogwizd SM, 2001, CIRC RES, V88, P1159, DOI 10.1161/hh1101.091193; Posnack NG, 2014, CARDIOVASC TOXICOL, V14, P339, DOI 10.1007/s12012-014-9258-y; Posnack NG, 2012, ENVIRON HEALTH PERSP, V120, P1243, DOI 10.1289/ehp.1205056; Posnack NG, 2011, TOXICOLOGY, V279, P54, DOI 10.1016/j.tox.2010.09.007; Radwanski PB, 2013, J MOL CELL CARDIOL, V58, P77, DOI 10.1016/j.yjmcc.2012.10.008; Rosa A, 2009, DEV CELL, V16, P517, DOI 10.1016/j.devcel.2009.02.007; Rudy Y, 2008, CIRCULATION, V118, P1202, DOI 10.1161/CIRCULATIONAHA.108.772715; Saravanabhavan G, 2013, INT J HYG ENVIR HEAL, V216, P652, DOI 10.1016/j.ijheh.2012.12.009; Sartiani L, 2007, STEM CELLS, V25, P1136, DOI 10.1634/stemcells.2006-0466; Satin J, 2008, STEM CELLS, V26, P1961, DOI 10.1634/stemcells.2007-0591; Shiba Y, 2012, NATURE, V489, P322, DOI 10.1038/nature11317; SHNEIDER B, 1989, NEW ENGL J MED, V320, P1563; Sirenko O, 2013, TOXICOL APPL PHARM, V273, P500, DOI 10.1016/j.taap.2013.09.017; Sobarzo CM, 2009, MICROSC RES TECHNIQ, V72, P868, DOI 10.1002/jemt.20741; Stahlhut RW, 2007, ENVIRON HEALTH PERSP, V115, P876, DOI 10.1289/ehp.9882; Swan SH, 2005, ENVIRON HEALTH PERSP, V113, P1056, DOI 10.1289/ehp.8100; Terentyev D, 2002, CIRC RES, V91, P414, DOI 10.1161/01.RES.0000032490.04207.BD; van den Heuvel NHL, 2014, J MOL CELL CARDIOL, V67, P12, DOI 10.1016/j.yjmcc.2013.12.011; Wittassek M, 2007, INT J HYG ENVIR HEAL, V210, P319, DOI 10.1016/j.ijheh.2007.01.037; Wittassek M, 2011, MOL NUTR FOOD RES, V55, P7, DOI 10.1002/mnfr.201000121; Xu CH, 2011, REGEN MED, V6, P53, DOI 10.2217/RME.10.91; Zhang JH, 2009, CIRC RES, V104, pE30, DOI 10.1161/CIRCRESAHA.108.192237; Zhang YH, 2009, J PEDIATR-US, V155, P500, DOI 10.1016/j.jpeds.2009.04.007; Zhu WZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005407	76	25	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121927	10.1371/journal.pone.0121927	http://dx.doi.org/10.1371/journal.pone.0121927			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799571	gold, Green Published, Green Submitted			2022-12-26	WOS:000351987300302
J	Sruamsiri, R; Ross-Degnan, D; Lu, CY; Chaiyakunapruk, N; Wagner, AK				Sruamsiri, Rosarin; Ross-Degnan, Dennis; Lu, Christine Y.; Chaiyakunapruk, Nathorn; Wagner, Anita K.			Policies and Programs to Facilitate Access to Targeted Cancer Therapies in Thailand	PLOS ONE			English	Article							HEALTH TECHNOLOGY-ASSESSMENT; PATIENT ASSISTANCE PROGRAMS; DECISIONS; COVERAGE	Background Increasing access to clinically beneficial targeted cancer medicines is a challenge in every country due to their high cost. We describe the interplay of innovative policies and programs involving multiple stakeholders to facilitate access to these medicines in Thailand, as well as the utilization of selected targeted therapies over time. Methods We selected two medicines on the 2013 Thai national list of essential medicines (NLEM) [letrozole and imatinib] and three unlisted medicines for the same indications [trastuzumab, nilotinib and dasatinib]. We created timelines of access policies and programs for these products based on scientific and grey literature. Using IMS Health sales data, we described the trajectories of sales volumes of the study medicines between January 2001 and December 2012. We compared estimated average numbers of patients treated before and after the implementation of policies and programs for each product. Results Different stakeholders implemented multiple interventions to increase access to the study medicines for different patient populations. During 2007-2009, the Thai Government created a special NLEM category with different coverage requirements for payers and issued compulsory licenses; payers negotiated prices with manufacturers and engaged in pooled procurement; pharmaceutical companies expanded patient assistance programs and lowered prices in different ways. Compared to before the interventions, estimated numbers of patients treated with each medicine increased significantly afterwards: for letrozole from 645 (95% CI 366-923) to 3683 (95% CI 2,748-4,618); for imatinib from 103 (95% CI 72174) to 350 (95% CI 307-398); and for trastuzumab from 68 (95% CI 45-118) to 412 (95% CI 344-563). Conclusions Government, payers, and manufacturers implemented multi-pronged approaches to facilitate access to targeted cancer therapies for the Thai population, which differed by medicine. Routine monitoring is needed to assess clinical and economic impacts of these strategies in the health system.	[Sruamsiri, Rosarin; Chaiyakunapruk, Nathorn] Naresuan Univ, Fac Pharmaceut Sci, Ctr Pharmaceut Outcomes Res, Dept Pharm Practice, Phitsanulok, Thailand; [Sruamsiri, Rosarin; Ross-Degnan, Dennis; Lu, Christine Y.; Wagner, Anita K.] Harvard Univ, Sch Med, Dept Populat Med, Boston, MA USA; [Sruamsiri, Rosarin; Ross-Degnan, Dennis; Lu, Christine Y.; Wagner, Anita K.] Harvard Pilgrim Hlth Care Inst, Boston, MA USA; [Chaiyakunapruk, Nathorn] Monash Univ Malaysia, Sch Pharm, Subang Jaya, Malaysia; [Chaiyakunapruk, Nathorn] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia; [Chaiyakunapruk, Nathorn] Univ Wisconsin, Sch Pharm, Madison, WI 53706 USA	Naresuan University; Harvard University; Harvard Medical School; Harvard Pilgrim Health Care; Monash University; Monash University Sunway; University of Queensland; University of Wisconsin System; University of Wisconsin Madison	Sruamsiri, R (corresponding author), Naresuan Univ, Fac Pharmaceut Sci, Ctr Pharmaceut Outcomes Res, Dept Pharm Practice, Phitsanulok, Thailand.	r.sruamsiri@gmail.com			Thailand Research Fund (TRF) through the Royal Golden Jubilee PhD program [PHD/0127/2552]	Thailand Research Fund (TRF) through the Royal Golden Jubilee PhD program(Thailand Research Fund (TRF))	This study was supported by a grant from the Thailand Research Fund (TRF) through the Royal Golden Jubilee PhD program (Grant No. PHD/0127/2552 to RS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American College of Physicians, 2011, CAN OUR NAT CONS DIS; CanTreat Int, 2010, ANN ONCOL, V21, P680, DOI 10.1093/annonc/mdq055; Choudhry NK, 2009, HEALTH AFFAIR, V28, P827, DOI 10.1377/hlthaff.28.3.827; Damrongplasit K, 2009, HEALTH AFFAIR, V28, pW457, DOI 10.1377/hlthaff.28.3.w457; Espin J, 2011, EXP IMP EUR RIUSK SH; Farmer P, 2010, LANCET, V376, P1186, DOI 10.1016/S0140-6736(10)61152-X; Felder TM, 2011, J HEALTH CARE POOR U, V22, P24, DOI 10.1353/hpu.2011.0003; Food Drug and Administration, 2013, PHARM PROD INF; Health Insurance System Research Office, 2012, THAIL U COV SCHE ACH; IMS Health, 2012, ONC SAL CHANN; Internaltional Agency for Research on Cancer, 2008, GLOBOCAN2008 EST CAN; International Agency for Research on Cancer, 2008, WORLD CANC REPORT 20; Kanavos P, 2006, ANN ONCOL, V17, P15, DOI 10.1093/annonc.mdl983; Kanavos P, 2010, OPTIONS FINANCING OP; Keskinaslan A, 2011, ASSESSMENT PRICING R; Lassarat S, 2006, ANN ONCOL, V17, P43, DOI [10.1093/annonc.mdl987, 10.1093/annonc/mdl987]; Lichtenberg FR, 2004, 10328 NAT BUR EC RES; Lopes GD, 2013, NAT REV CLIN ONCOL, V10, P314, DOI 10.1038/nrclinonc.2013.55; Low O, 2012, IDEALS IMPLEMENTATIO; Manager Online, 2012, NHSO SWO ALLOW REIMB; Mohara A, 2012, J COMP EFFECT RES, V1, P137, DOI [10.2217/CER.12.10, 10.2217/cer.12.10]; Mohara A, 2012, VALUE HEALTH, V15, pS95, DOI 10.1016/j.jval.2011.11.016; Murray SA, 2003, BRIT MED J, V326, P368, DOI 10.1136/bmj.326.7385.368; *NAT DRUG COMM, 2004, NAT LIST ESS MED; National Comprehensive Cancer Network, 2013, NCCN CLIN PRACT GUID; National Drug Commitee, 2013, NAT LIST MED 2013; National Drug Committee, 2008, NAT LIS ESS MED 2008; National Health Security Office, 2010, CLIN PRACT GUID BREA; National Health Security Office, 2006, CLIN PRACT AD CHRON; National statistical office Thailand, 2012, Q THAI POP; Rodin J, 2012, LANCET, V380, P861, DOI 10.1016/S0140-6736(12)61340-3; Sakunphanit T, 2006, UNIVERSAL HLTH COVER; Savedoff W.D., 2012, TRANSITIONS HLTH FIN; Savedoff WD, 2012, LANCET, V380, P924, DOI 10.1016/S0140-6736(12)61083-6; Sloan FA, 2007, CANC CONTR OPP LOW M; Tangcharoensathien V, 2011, LANCET, V377, P863, DOI 10.1016/S0140-6736(10)61890-9; Teerawattananon Y, 2009, INT J TECHNOL ASSESS, V25, P241, DOI 10.1017/S0266462309090709; Thai CML Patient Group (THCML), 2010, CLIN PRACT GUID AD C; Thai PR, 2008, 5 ANNIVERSARY GIPAP; Thai working group on National Health Account, 2010, REP 1994 2008 NAT HL; Thailand Health Insurance System Research Office, 2012, THAILANDS UNIVERSAL; The Ministry of Public Health and the National Health Security Office, 2008, 10 BURN QUEST GOV US; The National Health Security Office, 2013, Q ANN REP; The National Health Security Office, 2010, VMI HELPS SAV B4BN D; The World Health Organization, 2014, DEF UN HLTH COV; Towse A, 2004, BRIT MED J, V328, P103, DOI 10.1136/bmj.328.7431.103; Towse A, 2010, PHARMACOECONOMICS, V28, P93, DOI 10.2165/11314080-000000000-00000; Turongkaravee S, 2012, EVALUATION HIGH COST; Turongkarawee S, 2011, EVALUATION HIGH COST; University M, 2010, THAIL HLTH PROF 2009; Vatanasapt V, 2002, JPN J CLIN ONCOL, V32, pS82, DOI 10.1093/jjco/hye134; WHO, 2010, WOR HEALT REP, P1; Wibulpolprasert S, 2011, GLOBALIZATION HEALTH, V7, DOI 10.1186/1744-8603-7-32; World Health Organization, 2009, INT TRAD HLTH REF GU; World Health Organization, PROM RAT US MED COR; World Trade Organization, 2001, AGGR TRAD REL ASP IN; Yamabhai I, 2009, ASSESSING IMPLICATIO; Yamabhai I, 2011, GLOBALIZATION HEALTH, V7, DOI 10.1186/1744-8603-7-28; Yoongthong W, 2012, VALUE HEALTH, V15, pS126, DOI 10.1016/j.jval.2011.11.003	59	19	20	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0119945	10.1371/journal.pone.0119945	http://dx.doi.org/10.1371/journal.pone.0119945			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE6ZS	25798948	Green Published, gold, Green Submitted			2022-12-26	WOS:000351987300095
J	Wang, R; Fratiglioni, L; Liang, YJ; Welmer, AK; Xu, WL; Mangialasche, F; Johnell, K; Qiu, CX				Wang, Rui; Fratiglioni, Laura; Liang, Yajun; Welmer, Anna-Karin; Xu, Weili; Mangialasche, Francesca; Johnell, Kristina; Qiu, Chengxuan			Prevalence, Pharmacological Treatment, and Control of Cardiometabolic Risk Factors among Older People in Central Stockholm: A Population-Based Study	PLOS ONE			English	Article							BLOOD-PRESSURE; MANAGEMENT; DEMENTIA; DISEASE; BURDEN; ADULTS; HYPERTENSION; ASSOCIATION; GUIDELINES; MEN	Background Cardiometabolic risk factors and related cardiovascular diseases represent major threats to healthy aging. Objective We aimed to estimate distribution, pharmacological treatment, and control of main cardiometabolic risk factors among older people. Methods This population-based study included 3363 participants (age >= 60 years, 64.9% women) in the Swedish National study on Aging and Care in Kungsholmen, in central Stockholm, Sweden (2001-2004). Data on demographics, cardiometabolic risk factors (hypertension, obesity, diabetes, and high cholesterol), and medication use were collected through face-to-face interviews, clinical examinations, laboratory tests, and the inpatient register. Cardiometabolic risk factors were defined following the most commonly used criteria. Prevalence was standardized using local census data. Results The age-and sex-standardized prevalence of diabetes, obesity, high cholesterol, and hypertension was 9.5%, 12.8%, 49.7%, and 74.9%, respectively. The prevalence of hypertension and diabetes increased with age, whereas the prevalence of obesity and high cholesterol decreased with age. Forty-nine percent of older adults had two or more cardiometabolic risk factors; 9.8% had three or more. Overall, 55.5% of people with hypertension, 50.3% with diabetes, and 25.0% with high cholesterol received pharmacological treatment. Of those treated pharmacologically, 49.4%, 38.1%, and 85.5% reached therapeutic goals for hypertension (blood pressure<150/90 mmHg), diabetes (glycated haemoglobin<7%), and high cholesterol (total cholesterol<6.22 mmol/l), respectively. Conclusions Hypertension, high cholesterol, and clustering of cardiometabolic risk factors were common among older people in Stockholm, but pharmacological treatment and control of these major factors can be improved. Appropriate management of cardiometabolic profiles among older people may help improve cardiovascular health and achieve healthy aging.	[Wang, Rui; Fratiglioni, Laura; Liang, Yajun; Welmer, Anna-Karin; Xu, Weili; Mangialasche, Francesca; Johnell, Kristina; Qiu, Chengxuan] Stockholm Univ, Karolinska Inst, Aging Res Ctr, Dept Neurobiol Care Sci & Soc, S-10691 Stockholm, Sweden; [Fratiglioni, Laura; Johnell, Kristina] Stockholm Gerontol Res Ctr, Stockholm, Sweden; [Liang, Yajun] Jining Med Univ, Sch Publ Hlth, Jining, Shandong, Peoples R China; [Welmer, Anna-Karin] Karolinska Univ Hosp, Stockholm, Sweden	Karolinska Institutet; Stockholm University; Karolinska Institutet; Jining Medical University; Karolinska Institutet; Karolinska University Hospital	Wang, R (corresponding author), Stockholm Univ, Karolinska Inst, Aging Res Ctr, Dept Neurobiol Care Sci & Soc, S-10691 Stockholm, Sweden.	rui.wang@ki.se; chengxuan.qiu@ki.se	Wang, Rui/HGE-4083-2022; Xu, Weili/AAB-6530-2020; Welmer, Anna-Karin/AAL-3446-2021	Wang, Rui/0000-0001-7209-741X; Mangialasche, Francesca/0000-0002-2686-3926; Welmer, Anna-Karin/0000-0001-5819-8724	Swedish Ministry of Health and Social Affairs; Swedish Research Council; Swedish Council for Working Life and Social Research; Karolinska Institutet Faculty Funds; Gamla Tjanarinnor Foundation	Swedish Ministry of Health and Social Affairs; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Karolinska Institutet Faculty Funds; Gamla Tjanarinnor Foundation	This study (SNAC) was financially supported by the Swedish Ministry of Health and Social Affairs, the participating County Councils and Municipalities, and the Swedish Research Council. This work was supported in part by grants from the Swedish Research Council, the Swedish Council for Working Life and Social Research, Karolinska Institutet Faculty Funds (KID-funding), and Gamla Tjanarinnor Foundation (grant numbers and URLs will be submitted at request). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abed HS, 2013, JAMA-J AM MED ASSOC, V310, P2050, DOI 10.1001/jama.2013.280521; Acosta-Cazares B, 2010, AM HEART J, V160, P230, DOI 10.1016/j.ahj.2010.05.016; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS11, DOI 10.2337/dc13-S011; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc13-S067, 10.2337/dc10-S062, 10.2337/dc12-s064, 10.2337/dc11-S062]; [Anonymous], 2006, FOREBYGGANDE AV ATER; Boudreau DM, 2004, AM J EPIDEMIOL, V159, P308, DOI 10.1093/aje/kwh038; Casagrande SS, 2013, DIABETES CARE, V36, P2271, DOI 10.2337/dc12-2258; Chaput JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072832; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; Christensen K, 2009, LANCET, V374, P1196, DOI 10.1016/S0140-6736(09)61460-4; Clarke R, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3513; Danaei G, 2013, CIRCULATION, V127, P1493, DOI 10.1161/CIRCULATIONAHA.113.001470; de Bruijn RFAG, 2013, EUR J EPIDEMIOL, V28, P277, DOI 10.1007/s10654-013-9773-3; Eriksson M, 2011, J INTERN MED, V269, P219, DOI 10.1111/j.1365-2796.2010.02312.x; Ford ES, 2009, CIRCULATION, V120, P1181, DOI 10.1161/CIRCULATIONAHA.108.835728; Goodall Ian, 2005, Clin Biochem Rev, V26, P5; Gottesman RF, 2010, LANCET NEUROL, V9, P895, DOI 10.1016/S1474-4422(10)70164-2; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Haasum Y, 2011, DRUG AGING, V28, P283, DOI 10.2165/11587040-000000000-00000; Hee L, 2013, INT J CARDIOL, V167, P1276, DOI 10.1016/j.ijcard.2012.03.162; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Lee SJ, 2011, J AM GERIATR SOC, V59, P666, DOI 10.1111/j.1532-5415.2011.03362.x; Ligthart SA, 2012, EUR J PREV CARDIOL, V19, P1365, DOI 10.1177/1741826711422979; Luchsinger JA, 2005, NEUROLOGY, V65, P545, DOI 10.1212/01.wnl.0000172914.08967.dc; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/eht151, 10.1093/eurheartj/ehm236]; McDonald M, 2009, J GERONTOL A-BIOL, V64, P256, DOI 10.1093/gerona/gln016; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Navar-Boggan AM, 2014, JAMA-J AM MED ASSOC, V311, P1424, DOI 10.1001/jama.2014.2531; Neovius K, 2013, EUR J PUBLIC HEALTH, V23, P312, DOI 10.1093/eurpub/cks128; Paulsen MS, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.004531; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; Puska P., 2011, WHO GLOBAL ATLAS CAR, P3; Qiu C, 2012, EUR J NEUROL, V19, P876, DOI 10.1111/j.1468-1331.2011.03645.x; Qiu CX, 2012, J ALZHEIMERS DIS, V32, P721, DOI 10.3233/JAD-2012-120922; Redon J, 2007, HYPERTENSION, V49, P799, DOI 10.1161/01.HYP.0000259104.60878.43; Rizzuto D, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e5568; Robinson M, 2007, GLOBAL HEALTH AND GL, P159; Roth GA, 2011, B WORLD HEALTH ORGAN, V89, P92, DOI 10.2471/BLT.10.079947; Rydwik E, 2013, EUR J PUBLIC HEALTH, V23, P799, DOI 10.1093/eurpub/cks150; Sacco RL, 2011, CIRCULATION, V123, P2653, DOI 10.1161/CIR.0b013e318220dec1; Salive ME, 2013, EPIDEMIOL REV, V35, P75, DOI 10.1093/epirev/mxs009; Schipf S, 2012, DIABETIC MED, V29, pE88, DOI 10.1111/j.1464-5491.2012.03578.x; Schoenborn CA., 2009, NATL HLTH STAT REPOR, V16, P1, DOI DOI 10.1037/E623972009-001; Song AQ, 2014, EUR J PREV CARDIOL, V21, P1267, DOI 10.1177/2047487313487621; Tabak AG, 2012, LANCET, V379, P2279, DOI 10.1016/S0140-6736(12)60283-9; Welmer AK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065815; World Health Organisation. Use of glycated haemoglobin (HbA1c) in diagnosis of diabetes mellitus abbreviated report of a WHO consultation, 2011, WHO NMH CHP CPM 11 1; Xu WL, 2010, DIABETES, V59, P2928, DOI 10.2337/db10-0539	48	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0119582	10.1371/journal.pone.0119582	http://dx.doi.org/10.1371/journal.pone.0119582			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE6ZS	25799502	gold, Green Submitted, Green Published			2022-12-26	WOS:000351987300061
J	Wu, M; Dai, G; Yao, J; Hoyt, S; Wang, LS; Mu, J				Wu, Margaret; Dai, Ge; Yao, Jun; Hoyt, Scott; Wang, Liangsu; Mu, James			Potentiation of Insulin-Mediated Glucose Lowering without Elevated Hypoglycemia Risk by a Small Molecule Insulin Receptor Modulator	PLOS ONE			English	Article							ANTIDIABETIC ACTIVITY; IN-VITRO; ACTIVATION; IDENTIFICATION; RESISTANCE; THERAPY; MICE	Insulin resistance is the key feature of type 2 diabetes and is manifested as attenuated insulin receptor (IR) signaling in response to same levels of insulin binding. Several small molecule IR activators have been identified and reported to exhibit insulin sensitization properties. One of these molecules, TLK19781 (Cmpd1), was investigated to examine its IR sensitizing action in vivo. Our data demonstrate that Cmpd1, at doses that produced minimal efficacy in the absence of insulin, potentiated insulin action during an OGTT in non-diabetic mice and enhanced insulin-mediated glucose lowering in diabetic mice. Interestingly, different from insulin alone, Cmpd1 combined with insulin showed enhanced efficacy and duration of action without increased hypoglycemia. To explore the mechanism underlying the apparent glucose dependent efficacy, tissue insulin signaling was compared in healthy and diabetic mice. Cmpd1 enhanced insulin's effects on IR phosphorylation in both healthy and diabetic mice. In contrast, the compound potentiated insulin's effects on Akt phosphorylation in diabetic but not in non-diabetic mice. These differential effects on signaling corresponding to glucose levels could be part of the mechanism for reduced hypoglycemia risk. The in vivo efficacy of Cmpd1 is specific and dependent on IR expression. Results from these studies support the idea of targeting IR for insulin sensitization, which carries low hypoglycemia risk by standalone treatment and could improve the effectiveness of insulin therapies.	[Wu, Margaret; Dai, Ge; Yao, Jun; Hoyt, Scott; Wang, Liangsu; Mu, James] Merck Sharp & Dohme Corp, Merck Res Labs, Early Dev & Discovery Sci, Whitehouse Stn, NJ 08889 USA	Merck & Company	Mu, J (corresponding author), Merck Sharp & Dohme Corp, Merck Res Labs, Early Dev & Discovery Sci, Whitehouse Stn, NJ 08889 USA.	yingjun_mu@merck.com		Mu, James/0000-0001-8081-2401	Merck Co., Inc.	Merck Co., Inc.(Merck & Company)	Merck & Co., Inc. provided support in the form of salaries for authors MW, GD, JY, SH, LW, and JM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	CHAP Z, 1987, AM J PHYSIOL, V252, pE209, DOI 10.1152/ajpendo.1987.252.2.E209; Cheng MS, 2004, J CELL BIOCHEM, V92, P1234, DOI 10.1002/jcb.20150; Conarello SL, 2007, DIABETOLOGIA, V50, P142, DOI 10.1007/s00125-006-0481-3; Corbin JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088684; De Meyts P, 2009, ANN NY ACAD SCI, V1160, P45, DOI 10.1111/j.1749-6632.2009.03837.x; Fonte Pedro, 2013, J Diabetes Sci Technol, V7, P520; Fujimori Y, 2008, J PHARMACOL EXP THER, V327, P268, DOI 10.1124/jpet.108.140210; Gao ZG, 2006, DRUG DISCOV TODAY, V11, P191, DOI 10.1016/S1359-6446(05)03689-5; Hampp C, 2014, DIABETES CARE, V37, P1367, DOI 10.2337/dc13-2289; He KY, 2011, J BIOL CHEM, V286, P37379, DOI 10.1074/jbc.M111.247387; Henry RR, 2014, DIABETES CARE, V37, P2609, DOI 10.2337/dc14-0210; Herring R, 2014, DIABETES OBES METAB, V16, P1, DOI 10.1111/dom.12117; Jensen M, 2007, J BIOL CHEM, V282, P35179, DOI 10.1074/jbc.M704599200; Jensen M, 2009, VITAM HORM, V80, P51, DOI 10.1016/S0083-6729(08)00603-1; Jung SH, 2007, BIOCHEM J, V403, P243, DOI 10.1042/BJ20061123; Laborde E, 2002, CURR MED CHEM, V9, P2231, DOI 10.2174/0929867023368665; Leifke E, 2014, DRUG TODAY, V50, P181, DOI 10.1358/dot.2014.50.2.2095269; Lin B, 2007, J PHARMACOL EXP THER, V323, P579, DOI 10.1124/jpet.107.126102; Lum RT, 2008, J MED CHEM, V51, P6173, DOI 10.1021/jm800600v; Manchem VP, 2001, DIABETES, V50, P824, DOI 10.2337/diabetes.50.4.824; Melancon BJ, 2012, J MED CHEM, V55, P1445, DOI 10.1021/jm201139r; Mu J, 2006, DIABETES, V55, P1695, DOI 10.2337/db05-1602; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Pender C, 2002, J BIOL CHEM, V277, P43565, DOI 10.1074/jbc.M202426200; Perveen R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026238; Peyrot M, 2005, DIABETES CARE, V28, P2673, DOI 10.2337/diacare.28.11.2673; Pillutla RC, 2002, J BIOL CHEM, V277, P22590, DOI 10.1074/jbc.M202119200; Qureshi SA, 2000, J BIOL CHEM, V275, P36590, DOI 10.1074/jbc.M006287200; Robinson L, 2008, BIOORG MED CHEM LETT, V18, P3492, DOI 10.1016/j.bmcl.2008.05.031; Root-Bernstein R, 2009, CELL MOL LIFE SCI, V66, P2721, DOI 10.1007/s00018-009-0065-8; Schaffer L, 2003, P NATL ACAD SCI USA, V100, P4435, DOI 10.1073/pnas.0830026100; Schlein M, 2001, BIOCHEMISTRY-US, V40, P13520, DOI 10.1021/bi015672w; Seibler J, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm122; Soares S, 2012, EXPERT OPIN DRUG DEL, V9, P1539, DOI 10.1517/17425247.2012.737779; Tsai HJ, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-68; Vigneri R, 2012, DIABETES, V61, P984, DOI 10.2337/db12-0192; Zhang B, 1999, SCIENCE, V284, P974, DOI 10.1126/science.284.5416.974	37	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0122012	10.1371/journal.pone.0122012	http://dx.doi.org/10.1371/journal.pone.0122012			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799496	gold, Green Published, Green Submitted			2022-12-26	WOS:000351987300310
J	Zhang, SF; Xiao, Q; Le, WD				Zhang, Sufang; Xiao, Qian; Le, Weidong			Olfactory Dysfunction and Neurotransmitter Disturbance in Olfactory Bulb of Transgenic Mice Expressing Human A53T Mutant alpha-Synuclein	PLOS ONE			English	Article							IDIOPATHIC PARKINSONS-DISEASE; CHOLINERGIC MODULATION; DOPAMINERGIC CELLS; NUCLEUS BASALIS; DISCRIMINATION; RATS; IMPAIRMENT; RECEPTOR; MUTATION; INTERNEURONS	Parkinson disease is a multi-system neurodegenerative disease characterized by both motor and non-motor symptoms. Hyposmia is one of the early non-motor symptoms occurring in more than 90% of Parkinson disease cases, which can precede motor symptoms even several years. Up to now, the relationship between hyposmia and Parkinson disease remains elusive. Lack of proper animal models of hyposmia restricts the investigation. In this study we assessed olfactory function in Prp-A53T-alpha-synuclein transgenic (alpha Syn(A53)T) mice which had been reported to show age-dependent motor impairments and intracytoplasmic inclusions. We also examined cholinergic and dopaminergic systems in olfactory bulb of alpha Syn(A53)T mice by immunofluorescent staining, enzyme linked immunosorbent assay and western blot. We found that compared to wild type littermates, alpha Syn(A53)T mice at 6 months or older displayed a deficit of odor discrimination and odor detection. No significant changes were found in olfactory memory and odor habituation. Furthermore compared to wildtype littermates, in olfactory bulb of alpha Syn(A53)T mice at 10 months old we detected a marked decrease of cholinergic neurons in mitral cell layer and a decrease of acetylcholinesterase activity, while dopaminergic neurons were found increased in glomerular layer, accompanied with an increase of tyrosine hydroxylase protein. Our studies indicate that alpha Syn(A53)T mice have olfactory dysfunction before motor deficits occur, and the cholinergic and dopaminergic disturbance might be responsible for the Parkinson disease-related olfactory dysfunction.	[Zhang, Sufang; Xiao, Qian; Le, Weidong] Shanghai Jiao Tong Univ, RuiJin Hosp, Sch Med, Inst Neurol, Shanghai 200030, Peoples R China; [Le, Weidong] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, State Key Lab Stem Cell Biol, Shanghai, Peoples R China; [Le, Weidong] Shanghai Jiao Tong Univ, Sch Med, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University	Le, WD (corresponding author), Shanghai Jiao Tong Univ, RuiJin Hosp, Sch Med, Inst Neurol, Shanghai 200030, Peoples R China.	wdle@sibs.ac.cn			National Natural Sciences Foundation of China [81171201]; National Basic Research Program of China [2011CB510003]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This study was supported by grants from the National Natural Sciences Foundation of China (81171201, http://www.nsfc.gov.cn/) and the National Basic Research Program of China (No. 2011CB510003, http://www.973.gov.cn/Default_3.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANSARI KA, 1975, J CHRON DIS, V28, P493, DOI 10.1016/0021-9681(75)90058-2; Baba T, 2011, MOVEMENT DISORD, V26, P621, DOI 10.1002/mds.23602; Belzunegui S, 2007, SYNAPSE, V61, P1006, DOI 10.1002/syn.20451; Bohnen NI, 2011, BEHAV BRAIN RES, V221, P564, DOI 10.1016/j.bbr.2009.12.048; Bohnen NI, 2010, BRAIN, V133, P1747, DOI 10.1093/brain/awq079; Bohnen NI, 2008, NEUROSCI LETT, V447, P12, DOI 10.1016/j.neulet.2008.09.070; Braak H, 2004, CELL TISSUE RES, V318, P121, DOI 10.1007/s00441-004-0956-9; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Castillo PE, 1999, J NEUROSCI, V19, P9180; Chaudhuri KR, 2008, J NEUROL, V255, P33, DOI 10.1007/s00415-008-5006-1; Crespo C, 2000, EUR J NEUROSCI, V12, P3963, DOI 10.1046/j.1460-9568.2000.00289.x; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; de Lau LML, 2006, LANCET NEUROL, V5, P525, DOI 10.1016/S1474-4422(06)70471-9; Doty RL, 2008, ANN NEUROL, V63, P7, DOI 10.1002/ana.21327; Doty RL, 2012, NEUROBIOL DIS, V46, P527, DOI 10.1016/j.nbd.2011.10.026; DOTY RL, 1988, NEUROLOGY, V38, P1237, DOI 10.1212/WNL.38.8.1237; DOTY RL, 1992, J NEUROL NEUROSUR PS, V55, P138, DOI 10.1136/jnnp.55.2.138; Doty RL, 1999, PHYSIOL BEHAV, V65, P801; DOTY RL, 1989, PSYCHOPHARMACOLOGY, V98, P310, DOI 10.1007/BF00451680; Eibenstein A, 2005, NEUROL SCI, V26, P147, DOI 10.1007/s10072-005-0452-3; EZRINWATERS C, 1986, CAN J NEUROL SCI, V13, P8, DOI 10.1017/S0317167100035721; Fleming SM, 2008, EUR J NEUROSCI, V28, P247, DOI 10.1111/j.1460-9568.2008.06346.x; Fletcher ML, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-02-j0005.2002; Gheusi C, 2000, P NATL ACAD SCI USA, V97, P1823, DOI 10.1073/pnas.97.4.1823; Giasson BI, 2002, NEURON, V34, P521, DOI 10.1016/S0896-6273(02)00682-7; Graber TG, 2013, J GERONTOL A-BIOL, V68, P1326, DOI 10.1093/gerona/glt032; Haehner A, 2009, PARKINSONISM RELAT D, V15, P490, DOI 10.1016/j.parkreldis.2008.12.005; Haehner A, 2007, MOVEMENT DISORD, V22, P839, DOI 10.1002/mds.21413; Hawkes CH, 1999, QJM-MON J ASSOC PHYS, V92, P473, DOI 10.1093/qjmed/92.8.473; Hsia AY, 1999, J NEUROPHYSIOL, V82, P1082, DOI 10.1152/jn.1999.82.2.1082; Huisman E, 2004, MOVEMENT DISORD, V19, P687, DOI 10.1002/mds.10713; Hummel T, 2007, EUR ARCH OTO-RHINO-L, V264, P237, DOI 10.1007/s00405-006-0173-0; HUNTER AJ, 1989, PSYCHOPHARMACOLOGY, V99, P270, DOI 10.1007/BF00442821; Jeanclos EM, 2001, J BIOL CHEM, V276, P28281, DOI 10.1074/jbc.M011549200; Krosnowski K, 2012, NEUROSCIENCE, V213, P161, DOI 10.1016/j.neuroscience.2012.04.024; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Kuo YM, 2010, HUM MOL GENET, V19, P1633, DOI 10.1093/hmg/ddq038; Lashuel HA, 2013, NAT REV NEUROSCI, V14, P38, DOI 10.1038/nrn3406; Mandairon N, 2006, EUR J NEUROSCI, V24, P3234, DOI 10.1111/j.1460-9568.2006.05212.x; Marxreiter F, 2009, EUR J NEUROSCI, V29, P879, DOI 10.1111/j.1460-9568.2009.06641.x; Mundinano IC, 2011, ACTA NEUROPATHOL, V122, P61, DOI 10.1007/s00401-011-0830-2; Nathan BP, 2004, BEHAV BRAIN RES, V150, P1, DOI 10.1016/S0166-4328(03)00219-5; Ostrerova N, 1999, J NEUROSCI, V19, P5782, DOI 10.1523/JNEUROSCI.19-14-05782.1999; Paumier KL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070274; PEARCE RKB, 1995, MOVEMENT DISORD, V10, P283, DOI 10.1002/mds.870100309; Petit GH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060691; Pignatelli A, 2008, CHEM SENSES, V33, P331, DOI 10.1093/chemse/bjm091; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; QUINN NP, 1987, J NEUROL NEUROSUR PS, V50, P88, DOI 10.1136/jnnp.50.1.88; RAVEL N, 1994, BEHAV NEUROSCI, V108, P317, DOI 10.1037/0735-7044.108.2.317; RAVEL N, 1992, PSYCHOPHARMACOLOGY, V109, P439, DOI 10.1007/BF02247720; Restrepo D, 2004, HORM BEHAV, V46, P247, DOI 10.1016/j.yhbeh.2004.02.009; ROGERS JD, 1985, ANN NEUROL, V17, P163, DOI 10.1002/ana.410170210; Ross GW, 2008, ANN NEUROL, V63, P167, DOI 10.1002/ana.21291; Sanchez-Andrade G, 2005, J REPROD DEVELOP, V51, P547, DOI 10.1262/jrd.17031; Shimada H, 2009, NEUROLOGY, V73, P273, DOI 10.1212/WNL.0b013e3181ab2b58; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Tillerson JL, 2006, BEHAV BRAIN RES, V172, P97, DOI 10.1016/j.bbr.2006.04.025; WARD CD, 1983, NEUROLOGY, V33, P943, DOI 10.1212/WNL.33.7.943; Wattendorf E, 2009, J NEUROSCI, V29, P15410, DOI 10.1523/JNEUROSCI.1909-09.2009; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795	61	31	33	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0119928	10.1371/journal.pone.0119928	http://dx.doi.org/10.1371/journal.pone.0119928			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799501	Green Published, Green Submitted, gold			2022-12-26	WOS:000351987300091
J	Anand, A; LeDoyt, M; Karanian, C; Luthra, A; Koszelak-Rosenblum, M; Malkowski, MG; Puthenveetil, R; Vinogradova, O; Radolf, JD				Anand, Arvind; LeDoyt, Morgan; Karanian, Carson; Luthra, Amit; Koszelak-Rosenblum, Mary; Malkowski, Michael G.; Puthenveetil, Robbins; Vinogradova, Olga; Radolf, Justin D.			Bipartite Topology of Treponema pallidum Repeat Proteins C/D and I: OUTER MEMBRANE INSERTION, TRIMERIZATION, AND PORIN FUNCTION REQUIRE A C-TERMINAL -BARREL DOMAIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Electron Microscopy (EM); Microbial Pathogenesis; Outer Membrane; Small Angle X-ray Scattering (SAXS); X-ray Scattering; beta-Barrel; Syphilis; Treponema pallidum; Outer Membrane Proteins; Porins	SMALL-ANGLE SCATTERING; X-RAY-SCATTERING; PHOSPHOLIPID-BILAYER NANODISCS; GRAM-NEGATIVE BACTERIA; ESCHERICHIA-COLI; OMPA PROTEIN; SYPHILIS SPIROCHETE; MOLECULAR ARCHITECTURE; ELECTRON-MICROSCOPY; CRYSTAL-STRUCTURES	Background:Treponema pallidum contains a paucity of outer membrane proteins. Results: The C-terminal domains of TprC/D and TprI are -barrels with porin function; their N-terminal domains provide periplasmic anchors for the -barrels. Conclusion: Full-length TprC subfamily proteins possess a dual domain topology. Significance: TprC/D are bona fide rare outer membrane proteins and a new class of dual function, bipartite, bacterial outer membrane protein. We previously identified Treponemapallidumrepeat proteins TprC/D, TprF, and TprI as candidate outer membrane proteins (OMPs) and subsequently demonstrated that TprC is not only a rare OMP but also forms trimers and has porin activity. We also reported that TprC contains N- and C-terminal domains (TprC(N) and TprC(C)) orthologous to regions in the major outer sheath protein (MOSPN and MOSPC) of Treponema denticola and that TprC(C) is solely responsible for -barrel formation, trimerization, and porin function by the full-length protein. Herein, we show that TprI also possesses bipartite architecture, trimeric structure, and porin function and that the MOSPC-like domains of native TprC and TprI are surface-exposed in T. pallidum, whereas their MOSPN-like domains are tethered within the periplasm. TprF, which does not contain a MOSPC-like domain, lacks amphiphilicity and porin activity, adopts an extended inflexible structure, and, in T. pallidum, is tightly bound to the protoplasmic cylinder. By thermal denaturation, the MOSPN and MOSPC-like domains of TprC and TprI are highly thermostable, endowing the full-length proteins with impressive conformational stability. When expressed in Escherichia coli with PelB signal sequences, TprC and TprI localize to the outer membrane, adopting bipartite topologies, whereas TprF is periplasmic. We propose that the MOSPN-like domains enhance the structural integrity of the cell envelope by anchoring the -barrels within the periplasm. In addition to being bona fide T. pallidum rare outer membrane proteins, TprC/D and TprI represent a new class of dual function, bipartite bacterial OMP.	[Anand, Arvind; LeDoyt, Morgan; Luthra, Amit; Radolf, Justin D.] Univ Connecticut, Dept Med, Ctr Hlth, Farmington, CT 06030 USA; [Karanian, Carson; Radolf, Justin D.] Univ Connecticut, Dept Pediat, Ctr Hlth, Farmington, CT 06030 USA; [Radolf, Justin D.] Univ Connecticut, Dept Mol Biol & Biophys, Ctr Hlth, Farmington, CT 06030 USA; [Radolf, Justin D.] Univ Connecticut, Dept Genet & Genom Sci, Ctr Hlth, Farmington, CT 06030 USA; [Radolf, Justin D.] Univ Connecticut, Dept Immunol, Ctr Hlth, Farmington, CT 06030 USA; [Koszelak-Rosenblum, Mary; Malkowski, Michael G.] SUNY Buffalo, Hauptman Woodward Med Res Inst, Buffalo, NY 14203 USA; [Malkowski, Michael G.] SUNY Buffalo, Dept Biol Struct, Buffalo, NY 14203 USA; [Puthenveetil, Robbins] Univ Connecticut, Dept Mol Cell Biol, Storrs, CT 06269 USA; [Vinogradova, Olga] Univ Connecticut, Dept Pharmaceut Sci, Storrs, CT 06269 USA	University of Connecticut; University of Connecticut; University of Connecticut; University of Connecticut; University of Connecticut; Hauptman Woodward Medical Research Institute; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of Connecticut; University of Connecticut	Radolf, JD (corresponding author), Univ Connecticut, Dept Med, Ctr Hlth, 263 Farmington Ave, Farmington, CT 06030 USA.	JRadolf@uchc.edu	Puthenveetil, Robbins/H-8949-2019; Vinogradova, Olga/ABE-8367-2020	Puthenveetil, Robbins/0000-0003-4958-6295; Vinogradova, Olga/0000-0001-5101-7361; Malkowski, Michael/0000-0002-1203-7463	National Institutes of Health (NIH) Public Health Service Grant [AI-26756]; NIH PSI: Biology Grant [U54 GM094611]; Connecticut Children's Medical Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI026756, R01AI026756, R37AI026756] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094611] Funding Source: NIH RePORTER	National Institutes of Health (NIH) Public Health Service Grant; NIH PSI: Biology Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Connecticut Children's Medical Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health (NIH) Public Health Service Grant AI-26756 (to J. D. R.) and NIH PSI: Biology Grant U54 GM094611 (to M. G. M.). This work was also supported by research funds from Connecticut Children's Medical Center.	Allaire M, 2011, J SYNCHROTRON RADIAT, V18, P41, DOI 10.1107/S0909049510036022; Anand A, 2013, J BACTERIOL, V195, P2060, DOI 10.1128/JB.00078-13; Anand A, 2012, J BACTERIOL, V194, P2321, DOI 10.1128/JB.00101-12; Basle A, 2006, J MOL BIOL, V362, P933, DOI 10.1016/j.jmb.2006.08.002; BEHER MG, 1980, J BACTERIOL, V143, P906, DOI 10.1128/JB.143.2.906-913.1980; Bennion D, 2010, MOL MICROBIOL, V77, P1153, DOI 10.1111/j.1365-2958.2010.07280.x; Blanco DR, 1997, EMERG INFECT DIS, V3, P11, DOI 10.3201/eid0301.970102; Blanco DR, 1996, J BACTERIOL, V178, P6685, DOI 10.1128/jb.178.23.6685-6692.1996; BLANCO DR, 1995, J BACTERIOL, V177, P3556, DOI 10.1128/jb.177.12.3556-3562.1995; BOURELL KW, 1994, J BACTERIOL, V176, P1598, DOI 10.1128/jb.176.6.1598-1608.1994; BRUSCA JS, 1994, METHOD ENZYMOL, V228, P182; Cameron CE, 2006, PATHOGENIC TREPONEMA : MOLECULAR AND CELLULAR BIOLOGY, P237; Cameron CE, 2014, VACCINE, V32, P1602, DOI 10.1016/j.vaccine.2013.09.053; Centurion-Lara A, 1999, J EXP MED, V189, P647, DOI 10.1084/jem.189.4.647; COWAN SW, 1995, STRUCTURE, V3, P1041, DOI 10.1016/S0969-2126(01)00240-4; COWAN SW, 1992, NATURE, V358, P727, DOI 10.1038/358727a0; Cox DL, 2010, INFECT IMMUN, V78, P5178, DOI 10.1128/IAI.00834-10; COX DL, 1995, MOL MICROBIOL, V15, P1151, DOI 10.1111/j.1365-2958.1995.tb02288.x; COX DL, 1992, INFECT IMMUN, V60, P1076, DOI 10.1128/IAI.60.3.1076-1083.1992; Cox DL, 2001, MICROBIOL-SGM, V147, P1161, DOI 10.1099/00221287-147-5-1161; COX DL, 1994, METHOD ENZYMOL, V236, P390; Cullen PA, 2006, EXPERT REV VACCINES, V5, P67, DOI 10.1586/14760584.5.1.67; de la Rosa-Trevin JM, 2013, J STRUCT BIOL, V184, P321, DOI 10.1016/j.jsb.2013.09.015; Desrosiers DC, 2011, MOL MICROBIOL, V80, P1496, DOI 10.1111/j.1365-2958.2011.07662.x; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010; EGLI C, 1993, INFECT IMMUN, V61, P1694, DOI 10.1128/IAI.61.5.1694-1699.1993; Ericsson UB, 2006, ANAL BIOCHEM, V357, P289, DOI 10.1016/j.ab.2006.07.027; Fairman JW, 2011, CURR OPIN STRUC BIOL, V21, P523, DOI 10.1016/j.sbi.2011.05.005; Fraser CM, 1998, SCIENCE, V281, P375, DOI 10.1126/science.281.5375.375; Galvao TF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056463; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Gatzeva-Topalova PZ, 2010, STRUCTURE, V18, P1492, DOI 10.1016/j.str.2010.08.012; Greenfield NJ, 2006, NAT PROTOC, V1, P2527, DOI 10.1038/nprot.2006.204; Guinier A., 1939, ANN PHYS-LEIPZIG, DOI DOI 10.1051/ANPHYS/193911120161; Hazlett KRO, 2005, J BACTERIOL, V187, P6499, DOI 10.1128/JB.187.18.6499-6508.2005; Hazlett KRO, 2001, J EXP MED, V193, P1015, DOI 10.1084/jem.193.9.1015; Heinz E, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00370; Heuck AP, 2003, J BIOL CHEM, V278, P31218, DOI 10.1074/jbc.M303151200; Ho EL, 2011, J CLIN INVEST, V121, P4584, DOI 10.1172/JCI57173; Hook EW, 2004, NEW ENGL J MED, V351, P122, DOI 10.1056/NEJMp048126; Izard J, 2009, J BACTERIOL, V191, P7566, DOI 10.1128/JB.01031-09; Kim S, 2007, SCIENCE, V317, P961, DOI 10.1126/science.1143993; Klausner JD, 2013, B WORLD HEALTH ORGAN, V91, P158, DOI 10.2471/BLT.13.118604; Koebnik R, 2000, MOL MICROBIOL, V37, P239, DOI 10.1046/j.1365-2958.2000.01983.x; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kumar S, 2001, BIOCHEMISTRY-US, V40, P14152, DOI 10.1021/bi0106383; LaFond RE, 2006, CLIN MICROBIOL REV, V19, P29, DOI 10.1128/CMR.19.1.29-49.2006; Lavinder JJ, 2009, J AM CHEM SOC, V131, P3794, DOI 10.1021/ja8049063; Liu J, 2010, J MOL BIOL, V403, P546, DOI 10.1016/j.jmb.2010.09.020; LUKEHART SA, 1978, J IMMUNOL, V121, P2014; Luthra A, 2011, J BIOL CHEM, V286, P41656, DOI 10.1074/jbc.M111.305284; Magnuson Harold J., 1948, AMER JOUR SYPHILIS GONORRHEA AND VENEREAL DIS, V32, P1; Marcoux J, 2014, STRUCTURE, V22, P781, DOI 10.1016/j.str.2014.03.004; Mitchell J. C., 2011, THERMOSTABLE PROTEIN; Nath A, 2007, BIOCHEMISTRY-US, V46, P2059, DOI 10.1021/bi602371n; Nicolay T, 2015, CRIT REV MICROBIOL, V41, P109, DOI 10.3109/1040841X.2013.804032; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Noinaj N, 2014, STRUCTURE, V22, P1055, DOI 10.1016/j.str.2014.05.008; Noinaj N, 2013, NATURE, V501, P385, DOI 10.1038/nature12521; Noinaj N, 2010, ANNU REV MICROBIOL, V64, P43, DOI 10.1146/annurev.micro.112408.134247; Norris SJ, 2001, J MOL MICROB BIOTECH, V3, P37; Pace C. N., 1997, PROTEIN STRUCTURE PR, V2, P299; Park JS, 2012, FASEB J, V26, P219, DOI 10.1096/fj.11-188425; Pascual-Montano A, 2001, J STRUCT BIOL, V133, P233, DOI 10.1006/jsbi.2001.4369; Paster BJ, 2006, PATHOGENIC TREPONEMA : MOLECULAR AND CELLULAR BIOLOGY, P9; Patton ME, 2014, MMWR-MORBID MORTAL W, V63, P402; Pauw BR, 2013, J PHYS-CONDENS MAT, V25, DOI 10.1088/0953-8984/25/38/383201; Pelikan M, 2009, GEN PHYSIOL BIOPHYS, V28, P174, DOI 10.4149/gpb_2009_02_174; Perez J, 2012, CURR OPIN STRUC BIOL, V22, P670, DOI 10.1016/j.sbi.2012.07.014; Petoukhov MV, 2007, CURR OPIN STRUC BIOL, V17, P562, DOI 10.1016/j.sbi.2007.06.009; Phale PS, 1998, BIOCHEMISTRY-US, V37, P15663, DOI 10.1021/bi981215c; Phale PS, 2001, BIOCHEMISTRY-US, V40, P6319, DOI 10.1021/bi010046k; RADOLF JD, 1989, P NATL ACAD SCI USA, V86, P2051, DOI 10.1073/pnas.86.6.2051; RADOLF JD, 1995, INFECT IMMUN, V63, P4244, DOI 10.1128/IAI.63.11.4244-4252.1995; RADOLF JD, 1995, MOL MICROBIOL, V16, P1067, DOI 10.1111/j.1365-2958.1995.tb02332.x; Radolf JD, 2006, PATHOGENIC TREPONEMA : MOLECULAR AND CELLULAR BIOLOGY, P285; Radolf JD, 2006, PATHOGENIC TREPONEMA : MOLECULAR AND CELLULAR BIOLOGY, P197; Radolf JD, 2009, MOL MICROBIOL, V72, P1081, DOI 10.1111/j.1365-2958.2009.06711.x; Receveur-Brechot V, 2012, CURR PROTEIN PEPT SC, V13, P55, DOI 10.2174/138920312799277901; Ricci DP, 2012, BBA-BIOMEMBRANES, V1818, P1067, DOI 10.1016/j.bbamem.2011.08.020; Ritchie TK, 2009, METHOD ENZYMOL, V464, P211, DOI 10.1016/S0076-6879(09)64011-8; Robert V, 2006, PLOS BIOL, V4, P1984, DOI 10.1371/journal.pbio.0040377; Salazar JC, 2002, MICROBES INFECT, V4, P1133, DOI 10.1016/S1286-4579(02)01638-6; Selkrig J, 2014, BBA-MOL CELL RES, V1843, P1542, DOI 10.1016/j.bbamcr.2013.10.009; Silhavy TJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000414; Sklar JG, 2007, GENE DEV, V21, P2473, DOI 10.1101/gad.1581007; Smith SGJ, 2007, FEMS MICROBIOL LETT, V273, P1, DOI 10.1111/j.1574-6968.2007.00778.x; STRUYVE M, 1991, J MOL BIOL, V218, P141, DOI 10.1016/0022-2836(91)90880-F; SUGAWARA E, 1994, J BIOL CHEM, V269, P17981; SUGAWARA E, 1992, J BIOL CHEM, V267, P2507; Sun ES, 2004, MICROBES INFECT, V6, P725, DOI 10.1016/j.micinf.2004.04.001; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Thein M, 2010, J PROTEOME RES, V9, P6135, DOI 10.1021/pr1002438; Tommassen J, 2010, MICROBIOL-SGM, V156, P2587, DOI 10.1099/mic.0.042689-0; Ulrich T, 2014, J BIOL CHEM, V289, P29457, DOI 10.1074/jbc.M114.565655; Ulrich T, 2012, J BIOL CHEM, V287, P27467, DOI 10.1074/jbc.M112.382093; van Heel M, 2000, Q REV BIOPHYS, V33, P307, DOI 10.1017/S0033583500003644; Visudtiphole V, 2005, BIOCHEM J, V392, P375, DOI 10.1042/BJ20051257; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; WALFIELD AM, 1982, SCIENCE, V216, P522, DOI 10.1126/science.7041257; WALKER EM, 1989, J BACTERIOL, V171, P5005, DOI 10.1128/jb.171.9.5005-5011.1989; Walton TA, 2009, P NATL ACAD SCI USA, V106, P1772, DOI 10.1073/pnas.0809275106; Wang Y, 2002, BIOCHEM BIOPH RES CO, V292, P396, DOI 10.1006/bbrc.2002.6657; WEISS MS, 1991, SCIENCE, V254, P1627, DOI 10.1126/science.1721242; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Workowski Kimberly A, 2010, MMWR Recomm Rep, V59, P1; Yamashita E, 2008, EMBO J, V27, P2171, DOI 10.1038/emboj.2008.137; Yildiz O, 2006, EMBO J, V25, P3702, DOI 10.1038/sj.emboj.7601237	109	21	23	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2015	290	19					12313	12331		10.1074/jbc.M114.629188	http://dx.doi.org/10.1074/jbc.M114.629188			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH9XA	25805501	Green Published, hybrid			2022-12-26	WOS:000354388600041
J	Bello, ML; Junior, AM; Vieira, BA; Dias, LRS; de Sousa, VP; Castro, HC; Rodrigues, CR; Cabral, LM				Bello, Murilo L.; Junior, Aridio M.; Vieira, Barbara A.; Dias, Luiza R. S.; de Sousa, Valeria P.; Castro, Helena C.; Rodrigues, Carlos R.; Cabral, Lucio M.			Sodium Montmorillonite/Amine-Containing Drugs Complexes: New Insights on Intercalated Drugs Arrangement into Layered Carrier Material	PLOS ONE			English	Article							HEAD GROUP-STRUCTURE; MOLECULAR-DYNAMICS; CLAY-MINERALS; FORCE-FIELD; NANOCOMPOSITES; 5-FLUOROURACIL; DELIVERY; SIMULATION; DENSITY; SURFACE	Layered drug delivery carriers are current targets of nanotechnology studies since they are able to accommodate pharmacologically active substances and are effective at modulating drug release. Sodium montmorillonite (Na-MMT) is a clay that has suitable properties for developing new pharmaceutical materials due to its high degree of surface area and high capacity for cation exchange. Therefore Na-MMT is a versatile material for the preparation of new drug delivery systems, especially for slow release of protonable drugs. Herein, we describe the intercalation of several amine-containing drugs with Na-MMT so we can derive a better understanding of how these drugs molecules interact with and distribute throughout the Na-MMT interlayer space. Therefore, for this purpose nine sodium montmorillonite/amine-containing drugs complexes (Na-MMT/drug) were prepared and characterized. In addition, the physicochemical properties of the drugs molecules in combination with different experimental conditions were assessed to determine how these factors influenced experimental outcomes (e.g. increase of the interlayer spacing versus drugs arrangement and orientation). We also performed a molecular modeling study of these amine-containing drugs associated with different Na-MMT/drug complex models to analyze the orientation and arrangement of the drugs molecules in the complexes studied. Six amine-containing drugs (rivastigmine, doxazosin, 5-fluorouracil, chlorhexidine, dapsone, nystatin) were found to successfully intercalate Na-MMT. These findings provide important insights on the interlayer aspect of the molecular systems formed and may contribute to produce more efficient drug delivery nanosystems.	[Bello, Murilo L.; Vieira, Barbara A.; Rodrigues, Carlos R.] Univ Fed Rio de Janeiro, Fac Farm, Lab Modelagem Mol & QSAR ModMolQSAR, Rio De Janeiro, RJ, Brazil; [Junior, Aridio M.; de Sousa, Valeria P.; Cabral, Lucio M.] Univ Fed Rio de Janeiro, Fac Farm, Lab Tecnol Farmaceut Ind LabTIF, Rio De Janeiro, RJ, Brazil; [Dias, Luiza R. S.] Univ Fed Fluminense, Fac Farm, Lab Quim Med LQMed, Niteroi, RJ, Brazil; [Castro, Helena C.] Univ Fed Fluminense, Inst Biol, LABiEMol, Niteroi, RJ, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal Fluminense; Universidade Federal Fluminense	Cabral, LM (corresponding author), Univ Fed Rio de Janeiro, Fac Farm, Lab Tecnol Farmaceut Ind LabTIF, Rio De Janeiro, RJ, Brazil.	lmcabral@pharma.ufrj.br	Rodrigues, Carlos Rangel/Q-2316-2019; Castro, Helena/V-2137-2019; Dias, Luiza R S/X-2847-2018; Mattos Junior, Aridio/AAE-4666-2022; Cabral, Lucio Mendes/Q-3120-2019; de sousa, valeria/K-7180-2012; Abrahim-Vieira, Bárbara/ABE-8450-2021	Rodrigues, Carlos Rangel/0000-0001-8453-7654; Dias, Luiza R S/0000-0001-5809-5602; de sousa, valeria/0000-0003-1589-0846; Castro, Helena Carla/0000-0001-5283-1541	Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Financial support and fellowships from Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) were received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguzzi C, 2007, APPL CLAY SCI, V36, P22, DOI 10.1016/j.clay.2006.06.015; Arruebo M, 2012, WIRES NANOMED NANOBI, V4, P16, DOI 10.1002/wnan.132; Bar-On P, 2002, BIOCHEMISTRY-US, V41, P3555, DOI 10.1021/bi020016x; Bello ML, 2011, BIOORGAN MED CHEM, V19, P5046, DOI 10.1016/j.bmc.2011.06.023; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bongur R, 2010, J PHYS CHEM C, V114, P752, DOI 10.1021/jp907051f; Carretero MI, 2002, APPL CLAY SCI, V21, P155, DOI 10.1016/S0169-1317(01)00085-0; Choi YS, 2004, CHEM MATER, V16, P2522, DOI 10.1021/cm0348601; Cygan RT, 2012, J PHYS CHEM C, V116, P13079, DOI 10.1021/jp3007574; Cygan RT, 2009, J MATER CHEM, V19, P2470, DOI 10.1039/b819076c; Ewald PP, 1921, ANN PHYS-BERLIN, V64, P253; Fu YT, 2010, CHEM MATER, V22, P1595, DOI 10.1021/cm902784r; Funk RS, 2012, MOL PHARMACEUT, V9, P1384, DOI 10.1021/mp200641e; Ganguly S, 2011, J THERM ANAL CALORIM, V105, P199, DOI 10.1007/s10973-011-1356-5; Halgren TA, 1996, J COMPUT CHEM, V17, P490, DOI [10.1002/(SICI)1096-987X(199604)17:5/6<490::AID-JCC1>3.0.CO;2-P, 10.1002/(SICI)1096-987X(199604)17:5/6<616::AID-JCC5>3.0.CO;2-X]; Heinz H, 2005, CHEM MATER, V17, P5658, DOI 10.1021/cm0509328; Heinz H, 2012, CLAY MINER, V47, P205, DOI 10.1180/claymin.2012.047.2.05; Heinz H, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2202330; Heinz H, 2007, CHEM MATER, V19, P59, DOI 10.1021/cm062019s; HESTENES MR, 1952, J RES NAT BUR STAND, V49, P409, DOI 10.6028/jres.049.044; Holesova S, 2009, J MOL STRUCT, V923, P85, DOI 10.1016/j.molstruc.2009.02.005; Jha KC, 2013, J PHYS CHEM C, V117, P25969, DOI 10.1021/jp4032404; Joshi GV, 2009, APPL CLAY SCI, V45, P248, DOI 10.1016/j.clay.2009.06.001; Joshi GV, 2009, INT J PHARMACEUT, V374, P53, DOI 10.1016/j.ijpharm.2009.03.004; Kevadiya BD, 2012, EUR J PHARM BIOPHARM, V81, P91, DOI 10.1016/j.ejpb.2012.01.004; Krishnan M, 2013, J PHYS CHEM C, V117, P20592, DOI 10.1021/jp405321t; Lemmer H, 2012, CRYST GROWTH DES, V12, P1683, DOI 10.1021/cg300019f; Lin FH, 2002, BIOMATERIALS, V23, P1981, DOI 10.1016/S0142-9612(01)00325-8; Lopes S, 2002, J PHYS CHEM B, V106, P7278, DOI 10.1021/jp020160s; Markova N, 2010, J PHYS CHEM A, V114, P13154, DOI 10.1021/jp1063879; Meng N, 2009, INT J PHARMACEUT, V382, P45, DOI 10.1016/j.ijpharm.2009.08.004; Murray HH, 2000, APPL CLAY SCI, V17, P207, DOI 10.1016/S0169-1317(00)00016-8; Polizos G, 2013, J PHYS CHEM B, V117, P13667, DOI 10.1021/jp4067845; Pupe CG, 2011, INT J NANOMED, V6, P2581, DOI 10.2147/IJN.S25667; Ranade A, 2002, POLYMER, V43, P3759, DOI 10.1016/S0032-3861(02)00106-4; Rocha GB, 2006, J COMPUT CHEM, V27, P1101, DOI 10.1002/jcc.20425; Scocchi G, 2007, J PHYS CHEM B, V111, P2143, DOI 10.1021/jp067649w; Segad M, 2012, J PHYS CHEM C, V116, P7596, DOI 10.1021/jp300531y; Shaw YJ, 2004, J MED CHEM, V47, P4453, DOI 10.1021/jm049752k; Toth R, 2004, POLYMER, V45, P8075, DOI 10.1016/j.polymer.2004.09.025; TSIPURSKY SI, 1984, CLAY MINER, V19, P177, DOI 10.1180/claymin.1984.019.2.05; Viseras C, 2010, APPL CLAY SCI, V48, P291, DOI 10.1016/j.clay.2010.01.007; Wungu TDK, 2011, J NANOSCI NANOTECHNO, V11, P2793, DOI 10.1166/jnn.2011.3913; Xu Y, 2013, MINER ENG, V53, P101, DOI 10.1016/j.mineng.2013.07.006; Yang D, 2007, J THERM ANAL CALORIM, V89, P847, DOI 10.1007/s10973-006-8318-3; Zheng JP, 2007, J WUHAN UNIV TECHNOL, V22, P250, DOI 10.1007/s11595-005-2250-4	46	29	31	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0121110	10.1371/journal.pone.0121110	http://dx.doi.org/10.1371/journal.pone.0121110			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803292	Green Submitted, gold, Green Published			2022-12-26	WOS:000353889600126
J	Gramage, E; D'Cruz, T; Taylor, S; Thummel, R; Hitchcock, PF				Gramage, Esther; D'Cruz, Travis; Taylor, Scott; Thummel, Ryan; Hitchcock, Peter F.			Midkine-a Protein Localization in the Developing and Adult Retina of the Zebrafish and Its Function During Photoreceptor Regeneration	PLOS ONE			English	Article							MULLER GLIA; NEURONAL PROGENITORS; GENE-EXPRESSION; CELL-DEATH; REGIONAL DIFFERENCES; TELEOST RETINA; GROWTH-FACTORS; ROD; PLEIOTROPHIN; NEUROGENESIS	Midkine is a heparin binding growth factor with important functions in neuronal development and survival, but little is known about its function in the retina. Previous studies show that in the developing zebrafish, Midkine-a (Mdka) regulates cell cycle kinetics in retinal progenitors, and following injury to the adult zebrafish retina, mdka is strongly upregulated in Muller gila and the injury-induced photoreceptor progenitors. Here we provide the first data describing Mdka protein localization during different stages of retinal development and during the regeneration of photoreceptors in adults. We also experimentally test the role of Mdka during photoreceptor regeneration. The immuno-localization of Mdka reflects the complex spatiotemporal pattern of gene expression and also reveals the apparent secretion and extracellular trafficking of this protein. During embryonic retinal development the Mdka antibodies label all mitotically active cells, but at the onset of neuronal differentiation, immunostaining is also localized to the nascent inner plexiform layer. Starting at five days post fertilization through the juvenile stage, Mdka immunostaining labels the cytoplasm of horizontal cells and the overlying somata of rod photoreceptors. Double immunolabeling shows that in adult horizontal cells, Mdka co-localizes with markers of the Golgi complex. Together, these data are interpreted to show that Mdka is synthesized in horizontal cells and secreted into the outer nuclear layer. In adults, Mdka is also present in the end feet of Muller glia. Similar to mdka gene expression, Mdka in horizontal cells is regulated by circadian rhythms. After the light-induced death of photoreceptors, Mdka immuonolabeling is localized to Muller gila, the intrinsic stem cells of the zebrafish retina, and proliferating photoreceptor progenitors. Knockdown of Mdka during photoreceptor regeneration results in less proliferation and diminished regeneration of rod photoreceptors. These data suggest that during photoreceptor regeneration Mdka regulates aspects of injury-induced cell proliferation.	[Gramage, Esther; D'Cruz, Travis; Taylor, Scott; Hitchcock, Peter F.] Univ Michigan, Dept Ophthalmol & Visual Sci, Ann Arbor, MI 48109 USA; [Thummel, Ryan] Wayne State Univ, Sch Med, Dept Anat & Cell Biol, Detroit, MI 48201 USA; [Thummel, Ryan] Wayne State Univ, Sch Med, Dept Ophthalmol, Detroit, MI USA	University of Michigan System; University of Michigan; Wayne State University; Wayne State University	Hitchcock, PF (corresponding author), Univ Michigan, Dept Ophthalmol & Visual Sci, Ann Arbor, MI 48109 USA.	peterh@med.umich.edu	Hitchcock, Peter/AAY-9559-2020; Taylor, Scott/AAX-1304-2021; Taylor, Scott/AFY-7113-2022; Gramage, Esther/K-6441-2014	Hitchcock, Peter/0000-0001-9454-2684; Taylor, Scott/0000-0002-5823-5043; Gramage, Esther/0000-0002-5134-1273	National Institutes of Health (National Eye Institute) [R01 EY07060]; NATIONAL EYE INSTITUTE [R01EY007060] Funding Source: NIH RePORTER	National Institutes of Health (National Eye Institute)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the National Institutes of Health (National Eye Institute) R01 EY07060. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agathocleous M, 2009, ANNU REV CELL DEV BI, V25, P45, DOI 10.1146/annurev.cellbio.042308.113259; Baye LM, 2008, BRAIN RES, V1192, P29, DOI 10.1016/j.brainres.2007.05.021; Bernardos RL, 2007, J NEUROSCI, V27, P7028, DOI 10.1523/JNEUROSCI.1624-07.2007; Bibliowicz J, 2011, PROG MOL BIOL TRANSL, V100, P287, DOI 10.1016/B978-0-12-384878-9.00007-8; BLOCH B, 1992, DEV BRAIN RES, V70, P267, DOI 10.1016/0165-3806(92)90206-C; Calinescu AA, 2009, VISUAL NEUROSCI, V26, P495, DOI 10.1017/S0952523809990204; Calinescu AA, 2009, J COMP NEUROL, V514, P1, DOI 10.1002/cne.21999; Clark BS, 2012, DEVELOPMENT, V139, P1599, DOI 10.1242/dev.078097; Craig SEL, 2010, INVEST OPHTH VIS SCI, V51, P3244, DOI 10.1167/iovs.09-4879; Craig Sonya E L, 2008, J Ocul Biol Dis Infor, V1, P73, DOI 10.1007/s12177-008-9011-5; Easter SS, 2002, RES PRO CEL, V40, P346; Ezquerra L, 2007, EUR J PHARMACOL, V557, P147, DOI 10.1016/j.ejphar.2006.11.024; Fimbel SM, 2007, J NEUROSCI, V27, P1712, DOI 10.1523/JNEUROSCI.5317-06.2007; Flatscher-Bader T, 2008, ALCOHOL CLIN EXP RES, V32, P1849, DOI 10.1111/j.1530-0277.2008.00754.x; Fraser B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055410; Gemberling M, 2013, TRENDS GENETICS TIG, P1; Goldman D, 2014, MULLER GLIAL CELL RE; Gramage E, 2011, NEUROSCIENCE, V190, P307, DOI 10.1016/j.neuroscience.2011.06.014; Halfter W, 2001, DEV BIOL, V238, P79, DOI 10.1006/dbio.2001.0396; Herradon G, 2014, BRIT J PHARMACOL, V171, P837, DOI 10.1111/bph.12312; Hitchcock PF, 2004, ZEBRAFISH, V1, P257, DOI 10.1089/zeb.2004.1.257; Hoggard N, 2012, OBESITY, V20, P1158, DOI 10.1038/oby.2012.14; Hu M, 1999, DEV BIOL, V207, P309, DOI 10.1006/dbio.1998.9031; Karl MO, 2010, TRENDS MOL MED, V16, P193, DOI 10.1016/j.molmed.2010.02.003; Lenkowski JR, 2013, GLIA, V61, P1687, DOI 10.1002/glia.22549; Lenkowski JR, 2014, PROG RETIN EYE RES; Lien CL, 2006, PLOS BIOL, V4, P1386, DOI 10.1371/journal.pbio.0040260; LINSER P, 1979, P NATL ACAD SCI USA, V76, P6476, DOI 10.1073/pnas.76.12.6476; London A, 2013, NAT REV NEUROL, V9, P44, DOI 10.1038/nrneurol.2012.227; Luo J, 2012, INT J DISTRIB SENS N, DOI 10.1155/2012/398460; Marchionini DM, 2007, BRAIN RES, V1147, P77, DOI 10.1016/j.brainres.2007.02.028; Mathias JR, 2014, ZEBRAFISH, V11, P85, DOI 10.1089/zeb.2013.0937; Miyashiro M, 1998, CURR EYE RES, V17, P9, DOI 10.1076/ceyr.17.1.9.5257; Montgomery JE, 2010, J COMP NEUROL, V518, P800, DOI 10.1002/cne.22243; Morris AC, 2005, INVEST OPHTH VIS SCI, V46, P4762, DOI 10.1167/iovs.05-0797; Muramatsu T, 2010, P JPN ACAD B-PHYS, V86, P410, DOI 10.2183/pjab.86.410; Muramoto A, 2013, NEUROSCI LETT, V550, P150, DOI 10.1016/j.neulet.2013.06.025; Nagashima M, 2013, DEVELOPMENT, V140, P4510, DOI 10.1242/dev.090738; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Nelson CM, 2012, J COMP NEUROL, V520, P4294, DOI 10.1002/cne.23213; Ochocinska MJ, 2007, J COMP NEUROL, V501, P1, DOI 10.1002/cne.21150; Otteson DC, 2002, MECH DEVELOP, V117, P137, DOI 10.1016/S0925-4773(02)00188-0; Park JY, 2012, J NEUROSCI, V32, P7356, DOI 10.1523/JNEUROSCI.0397-12.2012; Prediger RDS, 2011, J NEURAL TRANSM, V118, P1215, DOI 10.1007/s00702-010-0568-3; Qi MS, 2000, J BIOCHEM, V127, P269, DOI 10.1093/oxfordjournals.jbchem.a022604; Qin Z, 2011, EXP EYE RES, V93, P726, DOI 10.1016/j.exer.2011.09.003; Ramachandran R, 2012, NAT CELL BIOL, V14, P1013, DOI 10.1038/ncb2586; Ramachandran R, 2011, P NATL ACAD SCI USA, V108, P15858, DOI 10.1073/pnas.1107220108; Raymond PA, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-36; Sakakima H, 2009, J NEUROSCI RES, V87, P2908, DOI 10.1002/jnr.22127; Schebesta M, 2006, THESCIENTIFICWORLDJO, V6, P38, DOI 10.1100/tsw.2006.326; Schmitt EA, 1996, J COMP NEUROL, V371, P222, DOI 10.1002/(SICI)1096-9861(19960722)371:2<222::AID-CNE3>3.0.CO;2-4; Shields CR, 2007, J COMP NEUROL, V501, P765, DOI 10.1002/cne.21282; Stenkamp DL, 2007, INT REV CYTOL, V259, P173, DOI 10.1016/S0074-7696(06)59005-9; Sun L, 2014, J CHEM-NY, DOI DOI 10.1155/2014/295149; Taravini IRE, 2005, BRAIN RES, V1066, P196, DOI 10.1016/j.brainres.2005.10.055; Taylor Scott, 2012, Methods Mol Biol, V884, P247, DOI 10.1007/978-1-61779-848-1_17; Thomas JL, 2013, JOVE-J VIS EXP, DOI 10.3791/51017; Thomas JL, 2012, EXP EYE RES, V97, P105, DOI 10.1016/j.exer.2012.02.004; Thummel R, 2008, EXP EYE RES, V87, P433, DOI 10.1016/j.exer.2008.07.009; Thummel R, 2011, JOVE-J VIS EXP, DOI 10.3791/3603; VANDERWINDEN JM, 1992, ANAT EMBRYOL, V186, P387; Vihtelic TS, 2006, EXP EYE RES, V82, P558, DOI 10.1016/j.exer.2005.08.015; Vihtelic TS, 2000, J NEUROBIOL, V44, P289, DOI 10.1002/1097-4695(20000905)44:3<289::AID-NEU1>3.0.CO;2-H; Weber A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080483; Winkler C, 2003, GENOME RES, V13, P1067, DOI 10.1101/gr.1097503; Winkler C, 2013, BR J PHARM; Yoshida Y, 2001, BRAIN RES, V894, P46, DOI 10.1016/S0006-8993(00)03209-1; Yoshida Y, 2014, BRIT J PHARMACOL, V171, P924, DOI 10.1111/bph.12497; Zhao XF, 2014, CELL REP, V9, P272, DOI 10.1016/j.celrep.2014.08.047; Zhou H, 1997, MOL CELL NEUROSCI, V10, P56, DOI 10.1006/mcne.1997.0638	71	21	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0121789	10.1371/journal.pone.0121789	http://dx.doi.org/10.1371/journal.pone.0121789			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803551	Green Published, Green Submitted, gold			2022-12-26	WOS:000353889600176
J	Oblak, A; Pohar, J; Jerala, R				Oblak, Alja; Pohar, Jelka; Jerala, Roman			MD-2 Determinants of Nickel and Cobalt-Mediated Activation of Human TLR4	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-4; LIPOPOLYSACCHARIDE RECOGNITION; SIGNAL-TRANSDUCTION; CONTACT-DERMATITIS; STRUCTURAL BASIS; COMPLEX; ENDOTOXIN; ALLERGY; INDUCTION; PALLADIUM	Recent findings unexpectedly revealed that human TLR4 can be directly activated by nickel ions. This activation is due to the coordination of nickel by a cluster of histidine residues on the ectodomain of human TLR4, which is absent in most other species. We aimed to elucidate the role of MD-2 in the molecular mechanism of TLR4/MD-2 activation by nickel, as nickel binding site on TLR4 is remote from MD-2, which directly binds the endotoxin as the main pathological activator of TLR4. We identified MD-2 and TLR4 mutants which abolished TLR4/MD-2 receptor activation by endotoxin but could nevertheless be significantly activated by nickel, which acts in synergy with LPS. Human TLR4/MD-2 was also activated by cobalt ions, while copper and cadmium were toxic in the tested concentration range. Activation of TLR4 by cobalt required MD-2 and was abolished by human TLR4 mutations of histidine residues at positions 456 and 458. We demonstrated that activation of TLR4 by nickel and cobalt ions can trigger both the MyD88-dependent and the -independent pathway. Based on our results we propose that predominantly hydrophobic interactions between MD-2 and TLR4 contribute to the stabilization of the TLR4/MD-2/metal ion complex in a conformation that enables activation.	[Oblak, Alja; Pohar, Jelka; Jerala, Roman] Natl Inst Chem, Dept Biotechnol, Ljubljana, Slovenia; [Oblak, Alja; Pohar, Jelka; Jerala, Roman] Ctr Excellence EN FIST, Ljubljana, Slovenia	National Institute of Chemistry - Slovenia	Jerala, R (corresponding author), Natl Inst Chem, Dept Biotechnol, Ljubljana, Slovenia.	roman.jerala@ki.si	Jerala, Roman/H-9850-2015	Jerala, Roman/0000-0002-6337-5251	Slovenian research agency; EN-FIST Centre of Excellence of Slovenia; EU	Slovenian research agency(Slovenian Research Agency - Slovenia); EN-FIST Centre of Excellence of Slovenia; EU(European Commission)	The project was supported by grants from the Slovenian research agency and EN-FIST Centre of Excellence of Slovenia, which is funded by the structural funds from the EU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi S, 2001, INT IMMUNOL, V13, P1595, DOI 10.1093/intimm/13.12.1595; Barceloux DG, 1999, J TOXICOL-CLIN TOXIC, V37, P201, DOI 10.1081/CLT-100102420; Erridge C, 2010, J LEUKOCYTE BIOL, V87, P989, DOI 10.1189/jlb.1209775; Faurschou A, 2011, CONTACT DERMATITIS, V64, P185, DOI 10.1111/j.1600-0536.2011.01878.x; Fitzgerald KA, 2004, MICROBES INFECT, V6, P1361, DOI 10.1016/j.micinf.2004.08.015; Gangloff M, 2012, TRENDS BIOCHEM SCI, V37, P92, DOI 10.1016/j.tibs.2011.11.003; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kawasaki K, 2000, J BIOL CHEM, V275, P2251, DOI 10.1074/jbc.275.4.2251; Lin RT, 2000, J BIOL CHEM, V275, P34320, DOI 10.1074/jbc.M002814200; Majumder S, 1998, J IMMUNOL, V161, P4736; Malachowski L, 2003, ANAL CHIM ACTA, V495, P151, DOI 10.1016/j.aca.2003.08.039; Meng JM, 2010, J BIOL CHEM, V285, P8695, DOI 10.1074/jbc.M109.075127; Nagai Y, 2002, NAT IMMUNOL, V3, P667, DOI 10.1038/ni809; Nijhawan RI, 2009, DERMATOL CLIN, V27, P355, DOI 10.1016/j.det.2009.05.005; Oblak A, 2015, MOL IMMUNOL, V63, P134, DOI 10.1016/j.molimm.2014.06.034; Oblak A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107520; Ohto U, 2007, SCIENCE, V316, P1632, DOI 10.1126/science.1139111; Ohto U, 2012, P NATL ACAD SCI USA, V109, P7421, DOI 10.1073/pnas.1201193109; Panter G, 2011, J BIOL CHEM, V286, P23334, DOI 10.1074/jbc.M110.205419; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rachmawati D, 2013, CONTACT DERMATITIS, V68, P331, DOI 10.1111/cod.12042; Raghavan B, 2012, EMBO REP, V13, P1109, DOI 10.1038/embor.2012.155; Resman N, 2009, J BIOL CHEM, V284, P15052, DOI 10.1074/jbc.M901429200; Schmidt M, 2010, NAT IMMUNOL, V11, P814, DOI 10.1038/ni.1919; Thyssen JP, 2011, CONTACT DERMATITIS, V64, P121, DOI 10.1111/j.1600-0536.2010.01852.x; Viriyakosol S, 2001, J BIOL CHEM, V276, P38044; Vocanson M, 2009, ALLERGY, V64, P1699, DOI 10.1111/j.1398-9995.2009.02082.x; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yamamoto M, 2003, NAT IMMUNOL, V4, P1144, DOI 10.1038/ni986; Zoroddu MA, 2013, DALT T, V43, P2764	31	25	26	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0120583	10.1371/journal.pone.0120583	http://dx.doi.org/10.1371/journal.pone.0120583			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803856	gold, Green Submitted, Green Published			2022-12-26	WOS:000353889600082
J	Rockenstein, E; Overk, CR; Ubhi, K; Mante, M; Patrick, C; Adame, A; Bisquert, A; Trejo-Morales, M; Spencer, B; Masliah, E				Rockenstein, Edward; Overk, Cassia R.; Ubhi, Kiren; Mante, Michael; Patrick, Christina; Adame, Anthony; Bisquert, Alejandro; Trejo-Morales, Margarita; Spencer, Brian; Masliah, Eliezer			A Novel Triple Repeat Mutant Tau Transgenic Model That Mimics Aspects of Pick's Disease and Fronto-Temporal Tauopathies	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; ALPHA-SYNUCLEIN; ANIMAL-MODELS; MOUSE MODEL; G272V TAU; MICE; PATHOLOGY; DEMENTIA; DEGENERATION; MUTATION	Tauopathies are a group of disorders leading to cognitive and behavioral impairment in the aging population. While four-repeat (4R) Tau is more abundant in corticobasal degeneration, progressive supranuclear palsy, and Alzheimer's disease, three-repeat (3R) Tau is the most abundant splice, in Pick's disease. A number of transgenic models expressing wildtype and mutant forms of the 4R Tau have been developed. However, few models of three-repeat Tau are available. A transgenic mouse model expressing three-repeat Tau was developed bearing the mutations associated with familial forms of Pick's disease (L266V and G272V mutations). Two lines expressing high (Line 13) and low (Line 2) levels of the three-repeat mutant Tau were analyzed. By Western blot, using antibodies specific to three-repeat Tau, Line 13 expressed 5-times more Tau than Line 2. The Tau expressed by these mice was most abundant in the frontal-temporal cortex and limbic system and was phosphorylated at residues detected by the PHF-1, AT8, CP9 and CP13 antibodies. The higher-expressing mice displayed hyperactivity, memory deficits in the water maze and alterations in the round beam. The behavioral deficits started at 6-8 months of age and were associated with a progressive increase in the accumulation of 3R Tau. By immunocytochemistry, mice from Line 13 displayed extensive accumulation of 3R Tau in neuronal cells bodies in the pyramidal neurons of the neocortex, CA1-3 regions, and dentate gyrus of the hippocampus. Aggregates in the granular cells had a globus appearance and mimic Pick's-like inclusions. There were abundant dystrophic neurites, astrogliosis and synapto-dendritic damage in the neocortex and hippocampus of the higher expresser line. The hippocampal lesions were moderately argyrophilic and Thioflavin-S negative. By electron microscopy, discrete straight filament aggregates were detected in some neurons in the hippocampus. This model holds promise for better understanding the natural history and progression of 3R tauopathies and their relationship with mitochondrial alterations and might be suitable for therapeutical testing.	[Rockenstein, Edward; Overk, Cassia R.; Ubhi, Kiren; Mante, Michael; Patrick, Christina; Adame, Anthony; Bisquert, Alejandro; Trejo-Morales, Margarita; Spencer, Brian; Masliah, Eliezer] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Masliah, Eliezer] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Masliah, E (corresponding author), Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA.	emasliah@ucsd.edu			National Institutes of Health [AG18440, NS044233, AG011385, AG010435, NS057096]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS044233, P30NS057096] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG018440, R01AG018440, P01AG010435, R37AG011385, R01AG011385, P50AG005131] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institutes of Health (AG18440, NS044233, AG011385, AG010435, NS057096) to EM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREADIS A, 1992, BIOCHEMISTRY-US, V31, P10626, DOI 10.1021/bi00158a027; Barker WW, 2002, ALZ DIS ASSOC DIS, V16, P203, DOI 10.1097/00002093-200210000-00001; Bronner IF, 2005, BRAIN, V128, P2645, DOI 10.1093/brain/awh591; Buee L, 1999, BRAIN PATHOL, V9, P681; Bunker JM, 2006, J BIOL CHEM, V281, P11856, DOI 10.1074/jbc.M509420200; Chen YM, 2012, J NEUROSCI, V32, P11390, DOI 10.1523/JNEUROSCI.0757-12.2012; CONSTANT.J, 1974, EUR NEUROL, V11, P208, DOI 10.1159/000114320; de Calignon A, 2012, NEURON, V73, P685, DOI 10.1016/j.neuron.2011.11.033; de Silva R, 2006, ACTA NEUROPATHOL, V111, P329, DOI 10.1007/s00401-006-0048-x; Dickson D, 2011, J MOL NEUROSCI, V45, P384, DOI 10.1007/s12031-011-9589-0; DuBoff B, 2012, NEURON, V75, P618, DOI 10.1016/j.neuron.2012.06.026; Filipcik P, 2012, NEUROBIOL AGING, V33, P1448, DOI 10.1016/j.neurobiolaging.2010.10.015; Frank S, 2008, ACTA NEUROPATHOL, V115, P39, DOI 10.1007/s00401-007-0291-9; Gotz J, 2001, EUR J NEUROSCI, V13, P2131, DOI 10.1046/j.0953-816x.2001.01604.x; Gotz J, 2008, NAT REV NEUROSCI, V9, P532, DOI 10.1038/nrn2420; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; Han D, 2009, J BIOL CHEM, V284, P13422, DOI 10.1074/jbc.M901095200; Hansen LA, 1997, NEUROLOGY, V48, P126, DOI 10.1212/WNL.48.1.126; Hogg M, 2003, ACTA NEUROPATHOL, V106, P323, DOI 10.1007/s00401-003-0734-x; Iqbal K, 2005, BBA-MOL BASIS DIS, V1739, P198, DOI 10.1016/j.bbadis.2004.09.008; Ishihara T, 1999, NEURON, V24, P751, DOI 10.1016/S0896-6273(00)81127-7; Ishihara T, 2001, AM J PATHOL, V158, P555, DOI 10.1016/S0002-9440(10)63997-1; Kobayashi T, 2003, ANN NEUROL, V53, P133, DOI 10.1002/ana.10447; LANG AE, 1994, NEUROLOGY, V44, P1436, DOI 10.1212/WNL.44.8.1436; Lee HJ, 2010, J BIOL CHEM, V285, P9262, DOI 10.1074/jbc.M109.081125; Lee VMY, 2005, BBA-MOL BASIS DIS, V1739, P251, DOI 10.1016/j.bbadis.2004.06.014; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Liu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031302; Mandelkow EM, 2003, NEUROBIOL AGING, V24, P1079, DOI 10.1016/j.neurobiolaging.2003.04.007; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; Masliah E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019338; Murrell JR, 1999, J NEUROPATH EXP NEUR, V58, P1207, DOI 10.1097/00005072-199912000-00002; Overk CR, 2009, NEUROBIOL DIS, V35, P415, DOI 10.1016/j.nbd.2009.06.004; Rockenstein E, 2002, J NEUROSCI RES, V68, P568, DOI 10.1002/jnr.10231; Rockenstein E, 2001, J NEUROSCI RES, V66, P573, DOI 10.1002/jnr.1247; Rockenstein E, 2014, BMC NEUROSCI, V15, DOI 10.1186/1471-2202-15-90; ROCKENSTEIN EM, 1995, J BIOL CHEM, V270, P28257; Sanchez PE, 2012, P NATL ACAD SCI USA, V109, pE2895, DOI 10.1073/pnas.1121081109; Schindowski K, 2006, AM J PATHOL, V169, P599, DOI 10.2353/ajpath.2006.060002; Schulz KL, 2012, MOL NEUROBIOL, V46, P205, DOI 10.1007/s12035-012-8308-3; Shiryaev N, 2010, J NEUROSCI RES, V88, P2727, DOI 10.1002/jnr.22431; Ubhi K, 2010, NEUROREPORT; Ubhi K, 2010, J NEUROSCI, V30, P6236, DOI 10.1523/JNEUROSCI.0567-10.2010; Zhukareva V, 2002, AM J PATHOL, V161, P1135, DOI 10.1016/S0002-9440(10)64390-8	44	21	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0121570	10.1371/journal.pone.0121570	http://dx.doi.org/10.1371/journal.pone.0121570			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803611	Green Published, Green Submitted, gold			2022-12-26	WOS:000353889600163
J	Walker, WH; Easton, E; Moreci, RS; Toocheck, C; Anamthathmakula, P; Jeyasuria, P				Walker, William H.; Easton, Evan; Moreci, Rebecca S.; Toocheck, Corey; Anamthathmakula, Prashanth; Jeyasuria, Pancharatnam			Restoration of Spermatogenesis and Male Fertility Using an Androgen Receptor Transgene	PLOS ONE			English	Article							BACTERIAL ARTIFICIAL CHROMOSOMES; BLOOD-TESTIS BARRIER; SERTOLI-CELLS; COPY NUMBER; SEMINIFEROUS EPITHELIUM; JUNCTION DYNAMICS; ROUND SPERMATIDS; MICE LACKING; GERM-CELLS; TESTOSTERONE	Androgens signal through the androgen receptor (AR) to regulate male secondary sexual characteristics, reproductive tract development, prostate function, sperm production, bone and muscle mass as well as body hair growth among other functions. We developed a transgenic mouse model in which endogenous AR expression was replaced by a functionally modified AR transgene. A bacterial artificial chromosome (BAC) was constructed containing all AR exons and introns plus 40 kb each of 5' and 3' regulatory sequence. Insertion of an internal ribosome entry site and the EGFP gene 3' to AR allowed co-expression of AR and EGFP. Pronuclear injection of the BAC resulted in six founder mice that displayed EGFP production in appropriate AR expressing tissues. The six founder mice were mated into a Sertoli cell specific AR knockout (SCARKO) background in which spermatogenesis is blocked at the meiosis stage of germ cell development. The AR-EGFP transgene was expressed in a cyclical manner similar to that of endogenous AR in Sertoli cells and fertility was restored as offspring were produced in the absence of Sertoli cell AR. Thus, the AREGFP transgene under the control of AR regulatory elements is capable of rescuing AR function in a cell selective, AR-null background. These initial studies provide proof of principle that a strategy employing the AR-EGFP transgene can be used to understand AR functions. Transgenic mice expressing selective modifications of the AR-EGFP transgene may provide crucial information needed to elicit the molecular mechanisms by which AR acts in the testis and other androgen responsive tissues.	[Walker, William H.; Easton, Evan; Moreci, Rebecca S.; Toocheck, Corey; Anamthathmakula, Prashanth; Jeyasuria, Pancharatnam] Univ Pittsburgh, Magee Womens Res Inst, Ctr Res Reprod Physiol, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute	Walker, WH (corresponding author), Univ Pittsburgh, Magee Womens Res Inst, Ctr Res Reprod Physiol, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA 15260 USA.	walker@pitt.edu	Anamthathmakula, Prashanth/AAP-8708-2021; Jeyasuria, Pancharatnam/B-4710-2008	Jeyasuria, Pancharatnam/0000-0002-1388-906X; Anamthathmakula, Prashanth/0000-0002-0664-9746	Eunice Kennedy Shiver National Institute of Child Health and Human Development (NICHD) National Institutes of Health (NIH) cooperative agreement, Specialized Centers Program in Reproduction and Infertility Research (Pilot Project) [2U54 HD008610-36A1]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U54HD008610] Funding Source: NIH RePORTER	Eunice Kennedy Shiver National Institute of Child Health and Human Development (NICHD) National Institutes of Health (NIH) cooperative agreement, Specialized Centers Program in Reproduction and Infertility Research (Pilot Project); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the Eunice Kennedy Shiver National Institute of Child Health and Human Development (NICHD) National Institutes of Health (NIH) cooperative agreement grant 2U54 HD008610-36A1 as part of the Specialized Centers Program in Reproduction and Infertility Research (Pilot Project, WHW and PJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballester M, 2004, BIOTECHNIQUES, V37, P610, DOI 10.2144/04374ST06; BREMNER WJ, 1994, ENDOCRINOLOGY, V135, P1227, DOI 10.1210/en.135.3.1227; Chandler KJ, 2007, MAMM GENOME, V18, P693, DOI 10.1007/s00335-007-9056-y; Chandler RL, 2007, MOL CELL BIOL, V27, P2934, DOI 10.1128/MCB.01609-06; Chang CS, 2004, P NATL ACAD SCI USA, V101, P6876, DOI 10.1073/pnas.0307306101; De Gendt K, 2004, P NATL ACAD SCI USA, V101, P1327, DOI 10.1073/pnas.0308114100; Foradori CD, 2007, NEUROSCIENCE, V149, P155, DOI 10.1016/j.neuroscience.2007.06.054; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Gong SC, 2002, GENOME RES, V12, P1992, DOI 10.1101/gr.476202; Hamdi MM, 2011, J PHYSIOL-LONDON, V589, P3623, DOI 10.1113/jphysiol.2011.207175; Hazra R, 2013, MOL ENDOCRINOL, V27, P12, DOI 10.1210/me.2012-1219; Holdcraft RW, 2004, DEVELOPMENT, V131, P459, DOI 10.1242/dev.00957; Johnston DS, 2001, ENDOCRINOLOGY, V142, P2405, DOI 10.1210/en.142.6.2405; Joshi MU, 2008, BIOTECHNIQUES, V45, P247, DOI 10.2144/000112913; LYON MF, 1975, NATURE, V258, P620, DOI 10.1038/258620a0; McLachlan RI, 2002, RECENT PROG HORM RES, V57, P149, DOI 10.1210/rp.57.1.149; Meng J, 2005, P NATL ACAD SCI USA, V102, P16696, DOI 10.1073/pnas.0506084102; ODonnell L, 1996, BIOL REPROD, V55, P895, DOI 10.1095/biolreprod55.4.895; ODONNELL L, 1994, ENDOCRINOLOGY, V135, P2608, DOI 10.1210/en.135.6.2608; Peterziel H, 1999, ONCOGENE, V18, P6322, DOI 10.1038/sj.onc.1203032; Sharpe RM, 1994, PHYSL REPROD, V1, P1363; Smith LB, 2014, SEMIN CELL DEV BIOL, V30, P2, DOI 10.1016/j.semcdb.2014.02.012; Sopher BL, 2004, NEURON, V41, P687, DOI 10.1016/S0896-6273(04)00082-0; Sopher BL, 2006, GENE, V371, P136, DOI 10.1016/j.gene.2005.11.034; Su LL, 2010, EXP CELL RES, V316, P2945, DOI 10.1016/j.yexcr.2010.07.018; Tan KAL, 2005, ENDOCRINOLOGY, V146, P2674, DOI 10.1210/en.2004-1630; Tsai MY, 2006, P NATL ACAD SCI USA, V103, P18975, DOI 10.1073/pnas.0608565103; Vicencio JM, 2006, ENDOCRINOLOGY, V147, P1386, DOI 10.1210/en.2005-1139; Walker William H, 2011, Spermatogenesis, V1, P116; Wang RS, 2009, ENDOCR REV, V30, P119, DOI 10.1210/er.2008-0025; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035; Willems A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014168; Wong CH, 2005, ENDOCRINOLOGY, V146, P1192, DOI 10.1210/en.2004-1275; Wunderlich F, 2002, STEROIDS, V67, P535, DOI 10.1016/S0039-128X(01)00175-1; Yan HHN, 2008, FASEB J, V22, P1945, DOI 10.1096/fj.06-070342; Ye XC, 2005, P NATL ACAD SCI USA, V102, P9487, DOI 10.1073/pnas.0503577102; Zhang JY, 2005, J CELL PHYSIOL, V204, P470, DOI 10.1002/jcp.20303; Zhang JY, 2005, ENDOCRINOLOGY, V146, P1268, DOI 10.1210/en.2004-1194	38	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0120783	10.1371/journal.pone.0120783	http://dx.doi.org/10.1371/journal.pone.0120783			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803277	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000353889600098
J	Chen, SX; Zhang, RR; Hao, LN; Chen, WF; Cheng, SQ				Chen, Shuxia; Zhang, Ranran; Hao, Lining; Chen, Weifeng; Cheng, Siqiong			Profiling of Volatile Compounds and Associated Gene Expression and Enzyme Activity during Fruit Development in Two Cucumber Cultivars	PLOS ONE			English	Article							HYDROPEROXIDE LYASE ACTIVITIES; DIFFERENTIAL EXPRESSION; LIPOXYGENASE GENES; AROMA VOLATILES; FLAVOR; ALDEHYDES; MICROEXTRACTION; IDENTIFICATION; BIOSYNTHESIS; SPECIFICITY	Changes in volatile content, as well as associated gene expression and enzyme activity in developing cucumber fruits were investigated in two Cucumis sativus L. lines (No. 26 and No. 14) that differ significantly in fruit flavor. Total volatile, six-carbon (C6) aldehyde, linolenic and linoleic acid content were higher during the early stages, whereas the nine-carbon (C9) aldehyde content was higher during the latter stages in both lines. Expression of C. sativus hydroperoxide lyase (CsHPL) mirrored 13-hydroperoxide lyase (13-HPL) enzyme activity in variety No. 26, whereas CsHPL expression was correlated with 9-hydroperoxide lyase (9-HPL) enzyme activity in cultivar No. 14. 13-HPL activity decreased significantly, while LOX (lipoxygenase) and 9-HPL activity increased along with fruit ripening in both lines, which accounted for the higher C6 and C9 aldehyde content at 0-6 day post anthesis (dpa) and 9-12 dpa, respectively. Volatile compounds from fruits at five developmental stages were analyzed by principal component analysis (PCA), and heatmaps of volatile content, gene expression and enzyme activity were constructed.	[Chen, Shuxia; Zhang, Ranran; Hao, Lining; Chen, Weifeng; Cheng, Siqiong] Northwest A&F Univ, Coll Hort, Key Lab Hort Plant Germplasm Resources Utilizat N, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China	Chen, SX (corresponding author), Northwest A&F Univ, Coll Hort, Key Lab Hort Plant Germplasm Resources Utilizat N, Yangling, Shaanxi, Peoples R China.	shuxiachen@nwsuaf.edu.cn	Chen, Wei/GZK-7348-2022		Scientific and Technological Project in Shaanxi Province [2013K02-04]; National Natural Science Foundation of China [31071813]; Technology Foundation for Selected Overseas Chinese Scholar for Generous; Fundamental Research Funds for the Central Universities [QN2011088]	Scientific and Technological Project in Shaanxi Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Technology Foundation for Selected Overseas Chinese Scholar for Generous; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by grants from the Scientific and Technological Project in Shaanxi Province (No. 2013K02-04), the National Natural Science Foundation of China (No. 31071813), the Technology Foundation for Selected Overseas Chinese Scholar for Generous, and the Fundamental Research Funds for the Central Universities (No. QN2011088). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaro AL, 2012, FOOD CHEM, V130, P49, DOI 10.1016/j.foodchem.2011.06.052; Bai SN, 2013, INT REV CEL MOL BIO, V304, P1, DOI 10.1016/B978-0-12-407696-9.00001-4; Chen GP, 2004, PLANT PHYSIOL, V136, P2641, DOI 10.1104/pp.104.041608; Defilippi BG, 2009, ADV BOT RES, V50, P1, DOI 10.1016/S0065-2296(08)00801-X; FERRIE BJ, 1994, PLANT PHYSIOL, V106, P109, DOI 10.1104/pp.106.1.109; FORSS DA, 1962, J FOOD SCI, V27, P90, DOI 10.1111/j.1365-2621.1962.tb00064.x; Gigot C, 2010, BIOTECHNOL AGRON SOC, V14, P451; Gomi K, 2003, J PLANT PHYSIOL, V160, P1219, DOI 10.1078/0176-1617-01177; Gonzalez-Mas MC, 2009, INT J FOOD SCI TECH, V44, P510, DOI 10.1111/j.1365-2621.2008.01779.x; Griffiths A, 1999, J EXP BOT, V50, P793, DOI 10.1093/jexbot/50.335.793; Guo SG, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-454; Hao LN, 2013, J NW A F U NATURAL S, V6, P25; Hornostaj AR, 1999, FOOD CHEM, V66, P173, DOI 10.1016/S0308-8146(98)00260-X; Kandzia R, 2003, J PLANT PHYSIOL, V160, P803, DOI 10.1078/0176-1617-01026; Kataoka H, 2011, J PHARMACEUT BIOMED, V54, P926, DOI 10.1016/j.jpba.2010.12.010; Kocsy G, 2013, PLANT SCI, V211, P77, DOI 10.1016/j.plantsci.2013.07.004; Ligor T, 2008, ANAL BIOANAL CHEM, V391, P2283, DOI 10.1007/s00216-008-2098-5; Liu ChunXiang, 2004, China Vegetables, P12; Liu ChunXiang, 2002, Acta Horticulturae Sinica, V29, P581; Matsui K, 2000, FEBS LETT, V481, P183, DOI 10.1016/S0014-5793(00)01997-9; Matsui K, 2006, PHYTOCHEMISTRY, V67, P649, DOI 10.1016/j.phytochem.2006.01.006; Melgarejo P, 2014, J SCI FOOD AGR, V94, P85, DOI 10.1002/jsfa.6201; Moing A, 2011, NEW PHYTOL, V190, P683, DOI 10.1111/j.1469-8137.2010.03626.x; Noordermeer MA, 2001, CHEMBIOCHEM, V2, P494, DOI 10.1002/1439-7633(20010803)2:7/8<494::AID-CBIC494>3.0.CO;2-1; Padilla MN, 2014, PHYTOCHEMISTRY, V102, P80, DOI 10.1016/j.phytochem.2014.01.024; Padilla MN, 2010, J AGR FOOD CHEM, V58, P5649, DOI 10.1021/jf9045396; Palma-Harris C, 2001, J AGR FOOD CHEM, V49, P4203, DOI 10.1021/jf010182w; Pandit SS, 2010, PLANT PHYSIOL BIOCH, V48, P426, DOI 10.1016/j.plaphy.2010.02.012; Pandit SS, 2009, J SCI FOOD AGR, V89, P2071, DOI 10.1002/jsfa.3692; Patui S, 2010, EUR J LIPID SCI TECH, V112, P780, DOI 10.1002/ejlt.200900167; Xisto ALRP, 2012, CIENCIA TECNOL ALIME, V32, P173, DOI 10.1590/S0101-20612012005000020; Riley JCM, 1996, POSTHARVEST BIOL TEC, V7, P97, DOI 10.1016/0925-5214(95)00032-1; Rudolph M, 2011, J EXP BOT, V62, P749, DOI 10.1093/jxb/erq310; Siderhurst MS, 2010, J CHEM ECOL, V36, P699, DOI 10.1007/s10886-010-9804-4; SIEDOW JN, 1991, ANNU REV PLANT PHYS, V42, P145, DOI 10.1146/annurev.pp.42.060191.001045; Tijet N, 2001, ARCH BIOCHEM BIOPHYS, V386, P281, DOI 10.1006/abbi.2000.2218; Traverso JA, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00465; Verhoeven Harrie A, 2012, Methods Mol Biol, V860, P85, DOI 10.1007/978-1-61779-594-7_6; Verzera A, 2011, FOOD ANAL METHOD, V4, P141, DOI 10.1007/s12161-010-9159-z; Vogt J, 2013, TREE GENET GENOMES, V9, P1493, DOI 10.1007/s11295-013-0653-5; Wan XH, 2013, INT J MOL SCI, V14, P22082, DOI 10.3390/ijms141122082; Xu Kun-fan, 2009, ACTA BOTANICA BOREALI-OCCIDENTALIA SINICA, V29, P390; Yang XY, 2012, INT J MOL SCI, V13, P2481, DOI 10.3390/ijms13022481; Zawirska-Wojtasiak R, 2009, J FOOD SCI, V74, pC204, DOI 10.1111/j.1750-3841.2009.01082.x; Zhang B, 2006, J EXP BOT, V57, P3825, DOI 10.1093/jxb/erl151; Zhang B, 2011, POSTHARVEST BIOL TEC, V60, P7, DOI 10.1016/j.postharvbio.2010.09.012; Zhang B, 2009, J AM SOC HORTIC SCI, V134, P472, DOI 10.21273/JASHS.134.4.472; Zhu BQ, 2012, MOL BIOL REP, V39, P7443, DOI 10.1007/s11033-012-1577-0	48	16	18	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0119444	10.1371/journal.pone.0119444	http://dx.doi.org/10.1371/journal.pone.0119444			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799542	Green Published, Green Submitted, gold			2022-12-26	WOS:000351987300051
J	Chugh, RM; Chaturvedi, M; Yerneni, LK				Chugh, Rishi Man; Chaturvedi, Madhusudan; Yerneni, Lakshmana Kumar			Occurrence and Control of Sporadic Proliferation in Growth Arrested Swiss 3T3 Feeder Cells	PLOS ONE			English	Article							HUMAN EPIDERMAL-KERATINOCYTES; EPITHELIAL-CELLS; CULTURE; TRANSFORMATION; LAYER	Growth arrested Swiss mouse embryonic 3T3 cells are used as feeders to support the growth of epidermal keratinocytes and several other target cells. The 3T3 cells have been extensively subcultured owing to their popularity and wide distribution in the world and, as a consequence selective inclusion of variants is a strong possibility in them. Inadvertently selected variants expressing innate resistance to mitomycin C may continue to proliferate even after treatment with such growth arresting agents. The failure of growth arrest can lead to a serious risk of proliferative feeder contamination in target cell cultures. In this study, we passaged Swiss 3T3 cells (CCL-92, ATCC) by different seeding densities and incubation periods. We tested the resultant cultures for differences in anchorage-independent growth, resumption of proliferation after mitomycin C treatment and occurrence of proliferative feeder contaminants in an epidermal keratinocyte co-culture system. The study revealed subculture dependent differential responses. The cultures of a particular subculture procedure displayed unique cell size distribution and disintegrated completely in 6 weeks following mitomycin C treatment, but their repeated subculture resulted in feeder regrowth as late as 11 weeks after the growth arrest. In contrast, mitomycin C failed to inhibit cell proliferation in cultures of the other subculture schemes and also in a clone that was established from a transformation focus of super-confluent culture. The resultant proliferative feeder cells contaminated the keratinocyte cultures. The anchorage-independent growth appeared in late passages as compared with the expression of mitomycin C resistance in earlier passages. The feeder regrowth was prevented by identifying a safe subculture protocol that discouraged the inclusion of resistant variants. We advocate routine anchorage-independent growth assay and absolute confirmation of feeder disintegration to qualify feeder batches and caution on the use of fetal bovine serum.	[Chugh, Rishi Man; Chaturvedi, Madhusudan; Yerneni, Lakshmana Kumar] Natl Inst Pathol ICMR, Cell Biol Lab, New Delhi, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Pathology (IOP)	Yerneni, LK (corresponding author), Natl Inst Pathol ICMR, Cell Biol Lab, New Delhi, India.	yernenilk@icmr.org.in	Chugh, Rishi Man/AAC-7545-2021		Indian Council of Medical Research, New Delhi, India [2009-02800]	Indian Council of Medical Research, New Delhi, India(Indian Council of Medical Research (ICMR))	The study was supported by extra mural Research grant 2009-02800 to LKY by the Indian Council of Medical Research, (http://www.icmr.nic.in) New Delhi, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALITALO K, 1982, J CELL BIOL, V94, P497, DOI 10.1083/jcb.94.3.497; ALLENHOFFMANN BL, 1984, P NATL ACAD SCI-BIOL, V81, P7802, DOI 10.1073/pnas.81.24.7802; American Type Culture Collection (ATCC) USA, CCL92 ATCC; Atiyeh BS, 2007, BURNS, V33, P139, DOI 10.1016/j.burns.2006.06.010; BERRY RD, 1988, BRIT J CANCER, V57, P287, DOI 10.1038/bjc.1988.62; Bowen-pope DF, 1994, PNAS US, V81, P2396; Bray LJ, 2012, CYTOTHERAPY, V14, P936, DOI 10.3109/14653249.2012.684379; ChangLiu CM, 1997, CANCER LETT, V113, P77, DOI 10.1016/S0304-3835(97)04599-0; Conner D A, 2001, Curr Protoc Mol Biol, VChapter 23, DOI 10.1002/0471142727.mb2302s51; Epstein Seth P, 2005, Trans Am Ophthalmol Soc, V103, P187; Hultman CS, 1996, J TRAUMA, V41, P51, DOI 10.1097/00005373-199607000-00009; Japan Tissue Engineering Co. Ltd, 2007, REV REP; Kumar A, 2008, IN VITRO CELL DEV-AN, V44, P189, DOI 10.1007/s11626-008-9081-5; Lamb R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052494; LECHNER JF, 1981, CANCER RES, V41, P2294; Lu R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038825; Mallon BS, 2006, INT J BIOCHEM CELL B, V38, P1063, DOI 10.1016/j.biocel.2005.12.014; Navasaria HA, 1994, KERATINOCYTE METHODS, P5; OCONNOR NE, 1981, LANCET, V1, P75; PALLEN CJ, 1991, P NATL ACAD SCI USA, V88, P6996, DOI 10.1073/pnas.88.16.6996; PEEHL DM, 1981, P NATL ACAD SCI-BIOL, V78, P3053, DOI 10.1073/pnas.78.5.3053; Ponchio L, 2000, CYTOTHERAPY, V2, P281, DOI 10.1080/146532400539215; Qin J, 2010, CANC STEM CELLS, P37; RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8; RUBIN H, 1989, P NATL ACAD SCI USA, V86, P1860, DOI 10.1073/pnas.86.6.1860; SORIANO JV, 1995, J CELL SCI, V108, P413; Takeuchi T, 2008, JPN J INFECT DIS, V61, P9; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; WATT FM, 1984, J CELL BIOL, V98, P16, DOI 10.1083/jcb.98.1.16; Zhou D, 2014, ARCH TOXICOL, DOI [10.1007/s00204-014-1250-56, DOI 10.1007/S00204-014-1250-56]	30	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0122056	10.1371/journal.pone.0122056	http://dx.doi.org/10.1371/journal.pone.0122056			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799110	Green Submitted, gold, Green Published			2022-12-26	WOS:000351987300316
J	Khan, ZA; Abdin, MZ; Khan, JA				Khan, Zainul A.; Abdin, Malik Z.; Khan, Jawaid A.			Functional Characterization of a Strong Bidirectional Constitutive Plant Promoter Isolated from Cotton Leaf Curl Burewala Virus	PLOS ONE			English	Article							MYB TRANSCRIPTION FACTOR; CIS-REGULATORY ELEMENTS; GOLDEN MOSAIC-VIRUS; GENE-EXPRESSION; GEMINIVIRUS REPLICATION; BETA-GLUCURONIDASE; IDENTIFICATION; ACTIVATION; DISEASE; SEQUENCES	Cotton leaf curl Burewala virus (CLCuBuV), belonging to the genus Begomovirus, possesses single-stranded monopartite DNA genome. The bidirectional promoters representing Rep and coat protein (CP) genes of CLCuBuV were characterized and their efficacy was assayed. Rep and CP promoters of CLCuBuV and 35S promoter of Cauliflower mosaic virus (CaMV) were fused with beta-glucuronidase (GUS) and green fluorescent protein (GFP) reporter genes. GUS activity in individual plant cells driven by Rep, CP and 35S promoters was estimated using real-time PCR and fluorometric GUS assay. Histochemical staining of GUS in transformed tobacco (Nicotiana tabacum cv. Xanthi) leaves showed highest expression driven by Rep promoter followed by 35S promoter and CP promoter. The expression level of GUS driven by Rep promoter in transformed tobacco plants was shown to be two to four-fold higher than that of 35S promoter, while the expression by CP promoter was slightly lower. Further, the expression of GFP was monitored in agroinfiltrated leaves of N. benthamiana, N. tabacum and cotton (Gossypium hirsutum) plants using confocal laser scanning microscopy. Rep promoter showed strong consistent transient expression in tobacco and cotton leaves as compared to 35S promoter. The strong constitutive CLCuBuV Rep promoter developed in this study could be very useful for high level expression of transgenes in a wide variety of plant cells.	[Khan, Zainul A.; Khan, Jawaid A.] Jamia Millia Islamia, Plant Virus Lab, Dept Biosci, New Delhi, India; [Abdin, Malik Z.] Hamdard Univ, Dept Biotechnol, New Delhi, India	Jamia Millia Islamia; Jamia Hamdard University	Khan, JA (corresponding author), Jamia Millia Islamia, Plant Virus Lab, Dept Biosci, New Delhi, India.	jkhan1@jmi.ac.in		Zainul Abdin, Malik/0000-0001-7346-0719; khan, jawaid/0000-0001-7191-5804; KHAN, ZAINUL/0000-0001-8043-2839	U.G.C.	U.G.C.(University Grants Commission, India)	Zainul A. Khan was supported by Ph.D. fellowship from U.G.C. Authors are thankful to DST-FIST, (Government of India) for infrastructure facility.	Agarwal M, 2006, J BIOL CHEM, V281, P37636, DOI 10.1074/jbc.M605895200; Akhtar S, 2014, ARCH VIROL, V159, P1199, DOI 10.1007/s00705-013-1926-x; Amrao L, 2010, VIRUS RES, V152, P153, DOI 10.1016/j.virusres.2010.06.019; ARGUELLOASTORGA GR, 1994, VIROLOGY, V203, P90, DOI 10.1006/viro.1994.1458; Ashraf M. A., 2013, Australian Journal of Crop Science, V7, P1113; Ashraf MA, 2014, VIRUSES-BASEL, V6, P223, DOI 10.3390/v6010223; Briddon RW, 2001, VIROLOGY, V285, P234, DOI 10.1006/viro.2001.0949; Buchel AS, 1999, PLANT MOL BIOL, V40, P387, DOI 10.1023/A:1006144505121; Chang WC, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-561; Dinant S, 2004, PHYSIOL PLANTARUM, V121, P108, DOI 10.1111/j.0031-9317.2004.00296.x; Dry I, 2000, MOL PLANT MICROBE IN, V13, P529, DOI 10.1094/MPMI.2000.13.5.529; Eagle PA, 1997, J VIROL, V71, P6947, DOI 10.1128/JVI.71.9.6947-6955.1997; ELMAYAN T, 1995, TRANSGENIC RES, V4, P388, DOI 10.1007/BF01973757; Fauquet CM, 2008, ARCH VIROL, V153, P783, DOI 10.1007/s00705-008-0037-6; FENOLL C, 1990, PLANT MOL BIOL, V15, P865, DOI 10.1007/BF00039426; FONTES EPB, 1994, PLANT CELL, V6, P405, DOI 10.1105/tpc.6.3.405; Frith MC, 2001, BIOINFORMATICS, V17, P878, DOI 10.1093/bioinformatics/17.10.878; Goda H, 2004, PLANT PHYSIOL, V134, P1555, DOI 10.1104/pp.103.034736; Gowik U, 2004, PLANT CELL, V16, P1077, DOI 10.1105/tpc.019729; Hanley-Bowdoin L, 1999, CRIT REV PLANT SCI, V18, P71, DOI 10.1016/S0735-2689(99)00383-4; Hartmann U, 2005, PLANT MOL BIOL, V57, P155, DOI 10.1007/s11103-004-6910-0; Hellens RP, 2000, PLANT MOL BIOL, V42, P819, DOI 10.1023/A:1006496308160; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; HOFER JMI, 1992, PLANT CELL, V4, P213, DOI 10.1105/tpc.4.2.213; HOLSTERS M, 1978, MOL GEN GENET, V163, P181, DOI 10.1007/BF00267408; Hong Y, 1996, VIROLOGY, V220, P119, DOI 10.1006/viro.1996.0292; HORSCH RB, 1985, SCIENCE, V227, P1229, DOI 10.1126/science.227.4691.1229; Hudson ME, 2003, PLANT PHYSIOL, V133, P1605, DOI 10.1104/pp.103.030437; JEFFERSON RA, 1987, EMBO J, V6, P3901; Jefferson RA, 1987, PLANT MOL BIOL REP, V5, P387, DOI [DOI 10.1007/BF02667740, 10.1007/bf02667740]; Koscianska E, 2005, PLANT MOL BIOL, V59, P647, DOI 10.1007/s11103-005-0668-x; Kumar A, 2010, VIRUS GENES, V41, P432, DOI 10.1007/s11262-010-0531-2; Kumar A, 2010, VIRUS GENES, V40, P282, DOI 10.1007/s11262-009-0439-x; Leke WN, 2013, VIRUS RES, V174, P116, DOI 10.1016/j.virusres.2013.03.010; Lescot M, 2002, NUCLEIC ACIDS RES, V30, P325, DOI 10.1093/nar/30.1.325; Mansoor S, 1999, VIROLOGY, V259, P190, DOI 10.1006/viro.1999.9766; Maruyama-Nakashita A, 2005, PLANT J, V42, P305, DOI 10.1111/j.1365-313X.2005.02363.x; MULLINEAUX PM, 1993, VIROLOGY, V193, P414, DOI 10.1006/viro.1993.1138; Nishiuchi T, 2004, J BIOL CHEM, V279, P55355, DOI 10.1074/jbc.M409674200; PETTY ITD, 1988, J GEN VIROL, V69, P1359, DOI 10.1099/0022-1317-69-6-1359; Rasul F, 2014, INT J AGRIC BIOL, V16, P342; Reese MG, 2001, COMPUT CHEM, V26, P51, DOI 10.1016/S0097-8485(01)00099-7; Rojas MR, 2005, ANNU REV PHYTOPATHOL, V43, P361, DOI 10.1146/annurev.phyto.43.040204.135939; Ross EJH, 2004, J EXP BOT, V55, P1721, DOI 10.1093/jxb/erh211; Ruiz-Medrano R, 1999, VIROLOGY, V253, P162, DOI 10.1006/viro.1998.9484; Sahoo DK, 2009, J VIROL METHODS, V161, P114, DOI 10.1016/j.jviromet.2009.06.011; Saunders K, 2003, NATURE, V422, P831, DOI 10.1038/422831a; SCHWARZ JJ, 1992, MOL CELL BIOL, V12, P266, DOI 10.1128/MCB.12.1.266; SHIRSAT A, 1989, MOL GEN GENET, V215, P326, DOI 10.1007/BF00339737; Shuja MN, 2014, ARCH VIROL, V159, P2787, DOI 10.1007/s00705-014-2097-0; SOLANO R, 1995, EMBO J, V14, P1773, DOI 10.1002/j.1460-2075.1995.tb07166.x; STANLEY J, 2005, VIRUS TAXONOMY, P301; Sunitha S, 2012, PLANT CELL TISS ORG, V109, P535, DOI 10.1007/s11240-012-0120-2; SUNTER G, 1990, VIROLOGY, V179, P69, DOI 10.1016/0042-6822(90)90275-V; SUNTER G, 1993, VIROLOGY, V195, P275, DOI 10.1006/viro.1993.1374; Thornton B, 2011, BIOCHEM MOL BIOL EDU, V39, P145, DOI 10.1002/bmb.20461; Usharani KS, 2006, VIRUS RES, V119, P154, DOI 10.1016/j.virusres.2005.12.013; Varsani A, 2014, ARCH VIROL, V159, P1873, DOI 10.1007/s00705-014-1982-x; Wanapu C, 1996, ANN NY ACAD SCI, V782, P107, DOI 10.1111/j.1749-6632.1996.tb40552.x; Xie YQ, 2003, PLANT MOL BIOL, V53, P1, DOI 10.1023/B:PLAN.0000009257.37471.02; Xie Z, 2005, PLANT PHYSIOL, V137, P176, DOI 10.1104/pp.104.054312; Xu NF, 1997, PLANT SCI, V126, P193, DOI 10.1016/S0168-9452(97)00110-6; Xu XP, 2006, PLANT CELL, V18, P1310, DOI 10.1105/tpc.105.037523; Yanagisawa S, 1999, PLANT J, V17, P209, DOI 10.1046/j.1365-313X.1999.00363.x; Yanagisawa S, 2000, PLANT J, V21, P281, DOI 10.1046/j.1365-313x.2000.00685.x; Yang TB, 2002, J BIOL CHEM, V277, P45049, DOI 10.1074/jbc.M207941200; ZHAN XC, 1991, J GEN VIROL, V72, P2849, DOI 10.1099/0022-1317-72-11-2849; Zhou XP, 2003, CHINESE SCI BULL, V48, P2205, DOI 10.1360/03wc0272	68	16	20	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121656	10.1371/journal.pone.0121656	http://dx.doi.org/10.1371/journal.pone.0121656			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799504	gold, Green Submitted, Green Published			2022-12-26	WOS:000351987300281
J	Li, C; Klco, JM; Helton, NM; George, DR; Mudd, JL; Miller, CA; Lu, C; Fulton, R; O'Laughlin, M; Fronick, C; Wilson, RK; Ley, TJ				Li, Cheng; Klco, Jeffery M.; Helton, Nichole M.; George, Daniel R.; Mudd, Jacqueline L.; Miller, Christopher A.; Lu, Charles; Fulton, Robert; O'Laughlin, Michelle; Fronick, Catrina; Wilson, Richard K.; Ley, Timothy J.			Genetic Heterogeneity of Induced Pluripotent Stem Cells: Results from 24 Clones Derived from a Single C57BL/6 Mouse	PLOS ONE			English	Article							COPY NUMBER; MUTATIONS; DIFFERENTIATION; FIBROBLASTS; IPSCS	Induced pluripotent stem cells (iPSCs) have tremendous potential as a tool for disease modeling, drug testing, and other applications. Since the generation of iPSCs "captures" the genetic history of the individual cell that was reprogrammed, iPSC clones (even those derived from the same individual) would be expected to demonstrate genetic heterogeneity. To assess the degree of genetic heterogeneity, and to determine whether some cells are more genetically "fit" for reprogramming, we performed exome sequencing on 24 mouse iPSC clones derived from skin fibroblasts obtained from two different sites of the same 8-week-old C57BL/6J male mouse. While no differences in the coding regions were detected in the two parental fibroblast pools, each clone had a unique genetic signature with a wide range of heterogeneity observed among the individual clones: a total of 383 iPSC variants were validated for the 24 clones (mean 16.0/clone, range 0-45). Since these variants were all present in the vast majority of the cells in each clone (variant allele frequencies of 40-60% for heterozygous variants), they most likely preexisted in the individual cells that were reprogrammed, rather than being acquired during reprogramming or cell passaging. We then tested whether this genetic heterogeneity had functional consequences for hematopoietic development by generating hematopoietic progenitors in vitro and enumerating colony forming units (CFUs). While there was a range of hematopoietic potentials among the 24 clones, only one clone failed to differentiate into hematopoietic cells; however, it was able to form a teratoma, proving its pluripotent nature. Further, no specific association was found between the mutational spectrum and the hematopoietic potential of each iPSC clone. These data clearly highlight the genetic heterogeneity present within individual fibroblasts that is captured by iPSC generation, and suggest that most of the changes are random, and functionally benign.	[Li, Cheng; Helton, Nichole M.; George, Daniel R.; Mudd, Jacqueline L.; Ley, Timothy J.] Washington Univ, Sch Med, Dept Med, Sect Stem Cell Biol,Div Oncol, St Louis, MO 63110 USA; [Klco, Jeffery M.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA; [Miller, Christopher A.; Lu, Charles; Fulton, Robert; O'Laughlin, Michelle; Fronick, Catrina; Wilson, Richard K.] Washington Univ, Sch Med, Genome Inst, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Ley, TJ (corresponding author), Washington Univ, Sch Med, Dept Med, Sect Stem Cell Biol,Div Oncol, St Louis, MO 63110 USA.	timley@wustl.edu	Wilson, Richard K./AAF-4139-2019; Miller, Christopher A./A-1060-2009; Klco, Jeffery/M-9717-2018	Wilson, Richard K./0000-0002-1992-1358; Miller, Christopher A./0000-0003-4266-6700; Klco, Jeffery/0000-0003-2961-6960	NIH [CA101937, CA162086, HL116605]; Barnes Jewish Hospital Foundation [00335-0505-02]; Burroughs Wellcome Fund; NATIONAL CANCER INSTITUTE [P01CA101937, R01CA162086, P30CA091842, R35CA197561] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL116605] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Barnes Jewish Hospital Foundation; Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the NIH (CA101937 and CA162086, to TJL, and HL116605, to JMK), the Barnes Jewish Hospital Foundation (00335-0505-02, to TJL), and the Burroughs Wellcome Fund (to JMK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abyzov A, 2012, NATURE, V492, P438, DOI 10.1038/nature11629; Bock C, 2011, CELL, V144, P439, DOI 10.1016/j.cell.2010.12.032; Boulting GL, 2011, NAT BIOTECHNOL, V29, P279, DOI 10.1038/nbt.1783; Cahan P, 2013, NAT REV MOL CELL BIO, V14, P357, DOI 10.1038/nrm3584; Chang CW, 2009, STEM CELLS, V27, P1042, DOI 10.1002/stem.39; Chen K, 2009, NAT METHODS, V6, P677, DOI [10.1038/NMETH.1363, 10.1038/nmeth.1363]; Gore A, 2011, NATURE, V471, P63, DOI 10.1038/nature09805; Kajiwara M, 2012, P NATL ACAD SCI USA, V109, P12538, DOI 10.1073/pnas.1209979109; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Kim K, 2011, NAT BIOTECHNOL, V29, P1117, DOI 10.1038/nbt.2052; Klco JM, 2014, CANCER CELL, V25, P379, DOI 10.1016/j.ccr.2014.01.031; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Larson DE, 2012, BIOINFORMATICS, V28, P311, DOI 10.1093/bioinformatics/btr665; Laurent LC, 2011, CELL STEM CELL, V8, P106, DOI 10.1016/j.stem.2010.12.003; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liang GY, 2013, CELL STEM CELL, V13, P149, DOI 10.1016/j.stem.2013.07.001; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mills JA, 2013, BLOOD, V122, P2047, DOI 10.1182/blood-2013-02-484444; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Saunders CT, 2012, BIOINFORMATICS, V28, P1811, DOI 10.1093/bioinformatics/bts271; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Vodyanik Maxim A, 2007, Curr Protoc Cell Biol, VChapter 23, DOI 10.1002/0471143030.cb2306s36; Yang SH, 2008, GENESIS, V46, P711, DOI 10.1002/dvg.20435; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394; Young MA, 2012, CELL STEM CELL, V10, P570, DOI 10.1016/j.stem.2012.03.002; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	27	10	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120585	10.1371/journal.pone.0120585	http://dx.doi.org/10.1371/journal.pone.0120585			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799070	Green Published, gold, Green Submitted			2022-12-26	WOS:000351987300156
J	McMillan, EM; Pare, MF; Baechler, BL; Graham, DA; Rush, JWE; Quadrilatero, J				McMillan, Elliott M.; Pare, Marie-France; Baechler, Brittany L.; Graham, Drew A.; Rush, James W. E.; Quadrilatero, Joe			Autophagic Signaling and Proteolytic Enzyme Activity in Cardiac and Skeletal Muscle of Spontaneously Hypertensive Rats following Chronic Aerobic Exercise	PLOS ONE			English	Article							DNA FRAGMENTATION; MOLECULAR CHARACTERIZATION; DEPENDENT DEGRADATION; OXIDATIVE STRESS; SOLEUS MUSCLE; SINGLE BOUT; BECLIN 1; APOPTOSIS; BCL-2; PHOSPHORYLATION	Hypertension is a cardiovascular disease associated with deleterious effects in skeletal and cardiac muscle. Autophagy is a degradative process essential to muscle health. Acute exercise can alter autophagic signaling. Therefore, we aimed to characterize the effects of chronic endurance exercise on autophagy in skeletal and cardiac muscle of normotensive and hypertensive rats. Male Wistar Kyoto (WKY) and spontaneously hypertensive rats (SHR) were assigned to a sedentary condition or 6 weeks of treadmill running. White gastrocnemius (WG) of hypertensive rats had higher (p<0.05) caspase-3 and proteasome activity, as well as elevated calpain activity. In addition, skeletal muscle of hypertensive animals had elevated (p<0.05) ATG7 and LC3I protein, LAMP2 mRNA, and cathepsin activity, indicative of enhanced autophagic signaling. Interestingly, chronic exercise training increased (p<0.05) Beclin-1, LC3, and p62 mRNA as well as proteasome activity, but reduced (p<0.05) Beclin-1 and ATG7 protein, as well as decreased (p<0.05) caspase-3, calpain, and cathepsin activity. Left ventricle (LV) of hypertensive rats had reduced (p<0.05) AMPKa and LC3II protein, as well as elevated (p<0.05) p-AKT, p-p70S6K, LC3I and p62 protein, which collectively suggest reduced autophagic signaling. Exercise training had little effect on autophagy-related signaling factors in LV; however, exercise training increased (p<0.05) proteasome activity but reduced (p<0.05) caspase-3 and calpain activity. Our results suggest that autophagic signaling is altered in skeletal and cardiac muscle of hypertensive animals. Regular aerobic exercise can effectively alter the proteolytic environment in both cardiac and skeletal muscle, as well as influence several autophagy-related factors in skeletal muscle of normotensive and hypertensive rats.	[McMillan, Elliott M.; Pare, Marie-France; Baechler, Brittany L.; Graham, Drew A.; Rush, James W. E.; Quadrilatero, Joe] Univ Waterloo, Dept Kinesiol, Waterloo, ON N2L 3G1, Canada	University of Waterloo	Quadrilatero, J (corresponding author), Univ Waterloo, Dept Kinesiol, Waterloo, ON N2L 3G1, Canada.	jquadril@uwaterloo.ca			Natural Sciences and Engineering Research Council of Canada (NSERC) [RGPIN 238342, RGPIN 258590]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This research was supported by funds provided by the Natural Sciences and Engineering Research Council of Canada (NSERC) to JWER (RGPIN 238342) and JQ (RGPIN 258590). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alers S, 2012, MOL CELL BIOL, V32, P2, DOI 10.1128/MCB.06159-11; Argiles JA, 2008, INT J BIOCHEM CELL B, V40, P1674, DOI 10.1016/j.biocel.2008.02.001; ATRAKCHI A, 1994, AM J PHYSIOL, V267, pC827, DOI 10.1152/ajpcell.1994.267.3.C827; Benziane B, 2008, AM J PHYSIOL-ENDOC M, V295, pE1427, DOI 10.1152/ajpendo.90428.2008; Bhatnagar S, 2012, J CELL PHYSIOL, V227, P1042, DOI 10.1002/jcp.22821; Bloemberg D, 2014, ACTA PHYSIOL, V210, P381, DOI 10.1111/apha.12178; Breitschopf K, 2000, MOL CELL BIOL, V20, P1886, DOI 10.1128/MCB.20.5.1886-1896.2000; Brunelle JK, 2009, J CELL SCI, V122, P437, DOI 10.1242/jcs.031682; Cao DJ, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000016; Condorelli G, 1999, CIRCULATION, V99, P3071, DOI 10.1161/01.CIR.99.23.3071; Cunha TF, 2012, J APPL PHYSIOL, V112, P1839, DOI 10.1152/japplphysiol.00346.2011; De Chiara G, 2006, J BIOL CHEM, V281, P21353, DOI 10.1074/jbc.M511052200; De Palma C, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.159; Deng XM, 2004, P NATL ACAD SCI USA, V101, P153, DOI 10.1073/pnas.2533920100; Dimmeler S, 1999, J EXP MED, V189, P1815, DOI 10.1084/jem.189.11.1815; Graham DA, 2004, J APPL PHYSIOL, V96, P2088, DOI 10.1152/japplphysiol.01252.2003; GRAY SD, 1994, AM J PHYSIOL, V267, pR735, DOI 10.1152/ajpregu.1994.267.3.R735; He CC, 2012, NATURE, V481, P511, DOI 10.1038/nature10758; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Huang STJ, 2002, FASEB J, V16, DOI 10.1096/fj.01-0852com; Hwee DT, 2014, AGING CELL, V13, P92, DOI 10.1111/acel.12150; Jamart C, 2012, J APPL PHYSIOL, V112, P1529, DOI 10.1152/japplphysiol.00952.2011; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kang R, 2011, CELL DEATH DIFFER, V18, P571, DOI 10.1038/cdd.2010.191; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kim R, 2005, BIOCHEM BIOPH RES CO, V333, P336, DOI 10.1016/j.bbrc.2005.04.161; Kim YA, 2013, J PHYSIOL BIOCHEM, V69, P697, DOI 10.1007/s13105-013-0246-7; Kim YA, 2012, J PHYSIOL BIOCHEM, V68, P229, DOI 10.1007/s13105-011-0135-x; Lepine S, 2011, J BIOL CHEM, V286, P44380, DOI 10.1074/jbc.M111.257519; Lira VA, 2013, FASEB J, V27, P4184, DOI 10.1096/fj.13-228486; Mammucari C, 2008, AUTOPHAGY, V4, P524, DOI 10.4161/auto.5905; Marquez RT, 2012, AM J CANCER RES, V2, P214; Masiero E, 2010, AUTOPHAGY, V6, P307, DOI 10.4161/auto.6.2.11137; McMillan EM, 2012, J APPL PHYSIOL, V113, P1048, DOI 10.1152/japplphysiol.00290.2012; McMillan EM, 2011, AM J PHYSIOL-REG I, V300, pR531, DOI 10.1152/ajpregu.00488.2010; Miyachi M, 2009, HYPERTENSION, V53, P701, DOI 10.1161/HYPERTENSIONAHA.108.127290; Mizushima N, 1998, J BIOL CHEM, V273, P33889, DOI 10.1074/jbc.273.51.33889; Muller AL, 2012, HEART FAIL REV, V17, P395, DOI 10.1007/s10741-011-9269-8; Ogura Y, 2011, BIOCHEM BIOPH RES CO, V414, P756, DOI 10.1016/j.bbrc.2011.09.152; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Plant PJ, 2009, J APPL PHYSIOL, V107, P224, DOI 10.1152/japplphysiol.90932.2008; Quadrilatero J, 2008, BIOCHEM BIOPH RES CO, V368, P168, DOI 10.1016/j.bbrc.2008.01.067; Quadrilatero J, 2006, J APPL PHYSIOL, V101, P1149, DOI 10.1152/japplphysiol.00194.2006; Quadrilatero J, 2011, APPL PHYSIOL NUTR ME, V36, P608, DOI [10.1139/h11-064, 10.1139/H11-064]; Quadrilatero J, 2010, BIOCHEM BIOPH RES CO, V391, P1437, DOI 10.1016/j.bbrc.2009.12.084; Raben N, 2008, HUM MOL GENET, V17, P3897, DOI 10.1093/hmg/ddn292; Ravikumar B, 2010, PHYSIOL REV, V90, P1383, DOI 10.1152/physrev.00030.2009; Rodriguez A, 2008, LIFE SCI, V83, P540, DOI 10.1016/j.lfs.2008.07.022; Sanchez AMJ, 2012, J CELL BIOCHEM, V113, P695, DOI 10.1002/jcb.23399; Sandri M, 2010, AM J PHYSIOL-CELL PH, V298, pC1291, DOI 10.1152/ajpcell.00531.2009; She PX, 2011, AM J PHYSIOL-ENDOC M, V301, pE49, DOI 10.1152/ajpendo.00630.2010; Smuder AJ, 2011, J APPL PHYSIOL, V111, P1190, DOI 10.1152/japplphysiol.00429.2011; Smuder AJ, 2011, J APPL PHYSIOL, V110, P935, DOI 10.1152/japplphysiol.00677.2010; Supinski GS, 2009, J APPL PHYSIOL, V107, P1389, DOI 10.1152/japplphysiol.00341.2009; Talbert EE, 2013, J APPL PHYSIOL, V114, P1482, DOI 10.1152/japplphysiol.00925.2012; Tsutsui H, 2011, AM J PHYSIOL-HEART C, V301, pH2181, DOI 10.1152/ajpheart.00554.2011; Vanhorebeek I, 2011, J CLIN ENDOCR METAB, V96, pE633, DOI 10.1210/jc.2010-2563; Wei YJ, 2008, MOL CELL, V30, P678, DOI 10.1016/j.molcel.2008.06.001; Xing SS, 2014, BIOCHEM BIOPH RES CO, V445, P375, DOI 10.1016/j.bbrc.2014.02.008; Yamamoto K, 1999, MOL CELL BIOL, V19, P8469; Yang ZF, 2006, MOL BIOL CELL, V17, P5094, DOI 10.1091/mbc.E06-06-0479; Zalckvar E, 2009, EMBO REP, V10, P285, DOI 10.1038/embor.2008.246; Zhang J, 2009, CELL DEATH DIFFER, V16, P939, DOI 10.1038/cdd.2009.16; Zhu HX, 2007, J CLIN INVEST, V117, P1782, DOI 10.1172/JCI27523	64	28	30	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0119382	10.1371/journal.pone.0119382	http://dx.doi.org/10.1371/journal.pone.0119382			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799101	gold, Green Published, Green Submitted			2022-12-26	WOS:000351987300046
J	Reyes, MB; Carelli, PV; Sartorelli, JC; Pinto, RD				Reyes, Marcelo Bussotti; Carelli, Pedro Valadao; Sartorelli, Jose Carlos; Pinto, Reynaldo Daniel			A Modeling Approach on Why Simple Central Pattern Generators Are Built of Irregular Neurons	PLOS ONE			English	Article							STOMATOGASTRIC NERVOUS-SYSTEM; GRADED SYNAPTIC-TRANSMISSION; FUNCTIONAL CONSEQUENCES; DYNAMIC CLAMP; CIRCUIT; MODULATION; LOBSTER; NETWORK; NEUROMODULATION; INTERNEURONS	The crustacean pyloric Central Pattern Generator (CPG) is a nervous circuit that endogenously provides periodic motor patterns. Even after about 40 years of intensive studies, the rhythm genesis is still not rigorously understood in this CPG, mainly because it is made of neurons with irregular intrinsic activity. Using mathematical models we addressed the question of using a network of irregularly behaving elements to generate periodic oscillations, and we show some advantages of using non-periodic neurons with intrinsic behavior in the transition from bursting to tonic spiking (as found in biological pyloric CPGs) as building components. We studied two-and three-neuron model CPGs built either with HindmarshRose or with conductance-based Hodgkin-Huxley-like model neurons. By changing a model's parameter we could span the neuron's intrinsic dynamical behavior from slow periodic bursting to fast tonic spiking, passing through a transition where irregular bursting was observed. Two-neuron CPG, half center oscillator (HCO), was obtained for each intrinsic behavior of the neurons by coupling them with mutual symmetric synaptic inhibition. Most of these HCOs presented regular antiphasic bursting activity and the changes of the bursting frequencies was studied as a function of the inhibitory synaptic strength. Among all HCOs, those made of intrinsic irregular neurons presented a wider burst frequency range while keeping a reliable regular oscillatory (bursting) behavior. HCOs of periodic neurons tended to be either hard to change their behavior with synaptic strength variations (slow periodic burster neurons) or unable to perform a physiologically meaningful rhythm (fast tonic spiking neurons). Moreover, 3-neuron CPGs with connectivity and output similar to those of the pyloric CPG presented the same results.	[Reyes, Marcelo Bussotti; Carelli, Pedro Valadao; Sartorelli, Jose Carlos; Pinto, Reynaldo Daniel] Univ Sao Paulo, Inst Fis, BR-01498 Sao Paulo, Brazil; [Reyes, Marcelo Bussotti] Univ Fed ABC, Ctr Matemat Comp & Cognicao, Santo Andre, Brazil; [Carelli, Pedro Valadao] Univ Fed Pernambuco, Dept Fis, BR-50739 Recife, PE, Brazil; [Pinto, Reynaldo Daniel] Univ Sao Paulo, Inst Fis Sao Carlos, Sao Carlos, SP, Brazil	Universidade de Sao Paulo; Universidade Federal do ABC (UFABC); Universidade Federal de Pernambuco; Universidade de Sao Paulo	Reyes, MB (corresponding author), Univ Sao Paulo, Inst Fis, CP 20516, BR-01498 Sao Paulo, Brazil.	marcelo.reyes@ufabc.edu.br	Carelli, Pedro V/F-8551-2011; Sartorelli, Jose C/N-6562-2016	Carelli, Pedro V/0000-0002-5666-9606; Sartorelli, Jose C/0000-0003-4686-6873; Reyes, Marcelo/0000-0001-7811-7696	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-FAPESP [98/15902-8]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq [473554/2011-9, 480053/2013-8]; Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco-FACEPE [APQ-1415-1.05/10]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco-FACEPE(Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE))	Funding: The authors received financial support from the Brazilian agencies: Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-FAPESP (grant 98/15902-8), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq (grants 473554/2011-9 and 480053/2013-8) and Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco-FACEPE (grant APQ-1415-1.05/10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayali A, 1998, J NEUROPHYSIOL, V79, P2063, DOI 10.1152/jn.1998.79.4.2063; Barabasi AL, 2005, NAT PHYS, V1, P68, DOI 10.1038/nphys162; Bartos M, 1999, J NEUROSCI, V19, P6650; Bohm H, 2001, J COMP PHYSIOL A, V187, P393, DOI 10.1007/s003590100212; Brezina V, 2005, J NEUROPHYSIOL, V93, P1523, DOI 10.1152/jn.00475.2004; Carelli PV, 2005, J NEUROPHYSIOL, V94, P1169, DOI 10.1152/jn.00070.2005; DESTEXHE A, 1994, NEURAL COMPUT, V6, P14, DOI 10.1162/neco.1994.6.1.14; Dickinson PS, 2006, CURR OPIN NEUROBIOL, V16, P604, DOI 10.1016/j.conb.2006.10.007; Elson RC, 1999, J NEUROPHYSIOL, V82, P115, DOI 10.1152/jn.1999.82.1.115; Gdovin MJ, 1999, COMP BIOCHEM PHYS A, V124, P275, DOI 10.1016/S1095-6433(99)00116-6; Goaillard JM, 2009, NAT NEUROSCI, V12, P1424, DOI 10.1038/nn.2404; Grashow R, 2009, P NATL ACAD SCI USA, V106, P11742, DOI 10.1073/pnas.0905614106; GRAUBARD K, 1980, P NATL ACAD SCI-BIOL, V77, P3733, DOI 10.1073/pnas.77.6.3733; GRAUBARD K, 1983, J NEUROPHYSIOL, V50, P508, DOI 10.1152/jn.1983.50.2.508; Harris -Warrick R.M., 1992, DYNAMIC BIOL NETWORK; HARRISWARRICK RM, 1995, J NEUROPHYSIOL, V74, P1404, DOI 10.1152/jn.1995.74.4.1404; HINDMARSH JL, 1982, NATURE, V296, P162, DOI 10.1038/296162a0; HINDMARSH JL, 1984, PROC R SOC SER B-BIO, V221, P87, DOI 10.1098/rspb.1984.0024; Holden A. V., 1992, Neural Network Dynamics. Proceedings of the Workshop on Complex Dynamics in Neural Networks, P155; HUGUENARD JR, 1992, J NEUROPHYSIOL, V68, P1373, DOI 10.1152/jn.1992.68.4.1373; Ivanov AI, 2006, J NEUROPHYSIOL, V96, P218, DOI 10.1152/jn.01093.2005; Kemenes G, 2001, J NEUROSCI, V21, P2903, DOI 10.1523/JNEUROSCI.21-08-02903.2001; KIEHN O, 1992, J NEUROPHYSIOL, V68, P496, DOI 10.1152/jn.1992.68.2.496; Liu Z, 1998, J NEUROSCI, V18, P2309; MacKay-Lyons M, 2002, PHYS THER, V82, P69, DOI 10.1093/ptj/82.1.69; Marder E, 2001, CURR BIOL, V11, pR986, DOI 10.1016/S0960-9822(01)00581-4; Marder E, 1996, PHYSIOL REV, V76, P687, DOI 10.1152/physrev.1996.76.3.687; Marder E, 2007, ANNU REV PHYSIOL, V69, P291, DOI 10.1146/annurev.physiol.69.031905.161516; Marder E, 2011, P NATL ACAD SCI USA, V108, P15542, DOI 10.1073/pnas.1010674108; MAYNARD DM, 1975, J COMP PHYSIOL, V97, P215, DOI 10.1007/BF00617544; MULLONEY B, 1974, J COMP PHYSIOL, V91, P1, DOI 10.1007/BF00696154; Nusbaum MP, 2002, NATURE, V417, P343, DOI 10.1038/417343a; Ohgane K, 2004, BIOL CYBERN, V90, P125, DOI 10.1007/s00422-003-0450-6; OTT E, 1990, PHYS REV LETT, V64, P1196, DOI 10.1103/PhysRevLett.64.1196; Pearson KG, 2000, ANNU REV PHYSIOL, V62, P723, DOI 10.1146/annurev.physiol.62.1.723; PERKEL DH, 1974, SCIENCE, V185, P181, DOI 10.1126/science.185.4146.181; Pinto RD, 2000, PHYS REV E, V62, P2644, DOI 10.1103/PhysRevE.62.2644; Pinto RD, 2001, J NEUROSCI METH, V108, P39, DOI 10.1016/S0165-0270(01)00368-5; Prinz AA, 2004, NAT NEUROSCI, V7, P1345, DOI 10.1038/nn1352; Prinz AA, 2003, J NEUROSCI, V23, P943; Rabinovich MI, 1998, NEUROSCIENCE, V87, P5, DOI 10.1016/S0306-4522(98)00091-8; Rabinovich MI, 1997, IEEE T CIRCUITS-I, V44, P997, DOI 10.1109/81.633889; Reyes MB, 2008, EUR J APPL PHYSIOL, V102, P667, DOI 10.1007/s00421-007-0635-0; Roffman RC, 2012, J NEUROPHYSIOL, V107, P1681, DOI 10.1152/jn.00903.2011; Rowat PF, 1997, J COMPUT NEUROSCI, V4, P103, DOI 10.1023/A:1008869411135; SCHIFF SJ, 1994, NATURE, V370, P615, DOI 10.1038/370615a0; Selverston A I, 1976, Prog Neurobiol, V7, P215, DOI 10.1016/0301-0082(76)90008-3; Selverston A.I., 1987, CRUSTACEAN STOMATOGA; Selverston AI, 2000, J PHYSIOLOGY-PARIS, V94, P357, DOI 10.1016/S0928-4257(00)01101-3; Sharp AA, 1996, J NEUROPHYSIOL, V76, P867, DOI 10.1152/jn.1996.76.2.867; Simoni MF, 2006, IEEE T NEUR SYS REH, V14, P281, DOI 10.1109/TNSRE.2006.881537; Skinner F K, 1994, J Comput Neurosci, V1, P69, DOI 10.1007/BF00962719; Stein P, 1997, NEURONS NETWORKS BEH; Szucs A, 2000, NEUROREPORT, V11, P563; Tang LS, 2012, J NEUROSCI, V32, P10075, DOI 10.1523/JNEUROSCI.1443-12.2012; TURRIGIANO G, 1995, J NEUROSCI, V15, P3640; WANG XJ, 1992, NEURAL COMPUT, V4, P84, DOI 10.1162/neco.1992.4.1.84; Weaver AL, 2003, J NEUROPHYSIOL, V90, P2378, DOI 10.1152/jn.00705.2002; Yakovenko S, 2005, J NEUROPHYSIOL, V94, P1057, DOI 10.1152/jn.00991.2004; Zhang Y, 2003, J NEUROSCI, V23, P9059	61	6	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120314	10.1371/journal.pone.0120314	http://dx.doi.org/10.1371/journal.pone.0120314			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799556	gold, Green Submitted, Green Published			2022-12-26	WOS:000351987300131
J	Yang, ZH; Fang, SR; Di, YC; Ying, WW; Tan, Y; Gu, W				Yang, Zhenhua; Fang, Surong; Di, Yicheng; Ying, Weiwei; Tan, Yan; Gu, Wei			Modulation of NF-kappa B/miR-21/PTEN Pathway Sensitizes Non-Small Cell Lung Cancer to Cisplatin	PLOS ONE			English	Article							GENE-EXPRESSION; MICRORNA-21; PTEN; TRANSCRIPTION; CHEMOTHERAPY; MUTATION; MIR-21; RNA	Background Platinum-based chemotherapy is a standard strategy for non-small cell lung cancer (NSCLC), while chemoresistance remains a major therapeutic challenge in current clinical practice. Our present study was aimed to determine whether inhibition of the NF-kappa B/miR21/PTEN pathway could increase the sensitivity of NSCLC to cisplatin. Methods The expression of miR-21 in NSCLC tissues was determined using in situ hybridization. Next, the effect of miR-21 on the sensitivity of A549 cells to cisplatin was determined in vitro. Whether miR-21 regulated PTEN expression was assessed by luciferase assay. Furthermore, whether NF-kappa B targeted its binding elements in the miR-21 gene promoter was determined by luciferase and ChIP assay. Finally, we measured the cell viability and apoptosis under cisplatin treatment when NF-kappa B was inhibited. Results An elevated level of miR-21 was observed in NSCLC lung tissues and was related to a short survival time. Exogenous miR-21 promoted cell survival when exposed to cisplatin, while miR-21 inhibition could reverse this process. The RNA and protein levels of PTEN were significantly decreased by exogenous miR-21, and the 30-untranslated region of PTEN was shown to be a target of miR-21. The expression of miR-21 was regulated by NF-kappa B binding to its element in the promoter, a finding that was verified by luciferase and ChIP assay. Hence, inhibition of NF-kappa B by RNA silencing protects cells against cisplatin via decreasing miR-21 expression. Conclusion Modulation of the NF-kappa B/miR-21/PTEN pathway in NSCLC showed that inhibition of this pathway may increase cisplatin sensitivity.	[Yang, Zhenhua; Fang, Surong; Di, Yicheng; Ying, Weiwei; Tan, Yan; Gu, Wei] Nanjing Med Univ, Nanjing Hosp 1, Dept Resp Med, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University	Gu, W (corresponding author), Nanjing Med Univ, Nanjing Hosp 1, Dept Resp Med, Nanjing, Jiangsu, Peoples R China.	njguwei@163.com			Program of Jiangsu Health Department [H201341]	Program of Jiangsu Health Department	This study was financially supported by the Program of Jiangsu Health Department (H201341). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, ISRN STROKE, DOI [DOI 10.1007/S00531-013-0931-3, DOI 10.1155/2013/858945]; Blanco R, 2014, ANN ONCOL; Cai JC, 2013, CANCER RES, V73, P5402, DOI 10.1158/0008-5472.CAN-13-0297; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; Gao W, 2012, CANCER BIOL THER, V13, P330, DOI 10.4161/cbt.19073; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Kim EJ, 2013, J CELL BIOCHEM, V114, P1248, DOI 10.1002/jcb.24465; Li X, 2012, ONCOGENE, V31, P4979, DOI 10.1038/onc.2011.655; Liu M, 2014, ONCOL LETT, V7, P1903, DOI 10.3892/ol.2014.2049; Liu ZL, 2013, MOL CELL BIOCHEM, V372, P35, DOI 10.1007/s11010-012-1443-3; Ma XL, 2012, ASIAN PAC J CANCER P, V13, P2329, DOI 10.7314/APJCP.2012.13.5.2329; Markou A, 2008, CLIN CHEM, V54, P1696, DOI 10.1373/clinchem.2007.101741; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Meng FY, 2006, GASTROENTEROLOGY, V130, P2113, DOI 10.1053/j.gastro.2006.02.057; Niu JX, 2012, J BIOL CHEM, V287, P21783, DOI 10.1074/jbc.M112.355495; Qian WF, 2011, BRAZ J MED BIOL RES, V44, P1222, DOI [10.1590/S0100-879X2011007500143, 10.1590/S0100-879X2011001200005]; Qiu ZH, 2014, EXPERT OPIN INV DRUG, V23, P347, DOI 10.1517/13543784.2014.867327; Reck M, 2014, ANN ONCOL, V25, P27, DOI 10.1093/annonc/mdu199; Seike M, 2009, P NATL ACAD SCI USA, V106, P12085, DOI 10.1073/pnas.0905234106; Shen H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103305; Stankovic T, 2014, BIOMED PHARMACOTHER, V68, P521, DOI 10.1016/j.biopha.2014.03.014; Umemura S, 2014, J THORAC ONCOL, V9, P1324, DOI 10.1097/JTO.0000000000000250; Xie B, 2011, J NEUROSCI, V31, P5032, DOI 10.1523/JNEUROSCI.5504-10.2011; Xu LF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103698; Yang CH, 2010, CANCER RES, V70, P8108, DOI 10.1158/0008-5472.CAN-10-2579; Zhang JG, 2010, CLIN CHIM ACTA, V411, P846, DOI 10.1016/j.cca.2010.02.074; Zhao N, 2014, LUNG CANCER, V86, P255, DOI 10.1016/j.lungcan.2014.08.013; Zhu WJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103373	28	68	73	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121547	10.1371/journal.pone.0121547	http://dx.doi.org/10.1371/journal.pone.0121547			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799148	Green Submitted, Green Published, gold			2022-12-26	WOS:000351987300267
J	Zhu, M; Lin, XA; Zha, XM; Zhou, WB; Xia, TS; Wang, S				Zhu, Miao; Lin, Xiao-An; Zha, Xiao-Ming; Zhou, Wen-Bin; Xia, Tian-Song; Wang, Shui			Evaluation of the Therapeutic Efficacy of Sequential Therapy Involving Percutaneous Microwave Ablation in Combination with I-131-Hypericin Using the VX2 Rabbit Breast Solid Tumor Model	PLOS ONE			English	Article							CARCINOMA-IN-SITU; EUROPEAN ORGANIZATION; CONSERVING TREATMENT; RADIOTHERAPY	Purpose Combination of percutaneous microwave ablation (PMWA) and intravenous injection of I-131-hypericin(IIIH) may bear potential as a mini-invasive treatment for tumor. The objective of this study was to assess the effect of PMWA and IIIH in breast tumor growth. Methods Ten New Zealand White rabbits bearing VX2 breast carcinomas were randomly divided into two groups (each 5 examples) and processed using PMWA followed by IIIH and IIIH alone. The IIIH activity was evaluated using planar scintigraphy, autoradiography and biodistribution analysis. The maximum effective safe dose of IIIH was found through 48 rabbits with VX2 breast tumor, which were randomized into six groups (n= 8 per group). Subsequently, a further 75 rabbits bearing VX2 breast solid tumors were randomly divided into five groups (each 15 examples) and treated as follows: A, no treatment group; B, PMWA alone; C, IIIH alone; D, PMWA+IIIHx1 (at 8 h post-PMWA); and E, PMWA+IIIHx2 (at 8 h and at 8 days post-PMWA). The therapeutic effect was assessed by measurement of tumor size and performation of positron emission tomography/computed tomograph (PET/CT) scans, liver and renal function tests and Kaplan-Meier survival analysis. Results The planar scintigraphy findings suggested a significant uptake of I-131 in necrotic tumor tissue. The autoradiography gray scales indicated higher selective uptake of IIIH by necrotic tissue, with significant differences between the groups with and those without necrotic tumor tissue (P< 0.05). The maximum effective safe dose of IIIH was 1mCi/kg. The PET/CT scans and tumor size measurement suggested improvements in treatment groups at all time points (P< 0.01). Significant differences were detected among Groups A, B, D and E (P< 0.05). Lower levels of lung metastasis were detected in Groups D and E (P< 0.05). There were no abnormalities in liver and renal functions tests or other reported side effects. Conclusion IIIH exhibited selective uptake by necrotic tumor tissue. Sequential therapy involving PMWA+IIIH was successfully inhibiting tumor growth and prolonging survival.	[Zhu, Miao; Lin, Xiao-An; Zha, Xiao-Ming; Zhou, Wen-Bin; Xia, Tian-Song; Wang, Shui] Nanjing Med Univ, Affiliated Hosp 1, Dept Breast Surg, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University	Wang, S (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Breast Surg, Nanjing, Jiangsu, Peoples R China.	ws0801@hotmail.com			National Natural Science Foundation of China [81270952, 81070684, 81071753, 81172505, 81202077, 81272916]; Natural Science Foundation of Jiangsu Province [BK2010581, BK2011853, BK2011855]; Program for Development of Innovative Research Team in the First Affiliated Hospital of NJMU [IRT-008]; Priority Academic Program Development of Jiangsu higher Education Institutions (PAPD); graduate research and innovation projects of colleges and universities in Jiangsu Province [CXZZ12_0581]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Program for Development of Innovative Research Team in the First Affiliated Hospital of NJMU; Priority Academic Program Development of Jiangsu higher Education Institutions (PAPD); graduate research and innovation projects of colleges and universities in Jiangsu Province	Funding: This work was supported in part by the National Natural Science Foundation of China (81270952, 81070684, 81071753, 81172505, 81202077 and 81272916), the Natural Science Foundation of Jiangsu Province (BK2010581, BK2011853 and BK2011855), the Program for Development of Innovative Research Team in the First Affiliated Hospital of NJMU (IRT-008) and a project Funded by the Priority Academic Program Development of Jiangsu higher Education Institutions (PAPD), the graduate research and innovation projects of colleges and universities in Jiangsu Province (CXZZ12_0581). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bijker N, 2006, J CLIN ONCOL, V24, P3381, DOI 10.1200/JCO.2006.06.1366; Chang CH, 2002, MOL CANCER THER, V1, P553; CHEN FM, 1989, CANCER RES, V49, P4578; de Putte MV, 2012, INT J CANCER, V131, pE129, DOI 10.1002/ijc.26492; DUPONT WD, 1990, CONTROL CLIN TRIALS, V11, P116, DOI 10.1016/0197-2456(90)90005-M; EPSTEIN AL, 1988, CANCER RES, V48, P5842; Groheux D, 2013, RADIOLOGY, V266, P388, DOI 10.1148/radiol.12110853; Hamamoto S, 2013, RADIOLOGY, V267, P405, DOI 10.1148/radiol.13120249; Hill-Kayser CE, 2012, INT J RADIAT ONCOL, V83, P839, DOI 10.1016/j.ijrobp.2011.08.013; Jones-Bolin S, 2012, CURR PROTOC PHARMACO, V4; Julien JP, 2000, LANCET, V355, P528, DOI 10.1016/S0140-6736(99)06341-2; Lei Z, 2011, EUR J RADIOL, V78, P277, DOI 10.1016/j.ejrad.2011.01.050; Li JJ, 2011, RADIOLOGY, V260, P799, DOI 10.1148/radiol.11102120; Lubner MG, 2010, J VASC INTERV RADIOL, V21, pS192, DOI 10.1016/j.jvir.2010.04.007; Simon CJ, 2005, RADIOGRAPHICS, V25, pS69, DOI 10.1148/rg.25si055501; Tanaka T, 2012, CARDIOVASC INTER RAD, V35, P914, DOI 10.1007/s00270-011-0253-4; Vaidya JS, 2011, INT J RADIAT ONCOL, V81, P1091, DOI 10.1016/j.ijrobp.2010.07.1996; van Dongen JA, 2000, JNCI-J NATL CANCER I, V92, P1143, DOI 10.1093/jnci/92.14.1143; Veronesi U, 2001, ANN ONCOL, V12, P997, DOI 10.1023/A:1011136326943; Veronesi U, 2010, BREAST CANCER RES TR, V124, P141, DOI 10.1007/s10549-010-1115-5; Webb H, 2011, SEMIN ROENTGENOL, V46, P133, DOI 10.1053/j.ro.2010.08.002; WOLTANSKI KP, 1990, EXP CLIN ENDOCRINOL, V95, P39, DOI 10.1055/s-0029-1210932; Yu J, 2011, EUR J RADIOL, V79, P124, DOI 10.1016/j.ejrad.2009.12.009; Zhang DK, 2009, J UROLOGY, V182, P1588, DOI 10.1016/j.juro.2009.06.004; Zhang K, 2005, CLIN CANCER RES, V11, P7532, DOI 10.1158/1078-0432.CCR-05-0400; ZHOU WD, 2012, BMC EVOL BIOL, V12, P37552, DOI DOI 10.1186/1477-7819-10-97; Zhou WB, 2012, RADIOLOGY, V263, P364, DOI 10.1148/radiol.12111901	27	12	13	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120303	10.1371/journal.pone.0120303	http://dx.doi.org/10.1371/journal.pone.0120303			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799220	Green Submitted, Green Published, gold			2022-12-26	WOS:000351987300127
J	Johjima, A; Noi, K; Nishikori, S; Ogi, H; Esaki, M; Ogura, T				Johjima, Ai; Noi, Kentaro; Nishikori, Shingo; Ogi, Hirotsugu; Esaki, Masatoshi; Ogura, Teru			Microtubule Severing by Katanin p60 AAA+ ATPase Requires the C-terminal Acidic Tails of Both alpha- and beta-Tubulins and Basic Amino Acid Residues in the AAA plus Ring Pore	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							QUARTZ-CRYSTAL MICROBALANCE; SPASTIC PARAPLEGIA PROTEIN; RECOGNITION; ENZYME; IDENTIFICATION; DEPOLYMERASE; SENSITIVITY; DIVERSITY; MACHINERY; FIDGETIN	The microtubule (MT) network is highly dynamic and undergoes dramatic reorganizations during the cell cycle. Dimers of alpha- and beta-tubulins rapidly polymerize to and depolymerize from the end of MT fibrils in an intrinsic GTP-dependent manner. MT severing by ATP-driven enzymes such as katanin and spastin contributes significantly to microtubule dynamics, and it has been shown that katanin p60, a AAA+ family protein, has ATPase and MT-severing activities. The mechanism of MT severing by katanin p60 is poorly understood, and the residues in katanin p60 and tubulins important for severing activity were therefore explored in this study. MT-severing activity, but not ATPase activity, was inhibited by mutations of the conserved aromatic residue and the flanking basic residues in the pore region of the katanin p60 hexameric ring. When the acidic residue-rich C-terminal unstructured segment of either alpha- or beta-tubulin was removed, polymerized MTs were resistant to katanin p60 treatment. Interactions between katanin p60 and the mutant MTs, on the other hand, were unaffected. Taken together, these findings led us to propose that the interactions between the positively charged residues of katanin p60 and the acidic tails of both tubulins are essential for efficient severing of MTs.	[Johjima, Ai; Noi, Kentaro; Nishikori, Shingo; Esaki, Masatoshi; Ogura, Teru] Kumamoto Univ, Inst Mol Embryol & Genet, Dept Mol Cell Biol, Kumamoto 8600811, Japan; [Noi, Kentaro; Esaki, Masatoshi; Ogura, Teru] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Tokyo 1020076, Japan; [Noi, Kentaro; Ogi, Hirotsugu] Osaka Univ, Grad Sch Engn Sci, Osaka 5608531, Japan	Kumamoto University; Japan Science & Technology Agency (JST); Osaka University	Esaki, M (corresponding author), Kumamoto Univ, Inst Mol Embryol & Genet, Dept Mol Cell Biol, Kumamoto 8600811, Japan.	esaki@kumamoto-u.ac.jp; ogura@gpo.kumamoto-u.ac.jp	Esaki, Masatoshi/L-6591-2017; Esaki, Masatoshi/ABS-6645-2022	Ogura, Teru/0000-0003-3784-0970	Japan Society for the Promotion of Science; MEXT of Japan; CREST program of JST	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); CREST program of JST(Core Research for Evolutional Science and Technology (CREST))	This work was supported in part by grants-in-aid from Japan Society for the Promotion of Science, from MEXT of Japan, and from the CREST program of JST.	Ando T, 2014, CURR OPIN STRUC BIOL, V28, P63, DOI 10.1016/j.sbi.2014.07.011; CONFALONIERI F, 1995, BIOESSAYS, V17, P639, DOI 10.1002/bies.950170710; Davis LJ, 2002, BIOPHYS J, V82, P2916, DOI 10.1016/S0006-3495(02)75632-4; Diaz-Valencia J. D., 2011, BIOPHYS J, V100, P2440; Downing KH, 1998, CURR OPIN CELL BIOL, V10, P16, DOI 10.1016/S0955-0674(98)80082-3; Dymek EE, 2012, J CELL SCI, V125, P3357, DOI 10.1242/jcs.096941; Eckert T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050161; Gupta ML, 2003, P NATL ACAD SCI USA, V100, P6394, DOI 10.1073/pnas.1131967100; Hartman JJ, 1998, CELL, V93, P277, DOI 10.1016/S0092-8674(00)81578-0; Hartman JJ, 1999, SCIENCE, V286, P782, DOI 10.1126/science.286.5440.782; Hazan J, 1999, NAT GENET, V23, P296, DOI 10.1038/15472; HEUSELE C, 1987, EUR J BIOCHEM, V165, P613, DOI 10.1111/j.1432-1033.1987.tb11484.x; Iwaya N, 2012, FEBS J, V279, P1339, DOI 10.1111/j.1742-4658.2012.08528.x; Iwaya N, 2010, J BIOL CHEM, V285, P16822, DOI 10.1074/jbc.M110.108365; Kannegaard E, 2014, MOL BIOL CELL, V25, P3686, DOI 10.1091/mbc.E14-06-1116; Llorca O, 2000, EMBO J, V19, P5971, DOI 10.1093/emboj/19.22.5971; Lowe J, 2001, J MOL BIOL, V313, P1045, DOI 10.1006/jmbi.2001.5077; Martin A, 2008, NAT STRUCT MOL BIOL, V15, P1147, DOI 10.1038/nsmb.1503; MARYA PK, 1994, J CELL SCI, V107, P339; Matsushita-Ishiodori Y, 2007, BIOCHEM BIOPH RES CO, V359, P157, DOI 10.1016/j.bbrc.2007.05.086; Matsushita-Ishiodori Y, 2009, GENES CELLS, V14, P925, DOI 10.1111/j.1365-2443.2009.01320.x; MCNALLY FJ, 1993, CELL, V75, P419, DOI 10.1016/0092-8674(93)90377-3; McNally K, 2006, J CELL BIOL, V175, P881, DOI 10.1083/jcb.200608117; McNally KP, 2000, J CELL SCI, V113, P1623; Mukherjee S, 2012, CELL CYCLE, V11, P2359, DOI 10.4161/cc.20849; Ogi H, 2008, ANAL CHEM, V80, P5494, DOI 10.1021/ac800459g; Ogi H, 2009, ANAL CHEM, V81, P4015, DOI 10.1021/ac9004524; Ogura T, 2001, GENES CELLS, V6, P575, DOI 10.1046/j.1365-2443.2001.00447.x; Onitake A, 2012, J STRUCT BIOL, V179, P143, DOI 10.1016/j.jsb.2012.04.022; Roll-Mecak A, 2008, NATURE, V451, P363, DOI 10.1038/nature06482; Roll-Mecak A, 2010, CURR OPIN CELL BIOL, V22, P96, DOI 10.1016/j.ceb.2009.11.001; Schlieker C, 2004, NAT STRUCT MOL BIOL, V11, P607, DOI 10.1038/nsmb787; Scott A, 2005, EMBO J, V24, P3658, DOI 10.1038/sj.emboj.7600818; Sharma N, 2007, J CELL BIOL, V178, P1065, DOI 10.1083/jcb.200704021; Sharp DJ, 2012, J CELL SCI, V125, P2561, DOI 10.1242/jcs.101139; SHIINA N, 1995, TRENDS CELL BIOL, V5, P283, DOI 10.1016/S0962-8924(00)89040-6; Siddiqui SM, 2004, GENE DEV, V18, P369, DOI 10.1101/gad.1170304; Snider J, 2008, BIOCHEM SOC T, V36, P72, DOI 10.1042/BST0360072; Srayko M, 2000, GENE DEV, V14, P1072; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Uchimura S, 2006, EMBO J, V25, P5932, DOI 10.1038/sj.emboj.7601442; Walczak CE, 2000, CURR OPIN CELL BIOL, V12, P52, DOI 10.1016/S0955-0674(99)00056-3; White SR, 2007, TRAFFIC, V8, P1657, DOI 10.1111/j.1600-0854.2007.00642.x; White SR, 2007, J CELL BIOL, V176, P995, DOI 10.1083/jcb.200610072; Widlund PO, 2012, MOL BIOL CELL, V23, P4393, DOI 10.1091/mbc.E12-06-0444; Yamada-Inagawa T, 2003, J BIOL CHEM, V278, P50182, DOI 10.1074/jbc.M308327200; Yu WQ, 2008, MOL BIOL CELL, V19, P1485, DOI 10.1091/mbc.E07-09-0878; Yu WQ, 2005, J NEUROSCI, V25, P5573, DOI 10.1523/JNEUROSCI.0834-05.2005; Zhang D, 2007, J CELL BIOL, V177, P231, DOI 10.1083/jcb.200612011; Zhang D, 2011, NAT CELL BIOL, V13, P361, DOI 10.1038/ncb2206	50	27	27	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2015	290	18					11762	11770		10.1074/jbc.M114.614768	http://dx.doi.org/10.1074/jbc.M114.614768			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH0OA	25805498	Green Published, hybrid			2022-12-26	WOS:000353719400048
J	Orabi, AI; Sah, S; Javed, TA; Lemon, KL; Good, ML; Guo, P; Xiao, XW; Prasadan, K; Gittes, GK; Jin, SQ; Husain, SZ				Orabi, Abrahim I.; Sah, Swati; Javed, Tanveer A.; Lemon, Kathryn L.; Good, Misty L.; Guo, Ping; Xiao, Xiangwei; Prasadan, Krishna; Gittes, George K.; Jin, Shunqian; Husain, Sohail Z.			Dynamic Imaging of Pancreatic Nuclear Factor kappa B (NF-kappa B) Activation in Live Mice Using Adeno-associated Virus (AAV) Infusion and Bioluminescence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VIVO; TRANSGENIC MICE; TRYPSINOGEN ACTIVATION; MOUSE MODEL; LUCIFERASE; KINASE; CELLS; GENE; EXPRESSION; CERULEIN	Nuclear factor kappa B (NF-kappa B) is an important signaling molecule that plays a critical role in the development of acute pancreatitis. Current methods for examining NF-kappa B activation involve infection of an adenoviral NF-kappa B-luciferase reporter into cell lines or electrophoretic mobility shift assay of lysate. The use of adeno-associated viruses (AAVs) has proven to be an effective method of transfecting whole organs in live animals. We examined whether intrapancreatic duct infusion of AAV containing an NF-kappa B-luciferase reporter (AAV-NF-kappa B-luciferase) can reliably measure pancreatic NF-kappa B activation. We confirmed the infectivity of the AAV-NF-kappa B-luciferase reporter in HEK293 cells using a traditional luciferase readout. Mice were infused with AAV-NF-kappa B-luciferase 5 weeks before induction of pancreatitis (caerulein, 50 mu g/kg). Unlike transgenic mice that globally express NF-kappa B-luciferase, AAV-infused mice showed a 15-fold increase in pancreas-specific NF-kappa B bioluminescence following 12 h of caerulein compared with baseline luminescence (p < 0.05). The specificity of the NF-kappa B-luciferase signal to the pancreas was confirmed by isolating the pancreas and adjacent organs and observing a predominant bioluminescent signal in the pancreas compared with liver, spleen, and stomach. A complementary mouse model of post-ERCP-pancreatitis also induced pancreatic NF-kappa B signals. Taken together these data provide the first demonstration that NF-kappa B activation can be examined in a live, dynamic fashion during pancreatic inflammation. Webelieve this technique offers a valuable tool to study real-time activation of NF-kappa B in vivo.	[Orabi, Abrahim I.; Sah, Swati; Javed, Tanveer A.; Lemon, Kathryn L.; Good, Misty L.; Jin, Shunqian; Husain, Sohail Z.] UPMC, Childrens Hosp Pittsburgh, Dept Pediat, Pittsburgh, PA 15224 USA; [Guo, Ping; Xiao, Xiangwei; Prasadan, Krishna; Gittes, George K.] UPMC, Childrens Hosp Pittsburgh, Dept Surg, Pittsburgh, PA 15224 USA; Univ Pittsburgh, Sch Med, Pittsburgh, PA 15224 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Husain, SZ (corresponding author), Rangos Res Ctr, 4401 Penn Ave, Pittsburgh, PA 15224 USA.	sohail.husain@chp.edu	Good, Misty/AAI-6192-2020; Regan, Clinton/E-6250-2012	Good, Misty/0000-0002-0264-5721; Xiao, Xiangwei/0000-0003-0890-9203; Husain, Sohail Z/0000-0003-3012-1308	National Institutes of Health [DK083327, DK093491, DK03002]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK103002, R01DK093491, R01DK083327] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK083327, DK093491, and DK03002 (to S. Z. H.).	Andriulli A, 2007, AM J GASTROENTEROL, V102, P1781, DOI 10.1111/j.1572-0241.2007.01279.x; [Anonymous], 2006, GASTROINTEST ENDOSC, V63, P361, DOI 10.1016/j.gie.2006.01.010; Badr CE, 2009, MOL IMAGING, V8, P278, DOI 10.2310/7290.2009.00026; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Bhakar AL, 2002, J NEUROSCI, V22, P8466; Carlsen H, 2002, J IMMUNOL, V168, P1441, DOI 10.4049/jimmunol.168.3.1441; Chen XQ, 2002, GASTROENTEROLOGY, V122, P448, DOI 10.1053/gast.2002.31060; Contag CH, 2000, NEOPLASIA, V2, P41, DOI 10.1038/sj.neo.7900079; D Frank C, 2006, NAT CLIN PRACT GASTR, V3, P680, DOI 10.1038/ncpgasthep0654; DEWET JR, 1987, MOL CELL BIOL, V7, P725, DOI 10.1128/MCB.7.2.725; Ding SP, 2003, WORLD J GASTROENTERO, V9, P584, DOI 10.3748/wjg.v9.i3.584; Dohlen G, 2005, PEDIATR RES, V58, P941, DOI 10.1203/01.PDR.0000182595.62545.EE; Ethridge RT, 2002, J AM COLL SURGEONS, V195, P497, DOI 10.1016/S1072-7515(02)01222-X; Gray KD, 2003, J SURG RES, V110, P310, DOI 10.1016/S0022-4804(03)00024-6; Gukovsky I, 1998, AM J PHYSIOL-GASTR L, V275, pG1402, DOI 10.1152/ajpgi.1998.275.6.G1402; Gukovsky I, 2013, GASTROENTEROLOGY, V144, P26, DOI 10.1053/j.gastro.2012.11.016; Guo P, 2013, LAB INVEST, V93, P1241, DOI 10.1038/labinvest.2013.113; Guo P, 2012, J VIROL METHODS, V183, P139, DOI 10.1016/j.jviromet.2012.04.004; Haridas V, 1999, ONCOGENE, V18, P6496, DOI 10.1038/sj.onc.1203059; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hietaranta AJ, 2001, BIOCHEM BIOPH RES CO, V280, P388, DOI 10.1006/bbrc.2000.4120; Houbracken I, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-74; Huang HJ, 2013, GASTROENTEROLOGY, V144, P202, DOI 10.1053/j.gastro.2012.09.059; Hyoudou K, 2007, MOL PHARMACOL, V71, P446, DOI 10.1124/mol.106.027169; Jamal MM, 2007, AM J GASTROENTEROL, V102, P966, DOI 10.1111/j.1572-0241.2007.01127.x; Kang R, 2014, GASTROENTEROLOGY, V146, P1097, DOI 10.1053/j.gastro.2013.12.015; LAMPEL M, 1977, VIRCHOWS ARCH A, V373, P97, DOI 10.1007/BF00432156; Le TM, 2015, PANCREAS, V44, P493, DOI 10.1097/MPA.0000000000000285; Liao GX, 2004, J BIOL CHEM, V279, P26243, DOI 10.1074/jbc.M403286200; LORENZ WW, 1991, P NATL ACAD SCI USA, V88, P4438, DOI 10.1073/pnas.88.10.4438; Magness ST, 2004, J IMMUNOL, V173, P1561, DOI 10.4049/jimmunol.173.3.1561; Moynagh Paul N, 2005, J Cell Sci, V118, P4589, DOI 10.1242/jcs.02579; Muili KA, 2013, J BIOL CHEM, V288, P21065, DOI 10.1074/jbc.M113.471425; Nakajima Y, 2004, BIOSCI BIOTECH BIOCH, V68, P565, DOI 10.1271/bbb.68.565; Neuhofer P, 2013, GASTROENTEROLOGY, V144, P192, DOI 10.1053/j.gastro.2012.09.058; NIEDERAU C, 1985, GASTROENTEROLOGY, V88, P1192, DOI 10.1016/S0016-5085(85)80079-2; Niu G, 2013, THERANOSTICS, V3, P190, DOI 10.7150/thno.5825; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Perides G, 2010, NAT PROTOC, V5, P335, DOI 10.1038/nprot.2009.243; Rakonczay Z, 2008, GUT, V57, P259, DOI 10.1136/gut.2007.124115; Sadikot Ruxana T, 2005, Proc Am Thorac Soc, V2, P537, DOI 10.1513/pats.200507-067DS; Sah RP, 2013, CURR OPIN GASTROEN, V29, P523, DOI 10.1097/MOG.0b013e328363e399; SchmidtUllrich R, 1996, DEVELOPMENT, V122, P2117; SEN R, 1986, CELL, V47, P921, DOI 10.1016/0092-8674(86)90807-X; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Tando Y, 2002, DIGESTION, V66, P237, DOI 10.1159/000068364; Tannous BA, 2005, MOL THER, V11, P435, DOI 10.1016/j.ymthe.2004.10.016; Vallabhapurapu S, 2008, NAT IMMUNOL, V9, P1364, DOI 10.1038/ni.1678; Xiao XW, 2014, NAT PROTOC, V9, P2719, DOI 10.1038/nprot.2014.183; Zangani M, 2009, AM J PATHOL, V174, P1358, DOI 10.2353/ajpath.2009.080700; Zarnegar BJ, 2008, NAT IMMUNOL, V9, P1371, DOI 10.1038/ni.1676; Zhang N, 2003, J IMMUNOL, V170, P6307, DOI 10.4049/jimmunol.170.12.6307; Zhang N, 2005, J IMMUNOL, V174, P8125, DOI 10.4049/jimmunol.174.12.8125; Zhang WS, 2001, TRANSGENIC RES, V10, P423, DOI 10.1023/A:1012042506002	54	12	13	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2015	290	18					11309	11320		10.1074/jbc.M115.647933	http://dx.doi.org/10.1074/jbc.M115.647933			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH0OA	25802340	hybrid, Green Published			2022-12-26	WOS:000353719400009
J	Garcia-Carracedo, D; Yu, CC; Akhavan, N; Fine, SA; Schonleben, F; Maehara, N; Karg, DC; Xie, CG; Qiu, WL; Fine, RL; Remotti, HE; Su, GH				Garcia-Carracedo, Dario; Yu, Chih-Chieh; Akhavan, Nathan; Fine, Stuart A.; Schoenleben, Frank; Maehara, Naoki; Karg, Dillon C.; Xie, Chuangao; Qiu, Wanglong; Fine, Robert L.; Remotti, Helen E.; Su, Gloria H.			Smad4 Loss Synergizes with TGF alpha Overexpression in Promoting Pancreatic Metaplasia, PanIN Development, and Fibrosis	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; PROGRESSION MODEL; TRANSGENIC MICE; FACTOR RECEPTOR; CANCER; BETA; ADENOCARCINOMA; EXPRESSION; MUCIN; GENE	Aims While overexpression of TGF alpha has been reported in human pancreatic ductal adenocarcinoma (PDAC), mice with overexpressed TGF alpha develop premalignant pancreatic acinar-to-ductal metaplasia (ADM) but not PDAC. TGF-beta signaling pathway is pivotal to the development of PDAC and tissue fibrosis. Here we sought to investigate the interplay between TGFa and TGF-beta signaling in pancreatic tumorigenesis and fibrosis, namely via Smad4 inactivation. Methods The MT-TGF alpha mouse was crossed with a new Smad4 conditional knock-out mouse (Smad4(flox/flox); p48-Cre or S4) to generate Smad4(flox/flox); MT-TGF alpha; p48-Cre (STP). After TGFa overexpression was induced with zinc sulfate water for eight months, the pancreata of the STP, MT-TGF alpha, and S4 mice were examined for tumor development and fibrotic responses. PanIN lesions and number of ducts were counted, and proliferation was measured by Ki67 immunohistochemistry (IHC). Qualitative analysis of fibrosis was analyzed by Trichrome Masson and Sirius Red staining, while vimentin was used for quantification. Expression analyses of fibrosis, pancreatitis, or desmoplasia associated markers (alpha-SMA, Shh, COX-2, Muc6, Col1a1, and Ctgf) were performed by IHC and/or qRT-PCR. Results Our STP mice exhibited advanced ADM, increased fibrosis, increased numbers of PanIN lesions, overexpression of chronic pancreatitis-related marker Muc6, and elevated expression of desmoplasia-associated marker Col1A1, compared to the MT-TGFa mice. The inactivation of Smad4 in the exocrine compartment was responsible for both the enhanced PanIN formation and fibrosis in the pancreas. The phenotype of the STP mice represents a transient state from ADMs to PanINs, closely mimicking the interface area seen in human chronic pancreatitis associated with PDAC. Conclusion We have documented a novel mouse model, the STP mice, which displayed histologic presentations reminiscent to those of human chronic pancreatitis with signs of early tumorigenesis. The STP mice could be a suitable animal model for interrogating the transition of chronic pancreatitis to pancreatic cancer.	[Garcia-Carracedo, Dario; Yu, Chih-Chieh; Xie, Chuangao; Qiu, Wanglong; Remotti, Helen E.; Su, Gloria H.] Columbia Univ, Med Ctr, Dept Pathol, New York, NY 10027 USA; [Garcia-Carracedo, Dario; Yu, Chih-Chieh; Akhavan, Nathan; Fine, Stuart A.; Karg, Dillon C.; Xie, Chuangao; Qiu, Wanglong; Su, Gloria H.] Columbia Univ, Med Ctr, Herbert Irving Comprehens Canc Ctr, New York, NY USA; [Schoenleben, Frank] Hosp Univ Munich, Dept Vasc Surg, Grosshadern, Germany; [Maehara, Naoki; Remotti, Helen E.] Miyazaki Univ, Sch Med, Dept Surg Oncol & Regulat Organ Funct, Miyazaki, Japan; [Fine, Robert L.] Columbia Univ, Med Ctr, Dept Med, New York, NY USA; [Fine, Robert L.; Su, Gloria H.] Columbia Univ, Med Ctr, Pancreas Ctr, New York, NY USA; [Su, Gloria H.] Columbia Univ, Med Ctr, Dept Otolaryngol & Head & Neck Surg, New York, NY USA	Columbia University; Columbia University; University of Munich; University of Miyazaki; Columbia University; Columbia University; Columbia University	Su, GH (corresponding author), Columbia Univ, Med Ctr, Dept Pathol, New York, NY 10027 USA.	gs2157@columbia.edu	Remotti, Helen/AAA-1671-2020; Su, Gloria/AAJ-1457-2020	Remotti, Helen/0000-0003-1555-9299; Su, Gloria/0000-0002-5158-6019; Fine, Stuart/0000-0003-1213-1799	Michael Rolfe Foundation, NCI Temin Award [CA95434, NCI R01 CA109525]; NCI ICBP Summer Cancer Research Fellowship; NATIONAL CANCER INSTITUTE [R01CA109525, R56CA109525, K01CA095434] Funding Source: NIH RePORTER	Michael Rolfe Foundation, NCI Temin Award; NCI ICBP Summer Cancer Research Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Michael Rolfe Foundation, NCI Temin Award CA95434, and NCI R01 CA109525. Dillon C. Karg was funded by the NCI ICBP Summer Cancer Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrianifahanana M, 2001, CLIN CANCER RES, V7, P4033; Bailey JM, 2008, CLIN CANCER RES, V14, P5995, DOI 10.1158/1078-0432.CCR-08-0291; Bardeesy N, 2006, GENE DEV, V20, P3130, DOI 10.1101/gad.1478706; Chen SJ, 1999, J INVEST DERMATOL, V112, P49, DOI 10.1046/j.1523-1747.1999.00477.x; Chen YW, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-181; Cheng N, 2005, ONCOGENE, V24, P5053, DOI 10.1038/sj.onc.1208685; DeCant BT, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00464; Friess H, 2001, ANN SURG, V234, P769, DOI 10.1097/00000658-200112000-00008; Hahn SA, 1996, SCIENCE, V271, P350, DOI 10.1126/science.271.5247.350; Hezel AF, 2006, GENE DEV, V20, P1218, DOI 10.1101/gad.1415606; Hill R, 2012, MOL CANCER THER, V11, P2127, DOI 10.1158/1535-7163.MCT-12-0342; Iacobuzio-Donahue CA, 2003, CANCER RES, V63, P8614; Izeradjene K, 2007, CANCER CELL, V11, P229, DOI 10.1016/j.ccr.2007.01.017; JHAPPAN C, 1990, CELL, V61, P1137, DOI 10.1016/0092-8674(90)90076-Q; Jorissen RN, 2003, EXP CELL RES, V284, P31, DOI 10.1016/S0014-4827(02)00098-8; Kawaguchi Y, 2002, NAT GENET, V32, P128, DOI 10.1038/ng959; Kim GE, 2002, GASTROENTEROLOGY, V123, P1052, DOI 10.1053/gast.2002.36018; Kojima K, 2007, CANCER RES, V67, P8121, DOI 10.1158/0008-5472.CAN-06-4167; KORC M, 1992, J CLIN INVEST, V90, P1352, DOI 10.1172/JCI116001; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; LOWENFELS AB, 1993, NEW ENGL J MED, V328, P1433, DOI 10.1056/NEJM199305203282001; Maitra A, 2003, MODERN PATHOL, V16, P902, DOI 10.1097/01.MP.0000086072.56290.FB; Means AL, 2005, DEVELOPMENT, V132, P3767, DOI 10.1242/dev.01925; MITCHELL ML, 1985, AM J CLIN PATHOL, V83, P171, DOI 10.1093/ajcp/83.2.171; Moniaux N, 2004, BRIT J CANCER, V91, P1633, DOI 10.1038/sj.bjc.6602163; Omary MB, 2007, J CLIN INVEST, V117, P50, DOI 10.1172/JCI30082; Pinho AV, 2014, CANCER LETT, V345, P203, DOI 10.1016/j.canlet.2013.08.015; Qiu WL, 2013, CANCER METAST REV, V32, P83, DOI 10.1007/s10555-012-9408-2; Raimondi S, 2010, BEST PRACT RES CL GA, V24, P349, DOI 10.1016/j.bpg.2010.02.007; Reid CJ, 1997, MOL MED, V3, P403; SANDGREN EP, 1990, CELL, V61, P1121, DOI 10.1016/0092-8674(90)90075-P; SANDGREN EP, 1993, MOL CELL BIOL, V13, P320, DOI 10.1128/MCB.13.1.320; Shi CJ, 2008, CANCER BIOL THER, V7, P353, DOI 10.4161/cbt.7.3.5362; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Swartz MJ, 2002, AM J CLIN PATHOL, V117, P791; VERMA M, 1994, CANCER BIOCHEM BIOPH, V14, P41; Wagner M, 2001, GENE DEV, V15, P286, DOI 10.1101/gad.184701; Yang G, 2010, INT J BIOL SCI, V6, P1; Yoo BM, 2005, PANCREAS, V30, pE71, DOI 10.1097/01.mpa.0000157388.54016.0a; Yoshida S, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-27; Zhu LQ, 2007, AM J PATHOL, V171, P263, DOI 10.2353/ajpath.2007.061176	41	12	13	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0120851	10.1371/journal.pone.0120851	http://dx.doi.org/10.1371/journal.pone.0120851			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803032	gold, Green Published, Green Submitted			2022-12-26	WOS:000353889600104
J	Gupta, S; Garg, V; Bhatia, S				Gupta, Shefali; Garg, Vanika; Bhatia, Sabhyata			A New Set of ESTs from Chickpea (Cicer arietinum L.) Embryo Reveals Two Novel F-Box Genes, CarF-box_PP2 and CarF-box_LysM, with Potential Roles in Seed Development	PLOS ONE			English	Article							EXPRESSED SEQUENCE TAGS; TRANSCRIPTOME ANALYSIS; REGULATORY ELEMENTS; TOBACCO LECTIN; HIGH-MANNOSE; PROMOTER; RICE; DIVERSITY; PROTEINS; COMPLEX	Considering the economic importance of chickpea (C. arietinum L.) seeds, it is important to understand the mechanisms underlying seed development for which a cDNA library was constructed from 6 day old chickpea embryos. A total of 8,186 ESTs were obtained from which 4,048 high quality ESTs were assembled into 1,480 unigenes that majorly encoded genes involved in various metabolic and regulatory pathways. Of these, 95 ESTs were found to be involved in ubiquitination related protein degradation pathways and 12 ESTs coded specifically for putative F-box proteins. Differential transcript accumulation of these putative F-box genes was observed in chickpea tissues as evidenced by quantitative real-time PCR. Further, to explore the role of F-box proteins in chickpea seed development, two F-box genes were selected for molecular characterization. These were named as CarF-box_PP2 and CarF-box_LysM depending on their C-terminal domains, PP2 and LysM, respectively. Their highly conserved structures led us to predict their target substrates. Subcellular localization experiment revealed that CarF-box_PP2 was localized in the cytoplasm and CarF-box_LysM was localized in the nucleus. We demonstrated their physical interactions with SKP1 protein, which validated that they function as F-box proteins in the formation of SCF complexes. Sequence analysis of their promoter regions revealed certain seed specific cis-acting elements that may be regulating their preferential transcript accumulation in the seed. Overall, the study helped in expanding the EST database of chickpea, which was further used to identify two novel F-box genes having a potential role in seed development.	[Gupta, Shefali; Garg, Vanika; Bhatia, Sabhyata] Natl Inst Plant Genome Res, New Delhi, India	Department of Biotechnology (DBT) India; National Institute of Plant Genome Research (NIPGR)	Bhatia, S (corresponding author), Natl Inst Plant Genome Res, New Delhi, India.	sabhyatabhatia@nipgr.ac.in		Bhatia, Sabhyata/0000-0003-0811-219X; Garg, Vanika/0000-0001-6446-4603	core grant of the National Institute of Plant Genome Research, New Delhi, India; Department of Biotechnology, Government of India, under the Next Generation Challenge Programme on Chickpea Genomics [BT/PR12919/AGR/02/676/2009]; Council for Scientific and Industrial Research (CSIR), India	core grant of the National Institute of Plant Genome Research, New Delhi, India; Department of Biotechnology, Government of India, under the Next Generation Challenge Programme on Chickpea Genomics; Council for Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by the core grant of the National Institute of Plant Genome Research, New Delhi, India and by the Department of Biotechnology, Government of India, under the Next Generation Challenge Programme on Chickpea Genomics (grant number BT/PR12919/AGR/02/676/2009). The authors are thankful to Council for Scientific and Industrial Research (CSIR), India, for providing fellowship to SG.	Agarwal G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052443; ALLEN RD, 1989, PLANT CELL, V1, P623, DOI 10.1105/tpc.1.6.623; Ashraf N, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-415; Awazuhara M, 2002, PLANT SCI, V163, P75, DOI 10.1016/S0168-9452(02)00064-X; BARLOW JJ, 1963, BIOCHEM BIOPH RES CO, V13, P61, DOI 10.1016/0006-291X(63)90163-3; Bateman A, 2000, J MOL BIOL, V299, P1113, DOI 10.1006/jmbi.2000.3778; Belmonte MF, 2013, P NATL ACAD SCI USA, V110, pE435, DOI 10.1073/pnas.1222061110; Beneteau J, 2010, PLANT PHYSIOL, V153, P1345, DOI 10.1104/pp.110.153882; Buhariwalla HK, 2005, BMC PLANT BIOL, V5, DOI 10.1186/1471-2229-5-16; Caiyin Qinggele, 2007, Frontiers of Agriculture in China, V1, P17, DOI 10.1007/s11703-007-0003-1; Casson S, 2005, PLANT J, V42, P111, DOI 10.1111/j.1365-313X.2005.02355.x; COLOT V, 1987, EMBO J, V6, P3559, DOI 10.1002/j.1460-2075.1987.tb02685.x; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Dinant S, 2003, PLANT PHYSIOL, V131, P114, DOI 10.1104/pp.013086; Doyle J. J., 1987, PHYTOCHEM B, P11; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; Ezcurra I, 1999, PLANT MOL BIOL, V40, P699, DOI 10.1023/A:1006206124512; Firnhaber C, 2005, PLANTA, V222, P269, DOI 10.1007/s00425-005-1543-3; FUJIWARA T, 1994, PLANT MOL BIOL, V24, P261, DOI 10.1007/BF00020166; Gagne JM, 2002, P NATL ACAD SCI USA, V99, P11519, DOI 10.1073/pnas.162339999; Gallardo K, 2007, MOL CELL PROTEOMICS, V6, P2165, DOI 10.1074/mcp.M700171-MCP200; Garg R, 2011, PLANT PHYSIOL, V156, P1661, DOI 10.1104/pp.111.178616; Garg R, 2011, DNA RES, V18, P53, DOI 10.1093/dnares/dsq028; Garg R, 2010, BIOCHEM BIOPH RES CO, V396, P283, DOI 10.1016/j.bbrc.2010.04.079; Ge XM, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-114; Glenn KA, 2008, J BIOL CHEM, V283, P12717, DOI 10.1074/jbc.M709508200; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Hua ZH, 2011, ANNU REV PLANT BIOL, V62, P299, DOI 10.1146/annurev-arplant-042809-112256; Hua ZH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016219; HUANG N, 1990, PLANT MOL BIOL, V14, P655, DOI 10.1007/BF00016499; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Jain M, 2007, PLANT PHYSIOL, V143, P1467, DOI 10.1104/pp.106.091900; Jain M, 2013, PLANT J, V74, P715, DOI 10.1111/tpj.12173; Jhanwar S, 2012, PLANT BIOTECHNOL J, V10, P690, DOI 10.1111/j.1467-7652.2012.00712.x; Jia YY, 2012, MOL BIOL REP, V39, P2337, DOI 10.1007/s11033-011-0984-y; Jones SI, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-136; Kim SY, 1997, PLANT J, V11, P1237, DOI 10.1046/j.1365-313X.1997.11061237.x; Lannoo N, 2008, BIOCHEM SOC T, V36, P843, DOI 10.1042/BST0360843; Lannoo N, 2006, FEBS LETT, V580, P6329, DOI 10.1016/j.febslet.2006.10.044; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lechner E, 2006, CURR OPIN PLANT BIOL, V9, P631, DOI 10.1016/j.pbi.2006.09.003; Lescot M, 2002, NUCLEIC ACIDS RES, V30, P325, DOI 10.1093/nar/30.1.325; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mizushima T, 2007, P NATL ACAD SCI USA, V104, P5777, DOI 10.1073/pnas.0610312104; Moon J, 2004, PLANT CELL, V16, P3181, DOI 10.1105/tpc.104.161220; Morita A, 1998, FEBS LETT, V423, P81, DOI 10.1016/S0014-5793(98)00067-2; PETERSON CM, 1992, ANN BOT-LONDON, V69, P59, DOI 10.1093/oxfordjournals.aob.a088307; Risseeuw EP, 2003, PLANT J, V34, P753, DOI 10.1046/j.1365-313X.2003.01768.x; Rodrigues JPGLM, 2012, NUCLEIC ACIDS RES, V40, pW323, DOI 10.1093/nar/gks376; Rossak M, 2001, PLANT MOL BIOL, V46, P717, DOI 10.1023/A:1011603923889; Rozen S, 2000, Methods Mol Biol, V132, P365; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sambrook J., 2001, MOL CLONING LAB MANU, P1, DOI DOI 10.1002/HUMU.1186.ABS; Schwechheimer C, 2004, PLANT CELL REP, V23, P353, DOI 10.1007/s00299-004-0858-z; Severin AJ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-160; Smalle J, 2004, ANNU REV PLANT BIOL, V55, P555, DOI 10.1146/annurev.arplant.55.031903.141801; Sparkes IA, 2006, NAT PROTOC, V1, P2019, DOI 10.1038/nprot.2006.286; Sutoh K, 2003, PLANT J, V34, P635, DOI 10.1046/j.1365-313X.2003.01753.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tanaka K, 2012, PLANT SIGNAL BEHAV, V8, P147; THOMAS MS, 1990, PLANT CELL, V2, P1171, DOI 10.1105/tpc.2.12.1171; Upadhyaya HD, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-106; Varshney RK, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-523; Wan YF, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-121; Washida H, 1999, PLANT MOL BIOL, V40, P1, DOI 10.1023/A:1026459229671; White JA, 2000, PLANT PHYSIOL, V124, P1582, DOI 10.1104/pp.124.4.1582; Wobus U, 1999, CURR OPIN PLANT BIOL, V2, P33, DOI 10.1016/S1369-5266(99)80007-7; Wu CY, 2000, PLANT J, V23, P415, DOI 10.1046/j.1365-313x.2000.00797.x; Yang YN, 2011, AFR J BIOTECHNOL, V10, P11477; Yoshida Y, 2002, NATURE, V418, P438, DOI 10.1038/nature00890; Zavallo D, 2010, PLANT CELL REP, V29, P239, DOI 10.1007/s00299-010-0816-x	71	6	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0121100	10.1371/journal.pone.0121100	http://dx.doi.org/10.1371/journal.pone.0121100			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803812	Green Published, Green Submitted, gold			2022-12-26	WOS:000353889600123
J	Ni, KK; Wang, YP; Li, DX; Cai, YM; Pang, HL				Ni, Kuikui; Wang, Yanping; Li, Dongxia; Cai, Yimin; Pang, Huili			Characterization, Identification and Application of Lactic Acid Bacteria Isolated from Forage Paddy Rice Silage	PLOS ONE			English	Article							LACTOBACILLUS-PLANTARUM; AEROBIC STABILITY; FERMENTATION CHARACTERISTICS; CROPS; INOCULANT; QUALITY; POPULATIONS; DIVERSITY; GRASS; CORN	There has been growing interest to develop forage rice as a new feed resource for livestock. This study was to characterize the natural population of lactic acid bacteria (LAB) and select potentially excellent strains for paddy rice silage preparation in China. One hundred and twenty-six strains were isolated and screened from paddy rice silage prepared using a small-scale fermentation system, and ninety-nine of these isolates were considered to be LAB based on their Gram-positive and catalase-negative morphology and the production of most of their metabolic products as lactic acid. These isolates were divided into eight groups (A-H) on the basis of their morphological and biochemical characteristics. The Group A to H strains were identified as Lactobacillus (L.) plantarum subsp. plantarum (species ratio: 8.1%), L. casei (5.1%), Leuconostoc (Ln.) pseudomesenteroides (11.1%), Pediococcus (P.) pentosaceus (24.2%), Enterococcus (E.) mundtii (12.1%), Lactococcus (Lc.) garvieae (15.2%), E. faecium (9.1%) and Lc. lactis subsp. lactis (15.2%) based on sequence analyses of their 16S rRNA and recA genes. P. pentosaceus was the most abundant member of the LAB population in the paddy rice silage. A selected strain, namely L. casei R 465, was found to be able to grow under low pH conditions and to improve the silage quality with low pH and a relatively high content of lactic acid. This study demonstrated that forage paddy rice silage contains abundant LAB species and its silage can be well preserved by inoculation with LAB, and that strain R 465 can be a potentially excellent inoculant for paddy rice silage.	[Ni, Kuikui; Wang, Yanping; Li, Dongxia; Pang, Huili] Zhengzhou Univ, Henan Prov Key Lab Ion Beam Bioengn, Zhengzhou, Henan, Peoples R China; [Cai, Yimin] Natl Inst Livestock & Grassland Sci, Anim Physiol & Nutr Div, Ibaraki, Japan	Zhengzhou University; National Agriculture & Food Research Organization - Japan	Pang, HL (corresponding author), Zhengzhou Univ, Henan Prov Key Lab Ion Beam Bioengn, Zhengzhou, Henan, Peoples R China.	pang@zzu.edu.cn	Ni, Kuikui/AAD-7049-2019		Foundation of Henan Science and Technology Committee [132300410054, 132300410123, 132300413205]	Foundation of Henan Science and Technology Committee	This work was supported by Foundation of Henan Science and Technology Committee (Grant No. 132300410054, 132300410123, and 132300413205). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AOAC, 2007, OFFICIAL METHODS ANA, V18th; Avila CLS, 2014, J DAIRY SCI, V97, P940, DOI 10.3168/jds.2013-6987; Cai YM, 1998, APPL ENVIRON MICROB, V64, P2982; Cai YM, 1999, J DAIRY SCI, V82, P2466, DOI 10.3168/jds.S0022-0302(99)75498-6; Cai YM, 1999, APPL ENVIRON MICROB, V65, P2901; Cao Y, 2011, J DAIRY SCI, V94, P3902, DOI 10.3168/jds.2010-3623; Carvalho BF, 2014, ANIM FEED SCI TECH, V195, P1, DOI 10.1016/j.anifeedsci.2014.04.003; Contreras-Govea FE, 2013, ANIM FEED SCI TECH, V179, P61, DOI 10.1016/j.anifeedsci.2012.11.008; Avila CLD, 2010, REV BRAS ZOOTECN, V39, P25, DOI 10.1590/S1516-35982010000100004; Driehuis F, 2001, GRASS FORAGE SCI, V56, P330, DOI 10.1046/j.1365-2494.2001.00282.x; Ennahar S, 2003, APPL ENVIRON MICROB, V69, P444, DOI 10.1128/AEM.69.1.444-451.2003; Filya I, 2000, ANIM FEED SCI TECH, V88, P39, DOI 10.1016/S0377-8401(00)00214-5; Frolking S, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001425; Kleinschmit DH, 2006, J DAIRY SCI, V89, P4005, DOI 10.3168/jds.S0022-0302(06)72444-4; Kozaki M., 1992, EXPT MANUAL LACTIC A; McDonald P, 1991, BIOCH SILAGE, V12, p[84, 108, 167]; Muck RE, 2013, AGR FOOD SCI, V22, P3, DOI 10.23986/afsci.6718; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Pang HL, 2012, J MICROBIOL, V50, P63, DOI 10.1007/s12275-012-1284-5; Pang HL, 2011, ANIM SCI J, V82, P642, DOI 10.1111/j.1740-0929.2011.00894.x; Pieper R, 2011, ANIM FEED SCI TECH, V164, P96, DOI 10.1016/j.anifeedsci.2010.11.013; Rossi F, 2007, J APPL MICROBIOL, V103, P1707, DOI 10.1111/j.1365-2672.2007.03416.x; Saarisalo E, 2007, J APPL MICROBIOL, V102, P327, DOI 10.1111/j.1365-2672.2006.03103.x; Strom K, 2005, FEMS MICROBIOL LETT, V246, P119, DOI 10.1016/j.femsle.2005.03.047; Tohno M, 2012, FEMS MICROBIOL LETT, V337, P112, DOI 10.1111/1574-6968.12014; Torriani S, 2001, APPL ENVIRON MICROB, V67, P3450, DOI 10.1128/AEM.67.8.3450-3454.2001; Wang XF, 2006, FEMS MICROBIOL ECOL, V57, P106, DOI 10.1111/j.1574-6941.2006.00099.x; Yang J, 2010, J DAIRY SCI, V93, P3136, DOI 10.3168/jds.2009-2898	29	44	49	3	134	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0121967	10.1371/journal.pone.0121967	http://dx.doi.org/10.1371/journal.pone.0121967			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803578	gold, Green Published, Green Submitted			2022-12-26	WOS:000353889600184
J	Reddy, TR; Fevat, LMS; Munson, SE; Stewart, AF; Cowley, SM				Reddy, Thimma R.; Fevat, Lena M. S.; Munson, Sarah E.; Stewart, A. Francis; Cowley, Shaun M.			Lambda Red Mediated Gap Repair Utilizes a Novel Replicative Intermediate in Escherichia coli	PLOS ONE			English	Article							STRAND-BREAK REPAIR; PHAGE-LAMBDA; HOMOLOGOUS RECOMBINATION; MOUSE GENOME; DNA CLONING; BETA; PROTEIN; SYSTEM; MODEL; CHROMOSOMES	The lambda phage Red recombination system can mediate efficient homologous recombination in Escherichia coli, which is the basis of the DNA engineering technique termed recombineering. Red mediated insertion of DNA requires DNA replication, involves a single-stranded DNA intermediate and is more efficient on the lagging strand of the replication fork. Lagging strand recombination has also been postulated to explain the Red mediated repair of gapped plasmids by an Okazaki fragment gap filling model. Here, we demonstrate that gap repair involves a different strand independent mechanism. Gap repair assays examining the strand asymmetry of recombination did not show a lagging strand bias. Directly testing an ssDNA plasmid showed lagging strand recombination is possible but dsDNA plasmids did not employ this mechanism. Insertional recombination combined with gap repair also did not demonstrate preferential lagging strand bias, supporting a different gap repair mechanism. The predominant recombination route involved concerted insertion and subcloning though other routes also operated at lower frequencies. Simultaneous insertion of DNA resulted in modification of both strands and was unaffected by mutations to DNA polymerase I, responsible for Okazaki fragment maturation. The lower efficiency of an alternate Red mediated ends-in recombination pathway and the apparent lack of a Holliday junction intermediate suggested that gap repair does not involve a different Red recombination pathway. Our results may be explained by a novel replicative intermediate in gap repair that does not involve a replication fork. We exploited these observations by developing a new recombineering application based on concerted insertion and gap repair, termed SPI (subcloning plus insertion). SPI selected against empty vector background and selected for correct gap repair recombinants. We used SPI to simultaneously insert up to four different gene cassettes in a single recombineering reaction. Consequently, our findings have important implications for the understanding of Escherichia coli replication and Red recombination.	[Reddy, Thimma R.; Cowley, Shaun M.] Univ Leicester, Dept Biochem, Leicester LE1 7RH, Leics, England; [Fevat, Lena M. S.] Ctr Fisheries Environm & Aquaculture Sci, Lowestoft, Suffolk, England; [Munson, Sarah E.] Univ Leicester, Ctr Core Biotechnol Serv, ES Cell Facil, Leicester LE1 7RH, Leics, England; [Stewart, A. Francis] Tech Univ Dresden, BioInnovat Zentrum, Genom, D-01062 Dresden, Germany	University of Leicester; Centre for Environment Fisheries & Aquaculture Science; University of Leicester; Technische Universitat Dresden	Cowley, SM (corresponding author), Univ Leicester, Dept Biochem, Leicester LE1 7RH, Leics, England.	smc57@le.ac.uk	Stewart, A. Francis/E-7789-2010	Cowley, Shaun/0000-0002-2510-1305	UK Medical Research Council (MRC) [MR/J009202/1]; University of Leicester, Centre for Core Biotechnology Services; EU 7th Framework integrated project, SyBoSS; Medical Research Council [MR/J009202/1, G0600135] Funding Source: researchfish; MRC [G0600135, MR/J009202/1] Funding Source: UKRI	UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Leicester, Centre for Core Biotechnology Services; EU 7th Framework integrated project, SyBoSS; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the UK Medical Research Council (MRC) grant (MR/J009202/1) to SMC and University of Leicester, Centre for Core Biotechnology Services funding to SEM. A.F.S. is supported by funding from the EU 7th Framework integrated project, SyBoSS (www.syboss.eu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao ZM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050617; Bird AW, 2012, NAT METHODS, V9, P103, DOI [10.1038/NMETH.1803, 10.1038/nmeth.1803]; Carr PA, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks455; Copeland NG, 2001, NAT REV GENET, V2, P769, DOI 10.1038/35093556; Court DL, 2002, ANNU REV GENET, V36, P361, DOI 10.1146/annurev.genet.36.061102.093104; Datta S, 2008, P NATL ACAD SCI USA, V105, P1626, DOI 10.1073/pnas.0709089105; Ellis HM, 2001, P NATL ACAD SCI USA, V98, P6742, DOI 10.1073/pnas.121164898; Erler A, 2009, J MOL BIOL, V391, P586, DOI 10.1016/j.jmb.2009.06.030; Fu J, 2012, NAT BIOTECHNOL, V30, P440, DOI 10.1038/nbt.2183; Fu J, 2010, METHOD ENZYMOL, V477, P125, DOI 10.1016/S0076-6879(10)77008-7; HALL SD, 1994, P NATL ACAD SCI USA, V91, P3205, DOI 10.1073/pnas.91.8.3205; HASTINGS PJ, 1993, GENETICS, V135, P973; Huen MSY, 2006, NUCLEIC ACIDS RES, V34, P6183, DOI 10.1093/nar/gkl852; Isaacs FJ, 2011, SCIENCE, V333, P348, DOI 10.1126/science.1205822; Kim YB, 2009, J BIOSCI BIOENG, V108, P441, DOI 10.1016/j.jbiosc.2009.05.015; Kobayashi I, 1992, Adv Biophys, V28, P81, DOI 10.1016/0065-227X(92)90023-K; KOBAYASHI I, 1988, GENETICS, V119, P751; Kuzminov A, 1999, MICROBIOL MOL BIOL R, V63, P751, DOI 10.1128/MMBR.63.4.751-813.1999; Lajoie MJ, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks751; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; LEHMAN IR, 1976, SCIENCE, V193, P963, DOI 10.1126/science.781842; Li XT, 2013, MOL MICROBIOL, V88, P906, DOI 10.1111/mmi.12231; Li Z, 1998, J MOL BIOL, V276, P733, DOI 10.1006/jmbi.1997.1572; Lia G, 2012, SCIENCE, V335, P328, DOI 10.1126/science.1210400; Lim SI, 2008, J MOL BIOL, V384, P1098, DOI 10.1016/j.jmb.2008.10.047; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Maresca M, 2011, United States Patent, Patent No. [2011/0165630 A1, 20110165630]; Maresca M, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-54; Mosberg JA, 2010, GENETICS, V186, P791, DOI 10.1534/genetics.110.120782; MUNIYAPPA K, 1986, J BIOL CHEM, V261, P7472; MURPHY KC, 1991, J BACTERIOL, V173, P5808, DOI 10.1128/jb.173.18.5808-5821.1991; Muyrers JPP, 2000, GENE DEV, V14, P1971; Nedelkova M, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr668; OLINER JD, 1993, NUCLEIC ACIDS RES, V21, P5192, DOI 10.1093/nar/21.22.5192; Perkins TT, 2003, SCIENCE, V301, P1914, DOI 10.1126/science.1088047; Poteete AR, 2008, MOL MICROBIOL, V68, P66, DOI 10.1111/j.1365-2958.2008.06133.x; Poteete AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067440; POTEETE AR, 1988, J BACTERIOL, V170, P2012, DOI 10.1128/jb.170.5.2012-2021.1988; Reddy TR, 2014, JOVE-J VIS EXP, V95; Rybalchenko N, 2004, P NATL ACAD SCI USA, V101, P17056, DOI 10.1073/pnas.0408046101; Sawitzke JA, 2011, J MOL BIOL, V407, P45, DOI 10.1016/j.jmb.2011.01.030; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Stahl MM, 1997, GENETICS, V147, P961; Subramanian K, 2003, NUCLEIC ACIDS RES, V31, P1585, DOI 10.1093/nar/gkg266; Swingle B, 2010, MOL MICROBIOL, V75, P138, DOI 10.1111/j.1365-2958.2009.06976.x; SZOSTAK JW, 1983, CELL, V33, P25, DOI 10.1016/0092-8674(83)90331-8; TAKAHASHI N, 1990, P NATL ACAD SCI USA, V87, P2790, DOI 10.1073/pnas.87.7.2790; TAKAHASHI NK, 1993, J BACTERIOL, V175, P5176, DOI 10.1128/JB.175.16.5176-5185.1993; Testa G, 2003, NAT BIOTECHNOL, V21, P443, DOI 10.1038/nbt804; THALER DS, 1987, GENETICS, V116, P501; Thomason LC, 2007, PLASMID, V58, P148, DOI 10.1016/j.plasmid.2007.03.001; VALANCIUS V, 1991, MOL CELL BIOL, V11, P4389, DOI 10.1128/MCB.11.9.4389; Valenzuela DM, 2003, NAT BIOTECHNOL, V21, P652, DOI 10.1038/nbt822; van Kessel JC, 2008, MOL MICROBIOL, V67, P1094, DOI 10.1111/j.1365-2958.2008.06109.x; van Kessel JC, 2007, NAT METHODS, V4, P147, DOI 10.1038/nmeth996; van Pijkeren JP, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks147; Venken KJT, 2006, SCIENCE, V314, P1747, DOI 10.1126/science.1134426; Wang HH, 2012, NAT METHODS, V9, P591, DOI [10.1038/NMETH.1971, 10.1038/nmeth.1971]; Wang HH, 2011, METHOD ENZYMOL, V498, P409, DOI 10.1016/B978-0-12-385120-8.00018-8; Wang HH, 2009, NATURE, V460, P894, DOI 10.1038/nature08187; Wang JP, 2006, MOL BIOTECHNOL, V32, P43, DOI 10.1385/MB:32:1:043; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035; Warner JR, 2010, NAT BIOTECHNOL, V28, P856, DOI 10.1038/nbt.1653; Westenberg M, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq596; Yu DG, 2000, P NATL ACAD SCI USA, V97, P5978, DOI 10.1073/pnas.100127597; Zhang Y, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-42; Zhang YM, 1998, NAT GENET, V20, P123, DOI 10.1038/2417; Zhang YM, 2000, NAT BIOTECHNOL, V18, P1314, DOI 10.1038/82449; Zhang YW, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1288	69	3	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0120681	10.1371/journal.pone.0120681	http://dx.doi.org/10.1371/journal.pone.0120681			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803509	Green Published, gold, Green Submitted			2022-12-26	WOS:000353889600092
J	Rowse, M; Qiu, SH; Tsao, J; Xian, TM; Khawaja, S; Yamauchi, Y; Yang, Z; Wang, GX; Luo, M				Rowse, Michael; Qiu, Shihong; Tsao, Jun; Xian, Tongmei; Khawaja, Sarah; Yamauchi, Yohei; Yang, Zhen; Wang, Guoxin; Luo, Ming			Characterization of Potent Fusion Inhibitors of Influenza Virus	PLOS ONE			English	Article							MEDIATED MEMBRANE-FUSION; A VIRUS; CONFORMATIONAL-CHANGE; SYNTHETIC PEPTIDE; ENVELOPED VIRUSES; HEMAGGLUTININ; ENTRY; RESISTANCE; IDENTIFICATION; DETERMINANTS	New inhibitors of influenza viruses are needed to combat the potential emergence of novel human influenza viruses. We have identified a class of small molecules that inhibit replication of influenza virus at picomolar concentrations in plaque reduction assays. The compound also inhibits replication of vesicular stomatitis virus. Time of addition and dilution experiments with influenza virus indicated that an early time point of infection was blocked and that inhibitor 136 tightly bound to virions. Using fluorescently labeled influenza virus, inhibition of viral fusion to cellular membranes by blocked lipid mixing was established as the mechanism of action for this class of inhibitors. Stabilization of the neutral pH form of hemagglutinin (HA) was ruled out by trypsin digestion studies in vitro and with conformation specific HA antibodies within cells. Direct visualization of 136 treated influenza virions at pH 7.5 or acidified to pH 5.0 showed that virions remain intact and that glycoproteins become disorganized as expected when HA undergoes a conformational change. This suggests that exposure of the fusion peptide at low pH is not inhibited but lipid mixing is inhibited, a different mechanism than previously reported fusion inhibitors. We hypothesize that this new class of inhibitors intercalate into the virus envelope altering the structure of the viral envelope required for fusion to cellular membranes.	[Rowse, Michael; Qiu, Shihong; Tsao, Jun] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; [Xian, Tongmei; Wang, Guoxin; Luo, Ming] Peking Univ, Shenzhen Grad Sch, Sch Chem Biol & Biotechnol, Struct Biol Lab, Shenzhen 518055, Peoples R China; [Khawaja, Sarah; Yamauchi, Yohei] ETH, Inst Biochem, CH-8093 Zurich, Switzerland; [Yang, Zhen] Peking Univ, Shenzhen Grad Sch, Sch Chem Biol & Biotechnol, Lab Chem Genom, Shenzhen 518055, Peoples R China; [Luo, Ming] Georgia State Univ, Coll Arts & Sci, Dept Chem, Atlanta, GA 30302 USA	University of Alabama System; University of Alabama Birmingham; Peking University; University Town of Shenzhen; Swiss Federal Institutes of Technology Domain; ETH Zurich; Peking University; University Town of Shenzhen; University System of Georgia; Georgia State University	Yamauchi, Y (corresponding author), ETH, Inst Biochem, HPM E8-2,Otto Stern Weg 3, CH-8093 Zurich, Switzerland.	yohei.yamauchi@bc.biol.ethz.ch; zyang@pku.edu.cn; wanggx@pkusz.edu.cn; mluo@gsu.edu	Yang, Zhen/J-6306-2015	Yang, Zhen/0000-0001-8036-934X; Yamauchi, Yohei/0000-0002-8233-9133	NIH [AI-080699, U54-AI-057157]; Shenzhen Municipal Government [ZDSY20130331145112855]; National Natural Science Foundation of China [81161120401, 91013004]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057157] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shenzhen Municipal Government; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding provided by NIH grants AI-080699 and U54-AI-057157, Shenzhen Municipal Government (ZDSY20130331145112855), National Natural Science Foundation of China (81161120401), (91013004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068450; Basu A, 2014, J VIROL, V88, P1447, DOI 10.1128/JVI.01225-13; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Edinger TO, 2014, J GEN VIROL, V95, P263, DOI 10.1099/vir.0.059477-0; Fontana J, 2012, J VIROL, V86, P2919, DOI 10.1128/JVI.06698-11; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Han X, 2001, NAT STRUCT BIOL, V8, P715, DOI 10.1038/90434; Hatakeyama S, 2007, JAMA-J AM MED ASSOC, V297, P1435, DOI 10.1001/jama.297.13.1435; HAYDEN FG, 1992, CURR TOP MICROBIOL, V176, P119; Ito T, 1998, J VIROL, V72, P7367, DOI 10.1128/JVI.72.9.7367-7373.1998; Lalezari JP, 2003, NEW ENGL J MED, V348, P2175, DOI 10.1056/NEJMoa035026; Lee KK, 2011, J BIOL CHEM, V286, P42141, DOI 10.1074/jbc.M111.254243; Leneva IA, 2009, ANTIVIR RES, V81, P132, DOI 10.1016/j.antiviral.2008.10.009; Luo GX, 1997, J VIROL, V71, P4062, DOI 10.1128/JVI.71.5.4062-4070.1997; Luo M, 2013, TREATING PREVENTING; Matsubara T, 2010, J MED CHEM, V53, P4441, DOI 10.1021/jm1002183; Nicol MQ, 2012, J GEN VIROL, V93, P980, DOI 10.1099/vir.0.038679-0; Plotch SJ, 1999, J VIROL, V73, P140, DOI 10.1128/JVI.73.1.140-151.1999; Poland GA, 2009, CLIN INFECT DIS, V48, P1254, DOI 10.1086/598989; Reid AH, 2004, NAT REV MICROBIOL, V2, P909, DOI 10.1038/nrmicro1027; Rimsky LT, 1998, J VIROL, V72, P986, DOI 10.1128/JVI.72.2.986-993.1998; ROGERS GN, 1983, VIROLOGY, V127, P361, DOI 10.1016/0042-6822(83)90150-2; Russell RJ, 2008, P NATL ACAD SCI USA, V105, P17736, DOI 10.1073/pnas.0807142105; SKEHEL JJ, 1982, P NATL ACAD SCI-BIOL, V79, P968, DOI 10.1073/pnas.79.4.968; Soares MM, 2008, NAT MED, V14, P1357, DOI 10.1038/nm.1885; St Vincent MR, 2010, P NATL ACAD SCI USA, V107, P17339, DOI 10.1073/pnas.1010026107; Staschke KA, 1998, VIROLOGY, V248, P264, DOI 10.1006/viro.1998.9273; Terabayashi T, 2006, CARBOHYD RES, V341, P2246, DOI 10.1016/j.carres.2006.06.017; Vigant F, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003297; Wang G, 2011, COMPOUNDS USEFUL ANT; WHITE JM, 1987, J CELL BIOL, V105, P2887, DOI 10.1083/jcb.105.6.2887; WILD C, 1993, AIDS RES HUM RETROV, V9, P1051, DOI 10.1089/aid.1993.9.1051; WILD C, 1992, P NATL ACAD SCI USA, V89, P10537, DOI 10.1073/pnas.89.21.10537; Wolf MC, 2010, P NATL ACAD SCI USA, V107, P3157, DOI 10.1073/pnas.0909587107; Yamauchi Y, 2013, J CELL SCI, V126, P1289, DOI 10.1242/jcs.119685; Yoshimoto J, 1999, ARCH VIROL, V144, P865, DOI 10.1007/s007050050552; Yoshimoto J, 2000, MICROBIOL IMMUNOL, V44, P677, DOI 10.1111/j.1348-0421.2000.tb02549.x	37	5	6	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0122536	10.1371/journal.pone.0122536	http://dx.doi.org/10.1371/journal.pone.0122536			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803288	Green Submitted, Green Published, gold			2022-12-26	WOS:000353889600203
J	Tello, JS; Myers, JA; Macia, MJ; Fuentes, AF; Cayola, L; Arellano, G; Loza, MI; Torrez, V; Cornejo, M; Miranda, TB; Jorgensen, PM				Sebastian Tello, J.; Myers, Jonathan A.; Macia, Manuel J.; Fuentes, Alfredo F.; Cayola, Leslie; Arellano, Gabriel; Loza, M. Isabel; Torrez, Vania; Cornejo, Maritza; Miranda, Tatiana B.; Jorgensen, Peter M.			Elevational Gradients in beta-Diversity Reflect Variation in the Strength of Local Community Assembly Mechanisms across Spatial Scales	PLOS ONE			English	Article							BIODIVERSITY PATTERNS; SPECIES TURNOVER; TROPICAL FORESTS; DRIVERS; TEMPERATE; ECOLOGY; PLANTS; ALPHA	Despite long-standing interest in elevational-diversity gradients, little is known about the processes that cause changes in the compositional variation of communities (beta-diversity) across elevations. Recent studies have suggested that beta-diversity gradients are driven by variation in species pools, rather than by variation in the strength of local community assembly mechanisms such as dispersal limitation, environmental filtering, or local biotic interactions. However, tests of this hypothesis have been limited to very small spatial scales that limit inferences about how the relative importance of assembly mechanisms may change across spatial scales. Here, we test the hypothesis that scale-dependent community assembly mechanisms shape biogeographic beta-diversity gradients using one of the most well-characterized elevational gradients of tropical plant diversity. Using an extensive dataset on woody plant distributions along a 4,000-m elevational gradient in the Bolivian Andes, we compared observed patterns of beta-diversity to null-model expectations. beta-deviations (standardized differences from null values) were used to measure the relative effects of local community assembly mechanisms after removing sampling effects caused by variation in species pools. To test for scale-dependency, we compared elevational gradients at two contrasting spatial scales that differed in the size of local assemblages and regions by at least an order of magnitude. Elevational gradients in beta-diversity persisted after accounting for regional variation in species pools. Moreover, the elevational gradient in beta-deviations changed with spatial scale. At small scales, local assembly mechanisms were detectable, but variation in species pools accounted for most of the elevational gradient in beta-diversity. At large spatial scales, in contrast, local assembly mechanisms were a dominant force driving changes in beta-diversity. In contrast to the hypothesis that variation in species pools alone drives beta-diversity gradients, we show that local community assembly mechanisms contribute strongly to systematic changes in beta-diversity across elevations. We conclude that scale-dependent variation in community assembly mechanisms underlies these iconic gradients in global biodiversity.	[Sebastian Tello, J.] Missouri Bot Garden, Ctr Conservat & Sustainable Dev, St Louis, MO 63166 USA; [Sebastian Tello, J.] Pontificia Univ Catolica Ecuador, Escuela Biol, Quito, Ecuador; [Myers, Jonathan A.] Washington Univ, Dept Biol, St Louis, MO 63130 USA; [Macia, Manuel J.; Arellano, Gabriel] Univ Autonoma Madrid, Dept Biol, Area Bot, E-28049 Madrid, Spain; [Fuentes, Alfredo F.; Cayola, Leslie; Cornejo, Maritza; Miranda, Tatiana B.] Herbario Nacl Bolivia, La Paz, Bolivia; [Arellano, Gabriel] CSIC, Real Jardin Bot, E-28014 Madrid, Spain; [Loza, M. Isabel; Jorgensen, Peter M.] Missouri Bot Garden, St Louis, MO 63166 USA; [Loza, M. Isabel] Univ Missouri, Dept Biol, St Louis, MO 63121 USA; [Torrez, Vania] Univ Leuven, Dept Biol, Div Plant Conservat & Populat Biol, B-3001 Leuven, Belgium	Missouri Botanical Gardens; Pontificia Universidad Catolica del Ecuador; Washington University (WUSTL); Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Real Jardin Botanico de Madrid; Missouri Botanical Gardens; University of Missouri System; University of Missouri Saint Louis; KU Leuven	Tello, JS (corresponding author), Missouri Bot Garden, Ctr Conservat & Sustainable Dev, POB 299, St Louis, MO 63166 USA.	sebastian.tello@mobot.org	Macia, Manuel J/H-4631-2012; Arellano, Gabriel/Z-3549-2019; Fuentes, Alfredo F./FNZ-7942-2022	Macia, Manuel J/0000-0002-4676-612X; Arellano, Gabriel/0000-0003-3990-5344; Fuentes, Alfredo/0000-0003-4848-4182	National Science Foundation [DEB-0101775, DEB-0743457]; Comunidad de Madrid; National Geographic Society [NGS 7754-04, NGS 8047-06]; Taylor Fund for Ecological Research; Andrew W. Mellon Foundation; Centro de Estudios de America Latina; Universidad Autonoma de Madrid; Christopher Davidson and Sharon Christoph	National Science Foundation(National Science Foundation (NSF)); Comunidad de Madrid(Comunidad de Madrid); National Geographic Society(National Geographic Society); Taylor Fund for Ecological Research; Andrew W. Mellon Foundation; Centro de Estudios de America Latina; Universidad Autonoma de Madrid; Christopher Davidson and Sharon Christoph	The Madidi Project has been funded by the National Science Foundation (DEB-0101775 and DEB-0743457), the Comunidad de Madrid, the National Geographic Society (NGS 7754-04 and NGS 8047-06), the Taylor Fund for Ecological Research, the Andrew W. Mellon Foundation, the Centro de Estudios de America Latina, Universidad Autonoma de Madrid, and Christopher Davidson and Sharon Christoph. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2011, ECOL LETT, V14, P19, DOI 10.1111/j.1461-0248.2010.01552.x; Arita HT, 2002, ECOGRAPHY, V25, P541, DOI 10.1034/j.1600-0587.2002.250504.x; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Charney N., 2010, VEGETARIAN JOST DIVE; Chase JM, 2002, NATURE, V416, P427, DOI 10.1038/416427a; Chase JM, 2013, ECOL LETT, V16, P17, DOI 10.1111/ele.12112; Chase JM, 2011, PHILOS T R SOC B, V366, P2351, DOI 10.1098/rstb.2011.0063; Chase JM, 2010, SCIENCE, V328, P1388, DOI 10.1126/science.1187820; Chave J, 2002, THEOR POPUL BIOL, V62, P153, DOI 10.1006/tpbi.2002.1597; Clark JS, 1999, ECOLOGY, V80, P1475, DOI 10.1890/0012-9658(1999)080[1475:SDNAFP]2.0.CO;2; COLEMAN BD, 1981, MATH BIOSCI, V54, P191, DOI 10.1016/0025-5564(81)90086-9; Crawley M.J., 2007, R BOOK; De Caceres M, 2012, GLOBAL ECOL BIOGEOGR, V21, P1191, DOI 10.1111/j.1466-8238.2012.00770.x; Fine PVA, 2011, ECOGRAPHY, V34, P552, DOI 10.1111/j.1600-0587.2010.06548.x; Fosaa AM, 2004, DIVERS DISTRIB, V10, P217, DOI 10.1111/j.1366-9516.2004.00080.x; Friedman-Rudovsky J, 2012, SCIENCE, V337, P285, DOI 10.1126/science.337.6092.285; Fuentes A., 2005, ECOL BOLIV REV I ECO, V40, P1; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Hillebrand H, 2004, AM NAT, V163, P192, DOI 10.1086/381004; Horner-Devine MC, 2007, ECOLOGY, V88, P1345, DOI 10.1890/06-0286; John R, 2007, P NATL ACAD SCI USA, V104, P864, DOI 10.1073/pnas.0604666104; Jost L, 2007, ECOLOGY, V88, P2427, DOI 10.1890/06-1736.1; Kerr JT, 2007, SCIENCE, V316, P1581, DOI 10.1126/science.1133267; Koleff P, 2003, GLOBAL ECOL BIOGEOGR, V12, P483, DOI 10.1046/j.1466-822X.2003.00056.x; Kraft NJB, 2011, SCIENCE, V333, P1755, DOI 10.1126/science.1208584; Legendre P., 2012, NUMERICAL ECOLOGY; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; Lessard JP, 2012, TRENDS ECOL EVOL, V27, P600, DOI 10.1016/j.tree.2012.07.006; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; Lomolino MV, 2001, GLOBAL ECOL BIOGEOGR, V10, P3, DOI 10.1046/j.1466-822x.2001.00229.x; Macia MJ, 2008, BIODIVERS CONSERV, V17, P2671, DOI 10.1007/s10531-008-9348-x; Mangan SA, 2010, NATURE, V466, P752, DOI 10.1038/nature09273; Marczak LB, 2011, ECOLOGY, V92, P276, DOI 10.1890/10-0760.1; Martiny JBH, 2011, P NATL ACAD SCI USA, V108, P7850, DOI 10.1073/pnas.1016308108; McCain CM, 2009, GLOBAL ECOL BIOGEOGR, V18, P346, DOI 10.1111/j.1466-8238.2008.00443.x; McGill BJ, 2011, AM J BOT, V98, P481, DOI 10.3732/ajb.1000509; McGill BJ, 2010, ECOL LETT, V13, P627, DOI 10.1111/j.1461-0248.2010.01449.x; Mena JL, 2005, GLOBAL ECOL BIOGEOGR, V14, P539, DOI 10.1111/j.1466-822x.2005.00189.x; Mori AS, 2013, GLOBAL ECOL BIOGEOGR, V22, P878, DOI 10.1111/geb.12058; Munkemuller T, 2014, GLOBAL ECOL BIOGEOGR, V23, P620, DOI 10.1111/geb.12137; Myers JA, 2013, ECOL LETT, V16, P151, DOI 10.1111/ele.12021; Nogues-Bravo D, 2008, NATURE, V453, P216, DOI 10.1038/nature06812; Ohtani K, 2000, ECON MODEL, V17, P473, DOI 10.1016/S0264-9993(99)00034-6; Orrock JL, 2010, P ROY SOC B-BIOL SCI, V277, P2185, DOI 10.1098/rspb.2009.2344; Poulsen AD, 2006, BIOTROPICA, V38, P468, DOI 10.1111/j.1744-7429.2006.00168.x; Qian H, 2007, ECOL LETT, V10, P737, DOI 10.1111/j.1461-0248.2007.01066.x; Qian H, 2012, SCIENCE, V335, DOI [10.1126/science.1216450, 10.1126/science.1216393]; Qian H, 2013, GLOBAL ECOL BIOGEOGR, V22, P659, DOI 10.1111/geb.12020; Rahbek C, 2005, ECOL LETT, V8, P224, DOI 10.1111/j.1461-0248.2004.00701.x; Rodriguez-Castaneda G, 2010, ECOL LETT, V13, P1348, DOI 10.1111/j.1461-0248.2010.01525.x; Sanders NJ, 2012, ECOGRAPHY, V35, P1, DOI 10.1111/j.1600-0587.2011.07338.x; Singh D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044494; Soininen J, 2007, ECOLOGY, V88, P2830, DOI 10.1890/06-1730.1; Soininen J, 2010, BIOSCIENCE, V60, P433, DOI 10.1525/bio.2010.60.6.7; Stegen JC, 2013, GLOBAL ECOL BIOGEOGR, V22, P202, DOI 10.1111/j.1466-8238.2012.00780.x; Stevens RD, 2002, ECOLOGY, V83, P545, DOI 10.1890/0012-9658(2002)083[0545:GEATCL]2.0.CO;2; Tuomisto H, 2010, ECOGRAPHY, V33, P2, DOI 10.1111/j.1600-0587.2009.05880.x; Uriarte M, 2010, ECOL LETT, V13, P1503, DOI 10.1111/j.1461-0248.2010.01541.x; Wang JJ, 2012, GLOBAL ECOL BIOGEOGR, V21, P743, DOI 10.1111/j.1466-8238.2011.00718.x; Wiegand T, 2012, P ROY SOC B-BIOL SCI, V279, P3312, DOI 10.1098/rspb.2012.0376	60	53	57	3	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0121458	10.1371/journal.pone.0121458	http://dx.doi.org/10.1371/journal.pone.0121458			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803846	Green Published, gold, Green Submitted			2022-12-26	WOS:000353889600159
J	Wong, AM; Abrams, MC; Micevych, PE				Wong, Angela M.; Abrams, Matthew C.; Micevych, Paul E.			beta-Arrestin Regulates Estradiol Membrane-Initiated Signaling in Hypothalamic Neurons	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-ALPHA; METABOTROPIC GLUTAMATE RECEPTORS; RNA LACKING EXON-4; MESSENGER-RNA; ARCUATE NUCLEUS; TRANSCRIPTIONAL ACTIVITY; SEXUAL RECEPTIVITY; NEUROPEPTIDE-Y; ERK ACTIVATION; WILD-TYPE	Estradiol (E2) action in the nervous system is the result of both direct nuclear and membrane- initiated signaling (EMS). E2 regulates membrane estrogen receptor-alpha (ER alpha) levels through opposing mechanisms of EMS-mediated trafficking and internalization. While beta-arrestin-mediated mER alpha internalization has been described in the cortex, a role of beta-arrestin in EMS, which underlies multiple physiological processes, remains undefined. In the arcuate nucleus of the hypothalamus (ARH), membrane-initiated E2 signaling modulates lordosis behavior, a measure of female sexually receptivity. To better understand EMS and regulation of ER alpha membrane levels, we examined the role of beta-arrestin, a molecule associated with internalization following agonist stimulation. In the present study, we used an immortalized neuronal cell line derived from embryonic hypothalamic neurons, the N-38 line, to examine whether beta-arrestins mediate internalization of mER alpha. beta-arrestin-1 (Arrb1) was found in the ARH and in N-38 neurons. In vitro, E2 increased trafficking and internalization of full-length ER alpha and ER alpha Delta 4, an alternatively spliced isoform of ER alpha, which predominates in the membrane. Treatment with E2 also increased phosphorylation of extracellular-signal regulated kinases 1/2 (ERK1/2) in N-38 neurons. Arrb1 siRNA knockdown prevented E2-induced ER alpha Delta 4 internalization and ERK1/2 phosphorylation. In vivo, microinfusions of Arrb1 antisense oligodeoxynucleotides (ODN) into female rat ARH knocked down Arrb1 and prevented estradiol benzoate-induced lordosis behavior compared with nonsense scrambled ODN (lordosis quotient: 3 +/- 2.1 vs. 85.0 +/- 6.0; p < 0.0001). These results indicate a role for Arrb1 in both EMS and internalization of mER alpha, which are required for the E2-induction of female sexual receptivity.	[Micevych, Paul E.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Brain Res Inst, Neuroendocrinol Lab, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	Micevych, PE (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA.	pmicevych@mednet.ucla.edu		Wong, Angela/0000-0003-2530-5727	National Institutes of Health [DA013185]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA013185] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported by the National Institutes of Health grant DA013185. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham IM, 2004, ENDOCRINOLOGY, V145, P3055, DOI 10.1210/en.2003-1676; Ahn SK, 2004, J BIOL CHEM, V279, P35518, DOI 10.1074/jbc.M405878200; Becker JB, 1999, PHARMACOL BIOCHEM BE, V64, P53, DOI 10.1016/S0091-3057(99)00091-X; Bollig A, 2000, MOL ENDOCRINOL, V14, P634, DOI 10.1210/me.14.5.634; Bondar G, 2009, J NEUROSCI, V29, P15323, DOI 10.1523/JNEUROSCI.2107-09.2009; Boulware MI, 2005, J NEUROSCI, V25, P5066, DOI 10.1523/JNEUROSCI.1427-05.2005; Chaban V., 2012, PAIN RES TREAT, DOI DOI 10.1155/2012/960780; Christensen A, 2012, HORM METAB RES, V44, P587, DOI 10.1055/s-0032-1306301; Christensen A, 2012, ENDOCRINOLOGY, V153, P3872, DOI 10.1210/en.2012-1312; Christensen A, 2011, J NEUROSCI, V31, P17583, DOI 10.1523/JNEUROSCI.3030-11.2011; Claing A, 2002, PROG NEUROBIOL, V66, P61, DOI 10.1016/S0301-0082(01)00023-5; Daaka Y, 1997, P NATL ACAD SCI USA, V94, P2180, DOI 10.1073/pnas.94.6.2180; Dewing P, 2007, J NEUROSCI, V27, P9294, DOI 10.1523/JNEUROSCI.0592-07.2007; Dewing P, 2008, ENDOCRINOLOGY, V149, P5934, DOI 10.1210/en.2008-0847; Dominguez R, 2013, STEROIDS; Dominguez R, 2010, J NEUROSCI, V30, P12589, DOI 10.1523/JNEUROSCI.1038-10.2010; Dominguez R, 2009, J NEUROSCI, V29, P4228, DOI 10.1523/JNEUROSCI.0550-09.2009; Eishingdrelo Haifeng, 2013, Curr Chem Genom Transl Med, V7, P9, DOI 10.2174/2213988501307010009; Feinstein TN, 2011, NAT CHEM BIOL, V7, P278, DOI 10.1038/nchembio.545; Ge L, 2003, J BIOL CHEM, V278, P34418, DOI 10.1074/jbc.M300573200; Goldsmith ZG, 2007, ONCOGENE, V26, P3122, DOI 10.1038/sj.onc.1210407; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; Gorosito SV, 2008, NEUROSCIENCE, V154, P1173, DOI 10.1016/j.neuroscience.2008.05.001; Hedges VL, 2010, FRONT NEUROENDOCRIN, V31, P217, DOI 10.1016/j.yfrne.2010.02.003; HOSHINO S, 1995, CALCIFIED TISSUE INT, V57, P466, DOI 10.1007/BF00301952; Inoue S, 1996, BIOCHEM BIOPH RES CO, V219, P766, DOI 10.1006/bbrc.1996.0308; Ishunina TA, 2013, BRAIN RES, V1500, P1, DOI 10.1016/j.brainres.2012.12.050; KOEHORST SGA, 1994, MOL CELL ENDOCRINOL, V101, P237, DOI 10.1016/0303-7207(94)90240-2; KOEHORST SGA, 1993, J STEROID BIOCHEM, V45, P227, DOI 10.1016/0960-0760(93)90336-U; Kow LM, 2004, P NATL ACAD SCI USA, V101, P12354, DOI 10.1073/pnas.0404889101; Krupnick JG, 1998, ANNU REV PHARMACOL, V38, P289, DOI 10.1146/annurev.pharmtox.38.1.289; Kuo J, 2009, ENDOCRINOLOGY, V150, P1369, DOI 10.1210/en.2008-0994; Lefkowitz RJ, 2004, CURR OPIN CELL BIOL, V16, P162, DOI 10.1016/j.ceb.2004.01.001; Lefkowitz RJ, 2006, MOL CELL, V24, P643, DOI 10.1016/j.molcel.2006.11.007; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Ma L, 2007, J CELL SCI, V120, P213, DOI 10.1242/jcs.03338; Mahavongtrakul M, 2013, ENDOCRINOLOGY, V154, P3251, DOI 10.1210/en.2013-1235; Meitzen J, 2013, ENDOCRINOLOGY, V154, P4293, DOI 10.1210/en.2013-1172; Meitzen J, 2011, J CHEM NEUROANAT, V42, P236, DOI 10.1016/j.jchemneu.2011.02.002; Meng D, 2009, J BIOL CHEM, V284, P11425, DOI 10.1074/jbc.M806395200; Micevych P, 2013, J NEUROENDOCRINOL, V25, P1012, DOI 10.1111/jne.12103; Micevych P, 2009, J NEUROENDOCRINOL, V21, P249, DOI 10.1111/j.1365-2826.2009.01833.x; Micevych P., 2007, HDB NEUROCHEMISTRY M, P151, DOI [10.1007/978-0-387-30405, DOI 10.1007/978-0-387-30405]; Micevych P, 2012, FRONT NEUROENDOCRIN, V33, P331, DOI 10.1016/j.yfrne.2012.07.003; Micevych P, 2009, FRONT NEUROENDOCRIN, V30, P315, DOI 10.1016/j.yfrne.2009.04.011; Micevych PE, 2008, MOL NEUROBIOL, V38, P66, DOI 10.1007/s12035-008-8034-z; Micevych PE, 2012, NEUROENDOCRINOLOGY, V96, P103, DOI 10.1159/000338400; Micevych Paul E, 2011, Front Endocrinol (Lausanne), V2, P26, DOI 10.3389/fendo.2011.00026; MICEVYCH PE, 1994, J NEUROSCI RES, V38, P386, DOI 10.1002/jnr.490380404; Miller WE, 2001, CURR OPIN CELL BIOL, V13, P139, DOI 10.1016/S0955-0674(00)00190-3; Mills RH, 2004, J NEUROSCI, V24, P947, DOI 10.1523/JNEUROSCI.1366-03.2004; Neves SR, 2002, SCIENCE, V296, P1636, DOI 10.1126/science.1071550; Pal K, 2013, J BIOL CHEM, V288, P3265, DOI 10.1074/jbc.M112.400234; Park W, 1996, CLIN CANCER RES, V2, P2029; Pasqualini C, 1999, ENDOCRINOLOGY, V140, P2781, DOI 10.1210/en.140.6.2781; Pasqualini C, 2001, MOL ENDOCRINOL, V15, P894, DOI 10.1210/me.15.6.894; Perez-Aso M, 2013, BBA-MOL CELL RES, V1833, P2322, DOI 10.1016/j.bbamcr.2013.06.013; PFEFFER U, 1993, CANCER RES, V53, P741; Poola I, 2001, J STEROID BIOCHEM, V78, P459, DOI 10.1016/S0960-0760(01)00118-2; Razandi M, 2002, MOL ENDOCRINOL, V16, P100, DOI 10.1210/me.16.1.100; Razandi M, 2003, J BIOL CHEM, V278, P2701, DOI 10.1074/jbc.M205692200; Reiter E, 2006, TRENDS ENDOCRIN MET, V17, P159, DOI 10.1016/j.tem.2006.03.008; Roepke TA, 2010, ENDOCRINOLOGY, V151, P4926, DOI 10.1210/en.2010-0573; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; Sinchak K, 2001, J NEUROSCI, V21, P5723, DOI 10.1523/JNEUROSCI.21-15-05723.2001; SKIPPER JK, 1993, P NATL ACAD SCI USA, V90, P7172, DOI 10.1073/pnas.90.15.7172; Sorkin A, 2002, NAT REV MOL CELL BIO, V3, P600, DOI 10.1038/nrm883; Stalheim L, 2005, MOL PHARMACOL, V67, P78, DOI 10.1124/mol.104.006072; Titolo D, 2008, J NEUROSCI, V28, P6473, DOI 10.1523/JNEUROSCI.0514-08.2008; Titolo D, 2006, MOL ENDOCRINOL, V20, P2080, DOI 10.1210/me.2006-0027; Tohgo A, 2003, J BIOL CHEM, V278, P6258, DOI 10.1074/jbc.M212231200; von Zastrow M, 2007, CURR OPIN CELL BIOL, V19, P436, DOI 10.1016/j.ceb.2007.04.021; Zhang J, 1997, J BIOL CHEM, V272, P27005, DOI 10.1074/jbc.272.43.27005	73	13	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0120530	10.1371/journal.pone.0120530	http://dx.doi.org/10.1371/journal.pone.0120530			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803606	Green Published, gold, Green Submitted			2022-12-26	WOS:000353889600079
J	Brandon, AE; Tid-Ang, J; Wright, LE; Stuart, E; Suryana, E; Bentley, N; Turner, N; Cooney, GJ; Ruderman, NB; Kraegen, EW				Brandon, Amanda E.; Tid-Ang, Jennifer; Wright, Lauren E.; Stuart, Ella; Suryana, Eurwin; Bentley, Nicholas; Turner, Nigel; Cooney, Gregory J.; Ruderman, Neil B.; Kraegen, Edward W.			Overexpression of SIRT1 in Rat Skeletal Muscle Does Not Alter Glucose Induced Insulin Resistance	PLOS ONE			English	Article							MITOCHONDRIAL BIOGENESIS DIFFERENCES; FATTY-ACID OXIDATION; IN-VIVO EXPERIMENTS; ACTIVATED PROTEIN-KINASE; BODY ENERGY-EXPENDITURE; AS160 PHOSPHORYLATION; CALORIC RESTRICTION; ENDOTHELIAL-CELLS; METABOLISM; EXERCISE	SIRT1 is a NAD(+)-dependent deacetylase thought to regulate cellular metabolic pathways in response to alterations in nutrient flux. In the current study we investigated whether acute changes in SIRT1 expression affect markers of muscle mitochondrial content and also determined whether SIRT1 influenced muscle insulin resistance induced by acute glucose oversupply. In male Wistar rats either SIRT1 or a deacetylase inactive mutant form (H363Y) was electroprated into the tibialis cranialis (TC) muscle. The other leg was electroporated with an empty control vector. One week later, glucose was infused and hyperglycaemia was maintained at similar to 11mM. After 5 hours, 11mM glucose induced significant insulin resistance in skeletal muscle. Interestingly, overexpression of either SIRT1 or SIRT1 (H363Y) for 1 week did not change markers of mitochondrial content or function. SIRT1 or SIRT1 (H363Y) overexpression had no effect on the reduction in glucose uptake and glycogen synthesis in muscle in response to hyperglycemia. Therefore we conclude that acute increases in SIRT1 protein have little impact on mitochondrial content and that overexpressing SIRT1 does not prevent the development of insulin resistance during hyperglycaemia.	[Brandon, Amanda E.; Tid-Ang, Jennifer; Wright, Lauren E.; Stuart, Ella; Suryana, Eurwin; Turner, Nigel; Cooney, Gregory J.; Kraegen, Edward W.] St Vincents Hosp, Garvan Inst Med Res, Diabet & Metab Div, Darlinghurst, NSW 2010, Australia; [Bentley, Nicholas; Turner, Nigel; Cooney, Gregory J.; Kraegen, Edward W.] Univ New S Wales, UNSW Med, Sydney, NSW, Australia; [Ruderman, Neil B.] Boston Univ, Sch Med, Boston, MA 02118 USA	Garvan Institute of Medical Research; St Vincents Hospital Sydney; University of New South Wales Sydney; Boston University	Brandon, AE (corresponding author), St Vincents Hosp, Garvan Inst Med Res, Diabet & Metab Div, 384 Victoria St, Darlinghurst, NSW 2010, Australia.	a.brandon@garvan.org.au	Turner, Nigel/H-7176-2013	Turner, Nigel/0000-0002-0119-9328	National Health and Medical Research Council (NHMRC) of Australia's Fellowship Scheme; National Institutes of Health, USA [RO1DK067509]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067509] Funding Source: NIH RePORTER	National Health and Medical Research Council (NHMRC) of Australia's Fellowship Scheme; National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	GJC and EWK are supported by the National Health and Medical Research Council (NHMRC) of Australia's Fellowship Scheme. NT is an Australian Research Council (ARC) Future Fellow. This study was also funded by a grant to NBR and EWK from the National Institutes of Health, USA (RO1DK067509). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai P, 2011, CELL METAB, V13, P450, DOI 10.1016/j.cmet.2011.03.013; Bai P, 2011, CELL METAB, V13, P461, DOI 10.1016/j.cmet.2011.03.004; Balestrieri ML, 2008, BBA-PROTEINS PROTEOM, V1784, P936, DOI 10.1016/j.bbapap.2008.03.004; Boily G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001759; Bordone L, 2007, AGING CELL, V6, P759, DOI 10.1111/j.1474-9726.2007.00335.x; Brandon AE, 2011, ARCH BIOCHEM BIOPHYS, V509, P133, DOI 10.1016/j.abb.2011.03.008; Bruce CR, 2007, AM J PHYSIOL-ENDOC M, V292, pE1231, DOI 10.1152/ajpendo.00561.2006; Canto C, 2012, CELL METAB, V15, P838, DOI 10.1016/j.cmet.2012.04.022; Canto C, 2009, CURR OPIN LIPIDOL, V20, P98, DOI 10.1097/MOL.0b013e328328d0a4; Cleasby ME, 2005, DIABETES, V54, P2702, DOI 10.2337/diabetes.54.9.2702; Feige JN, 2008, CELL METAB, V8, P347, DOI 10.1016/j.cmet.2008.08.017; Frojdo S, 2011, MOL CELL ENDOCRINOL, V335, P166, DOI 10.1016/j.mce.2011.01.008; Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633; Gurd BJ, 2012, J APPL PHYSIOL, V112, P931, DOI 10.1152/japplphysiol.00078.2012; Gurd BJ, 2012, J APPL PHYSIOL, V112, P926, DOI 10.1152/japplphysiol.01262.2011; Gurd BJ, 2009, J PHYSIOL-LONDON, V587, P1817, DOI 10.1113/jphysiol.2008.168096; Higashida K, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001603; Hoy AJ, 2007, AM J PHYSIOL-ENDOC M, V293, pE1358, DOI 10.1152/ajpendo.00133.2007; Hoy AJ, 2009, AM J PHYSIOL-ENDOC M, V297, pE67, DOI 10.1152/ajpendo.90945.2008; JAMES DE, 1985, AM J PHYSIOL, V248, pE567, DOI 10.1152/ajpendo.1985.248.5.E567; Kraegen EW, 2006, AM J PHYSIOL-ENDOC M, V290, pE471, DOI 10.1152/ajpendo.00316.2005; Lan F, 2008, J BIOL CHEM, V283, P27628, DOI 10.1074/jbc.M805711200; Larsen S, 2013, J AM COLL CARDIOL, V61, P44, DOI 10.1016/j.jacc.2012.09.036; McMahon JM, 2001, GENE THER, V8, P1264, DOI 10.1038/sj.gt.3301522; Menzies KJ, 2013, J BIOL CHEM, V288, P6968, DOI 10.1074/jbc.M112.431155; Menzies KJ, 2012, J APPL PHYSIOL, V112, P929, DOI 10.1152/japplphysiol.00094.2012; Montgomery MK, 2013, J LIPID RES, V54, P3322, DOI 10.1194/jlr.M040451; Nedachi T, 2008, AM J PHYSIOL-ENDOC M, V294, pE668, DOI 10.1152/ajpendo.00640.2007; Nogueiras R, 2012, PHYSIOL REV, V92, P1479, DOI 10.1152/physrev.00022.2011; Philp A, 2011, J BIOL CHEM, V286, P30561, DOI 10.1074/jbc.M111.261685; Price NL, 2012, CELL METAB, V15, P675, DOI 10.1016/j.cmet.2012.04.003; Purushotham A, 2009, CELL METAB, V9, P327, DOI 10.1016/j.cmet.2009.02.006; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Saha AK, 2010, DIABETES, V59, P2426, DOI 10.2337/db09-1870; Schenk S, 2011, J CLIN INVEST, V121, P4281, DOI 10.1172/JCI58554; Shabalina IG, 2013, CELL REP, V5, P1196, DOI 10.1016/j.celrep.2013.10.044; Suchankova G, 2009, BIOCHEM BIOPH RES CO, V378, P836, DOI 10.1016/j.bbrc.2008.11.130; Sun C, 2007, CELL METAB, V6, P307, DOI 10.1016/j.cmet.2007.08.014; Turner N, 2007, DIABETES, V56, P2085, DOI 10.2337/db07-0093; Wang RH, 2011, J CLIN INVEST, V121, P4477, DOI 10.1172/JCI46243; Wang Y, 2013, INVEST OPHTH VIS SCI, V54, P3806, DOI 10.1167/iovs.13-12091; White AT, 2013, DIABETOLOGIA, V56, P1629, DOI 10.1007/s00125-013-2912-2; White AT, 2014, AM J PHYSIOL-ENDOC M, V307, pE764, DOI 10.1152/ajpendo.00001.2014; Wright LE, 2011, DIABETOLOGIA; Xu Y, 2012, TOXICOL APPL PHARM, V259, P395, DOI 10.1016/j.taap.2011.09.028; Yuan Q, 2011, CAN J PHYSIOL PHARM, V89, P713, DOI [10.1139/Y11-069, 10.1139/y11-069]; Zu Y, 2010, CIRC RES, V106, P1384, DOI 10.1161/CIRCRESAHA.109.215483	47	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121959	10.1371/journal.pone.0121959	http://dx.doi.org/10.1371/journal.pone.0121959			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798922	gold, Green Published, Green Submitted			2022-12-26	WOS:000351987300304
J	Gao, L; Bai, LJ; Zhang, YC; Dai, XJ; Netra, R; Min, YJ; Zhou, FQ; Niu, C; Dun, WH; Gong, HH; Zhang, M				Gao, Lei; Bai, Lijun; Zhang, Yuchen; Dai, Xi-jian; Netra, Rana; Min, Youjiang; Zhou, Fuqing; Niu, Chen; Dun, Wanghuan; Gong, Honghan; Zhang, Ming			Frequency-Dependent Changes of Local Resting Oscillations in Sleep-Deprived Brain	PLOS ONE			English	Article							WORKING-MEMORY; DEFAULT-MODE; NEURAL BASIS; DEPRIVATION; CONNECTIVITY; NETWORKS; CORTEX; ACTIVATION; MECHANISMS; ATTENTION	Sleep deprivation (SD) adversely affects brain function and is accompanied by frequency dependent changes in EEG. Recent studies have suggested that BOLD fluctuations pertain to a spatiotemporal organization with different frequencies. The present study aimed to investigate the frequency-dependent SD-related brain oscillatory activity by using the amplitude of low-frequency fluctuation (ALFF) analysis. The ALFF changes were measured across different frequencies (Slow-4: 0.027-0.073 Hz; Slow-5: 0.01-0.027 Hz; and Typical band: 0.01-0.08 Hz) in 24 h SD as compared to rested wakeful during resting-state fMRI. Sixteen volunteers underwent two fMRI sessions, once during rested wakefulness and once after 24 h of SD. SD showed prominently decreased ALFF in the right inferior parietal lobule (IPL), bilateral orbitofrontal cortex (OFC) and dorsolateral prefrontal cortex (DLPFC), while increased ALFF in the visual cortex, left sensorimotor cortex and fusiform gyrus. Across the Slow-4 and Slow-5, results differed significantly in the OFC, DLPFC, thalamus and caudate in comparison to typical frequency band; and Slow-4 showed greater differences. In addition, negative correlations of behavior performance and ALFF patterns were found mainly in the right IPL across the typical frequency band. These observations provided novel insights about the physiological responses of SD, identified how it disturbs the brain rhythms, and linked SD with frequency-dependent alterations in amplitude patterns.	[Gao, Lei; Netra, Rana; Niu, Chen; Dun, Wanghuan; Zhang, Ming] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Med Imaging, Xian 710049, Peoples R China; [Gao, Lei; Dai, Xi-jian; Zhou, Fuqing; Gong, Honghan] Nanchang Univ, Affiliated Hosp 1, Dept Radiol, Nanchang, Jiangxi, Peoples R China; [Bai, Lijun] Xi An Jiao Tong Univ, Key Lab Biomed Informat Engn, Minist Educ, Dept Biomed Engn,Sch Life Sci & Technol, Xian 710049, Peoples R China; [Zhang, Yuchen] Xi An Jiao Tong Univ, Zonglian Expt Class, Xian 710049, Peoples R China; [Min, Youjiang] Jiangxi Univ Tradit Chinese Med, Affiliated Hosp, Acupuncture & Rehabil Dept, Nanchang, Jiangxi, Peoples R China	Xi'an Jiaotong University; Nanchang University; Xi'an Jiaotong University; Xi'an Jiaotong University; Jiangxi University of Traditional Chinese Medicine	Gong, HH (corresponding author), Nanchang Univ, Affiliated Hosp 1, Dept Radiol, Nanchang, Jiangxi, Peoples R China.	honghan_gong@sina.com; zmmri@163.com	Dai, Xi/HCG-9886-2022; Zhang, Yuchen/GYI-8858-2022; Bai, Lijun/C-5119-2015	Gao, Lei/0000-0002-0081-0172; Bai, Lijun/0000-0001-8790-5424; DAI, Xi-jian/0000-0001-5328-6522	National Natural Science Foundation of China [81371630, 81260217, 81371530]; Fundamental Research Funds for the Central Universities; Beijing Nova program [Z111101054511116]; Beijing Natural Science Foundation [4122082]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Beijing Nova program(Beijing Municipal Science & Technology Commission); Beijing Natural Science Foundation(Beijing Natural Science Foundation)	Funding: This study was supported by the National Natural Science Foundation of China (Grant No. 81371630, 81260217, and 81371530), the Fundamental Research Funds for the Central Universities, the Beijing Nova program (grant number Z111101054511116), and the Beijing Natural Science Foundation (grant number 4122082).	Abou Elseoud A, 2014, HUM BRAIN MAPP, V35, P161, DOI 10.1002/hbm.22164; Altena E, 2010, BIOL PSYCHIAT, V67, P182, DOI 10.1016/j.biopsych.2009.08.003; Anticevic A, 2012, TRENDS COGN SCI, V16, P584, DOI 10.1016/j.tics.2012.10.008; Baliki MN, 2011, J NEUROSCI, V31, P13981, DOI 10.1523/JNEUROSCI.1984-11.2011; Baria AT, 2011, J NEUROSCI, V31, P7910, DOI 10.1523/JNEUROSCI.1296-11.2011; BENINGTON JH, 1995, PROG NEUROBIOL, V45, P347, DOI 10.1016/0301-0082(94)00057-O; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Born J, 2012, NEURON, V75, P933, DOI 10.1016/j.neuron.2012.09.007; Bosch OG, 2013, P NATL ACAD SCI USA, V110, P19597, DOI 10.1073/pnas.1317010110; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Chee MWL, 2008, CURR OPIN NEUROL, V21, P417, DOI 10.1097/WCO.0b013e3283052cf7; Chee MWL, 2007, P NATL ACAD SCI USA, V104, P9487, DOI 10.1073/pnas.0610712104; Chee MWL, 2004, J NEUROSCI, V24, P4560, DOI 10.1523/JNEUROSCI.0007-04.2004; Chuah YML, 2006, J NEUROSCI, V26, P7156, DOI 10.1523/JNEUROSCI.0906-06.2006; De Havas JA, 2012, NEUROIMAGE, V59, P1745, DOI 10.1016/j.neuroimage.2011.08.026; Disner SG, 2011, NAT REV NEUROSCI, V12, P467, DOI 10.1038/nrn3027; Drummond SPA, 2005, SLEEP, V28, P1059; Dworak M, 2010, J NEUROSCI, V30, P9007, DOI 10.1523/JNEUROSCI.1423-10.2010; Etkin A, 2011, TRENDS COGN SCI, V15, P85, DOI 10.1016/j.tics.2010.11.004; Forster KI, 2003, BEHAV RES METH INS C, V35, P116, DOI 10.3758/BF03195503; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Gevins A, 1997, CEREB CORTEX, V7, P374, DOI 10.1093/cercor/7.4.374; Gevins A, 1998, HUM FACTORS, V40, P79, DOI 10.1518/001872098779480578; Goel N, 2009, SEMIN NEUROL, V29, P320, DOI 10.1055/s-0029-1237117; Gujar N, 2011, J NEUROSCI, V31, P4466, DOI 10.1523/JNEUROSCI.3220-10.2011; Gujar N, 2010, J COGNITIVE NEUROSCI, V22, P1637, DOI 10.1162/jocn.2009.21331; Han Y, 2011, NEUROIMAGE, V55, P287, DOI 10.1016/j.neuroimage.2010.11.059; Hasler G, 2011, MOL PSYCHIATR, V16, P604, DOI 10.1038/mp.2011.23; Hoptman MJ, 2010, SCHIZOPHR RES, V117, P13, DOI 10.1016/j.schres.2009.09.030; Jiao Q, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025159; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Killgore WDS, 2012, NEUROSCI LETT, V518, P10, DOI 10.1016/j.neulet.2012.04.029; Knoblauch V, 2002, CEREB CORTEX, V12, P1092, DOI 10.1093/cercor/12.10.1092; Koenis MMG, 2013, HUM BRAIN MAPP, V34, P487, DOI 10.1002/hbm.21455; Kong DY, 2014, NEUROIMAGE, V91, P169, DOI 10.1016/j.neuroimage.2014.01.037; Lawrence NS, 2003, J COGNITIVE NEUROSCI, V15, P1028, DOI 10.1162/089892903770007416; Libedinsky C, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00070; Lim JL, 2008, ANN NY ACAD SCI, V1129, P305, DOI 10.1196/annals.1417.002; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Menz MM, 2012, J NEUROSCI, V32, P6937, DOI 10.1523/JNEUROSCI.3553-11.2012; Motomura Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056578; Mullin BC, 2013, PSYCHOL MED, V43, P2215, DOI 10.1017/S0033291712002875; Olbrich E, 2013, J SLEEP RES; Piantoni G, 2013, NEUROIMAGE, V79, P213, DOI 10.1016/j.neuroimage.2013.04.103; Picchioni D, 2013, NEUROIMAGE, V80, P387, DOI 10.1016/j.neuroimage.2013.05.067; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Raichle ME, 2011, BRAIN CONNECT, V1, P3, DOI 10.1089/brain.2011.0019; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Samann PG, 2010, MAGN RESON MATER PHY, V23, P375, DOI 10.1007/s10334-010-0213-z; Satterthwaite TD, 2013, NEUROIMAGE, V64, P240, DOI 10.1016/j.neuroimage.2012.08.052; Shao YC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078830; Smith ME, 1999, COGNITIVE BRAIN RES, V7, P389, DOI 10.1016/S0926-6410(98)00043-3; Song XP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086818; Tallon-Baudry C, 2005, CEREB CORTEX, V15, P654, DOI 10.1093/cercor/bhh167; Thomas M, 2000, J SLEEP RES, V9, P335, DOI 10.1046/j.1365-2869.2000.00225.x; Thomas Maria L., 2003, Thalamus & Related Systems, V2, P199, DOI 10.1017/S1472928803000207; Tomasi D, 2009, CEREB CORTEX, V19, P233, DOI 10.1093/cercor/bhn073; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Venkatraman V, 2007, SLEEP, V30, P603, DOI 10.1093/sleep/30.5.603; Venkatraman V, 2011, J NEUROSCI, V31, P3712, DOI 10.1523/JNEUROSCI.4407-10.2011; Wei LQ, 2014, HUM BRAIN MAPP, V35, P331, DOI 10.1002/hbm.22176; WU JC, 1991, SLEEP, V14, P155; Yamasaki H, 2002, P NATL ACAD SCI USA, V99, P11447, DOI 10.1073/pnas.182176499; Yan CG, 2013, NEUROIMAGE, V80, P246, DOI 10.1016/j.neuroimage.2013.04.081; Yan CG, 2013, NEUROIMAGE, V76, P183, DOI 10.1016/j.neuroimage.2013.03.004; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Yoo SS, 2007, CURR BIOL, V17, pR877, DOI 10.1016/j.cub.2007.08.007; Yu RJ, 2014, HUM BRAIN MAPP, V35, P627, DOI 10.1002/hbm.22203; Zang YF, 2004, NEUROIMAGE, V22, P394, DOI 10.1016/j.neuroimage.2003.12.030; Zang YF, 2007, BRAIN DEV-JPN, V29, P83, DOI 10.1016/j.braindev.2006.07.002; Zuo XN, 2010, NEUROIMAGE, V49, P1432, DOI 10.1016/j.neuroimage.2009.09.037	71	55	57	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120323	10.1371/journal.pone.0120323	http://dx.doi.org/10.1371/journal.pone.0120323			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798918	Green Published, gold, Green Submitted			2022-12-26	WOS:000351987300134
J	Yap, TWC; Chan, WK; Leow, AHR; Azmi, AN; Loke, MF; Vadivelu, J; Goh, KL				Yap, Theresa Wan-Chen; Chan, Weng-Kai; Leow, Alex Hwong-Ruey; Azmi, Ahmad Najib; Loke, Mun-Fai; Vadivelu, Jamuna; Goh, Khean-Lee			Prevalence of Serum Celiac Antibodies in a Multiracial Asian Population-A First Study in the Young Asian Adult Population of Malaysia	PLOS ONE			English	Article							HELICOBACTER-PYLORI INFECTION; FUNCTIONAL GASTROINTESTINAL DISORDERS; TISSUE TRANSGLUTAMINASE ANTIBODIES; WORLD GASTROENTEROLOGY; SEROLOGICAL MARKER; GLUTEN SENSITIVITY; UNITED-STATES; DISEASE; CHILDREN; ASSOCIATION	Background Celiac disease (CD) is an immune-mediated disorder induced by the ingestion of gluten in genetically susceptible persons. The prevalence of CD in Malaysia is unknown. We aim to determine the seroprevalence of CD antibodies and also investigate the correlation between H. pylori infection and CD in the young and healthy multiracial Malaysian population. Methods Healthy young adult volunteers between the ages of 18-30 years were consecutively recruited from June 2012 to May 2014 at the University of Malaya Medical Centre (UMMC), Kuala Lumpur. Serum samples from all the participants were tested for anti-gliadin antibody immunoglobulin A/immunoglobulin G (IgA/IgG) and anti-tissue transglutaminase antibody (tTG) IgA/IgG. Samples positive for both anti-gliadin and anti-tTG were further validated for anti-human endomysial IgA antibodies (EmA). Serological diagnosis of CD was made when anti-gliadin, anti-tTG and anti-EmA were positive. Results 562 qualified participants with mean age 24 +/- 2.4 years old were recruited into our study. CD was found in 7 participants where most of them were asymptomatic and unaware of their CD status. The median of anti-gliadin and anti-tTG IgA/IgG value was 38.2 U/ml (interquartile range, 28.3-60.4 U/ml) and 49.2 U/ml (interquartile range, 41.1-65.9 U/ml), respectively. Seroprevalence of CD antibodies was 1.9% (6 out of 324) in female while only 0.4% (1 out of 238) in male. Seroprevalence among Malay was 0.8% (2 of 236), Chinese was 1.7% (3 of 177) and Indian was 1.3% (2 of 149). Overall, seroprevalence of CD antibodies in healthy asymptomatic adults in the Malaysian population was 1.25% (95% CI, 0.78%-1.72%). No significant relationship was discovered between CD and H. pylori infection. Conclusions The seroprevalence of CD antibodies in healthy young adults in the Malaysian population was 1.25% (1 in 100). CD is underdiagnosed and it could be a much greater problem in Malaysia than previously thought.	[Yap, Theresa Wan-Chen; Loke, Mun-Fai; Vadivelu, Jamuna] Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur 50603, Malaysia; [Chan, Weng-Kai; Leow, Alex Hwong-Ruey; Azmi, Ahmad Najib; Goh, Khean-Lee] Univ Malaya, Fac Med, Dept Med, Kuala Lumpur 50603, Malaysia	Universiti Malaya; Universiti Malaya	Goh, KL (corresponding author), Univ Malaya, Fac Med, Dept Med, Kuala Lumpur 50603, Malaysia.	klgoh56@gmail.com	Goh, Khean-Lee/B-6404-2009; Loke, Mun Fai/B-1060-2011; VADIVELU, JAMUNARANI S/B-8696-2010; Leow, Alex HR/B-1626-2017	Goh, Khean-Lee/0000-0002-9965-1561; Loke, Mun Fai/0000-0002-3554-5313; VADIVELU, JAMUNARANI S/0000-0001-7322-3676; Leow, Alex HR/0000-0003-1752-0435	University of Malaya-Ministry of Education (UM-MOE) High Impact Research (HIR) Grant [UM.C/HIR/MOE/13/4, H-50001-00-A000029]; Malaysian Society of Gastroenterology and Hepatology Research Grant [02/2013]	University of Malaya-Ministry of Education (UM-MOE) High Impact Research (HIR) Grant; Malaysian Society of Gastroenterology and Hepatology Research Grant	This study was supported by the University of Malaya-Ministry of Education (UM-MOE) High Impact Research (HIR) Grant (UM.C/HIR/MOE/13/4, HIR Account No: H-50001-00-A000029) and Malaysian Society of Gastroenterology and Hepatology Research Grant 02/2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amberbir A, 2011, CLIN EXP ALLERGY, V41, P1422, DOI 10.1111/j.1365-2222.2011.03831.x; Arram EO, 2012, EGYPT J CHEST DIS TU, V61, P41, DOI 10.1016/j.ejcdt.2012.10.009; Aydogdu S, 2008, SCAND J GASTROENTERO, V43, P1088, DOI 10.1080/00365520802101846; Aziz I, 2014, EUR J GASTROEN HEPAT, V26, P33, DOI 10.1097/01.meg.0000435546.87251.f7; Bai JC, 2013, J CLIN GASTROENTEROL, V47, P121, DOI 10.1097/MCG.0b013e31827a6f83; Bakhshipour Alireza, 2012, Arab J Gastroenterol, V13, P24, DOI 10.1016/j.ajg.2012.03.003; Barada K, 2010, WORLD J GASTROENTERO, V16, P1449, DOI 10.3748/wjg.v16.i12.1449; Baudon JJ, 2004, ARCH PEDIAT ADOL MED, V158, P584, DOI 10.1001/archpedi.158.6.584; Biagi F, 2001, SCAND J GASTROENTERO, V36, P955, DOI 10.1080/003655201750305477; Bizzaro N, 2012, CLIN REV ALLERG IMMU, V42, P279, DOI 10.1007/s12016-010-8223-1; Blaser MJ, 2008, GUT, V57, P561, DOI 10.1136/gut.2007.133462; Challar MH, 2004, JABMS, V6, P155; Ciacci C, 2000, EUR J GASTROEN HEPAT, V12, P1283, DOI 10.1097/00042737-200012120-00004; Ciclitira PJ, 2001, GASTROENTEROLOGY, V120, P1526, DOI 10.1053/gast.2001.24056; Cook HB, 2000, J GASTROEN HEPATOL, V15, P1032, DOI 10.1046/j.1440-1746.2000.02290.x; Cristofori F, 2014, JAMA PEDIATR, V168, P555, DOI 10.1001/jamapediatrics.2013.4984; Cummins AG, 2009, J GASTROEN HEPATOL, V24, P1347, DOI 10.1111/j.1440-1746.2009.05932.x; Diamanti A, 1999, AM J GASTROENTEROL, V94, P1313, DOI 10.1111/j.1572-0241.1999.01082.x; Drossman DA, 2006, GASTROENTEROLOGY, V130, P1377, DOI 10.1053/j.gastro.2006.03.008; Ertekin V, 2005, J CLIN GASTROENTEROL, V39, P689, DOI 10.1097/01.mcg.0000174026.26838.56; Fasano A, 2003, ARCH INTERN MED, V163, P286, DOI 10.1001/archinte.163.3.286; Fasano A, 2001, GASTROENTEROLOGY, V120, P636, DOI 10.1053/gast.2001.22123; FERGUSON A, 1993, GUT, V34, P150, DOI 10.1136/gut.34.2.150; Goh K L, 2009, Med J Malaysia, V64, P187; Grad YH, 2012, AM J EPIDEMIOL, V175, P54, DOI 10.1093/aje/kwr288; GRANBERG C, 1993, J CLIN MICROBIOL, V31, P1450, DOI 10.1128/JCM.31.6.1450-1453.1993; Green PHR, 2007, NEW ENGL J MED, V357, P1731, DOI 10.1056/NEJMra071600; Green PHR, 2001, AM J GASTROENTEROL, V96, P126, DOI 10.1111/j.1572-0241.2001.03462.x; Green PHR, 2003, LANCET, V362, P383, DOI 10.1016/S0140-6736(03)14027-5; Hovell CJ, 2001, MED J AUSTRALIA, V175, P247, DOI 10.5694/j.1326-5377.2001.tb143555.x; Imanzadeh F, 2005, J PEDIATR GASTR NUTR, V40, P309, DOI 10.1097/01.MPG.0000154012.10420.08; Jiang LL, 2009, J ZHEJIANG UNIV-SC B, V10, P168, DOI 10.1631/jzus.B0820164; Kaukinen K, 2007, SCAND J GASTROENTERO, V42, P1428, DOI 10.1080/00365520701452217; Kurppa K, 2010, J PEDIATR-US, V157, P373, DOI 10.1016/j.jpeds.2010.02.070; Kurppa K, 2009, GASTROENTEROLOGY, V136, P816, DOI 10.1053/j.gastro.2008.11.040; Lebwohl B, 2013, AM J EPIDEMIOL, V178, P1721, DOI 10.1093/aje/kwt234; Lebwohl B, 2012, GASTROINTEST ENDOSC, V76, P779, DOI 10.1016/j.gie.2012.05.011; Leffler DA, 2010, AM J GASTROENTEROL, V105, P2520, DOI 10.1038/ajg.2010.276; Lock RJ, 2004, EUR J GASTROEN HEPAT, V16, P467, DOI 10.1097/00042737-200405000-00005; Luzza F, 1999, J PEDIATR GASTR NUTR, V28, P143, DOI 10.1097/00005176-199902000-00009; Makharia GK, 2014, J GASTROEN HEPATOL, V29, P666, DOI 10.1111/jgh.12514; Makharia GK, 2011, J GASTROEN HEPATOL, V26, P894, DOI 10.1111/j.1440-1746.2010.06606.x; Maki M, 2003, NEW ENGL J MED, V348, P2517, DOI 10.1056/NEJMoa021687; MAKI M, 1991, LANCET, V338, P1350, DOI 10.1016/0140-6736(91)92234-S; Malfertheiner P, 2005, GUT, V54, pI13, DOI 10.1136/gut.2004.041533; Mansueto P, 2014, J AM COLL NUTR, V33, P39, DOI 10.1080/07315724.2014.869996; Martin FPJ, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00113; McColl KEL, 2010, NEW ENGL J MED, V362, P1597, DOI 10.1056/NEJMcp1001110; Mustalahti K, 2010, ANN MED, V42, P587, DOI 10.3109/07853890.2010.505931; Nejad MR, 2011, ARCH IRAN MED, V14, P115, DOI 011142/AIM.009; Oberhuber G, 1999, EUR J GASTROEN HEPAT, V11, P1185, DOI 10.1097/00042737-199910000-00019; Qua CS, 2011, J GASTROEN HEPATOL, V26, P1333, DOI 10.1111/j.1440-1746.2011.06732.x; Reeves GEM, 2006, EUR J GASTROEN HEPAT, V18, P493, DOI 10.1097/00042737-200605000-00006; Rewers M, 2005, GASTROENTEROLOGY, V128, pS47, DOI 10.1053/j.gastro.2005.02.030; Robinson K, 2008, GUT, V57, P1375, DOI 10.1136/gut.2007.137539; Rostami K, 1999, AM J GASTROENTEROL, V94, P888; Rostami-Nejad M, 2009, REV ESP ENFERM DIG, V101, P850, DOI 10.4321/s1130-01082009001200004; Rozenberg O, 2012, CLIN REV ALLERG IMMU, V42, P331, DOI 10.1007/s12016-010-8250-y; Rubio-Tapia A, 2012, AM J GASTROENTEROL, V107, P1538, DOI 10.1038/ajg.2012.219; Sestak Karol, 2013, Br Microbiol Res J, V3, P585; Shahbazkhani B, 2003, EUR J GASTROEN HEPAT, V15, P475, DOI 10.1097/01.meg.0000059118.41030.96; Shamir R, 2002, AM J GASTROENTEROL, V97, P2589, DOI 10.1111/j.1572-0241.2002.06028.x; Tatar G, 2004, DIGEST DIS SCI, V49, P1479, DOI 10.1023/B:DDAS.0000042250.59327.91; Tosco A, 2011, CLIN GASTROENTEROL H, V9, P320, DOI 10.1016/j.cgh.2010.09.006; Troncone R, 1996, ACTA PAEDIATR, V85, P10, DOI 10.1111/j.1651-2227.1996.tb14240.x; Turco R, 2011, ALIMENT PHARM THER, V34, P783, DOI 10.1111/j.1365-2036.2011.04787.x; Valdimarsson T, 1996, DIGEST DIS SCI, V41, P83, DOI 10.1007/BF02208588; vandeWouw BAM, 1995, NETH J MED, V47, P272, DOI 10.1016/0300-2977(95)00104-2; Villanacci V, 2006, AM J GASTROENTEROL, V101, P1880, DOI 10.1111/j.1572-0241.2006.00621.x; Wakim-Fleming J, 2013, CLIN GASTROENTEROL H, V11, P511, DOI 10.1016/j.cgh.2012.12.015; Wang SK, 2007, WORLD J GASTROENTERO, V13, P2923, DOI 10.3748/wjg.v13.i21.2923; Wang XQ, 2011, J PEDIATR GASTR NUTR, V53, P368, DOI 10.1097/MPG.0b013e31822a0128; Wang Xin-qiong, 2010, Zhonghua Er Ke Za Zhi, V48, P244; Watanabe C, 2014, J GASTROENTEROL, V49, P825, DOI 10.1007/s00535-013-0838-6; West J, 2003, GUT, V52, P960, DOI 10.1136/gut.52.7.960; Wu J, 2010, REV ESP ENFERM DIG, V102, P472, DOI 10.4321/s1130-01082010000800003; Wu J, 2010, GUT, V59, P418, DOI 10.1136/gut.2009.197863	77	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121908	10.1371/journal.pone.0121908	http://dx.doi.org/10.1371/journal.pone.0121908			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799401	Green Published, Green Submitted, gold			2022-12-26	WOS:000351987300299
J	Salama, MF; Carroll, B; Adada, M; Pulkoski-Gross, M; Hannun, YA; Obeid, LM				Salama, Mohamed F.; Carroll, Brittany; Adada, Mohamad; Pulkoski-Gross, Michael; Hannun, Yusuf A.; Obeid, Lina M.			A novel role of sphingosine kinase-1 in the invasion and angiogenesis of VHL mutant clear cell renal cell carcinoma	FASEB JOURNAL			English	Article						sphingosine 1-phosphate; S1P receptor; focal adhesion kinase; HIF-2	FOCAL ADHESION KINASE; TUMOR-SUPPRESSOR PROTEIN; HYPOXIA-INDUCIBLE FACTOR; SMALL-MOLECULE INHIBITOR; BREAST-CANCER; COLON-CANCER; SPHINGOLIPID METABOLISM; ENDOTHELIAL-CELLS; 1-PHOSPHATE; GROWTH	Sphingosine kinase 1 (SK1), the enzyme responsible for sphingosine 1-phosphate (S1P) production, is overexpressed in many human solid tumors. However, its role in clear cell renal cell carcinoma (ccRCC) has not been described previously. ccRCC cases are usually associated with mutations in vonHippel-Lindau (VHL) and subsequent normoxic stabilization of hypoxia-inducible factor (HIF). We previously showed that HIF-2 alpha up-regulates SK1 expression during hypoxia in glioma cells. Therefore, we hypothesized that the stabilized HIF in ccRCC cells will be associated with increased SK1 expression. Here, we demonstrate that SK1 is overexpressed in 786-0 renal carcinoma cells lacking functional VHL, with concomitant high S1P levels that appear to be HIF-2 alpha mediated. Moreover, examining the TCGA RNA seq database shows that SK1 expression was similar to 2.7-fold higher in solid tumor tissue from ccRCC patients, and this was associated with less survival. Knockdown of SK1 in 786-0 ccRCC cells had no effect on cell proliferation. On the other hand, this knockdown resulted in an similar to 3.5-fold decrease in invasion, less phosphorylation of focal adhesion kinase (FAK), and an similar to 2-fold decrease in angiogenesis. Moreover, S1P treatment of SK1 knockdown cells resulted in phosphorylation of FAK and invasion, and this was mediated by S1P receptor 2. These results suggest that higher SK1 and S1P levels in VHL-defective ccRCC could induce invasion in an autocrine manner and angiogenesis in a paracrine manner. Accordingly, targeting SK1 could reduce both the invasion and angiogenesis of ccRCC and therefore improve the survival rate of patients.	[Salama, Mohamed F.; Carroll, Brittany; Adada, Mohamad; Pulkoski-Gross, Michael; Hannun, Yusuf A.; Obeid, Lina M.] SUNY Stony Brook, Stony Brook Canc Ctr, Hlth Sci Ctr, Stony Brook, NY 11794 USA; [Salama, Mohamed F.; Carroll, Brittany; Adada, Mohamad; Pulkoski-Gross, Michael; Hannun, Yusuf A.; Obeid, Lina M.] SUNY Stony Brook, Dept Med, Hlth Sci Ctr, Stony Brook, NY 11794 USA; [Salama, Mohamed F.] Mansoura Univ, Dept Biochem, Fac Vet Med, Mansoura, Egypt; [Obeid, Lina M.] Northport Vet Affairs Med Ctr, Northport, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Egyptian Knowledge Bank (EKB); Mansoura University	Obeid, LM (corresponding author), SUNY Stony Brook, Dept Med, Hlth Sci Ctr, L-4,179, Stony Brook, NY 11794 USA.	lina.obeid@stonybrookmedicine.edu	Salama, Mohamed F/C-9010-2017; Salama, Mohamed/S-3493-2019	Salama, Mohamed F/0000-0002-0002-9108; Salama, Mohamed/0000-0002-0002-9108; Pulkoski-Gross, Michael/0000-0003-4644-1795; Adada, Mohamad/0000-0002-2988-2081	Science and Technology Development Fund, Egypt; U.S. Veterans Affairs Merit Award; U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences (NIGMS) [GM062887]; NIH National Cancer Institute [P01CA097132, F31CA186547-01]; NIH NIGMS [T32 GM007518]; NATIONAL CANCER INSTITUTE [P01CA097132, F31CA186547] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007518, R01GM062887] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000156] Funding Source: NIH RePORTER	Science and Technology Development Fund, Egypt(Science and Technology Development Fund (STDF)); U.S. Veterans Affairs Merit Award; U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences (NIGMS); NIH National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	The authors thank the Science and Technology Development Fund, Egypt, for providing travel funding for M.F.S. The authors thank Dr. Jizu Zhi (Department of Pathology, Health Sciences Center, Stony Brook Medicine, Stony Brook, NY, USA) for help with TCGA RNA seq database analysis and Dr. Masayuki Wada and Dr. Jean-Phillip Truman (Stony Brook Medicine) for valuable help and discussions. The authors also thank Dr. Leah Siskind (University of Louisville School of Medicine, Louisville, KY, USA) for providing shRNA plasmids used for production of lentiviral particles. This work was supported by a U.S. Veterans Affairs Merit Award (to L.M.O.), U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences (NIGMS) Grant GM062887 (to L.M.O.), NIH National Cancer Institute Grants P01CA097132 (to L.M.O. and Y.A.H.) and F31CA186547-01 (to B.L.C.), and NIH NIGMS Training Grant T32 GM007518 (M.P.G.). Lipid analyses were provided by the Lipidomics Core Facility at Stony Brook University.	Anelli V, 2008, J BIOL CHEM, V283, P3365, DOI 10.1074/jbc.M708241200; Anelli V, 2010, FASEB J, V24, P2727, DOI 10.1096/fj.09-150540; Aust S, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-67; Baldewijns MM, 2010, J PATHOL, V221, P125, DOI 10.1002/path.2689; Bao MY, 2012, LIVER INT, V32, P331, DOI 10.1111/j.1478-3231.2011.02666.x; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Chae SS, 2004, J CLIN INVEST, V114, P1082, DOI 10.1172/JCI200422716; Chumanevich AA, 2010, CARCINOGENESIS, V31, P1787, DOI 10.1093/carcin/bgq158; Cingolani F, 2014, J LIPID RES, V55, P1711, DOI 10.1194/jlr.M049759; Cockman ME, 2000, J BIOL CHEM, V275, P25733, DOI 10.1074/jbc.M002740200; Dia VP, 2011, CANCER LETT, V313, P167, DOI 10.1016/j.canlet.2011.09.002; Donati C, 2007, FEBS LETT, V581, P4384, DOI 10.1016/j.febslet.2007.08.007; Facchinetti MM, 2010, CELLS TISSUES ORGANS, V192, P314, DOI 10.1159/000318173; French KJ, 2003, CANCER RES, V63, P5962; Gandy KAO, 2013, FASEB J, V27, P3155, DOI 10.1096/fj.13-228460; Gandy KAO, 2013, BIOCHEM J, V449, P661, DOI 10.1042/BJ20120213; Gandy KAO, 2013, BBA-MOL CELL BIOL L, V1831, P157, DOI 10.1016/j.bbalip.2012.07.002; Gao P, 2011, MOL CANCER RES, V9, P1509, DOI 10.1158/1541-7786.MCR-11-0336; GNARRA JR, 1994, NAT GENET, V7, P85, DOI 10.1038/ng0594-85; Golubovskaya VM, 2008, J MED CHEM, V51, P7405, DOI 10.1021/jm800483v; Gordan JD, 2007, CANCER CELL, V11, P335, DOI 10.1016/j.ccr.2007.02.006; Guan HY, 2011, MOL ENDOCRINOL, V25, P1858, DOI 10.1210/me.2011-1048; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hao HF, 2009, WORLD J GASTROENTERO, V15, P5916, DOI 10.3748/wjg.15.5916; Hao HF, 2009, ONCOL REP, V22, P973, DOI 10.3892/or_00000524; HERMAN JG, 1994, P NATL ACAD SCI USA, V91, P9700, DOI 10.1073/pnas.91.21.9700; Hu CJ, 2003, MOL CELL BIOL, V23, P9361, DOI 10.1128/MCB.23.24.9361-9374.2003; Johnson KR, 2005, J HISTOCHEM CYTOCHEM, V53, P1159, DOI 10.1369/jhc.4A6606.2005; Kawamori T, 2006, FASEB J, V20, P386, DOI 10.1096/fj.05-4331fje; Keith B, 2012, NAT REV CANCER, V12, P9, DOI 10.1038/nrc3183; Kim S, 2011, ANTICANCER RES, V31, P3767; Kitatani K, 2007, J BIOL CHEM, V282, P20647, DOI 10.1074/jbc.M609162200; Kohno M, 2006, MOL CELL BIOL, V26, P7211, DOI 10.1128/MCB.02341-05; Kondo K, 2003, PLOS BIOL, V1, P439, DOI 10.1371/journal.pbio.0000083; Lahlou H, 2007, P NATL ACAD SCI USA, V104, P20302, DOI 10.1073/pnas.0710091104; Lee OH, 1999, BIOCHEM BIOPH RES CO, V264, P743, DOI 10.1006/bbrc.1999.1586; Lee OH, 2000, BIOCHEM BIOPH RES CO, V268, P47, DOI 10.1006/bbrc.2000.2087; Liu H, 2000, J BIOL CHEM, V275, P19513, DOI 10.1074/jbc.M002759200; Liu SQ, 2013, INT J ONCOL, V42, P617, DOI 10.3892/ijo.2012.1733; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Megison ML, 2014, MOL CANCER RES, V12, P514, DOI 10.1158/1541-7786.MCR-13-0505; Nagahashi M, 2012, CANCER RES, V72, P726, DOI 10.1158/0008-5472.CAN-11-2167; Pitson SM, 2000, BIOCHEM J, V350, P429, DOI 10.1042/0264-6021:3500429; Pitson SM, 2011, ANTI-CANCER AGENT ME, V11, P799; Quint P, 2013, J BIOL CHEM, V288, P5398, DOI 10.1074/jbc.M112.413583; Raval RR, 2005, MOL CELL BIOL, V25, P5675, DOI 10.1128/MCB.25.13.5675-5686.2005; Rini BI, 2009, LANCET, V373, P1119, DOI 10.1016/S0140-6736(09)60229-4; Ruckhaberle E, 2008, BREAST CANCER RES TR, V112, P41, DOI 10.1007/s10549-007-9836-9; Schraml P, 2002, J PATHOL, V196, P186, DOI 10.1002/path.1034; Schwock J, 2010, EXPERT OPIN THER TAR, V14, P77, DOI 10.1517/14728220903460340; Siow D, 2011, CRIT REV BIOCHEM MOL, V46, P365, DOI 10.3109/10409238.2011.580097; Stokes JB, 2011, MOL CANCER THER, V10, P2135, DOI 10.1158/1535-7163.MCT-11-0261; Taha TA, 2005, FASEB J, V19, P482, DOI 10.1096/fj.05-4412fje; Tamashiro PM, 2014, CANCER CELL INT, V14, DOI 10.1186/s12935-014-0076-x; Tolan D, 1999, CELL SIGNAL, V11, P349, DOI 10.1016/S0898-6568(99)00005-4; Vadas M, 2008, BBA-MOL CELL BIOL L, V1781, P442, DOI 10.1016/j.bbalip.2008.06.007; Van Brocklyn JR, 2005, J NEUROPATH EXP NEUR, V64, P695, DOI 10.1097/01.jnen.0000175329.59092.2c; Van Brocklyn JR, 2002, CANCER LETT, V181, P195, DOI 10.1016/S0304-3835(02)00050-2; VANVELDHOVEN PP, 1988, BIOCHIM BIOPHYS ACTA, V959, P185, DOI 10.1016/0005-2760(88)90030-6; Wang V, 2005, CANCER RES, V65, P3299, DOI 10.1158/0008-5472.CAN-04-4130; Wattenberg Binks W, 2010, World J Biol Chem, V1, P362, DOI 10.4331/wjbc.v1.i12.362; Young N, 2009, MOL CANCER RES, V7, P23, DOI 10.1158/1541-7786.MCR-08-0061; Zhao J, 2009, CELL SIGNAL, V21, P1945, DOI 10.1016/j.cellsig.2009.09.002; Zhuge Yong-hua, 2011, Zhonghua Yi Xue Za Zhi, V91, P2765; Zimmer M, 2004, MOL CANCER RES, V2, P89	65	36	36	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2015	29	7					2803	2813		10.1096/fj.15-270413	http://dx.doi.org/10.1096/fj.15-270413			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CL3OI	25805832	Green Published			2022-12-26	WOS:000356859100012
J	Burmeister, BT; Wang, L; Gold, MG; Skidgel, RA; O'Bryan, JP; Carnegie, GK				Burmeister, Brian T.; Wang, Li; Gold, Matthew G.; Skidgel, Randal A.; O'Bryan, John P.; Carnegie, Graeme K.			Protein Kinase A (PKA) Phosphorylation of Shp2 Protein Inhibits Its Phosphatase Activity and Modulates Ligand Specificity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						A-kinase Anchoring Protein (AKAP); Cardiac Hypertrophy; PKA; Signal Transduction; Tyrosine-protein Phosphatase (Tyrosine Phosphatase)	D-DEPENDENT ACTIVATION; CARDIAC-HYPERTROPHY; ANCHORING PROTEINS; NOONAN-SYNDROME; CARDIOMYOCYTE HYPERTROPHY; SIGNALING PATHWAYS; LEOPARD-SYNDROME; PTPN11 SHP2; KAPPA-B; HEART	Background: The AKAP-Lbc scaffold coordinates cardiac hypertrophic signaling. Results: PKA phosphorylation of Shp2 at Thr-73/Ser-189 inhibits tyrosine-phosphorylated ligand binding and PTP activity. Conclusion: AKAP-Lbc integrates PKA and Shp2 signaling, and AKAP-Lbc-associated Shp2 activity is reduced in hypertrophic hearts following chronic -adrenergic stimulation. Significance: PKA inhibition of AKAP-Lbc-anchored Shp2 activity is a previously unrecognized mechanism that may promote cardiac hypertrophy. Pathological cardiac hypertrophy (an increase in cardiac mass resulting from stress-induced cardiac myocyte growth) is a major factor underlying heart failure. Src homology 2 domain-containing phosphatase (Shp2) is critical for cardiac function because mutations resulting in loss of Shp2 catalytic activity are associated with congenital cardiac defects and hypertrophy. We identified a novel mechanism of Shp2 inhibition that may promote cardiac hypertrophy. We demonstrate that Shp2 is a component of the protein kinase A anchoring protein (AKAP)-Lbc complex. AKAP-Lbc facilitates PKA phosphorylation of Shp2, which inhibits Shp2 phosphatase activity. We identified two key amino acids in Shp2 that are phosphorylated by PKA. Thr-73 contributes a helix cap to helix B within the N-terminal SH2 domain of Shp2, whereas Ser-189 occupies an equivalent position within the C-terminal SH2 domain. Utilizing double mutant PKA phosphodeficient (T73A/S189A) and phosphomimetic (T73D/S189D) constructs, in vitro binding assays, and phosphatase activity assays, we demonstrate that phosphorylation of these residues disrupts Shp2 interaction with tyrosine-phosphorylated ligands and inhibits its protein-tyrosine phosphatase activity. Overall, our data indicate that AKAP-Lbc integrates PKA and Shp2 signaling in the heart and that AKAP-Lbc-associated Shp2 activity is reduced in hypertrophic hearts in response to chronic -adrenergic stimulation and PKA activation. Therefore, although induction of cardiac hypertrophy is a multifaceted process, inhibition of Shp2 activity through AKAP-Lbc-anchored PKA is a previously unrecognized mechanism that may promote this compensatory response.	[Burmeister, Brian T.; Wang, Li; Skidgel, Randal A.; O'Bryan, John P.; Carnegie, Graeme K.] Univ Illinois, Dept Pharmacol, Coll Med, Chicago, IL 60612 USA; [O'Bryan, John P.] Univ Illinois, Ctr Canc, Coll Med, Chicago, IL 60612 USA; [O'Bryan, John P.] Univ Illinois, Cardiovasc Res Ctr, Coll Med, Chicago, IL 60612 USA; [Gold, Matthew G.] UCL, Dept Neurosci Physiol & Pharmacol, London WC1E 6BT, England; [O'Bryan, John P.] Jessie Brown Vet Affairs Med Ctr, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of London; University College London; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center	O'Bryan, JP (corresponding author), Univ Illinois, Dept Pharmacol, E403 MSB,835 S Wolcott Ave, Chicago, IL 60612 USA.	obryanj@uic.edu	Regan, Clinton/E-6250-2012; Gold, Matthew/AAL-2546-2021	Gold, Matthew/0000-0002-1281-0815; O'Bryan, John/0000-0001-5386-1080	American Heart Association [11SDG5230003, 14PRE18830077]; Center for Clinical and Translational Science at UIC from National Institutes of Health National Center for Advancing Translational Sciences [UL1TR000050]; University of Illinois at Chicago; Veterans Administration MERIT Award [1I01BX002095]; National Institutes of Health [RO1CA116708]; NATIONAL CANCER INSTITUTE [R01CA116708] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000050] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002095] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); Center for Clinical and Translational Science at UIC from National Institutes of Health National Center for Advancing Translational Sciences; University of Illinois at Chicago; Veterans Administration MERIT Award; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Veterans Affairs(US Department of Veterans Affairs)	Deceased. Supported by American Heart Association Scientist Development Grant 11SDG5230003, by the Center for Clinical and Translational Science at UIC through Grant UL1TR000050 from the National Institutes of Health National Center for Advancing Translational Sciences, and by startup funds from the University of Illinois at Chicago.; Supported by American Heart Association Predoctoral Fellowship 14PRE18830077.; Supported by Veterans Administration MERIT Award 1I01BX002095 and by National Institutes of Health Award RO1CA116708. To whom correspondence should be addressed: Dept. of Pharmacology, University of Illinois at Chicago, E403 MSB, 835 S. Wolcott Ave., Chicago, IL 60612. Tel.: 312-996-6221; Fax: 312-996-1225; E-mail: obryanj@uic.edu.	Appert-Collin A, 2007, P NATL ACAD SCI USA, V104, P10140, DOI 10.1073/pnas.0701099104; Aye TT, 2012, J MOL CELL CARDIOL, V52, P511, DOI 10.1016/j.yjmcc.2011.06.003; Burmeister BT, 2012, J BIOL CHEM, V287, P40535, DOI 10.1074/jbc.M112.385641; Carnegie GK, 2004, MOL CELL, V15, P889, DOI 10.1016/j.molcel.2004.09.015; Carnegie GK, 2008, MOL CELL, V32, P169, DOI 10.1016/j.molcel.2008.08.030; Carnegie GK, 2011, J CARDIOVASC PHARM, V58, P451, DOI 10.1097/FJC.0b013e31821c0220; Carnegie GK, 2009, IUBMB LIFE, V61, P394, DOI 10.1002/iub.168; Depre C, 1998, NAT MED, V4, P1269, DOI 10.1038/3253; Diviani D, 2001, J BIOL CHEM, V276, P44247, DOI 10.1074/jbc.M106629200; Diviani D, 2008, CURR OPIN PHARMACOL, V8, P166, DOI 10.1016/j.coph.2007.11.001; Doppler H, 2007, J BIOL CHEM, V282, P31873, DOI 10.1074/jbc.M703584200; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Enns Linda C, 2010, BMC Res Notes, V3, P307, DOI 10.1186/1756-0500-3-307; Fielitz J, 2008, P NATL ACAD SCI USA, V105, P3059, DOI 10.1073/pnas.0712265105; Frey N, 2003, ANNU REV PHYSIOL, V65, P45, DOI 10.1146/annurev.physiol.65.092101.142243; Gold MG, 2006, MOL CELL, V24, P383, DOI 10.1016/j.molcel.2006.09.006; Heineke J, 2006, NAT REV MOL CELL BIO, V7, P589, DOI 10.1038/nrm1983; Hof P, 1998, CELL, V92, P441, DOI 10.1016/S0092-8674(00)80938-1; Keilhack H, 2005, J BIOL CHEM, V280, P30984, DOI 10.1074/jbc.M504699200; Kinderman FS, 2006, MOL CELL, V24, P397, DOI 10.1016/j.molcel.2006.09.015; Kontaridis MI, 2008, CIRCULATION, V117, P1423, DOI 10.1161/CIRCULATIONAHA.107.728865; Kontaridis MI, 2006, J BIOL CHEM, V281, P6785, DOI 10.1074/jbc.M513068200; Kratz CP, 2005, BLOOD, V106, P2183, DOI 10.1182/blood-2005-02-0531; Krenz M, 2008, P NATL ACAD SCI USA, V105, P18930, DOI 10.1073/pnas.0806556105; Mauban JRH, 2009, PHYSIOLOGY, V24, P78, DOI 10.1152/physiol.00041.2008; Nakamura T, 2007, J CLIN INVEST, V117, P2123, DOI 10.1172/JCI30756; Nakamura T, 2009, P NATL ACAD SCI USA, V106, P15436, DOI 10.1073/pnas.0903302106; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Pidoux G, 2010, J MOL ENDOCRINOL, V44, P271, DOI 10.1677/JME-10-0010; Rapacciuolo A, 2003, J BIOL CHEM, V278, P35403, DOI 10.1074/jbc.M305675200; Scott JD, 2009, SCIENCE, V326, P1220, DOI 10.1126/science.1175668; Stewart RA, 2010, DEV CELL, V18, P750, DOI [10.1016/j.devcel.2010.03.009, 10.1016/j.devce1.2010.03.009]; Storz P, 2004, MOL PHARMACOL, V66, P870, DOI 10.1124/mol.104.000687; Storz P, 2004, MOL CELL BIOL, V24, P2614, DOI 10.1128/MCB.24.7.2614-2626.2004; Wang L, 2015, CELL SIGNAL, V27, P908, DOI 10.1016/j.cellsig.2015.02.003; Welch EJ, 2010, MOL INTERV, V10, P86, DOI 10.1124/mi.10.2.6; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527	37	10	10	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2015	290	19					12058	12067		10.1074/jbc.M115.642983	http://dx.doi.org/10.1074/jbc.M115.642983			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH9XA	25802336	hybrid, Green Published			2022-12-26	WOS:000354388600021
J	Orita, M; Hayashida, N; Taira, Y; Fukushima, Y; Ide, J; Endo, Y; Kudo, T; Yamashita, S; Takamura, N				Orita, Makiko; Hayashida, Naomi; Taira, Yasuyuki; Fukushima, Yoshiko; Ide, Juichi; Endo, Yuuko; Kudo, Takashi; Yamashita, Shunichi; Takamura, Noboru			Measurement of Individual Doses of Radiation by Personal Dosimeter Is Important for the Return of Residents from Evacuation Order Areas after Nuclear Disaster	PLOS ONE			English	Article							FUKUSHIMA; VILLAGE	To confirm the availability of individual dose evaluation for the return of residents after the accident at the Fukushima Dai-ichi Nuclear Power Plant (FNPP), we evaluated individual doses of radiation as measured by personal dosimeters in residents who temporarily stayed in Evacuation Order Areas in Kawauchi village, which is partially located within a 20 km radius of the FNPP. We also compared individual doses with the external radiation doses estimated from the ambient dose rates and with doses estimated from the concentrations of radionuclides in the soil around each individual's house. Individual doses were significantly correlated with the ambient doses in front of the entrances to the houses (r = 0.90, p< 0.01), in the backyards (r = 0.41, p< 0.01) and in the nearby fields (r = 0.80, p< 0.01). The maximum cumulative ambient doses in the backyards and fields around the houses were 6.38 and 9.27 mSv/y, respectively. The maximum cumulative individual dose was 3.28 mSv/y, and the median and minimum doses were 1.35 and 0.71 mSv/y. The estimated external effective doses from concentrations of artificial radionuclides in soil samples ranged from 0.03 to 23.42 mSv/y. The individual doses were moderately correlated with external effective doses in the backyards (r = 0.38, p< 0.01) and in the fields (r = 0.36, p< 0.01); however, the individual doses were not significantly correlated with the external effective doses in front of the entrances (r = 0.01, p = 0.92). Our study confirmed that individual doses are low levels even in the evacuation order area in Kawauchi village, and external effective dose levels are certainly decreasing due to the decay of artificial radionuclides and the decontamination of contaminated soil. Long-term follow-up of individual doses as well as internal-exposure doses, environmental monitoring and reconstruction of infrastructure are needed so that residents may return to their hometowns after a nuclear disaster.	[Orita, Makiko; Hayashida, Naomi; Taira, Yasuyuki; Takamura, Noboru] Nagasaki Univ, Grad Sch Biomed Sci, Dept Global Hlth Med & Welf, Nagasaki 852, Japan; [Kudo, Takashi] Nagasaki Univ, Grad Sch Biomed Sci, Dept Radioisotope Med, Nagasaki 852, Japan; [Yamashita, Shunichi] Nagasaki Univ, Grad Sch Biomed Sci, Atom Bomb Dis Inst, Dept Disaster Med, Nagasaki 852, Japan; [Taira, Yasuyuki] Nagasaki Prefectural Off, Nagasaki, Japan; [Fukushima, Yoshiko] Hirosaki Univ, Grad Sch Hlth Sci, Dept Nursing, Hirosaki, Aomori, Japan; [Ide, Juichi; Endo, Yuuko] Kawauchi Municipal Govt, Fukushima, Japan	Nagasaki University; Nagasaki University; Nagasaki University; Hirosaki University	Takamura, N (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Global Hlth Med & Welf, Nagasaki 852, Japan.	takamura@nagasaki-u.ac.jp	Yamashita, Shunichi/GVS-9508-2022	Takamura, Noboru/0000-0002-5552-3234	Grants-in-Aid for Scientific Research [26305025, 15K00540] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Harada KH, 2014, P NATL ACAD SCI USA, V111, pE914, DOI 10.1073/pnas.1315684111; International Atomic Energy Agency, IAEATECDOC1162; International Commission on Radiological Protection, 2009, ANN ICRP, V39, DOI [10.1016/j.icrp.2009.09.008, DOI 10.1016/J.ICRP.2009.09.008]; Ministry of the Environment, OFF SIT DEC MEAS; Ministry of the Environment Government of Japan, OFF SIT DEC MEAS; Monzen S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101650; Nagataki S, 2013, RADIAT RES, V180, P439, DOI 10.1667/RR13351.1; Naito W, RAD PROT DO IN PRESS; Nuclear Emergency Response Headquarters of Japanese Government, ADD REP JAP GOV IAEA; Nuclear Emergency Response Headquarters of Japanese Government, REP JAP GOV IAEA MIN; Nuclear Regulation Authority, PRACT MEAS EV RET TH; Orita M, 2013, RADIAT PROT DOSIM, V156, P383, DOI 10.1093/rpd/nct082; Reconstruction agency, STAT FUK; Taira Y, 2014, ENVIRON SCI TECHNOL, V48, P4556, DOI 10.1021/es404534y; Taira Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045816; Tsubokura M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081909; United Nations Scientific Commission on the Effects of Atomic Radiation (UNSCEAR), UNSCEAR 2013 REP, VI; Yasumura S, 2012, J EPIDEMIOL, V22, P375, DOI 10.2188/jea.JE20120105; Yoshida K, 2012, RADIAT PROT DOSIM, V151, P144, DOI 10.1093/rpd/ncr466	19	21	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0121990	10.1371/journal.pone.0121990	http://dx.doi.org/10.1371/journal.pone.0121990			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25806523	Green Published, Green Submitted, gold			2022-12-26	WOS:000351880000195
J	Schulte, BM; Gielen, PR; Kers-Rebel, ED; Schreibelt, G; van Kuppeveld, FJM; Adema, GJ				Schulte, Barbara M.; Gielen, Paul R.; Kers-Rebel, Esther D.; Schreibelt, Gerty; van Kuppeveld, Frank J. M.; Adema, Gosse J.			Enterovirus-Infected beta-Cells Induce Distinct Response Patterns in BDCA1(+) and BDCA3(+) Human Dendritic Cells	PLOS ONE			English	Article							CD4(+) T-CELLS; ANTIGEN CROSS-PRESENTATION; IN-VIVO; IMMUNE-RESPONSES; ANTIVIRAL STATE; VIRUS-INFECTION; AUTOIMMUNITY; EXPRESSION; RECEPTOR; SUBSETS	Enteroviruses often cause mild disease, yet are also linked to development of autoimmune diabetes. Dendritic cells (DCs) shape both innate and adaptive immune responses, including anti-viral responses. How different human DC subsets shape anti-viral responses, whether they have complementary or overlapping functions and how this relates to autoimmune responses is largely unknown. We used enterovirus-infected beta-cells and freshly isolated human myeloid DC (mDC) subsets as a model for autoimmune type 1 diabetes. Our data show that both the BDCA1(+) and BDCA3(+) mDC subsets engulf mock-as well as virus-infected beta-cells, albeit BDCA1(+) mDCs are more efficient. Uptake of enterovirus-infected, but not mock-infected cells, activated both DC subsets as indicated by the induction of costimulatory molecules and secretion of type I and type III interferons. Both subsets produced similar amounts of interferon-alpha, yet the BDCA3(+) DC were superior in IFN-lambda. production. The BDCA1(+) mDCs more strongly upregulated PD-L1, and were superior in IL-12 and IL-10 production as compared to the BDCA3(+) DC. Despite lack of IL-12 production by the BDCA3+ DC, both BDCA1(+) and BDCA3(+) DCs activated T cells in allogeneic mixed lymphocyte reaction towards a Th1-type reactivity while suppressing Th2-associated cytokines.	[Schulte, Barbara M.; Gielen, Paul R.; Kers-Rebel, Esther D.; Schreibelt, Gerty; Adema, Gosse J.] Radboud Univ Nijmegen, Dept Tumor Immunol, Med Ctr, Radboud Inst Mol Life Sci, NL-6525 ED Nijmegen, Netherlands; [van Kuppeveld, Frank J. M.] Univ Utrecht, Fac Vet Med, Div Virol, Dept Infect Dis & Immunol, Utrecht, Netherlands	Radboud University Nijmegen; Utrecht University	Adema, GJ (corresponding author), Radboud Univ Nijmegen, Dept Tumor Immunol, Med Ctr, Radboud Inst Mol Life Sci, NL-6525 ED Nijmegen, Netherlands.	Gosse.Adema@radboudumc.nl	Adema, G.J./H-8007-2014; Schreibelt, Gerty/A-1260-2016; Kers-Rebel, Esther/F-2312-2016	Schreibelt, Gerty/0000-0002-0156-8365; van Kuppeveld, Frank/0000-0001-5800-749X	Juvenile Diabetes Research Foundation [24-2008-949]; Ruby grant from the Dutch Diabetes Research Foundation [2011.80.1427]	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Ruby grant from the Dutch Diabetes Research Foundation	This work was supported by grant 24-2008-949 from the Juvenile Diabetes Research Foundation (to GJA) and Ruby grant 2011.80.1427 from the Dutch Diabetes Research Foundation (to BMS and GJA). The funders had no role in conducting research and/or preparation of the article.	Allen JS, 2009, DIABETES, V58, P138, DOI 10.2337/db08-0964; Bachem A, 2010, J EXP MED, V207, P1273, DOI 10.1084/jem.20100348; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Craig ME, 2013, PEDIATR DIABETES, V14, P149, DOI 10.1111/pedi.12033; Crozat K, 2010, J EXP MED, V207, P1283, DOI 10.1084/jem.20100223; Dotta F, 2007, P NATL ACAD SCI USA, V104, P5115, DOI 10.1073/pnas.0700442104; Egli A, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/emi.2014.51; Poulin LF, 2010, J EXP MED, V207, P1261, DOI 10.1084/jem.20092618; Ganguly D, 2013, NAT REV IMMUNOL, V13, P566, DOI 10.1038/nri3477; Getts DR, 2013, IMMUNOL REV, V255, P197, DOI 10.1111/imr.12091; Hemont C, 2013, J LEUKOCYTE BIOL, V93, P599, DOI 10.1189/jlb.0912452; Hober D, 2010, NAT REV ENDOCRINOL, V6, P279, DOI 10.1038/nrendo.2010.27; Horwitz MS, 2004, CLIN IMMUNOL, V110, P134, DOI 10.1016/j.clim.2003.09.014; Igoe A, 2013, CURR OPIN RHEUMATOL, V25, P480, DOI 10.1097/BOR.0b013e32836200d2; Jongbloed SL, 2010, J EXP MED, V207, P1247, DOI 10.1084/jem.20092140; Jordan WJ, 2007, GENES IMMUN, V8, P254, DOI 10.1038/sj.gene.6364382; Kivity S, 2009, TRENDS IMMUNOL, V30, P409, DOI 10.1016/j.it.2009.05.005; Kramer M, 2008, J VIROL, V82, P2930, DOI 10.1128/JVI.02376-07; Kramer M, 2007, CELL MICROBIOL, V9, P1507, DOI 10.1111/j.1462-5822.2007.00888.x; Lauterbach H, 2010, J EXP MED, V207, P2703, DOI 10.1084/jem.20092720; Lind K, 2013, J VIROL, V87, P7646, DOI 10.1128/JVI.03431-12; Luber CA, 2010, IMMUNITY, V32, P279, DOI 10.1016/j.immuni.2010.01.013; Lucas S, 2003, P NATL ACAD SCI USA, V100, P15047, DOI 10.1073/pnas.2536517100; MacDonald KPA, 2002, BLOOD, V100, P4512, DOI 10.1182/blood-2001-11-0097; Maldonado-Lopez R, 1999, J EXP MED, V189, P587, DOI 10.1084/jem.189.3.587; Miyamoto S, 2012, CANCER RES, V72, P2609, DOI 10.1158/0008-5472.CAN-11-3185; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Munz C, 2009, NAT REV IMMUNOL, V9, P246, DOI 10.1038/nri2527; Nierkens S, 2013, TRENDS IMMUNOL, V34, P361, DOI 10.1016/j.it.2013.02.007; Padmos RC, 2008, DIABETES, V57, P2768, DOI 10.2337/db08-0496; Paulos CM, 2010, J CLIN INVEST, V120, P76, DOI 10.1172/JCI41811; Peng RH, 2003, ANN NY ACAD SCI, V1005, P222, DOI 10.1196/annals.1288.031; Pflanz S, 2002, IMMUNITY, V16, P779, DOI 10.1016/S1074-7613(02)00324-2; Piccotti JR, 1998, J IMMUNOL, V160, P1132; Richardson SJ, 2014, DIABETES, V63, P2203, DOI 10.2337/db14-0510; RICHARDSON SJ, 2009, DIABETOLOGIA; Roivainen M, 2006, INT J BIOCHEM CELL B, V38, P721, DOI 10.1016/j.biocel.2005.08.019; Sancho D, 2009, NATURE, V458, P899, DOI 10.1038/nature07750; Schreibelt G, 2012, BLOOD, V119, P2284, DOI 10.1182/blood-2011-08-373944; Schreibelt G, 2010, CANCER IMMUNOL IMMUN, V59, P1573, DOI 10.1007/s00262-010-0833-1; Schulte BM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062502; Schulte BM, 2010, DIABETES, V59, P1182, DOI 10.2337/db09-1071; Schulz O, 2005, NATURE, V433, P887, DOI 10.1038/nature03326; Segura E, 2012, J EXP MED, V209, P653, DOI 10.1084/jem.20111457; Soares H, 2007, J EXP MED, V204, P1095, DOI 10.1084/jem.20070176; Summers KL, 2006, CLIN IMMUNOL, V121, P81, DOI 10.1016/j.clim.2006.05.015; Summers KL, 2003, ANN NY ACAD SCI, V1005, P226, DOI 10.1196/annals.1288.032; Takeda A, 2003, J IMMUNOL, V170, P4886, DOI 10.4049/jimmunol.170.10.4886; Tel J, 2013, BLOOD, V121, P459, DOI 10.1182/blood-2012-06-435644; Vuckovic S, 2007, CLIN IMMUNOL, V123, P281, DOI 10.1016/j.clim.2007.03.002; Wang XW, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng154; Whitton JL, 2002, SPRINGER SEMIN IMMUN, V24, P201, DOI 10.1007/s00281-002-0100-4; Yeung WCG, 2012, DIABETES, V61, P1500, DOI 10.2337/db11-0264; Yeung WCG, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d35; Ylipaasto P, 2004, DIABETOLOGIA, V47, P225, DOI 10.1007/s00125-003-1297-z; Yu HR, 2005, EUR J IMMUNOL, V35, P3664, DOI 10.1002/eji.200526258	56	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0121670	10.1371/journal.pone.0121670	http://dx.doi.org/10.1371/journal.pone.0121670			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25806537	Green Published, gold, Green Submitted			2022-12-26	WOS:000351880000171
J	Baltazar, LM; Krausz, AE; Souza, ACO; Adler, BL; Landriscina, A; Musaev, T; Nosanchuk, JD; Friedman, AJ				Baltazar, Ludmila Matos; Krausz, Aimee E.; Souza, Ana Camila Oliveira; Adler, Brandon L.; Landriscina, Angelo; Musaev, Tagai; Nosanchuk, Joshua D.; Friedman, Adam J.			Trichophyton rubrum is Inhibited by Free and Nanoparticle Encapsulated Curcumin by Induction of Nitrosative Stress after Photodynamic Activation	PLOS ONE			English	Article							IN-VITRO ACTIVITY; NITRIC-OXIDE; BLUE-LIGHT; MURINE MODEL; SUSCEPTIBILITY; ONYCHOMYCOSIS; DERMATOPHYTES; CYCLODEXTRIN; MECHANISMS; RESISTANCE	Antimicrobial photodynamic inhibition (aPI) utilizes radical stress generated from the excitation of a photosensitizer (PS) with light to destroy pathogens. Its use against Trichophyton rubrum, a dermatophytic fungus with increasing incidence and resistance, has not been well characterized. Our aim was to evaluate the mechanism of action of aPI against Trichophyton rubrum using curcumin as the PS in both free and nanoparticle (curc-np) form. Nanocarriers stabilize curcumin and allow for enhanced solubility and PS delivery. Curcumin aPI, at optimal conditions of 10 mu g/mL of PS with 10 J/cm(2) of blue light (417 +/- 5 nm), completely inhibited fungal growth (p<0.0001) via induction of reactive oxygen (ROS) and nitrogen species (RNS), which was associated with fungal death by apoptosis. Interestingly, only scavengers of RNS impeded aPI efficacy, suggesting that curcumin acts potently via a nitrosative pathway. The curc-np induced greater NO center dot expression and enhanced apoptosis of fungal cells, highlighting curc-np aPI as a potential treatment for Trichophyton rubrum skin infections.	[Baltazar, Ludmila Matos; Souza, Ana Camila Oliveira; Nosanchuk, Joshua D.] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA; [Krausz, Aimee E.; Adler, Brandon L.; Landriscina, Angelo; Musaev, Tagai; Friedman, Adam J.] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Med, Div Dermatol, Bronx, NY 10467 USA; [Friedman, Adam J.] Albert Einstein Coll Med, Dept Physiol & Biophys, Bronx, NY 10467 USA; [Baltazar, Ludmila Matos; Nosanchuk, Joshua D.] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Med, Div Infect Dis, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine	Friedman, AJ (corresponding author), Montefiore Med Ctr, Albert Einstein Coll Med, Dept Med, Div Dermatol, Bronx, NY 10467 USA.	adfriedm@montefiore.org	Nosanchuk, Joshua/AAS-7801-2021; Souza, Ana Camila Oliveira/J-2061-2014; de Matos Baltazar, Ludmila/I-4323-2017	Souza, Ana Camila Oliveira/0000-0002-9639-1207; de Matos Baltazar, Ludmila/0000-0002-4255-3047; Friedman, Adam/0000-0001-8925-1620	Feldstein Medical Foundation; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Feldstein Medical Foundation; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was funded by the Feldstein Medical Foundation. LMB and ACOS were supported by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adimi P, 2013, IRAN J PHARM RES, V12, P537; Apisariyakul A, 1995, J ETHNOPHARMACOL, V49, P163, DOI 10.1016/0378-8741(95)01320-2; Araujo NC, 2013, LASER MED SCI, V30, P393; Baltazar LD, 2014, MED MYCOL, V52, P293, DOI 10.1093/mmy/myt011; Baltazar LD, 2013, J ANTIMICROB CHEMOTH, V68, P354, DOI 10.1093/jac/dks414; Bruzell EM, 2005, PHOTOCH PHOTOBIO SCI, V4, P523, DOI 10.1039/b503397g; Buytaert E, 2007, BBA-REV CANCER, V1776, P86, DOI 10.1016/j.bbcan.2007.07.001; Calzavara-Pinton P, 2012, PHOTOCHEM PHOTOBIOL, V88, P512, DOI 10.1111/j.1751-1097.2012.01107.x; Coelho LM, 2008, J ANTIMICROB CHEMOTH, V62, P758, DOI 10.1093/jac/dkn245; DAHL TA, 1989, ARCH MICROBIOL, V151, P183, DOI 10.1007/BF00414437; Dai TH, 2012, FRONT MICROBIOL, V3, DOI [10.3389/fmicb.2012.00120, 10.3389/fmicb.2012.00417]; DEGROOTE MA, 1995, CLIN INFECT DIS, V21, pS162, DOI 10.1093/clinids/21.Supplement_2.S162; Donnelly RF, 2008, MICROBIOL RES, V163, P1, DOI 10.1016/j.micres.2007.08.001; Dovigo LN, 2011, PHOTOCHEM PHOTOBIOL, V87, P895, DOI 10.1111/j.1751-1097.2011.00937.x; Dovigo LN, 2013, MED MYCOL, V51, P243, DOI 10.3109/13693786.2012.714081; Fang FC, 1997, J CLIN INVEST, V99, P2818, DOI 10.1172/JCI119473; Friedman AJ, 2008, NITRIC OXIDE-BIOL CH, V19, P12, DOI 10.1016/j.niox.2008.04.003; Ghelardi E, 2014, ANTIMICROB AGENTS CH, V58, P2825, DOI 10.1128/AAC.02382-13; Godley BF, 2005, J BIOL CHEM, V280, P21061, DOI 10.1074/jbc.M502194200; Gold Michael H, 2005, J Drugs Dermatol, V4, P64; Guimaraes AJ, 2009, INFECT IMMUN, V77, P1357, DOI 10.1128/IAI.01443-08; Gupta AK, 2000, EUR J DERMATOL, V10, P379; Hamblin MR, 2004, PHOTOCH PHOTOBIO SCI, V3, P436, DOI 10.1039/b311900a; Haukvik T, 2009, PHARMAZIE, V64, P666, DOI 10.1691/ph.2009.9130; Hegge AB, 2013, EUR J PHARM BIOPHARM, V83, P95, DOI 10.1016/j.ejpb.2012.09.011; Hegge AB, 2012, EUR J PHARM SCI, V47, P65, DOI 10.1016/j.ejps.2012.05.002; Hegge AB, 2012, J PHARM SCI-US, V101, P1524, DOI 10.1002/jps.23046; Hegge AB, 2011, J PHARM SCI-US, V100, P174, DOI 10.1002/jps.22263; Institute CaLS, 2008, REF METH BROTH DIL A; Kleinpenning MM, 2010, PHOTODERMATOL PHOTO, V26, P16, DOI 10.1111/j.1600-0781.2009.00474.x; Krausz AE, 2015, NANOMED-NANOTECHNOL, V11, P195, DOI 10.1016/j.nano.2014.09.004; Liebmann J, 2010, J INVEST DERMATOL, V130, P259, DOI 10.1038/jid.2009.194; Manzano-Gayosso P, 2008, GAC MED MEX, V144, P23; Martinez-Rossi NM, 2008, MYCOPATHOLOGIA, V166, P369, DOI 10.1007/s11046-008-9110-7; Moghadamtousi SZ, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/186864; Narayanan A, 2012, J BIOL CHEM, V287, P33198, DOI 10.1074/jbc.M112.356535; Perni S, 2011, PHOTOCH PHOTOBIO SCI, V10, P712, DOI 10.1039/c0pp00360c; Priyadarsini KI, 2009, J PHOTOCH PHOTOBIO C, V10, P81, DOI 10.1016/j.jphotochemrev.2009.05.001; Radi R, 2002, BIOL CHEM, V383, P401, DOI 10.1515/BC.2002.044; Rotta I, 2012, BRIT J DERMATOL, V166, P927, DOI 10.1111/j.1365-2133.2012.10815.x; Santos DA, 2006, MED MYCOL, V44, P357, DOI 10.1080/13693780500536893; Santos DA, 2006, J CLIN MICROBIOL, V44, P98, DOI 10.1128/JCM.44.1.98-101.2006; Schairer DO, 2012, VIRULENCE, V3, P271, DOI 10.4161/viru.20328; Sharma M, 2010, BIOSCIENCE REP, V30, P391, DOI 10.1042/BSR20090151; Shen L, 2005, CHEM PHYS LETT, V409, P300, DOI 10.1016/j.cplett.2005.05.023; Singh R, 2012, PHARMAZIE, V67, P131, DOI 10.1691/ph.2012.1097; Smijs TGM, 2011, PHOTOCHEM PHOTOBIOL, V87, P2, DOI 10.1111/j.1751-1097.2010.00848.x; TONNESEN HH, 1987, J PHARM SCI, V76, P371, DOI 10.1002/jps.2600760506; Vatansever F, 2013, FEMS MICROBIOL REV, V37, P955, DOI 10.1111/1574-6976.12026; Vena GA, 2012, NEW MICROBIOL, V35, P207; Vermout S, 2008, MYCOPATHOLOGIA, V166, P267, DOI 10.1007/s11046-008-9104-5; Wataha JC, 2004, DENT MATER, V20, P150, DOI 10.1016/S0109-5641(03)00086-1; Wikene KO, 2015, DRUG DEV IND PHARM, V41, P969, DOI 10.3109/03639045.2014.919315; Wuthi-udomlert M, 2000, Southeast Asian J Trop Med Public Health, V31 Suppl 1, P178	54	30	33	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0120179	10.1371/journal.pone.0120179	http://dx.doi.org/10.1371/journal.pone.0120179			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803281	Green Submitted, Green Published, gold			2022-12-26	WOS:000353889600063
J	Fransen, P; Van Hove, CE; Leloup, AJA; Martinet, W; De Meyer, GRY; Lemmens, K; Bult, H; Schrijvers, DM				Fransen, Paul; Van Hove, Cor E.; Leloup, Arthur J. A.; Martinet, Wim; De Meyer, Guido R. Y.; Lemmens, Katrien; Bult, Hidde; Schrijvers, Dorien M.			Dissecting out the Complex Ca2+-Mediated Phenylephrine-Induced Contractions of Mouse Aortic Segments	PLOS ONE			English	Article							VASCULAR SMOOTH-MUSCLE; NITRIC-OXIDE; CA2+ ENTRY; CYTOSOLIC CALCIUM; HYPERTENSIVE-RATS; CHANNELS; ARTERY; MECHANISMS; MYOCYTES; RABBIT	L-type Ca2+ channel (VGCC) mediated Ca2+ influx in vascular smooth muscle cells (VSMC) contributes to the functional properties of large arteries in arterial stiffening and central blood pressure regulation. How this influx relates to steady-state contractions elicited by alpha 1-adrenoreceptor stimulation and how it is modulated by small variations in resting membrane potential (V-m) of VSMC is not clear yet. Here, we show that alpha 1-adrenoreceptor stimulation of aortic segments of C57Bl6 mice with phenylephrine (PE) causes phasic and tonic contractions. By studying the relationship between Ca2+ mobilisation and isometric tension, it was found that the phasic contraction was due to intracellular Ca2+ release and the tonic contraction determined by Ca2+ influx. The latter component involves both Ca2+ influx via VGCC and via non-selective cation channels (NSCC). Influx via VGCC occurs only within the window voltage range of the channel. Modulation of this window Ca2+ influx by small variations of the VSMC Vm causes substantial effects on the contractile performance of aortic segments. The relative contribution of VGCC and NSCC to the contraction by alpha 1-adrenoceptor stimulation could be manipulated by increasing intracellular Ca2+ release from noncontractile sarcoplasmic reticulum Ca2+ stores. Results of this study point to a complex interactions between alpha 1-adrenoceptor-mediated VSMC contractile performance and Ca2+ release form contractile or non-contractile Ca2+ stores with concomitant Ca2+ influx. Given the importance of VGCC and their blockers in arterial stiffening and hypertension, they further point toward an additional role of NSCC (and NSCC blockers) herein.	[Fransen, Paul; Leloup, Arthur J. A.; Martinet, Wim; De Meyer, Guido R. Y.; Schrijvers, Dorien M.] Univ Antwerp, Dept Pharmaceut Sci, B-2020 Antwerp, Belgium; [Van Hove, Cor E.; Lemmens, Katrien; Bult, Hidde] Univ Antwerp, Dept Med & Hlth Sci, B-2020 Antwerp, Belgium	University of Antwerp; University of Antwerp	Fransen, P (corresponding author), Univ Antwerp, Dept Pharmaceut Sci, B-2020 Antwerp, Belgium.	paul.fransen@uantwerpen.be	Martinet, Wim/I-7375-2015; Fransen, Paul/AAP-4580-2020; De Meyer, Guido/R-8129-2016; Schrijvers, Dorien/I-7535-2013	Martinet, Wim/0000-0003-1967-9343; De Meyer, Guido/0000-0003-3848-8702; Schrijvers, Dorien/0000-0003-0826-4943	University of Antwerp	University of Antwerp	Research was funded by the University of Antwerp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe F, 1996, BRIT J PHARMACOL, V118, P1711, DOI 10.1111/j.1476-5381.1996.tb15596.x; Akata T, 2007, J ANESTH, V21, P220, DOI 10.1007/s00540-006-0487-5; Bannister RA, 2009, J GEN PHYSIOL, V133, P79, DOI 10.1085/jgp.200810105; Berra-Romani R, 2008, AM J PHYSIOL-CELL PH, V295, pC779, DOI 10.1152/ajpcell.00173.2008; Bratz IN, 2002, AM J PHYSIOL-HEART C, V282, pH1648, DOI 10.1152/ajpheart.00824.2001; CHEN XL, 1995, AM J PHYSIOL-HEART C, V268, pH74, DOI 10.1152/ajpheart.1995.268.1.H74; Clark JH, 2010, J BIOL CHEM, V285, P13542, DOI 10.1074/jbc.M110.101485; Curtis TM, 2001, J PHYSIOL-LONDON, V532, P609, DOI 10.1111/j.1469-7793.2001.0609e.x; Eckert RE, 2000, UROL RES, V28, P122, DOI 10.1007/s002400050149; Edwards G, 2004, PHARMACOL RES, V49, P535, DOI 10.1016/j.phrs.2003.11.013; Fanchaouy M, 2007, CELL CALCIUM, V41, P41, DOI 10.1016/j.ceca.2006.04.030; Olivera JF, 2010, J MUSCLE RES CELL M, V31, P127, DOI 10.1007/s10974-010-9216-7; FLEISCHMANN BK, 1994, P NATL ACAD SCI USA, V91, P11914, DOI 10.1073/pnas.91.25.11914; Fransen P., 2012, CURRENT BASIC PATHOL, P69; Fransen Paul, 2012, BMC Physiology, V12, P9, DOI 10.1186/1472-6793-12-9; GANITKEVICH VY, 1990, J PHYSIOL-LONDON, V426, P19, DOI 10.1113/jphysiol.1990.sp018125; Guibert C, 2008, PROG BIOPHYS MOL BIO, V98, P10, DOI 10.1016/j.pbiomolbio.2008.05.001; House SJ, 2008, PFLUG ARCH EUR J PHY, V456, P769, DOI 10.1007/s00424-008-0491-8; Isabelle M, 2012, J VASC RES, V49, P309, DOI 10.1159/000337470; Karaki H, 1997, PHARMACOL REV, V49, P157; MacrezLepretre N, 1997, J BIOL CHEM, V272, P5261, DOI 10.1074/jbc.272.8.5261; Michiels CF, 2014, EUR J PHARMACOL, V738, P170, DOI 10.1016/j.ejphar.2014.05.036; Ohya Y, 1998, HYPERTENSION, V31, P254, DOI 10.1161/01.HYP.31.1.254; Peppiatt CM, 2003, CELL CALCIUM, V34, P97, DOI 10.1016/S0143-4160(03)00026-5; Plane F, 1998, BRIT J PHARMACOL, V123, P1351, DOI 10.1038/sj.bjp.0701746; Quignard JF, 2000, EUR J PHARMACOL, V399, P9, DOI 10.1016/S0014-2999(00)00372-1; Richards GR, 2001, BRIT J PHARMACOL, V134, P1, DOI 10.1038/sj.bjp.0704256; Safar ME, 2010, CURR HYPERTENS REP, V12, P47, DOI 10.1007/s11906-009-0085-7; SCARBOROUGH NL, 1984, J PHARMACOL EXP THER, V231, P597; Shadwick RE, 1999, J EXP BIOL, V202, P3305; Sokolis DP, 2006, J BIOMECH, V39, P1651, DOI 10.1016/j.jbiomech.2005.05.003; Soucy KG, 2006, J APPL PHYSIOL, V101, P1751, DOI 10.1152/japplphysiol.00138.2006; Van Hove CE, 2009, BRIT J PHARMACOL, V158, P920, DOI 10.1111/j.1476-5381.2009.00396.x; Villalba N, 2007, AM J PHYSIOL-HEART C, V292, pH1157, DOI 10.1152/ajpheart.01034.2006; Wang YJ, 2008, CLIN EXP PHARMACOL P, V35, P1127, DOI 10.1111/j.1440-1681.2008.05018.x; Zulliger MA, 2004, AM J PHYSIOL-HEART C, V287, pH1335, DOI 10.1152/ajpheart.00094.2004	36	33	33	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0121634	10.1371/journal.pone.0121634	http://dx.doi.org/10.1371/journal.pone.0121634			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803863	Green Published, Green Submitted, gold			2022-12-26	WOS:000353889600166
J	Hasnain, J; Abbas, Z; Sajid, M				Hasnain, Jafar; Abbas, Zaheer; Sajid, Muhammad			Effects of Porosity and Mixed Convection on MHD Two Phase Fluid Flow in an Inclined Channel	PLOS ONE			English	Article							3RD GRADE FLUID; HEAT-TRANSFER; POROUS-MEDIUM; STEADY FLOW	The present study deals with the flow and heat transfer analysis of two immiscible fluids in an inclined channel embedded in a porous medium. The channel is divided in two phases such that a third grade fluid occupies the phase I and a viscous fluid occupies the phase II. Both viscous and third grade fluids are electrically conducting. A constant magnetic field is imposed perpendicular to the channel walls. The mathematical model is developed by using Darcy's and modified Darcy's laws for viscous and third grade fluids respectively. The transformed ordinary differential equations are solved numerically using a shooting method. The obtained results are presented graphically and influence of emerging parameters is discussed in detail.	[Hasnain, Jafar; Abbas, Zaheer] Islamia Univ Bahawalpur, Dept Math, Bahawalpur, Pakistan; [Sajid, Muhammad] PINSTECH, Div Theoret Phys, Islamabad, Pakistan	Islamia University of Bahawalpur; Pakistan Institute of Nuclear Science & Technology	Hasnain, J (corresponding author), Islamia Univ Bahawalpur, Dept Math, Bahawalpur, Pakistan.	jafar_hasnain14@yahoo.com	Sajid, Muhammad/G-2075-2015; Abbas, Zaheer/AAZ-4317-2021; Abbas, Zaheer/ABD-6378-2021; Abbas, Zaheer/AAZ-4295-2021	Abbas, Zaheer/0000-0002-1300-7098; Abbas, Zaheer/0000-0002-1300-7098	Higher Education of Pakistan (HEC)	Higher Education of Pakistan (HEC)(Higher Education Commission of Pakistan)	The author(s) received funding form Higher Education of Pakistan (HEC) for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas Z, 2014, THERMAL SCI IN PRESS; Ahmad F, 2009, COMMUN NONLINEAR SCI, V14, P2848, DOI 10.1016/j.cnsns.2008.09.029; Ariel PD, 2003, INT J ENG SCI, V41, P1267, DOI 10.1016/S0020-7225(02)00380-4; Aziz T, 2012, INT J NONLIN MECH, V47, P792, DOI 10.1016/j.ijnonlinmec.2012.04.002; Bear J., 1972, DYNAMICS FLUIDS PORO; Chamkha AJ, 2000, J FLUID ENG-T ASME, V122, P117, DOI 10.1115/1.483233; Chandrasekhar S, 1961, HYDROMAGNETIC HYDROD; Chauhan DS, 2012, J APPL SCI ENG, V15, P1; DUNN JE, 1995, INT J ENG SCI, V33, P689, DOI 10.1016/0020-7225(94)00078-X; FOSDICK RL, 1980, P ROY SOC LOND A MAT, V369, P351, DOI 10.1098/rspa.1980.0005; GREENKORN RA, 1981, AICHE J, V27, P529, DOI 10.1002/aic.690270402; Kumar JP, 2011, INT J NONLIN MECH, V46, P278, DOI 10.1016/j.ijnonlinmec.2010.09.008; LOHRASBI J, 1988, APPL SCI RES, V45, P53, DOI 10.1007/BF00384182; MAJHI SN, 1988, INT J ENG SCI, V26, P503, DOI 10.1016/0020-7225(88)90008-0; Malashetty MS, 1997, INT J MULTIPHAS FLOW, V23, P545, DOI 10.1016/S0301-9322(96)00068-7; MALASHETTY MS, 1992, INT J ENG SCI, V30, P371, DOI 10.1016/0020-7225(92)90082-R; Malashetty MS, 2001, HEAT MASS TRANSFER, V37, P259, DOI 10.1007/s002310000134; Malashetty MS, 1991, P NAT HEAT TRANSF C, V159, P171; NAKAYAMA A, 1988, WARME STOFFUBERTRAG, V23, P291, DOI 10.1007/BF01001055; PACKHAM BA, 1971, PROC CAMB PHILOS S-M, V69, P443, DOI 10.1017/S0305004100046880; RAJAGOPAL KR, 1980, ARCH MECH, V32, P867; Sajid M, 2008, COMPUT MATH APPL, V56, P1236, DOI 10.1016/j.camwa.2008.02.025; Sajid M, 2008, TRANSPORT POROUS MED, V71, P173, DOI 10.1007/s11242-007-9118-3; SHAIL R, 1973, INT J ENG SCI, V11, P1103, DOI 10.1016/0020-7225(73)90111-0; Singh AK, 2011, INT J HEAT MASS TRAN, V54, P1111, DOI 10.1016/j.ijheatmasstransfer.2010.11.011; Sivaraj R, 2012, APPL APPL MATH, V7, P99; Ullmann A., 2000, P INT S MULT FLOW TR, P112; Umavathi JC, 2009, NONLINEAR ANAL-MODEL, V14, P397, DOI 10.15388/NA.2009.14.3.14503; Umavathi JC, 1999, INT J NONLINEAR MECH, V34, P1037, DOI 10.1016/S0020-7462(98)00074-2; Umavathi JC, 2005, HEAT MASS TRANSFER, V42, P81, DOI 10.1007/s00231-004-0565-x; Vafai K, 1989, J HEAT TRANS-T ASME, V111, P1103, DOI 10.1115/1.3250779	31	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0119913	10.1371/journal.pone.0119913	http://dx.doi.org/10.1371/journal.pone.0119913			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803360	Green Published, Green Submitted, gold			2022-12-26	WOS:000353889600049
J	Kang, M; Jeong, CW; Ku, JH; Kwak, C; Kim, HH				Kang, Minyong; Jeong, Chang Wook; Ku, Ja Hyeon; Kwak, Choel; Kim, Hyeon Hoe			Hypertriglyceridemia Is a Potential Preoperative Predictor for Biochemical Recurrence after Radical Prostatectomy	PLOS ONE			English	Article							CANCER DEVELOPMENT; SERUM-CHOLESTEROL; HDL CHOLESTEROL; RISK; ASSOCIATION; PREVENTION; METABOLISM; NUTRITION; IMPACT	Objectives Many previous studies have suggested that the outcome of prostate cancer (PCa) may be closely related to abnormal lipid metabolism. Therefore, in this study, we evaluated the preoperative lipid profiles of patients with clinically localized prostate cancer (PCa) who underwent radical prostatectomy (RP), with particular emphasis on the relationship between these profiles and biochemical recurrence (BCR). Patients and Methods We evaluated 715 consecutive men with clinically localized PCa who underwent RP at our institution between January 2011 and December 2013. We defined hypertriglyceridemia as a fasting serum triglyceride (TG) level greater than 200 mg/dL. We used the Kaplan-Meier method to predict BCR-free survival and applied the log-rank test to determine the statistical significance between survival curves. Cox proportional hazard ratio (HR) models were used to identify the significant predictors of BCR according to clinicopathological variables. Results Of 663 patients who underwent RP for clinically localized PCa, 66 (10.0%) showed BCR during a median follow-up period of 21 months. Patients without BCR had higher levels of serum TG, and patients with hypertriglyceridemia were significantly more likely to achieve BCR-free survival in the Kaplan-Meier analysis (log-rank test, P = 0.009). In the multivariable analysis, the presence of hypertriglyceridemia (HR 0.22), pathologic Gleason score (>= 8; HR 2.85), pathologic T stage (>= pT3; HR 3.44), and a positive surgical margin (HR, 2.39) were still significant BCR predictors. Conclusions We found that preoperative hypertriglyceridemia was associated with a lower risk of BCR after RP in patients with clinically localized PCa. Our results could help to clarify the currently conflicting evidence on the relationship between serum lipid profiles, particularly the presence of hypertriglyceridemia, and the risk of BCR in PC a patients after surgery.	[Kang, Minyong; Jeong, Chang Wook; Ku, Ja Hyeon; Kwak, Choel; Kim, Hyeon Hoe] Seoul Natl Univ Hosp, Dept Urol, Seoul 110744, South Korea	Seoul National University (SNU); Seoul National University Hospital	Kim, HH (corresponding author), Seoul Natl Univ Hosp, Dept Urol, Seoul 110744, South Korea.	hhkim@snu.ac.kr	Ku, Ja Hyeon/E-6682-2016; Kang, Minyong/AAO-6484-2020					Allott EH, 2014, CANCER EPIDEM BIOMAR, V23, P2349, DOI 10.1158/1055-9965.EPI-14-0458; Chandra A, 2014, CURR ATHEROSCLER REP, V16, DOI 10.1007/s11883-013-0394-9; de Martino M, 2015, BJU INT, V115, P397, DOI 10.1111/bju.12767; Diffenderfer MR, 2014, CURR OPIN LIPIDOL, V25, P221, DOI 10.1097/MOL.0000000000000067; Gerber M, 2009, ANN NUTR METAB, V55, P140, DOI 10.1159/000229000; Griebling TL, 2012, J UROLOGY, V187, P1270, DOI 10.1016/j.juro.2011.12.086; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hayashi N, 2012, BJU INT, V109, P515, DOI 10.1111/j.1464-410X.2011.10358.x; His M, 2014, EUR J EPIDEMIOL, V29, P119, DOI 10.1007/s10654-014-9884-5; Jacobs EJ, 2012, CANCER CAUSE CONTROL, V23, P1289, DOI 10.1007/s10552-012-0006-y; Kitahara CM, 2011, J CLIN ONCOL, V29, P1592, DOI 10.1200/JCO.2010.31.5200; Ko K, 2013, BJU INT, V112, P775, DOI 10.1111/bju.12275; Kok DEG, 2011, PROSTATE CANCER P D, V14, P340, DOI 10.1038/pcan.2011.30; Kotani K, 2013, J EPIDEMIOL, V23, P313, DOI 10.2188/jea.JE20130006; Llaverias G, 2010, AM J PATHOL, V177, P3180, DOI 10.2353/ajpath.2010.100568; Magura L, 2008, CANCER CAUSE CONTROL, V19, P1259, DOI 10.1007/s10552-008-9197-7; Mondul AM, 2011, CANCER CAUSE CONTROL, V22, P1545, DOI 10.1007/s10552-011-9831-7; Mondul AM, 2010, CANCER CAUSE CONTROL, V21, P61, DOI 10.1007/s10552-009-9434-8; Okayama A, 2007, ASIAN PAC J CANCER P, V8, P199; Pelton K, 2012, CURR OPIN PHARMACOL, V12, P751, DOI 10.1016/j.coph.2012.07.006; Platz EA, 2008, INT J CANCER, V123, P1693, DOI 10.1002/ijc.23715; Platz EA, 2009, CANCER EPIDEM BIOMAR, V18, P2807, DOI 10.1158/1055-9965.EPI-09-0472; Solomon KR, 2011, UROL CLIN N AM, V38, P243, DOI 10.1016/j.ucl.2011.04.001; Tete S, 2012, INT J IMMUNOPATH PH, V25, P573, DOI 10.1177/039463201202500303; Zhuang LY, 2005, J CLIN INVEST, V115, P959	27	9	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0122438	10.1371/journal.pone.0122438	http://dx.doi.org/10.1371/journal.pone.0122438			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803284	Green Submitted, Green Published, gold			2022-12-26	WOS:000353889600196
J	Li, Z; Gabbard, JD; Johnson, S; Dlugolenski, D; Phan, S; Tompkins, SM; He, B				Li, Zhuo; Gabbard, Jon D.; Johnson, Scott; Dlugolenski, Daniel; Phan, Shannon; Tompkins, S. Mark; He, Biao			Efficacy of a Parainfluenza Virus 5 (PIV5)-Based H7N9 Vaccine in Mice and Guinea Pigs: Antibody Titer towards HA Was Not a Good Indicator for Protection	PLOS ONE			English	Article							INFLUENZA-A VIRUS; NEURAMINIDASE; IMMUNITY; HEMAGGLUTININ; TRANSMISSION; INFECTION; MODEL; SIMIAN-VIRUS-5; RESISTANCE; CHALLENGE	H7N9 has caused fatal infections in humans. A safe and effective vaccine is the best way to prevent large-scale outbreaks in the human population. Parainfluenza virus 5 (PIV5), an avirulent paramyxovirus, is a promising vaccine vector. In this work, we generated a recombinant PIV5 expressing the HA gene of H7N9 (PIV5-H7) and tested its efficacy against infection with influenza virus A/Anhui/1/2013 (H7N9) in mice and guinea pigs. PIV5-H7 protected the mice against lethal H7N9 challenge. Interestingly, the protection did not require antibody since PIV5-H7 protected JhD mice that do not produce antibody against lethal H7N9 challenge. Furthermore, transfer of anti-H7 serum did not protect mice against H7N9 challenge. PIV5-H7 generated high HAI titers in guinea pigs, however it did not protect against H7N9 infection or transmission. Intriguingly, immunization of guinea pigs with PIV5-H7 and PIV5 expressing NP of influenza A virus H5N1 (PIV5-NP) conferred protection against H7N9 infection and transmission. Thus, we have obtained a H7N9 vaccine that protected both mice and guinea pigs against lethal H7N9 challenge and infection respectively.	[Li, Zhuo; Gabbard, Jon D.; Johnson, Scott; Dlugolenski, Daniel; Phan, Shannon; Tompkins, S. Mark; He, Biao] Univ Georgia, Coll Vet Med, Dept Infect Dis, Athens, GA 30602 USA	University System of Georgia; University of Georgia	He, B (corresponding author), Univ Georgia, Coll Vet Med, Dept Infect Dis, Athens, GA 30602 USA.	bhe@uga.edu	Tompkins, Stephen/A-3317-2008	Tompkins, Stephen/0000-0002-1523-5588	University of Georgia College of Veterinary Medicine	University of Georgia College of Veterinary Medicine	This work was supported by internal funding from University of Georgia College of Veterinary Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], FIELDS VIROLOGY; Carragher DM, 2008, J IMMUNOL, V181, P4168, DOI 10.4049/jimmunol.181.6.4168; Chan OTM, 1999, J EXP MED, V189, P1639, DOI 10.1084/jem.189.10.1639; CHEN JZ, 1993, INT IMMUNOL, V5, P647, DOI 10.1093/intimm/5.6.647; Chen Z, 2012, PLOS ONE IN PRESS; Chen ZH, 2013, J VIROL, V87, P2986, DOI 10.1128/JVI.02886-12; Chen ZH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050144; COUCH RB, 1974, J INFECT DIS, V129, P411, DOI 10.1093/infdis/129.4.411; Couch RB, 2013, J INFECT DIS, V207, P974, DOI 10.1093/infdis/jis935; Couch RB, 2012, VACCINE, V31, P190, DOI 10.1016/j.vaccine.2012.10.065; Cox RJ, 2009, VACCINE, V27, P1889, DOI 10.1016/j.vaccine.2009.01.116; De Groot AS, 2014, HUMAN VACCINES IMMUN, V10; de Wit E, 2005, J VIROL, V79, P12401, DOI 10.1128/JVI.79.19.12401-12407.2005; Fouchier RAM, 2005, J VIROL, V79, P2814, DOI 10.1128/JVI.79.5.2814-2822.2005; Fries LF, 2013, NEW ENGL J MED, V369, P2564, DOI 10.1056/NEJMc1313186; Gabbard JD, 2014, J VIROL, V88, P1502, DOI 10.1128/JVI.02959-13; Hassantoufighi A, 2010, VACCINE, V28, P790, DOI 10.1016/j.vaccine.2009.10.066; He B, 2001, J VIROL, V75, P4068, DOI 10.1128/JVI.75.9.4068-4079.2001; Lamb R.A., 2001, FIELDS VIROLOGY; Li Q, 2014, NEW ENGL J MED, V370, P520, DOI 10.1056/NEJMoa1304617; Li ZQ, 2013, EUR MICROW INTEGRAT, P5; Li Z, 2013, J VIROL, V87, P354, DOI 10.1128/JVI.02321-12; Lowen AC, 2006, P NATL ACAD SCI USA, V103, P9988, DOI 10.1073/pnas.0604157103; Lowen AC, 2009, J VIROL, V83, P2803, DOI 10.1128/JVI.02424-08; Mooney AJ, 2013, J VIROL, V87, P363, DOI 10.1128/JVI.02330-12; MURPHY BR, 1972, NEW ENGL J MED, V286, P1329, DOI 10.1056/NEJM197206222862502; Phan SI, 2014, VACCINE, V32, P3050, DOI 10.1016/j.vaccine.2014.03.049; Poole E, 2002, VIROLOGY, V303, P33, DOI 10.1006/viro.2002.1737; SCHULMAN JL, 1968, J VIROL, V2, P778, DOI 10.1128/JVI.2.8.778-786.1968; Tompkins SM, 2007, VIROLOGY, V362, P139, DOI 10.1016/j.virol.2006.12.005; Tong SX, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003657; Tong SX, 2012, P NATL ACAD SCI USA, V109, P4269, DOI 10.1073/pnas.1116200109; Wan HQ, 2013, J VIROL, V87, P9290, DOI 10.1128/JVI.01203-13	33	12	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0120355	10.1371/journal.pone.0120355	http://dx.doi.org/10.1371/journal.pone.0120355			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803697	Green Published, gold, Green Submitted			2022-12-26	WOS:000353889600073
J	Liu, C; Huang, Y; Pang, M; Yang, Y; Li, SF; Liu, LS; Shu, T; Zhou, W; Wang, X; Rong, LM; Liu, B				Liu, Chang; Huang, Yong; Pang, Mao; Yang, Yang; Li, Shangfu; Liu, Linshan; Shu, Tao; Zhou, Wei; Wang, Xuan; Rong, Limin; Liu, Bin			Tissue-Engineered Regeneration of Completely Transected Spinal Cord Using Induced Neural Stem Cells and Gelatin-Electrospun Poly (Lactide-Co-Glycolide)/Polyethylene Glycol Scaffolds	PLOS ONE			English	Article							FUNCTIONAL RECOVERY; MOUSE FIBROBLASTS; INJURY; REPAIR; TRANSPLANTATION; NEUROGENESIS; STRATEGIES; GROWTH	Tissue engineering has brought new possibilities for the treatment of spinal cord injury. Two important components for tissue engineering of the spinal cord include a suitable cell source and scaffold. In our study, we investigated induced mouse embryonic fibroblasts (MEFs) directly reprogrammed into neural stem cells (iNSCs), as a cell source. Three-dimensional (3D) electrospun poly (lactide-co-glycolide)/polyethylene glycol (PLGA-PEG) nanofiber scaffolds were used for iNSCs adhesion and growth. Cell growth, survival and proliferation on the scaffolds were investigated. Scanning electron microcopy (SEM) and nuclei staining were used to assess cell growth on the scaffolds. Scaffolds with iNSCs were then transplanted into transected rat spinal cords. Two or 8 weeks following transplantation, immunofluorescence was performed to determine iNSC survival and differentiation within the scaffolds. Functional recovery was assessed using the Basso, Beattie, Bresnahan (BBB) Scale. Results indicated that iNSCs showed similar morphological features with wild-type neural stem cells (wt-NSCs), and expressed a variety of neural stem cell marker genes. Furthermore, iNSCs were shown to survive, with the ability to self-renew and undergo neural differentiation into neurons and glial cells within the 3D scaffolds in vivo. The iNSC-seeded scaffolds restored the continuity of the spinal cord and reduced cavity formation. Additionally, iNSC-seeded scaffolds contributed to functional recovery of the spinal cord. Therefore, PLGA-PEG scaffolds seeded with iNSCs may serve as promising supporting transplants for repairing spinal cord injury (SCI).	[Liu, Chang; Pang, Mao; Yang, Yang; Li, Shangfu; Shu, Tao; Zhou, Wei; Wang, Xuan; Rong, Limin; Liu, Bin] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Spine Surg, Guangzhou 510630, Guangdong, Peoples R China; [Huang, Yong] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Breast & Thyroid Surg, Guangzhou 510630, Guangdong, Peoples R China; [Liu, Linshan] Univ Calif Los Angeles, Dept Biochem, Los Angeles, CA 90095 USA	Sun Yat Sen University; Sun Yat Sen University; University of California System; University of California Los Angeles	Rong, LM (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 3, Dept Spine Surg, Guangzhou 510630, Guangdong, Peoples R China.	ronglm21@163.com; johnliu2001@sina.com	yang, yang/HGT-7999-2022; yang, yang/GVT-5210-2022; Lang, Ming/HIK-0758-2022	LIU, Chang/0000-0003-0597-6101; Rong, Limin/0000-0003-0373-7393	Natural Science Foundation of China [31170947, 31470949, 81472122]; Guangdong Natural Sciences Foundation of China [S2012020011099, S2013010016413]; Guangdong Science and Technology Planning Project of China [2012B060300008]; Guangzhou Science and Technology Planning Project of China [2013J4100062]; New Teachers' Fund for Doctor Stations of Ministry of Education of China [20100171120088]; China Postdoctoral Science Foundation [2014M552272]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Natural Sciences Foundation of China; Guangdong Science and Technology Planning Project of China; Guangzhou Science and Technology Planning Project of China; New Teachers' Fund for Doctor Stations of Ministry of Education of China; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by Natural Science Foundation of China (31170947) to LR, Natural Science Foundation of China (31470949) to BL, Natural Science Foundation of China (81472122) to LR, and Guangdong Natural Sciences Foundation of China (S2012020011099 and S2013010016413) to LR and BL. Additional funding was provided by Guangdong Science and Technology Planning Project of China (2012B060300008) to BL, Guangzhou Science and Technology Planning Project of China (2013J4100062) to BL, New Teachers' Fund for Doctor Stations of Ministry of Education of China (20100171120088) to BL, and China Postdoctoral Science Foundation (2014M552272) to TS. The funders had no role instudy design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arjmand B, 2014, STEM CELLS; Blits B, 2006, J NEUROTRAUM, V23, P508, DOI 10.1089/neu.2006.23.508; Bomstein Y, 2003, J NEUROIMMUNOL, V142, P10, DOI 10.1016/S0165-5728(03)00260-1; Bonfield W, 2006, PHILOS T R SOC A, V364, P227, DOI 10.1098/rsta.2005.1692; Chen SJ, 2010, J BIOMED MATER RES A, V93A, P1482, DOI 10.1002/jbm.a.32658; Elkabetz Y, 2008, COLD SH Q B, V73, P377, DOI 10.1101/sqb.2008.73.052; Evans NR, 2013, REGEN MED, V8, P49, DOI [10.2217/RME.12.106, 10.2217/rme.12.106]; Fabbro A, 2013, ADV DRUG DELIVER REV, V65, P2034, DOI 10.1016/j.addr.2013.07.002; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Ghasemi-Mobarakeh L, 2008, BIOMATERIALS, V29, P4532, DOI 10.1016/j.biomaterials.2008.08.007; Guest JD, 2005, EXP NEUROL, V192, P384, DOI 10.1016/j.expneurol.2004.11.033; Han DW, 2012, CELL STEM CELL, V10, P465, DOI 10.1016/j.stem.2012.02.021; He LM, 2013, CARBON, V56, P224, DOI 10.1016/j.carbon.2013.01.025; Houle JD, 2003, EXP NEUROL, V182, P247, DOI 10.1016/S0014-4886(03)00029-3; Ji WC, 2014, EXP THER MED, V7, P523, DOI 10.3892/etm.2013.1454; Jia YJ, 2014, NEUROSCI LETT, V573, P46, DOI 10.1016/j.neulet.2014.05.010; Kim J, 2011, P NATL ACAD SCI USA, V108, P7838, DOI 10.1073/pnas.1103113108; Lai BQ, 2014, STEM CELLS DEV, V23, P910, DOI 10.1089/scd.2013.0426; Lee TH, 2013, J EXERC REHABIL, V9, P230, DOI 10.12965/jer.130004; Li Y, 2014, STEM CELL REV; Lim SH, 2009, ADV DRUG DELIVER REV, V61, P1084, DOI 10.1016/j.addr.2009.07.011; Liu J, 2014, MACROMOL RAPID COMMU; Lu Y, 2012, NEUROSURGERY, V71, pN13, DOI 10.1227/01.neu.0000423041.74441.42; Lu JM, 2009, EXPERT REV MOL DIAGN, V9, P325, DOI 10.1586/ERM.09.15; Lujan E, 2012, P NATL ACAD SCI USA, V109, P2527, DOI 10.1073/pnas.1121003109; Luo J, 2004, J NEUROTRAUM, V21, P994, DOI 10.1089/0897715041651097; Mikami Y, 2004, J NEUROSCI RES, V76, P453, DOI 10.1002/jnr.20086; Ogawa Y, 2002, J NEUROSCI RES, V69, P925, DOI 10.1002/jnr.10341; Park BH, 2012, BONE, V51, P313, DOI 10.1016/j.bone.2012.05.019; Pearse DD, 2006, J NEUROTRAUM, V23, P438, DOI 10.1089/neu.2006.23.437; Philips MF, 2001, J NEUROSURG, V94, P765, DOI 10.3171/jns.2001.94.5.0765; Piltti KM, 2013, STEM CELL TRANSL MED, V2, P961, DOI 10.5966/sctm.2013-0064; Ramon-Cueto A, 2000, NEURON, V25, P425, DOI 10.1016/S0896-6273(00)80905-8; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Ring KL, 2012, CELL STEM CELL, V11, P100, DOI 10.1016/j.stem.2012.05.018; Salgado AJ, 2013, INT REV NEUROBIOL, V108, P1, DOI 10.1016/B978-0-12-410499-0.00001-0; Tavares I, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt210; Wang L, 2014, BRAIN RES; Wattendorf U, 2008, J PHARM SCI-US, V97, P4655, DOI 10.1002/jps.21350; Yang F, 2005, BIOMATERIALS, V26, P2603, DOI 10.1016/j.biomaterials.2004.06.051; Zhu T, 2014, NEUROSCI B	41	72	77	2	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0117709	10.1371/journal.pone.0117709	http://dx.doi.org/10.1371/journal.pone.0117709			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803031	Green Published, Green Submitted, gold			2022-12-26	WOS:000353889600006
J	Wadt, KAW; Aoude, LG; Krogh, L; Sunde, L; Bojesen, A; Gronskov, K; Wartacz, N; Ek, J; Tolstrup-Andersen, M; Klarskov-Andersen, M; Borg, A; Heegaard, S; Kiilgaard, JF; Hansen, TVO; Klein, K; Jonsson, G; Drzewiecki, KT; Duno, M; Hayward, NK; Gerdes, AM				Wadt, Karin A. W.; Aoude, Lauren G.; Krogh, Lotte; Sunde, Lone; Bojesen, Anders; Gronskov, Karen; Wartacz, Nine; Ek, Jakob; Tolstrup-Andersen, Morten; Klarskov-Andersen, Mette; Borg, Ake; Heegaard, Steffen; Kiilgaard, Jens F.; Hansen, Thomas V. O.; Klein, Kerenaftali; Jonsson, Goran; Drzewiecki, Krzysztof T.; Duno, Morten; Hayward, Nicholas K.; Gerdes, Anne-Marie			Molecular Characterization of Melanoma Cases in Denmark Suspected of Genetic Predisposition	PLOS ONE			English	Article							PANCREATIC-CANCER FAMILIES; GENOME-WIDE ASSOCIATION; POPULATION-BASED SAMPLE; MITF GERMLINE MUTATION; CUTANEOUS MELANOMA; CDKN2A MUTATIONS; UVEAL MELANOMA; MC1R VARIANTS; RISK-FACTORS; SUSCEPTIBILITY GENE	Both environmental and host factors influence risk of cutaneousmelanoma (CM), and worldwide, the incidence varies depending on constitutional determinants of skin type and pigmentation, latitude, and patterns of sun exposure. We performed genetic analysis of CDKN2A, CDK4, BAP1, MC1R, and MITFp.E318K in Danish high-risk melanoma cases and found CDKN2A germline mutations in 11.3% of CM families with three or more affected individuals, including four previously undescribed mutations. Rare mutations were also seen in CDK4 and BAP1, while MC1R variants were common, occurring at more than twice the frequency compared to Danish controls. The MITF p.E318K variant similarly occurred at an approximately three-fold higher frequency in melanoma cases than controls. To conclude, we propose that mutation screening of CDKN2A and CDK4 in Denmark should predominantly be performed in families with at least 3 cases of CM. In addition, we recommend that testing of BAP1 should not be conducted routinely in CM families but should be reserved for families with CM and uveal melanoma, or mesothelioma.	[Wadt, Karin A. W.; Gronskov, Karen; Wartacz, Nine; Ek, Jakob; Tolstrup-Andersen, Morten; Klarskov-Andersen, Mette; Duno, Morten; Gerdes, Anne-Marie] Univ Copenhagen Hosp, Dept Clin Genet, DK-2100 Copenhagen, Denmark; [Aoude, Lauren G.; Klein, Kerenaftali; Hayward, Nicholas K.] QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia; [Krogh, Lotte] Odense Univ Hosp, Dept Clin Genet, DK-5000 Odense, Denmark; [Sunde, Lone] Univ Hosp Arhus, Dept Clin Genet, Aarhus, Denmark; [Bojesen, Anders] Lillebaelt Hosp, Vejle Hosp, Dept Clin Genet, Vejle, Denmark; [Gronskov, Karen] Univ Copenhagen, Dept Cellular & Mol Med, Copenhagen, Denmark; [Borg, Ake; Jonsson, Goran] Lund Univ, Dept Oncol, Lund, Sweden; [Borg, Ake; Jonsson, Goran] Skane Univ Hosp, Lund, Sweden; [Heegaard, Steffen; Kiilgaard, Jens F.] Univ Copenhagen, Glostrup Hosp, Dept Ophthalmol, DK-1168 Copenhagen, Denmark; [Heegaard, Steffen] Univ Copenhagen, Eye Pathol Inst, Dept Neurosci & Pharmacol, Copenhagen, Denmark; [Hansen, Thomas V. O.] Copenhagen Univ Hosp, Rigshosp, Ctr Genom Med, Copenhagen, Denmark; [Drzewiecki, Krzysztof T.] Copenhagen Univ Hosp, Rigshosp, Dept Plast Surg Breast Surg & Burns, Copenhagen, Denmark	University of Copenhagen; QIMR Berghofer Medical Research Institute; University of Southern Denmark; Odense University Hospital; Aarhus University; University of Southern Denmark; Lillebaelt Hospital; University of Copenhagen; Lund University; Lund University; Skane University Hospital; University of Copenhagen; University of Copenhagen; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen	Wadt, KAW (corresponding author), Univ Copenhagen Hosp, Dept Clin Genet, DK-2100 Copenhagen, Denmark.	Karin.wadt@regionh.dk	Hansen, Thomas v. O./J-9361-2014; Bojesen, Anders B/G-6308-2010; Aoude, Lauren/C-7484-2014; hayward, nick/AAV-8802-2020; Hansen, Thomas/GWZ-2858-2022; Kiilgaard, Jens Folke/H-3943-2019; Sunde, Lone/AAG-7303-2019; hayward, nicholas k/C-1367-2015	Hansen, Thomas v. O./0000-0003-4635-2653; Aoude, Lauren/0000-0003-1448-3923; Kiilgaard, Jens Folke/0000-0003-1054-1460; Sunde, Lone/0000-0002-8479-165X; hayward, nicholas k/0000-0003-4760-1033; Bojesen, Anders/0000-0003-4289-8595; Gronskov, Karen/0000-0002-2341-1326; Gerdes, Anne-Marie/0000-0002-0328-3320	Nordic Cancer Union; Rigshospitalet; Fight for sight; Aase and Ejnar Danielsens Fund; Fonden til laegevidenskabens fremme; National Health and Medical Research Council of Australia; Australia and New Zealand Banking Group Limited Trustees	Nordic Cancer Union; Rigshospitalet; Fight for sight; Aase and Ejnar Danielsens Fund; Fonden til laegevidenskabens fremme; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australia and New Zealand Banking Group Limited Trustees	The Nordic Cancer Union provided funds to KW and GJ (http://www.ncu.nu/). Rigshospitalet funded KW with a PhD scholarship. Fight for sight funded KW (http://www.vos.dk/). Aase and Ejnar Danielsens Fund funded KW (http://www.danielsensfond.dk). Fonden til laegevidenskabens fremme funded KW (http://www.apmollerfonde.dk/). NH was supported by a fellowship from the National Health and Medical Research Council of Australia. LA was supported by a PhD scholarship from the Australia and New Zealand Banking Group Limited Trustees. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Rahman MH, 2011, MELANOMA RES, V21, P175, DOI 10.1097/CMR.0b013e328343eca2; Aitken J, 1999, JNCI-J NATL CANCER I, V91, P446, DOI 10.1093/jnci/91.5.446; Aitken JF, 1996, MELANOMA RES, V6, P313, DOI 10.1097/00008390-199608000-00006; Aoude L, 2014, JNCI-J NATL CANCER I, P107; Aoude LG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072144; Barrett JH, 2011, NAT GENET, V43, P1108, DOI 10.1038/ng.959; Begg CB, 2005, JNCI-J NATL CANCER I, V97, P1507, DOI 10.1093/jnci/dji312; Bertolotto C, 2011, NATURE, V480, P94, DOI 10.1038/nature10539; Bishop DT, 2002, J NATL CANCER I, V94, P894, DOI 10.1093/jnci/94.12.894; Box NF, 2001, AM J HUM GENET, V69, P765, DOI 10.1086/323412; BURCHILL SA, 1993, J ENDOCRINOL, V137, P189, DOI 10.1677/joe.0.1370189; Carbone M, 2013, NAT REV CANCER, V13, P153, DOI 10.1038/nrc3459; Christensen C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6348; Colantonio S, 2014, J AM ACAD DERMATOL, V70, P847, DOI 10.1016/j.jaad.2013.11.050; de Snoo FA, 2005, CANCER LETT, V230, P153, DOI 10.1016/j.canlet.2004.12.033; Djursby M, 2014, UGESKRIFT LAEGER, P176; Easton DF, 1997, AM J HUM GENET, V61, P120, DOI 10.1086/513891; Fallah M, 2014, EUR J CANCER, V50, P1176, DOI 10.1016/j.ejca.2013.12.023; Fargnoli MC, 2010, EUR J CANCER, V46, P1413, DOI 10.1016/j.ejca.2010.01.027; Gandini S, 2005, EUR J CANCER, V41, P2040, DOI 10.1016/j.ejca.2005.03.034; Gandini S, 2005, EUR J CANCER, V41, P45, DOI 10.1016/j.ejca.2004.10.016; Gandini S, 2005, EUR J CANCER, V41, P28, DOI 10.1016/j.ejca.2004.10.015; Garcia-Borron JC, 2014, PIGM CELL MELANOMA R, V27, P699, DOI 10.1111/pcmr.12257; Gerstenblith MR, 2010, PIGM CELL MELANOMA R, V23, P587, DOI 10.1111/j.1755-148X.2010.00730.x; Ghiorzo P, 2013, PIGM CELL MELANOMA R, V26, DOI 10.1111/pcmr.12047; Ghiorzo P, 2012, EXP DERMATOL, V21, P718, DOI 10.1111/j.1600-0625.2012.01549.x; Ghiorzo P, 2012, J MED GENET, V49, P164, DOI 10.1136/jmedgenet-2011-100281; Goldstein AM, 2007, J MED GENET, V44, P99, DOI 10.1136/jmg.2006.043802; Goldstein AM, 2004, HUM MUTAT, V23, P630, DOI 10.1002/humu.9247; Gromowski T, 2014, CANCER GENET-NY, V207, P128, DOI 10.1016/j.cancergen.2014.03.003; Gudbjartsson DF, 2008, NAT GENET, V40, P886, DOI 10.1038/ng.161; Harinck F, 2012, J MED GENET, V49, P362, DOI 10.1136/jmedgenet-2011-100563; Harland M, 2005, ONCOGENE, V24, P4604, DOI 10.1038/sj.onc.1208678; Helgadottir H, 2014, J MED GENET, V51, P545, DOI 10.1136/jmedgenet-2014-102320; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Horn S, 2013, SCIENCE, V339, P959, DOI 10.1126/science.1230062; Hu HH, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/925716; Kannengiesser C, 2003, GENE CHROMOSOME CANC, V38, P265, DOI 10.1002/gcc.10286; Lazovich D, 2010, CANCER EPIDEM BIOMAR, V19, P1557, DOI 10.1158/1055-9965.EPI-09-1249; Lohmueller KE, 2013, AM J HUM GENET, V93, P1072, DOI 10.1016/j.ajhg.2013.11.005; Lukowsky A, 2008, J DERMATOL SCI, V49, P163, DOI 10.1016/j.jdermsci.2007.08.006; McWilliams RR, 2011, EUR J HUM GENET, V19, P472, DOI 10.1038/ejhg.2010.198; Njauw CNJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035295; Panzella L, 2014, PIGM CELL MELANOMA R, V27, DOI 10.1111/pcmr.12199; Popova T, 2013, AM J HUM GENET, V92, P974, DOI 10.1016/j.ajhg.2013.04.012; Puntervoll HE, 2013, J MED GENET, V50, P264, DOI 10.1136/jmedgenet-2012-101455; Raimondi S, 2008, INT J CANCER, V122, P2753, DOI 10.1002/ijc.23396; Ribeiro C, 2013, ANN ONCOL, V24, P2147, DOI 10.1093/annonc/mdt135; Robles-Espinoza CD, 2014, NAT GENET, V46, P478, DOI 10.1038/ng.2947; Scaini MC, 2014, HUM MUTAT; Shekar SN, 2009, J INVEST DERMATOL, V129, P2211, DOI 10.1038/jid.2009.48; Shi JX, 2014, NAT GENET, V46, P482, DOI 10.1038/ng.2941; Sinilnikova OM, 1999, INT J CANCER, V82, P325; Slater EP, 2010, FAM CANCER, V9, P335, DOI 10.1007/s10689-010-9329-6; Sturm RA, 2003, ANN NY ACAD SCI, V994, P348, DOI 10.1111/j.1749-6632.2003.tb03199.x; Veinalde R, 2013, MELANOMA RES, V23, P221, DOI 10.1097/CMR.0b013e3283608695; Virgili G, 2007, OPHTHALMOLOGY, V114, P2309, DOI 10.1016/j.ophtha.2007.01.032; Vossen RHAM, 2009, HUM MUTAT, V30, P860, DOI 10.1002/humu.21019; Wadt K, 2012, PIGM CELL MELANOMA R, V25, P815, DOI 10.1111/pcmr.12006; Wadt KAW, 2014, CLIN GENET; Weis E, 2006, ARCH OPHTHALMOL-CHIC, V124, P54, DOI 10.1001/archopht.124.1.54; Wiesner T, 2011, NAT GENET, V43, P1018, DOI 10.1038/ng.910; Williams PF, 2011, INT J CANCER, V129, P1730, DOI 10.1002/ijc.25804; Yokoyama S, 2011, NATURE, V480, P99, DOI 10.1038/nature10630; Yonekawa Y, 2012, HEMATOL ONCOL CLIN N, V26, P1169, DOI 10.1016/j.hoc.2012.08.004; Zuo L, 1996, NAT GENET, V12, P97, DOI 10.1038/ng0196-97	66	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0122662	10.1371/journal.pone.0122662	http://dx.doi.org/10.1371/journal.pone.0122662			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803691	Green Published, Green Submitted, gold			2022-12-26	WOS:000353889600206
J	Cao, PR; Wang, L; Jiang, YC; Yi, YS; Qu, F; Liu, TC; Lv, Y				Cao, Peng-Rong; Wang, Lei; Jiang, Yu-Chao; Yi, Yin-Sha; Qu, Fang; Liu, Tao-Cheng; Lv, Yuan			De Novo Origin of VCY2 from Autosome to Y-Transposed Amplicon	PLOS ONE			English	Article							MALE-SPECIFIC REGION; DROSOPHILA-MELANOGASTER; CHROMOSOME EVOLUTION; SEX-CHROMOSOMES; GENE FAMILY; PROTEIN; IDENTIFICATION; ACCUMULATION; INVOLVEMENT; MECHANISMS	The formation of new genes is a primary driving force of evolution in all organisms. The de novo evolution of new genes from non-protein-coding genomic regions is emerging as an important additional mechanism for novel gene creation. Y chromosomes underlie sex determination in mammals and contain genes that are required for male-specific functions. In this study, a search was undertaken for Y chromosome de novo genes derived from non-protein-coding sequences. The Y chromosome orphan gene variable charge, Y-linked (VCY) 2, is an autosome-derived gene that has sequence similarity to large autosomal fragments but lacks an autosomal protein-coding homolog. VCY2 locates in the amplicon containing long DNA fragments that were transposed from autosomes to the Y chromosome before the ape-monkey split. We confirmed that VCY2cannot be encoded by autosomes due to the presence of multiple disablers that disrupt the open reading frame, such as the absence of start or stop codons and the presence of premature stop codons. Similar observations have been made for homologs in the autosomes of the chimpanzee, gorilla, rhesus macaque, baboon and out-group marmoset, which suggests that there was a non-protein-coding ancestral VCY2 that was common to apes and monkeys that predated the transposition event. Furthermore, while protein-coding orthologs are absent, a putative non-protein-coding VCY2 with conserved disablers was identified in the rhesus macaque Y chromosome male-specific region. This finding implies that VCY2 might have not acquired its protein-coding ability before the ape-monkey split. VCY2 encodes a testis-specific expressed protein and is involved in the pathologic process of male infertility, and the acquisition of this gene might improve male fertility. This is the first evidence that de novo genes can be generated from transposed autosomal non-protein-coding segments, and this evidence provides novel insights into the evolutionary history of the Y chromosome.	[Cao, Peng-Rong; Wang, Lei; Yi, Yin-Sha; Qu, Fang; Liu, Tao-Cheng; Lv, Yuan] Hunan Normal Univ, Coll Med, Dept Epidemiol, Changsha, Hunan, Peoples R China; [Jiang, Yu-Chao] Fudan Univ, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Jiang, Yu-Chao] Fudan Univ, Sch Life Sci, MOE Key Lab Contemporary Anthropol, Shanghai 200433, Peoples R China	Hunan Normal University; Fudan University; Fudan University	Lv, Y (corresponding author), Hunan Normal Univ, Coll Med, Dept Epidemiol, Changsha, Hunan, Peoples R China.	ly598598@126.com	Jiang, Yuchao/C-2691-2011; Jiang, Yuchao/AAE-3638-2022	Jiang, Yuchao/0000-0002-4465-0457; Jiang, Yuchao/0000-0002-4465-0457	National Natural Science Foundation of China [31170092]; Hunan Provincial Natural Science Foundation of China [13JJ2021]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hunan Provincial Natural Science Foundation of China(Natural Science Foundation of Hunan Province)	The authors greatly thank the support of National Natural Science Foundation of China (Grant No: 31170092) and Hunan Provincial Natural Science Foundation of China (Grant No: 13JJ2021).	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bachtrog D, 2013, NAT REV GENET, V14, P113, DOI 10.1038/nrg3366; Begun DJ, 2007, GENETICS, V176, P1131, DOI 10.1534/genetics.106.069245; Begun DJ, 2006, GENETICS, V172, P1675, DOI 10.1534/genetics.105.050336; Bhowmick BK, 2007, GENOME RES, V17, P441, DOI 10.1101/gr.5734907; Blaschke RJ, 2006, CURR OPIN GENET DEV, V16, P233, DOI 10.1016/j.gde.2006.04.004; Cai J, 2008, GENETICS, V179, P487, DOI 10.1534/genetics.107.084491; Carvunis AR, 2012, NATURE, V487, P370, DOI 10.1038/nature11184; Church DM, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000112; Cortez D, 2014, NATURE, V508, P488, DOI 10.1038/nature13151; Delbridge ML, 1999, REV REPROD, V4, P101, DOI 10.1530/ror.0.0040101; Dorus S, 2003, HUM MOL GENET, V12, P1643, DOI 10.1093/hmg/ddg185; Erlandsson R, 2000, MOL BIOL EVOL, V17, P804, DOI 10.1093/oxfordjournals.molbev.a026359; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; FergusonSmith MA, 1995, PHILOS T ROY SOC B, V350, P311; Ferlin A, 2005, J MED GENET, V42, P209, DOI 10.1136/jmg.2004.025833; Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196; Ginalski K, 2004, P NATL ACAD SCI USA, V101, P2305, DOI 10.1073/pnas.0306306101; Goto H, 2009, J MOL EVOL, V68, P134, DOI 10.1007/s00239-008-9189-y; Graves JAM, 2000, BIOL REPROD, V63, P667, DOI 10.1095/biolreprod63.3.667b; GRAVES JAM, 1995, BIOESSAYS, V17, P311, DOI 10.1002/bies.950170407; Graves JAM, 2006, CURR OPIN GENET DEV, V16, P219, DOI 10.1016/j.gde.2006.04.007; Graves Jennifer A. Marshall, 1995, Philosophical Transactions of the Royal Society of London B Biological Sciences, V350, P305, DOI 10.1098/rstb.1995.0166; Hellmann I, 2003, GENOME RES, V13, P831, DOI 10.1101/gr.944903; Hughes JF, 2012, NATURE, V483, P82, DOI 10.1038/nature10843; Hughes JF, 2010, NATURE, V463, P536, DOI 10.1038/nature08700; HURST LD, 1994, HEREDITY, V73, P223, DOI 10.1038/hdy.1994.127; Iwase M, 2003, P NATL ACAD SCI USA, V100, P5258, DOI 10.1073/pnas.0635848100; Junakovic N, 1998, J MOL EVOL, V46, P661, DOI 10.1007/PL00006346; Kaessmann H, 2010, GENOME RES, V20, P1313, DOI 10.1101/gr.101386.109; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kimura K, 2006, GENOME RES, V16, P55, DOI 10.1101/gr.4039406; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Knowles DG, 2009, GENOME RES, V19, P1752, DOI 10.1101/gr.095026.109; Lahn BT, 1997, SCIENCE, V278, P675, DOI 10.1126/science.278.5338.675; Lahn BT, 1999, NAT GENET, V21, P429, DOI 10.1038/7771; Lahn BT, 1999, SCIENCE, V286, P964, DOI 10.1126/science.286.5441.964; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Levine MT, 2006, P NATL ACAD SCI USA, V103, P9935, DOI 10.1073/pnas.0509809103; Li CY, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000734; Li D, 2010, CELL RES, V20, P408, DOI 10.1038/cr.2010.31; Long M, 2003, NAT REV GENET, V4, P865, DOI 10.1038/nrg1204; Mangs AH, 2007, CURR GENOMICS, V8, P129, DOI 10.2174/138920207780368141; Mazeyrat S, 1999, NAT GENET, V22, P224, DOI 10.1038/10282; Muffato M, 2010, BIOINFORMATICS, V26, P1119, DOI 10.1093/bioinformatics/btq079; Murphy DN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048650; Murphy WJ, 2006, PLOS GENET, V2, P353, DOI 10.1371/journal.pgen.0020043; Neme R, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-117; Pruitt KD, 2014, NUCLEIC ACIDS RES, V42, pD756, DOI 10.1093/nar/gkt1114; Reinhardt JA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003860; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Samonte RV, 2002, NAT REV GENET, V3, P65, DOI 10.1038/nrg705; Samusik N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056162; Saut N, 2000, MOL HUM REPROD, V6, P789, DOI 10.1093/molehr/6.9.789; Saxena R, 1996, NAT GENET, V14, P292, DOI 10.1038/ng1196-292; Sayres MAW, 2013, MOL BIOL EVOL, V30, P781, DOI 10.1093/molbev/mss267; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; States D J, 1994, J Comput Biol, V1, P39; Steinemann M, 2000, GENETICA, V109, P105, DOI 10.1023/A:1026584016524; Stuppia L, 2000, J ENDOCRINOL INVEST, V23, P659, DOI 10.1007/BF03343790; Stuppia L, 2005, GENOMICS, V85, P280, DOI 10.1016/j.ygeno.2004.10.015; Stuppia L, 2001, GENOMICS, V72, P153, DOI 10.1006/geno.2001.6450; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tatsumoto S, 2013, DNA RES, V20, P255, DOI 10.1093/dnares/dst007; Toll-Riera M, 2009, MOL BIOL EVOL, V26, P603, DOI 10.1093/molbev/msn281; Tse JYM, 2003, BIOL REPROD, V69, P746, DOI 10.1095/biolreprod.103.015792; Wissler L, 2013, GENOME BIOL EVOL, V5, P439, DOI 10.1093/gbe/evt009; Wong EYM, 2004, BIOL REPROD, V70, P775, DOI 10.1095/biolreprod.103.018531; Wong EYM, 2002, BIOCHEM BIOPH RES CO, V296, P1104, DOI 10.1016/S0006-291X(02)02040-5; Wu DD, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002379; Xiao WF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004603; Xie C, 2012, PLOS GENET, V8, DOI [10.1371/journal.pgen.1002942, DOI 10.1371/JOURNAL.PGEN.1002942]; Xie CY, 2014, NUCLEIC ACIDS RES, V42, pD98, DOI 10.1093/nar/gkt1222; Yang Yang, 2011, BMC Genomics, V12, P13, DOI 10.1186/1471-2164-12-13; Yang ZF, 2011, FEBS LETT, V585, P641, DOI 10.1016/j.febslet.2011.01.017; Yu YH, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-96; Zhang JH, 1997, GENOME RES, V7, P649, DOI 10.1101/gr.7.6.649; Zhao L, 2014, SCIENCE, V343, P769, DOI 10.1126/science.1248286; Zhou Q, 2008, GENOME RES, V18, P1446, DOI 10.1101/gr.076588.108	80	3	3	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0119651	10.1371/journal.pone.0119651	http://dx.doi.org/10.1371/journal.pone.0119651			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799347	Green Published, Green Submitted, gold			2022-12-26	WOS:000351987300068
J	Goeser, L; Fan, TJ; Tchaptchet, S; Stasulli, N; Goldman, WE; Sartor, RB; Hansen, JJ				Goeser, Laura; Fan, Ting-Jia; Tchaptchet, Sandrine; Stasulli, Nikolas; Goldman, William E.; Sartor, R. Balfour; Hansen, Jonathan J.			Small Heat-Shock Proteins, IbpAB, Protect Non-Pathogenic Escherichia coli from Killing by Macrophage-Derived Reactive Oxygen Species	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; CROHNS-DISEASE; COMMENSAL BACTERIA; PHAGOCYTE OXIDASE; OXIDATIVE STRESS; ILEAL MUCOSA; ADHERENT; EXPRESSION; SECRETION; GENES	Many intracellular bacterial pathogens possess virulence factors that prevent detection and killing by macrophages. However, similar virulence factors in non-pathogenic bacteria are less well-characterized and may contribute to the pathogenesis of chronic inflammatory conditions such as Crohn's disease. We hypothesize that the small heat shock proteins IbpAB, which have previously been shown to reduce oxidative damage to proteins in vitro and be upregulated in luminal non-pathogenic Escherichia strain NC101 during experimental colitis in vivo, protect commensal E. coli from killing by macrophage-derived reactive oxygen species (ROS). Using real-time PCR, we measured ibpAB expression in commensal E. coli NC101 within wild-type (wt) and ROS-deficient (gp91phox(-/-)) macrophages and in NC101 treated with the ROS generator paraquat. We also quantified survival of NC101 and isogenic mutants in wt and gp91phox(-/-) macrophages using gentamicin protection assays. Similar assays were performed using a pathogenic E. coli strain O157:H7. We show that non-pathogenic E. coli NC101inside macrophages upregulate ibpAB within 2 hrs of phagocytosis in a ROS-dependent manner and that ibpAB protect E. coli from killing by macrophage-derived ROS. Moreover, we demonstrate that ROS-induced ibpAB expression is mediated by the small E. coli regulatory RNA, oxyS. IbpAB are not upregulated in pathogenic E. coli O157:H7 and do not affect its survival within macrophages. Together, these findings indicate that ibpAB may be novel virulence factors for certain non-pathogenic E. coli strains.	[Goeser, Laura; Fan, Ting-Jia; Tchaptchet, Sandrine; Sartor, R. Balfour; Hansen, Jonathan J.] Univ N Carolina, Ctr Gastrointestinal Biol & Dis, Chapel Hill, NC 27515 USA; [Goeser, Laura; Fan, Ting-Jia; Tchaptchet, Sandrine; Sartor, R. Balfour; Hansen, Jonathan J.] Univ N Carolina, Dept Med, Div Gastroenterol & Hepatol, Chapel Hill, NC USA; [Fan, Ting-Jia; Stasulli, Nikolas; Goldman, William E.; Sartor, R. Balfour; Hansen, Jonathan J.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Hansen, JJ (corresponding author), Univ N Carolina, Ctr Gastrointestinal Biol & Dis, Chapel Hill, NC 27515 USA.	jjhansen@med.unc.edu		Stasulli, Nikolas/0000-0002-9419-2634; Goldman, William/0000-0002-1551-6718	National Institutes of Health [R01 DK53347, K08DK087896, R03 DK099419]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R03DK099419, K08DK087896, P30DK034987, R01DK053347] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010995] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding: This work was funded by grants from the National Institutes of Health, R01 DK53347 (R.B.S.), K08DK087896 (J.J.H.) and R03 DK099419 (J. J. H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altuvia S, 1997, CELL, V90, P43, DOI 10.1016/S0092-8674(00)80312-8; Barnich N, 2007, J CLIN INVEST, V117, P1566, DOI 10.1172/JCI30504; Bissonnette SA, 2010, MOL MICROBIOL, V75, P1539, DOI 10.1111/j.1365-2958.2010.07070.x; Boisen N, 2008, INFECT IMMUN, V76, P3281, DOI 10.1128/IAI.01646-07; Bringer MA, 2006, CELL MICROBIOL, V8, P471, DOI 10.1111/j.1462-5822.2005.00639.x; Bringer MA, 2005, INFECT IMMUN, V73, P712, DOI 10.1128/IAI.73.2.712-721.2005; Brown DE, 2013, VET PATHOL, V50, P867, DOI 10.1177/0300985813478213; CHUANG SE, 1993, GENE, V134, P1, DOI 10.1016/0378-1119(93)90167-2; Darfeuille-Michaud A, 2004, GASTROENTEROLOGY, V127, P412, DOI 10.1053/j.gastro.2004.04.061; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dubreuil JD, 2012, CURR ISSUES MOL BIOL, V14, P71; Etienne-Mesmin L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023594; Fang FC, 2004, NAT REV MICROBIOL, V2, P820, DOI 10.1038/nrmicro1004; Gaubig LC, 2011, MICROBIOL-SGM, V157, P66, DOI 10.1099/mic.0.043802-0; Hansen J, 2010, CURR OPIN GASTROEN, V26, P564, DOI 10.1097/MOG.0b013e32833f1195; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Keshavarzian A, 2003, GUT, V52, P720, DOI 10.1136/gut.52.5.720; KESHAVARZIAN A, 1992, GASTROENTEROLOGY, V103, P177, DOI 10.1016/0016-5085(92)91111-G; Kim SC, 2005, GASTROENTEROLOGY, V128, P891, DOI 10.1053/j.gastro.2005.02.009; Kitagawa M, 2000, FEMS MICROBIOL LETT, V184, P165, DOI 10.1111/j.1574-6968.2000.tb09009.x; Kitagawa M, 2002, EUR J BIOCHEM, V269, P2907, DOI 10.1046/j.1432-1033.2002.02958.x; Kuczynska-Wisnik D, 2002, MICROBIOL-SGM, V148, P1757, DOI 10.1099/00221287-148-6-1757; Kuczynska-Wisnik D, 2001, BIOCHEM BIOPH RES CO, V284, P57, DOI 10.1006/bbrc.2001.4926; Lee J, 2010, J APPL MICROBIOL, V108, P2088, DOI 10.1111/j.1365-2672.2009.04611.x; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Matuszewska E, 2008, MICROBIOL-SGM, V154, P1739, DOI 10.1099/mic.0.2007/014696-0; Patwa LG, 2011, GASTROENTEROLOGY, V141, P1842, DOI 10.1053/j.gastro.2011.06.064; Perez JFC, 2007, ARCH LATINOAM NUTR, V57, P211; Petruzziello-Pellegrini TN, 2013, VIRULENCE, V4, P556, DOI 10.4161/viru.26143; Poirier K, 2008, INFECT IMMUN, V76, P4814, DOI 10.1128/IAI.00446-08; Raymond B, 2013, TRENDS MICROBIOL, V21, P430, DOI 10.1016/j.tim.2013.06.008; Ruiz-Perez F, 2014, CELL MOL LIFE SCI, V71, P745, DOI 10.1007/s00018-013-1355-8; Shiloh MU, 1999, IMMUNITY, V10, P29, DOI 10.1016/S1074-7613(00)80004-7; Shimizu T, 2012, MOL MICROBIOL, V85, P492, DOI 10.1111/j.1365-2958.2012.08122.x; Smith AM, 2009, J EXP MED, V206, P1883, DOI 10.1084/jem.20091233; STANLEY ER, 1977, J BIOL CHEM, V252, P4305; Staudinger BJ, 2002, J CLIN INVEST, V110, P1151, DOI 10.1172/JCI200215268; Tjaden B, 2006, NUCLEIC ACIDS RES, V34, P2791, DOI 10.1093/nar/gkl356; VIDAL S, 1995, J EXP MED, V182, P655, DOI 10.1084/jem.182.3.655	39	10	11	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120249	10.1371/journal.pone.0120249	http://dx.doi.org/10.1371/journal.pone.0120249			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798870	Green Published, gold, Green Submitted			2022-12-26	WOS:000351987300114
J	Snowdon, CT; Ziegler, TE				Snowdon, Charles T.; Ziegler, Toni E.			Variation in Prolactin Is Related to Variation in Sexual Behavior and Contact Affiliation	PLOS ONE			English	Article							COTTON-TOP TAMARINS; PATERNAL RESPONSIVENESS; REPRODUCTIVE-BEHAVIOR; HORMONAL RESPONSES; SAGUINUS-OEDIPUS; CARE; TESTOSTERONE; FATHERHOOD; SECRETION; OXYTOCIN	Prolactin is associated with both maternal and paternal care and appears important in developing a bond between parent and infant. In contrast with oxytocin, another hormone important in infant care, there is scant information on the role of prolactin in maintaining adult heterosexual relationships. We present here the first results demonstrating a relationship between prolactin levels and sexual and contact affiliation behavior in a pair-bonded species. We studied cotton-top tamarins, a socially-monogamous, cooperatively-breeding primate. We measured chronic urinary prolactin levels over a four week period to include the entire female ovulatory cycle and correlated prolactin levels in males and females with simultaneous measures of contact affiliation and sexual behavior. Current mothers who were no longer nursing displayed lower amounts of sexual behavior and proximity than non-breeding females and also had marginally lower levels of prolactin. The prolactin levels of males and females were similar within pairs, and variation in prolactin levels for both sexes was explained both by the amount of sexual behavior and contact affiliation. The results parallel a previous study that compared oxytocin levels with sociosexual behavior in the same species, and supports the hypothesis that both prolactin and oxytocin are involved in pair-bonding as well as in infant care.	[Snowdon, Charles T.] Univ Wisconsin, Dept Psychol, Madison, WI 53706 USA; [Ziegler, Toni E.] Wisconsin Natl Primate Res Ctr, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison	Snowdon, CT (corresponding author), Univ Wisconsin, Dept Psychol, 1202 W Johnson St, Madison, WI 53706 USA.	snowdon@wisc.edu			United States Public Health Service National Institute of Health [MH035215, RR000167, P51OD011106]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000167] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH035215] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011106] Funding Source: NIH RePORTER	United States Public Health Service National Institute of Health(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	United States Public Health Service National Institute of Health MH035215 (CTS, TEZ, RR000167 (Wisconsin National Primate Research Center), P51OD011106 (Wisconsin National Primate Research Center). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almond REA, 2006, HORM BEHAV, V49, P673, DOI 10.1016/j.yhbeh.2005.12.009; Berridge KC, 2003, BRAIN COGNITION, V52, P106, DOI 10.1016/S0278-2626(03)00014-9; Berridge KC, 2003, TRENDS NEUROSCI, V26, P507, DOI 10.1016/S0166-2236(03)00233-9; Berridge KC, 2009, CURR OPIN PHARMACOL, V9, P65, DOI 10.1016/j.coph.2008.12.014; Bridges RS, 1996, ADV STUD BEHAV, V25, P215; Brooks PL, 2005, HORM BEHAV, V47, P358, DOI 10.1016/j.yhbeh.2004.10.003; Brown RE, 1995, HORM BEHAV, V29, P474, DOI 10.1006/hbeh.1995.1275; Buntin John D., 1996, Advances in the Study of Behavior, V25, P161; Carlson AA, 2006, HORM BEHAV, V50, P94, DOI 10.1016/j.yhbeh.2006.01.009; Carter CS, 1998, PSYCHONEUROENDOCRINO, V23, P779; DIXSON AF, 1982, NATURE, V299, P551, DOI 10.1038/299551a0; Donner N, 2009, NEUROENDOCRINOLOGY, V90, P315, DOI 10.1159/000225986; DRAGO F, 1981, PHARMACOL BIOCHEM BE, V15, P61, DOI 10.1016/0091-3057(81)90339-7; Drago F, 1998, ANN NY ACAD SCI, V525, P237; Egli M, 2010, REPRODUCTION, V140, P643, DOI 10.1530/REP-10-0033; Fitzgerald Peter, 2008, J Psychopharmacol, V22, P12, DOI 10.1177/0269216307087148; Fleming AS, 2002, HORM BEHAV, V42, P399, DOI 10.1006/hbeh.2002.1840; Gettler LT, 2012, AM J PHYS ANTHROPOL, V148, P362, DOI 10.1002/ajpa.22058; Ginther AJ, 2001, ANIM BEHAV, V61, P65, DOI 10.1006/anbe.2000.1587; Gordon I, 2010, HORM BEHAV, V58, P513, DOI 10.1016/j.yhbeh.2010.04.007; Gubernick DJ, 1989, HORM BEHAV, V29, P59; Khan MZ, 2001, HORM BEHAV, V40, P1, DOI 10.1006/hbeh.2001.1658; Kruger THC, 2002, NEUROSCI BIOBEHAV R, V26, P31, DOI 10.1016/S0149-7634(01)00036-7; Lazaro-Perea C, 2004, ANIM BEHAV, V67, P627, DOI 10.1016/j.anbehav.2003.06.004; Mota MTD, 2006, HORM BEHAV, V49, P293, DOI 10.1016/j.yhbeh.2005.07.012; Pi XJ, 1998, J COMP NEUROL, V394, P462, DOI 10.1002/(SICI)1096-9861(19980518)394:4<462::AID-CNE5>3.0.CO;2-#; Reburn CJ, 1999, HORM BEHAV, V35, P163, DOI 10.1006/hbeh.1998.1509; Roberts RL, 2001, PHYSIOL BEHAV, V72, P713, DOI 10.1016/S0031-9384(01)00430-9; Roberts RL, 2001, HORM BEHAV, V39, P106, DOI 10.1006/hbeh.2000.1639; Schoech SJ, 1996, ANIM BEHAV, V52, P445, DOI 10.1006/anbe.1996.0189; Schradin C, 2004, HORM BEHAV, V46, P670, DOI 10.1016/j.yhbeh.2004.04.010; Schradin C, 2003, J COMP PSYCHOL, V117, P166, DOI 10.1037/0735-7036.117.2.166; Schradin C, 2008, P ROY SOC B-BIOL SCI, V275, P1047, DOI 10.1098/rspb.2008.0004; Smith AS, 2010, HORM BEHAV, V57, P255, DOI 10.1016/j.yhbeh.2009.12.004; Snowdon C. T., 2007, J DEV PROCESSES, V2, P40; Snowdon CT, 2007, HANDBOOK OF PSYCHOPHYSIOLOGY, 3RD EDITION, P319, DOI 10.1017/CBO9780511546396.014; Snowdon CT, 2010, HORM BEHAV, V58, P614, DOI 10.1016/j.yhbeh.2010.06.014; Storey AE, 2000, EVOL HUM BEHAV, V21, P79, DOI 10.1016/S1090-5138(99)00042-2; Tietz N.W., 1976, FUNDAMENTALS CLIN CH; Toyoda F, 2005, GEN COMP ENDOCR, V141, P172, DOI 10.1016/j.ygcen.2004.12.015; Wolter MJ, 2012, J NEUROENDOCRINOL, V24, P413, DOI [10.1111/j.1365-2826.2011.02252.x, DOI 10.1111/J.1365-2826.2011.02252.X]; Wynne-Edwards KE, 2007, HORM BEHAV, V52, P114, DOI 10.1016/j.yhbeh.2007.03.018; Ziegler TE, 2004, HORM BEHAV, V45, P84, DOI 10.1016/j.yhbeh.2003.09.003; Ziegler TE, 1996, HORM BEHAV, V30, P287, DOI 10.1006/hbeh.1996.0035; Ziegler TE, 2009, HORM BEHAV, V56, P436, DOI 10.1016/j.yhbeh.2009.07.012	45	16	16	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120650	10.1371/journal.pone.0120650	http://dx.doi.org/10.1371/journal.pone.0120650			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799436	Green Published, Green Submitted, gold			2022-12-26	WOS:000351987300160
J	Wang, GX; van Driel, BJ; Liao, GX; O'Keeffe, MS; Halibozek, PJ; Flipse, J; Yigit, B; Azcutia, V; Luscinskas, FW; Wang, NH; Terhorst, C				Wang, Guoxing; van Driel, Boaz J.; Liao, Gongxian; O'Keeffe, Michael S.; Halibozek, Peter J.; Flipse, Jacky; Yigit, Burcu; Azcutia, Veronica; Luscinskas, Francis W.; Wang, Ninghai; Terhorst, Cox			Migration of Myeloid Cells during Inflammation Is Differentially Regulated by the Cell Surface Receptors Slamf1 and Slamf8	PLOS ONE			English	Article							SKIN DENDRITIC CELLS; NADPH OXIDASE; T-CELL; PROTEIN LIGAND; NOX2 ACTIVITY; CUTTING EDGE; FAMILY; ACTIVATION; EXPRESSION; RECRUITMENT	Previous studies have demonstrated that the cell surface receptor Slamf1 (CD150) is requisite for optimal NADPH-oxidase (Nox2) dependent reactive oxygen species (ROS) production by phagocytes in response to Gram-bacteria. By contrast, Slamf8 (CD353) is a negative regulator of ROS in response to Gram+ and Gram-bacteria. Employing in vivo migration after skin sensitization, induction of peritonitis, and repopulation of the small intestine demonstrates that in vivo migration of Slamf1(-/-) dendritic cells and macrophages is reduced, as compared to wt mice. By contrast, in vivo migration of Slamf8(-/-) dendritic cells, macrophages and neutrophils is accelerated. These opposing effects of Slamf1 and Slamf8 are cell-intrinsic as judged by in vitro migration in transwell chambers in response to CCL19, CCL21 or CSF-1. Importantly, inhibiting ROS production of Slamf8(-/-) macrophages by diphenyleneiodonium chloride blocks this in vitro migration. We conclude that Slamf1 and Slamf8 govern ROS-dependent innate immune responses of myeloid cells, thus modulating migration of these cells during inflammation in an opposing manner.	[Wang, Guoxing; van Driel, Boaz J.; Liao, Gongxian; O'Keeffe, Michael S.; Halibozek, Peter J.; Flipse, Jacky; Yigit, Burcu; Wang, Ninghai; Terhorst, Cox] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Med,Div Immunol, Boston, MA 02215 USA; [Azcutia, Veronica; Luscinskas, Francis W.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pathol,Ctr Excellence Vasc Biol, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Terhorst, C (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Med,Div Immunol, Boston, MA 02215 USA.	cterhors@bidmc.harvard.edu	Azcutia, Veronica/AAW-2443-2020; Azcutia, Veronica/A-7704-2017	Azcutia, Veronica/0000-0003-2160-5175; Azcutia, Veronica/0000-0003-2160-5175; Flipse, Jacky/0000-0002-2195-5282; Luscinskas, Francis/0000-0001-7100-4103	National Institutes of Health [AI-015066]; Dutch Digestive Foundation [10-04S]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI015066, P01AI065687, R56AI015066] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dutch Digestive Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health AI-015066 (nih.gov), and the Dutch Digestive Foundation #10-04S (mlds.nl) to Jacky Flipse. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acton SE, 2012, IMMUNITY, V37, P276, DOI 10.1016/j.immuni.2012.05.022; Anderson KE, 2008, BLOOD, V112, P5202, DOI 10.1182/blood-2008-04-149450; Azcutia V, 2013, MOL BIOL CELL, V24, P3358, DOI 10.1091/mbc.E13-01-0063; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Berger SB, 2010, NAT IMMUNOL, V11, P920, DOI 10.1038/ni.1931; Calpe S, 2008, ADV IMMUNOL, V97, P177, DOI 10.1016/S0065-2776(08)00004-7; Cannons JL, 2011, ANNU REV IMMUNOL, V29, P665, DOI 10.1146/annurev-immunol-030409-101302; Cao E, 2006, IMMUNITY, V25, P559, DOI 10.1016/j.immuni.2006.06.020; Chang SY, 2013, IMMUNITY, V38, P153, DOI 10.1016/j.immuni.2012.09.018; Chaubey S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054869; Comerford I, 2013, CYTOKINE GROWTH F R, V24, P269, DOI 10.1016/j.cytogfr.2013.03.001; Dong X, 2013, J CELL BIOCHEM, V114, P174, DOI 10.1002/jcb.24315; Hattori H, 2010, P NATL ACAD SCI USA, V107, P3546, DOI 10.1073/pnas.0914351107; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Kim SY, 2010, IMMUNOL CELL BIOL, V88, P197, DOI 10.1038/icb.2009.87; Kingsbury GA, 2001, J IMMUNOL, V166, P5675, DOI 10.4049/jimmunol.166.9.5675; Lam GY, 2010, SEMIN IMMUNOPATHOL, V32, P415, DOI 10.1007/s00281-010-0221-0; Lelli A, 2013, GLIA, V61, P1542, DOI 10.1002/glia.22540; Li QA, 2006, MOL CELL BIOL, V26, P140, DOI 10.1128/MCB.26.1.140-154.2006; Liao GX, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00035; Liao GX, 2014, FASEB J, V28, P474, DOI 10.1096/fj.13-236505; Longman RS, 2014, J EXP MED, V211, P1571, DOI 10.1084/jem.20140678; Ma CY, 2012, J BIOL CHEM, V287, P18359, DOI 10.1074/jbc.M112.367060; Malhotra D, 2013, IMMUNOL REV, V251, P160, DOI 10.1111/imr.12023; Malhotra D, 2012, NAT IMMUNOL, V13, P499, DOI 10.1038/ni.2262; Meng TC, 2002, MOL CELL, V9, P387, DOI 10.1016/S1097-2765(02)00445-8; Niess JH, 2010, GUT MICROBES, V1, P396, DOI 10.4161/gmic.1.6.13939; Niess JH, 2005, SCIENCE, V307, P254, DOI 10.1126/science.1102901; Noubade R, 2014, NATURE, V509, P235, DOI 10.1038/nature13152; Oyoshi MK, 2010, J ALLERGY CLIN IMMUN, V126, P976, DOI 10.1016/j.jaci.2010.08.041; Pasham V, 2012, AM J PHYSIOL-CELL PH, V303, pC416, DOI 10.1152/ajpcell.00420.2011; Romero X, 2005, J IMMUNOL, V174, P7033, DOI 10.4049/jimmunol.174.11.7033; Saeki H, 1999, J IMMUNOL, V162, P2472; Schroder K, 2014, ANTIOXID REDOX SIGN, V20, P2043, DOI 10.1089/ars.2013.5633; Sobierajska K, 2014, J BIOL CHEM, V289, P5758, DOI 10.1074/jbc.M113.479477; Stoitzner P, 2010, METHODS MOL BIOL, V595, P235, DOI 10.1007/978-1-60761-421-0_16; van Driel B, 2012, GASTROENTEROLOGY, V143, P1544, DOI 10.1053/j.gastro.2012.08.042; Veillette A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002469; Wang GX, 2012, J IMMUNOL, V188, P5829, DOI 10.4049/jimmunol.1102620; WANG JM, 1988, J IMMUNOL, V141, P575; Wang N, 2001, IMMUNOGENETICS, V53, P382, DOI 10.1007/s002510100337; Wang NH, 2004, J EXP MED, V199, P1255, DOI 10.1084/jem.20031835; Wang Y, 2012, ANTIOXID REDOX SIGN, V16, P649, DOI 10.1089/ars.2011.4313	43	23	24	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121968	10.1371/journal.pone.0121968	http://dx.doi.org/10.1371/journal.pone.0121968			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799045	Green Published, Green Submitted, gold			2022-12-26	WOS:000351987300305
J	Jhun, BW; Um, SW; Suh, GY; Chung, MP; Kim, H; Kwon, OJ; Lee, KS; Han, J; Kim, J				Jhun, Byung Woo; Um, Sang-Won; Suh, Gee Young; Chung, Man Pyo; Kim, Hojoong; Kwon, O. Jung; Lee, Kyung Soo; Han, Joungho; Kim, Jhingook			Preoperative Flexible Bronchoscopy in Patients with Persistent Ground-Glass Nodule	PLOS ONE			English	Article							THIN-SECTION CT; PULMONARY NODULES; LUNG-CANCER; BRONCHIOLOALVEOLAR CARCINOMA; FIBEROPTIC BRONCHOSCOPY; NATURAL-HISTORY; WORK-UP; OPACITY; ADENOCARCINOMA; GUIDELINES	There are no accurate data on the diagnostic value of preoperative flexible bronchoscopy (FB) for persistent ground-glass nodule (GGN) of the lung. We evaluated the value of preoperative FB in patients with suspected GGN-type lung cancer. We retrospectively searched a database for subjects who had 'ground-glass opacity', 'non-solid nodule', 'part-solid nodule', or 'sub-solid nodule' on chest computed tomography reports between February 2004 and March 2012. Patients who had infiltrative ground-glass opacity lesions, mediastinal lymphadenopathy, or pleural effusion, focal ground-glass opacity lesions >3 cm, and were lost to follow-up were excluded. We assessed the diagnostic value of preoperative FB in patients with persistent GGNs who underwent surgical resection. In total, 296 GGNs were evaluated by FB in 264 patients with persistent GGNs who underwent preoperative FB and surgical resection. The median size of the GGNs was 18 mm; 135 (46%) were pure GGN and 161 (54%) were part-solid GGN. No visible tumor or unsuspected endobronchial metastasis was identified by preoperative FB. Only 3 (1%, 3/208) GGNs were identified preoperatively as malignant by bronchial washing cytology; all were part-solid GGNs. No other etiology was identified by FB. Of the GGNs, 271 (91%) were subsequently confirmed as malignant and 25 (9%) were confirmed as benign at surgical resection. Consequently, the overall diagnostic sensitivity and negative predictive value of preoperative FB on a per-nodule basis was 1% (3/271) and 8% (25/293), respectively. The preoperative FB did not change the surgical strategy. Preoperative FB did not add much to the evaluation of persistent GGNs of the lung. Routine preoperative FB may have limited value in surgical candidates with small persistent pure GGNs.	[Jhun, Byung Woo; Um, Sang-Won; Suh, Gee Young; Chung, Man Pyo; Kim, Hojoong; Kwon, O. Jung] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med,Div Pulm & Crit Care Med, Seoul, South Korea; [Lee, Kyung Soo] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Radiol, Seoul, South Korea; [Lee, Kyung Soo] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Ctr Imaging Sci, Seoul, South Korea; [Han, Joungho] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pathol, Seoul, South Korea; [Kim, Jhingook] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Thorac & Cardiovasc Surg, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Um, SW (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med,Div Pulm & Crit Care Med, Seoul, South Korea.	sangwonum@skku.edu	Um, Sang Won/F-4610-2014; Suh, Gee Young/O-3676-2019	Suh, Gee Young/0000-0001-5473-1712	Samsung Medical Center	Samsung Medical Center(Samsung)	The authors received no specific funding for this work. Samsung Medical Center provided support in the form of salaries for authors BWJ, SWU, GYS, MPC, HK, OJK, KSL, JH, JK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. Samsung Medical Center is not-for profit organization. This does not alter our adherence to PLOS ONE policies on sharing data and materials.	Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Aoki T, 2001, RADIOLOGY, V220, P803, DOI 10.1148/radiol.2203001701; Asamura H, 2003, ANN THORAC SURG, V76, P1016, DOI 10.1016/S0003-4975(03)00835-X; Baaklini WA, 2000, CHEST, V117, P1049, DOI 10.1378/chest.117.4.1049; Breathnach OS, 2001, J THORAC CARDIOV SUR, V121, P42, DOI 10.1067/mtc.2001.110190; Chang B, 2013, CHEST, V143, P172, DOI 10.1378/chest.11-2501; CORTESE DA, 1979, CHEST, V75, P141, DOI 10.1378/chest.75.2.141; Fischbach F, 2003, EUR RADIOL, V13, P2378, DOI 10.1007/s00330-003-1915-7; GASPARINI S, 1995, CHEST, V108, P131, DOI 10.1378/chest.108.1.131; Godoy MCB, 2009, RADIOLOGY, V253, P606, DOI 10.1148/radiol.2533090179; Gould MK, 2013, CHEST, V143, pE93, DOI 10.1378/chest.12-2351; Hasegawa M, 2000, BRIT J RADIOL, V73, P1252, DOI 10.1259/bjr.73.876.11205667; Henschke CI, 2002, AM J ROENTGENOL, V178, P1053, DOI 10.2214/ajr.178.5.1781053; Infante M, 2009, EUR RESPIR J, V33, P821, DOI 10.1183/09031936.00047908; Jang HJ, 1996, RADIOLOGY, V199, P485, DOI 10.1148/radiology.199.2.8668800; Kishi K, 2004, LUNG CANCER, V44, P43, DOI 10.1016/j.lungcan.2003.09.024; Ko JP, 2005, J THORAC IMAG, V20, P196, DOI 10.1097/01.rti.0000171625.92574.8d; Kodama K, 2002, ANN THORAC SURG, V73, P386, DOI 10.1016/S0003-4975(01)03410-5; Lee HY, 2011, J THORAC IMAG, V26, P106, DOI 10.1097/RTI.0b013e3181fbaa64; MacMahon H, 2005, RADIOLOGY, V237, P395, DOI 10.1148/radiol.2372041887; Memoli JSW, 2012, CHEST, V142, P385, DOI 10.1378/chest.11-1764; Ost D, 2003, NEW ENGL J MED, V348, P2535, DOI 10.1056/NEJMcp012290; Rivera MP, 2007, CHEST, V132, p131S, DOI 10.1378/chest.07-1357; Schwarz C, 2013, EUR RESPIR J, V41, P177, DOI 10.1183/09031936.00018612; Suzuki K, 2000, ANN THORAC SURG, V69, P893, DOI 10.1016/S0003-4975(99)01331-4; Takamochi K, 2001, J THORAC CARDIOV SUR, V122, P325, DOI 10.1067/mtc.2001.114355; TORRINGTON KG, 1993, CHEST, V104, P1021, DOI 10.1378/chest.104.4.1021; Travis WD, 2011, J THORAC ONCOL, V6, P244, DOI 10.1097/JTO.0b013e318206a221; van't Westeinde SC, 2012, CHEST, V142, P377, DOI 10.1378/chest.11-2030	29	4	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0121250	10.1371/journal.pone.0121250	http://dx.doi.org/10.1371/journal.pone.0121250			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803430	Green Submitted, Green Published, gold			2022-12-26	WOS:000353889600141
J	Luo, YD; Regli, L; Bozinov, O; Sarnthein, J				Luo, Yeda; Regli, Luca; Bozinov, Oliver; Sarnthein, Johannes			Clinical Utility and Limitations of Intraoperative Monitoring of Visual Evoked Potentials	PLOS ONE			English	Article							OPTIC-NERVE FUNCTION; NITROUS-OXIDE; SURGERY; ANESTHESIA	Objectives During surgeries that put the visual pathway at risk of injury, continuous monitoring of the visual function is desirable. However, the intraoperative monitoring of the visual evoked potential (VEP) is not yet widely used. We evaluate here the clinical utility of intraoperative VEP monitoring. Methods We analyzed retrospectively 46 consecutive surgeries in 2011-2013. High luminance stimulating devices delivered flash stimuli on the closed eyelid during intravenous anesthesia. We monitored VEP features N75 and P100 and took patients' preoperative and postoperative visual function from patient charts. Postoperative ophthalmologic workup was performed in 25 (54%) patients and preoperatively in 28 (61%) patients. Results VEP recordings were feasible in 62 of 85 eyes (73%) in 46 patients. All 23 eyes without VEP had impaired vision. During surgery, VEPs remained stable throughout surgery in 50 eyes. In 44 of these, visual function did not deteriorate and three patients (6 eyes) developed hemianopia. VEP decreased transiently in 10 eyes and visual function of all was preserved. VEPs were lost permanently in 2 eyes in two patients without new postoperative visual impairment. Conclusions Satisfactory intraoperative VEP monitoring was feasible in all patients except in those with severe visual impairment. Preservation of VEPs predicted preserved visual function. During resection of lesions in the visual cortex, VEP monitoring could not detect new major visual field defects due to injury in the posterior visual pathway. Intraoperative VEPs were sensitive enough to detect vascular damage during aneurysm clipping and mechanical manipulation of the anterior visual pathway in an early reversible stage. Intraoperative VEP monitoring influenced surgical decisions in selected patients and proved to be a useful supplement to the toolbox of intraoperative neurophysiological monitoring.	[Luo, Yeda; Regli, Luca; Bozinov, Oliver; Sarnthein, Johannes] Univ Zurich Hosp, Dept Neurosurg, CH-8091 Zurich, Switzerland; [Sarnthein, Johannes] ETH, Zurich Neurosci Ctr, Zurich, Switzerland	University of Zurich; University Zurich Hospital; Swiss Federal Institutes of Technology Domain; ETH Zurich	Sarnthein, J (corresponding author), Univ Zurich Hosp, Dept Neurosurg, CH-8091 Zurich, Switzerland.	johannes.sarnthein@usz.ch	Sarnthein, Johannes/E-7959-2010	Sarnthein, Johannes/0000-0001-9141-381X; Bozinov, Oliver/0000-0002-4620-3992				CEDZICH C, 1988, ELECTROEN CLIN NEURO, V71, P142, DOI 10.1016/0168-5597(88)90072-X; CEDZICH C, 1987, NEUROSURGERY, V21, P709, DOI 10.1227/00006123-198711000-00018; CEDZICH C, 1990, INT ANESTHESIOL CLIN, V28, P165, DOI 10.1097/00004311-199002830-00006; Chacko AG, 1996, BRIT J NEUROSURG, V10, P275, DOI 10.1080/02688699650040133; CHI OZ, 1989, CAN J ANAESTH, V36, P637, DOI 10.1007/BF03005414; Chung SB, 2012, ACTA NEUROCHIR, V154, P1505, DOI 10.1007/s00701-012-1426-x; Cornaz F, 2015, CLIN NEUROPHYSIOL, V126, P218, DOI 10.1016/j.clinph.2014.04.018; DOMINO EF, 1963, ANESTH ANALG, V42, P735; FEINSOD M, 1976, J NEUROSURG, V44, P29, DOI 10.3171/jns.1976.44.1.0029; Goto T, 2007, J NEUROSURG, V107, P865, DOI 10.3171/JNS-07/10/0865; HARDING GFA, 1990, J NEUROL NEUROSUR PS, V53, P890, DOI 10.1136/jnnp.53.10.890; Jones NS, 1997, J LARYNGOL OTOL, V111, P513, DOI 10.1017/S0022215100137806; Kamada K, 2005, NEUROSURGERY, V57, P121, DOI 10.1227/01.NEU.0000163526.60240.B6; Kamio Y, 2014, NEUROL MED-CHIR, V54, P606, DOI 10.2176/nmc.oa.2014-0023; Kodama K, 2010, ACTA NEUROCHIR, V152, P643, DOI 10.1007/s00701-010-0600-2; RAUDZENS PA, 1982, ANN NY ACAD SCI, V388, P308, DOI 10.1111/j.1749-6632.1982.tb50799.x; Sasaki T, 2010, J NEUROSURG, V112, P273, DOI 10.3171/2008.9.JNS08451; SEBEL PS, 1984, BRIT J ANAESTH, V56, P1403, DOI 10.1093/bja/56.12.1403; Wang A D, 1985, Neurol Res, V7, P58; Wiedemayer H, 2004, EUR J ANAESTH, V21, P429, DOI 10.1017/S0265021504006039; Wiedemayer H, 2003, J NEUROSURG ANESTH, V15, P19, DOI 10.1097/00008506-200301000-00004; Wilson W B, 1976, Surg Neurol, V5, P323; WRIGHT JE, 1973, T OPHTHAL SOC UK, V93, P311	23	28	33	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0120525	10.1371/journal.pone.0120525	http://dx.doi.org/10.1371/journal.pone.0120525			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803287	Green Published, gold, Green Submitted			2022-12-26	WOS:000353889600077
J	Natalello, A; Relini, A; Penco, A; Halabelian, L; Bolognesi, M; Doglia, SM; Ricagno, S				Natalello, Antonino; Relini, Annalisa; Penco, Amanda; Halabelian, Levon; Bolognesi, Martino; Doglia, Silvia Maria; Ricagno, Stefano			Wild Type Beta-2 Microglobulin and DE Loop Mutants Display a Common Fibrillar Architecture	PLOS ONE			English	Article							INFRARED-SPECTROSCOPY; AMYLOID FORMATION; BETA(2)-MICROGLOBULIN; AGGREGATION; STABILITY; REFLECTION; INSIGHTS; REVEAL; LIPIDS	Beta-2 microglobulin (beta 2m) is the protein responsible for a pathologic condition known as dialysis related amyloidosis. In recent years an important role has been assigned to the peptide loop linking strands D and E (DE loop) in determining beta 2m stability and amyloid propensity. Several mutants of the DE loop have been studied, showing a good correlation between DE loop geometrical strain, protein stability and aggregation propensity. However, it remains unclear whether the aggregates formed by wild type (wt) beta 2m and by the DE loop variants are of the same kind, or whether the mutations open new aggregation pathways. In order to address this question, fibrillar samples of wt and mutated beta 2m variants have been analysed by means of atomic force microscopy and infrared spectroscopy. The data here reported indicate that the DE loop mutants form aggregates with morphology and structural organisation very similar to the wt protein. Therefore, the main effect of beta 2m DE loop mutations is proposed to stem from the different stabilities of the native fold. Considerations on the structural role of the DE loop in the free monomeric beta 2m and as part of the Major Histocompatibility Complex are also presented.	[Natalello, Antonino; Doglia, Silvia Maria] Univ Milano Bicocca, Dipartimento Fis G Occhialini, Milan, Italy; [Natalello, Antonino; Doglia, Silvia Maria] Univ Milano Bicocca, Dipartimento Biotecnol & Biosci, Milan, Italy; [Relini, Annalisa; Penco, Amanda] Univ Genoa, Dipartimento Fis, Genoa, Italy; [Halabelian, Levon; Bolognesi, Martino; Ricagno, Stefano] Univ Milan, Dipartimento Biosci, Milan, Italy; [Bolognesi, Martino] CIMAINA, Milan, Italy; [Bolognesi, Martino] Ist CNR Biofis, Milan, Italy	University of Milano-Bicocca; University of Milano-Bicocca; University of Genoa; University of Milan	Ricagno, S (corresponding author), Univ Milan, Dipartimento Biosci, Via Celoria 26, Milan, Italy.	stefano.ricagno@unimi.it	Bolognesi, Martino/B-7924-2017; Natalello, Antonino/B-9659-2012; Ricagno, Stefano/AAH-9763-2020; Relini, Annalisa/AHC-3105-2022; Ricagno, Stefano/G-1456-2015	Bolognesi, Martino/0000-0002-9253-5170; Natalello, Antonino/0000-0002-1489-272X; Ricagno, Stefano/0000-0001-6678-5873; Ricagno, Stefano/0000-0001-6678-5873; RELINI, ANNALISA/0000-0002-4040-9279	Italian Ministry of University and Research Project [FIRB RBFR109EOS]; Cariplo Foundation Milano (Italy) [2013-0964]; University of Genoa "Fondi di Ateneo"	Italian Ministry of University and Research Project; Cariplo Foundation Milano (Italy)(Fondazione Cariplo); University of Genoa "Fondi di Ateneo"	This work was supported by the Italian Ministry of University and Research Project FIRB RBFR109EOS, Cariplo Foundation Milano (Italy Project n 2013-0964) and the University of Genoa "Fondi di Ateneo". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ami D, 2012, BIOPHYS J, V102, P1676, DOI 10.1016/j.bpj.2012.02.045; Valdivia AA, 2013, BIOLOGICALS, V41, P104, DOI 10.1016/j.biologicals.2012.11.004; Barbet-Massin E, 2010, J AM CHEM SOC, V132, P5556, DOI 10.1021/ja1002839; Barth A, 2007, BBA-BIOENERGETICS, V1767, P1073, DOI 10.1016/j.bbabio.2007.06.004; Calabrese MF, 2008, NATURE STRUCTURAL MO; de Rosa M, 2014, FEBS J; Eakin CM, 2006, NAT STRUCT MOL BIOL, V13, P202, DOI 10.1038/nsmb1068; Esposito G, 2000, PROTEIN SCI, V9, P831, DOI 10.1110/ps.9.5.831; Esposito G, 2008, J MOL BIOL, V378, P887, DOI 10.1016/j.jmb.2008.03.002; Fabian H., 2012, PROTEIN FOLDING MISF, P53; Fabian H, 2008, BIOCHEMISTRY-US, V47, P6895, DOI 10.1021/bi800279y; Fabian H, 2013, BIOPHYS CHEM, V179, P35, DOI 10.1016/j.bpc.2013.05.001; Floege J, 2001, KIDNEY INT, V59, pS164, DOI 10.1046/j.1523-1755.2001.59780164.x; GEJYO F, 1985, BIOCHEM BIOPH RES CO, V129, P701, DOI 10.1016/0006-291X(85)91948-5; Gelain F, 2011, ACS NANO, V5, P1845, DOI 10.1021/nn102663a; Goormaghtigh E, 1999, BBA-REV BIOMEMBRANES, V1422, P105, DOI 10.1016/S0304-4157(99)00004-0; Halabelian L, 2014, J BIOL CHEM, V289, P3318, DOI 10.1074/jbc.M113.524157; Kardos J, 2005, BBA-PROTEINS PROTEOM, V1753, P108, DOI 10.1016/j.bbapap.2005.08.013; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; Merlini G, 2003, NEW ENGL J MED, V349, P583, DOI 10.1056/NEJMra023144; Myers SL, 2006, BIOCHEMISTRY-US, V45, P2311, DOI 10.1021/bi052434i; Natalello A, 2013, J MOL BIOL, V425, P1158, DOI 10.1016/j.jmb.2012.12.025; Natalello A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018789; Ohhashi Y, 2005, J BIOL CHEM, V280, P32843, DOI 10.1074/jbc.M506501200; OKON M, 1992, BIOCHEMISTRY-US, V31, P8906, DOI 10.1021/bi00152a030; Platt GW, 2008, J MOL BIOL, V378, P251, DOI 10.1016/j.jmb.2008.01.092; Porcelli SA, 1999, ANNU REV IMMUNOL, V17, P297, DOI 10.1146/annurev.immunol.17.1.297; Relini A, 2008, J BIOL CHEM, V283, P4912, DOI 10.1074/jbc.M702712200; Relini A, 2006, J BIOL CHEM, V281, P16521, DOI 10.1074/jbc.M513827200; Rennella E, 2010, J MOL BIOL, V401, P286, DOI 10.1016/j.jmb.2010.06.016; Ricagno S, 2008, BIOCHEM BIOPH RES CO, V377, P146, DOI 10.1016/j.bbrc.2008.09.108; Ricagno S, 2009, BIOCHEM BIOPH RES CO, V380, P543, DOI 10.1016/j.bbrc.2009.01.116; Santambrogio C, 2010, PROTEIN SCI, V19, P1386, DOI 10.1002/pro.419; Soldi G, 2008, J AM CHEM SOC, V130, P4295, DOI 10.1021/ja076628s; SUSI H, 1986, METHOD ENZYMOL, V130, P290; Valleix S, 2012, NEW ENGL J MED, V366, P2276, DOI 10.1056/NEJMoa1201356; Yamaguchi K, 2006, J MOL BIOL, V363, P279, DOI 10.1016/j.jmb.2006.08.030; Yamamoto S, 2004, J AM SOC NEPHROL, V15, P126, DOI 10.1097/01.ASN.0000103228.81623.C7	38	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0122449	10.1371/journal.pone.0122449	http://dx.doi.org/10.1371/journal.pone.0122449			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803608	Green Published, gold, Green Submitted			2022-12-26	WOS:000353889600198
J	Rancka, B; von Proschwitz, T; Hylander, K; Gotmark, F				Rancka, Birte; von Proschwitz, Ted; Hylander, Kristoffer; Gotmark, Frank			Conservation Thinning in Secondary Forest: Negative but Mild Effect on Land Molluscs in Closed-Canopy Mixed Oak Forest in Sweden	PLOS ONE			English	Article							SPECIES RICHNESS; WOODY DEBRIS; SNAILS; INDICATORS; RETENTION; COARSE; FUNGI	Secondary succession is changing the character of many temperate forests and often leads to closed-canopy stands. In such forests set aside for conservation, habitat management alternatives need to be tested experimentally, but this is rarely done. The Swedish Oak Project compares two often debated alternatives: minimal intervention and non-traditional active management (conservation thinning) on plots of each type replicated at 25 sites. We study responses of several taxa, and here report results for land molluscs. They are considered to be sensitive to more open, drier forest and we predicted a negative effect of the thinning (26% reduction of the basal area; mean value for 25 experimental forests). We sampled molluscs in the litter in ten 20 x 25 cm subplots, and by standardised visual search, in each plot. In total, we recorded 53 species of snails and slugs (24 369 individuals) and the mean species richness in plots was 17. Two seasons after thinning, mean (+/- SE) species richness had decreased by 1.4 (+/- 0.9) species in thinning plots, but increased by 0.7 (+/- 1.0) species in minimal intervention plots, a significant but small change with considerable variation among sites. In matched comparisons with minimal intervention, thinning reduced the overall abundance of molluscs. Most species responded negatively to thinning - but only five of the 53 species were significantly affected, and reproduction seemed to be negatively affected in only one species. An ordination analysis did not reveal any particular change in the species community due to thinning. Thus, the negative effect of conservation thinning on land molluscs was apparently mild - one reason was that many trees, shrubs and other forest structures remained after the treatment. Conservation thinning may be recommended, since other taxa are favoured, but minimal intervention is also a useful form of management for molluscs and saproxylic taxa.	[Rancka, Birte; Gotmark, Frank] Univ Gothenburg, Dept Biol & Environm Sci, Gothenburg, Sweden; [von Proschwitz, Ted] Museum Nat Hist, Gothenburg, Sweden; [Hylander, Kristoffer] Stockholm Univ, Dept Ecol Environm & Plant Sci, S-10691 Stockholm, Sweden	University of Gothenburg; Stockholm University	Gotmark, F (corresponding author), Univ Gothenburg, Dept Biol & Environm Sci, Gothenburg, Sweden.	frank.gotmark@gu.se						BAUR A, 1993, MALACOLOGIA, V35, P89; Belovsky GE, 2004, BIOSCIENCE, V54, P345, DOI 10.1641/0006-3568(2004)054[0345:TSTSTS]2.0.CO;2; Boch S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018770; Cameron RAD, 2005, J CONCHOL, V38, P529; Cameron RAD, 2004, J MOLLUS STUD, V70, P149, DOI 10.1093/mollus/70.2.149; CAMERON RAD, 1978, J CONCHOL, V29, P273; Cejka T, 2009, POL J ECOL, V57, P741; Chape S., 2009, BIOSCIENCE, V59, P623; Emberton KC, 1996, MALACOLOGIA, V38, P203; Falkner G, 2001, HELDIA, V4, P1; Foster D.R., 2000, FOREST HIST TODAY FA, P2; Franc N, 2008, BIOL CONSERV, V141, P2310, DOI 10.1016/j.biocon.2008.06.023; Gardenfors Ulf, 1995, Ecological Bulletins, V44, P259; Gotmark F, 2005, FOREST ECOL MANAG, V214, P124, DOI 10.1016/j.foreco.2005.03.052; Gotmark F, 2008, J BIOGEOGR, V35, P1062, DOI 10.1111/j.1365-2699.2008.01882.x; Gotmark F, 2007, BIOL CONSERV, V140, P349, DOI 10.1016/j.biocon.2007.08.018; Gotmark F, 2013, FOREST ECOL MANAG, V306, P292, DOI 10.1016/j.foreco.2013.06.014; GRAVELAND J, 1994, NATURE, V368, P446, DOI 10.1038/368446a0; Hylander K, 2004, CONSERV BIOL, V18, P1052, DOI 10.1111/j.1523-1739.2004.00199.x; Hylander K, 2011, FOREST ECOL MANAG, V261, P1811, DOI 10.1016/j.foreco.2011.02.003; Kerney M.P., 1979, FIELD GUIDE LAND SNA; MASON CF, 1970, OECOLOGIA, V5, P215, DOI 10.1007/BF00344885; Muller J, 2005, EUR J FOREST RES, V124, P233, DOI 10.1007/s10342-005-0071-9; Norden B, 2004, BIOL CONSERV, V117, P1, DOI 10.1016/S0006-3207(03)00235-0; Norden B, 2008, CAN J FOREST RES, V38, P1807, DOI 10.1139/X08-031; Okland B, 2008, BIODIVERS CONSERV, V17, P2599, DOI 10.1007/s10531-008-9325-4; Paltto H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024675; R Development Core Team, 2014, R LANG ENV STAT COMP; Ranius T, 2000, BIOL CONSERV, V95, P85, DOI 10.1016/S0006-3207(00)00007-0; Schmitt CB, 2009, BIOL CONSERV, V142, P2122, DOI 10.1016/j.biocon.2009.04.012; Sitzia T, 2010, FOREST ECOL MANAG, V259, P1354, DOI 10.1016/j.foreco.2010.01.048; Strom L, 2009, BIOL CONSERV, V142, P1580, DOI 10.1016/j.biocon.2009.02.028; Timonen J, 2010, SCAND J FOREST RES, V25, P309, DOI 10.1080/02827581.2010.497160; UNEP, 2010, CONV BIOL DIV NAG JA; Uys C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009100; VALOVIRTA I, 1996, LAND MOLLUSC MONITOR; von Proschwitz T, 1998, LANDLEVANDE MOLLUSKE, V22, P113; Walden HW, 1998, STUDIER SKOGSBRUKSAT; WAREBORN I, 1970, OIKOS, V21, P285, DOI 10.2307/3543685	39	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0120085	10.1371/journal.pone.0120085	http://dx.doi.org/10.1371/journal.pone.0120085			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803452	gold, Green Published, Green Submitted			2022-12-26	WOS:000353889600057
J	Azroyan, A; Cortez-Retamozo, V; Bouley, R; Liberman, R; Ruan, YC; Kiselev, E; Jacobson, KA; Pittet, MJ; Brown, D; Breton, S				Azroyan, Anie; Cortez-Retamozo, Virna; Bouley, Richard; Liberman, Rachel; Ruan, Ye Chun; Kiselev, Evgeny; Jacobson, Kenneth A.; Pittet, Mikael J.; Brown, Dennis; Breton, Sylvie			Renal Intercalated Cells Sense and Mediate Inflammation via the P2Y(14) Receptor	PLOS ONE			English	Article							VACUOLAR H+-ATPASE; LYSOPHOSPHATIDIC ACID RECEPTOR; PROTEIN-COUPLED RECEPTOR; EPIDIDYMAL CLEAR CELLS; DUCT EPITHELIAL-CELLS; V-ATPASE; COLLECTING DUCT; UDP-GLUCOSE; RAT-KIDNEY; FUNCTIONAL EXPRESSION	Uncontrolled inflammation is one of the leading causes of kidney failure. Pro-inflammatory responses can occur in the absence of infection, a process called sterile inflammation. Here we show that the purinergic receptor P2Y(14) (GPR105) is specifically and highly expressed in collecting duct intercalated cells (ICs) and mediates sterile inflammation in the kidney. P2Y(14) is activated by UDP-glucose, a damage-associated molecular pattern molecule (DAMP) released by injured cells. We found that UDP-glucose increases pro-inflammatory chemokine expression in ICs as well as MDCK-C11 cells, and UDP-glucose activates the MEK1/2-ERK1/2 pathway in MDCK-C11 cells. These effects were prevented following inhibition of P2Y(14) with the small molecule PPTN. Tail vein injection of mice with UDP-glucose induced the recruitment of neutrophils to the renal medulla. This study identifies ICs as novel sensors, mediators and effectors of inflammation in the kidney via P2Y(14).	[Azroyan, Anie; Cortez-Retamozo, Virna; Bouley, Richard; Liberman, Rachel; Ruan, Ye Chun; Pittet, Mikael J.; Brown, Dennis; Breton, Sylvie] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Syst Biol, Boston, MA 02114 USA; [Azroyan, Anie; Bouley, Richard; Liberman, Rachel; Ruan, Ye Chun; Brown, Dennis; Breton, Sylvie] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Program Membrane Biol,Nephrol Div, Boston, MA USA; [Kiselev, Evgeny; Jacobson, Kenneth A.] NIDDK, Bioorgan Chem Lab, NIH, Bethesda, MD 20892 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Breton, S (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Syst Biol, Boston, MA 02114 USA.	Breton.Sylvie@MGH.Harvard.edu	Pittet, Mikael/ABD-6300-2021; Jacobson, Kenneth Alan/A-1530-2009; Ruan, Ye Chun/T-7531-2019; RUAN, Ye Chun/T-5919-2017	Jacobson, Kenneth Alan/0000-0001-8104-1493; Ruan, Ye Chun/0000-0002-4266-6789; RUAN, Ye Chun/0000-0002-4266-6789	NIH [HD040793, DK097124, DK042956]; Boston Area Diabetes and Endocrinology Research Center [DK57521]; Center for the Study of Inflammatory Bowel Disease [DK43351]; Charles and Ann Sanders Research Scholar Award at MGH; Intramural Research Program of the NIH, NIDDK; PRAT Program, NIGMS; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD040793] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK097124, ZIADK031116, P30DK043351, R37DK042956, R01DK042956, P30DK057521] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Boston Area Diabetes and Endocrinology Research Center; Center for the Study of Inflammatory Bowel Disease; Charles and Ann Sanders Research Scholar Award at MGH; Intramural Research Program of the NIH, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); PRAT Program, NIGMS; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH grants HD040793 and DK097124 (to S.B.) and NIH grant DK042956 (to D.B.). The Microscopy Core facility of the MGH Program in Membrane Biology receives support from the Boston Area Diabetes and Endocrinology Research Center (DK57521) and the Center for the Study of Inflammatory Bowel Disease (DK43351). S.B. is a recipient of the Charles and Ann Sanders Research Scholar Award at MGH. K.A.J. is funded by the Intramural Research Program of the NIH, NIDDK. E.K. is funded by the PRAT Program, NIGMS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Awqati Q, 2011, PHYSIOLOGY, V26, P266, DOI 10.1152/physiol.00008.2011; ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; ALPER SL, 1989, P NATL ACAD SCI USA, V86, P5429, DOI 10.1073/pnas.86.14.5429; Anders HJ, 2011, J AM SOC NEPHROL, V22, P1007, DOI 10.1681/ASN.2010080798; Arase T, 2009, J IMMUNOL, V182, P7074, DOI 10.4049/jimmunol.0900001; Arulkumaran N, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00194; Awad AS, 2009, KIDNEY INT, V75, P689, DOI 10.1038/ki.2008.648; Azroyan A, 2012, AM J PHYSIOL-RENAL, V302, pF1180, DOI 10.1152/ajprenal.00403.2011; Ballerini R, 2006, INT J IMMUNOPATH PH, V19, P293, DOI 10.1177/039463200601900207; Barrett MO, 2013, MOL PHARMACOL, V84, P41, DOI 10.1124/mol.113.085654; Belleannee C, 2010, AM J PHYSIOL-CELL PH, V298, pC817, DOI 10.1152/ajpcell.00460.2009; Bolisetty S, 2009, KIDNEY INT, V75, P674, DOI 10.1038/ki.2008.689; Bonventre JV, 2004, KIDNEY INT, V66, P480, DOI 10.1111/j.1523-1755.2004.761_2.x; Breton S, 2013, PHYSIOLOGY, V28, P318, DOI 10.1152/physiol.00007.2013; BROWN D, 1988, NATURE, V331, P622, DOI 10.1038/331622a0; BROWN D, 1988, J CLIN INVEST, V82, P2114, DOI 10.1172/JCI113833; Brown D, 1996, HISTOCHEM CELL BIOL, V105, P261, DOI 10.1007/BF01463929; Brown D, 2012, AM J PHYSIOL-CELL PH, V302, pC1421, DOI 10.1152/ajpcell.00085.2012; Burnstock G, 2013, PURINERGIC IN PRESS; Chambers JK, 2000, J BIOL CHEM, V275, P10767, DOI 10.1074/jbc.275.15.10767; Chassin C, 2007, J EXP MED, V204, P2837, DOI 10.1084/jem.20071032; Chassin C, 2007, M S-MED SCI, V23, P32, DOI 10.1051/medsci/200723132; Chassin C, 2006, J IMMUNOL, V177, P4773, DOI 10.4049/jimmunol.177.7.4773; Chassin C, 2011, CELL MICROBIOL, V13, P1107, DOI 10.1111/j.1462-5822.2011.01614.x; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Chen Y, 2006, SCIENCE, V314, P1792, DOI 10.1126/science.1132559; Da Silva N, 2010, AM J PHYSIOL-CELL PH, V298, pC1326, DOI 10.1152/ajpcell.00552.2009; de Souza RM, 2008, NAT CLIN PRACT NEPHR, V4, P252, DOI 10.1038/ncpneph0781; Dovlatova N, 2008, THROMB HAEMOSTASIS, V100, P261, DOI 10.1160/TH07-10-0601; Elliott MR, 2009, NATURE, V461, P282, DOI 10.1038/nature08296; Freeman K, 2001, GENOMICS, V78, P124, DOI 10.1006/geno.2001.6662; Fricks IP, 2009, J PHARMACOL EXP THER, V330, P162, DOI 10.1124/jpet.109.150730; Gallagher J. A., 2004, Journal of Musculoskeletal & Neuronal Interactions, V4, P125; Gao ZG, 2010, BIOCHEM PHARMACOL, V79, P873, DOI 10.1016/j.bcp.2009.10.024; GEKLE M, 1994, PFLUG ARCH EUR J PHY, V428, P157, DOI 10.1007/BF00374853; Harden TK, 2010, ACTA PHYSIOL, V199, P149, DOI 10.1111/j.1748-1716.2010.02116.x; Hillman KA, 2005, NEPHRON EXP NEPHROL, V101, pE24, DOI 10.1159/000086036; Hoffmann E, 2002, J LEUKOCYTE BIOL, V72, P847; Holzer P, 2011, ACTA PHYSIOL, V201, P63, DOI 10.1111/j.1748-1716.2010.02143.x; Hurtado-Lorenzo A, 2006, NAT CELL BIOL, V8, P124, DOI 10.1038/ncb1348; Kaunitz JD, 2008, J CELL BIOCHEM, V105, P655, DOI 10.1002/jcb.21885; Kishore BK, 2009, PURINERG SIGNAL, V5, P491, DOI 10.1007/s11302-009-9151-5; Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215; Krzeminski P, 2008, EUR J PHARMACOL, V594, P49, DOI 10.1016/j.ejphar.2008.06.092; Lazarowski ER, 2011, SUBCELL BIOCHEM, V55, P1, DOI 10.1007/978-94-007-1217-1_1; Lazarowski ER, 2003, MOL PHARMACOL, V63, P1190, DOI 10.1124/mol.63.5.1190; Lee CW, 2006, J BIOL CHEM, V281, P23589, DOI 10.1074/jbc.M603670200; Leipziger J, 2011, CURR OPIN NEPHROL HY, V20, P518, DOI 10.1097/MNH.0b013e3283487393; Li Q, 1997, BIOCHEM BIOPH RES CO, V236, P455, DOI 10.1006/bbrc.1997.6984; Miller RL, 2005, AM J PHYSIOL-CELL PH, V288, pC1134, DOI 10.1152/ajpcell.00084.2004; Moore DJ, 2003, MOL BRAIN RES, V118, P10, DOI 10.1016/S0169-328X(03)00330-9; Muller T, 2005, AM J RESP CELL MOL, V33, P601, DOI 10.1165/rcmb.2005-0181OC; Murakami M, 2008, BIOCHEM BIOPH RES CO, V371, P707, DOI 10.1016/j.bbrc.2008.04.145; NELSON RD, 1992, P NATL ACAD SCI USA, V89, P3541, DOI 10.1073/pnas.89.8.3541; Okada SF, 2011, AM J RESP CELL MOL, V45, P253, DOI 10.1165/rcmb.2010-0253OC; Paragas N, 2014, J CLIN INVEST, V124, P2963, DOI 10.1172/JCI71630; Paunescu TG, 2008, AM J PHYSIOL-CELL PH, V295, pC923, DOI 10.1152/ajpcell.00237.2008; Paunescu TG, 2010, AM J PHYSIOL-RENAL, V298, pF643, DOI 10.1152/ajprenal.00584.2009; Pelle G, 2007, AM J TRANSPLANT, V7, P899, DOI 10.1111/j.1600-6143.2006.01700.x; Praetorius HA, 2010, ANNU REV PHYSIOL, V72, P377, DOI 10.1146/annurev-physiol-021909-135825; Rieg T, 2009, AM J PHYSIOL-REG I, V296, pR419, DOI 10.1152/ajpregu.90784.2008; Royaux IE, 2001, P NATL ACAD SCI USA, V98, P4221, DOI 10.1073/pnas.071516798; Scrivens M, 2005, BRIT J PHARMACOL, V146, P435, DOI 10.1038/sj.bjp.0706322; Scrivens M, 2006, EUR J PHARMACOL, V543, P166, DOI 10.1016/j.ejphar.2006.05.037; Sesma JI, 2009, J BIOL CHEM, V284, P12572, DOI 10.1074/jbc.M806759200; Shum WW, 2011, AM J PHYSIOL-CELL PH, V301, pC31, DOI 10.1152/ajpcell.00198.2010; Spencer JD, 2013, KIDNEY INT; Spencer JD, 2011, KIDNEY INT, V80, P175, DOI 10.1038/ki.2011.109; Spencer JD, 2013, KIDNEY INT, V83, P615, DOI 10.1038/ki.2012.410; Turner CM, 2003, CELLS TISSUES ORGANS, V175, P105, DOI 10.1159/000073754; Vallon Volker, 2012, Wiley Interdiscip Rev Membr Transp Signal, V1, P731; Vedovelli L, 2013, AM J PHYSIOL-RENAL, V304, pF522, DOI 10.1152/ajprenal.00394.2012; Wagner CA, 2004, PHYSIOL REV, V84, P1263, DOI 10.1152/physrev.00045.2003; Wall SM, 2003, AM J PHYSIOL-RENAL, V284, pF229, DOI 10.1152/ajprenal.00147.2002; Woda CB, 2002, AM J PHYSIOL-RENAL, V283, pF437, DOI 10.1152/ajprenal.00316.2001; Xu JF, 2012, J IMMUNOL, V189, P1992, DOI 10.4049/jimmunol.1103207; Zimmermann H, 2000, N-S ARCH PHARMACOL, V362, P299, DOI 10.1007/s002100000309	77	59	63	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121419	10.1371/journal.pone.0121419	http://dx.doi.org/10.1371/journal.pone.0121419			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799465	Green Published, gold, Green Submitted			2022-12-26	WOS:000351987300250
J	Castillo-Badillo, JA; Sanchez-Reyes, OB; Alfonzo-Mendez, MA; Romero-Avila, T; Reyes-Cruz, G; Garcia-Sainz, JA				Castillo-Badillo, Jean A.; Sanchez-Reyes, Omar B.; Alfonzo-Mendez, Marco A.; Romero-Avila, Teresa; Reyes-Cruz, Guadalupe; Adolfo Garcia-Sainz, J.			alpha(1B)-Adrenergic Receptors Differentially Associate with Rab Proteins during Homologous and Heterologous Desensitization	PLOS ONE			English	Article							MUSCARINIC ACETYLCHOLINE-RECEPTOR; RESONANCE ENERGY-TRANSFER; GROWTH-FACTOR-I; G-BETA-GAMMA; COUPLED RECEPTOR; ENDOCYTIC PATHWAY; ANGIOTENSIN-II; CROSS-TALK; BETA(2)-ADRENERGIC RECEPTOR; SUBCELLULAR-DISTRIBUTION	Internalization of G protein-coupled receptors can be triggered by agonists or by other stimuli. The process begins within seconds of cell activation and contributes to receptor desensitization. The Rab GTPase family controls endocytosis, vesicular trafficking, and endosomal fusion. Among their remarkable properties is the differential distribution of its members on the surface of various organelles. In the endocytic pathway, Rab 5 controls traffic from the plasma membrane to early endosomes, whereas Rab 4 and Rab 11 regulate rapid and slow recycling from early endosomes to the plasma membrane, respectively. Moreover, Rab 7 and Rab 9 regulate the traffic from late endosomes to lysosomes and recycling to the trans-Golgi. We explore the possibility that alpha(1B)-adrenergic receptor internalization induced by agonists (homologous) and by unrelated stimuli (heterologous) could involve different Rab proteins. This possibility was explored by Fluorescence Resonance Energy Transfer (FRET) using cells coexpressing alpha(1B)-adrenergic receptors tagged with the red fluorescent protein, DsRed, and different Rab proteins tagged with the green fluorescent protein. It was observed that when alpha(1B)-adrenergic receptors were stimulated with noradrenaline, the receptors interacted with proteins present in early endosomes, such as the early endosomes antigen 1, Rab 5, Rab 4, and Rab 11 but not with late endosome markers, such as Rab 9 and Rab 7. In contrast, sphingosine 1-phosphate stimulation induced rapid and transient alpha(1B)-adrenergic receptor interaction of relatively small magnitude with Rab 5 and a more pronounced and sustained one with Rab 9; interaction was also observed with Rab 7. Moreover, the GTPase activity of the Rab proteins appears to be required because no FRET was observed when dominant-negative Rab mutants were employed. These data indicate that alpha(1B)-adrenergic receptors are directed to different endocytic vesicles depending on the desensitization type (homologous vs. heterologous).	[Castillo-Badillo, Jean A.; Sanchez-Reyes, Omar B.; Alfonzo-Mendez, Marco A.; Romero-Avila, Teresa; Adolfo Garcia-Sainz, J.] Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Mexico City 04510, DF, Mexico; [Reyes-Cruz, Guadalupe] CINVESTAV, Inst Politecn Nacl, Ctr Invest & Estudios Avanzados, Dept Biol Celular, Mexico City 07360, DF, Mexico	Universidad Nacional Autonoma de Mexico; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico	Garcia-Sainz, JA (corresponding author), Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Ap Postal 70-248, Mexico City 04510, DF, Mexico.	agarcia@ifc.unam.mx	GARCIA-SAINZ, JESUS ADOLFO/A-5389-2008	GARCIA-SAINZ, JESUS ADOLFO/0000-0002-5235-0657; Sanchez Reyes, Omar/0000-0002-2099-4466; ROMERO, MA. TERESA/0000-0003-4505-5083	CONACyT [177556]; DGAPA-UNAM [200812]	CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); DGAPA-UNAM(Universidad Nacional Autonoma de Mexico)	This research was partially supported by grants from CONACyT [177556] (http://www.conacyt.gob.mx/) and DGAPA-UNAM [200812] (http://dgapa.unam.mx/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Garcia-Sainz JA, 2011, IUBMB LIFE, V63, P811, DOI 10.1002/iub.519; Alvarez SE, 2007, TRENDS ENDOCRIN MET, V18, P300, DOI 10.1016/j.tem.2007.07.005; Avendano-Vazquez SEA, 2005, BIOCHEM J, V385, P677, DOI 10.1042/BJ20040891; Bhattacharya M, 2004, BIOCHEM SOC T, V32, P1040, DOI 10.1042/BST0321040; Casas-Gonzalez P, 2003, BBA-MOL CELL BIOL L, V1633, P75, DOI 10.1016/S1388-1981(03)00089-1; Casas-Gonzalez P, 2006, EUR J PHARMACOL, V542, P31, DOI 10.1016/j.ejphar.2006.05.031; Castillo-Badillo JA, 2014, ARCH MED RES, V45, P283, DOI 10.1016/j.arcmed.2014.03.009; Castillo-Badillo JA, 2012, BBA-MOL CELL RES, V1823, P245, DOI 10.1016/j.bbamcr.2011.10.002; Claing A, 2002, PROG NEUROBIOL, V66, P61, DOI 10.1016/S0301-0082(01)00023-5; Colin-Santana CC, 2011, BBA-GEN SUBJECTS, V1810, P1170, DOI 10.1016/j.bbagen.2011.08.016; Dale LB, 2004, J BIOL CHEM, V279, P13110, DOI 10.1074/jbc.M313333200; Diviani D, 1997, J BIOL CHEM, V272, P28712, DOI 10.1074/jbc.272.45.28712; Diviani D, 1996, J BIOL CHEM, V271, P5049; Duvernay MT, 2011, J BIOL CHEM, V286, P14080, DOI 10.1074/jbc.M111.222323; Echard A, 1998, SCIENCE, V279, P580, DOI 10.1126/science.279.5350.580; Erickson MG, 2003, BIOPHYS J, V85, P599, DOI 10.1016/S0006-3495(03)74504-4; FENG Y, 1995, J CELL BIOL, V131, P1435, DOI 10.1083/jcb.131.6.1435; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; Ferguson SSG, 1998, LIFE SCI, V62, P1561, DOI 10.1016/S0024-3205(98)00107-6; FONSECA MI, 1995, J BIOL CHEM, V270, P8902, DOI 10.1074/jbc.270.15.8902; Fredriksson R, 2005, MOL PHARMACOL, V67, P1414, DOI 10.1124/mol.104.009001; Gaborik Z, 2004, TRENDS ENDOCRIN MET, V15, P286, DOI 10.1016/j.tem.2004.06.009; Garcia-Sainz JA, 2004, LIFE SCI, V75, P1937, DOI 10.1016/j.lfs.2004.03.025; Garcia-Sainz JA, 1999, ARCH MED RES, V30, P449, DOI 10.1016/S0188-0128(99)00059-7; Gavard J, 2006, NAT CELL BIOL, V8, P1223, DOI 10.1038/ncb1486; Gonzalez L, 1999, CELL, V96, P755, DOI 10.1016/S0092-8674(00)80585-1; Gonzalez-Arenas A, 2006, MOL PHARMACOL, V70, P154, DOI 10.1124/mol.106.025064; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; Grimsey NL, 2011, BBA-MOL CELL RES, V1813, P1554, DOI 10.1016/j.bbamcr.2011.05.010; Gruenberg J, 2001, NAT REV MOL CELL BIO, V2, P721, DOI 10.1038/35096054; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hachet-Haas M, 2006, MICROSC RES TECHNIQ, V69, P941, DOI 10.1002/jemt.20376; Hague C, 2006, MOL PHARMACOL, V69, P45, DOI 10.1124/mol.105.014985; HEUSER JE, 1989, J CELL BIOL, V108, P389, DOI 10.1083/jcb.108.2.389; Hunyady L, 2002, J CELL BIOL, V157, P1211, DOI 10.1083/jcb.200111013; Irannejad R, 2013, NATURE, V495, P534, DOI 10.1038/nature12000; Iwata K, 1999, EUR J BIOCHEM, V263, P596, DOI 10.1046/j.1432-1327.1999.00549.x; Jakobs S, 2000, FEBS LETT, V479, P131, DOI 10.1016/S0014-5793(00)01896-2; Jedd G, 1997, J CELL BIOL, V137, P563, DOI 10.1083/jcb.137.3.563; Kobilka B, 2013, ANGEW CHEM INT EDIT, V52, P6380, DOI 10.1002/anie.201302116; Krupnick JG, 1998, ANNU REV PHARMACOL, V38, P289, DOI 10.1146/annurev.pharmtox.38.1.289; LATTION AL, 1994, J BIOL CHEM, V269, P22887; Lefkowitz RJ, 2004, TRENDS PHARMACOL SCI, V25, P413, DOI 10.1016/j.tips.2004.06.006; Lefkowitz RJ, 2013, ANGEW CHEM INT EDIT, V52, P6366, DOI 10.1002/anie.201301924; Lindsay AJ, 2002, J BIOL CHEM, V277, P27193, DOI 10.1074/jbc.M200757200; Maeda T, 2003, PROG RETIN EYE RES, V22, P417, DOI 10.1016/S1350-9462(03)00017-X; McCaffrey MW, 2001, FEBS LETT, V495, P21, DOI 10.1016/S0014-5793(01)02359-6; McCune DF, 2000, MOL PHARMACOL, V57, P659, DOI 10.1124/mol.57.4.659; McLauchlan H, 1998, CURR BIOL, V8, P34, DOI 10.1016/S0960-9822(98)70018-1; Medina LD, 2000, BIOCHEM J, V350, P413, DOI 10.1042/bj3500413; Medina LD, 1998, FEBS LETT, V422, P141, DOI 10.1016/S0014-5793(97)01615-3; Mohrmann K, 1999, MOL MEMBR BIOL, V16, P81, DOI 10.1080/096876899294797; Molina-Munoz T, 2008, EUR J PHARMACOL, V578, P1, DOI 10.1016/j.ejphar.2007.08.047; Molina-Munoz T, 2006, MOL ENDOCRINOL, V20, P2773, DOI 10.1210/me.2006-0090; Mukhopadhyay A, 1997, J BIOL CHEM, V272, P13055, DOI 10.1074/jbc.272.20.13055; Nielsen E, 1999, NAT CELL BIOL, V1, P376, DOI 10.1038/14075; Novick P, 1997, CURR OPIN CELL BIOL, V9, P496, DOI 10.1016/S0955-0674(97)80025-7; NUOFFER C, 1994, ANNU REV BIOCHEM, V63, P949, DOI 10.1146/annurev.bi.63.070194.004505; Oztan A, 2007, MOL BIOL CELL, V18, P3978, DOI 10.1091/mbc.E07-02-0097; Pepe IM, 1999, J PHOTOCH PHOTOBIO B, V48, P1, DOI 10.1016/S1011-1344(99)00200-6; PITCHER JA, 1995, P NATL ACAD SCI USA, V92, P8343, DOI 10.1073/pnas.92.18.8343; Reyes-Ibarra AP, 2007, MOL ENDOCRINOL, V21, P1394, DOI 10.1210/me.2006-0523; Rodman JS, 2000, J CELL SCI, V113, P183; Rosenfeld JL, 2002, RECEPTOR CHANNEL, V8, P87, DOI 10.1080/10606820212398; Sanden C, 2011, MOL PHARMACOL, V79, P400, DOI 10.1124/mol.110.069500; Schimmoller F, 1998, J BIOL CHEM, V273, P22161, DOI 10.1074/jbc.273.35.22161; Seachrist JL, 2000, J BIOL CHEM, V275, P27221; Seachrist JL, 2003, LIFE SCI, V74, P225, DOI 10.1016/j.lfs.2003.09.009; Segura V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064996; Sekar RB, 2003, J CELL BIOL, V160, P629, DOI 10.1083/jcb.200210140; Shumay E, 2004, J CELL SCI, V117, P593, DOI 10.1242/jcs.00890; Stanasila L, 2008, MOL PHARMACOL, V74, P562, DOI 10.1124/mol.107.043422; Tuvim MJ, 2001, NEWS PHYSIOL SCI, V16, P56; van Rheenen J, 2004, BIOPHYS J, V86, P2517, DOI 10.1016/S0006-3495(04)74307-6; VANDERSLUIJS P, 1992, CELL, V70, P729, DOI 10.1016/0092-8674(92)90307-X; Vazquez-Prado J, 2003, CELL SIGNAL, V15, P549, DOI 10.1016/S0898-6568(02)00151-1; Vazquez-Prado J, 2000, J BIOL CHEM, V275, P6553, DOI 10.1074/jbc.275.9.6553; VazquezPrado J, 1997, J BIOL CHEM, V272, P27330, DOI 10.1074/jbc.272.43.27330; VazquezPrado J, 1996, MOL PHARMACOL, V50, P17; Vitelli R, 1997, J BIOL CHEM, V272, P4391, DOI 10.1074/jbc.272.7.4391; Volpicelli LA, 2002, J NEUROSCI, V22, P9776, DOI 10.1523/jneurosci.22-22-09776.2002; Volpicelli LA, 2001, J BIOL CHEM, V276, P47590, DOI 10.1074/jbc.M106535200; Wu GY, 2003, J BIOL CHEM, V278, P47062, DOI 10.1074/jbc.M305707200; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	84	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121165	10.1371/journal.pone.0121165	http://dx.doi.org/10.1371/journal.pone.0121165			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799564	Green Published, Green Submitted, gold			2022-12-26	WOS:000351987300222
J	Kang, BW; Jeon, HS; Chae, YS; Lee, SJ; Park, JY; Choi, JE; Park, JS; Choi, GS; Kim, JG				Kang, Byung Woog; Jeon, Hyo-Sung; Chae, Yee Soo; Lee, Soo Jung; Park, Jae Yong; Choi, Jin Eun; Park, Jun Seok; Choi, Gyu Seog; Kim, Jong Gwang			Association between GWAS-Identified Genetic Variations and Disease Prognosis for Patients with Colorectal Cancer	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; COLON-CANCER; RISK; METAANALYSIS; TARGET; 8Q23.3; SCAN	Genome-wide association studies (GWASs) have already identified at least 22 common susceptibility loci associated with an increased risk of colorectal cancer (CRC). This study examined the relationship between these single nucleotide polymorphisms (SNPs) and the clinical outcomes of patients with colorectal cancer. Seven hundred seventy-six patients with surgically resected colorectal adenocarcinoma were enrolled in the present study. Twenty-two of the GWAS-identified SNPs were genotyped using a Sequenom MassAR-RAY. Among the 22 SNPs, two (rs1321311G>T in CDKN1A and rs10411210C>T in RHPN2) were significantly associated with the survival outcomes of CRC in a multivariate survival analysis. In a recessive model, the rs1321311 TT genotype (vs. GG + GT) and rs10411210 TT genotype (vs. CC + CT) were associated with a worse prognosis for disease-free survival (adjusted HR = 1.90; 95% confidence interval = 1.00-3.60; P = 0.050, adjusted HR = 1.94; 95% confidence interval = 1.05-3.57; P = 0.034, respectively) and overall survival (adjusted HR = 2.05; 95% confidence interval = 1.00-4.20; P = 0.049, adjusted HR = 2.06; 95% confidence interval = 1.05-4.05; P = 0.036, respectively). None of the other SNPs was significantly associated with any clinicopathologic features or survival. The present results suggest that the genetic variants of the CDKN1A (rs1321311) and RHPN2 (rs10411210) genes can be used as prognostic biomarkers for patients with surgically resected colorectal cancer.	[Kang, Byung Woog; Chae, Yee Soo; Lee, Soo Jung; Kim, Jong Gwang] Kyungpook Natl Univ, Sch Med, Kyungpook Natl Univ Med Ctr, Dept Hematol Oncol, Daegu, South Korea; [Jeon, Hyo-Sung] Kyungpook Natl Univ, Sch Med, Dept Mol Diagnost & Imaging, Res Inst, Daegu, South Korea; [Park, Jae Yong; Choi, Jin Eun] Kyungpook Natl Univ, Sch Med, Dept Biochem & Cell Biol, Daegu, South Korea; [Park, Jae Yong] Kyungpook Natl Univ, Sch Med, Dept Internal Med, Daegu, South Korea; [Park, Jun Seok; Choi, Gyu Seog] Kyungpook Natl Univ, Sch Med, Kyungpook Natl Univ Med Ctr, Colorectal Canc Ctr, Daegu, South Korea	Kyungpook National University; Kyungpook National University; Kyungpook National University; Kyungpook National University; Kyungpook National University	Kim, JG (corresponding author), Kyungpook Natl Univ, Sch Med, Kyungpook Natl Univ Med Ctr, Dept Hematol Oncol, Daegu, South Korea.	jkk21c@knu.ac.kr			National Research Foundation of Korea - Korean Government [NRF-2011-0015862]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Korean Ministry of Education, Science and Technology [NRF-2013R1A1A4A01008144]	National Research Foundation of Korea - Korean Government(National Research Foundation of KoreaKorean Government); Basic Science Research Program through the National Research Foundation of Korea (NRF) - Korean Ministry of Education, Science and Technology	This work was supported in part by a National Research Foundation of Korea Grant funded by the Korean Government (NRF-2011-0015862), and in part by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Korean Ministry of Education, Science and Technology (NRF-2013R1A1A4A01008144).	Belt EJT, 2012, ANN SURG ONCOL, V19, pS682, DOI 10.1245/s10434-012-2216-7; Broderick P, 2007, NAT GENET, V39, P1315, DOI 10.1038/ng.2007.18; Carvajal-Carmona LG, 2011, HUM MOL GENET, V20, P2879, DOI 10.1093/hmg/ddr190; Dai JY, 2012, CARCINOGENESIS, V33, P1327, DOI 10.1093/carcin/bgs147; Dunlop MG, 2012, NAT GENET, V44, P770, DOI 10.1038/ng.2293; He J, 2011, CANCER EPIDEM BIOMAR, V20, P70, DOI 10.1158/1055-9965.EPI-10-0892; Houlston RS, 2010, NAT GENET, V42, P973, DOI 10.1038/ng.670; Hutter CM, 2012, CANCER RES, V72, P2036, DOI 10.1158/0008-5472.CAN-11-4067; Jaeger E, 2008, NAT GENET, V40, P26, DOI 10.1038/ng.2007.41; Ku G, 2012, LANCET ONCOL, V13, pE470, DOI 10.1016/S1470-2045(12)70424-2; Patel JN, 2013, BRIT J CLIN PHARMACO, V76, P370, DOI 10.1111/bcp.12166; Peck JW, 2002, J BIOL CHEM, V277, P43924, DOI 10.1074/jbc.M203569200; Peters U, 2013, GASTROENTEROLOGY, V144, P799, DOI 10.1053/j.gastro.2012.12.020; Phipps AI, 2012, GASTROENTEROLOGY, V143, P51, DOI 10.1053/j.gastro.2012.04.052; Poole AJ, 2004, ONCOGENE, V23, P8128, DOI 10.1038/sj.onc.1207994; Romanov VS, 2012, BIOCHEMISTRY-MOSCOW+, V77, P575, DOI 10.1134/S000629791206003X; Stivala LA, 2012, CURR CANCER DRUG TAR, V12, P85; Tenesa A, 2008, NAT GENET, V40, P631, DOI 10.1038/ng.133; Tomlinson I, 2007, NAT GENET, V39, P984, DOI 10.1038/ng2085; Tomlinson IPM, 2008, NAT GENET, V40, P623, DOI 10.1038/ng.111; Tsihlias J, 1999, ANNU REV MED, V50, P401; Wilson KF, 2013, TRENDS MOL MED, V19, P74, DOI 10.1016/j.molmed.2012.10.011; Xing JL, 2011, EUR J CANCER, V47, P1699, DOI 10.1016/j.ejca.2011.02.004	24	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0119649	10.1371/journal.pone.0119649	http://dx.doi.org/10.1371/journal.pone.0119649			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799222	gold, Green Published, Green Submitted			2022-12-26	WOS:000351987300067
J	Kato, K				Kato, Keiko			Differential Effects of Dietary Oils on Emotional and Cognitive Behaviors	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; LONG-TERM POTENTIATION; GROWTH-HORMONE; FATTY-ACIDS; KETOGENIC DIET; DENTATE GYRUS; RATS; FEAR; HIPPOCAMPUS; EXPRESSION	Several dietary oils have been used preventatively and therapeutically in the setting of neurological disease. However, the mechanisms underlying their influence on brain function and metabolism remain unknown. It was investigated whether 3 types of dietary oils affected emotional behaviors in mice. Wild-type (WT) mice and sialyltransferase ST3Gal IV-knockout (KO) mice, which exhibit increased emotional and cognitive behaviors, were fed diets containing 20% dietary oils from post-weaning to adulthood. Mice were fed pellets made from control feed AIN93G powder containing 18% fish oil, soybean oil, or a mixture of 1-palmitoyl-2-oleoyl-3-palmitoyl glycerol (POP) and 1-stearoyl-2-oleoyl-3-stearoyl glycerol (SOS), plus 2% soybean oil. Once mice reached adulthood, they were subjected to fear conditioning test to measure cognitive anxiety and forced swim test to measure depression. WT mice fed the POP-SOS diet showed a 0.6-fold decrease in percent freezing with contextual fear compared with WT mice fed the control diet. KO mice fed the fish oil diet showed a 1.4-fold increase in percent freezing with contextual fear compared with KO mice fed the control diet. These findings indicate that response to contextual fear was improved in WT mice that consumed POP-SOS but aggravated in KO mice that consumed fish oils. Furthermore, KO mice showed a 0.4-fold decrease in percent freezing in response to tone fear when they were fed POP-SOS diet compared to a control diet. Thus, POP-SOS diet reduced tone fear level of KO mice until the same level of WT mice. Finally, KO mice fed the soybean oil diet showed a 1.7-fold increase in immobility in the forced swim test compared to KO mice fed the control diet. Taken together, oil-rich diets differentially modulate anxiety and depression in normal and anxious mice. Oils rich in saturated fatty acids may alleviate anxiety more strongly than other oils.	Kyoto Sangyo Univ, Fac Life Sci, Kyoto 603, Japan	Kyoto Sangyo University	Kato, K (corresponding author), Kyoto Sangyo Univ, Fac Life Sci, Kyoto 603, Japan.	kato@cc.kyoto-su.ac.jp			Kyoto Sangyo University [E1105]; Ministry of Education, Science, Culture, and Sports; Japan Society for the Promotion of Science [22580338]; A-step of the Japan Science and Technology Agency (JST) [AS2211285E]	Kyoto Sangyo University; Ministry of Education, Science, Culture, and Sports(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); A-step of the Japan Science and Technology Agency (JST)	Support was provided by: Kyoto Sangyo University Research Grants (E1105, https://www.kyoto-su.ac.jp/english/research) for providing materials, equipment for making dietary foods, and persons for assisting with experiments; The Ministry of Education, Science, Culture, and Sports, a research fellowship from the Japan Society for the Promotion of Science (22580338, http://kaken.nii.ac.jp/en/p?q=22580338) for providing materials and an assistant for the paperwork; A-step of the Japan Science and Technology Agency (JST, AS2211285E, http://www.jst.go.jp/tt/EN/univ-ip/a-step.html) for providing materials, equipments for behavior tests and for preparation of digestive foods, and for technicians. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey EE, 2005, EPILEPSY BEHAV, V6, P4, DOI 10.1016/j.yebeh.2004.10.006; Beezhold BL, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-9; Beezhold BL, 2010, NUTR J, V9, DOI 10.1186/1475-2891-9-26; Bhathena SJ, 2006, NUTR NEUROSCI, V9, P1, DOI 10.1080/10284150600627128; Bhatia HS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028451; Boucher AA, 2011, NEUROSCIENCE, V189, P170, DOI 10.1016/j.neuroscience.2011.05.049; BROWNE TR, 2000, HDB EPILEPSY, P42; Cross JH, 2008, EPILEPSIA, V49, P6, DOI 10.1111/j.1528-1167.2008.01822.x; Donahue CP, 2002, HIPPOCAMPUS, V12, P821, DOI 10.1002/hipo.10058; Fabri DRS, 2014, EUR NEUROPSYCHOPHARM, V24, P1676, DOI 10.1016/j.euroneuro.2014.08.002; Fattore E, 2013, INT J FOOD SCI NUTR, V64, P648, DOI 10.3109/09637486.2013.768213; Fedorova I, 2006, PROSTAG LEUKOTR ESS, V75, P271, DOI 10.1016/j.plefa.2006.07.006; Goosens KA, 2001, LEARN MEMORY, V8, P148, DOI 10.1101/lm.37601; Kato K, 2001, BRAIN RES, V901, P281, DOI 10.1016/S0006-8993(01)02299-5; Kato K, 2009, J NEUROCHEM, V110, P509, DOI 10.1111/j.1471-4159.2009.06132.x; Kavraal S, 2012, BRAIN RES, V1482, P32, DOI 10.1016/j.brainres.2012.09.002; Kendler KS, 1999, AM J PSYCHIAT, V156, P837, DOI 10.1176/ajp.156.6.837; Koranda JL, 2011, J NEUROPHYSIOL, V106, P662, DOI 10.1152/jn.00001.2011; Le Greves M, 2002, P NATL ACAD SCI USA, V99, P7119, DOI 10.1073/pnas.092135399; LEDOUX JE, 1988, J NEUROSCI, V8, P2517; Mahmoud GS, 2006, J NEUROPHYSIOL, V95, P2962, DOI 10.1152/jn.00947.2005; Matsuhashi H, 2003, J NEUROCHEM, V84, P53, DOI 10.1046/j.1471-4159.2003.01257.x; McNally MA, 2012, J NEUROCHEM, V121, P28, DOI 10.1111/j.1471-4159.2012.07670.x; McNamara RK, 2006, PROSTAG LEUKOTR ESS, V75, P329, DOI 10.1016/j.plefa.2006.07.010; Moller N, 2009, ENDOCR REV, V30, P152, DOI 10.1210/er.2008-0027; Moore MD, 2010, NEUROBIOL LEARN MEM, V93, P383, DOI 10.1016/j.nlm.2009.12.004; NISHIKAWA M, 1994, J PHYSIOL-LONDON, V475, P83, DOI 10.1113/jphysiol.1994.sp020051; Patil S, 2005, NEUROSCI LETT, V384, P288, DOI 10.1016/j.neulet.2005.05.003; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Quirk GJ, 1997, NEURON, V19, P613, DOI 10.1016/S0896-6273(00)80375-X; Ross BM, 2007, LIPIDS HEALTH DIS, V6, DOI 10.1186/1476-511X-6-21; Spencer SS, 2002, LANCET NEUROL, V1, P375, DOI 10.1016/S1474-4422(02)00163-1; Srimontri P, 2014, J NEUROCHEM, V131, P675, DOI 10.1111/jnc.12838	33	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120753	10.1371/journal.pone.0120753	http://dx.doi.org/10.1371/journal.pone.0120753			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799588	gold, Green Published, Green Submitted			2022-12-26	WOS:000351987300172
J	Rivest, EB; Gouhier, TC				Rivest, Emily B.; Gouhier, Tarik C.			Complex Environmental Forcing across the Biogeographical Range of Coral Populations	PLOS ONE			English	Article							OCEAN ACIDIFICATION; ELEVATED-TEMPERATURE; CARBONATE CHEMISTRY; DIURNAL-VARIATION; LOCAL ADAPTATION; REEF; PH; SEAWATER; OXYGEN; CALCIFICATION	Although there is a substantial body of work on how temperature shapes coastal marine ecosystems, the spatiotemporal variability of seawater pH and corresponding in situ biological responses remain largely unknown across biogeographic ranges of tropical coral species. Environmental variability is important to characterize because it can amplify or dampen the biological consequences of global change, depending on the functional relationship between mean temperature or pH and organismal traits. Here, we characterize the spatiotemporal variability of pH, temperature, and salinity at fringing reefs in Moorea, French Polynesia and Nanwan Bay, Taiwan using advanced time series analysis, including wavelet analysis, and infer their potential impact on the persistence and stability of coral populations. Our results demonstrate that both the mean and variance of pH and temperature differed significantly between sites in Moorea and Taiwan. Seawater temperature at the Moorea site passed the local bleaching threshold several times within the similar to 45 day deployment while aragonite saturation state at the Taiwan site was often below commonly observed levels for coral reefs. Our results showcase how a better understanding of the differences in environmental conditions between sites can (1) provide an important frame of reference for designing laboratory experiments to study the effects of environmental variability, (2) identify the proximity of current environmental conditions to predicted biological thresholds for the coral reef, and (3) help predict when the temporal variability and mean of environmental conditions will interact synergistically or antagonistically to alter the abundance and stability of marine populations experiencing climate change.	[Rivest, Emily B.] Univ Calif Davis, Bodega Marine Lab, Bodega Bay, CA 94923 USA; [Gouhier, Tarik C.] Northeastern Univ, Ctr Marine Sci, Nahant, MA 01908 USA	University of California System; University of California Davis; Northeastern University	Rivest, EB (corresponding author), Univ Calif Davis, Bodega Marine Lab, Bodega Bay, CA 94923 USA.	ebrivest@ucdavis.edu	/AAL-3738-2021; Gouhier, Tarik/C-3611-2009	Gouhier, Tarik/0000-0002-9537-7358	Moorea Coral Reef Long-Term Ecological Research Program; National Science Foundation [OCE-1220359, CCF-1442728]; National Museum of Marine Biology and Aquarium in Taiwan; National Science Foundation Graduate Research Fellowship; Doctoral Dissertation Enhancement Program; Division Of Ocean Sciences [1236905] Funding Source: National Science Foundation	Moorea Coral Reef Long-Term Ecological Research Program; National Science Foundation(National Science Foundation (NSF)); National Museum of Marine Biology and Aquarium in Taiwan; National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); Doctoral Dissertation Enhancement Program; Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This study was funded by the Moorea Coral Reef Long-Term Ecological Research Program (http://mcr.lternet.edu), the National Science Foundation (OCE-1220359 to Gretchen Hofmann), and the National Museum of Marine Biology and Aquarium in Taiwan (http://www.nmmba.gov.tw). EBR was funded by the National Science Foundation Graduate Research Fellowship (http://www.nsf.gov/grfp) and the Doctoral Dissertation Enhancement Program (http://www.nsf.gov/publications/pub_summ.jsp?ods_key = nsf04036&org=NSF). TCG was funded by the National Science Foundation (CCF-1442728).	Albright R, 2013, BIOGEOSCIENCES, V10, P6747, DOI 10.5194/bg-10-6747-2013; Anderson CNK, 2008, NATURE, V452, P835, DOI 10.1038/nature06851; Boatta F, 2013, MAR POLLUT BULL, V73, P485, DOI 10.1016/j.marpolbul.2013.01.029; Cazelles B, 2008, OECOLOGIA, V156, P287, DOI 10.1007/s00442-008-0993-2; Chierici M, 2009, BIOGEOSCIENCES, V6, P2421, DOI 10.5194/bg-6-2421-2009; Cumbo VR, 2013, J EXP MAR BIOL ECOL, V439, P100, DOI 10.1016/j.jembe.2012.10.019; Cumbo VR, 2013, MAR BIOL, V160, P2903, DOI 10.1007/s00227-013-2280-y; Dickson A.G., 2007, GUIDE BEST PRACTICES; DICKSON AG, 1987, DEEP-SEA RES, V34, P1733, DOI 10.1016/0198-0149(87)90021-5; Gaitan-Espitia JD, 2014, J EXP MAR BIOL ECOL, V457, P51, DOI 10.1016/j.jembe.2014.03.018; Edenhofer O., 2014, CONTRIBUTION WORKING; Eliason EJ, 2011, SCIENCE, V332, P109, DOI 10.1126/science.1199158; Evans TG, 2013, MOL ECOL, V22, P1609, DOI 10.1111/mec.12188; Fabricius KE, 2011, NAT CLIM CHANGE, V1, P165, DOI 10.1038/NCLIMATE1122; Frieder CA, 2012, BIOGEOSCIENCES, V9, P3917, DOI 10.5194/bg-9-3917-2012; Frieder CA, 2014, BIOL BULL-US, V226, P1; Gagliano M, 2010, MAR BIOL, V157, P1849, DOI 10.1007/s00227-010-1456-y; GLEASON MG, 1993, CORAL REEFS, V12, P193, DOI 10.1007/BF00334479; Gouhier T.C., 2014, BIWAVELET CONDUCT UN; Gouhier TC, 2013, ECOL APPL, V23, P1488, DOI 10.1890/12-1801.1; Grinsted A, 2004, NONLINEAR PROC GEOPH, V11, P561, DOI 10.5194/npg-11-561-2004; Guadayol O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085213; Guinotte JM, 2003, CORAL REEFS, V22, P551, DOI 10.1007/s00338-003-0331-4; Hall-Spencer JM, 2008, NATURE, V454, P96, DOI 10.1038/nature07051; Harris KE, 2013, GEOPHYS RES LETT, V40, P2720, DOI 10.1002/grl.50460; Hauri C, 2009, OCEANOGRAPHY, V22, P60, DOI 10.5670/oceanog.2009.97; Hench JL, 2008, LIMNOL OCEANOGR, V53, P2681, DOI 10.4319/lo.2008.53.6.2681; Hofmann GE, 2014, BIOGEOSCIENCES, V11, P1053, DOI 10.5194/bg-11-1053-2014; Hofmann GE, 2013, OCEANOGRAPHY, V26, P140, DOI 10.5670/oceanog.2013.56; Hofmann GE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028983; Jan S, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2008JC004887; Kelly MW, 2013, GLOBAL CHANGE BIOL, V19, P2536, DOI 10.1111/gcb.12251; Kelly MW, 2013, FUNCT ECOL, V27, P980, DOI 10.1111/j.1365-2435.2012.02061.x; Kleypas JA, 1999, AM ZOOL, V39, P146; Lee HJ, 1999, ESTUAR COAST SHELF S, V49, P775, DOI 10.1006/ecss.1999.0524; Lee K, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027207; Manly B.F.J., 2006, RANDOMIZATION BOOTST, V3rd, DOI DOI 10.1201/9781315273075; Martz TR, 2010, LIMNOL OCEANOGR-METH, V8, P172, DOI 10.4319/lom.2010.8.172; MEHRBACH C, 1973, LIMNOL OCEANOGR, V18, P897, DOI 10.4319/lo.1973.18.6.0897; Ohde S, 1999, B MAR SCI, V65, P559; Padilla-Gamino JL, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0155; Palumbi SR, 2014, SCIENCE, V344, P895, DOI 10.1126/science.1251336; Pandolfi JM, 2011, SCIENCE, V333, P418, DOI 10.1126/science.1204794; Price NN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043843; Putnam HM, 2013, MAR BIOL, V160, P2157, DOI 10.1007/s00227-012-2129-9; Rivest EB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096172; Robbins L., 2010, US GEOLOGICAL SURVEY, P1, DOI DOI 10.3133/OFR20101280; Ruel JJ, 1999, TRENDS ECOL EVOL, V14, P361, DOI 10.1016/S0169-5347(99)01664-X; Sanford E, 2011, ANNU REV MAR SCI, V3, P509, DOI 10.1146/annurev-marine-120709-142756; Santos IR, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046053; SHASHAR N, 1993, BIOL BULL, V185, P455, DOI 10.2307/1542485; Shaw EC, 2014, MAR CHEM, V158, P49, DOI 10.1016/j.marchem.2013.11.007; Shaw EC, 2013, GEOPHYS RES LETT, V40, P4685, DOI 10.1002/grl.50883; Shaw EC, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007655; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; Torrence C, 1998, Q J ROY METEOR SOC, V124, P1985, DOI 10.1256/smsqj.55009; Waldbusser GG, 2011, ESTUAR COAST, V34, P221, DOI 10.1007/s12237-010-9307-0; Wilkinson C., 1998, 1997 1998 MASS BLEAC; Wootton JT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053396; Wootton JT, 2008, P NATL ACAD SCI USA, V105, P18848, DOI 10.1073/pnas.0810079105; Yates KK, 2007, MAR CHEM, V104, P110, DOI 10.1016/j.marchem.2006.12.008; Yates KK, 2006, ESTUARIES COASTS, V29, P24, DOI 10.1007/BF02784696; Yu PC, 2011, J EXP MAR BIOL ECOL, V400, P288, DOI 10.1016/j.jembe.2011.02.016	63	18	18	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121742	10.1371/journal.pone.0121742	http://dx.doi.org/10.1371/journal.pone.0121742			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799322	Green Submitted, Green Published, gold			2022-12-26	WOS:000351987300288
J	Roosink, M; McFadyen, BJ; Hebert, LJ; Jackson, PL; Bouyer, LJ; Mercier, C				Roosink, Meyke; McFadyen, Bradford J.; Hebert, Luc J.; Jackson, Philip L.; Bouyer, Laurent J.; Mercier, Catherine			Assessing the Perception of Trunk Movements in Military Personnel with Chronic Non-Specific Low Back Pain Using a Virtual Mirror	PLOS ONE			English	Article							REPOSITIONING ERROR; MOTOR IMAGERY; BODY SCHEMA; REPRESENTATIONS; MODULATION; POSITION; PEOPLE; FEAR	Chronic pain, including chronic non-specific low back pain (CNSLBP), is often associated with body perception disturbances, but these have generally been assessed under static conditions. The objective of this study was to use a "virtual mirror" that scaled visual movement feedback to assess body perception during active movement in military personnel with CNSLBP (n = 15) as compared to military healthy control subjects (n = 15). Subjects performed a trunk flexion task while sitting and standing in front of a large screen displaying a full-body virtual mirror-image (avatar) in real-time. Avatar movements were scaled to appear greater, identical, or smaller than the subjects' actual movements. A total of 126 trials with 11 different scaling factors were pseudo-randomized across 6 blocks. After each trial, subjects had to decide whether the avatar's movements were "greater" or "smaller" than their own movements. Based on this two-alternative forced choice paradigm, a psychophysical curve was fitted to the data for each subject, and several metrics were derived from this curve. In addition, task adherence (kinematics) and virtual reality immersion were assessed. Groups displayed a similar ability to discriminate between different levels of movement scaling. Still, subjects with CNSLBP showed an abnormal performance and tended to overestimate their own movements (a right-shifted psychophysical curve). Subjects showed adequate task adherence, and on average virtual reality immersion was reported to be very good. In conclusion, these results extend previous work in patients with CNSLBP, and denote an important relationship between body perception, movement and pain. As such, the assessment of body perception during active movement can offer new avenues for understanding and managing body perception disturbances and abnormal movement patterns in patients with pain.	[Roosink, Meyke; McFadyen, Bradford J.; Hebert, Luc J.; Jackson, Philip L.; Bouyer, Laurent J.; Mercier, Catherine] CIRRIS, Quebec City, PQ, Canada; [McFadyen, Bradford J.; Hebert, Luc J.; Bouyer, Laurent J.; Mercier, Catherine] Univ Laval, Fac Med, Dept Rehabil, Quebec City, PQ G1K 7P4, Canada; [Hebert, Luc J.] Valcartier Garrison, Canadian Forces Hlth Serv Grp Headquarters, Directorate Med Policy Physiotherapy, Quebec City, PQ, Canada; [Hebert, Luc J.] Univ Laval, Fac Med, Dept Radiol, Quebec City, PQ G1K 7P4, Canada; [Jackson, Philip L.] Univ Laval, Sch Psychol, Quebec City, PQ, Canada	Laval University; Laval University; Laval University; Laval University	Mercier, C (corresponding author), CIRRIS, Quebec City, PQ, Canada.	Catherine.Mercier@rea.ulaval.ca	Bouyer, Laurent J/A-9255-2010; Bouyer, Laurent/L-6471-2019	Bouyer, Laurent J/0000-0003-2034-4516; Bouyer, Laurent/0000-0003-2034-4516; Mercier, Catherine/0000-0002-2037-6916; Jackson, Philip/0000-0001-8991-3217; McFadyen, Bradford/0000-0003-1992-4927; Hebert, Luc J./0000-0001-8903-5258	Surgeon General Health Research Program (Canadian Armed Forces) [2011-07-038-004-0002]; Fonds de recherche Quebec-Sante; SensoriMotor Rehabilitation Research Team as part of the Regenerative Medicine; Nanomedicine Strategic Initiative of the Canadian Institute for Health Research; Canadian Institute for Health Research	Surgeon General Health Research Program (Canadian Armed Forces); Fonds de recherche Quebec-Sante; SensoriMotor Rehabilitation Research Team as part of the Regenerative Medicine; Nanomedicine Strategic Initiative of the Canadian Institute for Health Research; Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR))	Funding: Funding provided by Surgeon General Health Research Program (Canadian Armed Forces), 2011-07-038-004-0002, http://www.forces.gc.ca, Research Grant-BM LH CM LB PJ, Fonds de recherche Quebec-Sante, http://www.frqs.gouv.qc.ca, Postdoctoral fellowship-MR, Salary Grants-CM PLJ, SensoriMotor Rehabilitation Research Team as part of the Regenerative Medicine, and the Nanomedicine Strategic Initiative of the Canadian Institute for Health Research, (http://errsm.ca/), Postdoctoral fellowship-MR and Canadian Institute for Health Research, http://www.cihr-irsc.gc.ca, Salary Grants-CM PJL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anonymous, 2008, Annales de Readaptation et de Medecine Physique, V51, P379, DOI 10.1016/j.annrmp.2008.03.006; Balague F, 2012, LANCET, V379, P482, DOI 10.1016/S0140-6736(11)60610-7; Bouffard J, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00077; Bowering KJ, 2014, CLIN J PAIN, V30, P1070, DOI 10.1097/AJP.0000000000000066; Claeys K, 2013, EUR J APPL PHYSL, V111, P115; Coslett HB, 2010, J INT NEUROPSYCH SOC, V16, P603, DOI 10.1017/S1355617710000299; de Lussanet MHE, 2013, HUM MOVEMENT SCI, V32, P938, DOI 10.1016/j.humov.2013.05.002; de Lussanet MHE, 2012, PAIN, V153, P1459, DOI 10.1016/j.pain.2012.04.002; de Vignemont F, 2010, NEUROPSYCHOLOGIA, V48, P669, DOI 10.1016/j.neuropsychologia.2009.09.022; Fairbank JCT, 2000, SPINE, V25, P2940, DOI 10.1097/00007632-200011150-00017; George SZ, 2009, PHYS THER, V89, P969, DOI 10.2522/ptj.20090032; Geva N, 2013, PAIN, V154, P2317, DOI 10.1016/j.pain.2013.06.031; Haggard P, 2013, CURR BIOL, V23, pR164, DOI 10.1016/j.cub.2013.01.047; Hebert JS, 2014, 2D01 NEW TREATMENT P, P36; Hidalgo B, 2013, J BACK MUSCULOSKELET, V26, P381, DOI 10.3233/BMR-130396; Hodges PW, 2015, CLIN J PAIN, V31, P97, DOI 10.1097/AJP.0000000000000098; Kori SH, 1990, PAIN MANAG, V3, P35; Leeuw M, 2007, J BEHAV MED, V30, P77, DOI 10.1007/s10865-006-9085-0; Legrain V, 2012, PAIN, V153, P948, DOI 10.1016/j.pain.2011.12.010; Lewis JS, 2010, PAIN, V149, P463, DOI 10.1016/j.pain.2010.02.007; Lewis JS, 2010, PRACTICAL PAIN MANAG, V10, P1; Llobera J, 2013, EXP BRAIN RES, V225, P105, DOI 10.1007/s00221-012-3352-9; Longo MR, 2010, P NATL ACAD SCI USA, V107, P11727, DOI 10.1073/pnas.1003483107; Mann L, 2010, J BODYW MOV THER, V14, P361, DOI 10.1016/j.jbmt.2009.06.007; Mehling WE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005614; Moseley GL, 2008, PAIN, V140, P239, DOI 10.1016/j.pain.2008.08.001; Moseley GL, 2012, NEUROREHAB NEURAL RE, V26, P646, DOI 10.1177/1545968311433209; O'Sullivan K, 2013, MANUAL THER, V18, P526, DOI 10.1016/j.math.2013.05.005; Peltz E, 2011, J PAIN, V12, P1095, DOI 10.1016/j.jpain.2011.05.001; Proske U, 2012, PHYSIOL REV, V92, P1651, DOI 10.1152/physrev.00048.2011; Roosink M, 2015, J NEUROENG REHABIL, V12, DOI 10.1186/1743-0003-12-2; Schack T, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00328; SIRIGU A, 1991, BRAIN, V114, P629, DOI 10.1093/brain/114.1.629; Stenneken P, 2006, NEUROREPORT, V17, P545, DOI 10.1097/01.wnr.0000209013.01470.f8; Thurm BE, 2013, PERCEPT MOTOR SKILL, V116, P544, DOI 10.2466/15.27.PMS.116.2.544-553; Trojan J, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00369; Turton AJ, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00517; Uematsu H, 2009, ANN ACAD MED SINGAP, V38, P931; VLAEYEN JWS, 1995, PAIN, V62, P363, DOI 10.1016/0304-3959(94)00279-N; Witmer BG, 1998, PRESENCE-TELEOP VIRT, V7, P225, DOI 10.1162/105474698565686; Wright WG, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00056	41	11	12	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120251	10.1371/journal.pone.0120251	http://dx.doi.org/10.1371/journal.pone.0120251			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799009	Green Published, gold			2022-12-26	WOS:000351987300115
J	Torres, JJ; Elices, I; Marro, J				Torres, Joaquin J.; Elices, Irene; Marro, J.			Efficient Transmission of Subthreshold Signals in Complex Networks of Spiking Neurons	PLOS ONE			English	Article							STOCHASTIC RESONANCE; NEURAL-NETWORKS	We investigate the efficient transmission and processing of weak, subthreshold signals in a realistic neural medium in the presence of different levels of the underlying noise. Assuming Hebbian weights for maximal synaptic conductances-that naturally balances the network with excitatory and inhibitory synapses-and considering short-term synaptic plasticity affecting such conductances, we found different dynamic phases in the system. This includes a memory phase where population of neurons remain synchronized, an oscillatory phase where transitions between different synchronized populations of neurons appears and an asynchronous or noisy phase. When a weak stimulus input is applied to each neuron, increasing the level of noise in the medium we found an efficient transmission of such stimuli around the transition and critical points separating different phases for well-defined different levels of stochasticity in the system. We proved that this intriguing phenomenon is quite robust, as it occurs in different situations including several types of synaptic plasticity, different type and number of stored patterns and diverse network topologies, namely, diluted networks and complex topologies such as scale-free and small-world networks. We conclude that the robustness of the phenomenon in different realistic scenarios, including spiking neurons, short-term synaptic plasticity and complex networks topologies, make very likely that it could also occur in actual neural systems as recent psycho-physical experiments suggest.	[Torres, Joaquin J.; Elices, Irene; Marro, J.] Univ Granada, Dept Electromagnetism & Phys Matter, Granada, Spain	University of Granada	Torres, JJ (corresponding author), Univ Granada, Dept Electromagnetism & Phys Matter, Granada, Spain.	jtorres@onsager.ugr.es	Torres, Joaquín J./C-1385-2012; Torres, Joaquín J./AAE-6228-2019	Torres, Joaquín J./0000-0001-6175-9676; 	Spanish Ministry of economy and competitiveness [FIS2013-43201-P]	Spanish Ministry of economy and competitiveness(Spanish Government)	The authors acknowledge support from the Spanish Ministry of economy and competitiveness under the project FIS2013-43201-P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMIT DJ, 1987, PHYS REV A, V35, P2293, DOI 10.1103/PhysRevA.35.2293; Chakravarthy VS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075657; de Franciscis S, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.036114; Droste F, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00086; Gammaitoni L, 1998, REV MOD PHYS, V70, P223, DOI 10.1103/RevModPhys.70.223; Johnson S, 2010, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2010/03/P03003; Johnson S, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.108702; Krawiecki A, 2009, EUR PHYS J B, V69, P81, DOI 10.1140/epjb/e2009-00082-x; Luccioli S, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003823; Mejias JF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017255; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Ozer M, 2010, NEUROREPORT, V21, P338, DOI 10.1097/WNR.0b013e328336ee62; Ozer M, 2009, J THEOR BIOL, V261, P83, DOI 10.1016/j.jtbi.2009.07.006; Ozer M, 2009, PHYS LETT A, V373, P964, DOI 10.1016/j.physleta.2009.01.034; Palomino JM, 2009, THESIS U GRANADA; Pantic L, 2002, NEURAL COMPUT, V14, P2903, DOI 10.1162/089976602760805331; Perc M, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.066203; Pinamonti G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051170; Reis SDS, 2014, NAT PHYS, V10, P762, DOI 10.1038/NPHYS3081; Sancho JM, 2000, LECT NOTE PHYS, V557, P235; Schmidt S, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00325; Sporns O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001049; Torres JJ, 2007, NEURAL COMPUT, V19, P2739, DOI 10.1162/neco.2007.19.10.2739; Torres JJ, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/5/053014; Tsodyks M, 1998, NEURAL COMPUT, V10, P821, DOI 10.1162/089976698300017502; Tsodyks MV, 1997, P NATL ACAD SCI USA, V94, P719, DOI 10.1073/pnas.94.2.719; Uzun R, 2014, EPL-EUROPHYS LETT, V105, DOI 10.1209/0295-5075/105/60002; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Yasuda H, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.118103; Yoshimoto M, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2946710	30	16	16	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121156	10.1371/journal.pone.0121156	http://dx.doi.org/10.1371/journal.pone.0121156			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799449	Green Published, Green Submitted, gold			2022-12-26	WOS:000351987300220
J	Vitkov, L; Krautgartner, WD; Obermayer, A; Stoiber, W; Hannig, M; Klappacher, M; Hartl, D				Vitkov, Ljubomir; Krautgartner, Wolf-Dietrich; Obermayer, Astrid; Stoiber, Walter; Hannig, Matthias; Klappacher, Michaela; Hartl, Dominik			The Initial Inflammatory Response to Bioactive Implants Is Characterized by NETosis	PLOS ONE			English	Article							NEUTROPHIL EXTRACELLULAR TRAPS; BONE-FORMATION ADJACENT; TITANIUM IMPLANTS; PULMONARY RESPONSES; IN-VITRO; PLATELETS; ACTIVATION; SURFACES; COMPLEMENT; ADHESION	Implants trigger an inflammatory response, which is important for osseointegration. Here we studied neutrophil extracellular trap (NET) release of human neutrophils in response to sandblasted large-grit acid etched (SLA) implants using fluorescent, confocal laser scanning and scanning electron microscopy. Our studies demonstrate that human neutrophils rapidly adhered to SLA surfaces, which triggered histone citrullination and NET release. Further studies showed that albumin or acetylsalicylic acid had no significant effects on the inflammatory response to SLA surfaces. In contrast to bioinert materials, which do not osseointegrate, the bioactivity of SLA surfaces is coupled with the ability to release NETs. Further investigations are necessary for clarifying the role of NETosis for osseointegration.	[Vitkov, Ljubomir; Krautgartner, Wolf-Dietrich; Obermayer, Astrid; Stoiber, Walter; Klappacher, Michaela] Salzburg Univ, Cell Biol, Dept Zool Struct Res, A-5020 Salzburg, Austria; [Vitkov, Ljubomir; Hannig, Matthias] Univ Saarland, Clin Operat Dent Periodontol & Prevent Dent, Homburg, Germany; [Hartl, Dominik] Univ Tubingen, Childrens Hosp, Tubingen, Germany; [Hartl, Dominik] Univ Tubingen, Interdisciplinary Ctr Infect Dis, Tubingen, Germany	Salzburg University; Saarland University; Eberhard Karls University of Tubingen; TUBINGEN UNIVERSITY CHILDRENS HOSPITAL; Eberhard Karls University of Tubingen	Vitkov, L (corresponding author), Salzburg Univ, Cell Biol, Dept Zool Struct Res, A-5020 Salzburg, Austria.	lvitkov@yahoo.com; dominik.hartl@med.uni-tuebingen.de	Vitkov, Ljubomir/H-5873-2019	Vitkov, Ljubomir/0000-0002-1249-0161	Deutsche Forschungsgemeinschaft; Tuebingen University; Dental Ratio Company (Langenfeld, NRW, Germany)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Tuebingen University; Dental Ratio Company (Langenfeld, NRW, Germany)	The authors acknowledge support by Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of Tuebingen University. The authors thank the Dental Ratio Company (Langenfeld, NRW, Germany) for supply of SLA titanium test plates and financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AARONS L, 1980, J PHARM PHARMACOL, V32, P537, DOI 10.1111/j.2042-7158.1980.tb12991.x; Abrahamsson I, 2004, CLIN ORAL IMPLAN RES, V15, P381, DOI 10.1111/j.1600-0501.2004.01082.x; Ayukawa Y, 2010, J ORAL REHABIL, V37, P123, DOI 10.1111/j.1365-2842.2009.02011.x; Berglundh T, 2003, CLIN ORAL IMPLAN RES, V14, P251, DOI 10.1034/j.1600-0501.2003.00972.x; Bonner JC, 2013, ENVIRON HEALTH PERSP, V121, P676, DOI 10.1289/ehp.1205693; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; CARLSSON L, 1994, J ORTHOP RES, V12, P274, DOI 10.1002/jor.1100120218; Caudrillier A, 2012, J CLIN INVEST, V122, P2661, DOI 10.1172/JCI61303; Chow OA, 2010, CELL HOST MICROBE, V8, P445, DOI 10.1016/j.chom.2010.10.005; Ciapetti G, 1998, J BIOMED MATER RES, V41, P455, DOI 10.1002/(SICI)1097-4636(19980905)41:3<455::AID-JBM15>3.0.CO;2-H; Clark SR, 2007, NAT MED, V13, P463, DOI 10.1038/nm1565; Cochran DL, 2011, INT J ORAL MAX IMPL, V26, P1324; DAVISON C, 1971, ANN NY ACAD SCI, V179, P249, DOI 10.1111/j.1749-6632.1971.tb46905.x; DONATH K, 1992, VIRCHOWS ARCH A, V420, P131, DOI 10.1007/BF02358804; Eriksson C, 1997, COLLOID SURFACE B, V9, P67, DOI 10.1016/S0927-7765(97)00010-6; Eriksson C, 2001, BIOMATERIALS, V22, P1987, DOI 10.1016/S0142-9612(00)00382-3; Eriksson C, 1997, J BIOMED MATER RES, V37, P130, DOI 10.1002/(SICI)1097-4636(199710)37:1<130::AID-JBM16>3.0.CO;2-K; Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027; Goncalves DM, 2010, TOXICOL IN VITRO, V24, P1002, DOI 10.1016/j.tiv.2009.12.007; Gupta AK, 2005, HUM IMMUNOL, V66, P1146, DOI 10.1016/j.humimm.2005.11.003; Gupta AK, 2007, SEMIN IMMUNOPATHOL, V29, P163, DOI 10.1007/s00281-007-0073-4; Hahn S, 2006, SPRINGER SEMIN IMMUN, V27, P477, DOI 10.1007/s00281-006-0016-5; Hakkim A, 2010, P NATL ACAD SCI USA, V107, P9813, DOI 10.1073/pnas.0909927107; HEDENBORG M, 1988, INT ARCH OCC ENV HEA, V61, P1, DOI 10.1007/BF00381600; Hong J, 2013, CLIN IMPLANT DENT R, V15, P105, DOI 10.1111/j.1708-8208.2011.00362.x; JACOBSSON SA, 1994, J BONE JOINT SURG BR, V76B, P831, DOI 10.1302/0301-620X.76B5.8083279; Kahlenberg JM, 2013, J IMMUNOL, V190, P1217, DOI 10.4049/jimmunol.1202388; Kessenbrock K, 2009, NAT MED, V15, P623, DOI 10.1038/nm.1959; Le Guehennec L, 2007, DENT MATER, V23, P844, DOI 10.1016/j.dental.2006.06.025; Lethaus B, 2011, INT J ORAL MAX IMPL, V26, P887; Li B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055563; Marcos V, 2009, BLOOD, V114, P4908, DOI 10.1182/blood-2009-09-242388; Milleret V, 2011, EUR CELLS MATER, V21, P430, DOI 10.22203/eCM.v021a32; Mitchell GB, 2003, INFECT IMMUN, V71, P1643, DOI 10.1128/IAI.71.4.1643-1649.2003; Mohamed BM, 2012, NANOMEDICINE-UK, V7, P1181, DOI 10.2217/nnm.11.177; Moriyama Y, 2008, CLIN ORAL IMPLAN RES, V19, P600, DOI 10.1111/j.1600-0501.2007.01508.x; Nardi M, 2004, J CLIN INVEST, V113, P973, DOI 10.1172/JCI200420726; Nardi M, 2001, CELL, V106, P551, DOI 10.1016/S0092-8674(01)00477-9; Neeli I, 2008, J IMMUNOL, V180, P1895, DOI 10.4049/jimmunol.180.3.1895; Nimeri G, 2002, BIOMATERIALS, V23, P1785, DOI 10.1016/S0142-9612(01)00305-2; Noel A, 2013, PART FIBRE TOXICOL, V10, DOI 10.1186/1743-8977-10-48; Nygren H, 1997, J LAB CLIN MED, V129, P35, DOI 10.1016/S0022-2143(97)90159-1; Rao PJ, 2014, ORTHOP SURG, V6, P81, DOI 10.1111/os.12098; Remijsen Q, 2011, CELL DEATH DIFFER, V18, P581, DOI 10.1038/cdd.2011.1; Ribeiro FV, 2006, J PERIODONTOL, V77, P1731, DOI 10.1902/jop.2006.060119; ROTH RI, 1993, TRANSFUSION, V33, P919, DOI 10.1046/j.1537-2995.1993.331194082383.x; Sall J, 2013, J INNATE IMMUN, V5, P290, DOI 10.1159/000346587; TRANCIK T, 1989, CLIN ORTHOP RELAT R, P113; Van Dyke TE, 2015, J DENT RES, V94, P148, DOI 10.1177/0022034514557331; von Bruhl ML, 2012, J EXP MED, V209, P819, DOI 10.1084/jem.20112322; Wang YM, 2009, J CELL BIOL, V184, P205, DOI 10.1083/jcb.200806072; Wettero J, 2003, J BIOMED MATER RES A, V66A, P162, DOI 10.1002/jbm.a.10591; Wettero J, 2003, BIOMATERIALS, V24, P1559, DOI 10.1016/S0142-9612(02)00543-4; Wettero J, 2000, J BIOMED MATER RES, V51, P742, DOI 10.1002/1097-4636(20000915)51:4<742::AID-JBM24>3.0.CO;2-D; Yin H, 2011, J ARTHROPLASTY, V26, P1534, DOI 10.1016/j.arth.2010.10.008	55	18	18	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121359	10.1371/journal.pone.0121359	http://dx.doi.org/10.1371/journal.pone.0121359			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798949	gold, Green Submitted, Green Published			2022-12-26	WOS:000351987300245
J	Wynn, A; Cabeza, J; Adachi, K; Needleman, J; Garcia, PJ; Klausner, JD				Wynn, Adriane; Cabeza, Jeanne; Adachi, Kristina; Needleman, Jack; Garcia, Patricia J.; Klausner, Jeffrey D.			Frequency of Maternal and Newborn Birth Outcomes, Lima, Peru, 2013	PLOS ONE			English	Article								Objective This study describes the pregnancy and birth outcomes at two hospitals in Lima, Peru. The data collection and analysis is intended to inform patients, providers, and policy makers on Peru's progress toward achieving the Millennium Development Goals and to help set priorities for action and further research. Methods Data were collected retrospectively from a sample of 237 women who delivered between December 2012 and September 2013 at the Instituto Nacional Materno Perinatal or the Hospital Nacional Arzobispo Loayza. The outcomes were recorded by a trained mid-wife through telephone interviews with patients and by review of hospital records. Associations between participant demographic characteristics and pregnancy outcomes were tested with Chi-squared, Fisher's exact, or Student's t-test. Results Over 37% of women experienced at least one maternal or perinatal complication, and the most frequent were hypertension/preeclampsia and macrosomia. The women in our sample had a cesarean section rate of 50.2%. Conclusion Maternal and perinatal complications are not uncommon among women in the lower socioeconomic strata of Lima. Also, the high cesarean rate underpins the need for a more comprehensive understanding of the indications for cesarean section deliveries, which could help reduce the number of unnecessary procedures and preventable complications.	[Wynn, Adriane; Needleman, Jack] Univ Calif Los Angeles, Dept Hlth Policy & Management, Fielding Sch Publ Hlth, Los Angeles, CA 90095 USA; [Cabeza, Jeanne] Ctr AIDS Res & Educ CARE, Los Angeles, CA USA; [Adachi, Kristina] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Garcia, Patricia J.] Sch Publ Hlth & Adm FASPA, Lima, Peru; [Garcia, Patricia J.] Univ Peruana Cayetano Heredia, Lima, Peru; [Klausner, Jeffrey D.] Univ Calif Los Angeles, Div Infect Dis, Ctr World Hlth, Los Angeles, CA USA; [Klausner, Jeffrey D.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Epidemiol, Los Angeles, CA 90095 USA; [Klausner, Jeffrey D.] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Universidad Peruana Cayetano Heredia; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	Wynn, A (corresponding author), Univ Calif Los Angeles, Dept Hlth Policy & Management, Fielding Sch Publ Hlth, Los Angeles, CA 90095 USA.	adriane.wynn@gmail.com	Needleman, Jack/I-5461-2013	Needleman, Jack/0000-0002-2875-0589; Wynn, Adriane/0000-0001-8067-3616	National Institute of Mental Health [NIH R 25 MHO87222]; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH058107, R25MH087222] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by a grant (NIH R 25 MHO87222) from the National Institute of Mental Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Congress of Obstetrics and Gynecology, 2011, COCHRANE DATABASE SY; Beck S, 2010, B WORLD HEALTH ORGAN, V88, P31, DOI 10.2471/BLT.08.062554; Cabeza J, 2015, SEX TRANSM INFECT, V91, P7, DOI 10.1136/sextrans-2014-051531; Carcamo CP, 2012, LANCET INFECT DIS, V12, P765, DOI 10.1016/S1473-3099(12)70144-5; Cochran WG., 1963, SAMPLING TECHNIQUES; Cousens S, 2011, LANCET, V377, P1319, DOI 10.1016/S0140-6736(10)62310-0; Instituto Nacional de Estadistica e Informatica (INEI) Lima Peru and ICF International, 2013, PER ENC DEM SAL FAM; Koyanagi A, 2013, LANCET, V381, P476, DOI 10.1016/S0140-6736(12)61605-5; Lawn JE, 2009, BJOG-INT J OBSTET GY, V116, P49, DOI 10.1111/j.1471-0528.2009.02328.x; Lawn JE, 2011, LANCET, V377, P1448, DOI 10.1016/S0140-6736(10)62187-3; Lawn JE, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-S1-S1; Souza JP, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-71; United Nations Children's Fund, 2008, STAT WORLDS CHILDR M; WHO/UNICEF, 2012, COUNTD 2015 BUILD FU; World Health Organization, 2010, GLOB SURV MAT PER HL	15	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0116102	10.1371/journal.pone.0116102	http://dx.doi.org/10.1371/journal.pone.0116102			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25806522	gold, Green Published, Green Submitted			2022-12-26	WOS:000351880000003
J	Boivin, FJ; Sarin, S; Lim, J; Javidan, A; Svajger, B; Khalili, H; Bridgewater, D				Boivin, Felix J.; Sarin, Sanjay; Lim, Janice; Javidan, Ashkan; Svajger, Bruno; Khalili, Hadiseh; Bridgewater, Darren			Stromally Expressed beta-Catenin Modulates Wnt9b Signaling in the Ureteric Epithelium	PLOS ONE			English	Article							KIDNEY; GENE; MORPHOGENESIS; PATHWAY; CELLS	The mammalian kidney undergoes cell interactions between the epithelium and mesenchyme to form the essential filtration unit of the kidney, termed the nephron. A third cell type, the kidney stroma, is a population of fibroblasts located in the kidney capsule, cortex and medulla and is ideally located to affect kidney formation. We found beta-catenin, a transcriptional co-activator, is strongly expressed in distinctive intracellular patterns in the capsular, cortical, and medullary renal stroma. We investigated beta-catenin function in the renal stroma using a conditional knockout strategy that genetically deleted beta-catenin specifically in the renal stroma cell lineage (beta-cats(-/-)). beta-cats(-/-) mutant mice demonstrate marked kidney abnormalities, and surprisingly we show beta-catenin in the renal stroma is essential for regulating the condensing mesenchyme cell population. We show that the population of induced mesenchyme cells is significantly reduced in beta-cats(-/-) mutants and exhibited decreased cell proliferation and a specific loss of Cited 1, while maintaining the expression of other essential nephron progenitor proteins. Wnt9b, the key signal for the induction of nephron progenitors, was markedly reduced in adjacent ureteric epithelial cells in beta-cats(-/-). Analysis of Wnt9b-dependent genes in the neighboring nephron progenitors was significantly reduced while Wnt9b-independent genes remained unchanged. In contrast mice overexpressing beta-catenin exclusively in the renal stroma demonstrated massive increases in the condensing mesenchyme population and Wnt9b was markedly elevated. We propose that beta-catenin in the renal stroma modulates a genetic program in ureteric epithelium that is required for the induction of nephron progenitors.	[Boivin, Felix J.; Sarin, Sanjay; Lim, Janice; Javidan, Ashkan; Svajger, Bruno; Khalili, Hadiseh; Bridgewater, Darren] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada	McMaster University	Bridgewater, D (corresponding author), McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada.	Bridgew@mcmaster.ca	Boivin-Laframboise, Felix/U-4753-2017	Boivin-Laframboise, Felix/0000-0003-2325-0830	Kidney Foundation of Canada; National Science and Engineering Research Council; J.P. Bickell Foundation	Kidney Foundation of Canada; National Science and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); J.P. Bickell Foundation	Funding was provided by: 1. Kidney Foundation of Canada, 2. National Science and Engineering Research Council, 3. J.P. Bickell Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brault V, 2001, DEVELOPMENT, V128, P1253; Bridgewater D, 2008, DEV BIOL, V317, P83, DOI 10.1016/j.ydbio.2008.02.010; Cano-Gauci DF, 1999, J CELL BIOL, V146, P255; Carroll TJ, 2005, DEV CELL, V9, P283, DOI 10.1016/j.devcel.2005.05.016; Costantini F, 2010, DEV CELL, V18, P698, DOI 10.1016/j.devcel.2010.04.008; Cullen-McEwen LA, 2005, NEPHRON EXP NEPHROL, V99, pE1, DOI 10.1159/000081792; CUNHA GR, 1985, CELL DIFFER DEV, V17, P137, DOI 10.1016/0045-6039(85)90481-6; Das A, 2013, NAT CELL BIOL, V15, P1035, DOI 10.1038/ncb2828; Eger A, 2000, J CELL BIOL, V148, P173, DOI 10.1083/jcb.148.1.173; EKBLOM P, 1991, KIDNEY INT, V39, P394, DOI 10.1038/ki.1991.51; Gong KQ, 2007, MOL CELL BIOL, V27, P7661, DOI 10.1128/MCB.00465-07; Grobstein C, 1967, Natl Cancer Inst Monogr, V26, P279; Gumbiner BM, 2000, J CELL BIOL, V148, P399, DOI 10.1083/jcb.148.3.399; Hatini V, 1996, GENE DEV, V10, P1467, DOI 10.1101/gad.10.12.1467; Howard BA, 2014, SEMIN CELL DEV BIOL, V25, P43, DOI 10.1016/j.semcdb.2014.01.004; Hum S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088400; Humphreys BD, 2008, CELL STEM CELL, V2, P284, DOI 10.1016/j.stem.2008.01.014; Kanwar YS, 1997, KIDNEY INT, V52, P589, DOI 10.1038/ki.1997.372; Karner CM, 2011, DEVELOPMENT, V138, P1247, DOI 10.1242/dev.057646; Karner CM, 2009, NAT GENET, V41, P793, DOI 10.1038/ng.400; Levinson RS, 2005, DEVELOPMENT, V132, P529, DOI 10.1242/dev.01604; Li W, 2014, DEV DYNAM, V243, P853, DOI [10.1002/dvdy.24134, 10.1002/DVDY.24134]; Little MH, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008300; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Marose TD, 2008, DEV BIOL, V314, P112, DOI 10.1016/j.ydbio.2007.11.016; Mugford JW, 2009, DEV BIOL, V333, P312, DOI 10.1016/j.ydbio.2009.06.043; Park JS, 2007, DEVELOPMENT, V134, P2533, DOI 10.1242/dev.006155; Yu J, 2009, DEVELOPMENT, V136, P161, DOI 10.1242/dev.022087; Zhurinsky J, 2000, J CELL SCI, V113, P3127	29	23	23	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0120347	10.1371/journal.pone.0120347	http://dx.doi.org/10.1371/journal.pone.0120347			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803581	Green Published, Green Submitted, gold			2022-12-26	WOS:000353889600072
J	Soares, JBRC; Gaviraghi, A; Oliveira, MF				Correa Soares, Juliana B. R.; Gaviraghi, Alessandro; Oliveira, Marcus F.			Mitochondrial Physiology in the Major Arbovirus Vector Aedes aegypti: Substrate Preferences and Sexual Differences Define Respiratory Capacity and Superoxide Production	PLOS ONE			English	Article							HYDROGEN-PEROXIDE RELEASE; FLIGHT-MUSCLE MITOCHONDRIA; OXYGEN SPECIES GENERATION; REACTIVE OXYGEN; OXIDATIVE DAMAGE; AMINO-ACIDS; ADENOSINE-TRIPHOSPHATE; PROLINE DEHYDROGENASE; TRICARBOXYLATE-CYCLE; ENERGY-METABOLISM	Adult females of Aedes aegypti are facultative blood sucking insects and vectors of Dengue and yellow fever viruses. Insect dispersal plays a central role in disease transmission and the extremely high energy demand posed by flight is accomplished by a very efficient oxidative phosphorylation process, which take place within flight muscle mitochondria. These organelles play a central role in energy metabolism, interconnecting nutrient oxidation to ATP synthesis, but also represent an important site of cellular superoxide production. Given the importance of mitochondria to cell physiology, and the potential contributions of this organelle for A. aegypti biology and vectorial capacity, here, we conducted a systematic assessment of mitochondrial physiology in flight muscle of young adult A. aegypti fed exclusively with sugar. This was carried out by determining the activities of mitochondrial enzymes, the substrate preferences to sustain respiration, the mitochondrial bioenergetic efficiency and capacity, in both mitochondria-enriched preparations and mechanically permeabilized flight muscle in both sexes. We also determined the substrates preferences to promote mitochondrial superoxide generation and the main sites where it is produced within this organelle. We observed that respiration in A. aegypti mitochondria was essentially driven by complex I and glycerol 3 phosphate dehydrogenase substrates, which promoted distinct mitochondrial bioenergetic capacities, but with preserved efficiencies. Respiration mediated by proline oxidation in female mitochondria was strikingly higher than in males. Mitochondrial superoxide production was essentially mediated through proline and glycerol 3 phosphate oxidation, which took place at sites other than complex I. Finally, differences in mitochondrial superoxide production among sexes were only observed in male oxidizing glycerol 3 phosphate, exhibiting higher rates than in female. Together, these data represent a significant step towards the understanding of fundamental mitochondrial processes in A. aegypti, with potential implications for its physiology and vectorial capacity.	[Correa Soares, Juliana B. R.; Gaviraghi, Alessandro; Oliveira, Marcus F.] Univ Fed Rio de Janeiro, Inst Bioquim Med Leopoldo de Meis, Lab Bioquim Resposta Ao Estresse, Rio De Janeiro, Brazil; [Correa Soares, Juliana B. R.; Gaviraghi, Alessandro; Oliveira, Marcus F.] Univ Fed Rio de Janeiro, Inst Nacl Ciencia & Tecnol Biol Estrutural & Bioi, Lab Inflamacao & Metab, Rio De Janeiro, RJ, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Oliveira, MF (corresponding author), Univ Fed Rio de Janeiro, Inst Bioquim Med Leopoldo de Meis, Lab Bioquim Resposta Ao Estresse, Cidade Univ, Rio De Janeiro, Brazil.	maroli@bioqmed.ufrj.br	Oliveira, Marcus/G-3158-2011	Oliveira, Marcus/0000-0002-9890-8425; Gaviraghi, Alessandro/0000-0002-8246-2633	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) (through Institutos Nacionais de Ciencia e Tecnologia); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) (through Jovem Cientista do Nosso Estado) [E-26/101.492/2010]; Cientista do Nosso Estado [E-26/102.333/2013]; Pronem [E-26/111.169/2011]; CNPq (Produtividade em Pesquisa-PQ) [301571/2009-0]; PAPD-FAPERJ fellow (Apoio a Pos-Doutorado no Estado do Rio de Janeiro) [45879]; CsF-BJT-CNPq fellow (BJT-Ciencias sem Fronteiras) [402409/2012-4]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) (through Institutos Nacionais de Ciencia e Tecnologia)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) (through Jovem Cientista do Nosso Estado)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Cientista do Nosso Estado; Pronem; CNPq (Produtividade em Pesquisa-PQ)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); PAPD-FAPERJ fellow (Apoio a Pos-Doutorado no Estado do Rio de Janeiro); CsF-BJT-CNPq fellow (BJT-Ciencias sem Fronteiras)	This work was supported by grants from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) (through Institutos Nacionais de Ciencia e Tecnologia 2010), Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) (through Jovem Cientista do Nosso Estado E-26/101.492/2010; Cientista do Nosso Estado E-26/102.333/2013; Pronem E-26/111.169/2011). MFO is research scholar from CNPq (Produtividade em Pesquisa-PQ 301571/2009-0). JBRCS is a PAPD-FAPERJ fellow (Apoio a Pos-Doutorado no Estado do Rio de Janeiro, 45879) and AG is a CsF-BJT-CNPq fellow (BJT-Ciencias sem Fronteiras, 402409/2012-4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036801; AUERSWALD L, 1995, J EXP BIOL, V198, P1423; Auerswald L, 2002, J INSECT PHYSIOL, V48, P239, DOI 10.1016/S0022-1910(01)00169-X; Auerswald L, 1998, J EXP BIOL, V201, P2333; AVIDOR Y, 1959, BIOCHEM J, V72, P8, DOI 10.1042/bj0720008; Ballard JWO, 2007, AGING CELL, V6, P699, DOI 10.1111/j.1474-9726.2007.00331.x; BARRETT FM, 1975, COMP BIOCHEM PHYS B, V52, P427; Bayne ACV, 2005, BIOCHEM J, V391, P277, DOI 10.1042/BJ20041872; BEENAKKERS AMT, 1984, INSECT BIOCHEM, V14, P243, DOI 10.1016/0020-1790(84)90057-X; BEENAKKERS AMT, 1964, BIOCHIM BIOPHYS ACTA, V84, P205, DOI 10.1016/0926-6542(64)90081-2; BEEUWKES HENRY, 1933, TRANS ROY SOC TROP MED AND HYG [LONDON], V26, P425, DOI 10.1016/S0035-9203(33)90103-0; Benard G, 2006, AM J PHYSIOL-CELL PH, V291, pC1172, DOI 10.1152/ajpcell.00195.2006; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; BOVERIS A, 1973, BIOCHEM J, V134, P707, DOI 10.1042/bj1340707; Brand MD, 2010, EXP GERONTOL, V45, P466, DOI 10.1016/j.exger.2010.01.003; BURSELL E, 1975, COMP BIOCHEM PHYS B, V52, P235, DOI 10.1016/0305-0491(75)90057-7; CHILDRESS CC, 1967, J BIOL CHEM, V242, P754; Christophers SR, 1960, YELLOW FEVER MOSQUIT; CLEMENTS AN, 1955, J EXP BIOL, V32, P547; Clutton-Brock TH, 2007, P ROY SOC B-BIOL SCI, V274, P3097, DOI 10.1098/rspb.2007.1138; Correa CC, 2012, MITOCHONDRION, V12, P459, DOI 10.1016/j.mito.2012.06.005; CRABTREE B, 1972, BIOCHEM J, V130, P697, DOI 10.1042/bj1300697; CRABTREE B, 1972, BIOCHEM J, V126, P49, DOI 10.1042/bj1260049; CRABTREE B, 1970, BIOCHEM J, V117, P1019, DOI 10.1042/bj1171019; Dissanayake Sumudu N, 2010, BMC Res Notes, V3, P248, DOI 10.1186/1756-0500-3-248; FARMER KJ, 1989, FREE RADICAL BIO MED, V7, P23, DOI 10.1016/0891-5849(89)90096-8; Ferguson M, 2005, BIOCHEM J, V390, P501, DOI 10.1042/BJ20042130; FERNANDEZSOUSA JM, 1976, BIOCHEM BIOPH RES CO, V73, P217, DOI 10.1016/0006-291X(76)90696-3; Figueira TR, 2013, ANTIOXID REDOX SIGN, V18, P2029, DOI 10.1089/ars.2012.4729; FLORIDI A, 1973, EXPERIENTIA, V29, P1228, DOI 10.1007/BF01935087; Giulivi C, 2008, BIOCHEM J, V415, P309, DOI 10.1042/BJ20080973; Gnaiger E, 2002, BIOCHEM SOC T, V30, P252, DOI 10.1042/bst0300252; Gnaiger E, 2009, INT J BIOCHEM CELL B, V41, P1837, DOI 10.1016/j.biocel.2009.03.013; Godenschwege T, 2009, GENETICS, V183, P175, DOI 10.1534/genetics.109.103515; Goncalves RLS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041083; Goncalves RLS, 2014, REDOX BIOL, V2, P901, DOI 10.1016/j.redox.2014.07.003; Goncalves RLS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007854; GONDA O, 1957, BIOCHEM J, V67, P487, DOI 10.1042/bj0670487; GOTTSBERGER G, 1984, PLANT SYST EVOL, V145, P55, DOI 10.1007/BF00984031; HANSFORD RG, 1970, J BIOL CHEM, V245, P991; HANSFORD RG, 1971, BIOCHEM J, V121, P771, DOI 10.1042/bj1210771; HANSFORD RG, 1976, COMP BIOCHEM PHYS B, V55, P543, DOI 10.1016/0305-0491(76)90015-8; HANSFORD RG, 1972, BIOCHEM J, V127, P271, DOI 10.1042/bj1270271; HANSFORD RG, 1975, BIOCHEM J, V146, P537, DOI 10.1042/bj1460537; HANSFORD RG, 1975, BIOCHEM J, V148, P389, DOI 10.1042/bj1480389; HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x; HARRIS KL, 1986, DEV COMP IMMUNOL, V10, P305, DOI 10.1016/0145-305X(86)90021-2; Henn MW, 1998, J INVERTEBR PATHOL, V71, P42, DOI 10.1006/jipa.1997.4700; Herzig S, 2012, SCIENCE, V337, P93, DOI 10.1126/science.1218530; Hey-Mogensen M, 2014, FREE RADICAL BIO MED, V72, P149, DOI 10.1016/j.freeradbiomed.2014.04.007; HODKINSON ID, 1991, BIOL J LINN SOC, V43, P101, DOI 10.1111/j.1095-8312.1991.tb00587.x; Honorio NA, 2003, MEM I OSWALDO CRUZ, V98, P191, DOI 10.1590/S0074-02762003000200005; Hsieh YC, 2013, INSECT BIOCHEM MOLEC, V43, P859, DOI 10.1016/j.ibmb.2013.06.008; Huang JF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058499; Justo R, 2005, AM J PHYSIOL-CELL PH, V289, pC372, DOI 10.1152/ajpcell.00035.2005; Justo R, 2005, LIFE SCI, V76, P1147, DOI 10.1016/j.lfs.2004.08.019; Korshunov SS, 1997, FEBS LETT, V416, P15, DOI 10.1016/S0014-5793(97)01159-9; KROGH A, 1951, J EXP BIOL, V28, P344; Kuzmiak S, 2012, J EXP BIOL, V215, P2039, DOI 10.1242/jeb.065094; LINTS FA, 1983, GERONTOLOGY, V29, P336, DOI 10.1159/000213136; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Luckhart S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003180; MEYER J, 1977, ARCH BIOCHEM BIOPHYS, V178, P387, DOI 10.1016/0003-9861(77)90208-9; Micheu S, 2000, AMINO ACIDS, V18, P157, DOI 10.1007/s007260050014; Miller G, 2009, J BIOL CHEM, V284, P26482, DOI 10.1074/jbc.M109.009340; Miwa S, 2003, FREE RADICAL BIO MED, V35, P938, DOI 10.1016/S0891-5849(03)00464-7; Mora C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000606; Moreno-Sanchez R, 2013, FEBS J, V280, P927, DOI 10.1111/febs.12086; Oliveira JHM, 2011, INSECT BIOCHEM MOLEC, V41, P349, DOI 10.1016/j.ibmb.2011.02.001; Oliveira PL, 2002, FEBS LETT, V525, P3, DOI 10.1016/S0014-5793(02)03026-0; Orr AL, 2012, J BIOL CHEM, V287, P42921, DOI 10.1074/jbc.M112.397828; Padmanabha H, 2011, J MED ENTOMOL, V48, P974, DOI 10.1603/ME11020; Pennington JE, 2003, J INSECT PHYSIOL, V49, P115, DOI 10.1016/S0022-1910(02)00267-6; Perevoshchikova IV, 2013, FREE RADICAL BIO MED, V61, P298, DOI 10.1016/j.freeradbiomed.2013.04.006; Pesta D, 2012, METHODS MOL BIOL, V810, P25, DOI 10.1007/978-1-61779-382-0_3; Pichaud N, 2013, MITOCHONDRION, V13, P817, DOI 10.1016/j.mito.2013.05.008; Pichaud N, 2013, J BIOENERG BIOMEMBR, V45, P25, DOI 10.1007/s10863-012-9473-9; Pichaud N, 2011, AM J PHYSIOL-REG I, V301, pR48, DOI 10.1152/ajpregu.00542.2010; Pichaud N, 2010, J EXP BIOL, V213, P1665, DOI 10.1242/jeb.040261; Pon LA, 2007, METHOD CELL BIOL, V80, P1; Quinlan CL, 2014, J BIOL CHEM, V289, P8312, DOI 10.1074/jbc.M113.545301; Quinlan CL, 2013, REDOX BIOL, V1, P304, DOI 10.1016/j.redox.2013.04.005; Rauhamaki V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0078069; ROCKSTEIN M, 1961, SCIENCE, V133, P1476, DOI 10.1126/science.133.3463.1476; Rodriguez-Cuenca S, 2002, J BIOL CHEM, V277, P42958, DOI 10.1074/jbc.M207229200; Rossignol R, 1999, J BIOL CHEM, V274, P33426, DOI 10.1074/jbc.274.47.33426; ROWLEY WA, 1968, J INSECT PHYSIOL, V14, P719, DOI 10.1016/0022-1910(68)90230-8; Russell RC, 2005, MED VET ENTOMOL, V19, P451, DOI 10.1111/j.1365-2915.2005.00589.x; SACKTOR B, 1955, J BIOPHYS BIOCHEM CY, V1, P29, DOI 10.1083/jcb.1.1.29; SACKTOR B, 1966, J BIOL CHEM, V241, P624; Sacktor B, 1970, ADV INSECT PHYSIOL, V7, P268; SACKTOR BERTRAM, 1965, P483; Santiago APSA, 2008, BIOCHIMIE, V90, P1566, DOI 10.1016/j.biochi.2008.06.013; Sanz A, 2007, EXP GERONTOL, V42, P173, DOI 10.1016/j.exger.2006.10.003; Sanz A, 2010, J BIOENERG BIOMEMBR, V42, P135, DOI 10.1007/s10863-010-9281-z; Scaraffia PY, 2003, J INSECT PHYSIOL, V49, P591, DOI 10.1016/S0022-1910(03)00031-3; Seifert EL, 2010, J BIOL CHEM, V285, P5748, DOI 10.1074/jbc.M109.026203; Servet C, 2012, FRONT BIOSCI-LANDMRK, V17, P607, DOI 10.2741/3947; SOHAL RS, 1993, FREE RADICAL BIO MED, V14, P583, DOI 10.1016/0891-5849(93)90139-L; SOHAL RS, 1991, MECH AGEING DEV, V57, P187, DOI 10.1016/0047-6374(91)90034-W; SOHAL RS, 1994, FREE RADICAL BIO MED, V16, P621, DOI 10.1016/0891-5849(94)90062-0; SOHAL RS, 1995, FREE RADICAL BIO MED, V19, P499, DOI 10.1016/0891-5849(95)00037-X; SOTAVALTA O, 1952, NATURE, V170, P1057, DOI 10.1038/1701057a0; SRERE PA, 1963, ACTA CHEM SCAND, V17, P129, DOI 10.3891/acta.chem.scand.17s-0129; STEGWEE D, 1962, J INSECT PHYSIOL, V8, P117, DOI 10.1016/0022-1910(62)90081-1; Suarez RK, 2005, J EXP BIOL, V208, P3573, DOI 10.1242/jeb.01775; Suarez RK, 2000, J EXP BIOL, V203, P905; Syromyatnikov MY, 2013, BIOCHEMISTRY-MOSCOW+, V78, P909, DOI 10.1134/S0006297913080075; Tahara EB, 2009, FREE RADICAL BIO MED, V46, P1283, DOI 10.1016/j.freeradbiomed.2009.02.008; Testa ND, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058936; Treberg JR, 2011, J BIOL CHEM, V286, P27103, DOI 10.1074/jbc.M111.252502; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; VANDENBERGH SG, 1967, METHOD ENZYMOL, V10, P117; Vina J, 2003, ANTIOXID REDOX SIGN, V5, P549, DOI 10.1089/152308603770310194; WATANABE MI, 1951, J GEN PHYSIOL, V34, P675, DOI 10.1085/jgp.34.5.675; WATTAM AR, 1992, AM J TROP MED HYG, V47, P702, DOI 10.4269/ajtmh.1992.47.702; Yan LJ, 1997, P NATL ACAD SCI USA, V94, P11168, DOI 10.1073/pnas.94.21.11168; Yan LJ, 1998, P NATL ACAD SCI USA, V95, P12896, DOI 10.1073/pnas.95.22.12896; Yu TZ, 2006, P NATL ACAD SCI USA, V103, P2653, DOI 10.1073/pnas.0511154103	120	37	37	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0120600	10.1371/journal.pone.0120600	http://dx.doi.org/10.1371/journal.pone.0120600			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803027	gold, Green Published, Green Submitted			2022-12-26	WOS:000353889600083
J	Lopez-Martinez, G; Margalef-Catala, M; Salinas, F; Liti, G; Cordero-Otero, R				Lopez-Martinez, Gema; Margalef-Catala, Mar; Salinas, Francisco; Liti, Gianni; Cordero-Otero, Ricardo			ATG18 and FAB1 Are Involved in Dehydration Stress Tolerance in Saccharomyces cerevisiae	PLOS ONE			English	Article							WINE YEAST; TRANSCRIPTIONAL RESPONSE; GENE-EXPRESSION; VACUOLE; PROTEIN; RESOLUTION; LOCI; PCR; PTDINS(3,5)P-2; DESICCATION	Recently, different dehydration-based technologies have been evaluated for the purpose of cell and tissue preservation. Although some early results have been promising, they have not satisfied the requirements for large-scale applications. The long experience of using quantitative trait loci (QTLs) with the yeast Saccharomyces cerevisiae has proven to be a good model organism for studying the link between complex phenotypes and DNA variations. Here, we use QTL analysis as a tool for identifying the specific yeast traits involved in dehydration stress tolerance. Three hybrids obtained from stable haploids and sequenced in the Saccharomyces Genome Resequencing Project showed intermediate dehydration tolerance in most cases. The dehydration resistance trait of 96 segregants from each hybrid was quantified. A smooth, continuous distribution of the anhydrobiosis tolerance trait was found, suggesting that this trait is determined by multiple QTLs. Therefore, we carried out a QTL analysis to identify the determinants of this dehydration tolerance trait at the genomic level. Among the genes identified after reciprocal hemizygosity assays, RSM22, ATG18 and DBR1 had not been referenced in previous studies. We report new phenotypes for these genes using a previously validated test. Finally, our data illustrates the power of this approach in the investigation of the complex cell dehydration phenotype.	[Lopez-Martinez, Gema; Margalef-Catala, Mar; Cordero-Otero, Ricardo] Univ Rovira & Virgili, Dept Biochem & Biotechnol, E-43007 Tarragona, Spain; [Salinas, Francisco; Liti, Gianni] Univ Sophia Antipolis, Inst Res Canc & Ageing Nice, Nice, France	Universitat Rovira i Virgili; CHU Nice; UDICE-French Research Universities; Universite Cote d'Azur	Cordero-Otero, R (corresponding author), Univ Rovira & Virgili, Dept Biochem & Biotechnol, E-43007 Tarragona, Spain.	ricardo.cordero@urv.cat	Salinas, Francisco/AAP-9439-2020; Salinas, Francisco/W-3269-2017	Salinas, Francisco/0000-0002-8391-8145; Salinas, Francisco/0000-0002-8391-8145; Liti, Gianni/0000-0002-2318-0775; Margalef-Catala, Mar/0000-0002-6259-4348	Spanish Ministerio de Ciencia e Innovacion [AGL2012-40018]; Rovira i Virgili University	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Rovira i Virgili University	This work was supported by grant AGL2012-40018 from the Spanish Ministerio de Ciencia e Innovacion. The authors thank Rovira i Virgili University for the doctoral fellowships FI-DGR 2012, AGAUR to GL. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambroset C, 2011, G3-GENES GENOM GENET, V1, P263, DOI 10.1534/g3.111.000422; Barth H, 2001, FEBS LETT, V508, P23, DOI 10.1016/S0014-5793(01)03016-2; Brachmann CB, 1998, YEAST, V14, P115; Breslow DK, 2008, NAT METHODS, V5, P711, DOI 10.1038/nmeth.1234; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Bryant NJ, 1998, MICROBIOL MOL BIOL R, V62, P230, DOI 10.1128/MMBR.62.1.230-247.1998; CHAPMAN KB, 1991, CELL, V65, P483, DOI 10.1016/0092-8674(91)90466-C; Cubillos FA, 2011, MOL ECOL, V20, P1401, DOI 10.1111/j.1365-294X.2011.05005.x; Cubillos FA, 2009, FEMS YEAST RES, V9, P1217, DOI 10.1111/j.1567-1364.2009.00583.x; Deutschbauer AM, 2005, NAT GENET, V37, P1333, DOI 10.1038/ng1674; Dove SK, 2004, EMBO J, V23, P1922, DOI 10.1038/sj.emboj.7600203; Dove SK, 2002, CURR BIOL, V12, P885, DOI 10.1016/S0960-9822(02)00891-6; Dupont S, 2014, APPL MICROBIOL BIOT, V98, P8821, DOI 10.1007/s00253-014-6028-5; Efe JA, 2007, MOL BIOL CELL, V18, P4232, DOI 10.1091/mbc.E07-04-0301; Gary JD, 2002, MOL BIOL CELL, V13, P1238, DOI 10.1091/mbc.01-10-0498; Gary JD, 1998, J CELL BIOL, V143, P65, DOI 10.1083/jcb.143.1.65; Guan J, 2001, MOL BIOL CELL, V12, P3821, DOI 10.1091/mbc.12.12.3821; Hu XH, 2007, GENETICS, V175, P1479, DOI 10.1534/genetics.106.065292; HUXLEY C, 1990, TRENDS GENET, V6, P236, DOI 10.1016/0168-9525(90)90190-H; Katou T, 2009, J BIOSCI BIOENG, V107, P383, DOI 10.1016/j.jbiosc.2008.12.014; Kim JW, 2000, NUCLEIC ACIDS RES, V28, P3666, DOI 10.1093/nar/28.18.3666; KLIONSKY DJ, 1990, MICROBIOL REV, V54, P266, DOI 10.1128/MMBR.54.3.266-292.1990; Lettre G, 2008, NAT GENET, V40, P584, DOI 10.1038/ng.125; Li SC, 2009, BBA-MOL CELL RES, V1793, P650, DOI 10.1016/j.bbamcr.2008.08.003; Liti G, 2009, NATURE, V458, P337, DOI 10.1038/nature07743; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Martinez G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033324; LOUIS EJ, 1995, GENETICS, V139, P125; Maher B, 2008, NATURE, V456, P18, DOI 10.1038/456018a; Marullo P, 2006, FEMS YEAST RES, V6, P268, DOI 10.1111/j.1567-1364.2006.00034.x; Marullo P, 2007, FEMS YEAST RES, V7, P941, DOI 10.1111/j.1567-1364.2007.00252.x; Merz S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r95; Miermont A, 2013, P NATL ACAD SCI USA, V110, P5725, DOI 10.1073/pnas.1215367110; Nakamura T, 2008, J BIOSCI BIOENG, V106, P405, DOI 10.1263/jbb.106.405; North M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002699; Novo M, 2007, FEMS YEAST RES, V7, P304, DOI 10.1111/j.1567-1364.2006.00175.x; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Ratnakumar S, 2011, MOL BIOSYST, V7, P139, DOI 10.1039/c0mb00114g; Rodriguez-Porrata B, 2012, J APPL MICROBIOL, V112, P512, DOI 10.1111/j.1365-2672.2011.05219.x; Rodriguez-Porrata B, 2011, WORLD J MICROB BIOT, V27, P75, DOI 10.1007/s11274-010-0428-1; Rodriguez-Porrata B, 2012, FLOW CYTOMETRY, V1, P119; Romano GH, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.1; Rossignol T, 2006, APPL MICROBIOL BIOT, V71, P699, DOI 10.1007/s00253-006-0398-2; Salinas F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049640; Sambrook J., 2001, MOL CLONING LAB MANU; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; Shaw JD, 2003, TRAFFIC, V4, P479, DOI 10.1034/j.1600-0854.2003.t01-1-00106.x; Shima J, 2008, YEAST, V25, P179, DOI 10.1002/yea.1577; Singh J, 2005, APPL ENVIRON MICROB, V71, P8752, DOI 10.1128/AEM.71.12.8752-8763.2005; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Weedon MN, 2008, NAT GENET, V40, P575, DOI 10.1038/ng.121; YAMAMOTO A, 1995, MOL BIOL CELL, V6, P525, DOI 10.1091/mbc.6.5.525; Yang YD, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003693	53	9	9	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0119606	10.1371/journal.pone.0119606	http://dx.doi.org/10.1371/journal.pone.0119606			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803831	gold, Green Published, Green Submitted			2022-12-26	WOS:000353889600032
J	Aguiar, SA; Barela, JA				Aguiar, Stefane A.; Barela, Jose A.			Adaptation of Sensorimotor Coupling in Postural Control Is Impaired by Sleep Deprivation	PLOS ONE			English	Article							LATERAL STEP INITIATION; ADJUSTMENT ERRORS; VISUAL CONDITIONS; ALTERED SUPPORT; PERFORMANCE; OLDER; POPULATION; PERCEPTION	The purpose of the study was to investigate the effects of sleep deprivation (SD) in adaptation of the coupling between visual information and body sway in young adults' postural control due to changes in optic flow characteristics. Fifteen young adults were kept awake for approximately 25 hours and formed the SD group, while fifteen adults who slept normally the night before the experiment participated as part of the control group. All participants stood as still as possible in a moving room before and after being exposed to one trial with higher amplitude and velocity of room movement. Postural performance and the coupling between visual information, provided by a moving room, and body sway were examined. Results showed that after an abrupt change in visual cues, larger amplitude, and higher velocity of the room, the influence of room motion on body sway was decreased in both groups. However, such a decrease was less pronounced in sleep deprived as compared to control subjects. Sleep deprived adults were able to adapt motor responses to the environmental change provided by the increase in room motion amplitude. Nevertheless, they were not as efficient as control subjects in doing so, which demonstrates that SD impairs the ability to adapt sensorimotor coupling while controlling posture when a perturbation occurs.	[Aguiar, Stefane A.; Barela, Jose A.] Cruzeiro do Sul Univ, Inst Phys Act & Sport Sci, Sao Paulo, Brazil; [Barela, Jose A.] Sao Paulo State Univ, Inst Biosci, Rio Claro, Brazil	Universidade Estadual Paulista	Barela, JA (corresponding author), Cruzeiro do Sul Univ, Inst Phys Act & Sport Sci, Sao Paulo, Brazil.	jose.barela@cruzeirodosul.edu.br	Barela, José A/F-4284-2012	Barela, José A/0000-0003-0951-254X	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2011/16016-8]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) through a scholarship to Stefane A. Aguiar (grant number 2011/16016-8). The funder has analyzed and approved the study design but had no role in data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar S.A., 2014, PSYCHOL NEUROSCIENCE, V7, P593, DOI [https://doi.org/10.3922/j.psns.2014.4.19, DOI 10.3922/J.PSNS.2014.4.19, 10.3922/j.psns.2014.4.19]; Aguiar SA, 2014, NEUROSCI LETT, V574, P47, DOI 10.1016/j.neulet.2014.05.028; Avni N, 2006, PSYCHIAT CLIN NEUROS, V60, P340, DOI 10.1111/j.1440-1819.2006.01511.x; Ayalon RD, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.06.080; Barela JA, 2014, NEUROSCI LETT, V566, P6, DOI 10.1016/j.neulet.2014.02.029; Barela JA, 2011, RES DEV DISABIL, V32, P2075, DOI 10.1016/j.ridd.2011.08.018; Bertolazi AN, 2011, SLEEP MED, V12, P70, DOI 10.1016/j.sleep.2010.04.020; Bougard C, 2011, EXP BRAIN RES, V209, P109, DOI 10.1007/s00221-010-2524-8; Daviaux Y, 2014, EXP BRAIN RES, V232, P2243, DOI 10.1007/s00221-014-3915-z; Dawson D, 1997, NATURE, V388, P235, DOI 10.1038/40775; Fabbri M, 2006, NEUROPSYCHOLOGIA, V44, P2520, DOI 10.1016/j.neuropsychologia.2006.03.033; Forsman P, 2007, J SLEEP RES, V16, P259, DOI 10.1111/j.1365-2869.2007.00597.x; Forsman P, 2010, GAIT POSTURE, V32, P419, DOI 10.1016/j.gaitpost.2010.06.012; FORSSBERG H, 1982, J NEUROSCI, V2, P545; Gomez S, 2008, CLIN NEUROPHYSIOL, V119, P617, DOI 10.1016/j.clinph.2007.10.058; Haghighatdoost F, 2012, NUTRITION, V28, P1146, DOI 10.1016/j.nut.2012.04.015; Horak F, 1996, HDB PHYSIOL 12, V12, P255; Hublin C, 2001, SLEEP, V24, P392, DOI 10.1093/sleep/24.4.392; Jackson ML, 2013, ACCIDENT ANAL PREV, V50, P438, DOI 10.1016/j.aap.2012.05.020; Jeka JJ, 2008, EXP BRAIN RES, V191, P453, DOI 10.1007/s00221-008-1539-x; Kendall AP, 2006, INT J NEUROSCI, V116, P1125, DOI 10.1080/00207450500513922; Killgore WDS, 2010, PROG BRAIN RES, V185, P105, DOI 10.1016/B978-0-444-53702-7.00007-5; Klein TJ, 2011, BIOL CYBERN, V105, P291, DOI 10.1007/s00422-011-0466-2; NASHNER LM, 1982, J NEUROSCI, V2, P536; Ohayon MM, 2012, J PSYCHIATR RES, V46, P422, DOI 10.1016/j.jpsychires.2011.06.008; Oie KS, 2002, COGNITIVE BRAIN RES, V14, P164, DOI 10.1016/S0926-6410(02)00071-X; Patel M, 2008, EXP BRAIN RES, V185, P165, DOI 10.1007/s00221-007-1143-5; Philibert I, 2005, SLEEP, V28, P1392, DOI 10.1093/sleep/28.11.1392; Philip P, 2006, SLEEP MED REV, V10, P347, DOI 10.1016/j.smrv.2006.04.002; Prioli AC, 2006, HUM MOVEMENT SCI, V25, P435, DOI 10.1016/j.humov.2006.03.003; Rinaldi NM, 2009, NEUROSCI LETT, V467, P225, DOI 10.1016/j.neulet.2009.10.042; Robillard R, 2011, CLIN NEUROPHYSIOL, V122, P1771, DOI 10.1016/j.clinph.2011.02.010; Sagaspe P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039410; Sparto PJ, 2014, EXP BRAIN RES, V232, P3977, DOI 10.1007/s00221-014-4081-z; Sparto PJ, 2013, J NEUROPHYSIOL, V109, P415, DOI 10.1152/jn.00682.2012; Toledo DR, 2014, EXP BRAIN RES, V232, P493, DOI 10.1007/s00221-013-3756-1; Viana AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072719; Wu MC, 2012, PREV MED, V55, P305, DOI 10.1016/j.ypmed.2012.07.013	38	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0122340	10.1371/journal.pone.0122340	http://dx.doi.org/10.1371/journal.pone.0122340			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE6ZS	25799560	Green Published, gold			2022-12-26	WOS:000351987300332
J	Alimova, A; Wei, H; Katz, A; Spatz, L; Gottlieb, P				Alimova, Alexandra; Wei, Hui; Katz, Al; Spatz, Linda; Gottlieb, Paul			The phi 6 Cystovirus Protein P7 Becomes Accessible to Antibodies in the Transcribing Nucleocapsid: A Probe for Viral Structural Elements	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; DSRNA BACTERIOPHAGE PHI-6; NUCLEOTIDE-SEQUENCE; POLYMERASE COMPLEX; REPLICATION; SEGMENT; GENES; MECHANISM; MEMBRANE; GENOMES	Protein P7 is a component of the cystovirus viral polymerase complex. In the unpackaged procapsid, the protein is situated in close proximity to the viral directed RNA polymerase, P2. Cryo-electron microscopy difference maps from the species phi 6 procapsid have demonstrated that P7 and P2 likely interact prior to viral RNA packaging. The location of P7 in the post-packaged nucleocapsid (NC) remains unknown. P7 may translocate closer to the fivefold axis of a filled procapsid but this has not been directly visualized. We propose that monoclonal antibodies (Mabs) can be selected that serve as probe-reagents for viral assembly and structure. A set of Mabs have been isolated that recognize and bind to the phi 6 P7. The antibody set contains five unique Mabs, four of which recognize a linear epitope and one which recognizes a conformational epitope. The four unique Mabs that recognize a linear epitope display restricted utilization of V-kappa and V-H genes. The restricted genetic range among 4 of the 5 antibodies implies that the antibody repertoire is limited. The limitation could be the consequence of a paucity of exposed antigenic sites on the. phi 6 P7 surface. It is further demonstrated that within phi 6 nucleocapsids that are primed for early-phase transcription, P7 is partially accessible to the Mabs, indicating that the nucleocapsid shell (protein P8) has undergone partial disassembly exposing the protein's antigenic sites.	[Alimova, Alexandra; Wei, Hui; Spatz, Linda; Gottlieb, Paul] CUNY, Sophie Davis Sch Biomed Educ, New York, NY 10031 USA; [Katz, Al] CUNY City Coll, Dept Phys, New York, NY 10031 USA	City University of New York (CUNY) System; Sophie Davis School of Biomedical Education; City University of New York (CUNY) System; City College of New York (CUNY)	Gottlieb, P (corresponding author), CUNY, Sophie Davis Sch Biomed Educ, New York, NY 10031 USA.	pgottl@med.cuny.edu			National Institute of General Medical Science [SC1-GM092781]; National Institutes of Health Research Centers in Minority Institutions (NIH/NCRR/RCMI) CCNY/Grant [G12-RR03060]; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003060] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC1GM092781] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007603] Funding Source: NIH RePORTER	National Institute of General Medical Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health Research Centers in Minority Institutions (NIH/NCRR/RCMI) CCNY/Grant; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	Funding provided by National Institute of General Medical Science Grant SC1-GM092781, www.nigms.nih.gov (PG); National Institutes of Health Research Centers in Minority Institutions (NIH/NCRR/RCMI) CCNY/Grant G12-RR03060, www.nih.gov (PG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, PLOS ONE, DOI DOI 10.1371/J0URNAL.P0NE.0014488; BAMFORD DH, 1980, VIROLOGY, V107, P222, DOI 10.1016/0042-6822(80)90287-1; Butcher SJ, 1997, EMBO J, V16, P4477, DOI 10.1093/emboj/16.14.4477; de Haas F, 1999, J MOL BIOL, V294, P357, DOI 10.1006/jmbi.1999.3260; El Omari K, 2013, NUCL ACIDS RES; El Omari K, 2013, STRUCTURE, V21, P1384, DOI 10.1016/j.str.2013.06.017; EMORI Y, 1983, J VIROL, V46, P196, DOI 10.1128/JVI.46.1.196-203.1983; Eryilmaz E, 2008, J MOL BIOL, V382, P402, DOI 10.1016/j.jmb.2008.07.006; GOTTLIEB P, 1991, VIROLOGY, V181, P589, DOI 10.1016/0042-6822(91)90892-F; GOTTLIEB P, 1988, VIROLOGY, V163, P183, DOI 10.1016/0042-6822(88)90245-0; GOTTLIEB P, 1990, J BACTERIOL, V172, P5774, DOI 10.1128/jb.172.10.5774-5782.1990; Huiskonen JT, 2006, STRUCTURE, V14, P1039, DOI 10.1016/j.str.2006.03.018; Juuti JT, 1997, J MOL BIOL, V266, P891, DOI 10.1006/jmbi.1996.0817; Katz G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047489; Lefranc Marie-Paule, 2004, In Silico Biology, V4, P17; MCGRAW T, 1986, J VIROL, V58, P142, DOI 10.1128/JVI.58.1.142-151.1986; Mindich L, 1999, J BACTERIOL, V181, P4505, DOI 10.1128/JB.181.15.4505-4508.1999; Mindich L, 2004, VIRUS RES, V101, P83, DOI 10.1016/j.virusres.2003.12.008; MINDICH L, 1988, J VIROL, V62, P1180, DOI 10.1128/JVI.62.4.1180-1185.1988; MINDICH L, 1994, VIROLOGY, V202, P258, DOI 10.1006/viro.1994.1341; Nemecek D, 2012, J VIROL, V86, P11616, DOI 10.1128/JVI.01347-12; Nemecek D, 2011, J MOL BIOL, V414, P260, DOI 10.1016/j.jmb.2011.10.004; OLKKONEN VM, 1987, J VIROL, V61, P2362, DOI 10.1128/JVI.61.8.2362-2367.1987; OLKKONEN VM, 1991, J MOL BIOL, V218, P569, DOI 10.1016/0022-2836(91)90702-8; Poranen MM, 2008, J MOL BIOL, V383, P529, DOI 10.1016/j.jmb.2008.08.082; Qiao XY, 1997, P NATL ACAD SCI USA, V94, P4074, DOI 10.1073/pnas.94.8.4074; ROMANTSCHUK M, 1988, EMBO J, V7, P1821, DOI 10.1002/j.1460-2075.1988.tb03014.x; SEMANCIK JS, 1973, J MOL BIOL, V78, P617, DOI 10.1016/0022-2836(73)90283-0; Sun X, 2012, J VIROL, V86; Tiller T, 2009, J IMMUNOL METHODS, V350, P183, DOI 10.1016/j.jim.2009.08.009; Yadav P, 2010, J IMMUNOL, V184; Ye J, 2013, NUCLEIC ACIDS RES, V41, pW34, DOI 10.1093/nar/gkt382	32	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0122160	10.1371/journal.pone.0122160	http://dx.doi.org/10.1371/journal.pone.0122160			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799314	Green Published, gold			2022-12-26	WOS:000351987300318
J	Anagnostou, P; Capocasa, M; Milia, N; Sanna, E; Battaggia, C; Luzi, D; Bisol, GD				Anagnostou, Paolo; Capocasa, Marco; Milia, Nicola; Sanna, Emanuele; Battaggia, Cinzia; Luzi, Daniela; Bisol, Giovanni Destro			When Data Sharing Gets Close to 100%: What Human Paleogenetics Can Teach the Open Science Movement	PLOS ONE			English	Article							ANCIENT; SOCIETY; AVAILABILITY; GENETICS; FUTURE; DNA	This study analyzes data sharing regarding mitochondrial, Y chromosomal and autosomal polymorphisms in a total of 162 papers on ancient human DNA published between 1988 and 2013. The estimated sharing rate was not far from totality (97.6% +/- 2.1%) and substantially higher than observed in other fields of genetic research (evolutionary, medical and forensic genetics). Both a questionnaire-based survey and the examination of Journals' editorial policies suggest that this high sharing rate cannot be simply explained by the need to comply with stakeholders requests. Most data were made available through body text, but the use of primary databases increased in coincidence with the introduction of complete mitochondrial and next-generation sequencing methods. Our study highlights three important aspects. First, our results imply that researchers' awareness of the importance of openness and transparency for scientific progress may complement stakeholders' policies in achieving very high sharing rates. Second, widespread data sharing does not necessarily coincide with a prevalent use of practices which maximize data findability, accessibility, useability and preservation. A detailed look at the different ways in which data are released can be very useful to detect failures to adopt the best sharing modalities and understand how to correct them. Third and finally, the case of human paleogenetics tells us that a widespread awareness of the importance of Open Science may be important to build reliable scientific practices even in the presence of complex experimental challenges.	[Anagnostou, Paolo; Battaggia, Cinzia; Bisol, Giovanni Destro] Univ Roma La Sapienza, Dipartimento Biol Ambientale, Piazzale Aldo Moro 5, I-00185 Rome, Italy; [Anagnostou, Paolo; Capocasa, Marco; Bisol, Giovanni Destro] Ist Italiano Antropol, Rome, Italy; [Capocasa, Marco] Univ Roma La Sapienza, Dipartimento Biol & Biotecnol Charles Darwin, I-00185 Rome, Italy; [Milia, Nicola; Sanna, Emanuele] Univ Cagliari, Dipartimento Sci Vita & Ambiente, Cagliari, Italy; [Luzi, Daniela] CNR, Ist Ric Popolaz & Polit Sociali, Rome, Italy	Sapienza University Rome; Sapienza University Rome; University of Cagliari; Consiglio Nazionale delle Ricerche (CNR); Istituto di Ricerche sulla Popolazione e le Politiche Sociali (IRPPS-CNR)	Anagnostou, P (corresponding author), Univ Roma La Sapienza, Dipartimento Biol Ambientale, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	paolo.anagnostou@uniroma1.it; destrobisol@uniroma1.it	Capocasa, Marco/AAF-8315-2021; Luzi, Daniela/G-9899-2013	Luzi, Daniela/0000-0003-3404-3271; Destro Bisol, Giovanni/0000-0002-4232-9715; Anagnostou, Paolo/0000-0003-0768-4612	Ministero dell'Istruzione, dell'Universita e della Ricerca (PRIN) [200975T9EW]; Istituto Italiano di Antropologia	Ministero dell'Istruzione, dell'Universita e della Ricerca (PRIN)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Istituto Italiano di Antropologia	This work was supported by the Ministero dell'Istruzione, dell'Universita e della Ricerca (PRIN 2009-2011, prot.n. 200975T9EW) http://www.istruzione.it/ and the Istituto Italiano di Antropologia http://www.isita-org.com/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsheikh-Ali AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024357; Anagnostou P, 2014, EMB C 1 4 APR LEIC U; Barr C.D., 2012, CHANCE, V25, P8, DOI DOI 10.1109/EMBC.2012.6345862; Biotechnology and Biological Sciences Research Council, 2007, BBSRC DAT SHAR POL V; Bisol GD, 2014, J ANTHROPOL SCI, V92, P179, DOI 10.4436/JASS.92006; Bisol GD, 2014, J ANTHROPOL SCI, V92, pI, DOI 10.4436/JASS.92016; Blumenthal D, 2006, ACAD MED, V81, P137, DOI 10.1097/00001888-200602000-00008; Borgman CL, 2012, J AM SOC INF SCI TEC, V63, P1059, DOI 10.1002/asi.22634; Boulton G., 2012, SCI OPEN ENTERPRISE; Bowling A, 2005, J PUBLIC HEALTH-UK, V27, P281, DOI 10.1093/pubmed/fdi031; Caetano DS, 2014, PEERJ PREPRINTS, V2; Campbell EG, 2002, JAMA-J AM MED ASSOC, V287, P473, DOI 10.1001/jama.287.4.473; Contreras J.L., 2011, MINNESOTA J LAW SCI, V12, P61; Destro-Bisol G, 2013, J ANTHROPOL SCI, V91, P233, DOI [10.4436/JASS.91022, 10.4436/jass.91022]; Enke N, 2012, ECOL INFORM, V11, P25, DOI 10.1016/j.ecoinf.2012.03.004; Feldman L, 2012, LANCET, V379, P1877, DOI 10.1016/S0140-6736(12)60809-5; Fischer BA, 2010, SCI ENG ETHICS, V16, P783, DOI 10.1007/s11948-010-9239-x; Giffels J, 2010, SCI ENG ETHICS, V16, P801, DOI 10.1007/s11948-010-9230-6; Gonzalez Fortes G, 2013, BIOESSAYS, V35, P690, DOI 10.1002/bies.201300036; Groves T, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c564; Hampton SE, 2013, FRONT ECOL ENVIRON, V11, P156, DOI 10.1890/120103; Hebsgaard MB, 2005, TRENDS MICROBIOL, V13, P212, DOI 10.1016/j.tim.2005.03.010; Holdren J. P., 2013, INCREASING ACCESS TO; Kaye J, 2009, NAT REV GENET, V10, P331, DOI 10.1038/nrg2573; Kim Y., 2012, J COMPUTATIONAL SCI, V3, P47, DOI DOI 10.22369/ISSN.2153-4136/3/1/6; Kirsanow K, 2012, ANN ANAT, V194, P121, DOI 10.1016/j.aanat.2011.11.002; Kowalczyk S, 2011, ANNU REV INFORM SCI, V45, P247, DOI 10.1002/aris.2011.1440450113; Lecarpentier D, 2013, EGU GEN ASS C ABSTR, V15, P7202; Luzi D, 2013, INT J GREY LIT, V9, P69; Magee AF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110268; Manghi P, 2010, GREY J, V6, P1, DOI [10.1093/jscr/2010.6.1, DOI 10.1093/JSCR/2010.6.1]; MARKS J, 1988, J HUM EVOL, V17, P769, DOI 10.1016/0047-2484(88)90065-6; Milia N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037552; Murdoch CJ, 2009, GENOME MED, V1, DOI 10.1186/gm22; National Institutes of Health, 2003, NIH DATA SHARING POL; National Science Board, 2005, LONG LIV DIG DAT COL; Neylon C, 2009, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2009, P540; PAABO S, 1985, NATURE, V314, P644, DOI 10.1038/314644a0; Paabo S, 2004, ANNU REV GENET, V38, P645, DOI 10.1146/annurev.genet.37.110801.143214; Piwowar HA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018657; Piwowar HA, 2008, PLOS MED, V5, P1315, DOI 10.1371/journal.pmed.0050183; Savage CJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007078; Shapiro B, 2010, BIOESSAYS, V32, P388, DOI 10.1002/bies.201000026; Stoneking M, 2011, NAT REV GENET, V12, P603, DOI 10.1038/nrg3029; Tenopir C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021101; Thorley M, 2010, NERC DATA POLICY GUI; Vines TH, 2014, CURR BIOL, V24, P94, DOI 10.1016/j.cub.2013.11.014; Vines TH, 2013, FASEB J, V27, P1304, DOI 10.1096/fj.12-218164; Vogeli C, 2006, ACAD MED, V81, P128, DOI 10.1097/00001888-200602000-00007; Wall JD, 2007, PLOS GENET, V3, P1862, DOI 10.1371/journal.pgen.0030175; Whitlock MC, 2010, AM NAT, V175, pE45, DOI 10.1086/650340; Wicherts JM, 2006, AM PSYCHOL, V61, P726, DOI 10.1037/0003-066X.61.7.726; Wicherts JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026828	53	21	21	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121409	10.1371/journal.pone.0121409	http://dx.doi.org/10.1371/journal.pone.0121409			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE6ZS	25799293	Green Submitted, Green Published, gold			2022-12-26	WOS:000351987300248
J	Aulinas, A; Ramirez, MJ; Barahona, MJ; Valassi, E; Resmini, E; Mato, E; Santos, A; Crespo, I; Bell, O; Surralles, J; Webb, SM				Aulinas, Anna; Ramirez, Maria-Jose; Barahona, Maria-Jose; Valassi, Elena; Resmini, Eugenia; Mato, Eugenia; Santos, Alicia; Crespo, Iris; Bell, Olga; Surralles, Jordi; Webb, Susan M.			Dyslipidemia and Chronic Inflammation Markers Are Correlated with Telomere Length Shortening in Cushing's Syndrome	PLOS ONE			English	Article							CARDIOVASCULAR RISK; OXIDATIVE STRESS; DISEASE; ASSOCIATION; CHOLESTEROL; MORTALITY; DIAGNOSIS; MASS; AGE	Introduction Cushing's syndrome (CS) increases cardiovascular risk (CVR) and adipocytokine imbalance, associated with an increased inflammatory state. Telomere length (TL) shortening is a novel CVR marker, associated with inflammation biomarkers. We hypothesized that inflammatory state and higher CVR in CS might be related to TL shortening, as observed in premature aging. Aim To evaluate relationships between TL, CVR and inflammation markers in CS. Methods In a cross-sectional study, 77 patients with CS (14 males, 59 pituitary-, 17 adrenal-and 1 ectopic-origin; 21 active disease) and 77 age-, gender-, smoking-matched controls were included. Total white blood cell TL was measured by TRF-Southern technique. Clinical data and blood samples were collected (lipids, adrenal function, glucose). Adiponectin, interleukin-6 (IL6) and C-reactive protein (CRP) were available in a subgroup of patients (n= 32). Correlations between TL and clinical features were examined and multiple linear regression analysis was performed to investigate potential predictors of TL. Results Dyslipidemic CS had shorter TL than non-dyslipidemic subjects (7328 +/- 1274 vs 7957 +/- 1137 bp, p<0.05). After adjustment for age and body mass index, cured and active CS dyslipidemic patients had shorter TL than non-dyslipidemic CS (cured: 7187 +/- 1309 vs 7868 +/- 1104; active: 7203 +/- 1262 vs 8615 +/- 1056, respectively, p< 0.05). Total cholesterol and triglycerides negatively correlated with TL (r-0.279 and -0.259, respectively, p< 0.05), as well as CRP and IL6 (r-0.412 and -0.441, respectively, p< 0.05). No difference in TL according the presence of other individual CVR factors (hypertension, diabetes mellitus, obesity) were observed in CS or in the control group. Additional TL shortening was observed in dyslipidemic obese patients who were also hypertensive, compared to those with two or less CVR factors (6956 +/- 1280 vs 7860 +/- 1180, respectively, p< 0.001). Age and dyslipidemia were independent negative predictors of TL. Conclusion TL is shortened in dyslipidemic CS patients, further worse if hypertension and/or obesity coexist and is negatively correlated with increased inflammation markers. Increased lipids and a "low" grade inflammation may contribute to TL shortening and consequently to premature ageing and increased morbidity in CS.	[Aulinas, Anna; Valassi, Elena; Resmini, Eugenia; Mato, Eugenia; Santos, Alicia; Crespo, Iris; Bell, Olga; Webb, Susan M.] Univ Autonoma Barcelona, Hosp St Pau, St Pau Biomed Res Inst, Endocrinol Med Dept, E-08193 Barcelona, Spain; [Aulinas, Anna; Barahona, Maria-Jose; Valassi, Elena; Resmini, Eugenia; Santos, Alicia; Crespo, Iris; Webb, Susan M.] ISCIII, Ctr Biomed Network Res Rare Dis CIBERER Unit 747, Barcelona, Spain; [Ramirez, Maria-Jose; Surralles, Jordi] Univ Autonoma Barcelona, Dept Genet & Microbiol, E-08193 Barcelona, Spain; [Ramirez, Maria-Jose; Surralles, Jordi] ISCIII, Ctr Biomed Network Res Rare Dis CIBERER Unit 745, Barcelona, Spain; [Barahona, Maria-Jose] Hosp Univ Mutua Terrassa, Dept Endocrinol, Barcelona, Spain; [Mato, Eugenia; Bell, Olga] ISCIII, Ctr Biomed Network Res Bioengn Biomat & Nanomed C, Barcelona, Spain	Autonomous University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III; Autonomous University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III; Hospital Universitario Mutua Terrassa; Instituto de Salud Carlos III	Aulinas, A (corresponding author), Univ Autonoma Barcelona, Hosp St Pau, St Pau Biomed Res Inst, Endocrinol Med Dept, E-08193 Barcelona, Spain.	aaulinasm@gmail.com	Surrallés, Jordi/AAE-7667-2020; Crespo, Iris/L-2699-2017; Barahona, Maria José/ABE-9068-2021	Crespo, Iris/0000-0002-1212-4540; Ramirez de Haro, Maria Jose/0000-0003-1417-7731; Webb, Susan/0000-0001-7052-6436; Surralles, Jordi/0000-0002-4041-7519; Barahona, Maria-Jose/0000-0003-2935-6521; Santos, Alicia/0000-0002-2179-6189	Spanish Ministry of Health, ISCIII [PI 11/00001, PI 08/0302]; Fundacion de la Sociedad Espanola de Endocrinologia y Nutricion (FSEEN); European Society of Endocrinology (ESE); Generalitat de Catalunya [SGR0489-2009, SGR 355-2014]; ICREA-Academia award	Spanish Ministry of Health, ISCIII(Instituto de Salud Carlos IIISpanish Government); Fundacion de la Sociedad Espanola de Endocrinologia y Nutricion (FSEEN); European Society of Endocrinology (ESE); Generalitat de Catalunya(Generalitat de Catalunya); ICREA-Academia award(ICREA)	Funding: This work was supported by grants from the Spanish Ministry of Health, ISCIII, PI 11/00001 and PI 08/0302 and by two Young Investigator Awards of Fundacion de la Sociedad Espanola de Endocrinologia y Nutricion (FSEEN) and of the European Society of Endocrinology (ESE) to AA. JS's laboratory is funded by the Generalitat de Catalunya (SGR0489-2009) and the ICREA-Academia award. SMW's group is funded by the Generalitat de Catalunya (SGR 355-2014). CIBERER is an initiative of the ISCIII, Spain. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Al-Attas OS, 2010, EUR J ENDOCRINOL, V163, P601, DOI 10.1530/EJE-10-0241; Grundy Scott M, 2005, Crit Pathw Cardiol, V4, P198; Aulinas A, 2014, EUR J ENDOCRINOL, V171, P21, DOI 10.1530/EJE-14-0098; Barahona MJ, 2009, J CLIN ENDOCR METAB, V94, P3365, DOI 10.1210/jc.2009-0766; Bekaert S, 2007, AGING CELL, V6, P639, DOI 10.1111/j.1474-9726.2007.00321.x; Buxton JL, 2011, J CLIN ENDOCR METAB, V96, P1500, DOI 10.1210/jc.2010-2924; Calado RT, 2009, NEW ENGL J MED, V361, P2353, DOI 10.1056/NEJMra0903373; Cas AD, 2013, NUTR METAB CARDIOVAS, V23, P272, DOI 10.1016/j.numecd.2011.04.005; Castella A, 2007, TOXICOL LETT, V172, P29, DOI 10.1016/j.toxlet.2007.05.012; Dekkers OM, 2013, J CLIN ENDOCR METAB, V98, P2277, DOI 10.1210/jc.2012-3582; Epel ES, 2009, HORM-INT J ENDOCRINO, V8, P7, DOI 10.14310/horm.2002.1217; Farzaneh-Far R, 2008, ARTERIOSCL THROM VAS, V28, P1379, DOI 10.1161/ATVBAHA.108.167049; Friedrich U, 2000, MECH AGEING DEV, V119, P89, DOI 10.1016/S0047-6374(00)00173-1; Fuster JJ, 2006, CIRC RES, V99, P1167, DOI 10.1161/01.RES.0000251281.00845.18; Fyhrquist F, 2010, J INTERN MED, V267, P278, DOI 10.1111/j.1365-2796.2009.02139.x; Garcia-Calzon S, 2014, INT J OBESITY, V38, P177, DOI 10.1038/ijo.2013.68; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Harte AL, 2012, EXP DIABETES RES, DOI 10.1155/2012/895185; Kimura M, 2008, AM J EPIDEMIOL, V167, P799, DOI 10.1093/aje/kwm380; Lin KW, 2005, J CELL MOL MED, V9, P977, DOI 10.1111/j.1582-4934.2005.tb00395.x; Monickaraj F, 2013, J BIOSCIENCES, V38, P113, DOI 10.1007/s12038-012-9289-0; Monickaraj F, 2012, CLIN BIOCHEM, V45, P1432, DOI 10.1016/j.clinbiochem.2012.07.097; Muezzinler A, 2014, OBES REV, V15, P192, DOI 10.1111/obr.12126; Muezzinler A, 2013, AGEING RES REV, V12, P509, DOI 10.1016/j.arr.2013.01.003; Nieman LK, 2008, J CLIN ENDOCR METAB, V93, P1526, DOI 10.1210/jc.2008-0125; O'Donovan A, 2009, BRAIN BEHAV IMMUN, V23, P446, DOI 10.1016/j.bbi.2008.11.006; Petersen S, 1998, EXP CELL RES, V239, P152, DOI 10.1006/excr.1997.3893; Saliques S, 2011, ATHEROSCLEROSIS, V219, P753, DOI 10.1016/j.atherosclerosis.2011.09.011; Salpea KD, 2010, ATHEROSCLEROSIS, V209, P42, DOI 10.1016/j.atherosclerosis.2009.09.070; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Shen Q, 2012, J CLIN ENDOCR METAB, V97, P1371, DOI 10.1210/jc.2011-1562; Strandberg TE, 2011, J AM GERIATR SOC, V59, P1979, DOI 10.1111/j.1532-5415.2011.03610_13.x; Surralles J, 1999, AM J HUM GENET, V65, P1617, DOI 10.1086/302665; Valassi E, 2012, PITUITARY, V15, P319, DOI 10.1007/s11102-012-0394-8; Valassi E, 2012, NEUROENDOCRINOLOGY, V95, P187, DOI 10.1159/000330416; Valdes AM, 2005, LANCET, V366, P662, DOI 10.1016/S0140-6736(05)66630-5; Wilson WRW, 2008, EUR HEART J, V29, P2689, DOI 10.1093/eurheartj/ehn386; Ye SQ, 2013, AM J CARDIOL, V111, P962, DOI 10.1016/j.amjcard.2012.12.017; Zou Y, 2004, MOL BIOL CELL, V15, P3709, DOI 10.1091/mbc.E04-03-0207	39	27	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120185	10.1371/journal.pone.0120185	http://dx.doi.org/10.1371/journal.pone.0120185			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799396	Green Published, Green Submitted, gold			2022-12-26	WOS:000351987300109
J	Fraker, ME; Anderson, EJ; Brodnik, RM; Carreon-Martinez, L; DeVanna, KM; Fryer, BJ; Heath, DD; Reichert, JM; Ludsin, SA				Fraker, Michael E.; Anderson, Eric J.; Brodnik, Reed M.; Carreon-Martinez, Lucia; DeVanna, Kristen M.; Fryer, Brian J.; Heath, Daniel D.; Reichert, Julie M.; Ludsin, Stuart A.			Particle Backtracking Improves Breeding Subpopulation Discrimination and Natal-Source Identification in Mixed Populations	PLOS ONE			English	Article							PERCH PERCA-FLAVESCENS; GREAT-LAKES; LARVAL DISPERSAL; MODELING DISPERSAL; ASSIGNMENT METHODS; THERMAL STRUCTURE; GENETIC-STRUCTURE; FISH LARVAE; RECRUITMENT; WALLEYE	We provide a novel method to improve the use of natural tagging approaches for subpopulation discrimination and source-origin identification in aquatic and terrestrial animals with a passive dispersive phase. Our method integrates observed site-referenced biological information on individuals in mixed populations with a particle-tracking model to retrace likely dispersal histories prior to capture (i.e., particle backtracking). To illustrate and test our approach, we focus on western Lake Erie's yellow perch (Perca flavescens) population during 2006-2007, using microsatellite DNA and otolith microchemistry from larvae and juveniles as natural tags. Particle backtracking showed that not all larvae collected near a presumed hatching location may have originated there, owing to passive drift during the larval stage that was influenced by strong river-and wind-driven water circulation. Re-assigning larvae to their most probable hatching site (based on probabilistic dispersal trajectories from the particle backtracking model) improved the use of genetics and otolith microchemistry to discriminate among local breeding subpopulations. This enhancement, in turn, altered (and likely improved) the estimated contributions of each breeding subpopulation to the mixed population of juvenile recruits. Our findings indicate that particle backtracking can complement existing tools used to identify the origin of individuals in mixed populations, especially in flow-dominated systems.	[Fraker, Michael E.; Brodnik, Reed M.; DeVanna, Kristen M.; Ludsin, Stuart A.] Ohio State Univ, Dept Evolut Ecol & Organismal Biol, Aquat Ecol Lab, Columbus, OH 43210 USA; [Anderson, Eric J.] NOAA GLERL, Ann Arbor, MI USA; [Carreon-Martinez, Lucia] Univ Texas Brownsville, Dept Biol, Brownsville, TX 78520 USA; [Fryer, Brian J.; Heath, Daniel D.; Reichert, Julie M.] Univ Windsor, GLIER, Windsor, ON N9B 3P4, Canada	University System of Ohio; Ohio State University; National Oceanic Atmospheric Admin (NOAA) - USA; University of Texas System; University of Texas Rio Grande Valley; University of Windsor	Fraker, ME (corresponding author), Ohio State Univ, Dept Evolut Ecol & Organismal Biol, Aquat Ecol Lab, Columbus, OH 43210 USA.	fraker.24@osu.edu	Carreon Martinez, Lucia/B-9214-2017; FRYER, BRIAN/AAF-2128-2019	Fraker, Michael/0000-0002-1813-706X; Anderson, Eric/0000-0001-5342-8383	Great Lakes Fishery Commission's Fisheries Research Program; National Oceanic and Atmospheric Administration's Great Lakes Environmental Research Laboratory; Ohio State University Open Access Fund	Great Lakes Fishery Commission's Fisheries Research Program; National Oceanic and Atmospheric Administration's Great Lakes Environmental Research Laboratory; Ohio State University Open Access Fund	Funding for this research was provided by the Great Lakes Fishery Commission's Fisheries Research Program (http://www.glfc.org; to SAL) and the National Oceanic and Atmospheric Administration's Great Lakes Environmental Research Laboratory (http://www.glerl.noaa.gov; to SAL), with other in-kind support provided by the Ohio Department of Natural Resources-Division of Wildlife (http://wildlife.ohiodnr.gov). Funding for Open Access was provided by The Ohio State University Open Access Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allendorf FW, 2008, TRENDS ECOL EVOL, V23, P327, DOI 10.1016/j.tree.2008.02.008; Baker D, 2011, SOURCES TRANSPORT 2; Baumann H, 2006, FISH OCEANOGR, V15, P465, DOI 10.1111/j.1365-2419.2005.00395.x; Beletsky D, 2001, J GEOPHYS RES-OCEANS, V106, P19745, DOI 10.1029/2000JC000691; Beletsky D, 2013, J GEOPHYS RES-OCEANS, V118, P6238, DOI 10.1002/2013JC008854; Beneteau CL, 2009, CONSERV GENET, V10, P477, DOI 10.1007/s10592-008-9627-9; BENNETT JR, 1987, J COMPUT PHYS, V68, P272, DOI 10.1016/0021-9991(87)90058-1; Berry O, 2012, MOL ECOL, V21, P2145, DOI 10.1111/j.1365-294X.2012.05520.x; Bilton DT, 2001, ANNU REV ECOL SYST, V32, P159, DOI 10.1146/annurev.ecolsys.32.081501.114016; Blumberg A.F., 1987, 3 DIMENSIONAL COASTA, P1, DOI [10.1029/co004p0001, DOI 10.1029/CO004P0001]; Bradbury IR, 2008, MOL ECOL, V17, P1438, DOI 10.1111/j.1365-294X.2008.03694.x; Broekhuizen N, 2011, J SHELLFISH RES, V30, P643, DOI 10.2983/035.030.0307; Cadrin S. X., 2005, STOCK IDENTIFICATION; Campana SE, 1999, MAR ECOL PROG SER, V188, P263, DOI 10.3354/meps188263; Carreon-Martinez L., 2012, THESIS U WINDSOR; Christensen A, 2007, MAR ECOL PROG SER, V347, P221, DOI 10.3354/meps06980; Cowen RK, 2009, ANNU REV MAR SCI, V1, P443, DOI 10.1146/annurev.marine.010908.163757; Craig J.F., 1987, BIOL PERCH RELATED F; Dereki JA, 1983, 370 NOAA GREAT LAK E; Eagles D, 2012, MED VET ENTOMOL, V26, P334, DOI 10.1111/j.1365-2915.2011.01005.x; Elphinstone MS, 2003, MOL ECOL NOTES, V3, P317, DOI 10.1046/j.1471-8286.2003.00397.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fuller K, 1995, GREAT LAKES ENV ATLA; Gerlach G, 2001, HEREDITY, V86, P213, DOI 10.1046/j.1365-2540.2001.00825.x; Gillanders BM, 2009, ECOLOGICAL CONNECTIVITY AMONG TROPICAL COASTAL ECOSYSTEMS, P457, DOI 10.1007/978-90-481-2406-0_13; Gopalan G, 1998, CAN J FISH AQUAT SCI, V55, P2572, DOI 10.1139/cjfas-55-12-2572; Guichard S, 2012, J APPL ECOL, V49, P287, DOI 10.1111/j.1365-2664.2011.02072.x; Hale ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045170; Hand CP, 2008, CAN J FISH AQUAT SCI, V65, P1153, DOI 10.1139/F08-045; Hauser L, 2006, MOL ECOL, V15, P3157, DOI 10.1111/j.1365-294X.2006.03017.x; Hedges KJ, 2002, THESIS U WINDSOR; Hilborn R, 2003, P NATL ACAD SCI USA, V100, P6564, DOI 10.1073/pnas.1037274100; Hinrichsen HH, 2011, ICES J MAR SCI, V68, P1478, DOI 10.1093/icesjms/fsr056; Hobson KA, 1999, OECOLOGIA, V120, P314, DOI 10.1007/s004420050865; HOUDE ED, 1969, J FISH RES BOARD CAN, V26, P1647, DOI 10.1139/f69-148; Humphrey S, 2012, CAN J FISH AQUAT SCI, V69, P1959, DOI 10.1139/f2012-116; James MK, 2002, P ROY SOC B-BIOL SCI, V269, P2079, DOI 10.1098/rspb.2002.2128; Jombart T, 2010, BMC GENET, V11, DOI [DOI 10.1186/1471-2156-11-94, 10.1186/1471-2156-11-94]; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Jones ML, 2006, CAN J FISH AQUAT SCI, V63, P457, DOI 10.1139/F05-239; Kim KS, 2010, J R SOC INTERFACE, V7, P677, DOI 10.1098/rsif.2009.0345; Kimura R, 2000, MAR ECOL PROG SER, V208, P217, DOI 10.3354/meps208217; Kocovsky PM, 2013, J FISH BIOL, V82, P2015, DOI 10.1111/jfb.12129; Kool JT, 2013, LANDSCAPE ECOL, V28, P165, DOI 10.1007/s10980-012-9819-z; Leis JM, 2007, MAR ECOL PROG SER, V347, P185, DOI 10.3354/meps06977; Leis JM, 2010, ICHTHYOL RES, V57, P325, DOI 10.1007/s10228-010-0177-z; Lester SE, 2009, MAR ECOL PROG SER, V384, P33, DOI 10.3354/meps08029; Li L, 2007, MOL ECOL NOTES, V7, P600, DOI 10.1111/j.1471-8286.2006.01645.x; Ludsin S. A., 2000, THESIS OHIO STATE U; Ludsin SA, 2006, T AM FISH SOC, V135, P218, DOI 10.1577/T04-165.1; Ludsin SA, 2001, ECOL APPL, V11, P731, DOI 10.2307/3061113; Ludsin SA, 2014, CAN J FISH AQUAT SCI, V71, P775, DOI 10.1139/cjfas-2013-0512; McConkey KR, 2012, BIOL CONSERV, V146, P1, DOI 10.1016/j.biocon.2011.09.018; Mercier L, 2011, ECOL APPL, V21, P1352, DOI 10.1890/09-1887.1; Michalak AM, 2013, P NATL ACAD SCI USA, V110, P6448, DOI 10.1073/pnas.1216006110; Miller JA, 2010, FISH RES, V102, P152, DOI 10.1016/j.fishres.2009.11.005; Miller TJ, 2007, MAR ECOL PROG SER, V347, P127, DOI 10.3354/meps06973; Nathan R, 2005, DIVERS DISTRIB, V11, P131, DOI 10.1111/j.1366-9516.2005.00146.x; Nathan R, 2011, THEOR ECOL-NETH, V4, P113, DOI 10.1007/s12080-011-0115-3; Nickols KJ, 2012, MAR ECOL PROG SER, V464, P17, DOI 10.3354/meps09875; North E. W., 2009, 295 ICES; Paetkau D, 2004, MOL ECOL, V13, P55, DOI 10.1046/j.1365-294X.2004.02008.x; PAETKAU D, 1995, MOL ECOL, V4, P347, DOI 10.1111/j.1365-294X.1995.tb00227.x; Pedersen OP, 2003, FISH RES, V65, P173, DOI 10.1016/j.fishres.2003.09.014; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; Reichert JM, 2010, CAN J FISH AQUAT SCI, V67, P987, DOI 10.1139/F10-036; Ricciardi A, 2000, TRENDS ECOL EVOL, V15, P62, DOI 10.1016/S0169-5347(99)01745-0; Romero L, 2013, J PHYS OCEANOGR, V43, P1862, DOI 10.1175/JPO-D-13-011.1; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Scavia D, 2014, J GREAT LAKES RES, V40, P226, DOI 10.1016/j.jglr.2014.02.004; Schindler DE, 2010, NATURE, V465, P609, DOI 10.1038/nature09060; Schwab D. J., 1994, WATER POLL RES J CAN, V29, P203, DOI DOI 10.2166/wqrj.1994.014; Selkoe KA, 2006, ECOL LETT, V9, P615, DOI 10.1111/j.1461-0248.2006.00889.x; Sepulveda-Villet OJ, 2011, CAN J FISH AQUAT SCI, V68, P1435, DOI 10.1139/F2011-077; Sinclair M, 1988, MARINE POPULATIONS E; Smith DJ, 2013, APPL ENVIRON MICROB, V79, P1134, DOI 10.1128/AEM.03029-12; Soons MB, 2004, ECOLOGY, V85, P3056, DOI 10.1890/03-0522; Stepien CA, 2009, MOL ECOL, V18, P3411, DOI 10.1111/j.1365-294X.2009.04291.x; Tay YC, 2012, AQUAT BIOL, V15, P283, DOI 10.3354/ab00433; Thomas CFG, 2003, J APPL ECOL, V40, P912, DOI 10.1046/j.1365-2664.2003.00844.x; Thorrold SR, 2002, B MAR SCI, V70, P291; Thygesen UH, 2011, J MARINE SYST, V88, P159, DOI 10.1016/j.jmarsys.2011.03.009; Tilburg CE, 2010, ESTUAR COAST SHELF S, V88, P260, DOI 10.1016/j.ecss.2010.04.004; Turchin Peter, 1998; Wang J, 2012, J CLIMATE, V25, P1318, DOI 10.1175/2011JCLI4066.1; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Westbrook JK, 2011, INT J BIOMETEOROL, V55, P585, DOI 10.1007/s00484-010-0359-4; Willis J, 2011, ECOL MODEL, V222, P3869, DOI 10.1016/j.ecolmodel.2011.10.004; Willson M. F., 2000, Seeds: the ecology of regeneration in plant communities, P85, DOI 10.1079/9780851994321.0085; Yellow Perch Task Group, 2013, REP LAK ER YELL PERC; Zhao YM, 2009, CAN J FISH AQUAT SCI, V66, P114, DOI 10.1139/F08-188	92	7	7	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120752	10.1371/journal.pone.0120752	http://dx.doi.org/10.1371/journal.pone.0120752			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799555	gold, Green Submitted, Green Published			2022-12-26	WOS:000351987300171
J	Gonzalez-Barriga, A; Kranzen, J; Croes, HJE; Bijl, S; van den Broek, WJAA; van Kessel, IDG; van Engelen, BGM; van Deutekom, JCT; Wieringa, B; Mulders, SAM; Wansink, DG				Gonzalez-Barriga, Anchel; Kranzen, Julia; Croes, Huib J. E.; Bijl, Suzanne; van den Broek, Walther J. A. A.; van Kessel, Ingeborg D. G.; van Engelen, Baziel G. M.; van Deutekom, Judith C. T.; Wieringa, Be; Mulders, Susan A. M.; Wansink, Derick G.			Cell Membrane Integrity in Myotonic Dystrophy Type 1: Implications for Therapy	PLOS ONE			English	Article							RNA TOXICITY; MUSCULAR-DYSTROPHY; MOUSE MODEL; MUSCLE-FIBERS; ANIMAL-MODELS; MDX MICE; ABNORMALITIES; EXPANSIONS; REVERSAL; EXERCISE	Myotonic Dystrophy type 1 (DM1) is a multisystemic disease caused by toxic RNA from a DMPK gene carrying an expanded (CTG.CAG)n repeat. Promising strategies for treatment of DM1 patients are currently being tested. These include antisense oligonucleotides and drugs for elimination of expanded RNA or prevention of aberrant binding to RNP proteins. A significant hurdle for preclinical development along these lines is efficient systemic delivery of compounds across endothelial and target cell membranes. It has been reported that DM1 patients show elevated levels of markers of muscle damage or loss of sarcolemmal integrity in their serum and that splicing of dystrophin, an essential protein for muscle membrane structure, is abnormal. Therefore, we studied cell membrane integrity in DM1 mouse models commonly used for preclinical testing. We found that membranes in skeletal muscle, heart and brain were impermeable to Evans Blue Dye. Creatine kinase levels in serum were similar to those in wild type mice and expression of dystrophin protein was unaffected. Also in patient muscle biopsies cell surface expression of dystrophin was normal and calcium-positive fibers, indicating elevated intracellular calcium levels, were only rarely seen. Combined, our findings indicate that cells in DM1 tissues do not display compromised membrane integrity. Hence, the cell membrane is a barrier that must be overcome in future work towards effective drug delivery in DM1 therapy.	[Gonzalez-Barriga, Anchel; Kranzen, Julia; Croes, Huib J. E.; van den Broek, Walther J. A. A.; van Kessel, Ingeborg D. G.; Wieringa, Be; Mulders, Susan A. M.; Wansink, Derick G.] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Dept Cell Biol, NL-6525 ED Nijmegen, Netherlands; [van Engelen, Baziel G. M.] Radboud Univ Nijmegen, Med Ctr, Donders Ctr Neurosci, Dept Neurol, NL-6525 ED Nijmegen, Netherlands; [Gonzalez-Barriga, Anchel; Bijl, Suzanne; van Deutekom, Judith C. T.; Mulders, Susan A. M.] Prosensa Therapeut BV, Leiden, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; BioMarin Pharmaceutical Inc.; Prosensa	Wansink, DG (corresponding author), Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Dept Cell Biol, NL-6525 ED Nijmegen, Netherlands.	rick.wansink@radboudumc.nl	van Engelen, Baziel/H-8027-2014; Croes, Huib JE/G-4012-2016; Wieringa, Berend/A-5346-2011; Wansink, Derick G./F-3404-2010; van den Broek, Walther/G-8354-2016; González-Barriga, Anchel/G-5765-2016; van Kessel, Ingeborg/G-6681-2016	van Engelen, Baziel/0000-0001-9867-9047; Wieringa, Berend/0000-0001-9192-8020; González-Barriga, Anchel/0000-0001-7072-5494; 	Prinses Beatrix Spierfonds; Stichting Spieren voor Spieren	Prinses Beatrix Spierfonds; Stichting Spieren voor Spieren	This work was supported by grants from the Prinses Beatrix Spierfonds and the Stichting Spieren voor Spieren. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen DG, 2011, INT J BIOCHEM CELL B, V43, P290, DOI 10.1016/j.biocel.2010.11.005; Baird MF, 2012, J NUTR METAB, V2012, DOI 10.1155/2012/960363; Bareford LA, 2007, ADV DRUG DELIVER REV, V59, P748, DOI 10.1016/j.addr.2007.06.008; Beekman C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107494; BODENSTEINER JB, 1978, NEUROLOGY, V28, P439, DOI 10.1212/WNL.28.5.439; Brussee V, 1997, NEUROMUSCULAR DISORD, V7, P487, DOI 10.1016/S0960-8966(97)00115-6; BULFIELD G, 1984, P NATL ACAD SCI-BIOL, V81, P1189, DOI 10.1073/pnas.81.4.1189; Childs-Disney JL, 2012, ACS CHEM BIOL, V7, P1984, DOI 10.1021/cb3001606; Cleary JD, 2013, HUM MOL GENET, V22, pR45, DOI 10.1093/hmg/ddt371; de Calignon A, 2009, J NEUROPATH EXP NEUR, V68, P757, DOI 10.1097/NEN.0b013e3181a9fc66; Francois V, 2011, NAT STRUCT MOL BIOL, V18, P85, DOI 10.1038/nsmb.1958; Garcia-Lopez A, 2011, P NATL ACAD SCI USA, V108, P11866, DOI 10.1073/pnas.1018213108; GOLDBERG DM, 1986, CLIN PHYSIOL BIOCH, V4, P305; Gomes-Pereira M, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030052; Gomes-Pereira M, 2011, TRENDS MOL MED, V17, P506, DOI 10.1016/j.molmed.2011.05.004; Groenen P, 1998, BIOESSAYS, V20, P901, DOI 10.1002/(SICI)1521-1878(199811)20:11<901::AID-BIES5>3.0.CO;2-0; Harper PS, 2001, MYOTONIC DYSTROPHY; Heatwole CR, 2006, ARCH NEUROL-CHICAGO, V63, P1149, DOI 10.1001/archneur.63.8.1149; HOBBS AS, 1979, J NEUROL SCI, V41, P299, DOI 10.1016/0022-510X(79)90090-X; HORDER M, 1990, J AUTOM CHEM, V12, P22, DOI 10.1155/S1463924690000049; Huguet A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003043; Juliano RL, 2012, BIOCONJUGATE CHEM, V23, P147, DOI 10.1021/bc200377d; Koebis M, 2013, SCI REP-UK, V3, DOI 10.1038/srep02242; Lee JE, 2012, P NATL ACAD SCI USA, V109, P4221, DOI 10.1073/pnas.1117019109; Leger AJ, 2013, NUCLEIC ACID THER, V23, P109, DOI 10.1089/nat.2012.0404; LINDEMAN E, 1995, ARCH PHYS MED REHAB, V76, P612, DOI 10.1016/S0003-9993(95)80629-6; Mankodi A, 2000, SCIENCE, V289, P1769, DOI 10.1126/science.289.5485.1769; MISHRA SK, 1980, J NEUROL SCI, V46, P333, DOI 10.1016/0022-510X(80)90058-1; Mulders SAM, 2010, HUM MOL GENET, V19, pR90, DOI 10.1093/hmg/ddq161; Mulders SAM, 2009, P NATL ACAD SCI USA, V106, P13915, DOI 10.1073/pnas.0905780106; Nakamori M, 2007, MUSCLE NERVE, V36, P251, DOI 10.1002/mus.20809; Nakazato Y, 1993, Rinsho Shinkeigaku, V33, P1097; Orpana AK, 2013, J MOL DIAGN, V15, P110, DOI 10.1016/j.jmoldx.2012.07.004; Radley-Crabb H, 2012, NEUROMUSCULAR DISORD, V22, P170, DOI 10.1016/j.nmd.2011.07.008; Seznec H, 2000, HUM MOL GENET, V9, P1185, DOI 10.1093/hmg/9.8.1185; Seznec H, 2001, HUM MOL GENET, V10, P2717, DOI 10.1093/hmg/10.23.2717; SICINSKI P, 1989, SCIENCE, V244, P1578, DOI 10.1126/science.2662404; Sicot G, 2013, BBA-MOL BASIS DIS, V1832, P1390, DOI 10.1016/j.bbadis.2013.03.002; Sobczak K, 2013, MOL THER, V21, P380, DOI 10.1038/mt.2012.222; Straub V, 1997, J CELL BIOL, V139, P375, DOI 10.1083/jcb.139.2.375; Thornton C, 1999, SEMIN NEUROL, V19, P25, DOI 10.1055/s-2008-1040823; Udd B, 2012, LANCET NEUROL, V11, P891, DOI 10.1016/S1474-4422(12)70204-1; Warf MB, 2009, P NATL ACAD SCI USA, V106, P18551, DOI 10.1073/pnas.0903234106; Wheeler TM, 2012, NATURE, V488, P111, DOI 10.1038/nature11362; Wheeler TM, 2009, SCIENCE, V325, P336, DOI 10.1126/science.1173110; Yokota T, 2006, J CELL SCI, V119, P2679, DOI 10.1242/jcs.03000; Zhang WJ, 2014, MOL THER, V22, P312, DOI 10.1038/mt.2013.251	47	20	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121556	10.1371/journal.pone.0121556	http://dx.doi.org/10.1371/journal.pone.0121556			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799359	Green Published, Green Submitted, gold			2022-12-26	WOS:000351987300269
J	Hinske, LC; Galante, PAF; Limbeck, E; Mohnle, P; Parmigiani, RB; Ohno-Machado, L; Camargo, AA; Kreth, S				Hinske, Ludwig Christian; Galante, Pedro A. F.; Limbeck, Elisabeth; Moehnle, Patrick; Parmigiani, Raphael B.; Ohno-Machado, Lucila; Camargo, Anamaria A.; Kreth, Simone			Alternative Polyadenylation Allows Differential Negative Feedback of Human miRNA miR-579 on Its Host Gene ZFR	PLOS ONE			English	Article							BIOINFORMATICS; PATTERNS; ONTOLOGY; CLEAVAGE; GENOMES; BIOLOGY; MOTIFS; CELLS	About half of the known miRNA genes are located within protein-coding host genes, and are thus subject to co-transcription. Accumulating data indicate that this coupling may be an intrinsic mechanism to directly regulate the host gene's expression, constituting a negative feedback loop. Inevitably, the cell requires a yet largely unknown repertoire of methods to regulate this control mechanism. We propose APA as one possible mechanism by which negative feedback of intronic miRNA on their host genes might be regulated. Using in-silico analyses, we found that host genes that contain seed matching sites for their intronic miRNAs yield longer 32UTRs with more polyadenylation sites. Additionally, the distribution of polyadenylation signals differed significantly between these host genes and host genes of miRNAs that do not contain potential miRNA binding sites. We then transferred these in-silico results to a biological example and investigated the relationship between ZFR and its intronic miRNA miR-579 in a U87 cell line model. We found that ZFR is targeted by its intronic miRNA miR-579 and that alternative polyadenylation allows differential targeting. We additionally used bioinformatics analyses and RNA-Seq to evaluate a potential cross-talk between intronic miRNAs and alternative polyadenylation. CPSF2, a gene previously associated with alternative polyadenylation signal recognition, might be linked to intronic miRNA negative feedback by altering polyadenylation signal utilization.	[Hinske, Ludwig Christian; Moehnle, Patrick; Kreth, Simone] Clin Univ Munich, Dept Anaesthesiol, Res Grp Mol Med, Munich, Germany; [Galante, Pedro A. F.; Limbeck, Elisabeth; Parmigiani, Raphael B.; Camargo, Anamaria A.] Sirio Libanes Hosp, Ctr Mol Oncol, Sao Paulo, Brazil; [Ohno-Machado, Lucila] Univ Calif San Diego, Div Biomed Informat, La Jolla, CA 92093 USA	University of Munich; Hospital Sirio Libanes; University of California System; University of California San Diego	Hinske, LC (corresponding author), Clin Univ Munich, Dept Anaesthesiol, Res Grp Mol Med, Munich, Germany.	ludwig.hinske@med.uni-muenchen.de; simone.kreth@med.uni-muenchen.de	Möhnle, Patrick/C-9243-2018; Camargo, Anamaria A/E-9388-2012; Galante, Pedro A. F./C-6564-2012; PARMIGIANI, RAPHAEL B/A-7475-2014; Galante, Pedro/U-8594-2019; Hinske, Christian/AAN-4805-2021	Möhnle, Patrick/0000-0003-4769-7100; Camargo, Anamaria A/0000-0002-6076-9597; Galante, Pedro A. F./0000-0002-4820-4155; PARMIGIANI, RAPHAEL B/0000-0001-8360-3584; Galante, Pedro/0000-0002-4820-4155; Hinske, Christian/0000-0001-7273-5899; Kreth, Simone/0000-0002-0073-2098	National Institutes of Health [D43TW007015, U54HL108460]; FOGARTY INTERNATIONAL CENTER [D43TW007015] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U54HL108460] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work and two of the authors (PAFG and LOM) were partially supported by grants from the National Institutes of Health (grant numbers D43TW007015 and U54HL108460). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Barber JCK, 2011, AM J MED GENETICS A; Beaudoing E, 2000, GENOME RES, V10, P1001, DOI 10.1101/gr.10.7.1001; da Cunha JPC, 2009, P NATL ACAD SCI USA, V106, P16752, DOI 10.1073/pnas.0907939106; Derti A, 2012, GENOME RES; Di Giammartino DC, 2011, MOL CELL, V43, P853, DOI 10.1016/j.molcel.2011.08.017; Dill H, 2012, GENE DEV, V26, P25, DOI 10.1101/gad.177774.111; Elvira G, 2006, J NEUROCHEM, V96, P105, DOI 10.1111/j.1471-4159.2005.03523.x; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Galante PAF, 2011, NUCLEIC ACIDS RES, V39, P6056, DOI 10.1093/nar/gkr221; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Herr AJ, 2006, P NATL ACAD SCI USA, V103, P14994, DOI 10.1073/pnas.0606536103; Hinske Ludwig Christian, 2013, Methods Mol Biol, V936, P69; Hinske LCG, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-533; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Karolchik Donna, 2009, Curr Protoc Bioinformatics, VChapter 1, DOI 10.1002/0471250953.bi0104s28; Kim YK, 2007, EMBO J, V26, P775, DOI 10.1038/sj.emboj.7601512; Kolev NG, 2008, EMBO REP, V9, P1013, DOI 10.1038/embor.2008.146; Kreth S, 2010, NEURO-ONCOLOGY, V12, P570, DOI 10.1093/neuonc/nop072; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Mangan ME, CURRENT PROTOCOLS MO; Martin G, 2012, CELL REP, V1, P753, DOI 10.1016/j.celrep.2012.05.003; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; Monteys AM, 2010, RNA, V16, P495, DOI 10.1261/rna.1731910; Oliphant TE, 2007, COMPUT SCI ENG, V9, P10, DOI 10.1109/MCSE.2007.58; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390	30	22	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121507	10.1371/journal.pone.0121507	http://dx.doi.org/10.1371/journal.pone.0121507			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799583	Green Published, gold, Green Submitted			2022-12-26	WOS:000351987300262
J	Hood, WR; Hobensack, M				Hood, Wendy R.; Hobensack, Michael			The Effect of Locomotion on the Mobilization of Minerals from the Maternal Skeleton	PLOS ONE			English	Article							TOWER CLIMBING EXERCISE; KNOTS CALIDRIS-CANUTUS; ENERGY-METABOLISM; NATURAL-SELECTION; BONE METABOLISM; GROWING RATS; LACTATION; PREGNANCY; CALCIUM; TURNOVER	Bone is a dynamic tissue from which minerals are deposited or withdrawn according to the body's demand. During late pregnancy and lactation, female mammals mobilize mineral from bone to support the ossification of offspring skeleton(s). Conversely, in response to mechanical loading, minerals are deposited in bone enabling it to develop a stronger architecture. Despite their central importance to reproductive performance and skeletal integrity, the interactions between these potentially opposing forces remains poorly understood. It is possible that inter-individual differences in the loading imposed by different forms of locomotion may alter the amount of mineral mobilized during reproduction. Here, the impact of vertical versus horizontal locomotion on bone mobilization was examined during reproduction in the laboratory mouse. The vertical, or climbing, group had access to a 60-cm tower, increasing strain on their appendicular skeleton. The horizontal, or tunnel, group had access to a 100-cm tunnel, which encouraged movements within the horizontal plane. Form of locomotion did not impact the amount of bone females mobilized during reproduction or the amount of mineral females deposited in the litter, but maternal bone architecture differed between groups. The climbing group displayed more trabeculae than the tunnel group, whereas the tunnel group displayed greater cortical bone mineral density mid-shaft. Interestingly, pups born to mothers in the climbing group had a higher concentration of total body calcium at 16 days than pups of mothers in the tunnel group. As maternal total body calcium composition and the amount of calcium invested in the full litter were not different between groups, the difference in the relative calcium content of pups between groups is not suspected to reflect difference in mineral allocation. Future research should consider the impact of maternal activity on the efficiency of offspring skeletal ossification via hormones and other bioactive factors transferred in utero and in milk.	[Hood, Wendy R.; Hobensack, Michael] Auburn Univ, Auburn, AL 36849 USA	Auburn University System; Auburn University	Hood, WR (corresponding author), Auburn Univ, Auburn, AL 36849 USA.	wrhood@auburn.edu		Hood, Wendy/0000-0002-8398-3908	Auburn University College of Science and Mathematics	Auburn University College of Science and Mathematics	This work was supported by the Auburn University College of Science and Mathematics. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki N, 1999, BBA-GEN SUBJECTS, V1427, P298, DOI 10.1016/S0304-4165(99)00029-X; BENZIE D., 1955, Journal of Agricultural Science, V46, P425, DOI 10.1017/S0021859600040491; Biewener A. A., 1992, BIOMECHANICS STRUCTU; BIEWENER AA, 1982, J EXP BIOL, V98, P289; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; BROMMAGE R, 1989, J NUTR, V119, P428, DOI 10.1093/jn/119.3.428; BUTTNER D, 1991, J EXP ANIM SCI, V34, P165; Clutton-Brock T.H., 1991, EVOLUTION PARENTAL C; CLUTTONBROCK TH, 1984, AM NAT, V123, P212, DOI 10.1086/284198; Confavreux CB, 2009, MOL CELL ENDOCRINOL, V310, P21, DOI 10.1016/j.mce.2009.04.004; Currey JD, 2003, J BIOMECH, V36, P1487, DOI 10.1016/S0021-9290(03)00124-6; Currey JD., 1984, MECH ADAPTATIONS BON; Dimov M, 2010, J PHYS ACT HEALTH, V7, P239, DOI 10.1123/jpah.7.2.239; DOMINEY WJ, 1984, AM ZOOL, V24, P385; DRENT RH, 1980, ARDEA, V68, P225; DRINKWATER BL, 1991, BONE MINER, V14, P153, DOI 10.1016/0169-6009(91)90092-E; Florant GL, 1998, AM ZOOL, V38, P331; GROSVENOR CE, 1993, ENDOCR REV, V14, P710, DOI 10.1210/edrv-14-6-710; GUDMUNDSSON GA, 1991, IBIS, V133, P140, DOI 10.1111/j.1474-919X.1991.tb04825.x; Hood WR, 2006, J COMP PHYSIOL B, V176, P807, DOI 10.1007/s00360-006-0102-y; Hood WR, 2012, PHYSIOL BIOCHEM ZOOL, V85, P385, DOI 10.1086/666057; Iwamoto J, 1999, BONE, V24, P163, DOI 10.1016/S8756-3282(98)00189-6; Karsenty G, 2007, BONE, V40, pS147; Kovacs CS, 1997, ENDOCR REV, V18, P832, DOI 10.1210/er.18.6.832; Kunz TH, 1999, J COMP PHYSIOL B, V169, P61, DOI 10.1007/s003600050194; Lee NK, 2007, CELL, V130, P456, DOI 10.1016/j.cell.2007.05.047; Little KD, 1998, MED SCI SPORT EXER, V30, P831, DOI 10.1097/00005768-199806000-00009; Lovelady CA, 2009, MED SCI SPORT EXER, V41, P1902, DOI 10.1249/MSS.0b013e3181a5a68b; Mori T, 2003, J BONE MINER RES, V18, P2002, DOI 10.1359/jbmr.2003.18.11.2002; Notomi T, 2003, J BONE MINER RES, V18, P140, DOI 10.1359/jbmr.2003.18.1.140; Notomi T, 2002, J APPL PHYSIOL, V93, P1152, DOI 10.1152/japplphysiol.01221.2001; Notomi T, 2000, EUR J APPL PHYSIOL, V83, P469, DOI 10.1007/s004210000316; Oftedal O.T., 1984, Symposia of the Zoological Society of London, P33; Ott SM, 1999, J BONE MINER RES, V14, P1779, DOI 10.1359/jbmr.1999.14.10.1779; PENG TC, 1988, BONE MINER, V3, P293; PIANKA ER, 1976, AM ZOOL, V16, P775; Piersma T, 1996, CAN J ZOOL, V74, P2257, DOI 10.1139/z96-257; PRANGE HD, 1979, AM NAT, V113, P103, DOI 10.1086/283367; Racey PA, 1987, S ZOOL SOC LOND, V57, P107; Schaffer NM, 1974, ECOLOGY, V55, P291; Shahtaheri SM, 1999, J ANAT, V194, P407, DOI 10.1046/j.1469-7580.1999.19430407.x; SOARES MJ, 1994, CLIN SCI, V86, P441, DOI 10.1042/cs0860441; Sokal RR, 1995, BIOMETRY; SPRAY CM, 1950, BRIT J NUTR, V4, P332, DOI 10.1079/BJN19500058; Stearns SC, 1976, Q REV BIOL, P3; Tojo Y, 1998, AM J OBSTET GYNECOL, V178, P180, DOI 10.1016/S0002-9378(98)70649-0; TRIVERS RL, 1974, AM ZOOL, V14, P249; TURNER CH, 1993, BONE, V14, P595, DOI 10.1016/8756-3282(93)90081-K; Wang P, 1997, COMP BIOCHEM PHYS B, V118, P261, DOI 10.1016/S0305-0491(97)00102-8; WILLIAMS GC, 1966, AM NAT, V100, P687, DOI 10.1086/282461; Wysolmerski JJ, 2002, J MAMMARY GLAND BIOL, V7, P267, DOI 10.1023/A:1022800716196	51	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0122702	10.1371/journal.pone.0122702	http://dx.doi.org/10.1371/journal.pone.0122702			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799494	Green Published, gold, Green Submitted			2022-12-26	WOS:000351987300340
J	Jung, CKE; Keppler, K; Steinbach, S; Blazquez-Llorca, L; Herms, J				Jung, Christian K. E.; Keppler, Kevin; Steinbach, Sonja; Blazquez-Llorca, Lidia; Herms, Jochen			Fibrillar Amyloid Plaque Formation Precedes Microglial Activation	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; TRANSGENIC MICE; BETA PLAQUES; MOUSE MODEL; DEPOSITION; CX3CR1; BRAIN; NEURODEGENERATION; ASTROCYTES	In Alzheimer's disease (AD), hallmark alpha-amyloid deposits are characterized by the presence of activated microglia around them. Despite an extensive characterization of the relation of amyloid plaques with microglia, little is known about the initiation of this interaction. In this study, the detailed investigation of very small plaques in brain slices in AD transgenic mice of the line APP-PS1(dE9) revealed different levels of microglia recruitment. Analysing plaques with a diameter of up to 10 mu m we find that only the half are associated with clear morphologically activated microglia. Utilizing in vivo imaging of new appearing amyloid plaques in double-transgenic APP-PS1(dE9) xCX3CR1(+/-) mice further characterized the dynamic of morphological microglia activation. We observed no correlation of morphological microglia activation and plaque volume or plaque lifetime. Taken together, our results demonstrate a very prominent variation in size as well as in lifetime of new plaques relative to the state of microglia reaction. These observations might question the existing view that amyloid deposits by themselves are sufficient to attract and activate microglia in vivo.	[Jung, Christian K. E.; Keppler, Kevin; Steinbach, Sonja; Blazquez-Llorca, Lidia; Herms, Jochen] Univ Munich, Dept Translat Brain Res, German Ctr Neurodegenerat Dis Site Munich DZNE M, Munich, Germany; [Jung, Christian K. E.; Keppler, Kevin; Steinbach, Sonja; Blazquez-Llorca, Lidia; Herms, Jochen] Univ Munich, Ctr Neuropathol & Pr Res ZNP, Munich, Germany; [Herms, Jochen] Munich Cluster Syst Neurol SyNergy, Munich, Germany	Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Munich; University of Munich; University of Munich	Herms, J (corresponding author), Univ Munich, Dept Translat Brain Res, German Ctr Neurodegenerat Dis Site Munich DZNE M, Munich, Germany.	Jochen.Herms@med.uni-muenchen.de	Blazquez-Llorca, Lidia/AAS-8533-2020; Blazquez-Llorca, Lidia/H-6767-2014	Blazquez-Llorca, Lidia/0000-0002-4865-8974	German Federal Ministry of Education and Research (Bundesministerium fur Bildung und Forschung) [0316033C]; Fundacion Martin Escudero	German Federal Ministry of Education and Research (Bundesministerium fur Bildung und Forschung)(Federal Ministry of Education & Research (BMBF)); Fundacion Martin Escudero	This work was supported by grants from the German Federal Ministry of Education and Research (Bundesministerium fur Bildung und Forschung, 0316033C) and LB-L was awarded with a postdoctoral fellowship from the Fundacion Martin Escudero. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama H, 1999, GLIA, V25, P324, DOI 10.1002/(SICI)1098-1136(19990215)25:4<324::AID-GLIA2>3.0.CO;2-5; Bittner T, 2012, ACTA NEUROPATHOL, V124, P797, DOI 10.1007/s00401-012-1047-8; Burgold S, 2011, ACTA NEUROPATHOL, V121, P327, DOI 10.1007/s00401-010-0787-6; Cunningham C, 2013, GLIA, V61, P71, DOI 10.1002/glia.22350; Dheen ST, 2007, CURR MED CHEM, V14, P1189, DOI 10.2174/092986707780597961; DICKSON DW, 1988, AM J PATHOL, V132, P86; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Fuhrmann M, 2010, NAT NEUROSCI, V13, P411, DOI 10.1038/nn.2511; GRIFFIN WST, 1995, J NEUROPATH EXP NEUR, V54, P276; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; ITAGAKI S, 1989, J NEUROIMMUNOL, V24, P173, DOI 10.1016/0165-5728(89)90115-X; Jankowsky JL, 2004, HUM MOL GENET, V13, P159, DOI 10.1093/hmg/ddh019; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Klunk WE, 2002, J NEUROPATH EXP NEUR, V61, P797, DOI 10.1093/jnen/61.9.797; Lee S, 2010, AM J PATHOL, V177, P2549, DOI 10.2353/ajpath.2010.100265; Liu ZQ, 2010, J NEUROSCI, V30, P17091, DOI 10.1523/JNEUROSCI.4403-10.2010; Meyer-Luehmann M, 2008, NATURE, V451, P720, DOI 10.1038/nature06616; Shah P, 2010, AM J PATHOL, V177, P325, DOI 10.2353/ajpath.2010.090937; Sheng JG, 1997, J NEUROPATH EXP NEUR, V56, P285, DOI 10.1097/00005072-199703000-00007; Stence N, 2001, GLIA, V33, P256, DOI 10.1002/1098-1136(200103)33:3<256::AID-GLIA1024>3.0.CO;2-J; TROJANOWSKI JQ, 1995, NEUROBIOL AGING, V16, P335, DOI 10.1016/0197-4580(94)00176-2; Tsai J, 2004, NAT NEUROSCI, V7, P1181, DOI 10.1038/nn1335; Wyss-Coray Tony, 2006, Current Alzheimer Research, V3, P191, DOI 10.2174/156720506777632916; Xiang Z, 2006, DIS MARKERS, V22, P95, DOI 10.1155/2006/276239	24	24	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0119768	10.1371/journal.pone.0119768	http://dx.doi.org/10.1371/journal.pone.0119768			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799372	Green Submitted, Green Published, gold			2022-12-26	WOS:000351987300079
J	Nguyen, HDT; Jancic, S; Meijer, M; Tanney, JB; Zalar, P; Gunde-Cimerman, N; Seifert, KA				Nguyen, Hai D. T.; Jancic, Saso; Meijer, Martin; Tanney, Joey B.; Zalar, Polona; Gunde-Cimerman, Nina; Seifert, Keith A.			Application of the Phylogenetic Species Concept to Wallemia sebi from House Dust and Indoor Air Revealed by Multi-Locus Genealogical Concordance	PLOS ONE			English	Article							FARMERS LUNG; INTRAGENOMIC VARIATION; MAXIMUM-LIKELIHOOD; SEQUENCE ALIGNMENT; CONIDIUM ONTOGENY; PERFORMANCE; INFERENCE; MUSHROOMS; FUNGUS; DELIMITATION	A worldwide survey of Wallemia occurring in house dust and indoor air was conducted. The isolated strains were identified as Wallemia sebi and W. muriae. Previous studies suggested that the Wallemia sebi phylogenetic clade contained cryptic species but conclusive evidence was lacking because only the internal transcribed spacer (ITS) marker was analyzed. The ITS and four protein-coding genes (MCM7, RPB1, RPB2, and TSR1) were sequenced for 85 isolates. Based on an initial neighbor joining analysis of the concatenated genes, W. muriae remained monophyletic but four clades were found in Wallemia sebi, which we designated as Wallemia sebi clades 1, 2, 3, and 4. We hypothesized that these clades represent distinct phylogenetic species within the Wallemia sebi species complex (WSSC). We then conducted multiple phylogenetic analyses and demonstrated genealogical concordance, which supports the existence of four phylogenetic species within the WSSC. Geographically, W. muriae was only found in Europe, Wallemia sebi clade 3 was only found in Canada, Wallemia sebi clade 4 was found in subtropical regions, while Wallemia sebi clade 1 and 2 were found worldwide. Haplotype analysis showed that Wallemia sebi clades 1 and 2 had multiple haplotypes while Wallemia sebi clades 3 and 4 had one haplotype and may have been under sampled. We describe Wallemia sebi clades 2, 3, and 4 as new species in a companion study.	[Nguyen, Hai D. T.; Seifert, Keith A.] Univ Ottawa, Fac Sci, Dept Biol, Ottawa, ON, Canada; [Nguyen, Hai D. T.; Tanney, Joey B.; Seifert, Keith A.] Agr & Agri Food Canada, Eastern Cereal & Oilseed Res Ctr, Biodivers Mycol, Ottawa, ON, Canada; [Jancic, Saso; Zalar, Polona; Gunde-Cimerman, Nina] Univ Ljubljana, Biotech Fac, Dept Biol, Ljubljana, Slovenia; [Meijer, Martin] CBS KNAW Fungal Biodivers Ctr, Utrecht, Netherlands	University of Ottawa; Agriculture & Agri Food Canada; University of Ljubljana; Royal Netherlands Academy of Arts & Sciences; Westerdijk Fungal Biodiversity Institute (KNAW)	Nguyen, HDT (corresponding author), Univ Ottawa, Fac Sci, Dept Biol, Ottawa, ON, Canada.	hai.nguyen.1984@gmail.com; keith.seifert@agr.gc.ca		Gunde-Cimerman, Nina/0000-0002-9464-3263	Alfred P. Sloan Foundation Program on the Microbiology of the Built Environment; Slovenian Research Agency; Young Researcher Grant [1000-11-310102]; Slovenian Ministry of Higher Education, Science and Technology; European Regional Development Fund through Centre of Excellence for Integrated Approaches in Chemistry and Biology of Proteins (CIPKeBiP) [OP13.1.1.2.02.0005]	Alfred P. Sloan Foundation Program on the Microbiology of the Built Environment(Alfred P. Sloan Foundation); Slovenian Research Agency(Slovenian Research Agency - Slovenia); Young Researcher Grant; Slovenian Ministry of Higher Education, Science and Technology; European Regional Development Fund through Centre of Excellence for Integrated Approaches in Chemistry and Biology of Proteins (CIPKeBiP)	HDTN and KAS were supported by grants from the Alfred P. Sloan Foundation Program on the Microbiology of the Built Environment http://www.sloan.org/major-program-areas/basic-research/mobe/?L=chmalwgix. NGC, PZ and SJ were supported by the Slovenian Research Agency (https://www.arrs.gov.si/en/novo.asp) and the Young Researcher Grant to SJ (no. 1000-11-310102). This work was partly funded by Slovenian Ministry of Higher Education, Science and Technology (http://www.arhiv.mvzt.gov.si/en/) and European Regional Development Fund through the through the Centre of Excellence for Integrated Approaches in Chemistry and Biology of Proteins (CIPKeBiP; http://cipkebip.org/; no. OP13.1.1.2.02.0005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguileta G, 2008, SYST BIOL, V57, P613, DOI 10.1080/10635150802306527; Amend AS, 2010, P NATL ACAD SCI USA, V107, P13748, DOI 10.1073/pnas.1000454107; Auvrey M, 1909, B MEM SOC HIR PARIS, V20, P686; Beurmann L, 1909, B MEM SOC MED HOP P, V3, P911; Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537; Cole GT, 1979, PATTERNS DEV CONIDIA, P96; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Desroches TC, 2014, INDOOR AIR, V24, P533, DOI 10.1111/ina.12100; Dettman JR, 2003, EVOLUTION, V57, P2703, DOI 10.1554/03-073; Engelhart S, 2002, INT J HYG ENVIR HEAL, V205, P443, DOI 10.1078/1438-4639-00183; Gadberry MD, 2005, BIOINFORMATICS, V21, P1263, DOI 10.1093/bioinformatics/bti134; Ganley ARD, 2007, GENOME RES, V17, P184, DOI 10.1101/gr.5457707; Gougerot H, 1909, C R SOC BIOL PARIS, V11, P74; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Guarro J, 2008, J CLIN MICROBIOL, V46, P1129, DOI 10.1128/JCM.01920-07; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; Henk DA, 2011, MOL ECOL, V20, P4288, DOI 10.1111/j.1365-294X.2011.05244.x; HILL ST, 1974, J STORED PROD RES, V10, P209, DOI 10.1016/0022-474X(74)90008-3; Hovmoller R, 2013, MOL PHYLOGENET EVOL, V69, P1057, DOI 10.1016/j.ympev.2013.06.004; Jancic S, 2015, PLOS ONE IN PRESS; JANKE D, 1950, Arch Dermatol Syph, V190, P95, DOI 10.1007/BF00361600; Jia FZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095722; Johan-Olsen O, 1887, CHRISTIANIA VIDENKAB, V12, P5; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Kolossa-Gehring M, 2007, INT J HYG ENVIR HEAL, V210, P535, DOI 10.1016/j.ijheh.2007.07.018; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; Lappalainen MHJ, 2012, INT ARCH ALLERGY IMM, V159, P194, DOI 10.1159/000335596; Lappalainen S, 1998, ANN ALLERG ASTHMA IM, V81, P585, DOI 10.1016/S1081-1206(10)62710-X; Leavitt SD, 2011, MOL PHYLOGENET EVOL, V60, P317, DOI 10.1016/j.ympev.2011.05.012; Li DW, 2004, ADV APPL MICROBIOL, V55, P31, DOI 10.1016/S0065-2164(04)55002-5; Lindner DL, 2011, MYCOLOGIA, V103, P731, DOI 10.3852/10-331; MADELIN MF, 1974, T BRIT MYCOL SOC, V63, P121, DOI 10.1016/S0007-1536(74)80143-9; MALESZKA R, 1993, YEAST, V9, P53, DOI 10.1002/yea.320090107; Matheny PB, 2007, MOL PHYLOGENET EVOL, V43, P430, DOI 10.1016/j.ympev.2006.08.024; Matheny PB, 2006, CAN J BOT, V84, P1794, DOI 10.1139/B06-128; Matheny PB, 2005, MOL PHYLOGENET EVOL, V35, P1, DOI 10.1016/j.ympev.2004.11.014; Matheny PB, 2002, AM J BOT, V89, P688, DOI 10.3732/ajb.89.4.688; MOORE RT, 1986, A VAN LEEUW J MICROB, V52, P183, DOI 10.1007/BF00429322; Moore RT, 1996, RHIZOCTONIA SPECIES: TAXONOMY, MOLECULAR BIOLOGY, ECOLOGY, PATHOLOGY AND DISEASE CONTROL, P13; Nakayama Kunio, 2009, Nihon Eiseigaku Zasshi, V64, P689; Nguyen HDT, 2013, MYCOLOGIA, V105, P1231, DOI 10.3852/12-351; Nonnenmann MW, 2012, J ENVIRON MONITOR, V14, P2038, DOI 10.1039/c2em30229b; O'Donnell K, 2008, J CLIN MICROBIOL, V46, P2477, DOI 10.1128/JCM.02371-07; Padamsee M, 2012, FUNGAL GENET BIOL, V49, P217, DOI 10.1016/j.fgb.2012.01.007; Pieckova E, 1999, ANN AGR ENV MED, V6, P1; Posada D, 2004, COLLAPSE VERSION 1 2; Rannala B, 2003, GENETICS, V164, P1645; Reboux G, 2001, AM J RESP CRIT CARE, V163, P1534, DOI 10.1164/ajrccm.163.7.2006077; Ren P, 1999, J EXPO ANAL ENV EPID, V9, P560, DOI 10.1038/sj.jea.7500061; Roussel S, 2004, OCCUP ENVIRON MED, V61; SAKAMOTO T, 1989, INT ARCH ALLER A IMM, V90, P368, DOI 10.1159/000235055; Samson RA, 2010, FOOD INDOOR FUNGI; Schmitt I, 2009, PERSOONIA, V23, P35, DOI 10.3767/003158509X470602; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Sennekamp J, 2012, Pneumologie, V66, P297, DOI 10.1055/s-0031-1291676; Simon UK, 2008, MOL BIOL EVOL, V25, P2251, DOI 10.1093/molbev/msn188; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Swofford D. L, 2002, PAUP PHYLOGENETIC AN; Takahashi T, 1997, MYCOPATHOLOGIA, V139, P23, DOI 10.1023/A:1006831111595; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Taylor JW, 2000, FUNGAL GENET BIOL, V31, P21, DOI 10.1006/fgbi.2000.1228; TERRACINA FC, 1974, CAN J BOT, V52, P2587, DOI 10.1139/b74-335; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Visagie CM, 2014, STUD MYCOL, P63, DOI 10.1016/j.simyco.2014.07.002; VON ARX J. A., 1970, The genera of fungi sporulating in pure culture.; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Yang ZH, 2010, P NATL ACAD SCI USA, V107, P9264, DOI 10.1073/pnas.0913022107; Zajc J, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-617; Zalar P, 2005, ANTON LEEUW INT J G, V87, P311, DOI 10.1007/s10482-004-6783-x	73	21	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120894	10.1371/journal.pone.0120894	http://dx.doi.org/10.1371/journal.pone.0120894			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799362	Green Submitted, Green Published, gold			2022-12-26	WOS:000351987300189
J	Shabbir, M; Syed, DN; Lall, RK; Khan, MR; Mukhtar, H				Shabbir, Maria; Syed, Deeba N.; Lall, Rahul K.; Khan, Muhammad Rashid; Mukhtar, Hasan			Potent Anti-Proliferative, Pro-Apoptotic Activity of the Maytenus Royleanus Extract against Prostate Cancer Cells: Evidence in In-Vitro and In-Vivo Models	PLOS ONE			English	Article							ANDROGEN RECEPTOR GENE; DIETARY; PROGRESSION; THERAPY; RISK; MECHANISMS; RESISTANCE; QUERCETIN; MORTALITY; CYCLINS	Prostate cancer is a leading of cause of cancer related death in men. Despite intensive investment in improving early diagnosis, it often escapes timely detection. Mortality remains high in advanced stage prostate cancer where palliative care remains the only option. Effective strategies are therefore needed to prevent the occurrence and progression of the disease. Plant-derived compounds have been an important source of several clinically useful anti-cancer agents and offer an attractive approach against prostate cancer. We previously showed that the methanol extract of Maytenus royleanus (MEM) leaves and its fractions possess significant antioxidant activity with therapeutic potential against free-radical associated damages. The present study evaluated the anti-proliferative activity of MEM in the prostate cancer model system. Analysis of MEM and its various fractions revealed the presence of triterpenoids, flavonoids and tannins, conjugated to one or more polar groups and carbohydrate moieties. Further studies against known standards established the existence of caffeic acid and quercetin 3-rhamnoside in varying concentration in different MEM fractions. Time course analysis of MEM treated prostate cancer cells indicated significant decrease in cell viability, assessed by MTT and clonogenic survival assays. This was accompanied by G2 phase arrest of cell cycle, downregulation of cyclin/cdk network and increase in cdk inhibitors. MEM treated cells exhibited cleavage of Caspase-3 and PARP, and modulation of apoptotic proteins, establishing apoptosis as the primary mechanism of cell death. Notably MEM suppressed AR/PSA signaling both in prostate cancer cell cultures and in the in vivo model. Intraperitoneal injection of MEM (1.25 and 2.5mg/animal) to athymic nude mice implanted with androgen sensitive CWR22R.1 cells showed significant inhibition in tumor growth and decreased serum PSA levels reciprocating in vitro findings. Taken together, our data suggest that MEM may be explored further for its potential therapeutic effects against prostate cancer progression in humans.	[Shabbir, Maria; Syed, Deeba N.; Lall, Rahul K.; Mukhtar, Hasan] Univ Wisconsin, Dept Dermatol, Madison, WI 53706 USA; [Lall, Rahul K.] Univ Wisconsin, Dept Food Sci, Madison, WI 53706 USA; [Shabbir, Maria; Khan, Muhammad Rashid] Quaid I Azam Univ, Dept Biochem, Islamabad, Pakistan	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Quaid I Azam University	Mukhtar, H (corresponding author), Univ Wisconsin, Dept Dermatol, Madison, WI 53706 USA.	hmukhtar@wisc.edu	Razak, Suhail/ABD-1667-2020; Shabbir, Maria/AAA-5414-2019	Shabbir, Maria/0000-0002-5685-3059; Lall, Rahulkumar/0000-0002-0042-6103	National Institute of health/National Cancer Institute [RO1CA160867]; NATIONAL CANCER INSTITUTE [R01CA160867] Funding Source: NIH RePORTER	National Institute of health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Support was provided by the National Institute of health/National Cancer Institute RO1CA160867. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baillon L, 2014, SEMIN CELL DEV BIOL, V32, P137, DOI 10.1016/j.semcdb.2014.04.034; Buchanan G, 2001, CANCER METAST REV, V20, P207, DOI 10.1023/A:1015531326689; Cai X, 2013, CURR MED CHEM, V20, P2572, DOI 10.2174/09298673113209990120; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; Chen FZ, 2013, IRAN RED CRESCENT ME, V15, P279, DOI 10.5812/ircmj.6499; Ekstrom AM, 2000, INT J CANCER, V87, P133, DOI 10.1002/1097-0215(20000701)87:1&lt;133::AID-IJC20&gt;3.0.CO;2-E; Farooqi AA, 2014, CANCER CELL INT, V14, DOI 10.1186/1475-2867-14-34; Gottlieb B, 2001, HUM MUTAT, V17, P382, DOI 10.1002/humu.1113; Gregory CW, 1998, CANCER RES, V58, P5718; GUO WD, 1994, INT J EPIDEMIOL, V23, P1127, DOI 10.1093/ije/23.6.1127; Haag P, 2005, J STEROID BIOCHEM, V96, P251, DOI 10.1016/j.jsbmb.2005.04.029; Karantanos T, 2013, ONCOGENE, V32, P5501, DOI 10.1038/onc.2013.206; Kasibhatla S, 2003, MOL CANCER THER, V2, P573; Kellen E, 2006, INT J CANCER, V118, P2572, DOI 10.1002/ijc.21714; Kenfield SA, 2014, EUR UROL, V65, P887, DOI 10.1016/j.eururo.2013.08.009; Khan KH, 2014, CRIT REV ONCOL HEMAT, V90, P200, DOI 10.1016/j.critrevonc.2013.12.012; Kim J, 2008, ASIAN PAC J CANCER P, V9, P543; Lamb DJ, 2001, VITAM HORM, V62, P199, DOI 10.1016/S0083-6729(01)62005-3; Lansky EP, 2005, INVEST NEW DRUG, V23, P11, DOI 10.1023/B:DRUG.0000047101.02178.07; Liu RH, 2013, J FOOD SCI, V78, pA18, DOI 10.1111/1750-3841.12101; Madan RA, 2009, EXPERT OPIN INV DRUG, V18, P1001, DOI 10.1517/13543780902997928; Mahmoud AM, 2014, J STEROID BIOCHEM, V140, P116, DOI 10.1016/j.jsbmb.2013.12.010; Mariani S, 2014, INT J MOL SCI, V15, P1433, DOI 10.3390/ijms15011433; Mellado B, 2009, CLIN TRANSL ONCOL, V11, P5, DOI 10.1007/s12094-009-0304-3; Perestelo NR, 2010, J NAT PROD, V73, P127, DOI 10.1021/np900476a; Russo GL, 2014, CANCER TREAT RES, V159, P185, DOI 10.1007/978-3-642-38007-5_11; Sanchez I, 2005, SEMIN CELL DEV BIOL, V16, P311, DOI 10.1016/j.semcdb.2005.02.007; Santamaria D, 2006, FRONT BIOSCI-LANDMRK, V11, P1164, DOI 10.2741/1871; Schaneberg BT, 2001, J NAT PROD, V64, P624, DOI 10.1021/np010041o; Seeram NP, 2004, J AGR FOOD CHEM, V52, P2512, DOI 10.1021/jf0352778; SHABBIR M, 2013, BMC COMPLEM ALTERN M, V13, DOI DOI 10.1186/1472-6882-13-143; Sharifi N, 2009, ANTI-CANCER AGENT ME, V9, P1046, DOI 10.2174/187152009789735044; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Sola S, 2013, BBA-GEN SUBJECTS, V1830, P2160, DOI 10.1016/j.bbagen.2012.09.021; Soldani C, 2002, APOPTOSIS, V7, P321, DOI 10.1023/A:1016119328968; Solit DB, 2003, SEMIN ONCOL, V30, P709, DOI 10.1016/S0093-7754(03)00346-4; Syed DN, 2008, CANCER LETT, V265, P167, DOI 10.1016/j.canlet.2008.02.050; Syed DN, 2013, ANTI-CANCER AGENT ME, V13, P1149, DOI 10.2174/1871520611313080003; Touaibia M, 2011, MINI-REV MED CHEM, V11, P695, DOI 10.2174/138955711796268750; Tsao CK, 2014, THER ADV UROL, V6, P97, DOI 10.1177/1756287214528557; Viladomiu M, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/789764; VISAKORPI T, 1995, NAT GENET, V9, P401, DOI 10.1038/ng0495-401	42	24	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0119859	10.1371/journal.pone.0119859	http://dx.doi.org/10.1371/journal.pone.0119859			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798940	gold, Green Submitted, Green Published			2022-12-26	WOS:000351987300085
J	Xie, GP; Jiang, N; Liang, CX; Zeng, JC; Chen, ZY; Xu, Q; Qi, RZ; Chen, YR; Yu, B				Xie, Guo-ping; Jiang, Nan; Liang, Chang-xiang; Zeng, Jian-chun; Chen, Zhi-yuan; Xu, Qian; Qi, Rui-zhen; Chen, Yi-rong; Yu, Bin			Pigmented Villonodular Synovitis: A Retrospective Multicenter Study of 237 Cases	PLOS ONE			English	Article							GIANT-CELL TUMOR; TOTAL KNEE ARTHROPLASTY; OF-THE-LITERATURE; TENDON SHEATH; DIFFUSE; TENOSYNOVITIS; METASTASIS; FEATURES; SURGERY; JOINTS	Purpose To review clinical characteristics of pigmented villonodular synovitis (PVNS) in China. Methods Electronic medical records (EMR) of four Chinese institutes were queried for patients with histologically proven PVNS between January 2005 and February 2014. Their data were collected including gender, age at diagnosis, clinical presentation, affected site, symptom duration, comorbidities, treatment strategy, recurrence and routine laboratories. Results A total of 237 patients with biopsy-proven PVNS were investigated. The gender ratio was 1.35 for a female predominance (101 males and 136 females). The average age was 36 years (range, 2 to 83 years). The median delay from initial clinical symptom to diagnosis was 18 months. Main affected areas were the knee (73.84%) and the hip (18.14%). Forty patients had a clear history of joint trauma. Six patients were concurrently diagnosed with PVNS and avascular necrosis (AVN). Five patients suffered from PVNS following implantation of orthopaedic devices including artificial prosthesis, plate and wire. One hundred and twenty-nine patients underwent arthroscopic synovectomy and 108 open synovectomy. Altogether 48 patients (26 males and 22 females) had recurrence of disease. The relapse rate was 24% (knee) and 6.98% (hip), 20.93% (open surgery) and 19.44% (arthroscopy), respectively. Erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) rate were elevated in 45.83% and 38.41% of the patients respectively. Conclusions To our knowledge, this study is the largest sample size of PVNS patients reported as well as the largest sample of PVNS with concurrent AVN reported to date. Our outcomes suggest that PVNS shows a female predominance, occurs mostly between 20-40 years and favors the knee and hip. Recurrence is frequent, particularly in the knee. Serum ESR and CRP may be elevated in some patients. Additionally, the present study supports the theory of an association between PVNS and orthopedic surgery, which is not limited to joint replacement.	[Xie, Guo-ping; Jiang, Nan; Qi, Rui-zhen; Chen, Yi-rong; Yu, Bin] Southern Med Univ, Nanfang Hosp, Dept Orthopaed & Traumatol, Guangzhou, Guangdong, Peoples R China; [Xie, Guo-ping; Yu, Bin] Southern Med Univ, Nanfang Hosp, Key Lab Bone & Cartilage Regenerat Med Guangdong, Guangzhou, Guangdong, Peoples R China; [Liang, Chang-xiang] Guangdong Gen Hosp, Dept Orthopaed, Guangzhou, Guangdong, Peoples R China; [Zeng, Jian-chun] Guangzhou Univ Tradit Chinese Med, Affiliated Hosp 1, Dept Orthopaed 3, Guangzhou, Guangdong, Peoples R China; [Chen, Zhi-yuan] Guangzhou Mil Command, Gen Hosp, Dept Overseas Chinese Patients, Guangzhou, Guangdong, Peoples R China; [Xu, Qian] Guangzhou Univ Tradit Chinese Med, Dept Hlth Stat, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Southern Medical University - China; Guangdong Academy of Medical Sciences & Guangdong General Hospital; Guangzhou University of Chinese Medicine; Southern Theater Command General Hospital; Guangzhou University of Chinese Medicine	Yu, B (corresponding author), Southern Med Univ, Nanfang Hosp, Dept Orthopaed & Traumatol, Guangzhou, Guangdong, Peoples R China.	nanfanghot@126.com	Jiang, Nan/AAD-9841-2019	Jiang, Nan/0000-0003-2416-1653				BALLARD WT, 1993, J BONE JOINT SURG AM, V75A, P764; Bruns J, 2013, ARCH ORTHOP TRAUM SU, V133, P1047, DOI 10.1007/s00402-013-1770-1; Bunting D, 2007, J ARTHROPLASTY, V22, P1229, DOI 10.1016/j.arth.2006.11.022; BYERS P D, 1968, Journal of Bone and Joint Surgery British Volume, V50, P290; Cassier PA, 2012, CANCER-AM CANCER SOC, V118, P1649, DOI 10.1002/cncr.26409; Chin KR, 2002, J BONE JOINT SURG AM, V84A, P2192, DOI 10.2106/00004623-200212000-00011; CHOONG PFM, 1995, ACTA ORTHOP SCAND, V66, P64, DOI 10.3109/17453679508994643; Colman MW, 2013, CLIN ORTHOP RELAT R, V471, P883, DOI 10.1007/s11999-012-2589-8; COTTEN A, 1995, SKELETAL RADIOL, V24, P1, DOI 10.1007/BF02425936; Coutinho M, 2012, ACTA REUMATOL PORT, V37, P335; DALCIN P, 1994, CANCER RES, V54, P3986; De Ponti A, 2003, ARTHROSCOPY, V19, P602, DOI 10.1016/S0749-8063(03)00127-0; de Visser E, 1999, ARCH ORTHOP TRAUM SU, V119, P401, DOI 10.1007/s004020050009; FLANDRY FC, 1994, CLIN ORTHOP RELAT R, P183; Galli M, 2012, INT J IMMUNOPATH PH, V25, P1131, DOI 10.1177/039463201202500430; GOLDMAN AB, 1988, RADIOL CLIN N AM, V26, P1327; GRANOWITZ SP, 1976, CLIN ORTHOP RELAT R, P335; Griffin AM, 2012, CANCER-AM CANCER SOC, V118, P4901, DOI 10.1002/cncr.26529; Gu HF, 2014, KNEE SURG SPORT TR A, V22, P2830, DOI 10.1007/s00167-014-2852-5; Hirohata K, 1968, Kobe J Med Sci, V14, P251; Imakiire Naoaki, 2011, Open Orthop J, V5, P13, DOI 10.2174/1874325001105010013; Jaffe HL, 1941, ARCH PATHOL, V31, P731; Korim MT, 2014, FOOT ANKLE SURG, V20, P130, DOI 10.1016/j.fas.2014.01.007; Loriaut P, 2012, KNEE SURG SPORT TR A, V20, P1550, DOI 10.1007/s00167-011-1747-y; Ma XM, 2014, INT J CLIN EXP MED, V7, P1150; Ma XM, 2013, INT ORTHOP, V37, P1165, DOI 10.1007/s00264-013-1858-9; Mankin H, 2011, J SURG ONCOL, V103, P386, DOI 10.1002/jso.21835; Murphey MD, 2008, RADIOGRAPHICS, V28, P1493, DOI 10.1148/rg.285085134; Musluman Ahmet Murat, 2009, Spine J, V9, pe6, DOI 10.1016/j.spinee.2008.12.010; MYERS BW, 1980, MEDICINE, V59, P223, DOI 10.1097/00005792-198005000-00004; Oni Julius K, 2011, J Arthroplasty, V26, DOI 10.1016/j.arth.2010.11.006; Ottaviani S, 2011, SEMIN ARTHRITIS RHEU, V40, P539, DOI 10.1016/j.semarthrit.2010.07.005; Perka C, 2000, RHEUMATOLOGY, V39, P172, DOI 10.1093/rheumatology/39.2.172; Popov HI, 2012, MED ULTRASON, V14, P67; RAO AS, 1984, J BONE JOINT SURG AM, V66A, P76, DOI 10.2106/00004623-198466010-00012; Safaee M, 2015, HEAD NECK-J SCI SPEC, V37, P1213, DOI 10.1002/hed.23717; SAKKERS RJB, 1991, J BONE JOINT SURG AM, V73A, P1532, DOI 10.2106/00004623-199173100-00011; SCHWARTZ HS, 1989, CLIN ORTHOP RELAT R, P243; Sharma H, 2007, KNEE, V14, P390, DOI 10.1016/j.knee.2007.05.007; Sharma V, 2009, CLIN ORTHOP RELAT R, V467, P2852, DOI 10.1007/s11999-009-0922-7; Vela P, 2014, REUMATOL CLIN, V10, P270, DOI 10.1016/j.reuma.2013.11.001; Yoon HJ, 2011, ORAL SURG ORAL MED O, V111, pE30, DOI 10.1016/j.tripleo.2010.11.031	42	54	58	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121451	10.1371/journal.pone.0121451	http://dx.doi.org/10.1371/journal.pone.0121451			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799575	gold, Green Published, Green Submitted			2022-12-26	WOS:000351987300252
J	Modak, N; Spence, K; Sood, S; Rosati, JA				Modak, Nabanita; Spence, Kelley; Sood, Saloni; Rosati, Jacky Ann			Building a Comprehensive Mill-Level Database for the Industrial Sectors Integrated Solutions (ISIS) Model of the US Pulp and Paper Sector	PLOS ONE			English	Article								Air emissions from the U.S. pulp and paper sector have been federally regulated since 1978; however, regulations are periodically reviewed and revised to improve efficiency and effectiveness of existing emission standards. The Industrial Sectors Integrated Solutions (ISIS) model for the pulp and paper sector is currently under development at the U.S. Environmental Protection Agency (EPA), and can be utilized to facilitate multi-pollutant, sector-based analyses that are performed in conjunction with regulatory development. The model utilizes a multi-sector, multi-product dynamic linear modeling framework that evaluates the economic impact of emission reduction strategies for multiple air pollutants. The ISIS model considers facility-level economic, environmental, and technical parameters, as well as sector-level market data, to estimate the impacts of environmental regulations on the pulp and paper industry. Specifically, the model can be used to estimate U.S. and global market impacts of new or more stringent air regulations, such as impacts on product price, exports and imports, market demands, capital investment, and mill closures. One major challenge to developing a representative model is the need for an extensive amount of data. This article discusses the collection and processing of data for use in the model, as well as the methods used for building the ISIS pulp and paper database that facilitates the required analyses to support the air quality management of the pulp and paper sector.	[Modak, Nabanita] US EPA, Off Res & Dev, Air Pollut Prevent & Control Div, Res Triangle Pk, NC 27711 USA; [Spence, Kelley] US EPA, Off Air Qual Planning & Stand, Res Triangle Pk, NC 27711 USA; [Sood, Saloni; Rosati, Jacky Ann] US EPA, Off Res & Dev, Res Triangle Pk, NC 27711 USA	United States Environmental Protection Agency; United States Environmental Protection Agency; United States Environmental Protection Agency	Modak, N (corresponding author), US EPA, Off Res & Dev, Air Pollut Prevent & Control Div, Res Triangle Pk, NC 27711 USA.	modak.nabanita@epa.gov						[Anonymous], 2005, EN ENV PROF US PULP; [Anonymous], 2012, RISI DAT OFF TRACK W; AZO Materials, 2012, SUP ALL HAST N UNS N; Bureau of Labor Statistics, CONS PRIC IND ALL UR; CPBIS, 2013, MILSL ONL DAT; Ince PJ, 1994, RECYCLING LONG RANGE; National Health and Medical Research Council, 2004, AIR QUAL MAN US, P1; North Carolina State University, MUN SOL WAST COMP DO; Phillips R, 2009, GLOBAL DYNAMICS PULP; Pulp & Paperworkers' Resource Council, 2013, COMPL 1990 2012 CURT; RISI Inc, N AM GRAPH PAP CAP R; RISI Inc, N AM PAP PACK CAP RE; RISI Inc, US MILL ASS DAT; RISI Inc, WORLD MARK PULP CAP; RISI Inc, 2012, LOCKW POST DIR PULP; RISI Inc, WORLD TISS CAP REP 2; RISI Inc, WORLD REC PAP ANN HI; RISI Inc, WORLD PULP ANN HIST; RTI, 2011, PULPPAP SECT SURV; Skog K., 2013, Journal of Sustainable Forestry, V32, P14, DOI 10.1080/10549811.2011.651780; Smook G, 2002, HDB PULP PAPER TECHN, P21; Srivastava RK, 2011, ADV GLOB CHANGE RES, V38, P241, DOI 10.1007/978-90-481-3153-2_8; Stennes B, 2011, MODELLING BIOENERGY; U.S. Energy Information Administration, 2011, STAT EN DAT SYST WOO; U.S. Energy Information Administration, AV RET PRIC EL ULT C; U.S. Environmental Protection Agency, IND COMM I BOIL PROC; U.S. Environmental Protection Agency, 2012, AIR CLIM CHANG RES M; US Census Bureau, 2012, N AM IND CLASS SYST	28	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0120954	10.1371/journal.pone.0120954	http://dx.doi.org/10.1371/journal.pone.0120954			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25806516	Green Published, Green Submitted, gold			2022-12-26	WOS:000351880000115
J	Chaudhary, S; Sharma, PC				Chaudhary, Saurabh; Sharma, Prakash C.			DeepSAGE Based Differential Gene Expression Analysis under Cold and Freeze Stress in Seabuckthorn (Hippophae rhamnoides L.)	PLOS ONE			English	Article							TRANSCRIPTOME ANALYSIS; ACCLIMATION; RESPONSES; TOLERANCE; DEHYDRATION; DROUGHT; PROTEIN; PCR; DNA	Seabuckthorn (Hippophae rhamnoides L.), an important plant species of Indian Himalayas, is well known for its immense medicinal and nutritional value. The plant has the ability to sustain growth in harsh environments of extreme temperatures, drought and salinity. We employed DeepSAGE, a tag based approach, to identify differentially expressed genes under cold and freeze stress in seabuckthorn. In total 36.2 million raw tags including 13.9 million distinct tags were generated using Illumina sequencing platform for three leaf tissue libraries including control (CON), cold stress (CS) and freeze stress (FS). After discarding low quality tags, 35.5 million clean tags including 7 million distinct clean tags were obtained. In all, 11922 differentially expressed genes (DEGs) including 6539 up regulated and 5383 down regulated genes were identified in three comparative setups i.e. CON vs CS, CON vs FS and CS vs FS. Gene ontology and KEGG pathway analysis were performed to assign gene ontology term to DEGs and ascertain their biological functions. DEGs were mapped back to our existing seabuckthorn transcriptome assembly comprising of 88,297 putative unigenes leading to the identification of 428 cold and freeze stress responsive genes. Expression of randomly selected 22 DEGs was validated using qRT-PCR that further supported our DeepSAGE results. The present study provided a comprehensive view of global gene expression profile of seabuckthorn under cold and freeze stresses. The DeepSAGE data could also serve as a valuable resource for further functional genomics studies aiming selection of candidate genes for development of abiotic stress tolerant transgenic plants.	[Chaudhary, Saurabh; Sharma, Prakash C.] Guru Gobind Singh Indraprastha Univ, Univ Sch Biotechnol, New Delhi 110078, India	GGS Indraprastha University	Sharma, PC (corresponding author), Guru Gobind Singh Indraprastha Univ, Univ Sch Biotechnol, New Delhi 110078, India.	prof.pcsharma@gmail.com			Department of Biotechnology, Government of India, New Delhi [BT/PR10798/NDB/51/170/2008]	Department of Biotechnology, Government of India, New Delhi(Department of Biotechnology (DBT) India)	This study was funded by a research grant BT/PR10798/NDB/51/170/2008 received from the Department of Biotechnology, Government of India, New Delhi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcazar R, 2006, BIOTECHNOL LETT, V28, P1867, DOI 10.1007/s10529-006-9179-3; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Bartish IV, 2002, SYST BOT, V27, P41; Benjamini Y, 2001, ANN STAT, V29, P1165; Brenner S, 2000, NAT BIOTECHNOL, V18, P630, DOI 10.1038/76469; Chinnusamy V, 2006, PHYSIOL PLANTARUM, V126, P52, DOI 10.1111/j.1399-3054.2006.00596.x; Chinnusamy V, 2007, TRENDS PLANT SCI, V12, P444, DOI 10.1016/j.tplants.2007.07.002; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fatima T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034099; Fowler S, 2002, PLANT CELL, V14, P1675, DOI 10.1105/tpc.003483; Ghangal R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072516; Ghangal R, 2012, PLANT PHYSIOL BIOCH, V51, P123, DOI 10.1016/j.plaphy.2011.10.005; Ghangal R, 2009, PLANT PHYSIOL BIOCH, V47, P1113, DOI 10.1016/j.plaphy.2009.09.004; Gong ZZ, 2002, P NATL ACAD SCI USA, V99, P11507, DOI 10.1073/pnas.172399299; Gupta R, 2012, J PROTEOME RES, V11, P2684, DOI 10.1021/pr200944z; Gupta SM, 2009, DEFENCE SCI J, V59, P147, DOI 10.14429/dsj.59.1502; Hannah MA, 2006, PLANT PHYSIOL, V142, P98, DOI 10.1104/pp.106.081141; Jain A, 2014, PHYSIOL MOL BIOL PLA, V20, P115, DOI 10.1007/s12298-013-0210-6; Jain Ankit, 2010, Physiology and Molecular Biology of Plants, V16, P375, DOI 10.1007/s12298-010-0037-3; Jain M, 2012, BRIEF FUNCT GENOMICS, V11, P63, DOI 10.1093/bfgp/elr038; Joubes J, 2008, PLANT MOL BIOL, V67, P547, DOI 10.1007/s11103-008-9339-z; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kim KY, 2004, J EXP BOT, V55, P1153, DOI 10.1093/jxb/erh125; Lee BH, 2005, PLANT CELL, V17, P3155, DOI 10.1105/tpc.105.035568; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lockhart DJ, 1996, NAT BIOTECHNOL, V14, P1675, DOI 10.1038/nbt1296-1675; Lu R.S., 1992, 20 ICIMOD; Morrissy AS, 2009, GENOME RES, V19, P1825, DOI 10.1101/gr.094482.109; Nicot N, 2005, J EXP BOT, V56, P2907, DOI 10.1093/jxb/eri285; Nielsen KL, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl714; Ozsolak F, 2011, NAT REV GENET, V12, P87, DOI 10.1038/nrg2934; Rodriguez M., 2005, BIOTECNOL APL, V22, P1, DOI DOI 10.1007/S00284-005-4515-8; Sakuma Y, 2002, BIOCHEM BIOPH RES CO, V290, P998, DOI 10.1006/bbrc.2001.6299; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Sasaki K, 2011, FRONT PLANT SCI, V2, P1, DOI [10.3389/fpls.2011.00001, DOI 10.3389/FPLS.2011.00001]; Shinozaki K, 1996, CURR OPIN BIOTECH, V7, P161, DOI 10.1016/S0958-1669(96)80007-3; Stiff M, 2002, CURR OPIN PLANT BIOL, V5, P199; Suryakumar G, 2011, J ETHNOPHARMACOL, V138, P268, DOI 10.1016/j.jep.2011.09.024; Svensson JT, 2006, PLANT PHYSIOL, V141, P257, DOI 10.1104/pp.105.072645; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; Teng BS, 2006, PHARMACOL RES, V54, P186, DOI 10.1016/j.phrs.2006.04.007; Thomashow MF, 1999, ANNU REV PLANT PHYS, V50, P571, DOI 10.1146/annurev.arplant.50.1.571; Tian DQ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-827; Trajkovski V, 1999, BOT LITHUANICA S, V2, P37; VELCULESCU VE, 1995, SCIENCE, V270, P484, DOI 10.1126/science.270.5235.484; Winfield MO, 2010, PLANT BIOTECHNOL J, V8, P749, DOI 10.1111/j.1467-7652.2010.00536.x; Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444; Yang YQ, 2005, PHYSIOL PLANTARUM, V124, P431, DOI 10.1111/j.1399-3054.2005.00517.x; Zeb Alam, 2006, Asian Pac J Cancer Prev, V7, P32; Zhu J, 2008, P NATL ACAD SCI USA, V105, P4945, DOI 10.1073/pnas.0801029105	51	18	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0121982	10.1371/journal.pone.0121982	http://dx.doi.org/10.1371/journal.pone.0121982			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803684	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000353889600185
J	Simo, M; Ripolles, P; Fuentemilla, L; Vaquero, L; Bruna, J; Rodriguez-Fornells, A				Simo, Marta; Ripolles, Pablo; Fuentemilla, Lluis; Vaquero, Lucia; Bruna, Jordi; Rodriguez-Fornells, Antoni			Studying Memory Encoding to Promote Reliable Engagement of the Medial Temporal Lobe at the Single-Subject Level	PLOS ONE			English	Article							MATERIAL-SPECIFIC LATERALIZATION; TALAIRACH ATLAS; FUNCTIONAL MRI; HUMAN BRAIN; HIPPOCAMPUS; FMRI; EPILEPSY; CORTEX; INFORMATION; REGISTRATION	The medial temporal lobe (MTL)-comprising hippocampus and the surrounding neocortical regions-is a targeted brain area sensitive to several neurological diseases. Although functional magnetic resonance imaging (fMRI) has been widely used to assess brain functional abnormalities, detecting MTL activation has been technically challenging. The aim of our study was to provide an fMRI paradigm that reliably activates MTL regions at the individual level, thus providing a useful tool for future research in clinical memory-related studies. Twenty young healthy adults underwent an event-related fMRI study consisting of three encoding conditions: word-pairs, face-name associations and complex visual scenes. A region-of-interest analysis at the individual level comparing novel and repeated stimuli independently for each task was performed. The results of this analysis yielded activations in the hippocampal and parahippocampal regions in most of the participants. Specifically, 95% and 100% of participants showed significant activations in the left hippocampus during the face-name encoding and in the right parahippocampus, respectively, during scene encoding. Additionally, a whole brain analysis, also comparing novel versus repeated stimuli at the group level, showed mainly left frontal activation during the word task. In this group analysis, the face-name association engaged the HP and fusiform gyri bilaterally, along with the left inferior frontal gyrus, and the complex visual scenes activated mainly the parahippocampus and hippocampus bilaterally. In sum, our task design represents a rapid and reliable manner to study and explore MTL activity at the individual level, thus providing a useful tool for future research in clinical memory-related fMRI studies.	[Simo, Marta; Ripolles, Pablo; Fuentemilla, Lluis; Vaquero, Lucia; Rodriguez-Fornells, Antoni] Bellvitge Biomed Res Inst IDIBELL, Cognit & Brain Plast Grp, Barcelona, Spain; [Simo, Marta; Bruna, Jordi] HUB, Neurooncol Unit, Barcelona, Spain; [Simo, Marta; Bruna, Jordi] Hosp Duran & Reynals, Inst Catala Oncol, Barcelona, Spain; [Ripolles, Pablo; Fuentemilla, Lluis; Vaquero, Lucia; Rodriguez-Fornells, Antoni] Univ Barcelona, Dept Basic Psychol, Barcelona, Spain; [Rodriguez-Fornells, Antoni] ICREA, Catalan Inst Res & Adv Studies, Barcelona, Spain	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Hospital Duran i Reynals; University of Barcelona; ICREA	Simo, M (corresponding author), Bellvitge Biomed Res Inst IDIBELL, Cognit & Brain Plast Grp, Barcelona, Spain.	martasimo80@hotmail.com	Fuentemilla, Lluís/E-3926-2012; Bruna, Jordi/AAH-1182-2019; Vaquero, Lucia/AAS-9867-2020; Rodriguez Fornells, Antoni/L-5878-2014	Fuentemilla, Lluís/0000-0002-5482-7615; Bruna, Jordi/0000-0001-6895-5047; Vaquero, Lucia/0000-0003-0361-0771; Ripolles, Pablo/0000-0002-8463-3723; Rodriguez Fornells, Antoni/0000-0002-3249-6931	Fundacio Marato-TV3 [Acquired Spinal Cord and Brain Injuries Program]; Catalan Government [Generalitat de Catalunya] [SGR 93]; Carlos III National Health Institute (Spanish Government) [CM11/00256]; ICREA Funding Source: Custom	Fundacio Marato-TV3 [Acquired Spinal Cord and Brain Injuries Program]; Catalan Government [Generalitat de Catalunya](Generalitat de Catalunya); Carlos III National Health Institute (Spanish Government); ICREA(ICREA)	This work was supported by Fundacio Marato-TV3 [Acquired Spinal Cord and Brain Injuries Program (2012-2014) awarded to ARF] and the Catalan Government [Generalitat de Catalunya, 2009 SGR 93 to ARF]. MS was a recipient of a Rio Hortega research contract (code: CM11/00256) from the Carlos III National Health Institute (Spanish Government). The funders had no role in study	Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Brandt David J, 2013, Front Psychiatry, V4, P163, DOI 10.3389/fpsyt.2013.00163; Bunzeck N, 2006, NEURON, V51, P369, DOI 10.1016/j.neuron.2006.06.021; Cohen NJ, 1997, MEMORY, V5, P131, DOI 10.1080/741941149; Das SR, 2009, HIPPOCAMPUS, V19, P517, DOI 10.1002/hipo.20620; Davachi L, 2002, J NEUROPHYSIOL, V88, P982, DOI 10.1152/jn.2002.88.2.982; Detre JA, 1998, NEUROLOGY, V50, P926, DOI 10.1212/WNL.50.4.926; Diana RA, 2007, TRENDS COGN SCI, V11, P379, DOI 10.1016/j.tics.2007.08.001; Eichenbaum H, 2007, ANNU REV NEUROSCI, V30, P123, DOI 10.1146/annurev.neuro.30.051606.094328; Eichenbaum H, 1999, NEURON, V23, P209, DOI 10.1016/S0896-6273(00)80773-4; Eldridge LL, 2000, NAT NEUROSCI, V3, P1149, DOI 10.1038/80671; Friston KJ, 2011, BRAIN CONNECT, V1, P13, DOI 10.1089/brain.2011.0008; Golby AJ, 2001, BRAIN, V124, P1841, DOI 10.1093/brain/124.9.1841; Greicius MD, 2003, HIPPOCAMPUS, V13, P164, DOI 10.1002/hipo.10064; Hannula DE, 2006, J NEUROSCI, V26, P8352, DOI 10.1523/JNEUROSCI.5222-05.2006; Harrington GS, 2006, NEURORADIOLOGY, V48, P495, DOI 10.1007/s00234-006-0083-2; Henke K, 1999, P NATL ACAD SCI USA, V96, P5884, DOI 10.1073/pnas.96.10.5884; Huffman DJ, 2014, HIPPOCAMPUS, V24, P1394, DOI 10.1002/hipo.22321; Kelley WM, 1998, NEURON, V20, P927, DOI 10.1016/S0896-6273(00)80474-2; Kim H, 2011, NEUROIMAGE, V54, P2446, DOI 10.1016/j.neuroimage.2010.09.045; Klein A, 2009, NEUROIMAGE, V46, P786, DOI 10.1016/j.neuroimage.2008.12.037; Kohler S, 2005, HIPPOCAMPUS, V15, P763, DOI 10.1002/hipo.20098; Kumaran D, 2009, TRENDS COGN SCI, V13, P47, DOI 10.1016/j.tics.2008.11.004; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Lech RK, 2014, BEHAV BRAIN RES, V268, P22, DOI 10.1016/j.bbr.2014.03.030; Lech RK, 2013, BEHAV BRAIN RES, V254, P45, DOI 10.1016/j.bbr.2013.06.009; Lisman JE, 2005, NEURON, V46, P703, DOI 10.1016/j.neuron.2005.05.002; Litman L, 2009, HIPPOCAMPUS, V19, P308, DOI 10.1002/hipo.20515; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Maldjian JA, 2004, NEUROIMAGE, V21, P450, DOI 10.1016/j.neuroimage.2003.09.032; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; Mayes A, 2007, TRENDS COGN SCI, V11, P126, DOI 10.1016/j.tics.2006.12.003; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; Miro J, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-98; Pereira JM, 2012, NEUROIMAGE, V49, P2205; Powell HWR, 2005, NEUROIMAGE, V27, P231, DOI 10.1016/j.neuroimage.2005.04.033; Preston AR, 2008, CEREB CORTEX, V18, P2192, DOI 10.1093/cercor/bhm245; Pustina D, 2012, BEHAV BRAIN RES, V229, P57, DOI 10.1016/j.bbr.2011.12.034; Ranganath C, 2003, NAT REV NEUROSCI, V4, P193, DOI 10.1038/nrn1052; Richardson M, 2010, CLIN NEUROPHYSIOL, V121, P1153, DOI 10.1016/j.clinph.2010.01.004; Ripolles P, 2012, NEUROIMAGE, V60, P1296, DOI 10.1016/j.neuroimage.2012.01.094; Ripolles P, 2014, CURR BIOL, V24, P2606, DOI 10.1016/j.cub.2014.09.044; Rolls ET, 2000, HIPPOCAMPUS, V10, P380, DOI 10.1002/1098-1063(2000)10:4<380::AID-HIPO4>3.0.CO;2-0; Saling MM, 2009, BRAIN, V132, P570, DOI 10.1093/brain/awp012; Simo M, 2013, NEUROSCI BIOBEHAV R, V37, P1311, DOI 10.1016/j.neubiorev.2013.04.015; Sperling R, 2003, NEUROIMAGE, V20, P1400, DOI 10.1016/S1053-8119(03)00391-4; Sperling R, 2007, ANN NY ACAD SCI, V1097, P146, DOI 10.1196/annals.1379.009; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; Strange BA, 2002, J NEUROSCI, V22, P523, DOI 10.1523/JNEUROSCI.22-02-00523.2002; TREVES A, 1994, HIPPOCAMPUS, V4, P374, DOI 10.1002/hipo.450040319; Veltman DJ, 2000, NEUROIMAGE, V11, P575, DOI 10.1006/nimg.2000.0581; Wilson JL, 2002, NEUROIMAGE, V17, P967, DOI 10.1006/nimg.2002.1172	53	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0119159	10.1371/journal.pone.0119159	http://dx.doi.org/10.1371/journal.pone.0119159			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803273	Green Submitted, Green Published, gold			2022-12-26	WOS:000353889600014
J	Slusser, A; Bathula, CS; Sens, DA; Somji, S; Sens, MA; Zhou, XD; Garrett, SH				Slusser, Andrea; Bathula, Chandra S.; Sens, Donald A.; Somji, Seema; Sens, Mary Ann; Zhou, Xu Dong; Garrett, Scott H.			Cadherin Expression, Vectorial Active Transport, and Metallothionein Isoform 3 Mediated EMT/MET Responses in Cultured Primary and Immortalized Human Proximal Tubule Cells	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; GROWTH-INHIBITORY FACTOR; DIFFERENTIAL EXPRESSION; HUMAN-KIDNEY; N-CADHERIN; ALZHEIMERS-DISEASE; TISSUE-CULTURE; RENAL-DISEASE; BETA-CATENIN; FIBROSIS	Background Cultures of human proximal tubule cells have been widely utilized to study the role of EMT in renal disease. The goal of this study was to define the role of growth media composition on classic EMT responses, define the expression of E- and N-cadherin, and define the functional epitope of MT-3 that mediates MET in HK-2 cells. Methods Immunohistochemistry, microdissection, real-time PCR, western blotting, and ELISA were used to define the expression of E- and N-cadherin mRNA and protein in HK-2 and HPT cell cultures. Site-directed mutagenesis, stable transfection, measurement of transepithelial resistance and dome formation were used to define the unique amino acid sequence of MT-3 associated with MET in HK-2 cells. Results It was shown that both E- and N-cadherin mRNA and protein are expressed in the human renal proximal tubule. It was shown, based on the pattern of cadherin expression, connexin expression, vectorial active transport, and transepithelial resistance, that the HK-2 cell line has already undergone many of the early features associated with EMT. It was shown that the unique, six amino acid, C-terminal sequence of MT-3 is required for MT-3 to induce MET in HK-2 cells. Conclusions The results show that the HK-2 cell line can be an effective model to study later stages in the conversion of the renal epithelial cell to a mesenchymal cell. The HK-2 cell line, transfected with MT-3, may be an effective model to study the process of MET. The study implicates the unique C-terminal sequence of MT-3 in the conversion of HK-2 cells to display an enhanced epithelial phenotype.	[Slusser, Andrea; Bathula, Chandra S.; Sens, Donald A.; Somji, Seema; Sens, Mary Ann; Zhou, Xu Dong; Garrett, Scott H.] Univ N Dakota, Sch Med & Hlth Sci, Dept Pathol, Grand Forks, ND 58201 USA	University of North Dakota Grand Forks	Garrett, SH (corresponding author), Univ N Dakota, Sch Med & Hlth Sci, Dept Pathol, Grand Forks, ND 58201 USA.	scott.garrett@med.und.edu		Bathula, Chandra Sekhar/0000-0001-9110-4347	Department of Pathology and the School of Medicine and Health Sciences, University of North Dakota; ND INBRE program from the National Institute of General Medical Sciences, NIH [P20 BM103442]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103442] Funding Source: NIH RePORTER	Department of Pathology and the School of Medicine and Health Sciences, University of North Dakota; ND INBRE program from the National Institute of General Medical Sciences, NIH; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funds were provided by the Department of Pathology and the School of Medicine and Health Sciences, University of North Dakota. Undergraduate research, student mentoring, and core facilities for bioinformatics and statistics were supported by the ND INBRE program project P20 BM103442 from the National Institute of General Medical Sciences, NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alami J, 2003, J CLIN PATHOL-MOL PA, V56, P218, DOI 10.1136/mp.56.4.218; ALPERS CE, 1994, J AM SOC NEPHROL, V5, P201; Bai SJ, 2012, INT J BIOL SCI, V8, P859, DOI 10.7150/ijbs.3490; Bathula CS, 2008, TOXICOL SCI, V102, P310, DOI 10.1093/toxsci/kfn004; Bedford JJ, 2003, J AM SOC NEPHROL, V14, P2581, DOI 10.1097/01.ASN.0000089566.28106.F6; Berzal S, 2012, TOXICOL SCI, V127, P425, DOI 10.1093/toxsci/kfs108; Bohle A, 1996, KIDNEY INT, V49, pS2; Cho EA, 1998, DEVELOPMENT, V125, P803; Coca SG, 2009, AM J KIDNEY DIS, V53, P961, DOI 10.1053/j.ajkd.2008.11.034; DETRISAC CJ, 1984, KIDNEY INT, V25, P383, DOI 10.1038/ki.1984.28; Ding W, 2012, BIOCHEM BIOPH RES CO, V418, P451, DOI 10.1016/j.bbrc.2012.01.037; Docherty NG, 2009, KIDNEY INT, V75, P205, DOI 10.1038/ki.2008.482; Dudas PL, 2011, NEPHRON EXP NEPHROL, V117, pE114, DOI 10.1159/000320177; Dudas PL, 2009, NEPHROL DIAL TRANSPL, V24, P1406, DOI 10.1093/ndt/gfn662; Eddy AA, 2006, J AM SOC NEPHROL, V17, P2964, DOI 10.1681/ASN.2006070704; Eneling K, 2012, FASEB J, V26, P3230, DOI 10.1096/fj.12-205609; Esteban MA, 2006, CANCER RES, V66, P3567, DOI 10.1158/0008-5472.CAN-05-2670; FINE LG, 1995, KIDNEY INT, V47, pS48; FINE LG, 1993, EUR J CLIN INVEST, V23, P259, DOI 10.1111/j.1365-2362.1993.tb00771.x; Grabias BM, 2012, FASEB J, V26, P4131, DOI 10.1096/fj.12-207324; Guillen-Gomez E, 2012, J CELL PHYSIOL, V227, P1521, DOI 10.1002/jcp.22869; Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112; Huby AC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006721; Humphreys BD, 2010, AM J PATHOL, V176, P85, DOI 10.2353/ajpath.2010.090517; Jung KY, 2004, MECH AGEING DEV, V125, P445, DOI 10.1016/j.mad.2004.04.001; KEMPSON SA, 1989, J LAB CLIN MED, V113, P285; Kim D, 2002, KIDNEY INT, V61, P464, DOI 10.1046/j.1523-1755.2002.00153.x; Kirk A, 2010, NEPHROL DIAL TRANSPL, V25, P2107, DOI 10.1093/ndt/gfq006; Kiuchi-Saishin Y, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V134875; Langner C, 2004, MODERN PATHOL, V17, P180, DOI 10.1038/modpathol.3800032; Lever JE., 1985, TISSUE CULTURE EPITH, P3; Li Q, 2011, J CELL BIOCHEM, V112, P1585, DOI 10.1002/jcb.23074; Li YK, 2010, MOL CELL BIOCHEM, V339, P263, DOI 10.1007/s11010-010-0389-6; Lin HL, 2011, AM J PHYSIOL-RENAL, V300, pF1017, DOI 10.1152/ajprenal.00426.2010; Lin SL, 2008, AM J PATHOL, V173, P1617, DOI 10.2353/ajpath.2008.080433; Masola V, 2012, J BIOL CHEM, V287, P1478, DOI 10.1074/jbc.M111.279836; Mori K, 2005, J CLIN INVEST, V115, P610, DOI 10.1172/JCI200523056; NOUWEN EJ, 1993, KIDNEY INT, V44, P147, DOI 10.1038/ki.1993.225; Nurnberger J, 2010, HISTOCHEM CELL BIOL, V133, P641, DOI 10.1007/s00418-010-0702-1; PALMITER RD, 1992, P NATL ACAD SCI USA, V89, P6333, DOI 10.1073/pnas.89.14.6333; Picard N, 2008, HISTOCHEM CELL BIOL, V130, P141, DOI 10.1007/s00418-008-0433-8; Piepenhagen PA, 1998, MOL BIOL CELL, V9, P3161, DOI 10.1091/mbc.9.11.3161; Prozialeck Walter C, 2004, BMC Physiol, V4, P10, DOI 10.1186/1472-6793-4-10; Prozialeck WC, 2003, TOXICOL APPL PHARM, V189, P180, DOI 10.1016/S0041-008X(03)00130-3; Prunotto M, 2012, J PATHOL, V228, P131, DOI 10.1002/path.4049; Romero-Isart N, 2002, J BIOL CHEM, V277, P37023, DOI 10.1074/jbc.M205730200; RYAN MJ, 1994, KIDNEY INT, V45, P48, DOI 10.1038/ki.1994.6; Sarkozi R, 2012, BIOCHEM BIOPH RES CO, V424, P801, DOI 10.1016/j.bbrc.2012.07.042; Sens DA, 1999, EXP NEPHROL, V7, P344; Shimazui T, 2006, ONCOL REP, V15, P1181; Somji S, 2006, TOXICOL SCI, V90, P369, DOI 10.1093/toxsci/kfj089; Somji S, 2004, TOXICOL SCI, V80, P358, DOI 10.1093/toxsci/kfh158; STATES B, 1986, BIOCHEM MED METAB B, V36, P151, DOI 10.1016/0885-4505(86)90119-2; Todd J H, 1996, Methods Mol Med, V2, P431, DOI 10.1385/0-89603-335-X:431; TSUJI S, 1992, EMBO J, V11, P4843, DOI 10.1002/j.1460-2075.1992.tb05590.x; UCHIDA Y, 1991, NEURON, V7, P337, DOI 10.1016/0896-6273(91)90272-2; Veerasamy M, 2009, AM J PHYSIOL-RENAL, V297, pF1238, DOI 10.1152/ajprenal.90539.2008; Venkatachalam MA, 2010, AM J PHYSIOL-RENAL, V298, pF1078, DOI 10.1152/ajprenal.00017.2010; WILSON PD, 1985, AM J PHYSIOL, V248, pF436, DOI 10.1152/ajprenal.1985.248.3.F436; Wu CY, 2012, TRENDS GENET, V28, P454, DOI 10.1016/j.tig.2012.05.005; Yuan YG, 2012, FREE RADICAL BIO MED, V53, P30, DOI 10.1016/j.freeradbiomed.2012.03.015; Zeisberg M, 2010, J AM SOC NEPHROL, V21, P1819, DOI 10.1681/ASN.2010080793; Zheng Q, 2003, PROTEIN ENG, V16, P865, DOI 10.1093/protein/gzg127	63	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0120132	10.1371/journal.pone.0120132	http://dx.doi.org/10.1371/journal.pone.0120132			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803827	Green Published, gold, Green Submitted			2022-12-26	WOS:000353889600060
J	Wu, JS; Shi, R; Lu, X; Ma, YM; Cheng, NN				Wu, Jia-Sheng; Shi, Rong; Lu, Xiong; Ma, Yue-Ming; Cheng, Neng-Neng			Combination of Active Components of Xiexin Decoction Ameliorates Renal Fibrosis Through the Inhibition of NF-kappa B and TGF-beta 1/Smad Pathways in db/db Diabetic Mice	PLOS ONE			English	Article							TGF-BETA; NEPHROPATHY; PATHOGENESIS; INFLAMMATION; BLOCKADE; MEDICINE; DISEASE; RATS	Xiexin decoction, a herbal therapeutic agent commonly used in traditional Chinese medicine, is recognized for its beneficial effects on diabetic nephropathy exerted through the combined action of multiple components, including Rhizoma Coptidis alkaloids (A), Radix et Rhizoma Rhei polysaccharides (P), and Radix Scutellaria flavones (F). Our previous studies have shown that a combination of A, P, and F (APF) exhibits renoprotective effects against diabetic nephropathy. This study was aimed at determining the effects of APF on renal fibrosis in diabetic nephropathy and elucidating the underlying molecular mechanisms. To evaluate the effects of APF, in vivo, db/db diabetic mice were orally administered a low or high dose of APF (300 or 600 mg/kg, respectively) once a day for 8 weeks. We evaluated the blood and urine indices of metabolic and renal function, renal tissue histopathology, renal inflammation, and fibrosis. APF treatment significantly ameliorated glucose and lipid metabolism dysfunction, decreased urinary albumin excretion, normalized creatinine clearance, and reduced the morphological changes in renal tissue. Additionally, APF administration in db/db diabetic mice reduced the elevated levels of renal inflammation mediators such as intercellular adhesion molecule-1, monocyte chemotactic protein-1, tumor necrosis factor-alpha, interleukin-1 beta, and active nuclear factor kappa B (NF-kappa B). APF treatment also reduced type I and IV collagen, transforming growth factor-beta 1 (TGF-beta 1), and TGF-beta 1 type II receptor expression levels, and decreased the phosphorylation of Smad2/3 in the kidneys of db/db diabetic mice. These results suggest that APF reduces renal fibrosis in diabetic nephropathy through the NF-kappa B and TGF-beta 1/Smad signaling pathways. In vitro, APF treatment reduced cell proliferation and protein expression of a-smooth muscle actin, collagen I, TGF-beta 1 and NF-kappa B in mesangial cells cultured with high glucose concentrations. Our findings indicate that treatment with multi-component herbal therapeutic formulations may be a useful approach for the treatment of diabetic nephropathy.	[Wu, Jia-Sheng; Shi, Rong; Ma, Yue-Ming] Shanghai Univ Tradit Chinese Med, Dept Pharmacol, Shanghai, Peoples R China; [Lu, Xiong] Shanghai Univ Tradit Chinese Med, Expt Ctr Sci & Technol, Shanghai, Peoples R China; [Cheng, Neng-Neng] Fudan Univ, Sch Pharm, Dept Pharmacol, Shanghai 200433, Peoples R China	Shanghai University of Traditional Chinese Medicine; Shanghai University of Traditional Chinese Medicine; Fudan University	Ma, YM (corresponding author), Shanghai Univ Tradit Chinese Med, Dept Pharmacol, Shanghai, Peoples R China.	mayueming_117@hotmail.com; nncheng@gmail.com	ma, yue/GXE-9897-2022		National Natural Science Foundation of China [30873231]; Budget Project of the Shanghai Municipal Education Commission [2012JW07]; "085" First-Class Discipline Construction of Science and Technology Innovation [085ZY1205]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Budget Project of the Shanghai Municipal Education Commission; "085" First-Class Discipline Construction of Science and Technology Innovation	This work was supported by grants from the National Natural Science Foundation of China (No. 30873231), the Budget Project of the Shanghai Municipal Education Commission (2012JW07), "085" First-Class Discipline Construction of Science and Technology Innovation (085ZY1205). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, PLOS ONE; Chow FY, 2005, J AM SOC NEPHROL, V16, P1711, DOI 10.1681/ASN.2004070612; Deshpande SD, 2013, DIABETES, V62, P3151, DOI 10.2337/db13-0305; Fried LF, 2013, NEW ENGL J MED, V369, P1892, DOI 10.1056/NEJMoa1303154; Heerspink Hiddo J Lambers, 2011, Rev Diabet Stud, V8, P392, DOI 10.1900/RDS.2011.8.392; Huang CL, 2013, DIABETES, V62, P2923, DOI 10.2337/db13-0135; Ka SM, 2012, DIABETOLOGIA, V55, P509, DOI 10.1007/s00125-011-2364-5; Lan HY, 2012, CLIN EXP PHARMACOL P, V39, P731, DOI 10.1111/j.1440-1681.2011.05663.x; Lan HY, 2011, INT J BIOL SCI, V7, P1056, DOI 10.7150/ijbs.7.1056; Liu Y., 2012, CHINESE J CLIN PHARM, V21, P75; Ma LJ, 2004, KIDNEY INT, V65, P106, DOI 10.1111/j.1523-1755.2004.00381.x; Navarro-Gonzalez JF, 2011, NAT REV NEPHROL, V7, P327, DOI 10.1038/nrneph.2011.51; Niu HL, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-135; Petersen M, 2008, KIDNEY INT, V73, P705, DOI 10.1038/sj.ki.5002717; Sculy T, 2011, NATURE, V485, pS2; Shi X, 2011, DIABETOLOGIA, V54, P1888, DOI 10.1007/s00125-011-2147-z; Sun SM, 2009, BEI JI QIAN JIN YAO, P33; Tong XL, 2012, AM J CHINESE MED, V40, P877, DOI 10.1142/S0192415X12500656; Van Buren PN, 2013, CURR DIABETES REV, V9, P62, DOI 10.2174/1573399811309010062; Wen XY, 2012, J ETHNOPHARMACOL, V142, P144, DOI 10.1016/j.jep.2012.04.028; [吴家胜 WU Jia-sheng], 2010, [中草药, Chinese Traditional and Herbal Drugs], V41, P73; Wu JS, 2013, EVID-BASED COMPL ALT, V2013, DOI [10.1155/2013/715671, DOI 10.1155/2013/715671]; Xie W., 2011, EVID-BASED COMPL ALT, V2011, DOI DOI 10.1155/2011/726723; Xie Y, 2013, Drug Res (Stuttg), V63, P501, DOI 10.1055/s-0033-1345206; Yamout H, 2014, ADV CHRONIC KIDNEY D, V21, P281, DOI 10.1053/j.ackd.2014.03.005; Yang SM, 2014, DIABETOLOGIA, V57, P424, DOI 10.1007/s00125-013-3115-6; Yi B, 2014, PLOS ONE, V9; Zhao HL, 2012, DIABETES, V61, P933, DOI 10.2337/db11-1164; Zhao TT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090807; Zhong X, 2013, DIABETOLOGIA, V56, P663, DOI 10.1007/s00125-012-2804-x; Ziyadeh FN, 2004, J AM SOC NEPHROL, V15, pS55, DOI 10.1097/01.ASN.0000093460.24823.5B; Ziyadeh FN, 2008, CURR DIABETES REV, V4, P39, DOI 10.2174/157339908783502370; Zorena K, 2013, MEDIAT INFLAMM, V849457, P9	33	32	36	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0122661	10.1371/journal.pone.0122661	http://dx.doi.org/10.1371/journal.pone.0122661			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803610	Green Submitted, Green Published, gold			2022-12-26	WOS:000353889600205
J	Adams, J; Stamp, E; Nettle, D; Milne, EMG; Jagger, C				Adams, Jean; Stamp, Elaine; Nettle, Daniel; Milne, Eugene M. G.; Jagger, Carol			Anticipated Survival and Health Behaviours in Older English Adults: Cross Sectional and Longitudinal Analysis of the English Longitudinal Study of Ageing	PLOS ONE			English	Article							ILL HEALTH; MORTALITY; SMOKING; OBESITY; RISK	Background Individuals may make a rational decision not to engage in healthy behaviours based on their assessment of the benefits of such behaviours to them, compared to other uncontrollable threats to their health. Anticipated survival is one marker of perceived uncontrollable threats to health. We hypothesised that greater anticipated survival: a) is cross-sectionally associated with healthier patterns of behaviours; b) increases the probability that behaviours will be healthier at follow up than at baseline; and c) decreases the probability that behaviours will be 'less healthy' at follow than at baseline. Methods Data from waves 1 and 5 of the English Longitudinal Survey of Ageing provided 8 years of follow up. Perceptions of uncontrollable threats to health at baseline were measured using anticipated survival. Health behaviours considered were self-reported cigarette smoking, physical activity level, and frequency of alcohol consumption. A wide range of socio-economic, demographic, and health variables were adjusted for. Results Greater anticipated survival was cross-sectionally associated with lower likelihood of smoking, and higher physical activity levels, but was not associated with alcohol consumption. Lower anticipated survival was associated with decreased probability of adopting healthier patterns of physical activity, and increased probability of becoming a smoker at follow up. There were no associations between anticipated survival and change in alcohol consumption. Conclusions Our hypotheses were partially confirmed, though associations were inconsistent across behaviours and absent for alcohol consumption. Individual assessments of uncontrollable threats to health may be an important determinant of smoking and physical activity.	[Adams, Jean; Stamp, Elaine; Jagger, Carol] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Nettle, Daniel] Newcastle Univ, Inst Neurosci, Ctr Behav & Evolut, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Milne, Eugene M. G.; Jagger, Carol] Newcastle Univ, Inst Ageing & Hlth, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK; Newcastle University - UK	Adams, J (corresponding author), Univ Cambridge, MRC, Ctr Diet & Act Res, Epidemiol Unit, Cambridge, England.	jma79@medschl.cam.ac.uk	Adams, Jean/G-2402-2010	Adams, Jean/0000-0002-5733-7830; Jagger, Carol/0000-0002-6377-9926; Nettle, Daniel/0000-0001-9089-2599	British Medical Association Strutt Harper Award; Centre for Diet and Activity Research (CEDAR), a UKCRC Public Health Research Centre of Excellence; British Heart Foundation; Cancer Research UK; Economic and Social Research Council; Medical Research Council; National Institute for Health Research; Wellcome Trust under UK Clinical Research Collaboration; ESRC [ES/G007462/1] Funding Source: UKRI; MRC [MR/K023187/1, G106/1253] Funding Source: UKRI; Economic and Social Research Council [ES/G007462/1] Funding Source: researchfish; Medical Research Council [G106/1253, MR/K023187/1] Funding Source: researchfish	British Medical Association Strutt Harper Award; Centre for Diet and Activity Research (CEDAR), a UKCRC Public Health Research Centre of Excellence; British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); Wellcome Trust under UK Clinical Research Collaboration(Wellcome Trust); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by a British Medical Association Strutt Harper Award (2011). JA is funded by the Centre for Diet and Activity Research (CEDAR), a UKCRC Public Health Research Centre of Excellence. Funding from the British Heart Foundation, Cancer Research UK, Economic and Social Research Council, Medical Research Council, the National Institute for Health Research, and the Wellcome Trust, under the auspices of the UK Clinical Research Collaboration, is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 2014, J EPIDEMIOL COMMUNIT; AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; [Anonymous], 1995, SENS DRINK REP INT W; [Anonymous], 2013, HLTH SURVEY ENGLAND; Bull FC, 2010, PHYS ACT GUID UK REV; CHARLTON BG, 1995, PUBLIC HEALTH, V109, P235, DOI 10.1016/S0033-3506(95)80200-2; Demakakos P, 2010, DIABETES CARE, V33, P792, DOI 10.2337/dc09-1663; Department for Communities and Local Government, 2008, ENGLISH INDICES DEPR; Egger G, 1997, BRIT MED J, V315, P477, DOI 10.1136/bmj.315.7106.477; Kvaavik E, 2010, ARCH INTERN MED, V170, P711, DOI 10.1001/archinternmed.2010.76; Lader D, 2009, 40 OFF NAT STAT; Lawlor DA, 2003, AM J PUBLIC HEALTH, V93, P266, DOI 10.2105/AJPH.93.2.266; Ling J, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-892; MARMOT M, 2008, ENGLISH LONGITUDINAL; Marmot M, 2003, HLTH WEALTH LIFESTYL; National Obesity Observatory, 2011, KNOWL ATT HLTH EAT P; Nettle D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013371; Pepper GV, 2014, HUM NATURE-INT BIOS, V25, P378, DOI 10.1007/s12110-014-9204-5; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Ronksley PE, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d671; Scarborough P, 2011, J PUBLIC HEALTH-UK, V33, P527, DOI 10.1093/pubmed/fdr033; Steel N., 2003, HLTH WEALTH LIFESTYL; Steffick D, 2000, DR005 HRS AHEAD U MI; Taylor R., 2007, HLTH WEALTH LIFESTYL; Wilson GB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071792	25	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0118782	10.1371/journal.pone.0118782	http://dx.doi.org/10.1371/journal.pone.0118782			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE6ZS	25799199	Green Submitted, Green Published, gold			2022-12-26	WOS:000351987300017
J	Bhutta, HY; Rajpal, N; White, W; Freudenberg, JM; Liu, YP; Way, J; Rajpal, D; Cooper, DC; Young, A; Tavakkoli, A; Chen, LH				Bhutta, Hina Y.; Rajpal, Neetu; White, Wendy; Freudenberg, Johannes M.; Liu, Yaping; Way, James; Rajpal, Deepak; Cooper, David C.; Young, Andrew; Tavakkoli, Ali; Chen, Lihong			Effect of Roux-en-Y Gastric Bypass Surgery on Bile Acid Metabolism in Normal and Obese Diabetic Rats	PLOS ONE			English	Article							VERTICAL SLEEVE GASTRECTOMY; BARIATRIC SURGERY; WEIGHT-LOSS; GLUCOSE-METABOLISM; LIPID-METABOLISM; GLYCEMIC CONTROL; LIVER; MICE; TRANSPORTERS; HOMEOSTASIS	In addition to classic functions of facilitating hepatobiliary secretion and intestinal absorption of lipophilic nutrients, bile acids (BA) are also endocrine factors and regulate glucose and lipid metabolism. Recent data indicate that antiobesity bariatric procedures e.g. Roux-en-Y gastric bypass surgery (RYGB), which also remit diabetes, increase plasma BAs in humans, leading to the hypothesis that BAs may play a role in diabetes resolution following surgery. To investigate the effect of RYGB on BA physiology and its relationship with glucose homeostasis, we undertook RYGB and SHAM surgery in Zucker diabetic fatty (ZDF) and normoglycemic Sprague Dawley (SD) rats and measured plasma and fecal BA levels, as well as plasma glucose, insulin, Glucagon like peptide 1 (GLP-1) and Peptide YY (PYY), 2 days before and 3, 7, 14 and 28 days after surgery. RYGB decreased body weight and increased plasma GLP-1 in both SD and ZDF rats while decreasing plasma insulin and glucose in ZDF rats starting from the first week. Compared to SHAM groups, both SD-RYGB and ZDF-RYGB groups started to have increases in plasma total BAs in the second week, which might not contribute to early post-surgery metabolic changes. While there was no significant difference in fecal BA excretion between SD-RYGB and SD-SHAM groups, the ZDF-RYGB group had a transient 4.2-fold increase (P<0.001) in 24-hour fecal BA excretion on post-operative day 3 compared to ZDF-SHAM, which paralleled a significant increase in plasma PYY. Ratios of plasma and fecal cholic acid/chenodeoxycholic acid derived BAs were decreased in RYGB groups. In addition, tissue mRNA expression analysis suggested early intestinal BA reabsorption and potentially reduced hepatic cholic acid production in RYGB groups. In summary, we present novel data on RYGB-mediated changes in BA metabolism to further understand the role of BAs in RYGB-induced metabolic effects in humans.	[Bhutta, Hina Y.; Tavakkoli, Ali] Brigham & Womens Hosp, Dept Surg, Boston, MA 02115 USA; [Bhutta, Hina Y.; Tavakkoli, Ali] Harvard Univ, Sch Med, Boston, MA USA; [Bhutta, Hina Y.] Univ London Imperial Coll Sci Technol & Med, Dept Invest Med, London, England; [Rajpal, Neetu; Liu, Yaping; Way, James; Young, Andrew; Chen, Lihong] GlaxoSmithKline Inc, Metab Drug Discovery, Res Triangle Pk, NC 27709 USA; [White, Wendy] GlaxoSmithKline Inc, Mol Discovery Res, Res Triangle Pk, NC USA; [Freudenberg, Johannes M.; Rajpal, Deepak; Cooper, David C.] GlaxoSmithKline Inc, Quantitat Sci Div, Res Triangle Pk, NC USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Imperial College London; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline	Chen, LH (corresponding author), GlaxoSmithKline Inc, Metab Drug Discovery, Res Triangle Pk, NC 27709 USA.	atavakkoli@partners.org; lihong.a.chen@icloud.com		Freudenberg, Johannes/0000-0002-5327-4414	GlaxoSmithKline [209614]; GSK	GlaxoSmithKline(GlaxoSmithKline); GSK(GlaxoSmithKline)	Researches performed at Brigham and Women's Hospital (HYB and AT) were supported by a grant (Scientific Collaboration Agreement reference number 209614) from GlaxoSmithKline. Researches performed at GlaxoSmithKline (NR, WW, JMF, YL, JW, DR, DC, AY and LC) were supported by GSK internal research funding. Co-authors NR, WW, JMF, YL, JW, DR, DC, AY and LC are employed by GlaxoSmithKline. GlaxoSmithKline provided support in the form of salaries for authors NR, WW, JMF, YL, JW, DR, DC, AY and LC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ahmad NN, 2013, INT J OBESITY, V37, P1553, DOI 10.1038/ijo.2013.38; ANDERSEN E, 1988, EUR J CLIN INVEST, V18, P166, DOI 10.1111/j.1365-2362.1988.tb02408.x; [Anonymous], 2013, INT J PREV MED; Ashrafian H, 2013, J PROTEOME RES; Battle MA, 2008, GASTROENTEROLOGY, V135, P1676, DOI 10.1053/j.gastro.2008.07.074; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Beuling E, 2010, GUT, V59, P888, DOI 10.1136/gut.2009.204990; Buchwald H, 1981, World J Surg, V5, P781; Chen LH, 2012, AM J PHYSIOL-ENDOC M, V302, pE68, DOI 10.1152/ajpendo.00323.2011; Chen LH, 2010, J PHARMACOL EXP THER, V334, P164, DOI 10.1124/jpet.110.166892; Cummings BP, 2012, ENDOCRINOLOGY, V153, P3620, DOI 10.1210/en.2012-1131; Fiorucci S, 2009, TRENDS PHARMACOL SCI, V30, P570, DOI 10.1016/j.tips.2009.08.001; Gustafsson U, 2005, HEPATOLOGY, V41, P1322, DOI 10.1002/hep.20686; Haeusler RA, 2013, DIABETES, V62, P4184, DOI 10.2337/db13-0639; HASSAN AS, 1980, P SOC EXP BIOL MED, V164, P449; Ishida H, 2000, J BIOCHEM, V127, P57, DOI 10.1093/oxfordjournals.jbchem.a022584; Joyce S. A, 2014, GUT MICROBES; Kashyap SR, 2010, CLEV CLIN J MED, V77, P468, DOI 10.3949/ccjm.77a.09135; Katsuma S, 2005, BIOCHEM BIOPH RES CO, V329, P386, DOI 10.1016/j.bbrc.2005.01.139; Kim I, 2007, J LIPID RES, V48, P2664, DOI 10.1194/jlr.M700330-JLR200; Kohli R, 2013, ENDOCRINOLOGY, V154, P2341, DOI 10.1210/en.2012-2069; Kohli R, 2013, J CLIN ENDOCR METAB, V98, pE708, DOI 10.1210/jc.2012-3736; Kohli R, 2010, AM J PHYSIOL-GASTR L, V299, pG652, DOI 10.1152/ajpgi.00221.2010; Kramer W, 1999, J LIPID RES, V40, P1604; Meissner M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024564; Nakatani H, 2009, METABOLISM, V58, P1400, DOI 10.1016/j.metabol.2009.05.006; Neff KJ, 2013, CURR DIABETES REV, V9, P93, DOI 10.2174/1573399811309020001; NERVI FO, 1978, BIOCHIM BIOPHYS ACTA, V529, P212, DOI 10.1016/0005-2760(78)90064-4; Nguyen A, 2008, CELL SIGNAL, V20, P2180, DOI 10.1016/j.cellsig.2008.06.014; Patti ME, 2009, OBESITY, V17, P1671, DOI 10.1038/oby.2009.102; Peterson R.G., 1990, ILAR NEWS, V32, P16, DOI [10.1093/ilar.32.3.16, DOI 10.1093/ILAR.32.3.16, DOI 10.1093/ILAR.32.3.16)]; PLAISANCIE P, 1995, J ENDOCRINOL, V145, P521, DOI 10.1677/joe.0.1450521; Porez G, 2012, J LIPID RES, V53, P1723, DOI 10.1194/jlr.R024794; Pories WJ, 2011, SURG CLIN N AM, V91, P821, DOI 10.1016/j.suc.2011.04.008; Pournaras DJ, 2013, ENDOCRINOLOGY, V154, P2255, DOI 10.1210/en.2013-1383; Pournaras DJ, 2012, ENDOCRINOLOGY, V153, P3613, DOI 10.1210/en.2011-2145; REICHEN J, 1975, GASTROENTEROLOGY, V68, P132; Rhee NA, 2012, DIABETES OBES METAB, V14, P291, DOI 10.1111/j.1463-1326.2011.01505.x; Ryan KK, 2014, NATURE, V509, P183, DOI 10.1038/nature13135; Saeidi N, 2013, SCIENCE, V341, P406, DOI 10.1126/science.1235103; Schauer PR, 2012, NEW ENGL J MED, V366, P1567, DOI 10.1056/NEJMoa1200225; Simonen M, 2012, OBES SURG, V22, P1473, DOI 10.1007/s11695-012-0673-5; Sjostrom L, 2013, J INTERN MED, V273, P219, DOI 10.1111/joim.12012; Smushkin G, 2013, DIABETES, V62, P1094, DOI 10.2337/db12-0923; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Stearns AT, 2009, AM J PHYSIOL-GASTR L, V297, pG950, DOI 10.1152/ajpgi.00253.2009; Steinert RE, 2013, OBESITY, V21, pE660, DOI 10.1002/oby.20522; Stieger B, 2011, HANDB EXP PHARMACOL, V201, P205, DOI 10.1007/978-3-642-14541-4_5; UCHIDA K, 1979, JPN J PHARMACOL, V29, P553, DOI 10.1254/jjp.29.553; UCHIDA K, 1985, DIABETES, V34, P79, DOI 10.2337/diabetes.34.1.79; Vallim TQD, 2013, CELL METAB, V17, P657, DOI 10.1016/j.cmet.2013.03.013; Watanabe M, 2006, NATURE, V439, P484, DOI 10.1038/nature04330; Zhang EY, 2002, DRUG METAB REV, V34, P709, DOI 10.1081/DMR-120015692	53	56	58	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0122273	10.1371/journal.pone.0122273	http://dx.doi.org/10.1371/journal.pone.0122273			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798945	Green Published, Green Submitted, gold			2022-12-26	WOS:000351987300325
J	Chen, YP; Wang, HM; Edwards, TC; Wang, T; Jiang, XY; Lv, YR; Patrick, DL				Chen, Ying-Ping; Wang, Hong-Mei; Edwards, Todd C.; Wang, Ting; Jiang, Xiao-Ying; Lv, Yi-Ran; Patrick, Donald L.			Factors Influencing Quality of Life of Obese Students in Hangzhou, China	PLOS ONE			English	Article							UNITED-STATES; CHILDREN; ADOLESCENTS; OVERWEIGHT	Objective To evaluate the quality of life (QOL) of overweight and obese middle or high school students and identify relevant factors influencing their QOL scores. Methods 716 students were recruited from 6 middle or high schools in Hangzhou, China. The Chinese version of the Youth Quality of Life Instrument-Weight Module (YQOL-W) was self administered. The YQOL-W scores were compared among different BMI groups, gender, educational status, annual household income, parental education and recruitment community using t test or one-way analysis of variance. The independent association of these variables with QOL among overweight and obese students was examined using multivariable linear regression modeling. Results Overweight and obese students reported lower total scores, self, social and environment scores than their normal weight peers (all P<0.001). The QOL of overweight and obese middle and high school students was associated with BMI value, gender, educational status, parental education, and recruitment community. Girls had lower total scores, self, social and environment domain scores than boys (all P<0.001); high school students had lower total and three domain scores than middle school students (all P<0.05). Students whose fathers had higher education reported higher total scores, self and social scores than students with less educated fathers (all P<0.05). Students whose mothers had higher education reported higher environment scores than students with less educated mothers (P = 0.01). Students from migrant communities reported significantly lower total scores, self and social scores than those from rural communities (all P<0.05), but comparable scores with those from urban communities (P>0.05). Students from migrant communities reported comparable environment scores with those from rural and urban communities (P>0.05). Conclusions Overweight and obesity have negative effects on students' quality of life. Therefore weight specific QOL could be included in weight reduction interventions as a relevant outcome.	[Chen, Ying-Ping; Wang, Hong-Mei; Wang, Ting; Jiang, Xiao-Ying; Lv, Yi-Ran] Zhejiang Univ, Sch Med, Inst Social Med & Family Med, Hangzhou 310003, Zhejiang, Peoples R China; [Edwards, Todd C.; Patrick, Donald L.] Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA	Zhejiang University; University of Washington; University of Washington Seattle	Wang, HM (corresponding author), Zhejiang Univ, Sch Med, Inst Social Med & Family Med, Hangzhou 310003, Zhejiang, Peoples R China.	rosa@zju.edu.cn	Patrick, Donald/Y-2460-2019	Patrick, Donald/0000-0003-0756-0492	Health Policy and Systems Sciences (HPSS) Grants for Young Faculty Partnerships of the China Medical Board [11-043]	Health Policy and Systems Sciences (HPSS) Grants for Young Faculty Partnerships of the China Medical Board	This work was funded by Health Policy and Systems Sciences (HPSS) Grants for Young Faculty Partnerships of the China Medical Board (11-043). Funder's website: http://chinamedicalboard.org.cn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja B, 2014, QUAL LIFE RES, V23, P759, DOI 10.1007/s11136-013-0459-9; Al-Akour NA, 2012, CHILD CARE HLTH DEV, V38, P237, DOI 10.1111/j.1365-2214.2011.01248.x; Bonomi AE, 2000, J CLIN EPIDEMIOL, V53, P1, DOI 10.1016/S0895-4356(99)00123-7; Buttitta M, 2014, QUAL LIFE RES, V23, P1117, DOI 10.1007/s11136-013-0568-5; Chen YX, 2010, CHINESE J SCH HLTH, V31, P522; Conway K, 2014, QUAL LIFE RES, V23, P1199, DOI 10.1007/s11136-013-0572-9; Farhat T, 2010, AM J PREV MED, V38, P258, DOI 10.1016/j.amepre.2009.10.038; Gong Q, 2006, PIONEERING SCI TECHN, V19, P181; Group of China Obesity Task Force, 2004, Zhonghua Liu Xing Bing Xue Za Zhi, V25, P97; Hampel P, 2007, J ADOLESCENCE, V30, P885, DOI 10.1016/j.adolescence.2007.04.005; Janicke DM, 2007, OBESITY, V15, P1799, DOI 10.1038/oby.2007.214; Jiang XY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109221; Kim HS, 2014, J SCH NURS, V30, P281, DOI 10.1177/1059840513509839; Kolotkin RL, 2006, OBESITY, V14, P448, DOI 10.1038/oby.2006.59; Lee P Y, 2012, Malays J Nutr, V18, P207; Li SY, 2009, CHINESE J SCH HLTH, V30, P1112; Lou WQ, 2000, J PSYCHOL SCI, V23, P156; Michel G, 2009, QUAL LIFE RES, V18, P1147, DOI 10.1007/s11136-009-9538-3; Mirza NM, 2005, J ADOLESCENT HEALTH, V36; Morales LS, 2011, QUAL LIFE RES, V20, P215, DOI 10.1007/s11136-010-9735-0; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Palacio-Vieira JA, 2008, QUAL LIFE RES, V17, P1207, DOI 10.1007/s11136-008-9405-7; Patrick DL, 2011, QUAL LIFE RES, V20, P961, DOI 10.1007/s11136-010-9824-0; Patton GC, 2007, LANCET, V369, P1130, DOI 10.1016/S0140-6736(07)60366-3; Paula JS, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-6; Piovesan C, 2010, QUAL LIFE RES, V19, P1359, DOI 10.1007/s11136-010-9692-7; Reilly JJ, 2003, ARCH DIS CHILD, V88, P748, DOI 10.1136/adc.88.9.748; Research Group on Chinese Students' Physical Fitness and Health, 2011, CHINESE J SCH HLTH, V32, P1026; Schwimmer JB, 2003, JAMA-J AM MED ASSOC, V289, P1813, DOI 10.1001/jama.289.14.1813; Sun IY, 2013, SOC SCI RES, V42, P1737, DOI 10.1016/j.ssresearch.2013.08.002; Swallen KC, 2005, PEDIATRICS, V115, P340, DOI 10.1542/peds.2004-0678; TORO J, 1988, SOC PSYCH PSYCH EPID, V23, P132, DOI 10.1007/BF01788434; Tsiros MD, 2009, INT J OBESITY, V33, P387, DOI 10.1038/ijo.2009.42; Wang JZ, 2012, 15 CROSS STRAIT FAM; Wang SL., 2013, J JINING U, V34, P45; Wille N, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-36; Williams J, 2005, JAMA-J AM MED ASSOC, V293, P70, DOI 10.1001/jama.293.1.70; World Health Organization, 2014, COMM END CHILDH OB F; Yang SX, 2009, PRACTICAL PREVENTIVE, V16, P347; Zeller MH, 2009, OBESITY, V17, P1171, DOI 10.1038/oby.2009.47; Zeller MH, 2006, PEDIATRICS, V117, P1155, DOI 10.1542/peds.2005-1141	41	8	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121144	10.1371/journal.pone.0121144	http://dx.doi.org/10.1371/journal.pone.0121144			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE6ZS	25799275	Green Submitted, Green Published, gold			2022-12-26	WOS:000351987300218
J	Fernandez-Palomo, C; Mothersill, C; Brauer-Krisch, E; Laissue, J; Seymour, C; Schultke, E				Fernandez-Palomo, Cristian; Mothersill, Carmel; Braeuer-Krisch, Elke; Laissue, Jean; Seymour, Colin; Schueltke, Elisabeth			gamma-H2AX as a Marker for Dose Deposition in the Brain of Wistar Rats after Synchrotron Microbeam Radiation	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; DOUBLE-STRAND BREAKS; X-RAY MICROBEAMS; DNA-DAMAGE; BYSTANDER RESPONSES; MICROPLANAR BEAMS; HUMAN FIBROBLASTS; IRRADIATED-CELLS; 9L GLIOSARCOMA; GLIOMA MODEL	Objective Synchrotron radiation has shown high therapeutic potential in small animal models of malignant brain tumours. However, more studies are needed to understand the radiobiological effects caused by the delivery of high doses of spatially fractionated x-rays in tissue. The purpose of this study was to explore the use of the gamma-H2AX antibody as a marker for dose deposition in the brain of rats after synchrotron microbeam radiation therapy (MRT). Methods Normal and tumour-bearing Wistar rats were exposed to 35, 70 or 350 Gy of MRT to their right cerebral hemisphere. The brains were extracted either at 4 or 8 hours after irradiation and immediately placed in formalin. Sections of paraffin-embedded tissue were incubated with anti gamma-H2AX primary antibody. Results While the presence of the C6 glioma does not seem to modulate the formation of gamma-H2AX in normal tissue, the irradiation dose and the recovery versus time are the most important factors affecting the development of gamma-H2AX foci. Our results also suggest that doses of 350 Gy can trigger the release of bystander signals that significantly amplify the DNA damage caused by radiation and that the gamma-H2AX biomarker does not only represent DNA damage produced by radiation, but also damage caused by bystander effects. Conclusion In conclusion, we suggest that the gamma-H2AX foci should be used as biomarker for targeted and non-targeted DNA damage after synchrotron radiation rather than a tool to measure the actual physical doses.	[Fernandez-Palomo, Cristian; Schueltke, Elisabeth] Univ Freiburg, Med Ctr, Stereotact Neurosurg & Lab Mol Neurosurg, D-79106 Freiburg, Germany; [Fernandez-Palomo, Cristian; Mothersill, Carmel; Seymour, Colin] McMaster Univ, Med Phys & Appl Radiat Sci Dept, Hamilton, ON, Canada; [Braeuer-Krisch, Elke] European Synchrotron Radiat Facil, F-38043 Grenoble, France; [Laissue, Jean] Univ Bern, Inst Pathol, Bern, Switzerland; [Schueltke, Elisabeth] Univ Rostock, Med Ctr, Dept Radiotherapy, Radiobiol Lab, D-18055 Rostock, Germany	University of Freiburg; McMaster University; European Synchrotron Radiation Facility (ESRF); University of Bern; University of Rostock	Fernandez-Palomo, C (corresponding author), Univ Freiburg, Med Ctr, Stereotact Neurosurg & Lab Mol Neurosurg, Hugstetter Str 55, D-79106 Freiburg, Germany.	fernancg@mcmaster.ca	Fernandez-Palomo, Cristian/J-8943-2019; Brauer-Krisch, Elke/O-6026-2017	Fernandez-Palomo, Cristian/0000-0002-5095-262X; Brauer-Krisch, Elke/0000-0003-4587-1160	Canada Research Chairs programme; Natural Sciences and Engineering Research Council of Canada; ESRF [MD 516]; Innovative Methods in Radiotherapy and Radiosurgery using Synchrotron Radiation, which is part of the European Cooperation in Science and Technology (SYRA3 COST Action); Becas Chile; European Union [PIRG-GA-2010-268250]	Canada Research Chairs programme(Canada Research Chairs); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); ESRF; Innovative Methods in Radiotherapy and Radiosurgery using Synchrotron Radiation, which is part of the European Cooperation in Science and Technology (SYRA3 COST Action); Becas Chile; European Union(European Commission)	We acknowledge the European Synchrotron Radiation Facility (ESRF) for provision of beamtime and travel support. We would also like to acknowledge the financial support by the Canada Research Chairs programme; the Discovery Grants programme from the Natural Sciences and Engineering Research Council of Canada; the ESRF funded proposal MD 516; and the Innovative Methods in Radiotherapy and Radiosurgery using Synchrotron Radiation, which is part of the European Cooperation in Science and Technology (SYRA3 COST Action). Cristian Fernandez-Palomo's PhD studies were funded by Becas Chile. E. Schultke holds a Marie Curie Reintegration Grant from the European Union (PIRG-GA-2010-268250). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad SB, 2013, DOSE-RESPONSE, V11, P498, DOI 10.2203/dose-response.12-048.Ahmad; Al-Mayah AHJ, 2012, RADIAT RES, V177, P539, DOI 10.1667/RR2868.1; Anderson DL, 2014, J SYNCHROTRON RADIAT, V21, P801, DOI 10.1107/S1600577514011424; Atkinson MJ, 2013, ADV EXP MED BIOL, V990, P49, DOI 10.1007/978-94-007-5896-4_3; Autsavapromporn N, 2013, RADIAT RES, V180, P367, DOI 10.1667/RR3111.1; Azzam EI, 2004, CURR CANCER DRUG TAR, V4, P53, DOI 10.2174/1568009043481641; Balvay D, 2009, RADIOLOGY, V250, P692, DOI 10.1148/radiol.2501071929; BENDA P, 1968, SCIENCE, V161, P370, DOI 10.1126/science.161.3839.370; Beygi S, 2013, CANCER EPIDEMIOL, V37, P396, DOI 10.1016/j.canep.2013.03.002; Blattmann H, 2005, NUCL INSTRUM METH A, V548, P17, DOI 10.1016/j.nima.2005.03.060; Bouchet A, 2014, INT J CANC IN PRESS; Bouchet A, 2014, TUMOR BIOL, V35, P6221, DOI 10.1007/s13277-014-1783-6; Bouchet A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081874; Bouchet A, 2013, RADIOTHER ONCOL, V108, P143, DOI 10.1016/j.radonc.2013.05.013; Bouchet A, 2010, INT J RADIAT ONCOL, V78, P1503, DOI 10.1016/j.ijrobp.2010.06.021; Brauer-Krisch E, 2010, MUTAT RES-REV MUTAT, V704, P160, DOI 10.1016/j.mrrev.2009.12.003; Charles NA, 2012, GLIA, V60, P502, DOI 10.1002/glia.21264; Cho KT, 2012, J NEUROL SURG PART A, V73, P132, DOI 10.1055/s-0032-1304216; Costes SV, 2010, MUTAT RES-REV MUTAT, V704, P78, DOI 10.1016/j.mrrev.2009.12.006; Crosbie JC, 2010, INT J RADIAT ONCOL, V77, P886, DOI 10.1016/j.ijrobp.2010.01.035; DEVERELL MH, 1989, PATHOL RES PRACT, V185, P598, DOI 10.1016/S0344-0338(89)80201-8; Dilmanian FA, 2007, EXP HEMATOL, V35, P69, DOI 10.1016/j.exphem.2007.01.014; Dilmanian FA, 2005, NUCL INSTRUM METH A, V548, P30, DOI 10.1016/j.nima.2005.03.062; Dilmanian FA, 2003, RADIAT RES, V159, P632, DOI 10.1667/0033-7587(2003)159[0632:MECHTE]2.0.CO;2; Dilmanian FA, 2002, NEURO-ONCOLOGY, V4, P26, DOI 10.1093/neuonc/4.1.26; Dilmanian FA, 2001, CELL MOL BIOL, V47, P485; Dobrin PB, 1996, J SURG RES, V61, P413, DOI 10.1006/jsre.1996.0138; FARRELL CL, 1987, J NEURO-ONCOL, V4, P403, DOI 10.1007/BF00195612; Fazzari J, 2012, INT J RADIAT BIOL, V88, P786, DOI 10.3109/09553002.2012.714519; Fernandez-Palomo C, 2013, J INSTRUM, V8, DOI 10.1088/1748-0221/8/07/C07005; Fernandez-Palomo C, 2013, INT J RADIAT BIOL, V89, P445, DOI 10.3109/09553002.2013.766770; Gajewski TF, 2013, NAT IMMUNOL, V14, P1014, DOI 10.1038/ni.2703; Greve B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047185; Iyer R, 2000, CANCER RES, V60, P1290; Jella KK, 2014, RADIAT RES, V181, P138, DOI 10.1667/RR13337.1; Kashino G, 2009, INT J RADIAT ONCOL, V74, P229, DOI 10.1016/j.ijrobp.2008.09.060; Laissue JA, 2001, P SOC PHOTO-OPT INS, V4508, P65, DOI 10.1117/12.450774; Laissue JA, 1998, INT J CANCER, V78, P654, DOI 10.1002/(SICI)1097-0215(19981123)78:5<654::AID-IJC21>3.0.CO;2-L; Laissue JA, 1999, P SOC PHOTO-OPT INS, V3770, P38, DOI 10.1117/12.368185; Laissue JA, 2013, RADIOTHER ONCOL, V106, P106, DOI 10.1016/j.radonc.2012.12.007; Le Duc G, 2000, EUR RADIOL, V10, P1487, DOI 10.1007/s003300000509; Lyng FM, 2000, BRIT J CANCER, V83, P1223, DOI 10.1054/bjoc.2000.1433; Lyng FM, 2006, RADIAT RES, V165, P400, DOI 10.1667/RR3527.1; Lyng FM, 2002, RADIAT RES, V157, P365, DOI 10.1667/0033-7587(2002)157[0365:IOAICE]2.0.CO;2; Lyng FM, 2001, BIOCHEM SOC T, V29, P350; Maeda M, 2013, J RADIAT RES, V54, P1043, DOI 10.1093/jrr/rrt068; Maeda M, 2010, RADIAT RES, V174, P37, DOI 10.1667/RR2086.1; Martin OA, 2011, CANCER RES, V71, P3437, DOI 10.1158/0008-5472.CAN-10-4579; Miura M, 2006, BRIT J RADIOL, V79, P71, DOI 10.1259/bjr/50464795; Mothersill C, 2004, NAT REV CANCER, V4, P158, DOI 10.1038/nrc1277; Mothersill C, 1997, INT J RADIAT BIOL, V71, P421, DOI 10.1080/095530097144030; Mothersill C, 2014, DOSE-RESPONSE, V12, P72, DOI 10.2203/dose-response.13-011.Mothersill; Murphy JEJ, 2005, MUTAT RES-GEN TOX EN, V585, P127, DOI 10.1016/j.mrgentox.2005.04.011; Mutou-Yoshihara Y, 2012, INT J RADIAT BIOL, V88, P258, DOI 10.3109/09553002.2012.636138; NAGANO N, 1993, ACTA NEUROPATHOL, V86, P117, DOI 10.1007/BF00334878; NAGASAWA H, 1992, CANCER RES, V52, P6394; Narayanan PK, 1997, CANCER RES, V57, P3963; Narayanan PK, 1999, RADIAT RES, V152, P57, DOI 10.2307/3580049; Persano L, 2013, BIOCHEM PHARMACOL, V85, P612, DOI 10.1016/j.bcp.2012.10.001; Prise KM, 2009, NAT REV CANCER, V9, P351, DOI 10.1038/nrc2603; Priyadarshika RCU, 2011, BRIT J RADIOL, V84, P833, DOI 10.1259/bjr/58503354; Redon CE, 2010, P NATL ACAD SCI USA, V107, P17992, DOI 10.1073/pnas.1008260107; Ricard D, 2012, LANCET, V379, P1984, DOI 10.1016/S0140-6736(11)61346-9; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Russell JS, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00157; Safdie F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044603; Saroya R, 2010, DOSE-RESPONSE, V8, P317, DOI 10.2203/dose-response.09-043.Saroya; Schultke E, 2008, EUR J RADIOL, V68, pS142, DOI 10.1016/j.ejrad.2008.04.051; Sedelnikova OA, 2007, CANCER RES, V67, P4295, DOI 10.1158/0008-5472.CAN-06-4442; Serduc R, 2010, J SYNCHROTRON RADIAT, V17, P325, DOI 10.1107/S0909049510006667; Serduc R, 2009, PHYS MED BIOL, V54, P6711, DOI 10.1088/0031-9155/54/21/017; Shao C, 2003, CANCER RES, V63, P8437; Sheeran J, 2008, J NEUROSURG, V108, P972, DOI 10.3171/JNS/2008/108/5/0972; SLATKIN DN, 1992, MED PHYS, V19, P1395, DOI 10.1118/1.596771; SLATKIN DN, 1995, P NATL ACAD SCI USA, V92, P8783, DOI 10.1073/pnas.92.19.8783; Smith RW, 2013, INT J RADIAT BIOL, V89, P118, DOI 10.3109/09553002.2013.732252; Spiga J, 2007, MED PHYS, V34, P4322, DOI 10.1118/1.2794170; Sprung CN, 2011, J SYNCHROTRON RADIAT, V18, P630, DOI 10.1107/S0909049511011836; Tofilon PJ, 2000, RADIAT RES, V153, P357, DOI 10.1667/0033-7587(2000)153[0357:TROTCN]2.0.CO;2; Tomita M, 2012, J RADIAT RES, V53, P482, DOI 10.1269/jrr.11055; Tomita M, 2010, RADIAT RES, V173, P380, DOI 10.1667/RR1995.1; WORLD Health Organization, 2008, WORLD CANC REPORT; Zhong N, 2003, RADIAT RES, V160, P133, DOI 10.1667/3033; Zhou HN, 2008, CANCER RES, V68, P2233, DOI 10.1158/0008-5472.CAN-07-5278	84	25	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0119924	10.1371/journal.pone.0119924	http://dx.doi.org/10.1371/journal.pone.0119924			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799425	Green Submitted, Green Published, gold			2022-12-26	WOS:000351987300090
J	Langendorf, C; Le Hello, S; Moumouni, A; Gouali, M; Mamaty, AA; Grais, RF; Weill, FX; Page, AL				Langendorf, Celine; Le Hello, Simon; Moumouni, Aissatou; Gouali, Malika; Mamaty, Abdoul-Aziz; Grais, Rebecca F.; Weill, Francois-Xavier; Page, Anne-Laure			Enteric Bacterial Pathogens in Children with Diarrhea in Niger: Diversity and Antimicrobial Resistance	PLOS ONE			English	Article							NON-TYPHOIDAL SALMONELLA; ESCHERICHIA-COLI; ANTIBIOTIC-RESISTANCE; ROTAVIRUS SURVEILLANCE; DEVELOPING-COUNTRIES; VEROTOXIN GENES; YOUNG-CHILDREN; GLOBAL BURDEN; TIME TRENDS; SHIGELLA	Background Although rotavirus is the leading cause of severe diarrhea among children in sub-Saharan Africa, better knowledge of circulating enteric pathogenic bacteria and their antimicrobial resistance is crucial for prevention and treatment strategies. Methodology/Principal Findings As a part of rotavirus gastroenteritis surveillance in Maradi, Niger, we performed stool culture on a sub-population of children under 5 with moderate-to-severe diarrhea between April 2010 and March 2012. Campylobacter, Shigella and Salmonella were sought with conventional culture and biochemical methods. Shigella and Salmonella were serotyped by slide agglutination. Enteropathogenic Escherichia coli (EPEC) were screened by slide agglutination with EPEC O-typing antisera and confirmed by detection of virulence genes. Antimicrobial susceptibility was determined by disk diffusion. We enrolled 4020 children, including 230 with bloody diarrhea. At least one pathogenic bacterium was found in 28.0% of children with watery diarrhea and 42.2% with bloody diarrhea. Mixed infections were found in 10.3% of children. EPEC, Salmonella and Campylobacter spp. were similarly frequent in children with watery diarrhea (11.1%, 9.2% and 11.4% respectively) and Shigella spp. were the most frequent among children with bloody diarrhea (22.1%). The most frequent Shigella serogroup was S. flexneri (69/122, 56.5%). The most frequent Salmonella serotypes were Typhimurimum (71/355, 20.0%), Enteritidis (56/355, 15.8%) and Corvallis (46/355, 13.0%). The majority of putative EPEC isolates was confirmed to be EPEC (90/111, 81.1%). More than half of all Enterobacteriaceae were resistant to amoxicillin and co-trimoxazole. Around 13% (46/360) Salmonella exhibited an extended-spectrum beta-lactamase phenotype. Conclusions This study provides updated information on enteric bacteria diversity and antibiotic resistance in the Sahel region, where such data are scarce. Whether they are or not the causative agent of diarrhea, bacterial infections and their antibiotic resistance profiles should be closely monitored in countries like Niger where childhood malnutrition pre-disposes to severe and invasive infections.	[Langendorf, Celine; Grais, Rebecca F.; Page, Anne-Laure] Epicentre, Paris, France; [Le Hello, Simon; Gouali, Malika; Weill, Francois-Xavier] Inst Pasteur, Unite Bacteries Pathogenes Enter, Ctr Natl Reference Escherichia Coli Shigella & Sa, Paris, France; [Moumouni, Aissatou; Mamaty, Abdoul-Aziz] Epicentre, Niamey, Niger	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Langendorf, C (corresponding author), Epicentre, Paris, France.	celine.langendorf@epicentre.msf.org; francois-xavier.weill@pasteur.fr	Le Hello, Simon/K-6584-2018	Le Hello, Simon/0000-0001-7993-4305; Weill, Francois-Xavier/0000-0001-9941-5799; Freeman Grais, Rebecca/0000-0002-5037-8218; CELINE, LANGENDORF/0000-0002-0811-7540	Medecins Sans Frontieres (MSF); Institut Pasteur; Medecins sans Frontieres; Institut de Veille Sanitaire; French Government "Investissement d'Avenir" programme [ANR-10-LABX-62-IBEID]	Medecins Sans Frontieres (MSF); Institut Pasteur(European Commission); Medecins sans Frontieres; Institut de Veille Sanitaire; French Government "Investissement d'Avenir" programme(French National Research Agency (ANR))	Funding: Medecins Sans Frontieres (MSF; www.msf.org) and Institut Pasteur funded this study. Epicentre receives core funding from Medecins sans Frontieres. The French National Reference Center for E. coli, Shigella and Salmonella is cofunded by the Institut de Veille Sanitaire. The "Unite des Bacteries Pathogenes Enteriques" belongs to the "Integrative Biology of Emerging Infectious Diseases" Laboratory of Excellence funded by the French Government "Investissement d'Avenir" programme (grant no. ANR-10-LABX-62-IBEID). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed AA, 2000, AM J TROP MED HYG, V63, P259, DOI 10.4269/ajtmh.2000.63.259; [Anonymous], 2010, RECOMMANDATIONS 2010; Bangtrakulnonth A, 2008, FOODBORNE PATHOG DIS, V5, P773, DOI 10.1089/fpd.2008.0109; Beaudry M, 1996, J CLIN MICROBIOL, V34, P144, DOI 10.1128/JCM.34.1.144-148.1996; BEJ AK, 1991, APPL ENVIRON MICROB, V57, P1013, DOI 10.1128/AEM.57.4.1013-1017.1991; Bercion R, 2008, TROP MED INT HEALTH, V13, P468, DOI 10.1111/j.1365-3156.2008.02023.x; Bercion R, 2006, T ROY SOC TROP MED H, V100, P1151, DOI 10.1016/j.trstmh.2006.02.007; Bercion R, 2009, J INFECT DEV COUNTR, V3, P187, DOI 10.3855/jidc.34; Boisen N, 2008, INFECT IMMUN, V76, P3281, DOI 10.1128/IAI.01646-07; Bonkoungou IJO, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-36; Bopp CA, 2003, MANUAL CLIN MICROBIO, P645; Brooks JT, 2006, CLIN INFECT DIS, V43, P393, DOI 10.1086/505866; Coimbra RS, 2000, RES MICROBIOL, V151, P639, DOI 10.1016/S0923-2508(00)00134-0; Das JK, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-S3-S11; Djie-Maletz A, 2008, J ANTIMICROB CHEMOTH, V61, P1315, DOI 10.1093/jac/dkn108; Feasey NA, 2012, LANCET, V379, P2489, DOI 10.1016/S0140-6736(11)61752-2; FRANKEL G, 1989, MOL MICROBIOL, V3, P1729, DOI 10.1111/j.1365-2958.1989.tb00158.x; Grimont PAD, 2007, ANTIGENIC FORMULAE O; Guerrant RL, 2008, NUTR REV, V66, P487, DOI 10.1111/j.1753-4887.2008.00082.x; GUNZBURG ST, 1995, J CLIN MICROBIOL, V33, P1375, DOI 10.1128/JCM.33.5.1375-1377.1995; Ha V, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-204; Harrois D, 2014, CLIN MICROBIOL INFEC, V20, pO109, DOI 10.1111/1469-0691.12339; Holt KE, 2013, P NATL ACAD SCI USA, V110, P17522, DOI 10.1073/pnas.1308632110; Karambu S, 2013, PAN AFR MED J, V16, DOI 10.11604/pamj.2013.16.37.2947; Kariuki S, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-101; Kim YJ, 2013, CURR PHARM BIOTECHNO, V14, P903; Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2; Kotloff KL, 1999, B WORLD HEALTH ORGAN, V77, P651; Lanata CF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072788; Laxminarayan R, 2013, LANCET INFECT DIS, V13, P1057, DOI 10.1016/S1473-3099(13)70318-9; Le Hello S, 2013, LANCET INFECT DIS, V13, P672, DOI 10.1016/S1473-3099(13)70124-5; Le Hello S, 2011, J INFECT DIS, V204, P675, DOI 10.1093/infdis/jir409; Lewis K., VESIKARI CLINICAL SE; LIN Z, 1993, MICROBIOL IMMUNOL, V37, P543, DOI 10.1111/j.1348-0421.1993.tb01675.x; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Meng CY, 2011, PEDIATR INFECT DIS J, V30, P331, DOI 10.1097/INF.0b013e3181fb6f82; Morpeth SC, 2009, CLIN INFECT DIS, V49, P606, DOI 10.1086/603553; MOSELEY SL, 1983, INFECT IMMUN, V39, P1167, DOI 10.1128/IAI.39.3.1167-1174.1983; Moyo SJ, 2011, BMC PEDIATR, V11, DOI 10.1186/1471-2431-11-19; Mwenda JM, 2010, J INFECT DIS, V202, pS5, DOI 10.1086/653557; Nitiema LW, 2011, INT J INFECT DIS, V15, pE646, DOI 10.1016/j.ijid.2011.05.009; Njuguna HN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058437; Okeke IN, 2005, LANCET INFECT DIS, V5, P481, DOI 10.1016/S1473-3099(05)70189-4; Okoro CK, 2012, NAT GENET, V44, P1215, DOI 10.1038/ng.2423; Opintan JA, 2010, AM J TROP MED HYG, V83, P936, DOI 10.4269/ajtmh.2010.09-0792; Page AL, 2014, EMERG INFECT DIS, V20, P573, DOI 10.3201/eid2004.131328; Page AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068699; Paton AW, 1998, J CLIN MICROBIOL, V36, P598, DOI 10.1128/JCM.36.2.598-602.1998; Phan TG, 2012, J VIROL, V86, P11024, DOI 10.1128/JVI.01427-12; POLLARD DR, 1990, J CLIN MICROBIOL, V28, P540, DOI 10.1128/JCM.28.3.540-545.1990; Raji MA, 2013, J INFECT PUBLIC HEAL, V6, P431, DOI 10.1016/j.jiph.2013.05.002; Sanchez-Padilla E, 2009, LANCET INFECT DIS, V9, P567, DOI 10.1016/S1473-3099(09)70179-3; Sire JM, 2008, JPN J INFECT DIS, V61, P307; Sire JM, 2013, PAEDIATR INT CHILD H, V33, P139, DOI 10.1179/2046905512Y.0000000046; Swierczewski BE, 2013, T ROY SOC TROP MED H, V107, P83, DOI 10.1093/trstmh/trs022; Tabu C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031237; Tansarli GS, 2014, J ANTIMICROB CHEMOTH, V69, P1177, DOI 10.1093/jac/dkt500; Tiruneh M, 2009, JPN J INFECT DIS, V62, P93; Trabulsi LR, 2002, EMERG INFECT DIS, V8, P508, DOI 10.3201/eid0805.010385; Ud-Din AMS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082601; Vlieghe E, 2009, INT J ANTIMICROB AG, V34, P295, DOI 10.1016/j.ijantimicag.2009.04.015; Waggie Z, 2010, J INFECT DIS, V202, pS23, DOI 10.1086/653554; Walker CLF, 2013, LANCET, V381, P1405, DOI 10.1016/S0140-6736(13)60222-6; Walker CLF, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-220; Woerther PL, 2011, CLIN INFECT DIS, V53, P677, DOI 10.1093/cid/cir522; WOODWARD MJ, 1992, VET MICROBIOL, V31, P251, DOI 10.1016/0378-1135(92)90083-6; World Health Organization, 1987, MANUAL FOR LABORATOR; Zhang WL, 2011, J ANTIMICROB CHEMOTH, V66, P2527, DOI 10.1093/jac/dkr341	68	52	54	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120275	10.1371/journal.pone.0120275	http://dx.doi.org/10.1371/journal.pone.0120275			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799400	Green Submitted, Green Published, gold			2022-12-26	WOS:000351987300119
J	Sosunov, SA; Ameer, X; Niatsetskaya, ZV; Utkina-Sosunova, I; Ratner, VI; Ten, VS				Sosunov, Sergey A.; Ameer, Xavier; Niatsetskaya, Zoya V.; Utkina-Sosunova, Irina; Ratner, Veniamin I.; Ten, Vadim S.			Isoflurane Anesthesia Initiated at the Onset of Reperfusion Attenuates Oxidative and Hypoxic-Ischemic Brain Injury	PLOS ONE			English	Article							MITOCHONDRIAL COMPLEX I; OXYGEN-FREE RADICALS; CEREBRAL-BLOOD-FLOW; NEONATAL MICE; AMINO-ACIDS; NEUROPROTECTION; CYCLE; RESPIRATION; METABOLISM	This study demonstrates that in mice subjected to hypoxia-ischemia (HI) brain injury isoflurane anesthesia initiated upon reperfusion limits a release of mitochondrial oxidative radicals by inhibiting a recovery of complex-I dependent mitochondrial respiration. This significantly attenuates an oxidative stress and reduces the extent of HI brain injury. Neonatal mice were subjected to HI, and at the initiation of reperfusion were exposed to isoflurane with or without mechanical ventilation. At the end of HI and isoflurane exposure cerebral mitochondrial respiration, H2O2 emission rates were measured followed by an assessment of cerebral oxidative damage and infarct volumes. At 8 weeks after HI navigational memory and brain atrophy were assessed. In vitro, direct effect of isoflurane on mitochondrial H2O2 emission was compared to that of complex-I inhibitor, rotenone. Compared to controls, 15 minutes of isoflurane anesthesia inhibited recovery of the compex I-dependent mitochondrial respiration and decreased H2O2 production in mitochondria supported with succinate. This was associated with reduced oxidative brain injury, superior navigational memory and decreased cerebral atrophy compared to the vehicle-treated HI-mice. Extended isoflurane anesthesia was associated with sluggish recovery of cerebral blood flow (CBF) and the neuroprotection was lost. However, when isoflurane anesthesia was supported with mechanical ventilation the CBF recovery improved, the event associated with further reduction of infarct volume compared to HI-mice exposed to isoflurane without respiratory support. Thus, in neonatal mice brief isoflurane anesthesia initiated at the onset of reperfusion limits mitochondrial release of oxidative radicals and attenuates an oxidative stress. This novel mechanism contributes to neuroprotective action of isoflurane. The use of mechanical ventilation during isoflurane anesthesia counterbalances negative effect of isoflurane anesthesia on recovery of cerebral circulation which potentiates protection against reperfusion injury.	[Sosunov, Sergey A.; Ameer, Xavier; Niatsetskaya, Zoya V.; Utkina-Sosunova, Irina; Ratner, Veniamin I.; Ten, Vadim S.] Columbia Univ, Dept Pediat, Div Neonatol, New York, NY 10027 USA	Columbia University	Ten, VS (corresponding author), Columbia Univ, Dept Pediat, Div Neonatol, New York, NY 10027 USA.	vt82@columbia.edu			NIH [NS071121]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS071121] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was partially supported by NIH grant NS071121 (V.S.T). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal B, 2014, BBA-BIOENERGETICS, V1837, P354, DOI 10.1016/j.bbabio.2013.11.006; Aidakkak M, 2008, CARDIOVASC RES, V77, P406, DOI 10.1016/j.cardiores.2007.08.008; AMBROSIO G, 1993, J BIOL CHEM, V268, P18532; BENZI G, 1979, BIOCHEM PHARMACOL, V28, P2545, DOI 10.1016/0006-2952(79)90024-8; Bruins B, 2013, ANESTH ANALG, V116, P838, DOI 10.1213/ANE.0b013e3182860fe7; Burchell SR, 2013, J INVEST MED, V61, P1078, DOI 10.2310/JIM.0b013e3182a07921; Caspersen CS, 2008, DEV NEUROSCI-BASEL, V30, P319, DOI 10.1159/000121416; Chen H, 2011, TRANSL STROKE RES, V2, P382, DOI 10.1007/s12975-011-0081-5; Chouchani ET, 2014, NATURE, V515, P431, DOI 10.1038/nature13909; Elsersy H, 2006, ANESTHESIOLOGY, V105, P81, DOI 10.1097/00000542-200607000-00016; FOLBERGR.J, 1974, BRAIN RES, V80, P265, DOI 10.1016/0006-8993(74)90690-8; Harada H, 1999, ANESTH ANALG, V89, P1442, DOI 10.1097/00000539-199912000-00022; Hirata N, 2011, ANESTHESIOLOGY, V115, P531, DOI 10.1097/ALN.0b013e31822a2316; Kato K, 1994, Nagoya J Med Sci, V57, P43; Kayser EB, 2011, ANESTH ANALG, V112, P1321, DOI 10.1213/ANE.0b013e3182121d37; Li CX, 2013, NEUROSCI LETT, V541, P58, DOI 10.1016/j.neulet.2013.02.007; Loepke AW, 2006, ANESTH ANALG, V102, P75, DOI 10.1213/01.ANE.0000181102.92729.B8; Matsiukevich D, 2010, RESUSCITATION, V81, P224, DOI 10.1016/j.resuscitation.2009.11.024; McAuliffe JJ, 2009, ANESTHESIOLOGY, V111, P533, DOI 10.1097/ALN.0b013e3181b060d3; Niatsetskaya ZV, 2012, J NEUROSCI, V32, P3235, DOI 10.1523/JNEUROSCI.6303-11.2012; Niatsetskaya ZV, 2012, J CEREBR BLOOD F MET, V32, P232, DOI 10.1038/jcbfm.2011.164; Piantadosi CA, 1996, STROKE, V27, P327, DOI 10.1161/01.STR.27.2.327; PISARENKO O, 1987, BIOMED BIOCHIM ACTA, V46, pS568; Ratner V, 2013, AM J RESP CELL MOL, V49, P943, DOI 10.1165/rcmb.2012-0172OC; SIMS NR, 1991, J NEUROCHEM, V56, P1836, DOI 10.1111/j.1471-4159.1991.tb03438.x; Solberg R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009606; Starkov AA, 2003, J NEUROCHEM, V86, P1101, DOI 10.1046/j.1471-4159.2003.01908.x; Starkov AA, 2008, ANN NY ACAD SCI, V1147, P37, DOI 10.1196/annals.1427.015; Stewart S, 2009, TRANSL RES, V153, P224, DOI 10.1016/j.trsl.2009.02.003; Tahara EB, 2009, FREE RADICAL BIO MED, V46, P1283, DOI 10.1016/j.freeradbiomed.2009.02.008; Ten VS, 2012, NEUROL RES INT, V2012, DOI 10.1155/2012/542976; Ten VS, 2004, STROKE, V35, P2183, DOI 10.1161/01.STR.0000137768.25203.df; Vannucci RC, 1997, ANN NY ACAD SCI, V835, P234, DOI 10.1111/j.1749-6632.1997.tb48634.x; Xiong LZ, 2003, ANESTH ANALG, V96, P233, DOI 10.1097/00000539-200301000-00047; Zhao P, 2007, ANESTHESIOLOGY, V107, P963, DOI 10.1097/01.anes.0000291447.21046.4d; Zhou YL, 2010, STROKE, V41, P1521, DOI 10.1161/STROKEAHA.110.583757	36	22	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120456	10.1371/journal.pone.0120456	http://dx.doi.org/10.1371/journal.pone.0120456			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799166	Green Published, gold, Green Submitted			2022-12-26	WOS:000351987300147
J	Ryvkin, V; Rashel, M; Gaddapara, T; Ghazizadeh, S				Ryvkin, Vladislav; Rashel, Mohammad; Gaddapara, Trivikram; Ghazizadeh, Soosan			Opposing Growth Regulatory Roles of Protein Kinase D Isoforms in Human Keratinocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN EPIDERMAL-KERATINOCYTES; P63; DIFFERENTIATION; PROLIFERATION; EXPRESSION; PKD3; COMMITMENT; TRANSPORT; FAMILY; CELLS	PKD is a family of three serine/threonine kinases (PKD-1, -2, and -3) involved in the regulation of diverse biological processes including proliferation, migration, secretion, and cell survival. We have previously shown that despite expression of all three isoforms in mouse epidermis, PKD1 plays a unique and critical role in wound healing, phorbol ester-induced hyperplasia, and tumor development. In translating our findings to the human, we discovered that PKD1 is not expressed in human keratinocytes (KCs) and there is a divergence in the expression and function of other PKD isoforms. Contrary to mouse KCs, treatment of cultured human KCs with pharmacological inhibitors of PKDs resulted in growth arrest. We found that PKD2 and PKD3 are expressed differentially in proliferating and differentiating human KCs, with the former uniformly present in both compartments whereas the latter is predominantly expressed in the proliferating compartment. Knockdown of individual PKD isoforms in human KCs revealed contrasting growth regulatory roles for PKD2 and PKD3. Loss of PKD2 enhanced KC proliferative potential while loss of PKD3 resulted in a progressive proliferation defect, loss of clonogenicity and diminished tissue regenerative ability. This proliferation defect was correlated with up-regulation of CDK4/6 inhibitor p15(INK4B) and induction of a p53-independent G1 cell cycle arrest. Simultaneous silencing of PKD isoforms resulted in a more pronounced proliferation defect consistent with a predominant role for PKD3 in proliferating KCs. These data underline the importance and complexity of PKD signaling in human epidermis and suggest a central role for PKD3 signaling in maintaining human epidermal homeostasis.	[Ryvkin, Vladislav; Ghazizadeh, Soosan] SUNY Stony Brook, Grad Program Mol & Cell Biol, Stony Brook, NY 11794 USA; [Rashel, Mohammad; Gaddapara, Trivikram; Ghazizadeh, Soosan] SUNY Stony Brook, Dept Oral Biol & Pathol, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Ghazizadeh, S (corresponding author), SUNY Stony Brook, Dept Oral Biol & Pathol, Stony Brook, NY 11794 USA.	soosan.ghazizadeh@stonybrook.edu			National Institutes of Health [R21AR056013]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR056013] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R21AR056013 (to S. G.).	Alani RM, 1998, MOL CARCINOGEN, V23, P226, DOI 10.1002/(SICI)1098-2744(199812)23:4<226::AID-MC5>3.0.CO;2-N; Anderson G, 2005, CELL SIGNAL, V17, P1397, DOI 10.1016/j.cellsig.2005.02.007; Arun SN, 2011, ONCOGENE, V30, P1586, DOI 10.1038/onc.2010.540; Borges S, 2013, EXPERT REV ANTICANC, V13, P895, DOI 10.1586/14737140.2013.816460; Bossard C, 2007, J CELL BIOL, V179, P1123, DOI 10.1083/jcb.200703166; Canepa ET, 2007, IUBMB LIFE, V59, P419, DOI 10.1080/15216540701488358; Carlson M. W., 2001, CURRENT PROTOCOLS CE; Chen J, 2008, CANCER RES, V68, P3844, DOI 10.1158/0008-5472.CAN-07-5156; Dodd ME, 2005, J INVEST DERMATOL, V125, P294, DOI 10.1111/j.0022-202X.2005.23780.x; Egles C, 2010, METHODS MOL BIOL, V585, P345, DOI 10.1007/978-1-60761-380-0_24; Ellwanger K, 2013, IUBMB LIFE, V65, P98, DOI 10.1002/iub.1116; Fu Y, 2011, EMBO REP, V12, P785, DOI 10.1038/embor.2011.139; Galli F, 2010, J CELL SCI, V123, P2423, DOI 10.1242/jcs.061010; Ghazizadeh S, 2004, J INVEST DERM SYMP P, V9, P269, DOI 10.1111/j.1087-0024.2004.09302.x; Guha S, 2010, BIOCHEM PHARMACOL, V80, P1946, DOI 10.1016/j.bcp.2010.07.002; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; HANNON GJ, 1994, NATURE, V371, P257, DOI 10.1038/371257a0; Hao Q, 2013, ANTICANCER RES, V33, P393; Harikumar KB, 2010, MOL CANCER THER, V9, P1136, DOI 10.1158/1535-7163.MCT-09-1145; Hausser A, 2005, NAT CELL BIOL, V7, P880, DOI 10.1038/ncb1289; Ivanova P, 2008, ARCH DERMATOL RES, V300, P139, DOI 10.1007/s00403-008-0832-7; Jadali A, 2010, J BIOL CHEM, V285, P23385, DOI 10.1074/jbc.M110.105619; LaValle CR, 2012, MOL CANCER THER, V11, P1389, DOI 10.1158/1535-7163.MCT-11-0887; LaValle CR, 2010, BBA-REV CANCER, V1806, P183, DOI 10.1016/j.bbcan.2010.05.003; LEHMAN TA, 1993, CARCINOGENESIS, V14, P833, DOI 10.1093/carcin/14.5.833; Li CH, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/175721; Parsa R, 1999, J INVEST DERMATOL, V113, P1099, DOI 10.1046/j.1523-1747.1999.00780.x; Rashel M, 2014, J INVEST DERMATOL, V134, P902, DOI 10.1038/jid.2013.474; Rennecke J, 1999, INT J CANCER, V80, P98, DOI 10.1002/(SICI)1097-0215(19990105)80:1<98::AID-IJC19>3.3.CO;2-4; Rey O, 2006, J BIOL CHEM, V281, P5149, DOI 10.1074/jbc.M508014200; RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8; Ristich VL, 2006, BRIT J DERMATOL, V154, P586, DOI 10.1111/j.1365-2133.2005.07073.x; Rozengurt E, 2005, J BIOL CHEM, V280, P13205, DOI 10.1074/jbc.R500002200; Rozengurt E, 2011, PHYSIOLOGY, V26, P23, DOI 10.1152/physiol.00037.2010; Sanchez-Ruiloba L, 2006, J BIOL CHEM, V281, P18888, DOI 10.1074/jbc.M603044200; Senoo M, 2007, CELL, V129, P523, DOI 10.1016/j.cell.2007.02.045; Shin S, 2012, AM J PHYSIOL-CELL PH, V303, pC743, DOI 10.1152/ajpcell.00442.2011; Steinberg SF, 2012, MOL PHARMACOL, V81, P284, DOI 10.1124/mol.111.075986; Truong AB, 2006, GENE DEV, V20, P3185, DOI 10.1101/gad.1463206; Watt FM, 2014, SCIENCE, V346, P937, DOI 10.1126/science.1253734; Wille Christoph, 2014, Bioarchitecture, V4, P111, DOI 10.4161/bioa.29273; Wu N, 2012, J BIOL CHEM, V287, P5627, DOI 10.1074/jbc.M111.328120; WU YJ, 1982, CELL, V31, P693, DOI 10.1016/0092-8674(82)90324-5; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Zou ZP, 2012, J CELL SCI, V125, P4800, DOI 10.1242/jcs.106542	45	7	9	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2015	290	17					11199	11208		10.1074/jbc.M115.643742	http://dx.doi.org/10.1074/jbc.M115.643742			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG6IX	25802335	Green Published, hybrid			2022-12-26	WOS:000353404500052
J	Gunaydin, G; DeLong, JE				Gunaydin, Gul; DeLong, Jordan E.			Reverse Correlating Love: Highly Passionate Women Idealize Their Partner's Facial Appearance	PLOS ONE			English	Article							POSITIVE ILLUSIONS; FACES; REPRESENTATIONS; MOTIVATION; SYSTEMS; MEMORY	A defining feature of passionate love is idealization-evaluating romantic partners in an overly favorable light. Although passionate love can be expected to color how favorably individuals represent their partner in their mind, little is known about how passionate love is linked with visual representations of the partner. Using reverse correlation techniques for the first time to study partner representations, the present study investigated whether women who are passionately in love represent their partner's facial appearance more favorably than individuals who are less passionately in love. In a within-participants design, heterosexual women completed two forced-choice classification tasks, one for their romantic partner and one for a male acquaintance, and a measure of passionate love. In each classification task, participants saw two faces superimposed with noise and selected the face that most resembled their partner (or an acquaintance). Classification images for each of high passion and low passion groups were calculated by averaging across noise patterns selected as resembling the partner or the acquaintance and superimposing the averaged noise on an average male face. A separate group of women evaluated the classification images on attractiveness, trustworthiness, and competence. Results showed that women who feel high (vs. low) passionate love toward their partner tend to represent his face as more attractive and trustworthy, even when controlling for familiarity effects using the acquaintance representation. Using an innovative method to study partner representations, these findings extend our understanding of cognitive processes in romantic relationships.	[Gunaydin, Gul] Bilkent Univ, Dept Psychol, Ankara, Turkey; [DeLong, Jordan E.] Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN USA	Ihsan Dogramaci Bilkent University; Indiana University System; Indiana University Bloomington	Gunaydin, G (corresponding author), Bilkent Univ, Dept Psychol, Ankara, Turkey.	gulgunaydin@bilkent.edu.tr	Gunaydin, Gul/P-2117-2014	Gunaydin, Gul/0000-0003-0490-4528				Acevedo BP, 2012, SOC COGN AFFECT NEUR, V7, P145, DOI 10.1093/scan/nsq092; Andersen SM, 1996, J PERS SOC PSYCHOL, V71, P1108, DOI 10.1037/0022-3514.71.6.1108; Aron A, 2005, J NEUROPHYSIOL, V94, P327, DOI 10.1152/jn.00838.2004; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Bretherton I., 2008, HDB ATTACHMENT THEOR, P102; Collins NL, 2004, ADULT ATTACHMENT THE, P196; Cross SE, 1997, PSYCHOL BULL, V122, P5, DOI 10.1037/0033-2909.122.1.5; Dotsch R, 2008, PSYCHOL SCI, V19, P978, DOI 10.1111/j.1467-9280.2008.02186.x; Dotsch R, 2012, SOC PSYCHOL PERS SCI, V3, P562, DOI 10.1177/1948550611430272; Eisenberger NI, 2011, P NATL ACAD SCI USA, V108, P11721, DOI 10.1073/pnas.1108239108; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Gobbini MI, 2007, NEUROPSYCHOLOGIA, V45, P32, DOI 10.1016/j.neuropsychologia.2006.04.015; Gonzaga G. C., 2008, SOCIAL RELATIONSHIPS, V10, P39; Gonzaga GC, 2008, EVOL HUM BEHAV, V29, P119, DOI 10.1016/j.evolhumbehav.2007.11.003; Gunaydin G, 2012, J EXP SOC PSYCHOL, V48, P350, DOI 10.1016/j.jesp.2011.06.001; HATFIELD E, 1986, J ADOLESCENCE, V9, P383, DOI 10.1016/S0140-1971(86)80043-4; Hatfield E, 1985, NEW LOOK LOVE; Imhoff R, 2011, PSYCHOL SCI, V22, P1583, DOI 10.1177/0956797611419675; Karremans JC, 2011, COGNITION, V121, P422, DOI 10.1016/j.cognition.2011.07.008; Kimball S., 1996, GIMP GNU IMAGE MANIP; Lee S, 2010, PSYCHOL SCI, V21, P857, DOI 10.1177/0956797610371342; Mangini MC, 2004, COGNITIVE SCI, V28, P209, DOI 10.1016/j.cogsci.2003.11.004; Marazziti D, 2004, PSYCHONEUROENDOCRINO, V29, P931, DOI 10.1016/j.psyneuen.2003.08.006; Marazziti D, 1999, PSYCHOL MED, V29, P741, DOI 10.1017/S0033291798007946; Master SL, 2009, PSYCHOL SCI, V20, P1316, DOI 10.1111/j.1467-9280.2009.02444.x; Murray SL, 1997, PERS SOC PSYCHOL B, V23, P586, DOI 10.1177/0146167297236003; Murray SL, 1996, J PERS SOC PSYCHOL, V70, P79, DOI 10.1037/0022-3514.70.1.79; Niehuis S., 2011, J FAMILY THEORY REV, V3, P273, DOI [DOI 10.1111/J.1756-2589.2011.00100.X, 10.1111/j.1756-2589.2011.00100.x]; Ozener B, 2012, EVOL HUM BEHAV, V33, P169, DOI 10.1016/j.evolhumbehav.2011.08.001; Pietromonaco P.R., 2000, REV GEN PSYCHOL, V4, P155, DOI [10.1037/1089-2680.4.2.155, DOI 10.1037/1089-2680.4.2.155]; Regan PC, 1998, J SOC PERS RELAT, V15, P411, DOI 10.1177/0265407598153006; Selcuk E, 2013, HEALTH PSYCHOL, V32, P231, DOI 10.1037/a0028276; Selcuk E, 2012, J PERS SOC PSYCHOL, V103, P362, DOI 10.1037/a0028125; Sutherland CAM, 2013, COGNITION, V127, P105, DOI 10.1016/j.cognition.2012.12.001; Tennov D, 1998, LOVE LIMERENCE EXPER; Tiddeman B, 2001, IEEE COMPUT GRAPH, V21, P42, DOI 10.1109/38.946630; Todorov A, 2011, SOC PERSONAL PSYCHOL, V5, P775, DOI 10.1111/j.1751-9004.2011.00389.x; Xu XM, 2011, HUM BRAIN MAPP, V32, P249, DOI 10.1002/hbm.21017; Zayas V, 2015, BASES OF ADULT ATTACHMENT: LINKING BRAIN, MIND AND BEHAVIOR, P157, DOI 10.1007/978-1-4614-9622-98	39	9	10	3	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0121094	10.1371/journal.pone.0121094	http://dx.doi.org/10.1371/journal.pone.0121094			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE5MO	25806540	gold, Green Submitted, Green Published			2022-12-26	WOS:000351880000131
J	Yonezaki, K; Uchimoto, K; Miyazaki, T; Asakura, A; Kobayashi, A; Takase, K; Goto, T				Yonezaki, Kumiko; Uchimoto, Kazuhiro; Miyazaki, Tomoyuki; Asakura, Ayako; Kobayashi, Ayako; Takase, Kenkichi; Goto, Takahisa			Postanesthetic Effects of Isoflurane on Behavioral Phenotypes of Adult Male C57BL/6J Mice	PLOS ONE			English	Article							ELEVATED PLUS-MAZE; OVEREXPRESSING TRANSGENIC MICE; KNOCKOUT MICE; GENERAL-ANESTHESIA; INBRED STRAINS; TEST BATTERIES; MOUSE; ANXIETY; MEMORY; MODEL	Isoflurane was previously the major clinical anesthetic agent but is now mainly used for veterinary anesthesia. Studies have reported widespread sites of action of isoflurane, suggesting a wide array of side effects besides sedation. In the present study, we phenotyped isoflurane-treated mice to investigate the postanesthetic behavioral effects of isoflurane. We applied comprehensive behavioral test batteries comprising sensory test battery, motor test battery, anxiety test battery, depression test battery, sociability test battery, attention test battery, and learning test battery, which were started 7 days after anesthesia with 1.8% isoflurane. In addition to the control group, we included a yoked control group that was exposed to the same stress of handling as the isoflurane-treated animals before being anesthetized. Our comprehensive behavioral test batteries revealed impaired latent inhibition in the isoflurane-treated group, but the concentration of residual isoflurane in the brain was presumably negligible. The yoked control group and isoflurane-treated group exhibited higher anxiety in the elevated plus-maze test and impaired learning function in the cued fear conditioning test. No influences were observed in sensory functions, motor functions, antidepressant behaviors, and social behaviors. A number of papers have reported an effect of isoflurane on animal behaviors, but no systematic investigation has been performed. To the best of our knowledge, this study is the first to systematically investigate the general health, neurological reflexes, sensory functions, motor functions, and higher behavioral functions of mice exposed to isoflurane as adults. Our results suggest that the postanesthetic effect of isoflurane causes attention deficit in mice. Therefore, isoflurane must be used with great care in the clinical setting and veterinary anesthesia.	[Yonezaki, Kumiko; Uchimoto, Kazuhiro; Miyazaki, Tomoyuki; Asakura, Ayako; Kobayashi, Ayako; Goto, Takahisa] Yokohama City Univ, Grad Sch Med, Dept Anesthesiol, Yokohama, Kanagawa 232, Japan; [Miyazaki, Tomoyuki] Yokohama City Univ, Grad Sch Med, Dept Physiol, Yokohama, Kanagawa 232, Japan; [Takase, Kenkichi] Jichi Med Univ, Psychol Lab, Shimotsuke, Tochigi, Japan	Yokohama City University; Yokohama City University; Jichi Medical University	Takase, K (corresponding author), Jichi Med Univ, Psychol Lab, Shimotsuke, Tochigi, Japan.	tksknkch@yahoo.co.jp; takigoto@yokohama-cu.ac.jp			JSPS [25293330, 26670691]	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by JSPS KAKENHI Grant Number 25293330 (http://kaken.nii.ac.jp/d/p/25293330.en.html) and 26670691 (http://kaken.nii.ac.jp/d/p/26670691.en.html) to TG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkire MT, 2008, SCIENCE, V322, P876, DOI 10.1126/science.1149213; Blakeman KH, 2003, NEUROSCIENCE, V117, P221, DOI 10.1016/S0306-4522(02)00779-0; BORSINI F, 1988, PSYCHOPHARMACOLOGY, V94, P147; BRIONI JD, 1988, PSYCHOPHARMACOLOGY, V96, P505, DOI 10.1007/BF02180032; Bucan M, 2002, NAT REV GENET, V3, P114, DOI 10.1038/nrg728; Campagna JA, 2003, NEW ENGL J MED, V348, P2110, DOI 10.1056/NEJMra021261; Cao L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051431; Carter RJ, 1999, J NEUROSCI, V19, P3248; Crabbe JC, 1999, SCIENCE, V284, P1670, DOI 10.1126/science.284.5420.1670; Crawley J. N., 2007, WHATS WRONG MY MOUSE; Cryan JF, 2004, MOL PSYCHIATR, V9, P326, DOI 10.1038/sj.mp.4001457; Duncan GE, 1996, BRAIN RES, V713, P79, DOI 10.1016/0006-8993(95)01486-1; Espejo EF, 1997, BEHAV BRAIN RES, V87, P233, DOI 10.1016/S0166-4328(97)02286-9; Fidalgo AR, 2012, ACTA ANAESTH SCAND, V56, P1052, DOI 10.1111/j.1399-6576.2012.02691.x; Franks NP, 2008, NAT REV NEUROSCI, V9, P370, DOI 10.1038/nrn2372; FRANKS NP, 1994, NATURE, V367, P607, DOI 10.1038/367607a0; Fuchs PN, 1999, BRAIN RES, V821, P480, DOI 10.1016/S0006-8993(99)01060-4; Harrell AV, 2003, LEARN MEMORY, V10, P410, DOI 10.1101/lm.56103; HENRY KR, 1972, NATURE, V240, P481, DOI 10.1038/240481a0; Heyser CJ, 2003, CURRENT PROTOCOLS NE, P8181; Holmes A, 2002, J MOL NEUROSCI, V18, P151, DOI 10.1385/JMN:18:1-2:151; Holmes A, 2001, BEHAV NEUROSCI, V115, P1129, DOI 10.1037//0735-7044.115.5.1129; Holmes A, 2003, NEUROPSYCHOPHARMACOL, V28, P1031, DOI 10.1038/sj.npp.1300164; Holmes A, 2002, GENES BRAIN BEHAV, V1, P55, DOI 10.1046/j.1601-1848.2001.00005.x; HUANG JM, 1995, HEARING RES, V88, P61, DOI 10.1016/0378-5955(95)00099-P; Lee S, 2012, J PHARM PHARMACOL, V64, P302, DOI 10.1111/j.2042-7158.2011.01404.x; LINDZEY G, 1961, NATURE, V191, P474, DOI 10.1038/191474a0; MATHIS C, 1994, BEHAV GENET, V24, P171, DOI 10.1007/BF01067821; Matsuo N, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.003.2009; McIlwain KL, 2001, PHYSIOL BEHAV, V73, P705, DOI 10.1016/S0031-9384(01)00528-5; McNamara RK, 1996, MOL BRAIN RES, V40, P177, DOI 10.1016/0169-328X(96)00048-4; Miyakawa T, 2003, P NATL ACAD SCI USA, V100, P8987, DOI 10.1073/pnas.1432926100; Miyakawa T, 2001, HIPPOCAMPUS, V11, P763, DOI 10.1002/hipo.1092; Nakatani J, 2009, CELL, V137, P1235, DOI 10.1016/j.cell.2009.04.024; Ng D, 2009, PLOS BIOL, V7, P278, DOI 10.1371/journal.pbio.1000041; Paylor R, 2006, PHYSIOL BEHAV, V87, P95, DOI 10.1016/j.physbeh.2005.09.002; Paylor R, 1998, LEARN MEMORY, V5, P302; Pitcher GM, 1999, J NEUROSCI METH, V87, P185, DOI 10.1016/S0165-0270(99)00004-7; PORSOLT RD, 1977, NATURE, V266, P730, DOI 10.1038/266730a0; RODGERS RJ, 1993, PSYCHOPHARMACOLOGY, V113, P237, DOI 10.1007/BF02245704; RODGERS RJ, 1993, PHYSIOL BEHAV, V54, P729, DOI 10.1016/0031-9384(93)90084-S; Rudolph U, 2004, NAT REV NEUROSCI, V5, P709, DOI 10.1038/nrn1496; Sango K, 1996, NAT GENET, V14, P348, DOI 10.1038/ng1196-348; Schmajuk NA, 2001, BEHAV BRAIN RES, V118, P123, DOI 10.1016/S0166-4328(00)00319-3; TAKAHASHI JS, 1994, SCIENCE, V264, P1724, DOI 10.1126/science.8209253; Takao K, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-11; Takase K, 2012, BEHAV BRAIN RES, V232, P306, DOI 10.1016/j.bbr.2012.04.016; Uchimoto K, 2014, ANESTHESIOLOGY, V121, P302, DOI 10.1097/ALN.0000000000000269; Voikar V, 2004, GENES BRAIN BEHAV, V3, P27, DOI 10.1046/j.1601-183X.2003.0044.x; Wrenn CC, 2003, BEHAV NEUROSCI, V117, P21, DOI 10.1037/0735-7044.117.1.21; Yamasaki N, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-6	51	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0122118	10.1371/journal.pone.0122118	http://dx.doi.org/10.1371/journal.pone.0122118			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25806517	Green Published, Green Submitted, gold			2022-12-26	WOS:000351880000203
J	Chang, KY; Lin, TP; Shih, LY; Wang, CK				Chang, Kuan Y.; Lin, Tung-pei; Shih, Ling-Yi; Wang, Chien-Kuo			Analysis and Prediction of the Critical Regions of Antimicrobial Peptides Based on Conditional Random Fields	PLOS ONE			English	Article							MESSENGER-RNA; WEB SERVER; LACTOFERRIN; PROTEINS; CATHELICIDIN; EXPRESSION; SEQUENCES; HCAP-18; LL-37; CDNA	Antimicrobial peptides (AMPs) are potent drug candidates against microbes such as bacteria, fungi, parasites, and viruses. The size of AMPs ranges from less than ten to hundreds of amino acids. Often only a few amino acids or the critical regions of antimicrobial proteins matter the functionality. Accurately predicting the AMP critical regions could benefit the experimental designs. However, no extensive analyses have been done specifically on the AMP critical regions and computational modeling on them is either non-existent or settled to other problems. With a focus on the AMP critical regions, we thus develop a computational model AMPcore by introducing a state-of-the-art machine learning method, conditional random fields. We generate a comprehensive dataset of 798 AMPs cores and a low similarity dataset of 510 representative AMP cores. AMPcore could reach a maximal accuracy of 90% and 0.79 Matthew's correlation coefficient on the comprehensive dataset and a maximal accuracy of 83% and 0.66 MCC on the low similarity dataset. Our analyses of AMP cores follow what we know about AMPs: High in glycine and lysine, but low in aspartic acid, glutamic acid, and methionine; the abundance of a-helical structures; the dominance of positive net charges; the peculiarity of amphipathicity. Two amphipathic sequence motifs within the AMP cores, an amphipathic alpha-helix and an amphipathic p-helix, are revealed. In addition, a short sequence motif at the N-terminal boundary of AMP cores is reported for the first time: arginine at the P(-1) coupling with glycine at the P1 of AMP cores occurs the most, which might link to microbial cell adhesion.	[Chang, Kuan Y.; Lin, Tung-pei; Shih, Ling-Yi] Natl Taiwan Ocean Univ, Dept Comp Sci & Engn, Keelung, Taiwan; [Wang, Chien-Kuo] Asia Univ, Dept Biotechnol, Taichung, Taiwan	National Taiwan Ocean University; Asia University Taiwan	Chang, KY (corresponding author), Natl Taiwan Ocean Univ, Dept Comp Sci & Engn, Keelung, Taiwan.	kchang@ntou.edu.tw	Chang, Kuan Y./AAB-3639-2020	Chang, Kuan Y./0000-0002-2262-5218	National Science Council in Taiwan [NSC-102-2221-E-019-060]; Center for Excellence for the Oceans at National Taiwan Ocean University	National Science Council in Taiwan(Ministry of Science and Technology, Taiwan); Center for Excellence for the Oceans at National Taiwan Ocean University	The work was supported by National Science Council in Taiwan [NSC-102-2221-E-019-060]. T.-P.L. and L.-Y.S. were partially supported by Center for Excellence for the Oceans at National Taiwan Ocean University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adao R, 2011, J PHARM BIOALLIED SC, V3, P60, DOI 10.4103/0975-7406.76467; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; BELLAMY W, 1992, BIOCHIM BIOPHYS ACTA, V1121, P130, DOI 10.1016/0167-4838(92)90346-F; Chang KY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070166; Chapple DS, 2004, ANTIMICROB AGENTS CH, V48, P2190, DOI 10.1128/AAC.48.6.2190-2198.2004; Conchillo-Sole O, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-65; COWLAND JB, 1995, FEBS LETT, V368, P173, DOI 10.1016/0014-5793(95)00634-L; DeCaprio D, 2007, GENOME RES, V17, P1389, DOI 10.1101/gr.6558107; Di Nardo A, 2003, J IMMUNOL, V170, P2274, DOI 10.4049/jimmunol.170.5.2274; Dubos RJ, 1939, J EXP MED, V70, P1, DOI 10.1084/jem.70.1.11; EISENBERG D, 1982, NATURE, V299, P371, DOI 10.1038/299371a0; Fernandes FC, 2012, BIOPOLYMERS, V98, P280, DOI 10.1002/bip.22066; Fjell CD, 2012, NAT REV DRUG DISCOV, V11, P37, DOI 10.1038/nrd3591; Fleming A, 1922, P R SOC LOND B-CONTA, V93, P306, DOI 10.1098/rspb.1922.0023; Hancock REW, 2000, TRENDS MICROBIOL, V8, P402, DOI 10.1016/S0966-842X(00)01823-0; He X, 2004, 2004 CVPR 2004 P 200; Hilpert K, 2005, NAT BIOTECHNOL, V23, P1008, DOI 10.1038/nbt1113; Hong RW, 2003, ANTIMICROB AGENTS CH, V47, P1, DOI 10.1128/AAC.47.1.1-6.2003; Huang Y, 2010, BIOINFORMATICS, V26, P680, DOI 10.1093/bioinformatics/btq003; Jenssen H, 2008, J PEPT SCI, V14, P110, DOI 10.1002/psc.908; Kudo T, 2013, CRF YET ANOTHER CRF; Lafferty John D., 2001, ICML 01, P282, DOI DOI 10.5555/645530.655813; Lata S, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S19; LIU DC, 1989, MATH PROGRAM, V45, P503, DOI 10.1007/BF01589116; MASSON PL, 1971, COMP BIOCHEM PHYSIOL, V39, P119, DOI 10.1016/0305-0491(71)90258-6; McBride AE, 2009, NUCLEIC ACIDS RES, V37, P4322, DOI 10.1093/nar/gkp349; Murakami M, 2004, J IMMUNOL, V172, P3070, DOI 10.4049/jimmunol.172.5.3070; OKADA M, 1983, BIOCHEM J, V211, P727, DOI 10.1042/bj2110727; OPPENHEIM FG, 1988, J BIOL CHEM, V263, P7472; Orsi N, 2004, BIOMETALS, V17, P189, DOI 10.1023/B:BIOM.0000027691.86757.e2; PATTERSONDELAFIELD J, 1981, INFECT IMMUN, V31, P723, DOI 10.1128/IAI.31.2.723-731.1981; RADO TA, 1987, BLOOD, V70, P989; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; RUOSLAHTI E, 1986, CELL, V44, P517, DOI 10.1016/0092-8674(86)90259-X; Sato K, 2005, ANAL SCI, V21, P21, DOI 10.2116/analsci.21.21; Sha F, 2003, P 2003 C N AM CHAPT, V1; Sorensen OE, 2001, BLOOD, V97, P3951, DOI 10.1182/blood.V97.12.3951; STEINER H, 1981, NATURE, V292, P246, DOI 10.1038/292246a0; Stuart L. S., 1942, CEREAL CHEM, V19, P288; Thomas S, 2010, NUCLEIC ACIDS RES, V38, pD774, DOI 10.1093/nar/gkp1021; Torrent M, 2012, BIOINFORMATICS, V28, P130, DOI 10.1093/bioinformatics/btr604; Torrent M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016968; Waghu FH, 2014, NUCLEIC ACIDS RES, V42, pD1154, DOI 10.1093/nar/gkt1157; Wang G, 2010, ADV M C M, P1, DOI 10.1079/9781845936570.0000; Wang GS, 2008, J BIOL CHEM, V283, P32637, DOI 10.1074/jbc.M805533200; Wang GS, 2009, NUCLEIC ACIDS RES, V37, pD933, DOI 10.1093/nar/gkn823; Wang LX, 2008, BIOINFORMATICS, V24, P1401, DOI 10.1093/bioinformatics/btn132; Wang P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018476; Weaver TM, 2000, PROTEIN SCI, V9, P201; Yin A, 2003, ARCH ORAL BIOL, V48, P361, DOI 10.1016/S0003-9969(03)00012-8; Yuk JM, 2009, CELL HOST MICROBE, V6, P231, DOI 10.1016/j.chom.2009.08.004; ZASLOFF M, 1987, P NATL ACAD SCI USA, V84, P5449, DOI 10.1073/pnas.84.15.5449; Zhang XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060559; Zhang Y, 2012, PSSPRED MULTIPLE NEU	55	26	26	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0119490	10.1371/journal.pone.0119490	http://dx.doi.org/10.1371/journal.pone.0119490			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803302	gold, Green Published, Green Submitted			2022-12-26	WOS:000353889600028
J	Chansrichavala, P; Wongsuwan, N; Suddee, S; Malasit, M; Hongsuwan, M; Wannapinij, P; Kitphati, R; Day, NPJ; Michie, S; Peacock, SJ; Limmathurotsakul, D				Chansrichavala, Praveen; Wongsuwan, Nittayasee; Suddee, Suthee; Malasit, Mayura; Hongsuwan, Maliwan; Wannapinij, Prapass; Kitphati, Rungreung; Day, Nicholas P. J.; Michie, Susan; Peacock, Sharon J.; Limmathurotsakul, Direk			Public Awareness of Melioidosis in Thailand and Potential Use of Video Clips as Educational Tools	PLOS ONE			English	Article							BEHAVIOR-CHANGE INTERVENTIONS; BURKHOLDERIA-PSEUDOMALLEI; NORTHEAST THAILAND; YOUTUBE VIDEOS; ONE HEALTH; EPIDEMIOLOGY; CONSENSUS	Background Melioidosis causes more than 1,000 deaths in Thailand each year. Infection occurs via inoculation, ingestion or inhalation of the causative organism (Burkholderia pseuodmallei) present in soil and water. Here, we evaluated public awareness of melioidosis using a combination of population-based questionnaire, a public engagement campaign to obtain video clips made by the public, and viewpoints on these video clips as potential educational tools about the disease and its prevention. Methods A questionnaire was developed to evaluate public awareness of melioidosis, and knowledge about its prevention. From 1 March to 31 April 2012, the questionnaire was delivered to five randomly selected adults in each of 928 districts in Thailand. A video clip contest entitled "Melioidosis, an infectious disease that Thais must know" was run between May and October 2012. The best 12 video clips judged by a contest committee were shown to 71 people at risk from melioidosis (diabetics). Focus group interviews were used to evaluate their perceptions of the video clips. Results Of 4,203 Thais who completed our study questionnaire, 74% had never heard of melioidosis, and 19% had heard of the disease but had no further knowledge. Most participants in all focus group sessions felt that video clips were beneficial and could positively influence them to increase adherence to recommended preventive behaviours, including drinking boiled water and wearing protective gear if in contact with soil or environmental water. Participants suggested that video clips should be presented in the local dialect with simple words rather than medical terms, in a serious manner, with a doctor as the one presenting the facts, and having detailed pictures of each recommended prevention method. Conclusions In summary, public awareness of melioidosis in Thailand is very low, and video clips could serve as a useful medium to educate people and promote disease prevention.	[Chansrichavala, Praveen; Wongsuwan, Nittayasee; Malasit, Mayura; Hongsuwan, Maliwan; Wannapinij, Prapass; Day, Nicholas P. J.; Peacock, Sharon J.; Limmathurotsakul, Direk] Mahidol Univ, Mahidol Oxford Trop Med Res Unit, Fac Trop Med, Bangkok 10400, Thailand; [Suddee, Suthee] Warinchamrab Hosp, Ubon Ratchathani 34190, Thailand; [Kitphati, Rungreung] Minist Publ Hlth, Dept Dis Control, Bur Emerging Infect Dis, Nonthaburi 11000, Thailand; [Day, Nicholas P. J.] Univ Oxford, Ctr Trop Med, Nuffield Dept Med, Oxford OX3 7FZ, England; [Michie, Susan] UCL, Res Dept Clin Educ & Hlth Psychol, Ctr Outcomes Res Effectiveness, London WC1E 6BT, England; [Peacock, Sharon J.] Univ Cambridge, Dept Med, Addenbrookes Hosp, Cambridge CB2 0QQ, England; [Limmathurotsakul, Direk] Mahidol Univ, Fac Trop Med, Dept Trop Hyg, Bangkok 10400, Thailand	Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; Ministry of Public Health - Thailand; University of Oxford; University of London; University College London; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Mahidol University	Limmathurotsakul, D (corresponding author), Mahidol Univ, Mahidol Oxford Trop Med Res Unit, Fac Trop Med, Bangkok 10400, Thailand.	direk@tropmedres.ac	Peacock, Sharon J/ABE-6331-2020	Limmathurotsakul, Direk/0000-0001-7240-5320; Peacock, Sharon/0000-0002-1718-2782	Wellcome Trust [090219/Z/09/Z]; Intermediate Wellcome Trust Fellowship [101103/Z/13/Z]; NIHR Biomedical Research Centre; National Institute for Health Research [NF-SI-0512-10002] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Intermediate Wellcome Trust Fellowship; NIHR Biomedical Research Centre(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by the Wellcome Trust [grant number 090219/Z/09/Z]. DL is supported by an Intermediate Wellcome Trust Fellowship [grant number 101103/Z/13/Z]. SJP is supported by the NIHR Biomedical Research Centre. The authors declare no conflict of interest. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atlas RM, 2013, CURR TOP MICROBIOL, V365, P1, DOI 10.1007/82_2012_223; Azer SA, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2728; Carlos WG, 2014, MED EDUC, V48, P526, DOI 10.1111/medu.12457; Cheng AC, 2005, CLIN MICROBIOL REV, V18, P383, DOI 10.1128/CMR.18.2.383-416.2005; Currie BJ, 2004, TROP MED INT HEALTH, V9, P1167, DOI 10.1111/j.1365-3156.2004.01328.x; Fischer J, 2013, JCR-J CLIN RHEUMATOL, V19, P373, DOI 10.1097/RHU.0b013e3182a69fb2; Gongal G, 2013, CURR TOP MICROBIOL, V366, P113, DOI 10.1007/82_2012_242; Kanoksil M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054714; Kitphati R, 2013, PRINCE MAHIDOL AWARD; Limmathurotsakul D, 2014, EMERG INFECT DIS, V20, P265, DOI 10.3201/eid2002.121891; Limmathurotsakul D, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002105; Limmathurotsakul D, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002072; Limmathurotsakul D, 2010, AM J TROP MED HYG, V82, P1113, DOI 10.4269/ajtmh.2010.10-0038; Michie S, 2014, BEHAV CHANGE WHEEL G, DOI DOI 10.1186/s13012-015-0322-1; Michie S, 2013, ANN BEHAV MED, V46, P81, DOI 10.1007/s12160-013-9486-6; Michie S, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-42; Peacock SJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001488; Samarakoon YM, 2013, RURAL REMOTE HEALTH, V13; Stein ML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085256; Wiersinga WJ, 2012, NEW ENGL J MED, V367, P1035, DOI 10.1056/NEJMra1204699	20	14	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0121311	10.1371/journal.pone.0121311	http://dx.doi.org/10.1371/journal.pone.0121311			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803048	Green Published, gold, Green Submitted			2022-12-26	WOS:000353889600146
J	Gartner, MA; Bondzio, A; Braun, N; Jung, M; Einspanier, R; Gabler, C				Gaertner, Martina A.; Bondzio, Angelika; Braun, Nicole; Jung, Markus; Einspanier, Ralf; Gabler, Christoph			Detection and Characterisation of Lactobacillus spp. in the Bovine Uterus and Their Influence on Bovine Endometrial Epithelial Cells In Vitro	PLOS ONE			English	Article							STROMAL CELLS; DAIRY-COWS; ARCANOBACTERIUM-PYOGENES; PROBIOTIC STRAINS; IMMUNE-RESPONSE; GENE-EXPRESSION; POSTPARTUM; UTERINE; INFECTION; DISEASE	Bacterial infections and inflammation of the uterus are common in dairy cattle after parturition. In particular, pathogenic bacteria that cause endometritis have been the focus of research in cattle reproduction in the last ten years. The aim of the present study was to identify commensal lactobacilli in the bovine uterus and to examine their influence on the synthesis of pro-inflammatory factors in bovine endometrial epithelial cells in vitro. Lactobacillus species were isolated from healthy bovine uteri and further characterised. Bovine endometrial epithelial cells in the second passage (n = 5 animals) were co-cultured with the autochthonous isolates L. buchneri, L. ruminis and L. amylovorus as well as with a commercially available L. vaginalis in different multiplicities of infection (MOI = 1, 5 and 10, respectively). Endometrial epithelial cells cultured without bacteria served as controls. At distinct points in time (2, 4 and 6 h) total RNA was extracted from co-cultured epithelial cells and subjected to reverse transcription quantitative PCR of pro-inflammatory factors. Furthermore, the release of such factors by co-cultured epithelial cells was measured by ELISA or EIA after 24 and 48 h. L. ruminis and L. amylovorus induced increased interleukin (IL) IL1A, IL6, IL8 and prostaglandin-endoperoxide synthase 2 mRNA levels and the release of IL8 and prostaglandin F-2 alpha in endometrial epithelial cells compared with control cells. In contrast, L. buchneri did not significantly influence the expression and release of these factors. Toll-like receptors 2 and 6 transcripts were found unchanged in co-cultured and untreated epithelial cells in vitro. However, endometrial epithelial cells of each animal showed individual differences in the response to bacterial load. These results suggest that Lactobacillus species are present in the bovine uterus, revealing immunomodulatory properties.	[Gaertner, Martina A.; Bondzio, Angelika; Einspanier, Ralf; Gabler, Christoph] Free Univ Berlin, Dept Vet Med, Inst Vet Biochem, Berlin, Germany; [Braun, Nicole; Jung, Markus] Inst Reprod Farm Anim Schonow, Bernau, Germany	Free University of Berlin	Gabler, C (corresponding author), Free Univ Berlin, Dept Vet Med, Inst Vet Biochem, Berlin, Germany.	christoph.gabler@fu-berlin.de	Jung, Markus/M-2477-2019	Jung, Markus/0000-0002-0599-4417	Deutsche Forschungsgemeinschaft [GA 1077/5-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (GA 1077/5-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ametaj BN, 2014, RES VET SCI, V96, P365, DOI 10.1016/j.rvsc.2014.02.007; Arosh JA, 2002, BIOL REPROD, V67, P161, DOI 10.1095/biolreprod67.1.161; Asselin E, 1997, MOL CELL ENDOCRINOL, V132, P117, DOI 10.1016/S0303-7207(97)00128-7; Asselin E, 1996, BIOL REPROD, V54, P371, DOI 10.1095/biolreprod54.2.371; Atassi F, 2006, FEMS IMMUNOL MED MIC, V48, P424, DOI 10.1111/j.1574-695X.2006.00162.x; Beecher C, 2009, J DAIRY RES, V76, P340, DOI 10.1017/S0022029909004154; BETTS JG, 1992, LIFE SCI, V51, P1171, DOI 10.1016/0024-3205(92)90520-Y; Beutler BA, 2009, BLOOD, V113, P1399, DOI 10.1182/blood-2008-07-019307; BONNETT BN, 1991, CAN J VET RES, V55, P168; Borges AM, 2012, AM J REPROD IMMUNOL, V67, P526, DOI 10.1111/j.1600-0897.2012.01106.x; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chapwanya A, 2013, VET IMMUNOL IMMUNOP, V151, P157, DOI 10.1016/j.vetimm.2012.09.042; Chapwanya A, 2009, THERIOGENOLOGY, V71, P1396, DOI 10.1016/j.theriogenology.2009.01.006; Cronin JG, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.092718; Dinarello CA, 2002, CLIN EXP RHEUMATOL, V20, pS1; Dover S E, 2008, Int J Probiotics Prebiotics, V3, P219; Dubernet S, 2002, FEMS MICROBIOL LETT, V214, P271, DOI [10.1111/j.1574-6968.2002.tb11358.x, 10.1016/S0378-1097(02)00895-9]; Dubois RN, 1998, FASEB J, V12, P1063, DOI 10.1096/fasebj.12.12.1063; EMBLEY TM, 1989, INT J SYST BACTERIOL, V39, P368, DOI 10.1099/00207713-39-3-368; Erickson KL, 2000, J NUTR, V130, p403S, DOI 10.1093/jn/130.2.403S; Fischer C, 2010, REPROD FERT DEVELOP, V22, P818, DOI 10.1071/RD09120; Fourichon C, 2000, THERIOGENOLOGY, V53, P1729, DOI 10.1016/S0093-691X(00)00311-3; Frola ID, 2013, J DAIRY RES, V80, P28, DOI 10.1017/S0022029912000581; Gabler C, 2009, THERIOGENOLOGY, V71, P993, DOI 10.1016/j.theriogenology.2008.11.009; Gabler C, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-152; Gartner MA, 2016, REPROD FERT DEVELOP, V28, P982, DOI 10.1071/RD14219; Galvao KN, 2011, THERIOGENOLOGY, V76, P290, DOI 10.1016/j.theriogenology.2011.02.006; Herath S, 2006, ENDOCRINOLOGY, V147, P562, DOI 10.1210/en.2005-1113; Herath S, 2009, ENDOCRINOLOGY, V150, P1912, DOI 10.1210/en.2008-1379; HUSSAIN AM, 1990, THERIOGENOLOGY, V34, P291, DOI 10.1016/0093-691X(90)90522-U; Kandler O., 1986, BERGEYS MANUAL SYSTE, P1208; Kasimanickam R, 2004, THERIOGENOLOGY, V62, P9, DOI 10.1016/j.theriogenology.2003.03.001; KISHIMOTO T, 1995, BLOOD, V86, P1243, DOI 10.1182/blood.V86.4.1243.bloodjournal8641243; Konnai S, 2003, VET MICROBIOL, V94, P283, DOI 10.1016/S0378-1135(03)00119-6; Kummer V, 1997, VET MED-CZECH, V42, P217; LeBlanc SJ, 2012, REPROD DOMEST ANIM, V47, P18, DOI 10.1111/j.1439-0531.2012.02109.x; LeBlanc SJ, 2008, VET J, V176, P102, DOI 10.1016/j.tvjl.2007.12.019; Machado VS, 2012, VET MICROBIOL, V159, P460, DOI 10.1016/j.vetmic.2012.04.033; MESSIER S, 1984, CAN VET J, V25, P283; Miessen K, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-31; Miller ANA, 2007, THERIOGENOLOGY, V68, P972, DOI 10.1016/j.theriogenology.2007.07.013; Neville BA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040592; NOAKES DE, 1991, VET REC, V128, P440, DOI 10.1136/vr.128.19.440; Odau S, 2006, J ENDOCRINOL, V191, P263, DOI 10.1677/joe.1.06761; Otero C, 1999, ANAEROBE, V5, P305, DOI 10.1006/anae.1999.0245; Otero C, 2000, LETT APPL MICROBIOL, V31, P251, DOI 10.1046/j.1365-2672.2000.00809.x; Perez-Cano FJ, 2010, IMMUNOBIOLOGY, V215, P996, DOI 10.1016/j.imbio.2010.01.004; Petit T, 2009, REPROD DOMEST ANIM, V44, P88, DOI 10.1111/j.1439-0531.2007.01002.x; Reid G, 2002, MICROBES INFECT, V4, P319, DOI 10.1016/S1286-4579(02)01544-7; Rinaldi M, 2008, VET IMMUNOL IMMUNOP, V126, P199, DOI 10.1016/j.vetimm.2008.07.001; Rodriguez C, 2011, ANAEROBE, V17, P15, DOI 10.1016/j.anaerobe.2010.12.001; Rose WA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032728; Rusu D, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-42; Santos TMA, 2010, VET MICROBIOL, V145, P84, DOI 10.1016/j.vetmic.2010.03.001; Sheldon IM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009192; Sheldon IM, 2009, BIOL REPROD, V81, P1025, DOI 10.1095/biolreprod.109.077370; Sheldon IM, 2004, ANIM REPROD SCI, V82-3, P295, DOI 10.1016/j.anireprosci.2004.04.006; Sheldon IM, 2002, REPRODUCTION, V123, P837, DOI 10.1530/rep.0.1230837; Strober Warren, 2015, Curr Protoc Immunol, V111, DOI 10.1002/0471142735.ima03bs111; Taweechotipatr M, 2009, FEMS MICROBIOL LETT, V293, P65, DOI 10.1111/j.1574-6968.2009.01506.x; Tomas MSJ, 2005, BRIT J BIOMED SCI, V62, P170; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vitali B, 2007, APPL ENVIRON MICROB, V73, P5731, DOI 10.1128/AEM.01251-07; Wagner RD, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-58; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Werner A, 2012, J DAIRY SCI, V95, P7105, DOI 10.3168/jds.2012-5627; WILLIAMS BL, 1988, THERIOGENOLOGY, V30, P555, DOI 10.1016/0093-691X(88)90205-1; Williams EJ, 2005, THERIOGENOLOGY, V63, P102, DOI 10.1016/j.theriogenology.2004.03.017	68	25	29	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0119793	10.1371/journal.pone.0119793	http://dx.doi.org/10.1371/journal.pone.0119793			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803719	gold, Green Published, Green Submitted			2022-12-26	WOS:000353889600045
J	Guan, LZ; Tong, Q; Xu, J				Guan, Ling-Zhi; Tong, Qiang; Xu, Jing			Elevated Serum Levels of Mannose-Binding Lectin and Diabetic Nephropathy in Type 2 Diabetes	PLOS ONE			English	Article							VASCULAR COMPLICATIONS; COMPLEMENT ACTIVATION; ASSOCIATION; COAGULATION; PREDICTOR; MORTALITY; THERAPY	Objective Inflammation and complement activation initiated by mannose-binding lectin (MBL) may be implicated in the pathogenesis of diabetic vascular complications. We investigated serum MBL levels in type 2 diabetes with diabetic nephropathy (DN) and with persistent normoalbuminuria. Method Serum MBL levels were determined in 242 type 2 diabetes with overt nephropathy and 242 type 2 diabetes with persistent normoalbuminuria matched for age, sex, and duration of diabetes, as well as in 100 healthy control subjects. The prediction value of MBL was compared with HbA1c, Hs-CRP and with other known predictors. Multivariate analyses were performed using logistic regression models. Results The serum MBL levels were significantly higher in diabetes with DN as compared to with persistent normoalbuminuria (P<0.0001). Multivariate logistic regression analysis adjusted for common factors showed that serum MBL levels >= 2950ug/L was an independent indictor of DN (OR=7.55; 95% CI: 3.44-19.04). Based on the ROC curve, the optimal cutoff value of serum MBL levels as an indicator for diagnosis of DN was projected to be 2950ug/L, which yielded a sensitivity of 77.2% and a specificity of 80.8%, with the area under the curve at 0.809 (95% CI, 0.769-0.848). Conclusion Our findings suggested that MBL may be involved in the pathogenesis of DN in type 2 diabetes, and that determination of MBL status might be used to identify patients at increased risk of developing nephropathy complications.	[Guan, Ling-Zhi; Tong, Qiang; Xu, Jing] Third Mil Med Univ, Xinqiao Hosp, Dept Endocrinol, Chongqing, Peoples R China	Army Medical University	Xu, J (corresponding author), Third Mil Med Univ, Xinqiao Hosp, Dept Endocrinol, Chongqing, Peoples R China.	hujt1966@126.com						Acosta J, 2000, P NATL ACAD SCI USA, V97, P5450, DOI 10.1073/pnas.97.10.5450; Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; Aso Y, 2004, CLIN CHIM ACTA, V348, P139, DOI 10.1016/j.cccn.2004.05.006; Bouwman LH, 2005, DIABETES, V54, P3002, DOI 10.2337/diabetes.54.10.3002; Collard CD, 2000, AM J PATHOL, V156, P1549, DOI 10.1016/S0002-9440(10)65026-2; Duran-Salgado MB, 2014, WORLD J DIABETES, V5, P393, DOI 10.4239/wjd.v5.i3.393; Elmarakby AA, 2012, CARDIOVASC THER, V30, P49, DOI 10.1111/j.1755-5922.2010.00218.x; Granger CB, 2003, CIRCULATION, V108, P1184, DOI 10.1161/01.CIR.0000087447.12918.85; Hajishengallis G, 2010, BIOCHEM PHARMACOL, V80, P1992, DOI 10.1016/j.bcp.2010.06.017; Hansen TK, 2003, J CLIN ENDOCR METAB, V88, P1082, DOI 10.1210/jc.2002-021478; Hansen TK, 2004, DIABETES, V53, P1570, DOI 10.2337/diabetes.53.6.1570; Hansen TK, 2003, J CLIN ENDOCR METAB, V88, P4857, DOI 10.1210/jc.2003-030742; Hansen TK, 2006, ARCH INTERN MED, V166, P2007, DOI 10.1001/archinte.166.18.2007; Hovind P, 2005, DIABETES, V54, P1523, DOI 10.2337/diabetes.54.5.1523; Hsu SIH, 2003, J AM SOC NEPHROL, V14, pS186, DOI 10.1097/01.ASN.0000070032.58017.20; Ilyas R, 2011, IMMUNOBIOLOGY, V216, P126, DOI 10.1016/j.imbio.2010.06.002; Kim PS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024610; Krarup A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000623; Megia A, 2004, J CLIN ENDOCR METAB, V89, P5081, DOI 10.1210/jc.2004-0211; Nakagawa T, 2011, NAT REV NEPHROL, V7, P36, DOI 10.1038/nrneph.2010.152; Navarro-Gonzalez JF, 2011, NAT REV NEPHROL, V7, P327, DOI 10.1038/nrneph.2011.51; Pan HZ, 2010, ACTA DIABETOL, V47, pS71, DOI 10.1007/s00592-009-0128-1; Reutens AT, 2011, CONTRIB NEPHROL, V170, P1, DOI 10.1159/000324934; Saraheimo M, 2005, DIABETOLOGIA, V48, P198, DOI 10.1007/s00125-004-1594-1; Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957; Sone H, 2013, DIABETOLOGIA, V56, P1021, DOI 10.1007/s00125-012-2810-z; Wu Y, 2006, TRENDS CELL BIOL, V16, P189, DOI 10.1016/j.tcb.2006.02.003; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292	28	33	34	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0119699	10.1371/journal.pone.0119699	http://dx.doi.org/10.1371/journal.pone.0119699			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803807	Green Published, Green Submitted, gold			2022-12-26	WOS:000353889600039
J	Maimaitiyiming, H; Clemons, K; Zhou, Q; Norman, H; Wang, SX				Maimaitiyiming, Hasiyeti; Clemons, Kate; Zhou, Qi; Norman, Heather; Wang, Shuxia			Thrombospondin1 Deficiency Attenuates Obesity-Associated Microvascular Complications in ApoE-/- Mice	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; DIET-INDUCED OBESITY; SMOOTH-MUSCLE-CELLS; MESANGIAL CELLS; TGF-BETA; ENDOTHELIAL-CELLS; IN-VIVO; ATHEROSCLEROTIC LESIONS; ADIPOSE INFLAMMATION; GLUCOSE STIMULATION	Obesity is associated with insulin resistance and the increased development of vascular complications. Previously, we have demonstrated that thrombospondin1 (TSP1) regulates macrophage function and contributes to obesity associated inflammation and insulin resistance. However, the role of TSP1 in the development of obesity associated vascular complications is not clear. Therefore, in the current study, we investigated whether TSP1 deficiency protects mice from obesity associated micro as well as macro-vascular complications in ApoE-/- mice. In this study, male ApoE-/- mice and ApoE-/-TSP1-/- mice were fed with a low-fat (LF) or a high-fat (HF) diet for 16 weeks. We found that body weight and fat mass increased similarly between the ApoE-/-TSP1-/- mice and ApoE-/- mice under HF feeding conditions. However, as compared to obese ApoE-/- mice, obese ApoE-/-TSP1-/- mice had improved glucose tolerance, increased insulin sensitivity, and reduced systemic inflammation. Aortic atherosclerotic lesion formation was similar in these two groups of mice. In contrast, albuminuria was attenuated and kidney fibrosis was reduced in obese ApoE-/-TSP1-/- mice compared to obese ApoE-/- mice. The improved kidney function in obese ApoE-/-TSP1-/- mice was associated with decreased renal lipid accumulation. Together, these data suggest that TSP1 deficiency did not affect the development of obesity associated macro-vascular complication, but attenuated obesity associated microvascular complications.	[Maimaitiyiming, Hasiyeti; Clemons, Kate; Zhou, Qi; Norman, Heather; Wang, Shuxia] Univ Kentucky, Dept Pharmacol & Nutr Sci, Lexington, KY 40506 USA; [Maimaitiyiming, Hasiyeti; Clemons, Kate; Zhou, Qi; Norman, Heather; Wang, Shuxia] Lexington Vet Affairs Med Ctr, Lexington, KY USA	University of Kentucky; US Department of Veterans Affairs; Veterans Health Administration (VHA); Lexington VA Medical Center	Wang, SX (corresponding author), Univ Kentucky, Dept Pharmacol & Nutr Sci, Lexington, KY 40506 USA.	swang7@uky.edu			Veterans Affairs [I01 BX001204]; National Institutes of Health [R01 DK081555, DK098176]; National Institutes of Health Training Grant [DK07778]; Centers of Biomedical Research Excellence grant [P20GM103527-06]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021954] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098176, R01DK081555, T32DK007778] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103527] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001204] Funding Source: NIH RePORTER	Veterans Affairs(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Centers of Biomedical Research Excellence grant; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	Support was provided by I01 BX001204 from Veterans Affairs (to S. Wang); National Institutes of Health grants R01 DK081555 and DK098176 (to S. Wang); National Institutes of Health Training Grant DK07778 (to H. Norman); and a Centers of Biomedical Research Excellence grant P20GM103527-06. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alicic RZ, 2013, ADV CHRONIC KIDNEY D, V20, P121, DOI 10.1053/j.ackd.2012.12.006; BAENZIGE.NL, 1971, P NATL ACAD SCI USA, V68, P240, DOI 10.1073/pnas.68.1.240; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bobulescu IA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101285; Bobulescu IA, 2010, CURR OPIN NEPHROL HY, V19, P393, DOI 10.1097/MNH.0b013e32833aa4ac; Bornstein P, 2001, J CLIN INVEST, V107, P929, DOI 10.1172/JCI12749; Crawford SE, 1998, CELL, V93, P1159, DOI 10.1016/S0092-8674(00)81460-9; Cui WP, 2013, AM J PHYSIOL-RENAL, V305, pF871, DOI 10.1152/ajprenal.00209.2013; Daniel C, 2004, KIDNEY INT, V65, P459, DOI 10.1111/j.1523-1755.2004.00395.x; Daniel C., 2007, DIABETES, V18, P18; Daugherty A, 2000, J CLIN INVEST, V105, P1605, DOI 10.1172/JCI7818; Daugherty Alan, 2003, Methods Mol Biol, V209, P293; DONOVIEL DB, 1990, J CELL PHYSIOL, V145, P16, DOI 10.1002/jcp.1041450104; Guo NH, 1997, CANCER RES, V57, P1735; HUGO C, 1995, KIDNEY INT, V48, P1846, DOI 10.1038/ki.1995.483; Hugo C, 2009, NEPHRON EXP NEPHROL, V111, pE61, DOI 10.1159/000198235; Inoue M, 2013, ENDOCRINOLOGY, V154, P4548, DOI 10.1210/en.2013-1587; King VL, 2010, OBESITY, V18, P35, DOI 10.1038/oby.2009.176; Kong P, 2013, AM J PHYSIOL-ENDOC M, V305, pE439, DOI 10.1152/ajpendo.00006.2013; LAWLER JW, 1978, J BIOL CHEM, V253, P8609; Li Y, 2011, ABSTR APPL ANAL, V22, P1, DOI DOI 10.1371/J0URNAL.P0NE.0026656; Lu AL, 2011, AM J PATHOL, V178, P2573, DOI 10.1016/j.ajpath.2011.02.039; Mathew AV, 2011, CURR DIABETES REV, V7, P41, DOI 10.2174/157339911794273928; Moura R, 2008, CIRC RES, V103, P1181, DOI 10.1161/CIRCRESAHA.108.185645; Murphy-Ullrich JE, 2000, CYTOKINE GROWTH F R, V11, P59, DOI 10.1016/S1359-6101(99)00029-5; Patel MK, 1996, BIOCHEM SOC T, V24, pS446, DOI 10.1042/bst024446s; Phelan MW, 1998, J LAB CLIN MED, V132, P519, DOI 10.1016/S0022-2143(98)90131-7; Poczatek MH, 2000, AM J PATHOL, V157, P1353, DOI 10.1016/S0002-9440(10)64649-4; SCHULTZCHERRY S, 1994, J BIOL CHEM, V269, P26783; SCHULTZCHERRY S, 1993, J CELL BIOL, V122, P923, DOI 10.1083/jcb.122.4.923; Stenina OI, 2008, CIRC RES, V103, P1053, DOI 10.1161/CIRCRESAHA.108.188870; Stouffer GA, 1998, CIRCULATION, V97, P907, DOI 10.1161/01.CIR.97.9.907; Varma V, 2008, DIABETES, V57, P432, DOI 10.2337/db07-0840; Voros G, 2005, ENDOCRINOLOGY, V146, P4545, DOI 10.1210/en.2005-0532; Wang SX, 2004, J BIOL CHEM, V279, P34311, DOI 10.1074/jbc.M401629200; Wang SX, 2003, DIABETES, V52, P2144, DOI 10.2337/diabetes.52.8.2144; Wang SX, 2002, J BIOL CHEM, V277, P9880, DOI 10.1074/jbc.M108360200; Wen M, 2002, LAB INVEST, V82, P999, DOI 10.1097/01.LAB.0000022222.03120.D4; Wickman C, 2013, SEMIN NEPHROL, V33, P14, DOI 10.1016/j.semnephrol.2012.12.006; Wu YC, 2006, ENDOCRINOLOGY, V147, P44, DOI 10.1210/en.2005-0641; Yevdokimova N, 2001, J AM SOC NEPHROL, V12, P703, DOI 10.1681/ASN.V124703; Young GD, 2004, J BIOL CHEM, V279, P38032, DOI 10.1074/jbc.M405658200	42	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0121403	10.1371/journal.pone.0121403	http://dx.doi.org/10.1371/journal.pone.0121403			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803585	Green Submitted, Green Published, gold			2022-12-26	WOS:000353889600156
J	Mortlock, SA; Wei, J; Williamson, P				Mortlock, Sally-Anne; Wei, Jerry; Williamson, Peter			T-Cell Activation and Early Gene Response in Dogs	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; PHYTOHEMAGGLUTININ-INDUCED PROLIFERATION; FINGER TRANSCRIPTION FACTOR; PROSTAGLANDIN E-2; LYMPHOCYTE PROLIFERATION; KAPPA-B; EXPRESSION; GROWTH; INDUCTION; STIMULATION	T-cells play a crucial role in canine immunoregulation and defence against invading pathogens. Proliferation is fundamental to T-cell differentiation, homeostasis and immune response. Initiation of proliferation following receptor mediated stimuli requires a temporally programmed gene response that can be identified as immediate-early, mid-and late phases. The immediate-early response genes in T-cell activation engage the cell cycle machinery and promote subsequent gene activation events. Genes involved in this immediate-early response in dogs are yet to be identified. The present study was undertaken to characterise the early T-cell gene response in dogs to improve understanding of the genetic mechanisms regulating immune function. Gene expression profiles were characterised using canine gene expression microarrays and quantitative reverse transcription PCR (qRT-PCR), and paired samples from eleven dogs. Significant functional annotation clusters were identified following stimulation with phytohemagluttinin (PHA) (5 mu g/ml), including the Toll-like receptor signaling pathway and phosphorylation pathways. Using strict statistical criteria, 13 individual genes were found to be differentially expressed, nine of which have ontologies that relate to proliferation and cell cycle control. These included, prostaglandin-endoperoxide synthase 2 (PTGS2/COX2), early growth response 1 (EGR1), growth arrest and DNA damage-inducible gene (GADD45B), phorbol-12-myristate-13-acetate-induced protein 1 (PMAIP1), V-FOS FBJ murine osteosarcoma viral oncogene homolog (FOS), early growth response 2 (EGR2), hemogen (HEMGN), polo-like kinase 2 (PLK2) and polo-like kinase 3 (PLK3). Differential gene expression was re-examined using qRT-PCR, which confirmed that EGR1, EGR2, PMAIP1, PTGS2, FOS and GADD45B were significantly upregulated in stimulated cells and ALAS2 downregulated. PTGS2 and EGR1 showed the highest levels of response in these dogs. Both of these genes are involved in cell cycle regulation. This study provides a comprehensive analysis of the early T-cell gene response to activation in dogs.	[Mortlock, Sally-Anne; Wei, Jerry; Williamson, Peter] Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia; [Wei, Jerry] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney	Williamson, P (corresponding author), Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia.	p.williamson@sydney.edu.au	Mortlock, Sally/AAH-1584-2021; Wei, Jerry/B-7385-2013	Mortlock, Sally-Anne/0000-0003-2327-9465; Wei, Jerry/0000-0001-8802-7221	Maple Simmons Donation; Canine Research Foundation; University of Sydney; Australian Government	Maple Simmons Donation; Canine Research Foundation; University of Sydney(University of Sydney); Australian Government(Australian GovernmentCGIAR)	This work was funded by the Maple Simmons Donation, the Canine Research Foundation, and The University of Sydney. SM is the recipient of an Australian Postgraduate Award from the Australian Government. The funders had no role in the study design, data collection, decision to publish, or preparation of the manuscript.	Akdis M, 2011, J ALLERGY CLIN IMMUN, V127, P701, DOI 10.1016/j.jaci.2010.11.050; Bakin AV, 1999, SCIENCE, V283, P387, DOI 10.1126/science.283.5400.387; Baratelli F, 2005, J IMMUNOL, V175, P1483, DOI 10.4049/jimmunol.175.3.1483; Basson MA, 2000, J IMMUNOL, V165, P2444, DOI 10.4049/jimmunol.165.5.2444; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BETTENS F, 1984, J IMMUNOL, V132, P261; BETZ M, 1991, J IMMUNOL, V146, P108; Bin OY, 1999, ONCOGENE, V18, P6029, DOI 10.1038/sj.onc.1202983; Burns TF, 2003, MOL CELL BIOL, V23, P5556, DOI 10.1128/MCB.23.16.5556-5571.2003; Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10; Chang ZL, 2010, INFLAMM RES, V59, P791, DOI 10.1007/s00011-010-0208-2; CRABTREE GR, 1989, SCIENCE, V243, P355, DOI 10.1126/science.2783497; Cronin SJF, 2007, IMMUNOL REV, V220, P151, DOI 10.1111/j.1600-065X.2007.00570.x; De Smaele E, 2001, NATURE, V414, P308, DOI 10.1038/35104560; Decker EL, 2003, NUCLEIC ACIDS RES, V31, P911, DOI 10.1093/nar/gkg186; Diehn M, 2002, P NATL ACAD SCI USA, V99, P11796, DOI 10.1073/pnas.092284399; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Ellisen LW, 2001, EUR J CELL BIOL, V80, P321, DOI 10.1078/0171-9335-00162; ELLNER JJ, 1976, J IMMUNOL, V116, P876; Fukata M, 2006, GASTROENTEROLOGY, V131, P862, DOI 10.1053/j.gastro.2006.06.017; Geng DG, 2010, BLOOD, V116, P3494, DOI 10.1182/blood-2010-02-268169; Gianti M, 2013, RES VET SCI, V94, P90, DOI 10.1016/j.rvsc.2012.07.035; Harris JE, 2004, J IMMUNOL, V173, P7331, DOI 10.4049/jimmunol.173.12.7331; HELFAND SC, 1992, VET IMMUNOL IMMUNOP, V33, P1, DOI 10.1016/0165-2427(92)90030-T; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; HUTCHINS D, 1983, CLIN EXP IMMUNOL, V52, P355; Iniguez MA, 1999, J IMMUNOL, V163, P111; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kalinski P, 2012, J IMMUNOL, V188, P21, DOI 10.4049/jimmunol.1101029; Kawai T, 2008, ANN NY ACAD SCI, V1143, P1, DOI 10.1196/annals.1443.020; KELLY K, 1995, CURR OPIN IMMUNOL, V7, P327, DOI 10.1016/0952-7915(95)80106-5; Kersse K, 2011, CYTOKINE GROWTH F R, V22, P257, DOI 10.1016/j.cytogfr.2011.09.003; Kolenko V, 1999, BLOOD, V93, P2308, DOI 10.1182/blood.V93.7.2308.407k16_2308_2318; Li CY, 2007, LEUKEMIA, V21, P2277, DOI 10.1038/sj.leu.2404901; Li CY, 2004, CELL DEATH DIFFER, V11, P1299, DOI 10.1038/sj.cdd.4401490; Li SL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018498; Liaunardy-Jopeace A, 2014, SCI SIGNAL, V7, P12; Lin ZS, 2003, LAB INVEST, V83, P765, DOI 10.1097/01.LAB.0000073130.58435.E5; McGettrick AF, 2007, BRIT J HAEMATOL, V139, P185, DOI 10.1111/j.1365-2141.2007.06802.x; Miyazaki T, 1998, J EXP MED, V188, P715, DOI 10.1084/jem.188.4.715; Morrison C, 2011, FUTURE ONCOL, V7, P309, DOI [10.2217/fon.10.185, 10.2217/FON.10.185]; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; PEREZCASTILLO A, 1993, J BIOL CHEM, V268, P19445; Ploner A., 2014, HEATPLUS HEATMAPS RO; Rakoff-Nahoum S, 2008, BIOCHEMISTRY-MOSCOW+, V73, P555, DOI 10.1134/S0006297908050088; Safford M, 2005, NAT IMMUNOL, V6, P472, DOI 10.1038/ni1193; Sanges R, 2007, BIOINFORMATICS, V23, P3406, DOI 10.1093/bioinformatics/btm469; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; SOFUNI T, 1992, J RADIAT RES, V33, P222, DOI 10.1269/jrr.33.SUPPLEMENT_222; Teague TK, 1999, P NATL ACAD SCI USA, V96, P12691, DOI 10.1073/pnas.96.22.12691; Veenhof EZ, 2010, AM J VET RES, V71, P441, DOI 10.2460/ajvr.71.4.441; Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072; Virolle T, 2003, J BIOL CHEM, V278, P11802, DOI 10.1074/jbc.M210279200; Wang H, 2013, TRANSPL P, V45, P1822, DOI 10.1016/j.transproceed.2012.10.061; Warnke S, 2004, CURR BIOL, V14, P1200, DOI 10.1016/j.cub.2004.06.059; Xia DR, 2012, NAT MED, V18, P224, DOI 10.1038/nm.2608; Yokota I, 2010, INT J ONCOL, V37, P1407, DOI 10.3892/ijo_00000792	60	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0121169	10.1371/journal.pone.0121169	http://dx.doi.org/10.1371/journal.pone.0121169			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803042	Green Published, gold, Green Submitted			2022-12-26	WOS:000353889600132
J	Pintye, A; Ropars, J; Harvey, N; Shin, HD; Leyronas, C; Nicot, PC; Giraud, T; Kiss, L				Pintye, Alexandra; Ropars, Jeanne; Harvey, Nick; Shin, Hyeon-Dong; Leyronas, Christel; Nicot, Philippe C.; Giraud, Tatiana; Kiss, Levente			Host Phenology and Geography as Drivers of Differentiation in Generalist Fungal Mycoparasites	PLOS ONE			English	Article							PATHOGEN ASPERGILLUS-FUMIGATUS; POWDERY MILDEW FUNGI; AMPELOMYCES-QUISQUALIS; POPULATION-STRUCTURE; BOTRYTIS-CINEREA; GENETIC DIFFERENTIATION; SYMPATRIC SPECIATION; HABITAT PREFERENCE; EVOLUTION; PLANT	The question as to why parasites remain generalist or become specialist is a key unresolved question in evolutionary biology. Ampelomyces spp., intracellular mycoparasites of powdery mildew fungi, which are themselves plant pathogens, are a useful model for studies of this issue. Ampelomyces is used for the biological control of mildew. Differences in mycohost phenology promote temporal isolation between sympatric Ampelomyces mycoparasites. Apple powdery mildew (APM) causes spring epidemics, whereas other powdery mildew species on plants other than apple cause epidemics later in the season. This has resulted in genetic differentiation between APM and non-APM strains. It is unclear whether there is genetic differentiation between non-APM Ampelomyces lineages due to their specialization on different mycohosts. We used microsatellites to address this question and found no significant differentiation between non-APM Ampelomyces strains from different mycohosts or host plants, but strong differentiation between APM and non-APM strains. A geographical structure was revealed in both groups, with differences between European countries, demonstrating restricted dispersal at the continent scale and a high resolution for our markers. We found footprints of recombination in both groups, possibly more frequent in the APM cluster. Overall, Ampelomyces thus appears to be one of the rare genuine generalist pathogenic fungi able to parasitize multiple hosts in natural populations. It is therefore an excellent model for studying the evolution of pathogens towards a generalist rather than host-specific strategy, particularly in light of the tritrophic interaction between Ampelomyces mycoparasites, their powdery mildew fungal hosts and the mildew host plants.	[Pintye, Alexandra; Kiss, Levente] Hungarian Acad Sci MTA, Agr Res Ctr, Inst Plant Protect, Budapest, Hungary; [Ropars, Jeanne; Giraud, Tatiana] CNRS, Ecol Systemat & Evolut, F-91405 Orsay, France; [Ropars, Jeanne; Giraud, Tatiana] Univ Paris 11, Ecol Systemat & Evolut, Orsay, France; [Harvey, Nick] Genet Marker Serv, Brighton 7, E Sussex, England; [Shin, Hyeon-Dong] Korea Univ, Coll Life Sci & Biotechnol, Div Environm Sci & Ecol Engn, Seoul, South Korea; [Leyronas, Christel; Nicot, Philippe C.] INRA, Unite Rech UR407, Unite Pathol Vegetale, F-84143 Montfavet, France	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Agricultural Research; AgroParisTech; Centre National de la Recherche Scientifique (CNRS); AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; Korea University; INRAE	Giraud, T (corresponding author), CNRS, Ecol Systemat & Evolut, F-91405 Orsay, France.	tatiana.giraud@u-psud.fr; kiss.levente@agrar.mta.hu	Kiss, Levente/Q-3786-2018; Ropars, Jeanne/O-4113-2018	Kiss, Levente/0000-0002-4785-4308; Nicot, Philippe C./0000-0002-9272-3753; Ropars, Jeanne/0000-0002-3740-9673; Giraud, Tatiana/0000-0002-2685-6478; Leyronas, Christel/0000-0002-2693-1140	Hungarian Scientific Research Fund OTKA [NN100415]; Janos Bolyai Research Fellowship; Genetic Marker Services	Hungarian Scientific Research Fund OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Janos Bolyai Research Fellowship(Hungarian Academy of Sciences); Genetic Marker Services	This work was supported by Hungarian Scientific Research Fund OTKA NN100415 to LK (http://otka.hu/en) and Janos Bolyai Research Fellowship to PA (http://mta.hu/cikkek/?node_id=26057). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Genetic Marker Services provided support in the form of salaries for author NH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Amselem J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002230; Angeli D, 2010, P 6 INT WORKSH GRAP, P164; [Anonymous], 1996, 5000 CNRS UMR; Arnaud-Haond S, 2007, MOL ECOL NOTES, V7, P15, DOI 10.1111/j.1471-8286.2006.01522.x; Barres B, 2008, INFECT GENET EVOL, V8, P577, DOI 10.1016/j.meegid.2008.04.005; Barrett LG, 2012, TRENDS PLANT SCI, V17, P282, DOI 10.1016/j.tplants.2012.02.009; Bruns E, 2014, EVOLUTION, V68, P2453, DOI 10.1111/evo.12461; Burt A, 1996, P NATL ACAD SCI USA, V93, P770, DOI 10.1073/pnas.93.2.770; Dutech C, 2008, MOL ECOL, V17, P4597, DOI 10.1111/j.1365-294X.2008.03941.x; Dyer PS, 2011, CURR OPIN MICROBIOL, V14, P649, DOI 10.1016/j.mib.2011.10.001; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; FALK SP, 1995, PLANT DIS, V79, P483, DOI 10.1094/PD-79-0483; Farrer RA, 2011, P NATL ACAD SCI USA, V108, P18732, DOI 10.1073/pnas.1111915108; Fisher MC, 2012, NATURE, V484, P186, DOI 10.1038/nature10947; Fournier E, 2008, J EVOLUTION BIOL, V21, P122, DOI 10.1111/j.1420-9101.2007.01462.x; Gibson AK, 2012, EVOLUTION, V66, P1917, DOI 10.1111/j.1558-5646.2011.01563.x; Giraud T, 2008, PARASITE, V15, P449, DOI 10.1051/parasite/2008153449; Giraud T, 2004, HEREDITY, V93, P559, DOI 10.1038/sj.hdy.6800554; Giraud T, 1999, PHYTOPATHOLOGY, V89, P967, DOI 10.1094/PHYTO.1999.89.10.967; Giraud T, 1997, MOL BIOL EVOL, V14, P1177, DOI 10.1093/oxfordjournals.molbev.a025727; Giraud T, 2006, PHYTOPATHOLOGY, V96, P280, DOI 10.1094/PHYTO-96-0280; Giraud T, 2008, FUNGAL GENET BIOL, V45, P791, DOI 10.1016/j.fgb.2008.02.001; Giraud T, 2010, TRENDS ECOL EVOL, V25, P387, DOI 10.1016/j.tree.2010.03.006; Gladieux P, 2011, MOL ECOL, V20, P4521, DOI 10.1111/j.1365-294X.2011.05288.x; Gladieux P, 2011, GENETICS AND EVOLUTION OF INFECTIOUS DISEASES, P59, DOI 10.1016/B978-0-12-384890-1.00004-2; Gladieux P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001455; Grunwald NJ, 2006, PHYTOPATHOLOGY, V96, P1134, DOI 10.1094/PHYTO-96-1134; Harvey NG, 2006, MOL ECOL NOTES, V6, P1188, DOI 10.1111/j.1471-8286.2006.01487.x; Hoff B, 2008, EUKARYOT CELL, V7, P465, DOI 10.1128/EC.00430-07; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Johnson PA, 1996, EVOL ECOL, V10, P187, DOI 10.1007/BF01241784; Kiss L, 1998, CURR GENET, V33, P362, DOI 10.1007/s002940050348; Kiss L, 2004, BIOCONTROL SCI TECHN, V14, P635, DOI 10.1080/09583150410001683600; KISS L, 2008, STRESS YEASTS FILAME, P37; Kiss L, 2011, MOL ECOL, V20, P1492, DOI 10.1111/j.1365-294X.2011.05007.x; Le Gac M, 2008, J EVOLUTION BIOL, V21, P761, DOI 10.1111/j.1420-9101.2008.01511.x; Le Gac M, 2007, EVOLUTION, V61, P15, DOI 10.1111/j.1558-5646.2007.00002.x; Lee SC, 2010, MICROBIOL MOL BIOL R, V74, P298, DOI 10.1128/MMBR.00005-10; Legler S. E., 2011, IOBC/WPRS Bulletin, V67, P149; Liang C, 2007, FUNGAL DIVERS, V24, P225; Lopez-Villavicencio M, 2010, FUNGAL GENET BIOL, V47, P693, DOI 10.1016/j.fgb.2010.05.002; Millanes AM, 2014, EVOLUTION, V68, P1576, DOI 10.1111/evo.12374; Molina MC, 2005, MYCOLOGIA, V97, P454, DOI 10.3852/mycologia.97.2.454; O'Gorman CM, 2009, NATURE, V457, P471, DOI 10.1038/nature07528; Paoletti M, 2005, CURR BIOL, V15, P1242, DOI 10.1016/j.cub.2005.05.045; Park MJ, 2010, FUNGAL BIOL-UK, V114, P235, DOI 10.1016/j.funbio.2010.01.003; Pintye A, 2012, PHYTOPATHOLOGY, V102, P707, DOI 10.1094/PHYTO-10-11-0270; Pritchard JK, 2000, GENETICS, V155, P945; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; RICE WR, 1984, EVOLUTION, V38, P1251, DOI 10.1111/j.1558-5646.1984.tb05647.x; Rieux A, 2013, ECOL LETT, V16, P721, DOI 10.1111/ele.12090; Rieux A, 2013, HEREDITY, V110, P29, DOI 10.1038/hdy.2012.55; Rieux A, 2011, MOL ECOL, V20, P1661, DOI 10.1111/j.1365-294X.2011.05053.x; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Soler JJ, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-88; Sullivan RF, 2000, APPL ENVIRON MICROB, V66, P425, DOI 10.1128/AEM.66.1.425-427.2000; Szentivanyi O, 2005, MYCOL RES, V109, P429, DOI 10.1017/S0953756204001820; SZTEJNBERG A, 1989, J PHYTOPATHOL, V124, P285, DOI 10.1111/j.1439-0434.1989.tb04925.x; Takamatsu Susumu, 2004, Mycoscience, V45, P147, DOI 10.1007/s10267-003-0159-3; Taylor JW, 2000, FUNGAL GENET BIOL, V31, P21, DOI 10.1006/fgbi.2000.1228; THERON A, 1995, EVOLUTION, V49, P372, DOI [10.2307/2410347, 10.1111/j.1558-5646.1995.tb02249.x]; VANTIENDEREN PH, 1991, EVOLUTION, V45, P1317, DOI [10.1111/j.1558-5646.1991.tb02638.x, 10.2307/2409882]; Werth S, 2013, FUNGAL BIOL-UK, V117, P71, DOI 10.1016/j.funbio.2012.11.007; Whitlock MC, 1996, AM NAT, V148, pS65, DOI 10.1086/285902	66	9	9	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0120703	10.1371/journal.pone.0120703	http://dx.doi.org/10.1371/journal.pone.0120703			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803832	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000353889600095
J	Recek, N; Cheng, XQ; Keidar, M; Cvelbar, U; Vesel, A; Mozetic, M; Sherman, J				Recek, Nina; Cheng, Xiaoqian; Keidar, Michael; Cvelbar, Uros; Vesel, Alenka; Mozetic, Miran; Sherman, Jonathan			Effect of Cold Plasma on Glial Cell Morphology Studied by Atomic Force Microscopy	PLOS ONE			English	Article							NITRIC-OXIDE; PEROXYNITRITE; FIBROBLASTS; EXPRESSION; HYBRIDIZATION; RESOLUTION; DEATH	The atomic force microscope (AFM) is broadly used to study the morphology of cells. The morphological characteristics and differences of the cell membrane between normal human astrocytes and glial tumor cells are not well explored. Following treatment with cold atmospheric plasma, evaluation of the selective effect of plasma on cell viability of tumor cells is poorly understood and requires further evaluation. Using AFM we imaged morphology of glial cells before and after cold atmospheric plasma treatment. To look more closely at the effect of plasma on cell membrane, high resolution imaging was used. We report the differences between normal human astrocytes and human glioblastoma cells by considering the membrane surface details. Our data, obtained for the first time on these cells using atomic force microscopy, argue for an architectural feature on the cell membrane, i.e. brush layers, different in normal human astrocytes as compared to glioblastoma cells. The brush layer disappears from the cell membrane surface of normal E6/E7 cells and is maintained in the glioblastoma U87 cells after plasma treatment.	[Recek, Nina; Cvelbar, Uros; Vesel, Alenka; Mozetic, Miran] Jozef Stefan Inst, Plasma Lab, Dept Surface Engn & Optoelect, Ljubljana, Slovenia; [Recek, Nina] Jozef Stefan Int Postgrad Sch, Ljubljana, Slovenia; [Cheng, Xiaoqian; Keidar, Michael] George Washington Univ, Dept Mech & Aerosp Engn, Washington, DC 20052 USA; [Keidar, Michael; Sherman, Jonathan] George Washington Univ, Dept Neurosurg, Washington, DC USA	Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; George Washington University; George Washington University	Keidar, M (corresponding author), George Washington Univ, Dept Mech & Aerosp Engn, Washington, DC 20052 USA.	keidar@gwu.edu	Cvelbar, Uros/AAE-7916-2019; Vesel, Alenka/I-3934-2014	Vesel, Alenka/0000-0003-3782-6001; Cvelbar, Uros/0000-0002-1957-0789; Cheng, Xiaoqian/0000-0002-2544-4260	Katzen Research Grant	Katzen Research Grant	Support was provided by a Katzen Research Grant (http://www.katzencancer.org/research/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424; Braga PC RD, 2004, ATOMIC FORCE MICROSC, P3; Bustamante C, 1996, ANNU REV BIOPH BIOM, V25, P395; Cheng XQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098652; Czajkowsky DM, 1998, FEBS LETT, V430, P51, DOI 10.1016/S0014-5793(98)00461-X; ENGEL A, 1991, ANNU REV BIOPHYS BIO, V20, P79, DOI 10.1146/annurev.biophys.20.1.79; FRIDMAN A, 2008, PLASMA CHEM, P848; Fridman G, 2008, PLASMA PROCESS POLYM, V5, P503, DOI 10.1002/ppap.200700154; Georgescu N, 2010, IEEE T PLASMA SCI, V38, P1949, DOI 10.1109/TPS.2010.2041075; Haga H, 2000, ULTRAMICROSCOPY, V82, P253, DOI 10.1016/S0304-3991(99)00157-6; HANSMA HG, 1994, ANNU REV BIOPH BIOM, V23, P115, DOI 10.1146/annurev.bb.23.060194.000555; Harada K, 1998, CANCER RES, V58, P4694; Hesketh IFP J.E, 1996, CYTOSKELETON CYTOSKE, P526; HOH JH, 1994, J CELL SCI, V107, P1105; Horber JKH, 2003, SCIENCE, V302, P1002, DOI 10.1126/science.1067410; Isbary G, 2012, BRIT J DERMATOL, V167, P404, DOI 10.1111/j.1365-2133.2012.10923.x; Johnson DR, 2012, J NEURO-ONCOL, V107, P359, DOI 10.1007/s11060-011-0749-4; Johnson W.T., 2008, LIVE CELL IMAGING AF; Kalghatgi SU, 2009, NONTHERMAL PLASMA EN, P1; Keidar M, 2011, BRIT J CANCER, V105, P1295, DOI 10.1038/bjc.2011.386; Keidar M, 2013, PHYS PLASMAS, V20, DOI 10.1063/1.4801516; Kim JY, 2010, APPL PHYS LETT, V96; Kim Y, 2012, GENE DEV, V26, P1247, DOI 10.1101/gad.193565.112; Kong MG, 2009, PLASMA MED OPPORTUNI, P1; KW J, 2005, KRAUSES ESSENTIAL HU, P37; Le Grimellec C, 2002, J COMP NEUROL, V451, P62, DOI 10.1002/cne.10338; Linder S, 2007, TRENDS CELL BIOL, V17, P107, DOI 10.1016/j.tcb.2007.01.002; Lukes P, 2014, PLASMA SOURCES SCI T, V23, DOI 10.1088/0963-0252/23/1/015019; Moloney M, 2004, ULTRAMICROSCOPY, V100, P153, DOI 10.1016/j.ultramic.2003.12.010; Morfill GE, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/11/115011; Morris ARK, 1999, ATOMIC FORCE MICROSC; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Parsa AT, 2007, NAT MED, V13, P84, DOI 10.1038/nm1517; Plodinec M, 2010, COLD SPRING HARBOR P, V2010; Rhode S, 2004, CELL BIOCHEM BIOPHYS, V41, P343, DOI 10.1385/CBB:41:3:343; Rotsch C, 2000, BIOPHYS J, V78, P520, DOI 10.1016/S0006-3495(00)76614-8; Ruemmele FM, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-22; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Shashurin A, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.3020223; Shashurin A, 2010, PLASMA PROCESS POLYM, V7, P294, DOI 10.1002/ppap.200900086; Shi XM, 2012, IEEE T PLASMA SCI, V40, P2711, DOI 10.1109/TPS.2012.2210567; Vandamme M, 2010, PLASMA PROCESS POLYM, V7, P264, DOI 10.1002/ppap.200900080; Virag L, 2003, TOXICOL LETT, V140, P113, DOI 10.1016/S0378-4274(02)00508-8; Volotskova O, 2012, SCI REP-UK, V2, DOI 10.1038/srep00636; Walk RM, 2013, J PEDIATR SURG, V48, P67, DOI 10.1016/j.jpedsurg.2012.10.020; Weaver AM, 2006, CLIN EXP METASTAS, V23, P97, DOI 10.1007/s10585-006-9014-1; Yan X, 2012, PLASMA PROCESS POLYM, V9, P59, DOI 10.1002/ppap.201100031; Yu QS, 2007, J BIOMED MATER RES B, V80B, P211, DOI 10.1002/jbm.b.30586; Zelzer M, 2012, PLASMA PROCESS POLYM, V9, P149, DOI 10.1002/ppap.201100054; Zhang X, 2008, POWER DEMAND SIDE MA, V10, P39; Zirnheld JL, 2010, IEEE T PLASMA SCI, V38, P948, DOI 10.1109/TPS.2010.2041470; Zucker SN, 2012, CANCER BIOL THER, V13, P1299, DOI 10.4161/cbt.21787	52	25	25	4	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0119111	10.1371/journal.pone.0119111	http://dx.doi.org/10.1371/journal.pone.0119111			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803024	Green Submitted, gold, Green Published			2022-12-26	WOS:000353889600013
J	Shapcott, A; Forster, PI; Guymer, GP; McDonald, WJF; Faith, DP; Erickson, D; Kress, WJ				Shapcott, Alison; Forster, Paul I.; Guymer, Gordon P.; McDonald, William J. F.; Faith, Daniel P.; Erickson, David; Kress, W. John			Mapping Biodiversity and Setting Conservation Priorities for SE Queensland's Rainforests Using DNA Barcoding	PLOS ONE			English	Article							PHYLOGENETIC BETA DIVERSITY; MULTIPLE SEQUENCE ALIGNMENT; HABITAT FRAGMENTATION; SPECIES-DIVERSITY; PLANT DIVERSITY; CLIMATE-CHANGE; PATTERNS; BIOGEOGRAPHY; DIVERSIFICATION; COMMUNITIES	Australian rainforests have been fragmented due to past climatic changes and more recently landscape change as a result of clearing for agriculture and urban spread. The subtropical rainforests of South Eastern Queensland are significantly more fragmented than the tropical World Heritage listed northern rainforests and are subject to much greater human population pressures. The Australian rainforest flora is relatively taxonomically rich at the family level, but less so at the species level. Current methods to assess biodiversity based on species numbers fail to adequately capture this richness at higher taxonomic levels. We developed a DNA barcode library for the SE Queensland rainforest flora to support a methodology for biodiversity assessment that incorporates both taxonomic diversity and phylogenetic relationships. We placed our SE Queensland phylogeny based on a three marker DNA barcode within a larger international rainforest barcode library and used this to calculate phylogenetic diversity (PD). We compared phylo-diversity measures, species composition and richness and ecosystem diversity of the SE Queensland rainforest estate to identify which bio subregions contain the greatest rainforest biodiversity, subregion relationships and their level of protection. We identified areas of highest conservation priority. Diversity was not correlated with rainforest area in SE Queensland subregions but PD was correlated with both the percent of the subregion occupied by rainforest and the diversity of regional ecosystems (RE) present. The patterns of species diversity and phylogenetic diversity suggest a strong influence of historical biogeography. Some subregions contain significantly more PD than expected by chance, consistent with the concept of refugia, while others were significantly phylogenetically clustered, consistent with recent range expansions.	[Shapcott, Alison] Univ Sunshine Coast, Fac Sci Hlth Educ & Engn, Genecol Res Ctr, Maroochydore, Qld, Australia; [Forster, Paul I.; Guymer, Gordon P.; McDonald, William J. F.] Queensland Herbarium, Queensland Dept Sci Informat Technol Innovat, Toowong, Qld, Australia; [Forster, Paul I.; Guymer, Gordon P.; McDonald, William J. F.] Queensland Herbarium, Arts Brisbane Bot Gardens, Toowong, Qld, Australia; [Faith, Daniel P.] Australian Museum, Sydney, NSW 2000, Australia; [Erickson, David; Kress, W. John] Smithsonian Inst, Natl Museum Nat Hist, Washington, DC 20560 USA	University of the Sunshine Coast; Australian Museum; Smithsonian Institution; Smithsonian National Museum of Natural History	Shapcott, A (corresponding author), Univ Sunshine Coast, Fac Sci Hlth Educ & Engn, Genecol Res Ctr, Maroochydore, Qld, Australia.	ashapcot@usc.edu.au			Queensland Smithsonian fellowship; Smithsonian Institution National Museum of Natural History; University Sunshine Coast Genecology Research Centre	Queensland Smithsonian fellowship; Smithsonian Institution National Museum of Natural History(Smithsonian InstitutionSmithsonian National Museum of Natural History); University Sunshine Coast Genecology Research Centre	This project was funded by the Queensland Smithsonian fellowship, Smithsonian Institution National Museum of Natural History, and the University Sunshine Coast Genecology Research Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accad A, 2013, REMNANT VEGETATION Q, DOI [10.1016/j.jenvman.2014.01.041, DOI 10.1016/J.JENVMAN.2014.01.041]; Adam P., 1994, AUSTR RAINFORESTS; Alexander HM, 2012, J ECOL, V100, P88, DOI 10.1111/j.1365-2745.2011.01917.x; Barker NP, 2007, J BIOGEOGR, V34, P2012, DOI 10.1111/j.1365-2699.2007.01749.x; Bininda-Emonds ORP, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-156; Bostock PD, 2013, CENSUS QUEENSLAND FL; Britton T, 2007, SYSTEMATIC BIOL, V56, P741, DOI 10.1080/10635150701613783; Butler DW, 2007, J BIOGEOGR, V34, P1736, DOI 10.1111/j.1365-2699.2007.01734.x; Byrne M, 2011, J BIOGEOGR, V38, P1635, DOI 10.1111/j.1365-2699.2011.02535.x; Cagnolo L, 2006, BIOL CONSERV, V132, P510, DOI 10.1016/j.biocon.2006.05.012; Chape S, 2005, PHILOS T R SOC B, V360, P443, DOI 10.1098/rstb.2004.1592; Chapple DG, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-191; Clarke KR, 2006, PRIMER V 6 1 5 2006; Cook WM, 2002, ECOL LETT, V5, P619, DOI 10.1046/j.1461-0248.2002.00366.x; Cornell HV, 2013, BIOL REV, V88, P140, DOI 10.1111/j.1469-185X.2012.00245.x; Costion C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026841; Cowling RM, 2002, DIVERS DISTRIB, V8, P163, DOI 10.1046/j.1472-4642.2002.00143.x; Crisp MD, 2001, J BIOGEOGR, V28, P183, DOI 10.1046/j.1365-2699.2001.00524.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edwards DP, 2012, BIOL CONSERV, V151, P41, DOI 10.1016/j.biocon.2011.10.028; Erickson DL, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00358; Etherington R, 2014, AUST J BOT, V62, P36, DOI 10.1071/BT13232; Faith D P, 2009, INTECOL 10 ECOLOGY C; Faith DP, 2013, ANN NY ACAD SCI, V1289, P69, DOI 10.1111/nyas.12186; Faith DP, 2009, INT J MOL SCI, V10, P4723, DOI 10.3390/ijms10114723; Faith Daniel P., 2008, P99; Faith DP, 2004, J BIOGEOGR, V31, P1207, DOI 10.1111/j.1365-2699.2004.01145.x; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Fazekas AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002802; Ferrier S, 2004, BIOSCIENCE, V54, P1101, DOI 10.1641/0006-3568(2004)054[1101:MMOTBF]2.0.CO;2; Fine PVA, 2011, ECOGRAPHY, V34, P552, DOI 10.1111/j.1600-0587.2010.06548.x; Fisher B, 2011, FRONT ECOL ENVIRON, V9, P329, DOI 10.1890/100079; Forest F, 2007, NATURE, V445, P757, DOI 10.1038/nature05587; Gerstner K, 2014, J BIOGEOGR, V41, P261, DOI 10.1111/jbi.12213; Groves CR, 2012, BIODIVERS CONSERV, V21, P1651, DOI 10.1007/s10531-012-0269-3; Hanksi I, 1997, METAPOPULATION ECOLO; Haston E, 2009, BOT J LINN SOC, V161, P128, DOI 10.1111/j.1095-8339.2009.00996.x; Helmus MR, 2010, ECOL LETT, V13, P162, DOI 10.1111/j.1461-0248.2009.01411.x; Hill RS, 2004, PHILOS T R SOC B, V359, P1537, DOI 10.1098/rstb.2004.1526; Hollingsworth PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019254; Honnay O, 2005, NEW PHYTOL, V166, P723, DOI 10.1111/j.1469-8137.2005.01352.x; Hubbell SP, 2013, ECOL EVOL, V3, P3263, DOI 10.1002/ece3.705; Ivanova NV, 2008, PLANT MOL BIOL REP, V26, P186, DOI 10.1007/s11105-008-0029-4; Janzen DH, 2009, MOL ECOL RESOUR, V9, P1, DOI 10.1111/j.1755-0998.2009.02628.x; Katoh Kazutaka, 2010, Bioinformatics, V26, P1899, DOI 10.1093/bioinformatics/btq224; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Kershaw AP, 2007, PALAEOGEOGR PALAEOCL, V251, P23, DOI 10.1016/j.palaeo.2007.02.015; Kisel Y, 2011, PHILOS T R SOC B, V366, P2514, DOI 10.1098/rstb.2011.0022; Koh LP, 2010, CONSERV BIOL, V24, P994, DOI 10.1111/j.1523-1739.2010.01464.x; Kooyman R, 2012, BIOTROPICA, V44, P668, DOI 10.1111/j.1744-7429.2012.00861.x; Kooyman R, 2011, GLOBAL ECOL BIOGEOGR, V20, P707, DOI 10.1111/j.1466-8238.2010.00641.x; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Laidlaw MJ, 2011, AUST J BOT, V59, P440, DOI 10.1071/BT10319; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Larsen FW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036971; Laurance WF, 2008, BIOL CONSERV, V141, P1731, DOI 10.1016/j.biocon.2008.05.011; Laurance WF, 2011, BIOL CONSERV, V144, P56, DOI 10.1016/j.biocon.2010.09.021; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; MacArthur R.H., 1967, THEORY ISLAND BIOGEO; MACKEY BG, 1989, BIOL CONSERV, V50, P279, DOI 10.1016/0006-3207(89)90014-1; Maddison WP, 2009, MESQUITE MODULAR SYS; Magallon S, 2009, AM J BOT, V96, P349, DOI 10.3732/ajb.0800060; Margules CR, 2007, ECOL BIODIVERS CONS, P1; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Mayfield MM, 2010, ECOL LETT, V13, P1085, DOI 10.1111/j.1461-0248.2010.01509.x; Miller M.A., 2010, P GAT COMP ENV WORKS; Moilanen A, 2010, SPATIAL CONSERVATION; Moritz Craig, 1997, P442; Normand S, 2011, P ROY SOC B-BIOL SCI, V278, P3644, DOI 10.1098/rspb.2010.2769; Olson DM, 1998, CONSERV BIOL, V12, P502, DOI 10.1046/j.1523-1739.1998.012003502.x; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pio DV, 2011, CONSERV BIOL, V25, P1229, DOI 10.1111/j.1523-1739.2011.01773.x; Pressey RL, 2007, TRENDS ECOL EVOL, V22, P583, DOI 10.1016/j.tree.2007.10.001; Ricketts TH, 2001, AM NAT, V158, P87, DOI 10.1086/320863; Rodrigues ASL, 2002, BIOL CONSERV, V105, P103, DOI 10.1016/S0006-3207(01)00208-7; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Sattler P., 1999, CONSERVATION STATUS; Secretariat of the Convention on Biological Diversity, 2011, REDD PLUS BIOD TECHN, V59; Soutullo A, 2008, DIVERS DISTRIB, V14, P604, DOI 10.1111/j.1472-4642.2007.00445.x; Spasojevic MJ, 2012, J ECOL, V100, P652, DOI 10.1111/j.1365-2745.2011.01945.x; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Storch D., 2007, SCALING BIODIVERSITY; Swenson Nathan G, 2012, Methods Mol Biol, V858, P409, DOI 10.1007/978-1-61779-591-6_20; Tscharntke T, 2012, BIOL REV, V87, P661, DOI 10.1111/j.1469-185X.2011.00216.x; Turner WR, 2005, ECOGRAPHY, V28, P721, DOI 10.1111/j.2005.0906-7590.04273.x; Valiente-Banuet A, 2007, ECOL LETT, V10, P1029, DOI 10.1111/j.1461-0248.2007.01100.x; van Vuuren DP, 2006, ECOL SOC, V11; Watson JEM, 2011, CONSERV BIOL, V25, P324, DOI 10.1111/j.1523-1739.2010.01587.x; Webb CO, 2005, MOL ECOL NOTES, V5, P181, DOI 10.1111/j.1471-8286.2004.00829.x; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Webb CO, 2000, AM NAT, V156, P145, DOI 10.1086/303378; WEBB LJ, 1984, AUST J ECOL, V9, P169, DOI 10.1111/j.1442-9993.1984.tb01356.x; Webb LJ, 1981, ECOLOGICAL BIOGEOGRA, P605, DOI DOI 10.1007/978-94-009-8629-9_22; Weber LC, 2014, J BIOGEOGR, V41, P222, DOI 10.1111/jbi.12219; Whittaker RJ, 2005, DIVERS DISTRIB, V11, P3, DOI 10.1111/j.1366-9516.2005.00143.x; Wilson KA, 2006, NATURE, V440, P337, DOI 10.1038/nature04366; Yessoufou K, 2013, J ECOL, V101, P614, DOI 10.1111/1365-2745.12059; Young PAR, 1987, RAIN FOREST LEGACY A, V1, P119; Zhang JL, 2013, J SYST EVOL, V51, P71, DOI 10.1111/j.1759-6831.2012.00220.x; Zobel M, 2011, GLOBAL ECOL BIOGEOGR, V20, P251, DOI 10.1111/j.1466-8238.2010.00593.x	103	31	34	1	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0122164	10.1371/journal.pone.0122164	http://dx.doi.org/10.1371/journal.pone.0122164			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803607	Green Submitted, Green Published, gold			2022-12-26	WOS:000353889600191
J	Machova, I; Snasel, J; Dostal, J; Brynda, J; Fanfrlik, J; Singh, M; Tarabek, J; Vanek, O; Bednarova, L; Pichova, I				Machova, Iva; Snasel, Jan; Dostal, Jiri; Brynda, Jiri; Fanfrlik, Jindrich; Singh, Mahavir; Tarabek, Jan; Vanek, Ondrej; Bednarova, Lucie; Pichova, Iva			Structural and Functional Studies of Phosphoenolpyruvate Carboxykinase from Mycobacterium tuberculosis	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; MECHANISM; DISPERSION; PURIFICATION; REVEALS; PEPCK; FERROACTIVATOR; COMPLEXES; CRUZI	Tuberculosis, the second leading infectious disease killer after HIV, remains a top public health priority. The causative agent of tuberculosis, Mycobacterium tuberculosis (Mtb), which can cause both acute and clinically latent infections, reprograms metabolism in response to the host niche. Phosphoenolpyruvate carboxykinase (Pck) is the enzyme at the center of the phosphoenolpyruvate-pyruvate-oxaloacetate node, which is involved in regulating the carbon flow distribution to catabolism, anabolism, or respiration in different states of Mtb infection. Under standard growth conditions, Mtb Pck is associated with gluconeogenesis and catalyzes the metal-dependent formation of phosphoenolpyruvate. In non-replicating Mtb, Pck can catalyze anaplerotic biosynthesis of oxaloacetate. Here, we present insights into the regulation of Mtb Pck activity by divalent cations. Through analysis of the Xray structure of Pck-GDP and Pck-GDP-Mn2+ complexes, mutational analysis of the GDP binding site, and quantum mechanical (QM)-based analysis, we explored the structural determinants of efficient Mtb Pck catalysis. We demonstrate that Mtb Pck requires presence of Mn2+ and Mg2+ cations for efficient catalysis of gluconeogenic and anaplerotic reactions. The anaplerotic reaction, which preferably functions in reducing conditions that are characteristic for slowed or stopped Mtb replication, is also effectively activated by Fe2+ in the presence of Mn2+ or Mg2+ cations. In contrast, simultaneous presence of Fe2+ and Mn2+ or Mg2+ inhibits the gluconeogenic reaction. These results suggest that inorganic ions can contribute to regulation of central carbon metabolism by influencing the activity of Pck. Furthermore, the X-ray structure determination, biochemical characterization, and QM analysis of Pck mutants confirmed the important role of the Phe triad for proper binding of the GDP-Mn2+ complex in the nucleotide binding site and efficient catalysis of the anaplerotic reaction.	[Machova, Iva; Snasel, Jan; Dostal, Jiri; Brynda, Jiri; Fanfrlik, Jindrich; Tarabek, Jan; Bednarova, Lucie; Pichova, Iva] Acad Sci Czech Republ, Inst Organ Chem & Biochem, Prague, Czech Republic; [Singh, Mahavir] LIONEX Diagnost & Therapeut, Braunschweig, Germany; [Vanek, Ondrej] Charles Univ Prague, Fac Sci, Dept Biochem, Prague, Czech Republic	Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences; Lionex Diagnostics & Therapeutics GmbH; Charles University Prague	Pichova, I (corresponding author), Acad Sci Czech Republ, Inst Organ Chem & Biochem, Prague, Czech Republic.	iva.pichova@uochb.cas.cz	Machova, Iva/G-5578-2014; Machova, Iva/AAH-7522-2020; Tarabek, Jan/G-5319-2014; Vaněk, Ondřej/I-7022-2016; Tarabek, Jan/ABE-3843-2021; Bednarova, Lucie/E-7622-2012; Pichova, Iva/G-7917-2014; Dostal, Jiri/E-9584-2012; Brynda, Jiri/G-2760-2014	Machova, Iva/0000-0003-3231-4509; Machova, Iva/0000-0003-3231-4509; Tarabek, Jan/0000-0003-0116-3824; Vaněk, Ondřej/0000-0003-1190-8535; Tarabek, Jan/0000-0003-0116-3824; Brynda, Jiri/0000-0003-3675-6769; Fanfrlik, Jindrich/0000-0002-1257-1201	EU-PF7 SysteMtb Collaborative [241587]; RVO [61388963]; NPU from the Ministry of Education, Czech Republic [LO 1302]	EU-PF7 SysteMtb Collaborative; RVO; NPU from the Ministry of Education, Czech Republic	This work was supported by EU-PF7 SysteMtb Collaborative Project no. 241587, RVO 61388963 and NPU project No: LO 1302 from the Ministry of Education, Czech Republic.	Abramovitch RB, 2011, MOL MICROBIOL, V80, P678, DOI 10.1111/j.1365-2958.2011.07601.x; AHLRICHS R, 1989, CHEM PHYS LETT, V162, P165, DOI 10.1016/0009-2614(89)85118-8; [Anonymous], 2008, AMBER 10; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; BENTLE LA, 1977, J BIOL CHEM, V252, P1431; BENTLE LA, 1976, J BIOL CHEM, V251, P2916; Beste DJV, 2013, CHEM BIOL, V20, P1012, DOI 10.1016/j.chembiol.2013.06.012; Beste DJV, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002091; Bradbrook GM, 1998, J CHEM SOC FARADAY T, V94, P1603, DOI 10.1039/a800429c; BrUnger A. T., 1992, X PLOR VERSION 3 1 S; Carlson GM, 2009, J BIOL CHEM, V284, P27037, DOI 10.1074/jbc.R109.040568; COLOMBO G, 1981, BIOCHEMISTRY-US, V20, P2749, DOI 10.1021/bi00513a008; Dapprich S, 1999, J MOL STRUC-THEOCHEM, V461, P1, DOI 10.1016/S0166-1280(98)00475-8; de Carvalho LPS, 2010, CHEM BIOL, V17, P323, DOI 10.1016/j.chembiol.2010.03.009; Dunten P, 2002, J MOL BIOL, V316, P257, DOI 10.1006/jmbi.2001.5364; FINNEGAN PM, 1995, PLANT MOL BIOL, V27, P365, DOI 10.1007/BF00020190; FOSTER DO, 1967, BIOCHEMISTRY-US, V6, P2120, DOI 10.1021/bi00859a033; Gandhi NR, 2010, LANCET, V375, P1830, DOI 10.1016/S0140-6736(10)60410-2; Gobin J, 1996, J EXP MED, V183, P1527, DOI 10.1084/jem.183.4.1527; Grimme S, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3382344; HEBDA CA, 1982, J BIOL CHEM, V257, P5515; HOLTEN DD, 1965, BIOCHEMISTRY-US, V4, P723, DOI 10.1021/bi00880a018; Holyoak T, 2006, BIOCHEMISTRY-US, V45, P8254, DOI 10.1021/bi060269g; Jabalquinto AM, 2003, J PROTEIN CHEM, V22, P515, DOI 10.1023/B:JOPC.0000005500.67125.71; Johnson TA, 2012, BIOCHEMISTRY-US, V51, P9547, DOI 10.1021/bi301278t; Jurecka P, 2007, J COMPUT CHEM, V28, P555, DOI 10.1002/jcc.20570; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KLAMT A, 1993, J CHEM SOC PERK T 2, P799, DOI 10.1039/p29930000799; Krug M, 2012, J APPL CRYSTALLOGR, V45, P568, DOI 10.1107/S0021889812011715; LEE MH, 1981, J BIOL CHEM, V256, P2793; Lobley A, 2002, BIOINFORMATICS, V18, P211, DOI 10.1093/bioinformatics/18.1.211; Lovell S.C., 2003, PROTEINS STRUCT FUNC, V50, P437, DOI [10.1002/prot.10286, DOI 10.1002/PROT.10286]; MACDONALD MJ, 1978, J BIOL CHEM, V253, P116; MACDONALD MJ, 1978, J BIOL CHEM, V253, P2300; MACDONALD MJ, 1980, BIOCHIM BIOPHYS ACTA, V615, P223, DOI 10.1016/0005-2744(80)90025-X; MACDONALD MJ, 1978, BIOCHEM J, V176, P495, DOI 10.1042/bj1760495; Machova I, 2014, J BIOL CHEM, V289, P13066, DOI 10.1074/jbc.M113.536748; Marrero J, 2010, P NATL ACAD SCI USA, V107, P9819, DOI 10.1073/pnas.1000715107; Massova I, 1999, J AM CHEM SOC, V121, P8133, DOI 10.1021/ja990935j; Matte A, 1996, J MOL BIOL, V256, P126, DOI 10.1006/jmbi.1996.0072; Matte A, 1997, J BIOL CHEM, V272, P8105, DOI 10.1074/jbc.272.13.8105; Mukhopadhyay B, 2001, J BIOL CHEM, V276, P16137, DOI 10.1074/jbc.M008960200; Pecina A, 2013, J PHYS CHEM B, V117, P16096, DOI 10.1021/jp410216m; PUNEKAR NS, 1987, J BIOL CHEM, V262, P6714; Rezac J, 2012, J CHEM THEORY COMPUT, V8, P141, DOI 10.1021/ct200751e; Rezac J, 2009, J CHEM THEORY COMPUT, V5, P1749, DOI 10.1021/ct9000922; Schocke L, 1997, ARCH MICROBIOL, V167, P289, DOI 10.1007/s002030050446; Schuck P, 2003, ANAL BIOCHEM, V320, P104, DOI 10.1016/S0003-2697(03)00289-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Sherman DR, 2001, P NATL ACAD SCI USA, V98, P7534, DOI 10.1073/pnas.121172498; Shi LB, 2010, MOL MICROBIOL, V78, P1199, DOI 10.1111/j.1365-2958.2010.07399.x; Stewart J. J. P., MOPAC2009; Sudom AM, 2001, J MOL BIOL, V314, P83, DOI 10.1006/jmbi.2001.5120; Sullivan SM, 2008, P NATL ACAD SCI USA, V105, P13829, DOI 10.1073/pnas.0805364105; Sullivan SM, 2007, BIOCHEMISTRY-US, V46, P10078, DOI 10.1021/bi701038x; TORTORA P, 1985, ANAL BIOCHEM, V144, P179, DOI 10.1016/0003-2697(85)90101-0; Trapani S, 2001, J MOL BIOL, V313, P1059, DOI 10.1006/jmbi.2001.5093; URBINA JA, 1987, ARCH BIOCHEM BIOPHYS, V258, P186, DOI 10.1016/0003-9861(87)90335-3; Velayati AA, 2009, CHEST, V136, P420, DOI 10.1378/chest.08-2427; Via LE, 2008, INFECT IMMUN, V76, P2333, DOI 10.1128/IAI.01515-07; Wagner D, 2005, J IMMUNOL, V174, P1491, DOI 10.4049/jimmunol.174.3.1491; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Watanabe S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002287	63	3	3	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120682	10.1371/journal.pone.0120682	http://dx.doi.org/10.1371/journal.pone.0120682			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798914	Green Submitted, gold, Green Published			2022-12-26	WOS:000351987300164
J	Martoni, F; Eickbush, DG; Scavariello, C; Luchetti, A; Mantovani, B				Martoni, Francesco; Eickbush, Danna G.; Scavariello, Claudia; Luchetti, Andrea; Mantovani, Barbara			Dead Element Replicating: Degenerate R2 Element Replication and rDNA Genomic Turnover in the Bacillus rossius Stick Insect (Insecta: Phasmida)	PLOS ONE			English	Article							NON-LTR RETROTRANSPOSONS; REVERSE-TRANSCRIPTASE; RNA; DYNAMICS; BRANCHIOPODA; INHERITANCE; EVOLUTION; BINDING; HYBRIDS; GENE	R2 is an extensively investigated non-LTR retrotransposon that specifically inserts into the 28S rRNA gene sequences of a wide range of metazoans, disrupting its functionality. During R2 integration, first strand synthesis can be incomplete so that 5' end deleted copies are occasionally inserted. While active R2 copies repopulate the locus by retrotransposing, the non-functional truncated elements should frequently be eliminated by molecular drive processes leading to the concerted evolution of the rDNA array(s). Although, multiple R2 lineages have been discovered in the genome of many animals, the rDNA of the stick insect Bacillus rossius exhibits a peculiar situation: it harbors both a canonical, functional R2 element (R2Br(fun)) as well as a full-length but degenerate element (R2Br(deg)). An intensive sequencing survey in the present study reveals that all truncated variants in stick insects are present in multiple copies suggesting they were duplicated by unequal recombination. Sequencing results also demonstrate that all R2Br(deg) copies are full-length, i.e. they have no associated 5' end deletions, and functional assays indicate they have lost the active ribozyme necessary for R2 RNA maturation. Although it cannot be completely ruled out, it seems unlikely that the degenerate elements replicate via reverse transcription, exploiting the R2Br(fun) element enzymatic machinery, but rather via genomic amplification of inserted 28S by unequal recombination. That inactive copies (both R2Br(deg) or 5'-truncated elements) are not eliminated in a short term in stick insects contrasts with findings for the Drosophila R2, suggesting a widely different management of rDNA loci and a lower efficiency of the molecular drive while achieving the concerted evolution.	[Martoni, Francesco; Scavariello, Claudia; Luchetti, Andrea; Mantovani, Barbara] Univ Bologna, Dipartimento Sci Biol Geol & Ambientali, Bologna, Italy; [Eickbush, Danna G.] Univ Rochester, Dept Biol, Rochester, NY 14627 USA	University of Bologna; University of Rochester	Luchetti, A (corresponding author), Univ Bologna, Dipartimento Sci Biol Geol & Ambientali, Bologna, Italy.	andrea.luchetti@unibo.it	Martoni, Francesco/AAB-1742-2019	Martoni, Francesco/0000-0001-8064-4460; Luchetti, Andrea/0000-0002-2986-721X	RFO - University of Bologna; Canziani; National Institutes of Health [R01GM42790]	RFO - University of Bologna; Canziani; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by RFO - University of Bologna and Canziani funding to AL and BM and National Institutes of Health Grant Number R01GM42790 to DGE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arkhipova IR, 2013, CYTOGENET GENOME RES, V140, P295, DOI 10.1159/000352069; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Bibillo A, 2004, J BIOL CHEM, V279, P14945, DOI 10.1074/jbc.M310450200; Bibillo A, 2002, J BIOL CHEM, V277, P34836, DOI 10.1074/jbc.M204345200; Bonandin L, 2014, INSECT MOL BIOL, V23, P808, DOI 10.1111/imb.12126; Chenais B, 2012, GENE, V509, P7, DOI 10.1016/j.gene.2012.07.042; Christensen SM, 2006, P NATL ACAD SCI USA, V103, P17602, DOI 10.1073/pnas.0605476103; Doma MK, 2007, CELL, V131, P660, DOI 10.1016/j.cell.2007.10.041; DOVER G, 1982, NATURE, V299, P111, DOI 10.1038/299111a0; Eickbush DG, 2008, MOL CELL BIOL, V28, P6452, DOI 10.1128/MCB.01015-08; Eickbush DG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066441; Eickbush DG, 2012, MOBILE DNA-UK, V3, DOI 10.1186/1759-8753-3-10; Eickbush DG, 2010, MOL CELL BIOL, V30, P3142, DOI 10.1128/MCB.00300-10; Eickbush T.H., 2002, MOBILE DNA, P813; Eickbush TH, 2007, GENETICS, V175, P477, DOI 10.1534/genetics.107.071399; Huang CRL, 2012, ANNU REV GENET, V46, P651, DOI 10.1146/annurev-genet-110711-155616; Jamburuthugoda VK, 2014, NUCLEIC ACIDS RES, V42, P8405, DOI 10.1093/nar/gku514; Kojima KK, 2005, MOL BIOL EVOL, V22, P2157, DOI 10.1093/molbev/msi210; Kojima KK, 2004, MOL BIOL EVOL, V21, P207, DOI 10.1093/molbev/msg235; Kojima KK, 2013, REPBASE REPORTS, V13, P1215; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; LUAN DD, 1993, CELL, V72, P595, DOI 10.1016/0092-8674(93)90078-5; Luchetti A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057076; Luchetti A, 2012, GENOMICS, V100, P51, DOI 10.1016/j.ygeno.2012.04.005; Malik HS, 1999, MOL BIOL EVOL, V16, P793, DOI 10.1093/oxfordjournals.molbev.a026164; Malik HS, 2000, GENETICS, V154, P193; MANARESI S, 1991, CARYOLOGIA, V44, P265, DOI 10.1080/00087114.1991.10797192; Mantovani B, 2001, MOL PHYLOGENET EVOL, V19, P157, DOI 10.1006/mpev.2000.0850; Mingazzini V, 2011, HEREDITY, V106, P567, DOI 10.1038/hdy.2010.86; Moss WN, 2011, RNA BIOL, V8, P714, DOI 10.4161/rna.8.5.16033; Perez-Gonzalez CE, 2001, GENETICS, V158, P1557; Ruminski DJ, 2011, J BIOL CHEM, V286, P41286, DOI 10.1074/jbc.M111.297283; Stage DE, 2010, INSECT MOL BIOL, V19, P37, DOI 10.1111/j.1365-2583.2009.00949.x; Stage DE, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-r49; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; TINTI F, 1991, B ZOOL, V58, P235, DOI 10.1080/11250009109355759; Zhou J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003179; Zhou J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000386	38	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121831	10.1371/journal.pone.0121831	http://dx.doi.org/10.1371/journal.pone.0121831			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799008	Green Published, gold, Green Submitted			2022-12-26	WOS:000351987300295
J	Ning, P; Li, S; White, PJ; Li, CJ				Ning, Peng; Li, Sa; White, Philip J.; Li, Chunjian			Maize Varieties Released in Different Eras Have Similar Root Length Density Distributions in the Soil, Which Are Negatively Correlated with Local Concentrations of Soil Mineral Nitrogen	PLOS ONE			English	Article							SYSTEM ARCHITECTURE; NITRATE UPTAKE; DRY-MATTER; PLANT; PHOSPHORUS; GROWTH; WATER; ACCUMULATION; ACQUISITION; EFFICIENCY	Larger, and deeper, root systems of new maize varieties, compared to older varieties, are thought to have enabled improved acquisition of soil resources and, consequently, greater grain yields. To compare the spatial distributions of the root systems of new and old maize varieties and their relationships with spatial variations in soil concentrations of available nitrogen (N), phosphorus (P) and potassium (K), two years of field experiments were performed using six Chinese maize varieties released in different eras. Vertical distributions of roots, and available N, P and K in the 0-60 cm soil profile were determined in excavated soil monoliths at silking and maturity. The results demonstrated that new maize varieties had larger root dry weight, higher grain yield and greater nutrient accumulation than older varieties. All varieties had similar total root length and vertical root distribution at silking, but newer varieties maintained greater total root length and had more roots in the 30-60 cm soil layers at maturity. The spatial variation of soil mineral N (N-min) in each soil horizon was larger than that of Olsen-P and ammonium-acetate-extractable K, and was inversely correlated with root length density (RLD), especially in the 0-20 cm soil layer. It was concluded that greater acquisition of mineral nutrients and higher yields of newer varieties were associated with greater total root length at maturity. The negative relationship between RLD and soil Nmin at harvest for all varieties suggests the importance of the spatial distribution of the root system for N uptake by maize.	[Ning, Peng; Li, Sa; Li, Chunjian] China Agr Univ, Dept Plant Nutr, Beijing 100094, Peoples R China; [White, Philip J.] James Hutton Inst, Ecol Sci, Dundee, Scotland	China Agricultural University; James Hutton Institute	Li, CJ (corresponding author), China Agr Univ, Dept Plant Nutr, Beijing 100094, Peoples R China.	lichj@cau.edu.cn	White, Philip John/C-5860-2008	White, Philip John/0000-0003-0827-288X; Ning, Peng/0000-0002-9186-1150	State Key Basic Research and Development Plan of China [2013CB127402]; National Natural Science Foundation of China [31272232]; Chinese Universities Scientific Fund [2013YJ003]; Rural and Environment Science and Analytical Services Division (RESAS) of the Scottish Government	State Key Basic Research and Development Plan of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Universities Scientific Fund; Rural and Environment Science and Analytical Services Division (RESAS) of the Scottish Government	The research is supported by the State Key Basic Research and Development Plan of China (No. 2013CB127402), the National Natural Science Foundation of China (No. 31272232), and the Chinese Universities Scientific Fund (2013YJ003) for financial support. Work at the James Hutton Institute was supported by the Rural and Environment Science and Analytical Services Division (RESAS) of the Scottish Government through Work package 3.3 (2011-2016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adu MO, 2014, J EXP BOT, V65, P2039, DOI 10.1093/jxb/eru048; Babu RC, 2001, PLANT BREEDING, V120, P233, DOI 10.1046/j.1439-0523.2001.00578.x; Barber S. A., 1984, Soil nutrient bioavailability. A mechanistic approach.; Bohm W, 1979, METHODS STUDYING ROO, P61; Borrell A, 2001, ANN APPL BIOL, V138, P91, DOI 10.1111/j.1744-7348.2001.tb00088.x; Chapman N, 2012, TRENDS PLANT SCI, V17, P701, DOI 10.1016/j.tplants.2012.08.001; Chen XC, 2014, PLANT SOIL, V374, P121, DOI 10.1007/s11104-013-1872-0; Ciampitti IA, 2012, FIELD CROP RES, V133, P48, DOI 10.1016/j.fcr.2012.03.008; CLARKSON DT, 1988, SYM SOC EXP BIOL, V42, P281; COOPER HD, 1989, J EXP BOT, V40, P753, DOI 10.1093/jxb/40.7.753; DONALD CM, 1968, EUPHYTICA, V17, P385, DOI 10.1007/BF00056241; DREW MC, 1973, J EXP BOT, V24, P1189, DOI 10.1093/jxb/24.6.1189; Dunbabin V, 2003, PLANT CELL ENVIRON, V26, P835, DOI 10.1046/j.1365-3040.2003.01015.x; Duvick DN, 2005, ADV AGRON, V86, P83, DOI 10.1016/S0065-2113(05)86002-X; Duvick DN, 1999, CROP SCI, V39, P1622, DOI 10.2135/cropsci1999.3961622x; Echarte L, 2008, CROP SCI, V48, P656, DOI 10.2135/cropsci2007.06.0366; ENNOS AR, 1991, J EXP BOT, V42, P1607, DOI 10.1093/jxb/42.12.1607; Forde BG, 2009, PLANT CELL ENVIRON, V32, P682, DOI 10.1111/j.1365-3040.2008.01927.x; Hammer GL, 2009, CROP SCI, V49, P299, DOI 10.2135/cropsci2008.03.0152; Hinsinger P, 2001, PLANT SOIL, V237, P173, DOI 10.1023/A:1013351617532; Hodge A, 2004, NEW PHYTOL, V162, P9, DOI 10.1111/j.1469-8137.2004.01015.x; HOUBA VJG, 1986, PLANT SOIL, V96, P433, DOI 10.1007/BF02375149; Hund A, 2009, PLANT SOIL, V318, P311, DOI 10.1007/s11104-008-9843-6; IMSANDE J, 1994, PLANT PHYSIOL, V105, P3, DOI 10.1104/pp.105.1.3; Ju XT, 2009, P NATL ACAD SCI USA, V106, P3041, DOI 10.1073/pnas.0813417106; Jungk A. O., 2002, Plant roots: the hidden half, P587; Kato Y, 2006, PLANT SOIL, V287, P117, DOI 10.1007/s11104-006-9008-4; Lambers H., 2008, PLANT PHYSL ECOLOGY; [李飒 Li Sa], 2011, [植物营养与肥料学报, Plant Nutrition and Fertitizer Science], V17, P325; Linkohr BI, 2002, PLANT J, V29, P751, DOI 10.1046/j.1365-313X.2002.01251.x; LYNCH J, 1995, PLANT PHYSIOL, V109, P7, DOI 10.1104/pp.109.1.7; Lynch JP, 2013, ANN BOT-LONDON, V112, P347, DOI 10.1093/aob/mcs293; Maddonni GA, 2001, FIELD CROP RES, V71, P183, DOI 10.1016/S0378-4290(01)00158-7; Malamy JE, 2005, PLANT CELL ENVIRON, V28, P67, DOI 10.1111/j.1365-3040.2005.01306.x; Marschner H, 1996, J EXP BOT, V47, P1255, DOI 10.1093/jxb/47.Special_Issue.1255; Marschner P, 2012, MARSCHNER'S MINERAL NUTRITION OF HIGHER PLANTS, 3RD EDITION, P1; Marschner P, 2012, MARSCHNER'S MINERAL NUTRITION OF HIGHER PLANTS, 3RD EDITION, P315, DOI 10.1016/B978-0-12-384905-2.00012-1; MURPHY J, 1962, ANAL CHIM ACTA, V26, P31; NELSON DW, 1973, AGRON J, V65, P109, DOI 10.2134/agronj1973.00021962006500010033x; Neumann G, 2012, MARSCHNER'S MINERAL NUTRITION OF HIGHER PLANTS, 3RD EDITION, P347, DOI 10.1016/B978-0-12-384905-2.00014-5; Nibau C, 2008, NEW PHYTOL, V179, P595, DOI 10.1111/j.1469-8137.2008.02472.x; Ning P, 2013, FIELD CROP RES, V144, P19, DOI 10.1016/j.fcr.2013.01.020; Ning P, 2012, FIELD CROP RES, V130, P38, DOI 10.1016/j.fcr.2012.02.010; Paterson E, 2003, EUR J SOIL SCI, V54, P741, DOI 10.1046/j.1351-0754.2003.0557.x; Peng YF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037726; Peng YF, 2010, FIELD CROP RES, V115, P85, DOI 10.1016/j.fcr.2009.10.006; Postma JA, 2014, PLANT PHYSIOL, V166, P590, DOI 10.1104/pp.113.233916; ROBINSON D, 1991, PLANT CELL ENVIRON, V14, P77, DOI 10.1111/j.1365-3040.1991.tb01373.x; SOON YK, 1995, CAN J SOIL SCI, V75, P243, DOI 10.4141/cjss95-034; Sullivan WM, 2000, CROP SCI, V40, P765, DOI 10.2135/cropsci2000.403765x; Trachsel S, 2011, PLANT SOIL, V341, P75, DOI 10.1007/s11104-010-0623-8; WALKER J. M., 1962, Plant and Soil, V17, P243, DOI 10.1007/BF01376227; White P. J., 2005, Proceedings - International Fertiliser Society, P1; White PJ, 2013, ANN BOT-LONDON, V112, P207, DOI 10.1093/aob/mct123; White PJ, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00193; WHITE PJ, 1987, PLANTA, V171, P377, DOI 10.1007/BF00398683; WIESLER F, 1994, PLANT SOIL, V163, P267, DOI 10.1007/BF00007976; Yan HF, 2011, CROP SCI, V51, P265, DOI 10.2135/cropsci2010.03.0180; Yan Yun, 2010, Plant Nutrition and Fertilizer Science, V16, P257; Yu P, 2014, PHYSIOL PLANTARUM, V150, P133, DOI 10.1111/ppl.12075; Zhu JM, 2005, FUNCT PLANT BIOL, V32, P749, DOI 10.1071/FP05005	61	17	17	6	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121892	10.1371/journal.pone.0121892	http://dx.doi.org/10.1371/journal.pone.0121892			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799291	Green Published, gold, Green Submitted			2022-12-26	WOS:000351987300298
J	Sakal, F; Chochua, S; Satzke, C; Dunne, EM; Mulholland, K; Klugman, KP; Vidal, JE				Sakal, Fuminori; Chochua, Sopio; Satzke, Catherine; Dunne, Eileen M.; Mulholland, Kim; Klugman, Keith P.; Vidal, Jorge E.			Single-Plex Quantitative Assays for the Detection and Quantification of Most Pneumococcal Serotypes	PLOS ONE			English	Article							DETERMINING CAPSULAR SEROTYPES; UPPER RESPIRATORY CARRIAGE; SEQUENTIAL MULTIPLEX PCR; STREPTOCOCCUS-PNEUMONIAE; NASOPHARYNGEAL CARRIAGE; STANDARD METHOD; CHILDREN; DISEASE; IDENTIFICATION; CULTURE	Streptococcus pneumoniae globally kills more children than any other infectious disease every year. A prerequisite for pneumococcal disease and transmission is colonization of the nasopharynx. While the introduction of pneumococcal conjugate vaccines has reduced the burden of pneumococcal disease, understanding the impact of vaccination on nasopharyngeal colonization has been hampered by the lack of sensitive quantitative methods for the detection of >90 known S. pneumoniae serotypes. In this work, we developed 27 new quantitative (q) PCR reactions and optimized 26 for a total of 53 qPCR reactions targeting pneumococcal serotypes or serogroups, including all vaccine types. Reactions proved to be target-specific with a limit of detection of 2 genome equivalents per reaction. Given the number of probes required for these assays and their unknown shelf-life, the stability of cryopreserved reagents was evaluated. Our studies demonstrate that two-year cryopreserved probes had similar limit of detection as freshly-diluted probes. Moreover, efficiency and limit of detection of 1-month cryopreserved, ready-to-use, qPCR reaction mixtures were similar to those of freshly prepared mixtures. Using these reactions, our proof-of-concept studies utilizing nasopharyngeal samples (N=30) collected from young children detected samples containing >= 2 serotypes/serogroups. Samples colonized by multiple serotypes/serogroups always had a serotype that contributes at least 50% of the pneumococcal load. In addition, a molecular approach called S6-q(PCR)(2) was developed and proven to individually detect and quantify epidemiologically-important serogroup 6 strains including 6A, 6B, 6C and 6D. This technology will be useful for epidemiological studies, diagnostic platforms and to study the pneumobiome.	[Sakal, Fuminori; Chochua, Sopio; Klugman, Keith P.; Vidal, Jorge E.] Emory Univ, Rollins Sch Publ Hlth, Hubert Dept Global Hlth, Atlanta, GA 30322 USA; [Satzke, Catherine; Dunne, Eileen M.; Mulholland, Kim] Univ Melbourne, Dept Paediat, Royal Childrens Hosp, Pneumococcal Res,Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Satzke, Catherine] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Melbourne, Vic 3010, Australia; [Mulholland, Kim] London Sch Hyg & Trop Med, London WC1, England	Emory University; Rollins School Public Health; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; University of Melbourne; University of London; London School of Hygiene & Tropical Medicine	Vidal, JE (corresponding author), Emory Univ, Rollins Sch Publ Hlth, Hubert Dept Global Hlth, Atlanta, GA 30322 USA.	jvidalg@emory.edu	Satzke, Catherine/D-6501-2013; Dunne, Eileen M/M-3203-2019	Satzke, Catherine/0000-0003-3164-8849; Dunne, Eileen M/0000-0001-5542-0780	Murdoch Childrens Research Institute [26180]; Bill and Melinda Gates Foundation [52099]; Victorian Government's Operational Infrastructure Support Program	Murdoch Childrens Research Institute; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Victorian Government's Operational Infrastructure Support Program	This study was supported by a subcontract granted to JEV (#26180) by Murdoch Childrens Research Institute which received funds from the Bill and Melinda Gates Foundation (Grant 52099). Research at MCRI was also supported by the Victorian Government's Operational Infrastructure Support Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrich WC, 2012, CLIN INFECT DIS, V54, P601, DOI 10.1093/cid/cir859; Azzari C, 2012, VACCINE, V30, P2701, DOI 10.1016/j.vaccine.2011.12.008; Azzari C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009282; Carvalho MDG, 2013, PEERJ, V1, DOI 10.7717/peerj.97; Carvalho MD, 2012, J CLIN MICROBIOL, V50, P3146, DOI 10.1128/JCM.01505-12; Carvalho MD, 2010, J CLIN MICROBIOL, V48, P1611, DOI 10.1128/JCM.02243-09; Carvalho MDS, 2007, J CLIN MICROBIOL, V45, P2460, DOI 10.1128/JCM.02498-06; Chien YW, 2013, PEDIATR INFECT DIS J, V32, P72, DOI 10.1097/INF.0b013e318270d850; Dias CA, 2007, J MED MICROBIOL, V56, P1185, DOI 10.1099/jmm.0.47347-0; du Plessis M, 2008, INT J ANTIMICROB AG, V32, pS66, DOI 10.1016/j.ijantimicag.2008.06.002; Dunne EM, 2013, VACCINE, V31, P2333, DOI 10.1016/j.vaccine.2013.03.024; Ercibengoa M, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-69; Green M, 2009, TLS-TIMES LIT SUPPL, P6; HOLT LB, 1962, J GEN MICROBIOL, V27, P327, DOI 10.1099/00221287-27-2-327; Huebner RE, 2000, PEDIATR INFECT DIS J, V19, P1017, DOI 10.1097/00006454-200010000-00019; Jedrzejas MJ, 2001, MICROBIOL MOL BIOL R, V65, P187, DOI 10.1128/MMBR.65.2.187-207.2001; Jin P, 2009, J INFECT DIS, V200, P1375, DOI 10.1086/606118; Jin P, 2009, J CLIN MICROBIOL, V47, P2470, DOI 10.1128/JCM.00484-09; Klugman KP, 2008, CLIN INFECT DIS, V47, pS202, DOI 10.1086/591405; Klugman KP, 2009, ADV EXP MED BIOL, V634, P121, DOI 10.1007/978-0-387-79838-7_11; Ko KS, 2013, J CLIN MICROBIOL, V51, P3395, DOI 10.1128/JCM.01645-13; Levine OS, 2009, AM J EPIDEMIOL, V170, P1067, DOI 10.1093/aje/kwp316; Menezes APD, 2013, J CLIN MICROBIOL, V51, P2470, DOI 10.1128/JCM.00743-13; Mercado E, 2011, J CLIN MICROBIOL, V49, P2080, DOI 10.1128/JCM.00153-11; Moore CE, 2010, AM J TROP MED HYG, V83, P451, DOI 10.4269/ajtmh.2010.10-0225; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; O'Brien KL, 2003, PEDIATR INFECT DIS J, V22, P133, DOI [10.1097/00006454-200302000-00009, 10.1097/00006454-200302000-00010]; O'Brien KL, 2001, J CLIN MICROBIOL, V39, P1021, DOI 10.1128/JCM.39.3.1021-1024.2001; Oftadeh S, 2010, J CLIN MICROBIOL, V48, P3378, DOI 10.1128/JCM.00675-10; Pai R, 2006, J CLIN MICROBIOL, V44, P124, DOI 10.1128/JCM.44.1.124-131.2006; Pimenta FC, 2013, J CLIN MICROBIOL, V51, P647, DOI 10.1128/JCM.02927-12; Pimenta FC, 2009, J CLIN MICROBIOL, V47, P2353, DOI 10.1128/JCM.00704-09; Rodgers Gail L, 2011, Vaccine, V29 Suppl 3, pC43, DOI 10.1016/j.vaccine.2011.07.047; Sakai F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067147; Satzke, 2014, 9 INT S PNEUM PNEUM; Satzke C, 2013, VACCINE, V32, P165, DOI 10.1016/j.vaccine.2013.08.062; Shakl JR, 2013, TRENDS MICROBIOL, V21, P129, DOI 10.1016/j.tim.2012.11.005; Simell B, 2012, EXPERT REV VACCINES, V11, P841, DOI [10.1586/ERV.12.53, 10.1586/erv.12.53]; Staples M, 2014, DIAGN MICR INFEC DIS, V78, P307, DOI 10.1016/j.diagmicrobio.2013.11.017; Tarrago D, 2008, CLIN MICROBIOL INFEC, V14, P828, DOI 10.1111/j.1469-0691.2008.02028.x; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; Tokarz R, 2013, J CLIN MICROBIOL, V51, P995, DOI 10.1128/JCM.02974-12; Turner P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067933; Turner P, 2011, J CLIN MICROBIOL, V49, P1784, DOI 10.1128/JCM.00157-11; van der Poll T, 2009, LANCET, V374, P1543, DOI 10.1016/S0140-6736(09)61114-4; Walker CLF, 2013, LANCET, V381, P1405, DOI 10.1016/S0140-6736(13)60222-6; WU TC, 1980, J CLIN MICROBIOL, V12, P772, DOI 10.1128/JCM.12.6.772-775.1980; Wyllie AL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102045	48	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121064	10.1371/journal.pone.0121064	http://dx.doi.org/10.1371/journal.pone.0121064			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798884	gold, Green Published			2022-12-26	WOS:000351987300204
J	Lagman, D; Callado-Perez, A; Franzen, IE; Larhammar, D; Abalo, XM				Lagman, David; Callado-Perez, Amalia; Franzen, Ilkin E.; Larhammar, Dan; Abalo, Xesus M.			Transducin Duplicates in the Zebrafish Retina and Pineal Complex: Differential Specialisation after the Teleost Tetraploidisation	PLOS ONE			English	Article							EXPRESSION PATTERN; GENE-EXPRESSION; ALPHA-SUBUNITS; DANIO-RERIO; SEA LAMPREY; ROD; EVOLUTION; LIGHT; PHOTOTRANSDUCTION; PHOTORECEPTORS	Gene duplications provide raw materials that can be selected for functional adaptations by evolutionary mechanisms. We describe here the results of 350 million years of evolution of three functionally related gene families: the alpha, beta and gamma subunits of transducins, the G protein involved in vision. Early vertebrate tetraploidisations resulted in separate transducin heterotrimers: gnat1/gnb1/gngt1 for rods, and gnat2/gnb3/gngt2 for cones. The teleost- specific tetraploidisation generated additional duplicates for gnb1, gnb3 and gngt2. We report here that the duplicates have undergone several types of subfunctionalisation or neofunctionalisation in the zebrafish. We have found that gnb1a and gnb1b are co-expressed at different levels in rods; gnb3a and gnb3b have undergone compartmentalisation restricting gnb3b to the dorsal and medial retina, however, gnb3a expression was detected only at very low levels in both larvae and adult retina; gngt2b expression is restricted to the dorsal and medial retina, whereas gngt2a is expressed ventrally. This dorsoventral distinction could be an adaptation to protect the lower part of the retina from intense light damage. The ontogenetic analysis shows earlier onset of expression in the pineal complex than in the retina, in accordance with its earlier maturation. Additionally, gnb1a but not gnb1b is expressed in the pineal complex, and gnb3b and gngt2b are transiently expressed in the pineal during ontogeny, thus showing partial temporal subfunctionalisation. These retina-pineal distinctions presumably reflect their distinct functional roles in vision and circadian rhythmicity. In summary, this study describes several functional differences between transducin gene duplicates resulting from the teleost-specific tetraploidisation.	[Lagman, David; Callado-Perez, Amalia; Franzen, Ilkin E.; Larhammar, Dan; Abalo, Xesus M.] Uppsala Univ, Sci Life Lab, Dept Neurosci, Uppsala, Sweden	Uppsala University	Abalo, XM (corresponding author), Uppsala Univ, Sci Life Lab, Dept Neurosci, Uppsala, Sweden.	xesus.abalo@neuro.uu.se	Abalo, Xesus/AAU-6900-2021	Abalo, Xesus/0000-0002-1643-0705	Swedish Research Council [621-2012-4521]; Carl Tryggers Foundation; Olle Engkvist Byggastare Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Carl Tryggers Foundation; Olle Engkvist Byggastare Foundation	This work was supported by the Swedish Research Council Grant to DLar: 621-2012-4521, the Carl Tryggers Foundation Grant to D. Larhammar, and the Olle Engkvist Byggastare Foundation Grant to XA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015063; Allwardt BA, 2001, J NEUROCYTOL, V30, P493, DOI 10.1023/A:1015689116620; [Anonymous], 1992, MICROSC RES TECHNIQ; Blackshaw S, 1997, J NEUROSCI, V17, P8074; BRANCHEK T, 1984, J COMP NEUROL, V224, P107, DOI 10.1002/cne.902240109; Brockerhoff SE, 2003, J NEUROSCI, V23, P470, DOI 10.1523/JNEUROSCI.23-02-00470.2003; Chen H, 2007, GENE EXPR PATTERNS, V7, P574, DOI 10.1016/j.modgep.2007.01.003; Fadool JM, 2008, PROG RETIN EYE RES, V27, P89, DOI 10.1016/j.preteyeres.2007.08.002; Falcon J, 2009, ANN NY ACAD SCI, V1163, P101, DOI 10.1111/j.1749-6632.2009.04435.x; Fleisch VC, 2008, J NEUROSCI, V28, P8208, DOI 10.1523/JNEUROSCI.2367-08.2008; Force A, 1999, GENETICS, V151, P1531; Forsell J, 1997, INT J DEV BIOL, V41, P591; Forsell J, 2001, J EXP BIOL, V204, P2517; Gamse JT, 2003, DEVELOPMENT, V130, P1059, DOI 10.1242/dev.00270; Gamse JT, 2002, NAT GENET, V30, P117, DOI 10.1038/ng793; Hauptmann G, 2000, METH MOL B, V137, P139; Hauptmann G, 2001, METHODS, V23, P359, DOI 10.1006/meth.2000.1148; Huang LQ, 2003, J COMP NEUROL, V455, P1, DOI 10.1002/cne.10396; Imanishi Y, 2004, J MOL EVOL, V59, P204, DOI 10.1007/s00239-004-2614-y; Imanishi Y, 2002, EUR J NEUROSCI, V15, P63, DOI 10.1046/j.0953-816x.2001.01835.x; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; Kojima D, 2008, PHOTOCHEM PHOTOBIOL, V84, P1011, DOI 10.1111/j.1751-1097.2008.00363.x; Lagman D, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-238; Lagman D, 2012, GENOMICS, V100, P203, DOI 10.1016/j.ygeno.2012.07.005; Lamb TD, 2013, PROG RETIN EYE RES, V36, P52, DOI 10.1016/j.preteyeres.2013.06.001; Larhammar D, 2009, PHILOS T R SOC B, V364, P2867, DOI 10.1098/rstb.2009.0077; LEREA CL, 1986, SCIENCE, V234, P77, DOI 10.1126/science.3529395; Li L, 1998, VISUAL NEUROSCI, V15, P851, DOI 10.1017/S0952523898155050; Li XL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040508; Liu Q, 2007, EXP EYE RES, V84, P163, DOI 10.1016/j.exer.2006.09.011; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Lynch M, 2000, GENETICS, V154, P459; Mano H, 1999, MOL BRAIN RES, V73, P110, DOI 10.1016/S0169-328X(99)00242-9; Marc RE, 2001, J NEUROCYTOL, V30, P593, DOI 10.1023/A:1016516818393; Melendez-Ferro M, 2002, J COMP NEUROL, V442, P250, DOI 10.1002/cne.10090; Mulligan T, 2010, CELL SIGNAL, V22, P221, DOI 10.1016/j.cellsig.2009.09.017; Nakatani Y, 2007, GENOME RES, V17, P1254, DOI 10.1101/gr.6316407; NEGISHI K, 1995, DEV BRAIN RES, V89, P87, DOI 10.1016/0165-3806(95)00126-X; Nelson RF, 2009, VISUAL NEUROSCI, V26, P349, DOI 10.1017/S0952523809990113; Nelson SM, 2008, DEV DYNAM, V237, P2903, DOI 10.1002/dvdy.21721; Nelson SM, 2009, DEV BIOL, V328, P24, DOI 10.1016/j.ydbio.2008.12.040; Nikonov SS, 2013, J NEUROSCI, V33, P5182, DOI 10.1523/JNEUROSCI.5204-12.2013; Nordstrom K, 2004, GENOMICS, V83, P852, DOI 10.1016/j.ygeno.2003.11.008; PENG YW, 1992, P NATL ACAD SCI USA, V89, P10882, DOI 10.1073/pnas.89.22.10882; Pichaud F, 2002, CURR OPIN GENET DEV, V12, P430, DOI 10.1016/S0959-437X(02)00321-0; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; Ratscho N, 2009, BBA-MOL CELL RES, V1793, P1110, DOI 10.1016/j.bbamcr.2008.12.021; Randlett O, 2011, DEV NEUROBIOL, V71, P567, DOI 10.1002/dneu.20841; Rauch GJ, 2003, ZFIN DIRECT DATA SUB; Raymond PA, 2004, INT J DEV BIOL, V48, P935, DOI 10.1387/ijdb.041873pr; RAYMOND PA, 1995, J COMP NEUROL, V359, P537, DOI 10.1002/cne.903590403; Renninger SL, 2011, EUR J NEUROSCI, V33, P658, DOI 10.1111/j.1460-9568.2010.07574.x; Rinner O, 2005, NEURON, V47, P231, DOI 10.1016/j.neuron.2005.06.010; Ritchey ER, 2010, NEUROSCIENCE, V169, P1376, DOI 10.1016/j.neuroscience.2010.05.081; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Schilling TF, 2007, J EXP ZOOL PART B, V308B, P515, DOI 10.1002/jez.b.21191; Schmitt EA, 1999, J COMP NEUROL, V404, P515; Segner H, 2003, ECOTOX ENVIRON SAFE, V54, P302, DOI 10.1016/S0147-6513(02)00039-8; Shen YC, 2004, DEV BIOL, V269, P237, DOI 10.1016/j.ydbio.2004.01.037; Smyth VA, 2008, J BIOL CHEM, V283, P10881, DOI 10.1074/jbc.M710454200; Takechi M, 2005, J EXP BIOL, V208, P1337, DOI 10.1242/jeb.01532; TAMOTSU S, 1994, CELL TISSUE RES, V278, P1; Thisse B, 2004, ZFIN DIRECT DATA SUB; Thomas JL, 2012, EXP EYE RES, V97, P105, DOI 10.1016/j.exer.2012.02.004; Tsujikawa M, 2004, INT J DEV BIOL, V48, P925, DOI 10.1387/ijdb.041890mt; Tsujimura T, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001245; VANVEEN T, 1984, CELL TISSUE RES, V237, P559, DOI 10.1007/BF00228440; VIGHTEICHMANN I, 1992, PROG BRAIN RES, V91, P307; Vihtelic TS, 2006, EXP EYE RES, V82, P558, DOI 10.1016/j.exer.2005.08.015; Villar-Cervino V, 2006, J COMP NEUROL, V499, P810, DOI 10.1002/cne.21136; Wada Y, 2006, J NEUROCHEM, V98, P824, DOI 10.1111/j.1471-4159.2006.03920.x; Xu H, 2012, DEVELOPMENT, V139, P57, DOI 10.1242/dev.073924	72	24	24	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0121330	10.1371/journal.pone.0121330	http://dx.doi.org/10.1371/journal.pone.0121330			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25806532	Green Published, Green Submitted, gold			2022-12-26	WOS:000351880000147
J	Benini, A; Cignarella, F; Calvarini, L; Mantovanelli, S; Giacopuzzi, E; Zizioli, D; Borsani, G				Benini, Anna; Cignarella, Francesca; Calvarini, Laura; Mantovanelli, Silvia; Giacopuzzi, Edoardo; Zizioli, Daniela; Borsani, Giuseppe			slc7a6os Gene Plays a Critical Role in Defined Areas of the Developing CNS in Zebrafish	PLOS ONE			English	Article							LATERAL-LINE; EXPRESSION; MIDBRAIN; IDENTIFICATION; PREDICTION; ALIGNMENT; SYNTENY; SYSTEM; MODEL; LEF1	The aim of this study is to shed light on the functional role of slc7a6os, a gene highly conserved in vertebrates. The Danio rerio slc7a6os gene encodes a protein of 326 amino acids with 46% identity to human SLC7A6OS and 14% to Saccharomyces cerevisiae polypeptide Iwr1. Yeast Iwr1 specifically binds RNA pol II, interacts with the basal transcription machinery and regulates the transcription of specific genes. In this study we investigated for the first time the biological role of SLC7A6OS in vertebrates. Zebrafish slc7a6os is a maternal gene that is expressed throughout development, with a prevalent localization in the developing central nervous system (CNS). The gene is also expressed, although at different levels, in various tissues of the adult fish. To determine the functional role of slc7a6os during zebrafish development, we knocked-down the gene by injecting a splice-blocking morpholino. At 24 hpf morphants show morphological defects in the CNS, particularly the interface between hindbrain and midbrain is not well-defined. At 28 hpf the morpholino injected embryos present an altered somite morphology and appear partially or completely immotile. At this stage the midbrain, hindbrain and cerebellum are compromised and not well defined compared with control embryos. The observed alterations persist at later developmental stages. Consistently, the expression pattern of two markers specifically expressed in the developing CNS, pax2a and neurod, is significantly altered in morphants. The co-injection of embryos with synthetic slc7a6os mRNA, rescues the morphant phenotype and restores the wild type expression pattern of pax2a and neurod. Our data suggest that slc7a6os might play a critical role in defined areas of the developing CNS in vertebrates, probably by regulating the expression of key genes.	[Benini, Anna; Cignarella, Francesca; Calvarini, Laura; Mantovanelli, Silvia; Giacopuzzi, Edoardo; Zizioli, Daniela; Borsani, Giuseppe] Univ Brescia, Dept Mol & Translat Med, I-25123 Brescia, Italy	University of Brescia	Borsani, G (corresponding author), Univ Brescia, Dept Mol & Translat Med, Viale Europa 11, I-25123 Brescia, Italy.	giuseppe.borsani@unibs.it	Borsani, Giuseppe/B-1709-2010	Borsani, Giuseppe/0000-0003-0110-1148; Giacopuzzi, Edoardo/0000-0002-5692-366X; Cignarella, Francesca/0000-0003-0342-5699	Fondazione Cariplo "ZebraGene" Grant	Fondazione Cariplo "ZebraGene" Grant	This work was supported by the Fondazione Cariplo "ZebraGene" Grant to G.B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Benini A, 2013, INT J DEV BIOL, V57, P85, DOI 10.1387/ijdb.120033gb; Boulon S, 2010, MOL CELL, V39, P912, DOI 10.1016/j.molcel.2010.08.023; Catchen JM, 2009, GENOME RES, V19, P1497, DOI 10.1101/gr.090480.108; Cramer P, 2008, ANNU REV BIOPHYS, V37, P337, DOI 10.1146/annurev.biophys.37.032807.130008; Czeko E, 2011, MOL CELL, V42, P261, DOI 10.1016/j.molcel.2011.02.033; Dambly-Chaudiere C, 2003, BIOL CELL, V95, P579, DOI 10.1016/j.biolcel.2003.10.005; Tommaso P, 2011, NUCLEIC ACIDS RES, V39, pW13, DOI 10.1093/nar/gkr245; Esberg A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020829; Gamba L, 2010, DEV DYNAM, V239, P3163, DOI 10.1002/dvdy.22469; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; He XJ, 2009, GENE DEV, V23, P2717, DOI 10.1101/gad.1851809; Hill AJ, 2004, TOXICOL SCI, V78, P78, DOI 10.1093/toxsci/kfh056; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Korzh V, 1998, DEV DYNAM, V213, P92, DOI 10.1002/(SICI)1097-0177(199809)213:1<92::AID-AJA9>3.0.CO;2-T; Kosugi S, 2009, P NATL ACAD SCI USA, V106, P10171, DOI 10.1073/pnas.0900604106; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; Lekven AC, 2003, DEV BIOL, V254, P172, DOI 10.1016/S0012-1606(02)00044-1; Liu AM, 2001, ANNU REV NEUROSCI, V24, P869, DOI 10.1146/annurev.neuro.24.1.869; Lush ME, 2014, ELIFE, V3, DOI 10.7554/eLife.01832; MARCK C, 1988, NUCLEIC ACIDS RES, V16, P1829, DOI 10.1093/nar/16.5.1829; McGraw HF, 2011, DEVELOPMENT, V138, P3921, DOI 10.1242/dev.062554; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; Mueller T, 2002, BRAIN RES BULL, V57, P377, DOI 10.1016/S0361-9230(01)00694-3; Muffato M, 2010, BIOINFORMATICS, V26, P1119, DOI 10.1093/bioinformatics/btq079; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Pauli A, 2012, GENOME RES, V22, P577, DOI 10.1101/gr.133009.111; Peiro-Chova L, 2009, J BIOL CHEM, V284, P28958, DOI 10.1074/jbc.M109.012153; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Picker A, 2002, DEVELOPMENT, V129, P3227; Rhinn M, 2001, CURR OPIN NEUROBIOL, V11, P34, DOI 10.1016/S0959-4388(00)00171-9; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Sato A, 2013, J NEUROSCI, V33, P556, DOI 10.1523/JNEUROSCI.4568-12.2013; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Westerfield M, 1993, ZEBRAFISH BOOK; Wild T, 2012, TRENDS BIOCHEM SCI, V37, P99, DOI 10.1016/j.tibs.2011.12.001	39	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0119696	10.1371/journal.pone.0119696	http://dx.doi.org/10.1371/journal.pone.0119696			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803583	Green Published, gold, Green Submitted			2022-12-26	WOS:000353889600037
J	Gunther, L; Beck, R; Xiong, GM; Potschka, H; Jahn, K; Bartenstein, P; Brandt, T; Dutia, M; Dieterich, M; Strupp, M; la Fougere, C; Zwergal, A				Guenther, Lisa; Beck, Roswitha; Xiong, Guoming; Potschka, Heidrun; Jahn, Klaus; Bartenstein, Peter; Brandt, Thomas; Dutia, Mayank; Dieterich, Marianne; Strupp, Michael; la Fougere, Christian; Zwergal, Andreas			N-Acetyl-L-Leucine Accelerates Vestibular Compensation after Unilateral Labyrinthectomy by Action in the Cerebellum and Thalamus	PLOS ONE			English	Article							DL-LEUCINE; NUCLEUS NEURONS; EXPRESSION; PLASTICITY; FLOCCULUS; RECOVERY; SYSTEM; BRAIN; MICE	An acute unilateral vestibular lesion leads to a vestibular tone imbalance with nystagmus, head roll tilt and postural imbalance. These deficits gradually decrease over days to weeks due to central vestibular compensation (VC). This study investigated the effects of i.v. N-acetyl-DL-leucine, N-acetyl-L-leucine and N-acetyl-D-leucine on VC using behavioural testing and serial [18F]-Fluoro-desoxyglucose ([18F]-FDG)-mu PET in a rat model of unilateral chemical labyrinthectomy (UL). Vestibular behavioural testing included measurements of nystagmus, head roll tilt and postural imbalance as well as sequential whole-brain [18F]FDG-mu PET was done before and on days 1,3,7 and 15 after UL. A significant reduction of postural imbalance scores was identified on day 7 in the N-acetyl-DL-leucine (p < 0.03) and the N-acetyl-L-leucine groups (p < 0.01), compared to the sham treatment group, but not in the N-acetyl-D-leucine group (comparison for applied dose of 24 mg i.v. per rat, equivalent to 60 mg/kg body weight, in each group). The course of postural compensation in the DL-and L-group was accelerated by about 6 days relative to controls. The effect of N-acetyl-L-leucine on postural compensation depended on the dose: in contrast to 60 mg/kg, doses of 15 mg/kg and 3.75 mg/kg had no significant effect. N-acetyl-L-leucine did not change the compensation of nystagmus or head roll tilt at any dose. Measurements of the regional cerebral glucose metabolism (rCGM) by means of mu PET revealed that only N-acetyl-L-leucine but not N-acetyl-D-leucine caused a significant increase of rCGM in the vestibulocerebellum and a decrease in the posterolateral thalamus and subthalamic region on days 3 and 7. A similar pattern was found when comparing the effect of N-acetyl-L-leucine on rCGM in an UL-group and a sham UL-group without vestibular damage. In conclusion, N-acetyl-L-leucine improves compensation of postural symptoms after UL in a dose-dependent and specific manner, most likely by activating the vestibulocerebellum and deactivating the posterolateral thalamus.	[Guenther, Lisa; Beck, Roswitha; Xiong, Guoming; Potschka, Heidrun; Jahn, Klaus; Bartenstein, Peter; Brandt, Thomas; Dieterich, Marianne; Strupp, Michael; la Fougere, Christian; Zwergal, Andreas] Univ Munich, DSGZ, German Ctr Vertigo & Balance Disorders, Munich, Germany; [Potschka, Heidrun] Univ Munich, Inst Pharmacol Toxicol & Pharm, Munich, Germany; [Jahn, Klaus; Dieterich, Marianne; Strupp, Michael; Zwergal, Andreas] Univ Munich, Dept Neurol, D-80539 Munich, Germany; [Bartenstein, Peter; la Fougere, Christian] Univ Munich, Dept Nucl Med, Munich, Germany; [Brandt, Thomas] Univ Munich, Clin Neurosci, Munich, Germany; [Dutia, Mayank] Univ Edinburgh, Ctr Integrat Physiol, Edinburgh, Midlothian, Scotland; [la Fougere, Christian] Univ Tubingen, Dept Nucl Med, Tubingen, Germany	University of Munich; University of Munich; University of Munich; University of Munich; University of Munich; University of Edinburgh; Eberhard Karls University of Tubingen	Zwergal, A (corresponding author), Univ Munich, DSGZ, German Ctr Vertigo & Balance Disorders, Munich, Germany.	andreas.zwergal@med.uni-muenchen.de	la Fougere, Christian/G-6514-2012; Jahn, Klaus/F-9902-2010; la Fougère, Christian/AAN-2811-2021; Jahn, Klaus/AAC-4969-2021	Jahn, Klaus/0000-0002-1669-3652; la Fougère, Christian/0000-0001-7519-0417; Potschka, Heidrun/0000-0003-1506-0252	German Federal Ministry of Education and Research [01 EO 0901]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This project was supported by the German Federal Ministry of Education and Research (grant number 01 EO 0901; funding volume: 730.000 (sic); funding initiative Integrated Center for Research and Treatment of Vertigo, Balance and Ocular Motor Disorders, University of Munich) and Pierre Fabre Laboratories (consumables, pharmaceuticals, chemicals, animal costs; funding volume 40.000 (sic)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleisa M, 2007, J OTOLARYNGOL, V36, P315, DOI 10.2310/7070.2007.0050; Becker-Bense S, 2013, NEUROLOGY, V80, P1103, DOI 10.1212/WNL.0b013e31828868a6; Bense S, 2004, ANN NEUROL, V56, P624, DOI 10.1002/ana.20244; Beraneck M, 2008, J NEUROPHYSIOL, V100, P945, DOI 10.1152/jn.90319.2008; Bergquist F, 2008, J PHYSIOL-LONDON, V586, P4441, DOI 10.1113/jphysiol.2008.155291; Borsook D, 2011, EXPERT OPIN DRUG DIS, V6, P597, DOI 10.1517/17460441.2011.584529; Boyden ES, 2004, ANNU REV NEUROSCI, V27, P581, DOI 10.1146/annurev.neuro.27.070203.144238; Brandt T, 2000, J NEUROL, V247, P491, DOI 10.1007/s004150070146; Cameron SA, 1999, J PHYSIOL-LONDON, V518, P151, DOI 10.1111/j.1469-7793.1999.0151r.x; Curthoys I S, 1995, J Vestib Res, V5, P67, DOI 10.1016/0957-4271(94)00026-X; Darlington CL, 2002, EUR J NEUROSCI, V15, P1719, DOI 10.1046/j.1460-9568.2002.02024.x; Dutia MB, 2010, CURR OPIN OTOLARYNGO, V18, P420, DOI 10.1097/MOO.0b013e32833de71f; Eulenburg PZ, 2010, ANN NEUROL, V68, P241, DOI 10.1002/ana.22063; Ferber-Viart C, 2009, AUDIOL NEURO-OTOL, V14, P17, DOI 10.1159/000148206; Goto MM, 1997, J NEUROSCI, V17, P4367; Hong SM, 2009, NEUROSCI LETT, V460, P52, DOI 10.1016/j.neulet.2009.05.017; Hull J, 2012, J NEUROCHEM, V123, P997, DOI 10.1111/jnc.12044; Johnston AR, 2002, J PHYSIOL-LONDON, V545, P903, DOI 10.1113/jphysiol.2002.024281; Kitahara T, 1997, NEUROSCIENCE, V76, P571, DOI 10.1016/S0306-4522(96)00374-0; Kitahara T, 1998, MOL BRAIN RES, V61, P170, DOI 10.1016/S0169-328X(98)00228-9; Lacour M, 1995, THESIS PIERRE FABRE; LEAU O, 1957, CR SOC BIOL, V151, P1365; LEGER A, 1985, MED ARMEES, V13, P269; Malinvaud D, 2010, J NEUROSCI, V30, P3310, DOI 10.1523/JNEUROSCI.5318-09.2010; Meng H, 2007, J NEUROSCI, V27, P13590, DOI 10.1523/JNEUROSCI.3931-07.2007; Murai N, 2004, EUR ARCH OTO-RHINO-L, V261, P82, DOI 10.1007/s00405-003-0644-5; PRECHT W, 1966, J NEUROPHYSIOL, V29, P996, DOI 10.1152/jn.1966.29.6.996; Straka H, 2005, PROG NEUROBIOL, V76, P349, DOI 10.1016/j.pneurobio.2005.10.002; Strupp M, 2013, J NEUROL, V260, P2556, DOI 10.1007/s00415-013-7016-x; Sweatt AJ, 2004, J COMP NEUROL, V477, P360, DOI 10.1002/cne.20200; Vibert N, 2001, EUR J NEUROSCI, V13, P735, DOI 10.1046/j.0953-816x.2000.01447.x; Yennawar NH, 2002, BIOCHEMISTRY-US, V41, P11592, DOI 10.1021/bi020221c; Zwergal A., 2014, BRAIN STRUCT FUNCT	33	34	39	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0120891	10.1371/journal.pone.0120891	http://dx.doi.org/10.1371/journal.pone.0120891			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803613	gold, Green Published, Green Submitted			2022-12-26	WOS:000353889600107
J	Le Vee, M; Jouan, E; Stieger, B; Lecureur, V; Fardel, O				Le Vee, Marc; Jouan, Elodie; Stieger, Bruno; Lecureur, Valerie; Fardel, Olivier			Regulation of Human Hepatic Drug Transporter Activity and Expression by Diesel Exhaust Particle Extract	PLOS ONE			English	Article							ARYL-HYDROCARBON RECEPTOR; MULTIDRUG-RESISTANCE; OXIDATIVE STRESS; ORGANIC EXTRACT; GENE-EXPRESSION; UP-REGULATION; BILIARY-EXCRETION; RAT HEPATOCYTES; CANCER-CELLS; AH-RECEPTOR	Diesel exhaust particles (DEPs) are common environmental air pollutants primarily affecting the lung. DEPs or chemicals adsorbed on DEPs also exert extra-pulmonary effects, including alteration of hepatic drug detoxifying enzyme expression. The present study was designed to determine whether organic DEP extract (DEPe) may target hepatic drug transporters that contribute in a major way to drug detoxification. Using primary human hepatocytes and transporter-overexpressing cells, DEPe was first shown to strongly inhibit activities of the sinusoidal solute carrier (SLC) uptake transporters organic anion-transporting polypeptides (OATP) 1B1, 1B3 and 2B1 and of the canalicular ATP-binding cassette (ABC) efflux pump multidrug resistance-associated protein 2, with IC50 values ranging from approximately 1 to 20 mu g/mL and relevant to environmental exposure situations. By contrast, 25 mu g/mL DEPe failed to alter activities of the SLC transporter organic cation transporter (OCT) 1 and of the ABC efflux pumps P-glycoprotein and bile salt export pump (BSEP), whereas it only moderately inhibited those of sodium taurocholate co-transporting polypeptide and of breast cancer resistance protein (BCRP). Treatment by 25 mu g/mL DEPe was next demonstrated to induce expression of BCRP at both mRNA and protein level in cultured human hepatic cells, whereas it concomitantly repressed mRNA expression of various transporters, including OATP1B3, OATP2B1, OCT1 and BSEP. Such changes in transporter expression were found to be highly correlated to those caused by 2,3,7,8-tetrachlorodi-benzo-p-dioxin (TCDD), a reference activator of the aryl hydrocarbon receptor (AhR) pathway. This suggests that DEPe, which is enriched in known ligands of AhR like polycyclic aromatic hydrocarbons, alters drug transporter expression via activation of the AhR cascade. Taken together, these data established human hepatic transporters as targets of organic chemicals containing in DEPs, which may contribute to their systemic effects through impairing hepatic transport of endogenous compound or drug substrates of these transporters.	[Le Vee, Marc; Jouan, Elodie; Lecureur, Valerie; Fardel, Olivier] Fac Pharm, IRSET, UMR INSERM U1085, F-35043 Rennes, France; [Stieger, Bruno] Univ Zurich Hosp, Dept Clin Pharmacol & Toxicol, CH-8091 Zurich, Switzerland; [Fardel, Olivier] Ctr Hosp Univ, Pole Biol, F-35033 Rennes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; University of Zurich; University Zurich Hospital; CHU Rennes	Fardel, O (corresponding author), Fac Pharm, IRSET, UMR INSERM U1085, 2 Ave Pr Leon Bernard, F-35043 Rennes, France.	olivier.fardel@univ-rennes1.fr	LECUREUR, Valérie/J-9095-2015; Fardel, Olivier/J-8560-2015; Stieger, Bruno/U-6323-2017; Le Vee, Marc/U-8843-2019; LE VÉE, Marc/AAP-6961-2020	Stieger, Bruno/0000-0002-7190-5785; 				Annaert PP, 2001, DRUG METAB DISPOS, V29, P1277; Antherieu S, 2012, TOXICOL IN VITRO, V26, P1278, DOI 10.1016/j.tiv.2012.05.008; Anwer MS, 2014, PFLUG ARCH EUR J PHY, V466, P77, DOI 10.1007/s00424-013-1367-0; Bellamy WT, 1996, ANNU REV PHARMACOL, V36, P161, DOI 10.1146/annurev.pa.36.040196.001113; Bock KW, 2009, BIOL CHEM, V390, P1225, DOI 10.1515/BC.2009.138; Bosquillon C, 2010, J PHARM SCI-US, V99, P2240, DOI 10.1002/jps.21995; Boxberger KH, 2014, DRUG METAB DISPOS, V42, P990, DOI 10.1124/dmd.113.055095; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bronger H, 2005, CANCER RES, V65, P11419, DOI 10.1158/0008-5472.CAN-05-1271; Chuang HC, 2013, TOXICOL APPL PHARM, V266, P329, DOI 10.1016/j.taap.2012.12.004; De Bruyn T, 2013, MOL PHARMACOL, V83, P1257, DOI 10.1124/mol.112.084152; De Bruyn T, 2011, J PHARM SCI-US, V100, P5018, DOI 10.1002/jps.22694; Doring B, 2014, DRUG METAB REV, V46, P261, DOI 10.3109/03602532.2014.882353; DRENOU B, 1993, LEUKEMIA RES, V17, P1031, DOI 10.1016/0145-2126(93)90159-I; Ebert B, 2005, CARCINOGENESIS, V26, P1754, DOI 10.1093/carcin/bgi139; Fardel O, 1996, BIOCHEM PHARMACOL, V51, P1427, DOI 10.1016/0006-2952(96)00081-0; FARDEL O, 1993, CARCINOGENESIS, V14, P781, DOI 10.1093/carcin/14.4.781; Fardel O, 2012, EXPERT OPIN DRUG MET, V8, P29, DOI 10.1517/17425255.2012.637918; Fardel O, 2009, EXPERT OPIN DRUG MET, V5, P1469, DOI 10.1517/17425250903304056; Fenner KS, 2012, XENOBIOTICA, V42, P28, DOI 10.3109/00498254.2011.626464; Funk C, 2008, EXPERT OPIN DRUG MET, V4, P363, DOI [10.1517/17425255.4.4.363, 10.1517/17425255.4.4.363 ]; Gerde P, 2001, CARCINOGENESIS, V22, P741, DOI 10.1093/carcin/22.5.741; Gouge B, 2010, ENVIRON SCI TECHNOL, V44, P7163, DOI 10.1021/es101391r; Gripon P, 2002, P NATL ACAD SCI USA, V99, P15655, DOI 10.1073/pnas.232137699; Gui C, 2008, EUR J PHARMACOL, V584, P57, DOI 10.1016/j.ejphar.2008.01.042; Hartz AMS, 2008, FASEB J, V22, P2723, DOI 10.1096/fj.08-106997; Hatanaka N, 2001, CARCINOGENESIS, V22, P2033, DOI 10.1093/carcin/22.12.2033; Hessel S, 2013, ARCH TOXICOL, V87, P269, DOI 10.1007/s00204-012-0917-0; Hesterberg TW, 2012, INHAL TOXICOL, V24, P1, DOI 10.3109/08958378.2012.691913; Hooijberg JH, 2004, NUCLEOS NUCLEOT NUCL, V23, P1451, DOI 10.1081/NCN-200027672; Huber RD, 2007, AM J PHYSIOL-CELL PH, V292, pC795, DOI 10.1152/ajpcell.00597.2005; Hughes TJ, 1997, MUTAT RES-GEN TOX EN, V391, P243, DOI 10.1016/S1383-5718(97)00075-2; Izumi S, 2013, DRUG METAB DISPOS, V41, P1859, DOI 10.1124/dmd.113.052290; Jacob A, 2011, FLUIDS BARRIERS CNS, V8, DOI 10.1186/2045-8118-8-23; Jigorel E, 2005, DRUG METAB DISPOS, V33, P1418, DOI 10.1124/dmd.105.004762; Jigorel E, 2006, DRUG METAB DISPOS, V34, P1756, DOI 10.1124/dmd.106.010033; Keppler D, 1999, FREE RADICAL BIO MED, V27, P985, DOI 10.1016/S0891-5849(99)00171-9; Konig J, 2011, HANDB EXP PHARMACOL, V201, P1, DOI 10.1007/978-3-642-14541-4_1; Koike E, 2002, TOXICOL SCI, V67, P241, DOI 10.1093/toxsci/67.2.241; Kroon LA, 2007, AM J HEALTH-SYST PH, V64, P1917, DOI 10.2146/ajhp060414; Landvik NE, 2007, TOXICOLOGY, V231, P159, DOI 10.1016/j.tox.2006.12.009; Le Vee M, 2008, DRUG METAB DISPOS, V36, P217, DOI 10.1124/dmd.107.016907; Le Vee M, 2013, TOXICOL IN VITRO, V27, P1979, DOI 10.1016/j.tiv.2013.07.003; Le Vee M, 2010, TOXICOL IN VITRO, V24, P1775, DOI 10.1016/j.tiv.2010.07.001; Le Vee M, 2009, DRUG METAB DISPOS, V37, P2228, DOI 10.1124/dmd.109.028035; Le Vee M, 2009, DRUG METAB DISPOS, V37, P685, DOI 10.1124/dmd.108.023630; Li N, 2003, CLIN IMMUNOL, V109, P250, DOI 10.1016/j.clim.2003.08.006; Li Ying-Ji, 2010, Inflammation & Allergy Drug Targets, V9, P300; Liu XR, 1999, AM J PHYSIOL-GASTR L, V277, pG12, DOI 10.1152/ajpgi.1999.277.1.G12; Meek MD, 1998, ENVIRON RES, V79, P114, DOI 10.1006/enrs.1998.3870; Miller MR, 2013, PART FIBRE TOXICOL, V10, DOI 10.1186/1743-8977-10-61; Misaki K, 2007, ENVIRON TOXICOL CHEM, V26, P1370, DOI 10.1897/06-465R.1; Moreau A, 2011, FUND CLIN PHARMACOL, V25, P743, DOI 10.1111/j.1472-8206.2010.00913.x; Morjani H, 2001, INT J CANCER, V94, P157, DOI 10.1002/ijc.1449; National Institute of Standards & Technology, 2008, CERT AN STAND RES MA; Nejad SH, 2015, J APPL TOXICOL, V35, P41, DOI 10.1002/jat.2985; Nemmar A, 2004, TOXICOL LETT, V149, P243, DOI 10.1016/j.toxlet.2003.12.061; Oh SM, 2008, ARCH PHARM RES, V31, P75, DOI 10.1007/s12272-008-1123-8; Olsavsky KM, 2007, TOXICOL APPL PHARM, V222, P42, DOI 10.1016/j.taap.2007.03.032; Pan WC, 2009, TOXICOL LETT, V185, P116, DOI 10.1016/j.toxlet.2008.12.007; Payen L, 2000, BIOCHEM PHARMACOL, V60, P1967, DOI 10.1016/S0006-2952(00)00496-2; Payen L, 1999, BIOCHEM BIOPH RES CO, V258, P513, DOI 10.1006/bbrc.1999.0671; Pedersen JM, 2008, J MED CHEM, V51, P3275, DOI 10.1021/jm7015683; Potschka H, 2003, J PHARMACOL EXP THER, V306, P124, DOI 10.1124/jpet.103.049858; Rabindran SK, 2000, CANCER RES, V60, P47; Rahi MM, 2009, EUR J PHARM SCI, V37, P588, DOI 10.1016/j.ejps.2009.05.005; Riedl M, 2005, J ALLERGY CLIN IMMUN, V115, P221, DOI 10.1016/j.jaci.2004.11.047; Romero-Calvo I, 2010, ANAL BIOCHEM, V401, P318, DOI 10.1016/j.ab.2010.02.036; Santos KT, 2014, ARCH TOXICOL, V88, P1589, DOI 10.1007/s00204-014-1212-z; Shvedova AA, 2013, J TOXICOL ENV HEAL A, V76, P907, DOI 10.1080/15287394.2013.825217; Sugihara N, 2006, TOXICOLOGY, V223, P156, DOI 10.1016/j.tox.2006.03.011; Sydbom A, 2001, EUR RESPIR J, V17, P733, DOI 10.1183/09031936.01.17407330; Takano H, 2002, ARCH TOXICOL, V76, P146, DOI 10.1007/s00204-002-0323-0; TEEPE AG, 1992, ENVIRON MOL MUTAGEN, V20, P134, DOI 10.1002/em.2850200209; Tompkins LM, 2010, BIOCHEM PHARMACOL, V80, P1754, DOI 10.1016/j.bcp.2010.08.016; Tornqvist H, 2007, AM J RESP CRIT CARE, V176, P395, DOI 10.1164/rccm.200606-872OC; Totlandsdal AI, 2012, TOXICOL LETT, V208, P262, DOI 10.1016/j.toxlet.2011.10.025; Tournier N, 2010, INT J NEUROPSYCHOPH, V13, P905, DOI 10.1017/S1461145709990848; Wang XQ, 2011, FASEB J, V25, P644, DOI 10.1096/fj.10-169227; Washio I, 2011, DRUG METAB DISPOS, V39, P1, DOI 10.1124/dmd.110.034504; Wichmann HE, 2007, INHAL TOXICOL, V19, P241, DOI 10.1080/08958370701498075; Xu YY, 2013, PART FIBRE TOXICOL, V10, DOI 10.1186/1743-8977-10-60; Xu Y, 2013, MOL PHARMACEUT, V10, P4611, DOI 10.1021/mp400423g; Yin F, 2013, ARTERIOSCL THROM VAS, V33, P1153, DOI 10.1161/ATVBAHA.112.300552; Zielinska B, 2004, J AIR WASTE MANAGE, V54, P1138, DOI 10.1080/10473289.2004.10470973	85	26	28	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0121232	10.1371/journal.pone.0121232	http://dx.doi.org/10.1371/journal.pone.0121232			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803276	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000353889600140
J	Tampaki, Z; Mwakubambanya, RS; Goulielmaki, E; Kaforou, S; Kim, K; Waters, AP; Carruthers, VB; Siden-Kiamos, I; Loukeris, TG; Koussis, K				Tampaki, Zoi; Mwakubambanya, Ramadhan S.; Goulielmaki, Evi; Kaforou, Sofia; Kim, Kami; Waters, Andrew P.; Carruthers, Vern B.; Siden-Kiamos, Inga; Loukeris, Thanasis G.; Koussis, Konstantinos			Ectopic Expression of a Neospora caninum Kazal Type Inhibitor Triggers Developmental Defects in Toxoplasma and Plasmodium	PLOS ONE			English	Article							SUBTILISIN-LIKE PROTEIN; HOST-CELL INVASION; MOSQUITO MIDGUT INVASION; RODENT MALARIA PARASITE; MOLECULAR CHARACTERIZATION; FALCIPARUM MEROZOITES; BLOOD STAGES; GONDII; PROTEASES; BERGHEI	Regulated proteolysis is known to control a variety of vital processes in apicomplexan parasites including invasion and egress of host cells. Serine proteases have been proposed as targets for drug development based upon inhibitor studies that show parasite attenuation and transmission blockage. Genetic studies suggest that serine proteases, such as subtilisin and rhomboid proteases, are essential but functional studies have proved challenging as active proteases are difficult to express. Proteinaceous Protease Inhibitors (PPIs) provide an alternative way to address the role of serine proteases in apicomplexan biology. To validate such an approach, a Neospora caninum Kazal inhibitor (NcPI-S) was expressed ectopically in two apicomplexan species, Toxoplasma gondii tachyzoites and Plasmodium berghei ookinetes, with the aim to disrupt proteolytic processes taking place within the secretory pathway. NcPI-S negatively affected proliferation of Toxoplasma tachyzoites, while it had no effect on invasion and egress. Expression of the inhibitor in P. berghei zygotes blocked their development into mature and invasive ookinetes. Moreover, ultra-structural studies indicated that expression of NcPI-S interfered with normal formation of micronemes, which was also confirmed by the lack of expression of the micronemal protein SOAP in these parasites. Our results suggest that NcPI-S could be a useful tool to investigate the function of proteases in processes fundamental for parasite survival, contributing to the effort to identify targets for parasite attenuation and transmission blockage.	[Tampaki, Zoi; Mwakubambanya, Ramadhan S.; Goulielmaki, Evi; Kaforou, Sofia; Siden-Kiamos, Inga; Loukeris, Thanasis G.; Koussis, Konstantinos] Fdn Res & Technol Hellas, Inst Mol Biol & Biotechnol, Iraklion, Greece; [Tampaki, Zoi; Mwakubambanya, Ramadhan S.; Goulielmaki, Evi] Univ Crete, Dept Biol, Iraklion, Greece; [Kim, Kami] Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA; [Waters, Andrew P.] Univ Glasgow, Fac Biomed & Life Sci, Glasgow Biomed Res Ctr, Glasgow, Lanark, Scotland; [Carruthers, Vern B.] Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA	Foundation for Research & Technology - Hellas (FORTH); University of Crete; Yeshiva University; Albert Einstein College of Medicine; University of Glasgow; University of Michigan System; University of Michigan	Koussis, K (corresponding author), Fdn Res & Technol Hellas, Inst Mol Biol & Biotechnol, Iraklion, Greece.	kousis@imbb.forth.gr	Kousis, Konstantinos/K-7371-2019	Kousis, Konstantinos/0000-0002-6737-8724; Kim, Kami/0000-0003-3384-152X; Carruthers, Vern/0000-0001-6859-8895	General Secretariat for Research and Technology, Ministry of Education, Greece [MIS-448301 (2013SE01380036)]; European Regional Development Fund (Sectoral Operational Programme: Competitiveness and Entrepreneurship, NSRF)/European Commission	General Secretariat for Research and Technology, Ministry of Education, Greece; European Regional Development Fund (Sectoral Operational Programme: Competitiveness and Entrepreneurship, NSRF)/European Commission	This work was performed in the framework of the BIOSYS research project, Action KRIPIS, project No. MIS-448301 (2013SE01380036) that was funded by the General Secretariat for Research and Technology, Ministry of Education, Greece and the European Regional Development Fund (Sectoral Operational Programme: Competitiveness and Entrepreneurship, NSRF 2007-2013)/European Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham EG, 2005, P NATL ACAD SCI USA, V102, P16327, DOI 10.1073/pnas.0508335102; Alam A, 2012, MOL BIOCHEM PARASIT, V183, P84, DOI 10.1016/j.molbiopara.2011.12.009; BANYAL HS, 1981, J PARASITOL, V67, P623, DOI 10.2307/3280435; Barale JC, 1999, P NATL ACAD SCI USA, V96, P6445, DOI 10.1073/pnas.96.11.6445; Bergbold N, 2013, BBA-BIOMEMBRANES, V1828, P2840, DOI 10.1016/j.bbamem.2013.03.025; Binder EM, 2004, TRAFFIC, V5, P914, DOI 10.1111/j.1600-0854.2004.00244.x; Black M, 1995, MOL BIOCHEM PARASIT, V74, P55, DOI 10.1016/0166-6851(95)02483-2; Black MW, 2000, MOL CELL BIOL, V20, P9399, DOI 10.1128/MCB.20.24.9399-9408.2000; Blackman MJ, 2008, CELL MICROBIOL, V10, P1925, DOI 10.1111/j.1462-5822.2008.01176.x; Blackman MJ, 1998, J BIOL CHEM, V273, P23398, DOI 10.1074/jbc.273.36.23398; Blackman MJ, 2002, BIOCHEMISTRY-US, V41, P12244, DOI 10.1021/bi0263661; Brossier F, 2008, EUKARYOT CELL, V7, P664, DOI 10.1128/EC.00331-07; Bruno S, 2004, MOL BIOCHEM PARASIT, V136, P101, DOI 10.1016/j.molbiopara.2004.03.005; CESBRONDELAUW MF, 1989, P NATL ACAD SCI USA, V86, P7537, DOI 10.1073/pnas.86.19.7537; Nogueira NPD, 2013, ACTA TROP, V128, P27, DOI 10.1016/j.actatropica.2013.05.013; Derouin F, 2001, Curr Opin Investig Drugs, V2, P1368; Dessens JT, 2003, MOL MICROBIOL, V49, P319, DOI 10.1046/j.1365-2958.2003.03566.x; Donald RGK, 1996, J BIOL CHEM, V271, P14010, DOI 10.1074/jbc.271.24.14010; Dowse TJ, 2005, TRENDS PARASITOL, V21, P254, DOI 10.1016/j.pt.2005.04.009; Dowse TJ, 2005, INT J PARASITOL, V35, P747, DOI 10.1016/j.ijpara.2005.04.001; Fennell C, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-99; FENTON JW, 1992, HEMATOL ONCOL CLIN N, V6, P1121, DOI 10.1016/S0889-8588(18)30299-5; Franke-Fayard B, 2004, MOL BIOCHEM PARASIT, V137, P23, DOI 10.1016/j.molbiopara.2004.04.007; Hackett F, 1999, MOL BIOCHEM PARASIT, V103, P183, DOI 10.1016/S0166-6851(99)00122-X; HADLEY T, 1983, EXP PARASITOL, V55, P306, DOI 10.1016/0014-4894(83)90027-9; Huynh MH, 2003, EMBO J, V22, P2082, DOI 10.1093/emboj/cdg217; Janse CJ, 2006, NAT PROTOC, V1, P614, DOI 10.1038/nprot.2006.88; Janse CJ, 2006, NAT PROTOC, V1, P346, DOI 10.1038/nprot.2006.53; Joyce BR, 2013, EUKARYOT CELL, V12, P979, DOI 10.1128/EC.00021-13; Kim K, 2004, ACTA TROP, V91, P69, DOI 10.1016/j.actaropia.2003.11.016; Kim K, 2001, MOL BIOCHEM PARASIT, V113, P309, DOI 10.1016/S0166-6851(01)00212-2; Koussis K, 2009, EMBO J, V28, P725, DOI 10.1038/emboj.2009.22; Krowarsch D, 2003, CELL MOL LIFE SCI, V60, P2427, DOI 10.1007/s00018-003-3120-x; Lagal V, 2010, CELL MICROBIOL, V12, P1792, DOI 10.1111/j.1462-5822.2010.01509.x; Li H, 2012, BBA-PROTEINS PROTEOM, V1824, P177, DOI 10.1016/j.bbapap.2011.06.002; Lin JW, 2013, MOL MICROBIOL, V88, P318, DOI 10.1111/mmi.12187; McKerrow JH, 2008, CURR OPIN INFECT DIS, V21, P668, DOI 10.1097/QCO.0b013e328315cca9; Meissner M, 2002, SCIENCE, V298, P837, DOI 10.1126/science.1074553; Miller SA, 2003, MOL MICROBIOL, V49, P883, DOI 10.1046/j.1365-2958.2003.03604.x; Miller SA, 2001, J BIOL CHEM, V276, P45341, DOI 10.1074/jbc.M106665200; Monzote L, 2013, REV INST MED TROP SP, V55, P65, DOI 10.1590/S0036-46652013000100012; Morris MT, 2004, INT J PARASITOL, V34, P693, DOI 10.1016/j.ijpara.2004.01.004; Morris MT, 2003, MOL BIOCHEM PARASIT, V128, P119, DOI 10.1016/S0166-6851(03)00051-3; MS J, 2012, MOL BIOCHEM PARASIT, V182, P27, DOI [10.1016/j.molbiopara.2011.11.010, DOI 10.1016/J.MOLBIOPARA.2011.11.010]; Nall TA, 2004, J BIOL CHEM, V279, P48535, DOI 10.1074/jbc.M406810200; Narasimhan J, 2008, J BIOL CHEM, V283, P16591, DOI 10.1074/jbc.M800681200; OSSORIO PN, 1992, MOL BIOCHEM PARASIT, V50, P1, DOI 10.1016/0166-6851(92)90239-G; Parikh S, 2005, ANTIMICROB AGENTS CH, V49, P2983, DOI 10.1128/AAC.49.7.2983-2985.2005; PFEFFERKORN ER, 1994, EXP PARASITOL, V79, P374, DOI 10.1006/expr.1994.1099; Pszenny V, 2000, MOL BIOCHEM PARASIT, V107, P241, DOI 10.1016/S0166-6851(00)00202-4; Pszenny V, 2012, INFECT IMMUN, V80, P1156, DOI 10.1128/IAI.06167-11; Reininger L, 2005, J BIOL CHEM, V280, P31957, DOI 10.1074/jbc.M504523200; Rimphanitchayakit V, 2010, DEV COMP IMMUNOL, V34, P377, DOI 10.1016/j.dci.2009.12.004; Roiko MS, 2009, CELL MICROBIOL, V11, P1444, DOI 10.1111/j.1462-5822.2009.01357.x; ROOS DS, 1994, METHOD CELL BIOL, V45, P27; Santos JM, 2011, SCIENCE, V331, P473, DOI 10.1126/science.1199284; Savoia D, 2005, INT J ANTIMICROB AG, V26, P92, DOI 10.1016/j.ijantimicag.2005.04.003; Shaw MK, 2002, MICROBES INFECT, V4, P119, DOI 10.1016/S1286-4579(01)01520-9; Silva-Lopez RE, 2007, PARASITOL RES, V101, P1627, DOI 10.1007/s00436-007-0706-5; SINDEN RE, 1985, PARASITOLOGY, V91, P227, DOI 10.1017/S0031182000057334; Soldati D, 1998, MOL BIOCHEM PARASIT, V96, P37, DOI 10.1016/S0166-6851(98)00090-5; SOLDATI D, 1993, SCIENCE, V260, P349, DOI 10.1126/science.8469986; Spork S, 2009, EUKARYOT CELL, V8, P1134, DOI 10.1128/EC.00083-09; Srinivasan P, 2008, CELL MICROBIOL, V10, P1304, DOI 10.1111/j.1462-5822.2008.01127.x; Srinivasan P, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000262; STUBBS MT, 1995, FEBS LETT, V375, P103, DOI 10.1016/0014-5793(95)01190-P; Teo CF, 2007, ANTIMICROB AGENTS CH, V51, P679, DOI 10.1128/AAC.01059-06; Tian MY, 2004, J BIOL CHEM, V279, P26370, DOI 10.1074/jbc.M400941200; Uzureau P, 2004, CELL MICROBIOL, V6, P65, DOI 10.1046/j.1462-5822.2003.00343.x; van Spaendonk RML, 2001, J BIOL CHEM, V276, P22638, DOI 10.1074/jbc.M101234200; Vlachou D, 2004, CELL MICROBIOL, V6, P671, DOI 10.1111/j.1462-5822.2004.00394.x; Wan KL, 1997, MOL BIOCHEM PARASIT, V84, P203, DOI 10.1016/S0166-6851(96)02796-X; WINGER LA, 1988, PARASITE IMMUNOL, V10, P193, DOI 10.1111/j.1365-3024.1988.tb00214.x; Yeoh S, 2007, CELL, V131, P1072, DOI 10.1016/j.cell.2007.10.049; Zhang M, 2010, J EXP MED, V207, P1, DOI 10.1084/jem.20091975	75	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0121379	10.1371/journal.pone.0121379	http://dx.doi.org/10.1371/journal.pone.0121379			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803874	Green Submitted, Green Accepted, Green Published, gold			2022-12-26	WOS:000353889600152
J	Fayon, M; Andrieux, A; Bara, I; Rebola, M; Labbe, A; Marthan, R; Berger, P				Fayon, Michael; Andrieux, Annick; Bara, Imane; Rebola, Muriel; Labbe, Andre; Marthan, Roger; Berger, Patrick			An Age-Wise Comparison of Human Airway Smooth Muscle Proliferative Capacity	PLOS ONE			English	Article							CHILDREN BORN; LUNG; EXPRESSION; ASTHMA; RECEPTOR; FETAL; SIZE	We compared the proliferation of neonatal and adult airway smooth muscle cells (ASMC) with no/moderate lung disease, in glucose-(energy production by glycolysis) or glucose-free medium (ATP production from mitochondrial oxidative phosphorylations only), in response to 10% fetal calf serum (FCS) and PDGF-AA. In the presence of glucose, cell counts were significantly greater in neonatal vs. adult ASMC. Similarly, neonatal ASMC DNA synthesis in 10% FCS and PDGF-AA, and [Ca2+]i responses in the presence of histamine were significantly enhanced vs. adults. In glucose-free medium, cell proliferation was preserved in neonatal cells, unlike in adult cells, with concomitant increased porin (an indicator of mitochondrial activity) protein expression. Compared to adults, stimulated neonatal human ASMC are in a rapid and robust proliferative phase and have the capacity to respond disproportionately under abnormal environmental conditions, through increased mitochondrial biogenesis and altered calcium homeostasis.	[Fayon, Michael; Andrieux, Annick; Bara, Imane; Rebola, Muriel; Marthan, Roger; Berger, Patrick] Univ Bordeaux, Ctr Rech Cardiothorac Bordeaux, U1045, F-33000 Bordeaux, France; [Fayon, Michael; Andrieux, Annick; Rebola, Muriel] CHU Bordeaux, Hop Pellegrin Enfants, Pneumol Pediat, Ctr Invest Clin CIC 1401, F-33076 Bordeaux, France; [Labbe, Andre] CHU Clermont Ferrand, Pediat Pulmonol & Intens Care Unit, F-63000 Clermont Ferrand, France	UDICE-French Research Universities; Universite de Bordeaux; CHU Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Clermont Ferrand	Fayon, M (corresponding author), Univ Bordeaux, Ctr Rech Cardiothorac Bordeaux, U1045, F-33000 Bordeaux, France.	michael.fayon@chu-bordeaux.fr	Fayon, Michael/HDN-7887-2022; Berger, Patrick/D-8779-2012	Fayon, Michael/0000-0002-1238-2128; Berger, Patrick/0000-0003-4702-0343; Marthan, Roger/0000-0001-5412-5712				Bara I, 2012, AM J RESP CRIT CARE, V185, P715, DOI 10.1164/rccm.201105-0915OC; Baraldi E, 2007, NEW ENGL J MED, V357, P1946, DOI 10.1056/NEJMra067279; Choukroun ML, 2013, RESP MED, V107, P1966, DOI 10.1016/j.rmed.2013.06.020; El-Shazly A, 2006, J IMMUNOL, V176, P1860, DOI 10.4049/jimmunol.176.3.1860; Fawke J, 2010, AM J RESP CRIT CARE, V182, P237, DOI 10.1164/rccm.200912-1806OC; FAYON M, 1994, AM J PHYSIOL, V267, pL180, DOI 10.1152/ajplung.1994.267.2.L180; Fayon M, 2006, AM J PHYSIOL-LUNG C, V291, pL244, DOI 10.1152/ajplung.00474.2005; Girodet PO, 2015, AM J RESP CRIT CARE, V191, P876, DOI 10.1164/rccm.201410-1874OC; HALL IP, 1988, BRIT J PHARMACOL, V95, P1204, DOI 10.1111/j.1476-5381.1988.tb11757.x; Halvorsen T, 2005, PEDIAT ALLERG IMM-UK, V16, P487, DOI 10.1111/j.1399-3038.2005.00314.x; Hartman WR, 2012, AM J PHYSIOL-LUNG C, V303, pL711, DOI 10.1152/ajplung.00037.2012; Hirota JA, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-120; Hirst SJ, 1996, AM J PHYSIOL-LUNG C, V270, pL415, DOI 10.1152/ajplung.1996.270.3.L415; HISLOP AA, 1989, AM REV RESPIR DIS, V140, P1717, DOI 10.1164/ajrccm/140.6.1717; Holgate Stephen T., 2003, Journal of Allergy and Clinical Immunology, V111, pS18, DOI 10.1067/mai.2003.25; Holgate ST, 2010, CLIN SCI, V118, P439, DOI 10.1042/CS20090474; Hulsmann A R, 1997, Monaldi Arch Chest Dis, V52, P272; Jeffery P, 2001, PEDIATR PULM, P3; Johnson PRA, 2001, AM J RESP CRIT CARE, V164, P474, DOI 10.1164/ajrccm.164.3.2010109; Mahn K, 2010, THORAX, V65, P547, DOI 10.1136/thx.2009.129296; MCCRAY PB, 1993, AM J RESP CELL MOL, V8, P573, DOI 10.1165/ajrcmb/8.5.573; Mochizuki H, 2006, J ASTHMA, V43, P25, DOI 10.1080/02770900500446948; Naureckas ET, 1999, AM J RESP CRIT CARE, V160, P2062, DOI 10.1164/ajrccm.160.6.9903131; NORTHWAY WH, 1990, NEW ENGL J MED, V323, P1793, DOI 10.1056/NEJM199012273232603; Regamey N, 2008, AM J RESP CRIT CARE, V177, P837, DOI 10.1164/rccm.200707-977OC; Regamey N, 2007, CHEST, V131, P1710, DOI 10.1378/chest.06-2666; Rossignol R, 2004, CANCER RES, V64, P985, DOI 10.1158/0008-5472.CAN-03-1101; Roth M, 2004, NEW ENGL J MED, V351, P560, DOI 10.1056/NEJMoa021660; Shimotake TK, 2004, PEDIATR RES, V56, P907, DOI 10.1203/01.PDR.0000145274.47221.10; Sweeney M, 2002, J APPL PHYSIOL, V92, P1594, DOI 10.1152/japplphysiol.00722.2001; Sweet David G, 2002, Paediatr Respir Rev, V3, P140, DOI 10.1016/S1526-0550(02)00010-0; Trian T, 2006, AM J RESP CELL MOL, V34, P49, DOI 10.1165/rcmb.2005-0187OC; Trian T, 2007, J EXP MED, V204, P3173, DOI 10.1084/jem.20070956; Tulic MK, 2003, CHEST, V123, p348S, DOI 10.1378/chest.123.3_suppl.348S	34	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0122446	10.1371/journal.pone.0122446	http://dx.doi.org/10.1371/journal.pone.0122446			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798916	Green Published, Green Submitted, gold			2022-12-26	WOS:000351987300334
J	Kim, M; Cho, A; Lim, HS; Hong, SG; Kim, JH; Lee, J; Choi, T; Ahn, TS; Kim, OS				Kim, Mincheol; Cho, Ahnna; Lim, Hyoun Soo; Hong, Soon Gyu; Kim, Ji Hee; Lee, Joohan; Choi, Taejin; Ahn, Tae Seok; Kim, Ok-Sun			Highly Heterogeneous Soil Bacterial Communities around Terra Nova Bay of Northern Victoria Land, Antarctica	PLOS ONE			English	Article							DIVERSITY; ECOSYSTEMS	Given the diminished role of biotic interactions in soils of continental Antarctica, abiotic factors are believed to play a dominant role in structuring of microbial communities. However, many ice-free regions remain unexplored, and it is unclear which environmental gradients are primarily responsible for the variations among bacterial communities. In this study, we investigated the soil bacterial community around Terra Nova Bay of Victoria Land by pyrosequencing and determined which environmental variables govern the bacterial community structure at the local scale. Six bacterial phyla, Actinobacteria, Proteobacteria, Acidobacteria, Chloroflexi, Cyanobacteria, and Bacteroidetes, were dominant, but their relative abundance varied greatly across locations. Bacterial community structures were affected little by spatial distance, but structured more strongly by site, which was in accordance with the soil physicochemical compositions. At both the phylum and species levels, bacterial community structure was explained primarily by pH and water content, while certain earth elements and trace metals also played important roles in shaping community variation. The higher heterogeneity of the bacterial community structure found at this site indicates how soil bacterial communities have adapted to different compositions of edaphic variables under extreme environmental conditions. Taken together, these findings greatly advance our understanding of the adaption of soil bacterial populations to this harsh environment.	[Kim, Mincheol] Korea Polar Res Inst, Arctic Res Ctr, Inchon, South Korea; [Cho, Ahnna; Hong, Soon Gyu; Kim, Ok-Sun] Korea Polar Res Inst, Div Life Sci, Inchon, South Korea; [Cho, Ahnna; Ahn, Tae Seok] Kangwon Natl Univ, Dept Environm Sci, Chunchon, South Korea; [Lim, Hyoun Soo] Pusan Natl Univ, Dept Geol Sci, Busan, South Korea; [Kim, Ji Hee; Lee, Joohan] Korea Polar Res Inst, Dept New Antarctic Stn, Inchon, South Korea; [Choi, Taejin] Korea Polar Res Inst, Div Climate Change, Inchon, South Korea	Korea Institute of Ocean Science & Technology (KIOST); Korea Polar Research Institute (KOPRI); Korea Institute of Ocean Science & Technology (KIOST); Korea Polar Research Institute (KOPRI); Kangwon National University; Pusan National University; Korea Institute of Ocean Science & Technology (KIOST); Korea Polar Research Institute (KOPRI); Korea Institute of Ocean Science & Technology (KIOST); Korea Polar Research Institute (KOPRI)	Kim, OS (corresponding author), Korea Polar Res Inst, Div Life Sci, Inchon, South Korea.	oskim@kopri.re.kr	Lim, Hyoun Soo/AAC-5499-2022	Lim, Hyoun Soo/0000-0002-2489-4470	Korea Polar Research Institute [PE11030, PP13050, PE14020]; Ministry of Oceans and Fisheries [PM10050]	Korea Polar Research Institute(Korea Polar Research Institute of Marine Research Placement (KOPRI)); Ministry of Oceans and Fisheries	This work was supported by the Korea Polar Research Institute (grant PE11030, PP13050 and PE14020) and the Ministry of Oceans and Fisheries (Grant PM10050). The funders played a key role in study design, data collection and analysis, but not in the decision to publish and preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Barrett JE, 2006, SOIL BIOL BIOCHEM, V38, P3019, DOI 10.1016/j.soilbio.2006.04.041; Bottos EM., 2014, ANTARCTIC TERRESTRIA, P9, DOI [10.1007/978-3-642-45213-0_2, DOI 10.1007/978-3-642-45213-0_2]; Cary SC, 2010, NAT REV MICROBIOL, V8, P129, DOI 10.1038/nrmicro2281; Cavaletti L, 2006, APPL ENVIRON MICROB, V72, P4360, DOI 10.1128/AEM.00132-06; Chong CW, 2012, POLAR BIOL, V35, P387, DOI 10.1007/s00300-011-1084-0; Chu HY, 2010, ENVIRON MICROBIOL, V12, P2998, DOI 10.1111/j.1462-2920.2010.02277.x; Convey P, 2006, PLANT ECOL, V182, P1, DOI 10.1007/s11258-005-9022-2; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Foesel BU, 2013, SYST APPL MICROBIOL, V36, P82, DOI 10.1016/j.syapm.2012.11.002; FOLK RL, 1970, NEW ZEAL J GEOL GEOP, V13, P937, DOI 10.1080/00288306.1970.10418211; Geyer KM, 2013, ECOSPHERE, V4, DOI 10.1890/ES13-00048.1; Gorley C.K., 2006, GETTING STARTED PRIM; Hogg ID, 2006, SOIL BIOL BIOCHEM, V38, P3035, DOI 10.1016/j.soilbio.2006.04.026; Jones RT, 2009, ISME J, V3, P442, DOI 10.1038/ismej.2008.127; Kennicutt MC, 2010, ENVIRON RES LETT, V5, DOI 10.1088/1748-9326/5/3/034010; Kim OS, 2012, INT J SYST EVOL MICR, V62, P716, DOI 10.1099/ijs.0.038075-0; Korea Polar Research Institute (KOPRI), 2012, FIN CEE CONSTR OP JA; Lee CK, 2012, ISME J, V6, P1046, DOI 10.1038/ismej.2011.170; Niederberger TD, 2008, ENVIRON MICROBIOL, V10, P1713, DOI 10.1111/j.1462-2920.2008.01593.x; Niederberger TD, 2012, FEMS MICROBIOL ECOL, V82, P376, DOI 10.1111/j.1574-6941.2012.01390.x; Oh J, 2012, J MICROBIOL, V50, P766, DOI 10.1007/s12275-012-2494-6; Oksanen J, 2013, COMMUNITY ECOLOGY PA, V2, P1; Pinheiro J., 2011, PACKAGE R SOFTWARE S, P21; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sokol ER, 2013, ECOSPHERE, V4, DOI 10.1890/ES13-00136.1; Stackebrant E, 1991, NUCL ACID TECHNIQUES; Tripathi BM, 2012, MICROB ECOL, V64, P474, DOI 10.1007/s00248-012-0028-8; Ugolini FC, 2008, GEODERMA, V144, P1, DOI 10.1016/j.geoderma.2007.10.005; Van Horn DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066103; Ward NL, 2009, APPL ENVIRON MICROB, V75, P2046, DOI 10.1128/AEM.02294-08; Yergeau E, 2009, ISME J, V3, P340, DOI 10.1038/ismej.2008.111; Yergeau E, 2007, ISME J, V1, P163, DOI 10.1038/ismej.2007.24	35	32	34	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0119966	10.1371/journal.pone.0119966	http://dx.doi.org/10.1371/journal.pone.0119966			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799273	Green Published, gold			2022-12-26	WOS:000351987300098
J	Krischik, V; Rogers, M; Gupta, G; Varshney, A				Krischik, Vera; Rogers, Mary; Gupta, Garima; Varshney, Aruna			Soil-Applied Imidacloprid Translocates to Ornamental Flowers and Reduces Survival of Adult Coleomegilla maculata, Harmonia axyridis, and Hippodamia convergens Lady Beetles, and Larval Danaus plexippus and Vanessa cardui Butterflies	PLOS ONE			English	Article							COORDINATED AGRICULTURAL PROJECT; BIOLOGICAL-CONTROL; NATIONAL RESEARCH; BEE HYMENOPTERA; HONEY-BEES; PESTICIDES; EXPOSURE; POLLEN; TOXICITY; RESIDUES	Integrated Pest Management (IPM) is a decision making process used to manage pests that relies on many tactics, including cultural and biological control, which are practices that conserve beneficial insects and mites, and when needed, the use of conventional insecticides. However, systemic, soil-applied neonicotinoid insecticides are translocated to pollen and nectar of flowers, often for months, and may reduce survival of flower-feeding beneficial insects. Imidacloprid seed-treated crops (0.05 mg AI (active ingredient)/canola seed and 1.2 mg AI/corn seed) translocate less than 10 ppb to pollen and nectar. However, higher rates of soil-applied imidacloprid are used in nurseries and urban landscapes, such as 300 mg AI/10 L (3 gallon) pot and 69 g AI applied to the soil under a 61 (24 in) cm diam. tree. Translocation of imidacloprid from soil (300 mg AI) to flowers of Asclepias curassavica resulted in 6,030 ppb in 1X and 10,400 ppb in 2X treatments, which are similar to imidacloprid residues found in another plant species we studied. A second imidacloprid soil application 7 months later resulted in 21,000 ppb in 1X and 45,000 ppb in 2X treatments. Consequently, greenhouse/nursery use of imidacloprid applied to flowering plants can result in 793 to 1,368 times higher concentration compared to an imidacloprid seed treatment (7.6 ppb pollen in seed-treated canola), where most research has focused. These higher imidacloprid levels caused significant mortality in both 1X and 2X treatments in 3 lady beetle species, Coleomegilla maculata, Harmonia axyridis, and Hippodamia convergens, but not a fourth species, Coccinella septempunctata. Adult survival were not reduced for monarch, Danaus plexippus and painted lady, Vanessa cardui, butterflies, but larval survival was significantly reduced. The use of the neonicotinoid imidacloprid at greenhouse/nursery rates reduced survival of beneficial insects feeding on pollen and nectar and is incompatible with the principles of IPM.	[Krischik, Vera; Varshney, Aruna] Univ Minnesota, Dept Entomol, St Paul, MN 55455 USA; [Rogers, Mary] Univ Minnesota, Dept Hort Sci, St Paul, MN USA; [Gupta, Garima] Panjab Univ, Dept Zool, Chandigarh 160014, India	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Panjab University	Krischik, V (corresponding author), Univ Minnesota, Dept Entomol, St Paul, MN 55455 USA.	krisc001@umn.edu	Gupta, Garima/AAC-5424-2021	Rogers, Mary/0000-0001-6609-3113; Gupta, Garima/0000-0003-1088-4957	USDA SARE [00015590]; grant "Mitigating pollinator decline" [2010 MN LCCMR 221G]; University of Minnesota Experiment Station (MAES) project [MN 17-027]; Minnesota Nursery and Landscape Association	USDA SARE(United States Department of Agriculture (USDA)); grant "Mitigating pollinator decline"; University of Minnesota Experiment Station (MAES) project; Minnesota Nursery and Landscape Association	Research was supported by a USDA SARE (00015590) grant "The role of imidacloprid systemic insecticide on colony collapse disorder of honey bees and decline of bumblebee pollinators", 2010 MN LCCMR 221G grant "Mitigating pollinator decline", and University of Minnesota Experiment Station (MAES) project MN 17-027 and a small grant from the Minnesota Nursery and Landscape Association in 2007. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackery P.R., 1998, LEPIDOPTERA MOTHS BU, V4, P263, DOI [10.1515/9783110804744, DOI 10.1515/9783110804744]; Aliouane Y, 2009, ENVIRON TOXICOL CHEM, V28, P113, DOI 10.1897/08-110.1; Altizer SM, 1999, J INVERTEBR PATHOL, V74, P76, DOI 10.1006/jipa.1999.4853; Averill AL, 2011, AM BEE J, V151, P1187; Blacquiere T, 2012, ECOTOXICOLOGY, V21, P973, DOI 10.1007/s10646-012-0863-x; Bonmatin JM, 2005, ENVIRONMENTAL CHEMISTRY: GREEN CHEMISTRY AND POLLUTANTS IN ECOSYSTEMS, P483; California Department Agriculture, 2009, EV REP MER 2F; Chauzat MP, 2006, J ECON ENTOMOL, V99, P253, DOI 10.1603/0022-0493-99.2.253; Colin ME, 2004, ARCH ENVIRON CON TOX, V47, P387, DOI 10.1007/s00244-004-3052-y; Cresswell JE, 2011, ECOTOXICOLOGY, V20, P149, DOI 10.1007/s10646-010-0566-0; Cutler GC, 2007, J ECON ENTOMOL, V100, P765, DOI 10.1603/0022-0493(2007)100[765:ETCSCH]2.0.CO;2; Cutler P, 2013, PEST MANAG SCI, V69, P607, DOI 10.1002/ps.3413; Dively GP, 2012, J AGR FOOD CHEM, V60, P4449, DOI 10.1021/jf205393x; Doering J, 2005, RESIDUES IMIDACLOPRI; Doering J., 2004, RESIDUES IMIDACLOPRI; European Food Safety Authority, 2012, EFSA J, V10, DOI 10.2903/j.efsa.2012.2597; Fischer D. L., 2007, NEONICOTINOID INSECT; Frankfater C, 2005, J CHEM ECOL, V31, P2541, DOI 10.1007/s10886-005-7612-z; Frazier J, 2011, AM BEE J, V151, P779; Garrigan D.A., 1994, THESIS U UTAH SALT L; Gill RJ, 2012, NATURE, V491, P105, DOI 10.1038/nature11585; Girolami V, 2009, J ECON ENTOMOL, V102, P1808, DOI 10.1603/029.102.0511; Goulson D, 2013, J APPL ECOL, V50, P977, DOI 10.1111/1365-2664.12111; HAUSMAN SA, 1951, AM NAT, V85, P389, DOI 10.1086/281694; Henry M, 2012, SCIENCE, V336, P348, DOI 10.1126/science.1215039; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Janz N, 2005, J INSECT BEHAV, V18, P767, DOI 10.1007/s10905-005-8739-z; Kamel A, 2010, J AGR FOOD CHEM, V58, P5926, DOI 10.1021/jf904120n; Kelly L, 1999, AM MIDL NAT, V141, P315, DOI 10.1674/0003-0031(1999)141[0315:EOLFLO]2.0.CO;2; Kopper BJ, 2002, ENVIRON ENTOMOL, V31, P10, DOI 10.1603/0046-225X-31.1.10; Krischik VA, 2007, ENVIRON ENTOMOL, V36, P1238, DOI 10.1603/0046-225X(2007)36[1238:SIITTN]2.0.CO;2; Krupke CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029268; Lambin M, 2001, ARCH INSECT BIOCHEM, V48, P129, DOI 10.1002/arch.1065; Larson JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066375; Lehotay SJ, 2005, METH BIOTEC, V19, P239; Lehotay SJ, 2005, J AOAC INT, V88, P595; Leong KLH, 1997, J INVERTEBR PATHOL, V69, P79, DOI 10.1006/jipa.1996.4634; Losey JE, 1999, NATURE, V399, P214, DOI 10.1038/20338; Maus C, 2004, G201815 BAYER CROPSC; Mommaerts V, 2010, ECOTOXICOLOGY, V19, P207, DOI 10.1007/s10646-009-0406-2; Morandin LA, 2003, ENVIRON ENTOMOL, V32, P555, DOI 10.1603/0046-225X-32.3.555; Oregon Depart Agric, 2013, BUMBL BEE INC RES PE; Paine TD, 2011, BIOL CONTROL, V56, P175, DOI 10.1016/j.biocontrol.2010.08.007; Pilatic H, 2012, HUFFINGTON POST; Pilling E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077193; Pollack P., 2011, FINE CHEM IND BUSINE; R Core Team, 2021, R LANGUAGE ENV STAT; Rogers MA, 2007, BIOL CONTROL, V42, P172, DOI 10.1016/j.biocontrol.2007.05.006; SAS, 2010, SAS ENT GUID 4 3; SAS, 2010, JMP PRO 9 0 2; Schmuck R, 2001, PEST MANAG SCI, V57, P225, DOI 10.1002/ps.270; Schmuck R., 1999, PFLANZENSCHUTZ NACHR, V52, P257; Schneider CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030023; Scott-Dupree CD, 2001, 110405 U GUELF ONT C; Seagraves MP, 2012, J PEST SCI, V85, P125, DOI 10.1007/s10340-011-0374-1; Sears MK, 2001, P NATL ACAD SCI USA, V98, P11937, DOI 10.1073/pnas.211329998; Smith SF, 2000, J ECON ENTOMOL, V93, P732, DOI 10.1603/0022-0493-93.3.732; Smith SF, 1990, ENVIRON ENTOMOL, V28, P1189; Stoner KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039114; Suchail S, 2000, ENVIRON TOXICOL CHEM, V19, P1901, DOI [10.1897/1551-5028(2000)019&lt;1901:COITIT&gt;2.3.CO;2, 10.1002/etc.5620190726]; Suchail S, 2001, ENVIRON TOXICOL CHEM, V20, P2482, DOI [10.1002/etc.5620201113, 10.1897/1551-5028(2001)020&lt;2482:DBAACT&gt;2.0.CO;2]; Szczepaniec Adrianna, 2007, Journal of Environmental Horticulture, V25, P43; Tasei JN, 2001, J ECON ENTOMOL, V94, P623, DOI 10.1603/0022-0493-94.3.623; Themeau T., 2012, COXME MIXED EFFECTS; Tomizawa M, 2005, ANNU REV PHARMACOL, V45, P247, DOI 10.1146/annurev.pharmtox.45.120403.095930; USDA APHIS, 2003, ENV MON REP AS LONGH; Whitehorn PR, 2012, SCIENCE, V336, P351, DOI 10.1126/science.1215025; WYATT R, 1994, ANNU REV ECOL SYST, V25, P423; Yang EC, 2008, J ECON ENTOMOL, V101, P1743, DOI 10.1603/0022-0493-101.6.1743	69	41	41	2	123	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0119133	10.1371/journal.pone.0119133	http://dx.doi.org/10.1371/journal.pone.0119133			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799432	Green Published, Green Submitted, gold			2022-12-26	WOS:000351987300030
J	Mi, YJ; Geng, GJ; Zou, ZZ; Gao, J; Luo, XY; Liu, Y; Li, N; Li, CL; Chen, YQ; Yu, XY; Jiang, J				Mi, Yan-jun; Geng, Guo-jun; Zou, Zheng-zhi; Gao, Jing; Luo, Xian-yang; Liu, Yu; Li, Ning; Li, Chun-lei; Chen, Yu-qiang; Yu, Xiu-yi; Jiang, Jie			Dihydroartemisinin Inhibits Glucose Uptake and Cooperates with Glycolysis Inhibitor to Induce Apoptosis in Non-Small Cell Lung Carcinoma Cells	PLOS ONE			English	Article							COLORECTAL-CANCER CELLS; MAMMALIAN TARGET; METABOLISM; EXPRESSION; MTOR; RESISTANCE; AUTOPHAGY; GROWTH	Despite recent advances in the therapy of non-small cell lung cancer (NSCLC), the chemotherapy efficacy against NSCLC is still unsatisfactory. Previous studies show the herbal antimalarial drug dihydroartemisinin (DHA) displays cytotoxic to multiple human tumors. Here, we showed that DHA decreased cell viability and colony formation, induced apoptosis in A549 and PC-9 cells. Additionally, we first revealed DHA inhibited glucose uptake in NSCLC cells. Moreover, glycolytic metabolism was attenuated by DHA, including inhibition of ATP and lactate production. Consequently, we demonstrated that the phosphorylated forms of both S6 ribosomal protein and mechanistic target of rapamycin (mTOR), and GLUT1 levels were abrogated by DHA treatment in NSCLC cells. Furthermore, the upregulation of mTOR activation by high expressed Rheb increased the level of glycolytic metabolism and cell viability inhibited by DHA. These results suggested that DHA-suppressed glycolytic metabolism might be associated with mTOR activation and GLUT1 expression. Besides, we showed GLUT1 overexpression significantly attenuated DHA-triggered NSCLC cells apoptosis. Notably, DHA synergized with 2-Deoxy-D-glucose (2DG, a glycolysis inhibitor) to reduce cell viability and increase cell apoptosis in A549 and PC-9 cells. However, the combination of the two compounds displayed minimal toxicity to WI-38 cells, a normal lung fibroblast cell line. More importantly, 2DG synergistically potentiated DHA-induced activation of caspase-9, -8 and -3, as well as the levels of both cytochrome c and AIF of cytoplasm. However, 2DG failed to increase the reactive oxygen species (ROS) levels elicited by DHA. Overall, the data shown above indicated DHA plus 2DG induced apoptosis was involved in both extrinsic and intrinsic apoptosis pathways in NSCLC cells.	[Mi, Yan-jun; Geng, Guo-jun; Liu, Yu; Li, Ning; Li, Chun-lei; Yu, Xiu-yi; Jiang, Jie] Xiamen Univ, Affiliated Hosp 1, Dept Thorac Surg, Xiamen, Peoples R China; [Mi, Yan-jun; Chen, Yu-qiang] Xiamen Univ, Chenggong Hosp, Dept Med Oncol, Xiamen, Peoples R China; [Zou, Zheng-zhi] S China Normal Univ, Coll Biophoton, MOE Key Lab Laser Life Sci, Guangzhou, Guangdong, Peoples R China; [Zou, Zheng-zhi] S China Normal Univ, Coll Biophoton, Inst Laser Life Sci, Guangzhou, Guangdong, Peoples R China; [Gao, Jing; Luo, Xian-yang] Xiamen Univ, Affiliated Hosp 1, Dept Head & Neck Surg, Xiamen, Peoples R China	Xiamen University; Xiamen University; South China Normal University; South China Normal University; Xiamen University	Yu, XY (corresponding author), Xiamen Univ, Affiliated Hosp 1, Dept Thorac Surg, Xiamen, Peoples R China.	Xiuyiyu@126.com; Jiejiangfy@163.com			Postdoctoral Science Foundation of China [2014M561853]; National Natural Science Foundation of China [81402187]; South China Normal University Science Fund for Young Scholars [670325]; Fujian Provincial Department of Science Technology [2014D020]; Fujian Provincial Department of Health [wzhw201304, wst201214]	Postdoctoral Science Foundation of China(China Postdoctoral Science Foundation); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); South China Normal University Science Fund for Young Scholars; Fujian Provincial Department of Science Technology; Fujian Provincial Department of Health	This study was supported by grants from the Postdoctoral Science Foundation of China (No. 2014M561853 to YJM), the National Natural Science Foundation of China (No. 81402187 to ZZZ), the South China Normal University Science Fund for Young Scholars (No. 670325 to ZZZ), the Fujian Provincial Department of Science & Technology (No. 2014D020 to JJ) and Fujian Provincial Department of Health (wzhw201304, wst201214). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariffin AB, 2014, CANCER RES, V74, P2655, DOI 10.1158/0008-5472.CAN-13-3696; Ben Sahra I, 2010, AUTOPHAGY, V6, P670, DOI 10.4161/auto.6.5.12434; Buller CL, 2008, AM J PHYSIOL-CELL PH, V295, pC836, DOI 10.1152/ajpcell.00554.2007; Cai Y, 2014, J OBSTET GYNAECOL RE, V40, P1925, DOI 10.1111/jog.12447; Chen H, 2010, J CANCER RES CLIN, V136, P897, DOI 10.1007/s00432-009-0731-0; Chen TS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059827; Cheng SC, 2014, SCIENCE, V345, P1579, DOI 10.1126/science.1250684; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Cornu M, 2013, CURR OPIN GENET DEV, V23, P53, DOI 10.1016/j.gde.2012.12.005; Disbrow GL, 2005, CANCER RES, V65, P10854, DOI 10.1158/0008-5472.CAN-05-1216; Dodson M, 2013, AUTOPHAGY, V9, P1996, DOI 10.4161/auto.26094; El Mjiyad N, 2011, ONCOGENE, V30, P253, DOI 10.1038/onc.2010.466; Feng X, 2014, BIOCHEM BIOPH RES CO, V444, P376, DOI 10.1016/j.bbrc.2014.01.053; Handrick R, 2010, MOL CANCER THER, V9, P2497, DOI 10.1158/1535-7163.MCT-10-0051; He Q, 2010, CANCER BIOL THER, V9, P819, DOI 10.4161/cbt.9.10.11552; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Kim SM, 2013, MOL CANCER THER, V12, P2145, DOI 10.1158/1535-7163.MCT-12-1188; Kong R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037222; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Li X, 2006, INT J MOL SCI, V7, P59, DOI 10.3390/i7020059; Liu T, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.493; Lou YF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097719; Lu M, 2014, TUMOR BIOL, V35, P5307, DOI 10.1007/s13277-014-1691-9; Munoz-Pinedo C, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2011.123; Odaka Y, 2014, CARCINOGENESIS, V35, P192, DOI 10.1093/carcin/bgt277; Raina K, 2013, AUTOPHAGY, V9, P697, DOI 10.4161/auto.23960; Rashmi R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092948; Shackelford DB, 2013, CANCER CELL, V23, P143, DOI 10.1016/j.ccr.2012.12.008; Takanaga H, 2010, FASEB J, V24, P2849, DOI 10.1096/fj.09-146472; Vuyyuri SB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067081; Wang QL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017234; Wang SJ, 2011, CANCER CHEMOTH PHARM, V68, P1421, DOI 10.1007/s00280-011-1643-7; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wu GS, 2013, PHARMACOL REP, V65, P453, DOI 10.1016/S1734-1140(13)71021-1; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Zhang CZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039870; Zhang SQ, 2014, ONCOL LETT, V7, P1375, DOI 10.3892/ol.2014.1918; Zhang T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080544; Zhao CB, 2014, APOPTOSIS, V19, P668, DOI 10.1007/s10495-013-0953-0; Zhao YG, 2012, J IMMUNOL, V189, P4417, DOI 10.4049/jimmunol.1200919; Zhou HJ, 2010, CANCER CHEMOTH PHARM, V66, P21, DOI 10.1007/s00280-009-1129-z; Zhu H, 2014, FREE RADICAL BIO MED, V71, P121, DOI 10.1016/j.freeradbiomed.2014.03.026; Zou ZZ, 2012, AUTOPHAGY, V8, P1798, DOI 10.4161/auto.22110	43	44	48	3	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120426	10.1371/journal.pone.0120426	http://dx.doi.org/10.1371/journal.pone.0120426			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799586	Green Published, Green Submitted, gold			2022-12-26	WOS:000351987300142
J	Mougeolle, A; Poussard, S; Decossas, M; Lamaze, C; Lambert, O; Dargelos, E				Mougeolle, Alexis; Poussard, Sylvie; Decossas, Marion; Lamaze, Christophe; Lambert, Olivier; Dargelos, Elise			Oxidative Stress Induces Caveolin 1 Degradation and Impairs Caveolae Functions in Skeletal Muscle Cells	PLOS ONE			English	Article							PROTEINS; LOCALIZATION; TRAFFICKING; ACTIVATION; EXPRESSION; SARCOPENIA; INCREASES; RESPOND; MUTANT; ALPHA	Increased level of oxidative stress, a major actor of cellular aging, impairs the regenerative capacity of skeletal muscle and leads to the reduction in the number and size of muscle fibers causing sarcopenia. Caveolin 1 is the major component of caveolae, small membrane invaginations involved in signaling and endocytic trafficking. Their role has recently expanded to mechanosensing and to the regulation of oxidative stress- induced pathways. Here, we increased the amount of reactive oxidative species in myoblasts by addition of hydrogen peroxide (H2O2) at non-toxic concentrations. The expression level of caveolin 1 was significantly decreased as early as 10 min after 500 mu MH2O2 treatment. This reduction was not observed in the presence of a proteasome inhibitor, suggesting that caveolin 1 was rapidly degraded by the proteasome. In spite of caveolin 1 decrease, caveolae were still able to assemble at the plasma membrane. Their functions however were significantly perturbed by oxidative stress. Endocytosis of a ceramide analog monitored by flow cytometry was significantly diminished after H2O2 treatment, indicating that oxidative stress impaired its selective internalization via caveolae. The contribution of caveolae to the plasma membrane reservoir has been monitored after osmotic cell swelling. H2O2 treatment increased membrane fragility revealing that treated cells were more sensitive to an acute mechanical stress. Altogether, our results indicate that H2O2 decreased caveolin 1 expression and impaired caveolae functions. These data give new insights on age-related deficiencies in skeletal muscle.	[Mougeolle, Alexis; Poussard, Sylvie; Decossas, Marion; Lambert, Olivier; Dargelos, Elise] Univ Bordeaux, UMR 5248, Chim & Biol Membranes & Nanoobjets, F-33600 Pessac, France; [Mougeolle, Alexis; Poussard, Sylvie; Decossas, Marion; Lambert, Olivier; Dargelos, Elise] CNRS, UMR 5248, Chim & Biol Membranes & Nanoobjets, F-33600 Pessac, France; [Mougeolle, Alexis; Poussard, Sylvie; Decossas, Marion; Lambert, Olivier; Dargelos, Elise] Bordeaux INP, UMR 5248, Chim & Biol Membranes & Nanoobjets, F-33600 Pessac, France; [Lamaze, Christophe] Inst Curie, CNRS, Membrane Dynam & Mech Intracellular Signaling Tea, Ctr Rech,INSERM,U1143,UMR 3666, F-75231 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Universite Paris Cite	Dargelos, E (corresponding author), Univ Bordeaux, UMR 5248, Chim & Biol Membranes & Nanoobjets, F-33600 Pessac, France.	dargelos@enscbp.fr	Lamaze, Christophe/M-4912-2017	decossas, marion/0000-0003-0810-4309; Lambert, Olivier/0000-0002-5651-8082; LAMAZE, Christophe/0000-0001-5430-2707	region Aquitaine; Institut Polytechnique Bordeaux (IPB) [20111301001]; Association Francaise contre les Myopathies (AFM) [15485]; AFM [15717]	region Aquitaine(Region Nouvelle-Aquitaine); Institut Polytechnique Bordeaux (IPB); Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); AFM(Association Francaise contre les Myopathies)	A PhD fellowship was awarded to Alexis Mougeolle by the region Aquitaine and the Institut Polytechnique Bordeaux (IPB) for three years (grant no. 20111301001). The Association Francaise contre les Myopathies (AFM) also supported this work during the last two years (grant no. 15485, name "CAVEOX"). C. Lamaze work on caveolae is supported by an AFM grant no. 15717 ("CAV-DYSSTRESS"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barani AE, 2003, J APPL PHYSIOL, V95, P2089, DOI 10.1152/japplphysiol.00437.2003; Barbieri Elena, 2012, J Signal Transduct, V2012, P982794, DOI 10.1155/2012/982794; Bawa R, 2012, NANOMED-NANOTECHNOL, V8, P647, DOI 10.1016/j.nano.2011.08.007; Bernatchez P, 2011, J CLIN INVEST, V121, P3747, DOI 10.1172/JCI44778; Bonor J, 2012, J CELL PHYSIOL, V227, P2880, DOI 10.1002/jcp.23032; Brule C, 2010, BIOCHIMIE, V92, P1923, DOI 10.1016/j.biochi.2010.09.003; Capel F, 2005, MECH AGEING DEV, V126, P505, DOI 10.1016/j.mad.2004.11.001; Capozza F, 2005, AM J PHYSIOL-CELL PH, V288, pC677, DOI 10.1152/ajpcell.00232.2004; Clavel S, 2010, MOL CELL BIOL, V30, P470, DOI 10.1128/MCB.00666-09; Corrotte M, 2013, ELIFE, V2, DOI 10.7554/eLife.00926; Dargelos E, 2010, EXP CELL RES, V316, P115, DOI 10.1016/j.yexcr.2009.07.025; Dasari A, 2006, CANCER RES, V66, P10805, DOI 10.1158/0008-5472.CAN-06-1236; Decossas M, 2003, J COMP NEUROL, V462, P302, DOI 10.1002/cne.10734; Echarri A, 2012, J CELL SCI, V125, P3097, DOI 10.1242/jcs.090134; Evans WJ, 2010, AM J CLIN NUTR, V91, p1123S, DOI 10.3945/ajcn.2010.28608A; EVANS WJ, 1995, J GERONTOL A-BIOL, V50, P5, DOI 10.1093/gerona/50A.Special_Issue.5; Fan XY, 2010, FREE RADICAL BIO MED, V49, P1646, DOI 10.1016/j.freeradbiomed.2010.08.024; FRA AM, 1995, P NATL ACAD SCI USA, V92, P8655, DOI 10.1073/pnas.92.19.8655; Gazzerro E, 2010, EUR J HUM GENET, V18, P137, DOI 10.1038/ejhg.2009.103; Gervasio OL, 2011, J CELL SCI, V124, P3581, DOI 10.1242/jcs.084376; Goudenege S, 2005, INT J BIOCHEM CELL B, V37, P1900, DOI 10.1016/j.biocel.2005.04.010; Head BP, 2006, J BIOL CHEM, V281, P26391, DOI 10.1074/jbc.M602577200; Hill MM, 2008, CELL, V132, P113, DOI 10.1016/j.cell.2007.11.042; Hsieh SR, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-86; Jang YC, 2011, COLD SH Q B, V76, P101, DOI 10.1101/sqb.2011.76.010652; Janssen I, 2004, J AM GERIATR SOC, V52, P80, DOI 10.1111/j.1532-5415.2004.52014.x; Kozera L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008312; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lamberts SWJ, 1997, SCIENCE, V278, P419, DOI 10.1126/science.278.5337.419; Langen RCJ, 2002, AM J PHYSIOL-CELL PH, V283, pC714, DOI 10.1152/ajpcell.00418.2001; Li W, 2012, J BIOL CHEM, V287, P20922, DOI 10.1074/jbc.M112.352336; Ludwig A, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001640; Martone AM, 2013, NUTRIENTS, V5, P4126, DOI 10.3390/nu5104126; Mercier I, 2012, ADV EXP MED BIOL, V729, P83, DOI 10.1007/978-1-4614-1222-9_6; Nassoy P, 2012, TRENDS CELL BIOL, V22, P381, DOI 10.1016/j.tcb.2012.04.007; Palomero J, 2013, AM J PHYSIOL-REG I, V305, pR351, DOI 10.1152/ajpregu.00530.2012; Parpal S, 2001, J BIOL CHEM, V276, P9670, DOI 10.1074/jbc.M007454200; Parton RG, 1997, J CELL BIOL, V136, P137, DOI 10.1083/jcb.136.1.137; Parton RG, 2013, NAT REV MOL CELL BIO, V14, P98, DOI 10.1038/nrm3512; Patel HH, 2008, ANNU REV PHARMACOL, V48, P359, DOI 10.1146/annurev.pharmtox.48.121506.124841; Patel HH, 2009, ANTIOXID REDOX SIGN, V11, P1357, DOI [10.1089/ars.2008.2365, 10.1089/ARS.2008.2365]; Pavlides S, 2012, ADV EXP MED BIOL, V729, P127, DOI 10.1007/978-1-4614-1222-9_9; Pickering AM, 2012, PROG MOL BIOL TRANSL, V109, P227, DOI 10.1016/B978-0-12-397863-9.00006-7; Puri V, 2001, J CELL BIOL, V154, P535, DOI 10.1083/jcb.200102084; Repetto S, 1999, BIOCHEM BIOPH RES CO, V261, P547, DOI 10.1006/bbrc.1999.1055; Shang F, 2011, FREE RADICAL BIO MED, V51, P5, DOI 10.1016/j.freeradbiomed.2011.03.031; Sharma DK, 2005, CANCER RES, V65, P8233, DOI 10.1158/0008-5472.CAN-05-0803; Siebel A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075523; Sinha B, 2011, CELL, V144, P402, DOI 10.1016/j.cell.2010.12.031; Smythe GM, 2003, J CELL SCI, V116, P4739, DOI 10.1242/jcs.00806; STADTMAN ER, 1991, J BIOL CHEM, V266, P2005; Szulc P, 2005, J BONE MINER RES, V20, P721, DOI 10.1359/JBMR.041230; Ushio-Fukai M, 2009, ANTIOXID REDOX SIGN, V11, P1289, DOI [10.1089/ars.2008.2333, 10.1089/ARS.2008.2333]; Volonte D, 2013, MOL BIOL CELL, V24, P1852, DOI 10.1091/mbc.E12-09-0666; von Haehling S, 2010, J CACHEXIA SARCOPENI, V1, P1, DOI 10.1007/s13539-010-0002-6; Won H, 2012, ANTIOXID REDOX SIGN, V16, P245, DOI 10.1089/ars.2011.3952	56	32	34	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0122654	10.1371/journal.pone.0122654	http://dx.doi.org/10.1371/journal.pone.0122654			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799323	gold, Green Submitted, Green Published			2022-12-26	WOS:000351987300338
J	Tadokoro, S; Ide, S; Tokuyama, R; Umeki, H; Tatehara, S; Kataoka, S; Satomura, K				Tadokoro, Susumu; Ide, Shinji; Tokuyama, Reiko; Umeki, Hirochika; Tatehara, Seiko; Kataoka, Shiki; Satomura, Kazuhito			Leptin Promotes Wound Healing in the Skin	PLOS ONE			English	Article							RECEPTOR EXPRESSION; GENE-EXPRESSION; PROLIFERATION; LOCALIZATION; BRAIN; METABOLISM; ACTIVATION; PITUITARY; HORMONE; MITOGEN	Introduction Leptin, a 16 kDa anti-obesity hormone, exhibits various physiological properties. Interestingly, skin wound healing was proven to delay in leptin-deficient ob/ob mice. However, little is known on the mechanisms of this phenomenon. In this study, we attempted to elucidate a role of leptin in wound healing of skin. Methods Immunohistochemical analysis was performed to confirm the expression of the leptin receptor (Ob-R) in human and mouse skin. Leptin was topically administered to chemical wounds created in mouse back skin along with sustained-release absorbable hydrogel. The process of wound repair was histologically observed and the area of ulceration was measured over time. The effect of leptin on the proliferation, differentiation and migration of human epidermal keratinocytes was investigated. Results Ob-R was expressed in epidermal cells of human and mouse skin. Topical administration of leptin significantly promoted wound healing. Histological analysis showed more blood vessels in the dermal connective tissues in the leptin-treated group. The proliferation, differentiation/function and migration of human epidermal keratinocytes were enhanced by exogenous leptin. Conclusion Topically administered leptin was proven to promote wound healing in the skin by accelerating proliferation, differentiation/function and migration of epidermal keratinocytes and enhancing angiogenesis around the wounded area. These results strongly suggest that topical administration of leptin may be useful as a treatment to promote wound healing in the skin.	[Tadokoro, Susumu; Ide, Shinji; Tokuyama, Reiko; Umeki, Hirochika; Tatehara, Seiko; Kataoka, Shiki; Satomura, Kazuhito] Tsurumi Univ, Sch Dent Med, Dept Oral Med & Stomatol, Tsurumi ku, Yokohama, Kanagawa 2308501, Japan	Tsurumi University	Satomura, K (corresponding author), Tsurumi Univ, Sch Dent Med, Dept Oral Med & Stomatol, Tsurumi ku, 2-1-3 Tsurumi, Yokohama, Kanagawa 2308501, Japan.	satomura-k@tsurumi-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [24593015, 24593016, 24659905, 24792262, 25861984, 25293415]; Grants-in-Aid for Scientific Research [25861984] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research (No. 24593015, 24593016, 24659905, 24792262, 25861984, and 25293415) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bado A, 1998, NATURE, V394, P790, DOI 10.1038/29547; Bouloumie A, 1998, CIRC RES, V83, P1059, DOI 10.1161/01.RES.83.10.1059; Bryson JM, 1999, AM J PHYSIOL-ENDOC M, V277, pE417, DOI 10.1152/ajpendo.1999.277.3.E417; Cohen P, 2005, J BIOL CHEM, V280, P10034, DOI 10.1074/jbc.M413684200; De Matteis R, 1998, P NUTR SOC, V57, P441, DOI 10.1079/PNS19980063; Ducy P, 2000, CELL, V100, P197, DOI 10.1016/S0092-8674(00)81558-5; FEDARKO NS, 1995, J BONE MINER RES, V10, P1705; Fei H, 1997, P NATL ACAD SCI USA, V94, P7001, DOI 10.1073/pnas.94.13.7001; Frank S, 2000, J CLIN INVEST, V106, P501, DOI 10.1172/JCI9148; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Gainsford T, 1996, P NATL ACAD SCI USA, V93, P14564, DOI 10.1073/pnas.93.25.14564; Guerra B, 2007, J APPL PHYSIOL, V102, P1786, DOI 10.1152/japplphysiol.01313.2006; Hwa JJ, 1996, HORM METAB RES, V28, P659, DOI 10.1055/s-2007-979873; Ide S, 2011, HISTOCHEM CELL BIOL, V135, P281, DOI 10.1007/s00418-011-0789-z; Islam MS, 1997, BIOCHEM BIOPH RES CO, V238, P851, DOI 10.1006/bbrc.1997.7399; Jin L, 1999, J CLIN ENDOCR METAB, V84, P2903, DOI 10.1210/jc.84.8.2903; Kume K, 2002, J HISTOCHEM CYTOCHEM, V50, P159, DOI 10.1177/002215540205000204; Liapaki I, 2008, ACTA CIR BRAS, V23, P118, DOI 10.1590/S0102-86502008000200002; Marikovsky M, 2002, WOUND REPAIR REGEN, V10, P302, DOI 10.1046/j.1524-475X.2002.10505.x; Masuzaki H, 1997, NAT MED, V3, P1029, DOI 10.1038/nm0997-1029; Mercer JG, 1996, FEBS LETT, V387, P113, DOI 10.1016/0014-5793(96)00473-5; Morash B, 1999, ENDOCRINOLOGY, V140, P5995, DOI 10.1210/en.140.12.5995; Murad A, 2003, FASEB J, V17, P1895, DOI 10.1096/fj.03-0068fje; Ring BD, 2000, ENDOCRINOLOGY, V141, P446, DOI 10.1210/en.141.1.446; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sierra-Honigmann MR, 1998, SCIENCE, V281, P1683, DOI 10.1126/science.281.5383.1683; Skobowiat C, 2015, J INVEST DERMATOL, V135, P1638, DOI 10.1038/jid.2014.450; Slominski A, 2000, PHYSIOL REV, V80, P979, DOI 10.1152/physrev.2000.80.3.979; Slominski AT, 2012, ADV ANAT EMBRYOL CEL, V212, P1; Slominski AT, 2013, ENDOCR REV, V34, P827, DOI 10.1210/er.2012-1092; Spicer LJ, 1997, ENDOCRINOLOGY, V138, P3374, DOI 10.1210/en.138.8.3374; Stallmeyer B, 2001, J INVEST DERMATOL, V117, P98, DOI 10.1046/j.0022-202x.2001.01387.x; Tanabe K, 1997, BIOCHEM BIOPH RES CO, V241, P765, DOI 10.1006/bbrc.1997.7894; Tsuchiya T, 1999, EUR J PHARMACOL, V365, P273, DOI 10.1016/S0014-2999(98)00884-X; Umeki H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101984; Wang JL, 1998, NATURE, V393, P684, DOI 10.1038/31474; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0; Zhu G, 2014, EXP DERMATOL, V23, P15, DOI 10.1111/exd.12275	38	54	57	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121242	10.1371/journal.pone.0121242	http://dx.doi.org/10.1371/journal.pone.0121242			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799398	Green Submitted, gold, Green Published			2022-12-26	WOS:000351987300229
J	Yamada, A; Aki, T; Unuma, K; Funakoshi, T; Uemura, K				Yamada, Atsushi; Aki, Toshihiko; Unuma, Kana; Funakoshi, Takeshi; Uemura, Koichi			Paraquat Induces Epithelial-Mesenchymal Transition-Like Cellular Response Resulting in Fibrogenesis and the Prevention of Apoptosis in Human Pulmonary Epithelial Cells	PLOS ONE			English	Article							SMOOTH MUSCLE ACTIN; LUNG; FIBROSIS; PIRFENIDONE; FIBROBLASTS; SUPPRESSION; MECHANISMS; SB-431542; INHIBITOR; CLEAVAGE	The aim of this study is to investigate the molecular mechanisms underlying delayed progressive pulmonary fibrosis, a characteristic of subacute paraquat (PQ) poisoning. Epithelial-mesenchymal transition (EMT) has been proposed as a cause of organ fibrosis, and transforming growth factor-beta (TGF-beta) is suggested to be a powerful mediator of EMT. We thus examined the possibility that EMT is involved in pulmonary fibrosis during PQ poisoning using A549 human alveolar epithelial cells in vitro. The cells were treated with various concentrations of PQ (0-500 mu M) for 2-12 days. Short-term (2 days) high-dose (> 100 mu M) treatments with PQ induced cell death accompanied by the activation of caspase9 as well as a decrease in E-cadherin (an epithelial cell marker), suggesting apoptotic cell death with the features of anoikis (cell death due to the loss of cell-cell adhesion). In contrast, long-term (6-12 days) low-dose (30 mu M) treatments with PQ resulted in a transformation into spindle-shaped mesenchymal-like cells with a decrease of E-cadherin as well as an increase of alpha-smooth muscle actin (alpha-SMA). The mesenchymal-like cells also secreted the extracellular matrix (ECM) protein fibronectin into the culture medium. The administration of a TGF-beta 1 receptor antagonist, SB431542, almost completely attenuated the mesenchymal transformation as well as fibronectin secretion, suggesting a crucial role of TGF-beta 1 in EMT-like cellular response and subsequent fibrogenesis. It is noteworthy that despite the suppression of EMT-fibrogenesis, apoptotic death was observed in cells treated with PQ+SB431542. EMT-like cellular response and subsequent fibrogenesis were also observed in normal human bronchial epithelial (NHBE) cells exposed to PQ in a TGF-beta 1-dependent manner. Taken together, our experimental model reflects well the etiology of PQ poisoning in human and shows the involvement of EMT-like cellular response in both fibrogenesis and resistance to cell death during subacute PQ poisoning of pulmonary epithelial cells.	[Yamada, Atsushi; Aki, Toshihiko; Unuma, Kana; Funakoshi, Takeshi; Uemura, Koichi] Tokyo Med & Dent Univ, Dept Forens Med, Grad Sch Med & Dent Sci, Tokyo, Japan	Tokyo Medical & Dental University (TMDU)	Aki, T (corresponding author), Tokyo Med & Dent Univ, Dept Forens Med, Grad Sch Med & Dent Sci, Tokyo, Japan.	aki.legm@tmd.ac.jp		Yamada, Atsushi/0000-0001-7598-5877	MEXT KAKENHI [25460862, 25460863]	MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Funding: MEXT KAKENHI Grant Number 25460862 to TA and Grant Number 25460863 to K. Uemura.	Nieto MA, 2011, ANNU REV CELL DEV BI, V27, P347, DOI 10.1146/annurev-cellbio-092910-154036; Barth K, 2005, HISTOCHEM CELL BIOL, V124, P453, DOI 10.1007/s00418-005-0048-2; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cappelletti G, 1998, CELL BIOL INT, V22, P671, DOI 10.1006/cbir.1998.0305; Chapman HA, 2011, ANNU REV PHYSIOL, V73, P413, DOI 10.1146/annurev-physiol-012110-142225; Chen T, 2014, TOXICOL LETT, V226, P150, DOI 10.1016/j.toxlet.2014.02.004; Chen YW, 2012, ARCH TOXICOL, V86, P1547, DOI 10.1007/s00204-012-0873-8; Chiarugi P, 2008, BIOCHEM PHARMACOL, V76, P1352, DOI 10.1016/j.bcp.2008.07.023; Frisch SM, 2013, J CELL SCI, V126, P21, DOI 10.1242/jcs.120907; Gawarammana IB, 2011, BRIT J CLIN PHARMACO, V72, P745, DOI 10.1111/j.1365-2125.2011.04026.x; Gorowiec MR, 2012, FREE RADICAL BIO MED, V52, P1024, DOI 10.1016/j.freeradbiomed.2011.12.020; Grooteclaes ML, 2000, ONCOGENE, V19, P3823, DOI 10.1038/sj.onc.1203721; Halder SK, 2005, NEOPLASIA, V7, P509, DOI 10.1593/neo.04640; Hong SY, 2003, TOXICOL IND HEALTH, V19, P17, DOI 10.1191/0748233703th171oa; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Ishiguro S, 2009, WOUND REPAIR REGEN, V17, P617, DOI 10.1111/j.1524-475X.2009.00511.x; Ishii G, 2007, STEM CELLS, V25, P1469, DOI 10.1634/stemcells.2006-0449; Ishii GH, 2005, STEM CELLS, V23, P699, DOI 10.1634/stemcells.2004-0183; Kage H, 2012, CURR OPIN PULM MED, V18, P517, DOI 10.1097/MCP.0b013e3283566721; Kan BT, 2014, MOL MED REP, V9, P1232, DOI 10.3892/mmr.2014.1938; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Mejlvang J, 2007, MOL BIOL CELL, V18, P4615, DOI 10.1091/mbc.E07-05-0406; Nakazono-Kusaba A, 2002, J INVEST DERMATOL, V119, P1008, DOI 10.1046/j.1523-1747.2002.19525.x; Oku H, 2008, EUR J PHARMACOL, V590, P400, DOI 10.1016/j.ejphar.2008.06.046; Omura T, 2013, BIOCHEM BIOPH RES CO, V432, P689, DOI 10.1016/j.bbrc.2013.01.131; Reddig PJ, 2005, CANCER METAST REV, V24, P425, DOI 10.1007/s10555-005-5134-3; Seifirad S, 2012, CLIN TOXICOL, V50, P754, DOI 10.3109/15563650.2012.718783; Smith P, 1975, J Clin Pathol Suppl (R Coll Pathol), V9, P81, DOI 10.1136/jcp.28.Suppl_9.81; Suntres ZE, 2002, TOXICOLOGY, V180, P65, DOI 10.1016/S0300-483X(02)00382-7; Tsai JH, 2013, GENE DEV, V27, P2192, DOI 10.1101/gad.225334.113; Vega S, 2004, GENE DEV, V18, P1131, DOI 10.1101/gad.294104; Xie H, 2013, EXP BIOL MED, V238, P1062, DOI 10.1177/1535370213498978; Yang W, 2009, TOXICOL LETT, V191, P203, DOI 10.1016/j.toxlet.2009.08.024; Yang YA, 2014, J CLIN INVEST, V124, P2696, DOI 10.1172/JCI72171; Yu NW, 2010, UROLOGY, V76, DOI 10.1016/j.urology.2010.03.061	36	31	37	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120192	10.1371/journal.pone.0120192	http://dx.doi.org/10.1371/journal.pone.0120192			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799450	Green Published, gold, Green Submitted			2022-12-26	WOS:000351987300110
J	Zhang, Q; Yu, L; Qin, DD; Huang, R; Jiang, XC; Zou, CD; Tang, QC; Chen, YG; Wang, GY; Wang, XS; Gao, X				Zhang, Qian; Yu, Lei; Qin, Dandan; Huang, Rui; Jiang, Xiaochen; Zou, Chendan; Tang, Qingchao; Chen, Yinggang; Wang, Guiyu; Wang, Xishan; Gao, Xu			Role of microRNA-30c Targeting ADAM19 in Colorectal Cancer	PLOS ONE			English	Article							CELL LUNG-CANCER; POTENTIAL TUMOR-SUPPRESSOR; BREAST-CANCER; HEPATOCELLULAR-CARCINOMA; MESENCHYMAL TRANSITION; PROGNOSTIC VALUE; EXPRESSION; METASTASIS; INVASION; PROLIFERATION	MicroRNAs (miRNAs) are deregulated in a number of cancers including colorectal cancer. MiR-30c belongs to miR-30 family, and is involved in a variety of malignant diseases. In this study, we detected the expression of miR-30c in colon cancer cell lines and clinical colon cancer specimens. MiR-30c was shown to be dramatically down-regulated both in cell lines and cancer tissues. Additionally, miR-30c could inhibit cancer cell growth, migration and invasion in vitro. Consistently, stable over-expression of miR-30c inhibited the growth and lung metastasis of colon cancer cell xenografts in vivo. Furthermore, bioinformatics algorithm and luciferase reporter assay indicated ADAM19 as a direct target of miR-30c. Of interest, further experiments demonstrated that inhibition of ADAM19 by miR-30c partially mediated the anti-tumor effect of miR-30c. Overall, our study provides the new insight that miR-30c inhibited colon cancer cells via targeting ADAM19. Thus, miR-30c might serve as a promising therapeutic strategy for colon cancer treatment.	[Zhang, Qian; Yu, Lei; Huang, Rui; Tang, Qingchao; Chen, Yinggang; Wang, Guiyu; Wang, Xishan] Harbin Med Univ, Affiliated Hosp 2, Dept Colorectal Surg, Harbin 150086, Heilongjiang, Peoples R China; [Zhang, Qian; Yu, Lei; Huang, Rui; Tang, Qingchao; Chen, Yinggang; Wang, Guiyu; Wang, Xishan] Harbin Med Univ, Colorectal Canc Inst, Harbin 150086, Heilongjiang, Peoples R China; [Qin, Dandan] Harbin Med Univ, Affiliated Hosp 2, Dept Nephrol, Harbin 150086, Heilongjiang, Peoples R China; [Jiang, Xiaochen; Zou, Chendan; Gao, Xu] Harbin Med Univ, Dept Biochem & Mol Biol, Harbin 150086, Heilongjiang, Peoples R China	Harbin Medical University; Harbin Medical University; Harbin Medical University; Harbin Medical University	Wang, GY (corresponding author), Harbin Med Univ, Affiliated Hosp 2, Dept Colorectal Surg, Harbin 150086, Heilongjiang, Peoples R China.	guiywang@163.com; wxshan1208@126.com; Gaoxu_671227@yahoo.com.cn	gao, xu/U-4765-2019					Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Budhu A, 2008, HEPATOLOGY, V47, P897, DOI 10.1002/hep.22160; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Calin GA, 2004, P NATL ACAD SCI USA, V101, P11755, DOI 10.1073/pnas.0404432101; Chan SH, 2014, ONCOGENE, V33, P4496, DOI 10.1038/onc.2014.10; Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; Cheng CW, 2012, BREAST CANCER RES TR, V134, P1081, DOI 10.1007/s10549-012-2034-4; Dobson JR, 2014, CANCER CELL INT, V14, DOI 10.1186/s12935-014-0073-0; Fernandez S, 2014, ONCOGENE; Fuster O, 2013, LEUKEMIA RES, V37, P1690, DOI 10.1016/j.leukres.2013.09.015; Gaziel-Sovran A, 2011, CANCER CELL, V20, P104, DOI 10.1016/j.ccr.2011.05.027; Hu ZB, 2010, J CLIN ONCOL, V28, P1721, DOI 10.1200/JCO.2009.24.9342; Huang JW, 2013, CANCER SCI, V104, P1609, DOI 10.1111/cas.12291; Ichikawa T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031422; Jurmeister S, 2012, MOL CELL BIOL, V32, P633, DOI 10.1128/MCB.06212-11; Kong X, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0090810, DOI 10.1371/JOURNAL.PONE.0090810]; Kumarswamy R, 2012, INT J CANCER, V130, P2044, DOI 10.1002/ijc.26218; Leung YK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098037; Li N, 2012, CANCER RES, V72, P154, DOI 10.1158/0008-5472.CAN-11-2484; Li Q, 2013, CANCER LETT, V335, P168, DOI 10.1016/j.canlet.2013.02.029; Li S, 2012, BREAST CANCER RES TR, V136, P77, DOI 10.1007/s10549-012-2166-6; Li XH, 2010, GUT, V59, P579, DOI 10.1136/gut.2008.175497; Ling XH, 2014, MOL BIOL REP, V41, P2779, DOI 10.1007/s11033-014-3132-7; Liu N, 2012, LANCET ONCOL, V13, DOI 10.1016/S1470-2045(12)70102-X; Michael MZ, 2003, MOL CANCER RES, V1, P882; Mochizuki S, 2007, CANCER SCI, V98, P621, DOI 10.1111/j.1349-7006.2007.00434.x; Quintavalle C, 2013, ONCOGENE, V32, P4001, DOI 10.1038/onc.2012.410; Ramdas V, 2013, AM J PATHOL, V183, P1885, DOI 10.1016/j.ajpath.2013.08.027; Rodriguez-Gonzalez FG, 2011, BREAST CANCER RES TR, V127, P43, DOI 10.1007/s10549-010-0940-x; Roemer A, 2004, ONCOL REP, V11, P529; Seals DF, 2003, GENE DEV, V17, P7, DOI 10.1101/gad.1039703; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Visone R, 2007, ONCOGENE, V26, P7590, DOI 10.1038/sj.onc.1210564; Wang HX, 2005, MOL HUM REPROD, V11, P429, DOI 10.1093/molehr/gah183; Wang YH, 2014, BIOCHEM BIOPH RES CO, V444, P199, DOI 10.1016/j.bbrc.2014.01.028; Wildeboer D, 2006, J NEUROPATH EXP NEUR, V65, P516, DOI 10.1097/01.jnen.0000229240.51490.d3; Wu FT, 2009, CLIN CANCER RES, V15, P1550, DOI 10.1158/1078-0432.CCR-08-0820; Yamakuchi M, 2008, P NATL ACAD SCI USA, V105, P13421, DOI 10.1073/pnas.0801613105; Yamakuchi M, 2010, P NATL ACAD SCI USA, V107, P6334, DOI 10.1073/pnas.0911082107; Yao J, 2010, HEPATOLOGY, V51, P846, DOI 10.1002/hep.23443; Zhong K, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-703; Zhou HM, 2004, MOL CELL BIOL, V24, P96, DOI 10.1128/MCB.24.1.96-104.2004	42	40	45	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120698	10.1371/journal.pone.0120698	http://dx.doi.org/10.1371/journal.pone.0120698			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799050	Green Submitted, Green Published, gold			2022-12-26	WOS:000351987300165
J	Bertram, K; Valcu, CM; Weitnauer, M; Linne, U; Gorlach, A				Bertram, Katharina; Valcu, Cristina-Maria; Weitnauer, Michael; Linne, Uwe; Goerlach, Agnes			NOX1 Supports the Metabolic Remodeling of HepG2 Cells	PLOS ONE			English	Article							HUMAN HEPATOCELLULAR-CARCINOMA; ALPHA-FETOPROTEIN EXPRESSION; NADPH OXIDASE; PROTEOMIC ANALYSIS; RAT-LIVER; SIGNALING PATHWAY; GENE-EXPRESSION; CANCER GROWTH; ANNEXIN A3; PROTEIN	NADPH oxidases are important sources of reactive oxygen species (ROS) which act as signaling molecules in the regulation of protein expression, cell proliferation, differentiation, migration and cell death. The NOX1 subunit is over-expressed in several cancers and NOX1 derived ROS have been repeatedly linked with tumorigenesis and tumor progression although underlying pathways are ill defined. We engineered NOX1-depleted HepG2 hepatoblastoma cells and employed differential display 2DE experiments in order to investigate changes in NOX1-dependent protein expression profiles. A total of 17 protein functions were identified to be dysregulated in NOX1-depleted cells. The proteomic results support a connection between NOX1 and the Warburg effect and a role for NOX in the regulation of glucose and glutamine metabolism as well as of lipid, protein and nucleotide synthesis in hepatic tumor cells. Metabolic remodeling is a common feature of tumor cells and understanding the underlying mechanisms is essential for the development of new cancer treatments. Our results reveal a manifold involvement of NOX1 in the metabolic remodeling of hepatoblastoma cells towards a sustained production of building blocks required to maintain a high proliferative rate, thus rendering NOX1 a potential target for cancer therapy.	[Bertram, Katharina; Valcu, Cristina-Maria; Weitnauer, Michael; Goerlach, Agnes] Tech Univ Munich, German Heart Ctr Munich, Expt & Mol Paediat Cardiol, D-80290 Munich, Germany; [Linne, Uwe] Univ Marburg, Chem Dept Mass Spectrometry, Marburg, Germany	German Heart Centre Munich; Technical University of Munich; Philipps University Marburg	Valcu, CM (corresponding author), Max Planck Inst Ornithol, Behav Ecol & Evolutionary Genet, Eberhard Gwinner Str 8, D-82319 Seewiesen, Germany.	cvalcu@orn.mpg.de; goerlach@dhm.mhn.de		Valcu, Cristina-Maria/0000-0002-3336-6979	EU 7th Metoxia [FP222471]; DFG [GO709/4-5]; EU COST action [BM1203]; German Ministry of Education and Research (BMBF); Technical University Munich through research scholarships within the program "Chancengleicheit fur Frauen in Forschung und Lehre"	EU 7th Metoxia; DFG(German Research Foundation (DFG)); EU COST action(European Cooperation in Science and Technology (COST)European Commission); German Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Technical University Munich through research scholarships within the program "Chancengleicheit fur Frauen in Forschung und Lehre"	This work was supported by EU 7th FP222471 Metoxia, DFG GO709/4-5, EU COST action BM1203 and in part by the German Ministry of Education and Research (BMBF) (AG). CMV and KB were supported by Technical University Munich through research scholarships within the program "Chancengleicheit fur Frauen in Forschung und Lehre". AG is member of the German Center for Cardiovascular disease (DZHK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelev GI, 1999, SEMIN CANCER BIOL, V9, P95, DOI 10.1006/scbi.1998.0084; Adachi Y, 2008, ONCOGENE, V27, P4921, DOI 10.1038/onc.2008.133; Adams JC, 2004, CURR OPIN CELL BIOL, V16, P590, DOI 10.1016/j.ceb.2004.07.009; Alberghina L, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00362; ANDERSON NL, 1991, ELECTROPHORESIS, V12, P907, DOI 10.1002/elps.1150121110; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Block K, 2012, NAT REV CANCER, V12, P627, DOI 10.1038/nrc3339; Block K, 2010, AM J PATHOL, V176, P2447, DOI 10.2353/ajpath.2010.090606; BRICKER LA, 1972, J CLIN INVEST, V51, P206, DOI 10.1172/JCI106805; Chaerkady R, 2008, J PROTEOME RES, V7, P4289, DOI 10.1021/pr800197z; Cheng G, 2006, J BIOL CHEM, V281, P17718, DOI 10.1074/jbc.M512751200; Chintagari NR, 2006, AM J RESP CELL MOL, V34, P677, DOI 10.1165/rcmb.2005-0418OC; Chopra A, 2010, PEDIATR SURG INT, V26, P1173, DOI 10.1007/s00383-010-2699-x; Codarin E, 2009, J PROTEOME RES, V8, P2273, DOI 10.1021/pr8009275; Deisenroth C, 2010, MOL CELL BIOL, V30, P3981, DOI 10.1128/MCB.01284-09; DESDOUETS C, 1995, J HEPATOL, V23, P569, DOI 10.1016/0168-8278(95)80064-6; Desouki MM, 2005, CANCER BIOL THER, V4, P1367, DOI 10.4161/cbt.4.12.2233; Djordjevic T, 2005, FREE RADICAL BIO MED, V38, P616, DOI 10.1016/j.freeradbiomed.2004.09.036; Fella K, 2005, PROTEOMICS, V5, P1914, DOI 10.1002/pmic.200401067; Fox J, EFFECTS EFFECT DISPL; Friesen WJ, 2002, J BIOL CHEM, V277, P8243, DOI 10.1074/jbc.M109984200; FROHLICH M, 1990, MOL CELL BIOL, V10, P3216, DOI 10.1128/MCB.10.6.3216; Fukuyama M, 2005, CANCER LETT, V221, P97, DOI 10.1016/j.canlet.2004.08.031; Geiszt M, 2003, J IMMUNOL, V171, P299, DOI 10.4049/jimmunol.171.1.299; GLAZER RI, 1974, CANCER RES, V34, P2975; Gorlach A, 2001, CIRC RES, V89, P47, DOI 10.1161/hh1301.092678; Gupta D, 2010, NUTR J, V9, DOI 10.1186/1475-2891-9-69; Harashima M, 2008, J BIOCHEM, V143, P537, DOI 10.1093/jb/mvm248; Harrell FE, HMISC S FUNCTION LIB; Hashimoto Y, 2005, INT J BIOCHEM CELL B, V37, P1787, DOI 10.1016/j.biocel.2005.05.004; Hayashi Y, 2011, CANCER SCI, V102, P1228, DOI 10.1111/j.1349-7006.2011.01910.x; Hothorn T, MULTCOMP R PACK VERS; Huang Y, 2008, MOL CELL BIOCHEM, V309, P117, DOI 10.1007/s11010-007-9649-5; Igleslas J, 1999, AM J PHYSIOL-RENAL, V277, pF711, DOI 10.1152/ajprenal.1999.277.5.F711; Iguchi T, 2009, J SURG ONCOL, V100, P575, DOI 10.1002/jso.21377; Jin JY, 2005, J BIOL CHEM, V280, P41207, DOI 10.1074/jbc.M509128200; Jones DT, 2003, BLOOD, V101, P3174, DOI 10.1182/blood-2002-07-2143; Kamata T, 2009, CANCER SCI, V100, P1382, DOI 10.1111/j.1349-7006.2009.01207.x; Kawano K, 2001, EXP CELL RES, V262, P180, DOI 10.1006/excr.2000.5083; KAWATA S, 1990, CANCER RES, V50, P3270; Kim JY, 2012, NUCLEIC ACIDS RES, V40, P75, DOI 10.1093/nar/gkr614; Kuhlmann WD, 2006, INT J EXP PATHOL, V87, P343, DOI 10.1111/j.1365-2613.2006.00485.x; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Lapsley M, ODBC DATABASE CONNEC; Laurent E, 2008, INT J CANCER, V123, P100, DOI 10.1002/ijc.23423; LEA MA, 1972, CANCER RES, V32, P61; Lee JS, 2004, HEPATOLOGY, V40, P667, DOI 10.1002/hep.20375; Leithner K, 2015, ONCOGENE, V34, P1044, DOI 10.1038/onc.2014.47; Li C, 2004, MOL CELL PROTEOMICS, V3, P399, DOI 10.1074/mcp.M300133-MCP200; Li C, 2012, J PROTEOME RES, V11, P871, DOI 10.1021/pr2006999; Li LF, 2010, FEBS LETT, V584, P995, DOI 10.1016/j.febslet.2010.01.044; Li LO, 2010, BBA-MOL CELL BIOL L, V1801, P246, DOI 10.1016/j.bbalip.2009.09.024; Li LO, 2009, J BIOL CHEM, V284, P27816, DOI 10.1074/jbc.M109.022467; Li YC, 2006, AM J PATHOL, V168, P1107, DOI 10.2353/ajpath.2006.050959; Liang RCMY, 2002, J CHROMATOGR B, V771, P303, DOI 10.1016/S1570-0232(02)00041-7; Lim SD, 2005, PROSTATE, V62, P200, DOI 10.1002/pros.20137; Liu YF, 2009, J PATHOL, V217, P54, DOI 10.1002/path.2429; Lu WQ, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001326; MATSUNO T, 1991, J CELL PHYSIOL, V148, P290, DOI 10.1002/jcp.1041480215; Mayer G, 2008, J BIOL CHEM, V283, P31791, DOI 10.1074/jbc.M805971200; Mendez-Lucas A, 2014, J BIOL CHEM; Mitsushita J, 2004, CANCER RES, V64, P3580, DOI 10.1158/0008-5472.CAN-03-3909; Mohammad HS, 2008, INT J ONCOL, V33, P1157, DOI 10.3892/ijo_00000105; Monge M, 2009, CARCINOGENESIS, V30, P1288, DOI 10.1093/carcin/bgp119; MOSIALOS G, 1994, J VIROL, V68, P7320, DOI 10.1128/JVI.68.11.7320-7328.1994; Murray MJ, 2011, ARCH DIS CHILDHOOD-E, V96, P141, DOI 10.1136/adc.2011.213181; NAKABAYASHI H, 1982, CANCER RES, V42, P3858; Niimi S, 2005, BIOL PHARM BULL, V28, P424, DOI 10.1248/bpb.28.424; Niwa Y, 1996, HEPATOLOGY, V23, P1384, DOI 10.1053/jhep.1996.v23.pm0008675155; Ouellet V, 2006, INT J CANCER, V119, P2119, DOI 10.1002/ijc.22054; Park JE, 2005, BIOCHEM BIOPH RES CO, V337, P1283, DOI 10.1016/j.bbrc.2005.10.004; Parkes HA, 2006, AM J PHYSIOL-ENDOC M, V291, pE737, DOI 10.1152/ajpendo.00112.2006; Pellegrini S, 2002, BBA-GENE STRUCT EXPR, V1574, P215, DOI 10.1016/S0167-4781(01)00323-2; Peng Y, 2008, P NATL ACAD SCI USA, V105, P5236, DOI 10.1073/pnas.0712262105; Peng Y, 2010, J CELL MOL MED, V14, P2780, DOI 10.1111/j.1582-4934.2009.00936.x; Petry A, 2006, ANTIOXID REDOX SIGN, V8, P1473, DOI 10.1089/ars.2006.8.1473; Petry A, 2010, ANTIOXID REDOX SIGN, V13, P467, DOI 10.1089/ars.2009.3026; Pinheiro J, 2001, MIXED EFFECTS MODELS; Pinheiro J., NLME LINEAR NONLINEA; Puca R, 2010, FREE RADICAL BIO MED, V48, P1338, DOI 10.1016/j.freeradbiomed.2010.02.015; R Development Core Team, 2006, R LANG ENV STAT COMP; Rampersad SN, 2012, SENSORS-BASEL, V12, P12347, DOI 10.3390/s120912347; Rasheed Z, 2007, J EXP CLIN CANC RES, V26, P395; Rechsteiner M, 2000, BIOCHEM J, V345, P1, DOI 10.1042/0264-6021:3450001; Sadok A, 2008, BBA-MOL CELL RES, V1783, P23, DOI 10.1016/j.bbamcr.2007.10.010; Sadok A, 2009, MOL CELL BIOL, V29, P3915, DOI 10.1128/MCB.01199-08; Sancho P, 2010, J BIOL CHEM, V285, P24815, DOI 10.1074/jbc.M110.114280; Sarkar D., LATTICE MULTIVARIATE; Seifert U, 2010, CELL, V142, P613, DOI 10.1016/j.cell.2010.07.036; SELL S, 1979, BIOCHIM BIOPHYS ACTA, V564, P173, DOI 10.1016/0005-2787(79)90198-9; Shafqat N, 2006, CELL MOL LIFE SCI, V63, P1205, DOI 10.1007/s00018-006-6013-y; Shevchenko A, 2009, J PROTEOMICS, V72, P137, DOI 10.1016/j.jprot.2009.01.012; Shimada K, 2009, CANCER RES, V69, P3157, DOI 10.1158/0008-5472.CAN-08-3530; Shinohara M, 2007, J BIOL CHEM, V282, P17640, DOI 10.1074/jbc.M609450200; Son J, 2013, NATURE, V496, P101, DOI 10.1038/nature12040; Tanaka T, 2004, ONCOGENE, V23, P3980, DOI 10.1038/sj.onc.1207555; Tominaga K, 2007, FREE RADICAL BIO MED, V43, P1627, DOI 10.1016/j.freeradbiomed.2007.08.029; Valcu CM, 2009, J PROTEOME RES, V8, P4077, DOI 10.1021/pr900456c; VILLA P, 1992, IN VITRO CELL DEV-AN, V28A, P157; Wang CY, 2014, DIS MARKERS, V2014, DOI 10.1155/2014/308976; Warburg O, 1927, J GEN PHYSIOL, V8, P519, DOI 10.1085/jgp.8.6.519; Warnes GR, SSIZE COMPUTE PLOT P; White-Gilbertson S, 2009, MOL ONCOL, V3, P402, DOI 10.1016/j.molonc.2009.05.003; Yokoo H, 2004, HEPATOLOGY, V40, P609, DOI 10.1002/hep.20372; Zhang Feng, 2012, World J Biol Chem, V3, P167, DOI 10.4331/wjbc.v3.i8.167	105	12	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0122002	10.1371/journal.pone.0122002	http://dx.doi.org/10.1371/journal.pone.0122002			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25806803	gold, Green Published			2022-12-26	WOS:000351880000196
J	Kovacs, L; Nagy, O; Pal, M; Udvardy, A; Popescu, O; Deak, P				Kovacs, Levente; Nagy, Olga; Pal, Margit; Udvardy, Andor; Popescu, Octavian; Deak, Peter			Role of the Deubiquitylating Enzyme DmUsp5 in Coupling Ubiquitin Equilibrium to Development and Apoptosis in Drosophila melanogaster	PLOS ONE			English	Article							CELL-CYCLE CONTROL; DEUBIQUITINATING ENZYMES; REGULATORY MECHANISMS; POLYUBIQUITIN CHAINS; PROTEIN-DEGRADATION; ALPHA-SYNUCLEIN; STRESS-RESPONSE; PROTEASOME; ISOPEPTIDASE; GENES	Protein ubiquitylation is a dynamic process that affects the function and stability of proteins and controls essential cellular processes ranging from cell proliferation to cell death. This process is regulated through the balanced action of E3 ubiquitin ligases and deubiquitylating enzymes (DUB) which conjugate ubiquitins to, and remove them from target proteins, respectively. Our genetic analysis has revealed that the deubiquitylating enzyme DmUsp5 is required for maintenance of the ubiquitin equilibrium, cell survival and normal development in Drosophila. Loss of the DmUsp5 function leads to late larval lethality accompanied by the induction of apoptosis. Detailed analyses at a cellular level demonstrated that DmUsp5 mutants carry multiple abnormalities, including a drop in the free monoubiquitin level, the excessive accumulation of free polyubiquitins, polyubiquitylated proteins and sub-units of the 26S proteasome. A shortage in free ubiquitins results in the induction of a ubiquitin stress response previously described only in the unicellular budding yeast. It is characterized by the induction of the proteasome-associated deubiquitylase DmUsp14 and sensitivity to cycloheximide. Removal of DmUsp5 also activates the pro-apoptotic machinery thereby resulting in widespread apoptosis, indicative of an anti-apoptotic role of DmUsp5. Collectively, the pleiotropic effects of a loss of DmUsp5 function can be explained in terms of the existence of a limited pool of free monoubiquitins which makes the ubiquitin-dependent processes mutually interdependent.	[Kovacs, Levente; Pal, Margit; Deak, Peter] Univ Szeged, Dept Genet, Szeged, Hungary; [Kovacs, Levente; Nagy, Olga; Pal, Margit; Udvardy, Andor; Deak, Peter] Hungarian Acad Sci, Biol Res Ctr, Inst Biochem, H-6701 Szeged, Hungary; [Popescu, Octavian] Univ Babes Bolyai, Ctr Mol Biol, Interdisciplinary Res Inst Bionanosci, R-3400 Cluj Napoca, Romania	Szeged University; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center; Babes Bolyai University from Cluj	Deak, P (corresponding author), Univ Szeged, Dept Genet, Szeged, Hungary.	deakp@bio.u-szeged.hu	Udvardy, Andor/AAA-1473-2022; Deák, Péter/M-5674-2018; Popescu, Octavian/O-2134-2019; Popescu, Octavian/E-4942-2010; Kovacs, Levente/AAA-6730-2022	Popescu, Octavian/0000-0002-2597-7155; Popescu, Octavian/0000-0002-2597-7155; Deak, Peter/0000-0002-8849-0352; Nagy, Olga/0000-0003-1471-5165; Kovacs, Levente/0000-0002-3226-3740	European Union; European Social Fund [TAMOP4.2.2.A-11/1/KONV-2012-0035, TAMOP-4.1.1.C-13/1/KONV-2014-0001]; European Union Hungary-Romania Cross-Border Co-operation Programme grant [HURO/1101/173/2.2]; Hungarian Scientific Research Fund (OTKA) [K 68784]	European Union(European Commission); European Social Fund(European Social Fund (ESF)); European Union Hungary-Romania Cross-Border Co-operation Programme grant; Hungarian Scientific Research Fund (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	This work was supported by the European Union and co-financed by the European Social Fund, project numbers TAMOP4.2.2.A-11/1/KONV-2012-0035 and TAMOP-4.1.1.C-13/1/KONV-2014-0001 together with the European Union Hungary-Romania Cross-Border Co-operation Programme grant, grant number HURO/1101/173/2.2 and a Hungarian Scientific Research Fund (OTKA) grant awarded to PD (K 68784). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amerik AY, 1997, EMBO J, V16, P4826; Amerik AY, 2004, BBA-MOL CELL RES, V1695, P189, DOI 10.1016/j.bbamcr.2004.10.003; Bader M, 2009, CURR OPIN CELL BIOL, V21, P878, DOI 10.1016/j.ceb.2009.09.005; BAINBRIDGE SP, 1981, J EMBRYOL EXP MORPH, V66, P57; Beal R, 1996, P NATL ACAD SCI USA, V93, P861, DOI 10.1073/pnas.93.2.861; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Broemer M, 2009, TRENDS CELL BIOL, V19, P130, DOI 10.1016/j.tcb.2009.01.004; Chen X, 2000, GENETICS, V156, P1829; Chernova TA, 2003, J BIOL CHEM, V278, P52102, DOI 10.1074/jbc.M310283200; Dantuma NP, 2006, J CELL BIOL, V173, P19, DOI 10.1083/jcb.200510071; Dayal S, 2009, J BIOL CHEM, V284, P5030, DOI 10.1074/jbc.M805871200; DEVERAUX Q, 1994, J BIOL CHEM, V269, P7059; Ditzel M, 2008, MOL CELL, V32, P540, DOI 10.1016/j.molcel.2008.09.025; Doelling JH, 2001, PLANT J, V27, P393, DOI 10.1046/j.1365-313X.2001.01106.x; Ecroyd H, 2008, IUBMB LIFE, V60, P769, DOI 10.1002/iub.117; FALQUET L, 1995, FEBS LETT, V359, P73, DOI 10.1016/0014-5793(94)01451-6; Fan XF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091423; Fan Y, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004131; HADARI T, 1992, J BIOL CHEM, V267, P719; Hanna J, 2003, MOL CELL BIOL, V23, P9251, DOI 10.1128/MCB.23.24.9251-9261.2003; Hanna J, 2007, CELL, V129, P747, DOI 10.1016/j.cell.2007.03.042; Hanna J, 2006, CELL, V127, P99, DOI 10.1016/j.cell.2006.07.038; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Holley CL, 2002, NAT CELL BIOL, V4, P439, DOI 10.1038/ncb798; Hu M, 2005, EMBO J, V24, P3747, DOI 10.1038/sj.emboj.7600832; Jentsch S, 2007, TRENDS BIOCHEM SCI, V32, P6, DOI 10.1016/j.tibs.2006.11.005; Ju DH, 2004, BIOCHEM BIOPH RES CO, V321, P51, DOI 10.1016/j.bbrc.2004.06.105; Junn E, 2003, P NATL ACAD SCI USA, V100, P2047, DOI 10.1073/pnas.0438021100; Kaiser P, 2000, CELL, V102, P303, DOI 10.1016/S0092-8674(00)00036-2; Kaiser SE, 2011, NAT METHODS, V8, P691, DOI [10.1038/NMETH.1649, 10.1038/nmeth.1649]; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Kimura Y, 2010, J BIOCHEM, V147, P793, DOI 10.1093/jb/mvq044; Larsen CN, 1998, BIOCHEMISTRY-US, V37, P3358, DOI 10.1021/bi972274d; Mimnaugh EG, 1997, BIOCHEMISTRY-US, V36, P14418, DOI 10.1021/bi970998j; Mocciaro A, 2012, J CELL SCI, V125, P255, DOI 10.1242/jcs.091199; Morris EJ, 2006, PLOS GENET, V2, P1834, DOI 10.1371/journal.pgen.0020196; Nakajima S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084899; Oh C, 2013, ANAL BIOCHEM, V443, P153, DOI 10.1016/j.ab.2013.09.011; Oh SW, 2003, GENETICS, V163, P195; Pal M, 2007, J CELL SCI, V120, P3238, DOI 10.1242/jcs.004762; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Reyes-Turcu FE, 2006, CELL, V124, P1197, DOI 10.1016/j.cell.2006.02.038; Ryoo HD, 2002, NAT CELL BIOL, V4, P432, DOI 10.1038/ncb795; Snyder H, 2003, J BIOL CHEM, V278, P11753, DOI 10.1074/jbc.M208641200; Song L, 2008, CURR OPIN CELL BIOL, V20, P156, DOI 10.1016/j.ceb.2008.01.012; STELLER H, 1995, SCIENCE, V267, P1445, DOI 10.1126/science.7878463; Szlanka T, 2003, J CELL SCI, V116, P1023, DOI 10.1242/jcs.00332; Tsou WL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043112; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Wang CH, 2014, BIOCHEM BIOPH RES CO, V452, P369, DOI 10.1016/j.bbrc.2014.08.069; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; WILKINSON KD, 1995, BIOCHEMISTRY-US, V34, P14535, DOI 10.1021/bi00044a032; Wilkinson KD, 1997, FASEB J, V11, P1245, DOI 10.1096/fasebj.11.14.9409543; Xu DB, 2009, FLY, V3, P78, DOI 10.4161/fly.3.1.7800; Yang CS, 2014, CELL DEATH DIFFER, V21, P604, DOI 10.1038/cdd.2013.184; Zaman MMU, 2013, MOL CELL BIOL, V33, P4971, DOI 10.1128/MCB.00465-13	56	15	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0120875	10.1371/journal.pone.0120875	http://dx.doi.org/10.1371/journal.pone.0120875			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25806519	Green Published, gold, Green Submitted			2022-12-26	WOS:000351880000107
J	Fichtner, A; Forrester, DI; Hardtle, W; Sturm, K; von Oheimb, G				Fichtner, Andreas; Forrester, David I.; Haerdtle, Werner; Sturm, Knut; von Oheimb, Goddert			Facilitative-Competitive Interactions in an Old-Growth Forest: The Importance of Large-Diameter Trees as Benefactors and Stimulators for Forest Community Assembly	PLOS ONE			English	Article							FAGUS-SYLVATICA L.; MIXED-SPECIES FORESTS; LIGHT-USE EFFICIENCY; ROOT BIOMASS; PICEA-ABIES; PATTERN; SIZE; PLASTICITY; DYNAMICS; MECHANISMS	The role of competition in tree communities is increasingly well understood, while little is known about the patterns and mechanisms of the interplay between above- and belowground competition in tree communities. This knowledge, however, is crucial for a better understanding of community dynamics and developing adaptive near-natural management strategies. We assessed neighbourhood interactions in an unmanaged old-growth European beech (Fagus sylvatica) forest by quantifying variation in the intensity of above- (shading) and belowground competition (crowding) among dominant and co-dominant canopy beech trees during tree maturation. Shading had on average a much larger impact on radial growth than crowding and the sensitivity to changes in competitive conditions was lowest for crowding effects. We found that each mode of competition reduced the effect of the other. Increasing crowding reduced the negative effect of shading, and at high levels of shading, crowding actually had a facilitative effect and increased growth. Our study demonstrates that complementarity in above- and belowground processes enable Fagus sylvatica to alter resource acquisition strategies, thus optimising tree radial growth. As a result, competition seemed to become less important in stands with a high growing stock and tree communities with a long continuity of anthropogenic undisturbed population dynamics. We suggest that growth rates do not exclusively depend on the density of potential competitors at the intraspecific level, but on the conspecific aggregation of large-diameter trees and their functional role for regulating biotic filtering processes. This finding highlights the potential importance of the rarely examined relationship between the spatial aggregation pattern of large-diameter trees and the outcome of neighbourhood interactions, which may be central to community dynamics and the related forest ecosystem services.	[Fichtner, Andreas; Haerdtle, Werner] Leuphana Univ Luneburg, Inst Ecol, Luneburg, Germany; [Forrester, David I.] Univ Freiburg, Chair Silviculture, D-79106 Freiburg, Germany; [Sturm, Knut] Community Forest Lubeck, Lubeck, Germany; [von Oheimb, Goddert] Tech Univ Dresden, Inst Gen Ecol & Environm Protect, Tharandt, Germany	Leuphana University Luneburg; University of Freiburg; Technische Universitat Dresden	Fichtner, A (corresponding author), Leuphana Univ Luneburg, Inst Ecol, Luneburg, Germany.	fichtner@leuphana.de	Fichtner, Andreas/AAP-3188-2021; Forrester, David I/L-5351-2013; Forrester, David Ian/AHE-0298-2022; von Oheimb, Goddert/O-9483-2015; Haerdtle, Werner/B-2568-2016	Fichtner, Andreas/0000-0003-0499-4893; von Oheimb, Goddert/0000-0001-7408-425X; Hardtle, Werner/0000-0002-5599-5792				Baribault TW, 2011, J ECOL, V99, P1358, DOI 10.1111/j.1365-2745.2011.01862.x; BERTNESS MD, 1994, TRENDS ECOL EVOL, V9, P191, DOI 10.1016/0169-5347(94)90088-4; Beyer F, 2013, FOREST ECOL MANAG, V302, P14, DOI 10.1016/j.foreco.2013.03.020; Bosela M, 2013, FOREST ECOL MANAG, V310, P577, DOI 10.1016/j.foreco.2013.09.005; Brooker RW, 2008, J ECOL, V96, P18, DOI 10.1111/j.1365-2745.2007.01295.x; Brunet J., 2010, ECOL BULL, V53, P77, DOI DOI 10.1046/J.1365-294X.1996.00094.X; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Cahill JF, 2000, OIKOS, V90, P311, DOI 10.1034/j.1600-0706.2000.900211.x; Canham CD, 2006, ECOL APPL, V16, P540, DOI 10.1890/1051-0761(2006)016[0540:NAOCTC]2.0.CO;2; Canham CD, 2004, CAN J FOREST RES, V34, P778, DOI [10.1139/x03-232, 10.1139/X03-232]; Coates KD, 2013, J ECOL, V101, P806, DOI 10.1111/1365-2745.12072; Coates KD, 2009, J ECOL, V97, P118, DOI 10.1111/j.1365-2745.2008.01458.x; Coomes DA, 2007, J ECOL, V95, P1084, DOI 10.1111/j.1365-2745.2007.01280.x; Craine JM, 2005, NEW PHYTOL, V166, P933, DOI 10.1111/j.1469-8137.2005.01386.x; del Rio M, 2014, PLANT BIOLOGY, V16, P166, DOI 10.1111/plb.12029; Dieckmann O, 2012, AFZ WALD, P12; Dieler J, 2013, FOREST ECOL MANAG, V295, P97, DOI 10.1016/j.foreco.2012.12.049; Eastaugh CS, 2014, STEPHENSONS ECOLOGIC; Fajardo A, 2011, J ECOL, V99, P642, DOI 10.1111/j.1365-2745.2010.01771.x; Fichtner A, 2013, FOREST ECOL MANAG, V302, P178, DOI 10.1016/j.foreco.2013.03.027; Fichtner A, 2012, J APPL ECOL, V49, P1306, DOI 10.1111/j.1365-2664.2012.02196.x; Forrester DI, 2014, FOREST ECOL MANAG, V328, P94, DOI 10.1016/j.foreco.2014.05.026; Forrester DI, 2014, FOREST ECOL MANAG, V312, P282, DOI 10.1016/j.foreco.2013.10.003; Forrester DI, 2011, OECOLOGIA, V166, P265, DOI 10.1007/s00442-011-1937-9; Fortin M, 2007, EUR J FOREST RES, V126, P573, DOI 10.1007/s10342-007-0179-1; Fraver S, 2014, J VEG SCI, V25, P374, DOI 10.1111/jvs.12096; Garcia-Cervigon AI, 2013, PERSPECT PLANT ECOL, V15, P226, DOI 10.1016/j.ppees.2013.04.001; Hardtle W, 2013, ECOSYSTEMS, V16, P1413, DOI 10.1007/s10021-013-9692-x; He Q, 2013, ECOL LETT, V16, P695, DOI 10.1111/ele.12080; Hedges LV, 1999, ECOLOGY, V80, P1150, DOI 10.2307/177062; Hertel D, 2013, J ECOL, V101, DOI 10.1111/1365-2745.12124; Kiaer LP, 2013, J ECOL, V101, P1298, DOI 10.1111/1365-2745.12129; Kunstler G, 2011, J ECOL, V99, P300, DOI 10.1111/j.1365-2745.2010.01751.x; Lang AC, 2010, FOREST ECOL MANAG, V260, P1708, DOI 10.1016/j.foreco.2010.08.015; Larocque GR, 2013, ENVIRON REV, V21, P71, DOI 10.1139/er-2012-0033; Lebourgeois F, 2013, FOREST ECOL MANAG, V303, P61, DOI 10.1016/j.foreco.2013.04.003; Lei PF, 2012, FOREST ECOL MANAG, V265, P191, DOI 10.1016/j.foreco.2011.10.033; Lindenmayer DB, 2012, SCIENCE, V338, P1305, DOI 10.1126/science.1231070; Lukac M., 2011, SOIL ECOLOGY NO FORE; Lutz JA, 2014, ECOLOGY, V95, P2047, DOI 10.1890/14-0157.1; Lutz JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082784; McIntire EJB, 2014, NEW PHYTOL, V201, P403, DOI 10.1111/nph.12478; Molder I, 2014, TREES-STRUCT FUNCT, V28, P777, DOI 10.1007/s00468-014-0991-4; Oliver C.D., 1996, FOREST STAND DYNAMIC; Onoda Y, 2014, J ECOL, V102, P167, DOI 10.1111/1365-2745.12184; Penuelas J, 2008, GLOBAL CHANGE BIOL, V14, P1076, DOI 10.1111/j.1365-2486.2008.01563.x; Pinheiro J, 2001, MIXED EFFECTS MODELS; Piovesan G, 2005, J VEG SCI, V16, P13, DOI 10.1111/j.1654-1103.2005.tb02334.x; Pretzsch H, 2014, FOREST ECOL MANAG, V327, P251, DOI 10.1016/j.foreco.2014.04.027; R Development Core Team, 2012, R LANG ENV STAT COMP; Rewald B, 2009, EUR J FOREST RES, V128, P387, DOI 10.1007/s10342-009-0276-4; Rothe A, 2001, CAN J FOREST RES, V31, P1855, DOI 10.1139/cjfr-31-11-1855; Ruger N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025330; Schroter M, 2012, EUR J FOREST RES, V131, P787, DOI 10.1007/s10342-011-0552-y; Schwinning S, 1998, OECOLOGIA, V113, P447, DOI 10.1007/s004420050397; Seidel D, 2011, FOREST ECOL MANAG, V261, P2123, DOI 10.1016/j.foreco.2011.03.008; Semchenko M, 2013, J ECOL, V101, P1313, DOI 10.1111/1365-2745.12127; Sillett SC, 2010, FOREST ECOL MANAG, V259, P976, DOI 10.1016/j.foreco.2009.12.003; Simard Suzanne W., 2012, Fungal Biology Reviews, V26, P39, DOI 10.1016/j.fbr.2012.01.001; Simard SW, 2009, FOREST ECOL MANAG, V258, pS95, DOI 10.1016/j.foreco.2009.05.001; Simard SW, 1997, NATURE, V388, P579, DOI 10.1038/41557; Stephenson NL, 2014, NATURE, V507, P90, DOI 10.1038/nature12914; Teste FP, 2009, FUNGAL ECOL, V2, P21, DOI 10.1016/j.funeco.2008.11.003; von Oheimb G, 2005, FOREST ECOL MANAG, V212, P253, DOI 10.1016/j.foreco.2005.03.033; Weiner J, 2004, PERSPECT PLANT ECOL, V6, P207, DOI 10.1078/1433-8319-00083; WEINER J, 1990, TRENDS ECOL EVOL, V5, P360, DOI 10.1016/0169-5347(90)90095-U; Weiner J, 2001, AM NAT, V158, P438, DOI 10.1086/321988; Westphal C, 2006, FOREST ECOL MANAG, V223, P75, DOI 10.1016/j.foreco.2005.10.057; Xu H, 2006, PLANT SOIL, V285, P5, DOI 10.1007/s11104-005-5108-9; Zuur Alain F., 2009, P1	70	15	15	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0120335	10.1371/journal.pone.0120335	http://dx.doi.org/10.1371/journal.pone.0120335			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803035	Green Published, gold, Green Submitted			2022-12-26	WOS:000353889600069
J	Hsieh, TF; Yang, YW; Lee, SS; Lin, TH; Liu, HH; Tsai, TH; Chen, CC; Huang, YS; Lee, CC				Hsieh, Teng-Fu; Yang, Yu-Wan; Lee, Shang-Sen; Lin, Tien-Huang; Liu, Hsin-Ho; Tsai, Tsung-Hsun; Chen, Chi-Cheng; Huang, Yung-Sung; Lee, Ching-Chih			Use of 5-Alpha-Reductase Inhibitors Did Not Increase the Risk of Cardiovascular Diseases in Patients with Benign Prostate Hyperplasia: A Five-Year Follow-Up Study	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; HEART-DISEASE; STROKE; FINASTERIDE; MEN; TESTOSTERONE; ASSOCIATION; DUTASTERIDE; VALIDATION; MANAGEMENT	Background This nationwide population-based study investigated the risk of cardiovascular diseases after 5-alpha-reductase inhibitor therapy for benign prostate hyperplasia (BPH) using the National Health Insurance Research Database (NHIRD) in Taiwan. Methods In total, 1,486 adult patients newly diagnosed with BPH and who used 5-alpha-reductase inhibitors were recruited as the study cohort, along with 9,995 subjects who did not use 5-alpha-reductase inhibitors as a comparison cohort from 2003 to 2008. Each patient was monitored for 5 years, and those who subsequently had cardiovascular diseases were identified. A Cox proportional hazards model was used to compare the risk of cardiovascular diseases between the study and comparison cohorts after adjusting for possible confounding risk factors. Results The patients who received 5-alpha-reductase inhibitor therapy had a lower cumulative rate of cardiovascular diseases than those who did not receive 5-alpha-reductase inhibitor therapy during the 5-year follow-up period (8.4% vs. 11.2%, P=0.003). In subgroup analysis, the 5-year cardiovascular event hazard ratio (HR) was lower among the patients older than 65 years with 91 to 365 cumulative defined daily dose (cDDD) 5-alpha-reductase inhibitor use (HR=0.63, 95% confidence interval (CI) 0.42 to 0.92; P=0.018), however there was no difference among the patients with 28 to 90 and more than 365 cDDD 5-alpha-reductase inhibitor use (HR=1.14, 95% CI 0.77 to 1.68; P=0.518 and HR=0.83, 95% CI 0.57 to 1.20; P=0.310, respectively). Conclusions 5-alpha-reductase inhibitor therapy did not increase the risk of cardiovascular events in the BPH patients in 5 years of follow-up. Further mechanistic research is needed.	[Hsieh, Teng-Fu; Lee, Shang-Sen; Lin, Tien-Huang; Liu, Hsin-Ho; Tsai, Tsung-Hsun; Chen, Chi-Cheng] Buddhist Tzu Chi Med Fdn, Taichung Tzu Chi Hosp, Dept Urol, Taichung, Taiwan; [Hsieh, Teng-Fu; Lee, Shang-Sen; Lin, Tien-Huang; Liu, Hsin-Ho; Tsai, Tsung-Hsun; Chen, Chi-Cheng; Lee, Ching-Chih] Tzu Chi Univ, Sch Med, Hualien, Taiwan; [Yang, Yu-Wan] China Med Univ Hosp, Dept Neurol, Taichung, Taiwan; [Yang, Yu-Wan] China Med Univ, Sch Med, Taichung, Taiwan; [Huang, Yung-Sung] Buddhist Tzu Chi Med Fdn, Dalin Tzu Chi Hosp, Dept Internal Med, Div Neurol, Chiayi, Taiwan; [Lee, Ching-Chih] Buddhist Tzu Chi Med Fdn, Dalin Tzu Chi Hosp, Dept Otolaryngol, Chiayi, Taiwan; [Lee, Ching-Chih] Buddhist Tzu Chi Med Fdn, Dalin Tzu Chi Hosp, Dept Educ, Chiayi, Taiwan; [Lee, Ching-Chih] Buddhist Tzu Chi Med Fdn, Dalin Tzu Chi Hosp, Ctr Clin Epidemiol & Biostat, Chiayi, Taiwan	Buddhist Tzu Chi General Hospital; Taichung Tzu Chi Hospital; Tzu Chi University; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital	Huang, YS (corresponding author), Buddhist Tzu Chi Med Fdn, Dalin Tzu Chi Hosp, Dept Internal Med, Div Neurol, Chiayi, Taiwan.	solomons1117@yahoo.com.tw; hematcd@hotmail.com						Andriole GL, 2010, NEW ENGL J MED, V362, P1192, DOI 10.1056/NEJMoa0908127; Chen YM, 2014, RHEUMATOLOGY, V53, P180, DOI 10.1093/rheumatology/ket330; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Chiang TL, 1997, HEALTH POLICY, V39, P225, DOI 10.1016/S0168-8510(96)00877-9; Cindolo L, 2014, INT UROL NEPHROL, V46, P695, DOI 10.1007/s11255-013-0587-8; DAGOSTINO RB, 1991, BRIT MED J, V303, P385, DOI 10.1136/bmj.303.6799.385; Fleshner NE, 2012, LANCET, V379, P1103, DOI 10.1016/S0140-6736(11)61619-X; Gisleskog PO, 1999, EUR J PHARM SCI, V8, P291, DOI 10.1016/S0928-0987(99)00024-X; IRIE K, 1993, STROKE, V24, P1844, DOI 10.1161/01.STR.24.12.1844; Jespersen CG, 2014, EUR UROL, V65, P704, DOI 10.1016/j.eururo.2013.02.002; Kaplan SA, 2001, UROLOGY, V57, P1073, DOI 10.1016/S0090-4295(01)00985-2; Keating NL, 2010, J NATL CANCER I, V102, P39, DOI 10.1093/jnci/djp404; Khaw KT, 2007, CIRCULATION, V116, P2694, DOI 10.1161/CIRCULATIONAHA.107.719005; Lee CC, 2011, STROKE, V42, P48, DOI 10.1161/STROKEAHA.110.597070; Lin HC, 2008, STROKE, V39, P2744, DOI 10.1161/STROKEAHA.108.519090; Loke YK, 2013, J CLIN PHARM THER, V38, P405, DOI 10.1111/jcpt.12080; McVary KT, 2011, J UROLOGY, V185, P1793, DOI 10.1016/j.juro.2011.01.074; NORMAN RW, 1993, J UROLOGY, V150, P1736, DOI 10.1016/S0022-5347(17)35882-2; Oelke M, 2013, EUR UROL, V64, P118, DOI 10.1016/j.eururo.2013.03.004; Sacks FM, 1998, CIRCULATION, V97, P1446; Saylor PJ, 2009, J UROLOGY, V181, P1998, DOI 10.1016/j.juro.2009.01.047; Silva J, 2014, CURR OPIN UROL, V24, P21, DOI 10.1097/MOU.0000000000000007; Souverein PC, 2002, EUR UROL, V42, P254, DOI 10.1016/S0302-2838(02)00273-7; Tsan YT, 2013, J CLIN ONCOL, V31, P1514, DOI 10.1200/JCO.2012.44.6831; Tsan YT, 2012, J CLIN ONCOL, V30, P623, DOI 10.1200/JCO.2011.36.0917; Tseng CH, 2004, DIABETES CARE, V27, P1605, DOI 10.2337/diacare.27.7.1605; Wu CY, 2012, JAMA-J AM MED ASSOC, V308, P1906, DOI 10.1001/2012.jama.11975; Yeap BB, 2009, J CLIN ENDOCR METAB, V94, P2353, DOI 10.1210/jc.2008-2416	28	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0119694	10.1371/journal.pone.0119694	http://dx.doi.org/10.1371/journal.pone.0119694			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803433	Green Submitted, Green Published, gold			2022-12-26	WOS:000353889600036
J	Velasco-Hernandez, JX; Nunez-Lopez, M; Comas-Garcia, A; Cherpitel, DEN; Ocampo, MC				Xicotencatl Velasco-Hernandez, Jorge; Nunez-Lopez, Mayra; Comas-Garcia, Andreu; Noyola Cherpitel, Daniel Ernesto; Capistran Ocampo, Marcos			Superinfection between Influenza and RSV Alternating Patterns in San Luis Potosi State, Mexico	PLOS ONE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; INFECTION; MORTALITY; CHILDREN; FREQUENCY; EPIDEMICS; EVOLUTION; DYNAMICS; ILLNESS	The objective of this paper is to explain through the ecological hypothesis superinfection and competitive interaction between two viral populations and niche (host) availability, the alternating patterns of Respiratory Syncytial Virus (RSV) and influenza observed in a regional hospital in San Luis Potosi State, Mexico using a mathematical model as a methodological tool. The data analyzed consists of community-based and hospital-based Acute Respiratory Infections (ARI) consultations provided by health-care institutions reported to the State Health Service Epidemiology Department from 2003 through 2009.	[Xicotencatl Velasco-Hernandez, Jorge] Univ Nacl Autonoma Mexico, Inst Matemat, Juriquilla 76230, Mexico; [Nunez-Lopez, Mayra] Univ Autonoma Metropolitana, DMAS, Mexico City 05300, DF, Mexico; [Comas-Garcia, Andreu] Univ Nacl Autonoma Mexico, Fac Med, Mexico City 04510, DF, Mexico; [Noyola Cherpitel, Daniel Ernesto] Univ Autonoma San Luis Potosi, Fac Med, Dept Microbiol, San Luis Potosi 78210, Mexico; [Capistran Ocampo, Marcos] Ctr Investigac Matemat AC, Guanajuato 36240, Gto, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Autonoma Metropolitana - Mexico; Universidad Nacional Autonoma de Mexico; Universidad Autonoma de San Luis Potosi	Nunez-Lopez, M (corresponding author), Univ Autonoma Metropolitana, DMAS, Av Vasco Quiroga 4871,Col Santa Fe Cuajimalpa, Mexico City 05300, DF, Mexico.	maynunlop@gmail.com	Comas-Garcia, Andreu/ABB-8489-2021; Velasco-Hernandez, Jorge/A-5391-2008	Comas-Garcia, Andreu/0000-0002-2368-1529; Velasco-Hernandez, Jorge/0000-0002-5604-7719; Noyola, Daniel/0000-0002-4840-6742; Capistran, Marcos/0000-0002-7891-6380	Fondos Mixtos de Fomento a la Investigacion Cientifica y Tecnologica del Consejo Nacional de Ceincia y Tecnologia (FOMIX CONACyT) [168676]; Universidad Autonoma Metropolitana; Programa de Mejoramiento del Profesorado (PROMEP) [54510041]	Fondos Mixtos de Fomento a la Investigacion Cientifica y Tecnologica del Consejo Nacional de Ceincia y Tecnologia (FOMIX CONACyT); Universidad Autonoma Metropolitana; Programa de Mejoramiento del Profesorado (PROMEP)	This work was supported by Fondos Mixtos de Fomento a la Investigacion Cientifica y Tecnologica del Consejo Nacional de Ceincia y Tecnologia (FOMIX CONACyT) grant 168676 (JXVH ACG DEN MC); www.conacyt.mx, the Universidad Autonoma Metropolitana; www.uam.mx, and the Programa de Mejoramiento del Profesorado (PROMEP) grant 54510041 (MNL); www.promep.sep.gob.mx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agoti CN, 2012, J INFECT DIS, V206, P1532, DOI 10.1093/infdis/jis570; ANESTAD G, 1987, EPIDEMIOL INFECT, V99, P523, DOI 10.1017/S0950268800068023; Avedano LF, 2003, J CLIN MICROBIOL, V41, P4879, DOI [10.1128/JCM.41.10.4879-4882.2003, DOI 10.1128/JCM.41.10.4879-4882.2003]; Bahl J, 2009, VIROLOGY, V390, P289, DOI 10.1016/j.virol.2009.05.002; Bedford T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000918; BREMERMANN HJ, 1989, J MATH BIOL, V27, P179, DOI 10.1007/BF00276102; Castillo-Chavez C, 1998, J THEOR BIOL, V192, P437, DOI 10.1006/jtbi.1998.0661; Cazelles B, 2005, PLOS MED, V2, P313, DOI 10.1371/journal.pmed.0020106; Chowell G, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000436; Comas-Garcia A, 2011, INFLUENZA OTHER RESP, V5, P76, DOI 10.1111/j.1750-2659.2010.00187.x; Elliot AJ, 2008, J PUBLIC HEALTH-UK, V30, P91, DOI 10.1093/pubmed/fdn003; Falsey AR, 2000, CLIN MICROBIOL REV, V13, P371, DOI 10.1128/CMR.13.3.371-384.2000; Fleming DM, 2007, EUR RESPIR J, V30, P1029, DOI 10.1183/09031936.00120707; Fleming DM, 2007, EPIDEMIOL INFECT, V135, P1099, DOI 10.1017/S0950268807007881; Fleming DM, 2005, J EPIDEMIOL COMMUN H, V59, P586, DOI 10.1136/jech.2004.026450; Fleming DM, 2005, ARCH DIS CHILD, V90, P741, DOI 10.1136/adc.2004.063461; GLEZEN WP, 1986, AM J DIS CHILD, V140, P543, DOI 10.1001/archpedi.1986.02140200053026; Heddini A, 2009, EUROSURVEILLANCE, V14; Hethcote HW, 2000, SIAM REV, V42, P599, DOI 10.1137/S0036144500371907; Koelle K, 2006, SCIENCE, V314, P1898, DOI 10.1126/science.1132745; Lau KM, 1995, B AM METEOROL SOC, V76, P2391, DOI 10.1175/1520-0477(1995)076<2391:CSDUWT>2.0.CO;2; LEVIN S, 1981, AM NAT, V117, P308, DOI 10.1086/283708; Lovato-Salas F, 2010, J INFECTION, V61, P382, DOI 10.1016/j.jinf.2010.08.008; Manjarrez ME, 2003, J MED MICROBIOL, V52, P579, DOI 10.1099/jmm.0.05007-0; Wong-Chew RM, 2010, SALUD PUBLICA MEXICO, V52, P528; Marquet PA, 1997, REV CHIL HIST NAT, V70, P371; Mena-Lorca J, 1999, IMA J MATH APPL MED, V16, P307; Milnaric-Galinovic G, 2008, VIROL J, V28, P18, DOI [10.1186/1743-422X-5-18, DOI 10.1186/1743-422X-5-18]; Munywoki PK, 2014, J INFECT DIS, V209, P1685, DOI 10.1093/infdis/jit828; Murray EA, 2011, BMC PUBLIC HLTH S1, V11, pS8, DOI [10.1186/1471-2458-11-S2-S8, DOI 10.1186/1471-2458-11-S2-S8]; Nicholson KG, 2003, LANCET, V362, P1733, DOI 10.1016/S0140-6736(03)14854-4; Nishimura N, 2005, PEDIATR INT, V47, P412, DOI 10.1111/j.1442-200x.2005.02099.x; Noyola DE, 2008, EPIDEMIOL INFECT, V136, P1328, DOI 10.1017/S0950268807000143; Noyola DE, 2005, PEDIATR INFECT DIS J, V24, P1049, DOI 10.1097/01.inf.0000190026.58557.93; Obadia T, 2012, BMC MED INFORM DECIS, V12, DOI 10.1186/1472-6947-12-147; Rambaut A, 2008, NATURE, V453, P615, DOI 10.1038/nature06945; Scott PD, 2006, J INFECT DIS, V193, P59, DOI 10.1086/498246; Shinjoh M, 2000, ACTA VIROL, V44, P91; Terletskaia-Ladwig E, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-20; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; Walzl G, 2000, J EXP MED, V192, P1317, DOI 10.1084/jem.192.9.1317; Weber A, 2001, MATH BIOSCI, V172, P95, DOI 10.1016/S0025-5564(01)00066-9; Zambon MC, 2001, LANCET, V358, P1410, DOI 10.1016/S0140-6736(01)06528-X	44	14	14	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0115674	10.1371/journal.pone.0115674	http://dx.doi.org/10.1371/journal.pone.0115674			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803450	Green Published, Green Submitted, gold			2022-12-26	WOS:000353889600001
J	Jenkins, MH; Brinckerhoff, CE; Mullins, DW				Jenkins, Molly H.; Brinckerhoff, Constance E.; Mullins, David W.			CXCR3 Signaling in BRAF(WT) Melanoma Increases IL-8 Expression and Tumorigenicity	PLOS ONE			English	Article							CHEMOKINE RECEPTOR CXCR3; CELL-LINES; METASTATIC MELANOMA; TUMOR-GROWTH; STROMAL FIBROBLASTS; CUTANEOUS MELANOMA; ANTITUMOR-ACTIVITY; LYMPH-NODES; PROGRESSION; INTERLEUKIN-8	Patients with early stage, radial growth phase (RGP) melanoma have a 97% survival rate; however, when the melanoma progresses to the invasive vertical growth phase (VGP), survival rates decrease to 15%. The targets of many clinical trials are the known genetic and molecular mechanisms involved in melanoma progression, with the most common oncogenic mutation being the BRAF(V600E). However, less than half of melanomas harbor this mutation, and consequently, do not respond to the current BRAF targeted treatments. It is therefore critical to elucidate alternative mechanisms regulating melanoma progression. Increased expression of the chemokine receptor, CXCR3, on melanoma cells is correlated with increased metastasis and poor patient outcomes, suggesting a role for CXCR3 in the RGP to VGP transition. We found that endogenous CXCR3 can be induced in two RGP cell lines, BOWES (BRAF(WT)) and WM35 (BRAF(V600E)), with in vitro environmental stress and nutrient deprivation. Signaling via induced endogenous CXCR3 is linked with IL-8 expression in BOWES cells. Ectopic overexpression of CXCR3 in BOWES cells leads to increased ligand-mediated phERK, cellular migration, and IL-8 expression in vitro, and to increased tumorigenesis and lymph node metastasis in vivo. Our results demonstrate that, in BRAF(WT) melanomas, CXCR3 signaling mediates significant increases in IL-8 expression, suggesting that CXCR3 expression and signaling may represent a transformative event that drives the progression of BRAF(WT) melanomas. Implications: Expression of CXCR3 on BRAF(WT) melanoma cells may be a mediator of melanoma progression.	[Jenkins, Molly H.; Brinckerhoff, Constance E.] Geisel Sch Med Dartmouth, Dept Med, Lebanon, NH USA; [Jenkins, Molly H.; Mullins, David W.] Geisel Sch Med Dartmouth, Dept Microbiol & Immunol, Lebanon, NH USA; [Brinckerhoff, Constance E.] Geisel Sch Med Dartmouth, Dept Biochem, Lebanon, NH USA; [Jenkins, Molly H.; Brinckerhoff, Constance E.; Mullins, David W.] Geisel Sch Med Dartmouth, Norris Cotton Canc Ctr, Lebanon, NH USA	Dartmouth College; Dartmouth College; Dartmouth College; Dartmouth College; Norris Cotton Cancer Center	Mullins, DW (corresponding author), Geisel Sch Med Dartmouth, Dept Microbiol & Immunol, Lebanon, NH USA.	david.w.mullins@dartmouth.edu	Mullins, David/J-1085-2019	Mullins, David/0000-0002-2644-350X	National Institutes of Health [CA009658, AI007363, R01 CA134799]; Hitchcock Foundation Pilot Studies Award; NATIONAL CANCER INSTITUTE [T32CA009658, P30CA023108, R01CA134799] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007363] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hitchcock Foundation Pilot Studies Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was funded by: National Institutes of Health T32 - Cancer Center Training Grant CA009658 (MHJ/CEB); National Institutes of Health T32 - Immunology Training Grant AI007363 (MHJ/DWM); National Institutes of Health R01 CA134799 (DWM); and Hitchcock Foundation Pilot Studies Award (DWM and CEB).	American Cancer Society, 2014, CANC FACTS FIG 2014; Apte RN, 2006, CANCER METAST REV, V25, P387, DOI 10.1007/s10555-006-9004-4; Balch CM, 2004, CA-CANCER J CLIN, V54, P131, DOI 10.3322/canjclin.54.3.131; Bar-Eli M, 1999, PATHOBIOLOGY, V67, P12, DOI 10.1159/000028045; Blackburn JS, 2009, ONCOGENE, V28, P4237, DOI 10.1038/onc.2009.272; Blackburn JS, 2007, CANCER RES, V67, P10849, DOI 10.1158/0008-5472.CAN-07-1791; Bromley SK, 2008, NAT IMMUNOL, V9, P970, DOI 10.1038/ni.f.213; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; CLARK WH, 1984, HUM PATHOL, V15, P1147, DOI 10.1016/S0046-8177(84)80310-X; Colvin RA, 2006, MOL CELL BIOL, V26, P5838, DOI 10.1128/MCB.00556-06; Croteau W, 2013, J CELL PHYSIOL, V228, P773, DOI 10.1002/jcp.24225; Fedorenko I V, 2014, BR J CANC; Frederick DT, 2013, CLIN CANCER RES, V19, P1225, DOI 10.1158/1078-0432.CCR-12-1630; Fulton AM, 2009, CURR ONCOL REP, V11, P125, DOI 10.1007/s11912-009-0019-1; Gogas HJ, 2007, CANCER-AM CANCER SOC, V109, P455, DOI 10.1002/cncr.22427; Goldberg-Bittman L, 2004, IMMUNOL LETT, V92, P171, DOI 10.1016/j.imlet.2003.10.020; Groom JR, 2011, EXP CELL RES, V317, P620, DOI 10.1016/j.yexcr.2010.12.017; Hofmann UB, 1999, BRIT J CANCER, V81, P774, DOI 10.1038/sj.bjc.6690763; Huntington JT, 2004, J BIOL CHEM, V279, P33168, DOI 10.1074/jbc.M405102200; Hussein MR, 2005, J CLIN PATHOL, V58, P389, DOI 10.1136/jcp.2004.021519; Iida J, 2004, J INVEST DERMATOL, V122, P167, DOI 10.1046/j.0022-202X.2003.22114.x; Johnson M, 2007, BIOORG MED CHEM LETT, V17, P3339, DOI 10.1016/j.bmcl.2007.03.106; Joseph EW, 2010, P NATL ACAD SCI USA, V107, P14903, DOI 10.1073/pnas.1008990107; Kawada K, 2007, ONCOGENE, V26, P4679, DOI 10.1038/sj.onc.1210267; Kawada K, 2004, CANCER RES, V64, P4010, DOI 10.1158/0008-5472.CAN-03-1757; Khalili JS, 2012, CLIN CANCER RES, V18, P5329, DOI 10.1158/1078-0432.CCR-12-1632; Koya RC, 2012, CANCER RES, V72, P3928, DOI 10.1158/0008-5472.CAN-11-2837; Lazar-Molnar E, 2000, CYTOKINE, V12, P547, DOI 10.1006/cyto.1999.0614; Lee JH, 2011, BRIT J DERMATOL, V164, P776, DOI 10.1111/j.1365-2133.2010.10185.x; Lee JT, 2007, J CELL BIOCHEM, V101, P862, DOI 10.1002/jcb.21204; Leslie MC, 2005, J CELL BIOCHEM, V94, P25, DOI 10.1002/jcb.20296; Long GV, 2011, J CLIN ONCOL, V29, P1239, DOI 10.1200/JCO.2010.32.4327; Luca M, 1997, AM J PATHOL, V151, P1105; Meier Friedegund, 1998, Frontiers in Bioscience, V3, pD1005; Menzies AM, 2012, CLIN CANCER RES, V18, P3242, DOI 10.1158/1078-0432.CCR-12-0052; Monteagudo C, 2007, J CLIN PATHOL, V60, P596, DOI 10.1136/jcp.2005.032144; Rubinstein JC, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-67; Ryu B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000594; Smalley KSM, 2005, EXPERT REV ANTICANC, V5, P1069, DOI 10.1586/14737140.5.6.1069; SUZUKI H, 1994, J BIOL CHEM, V269, P18263; Tsai J, 2008, P NATL ACAD SCI USA, V105, P3041, DOI 10.1073/pnas.0711741105; Vultur A, 2011, CLIN CANCER RES, V17, P1658, DOI 10.1158/1078-0432.CCR-10-0174; Walser TC, 2006, CANCER RES, V66, P7701, DOI 10.1158/0008-5472.CAN-06-0709; WANG JM, 1990, BIOCHEM BIOPH RES CO, V169, P165, DOI 10.1016/0006-291X(90)91449-3; Whipple CA, 2014, BRIT J CANCER, V111, P1625, DOI 10.1038/bjc.2014.452; Whipple CA, 2014, BR J CANC C IN PRESS, P1625; Wyatt CA, 2005, CANCER RES, V65, P11101, DOI 10.1158/0008-5472.CAN-05-2446; Yang H, 2010, CANCER RES, V70, P5518, DOI 10.1158/0008-5472.CAN-10-0646	48	18	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121140	10.1371/journal.pone.0121140	http://dx.doi.org/10.1371/journal.pone.0121140			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798946	Green Published, Green Submitted, gold			2022-12-26	WOS:000351987300215
J	Li, LL; Wang, QQ; Zhang, Y; Niu, YZ; Yao, XJ; Liu, HX				Li, Lanlan; Wang, Qianqian; Zhang, Yan; Niu, Yuzhen; Yao, Xiaojun; Liu, Huanxiang			The Molecular Mechanism of Bisphenol A (BPA) as an Endocrine Disruptor by Interacting with Nuclear Receptors: Insights from Molecular Dynamics (MD) Simulations	PLOS ONE			English	Article							RESP METHODOLOGY; ACCURATE DOCKING; FREE-ENERGIES; BINDING; MODEL; GLIDE; INTEGRATION; RESISTANCE; CHEMICALS; WELL	Bisphenol A (BPA) can interact with nuclear receptors and affect the normal function of nuclear receptors in very low doses, which causes BPA to be one of the most controversial endocrine disruptors. However, the detailed molecular mechanism about how BPA interferes the normal function of nuclear receptors is still undiscovered. Herein, molecular dynamics simulations were performed to explore the detailed interaction mechanism between BPA with three typical nuclear receptors, including hER alpha, hERR gamma and hPPAR gamma. The simulation results and calculated binding free energies indicate that BPA can bind to these three nuclear receptors. The binding affinities of BPA were slightly lower than that of E2 to these three receptors. The simulation results proved that the binding process was mainly driven by direct hydrogen bond and hydrophobic interactions. In addition, structural analysis suggested that BPA could interact with these nuclear receptors by mimicking the action of natural hormone and keeping the nuclear receptors in active conformations. The present work provided the structural evidence to recognize BPA as an endocrine disruptor and would be important guidance for seeking safer substitutions of BPA.	[Li, Lanlan; Wang, Qianqian; Zhang, Yan; Liu, Huanxiang] Lanzhou Univ, Sch Pharm, Lanzhou 730000, Peoples R China; [Niu, Yuzhen; Yao, Xiaojun] Lanzhou Univ, State Key Lab Appl Organ Chem, Lanzhou 730000, Peoples R China; [Niu, Yuzhen; Yao, Xiaojun] Lanzhou Univ, Dept Chem, Lanzhou 730000, Peoples R China; [Liu, Huanxiang] Lanzhou Univ, Key Lab Preclin Study New Drugs Gansu Prov, Lanzhou 730000, Peoples R China; [Yao, Xiaojun] Macau Univ Sci & Technol, Macau Inst Appl Res Med & Hlth, State Key Lab Qual Res Chinese Med, Taipa, Macau, Peoples R China	Lanzhou University; Lanzhou University; Lanzhou University; Lanzhou University; Macau University of Science & Technology	Liu, HX (corresponding author), Lanzhou Univ, Sch Pharm, Lanzhou 730000, Peoples R China.	hxliu@lzu.edu.cn		Wang, Qianqian/0000-0003-2574-0120; Liu, Huanxiang/0000-0002-9284-3667	Natural Science Foundation of Gansu Province, China [1208RJYA034]	Natural Science Foundation of Gansu Province, China	Funding: Funding was provided by the Natural Science Foundation of Gansu Province, China (Grant No: 1208RJYA034). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; Bonefeld-Jorgensen EC, 2007, ENVIRON HEALTH PERSP, V115, P69, DOI 10.1289/ehp.9368; Bourguet W, 2000, TRENDS PHARMACOL SCI, V21, P381, DOI 10.1016/S0165-6147(00)01548-0; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; CIEPLAK P, 1995, J COMPUT CHEM, V16, P1357, DOI 10.1002/jcc.540161106; Colborn T, 2011, ENV HLTH PERSPECT, V101, P378; Delfosse V, 2012, P NATL ACAD SCI USA, V109, P14930, DOI 10.1073/pnas.1203574109; Deserno M, 1998, J CHEM PHYS, V109, P7678, DOI 10.1063/1.477414; Diamanti-Kandarakis E, 2009, ENDOCR REV, V30, P293, DOI 10.1210/er.2009-0002; Fox T, 1998, J PHYS CHEM B, V102, P8070, DOI 10.1021/jp9717655; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o; Frisch M. J., 2009, GAUSSIAN 09 SOFTWARE; Gaido KW, 1997, TOXICOL APPL PHARM, V143, P205, DOI 10.1006/taap.1996.8069; Gao Y, 2012, J HAZARD MATER, V199, P111, DOI 10.1016/j.jhazmat.2011.10.066; Gouda H, 2003, BIOPOLYMERS, V68, P16, DOI 10.1002/bip.10270; Gould JC, 1998, MOL CELL ENDOCRINOL, V142, P203, DOI 10.1016/S0303-7207(98)00084-7; Halgren TA, 2004, J MED CHEM, V47, P1750, DOI 10.1021/jm030644s; Hou TJ, 2007, J MED CHEM, V50, P1177, DOI 10.1021/jm0609162; Hou TJ, 2009, PROTEINS, V74, P837, DOI 10.1002/prot.22192; Hunt PA, 2012, P NATL ACAD SCI USA, V109, P17525, DOI 10.1073/pnas.1207854109; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; Kumar R, 1999, STEROIDS, V64, P310, DOI 10.1016/S0039-128X(99)00014-8; le Maire A, 2010, CELL MOL LIFE SCI, V67, P1219, DOI 10.1007/s00018-009-0249-2; Li QA, 2010, J HAZARD MATER, V180, P703, DOI 10.1016/j.jhazmat.2010.04.094; Massova I, 2000, PERSPECT DRUG DISCOV, V18, P113, DOI 10.1023/A:1008763014207; Matsushima A, 2007, J BIOCHEM, V142, P517, DOI 10.1093/jb/mvm158; McKenna NJ, 1999, ENDOCR REV, V20, P321, DOI 10.1210/er.20.3.321; Moriyama K, 2002, J CLIN ENDOCR METAB, V87, P5185, DOI 10.1210/jc.2002-020209; Okada H, 2008, ENVIRON HEALTH PERSP, V116, P32, DOI 10.1289/ehp.10587; Onufriev A, 2000, J PHYS CHEM B, V104, P3712, DOI 10.1021/jp994072s; Osz J, 2012, P NATL ACAD SCI USA, V109, pE588, DOI 10.1073/pnas.1118192109; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Riu A, 2011, ENVIRON HEALTH PERSP, V119, P1227, DOI 10.1289/ehp.1003328; Rubin BS, 2011, J STEROID BIOCHEM, V127, P27, DOI 10.1016/j.jsbmb.2011.05.002; Rubin BS, 2009, MOL CELL ENDOCRINOL, V304, P55, DOI 10.1016/j.mce.2009.02.023; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Saiyood S, 2010, J HAZARD MATER, V178, P777, DOI 10.1016/j.jhazmat.2010.02.008; SITKOFF D, 1994, J PHYS CHEM-US, V98, P1978, DOI 10.1021/j100058a043; Sohoni P, 1998, J ENDOCRINOL, V158, P327, DOI 10.1677/joe.0.1580327; Sonoda J, 2008, FEBS LETT, V582, P2, DOI 10.1016/j.febslet.2007.11.016; Sui YP, 2012, ENVIRON HEALTH PERSP, V120, P399, DOI 10.1289/ehp.1104426; Tabb MM, 2006, MOL ENDOCRINOL, V20, P475, DOI 10.1210/me.2004-0513; Takayanagi S, 2006, TOXICOL LETT, V167, P95, DOI 10.1016/j.toxlet.2006.08.012; Tsai WT, 2009, J HAZARD MATER, V168, P269, DOI 10.1016/j.jhazmat.2009.02.034; Uppenberg J, 1998, J BIOL CHEM, V273, P31108, DOI 10.1074/jbc.273.47.31108; Vandenberg LN, 2007, ENDOCRINOLOGY, V148, P116, DOI 10.1210/en.2006-0561; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Warnmark A, 2002, J BIOL CHEM, V277, P21862, DOI 10.1074/jbc.M200764200; Xue WW, 2014, J CHEM INF MODEL, V54, P621, DOI 10.1021/ci400060j; Xue WW, 2012, ANTIVIR RES, V93, P126, DOI 10.1016/j.antiviral.2011.11.007; Zalko D, 2011, CHEMOSPHERE, V82, P424, DOI 10.1016/j.chemosphere.2010.09.058; Zoeller RT, 2005, ENDOCRINOLOGY, V146, P607, DOI 10.1210/en.2004-1018	55	68	69	5	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120330	10.1371/journal.pone.0120330	http://dx.doi.org/10.1371/journal.pone.0120330			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799048	Green Published, gold, Green Submitted			2022-12-26	WOS:000351987300135
J	Lu, AT; Yu, YP; Niu, JX; Zhang, JX				Lu, Aitao; Yu, Yanping; Niu, Jiaxin; Zhang, John X.			The Effect of Sign Language Structure on Complex Word Reading in Chinese Deaf Adolescents	PLOS ONE			English	Article							MORPHOLOGICAL AWARENESS; CHILDREN; RECOGNITION; BILINGUALS; KNOWLEDGE; HEARING; CONTEXT	The present study was carried out to investigate whether sign language structure plays a role in the processing of complex words (i.e., derivational and compound words), in particular, the delay of complex word reading in deaf adolescents. Chinese deaf adolescents were found to respond faster to derivational words than to compound words for one-sign-structure words, but showed comparable performance for two-sign-structure words. For both derivational and compound words, response latencies to one-sign-structure words were shorter than to two-sign-structure words. These results provide strong evidence that the structure of sign language affects written word processing in Chinese. Additionally, differences between derivational and compound words in the one-sign-structure condition indicate that Chinese deaf adolescents acquire print morphological awareness. The results also showed that delayed word reading was found in derivational words with two signs (DW-2), compound words with one sign (CW-1), and compound words with two signs (CW-2), but not in derivational words with one sign (DW-1), with the delay being maximum in DW-2, medium in CW-2, and minimum in CW-1, suggesting that the structure of sign language has an impact on the delayed processing of Chinese written words in deaf adolescents. These results provide insight into the mechanisms about how sign language structure affects written word processing and its delayed processing relative to their hearing peers of the same age.	[Lu, Aitao; Yu, Yanping; Niu, Jiaxin] S China Normal Univ, Ctr Studies Psychol Applicat, Guangzhou, Guangdong, Peoples R China; [Lu, Aitao; Yu, Yanping; Niu, Jiaxin] S China Normal Univ, Sch Psychol, Guangzhou, Guangdong, Peoples R China; [Lu, Aitao; Yu, Yanping; Niu, Jiaxin] Guangdong Key Lab Mental Hlth & Cognit Sci, Guangzhou, Guangdong, Peoples R China; [Lu, Aitao; Yu, Yanping; Niu, Jiaxin] Guangdong Ctr Mental Assistance & Contingency Tec, Guangzhou, Guangdong, Peoples R China; [Zhang, John X.] Fudan Univ, Dept Psychol, Shanghai 200433, Peoples R China	South China Normal University; South China Normal University; Fudan University	Lu, AT (corresponding author), S China Normal Univ, Ctr Studies Psychol Applicat, Guangzhou, Guangdong, Peoples R China.	atlupsy@gmail.com	Yu, Yan/GYV-4514-2022		National Natural Science Foundation of China [31200762]; National Training Fund for Basic Research [J1030729, J1210024]; Foundation for Outstanding Young Teachers in Higher Education of Guangdong, China [HS2015001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Training Fund for Basic Research; Foundation for Outstanding Young Teachers in Higher Education of Guangdong, China	This work was supported by the National Natural Science Foundation of China (No. 31200762), the National Training Fund for Basic Research (J1030729 and J1210024), and the Foundation for Outstanding Young Teachers in Higher Education of Guangdong, China (HS2015001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander KL, 1997, SOCIOL EDUC, V70, P87, DOI 10.2307/2673158; Andrew KN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089994; Aronoff M., 1994, MORPHOLOGY ITSELF; Beard R., 1995, LEXEME MORPHEME BASE; Cai Q, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010729; Casey S, 2009, LANG COGNITIVE PROC, V24, P290, DOI 10.1080/01690960801916188; Costa A, 2000, J EXP PSYCHOL LEARN, V26, P1283, DOI 10.1037//0278-7393.26.5.1283; Dijkstra T, 2002, BILING-LANG COGN, V5, P175, DOI 10.1017/S1366728902003012; Dong XF, 2005, CHINESE LANGUAGE LEA, V6, P13; Duyck W, 2007, J EXP PSYCHOL LEARN, V33, P663, DOI 10.1037/0278-7393.33.4.663; Emmorey K, 2008, BILING-LANG COGN, V11, P43, DOI 10.1017/S1366728907003203; Friesen DC, 2012, READ WRIT, V25, P375, DOI 10.1007/s11145-010-9275-6; Gaustad Martha Gonter, 2004, J Deaf Stud Deaf Educ, V9, P269; Gaustad MG, 2002, AM ANN DEAF, V147, P5, DOI 10.1353/aad.2012.0264; Hayes H, 2011, SCI STUD READ, V15, P522, DOI 10.1080/10888438.2010.528480; Hoosain R, 1991, PSYCHOLINGUISTIC IMP; Jin Y, 1988, COMMUNICATION PSYCHO, V1, P16; Kerkhofs R, 2006, BRAIN RES, V1068, P170, DOI 10.1016/j.brainres.2005.10.087; Kuo LJ, 2006, EDUC PSYCHOL-US, V41, P161, DOI 10.1207/s15326985ep4103_3; Liu PP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055440; Lu J., 2008, P 6 SIGHAN WORKSH CH, P53; Moats LC, 1999, TEACHING IS ROCKET S; Morford JP, 2011, COGNITION, V118, P286, DOI 10.1016/j.cognition.2010.11.006; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pittman AL, 2005, EAR HEARING, V26, P619, DOI 10.1097/01.aud.0000189921.34322.68; Schwartz AI, 2008, BILING-LANG COGN, V11, P95, DOI 10.1017/S1366728907003239; Shen D, 2008, COGNITIVE CULTURAL I, P255; Shook A, 2012, COGNITION, V124, P314, DOI 10.1016/j.cognition.2012.05.014; Sterne A, 2000, J CHILD PSYCHOL PSYC, V41, P609, DOI 10.1111/1469-7610.00648; Sun FC, 1999, READING CHINESE SCRIPT, P189; Sunderman G, 2006, STUD SECOND LANG ACQ, V28, P387, DOI 10.1017/S0272263106060177; Taft M., 1995, MORPHOLOGICAL ASPECT, P293; Transler C, 1999, J Deaf Stud Deaf Educ, V4, P124, DOI 10.1093/deafed/4.2.124; Traxler C B, 2000, J Deaf Stud Deaf Educ, V5, P337; van Hell JG, 2002, PSYCHON B REV, V9, P780, DOI 10.3758/BF03196335; van Hoogmoed AH, 2013, RES DEV DISABIL, V34, P1083, DOI 10.1016/j.ridd.2012.12.010; Wang M, 2006, J EDUC PSYCHOL, V98, P542, DOI 10.1037/0022-0663.98.3.542; Wauters LN, 2006, READ WRIT, V19, P49, DOI 10.1007/s11145-004-5894-0; Zhou XL, 1995, LANG COGNITIVE PROC, V10, P545, DOI 10.1080/01690969508407114	39	5	5	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120943	10.1371/journal.pone.0120943	http://dx.doi.org/10.1371/journal.pone.0120943			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE6ZS	25799066	gold, Green Published, Green Submitted			2022-12-26	WOS:000351987300196
J	Lu, JY; Jiao, TT; Li, YM; Liu, Y; Wang, YN; Wang, YT; Zheng, MH; Lu, XF				Lu, Jiaoyang; Jiao, Taotao; Li, Yanmei; Liu, Ying; Wang, Yanan; Wang, Yatian; Zheng, Minhua; Lu, Xuefeng			Heading toward the Right Direction-Solution Package for Endoscopic Submucosal Tunneling Resection in the Stomach	PLOS ONE			English	Article							GASTRIC SUBEPITHELIAL TUMORS; MUSCULARIS PROPRIA; DISSECTION	Background The emerging submucosal tunneling and endoscopic resection (STER) technique provides definitive histological diagnosis as well as a therapeutic method for the gastric submucosal tumors (SMTs). We aim to present our experience and discuss key technical issues of STER. Methods 45 patients with gastric SMTs arising from MP received STER. First, a mucosal incision was made 3cm proximal to the tumour, a submucosal tunnel was subsequently built from the incision to the tumor. The tumor was gradually exposed and dissected from surrounding tissue and retrieved from the tunnel. The initial mucosal incision was closed by metal clips. For SMTs in the gastric fundus near cardia, the submucosal tunnel was built from lower esophagus, through the angle of His, to the tumor for resection. Results STER was successfully performed in 43 patients; the other two were converted to surgery. Mean operating time was 79.3min (range 45-150min). Mean tumor size was 1.4cm (range 0.5-5cm). Of the total 47 resected SMTs, 36 were GISTs, 10 were leiomyomas and 1 was schwannoma. Complete resection was achieved in all patients. Intra-procedural peumoperitoneum occurred in 3 cases because of iatrogenic perforation, no special treatment was given. 7 patients presented with mild abdominal pain/distention and fever were given antibotics. No severe post-operative complication happened. No tumor recurrence occurred in the median 11 month follow-up period. Conclusion Based on short-term follow-up observation, STER is a feasible, safe and minimally invasive method for the diagnosis and treatment of small (<3cm) SMTs in gastric body, antrum and proximal cardia.	[Lu, Jiaoyang; Li, Yanmei; Liu, Ying; Wang, Yanan; Wang, Yatian; Lu, Xuefeng] Shandong Univ, Sch Med, Dept Gastroenterol, Qilu Hosp, Jinan 250100, Shandong, Peoples R China; [Jiao, Taotao] Shandong Prov Hosp, Dept Stat, Jinan, Shandong, Peoples R China; [Lu, Jiaoyang; Zheng, Minhua] Shanghai Jiao Tong Univ, Sch Med, Dept Gen Surg, Ruijin Hosp, Shanghai 200030, Peoples R China	Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shanghai Jiao Tong University	Zheng, MH (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Dept Gen Surg, Ruijin Hosp, Shanghai 200030, Peoples R China.	zheng_minhua@yeah.net; lu0801shanyi@163.com						Blay JY, 2012, ANN ONCOL, V23, P49, DOI 10.1093/annonc/mds252; Chu YY, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-124; Chun SY, 2013, SURG ENDOSC, V27, P3271, DOI 10.1007/s00464-013-2904-9; Gong W, 2012, ENDOSCOPY, V44, P231, DOI 10.1055/s-0031-1291720; Hoda KM, 2009, GASTROINTEST ENDOSC, V69, P1218, DOI 10.1016/j.gie.2008.09.045; Huang ZG, 2012, WORLD J GASTRO ENDOS, V4, P565, DOI 10.4253/wjge.v4.i12.565; Joensuu H, 2008, HUM PATHOL, V39, P1411, DOI 10.1016/j.humpath.2008.06.025; Joensuu H, 2013, LANCET, V382, P973, DOI 10.1016/S0140-6736(13)60106-3; Karaca C, 2010, GASTROINTEST ENDOSC, V71, P722, DOI 10.1016/j.gie.2009.10.019; Lee CH, 2012, J AM COLL SURGEONS, V215, P831, DOI 10.1016/j.jamcollsurg.2012.07.009; Lee IL, 2006, ENDOSCOPY, V38, P1024, DOI 10.1055/s-2006-944814; Liu BR, 2013, SURG ENDOSC, V27, P4354, DOI 10.1007/s00464-013-3023-3; Lu J, 2014, ENDOSCOPY; Lu JY, 2014, SURG ENDOSC, V28, P3401, DOI 10.1007/s00464-014-3610-y; Matthews BD, 2002, SURG ENDOSC, V16, P803, DOI 10.1007/s00464-001-8319-z; Park YS, 2004, GASTROINTEST ENDOSC, V59, P409, DOI 10.1016/S0016-5107(03)02717-2; Sepe PS, 2009, GASTROINTEST ENDOSC, V70, P254, DOI 10.1016/j.gie.2008.11.038; Sepe PS, 2009, NAT REV GASTRO HEPAT, V6, P363, DOI 10.1038/nrgastro.2009.43; Shi Q, 2011, GASTROINTEST ENDOSC, V74, P1194, DOI 10.1016/j.gie.2011.07.039; Xu MD, 2012, GASTROINTEST ENDOSC, V75, P195, DOI 10.1016/j.gie.2011.08.018	20	14	15	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0119870	10.1371/journal.pone.0119870	http://dx.doi.org/10.1371/journal.pone.0119870			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799065	Green Published, gold, Green Submitted			2022-12-26	WOS:000351987300086
J	Martinez-Barquero, V; de Marco, G; Martinez-Hervas, S; Rentero, P; Galan-Chilet, I; Blesa, S; Morchon, D; Morcillo, S; Rojo, G; Ascaso, JF; Real, JT; Martin-Escudero, JC; Chaves, FJ				Martinez-Barquero, Vanesa; de Marco, Griselda; Martinez-Hervas, Sergio; Rentero, Pilar; Galan-Chilet, Inmaculada; Blesa, Sebastian; Morchon, David; Morcillo, Sonsoles; Rojo, Gemma; Francisco Ascaso, Juan; Tomas Real, Jose; Carlos Martin-Escudero, Juan; Javier Chaves, Felipe			Polymorphisms in Endothelin System Genes, Arsenic Levels and Obesity Risk	PLOS ONE			English	Article							METABOLIC SYNDROME; 3T3-L1 ADIPOCYTES; ASSOCIATION; INFLAMMATION; LIPOLYSIS; BLOOD; LOCI; ACCUMULATION; PATHOGENESIS; METAANALYSIS	Background/Objectives Obesity has been linked to morbidity and mortality through increased risk for many chronic diseases. Endothelin (EDN) system has been related to endothelial function but it can be involved in lipid metabolism regulation: Receptor type A (EDNRA) activates lipolysis in adipocytes, the two endothelin receptors mediate arsenic-stimulated adipocyte dysfunction, and endothelin system can regulate adiposity by modulating adiponectin activity in different situations and, therefore, influence obesity development. The aim of the present study was to analyze if single nucleotide polymorphisms (SNPs) in the EDN system could be associated with human obesity. Subjects/Methods We analyzed two samples of general-population-based studies from two different regions of Spain: the VALCAR Study, 468 subjects from the area of Valencia, and the Hortega Study, 1502 subjects from the area of Valladolid. Eighteen SNPs throughout five genes were analyzed using SNPlex. Results We found associations for two polymorphisms of the EDNRB gene which codifies for EDN receptor type B. Genotypes AG and AA of the rs5351 were associated with a lower risk for obesity in the VALCAR sample (p=0.048, OR=0.63) and in the Hortega sample (p=0.001, OR=0.62). Moreover, in the rs3759475 polymorphism, genotypes CT and TT were also associated with lower risk for obesity in the Hortega sample (p=0.0037, OR=0.66) and in the VALCAR sample we found the same tendency (p=0.12, OR=0.70). Furthermore, upon studying the pooled population, we found a stronger association with obesity (p=0.0001, OR=0.61 and p=0.0008, OR=0.66 for rs5351 and rs3759475, respectively). Regarding plasma arsenic levels, we have found a positive association for the two SNPs studied with obesity risk in individuals with higher arsenic levels in plasma: rs5351 (p=0.0054, OR=0.51) and rs3759475 (p=0.009, OR=0.53) Conclusions Our results support the hypothesis that polymorphisms of the EDNRB gene may influence the susceptibility to obesity and can interact with plasma arsenic levels.	[Martinez-Barquero, Vanesa; Martinez-Hervas, Sergio; Francisco Ascaso, Juan; Tomas Real, Jose] Univ Valencia, Dept Med, Valencia, Spain; [Martinez-Barquero, Vanesa; de Marco, Griselda; Rentero, Pilar; Galan-Chilet, Inmaculada; Blesa, Sebastian; Javier Chaves, Felipe] Hosp Clin Res Fdn INCLIVA, Genotyping & Genet Diag Unit, Valencia, Spain; [Martinez-Hervas, Sergio; Morcillo, Sonsoles; Rojo, Gemma; Francisco Ascaso, Juan; Tomas Real, Jose; Javier Chaves, Felipe] CIBER Diabet & Associated Metab Dis CIBERDEM, Barcelona, Spain; [Morcillo, Sonsoles; Rojo, Gemma] Hosp Reg Univ, Serv Endocrinol & Nutr, Malaga, Spain; [Morcillo, Sonsoles; Rojo, Gemma] Inst Biomed Malaga IBIMA, Malaga, Spain; [Martinez-Hervas, Sergio; Francisco Ascaso, Juan; Tomas Real, Jose] Hosp Clin Univ Valencia, Serv Endocrinol & Nutr, Valencia, Spain; [Morchon, David; Carlos Martin-Escudero, Juan] Univ Valladolid, Rio Hortega Hosp, Internal Med, Valladolid, Spain	University of Valencia; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Universidad de Malaga; Hospital Clinic Universitari de Valencia; Hospital del Rio Hortega; Universidad de Valladolid	Chaves, FJ (corresponding author), Hosp Clin Res Fdn INCLIVA, Genotyping & Genet Diag Unit, Valencia, Spain.	felipe.chaves@uv.es	Blesa, Sebastián/AAC-3857-2019; Chaves-Martinez, Felipe Javier/ABC-3294-2021; Martinez-Hervas, Sergio/K-2829-2014; Rentero-Garrido, Pilar/AAC-1788-2019; Rojo-Martinez, Gemma/E-3351-2010; MORCILLO, SONSOLES/N-9970-2017	Blesa, Sebastián/0000-0002-5219-0796; Chaves-Martinez, Felipe Javier/0000-0001-8009-3689; Martinez-Hervas, Sergio/0000-0002-6775-2034; De Marco, Griselda/0000-0003-2344-9348; Martin-Escudero, Juan Carlos/0000-0002-6209-6509; Rojo-Martinez, Gemma/0000-0003-2179-2134; Rentero-Garrido, Pilar/0000-0002-6158-0104; MORCILLO, SONSOLES/0000-0001-6932-5637	Carlos III Health Institute [PI07/0497, PI11/00726]; CIBER de Diabetes y Enfermedades Metabolicas Relacionadas (CIBERDEM); Valencian Government [PROMETEO/2009/029, AP-091/11, ACOMP/2013/039]; JUNTA DE CASTILLA Y LEON Government [GRS 279/a/08]; Spanish Ministry of Education, Social Politics and Sport [AP2010-4754]	Carlos III Health Institute(Instituto de Salud Carlos III); CIBER de Diabetes y Enfermedades Metabolicas Relacionadas (CIBERDEM); Valencian Government; JUNTA DE CASTILLA Y LEON Government(Junta de Castilla y Leon); Spanish Ministry of Education, Social Politics and Sport	This work was supported by the funds for research in health sciences from Carlos III Health Institute (PI07/0497 and PI11/00726), by CIBER de Diabetes y Enfermedades Metabolicas Relacionadas (CIBERDEM); CIBERDEM is an initiative by Carlos III Health Institute in Madrid and the Spanish Health Ministry, by PROMETEO/2009/029, AP-091/11, and ACOMP/2013/039 from the Valencian Government, and by GRS 279/a/08 research project from JUNTA DE CASTILLA Y LEON Government. V. Martinez-Barquero is granted by Spanish Ministry of Education, Social Politics and Sport with the "Formacion del Profesorado Universitario" Program (AP2010-4754). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Alemany M, 2012, FREE RADICAL BIO MED, V52, P2108, DOI 10.1016/j.freeradbiomed.2012.03.003; Alg VS, 2013, NEUROLOGY, V80, P2154, DOI 10.1212/WNL.0b013e318295d751; Barton M, 2008, CAN J PHYSIOL PHARM, V86, P485, DOI 10.1139/Y08-059; Barton M, 2008, NAT CLIN PRACT NEPHR, V4, P490, DOI 10.1038/ncpneph0891; Berndt SI, 2013, NAT GENET, V45, P501, DOI 10.1038/ng.2606; Birgisdottir BE, 2013, SCI TOTAL ENVIRON, V463, P836, DOI 10.1016/j.scitotenv.2013.06.078; Brunner F, 2006, PHARMACOL THERAPEUT, V111, P508, DOI 10.1016/j.pharmthera.2005.11.001; Campia U, 2014, LIFE SCI, DOI S0024-3205(14)00285-9; Campia U, 2012, BRIT J PHARMACOL, V165, P561, DOI 10.1111/j.1476-5381.2011.01661.x; Chang HH, 2012, GEN COMP ENDOCR, V178, P450, DOI 10.1016/j.ygcen.2012.06.024; Chen Y, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2431; Eriksson AKS, 2009, INT J OBESITY, V33, P67, DOI 10.1038/ijo.2008.212; Fong JC, 2001, CELL SIGNAL, V13, P491, DOI 10.1016/S0898-6568(01)00174-7; Garciafigueroa DY, 2013, TOXICOL SCI, V134, P335, DOI 10.1093/toxsci/kft108; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Gribble MO, 2012, AM J EPIDEMIOL, V176, P865, DOI 10.1093/aje/kws153; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Ishibashi KI, 2000, ENDOCRINOLOGY, V141, P4623, DOI 10.1210/en.141.12.4623; Jabeen R, 2012, MOL BIOL REP, V39, P785, DOI 10.1007/s11033-011-0799-x; Juan CC, 2006, OBESITY, V14, P398, DOI 10.1038/oby.2006.53; Juan CC, 2007, ENDOCRINOLOGY, V148, P1835, DOI 10.1210/en.2006-0654; Loos RJF, 2009, BRIT J CLIN PHARMACO, V68, P811, DOI 10.1111/j.1365-2125.2009.03523.x; Lorente-Galdos B, 2012, INT J DATA MIN BIOIN, V6, P324, DOI 10.1504/IJDMB.2012.049249; Low SK, 2012, HUM MOL GENET, V21, P2102, DOI 10.1093/hmg/dds020; Malnick SDH, 2006, QJM-INT J MED, V99, P565, DOI 10.1093/qjmed/hcl085; Martinez-Garcia F, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-111; Maull EA, 2012, ENVIRON HEALTH PERSP, V120, P1658, DOI 10.1289/ehp.1104579; Michel S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013894; Moon K, 2012, CURR ATHEROSCLER REP, V14, P542, DOI 10.1007/s11883-012-0280-x; Nacci C, 2013, J CLIN ENDOCR METAB, V98, pE683, DOI 10.1210/jc.2012-4119; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Paul DS, 2008, METAL IONS BIOL MED, V10, P1; Rodriguez-Pascual F, 2011, PHARMACOL RES, V63, P463, DOI 10.1016/j.phrs.2011.01.014; Sanchez-Mejias A, 2010, GENET MED, V12, P39, DOI 10.1097/GIM.0b013e3181c371b0; Serre D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000006; Shemyakin A, 2011, DIABETES, V60, P2061, DOI 10.2337/db10-1281; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Tan LJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096149; Thorin E, 2010, PFLUG ARCH EUR J PHY, V459, P951, DOI 10.1007/s00424-009-0763-y; Tjaden NEB, 2013, TRANSL RES, V162, P1, DOI 10.1016/j.trsl.2013.03.001; van Harmelen V, 2008, DIABETES, V57, P378, DOI 10.2337/db07-0893; Wenner MM, 2011, J PHYSIOL-LONDON, V589, P4671, DOI 10.1113/jphysiol.2011.216218; YANAGISAWA M, 1988, NATURE, V332, P411, DOI 10.1038/332411a0; Yasuda H, 2007, J HUM HYPERTENS, V21, P883, DOI 10.1038/sj.jhh.1002234	48	28	34	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0118471	10.1371/journal.pone.0118471	http://dx.doi.org/10.1371/journal.pone.0118471			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799405	Green Published, gold			2022-12-26	WOS:000351987300009
J	Tencerova, M; Aouadi, M; Vangala, P; Nicoloro, SM; Yawe, JC; Cohen, JL; Shen, YF; Garcia-Menendez, L; Pedersen, DJ; Gallagher-Dorval, K; Perugini, RA; Gupta, OT; Czech, MP				Tencerova, Michaela; Aouadi, Myriam; Vangala, Pranitha; Nicoloro, Sarah M.; Yawe, Joseph C.; Cohen, Jessica L.; Shen, Yuefei; Garcia-Menendez, Lorena; Pedersen, David J.; Gallagher-Dorval, Karen; Perugini, Richard A.; Gupta, Olga T.; Czech, Michael P.			Activated Kupffer cells inhibit insulin sensitivity in obese mice	FASEB JOURNAL			English	Article						small interfering RNA; liver macrophages; insulin resistance; hepatic steatosis	HEPATIC STEATOSIS; FATTY LIVER; IKK-BETA; RESISTANCE; MACROPHAGES; SIRNA; INFLAMMATION; FAILURE	Obesity promotes insulin resistance associated with liver inflammation, elevated glucose production, and type 2 diabetes. Although insulin resistance is attenuated in genetic mouse models that suppress systemic inflammation, it is not clear whether local resident macrophages in liver, denoted Kupffer cells (KCs), directly contribute to this syndrome. We addressed this question by selectively silencing the expression of the master regulator of inflammation, NF-kappa B, in KCs in obese mice. We used glucan-encapsulated small interfering RNA particles (GeRPs) that selectively silence gene expression in macrophages in vivo. Following intravenous injections, GeRPs containing siRNA against p65 of the NF-kappa B complex caused loss of NF-kappa B p65 expression in KCs without disrupting NF-kappa B in hepatocytes or macrophages in other tissues. Silencing of NF-kappa B expression in KCs in obese mice decreased cytokine secretion and improved insulin sensitivity and glucose tolerance without affecting hepatic lipid accumulation. Importantly, GeRPs had no detectable toxic effect. Thus, KCs are key contributors to hepatic insulin resistance in obesity and a potential therapeutic target formetabolic disease.	[Tencerova, Michaela; Aouadi, Myriam; Vangala, Pranitha; Nicoloro, Sarah M.; Yawe, Joseph C.; Cohen, Jessica L.; Shen, Yuefei; Garcia-Menendez, Lorena; Pedersen, David J.; Czech, Michael P.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA USA; [Gallagher-Dorval, Karen; Perugini, Richard A.] Univ Massachusetts, Sch Med, Dept Surg, Worcester, MA USA; [Gupta, Olga T.] Univ Massachusetts, Sch Med, Dept Pediat, Worcester, MA USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Aouadi, M (corresponding author), Karolinska Inst, Novum, Dept Med, Integrated Cardio Metab Ctr, Blickagangen 6, S-14157 Huddinge, Sweden.	myriam.aouadi@ki.se; michael.czech@umassmed.edu	Tencerova, Michaela/G-8089-2017	Tencerova, Michaela/0000-0001-8670-425X; Nicoloro, Sarah/0000-0002-8638-4556	U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [DK085753, DK030898]; NIH National Institute of Allergy and Infectious Diseases [AI046629]; International Research Alliance of the Novo Nordisk Foundation Center for Metabolic Research; NIH NIDDK [DK325220, DK096948-02]; NIDDK under a Ruth L. Kirschstein National Research Service Award (NRSA) [F32DK098879]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI046629] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK030898, R01DK085753, R37DK030898, R01DK103047, F32DK098879, F31DK096948] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); International Research Alliance of the Novo Nordisk Foundation Center for Metabolic Research; NIH NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK under a Ruth L. Kirschstein National Research Service Award (NRSA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank members of their laboratory group for excellent discussion. The authors appreciate the help of Mary Rusckowski and Miles Smith at the small animal imaging core, and the staff of the Flow Cytometry Core, the Morphology Core, and Paul Furcinitti for the spinning disk confocal microscopy at the University of Massachusetts (UMass) Medical School. These studies were supported by grants to M.P.C. from the U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK; DK085753 and DK030898), NIH National Institute of Allergy and Infectious Diseases (AI046629), and the International Research Alliance of the Novo Nordisk Foundation Center for Metabolic Research. The Morphology Core Facility at the UMass Medical School Diabetes and Endocrinology Research Center, funded by NIH NIDDK Grant DK325220 is also gratefully acknowledged. J.L.C. is supported by the NIDDK under a Ruth L. Kirschstein National Research Service Award (NRSA) postdoctoral fellowship (F32DK098879). J.C.Y. is supported by a predoctoral NRSA from the NIH NIDDK (DK096948-02). The authors declare no conflicts of interest.	Amano SU, 2014, CELL METAB, V19, P162, DOI 10.1016/j.cmet.2013.11.017; Aouadi M, 2013, P NATL ACAD SCI USA, V110, P8278, DOI 10.1073/pnas.1300492110; Aouadi M, 2009, NATURE, V458, P1180, DOI 10.1038/nature07774; Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; Benhamed F, 2012, J CLIN INVEST, V122, P2176, DOI 10.1172/JCI41636; Beraza N, 2008, GUT, V57, P655, DOI 10.1136/gut.2007.134288; Bertola A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013577; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; Chavez JA, 2012, CELL METAB, V15, P585, DOI 10.1016/j.cmet.2012.04.002; Chiang SH, 2009, CELL, V138, P961, DOI 10.1016/j.cell.2009.06.046; Clementi AH, 2009, BBA-MOL BASIS DIS, V1792, P1062, DOI 10.1016/j.bbadis.2009.08.007; Dolina JS, 2013, MOL THER-NUCL ACIDS, V2, DOI 10.1038/mtna.2012.63; Fu SN, 2012, CELL METAB, V15, P623, DOI 10.1016/j.cmet.2012.03.007; Glass CK, 2012, CELL METAB, V15, P635, DOI 10.1016/j.cmet.2012.04.001; Han MS, 2013, SCIENCE, V339, P218, DOI 10.1126/science.1227568; Hoffmann F, 2009, GUT, V58, P1670, DOI 10.1136/gut.2008.165647; Jing YW, 2008, BBA-GEN SUBJECTS, V1780, P34, DOI 10.1016/j.bbagen.2007.09.015; Jourdan T, 2013, NAT MED, V19, P1132, DOI 10.1038/nm.3265; Lee S, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp758; Lian GW, 2006, EXP HEMATOL, V34, P348, DOI 10.1016/j.exphem.2005.12.004; Moon YA, 2012, CELL METAB, V15, P240, DOI 10.1016/j.cmet.2011.12.017; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Ogushi I, 2003, HEPATOLOGY, V38, P335, DOI 10.1053/jhep.2003.50298; Perry RJ, 2014, NATURE, V510, P84, DOI 10.1038/nature13478; Ramadori G, 2001, EUR J GASTROEN HEPAT, V13, P777, DOI 10.1097/00042737-200107000-00004; Reilly SM, 2013, NAT MED, V19, P313, DOI 10.1038/nm.3082; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; Stienstra R, 2010, HEPATOLOGY, V51, P511, DOI 10.1002/hep.23337; Sun Z, 2013, TRENDS ENDOCRIN MET, V24, P4, DOI 10.1016/j.tem.2012.09.005; Tesz GJ, 2011, BIOCHEM J, V436, P351, DOI 10.1042/BJ20110352; Thobe BM, 2007, J CELL PHYSIOL, V210, P667, DOI 10.1002/jcp.20860; Tosello-Trampont AC, 2012, J BIOL CHEM, V287, P40161, DOI 10.1074/jbc.M112.417014; Yang CY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065070; Yuan MS, 2001, SCIENCE, V293, P1673, DOI 10.1126/science.1061620	34	43	45	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2015	29	7					2959	2969		10.1096/fj.15-270496	http://dx.doi.org/10.1096/fj.15-270496			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CL3OI	25805830	Green Published			2022-12-26	WOS:000356859100024
J	Li, YF; Song, DL; Song, Y; Zhao, LL; Wolkow, N; Tobias, JW; Song, WC; Dunaief, JL				Li, Yafeng; Song, Delu; Song, Ying; Zhao, Liangliang; Wolkow, Natalie; Tobias, John W.; Song, Wenchao; Dunaief, Joshua L.			Iron-induced Local Complement Component 3 (C3) Up-regulation via Non-canonical Transforming Growth Factor (TGF)- Signaling in the Retinal Pigment Epithelium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						CCAAT; Enhancer-binding Protein (C; EBP); Extracellular Signal-regulated Kinase (ERK); Iron; Signaling; Transforming Growth Factor (TGF-); AMD; C3; RPE; SMAD3	FACTOR-H POLYMORPHISM; MACULAR DEGENERATION; OXIDATIVE STRESS; FACTOR-B; SMAD PROTEINS; KNOCKOUT MICE; ACTIVATION; CELLS; PHOSPHORYLATION; RISK	Background: Human age-related macular degeneration (AMD) retinas exhibit iron overload and localized C3 accumulation in the retinal pigment epithelium (RPE). Results: Iron induces C3 expression via ERK1/2, SMAD3, and CCAAT/enhancer-binding protein- (C/EBP-) in a non-canonical TGF- signaling pathway. Conclusion: An iron-mediated pathway leads to complement dysregulation, an etiologic feature of AMD. Significance: Regulating iron-induced C3 expression suggests a novel therapeutic approach for AMD. Dysregulation of iron homeostasis may be a pathogenic factor in age-related macular degeneration (AMD). Meanwhile, the formation of complement-containing deposits under the retinal pigment epithelial (RPE) cell layer is a pathognomonic feature of AMD. In this study, we investigated the molecular mechanisms by which complement component 3 (C3), a central protein in the complement cascade, is up-regulated by iron in RPE cells. Modulation of TGF- signaling, involving ERK1/2, SMAD3, and CCAAT/enhancer-binding protein-, is responsible for iron-induced C3 expression. The differential effects of spatially distinct SMAD3 phosphorylation sites at the linker region and at the C terminus determined the up-regulation of C3. Pharmacologic inhibition of either ERK1/2 or SMAD3 phosphorylation decreased iron-induced C3 expression levels. Knockdown of SMAD3 blocked the iron-induced up-regulation and nuclear accumulation of CCAAT/enhancer-binding protein-, a transcription factor that has been shown previously to bind the basic leucine zipper 1 domain in the C3 promoter. We show herein that mutation of this domain reduced iron-induced C3 promoter activity. In vivo studies support our in vitro finding of iron-induced C3 up-regulation. Mice with a mosaic pattern of RPE-specific iron overload demonstrated co-localization of iron-induced ferritin and C3d deposits. Humans with aceruloplasminemia causing RPE iron overload had increased RPE C3d deposition. The molecular events in the iron-C3 pathway represent therapeutic targets for AMD or other diseases exacerbated by iron-induced local complement dysregulation.	[Li, Yafeng; Song, Delu; Song, Ying; Zhao, Liangliang; Wolkow, Natalie; Dunaief, Joshua L.] Univ Penn, Scheie Eye Inst, FM Kirby Ctr Mol Ophthalmol, Philadelphia, PA 19104 USA; [Tobias, John W.] Univ Penn, Penn Mol Profiling Facil, Philadelphia, PA 19104 USA; [Song, Wenchao] Univ Penn, Perelman Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	Dunaief, JL (corresponding author), Univ Penn, Scheie Eye Inst, Perelman Sch Med, Dept Ophthalmol,Stellar Chance Labs 305B, 422 Curie Blvd, Philadelphia, PA 19104 USA.	jdunaief@mail.med.upenn.edu	Regan, Clinton/E-6250-2012	Wolkow, Natalie/0000-0003-1524-115X	National Institutes of Health [R01EY015240, R01EY023709, T32EY007035]; Research to Prevent Blindness; Beckman Institute for Macular Research; Paul and Evanina Bell Mackall Foundation Trust; F. M. Kirby Foundation; NATIONAL EYE INSTITUTE [R01EY023709, T32EY007035, P30EY001583, R01EY015240] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Beckman Institute for Macular Research; Paul and Evanina Bell Mackall Foundation Trust; F. M. Kirby Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01EY015240 (to J. L. D.), R01EY023709 (to W. S.), and T32EY007035, a vision science training grant (to the University of Pennsylvania). This work was also supported by Research to Prevent Blindness, The Beckman Institute for Macular Research, the Paul and Evanina Bell Mackall Foundation Trust, and the F. M. Kirby Foundation.	Anderson DH, 2002, AM J OPHTHALMOL, V134, P411, DOI 10.1016/S0002-9394(02)01624-0; Bae E, 2012, BIOCHEM BIOPH RES CO, V427, P593, DOI 10.1016/j.bbrc.2012.09.103; Chen M, 2007, EXP EYE RES, V84, P635, DOI 10.1016/j.exer.2006.11.015; Chen M, 2008, EXP EYE RES, V87, P543, DOI 10.1016/j.exer.2008.09.005; Choy L, 2003, J BIOL CHEM, V278, P9609, DOI 10.1074/jbc.M212259200; Coffey PJ, 2007, P NATL ACAD SCI USA, V104, P16651, DOI 10.1073/pnas.0705079104; Dixon SJ, 2014, NAT CHEM BIOL, V10, P9, DOI 10.1038/nchembio.1416; Dridi S, 2012, P NATL ACAD SCI USA, V109, P13781, DOI 10.1073/pnas.1206494109; Dunaief JL, 2006, INVEST OPHTH VIS SCI, V47, P4660, DOI 10.1167/iovs.06-0568; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Feinberg MW, 2004, J BIOL CHEM, V279, P16388, DOI 10.1074/jbc.M309664200; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; FLINT DH, 1993, J BIOL CHEM, V268, P22369; Fritsche LG, 2013, NAT GENET, V45, P433, DOI 10.1038/ng.2578; Gao S, 2009, MOL CELL, V36, P457, DOI 10.1016/j.molcel.2009.09.043; Gold B, 2006, NAT GENET, V38, P458, DOI 10.1038/ng1750; Grassmann F, 2014, ADV EXP MED BIOL, V801, P291, DOI 10.1007/978-1-4614-3209-8_37; Guymer RH, 2011, INVEST OPHTH VIS SCI, V52, P4639, DOI 10.1167/iovs.10-7120; Hadziahmetovic M, 2008, INVEST OPHTH VIS SCI, V49, P2728, DOI 10.1167/iovs.07-1472; Hadziahmetovic M, 2012, TRANSL VIS SCI TECHN, V1, DOI 10.1167/tvst.1.3.2; Hadziahmetovic M, 2012, INVEST OPHTH VIS SCI, V53, P5231, DOI 10.1167/iovs.12-10204; Hadziahmetovic M, 2011, INVEST OPHTH VIS SCI, V52, P109, DOI 10.1167/iovs.10-6113; Hahn P, 2004, P NATL ACAD SCI USA, V101, P13850, DOI 10.1073/pnas.0405146101; Hahn P, 2003, ARCH OPHTHALMOL-CHIC, V121, P1099, DOI 10.1001/archopht.121.8.1099; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Handa JT, 2012, MOL ASPECTS MED, V33, P418, DOI 10.1016/j.mam.2012.03.006; Hough C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042513; Hua XX, 1998, GENE DEV, V12, P3084, DOI 10.1101/gad.12.19.3084; Jayaraman L, 2000, J BIOL CHEM, V275, P40710, DOI 10.1074/jbc.M005799200; Jinnin M, 2006, MOL PHARMACOL, V69, P597, DOI 10.1124/mol.105.017483; Johnson LV, 2001, EXP EYE RES, V73, P887, DOI 10.1006/exer.2001.1094; JUAN TSC, 1993, P NATL ACAD SCI USA, V90, P2584, DOI 10.1073/pnas.90.7.2584; Kamato D, 2014, J PHARM PHARMACOL, V66, P1722, DOI 10.1111/jphp.12298; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; KOLB WP, 1989, COMPLEMENT INFLAMMAT, V6, P175, DOI 10.1159/000463093; Kretzschmar M, 1999, GENE DEV, V13, P804, DOI 10.1101/gad.13.7.804; Kunchithapautham K, 2014, J BIOL CHEM, V289, P14534, DOI 10.1074/jbc.M114.564674; Kunchithapautham K, 2011, J BIOL CHEM, V286, P23717, DOI 10.1074/jbc.M110.214593; Liu XD, 1997, P NATL ACAD SCI USA, V94, P10669, DOI 10.1073/pnas.94.20.10669; Maranto J, 2008, J NEUROIMMUNE PHARM, V3, P43, DOI 10.1007/s11481-007-9096-9; Markiewski MM, 2007, AM J PATHOL, V171, P715, DOI 10.2353/ajpath.2007.070166; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Matsuura I, 2005, BIOCHEMISTRY-US, V44, P12546, DOI 10.1021/bi050560g; Morgan BP, 2005, IMMUNOL LETT, V97, P171, DOI 10.1016/j.imlet.2004.11.010; Munoz P, 2011, J BIOL CHEM, V286, P13382, DOI 10.1074/jbc.M110.213785; Perkins SJ, 2012, IMMUNOBIOLOGY, V217, P281, DOI 10.1016/j.imbio.2011.10.003; Pickering MC, 2002, NAT GENET, V31, P424, DOI 10.1038/ng912; Sahu A, 2001, IMMUNOL REV, V180, P35, DOI 10.1034/j.1600-065X.2001.1800103.x; Salvador GA, 2011, NEUROTOXICOLOGY, V32, P75, DOI 10.1016/j.neuro.2010.11.006; Seddon JM, 2013, NAT GENET, V45, P1366, DOI 10.1038/ng.2741; Song DL, 2012, FREE RADICAL BIO MED, V53, P64, DOI 10.1016/j.freeradbiomed.2012.04.020; Tarasewicz E, 2012, CELL CYCLE, V11, P2443, DOI 10.4161/cc.20546; Thurman JM, 2009, J BIOL CHEM, V284, P16939, DOI 10.1074/jbc.M808166200; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wang G., 2008, THESIS STATE U NEW J; Wang GN, 2009, J BIOL CHEM, V284, P9663, DOI 10.1074/jbc.M809281200; WILSON DR, 1990, MOL CELL BIOL, V10, P6181, DOI 10.1128/MCB.10.12.6181; Wolkow N, 2012, AM J PATHOL, V180, P1614, DOI 10.1016/j.ajpath.2011.12.041; Wolkow N, 2011, ARCH OPHTHALMOL-CHIC, V129, P1466, DOI 10.1001/archophthalmol.2011.309; Yates JRW, 2007, NEW ENGL J MED, V357, P553, DOI 10.1056/NEJMoa072618; Zipfel PF, 2010, ADV EXP MED BIOL, V703, P9, DOI 10.1007/978-1-4419-5635-4_2	61	25	25	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2015	290	19					11918	11934		10.1074/jbc.M115.645903	http://dx.doi.org/10.1074/jbc.M115.645903			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH9XA	25802332	Green Published, hybrid			2022-12-26	WOS:000354388600010
J	Zuo, GL; Zhang, LF; Qi, J; Kang, H; Jia, P; Chen, H; Shen, X; Guo, L; Zhou, HB; Wang, JS; Zhou, Q; Qian, ND; Deng, LF				Zuo, Gui-lai; Zhang, Lian-fang; Qi, Jin; Kang, Hui; Jia, Peng; Chen, Hao; Shen, Xing; Guo, Lei; Zhou, Han-bing; Wang, Jin-shen; Zhou, Qi; Qian, Nian-dong; Deng, Lian-fu			Activation of HIFa Pathway in Mature Osteoblasts Disrupts the Integrity of the Osteocyte/Canalicular Network	PLOS ONE			English	Article							BONE-FORMATION; 3-DIMENSIONAL RECONSTRUCTION; OSTEOCYTE PROCESSES; OXYGEN-TENSION; BMP ANTAGONIST; DIFFERENTIATION; HYPOXIA; SCLEROSTIN; MICROSCOPY; CELLS	The hypoxia-inducible factors (HIFs), HIF-1 alpha and HIF-2 alpha, are the central mediators of the homeostatic response that enables cells to survive and differentiate in low-oxygen conditions. Previous studies indicated that disruption of the von Hippel-Lindau gene (Vhl) coincides with the activation of HIF alpha signaling. Here we show that inactivation of Vhl in mature osteoblasts/osteocytes induces their apoptosis and disrupts the cell/canalicular network. VHL-deficient (Delta VHL) mice exhibited a significantly increased cortical bone area resulting from enhanced proliferation and osteogenic differentiation of the bone marrow stromal cells (BMSCs) by inducing the expression of beta-catenin in the BMSC. Our data suggest that the VHL/HIF alpha pathway in mature osteoblasts/osteocytes plays a critical role in the bone cell/canalicular network and that the changes of osteocyte morphology/function and cell/canalicular network may unleash the bone formation, The underlying mechanism of which was the accumulation of beta-catenin in the osteoblasts/osteoprogenitors of the bone marrow.	[Zuo, Gui-lai; Qi, Jin; Kang, Hui; Jia, Peng; Chen, Hao; Shen, Xing; Guo, Lei; Zhou, Han-bing; Wang, Jin-shen; Zhou, Qi; Qian, Nian-dong; Deng, Lian-fu] Shanghai Jiao Tong Univ, Shanghai Key Lab Prevent Treatment Bone & Joint D, Shanghai Inst Traumatol & Orthopaed, Ruijin Hosp,Sch Med, Shanghai 200025, Peoples R China; [Zhang, Lian-fang] Soochow Univ, Affiliated Hosp 1, Dept Orthopaed, Suzhou, Peoples R China; [Zuo, Gui-lai] Shang Dong Univ, Qian Fo Shan Hosp, Dept Orthopaed, Jinan, Peoples R China	Shanghai Jiao Tong University; Soochow University - China	Deng, LF (corresponding author), Shanghai Jiao Tong Univ, Shanghai Key Lab Prevent Treatment Bone & Joint D, Shanghai Inst Traumatol & Orthopaed, Ruijin Hosp,Sch Med, Shanghai 200025, Peoples R China.	deng_lianfu@hotmail.com			Natural Science Foundation of China [81371958, 81061160510]; Basic Key Project of Science and Technology Commission of Shanghai Municipality [12JC1408200]; Scientific and Technological Support Program in Biological Medicine of Science and Technology Commission of Shanghai Municipality [13431900702]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Basic Key Project of Science and Technology Commission of Shanghai Municipality; Scientific and Technological Support Program in Biological Medicine of Science and Technology Commission of Shanghai Municipality	Deng Lian Fu received funds from Natural Science Foundation of China (No. 81371958, 81061160510), the Basic Key Project of Science and Technology Commission of Shanghai Municipality (12JC1408200), and the Scientific and Technological Support Program in Biological Medicine of Science and Technology Commission of Shanghai Municipality (13431900702), http://www.nsfc.gov.cn/, http://www.stcsm.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asada N, 2013, CELL STEM CELL, V12, P737, DOI 10.1016/j.stem.2013.05.001; Baron R, 2013, NAT MED, V19, P179, DOI 10.1038/nm.3074; Bezooijen RL, 2005, CYTOKINE GROWTH F R, V16, P319, DOI 10.1016/j.cytogfr.2005.02.005; Bivi N, 2012, J BONE MINER RES, V27, P374, DOI 10.1002/jbmr.548; Bonewald LF, 2011, J BONE MINER RES, V26, P229, DOI 10.1002/jbmr.320; Bozal CB, 2013, CELLS TISSUES ORGANS, V197, P474, DOI 10.1159/000347237; Capulli M, 2014, ARCH BIOCH BIOPHYS; Dallas SL, 2013, ENDOCR REV, V34, P658, DOI 10.1210/er.2012-1026; Dallas SL, 2010, ANN NY ACAD SCI, V1192, P437, DOI 10.1111/j.1749-6632.2009.05246.x; Franz-Odendaal TA, 2006, DEV DYNAM, V235, P176, DOI 10.1002/dvdy.20603; Glass DA, 2005, DEV CELL, V8, P751, DOI 10.1016/j.devcel.2005.02.017; Gorustovich AA, 2007, J BIOMED MATER RES A, V81A, P443, DOI 10.1002/jbm.a.31071; Haase VH, 2001, P NATL ACAD SCI USA, V98, P1583, DOI 10.1073/pnas.98.4.1583; Hall KC, 2013, MOL CELL BIOL, V33, P3077, DOI 10.1128/MCB.00291-13; Himeno-Ando A, 2012, BIOCHEM BIOPH RES CO, V417, P765, DOI 10.1016/j.bbrc.2011.12.031; Hirao M, 2007, J BONE MINER METAB, V25, P266, DOI 10.1007/s00774-007-0765-9; Hirose S, 2007, J BONE MINER METAB, V25, P374, DOI 10.1007/s00774-007-0764-x; Holmbeck K, 2005, J CELL SCI, V118, P147, DOI 10.1242/jcs.01581; Izu Y, 2011, J CELL BIOL, V193, P1115, DOI 10.1083/jcb.201010010; Kamioka H, 2001, BONE, V28, P145, DOI 10.1016/S8756-3282(00)00421-X; Komori T, 2013, CELL TISSUE RES, V352, P191, DOI 10.1007/s00441-012-1546-x; Kubek DJ, 2010, MICROSC RES TECHNIQ, V73, P182, DOI 10.1002/jemt.20772; Marotti G., 2000, Journal of Musculoskeletal & Neuronal Interactions, V1, P133; Milovanovic P, 2013, ACS NANO; Moriishi T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040143; Moriishi T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027487; Nakashima T, 2011, NAT MED, V17, P1231, DOI 10.1038/nm.2452; Poole KES, 2005, FASEB J, V19, P1842, DOI 10.1096/fj.05-4221fje; Raheja LF, 2008, BIOCHEM BIOPH RES CO, V366, P1061, DOI 10.1016/j.bbrc.2007.12.076; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Schipani Ernestina, 2013, Front Endocrinol (Lausanne), V4, P85, DOI 10.3389/fendo.2013.00085; Semenza GL, 2001, CELL, V107, P1, DOI 10.1016/S0092-8674(01)00518-9; Semenza GL, 2013, J CLIN INVEST, V123, P3664, DOI 10.1172/JCI67230; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Stern AR, 2012, BIOTECHNIQUES, V52, P361, DOI 10.2144/0000113876; Sugawara Y, 2005, BONE, V36, P877, DOI 10.1016/j.bone.2004.10.008; Sugawara Y, 2013, BONE, V52, P189, DOI 10.1016/j.bone.2012.09.033; Sugawara Y, 2011, CALCIFIED TISSUE INT, V88, P416, DOI 10.1007/s00223-011-9471-7; Tang N, 2009, J CELL MOL MED, V13, P2448, DOI 10.1111/j.1582-4934.2008.00569.x; Tatsumi S, 2007, CELL METAB, V5, P464, DOI 10.1016/j.cmet.2007.05.001; van Bezooijen RL, 2004, J EXP MED, V199, P805, DOI 10.1084/jem.20031454; Vatsa A, 2008, BONE, V43, P452, DOI 10.1016/j.bone.2008.01.030; Wang Y, 2007, J CLIN INVEST, V117, P1616, DOI 10.1172/JCI31581; Winkler DG, 2003, EMBO J, V22, P6267, DOI 10.1093/emboj/cdg599; Xiong JH, 2011, NAT MED, V17, P1235, DOI 10.1038/nm.2448; Zahm AM, 2008, BONE, V43, P25, DOI 10.1016/j.bone.2008.03.010; Zhang KQ, 2006, MOL CELL BIOL, V26, P4539, DOI 10.1128/MCB.02120-05; Zhang M, 2002, J BIOL CHEM, V277, P44005, DOI 10.1074/jbc.M208265200; Zhao WG, 2000, J CLIN INVEST, V106, P941, DOI 10.1172/JCI10158; Zhong ZD, 2012, P NATL ACAD SCI USA, V109, pE2197, DOI 10.1073/pnas.1120407109; Zhu ED, 2008, J BIOL CHEM, V283, P7361, DOI 10.1074/jbc.M703304200	51	12	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0121266	10.1371/journal.pone.0121266	http://dx.doi.org/10.1371/journal.pone.0121266			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25806791	Green Submitted, Green Published, gold			2022-12-26	WOS:000351880000140
J	Higashi, K; Takeuchi, Y; Mukuno, A; Tomitori, H; Miya, M; Linhardt, RJ; Toida, T				Higashi, Kyohei; Takeuchi, Yoshiki; Mukuno, Ann; Tomitori, Hideyuki; Miya, Masaki; Linhardt, Robert J.; Toida, Toshihiko			Composition of Glycosaminoglycans in Elasmobranchs including Several Deep-Sea Sharks: Identification of Chondroitin/Dermatan Sulfate from the Dried Fins of Isurus oxyrinchus and Prionace glauca	PLOS ONE			English	Article							DERMATAN SULFATE; ANTICOAGULANT ACTIVITY; BIOSYNTHESIS; BRAIN; PURIFICATION; DISACCHARIDE; SEQUENCE; UNITS; ACID; SKIN	Shark fin, used as a food, is a rich source of glycosaminoglyans (GAGs), acidic polysaccharides having important biological activities, suggesting their nutraceutical and pharmaceutical application. A comprehensive survey of GAGs derived from the fin was performed on 11 elasmobranchs, including several deep sea sharks. Chondroitin sulfate (CS) and hyaluronic acid (HA) were found in Isurus oxyrinchus, Prionace glauca, Scyliorhinus torazame, Deania calcea, Chlamydoselachus anguineus, Mitsukurina owatoni, Mustelus griseus and Dasyatis akajei, respectively. CS was only found from Chimaera phantasma, Dalatias licha, and Odontaspis ferox, respectively. Characteristic disaccharide units of most of the CS were comprised of C- and D-type units. Interestingly, substantial amount of CS/dermatan sulfate (DS) was found in the dried fin (without skin and cartilage) of Isurus oxyrinchus and Prionace glauca. 1H-NMR analysis showed that the composition of glucuronic acid (GlcA) and iduronic acid (IdoA) in shark CS/DS was 41.2% and 58.8%(Isurus oxyrinchus), 36.1% and 63.9% (Prionace glauca), respectively. Furthermore, a substantial proportion of this CS/DS consisted of E-, B- and D-type units. Shark CS/DS stimulated neurite outgrowth of hippocampal neurons at a similar level as DS derived from invertebrate species. Midkine and pleiotrophin interact strongly with CS/DS from Isurus oxyrinchus and Prionace glauca, affording Kd values of 1.07 nM, 6.25 nM and 1.70 nM, 1.88 nM, respectively. These results strongly suggest that the IdoA-rich domain of CS/DS is required for neurite outgrowth activity. A detailed examination of oligosaccharide residues, produced by chondroitinase ACII digestion, suggested that the IdoA and B- type units as well as A- and C-type units were found in clusters in shark CS/DS. In addition, it was discovered that the contents of B- type units in these IdoA-rich domain increased in a length dependent manner, while C- and D-type units were located particularly in the immediate vicinity of the IdoA-rich domain.	[Higashi, Kyohei; Takeuchi, Yoshiki; Mukuno, Ann; Toida, Toshihiko] Chiba Univ, Grad Sch Pharmaceut Sci, Chuo Ku, Chiba 2608675, Japan; [Tomitori, Hideyuki] Chiba Inst Sci, Fac Pharm, Choshi, Chiba 2880025, Japan; [Miya, Masaki] Nat Hist Museum & Inst, Chuo Ku, Chiba 2608682, Japan; [Linhardt, Robert J.] Rensselaer Polytech Inst, Dept Biol, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA	Chiba University; Rensselaer Polytechnic Institute	Toida, T (corresponding author), Chiba Univ, Grad Sch Pharmaceut Sci, Chuo Ku, 1-8-1 Inohana, Chiba 2608675, Japan.	toida@faculty.chiba-u.jp	Miya, Masaki/O-2664-2019	Miya, Masaki/0000-0002-9791-9886; Higashi, Kyohei/0000-0002-2622-4825	 [24590046]		The work was funded by 24590046 Grant-in-Aid for Scientific Research (http://www-shinsei.jsps.go.jp/kaken/index.html) TT. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANNO K, 1971, BIOCHIM BIOPHYS ACTA, V237, P173, DOI 10.1016/0304-4165(71)90046-8; Bao XF, 2005, J BIOL CHEM, V280, P35318, DOI 10.1074/jbc.M507304200; Bao XF, 2005, J BIOL CHEM, V280, P23184, DOI 10.1074/jbc.M503036200; CASSARO CMF, 1977, J BIOL CHEM, V252, P2254; Fongmoon D, 2007, J BIOL CHEM, V282, P36895, DOI 10.1074/jbc.M707082200; FRANSSON LA, 1970, J BIOL CHEM, V245, P4770; HABUCHI O, 1993, J BIOL CHEM, V268, P21968; Hikino M, 2003, J BIOL CHEM, V278, P43744, DOI 10.1074/jbc.M308169200; Homma R, 2005, INT J BIOCHEM CELL B, V37, P1911, DOI 10.1016/j.biocel.2005.04.014; Hoshino K, 2005, J BIOL CHEM, V280, P42801, DOI 10.1074/jbc.M505445200; Igarashi N., 2013, INT J CARBOHYDR CHEM; Kinoshita A, 1997, J BIOL CHEM, V272, P19656, DOI 10.1074/jbc.272.32.19656; Kobayashi M, 1999, J BIOL CHEM, V274, P10474, DOI 10.1074/jbc.274.15.10474; Laremore TN, 2010, BIOCHEM J, V431, P199, DOI 10.1042/BJ20100788; Ly M, 2011, NAT CHEM BIOL, V7, P827, DOI 10.1038/nchembio.673; Maccarana M, 2009, MOL CELL BIOL, V29, P5517, DOI 10.1128/MCB.00430-09; Malmstrom A, 2012, J HISTOCHEM CYTOCHEM, V60, P916, DOI 10.1369/0022155412459857; Matsumoto A, 2012, CARBOHYD RES, V358, P82, DOI 10.1016/j.carres.2012.06.018; Mikami T, 2009, J BIOL CHEM, V284, P4494, DOI 10.1074/jbc.M809227200; Nairn AV, 2007, J PROTEOME RES, V6, P4374, DOI 10.1021/pr070446f; Pavao MSG, 1995, J BIOL CHEM, V270, P31027, DOI 10.1074/jbc.270.52.31027; Pavao MSG, 1998, J BIOL CHEM, V273, P27848, DOI 10.1074/jbc.273.43.27848; Roden L., BIOCH GLYCOPROTEINS, P267; Sakai S, 2003, CARBOHYD RES, V338, P263, DOI 10.1016/S0008-6215(02)00442-1; Schwartz NB, 2004, GLYCOCONJUGATE J, V21, P329, DOI 10.1023/B:GLYC.0000046278.34016.36; Silbert JE, 2002, IUBMB LIFE, V54, P177, DOI 10.1080/15216540214923; Sugahara K, 2000, CURR OPIN STRUC BIOL, V10, P518, DOI 10.1016/S0959-440X(00)00125-1; Sugahara K, 2003, CURR OPIN STRUC BIOL, V13, P612, DOI 10.1016/j.sbi.2003.09.011; Sugahara K, 2007, CURR OPIN STRUC BIOL, V17, P536, DOI 10.1016/j.sbi.2007.08.015; TOIDA T, 1993, ANAL SCI, V9, P53, DOI 10.2116/analsci.9.53; Toida T, 2006, ADV PHARMACOL, V53, P403, DOI 10.1016/S1054-3589(05)53019-9; TOLLEFSEN DM, 1983, J BIOL CHEM, V258, P6713; Toyoda H, 2011, J CHROMATOGR B, V879, P950, DOI 10.1016/j.jchromb.2011.03.007; Vilela-Silva ACES, 2001, GLYCOBIOLOGY, V11, P433, DOI 10.1093/glycob/11.6.433; Volpi N, 2009, GLYCOBIOLOGY, V19, P356, DOI 10.1093/glycob/cwn140; Zhao X, 2013, J BIOL CHEM, V288, P9226, DOI 10.1074/jbc.M112.437236	36	32	32	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0120860	10.1371/journal.pone.0120860	http://dx.doi.org/10.1371/journal.pone.0120860			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803296	Green Published, Green Submitted, gold			2022-12-26	WOS:000353889600105
J	Rasmussen, TL; Ma, Y; Park, CY; Harriss, J; Pierce, SA; Dekker, JD; Valenzuela, N; Srivastava, D; Schwartz, RJ; Stewart, MD; Tucker, HO				Rasmussen, Tara L.; Ma, Yanlin; Park, Chong Yon; Harriss, June; Pierce, Stephanie A.; Dekker, Joseph D.; Valenzuela, Nicolas; Srivastava, Deepak; Schwartz, Robert J.; Stewart, M. David; Tucker, Haley O.			Smyd1 Facilitates Heart Development by Antagonizing Oxidative and ER Stress Responses	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; DIRECT TRANSCRIPTIONAL TARGET; PROGENITOR CELLS; SMOOTH-MUSCLE; IN-VIVO; GENE; PROTEIN; FIELD; AUTOPHAGY; MYND	Smyd1/Bop is an evolutionary conserved histone methyltransferase previously shown by conventional knockout to be critical for embryonic heart development. To further explore the mechanism(s) in a cell autonomous context, we conditionally ablated Smyd1 in the first and second heart fields of mice using a knock-in (KI) Nkx2.5-cre driver. Robust deletion of floxed-Smyd1 in cardiomyocytes and the outflow tract (OFT) resulted in embryonic lethality at E9.5, truncation of the OFT and right ventricle, and additional defects consistent with impaired expansion and proliferation of the second heart field (SHF). Using a transgenic (Tg) Nkx2.5-cre driver previously shown to not delete in the SHF and OFT, early embryonic lethality was bypassed and both ventricular chambers were formed; however, reduced cardiomyocyte proliferation and other heart defects resulted in later embryonic death at E11.5-12.5. Proliferative impairment prior to both early and mid-gestational lethality was accompanied by dysregulation of transcripts critical for endoplasmic reticulum (ER) stress. Mid-gestational death was also associated with impairment of oxidative stress defense-a phenotype highly similar to the previously characterized knockout of the Smyd1-interacting transcription factor, skNAC. We describe a potential feedback mechanism in which the stress response factor Tribbles3/TRB3, when directly methylated by Smyd1, acts as a corepressor of Smyd1-mediated transcription. Our findings suggest that Smyd1 is required for maintaining cardiomyocyte proliferation at minimally two different embryonic heart developmental stages, and its loss leads to linked stress responses that signal ensuing lethality.	[Rasmussen, Tara L.; Harriss, June; Dekker, Joseph D.; Tucker, Haley O.] Univ Texas Austin, Mol Biosci & Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Ma, Yanlin] Hainan Med Univ, Affiliated Hosp, Hainan Prov Key Lab Human Reprod Med & Genet Res, Haikou, Hainan, Peoples R China; [Ma, Yanlin; Valenzuela, Nicolas; Schwartz, Robert J.; Stewart, M. David] Univ Houston, Dept Biol & Biochem, Houston, TX 77004 USA; [Park, Chong Yon; Pierce, Stephanie A.; Srivastava, Deepak] Univ Calif San Francisco, Gladstone Inst Cardiovasc Dis, San Francisco, CA 94143 USA; [Park, Chong Yon; Pierce, Stephanie A.; Srivastava, Deepak] Univ Calif San Francisco, Dept Pediat & Biochem & Biophys, San Francisco, CA 94143 USA	University of Texas System; University of Texas Austin; Hainan Medical University; University of Houston System; University of Houston; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco	Stewart, MD (corresponding author), Univ Houston, Dept Biol & Biochem, Houston, TX 77004 USA.	dstewart@uh.edu; haleytucker@austin.utexas.edu	Dekker, Joseph D/G-4924-2013; Ma, Yanlin/CAH-2185-2022	Dekker, Joseph D/0000-0002-2068-3529; Ma, Yanlin/0000-0001-9668-0204; Srivastava, Deepak/0000-0002-3480-5953; Stewart, M. David/0000-0002-4794-6843	National Institutes of Health (NIH) [CA-31534]; Norman Hackerman Advanced Research Program [NHARP-003658-0149]; Cancer Prevention Research Institute of Texas (CPRIT) [RP100612]; Maria Betzner Morrow Endowment; American Heart Association [10BGIA4250008, 12BGIA11860006]; Natural Science Foundation of China [31140021, 81260032]; NIH; National Heart Lung and Blood Institute/NIH; California Institute for Regenerative Medicine; CPRIT [CPRIT- RP120348]; NATIONAL CANCER INSTITUTE [R01CA031534] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089902] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Norman Hackerman Advanced Research Program; Cancer Prevention Research Institute of Texas (CPRIT); Maria Betzner Morrow Endowment; American Heart Association(American Heart Association); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart Lung and Blood Institute/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); CPRIT; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by grants from the National Institutes of Health (NIH)(CA-31534), The Norman Hackerman Advanced Research Program (NHARP-003658-0149), Cancer Prevention Research Institute of Texas (CPRIT RP100612), and the Maria Betzner Morrow Endowment to HOT. Additional funding for this work came from grants from the American Heart Association (10BGIA4250008 and 12BGIA11860006) to MDS; by grants from the Natural Science Foundation of China (31140021 and 81260032) to YM; and by NIH grant HL-089902 to RJS. DS was supported by grants from the National Heart Lung and Blood Institute/NIH and the California Institute for Regenerative Medicine. Microarray analysis at the University of Texas is supported by CPRIT (CPRIT- RP120348). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Farha M, 2011, J MOL CELL BIOL, V3, P301, DOI 10.1093/jmcb/mjr025; Ai D, 2007, P NATL ACAD SCI USA, V104, P9319, DOI 10.1073/pnas.0701212104; Avery J, 2010, CIRC RES, V106, P1516, DOI 10.1161/CIRCRESAHA.109.211920; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; Cunard R, 2013, SCIENTIFICA, V2013, DOI 10.1155/2013/750871; Dennery Phyllis A., 2007, Birth Defects Research, V81, P155, DOI 10.1002/bdrc.20098; Dodou E, 2004, DEVELOPMENT, V131, P3931, DOI 10.1242/dev.01256; Fang BA, 2014, BBA-REV CANCER, V1845, P1, DOI 10.1016/j.bbcan.2013.11.002; Foreman KW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022290; Francou A, 2013, BBA-MOL CELL RES, V1833, P795, DOI 10.1016/j.bbamcr.2012.10.003; Galli D, 2008, DEVELOPMENT, V135, P1157, DOI 10.1242/dev.014563; Gittenberger-de Groot AC, 2013, SEMIN FETAL NEONAT M, V18, P237, DOI 10.1016/j.siny.2013.04.008; Gottlieb PD, 2002, NAT GENET, V31, P25, DOI 10.1038/ng866; Groenendyk J, 2010, CIRC RES, V107, P1185, DOI 10.1161/CIRCRESAHA.110.227033; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Hendgen-Cotta UB, 2014, TRENDS CARDIOVAS MED, V24, P69, DOI 10.1016/j.tcm.2013.06.006; Hildreth V, 2009, J ANAT, V214, P894, DOI 10.1111/j.1469-7580.2009.01087.x; Hill C, 2013, CARDIOVASC RES, V99, P121, DOI 10.1093/cvr/cvt094; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang J, 2006, NATURE, V444, P629, DOI 10.1038/nature05287; IWAKI K, 1990, J BIOL CHEM, V265, P13809; Jiang Yan, 2010, J Mol Signal, V5, P7, DOI 10.1186/1750-2187-5-7; Just S, 2011, J CELL SCI, V124, P3127, DOI 10.1242/jcs.084772; Kattman SJ, 2006, DEV CELL, V11, P723, DOI 10.1016/j.devcel.2006.10.002; Kawamura S, 2008, CYTOTECHNOLOGY, V57, P161, DOI 10.1007/s10616-008-9128-1; Koh HJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2851; KOMURO I, 1990, JPN CIRC J, V54, P526, DOI 10.1253/jcj.54.526; KOMURO I, 1990, J BIOL CHEM, V265, P3595; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Lane DJR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057273; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Li DL, 2009, NUCLEIC ACIDS RES, V37, P7059, DOI 10.1093/nar/gkp773; Lien CL, 1999, DEVELOPMENT, V126, P75; LIU Q, 1995, MOL CELL BIOL, V15, P2800; Liu YZ, 2007, CANCER CELL, V11, P483, DOI 10.1016/j.ccr.2007.04.010; Lutterbach B, 1998, MOL CELL BIOL, V18, P3604, DOI 10.1128/MCB.18.6.3604; Masselink H, 2000, ONCOGENE, V19, P1538, DOI 10.1038/sj.onc.1203421; McFadden DG, 2005, DEVELOPMENT, V132, P189, DOI 10.1242/dev.01562; Moretti A, 2006, CELL, V127, P1151, DOI 10.1016/j.cell.2006.10.029; Moses Kelvin A., 2001, Genesis The Journal of Genetics and Development, V31, P176, DOI 10.1002/gene.10022; Mungrue IN, 2009, J IMMUNOL, V182, P466, DOI 10.4049/jimmunol.182.1.466; Nagy A., 2003, MANIPULATING MOUSE E; Niu Z, 2008, P NATL ACAD SCI USA, V105, P17824, DOI 10.1073/pnas.0805491105; Ohoka N, 2005, EMBO J, V24, P1243, DOI 10.1038/sj.emboj.7600596; Oka T, 2014, CIRC RES, V114, P565, DOI 10.1161/CIRCRESAHA.114.300507; Park CY, 2010, P NATL ACAD SCI USA, V107, P20750, DOI 10.1073/pnas.1013493107; Phan D, 2005, DEVELOPMENT, V132, P2669, DOI 10.1242/dev.01849; Quick QA, 2012, EXP THER MED, V3, P487, DOI 10.3892/etm.2011.422; Saddic LA, 2010, J BIOL CHEM, V285, P37733, DOI 10.1074/jbc.M110.137612; Sahni S, 2014, J BIOL CHEM, V289, P9692, DOI 10.1074/jbc.M113.529511; Sasaki M, 2012, GENE DEV, V26, P2038, DOI 10.1101/gad.198200.112; Sen Banerjee S, 2012, TOXICOL MECH METHOD, V22, P347, DOI 10.3109/15376516.2012.673088; Sims RJ, 2002, J BIOL CHEM, V277, P26524, DOI 10.1074/jbc.M204121200; Sridhar S, 2012, J PATHOL, V226, P255, DOI 10.1002/path.3025; Strahl BD, 1999, P NATL ACAD SCI USA, V96, P14967, DOI 10.1073/pnas.96.26.14967; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; TAKAHASHI M, 1993, GUT, V34, P823, DOI 10.1136/gut.34.6.823; Tan XG, 2006, P NATL ACAD SCI USA, V103, P2713, DOI 10.1073/pnas.0509503103; Tanigawa S, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.448; Tsuchihashi T, 2011, DEV BIOL, V351, P62, DOI 10.1016/j.ydbio.2010.12.023; Tsutsui H, 2011, AM J PHYSIOL-HEART C, V301, pH2181, DOI 10.1152/ajpheart.00554.2011; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Wetzel-Strong SE, 2013, DEV DYN; Yotov WV, 1996, GENE DEV, V10, P1763, DOI 10.1101/gad.10.14.1763	64	31	31	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0121765	10.1371/journal.pone.0121765	http://dx.doi.org/10.1371/journal.pone.0121765			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803368	gold, Green Submitted, Green Published			2022-12-26	WOS:000353889600175
J	bin Shawkataly, O; Goh, CP; Abu Tariq; Khan, IA; Fun, HK; Rosli, MM				bin Shawkataly, Omar; Goh, Chin-Ping; Abu Tariq; Khan, Imthyaz Ahmad; Fun, Hoong-Kun; Rosli, Mohd Mustaqim			Synthesis, Spectral Characterization and Crystals Structure of some Arsane Derivatives of Gold (I) Complexes: A Comparative Density Functional Theory Study	PLOS ONE			English	Article							AB-INITIO; CHEMISTRY; PLATINUM; POLYMERS; LIGANDS; HALIDES	A series of complexes of the type LAuCl where L = tris(p-tolylarsane), tris(m-tolylarsane), bis(diphenylarsano)ethane, and tris(naphthyl)arsane have been synthesized. All of the new complexes, 1-4, have been fully characterized by means of H-1 NMR and C-13 NMR spectroscopy and single crystal X-ray crystallography. The structures of complexes 1-4 have been determined from X-ray diffraction data. The linear molecules have an average bond distance between gold-arsenic and gold-chlorine of 2.3390 angstrom and 2.2846 angstrom, respectively. Aurophilic interaction was prominent in complex 1 and 3, whereas complex 2 and 4 do not show any such interaction. The intermolecular gold interaction bond length was affected by the electronegativity of the molecule. The computed values calculated at DFT level using B3LYP function are in good agreement with the experimental results.	[bin Shawkataly, Omar; Goh, Chin-Ping; Abu Tariq; Khan, Imthyaz Ahmad] Univ Sains Malaysia, Sch Distance Educ, Chem Sci Programme, George Town 11800, Malaysia; [Fun, Hoong-Kun; Rosli, Mohd Mustaqim] Univ Sains Malaysia, Sch Phys, Xray Crystallog Unit, George Town 11800, Malaysia; [Fun, Hoong-Kun] King Saud Univ, Dept Pharmaceut Chem, Coll Pharm, Riyadh 11451, Saudi Arabia	Universiti Sains Malaysia; Universiti Sains Malaysia; King Saud University	bin Shawkataly, O (corresponding author), Univ Sains Malaysia, Sch Distance Educ, Chem Sci Programme, George Town 11800, Malaysia.	omarsa@usm.my	Shawkataly, Omar/B-6034-2009; Fun, Hoong-Kun/A-3561-2009; Goh, Chin-Ping/K-6134-2013	Shawkataly, Omar/0000-0002-6248-6785; Rosli, Mohd Mustaqim/0000-0001-8402-1914	Malaysian Government; Universiti Sains Malaysia (USM) [1001/PJJAUH/811225]; Ministry of Education Malaysia; Universiti Sains Malaysia [1001/PFIZIK/811160]; Deanship of Scientific Research at King Saud University [RGP-VPP-207]	Malaysian Government; Universiti Sains Malaysia (USM)(Universiti Sains Malaysia); Ministry of Education Malaysia(Ministry of Education, Malaysia); Universiti Sains Malaysia(Universiti Sains Malaysia); Deanship of Scientific Research at King Saud University(King Saud University)	This study was supported by the Malaysian Government and Universiti Sains Malaysia (USM) (University Research Grant 1001/PJJAUH/811225 received by OBS); the Ministry of Education Malaysia, (MyPhD Scholarship Programme received by CPG) (https://biasiswa.moe.gov.my/MyBrain15/v2/index_myphd.php); the Universiti Sains Malaysia, (Post-Doctoral Fellowship received by AT); the Universiti Sains Malaysia, (Visiting Researcher Position received by IAK); Malaysian Government and Universiti Sains Malaysia (USM) (University Research Grant 1001/PFIZIK/811160 received by HKF and MMR); the Deanship of Scientific Research at King Saud University (project No. RGP-VPP-207 received by HKF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdou HE, 2009, COORDIN CHEM REV, V253, P1661, DOI 10.1016/j.ccr.2009.02.010; Anderson KM, 2007, INORG CHEM, V46, P6444, DOI 10.1021/ic700466y; [Anonymous], 2002, CRIT REV HEMATOL ONC; Balch AL, 1999, COORDIN CHEM REV, V185-6, P601, DOI 10.1016/S0010-8545(99)00013-2; BALCH AL, 1990, J AM CHEM SOC, V112, P5181, DOI 10.1021/ja00169a028; Barnard PJ, 2007, COORDIN CHEM REV, V251, P1889, DOI 10.1016/j.ccr.2007.04.006; Barnes NA, 2010, CRYSTENGCOMM, V12, P4240, DOI 10.1039/c0ce00024h; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; Bott RC, 2004, AUST J CHEM, V57, P213, DOI 10.1071/CH03172; BRUCE MI, 1989, INORG SYN, V26, P324, DOI 10.1002/9780470132579.ch59; Bruker, 2009, APEX2 SAINT SADABS; Bunge SD, 2000, ANGEW CHEM INT EDIT, V39, P3082, DOI 10.1002/1521-3773(20000901)39:17<3082::AID-ANIE3082>3.0.CO;2-2; Cabeza JA, 2008, ORGANOMETALLICS, V27, P4697, DOI 10.1021/om8006085; Cabrera GS, 2002, J ORGANOMET CHEM, V660, P153; Chiffey AF, 1996, POLYHEDRON, V15, P591, DOI 10.1016/0277-5387(95)00294-3; COOPER MK, 1984, INORG CHIM A-ART LET, V84, pL9, DOI 10.1016/S0020-1693(00)87658-6; DHUBHGHAILL OMN, 1990, J CHEM SOC DALTON, P2913; Feller D, 1996, J COMPUT CHEM, V17, P1571, DOI 10.1002/jcc.9; Frisch M.J., 2016, GAUSSIAN16 REV B01; HAY PJ, 1978, J CHEM PHYS, V69, P984, DOI 10.1063/1.436651; Hayashi A, 2002, J AM CHEM SOC, V124, P5791, DOI 10.1021/ja012416y; Irwin MJ, 1996, CHEM COMMUN, P1281, DOI 10.1039/cc9960001281; Irwin MJ, 1996, J AM CHEM SOC, V118, P13101, DOI 10.1021/ja963441k; Jensen F., 2007, INTRO COMPUTATIONAL, P30; JONES PG, 1980, ACTA CRYSTALLOGR B, V36, P2775, DOI 10.1107/S0567740880009983; Kitadai K, 2006, DALTON T, P2560, DOI 10.1039/b516538e; Laguna A, 2008, GOLD GOLD INTERACTIO, P65; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Lim SH, 2012, INORG CHEM, V51, P1925, DOI 10.1021/ic2022165; Monkowius U, 2003, Z NATURFORSCH B, V58, P751, DOI 10.1515/znb-2003-0806; Monkowius U, 2009, Z NATURFORSCH B, V64, P1513, DOI 10.1515/znb-2009-11-1235; Nomiya K, 1998, J CHEM SOC DALTON, P4101, DOI 10.1039/a806283h; Odoh SO, 2010, J PHYS CHEM A, V114, P1957, DOI 10.1021/jp909576w; Ott I, 2009, COORDIN CHEM REV, V253, P1670, DOI 10.1016/j.ccr.2009.02.019; Pantazis DA, 2008, J CHEM THEORY COMPUT, V4, P908, DOI 10.1021/ct800047t; Paul M, 1996, CHEM BER, V129, P77, DOI 10.1002/cber.19961290116; Phillips FC, 1901, J AM CHEM SOC, V23, P250, DOI 10.1021/ja02030a008; PITZER KS, 1979, ACCOUNTS CHEM RES, V12, P272; Puddephatt RJ, 1998, CHEM COMMUN, P1055, DOI 10.1039/a800244d; PYYKKO P, 1979, ACCOUNTS CHEM RES, V12, P276, DOI 10.1021/ar50140a002; PYYKKO P, 1988, CHEM REV, V88, P563, DOI 10.1021/cr00085a006; Rackham O, 2007, BIOCHEM PHARMACOL, V74, P992, DOI 10.1016/j.bcp.2007.07.022; Schuchardt KL, 2007, J CHEM INF MODEL, V47, P1045, DOI 10.1021/ci600510j; SCHWERDTFEGER P, 1990, INORG CHEM, V29, P3593, DOI 10.1021/ic00343a057; SCHWERDTFEGER P, 1989, J CHEM PHYS, V91, P1762, DOI 10.1063/1.457082; Shawkataly OB, 2011, ACTA CRYSTALLOGR E, VE67, P427; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; STEPHENS PJ, 1994, J PHYS CHEM-US, V98, P11623, DOI 10.1021/j100096a001; Tiekink Edward R T, 2003, Bioinorg Chem Appl, P53, DOI 10.1155/S1565363303000050; Wang XY, 2008, DALTON T, P1521, DOI 10.1039/b715903j; WEISSBART B, 1995, INORG CHEM, V34, P393, DOI 10.1021/ic00105a060; ZIEGLER T, 1980, CHEM PHYS LETT, V75, P1, DOI 10.1016/0009-2614(80)80451-9	52	1	1	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0119620	10.1371/journal.pone.0119620	http://dx.doi.org/10.1371/journal.pone.0119620			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798915	Green Published, gold, Green Submitted			2022-12-26	WOS:000351987300064
J	de Oliveira, PB; Puchnick, A; Szejnfeld, J; Goldman, SM				de Oliveira, Patricia Bedesco; Puchnick, Andrea; Szejnfeld, Jacob; Goldman, Suzan Menasce			Prevalence of Incidental Pancreatic Cysts on 3 Tesla Magnetic Resonance	PLOS ONE			English	Article							LESIONS; NEOPLASMS; DILATATION; DUCT	Objectives To ascertain the prevalence of pancreatic cysts detected incidentally on 3-Tesla magnetic resonance imaging (MRI) of the abdomen and correlate this prevalence with patient age and gender; assess the number, location, and size of these lesions, as well as features suspicious for malignancy; and determine the prevalence of incidentally detected dilatation of the main pancreatic duct (MPD). Methods Retrospective analysis of 2,678 reports of patients who underwent abdominal MRI between January 2012 and June 2013. Patients with a known history of pancreatic conditions or surgery were excluded, and the remaining 2,583 reports were examined for the presence of pancreatic cysts, which was then correlated with patient age and gender. We also assessed whether cysts were solitary or multiple, as well as their location within the pancreatic parenchyma, size, and features suspicious for malignancy. Finally, we calculated the prevalence of incidental MPD dilatation, defined as MPD diameter >= 2.5 mm. Results Pancreatic cysts were detected incidentally in 9.3% of patients (239/2,583). The prevalence of pancreatic cysts increased significantly with age (p<0.0001). There were no significant differences in prevalence between men and women (p=0.588). Most cysts were multiple (57.3%), distributed diffusely throughout the pancreas (41.8%), and 5 mm or larger (81.6%). In 12.1% of cases, cysts exhibited features suspicious for malignancy. Overall, 2.7% of subjects exhibited incidental MPD dilatation. Conclusions In this sample, the prevalence of pancreatic cysts detected incidentally on 3T MRI of the abdomen was 9.3%. Prevalence increased with age and was not associated with gender. The majority of cysts were multiple, diffusely distributed through the pancreatic parenchyma, and >= 5 mm in size; 12.1% were suspicious for malignancy. An estimated 2.7% of subjects had a dilated MPD.	[de Oliveira, Patricia Bedesco; Puchnick, Andrea; Szejnfeld, Jacob; Goldman, Suzan Menasce] Univ Fed Sao Paulo UNIFESP, Escola Paulista Med, Dept Imaging Diag, Sao Paulo, SP, Brazil	Universidade Federal de Sao Paulo (UNIFESP)	de Oliveira, PB (corresponding author), Univ Fed Sao Paulo UNIFESP, Escola Paulista Med, Dept Imaging Diag, Sao Paulo, SP, Brazil.	patricia_oliveira72@yahoo.com	Puchnick, Andrea/E-7826-2014	Puchnick, Andrea/0000-0002-7234-7121				Balcom IV J H, 2000, Curr Gastroenterol Rep, V2, P152; Canto MI, 2012, GASTROENTEROLOGY, V142, P796, DOI 10.1053/j.gastro.2012.01.005; Fernandez-del Castillo C, 2003, ARCH SURG-CHICAGO, V138, P427; Goh BKP, 2006, AM J SURG, V192, P148, DOI 10.1016/j.amjsurg.2006.02.020; Hruban RH, 2007, J HEPATO-BILIARY-PAN, V14, P255, DOI 10.1007/s00534-006-1170-9; IKEDA M, 1994, PANCREAS, V9, P508, DOI 10.1097/00006676-199407000-00014; Kiely JM, 2003, J GASTROINTEST SURG, V7, P890, DOI 10.1016/S1091-255X(03)00145-8; Kimura W, 1995, INT J PANCREATOL, V18, P197; Laffan TA, 2008, AM J ROENTGENOL, V191, P802, DOI 10.2214/AJR.07.3340; Lee KS, 2010, AM J GASTROENTEROL, V105, P2079, DOI 10.1038/ajg.2010.122; Matsubara S, 2012, PANCREAS, V41, P1241, DOI 10.1097/MPA.0b013e31824f5970; Megibow AJ, 2001, ABDOM IMAGING, V26, P640, DOI 10.1007/s00261-001-0024-9; MINAMI M, 1989, RADIOLOGY, V171, P53, DOI 10.1148/radiology.171.1.2928546; Spinelli KS, 2004, ANN SURG, V239, P651, DOI 10.1097/01.sla.0000124299.57430.ce; Tanaka S, 2010, RADIOLOGY, V254, P965, DOI 10.1148/radiol.09090992; Zaheer A, 2013, ABDOM IMAGING, V38, P331, DOI 10.1007/s00261-012-9898-y; Zhang XM, 2002, RADIOLOGY, V223, P547, DOI 10.1148/radiol.2232010815	17	28	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121317	10.1371/journal.pone.0121317	http://dx.doi.org/10.1371/journal.pone.0121317			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798910	Green Published, Green Submitted, gold			2022-12-26	WOS:000351987300234
J	Erzurumluoglu, AM; Alsaadi, MM; Rodriguez, S; Alotaibi, TS; Guthrie, PAI; Lewis, S; Ginwalla, A; Gaunt, TR; Alharbi, KK; Alsaif, FM; Alsaadi, BM; Day, INM				Erzurumluoglu, A. Mesut; Alsaadi, Muslim M.; Rodriguez, Santiago; Alotaibi, Tahani S.; Guthrie, Philip A. I.; Lewis, Sian; Ginwalla, Aasiya; Gaunt, Tom R.; Alharbi, Khalid K.; Alsaif, Fahad M.; Alsaadi, Basma M.; Day, Ian N. M.			Proxy Molecular Diagnosis from Whole-Exome Sequencing Reveals Papillon-Lefevre Syndrome Caused by a Missense Mutation in CTSC	PLOS ONE			English	Article							CATHEPSIN-C GENE; CONSEQUENCES; VARIANTS; FORMAT; READ	Papillon-Lefevre syndrome (PLS) is an autosomal recessive disorder characterised by severe early onset periodontitis and palmoplantar hyperkeratosis. A previously reported missense mutation in the CTSC gene (NM_001814.4: c.899G>A: p.(G300D)) was identified in a homozygous state in two siblings diagnosed with PLS in a consanguineous family of Arabic ancestry. The variant was initially identified in a heterozygous state in a PLS unaffected sibling whose whole exome had been sequenced as part of a previous Primary ciliary dyskinesia study. Using this information, a proxy molecular diagnosis was made on the PLS affected siblings after consent was given to study this second disorder found to be segregating within the family. The prevalence of the mutation was then assayed in the local population using a representative sample of 256 unrelated individuals. The variant was absent in all subjects indicating that the variant is rare in Saudi Arabia. This family study illustrates how whole-exome sequencing can generate findings and inferences beyond its primary goal.	[Erzurumluoglu, A. Mesut; Rodriguez, Santiago; Guthrie, Philip A. I.; Lewis, Sian; Ginwalla, Aasiya; Gaunt, Tom R.; Day, Ian N. M.] Univ Bristol, BGEL, Bristol BS8 2BN, Avon, England; [Alsaadi, Muslim M.; Alotaibi, Tahani S.] King Saud Univ, Dept Pediat, Coll Med, Riyadh 11533, Saudi Arabia; [Gaunt, Tom R.] Univ Bristol, Sch Social & Community Med, MRC Integrat Epidemiol Unit IEU, Bristol BS8 2BN, Avon, England; [Alharbi, Khalid K.] King Saud Univ, Coll Appl Med Sci, Clin Lab Sci Dept, Riyadh 11433, Saudi Arabia; [Alsaif, Fahad M.; Alsaadi, Basma M.] King Saud Univ, Dept Dermatol, Riyadh 11472, Saudi Arabia	University of Bristol; King Saud University; University of Bristol; King Saud University; King Saud University	Erzurumluoglu, AM (corresponding author), Univ Bristol, BGEL, Oakfield House, Bristol BS8 2BN, Avon, England.	epmmee@bristol.ac.uk	Erzurumluoglu, A Mesut/E-4445-2018; Gaunt, Tom R/O-3918-2014; alsaif, fahad mohammed/A-3728-2017	Erzurumluoglu, A Mesut/0000-0003-1322-8138; Gaunt, Tom R/0000-0003-0924-3247; Rodriguez, Santiago/0000-0001-6551-932X	Medical Research Council UK; King Saud University; National Plan for Science, Technology and Innovation (NPST) [11-MED2106-02]; Medical Research Council [MC_UU_12013/8]; MRC [MC_UU_12013/8] Funding Source: UKRI; Medical Research Council [1171120] Funding Source: researchfish	Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); King Saud University(King Saud University); National Plan for Science, Technology and Innovation (NPST); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	A. Mesut Erzurumluoglu is a PhD student funded by the Medical Research Council UK. This work was supported by the King Saud University and in part by the National Plan for Science, Technology and Innovation (NPST) grant (11-MED2106-02). Tom R. Gaunt received funding from the Medical Research Council (MC_UU_12013/8). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Alsaadi MM, 2014, HUM MUTAT, V35, P1446, DOI 10.1002/humu.22698; AlSaadi MM, 2012, ANN HUM GENET, V76, P211, DOI 10.1111/j.1469-1809.2012.00704.x; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Davydov EV, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001025; DAY INM, 1994, ANAL BIOCHEM, V222, P389, DOI 10.1006/abio.1994.1507; ESP NG, 2013, EX VAR SERV; Gaunt TR, 2001, HUM MOL GENET, V10, P1491, DOI 10.1093/hmg/10.14.1491; Gonzalez-Perez A, 2011, AM J HUM GENET, V88, P440, DOI 10.1016/j.ajhg.2011.03.004; Hart TC, 1999, J MED GENET, V36, P881; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Nagy N, 2014, MOL GENET GENOM MED, V2, P217, DOI 10.1002/mgg3.61; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Rabbani B, 2014, J HUM GENET, V59, P5, DOI 10.1038/jhg.2013.114; Shihab HA, 2013, HUM MUTAT, V34, P57, DOI 10.1002/humu.22225; Stenson Peter D, 2012, Curr Protoc Bioinformatics, VChapter 1, DOI 10.1002/0471250953.bi0113s39; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Yu JH, 2014, AM J HUM GENET, V95, P77, DOI 10.1016/j.ajhg.2014.06.004; Zhang Y, 2001, J MED GENET, V38, P96, DOI 10.1136/jmg.38.2.96	24	4	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121351	10.1371/journal.pone.0121351	http://dx.doi.org/10.1371/journal.pone.0121351			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799584	Green Published, gold, Green Submitted			2022-12-26	WOS:000351987300242
J	Kim, SW; Fishilevich, E; Arango-Argoty, G; Lin, YF; Liu, GD; Li, ZH; Monaghan, AP; Nichols, M; John, B				Kim, Sang Woo; Fishilevich, Elane; Arango-Argoty, Gustavo; Lin, Yuefeng; Liu, Guodong; Li, Zhihua; Monaghan, A. Paula; Nichols, Mark; John, Bino			Genome-Wide Transcript Profiling Reveals Novel Breast Cancer-Associated Intronic Sense RNAs	PLOS ONE			English	Article							NONCODING RNAS; HIRSCHSPRUNG-DISEASE; MENTAL-RETARDATION; MICRORNA; GENE; IDENTIFICATION; BIOMARKERS; SITES; MODEL	Non-coding RNAs (ncRNAs) play major roles in development and cancer progression. To identify novel ncRNAs that may identify key pathways in breast cancer development, we performed high-throughput transcript profiling of tumor and normal matched-pair tissue samples. Initial transcriptome profiling using high-density genome-wide tiling arrays revealed changes in over 200 novel candidate genomic regions that map to intronic regions. Sixteen genomic loci were identified that map to the long introns of five key protein-coding genes, CRIM1, EPAS1, ZEB2, RBMS1, and RFX2. Consistent with the known role of the tumor suppressor ZEB2 in the cancer-associated epithelial to mesenchymal transition (EMT), in situ hybridization reveals that the intronic regions deriving from ZEB2 as well as those from RFX2 and EPAS1 are down-regulated in cells of epithelial morphology, suggesting that these regions may be important for maintaining normal epithelial cell morphology. Paired-end deep sequencing analysis reveals a large number of distinct genomic clusters with no coding potential within the introns of these genes. These novel transcripts are only transcribed from the coding strand. A comprehensive search for breast cancer associated genes reveals enrichment for transcribed intronic regions from these loci, pointing to an underappreciated role of introns or mechanisms relating to their biology in EMT and breast cancer.	[Kim, Sang Woo; Fishilevich, Elane; Arango-Argoty, Gustavo; Lin, Yuefeng; Liu, Guodong; Li, Zhihua; John, Bino] Univ Pittsburgh, Sch Med, Pittsburgh, PA 15260 USA; [Monaghan, A. Paula] Univ Pittsburgh, Dept Neurobiol, Pittsburgh, PA 15260 USA; [Nichols, Mark] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Sch Med, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Monaghan, AP (corresponding author), Univ Pittsburgh, Dept Neurobiol, 3501 Fifth Ave, Pittsburgh, PA 15260 USA.	monaghan@pitt.edu; mnichols@pitt.edu; bino@pitt.edu		Kim, Sang Woo/0000-0002-3144-4822	American Cancer Society [RSG-09-054-01]; Magee-Womens foundation [0027467]; National Institutes of Health [GM079756]; NATIONAL CANCER INSTITUTE [R21CA087414] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK059516] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079756] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); Magee-Womens foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding: The work was supported by American Cancer Society [RSG-09-054-01 to BJ] - www.cancer.org/, Magee-Womens foundation [0027467 to BJ] www.mwrif.org; and National Institutes of Health [GM079756 to BJ] - www.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acun T, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-223; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Brooks Mai, 2009, V472, P307, DOI 10.1007/978-1-60327-492-0_13; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Cawley S, 2004, CELL, V116, P499, DOI 10.1016/S0092-8674(04)00127-8; Clement JQ, 2001, J BIOL CHEM, V276, P16919, DOI 10.1074/jbc.M005104200; Comijn J, 2001, MOL CELL, V7, P1267, DOI 10.1016/S1097-2765(01)00260-X; Danin-Kreiselman M, 2003, MOL CELL, V11, P1279, DOI 10.1016/S1097-2765(03)00137-0; De Flora S, 2012, INT J CANCER, V131, P2763, DOI 10.1002/ijc.27814; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Guay C, 2012, DIABETES OBES METAB, V14, P12, DOI 10.1111/j.1463-1326.2012.01654.x; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Hinton A, 2012, ADV GENET, V79, P1, DOI 10.1016/B978-0-12-394395-8.00001-3; Johnson WE, 2006, P NATL ACAD SCI USA, V103, P12457, DOI 10.1073/pnas.0601180103; Karreth FA, 2011, CELL, V147, P382, DOI 10.1016/j.cell.2011.09.032; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Leisegang MS, 2012, BIOL CHEM, V393, P599, DOI 10.1515/hsz-2012-0146; Lin SY, 2003, CELL, V113, P881, DOI 10.1016/S0092-8674(03)00430-6; Lin YF, 2012, NUCLEIC ACIDS RES, V40, P8460, DOI 10.1093/nar/gks637; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maher CA, 2009, NATURE, V458, P97, DOI 10.1038/nature07638; Mardis ER, 2012, NAT REV GASTRO HEPAT, V9, P477, DOI 10.1038/nrgastro.2012.126; McCarthy M, 2006, LANCET NEUROL, V5, P907, DOI 10.1016/S1474-4422(06)70594-4; Morlando M, 2008, NAT STRUCT MOL BIOL, V15, P902, DOI 10.1038/nsmb.1475; Mowat DR, 1998, J MED GENET, V35, P617, DOI 10.1136/jmg.35.8.617; Okamura K, 2007, CELL, V130, P89, DOI 10.1016/j.cell.2007.06.028; Prensner JR, 2011, NAT BIOTECHNOL, V29, P742, DOI 10.1038/nbt.1914; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Ruby JG, 2007, NATURE, V448, P83, DOI 10.1038/nature05983; Sleutels F, 2002, NATURE, V415, P810, DOI 10.1038/415810a; St Laurent G, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-504; Tijsen AJ, 2012, AM J PHYSIOL-HEART C, V303, pH1085, DOI 10.1152/ajpheart.00191.2012; Ulitsky I, 2013, CELL, V154, P26, DOI 10.1016/j.cell.2013.06.020; Van de Putte T, 2003, AM J HUM GENET, V72, P465, DOI 10.1086/346092; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Venables JP, 2004, CANCER RES, V64, P7647, DOI 10.1158/0008-5472.CAN-04-1910; Washietl S, 2012, WIRES RNA, V3, P759, DOI 10.1002/wrna.1134; Weigel MT, 2010, ENDOCR-RELAT CANCER, V17, pR245, DOI 10.1677/ERC-10-0136; Wurmbach E, 2007, HEPATOLOGY, V45, P938, DOI 10.1002/hep.21622	39	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120296	10.1371/journal.pone.0120296	http://dx.doi.org/10.1371/journal.pone.0120296			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798919	Green Published, gold, Green Accepted			2022-12-26	WOS:000351987300124
J	Li, TJ; Ren, BW; Wang, DH; Liu, GB				Li, Taijun; Ren, Bowen; Wang, Dahui; Liu, Guobin			Spatial Variation in the Storages and Age-Related Dynamics of Forest Carbon Sequestration in Different Climate Zones-Evidence from Black Locust Plantations on the Loess Plateau of China	PLOS ONE			English	Article							OLD-GROWTH FORESTS; PRECIPITATION GRADIENT; SOIL; BIOMASS; ACCUMULATION; CHRONOSEQUENCE; STOCKS; ALLOCATION; REDUCTION; FLUXES	Knowledge about the long-term influences of climate change on the amount of potential carbon (C) sequestration in forest ecosystems, including age-related dynamics, remains unclear. This study used two similar age-sequences of black locust forests (Robinia pseudoacacia L.) in the semi-arid and semi-humid zones of China's Loess Plateau to assess the variation in C stocks and age-related dynamics. Our results demonstrated that black locust forests of the semi-humid zone stored significantly more C than did forests in the semi-arid zone, across the chronosequence (P < 0.001). The C carrying capacity of the plantations was measured at 166.4 Mg C ha(-1) (1 Mg = 10(6) g) in the semi-humid zone, while the semi-arid zone had a capacity of only 79.4 Mg C ha(-1). Soil organic C (SOC) increased continuously with stand age in the semi-arid zone (R-2 = 0.84, P = 0.010). However, in the semi-humid zone, SOC declined sharply by 47.8% after the initial stage (5 to 10 y). The C stock in trees increased continuously with stand age in the semi-humid zone (R-2 = 0.83, P = 0.011), yet in the semi-arid zone, it decreased dramatically from 43.0 Mg C ha(-1) to 28.4 Mg C ha(-1) during the old forest stage (38 to 56 y). The shift from being a net C sink to a net C source occurred at the initial stage in the semi-humid zone versus at the old forest stage in the semi-arid zone after reforestation. Surprisingly, with the exception of the initial and later stages (55 y), the patterns of C allocation among trees, soils, understory and litter were not statistically different between the two climate zones. Our results suggest that climate factors can alter the potential amount and age-related dynamics of forest C sequestration.	[Li, Taijun; Ren, Bowen; Liu, Guobin] Northwest Agr & Forestry Univ, Coll Forestry, Yang Ling, Shaanxi, Peoples R China; [Wang, Dahui] Northwest Agr & Forestry Univ, Coll Vet Med, Yang Ling, Shaanxi, Peoples R China; [Liu, Guobin] Chinese Acad Sci, Inst Water & Soil Conservat, Yang Ling, Shaanxi, Peoples R China	Northwest A&F University - China; Northwest A&F University - China; Chinese Academy of Sciences	Liu, GB (corresponding author), Northwest Agr & Forestry Univ, Coll Forestry, Yang Ling, Shaanxi, Peoples R China.	gbliu@ms.iswc.ac.cn			foundation "Strategic Priority Research Program-Climate Change: Carbon Budget and Relevant Issues" of the Chinese Academy of Sciences [XDA05060300]	foundation "Strategic Priority Research Program-Climate Change: Carbon Budget and Relevant Issues" of the Chinese Academy of Sciences	This study was supported by the foundation "Strategic Priority Research Program-Climate Change: Carbon Budget and Relevant Issues" of the Chinese Academy of Sciences (Grant No. XDA05060300). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin AT, 2002, J VEG SCI, V13, P351, DOI 10.1111/j.1654-1103.2002.tb02059.x; Bellassen V, 2014, NATURE, V506, P153, DOI 10.1038/506153a; Berthrong ST, 2012, ECOL APPL, V22, P76, DOI 10.1890/10-2210.1; Cao JX, 2012, ECOL RES, V27, P883, DOI 10.1007/s11284-012-0965-1; Cao MK, 1998, NATURE, V393, P249, DOI 10.1038/30460; Fang JY, 2001, SCIENCE, V293, P1723, DOI 10.1126/science.293.5536.1723a; Fang S, 2007, J ENVIRON MANAGE, V85, P672, DOI 10.1016/j.jenvman.2006.09.014; Feng XM, 2013, SCI REP-UK, V3, DOI 10.1038/srep02846; Guo LB, 2002, GLOBAL CHANGE BIOL, V8, P345, DOI 10.1046/j.1354-1013.2002.00486.x; Guo ZD, 2010, FOREST ECOL MANAG, V259, P1225, DOI 10.1016/j.foreco.2009.09.047; Huxman TE, 2004, OECOLOGIA, V141, P254, DOI 10.1007/s00442-004-1682-4; Jackson RB, 2002, NATURE, V418, P623, DOI 10.1038/nature00910; Law BE, 2003, GLOBAL CHANGE BIOL, V9, P510, DOI 10.1046/j.1365-2486.2003.00624.x; Levasseur A, 2012, NAT CLIM CHANGE, V2, P6, DOI 10.1038/nclimate1335; Li TJ, 2014, CHINESE GEOGR SCI, V24, P414, DOI 10.1007/s11769-014-0704-3; Li X, 2011, J PLANT BIOL, V54, P33, DOI 10.1007/s12374-010-9140-9; Li X, 2010, J PLANT BIOL, V53, P381, DOI 10.1007/s12374-010-9134-7; Liao CZ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010867; Liu JG, 2008, P NATL ACAD SCI USA, V105, P9477, DOI 10.1073/pnas.0706436105; Lu N, 2013, BIOGEOSCIENCES DISCU, V10, P11181, DOI DOI 10.5194/BGD-10-11181-2013; Lu YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031782; Luyssaert S, 2008, NATURE, V455, P213, DOI 10.1038/nature07276; Ma ZH, 2012, P NATL ACAD SCI USA, V109, P2423, DOI 10.1073/pnas.1111576109; Meier IC, 2010, GLOBAL CHANGE BIOL, V16, P1035, DOI 10.1111/j.1365-2486.2009.02074.x; Peri PL, 2006, FOREST ECOL MANAG, V233, P85, DOI 10.1016/j.foreco.2006.06.009; Poll C, 2013, AGR ECOSYST ENVIRON, V165, P88, DOI 10.1016/j.agee.2012.12.012; Powers MD, 2012, ECOL APPL, V22, P1297, DOI 10.1890/11-0411.1; Saiz G, 2012, GLOBAL CHANGE BIOL, V18, P1670, DOI 10.1111/j.1365-2486.2012.02657.x; Schrag DP, 2007, SCIENCE, V315, P812, DOI 10.1126/science.1137632; Schuur EAG, 2001, ECOLOGY, V82, P3182, DOI 10.1890/0012-9658(2001)082[3182:CCASCS]2.0.CO;2; Steffen W, 1998, SCIENCE, V280, P1393; Talmon Y, 2011, GLOBAL CHANGE BIOL, V17, P1108, DOI 10.1111/j.1365-2486.2010.02285.x; Varik M, 2013, FOREST ECOL MANAG, V302, P62, DOI 10.1016/j.foreco.2013.03.033; Vucetich JA, 2000, FOREST ECOL MANAG, V136, P135, DOI 10.1016/S0378-1127(99)00288-1; Wang B, 2012, ENVIRON EARTH SCI, V65, P597, DOI 10.1007/s12665-011-1107-8; Wei YW, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0072201, 10.1371/journal.pone.0060044]; Xia JY, 2014, NAT GEOSCI, V7, P173, DOI [10.1038/NGEO2093, 10.1038/ngeo2093]; Xu CY, 2012, J ECOL, V100, P428, DOI 10.1111/j.1365-2745.2011.01933.x; Zhang JF, 2010, INT J SUST DEV WORLD, V17, P475, DOI 10.1080/13504509.2010.520855; Zhou GY, 2006, SCIENCE, V314, P1417, DOI 10.1126/science.1130168; Zhou XH, 2009, ECOSYSTEMS, V12, P1369, DOI 10.1007/s10021-009-9296-7; Zhou ZC, 2005, J INTEGR PLANT BIOL, V47, P676, DOI 10.1111/j.1744-7909.2005.00067.x	42	13	14	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121862	10.1371/journal.pone.0121862	http://dx.doi.org/10.1371/journal.pone.0121862			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799100	Green Published, Green Submitted, gold			2022-12-26	WOS:000351987300296
J	Luo, T; Yin, SZ; Shi, R; Xu, CS; Wang, Y; Cai, J; Yue, Y; Wu, AS				Luo, Ting; Yin, Shuzhou; Shi, Rong; Xu, Chengshi; Wang, Yun; Cai, Jun; Yue, Yun; Wu, Anshi			miRNA Expression Profile and Involvement of Let-7d-APP in Aged Rats with Isoflurane-Induced Learning and Memory Impairment	PLOS ONE			English	Article							BRAIN; APOPTOSIS; ANESTHESIA; PERSISTENT; MICRORNAS; EXPOSURE; DISEASE	MicroRNAs (miRNAs) play a key role in different nervous system diseases. We sought to determine the role of miRNAs in isoflurane-induced learning and memory impairment in aged rats. Male Sprague-Dawley (SD) rats of 18 month were randomly assigned to control group (exposed to mock anesthesia), 2-hour group and 6-hour group (exposed to 2% isoflurane for 2 and 6 hours respectively). By Morris Water Maze, 6-hour group showed impaired learning and memory ability while 2-hour group not. As shown by miRNA array, control group and 2-hour group showed a similar miRNA expression profile. And 38 miRNAs are differently expressed in 6-hour group compared to the other 2 groups, including 21 up-regulated miRNAs and 17 down-regulated miRNAs. And 4 of the differentially expressed miRNAs were validated independently by qRT-PCR. Let-7d was downregulated in 6-hour group. Additionally, we demonstrated that amyloid precursor protein (APP) was a direct target of let-7d by Fluorescent report assay. Increased expression of APP and amyloid-beta (A beta) were found in the hippocampi of 6-hour group. Downregulation of let-7d might contribute to isoflurane-induced learning and memory impairment through upregulating its target APP, and increasing the production of A beta subsequently.	[Luo, Ting; Shi, Rong; Wang, Yun; Yue, Yun; Wu, Anshi] Capital Med Univ, Chaoyang Hosp, Dept Anesthesiol, Beijing, Peoples R China; [Yin, Shuzhou] Shanghai Jiao Tong Univ, Suzhou Kowloon Hosp, Sch Med, Suzhou, Jiangsu, Peoples R China; [Xu, Chengshi] Peking Univ, Coll Med 4, Beijing Jishuitan Hosp, Dept Anesthesiol, Beijing 100871, Peoples R China; [Cai, Jun] Capital Med Univ, Chaoyang Hosp, Dept Cardiol, Beijing, Peoples R China	Capital Medical University; Shanghai Jiao Tong University; Peking University; Capital Medical University	Wu, AS (corresponding author), Capital Med Univ, Chaoyang Hosp, Dept Anesthesiol, Beijing, Peoples R China.	wuanshi230@163.com	Wang, Yun/ABA-3010-2021	Wu, Anshi/0000-0003-2353-2184				Bianchi SL, 2008, NEUROBIOL AGING, V29, P1002, DOI 10.1016/j.neurobiolaging.2007.02.009; Bittner EA, 2011, CAN J ANESTH, V58, P216, DOI 10.1007/s12630-010-9418-x; Bredy TW, 2011, NEUROBIOL LEARN MEM, V96, P89, DOI 10.1016/j.nlm.2011.04.004; Christensen M, 2009, NEUROSCI LETT, V466, P55, DOI 10.1016/j.neulet.2009.04.043; Cogswell JP, 2008, J ALZHEIMERS DIS, V14, P27, DOI 10.3233/jad-2008-14103; Cullen BR, 2004, MOL CELL, V16, P861, DOI 10.1016/j.molcel.2004.12.002; Culley DJ, 2004, ANESTHESIOLOGY, V100, P309, DOI 10.1097/00000542-200402000-00020; De Smaele E, 2010, BRAIN RES, V1338, P100, DOI 10.1016/j.brainres.2010.03.103; Eckenhoff RG, 2004, ANESTHESIOLOGY, V101, P703, DOI 10.1097/00000542-200409000-00019; FORLONI G, 1993, NEUROREPORT, V4, P523, DOI 10.1097/00001756-199305000-00015; Jevtovic-Todorovic V, 2003, J NEUROSCI, V23, P876, DOI 10.1523/jneurosci.23-03-00876.2003; Johnson CD, 2007, CANCER RES, V67, P7713, DOI 10.1158/0008-5472.CAN-07-1083; Kocerha J, 2009, NEUROMOL MED, V11, P162, DOI 10.1007/s12017-009-8066-1; Li YJ, 2007, NEUROPHARMACOLOGY, V53, P942, DOI 10.1016/j.neuropharm.2007.09.005; Liang G, 2008, ANESTH ANALG, V106, P492, DOI 10.1213/ane.0b013e3181605b71; LOO DT, 1993, P NATL ACAD SCI USA, V90, P7951, DOI 10.1073/pnas.90.17.7951; Lukiw WJ, 2008, J BIOL CHEM, V283, P31315, DOI 10.1074/jbc.M805371200; Meza-Sosa KF, 2012, J NEUROSCI RES, V90, P1, DOI 10.1002/jnr.22701; Persengiev S, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.03.014; Rosczyk HA, 2008, EXP GERONTOL, V43, P840, DOI 10.1016/j.exger.2008.06.004; Schratt G, 2009, CURR OPIN NEUROBIOL, V19, P213, DOI 10.1016/j.conb.2009.05.015; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Wei HF, 2005, BRAIN RES, V1037, P139, DOI 10.1016/j.brainres.2005.01.009; Wei HF, 2008, ANESTHESIOLOGY, V108, P251, DOI 10.1097/01.anes.0000299435.59242.0e; Wise-Faberowski L, 2005, ANESTH ANALG, V101, P651, DOI 10.1213/01.ane.0000167382.79889.7c; Xie ZC, 2006, ANESTHESIOLOGY, V104, P988, DOI 10.1097/00000542-200605000-00015; Zhu CL, 2010, J CEREBR BLOOD F MET, V30, P1017, DOI 10.1038/jcbfm.2009.274; Zuo ZY, 2012, MED GAS RES, V2, DOI 10.1186/2045-9912-2-10	29	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0119336	10.1371/journal.pone.0119336	http://dx.doi.org/10.1371/journal.pone.0119336			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799420	Green Published, gold, Green Submitted			2022-12-26	WOS:000351987300040
J	Luo, Y; Sun, GB; Dong, X; Wang, M; Qin, M; Yu, YL; Sun, XB				Luo, Yun; Sun, Guibo; Dong, Xi; Wang, Min; Qin, Meng; Yu, Yingli; Sun, Xiaobo			Isorhamnetin Attenuates Atherosclerosis by Inhibiting Macrophage Apoptosis via PI3K/AKT Activation and HO-1 Induction	PLOS ONE			English	Article							HEME OXYGENASE-1; OXIDATIVE STRESS; REACTIVE OXYGEN; CELL-DEATH; EXPRESSION; EFFEROCYTOSIS; LIPOPROTEINS; PROTECTS; PATHWAY; GENE	Background and Purpose Isorhamnetin (Iso) is a flavonoid compound extracted from the Chinese herb Hippophae rhamnoides L. Previous studies have revealed its anti-cancer, anti-inflammatory, and antioxidant activities. This study investigated the ability of Iso to inhibit oxidized low-density lipoprotein (ox-LDL)-induced cell apoptosis in THP-1-derived macrophages. The effects of Iso on atherosclerosis in vivo were also evaluated in apolipoprotein E knockout (ApoE-/-) mice fed a high fat diet. Methods and Results Iso showed significant inhibitory effects on ox-LDL-induced THP-1-derived macrophage injuries via decreasing reactive oxygen species levels, lipid deposition, and caspase-3 activation, restoring mitochondrial membrane potential, reducing the number of terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling (TUNEL)-positive cells, and regulating apoptosis-related proteins. We also determined the protective effects of Iso by PI3K/AKT activation and HO-1 induction. Iso reduced the atherosclerotic plaque size in vivo in ApoE-/- mice as assessed by oil red O, Sudan IV staining, and CD68-positive cells, and reduced macrophage apoptosis as assessed by caspase-3 and TUNEL assays in lesions. Conclusion In conclusion, our results show that Iso inhibited atherosclerotic plaque development in ApoE-/- mice by PI3K/AKT activation and HO-1 induction.	[Luo, Yun; Sun, Guibo; Wang, Min; Qin, Meng; Yu, Yingli; Sun, Xiaobo] Chinese Acad Med Sci, Key Lab Bioact Subst & Resources Utilizat Chinese, Minist Educ, Inst Med Plant Dev, Beijing 100730, Peoples R China; [Luo, Yun; Sun, Guibo; Wang, Min; Qin, Meng; Yu, Yingli; Sun, Xiaobo] Peking Union Med Coll, Beijing 100021, Peoples R China; [Dong, Xi] Wenzhou Med Univ, Acad Chinese Mat Med, Wenzhou, Zhejiang, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Plant Development - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Wenzhou Medical University	Sun, GB (corresponding author), Chinese Acad Med Sci, Key Lab Bioact Subst & Resources Utilizat Chinese, Minist Educ, Inst Med Plant Dev, Beijing 100730, Peoples R China.	sunguibo@126.com; sun_xiaobo163@163.com			Natural Science Foundation of China [81374010, 81374011]; Major Scientific and Technological Special Project for "Significant New Drugs Formulation" [2012ZX09501001-004]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Scientific and Technological Special Project for "Significant New Drugs Formulation"	Funding: This work was supported by the Natural Science Foundation of China (Grants no. 81374010; 81374011) and the Major Scientific and Technological Special Project for "Significant New Drugs Formulation" (Grants no. 2012ZX09501001-004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam J, 2003, CURR PHARM DESIGN, V9, P2499, DOI 10.2174/1381612033453730; Bao M, 2006, EUR J PHARMACOL, V547, P22, DOI 10.1016/j.ejphar.2006.07.021; Boesch-Saadatmandi C, 2011, J NUTR BIOCHEM, V22, P293, DOI 10.1016/j.jnutbio.2010.02.008; Circu ML, 2010, FREE RADICAL BIO MED, V48, P749, DOI 10.1016/j.freeradbiomed.2009.12.022; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Fischer B, 2002, J IMMUNOL, V168, P2828, DOI 10.4049/jimmunol.168.6.2828; Fortuno A, 2005, EXP PHYSIOL, V90, P457, DOI 10.1113/expphysiol.2005.030098; Gautier EL, 2009, CIRCULATION, V119, P1795, DOI 10.1161/CIRCULATIONAHA.108.806158; Gu L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065477; Hwang YP, 2008, TOXICOL APPL PHARM, V231, P318, DOI 10.1016/j.taap.2008.04.019; Itabe H, 2003, BIOL PHARM BULL, V26, P1, DOI 10.1248/bpb.26.1; Itoh K, 2004, FREE RADICAL BIO MED, V36, P1208, DOI 10.1016/j.freeradbiomed.2004.02.075; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; Khallou-Laschet J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008852; Kim E, 2008, J NEUROSCI, V28, P4661, DOI 10.1523/JNEUROSCI.0982-08.2008; Kim JE, 2011, CANCER PREV RES, V4, P582, DOI 10.1158/1940-6207.CAPR-11-0032; Kim SJ, 2012, EXP MOL PATHOL, V93, P129, DOI 10.1016/j.yexmp.2012.04.003; Kriszbacher I, 2005, NEW ENGL J MED, V353, P429; Liu PF, 2009, PLANT FOOD HUM NUTR, V64, P141, DOI 10.1007/s11130-009-0116-1; MATSUMOTO A, 1990, P NATL ACAD SCI USA, V87, P9133, DOI 10.1073/pnas.87.23.9133; Nakaso K, 2003, FEBS LETT, V546, P181, DOI 10.1016/S0014-5793(03)00517-9; Ning YX, 2009, ATHEROSCLEROSIS, V204, P114, DOI 10.1016/j.atherosclerosis.2008.09.006; Park SY, 2011, INT IMMUNOPHARMACOL, V11, P1907, DOI 10.1016/j.intimp.2011.07.023; Park TS, 2008, PHARMACOL RES, V58, P45, DOI 10.1016/j.phrs.2008.06.005; Qin WW, 2012, CARDIOVASC DRUG THER, V26, P23, DOI 10.1007/s10557-011-6347-z; Ryter SW, 2007, ANTIOXID REDOX SIGN, V9, P49, DOI 10.1089/ars.2007.9.49; Salagianni M, 2012, CIRCULATION, V126, P952, DOI 10.1161/CIRCULATIONAHA.111.067678; Schachtele SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036216; Seimon T, 2009, J LIPID RES, V50, pS382, DOI 10.1194/jlr.R800032-JLR200; Su B, 2007, CARDIOVASC DRUG THER, V21, P37, DOI 10.1007/s10557-007-6002-x; Sun B, 2012, J CELL BIOCHEM, V113, P473, DOI 10.1002/jcb.23371; Sun GB, 2013, TOXICOL APPL PHARM, V271, P114, DOI 10.1016/j.taap.2013.04.015; Sun J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064526; Sun X, 2011, J CELL BIOCHEM, V112, P2019, DOI 10.1002/jcb.23121; Takahashi T, 2004, CURR MED CHEM, V11, P1545, DOI 10.2174/0929867043365080; Thorp E, 2008, ARTERIOSCL THROM VAS, V28, P1421, DOI 10.1161/ATVBAHA.108.167197; Tsuchiya S, 1982, CANC RES, P42; Wang H, 2012, J ETHNOPHARMACOL, V144, P138, DOI 10.1016/j.jep.2012.08.040; Xiao J, 2010, ENDOCRINOLOGY, V151, P3141, DOI 10.1210/en.2009-1381; Xu SL, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/278273; Yancey PG, 2010, ARTERIOSCL THROM VAS, V30, P787, DOI 10.1161/ATVBAHA.109.202051; Yao Z, 2009, ANTIOXID REDOX SIGN, V11, P2135, DOI [10.1089/ars.2009.2624, 10.1089/ARS.2009.2624]; Zhu H, 2005, FEBS LETT, V579, P3029, DOI 10.1016/j.febslet.2005.04.058; Zhu H, 2008, CARDIOVASC TOXICOL, V8, P71, DOI 10.1007/s12012-008-9016-0	44	49	56	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120259	10.1371/journal.pone.0120259	http://dx.doi.org/10.1371/journal.pone.0120259			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799286	Green Submitted, gold, Green Published			2022-12-26	WOS:000351987300118
J	Paul, D; Kazy, SK; Gupta, AK; Pal, T; Sar, P				Paul, Dhiraj; Kazy, Sufia K.; Gupta, Ashok K.; Pal, Taraknath; Sar, Pinaki			Diversity, Metabolic Properties and Arsenic Mobilization Potential of Indigenous Bacteria in Arsenic Contaminated Groundwater of West Bengal, India	PLOS ONE			English	Article							MICROBIAL COMMUNITIES; REDUCING BACTERIA; AQUIFER SEDIMENTS; ORGANIC-MATTER; DELTA PLAIN; SHALLOW; BANGLADESH; RELEASE; WATER; IRON	Arsenic (As) mobilization in alluvial aquifers is caused by a complex interplay of hydro-geo-microbiological activities. Nevertheless, diversity and biogeochemical significance of indigenous bacteria in Bengal Delta Plain are not well documented. We have deciphered bacterial community compositions and metabolic properties in As contaminated groundwater of West Bengal to define their role in As mobilization. Groundwater samples showed characteristic high As, low organic carbon and reducing property. Culture-independent and -dependent analyses revealed presence of diverse, yet near consistent community composition mostly represented by genera Pseudomonas, Flavobacterium, Brevundimonas, Polaromonas, Rhodococcus, Methyloversatilis and Methylotenera. Along with As-resistance and -reductase activities, abilities to metabolize a wide range carbon substrates including long chain and polyaromatic hydrocarbons and HCO3, As3+ as electron donor and As5+/Fe3+ as terminal electron acceptor during anaerobic growth were frequently observed within the cultivable bacteria. Genes encoding cytosolic As5+ reductase (arsC) and As3+ efflux/transporter [arsB and acr3(2)] were found to be more abundant than the dissimilatory As5+ reductase gene arrA. The observed metabolic characteristics showed a good agreement with the same derived from phylogenetic lineages of constituent populations. Selected bacterial strains incubated anaerobically over 300 days using natural orange sand of Pleistocene aquifer showed release of soluble As mostly as As3+ along with several other elements (Al, Fe, Mn, K, etc.). Together with the production of oxalic acid within the biotic microcosms, change in sediment composition and mineralogy indicated dissolution of orange sand coupled with As/Fe reduction. Presence of arsC gene, As5+ reductase activity and oxalic acid production by the bacteria were found to be closely related to their ability to mobilize sediment bound As. Overall observations suggest that indigenous bacteria in oligotrophic groundwater possess adequate catabolic ability to mobilize As by a cascade of reactions, mostly linked to bacterial necessity for essential nutrients and detoxification.	[Paul, Dhiraj; Sar, Pinaki] Indian Inst Technol, Dept Biotechnol, Kharagpur 721302, W Bengal, India; [Kazy, Sufia K.] Natl Inst Technol, Dept Biotechnol, Durgapur 713209, India; [Gupta, Ashok K.] Indian Inst Technol, Dept Civil Engn, Kharagpur 721302, W Bengal, India; [Pal, Taraknath] Geol Survey India, Cent Headquarters, Kolkata 700016, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kharagpur; National Institute of Technology (NIT System); National Institute of Technology Durgapur; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kharagpur; Geological Survey India	Sar, P (corresponding author), Indian Inst Technol, Dept Biotechnol, Kharagpur 721302, W Bengal, India.	psar@hijli.iitkgp.ernet.in			Department of Biotechnology, Govt. of India [BT/PR8933/GBD/27/41/2006]; Council of Scientific and Industrial Research [38/1314/11/EMR II]	Department of Biotechnology, Govt. of India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by the Department of Biotechnology, Govt. of India (RGYI scheme No. BT/PR8933/GBD/27/41/2006), Council of Scientific and Industrial Research (scheme No. 38/1314/11/EMR II). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achour AR, 2007, RES MICROBIOL, V158, P128, DOI 10.1016/j.resmic.2006.11.006; Akai J, 2004, APPL GEOCHEM, V19, P215, DOI 10.1016/j.apgeochem.2003.09.008; [Anonymous], 2001, WHO ENV HLTH CRIT 22; APHA-AWWA-WPCF, 1985, STANDARD METHODS EXA; Battaglia-Brunet F, 2006, ANTON LEEUW INT J G, V89, P99, DOI 10.1007/s10482-005-9013-2; Bondici VF, 2013, J APPL MICROBIOL, V114, P1671, DOI 10.1111/jam.12180; Corsini A, 2014, J HAZARD MATER, V269, P89, DOI 10.1016/j.jhazmat.2013.12.037; Costa PS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095655; Das R, 2014, ENVIRON SCI POLLUT R, V21, P7369, DOI 10.1007/s11356-014-2640-2; Delavat F, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-28; Dhar RK, 2011, ENVIRON SCI TECHNOL, V45, P2648, DOI 10.1021/es1022015; Donachie SP, 2007, ISME J, V1, P97, DOI 10.1038/ismej.2007.22; Drewniak L, 2008, ENVIRON POLLUT, V156, P1069, DOI 10.1016/j.envpol.2008.04.019; Duan MY, 2009, ENVIRON GEOL, V57, P997, DOI 10.1007/s00254-008-1384-z; Escudero LV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078890; Fendorf S, 2010, SCIENCE, V328, P1123, DOI 10.1126/science.1172974; Freikowski D, 2013, ECOTOX ENVIRON SAFE, V91, P139, DOI 10.1016/j.ecoenv.2013.01.021; Frey B, 2010, APPL ENVIRON MICROB, V76, P4788, DOI 10.1128/AEM.00657-10; Gault AG, 2005, MINERAL MAG, V69, P855, DOI 10.1180/0026461056950293; Ghosh S, 2013, WATER RES, V47, P6992, DOI 10.1016/j.watres.2013.08.044; GOOD IJ, 1953, BIOMETRIKA, V40, P237, DOI 10.2307/2333344; Gorra R, 2012, MICROB ECOL, V64, P171, DOI 10.1007/s00248-012-0014-1; Hasan MA, 2009, ENVIRON GEOL, V57, P499, DOI 10.1007/s00254-008-1319-8; Hery M, 2010, GEOBIOLOGY, V8, P155, DOI 10.1111/j.1472-4669.2010.00233.x; Inskeep WP, 2007, ENVIRON MICROBIOL, V9, P934, DOI 10.1111/j.1462-2920.2006.01215.x; Islam ABMR, 2013, J HAZARD MATER, V262, P989, DOI 10.1016/j.jhazmat.2012.07.022; Islam FS, 2004, NATURE, V430, P68, DOI 10.1038/nature02638; Jiang Z, 2014, ENVIRON EARTH SCI, V71, P311, DOI 10.1007/s12665-013-2435-7; Kalyuzhnaya MG, 2006, INT J SYST EVOL MICR, V56, P2819, DOI 10.1099/ijs.0.64191-0; Kar S, 2010, APPL GEOCHEM, V25, P1805, DOI 10.1016/j.apgeochem.2010.09.007; Kazy SK, 1999, WORLD J MICROB BIOT, V15, P599, DOI 10.1023/A:1008997718811; Lear G, 2007, APPL ENVIRON MICROB, V73, P1041, DOI 10.1128/AEM.01654-06; Lee JT, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-42; Li XK, 2007, J BACTERIOL, V189, P3705, DOI 10.1128/JB.01913-06; Liao VHC, 2011, J CONTAM HYDROL, V123, P20, DOI 10.1016/j.jconhyd.2010.12.003; LOVLEY DR, 1986, APPL ENVIRON MICROB, V52, P751, DOI 10.1128/AEM.52.4.751-757.1986; Mailloux BJ, 2009, APPL ENVIRON MICROB, V75, P2558, DOI 10.1128/AEM.02440-07; McArthur JM, 2004, APPL GEOCHEM, V19, P1255, DOI 10.1016/j.apgeochem.2004.02.001; Miles AA, 1938, J HYG-CAMBRIDGE, V38, P732, DOI 10.1017/S002217240001158X; Mukherjee A, 2008, J CONTAM HYDROL, V99, P31, DOI 10.1016/j.jconhyd.2007.10.005; Mukherjee A, 2008, APPL GEOCHEM, V23, P863, DOI 10.1016/j.apgeochem.2007.07.011; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Nath B, 2011, APPL GEOCHEM, V26, P705, DOI 10.1016/j.apgeochem.2011.01.029; Neidhardt H, 2013, J HAZARD MATER, V262, P941, DOI 10.1016/j.jhazmat.2013.01.044; Neidhardt H, 2013, APPL GEOCHEM, V36, P70, DOI 10.1016/j.apgeochem.2013.06.017; Newman DK, 2001, SCIENCE, V292, P1312, DOI 10.1126/science.1060572; Nickson RT, 2000, APPL GEOCHEM, V15, P403, DOI 10.1016/S0883-2927(99)00086-4; Omoregie EO, 2013, APPL ENVIRON MICROB, V79, P4325, DOI 10.1128/AEM.00683-13; Oremland RS, 2005, TRENDS MICROBIOL, V13, P45, DOI 10.1016/j.tim.2004.12.002; Pal T, 2009, ENVIRON GEOL, V56, P1211, DOI 10.1007/s00254-008-1221-4; Patrauchan MA, 2012, APPL ENVIRON MICROB, V78, P6714, DOI 10.1128/AEM.01293-12; Ravenscroft P, 2001, ARSENIC EXPOSURE AND HEALTH EFFECTS IV, P53; Reardon CL, 2004, APPL ENVIRON MICROB, V70, P6037, DOI 10.1128/AEM.70.10.6037-6046.2004; Rowland HAL, 2006, ORG GEOCHEM, V37, P1101, DOI 10.1016/j.orggeochem.2006.04.011; Rowland HAL, 2009, J ENVIRON QUAL, V38, P1598, DOI 10.2134/jeq2008.0223; Sarkar A, 2014, ENVIRON SCI POLLUT R, V21, P8645, DOI 10.1007/s11356-014-2759-1; Sarkar A, 2013, ECOTOXICOLOGY, V22, P363, DOI 10.1007/s10646-012-1031-z; Saunders JA, 2005, GEOCHEM GEOPHY GEOSY, V6, DOI 10.1029/2004GC000803; SCHWYN B, 1987, ANAL BIOCHEM, V160, P47, DOI 10.1016/0003-2697(87)90612-9; Song B, 2009, FEMS MICROBIOL ECOL, V68, P108, DOI 10.1111/j.1574-6941.2009.00657.x; Sultana M, 2011, GEOMICROBIOL J, V28, P198, DOI 10.1080/01490451.2010.490078; Sun Z, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003701; Sutton NB, 2009, WATER RES, V43, P1720, DOI 10.1016/j.watres.2009.01.006; Swartz CH, 2004, GEOCHIM COSMOCHIM AC, V68, P4539, DOI 10.1016/j.gca.2004.04.020; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Uroz S, 2009, TRENDS MICROBIOL, V17, P378, DOI 10.1016/j.tim.2009.05.004; van Dongen BE, 2008, APPL GEOCHEM, V23, P3047, DOI 10.1016/j.apgeochem.2008.06.012; Van Geen A, 2004, GEOCHIM COSMOCHIM AC, V68, P3475, DOI 10.1016/j.gca.2004.02.014; Yan ZS, 2012, J HAZARD MATER, V199, P217, DOI 10.1016/j.jhazmat.2011.10.087; Zheng Y, 2005, GEOCHIM COSMOCHIM AC, V69, P5203, DOI 10.1016/j.gca.2005.06.001	70	43	44	2	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0118735	10.1371/journal.pone.0118735	http://dx.doi.org/10.1371/journal.pone.0118735			40	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799109	Green Published, Green Submitted, gold			2022-12-26	WOS:000351987300016
J	Rapino, D; Sabirzhanova, I; Lopes-Pacheco, M; Grover, R; Guggino, WB; Cebotaru, L				Rapino, Daniele; Sabirzhanova, Inna; Lopes-Pacheco, Miqueias; Grover, Rahul; Guggino, William B.; Cebotaru, Liudmila			Rescue of NBD2 Mutants N1303K and S1235R of CFTR by Small-Molecule Correctors and Transcomplementation	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; CYSTIC-FIBROSIS; PLASMA-MEMBRANE; MUTATION; EXPRESSION; INHIBITOR; PHENOTYPE; MECHANISM; COMPOUND; HSP70	Although, the most common Cystic Fibrosis mutation, Delta F508, in the cystic fibrosis transmembrane regulator. (CFTR), is located in nucleotide binding domain (NBD1), disease-causing mutations also occur in NBD2. To provide information on potential therapeutic strategies for mutations in NBD2, we studied, using a combination of biochemical approaches and newly created cell lines, two disease-causing NBD2 mutants, N1303K and S1235R. Surprisingly, neither was rescued by low temperature. Inhibition of proteasomes with MG132 or aggresomes with tubacin rescued the immature B and mature C bands of N1303K and S1235R, indicating that degradation occurs via proteasomes and aggresomes. We found no effect of the lysosome inhibitor E64. Thus, our results show that these NBD2 mutants are processing mutants with unique characteristics. Several known correctors developed to rescue Delta F508-CFTR, when applied either alone or in combination, significantly increased the maturation of bands B and C of both NBD 2 mutants. The best correction occurred with the combinations of C4 plus C18 or C3 plus C4. Co-transfection of truncated CFTR (Delta 27-264) into stably transfected cells was also able to rescue them. This demonstrates for the first time that transcomplementation with a truncated version of CFTR can rescue NBD2 mutants. Our results show that the N1303K mutation has a more profound effect on NBD2 processing than S1235R and that small-molecule correctors increase the maturation of bands B and C in NBD2 mutants. In addition, Delta 27-264 was able to trans-complement both NDB2 mutants. We conclude that differences and similarities occur in the impact of mutations on NBD2 when compared to Delta F508-CFTR suggesting that individualized strategies may be needed to restore their function. Finally our results are important because they suggest that gene or corrector molecule therapies either alone or in combination individualized for NBD2 mutants may be beneficial for patients bearing N1303K or S1235R mutations.	[Rapino, Daniele; Sabirzhanova, Inna; Lopes-Pacheco, Miqueias; Grover, Rahul; Cebotaru, Liudmila] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Rapino, Daniele; Sabirzhanova, Inna; Lopes-Pacheco, Miqueias; Grover, Rahul; Guggino, William B.] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Cebotaru, L (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA.	lcebotaru@jhmi.edu	Lopes-Pacheco, Miquéias/AAM-7432-2020; Lopes-Pacheco, Miquéias/I-1290-2017	Lopes-Pacheco, Miquéias/0000-0002-7444-9359; Lopes-Pacheco, Miquéias/0000-0002-7444-9359; Grover, Rahul/0000-0002-3143-0228	United States CF Foundation; University of Chieti, Italy; National Council for Scientific and Technological Development (CNPq) Brazil	United States CF Foundation; University of Chieti, Italy; National Council for Scientific and Technological Development (CNPq) Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Funded by the United States CF Foundation, the University of Chieti, Italy (Rapino) and National Council for Scientific and Technological Development (CNPq) Brazil (Lopes Pacheco). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accurso FJ, 2010, NEW ENGL J MED, V363, P1991, DOI 10.1056/NEJMoa0909825; Amaral MD, 2004, J MOL NEUROSCI, V23, P41, DOI 10.1385/JMN:23:1-2:041; Ataseven F, 2010, TUBERK TORAK, V58, P181; Auriche C, 2010, GENE THER, V17, P1341, DOI 10.1038/gt.2010.89; BARRETT AJ, 1981, ACTA BIOL MED GER, V40, P1513; Boyault C, 2006, EMBO J, V25, P3357, DOI 10.1038/sj.emboj.7601210; Castellani C, 2001, Hum Mutat, V18, P166, DOI 10.1002/humu.1172; Cebotaru L, 2013, J BIOL CHEM; Cebotaru L, 2008, J BIOL CHEM, V283, P21926, DOI 10.1074/jbc.M709156200; Cebotaru L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085183; Choo-Kang LR, 2001, AM J PHYSIOL-LUNG C, V281, pL58, DOI 10.1152/ajplung.2001.281.1.L58; Clancy JP, 2012, THORAX, V67, P12, DOI 10.1136/thoraxjnl-2011-200393; Cotellessa M, 1996, ARCH DIS CHILD, V75, P546, DOI 10.1136/adc.75.6.546; Csanady L, 2010, P NATL ACAD SCI USA, V107, P1241, DOI 10.1073/pnas.0911061107; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; Du K, 2005, NAT STRUCT MOL BIOL, V12, P17, DOI 10.1038/nsmb882; Federici S, ARCH PEDIAT, V8, P150; Feldmann Delphine, 2003, Hum Mutat, V22, P340, DOI 10.1002/humu.9183; FULLER CM, 1992, AM J PHYSIOL, V263, pC267, DOI 10.1152/ajpcell.1992.263.2.C267; FULMER SB, 1995, P NATL ACAD SCI USA, V92, P6832, DOI 10.1073/pnas.92.15.6832; Haggarty SJ, 2003, P NATL ACAD SCI USA, V100, P4389, DOI 10.1073/pnas.0430973100; Heda GD, 2001, AM J PHYSIOL-CELL PH, V280, pC166, DOI 10.1152/ajpcell.2001.280.1.C166; Holleran JP, 2012, MOL MED, V18, P685, DOI 10.2119/molmed.2012.00001; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; KEREM E, 1990, NEW ENGL J MED, V323, P1517, DOI 10.1056/NEJM199011293232203; Kleizen B, 2005, MOL CELL, V20, P277, DOI 10.1016/j.molcel.2005.09.007; Lewis HA, 2004, EMBO J, V23, P282, DOI 10.1038/sj.emboj.7600040; Li JZ, 2009, PROTEIN PEPTIDE LETT, V16, P606, DOI 10.2174/092986609788490159; Loo MA, 1998, EMBO J, V17, P6879, DOI 10.1093/emboj/17.23.6879; Lu Y, 1998, J BIOL CHEM, V273, P568, DOI 10.1074/jbc.273.1.568; LUKACS GL, 1993, J BIOL CHEM, V268, P21592; Ma TH, 2002, J CLIN INVEST, V110, P1651, DOI 10.1172/JCI200216112; Mendoza JL, 2012, CELL, V148, P164, DOI 10.1016/j.cell.2011.11.023; OBRIG TG, 1971, J BIOL CHEM, V246, P174; Okiyoneda T, 2013, NAT CHEM BIOL, V9, P444, DOI [10.1038/NCHEMBIO.1253, 10.1038/nchembio.1253]; OSBORNE L, 1992, HUM GENET, V89, P653, DOI 10.1007/BF00221957; Pedemonte N, 2005, J CLIN INVEST, V115, P2564, DOI 10.1172/JCI24898; Reboul MP, 2003, GASTROEN CLIN BIOL, V27, P821; RIORDAN JR, 1989, SCIENCE, V245, P1066; Sosnay PR, 2013, NAT GENET, V45, P1160, DOI 10.1038/ng.2745; Thibodeau PH, 2010, J BIOL CHEM, V285, P35825, DOI 10.1074/jbc.M110.131623; Van Goor F, 2006, AM J PHYSIOL-LUNG C, V290, pL1117, DOI 10.1152/ajplung.00169.2005; Van Goor F, 2011, P NATL ACAD SCI USA, V108, P18843, DOI 10.1073/pnas.1105787108; Van Goor F, 2009, P NATL ACAD SCI USA, V106, P18825, DOI 10.1073/pnas.0904709106; YANG YP, 1993, P NATL ACAD SCI USA, V90, P9480, DOI 10.1073/pnas.90.20.9480; Zolotukhin S, 2002, METHODS, V28, P158, DOI 10.1016/S1046-2023(02)00220-7	46	29	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0119796	10.1371/journal.pone.0119796	http://dx.doi.org/10.1371/journal.pone.0119796			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799511	Green Published, gold, Green Submitted			2022-12-26	WOS:000351987300081
J	Zhang, GW; Wang, WJ; Zhang, XM; Xia, QQ; Zhao, XM; Ahn, Y; Ahmed, N; Cosoveanu, A; Wang, M; Wang, JL; Shu, SH				Zhang, Guowei; Wang, Wenjuan; Zhang, Xiangmei; Xia, Qianqian; Zhao, Xinmei; Ahn, Youngjoon; Ahmed, Nevin; Cosoveanu, Andreea; Wang, Mo; Wang, Jialu; Shu, Shaohua			De Novo RNA Sequencing and Transcriptome Analysis of Colletotrichum gloeosporioides ES026 Reveal Genes Related to Biosynthesis of Huperzine A	PLOS ONE			English	Article							LYCOPODIUM ALKALOIDS; SERRATA; FUNGUS; CHINA	Huperzine A is important in the treatment of Alzheimer's disease. There are major challenges for the mass production of huperzine A from plants due to the limited number of huperzine-A-producing plants, as well as the low content of huperzine A in these plants. Various endophytic fungi produce huperzine A. Colletotrichum gloeosporioides ES026 was previously isolated from a huperzine-A-producing plant Huperzia serrata, and this fungus also produces huperzine A. In this study, de novo RNA sequencing of C. gloeosporioides ES026 was carried out with an Illumina HiSeq2000. A total of 4,324,299,051 bp from 50,442,617 high-quality sequence reads of ES026 were obtained. These raw data were assembled into 24,998 unigenes, 40,536,684 residues and 19,790 genes. The majority of the unique sequences were assigned to corresponding putative functions based on BLAST searches of public databases. The molecular functions, biological processes and biochemical pathways of these unique sequences were determined using gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) assignments. A gene encoding copper amine oxidase (CAO) (unigene 9322) was annotated for the conversion of cadaverine to 5-aminopentanal in the biosynthesis of huperzine A. This gene was also detected in the root, stem and leaf of H. serrata. Furthermore, a close relationship was observed between expression of the CAO gene (unigene 9322) and quantity of crude huperzine A extracted from ES026. Therefore, CAO might be involved in the biosynthesis of huperzine A and it most likely plays a key role in regulating the content of huperzine A in ES026.	[Zhang, Guowei; Wang, Wenjuan; Zhang, Xiangmei; Xia, Qianqian; Ahmed, Nevin; Wang, Mo; Wang, Jialu; Shu, Shaohua] Huazhong Agr Univ, Coll Plant Sci & Technol, Wuhan, Peoples R China; [Zhao, Xinmei] Xinyang Normal Univ, Coll Life Sci, Xinyang, Peoples R China; [Ahn, Youngjoon] Seoul Natl Univ, Coll Agr & Life Sci, Seoul 151742, South Korea; [Ahmed, Nevin] Benha Univ, Fac Agr, Dept Plant Protect, Banha, Egypt; [Cosoveanu, Andreea] Univ La Laguna, Fac Biol, Phytopathol Unit, E-38207 San Cristobal la Laguna, Tenerife, Spain	Huazhong Agricultural University; Xinyang Normal University; Seoul National University (SNU); Egyptian Knowledge Bank (EKB); Benha University; Universidad de la Laguna	Shu, SH (corresponding author), Huazhong Agr Univ, Coll Plant Sci & Technol, Wuhan, Peoples R China.	shushaohua@mail.hzau.edu.cn	Cosoveanu, Andreea/J-3093-2019	Cosoveanu, Andreea/0000-0002-6233-7296	National Natural Science Foundation of China [81202870]; Ministry of Science and Technology of the People's Republic of China through the Project of International Scientific and Technological Cooperation between China and South Korea [2011DFA31290]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of the People's Republic of China through the Project of International Scientific and Technological Cooperation between China and South Korea	Funding for this work came from the National Natural Science Foundation of China (Grant No. 81202870, http://www.nsfc.gov.cn/) and the Ministry of Science and Technology of the People's Republic of China through the Project of International Scientific and Technological Cooperation between China and South Korea (Grant No. 2011DFA31290, http://www.most.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balasubramanian S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-1-r2; Cheng DH, 1996, NEUROREPORT, V8, P97, DOI 10.1097/00001756-199612200-00020; Choi JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042462; Hemscheidt T, 2000, TOP CURR CHEM, V209, P175; Ju Z., 2009, FUDAN XUEBAO-YIXUEBA, V4, P017, DOI [10.3969/j.issn.1672-8467.2009.04.015, DOI 10.3969/J.ISSN.1672-8467.2009.04.015]; Koshiba T, 2009, ORG LETT, V11, P5354, DOI 10.1021/ol9022408; Kusari S, 2013, PHYTOCHEMISTRY, V91, P81, DOI 10.1016/j.phytochem.2012.07.021; Li W., 2007, CHIN MED BIOTECHNOL, V2, P254; Liu DB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036146; Luo HM, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-209; Luo HM, 2010, PHYSIOL PLANTARUM, V139, P1, DOI 10.1111/j.1399-3054.2009.01339.x; Ma XQ, 2007, J ETHNOPHARMACOL, V113, P15, DOI 10.1016/j.jep.2007.05.030; Ma XQ, 2006, J ETHNOPHARMACOL, V104, P54, DOI 10.1016/j.jep.2005.08.042; Ma XQ, 2005, J AGR FOOD CHEM, V53, P1393, DOI 10.1021/jf048193n; Ma XQ, 2004, NAT PROD REP, V21, P752, DOI 10.1039/b409720n; QIAN BC, 1995, ACTA PHARM SINIC, V16, P396; Saikkonen K, 1998, ANNU REV ECOL SYST, V29, P319, DOI 10.1146/annurev.ecolsys.29.1.319; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sun JY, 2012, BIOORG MED CHEM LETT, V22, P5784, DOI 10.1016/j.bmcl.2012.07.102; Temnykh S, 2001, GENOME RES, V11, P1441, DOI 10.1101/gr.184001; Tong XT, 2003, PLANTA MED, V69, P576, DOI 10.1055/s-2003-40648; XIA Y, 1989, J AM CHEM SOC, V111, P4116, DOI 10.1021/ja00193a062; Yang F, 2012, J BIOSCI BIOENG, V114, P228, DOI 10.1016/j.jbiosc.2012.03.009; [张磊 Zhang Lei], 2005, [中草药, Chinese Traditional and Herbal Drugs], V36, P1422; Zhang ZB, 2011, WORLD J MICROB BIOT, V27, P479, DOI 10.1007/s11274-010-0476-6; Zhao XM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061777; Zhu D, 2010, J APPL MICROBIOL, V109, P1469, DOI 10.1111/j.1365-2672.2010.04777.x	27	12	14	3	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120809	10.1371/journal.pone.0120809	http://dx.doi.org/10.1371/journal.pone.0120809			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799531	Green Submitted, gold, Green Published			2022-12-26	WOS:000351987300180
J	Fiala, M; Halder, RC; Sagong, B; Ross, O; Sayre, J; Porter, V; Bredesen, DE				Fiala, Milan; Halder, Ramesh C.; Sagong, Bien; Ross, Olivia; Sayre, James; Porter, Verna; Bredesen, Dale E.			omega-3 Supplementation increases amyloid-beta phagocytosis and resolvin D1 in patients with minor cognitive impairment	FASEB JOURNAL			English	Article						specialized proresolving mediators; omega-3 fatty acids; minimental state examination; monocyte/macrophages; inflammatory genes	PRORESOLVING LIPID MEDIATORS; POLYUNSATURATED FATTY-ACIDS; ALZHEIMERS-DISEASE; MOUSE MODELS; THERAPEUTICS; INFLAMMATION; TRIAL; OMEGA-3-FATTY-ACIDS	We investigated the effects of 4-17 month supplementation with omega-3 fatty acids and antioxidants (Smartfish drink; Smartfish AS, Oslo, Norway) in 12 patients with minor cognitive impairment (MCI) [minimental state examination (MMSE) >= 19], 2 patients with pre-MCI (normal MMSE), and 7 patients with Alzheimer disease (AD) (MMSE <19). We measured the phagocytosis of amyloid-beta 1-42 (A beta) by flow cytometry and microscopy, the transcription of inflammatory genes by RT-PCR, the production of resolvin D1 (RvD1) by enzyme immunoassay, and the cognitive status by MMSE. In patients with MCI and pre-MCI, phagocytosis of A beta by monocytes increased from 530 to 1306 mean fluorescence intensity units (P = 0.016). The increase in patients with AD was not significant (N.S.). The lipidic mediator RvD1, which stimulates A beta phagocytosis in vitro, increased in macrophages in 80% of patients with MCI and pre-MCI (mean increase 9.95 pg/ml) (N.S.). Transcription of inflammatory genes' mRNAs was increased in a subgroup of patients with low transcription at baseline, whereas it was not significantly changed in patients with high transcription at baseline. The mean MMSE score of patients with MCI and pre-MCI was 25.9 at baseline and 25.7 after 4-17 months (N.S.). Our study is the first to show significant immune and biochemical effects of omega-3 fatty acids with antioxidants in patients with MCI. Cognitive benefits of omega-3 supplementation in patients with MCI should be tested in a clinical trial.	[Fiala, Milan; Halder, Ramesh C.; Sagong, Bien; Ross, Olivia] Univ Calif Los Angeles, Sch Med, Dept Surg, Los Angeles, CA 90024 USA; [Sayre, James] Univ Calif Los Angeles, Sch Med, Dept Neurol, Los Angeles, CA 90024 USA; [Porter, Verna; Bredesen, Dale E.] Univ Calif Los Angeles, Sch Publ Hlth, Dept Biostat, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	Fiala, M (corresponding author), 100 UCLA Med Plaza,Suite 220, Los Angeles, CA 90095 USA.	fiala@mednet.ucla.edu			Smartfish AS (Oslo, Norway)	Smartfish AS (Oslo, Norway)	The authors thank Veena Theendakara and Rammohan V. Rao for ApoE genotype testing. Smartfish AS (Oslo, Norway) provided the funding for publication and supplied the drink to patients who requested it. Smartfish was not involved in the design, analysis, interpretation of the data, or the decision to submit the manuscript for publication. M.F. received paid travel to meetings and honoraria for consultations from Smartfish.	Anand R, 2014, NEUROPHARMACOLOGY, V76, P27, DOI 10.1016/j.neuropharm.2013.07.004; Avagyan H, 2009, J NEUROIMMUNOL, V210, P67, DOI 10.1016/j.jneuroim.2009.02.015; Barberger-Gateau P, 2011, CURR ALZHEIMER RES, V8, P479, DOI 10.2174/156720511796391926; Bredesen DE, 2013, EMBO MOL MED, V5, P795, DOI 10.1002/emmm.201202307; Buckley CD, 2014, IMMUNITY, V40, P315, DOI 10.1016/j.immuni.2014.02.009; Chiang N, 2012, NATURE, V484, P524, DOI 10.1038/nature11042; Freund-Levi Y, 2006, ARCH NEUROL-CHICAGO, V63, P1402, DOI 10.1001/archneur.63.10.1402; Jicha GA, 2010, CLIN INTERV AGING, V5, P45; Kokjohn TA, 2009, ALZHEIMERS DEMENT, V5, P340, DOI 10.1016/j.jalz.2009.03.002; Lue LF, 1996, J NEUROPATH EXP NEUR, V55, P1083, DOI 10.1097/00005072-199655100-00008; Lukiw WJ, 2005, J CLIN INVEST, V115, P2774, DOI 10.1172/JCI25420; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Mizwicki MT, 2013, J ALZHEIMERS DIS, V34, P155, DOI 10.3233/JAD-121735; Netea MG, 2012, NAT IMMUNOL, V13, P535, DOI 10.1038/ni.2284; Otaegui-Arrazola A, 2014, EUR J NUTR, V53, P1, DOI 10.1007/s00394-013-0561-3; Petersen RC, 2001, ARCH NEUROL-CHICAGO, V58, P1985, DOI 10.1001/archneur.58.12.1985; Quinn JF, 2010, JAMA-J AM MED ASSOC, V304, P1903, DOI 10.1001/jama.2010.1510; Selkoe DJ, 2011, NAT MED, V17, P1060, DOI 10.1038/nm.2460; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Shinto L, 2014, J ALZHEIMERS DIS, V38, P111, DOI 10.3233/JAD-130722; Spite M, 2014, CELL METAB, V19, P21, DOI 10.1016/j.cmet.2013.10.006; Theendakara V, 2013, P NATL ACAD SCI USA, V110, P18303, DOI 10.1073/pnas.1314145110; Yates CM, 2014, PHARMACOL THERAPEUT, V141, P272, DOI 10.1016/j.pharmthera.2013.10.010; Zaghi J, 2009, ACTA NEUROPATHOL, V117, P111, DOI 10.1007/s00401-008-0481-0	24	47	49	1	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2015	29	7					2681	2689		10.1096/fj.14-264218	http://dx.doi.org/10.1096/fj.14-264218			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CL3OI	25805829				2022-12-26	WOS:000356859100001
J	Dewhare, SS; Umesh, TG; Muniyappa, K				Dewhare, Shivendra Singh; Umesh, T. G.; Muniyappa, K.			Molecular and Functional Characterization of RecD, a Novel Member of the SF1 Family of Helicases, from Mycobacterium tuberculosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Atomic Force Microscopy (AFM); ATPase; Bioinformatics; Cloning; DNA Helicase; DNA Recombination; Enzyme Kinetics; Infectious Disease; Mycobacteria; Mycobacterium tuberculosis	BACTERIOPHAGE-T4 DDA HELICASE; ATOMIC-FORCE MICROSCOPY; ESCHERICHIA-COLI-UVRD; DNA-DEPENDENT ATPASE; RECBCD ENZYME; BACILLUS-SUBTILIS; STRAND EXCHANGE; IN-VITRO; HOMOLOGOUS RECOMBINATION; DEINOCOCCUS-RADIODURANS	Background: The heterotrimeric M. tuberculosis RecBCD complex, or each of its individual subunits, remains uncharacterized. Results: MtRecD exists as a homodimer in solution, catalyzes ssDNA-dependent ATP hydrolysis, unwinding of DNA replication/recombination intermediates, and interacts with RecA. Conclusion: MtRecD possesses strong 5 3- and weak 3 5-helicase activities. Significance: These findings provide insights into the mechanism underlying DSB repair and homologous recombination in mycobacteria. The annotated whole-genome sequence of Mycobacterium tuberculosis revealed the presence of a putative recD gene; however, the biochemical characteristics of its encoded protein product (MtRecD) remain largely unknown. Here, we show that MtRecD exists in solution as a stable homodimer. Protein-DNA binding assays revealed that MtRecD binds efficiently to single-stranded DNA and linear duplexes containing 5 overhangs relative to the 3 overhangs but not to blunt-ended duplex. Furthermore, MtRecD bound more robustly to a variety of Y-shaped DNA structures having 18-nucleotide overhangs but not to a similar substrate containing 5-nucleotide overhangs. MtRecD formed more salt-tolerant complexes with Y-shaped structures compared with linear duplex having 3 overhangs. The intrinsic ATPase activity of MtRecD was stimulated by single-stranded DNA. Site-specific mutagenesis of Lys-179 in motif I abolished the ATPase activity of MtRecD. Interestingly, although MtRecD-catalyzed unwinding showed a markedly higher preference for duplex substrates with 5 overhangs, it could also catalyze significant unwinding of substrates containing 3 overhangs. These results support the notion that MtRecD is a bipolar helicase with strong 5 3 and weak 3 5 unwinding activities. The extent of unwinding of Y-shaped DNA structures was approximate to 3-fold lower compared with duplexes with 5 overhangs. Notably, direct interaction between MtRecD and its cognate RecA led to inhibition of DNA strand exchange promoted by RecA. Altogether, these studies provide the first detailed characterization of MtRecD and present important insights into the type of DNA structure the enzyme is likely to act upon during the processes of DNA repair or homologous recombination.	[Dewhare, Shivendra Singh; Umesh, T. G.; Muniyappa, K.] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Muniyappa, K (corresponding author), Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India.	kmbc@biochem.iisc.ernet.in			Council of Scientific and Industrial Research; Dept. of Biotechnology, New Delhi, India; J.C. Bose National Fellowship, Department of Science and Technology, New Delhi, India	Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); Dept. of Biotechnology, New Delhi, India; J.C. Bose National Fellowship, Department of Science and Technology, New Delhi, India	This work was supported in part by a senior research fellowship (to S. S. D.) and a postdoctoral fellowship (to T. G. U.) from the Council of Scientific and Industrial Research and Dept. of Biotechnology, New Delhi, India.; Recipient of J.C. Bose National Fellowship, Department of Science and Technology, New Delhi, India. To whom correspondence should be addressed. Tel.: 91-80-2293-2235/2360 0278; Fax: 91-80-23600814/0683; E-mail: kmbc@biochem.iisc.ernet.in.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amundsen SK, 2000, P NATL ACAD SCI USA, V97, P7399, DOI 10.1073/pnas.130192397; AMUNDSEN SK, 1986, P NATL ACAD SCI USA, V83, P5558, DOI 10.1073/pnas.83.15.5558; Anand SP, 2007, J BACTERIOL, V189, P4502, DOI 10.1128/JB.00376-07; Bayburt TH, 2002, P NATL ACAD SCI USA, V99, P6725, DOI 10.1073/pnas.062565599; Bianco P R, 1998, Front Biosci, V3, pD570; BIEK DP, 1986, J BACTERIOL, V167, P594, DOI 10.1128/jb.167.2.594-603.1986; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chedin F, 2000, J MOL BIOL, V298, P7, DOI 10.1006/jmbi.2000.3556; Chedin F, 1998, MOL MICROBIOL, V29, P1369, DOI 10.1046/j.1365-2958.1998.01018.x; Chedin F, 2002, MOL MICROBIOL, V43, P823, DOI 10.1046/j.1365-2958.2002.02785.x; Chen HW, 1997, J BIOL CHEM, V272, P10072; Chen HW, 1998, J MOL BIOL, V278, P89, DOI 10.1006/jmbi.1998.1694; Cox MM, 2007, CRIT REV BIOCHEM MOL, V42, P41, DOI 10.1080/10409230701260258; Curti E, 2007, J BACTERIOL, V189, P1542, DOI 10.1128/JB.01421-06; Dillingham MS, 2008, MICROBIOL MOL BIOL R, V72, P642, DOI 10.1128/MMBR.00020-08; Dillingham MS, 2003, NATURE, V423, P893, DOI 10.1038/nature01673; Dos Vultos T, 2009, FEMS MICROBIOL REV, V33, P471, DOI 10.1111/j.1574-6976.2009.00170.x; Drees JC, 2004, MOL CELL, V15, P789, DOI 10.1016/j.molcel.2004.08.026; EDSTROM RD, 1990, BIOPHYS J, V58, P1437, DOI 10.1016/S0006-3495(90)82489-9; Fagerburg MV, 2012, NUCLEIC ACIDS RES, V40, P8416, DOI 10.1093/nar/gks641; Ganesh N, 2003, PROTEINS, V53, P6, DOI 10.1002/prot.10433; Gilhooly Neville Surain, 2013, Front Biosci (Schol Ed), V5, P206; Guhan N, 2003, NUCLEIC ACIDS RES, V31, P4184, DOI 10.1093/nar/gkg475; Gupta R, 2011, MOL MICROBIOL, V79, P316, DOI 10.1111/j.1365-2958.2010.07463.x; HABEEB AFS, 1968, ARCH BIOCHEM BIOPHYS, V126, P16, DOI 10.1016/0003-9861(68)90554-7; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; HOWARDFLANDERS P, 1966, GENETICS, V53, P1137; JULIN DA, 1987, J BIOL CHEM, V262, P9044; Khan K, 2010, PROTEIN EXPRES PURIF, V72, P42, DOI 10.1016/j.pep.2010.03.016; Kironmai KM, 1998, MOL CELL BIOL, V18, P1424, DOI 10.1128/MCB.18.3.1424; Kooistra J, 1997, MOL MICROBIOL, V23, P137, DOI 10.1046/j.1365-2958.1997.1991570.x; KORANGY F, 1992, J BIOL CHEM, V267, P1733; Kumar RA, 1996, BIOCHEMISTRY-US, V35, P1793, DOI 10.1021/bi9517751; Kuzminov A, 1999, MICROBIOL MOL BIOL R, V63, P751, DOI 10.1128/MMBR.63.4.751-813.1999; Li F, 2008, MUTAT RES-FUND MOL M, V637, P101, DOI 10.1016/j.mrfmmm.2007.07.008; LOVETT ST, 1988, GENETICS, V120, P37; Maluf NK, 2003, J BIOL CHEM, V278, P31930, DOI 10.1074/jbc.M304223200; Maluf NK, 2003, J MOL BIOL, V325, P913, DOI 10.1016/S0022-2836(02)01277-9; MASTERSON C, 1992, J BIOL CHEM, V267, P13564; MENDONCA VM, 1993, J BACTERIOL, V175, P4641, DOI 10.1128/JB.175.15.4641-4651.1993; Mizrahi V, 1998, MOL MICROBIOL, V29, P1331, DOI 10.1046/j.1365-2958.1998.01038.x; Morris PD, 2001, J BIOL CHEM, V276, P19691, DOI 10.1074/jbc.M010928200; Muniyappa K, 2000, MICROBIOL-UK, V146, P2093, DOI 10.1099/00221287-146-9-2093; Nanduri B, 2002, P NATL ACAD SCI USA, V99, P14722, DOI 10.1073/pnas.232401899; PALAS KM, 1990, J BIOL CHEM, V265, P3447; Patel SS, 2006, J BIOL CHEM, V281, P18265, DOI 10.1074/jbc.R600008200; Patel SS, 2000, ANNU REV BIOCHEM, V69, P651, DOI 10.1146/annurev.biochem.69.1.651; Pitcher RS, 2007, ANNU REV MICROBIOL, V61, P259, DOI 10.1146/annurev.micro.61.080706.093354; Quiberoni A, 2001, J BACTERIOL, V183, P4071, DOI 10.1128/JB.183.13.4071-4078.2001; Reddy MS, 2001, J BIOL CHEM, V276, P45959, DOI 10.1074/jbc.M103523200; Rocha EPC, 2005, PLOS GENET, V1, P247, DOI 10.1371/journal.pgen.0010015; RUNYON GT, 1993, BIOCHEMISTRY-US, V32, P602, DOI 10.1021/bi00053a028; Saikrishnan K, 2008, EMBO J, V27, P2222, DOI 10.1038/emboj.2008.144; Saikrishnan K, 2009, CELL, V137, P849, DOI 10.1016/j.cell.2009.03.036; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Satapathy AK, 2008, FEBS J, V275, P1835, DOI 10.1111/j.1742-4658.2008.06342.x; Shadrick WR, 2010, J BIOL CHEM, V285, P17292, DOI 10.1074/jbc.M110.111427; Sikora B, 2006, J BIOL CHEM, V281, P36110, DOI 10.1074/jbc.M604412200; Singh P, 2010, BIOCHEMISTRY-US, V49, P4872, DOI 10.1021/bi902021d; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Sinha KM, 2009, GENE DEV, V23, P1423, DOI 10.1101/gad.1805709; SMITH GR, 1995, PHILOS T ROY SOC B, V347, P13, DOI 10.1098/rstb.1995.0003; Spies M, 2006, MOL CELL, V21, P573, DOI 10.1016/j.molcel.2006.01.007; Stephanou NC, 2007, J BACTERIOL, V189, P5237, DOI 10.1128/JB.00332-07; Stohl EA, 2003, J BIOL CHEM, V278, P2278, DOI 10.1074/jbc.M210496200; STORY RM, 1992, NATURE, V355, P318, DOI 10.1038/355318a0; Symington LS, 2011, ANNU REV GENET, V45, P247, DOI 10.1146/annurev-genet-110410-132435; Unciuleac MC, 2010, J BIOL CHEM, V285, P34319, DOI 10.1074/jbc.M110.162925; Unciuleac MC, 2010, J BIOL CHEM, V285, P2632, DOI 10.1074/jbc.M109.076133; Veaute X, 2005, EMBO J, V24, P180, DOI 10.1038/sj.emboj.7600485; Venkatesh R, 2002, P NATL ACAD SCI USA, V99, P12091, DOI 10.1073/pnas.192178999; Wang JL, 2004, J BIOL CHEM, V279, P52024, DOI 10.1074/jbc.M408645200; Warner DF, 2011, MOL MICROBIOL, V79, P283, DOI 10.1111/j.1365-2958.2010.07462.x; Yang Y, 2003, METHODS, V29, P175, DOI 10.1016/S1046-2023(02)00308-0; Yang Y, 2008, NUCLEIC ACIDS RES, V36, P1976, DOI 10.1093/nar/gkm1174	76	3	3	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2015	290	19					11948	11968		10.1074/jbc.M114.619395	http://dx.doi.org/10.1074/jbc.M114.619395			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH9XA	25802334	hybrid, Green Published			2022-12-26	WOS:000354388600013
J	Cheng, TC; Fu, BH; Wu, YQ; Long, RW; Liu, C; Xia, QY				Cheng, Tingcai; Fu, Bohua; Wu, Yuqian; Long, Renwen; Liu, Chun; Xia, Qingyou			Transcriptome Sequencing and Positive Selected Genes Analysis of Bombyx mandarina	PLOS ONE			English	Article							SILKWORM BOMBYX; MORI; GENERATION; REVEALS; GENOME; TOOL	The wild silkworm Bombyx mandarina is widely believed to be an ancestor of the domesticated silkworm, Bombyx mori. Silkworms are often used as a model for studying the mechanism of species domestication. Here, we performed transcriptome sequencing of the wild silkworm using an Illumina HiSeq2000 platform. We produced 100,004,078 high-quality reads and assembled them into 50,773 contigs with an N50 length of 1764 bp and a mean length of 941.62 bp. A total of 33,759 unigenes were identified, with 12,805 annotated in the Nr database, 8273 in the Pfam database, and 9093 in the Swiss-Prot database. Expression profile analysis found significant differential expression of 1308 unigenes between the middle silk gland (MSG) and posterior silk gland (PSG). Three sericin genes (sericin 1, sericin 2, and sericin 3) were expressed specifically in the MSG and three fibroin genes (fibroin-H, fibroin-L, and fibroin/P25) were expressed specifically in the PSG. In addition, 32,297 Single-nucleotide polymorphisms (SNPs) and 361 insertion-deletions (INDELs) were detected. Comparison with the domesticated silkworm p50/Dazao identified 5,295 orthologous genes, among which 400 might have experienced or to be experiencing positive selection by Ka/Ks analysis. These data and analyses presented here provide insights into silkworm domestication and an invaluable resource for wild silkworm genomics research.	[Cheng, Tingcai; Fu, Bohua; Wu, Yuqian; Long, Renwen; Liu, Chun; Xia, Qingyou] Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing, Peoples R China	Southwest University - China	Xia, QY (corresponding author), Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing, Peoples R China.	xiaqy@swu.edu.cn		cheng, tingcai/0000-0002-3862-0817	National Basic Research Program of China (973 program) [2012CB114600]; National High-tech R&D Program (863 program) [2011AA100306]; National Natural Science Foundation of China [31001034]; Fundamental Research Funds for the Central Universities [XDJK2013C004]	National Basic Research Program of China (973 program)(National Basic Research Program of China); National High-tech R&D Program (863 program)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by grants from the National Basic Research Program of China (973 program, 2012CB114600), the National High-tech R&D Program (863 program, 2011AA100306), the National Natural Science Foundation of China (no. 31001034), and the Fundamental Research Funds for the Central Universities (XDJK2013C004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altenhoff AM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000262; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Badouin H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068200; Elmer KR, 2010, MOL ECOL, V19, P197, DOI 10.1111/j.1365-294X.2009.04488.x; Ferreira PG, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-2-r20; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hao QN, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-525; Howell JJ, 2011, TRENDS ENDOCRIN MET, V22, P94, DOI 10.1016/j.tem.2010.12.003; Inoue S, 2000, J BIOL CHEM, V275, P40517, DOI 10.1074/jbc.M006897200; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li D, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-81; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Liu TM, 2014, PLANT MOL BIOL, V86, P85, DOI 10.1007/s11103-014-0214-9; Liu YT, 1998, J BIOL CHEM, V273, P7920, DOI 10.1074/jbc.273.14.7920; Martin JA, 2011, NAT REV GENET, V12, P671, DOI 10.1038/nrg3068; MIKLOS GLG, 1990, J NEUROGENET, V6, P133, DOI 10.3109/01677069009107106; Nakhaei P, 2009, SEMIN IMMUNOL, V21, P215, DOI 10.1016/j.smim.2009.05.001; Ozawa R, 1996, INSECT BIOCHEM MOLEC, V26, P259, DOI 10.1016/0965-1748(95)00088-7; Riesgo A, 2012, FRONT ZOOL, V9, DOI 10.1186/1742-9994-9-33; Robbins RM, 1985, HDB FIBRE SCI TECHNO, P649; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sakudoh T, 2011, GENETICS, V187, P965, DOI 10.1534/genetics.110.124982; Sandrelli F, 2007, GENET RES, V89, P73, DOI 10.1017/S0016672307008713; Siddle Kenneth, 2012, Front Endocrinol (Lausanne), V3, P34, DOI 10.3389/fendo.2012.00034; Sugiura N, 2013, GLYCOBIOLOGY, V23, P1520, DOI 10.1093/glycob/cwt082; Swanson WJ, 2004, GENETICS, V168, P1457, DOI 10.1534/genetics.104.030478; Szovenyi P, 2014, MOL ECOLOGY RESOURCE; Xia QY, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r162; Xia QY, 2009, SCIENCE, V326, P433, DOI 10.1126/science.1176620; Xia QY, 2008, INSECT BIOCHEM MOLEC, V38, P1036, DOI [10.1016/j.ibmb.2009.01.004, 10.1016/j.ibmb.2008.11.004]; Xiang H, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-646; Yang ZH, 2000, MOL BIOL EVOL, V17, P32, DOI 10.1093/oxfordjournals.molbev.a026236; Yang ZH, 2000, TRENDS ECOL EVOL, V15, P496, DOI 10.1016/S0169-5347(00)01994-7; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yu HS, 2011, MOL BIOL EVOL, V28, P1785, DOI 10.1093/molbev/msr002; Zhan S, 2011, CELL, V147, P1171, DOI 10.1016/j.cell.2011.09.052; Zhang YJ, 2014, G3-GENES GENOM GENET, V4, P851, DOI 10.1534/g3.113.009779; Zhang Zhang, 2006, Genomics Proteomics & Bioinformatics, V4, P259, DOI 10.1016/S1672-0229(07)60007-2; Zhao Q, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-251	40	29	29	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0122837	10.1371/journal.pone.0122837	http://dx.doi.org/10.1371/journal.pone.0122837			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25806526	Green Submitted, Green Published, gold			2022-12-26	WOS:000351880000227
J	Howlader, MSA; Nair, A; Gopalan, SV; Merila, J				Howlader, Mohammad Sajid Ali; Nair, Abhilash; Gopalan, Sujith V.; Merila, Juha			A New Species of Microhyla (Anura: Microhylidae) from Nilphamari, Bangladesh	PLOS ONE			English	Article							NARROW-MOUTH FROGS; WESTERN-GHATS; EVOLUTIONARY RELATIONSHIPS; CROSSING EXPERIMENTS; GENETIC-DIVERGENCE; SRI-LANKA; BIODIVERSITY; AMPHIBIA; GENUS; UNDERESTIMATION	A new species of Microhyla frog from the Nilphamari district of Bangladesh is described and compared with its morphologically similar and geographically proximate congeners. Molecular phylogeny derived from mitochondrial DNA sequences revealed that although the new species - designated here as Microhyla nilphamariensis sp. nov. - forms a clade with M. ornate, it is highly divergent from M. ornata and all of its congeners, with 5.7 - 13.2% sequence divergence at the 16S rRNA gene. The new species can be identified phenotypically on the basis of a set of diagnostic (both qualitative and quantitative) characters as follows: head length is 77% of head width, distance from front of eyes to the nostril is roughly six times greater than nostril-snout length, internarial distance is roughly five times greater than nostril-snout length, interorbital distance is two times greater than internarial distance, and distance from back of mandible to back of the eye is 15% of head length. Furthermore, inner metacarpal tubercle is small and ovoid-shaped, whereas outer metacarpal tubercle is very small and rounded. Toes have rudimentary webbing, digital discs are absent, inner metatarsal tubercle is small and round, outer metatarsal tubercle is ovoid-shaped, minute, and indistinct.	[Howlader, Mohammad Sajid Ali; Nair, Abhilash; Merila, Juha] Univ Helsinki, Dept Biosci, Ecol Genet Res Unit, Helsinki, Finland; [Gopalan, Sujith V.] Rajiv Gandhi Ctr Biotechnol, Mol Ecol Lab, Thiruvananthapuram, Kerala, India	University of Helsinki; Department of Biotechnology (DBT) India; Rajiv Gandhi Centre for Biotechnology (RGCB)	Howlader, MSA (corresponding author), Univ Helsinki, Dept Biosci, Ecol Genet Res Unit, Helsinki, Finland.	sajidpabc@gmail.com	Merila, Juha/A-4061-2008; Nair, Abhilash/AAE-4011-2019	Merila, Juha/0000-0001-9614-0072; Nair, Abhilash/0000-0003-3487-1114; Howlader, Mohammad Sajid Ali/0000-0002-4941-6125	Center for International Mobility (CIMO; Finland); Finnish Cultural Foundation	Center for International Mobility (CIMO; Finland); Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science)	This work was funded by Center for International Mobility (CIMO; Finland) and Finnish Cultural Foundation (https://www.skr.fi/en/finnish-cultural-foundation). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam M, 2003, SEDIMENT GEOL, V155, P179, DOI 10.1016/S0037-0738(02)00180-X; Alam MS, 2008, MOL PHYLOGENET EVOL, V48, P515, DOI 10.1016/j.ympev.2008.04.020; Andersson L. G., 1942, Arkiv for Zoologi Stockholm, V34A, P1; Asmat G.M.S., 2003, U J ZOOL RAJSHAHI U, V22, P141; Bain RH, 2004, COPEIA, P507; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Biju S.D., 2014, Ceylon Journal of Science Biological Sciences, V43, P37; Biju S.D., 2011, Zootaxa, V3029, P1; Biju SD, 2009, ZOOL J LINN SOC-LOND, V155, P374, DOI 10.1111/j.1096-3642.2008.00466.x; Biju S. D., 2001, OCCAS PUBL INDIAN SO, V1, P1; Blyth E, 1856, J ASIATIC SOC BENGAL, V24, P711; Bossuyt F, 2000, P NATL ACAD SCI USA, V97, P6585, DOI 10.1073/pnas.97.12.6585; Bossuyt F, 2004, SCIENCE, V306, P479, DOI 10.1126/science.1100167; Boulenger G. A., 1897, Annals of Natural History (Ser 6), Vxix, P106; Boulenger G. A., 1900, ANN MAG NAT HIST, V6, P186, DOI [DOI 10.1080/00222930008678356, DOI 10.1111/j.1469-8137.2009.03166.x]; Boulenger GA, 1884, ANN MAGAZINE NATURAL, V13, P396, DOI [10.1080/00222938409459259, DOI 10.1080/00222938409459259]; Das Indraneil, 2007, Hamadryad, V31, P304; De Silva A, 2009, AMPHIBIANS SRI LANKA; Drummond AJ, GENEIOUS V5 0 4; Dumeril AMC, 1841, ERPETOLOGIE GEN HIST, V8, P745; Dutta S.K., 2000, Hamadryad, V25, P38; Dutta SK, 1996, AMPHIBIAN FAUNA SRI; EMERSON SB, 1986, AM NAT, V127, P167, DOI 10.1086/284476; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fernando Prithiviraj, 1996, Journal of South Asian Natural History, V2, P135; Fouquet A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001109; Frost DR, AMPHIBIAN SPECEIS WO; Glaw F, 2007, FIELD GUIDE AMPHIBIA; Guibe J, 1950, CATALOGUE TYPES DAMP; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hallowell E., 1861, P ACAD NAT SCI PHILA, V12, P480; Hasan M, 2014, TURK J ZOOL, V38, P389, DOI 10.3906/zoo-1308-36; Hasan M, 2014, ZOOTAXA, V 3755, P401, DOI 10.11646/zootaxa.3755.5.1; Hasan M, 2012, ZOOL SCI, V29, P162, DOI 10.2108/zsj.29.162; Holman J.A., 2003, FOSSIL FROGS TOADS N, DOI DOI 10.1111/nph.13920; HU SHU-CH'IN, 1966, ACTA ZOOL SINICA, V18, P57; Inger R.F., 1979, Sarawak Museum Journal, V27, P311; Inger R.F., 1989, MALAY NAT J, V42, P229, DOI DOI 10.1016/j.ympev.2009.06.023; Islam MM, 2008, ZOOL SCI, V25, P1084, DOI 10.2108/zsj.25.1084; IUCN, IUCN RED LIST THREAT; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Jerdon T.C., 1853, J ASIATIC SOC BENGAL, V22, P522; Kuramoto Mitsuru, 2006, Current Herpetology, V25, P15, DOI 10.3105/1345-5834(2006)25[15:MAACOM]2.0.CO;2; Mathew R, 2010, PICTORIAL GUIDE AMPH; Matsui M, 2005, ZOOL SCI, V22, P489, DOI 10.2108/zsj.22.489; Matsui M, 2013, ZOOTAXA, V3670, P579, DOI 10.11646/zootaxa.3670.4.9; Matsui Masafumi, 2011, Zootaxa, V2814, P33; Meegaskumbura M, 2002, SCIENCE, V298, P379, DOI 10.1126/science.298.5592.379; Nair A, 2012, ANIM CONSERV, V15, P489, DOI 10.1111/j.1469-1795.2012.00539.x; Parker H., 1948, J NAT HIST, V1, P759, DOI [10.1080/00222934808653944, DOI 10.1080/00222934808653944]; Parker HW, 1928, J NATURAL HIST, V2, P473, DOI [10.1080/00222932808672911, DOI 10.1080/00222932808672911]; Parker HW, 1934, MONOGRAPH FROGS FAMI; PILLAI RS, 1977, P INDIAN ACAD SCI B, V86, P135; Poyarkov NA, 2014, RUSS J HERPETOL, V21, P89; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sanchiz B., 1998, ENCY PALEOHERPETOL 4; Schenkel E., 1901, Verhandlungen Ges Basel, Vxiii, P142; Smith M. A., 1923, Journal of the Natural History Society of Siam, V6, P47; Sumida M, 2002, MOL PHYLOGENET EVOL, V25, P293, DOI 10.1016/S1055-7903(02)00243-9; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tarkhnishvili David N., 1994, Journal of Bengal Natural History Society, V13, P3; TAYLOR EDWARD H., 1934, PROC ACAD NAT SCI PHILADELPHIA, V86, P281; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tschudi J.J., 1838, CLASSIFICATION BATRA; Vieites DR, 2009, P NATL ACAD SCI USA, V106, P8267, DOI 10.1073/pnas.0810821106; Vogt Theodor, 1911, Sitzungsberichte der Gesellschaft Naturforschender Freunde zu Berlin, V1911; WHEELER WC, 1990, CLADISTICS, V6, P363, DOI 10.1111/j.1096-0031.1990.tb00550.x	67	36	38	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0119825	10.1371/journal.pone.0119825	http://dx.doi.org/10.1371/journal.pone.0119825			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25806804	Green Submitted, Green Published, gold			2022-12-26	WOS:000351880000044
J	Czajkowski, R; Ozymko, Z; de Jager, V; Siwinska, J; Smolarska, A; Ossowicki, A; Narajczyk, M; Lojkowska, E				Czajkowski, Robert; Ozymko, Zofia; de Jager, Victor; Siwinska, Joanna; Smolarska, Anna; Ossowicki, Adam; Narajczyk, Magdalena; Lojkowska, Ewa			Genomic, Proteomic and Morphological Characterization of Two Novel Broad Host Lytic Bacteriophages Phi PD10.3 and Phi PD23.1 Infecting Pectinolytic Pectobacterium spp. and Dickeya spp.	PLOS ONE			English	Article							CAROTOVORA SUBSP CAROTOVORA; SOFT-ROT DISEASE; ERWINIA-CAROTOVORA; SP-NOV.; POTATO; STRAINS; WASABIAE; BLACKLEG; PATHOGENICITY; SPECIFICITY	Pectinolytic Pectobacterium spp. and Dickeya spp. are necrotrophic bacterial pathogens of many important crops, including potato, worldwide. This study reports on the isolation and characterization of broad host lytic bacteriophages able to infect the dominant Pectobacterium spp. and Dickeya spp. affecting potato in Europe viz. Pectobacterium carotovorum subsp. carotovorum (Pcc), P. wasabiae (Pwa) and Dickeya solani (Dso) with the objective to assess their potential as biological disease control agents. Two lytic bacteriophages infecting stains of Pcc, Pwa and Dso were isolated from potato samples collected from two potato fields in central Poland. The phi PD10.3 and phi PD23.1 phages have morphology similar to other members of the Myoviridae family and the Caudovirales order, with a head diameter of 85 and 86 nm and length of tails of 117 and 121 nm, respectively. They were characterized for optimal multiplicity of infection, the rate of adsorption to the Pcc, Pwa and Dso cells, the latent period and the burst size. The phages were genotypically characterized with RAPD-PCR and RFLP techniques. The structural proteomes of both phages were obtained by fractionation of phage proteins by SDS-PAGE. Phage protein identification was performed by liquid chromatography-mass spectrometry (LC-MS) analysis. Pulsed-field gel electrophoresis (PFGE), genome sequencing and comparative genome analysis were used to gain knowledge of the length, organization and function of the FPD10.3 and phi PD23.1 genomes. The potential use of FPD10.3 and phi PD23.1 phages for the biocontrol of Pectobacterium spp. and Dickeya spp. infections in potato is discussed.	[Czajkowski, Robert; Ozymko, Zofia; Siwinska, Joanna; Smolarska, Anna; Lojkowska, Ewa] Univ Gdansk, Dept Biotechnol, Intercollegiate Fac Biotechnol, Lab Plant Protect & Biotechnol, PL-80952 Gdansk, Poland; [Czajkowski, Robert; Ozymko, Zofia; Siwinska, Joanna; Smolarska, Anna; Ossowicki, Adam; Lojkowska, Ewa] Med Univ Gdansk, Gdansk, Poland; [de Jager, Victor] Netherlands Inst Ecol NIOO KNAW, Wageningen, Netherlands; [Smolarska, Anna] Univ Gdansk, Intercollegiate Fac Biotechnol, Dept Biotechnol, Lab Biol Plant Protect, PL-80952 Gdansk, Poland; [Narajczyk, Magdalena] Univ Gdansk, Fac Biol, Lab Elect Microscopy, PL-80952 Gdansk, Poland	Fahrenheit Universities; University of Gdansk; Fahrenheit Universities; Medical University Gdansk; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Fahrenheit Universities; University of Gdansk; Fahrenheit Universities; University of Gdansk	Czajkowski, R (corresponding author), Univ Gdansk, Dept Biotechnol, Intercollegiate Fac Biotechnol, Lab Plant Protect & Biotechnol, PL-80952 Gdansk, Poland.	Robert.Czajkowski@biotech.ug.edu.pl	Czajkowski, Robert/B-2925-2012; de Jager, Victor/ABC-4002-2020; Lojkowska, Ewa/S-3402-2019; Ossowicki, Adam/B-6787-2018; Czajkowski, Robert/M-4612-2014; Narajczyk, Magdalena/ABF-6597-2021; Lojkowska, Ewa/F-5408-2011; KNAW, NIOO-KNAW/A-4320-2012	Czajkowski, Robert/0000-0001-9641-5603; Lojkowska, Ewa/0000-0001-8640-2307; Ossowicki, Adam/0000-0003-1903-9688; Czajkowski, Robert/0000-0001-9641-5603; Narajczyk, Magdalena/0000-0001-9806-8844; KNAW, NIOO-KNAW/0000-0002-3835-159X; Smolarska, Anna/0000-0001-6995-6316	National Science Centre, Poland (Narodowe Centrum Nauki, Polska) [DEC-2012/04/S/NZ9/00018]; European Commission from the FP7 project MOBI4Health [GA 316094]	National Science Centre, Poland (Narodowe Centrum Nauki, Polska); European Commission from the FP7 project MOBI4Health	National Science Centre, Poland (Narodowe Centrum Nauki, Polska) via a postdoctoral research grant (DEC-2012/04/S/NZ9/00018) to Robert Czajkowski. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Open access publication supported by the European Commission from the FP7 project MOBI4Health, GA 316094.	Ackermann HW, 2007, ARCH VIROL, V152, P227, DOI 10.1007/s00705-006-0849-1; Ackermann HW, 1999, ADV VIRUS RES, V51, P135; Ackermann HW, 2003, RES MICROBIOL, V154, P245, DOI 10.1016/S0923-2508(03)00067-6; Adriaenssens EM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033227; Bell KS, 2004, P NATL ACAD SCI USA, V101, P11105, DOI 10.1073/pnas.0402424101; BERTANI G, 1951, J BACTERIOL, V62, P293, DOI 10.1128/JB.62.3.293-300.1951; Blom J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-154; Chan BK, 2013, FUTURE MICROBIOL, V8, P769, DOI [10.2217/FMB.13.47, 10.2217/fmb.13.47]; Clokie MRJ., 2009, BACTERIOPHAGES METHO, DOI 10.1007/978-1-60327-164-6; Comeau AM, 2004, J VIROL METHODS, V118, P95, DOI 10.1016/j.jviromet.2004.01.020; Czajkowski R, 2014, PLANT PATHOL, V63, P758, DOI 10.1111/ppa.12157; Czajkowski R, 2013, PLANT PATHOL, V62, P597, DOI 10.1111/j.1365-3059.2012.02664.x; Czajkowski R, 2011, PLANT PATHOL, V60, P999, DOI 10.1111/j.1365-3059.2011.02470.x; Czajkowski R, 2014, ARCH VIROL, V159, P3153, DOI 10.1007/s00705-014-2170-8; Czajkowski R, 2009, EUR J PLANT PATHOL, V125, P263, DOI 10.1007/s10658-009-9480-9; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; De Boer SH, 2012, PHYTOPATHOLOGY, V102, P937, DOI 10.1094/PHYTO-04-12-0083-R; Degefu Y, 2013, ANN APPL BIOL, V162, P231, DOI 10.1111/aab.12020; Degefu Y, 2009, J PHYTOPATHOL, V157, P370, DOI 10.1111/j.1439-0434.2008.01504.x; Duarte V, 2004, J APPL MICROBIOL, V96, P535, DOI 10.1111/j.1365-2672.2004.02173.x; EAYRE CG, 1995, PLANT DIS, V79, P801, DOI 10.1094/PD-79-0801; Ellis EL, 1939, J GEN PHYSIOL, V22, P365, DOI 10.1085/jgp.22.3.365; Frampton R. A., 2012, INT J MICROBIOL, V2012, DOI [10.1155/2012/326452, DOI 10.1155/2012/326452]; Gagic K, 2011, J PLANT PATHOL, V93, P415; Garcia P, 2008, LETT APPL MICROBIOL, V47, P479, DOI 10.1111/j.1472-765X.2008.02458.x; Gardan L, 2003, INT J SYST EVOL MICR, V53, P381, DOI 10.1099/ijs.0.02423-0; Garlant L, 2014, P 3 INT ERW WORKSH J; Gill JJ, 2003, APPL ENVIRON MICROB, V69, P2133, DOI 10.1128/AEM.69.4.2133-2138.2003; Glasner JD, 2008, MOL PLANT MICROBE IN, V21, P1549, DOI 10.1094/MPMI-21-12-1549; GOTO M, 1987, INT J SYST BACTERIOL, V37, P130, DOI 10.1099/00207713-37-2-130; GROSS DC, 1991, PHYTOPATHOLOGY, V81, P220, DOI 10.1094/Phyto-81-220; Hunter SB, 2005, J CLIN MICROBIOL, V43, P1045, DOI 10.1128/JCM.43.3.1045-1050.2005; JANSE JD, 1988, PHYTOPATHOLOGY, V78, P800, DOI 10.1094/Phyto-78-800; Jiang SC, 1998, APPL ENVIRON MICROB, V64, P535; Jones JB, 2007, ANNU REV PHYTOPATHOL, V45, P245, DOI 10.1146/annurev.phyto.45.062806.094411; Jones Jeffrey B, 2012, Bacteriophage, V2, P208, DOI 10.4161/bact.23857; Kawabata T, 2000, GENE, V259, P223, DOI 10.1016/S0378-1119(00)00442-X; Koskella B, 2013, VIRUSES-BASEL, V5, P806, DOI 10.3390/v5030806; Kumaragurubaran Karthik, 2014, Advances in Animal and Veterinary Sciences, V2, P1, DOI 10.14737/journal.aavs/2014/2.3s.1.7; Kurowski MA, 2003, NUCLEIC ACIDS RES, V31, P3305, DOI 10.1093/nar/gkg557; Leite L. N., 2014, New Disease Reports, V29, P24, DOI 10.5197/j.2044-0588.2014.029.024; Lingohr Erika, 2009, V502, P19, DOI 10.1007/978-1-60327-565-1_3; Ma B, 2007, PHYTOPATHOLOGY, V97, P1150, DOI 10.1094/PHYTO-97-9-1150; Mansfield J, 2012, MOL PLANT PATHOL, V13, P614, DOI 10.1111/j.1364-3703.2012.00804.x; McNair K, 2012, BIOINFORMATICS, V28, P614, DOI 10.1093/bioinformatics/bts014; Nabhan S, 2012, J APPL MICROBIOL, V113, P904, DOI 10.1111/j.1365-2672.2012.05383.x; Nykyri J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003013; Perombelon M. C. M., 2000, Bulletin OEPP, V30, P413, DOI 10.1111/j.1365-2338.2000.tb00921.x; PEROMBELON MCM, 1980, ANNU REV PHYTOPATHOL, V18, P361, DOI 10.1146/annurev.py.18.090180.002045; Perombelon MCM, 2002, PLANT PATHOL, V51, P1, DOI 10.1046/j.0032-0862.2001.Short title.doc.x; Perombelon MCM, 1982, PHYTOPATHOGENIC PROK, V2, P55; Perombelon MCM, 1995, PATHOGENESIS HOST SP, P1; Petrov VM, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-292; PIRHONEN M, 1991, MOL PLANT MICROBE IN, V4, P276, DOI 10.1094/MPMI-4-276; Pitman AR, 2008, AUSTRALAS PLANT PATH, V37, P559, DOI 10.1071/AP08056; Pitman AR, 2010, EUR J PLANT PATHOL, V126, P423, DOI 10.1007/s10658-009-9551-y; Prins H, 2008, PUREE GEVOLGEN AANTA; Ravensdale M, 2007, CAN J PLANT PATHOL, V29, P121, DOI 10.1080/07060660709507448; Samson R, 2005, INT J SYST EVOL MICR, V55, P1415, DOI 10.1099/ijs.0.02791-0; Slawiak M, 2009, EUR J PLANT PATHOL, V125, P245, DOI 10.1007/s10658-009-9479-2; SMITH C, 1990, PLANT DIS, V74, P505, DOI 10.1094/PD-74-0505; Thiel K, 2004, NAT BIOTECHNOL, V22, P31, DOI 10.1038/nbt0104-31; Toth IK, 2011, PLANT PATHOL, V60, P385, DOI 10.1111/j.1365-3059.2011.02427.x; van der Merwe JJ, 2010, EUR J PLANT PATHOL, V126, P175, DOI 10.1007/s10658-009-9531-2; van der Wolf JM, 2014, INT J SYST EVOL MICR, V64, P768, DOI 10.1099/ijs.0.052944-0; Van Twest Rohan, 2009, V501, P15, DOI 10.1007/978-1-60327-164-6_2; Waleron M, 2013, EUR J PLANT PATHOL, V137, P149, DOI 10.1007/s10658-013-0227-2; WILLIS JW, 1987, PHYTOPATHOLOGY, V77, P1199, DOI 10.1094/Phyto-77-1199	68	55	58	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0119812	10.1371/journal.pone.0119812	http://dx.doi.org/10.1371/journal.pone.0119812			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803051	Green Published, gold, Green Submitted			2022-12-26	WOS:000353889600048
J	Gaddipati, S; Lu, QX; Kasetti, RB; Miller, MC; Lu, QJ; Trent, JO; Kaplan, HJ; Li, QT				Gaddipati, Subhash; Lu, Qingxian; Kasetti, Ramesh Babu; Miller, M. Clarke; Lu, Qingjun; Trent, John O.; Kaplan, Henry J.; Li, Qiutang			IKK2 Inhibition Using TPCA-1-Loaded PLGA Microparticles Attenuates Laser-Induced Choroidal Neovascularization and Macrophage Recruitment	PLOS ONE			English	Article							NF-KAPPA-B; MACULAR DEGENERATION; BETA; MICROSPHERES; INFLAMMATION; CELLS; MODEL; MICE; RANIBIZUMAB; RETINOPATHY	The inhibition of NF-kappa B by genetic deletion or pharmacological inhibition of IKK2 significantly reduces laser-induced choroid neovascularization (CNV). To achieve a sustained and controlled intraocular release of a selective and potent IKK2 inhibitor, 2-[(aminocarbonyl) amino]-5-(4-fluorophenyl)-3-thiophenecarboxamide (TPCA-1) (MW: 279.29), we developed a biodegradable poly-lactide-co-glycolide (PLGA) polymer-delivery system to further investigate the anti-neovascularization effects of IKK2 inhibition and in vivo biosafety using laser-induced CNV mouse model. The solvent-evaporation method produced spherical TPCA-1-loaded PLGA microparticles characterized with a mean diameter of 2.4 1/4m and loading efficiency of 80%. Retrobulbar administration of the TPCA-1-loaded PLGA microparticles maintained a sustained drug level in the retina during the study period. No detectable TPCA-1 level was observed in the untreated contralateral eye. The anti-CNV effect of retro-bulbarly administrated TPCA-1-loaded PLGA microparticles was assessed by retinal fluorescein leakage and isolectin staining methods, showing significantly reduced CNV development on day 7 after laser injury. Macrophage infiltration into the laser lesion was attenuated as assayed by choroid/RPE flat-mount staining with anti-F4/80 antibody. Consistently, laser induced expressions of Vegfa and Ccl2 were inhibited by the TPCA-1-loaded PLGA treatment. This TPCA-1 delivery system did not cause any noticeable cellular or functional toxicity to the treated eyes as evaluated by histology and optokinetic reflex (OKR) tests; and no systemic toxicity was observed. We conclude that retrobulbar injection of the small-molecule IKK2 inhibitor TPCA-1, delivered by biodegradable PLGA microparticles, can achieve a sustained and controllable drug release into choroid/retina and attenuate laser-induced CNV development without causing apparent systemic toxicity. Our results suggest a potential clinical application of TPCA-1 delivered by microparticles in treatment of CNV in the patients with age-related macular degeneration and other retinal neovascularization diseases.	[Gaddipati, Subhash; Lu, Qingxian; Kasetti, Ramesh Babu; Kaplan, Henry J.; Li, Qiutang] Univ Louisville, Sch Med, Dept Ophthalmol, Louisville, KY 40292 USA; [Gaddipati, Subhash; Lu, Qingxian; Kasetti, Ramesh Babu; Kaplan, Henry J.; Li, Qiutang] Univ Louisville, Sch Med, Dept Visual Sci, Louisville, KY 40292 USA; [Gaddipati, Subhash; Lu, Qingxian; Miller, M. Clarke; Trent, John O.; Li, Qiutang] Univ Louisville, Sch Med, James Graham Brown Canc Ctr, Louisville, KY 40292 USA; [Miller, M. Clarke] Univ North Georgia, Dept Chem & Biochem, Oakwood, GA USA; [Lu, Qingjun] Capital Med Univ, Beijing Tong Ren Eye Ctr, Beijing Inst Ophthalmol, Beijing, Peoples R China; [Trent, John O.] Univ Louisville, Sch Med, Dept Med, Louisville, KY 40292 USA	University of Louisville; University of Louisville; University of Louisville; University of North Georgia; Capital Medical University; University of Louisville	Li, QT (corresponding author), Univ Louisville, Sch Med, Dept Ophthalmol, Louisville, KY 40292 USA.	q.li@louisville.edu	Miller, M. Clarke/C-9483-2011; Kasetti, Ramesh Babu/H-5157-2019	Miller, M. Clarke/0000-0002-9877-6581; trent, John/0000-0002-7346-4231; KASETTI, RAMESH/0000-0001-7874-3988; Gaddipati, Subhash/0000-0002-5323-5466	National Eye Institute [R01-EY019891, EY021548]; National Institute of General Medical Sciences [1P30GM106396]; Research to Prevent Blindness Ernest & Elizabeth Althouse Special Scholar Award; NATIONAL EYE INSTITUTE [R01EY019891] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM106396] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Research to Prevent Blindness Ernest & Elizabeth Althouse Special Scholar Award; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Eye Institute grants R01-EY019891 and EY021548, National Institute of General Medical Sciences grant 1P30GM106396, and a Research to Prevent Blindness Ernest & Elizabeth Althouse Special Scholar Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambati J, 2003, NAT MED, V9, P1390, DOI 10.1038/nm950; Arkan MC, 2011, CURR TOP MICROBIOL, V349, P159, DOI 10.1007/82_2010_97; Birch DG, 2007, INT J NANOMED, V2, P65, DOI 10.2147/nano.2007.2.1.65; BODMEIER R, 1987, PHARMACEUT RES, V4, P465, DOI 10.1023/A:1016419303727; Brown DM, 2006, NEW ENGL J MED, V355, P1432, DOI 10.1056/NEJMoa062655; Chaisri Wasana, 2009, Current Drug Delivery, V6, P69; Connor KM, 2009, NAT PROTOC, V4, P1565, DOI 10.1038/nprot.2009.187; Cursiefen C, 2004, J CLIN INVEST, V113, P1040, DOI 10.1172/JCI200420465; Danhier F., 2012, J CONTROLLED RELEASE; Espinosa-Heidmann DG, 2003, INVEST OPHTH VIS SCI, V44, P3586, DOI 10.1167/iovs.03-0038; Gragoudas ES, 2004, NEW ENGL J MED, V351, P2805, DOI 10.1056/NEJMoa042760; Greten FR, 2007, CELL, V130, P918, DOI 10.1016/j.cell.2007.07.009; Grossmann M, 1999, P NATL ACAD SCI USA, V96, P11848, DOI 10.1073/pnas.96.21.11848; Gupta SC, 2010, BBA-GENE REGUL MECH, V1799, P775, DOI 10.1016/j.bbagrm.2010.05.004; HACKER H, 2006, SCI STKE, V357, pRE13, DOI DOI 10.1126/STKE.3572006RE13; IWATA M, 1992, J MICROENCAPSUL, V9, P201; Joussen AM, 2004, FASEB J, V18, P1450, DOI 10.1096/fj.03-1476fje; Karin M, 2004, NAT REV DRUG DISCOV, V3, P17, DOI 10.1038/nrd1279; Kohane DS, 2007, BIOTECHNOL BIOENG, V96, P203, DOI 10.1002/bit.21301; Kompella UB, 2003, INVEST OPHTH VIS SCI, V44, P1192, DOI 10.1167/iovs.02-0791; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Li QT, 1999, SCIENCE, V284, P321, DOI 10.1126/science.284.5412.321; Li QT, 2005, TRENDS IMMUNOL, V26, P318, DOI 10.1016/j.it.2005.04.003; Lu HY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087530; Mankan AK, 2011, P NATL ACAD SCI USA, V108, P6567, DOI 10.1073/pnas.1018331108; Marumo T, 1999, DIABETES, V48, P1131, DOI 10.2337/diabetes.48.5.1131; Moshfeghi AA, 2005, ADV DRUG DELIVER REV, V57, P2047, DOI 10.1016/j.addr.2005.09.006; Nagashima K, 2006, BLOOD, V107, P4266, DOI 10.1182/blood-2005-09-3852; Podolin PL, 2005, J PHARMACOL EXP THER, V312, P373, DOI 10.1124/jpet.104.074484; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Rius J, 2008, NATURE, V453, P807, DOI 10.1038/nature06905; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; Senftleben U, 2001, IMMUNITY, V14, P217, DOI 10.1016/S1074-7613(01)00104-2; Shibata A, 2002, BREAST CANCER RES TR, V73, P237, DOI 10.1023/A:1015872531675; Strnad J, 2007, TRENDS PHARMACOL SCI, V28, P142, DOI 10.1016/j.tips.2007.01.005; Tobe T, 1998, AM J PATHOL, V153, P1641, DOI 10.1016/S0002-9440(10)65753-7; Wu WK, 2010, IMMUNOBIOLOGY, V215, P796, DOI 10.1016/j.imbio.2010.05.025; Wullaert A, 2011, CELL RES, V21, P146, DOI 10.1038/cr.2010.175; Ye F, 2011, J IMMUNOL, V187, P4178, DOI 10.4049/jimmunol.1101201	39	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0121185	10.1371/journal.pone.0121185	http://dx.doi.org/10.1371/journal.pone.0121185			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803615	gold, Green Published, Green Submitted			2022-12-26	WOS:000353889600135
J	Kim, M; Hwang, S; Park, K; Kim, SY; Lee, YK; Lee, DS				Kim, Miyoung; Hwang, Seungwoo; Park, Kiejung; Kim, Seon Young; Lee, Young Kyung; Lee, Dong Soon			Increased Expression of Interferon Signaling Genes in the Bone Marrow Microenvironment of Myelodysplastic Syndromes	PLOS ONE			English	Article							SEQUENCE-BINDING-PROTEIN; REGULATORY FACTOR FAMILY; MESENCHYMAL STEM-CELLS; ACUTE MYELOID-LEUKEMIA; FACTOR DEC1 STRA13; IN-VITRO; TRANSCRIPTION; MECHANISMS; MUTATIONS; PATHWAYS	Introduction The bone marrow (BM) microenvironment plays an important role in the pathogenesis of myelodysplastic syndromes (MDS) through a reciprocal interaction with resident BM hematopoietic cells. We investigated the differences between BM mesenchymal stromal cells (MSCs) in MDS and normal individuals and identified genes involved in such differences. Materials and Methods BM-derived MSCs from 7 MDS patients (3 RCMD, 3 RAEB-1, and 1 RAEB-2) and 7 controls were cultured. Global gene expression was analyzed using a microarray. Result We found 314 differentially expressed genes (DEGs) in RCMD vs. control, 68 in RAEB vs. control, and 51 in RAEB vs. RCMD. All comparisons were clearly separated from one another by hierarchical clustering. The overall similarity between differential expression signatures from the RCMD vs. control comparison and the RAEB vs. control comparison was highly significant (p = 0), which indicates a common transcriptomic response in these two MDS subtypes. RCMD and RAEB simultaneously showed an up-regulation of interferon alpha/beta signaling and the ISG15 antiviral mechanism, and a significant fraction of the RAEB vs. control DEGs were also putative targets of transcription factors IRF and ICSBP. Pathways that involved RNA polymerases I and III and mitochondrial transcription were down-regulated in RAEB compared to RCMD. Conclusion Gene expression in the MDS BM microenvironment was different from that in normal BM and exhibited altered expression according to disease progression. The present study provides genetic evidence that inflammation and immune dysregulation responses that involve the interferon signaling pathway in the BM microenvironment are associated with MDS pathogenesis, which suggests BM MSCs as a possible therapeutic target in MDS.	[Kim, Miyoung; Lee, Young Kyung] Hallym Univ, Sacred Heart Hosp, Dept Lab Med, Anyang, South Korea; [Kim, Miyoung; Kim, Seon Young; Lee, Dong Soon] Seoul Natl Univ, Coll Med, Dept Lab Med, Seoul, South Korea; [Hwang, Seungwoo; Park, Kiejung] Korea Res Inst Biosci & Biotechnol, Korean Bioinformat Ctr, Taejon, South Korea; [Lee, Young Kyung] Hallym Univ, Coll Med, Dept Lab Med, Anyang, South Korea; [Lee, Dong Soon] Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul, South Korea	Hallym University; Seoul National University (SNU); Korea Research Institute of Bioscience & Biotechnology (KRIBB); Hallym University; Seoul National University (SNU)	Lee, DS (corresponding author), Seoul Natl Univ, Coll Med, Dept Lab Med, Seoul, South Korea.	soonlee@snu.ac.kr			Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [HI12C0169]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and future Planning [NRF-2014R1A2A1A10052286]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2014R1A1A2A16049597]; SNUH Research Fund [04-20120430]; KRIBB Research Initiative Program	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and future Planning; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education; SNUH Research Fund; KRIBB Research Initiative Program	This study was supported by (1) a grant from the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (HI12C0169), (2) Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and future Planning (NRF-2014R1A2A1A10052286), and (3) Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2014R1A1A2A16049597), (4) grant no. 04-20120430 from the SNUH Research Fund. SH and KP were supported by KRIBB Research Initiative Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Wahab O, 2012, HEMATOL-AM SOC HEMAT, P56, DOI 10.1182/asheducation-2012.1.56; Aizawa S, 1999, LEUKEMIA RES, V23, P239, DOI 10.1016/S0145-2126(98)00163-5; Barrett AJ, 2009, HAEMATOL-HEMATOL J, V94, P449, DOI 10.3324/haematol.2009.006080; Bernasconi P, 2008, BRIT J HAEMATOL, V142, P695, DOI 10.1111/j.1365-2141.2008.07245.x; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Borojevic R, 2004, LEUKEMIA RES, V28, P831, DOI 10.1016/j.leukres.2003.11.019; BOVOLENTA C, 1994, P NATL ACAD SCI USA, V91, P5046, DOI 10.1073/pnas.91.11.5046; Brosseau JP, 2014, RNA, V20, P189, DOI 10.1261/rna.042168.113; Chakrabarti J, 2004, BRIT J CANCER, V91, P954, DOI 10.1038/sj.bjc.6602059; Choi H, 2006, MOL PHARMACOL, V70, P1664, DOI 10.1124/mol.106.025817; Cilloni D, 2003, J CLIN ONCOL, V21, P1988, DOI 10.1200/JCO.2003.10.503; Contursi C, 2000, P NATL ACAD SCI USA, V97, P91, DOI 10.1073/pnas.97.1.91; Croft D, 2014, NUCLEIC ACIDS RES, V42, pD472, DOI 10.1093/nar/gkt1102; D'Incalci M, 2014, BRIT J CANCER, V111, P646, DOI 10.1038/bjc.2014.149; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Duhrsen U, 1996, ANN HEMATOL, V73, P53, DOI 10.1007/s002770050203; Felli N, 2005, J IMMUNOL, V175, P1464, DOI 10.4049/jimmunol.175.3.1464; Feng XM, 2011, HAEMATOL-HEMATOL J, V96, P602, DOI 10.3324/haematol.2010.030536; Ferrer RA, 2013, HAEMATOLOGICA, V98, P1677, DOI 10.3324/haematol.2013.083972; Flores-Figueroa E, 2002, LEUKEMIA RES, V26, P677, DOI 10.1016/S0145-2126(01)00193-X; Gattermann N, 2000, LEUKEMIA RES, V24, P141, DOI 10.1016/S0145-2126(99)00160-5; Graubert T, 2011, HEMATOL-AM SOC HEMAT, P543, DOI 10.1182/asheducation-2011.1.543; Hirai H, 2003, JPN J CLIN ONCOL, V33, P153, DOI 10.1093/jjco/hyg037; Hughes M, 2004, DEV BIOL, V271, P26, DOI 10.1016/j.ydbio.2004.03.029; Ismail PM, 1999, ONCOGENE, V18, P5582, DOI 10.1038/sj.onc.1202932; Ivanov SV, 2007, ONCOGENE, V26, P802, DOI 10.1038/sj.onc.1209842; Kielbasa SM, 2010, NUCLEIC ACIDS RES, V38, pW275, DOI 10.1093/nar/gkq438; Kim M, 2010, LEUKEMIA RES, V34, P718, DOI 10.1016/j.leukres.2009.09.007; Klaus M, 2010, STEM CELLS DEV, V19, P1043, DOI 10.1089/scd.2009.0286; Langerak AW, 2012, LEUKEMIA, V26, P2159, DOI 10.1038/leu.2012.246; Le Blanc K, 2007, J INTERN MED, V262, P509, DOI 10.1111/j.1365-2796.2007.01844.x; Lottaz C, 2006, BIOINFORMATICS, V22, P2315, DOI 10.1093/bioinformatics/btl385; Misawa Shinichi, 1997, Leukemia (Basingstoke), V11, P533; NELSON N, 1993, MOL CELL BIOL, V13, P588, DOI 10.1128/MCB.13.1.588; Nishino HT, 2005, ARCH PATHOL LAB MED, V129, P1299; Ozato K, 2007, J BIOL CHEM, V282, P20065, DOI 10.1074/jbc.R700003200; Padua RA, 1998, LEUKEMIA, V12, P887, DOI 10.1038/sj.leu.2401044; Papaemmanuil E, 2013, BLOOD, V122, P3616, DOI 10.1182/blood-2013-08-518886; Pawlus MR, 2012, MOL CELL BIOL, V32, P4595, DOI 10.1128/MCB.00724-12; Pellagatti A, 2010, LEUKEMIA, V24, P756, DOI 10.1038/leu.2010.31; Qyang YB, 1999, MOL CELL BIOL, V19, P1508; Raaijmakers MHGP, 2012, INT J HEMATOL, V95, P17, DOI 10.1007/s12185-011-1001-x; Roela RA, 2007, LEUKEMIA RES, V31, P579, DOI 10.1016/j.leukres.2006.10.007; Sandberg Y, 2005, J MOL DIAGN, V7, P495, DOI 10.1016/S1525-1578(10)60580-6; Schildgen V, 2011, EXP HEMATOL, V39, P666, DOI 10.1016/j.exphem.2011.03.007; Servant Nicolas, 2010, BMC Res Notes, V3, P277, DOI 10.1186/1756-0500-3-277; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Suarez-Farinas M, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-99; Sun H, 2000, P NATL ACAD SCI USA, V97, P4058, DOI 10.1073/pnas.070526297; Swerdlow SH, 2008, WHO CLASSIFICATION T; Tauro S, 2002, LEUKEMIA, V16, P785, DOI 10.1038/sj.leu.2402440; Tauro S, 2001, HAEMATOLOGICA, V86, P1038; Tefferi A, 2009, NEW ENGL J MED, V361, P1872, DOI 10.1056/NEJMra0902908; Tlsty TD, 2006, ANNU REV PATHOL-MECH, V1, P119, DOI 10.1146/annurev.pathol.1.110304.100224; van Dongen JJM, 2003, LEUKEMIA, V17, P2257, DOI 10.1038/sj.leu.2403202; Warlick ED, 2011, LEUKEMIA LYMPHOMA, V52, P2045, DOI 10.3109/10428194.2011.584002; Warsow G, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-164; Xie C, 2011, NUCLEIC ACIDS RES, V39, pW316, DOI 10.1093/nar/gkr483; Zheng Y, 2009, OMICS, V13, P301, DOI 10.1089/omi.2009.0014	59	12	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0120602	10.1371/journal.pone.0120602	http://dx.doi.org/10.1371/journal.pone.0120602			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803272	gold, Green Published, Green Submitted			2022-12-26	WOS:000353889600084
J	Takeda, E; Kono, K; Hulme, AE; Hope, TJ; Nakayama, EE; Shioda, T				Takeda, Eri; Kono, Ken; Hulme, Amy E.; Hope, Thomas J.; Nakayama, Emi E.; Shioda, Tatsuo			Fluorescent Image Analysis of HIV-1 and HIV-2 Uncoating Kinetics in the Presence of Old World Monkey TRIM5a	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; TRIM5-ALPHA DETERMINES; CYNOMOLGUS MONKEY; NUCLEAR IMPORT; B30.2 DOMAIN; AMINO-ACID; RESTRICTION; VPR; REPLICATION; P6(GAG)	Uncoating of Human Immunodeficiency Virus type 1 (HIV-1) and type 2 (HIV-2) conical cores is an important early step for establishment of infection. In Old World Monkey (OWM) cells, the TRIM5a cellular factor potently suppresses an early step of infection by HIV-1. Previously, biochemical studies using whole cell lysates of infected cells revealed that OWM TRIM5a accelerates the uncoating of HIV-1, leading to premature reverse transcription. In the present study, we re-evaluated uncoating kinetics of HIV-1 in the presence of OWM TRIM5a by using an in situ uncoating assay, which allowed us to differentiate productive HIV-1 entry from simple (non-productive) endocytosis. Results showed that the uncoating kinetics of HIV-1 was indeed accelerated in the presence of OWM TRIM5a. Furthermore, we adapted an in situ uncoating assay to HIV-2, which showed wide variations in TRIM5a sensitivity among different isolates. HIV-2 isolate GH123, whose infectivity was suppressed by cynomolgus monkey (CM) TRIM5a, showed accelerated uncoating in the presence of CM TRIM5a. In contrast, mutant HIV-2 ASA, whose infectivity was unaltered by CM TRIM5a, showed no change in uncoating kinetics in the presence of CM TRIM5a. These results confirmed and further extended the previous notion that accelerated uncoating is associated with restriction activity of TRIM5a against lentiviruses.	[Takeda, Eri; Kono, Ken; Nakayama, Emi E.; Shioda, Tatsuo] Osaka Univ, Microbial Dis Res Inst, Dept Viral Infect, Suita, Osaka 565, Japan; [Hulme, Amy E.; Hope, Thomas J.] Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA	Osaka University; Northwestern University; Feinberg School of Medicine	Shioda, T (corresponding author), Osaka Univ, Microbial Dis Res Inst, Dept Viral Infect, Suita, Osaka 565, Japan.	shioda@biken.osaka-u.ac.jp		ying mei, zhong shan/0000-0002-0477-0980	Ministry of Health, Labour and Welfare of Japan [H24-005, H2-2003]; Ministry of Education, Culture, Sports, Science, and Technology, Japan [23590541, 23390111]; NIH [P50 GM082545, 5F32AI089359-03]; NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM082545] Funding Source: NIH RePORTER	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the Ministry of Health, Labour and Welfare of Japan (Research on HIV/AIDS project no. H24-005, H2-2003), and the Ministry of Education, Culture, Sports, Science, and Technology, Japan (23590541 to EEN, 23390111 to TS). This work also was supported by NIH grants P50 GM082545 to TJH, and 5F32AI089359-03 to AEH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accola MA, 1999, J VIROL, V73, P9992, DOI 10.1128/JVI.73.12.9992-9999.1999; Burdick RC, 2013, P NATL ACAD SCI USA, V110, pE4780, DOI 10.1073/pnas.1315996110; Campbell EM, 2007, VIROLOGY, V360, P286, DOI 10.1016/j.virol.2006.10.025; CONNOR RI, 1995, VIROLOGY, V206, P935, DOI 10.1006/viro.1995.1016; Dismuke DJ, 2006, J VIROL, V80, P3712, DOI 10.1128/JVI.80.8.3712-3720.2006; Forshey BM, 2002, J VIROL, V76, P5667, DOI 10.1128/JVI.76.11.5667-5677.2002; FREED EO, 1995, J VIROL, V69, P3949, DOI 10.1128/JVI.69.6.3949-3954.1995; Hatziioannou T, 2004, P NATL ACAD SCI USA, V101, P10774, DOI 10.1073/pnas.0402361101; Hulme AE, 2011, P NATL ACAD SCI USA, V108, P9975, DOI 10.1073/pnas.1014522108; Julias JG, 2001, J VIROL, V75, P6537, DOI 10.1128/JVI.75.14.6537-6546.2001; Kewalramani VN, 1996, VIROLOGY, V218, P159, DOI 10.1006/viro.1996.0176; Kondo E, 1996, J VIROL, V70, P159, DOI 10.1128/JVI.70.1.159-164.1996; Kono K, 2008, VIROLOGY, V373, P447, DOI 10.1016/j.virol.2007.12.022; Kono K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072531; Kutluay SB, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003214; Li Y, 2006, APPL BIOCHEM BIOTECH, V135, P181, DOI 10.1385/ABAB:135:3:181; LU YL, 1995, J VIROL, V69, P6873, DOI 10.1128/JVI.69.11.6873-6879.1995; Maegawa H, 2010, VIROLOGY, V399, P212, DOI 10.1016/j.virol.2010.01.003; Miyamoto T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047757; Nakayama EE, 2005, J VIROL, V79, P8870, DOI 10.1128/JVI.79.14.8870-8877.2005; Nakayama EE, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00013; Nisole S, 2005, NAT REV MICROBIOL, V3, P799, DOI 10.1038/nrmicro1248; Ohishi M, 2007, VIROLOGY, V362, P131, DOI 10.1016/j.virol.2006.12.030; Ohkura S, 2006, J VIROL, V80, P8554, DOI 10.1128/JVI.00688-06; Onyango CO, 2010, VACCINE, V28, pB60, DOI 10.1016/j.vaccine.2009.08.060; Song H, 2007, J VIROL, V81, P7280, DOI 10.1128/JVI.00406-07; Stremlau M, 2006, P NATL ACAD SCI USA, V103, P5514, DOI 10.1073/pnas.0509996103; Stremlau M, 2005, J VIROL, V79, P3139, DOI 10.1128/JVI.79.5.3139-3145.2005; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; Subbramanian RA, 1998, J MOL BIOL, V278, P13, DOI 10.1006/jmbi.1998.1685; Van Maele B, 2003, J VIROL, V77, P4685, DOI 10.1128/JVI.77.8.4685-4694.2003; Yamashita M, 2007, PLOS PATHOG, V3, P1502, DOI 10.1371/journal.ppat.0030156; Zhang F, 2008, NAT MED, V14, P235, DOI 10.1038/nm0308-235	33	7	7	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0121199	10.1371/journal.pone.0121199	http://dx.doi.org/10.1371/journal.pone.0121199			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803716	gold, Green Published, Green Submitted			2022-12-26	WOS:000353889600136
J	Wu, LJ; You, QS; Duan, JL; Luo, YX; Liu, LJ; Li, X; Gao, Q; Zhu, HP; He, Y; Xu, L; Jonas, JB; Wang, W; Guo, XH				Wu, Li Juan; You, Qi Sheng; Duan, Jia Li; Luo, Yan Xia; Liu, Li Juan; Li, Xia; Gao, Qi; Zhu, Hui Ping; He, Yan; Xu, Liang; Jonas, Jost B.; Wang, Wei; Guo, Xiu Hua			Prevalence and Associated Factors of Myopia in High-School Students in Beijing	PLOS ONE			English	Article							REFRACTIVE-ERROR; VISUAL IMPAIRMENT; OUTDOOR ACTIVITY; PARENTAL HISTORY; INCIDENT MYOPIA; CHILDREN; SCHOOLCHILDREN; PROGRESSION; CHILDHOOD; URBAN	Purpose To evaluate prevalence and associated factors for myopia in high school students in Beijing. Methods Grade 10 and 11 high school students were randomly selected from nine randomly selected districts of Beijing. The students underwent non-cylcoplegic auto-refractometry and an interview. Results Out of 4798 eligible students, 4677 (93.4%) students (mean age: 16.9 +/- 0.7 years; range: 1618 years) participated. Mean refractive error of right eyes and left eyes was -2.78 +/- 2.29 diopters and -2.59 +/- 2.50 diopters, respectively. Prevalence of myopia (defined as <= -1.00 diopters in the worse eye) was 80.7%(95% Confidence Interval (CI): 79.6-81.8%). Out of 3773 students with myopia, 1525 (40.4%) wore glasses daily. In multiple logistic regression analysis, a higher prevalence of myopia was associated with female sex (odds ratio (OR) = 1.31; 95% CI: 1.11-1.55), Han ethnicity (OR = 1.64;95% CI:1.28-2.11), attending key schools (OR = 1.48;95% CI:1.24,1.77), higher family income (OR = 1.37; 95% CI:1.09-1.71), longer time spent for near work (OR = 1.43;95% CI:1.06-1.93), shorter near work distance (OR = 1.87;95% CI:1.55-2.26), lower frequency of active rest during studying (OR = 1.40;95% CI:1.16-1.70), and parental myopia (OR = 2.28; 95% CI:1.80-2.87). The interaction between distance from near work and time spent for near work was statistically (P = 0.03) significant. In multiple logistic regression analysis, higher prevalence of high myopia (<= -6.0 diopters) was associated with studying in key schools (OR = 1.38;95% CI:1.05,1.81), lower frequency of active rest during studying (OR = 1.40;95% CI:1.09,1.79), and a higher number of myopic parents (OR = 2.66;95% CI:2.08,3.40). Conclusions A prevalence of about 80% for myopia and a prevalence of about 10% for high myopia in students aged 16 to 18 years and attending classes of grade 10 and 11 in a Chinese metropolitan region is another example of the high prevalence of moderate and high myopia in metropolitan areas of China. With this young myopic generation getting older, myopia as cause for visual impairment and blindness may further increase in importance. Future studies may address whether active rests during studying with looking into the distance are preventive against myopia development or progression.	[Wu, Li Juan; Luo, Yan Xia; Li, Xia; Gao, Qi; Zhu, Hui Ping; He, Yan; Wang, Wei; Guo, Xiu Hua] Capital Med Univ, Sch Publ Hlth, Beijing, Peoples R China; [Wu, Li Juan; Luo, Yan Xia; Li, Xia; Gao, Qi; Zhu, Hui Ping; He, Yan; Wang, Wei; Guo, Xiu Hua] Capital Med Univ, Beijing Key Lab Epidemiol, Beijing, Peoples R China; [You, Qi Sheng; Liu, Li Juan; Xu, Liang; Jonas, Jost B.] Capital Med Univ, Beijing Tongren Hosp, Beijing Ophthalmol & Visual Sci Key Lab, Beijing Inst Ophthalmol,Beijing Tongren Eye Ctr, Beijing, Peoples R China; [Duan, Jia Li] Beijing Ctr Dis Prevent & Control, Beijing, Peoples R China; [Jonas, Jost B.] Heidelberg Univ, Seegartenklin Heidelberg, Med Fac Mannheim, Dept Ophthalmol, D-69115 Heidelberg, Germany; [Wang, Wei] Edith Cowan Univ, Sch Med Sci, Perth, WA, Australia	Capital Medical University; Capital Medical University; Capital Medical University; Ruprecht Karls University Heidelberg; Edith Cowan University	Wang, W (corresponding author), Capital Med Univ, Sch Publ Hlth, Beijing, Peoples R China.	wei.wang@ecu.edu.au; guoxiuh@ccmu.edu.cn	You, Qisheng/AAG-7153-2020; liu, li/HGC-0900-2022; Gao, Qi/N-8721-2019	You, Qisheng/0000-0003-0743-7320; wang, wei/0000-0002-1430-1360; Gao, Qi/0000-0002-5370-5536	Authorized Project from Beijing Municipal Commission of Education, and National 12th Five-Year Major Projects of China [2012BAI37B03]; Beijing Natural Science Foundation [7131002]; National Natural Science Foundation of China [81400422]; Mason Foundation National Medical Program, ANZ, Australia, Commonwealth of Australia [ACSRF06444]; European Union Foundation (EU-fp7) [Pain-Omics 602730]; Importation and Development of High-Calibre Talents Project of Beijing Municipal Institutions	Authorized Project from Beijing Municipal Commission of Education, and National 12th Five-Year Major Projects of China; Beijing Natural Science Foundation(Beijing Natural Science Foundation); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Mason Foundation National Medical Program, ANZ, Australia, Commonwealth of Australia; European Union Foundation (EU-fp7); Importation and Development of High-Calibre Talents Project of Beijing Municipal Institutions	The study was funded by the Authorized Project from Beijing Municipal Commission of Education, and National 12th Five-Year Major Projects of China (2012BAI37B03); the Beijing Natural Science Foundation (7131002); National Natural Science Foundation of China (No. 81400422); the Mason Foundation National Medical Program-2014, ANZ, Australia, Commonwealth of Australia (ACSRF06444); and the European Union Foundation (EU-fp7; Pain-Omics 602730). Professor Wei Wang is supported by the Importation and Development of High-Calibre Talents Project of Beijing Municipal Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	China Youth and Children Research Center Research Group, 2009, BI JIAO YAN JIU, V6, P62; Congdon N, 2008, INVEST OPHTH VIS SCI, V49, P2888, DOI 10.1167/iovs.07-1160; Dirani M, 2009, BRIT J OPHTHALMOL, V93, P997, DOI 10.1136/bjo.2008.150979; Fan DS, INVEST OPHTHALMOL VI, V45, P1071; Fotouhi A, 2007, BRIT J OPHTHALMOL, V91, P287, DOI 10.1136/bjo.2006.099937; French AN, 2013, OPHTHALMOLOGY, V120, P2100, DOI 10.1016/j.ophtha.2013.02.035; Funarunart Panrapee, 2009, Journal of the Medical Association of Thailand, V92, P806; Guggenheim JA, 2012, INVEST OPHTH VIS SCI, V53, P2856, DOI 10.1167/iovs.11-9091; Guo Y, 2013, OPHTHALMOLOGY, V120, P277, DOI 10.1016/j.ophtha.2012.07.086; Hashemi Hassan, 2014, J Ophthalmic Vis Res, V9, P232; He MG, 2004, INVEST OPHTH VIS SCI, V45, P793, DOI 10.1167/iovs.03-1051; He MG, 2007, OPHTHALMOLOGY, V114, P374, DOI 10.1016/j.ophtha.2006.08.020; Ip JM, 2008, INVEST OPHTH VIS SCI, V49, P2903, DOI 10.1167/iovs.07-0804; Jones-Jordan LA, 2010, INVEST OPHTH VIS SCI, V51, P115, DOI 10.1167/iovs.08-3210; Kurtz D, 2007, INVEST OPHTH VIS SCI, V48, P562, DOI 10.1167/iovs.06-0408; Lam DSC, 2008, INVEST OPHTH VIS SCI, V49, P873, DOI 10.1167/iovs.06-1097; Lee YY, 2013, INVEST OPHTH VIS SCI, V54, P1026, DOI 10.1167/iovs.12-10480; Lin LLK, 2004, ANN ACAD MED SINGAP, V33, P27; Liu HH, 2010, OPHTHALMOLOGY, V117, P1763, DOI 10.1016/j.ophtha.2010.01.020; Lu B, 2009, ARCH OPHTHALMOL-CHIC, V127, P769, DOI 10.1001/archophthalmol.2009.105; Ministry of Education in China, 2012, COMP STUD SEN SEC ED; Morgan IG, 2012, LANCET, V379, P1739, DOI 10.1016/S0140-6736(12)60272-4; Morgan IG, 2010, ACTA OPHTHALMOL, V88, P877, DOI 10.1111/j.1755-3768.2009.01800.x; Mutti DO, 2002, INVEST OPHTH VIS SCI, V43, P3633; Pi LH, 2010, INT J MED SCI, V7, P342; Qian YS, 2009, INVEST OPHTH VIS SCI, V50, P1598, DOI 10.1167/iovs.07-1362; Quek TPL, 2004, OPHTHAL PHYSL OPT, V24, P47, DOI 10.1046/j.1475-1313.2003.00166.x; Rose KA, 2008, OPHTHALMOLOGY, V115, P1279, DOI 10.1016/j.ophtha.2007.12.019; Saw SM, 2002, ARCH OPHTHALMOL-CHIC, V120, P620, DOI 10.1001/archopht.120.5.620; Sun J, 2012, INVEST OPHTH VIS SCI, V53, P7504, DOI 10.1167/iovs.11-8343; Tang DH, 2007, J BEIJING SPORT U, V30, P936; Wang YX, 2006, AM J OPHTHALMOL, V141, P1078, DOI 10.1016/j.ajo.2006.01.023; Wu PC, 2013, OPHTHALMOLOGY, V120, P1080, DOI 10.1016/j.ophtha.2012.11.009; Xu LA, 2007, OPHTHALMOLOGY, V114, P216, DOI 10.1016/j.ophtha.2006.06.050; Xu L, 2006, OPHTHALMOLOGY, V113, P1134, DOI 10.1016/j.ophtha.2006.01.035; You QS, 2014, ACTA OPHTHALMOL, V92, pE398, DOI 10.1111/aos.12299; You QS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052668; Zhao JL, 2000, AM J OPHTHALMOL, V129, P427, DOI 10.1016/S0002-9394(99)00452-3	38	104	120	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0120764	10.1371/journal.pone.0120764	http://dx.doi.org/10.1371/journal.pone.0120764			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803875	Green Submitted, Green Published, gold			2022-12-26	WOS:000353889600096
J	Bu, NS; Qu, JF; Li, ZL; Li, G; Zhao, H; Zhao, B; Li, B; Chen, JK; Fang, CM				Bu, Naishun; Qu, Junfeng; Li, Zhaolei; Li, Gang; Zhao, Hua; Zhao, Bin; Li, Bo; Chen, Jiakuan; Fang, Changming			Effects of Spartina alterniflora Invasion on Soil Respiration in the Yangtze River Estuary, China	PLOS ONE			English	Article							CHESAPEAKE BAY WETLAND; PHRAGMITES-AUSTRALIS; CO2 EFFLUX; SEA-LEVEL; ECOSYSTEM CARBON; TIDAL MARSHES; SALT MARSHES; ELEVATED CO2; COMMON REED; PLANT	Many studies have found that plant invasion can enhance soil organic carbon (SOC) pools, by increasing net primary production (NPP) and/or decreased soil respiration. While most studies have focused on C input, little attention has been paid to plant invasion effects on soil respiration, especially in wetland ecosystems. Our study examined the effects of Spartina alterniflora invasion on soil respiration and C dynamics in the Yangtze River estuary. The estuary was originally occupied by two native plant species: Phragmites australis in the high tide zone and Scirpus mariqueter in the low tide zone. Mean soil respiration rates were 185.8 and 142.3 mg CO2 m(-2) h(-1) in S. alterniflora and P. australis stands in the high tide zone, and 159.7 and 112.0 mg CO2 m(-2) h(-1) in S. alterniflora and S. mariqueter stands in the low tide zone, respectively. Aboveground NPP (ANPP), SOC, and microbial biomass were also significantly higher in the S. alterniflora stands than in the two native plant stands. S. alterniflora invasion did not significantly change soil inorganic carbon or pH. Our results indicated that enhanced ANPP by S. alterniflora exceeded invasion-induced C loss through soil respiration. This suggests that S. alterniflora invasion into the Yangtze River estuary could strengthen the net C sink of wetlands in the context of global climate change.	[Bu, Naishun; Li, Zhaolei; Zhao, Bin; Li, Bo; Chen, Jiakuan; Fang, Changming] Fudan Univ, Coastal Ecosyst Res Stn Yangtze River Estuary, Key Lab Biodivers Sci & Ecol Engn, Minist Educ,Inst Biodivers Sci, Shanghai 200433, Peoples R China; [Bu, Naishun; Li, Gang; Zhao, Hua] China Univ Min & Technol, Sch Environm Sci & Spatial Informat, Xuzhou, Peoples R China; [Qu, Junfeng] China Univ Min & Technol, Low Carbon Energy Res Inst, Xuzhou, Peoples R China	Fudan University; China University of Mining & Technology; China University of Mining & Technology	Fang, CM (corresponding author), Fudan Univ, Coastal Ecosyst Res Stn Yangtze River Estuary, Key Lab Biodivers Sci & Ecol Engn, Minist Educ,Inst Biodivers Sci, Shanghai 200433, Peoples R China.	cmfang@fudan.edu.cn	Li, Bo/B-8016-2010; Zhao, Bin/I-3651-2013; Li, Bo/AAA-8968-2020	Li, Bo/0000-0002-0439-5666; Zhao, Bin/0000-0002-3530-2469; Li, Bo/0000-0002-7294-6888	National Basic Research Program of China [2010CB950602]; "12th Five-Year" national science and technology support program [2011BA11B06]; National Major Scientific and Technological Project in China [2010BAK69B14]; National Science Foundation of China [30930019]; Key Project of the Shanghai Scientific and Technological Committee [10DZ1200700]	National Basic Research Program of China(National Basic Research Program of China); "12th Five-Year" national science and technology support program; National Major Scientific and Technological Project in China; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project of the Shanghai Scientific and Technological Committee	This work was supported by National Basic Research Program of China (2010CB950602), "12th Five-Year" national science and technology support program (2011BA11B06), National Major Scientific and Technological Project in China (2010BAK69B14), National Science Foundation of China (30930019) and Key Project of the Shanghai Scientific and Technological Committee (10DZ1200700). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An SQ, 2007, WEED RES, V47, P183, DOI 10.1111/j.1365-3180.2007.00559.x; Baustian JJ, 2012, GLOBAL CHANGE BIOL, V18, P3377, DOI 10.1111/j.1365-2486.2012.02792.x; Blankespoor B, 2014, AMBIO, V43, P996, DOI 10.1007/s13280-014-0500-4; Bridgham SD, 2006, WETLANDS, V26, P889, DOI 10.1672/0277-5212(2006)26[889:TCBONA]2.0.CO;2; Chambers RM, 1999, AQUAT BOT, V64, P261, DOI 10.1016/S0304-3770(99)00055-8; Chen HL, 2007, MAR ECOL PROG SER, V336, P99, DOI 10.3354/meps336099; Cheng XL, 2008, GEODERMA, V145, P177, DOI 10.1016/j.geoderma.2008.02.013; Cheng XL, 2007, CHEMOSPHERE, V68, P420, DOI 10.1016/j.chemosphere.2007.01.004; Cheng XL, 2006, SOIL BIOL BIOCHEM, V38, P3380, DOI 10.1016/j.soilbio.2006.05.016; Colmer TD, 2003, PLANT CELL ENVIRON, V26, P17, DOI 10.1046/j.1365-3040.2003.00846.x; Currin CA, 1998, ESTUARIES, V21, P108, DOI 10.2307/1352550; Davidson EA, 2002, AGR FOREST METEOROL, V113, P21, DOI 10.1016/S0168-1923(02)00100-4; Didham RK, 2005, TRENDS ECOL EVOL, V20, P470, DOI 10.1016/j.tree.2005.07.006; Drake BG, 2014, GLOBAL CHANGE BIOL, V20, P3329, DOI 10.1111/gcb.12631; Ehrenfeld JG, 2003, ECOSYSTEMS, V6, P503, DOI 10.1007/s10021-002-0151-3; Eldridge DJ, 2011, ECOL LETT, V14, P709, DOI 10.1111/j.1461-0248.2011.01630.x; Everard K, 2010, AM NAT, V175, P85, DOI 10.1086/648557; Fang C, 2001, SOIL BIOL BIOCHEM, V33, P155, DOI 10.1016/S0038-0717(00)00125-5; Gratton C, 2005, RESTOR ECOL, V13, P358, DOI 10.1111/j.1526-100X.2005.00045.x; Heinemeyer A, 2011, EUR J SOIL SCI, V62, P82, DOI 10.1111/j.1365-2389.2010.01331.x; HINES ME, 1994, LIMNOL OCEANOGR, V39, P140, DOI 10.4319/lo.1994.39.1.0140; HOWES BL, 1986, J ECOL, V74, P881, DOI 10.2307/2260404; Jiang LF, 2009, ESTUAR COAST SHELF S, V81, P74, DOI 10.1016/j.ecss.2008.09.018; Keller JK, 2011, NEW PHYTOL, V192, P789, DOI 10.1111/j.1469-8137.2011.03954.x; Kuzyakov Y, 2006, SOIL BIOL BIOCHEM, V38, P425, DOI 10.1016/j.soilbio.2005.08.020; Li B, 2009, ECOL ENG, V35, P511, DOI 10.1016/j.ecoleng.2008.05.013; Liao CZ, 2008, OECOLOGIA, V156, P589, DOI 10.1007/s00442-008-1007-0; Liao CZ, 2007, ECOSYSTEMS, V10, P1351, DOI 10.1007/s10021-007-9103-2; Liao CZ, 2008, NEW PHYTOL, V177, P706, DOI 10.1111/j.1469-8137.2007.02290.x; Lu R., 2000, CHEMICAL ANLYSIS OF; McCulley RL, 2004, ECOLOGY, V85, P2804, DOI 10.1890/03-0645; Mcleod E, 2011, FRONT ECOL ENVIRON, V9, P552, DOI 10.1890/110004; Metcalfe DB, 2011, BIOGEOSCIENCES, V8, P2047, DOI 10.5194/bg-8-2047-2011; Mi N, 2008, GLOBAL CHANGE BIOL, V14, P2380, DOI 10.1111/j.1365-2486.2008.01642.x; Mozdzer TJ, 2011, MAR ECOL PROG SER, V433, P43, DOI 10.3354/meps09117; Mudd SM, 2010, J GEOPHYS RES-EARTH, V115, DOI 10.1029/2009JF001566; Neubauer SC, 2008, ESTUAR COAST SHELF S, V78, P78, DOI 10.1016/j.ecss.2007.11.011; Patra S, 2007, EARTH AND ENVIRONMEN, V38, P409; Peng RH, 2009, THESIS; Peng RH, 2011, OECOLOGIA, V165, P797, DOI 10.1007/s00442-010-1887-7; Rasse DP, 2005, GLOBAL CHANGE BIOL, V11, P369, DOI 10.1111/j.1365-2486.2005.00913.x; Ravit B, 2006, SOIL BIOL BIOCHEM, V38, P2359, DOI 10.1016/j.soilbio.2006.02.012; Rovira P, 2002, GEODERMA, V107, P109, DOI 10.1016/S0016-7061(01)00143-4; Ryan MG, 2005, BIOGEOCHEMISTRY, V73, P3, DOI 10.1007/s10533-004-5167-7; Sax DF, 2007, TRENDS ECOL EVOL, V22, P465, DOI 10.1016/j.tree.2007.06.009; Shang QY, 2011, GLOBAL CHANGE BIOL, V17, P2196, DOI 10.1111/j.1365-2486.2010.02374.x; Smith DL, 2004, ECOLOGY, V85, P3348, DOI 10.1890/03-0576; Smith KA, 2003, EUR J SOIL SCI, V54, P779, DOI 10.1046/j.1351-0754.2003.0567.x; Sung CY, 2011, LANDSCAPE URBAN PLAN, V100, P278, DOI 10.1016/j.landurbplan.2010.12.014; Tang L, 2010, BIOL INVASIONS, V12, P593, DOI 10.1007/s10530-009-9465-9; van Kleunen M, 2010, ECOL LETT, V13, P235, DOI 10.1111/j.1461-0248.2009.01418.x; Vila M, 2011, ECOL LETT, V14, P702, DOI 10.1111/j.1461-0248.2011.01628.x; Wang C., 2009, THESIS; Wang M, 2007, PEDOSPHERE, V17, P545, DOI 10.1016/S1002-0160(07)60065-4; Wang Q, 2006, BIOL INVASIONS, V8, P1547, DOI 10.1007/s10530-005-5846-x; Wang Q, 2006, ACTA PHYTOTAXON SIN, V44, P559, DOI 10.1360/aps06044; Weis JS, 2003, MAR POLLUT BULL, V46, P816, DOI 10.1016/S0025-326X(03)00036-5; Windham L, 2001, WETLANDS, V21, P179, DOI 10.1672/0277-5212(2001)021[0179:COBPAD]2.0.CO;2; Wu HB, 2009, AGR ECOSYST ENVIRON, V129, P413, DOI 10.1016/j.agee.2008.10.020; WU J, 1990, SOIL BIOL BIOCHEM, V22, P1167, DOI 10.1016/0038-0717(90)90046-3; Xu HF, 2003, SCIENTIFIC SURVEY ON; Yan Y, 2008, GLOBAL CHANGE BIOL, V14, P1690, DOI 10.1111/j.1365-2486.2008.01589.x; Yang SL, 2003, ESTUAR COAST SHELF S, V57, P689, DOI 10.1016/S0272-7714(02)00409-2; Yang SL, 2001, GEOMORPHOLOGY, V38, P167, DOI 10.1016/S0169-555X(00)00079-9; Zedler JB, 2004, CRIT REV PLANT SCI, V23, P431, DOI 10.1080/07352680490514673; Zhang L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092301; Zhou LY, 2014, CLEAN-SOIL AIR WATER, V42, P1	67	26	30	8	113	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121571	10.1371/journal.pone.0121571	http://dx.doi.org/10.1371/journal.pone.0121571			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799512	gold, Green Submitted, Green Published			2022-12-26	WOS:000351987300271
J	Cui, J; Frankham, GJ; Johnson, RN; Polkinghorne, A; Timms, P; O'Meally, D; Cheng, YY; Belov, K				Cui, Jian; Frankham, Greta J.; Johnson, Rebecca N.; Polkinghorne, Adam; Timms, Peter; O'Meally, Denis; Cheng, Yuanyuan; Belov, Katherine			SNP Marker Discovery in Koala TLR Genes	PLOS ONE			English	Article							TOLL-LIKE-RECEPTOR; LEUCINE-RICH REPEATS; PHASCOLARCTOS-CINEREUS; EXPRESSION ANALYSIS; CHLAMYDIA-TRACHOMATIS; TRACT DISEASE; IMMUNE GENES; STRANDED-RNA; RECOGNITION; DIVERSITY	Toll-like receptors (TLRs) play a crucial role in the early defence against invading pathogens, yet our understanding of TLRs in marsupial immunity is limited. Here, we describe the characterisation of nine TLRs from a koala immune tissue transcriptome and one TLR from a draft sequence of the koala genome and the subsequent development of an assay to study genetic diversity in these genes. We surveyed genetic diversity in 20 koalas from New South Wales, Australia and showed that one gene, TLR10 is monomorphic, while the other nine TLR genes have between two and 12 alleles. 40 SNPs (16 non-synonymous) were identified across the ten TLR genes. These markers provide a springboard to future studies on innate immunity in the koala, a species under threat from two major infectious diseases.	[Cui, Jian; O'Meally, Denis; Cheng, Yuanyuan; Belov, Katherine] Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia; [Frankham, Greta J.; Johnson, Rebecca N.] Australian Museum, Australian Museum Res Inst, Sydney, NSW 2000, Australia; [Polkinghorne, Adam; Timms, Peter] Univ Sunshine Coast, Fac Sci Hlth Educ & Engn, Sippy Downs, Qld 4556, Australia	University of Sydney; Australian Museum; University of the Sunshine Coast	Belov, K (corresponding author), Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia.	kathy.belov@sydney.edu.au	Cheng, Yuanyuan/M-6476-2017; O'Meally, Denis/A-3746-2012; Johnson, Rebecca N/U-6514-2017	Cheng, Yuanyuan/0000-0002-1747-9308; O'Meally, Denis/0000-0001-7749-9506; Belov, Katherine/0000-0002-9762-5554; Frankham, Greta/0000-0002-0585-6700; Timms, Peter/0000-0002-1682-0025; Polkinghorne, Adam/0000-0002-6803-9222; Polkinghorne, Adam/0000-0002-6567-2962; Johnson, Rebecca/0000-0003-3035-2827	ARC Future Fellowship [FT0992212]; ARC Linkage Grant [LP120200051]; University of Sydney; Bioplatforms Australia; NSW Foundation for National Parks and Wildlife	ARC Future Fellowship(Australian Research Council); ARC Linkage Grant(Australian Research Council); University of Sydney(University of Sydney); Bioplatforms Australia; NSW Foundation for National Parks and Wildlife	KB is supported by an ARC Future Fellowship (FT0992212). This work was partially supported by an ARC Linkage Grant (LP120200051) awarded to PT and AP and funding from the University of Sydney to KB. The authors thank Bioplatforms Australia for financial support. The Australian Museum mitochondrial work was supported by a grant from the NSW Foundation for National Parks and Wildlife. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2003, CURR OPIN IMMUNOL, V15, P5, DOI 10.1016/S0952-7915(02)00013-4; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Bachmann NL, 2014, TRENDS MICROBIOL; Barreiro LB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000562; Bell JK, 2006, P NATL ACAD SCI USA, V103, P8792, DOI 10.1073/pnas.0603245103; Bell JK, 2003, TRENDS IMMUNOL, V24, P528, DOI 10.1016/S1471-4906(03)00242-4; Bell JK, 2005, P NATL ACAD SCI USA, V102, P10976, DOI 10.1073/pnas.0505077102; Campos MA, 2001, J IMMUNOL, V167, P416, DOI 10.4049/jimmunol.167.1.416; Cui J, 2015, IMMUNOGENETICS, P1; Darville T, 2010, J INFECT DIS, V201, pS114, DOI 10.1086/652397; Denner J, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-108; Fowler EV, 2000, MOL ECOL, V9, P155, DOI 10.1046/j.1365-294x.2000.00844.x; Frankham GJ, 2014, CONSERV GENET, V15, P547, DOI 10.1007/s10592-013-0560-1; Grueber CE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045011; Guan Y, 2010, J IMMUNOL, V184, P5094, DOI 10.4049/jimmunol.0901888; Hajjar AM, 2002, NAT IMMUNOL, V3, P354, DOI 10.1038/ni777; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hawn TR, 2005, P NATL ACAD SCI USA, V102, P2487, DOI 10.1073/pnas.0409831102; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Higuchi M, 2008, DEV COMP IMMUNOL, V32, P147, DOI 10.1016/j.dci.2007.05.003; Hobbs M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-786; Houlden BA, 1996, MOL BIOL EVOL, V13, P1119, DOI 10.1093/oxfordjournals.molbev.a025674; Houlden BA, 1996, MOL ECOL, V5, P269, DOI 10.1111/j.1365-294X.1996.tb00314.x; Houlden BA, 1999, MOL ECOL, V8, P999, DOI 10.1046/j.1365-294x.1999.00656.x; Huang YH, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-149; Iqbal M, 2005, VET IMMUNOL IMMUNOP, V104, P117, DOI 10.1016/j.vetimm.2004.11.003; Ishii A, 2007, IMMUNOGENETICS, V59, P281, DOI 10.1007/s00251-007-0193-y; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; Jobbins SE, 2012, AUST J ZOOL, V60, P1, DOI 10.1071/ZO12013; Johnson Rebecca N., 2014, Technical Reports of the Australian Museum Online, V24, DOI 10.3853/j.1835-4211.24.2014.1624; Joyee AG, 2008, CURR PHARM DESIGN, V14, P593, DOI 10.2174/138161208783885344; Kaisho T, 2006, J ALLERGY CLIN IMMUN, V117, P979, DOI 10.1016/j.jaci.2006.02.023; Kang JY, 2009, IMMUNITY, V31, P873, DOI 10.1016/j.immuni.2009.09.018; Kollipara A, 2012, VACCINE, V30, P1875, DOI 10.1016/j.vaccine.2011.12.125; Kopp EB, 1999, CURR OPIN IMMUNOL, V11, P13, DOI 10.1016/S0952-7915(99)80003-X; Lau Q, 2013, IMMUNOGENETICS, V65, P37, DOI 10.1007/s00251-012-0658-5; Lee AK, 1988, KOALA NATURAL HIST; Lee KE, 2010, CONSERV GENET, V11, P2091, DOI 10.1007/s10592-009-9987-9; Maher IE, 2014, PEERJ, V2, DOI 10.7717/peerj.280; Mathew M, 2014, DEV COMP IMMUNOL, V46, P423, DOI 10.1016/j.dci.2014.05.015; Mathew M, 2013, GENE, V527, P570, DOI 10.1016/j.gene.2013.06.019; Mathew M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059958; Matsushima N, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-124; McCartney SA, 2009, IMMUNOL REV, V227, P87, DOI 10.1111/j.1600-065X.2008.00726.x; McGuire K, 2006, ANIM GENET, V37, P47, DOI 10.1111/j.1365-2052.2005.01364.x; Medzhitov R, 2000, TRENDS MICROBIOL, V8, P452, DOI 10.1016/S0966-842X(00)01845-X; Mehta SD, 2009, J INFECT DIS, V200, P370, DOI 10.1086/600074; Meijer AH, 2004, MOL IMMUNOL, V40, P773, DOI 10.1016/j.molimm.2003.10.003; Melzer A, 2000, CONSERV BIOL, V14, P619, DOI 10.1046/j.1523-1739.2000.99383.x; Miller SI, 2005, NAT REV MICROBIOL, V3, P36, DOI 10.1038/nrmicro1068; Mizel SB, 2003, J BIOL CHEM, V278, P23624, DOI 10.1074/jbc.M303481200; Morris K, 2014, AUST J ZOOL; Oldenburg M, 2012, SCIENCE, V337, P1111, DOI 10.1126/science.1220363; Palermo S, 2009, ANIM GENET, V40, P289, DOI 10.1111/j.1365-2052.2008.01833.x; Polkinghorne A, 2013, VET MICROBIOL, V165, P214, DOI 10.1016/j.vetmic.2013.02.026; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Purcell MK, 2006, COMP BIOCHEM PHYS D, V1, P77, DOI 10.1016/j.cbd.2005.07.003; Roach JC, 2005, P NATL ACAD SCI USA, V102, P9577, DOI 10.1073/pnas.0502272102; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Seabury CM, 2010, P NATL ACAD SCI USA, V107, P151, DOI 10.1073/pnas.0913006107; Simmons GS, 2012, AUST VET J, V90, P404, DOI 10.1111/j.1751-0813.2012.00964.x; Smirnova I, 2000, GENOME BIOL, V1; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tarlinton RE, 2006, NATURE, V442, P79, DOI 10.1038/nature04841; Taylor BD, 2012, J INFECT DIS, V205, P603, DOI 10.1093/infdis/jir822; Temperley ND, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-62; Wan C, 2011, AUST VET J, V89, P409, DOI 10.1111/j.1751-0813.2011.00827.x; Werling D, 2007, VET J, V174, P240, DOI 10.1016/j.tvjl.2006.10.010; Wochrle T, 2008, CYTOKINE, V41, P322, DOI 10.1016/j.cyto.2007.12.006; Yang ZH, 1998, MOL BIOL EVOL, V15, P568, DOI 10.1093/oxfordjournals.molbev.a025957; Zhang DX, 2003, MOL ECOL, V12, P563, DOI 10.1046/j.1365-294X.2003.01773.x; Zhang XY, 2004, BIOINFORMATIOCS, V4, P3	74	7	7	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121068	10.1371/journal.pone.0121068	http://dx.doi.org/10.1371/journal.pone.0121068			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799012	Green Published, Green Submitted, gold			2022-12-26	WOS:000351987300205
J	Harder, MN; Appel, EVR; Grarup, N; Gjesing, AP; Ahluwalia, TS; Jorgensen, T; Christensen, C; Brandslund, I; Linneberg, A; Sorensen, TIA; Pedersen, O; Hansen, T				Harder, Marie Neergaard; Appel, Emil Vincent Rosenbaum; Grarup, Niels; Gjesing, Anette Prior; Ahluwalia, Tarunveer S.; Jorgensen, Torben; Christensen, Cramer; Brandslund, Ivan; Linneberg, Allan; Sorensen, Thorkild I. A.; Pedersen, Oluf; Hansen, Torben			The Type 2 Diabetes Risk Allele of TMEM154-rs6813195 Associates with Decreased Beta Cell Function in a Study of 6,486 Danes	PLOS ONE			English	Article							INSULIN SENSITIVITY; GENETIC ARCHITECTURE; GLUCOSE-TOLERANCE	Objectives A trans-ethnicmeta-analysis of type 2 diabetes genome-wide association studies has identified seven novel susceptibility variants in or near TMEM154, SSR1/RREB1, FAF1, POU5F1/TCF19, LPP, ARL15 and ABCB9/MPHOSPH9. The aim of our study was to investigate associations between these novel risk variants and type 2 diabetes and pre-diabetic traits in a Danish population-based study with measurements of plasma glucose and serum insulin after an oral glucose tolerance test in order to elaborate on the physiological impact of the variants. Methods Case-control analyses were performed in up to 5,777 patients with type 2 diabetes and 7,956 individuals with normal fasting glucose levels. Quantitative trait analyses were performed in up to 5,744 Inter99 participants naive to glucose-lowering medication. Significant associations between TMEM154-rs6813195 and the beta cell measures insulinogenic index and disposition index and between FAF1-rs17106184 and 2-hour serum insulin levels were selected for further investigation in additional Danish studies and results were combined in meta-analyses including up to 6,486 Danes. Results We confirmed associations with type 2 diabetes for five of the seven SNPs (TMEM154-rs6813195, FAF1-rs17106184, POU5F1/TCF19-rs3130501, ARL15-rs702634 and ABCB9/MPHOSPH9-rs4275659). The type 2 diabetes risk C-allele of TMEM154-rs6813195 associated with decreased disposition index (n=5,181, beta=-0.042, p=0.012) and insulinogenic index (n=5,181, beta=-0.032, p=0.043) in Inter99 and these associations remained significant in meta-analyses including four additional Danish studies (disposition index n=6,486, beta=-0.042, p=0.0044; and insulinogenic index n=6,486, beta=-0.037, p=0.0094). The type 2 diabetes risk G-allele of FAF1-rs17106184 associated with increased levels of 2-hour serum insulin (n=5,547, beta=0.055, p=0.017) in Inter99 and also when combining effects with three additional Danish studies (n=6,260, beta=0.062, p=0.0040). Conclusion Studies of type 2 diabetes intermediary traits suggest the diabetogenic impact of the C-allele of TMEM154-rs6813195 is mediated through reduced beta cell function. The impact of the diabetes risk G-allele of FAF1-rs17106184 on increased 2-hour insulin levels is however unexplained.	[Harder, Marie Neergaard; Appel, Emil Vincent Rosenbaum; Grarup, Niels; Gjesing, Anette Prior; Ahluwalia, Tarunveer S.; Sorensen, Thorkild I. A.; Pedersen, Oluf; Hansen, Torben] Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn Ctr Basic Metab Res, Copenhagen, Denmark; [Ahluwalia, Tarunveer S.] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen Prospect Studies Asthma Childhood, Copenhagen, Denmark; [Ahluwalia, Tarunveer S.] Gentofte Univ Hosp, Danish Pediat Asthma Ctr, Capital Reg, Copenhagen, Denmark; [Jorgensen, Torben; Linneberg, Allan] Glostrup Univ Hosp, Res Ctr Prevent & Hlth, Glostrup, Denmark; [Jorgensen, Torben] Univ Copenhagen, Fac Hlth & Med Sci, Dept Publ Hlth, Copenhagen, Denmark; [Christensen, Cramer] Vejle Hosp, Lillebaelt Hosp, Dept Med, Vejle, Denmark; [Brandslund, Ivan] Vejle Hosp, Lillebaelt Hosp, Dept Clin Immunol & Biochem, Vejle, Denmark; [Brandslund, Ivan] Univ Southern Denmark, Inst Reg Hlth Res, Odense, Denmark; [Linneberg, Allan] Glostrup Univ Hosp, Dept Clin Expt Res, Glostrup, Denmark; [Linneberg, Allan] Univ Copenhagen, Fac Hlth & Med Sci, Dept Clin Med, Copenhagen, Denmark; [Sorensen, Thorkild I. A.] Bispebjerg & Frederiksberg Hosp, Inst Prevent Med, Capital Reg, Copenhagen, Denmark; [Hansen, Torben] Univ Southern Denmark, Fac Hlth Sci, Odense, Denmark	Novo Nordisk Foundation; University of Copenhagen; University of Copenhagen; University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; University of Copenhagen; University of Southern Denmark; Lillebaelt Hospital; University of Southern Denmark; Lillebaelt Hospital; University of Southern Denmark; University of Copenhagen; University of Copenhagen; University of Copenhagen; Bispebjerg Hospital; University of Southern Denmark	Harder, MN (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn Ctr Basic Metab Res, Copenhagen, Denmark.	marie.harder@sund.ku.dk	Grarup, Niels/K-2807-2015; Jørgensen, Torben/Z-1335-2018; Pedersen, Oluf/Z-1731-2019; Gjesing, Anette/ACC-7521-2022; Dina, Christian R/D-3535-2015; Pedersen, Oluf/AAG-8015-2020; Ahluwalia, Tarunveer Singh/C-5549-2009	Grarup, Niels/0000-0001-5526-1070; Pedersen, Oluf/0000-0002-3321-3972; Gjesing, Anette/0000-0003-4580-1576; Dina, Christian R/0000-0002-7722-7348; Ahluwalia, Tarunveer Singh/0000-0002-7464-3354; Jorgensen, Torben/0000-0001-9453-2830; Hansen, Torben/0000-0001-8748-3831; Brandslund, Ivan/0000-0002-4203-5442; Linneberg, Allan/0000-0002-0994-0184	Novo Nordisk Foundation Center for Basic Metabolic Research, independent Research Center at the University of Copenhagen - Novo Nordisk Foundation; PhD School of Molecular Metabolism University of Southern Denmark; Copenhagen Graduate School of Health and Medical Sciences; Danish Council for Independent Research; Gene Diet Interactions in Obesity (GENDINOB) project; Lundbeck Foundation	Novo Nordisk Foundation Center for Basic Metabolic Research, independent Research Center at the University of Copenhagen - Novo Nordisk Foundation; PhD School of Molecular Metabolism University of Southern Denmark; Copenhagen Graduate School of Health and Medical Sciences; Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Gene Diet Interactions in Obesity (GENDINOB) project; Lundbeck Foundation(Lundbeckfonden)	This work was supported by research grants from The Novo Nordisk Foundation Center for Basic Metabolic Research, an independent Research Center at the University of Copenhagen partially funded by an unrestricted donation from the Novo Nordisk Foundation, the PhD School of Molecular Metabolism University of Southern Denmark, the Copenhagen Graduate School of Health and Medical Sciences, the Danish Council for Independent Research and the Gene Diet Interactions in Obesity (GENDINOB, www.gendinob.dk) project. The study is a part of the LuCamp initiative (www.lucamp.org) and is sponsored by the Lundbeck Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; Black E, 2005, DIABETIC MED, V22, P1199, DOI 10.1111/j.1464-5491.2005.01615.x; Byberg S, 2012, DIABETIC MED, V29, pE354, DOI 10.1111/j.1464-5491.2012.03711.x; Gjesing AP, 2012, DIABETOLOGIA, V55, P1338, DOI 10.1007/s00125-012-2484-6; Grarup N, 2014, DIABETOLOGIA; Grarup N, 2010, CURR DIABETES REP, V10, P485, DOI 10.1007/s11892-010-0154-y; Hansen T, 2007, DIABETES CARE, V30, P257, DOI 10.2337/dc06-1240; Harder MN, 2013, J CLIN ENDOCR METAB, V98, pE801, DOI 10.1210/jc.2012-4169; Huyghe JR, 2013, NAT GENET, V45, P197, DOI 10.1038/ng.2507; Jorgensen T, 2003, OFFICIAL J EUROPEAN, V10, P377; KAHN SE, 1993, DIABETES, V42, P1663, DOI 10.2337/diabetes.42.11.1663; Lauritzen T, 2000, INT J OBESITY, V24, pS6, DOI 10.1038/sj.ijo.0801420; Lee EK, 2012, MOL CELL, V45, P826, DOI 10.1016/j.molcel.2012.01.016; Lyssenko V, 2013, DIABETES CARE, V36, pS120, DOI 10.2337/dcS13-2009; Mahajan A, 2014, NAT GENET, V46, P234, DOI 10.1038/ng.2897; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Paternoster L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024303; SELTZER HS, 1967, J CLIN INVEST, V46, P323, DOI 10.1172/JCI105534; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Thuesen BH, 2013, INT J EPIDEMIOL; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Voight BF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002793	23	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120890	10.1371/journal.pone.0120890	http://dx.doi.org/10.1371/journal.pone.0120890			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799151	gold, Green Published, Green Submitted			2022-12-26	WOS:000351987300187
J	Iervolino, A; Trepiccione, F; Petrillo, F; Spagnuolo, M; Scarfo, M; Frezzetti, D; De Vita, G; De Felice, M; Capasso, G				Iervolino, Anna; Trepiccione, Francesco; Petrillo, Federica; Spagnuolo, Manuela; Scarfo, Marzia; Frezzetti, Daniela; De Vita, Gabriella; De Felice, Mario; Capasso, Giovambattista			Selective Dicer Suppression in the Kidney Alters GSK3 beta/beta-Catenin Pathways Promoting a Glomerulocystic Disease	PLOS ONE			English	Article							BETA-CATENIN; MICRORNAS; PHOSPHORYLATION; HOMEOSTASIS; LEADS; GSK3; WNT	Dicer is a crucial enzyme for the maturation of miRNAs. Mutations in the Dicer gene are highly associated with Pleuro Pulmonary Blastoma-Family Dysplasia Syndrome (PPB-FDS, OMIM 601200), recently proposed to be renamed Dicer syndrome. Aside from the pulmonary phenotype (blastoma), renal nephroma and thyroid goiter are frequently part of Dicer syndrome. To investigate the renal phenotype, conditional knockout (cKO) mice for Dicer in Pax8 expressing cells were generated. Dicer cKO mice progressively develop a glomerulocystic phenotype coupled with urinary concentration impairment, proteinuria and severe renal failure. Higher cellular turnover of the parietal cells of Bowman's capsule precedes the development of the cysts and the primary cilium progressively disappears with cyst-enlargement. Upregulation of GSK3 beta precedes the development of the glomerulocystic phenotype. Downregulation of beta-catenin in the renal cortex and its cytosolic removal in the cells lining the cysts may be associated with observed accumulation of GSK3 beta. Alterations of beta-catenin regulating pathways could promote cystic degeneration as in other models. Thus, miRNAs are fundamental in preserving renal morphology and function. Alteration of the GSK3 beta/beta-catenin pathway could be a crucial mechanism linking miRNA dysregulation and the development of a glomerulocystic disease.	[Iervolino, Anna; Petrillo, Federica; Scarfo, Marzia; Frezzetti, Daniela; De Felice, Mario] Biogem, Ist Ric Genet Gaetano Salvatore, Ariano Irpino, Italy; [Trepiccione, Francesco; Petrillo, Federica; Spagnuolo, Manuela; Capasso, Giovambattista] Univ Naples 2, Dept Cardiothorac & Resp Sci, Naples, Italy; [De Vita, Gabriella; De Felice, Mario] Univ Naples Federico II, Dept Mol Med & Med Biotechnol, Naples, Italy; [Spagnuolo, Manuela] CNR Naples, Inst Genet & Biophys A Buzzati Traverso, Naples, Italy	Universita della Campania Vanvitelli; University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR)	Trepiccione, F (corresponding author), Univ Naples 2, Dept Cardiothorac & Resp Sci, Naples, Italy.	Francesco.trepiccione@ana.au.dk	Trepiccione, Francesco/W-4493-2017; Petrillo, Federica/AAA-5251-2022; Frezzetti, Daniela/AAI-2410-2019; De Vita, Gabriella/H-4422-2011; Spagnuolo, Manuela/B-2204-2018	Trepiccione, Francesco/0000-0002-0622-6612; Frezzetti, Daniela/0000-0002-7500-5506; De Vita, Gabriella/0000-0002-7302-1174; Spagnuolo, Manuela/0000-0002-4303-7327; Iervolino, Anna/0000-0003-0450-9587; Capasso, Giovambattista/0000-0003-3469-8614; Petrillo, Federica/0000-0003-3297-4953	Italian Ministry Scientific Research	Italian Ministry Scientific Research	This work was supported by a grant from the Italian Ministry Scientific Research to G.C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Bissler JJ, 2010, PEDIATR NEPHROL, V25, P2049, DOI 10.1007/s00467-009-1416-2; Boca M, 2007, MOL BIOL CELL, V18, P4050, DOI 10.1091/mbc.E07-02-0142; Bouchard M, 2004, GENESIS, V38, P105, DOI 10.1002/gene.20008; Bulbul M, 2009, PEDIATR NEPHROL, V24, P333, DOI 10.1007/s00467-008-0992-x; Chandrasekaran K, 2012, KIDNEY INT, V81, P617, DOI 10.1038/ki.2011.448; Damiano S, 2013, NEPHROL DIAL TRANSPL, V28, P2066, DOI 10.1093/ndt/gft020; Fang DX, 2007, J BIOL CHEM, V282, P11221, DOI 10.1074/jbc.M611871200; Frezzetti D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027648; GABOW PA, 1989, KIDNEY INT, V35, P675, DOI 10.1038/ki.1989.38; Grouls S, 2012, J AM SOC NEPHROL, V23, P63, DOI 10.1681/ASN.2010121257; Hoffert JD, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014613; Inoki K, 2006, CELL, V126, P955, DOI 10.1016/j.cell.2006.06.055; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Lancaster MA, 2009, NAT MED, V15, P1046, DOI 10.1038/nm.2010; Lazzeri E, 2007, J AM SOC NEPHROL, V18, P3128, DOI 10.1681/ASN.2007020210; Murchison EP, 2005, P NATL ACAD SCI USA, V102, P12135, DOI 10.1073/pnas.0505479102; Murcia NS, 1999, KIDNEY INT, V55, P1187, DOI 10.1046/j.1523-1755.1999.00370.x; Nagalakshmi VK, 2011, KIDNEY INT, V79, P317, DOI 10.1038/ki.2010.385; Pastorelli LM, 2009, MAMM GENOME, V20, P140, DOI 10.1007/s00335-008-9169-y; Patel V, 2012, J AM SOC NEPHROL, V23, P1941, DOI 10.1681/ASN.2012030321; Schmitz Y, 2013, CELL SIGNAL, V25, P2210, DOI 10.1016/j.cellsig.2013.07.005; Sequeira-Lopez MLS, 2010, J AM SOC NEPHROL, V21, P460, DOI 10.1681/ASN.2009090964; Shi SL, 2008, J AM SOC NEPHROL, V19, P2159, DOI 10.1681/ASN.2008030312; Slade I, 2011, J MED GENET, V48, P273, DOI 10.1136/jmg.2010.083790; Tomari Y, 2005, GENE DEV, V19, P517, DOI 10.1101/gad.1284105; Trepiccione F, 2013, AM J PHYSIOL-RENAL, V305, pF919, DOI 10.1152/ajprenal.00152.2012; Trepiccione F, 2010, J NEPHROL, V23, pS43; Zullo A, 2010, HUM MOL GENET, V19, P2792, DOI 10.1093/hmg/ddq180	30	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0119142	10.1371/journal.pone.0119142	http://dx.doi.org/10.1371/journal.pone.0119142			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799508	Green Published, gold, Green Submitted			2022-12-26	WOS:000351987300031
J	Joddar, B; Firstenberg, MS; Reen, RK; Varadharaj, S; Khan, M; Childers, RC; Zweier, JL; Gooch, KJ				Joddar, Binata; Firstenberg, Michael S.; Reen, Rashmeet K.; Varadharaj, Saradhadevi; Khan, Mahmood; Childers, Rachel C.; Zweier, Jay L.; Gooch, Keith J.			Arterial Levels of Oxygen Stimulate Intimal Hyperplasia in Human Saphenous Veins via a ROS-Dependent Mechanism	PLOS ONE			English	Article							AORTIC ENDOTHELIAL-CELLS; ACTIVATED PROTEIN-KINASE; ORGAN-CULTURE MODEL; NEOINTIMAL HYPERPLASIA; ANTIOXIDANT VITAMINS; OXIDATIVE STRESS; HYPOXIA; GROWTH; INJURY; ATHEROMATOSIS	Saphenous veins used as arterial grafts are exposed to arterial levels of oxygen partial pressure (pO(2)), which are much greater than what they experience in their native environment. The object of this study is to determine the impact of exposing human saphenous veins to arterial pO(2). Saphenous veins and left internal mammary arteries from consenting patients undergoing coronary artery bypass grafting were cultured ex vivo for 2 weeks in the presence of arterial or venous pO(2) using an established organ culture model. Saphenous veins cultured with arterial pO(2) developed intimal hyperplasia as evidenced by 2.8-fold greater intimal area and 5.8-fold increase in cell proliferation compared to those freshly isolated. Saphenous veins cultured at venous pO(2) or internal mammary arteries cultured at arterial pO(2) did not develop intimal hyperplasia. Intimal hyperplasia was accompanied by two markers of elevated reactive oxygen species (ROS): increased dihydroethidium associated fluorescence (4-fold, p< 0.05) and increased levels of the lipid peroxidation product, 4-hydroxynonenal (10-fold, p< 0.05). A functional role of the increased ROS saphenous veins exposed to arterial pO(2) is suggested by the observation that chronic exposure to tiron, a ROS scavenger, during the two-week culture period, blocked intimal hyperplasia. Electron paramagnetic resonance based oximetry revealed that the pO(2) in the wall of the vessel tracked that of the atmosphere with a similar to 30 mmHg offset, thus the cells in the vessel wall were directly exposed to variations in pO(2). Monolayer cultures of smooth muscle cells isolated from saphenous veins exhibited increased proliferation when exposed to arterial pO(2) relative to those cultured at venous pO(2). This increased proliferation was blocked by tiron. Taken together, these data suggest that exposure of human SV to arterial pO(2) stimulates IH via a ROS-dependent pathway.	[Joddar, Binata; Reen, Rashmeet K.; Childers, Rachel C.; Gooch, Keith J.] Ohio State Univ, Dept Biomed Engn, Columbus, OH 43210 USA; [Joddar, Binata; Reen, Rashmeet K.; Varadharaj, Saradhadevi; Khan, Mahmood; Childers, Rachel C.; Zweier, Jay L.; Gooch, Keith J.] Ohio State Univ, Davis Heart & Lung Res Inst, Columbus, OH 43210 USA; [Firstenberg, Michael S.] Ohio State Univ, Div Cardiothorac Surg, Columbus, OH 43210 USA; [Khan, Mahmood] Ohio State Univ, Dept Emergency Med, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Gooch, KJ (corresponding author), Ohio State Univ, Dept Biomed Engn, Columbus, OH 43210 USA.	gooch.20@osu.edu	Joddar, Binata/GYD-4661-2022; Gooch, Keith/E-3135-2011	Childers, Rachel/0000-0001-9430-4897	American Heart Association [0655323B]; National Institutes of Health [HL38324, HL63744, HL65608]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL065608, R29HL038324, R01HL038324, R01HL063744] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding: American Heart Association (0655323B) to KJG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. National Institutes of Health (HL38324, HL63744, HL65608) to JLZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berard X, 2013, J VASC SURG, V57, P1371, DOI 10.1016/j.jvs.2012.09.041; Bindokas VP, 1996, J NEUROSCI, V16, P1324; Campbell GR, 1987, VASCULAR SMOOTH MUSC, V1, P39; Carr A, 1999, FASEB J, V13, P1007, DOI 10.1096/fasebj.13.9.1007; Castronuovo JJ, 2002, J VASC SURG, V35, P152, DOI 10.1067/mva.2002.119231; Das A, 2014, BRIT J PHARMACOL, V171, P2321, DOI 10.1111/bph.12572; De Pascali F, 2014, BIOCHEMISTRY-US, V53, P3679, DOI 10.1021/bi500076r; Deglise S, 2005, J VASC SURG, V41, P1043, DOI 10.1016/j.jvs.2005.02.036; Griendling KK, 2003, CIRCULATION, V108, P1912, DOI 10.1161/01.CIR.0000093660.86242.BB; Gusic RJ, 2005, J BIOMECH, V38, P1770, DOI 10.1016/j.jbiomech.2005.04.002; Gusic RJ, 2005, J BIOMECH, V38, P1760, DOI 10.1016/j.jbiomech.2004.10.030; Harrison D, 2003, AM J CARDIOL, V91, p7A; Jeremy JY, 2007, BIOMATERIALS, V28, P895, DOI 10.1016/j.biomaterials.2006.10.023; JHA P, 1995, ANN INTERN MED, V123, P860, DOI 10.7326/0003-4819-123-11-199512010-00009; Joddar B, 2011, BIOMECH MODEL MECHAN, V10, P161, DOI 10.1007/s10237-010-0224-8; Joddar B, 2011, FREE RADICAL BIO MED, V50, P700, DOI 10.1016/j.freeradbiomed.2010.12.008; Khan M, 2010, J PHARMACOL EXP THER, V333, P421, DOI 10.1124/jpet.109.165175; KJELDSEN K, 1968, J ATHEROSCLER RES, V8, P835, DOI 10.1016/S0368-1319(68)80046-8; KJELDSEN K, 1969, J ATHEROSCLER RES, V10, P173, DOI 10.1016/S0368-1319(69)80005-0; Lau AK, 2006, ATHEROSCLEROSIS, V185, P254, DOI 10.1016/j.atherosclerosis.2005.06.040; Medalion B, 1997, CIRCULATION, V95, P1853; Motwani JG, 1998, CIRCULATION, V97, P916, DOI 10.1161/01.CIR.97.9.916; Pandian RP, 2003, ARCH BIOCHEM BIOPHYS, V420, P169, DOI 10.1016/j.abb.2003.09.008; Paolini M, 2003, LANCET, V362, P920, DOI 10.1016/S0140-6736(03)14318-8; Porter KE, 1996, CARDIOVASC RES, V31, P607; Porter KE, 1998, J VASC SURG, V28, P695, DOI 10.1016/S0741-5214(98)70096-5; Porter KE, 2001, J VASC SURG, V34, P548, DOI 10.1067/mva.2001.115960; Rose BA, 2010, PHYSIOL REV, V90, P1507, DOI 10.1152/physrev.00054.2009; Ruef J, 1998, CIRCULATION, V97, P1071, DOI 10.1161/01.CIR.97.11.1071; Schachner T, 2006, J THORAC CARDIOV SUR, V131, P1065, DOI 10.1016/j.jtcvs.2005.11.043; Shi Y, 2001, CIRCULATION, V103, P2408; Ulrich-Merzenich G, 2002, IN VITRO CELL DEV-AN, V38, P265; Wilson YG, 1997, EUR J VASC ENDOVASC, V13, P557, DOI 10.1016/S1078-5884(97)80064-0; Wilson YG, 1996, J ENDOVASC SURG, V3, P436, DOI 10.1583/1074-6218(1996)003<0436:IOAVGP>2.0.CO;2; Zhao HT, 2005, P NATL ACAD SCI USA, V102, P5727, DOI 10.1073/pnas.0501719102	35	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120301	10.1371/journal.pone.0120301	http://dx.doi.org/10.1371/journal.pone.0120301			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799140	gold, Green Submitted, Green Published			2022-12-26	WOS:000351987300126
J	Leng, JH; Shao, P; Zhang, CP; Tian, HG; Zhang, FX; Zhang, S; Dong, L; Li, LL; Yu, ZJ; Chan, JCN; Hu, G; Yang, XL				Leng, Junhong; Shao, Ping; Zhang, Cuiping; Tian, Huiguang; Zhang, Fuxia; Zhang, Shuang; Dong, Ling; Li, Lili; Yu, Zhijie; Chan, Juliana C. N.; Hu, Gang; Yang, Xilin			Prevalence of Gestational Diabetes Mellitus and Its Risk Factors in Chinese Pregnant Women: A Prospective Population-Based Study in Tianjin, China	PLOS ONE			English	Article							BLOOD-PRESSURE; INTERNATIONAL ASSOCIATION; HYPERGLYCEMIA; DIAGNOSIS; WEIGHT; CLASSIFICATION; OBESITY	Objective We compared the increases in the prevalence of gestational diabetes mellitus (GDM) based on the 1999 World Health Organization (WHO) criteria and its risk factors in Tianjin, China, over a 12-year period. We also examined the changes in the prevalence using the criteria of International Association of Diabetes and Pregnancy Study Group (IADPSG). Methods In 2010-2012, 18589 women who registered within 12 weeks of gestation underwent a glucose challenge test (GCT) at 24-28 gestational weeks. Amongst them, 2953 women with 1-hour plasma glucose >= 7.8 mmol/L underwent a 75-gram 2-hour oral glucose tolerance test (OGTT) and 781 women had a positive GCT but absented from the standard OGTT. An adjusted prevalence of GDM was calculated for the whole cohort of women by including an estimate of the proportion of women with positive GCTs who did not have OGTTs but would have been expected to have GDM. Logistic regression was used to obtain odds ratios and 95% confidence intervals using the IADPSG criteria. The prevalence of GDM risk factors was compared to the 1999 survey. Results The adjusted prevalence of GDM by the 1999 WHO criteria was 8.1%, a 3.5-fold increase as in 1999. Using the IADPSG criteria increased the adjusted prevalence further to 9.3%. Advanced age, higher pre-pregnancy body mass index, Han-nationality, higher systolic blood pressure (BP), a family history of diabetes, weight gain during pregnancy and habitual smoking were risk factors for GDM. Compared to the 1999 survey, the prevalence of overweight plus obesity had increased by 1.8 folds, age >= 30 years by 2.3 folds, systolic BP by 2.3 mmHg over the 12-year period. Conclusions Increasing prevalence of overweight/obesity and older age at pregnancy were accompanied by increasing prevalence of GDM, further increased by change in diagnostic criteria.	[Leng, Junhong; Yang, Xilin] Tianjin Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Tianjin, Peoples R China; [Leng, Junhong; Shao, Ping; Zhang, Cuiping; Tian, Huiguang; Zhang, Fuxia; Zhang, Shuang; Dong, Ling; Li, Lili] Tianjin Women & Childrens Hlth Ctr, Tianjin, Peoples R China; [Yu, Zhijie] Dalhousie Univ, Populat Canc Res Program, Halifax, NS, Canada; [Yu, Zhijie] Dalhousie Univ, Dept Pediat, Halifax, NS, Canada; [Chan, Juliana C. N.] Chinese Univ Hong Kong, Int Diabet Federat Ctr Educ, Hong Kong Inst Diabet & Obes, Dept Med & Therapeut,Prince Wales Hosp,Int Diabet, Hong Kong, Hong Kong, Peoples R China; [Hu, Gang] Pennington Biomed Res Ctr, Chron Dis Epidemiol Lab, Baton Rouge, LA 70808 USA	Tianjin Medical University; Dalhousie University; Dalhousie University; Chinese University of Hong Kong; Prince of Wales Hospital; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center	Yang, XL (corresponding author), Tianjin Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Tianjin, Peoples R China.	yxl@hotmail.com	Chan, Juliana/B-7918-2016; Hu, Gang/N-1971-2017; Hu, Gang/V-7947-2019	Chan, Juliana/0000-0003-1325-1194; Hu, Gang/0000-0002-6172-8017; Hu, Gang/0000-0002-6172-8017	BRIDGES [LT09-227]; Lilly Diabetes	BRIDGES; Lilly Diabetes	This project was supported by BRIDGES (Grant number: LT09-227). BRIDGES is an International Diabetes Federation program supported by an educational grant from Lilly Diabetes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Ben-Haroush A, 2004, DIABETIC MED, V21, P103, DOI 10.1046/j.1464-5491.2003.00985.x; Chen Chunming, 2004, Biomed Environ Sci, V17 Suppl, P1; Chu SY, 2007, DIABETES CARE, V30, P2070, DOI 10.2337/dc06-2559a; Conen D, 2007, EUR HEART J, V28, P2937, DOI 10.1093/eurheartj/ehm400; Davey RX, 2001, MED J AUSTRALIA, V174, P118, DOI 10.5694/j.1326-5377.2001.tb143181.x; Dearth-Wesley T, 2008, EUR J CLIN NUTR, V62, P1302, DOI 10.1038/sj.ejcn.1602853; Di Cianni G, 2003, DIABETES RES CLIN PR, V62, P131, DOI 10.1016/j.diabres.2003.07.004; Fattah C, 2010, ACTA OBSTET GYN SCAN, V89, P952, DOI 10.3109/00016341003801706; Feig DS, 2008, CAN MED ASSOC J, V179, P229, DOI 10.1503/cmaj.080012; Hedderson MM, 2010, OBSTET GYNECOL, V115, P597, DOI 10.1097/AOG.0b013e3181cfce4f; Hedderson MM, 2008, DIABETES CARE, V31, P2362, DOI 10.2337/dc08-1193; Hillier TA, 2007, DIABETES CARE, V30, P2287, DOI 10.2337/dc06-2361; Hu FB, 2011, DIABETES CARE, V34, P1249, DOI 10.2337/dc11-0442; Jesmin S, 2014, DIABETES RES CLIN PR, V103, P57, DOI 10.1016/j.diabres.2013.11.024; Kessous R, 2013, HEART, V99, P1118, DOI 10.1136/heartjnl-2013-303945; Lao TT, 2003, J SOC GYNECOL INVEST, V10, P94, DOI 10.1016/S1071-5576(02)00218-6; Li N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082310; Ludbrook J, 2000, CLIN EXP PHARMACOL P, V27, P212, DOI 10.1046/j.1440-1681.2000.03223.x; Ludbrook J, 1998, CLIN EXP PHARMACOL P, V25, P1032, DOI 10.1111/j.1440-1681.1998.tb02179.x; Metzger BE, 2008, NEW ENGL J MED, V358, P1991, DOI 10.1056/NEJMoa0707943; Metzger BE, 2010, DIABETES CARE, V33, P676, DOI 10.2337/dc09-1848; Monda KL, 2008, EUR J CLIN NUTR, V62, P1318, DOI 10.1038/sj.ejcn.1602849; Morikawa M, 2012, INT J GYNECOL OBSTET, V118, P198, DOI 10.1016/j.ijgo.2012.04.019; Rassi A, 2006, NEW ENGL J MED, V355, P799, DOI 10.1056/NEJMoa053241; Shang M, 2014, J OBSTET GYNAECOL, V34, P141, DOI 10.3109/01443615.2013.832177; Tam WH, 2007, DIABETES-METAB RES, V23, P485, DOI 10.1002/dmrr.741; Torloni MR, 2009, OBES REV, V10, P194, DOI 10.1111/j.1467-789X.2008.00541.x; Wei Yu-mei, 2011, Zhonghua Fu Chan Ke Za Zhi, V46, P578; Xu Y, 2013, JAMA-J AM MED ASSOC, V310, P948, DOI 10.1001/jama.2013.168118; Yang XL, 2002, DIABETES CARE, V25, P847, DOI 10.2337/diacare.25.5.847; Zhang F, 2011, DIABETIC MED, V28, P652, DOI 10.1111/j.1464-5491.2010.03205.x	32	163	181	4	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121029	10.1371/journal.pone.0121029	http://dx.doi.org/10.1371/journal.pone.0121029			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799433	gold, Green Published, Green Submitted			2022-12-26	WOS:000351987300200
J	Samia, DSM; Blumstein, DT				Samia, Diogo S. M.; Blumstein, Daniel T.			Birds Flush Early and Avoid the Rush: An Interspecific Study	PLOS ONE			English	Article							FLIGHT-INITIATION DISTANCE; DISTURBANCE; BEHAVIOR; PREDATORS; WILDLIFE; ECOLOGY; TRAITS; FEAR	Since 1986, studies about the escape decisions made by prey are grounded in optimal escape theory (OET) which states that prey will initiate escape when the risk of remaining and the costs of leaving are equal. However, a recent hypothesis, Flush Early and Avoid the Rush (FEAR), acknowledged that the cost of monitoring approaching predators might be a ubiquitous cost. The FEAR hypothesis predicts that prey will generally flee soon after they detect a predator so as to minimize the costs incurred by monitoring the predator. Knowing whether animals flee to reduce monitoring costs is of applied interest because wildlife managers use escape behavior to create set-back zones to reduce human-wildlife conflict. Here we provide the most comprehensive assessment of the FEAR hypothesis using data collected from 178 bird species representing 67 families from two continents. The FEAR hypothesis explains escape behavior in 79% of studied species. Because the FEAR hypothesis is a widespread phenomenon that drives escape behavior in birds, alert distance must be systematically incorporated into the design of set-back zones to protect vulnerable species.	[Samia, Diogo S. M.] Univ Fed Goias, Dept Ecol, Lab Theoret Ecol & Synth, Goiania, Go, Brazil; [Blumstein, Daniel T.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA USA	Universidade Federal de Goias; University of California System; University of California Los Angeles	Samia, DSM (corresponding author), Univ Fed Goias, Dept Ecol, Lab Theoret Ecol & Synth, Goiania, Go, Brazil.	diogosamia@gmail.com		Blumstein, Daniel/0000-0001-5793-9244				Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Blumstein DT, 2010, PRIMER OF CONSERVATION BEHAVIOR, P1; Blumstein DT, 2010, BEHAV ECOL, V21, P440, DOI 10.1093/beheco/arq030; Blumstein DT, 2006, ANIM BEHAV, V71, P389, DOI 10.1016/j.anbehav.2005.05.010; Blumstein DT, 2004, ETHOLOGY, V110, P615, DOI 10.1111/j.1439-0310.2004.01000.x; Blumstein DT, 2003, J WILDLIFE MANAGE, V67, P852, DOI 10.2307/3802692; Butler MA, 2004, AM NAT, V164, P683, DOI 10.1086/426002; Cooper Jr W. E., 2015, ESCAPING PREDATORS I; Cooper WE, 2014, BEHAV ECOL, V25, P44, DOI 10.1093/beheco/art083; Dukas R, 2004, BRAIN BEHAV EVOLUT, V63, P197, DOI 10.1159/000076781; Felsenstein J., 2004, INFERRING PHYLOGENIE; Fernandez-Juricic E, 2005, BIOL CONSERV, V125, P225, DOI 10.1016/j.biocon.2005.03.020; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; Hansen TF, 1997, EVOLUTION, V51, P1341, DOI 10.1111/j.1558-5646.1997.tb01457.x; Jetz W, 2012, NATURE, V491, P444, DOI 10.1038/nature11631; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Koricheva J., 2013, HDB META ANAL ECOLOG; Lee SI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064977; Mccoy MW, 2008, J ANIM ECOL, V77, P478, DOI 10.1111/j.1365-2656.2008.01372.x; McGowan MM, 2014, ETHOLOGY, V120, P1081, DOI 10.1111/eth.12281; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Preisser EL, 2005, ECOLOGY, V86, P501, DOI 10.1890/04-0719; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; Rodgers JA, 2002, CONSERV BIOL, V16, P216, DOI 10.1046/j.1523-1739.2002.00316.x; Runyan AM, 2004, J WILDLIFE MANAGE, V68, P1124, DOI 10.2193/0022-541X(2004)068[1124:DIDIFI]2.0.CO;2; Samia DSM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113134; Samia DSM, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0016; Samia DSM, 2015, BIOL REV IN PRESS; Stankowich T, 2005, P ROY SOC B-BIOL SCI, V272, P2627, DOI 10.1098/rspb.2005.3251; Symonds MRE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091960; Taylor AR, 2003, ECOL APPL, V13, P951, DOI 10.1890/1051-0761(2003)13[951:WRTRAA]2.0.CO;2; Weston MA, 2012, EMU, V112, P269, DOI 10.1071/MU12026; Williams DM, 2014, BEHAV ECOL, V25, P1136, DOI 10.1093/beheco/aru098; YDENBERG RC, 1986, ADV STUD BEHAV, V16, P229, DOI 10.1016/S0065-3454(08)60192-8	34	20	21	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0119906	10.1371/journal.pone.0119906	http://dx.doi.org/10.1371/journal.pone.0119906			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799238	Green Submitted, Green Published, gold			2022-12-26	WOS:000351987300088
J	Stepanova, LA; Kotlyarov, RY; Kovaleva, AA; Potapchuk, MV; Korotkov, AV; Sergeeva, MV; Kasianenko, MA; Kuprianov, VV; Ravin, NV; Tsybalova, LM; Skryabin, KG; Kiselev, OI				Stepanova, Liudmila A.; Kotlyarov, Roman Y.; Kovaleva, Anna A.; Potapchuk, Marina V.; Korotkov, Alexandr V.; Sergeeva, Mariia V.; Kasianenko, Marina A.; Kuprianov, Victor V.; Ravin, Nikolai V.; Tsybalova, Liudmila M.; Skryabin, Konstantin G.; Kiselev, Oleg I.			Protection against Multiple Influenza A Virus Strains Induced by Candidate Recombinant Vaccine Based on Heterologous M2e Peptides Linked to Flagellin	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-5; GRAM-NEGATIVE FLAGELLIN; FUSION PROTEIN VACCINE; EXTRACELLULAR DOMAIN; MATRIX PROTEIN-2; SALMONELLA-TYPHIMURIUM; INTRANASAL IMMUNIZATION; MONOCLONAL-ANTIBODIES; RESPIRATORY CHALLENGE; BACTERIAL FLAGELLIN	Matrix 2 protein ectodomain (M2e) is considered a promising candidate for a broadly protective influenza vaccine. M2e-based vaccines against human influenza A provide only partial protection against avian influenza viruses because of differences in the M2e sequences. In this work, we evaluated the possibility of obtaining equal protection and immune response by using recombinant protein on the basis of flagellin as a carrier of the M2e peptides of human and avian influenza A viruses. Recombinant protein was generated by the fusion of two tandem copies of consensus M2e sequence from human influenza A and two copies of M2e from avian A/H5N1 viruses to flagellin (Flg-2M2eh2M2ek). Intranasal immunisation of Balb/c mice with recombinant protein significantly elicited anti-M2e IgG in serum, IgG and sIgA in BAL. Antibodies induced by the fusion protein Flg-2M2eh2M2ek bound efficiently to synthetic peptides corresponding to the human consensus M2e sequence as well as to the M2e sequence of A/Chicken/Kurgan/05/05 RG (H5N1) and recognised native M2e epitopes exposed on the surface of the MDCK cells infected with A/PR/8/34 (H1N1) and A/Chicken/ Kurgan/05/05 RG (H5N1) to an equal degree. Immunisation led to both anti-M2e IgG1 and IgG2a response with IgG1 prevalence. We observed a significant intracellular production of IL-4, but not IFN-gamma, by CD4+ T-cells in spleen of mice following immunisation with Flg-2M2eh2M2ek. Immunisation with the Flg-2M2eh2M2ek fusion protein provided similar protection from lethal challenge with human influenza A viruses (H1N1, H3N2) and avian influenza virus (H5N1). Immunised mice experienced significantly less weight loss and decreased lung viral titres compared to control mice. The data obtained show the potential for the development of an M2e-flagellin candidate influenza vaccine with broad spectrum protection against influenza A viruses of various origins.	[Stepanova, Liudmila A.; Kovaleva, Anna A.; Potapchuk, Marina V.; Korotkov, Alexandr V.; Sergeeva, Mariia V.; Kasianenko, Marina A.; Tsybalova, Liudmila M.; Kiselev, Oleg I.] Minist Hlth Russian Federat, Res Inst Influenza, Dept Influenza Vaccines, St Petersburg, Russia; [Kotlyarov, Roman Y.; Kuprianov, Victor V.; Ravin, Nikolai V.; Skryabin, Konstantin G.] Russian Acad Sci, Ctr Bioengn, Moscow, Russia; [Ravin, Nikolai V.] GenNanotech Ltd, St Petersburg, Russia	Ministry of Health of the Russian Federation; Research Center of Biotechnology RAS; Russian Academy of Sciences	Stepanova, LA (corresponding author), Minist Hlth Russian Federat, Res Inst Influenza, Dept Influenza Vaccines, St Petersburg, Russia.	stepanoval60@mail.ru	Kotlyarov, Roman/ABI-7582-2020; Sergeeva, Mariia/F-8963-2017; Ravin, Nikolai V/C-5907-2014; Tsybalova, Liudmila/A-5073-2017; kuprianov, victor/ABI-6803-2020	Kotlyarov, Roman/0000-0002-4387-2592; Sergeeva, Mariia/0000-0003-0411-9896; Tsybalova, Liudmila/0000-0002-1193-5907; Ravin, Nikolai/0000-0002-1456-1832; Stepanova, Liudmila/0000-0002-8731-1834	Ministry of Education and Science of the Russian Federation [8292]; President of Russia for young scientists award	Ministry of Education and Science of the Russian Federation(Ministry of Education and Science, Russian Federation); President of Russia for young scientists award	This work was supported by the Ministry of Education and Science of the Russian Federation (grant No 8292) and the fellowship of the President of Russia for young scientists awarded to R. Kotlyarov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adar Y, 2009, VACCINE, V27, P2099, DOI 10.1016/j.vaccine.2009.02.011; Ameiss K, 2010, VACCINE, V28, P6704, DOI 10.1016/j.vaccine.2010.07.083; Andersson AMC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046395; Camacho AGA, 2011, MEM I OSWALDO CRUZ, V106, P167, DOI 10.1590/S0074-02762011000900021; Arulanandam BP, 2001, J IMMUNOL, V166, P226, DOI 10.4049/jimmunol.166.1.226; Bargieri DY, 2010, VACCINE, V28, P2818, DOI 10.1016/j.vaccine.2010.02.004; Bates JT, 2008, MECH AGEING DEV, V129, P271, DOI 10.1016/j.mad.2008.01.009; Bates JT, 2009, J IMMUNOL, V182, P7539, DOI 10.4049/jimmunol.0804225; Ben-Yedidia T, 1999, INFECT IMMUN, V67, P4360, DOI 10.1128/IAI.67.9.4360-4366.1999; Berhanu A, 2008, J VIROL, V82, P3517, DOI 10.1128/JVI.01854-07; Bizanov G, 2005, SCAND J IMMUNOL, V61, P503, DOI 10.1111/j.1365-3083.2005.01627.x; Blokhina EA, 2013, VIROLOGY, V435, P293, DOI 10.1016/j.virol.2012.09.014; Bobat S, 2011, EUR J IMMUNOL, V41, P1606, DOI 10.1002/eji.201041089; Chen LM, 2012, VIROLOGY, V422, P105, DOI 10.1016/j.virol.2011.10.006; Nguyen CT, 2011, VACCINE, V29, P5731, DOI 10.1016/j.vaccine.2011.05.095; Cuadros C, 2004, INFECT IMMUN, V72, P2810, DOI 10.1128/IAI.72.5.2810-2816.2004; Cunningham AF, 2004, EUR J IMMUNOL, V34, P2986, DOI 10.1002/eji.200425403; De Filette M, 2005, VIROLOGY, V337, P149, DOI 10.1016/j.virol.2005.04.004; De Filette M, 2008, J BIOL CHEM, V283, P11382, DOI 10.1074/jbc.M800650200; De Filette M, 2006, VACCINE, V24, P6597, DOI 10.1016/j.vaccine.2006.05.082; Delaney KN, 2010, VIRAL IMMUNOL, V23, P201, DOI 10.1089/vim.2009.0107; Didierlaurent A, 2004, J IMMUNOL, V172, P6922, DOI 10.4049/jimmunol.172.11.6922; Donnelly MA, 2002, J BIOL CHEM, V277, P40456, DOI 10.1074/jbc.M206851200; Eaves-Pyles TD, 2001, J IMMUNOL, V167, P7009, DOI 10.4049/jimmunol.167.12.7009; Ebrahimi SM, 2012, VIROLOGY, V430, P63, DOI 10.1016/j.virol.2012.04.015; El Bakkouri K, 2011, J IMMUNOL, V186, P1022, DOI 10.4049/jimmunol.0902147; Feng T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035918; Fiers W, 2009, VACCINE, V27, P6280, DOI 10.1016/j.vaccine.2009.07.007; Gat O, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001373; Hashimoto Y, 2007, J IMMUNOL, V178, P2448, DOI 10.4049/jimmunol.178.4.2448; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Hazenbos WLW, 1996, IMMUNITY, V5, P181, DOI 10.1016/S1074-7613(00)80494-X; Hong SH, 2012, VACCINE, V30, P466, DOI 10.1016/j.vaccine.2011.10.058; Honko AN, 2006, INFECT IMMUN, V74, P1113, DOI 10.1128/IAI.74.2.1113-1120.2006; Huleatt JW, 2008, VACCINE, V26, P201, DOI 10.1016/j.vaccine.2007.10.062; Huleatt JW, 2007, VACCINE, V25, P763, DOI 10.1016/j.vaccine.2006.08.013; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; ITO T, 1991, J VIROL, V65, P5491, DOI 10.1128/JVI.65.10.5491-5498.1991; Jegerlehner A, 2004, J IMMUNOL, V172, P5598, DOI 10.4049/jimmunol.172.9.5598; Jeon SH, 2002, VACCINE, V20, P2772, DOI 10.1016/S0264-410X(02)00187-1; Kim MC, 2013, MOL THER, V21, P485, DOI 10.1038/mt.2012.246; Kotlyarov RY, 2010, ACTA NATURAE, V2, P71, DOI 10.32607/20758251-2010-2-2-71-76; Lee LH, 1999, INFECT IMMUN, V67, P5799, DOI 10.1128/IAI.67.11.5799-5805.1999; Lin SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039075; Liu G, 2011, PLOS ONE, V6, DOI DOI 10.1371/JOURNAL.PONE.0020928; Liu G, 2012, VACCINE, V30, P6833, DOI 10.1016/j.vaccine.2012.09.013; Liu WL, 2005, MICROBES INFECT, V7, P171, DOI 10.1016/j.micinf.2004.10.006; Liu WL, 2004, IMMUNOL LETT, V93, P131, DOI 10.1016/j.imlet.2004.03.003; Ma JH, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-227; MAZANEC MB, 1995, J VIROL, V69, P1339, DOI 10.1128/JVI.69.2.1339-1343.1995; McDonald WF, 2007, J INFECT DIS, V195, P1607, DOI 10.1086/517613; McSorley SJ, 2002, J IMMUNOL, V169, P3914, DOI 10.4049/jimmunol.169.7.3914; Mizel SB, 2003, J BIOL CHEM, V278, P23624, DOI 10.1074/jbc.M303481200; Mizel SB, 2002, J BIOL CHEM, V277, P22414, DOI 10.1074/jbc.M201762200; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Mozdzanowska K, 2003, VACCINE, V21, P2616, DOI 10.1016/S0264-410X(03)00040-9; Mozdzanowska K, 1999, VIROLOGY, V254, P138, DOI 10.1006/viro.1998.9534; Mozdzanowska K, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-118; Munoz N, 2010, INFECT IMMUN, V78, P4226, DOI 10.1128/IAI.00224-10; Neirynck S, 1999, NAT MED, V5, P1157, DOI 10.1038/13484; Nimmerjahn F, 2006, IMMUNITY, V24, P19, DOI 10.1016/j.immuni.2005.11.010; Nimmerjahn F, 2005, SCIENCE, V310, P1510, DOI 10.1126/science.1118948; Petukhova NV, 2013, CURR PHARM DESIGN, V19, P5587, DOI 10.2174/13816128113199990337; Ravin NV, 2012, BIOCHEMISTRY-MOSCOW+, V77, P33, DOI 10.1134/S000629791201004X; Sanders CJ, 2009, EUR J IMMUNOL, V39, P359, DOI 10.1002/eji.200838804; Schmitz N, 2012, EUR J IMMUNOL, V42, P863, DOI 10.1002/eji.201041225; Schnell JR, 2008, NATURE, V451, P591, DOI 10.1038/nature06531; Shibuya A, 2006, SPRINGER SEMIN IMMUN, V28, P377, DOI 10.1007/s00281-006-0050-3; Shim BS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027953; Singh M, 1999, NAT BIOTECHNOL, V17, P1075, DOI 10.1038/15058; Song L, 2009, VACCINE, V27, P5875, DOI 10.1016/j.vaccine.2009.07.060; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; TREANOR JJ, 1990, J VIROL, V64, P1375, DOI 10.1128/JVI.64.3.1375-1377.1990; Vyas SP, 2007, EXPERT REV VACCINES, V6, P401, DOI 10.1586/14760584.6.3.401; Wang BZ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013972; Wang L, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/686549; Weimer ET, 2009, INFECT IMMUN, V77, P2356, DOI 10.1128/IAI.00054-09; ZEBEDEE SL, 1988, J VIROL, V62, P2762, DOI 10.1128/JVI.62.8.2762-2772.1988; Zharikova D, 2005, J VIROL, V79, P6644, DOI 10.1128/JVI.79.11.6644-6654.2005	79	38	42	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0119520	10.1371/journal.pone.0119520	http://dx.doi.org/10.1371/journal.pone.0119520			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799221	Green Published, Green Submitted, gold			2022-12-26	WOS:000351987300058
J	Todorovic, A; Schoffelen, JM; van Ede, F; Maris, E; de Lange, FP				Todorovic, Ana; Schoffelen, Jan-Mathijs; van Ede, Freek; Maris, Eric; de lange, Floris P.			Temporal Expectation and Attention Jointly Modulate Auditory Oscillatory Activity in the Beta Band	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; PRIMARY VISUAL-CORTEX; REPETITION SUPPRESSION; MISMATCH NEGATIVITY; ORIENTING ATTENTION; HUMAN BRAIN; FREQUENCY OSCILLATIONS; CORTICAL OSCILLATIONS; NEURAL OSCILLATIONS; EEG-DATA	The neural response to a stimulus is influenced by endogenous factors such as expectation and attention. Current research suggests that expectation and attention exert their effects in opposite directions, where expectation decreases neural activity in sensory areas, while attention increases it. However, expectation and attention are usually studied either in isolation or confounded with each other. A recent study suggests that expectation and attention may act jointly on sensory processing, by increasing the neural response to expected events when they are attended, but decreasing it when they are unattended. Here we test this hypothesis in an auditory temporal cueing paradigm using magnetoencephalography in humans. In our study participants attended to, or away from, tones that could arrive at expected or unexpected moments. We found a decrease in auditory beta band synchrony to expected (versus unexpected) tones if they were unattended, but no difference if they were attended. Modulations in beta power were already evident prior to the expected onset times of the tones. These findings suggest that expectation and attention jointly modulate sensory processing.	[Todorovic, Ana; Schoffelen, Jan-Mathijs; van Ede, Freek; Maris, Eric; de lange, Floris P.] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6500 HB Nijmegen, Netherlands; [Schoffelen, Jan-Mathijs] Radboud Univ Nijmegen, Max Planck Inst Psycholinguist, NL-6500 HB Nijmegen, Netherlands	Radboud University Nijmegen; Max Planck Society; Radboud University Nijmegen	Todorovic, A (corresponding author), Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6500 HB Nijmegen, Netherlands.	todorovic.ana@gmail.com	van Ede, Freek/AAV-9013-2020; de Lange, Floris/D-2860-2009; Todorovic, Ana/ABG-2264-2020; Schoffelen, Jan-Mathijs/D-3716-2009	van Ede, Freek/0000-0002-7434-1751; de Lange, Floris/0000-0002-6730-1452; Schoffelen, Jan-Mathijs/0000-0003-0923-6610; Todorovic, Ana/0000-0003-2697-9635	Netherlands Organisation for Scientific Research (NWO VENI MaGW)	Netherlands Organisation for Scientific Research (NWO VENI MaGW)	Funding: FdL received funding from the Netherlands Organisation for Scientific Research in 2009 (NWO VENI MaGW), http://www.nwo.nl/en/research-and-results/programmes/Talent+Scheme/awards/veni+awards. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALHO K, 1995, EAR HEARING, V16, P38, DOI 10.1097/00003446-199502000-00004; Alink A, 2010, J NEUROSCI, V30, P2960, DOI 10.1523/JNEUROSCI.3730-10.2010; Arnal L.H., 2014, CEREB CORTEX; Arnal LH, 2012, TRENDS COGN SCI, V16, P390, DOI 10.1016/j.tics.2012.05.003; Bastiaansen MCM, 2000, CLIN NEUROPHYSIOL, V111, P1300, DOI 10.1016/S1388-2457(00)00272-8; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Bendixen A, 2012, INT J PSYCHOPHYSIOL, V83, P120, DOI 10.1016/j.ijpsycho.2011.08.003; Bendixen A, 2009, J NEUROSCI, V29, P8447, DOI 10.1523/JNEUROSCI.1493-09.2009; Clark A, 2013, BEHAV BRAIN SCI, V36, P181, DOI 10.1017/S0140525X12000477; Correa A, 2006, EXP BRAIN RES, V169, P58, DOI 10.1007/s00221-005-0131-x; Costa-Faidella J, 2011, J NEUROSCI, V31, P18590, DOI 10.1523/JNEUROSCI.2599-11.2011; Cravo AM, 2011, J NEUROPHYSIOL, V106, P2964, DOI 10.1152/jn.00157.2011; den Ouden HEM, 2009, CEREB CORTEX, V19, P1175, DOI 10.1093/cercor/bhn161; Donner TH, 2011, TRENDS COGN SCI, V15, P191, DOI 10.1016/j.tics.2011.03.007; Feldman H, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00215; Fischer R, 2013, NEUROIMAGE, V66, P261, DOI 10.1016/j.neuroimage.2012.10.091; Friston KJ, 2010, NAT REV NEUROSCI, V11, P127, DOI 10.1038/nrn2787; Garrido MI, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002999; Geiser E, 2012, J NEUROSCI, V32, P6177, DOI 10.1523/JNEUROSCI.5153-11.2012; Giraud AL, 2012, NAT NEUROSCI, V15, P511, DOI 10.1038/nn.3063; Gross J, 2001, P NATL ACAD SCI USA, V98, P694, DOI 10.1073/pnas.98.2.694; Haenschel C, 2000, P NATL ACAD SCI USA, V97, P7645, DOI 10.1073/pnas.120162397; HAMALAINEN M, 1993, REV MOD PHYS, V65, P413, DOI 10.1103/RevModPhys.65.413; Hong LE, 2008, PSYCHOPHYSIOLOGY, V45, P197, DOI 10.1111/j.1469-8986.2007.00624.x; Jones SR, 2010, J NEUROSCI, V30, P13760, DOI 10.1523/JNEUROSCI.2969-10.2010; Jung TP, 2000, CLIN NEUROPHYSIOL, V111, P1745, DOI 10.1016/S1388-2457(00)00386-2; Kosem A, 2014, NEUROIMAGE, V92, P274, DOI 10.1016/j.neuroimage.2014.02.010; Kok P, 2012, CEREB CORTEX, V22, P2197, DOI 10.1093/cercor/bhr310; Kok P, 2012, NEURON, V75, P265, DOI 10.1016/j.neuron.2012.04.034; Lampar A, 2011, ATTEN PERCEPT PSYCHO, V73, P1916, DOI 10.3758/s13414-011-0149-z; Lange K, 2006, J COGNITIVE NEUROSCI, V18, P715, DOI 10.1162/jocn.2006.18.5.715; Lange K, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00263; Lange K, 2009, BRAIN COGNITION, V69, P127, DOI 10.1016/j.bandc.2008.06.004; Larsson J, 2012, CEREB CORTEX, V22, P567, DOI 10.1093/cercor/bhr119; Lee TS, 2003, J OPT SOC AM A, V20, P1434, DOI 10.1364/JOSAA.20.001434; Liljestrom M, 2005, NEUROIMAGE, V25, P734, DOI 10.1016/j.neuroimage.2004.11.034; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; Martikainen MH, 2005, CEREB CORTEX, V15, P299, DOI 10.1093/cercor/bhh131; Merchant H, 2013, ANNU REV NEUROSCI, V36, P313, DOI 10.1146/annurev-neuro-062012-170349; Miniussi C, 1999, BRAIN, V122, P1507, DOI 10.1093/brain/122.8.1507; Mitra PP, 1999, BIOPHYS J, V76, P691, DOI 10.1016/S0006-3495(99)77236-X; NAATANEN R, 1990, BEHAV BRAIN SCI, V13, P201, DOI 10.1017/S0140525X00078407; Nazimek JM, 2013, NEUROPSYCHOLOGIA, V51, P2245, DOI 10.1016/j.neuropsychologia.2013.07.019; Nobrel AC, 2007, CURR OPIN NEUROBIOL, V17, P465, DOI 10.1016/j.conb.2007.07.006; Oostenveld R, 2011, COMPUT INTEL NEUROSC; Percival Donald B., 1993, SPECTRAL ANAL PHYS A; Pfurtscheller G, 2003, CLIN NEUROPHYSIOL, V114, P1226, DOI 10.1016/S1388-2457(03)00067-1; POSNER MI, 1980, J EXP PSYCHOL GEN, V109, P160, DOI 10.1037/0096-3445.109.2.160; Raij T, 1997, BRAIN RES, V745, P134, DOI 10.1016/S0006-8993(96)01140-7; Rao RPN, 1999, NAT NEUROSCI, V2, P79, DOI 10.1038/4580; Saleh M, 2010, NEURON, V65, P461, DOI 10.1016/j.neuron.2010.02.001; SanMiguel I, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00407; SanMiguel I, 2013, J NEUROSCI, V33, P8633, DOI 10.1523/JNEUROSCI.5821-12.2013; Schroeder CE, 2009, TRENDS NEUROSCI, V32, P9, DOI 10.1016/j.tins.2008.09.012; Schubotz RI, 2000, NEUROIMAGE, V11, P1, DOI 10.1006/nimg.1999.0514; Schwartze M, 2013, NEUROPSYCHOLOGIA, V51, P320, DOI 10.1016/j.neuropsychologia.2012.09.037; Schwartze M, 2012, INT J PSYCHOPHYSIOL, V83, P200, DOI 10.1016/j.ijpsycho.2011.11.003; Siegel M, 2012, NAT REV NEUROSCI, V13, P121, DOI 10.1038/nrn3137; Spratling MW, 2010, J NEUROSCI, V30, P3531, DOI 10.1523/JNEUROSCI.4911-09.2010; Spratling MW, 2008, FRONT COMPUT NEUROSC, V2, P1, DOI 10.3389/neuro.10.004.2008; Stefanics G, 2010, J NEUROSCI, V30, P13578, DOI 10.1523/JNEUROSCI.0703-10.2010; Summerfield C, 2008, NAT NEUROSCI, V11, P1004, DOI 10.1038/nn.2163; Summerfield C, 2009, TRENDS COGN SCI, V13, P403, DOI 10.1016/j.tics.2009.06.003; Todorovic A, 2012, J NEUROSCI, V32, P13389, DOI 10.1523/JNEUROSCI.2227-12.2012; Todorovic A, 2011, J NEUROSCI, V31, P9118, DOI 10.1523/JNEUROSCI.1425-11.2011; Valentini E, 2011, J COGNITIVE NEUROSCI, V23, P2822, DOI 10.1162/jocn.2011.21609; van Ede F, 2011, J NEUROSCI, V31, P2016, DOI 10.1523/JNEUROSCI.5630-10.2011; van Ede F, 2010, NEUROIMAGE, V51, P867, DOI 10.1016/j.neuroimage.2010.02.053; Vetter P, 2014, CONSCIOUS COGN, V27, P62, DOI 10.1016/j.concog.2014.04.007; Wacongne C, 2012, J NEUROSCI, V32, P3665, DOI 10.1523/JNEUROSCI.5003-11.2012; WOLDORFF MG, 1991, PSYCHOPHYSIOLOGY, V28, P30, DOI 10.1111/j.1469-8986.1991.tb03384.x	71	44	48	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120288	10.1371/journal.pone.0120288	http://dx.doi.org/10.1371/journal.pone.0120288			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799572	Green Published, Green Submitted, gold			2022-12-26	WOS:000351987300122
J	Zhan, RX; Yang, SW; He, WF; Wang, F; Tan, JL; Zhou, JY; Yang, SS; Yao, ZH; Wu, J; Luo, GX				Zhan, Rixing; Yang, Shiwei; He, Weifeng; Wang, Fan; Tan, Jianglin; Zhou, Junyi; Yang, Sisi; Yao, Zhihui; Wu, Jun; Luo, Gaoxing			Nitric Oxide Enhances Keratinocyte Cell Migration by Regulating Rho GTPase via cGMP-PKG Signalling	PLOS ONE			English	Article							FAMILY-MEMBERS; CANCER CELLS; EXPRESSION; IDENTIFICATION; PROTEINS; DYNAMICS; RELEASE	Objective Nitric oxide (NO) has been shown to improve wound healing, but the mechanism underlying this function is not well defined. Here, we explored the effect of NO on the migration of a human keratinocyte cell line (HaCaT) and its possible mechanism. Methods The effects of NO on HaCaT cells in the presence of different concentrations of the NO donor sodium nitroprusside (SNP) were evaluated in a cell migration assay. Subsequently, the cytoskeleton reorganization of cultured HaCaT cells stained with rhodamine-phalloidin was observed with a confocal laser scanning microscope. The mRNA expression and active proteins of CDC42, Rac1 and RhoA in the cultured cells were determined via RT-PCR and pull-down assays, respectively. Furthermore, the roles of various inhibitors or agonists specific to cGMP, PKG and CDC42, Rac1, RhoA in the effects of NO on HaCaT cell migration, F-actin stress fibre formation, and Rho GTPase expression were observed. Results It was also found HaCaT cell migration was increased by SNP in a dose-dependent manner, and the other two NO donors either spermine NONOate or SNAP had almost the same effects on HaCat cell migrations. The formation of F-actin stress fibres in SNP-treated HaCaT cells was increased. The mRNA expression and the active proteins of CDC42, Rac1 and RhoA were found to be upregulated after SNP treatment. Similar effects were observed after the cells were treated with a cGMP or PKG agonist. Additionally, the SNP-mediated upregulation of the mRNA expression and the active proteins of CDC42, Rac1 and RhoA were inhibited by the addition of an inhibitor of cGMP or PKG. Moreover, the SNP-mediated promoting effects of migration and cytoskeleton reorganization were inhibited by treatment with inhibitors of cGMP, PKG, CDC42, Rac1 and RhoA respectively. Conclusion Our data indicated that the stimulatory effects of NO on cell migration of HaCaT cells are mediated by the cGMP signalling pathway via the upregulation of Rho-GTPase expression, which might promote cytoskeleton reorganization.	[Zhan, Rixing; Yang, Shiwei; He, Weifeng; Wang, Fan; Tan, Jianglin; Zhou, Junyi; Yang, Sisi; Yao, Zhihui; Wu, Jun; Luo, Gaoxing] Third Mil Med Univ, State Key Lab Trauma Burn & Combined Injury, Key Lab Dis Prote Chongqing, Inst Burn Res,Southwest Hosp, Chongqing, Peoples R China	Army Medical University	Wu, J (corresponding author), Third Mil Med Univ, State Key Lab Trauma Burn & Combined Injury, Key Lab Dis Prote Chongqing, Inst Burn Res,Southwest Hosp, Chongqing, Peoples R China.	junwupro@cta.cq.cn; logxw@hotmail.com	Gaoxing, LUO/AAE-4505-2020	LUO, Gaoxing/0000-0003-4764-3209	National Natural Science Foundation of China [30973116, 81171809]; "863" project in China [2012AA020504]; Military medical program [AWS11J012-05, BWS11J039]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); "863" project in China(National High Technology Research and Development Program of China); Military medical program	This work was supported by the National Natural Science Foundation of China(30973116, 81171809), "863" project in China (2012AA020504), Military medical program (AWS11J012-05) & (BWS11J039). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aspenstrom P, 1999, EXP CELL RES, V246, P20, DOI 10.1006/excr.1998.4300; Babykutty S, 2012, CLIN EXP METASTAS, V29, P471, DOI 10.1007/s10585-012-9464-6; Begum R, 2004, EXP MOL MED, V36, P358, DOI 10.1038/emm.2004.47; Bernatchez SF, 2013, WOUND REPAIR REGEN, V21, P410, DOI 10.1111/wrr.12048; Blanchard JM, 2000, PATHOL BIOL, V48, P318; Bove PF, 2007, AM J RESP CELL MOL, V36, P138, DOI 10.1165/rcmb.2006-0253SM; Bulotta S, 2009, BIOCHEM BIOPH RES CO, V386, P744, DOI 10.1016/j.bbrc.2009.06.118; BURBELO PD, 1995, J BIOL CHEM, V270, P29071, DOI 10.1074/jbc.270.49.29071; Di Lorenzo A, 2013, J CELL SCI, V126, P5541, DOI 10.1242/jcs.115972; Fichter CD, 2014, J MOL MED, V92, P1209, DOI 10.1007/s00109-014-1187-5; Francis SH, 2010, PHARMACOL REV, V62, P525, DOI 10.1124/pr.110.002907; Frank S, 2000, BIOCHEM J, V346, P719, DOI 10.1042/0264-6021:3460719; Gomez R, 2013, J ORTHOP RES, V31, P1046, DOI 10.1002/jor.22331; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hall A, 2000, PHILOS T R SOC B, V355, P965, DOI 10.1098/rstb.2000.0632; Iden S, 2008, NAT REV MOL CELL BIO, V9, P846, DOI 10.1038/nrm2521; Kiwanuka E, 2016, INT WOUND J, V13, P372, DOI 10.1111/iwj.12315; Koyama T, 2001, J PHYSIOL-LONDON, V532, P759, DOI 10.1111/j.1469-7793.2001.0759e.x; KOZMA R, 1995, MOL CELL BIOL, V15, P1942; Krischel V, 1998, J INVEST DERMATOL, V111, P286, DOI 10.1046/j.1523-1747.1998.00268.x; Kumar S, 2010, FREE RADICAL BIO MED, V48, P851, DOI 10.1016/j.freeradbiomed.2010.01.004; Lee JS, 2005, AM J PATHOL, V166, P1861, DOI 10.1016/S0002-9440(10)62495-9; Li Q, 2014, CHEMOSPHERE, V96, P39, DOI 10.1016/j.chemosphere.2013.07.012; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Liu YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052280; Mashiach-Farkash E, 2012, ONCOTARGET, V3, P629; McDonald L J, 1995, Adv Pharmacol, V34, P263; Miyamoto T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1371; Murali A, 2014, CELL MOL LIFE SCI, V71, P1703, DOI 10.1007/s00018-013-1519-6; Nasca MR, 1999, J INVEST DERMATOL, V113, P720, DOI 10.1046/j.1523-1747.1999.00744.x; O'Toole EA, 2001, CLIN EXP DERMATOL, V26, P525, DOI 10.1046/j.1365-2230.2001.00891.x; Pan YL, 2004, BIOCHEM BIOPH RES CO, V315, P686, DOI 10.1016/j.bbrc.2004.01.108; Polytarchou C, 2009, INT J CANCER, V124, P1785, DOI 10.1002/ijc.24084; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Raja, 2007, Front Biosci, V12, P2849; Rausch S, 2013, BIOINTERPHASES, V8, DOI 10.1186/1559-4106-8-32; Sadok Amine, 2014, Small GTPases, V5, pe29710, DOI 10.4161/sgtp.29710; Senoo Hiroshi, 2013, Commun Integr Biol, V6, pe27681, DOI 10.4161/cib.27681; Sheng WW, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-121; Sit ST, 2011, J CELL SCI, V124, P679, DOI 10.1242/jcs.064964; Spitler R, 2013, CELL SIGNAL, V25, P2374, DOI 10.1016/j.cellsig.2013.07.029; Sugita K, 2010, J INVEST DERMATOL, V130, P464, DOI 10.1038/jid.2009.288; Williams Michael J, 2012, Small GTPases, V3, P1, DOI 10.4161/sgtp.20335; Zhou J, 2009, FREE RADICAL BIO MED, V47, P741, DOI 10.1016/j.freeradbiomed.2009.06.006	44	38	38	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121551	10.1371/journal.pone.0121551	http://dx.doi.org/10.1371/journal.pone.0121551			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799230	gold, Green Published, Green Submitted			2022-12-26	WOS:000351987300268
J	Su, XJ; Yuan, W; Huang, GY; Olsen, J; Li, J				Su, Xiu Juan; Yuan, Wei; Huang, Guo Ying; Olsen, Jorn; Li, Jiong			Paternal Age and Offspring Congenital Heart Defects: A National Cohort Study	PLOS ONE			English	Article							SPERM DNA-DAMAGE; RISK-FACTORS; METROPOLITAN ATLANTA; HIGH PREVALENCE; BIRTH-DEFECTS; MATERNAL AGE; PARENTAL AGE; FATHERS AGE; DISEASE; POPULATION	Paternal age has been associated with offspring congenital heart defects (CHDs), which might be caused by increased mutations in the germ cell line because of cumulated cell replications. Empirical evidences, however, remain inconclusive. Furthermore, it is unknown whether all subtypes of CHDs are affected by paternal age. We aimed to explore the relationship between paternal age and the risk of offspring CHDs and its five common subtypes using national register data in Denmark. A total of 1 893 899 singletons born in Denmark from 1977 to 2008 were included in this national-based cohort study. Cox's proportion hazards model with robust sandwich estimate option was used to estimate the hazards ratio (95% confidence interval) for the associations between paternal age and all CHDs, as well as subtypes of CHDs (patent ductus arteriosus (PDA), ventricular septal defect (VSD), atrial septal defect (ASD), tetralogy of fallot (TOF) and coarctation of the aorta (CoA)). We did not observe an overall association between paternal age and offspring CHDs. However, compared to the paternal age of 25-29 years, paternal age of older than 45 years was associated with a 69% increased risk of PDA (HR45+ = 1.69, 95 A,CI:1.17-2.43). We observed similar results when subanalyses were restricted to children born to mothers of 27-30 years old. After taking into consideration of maternal age, our data suggested that advanced paternal age was associated with an increased prevalence of one subtype of offspring congenital heart defects (CHDs), namely patent ductus arteriosus (PDA).	[Su, Xiu Juan] Tongji Univ, Sch Med, Shanghai Matern & Infant Hosp 1, Clin & Translat Res Ctr, Shanghai 200092, Peoples R China; [Su, Xiu Juan; Olsen, Jorn; Li, Jiong] Aarhus Univ, Epidemiol Sect, Dept Publ Hlth, Aarhus, Denmark; [Yuan, Wei] Shanghai Inst Planned Parenthood Res, NPFPC Lab Contracept & Devices, Shanghai, Peoples R China; [Yuan, Wei] Fudan Univ, Inst Reprod & Dev, Shanghai 200433, Peoples R China; [Huang, Guo Ying] Fudan Univ, Childrens Hosp, Shanghai 200433, Peoples R China	Tongji University; Aarhus University; Fudan University; Fudan University	Su, XJ (corresponding author), Tongji Univ, Sch Med, Shanghai Matern & Infant Hosp 1, Clin & Translat Res Ctr, Shanghai 200092, Peoples R China.	leilei7553@gmail.com; yuanwei11@yahoo.com	Olsen, Jørn/F-8801-2015; li, jiong/L-6534-2014	Olsen, Jørn/0000-0001-7462-5140; li, jiong/0000-0002-1716-8067; li, jiong/0000-0003-1125-026X	European Research Council [ERC-2010-StG-260242-PROGEURO]; Danish Medical Research Council [09-072986]; National Basic Research Program of China (973 program) [2010 CB 529504]; Shanghai First Maternity and Infant Hospital, Tongji University School of Medicine and Youth Foundation of Shanghai Municipal Commission of Health and Family Planning [20124y176]	European Research Council(European Research Council (ERC)European Commission); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Basic Research Program of China (973 program)(National Basic Research Program of China); Shanghai First Maternity and Infant Hospital, Tongji University School of Medicine and Youth Foundation of Shanghai Municipal Commission of Health and Family Planning	The study was supported by the European Research Council (ERC-2010-StG-260242-PROGEURO), the Danish Medical Research Council (project no. 09-072986), the National Basic Research Program of China (973 program), 2010 CB 529504. XJS is partly supported by a travel grant from Shanghai First Maternity and Infant Hospital, Tongji University School of Medicine and Youth Foundation of Shanghai Municipal Commission of Health and Family Planning (20124y176). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alio AP, 2012, AM J MENS HEALTH, V6, P427, DOI 10.1177/1557988312440718; Baltaxe Erik, 2006, Arch. Cardiol. Méx., V76, P263; Bassili A, 2000, EUR J EPIDEMIOL, V16, P805, DOI 10.1023/A:1007601919164; Bjornard K, 2013, BIRTH DEFECTS RES A, V97, P87, DOI 10.1002/bdra.23111; Botto LD, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2013.10.880; Canada S, 2010, GEN SOC SURV 1995 20; Cedergren MI, 2002, SCAND J WORK ENV HEA, V28, P12, DOI 10.5271/sjweh.641; CROEN LA, 1995, AM J PUBLIC HEALTH, V85, P710, DOI 10.2105/AJPH.85.5.710; Das M, 2013, J ASSIST REPROD GEN, V30, P843, DOI 10.1007/s10815-013-0015-0; Du ZD, 1996, AM J CARDIOL, V78, P1183, DOI 10.1016/S0002-9149(96)90080-6; Ewing CK, 1997, AM J MED GENET, V71, P42, DOI 10.1002/(SICI)1096-8628(19970711)71:1<42::AID-AJMG8>3.3.CO;2-A; Farag AT, 2010, REPROD TOXICOL, V29, P80, DOI 10.1016/j.reprotox.2009.10.003; Gelb BD, 2004, CURR OPIN CARDIOL, V19, P110, DOI 10.1097/00001573-200403000-00007; Goriely A, 2012, AM J HUM GENET, V90, P175, DOI 10.1016/j.ajhg.2011.12.017; Green RF, 2010, ANN EPIDEMIOL, V20, P241, DOI 10.1016/j.annepidem.2009.10.009; Grewal J, 2012, MATERN CHILD HLTH J, V16, P385, DOI 10.1007/s10995-011-0759-z; Jafarabadi M, 2007, HUM REPROD, V22, P3263, DOI 10.1093/humrep/dem329; Jaleel R, 2013, PAK J MED SCI, V29, P748, DOI 10.12669/pjms.293.3388; Jepsen P, 2006, INT J RISK SAF MED, V18, P77; Kazaura M, 2004, ANN EPIDEMIOL, V14, P566, DOI 10.1016/j.annepidem.2003.10.003; Knudsen LB, 1998, DAN MED BULL, V45, P320; Kong A, 2012, NATURE, V488, P471, DOI 10.1038/nature11396; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Martin J. A., 2013, 62 NAT VIT STAT; Materna-Kiryluk A, 2009, PAEDIATR PERINAT EP, V23, P29, DOI 10.1111/j.1365-3016.2008.00979.x; McDonald JH, 2008, HDB BIOL STAT SPARKI, P205; Miller A, 2011, AM J MED GENET A, V155A, P2137, DOI 10.1002/ajmg.a.34130; Mutsaerts MAQ, 2012, HUM REPROD, V27, P583, DOI 10.1093/humrep/der429; Nembhard WN, 2010, J PEDIATR-US, V156, P259, DOI 10.1016/j.jpeds.2009.07.058; OECD, 2020, OECD FAM DAT, DOI 10.1787/efd30a09-en; Olsen M, 2011, SCAND J PUBLIC HEALT, V39, P50, DOI 10.1177/1403494811399169; OLSHAN AF, 1994, TERATOLOGY, V50, P80, DOI 10.1002/tera.1420500111; Oyen N, 2009, AM HEART J, V157, P467, DOI 10.1016/j.ahj.2008.10.017; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; Penrose LS, 1995, LANCET, V269, P312; Reller MD, 2008, J PEDIATR-US, V153, P807, DOI 10.1016/j.jpeds.2008.05.059; SAMANEK M, 1994, PEDIATR CARDIOL, V15, P53; Satoda M, 2000, NAT GENET, V25, P42, DOI 10.1038/75578; SAVITZ DA, 1991, TERATOLOGY, V44, P429, DOI 10.1002/tera.1420440409; Schmid TE, 2007, HUM REPROD, V22, P180, DOI 10.1093/humrep/del338; Snijder CA, 2012, HUM REPROD, V27, P1510, DOI 10.1093/humrep/des043; TAY JSH, 1982, J MED GENET, V19, P441, DOI 10.1136/jmg.19.6.441; Yang Q, 2007, HUM REPROD, V22, P696, DOI 10.1093/humrep/del453; ZHAN SY, 1991, J EPIDEMIOL COMMUN H, V45, P299, DOI 10.1136/jech.45.4.299; Zhu JL, 2005, HUM REPROD, V20, P3173, DOI 10.1093/humrep/dei186	45	24	25	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0121030	10.1371/journal.pone.0121030	http://dx.doi.org/10.1371/journal.pone.0121030			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25806788	gold, Green Submitted, Green Published			2022-12-26	WOS:000351880000124
J	Cladel, NM; Budgeon, LR; Balogh, KK; Cooper, TK; Hu, JF; Christensen, ND				Cladel, Nancy M.; Budgeon, Lynn R.; Balogh, Karla K.; Cooper, Timothy K.; Hu, Jiafen; Christensen, Neil D.			A Novel Pre-Clinical Murine Model to Study the Life Cycle and Progression of Cervical and Anal Papillomavirus Infections	PLOS ONE			English	Article							COTTONTAIL RABBIT PAPILLOMAVIRUS; PROTECTIVE IMMUNITY; DNA VACCINATION; E6; PROTEIN; GENE; REGRESSION; E2; EXPRESSION; CHALLENGE	Background Papillomavirus disease and associated cancers remain a significant health burden in much of the world. The current protective vaccines, Gardasil and Cervarix, are expensive and not readily available to the underprivileged. In addition, the vaccines have not gained wide acceptance in the United States nor do they provide therapeutic value. Papillomaviruses are strictly species specific and thus human viruses cannot be studied in an animal host. An appropriate model for mucosal disease has long been sought. We chose to investigate whether the newly discovered mouse papillomavirus, MmuPV1, could infect mucosal tissues in Foxn1(nu)/Foxn1(nu) mice. Methods The vaginal and anal canals of Foxn1(nu)/Foxn1(nu) mice were gently abraded using Nonoxynol-9 and "Doctor's BrushPicks" and MmuPV1 was delivered into the vaginal tract or the anal canal. Results Productive vaginal, cervical and anal infections developed in all mice. Vaginal/cervical infections could be monitored by vaginal lavage. Dysplasias were evident in all animals. Conclusions Anogenital tissues of a common laboratory mouse can be infected with a papillomavirus unique to that animal. This observation will pave the way for fundamental virological and immunological studies that have been challenging to carry out heretofore due to lack of a suitable model system.	[Cladel, Nancy M.; Budgeon, Lynn R.; Balogh, Karla K.; Hu, Jiafen; Christensen, Neil D.] Penn State Univ, Jake Gittlen Labs Canc Res, Coll Med, Hershey, PA 17033 USA; [Cladel, Nancy M.; Budgeon, Lynn R.; Balogh, Karla K.; Hu, Jiafen; Christensen, Neil D.] Penn State Univ, Dept Pathol, Coll Med, Hershey, PA USA; [Christensen, Neil D.] Penn State Univ, Dept Microbiol & Immunol, Coll Med, Hershey, PA USA; [Cooper, Timothy K.] Penn State Univ, Dept Comparat Med, Coll Med Hershey, Hershey, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Cladel, NM (corresponding author), Penn State Univ, Jake Gittlen Labs Canc Res, Coll Med, Hershey, PA 17033 USA.	nmc4@psu.edu	Hu, Jiafen/G-5748-2017	Hu, Jiafen/0000-0001-8700-9937	Jake Gittlen Memorial Golf Tournament [501C3]; Gittlen Cancer Institute	Jake Gittlen Memorial Golf Tournament; Gittlen Cancer Institute	This work was supported by contributions from the Jake Gittlen Memorial Golf Tournament. This is a strictly non-profit (501C3) event designed to support our laboratory and others in the Gittlen Cancer Institute. No commercial enterprise is involved. The EIN number for the tournament is 23 2149559. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbyn M, 2011, ANN ONCOL, V22, P2675, DOI 10.1093/annonc/mdr015; Behren A, 2005, CANCER RES, V65, P11613, DOI 10.1158/0008-5472.CAN-05-2672; Brandsma JL, 2005, METH MOLEC MED, V119, P217; BRANDSMA JL, 1991, P NATL ACAD SCI USA, V88, P4816, DOI 10.1073/pnas.88.11.4816; BRANDSMA JL, 1992, J VIROL, V66, P6204, DOI 10.1128/JVI.66.10.6204-6207.1992; Breitburd F. NMSJOG, 2007, RABBIT VIRAL PAPILLO, P339; Christensen ND, 2000, VIROLOGY, V269, P451, DOI 10.1006/viro.2000.0237; Christensen ND, 1996, J VIROL, V70, P960, DOI 10.1128/JVI.70.2.960-965.1996; Christensen Neil D., 2005, Antiviral Chemistry & Chemotherapy, V16, P355; Cladel NM, 2013, J VIROL, V87, P9391, DOI 10.1128/JVI.00777-13; Cladel NM, 2013, VIROLOGY, V438, P70, DOI 10.1016/j.virol.2013.01.005; D'Souza G, 2007, NEW ENGL J MED, V356, P1944, DOI 10.1056/NEJMoa065497; Du MJ, 2005, J CELL BIOCHEM, V94, P1038, DOI 10.1002/jcb.20383; Ganzenmueller T, 2008, VIROLOGY, V372, P313, DOI 10.1016/j.virol.2007.11.006; Gillgrass AE, 2005, J VIROL, V79, P3107, DOI 10.1128/JVI.79.5.3107-3116.2005; Han R, 2000, VACCINE, V18, P2937, DOI 10.1016/S0264-410X(00)00110-9; HAN R, 1992, NATURE, V356, P66, DOI 10.1038/356066a0; Han R, 1998, VIROLOGY, V251, P253, DOI 10.1006/viro.1998.9416; Han R, 2000, J VIROL, V74, P9712, DOI 10.1128/JVI.74.20.9712-9716.2000; Han RC, 1999, J VIROL, V73, P7039, DOI 10.1128/JVI.73.8.7039-7043.1999; Handisurya A, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004314; Handisurya A, 2013, J VIROL, V87, P13214, DOI 10.1128/JVI.02162-13; Hu JF, 2005, J GEN VIROL, V86, P55, DOI 10.1099/vir.0.80448-0; Hu JF, 2002, J VIROL, V76, P6453, DOI 10.1128/JVI.76.13.6453-6459.2002; Hu JF, 2002, J VIROL, V76, P11801, DOI 10.1128/JVI.76.23.11801-11808.2002; Hu J, 2007, J GEN VIROL, V88, P3286, DOI 10.1099/vir.0.82879-0; Hu JF, 2007, VIROLOGY, V358, P384, DOI 10.1016/j.virol.2006.08.045; Hu JF, 2009, VIRUS RES, V144, P117, DOI 10.1016/j.virusres.2009.04.006; Ingle A, 2011, VET PATHOL, V48, P500, DOI 10.1177/0300985810377186; Jabbar SF, 2012, CANCER RES, V72, P4008, DOI 10.1158/0008-5472.CAN-11-3085; Jeckel S, 2002, J VIROL, V76, P11209, DOI 10.1128/JVI.76.22.11209-11215.2002; Jenkins AJ, 2003, VIRUS RES, V93, P109, DOI 10.1016/S0168-1702(03)00071-6; Joh J, 2011, J GEN VIROL, V92, P692, DOI 10.1099/vir.0.026138-0; Machalek DA, 2012, LANCET ONCOL, V13, P487, DOI 10.1016/S1470-2045(12)70080-3; Mejia AF, 2006, J VIROL, V80, P12393, DOI 10.1128/JVI.01583-06; Muhlen S, 2009, VIRUS RES, V139, P100, DOI 10.1016/j.virusres.2008.09.007; Nafz J, 2008, VIROLOGY, V374, P186, DOI 10.1016/j.virol.2007.12.012; Nasir L, 2008, VET DERMATOL, V19, P243, DOI 10.1111/j.1365-3164.2008.00683.x; Nicholls PK, 1999, J COMP PATHOL, V120, P219, DOI 10.1053/jcpa.1998.0278; OSTROW RS, 1990, P NATL ACAD SCI USA, V87, P8170, DOI 10.1073/pnas.87.20.8170; Peh WL, 2004, J VIROL, V78, P2142, DOI 10.1128/JVI.78.4.2142-2151.2004; Riley RR, 2003, CANCER RES, V63, P4862; Roberts JN, 2007, NAT MED, V13, P857, DOI 10.1038/nm1598; Roberts JN, 2011, JNCI-J NATL CANCER I, V103, P737, DOI 10.1093/jnci/djr061; Salmon J, 2000, J VIROL, V74, P10766, DOI 10.1128/JVI.74.22.10766-10777.2000; Salmon J, 1997, VIROLOGY, V235, P228, DOI 10.1006/viro.1997.8680; Schmitt A, 1996, J VIROL, V70, P1912, DOI 10.1128/JVI.70.3.1912-1922.1996; Selvakumar R, 1997, J VIROL, V71, P5540, DOI 10.1128/JVI.71.7.5540-5548.1997; Simard EP, 2013, CANCER-AM CANCER SOC, V119, P3539, DOI 10.1002/cncr.28252; Sundberg JP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113582; Zeltner R, J VIROLOGY, V68, P3620	51	33	34	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0120128	10.1371/journal.pone.0120128	http://dx.doi.org/10.1371/journal.pone.0120128			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803616	Green Submitted, gold, Green Published			2022-12-26	WOS:000353889600058
J	Derbridge, JJ; Merkle, JA; Bucci, ME; Callahan, P; Koprowski, JL; Polfus, JL; Krausman, PR				Derbridge, Jonathan J.; Merkle, Jerod A.; Bucci, Melanie E.; Callahan, Peggy; Koprowski, John L.; Polfus, Jean L.; Krausman, Paul R.			Experimentally Derived delta C-13 and delta N-15 Discrimination Factors for Gray Wolves and the Impact of Prior Information in Bayesian Mixing Models	PLOS ONE			English	Article							STABLE-ISOTOPES; DIET; UNCERTAINTY; ECOLOGY; NICHE; FRACTIONATION; CARBON	Stable isotope analysis of diet has become a common tool in conservation research. However, the multiple sources of uncertainty inherent in this analysis framework involve consequences that have not been thoroughly addressed. Uncertainty arises from the choice of trophic discrimination factors, and for Bayesian stable isotope mixing models (SIMMs), the specification of prior information; the combined effect of these aspects has not been explicitly tested. We used a captive feeding study of gray wolves (Canis lupus) to determine the first experimentally-derived trophic discrimination factors of C and N for this large carnivore of broad conservation interest. Using the estimated diet in our controlled system and data from a published study on wild wolves and their prey in Montana, USA, we then investigated the simultaneous effect of discrimination factors and prior information on diet reconstruction with Bayesian SIMMs. Discrimination factors for gray wolves and their prey were 1.97% for delta C-13 and 3.04% for delta N-15. Specifying wolf discrimination factors, as opposed to the commonly used red fox (Vulpes vulpes) factors, made little practical difference to estimates of wolf diet, but prior information had a strong effect on bias, precision, and accuracy of posterior estimates. Without specifying prior information in our Bayesian SIMM, it was not possible to produce SIMM posteriors statistically similar to the estimated diet in our controlled study or the diet of wild wolves. Our study demonstrates the critical effect of prior information on estimates of animal diets using Bayesian SIMMs, and suggests species-specific trophic discrimination factors are of secondary importance. When using stable isotope analysis to inform conservation decisions researchers should understand the limits of their data. It may be difficult to obtain useful information from SIMMs if informative priors are omitted and species-specific discrimination factors are unavailable.	[Derbridge, Jonathan J.; Koprowski, John L.] Univ Arizona, Sch Nat Resources & Environm, Tucson, AZ 85721 USA; [Merkle, Jerod A.] Univ Laval, Dept Biol, Jerod A Merkle, Quebec City, PQ G1K 7P4, Canada; [Merkle, Jerod A.] Univ Laval, Ctr Etude Foret, Quebec City, PQ G1K 7P4, Canada; [Bucci, Melanie E.; Krausman, Paul R.] Univ Montana, Wildlife Biol Program, Boone & Crockett Program Wildlife Conservat, Missoula, MT 59812 USA; [Callahan, Peggy] Wildlife Sci Ctr, Forest Lake, MN USA; [Polfus, Jean L.] Univ Manitoba, Nat Resources Inst, Winnipeg, MB, Canada	University of Arizona; Laval University; Laval University; University of Montana System; University of Montana; University of Manitoba	Derbridge, JJ (corresponding author), Univ Arizona, Sch Nat Resources & Environm, Tucson, AZ 85721 USA.	derbridge@email.arizona.edu	Merkle, Jerod A/ABB-5431-2021	Merkle, Jerod A/0000-0003-0100-1833; Polfus, Jean/0000-0002-1886-4232; Koprowski, John/0000-0003-1406-9853	Boone and Crockett Professor's Program at the University of Montana [MFR100-UMF]	Boone and Crockett Professor's Program at the University of Montana	Boone and Crockett Professor's Program at the University of Montana-account#: MFR100-UMF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo MS, 2009, J ANIM ECOL, V78, P848, DOI 10.1111/j.1365-2656.2009.01546.x; Ben-David M, 2001, OECOLOGIA, V127, P180, DOI 10.1007/s004420000570; Ben-David M, 2012, J MAMMAL, V93, P309, DOI 10.1644/11-MAMM-S-315.1; Berger J, 2006, BAYESIAN ANAL, V1, P385, DOI 10.1214/06-BA115; Boecklen WJ, 2011, ANNU REV ECOL EVOL S, V42, P411, DOI 10.1146/annurev-ecolsys-102209-144726; Bond AL, 2011, ECOL APPL, V21, P1017, DOI 10.1890/09-2409.1; Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675; Caut S, 2009, J APPL ECOL, V46, P443, DOI 10.1111/j.1365-2664.2009.01620.x; Darimont CT, 2009, J ANIM ECOL, V78, P126, DOI 10.1111/j.1365-2656.2008.01473.x; del Rio CM, 2009, BIOL REV, V84, P91, DOI 10.1111/j.1469-185X.2008.00064.x; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; Derbridge JJ, 2012, J WILDLIFE MANAGE, V76, P1277, DOI 10.1002/jwmg.359; Doucette JL, 2011, ECOL APPL, V21, P2987, DOI 10.1890/10-2384.1; Efron B, 1986, STAT SCI, V1, P54, DOI DOI 10.1214/SS/1177013815; Ellison AM, 2004, ECOL LETT, V7, P509, DOI 10.1111/j.1461-0248.2004.00603.x; Evans M., 1993, STAT DISTRIBUTIONS; FLOYD TJ, 1978, J WILDLIFE MANAGE, V42, P528, DOI 10.2307/3800814; Fox-Dobbs K, 2007, CAN J ZOOL, V85, P458, DOI 10.1139/Z07-018; Gannes LZ, 1997, ECOLOGY, V78, P1271, DOI 10.1890/0012-9658(1997)078[1271:SIIAEA]2.0.CO;2; Gelman A, 2006, BAYESIAN ANAL, V1, P515, DOI 10.1214/06-BA117A; Hazard E. B., 1982, MAMMALS MINNESOTA; Hopkins JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028478; Jackson AL, 2009, ECOL LETT, V12, pE1, DOI 10.1111/j.1461-0248.2008.01233.x; McCarthy MA, 2005, J APPL ECOL, V42, P1012, DOI 10.1111/j.1365-2664.2005.01101.x; MCLANDRESS MR, 1981, AUK, V98, P65; MECH L D, 1974, Mammalian Species, V37, P1; Merkle JA, 2013, J MAMMAL, V94, P378, DOI 10.1644/12-MAMM-A-002.1; Moore JW, 2008, ECOL LETT, V11, P470, DOI 10.1111/j.1461-0248.2008.01163.x; Parnell AC, 2013, ENVIRONMETRICS, V24, P387, DOI 10.1002/env.2221; Parnell AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009672; Phillips DL, 2001, OECOLOGIA, V127, P171, DOI 10.1007/s004420000578; Plummer M., 2003, P 3 INT WORKSH DISTR; Plummer M., 2013, RJAGS BAYESIAN GRAPH; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; RAU GH, 1992, MAR ECOL PROG SER, V84, P1, DOI 10.3354/meps084001; REYNOLDS PS, 1993, CAN J ZOOL, V71, P876, DOI 10.1139/z93-114; Roth JD, 2000, CAN J ZOOL, V78, P848, DOI 10.1139/cjz-78-5-848; Semmens BX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006187; Sikes RS, 2011, J MAMMAL, V92, P235, DOI 10.1644/10-MAMM-F-355.1; SPARKS DR, 1968, J RANGE MANAGE, V21, P264, DOI 10.2307/3895829; TIESZEN LL, 1983, OECOLOGIA, V57, P32, DOI 10.1007/BF00379558; Van Dongen S, 2006, J THEOR BIOL, V242, P90, DOI 10.1016/j.jtbi.2006.02.002; Vanderklift MA, 2003, OECOLOGIA, V136, P169, DOI 10.1007/s00442-003-1270-z; Ward EJ, 2010, ENVIRON SCI TECHNOL, V44, P4645, DOI 10.1021/es100053v; Wolf N, 2009, FUNCT ECOL, V23, P17, DOI 10.1111/j.1365-2435.2009.01529.x; Yeakel JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022015; Young S.P., 1944, WOLVES N AM	48	21	22	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0119940	10.1371/journal.pone.0119940	http://dx.doi.org/10.1371/journal.pone.0119940			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803664	Green Published, Green Submitted, gold			2022-12-26	WOS:000353889600051
J	Shi, YB; Yu, H; Ding, D; Yu, PM; Wu, DY; Hong, Z				Shi, Yunbo; Yu, Huan; Ding, Ding; Yu, Peimin; Wu, Dongyan; Hong, Zhen			Prevalence and Risk Factors of Restless Legs Syndrome among Chinese Adults in a Rural Community of Shanghai in China	PLOS ONE			English	Article							DIAGNOSTIC-CRITERIA; PRIMARY-CARE; POPULATION; EPIDEMIOLOGY; VALIDATION; SYMPTOMS; SEVERITY; HEALTH; IMPACT; WOMEN	Aims The primary objective of this study was to investigate the prevalence and risk factors of restless legs syndrome (RLS) in an adult Chinese population living in a rural community. We also aimed to determine the predictive diagnostic value of the 4-item screening questionnaire for RLS in this population. Methods This study was designed as a 2-phase survey. In phase 1 we performed a face-to-face interview of eligible individuals living in a rural community in Shanghai using a 4-item screening questionnaire. In phase 2, sleep specialists performed a phone interview of the individuals who screened positive to diagnosis RLS. Results Forty-one RLS cases were confirmed among 2941 eligible individuals 18 years of age or older in the study community. The prevalence of RLS was 1.4% (95% confidence interval (CI) = 1.0-1.9%), with a significantly higher rate observed in females (1.9%[95% CI = 1.3-2.7%]) than that in males (0.9% [95% CI = 0.5-1.5%], p=0.019). The prevalence rate increased significantly with age, from 0.2%(95% CI = 0.08-0.6%) in those 18-39 years old to 4.1% (95% CI = 2.1-7.9%) in those >= 70 years old (p<0.001). The multivariate logistic regression analysis indicated that gastritis, anemia and hypertension were risk factors for RLS. The sensitivity and specificity of the 4-itemscreening questionnaire used in this study were 63.4% and 97.5%, respectively. Conclusion RLS prevalence is relatively low among Chinese adults living in rural Shanghai. Furthermore, population-based studies with a larger sample size and a longitudinal follow-up may help to determine the risk factors of RLS and potential interventions for RLS.	[Shi, Yunbo; Yu, Huan; Ding, Ding; Yu, Peimin; Wu, Dongyan; Hong, Zhen] Fudan Univ, Huashan Hosp, Dept Neurol, Shanghai 200433, Peoples R China	Fudan University	Hong, Z (corresponding author), Fudan Univ, Huashan Hosp, Dept Neurol, Shanghai 200433, Peoples R China.	profzhong@sina.com						Alattar M, 2007, J AM BOARD FAM MED, V20, P365, DOI 10.3122/jabfm.2007.04.060153; Allen RP, 2001, SLEEP MED, V2, P239, DOI 10.1016/S1389-9457(00)00080-0; Allen RP, 2003, SLEEP MED, V4, P101, DOI 10.1016/S1389-9457(03)00010-8; Allen RP, 2005, ARCH INTERN MED, V165, P1286, DOI 10.1001/archinte.165.11.1286; Banerji N K, 1970, Br Med J, V4, P774; Bartzokis G, 2007, NEUROBIOL AGING, V28, P414, DOI 10.1016/j.neurobiolaging.2006.02.005; Batool-Anwar S, 2011, HYPERTENSION, V58, P791, DOI 10.1161/HYPERTENSIONAHA.111.174037; Bjorvatn B, 2005, SLEEP MED, V6, P307, DOI 10.1016/j.sleep.2005.03.008; Chen NH, 2010, PSYCHIAT CLIN NEUROS, V64, P170, DOI 10.1111/j.1440-1819.2010.02067.x; Hening W, 2004, SLEEP MED, V5, P237, DOI 10.1016/j.sleep.2004.03.006; Hening WA, 2003, SLEEP MED, V4, P137, DOI 10.1016/S1389-9457(03)00006-6; Hening WA, 2009, SLEEP MED, V10, P976, DOI 10.1016/j.sleep.2008.09.015; Kim J, 2005, PSYCHIAT CLIN NEUROS, V59, P350, DOI 10.1111/j.1440-1819.2005.01381.x; Li LH, 2012, SLEEP MED, V13, P342, DOI 10.1016/j.sleep.2011.09.008; Li YP, 2012, CIRCULATION, V126, P1689, DOI 10.1161/CIRCULATIONAHA.112.112698; Ma JF, 2012, PARKINSONISM RELAT D, V18, P294, DOI 10.1016/j.parkreldis.2011.11.014; Mallon L, 2008, PSYCHIAT CLIN NEUROS, V62, P457, DOI 10.1111/j.1440-1819.2008.01831.x; Nomura T, 2008, MOVEMENT DISORD, V23, P2363, DOI 10.1002/mds.22274; Pennestri MH, 2007, NEUROLOGY, V68, P1213, DOI 10.1212/01.wnl.0000259036.89411.52; Phillips B, 2006, CHEST, V129, P76, DOI 10.1378/chest.129.1.76; Phillips B, 2000, ARCH INTERN MED, V160, P2137, DOI 10.1001/archinte.160.14.2137; Rangarajan S, 2007, SLEEP MED, V8, P247, DOI 10.1016/j.sleep.2006.10.004; Rangarajan S, 2007, SLEEP MED, V9, P88, DOI 10.1016/j.sleep.2006.11.004; Tan EK, 2001, MOVEMENT DISORD, V16, P577, DOI 10.1002/mds.1102; Tison F, 2005, NEUROLOGY, V65, P239, DOI 10.1212/01.wnl.0000168910.48309.4a; Ulfberg J, 2007, SLEEP MED, V8, P768, DOI 10.1016/j.sleep.2006.11.015; Walters AS, 2003, SLEEP MED, V4, P121, DOI 10.1016/S1389-9457(02)00258-7; WALTERS AS, 1995, MOVEMENT DISORD, V10, P634, DOI 10.1002/mds.870100517; Yilmaz NH, 2013, ACTA NEUROL BELG, V113, P247, DOI 10.1007/s13760-012-0153-7	29	20	24	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0121215	10.1371/journal.pone.0121215	http://dx.doi.org/10.1371/journal.pone.0121215			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803876	Green Submitted, gold, Green Published			2022-12-26	WOS:000353889600138
J	Veiga, NJ; Pereira, CM; Ferreira, PC; Correia, IJ				Veiga, Nelio J.; Pereira, Carlos M.; Ferreira, Paula C.; Correia, Ilidio J.			Prevalence of Dental Caries and Fissure Sealants in a Portuguese Sample of Adolescents	PLOS ONE			English	Article							HEALTH-RELATED BEHAVIORS; ORAL-HEALTH; CHILDREN	Introduction The aims of this study were to assess the prevalence of dental caries and the DMFT index, as well as the distribution pattern of pit and fissure sealants on permanent teeth in a Portuguese sample of adolescents, and to assess whether the existing usage of sealants and socio-demographic factors are correlated to caries prevalence on the examined sample. Materials and Methods A cross-sectional study was designed with a sample of 447 adolescents aged 12 to 18 years old, attending a public school in Satao, Portugal. A self-administered questionnaire with questions about oral health behaviours and socio-economic status was answered by adolescents in the classroom. Clinical examination of oral health status and assessment of fissure sealants were accomplished by only one trained member of the research team. Results We obtained a DMFT index of 3.32 (2.92), which indicates a moderate level of prevalence of dental caries. When considering a DMFT = 0, we found significant statistical differences between the parents' level of education (<= 4th grade = 26.3 vs 5th-12th grade = 18.8 vs <12th grade = 43.3, p = 0.001), gender (male = 27.3 vs female = 19.6, p = 0.04), age (<= 15 years = 27.1 vs <15 years = 18.5, p = 0.02), presence of fissure sealants (yes = 30.6 vs no = 13.5, p = 0.001) and experience of dental pain (no = 25.4 vs yes = 16.8, p = 0.02). When analyzing the prevalence of fissure sealants, we verified that 58.8% of adolescents had at least one fissure sealant applied. Significant statistical differences were found when analyzing the presence of fissure sealants related with parents' educational level (<9th grade, OR = 1.56 CI95% = 1.05-2.54), gender (female, OR = 1.86 CI95% = 1.19-2.98), experience of dental pain (yes, OR = 0.62 CI95% = 0.39-0.97) and presence of dental caries (yes, OR = 0.35 CI95% = 0.19-0.65). Conclusions The moderate level of caries prevalence reveals the need of improvement of primary prevention interventions among Portuguese adolescents. The establishment of a more targeted preventive program with better and more effective oral health education is essential, having into account socio-demographic aspects.	[Veiga, Nelio J.; Correia, Ilidio J.] Beira Interior Univ, Fac Hlth Sci, Hlth Sci Res Ctr, Covilha, Portugal; [Veiga, Nelio J.; Pereira, Carlos M.] Technol & Hlth Studies Polytech Inst Viseu, Res Ctr Educ, Viseu, Portugal; [Veiga, Nelio J.; Ferreira, Paula C.] Univ Coimbra, Chem Proc Engn & Forest Prod Res Ctr, Dept Chem Engn, Coimbra, Portugal; [Veiga, Nelio J.] Portuguese Catholic Univ, Dept Hlth Sci, Viseu, Portugal	Universidade da Beira Interior; Universidade de Coimbra; Universidade Catolica Portuguesa	Veiga, NJ (corresponding author), Beira Interior Univ, Fac Hlth Sci, Hlth Sci Res Ctr, Covilha, Portugal.	nelioveiga@gmail.com	Ferreira, Paula/I-6288-2013; Correia, I. J./AAE-2400-2020; Correia, Ilidio/S-8295-2016; Ferreira, Paula/GQP-0550-2022; Ferreira, Paula/ABD-5826-2020; Veiga, Nelio/F-5279-2017	Ferreira, Paula/0000-0003-3393-4427; Correia, I. J./0000-0003-1613-9675; Correia, Ilidio/0000-0003-1613-9675; Ferreira, Paula/0000-0003-3393-4427; Veiga, Nelio/0000-0001-6288-0435	Fundacao para a Ciencia e Tecnologia; Research Centre for Education, Technology and Health Studies of the Polytechnic Institute of Viseu, Portugal (CIDETS)	Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Research Centre for Education, Technology and Health Studies of the Polytechnic Institute of Viseu, Portugal (CIDETS)	This study was funded by the Fundacao para a Ciencia e Tecnologia and the Research Centre for Education, Technology and Health Studies of the Polytechnic Institute of Viseu, Portugal (CI&DETS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ak AT, 2010, EUR J PAEDIATR DENT, V11, P93; Almerich Silla Jose Manuel, 2006, Med Oral Patol Oral Cir Bucal, V11, pE369; Axelsson P, 2004, AXELSSON SERIES ON P, V4, p[1, 37, 92, 103, 469]; Ayo-Yusuf O A, 2011, SADJ, V66, P380; Baldini V, 2011, J APPL ORAL SCI, V19, P396, DOI 10.1590/S1678-77572011005000016; Barata C, 2013, REV PORT ESTOMATOL M, V54, P27, DOI 10.1016/j.rpemd.2012.12.001; Cortelli S, 2004, CIENC ODONTOL BRAS, V7, P75; Crocombe LA, 2012, J PUBLIC HEALTH DENT, V72, P36, DOI 10.1111/j.1752-7325.2011.00281.x; Daniel S, 2008, MOSBYS DENTAL HYGIEN; de Almeida Cesar Mexia, 2003, Community Dent Health, V20, P211; Borges BCD, 2012, INT DENT J, V62, P251, DOI 10.1111/j.1875-595X.2012.00117.x; Feigal Robert J, 2002, Pediatr Dent, V24, P415; General Health Directory, 2008, NAT STUD PREV OR DIS; Griffin S, 2010, J AM DENT ASSOC, V10, P7; Irish Oral Health Services Guideline Initiative, 2010, PIT FISSURE SEALANTS; Jablonski-Momeni A, 2014, INT J PAEDIATR DENT, V24, P90, DOI 10.1111/ipd.12031; Julihn A, 2006, ACTA ODONTOL SCAND, V64, P267, DOI 10.1080/00016350600613534; Klein H, 1937, PUBLIC HLTH B, V239, P1; Leskinen K, 2008, ACTA ODONTOL SCAND, V66, P65, DOI 10.1080/00016350801926933; Murthy AK, 2014, EUR ARCH PAEDIATR DE, V15, P45, DOI 10.1007/s40368-013-0064-1; O'Mullane D, 1986, CHILDRENS DENT HLTH; Okullo I, 2004, COMMUNITY DENT ORAL, V32, P447, DOI 10.1111/j.1600-0528.2004.00183.x; Oulis CJ, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-100; Parnell C A, 2003, Community Dent Health, V20, P146; Pereira A, 2003, ODONTOLOGIA SAUDE CO, DOI [10.1002/lsm.20758, DOI 10.1002/LSM.20758]; Peres MA, 2007, J EPIDEMIOL COMMUN H, V61, P141, DOI 10.1136/jech.2005.044818; Poutanen R, 2007, ACTA ODONTOL SCAND, V65, P87, DOI 10.1080/00016350601058077; Qiu RM, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-239; Ravaghi Vahid, 2013, J Can Dent Assoc, V79, pd3; Ravera Enilde, 2012, Acta odontol. latinoam., V25, P138; Rose G, 2001, INT J EPIDEMIOL, V30, P427, DOI 10.1093/ije/30.3.427; Sagheri D, 2009, COMMUNITY DENT HLTH, V26, P32, DOI 10.1922/CDH_2261Sagheri06; Sistani M, 2013, ISRN DENTISTRY; Martin LFT, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-337; Tellez M, 2011, J AM DENT ASSOC, V142, P1033, DOI 10.14219/jada.archive.2011.0324; Truman BI, 2002, AM J PREV MED, V23, P21, DOI 10.1016/S0749-3797(02)00449-X; Vettore MV, 2012, CAD SAUDE PUBLICA, V28, pS101, DOI 10.1590/S0102-311X2012001300011; WHO World Health Organization, 2003, OR HLTH SURV BAS MET; World Health Organization, 2003, CONT IMPR OR HLTH 21, DOI [10.1111/j.1600-0528.2008.00448.x, DOI 10.1111/J.1600-0528.2008.00448.X]	39	13	14	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0121299	10.1371/journal.pone.0121299	http://dx.doi.org/10.1371/journal.pone.0121299			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803849	Green Submitted, Green Published, gold			2022-12-26	WOS:000353889600145
J	Yang, B; Ozaki, K; Ishikawa, Y; Matsuo, T				Yang, Bin; Ozaki, Katsuhisa; Ishikawa, Yukio; Matsuo, Takashi			Identification of Candidate Odorant Receptors in Asian Corn Borer Ostrinia furnacalis	PLOS ONE			English	Article							SEX-PHEROMONE; RESPONSE CHARACTERISTICS; MOTH; TRANSCRIPTOMES; LEPIDOPTERA; SPECIFICITY; EXPRESSION; EVOLUTION; SILKWORM; PROTEINS	In lepidopteran insects, odorant receptors are involved in the perception of sex pheromones and general odorants. In the Asian corn borer, Ostrinia furnacalis, although several pheromone receptors have been identified, no general odorant receptor has been reported. In this study, an RNA sequencing analysis was carried out to identify the whole repertoire of the odorant receptors expressed in the antennae of O. furnacalis. Among 12 million reads obtained from the antennae of male and female moths, 52 candidate odorant receptors were identified, including 45 novel ones. Expression levels of candidate odorant receptors were estimated by read mapping and quantitative reverse transcription PCR. These analyses confirmed that the expression of the previously identified pheromone receptors was highly male biased. In contrast, none of the newly identified odorant receptors showed male-biased expression. Three of the newly identified odorant receptors showed female-biased expression. Two of them were the most highly expressed odorant receptors in the female antennae, suggesting that they may be involved in the detection of odorants important for the induction of female-specific behaviors such as oviposition site selection. In addition, candidate genes of 21 ionotropic receptors, 5 gustatory receptors, 2 sensory neuron membrane proteins, and 26 odorant degrading enzymes were identified. Our results provide a basis for further analysis of the chemosensory system in the Ostrinia species.	[Yang, Bin; Ishikawa, Yukio; Matsuo, Takashi] Univ Tokyo, Dept Agr & Environm Biol, Bunkyo Ku, Tokyo 1138657, Japan	University of Tokyo	Matsuo, T (corresponding author), Univ Tokyo, Dept Agr & Environm Biol, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	matsuo@utlae.org	Ishikawa, Yukio/J-5676-2019; Matsuo, Takashi/AAR-8291-2021	Ishikawa, Yukio/0000-0003-3067-2513; Matsuo, Takashi/0000-0002-4185-6740	Japan Society for the Promotion of Science [24380030]; Grants-in-Aid for Scientific Research [23248008] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grant-in-Aid for Scientific Research number 24380030 from Japan Society for the Promotion of Science (http://www.jsps.go.jp/english/e-grants/index.html) to TM and KO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JE, 2011, INSECT BIOCHEM MOLEC, V41, P141, DOI 10.1016/j.ibmb.2010.10.005; Bengtsson JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031620; Benton R, 2007, NATURE, V450, P289, DOI 10.1038/nature06328; Benton R, 2009, CELL, V136, P149, DOI 10.1016/j.cell.2008.12.001; Croset V, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001064; de Bruyne M, 2008, J CHEM ECOL, V34, P882, DOI 10.1007/s10886-008-9485-4; FERKOVICH SM, 1980, CHEM SENSES, V5, P33, DOI 10.1093/chemse/5.1.33; GLOVER TJ, 1989, J CHEM ECOL, V15, P863, DOI 10.1007/BF01015182; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Grosse-Wilde E, 2011, P NATL ACAD SCI USA, V108, P7449, DOI 10.1073/pnas.1017963108; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hansson BS, 2014, J CHEM ECOL, V40, P409, DOI 10.1007/s10886-014-0437-x; Hansson BS, 2011, NEURON, V72, P698, DOI 10.1016/j.neuron.2011.11.003; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Hoeppner MP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091172; Huang YP, 1998, ENTOMOL EXP APPL, V89, P281, DOI 10.1023/A:1003577714551; Huang YP, 1998, J CHEM ECOL, V24, P2079, DOI 10.1023/A:1020737726636; Ishikawa Y, 1999, CHEMOECOLOGY, V9, P25, DOI 10.1007/s000490050030; Jacquin-Joly E, 2004, J CHEM ECOL, V30, P2359, DOI 10.1007/s10886-004-7941-3; Johansson BG, 2007, BIOL REV, V82, P265, DOI 10.1111/j.1469-185X.2007.00009.x; Jordan MD, 2009, CHEM SENSES, V34, P383, DOI 10.1093/chemse/bjp010; Katoh K, 2010, BIOINFORMATICS, V26, P1899, DOI 10.1093/bioinformatics/btq224; King JR, 2000, J NEUROSCI, V20, P2391; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lassance JM, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-10; Leal WS, 2013, ANNU REV ENTOMOL, V58, P373, DOI 10.1146/annurev-ento-120811-153635; Leary GP, 2012, P NATL ACAD SCI USA, V109, P14081, DOI 10.1073/pnas.1204661109; Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520; Liu NY, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-597; Liu Y, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0036949, 10.1371/journal.pone.0032127, 10.1371/journal.pone.0040003, 10.1186/1746-1596-7-49]; Marcel M., 2008, EMBNET J, V17, P10; Miura N, 2010, INSECT BIOCHEM MOLEC, V40, P64, DOI 10.1016/j.ibmb.2009.12.011; Miura N, 2009, INT J BIOL SCI, V5, P319; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; MUTUURA A, 1970, MEM ENTOMOL SOC CAN, P1; Nakagawa T, 2005, SCIENCE, V307, P1638, DOI 10.1126/science.1106267; Obiero GFO, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002663; Ohno Suguru, 2003, Entomological Science, V6, P77, DOI 10.1046/j.1343-8786.2003.00007.x; Poivet E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060263; Roberts A, 2013, NAT METHODS, V10, P71, DOI [10.1038/NMETH.2251, 10.1038/nmeth.2251]; ROELOFS WL, 1985, J CHEM ECOL, V11, P829, DOI 10.1007/BF01012071; Rogers ME, 2001, J NEUROBIOL, V49, P47, DOI 10.1002/neu.1065; Sato K, 2011, P NATL ACAD SCI USA, V108, P11680, DOI 10.1073/pnas.1019622108; Stamatakis A, 2012, BIOINFORMATICS, V28, P2064, DOI 10.1093/bioinformatics/bts309; Takanashi T, 2000, CHEMOECOLOGY, V10, P143, DOI 10.1007/PL00001816; Takanashi T, 2006, J EXP BIOL, V209, P4946, DOI 10.1242/jeb.02587; Tanaka K, 2009, CURR BIOL, V19, P881, DOI 10.1016/j.cub.2009.04.035; Vieira FG, 2011, GENOME BIOL EVOL, V3, P476, DOI 10.1093/gbe/evr033; Wanner KW, 2008, INSECT MOL BIOL, V17, P621, DOI 10.1111/j.1365-2583.2008.00836.x; Wanner KW, 2007, INSECT MOL BIOL, V16, P107, DOI 10.1111/j.1365-2583.2007.00708.x; Wanner KW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008685; Yang Y, 2014, MOL BIOL EVOL, V31, P3081, DOI 10.1093/molbev/msu245; Zhang J, 2013, INSECT MOL BIOL, V22, P424, DOI 10.1111/imb.12033; Zhang YN, 2014, J CHEM ECOL, V40, P439, DOI 10.1007/s10886-014-0433-1	54	39	42	3	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0121261	10.1371/journal.pone.0121261	http://dx.doi.org/10.1371/journal.pone.0121261			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803580	Green Submitted, gold, Green Published			2022-12-26	WOS:000353889600142
J	Zhang, L; Sun, R; Xu, ZW; Qiao, C; Jiang, GQ				Zhang, Lei; Sun, Rui; Xu, Ziwei; Qiao, Chen; Jiang, Guoqing			Diurnal and Seasonal Variations in Carbon Dioxide Exchange in Ecosystems in the Zhangye Oasis Area, Northwest China	PLOS ONE			English	Article							GROSS PRIMARY PRODUCTION; TOTAL SOIL RESPIRATION; WATER-VAPOR EXCHANGE; EDDY-COVARIANCE; NET ECOSYSTEM; ENVIRONMENTAL-CONTROL; DEGRADED GRASSLAND; CO2 FLUX; CROPLAND; BALANCE	Quantifying carbon dioxide exchange and understanding the response of key environmental factors in various ecosystems are critical to understanding regional carbon budgets and ecosystem behaviors. For this study, CO2 fluxes were measured in a variety of ecosystems with an eddy covariance observation matrix between June 2012 and September 2012 in the Zhangye oasis area of Northwest China. The results show distinct diurnal variations in the CO2 fluxes in vegetable field, orchard, wetland, and maize cropland. Diurnal variations of CO2 fluxes were not obvious, and their values approached zero in the sandy desert, desert steppe, and Gobi ecosystems. Additionally, daily variations in the Gross Primary Production (GPP), Ecosystem Respiration (R-eco) and Net Ecosystem Exchange (NEE) were not obvious in the sandy desert, desert steppe, and Gobi ecosystems. In contrast, the distributions of the GPP, R-eco, and NEE show significant daily variations, that are closely related to the development of vegetation in the maize, wetland, orchard, and vegetable field ecosystems. All of the ecosystems are characterized by their carbon absorption during the observation period. The ability to absorb CO2 differed significantly among the tested ecosystems. We also used the Michaelis-Menten equation and exponential curve fitting methods to analyze the impact of Photosynthetically Active Radiation (PAR) on the daytime CO2 flux and impact of air temperature on R-eco at night. The results show that PAR is the dominant factor in controlling photosynthesis with limited solar radiation, and daytime CO2 assimilation increases rapidly with PAR. Additionally, the carbon assimilation rate was found to increase slowly with high solar radiation. The light response parameters changed with each growth stage for all of the vegetation types, and higher light response values were observed during months or stages when the plants grew quickly. Light saturation points are different for different species. Nighttime R-eco increases exponentially with air temperature. High Q(10) values were observed when the vegetation coverage was relatively low, and low Q(10) values occurred when the vegetables grew vigorously.	[Zhang, Lei; Sun, Rui; Xu, Ziwei] Chinese Acad Sci, State Key Lab Remote Sensing Sci, Beijing Normal Univ & Inst Remote Sensing Applica, Beijing, Peoples R China; [Zhang, Lei; Sun, Rui; Xu, Ziwei; Qiao, Chen; Jiang, Guoqing] Beijing Normal Univ, Sch Geog & Remote Sensing Sci, Beijing 100875, Peoples R China; [Zhang, Lei; Sun, Rui; Xu, Ziwei] Beijing Key Lab Remote Sensing Environm & Digital, Beijing, Peoples R China	Beijing Normal University; Chinese Academy of Sciences; Beijing Normal University	Sun, R (corresponding author), Chinese Acad Sci, State Key Lab Remote Sensing Sci, Beijing Normal Univ & Inst Remote Sensing Applica, Beijing, Peoples R China.	sunrui@bnu.edu.cn			National Natural Science Foundation of China [41471349, 91125002]; Fundamental Research Funds for the Central Universities [2014kJJCA02]; National Key Project of Scientific and Technical Supporting Programs - Ministry of Science & Technology of China [2013BAC03B02]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Key Project of Scientific and Technical Supporting Programs - Ministry of Science & Technology of China	This work was supported by the National Natural Science Foundation of China (41471349, 91125002), the Fundamental Research Funds for the Central Universities (2014kJJCA02), and the National Key Project of Scientific and Technical Supporting Programs Funded by Ministry of Science & Technology of China (2013BAC03B02). The data used in the paper are from the Heihe Watershed Allied Telemetry Experimental Research experiment, we greatly thank all participants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker JM, 2005, AGR FOREST METEOROL, V128, P163, DOI 10.1016/j.agrformet.2004.11.005; Baldocchi D, 2001, B AM METEOROL SOC, V82, P2415, DOI 10.1175/1520-0477(2001)082<2415:FANTTS>2.3.CO;2; Bond-Lamberty B, 2004, GLOBAL CHANGE BIOL, V10, P1756, DOI 10.1111/j.1365-2486.2004.00816.x; Dannoura M, 2006, TELLUS B, V58, P502, DOI 10.1111/j.1600-0889.2006.00216.x; Falge E, 2001, AGR FOREST METEOROL, V107, P43, DOI 10.1016/S0168-1923(00)00225-2; Flanagan LB, 2002, GLOBAL CHANGE BIOL, V8, P599, DOI 10.1046/j.1365-2486.2002.00491.x; Friend AD, 1997, ECOL MODEL, V95, P249, DOI 10.1016/S0304-3800(96)00034-8; [符淙斌 Fu Congbin], 2002, [气候与环境研究, Climatic and environmental research], V7, P22; Gilmanov TG, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB002023; Goodrich DC, 2000, AGR FOREST METEOROL, V105, P3, DOI 10.1016/S0168-1923(00)00178-7; Guo H Q, 2010, CARBON FLUXES ESTUAR; Guo WH, 2010, RES VARIATION VINEYA; Hollinger DY, 1999, GLOB CHANGE BIOL, V5, P891, DOI 10.1046/j.1365-2486.1999.00281.x; Hollinger SE, 2005, AGR FOREST METEOROL, V130, P59, DOI 10.1016/j.agrformet.2005.01.005; Huenneke LF, 2002, GLOBAL CHANGE BIOL, V8, P247, DOI 10.1046/j.1365-2486.2002.00473.x; Jomura M, 2007, TELLUS B, V59, P211, DOI 10.1111/j.1600-0889.2006.00234.x; Kim H, 2005, PHYTON-ANN REI BOT A, V45, P385; Kim Honghyun, 2005, Journal of Agricultural Meteorology, V61, P95, DOI 10.2480/agrmet.61.95; Kosugi Y, 2008, AGR FOREST METEOROL, V148, P439, DOI 10.1016/j.agrformet.2007.10.007; Law BE, 2002, AGR FOREST METEOROL, V113, P97, DOI 10.1016/S0168-1923(02)00104-1; Lee MS, 2003, PLANT SOIL, V255, P311, DOI 10.1023/A:1026192607512; Lei HM, 2010, GLOBAL CHANGE BIOL, V16, P2944, DOI 10.1111/j.1365-2486.2009.02136.x; Li J, 2006, SCI CHINA SER D, V49, P226, DOI 10.1007/s11430-006-8226-1; [李鸣骥 LI Mingji], 2007, [中国沙漠, Journal of Desert Research], V27, P1048; Li X, 2013, B AM METEOROL SOC, V94, P1145, DOI 10.1175/BAMS-D-12-00154.1; Li ZQ, 2007, REMOTE SENS ENVIRON, V107, P510, DOI 10.1016/j.rse.2006.10.003; Liang N, 2005, PHYTON-ANN REI BOT A, V45, P109; Liao CZ, 2007, ECOSYSTEMS, V10, P1351, DOI 10.1007/s10021-007-9103-2; Lieth H, 1975, PRIMARY PRODUCTIVITY; Liu HZ, 2008, ADV ATMOS SCI, V25, P1009, DOI 10.1007/s00376-008-1009-1; [刘冉 Liu Ran], 2011, [中国沙漠, Journal of Desert Research], V31, P108; Liu SM, 2013, J HYDROL, V487, P24, DOI 10.1016/j.jhydrol.2013.02.025; Liu SM, 2011, HYDROL EARTH SYST SC, V15, P1291, DOI 10.5194/hess-15-1291-2011; LLOYD J, 1994, FUNCT ECOL, V8, P315, DOI 10.2307/2389824; Miyama T, 2003, TELLUS B, V55, P322, DOI 10.1034/j.1600-0889.2003.00010.x; Miyama T, 2006, TELLUS B, V58, P550, DOI 10.1111/j.1600-0889.2006.00207.x; Papale D, 2006, BIOGEOSCIENCES, V3, P571, DOI 10.5194/bg-3-571-2006; Pilegaard K, 2001, AGR FOREST METEOROL, V107, P29, DOI 10.1016/S0168-1923(00)00227-6; RAICH JW, 1995, GLOBAL BIOGEOCHEM CY, V9, P23, DOI 10.1029/94GB02723; Soegaard H, 2003, AGR FOREST METEOROL, V114, P153, DOI 10.1016/S0168-1923(02)00177-6; Subke JA, 2006, GLOBAL CHANGE BIOL, V12, P921, DOI 10.1111/j.1365-2486.2006.01117.x; Suyker AE, 2004, AGR FOREST METEOROL, V124, P1, DOI 10.1016/j.agrformet.2004.01.011; Suyker AE, 2001, GLOBAL CHANGE BIOL, V7, P279, DOI 10.1046/j.1365-2486.2001.00407.x; Trumbore S, 2006, GLOBAL CHANGE BIOL, V12, P141, DOI 10.1111/j.1365-2486.2006.01067.x; Uchida M, 2005, AGR FOREST METEOROL, V134, P102, DOI 10.1016/j.agrformet.2005.11.003; Veenendaal EM, 2004, GLOBAL CHANGE BIOL, V10, P318, DOI 10.1111/j.1365-2486.2003.00699.x; [王宇 Wang Yu], 2010, [生态学报, Acta Ecologica Sinica], V30, P4376; Wang Z, 2010, AGR FOREST METEOROL, V150, P1160, DOI 10.1016/j.agrformet.2010.04.015; Wilczak JM, 2001, BOUND-LAY METEOROL, V99, P127, DOI 10.1023/A:1018966204465; Wohlfahrt G, 2008, GLOBAL CHANGE BIOL, V14, P1475, DOI 10.1111/j.1365-2486.2008.01593.x; Xu LK, 2004, AGR FOREST METEOROL, V123, P79, DOI 10.1016/j.agrformet.2003.10.004; Xu ZW, 2013, J GEOPHYS RES-ATMOS, V118, P13140, DOI 10.1002/2013JD020260; Zhao CY, 2004, STUDY SOIL RESP SOIL; Zhao L, 2010, BIOGEOSCIENCES, V7, P1207, DOI 10.5194/bg-7-1207-2010; Zhu ZL, 2006, SCI CHINA SER D, V49, P36, DOI 10.1007/s11430-006-8036-5	55	17	19	8	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0120660	10.1371/journal.pone.0120660	http://dx.doi.org/10.1371/journal.pone.0120660			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803840	gold, Green Published, Green Submitted			2022-12-26	WOS:000353889600089
J	Cook, BW; Barber, KR; Shilton, BH; Shaw, GS				Cook, Benjamin W.; Barber, Kathryn R.; Shilton, Brian H.; Shaw, Gary S.			The HIP2 similar to Ubiquitin Conjugate Forms a Non-Compact Monomeric Thioester during Di-Ubiquitin Synthesis	PLOS ONE			English	Article							STRUCTURAL BASIS; POLYUBIQUITIN CHAINS; CRYSTAL-STRUCTURE; ENZYME E2-25K; E2; INSIGHTS; COMPLEX; CATALYSIS; REVEALS; TAIL	Polyubiquitination is a post-translational event used to control the degradation of damaged or unwanted proteins by modifying the target protein with a chain of ubiquitin molecules. One potential mechanism for the assembly of polyubiquitin chains involves the dimerization of an E2 conjugating enzyme allowing conjugated ubiquitin molecules to be put into close proximity to assist reactivity. HIP2 (UBE2K) and Ubc1 (yeast homolog of UBE2K) are unique E2 conjugating enzymes that each contain a C-terminal UBA domain attached to their catalytic domains, and they have basal E3-independent polyubiquitination activity. Although the isolated enzymes are monomeric, polyubiquitin formation activity assays show that both can act as ubiquitin donors or ubiquitin acceptors when in the activated thioester conjugate suggesting dimerization of the E2-ubiquitin conjugates. Stable disulfide complexes, analytical ultracentrifugation and small angle x-ray scattering were used to show that the HIP2-Ub and Ubc1-Ub thioester complexes remain predominantly monomeric in solution. Models of the HIP2-Ub complex derived from SAXS data show the complex is not compact but instead forms an open or backbent conformation similar to UbcH5b similar to Ub or Ubc13 similar to Ub where the UBA domain and covalently attached ubiquitin reside on opposite ends of the catalytic domain. Activity assays showed that full length HIP2 exhibited a fivefold increase in the formation rate of di-ubiquitin compared to a HIP2 lacking the UBA domain. This difference was not observed for Ubc1 and may be attributed to the closer proximity of the UBA domain in HIP2 to the catalytic core than for Ubc1.	[Cook, Benjamin W.; Barber, Kathryn R.; Shilton, Brian H.; Shaw, Gary S.] Univ Western Ontario, Schulich Sch Med Dent, Dept Biochem, London, ON N6A 5C1, Canada	Western University (University of Western Ontario)	Shaw, GS (corresponding author), Univ Western Ontario, Schulich Sch Med Dent, Dept Biochem, London, ON N6A 5C1, Canada.	gshaw1@uwo.ca	Shaw, Gary S./C-7656-2009; Shilton, Brian H/A-6667-2011	Shaw, Gary S./0000-0002-4685-9625; 	Canadian Institutes of Health Research [MOP-14606]; Canada Research Chairs Program; United States Department of Energy, Basic Energy Sciences, Office of Science [W-31-109-ENG-38]; National Institutes of Health Research [RR-08630]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chairs Program(Canada Research Chairs); United States Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); National Institutes of Health Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding: This work was supported by a grant from the Canadian Institutes of Health Research (MOP-14606) and Canada Research Chairs Program (G.S.S). Use of the Advanced Photon Source is supported by the United States Department of Energy, Basic Energy Sciences, Office of Science, under Contract W-31-109-ENG-38, and BioCAT is supported by National Institutes of Health Research Grant RR-08630. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brzovic PS, 2006, MOL CELL, V21, P873, DOI 10.1016/j.molcel.2006.02.008; CHEN ZJ, 1990, J BIOL CHEM, V265, P21835; Cook BW, 2012, BIOCHEM J, V445, P167, DOI 10.1042/BJ20120504; Eddins MJ, 2006, NAT STRUCT MOL BIOL, V13, P915, DOI 10.1038/nsmb1148; Haldeman MT, 1997, BIOCHEMISTRY-US, V36, P10526, DOI 10.1021/bi970750u; Hamilton KS, 2000, J BIOMOL NMR, V18, P319, DOI 10.1023/A:1026773008237; Hamilton KS, 2001, STRUCTURE, V9, P897, DOI 10.1016/S0969-2126(01)00657-8; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hochstrasser M, 2006, CELL, V124, P27, DOI 10.1016/j.cell.2005.12.025; Hodgins R, 1996, J BIOL CHEM, V271, P28766, DOI 10.1074/jbc.271.46.28766; Huzil JT, 2007, J BIOL CHEM, V282, P37454, DOI 10.1074/jbc.M705242200; JOHNSON ML, 1981, BIOPHYS J, V36, P575, DOI 10.1016/S0006-3495(81)84753-4; Kamadurai HB, 2009, MOL CELL, V36, P1095, DOI 10.1016/j.molcel.2009.11.010; Ko S, 2010, J BIOL CHEM, V285, P36070, DOI 10.1074/jbc.M110.145219; Li W, 2007, NATURE, V446, P333, DOI 10.1038/nature05542; Li W, 2009, P NATL ACAD SCI USA, V106, P3722, DOI 10.1073/pnas.0808564106; Markin CJ, 2010, J AM CHEM SOC, V132, P17775, DOI 10.1021/ja105267w; McKenna S, 2003, J BIOL CHEM, V278, P13151, DOI 10.1074/jbc.M212353200; Merkley N, 2004, J BIOL CHEM, V279, P47139, DOI 10.1074/jbc.M409576200; Merkley N, 2005, J BIOL CHEM, V280, P31732, DOI 10.1074/jbc.M505205200; Moraes TF, 2001, NAT STRUCT BIOL, V8, P669, DOI 10.1038/90373; Page RC, 2012, BIOCHEMISTRY-US, V51, P4175, DOI 10.1021/bi300058m; Plechanovova A, 2012, NATURE, V489, P115, DOI 10.1038/nature11376; Raasi S, 2005, NAT STRUCT MOL BIOL, V12, P708, DOI 10.1038/nsmb962; Rodrigo-Brenni MC, 2007, CELL, V130, P127, DOI 10.1016/j.cell.2007.05.027; Rodrigo-Brenni MC, 2010, MOL CELL, V39, P548, DOI 10.1016/j.molcel.2010.07.027; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; VanDemark AP, 2001, CELL, V105, P711, DOI 10.1016/S0092-8674(01)00387-7; VANNOCKER S, 1993, J BIOL CHEM, V268, P24766; Vittal V, 2013, CELL BIOCHEM BIOPHYS, V67, P103, DOI 10.1007/s12013-013-9633-5; Wilson RC, 2009, ACTA CRYSTALLOGR F, V65, P440, DOI 10.1107/S1744309109011117; WILTFANG J, 1991, ELECTROPHORESIS, V12, P352, DOI 10.1002/elps.1150120507; Wu K, 2010, MOL CELL, V37, P784, DOI 10.1016/j.molcel.2010.02.025	33	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120318	10.1371/journal.pone.0120318	http://dx.doi.org/10.1371/journal.pone.0120318			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799589	gold, Green Submitted, Green Published			2022-12-26	WOS:000351987300132
J	Droppa, M; Tschernow, D; Mueller, KAL; Tavlaki, E; Karathanos, A; Stimpfle, F; Schaeffeler, E; Schwab, M; Tolios, A; Siller-Matula, JM; Gawaz, M; Geisler, T				Droppa, Michal; Tschernow, Dimitri; Mueller, Karin A. L.; Tavlaki, Elli; Karathanos, Athanasios; Stimpfle, Fabian; Schaeffeler, Elke; Schwab, Matthias; Tolios, Alexander; Siller-Matula, Jolanta M.; Gawaz, Meinrad; Geisler, Tobias			Evaluation of Clinical Risk Factors to Predict High On-Treatment Platelet Reactivity and Outcome in Patients with Stable Coronary Artery Disease (PREDICT-STABLE)	PLOS ONE			English	Article							STENT THROMBOSIS; ANTIPLATELET THERAPY; CLOPIDOGREL; INTERVENTION; MORTALITY; REVASCULARIZATION; CYTOCHROME-P450; RESPONSIVENESS; INHIBITION; PRASUGREL	Objectives This study was designed to identify the multivariate effect of clinical risk factors on high on-treatment platelet reactivity (HPR) and 12 months major adverse events (MACE) under treatment with aspirin and clopidogrel in patients undergoing non-urgent percutaneous coronary intervention (PCI). Methods 739 consecutive patients with stable coronary artery disease (CAD) undergoing PCI were recruited. On-treatment platelet aggregation was tested by light transmittance aggregometry. Clinical risk factors and MACE during one-year follow-up were recorded. An independent population of 591 patients served as validation cohort. Results Degree of on-treatment platelet aggregation was influenced by different clinical risk factors. In multivariate regression analysis older age, diabetes mellitus, elevated BMI, renal function and left ventricular ejection fraction were independent predictors of HPR. After weighing these variables according to their estimates in multivariate regression model, we developed a score to predict HPR in stable CAD patients undergoing elective PCI (PREDICT-STABLE Score, ranging 0-9). Patients with a high score were significantly more likely to develop MACE within one year of follow-up, 3.4% (score 0-3), 6.3% (score 4-6) and 10.3% (score 7-9); odds ratio 3.23, P=0.02 for score 7-9 vs. 0-3. This association was confirmed in the validation cohort. Conclusions Variability of on-treatment platelet function and associated outcome is mainly influenced by clinical risk variables. Identification of high risk patients (e.g. with high PREDICT-STABLE score) might help to identify risk groups that benefit from more intensified antiplatelet regimen. Additional clinical risk factor assessment rather than isolated platelet function-guided approaches should be investigated in future to evaluate personalized antiplatelet therapy in stable CAD-patients.	[Droppa, Michal; Tschernow, Dimitri; Mueller, Karin A. L.; Tavlaki, Elli; Karathanos, Athanasios; Stimpfle, Fabian; Gawaz, Meinrad; Geisler, Tobias] Univ Tubingen Hosp, Dept Cardiol & Cardiovasc Med, Tubingen, Germany; [Schaeffeler, Elke; Schwab, Matthias] Dr Margarete Fischer Bosch Inst Clin Pharmacol, Stuttgart, Germany; [Schwab, Matthias] Univ Tubingen Hosp, Dept Clin Pharmacol, Tubingen, Germany; [Tolios, Alexander] Univ Munich, Med Ctr, Inst Lab Med, Munich, Germany; [Siller-Matula, Jolanta M.] Med Univ Vienna, Dept Cardiol, Vienna, Austria	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Munich; Medical University of Vienna	Geisler, T (corresponding author), Univ Tubingen Hosp, Dept Cardiol & Cardiovasc Med, Tubingen, Germany.	tobias.geisler@med.uni-tuebingen.de	Schwab, Matthias/ABH-7449-2020; Geisler, Tobias/AAO-4472-2020; Jolanta Siller-Matula, PD/J-8992-2015	Jolanta Siller-Matula, PD/0000-0001-6041-1635; Droppa, Michal/0000-0001-5807-7615	Deutsche Forschungsgemeinschaft [SCHW 858/1-1]; Deutsche Forschungsgemeinschaft (Klinische Forschergruppe 274 Platelets - Molecular Mechanisms and Translational Implications); FP7 EU Initial Training Network program Fighting-DrugFailure [PITN-GA-2009-238132]; Robert Bosch Stiftung, Germany; Deutsche Forschungsgemeinschaft; Open Access Publishing Fund of Tuebingen University	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft (Klinische Forschergruppe 274 Platelets - Molecular Mechanisms and Translational Implications)(German Research Foundation (DFG)); FP7 EU Initial Training Network program Fighting-DrugFailure; Robert Bosch Stiftung, Germany; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Open Access Publishing Fund of Tuebingen University	This work was supported by the Deutsche Forschungsgemeinschaft, (www.dfg.de) (Grant SCHW 858/1-1 and Klinische Forschergruppe 274 Platelets - Molecular Mechanisms and Translational Implications), the FP7 EU Initial Training Network program Fighting-DrugFailure, (http://www.fightingdrugfailure.net) (Grant PITN-GA-2009-238132), and the Robert Bosch Stiftung, (www.bosch-stiftung.de), Germany. We acknowledge support by Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of Tuebingen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angiolillo Dominick J, 2004, J Invasive Cardiol, V16, P169; Bonello-Palot N, 2009, AM J CARDIOL, V104, P1511, DOI 10.1016/j.amjcard.2009.07.015; Bucher HC, 2000, BMJ-BRIT MED J, V321, P73, DOI 10.1136/bmj.321.7253.73; Chung I, 2006, EUR HEART J, V27, P2623, DOI 10.1093/eurheartj/ehl305; Collet JP, 2012, NEW ENGL J MED, V367, P2100, DOI 10.1056/NEJMoa1209979; Cuisset T, 2006, J THROMB HAEMOST, V4, P542, DOI 10.1111/j.1538-7836.2005.01751.x; Cuisset T, 2011, AM J CARDIOL, V108, P1411, DOI 10.1016/j.amjcard.2011.06.060; de Mulder M, 2011, EUR HEART J, V32, P1398, DOI 10.1093/eurheartj/ehr034; Gawaz M, 1997, CORONARY ARTERY DIS, V8, P121, DOI 10.1097/00019501-199703000-00001; Geisler T, 2008, J THROMB HAEMOST, V6, P54; Geisler T, 2007, DIABETES CARE, V30, P372, DOI 10.2337/dc06-1625; Geisler T, 2006, EUR HEART J, V27, P2420, DOI 10.1093/eurheartj/ehl275; Geisler T, 2010, CLIN RES CARDIOL, V99, P743, DOI 10.1007/s00392-010-0179-x; Gurbel PA, 2005, J AM COLL CARDIOL, V46, P1820, DOI 10.1016/j.jacc.2005.07.041; Gurbel PA, 2003, CIRCULATION, V107, P2908, DOI 10.1161/01.CIR.0000072771.11429.83; Gurbel PA, 2005, J AM COLL CARDIOL, V46, P1827, DOI 10.1016/j.jacc.2005.07.056; Gurbel PA, 2012, JAMA-J AM MED ASSOC, V308, P1785, DOI 10.1001/jama.2012.17312; Hochholzer W, 2005, CIRCULATION, V111, P2560, DOI 10.1161/01.CIR.0000160869.75810.98; Htun P, 2011, J AM SOC NEPHROL, V22, P627, DOI 10.1681/ASN.2010020220; Hulot JS, 2006, BLOOD, V108, P2244, DOI 10.1182/blood-2006-04-013052; James S, 2010, CIRCULATION, V122, P1056, DOI 10.1161/CIRCULATIONAHA.109.933796; Jeremias A, 2009, AM J MED, V122, P152, DOI 10.1016/j.amjmed.2008.07.027; Kotlyar M, 1999, INT J CLIN PHARM TH, V37, P8; Leblond F, 2001, J AM SOC NEPHROL, V12, P326, DOI 10.1681/ASN.V122326; Marcucci Rossella, 2007, Atherosclerosis, V195, pe217, DOI 10.1016/j.atherosclerosis.2007.04.048; Mega JL, 2012, NEW ENGL J MED, V366, P9, DOI 10.1056/NEJMoa1112277; Morel O, 2011, J AM COLL CARDIOL, V57, P399, DOI 10.1016/j.jacc.2010.09.032; Morrow DA, 2012, NEW ENGL J MED, V366, P1404, DOI 10.1056/NEJMoa1200933; Muller I, 2003, THROMB HAEMOSTASIS, V89, P783, DOI 10.1055/s-0037-1613462; Neumann FJ, 1996, J AM COLL CARDIOL, V27, P15, DOI 10.1016/0735-1097(95)00433-5; Peterson ED, 2010, J AM COLL CARDIOL, V55, P1923, DOI 10.1016/j.jacc.2010.02.005; Price MJ, 2011, JAMA-J AM MED ASSOC, V305, P1097, DOI 10.1001/jama.2011.290; Reny JL, 2012, CIRCULATION, V125, P3201, DOI 10.1161/CIRCULATIONAHA.111.085464; Serebruany VL, 2005, J AM COLL CARDIOL, V45, P246, DOI 10.1016/j.jacc.2004.09.067; Sibbing D, 2008, THROMB HAEMOSTASIS, V99, P121, DOI 10.1160/TH07-07-0478; Siller-Matula JM, 2012, J THROMB HAEMOST, V10, P529, DOI 10.1111/j.1538-7836.2012.04639.x; Silvain J, 2012, EUR HEART J, V33, P1241, DOI 10.1093/eurheartj/ehr407; Spiliopoulos S, 2013, J AM COLL CARDIOL, V61, P2428, DOI 10.1016/j.jacc.2013.03.036; Suh JW, 2006, CAN MED ASSOC J, V174, P1715, DOI 10.1503/cmaj.060664; Tantry US, 2013, J AM COLL CARDIOL, V62, P2261, DOI 10.1016/j.jacc.2013.07.101; Thygesen K, 2012, EUR HEART J, V33, P2551, DOI 10.1093/eurheartj/ehs184; TOUCHETTE MA, 1991, DICP ANN PHARMAC, V25, P1214, DOI 10.1177/106002809102501111; Trenk D, 2012, J AM COLL CARDIOL, V59, P2159, DOI 10.1016/j.jacc.2012.02.026; Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327; Wenaweser P, 2005, J AM COLL CARDIOL, V45, P1748, DOI 10.1016/j.jacc.2005.01.058; WIJNS W, 2010, EUR HEART J, V31, P2501, DOI DOI 10.1093/EURHEARTJ/EHQ277; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482	47	27	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121620	10.1371/journal.pone.0121620	http://dx.doi.org/10.1371/journal.pone.0121620			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799149	gold, Green Published, Green Submitted			2022-12-26	WOS:000351987300277
J	Fang, S; Shen, X; Chen, AJ; Li, S; Shan, K				Fang, Sheng; Shen, Xiao; Chen, Ai-Jun; Li, Shuang; Shan, Kui			Health-Related Quality of Life in Patients with Primary Cutaneous Amyloidosis	PLOS ONE			English	Article							ATOPIC-DERMATITIS; INDEX DLQI; PSORIASIS; VALIDATION; PRURITUS; SF-36	Background Primary cutaneous amyloidosis (PCA) is a relatively rare and itchy skin disorder characterized by amyloid deposits in the superficial dermis. The cosmetic disfigurement and severe pruritus dramatically affects the patient's quality of life. In spite of the prevalence of the disease in China, the quality of life (QoL) impact of the PCA has not been well defined and is the focus of this study. Objective To examine the HRQoL of patients with PCA and to evaluate the association between HRQoL scores, disease, and socio-demographic determinants. Methods A total of 104 PCA patients and 101 healthy participants completed the questionnaires. HRQoL was measured using dermatology life quality index (DLQI) and SF-36. The socio demographic and clinical data such as age, sex, duration of disease and distribution of lesion pattern were analyzed mainly by hierarchical multiple regression analyses. Results Patients with PCA experienced significantly impaired health-related quality of life. The mean DLQI score was 9.05. Younger age, female gender, more pruritus and distribution pattern were independent predictor correlates of the high DLQI scores. The PCA group showed significantly decreasing average scores in several aspects of psychological symptoms, including SF, RE and MH. Conclusions PCA disease has a negative impact on the HRQoL of patients, and the HRQoL is associated with various disease characteristics. In conjunction with medical interventions, psychological and sociocultural assessment and intervention should be an essential part of the management of these cases.	[Fang, Sheng; Chen, Ai-Jun; Li, Shuang; Shan, Kui] Chongqing Med Univ, Affiliated Hosp 1, Dept Dermatol, Chongqing, Peoples R China; [Shen, Xiao] Chongqing Med Univ, Affiliated Hosp 1, Dept Burn & Plast Surg, Chongqing, Peoples R China	Chongqing Medical University; Chongqing Medical University	Fang, S (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Dept Dermatol, Chongqing, Peoples R China.	fangshengderm@163.com	Fang, Sheng/AGW-7034-2022	Fang, Sheng/0000-0003-1098-7542				Basra MKA, 2008, BRIT J DERMATOL, V159, P997, DOI 10.1111/j.1365-2133.2008.08832.x; Blackford S, 1997, BRIT J DERMATOL, V136, P293, DOI 10.1111/j.1365-2133.1997.tb14924.x; Ferraz LB, 2006, QUAL LIFE RES, V15, P565, DOI 10.1007/s11136-005-2638-9; FINLAY AY, 1994, CLIN EXP DERMATOL, V19, P210, DOI 10.1111/j.1365-2230.1994.tb01167.x; Gelfand JM, 2004, J AM ACAD DERMATOL, V51, P704, DOI 10.1016/j.jaad.2004.04.014; Ghajarzadeh Mahsa, 2012, Acta Med Iran, V50, P511; Gupta MA, 1998, BRIT J DERMATOL, V139, P846; Harris A, 1996, BRIT J DERMATOL, V135, P959, DOI 10.1046/j.1365-2133.1996.d01-1102.x; Hayes M.H.S., 1921, PSYCHOL BULL, V18, P98, DOI DOI 10.4236/OJPSYCH.2014.41010; Horn HM, 2002, CLIN EXP DERMATOL, V27, P707, DOI 10.1046/j.1365-2230.2002.01121.x; Kanikowska A, 2009, J EUR ACAD DERMATOL, V23, P93, DOI 10.1111/j.1468-3083.2008.02712.x; Li L, 2003, J EPIDEMIOL COMMUN H, V57, P259, DOI 10.1136/jech.57.4.259; Liu JB, 2012, J EUR ACAD DERMATOL, V26, P1252, DOI 10.1111/j.1468-3083.2011.04277.x; Maksimovic N, 2012, J DERMATOL, V39, P42, DOI 10.1111/j.1346-8138.2011.01295.x; Mayrshofer Franziska, 2005, J Dtsch Dermatol Ges, V3, P431, DOI 10.1111/j.1610-0387.2005.05722.x; Mazharinia N, 2007, J BURN CARE RES, V28, P312, DOI 10.1097/BCR.0B013E318031A151; Nakjang Y S, 1982, Australas J Dermatol, V23, P82, DOI 10.1111/j.1440-0960.1982.tb00607.x; Phan NQ, 2012, ACTA DERM-VENEREOL, V92, P502, DOI 10.2340/00015555-1246; TAN T, 1990, CLIN DERMATOL, V8, P20, DOI 10.1016/0738-081X(90)90083-D; Wang KY, 2011, J EUR ACAD DERMATOL, V25, P429, DOI 10.1111/j.1468-3083.2010.03808.x; Wang Xiao-ling, 2004, Zhonghua Liu Xing Bing Xue Za Zhi, V25, P791; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Williamson D, 2001, J EUR ACAD DERMATOL, V15, P137, DOI 10.1046/j.1468-3083.2001.00229.x; Wright A, 2013, J PAIN SYMPTOM MANAG, V45, P114, DOI 10.1016/j.jpainsymman.2012.01.012; Zachariae R, 2002, BRIT J DERMATOL, V146, P1006, DOI 10.1046/j.1365-2133.2002.04742.x	25	9	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120623	10.1371/journal.pone.0120623	http://dx.doi.org/10.1371/journal.pone.0120623			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE6ZS	25799390	Green Submitted, Green Published, gold			2022-12-26	WOS:000351987300159
J	Ma, A; Mondragon, RJ				Ma, Athen; Mondragon, Raul J.			Rich-Cores in Networks	PLOS ONE			English	Article							COMMUNITY STRUCTURE; PERIPHERY STRUCTURE; COMPLEX NETWORKS; CLUB; ORGANIZATION; CENTRALITY; DYNAMICS; ELEGANS; GROWTH; MODELS	A core comprises of a group of central and densely connected nodes which governs the overall behaviour of a network. It is recognised as one of the key meso-scale structures in complex networks. Profiling this meso-scale structure currently relies on a limited number of methods which are often complex and parameter dependent or require a null model. As a result, scalability issues are likely to arise when dealing with very large networks together with the need for subjective adjustment of parameters. The notion of a rich-club describes nodes which are essentially the hub of a network, as they play a dominating role in structural and functional properties. The definition of a rich-club naturally emphasises high degree nodes and divides a network into two subgroups. Here, we develop a method to characterise a rich-core in networks by theoretically coupling the underlying principle of a rich-club with the escape time of a random walker. The method is fast, scalable to large networks and completely parameter free. In particular, we show that the evolution of the core in World Trade and C. elegans networks correspond to responses to historical events and key stages in their physical development, respectively.	[Ma, Athen; Mondragon, Raul J.] Queen Mary Univ London, Sch Elect Engn & Comp Sci, London E1 4NS, England	University of London; Queen Mary University London	Ma, A (corresponding author), Queen Mary Univ London, Sch Elect Engn & Comp Sci, Mile End Rd, London E1 4NS, England.	athen.ma@qmul.ac.uk	Ma, Athen/GLR-0384-2022					[Anonymous], 2014, PLOS ONE, DOI DOI 10.1371/J0URNAL.P0NE.0088297; Ball G., 2014, P NATL ACAD SCI; Borgatti SP, 1999, SOC NETWORKS, V21, P375; Bullmore ET, 2012, NAT REV NEUROSCI, V13, P336, DOI 10.1038/nrn3214; BYERLY L, 1976, DEV BIOL, V51, P23, DOI 10.1016/0012-1606(76)90119-6; Chen Q, 2002, IEEE INFOCOM SER, P608, DOI 10.1109/INFCOM.2002.1019306; Colizza V, 2006, NAT PHYS, V2, P110, DOI 10.1038/nphys209; Colizza V, 2007, NAT PHYS, V3, P276, DOI 10.1038/nphys560; Csermely P, 2013, J COMPLEX NETW, V1, P93, DOI 10.1093/comnet/cnt016; Csete M, 2004, TRENDS BIOTECHNOL, V22, P446, DOI 10.1016/j.tibtech.2004.07.007; Da Silva MR, 2008, P IEEE, V96, P1411, DOI 10.1109/JPROC.2008.925418; Della Rossa F, 2013, SCI REP-UK, V3, DOI 10.1038/srep01467; Fagiolo G, 2010, J EVOL ECON, V20, P479, DOI 10.1007/s00191-009-0160-x; Fortunato S, 2008, LECT NOTES COMPUT SC, V4936, P59, DOI 10.1007/978-3-540-78808-9_6; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Gleditsch KS, 2002, J CONFLICT RESOLUT, V46, P712, DOI 10.1177/002200202236171; Holme P, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.046111; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Kostakos V, 2009, PHYSICA A, V388, P1007, DOI 10.1016/j.physa.2008.11.021; Leskovec J, 2008, DYNAMICS LARGE NETWO; Leskovec J, 2009, INTERNET MATH, V6, P29, DOI 10.1080/15427951.2009.10129177; Leskovec J, 2007, ACM T WEB, V1, DOI 10.1145/1232722.1232727; Liu YY, 2011, NATURE, V473, P167, DOI 10.1038/nature10011; Maslov S, 2004, PHYSICA A, V333, P529, DOI 10.1016/j.physa.2003.06.002; Masuda N, 2006, SOC NETWORKS, V28, P297, DOI 10.1016/j.socnet.2005.07.005; MAY RM, 1972, NATURE, V238, P413, DOI 10.1038/238413a0; Melian CJ, 2004, ECOLOGY, V85, P352, DOI 10.1890/02-0638; Mondragon RJ, 2014, J COMPLEX NETWORKS; Newman MEJ, 2001, P NATL ACAD SCI USA, V98, P404, DOI 10.1073/pnas.021544898; Nicosia V, 2013, P NATL ACAD SCI USA, V110, P7880, DOI 10.1073/pnas.1300753110; Piccardi C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027028; Rombach MP, 2014, SIAM J APPL MATH, V74, P167, DOI 10.1137/120881683; Serrano MA, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.026101; Towlson EK, 2013, J NEUROSCI, V33, P6380, DOI 10.1523/JNEUROSCI.3784-12.2013; Valverde S, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.046118; van den Heuvel MP, 2011, J NEUROSCI, V31, P15775, DOI 10.1523/JNEUROSCI.3539-11.2011; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; World Trade Organisation, 2013, WORLD TRAD REP 2013; Xu XK, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.046117; ZACHARY WW, 1977, J ANTHROPOL RES, V33, P452, DOI 10.1086/jar.33.4.3629752; Zhou S, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066108; Zlatic V, 2009, EUR PHYS J B, V67, P271, DOI 10.1140/epjb/e2009-00007-9	42	50	50	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0119678	10.1371/journal.pone.0119678	http://dx.doi.org/10.1371/journal.pone.0119678			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799585	Green Submitted, Green Published, gold			2022-12-26	WOS:000351987300072
J	Marangoni, A; Foschi, C; Nardini, P; Compri, M; Cevenini, R				Marangoni, Antonella; Foschi, Claudio; Nardini, Paola; Compri, Monica; Cevenini, Roberto			Evaluation of the Versant CT/GC DNA 1.0 Assay (kPCR) for the Detection of Extra-Genital Chlamydia trachomatis and Neisseria gonorrhoeae Infections	PLOS ONE			English	Article							ACID AMPLIFICATION TESTS; RECTAL SWABS; MEN; SEX; PHARYNGEAL; DIAGNOSIS; CT/NG; PERFORMANCE; GUIDELINES	Screening for extra-genital Chlamydia trachomatis and Neisseria gonorrhoeae infections is a crucial component for sexually transmitted diseases management, even if at present days no commercial methods have been approved for use on pharyngeal and rectal specimens by the US FDA or have received the conformity CE marking. Here we report the analytical sensitivities of the Versant CT/GC 1.0 assay (Siemens Healthcare Diagnostics, Tarrytown, NY, USA) on rectal and pharyngeal swabs, and an evaluation about the suitability for this assay with two widely used swab collection devices (E-Swab and eNAT, Copan, Brescia, Italy). The limits of detection for rectal and pharyngeal specimens with the Versant assay were 10 copies/ml and 1.0 copies/ml, for C. trachomatis and N. gonorrhoeae, respectively. False positive results due to the presence of non-gonococcal Neisseria species were excluded when clinical rectal and pharyngeal samples containing organisms identified as N. meningitidis, N. sicca, N. flavescens and N. subflava were tested. Due to its sensitivity and specificity, the Versant assay represents a good choice for the diagnosis of chlamydial and/or gonococcal infections not only in genito-urinary samples, but also on rectal and pharyngeal swabs.	[Marangoni, Antonella; Foschi, Claudio; Nardini, Paola; Compri, Monica; Cevenini, Roberto] Univ Bologna, Microbiol Expt Diagnost & Specialty Dept DIMES, Bologna, Italy	University of Bologna	Marangoni, A (corresponding author), Univ Bologna, Microbiol Expt Diagnost & Specialty Dept DIMES, Bologna, Italy.	antonella.marangoni@unibo.it	Foschi, Claudio/A-7299-2016	Foschi, Claudio/0000-0001-7253-8799; Marangoni, Antonella/0000-0002-7397-6560				Alexander S, 2008, SEX TRANSM INFECT, V84, P488, DOI 10.1136/sti.2008.031443; Bachmann LH, 2010, J CLIN MICROBIOL, V48, P1827, DOI 10.1128/JCM.02398-09; Bachmann LH, 2009, J CLIN MICROBIOL, V47, P902, DOI 10.1128/JCM.01581-08; Bongaerts M, 2011, J MICROBIOL METH, V87, P139, DOI 10.1016/j.mimet.2011.09.001; Bourne C, 2008, SEX HEALTH, V5, P189, DOI 10.1071/SH07092; Bromhead C, 2013, J CLIN MICROBIOL, V51, P1609, DOI 10.1128/JCM.00485-13; Cosentino LA, 2012, J CLIN MICROBIOL, V50, P2005, DOI 10.1128/JCM.00185-12; European Centre for Disease Prevention and Control, 2013, SEXUALLY TRANSMITTED; Foschi C, 2014, NEW MICROBIOL, V37, P399; Foschi Claudio, 2014, BMC Res Notes, V7, P225, DOI 10.1186/1756-0500-7-225; Gaydos CA, 2010, J CLIN MICROBIOL, V48, P3236, DOI 10.1128/JCM.01019-10; Geelen Tanja H, 2013, Diagn Microbiol Infect Dis, V77, P101, DOI 10.1016/j.diagmicrobio.2013.06.020; Goldenberg SD, 2012, J CLIN MICROBIOL, V50, P3867, DOI 10.1128/JCM.01930-12; JONES RB, 1985, ANN INTERN MED, V102, P757, DOI 10.7326/0003-4819-102-6-757; Kent CK, 2005, CLIN INFECT DIS, V41, P67, DOI 10.1086/430704; Kerndt PR, 2011, J CLIN MICROBIOL, V49, P1347, DOI 10.1128/JCM.01634-10; LAN J, 1994, J CLIN MICROBIOL, V32, P528, DOI 10.1128/JCM.32.2.528-530.1994; Marangoni A, 2012, J CLIN LAB ANAL, V26, P70, DOI 10.1002/jcla.21485; Moncada J, 2009, J CLIN MICROBIOL, V47, P1657, DOI 10.1128/JCM.02269-08; Papp JR, 2014, MMWR RECOMM REP, V63, P1; Parra-Sanchez M, 2012, DIAGN MICR INFEC DIS, V74, P338, DOI 10.1016/j.diagmicrobio.2012.08.004; Peters RPH, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-203; Schachter J, 2008, SEX TRANSM DIS, V35, P637, DOI 10.1097/OLQ.0b013e31817bdd7e; Tabrizi SN, 2011, J CLIN MICROBIOL, V49, P3610, DOI 10.1128/JCM.01217-11; Walsh A, 2011, EUR J CLIN MICROBIOL, V30, P561, DOI 10.1007/s10096-010-1120-y; Whiley DM, 2006, J MOL DIAGN, V8, P3, DOI 10.2353/jmoldx.2006.050045; Whiley DM, 2004, EUR J CLIN MICROBIOL, V23, P705, DOI 10.1007/s10096-004-1170-0; Workowski Kimberly A, 2010, MMWR Recomm Rep, V59, P1	28	21	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120979	10.1371/journal.pone.0120979	http://dx.doi.org/10.1371/journal.pone.0120979			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799263	gold, Green Submitted, Green Published			2022-12-26	WOS:000351987300198
J	Mo, M; Zhou, M; Wang, L; Qi, L; Zhou, KH; Liu, LF; Chen, Z; Zu, XB				Mo, Miao; Zhou, Mi; Wang, Lu; Qi, Lin; Zhou, Kehua; Liu, Long-Fei; Chen, Zhi; Zu, Xiong-Bing			CCL21/CCR7 Enhances the Proliferation, Migration, and Invasion of Human Bladder Cancer T24 Cells	PLOS ONE			English	Article							LYMPH-NODE METASTASIS; CHEMOKINE RECEPTOR CCR7; MESSENGER-RNA; GROWTH-FACTOR; EXPRESSION; OVEREXPRESSION; ASSOCIATION; INVOLVEMENT; APOPTOSIS; PROTEINS	Objective To investigate the effects of CCL21/CCR7 on the proliferation, migration, and invasion of T24 cells and the possible associated mechanisms: expression of MMP-2 and MMP-9, and regulation of BCL-2 and BAX proteins. Methods T24 cells received corresponding treatments including vehicle control, antibody (20ng/mL CCR7 antibody and 50 ng/ml CCL21), and 50, 100, and 200 ng/ml CCL21. Proliferation was evaluated by MTT assay; cell migration and invasion were assayed using a transwell chamber. Cell apoptosis was induced by Adriamycin (ADM). The rate of cell apoptosis was examined by flow cytometry using annexin V-FITC/PI staining. Western-blot was used to analyze MMP-2 and MMP-9 and BCL-2 and BAX proteins. Results CCL21 promoted T24 cell proliferation in concentration-dependent manner with that 200 ng/mL induced the largest amount of proliferation. Significant differences of cell migration were found between CCL21treatment groups and the control group in both the migration and invasion studies (P < 0.001 for all). The expressions of MMP-2 and MMP-9 proteins were significantly increased after CCL21 treatment (p < 0.05 for all). Protein expression of Bcl-21 follows an ascending trend while the expression of Bax follows a descending trend as the concentration of CCL21 increases. No difference was found between the control group and antibody group for all assessments. Conclusion CCL21/CCR7 promoted T24 cell proliferation and enhanced its migration and invasion via the increased expression of MMP-2 and MMP-9. CCL21/CCR7 had antiapoptotic activities on T24 cells via regulation of Bcl-2 and Bax proteins. CCL21/CCR7 may promote bladder cancer development and metastasis.	[Mo, Miao; Qi, Lin; Liu, Long-Fei; Chen, Zhi; Zu, Xiong-Bing] Cent South Univ, Xiangya Hosp, Dept Urol, Changsha 410008, Hunan, Peoples R China; [Zhou, Mi] Zhejiang Prov Peoples Hosp, Dept Urol, Hangzhou 310014, Zhejiang, Peoples R China; [Wang, Lu] Cent South Univ, Xiangya Hosp, Hlth Management Ctr, Changsha 410008, Hunan, Peoples R China; [Zhou, Kehua] Daemen Coll, Dept Hlth Care Studies, Amherst, NY 14226 USA	Central South University; Zhejiang Provincial People's Hospital; Central South University	Chen, Z (corresponding author), Cent South Univ, Xiangya Hosp, Dept Urol, Changsha 410008, Hunan, Peoples R China.	czhi1011@126.com; xymnwk@yeah.net						Banas B, 2002, J IMMUNOL, V168, P4301, DOI 10.4049/jimmunol.168.9.4301; Beavon IRG, 2000, EUR J CANCER, V36, P1607, DOI 10.1016/S0959-8049(00)00158-1; Bleul CC, 1996, J EXP MED, V184, P1101, DOI 10.1084/jem.184.3.1101; Bukholm IRK, 2002, APMIS, V110, P214, DOI 10.1034/j.1600-0463.2002.100303.x; Burger JA, 1999, BLOOD, V94, P3658, DOI 10.1182/blood.V94.11.3658.423k11_3658_3667; Cabioglu N, 2005, CLIN CANCER RES, V11, P5686, DOI 10.1158/1078-0432.CCR-05-0014; Carlsen HS, 2005, BLOOD, V106, P444, DOI 10.1182/blood-2004-11-4353; Chaffer CL, 2007, DIFFERENTIATION, V75, P831, DOI 10.1111/j.1432-0436.2007.00210.x; Ciborowski P, 2002, CLIN EXP METASTAS, V19, P339, DOI 10.1023/A:1015590515957; Ding YZ, 2003, CLIN CANCER RES, V9, P3406; Forster R, 2008, NAT REV IMMUNOL, V8, P362, DOI 10.1038/nri2297; Gao ZH, 2014, HISTOPATHOLOGY, V65, P527, DOI 10.1111/his.12435; Gunther K, 2005, INT J CANCER, V116, P726, DOI 10.1002/ijc.21123; Guruvayoorappan C, 2008, INTEGR CANCER THER, V7, P42, DOI 10.1177/1534735407313744; Han TT, 2014, CANCER BIOL THER, V15, P3, DOI 10.4161/cbt.26607; Heresi GA, 2005, UROL ONCOL-SEMIN ORI, V23, P261, DOI 10.1016/j.urolonc.2005.02.004; Ishida K, 2009, INT J ONCOL, V34, P915, DOI 10.3892/ijo_00000217; Itoh M, 2006, ONCOGENE, V25, P1195, DOI 10.1038/sj.onc.1209149; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kawakami S, 2001, ANTICANCER RES, V21, P213; Kim GC, 2003, INT ARCH ALLERGY IMM, V131, P101, DOI 10.1159/000070925; Li J, 2011, DIGEST LIVER DIS, V43, P40, DOI 10.1016/j.dld.2010.05.013; Maekawa S, 2008, ONCOL REP, V19, P1461; Mashino K, 2002, CANCER RES, V62, P2937; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Nakata B, 2008, ONCOLOGY-BASEL, V74, P69, DOI 10.1159/000139126; Nakopoulou L, 2001, APPL IMMUNOHISTO M M, V9, P130, DOI 10.1097/00022744-200106000-00005; Ohkouchi T, 2002, AM J OBSTET GYNECOL, V187, P353, DOI 10.1067/mob.2002.123203; Ploix C, 2001, J IMMUNOL, V167, P6724, DOI 10.4049/jimmunol.167.12.6724; Redondo-Munoz J, 2008, BLOOD, V111, P383, DOI 10.1182/blood-2007-08-107300; Salazar N, 2013, CRIT REV EUKAR GENE, V23, P77, DOI 10.1615/CritRevEukaryotGeneExpr.2013006905; Sancho M, 2006, J ENDOCRINOL, V191, P229, DOI 10.1677/joe.1.06688; Sehgal I, 2003, ANTICANCER RES, V23, P39; Takanami I, 2003, INT J CANCER, V105, P186, DOI 10.1002/ijc.11063; Vindrieux D, 2009, ENDOCR-RELAT CANCER, V16, P663, DOI 10.1677/ERC-09-0109; Wang J, 2005, ONCOGENE, V24, P5897, DOI 10.1038/sj.onc.1208740; Xu Y, 2012, J ENG FIBER FABR, V7, P7; Xu Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021119; Yang Zhi, 2009, Zhongguo Fei Ai Za Zhi, V12, P397, DOI 10.3779/j.issn.1009-3419.2009.05.004; Zhao B, 2011, J HEPATO-BIL-PAN SCI, V18, P821, DOI 10.1007/s00534-011-0395-4; Zyada MM, 2009, ANN DIAGN PATHOL, V13, P313, DOI 10.1016/j.anndiagpath.2009.06.003	41	41	44	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0119506	10.1371/journal.pone.0119506	http://dx.doi.org/10.1371/journal.pone.0119506			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798926	Green Published, gold, Green Submitted			2022-12-26	WOS:000351987300055
J	Nadeau, VG; Gao, AQ; Deber, CM				Nadeau, Vincent G.; Gao, Anqi; Deber, Charles M.			Design and Characterization of a Membrane Protein Unfolding Platform in Lipid Bilayers	PLOS ONE			English	Article							FOLDING PROBLEM; STABILITY; LOOP; HAIRPIN; STATE; SITE; UREA	Accurate measurement of membrane protein stability-and particularly how it may vary as a result of disease-phenotypic mutations-ideally requires a denaturant that can unfold a membrane-embedded structure while leaving the solubilizing environment unaffected. The steric trap method fulfills this requirement by using monovalent streptavidin (mSA) molecules to unfold membrane proteins engineered with two spatially close biotin tags. Here we adapted this method to an 87-residue helix-loop-helix (hairpin) construct derived from helices 3 and 4 in the transmembrane domain of the human cystic fibrosis transmembrane conductance regulator (CFTR), wherein helix-helix tertiary interactions are anticipated to confer a portion of construct stability. The wild type CFTR TM3/4 hairpin construct was modified with two accessible biotin tags for mSA-induced unfolding, along with two helix-terminal pyrene labels to monitor loss of inter-helical contacts by pyrene excimer fluorescence. A series of eight constructs with biotin tags at varying distances from the helix-terminal pyrene labels were expressed, purified and labeled appropriately; all constructs exhibited largely helical circular dichroism spectra. We found that addition of mSA to an optimized construct in lipid vesicles led to a complete and reversible loss in pyrene excimer fluorescence and mSA binding, and hence hairpin unfolding-results further supported by SDS-PAGE visualization of mSA bound and unbound species. While some dimeric/oligomeric populations persist that may affect quantitation of the unfolding step, our characterization of the design yields a promising prototype of a future platform for the systematic study of membrane protein folding in a lipid bilayer environment.	[Nadeau, Vincent G.; Gao, Anqi; Deber, Charles M.] Hosp Sick Children, Res Inst, Div Mol Struct & Funct, Toronto, ON M5G 0A4, Canada; [Nadeau, Vincent G.; Gao, Anqi; Deber, Charles M.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Deber, CM (corresponding author), Hosp Sick Children, Res Inst, Div Mol Struct & Funct, Toronto, ON M5G 0A4, Canada.	deber@sickkids.ca			Cystic Fibrosis Canada; Canadian Institutes of Health Research (CIHR) [FRN-5810]; Fonds de la Recherche en Sante du Quebec (FRSQ); Banting and Best Canada Graduate Scholarship from CIHR	Cystic Fibrosis Canada; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Fonds de la Recherche en Sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); Banting and Best Canada Graduate Scholarship from CIHR	Funding: This work was supported, in part, by grants to C. M. D. from Cystic Fibrosis Canada, and by the Canadian Institutes of Health Research (CIHR FRN-5810). V. G. N. is the recipient of a Doctoral Training Award from the Fonds de la Recherche en Sante du Quebec (FRSQ) and a Banting and Best Canada Graduate Scholarship from CIHR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beckett D, 1999, PROTEIN SCI, V8, P921, DOI 10.1110/ps.8.4.921; Blois TM, 2009, J AM CHEM SOC, V131, P13914, DOI 10.1021/ja905725n; Broecker J, 2013, LANGMUIR, V29, P8502, DOI 10.1021/la4013747; Chang YC, 2014, P NATL ACAD SCI USA, V111, P219, DOI 10.1073/pnas.1318576111; Chen I, 2005, NAT METHODS, V2, P99, DOI 10.1038/NMETH735; Choi MY, 2004, BIOCHEMISTRY-US, V43, P8077, DOI 10.1021/bi0494525; Curnow P, 2011, P NATL ACAD SCI USA, V108, P14133, DOI 10.1073/pnas.1012594108; Dill KA, 2008, ANNU REV BIOPHYS, V37, P289, DOI 10.1146/annurev.biophys.37.092707.153558; Dill KA, 2012, SCIENCE, V338, P1042, DOI 10.1126/science.1219021; Fiedler S, 2010, CELL MOL LIFE SCI, V67, P1779, DOI 10.1007/s00018-010-0259-0; Hong H, 2011, J AM CHEM SOC, V133, P11389, DOI 10.1021/ja204524c; Hong H, 2010, P NATL ACAD SCI USA, V107, P19802, DOI 10.1073/pnas.1010348107; Howarth M, 2006, NAT METHODS, V3, P267, DOI 10.1038/NMETH861; Jefferson RE, 2013, J AM CHEM SOC, V135, P15183, DOI 10.1021/ja407232b; Joh NH, 2008, NATURE, V453, P1266, DOI 10.1038/nature06977; Lau FW, 1997, BIOCHEMISTRY-US, V36, P5884, DOI 10.1021/bi963095j; Lehrer SS, 1997, METHOD ENZYMOL, V278, P286; McKibbin C, 2009, PHOTOCHEM PHOTOBIOL, V85, P494, DOI 10.1111/j.1751-1097.2008.00503.x; Mulvihill CM, 2012, BBA-BIOMEMBRANES, V1818, P49, DOI 10.1016/j.bbamem.2011.09.027; Nadeau VG, 2013, BIOCHEMISTRY-US, V52, P2419, DOI 10.1021/bi400187w; Nadeau VG, 2012, BIOCHEMISTRY-US, V51, P6228, DOI 10.1021/bi201853n; Otzen DE, 2002, BIOPHYS J, V83, P2219, DOI 10.1016/S0006-3495(02)73982-9; Rath A, 2012, ANNU REV BIOPHYS, V41, P135, DOI [10.1146/annurev-biophys-050511-102310, 10.1146/annurev-biophys-050591-102310]; Rath A, 2009, P NATL ACAD SCI USA, V106, P1760, DOI 10.1073/pnas.0813167106; Shortle D, 1996, FASEB J, V10, P27, DOI 10.1096/fasebj.10.1.8566543; Therien AG, 2002, J BIOL CHEM, V277, P6067, DOI 10.1074/jbc.M110264200; Wehbi H, 2007, BIOCHEMISTRY-US, V46, P7099, DOI 10.1021/bi602570u	27	2	2	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120253	10.1371/journal.pone.0120253	http://dx.doi.org/10.1371/journal.pone.0120253			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799099	Green Submitted, Green Published, gold			2022-12-26	WOS:000351987300116
J	Roelke, DL; Spatharis, S				Roelke, Daniel L.; Spatharis, Sofie			Phytoplankton Assemblage Characteristics in Recurrently Fluctuating Environments	PLOS ONE			English	Article							FRESH-WATER INFLOW; NUTRIENT LIMITATION; SPECIES RICHNESS; P-LIMITATION; DIVERSITY; DYNAMICS; BIOMASS; BAY; PRODUCTIVITY; BIODIVERSITY	Annual variations in biogeochemical and physical processes can lead to nutrient variability and seasonal patterns in phytoplankton productivity and assemblage structure. In many coastal systems river inflow and water exchange with the ocean varies seasonally, and alternating periods can arise where the nutrient most limiting to phytoplankton growth switches. Transitions between these alternating periods can be sudden or gradual and this depends on human activities, such as reservoir construction and interbasin water transfers. How such activities might influence phytoplankton assemblages is largely unknown. Here, we employed a multispecies, multi-nutrient model to explore how nutrient loading switching mode might affect characteristics of phytoplankton assemblages. The model is based on the Monod-relationship, predicting an instantaneous growth rate from ambient inorganic nutrient concentrations whereas the limiting nutrient at any given time was determined by Liebig's Law of the Minimum. Our simulated phytoplankton assemblages self-organized from species rich pools over a 15-year period, and only the surviving species were considered as assemblage members. Using the model, we explored the interactive effects of complementarity level in trait trade-offs within phytoplankton assemblages and the amount of noise in the resource supply concentrations. We found that the effect of shift from a sudden resource supply transition to a gradual one, as observed in systems impacted by watershed development, was dependent on the level of complementarity. In the extremes, phytoplankton species richness and relative overyielding increased when complementarity was lowest, and phytoplankton biomass increased greatly when complementarity was highest. For low-complementarity simulations, the persistence of poorer-performing phytoplankton species of intermediate R*s led to higher richness and relative overyielding. For high-complementarity simulations, the formation of phytoplankton species clusters and niche compression enabled higher biomass accumulation. Our findings suggest that an understanding of factors influencing the emergence of life history traits important to complementarity is necessary to predict the impact of watershed development on phytoplankton productivity and assemblage structure.	[Roelke, Daniel L.] Texas A&M Univ, Dept Wildlife & Fisheries Sci, College Stn, TX 77843 USA; [Roelke, Daniel L.] Texas A&M Univ, Dept Oceanog, College Stn, TX 77843 USA; [Spatharis, Sofie] Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Glasgow G12 8QQ, Lanark, Scotland	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; University of Glasgow	Roelke, DL (corresponding author), Texas A&M Univ, Dept Wildlife & Fisheries Sci, College Stn, TX 77843 USA.	droelke@tamu.edu	Spatharis, Sofie/I-9193-2019; Roelke, Daniel L/B-5766-2008	Spatharis, Sofie/0000-0003-1030-9821; Roelke, Daniel L/0000-0002-3166-3793				Anabalon V, 2014, PROG OCEANOGR, V120, P320, DOI 10.1016/j.pocean.2013.10.015; Barbosa AB, 2010, ESTUAR COAST, V33, P324, DOI 10.1007/s12237-009-9200-x; Calic M, 2013, ENVIRON MONIT ASSESS, V185, P7543, DOI 10.1007/s10661-013-3118-2; CARACO N, 1988, CAN J FISH AQUAT SCI, V45, P381; Cardinale BJ, 2007, P NATL ACAD SCI USA, V104, P18123, DOI 10.1073/pnas.0709069104; Chen XY, 2013, DEEP-SEA RES PT I, V73, P17, DOI 10.1016/j.dsr.2012.11.011; Davis SE, 2001, ESTUAR COAST SHELF S, V52, P753, DOI 10.1006/ecss.2001.0755; DEBAAR HJW, 1994, PROG OCEANOGR, V33, P347, DOI 10.1016/0079-6611(94)90022-1; FISHER TR, 1992, MAR ECOL PROG SER, V82, P51, DOI 10.3354/meps082051; Fridley JD, 2001, OIKOS, V93, P514, DOI 10.1034/j.1600-0706.2001.930318.x; Grover J. P., 1997, RESOURCE COMPETITION; Grover JP, 1999, ARCH HYDROBIOL, V145, P1; Hector A, 1998, OIKOS, V82, P597, DOI 10.2307/3546380; HilleRisLambers J, 2004, ECOL LETT, V7, P661, DOI 10.1111/j.1461-0248.2004.00623.x; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Hu S, 2011, MAR ECOL PROG SER, V427, P29, DOI 10.3354/meps09043; Huisman J, 2001, ECOL LETT, V4, P408, DOI 10.1046/j.1461-0248.2001.00256.x; Interlandi SJ, 2001, ECOLOGY, V82, P1270, DOI 10.2307/2679988; Lares ML, 2009, ARCH ENVIRON CON TOX, V56, P707, DOI 10.1007/s00244-008-9210-x; Loreau M, 1998, OIKOS, V82, P600, DOI 10.2307/3546381; Magilligan FJ, 2005, GEOMORPHOLOGY, V71, P61, DOI 10.1016/j.geomorph.2004.08.017; Marquard E, 2009, ECOLOGY, V90, P3290, DOI 10.1890/09-0069.1; McLusky D.S., 2004, ESTUARINE ECOSYSTEM; MONOD J, 1950, ANN I PASTEUR PARIS, V79, P390; Morse RE, 2014, MAR ECOL PROG SER, V503, P59, DOI 10.3354/meps10743; Picasso VD, 2011, RENEW AGR FOOD SYST, V26, P317, DOI 10.1017/S1742170511000135; Pielou E. C., 1975, ECOLOGICAL DIVERSITY; Pilkaityte R, 2007, BOREAL ENVIRON RES, V12, P551; Poff NL, 2007, P NATL ACAD SCI USA, V104, P5732, DOI 10.1073/pnas.0609812104; Pulina S, 2012, PLANT BIOSYST, V146, P259, DOI 10.1080/11263504.2012.717545; Reynolds CS, 2006, ECOL BIODIVERS CONS, P1, DOI 10.2277/ 0521605199; Roelke D, 2004, HYDROBIOLOGIA, V513, P205, DOI 10.1023/B:hydr.0000018185.41861.07; Roelke DL, 2008, AM NAT, V171, P162, DOI 10.1086/524955; Roelke DL, 2007, FRESHWATER BIOL, V52, P399, DOI 10.1111/j.1365-2427.2006.01703.x; Roelke DL, 2013, MAR ECOL PROG SER, V477, P61, DOI 10.3354/meps10182; Roelke DL, 1997, ESTUARIES, V20, P725, DOI 10.2307/1352247; Roelke DL, PLOS1 IN PRESS; Roy ED, 2013, SCI TOTAL ENVIRON, V458, P374, DOI 10.1016/j.scitotenv.2013.04.046; Russell MJ, 2006, ESTUAR COAST SHELF S, V68, P231, DOI 10.1016/j.ecss.2006.02.005; Scheffer M, 2006, P NATL ACAD SCI USA, V103, P6230, DOI 10.1073/pnas.0508024103; Schmidtke A, 2010, ECOLOGY, V91, P212, DOI 10.1890/08-2370.1; Shannon C. E., 1949, MATH THEORY COMMUNIC; Sommer U., 1989, P57; SOMMER U, 1984, LIMNOL OCEANOGR, V29, P633, DOI 10.4319/lo.1984.29.3.0633; Sommer U, 1989, SUCCESSION PLANKTON; Spatharis S, 2008, J EXP MAR BIOL ECOL, V362, P55, DOI 10.1016/j.jembe.2008.06.003; Stachowicz JJ, 2008, ECOLOGY, V89, P3008, DOI 10.1890/07-1873.1; Tilman D., 1982, Monographs in Population Biology, pi; Tilman D, 2001, SCIENCE, V294, P843, DOI 10.1126/science.1060391; Vincent TLS, 1996, AM NAT, V148, P1038, DOI 10.1086/285970; WEBB KL, 1988, CAN J FISH AQUAT SCI, V45, P380; Wollast R, 1983, 21 SCOPE; Yamamoto T, 2004, ECOL MODEL, V171, P247, DOI 10.1016/j.ecolmodel.2003.08.011; Yin KD, 2004, CONT SHELF RES, V24, P1895, DOI 10.1016/j.csr.2004.06.014; Yin KD, 2002, MAR ECOL PROG SER, V245, P111, DOI 10.3354/meps245111; Zhou WH, 2014, ENVIRON MONIT ASSESS, V186, P1705, DOI 10.1007/s10661-013-3487-6	56	8	8	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120673	10.1371/journal.pone.0120673	http://dx.doi.org/10.1371/journal.pone.0120673			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799563	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000351987300162
J	Sie, M; den Dunnen, WFA; Lourens, HJ; Boer, TGJD; Scherpen, FJG; Zomerman, WW; Kampen, KR; Hoving, EW; de Bont, ESJM				Sie, Mariska; den Dunnen, Wilfred F. A.; Lourens, Harm Jan; Boer, Tiny G. J. Meeuwsen-de; Scherpen, Frank J. G.; Zomerman, Walderik W.; Kampen, Kim R.; Hoving, Eelco W.; de Bont, Eveline S. J. M.			Growth-Factor-Driven Rescue to Receptor Tyrosine Kinase (RTK) Inhibitors through Akt and Erk Phosphorylation in Pediatric Low Grade Astrocytoma and Ependymoma	PLOS ONE			English	Article							RESISTANCE PROTEIN ABCG2; P-GLYCOPROTEIN ABCB1; PHASE-I; BRAIN ACCUMULATION; PILOCYTIC ASTROCYTOMA; CELL-PROLIFERATION; DRUG-RESISTANCE; YOUNG-ADULTS; SORAFENIB; CHILDREN	Up to now, several clinical studies have been started investigating the relevance of receptor tyrosine kinase (RTK) inhibitors upon progression free survival in various pediatric brain tumors. However, single targeted kinase inhibition failed, possibly due to tumor resistance mechanisms. The present study will extend our previous observations that vascular endothelial growth factor receptor (VEGFR)-2, platelet derived growth factor receptor (PDGFR) beta, Src, the epidermal growth factor receptor (ErbB) family, and hepatocyte growth factor receptor (HGFR/cMet) are potentially drugable targets in pediatric low grade astrocytoma and ependymoma with investigations concerning growth-factor-driven rescue. This was investigated in pediatric low grade astrocytoma and ependymoma cell lines treated with receptor tyrosine kinase (RTK) inhibitors e.g. sorafenib, dasatinib, canertinib and crizotinib. Flow cytometry analyses showed high percentage of cells expressing VEGFR-1, fibroblast growth factor receptor (FGFR)-1, ErbB1/EGFR, HGFR and recepteur d'origine nantais (RON) (respectively 52-77%, 34-51%, 63-90%, 83-98%, 65-95%). Their respective inhibitors induced decrease of cell viability, measured with WST-1 cell viability assays. At least this was partially due to increased apoptotic levels measured by Annexin V/Propidium Iodide apoptosis assays. EGF, HGF and FGF, which are normally expressed in brain (tumor) tissue, showed to be effective rescue inducing growth factors resulting in increased cell survival especially during treatment with dasatinib (complete rescue) or sorafenib (partial rescue). Growth-factor-driven rescue was less prominent when canertinib or crizotinib were used. Rescue was underscored by significantly activating downstream Akt and/or Erk phosphorylation and increased tumor cell migration. Combination treatment showed to be able to overcome the growth-factor-driven rescue. In conclusion, our study highlights the extensive importance of environmentally present growth factors in developing tumor escape towards RTK inhibitors in pediatric low grade astrocytoma and ependymoma. It is of great interest to anticipate upon these results for the design of new therapeutic trials with RTK inhibitors in these pediatric brain tumors.	[Sie, Mariska; Lourens, Harm Jan; Boer, Tiny G. J. Meeuwsen-de; Scherpen, Frank J. G.; Zomerman, Walderik W.; Kampen, Kim R.; de Bont, Eveline S. J. M.] Univ Groningen, Univ Med Ctr Groningen, Dept Pediat, Beatrix Childrens Hosp,Pediat Oncol Hematol Div, Groningen, Netherlands; [den Dunnen, Wilfred F. A.] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Div Pathol, Groningen, Netherlands; [Hoving, Eelco W.] Univ Groningen, Univ Med Ctr Groningen, Dept Neurosurg, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen	de Bont, ESJM (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Pediat, Beatrix Childrens Hosp,Pediat Oncol Hematol Div, Groningen, Netherlands.	e.s.j.m.de.bont@umcg.nl	Kampen, Kim R/Q-8879-2018	Kampen, Kim R/0000-0001-5065-1272; den Dunnen, Wilfred/0000-0002-4168-1207	Jan Kornelis de Cock Stichting [2013-75]	Jan Kornelis de Cock Stichting	This work was supported by a grant from Jan Kornelis de Cock Stichting (project code 2013-75 to M. Sie). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achim CL, 1997, DEV BRAIN RES, V102, P299, DOI 10.1016/S0165-3806(97)00108-9; Akiyama K, 2012, AM J PATHOL, V180, P1283, DOI 10.1016/j.ajpath.2011.11.029; Batchelor TT, 2007, CANCER CELL, V11, P83, DOI 10.1016/j.ccr.2006.11.021; Bobola MS, 2005, CLIN CANCER RES, V11, P2747, DOI 10.1158/1078-0432.CCR-04-2045; Broniscer A, 2009, CLIN CANCER RES, V15, P701, DOI 10.1158/1078-0432.CCR-08-1923; Casanovas O, 2005, CANCER CELL, V8, P299, DOI 10.1016/j.ccr.2005.09.005; Chapuy B, 2011, BRIT J HAEMATOL, V152, P401, DOI 10.1111/j.1365-2141.2010.08526.x; di Tomaso E, 2011, CANCER RES, V71, P19, DOI 10.1158/0008-5472.CAN-10-2602; Due-Tonnessen BJ, 2002, PEDIATR NEUROSURG, V37, P71, DOI 10.1159/000065108; Duncan JS, 2012, CELL, V149, P307, DOI 10.1016/j.cell.2012.02.053; Fernandez C, 2003, NEUROSURGERY, V53, P544, DOI 10.1227/01.NEU.0000079330.01541.6E; Geoerger B, 2011, NEURO-ONCOLOGY, V13, P109, DOI 10.1093/neuonc/noq141; Geyer JR, 2010, EUR J CANCER, V46, P3287, DOI 10.1016/j.ejca.2010.07.005; Gilbertson RJ, 2002, CLIN CANCER RES, V8, P3054; Gremo F, 2000, INT J DEV NEUROSCI, V18, P271, DOI 10.1016/S0736-5748(99)00095-7; Gronych J, 2011, J CLIN INVEST, V121, P1344, DOI 10.1172/JCI44656; Hainsworth JD, 2010, CANCER-AM CANCER SOC, V116, P3663, DOI 10.1002/cncr.25275; Ho AL, 2012, CANCER RES, V72, P4515, DOI 10.1158/0008-5472.CAN-12-1319; Jain RK, 2007, NAT REV NEUROSCI, V8, P610, DOI 10.1038/nrn2175; Jakacki RI, 2008, J CLIN ONCOL, V26, P4921, DOI 10.1200/JCO.2007.15.2306; Jane EP, 2006, J PHARMACOL EXP THER, V319, P1070, DOI 10.1124/jpet.106.108621; Jun HJ, 2012, ONCOGENE, V31, P3039, DOI 10.1038/onc.2011.474; Lagas JS, 2009, CLIN CANCER RES, V15, P2344, DOI 10.1158/1078-0432.CCR-08-2253; Lee EQ, 2012, NEURO-ONCOLOGY, V14, P1511, DOI 10.1093/neuonc/nos264; Louis DN., 2007, CLASSIFICATION TUMOU, V4th; Maekawa T, 2007, INT J CLIN ONCOL, V12, P327, DOI 10.1007/s10147-007-0699-1; Minocha M, 2012, INT J PHARMACEUT, V436, P127, DOI 10.1016/j.ijpharm.2012.05.038; Mosse YP, 2013, LANCET ONCOL, V14, P472, DOI 10.1016/S1470-2045(13)70095-0; Namba H, 2009, NEUROSCIENCE, V158, P1731, DOI 10.1016/j.neuroscience.2008.10.057; Omerovic J, 2008, ONCOGENE, V27, P2754, DOI 10.1038/sj.onc.1210925; Pollack IF, 2011, NEURO-ONCOLOGY, V13, P290, DOI 10.1093/neuonc/noq199; Ramakrishnan V, 2012, AM J HEMATOL, V87, P277, DOI 10.1002/ajh.22263; Reardon DA, 2011, J NEURO-ONCOL, V101, P57, DOI 10.1007/s11060-010-0217-6; Rodriguez FJ, 2013, ANNU REV PATHOL-MECH, V8, P361, DOI 10.1146/annurev-pathol-020712-164009; Rosser AE, 2000, EUR J NEUROSCI, V12, P2405, DOI 10.1046/j.1460-9568.2000.00135.x; Severinsson EAD, 2011, BIOCHEM BIOPH RES CO, V414, P563, DOI 10.1016/j.bbrc.2011.09.118; Shao HW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080832; Shim KW, 2009, CHILD NERV SYST, V25, P1167, DOI 10.1007/s00381-009-0900-0; Sie M, 2014, CRIT REV ONCOL HEMAT, V89, P418, DOI 10.1016/j.critrevonc.2013.09.005; Sikkema AH, 2011, NEUROPATH APPL NEURO, V37, P538, DOI 10.1111/j.1365-2990.2011.01160.x; Sikkema AH, 2009, CANCER RES, V69, P5987, DOI 10.1158/0008-5472.CAN-08-3660; Slichenmyer WJ, 2001, SEMIN ONCOL, V28, P80, DOI 10.1016/S0093-7754(01)90285-4; Sugiyama H, 2011, J GASTROENTEROL, V46, P779, DOI 10.1007/s00535-011-0380-3; Tang SC, 2014, INT J CANCER, V134, P1484, DOI 10.1002/ijc.28475; Thewke DP, 1999, BRAIN RES, V821, P356, DOI 10.1016/S0006-8993(99)01115-4; Valenzuela CF, 1997, BRAIN RES REV, V24, P77; Lafuente JV, 2012, INT REV NEUROBIOL, V102, P317, DOI 10.1016/B978-0-12-386986-9.00012-0; Ware Kathryn E, 2010, PLoS One, V5, pe14117, DOI 10.1371/journal.pone.0014117; Wilson TR, 2012, NATURE, V487, P505, DOI 10.1038/nature11249; Yadav V, 2012, J BIOL CHEM, V287, P28087, DOI 10.1074/jbc.M112.377218; Young A, 2013, CANCER DISCOV, V3, P112, DOI 10.1158/2159-8290.CD-12-0231	51	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0122555	10.1371/journal.pone.0122555	http://dx.doi.org/10.1371/journal.pone.0122555			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799134	Green Submitted, Green Published, gold			2022-12-26	WOS:000351987300336
J	Yokoi, F; Chen, HX; Dang, MT; Cheetham, CC; Campbell, SL; Roper, SN; Sweatt, JD; Li, YQ				Yokoi, Fumiaki; Chen, Huan-Xin; Dang, Mai Tu; Cheetham, Chad C.; Campbell, Susan L.; Roper, Steven N.; Sweatt, J. David; Li, Yuqing			Behavioral and Electrophysiological Characterization of Dyt1 Heterozygous Knockout Mice	PLOS ONE			English	Article							ONSET TORSION DYSTONIA; DELTA-E-TORSINA; NUCLEAR-ENVELOPE; MOTOR DEFICITS; PROTEIN TORSINA; MUTANT TORSINA; SYNAPTIC PLASTICITY; TRANSGENIC MICE; MOUSE MODELS; IN MOUSE	DYT1 dystonia is an inherited movement disorder caused by mutations in DYT1 (TOR1A), which codes for torsinA. Most of the patients have a trinucleotide deletion (Delta GAG) corresponding to a glutamic acid in the C-terminal region (torsinA(Delta E)). Dyt1 Delta GAG heterozygous knock-in (KI) mice, which mimic Delta GAG mutation in the endogenous gene, exhibit motor deficits and deceased frequency of spontaneous excitatory post-synaptic currents (sEPSCs) and normal theta-burst-induced long-term potentiation (LTP) in the hippocampal CA1 region. Although Dyt1 KI mice show decreased hippocampal torsinA levels, it is not clear whether the decreased torsinA level itself affects the synaptic plasticity or torsinA(Delta E) does it. To analyze the effect of partial torsinA loss on motor behaviors and synaptic transmission, Dyt1 heterozygous knock-out (KO) mice were examined as a model of a frame-shift DYT1 mutation in patients. Consistent with Dyt1 KI mice, Dyt1 heterozygous KO mice showed motor deficits in the beam-walking test. Dyt1 heterozygous KO mice showed decreased hippocampal torsinA levels lower than those in Dyt1 KI mice. Reduced sEPSCs and normal miniature excitatory post-synaptic currents (mEPSCs) were also observed in the acute hippocampal brain slices from Dyt1 heterozygous KO mice, suggesting that the partial loss of torsinA function in Dyt1 KI mice causes action potential-dependent neurotransmitter release deficits. On the other hand, Dyt1 heterozygous KO mice showed enhanced hippocampal LTP, normal input-output relations and paired pulse ratios in the extracellular field recordings. The results suggest that maintaining an appropriate torsinA level is important to sustain normal motor performance, synaptic transmission and plasticity. Developing therapeutics to restore a normal torsinA level may help to prevent and treat the symptoms in DYT1 dystonia.	[Yokoi, Fumiaki; Chen, Huan-Xin; Li, Yuqing] Univ Florida, Coll Med, Dept Neurol, Gainesville, FL 32611 USA; [Dang, Mai Tu] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Cheetham, Chad C.] Univ Alabama Birmingham, Sch Med, Dept Neurol, Ctr Neurodegenerat & Expt Therapeut, Birmingham, AL USA; [Cheetham, Chad C.; Campbell, Susan L.; Sweatt, J. David] Univ Alabama Birmingham, Sch Med, Dept Neurobiol, Birmingham, AL USA; [Roper, Steven N.] Univ Florida, Coll Med, Dept Neurosurg, Gainesville, FL USA	State University System of Florida; University of Florida; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; State University System of Florida; University of Florida	Li, YQ (corresponding author), Univ Florida, Coll Med, Dept Neurol, Gainesville, FL 32611 USA.	yuqing.li@neurology.ufl.edu	Li, Yuqing/AAR-9383-2021; Li, Yuqing/G-1596-2011	Li, Yuqing/0000-0003-1211-5529; Li, Yuqing/0000-0003-1211-5529; Sweatt, J. David/0000-0003-3567-485X; Tilahin, Shimelis/0000-0001-8975-8026	Tyler's Hope for a Dystonia Cure, Inc.; National Institutes of Health [NS37409, NS47466, NS47692, NS54246, NS57098, NS65273, NS72872, NS 74423, NS82244]; Howard Hughes Med-Grad Graduate Fellowship; Lucille P. Markey Charitable Trust (UIUC); Department of Neurology (UAB); Department of Neurology (UF); NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH057014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS037409, R03NS074423, R01NS054246, P30NS057098, P01NS037409, R21NS047692, P30NS047466, R21NS065273, R21NS072872, R01NS082244] Funding Source: NIH RePORTER	Tyler's Hope for a Dystonia Cure, Inc.; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Med-Grad Graduate Fellowship; Lucille P. Markey Charitable Trust (UIUC); Department of Neurology (UAB); Department of Neurology (UF); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by Tyler's Hope for a Dystonia Cure, Inc., National Institutes of Health grants (NS37409, NS47466, NS47692, NS54246, NS57098, NS65273, NS72872, NS 74423, and NS82244), Howard Hughes Med-Grad Graduate Fellowship (CCC), and startup funds from the Lucille P. Markey Charitable Trust (UIUC) and Department of Neurology (UAB and UF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albanese A, 2013, MOVEMENT DISORD, V28, P863, DOI 10.1002/mds.25475; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Breakefield XO, 2008, NAT REV NEUROSCI, V9, P222, DOI 10.1038/nrn2337; Cho JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110086; Chou JL, 2004, J BIOL CHEM, V279, P46271, DOI 10.1074/jbc.M407206200; Cookson MR, 2005, NEURON, V48, P875, DOI 10.1016/j.neuron.2005.12.006; Dang MT, 2006, NEUROSCI RES, V56, P470, DOI 10.1016/j.neures.2006.09.005; Dang MT, 2012, BEHAV BRAIN RES, V226, P465, DOI 10.1016/j.bbr.2011.10.002; Dang MT, 2005, EXP NEUROL, V196, P452, DOI 10.1016/j.expneurol.2005.08.025; DeAndrade MP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035518; DeAndrade MP, 2011, BEHAV BRAIN RES, V216, P659, DOI 10.1016/j.bbr.2010.09.009; Debanne D, 1996, J PHYSIOL-LONDON, V491, P163, DOI 10.1113/jphysiol.1996.sp021204; Doheny D, 2002, NEUROLOGY, V59, P1244, DOI 10.1212/WNL.59.8.1244; Fahn S, 1991, Int J Neurol, V25-26, P70; Fahn S, 1988, Adv Neurol, V50, P1; Fernagut PO, 2002, NEUROSCIENCE, V114, P1005, DOI 10.1016/S0306-4522(02)00205-1; Giles LM, 2008, HUM MOL GENET, V17, P2712, DOI 10.1093/hmg/ddn173; Gonzalez-Alegre P, 2005, J NEUROSCI, V25, P10502, DOI 10.1523/JNEUROSCI.3016-05.2005; Gonzalez-Alegre P, 2004, J NEUROSCI, V24, P2593, DOI 10.1523/JNEUROSCI.4461-03.2004; Goodchild RE, 2005, NEURON, V48, P923, DOI 10.1016/j.neuron.2005.11.010; Goodchild RE, 2004, P NATL ACAD SCI USA, V101, P847, DOI 10.1073/pnas.0304375101; Gordon KL, 2008, NEUROSCIENCE, V157, P588, DOI 10.1016/j.neuroscience.2008.09.028; Granata A, 2010, EUR J NEUROL, V17, P81, DOI 10.1111/j.1468-1331.2010.03057.x; Granata A, 2008, J BIOL CHEM, V283, P7568, DOI 10.1074/jbc.M704097200; Granata A, 2011, EMBO J, V30, P181, DOI 10.1038/emboj.2010.285; Granata A, 2009, J NEUROCHEM, V109, P1596, DOI 10.1111/j.1471-4159.2009.06095.x; Grundmann K, 2012, NEUROBIOL DIS, V47, P61, DOI 10.1016/j.nbd.2012.03.024; Hewett J, 2000, HUM MOL GENET, V9, P1403, DOI 10.1093/hmg/9.9.1403; Ilardi JM, 1999, NAT NEUROSCI, V2, P119, DOI 10.1038/5673; Kakazu Y, 2012, SYNAPSE, V66, P807, DOI 10.1002/syn.21571; Klein C, 2002, ANN NEUROL, V52, P675, DOI 10.1002/ana.10358; Koh YH, 2004, HUM MOL GENET, V13, P2019, DOI 10.1093/hmg/ddh208; Konakova M, 2005, J MOL NEUROSCI, V25, P105, DOI 10.1385/JMN:25:1:105; Kustedjo K, 2000, J BIOL CHEM, V275, P27933; Kustedjo K, 2003, BIOCHEMISTRY-US, V42, P15333, DOI 10.1021/bi0349569; Leung JC, 2001, NEUROGENETICS, V3, P133, DOI 10.1007/s100480100111; Maltese M, 2014, MOVEMENT DISORD, V29, P1655, DOI 10.1002/mds.26009; Maniak S, 2003, ACTA NEUROL SCAND, V107, P228, DOI 10.1034/j.1600-0404.2003.01362.x; Martella G, 2014, NEUROBIOL DIS, V65, P124, DOI 10.1016/j.nbd.2014.01.016; Misbahuddin A, 2005, MOVEMENT DISORD, V20, P432, DOI 10.1002/mds.20351; Morgante F, 2013, DYSTONIA CONTINUUM M, V19, DOI [10.1212/01.con.0000436154.08791.67, DOI 10.1212/01.CON.0000436154.08791.67]; Naismith TV, 2004, P NATL ACAD SCI USA, V101, P7612, DOI 10.1073/pnas.0308760101; O'Farrell CA, 2009, NEUROSCIENCE, V164, P1127, DOI 10.1016/j.neuroscience.2009.09.017; Oleas J, 2013, MOVEMENT DISORD, V28, P990, DOI 10.1002/mds.25583; Ozelius LJ, 1997, NAT GENET, V17, P40, DOI 10.1038/ng0997-40; Page ME, 2010, NEUROBIOL DIS, V39, P318, DOI 10.1016/j.nbd.2010.04.016; Pan PY, 2009, NEURON, V61, P412, DOI 10.1016/j.neuron.2008.12.029; Ramirez DMO, 2011, CURR OPIN NEUROBIOL, V21, P275, DOI 10.1016/j.conb.2011.01.007; Ritz K, 2009, J NEUROL NEUROSUR PS, V80, P653, DOI 10.1136/jnnp.2008.162099; Sibbing D, 2003, NEUROLOGY, V61, P1097, DOI 10.1212/01.WNL.0000090560.20641.AB; Torres GE, 2004, P NATL ACAD SCI USA, V101, P15650, DOI 10.1073/pnas.0308088101; Yokoi F, 2008, J BIOCHEM, V143, P39, DOI 10.1093/jb/mvm191; Yokoi F, 2006, J BIOCHEM, V140, P141, DOI 10.1093/jb/mvj138; Yokoi F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072491; Yokoi F, 2012, BEHAV BRAIN RES, V230, P389, DOI 10.1016/j.bbr.2012.02.029; Yokoi F, 2012, HUM MOL GENET, V21, P916, DOI 10.1093/hmg/ddr528; Yokoi F, 2012, BEHAV BRAIN RES, V227, P12, DOI 10.1016/j.bbr.2011.10.024; Yokoi F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024539; Yokoi F, 2010, J BIOCHEM, V148, P459, DOI 10.1093/jb/mvq078; Yokoi F, 2009, NEUROSCI RES, V65, P228, DOI 10.1016/j.neures.2009.07.004; Zhao Y, 2008, EXP NEUROL, V210, P719, DOI 10.1016/j.expneurol.2007.12.027; Zim B, 2008, J NEUROL NEUROSUR PS, V79, P1327, DOI 10.1136/jnnp.2008.148270	62	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120916	10.1371/journal.pone.0120916	http://dx.doi.org/10.1371/journal.pone.0120916			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799505	gold, Green Published, Green Submitted			2022-12-26	WOS:000351987300191
J	Zhang, M; Gao, YX; Caja, K; Zhao, BC; Kim, JA				Zhang, Mei; Gao, Yunxiang; Caja, Kevin; Zhao, Bocheng; Kim, Julian A.			Non-Viral Nanoparticle Delivers Small Interfering RNA to Macrophages In Vitro and In Vivo	PLOS ONE			English	Article							MIGRATION INHIBITORY FACTOR; HUMAN BREAST-CANCER; FACTOR MIF; SIRNA DELIVERY; GENE DELIVERY; TUMOR-GROWTH; CELLS; INFLAMMATION; DEGRADATION; MECHANISMS	Macrophages are increasingly being viewed as therapeutic target for various cancers and many inflammatory diseases. Sequence specific gene reduction by siRNA represents an attractive approach to modulate macrophage function. However, delivery of the therapeutic siRNA into macrophages by non-viral nanoparticles has been a major technical challenge. In this study, we developed a glucan-based siRNA carrier system (BG34-10-Re-I) and demonstrated that the BG34-10-Re-I can effectively assemble siRNA into uniformly distributed nanoparticles of the novel core-shell structure. The BG34-10-Re-I/siRNA nanoparticles effectively reduced gene expression of macrophage migration inhibitory factor (MIF) in primary macrophages at both protein and mRNA level. The nanoparticles also mediated a sustained reduction of MIF within primary macrophages. Moreover, systemic injection of the nanoparticles into the Balb/c mice bearing 4T1 mammary tumors resulted in the MIF reduction in tumor-associated macrophages. Mechanistic studies demonstrated that the glucan-shell and the siRNA-core structure contribute to the effective delivery of MIF siRNA to macrophages both in vitro and in vivo. This study represents the first development of the primary macrophage MIF gene targeted non-viral nanoparticle system for both in vitro and in vivo applications.	[Zhang, Mei; Caja, Kevin; Zhao, Bocheng; Kim, Julian A.] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA; [Zhang, Mei; Caja, Kevin; Zhao, Bocheng; Kim, Julian A.] Case Western Reserve Univ, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA; [Gao, Yunxiang] Case Western Reserve Univ, Dept Macromol Sci & Engn, Sch Engn, Cleveland, OH 44106 USA; [Kim, Julian A.] Univ Hosp Cleveland, Div Surg Oncol, Case Med Ctr, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; University Hospitals of Cleveland	Zhang, M (corresponding author), Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.	mxz128@case.edu; julian.kim1@case.edu		Gao, Yunxiang/0000-0002-3522-5838	NIH-NCI Case Comprehensive Cancer Center, Imaging Pilot [CON500659]; NATIONAL CANCER INSTITUTE [K23CA109115, P30CA043703] Funding Source: NIH RePORTER	NIH-NCI Case Comprehensive Cancer Center, Imaging Pilot; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding was provided by NIH-NCI Case Comprehensive Cancer Center, Imaging Pilot, CON500659. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Faraj A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090829; Bach JP, 2008, ONCOLOGY-BASEL, V75, P127, DOI 10.1159/000155223; Bando H, 2002, JPN J CANCER RES, V93, P389, DOI 10.1111/j.1349-7006.2002.tb01269.x; Barros MHM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080908; Bartlett DW, 2006, NUCLEIC ACIDS RES, V34, P322, DOI 10.1093/nar/gkj439; Basha G, 2011, MOL THER, V19, P2186, DOI 10.1038/mt.2011.190; Beduneau A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004343; Bifulco C, 2008, CURR PHARM DESIGN, V14, P3790, DOI 10.2174/138161208786898608; Bloomfield VA, 1997, BIOPOLYMERS, V44, P269, DOI 10.1002/(SICI)1097-0282(1997)44:3<269::AID-BIP6>3.0.CO;2-T; Chao Y, 2012, ADV EXP MED BIOL, V733, P115, DOI 10.1007/978-94-007-2555-3_11; Coffelt SB, 2009, BBA-REV CANCER, V1796, P11, DOI 10.1016/j.bbcan.2009.02.004; Courties G, 2014, J AM COLL CARDIOL, V63, P1556, DOI 10.1016/j.jacc.2013.11.023; Dominska M, 2010, J CELL SCI, V123, P1183, DOI 10.1242/jcs.066399; Faure AM, 2014, CARBOHYD POLYM, V99, P679, DOI 10.1016/j.carbpol.2013.08.022; Fernandez-Boyanapalli R, 2010, J IMMUNOL, V185, P4030, DOI 10.4049/jimmunol.1001778; Gordon S, 2007, EUR J IMMUNOL, V37, pS9, DOI 10.1002/eji.200737638; Hu Y, 2002, BIOMATERIALS, V23, P3193, DOI 10.1016/S0142-9612(02)00071-6; Jokerst JV, 2011, NANOMEDICINE-UK, V6, P715, DOI [10.2217/NNM.11.19, 10.2217/nnm.11.19]; Kambal A, 2011, MOL THER, V19, P584, DOI 10.1038/mt.2010.269; Kang JH, 2010, BIOORGAN MED CHEM, V18, P3946, DOI 10.1016/j.bmc.2010.04.031; Larson DF, 2006, CRIT CARE, V10, DOI 10.1186/cc4899; Leuschner F, 2011, NAT BIOTECHNOL, V29, P1005, DOI 10.1038/nbt.1989; Love KT, 2010, P NATL ACAD SCI USA, V107, P1864, DOI 10.1073/pnas.0910603106; Lue HQ, 2002, MICROBES INFECT, V4, P449, DOI 10.1016/S1286-4579(02)01560-5; Muta T, 2006, CURR PHARM DESIGN, V12, P4155, DOI 10.2174/138161206778743529; Nishihira J, 2003, ANN NY ACAD SCI, V995, P171, DOI 10.1111/j.1749-6632.2003.tb03220.x; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Ovchinnikov DA, 2008, GENESIS, V46, P447, DOI 10.1002/dvg.20417; Pan B, 2011, J PHYS CHEM B, V115, P5958, DOI 10.1021/jp1076802; Pecot CV, 2011, NAT REV CANCER, V11, P59, DOI 10.1038/nrc2966; Pelosi L, 2003, BIOCHEMISTRY-US, V42, P6264, DOI 10.1021/bi0340550; Pires LR, 2011, NANOMEDICINE-UK, V6, P1499, DOI [10.2217/nnm.11.51, 10.2217/NNM.11.51]; Price Sarah, 2011, Nat Rev Rheumatol, V7, P70, DOI 10.1038/nrrheum.2010.217; Rinaudo M, 2008, POLYM INT, V57, P397, DOI 10.1002/pi.2378; Rudzinski WE, 2010, INT J PHARMACEUT, V399, P1, DOI 10.1016/j.ijpharm.2010.08.022; Semple SC, 2010, NAT BIOTECHNOL, V28, P172, DOI 10.1038/nbt.1602; Siveen KS, 2009, IMMUNOL LETT, V123, P97, DOI 10.1016/j.imlet.2009.02.011; Song HM, 2012, INT J NANOMED, V7, P4637, DOI 10.2147/IJN.S33923; Verjans E, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-230; Wilson HM, 2010, J CELL MOL MED, V14, P2055, DOI 10.1111/j.1582-4934.2010.01121.x; Wilson RC, 2013, ANNU REV BIOPHYS, V42, P217, DOI 10.1146/annurev-biophys-083012-130404; Xia Y, 2012, WORLD J GASTROENTERO, V18, P9; YOSHIMORI T, 1991, J BIOL CHEM, V266, P17707; Zhang M, 2012, INT J BIOCHEM CELL B, V44, P914, DOI 10.1016/j.biocel.2012.02.018; Zhang Nan, 2013, Pharmaceutics, V5, P329, DOI 10.3390/pharmaceutics5020329; Zhang Xia, 2009, V531, P123, DOI 10.1007/978-1-59745-396-7_9	46	20	21	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0118472	10.1371/journal.pone.0118472	http://dx.doi.org/10.1371/journal.pone.0118472			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799489	Green Published, gold, Green Submitted			2022-12-26	WOS:000351987300010
J	Baxter-Gilbert, JH; Riley, JL; Lesbarreres, D; Litzgus, JD				Baxter-Gilbert, James H.; Riley, Julia L.; Lesbarreres, David; Litzgus, Jacqueline D.			Mitigating Reptile Road Mortality: Fence Failures Compromise Ecopassage Effectiveness	PLOS ONE			English	Article							TURTLES CHELYDRA-SERPENTINA; HIGHWAY MORTALITY; GENETIC DIVERSITY; UNITED-STATES; MOVEMENT; PERMEABILITY; CONSERVATION; BIODIVERSITY; ORIENTATION; AMPHIBIANS	Roadways pose serious threats to animal populations. The installation of roadway mitigation measures is becoming increasingly common, yet studies that rigorously evaluate the effectiveness of these conservation tools remain rare. A highway expansion project in Ontario, Canada included exclusion fencing and ecopassages as mitigation measures designed to offset detrimental effects to one of the most imperial groups of vertebrates, reptiles. Taking a multispecies approach, we used a Before-After-Control-Impact study design to compare reptile abundance on the highway before and after mitigation at an Impact site and a Control site from 1 May to 31 August in 2012 and 2013. During this time, radio telemetry, wildlife cameras, and an automated PIT-tag reading system were used to monitor reptile movements and use of ecopassages. Additionally, a willingness to utilize experiment was conducted to quantify turtle behavioral responses to ecopassages. We found no difference in abundance of turtles on the road between the un-mitigated and mitigated highways, and an increase in the percentage of both snakes and turtles detected dead on the road post-mitigation, suggesting that the fencing was not effective. Although ecopassages were used by reptiles, the number of crossings through ecopassages was lower than road-surface crossings. Furthermore, turtle willingness to use ecopassages was lower than that reported in previous arena studies, suggesting that effectiveness of ecopassages may be compromised when alternative crossing options are available (e.g., through holes in exclusion structures). Our rigorous evaluation of reptile roadway mitigation demonstrated that when exclusion structures fail, the effectiveness of population connectivity structures is compromised. Our project emphasizes the need to design mitigation measures with the biology and behavior of the target species in mind, to implement mitigation designs in a rigorous fashion, and quantitatively evaluate road mitigation to ensure allow for adaptive management and optimization of these increasingly important conservation tools.	[Baxter-Gilbert, James H.; Lesbarreres, David; Litzgus, Jacqueline D.] Laurentian Univ, Dept Biol, Sudbury, ON P3E 2C6, Canada; [Riley, Julia L.] Magnetawan First Nation, Britt, ON P0G 1A0, Canada	Laurentian University	Litzgus, JD (corresponding author), Laurentian Univ, Dept Biol, Sudbury, ON P3E 2C6, Canada.	jlitzgus@laurentian.ca	Riley, Julia/H-6756-2019	Riley, Julia/0000-0001-7691-6910; Lesbarreres, David/0000-0002-5505-1935	Magnetawan First Nation; Laurentian University; Ontario Ministry of Natural Resources; Ontario Ministry of Transportation (MTO) HIIFP Grant; NSERC Discovery Grant	Magnetawan First Nation; Laurentian University; Ontario Ministry of Natural Resources; Ontario Ministry of Transportation (MTO) HIIFP Grant; NSERC Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC))	Financial support for this research was provided by Magnetawan First Nation, Laurentian University, Ontario Ministry of Natural Resources, Ontario Ministry of Transportation (MTO) HIIFP Grant, and NSERC Discovery Grant. Opinions expressed in this paper are those of the authors and may not necessarily reflect the views and policies of the MTO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews Kimberly M., 2008, P121; Andrews KM, 2005, COPEIA, P772, DOI 10.1643/0045-8511(2005)005[0772:HDHISM]2.0.CO;2; Aresco MJ, 2005, J WILDLIFE MANAGE, V69, P549, DOI 10.2193/0022-541X(2005)069[0549:MMTRHM]2.0.CO;2; Ashley E. Paul, 2007, Human Dimensions of Wildlife, V12, P137, DOI 10.1080/10871200701322423; Baxter-Gilbert J H, 2014, THESIS LAURENTIAN U; Bissonette JA, 2008, BIOL CONSERV, V141, P482, DOI 10.1016/j.biocon.2007.10.019; Bohm M, 2013, BIOL CONSERV, V157, P372, DOI 10.1016/j.biocon.2012.07.015; Bowne DR, 2006, CONSERV BIOL, V20, P780, DOI 10.1111/j.1523-1739.2006.00355.x; Brehme CS, 2013, CONSERV BIOL, V27, P710, DOI 10.1111/cobi.12081; Brown W, 1997, EC STORMWATER BMPS M; Caldwell IR, 2006, CAN J ZOOL, V84, P1129, DOI 10.1139/Z06-102; Clark RW, 2010, CONSERV BIOL, V24, P1059, DOI 10.1111/j.1523-1739.2009.01439.x; CONGDON JD, 1994, AM ZOOL, V34, P397; COSEWIC, 2011, CAN WILDL SPEC RISK; DEROSA CT, 1978, J HERPETOL, V12, P25, DOI 10.2307/1563498; Dodd CK, 2004, BIOL CONSERV, V118, P619, DOI 10.1016/j.biocon.2003.10.011; Epps CW, 2005, ECOL LETT, V8, P1029, DOI 10.1111/j.1461-0248.2005.00804.x; ERNST C H, 1970, Herpetologica, V26, P399; Ernst CH, 2009, TURTLES US CANADA; Fahrig L, 2009, ECOL SOC, V14; Ford AT, 2010, CONSERV BIOL, V24, P1679, DOI 10.1111/j.1523-1739.2010.01564.x; Forman RTT, 1998, ANNU REV ECOL SYST, V29, P207, DOI 10.1146/annurev.ecolsys.29.1.207; Forman RTT, 2003, ROAD ECOLOGY SCI SOL; FOSTER ML, 1995, WILDLIFE SOC B, V23, P95; GALBRAITH DA, 1988, CAN J ZOOL, V66, P1233, DOI 10.1139/z88-178; Gibbs JP, 2005, CONSERV BIOL, V19, P552, DOI 10.1111/j.1523-1739.2005.000155.x; Gibbs JP, 2002, CONSERV BIOL, V16, P1647, DOI 10.1046/j.1523-1739.2002.01215.x; Glista DJ, 2009, LANDSCAPE URBAN PLAN, V91, P1, DOI 10.1016/j.landurbplan.2008.11.001; Griffin KA, 2006, FHWAMT060108169 MONT; Hecnar SJ, 2002, J BIOGEOGR, V29, P475, DOI 10.1046/j.1365-2699.2002.00686.x; Holderegger R, 2010, BASIC APPL ECOL, V11, P522, DOI 10.1016/j.baae.2010.06.006; Huijser MP, 2009, ECOL SOC, V14; Huijser MP, 2007, FHWAHRT08034 US DEP; Jochimsen DM, 2004, LIT REV EFFECTS ROAD; Lesbarreres D, 2004, ORYX, V38, P220, DOI 10.1017/S0030605304000389; Lesbarreres D, 2012, TRENDS ECOL EVOL, V27, P374, DOI 10.1016/j.tree.2012.01.015; Little SJ, 2002, BIOL CONSERV, V107, P135, DOI 10.1016/S0006-3207(02)00059-9; Litzgus JD, 2004, COPEIA, P804; Marchand MN, 2004, CONSERV BIOL, V18, P758, DOI 10.1111/j.1523-1739.2004.00019.x; McKee JK, 2004, BIOL CONSERV, V115, P161, DOI 10.1016/S0006-3207(03)00099-5; McKinney ML, 2002, BIOSCIENCE, V52, P883, DOI 10.1641/0006-3568(2002)052[0883:UBAC]2.0.CO;2; MTO, 2010, PROV HIGHW TRAFF; Pagnucco KS, 2011, HERPETOL CONSERV BIO, V6, P277; Paulson DJ, 2010, THESIS U MASSACHUSET; Roedenbeck IA, 2007, ECOL SOC, V12; ROSEN PC, 1994, BIOL CONSERV, V68, P143, DOI 10.1016/0006-3207(94)90345-X; Rouse JD, 2011, COPEIA, P443, DOI 10.1643/CE-09-036; Row JR, 2007, BIOL CONSERV, V137, P117, DOI 10.1016/j.biocon.2007.01.020; Rowell J.C., 2012, SNAKES ONTARIO NATUR; Trombulak SC, 2000, CONSERV BIOL, V14, P18, DOI 10.1046/j.1523-1739.2000.99084.x; van der Grift EA, 2013, BIODIVERS CONSERV, V22, P425, DOI 10.1007/s10531-012-0421-0; van der Ree R, 2011, ECOL SOC, V16; Wilson Joseph S., 2009, Contemporary Herpetology, V2009, P1; Woltz HW, 2008, BIOL CONSERV, V141, P2745, DOI 10.1016/j.biocon.2008.08.010	54	56	63	4	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0120537	10.1371/journal.pone.0120537	http://dx.doi.org/10.1371/journal.pone.0120537			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25806531	gold, Green Published			2022-12-26	WOS:000351880000083
J	Frazzitta, G; Ferrazzoli, D; Maestri, R; Rovescala, R; Guaglio, G; Bera, R; Volpe, D; Pezzoli, G				Frazzitta, Giuseppe; Ferrazzoli, Davide; Maestri, Roberto; Rovescala, Roberta; Guaglio, Gabriele; Bera, Rossana; Volpe, Daniele; Pezzoli, Gianni			Differences in Muscle Strength in Parkinsonian Patients Affected on the Right and Left Side	PLOS ONE			English	Article							DISEASE; ASYMMETRY; DISORDERS; WEAKNESS; GAIT	Background Muscular weakness is a frequent cause of instability that contributes to falls in Parkinson's disease (PD). Isokinetic dynamometry is a method of muscle assessment useful to measure the muscular strength giving a quantification of the weakness, but only few studies about isokinetic assessment were performed in PD. The aims of the study were to evaluate the muscle strength in PD and to investigate the differences in patients affected on the right and left side. Methods Knee flexor and extensor muscles strength was assessed using an isokinetic dynamometer in 25 patients in stage 3 H&Y and in 15 healthy controls. Subjects were tested in both legs at three fixed angular velocities: 90 degrees/s, 120 degrees/s, 180 degrees/s. Results Considering the whole population of Parkinsonians, no difference in strength was observed with respect to controls. Considering the side, patients affected on the right side showed a clear tendency to be weaker than patients affected on the left side and controls. Conclusions PD patients affected on the right side, but not those affected on the left side, had a reduction in muscle strength as compared to controls. We postulate a central origin deficit in muscle strength in PD. It is known that dopamine transporter binding is more severely reduced in the left posterior putamen and our results suggest that the control of the muscle strength in PD is linked to the right-left hemispheric asymmetry of the functional organization of basal ganglia and with their connections to cortical motor and pre-motor areas.	[Frazzitta, Giuseppe; Ferrazzoli, Davide; Bera, Rossana] Moriggia Pelascini Hosp, Dept Parkinson Dis & Brain Injury Rehabil, Gravedona Ed Uniti, Italy; [Maestri, Roberto] Sci Inst Montescano S Maugeri Fdn, IRCCS, Dept Biomed Engn, Montescano, Italy; [Rovescala, Roberta; Guaglio, Gabriele] Sci Inst Montescano S Maugeri Fdn, IRCCS, Dept Neurorehabilitat, Montescano, Italy; [Volpe, Daniele] S Raffaele Arcangelo Fatebenefratelli Hosp, Dept Phys Med & Rehabil, Venice, Italy; [Pezzoli, Gianni] Parkinson Inst, Ist Clin Perfezionamento, Milan, Italy; [Frazzitta, Giuseppe] S Isidoro Hosp, Fdn Europea Ric Biomed, Trescore Balneario, Italy		Ferrazzoli, D (corresponding author), Moriggia Pelascini Hosp, Dept Parkinson Dis & Brain Injury Rehabil, Gravedona Ed Uniti, Italy.	davideferrazzoli@gmail.com	Maestri, Roberto/AAA-7585-2019; Maestri, Roberto/J-8168-2016	Maestri, Roberto/0000-0002-2873-0430; Maestri, Roberto/0000-0002-2873-0430; Pezzoli, Gianni/0000-0003-4665-6710; Ferrazzoli, Davide/0000-0002-4005-0235; Frazzitta, Giuseppe/0000-0002-5555-4145				Barrett MJ, 2011, J NEUROL NEUROSUR PS, V82, P1122, DOI 10.1136/jnnp.2010.209783; Braak H, 2004, CELL TISSUE RES, V318, P121, DOI 10.1007/s00441-004-0956-9; Braak H, 2004, NEUROBIOL AGING, V25, P19, DOI 10.1016/j.neurobiolaging.2003.04.001; Cano-de-la-Cuerda R, 2010, AM J PHYS MED REHAB, V89, P70, DOI 10.1097/PHM.0b013e3181a9ed9b; Corcos DM, 1996, ANN NEUROL, V39, P79, DOI 10.1002/ana.410390112; Cronin-Golomb A, 2010, NEUROPSYCHOL REV, V20, P191, DOI 10.1007/s11065-010-9128-8; de Boer A, 1982, ENG MED, V11, P169; Durmus B, 2010, J CLIN NEUROSCI, V17, P893, DOI 10.1016/j.jocn.2009.11.014; Edstrom L, 1970, J NEUROL SCI, V11, P537; El Mhandi L, 2013, AM J PHYS MED REHAB, V92, P163, DOI 10.1097/PHM.0b013e31826ed94c; Frazzitta G, 2013, J NEUROL, V260, P71, DOI 10.1007/s00415-012-6585-4; Gelb DJ, 1999, ARCH NEUROL-CHICAGO, V56, P33, DOI 10.1001/archneur.56.1.33; GLENDINNING DS, 1994, PHYS THER, V74, P61, DOI 10.1093/ptj/74.1.61; Horstmann T, 1999, INT J SPORTS MED, V20, P362, DOI 10.1055/s-2007-971145; Inkster LM, 2003, MOVEMENT DISORD, V18, P157, DOI 10.1002/mds.10299; Kakinuma S, 1998, EUR NEUROL, V39, P218, DOI 10.1159/000007937; KEMPSTER PA, 1989, J NEUROL NEUROSUR PS, V52, P72, DOI 10.1136/jnnp.52.1.72; Middleton FA, 2000, BRAIN COGNITION, V42, P183, DOI 10.1006/brcg.1999.1099; MOLCZYK L, 1991, Journal of Orthopaedic and Sports Physical Therapy, V14, P37; Moreno Catala M, 2013, NEUROREHAB NEURAL RE, V27, P753, DOI DOI 10.1177/1545968313491011; Nallegowda M, 2004, AM J PHYS MED REHAB, V83, P898, DOI 10.1097/01.PHM.0000146505.18244.43; Rossi B, 1996, ELECTROMYOGR MOTOR C, V101, P211, DOI 10.1016/0924-980X(96)94672-X; Scherfler C, 2012, BRAIN, V135, P3348, DOI 10.1093/brain/aws253; Schrag A, 2000, J NEUROL NEUROSUR PS, V69, P308, DOI 10.1136/jnnp.69.3.308; Tiffreau V, 2007, NEUROMUSCULAR DISORD, V17, P524, DOI 10.1016/j.nmd.2007.03.014; Tissingh G, 1998, J NUCL MED, V39, P1143	26	17	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0121251	10.1371/journal.pone.0121251	http://dx.doi.org/10.1371/journal.pone.0121251			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25806509	Green Submitted, gold, Green Published			2022-12-26	WOS:000351880000139
J	Li, F; Gao, BX; Dong, HX; Shi, JS; Fang, DY				Li, Fei; Gao, Beixue; Dong, Hongxin; Shi, Jingshan; Fang, Deyu			Icariin Induces Synoviolin Expression through NFE2L1 to Protect Neurons from ER Stress-Induced Apoptosis	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; UBIQUITIN LIGASE HRD1; CORTICOSTERONE-INDUCED APOPTOSIS; HIPPOCAMPAL-NEURONS; SIGNALING PATHWAY; CELL INJURY; IN-VIVO; DEGRADATION; BRAIN; ACTIVATION	By suppressing neuronal apoptosis, Icariin is a potential therapeutic drug for neuronal degenerative diseases. The molecular mechanisms of Icariin anti-apoptotic functions are still largely unclear. In this report, we found that Icariin induces the expression of Synoviolin, an endoplasmic reticulum (ER)-anchoring E3 ubiquitin ligase that functions as a suppressor of ER stress-induced apoptosis. The nuclear factor erythroid 2-related factor 1 (NFE2L1) is responsible for Icariin-mediated Synoviolin gene expression. Mutation of the NFE2L1-binding sites in a distal region of the Synoviolin promoter abolished Icariin-induced Synoviolin promoter activity, and knockdown of NFE2L1 expression prevented Icariin-stimulated Synoviolin expression. More importantly, Icariin protected ER stress-induced apoptosis of PC12 cells in a Synoviolin-dependent manner. Therefore, our study reveals Icariin-induced Synoviolin expression through NFE2L1 as a previously unappreciated molecular mechanism underlying the neuronal protective function of Icariin.	[Li, Fei; Shi, Jingshan] Zunyi Med Coll, Dept Pharmacol, Zunyi, Peoples R China; [Li, Fei; Shi, Jingshan] Zunyi Med Coll, Key Lab Basic Pharmacol Guizhou Prov, Zunyi, Peoples R China; [Gao, Beixue; Fang, Deyu] Northwestern Univ, Feinberg Sch Med, Dept Pathol, Chicago, IL 60611 USA; [Li, Fei; Dong, Hongxin] Northwestern Univ, Feinberg Sch Med, Dept Psychiat & Behav Sci, Chicago, IL 60611 USA	Zunyi Medical University; Zunyi Medical University; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Li, F (corresponding author), Zunyi Med Coll, Dept Pharmacol, Zunyi, Peoples R China.	lifei_2009@163.com; fangd@northwestern.edu			 [R01AI079056];  [R01AI108634];  [R01AR066634]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079056, R56AI079056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR066634] Funding Source: NIH RePORTER	; ; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by research grants R01AI079056, R01AI108634, and R01AR066634 to D.F. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert Y, 2005, J CELL BIOL, V169, P257, DOI 10.1083/jcb.200501156; Almeida MI, 2012, GASTROENTEROLOGY, V142, P886, DOI 10.1053/j.gastro.2011.12.047; Amano T, 2003, GENE DEV, V17, P2436, DOI 10.1101/gad.1096603; Atanassov BS, 2009, MOL CELL, V35, P352, DOI 10.1016/j.molcel.2009.06.015; Beier UH, 2011, CURR OPIN IMMUNOL, V23, P670, DOI 10.1016/j.coi.2011.07.002; Bordallo J, 1998, MOL BIOL CELL, V9, P209, DOI 10.1091/mbc.9.1.209; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; Chen A, 2009, MOL CELL BIOL, V29, P5348, DOI 10.1128/MCB.00407-09; Chen P, 2010, HUM MOL GENET, V19, P3502, DOI 10.1093/hmg/ddq266; Chen Yang, 2011, Zhong Xi Yi Jie He Xue Bao, V9, P1179, DOI 10.3736/jcim20111104; Denic V, 2006, CELL, V126, P349, DOI 10.1016/j.cell.2006.05.045; Gao BX, 2008, EMBO REP, V9, P480, DOI 10.1038/embor.2008.37; Gao BX, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2081; Gao BX, 2006, J BIOL CHEM, V281, P29711, DOI 10.1074/jbc.M604596200; Gao Yi-ning, 2012, Zhejiang Da Xue Xue Bao Yi Xue Ban, V41, P373; Guo J, 2010, PHYTOMEDICINE, V17, P950, DOI 10.1016/j.phymed.2010.03.007; Huang JH, 2014, CHIN J INTEGR MED, V20, P107, DOI 10.1007/s11655-013-1583-7; Izumi T, 2009, ARTHRITIS RHEUM-US, V60, P63, DOI 10.1002/art.24178; Jin QH, 2011, EMBO J, V30, P249, DOI 10.1038/emboj.2010.318; Kaneko M, 2012, YAKUGAKU ZASSHI, V132, P1437, DOI 10.1248/yakushi.12-00249; Kaneko M, 2010, J NEUROSCI, V30, P3924, DOI 10.1523/JNEUROSCI.2422-09.2010; Kawada K, 2014, J NEUROSCIENCE RES; Kawada K, 2011, J PHARMACOL SCI, V117, P208, DOI 10.1254/jphs.11120SC; Kong SY, 2011, J BIOL CHEM, V286, P16967, DOI 10.1074/jbc.M111.218206; Kuroda M, 2000, PLANTA MED, V66, P575, DOI 10.1055/s-2000-8611; Lee CS, 2011, P NATL ACAD SCI USA, V108, P8408, DOI 10.1073/pnas.1019209108; Lee SM, 2008, BLOOD, V111, P3599, DOI 10.1182/blood-2007-09-115014; Li F, 2010, PHARMACOL BIOCHEM BE, V96, P301, DOI 10.1016/j.pbb.2010.05.021; Li L, 2005, CHINESE MED J-PEKING, V118, P1637; Li L, 2010, AM J CHINESE MED, V38, P113, DOI 10.1142/S0192415X10007701; Li SG, 2010, CANCER LETT, V298, P222, DOI 10.1016/j.canlet.2010.07.009; Li WW, 2011, MUTAT RES-FUND MOL M, V708, P1, DOI 10.1016/j.mrfmmm.2010.12.017; LIANG H R, 1988, Yaoxue Xuebao, V23, P34; Liu BJ, 2011, BRAIN RES, V1375, P59, DOI 10.1016/j.brainres.2010.12.053; Luo Y, 2007, CLIN EXP PHARMACOL P, V34, P792, DOI 10.1111/j.1440-1681.2007.04647.x; Marshall BA, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-64; Mei JM, 2010, NEUROSCI LETT, V474, P63, DOI 10.1016/j.neulet.2010.02.033; Mengesdorf T, 2002, P NATL ACAD SCI USA, V99, P15042, DOI 10.1073/pnas.232588799; Nassif M, 2010, ANTIOXID REDOX SIGN, V13, P1955, DOI 10.1089/ars.2009.2991; Nie J, 2010, EUR J PHARMACOL, V626, P213, DOI 10.1016/j.ejphar.2009.09.039; Nomura Y, 2004, BIOL PHARM BULL, V27, P961, DOI 10.1248/bpb.27.961; Oh SY, 2011, CLIN EXP ALLERGY, V41, P434, DOI 10.1111/j.1365-2222.2010.03593.x; Omura T, 2008, J NEUROSCI RES, V86, P1577, DOI 10.1002/jnr.21616; Omura T, 2006, J NEUROCHEM, V99, P1456, DOI 10.1111/j.1471-4159.2006.04155.x; Paschen W, 2003, CELL CALCIUM, V34, P365, DOI 10.1016/S0143-4160(03)00139-8; Paschen W, 2005, CELL CALCIUM, V38, P409, DOI 10.1016/j.ceca.2005.06.019; Paschen W, 2001, CELL CALCIUM, V29, P1, DOI 10.1054/ceca.2000.0162; Paschen W, 1999, J CEREBR BLOOD F MET, V19, P1, DOI 10.1097/00004647-199901000-00001; Roussel BD, 2013, HUM MOL GENET, V22, P4616, DOI 10.1093/hmg/ddt310; Saito R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094576; Saito R, 2010, J PHARMACOL SCI, V113, P285, DOI 10.1254/jphs.10118SC; Sha DJ, 2009, NEUROREPORT, V20, P1564, DOI 10.1097/WNR.0b013e328332d345; Shen YX, 2012, CURR MOL MED, V12, P138, DOI 10.2174/156652412798889009; Shindel AW, 2010, J SEX MED, V7, P1518, DOI 10.1111/j.1743-6109.2009.01699.x; Song LG, 2013, EUR J PHARMACOL, V714, P15, DOI 10.1016/j.ejphar.2013.05.039; Steffen J, 2010, MOL CELL, V40, P147, DOI 10.1016/j.molcel.2010.09.012; Tsuchimochi K, 2005, MOL CELL BIOL, V25, P7344, DOI 10.1128/MCB.25.16.7344-7356.2005; Tsuchiya Y, 2011, MOL CELL BIOL, V31, P4500, DOI 10.1128/MCB.05663-11; Umeda T, 2011, J NEUROSCI RES, V89, P1031, DOI 10.1002/jnr.22640; Urano T, 2010, PHYTOTHER RES, V24, P1658, DOI 10.1002/ptr.3183; Wang L, 2009, EUR J PHARMACOL, V609, P40, DOI 10.1016/j.ejphar.2009.03.033; Wang RH, 2008, MOL CELL, V32, P11, DOI 10.1016/j.molcel.2008.09.011; Wu TD, 2014, GENE DEV, V28, P708, DOI 10.1101/gad.238246.114; Yamasaki S, 2007, EMBO J, V26, P113, DOI 10.1038/sj.emboj.7601490; Yang CR, 2013, NEUROL SCI, V34, P941, DOI 10.1007/s10072-012-1165-z; Ying Z, 2011, J BIOL CHEM, V286, P20835, DOI 10.1074/jbc.M110.200808; Zemoura K, 2013, J BIOL CHEM, V288, P34897, DOI 10.1074/jbc.M113.514745; Zeng KW, 2010, NEUROPHARMACOLOGY, V59, P542, DOI 10.1016/j.neuropharm.2010.07.020; Zeng KW, 2010, INT IMMUNOPHARMACOL, V10, P668, DOI 10.1016/j.intimp.2010.03.010; Zhang HY, 2012, MOL MED REP, V6, P967, DOI 10.3892/mmr.2012.1041; Zhang JN, 2009, J CLIN INVEST, V119, P3048, DOI 10.1172/JCI38902; Zhang L, 2010, BASIC CLIN PHARMACOL, V107, P899, DOI 10.1111/j.1742-7843.2010.00595.x; Zheng M, 2008, PHYTOTHER RES, V22, P597, DOI 10.1002/ptr.2276; Zhou H, 2014, EXP THER MED, V7, P1116, DOI 10.3892/etm.2014.1598; Zhu HR, 2010, NEUROPHARMACOLOGY, V59, P70, DOI 10.1016/j.neuropharm.2010.03.017	75	24	27	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0119955	10.1371/journal.pone.0119955	http://dx.doi.org/10.1371/journal.pone.0119955			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25806530	Green Submitted, gold, Green Published			2022-12-26	WOS:000351880000051
J	Chen, YZ; Xiao, HZ; Zheng, J; Liang, GZ				Chen, Yuzhen; Xiao, Huizhi; Zheng, Jie; Liang, Guizhao			Structure-Thermodynamics-Antioxidant Activity Relationships of Selected Natural Phenolic Acids and Derivatives: An Experimental and Theoretical Evaluation	PLOS ONE			English	Article							RADICAL SCAVENGING ACTIVITY; CHAIN-BREAKING ANTIOXIDANTS; DENSITY-FUNCTIONAL THEORY; H BOND-CLEAVAGE; PREDICTION; DESCRIPTORS; MECHANISMS; ELECTRON; POLYPHENOLS; ENTHALPIES	Phenolic acids and derivatives have potential biological functions, however, little is known about the structure-activity relationships and the underlying action mechanisms of these phenolic acids to date. Herein we investigate the structure-thermodynamics-antioxidant relationships of 20 natural phenolic acids and derivatives using DPPH center dot scavenging assay, density functional theory calculations at the B3LYP/6-311++G(d,p) levels of theory, and quantitative structure-activity relationship (QSAR) modeling. Three main working mechanisms (HAT, SETPT and SPLET) are explored in four micro-environments (gas-phase, benzene, water and ethanol). Computed thermodynamics parameters (BDE, IP, PDE, PA and ETE) are compared with the experimental radical scavenging activities against DPPH center dot. Available theoretical and experimental investigations have demonstrated that the extended delocalization and intra-molecular hydrogen bonds are the two main contributions to the stability of the radicals. The C = O or C = C in COOH, COOR, C = CCOOH and C = CCOOR groups, and orthodiphenolic functionalities are shown to favorably stabilize the specific radical species to enhance the radical scavenging activities, while the presence of the single OH in the ortho position of the COOH group disfavors the activities. HAT is the thermodynamically preferred mechanism in the gas phase and benzene, whereas SPLET in water and ethanol. Furthermore, our QSAR models robustly represent the structure-activity relationships of these explored compounds in polar media.	[Chen, Yuzhen] Henan Inst Sci & Technol, Sch Math Sci, Xinxiang 453003, Peoples R China; [Xiao, Huizhi; Liang, Guizhao] Chongqing Univ, Sch Bioengn, Key Lab Biorheol Sci & Technol, Minist Educ, Chongqing 400044, Peoples R China; [Zheng, Jie] Univ Akron, Dept Chem & Biomol Engn, Akron, OH 44325 USA	Henan Institute of Science & Technology; Chongqing University; University System of Ohio; University of Akron	Liang, GZ (corresponding author), Chongqing Univ, Sch Bioengn, Key Lab Biorheol Sci & Technol, Minist Educ, Chongqing 400044, Peoples R China.	gzliang@cqu.edu.cn	Zheng, Jie/B-5057-2013	Zheng, Jie/0000-0003-1547-3612	National Natural Science Foundation of China [10901169]; Natural Science Foundation Project of Chongqing CSTC [cstc2012gg-gjhz10003]; Fundamental Research Funds for the Central Universities [CQDXWL-2014-Z009]; National Science Foundation of USA (CAREER Award) [CBET-0952624, CBET-1158447]; Directorate For Engineering [0952624, 1158447] Funding Source: National Science Foundation	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation Project of Chongqing CSTC(Natural Science Foundation of ChongqingNatural Science Foundation Project of CQ CSTC); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Science Foundation of USA (CAREER Award); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	G.L. is thankful for financial support from the National Natural Science Foundation of China (No. 10901169), the Natural Science Foundation Project of Chongqing CSTC (No. cstc2012gg-gjhz10003), and the Fundamental Research Funds for the Central Universities (No. CQDXWL-2014-Z009). J.Z. thanks the National Science Foundation of USA (CAREER Award No. CBET-0952624 and CBET-1158447). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajitha MJ, 2012, J AGR FOOD CHEM, V60, P3693, DOI 10.1021/jf204826e; Amic A, 2014, FOOD CHEM, V152, P578, DOI 10.1016/j.foodchem.2013.12.025; BARTMESS JE, 1994, J PHYS CHEM-US, V98, P6420, DOI 10.1021/j100076a029; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; BINKLEY JS, 1980, J AM CHEM SOC, V102, P939, DOI 10.1021/ja00523a008; Bizarro MM, 1999, PURE APPL CHEM, V71, P1249, DOI 10.1351/pac199971071249; Cances E, 1997, J CHEM PHYS, V107, P3032, DOI 10.1063/1.474659; Cherblanc FL, 2013, NAT PROD REP, V30, P605, DOI 10.1039/c3np20097c; Cherkasov A, 2014, J MED CHEM, V57, P4977, DOI 10.1021/jm4004285; Chou KC, 2007, ANAL BIOCHEM, V370, P1, DOI 10.1016/j.ab.2007.07.006; CIOSLOWSKI J, 1989, J AM CHEM SOC, V111, P8333, DOI 10.1021/ja00204a001; Cumming JG, 2013, NAT REV DRUG DISCOV, V12, P948, DOI 10.1038/nrd4128; Feng Y, 2003, J CHEM INF COMP SCI, V43, P2005, DOI 10.1021/ci034033k; Fiorucci S, 2007, J AGR FOOD CHEM, V55, P903, DOI 10.1021/jf061864s; Frisch M. J., 2009, GAUSSIAN 16 REVISION; Golbraikh A, 2002, J MOL GRAPH MODEL, V20, P269, DOI 10.1016/S1093-3263(01)00123-1; HANSCH C, 1962, NATURE, V194, P178, DOI 10.1038/194178b0; Ianni JC, 2006, ANGEW CHEM INT EDIT, V45, P5502, DOI 10.1002/anie.200600329; Javan AJ, 2013, J AGR FOOD CHEM, V61, P1534, DOI 10.1021/jf304926m; Jayasena T, 2013, AGEING RES REV, V12, P867, DOI 10.1016/j.arr.2013.06.003; Karelson M, 1996, CHEM REV, V96, P1027, DOI 10.1021/cr950202r; Lengyel J, 2013, PHYS CHEM CHEM PHYS, V15, P10895, DOI 10.1039/c3cp00095h; Leopoldini M, 2004, J PHYS CHEM A, V108, P92, DOI 10.1021/jp035901j; Leopoldini M, 2011, FOOD CHEM, V125, P288, DOI 10.1016/j.foodchem.2010.08.012; Liang GZ, 2009, EUR J MED CHEM, V44, P1144, DOI 10.1016/j.ejmech.2008.06.011; Litwinienko G, 2007, ACCOUNTS CHEM RES, V40, P222, DOI 10.1021/ar0682029; Manach C, 2004, AM J CLIN NUTR, V79, P727, DOI 10.1093/ajcn/79.5.727; Mazzone G, 2013, J AGR FOOD CHEM, V61, P9650, DOI 10.1021/jf403262k; Mazzone G, 2013, FOOD CHEM, V141, P2017, DOI 10.1016/j.foodchem.2013.05.071; Nenadis N, 2003, J AGR FOOD CHEM, V51, P1874, DOI 10.1021/jf0261452; Nenadis N, 2012, FOOD RES INT, V48, P538, DOI 10.1016/j.foodres.2012.05.014; PARKER VD, 1992, J AM CHEM SOC, V114, P7458, DOI 10.1021/ja00045a018; Pratt DA, 2001, J AM CHEM SOC, V123, P4625, DOI 10.1021/ja005679l; Puzyn T, 2011, NAT NANOTECHNOL, V6, P175, DOI [10.1038/nnano.2011.10, 10.1038/NNANO.2011.10]; Puzyn T, 2009, SMALL, V5, P2494, DOI 10.1002/smll.200900179; Rimarcik J, 2010, J MOL STRUC-THEOCHEM, V952, P25, DOI 10.1016/j.theochem.2010.04.002; Robbins RJ, 2003, J AGR FOOD CHEM, V51, P2866, DOI 10.1021/jf026182t; Sanchez-Moreno C, 2002, FOOD SCI TECHNOL INT, V8, P121, DOI [10.1177/1082013202008003770, 10.1106/108201302026770]; Stepanic V, 2013, FOOD CHEM, V141, P1562, DOI 10.1016/j.foodchem.2013.03.072; Sun T, 2005, FOOD CHEM, V90, P743, DOI 10.1016/j.foodchem.2004.04.035; Tishchenko O, 2008, J AM CHEM SOC, V130, P7000, DOI 10.1021/ja7102907; Wijtmans M, 2003, ANGEW CHEM INT EDIT, V42, P4370, DOI 10.1002/anie.200351881; Wright JS, 2001, J AM CHEM SOC, V123, P1173, DOI 10.1021/ja002455u; Xie J, 2014, J AGR FOOD CHEM, V62, P4251, DOI 10.1021/jf500180u; Xue YS, 2014, FOOD CHEM, V151, P198, DOI 10.1016/j.foodchem.2013.11.064	45	111	114	3	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0121276	10.1371/journal.pone.0121276	http://dx.doi.org/10.1371/journal.pone.0121276			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803685	gold, Green Published, Green Submitted			2022-12-26	WOS:000353889600143
J	Chevalier, C; Cannet, A; Descamps, S; Sirvent, A; Simon, V; Roche, S; Benistant, C				Chevalier, Clement; Cannet, Aude; Descamps, Simon; Sirvent, Audrey; Simon, Valerie; Roche, Serge; Benistant, Christine			ABL Tyrosine Kinase Inhibition Variable Effects on the Invasive Properties of Different Triple Negative Breast Cancer Cell Lines	PLOS ONE			English	Article							SIGNALING AXIS; GEF TRIO; IN-VIVO; DEGRADATION; EXTENSION; PATHWAY; TARGETS; REVEAL; FAMILY	The non-receptor tyrosine kinase ABL drives myeloid progenitor expansion in human chronic myeloid leukemia. ABL inhibition by the tyrosine kinase inhibitor nilotinib is a first-line treatment for this disease. Recently, ABL has also been implicated in the transforming properties of solid tumors, including triple negative (TN) breast cancer. TN breast cancers are highly metastatic and several cell lines derived from these tumors display high invasive activity in vitro. This feature is associated with the activation of actin-rich membrane structures called invadopodia that promote extracellular matrix degradation. Here, we investigated nilotinib effect on the invasive and migratory properties of different TN breast cancer cell lines. Nilotinib decreased both matrix degradation and invasion in the TN breast cancer cell lines MDA-MB 231 and MDA-MB 468. However, and unexpectedly, nilotinib increased by two-fold the invasive properties of the TN breast cancer cell line BT-549 and of Src-transformed fibroblasts. Both display much higher levels of ABL kinase activity compared to MDA-MB 231. Similar effects were obtained by siRNA-mediated down-regulation of ABL expression, confirming ABL central role in this process. ABL anti-tumor effect in BT-549 cells and Src-transformed fibroblasts was not dependent on EGF secretion, as recently reported in neck and squamous carcinoma cells. Rather, we identified the TRIO-RAC1 axis as an important downstream element of ABL activity in these cancer cells. In conclusion, the observation that TN breast cancer cell lines respond differently to ABL inhibitors could have implications for future therapies.	[Chevalier, Clement; Cannet, Aude; Descamps, Simon; Sirvent, Audrey; Simon, Valerie; Roche, Serge] Univ Montpellier, CNRS, Ctr Rech Biochim Macromol, UMR5237, F-34000 Montpellier, France; [Benistant, Christine] Univ Montpellier, CNRS, INSERM, Ctr Biochim Struct,UMR 5048,UMR 1054, F-34090 Montpellier, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Roche, S (corresponding author), Univ Montpellier, CNRS, Ctr Rech Biochim Macromol, UMR5237, F-34000 Montpellier, France.	serge.roche@crbm.cnrs.fr; christine.benistant@cbs.cnrs.fr	Benistant, Christine/M-5771-2018	roche, serge/0000-0003-3413-3859	ARC; CNRS; University of Montpellier	ARC(Australian Research Council); CNRS(Centre National de la Recherche Scientifique (CNRS)); University of Montpellier	This work was supported by ARC, CNRS and the University of Montpellier.	Allington TM, 2009, FASEB J, V23, P4231, DOI 10.1096/fj.09-138412; Artym Vira V., 2009, V522, P211, DOI 10.1007/978-1-59745-413-1_15; Beaty BT, 2013, MOL BIOL CELL, V24, P1661, DOI 10.1091/mbc.E12-12-0908; Bouquier N, 2009, CHEM BIOL, V16, P657, DOI 10.1016/j.chembiol.2009.04.012; Carey L, 2010, NAT REV CLIN ONCOL, V7, P683, DOI 10.1038/nrclinonc.2010.154; Charrasse S, 2007, MOL BIOL CELL, V18, P1734, DOI 10.1091/mbc.E06-08-0766; Collin G, 2007, MOL CELL BIOL, V27, P7631, DOI 10.1128/MCB.00543-07; DeGeer J, 2013, MOL CELL BIOL, V33, P739, DOI 10.1128/MCB.01264-12; Fitamant J, 2008, P NATL ACAD SCI USA, V105, P4850, DOI 10.1073/pnas.0709810105; Ganguly SS, 2012, GENES CANC, V5-6, P414; Garcia-Mata R, 2011, NAT REV MOL CELL BIO, V12, P493, DOI 10.1038/nrm3153; Gil-Henn H, 2013, ONCOGENE, V32, P2622, DOI 10.1038/onc.2012.284; Greuber EK, 2013, NAT REV CANCER, V13, P559, DOI 10.1038/nrc3563; Hagedorn EJ, 2013, J CELL BIOL, V201, P903, DOI 10.1083/jcb.201301091; Hayes KE, 2013, ONCOGENE, V32, P4766, DOI 10.1038/onc.2012.513; Hoshino D, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002964; Jin H, 2007, MOL BIOL CELL, V18, P4143, DOI 10.1091/mbc.E07-01-0085; Kau P, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-120; Liebl EC, 2000, NEURON, V26, P107, DOI 10.1016/S0896-6273(00)81142-3; Lock P, 1998, EMBO J, V17, P4346, DOI 10.1093/emboj/17.15.4346; Moshfegh Y, 2014, NAT CELL BIOL, V16, P571, DOI 10.1038/ncb2972; Noren NK, 2006, NAT CELL BIOL, V8, P815, DOI 10.1038/ncb1438; Pusztai L, 2014, CLIN CANC R IN PRESS; Rix U, 2007, BLOOD, V110, P4055, DOI 10.1182/blood-2007-07-102061; Sirvent A, 2007, ONCOGENE, V26, P7313, DOI 10.1038/sj.onc.1210543; Sirvent A, 2008, BIOL CELL, V100, P617, DOI 10.1042/BC20080020; van Haren J, 2014, CURR BIOL, V24, P1778, DOI 10.1016/j.cub.2014.06.037; Weigelt B, 2011, ONCOGENE, V30, P3222, DOI 10.1038/onc.2011.42; Woodring PJ, 2003, J CELL SCI, V116, P2613, DOI 10.1242/jcs.00622; Zhang JM, 2009, NAT REV CANCER, V9, P28, DOI 10.1038/nrc2559	30	9	11	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0118854	10.1371/journal.pone.0118854	http://dx.doi.org/10.1371/journal.pone.0118854			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803821	Green Published, gold, Green Submitted			2022-12-26	WOS:000353889600011
J	Gan, F; Xue, HX; Huang, Y; Pan, CL; Huang, KH				Gan, Fang; Xue, Hongxia; Huang, Yu; Pan, Cuiling; Huang, Kehe			Selenium Alleviates Porcine Nephrotoxicity of Ochratoxin A by Improving Selenoenzyme Expression In Vitro	PLOS ONE			English	Article							KIDNEY PK15 CELLS; OXIDATIVE STRESS; N-ACETYLCYSTEINE; T-2 TOXIN; ENRICHED PROBIOTICS; LIPID-PEROXIDATION; ORGANIC SELENIUM; DNA-DAMAGE; APOPTOSIS; CYTOTOXICITY	Ochratoxin A (OTA), a mycotoxin, is a potent nephrotoxin in humans and animals. Selenium (Se) is an essential micronutrient for humans and animals, and plays a key role in antioxidant defense. To date, little is known about the effect of Se on OTA-induced nephrotoxicity. In this study, the protective effects of selenomethionine against OTA-induced nephrotoxicity were investigated using the porcine kidney 15 (PK15) cells as a model. The results showed that OTA induced nephrotoxicity in a dose-dependent manner. Se at 0.5, 1, 2 and 4 mu M had significant protective effects against OTA-induced nephrotoxicity. Furthermore, selenomethionine enhanced the activity and mRNA and protein expression of glutathione peroxidase 1 (GPx1), mRNA expression of GPx4, and mRNA expression of thioredoxin reductase 1 in the presence and absence of OTA. Among them, promoting effect of selenomethionine on GPx1 was maximal. Knock-down of GPx1 by using a GPx1-specific siRNA eliminated the protective effects of selenomethionine against OTA-induced nephrotoxicity. The results suggest that selenomethionine alleviates OTA-induced nephrotoxicity by improving selenoenzyme expression in PK15 cells. Therefore, selenomethionine supplementation may be an attractive strategy for protecting humans and animals from the risk of kidney damage induced by OTA.	[Gan, Fang; Xue, Hongxia; Huang, Yu; Pan, Cuiling; Huang, Kehe] Nanjing Agr Univ, Coll Vet Med, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Huang, KH (corresponding author), Nanjing Agr Univ, Coll Vet Med, Nanjing, Jiangsu, Peoples R China.	khhuang@njau.edu.cn			Natural Science Foundation of China [31272627]; Natural Science Foundation of Jiangsu Province [BK 2012772]; Priority Academic Program Development of Jiangsu Higher Education Institutions	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was funded by the Natural Science Foundation of China (Grant number, 31272627), the Natural Science Foundation of Jiangsu Province (Grant number, BK 2012772), and the Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbillaga L, 2007, MUTAGENESIS, V22, P35, DOI 10.1093/mutage/gel049; Arner ESJ, 2009, BBA-GEN SUBJECTS, V1790, P495, DOI 10.1016/j.bbagen.2009.01.014; Battacone G, 2010, TOXINS, V2, P1796, DOI 10.3390/toxins2071796; Bennett JW, 2003, CLIN MICROBIOL REV, V16, P497, DOI 10.1128/CMR.16.3.497-516.2003; Bernabucci U, 2011, TOXICOL IN VITRO, V25, P684, DOI 10.1016/j.tiv.2011.01.009; Boesch-Saadatmandi C, 2008, FOOD CHEM TOXICOL, V46, P2665, DOI 10.1016/j.fct.2008.04.023; Bouaziz C, 2008, TOXICOLOGY, V254, P19, DOI 10.1016/j.tox.2008.08.020; Bouslimi A, 2008, TOXICOLOGY, V251, P1, DOI 10.1016/j.tox.2008.06.008; Briens M, 2013, BRIT J NUTR, V110, P617, DOI 10.1017/S0007114512005545; Cao JJ, 2012, J NUTR, V142, P1526, DOI 10.3945/jn.111.157040; Chen XX, 2012, FREE RADICAL BIO MED, V53, P395, DOI 10.1016/j.freeradbiomed.2012.04.035; Chitta KR, 2013, METALLOMICS, V5, P673, DOI 10.1039/c3mt20213e; Costa S, 2008, WORLD MYCOTOXIN J, V1, P469, DOI 10.3920/WMJ2007.1007; Doorten AYS, 2004, TOXICOL IN VITRO, V18, P271, DOI 10.1016/j.tiv.2003.10.001; Dringen R, 1998, BRAIN RES PROTOC, V2, P223, DOI 10.1016/S1385-299X(97)00047-0; Dvorska JE, 2007, COMP BIOCHEM PHYS C, V145, P582, DOI 10.1016/j.cbpc.2007.02.005; Erkekoglu P, 2010, TOXICON, V55, P507, DOI 10.1016/j.toxicon.2009.10.002; Gan F, 2014, J AGR FOOD CHEM, V62, P4502, DOI 10.1021/jf501065d; Gan F, 2013, J AGR FOOD CHEM, V61, P2385, DOI 10.1021/jf300249j; Hennemeier I, 2012, MOL NUTR FOOD RES, V56, P1375, DOI 10.1002/mnfr.201200164; Hernandez-Garcia D, 2010, FREE RADICAL BIO MED, V49, P130, DOI 10.1016/j.freeradbiomed.2010.03.020; Hoffmann FW, 2010, J NUTR, V140, P1155, DOI 10.3945/jn.109.120725; Hsieh CC, 2006, FASEB J, V20, P259, DOI 10.1096/fj.05-4376com; Jilani K, 2012, KIDNEY BLOOD PRESS R, V36, P107, DOI 10.1159/000341488; KHALEF A, 1993, COLLOQ INSE, V231, P123; Klaric MK, 2008, ARCH TOXICOL, V82, P247, DOI 10.1007/s00204-007-0245-y; Klaric MS, 2007, BASIC CLIN PHARMACOL, V100, P157, DOI 10.1111/j.1742-7843.2006.00019.x; Kumar M, 2014, TOXICOL IND HEALTH, V30, P90, DOI 10.1177/0748233712452598; Li ZN, 2012, J BIOCHEM MOL TOXIC, V26, P139, DOI 10.1002/jbt.20420; Luhe A, 2003, TOXICOL SCI, V73, P315, DOI 10.1093/toxsci/kfg073; Mu PQ, 2013, PROTEOMICS, V13, P3175, DOI 10.1002/pmic.201300015; Naziroglu M, 2013, NEUROSCIENCE, V242, P151, DOI 10.1016/j.neuroscience.2013.03.032; Naziroglu M, 2004, TOXICOLOGY, V195, P221, DOI 10.1016/j.tox.2003.10.012; Naziroglu M, 2014, CELL MOL NEUROBIOL, V34, P895, DOI 10.1007/s10571-014-0069-2; Naziroglu M, 2011, J MEMBRANE BIOL, V242, P109, DOI 10.1007/s00232-011-9382-6; Ozcelik N, 2001, TOXICOL LETT, V121, P9, DOI 10.1016/S0378-4274(00)00291-5; Palabiyik SS, 2013, EXP TOXICOL PATHOL, V65, P853, DOI 10.1016/j.etp.2012.12.004; Parveen F, 2014, BIOL TRACE ELEM RES, V157, P266, DOI 10.1007/s12011-014-9887-9; Patel T, 1996, FASEB J, V10, P587, DOI 10.1096/fasebj.10.5.8621058; PITT JI, 1987, APPL ENVIRON MICROB, V53, P266, DOI 10.1128/AEM.53.2.266-269.1987; Schaaf GJ, 2002, BBA-MOL BASIS DIS, V1588, P149, DOI 10.1016/S0925-4439(02)00159-X; SHI CY, 1995, HUM EXP TOXICOL, V14, P55, DOI 10.1177/096032719501400111; Shokri F, 2000, TOXICOLOGY, V146, P171, DOI 10.1016/S0300-483X(00)00172-4; Squires JE, 2007, MOL CELL BIOL, V27, P7848, DOI 10.1128/MCB.00793-07; Stachurska A, 2013, MOL NUTR FOOD RES, V57, P504, DOI 10.1002/mnfr.201200456; Stefanovic V, 2009, NEPHRON CLIN PRACT, V112, pC51, DOI 10.1159/000213081; Wu XS, 2010, J NUTR BIOCHEM, V21, P153, DOI 10.1016/j.jnutbio.2008.12.006; Yang Q, 2014, FOOD CHEM TOXICOL, V70, P40, DOI 10.1016/j.fct.2014.04.039; Yen YH, 2014, MOLECULES, V19, P18721, DOI 10.3390/molecules191118721; Zain ME, 2011, J SAUDI CHEM SOC, V15, P129, DOI 10.1016/j.jscs.2010.06.006	50	36	36	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0119808	10.1371/journal.pone.0119808	http://dx.doi.org/10.1371/journal.pone.0119808			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803869	Green Submitted, gold, Green Published			2022-12-26	WOS:000353889600047
J	Jearaphunt, M; Amparyup, P; Sangsuriya, P; Charoensapsri, W; Senapin, S; Tassanakajon, A				Jearaphunt, Miti; Amparyup, Piti; Sangsuriya, Pakkakul; Charoensapsri, Walaiporn; Senapin, Saengchan; Tassanakajon, Anchalee			Shrimp Serine Proteinase Homologues PmMasSPH-1 and-2 Play a Role in the Activation of the Prophenoloxidase System	PLOS ONE			English	Article							PATTERN-RECOGNITION PROTEIN; MASQUERADE-LIKE PROTEIN; GIANT TIGER SHRIMP; IMMUNE-RESPONSES; PROPO-SYSTEM; PHENOLOXIDASE; MELANIZATION; INSECT; DEFENSE; COLEOPTERAN	Melanization mediated by the prophenoloxidase (proPO) activating system is a rapid immune response used by invertebrates against intruding pathogens. Several masquerade-like and serine proteinase homologues (SPHs) have been demonstrated to play an essential role in proPO activation in insects and crustaceans. In a previous study, we characterized the masquerade-like SPH, PmMasSPH1, in the black tiger shrimp Penaeus monodon as a multifunctional immune protein based on its recognition and antimicrobial activity against the Gramnegative bacteria Vibrio harveyi. In the present study, we identify a novel SPH, known as PmMasSPH2, composed of an N-terminal clip domain and a C-terminal SP-like domain that share high similarity to those of other insect and crustacean SPHs. We demonstrate that gene silencing of PmMasSPH1 and PmMasSPH2 significantly reduces PO activity, resulting in a high number of V. harveyi in the hemolymph. Interestingly, knockdown of PmMasSPH1 suppressed not only its gene transcript but also other immune-related genes in the proPO system (e.g., PmPPAE2) and antimicrobial peptides (e.g., PenmonPEN3, PenmonPEN5, crustinPm1 and Crus-likePm). The PmMasSPH1 and PmMasSPH2 also show binding activity to peptidoglycan (PGN) of Gram-positive bacteria. Using a yeast two-hybrid analysis and co-immunoprecipitation, we demonstrate that PmMasSPH1 specifically interacted with the final proteinase of the proPO cascade, PmPPAE2. Furthermore, the presence of both PmMasSPH1 and PmPPAE2 enhances PGN-induced PO activity in vitro. Taken together, these results suggest the importance of PmMasSPHs in the activation of the shrimp proPO system.	[Jearaphunt, Miti; Amparyup, Piti; Sangsuriya, Pakkakul; Tassanakajon, Anchalee] Chulalongkorn Univ, Fac Sci, Ctr Excellence Mol Biol & Genom Shrimp, Dept Biochem, Bangkok, Thailand; [Amparyup, Piti; Sangsuriya, Pakkakul; Charoensapsri, Walaiporn; Senapin, Saengchan] NSTDA, Natl Ctr Genet Engn & Biotechnol BIOTEC, Klongluang, Pathumthani, Thailand; [Charoensapsri, Walaiporn; Senapin, Saengchan] Mahidol Univ, Ctr Excellence Shrimp Mol Biol & Biotechnol Cente, Bangkok 10700, Thailand	Chulalongkorn University; National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); Mahidol University	Tassanakajon, A (corresponding author), Chulalongkorn Univ, Fac Sci, Ctr Excellence Mol Biol & Genom Shrimp, Dept Biochem, Bangkok, Thailand.	anchalee.k@chula.ac.th	Senapin, Saengchan/F-1323-2011	Senapin, Saengchan/0000-0002-5599-4343; Sangsuriya, Pakkakul/0000-0001-5978-7977; Sangsuriya, Panpanga/0000-0002-5522-0620; Charoensapsri, Walaiporn/0000-0002-8651-383X	Thailand Research Fund [RTA5580008, IRG5780008]; Thailand Research Fund; National Center for Genetic Engineering and Biotechnology, National Science and Technology Development Agency [RSA5580046]; Higher Education Research Promotion and National Research University Project of Thailand, Office of the Higher Education Commission [WCU-017-FW-57]; program Strategic Scholarships for Frontier Research Network for the Joint Ph.D. Program: The Office of the Higher Education Commission [28/2551]; 90th Anniversary of Chulalongkorn University Fund (Ratchadaphiseksomphot Endowment Fund)	Thailand Research Fund(Thailand Research Fund (TRF)); Thailand Research Fund(Thailand Research Fund (TRF)); National Center for Genetic Engineering and Biotechnology, National Science and Technology Development Agency; Higher Education Research Promotion and National Research University Project of Thailand, Office of the Higher Education Commission; program Strategic Scholarships for Frontier Research Network for the Joint Ph.D. Program: The Office of the Higher Education Commission; 90th Anniversary of Chulalongkorn University Fund (Ratchadaphiseksomphot Endowment Fund)(Chulalongkorn University)	This work was supported by research grants from the Thailand Research Fund to AT (TRF Senior Scholar No. RTA5580008; IRG5780008), the Thailand Research Fund and National Center for Genetic Engineering and Biotechnology, National Science and Technology Development Agency to PA (Grant No. RSA5580046) and the Higher Education Research Promotion and National Research University Project of Thailand, Office of the Higher Education Commission (WCU-017-FW-57). Research exchanges are from the Japan Science and Technology Agency/Japan International Cooperation Agency, Science and Technology Research Partnership for Sustainable Development (JST/JICA, SATREPS) and the JSPS core-University Program. MJ is supported by the program Strategic Scholarships for Frontier Research Network for the Joint Ph.D. Program: The Office of the Higher Education Commission (28/2551) and the 90th Anniversary of Chulalongkorn University Fund (Ratchadaphiseksomphot Endowment Fund). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amparyup P, 2009, DEV COMP IMMUNOL, V33, P247, DOI 10.1016/j.dci.2008.09.003; Amparyup P, 2007, FISH SHELLFISH IMMUN, V22, P535, DOI 10.1016/j.fsi.2006.07.004; Amparyup P, 2013, DEV COMP IMMUNOL, V41, P597, DOI 10.1016/j.dci.2013.06.013; Amparyup P, 2013, FISH SHELLFISH IMMUN, V34, P990, DOI 10.1016/j.fsi.2012.08.019; Amparyup P, 2012, J BIOL CHEM, V287, P10060, DOI 10.1074/jbc.M111.294744; An CJ, 2009, J BIOL CHEM, V284, P19716, DOI 10.1074/jbc.M109.007112; Ayres JS, 2008, PLOS BIOL, V6, P2764, DOI 10.1371/journal.pbio.0060305; Binggeli O, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004067; Cerenius L, 2004, IMMUNOL REV, V198, P116, DOI 10.1111/j.0105-2896.2004.00116.x; Cerenius L, 2008, TRENDS IMMUNOL, V29, P263, DOI 10.1016/j.it.2008.02.009; Cerenius L, 2010, TRENDS BIOCHEM SCI, V35, P575, DOI 10.1016/j.tibs.2010.04.006; Charoensapsri W, 2014, DEV COMP IMMUNOL, V47, P150, DOI 10.1016/j.dci.2014.07.010; Charoensapsri W, 2011, DEV COMP IMMUNOL, V35, P115, DOI 10.1016/j.dci.2010.09.002; Charoensapsri W, 2009, DEV COMP IMMUNOL, V33, P811, DOI 10.1016/j.dci.2009.01.006; Choe KM, 2002, SCIENCE, V296, P359, DOI 10.1126/science.1070216; Dziarski R, 2006, CELL MICROBIOL, V8, P1059, DOI 10.1111/j.1462-5822.2006.00726.x; Fagutao FF, 2009, FEBS J, V276, P5298, DOI 10.1111/j.1742-4658.2009.07225.x; Felfoldi G, 2011, J IMMUNOL, V186, P4828, DOI 10.4049/jimmunol.1003246; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; Gorman MJ, 2007, J BIOL CHEM, V282, P11742, DOI 10.1074/jbc.M611243200; Gupta S, 2005, INSECT BIOCHEM MOLEC, V35, P241, DOI 10.1016/j.ibmb.2004.12.003; Isono E, 2010, METHODS MOL BIOL, V655, P377, DOI 10.1007/978-1-60761-765-5_25; Iwanaga S, 2005, J BIOCHEM MOL BIOL, V38, P128; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Jiravanichpaisal P, 2007, FISH SHELLFISH IMMUN, V23, P815, DOI 10.1016/j.fsi.2007.03.003; Jiravanichpaisal P, 2006, IMMUNOBIOLOGY, V211, P213, DOI 10.1016/j.imbio.2005.10.015; Jitvaropas R, 2009, COMP BIOCHEM PHYS B, V153, P236, DOI 10.1016/j.cbpb.2009.03.007; Kan H, 2008, J BIOL CHEM, V283, P25316, DOI 10.1074/jbc.M804364200; Kanost MR, 2008, INSECT IMMUNOLOGY, P69, DOI 10.1016/B978-012373976-6.50006-9; Kim MS, 2002, J BIOL CHEM, V277, P39999, DOI 10.1074/jbc.M205508200; Kwon TH, 2000, EUR J BIOCHEM, V267, P6188, DOI 10.1046/j.1432-1327.2000.01695.x; Lee KY, 2002, EUR J BIOCHEM, V269, P4375, DOI 10.1046/j.1432-1033.2002.03155.x; Lee SY, 2001, J IMMUNOL, V166, P7319, DOI 10.4049/jimmunol.166.12.7319; Ligoxygakis P, 2002, EMBO J, V21, P6330, DOI 10.1093/emboj/cdf661; Liu H, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M706113200; Liu HP, 2011, DEV COMP IMMUNOL, V35, P51, DOI 10.1016/j.dci.2010.08.005; MURUGASUOEI B, 1995, GENE DEV, V9, P139, DOI 10.1101/gad.9.2.139; Nappi AJ, 2005, INSECT BIOCHEM MOLEC, V35, P443, DOI 10.1016/j.ibmb.2005.01.014; Piao S, 2005, EMBO J, V24, P4404, DOI 10.1038/sj.emboj.7600891; Royet J, 2011, NAT REV IMMUNOL, V11, P837, DOI 10.1038/nri3089; Soderhall K, 2013, HANDBOOK OF PROTEOLYTIC ENZYMES, VOLS 1 AND 2, 3RD EDITION, P3068, DOI 10.1016/B978-0-12-382219-2.00676-1; Sriphaijit T, 2007, DEV COMP IMMUNOL, V31, P1145, DOI 10.1016/j.dci.2007.03.005; Strand MR, 2008, INSECT IMMUNOLOGY, P25, DOI 10.1016/S0965-1748(02)00092-9; Tassanakajon A, 2006, GENE, V384, P104, DOI 10.1016/j.gene.2006.07.012; Udompetcharaporn A, 2014, DEV COMP IMMUNOL, V46, P146, DOI 10.1016/j.dci.2014.04.003; Yassine H, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003029; Yu XQ, 2003, INSECT BIOCHEM MOLEC, V33, P197, DOI 10.1016/S0965-1748(02)00191-1; Zhang QX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063787; Zhang YJ, 2010, FISH SHELLFISH IMMUN, V28, P649, DOI 10.1016/j.fsi.2009.12.021	49	14	14	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0121073	10.1371/journal.pone.0121073	http://dx.doi.org/10.1371/journal.pone.0121073			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803442	Green Published, gold, Green Submitted			2022-12-26	WOS:000353889600120
J	Schulz, M; Karpova, D; Spohn, G; Damert, A; Seifried, E; Binder, V; Bonig, H				Schulz, Miriam; Karpova, Darja; Spohn, Gabriele; Damert, Annette; Seifried, Erhard; Binder, Vera; Boenig, Halvard			Variant rs1801157 in the 3'UTR of SDF-1 beta Does Not Explain Variability of Healthy-Donor G-CSF Responsiveness	PLOS ONE			English	Article							STEM-CELL MOBILIZATION; PERIPHERAL-BLOOD; ALLOGENEIC TRANSPLANTATION; BONE-MARROW; IMPACT; CYCLOPHOSPHAMIDE; POLYMORPHISM; ASSOCIATION; ENGRAFTMENT; ALLELE	The genetics responsible for the inter-individually variable G-CSF responsiveness remain elusive. A single nucleotide polymorphism (SNP) in the 3'UTR of CXCL12, rs1801157, was implicated in X4-tropic HiV susceptibility and later, in two small studies, in G-CSR responsiveness in patients and donors. The position of the SNP in the 3'UTR together with in-silico predictions suggested differential binding of micro-RNA941 as an underlying mechanism. In a cohort of 515 healthy stem cell donors we attempted to reproduce the correlation of the CXCL12 3'UTR SNP and mobilization responses and tested the role of miR941 in this context. The SNP was distributed with the expected frequency. Mobilization efficiency for CD34 + cells in WT, heterozygous and homozygous SNP individuals was indistinguishable, even after controlling for gender. miR941 expression in non-hematopoietic bone marrow cells was undetectable and miR941 did not interact with the 3' UTR of CXCL12. Proposed effects of the SNP rs1801157 on G-CSF responsiveness cannot be confirmed in a larger cohort.	[Schulz, Miriam; Seifried, Erhard; Boenig, Halvard] German Red Cross Blood Serv Baden Wurttemberg He, Frankfurt, Germany; [Karpova, Darja; Spohn, Gabriele; Damert, Annette; Seifried, Erhard; Boenig, Halvard] Goethe Univ Frankfurt, Inst Transfus Med & Immunohematol, D-60054 Frankfurt, Germany; [Binder, Vera] Univ Dusseldorf, Fac Med, Dept Pediat Oncol Hematol & Clin Immunol, Dusseldorf, Germany; [Boenig, Halvard] Univ Washington, Dept Med, Div Hematol, Seattle, WA 98195 USA	Goethe University Frankfurt; Heinrich Heine University Dusseldorf; University of Washington; University of Washington Seattle	Bonig, H (corresponding author), German Red Cross Blood Serv Baden Wurttemberg He, Frankfurt, Germany.	h.boenig@blutspende.de	Bönig, Halvard/AAG-3029-2021; Binder, Vera/N-2078-2015	Bönig, Halvard/0000-0003-0088-2675; 	clinician-scientist scholarship; Hessian Ministry of Higher Education, Research and the Arts [III L 4 518/17.004]	clinician-scientist scholarship; Hessian Ministry of Higher Education, Research and the Arts	MS is the recipient of a clinician-scientist scholarship, ES and HB are members of the LOEWE Cell and Gene Therapy Frankfurt faculty, funded by Hessian Ministry of Higher Education, Research and the Arts ref.no.: III L 4 518/17.004 (2010/2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbona C, 1998, BONE MARROW TRANSPL, V22, P39, DOI 10.1038/sj.bmt.1701293; Arya SK, 1999, J HUMAN VIROL, V2, P133; Ben Nasr M, 2011, TRANSPL P, V43, P635, DOI 10.1016/j.transproceed.2011.01.016; Benboubker L, 2001, BRIT J HAEMATOL, V113, P247, DOI 10.1046/j.1365-2141.2001.02717.x; Bertani G, 2014, TRANSFUSION, V54, P2028, DOI 10.1111/trf.12612; Bogunia-Kubik K, 2009, BONE MARROW TRANSPL, V44, P273, DOI 10.1038/bmt.2009.30; Clark RE, 1998, BONE MARROW TRANSPL, V22, P859, DOI 10.1038/sj.bmt.1701461; Dauber K, 2011, CYTOTHERAPY, V13, P449, DOI 10.3109/14653249.2010.529894; deHaan G, 1997, BLOOD, V89, P1543, DOI 10.1182/blood.V89.5.1543.1543_1543_1550; Favre G, 2003, BONE MARROW TRANSPL, V32, P873, DOI 10.1038/sj.bmt.1704245; Holig K, 2009, BLOOD, V114, P3757, DOI 10.1182/blood-2009-04-218651; Ings SJ, 2006, BRIT J HAEMATOL, V134, P517, DOI 10.1111/j.1365-2141.2006.06223.x; Kroger N, 2000, BRIT J HAEMATOL, V111, P761, DOI 10.1046/j.1365-2141.2000.02412.x; Lenk J, 2013, BIOL BLOOD MARROW TR, V19, P1517, DOI 10.1016/j.bbmt.2013.07.018; McLaren PJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003515; Morton J, 1997, LEUKEMIA RES, V21, P21, DOI 10.1016/S0145-2126(96)00059-8; Motabi IH, 2012, BLOOD REV, V26, P267, DOI 10.1016/j.blre.2012.09.003; Mueller MM, 2013, VOX SANG, V104, P46, DOI 10.1111/j.1423-0410.2012.01632.x; Noach EJK, 2003, EXP HEMATOL, V31, P528, DOI 10.1016/S0301-472X(03)00068-7; PHILLIPS RL, 1995, J CELL PHYSIOL, V164, P99, DOI 10.1002/jcp.1041640113; Russell NH, 2001, BEST PRACT RES CL HA, V14, P685, DOI 10.1053/beha.2001.0167; Soriano A, 2002, J INFECT DIS, V186, P922, DOI 10.1086/343741; Tournilhac O, 2004, BLOOD, V103, P363, DOI 10.1182/blood-2003-05-1449; Winkler C, 1998, SCIENCE, V279, P389, DOI 10.1126/science.279.5349.389; Xiao QZ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004061; Zhang Y, 2013, NAT CELL BIOL, V15, P284, DOI 10.1038/ncb2690	26	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0121859	10.1371/journal.pone.0121859	http://dx.doi.org/10.1371/journal.pone.0121859			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803672	Green Published, gold, Green Submitted			2022-12-26	WOS:000353889600177
J	Wang, YX; Marshall, KL; Baba, Y; Lumpkin, EA; Gerling, GJ				Wang, Yuxiang; Marshall, Kara L.; Baba, Yoshichika; Lumpkin, Ellen A.; Gerling, Gregory J.			Compressive Viscoelasticity of Freshly Excised Mouse Skin Is Dependent on Specimen Thickness, Strain Level and Rate	PLOS ONE			English	Article							2-DIMENSIONAL MECHANICAL-PROPERTIES; RABBIT SKIN; TISSUE	Although the skin's mechanical properties are well characterized in tension, little work has been done in compression. Here, the viscoelastic properties of a population of mouse skin specimens (139 samples from 36 mice, aged 5 to 34 weeks) were characterized upon varying specimen thickness, as well as strain level and rate. Over the population, we observed the skin's viscoelasticity to be quite variable, yet found systematic correlation of residual stress ratio with skin thickness and strain, and of relaxation time constants with strain rates. In particular, as specimen thickness ranged from 211 to 671 mu m, we observed significant variation in both quasi-linear viscoelasticity (QLV) parameters, the relaxation time constant (tau(1) = 0.19 +/- 0.10 s) and steady-state residual stress ratio (G(infinity) = 0.28 +/- 0.13). Moreover, when t1 was decoupled and fixed, we observed that G(infinity) positively correlated with skin thickness. Second, as steady-state stretch was increased (lambda(infinity) from 0.22 to 0.81), we observed significant variation in both QLV parameters (tau(1) = 0.26 +/- 0.14 s, G(infinity) = 0.47 +/- 0.17), and when tau(1) was fixed, G(infinity) positively correlated with stretch level. Third, as strain rate was increased from 0.06 to 22.88 s(-1), the median time constant tau(1) varied from 1.90 to 0.31 s, and thereby negatively correlated with strain rate. These findings indicate that the natural range of specimen thickness, as well as experimental controls of compression level and rate, significantly influence measurements of skin viscoelasticity.	[Wang, Yuxiang; Gerling, Gregory J.] Univ Virginia, Dept Syst & Informat Engn, Charlottesville, VA 22903 USA; [Wang, Yuxiang] Univ Virginia, Dept Mech & Aerosp Engn, Charlottesville, VA 22903 USA; [Gerling, Gregory J.] Univ Virginia, Dept Biomed Engn, Charlottesville, VA 22908 USA; [Marshall, Kara L.; Baba, Yoshichika; Lumpkin, Ellen A.] Columbia Univ, Coll Phys & Surg, Dept Dermatol, New York, NY 10032 USA; [Lumpkin, Ellen A.] Columbia Univ, Coll Phys & Surg, Dept Physiol & Cellular Biophys, New York, NY 10032 USA	University of Virginia; University of Virginia; University of Virginia; Columbia University; Columbia University	Gerling, GJ (corresponding author), Univ Virginia, Dept Syst & Informat Engn, 151 Engn Way, Charlottesville, VA 22903 USA.	gg7h@virginia.edu		Lumpkin, Ellen/0000-0002-1166-3374	National Institutes of Health (NINDS) [R01NS073119]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073119] Funding Source: NIH RePORTER	National Institutes of Health (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by a grant from the National Institutes of Health (NINDS R01NS073119 to EAL and GJG). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The authors have no financial conflicts of interest to disclose. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRETAG AH, 1969, LIFE SCI PT 1 PHYSI, V8, P319, DOI 10.1016/0024-3205(69)90283-5; Burns T., 2010, ROOKS TXB DERMATOLOG; Butler DL, 2000, J BIOMECH ENG-T ASME, V122, P570, DOI 10.1115/1.1318906; Crichton ML, 2013, BIOMATERIALS, V34, P2087, DOI 10.1016/j.biomaterials.2012.11.035; Crichton ML, 2011, BIOMATERIALS, V32, P4670, DOI 10.1016/j.biomaterials.2011.03.012; DALY CH, 1982, J INVEST DERMATOL, V79, pS17, DOI 10.1111/1523-1747.ep12544620; DiSilvestro MR, 2001, J BIOMECH ENG-T ASME, V123, P198, DOI 10.1115/1.1351887; Driskell RR, 2014, EXP DERMATOL, V23, P629, DOI 10.1111/exd.12450; ESCOFFIER C, 1989, J INVEST DERMATOL, V93, P353, DOI 10.1111/1523-1747.ep12280259; Eshel H, 2001, ANN BIOMED ENG, V29, P164, DOI 10.1114/1.1349697; Fung Y, 2001, CLASSICAL COMPUTATIO, P930; Fung YC, 1994, J BIOMECH ENG-T ASME, V61, P1007, DOI [10.1115/1.2901550, DOI 10.1115/1.2901550]; Funk JR, 2000, J BIOMECH ENG-T ASME, V122, P15, DOI 10.1115/1.429623; Gitis N, 2004, TRIBOL T, V47, P461, DOI 10.1080/05698190490493355; Holzapfel G., 2000, NONLINEAR SOLID MECH; Johnson KO, 2001, CURR OPIN NEUROBIOL, V11, P455, DOI 10.1016/S0959-4388(00)00234-8; Kent RW, 2009, J BIOMECH, V42, P1656, DOI 10.1016/j.jbiomech.2009.04.027; Kim EK, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-45; Krueger N, 2011, SKIN RES TECHNOL, V17, P141, DOI 10.1111/j.1600-0846.2010.00486.x; Lakes R.S., 1998, CRC MEC ENG SER; Laksari K, 2012, J BIOMECH, V45, P642, DOI 10.1016/j.jbiomech.2011.12.023; LANIR Y, 1974, J BIOMECH, V7, P29, DOI 10.1016/0021-9290(74)90067-0; LANIR Y, 1974, J BIOMECH, V7, P171, DOI 10.1016/0021-9290(74)90058-X; Lapczyk I, 2012, 182 FALL TECHN M RUB; Lesniak DR, 2014, ELIFE, V3, DOI 10.7554/eLife.01488; Martin PG, 2000, THESIS U VIRGINIA; Muller-Rover S, 2001, J INVEST DERMATOL, V117, P3, DOI 10.1046/j.0022-202x.2001.01377.x; Neerken S, 2004, J BIOMED OPT, V9, P274, DOI 10.1117/1.1645795; OOMENS CWJ, 1987, J BIOMECH, V20, P877, DOI 10.1016/0021-9290(87)90147-3; Pioletti DP, 1998, J BIOMECH, V31, P753, DOI 10.1016/S0021-9290(98)00077-3; PUBOLS BH, 1982, J NEUROPHYSIOL, V47, P515, DOI 10.1152/jn.1982.47.3.515; Ruvolo EC, 2007, SKIN PHARMACOL PHYS, V20, P313, DOI 10.1159/000108147; SIMULIA, 2012, AB AN US MAN; Smalls LK, 2006, SKIN RES TECHNOL, V12, P43, DOI 10.1111/j.0909-725X.2006.00135.x; TAN CY, 1982, BRIT J DERMATOL, V106, P657, DOI 10.1111/j.1365-2133.1982.tb14702.x; THORNBURY JM, 1981, J GERONTOL, V36, P34, DOI 10.1093/geronj/36.1.34; WANG Y, 2013, PLOS ONE, V2013; Wang YX, 2013, 2013 WORLD HAPTICS CONFERENCE (WHC), P645, DOI 10.1109/WHC.2013.6548484; Wellnitz SA, 2010, J NEUROPHYSIOL, V103, P3378, DOI 10.1152/jn.00810.2009; WESTLING G, 1984, EXP BRAIN RES, V53, P277; Williams AL, 2010, IEEE ENG MED BIO, P6678, DOI 10.1109/IEMBS.2010.5626264; Wu JZ, 2003, BIO-MED MATER ENG, V13, P373	42	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0120897	10.1371/journal.pone.0120897	http://dx.doi.org/10.1371/journal.pone.0120897			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803703	Green Published, gold, Green Submitted			2022-12-26	WOS:000353889600108
J	Harris, DA; Patel, SH; Gucek, M; Hendrix, A; Westbroek, W; Taraska, JW				Harris, Dinari A.; Patel, Sajni H.; Gucek, Marjan; Hendrix, An; Westbroek, Wendy; Taraska, Justin W.			Exosomes Released from Breast Cancer Carcinomas Stimulate Cell Movement	PLOS ONE			English	Article							METASTASIS SUPPRESSOR GENE; MEMBRANE-VESICLES; PROSTATE-CANCER; MICROVESICLES; GROWTH; MIGRATION; MICROENVIRONMENT; BIOMARKERS; SECRETION; MICRORNAS	For metastasis to occur cells must communicate with to their local environment to initiate growth and invasion. Exosomes have emerged as an important mediator of cell-to-cell signalling through the transfer of molecules such as mRNAs, microRNAs, and proteins between cells. Exosomes have been proposed to act as regulators of cancer progression. Here, we study the effect of exosomes on cell migration, an important step in metastasis. We performed cell migration assays, endocytosis assays, and exosome proteomic profiling on exosomes released from three breast cancer cell lines that model progressive stages of metastasis. Results from these experiments suggest: (1) exosomes promote cell migration and (2) the signal is stronger from exosomes isolated from cells with higher metastatic potentials; (3) exosomes are endocytosed at the same rate regardless of the cell type; (4) exosomes released from cells show differential enrichment of proteins with unique protein signatures of both identity and abundance. We conclude that breast cancer cells of increasing metastatic potential secrete exosomes with distinct protein signatures that proportionally increase cell movement and suggest that released exosomes could play an active role in metastasis.	[Harris, Dinari A.; Taraska, Justin W.] NHLBI, Lab Mol Biophys, NIH, Bethesda, MD 20892 USA; [Patel, Sajni H.; Gucek, Marjan] NHLBI, Prote Core Facil, NIH, Bethesda, MD 20892 USA; [Hendrix, An] Ghent Univ Hosp, Lab Expt Canc Res, Dept Radiat Oncol & Expt Canc Res, Ghent, Belgium; [Westbroek, Wendy] NHGRI, Med Genet Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Ghent University; Ghent University Hospital; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Taraska, JW (corresponding author), NHLBI, Lab Mol Biophys, NIH, Bldg 10, Bethesda, MD 20892 USA.	justin.taraska@nih.gov	Hendrix, An/L-5918-2019; Taraska, Justin/H-8876-2016	Taraska, Justin/0000-0001-5355-9535	National Heart Lung and Blood Institute, National Institutes of Health [HL006098-02]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006098, ZICHL006019, ZICHL005903] Funding Source: NIH RePORTER	National Heart Lung and Blood Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	All Authors were supported by the Intramural Research Program of the National Heart Lung and Blood Institute, National Institutes of Health, HL006098-02. (http://www.nhlbi.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelkarim M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023334; Berditchevski F, 2001, J CELL SCI, V114, P4143; Bobrie A, 2012, J EXTRACELL VESICLES, V1, DOI 10.3402/jev.v1i0.18397; Bobrie A, 2012, CANCER RES, V72, P4920, DOI 10.1158/0008-5472.CAN-12-0925; Boucheix C, 2001, Expert Rev Mol Med, V2001, P1, DOI 10.1017/S1462399401002381; Brabek J, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-22; Camussi G, 2011, AM J CANCER RES, V1, P98; Castellana D, 2010, THROMB RES, V125, pS84, DOI 10.1016/S0049-3848(10)70021-9; Chaerkady R, 2008, J PROTEOME RES, V7, P4289, DOI 10.1021/pr800197z; Cocucci E, 2009, TRENDS CELL BIOL, V19, P43, DOI 10.1016/j.tcb.2008.11.003; Dimmer EC, 2012, NUCLEIC ACIDS RES, V40, pD565, DOI 10.1093/nar/gkr1048; DONG JT, 1995, SCIENCE, V268, P884, DOI 10.1126/science.7754374; Frost AR, 2012, INT J BREAST CANCER, V2012, DOI 10.1155/2012/756257; Ginestra A, 1998, ANTICANCER RES, V18, P3433; Ginestra A, 1999, ANTICANCER RES, V19, P3439; Guo XZ, 1998, HEPATOLOGY, V28, P1481, DOI 10.1002/hep.510280606; Hao S., 2006, Experimental Oncology, V28, P126; Hendrix A, 2010, JNCI-J NATL CANCER I, V102, P866, DOI 10.1093/jnci/djq153; Hessvik NP, 2012, BBA-GENE REGUL MECH, V1819, P1154, DOI 10.1016/j.bbagrm.2012.08.016; Higginbotham JN, 2011, CURR BIOL, V21, P779, DOI 10.1016/j.cub.2011.03.043; Hood JL, 2011, CANCER RES, V71, P3792, DOI 10.1158/0008-5472.CAN-10-4455; Iero M, 2008, CELL DEATH DIFFER, V15, P80, DOI 10.1038/sj.cdd.4402237; IKEYAMA S, 1993, J EXP MED, V177, P1231, DOI 10.1084/jem.177.5.1231; Kalra H, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001450; Koumangoye RB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024234; Lai TC, 2010, J PROTEOME RES, V9, P1302, DOI 10.1021/pr900825t; Liu L, 2007, J BIOL CHEM, V282, P31631, DOI 10.1074/jbc.M701165200; Lu Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001149; Mantegazza AR, 2004, BLOOD, V104, P1183, DOI 10.1182/blood-2004-01-0104; McCready J, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-294; Mineo M, 2012, ANGIOGENESIS, V15, P33, DOI 10.1007/s10456-011-9241-1; Muralidharan-Chari V, 2010, J CELL SCI, V123, P1603, DOI 10.1242/jcs.064386; Nagaraja GM, 2006, ONCOGENE, V25, P2328, DOI 10.1038/sj.onc.1209265; Nazarenko I, 2010, CANCER RES, V70, P1668, DOI 10.1158/0008-5472.CAN-09-2470; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; O'Brien K, 2013, EUR J CANCER, V49, P1845, DOI 10.1016/j.ejca.2013.01.017; Ochieng J, 2009, EXP CELL RES, V315, P1875, DOI 10.1016/j.yexcr.2009.03.010; Palazzolo G, 2012, ANTICANCER RES, V32, P847; Park JE, 2010, MOL CELL PROTEOMICS, V9, P1085, DOI 10.1074/mcp.M900381-MCP200; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Peinado H, 2011, SEMIN CANCER BIOL, V21, P139, DOI 10.1016/j.semcancer.2011.01.002; Pelchen-Matthews A, 2004, TRENDS MICROBIOL, V12, P310, DOI 10.1016/j.tim.2004.05.004; Pierre M, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-176; RADFORD KJ, 1995, INT J CANCER, V62, P631, DOI 10.1002/ijc.2910620523; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Ratajczak J, 2006, LEUKEMIA, V20, P1487, DOI 10.1038/sj.leu.2404296; Ratajczak J, 2006, LEUKEMIA, V20, P847, DOI 10.1038/sj.leu.2404132; Roepman P, 2006, CANCER RES, V66, P11110, DOI 10.1158/0008-5472.CAN-06-3161; Sethi N, 2011, NAT REV CANCER, V11, P735, DOI 10.1038/nrc3125; Shen XY, 2012, P NATL ACAD SCI USA, V109, P14464, DOI 10.1073/pnas.1211877109; Simpson RJ, 2008, PROTEOMICS, V8, P4083, DOI 10.1002/pmic.200800109; Simpson RJ, 2009, EXPERT REV PROTEOMIC, V6, P267, DOI [10.1586/epr.09.17, 10.1586/EPR.09.17]; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Tian TA, 2010, J CELL BIOCHEM, V111, P488, DOI 10.1002/jcb.22733; Turner S, 2002, J THEOR BIOL, V216, P85, DOI 10.1006/jtbi.2001.2522; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Webber J, 2010, CANCER RES, V70, P9621, DOI 10.1158/0008-5472.CAN-10-1722; ZETTER BR, 1993, SEMIN CANCER BIOL, V4, P219	62	117	127	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0117495	10.1371/journal.pone.0117495	http://dx.doi.org/10.1371/journal.pone.0117495			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798887	gold, Green Published, Green Submitted			2022-12-26	WOS:000351987300004
J	Kobayashi, K; Fujii, T; Asada, R; Ooka, M; Hirota, K				Kobayashi, Kaori; Fujii, Toshihiko; Asada, Ryuta; Ooka, Masato; Hirota, Kouji			Development of a Targeted Flip-in System in Avian DT40 Cells	PLOS ONE			English	Article							TYROSYL-DNA PHOSPHODIESTERASE; GERM-LINE TRANSMISSION; EMBRYONIC STEM-CELLS; HOMOLOGOUS RECOMBINATION; INT-1 PROTOONCOGENE; HPRT GENE; DISRUPTION; MUTATION; YEAST; INTEGRATION	Gene-targeting to create null mutants or designed-point mutants is a powerful tool for the molecular dissection of complex phenotypes involving DNA repair, signal transduction, and metabolism. Because gene-targeting is critically impaired in mutants exhibiting attenuated homologous recombination (HR), it is believed that gene-targeting is mediated via homologous recombination, though the precise mechanism remains unknown. We explored gene-targeting in yeast and avian DT40 cells. In animal cells, gene-targeting is activated by DNA double strand breaks introduced into the genomic region where gene-targeting occurs. This is evidenced by the fact that introducing double strand breaks at targeted genome sequences via artificial endonucleases such as TALEN and CRISPR facilitates gene-targeting. We found that in fission yeast, Schizosaccharomyces pombe, gene-targeting was initiated from double strand breaks on both edges of the homologous arms in the targeting construct. Strikingly, we also found efficient gene-targeting initiated on the edges of homologous arms in avian DT40 cells, a unique animal cell line in which efficient gene-targeting has been demonstrated. It may be that yeast and DT40 cells share some mechanism in which unknown factors detect and recombine broken DNA ends at homologous arms accompanied by crossover. We found efficient targeted integration of gapped plasmids accompanied by crossover in the DT40 cells. To take advantage of this finding, we developed a targeted flip-in system for avian DT40 cells. This flip-in system enables the rapid generation of cells expressing tag-fused proteins and the stable expression of transgenes from OVA loci.	[Kobayashi, Kaori; Fujii, Toshihiko; Asada, Ryuta; Ooka, Masato; Hirota, Kouji] Tokyo Metropolitan Univ, Dept Chem, Grad Sch Sci & Engn, Hachioji, Tokyo 1920397, Japan	Tokyo Metropolitan University	Hirota, K (corresponding author), Tokyo Metropolitan Univ, Dept Chem, Grad Sch Sci & Engn, Minamiosawa 1-1, Hachioji, Tokyo 1920397, Japan.	khirota@tmu.ac.jp	Ooka, Masato/HHN-0222-2022	Ooka, Masato/0000-0002-2729-2619; Asada, Ryuta/0000-0001-8360-6355	Uehara memorial foundation; KAKENHI [25281021, 26116518]	Uehara memorial foundation(Uehara Memorial Foundation); KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Uehara memorial foundation and KAKENHI (25281021, 26116518) to K.H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BUERSTEDDE JM, 1991, CELL, V67, P179, DOI 10.1016/0092-8674(91)90581-I; Carroll D, 2011, GENETICS, V188, P773, DOI 10.1534/genetics.111.131433; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Daley JM, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a017954; DECHIARA TM, 1990, NATURE, V345, P78, DOI 10.1038/345078a0; Dexheimer TS, 2008, ANTI-CANCER AGENT ME, V8, P381, DOI 10.2174/187152008784220357; DOETSCHMAN T, 1988, P NATL ACAD SCI USA, V85, P8583, DOI 10.1073/pnas.85.22.8583; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; HASTY P, 1991, MOL CELL BIOL, V11, P4509, DOI 10.1128/MCB.11.9.4509; Hirota K, 2001, GENES CELLS, V6, P201, DOI 10.1046/j.1365-2443.2001.00415.x; Johnson RD, 2000, EMBO J, V19, P3398, DOI 10.1093/emboj/19.13.3398; JOHNSON RS, 1989, SCIENCE, V245, P1234, DOI 10.1126/science.2506639; JOYNER AL, 1989, NATURE, V338, P153, DOI 10.1038/338153a0; KOLLER BH, 1989, P NATL ACAD SCI USA, V86, P8932, DOI 10.1073/pnas.86.22.8932; Langston LD, 2004, P NATL ACAD SCI USA, V101, P15392, DOI 10.1073/pnas.0403748101; Ledesma FC, 2009, NATURE, V461, P674, DOI 10.1038/nature08444; Loprieno N, 1974, HDB GENETICS, P395; MANSOUR SL, 1988, NATURE, V336, P348, DOI 10.1038/336348a0; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; Mitchel K, 2010, MOL CELL, V38, P211, DOI 10.1016/j.molcel.2010.02.028; Murai J, 2012, J BIOL CHEM, V287, P12848, DOI 10.1074/jbc.M111.333963; Mussolino C, 2012, CURR OPIN BIOTECH, V23, P644, DOI 10.1016/j.copbio.2012.01.013; Nemudryi AA, 2014, ACTA NATURAE, V6, P19, DOI 10.32607/20758251-2014-6-3-19-40; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Saitoh S, 1997, CELL, V90, P131, DOI 10.1016/S0092-8674(00)80320-7; SCHIESTL RH, 1994, MOL CELL BIOL, V14, P4493, DOI 10.1128/MCB.14.7.4493; SCHWARTZBERG PL, 1989, SCIENCE, V246, P799, DOI 10.1126/science.2554496; Sherman F., 1986, METHODS YEAST GENETI; Sonoda E, 1999, MOL CELL BIOL, V19, P5166; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; Symington LS, 2002, MICROBIOL MOL BIOL R, V66, P630, DOI 10.1128/MMBR.66.4.630-670.2002; THOMAS KR, 1990, NATURE, V346, P847, DOI 10.1038/346847a0; THOMPSON S, 1989, CELL, V56, P313, DOI 10.1016/0092-8674(89)90905-7; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842	34	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0122006	10.1371/journal.pone.0122006	http://dx.doi.org/10.1371/journal.pone.0122006			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799417	Green Published, gold, Green Submitted			2022-12-26	WOS:000351987300309
J	Nakamura, K; Nakabayashi, K; Aung, KH; Aizawa, K; Hori, N; Yamauchi, J; Hata, K; Tanoue, A				Nakamura, Kazuaki; Nakabayashi, Kazuhiko; Aung, Kyaw Htet; Aizawa, Kazuko; Hori, Naoko; Yamauchi, Junji; Hata, Kenichiro; Tanoue, Akito			DNA Methyltransferase Inhibitor Zebularine Induces Human Cholangiocarcinoma Cell Death through Alteration of DNA Methylation Status	PLOS ONE			English	Article							CANCER-CELLS; IN-VITRO; EXPRESSION; APOPTOSIS; DECITABINE; CARCINOMA; TARGET; GENES; DRUG; OVEREXPRESSION	Cholangiocarcinoma (CCA) is a cancer arising from the neoplastic transformation of cholangiocytes. During tumorigenesis, tumor suppressor and cancer-related genes are commonly silenced by aberrant DNA methylation in their promoter regions. Zebularine (1-(beta-D-ribofuranosyl)-1,2-dihydropyrimidin-2-one) acts as an inhibitor of DNA methylation and exhibits chemical stability and minimal cytotoxicity both in vitro and in vivo. In this study, we explore the effect and possible mechanism of action of zebularine on CCA cells. We demonstrate that zebularine exerts an antitumor effect on CCA cells. Zebularine treatment decreased the concentrations of DNA methyltransferase (DNMT) proteins, and DNMT1 knockdown led to apoptotic cell death in the CCA cell lines TFK-1 and HuCCT1. DNA methylation analysis demonstrated that zebularine induced DNA demethylation, and the GO Biological Process terms "hemophilic cell adhesion", "regulation of transcription, DNA-dependent" and "Wnt signaling pathway" were found to be significantly enriched in association with demethylated genes. Furthermore, we observed that zebularine treatment decreased beta-catenin protein levels in TFK-1 and HuCCT1 cells. These results suggest that zebularine alters DNA methylation status, and that some aspect of DNA demethylation by zebularine induces suppression of the Wnt signaling pathway, which leads to apoptotic cell death in CCA. We previously reported a novel mechanism of zebularine-induced cell growth arrest and apoptosis in hepatocellular carcinoma via a DNA methylation-independent pathway. Together, our present and previous studies indicate that zebularine could function as both a DNMT inhibitor and a non-DNMT inhibitor reagent, and that, while the optimal usage of zebularine may depend on cancer type, zebularine may be useful for chemotherapy against cancer.	[Nakamura, Kazuaki; Aung, Kyaw Htet; Aizawa, Kazuko; Hori, Naoko; Yamauchi, Junji; Tanoue, Akito] Natl Res Inst Child Hlth & Dev, Dept Pharmacol, Tokyo, Japan; [Nakabayashi, Kazuhiko; Hata, Kenichiro] Natl Res Inst Child Hlth & Dev, Dept Maternal Fetal Biol, Tokyo, Japan	National Center for Child Health & Development - Japan; National Center for Child Health & Development - Japan	Nakamura, K (corresponding author), Natl Res Inst Child Hlth & Dev, Dept Pharmacol, Tokyo, Japan.	nakamura-kz@ncchd.go.jp			National Center for Child Health and Development (Tokyo, Japan) [24-26, 24-3, 25-3]; Health and Labor Sciences Research Grant for Research into Rare and Intractable Diseases [Nanbyo-Ippan-082]; JSPS KAKENHI [25460088]	National Center for Child Health and Development (Tokyo, Japan); Health and Labor Sciences Research Grant for Research into Rare and Intractable Diseases; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by research grants from The Grant of National Center for Child Health and Development (24-26 to K. Nakamura, 24-3 to K. Nakabayashi, 25-3 to AT) (Tokyo, Japan, http://www.ncchd.go.jp/index.php), the Health and Labor Sciences Research Grant for Research into Rare and Intractable Diseases (Nanbyo-Ippan-082 to KH AT)(http://www.mhlw.go.jp/), and JSPS KAKENHI Grant Numbers 25460088 (K. Nakamura)(http://www.jsps.go.jp/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amara K, 2010, CANCER SCI, V101, P1722, DOI 10.1111/j.1349-7006.2010.01569.x; Andersen JB, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001338; Bibikova M, 2011, GENOMICS, V98, P288, DOI 10.1016/j.ygeno.2011.07.007; Billam M, 2010, BREAST CANCER RES TR, V120, P581, DOI 10.1007/s10549-009-0420-3; Blechacz B, 2008, HEPATOLOGY, V48, P308, DOI 10.1002/hep.22310; Blendis Laurie, 2004, Gastroenterology, V127, P1008, DOI 10.1053/j.gastro.2004.07.035; Cheng JC, 2003, J NATL CANCER I, V95, P399, DOI 10.1093/jnci/95.5.399; Cheng JC, 2004, MOL CELL BIOL, V24, P1270, DOI 10.1128/MCB.24.3.1270-1278.2004; Cheng JC, 2004, CANCER CELL, V6, P151, DOI 10.1016/j.ccr.2004.06.023; Costello JF, 2000, NAT GENET, V24, P132, DOI 10.1038/72785; Derissen EJB, 2013, ONCOLOGIST, V18, P619, DOI 10.1634/theoncologist.2012-0465; Dote H, 2005, CLIN CANCER RES, V11, P4571, DOI 10.1158/1078-0432.CCR-05-0050; ELDEIRY WS, 1991, P NATL ACAD SCI USA, V88, P3470, DOI 10.1073/pnas.88.8.3470; Fandy TE, 2009, CURR MED CHEM, V16, P2075, DOI 10.2174/092986709788612738; Feinberg AP, 2006, NAT REV GENET, V7, P21, DOI 10.1038/nrg1748; Feinberg AP, 2004, NAT REV CANCER, V4, P143, DOI 10.1038/nrc1279; Gatto M, 2010, DIGEST LIVER DIS, V42, P253, DOI 10.1016/j.dld.2009.12.008; Girault I, 2003, CLIN CANCER RES, V9, P4415; Goeppert B, 2014, HEPATOLOGY, V59, P544, DOI 10.1002/hep.26721; Gravina GL, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-305; Griffiths EA, 2013, ADV EXP MED BIOL, V754, P253, DOI 10.1007/978-1-4419-9967-2_13; Harbour JW, 2000, NAT CELL BIOL, V2, pE65, DOI 10.1038/35008695; Holleran JL, 2005, CLIN CANCER RES, V11, P3862, DOI 10.1158/1078-0432.CCR-04-2406; Hurd PJ, 1999, J MOL BIOL, V286, P389, DOI 10.1006/jmbi.1998.2491; Ilyas M, 2005, J PATHOL, V205, P130, DOI 10.1002/path.1692; Issa JPJ, 2009, CLIN CANCER RES, V15, P3938, DOI 10.1158/1078-0432.CCR-08-2783; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Juntavee A, 2005, WORLD J GASTROENTERO, V11, P249, DOI 10.3748/wjg.v11.i2.249; Kawano Y, 2003, J CELL SCI, V116, P2627, DOI 10.1242/jcs.00623; Kobayashi Y, 2011, GENOME RES, V21, P1017, DOI 10.1101/gr.119487.110; LEIST M, 1994, J IMMUNOL, V153, P1778; Liedtke C, 2002, HEPATOLOGY, V36, P315, DOI 10.1053/jhep.2002.34615; Lu DS, 2004, P NATL ACAD SCI USA, V101, P3118, DOI 10.1073/pnas.0308648100; Marques CJ, 2011, EPIGENETICS-US, V6, P1354, DOI 10.4161/epi.6.11.17993; Melki JR, 1998, LEUKEMIA, V12, P311, DOI 10.1038/sj.leu.2400932; Miremadi A, 2007, HUM MOL GENET, V16, pR28, DOI 10.1093/hmg/ddm021; MIYAGIWA M, 1989, IN VITRO CELL DEV B, V25, P503; Mosconi S, 2009, CRIT REV ONCOL HEMAT, V69, P259, DOI 10.1016/j.critrevonc.2008.09.008; Nakamura K, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054036, 10.1371/journal.pone.0074720, 10.1371/journal.pone.0064134]; Neureiter D, 2007, SCAND J GASTROENTERO, V42, P103, DOI 10.1080/00365520600874198; Obaya AJ, 2002, CELL MOL LIFE SCI, V59, P126, DOI 10.1007/s00018-002-8410-1; Oh BK, 2007, INT J MOL MED, V20, P65; Okano M, 1999, CYTOGENET CELL GENET, V86, P333, DOI 10.1159/000015331; Patra SK, 2002, MOL CARCINOGEN, V33, P163, DOI 10.1002/mc.10033; PINTO A, 1993, LEUKEMIA, V7, P51; Qu Y, 2010, AM J CLIN PATHOL, V134, P826, DOI 10.1309/AJCPHGQ69FXDFWII; Ruiz-Magana MJ, 2012, INT J CANCER, V130, P1195, DOI 10.1002/ijc.26107; SAIJYO S, 1995, TOHOKU J EXP MED, V177, P61, DOI 10.1620/tjem.177.61; Schwartsmann G, 2000, INVEST NEW DRUG, V18, P83, DOI 10.1023/A:1006388031954; Shu Y, 2011, WORLD J GASTROENTERO, V17, P3407, DOI 10.3748/wjg.v17.i29.3407; Subramaniam D, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00080; Sugimachi K, 2001, MODERN PATHOL, V14, P900, DOI 10.1038/modpathol.3880409; Suzuki T, 2005, CURR MED CHEM, V12, P2867, DOI 10.2174/092986705774454706; Tepsiri N, 2005, WORLD J GASTROENTERO, V11, P2748, DOI 10.3748/wjg.v11.i18.2748; Tokumoto N, 2005, INT J ONCOL, V27, P973; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Wehbe H, 2006, CANCER RES, V66, P10517, DOI 10.1158/0008-5472.CAN-06-2130; Weisenberger DJ, 2004, MOL CANCER RES, V2, P62; Yang PM, 2013, SCI REP-UK, V3, DOI 10.1038/srep03219; Yoo CB, 2004, BIOCHEM SOC T, V32, P910, DOI 10.1042/BST0320910; You BR, 2012, MOL BIOL REP, V39, P9723, DOI 10.1007/s11033-012-1837-z; Zhang KS, 2013, ONCOL REP, V30, P1430, DOI 10.3892/or.2013.2560	62	36	40	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120545	10.1371/journal.pone.0120545	http://dx.doi.org/10.1371/journal.pone.0120545			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799509	Green Published, Green Submitted, gold			2022-12-26	WOS:000351987300151
J	Paciello, G; Acquaviva, A; Pighi, C; Ferrarini, A; Macii, E; Zamo', A; Ficarra, E				Paciello, Giulia; Acquaviva, Andrea; Pighi, Chiara; Ferrarini, Alberto; Macii, Enrico; Zamo', Alberto; Ficarra, Elisa			VDJSeq-Solver: In Silico V(D)J Recombination Detection Tool	PLOS ONE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; POLYMERASE-CHAIN-REACTION; CONCERTED ACTION BMH4-CT98-3936; ACUTE LYMPHOBLASTIC-LEUKEMIA; MANTLE CELL LYMPHOMA; V-H REGION; GENE REARRANGEMENTS; ANTIGEN RECEPTORS; B-CELLS; IMMUNOGLOBULIN	In this paper we present VDJSeq-Solver, a methodology and tool to identify clonal lymphocyte populations from paired-end RNA Sequencing reads derived from the sequencing of mRNA neoplastic cells. The tool detects the main clone that characterises the tissue of interest by recognizing the most abundant V(D)J rearrangement among the existing ones in the sample under study. The exact sequence of the clone identified is capable of accounting for the modifications introduced by the enzymatic processes. The proposed tool overcomes limitations of currently available lymphocyte rearrangements recognition methods, working on a single sequence at a time, that are not applicable to high-throughput sequencing data. In this work, VDJSeq-Solver has been applied to correctly detect the main clone and identify its sequence on five Mantle Cell Lymphoma samples; then the tool has been tested on twelve Diffuse Large B-Cell Lymphoma samples. In order to comply with the privacy, ethics and intellectual property policies of the University Hospital and the University of Verona, data is available upon request to supporto. utenti@ateneo.univr.it after signing a mandatory Materials Transfer Agreement. VDJSeq-Solver JAVA/Perl/Bash software implementation is free and available at http://eda.polito.it/VDJSeq-Solver/.	[Paciello, Giulia; Acquaviva, Andrea; Macii, Enrico; Ficarra, Elisa] Politecn Torino, Dept Control & Comp Engn, Turin, Italy; [Pighi, Chiara; Zamo', Alberto] Univ Verona, Dept Pathol & Diagnost, I-37100 Verona, Italy; [Pighi, Chiara] Harvard Univ, Sch Med, Dept Pathol, Children Hosp Boston, Boston, MA 02115 USA; [Ferrarini, Alberto] Univ Verona, Dept Biotechnol, I-37100 Verona, Italy	Polytechnic University of Turin; University of Verona; Harvard University; Boston Children's Hospital; Harvard Medical School; University of Verona	Paciello, G (corresponding author), Politecn Torino, Dept Control & Comp Engn, Turin, Italy.	giulia.paciello@studenti.polito.it	Zamò, Alberto/ABF-4436-2020	Zamo, Alberto/0000-0001-6203-7966; FICARRA, Elisa/0000-0002-8061-2124				ACHILLE A, 1995, DIAGN MOL PATHOL, V4, P14, DOI 10.1097/00019606-199503000-00005; Alamyar E., 2012, IMMUNOME RES, V8, P1, DOI [10.4172/1745-7580.1000056, DOI 10.4172/1745-7580.1000056]; Alamyar Eltaf, 2012, Methods Mol Biol, V882, P569, DOI 10.1007/978-1-61779-842-9_32; ALT FW, 1982, P NATL ACAD SCI-BIOL, V79, P4118, DOI 10.1073/pnas.79.13.4118; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bassing CH, 2002, CELL, V109, pS45, DOI 10.1016/S0092-8674(02)00675-X; BEISHUIZEN A, 1993, LEUKEMIA, V7, P2045; BERTIN PA, 1992, ANN NY ACAD SCI, V651, P464; Bossen C, 2012, ANNU REV IMMUNOL, V30, P337, DOI 10.1146/annurev-immunol-020711-075003; Boyd SD, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000540; BREIT TM, 1993, BLOOD, V82, P3063; Brochet X, 2007, ACT JOURN OUV BIOL I, V2007, P329; Burger JA, 2012, CURR HEMATOL MALIG R, V7, P26, DOI 10.1007/s11899-011-0104-z; Burger JA, 2011, SEMIN CANCER BIOL, V21, P308, DOI 10.1016/j.semcancer.2011.09.006; Chen LF, 2008, BLOOD, V111, P2230, DOI 10.1182/blood-2007-07-100115; Damle RN, 1999, BLOOD, V94, P1840, DOI 10.1182/blood.V94.6.1840; DEANE M, 1991, LEUKEMIA, V5, P726; Edgren H, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r6; Efremov DG, 1996, BLOOD, V87, P3869, DOI 10.1182/blood.V87.9.3869.bloodjournal8793869; Fais F, 1998, J CLIN INVEST, V102, P1515, DOI 10.1172/JCI3009; Gaeta BA, 2007, BIOINFORMATICS, V23, P1580, DOI 10.1093/bioinformatics/btm147; Ghiotto F, 2004, J CLIN INVEST, V113, P1008, DOI 10.1172/JCI200419399; Ghiotto F, 2006, MOL MED, V12, P300, DOI 10.2119/2006-00080.Ghiotto; Giudicelli V, 2004, NUCLEIC ACIDS RES, V32, pW435, DOI 10.1093/nar/gkh412; Giudicelli Veronique, 2011, Cold Spring Harb Protoc, V2011, P695, DOI 10.1101/pdb.prot5633; Giudicelli Veronique, 2011, Cold Spring Harb Protoc, V2011, P716, DOI 10.1101/pdb.prot5634; Groenen Patricia J T A, 2008, J Hematop, V1, P97, DOI 10.1007/s12308-008-0013-9; Hadzidimitriou A, 2011, BLOOD, V118, P3088, DOI 10.1182/blood-2011-03-343434; Hamblin TJ, 1999, BLOOD, V94, P1848, DOI 10.1182/blood.V94.6.1848; Ippolito GC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035497; Jackson KJL, 2012, IMMUNOGENETICS, V64, P3, DOI 10.1007/s00251-011-0559-z; Johnson TA, 1997, J IMMUNOL, V158, P235; Jung D, 2004, CELL, V116, P299, DOI 10.1016/S0092-8674(04)00039-X; Jung D, 2006, ANNU REV IMMUNOL, V24, P541, DOI 10.1146/annurev.immunol.23.021704.115830; KIPPS TJ, 1989, P NATL ACAD SCI USA, V86, P5913, DOI 10.1073/pnas.86.15.5913; Kuppers R, 2005, NAT REV CANCER, V5, P251, DOI 10.1038/nrc1589; KUPPERS R, 1993, AM J PATHOL, V143, P230; Langerak AW, 2007, LEUKEMIA, V21, P222, DOI 10.1038/sj.leu.2404482; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lefranc M-P., 2001, IMMUNOGLOBULIN FACTS; Li HH, 2002, IMMUNOL REV, V190, P53, DOI 10.1034/j.1600-065X.2002.19005.x; LI S, 2013, NATURE COMM, V4, P1; McCarthy K P, 1992, Diagn Mol Pathol, V1, P173, DOI 10.1097/00019606-199203000-00025; Messmer BT, 2004, J EXP MED, V200, P519, DOI 10.1084/jem.20040544; Monod MY, 2004, BIOINFORMATICS, V20, P379, DOI 10.1093/bioinformatics/bth945; Mueller-Hermelink HK, 2008, WHO CLASSIFICATION T, P180; Ohm-Laursen L, 2006, IMMUNOLOGY, V119, P265, DOI 10.1111/j.1365-2567.2006.02431.x; Oscier DG, 1997, BLOOD, V89, P4153, DOI 10.1182/blood.V89.11.4153; Pighi C, 2011, CELL ONCOL, V34, P141, DOI 10.1007/s13402-011-0019-7; Prabakaran P, 2012, IMMUNOGENETICS, V64, P337, DOI 10.1007/s00251-011-0595-8; PRITSCH O, 1993, BLOOD, V82, P3103; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rinaldi A, 2006, BRIT J HAEMATOL, V132, P303, DOI 10.1111/j.1365-2141.2005.05883.x; Rosenquist R, 1999, EUR J HAEMATOL, V63, P171; Rumble SM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000386; Schweighofer CD, 2011, INT J CANCER, V128, P2759, DOI 10.1002/ijc.25605; Sebastian E, 2012, AM J PATHOL, V181, P1879, DOI 10.1016/j.ajpath.2012.07.028; Souto-Carneiro MM, 2004, J IMMUNOL, V172, P6790, DOI 10.4049/jimmunol.172.11.6790; Tobin G, 2004, BLOOD, V104, P2879, DOI 10.1182/blood-2004-01-0132; Tobin G, 2003, BLOOD, V101, P4952, DOI 10.1182/blood-2002-11-3485; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; van Dongen JJM, 2003, LEUKEMIA, V17, P2257, DOI 10.1038/sj.leu.2403202; van Krieken JHJM, 2007, LEUKEMIA, V21, P201, DOI 10.1038/sj.leu.2404467; Visco C, 2008, BLOOD, V111, P1110, DOI 10.1182/blood-2007-09-111492; Volpe JM, 2006, BIOINFORMATICS, V22, P438, DOI 10.1093/bioinformatics/btk004; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Widhopf GF, 2004, BLOOD, V104, P2499, DOI 10.1182/blood-2004-03-0818; Wu YC, 2010, BLOOD, V116, P1070, DOI 10.1182/blood-2010-03-275859; Zanotti R, 2010, AM J HEMATOL, V85, P494, DOI 10.1002/ajh.21737; Zhang J, 2011, J GENET GENOMICS, V38, P95, DOI 10.1016/j.jgg.2011.02.003	70	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0118192	10.1371/journal.pone.0118192	http://dx.doi.org/10.1371/journal.pone.0118192			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799103	Green Published, Green Submitted, gold			2022-12-26	WOS:000351987300006
J	Yusuf, NA; Green, JL; Wall, RJ; Knuepfer, E; Moon, RW; Schulte-Huxel, C; Stanway, RR; Martin, SR; Howell, SA; Douse, CH; Cota, E; Tate, EW; Tewari, R; Holder, AA				Yusuf, Noor A.; Green, Judith L.; Wall, Richard J.; Knuepfer, Ellen; Moon, Robert W.; Schulte-Huxel, Christina; Stanway, Rebecca R.; Martin, Stephen R.; Howell, Steven A.; Douse, Christopher H.; Cota, Ernesto; Tate, Edward W.; Tewari, Rita; Holder, Anthony A.			The Plasmodium Class XIV Myosin, MyoB, Has a Distinct Subcellular Location in Invasive and Motile Stages of the Malaria Parasite and an Unusual Light Chain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Invasion; Malaria; Molecular Motor; Myosin; Parasite; Peptide Interaction; Plasmodium; Myosin Light Chain	TOXOPLASMA-GONDII; CELL INVASION; FALCIPARUM MEROZOITES; PHYLOGENETIC TREES; CIRCULAR-DICHROISM; COMPLEX; MOTOR; TAIL; GLIDEOSOME; SEQUENCES	Background: Malaria parasites possess two unusual class XIV myosins, myosin A that drives gliding motility and myosin B that is uncharacterized. Results: Myosin B is located at the extreme apical end of motile and invasive parasites, binding a very large and unusual light chain. Conclusion: Myosin B differs substantially from myosin A in location and function. Significance: An unusual myosin and its light chain extend the known diversity of these families. Myosin B (MyoB) is one of the two short class XIV myosins encoded in the Plasmodium genome. Class XIV myosins are characterized by a catalytic head, a modified neck, and the absence of a tail region. Myosin A (MyoA), the other class XIV myosin in Plasmodium, has been established as a component of the glideosome complex important in motility and cell invasion, but MyoB is not well characterized. We analyzed the properties of MyoB using three parasite species as follows: Plasmodium falciparum, Plasmodium berghei, and Plasmodium knowlesi. MyoB is expressed in all invasive stages (merozoites, ookinetes, and sporozoites) of the life cycle, and the protein is found in a discrete apical location in these polarized cells. In P. falciparum, MyoB is synthesized very late in schizogony/merogony, and its location in merozoites is distinct from, and anterior to, that of a range of known proteins present in the rhoptries, rhoptry neck or micronemes. Unlike MyoA, MyoB is not associated with glideosome complex proteins, including the MyoA light chain, myosin A tail domain-interacting protein (MTIP). A unique MyoB light chain (MLC-B) was identified that contains a calmodulin-like domain at the C terminus and an extended N-terminal region. MLC-B localizes to the same extreme apical pole in the cell as MyoB, and the two proteins form a complex. We propose that MLC-B is a MyoB-specific light chain, and for the short class XIV myosins that lack a tail region, the atypical myosin light chains may fulfill that role.	[Yusuf, Noor A.; Green, Judith L.; Knuepfer, Ellen; Moon, Robert W.; Schulte-Huxel, Christina; Holder, Anthony A.] MRC, Natl Inst Med Res, Div Parasitol, London NW7 1AA, England; [Martin, Stephen R.] MRC, Natl Inst Med Res, Div Phys Biochem, London NW7 1AA, England; [Howell, Steven A.] MRC, Natl Inst Med Res, Div Mol Struct, London NW7 1AA, England; [Wall, Richard J.; Tewari, Rita] Univ Nottingham, Sch Life Sci, Queens Med Ctr, Nottingham NG2 7UH, England; [Stanway, Rebecca R.] Univ Bern, Inst Cell Biol, CH-3012 Bern, Switzerland; [Douse, Christopher H.; Cota, Ernesto; Tate, Edward W.] Univ London Imperial Coll Sci Technol & Med, Inst Chem Biol, London SW7 2AZ, England	MRC National Institute for Medical Research; MRC National Institute for Medical Research; MRC National Institute for Medical Research; University of Nottingham; University of Bern; Imperial College London	Holder, AA (corresponding author), MRC, Natl Inst Med Res, Div Parasitol, Mill Hill, London NW7 1AA, England.	aholder@nimr.mrc.ac.uk	Moon, Robert/AAF-9808-2019; Holder, Anthony A/A-7554-2013	Holder, Anthony A/0000-0002-8490-6058; Moon, Robert/0000-0002-9070-4292; Knuepfer, Ellen/0000-0002-6090-1877; Green, Judith/0000-0001-6825-9404; Douse, Christopher/0000-0002-1604-8944; Tate, Edward/0000-0003-2213-5814; Wall, Richard J./0000-0003-3487-3187; Tewari, Rita/0000-0003-3943-1847	Medical Research Council [U117532067, G0900109, MR/K011782/1]; Islamic Development Bank, Saudi Arabia; Institute of Chemical Biology EPSRC Centre for Doctoral Training at the Department of Chemistry, Imperial College London; The Francis Crick Institute [10015, 10097] Funding Source: researchfish; MRC [G0900109, MR/K011782/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Islamic Development Bank, Saudi Arabia; Institute of Chemical Biology EPSRC Centre for Doctoral Training at the Department of Chemistry, Imperial College London(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); The Francis Crick Institute; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported in part Medical Research Council Grant U117532067.; Recipient of a Ph.D. Merit Scholarship from the Islamic Development Bank, Saudi Arabia. Present address: Institute for Medical Research, Jalan Pahang, 50588 Kuala Lumpur, Malaysia.; Supported by Medical Research Council Investigator Award and Medical Research Council Grant G0900109 and MR/K011782/1.; Recipient of a studentship from the Institute of Chemical Biology EPSRC Centre for Doctoral Training at the Department of Chemistry, Imperial College London. Present address: Medical Research Council Laboratory of Molecular Biology, Francis Crick Ave., Cambridge, CB2 0QH, United Kingdom.	Angrisano F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032188; Armstrong CT, 2011, BIOINFORMATICS, V27, P1908, DOI 10.1093/bioinformatics/btr299; BANNISTER LH, 1995, ANN TROP MED PARASIT, V89, P105, DOI 10.1080/00034983.1995.11812940; Baum J, 2006, J BIOL CHEM, V281, P5197, DOI 10.1074/jbc.M509807200; Beetsma AL, 1998, EXP PARASITOL, V88, P69, DOI 10.1006/expr.1998.4203; Bergman LW, 2003, J CELL SCI, V116, P39, DOI 10.1242/jcs.00194; Bookwalter CS, 2014, J BIOL CHEM, V289, P30832, DOI 10.1074/jbc.M114.572453; Bosch J, 2006, P NATL ACAD SCI USA, V103, P4852, DOI 10.1073/pnas.0510907103; Bosch J, 2007, J MOL BIOL, V372, P77, DOI 10.1016/j.jmb.2007.06.016; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; Chaparro-Olaya J, 2005, CELL MOTIL CYTOSKEL, V60, P200, DOI 10.1002/cm.20055; Chaparro-Olaya J, 2003, EUR J PROTISTOL, V39, P423, DOI 10.1078/0932-4739-00015; Delorenzi M, 2002, BIOINFORMATICS, V18, P617, DOI 10.1093/bioinformatics/18.4.617; Douse CH, 2014, ACS CHEM BIOL, V9, P2204, DOI 10.1021/cb500271c; Douse CH, 2012, J BIOL CHEM, V287, P36968, DOI 10.1074/jbc.M112.379842; Farrow RE, 2011, SEMIN CELL DEV BIOL, V22, P953, DOI 10.1016/j.semcdb.2011.09.022; Feng DF, 1996, METHOD ENZYMOL, V266, P368; Foth BJ, 2006, P NATL ACAD SCI USA, V103, P3681, DOI 10.1073/pnas.0506307103; Fowler RE, 2001, MOL BIOCHEM PARASIT, V117, P187, DOI 10.1016/S0166-6851(01)00351-6; Frenal K, 2010, CELL HOST MICROBE, V8, P343, DOI 10.1016/j.chom.2010.09.002; Gaskins E, 2004, J CELL BIOL, V165, P383, DOI 10.1083/jcb.200311137; Green JL, 2006, J MOL BIOL, V355, P933, DOI 10.1016/j.jmb.2005.11.027; Guttery DS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002948; Herm-Gotz A, 2002, EMBO J, V21, P2149, DOI 10.1093/emboj/21.9.2149; Hettmann C, 2000, MOL BIOL CELL, V11, P1385, DOI 10.1091/mbc.11.4.1385; Heuck A, 2007, P NATL ACAD SCI USA, V104, P19778, DOI 10.1073/pnas.0706780104; Janse CJ, 2006, MOL BIOCHEM PARASIT, V145, P60, DOI 10.1016/j.molbiopara.2005.09.007; Johnson TM, 2007, MOL BIOL CELL, V18, P3039, DOI 10.1091/mbc.E07-01-0040; Jones ML, 2012, CELL HOST MICROBE, V12, P246, DOI 10.1016/j.chom.2012.06.005; Keeley A, 2004, TRENDS CELL BIOL, V14, P528, DOI 10.1016/j.tcb.2004.08.002; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Knuepfer E, 2014, CELL MICROBIOL, V16, P657, DOI 10.1111/cmi.12181; LOWEY S, 1993, NATURE, V365, P454, DOI 10.1038/365454a0; MARSDEN BJ, 1990, BIOCHEM CELL BIOL, V68, P587, DOI 10.1139/o90-084; Martin SR, 2008, METHOD CELL BIOL, V84, P263, DOI 10.1016/S009l-679X(07)84010-6; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Moon RW, 2013, P NATL ACAD SCI USA, V110, P531, DOI 10.1073/pnas.1216457110; Nebl T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002222; Patzewitz EM, 2013, CELL REP, V3, P622, DOI 10.1016/j.celrep.2013.01.032; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pinder JC, 1998, J CELL SCI, V111, P1831; READ M, 1993, PARASITOLOGY, V106, P223, DOI 10.1017/S0031182000075041; Rees-Channer RR, 2006, MOL BIOCHEM PARASIT, V149, P113, DOI 10.1016/j.molbiopara.2006.04.008; Ridzuan MAM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033845; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Thomas JC, 2010, MOL BIOSYST, V6, P494, DOI 10.1039/b922093c; TRYBUS KM, 1994, J MUSCLE RES CELL M, V15, P587, DOI 10.1007/BF00121066; Wang Q, 2008, STRUCTURE, V16, P1817, DOI 10.1016/j.str.2008.10.008; Yu C, 2009, CELL, V138, P537, DOI 10.1016/j.cell.2009.05.030	50	20	20	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2015	290	19					12147	12164		10.1074/jbc.M115.637694	http://dx.doi.org/10.1074/jbc.M115.637694			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH9XA	25802338	Green Accepted, Green Published, hybrid			2022-12-26	WOS:000354388600028
J	Hollevoet, K; Mason-Osann, E; Muller, F; Pastan, I				Hollevoet, Kevin; Mason-Osann, Emily; Mueller, Fabian; Pastan, Ira			Methylation-Associated Partial Down-Regulation of Mesothelin Causes Resistance to Anti-Mesothelin Immunotoxins in a Pancreatic Cancer Cell Line	PLOS ONE			English	Article							RECOMBINANT IMMUNOTOXIN; ANTIMESOTHELIN IMMUNOTOXIN; GENE-EXPRESSION; PHASE-I; OVARIAN; PROMOTER; RECEPTOR; IDENTIFICATION; INFUSION; LEUKEMIA	Anti-mesothelin Pseudomonas exotoxin A-based recombinant immunotoxins (RITs) present a potential treatment modality for pancreatic ductal adenocarcinoma (PDAC). To study mechanisms of resistance, the sensitive PDAC cell line KLM-1 was intermittently exposed to the anti-mesothelin SS1-LR-GGS RIT. Surviving cells were resistant to various anti-mesothelin RITs (IC(50)s > 1 mu g/ml), including the novel de-immunized RG7787. These resistant KLM-1-R cells were equally sensitive to the anti-CD71 HB21(Fv)-PE40 RIT as KLM-1, indicating resistance was specific to anti-mesothelin RITs. Mesothelin gene expression was partially down-regulated in KLM-1-R, resulting in 5-fold lower surface protein levels and decreased cellular uptake of RG7787 compared to KLM-1. Bisulfite sequencing analysis found that the mesothelin promoter region was significantly more methylated in KLM-1-R (59 +/- 3.6%) compared to KLM-1 (41 +/- 4.8%), indicating hypermethylation as a mechanism of mesothelin downregulation. The DNA methyltransferase inhibitor 5-azacytidine restored original mesothelin surface expression to more than half in KLM-1-R and increased sensitivity to RG7787 (IC50 = 722.4 +/- 232.6 ng/ml), although cells remained significantly less sensitive compared to parental KLM-1 cells (IC50 = 4.41 +/- 0.38 ng/ml). Mesothelin cDNA introduction in KLM-1-R led to 5-fold higher surface protein levels and significantly higher RG7887 uptake compared to KLM-1. As a result, the original sensitivity to RG7787 was fully restored (IC50 = 4.49 +/- 1.11 ng/ml). A significantly higher RG7787 uptake was thus required to reach the original cytotoxicity in resistant cells, hinting that intracellular RIT trafficking is also a limiting factor. RNA deep sequencing analysis of KLM-1 and KLM-1-R cells supported our experimental findings; compared to KLM-1, resistant cells displayed differential expression of genes linked to intracellular transport and an expression pattern that matched a more general hypermethylation status. In conclusion, resistance to anti-mesothelin RITs in KLM-1 is linked to a methylation-associated down-regulation of mesothelin, while aberrations in RIT trafficking could also play a role.	[Hollevoet, Kevin; Mason-Osann, Emily; Mueller, Fabian; Pastan, Ira] NCI, Ctr Canc Res, Mol Biol Lab, NIH, Bethesda, MD 20892 USA; [Hollevoet, Kevin] Leuven Univ, KU Leuven, Dept Pharmaceut & Pharmacol Sci, Lab Therapeut & Diagnost Antibodies, Leuven, Belgium	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); KU Leuven	Pastan, I (corresponding author), NCI, Ctr Canc Res, Mol Biol Lab, NIH, Bethesda, MD 20892 USA.	pastani@mail.nih.gov	pastan, ira/P-9319-2019	pastan, ira/0000-0002-9223-0270; Mason-Osann, Emily/0000-0003-0890-6440; Muller, Fabian/0000-0001-5487-5839	Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research; National Cancer Institute [2791]; Roche Pharmaceuticals [2791]; Fund for Scientific Research Flanders (FWO, Belgium); NATIONAL CANCER INSTITUTE [ZIABC010298, ZIABC008753] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Roche Pharmaceuticals(Roche Holding); Fund for Scientific Research Flanders (FWO, Belgium)(FWO); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research, and by a Cooperative Research and Development Agreement (#2791) between the National Cancer Institute and Roche Pharmaceuticals. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials. K.H. was supported in part by the Fund for Scientific Research Flanders (FWO, Belgium). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Argani P, 2001, CLIN CANCER RES, V7, P3862; Bharadwaj U, 2011, CARCINOGENESIS, V32, P1013, DOI 10.1093/carcin/bgr075; Chang K, 1996, P NATL ACAD SCI USA, V93, P136, DOI 10.1073/pnas.93.1.136; Du X, 2011, CLIN CANCER RES, V17, P5926, DOI 10.1158/1078-0432.CCR-11-1235; DUX, 2010, MOL CELL BIOL, V30, P3444, DOI DOI 10.1128/MCB.00813-09; FABRICANT RN, 1977, P NATL ACAD SCI USA, V74, P565, DOI 10.1073/pnas.74.2.565; Glasspool RM, 2006, BRIT J CANCER, V94, P1087, DOI 10.1038/sj.bjc.6603024; Greganova E, 2011, FEBS J, V278, P2613, DOI 10.1111/j.1742-4658.2011.08199.x; Hassan R, 2007, CLIN CANCER RES, V13, P5144, DOI 10.1158/1078-0432.CCR-07-0869; Hassan R, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006941; Ho M, 2005, CLIN CANCER RES, V11, P3814, DOI 10.1158/1078-0432.CCR-04-2304; Hollevoet K, 2014, MOL CANCER THER, V13, P2040, DOI 10.1158/1535-7163.MCT-14-0089-T; Hollevoet K, 2014, J IMMUNOTHER, V37, P8, DOI 10.1097/CJI.0000000000000010; Hu XB, 2013, LEUKEMIA RES, V37, P1551, DOI 10.1016/j.leukres.2013.08.005; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Kepp O, 2011, NAT REV DRUG DISCOV, V10, P221, DOI 10.1038/nrd3373; Kimura Y, 1996, INT J PANCREATOL, V20, P43; Kreitman RJ, 1999, BLOOD, V94, P3340, DOI 10.1182/blood.V94.10.3340.422k19_3340_3348; Kreitman RJ, 2009, CLIN CANCER RES, V15, P5274, DOI 10.1158/1078-0432.CCR-09-0062; Liu WM, 2012, P NATL ACAD SCI USA, V109, P490, DOI 10.1073/pnas.1110368109; Liu WH, 2012, PROTEIN ENG DES SEL, V25, P1, DOI 10.1093/protein/gzr053; Mazor R, 2012, P NATL ACAD SCI USA, V109, pE3597, DOI 10.1073/pnas.1218138109; Missiaglia E, 2005, ONCOGENE, V24, P199, DOI 10.1038/sj.onc.1208018; Nelson HH, 2011, EPIGENETICS-US, V6, P1029, DOI 10.4161/epi.6.8.16074; O'Shannessy DJ, 2013, J OVARIAN RES, V6, DOI 10.1186/1757-2215-6-29; Obulhasim G, 2010, EUR J GYNAECOL ONCOL, V31, P63; Ordonez NG, 2003, AM J SURG PATHOL, V27, P1031, DOI 10.1097/00000478-200308000-00001; Pastan Ira, 2004, Methods Mol Biol, V248, P503; Pastan I, 2014, CANCER RES, V74, P2907, DOI 10.1158/0008-5472.CAN-14-0337; Pastan I, 2006, NAT REV CANCER, V6, P559, DOI 10.1038/nrc1891; Pruitt KD, 2014, NUCLEIC ACIDS RES, V42, pD756, DOI 10.1093/nar/gkt1114; Rasband W., 2006, IMAGEJ; Sato N, 2003, CANCER RES, V63, P4158; Shinohara H, 2000, INT J ONCOL, V17, P643; Su XY, 2012, J AM CHEM SOC, V134, P773, DOI 10.1021/ja208870a; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tortorella LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047320; Wei H, 2013, J BIOL CHEM, V288, P12305, DOI 10.1074/jbc.M113.461343; Wei H, 2012, P NATL ACAD SCI USA, V109, P6898, DOI 10.1073/pnas.1204523109; Weldon JE, 2013, MOL CANCER THER, V12, P48, DOI 10.1158/1535-7163.MCT-12-0336; Weldon JE, 2011, FEBS J, V278, P4683, DOI 10.1111/j.1742-4658.2011.08182.x	42	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0122462	10.1371/journal.pone.0122462	http://dx.doi.org/10.1371/journal.pone.0122462			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803818	Green Submitted, Green Published, gold			2022-12-26	WOS:000353889600200
J	Parsons, DM; Middleton, C; Spong, KT; Mackay, G; Smith, MD; Buckthought, D				Parsons, Darren M.; Middleton, Crispin; Spong, Keren T.; Mackay, Graeme; Smith, Matt D.; Buckthought, Dane			Mechanisms Explaining Nursery Habitat Association: How Do Juvenile Snapper (Chrysophrys auratus) Benefit from Their Nursery Habitat?	PLOS ONE			English	Article							COD GADUS-MORHUA; MARINE NURSERIES; PREY SELECTION; BOUNDARY-LAYER; PREDATION RISK; LIFE-HISTORY; REEF FISH; ZOOPLANKTON; DIET; ESTUARY	Nursery habitats provide elevated survival and growth to the organisms that associate with them, and as such are a crucial early life-stage component for many fishes and invertebrates. The exact mechanisms by which these benefits are afforded to associated organisms, however, are often unclear. Here we assessed potential explanations of the nursery function of structurally complex habitats for post-settlement snapper, Chrysophrys auratus, in New Zealand. Specifically, we deployed Artificial Seagrass Units (ASUs) and used a combination of video observation, netting and diet analysis of associated post-settlement snapper as well describing potential prey within the micro-habitats surrounding ASUs. We did not observe any predation attempts and few potential predators, suggesting that for snapper the nursery value of structurally complex habitats is not as a predation refuge. The diet of post-settlement snapper mostly consisted of calanoid and cyclopoid copepods, which were most commonly sampled from within the water column. Nearly all suspected feeding events were also observed within the water column. When considering the velocity of water flow at each ASU, plankton sampling revealed a greater availability of copepods with increasing current strength, while netting and video observation demonstrated that the abundance of snapper was highest at sites with intermediate water velocity. This study highlights that the interaction between water flow and food availability may represent an important trade-off between energy expenditure and food intake for post-settlement snapper. Structurally complex habitats may mediate this relationship, allowing snapper to access sites with higher food availability while reducing swimming costs. This mechanism may have broader relevance, potentially explaining the importance of estuarine nursery habitats for other species.	[Parsons, Darren M.; Spong, Keren T.; Smith, Matt D.; Buckthought, Dane] NIWA, Auckland, New Zealand; [Middleton, Crispin; Mackay, Graeme] NIWA, Ruakaka, New Zealand	National Institute of Water & Atmospheric Research (NIWA) - New Zealand; National Institute of Water & Atmospheric Research (NIWA) - New Zealand	Parsons, DM (corresponding author), NIWA, Auckland, New Zealand.	darren.parsons@niwa.co.nz		Parsons, Darren/0000-0002-4030-512X	NIWA's Coasts and Oceans research programme	NIWA's Coasts and Oceans research programme	Funding was provided by NIWA's Coasts and Oceans research programme 3 (2013/24 Statement of Corporate Intent). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelrhman MA, 2003, MAR ECOL PROG SER, V248, P67, DOI 10.3354/meps248067; Asaeda T, 2005, T AM FISH SOC, V134, P537, DOI 10.1577/T03-083.1; Beck MW, 2001, BIOSCIENCE, V51, P633, DOI 10.1641/0006-3568(2001)051[0633:TICAMO]2.0.CO;2; Belcher SE, 2003, J FLUID MECH, V488, P369, DOI 10.1017/S0022112003005019; Bray R.N, 1981, FISHERY B, V78, P829; Bryan KR, 2007, J COASTAL RES, P668; Clark PE, 2006, T AM FISH SOC, V135, P1361, DOI 10.1577/T05-313.1; Clarke RD, 2005, MAR BIOL, V146, P1145, DOI 10.1007/s00227-004-1528-y; Dahlgren CP, 2006, MAR ECOL PROG SER, V312, P291, DOI 10.3354/meps312291; FAUSCH KD, 1981, CAN J FISH AQUAT SCI, V38, P1220, DOI 10.1139/f81-164; FRANCIS MP, 1994, NEW ZEAL J MAR FRESH, V28, P201, DOI 10.1080/00288330.1994.9516608; Genin A, 2004, J MARINE SYST, V50, P3, DOI 10.1016/j.jmarsys.2003.10.008; Ghisalberti M, 2009, TRANSPORT POROUS MED, V78, P385, DOI [10.1007/s11242-009-9434-x, 10.1007/s11242-008-9305-x]; Godfriaux B. L., 1969, New Zealand Journal of Marine and Freshwater Research, V3, P518; Gorman AM, 2009, J EXP MAR BIOL ECOL, V371, P1, DOI 10.1016/j.jembe.2008.12.008; Grubich JR, 2001, AM ZOOL, V41, P1258, DOI 10.1668/0003-1569(2001)041[1258:PCIAFA]2.0.CO;2; Hammerschlag N, 2010, MAR ECOL PROG SER, V414, P223, DOI 10.3354/meps08731; Heck K.L. Jr, 1991, P281; Heck KL, 2003, MAR ECOL PROG SER, V253, P123, DOI 10.3354/meps253123; HOBSON ES, 1978, FISH B-NOAA, V76, P133; Horinouchi M, 2007, ESTUAR COAST SHELF S, V72, P657, DOI 10.1016/j.ecss.2006.11.025; Horinouchi M, 2013, MAR ECOL PROG SER, V488, P255, DOI 10.3354/meps10396; Hume TM, 2007, OCEAN COAST MANAGE, V50, P905, DOI 10.1016/j.ocecoaman.2007.05.009; HYSLOP EJ, 1980, J FISH BIOL, V17, P411, DOI 10.1111/j.1095-8649.1980.tb02775.x; Kiflawi M, 1997, ECOLOGY, V78, P1062, DOI 10.1890/0012-9658(1997)078[1062:PFMATF]2.0.CO;2; KINGSFORD MJ, 1988, MAR ECOL PROG SER, V48, P103, DOI 10.3354/meps048103; Liao JC, 2003, J EXP BIOL, V206, P1059, DOI 10.1242/jeb.00209; Link JS, 2002, MAR ECOL PROG SER, V227, P109, DOI 10.3354/meps227109; Lowe M., 2013, THESIS U AUCKLAND; LUCZKOVICH JJ, 1995, ENVIRON BIOL FISH, V44, P79, DOI 10.1007/BF00005908; Lundquist C, 2012, PREDICTING SUITABLE; Martin AP, 2003, PROG OCEANOGR, V57, P125, DOI 10.1016/S0079-6611(03)00085-5; Morrison M.A., 2014, 137 NZ AQ ENV BIOD; Mumby PJ, 2004, NATURE, V427, P533, DOI 10.1038/nature02286; Nakamura Y, 2012, MAR BIOL, V159, P1305, DOI 10.1007/s00227-012-1911-z; Parsons DM, 2014, NEW ZEAL J MAR FRESH, V48, P256, DOI 10.1080/00288330.2014.892013; Parsons DM, 2013, MAR ECOL-EVOL PERSP, V34, P492, DOI 10.1111/maec.12050; PETERS KM, 1987, ESTUARIES, V10, P92, DOI 10.2307/1352173; Plaut I, 2001, COMP BIOCHEM PHYS A, V131, P41, DOI 10.1016/S1095-6433(01)00462-7; Ramsvatn S, 2012, MAR ECOL PROG SER, V451, P175, DOI 10.3354/meps09604; Reed J, 2004, FEASIBILITY STUDY IN; Rominger JT, 2011, J FLUID MECH, V680, P636, DOI 10.1017/jfm.2011.199; Rowlands WL, 2008, CAN J FISH AQUAT SCI, V65, P1297, DOI 10.1139/F08-041; Schultz ST, 2009, MAR ECOL PROG SER, V374, P85, DOI 10.3354/meps07779; Stehlik LL, 2000, ESTUARIES, V23, P381, DOI 10.2307/1353330; Swadling K., 2013, AUSTR MARINE ZOOPLAN; Usmar NR, 2012, NEW ZEAL J MAR FRESH, V46, P31, DOI 10.1080/00288330.2011.587824; Wells RJD, 2008, MAR ECOL PROG SER, V361, P213, DOI 10.3354/meps07425	48	13	14	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0122137	10.1371/journal.pone.0122137	http://dx.doi.org/10.1371/journal.pone.0122137			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803443	gold, Green Published, Green Submitted			2022-12-26	WOS:000353889600190
J	Reeder, TW; Townsend, TM; Mulcahy, DG; Noonan, BP; Wood, PL; Sites, JW; Wiens, JJ				Reeder, Tod W.; Townsend, Ted M.; Mulcahy, Daniel G.; Noonan, Brice P.; Wood, Perry L., Jr.; Sites, Jack W., Jr.; Wiens, John J.			Integrated Analyses Resolve Conflicts over Squamate Reptile Phylogeny and Reveal Unexpected Placements for Fossil Taxa	PLOS ONE			English	Article							LIZARDS; SNAKES; HISTORY; TREE	Squamate reptiles (lizards and snakes) are a pivotal group whose relationships have become increasingly controversial. Squamates include >9000 species, making them the second largest group of terrestrial vertebrates. They are important medicinally and as model systems for ecological and evolutionary research. However, studies of squamate biology are hindered by uncertainty over their relationships, and some consider squamate phylogeny unresolved, given recent conflicts between molecular and morphological results. To resolve these conflicts, we expand existing morphological and molecular datasets for squamates (691 morphological characters and 46 genes, for 161 living and 49 fossil taxa, including a new set of 81 morphological characters and adding two genes from published studies) and perform integrated analyses. Our results resolve higher-level relationships as indicated by molecular analyses, and reveal hidden morphological support for the molecular hypothesis (but not vice-versa). Furthermore, we find that integrating molecular, morphological, and paleontological data leads to surprising placements for two major fossil clades (Mosasauria and Polyglyphanodontia). These results further demonstrate the importance of combining fossil and molecular information, and the potential problems of estimating the placement of fossil taxa from morphological data alone. Thus, our results caution against estimating fossil relationships without considering relevant molecular data, and against placing fossils into molecular trees (e.g. for dating analyses) without considering the possible impact of molecular data on their placement.	[Reeder, Tod W.; Townsend, Ted M.] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; [Mulcahy, Daniel G.] Smithsonian Inst, Labs Analyt Biol, Washington, DC 20560 USA; [Noonan, Brice P.] Univ Mississippi, Dept Biol, University, MS 38677 USA; [Wood, Perry L., Jr.; Sites, Jack W., Jr.] Brigham Young Univ, Dept Biol, Provo, UT 84602 USA; [Wood, Perry L., Jr.; Sites, Jack W., Jr.] Brigham Young Univ, Bean Life Sci Museum, Provo, UT 84602 USA; [Wiens, John J.] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA	California State University System; San Diego State University; Smithsonian Institution; Smithsonian National Museum of Natural History; University of Mississippi; Brigham Young University; Brigham Young University; University of Arizona	Wiens, JJ (corresponding author), Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA.	wiensj@email.arizona.edu	Wood, Perry/ABA-3954-2020	Wood, Perry/0000-0003-3767-5274; Wiens, John/0000-0003-4243-1127; Mulcahy, Daniel G./0000-0001-6614-2405	United States National Science Foundation grant [EF 0334967, EF 0334966, EF 0334923]	United States National Science Foundation grant	This project was supported by a United States National Science Foundation grant, with awards to T.W.R. (EF 0334967), J.W.S. (EF 0334966) and J.J.W. (EF 0334923). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberer AJ, 2013, SYST BIOL, V62, P162, DOI 10.1093/sysbio/sys078; Castoe TA, 2009, P NATL ACAD SCI USA, V106, P8986, DOI 10.1073/pnas.0900233106; Conrad JL, 2008, B AM MUS NAT HIST, P1, DOI 10.1206/310.1; DEBRAGA M, 1993, EVOL BIOL, V27, P245; Estes R, 1983, SAURIA TERRESTRIA AM; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Felsenstein J., 2004, INFERRING PHYLOGENIE; Fox JW, 2007, CURR PHARM DESIGN, V13, P2927, DOI 10.2174/138161207782023739; Fry BG, 2006, NATURE, V439, P584, DOI 10.1038/nature04328; Gauthier JA, 2012, B PEABODY MUS NAT HI, V53, P3, DOI 10.3374/014.053.0101; Gilmore CW, 1943, B AM MUS NAT HIST, V81, P361; Greene H.W., 1997, SNAKES EVOLUTION MYS; Hillis DM, 2000, SM S COMP E, P1; HILLIS DM, 1987, ANNU REV ECOL SYST, V18, P23, DOI 10.1146/annurev.es.18.110187.000323; Kasturiratne A, 2008, PLOS MED, V5, P1591, DOI 10.1371/journal.pmed.0050218; KLUGE AG, 1989, SYST ZOOL, V38, P7, DOI 10.2307/2992432; Lee MSY, 2000, J PALEONTOL, V74, P915, DOI 10.1666/0022-3360(2000)074<0915:AATAOM>2.0.CO;2; Lewis PO, 2001, SYST BIOL, V50, P913, DOI 10.1080/106351501753462876; Losos, 2009, ECOLOGY ADAPTIVE RAD; Losos JB, 2012, SCIENCE, V338, P1428, DOI 10.1126/science.1232455; Maddison DR, 2000, MACCLADE 4 0; McDOWELL SAMUEL BOOKER, 1954, BULL AMER MUS NAT HIST, V105, P1; Mulcahy DG, 2012, MOL PHYLOGENET EVOL, V65, P974, DOI 10.1016/j.ympev.2012.08.018; Nydam RL, 2007, J PALEONTOL, V81, P538, DOI 10.1666/03097.1; Pianka E.R., 2003, LIZARDS WINDOWS EVOL; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Pyron RA, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-93; Rambaut A, 2009, TRACER V1 5; Ronquist F, 2012, SYST BIOL, V61, P973, DOI 10.1093/sysbio/sys058; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Russell D. A., 1967, Bulletin of the Peabody Museum of Natural History, V23, P1; Sanderson MJ, 2002, ANNU REV ECOL SYST, V33, P49, DOI 10.1146/annurev.ecolsys.33.010802.150509; Schachner ER, 2014, NATURE, V506, P367, DOI 10.1038/nature12871; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Sites JW, 2011, ANNU REV ECOL EVOL S, V42, P227, DOI 10.1146/annurev-ecolsys-102710-145051; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Thorley JL, 1999, J THEOR BIOL, V200, P343, DOI 10.1006/jtbi.1999.0999; Townsend TM, 2004, SYST BIOL, V53, P735, DOI 10.1080/10635150490522340; Uetz P., REPTILE DATABASE; Vidal N, 2005, CR BIOL, V328, P1000, DOI 10.1016/j.crvi.2005.10.001; Vitt LJ, 2003, AM NAT, V162, P44, DOI 10.1086/375172; Wiens JJ, 2012, BIOL LETTERS, V8, P1043, DOI 10.1098/rsbl.2012.0703; Wiens JJ, 2010, SYST BIOL, V59, P674, DOI 10.1093/sysbio/syq048; Wilkinson M, 1996, MOL BIOL EVOL, V13, P437, DOI 10.1093/oxfordjournals.molbev.a025604	45	176	183	0	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0118199	10.1371/journal.pone.0118199	http://dx.doi.org/10.1371/journal.pone.0118199			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803280	Green Published, gold, Green Submitted			2022-12-26	WOS:000353889600007
J	de Oliveira, LFV; Margis, R				Valter de Oliveira, Luiz Felipe; Margis, Rogerio			The Source of the River as a Nursery for Microbial Diversity	PLOS ONE			English	Article							BACTERIAL COMMUNITY; SYNCHRONY; SEQUENCES	Bacteria are highly diverse and ubiquitous organisms that play a key role as drivers for ecosystem processes. The application of NGS (next-generation sequencing technologies) for 16S analysis has been broadly used for understanding bacterioplankton composition and structure. Most of studies conducted on aquatic ecosystems with 16S NGS have been in seawater and lakes. A few studies using NGS have been conducted in river environments and have suggested the presence of a bacterial seed-bank. We performed 16S highly variable V4 region high-throughput analysis in the Sinos River, which is located in one of most important Brazilian industrial centers. This region has several contrasts in its environmental characteristics, presenting a longitudinal gradient of eutrophication and making it a remarkable study site for observing the dynamics of bacterioplankton. We demonstrated consistent evidence for the existence of a bacterial seed-bank and its longitudinal persistence. Seasonal shifts reinforce the importance of the source of the river in maintaining the bacterial seed-bank that spreads throughout the river. Therefore, the preservation of the source of the river is important not only for hydrologic reasons but also to maintain the microbial composition and the ecological integrity of the river.	[Valter de Oliveira, Luiz Felipe; Margis, Rogerio] Univ Fed Rio Grande do Sul, Programa Posgrad Genet & Biol Mol, Porto Alegre, RS, Brazil; [Margis, Rogerio] Univ Fed Rio Grande do Sul, Ctr Biotecnol, Porto Alegre, RS, Brazil; [Margis, Rogerio] Univ Fed Rio Grande do Sul, Dept Biofis, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul	Margis, R (corresponding author), Univ Fed Rio Grande do Sul, Programa Posgrad Genet & Biol Mol, Porto Alegre, RS, Brazil.	rogerio.margis@ufrgs.br	de Oliveira, Luiz Felipe Valter/C-6850-2008; Margis, Rogerio/A-7230-2008	de Oliveira, Luiz Felipe Valter/0000-0003-4535-0621; Margis, Rogerio/0000-0002-2871-4473	CNPq Universal Grant [476119/2011-1]	CNPq Universal Grant(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by the CNPq Universal Grant Number 476119/2011-1. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bolhuis H, 2011, ISME J, V5, P1701, DOI [10.1038/Ismej.2011.52, 10.1038/ismej.2011.52]; Campbell BJ, 2013, ISME J, V7, P210, DOI 10.1038/ismej.2012.93; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2012, ISME J, V6, P1089, DOI 10.1038/ismej.2011.162; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; CHAO A, 1984, SCAND J STAT, V11, P265; Costa PF, 2010, BRAZ J BIOL, V70, P1195, DOI 10.1590/S1519-69842010000600009; Crump BC, 2005, LIMNOL OCEANOGR, V50, P1718, DOI 10.4319/lo.2005.50.6.1718; Crump BC, 2012, ISME J, V6, P1629, DOI 10.1038/ismej.2012.9; Crump BC, 2009, P NATL ACAD SCI USA, V106, P21208, DOI 10.1073/pnas.0906149106; Dai TH, 2012, FRONT MICROBIOL, V3, DOI [10.3389/fmicb.2012.00120, 10.3389/fmicb.2012.00417]; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Eiler A, 2012, ISME J, V6, P330, DOI 10.1038/ismej.2011.113; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Figueiredo JAS, 2010, BRAZ J BIOL, V70, P1131, DOI 10.1590/S1519-69842010000600001; Gibbons Sean M, 2013, Proc Natl Acad Sci U S A, V110, P4651, DOI 10.1073/pnas.1217767110; Gilbert JA, 2012, ISME J, V6, P298, DOI 10.1038/ismej.2011.107; Jones SE, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00318; Knights D, 2011, NAT METHODS, V8, P761, DOI 10.1038/nmeth.1650; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone C, 2011, ISME J, V5, P169, DOI 10.1038/ismej.2010.133; Masella AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-31; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Newton RJ, 2011, MICROBIOL MOL BIOL R, V75, P14, DOI 10.1128/MMBR.00028-10; Oksanen J., 2017, COMMUNITY ECOLOGY PA; Scalon MCS, 2013, SCI WORLD J, DOI 10.1155/2013/209737; Shade A, 2008, ENVIRON MICROBIOL, V10, P1057, DOI 10.1111/j.1462-2920.2007.01527.x; Shade A, 2013, ISME J, V7, P1493, DOI 10.1038/ismej.2013.54; Shade A, 2012, ISME J, V6, P2153, DOI 10.1038/ismej.2012.56; Staley C, 2013, J APPL MICROBIOL, V115, P1147, DOI 10.1111/jam.12323; Zinger L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024570; Zwart G, 2002, AQUAT MICROB ECOL, V28, P141, DOI 10.3354/ame028141	33	26	28	3	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0120608	10.1371/journal.pone.0120608	http://dx.doi.org/10.1371/journal.pone.0120608			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803426	Green Submitted, gold, Green Published			2022-12-26	WOS:000353889600085
J	Yamamoto, K; Takahashi, K; Shiozaki, K; Yamaguchi, K; Moriya, S; Hosono, M; Shima, H; Miyagi, T				Yamamoto, Koji; Takahashi, Kohta; Shiozaki, Kazuhiro; Yamaguchi, Kazunori; Moriya, Setsuko; Hosono, Masahiro; Shima, Hiroshi; Miyagi, Taeko			Potentiation of Epidermal Growth Factor-Mediated Oncogenic Transformation by Sialidase NEU3 Leading to Src Activation	PLOS ONE			English	Article							MEMBRANE-ASSOCIATED SIALIDASE; SITE-DIRECTED MUTAGENESIS; HUMAN EGF RECEPTOR; GANGLIOSIDE SIALIDASE; APOPTOSIS SUPPRESSION; TYROSINE KINASE; HUMAN CANCER; EXPRESSION; MICRODOMAINS; PHENOTYPE	We previously demonstrated that sialidase NEU3, a key glycosidase for ganglioside degradation, is up-regulated in various human cancers, leading to increased cell invasion, motility and survival of cancer cells possibly through activation of EGF signaling. Its up-regulation is also important for promotion of the stage of colorectal carcinogenesis in vivo in human NEU3 transgenic mice treated with azoxymethane for the induction of aberrant crypt foci in the colon mucosa, accompanied by enhanced phosphorylation of EGF receptor ( EGFR). To address whether the activation of EGF signaling by the sialidase is associated with oncogenic transformation, we here analyzed the effects of overexpression of NEU3 and EGFR in NIH-3T3 cells. When NEU3 was stably transfected with or without EGFR, it was associated with significant increases in clonogenic growth, clonogenicity on soft agar and in vivo tumor growth in nude mice either with or without the receptor overexpression in the presence of EGF, compared with the levels in their vector controls. Despite the fact that the endogenous level of EGFR is known to be extremely low in these cells, NEU3 significantly enhanced the phosphorylation of Akt and ERK, as well as that of the receptor. The NEU3mediated activation was largely abrogated by the EGFR inhibitor AG1478 or PD153035, but significant clonogenic growth still remained. NEU3 was then found to activate Src kinase, and the clonogenicity was completely suppressed by an Src inhibitor, PP2. The activity- null mutants failed to activate Src and EGFR, indicating that ganglioside modulation by NEU3 may be necessary for the activation. NEU3 and Src were co-immunoprecipitated with EGFR in NEU3- and EGFR- transfected cells. These findings identify NEU3 as an essential participant in tumorigenesis through the EGFR/Src signaling pathway and a potential target for inhibiting EGFR-mediated tumor progression.	[Yamamoto, Koji; Takahashi, Kohta; Moriya, Setsuko; Miyagi, Taeko] Tohoku Pharmaceut Univ, Inst Mol Biomembrane & Glycobiol, Dept Cancar Glycosylat Res, Sendai, Miyagi, Japan; [Shiozaki, Kazuhiro] Kagoshima Univ, Fac Fisheries, Kagoshima 890, Japan; [Shiozaki, Kazuhiro] Kagoshima Univ, United Grad Sch Agr Sci, Kagoshima 890, Japan; [Yamaguchi, Kazunori] Miyagi Canc Ctr, Res Inst, Mol & Cellular Oncol, Natori, Miyagi 9811293, Japan; [Hosono, Masahiro] Tohoku Pharmaceut Univ, Inst Mol Biomembrane & Glycobiol, Dept Cell Recognit Study, Sendai, Miyagi, Japan; [Shima, Hiroshi] Tohoku Univ, Grad Sch Med, Div Canc Mol Biol, Sendai, Miyagi 980, Japan	Tohoku Medical & Pharmaceutical University; Kagoshima University; Kagoshima University; Miyagi Cancer Center; Tohoku Medical & Pharmaceutical University; Tohoku University	Miyagi, T (corresponding author), Tohoku Pharmaceut Univ, Inst Mol Biomembrane & Glycobiol, Dept Cancar Glycosylat Res, Sendai, Miyagi, Japan.	tmiyagi@tohoku-pharm.ac.jp		Shiozaki, Kazuhiro/0000-0002-0523-838X	Ministry of Education, Culture, Sports, Science and Technology of Japan [23110002]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported in part by Grants-in-Aid for Scientific Research on Innovative Areas (No. 23110002) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albohy A, 2010, GLYCOBIOLOGY, V20, P1127, DOI 10.1093/glycob/cwq077; Baselga J, 2005, J CLIN ONCOL, V23, P2445, DOI 10.1200/JCO.2005.11.890; Brewer M Red, 2009, MOL CELL, V34, P641, DOI [10.1016/j.molcel.2009.04.034, DOI 10.1016/J.MOLCEL.2009.04.034]; Chung BM, 2009, ONCOGENE, V28, P1821, DOI 10.1038/onc.2009.31; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Coskun U, 2011, P NATL ACAD SCI USA, V108, P9044, DOI 10.1073/pnas.1105666108; Greulich H, 2005, PLOS MED, V2, P1167, DOI 10.1371/journal.pmed.0020313; Hakomori S, 2010, FEBS LETT, V584, P1901, DOI 10.1016/j.febslet.2009.10.065; Ishizawar R, 2004, CANCER CELL, V6, P209, DOI 10.1016/j.ccr.2004.09.001; Jura N, 2009, CELL, V137, P1293, DOI 10.1016/j.cell.2009.04.025; Kakugawa Y, 2002, P NATL ACAD SCI USA, V99, P10718, DOI 10.1073/pnas.152597199; Kato K, 2006, BIOCHEM J, V394, P647, DOI 10.1042/BJ20050737; Kato T, 2001, INT J CANCER, V92, P797, DOI 10.1002/ijc.1268; Kawamura S, 2012, CELL DEATH DIFFER, V19, P170, DOI 10.1038/cdd.2011.83; Kawashima N, 2009, J BIOL CHEM, V284, P6147, DOI 10.1074/jbc.M808171200; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Lau KS, 2008, GLYCOBIOLOGY, V18, P750, DOI 10.1093/glycob/cwn071; Miljan EA, 2002, J BIOL CHEM, V277, P10108, DOI 10.1074/jbc.M111669200; Miyagi T, 2008, J BIOCHEM, V144, P279, DOI 10.1093/jb/mvn089; Miyagi T, 2012, GLYCOCONJUGATE J, V29, P567, DOI 10.1007/s10719-012-9394-1; Miyagi T, 2012, GLYCOBIOLOGY, V22, P880, DOI 10.1093/glycob/cws057; Nomura H, 2006, ONCOL RES, V16, P289, DOI 10.3727/000000006783981035; Parsons SJ, 2004, ONCOGENE, V23, P7906, DOI 10.1038/sj.onc.1208160; SHIH C, 1981, NATURE, V290, P261, DOI 10.1038/290261a0; Shiozaki K, 2009, CANCER SCI, V100, P588, DOI 10.1111/j.1349-7006.2008.01080.x; Tice DA, 1999, P NATL ACAD SCI USA, V96, P1415, DOI 10.1073/pnas.96.4.1415; TSUTSUMI O, 1986, SCIENCE, V233, P975, DOI 10.1126/science.3090686; Ueno S, 2006, J BIOL CHEM, V281, P7756, DOI 10.1074/jbc.M509668200; VELU TJ, 1987, SCIENCE, V238, P1408, DOI 10.1126/science.3500513; Wada T, 2007, ONCOGENE, V26, P2483, DOI 10.1038/sj.onc.1210341; Wada T, 1999, BIOCHEM BIOPH RES CO, V261, P21, DOI 10.1006/bbrc.1999.0973; Wang XQ, 2002, J BIOL CHEM, V277, P47028, DOI 10.1074/jbc.M208257200; Wang Y, 2002, J BIOL CHEM, V277, P26252, DOI 10.1074/jbc.M110515200; Wang Y, 2001, EUR J BIOCHEM, V268, P2201, DOI 10.1046/j.1432-1327.2001.02069.x; Yamaguchi K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041132; Yamaguchi K, 2010, BIOCHEM J, V430, P107, DOI 10.1042/BJ20100350; Yoon SJ, 2006, P NATL ACAD SCI USA, V103, P18987, DOI 10.1073/pnas.0609281103	37	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0120578	10.1371/journal.pone.0120578	http://dx.doi.org/10.1371/journal.pone.0120578			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803810	Green Submitted, Green Published, gold			2022-12-26	WOS:000353889600081
J	Bechlars, S; Jackel, C; Diescher, S; Wustenhagen, DA; Kubick, S; Dieckmann, R; Strauch, E				Bechlars, Silke; Jaeckel, Claudia; Diescher, Susanne; Wuestenhagen, Doreen A.; Kubick, Stefan; Dieckmann, Ralf; Strauch, Eckhard			Characterization of trh2 Harbouring Vibrio parahaemolyticus Strains Isolated in Germany	PLOS ONE			English	Article							THERMOSTABLE DIRECT HEMOLYSIN; III SECRETION SYSTEM; TDH-RELATED HEMOLYSIN; VIRULENCE FACTORS; CLINICAL ISOLATE; COASTAL AREAS; GENE TDH; EFFECTOR; IDENTIFICATION; PATHOGENICITY	Background Vibrio parahaemolyticus is a recognized human enteropathogen. Thermostable direct hemolysin (TDH) and TDH-related hemolysin (TRH) as well as the type III secretion system 2 (T3SS2) are considered as major virulence factors. As tdh positive strains are not detected in coastal waters of Germany, we focused on the characterization of trh positive strains, which were isolated from mussels, seawater and patients in Germany. Results Ten trh harbouring V. parahaemolyticus strains from Germany were compared to twenty-one trh positive strains from other countries. The complete trh sequences revealed clustering into three different types: trh1 and trh2 genes and a pseudogene psi trh. All German isolates possessed alleles of the trh2 gene. MLST analysis indicated a close relationship to Norwegian isolates suggesting that these strains belong to the autochthonous microflora of Northern Europe seawaters. Strains carrying the pseudogene psi trh were negative for T3SS2 beta effector vopC. Transcription of trh and vopC genes was analyzed under different growth conditions. Trh2 gene expression was not altered by bile while trh1 genes were inducible. VopC could be induced by urea in trh2 bearing strains. Most trh1 carrying strains were hemolytic against sheep erythrocytes while all trh2 positive strains did not show any hemolytic activity. TRH variants were synthesized in a prokaryotic cell-free system and their hemolytic activity was analyzed. TRH1 was active against sheep erythrocytes while TRH2 variants were not active at all. Conclusion Our study reveals a high diversity among trh positive V. parahaemolyticus strains. The function of TRH2 hemolysins and the role of the pseudogene psi trh as pathogenicity factors are questionable. To assess the pathogenic potential of V. parahaemolyticus strains a differentiation of trh variants and the detection of T3SS2 beta components like vopC would improve the V. parahaemolyticus diagnostics and could lead to a refinement of the risk assessment in food analyses and clinical diagnostics.	[Bechlars, Silke; Jaeckel, Claudia; Diescher, Susanne; Dieckmann, Ralf; Strauch, Eckhard] Fed Inst Risk Assessment, Natl Reference Lab Monitoring Bacteriol Contamina, Dept Biol Safety, Berlin, Germany; [Wuestenhagen, Doreen A.; Kubick, Stefan] Fraunhofer Inst Cell Therapy & Immunol, Branch Bioanalyt & Bioproc Fraunhofer IZI BB, Potsdam, Germany	Federal Institute for Risk Assessment; Fraunhofer Gesellschaft	Strauch, E (corresponding author), Fed Inst Risk Assessment, Natl Reference Lab Monitoring Bacteriol Contamina, Dept Biol Safety, Berlin, Germany.	Eckhard.Strauch@bfr.bund.de		Dieckmann, Ralf/0000-0002-1533-7496	Federal Ministry for Research and Education of Germany [01KI1015A, 0315942, 0312039]	Federal Ministry for Research and Education of Germany	Funding provided by Federal Ministry for Research and Education of Germany (VibrioNet 01KI1015A, Nos 0315942 and 0312039). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, RISK ASSESSMENT VIBR; Baker-Austin C, 2010, ENV MICROBIOL REP, V2, P7, DOI 10.1111/j.1758-2229.2009.00096.x; Banerjee SK, 2014, J CLIN MICROBIOL, V52, P1081, DOI 10.1128/JCM.03047-13; Bechlars S, 2013, TOXICON, V76, P132, DOI 10.1016/j.toxicon.2013.09.012; Bier N, 2013, APPL ENVIRON MICROB, V79, P3570, DOI 10.1128/AEM.00477-13; BLAKE PA, 1980, ANNU REV MICROBIOL, V34, P341, DOI 10.1146/annurev.mi.34.100180.002013; Boer SI, 2013, MICROB ECOL, V65, P1052, DOI 10.1007/s00248-013-0221-4; Boquet P, 2003, TRENDS CELL BIOL, V13, P238, DOI 10.1016/S0962-8924(03)00037-0; Burne RA, 2000, MICROBES INFECT, V2, P533, DOI 10.1016/S1286-4579(00)00312-9; Caburlotto G, 2010, INFECT IMMUN, V78, P3280, DOI 10.1128/IAI.00050-10; Caburlotto G, 2009, FEMS MICROBIOL ECOL, V70, P506, DOI 10.1111/j.1574-6941.2009.00764.x; CAREY MC, 1983, ANNU REV PHYSIOL, V45, P651, DOI 10.1146/annurev.ph.45.030183.003251; Ceccarelli D, 2013, DISTRIBUTION DYNAMIC, V3; Chao GX, 2010, FOODBORNE PATHOG DIS, V7, P649, DOI 10.1089/fpd.2009.0441; Chen YS, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-294; Ellingsen AB, 2008, J APPL MICROBIOL, V105, P2195, DOI 10.1111/j.1365-2672.2008.03964.x; Ellingsen AB, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00107; Enos-Berlage JL, 2005, MOL MICROBIOL, V55, P1160, DOI 10.1111/j.1365-2958.2004.04453.x; Glibert PM, 2006, BIOGEOCHEMISTRY, V77, P441, DOI 10.1007/s10533-005-3070-5; Gonzalez-Escalona N, 2008, J BACTERIOL, V190, P2831, DOI 10.1128/JB.01808-07; Gotoh K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013365; Hervio-Heath D, 2002, J APPL MICROBIOL, V92, P1123, DOI 10.1046/j.1365-2672.2002.01663.x; Hiyoshi H, 2011, CELL HOST MICROBE, V10, P401, DOI 10.1016/j.chom.2011.08.014; Hiyoshi H, 2010, INFECT IMMUN, V78, P1772, DOI 10.1128/IAI.01051-09; HONDA T, 1988, INFECT IMMUN, V56, P961, DOI 10.1128/IAI.56.4.961-965.1988; HONDA T, 1990, CAN J MICROBIOL, V36, P395, DOI 10.1139/m90-069; Iida T, 1997, J MED MICROBIOL, V46, P639, DOI 10.1099/00222615-46-8-639; Jones JL, 2012, J CLIN MICROBIOL, V50, P2343, DOI 10.1128/JCM.00196-12; Kamruzzaman M, 2008, GENE, V421, P67, DOI 10.1016/j.gene.2008.06.009; KANEKO T, 1975, APPL MICROBIOL, V30, P251, DOI 10.1128/AEM.30.2.251-257.1975; KISHISHITA M, 1992, APPL ENVIRON MICROB, V58, P2449, DOI 10.1128/AEM.58.8.2449-2457.1992; Kodama T, 2007, CELL MICROBIOL, V9, P2598, DOI 10.1111/j.1462-5822.2007.00980.x; Lemonnier M, 2007, FEMS MICROBIOL REV, V31, P515, DOI 10.1111/j.1574-6976.2007.00078.x; Mahoney JC, 2010, APPL ENVIRON MICROB, V76, P7459, DOI 10.1128/AEM.01450-10; Matz C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020275; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; Messelhausser U, 2010, INT J FOOD MICROBIOL, V142, P360, DOI 10.1016/j.ijfoodmicro.2010.07.020; Miller KA, 2012, INFECT IMMUN, V80, P4444, DOI 10.1128/IAI.00832-12; MOLL A, 1979, FEMS MICROBIOL LETT, V6, P273, DOI 10.1111/j.1574-6968.1979.tb03720.x; Nair GB, 2007, CLIN MICROBIOL REV, V20, P39, DOI 10.1128/CMR.00025-06; Nelapati S, 2012, VET WORLD, V5, P48, DOI [10.5455/vetworld.2012.48-63, 10.5455/vetworld.2012.48-62]; NISHIBUCHI M, 1995, INFECT IMMUN, V63, P2093, DOI 10.1128/IAI.63.6.2093-2099.1995; NISHIBUCHI M, 1990, MOL MICROBIOL, V4, P87, DOI 10.1111/j.1365-2958.1990.tb02017.x; Nishibuchi M., BOOKL C VIBRIO 2014, P21; Noriea NF, 2010, J APPL MICROBIOL, V109, P953, DOI 10.1111/j.1365-2672.2010.04722.x; Ohnishi K, 2011, FEMS MICROBIOL LETT, V318, P10, DOI 10.1111/j.1574-6968.2011.02233.x; Okada N, 2009, INFECT IMMUN, V77, P904, DOI 10.1128/IAI.01184-08; Okada R, 2014, CELL MICROBIOL, V16, P938, DOI 10.1111/cmi.12252; Okuda J, 1997, J CLIN MICROBIOL, V35, P1965, DOI 10.1128/JCM.35.8.1965-1971.1997; Ottaviani D, 2012, J CLIN MICROBIOL, V50, P4141, DOI 10.1128/JCM.01993-12; Pan TM, 1996, J FORMOS MED ASSOC, V95, P417; Park KS, 2004, INFECT IMMUN, V72, P6659, DOI 10.1128/IAI.72.11.6659-6665.2004; Park KS, 2000, INFECT IMMUN, V68, P5742, DOI 10.1128/IAI.68.10.5742-5748.2000; Ritchie JM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002593; Robert-Pillot A, 2004, INT J FOOD MICROBIOL, V91, P319, DOI 10.1016/j.ijfoodmicro.2003.07.006; Salomon D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061086; SHIRAI H, 1990, INFECT IMMUN, V58, P3568, DOI 10.1128/IAI.58.11.3568-3573.1990; Stech M, 2013, J BIOTECHNOL, V164, P220, DOI 10.1016/j.jbiotec.2012.08.020; TADA J, 1992, MOL CELL PROBE, V6, P477, DOI 10.1016/0890-8508(92)90044-X; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thompson FL, 2004, MICROBIOL MOL BIOL R, V68, P403, DOI 10.1128/MMBR.68.3.403-431.2004; Thongjun Junthip, 2013, Trop Med Health, V41, P151, DOI 10.2149/tmh.2013-06; Urmersbach S, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-59; Velazquez-Roman J, 2014, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00110; Wang HZ, 2006, APPL ENVIRON MICROB, V72, P4455, DOI 10.1128/AEM.02095-05; Xiao X, 2011, INT J FOOD MICROBIOL, V149, P143, DOI 10.1016/j.ijfoodmicro.2011.06.014; Yanagihara I, 2010, J BIOL CHEM, V285, P16267, DOI 10.1074/jbc.M109.074526; Zhang LL, 2013, CURR OPIN MICROBIOL, V16, P70, DOI 10.1016/j.mib.2013.02.002; Zhang LL, 2012, CELL REP, V1, P453, DOI 10.1016/j.celrep.2012.04.004; Zhou XH, 2013, CELL REP, V3, P1690, DOI 10.1016/j.celrep.2013.03.039	70	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0118559	10.1371/journal.pone.0118559	http://dx.doi.org/10.1371/journal.pone.0118559			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799574	Green Published, gold			2022-12-26	WOS:000351987300012
J	Hu, JD; Chen, RP; Wang, S; Wang, TT; Zhao, YY; Li, JW; Hu, XR; Liang, H; Zhu, JH; Sun, XH; Ma, LZ; Jiang, M				Hu, Jiandong; Chen, Ruipeng; Wang, Shun; Wang, Tingting; Zhao, Yuanyuan; Li, Jianwei; Hu, Xinran; Liang, Hao; Zhu, Juanhua; Sun, Xiaohui; Ma, Liuzheng; Jiang, Min			Detection of Clenbuterol Hydrochloride Residuals in Pork Liver Using a Customized Surface Plasmon Resonance Bioanalyzer	PLOS ONE			English	Article							ELECTROCHEMICAL IMMUNOSENSOR; RAPID-DETERMINATION; CARBON NANOTUBE; LABEL-FREE; RACTOPAMINE; BIOSENSOR; SENSOR; MATRIX; FOOD	A surface plasmon resonance (SPR) immunoassay with an immobilization of self-assembled molecular identification membrane for the detection of residual Clenbuterol Hydrochloride (CLB) in pork liver was systematically investigated and experimentally validated for its high performance. SPR immunoassay with a regular competitive inhibition assay cannot be directly verified to detect CLB residuals. In this study, the binding of Au film with mercaptopropionic acid was investigated using the known form of the strong S-Au covalent bonds formed by the chemical radical of the mercaptopropionic acid and the Au film. After that, the immunoglobulin IgG of swine (SwIgG-CLB) was bonded with the mercaptopropionic acid by covalent -CO-NH-amide bonding. The modified comprehensive analysis of how the membrane structure works was introduced together with the customized SPR bioanalyzer. In order to evaluate the performance of this biomembrane structure, the concentrations of CLB-contained solutions of 0 ng.mL(-1), 10 ng.mL(-1), 20 ng.mL(-1), 33.3 ng.mL(-1), and 40 ng.mL(-1) were prepared by adding CLB reagents into the solutions of CLB antibody (Clenbuterol Hydrochloride Antibody, CLB-Ab), successively and then the response unit (RU) was measured individually. Using the data collected from the linear CCD array, the fitting curve was established with the R-Square value of 0.9929. Correspondingly, the recovery rate ranged from 88.48% to 103.21% was experimented and the limit of detection of CLB in 1.26 ng.mL(-1) was obtained efficiently. It was concluded that the detection method associated with biomembrane properties is expected to contribute much to the determination of residual CLB in pork liver quantitatively by using the customized SPR bioanalyzer.	[Hu, Jiandong; Chen, Ruipeng; Wang, Shun; Wang, Tingting; Li, Jianwei; Zhu, Juanhua; Sun, Xiaohui; Ma, Liuzheng] Henan Agr Univ, Dept Elect Engn, Zhengzhou, Peoples R China; [Hu, Jiandong] State Key Lab Wheat & Maize Crop Sci, Zhengzhou, Peoples R China; [Zhao, Yuanyuan] Hanan Mech & Elect Vocat Coll, Zhengzhou, Peoples R China; [Hu, Xinran] McGill Univ, Sch Human Nutr & Dietet, Ste Anne De Bellevue, PQ, Canada; [Liang, Hao] Univ Gavle, Dept Elect & Telecommun, Gavle, Sweden; [Jiang, Min] Henan Agr Univ, Coll Life Sci, Zhengzhou, Peoples R China	Henan Agricultural University; McGill University; University of Gavle; Henan Agricultural University	Hu, JD (corresponding author), Henan Agr Univ, Dept Elect Engn, Zhengzhou, Peoples R China.	jiandonghu@163.com	wang, tingting/AAK-2640-2020; ZHAO, YUAN/HCI-5831-2022		State Key Laboratory of Wheat and Maize Crop Science [SKL2014ZH-06]; Henan province joint funding program of the National Natural Science Foundation of China [U1304305]	State Key Laboratory of Wheat and Maize Crop Science; Henan province joint funding program of the National Natural Science Foundation of China	This research was supported by State Key Laboratory of Wheat and Maize Crop Science, Grant No. SKL2014ZH-06, and also supported by Henan province joint funding program, Grant No. U1304305 of the National Natural Science Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao H, 2012, CHEM LETT, V41, P237, DOI 10.1246/cl.2012.237; Chabot V, 2013, BIOSENS BIOELECTRON, V50, P125, DOI 10.1016/j.bios.2013.06.018; He LM, 2007, ANIM FEED SCI TECH, V132, P316, DOI 10.1016/j.anifeedsci.2006.03.013; He PL, 2009, FOOD CHEM, V112, P707, DOI 10.1016/j.foodchem.2008.05.116; Hu JD, 2012, BIOSENS BIOELECTRON, V31, P475, DOI 10.1016/j.bios.2011.11.019; Hu JD, 2009, BIOSENS BIOELECTRON, V24, P1974, DOI 10.1016/j.bios.2008.10.033; Li Y, 2014, EUR FOOD RES TECHNOL, V239, P195, DOI 10.1007/s00217-014-2201-4; Liu G, 2011, BIOSENS BIOELECTRON, V28, P308, DOI 10.1016/j.bios.2011.07.037; Lu X, 2012, FOOD CHEM, V130, P1061, DOI 10.1016/j.foodchem.2011.07.133; Nicoli R, 2013, J CHROMATOGR A, V1292, P142, DOI 10.1016/j.chroma.2012.12.008; Pleadin J, 2010, MEAT SCI, V86, P733, DOI 10.1016/j.meatsci.2010.06.013; Qiao FX, 2013, J CHROMATOGR B, V923, P136, DOI 10.1016/j.jchromb.2013.02.016; Sellos-Moura M, 2011, J IMMUNOL METHODS, V373, P45, DOI 10.1016/j.jim.2011.07.020; Shankaran DR, 2007, SENSOR ACTUAT B-CHEM, V121, P158, DOI 10.1016/j.snb.2006.09.014; Situ C, 2010, TRAC-TREND ANAL CHEM, V29, P1305, DOI 10.1016/j.trac.2010.09.003; Suzuki A, 2005, SENSOR ACTUAT B-CHEM, V106, P383, DOI 10.1016/j.snb.2004.08.021; Tomassetti M, 2013, J PHARMACEUT BIOMED, V73, P90, DOI 10.1016/j.jpba.2012.03.020; Traynor IM, 2003, ANAL CHIM ACTA, V483, P187, DOI 10.1016/S0003-2670(03)00256-3; Wu C, 2012, SENSOR ACTUAT B-CHEM, V168, P178, DOI 10.1016/j.snb.2012.03.084; Yan PP, 2014, SENSOR ACTUAT B-CHEM, V191, P508, DOI 10.1016/j.snb.2013.10.047; Yang X, 2014, SENSOR ACTUAT B-CHEM, V192, P529, DOI 10.1016/j.snb.2013.11.011; Zhang GP, 2006, J IMMUNOL METHODS, V312, P27, DOI 10.1016/j.jim.2006.02.017; Zhao C, 2011, FOOD CHEM, V129, P595, DOI 10.1016/j.foodchem.2011.04.072	23	10	11	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0122005	10.1371/journal.pone.0122005	http://dx.doi.org/10.1371/journal.pone.0122005			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799327	Green Submitted, gold, Green Published			2022-12-26	WOS:000351987300308
J	Li, LL; Li, SS; Sun, GH; Peng, RZ; Zhao, LJ; Zhong, RG				Li, Lili; Li, Sisi; Sun, Guohui; Peng, Ruizeng; Zhao, Lijiao; Zhong, Rugang			Influence of the Expression Level of O-6-Alkylguanine-DNA Alkyltransferase on the Formation of DNA Interstrand Crosslinks Induced by Chloroethylnitrosoureas in Cells: A Quantitation Using High-Performance Liquid Chromatography-Mass Spectrometry	PLOS ONE			English	Article							DENSITY-FUNCTIONAL THEORY; BLOOD-BRAIN-BARRIER; ALKYLATION PRODUCTS; O-6-METHYLGUANINE-DNA METHYLTRANSFERASE; REACTION-MECHANISM; REPAIR; RESISTANCE; AGENTS; NITROSOUREAS; GLIOMA	Chloroethylnitrosoureas (CENUs), which are bifunctional alkylating agents widely used in the clinical treatment of cancer, exert anticancer activity by inducing crosslink within a guanine-cytosine DNA base pair. However, the formation of dG-dC crosslinks can be prevented by O-6-alkylguanine-DNA alkyltransferase (AGT), ultimately leading to drug resistance. Therefore, the level of AGT expression is related to the formation of dG-dC crosslinks and the sensitivity of cells to CENUs. In this work, we determined the CENU-induced dG-dC crosslink in mouse L1210 leukemia cells and in human glioblastoma cells (SF-763, SF-767 and SF-126) containing different levels of AGT using high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry. The results indicate that nimustine (ACNU) induced more dG-dC crosslinks in L1210 leukemia cells than those induced by carmustine (BCNU), lomustine (CCNU) and fotemustine (FTMS). This result was consistent with a previously reported cohort study, which demonstrated that ACNU had a better survival gain than BCNU, CCNU and FTMS for patients with high-grade glioma. Moreover, we compared the crosslinking levels and the cytotoxicity in SF-763, SF-767 and SF-126 cells with different AGT expression levels after exposure to ACNU. The levels of dG-dC crosslink in SF-126 cells (low AGT expression) were significantly higher than those in SF-767 (medium AGT expression) and SF-763 (high AGT expression) cells at each time point. Correspondingly, the cytotoxicity of SF-126 was the highest followed by SF-767 and SF-763. The results obtained in this work provided unequivocal evidence for drug resistance to CENUs induced by AGT-mediated repair of DNA ICLs. We postulate that the level of dG-dC crosslink has the potential to be employed as a biomarker for estimating drug resistance and anticancer efficiencies of novel CENU chemotherapies.	[Li, Lili; Li, Sisi; Sun, Guohui; Peng, Ruizeng; Zhao, Lijiao; Zhong, Rugang] Beijing Univ Technol, Coll Life Sci & Bioengn, Beijing Key Lab Environm & Viral Oncol, Beijing, Peoples R China	Beijing University of Technology	Zhao, LJ (corresponding author), Beijing Univ Technol, Coll Life Sci & Bioengn, Beijing Key Lab Environm & Viral Oncol, Beijing, Peoples R China.	zhaolijiao@bjut.edu.cn		sun, guo hui/0000-0003-2259-5431	National Natural Science Foundation of China [21277001]; Beijing Municipal Education Commission Science and Technology Project [KZ201110005003]; Beijing Nova Program [2009B08]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal Education Commission Science and Technology Project; Beijing Nova Program(Beijing Municipal Science & Technology Commission)	This work was supported by grants from the National Natural Science Foundation of China (No. 21277001, http://www.nsfc.gov.cn/), the Beijing Municipal Education Commission Science and Technology Project (No. KZ201110005003, http://www.bjedu.gov.cn/) and the Beijing Nova Program (No. 2009B08, http://www.bjkw.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIDA T, 1987, CANCER RES, V47, P1361; Bai BQ, 2011, RAPID COMMUN MASS SP, V25, P2027, DOI 10.1002/rcm.5064; Baumann RP, 2004, CANCER CHEMOTH PHARM, V53, P288, DOI 10.1007/s00280-003-0739-0; BOBOLA MS, 1995, MOL CARCINOGEN, V13, P70, DOI 10.1002/mc.2940130203; Bodell WJ, 2009, J NEURO-ONCOL, V91, P257, DOI 10.1007/s11060-008-9715-1; BODELL WJ, 1985, ENVIRON HEALTH PERSP, V62, P119, DOI 10.2307/3430103; BODELL WJ, 1988, CANCER RES, V48, P4489; Bodell WJ, 2003, MUTAT RES-FUND MOL M, V522, P85, DOI 10.1016/S0027-5107(02)00262-2; BODELL WJ, 1993, CHEM RES TOXICOL, V6, P434, DOI 10.1021/tx00034a008; Bodell WJ, 1999, CHEM RES TOXICOL, V12, P965, DOI 10.1021/tx980200c; BODELL WJ, 1985, CANCER RES, V45, P3460; Cao HC, 2008, ANAL CHEM, V80, P2932, DOI 10.1021/ac7023969; Chen FX, 1996, CHEM RES TOXICOL, V9, P208, DOI 10.1021/tx950097g; DEVITA VT, 1965, CANCER RES, V25, P1876; Drablos F, 2004, DNA REPAIR, V3, P1389, DOI 10.1016/j.dnarep.2004.05.004; Dronkert MLG, 2001, MUTAT RES-DNA REPAIR, V486, P217, DOI 10.1016/S0921-8777(01)00092-1; ERICKSON LC, 1980, NATURE, V288, P727, DOI 10.1038/288727a0; Georgieva P, 2008, CHEM PHYS LETT, V463, P214, DOI 10.1016/j.cplett.2008.08.043; GERSON SL, 1995, HEMATOL ONCOL CLIN N, V9, P431, DOI 10.1016/S0889-8588(18)30103-5; Gnewuch CT, 1997, CHEM REV, V97, P829, DOI 10.1021/cr941192h; Hou QQ, 2010, J PHYS CHEM B, V114, P15296, DOI 10.1021/jp106714m; Kemper EM, 2004, CANCER TREAT REV, V30, P415, DOI 10.1016/j.ctrv.2004.04.001; Kothandapani A, 2013, MUTAT RES-FUND MOL M, V743, P44, DOI 10.1016/j.mrfmmm.2012.11.007; Lawley PD, 1996, MUTAT RES-FUND MOL M, V355, P13, DOI 10.1016/0027-5107(96)00020-6; Li LL, 2014, RAPID COMMUN MASS SP, V28, P439, DOI 10.1002/rcm.6800; Liu HL, 2010, RADIOLOGY, V255, P415, DOI 10.1148/radiol.10090699; MAGANASCHWENCKE N, 1982, P NATL ACAD SCI-BIOL, V79, P1722, DOI 10.1073/pnas.79.6.1722; MATIJASEVIC Z, 1991, CANCER RES, V51, P1568; Michaelson-Richie ED, 2011, J PROTEOME RES, V10, P2785, DOI 10.1021/pr200042u; Mouawad R, 2010, CRIT REV ONCOL HEMAT, V74, P27, DOI 10.1016/j.critrevonc.2009.08.005; PEGG AE, 1990, CANCER RES, V50, P6119; Pegg AE, 2011, CHEM RES TOXICOL, V24, P618, DOI 10.1021/tx200031q; Penketh PG, 2000, BIOCHEM PHARMACOL, V59, P283, DOI 10.1016/S0006-2952(99)00328-7; Preuss I, 1996, INT J CANCER, V65, P506, DOI 10.1002/(SICI)1097-0215(19960208)65:4<506::AID-IJC19>3.0.CO;2-7; Rajski SR, 1998, CHEM REV, V98, P2723, DOI 10.1021/cr9800199; SCHABEL FM, 1963, CANCER RES, V23, P725; SCHOLD SC, 1989, J NEUROSURG, V70, P573, DOI 10.3171/jns.1989.70.4.0573; Sugiyama SI, 2007, J NEURO-ONCOL, V82, P41, DOI 10.1007/s11060-006-9247-5; Sun GH, 2014, CHEM RES TOXICOL, V27, P1253, DOI 10.1021/tx500143b; Ueda-Kawamitsu H, 2002, BIOCHEM PHARMACOL, V63, P1209, DOI 10.1016/S0006-2952(02)00878-X; Winum JY, 2003, EUR J MED CHEM, V38, P319, DOI 10.1016/S0223-5234(03)00014-X; Wolff JEA, 2008, J NEURO-ONCOL, V88, P57, DOI 10.1007/s11060-008-9533-5; Zhao LJ, 2013, INT J QUANTUM CHEM, V113, P1299, DOI 10.1002/qua.24283; Zhao LJ, 2013, CHEM RES TOXICOL, V26, P1526, DOI 10.1021/tx400235x; Zhao LJ, 2012, J PHYS ORG CHEM, V25, P1153, DOI 10.1002/poc.2970; Zhu R, 2013, BIOORG MED CHEM LETT, V23, P1853, DOI 10.1016/j.bmcl.2013.01.016; Zhu R, 2011, J MED CHEM, V54, P7720, DOI 10.1021/jm201115f	47	5	5	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121225	10.1371/journal.pone.0121225	http://dx.doi.org/10.1371/journal.pone.0121225			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799182	Green Submitted, gold, Green Published			2022-12-26	WOS:000351987300227
J	Schauss, T; Glaeser, SP; Gutschow, A; Dott, W; Kampfer, P				Schauss, Thorsten; Glaeser, Stefanie P.; Guetschow, Alexandra; Dott, Wolfgang; Kaempfer, Peter			Improved Detection of Extended Spectrum Beta-Lactamase (ESBL)-Producing Escherichia coli in Input and Output Samples of German Biogas Plants by a Selective Pre-Enrichment Procedure	PLOS ONE			English	Article							CTX-M; COMPANION ANIMALS; MOLECULAR CHARACTERIZATION; ANAEROBIC-DIGESTION; CHROMAGAR STEC; IN-VITRO; ENTEROBACTERIACEAE; GENES; RESISTANCE; PREVALENCE	The presence of extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli was investigated in input (manure from livestock husbandry) and output samples of six German biogas plants in 2012 (one sampling per biogas plant) and two German biogas plants investigated in an annual cycle four times in 2013/2014. ESBL-producing Escherichia coli were cultured by direct plating on CHROMagar ESBL from input samples in the range of 100 to 104 colony forming units (CFU) per g dry weight but not from output sample. This initially indicated a complete elimination of ESBL-producing E. coli by the biogas plant process. Detected non target bacteria were assigned to the genera Acinetobacter, Pseudomonas, Bordetella, Achromobacter, Castellaniella, and Ochrobactrum. A selective pre-enrichment procedure increased the detection efficiency of ESBL-producing E. coli in input samples and enabled the detection in five of eight analyzed output samples. In total 119 ESBL-producing E. coli were isolated from input and 46 from output samples. Most of the E. coli isolates carried CTX-M-type and/or TEM-type beta lactamases (94%), few SHV-type beta lactamase (6%). Sixty-four blaCTX-M genes were characterized more detailed and assigned mainly to CTX-M-groups 1 (85%) and 9 (13%), and one to group 2. Phylogenetic grouping of 80 E. coli isolates showed that most were assigned to group A (71%) and B1 (27%), only one to group D (2%). Genomic fingerprinting and multilocus sequence typing (MLST) showed a high clonal diversity with 41 BOX-types and 19 ST-types. The two most common ST-types were ST410 and ST1210. Antimicrobial susceptibility testing of 46 selected ESBL-producing E. coli revealed that several isolates were additionally resistant to other veterinary relevant antibiotics and some grew on CHROMagar STEC but shiga-like toxine (SLT) genes were not detected. Resistance to carbapenems was not detected. In summary the study showed for the first time the presence of ESBL-producing E. coli in output samples of German biogas plants.	[Schauss, Thorsten; Glaeser, Stefanie P.; Guetschow, Alexandra; Kaempfer, Peter] Univ Giessen, Inst Angew Mikrobiol, D-35390 Giessen, Germany; [Dott, Wolfgang] Rhein Westfal TH Aachen, Inst Hyg & Umweltmed, D-52057 Aachen, Germany	Justus Liebig University Giessen; RWTH Aachen University	Glaeser, SP (corresponding author), Univ Giessen, Inst Angew Mikrobiol, IFZ Heinrich Buff Ring 26-32, D-35390 Giessen, Germany.	stefanie.glaeser@umwelt.uni-giessen.de; peter.kaempfer@umwelt.uni-giessen.de	Glaeser, Stefanie/ABI-5518-2020; Kampfer, Peter/P-7643-2019	Kampfer, Peter/0000-0002-7165-3418	Federal Ministry of Education and Research, Germany [02WRS1274A]	Federal Ministry of Education and Research, Germany(Federal Ministry of Education & Research (BMBF))	This study is part of the project RiskAGuA (02WRS1274A) funded by the Federal Ministry of Education and Research, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANGELIDAKI I, 1993, BIOTECHNOL BIOENG, V42, P159, DOI 10.1002/bit.260420203; [Anonymous], 2012, CLIN LAB STAND I MET; Batchelor M, 2005, ANTIMICROB AGENTS CH, V49, P1319, DOI 10.1128/AAC.49.4.1319-1322.2005; Bielaszewska M, 2007, APPL ENVIRON MICROB, V73, P3144, DOI 10.1128/AEM.02937-06; Blaak H, 2014, APPL ENVIRON MICROB, V80, P239, DOI 10.1128/AEM.02616-13; Boxall ABA, 2004, REV ENVIRON CONTAM T, V180, P1, DOI 10.1007/0-387-21729-0_1; CEBULA TA, 1995, J CLIN MICROBIOL, V33, P248, DOI 10.1128/JCM.33.1.248-250.1995; Clermont O, 2000, APPL ENVIRON MICROB, V66, P4555, DOI 10.1128/AEM.66.10.4555-4558.2000; Dobiasova H, 2013, FEMS MICROBIOL ECOL, V85, P604, DOI 10.1111/1574-6941.12149; Doumith M, 2012, J CLIN MICROBIOL, V50, P3108, DOI 10.1128/JCM.01468-12; Ewers C, 2012, CLIN MICROBIOL INFEC, V18, P646, DOI 10.1111/j.1469-0691.2012.03850.x; Ewers C, 2011, BERL MUNCH TIERARZTL, V124, P94, DOI 10.2376/0005-9366-124-94; Fischer J, 2012, J ANTIMICROB CHEMOTH, V67, P1793, DOI 10.1093/jac/dks108; Friese A, 2013, BERL MUNCH TIERARZTL, V126, P175, DOI 10.2376/0005-9366-126-175; Glaeser SP, 2013, INT J SYST EVOL MICR, V63, P3487, DOI 10.1099/ijs.0.050823-0; Gouali M, 2013, J CLIN MICROBIOL, V51, P894, DOI 10.1128/JCM.03121-12; Grimm V, 2004, J CLIN MICROBIOL, V42, P3766, DOI 10.1128/JCM.42.8.3766-3774.2004; Grohs P, 2013, J CLIN MICROBIOL, V51, P2713, DOI 10.1128/JCM.00077-13; Guenther S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050331; Hartmann A, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00083; Hernandez J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076150; Heuer H, 2011, CURR OPIN MICROBIOL, V14, P236, DOI 10.1016/j.mib.2011.04.009; Higgins CS, 2001, J ANTIMICROB CHEMOTH, V47, P745, DOI 10.1093/jac/47.6.745; Hirvonen JJ, 2012, J CLIN MICROBIOL, V50, P3586, DOI 10.1128/JCM.01754-12; Hopkins KL, 2006, INT J ANTIMICROB AG, V27, P572, DOI 10.1016/j.ijantimicag.2006.03.003; Huber H, 2013, VET MICROBIOL, V162, P992, DOI 10.1016/j.vetmic.2012.10.029; Jakobsen L, 2011, J MED MICROBIOL, V60, P1502, DOI 10.1099/jmm.0.033993-0; Kanamori H, 2011, ACTA TROP, V120, P140, DOI 10.1016/j.actatropica.2011.07.007; Kaur M, 2013, J CLIN DIAGN RES, V7, P642, DOI 10.7860/JCDR/2013/5081.2872; Kim OS, 2012, INT J SYST EVOL MICR, V62, P716, DOI 10.1099/ijs.0.038075-0; Kola A, 2012, J ANTIMICROB CHEMOTH, V67, P2631, DOI 10.1093/jac/dks295; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; Laube H, 2013, APPL ENVIRON MICROB, V79, P4815, DOI 10.1128/AEM.00856-13; Leistner R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074323; Lister PD, 2009, CLIN MICROBIOL REV, V22, P582, DOI 10.1128/CMR.00040-09; Manoharan A, 2011, INDIAN J MED MICROBI, V29, P161, DOI 10.4103/0255-0857.81799; Mellmann A, 2008, EMERG INFECT DIS, V14, P1287, DOI 10.3201/eid1408.071082; Monstein HJ, 2007, APMIS, V115, P1400, DOI 10.1111/j.1600-0463.2007.00722.x; Monteiro J, 2012, J ANTIMICROB CHEMOTH, V67, P906, DOI 10.1093/jac/dkr563; Nadjar D, 2001, ANTIMICROB AGENTS CH, V45, P2324, DOI 10.1128/AAC.45.8.2324-2330.2001; Pai H, 1999, J CLIN MICROBIOL, V37, P1758, DOI 10.1128/JCM.37.6.1758-1763.1999; Perez F, 2007, ANTIMICROB AGENTS CH, V51, P3471, DOI 10.1128/AAC.01464-06; Philipp W, 2012, GEFAHRST REINHALT L, V72, P216; Poulsen AB, 2003, J ANTIMICROB CHEMOTH, V51, P419, DOI 10.1093/jac/dkg084; Randall LP, 2009, J ANTIMICROB CHEMOTH, V63, P302, DOI 10.1093/jac/dkn485; Resende JA, 2014, BIORESOURCE TECHNOL, V153, P284, DOI 10.1016/j.biortech.2013.12.007; Rogers BA, 2011, J ANTIMICROB CHEMOTH, V66, P1, DOI 10.1093/jac/dkq415; del Castillo BR, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-84; Saito R, 2010, LETT APPL MICROBIOL, V51, P704, DOI 10.1111/j.1472-765X.2010.02945.x; Schink AK, 2011, APPL ENVIRON MICROB, V77, P7142, DOI 10.1128/AEM.00559-11; Schmid A, 2013, APPL ENVIRON MICROB, V79, P3027, DOI 10.1128/AEM.00204-13; Schmiedel J, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-187; Singh A, 2011, ASIAN PAC J TROP MED, V4, P764, DOI 10.1016/S1995-7645(11)60190-9; Snow LC, 2012, PREV VET MED, V106, P225, DOI 10.1016/j.prevetmed.2012.03.009; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tenaillon O, 2010, NAT REV MICROBIOL, V8, P207, DOI 10.1038/nrmicro2298; Tzschoppe M, 2012, INT J FOOD MICROBIOL, V152, P19, DOI 10.1016/j.ijfoodmicro.2011.10.009; Valenza G, 2014, ANTIMICROB AGENTS CH, V58, P1228, DOI 10.1128/AAC.01993-13; Versalovic James, 1994, Methods in Molecular and Cellular Biology, V5, P25; Vincent C, 2010, EMERG INFECT DIS, V16, P88, DOI 10.3201/eid1601.091118; Weiland P, 2010, APPL MICROBIOL BIOT, V85, P849, DOI 10.1007/s00253-009-2246-7; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x	62	32	32	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0119791	10.1371/journal.pone.0119791	http://dx.doi.org/10.1371/journal.pone.0119791			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799434	Green Submitted, Green Published, gold			2022-12-26	WOS:000351987300080
J	Toma, A; Takahashi, TS; Sato, Y; Yamagata, A; Goto-Ito, S; Nakada, S; Fukuto, A; Horikoshi, Y; Tashiro, S; Fukai, S				Toma, Aya; Takahashi, Tomio S.; Sato, Yusuke; Yamagata, Atsushi; Goto-Ito, Sakurako; Nakada, Shinichiro; Fukuto, Atsuhiko; Horikoshi, Yasunori; Tashiro, Satoshi; Fukai, Shuya			Structural Basis for Ubiquitin Recognition by Ubiquitin-Binding Zinc Finger of FAAP20	PLOS ONE			English	Article							63-LINKED POLYUBIQUITIN CHAINS; DNA-DAMAGE; UBZ DOMAINS; PROTEIN; KIAA1018/FAN1; NUCLEASE; COMPLEX; KAPPA; IDENTIFICATION; SPECIFICITY	Several ubiquitin-binding zinc fingers (UBZs) have been reported to preferentially bind K63-linked ubiquitin chains. In particular, the UBZ domain of FAAP20 (FAAP20-UBZ), a member of the Fanconi anemia core complex, seems to recognize K63-linked ubiquitin chains, in order to recruit the complex to DNA interstrand crosslinks and mediate DNA repair. By contrast, it is reported that the attachment of a single ubiquitin to Rev1, a translesion DNA polymerase, increases binding of Rev1 to FAAP20. To clarify the specificity of FAAP20-UBZ, we determined the crystal structure of FAAP20-UBZ in complex with K63-linked diubiquitin at 1.9 angstrom resolution. In this structure, FAAP20-UBZ interacts only with one of the two ubiquitin moieties. Consistently, binding assays using surface plasmon resonance spectrometry showed that FAAP20-UBZ binds ubiquitin and M1-, K48- and K63-linked diubiquitin chains with similar affinities. Residues in the vicinity of Ala168 within the a-helix and the C-terminal Trp180 interact with the canonical Ile44-centered hydrophobic patch of ubiquitin. Asp164 within the alpha-helix and the C-terminal loop mediate a hydrogen bond network, which reinforces ubiquitin-binding of FAAP20-UBZ. Mutations of the ubiquitin-interacting residues disrupted binding to ubiquitin in vitro and abolished the accumulation of FAAP20 to DNA damage sites in vivo. Finally, structural comparison among FAAP20-UBZ, WRNIP1-UBZ and RAD18-UBZ revealed distinct modes of ubiquitin binding. UBZ family proteins could be divided into at least three classes, according to their ubiquitin-binding modes.	[Toma, Aya; Takahashi, Tomio S.; Sato, Yusuke; Yamagata, Atsushi; Goto-Ito, Sakurako; Fukai, Shuya] Univ Tokyo, Struct Biol Lab, Div Life Sci, Synchrotron Radiat Res Org, Tokyo 1130032, Japan; [Toma, Aya; Takahashi, Tomio S.; Sato, Yusuke; Yamagata, Atsushi; Goto-Ito, Sakurako; Fukai, Shuya] Univ Tokyo, Inst Mol & Cellular Biosci, Tokyo 1130032, Japan; [Toma, Aya; Sato, Yusuke; Yamagata, Atsushi; Goto-Ito, Sakurako; Fukai, Shuya] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Chiba 2778501, Japan; [Nakada, Shinichiro] Osaka Univ, Grad Sch Med, Dept Bioregulat & Cellular Response, Osaka 5650871, Japan; [Fukuto, Atsuhiko; Horikoshi, Yasunori; Tashiro, Satoshi] Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Cellular Biol, Hiroshima 7348553, Japan	University of Tokyo; University of Tokyo; University of Tokyo; Osaka University; Hiroshima University	Fukai, S (corresponding author), Univ Tokyo, Struct Biol Lab, Div Life Sci, Synchrotron Radiat Res Org, Tokyo 1130032, Japan.	fukai@iam.u-tokyo.ac.jp	Sato, Yusuke/GPW-9280-2022; takahashi, tomio/AAL-3599-2020; Fukai, Shuya/X-4838-2018; Horikoshi, Yasunori/G-8988-2019; Takahashi, Tomio S/H-5311-2017; OsakaU/AAY-3661-2020	Sato, Yusuke/0000-0001-8495-8950; takahashi, tomio/0000-0002-9381-3881; Fukai, Shuya/0000-0002-1241-1443; Nakada, Shinichiro/0000-0001-9297-1565	MEXT; JSPS; JST CREST; Grants-in-Aid for Scientific Research [22121003] Funding Source: KAKEN	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JST CREST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from MEXT and JSPS to S.F., A.Y., Y.S., K.K., S.G.-I. and S.N., and JST CREST to S.F. This work was partly carried out at the Joint Usage/Research Center (RIRBM), Hiroshima University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali AM, 2012, BLOOD, V119, P3285, DOI 10.1182/blood-2011-10-385963; Ceregido MA, 2014, J MOL BIOL, V426, P674, DOI 10.1016/j.jmb.2013.11.006; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bienko M, 2005, SCIENCE, V310, P1821, DOI 10.1126/science.1120615; Bish RA, 2007, J BIOL CHEM, V282, P23184, DOI 10.1074/jbc.M701042200; Bomar MG, 2007, EMBO REP, V8, P247, DOI 10.1038/sj.embor.7400901; Cordier F, 2008, J MOL BIOL, V377, P1419, DOI 10.1016/j.jmb.2008.01.048; Dikic I, 2009, NAT REV MOL CELL BIO, V10, P659, DOI 10.1038/nrm2767; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Guo C, 2008, J BIOL CHEM, V283, P4658, DOI 10.1074/jbc.M709275200; Huang J, 2009, NAT CELL BIOL, V11, P592, DOI 10.1038/ncb1865; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; Kim H, 2012, NAT STRUCT MOL BIOL, V19, P164, DOI 10.1038/nsmb.2222; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Kratz K, 2010, CELL, V142, P77, DOI 10.1016/j.cell.2010.06.022; Kulathu Y, 2009, NAT STRUCT MOL BIOL, V16, P1328, DOI 10.1038/nsmb.1731; Lachaud C, 2014, J CELL SCI, V127, P2811, DOI 10.1242/jcs.146167; Lee S, 2006, NAT STRUCT MOL BIOL, V13, P264, DOI 10.1038/nsmb1064; Leung JWC, 2012, P NATL ACAD SCI USA, V109, P4491, DOI 10.1073/pnas.1118720109; MacKay C, 2010, CELL, V142, P65, DOI 10.1016/j.cell.2010.06.021; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Peisley A, 2014, NATURE, V509, P110, DOI 10.1038/nature13140; Penengo L, 2006, CELL, V124, P1183, DOI 10.1016/j.cell.2006.02.020; Plosky BS, 2006, EMBO J, V25, P2847, DOI 10.1038/sj.emboj.7601178; Rahighi S, 2009, CELL, V136, P1098, DOI 10.1016/j.cell.2009.03.007; Rizzo AA, 2014, BIOCHEMISTRY-US, V53, P5895, DOI 10.1021/bi500823h; Sato Y, 2008, NATURE, V455, P358, DOI 10.1038/nature07254; Sato Y, 2011, P NATL ACAD SCI USA, V108, P20520, DOI 10.1073/pnas.1109088108; Sato Y, 2009, EMBO J, V28, P3903, DOI 10.1038/emboj.2009.345; Sato Y, 2009, EMBO J, V28, P2461, DOI 10.1038/emboj.2009.160; Shereda RD, 2010, CELL CYCLE, V9, P3977, DOI 10.4161/cc.9.19.13207; Smogorzewska A, 2007, CELL, V129, P289, DOI 10.1016/j.cell.2007.03.009; Smogorzewska A, 2010, MOL CELL, V39, P36, DOI 10.1016/j.molcel.2010.06.023; Swanson KA, 2003, EMBO J, V22, P4597, DOI 10.1093/emboj/cdg471; Tashiro S, 2000, J CELL BIOL, V150, P283, DOI 10.1083/jcb.150.2.283; Tokunaga F, 2012, EMBO J, V31, P3856, DOI 10.1038/emboj.2012.241; Williams SA, 2011, BLOOD, V117, P5078, DOI 10.1182/blood-2010-10-311761; Yan ZJ, 2012, MOL CELL, V47, P61, DOI 10.1016/j.molcel.2012.05.026	39	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120887	10.1371/journal.pone.0120887	http://dx.doi.org/10.1371/journal.pone.0120887			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799058	Green Published, gold, Green Submitted			2022-12-26	WOS:000351987300186
J	Venardos, K; De Jong, KA; Elkamie, M; Connor, T; Mcgee, SL				Venardos, Kylie; De Jong, Kirstie A.; Elkamie, Mansour; Connor, Timothy; Mcgee, Sean L.			The PKD Inhibitor CID755673 Enhances Cardiac Function in Diabetic db/db Mice	PLOS ONE			English	Article							PROTEIN-KINASE-D; D ACTIVATION; TRANSCRIPTION; EXPRESSION; MOUSE; DEATH; HEART	The development of diabetic cardiomyopathy is a key contributor to heart failure and mortality in obesity and type 2 diabetes (T2D). Current therapeutic interventions for T2D have limited impact on the development of diabetic cardiomyopathy. Clearly, new therapies are urgently needed. A potential therapeutic target is protein kinase D (PKD), which is activated by metabolic insults and implicated in the regulation of cardiac metabolism, contractility and hypertrophy. We therefore hypothesised that PKD inhibition would enhance cardiac function in T2D mice. We first validated the obese and T2D db/db mouse as a model of early stage diabetic cardiomyopathy, which was characterised by both diastolic and systolic dysfunction, without overt alterations in left ventricular morphology. These functional characteristics were also associated with increased PKD2 phosphorylation in the fed state and a gene expression signature characteristic of PKD activation. Acute administration of the PKD inhibitor CID755673 to normal mice reduced both PKD1 and 2 phosphorylation in a time and dose-dependent manner. Chronic CID755673 administration to T2D db/db mice for two weeks reduced expression of the gene expression signature of PKD activation, enhanced indices of both diastolic and systolic left ventricular function and was associated with reduced heart weight. These alterations in cardiac function were independent of changes in glucose homeostasis, insulin action and body composition. These findings suggest that PKD inhibition could be an effective strategy to enhance heart function in obese and diabetic patients and provide an impetus for further mechanistic investigations into the role of PKD in diabetic cardiomyopathy.	[Venardos, Kylie; De Jong, Kirstie A.; Elkamie, Mansour; Connor, Timothy; Mcgee, Sean L.] Deakin Univ, Sch Med, Metab Res Unit, Metab Remodelling Lab, Waurn Ponds, Vic, Australia; [Mcgee, Sean L.] Baker IDI Heart & Diabet Inst, Program Metab & Inflammat, Melbourne, Vic, Australia	Deakin University; Baker Heart and Diabetes Institute	Mcgee, SL (corresponding author), Deakin Univ, Sch Med, Metab Res Unit, Metab Remodelling Lab, Waurn Ponds, Vic, Australia.	sean.mcgee@deakin.edu.au	Venardos, kylie/AAH-3234-2019	Venardos, kylie/0000-0002-1714-5594	Deakin University Molecular and Medical Research Strategic Research Centre; NHMRC Career Development Fellowship [APP1030474]	Deakin University Molecular and Medical Research Strategic Research Centre; NHMRC Career Development Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This study was supported by grants from the Deakin University Molecular and Medical Research Strategic Research Centre. SLM is supported by a NHMRC Career Development Fellowship (APP1030474). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belke Darrell D, 2012, Methods Mol Biol, V933, P47, DOI 10.1007/978-1-62703-068-7_4; Bossuyt J, 2011, J BIOL CHEM, V286, P33390, DOI 10.1074/jbc.M111.246447; Cuello F, 2007, CIRC RES, V100, P864, DOI 10.1161/01.RES.0000260809.15393.fa; Dirkx E, 2012, J BIOL CHEM, V287, P5871, DOI 10.1074/jbc.M111.281881; El Messaoudi S, 2011, CURR OPIN LIPIDOL, V22, P445, DOI 10.1097/MOL.0b013e32834ae1a7; Fillmore N, 2014, BRIT J PHARMACOL, V171, P2080, DOI 10.1111/bph.12475; Fillmore N, 2013, BR J PHARM; Forcheron F, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-16; Geiss LS, 1995, DIABETES IN AMERICA, P233; Guo JF, 2011, J BIOL CHEM, V286, P6500, DOI 10.1074/jbc.M110.208058; Huang HY, 2013, J MOL CELL CARDIOL, V59, P151, DOI 10.1016/j.yjmcc.2013.03.007; Huck B, 2014, J BIOL CHEM, V289, P3138, DOI 10.1074/jbc.M113.502633; HUMMEL KP, 1972, BIOCHEM GENET, V7, P1, DOI 10.1007/BF00487005; Iglesias T, 1999, FEBS LETT, V454, P53, DOI 10.1016/S0014-5793(99)00772-3; Iglesias T, 1998, J BIOL CHEM, V273, P27662, DOI 10.1074/jbc.273.42.27662; Isfort M, 2014, HEART FAIL REV, V19, P35, DOI 10.1007/s10741-013-9377-8; Kim MS, 2008, CIRC RES, V103, P252, DOI 10.1161/CIRCRESAHA.108.178681; LaValle Courtney R., 2010, BMC Chemical Biology, V10, P5, DOI 10.1186/1472-6769-10-5; Matthews SA, 1999, J BIOL CHEM, V274, P26543, DOI 10.1074/jbc.274.37.26543; Mcgee SL, 2008, DIABETES, V57, P860, DOI 10.2337/db07-0843; McGee SL, 2014, FASEB J, V28, P3384, DOI 10.1096/fj.14-249359; Minamisawa S, 1999, CELL, V99, P313, DOI 10.1016/S0092-8674(00)81662-1; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Rozengurt E, 2011, PHYSIOLOGY, V26, P23, DOI 10.1152/physiol.00037.2010; Sharlow ER, 2008, J BIOL CHEM, V283, P33516, DOI 10.1074/jbc.M805358200; Steinbusch LKM, 2013, J MOL CELL CARDIOL, V55, P165, DOI 10.1016/j.yjmcc.2012.11.005; TROY BL, 1972, CIRCULATION, V45, P602, DOI 10.1161/01.CIR.45.3.602; Vega RB, 2004, MOL CELL BIOL, V24, P8374, DOI 10.1128/MCB.24.19.8374-8385.2004; Xiang SY, 2011, J CLIN INVEST, V121, P3269, DOI 10.1172/JCI44371; Xie ZL, 2011, DIABETES, V60, P1770, DOI 10.2337/db10-0351; Yuan JZ, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00060	31	23	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120934	10.1371/journal.pone.0120934	http://dx.doi.org/10.1371/journal.pone.0120934			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798941	Green Published, Green Submitted, gold			2022-12-26	WOS:000351987300195
J	Zobay, O; Palmer, AR; Hall, DA; Sereda, M; Adjamian, P				Zobay, Oliver; Palmer, Alan R.; Hall, Deborah A.; Sereda, Magdalena; Adjamian, Peyman			Source Space Estimation of Oscillatory Power and Brain Connectivity in Tinnitus	PLOS ONE			English	Article							RESIDUAL INHIBITION FUNCTIONS; FUNCTIONAL CONNECTIVITY; NEURAL ACTIVITY; WORKING-MEMORY; EEG-DATA; MEG; GENERATION; NETWORKS; PERCEPTION; MECHANISMS	Tinnitus is the perception of an internally generated sound that is postulated to emerge as a result of structural and functional changes in the brain. However, the precise pathophysiology of tinnitus remains unknown. Llinas' thalamocortical dysrhythmia model suggests that neural deafferentation due to hearing loss causes a dysregulation of coherent activity between thalamus and auditory cortex. This leads to a pathological coupling of theta and gamma oscillatory activity in the resting state, localised to the auditory cortex where normally alpha oscillations should occur. Numerous studies also suggest that tinnitus perception relies on the interplay between auditory and non-auditory brain areas. According to the Global Brain Model, a network of global fronto-parietal-cingulate areas is important in the generation and maintenance of the conscious perception of tinnitus. Thus, the distress experienced by many individuals with tinnitus is related to the top-down influence of this global network on auditory areas. In this magnetoencephalographic study, we compare resting-state oscillatory activity of tinnitus participants and normal-hearing controls to examine effects on spectral power as well as functional and effective connectivity. The analysis is based on beamformer source projection and an atlas-based region-of-interest approach. We find increased functional connectivity within the auditory cortices in the alpha band. A significant increase is also found for the effective connectivity from a global brain network to the auditory cortices in the alpha and beta bands. We do not find evidence of effects on spectral power. Overall, our results provide only limited support for the thalamocortical dysrhythmia and Global Brain models of tinnitus.	[Zobay, Oliver; Palmer, Alan R.; Adjamian, Peyman] MRC Inst Hearing Res, Nottingham, England; [Hall, Deborah A.; Sereda, Magdalena] Natl Inst Hlth Res NIHR Nottingham Hearing Biomed, Nottingham, England; [Hall, Deborah A.; Sereda, Magdalena] Univ Nottingham, Sch Med, Div Clin Neurosci, Otol & Hearing Grp, Nottingham, England	University of Nottingham	Adjamian, P (corresponding author), MRC Inst Hearing Res, Univ Pk, Nottingham, England.	peyman@ihr.mrc.ac.uk		Hall, Deborah/0000-0002-3804-1452; Zobay, Oliver/0000-0002-0229-0668; Palmer, Alan/0000-0001-5893-4525; Sereda, Magdalena/0000-0002-2792-8496; Adjamian, Peyman/0000-0002-3796-380X	Medical Research Council in the UK; MRC [MC_U135097129, MC_U135097126] Funding Source: UKRI; Medical Research Council [MC_U135097126, MC_U135097129] Funding Source: researchfish	Medical Research Council in the UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Funding: This study was entirely funded by the Medical Research Council in the UK.	Adamchic I, 2014, HUM BRAIN MAPP, V35, P2099, DOI 10.1002/hbm.22314; Adjamian P, 2004, CLIN NEUROPHYSIOL, V115, P691, DOI 10.1016/j.clinph.2003.10.023; Adjamian P, 2009, J NEUROSCI METH, V178, P120, DOI 10.1016/j.jneumeth.2008.12.006; Adjamian P, 2012, JARO-J ASSOC RES OTO, V13, P715, DOI 10.1007/s10162-012-0340-5; Adjamian P, 2009, HEARING RES, V253, P15, DOI 10.1016/j.heares.2009.04.001; Anderson MJ, 2001, AUST NZ J STAT, V43, P75, DOI 10.1111/1467-842X.00156; Ashton H, 2007, NEUROSCI LETT, V426, P23, DOI 10.1016/j.neulet.2007.08.034; Baccala LA, 2001, BIOL CYBERN, V84, P463, DOI 10.1007/PL00007990; Bressler SL, 2010, TRENDS COGN SCI, V14, P277, DOI 10.1016/j.tics.2010.04.004; Brookes MJ, 2008, NEUROIMAGE, V39, P1788, DOI 10.1016/j.neuroimage.2007.09.050; Burton H, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-3; Davis A., 2000, TINNITUS HDB, P1; De Ridder D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024273; De Ridder D, 2011, TEXTBOOK OF TINNITUS, P171, DOI 10.1007/978-1-60761-145-5_21; Dehaene S, 2006, TRENDS COGN SCI, V10, P204, DOI 10.1016/j.tics.2006.03.007; Eggermont JJ, 2004, TRENDS NEUROSCI, V27, P676, DOI 10.1016/j.tins.2004.08.010; Friston KJ, 2011, BRAIN CONNECT, V1, P13, DOI 10.1089/brain.2011.0008; Goebel G, 1998, TINNITUS FRAGEBOGEN; Hillebrand A, 2012, NEUROIMAGE, V59, P3909, DOI 10.1016/j.neuroimage.2011.11.005; Horwitz B, 2003, NEUROIMAGE, V19, P466, DOI 10.1016/S1053-8119(03)00112-5; Husain FT, 2014, HEARING RES, V307, P153, DOI 10.1016/j.heares.2013.07.010; Hyvarinen A, 2000, NEURAL NETWORKS, V13, P411, DOI 10.1016/S0893-6080(00)00026-5; JASTREBOFF PJ, 1990, NEUROSCI RES, V8, P221, DOI 10.1016/0168-0102(90)90031-9; Khalfa S, 2002, ORL-J OTO-RHIN-LARYN, V64, P436, DOI 10.1159/000067570; Lachaux JP, 1999, HUM BRAIN MAPP, V8, P194, DOI 10.1002/(SICI)1097-0193(1999)8:4<194::AID-HBM4>3.0.CO;2-C; Lehtela L, 1997, NEUROSCI LETT, V222, P111, DOI 10.1016/S0304-3940(97)13361-4; Llinas R, 2005, TRENDS NEUROSCI, V28, P325, DOI 10.1016/j.tins.2005.04.006; Llinas RR, 1999, P NATL ACAD SCI USA, V96, P15222, DOI 10.1073/pnas.96.26.15222; Lockwood AH, 2001, NEUROLOGY, V56, P472, DOI 10.1212/WNL.56.4.472; Lorenz I, 2009, NEUROSCI LETT, V453, P225, DOI 10.1016/j.neulet.2009.02.028; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; Maudoux A, 2012, BRAIN RES, V1485, P10, DOI 10.1016/j.brainres.2012.05.006; Mazaheri A, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00177; McCombe A, 2001, CLIN OTOLARYNGOL, V26, P388, DOI 10.1046/j.1365-2273.2001.00490.x; Moazami-Goudarzi M, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-40; Moller AR, 2011, TEXTBOOK OF TINNITUS, P29, DOI 10.1007/978-1-60761-145-5_5; Newman CW, 1996, ARCH OTOLARYNGOL, V122, P143; Nolte G, 2004, CLIN NEUROPHYSIOL, V115, P2292, DOI 10.1016/j.clinph.2004.04.029; Norena AJ, 2013, HEARING RES, V295, P161, DOI 10.1016/j.heares.2012.09.010; Norena AJ, 2011, NEUROSCI BIOBEHAV R, V35, P1089, DOI 10.1016/j.neubiorev.2010.11.003; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Pierce KJ, 2012, J CLIN EXP NEUROPSYC, V34, P126, DOI 10.1080/13803395.2011.623120; Roberts LE, 2008, JARO-J ASSOC RES OTO, V9, P417, DOI 10.1007/s10162-008-0136-9; Roberts LE, 2006, ACTA OTO-LARYNGOL, V126, P27, DOI 10.1080/03655230600895358; Roberts LE, 2013, NEUROSCI BIOBEHAV R, V37, P1754, DOI 10.1016/j.neubiorev.2013.07.007; Rossiter S, 2006, J SPEECH LANG HEAR R, V49, P150, DOI 10.1044/1092-4388(2006/012); Schaette R, 2011, J NEUROSCI, V31, P13452, DOI 10.1523/JNEUROSCI.2156-11.2011; Schlee W, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-16; Schlee W, 2011, TEXTBOOK OF TINNITUS, P161, DOI 10.1007/978-1-60761-145-5_20; Schlee W, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-80; Schlee W, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-11; Schlee W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003720; Schoffelen JM, 2009, HUM BRAIN MAPP, V30, P1857, DOI 10.1002/hbm.20745; Sekihara K, 2008, SER BIOMED ENG, P1; Sereda M, 2011, INT J AUDIOL, V50, P303, DOI 10.3109/14992027.2010.551221; Shulman Abraham, 2002, Int Tinnitus J, V8, P77; Song JJ, 2013, NEUROBIOL AGING, V34, P1853, DOI 10.1016/j.neurobiolaging.2013.01.014; Spaak E, 2012, CURR BIOL, V22, P2313, DOI 10.1016/j.cub.2012.10.020; Ueyama T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067778; van der Loo E, 2011, AUTON NEUROSCI-BASIC, V165, P191, DOI 10.1016/j.autneu.2011.06.007; van Dijk H, 2010, EUR J NEUROSCI, V31, P1701, DOI 10.1111/j.1460-9568.2010.07227.x; Vanneste S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059728; VanVeen BD, 1997, IEEE T BIO-MED ENG, V44, P867, DOI 10.1109/10.623056; Vidaurre C, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/935364; Vrba J, 2001, METHODS, V25, P249, DOI 10.1006/meth.2001.1238; Weiler Elmar W J, 2004, Int Tinnitus J, V10, P127; Weisz N, 2005, PLOS MED, V2, P546, DOI 10.1371/journal.pmed.0020153; Weisz N, 2007, J NEUROSCI, V27, P1479, DOI 10.1523/JNEUROSCI.3711-06.2007	70	29	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120123	10.1371/journal.pone.0120123	http://dx.doi.org/10.1371/journal.pone.0120123			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799178	Green Published, Green Submitted, gold			2022-12-26	WOS:000351987300107
J	Falcone-Dias, MF; Centron, D; Pavan, F; Moura, ACDS; Naveca, FG; de Souza, VC; Farache, A; Leite, CQF				Falcone-Dias, Maria Fernanda; Centron, Daniela; Pavan, Fernando; da Silva Moura, Adriana Candido; Naveca, Felipe Gomes; de Souza, Victor Costa; Farache Filho, Adalberto; Fujimura Leite, Clarice Queico			Opportunistic Pathogens and Elements of the Resistome that Are Common in Bottled Mineral Water Support the Need for Continuous Surveillance	PLOS ONE			English	Article							HETEROTROPHIC PLATE-COUNT; BURKHOLDERIA-CEPACIA COMPLEX; ANTIBIOTIC-RESISTANCE; RALSTONIA-PICKETTII; POTENTIAL SOURCE; DRINKING-WATER; BACTERIA; POPULATIONS; DIVERSITY; QUALITY	Several differences concerning bacterial species, opportunistic pathogens, elements of the resistome as well as variations concerning the CFU/mL counts were identified in some of the five most marketed bottled mineral water from Araraquara city, Sao Paulo, Brazil. Two out of five brands tested were confirmed as potential source of opportunistic pathogens, including Mycobacterium gordonae, Ralstonia picketti and Burkholderia cepacia complex (Bcc). A total of one hundred and six isolates were recovered from four of these bottled mineral water brands. Betaproteobacteria was predominant followed by Alphaproteobacteria, Gammaproteobacteria and Firmicutes. Ninety percent of the bacteria isolated demonstrated resistance to seventeen of the nineteen antimicrobials tested. These antimicrobials included eight different classes, including 3rd and 4th generation cephalosporins, carbapenems and fluoroquinolones. Multidrug resistant bacteria were detected for fifty-nine percent of isolates in three water brands at counts up to 103 CFU/ml. Of major concern, the two bottled mineral water harboring opportunistic pathogens were also source of elements of the resistome that could be directly transferred to humans. All these differences found among brands highlight the need for continuous bacteriological surveillance of bottled mineral water.	[Falcone-Dias, Maria Fernanda; Pavan, Fernando; da Silva Moura, Adriana Candido; Farache Filho, Adalberto; Fujimura Leite, Clarice Queico] Univ Estadual Paulista, Sch Pharmaceut Sci, Araraquara, SP, Brazil; [Falcone-Dias, Maria Fernanda; Centron, Daniela] Univ Buenos Aires, Fac Med, Dept Microbiol, Buenos Aires, DF, Argentina; [Naveca, Felipe Gomes; de Souza, Victor Costa] Fiocruz MS, ILMD, Manaus, Amazonas, Brazil	Universidade Estadual Paulista; University of Buenos Aires; Fundacao Oswaldo Cruz	Falcone-Dias, MF (corresponding author), Univ Estadual Paulista, Sch Pharmaceut Sci, Araraquara, SP, Brazil.	mariafernandafdias@hotmail.com	Falcone-Dias, Maria Fernanda/D-9583-2012; Pavan, Fernando Rogério/F-6046-2010; Fernandes, Guilherme/HHT-1055-2022; Naveca, Felipe/H-1130-2012	Falcone-Dias, Maria Fernanda/0000-0002-5836-5112; Pavan, Fernando Rogério/0000-0002-6969-3963; Naveca, Felipe/0000-0002-2888-1060; Souza, Victor Costa de/0000-0002-3869-1519; Centron, Daniela/0000-0001-9308-3762	CAPES [18207/12-0]; Programa Recem-Doutor, Pro-Reitoria de Pesquisa/UNESP-Univ Estadual Paulista [05/2012]	CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Programa Recem-Doutor, Pro-Reitoria de Pesquisa/UNESP-Univ Estadual Paulista	This work has been partially supported by the Brazilian agency CAPES (http://www.capes.gov.br); CAPES, Scholarship Grant #18207/12-0 to MFFD; Programa Recem-Doutor (05/2012), Pro-Reitoria de Pesquisa/UNESP-Univ Estadual Paulista, Scholarship to MFFD (http://www.unesp.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed W, 2014, WATER RES, V53, P361, DOI 10.1016/j.watres.2013.12.021; Baquero F, 2008, CURR OPIN BIOTECH, V19, P260, DOI 10.1016/j.copbio.2008.05.006; BISCHOFBERGER T, 1990, INT J FOOD MICROBIOL, V11, P51, DOI 10.1016/0168-1605(90)90039-8; Burns JL, 1998, CLIN INFECT DIS, V27, P158, DOI 10.1086/514631; Carlet J, 2011, LANCET, V378, P369, DOI 10.1016/S0140-6736(11)60401-7; CAROLI G, 1985, J APPL BACTERIOL, V58, P461, DOI 10.1111/j.1365-2672.1985.tb01486.x; Casanovas-Massana A, 2012, INT J FOOD MICROBIOL, V153, P38, DOI 10.1016/j.ijfoodmicro.2011.10.012; Clinical and Laboratory Standards Institute, 2011, M100S21 CLSI; Codex Alimentarius Commission, 1081981 COD AL COMM; D'Costa VM, 2011, NATURE, V477, P457, DOI 10.1038/nature10388; D'Costa VM, 2006, SCIENCE, V311, P374, DOI 10.1126/science.1120800; Dantas G, 2008, SCIENCE, V320, P100, DOI 10.1126/science.1155157; Eckburg PB, 2000, CHEST, V117, P96, DOI 10.1378/chest.117.1.96; Falcone-Dias MF, 2013, FOOD CONTROL, V31, P90, DOI 10.1016/j.foodcont.2012.09.038; Falcone-Dias MF, 2012, WATER RES, V46, P3612, DOI 10.1016/j.watres.2012.04.007; Ferreira AC, 1996, J APPL BACTERIOL, V80, P479, DOI 10.1111/j.1365-2672.1996.tb03246.x; Finley RL, 2013, CLIN INFECT DIS, V57, P704, DOI 10.1093/cid/cit355; Griffith DE, 2007, AM J RESP CRIT CARE, V175, P367, DOI 10.1164/rccm.200604-571ST; Jorda-Vargas L, 2008, J CLIN MICROBIOL, V46, P1151, DOI 10.1128/JCM.01595-07; LEAO S. C, 2004, PRACTICAL HDB PHENOT; Leclerc H, 2002, FEMS MICROBIOL REV, V26, P207, DOI [10.1111/j.1574-6976.2002.tb00611.x, 10.1016/S0168-6445(02)00097-9]; Lis J T, 1980, Methods Enzymol, V65, P347; Loy A, 2005, APPL ENVIRON MICROB, V71, P3624, DOI 10.1128/AEM.71.7.3624-3632.2005; Mahenthiralingam E, 2014, PAEDIATR RESPIR REV, V15, P13, DOI 10.1016/j.prrv.2014.04.006; Messi P, 2005, SCI TOTAL ENVIRON, V346, P213, DOI 10.1016/j.scitotenv.2004.12.005; MORAIS PV, 1990, J APPL BACTERIOL, V69, P750, DOI 10.1111/j.1365-2672.1990.tb01572.x; Moreira BM, 2005, J HOSP INFECT, V60, P51, DOI 10.1016/j.jhin.2004.09.036; Nardelli M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039223; Naveca FG, 2012, J VIROL, V86, P1897, DOI 10.1128/JVI.06731-11; Otterholt E, 2011, INT J FOOD MICROBIOL, V144, P455, DOI 10.1016/j.ijfoodmicro.2010.10.034; PAITHANKAR KR, 1991, NUCLEIC ACIDS RES, V19, P1346, DOI 10.1093/nar/19.6.1346; Papapetropoulou M, 1997, CAN J MICROBIOL, V43, P499, DOI 10.1139/m97-071; Pavlov D, 2004, INT J FOOD MICROBIOL, V92, P275, DOI 10.1016/j.ijfoodmicro.2003.08.018; Rosenberg F. A., 2003, Clinical Microbiology Newsletter, V25, P41, DOI 10.1016/S0196-4399(03)80019-3; Ryan MP, 2006, J HOSP INFECT, V62, P278, DOI 10.1016/j.jhin.2005.08.015; Sartory DP, 2004, INT J FOOD MICROBIOL, V92, P297, DOI 10.1016/j.ijfoodmicro.2003.08.006; Thomson R, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-241; Varga L, 2011, FOOD CONTROL, V22, P591, DOI 10.1016/j.foodcont.2010.10.009; Wallace RJ, 1998, ANNU REV MICROBIOL, V52, P453, DOI 10.1146/annurev.micro.52.1.453; Wright GD, 2010, CURR OPIN MICROBIOL, V13, P589, DOI 10.1016/j.mib.2010.08.005	40	5	5	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0121284	10.1371/journal.pone.0121284	http://dx.doi.org/10.1371/journal.pone.0121284			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803794	gold, Green Published, Green Submitted			2022-12-26	WOS:000353889600144
J	Li, TH; Chang, CC; Cheng, IJ; Lin, SC				Li, Tsung-Hsien; Chang, Chao-Chin; Cheng, I-Jiunn; Lin, Suen-Chuain			Development of a Summarized Health Index (SHI) for Use in Predicting Survival in Sea Turtles	PLOS ONE			English	Article							CARETTA-CARETTA; CYTOCHEMICAL CHARACTERISTICS; DERMOCHELYS-CORIACEA; PLASMA BIOCHEMISTRY; CHELONIA-MYDAS; BLOOD VALUES; HEMATOLOGY; CHEMISTRY; JUVENILE; COAST	Veterinary care plays an influential role in sea turtle rehabilitation, especially in endangered species. Physiological characteristics, hematological and plasma biochemistry profiles, are useful references for clinical management in animals, especially when animals are during the convalescence period. In this study, these factors associated with sea turtle surviving were analyzed. The blood samples were collected when sea turtles remained alive, and then animals were followed up for surviving status. The results indicated that significantly negative correlation was found between buoyancy disorders (BD) and sea turtle surviving (p < 0.05). Furthermore, non-surviving sea turtles had significantly higher levels of aspartate aminotranspherase (AST), creatinine kinase (CK), creatinine and uric acid (UA) than surviving sea turtles (all p < 0.05). After further analysis by multiple logistic regression model, only factors of BD, creatinine and UA were included in the equation for calculating summarized health index (SHI) for each individual. Through evaluation by receiver operating characteristic (ROC) curve, the result indicated that the area under curve was 0.920 +/- 0.037, and a cut-off SHI value of 2.5244 showed 80.0% sensitivity and 86.7% specificity in predicting survival. Therefore, the developed SHI could be a useful index to evaluate health status of sea turtles and to improve veterinary care at rehabilitation facilities.	[Li, Tsung-Hsien] Natl Museum Marine Biol & Aquarium, Checheng 94450, Pingtung, Taiwan; [Li, Tsung-Hsien; Chang, Chao-Chin] Natl Chung Hsing Univ, Grad Inst Microbiol & Publ Hlth, Taichung 40227, Taiwan; [Cheng, I-Jiunn] Natl Taiwan Ocean Univ, Inst Marine Biol, Keelung 20224, Taiwan; [Lin, Suen-Chuain] Natl Pingtung Univ Sci & Technol, Dept Vet Med, Pingtung 91201, Taiwan	National Museum of Marine Biology & Aquarium; National Chung Hsing University; National Taiwan Ocean University; National Pingtung University Science & Technology	Chang, CC (corresponding author), Natl Chung Hsing Univ, Grad Inst Microbiol & Publ Hlth, Taichung 40227, Taiwan.	changcc@dragon.nchu.edu.tw		Chang, Chao-chin/0000-0002-6299-9214; Li, Tsung-Hsien/0000-0002-2447-2382				Anderson ET, 2011, J ZOO WILDLIFE MED, V42, P247, DOI 10.1638/2010-0217.1; Caliendo Valentina, 2010, Journal of Herpetological Medicine and Surgery, V20, P117, DOI 10.5818/1529-9651-20.4.117; Camacho M, 2013, SCI TOTAL ENVIRON, V458, P283, DOI 10.1016/j.scitotenv.2013.04.043; Camacho M, 2013, JAVMA-J AM VET MED A, V242, P396, DOI 10.2460/javma.242.3.396; Campbell T., 2006, REPTILE MED SURG, P453, DOI 10.1016/B0-72-169327-X/50032-8; Casal AB, 2007, RES VET SCI, V82, P158, DOI 10.1016/j.rvsc.2006.07.017; Casal AB, 2009, VET CLIN PATH, V38, P213, DOI 10.1111/j.1939-165X.2008.00106.x; Chen HC, 2012, J PARASITOL, V98, P437, DOI 10.1645/GE-2875.1; Day RD, 2010, J WILDLIFE DIS, V46, P111, DOI 10.7589/0090-3558-46.1.111; Deem SL, 2006, J ZOO WILDLIFE MED, V37, P464, DOI 10.1638/05-102.1; Deem SL, 2009, J WILDLIFE DIS, V45, P41, DOI 10.7589/0090-3558-45.1.41; Delgado C, 2011, J WILDLIFE DIS, V47, P523, DOI 10.7589/0090-3558-47.3.523; Flint M, 2010, J WILDLIFE DIS, V46, P731, DOI 10.7589/0090-3558-46.3.731; Flint M, 2010, ECOHEALTH, V7, P135, DOI 10.1007/s10393-010-0300-7; Fong ChiaLing, 2010, Journal of Veterinary Medicine and Animal Health, V2, P008; Goldberg DW, 2013, CONSERV PHYSIOL, V1, DOI 10.1093/conphys/cot016; Harris HS, 2011, J WILDLIFE DIS, V47, P321, DOI 10.7589/0090-3558-47.2.321; Honarvar S, 2011, HERPETOLOGICA, V67, P222, DOI 10.1655/HERPETOLOGICA-D-10-00061.1; Innis CJ, 2009, JAVMA-J AM VET MED A, V235, P426, DOI 10.2460/javma.235.4.426; Jacob F, 2005, JAVMA-J AM VET MED A, V226, P393, DOI 10.2460/javma.2005.226.393; Keller KA, 2012, JAVMA-J AM VET MED A, V240, P317, DOI 10.2460/javma.240.3.317; King R, 2013, J EXP MAR BIOL ECOL, V445, P140, DOI 10.1016/j.jembe.2013.03.016; Knotek Z, 2002, ACTA VET BRNO, V71, P333, DOI 10.2754/avb200271030333; Lewbart GA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096487; LUTCAVAGE ME, 1995, ARCH ENVIRON CON TOX, V28, P417; McLeland SM, 2014, J VET INTERN MED, V28, P827, DOI 10.1111/jvim.12342; Perrault JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031841; Rousselet E, 2013, J ZOO WILDLIFE MED, V44, P859, DOI 10.1638/2012-0162R1.1; Santoro M, 2007, VET REC, V161, P818; Schmitt TL, 2013, J ZOO WILDLIFE MED, V44, P645, DOI 10.1638/2012-0210R.1; Stamper MA, 2005, J ZOO WILDLIFE MED, V36, P635, DOI 10.1638/04-074.1; Swimmer JY, 2000, J WILDLIFE DIS, V36, P102, DOI 10.7589/0090-3558-36.1.102; Whiting Scott D., 2007, Comparative Clinical Pathology, V16, P109, DOI 10.1007/s00580-006-0646-y; Wolf KN, 2008, JAVMA-J AM VET MED A, V233, P470, DOI 10.2460/javma.233.3.470; Work TM, 1998, AM J VET RES, V59, P1252; Wyneken JE., 2006, REPTILE MED SURG, P972	36	11	12	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0120796	10.1371/journal.pone.0120796	http://dx.doi.org/10.1371/journal.pone.0120796			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803431	Green Submitted, gold, Green Published			2022-12-26	WOS:000353889600099
J	Siddappa, D; Beaulieu, E; Gevry, N; Roux, PP; Bordignon, V; Duggavathi, R				Siddappa, Dayananda; Beaulieu, Elaine; Gevry, Nicolas; Roux, Philippe P.; Bordignon, Vilceu; Duggavathi, Raj			Effect of the Transient Pharmacological Inhibition of Mapk3/1 Pathway on Ovulation in Mice	PLOS ONE			English	Article							SIGNAL-REGULATED KINASE; OVARIAN GRANULOSA-CELLS; RESPONSE FACTOR-I; MEK INHIBITORS; GROWTH-FACTORS; CORPUS-LUTEUM; GENE; TRANSCRIPTION; GONADOTROPIN; ACTIVATION	Mitogen-activated protein kinase 3/1 (Mapk3/1) pathway is critical for LH signal transduction during ovulation. However, the mechanisms remain incompletely understood. We hypothesized that Mapk pathway regulates ovulation through transcriptional regulation of ovulatory genes. To test this hypothesis we used immature mice superovulated with equine and human chorionic gonadotropins (eCG and hCG) and PD0325901, to inhibit hCG-induced Mapk3/1 activity. Mice received either the inhibitor PD0325901 (25 mu g/g, i.p.) or vehicle at 2h before hCG stimulation. Administration of the inhibitor abolished Mapk3/1 phosphorylation in granulosa cells. While vehicle-treated mice ovulated normally, there were no ovulations in inhibitor-treated mice. First, we analyzed gene expression in granulosa cells at 0h, 1h and 4h post-hCG. There was expected hCG-driven increase in mRNA abundance of many ovulation-related genes including Ptgs2 in vehicle-treated granulosa cells, but not (P<0.05) in inhibitor-treated group. There was also reduced mRNA and protein abundance of the transcription factor, early growth response 1 (Egr1) in inhibitor-treated granulosa cells. We then used GRMO2 cell-line to test if Egr1 is recruited to promoter of Ptgs2 followed by chromatin immunoprecipitation with either Egr1 or control antibody. Enrichment of the promoter regions in immunoprecipitants of Egr1 antibody indicated that Egr1 binds to the Ptgs2 promoter. We then knocked down Egr1 expression in mouse primary granulosa cells using siRNA technology. Treatment with Egr1-siRNA inhibited Egr1 transcript accumulation, which was associated with reduced expression of Ptgs2 when compared to control-siRNA treated granulosa cells. These data demonstrate that transient inhibition of LH-stimulated MAPK3/1 activity abrogates ovulation in mice. We conclude that Mapk3/1 regulates ovulation, at least in part, through Egr1 and its target gene, Ptgs2 in granulosa cells of ovulating follicles in mice.	[Siddappa, Dayananda; Bordignon, Vilceu; Duggavathi, Raj] McGill Univ, Dept Anim Sci, Ste Anne De Bellevue, PQ H9X 3V9, Canada; [Beaulieu, Elaine; Gevry, Nicolas] Univ Sherbrooke, Dept Biol, Sherbrooke, PQ J1K 2R1, Canada; [Roux, Philippe P.] Univ Montreal, Fac Med, Inst Res Immunol & Canc, Montreal, PQ H3C 3J7, Canada	McGill University; University of Sherbrooke; Universite de Montreal	Duggavathi, R (corresponding author), McGill Univ, Dept Anim Sci, Ste Anne De Bellevue, PQ H9X 3V9, Canada.	raj.duggavathi@mcgill.ca	Roux, Philippe P./J-3996-2012; Duggavathi, Raj/GSJ-3503-2022	Roux, Philippe P./0000-0002-5962-0250; Beaulieu, Elaine/0000-0002-9529-9943; Bordignon, Vilceu/0000-0001-7076-7707	McGill Graduate Student Fellowship; Department of Animal Science Graduate Excellence Fellowship; Reseau Quebecois en Reproduction; RQR	McGill Graduate Student Fellowship; Department of Animal Science Graduate Excellence Fellowship; Reseau Quebecois en Reproduction; RQR	DS was funded by McGill Graduate Student Fellowship, Department of Animal Science Graduate Excellence Fellowship and RQR. This study was also partly funded by Reseau Quebecois en Reproduction. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashkenazi H, 2005, ENDOCRINOLOGY, V146, P77, DOI 10.1210/en.2004-0588; Barrett SD, 2008, BIOORG MED CHEM LETT, V18, P6501, DOI 10.1016/j.bmcl.2008.10.054; Ben-Ami I, 2009, HUM REPROD, V24, P176, DOI 10.1093/humrep/den359; Cherian-Shaw M, 2009, ENDOCRINOLOGY, V150, P957, DOI 10.1210/en.2008-0619; Deroo BJ, 2009, MOL ENDOCRINOL, V23, P955, DOI 10.1210/me.2008-0213; DINCHUK JE, 1995, NATURE, V378, P406, DOI 10.1038/378406a0; Duan WR, 2002, MOL ENDOCRINOL, V16, P221, DOI 10.1210/me.16.2.221; Duggavathi R, 2008, GENE DEV, V22, P1871, DOI 10.1101/gad.472008; Dupuis L, 2014, REPRODUCTION, V147, P221, DOI 10.1530/REP-13-0356; Espey LL, 2000, ENDOCRINOLOGY, V141, P2385, DOI 10.1210/en.141.7.2385; Fan HY, 2008, MOL ENDOCRINOL, V22, P2128, DOI 10.1210/me.2008-0095; Fan HY, 2011, MOL ENDOCRINOL, V25, P253, DOI 10.1210/me.2010-0318; Fan HY, 2009, SCIENCE, V324, P938, DOI 10.1126/science.1171396; Fulop C, 2003, DEVELOPMENT, V130, P2253, DOI 10.1242/dev.00422; Hou XY, 2008, MOL ENDOCRINOL, V22, P403, DOI 10.1210/me.2007-0272; IWAMASA J, 1992, BIOL REPROD, V46, P309, DOI 10.1095/biolreprod46.2.309; Jimenez LM, 2010, J LIPID RES, V51, P2362, DOI 10.1194/jlr.M006973; Jones N, 2003, J CELL PHYSIOL, V196, P326, DOI 10.1002/jcp.10308; Lee GH, 1996, NATURE, V379, P632, DOI 10.1038/379632a0; Lim H, 1997, CELL, V91, P197, DOI 10.1016/S0092-8674(00)80402-X; LYDON JP, 1995, GENE DEV, V9, P2266, DOI 10.1101/gad.9.18.2266; Micu MC, 2011, ARTHRIT CARE RES, V63, P1334, DOI 10.1002/acr.20510; Mittaz L, 2004, BIOL REPROD, V70, P1096, DOI 10.1095/biolreprod.103.023911; Nyegaard M, 2010, BIOL REPROD, V82, P1129, DOI 10.1095/biolreprod.109.079517; Pagel JI, 2011, INDIAN J BIOCHEM BIO, V48, P226; Park JY, 2004, SCIENCE, V303, P682, DOI 10.1126/science.1092463; Ramos JW, 2008, INT J BIOCHEM CELL B, V40, P2707, DOI 10.1016/j.biocel.2008.04.009; Richards JS, 2002, ANNU REV PHYSIOL, V64, P69, DOI 10.1146/annurev.physiol.64.081501.131029; Russell DL, 2003, MOL ENDOCRINOL, V17, P520, DOI 10.1210/me.2002-0066; Sayasith K, 2006, J MOL ENDOCRINOL, V37, P239, DOI 10.1677/jme.1.02078; Solit DB, 2006, NATURE, V439, P358, DOI 10.1038/nature04304; Su YQ, 2009, SEMIN REPROD MED, V27, P32, DOI 10.1055/s-0028-1108008; Su YQ, 2003, DEV BIOL, V263, P126, DOI 10.1016/S0012-1606(03)00437-8; Sugden PH, 1997, CELL SIGNAL, V9, P337, DOI 10.1016/S0898-6568(96)00191-X; Svotelis A, 2011, EMBO J, V30, P3947, DOI 10.1038/emboj.2011.284; Topilko P, 1998, MOL ENDOCRINOL, V12, P107, DOI 10.1210/mend.12.1.0049; Varani S, 2002, MOL ENDOCRINOL, V16, P1154, DOI 10.1210/me.16.6.1154; Wauson EM, 2013, BIOCHEMISTRY-US, V52, P5164, DOI 10.1021/bi4007644; Weck J, 2006, MOL ENDOCRINOL, V20, P1090, DOI 10.1210/me.2005-0199; Wu SQ, 2002, BLOOD, V100, P4454, DOI 10.1182/blood-2002-02-0415; Yoon S, 2006, GROWTH FACTORS, V24, P21, DOI 10.1080/02699050500284218	41	20	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0119387	10.1371/journal.pone.0119387	http://dx.doi.org/10.1371/journal.pone.0119387			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803847	Green Published, Green Submitted, gold			2022-12-26	WOS:000353889600026
J	Comblain, F; Sanchez, C; Lesponne, I; Balligand, M; Serisier, S; Henrotin, Y				Comblain, Fanny; Sanchez, Christelle; Lesponne, Isabelle; Balligand, Marc; Serisier, Samuel; Henrotin, Yves			Curcuminoids Extract, Hydrolyzed Collagen and Green Tea Extract Synergically Inhibit Inflammatory and Catabolic Mediator's Synthesis by Normal Bovine and Osteoarthritic Human Chondrocytes in Monolayer	PLOS ONE			English	Article							FACTOR-KAPPA-B; ARTICULAR CHONDROCYTES; KNEE OSTEOARTHRITIS; EXPRESSION; INTERLEUKIN-1-BETA; CARTILAGE	The main objective of this study was to assess the in vitro effects of curcuminoids extract, hydrolyzed collagen and green tea extract in normal bovine chondrocytes and osteoarthritic human chondrocytes cultured in monolayer. This study also investigated the synergic or additive effects of these compounds. Enzymatically isolated primary bovine or human chondrocytes were cultured in monolayer until confluence and then incubated for 24 hours or 48 hours in the absence or in the presence of interleukin-1 beta and with or without curcuminoids extract, hydrolyzed collagen or green tea extract, added alone or in combination, at different concentrations. Cell viability was neither affected by these compounds, nor by interleukin 1 beta. In the absence of interleukin-1 beta, compounds did not significantly affect bovine chondrocytes metabolism. In human chondrocytes and in the absence of interleukin 1 beta, curcuminoids extract alone or in combination with hydrolyzed collagen and green tea extract significantly inhibited matrix metalloproteinase-3 production. In interleukin-1 beta-stimulated bovine chondrocytes, interleukin-6, inducible nitric oxide synthase, cyclooxygenase2, matrix metalloproteinase 3, a disintegrin and metalloproteinase with thrombospondin type I motifs 4 and a disintegrin and metalloproteinase with thrombospondin type I motifs 5 expressions were decreased by curcuminoids extract alone or in combination with hydrolyzed collagen and green tea extract. The combination of the three compounds was significantly more efficient to inhibit interleukin-1 beta stimulated matrix metalloproteinase-3 expression than curcuminoids extract alone. In interleukin-1 beta-stimulated human chondrocytes, nitric oxide, interleukin-6 and matrix metalloproteinase 3 productions were significantly reduced by curcuminoids extract alone or in combination with hydrolyzed collagen and green tea extract. These findings indicate that a mixture of curcuminoids extract, hydrolyzed collagen and green tea extract has beneficial effects on chondrocytes culture in inflammatory conditions and provide a preclinical basis for the in vivo testing of this mixture.	[Comblain, Fanny; Sanchez, Christelle; Henrotin, Yves] Univ Liege, CHU Sart Tilman, Bone & Cartilage Res Unit, Arthropole Liege, Liege, Belgium; [Lesponne, Isabelle; Serisier, Samuel] Royal Canin Res Ctr, Aimargues, France; [Balligand, Marc] Univ Liege, Dept Clin Sci, Fac Vet Med, Liege, Belgium; [Henrotin, Yves] Princess Paola Hosp, Phys Therapy & Rehabil Dept, Marche En Famenne, Belgium	University of Liege; University of Liege	Henrotin, Y (corresponding author), Univ Liege, CHU Sart Tilman, Bone & Cartilage Res Unit, Arthropole Liege, Liege, Belgium.	yhenrotin@ulg.ac.be	Serisier, Samuel/AAI-4608-2020	sanchez, christelle/0000-0002-1005-8172; Henrotin, Yves/0000-0003-1073-449X; Serisier, Samuel/0000-0002-5702-1350	Royal Canin SAS	Royal Canin SAS	The research leading to these results was supported by a grant of Royal Canin SAS. FC receives her PhD fellow from Royal Canin SAS. Royal Canin conceived and designed the work, analyzed the data, contributed compounds, revised the article, gave their final approval of the version to be published and agreed to be accountable for all aspects of the work.	Aggarwal BB, 2007, EXPERT OPIN THER TAR, V11, P109, DOI 10.1517/14728222.11.2.109; Ahmed S, 2004, J PHARMACOL EXP THER, V308, P767, DOI 10.1124/jpet.103.059220; Ahmed S, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2982; Akhtar N, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3368; Ameye LG, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2016; Belcaro G, 2010, PANMINERVA MED, V52, P269; Belcaro G, 2010, ALTERN MED REV, V15, P337; Carter GT, 2014, PHYS MED REH CLIN N, V25, P457, DOI 10.1016/j.pmr.2014.01.007; Cheng AL, 2001, ANTICANCER RES, V21, P2895; Csaki C, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2850; Daheshia M, 2008, J RHEUMATOL, V35, P2306, DOI 10.3899/jrheum.080346; EFSA, 2005, EUROPEAN FOOD SAFETY, V174, P1; Heinecke LF, 2010, OSTEOARTHR CARTILAGE, V18, P220, DOI 10.1016/j.joca.2009.08.015; Henrotin Y, 2011, OSTEOARTHR CARTILAGE, V19, P1, DOI 10.1016/j.joca.2010.10.017; Henrotin Y, 2010, OSTEOARTHR CARTILAGE, V18, P141, DOI 10.1016/j.joca.2009.10.002; Henrotin Y, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-56; Hochberg MC, 2012, OSTEOARTHR CARTILAGE, V20, P1465, DOI 10.1016/j.joca.2012.07.022; Kapoor M, 2011, NAT REV RHEUMATOL, V7, P33, DOI 10.1038/nrrheum.2010.196; Kobayashi M, 2005, ARTHRITIS RHEUM-US, V52, P128, DOI 10.1002/art.20776; Kumar A, 2004, J MOL MED, V82, P434, DOI 10.1007/s00109-004-0555-y; LABARCA C, 1980, ANAL BIOCHEM, V102, P344, DOI 10.1016/0003-2697(80)90165-7; Lee AS, 2013, GENE, V527, P440, DOI 10.1016/j.gene.2013.05.069; Malemud CJ, 2010, DRUG AGING, V27, P95, DOI 10.2165/11319950-000000000-00000; Mathy M, 2007, OSTEOARTHR CARTILAGE, V15, pC115; Mathy-Hartert M, 2008, OSTEOARTHR CARTILAGE, V16, P756, DOI 10.1016/j.joca.2007.10.009; Mathy-Hartert M, 2009, INFLAMM RES, V58, P899, DOI 10.1007/s00011-009-0063-1; McAlindon TE, 2014, OSTEOARTHR CARTILAGE, V22, P363, DOI 10.1016/j.joca.2014.01.003; Nakagawa Y, 2014, J ORTHOP SCI, V19, P933, DOI 10.1007/s00776-014-0633-0; Nakatani S, 2009, OSTEOARTHR CARTILAGE, V17, P1620, DOI 10.1016/j.joca.2009.07.001; Nelson AE, 2014, SEMIN ARTHRITIS RHEU, V43, P701, DOI 10.1016/j.semarthrit.2013.11.012; Oesser S, 2003, CELL TISSUE RES, V311, P393, DOI 10.1007/s00441-003-0702-8; Ohara H, 2010, BIOSCI BIOTECH BIOCH, V74, P2096, DOI 10.1271/bbb.100193; Pesesse L, 2013, OSTEOARTHR CARTILAGE, V21, P1913, DOI 10.1016/j.joca.2013.08.018; Rasheed Z, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2700; Sanchez C, 2012, ARTHRITIS RHEUM-US, V64, P1193, DOI 10.1002/art.33445; Schadow S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053955; Schulze-Tanzil G, 2004, ANN NY ACAD SCI, V1030, P578, DOI 10.1196/annals.1329.067; Schunck M, 2006, OSTEOARTHR CARTILAGE, V14, pS114; Shakibaei M, 2007, BIOCHEM PHARMACOL, V73, P1434, DOI 10.1016/j.bcp.2007.01.005; Shoba G, 1998, PLANTA MED, V64, P353, DOI 10.1055/s-2006-957450; Walrand S, 2008, J AGR FOOD CHEM, V56, P7790, DOI 10.1021/jf800691f; Xu J, 2014, IN VITRO CELL DEV BI	42	21	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121654	10.1371/journal.pone.0121654	http://dx.doi.org/10.1371/journal.pone.0121654			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799427	Green Published, Green Submitted, gold			2022-12-26	WOS:000351987300280
J	Coubart, A; Streri, A; de Hevia, MD; Izard, V				Coubart, Aurelie; Streri, Arlette; de Hevia, Maria Dolores; Izard, Veronique			Crossmodal Discrimination of 2 vs. 4 Objects across Touch and Vision in 5-Month-Old Infants	PLOS ONE			English	Article							NUMBER DISCRIMINATION; REPRESENTATION; NUMEROSITIES; SYSTEMS	Infants are known to possess two different cognitive systems to encode numerical information. The first system encodes approximate numerosities, has no known upper limit and is functional from birth on. The second system relies on infants' ability to track up to 3 objects in parallel, and enables them to represent exact numerosity for such small sets. It is unclear, however, whether infants may be able to represent numerosities from all ranges in a common format. In various studies, infants failed to discriminate a small vs. a large numerosity (e.g., 2 vs. 4, 3 vs. 6), although more recent studies presented evidence that infants can succeed at these discriminations in some situations. Here, we used a transfer paradigm between the tactile and visual modalities in 5-month-olds, assuming that such cross-modal paradigm may promote access to abstract representations of numerosities, continuous across the small and large ranges. Infants were first familiarized with 2 to 4 objects in the tactile modality, and subsequently tested for their preference between 2 vs. 4, or 3 vs. 6 visual objects. Results were mixed, with only partial evidence that infants may have transferred numerical information across modalities. Implications on 5-month-old infants' ability to represent small and large numerosities in a single or in separate formats are discussed.	[Coubart, Aurelie; Streri, Arlette; de Hevia, Maria Dolores; Izard, Veronique] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Coubart, Aurelie; Streri, Arlette; de Hevia, Maria Dolores; Izard, Veronique] CNRS, Lab Psychol Percept, UMR 8242, Paris, France	UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite	Coubart, A (corresponding author), Univ Paris 05, Sorbonne Paris Cite, Paris, France.	aurelie.coubart@gmail.com			European Research Council [263179]	European Research Council(European Research Council (ERC)European Commission)	This work was supported by a Starting Grant from the European Research Council awarded to V.I. (Project MathConstruction 263179). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burr DC, 2010, J VISION, V10, DOI 10.1167/10.6.20; Cordes S, 2009, DEV PSYCHOL, V45, P1583, DOI 10.1037/a0015666; Coubart A, 2014, DEVELOPMENTAL SCI, V17, P11, DOI 10.1111/desc.12108; Feigenson L, 2002, PSYCHOL SCI, V13, P150, DOI 10.1111/1467-9280.00427; Feigenson L, 2005, COGNITION, V97, P295, DOI 10.1016/j.cognition.2004.09.010; Feigenson L, 2004, TRENDS COGN SCI, V8, P307, DOI 10.1016/j.tics.2004.05.002; Feigenson L, 2011, J EXP CHILD PSYCHOL, V110, P347, DOI 10.1016/j.jecp.2011.04.004; Feron J, 2006, COGNITIVE DEV, V21, P81, DOI 10.1016/j.cogdev.2006.01.005; Hyde DC, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00150; Izard V, 2009, P NATL ACAD SCI USA, V106, P10382, DOI 10.1073/pnas.0812142106; Jones SM, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00550; Jordan KE, 2008, COGNITION, V108, P210, DOI 10.1016/j.cognition.2007.12.001; Lipton JS, 2004, INFANCY, V5, P271, DOI 10.1207/s15327078in0503_2; Nieder A, 2003, NEURON, V37, P149, DOI 10.1016/S0896-6273(02)01144-3; Nieder A, 2002, SCIENCE, V297, P1708, DOI 10.1126/science.1072493; PETRIE BF, 1980, INFANT BEHAV DEV, V3, P215, DOI 10.1016/S0163-6383(80)80027-0; SLATER A, 1991, J EXP CHILD PSYCHOL, V51, P395, DOI 10.1016/0022-0965(91)90084-6; Starr A, 2013, INFANCY, V18, P927, DOI 10.1111/infa.12008; Streri A, 2013, BEHAV SCI, V3, P154, DOI 10.3390/bs3010154; Vanmarle K, 2006, DEVELOPMENTAL SCI, V9, pF41, DOI 10.1111/j.1467-7687.2006.00508.x; Wood JN, 2005, COGNITION, V97, P23, DOI 10.1016/j.cognition.2004.06.007; Xu F, 2003, COGNITION, V89, pB15, DOI 10.1016/S0010-0277(03)00050-7; Xu F, 2000, COGNITION, V74, pB1, DOI 10.1016/S0010-0277(99)00066-9	23	6	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120868	10.1371/journal.pone.0120868	http://dx.doi.org/10.1371/journal.pone.0120868			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE6ZS	25798931	Green Published, gold, Green Submitted			2022-12-26	WOS:000351987300185
J	Riahi, Z; Bonnet, C; Zainine, R; Lahbib, S; Bouyacoub, Y; Bechraoui, R; Marrakchi, J; Hardelin, JP; Louha, M; Largueche, L; Ben Yahia, S; Kheirallah, M; Elmatri, L; Besbes, G; Abdelhak, S; Petit, C				Riahi, Zied; Bonnet, Crystel; Zainine, Rim; Lahbib, Saida; Bouyacoub, Yosra; Bechraoui, Rym; Marrakchi, Jihene; Hardelin, Jean-Pierre; Louha, Malek; Largueche, Leila; Ben Yahia, Salim; Kheirallah, Moncef; Elmatri, Leila; Besbes, Ghazi; Abdelhak, Sonia; Petit, Christine			Whole Exome Sequencing Identifies Mutations in Usher Syndrome Genes in Profoundly Deaf Tunisian Patients	PLOS ONE			English	Article							HEARING IMPAIRMENT; UPDATE; DNA	Usher syndrome (USH) is an autosomal recessive disorder characterized by combined deafness-blindness. It accounts for about 50% of all hereditary deafness blindness cases. Three clinical subtypes (USH1, USH2, and USH3) are described, of which USH1 is the most severe form, characterized by congenital profound deafness, constant vestibular dysfunction, and a prepubertal onset of retinitis pigmentosa. We performed whole exome sequencing in four unrelated Tunisian patients affected by apparently isolated, congenital profound deafness, with reportedly normal ocular fundus examination. Four biallelic mutations were identified in two USH1 genes: a splice acceptor site mutation, c.2283-1G>T, and a novel missense mutation, c.5434G>A (p.Glu1812Lys), in MYO7A, and two previously unreported mutations in USH1G, i.e. a frameshift mutation, c.1195_1196delAG (p.Leu399Alafs*24), and a nonsense mutation, c.52A>T (p.Lys18*). Another ophthalmological examination including optical coherence tomography actually showed the presence of retinitis pigmentosa in all the patients. Our findings provide evidence that USH is under-diagnosed in Tunisian deaf patients. Yet, early diagnosis of USH is of utmost importance because these patients should undergo cochlear implant surgery in early childhood, in anticipation of the visual loss.	[Riahi, Zied; Lahbib, Saida; Bouyacoub, Yosra; Abdelhak, Sonia] Inst Pasteur Tunis, LR11IPT05, Biomed Genom & Oncogenet Lab, Tunis 1002, Tunisia; [Riahi, Zied] Univ Tunis El Manar, Fac Sci Tunis, Tunis 2092, Tunisia; [Bonnet, Crystel; Petit, Christine] UPMC Paris 6, INSERM UMRS 1120, Inst Vis, Paris, France; [Zainine, Rim; Bechraoui, Rym; Marrakchi, Jihene; Besbes, Ghazi] La Rabta Hosp, Otorhinolaryngol Dis, Tunis, Tunisia; [Bouyacoub, Yosra] Univ Monastir, Inst Super Biotechnol, Monastir, Tunisia; [Hardelin, Jean-Pierre; Petit, Christine] Inst Pasteur, Unite Genet & Physiol Audit, Paris, France; [Louha, Malek] Hop Armand Trousseau, AP HP, Lab Biochim & Biol Mol, Paris, France; [Largueche, Leila; Elmatri, Leila] Hedi Rais Inst Ophthalmol, Dept Ophthalmol B, Tunis, Tunisia; [Ben Yahia, Salim; Kheirallah, Moncef] Univ Monastir, Fac Med, Fattouma Bourguiba Univ Hosp, Dept Ophthalmol, Monastir 5000, Tunisia; [Petit, Christine] Coll France, F-75231 Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Universite de Tunis-El-Manar; Institut Pasteur Tunis; Universite de Tunis-El-Manar; Faculte des Sciences de Tunis (FST); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite de Bordeaux; Universite de Tunis-El-Manar; Hopital La Rabta; Universite de Monastir; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; Universite de Tunis-El-Manar; Institut Hedi Raies d'ophtalmologie de Tunis; Universite de Monastir; Hopital Fattouma Bourguiba; UDICE-French Research Universities; PSL Research University Paris; College de France	Abdelhak, S (corresponding author), Inst Pasteur Tunis, LR11IPT05, Biomed Genom & Oncogenet Lab, Tunis 1002, Tunisia.	sonia.abdelhak@pasteur.rns.tn	jihene, marrakchi/A-1415-2016; Bonnet, Crystel/AAN-5950-2021; Abdelhak, Sonia/L-2831-2013	jihene, marrakchi/0000-0001-8759-2894; Bonnet, Crystel/0000-0002-1916-9119; Petit, Christine/0000-0002-9069-002X; BOUYACOUB, Yosra/0000-0003-2423-199X; Abdelhak, Sonia/0000-0001-8466-5525	Tunisian Ministry of Public Health; Ministry of Higher Education and Scientific Research [LR11IPT05]; FP7 project GM-NCD-Inco [295097]; Mobidoc Fellowship under the Programme d'Appui au Systeme de recherche et d'Innovation (PASRI-Europe Aid); BNP Paribas foundation	Tunisian Ministry of Public Health; Ministry of Higher Education and Scientific Research(Ministry of Higher Education & Scientific Research (MHESR)); FP7 project GM-NCD-Inco; Mobidoc Fellowship under the Programme d'Appui au Systeme de recherche et d'Innovation (PASRI-Europe Aid); BNP Paribas foundation	This work was supported by the Tunisian Ministry of Public Health, the Ministry of Higher Education and Scientific Research (LR11IPT05), the E.C. Grant agreement No 295097 for FP7 project GM-NCD-Inco (www.genomedika.org), ZR is recipient of a Mobidoc Fellowship under the Programme d'Appui au Systeme de recherche et d'Innovation (PASRI-Europe Aid) and BNP Paribas foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonnet C, 2013, GENE, V527, P537, DOI 10.1016/j.gene.2013.06.044; Bonnet C, 2012, CURR OPIN NEUROL, V25, P42, DOI 10.1097/WCO.0b013e32834ef8b2; Bonnet C, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-21; Delmaghani S, 2012, HUM MOL GENET, V21, P3835, DOI 10.1093/hmg/dds212; Hilgert N, 2009, MUTAT RES-REV MUTAT, V681, P189, DOI 10.1016/j.mrrev.2008.08.002; Kimberling WJ, 2010, GENET MED, V12, P512, DOI 10.1097/GIM.0b013e3181e5afb8; Millan JM, 2011, J OPHTHALMOL, V2011, DOI 10.1155/2011/417217; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Morton CC, 2006, NEW ENGL J MED, V354, P2151, DOI 10.1056/NEJMra050700; Riahi Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099797; Riahi Z, 2013, GENE, V525, P1, DOI 10.1016/j.gene.2013.04.078; Riazuddin S, 2012, NAT GENET, V44, P1265, DOI 10.1038/ng.2426; Roux AF, 2011, INVEST OPHTH VIS SCI, V52, P4063, DOI 10.1167/iovs.10-6869; Saihan Z, 2009, CURR OPIN NEUROL, V22, P19, DOI 10.1097/WCO.0b013e3283218807; Smith RJ., 1993, GENEREVIEWS; Woo HM, 2013, BMC MED GENET, V14, DOI 10.1186/1471-2350-14-72	16	16	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120584	10.1371/journal.pone.0120584	http://dx.doi.org/10.1371/journal.pone.0120584			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798947	Green Published, gold, Green Submitted			2022-12-26	WOS:000351987300155
J	Yang, SP; Lin, SM; Fu, Q; Cai, BZ; Kong, F; Huang, G; Li, FF; Wang, H				Yang, Shiping; Lin, Shaomin; Fu, Qiang; Cai, Baizhen; Kong, Fei; Huang, Guang; Li, Fafen; Wang, Han			The Effect of Adjuvant Chemotherapy on Survival in Patients with Residual Nasopharyngeal Carcinoma after Undergoing Concurrent Chemoradiotherapy	PLOS ONE			English	Article							THERAPEUTIC GAIN; PHASE-III; RADIOTHERAPY; CANCER; TRIAL; BRACHYTHERAPY	Background Guidelines from the U.S. National Comprehensive Cancer Network have recommended use of concurrent chemoradiotherapy (CCRT), followed by a 3-cycles combination of platinum and 5-fluorouracil chemotherapy as standard treatment for nasopharyngeal carcinoma (NPC). The benefits of CCRT for treatment of locally advanced NPC have been established. Whether platinum and 5-fluorouracil chemotherapy should be routinely added to locally advanced NPC after CCRT is still open to debate. Whether adjuvant chemotherapy provides an additional survival benefit for the subgroup of patients with residual nasopharyngeal carcinoma who have undergone CCRT is also unclear. This retrospective study was initiated to determine the survival benefit of adjuvant chemotherapy (AC) in residual NPC patients who have undergone concurrent chemoradiotherapy. Methods The retrospective study included 155 nasopharyngeal carcinoma patients who had local residual lesions after the platinum-based CCRT without or with AC. Kaplan-Meier analysis and the log-rank test were used to estimate overall survival (OS), failure-free survival (FFS), local relapse-free survival (LRFS) and distant metastasis-free survival (DMFS). Results Median follow-up was 47 months. Adjuvant cisplatin or nedaplatin plus 5-fluorouracil chemotherapy did not significantly improve 3-year OS, LRFS, FFS, and DMFS for patients with residual nasopharyngeal carcinoma after undergoing CCRT. The 3-year OS rates for the no-AC group and AC group were 71.6% and 73.7%, respectively (P= 0.44). The 3-year FFS rates for no-AC group and AC group were 57.5% and 66.9%, respectively ((P= 0.19). The 3-year LRFS rates for no-AC group and AC group were 84.7% and 87.9%, respectively ((P= 0.51). The 3-year DMFS rates for no-AC group and AC group were 71.4% and 77.4%, respectively ((P= 0.23). Conclusions Since we did not find sufficient data to support significant survival in 3-year OS, LRFS, FFS, and DMFS, whether Adjuvant cisplatin or nedaplatin and 5-fluorouracil chemotherapy should be routinely added to residual nasopharyngeal carcinoma patients after undergoing CCRT remain uncertain.	[Yang, Shiping; Lin, Shaomin; Fu, Qiang; Cai, Baizhen; Kong, Fei; Huang, Guang; Li, Fafen] Hainan Prov Peoples Hosp, Dept Radiat Oncol, Haikou, Hainan, Peoples R China; [Wang, Han] Hainan Med Coll, Dept Physiol, Haikou, Hainan, Peoples R China	Hainan Medical University	Yang, SP (corresponding author), Hainan Prov Peoples Hosp, Dept Radiat Oncol, Haikou, Hainan, Peoples R China.	shipingyang1982@sina.com; wanghan2801@sohu.com						Al-Sarraf M, 1998, J CLIN ONCOL, V16, P1310, DOI 10.1200/JCO.1998.16.4.1310; Al-Sarraf M, 2001, P AN M AM SOC CLIN, V20, p227a; Chen L, 2012, LANCET ONCOL, V13, P163, DOI 10.1016/S1470-2045(11)70320-5; Chi KH, 2002, INT J RADIAT ONCOL, V52, P1238, DOI 10.1016/S0360-3016(01)02781-X; Chua DTT, 2001, CANCER-AM CANCER SOC, V92, P2845, DOI 10.1002/1097-0142(20011201)92:11<2845::AID-CNCR10133>3.0.CO;2-7; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Kwong DLW, 2004, J CLIN ONCOL, V22, P2643, DOI 10.1200/JCO.2004.05.173; Kwong DLW, 1999, CANCER, V85, P1446, DOI 10.1002/(SICI)1097-0142(19990401)85:7<1446::AID-CNCR4>3.0.CO;2-3; Lai SZ, 2011, INT J RADIAT ONCOL, V80, P661, DOI 10.1016/j.ijrobp.2010.03.024; Lee AWM, 2006, INT J RADIAT ONCOL, V66, P142, DOI 10.1016/j.ijrobp.2006.03.054; Lee AWM, 2005, J CLIN ONCOL, V23, P6966, DOI 10.1200/JCO.2004.00.7542; Leung TW, 2000, INT J RADIAT ONCOL, V47, P405, DOI 10.1016/S0360-3016(00)00463-6; Leung TW, 2005, HEAD NECK-J SCI SPEC, V27, P555, DOI 10.1002/hed.20189; ROSSI A, 1988, J CLIN ONCOL, V6, P1401, DOI 10.1200/JCO.1988.6.9.1401; Stoker SD, 2013, CURR TREAT OPTION ON, V14, P475, DOI 10.1007/s11864-013-0261-5; TEO P, 1994, BRIT J RADIOL, V67, P181, DOI 10.1259/0007-1285-67-794-181; Teo P M, 1996, Clin Oncol (R Coll Radiol), V8, P160, DOI 10.1016/S0936-6555(96)80040-9; Vikram B, 2003, RADIOTHER ONCOL, V67, P1, DOI 10.1016/S0167-8140(03)00058-6; Wee J, 2005, J CLIN ONCOL, V23, P6730, DOI 10.1200/JCO.2005.16.790; Zheng XK, 2004, INT J RADIAT ONCOL, V60, P165, DOI 10.1016/j.ijrobp.2004.02.059	20	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120019	10.1371/journal.pone.0120019	http://dx.doi.org/10.1371/journal.pone.0120019			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799566	Green Submitted, gold, Green Published			2022-12-26	WOS:000351987300102
J	Mulukutla, BC; Yongky, A; Grimm, S; Daoutidis, P; Hu, WS				Mulukutla, Bhanu Chandra; Yongky, Andrew; Grimm, Simon; Daoutidis, Prodromos; Hu, Wei-Shou			Multiplicity of Steady States in Glycolysis and Shift of Metabolic State in Cultured Mammalian Cells	PLOS ONE			English	Article							ISOLATED YEAST-CELLS; HAMSTER OVARY CELLS; FED-BATCH CULTURES; LACTATE METABOLISM; CELLULAR-METABOLISM; GENE-TRANSCRIPTION; MATHEMATICAL-MODEL; HYBRIDOMA CELLS; OSCILLATIONS; PHOSPHOFRUCTOKINASE	Cultured mammalian cells exhibit elevated glycolysis flux and high lactate production. In the industrial bioprocesses for biotherapeutic protein production, glucose is supplemented to the culture medium to sustain continued cell growth resulting in the accumulation of lactate to high levels. In such fed-batch cultures, sometimes a metabolic shift from a state of high glycolysis flux and high lactate production to a state of low glycolysis flux and low lactate production or even lactate consumption is observed. While in other cases with very similar culture conditions, the same cell line and medium, cells continue to produce lactate. A metabolic shift to lactate consumption has been correlated to the productivity of the process. Cultures that exhibited the metabolic shift to lactate consumption had higher titers than those which didn't. However, the cues that trigger the metabolic shift to lactate consumption state (or low lactate production state) are yet to be identified. Metabolic control of cells is tightly linked to growth control through signaling pathways such as the AKT pathway. We have previously shown that the glycolysis of proliferating cells can exhibit bistability with well-segregated high flux and low flux states. Low lactate production (or lactate consumption) is possible only at a low glycolysis flux state. In this study, we use mathematical modeling to demonstrate that lactate inhibition together with AKT regulation on glycolysis enzymes can profoundly influence the bistable behavior, resulting in a complex steady-state topology. The transition from the high flux state to the low flux state can only occur in certain regions of the steady state topology, and therefore the metabolic fate of the cells depends on their metabolic trajectory encountering the region that allows such a metabolic state switch. Insights from such switch behavior present us with new means to control the metabolism of mammalian cells in fed-batch cultures.	[Mulukutla, Bhanu Chandra; Yongky, Andrew; Grimm, Simon; Daoutidis, Prodromos; Hu, Wei-Shou] Univ Minnesota, Dept Chem Engn & Mat Sci, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Hu, WS (corresponding author), Univ Minnesota, Dept Chem Engn & Mat Sci, 421 Washington Ave SE, Minneapolis, MN 55455 USA.	acre@umn.edu			Graduate School, University of Minnesota	Graduate School, University of Minnesota(University of Minnesota System)	The computational support from University of Minnesota Supercomputing Institute is gratefully acknowledged. Andrew Yongky was supported by the Interdisciplinary Doctoral Fellowship from the Graduate School, University of Minnesota.	Barthel A, 1999, J BIOL CHEM, V274, P20281, DOI 10.1074/jbc.274.29.20281; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Charaniya S, 2010, J BIOTECHNOL, V147, P186, DOI 10.1016/j.jbiotec.2010.04.005; Dorai H, 2009, BIOTECHNOL BIOENG, V103, P592, DOI 10.1002/bit.22269; du Preez FB, 2012, FEBS J, V279, P2810, DOI 10.1111/j.1742-4658.2012.08665.x; du Preez FB, 2012, FEBS J, V279, P2823, DOI 10.1111/j.1742-4658.2012.08658.x; Duran J, 2009, FEBS J, V276, P4555, DOI 10.1111/j.1742-4658.2009.07161.x; Europa AF, 2000, BIOTECHNOL BIOENG, V67, P25, DOI 10.1002/(SICI)1097-0290(20000105)67:1<25::AID-BIT4>3.0.CO;2-K; Folmes CDL, 2012, CELL STEM CELL, V11, P596, DOI 10.1016/j.stem.2012.10.002; Folmes CDL, 2011, CELL METAB, V14, P264, DOI 10.1016/j.cmet.2011.06.011; Gagnon M, 2011, BIOTECHNOL BIOENG, V108, P1328, DOI 10.1002/bit.23072; Gambhir A, 1999, J BIOSCI BIOENG, V87, P805, DOI 10.1016/S1389-1723(99)80157-1; Gambhir A, 2003, J BIOSCI BIOENG, V95, P317, DOI 10.1263/jbb.95.317; Gambhir A, 1999, CYTOTECHNOLOGY, V31, P243, DOI 10.1023/A:1008026613975; Gustavsson AK, 2014, FEBS J, V281, P2784, DOI 10.1111/febs.12820; Gustavsson AK, 2012, FEBS J, V279, P2837, DOI 10.1111/j.1742-4658.2012.08639.x; KRETSCHMER M, 1985, BIOCHEM BIOPH RES CO, V131, P899, DOI 10.1016/0006-291X(85)91324-5; Le H, 2012, J BIOTECHNOL, V162, P210, DOI 10.1016/j.jbiotec.2012.08.021; Leite TC, 2011, FEBS LETT, V585, P92, DOI 10.1016/j.febslet.2010.11.009; Leite TC, 2007, BIOCHEM J, V408, P123, DOI 10.1042/BJ20070687; Levine AJ, 2010, SCIENCE, V330, P1340, DOI 10.1126/science.1193494; Luo J, 2012, BIOTECHNOL BIOENG, V109, P146, DOI 10.1002/bit.23291; Ma NN, 2009, BIOTECHNOL PROGR, V25, P1353, DOI 10.1002/btpr.238; Majewski N, 2004, MOL CELL, V16, P819, DOI 10.1016/j.molcel.2004.11.014; Manes NP, 2005, ARCH BIOCHEM BIOPHYS, V438, P125, DOI 10.1016/j.abb.2005.04.011; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Mosca E, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00418; Mosca E, 2012, BIOTECHNOL ADV, V30, P131, DOI 10.1016/j.biotechadv.2011.08.004; Mulukutla BC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098756; Mulukutla BC, 2012, METAB ENG, V14, P138, DOI 10.1016/j.ymben.2011.12.006; Mulukutla BC, 2010, TRENDS BIOTECHNOL, V28, P476, DOI 10.1016/j.tibtech.2010.06.005; Novellasdemunt L, 2013, J BIOL CHEM, V288, P10640, DOI 10.1074/jbc.M113.455998; Qian YM, 2011, BIOTECHNOL PROGR, V27, P1190, DOI 10.1002/btpr.630; REINHART GD, 1980, BIOCHEMISTRY-US, V19, P1477, DOI 10.1021/bi00548a034; Rizzi M, 1997, BIOTECHNOL BIOENG, V55, P592; Robey RB, 2006, ONCOGENE, V25, P4683, DOI 10.1038/sj.onc.1209595; Ros S, 2013, CANCER METAB, V1, DOI 10.1186/2049-3002-1-8; Segel IH, 1975, ENZYME KINETICS BEHA; SELKOV EE, 1987, BIOFIZIKA+, V32, P242; Smallbone K, 2013, FEBS LETT, V587, P2832, DOI 10.1016/j.febslet.2013.06.043; Templeton N, 2013, BIOTECHNOL BIOENG, V110, P2013, DOI 10.1002/bit.24858; Tominaga N, 1997, ARCH BIOCHEM BIOPHYS, V347, P275, DOI 10.1006/abbi.1997.0346; VANSCHAFTINGEN E, 1981, P NATL ACAD SCI-BIOL, V78, P3483; VORA S, 1985, BIOCHEM J, V229, P333, DOI 10.1042/bj2290333; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Westermark PO, 2003, BIOPHYS J, V85, P126, DOI 10.1016/S0006-3495(03)74460-9; Yamada K, 1999, BIOCHEM J, V337, P1, DOI 10.1042/0264-6021:3370001; YANEY GC, 1995, DIABETES, V44, P1285, DOI 10.2337/diabetes.44.11.1285; Young JD, 2013, CURR OPIN BIOTECH, V24, P1108, DOI 10.1016/j.copbio.2013.04.016; Yuk IH, 2014, BIOTECHNOL PROGR, V30, P429, DOI 10.1002/btpr.1868; Zagari F, 2013, NEW BIOTECHNOL, V30, P238, DOI 10.1016/j.nbt.2012.05.021; ZHOU WC, 1995, BIOTECHNOL BIOENG, V46, P579, DOI 10.1002/bit.260460611; Zhou WC, 1997, CYTOTECHNOLOGY, V24, P99, DOI 10.1023/A:1007945826228	53	39	39	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0121561	10.1371/journal.pone.0121561	http://dx.doi.org/10.1371/journal.pone.0121561			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25806512	Green Published, Green Submitted, gold			2022-12-26	WOS:000351880000163
J	Conser, C; Seebacher, L; Fujino, DW; Reichard, S; DiTomaso, JM				Conser, Christiana; Seebacher, Lizbeth; Fujino, David W.; Reichard, Sarah; DiTomaso, Joseph M.			The Development of a Plant Risk Evaluation (PRE) Tool for Assessing the Invasive Potential of Ornamental Plants	PLOS ONE			English	Article							ASSESSMENT SYSTEM; PREDICTING INVASIONS; INTRODUCTIONS; HORTICULTURE	Weed Risk Assessment (WRA) methods for evaluating invasiveness in plants have evolved rapidly in the last two decades. Many WRA tools exist, but none were specifically designed to screen ornamental plants prior to being released into the environment. To be accepted as a tool to evaluate ornamental plants for the nursery industry, it is critical that a WRA tool accurately predicts non-invasiveness without falsely categorizing them as invasive. We developed a new Plant Risk Evaluation (PRE) tool for ornamental plants. The 19 questions in the final PRE tool were narrowed down from 56 original questions from existing WRA tools. We evaluated the 56 WRA questions by screening 21 known invasive and 14 known non-invasive ornamental plants. After statistically comparing the predictability of each question and the frequency the question could be answered for both invasive and non-invasive species, we eliminated questions that provided no predictive power, were irrelevant in our current model, or could not be answered reliably at a high enough percentage. We also combined many similar questions. The final 19 remaining PRE questions were further tested for accuracy using 56 additional known invasive plants and 36 known non-invasive ornamental species. The resulting evaluation demonstrated that when "needs further evaluation" classifications were not included, the accuracy of the model was 100% for both predicting invasiveness and non-invasiveness. When "needs further evaluation" classifications were included as either false positive or false negative, the model was still 93% accurate in predicting invasiveness and 97% accurate in predicting non-invasiveness, with an overall accuracy of 95%. We conclude that the PRE tool should not only provide growers with a method to accurately screen their current stock and potential new introductions, but also increase the probability of the tool being accepted for use by the industry as the basis for a nursery certification program.	[Conser, Christiana; DiTomaso, Joseph M.] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Seebacher, Lizbeth] Washington State Dept Ecol, Lacey, WA USA; [Fujino, David W.] Univ Calif Davis, Ctr Urban Hort, Davis, CA 95616 USA; [Reichard, Sarah] Univ Washington, Bot Gardens, Seattle, WA 98195 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of Washington; University of Washington Seattle	DiTomaso, JM (corresponding author), Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA.	jmditomaso@ucdavis.edu			Horticultural Research Institute [446]	Horticultural Research Institute	Horticultural Research Institute, Grant #446, http://www.hriresearch.org/, JD. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, SUGG ALT INV GARD PL, V3, P14, DOI DOI 10.1039/C; [Anonymous], 2014, SIERRA, V99, P3; [Anonymous], 2012, ARCH REV, V10, P3, DOI [DOI 10.5121/IJAIA.2012.3412161,(19), DOI 10.2151/JMSJ.2012-A02]; Bell CE, 2003, HORTSCIENCE, V38, P14, DOI 10.21273/HORTSCI.38.1.14; Bell CE, 2007, U CALIF AGR NAT RES; Bewick V, 2004, CRIT CARE, V8, P508, DOI 10.1186/cc3000; Bradley BA, 2012, FRONT ECOL ENVIRON, V10, P20, DOI 10.1890/110145; Brunel S., 2010, Bulletin OEPP, V40, P407, DOI 10.1111/j.1365-2338.2010.02423.x; Caley P, 2006, AUSTRAL ECOL, V31, P647, DOI 10.1111/j.1442-9993.2006.01617.x; Chong KY, 2011, BIOL INVASIONS, V13, P1571, DOI 10.1007/s10530-010-9914-5; Crosti R, 2010, BIOL INVASIONS, V12, P1607, DOI 10.1007/s10530-009-9573-6; Daehler CC, 2004, CONSERV BIOL, V18, P360, DOI 10.1111/j.1523-1739.2004.00066.x; Darin GMS, 2011, J ENVIRON MANAGE, V92, P131, DOI 10.1016/j.jenvman.2010.08.013; DiTomaso JM, 2007, U CALIF AGR NAT RES, V3488; DiTomaso JM, 2013, CALIF AGR, V67, P96, DOI 10.3733/ca.v067n02p96; Drew J, 2010, BIOL INVASIONS, V12, P2837, DOI 10.1007/s10530-010-9689-8; Gasso N, 2010, BIOL INVASIONS, V12, P463, DOI 10.1007/s10530-009-9451-2; Gilman EF, 2007, KOELREUTERIA PANICUL, V7, P14; Gordon DR, 2008, DIVERS DISTRIB, V14, P234, DOI 10.1111/j.1472-4642.2007.00460.x; Gordon DR, 2008, CONSERV LETT, V1, P227, DOI 10.1111/j.1755-263X.2008.00032.x; Gordon DR, 2008, INVAS PLANT SCI MANA, V1, P178, DOI 10.1614/IPSM-07-037.1; Kenis M., 2012, Bulletin OEPP, V42, P21, DOI [10.1111/epp.2527, 10.1111/j.1365-2338.2012.02527.x]; Koop AL, 2012, BIOL INVASIONS, V14, P273, DOI 10.1007/s10530-011-0061-4; Krivanek M, 2006, DIVERS DISTRIB, V12, P319, DOI 10.1111/j.1366-9516.2006.00249.x; Leung B, 2002, P ROY SOC B-BIOL SCI, V269, P2407, DOI 10.1098/rspb.2002.2179; Levine JM, 2003, CONSERV BIOL, V17, P322, DOI 10.1046/j.1523-1739.2003.02038.x; Lonsdale W. M., 2001, Weed risk assessment, P52; McClay A, 2010, BIOL INVASIONS, V12, P4085, DOI 10.1007/s10530-010-9819-3; METZ CE, 1978, SEMIN NUCL MED, V8, P283, DOI 10.1016/S0001-2998(78)80014-2; Morse LE, 2004, ALL U S GOVT DOCUMEN, V11, P14; Niemiera Alex X., 2009, V5, P167; Nishida T, 2009, BIOL INVASIONS, V11, P1319, DOI 10.1007/s10530-008-9340-0; Onderdonk Daphne A., 2010, Plant Protection Quarterly, V25, P79; Pheloung PC, 1999, J ENVIRON MANAGE, V57, P239, DOI 10.1006/jema.1999.0297; Puth LM, 2005, ECOL LETT, V8, P715, DOI 10.1111/j.1461-0248.2005.00774.x; Reichard S., 2001, Weed risk assessment, P10; Reichard SH, 2001, BIOSCIENCE, V51, P103, DOI 10.1641/0006-3568(2001)051[0103:HAAPOI]2.0.CO;2; Reichard SH, 1997, CONSERV BIOL, V11, P193, DOI 10.1046/j.1523-1739.1997.95473.x; Schrader Gritta, 2009, P195; Smith C.S., 1999, Biological Invasions, V1, P89, DOI 10.1023/A:1010091918466; Steffen K., 2012, Bulletin OEPP, V42, P28, DOI [10.1111/epp.2539, 10.1111/j.1365-2338.2012.02539.x]; UC Davis Arboretum, 2012, ARB ALL STARTS, V3, P14; Virtue J. G., 2008, Plant Protection Quarterly, V23, P166; Warner PJ, 2003, CALIFORNIA EXOTIC PE, V11, P14; Williamson M, 1996, ECOLOGY, V77, P1661, DOI 10.2307/2265769; Wrede Jan., 2010, TREES SHRUBS VINES T	46	22	24	3	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0121053	10.1371/journal.pone.0121053	http://dx.doi.org/10.1371/journal.pone.0121053			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803830	Green Published, Green Submitted, gold			2022-12-26	WOS:000353889600116
J	Libungan, LA; Palsson, S				Libungan, Lisa Anne; Palsson, Snaebjoern			ShapeR: An R Package to Study Otolith Shape Variation among Fish Populations	PLOS ONE			English	Article							SIZE	ShapeR is an open source software package that runs on the R platform and is specifically designed to study otolith shape variation among fish populations. The package extends previously described software used for otolith shape analysis by allowing the user to automatically extract closed contour outlines from a large number of images, perform smoothing to eliminate pixel noise, choose from conducting either a Fourier or Wavelet transform to the outlines and visualize the mean shape. The output of the package are independent Fourier or Wavelet coefficients which can be directly imported into a wide range of statistical packages in R. The package might prove useful in studies of any two dimensional objects.	[Libungan, Lisa Anne; Palsson, Snaebjoern] Univ Iceland, Dept Life & Environm Sci, Reykjavik, Iceland	University of Iceland	Libungan, LA (corresponding author), Univ Iceland, Dept Life & Environm Sci, Reykjavik, Iceland.	lisa.libungan@gmail.com	Palsson, Snaebjorn/J-9113-2012	Palsson, Snaebjorn/0000-0002-4297-3500	Icelandic Research Fund for Graduate Students [100710001]; Assistantship Fund of the University of Iceland; Entrepreneur Fund of Islandsbanki	Icelandic Research Fund for Graduate Students; Assistantship Fund of the University of Iceland; Entrepreneur Fund of Islandsbanki	This work was funded by the Icelandic Research Fund for Graduate Students (grant nr. 100710001, www.rannis.is, LAL), the Assistantship Fund of the University of Iceland (www.hi.is, LAL) and by The Entrepreneur Fund of Islandsbanki (www.islandsbanki.is, LAL, SP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2003, ECOLOGY, V84, P511, DOI 10.1890/0012-9658(2003)084[0511:CAOPCA]2.0.CO;2; BIRD JL, 1986, CAN J FISH AQUAT SCI, V43, P1228, DOI 10.1139/f86-152; Bivand R, 2011, PIXMAP BITMAP IMAGES; Bookstein FL, 1985, MORPHOMETRICS EVOLUT, P277; Cadrin S. X., 2013, STOCK IDENTIFICATION, P109, DOI DOI 10.1109/EMBC.2013.6609449; Claude J, 2008, MORPHOMETRICS R, P316; Gencay R, 2001, PHYSICA A, V289, P543, DOI 10.1016/S0378-4371(00)00463-5; GRAPS A, 1995, IEEE COMPUT SCI ENG, V2, P50, DOI 10.1109/99.388960; Haines AJ, 2000, PALAEONTOLOGY, V43, P765, DOI 10.1111/1475-4983.00148; Kotsiantis S B, 2007, INFORMATICA, V31, P249, DOI DOI 10.31449/INF.V31I3.148; Libungan LA, 2015, J FISH BIOL; Lleonart J, 2000, J THEOR BIOL, V205, P85, DOI 10.1006/jtbi.2000.2043; Marcus LF, 1996, NATO ASI SERIES A, V284, P587; Nason G, 2012, WAVETHREST WAVELETS; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Peters A., 2013, IPRED IMPROVED PREDI; R Core Team, 2021, R LANGUAGE ENV STAT; REIST JD, 1985, CAN J ZOOL, V63, P1429, DOI 10.1139/z85-213; Rohlf F. J., 1990, P MICH MORPH WORKSH, V2, P37; ROHLF FJ, 1990, SYST ZOOL, V39, P40, DOI 10.2307/2992207; ROHLF FJ, 1993, TRENDS ECOL EVOL, V8, P129, DOI 10.1016/0169-5347(93)90024-J; Sokal R. H., 1995, BIOMETRY PRINCIPLES; Stransky C., 2013, STOCK IDENTIFICATION, P129; Urbanek S, 2019, JPEG READ WRITE JPEG; Warnes GR, 2014, GPLOTS VARIOUS R PRO	25	77	80	4	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0121102	10.1371/journal.pone.0121102	http://dx.doi.org/10.1371/journal.pone.0121102			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803855	Green Published, Green Submitted, gold			2022-12-26	WOS:000353889600124
J	Podlesek, D; Meyer, T; Morgenstern, U; Schackert, G; Kirsch, M				Podlesek, Dino; Meyer, Tobias; Morgenstern, Ute; Schackert, Gabriele; Kirsch, Matthias			Improved Visualization of Intracranial Vessels with Intraoperative Coregistration of Rotational Digital Subtraction Angiography and Intraoperative 3D Ultrasound	PLOS ONE			English	Article							INDOCYANINE GREEN VIDEOANGIOGRAPHY; ANEURYSM SURGERY; MR-IMAGES; QUALITY; REGISTRATION; LIMITATIONS; INTEGRATION; ROUTINE; FLOW	Introduction Ultrasound can visualize and update the vessel status in real time during cerebral vascular surgery. We studied the depiction of parent vessels and aneurysms with a high-resolution 3D intraoperative ultrasound imaging system during aneurysm clipping using rotational digital subtraction angiography as a reference. Methods We analyzed 3D intraoperative ultrasound in 39 patients with cerebral aneurysms to visualize the aneurysm intraoperatively and the nearby vascular tree before and after clipping. Simultaneous coregistration of preoperative subtraction angiography data with 3D intraoperative ultrasound was performed to verify the anatomical assignment. Results Intraoperative ultrasound detected 35 of 43 aneurysms (81%) in 39 patients. Thirty-nine intraoperative ultrasound measurements were matched with rotational digital subtraction angiography and were successfully reconstructed during the procedure. In 7 patients, the aneurysm was partially visualized by 3D-ioUS or was not in field of view. Post-clipping intraoperative ultrasound was obtained in 26 and successfully reconstructed in 18 patients (69%) despite clip related artefacts. The overlap between 3D-ioUS aneurysm volume and preoperative rDSA aneurysm volume resulted in a mean accuracy of 0.71 (Dice coefficient). Conclusions Intraoperative coregistration of 3D intraoperative ultrasound data with preoperative rotational digital subtraction angiography is possible with high accuracy. It allows the immediate visualization of vessels beyond the microscopic field, as well as parallel assessment of blood velocity, aneurysm and vascular tree configuration. Although spatial resolution is lower than for standard angiography, the method provides an excellent vascular overview, advantageous interpretation of 3D-ioUS and immediate intraoperative feedback of the vascular status. A prerequisite for understanding vascular intraoperative ultrasound is image quality and a successful match with preoperative rotational digital subtraction angiography.	[Podlesek, Dino; Schackert, Gabriele; Kirsch, Matthias] Tech Univ Dresden, Dept Neurosurg, Carl Gustav Carus Fac Med, Dresden, Germany; [Meyer, Tobias; Morgenstern, Ute] Tech Univ Dresden, Inst Biomed Engn, Fac Elect Engn & Informat Technol, Dresden, Germany	Technische Universitat Dresden; Technische Universitat Dresden	Kirsch, M (corresponding author), Tech Univ Dresden, Dept Neurosurg, Carl Gustav Carus Fac Med, Dresden, Germany.	matthias.kirsch@uniklinikum-dresden.de	Podlesek, D/O-5236-2019					AASLID R, 1982, J NEUROSURG, V57, P769, DOI 10.3171/jns.1982.57.6.0769; Abla AA, 2014, WORLD NEUROSURG, V82, pE585, DOI 10.1016/j.wneu.2014.08.019; Berntsen EM, 2009, MINIM INVAS NEUROSUR, V52, P83, DOI 10.1055/s-0028-1124104; Brinjikji W, 2009, AM J NEURORADIOL, V30, P831, DOI 10.3174/ajnr.A1444; Chiang VL, 2002, J NEUROSURG, V96, P988, DOI 10.3171/jns.2002.96.6.0988; Dashti R, 2014, WORLD NEUROSURG, V82, pE589, DOI 10.1016/j.wneu.2014.08.060; de Oliveira JG, 2008, NEUROSURGERY, V62, P1300, DOI [10.1227/01.neu.0000333795.21468.d4, 10.1227/01.NEU.0000279982.48426.A1]; DERDEYN CP, 1995, AM J NEURORADIOL, V16, P307; Ferrant M, 2002, MED IMAGE ANAL, V6, P337, DOI 10.1016/S1361-8415(02)00060-9; Ferrant M, 2001, IEEE T MED IMAGING, V20, P1384, DOI 10.1109/42.974933; Fischer G, 2010, ACTA NEUROCHIR, V152, P1519, DOI 10.1007/s00701-010-0723-5; Hanggi D, 2010, NEUROSURGERY, V67, P1094, DOI 10.1227/NEU.0b013e3181eb5049; Klopfenstein JD, 2004, J NEUROSURG, V100, P230, DOI 10.3171/jns.2004.100.2.0230; Klotzsch C, 1999, STROKE, V30, P2285, DOI 10.1161/01.STR.30.11.2285; Klotzsch C, 1996, NEURORADIOLOGY, V38, P555; Le Roux PD, 1998, NEUROSURGERY, V42, P1248, DOI 10.1097/00006123-199806000-00026; Lee MC, 2003, NEUROSURGERY, V53, P1067, DOI 10.1227/01.NEU.0000088739.89056.04; Letteboer MMJ, 2005, IEEE T BIO-MED ENG, V52, P268, DOI 10.1109/TBME.2004.840186; Lindseth Frank, 2003, Comput Aided Surg, V8, P49, DOI 10.3109/10929080309146040; Lindseth Frank, 2002, Comput Aided Surg, V7, P197; Lindseth F, 2009, NEUROSURGERY, V65, P149, DOI 10.1227/01.NEU.0000345945.92559.C5; Meyer T, 2013, BIOMED ENG-BIOMED TE, V58, P281, DOI 10.1515/bmt-2012-0079; Muns A, 2011, ACTA NEUROCHIR, V153, P1529, DOI 10.1007/s00701-011-0994-5; Munteanu C, 2008, IEEE T BIO-MED ENG, V55, P365, DOI 10.1109/TBME.2007.897833; Murai Y, 2011, WORLD NEUROSURG, V76, DOI 10.1016/j.wneu.2011.03.044; Ozgiray E, 2013, CLIN NEUROL NEUROSUR, V115, P870, DOI 10.1016/j.clineuro.2012.08.027; Raabe A, 2005, J NEUROSURG, V103, P982, DOI 10.3171/jns.2005.103.6.0982; Raabe A, 2005, ZBL NEUROCHIR, V66, P1, DOI 10.1055/s-2004-836223; Rasmussen IA, 2007, ACTA NEUROCHIR, V149, P365, DOI 10.1007/s00701-006-1110-0; Schnell O, 2012, ACTA NEUROCHIR, V154, P1861, DOI 10.1007/s00701-012-1386-1; Sergeeva O, 2006, ZBL NEUROCHIR, V67, P197, DOI 10.1055/s-2006-942186; Sharma M, 2014, WORLD NEUROSURG, V82, pE607, DOI 10.1016/j.wneu.2014.05.033; Sindou R, 1998, ACTA NEUROCHIR, V140, P1153, DOI 10.1007/s007010050230; Solheim O, 2009, ACTA NEUROCHIR, V151, P1143, DOI 10.1007/s00701-009-0395-1; Stendel R, 2000, J NEUROL NEUROSUR PS, V68, P29, DOI 10.1136/jnnp.68.1.29; Tay PC, 2011, COMPUT MED IMAG GRAP, V35, P42, DOI 10.1016/j.compmedimag.2010.09.003; Turner CL, 2000, J NEUROL NEUROSUR PS, V68, P489, DOI 10.1136/jnnp.68.4.489; Wardlaw JM, 1996, J NEUROSURG, V84, P459, DOI 10.3171/jns.1996.84.3.0459; WROBEL CJ, 1994, NEUROSURGERY, V35, P970, DOI 10.1227/00006123-199411000-00027; Yasuda K, 2003, MINIM INVAS NEUROSUR, V46, P323, DOI 10.1055/s-2003-812468; Yoo TS, 2002, STUD HEALTH TECHNOL, V85, P586; Zou KH, 2004, ACAD RADIOL, V11, P178, DOI 10.1016/S1076-6332(03)00671-8	42	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0121345	10.1371/journal.pone.0121345	http://dx.doi.org/10.1371/journal.pone.0121345			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803318	Green Published, gold, Green Submitted			2022-12-26	WOS:000353889600147
J	Ruan, XS; Sack, DA; Zhang, WP				Ruan, Xiaosai; Sack, David A.; Zhang, Weiping			Genetic Fusions of a CFA/I/II/IV MEFA (Multiepitope Fusion Antigen) and a Toxoid Fusion of Heat-Stable Toxin (STa) and Heat-Labile Toxin (LT) of Enterotoxigenic Escherichia coli (ETEC) Retain Broad Anti-CFA and Antitoxin Antigenicity	PLOS ONE			English	Article							HUMAN CHALLENGE MODEL; B-SUBUNIT VACCINE; COLONIZATION FACTORS; CHOLERA-TOXIN; DEVELOPING-COUNTRIES; ORAL IMMUNIZATION; IMMUNE-RESPONSES; DOUBLE-BLIND; IMMUNOGENICITY; SAFETY	Immunological heterogeneity has long been the major challenge in developing broadly effective vaccines to protect humans and animals against bacterial and viral infections. Enterotoxigenic Escherichia coli (ETEC) strains, the leading bacterial cause of diarrhea in humans, express at least 23 immunologically different colonization factor antigens (CFAs) and two distinct enterotoxins [heat-labile toxin (LT) and heat-stable toxin type Ib (STa or hSTa)]. ETEC strains expressing any one or two CFAs and either toxin cause diarrhea, therefore vaccines inducing broad immunity against a majority of CFAs, if not all, and both toxins are expected to be effective against ETEC. In this study, we applied the multiepitope fusion antigen (MEFA) strategy to construct ETEC antigens and examined antigens for broad anti-CFA and antitoxin immunogenicity. CFA MEFA CFA/I/II/IV [CVI 2014, 21(2): 2439], which carried epitopes of seven CFAs [CFA/I, CFA/II (CS1, CS2, CS3), CFA/IV (CS4, CS5, CS6)] expressed by the most prevalent and virulent ETEC strains, was genetically fused to LT-STa toxoid fusion monomer 3xSTa(A14Q)-dmLT or 3xSTa(N12S)-dmLT [IAI 2014, 82(5): 1823-32] for CFA/I/II/IV-STaA14Q-dmLT and CFA/I/II/IV-STaN12S-dmLT MEFAs. Mice intraperitoneally immunized with either CFA/I/II/IV-STa-(toxoid)-dmLT MEFA developed antibodies specific to seven CFAs and both toxins, at levels equivalent or comparable to those induced from co-administration of the CFA/I/II/IV MEFA and toxoid fusion 3xSTaN12S-dmLT. Moreover, induced antibodies showed in vitro adherence inhibition activities against ETEC or E. coli strains expressing these seven CFAs and neutralization activities against both toxins. These results indicated CFA/I/II/IV-STa-(toxoid)-dmLT MEFA or CFA/I/II/IV MEFA combined with 3xSTa(N12S)-dmLT induced broadly protective anti-CFA and antitoxin immunity, suggested their potential application in broadly effective ETEC vaccine development. This MEFA strategy may be generally used in multivalent vaccine development.	[Ruan, Xiaosai; Zhang, Weiping] Kansas State Univ, Coll Vet Med, Dept Diagnost Med Pathobiol, Manhattan, KS 66506 USA; [Sack, David A.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA	Kansas State University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Zhang, WP (corresponding author), Kansas State Univ, Coll Vet Med, Dept Diagnost Med Pathobiol, Manhattan, KS 66506 USA.	dsack@jhsph.edu; wpzhang@vet.k-state.edu			NIH [R56AI101302, 1R21AI109209]; PATH; Kansas State University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI101302, R21AI109209] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PATH; Kansas State University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Financial support for this study was provided by NIH R56AI101302, NIH 1R21AI109209, PATH, and Kansas State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahren C, 1998, INFECT IMMUN, V66, P3311; Alam MM, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002822; [Anonymous], 2006, Wkly Epidemiol Rec, V81, P97; Bertschinger HU, 2000, VET MICROBIOL, V71, P255, DOI 10.1016/S0378-1135(99)00166-2; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Boedeker EC, 2005, CURR OPIN GASTROEN, V21, P15; CLEMENS JD, 1988, J INFECT DIS, V158, P372, DOI 10.1093/infdis/158.2.372; Coddens A, 2007, VET MICROBIOL, V122, P332, DOI 10.1016/j.vetmic.2007.02.007; Darsley MJ, 2012, CLIN VACCINE IMMUNOL, V19, P1921, DOI 10.1128/CVI.00364-12; Evans D G, 1988, FEMS Microbiol Immunol, V1, P117; Evans D J Jr, 1988, FEMS Microbiol Immunol, V1, P9; FRANTZ JC, 1981, INFECT IMMUN, V33, P193, DOI 10.1128/IAI.33.1.193-198.1981; Frantz JC, 1983, P 4 INT S NEON DIARR; FROEHLICH BJ, 1995, INFECT IMMUN, V63, P4849, DOI 10.1128/IAI.63.12.4849-4856.1995; Gaastra W, 1996, TRENDS MICROBIOL, V4, P444, DOI 10.1016/0966-842X(96)10068-8; Harro C, 2011, CLIN VACCINE IMMUNOL, V18, P2118, DOI 10.1128/CVI.05342-11; Harro C, 2011, CLIN VACCINE IMMUNOL, V18, P1719, DOI 10.1128/CVI.05194-11; Holmgren J, 2013, VACCINE, V31, P2457, DOI 10.1016/j.vaccine.2013.03.027; Isidean SD, 2011, VACCINE, V29, P6167, DOI 10.1016/j.vaccine.2011.06.084; Jertborn M, 1998, VACCINE, V16, P255, DOI 10.1016/S0264-410X(97)00169-2; Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2; LEVINE MM, 1990, LANCET, V335, P958, DOI 10.1016/0140-6736(90)91013-Z; Liu M, 2011, INFECT IMMUN, V79, P4002, DOI 10.1128/IAI.00165-11; Lundgren A, 2013, VACCINE, V31, P1163, DOI 10.1016/j.vaccine.2012.12.063; Nataro JP, 1998, CLIN MICROBIOL REV, V11, P403; National Research Council, 1996, GUIDE CARE USE LAB A, V7th ed., P140, DOI [10.17226/5140, DOI 10.17226/5140]; OFEK I, 1990, INFECT IMMUN, V58, P3737, DOI 10.1128/IAI.58.11.3737-3742.1990; PEREZCASAL J, 1990, INFECT IMMUN, V58, P3594, DOI 10.1128/IAI.58.11.3594-3600.1990; Qadri F, 2000, INFECT IMMUN, V68, P6077, DOI 10.1128/IAI.68.10.6077-6081.2000; Qadri F, 2006, VACCINE, V24, P1726, DOI 10.1016/j.vaccine.2005.08.110; Qadri F, 2000, J CLIN MICROBIOL, V38, P27; Qadri F, 2013, VACCINE, V31, P452, DOI 10.1016/j.vaccine.2012.11.012; Ruan X, 2014, INFECT IMMUN, V82, P1823, DOI 10.1128/IAI.01394-13; Ruan XS, 2014, CLIN VACCINE IMMUNOL, V21, P243, DOI 10.1128/CVI.00652-13; Ruan XS, 2013, VACCINE, V31, P1458, DOI 10.1016/j.vaccine.2013.01.030; Ruan XS, 2011, CLIN VACCINE IMMUNOL, V18, P1593, DOI 10.1128/CVI.05120-11; Sack DA, 2007, VACCINE, V25, P4392, DOI 10.1016/j.vaccine.2007.03.034; Savarino SJ, 2002, PEDIATR INFECT DIS J, V21, P322, DOI 10.1097/00006454-200204000-00012; SOMMERFELT H, 1988, J CLIN MICROBIOL, V26, P530, DOI 10.1128/JCM.26.3.530-534.1988; SVENNERHOLM AM, 1989, VACCINE, V7, P196, DOI 10.1016/0264-410X(89)90228-4; SVENNERHOLM AM, 1990, INFECT IMMUN, V58, P341, DOI 10.1128/IAI.58.2.341-346.1990; Svennerholm AM, 2008, EXPERT REV VACCINES, V7, P795, DOI 10.1586/14760584.7.6.795; Taxt A, 2010, INFECT IMMUN, V78, P1824, DOI 10.1128/IAI.01397-09; Taxt AM, 2014, INFECT IMMUN, V82, P2913, DOI 10.1128/IAI.01749-14; Turner AK, 2001, INFECT IMMUN, V69, P4969, DOI 10.1128/IAI.69.8.4969-4979.2001; Wolf MK, 1997, CLIN MICROBIOL REV, V10, P569, DOI 10.1128/CMR.10.4.569; Zhang CX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077386; Zhang W, 2014, PATHOGENIC ESCHERICH, P273; Zhang WP, 2012, EXPERT REV VACCINES, V11, P677, DOI [10.1586/erv.12.37, 10.1586/ERV.12.37]; Zhang WP, 2010, INFECT IMMUN, V78, P316, DOI 10.1128/IAI.00497-09	50	29	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0121623	10.1371/journal.pone.0121623	http://dx.doi.org/10.1371/journal.pone.0121623			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803825	Green Published, gold			2022-12-26	WOS:000353889600165
J	Upadhyayula, SM; Mutheneni, SR; Chenna, S; Parasaram, V; Kadiri, MR				Upadhyayula, Suryanaryana Murty; Mutheneni, Srinivasa Rao; Chenna, Sumana; Parasaram, Vaideesh; Kadiri, Madhusudhan Rao			Climate Drivers on Malaria Transmission in Arunachal Pradesh, India	PLOS ONE			English	Article							ANOPHELES-GAMBIAE; FALCIPARUM-MALARIA; CONTROL CHART; RISK; SELECTION; RAINFALL; HEALTH; IMPACT; AREA; T-2	The present study was conducted during the years 2006 to 2012 and provides information on prevalence of malaria and its regulation with effect to various climatic factors in East Siang district of Arunachal Pradesh, India. Correlation analysis, Principal Component Analysis and Hotelling's T-2 statistics models are adopted to understand the effect of weather variables on malaria transmission. The epidemiological study shows that the prevalence of malaria is mostly caused by the parasite Plasmodium vivax followed by Plasmodium falciparum. It is noted that, the intensity of malaria cases declined gradually from the year 2006 to 2012. The transmission of malaria observed was more during the rainy season, as compared to summer and winter seasons. Further, the data analysis study with Principal Component Analysis and Hotelling's T2 statistic has revealed that the climatic variables such as temperature and rainfall are the most influencing factors for the high rate of malaria transmission in East Siang district of Arunachal Pradesh.	[Upadhyayula, Suryanaryana Murty; Mutheneni, Srinivasa Rao; Kadiri, Madhusudhan Rao] Indian Inst Chem Technol, Council Sci & Ind Res, Div Biol, Hyderabad 500607, Andhra Pradesh, India; [Chenna, Sumana; Parasaram, Vaideesh] Indian Inst Chem Technol, Council Sci & Ind Res, Chem Engn Sci, Hyderabad 500607, Andhra Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Technology (IICT); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Technology (IICT)	Upadhyayula, SM (corresponding author), Indian Inst Chem Technol, Council Sci & Ind Res, Div Biol, Hyderabad 500607, Andhra Pradesh, India.	murty_usn@yahoo.com	Parasaram, Vaideesh/AAM-7970-2021; Mutheneni, Srinivasa Rao/AAI-2262-2020	Parasaram, Vaideesh/0000-0003-2990-8269; Mutheneni, Srinivasa Rao/0000-0003-3263-3905	CSIR; DST Govt. of India	CSIR(Council of Scientific & Industrial Research (CSIR) - India); DST Govt. of India(Department of Science & Technology (India))	This work was supported and financed by CSIR and DST Govt. of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2001, ADV TK CONT SIGN PRO; [Anonymous], J BIOSCI; [Anonymous], 2009, ICMR B; [Anonymous], 2004, PARASITOL; Bayoh MN, 2004, MED VET ENTOMOL, V18, P174, DOI 10.1111/j.0269-283X.2004.00495.x; Bhattacharya S, 2006, CURR SCI INDIA, V90, P369; Blanford JI, 2013, SCI REP-UK, V3, DOI 10.1038/srep01300; Campbell P, 2006, T ROY SOC TROP MED H, V100, P108, DOI 10.1016/j.trstmh.2005.06.016; Viteri MVC, 2012, CHEMOMETR INTELL LAB, V118, P120, DOI 10.1016/j.chemolab.2012.08.004; Chenouri S, 2009, J QUAL TECHNOL, V41, P259, DOI 10.1080/00224065.2009.11917781; Das Sutar SK, 2013, ACTA TROP, V126, P84, DOI 10.1016/j.actatropica.2013.01.010; Dhiman R. C., 2008, Regional Health Forum, V12, P27; Dhiman S, 2010, DEFENCE SCI J, V60, P213, DOI 10.14429/dsj.60.342; Epstein PR, 2005, NEW ENGL J MED, V353, P1433, DOI 10.1056/NEJMp058079; Goswami P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049713; Gupta S, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-227; Hay SI, 2004, LANCET INFECT DIS, V4, P327, DOI 10.1016/S1473-3099(04)01043-6; Hotelling H, 1947, TECHNIQUES STAT ANAL, P111; Huang F, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-54; Ijumba JN, 2002, MED VET ENTOMOL, V16, P28, DOI 10.1046/j.0269-283x.2002.00337.x; Jackson JE, 1991, USERS GUIDE PRINCIPA; Jusot JF, 2011, T ROY SOC TROP MED H, V105, P637, DOI 10.1016/j.trstmh.2011.07.011; Kanwal KS, 2013, CURR SCI INDIA, V105, P1037; Keiser J, 2002, J AM MOSQUITO CONTR, V18, P329; Koenraadt CJM, 2004, ACTA TROP, V90, P141, DOI 10.1016/j.actatropica.2003.11.007; Macdonald G., 1957, EPIDEMIOLOGY CONTROL; MARTENS WJM, 1995, ENVIRON HEALTH PERSP, V103, P458, DOI 10.2307/3432584; MASON RL, 1995, J QUAL TECHNOL, V27, P99; Model Fabian, 2002, Bioinformatics, V18 Suppl 1, pS155; Oesterholt MJAM, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-98; Paaijmans KP, 2009, P NATL ACAD SCI USA, V106, P13844, DOI 10.1073/pnas.0903423106; Paaijmans KP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001146; Parham PE, 2010, ENVIRON HEALTH PERSP, V118, P620, DOI 10.1289/ehp.0901256; Sattenspiel L, 2000, YEARB PHYS ANTHROPOL, V43, P3, DOI 10.1002/1096-8644(2000)43:31+&lt;3::AID-AJPA2&gt;3.0.CO;2-Z; Smith AD, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a120; Sumana C, 2011, ASIA-PAC J CHEM ENG, V6, P460, DOI 10.1002/apj.573; Valle S, 1999, IND ENG CHEM RES, V38, P4389, DOI 10.1021/ie990110i; Waldock J, 2013, PATHOG GLOB HEALTH, V107, P387, DOI 10.1179/2047772413Z.000000000161; WHO, 2012, WORLD MALARIA REPORT 2012, P1; WHO, 2010, WORLD MALARIA REPORT 2010, P1; Xiong MM, 2002, AM J HUM GENET, V70, P1257, DOI 10.1086/340392; Zhang Y, 2010, ENVIRON INT, V36, P439, DOI 10.1016/j.envint.2010.03.005; Zhou G, 2004, P NATL ACAD SCI USA, V101, P2375, DOI 10.1073/pnas.0308714100	43	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0119514	10.1371/journal.pone.0119514	http://dx.doi.org/10.1371/journal.pone.0119514			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803481	Green Published, gold, Green Submitted			2022-12-26	WOS:000353889600029
J	Anton, L; Olarerin-George, AO; Hogenesch, JB; Elovitz, MA				Anton, Lauren; Olarerin-George, Anthony O.; Hogenesch, John B.; Elovitz, Michal A.			Placental Expression of miR-517a/b and miR-517c Contributes to Trophoblast Dysfunction and Preeclampsia	PLOS ONE			English	Article							HUMAN CYTOTROPHOBLAST DIFFERENTIATION; GROWTH-FACTOR; CIRCULATING LEVELS; C19MC MICRORNAS; GENE-EXPRESSION; HYPOXIA ALTERS; INVASION; ANGIOGENESIS; PREGNANCY; MIR-210	Preeclampsia is a pregnancy specific hypertensive disease that confers significant maternal and fetal risks. While the exact pathophysiology of preeclampsia is unknown, it is widely accepted that placental dysfunction is mechanistically involved. Recent studies reported aberrant expression of placenta-specific microRNAs ( miRNAs) in preeclampsia including miR-517a/b and miR-517c. Using placental biopsies from a preeclampsia case-control study, we found increased expression of miR-517a/b in term and preterm preeclampsia vs controls, while, miR-517c was increased only in preterm preeclampsia vs controls. To determine if miR-517a/b and miR-517c are regulated by hypoxia, we treated first trimester primary extravillous trophoblast cells (EVTs) with a hypoxia mimetic and found both were induced. To test for a mechanistic role in placental function, we overexpressed miR-517a/b or miR-517c in EVTs which resulted in decreased trophoblast invasion. Additionally, we found that miR-517a/b and miR-517c overexpression increased expression of the anti-angiogenic protein, sFLT1. The regulation of sFLT1 is mostly unknown, however, TNFSF15, a cytokine involved in FLT1 splicing, was also increased by miR-517a/b and miR-517c in EVTs. In summary, we demonstrate that miR-517a/b and miR-517c contribute to the development of preeclampsia and suggest that these miRNAs play a critical role in regulating trophoblast and placental function.	[Anton, Lauren; Elovitz, Michal A.] Univ Penn, Dept Obstet & Gynecol, Maternal & Child Hlth Res Program, Perelman Sch Med, Philadelphia, PA 19104 USA; [Olarerin-George, Anthony O.; Hogenesch, John B.] Univ Penn, Genom & Computat Biol Grad Grp, Perelman Sch Med, Philadelphia, PA 19104 USA; [Olarerin-George, Anthony O.; Hogenesch, John B.] Univ Penn, Dept Pharmacol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Olarerin-George, Anthony O.; Hogenesch, John B.] Univ Penn, Perelman Sch Med, Inst Translat Med & Therapeut, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Anton, L (corresponding author), Univ Penn, Dept Obstet & Gynecol, Maternal & Child Hlth Res Program, Perelman Sch Med, Philadelphia, PA 19104 USA.	lanton@mail.med.upenn.edu		Elovitz, Michal/0000-0001-7554-7180; Olarerin-George, Anthony/0000-0002-6109-3824	Maternal and Child Health Research Fund at the University of Pennsylvania (MAE); National Human Genome Research Institute [T32HG000046]; National Institute of Neurological Disorders and Stroke [1R01NS054794-06]; Defense Advanced Research Projects Agency [DARPA-D12AP00025]; Penn Genome Frontiers Institute under a HRFF; Pennsylvania Department of Health; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000046] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES013508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054794] Funding Source: NIH RePORTER	Maternal and Child Health Research Fund at the University of Pennsylvania (MAE); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Penn Genome Frontiers Institute under a HRFF; Pennsylvania Department of Health; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Maternal and Child Health Research Fund at the University of Pennsylvania (MAE). Additionally, support was provided by National Human Genome Research Institute training grant T32HG000046 (AO) and by the National Institute of Neurological Disorders and Stroke (1R01NS054794-06 to JBH), the Defense Advanced Research Projects Agency (DARPA-D12AP00025, to John Harer, Duke University) (JBH), and by the Penn Genome Frontiers Institute under a HRFF grant with the Pennsylvania Department of Health (JBH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2004, CIRC RES, V95, P884, DOI 10.1161/01.RES.0000147365.86159.f5; Anton L, 2013, AM J PATHOL, V183, P1437, DOI 10.1016/j.ajpath.2013.07.021; Anton L, 2012, HUM REPROD, V27, P61, DOI 10.1093/humrep/der362; Barad O, 2004, GENOME RES, V14, P2486, DOI 10.1101/gr.2845604; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Biadasiewicz K, 2011, ENDOCRINOLOGY, V152, P1458, DOI 10.1210/en.2010-0936; Boeckel JN, 2011, P NATL ACAD SCI USA, V108, P3276, DOI 10.1073/pnas.1008098108; BROSENS I, 1967, J PATHOL BACTERIOL, V93, P569, DOI 10.1002/path.1700930218; Chang Jeani, 2003, MMWR Surveill Summ, V52, P1; Conrad KP, 1998, AM J REPROD IMMUNOL, V40, P102; Donker RB, 2012, MOL HUM REPROD, V18, P417, DOI 10.1093/molehr/gas013; Endo K, 2010, CYTOKINE, V49, P215, DOI 10.1016/j.cyto.2009.09.006; Enquobahrie DA, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.09.004; Enquobahrie DA, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.04.020; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Genbacev O, 1996, J CLIN INVEST, V97, P540, DOI 10.1172/JCI118447; Getsios S, 1998, J REPROD FERTIL, V114, P357; Gomez LM, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.10.872; GRAHAM CH, 1992, BIOL REPROD, V46, P561, DOI 10.1095/biolreprod46.4.561; Huang X, 2009, MOL CELL, V35, P856, DOI 10.1016/j.molcel.2009.09.006; Ishibashi O, 2012, HYPERTENSION, V59, P265, DOI 10.1161/HYPERTENSIONAHA.111.180232; Kambe S, 2014, BIOLOGY OF REPRODUCT; Karumanchi SA, 2004, ENDOCRINOLOGY, V145, P4835, DOI 10.1210/en.2004-1028; Koi H, 2002, BIOL REPROD, V67, P1572, DOI 10.1095/biolreprod.102.004325; Koonin L M, 1988, MMWR CDC Surveill Summ, V37, P19; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; LaMarca BD, 2007, CURR HYPERTENS REP, V9, P480, DOI 10.1007/s11906-007-0088-1; Laresgoiti-Servitje E, 2010, HUM REPROD UPDATE, V16, P510, DOI 10.1093/humupd/dmq007; Lipinski CA, 2005, NEOPLASIA, V7, P435, DOI 10.1593/neo.04712; Liu RF, 2013, CANCER LETT, V329, P164, DOI 10.1016/j.canlet.2012.10.027; Liu XH, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-348; Luo SS, 2009, BIOL REPROD, V81, P717, DOI 10.1095/biolreprod.108.075481; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; MEEKINS JW, 1994, BRIT J OBSTET GYNAEC, V101, P669, DOI 10.1111/j.1471-0528.1994.tb13182.x; Miura K, 2014, PLACENTA, V35, P848, DOI 10.1016/j.placenta.2014.06.002; Miura K, 2010, CLIN CHEM, V56, P1767, DOI 10.1373/clinchem.2010.147660; Mouillet JF, 2010, PLACENTA, V31, P781, DOI 10.1016/j.placenta.2010.07.001; Mouillet JF, 2010, FASEB J, V24, P2030, DOI 10.1096/fj.09-149724; Murphy SR, 2013, AM J PHYSIOL-REG I, V304, pR130, DOI 10.1152/ajpregu.00069.2012; Neudeck H, 1997, HISTOCHEM J, V29, P419, DOI 10.1023/A:1026499203743; Nguyen QD, 2006, MOL CANCER THER, V5, P2070, DOI 10.1158/1535-7163.MCT-06-0044; Noguer-Dance M, 2010, HUM MOL GENET, V19, P3566, DOI 10.1093/hmg/ddq272; Olarerin-George AO, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-19; Pineles BL, 2007, AM J OBSTET GYNECOL, V196, P261, DOI 10.1016/j.ajog.2007.01.008; Piret JP, 2002, ANN NY ACAD SCI, V973, P443, DOI 10.1111/j.1749-6632.2002.tb04680.x; Qi JW, 2013, P NATL ACAD SCI USA, V110, P13863, DOI 10.1073/pnas.1304529110; Sitras V, 2009, PLACENTA, V30, P424, DOI 10.1016/j.placenta.2009.01.012; Soleymanlou N, 2005, J CLIN ENDOCR METAB, V90, P4299, DOI 10.1210/jc.2005-0078; Srinivas SK, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.01.040; Srinivas SK, 2009, J MATERN-FETAL NEO M, V22, P501, DOI 10.1080/14767050902794642; Staun-Ram E, 2009, PLACENTA, V30, P1029, DOI 10.1016/j.placenta.2009.09.010; Steegers EAP, 2010, LANCET, V376, P631, DOI 10.1016/S0140-6736(10)60279-6; Taylor RN, 2003, AM J OBSTET GYNECOL, V188, P177, DOI 10.1067/mob.2003.111; Tsai KW, 2009, EPIGENETICS-US, V4, P587, DOI 10.4161/epi.4.8.10230; Wang W, 2012, J CLIN ENDOCR METAB, V97, pE1051, DOI 10.1210/jc.2011-3131; Webby CJ, 2009, SCIENCE, V325, P90, DOI 10.1126/science.1175865; Xie L, 2014, ENDOCRINOLOGY, V155, P4975, DOI 10.1210/en.2014-1501; Yaung J, 2008, EXP EYE RES, V86, P355, DOI 10.1016/j.exer.2007.11.007; Yu JY, 2001, CIRC RES, V89, P1161, DOI 10.1161/hh2401.101909; Yuen RKC, 2013, EPIGENETICS-US, V8, P192, DOI 10.4161/epi.23400; Zhai YF, 1999, FASEB J, V13, P181, DOI 10.1096/fasebj.13.1.181; Zhang R, 2008, MOL BIOL EVOL, V25, P1493, DOI 10.1093/molbev/msn094; Zhou Y, 1998, J REPROD IMMUNOL, V39, P197, DOI 10.1016/S0165-0378(98)00022-9; Zhu XM, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.12.045	65	58	62	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0122707	10.1371/journal.pone.0122707	http://dx.doi.org/10.1371/journal.pone.0122707			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799546	Green Published, Green Submitted, gold			2022-12-26	WOS:000351987300341
J	Arias, C; Fussero, G; Zacharonok, M; Macias, A				Arias, Carolina; Fussero, Gimena; Zacharonok, Marcelo; Macias, Ana			Dpp-Expressing and Non-Expressing Cells: Two Different Populations of Growing Cells in Drosophila	PLOS ONE			English	Article							JNK-DEPENDENT APOPTOSIS; PROLIFERATION; DEATH; GROWTH; GRADIENT; GENE; PHOSPHATASE; SURVIVAL; HOMOLOG; ENCODES	There are different models that explain growth during development. One model is based on insect and amphibian regeneration studies. This model proposes that growth is directed by pattern, and growth takes place by intercalation at a growth discontinuity; therefore, proliferation should surround the discontinuity. Currently, this model, apart from regenerative studies on mostly adult patterning, has not found supporting evidence in Drosophila that shows proliferation surrounding a discontinuity. Despite this lack of evidence, the importance of discontinuities has been shown in different experiments, even under wt conditions, more specifically in the formation of the leg joints because of the occurrence of cell death at their boundaries. Here, we show the existence of a sharp discontinuity in Decapentaplegic (Dpp) in the genital discs at the third larvae stage (L3), which determines the upregulation in the Jun-NH2-Terminal-Kinase (JNK) pathway, reaper (rpr), head involution defective (hid) and active caspases from its boundaries. The proliferation and cell death surrounding the discontinuity suggest that growth can proceed by intercalation and competitive death takes place in this area. Finally, we show that the Rpr, Grim and Hid (RGH) products are a few of the factors that define the growth discontinuity because they are negative regulators of growth, a new function that is unique from their known functions in apoptosis.	[Arias, Carolina; Fussero, Gimena; Zacharonok, Marcelo; Macias, Ana] Univ Nacl Cordoba, Fac Ciencias Exactas Fis & Nat, Dept Fisiol, Catedra Genet, RA-5000 Cordoba, Argentina	National University of Cordoba	Macias, A (corresponding author), Univ Nacl Cordoba, Fac Ciencias Exactas Fis & Nat, Dept Fisiol, Catedra Genet, RA-5000 Cordoba, Argentina.	amacias@com.uncor.edu		Fussero, Gimena Betina/0000-0003-0213-0637	Secretaria de Ciencia y Tecnica de la Universidad Nacional de Cordoba, Argentina (SECYT-UNC) [21610, 217-11, 162-12, 124-13]; Consejo Nacional de Ciencia y Tecnica (CONICET) [4541-12]; CONICET-UNC; UNC	Secretaria de Ciencia y Tecnica de la Universidad Nacional de Cordoba, Argentina (SECYT-UNC); Consejo Nacional de Ciencia y Tecnica (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); CONICET-UNC; UNC	Funding for the research was provided by Secretaria de Ciencia y Tecnica de la Universidad Nacional de Cordoba, Argentina (SECYT-UNC) 21610; 217-11; 162-12; 124-13) and Consejo Nacional de Ciencia y Tecnica (CONICET) (4541-12) to A. Macias. Ana Macias is supported by CONICET-UNC. Carolina Arias and Gimena Fussero were supported by UNC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi-Yamada T, 2002, DEV BIOL, V251, P74, DOI 10.1006/dbio.2002.0821; Adachi-Yamada T, 1999, NATURE, V400, P166, DOI 10.1038/22112; Benitez S, 2010, INT J DEV BIOL, V54, P643, DOI 10.1387/ijdb.082724sb; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Campbell G, 1999, CELL, V96, P553, DOI 10.1016/S0092-8674(00)80659-5; de Navas L, 2006, MECH DEVELOP, V123, P860, DOI 10.1016/j.mod.2006.07.010; Di Rienzo JA., 2012, INFOSTAT; Entchev EV, 2000, CELL, V103, P981, DOI 10.1016/S0092-8674(00)00200-2; Estrada B, 2003, DIFFERENTIATION, V71, P299, DOI 10.1046/j.1432-0436.2003.03017.x; FRENCH V, 1976, SCIENCE, V193, P969, DOI 10.1126/science.948762; Golic MM, 1997, NUCLEIC ACIDS RES, V25, P3665, DOI 10.1093/nar/25.18.3665; GRETHER ME, 1995, GENE DEV, V9, P1694, DOI 10.1101/gad.9.14.1694; Hay BA, 2006, ANNU REV CELL DEV BI, V22, P623, DOI 10.1146/annurev.cellbio.21.012804.093845; HAYNIE JL, 1976, NATURE, V259, P659, DOI 10.1038/259659b0; Holley CL, 2002, NAT CELL BIOL, V4, P439, DOI 10.1038/ncb798; Huh JR, 2004, CURR BIOL, V14, P1262, DOI 10.1016/j.cub.2004.06.015; Jiang CA, 2000, MOL CELL, V5, P445, DOI 10.1016/S1097-2765(00)80439-6; Kurada P, 1998, CELL, V95, P319, DOI 10.1016/S0092-8674(00)81764-X; Lawrence PA, 1996, CELL, V85, P951, DOI 10.1016/S0092-8674(00)81297-0; Li W, 2007, CELL, V129, P1215, DOI 10.1016/j.cell.2007.03.054; Manjon C, 2007, NAT CELL BIOL, V9, P57, DOI 10.1038/ncb1518; Martin FA, 2004, DEVELOPMENT, V131, P4921, DOI 10.1242/dev.01385; Martin-Blanco E, 1998, GENE DEV, V12, P557, DOI 10.1101/gad.12.4.557; Martin-Castellanos C, 2002, DEVELOPMENT, V129, P1003; McEwen DG, 2005, DEVELOPMENT, V132, P3935, DOI 10.1242/dev.01949; Moreno E, 2002, CURR BIOL, V12, P1263, DOI 10.1016/S0960-9822(02)00954-5; Moreno E, 2002, NATURE, V416, P755, DOI 10.1038/416755a; Muller B, 2003, CELL, V113, P221, DOI 10.1016/S0092-8674(03)00241-1; Neufeld TP, 1998, CELL, V93, P1183, DOI 10.1016/S0092-8674(00)81462-2; Perez-Garijo A, 2004, DEVELOPMENT, V131, P5591, DOI 10.1242/dev.01432; Ryoo HD, 2004, DEV CELL, V7, P491, DOI 10.1016/j.devcel.2004.08.019; STAEHLINGHAMPTON K, 1994, CELL GROWTH DIFFER, V5, P585; Wartlick O, 2011, SCIENCE, V331, P1154, DOI 10.1126/science.1200037; WHITE K, 1994, SCIENCE, V264, P677, DOI 10.1126/science.8171319	35	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121457	10.1371/journal.pone.0121457	http://dx.doi.org/10.1371/journal.pone.0121457			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798905	Green Published, gold, Green Submitted			2022-12-26	WOS:000351987300254
J	Castro, LM; Calvas, B; Knoke, T				Castro, Luz Maria; Calvas, Baltazar; Knoke, Thomas			Ecuadorian Banana Farms Should Consider Organic Banana with Low Price Risks in Their Land-Use Portfolios	PLOS ONE			English	Article							REAL OPTIONS; POLICY; AGRICULTURE; FORESTRY; BIODIVERSITY; VALUATION; PAYMENTS	Organic farming is a more environmentally friendly form of land use than conventional agriculture. However, recent studies point out production tradeoffs that often prevent the adoption of such practices by farmers. Our study shows with the example of organic banana production in Ecuador that economic tradeoffs depend much on the approach of the analysis. We test, if organic banana should be included in economic land-use portfolios, which indicate how much of the land is provided for which type of land-use. We use time series data for productivity and prices over 30 years to compute the economic return (as annualized net present value) and its volatility (with standard deviation as risk measure) for eight crops to derive land-use portfolios for different levels of risk, which maximize economic return. We find that organic banana is included in land-use portfolios for almost every level of accepted risk with proportions from 1% to maximally 32%, even if the same high uncertainty as for conventional banana is simulated for organic banana. A more realistic, lower simulated price risk increased the proportion of organic banana substantially to up to 57% and increased annual economic returns by up to US$ 187 per ha. Under an assumed integration of both markets, for organic and conventional banana, simulated by an increased coefficient of correlation of economic return from organic and conventional banana (rho up to + 0.7), organic banana holds significant portions in the land-use portfolios tested only, if a low price risk of organic banana is considered. We conclude that uncertainty is a key issue for the adoption of organic banana. As historic data support a low price risk for organic banana compared to conventional banana, Ecuadorian farmers should consider organic banana as an advantageous land-use option in their land-use portfolios.	[Castro, Luz Maria; Knoke, Thomas] Tech Univ Munich, Dept Ecol & Ecosyst Management, TUM Sch Life Sci Weihenstephan, Inst Forest Management, Freising Weihenstephan, Germany; [Calvas, Baltazar] Tech Univ Munich, Dept Ecol & Ecosyst Management, TUM Sch Life Sci Weihenstephan, Inst Silviculture, Freising Weihenstephan, Germany; [Castro, Luz Maria] Univ Tecn Particular Loja, Dept Econ, Loja, Ecuador	Technical University of Munich; Technical University of Munich; Universidad Tecnica Particular de Loja	Knoke, T (corresponding author), Tech Univ Munich, Dept Ecol & Ecosyst Management, TUM Sch Life Sci Weihenstephan, Inst Forest Management, Freising Weihenstephan, Germany.	knoke@forst.wzw.tum.de	Knoke, Thomas Friedrich/H-8965-2019; Castro, Luz Maria/S-5518-2019; Knoke, Thomas F/B-2617-2009	Knoke, Thomas Friedrich/0000-0003-1380-3438; Knoke, Thomas F/0000-0003-0535-5946	Deutsche Forschugsgemeinschaft [KN 586/5-2, KN 586/9-1]	Deutsche Forschugsgemeinschaft(German Research Foundation (DFG))	Funding: This work was supported by Deutsche Forschugsgemeinschaft KN 586/5-2; KN 586/9-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acs S, 2005, NJAS-WAGEN J LIFE SC, V53, P1, DOI 10.1016/S1573-5214(05)80007-7; Adl S, 2011, SCI TOTAL ENVIRON, V409, P2192, DOI 10.1016/j.scitotenv.2011.02.026; Adner R, 2004, ACAD MANAGE REV, V29, P74, DOI 10.2307/20159010; Almeida P, 1992, TIPO CAMBIO ECUADOR; Alston JM, 2009, SCIENCE, V325, P1209, DOI 10.1126/science.1170451; Anderson JR, 2003, AGR SYST, V75, P161, DOI 10.1016/S0308-521X(02)00064-1; Baquero M, 2004, APUNTES EC; Baumgartner S, 2010, AGR ECON-BLACKWELL, V41, P483, DOI 10.1111/j.1574-0862.2010.00460.x; Beddington J, 2010, PHILOS T R SOC B, V365, P61, DOI 10.1098/rstb.2009.0201; Bolwig S, 2009, WORLD DEV, V37, P1094, DOI 10.1016/j.worlddev.2008.09.012; Borbor-Cordova MJ, 2006, BIOGEOCHEMISTRY, V79, P135, DOI 10.1007/s10533-006-9009-7; Busby J.S., 1997, MANAGE ACCOUNTING, V8, P169, DOI [10.1006/mare.1996.0040, DOI 10.1006/MARE.1996.0040]; CAPOZZA DR, 1994, J URBAN ECON, V35, P297, DOI 10.1006/juec.1994.1018; Castro LM, 2013, AGROFOREST SYST, V87, P331, DOI 10.1007/s10457-012-9554-0; DIXIT AK, 1995, HARVARD BUS REV, V73, P105; Duku-Kaakyire A, 2004, FOREST POLICY ECON, V6, P539, DOI 10.1016/S1389-9341(03)00003-0; Evenson RE, 2003, SCIENCE, V300, P758, DOI 10.1126/science.1078710; FAO, 2013, STAT FOOD AGR INV AG; FAO, 2010, GROW FOOD 9 BILL; FAO (Food and Agriculture Organization of the United Nations), 2007, STAT FOOD AGR PAYING; Francis JK, 1991, OCHROMA PYRAMIDALE C; Green RE, 2005, SCIENCE, V307, P550, DOI 10.1126/science.1106049; Gunapala N, 1998, SOIL BIOL BIOCHEM, V30, P805, DOI 10.1016/S0038-0717(97)00162-4; Hao AM, 2010, AGRIC AGRIC SCI PROC, V1, P152, DOI 10.1016/j.aaspro.2010.09.018; Hazell P, 2008, PHILOS T R SOC B, V363, P495, DOI 10.1098/rstb.2007.2166; Hildebrandt P, 2011, FOREST POLICY ECON, V13, P1, DOI 10.1016/j.forpol.2010.09.001; Hirshleifer J., 2002, ANAL UNCERTAINTY INF; INIAP, 2000, COST TECHN PRINC CUL; Insley M, 2002, J ENVIRON ECON MANAG, V44, P471, DOI 10.1006/jeem.2001.1209; Intergovernmental Group on Bananas and Tropical Fruits, 2014, BAN MARK REV BAN STA; International Institute for Sustainable Development (IISD) and the International Institute for Environment and Development (IIED), 2014, STAT SUST IN REV 201; Jacobsen JB, 2003, FOREST ECOL MANAG, V180, P375, DOI 10.1016/S0378-1127(02)00652-7; Jimenez M, 2007, RENEW AGR FOOD SYST, V22, P297, DOI 10.1017/S1742170507001895; Kilian B, 2005, VALUE CHAIN ORGANIC; Kleemann L, 2014, ECONOMICS-KIEL, V8, DOI 10.5018/economics-ejournal.ja.2014-14; Knoke T, 2006, EUR J FOREST RES, V125, P303, DOI 10.1007/s10342-006-0119-5; Knoke T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6612; Knoke T, 2013, GLOBAL ENVIRON CHANG, V23, P1064, DOI 10.1016/j.gloenvcha.2013.07.004; Knoke T, 2012, FRONT ECOL ENVIRON, V10, P438, DOI 10.1890/110203; Knoke T, 2011, ECOL ECON, V70, P1139, DOI 10.1016/j.ecolecon.2011.01.007; Knoke T, 2009, ERDKUNDE, V63, P365, DOI 10.3112/erdkunde.2009.04.06; Liu P, 2008, CERTIFICATION VALUE; Mader P, 2002, SCIENCE, V296, P1694, DOI 10.1126/science.1071148; Markowitz H, 1952, J FINANC, V7, P77, DOI 10.1111/j.1540-6261.1952.tb01525.x; Markowitz HM, 2010, ANNU REV FINANC ECON, V2, P1, DOI 10.1146/annurev-financial-011110-134602; Matson PA, 1997, SCIENCE, V277, P504, DOI 10.1126/science.277.5325.504; Mukul A.Z.A., 2013, INT J EC FINANC MANA, V1, P159; Ogurtsov VA, 2008, NJAS-WAGEN J LIFE SC, V56, P39, DOI 10.1016/S1573-5214(08)80016-4; Parvin MM, 2013, INT J RES COMMERCE I, V3, P113; Pearce D, 2003, FOREST ECOL MANAG, V172, P229, DOI 10.1016/S0378-1127(01)00798-8; Phalan B, 2011, SCIENCE, V333, P1289, DOI 10.1126/science.1208742; Phalan B, 2011, FOOD POLICY, V36, pS62, DOI 10.1016/j.foodpol.2010.11.008; Pimentel D, 2005, BIOSCIENCE, V55, P573, DOI 10.1641/0006-3568(2005)055[0573:EEAECO]2.0.CO;2; Plantinga AJ, 1998, FOREST SCI, V44, P192; Power AG, 2010, PHILOS T R SOC B, V365, P2959, DOI 10.1098/rstb.2010.0143; Roberts L, 2009, SCIENCE, V325, P555, DOI 10.1126/science.325_555; ROLL R, 1977, J FINANC ECON, V4, P129, DOI 10.1016/0304-405X(77)90009-5; Rosenzweig M. R., 1992, WEALTH WEATHER RISK, V1055; Seufert V, 2012, NATURE, V485, P229, DOI 10.1038/nature11069; Sherwood S, 2000, APPL SOIL ECOL, V15, P85, DOI 10.1016/S0929-1393(00)00074-3; Su Y, 2013, C PAPER AAEA 2013 AN; Tilman D, 2002, NATURE, V418, P671, DOI 10.1038/nature01014; TRIGEORGIS L, 1993, J FINANC QUANT ANAL, V28, P1, DOI 10.2307/2331148; Tscharntke T, 2012, BIOL CONSERV, V151, P53, DOI 10.1016/j.biocon.2012.01.068; van Putten AB, 2004, HARVARD BUS REV, V82, P134; Von Thuanen J.H., 1842, ISOLIERTE STAAT BEZI; Weber M., 2008, V198, P431; Wunder S, 2001, AGRICULTURAL TECHNOLOGIES AND TROPICAL DEFORESTATION, P167, DOI 10.1079/9780851994512.0167; Yemshanov D, 2014, FOR POL EC	69	26	28	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120384	10.1371/journal.pone.0120384	http://dx.doi.org/10.1371/journal.pone.0120384			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE6ZS	25799506	Green Published, gold, Green Submitted			2022-12-26	WOS:000351987300140
J	Chen, X; Liu, XJ; Lang, HB; Zhang, SQ; Luo, YL; Zhang, J				Chen, Xue; Liu, Xinjuan; Lang, Haibo; Zhang, Shiqi; Luo, Yanlin; Zhang, Jie			S100 Calcium-Binding Protein A6 Promotes Epithelial-Mesenchymal Transition through beta-Catenin in Pancreatic Cancer Cell Line	PLOS ONE			English	Article							INTERACTING PROTEIN; TUMOR-CELLS; EXPRESSION; CALCYCLIN; DEGRADATION; METASTASIS; SIAH-1; TARGET	The pathogenesis of pancreatic ductal adenocarcinoma (PDAC) remains poorly understood. S100 calcium-binding protein A6 (S100A6) has been associated with PDAC; however, the effect of S100A6 on PDAC migration and invasion has not yet been explored. In this study, Panc-1 cells were transfected with a plasmid to induce overexpression of S100A6, and beta-catenin was knocked down using a specific short hairpin RNA (shRNA). The wound-healing and Transwell assays demonstrated that S100A6 promoted PDAC cell migration and invasion. Furthermore, beta-catenin shRNA inhibited the migration and invasion of PDAC cells. We confirmed that S100A6 induces PDAC cell migration and invasion via activation of beta-catenin in vitro. Assessment of mRNA and protein levels revealed that S100A6 induces increased expression of beta-catenin, N-cadherin and vimentin, and decreased expression of E-cadherin in PDAC cells. beta-catenin shRNA also altered the expression of epithelial-mesenchymal transition (EMT)-related markers in PDAC cells. Specifically, expression of E-cadherin was increased, whereas expression of N-cadherin and vimentin was decreased. Finally, we demonstrated that S100A6 alters the expression of EMT-related markers via beta-catenin activation. In conclusion, S100A6 induces EMT and promotes cell migration and invasion in a beta-catenin-dependent manner. S100A6 may therefore represent a novel potential therapeutic target for the treatment of pancreatic cancer.	[Chen, Xue; Lang, Haibo; Zhang, Shiqi; Zhang, Jie] Capital Med Univ, Beijing An Zhen Hosp, Dept Gastroenterol, Beijing, Peoples R China; [Liu, Xinjuan] Capital Med Univ, Beijing Chao Yang Hosp, Dept Gastroenterol, Beijing, Peoples R China; [Luo, Yanlin] Capital Med Univ, Dept Neurobiol, Beijing, Peoples R China; [Luo, Yanlin] Capital Med Univ, Sch Basic Med Sci, Beijing Inst Brain Disorders, Beijing, Peoples R China	Capital Medical University; Capital Medical University; Capital Medical University; Capital Medical University	Zhang, J (corresponding author), Capital Med Univ, Beijing An Zhen Hosp, Dept Gastroenterol, Beijing, Peoples R China.	zhangjie4155@sina.com			Basic and Clinical Cooperation Foundation of Capital Medical University(China) [13JL77]	Basic and Clinical Cooperation Foundation of Capital Medical University(China)	This work was supported by the Basic and Clinical Cooperation Foundation of Capital Medical University No. 13JL77 (China). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bo HJ, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-496; Bonnomet A, 2010, J MAMMARY GLAND BIOL, V15, P261, DOI 10.1007/s10911-010-9174-0; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; De Craene B, 2013, NAT REV CANCER, V13, P97, DOI 10.1038/nrc3447; Filipek A, 2006, CHEMOTHERAPY, V52, P32, DOI 10.1159/000090240; Gao ZH, 2014, ONCOL LETT, V8, P2069, DOI 10.3892/ol.2014.2433; Guo ZH, 2013, J CLIN GASTROENTEROL, V47, P69, DOI 10.1097/MCG.0b013e3182601752; Cao H, 2013, ANTICANCER RES, V33, P1785; Ji YF, 2014, INT J MOL MED, V33, P769, DOI 10.3892/ijmm.2014.1633; Jurewicz E, 2013, NEUROCHEM RES, V38, P1941, DOI 10.1007/s11064-013-1100-6; Kahn M, 2014, NAT REV DRUG DISCOV, V13, P513, DOI 10.1038/nrd4233; Krantz SB, 2012, J SURG RES, V173, P105, DOI 10.1016/j.jss.2011.09.020; Lee YT, 2008, BIOCHEMISTRY-US, V47, P10921, DOI 10.1021/bi801233z; Lesniak W, 2009, BIOCHEM BIOPH RES CO, V390, P1087, DOI 10.1016/j.bbrc.2009.10.150; Li ZQ, 2014, J MOL MED, V92, P291, DOI 10.1007/s00109-013-1104-3; Logsdon CD, 2003, CANCER RES, V63, P2649; Long J, 2014, CANCER LETT, V346, P273, DOI 10.1016/j.canlet.2014.01.004; Matsuzawa S, 2001, MOL CELL, V7, P915, DOI 10.1016/S1097-2765(01)00242-8; Micalizzi DS, 2010, J MAMMARY GLAND BIOL, V15, P117, DOI 10.1007/s10911-010-9178-9; Nowotny M, 2000, J BIOL CHEM, V275, P31178, DOI 10.1074/jbc.M001622200; Ohuchida K, 2005, CLIN CANCER RES, V11, P7785, DOI 10.1158/1078-0432.CCR-05-0714; Ohuchida K, 2007, CANCER EPIDEM BIOMAR, V16, P649, DOI 10.1158/1055-9965.EPI-06-0157; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Rosenbluh J, 2014, TRENDS PHARMACOL SCI, V35, P103, DOI 10.1016/j.tips.2013.11.007; Saito-Diaz K, 2013, GROWTH FACTORS, V31, P1, DOI 10.3109/08977194.2012.752737; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Ueno K, 2013, INT J CANCER, V132, P1731, DOI 10.1002/ijc.27746; Vimalachandran D, 2005, CANCER RES, V65, P3218, DOI 10.1158/0008-5472.CAN-04-4311; Wang YH, 2014, NAT CELL BIOL, V16, P1092, DOI 10.1038/ncb3050; Xu W, 2015, CANCER LETT IN PRESS; Xu XF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096441; Yu M, 2012, NATURE, V487, P510, DOI 10.1038/nature11217; Zhai HH, 2008, J HISTOCHEM CYTOCHEM, V56, P765, DOI 10.1369/jhc.2008.950519; Zhang JL, 2014, DIGEST DIS SCI, V59, P2136, DOI 10.1007/s10620-014-3137-z	35	25	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121319	10.1371/journal.pone.0121319	http://dx.doi.org/10.1371/journal.pone.0121319			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799022	Green Submitted, Green Published, gold			2022-12-26	WOS:000351987300235
J	Chung, D; Young, J; Bomble, YJ; Vander Wall, TA; Groom, J; Himmel, ME; Westpheling, J				Chung, Daehwan; Young, Jenna; Bomble, Yannick J.; Vander Wall, Todd A.; Groom, Joseph; Himmel, Michael E.; Westpheling, Janet			Homologous Expression of the Caldicellulosiruptor bescii CelA Reveals that the Extracellular Protein Is Glycosylated	PLOS ONE			English	Article							STREPTOMYCES-LIVIDANS GLYCOSYLATES; CARBOHYDRATE-BINDING MODULE; ACCESSORY SEC SYSTEM; STREPTOCOCCUS-GORDONII; CELLULOMONAS-FIMI; PLANT BIOMASS; DELETION; ENZYME; THERMOSTABILITY; GLYCOPROTEINS	Members of the bacterial genus Caldicellulosiruptor are the most thermophilic cellulolytic microbes described with ability to digest lignocellulosic biomass without conventional pretreatment. The cellulolytic ability of different species varies dramatically and correlates with the presence of the multimodular cellulase CelA, which contains both a glycoside hydrolase family 9 endoglucanase and a glycoside hydrolase family 48 exoglucanase known to be synergistic in their activity, connected by three cellulose-binding domains via linker peptides. This architecture exploits the cellulose surface ablation driven by its general cellulase processivity as well as excavates cavities into the surface of the substrate, revealing a novel paradigm for cellulase activity. We recently reported that a deletion of celA in C. bescii had a significant effect on its ability to utilize complex biomass. To analyze the structure and function of CelA and its role in biomass deconstruction, we constructed a new expression vector for C. bescii and were able, for the first time, to express significant quantities of full-length protein in vivo in the native host. The protein, which contains a Histidine tag, was active and excreted from the cell. Expression of CelA protein with and without its signal sequence allowed comparison of protein retained intracellularly to protein transported extra-cellularly. Analysis of protein in culture supernatants revealed that the extracellular CelA protein is glycosylated whereas the intracellular CelA is not, suggesting that either protein transport is required for this post-translational modification or that glycosylation is required for protein export. The mechanism and role of protein glycosylation in bacteria is poorly understood and the ability to express CelA in vivo in C. bescii will allow the study of the mechanism of protein glycosylation in this thermophile. It will also allow the study of glycosylation of CelA itself and its role in the structure and function of this important enzyme in biomass deconstruction.	[Chung, Daehwan; Young, Jenna; Groom, Joseph; Westpheling, Janet] Univ Georgia, Dept Genet, Athens, GA 30602 USA; [Bomble, Yannick J.; Vander Wall, Todd A.; Himmel, Michael E.] Natl Renewable Energy Lab, Biosci Ctr, Golden, CO USA; [Chung, Daehwan; Young, Jenna; Bomble, Yannick J.; Vander Wall, Todd A.; Groom, Joseph; Himmel, Michael E.; Westpheling, Janet] Oak Ridge Natl Lab, BioEnergy Sci Ctr, Oak Ridge, TN USA	University System of Georgia; University of Georgia; United States Department of Energy (DOE); National Renewable Energy Laboratory - USA; United States Department of Energy (DOE); Oak Ridge National Laboratory; BioEnergy Science Center (BESC)	Westpheling, J (corresponding author), Univ Georgia, Dept Genet, Athens, GA 30602 USA.	janwest@uga.edu		Bomble, Yannick/0000-0001-7624-8000	Office of Biological and Environmental Research in the DOE Office of Science [10-21-RR093-367]	Office of Biological and Environmental Research in the DOE Office of Science(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The BioEnergy Science Center is a U.S. Department of Energy Bioenergy Research Center supported by the Office of Biological and Environmental Research in the DOE Office of Science, grant # 10-21-RR093-367. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adney WS, 2009, CELLULOSE, V16, P699, DOI 10.1007/s10570-009-9305-1; Beckham GT, 2012, CURR OPIN BIOTECH, V23, P338, DOI 10.1016/j.copbio.2011.11.030; Bensing BA, 2002, MOL MICROBIOL, V44, P1081, DOI 10.1046/j.1365-2958.2002.02949.x; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Boraston AB, 2003, J MOL MICROB BIOTECH, V5, P29, DOI 10.1159/000068721; Boraston AB, 2001, BIOCHEM J, V358, P423, DOI 10.1042/0264-6021:3580423; Brunecky R, 2013, SCIENCE, V342, P1513, DOI 10.1126/science.1244273; Chauhan JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040155; Chung DH, 2011, J IND MICROBIOL BIOT, V38, P1867, DOI 10.1007/s10295-011-0976-x; Chung D, 2014, P NATL ACAD SCI USA, V111, P8931, DOI 10.1073/pnas.1402210111; Chung D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062881; Chung DW, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-82; Chung D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043844; Farkas J, 2013, J IND MICROBIOL BIOT, V40, P41, DOI 10.1007/s10295-012-1202-1; Garvey M, 2013, TRENDS BIOTECHNOL, V31, P581, DOI 10.1016/j.tibtech.2013.06.006; Groom J, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/s13068-014-0132-8; Jeoh T, 2008, BIOTECHNOL BIOFUELS, V1, DOI 10.1186/1754-6834-1-10; Kanafusa-Shinkai S, 2013, J BIOSCI BIOENG, V115, P64, DOI 10.1016/j.jbiosc.2012.07.019; LANGSFORD ML, 1987, FEBS LETT, V225, P163, DOI 10.1016/0014-5793(87)81150-X; MACLEOD AM, 1992, GENE, V121, P143, DOI 10.1016/0378-1119(92)90173-M; Messner P, 2004, J BACTERIOL, V186, P2517, DOI 10.1128/JB.186.9.2517-2519.2004; Messner P, 1997, GLYCOCONJUGATE J, V14, P3, DOI 10.1023/A:1018551228663; Moens S, 1997, ARCH MICROBIOL, V168, P169, DOI 10.1007/s002030050484; Nothaft H, 2010, NAT REV MICROBIOL, V8, P765, DOI 10.1038/nrmicro2383; OLSEN O, 1991, J GEN MICROBIOL, V137, P579, DOI 10.1099/00221287-137-3-579; ONG E, 1994, J BACTERIOL, V176, P999, DOI 10.1128/JB.176.4.999-1008.1994; Payne CM, 2013, P NATL ACAD SCI USA, V110, P14646, DOI 10.1073/pnas.1309106110; Sambrook J., 2001, MOL CLONING LAB MANU; Sammond DW, 2014, J BIOL CHEM, V289, P20960, DOI 10.1074/jbc.M114.573642; Schneewind O, 2012, PHILOS T R SOC B, V367, P1123, DOI 10.1098/rstb.2011.0210; SHEN H, 1991, J BIOL CHEM, V266, P11335; Sibbald MJJB, 2006, MICROBIOL MOL BIOL R, V70, P755, DOI 10.1128/MMBR.00008-06; Siboo IR, 2008, J BACTERIOL, V190, P6188, DOI 10.1128/JB.00300-08; Takamatsu D, 2005, J BACTERIOL, V187, P3878, DOI 10.1128/JB.187.11.3878-3883.2005; Voutilainen SP, 2010, PROTEIN ENG DES SEL, V23, P69, DOI 10.1093/protein/gzp072; Yi ZL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084172; Young J, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/s13068-014-0142-6; Zverlov V, 1998, MICROBIOL-SGM, V144, P457, DOI 10.1099/00221287-144-2-457	38	35	37	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0119508	10.1371/journal.pone.0119508	http://dx.doi.org/10.1371/journal.pone.0119508			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799047	Green Published, Green Submitted, gold			2022-12-26	WOS:000351987300056
J	Lester, PJ; Bosch, PJ; Gruber, MAM; Kapp, EA; Peng, LF; Brenton-Rule, EC; Buchanan, J; Stanislawek, WL; Archer, M; Corley, JC; Masciocchi, M; Van Oystaeyen, A; Wenseleers, T				Lester, Philip J.; Bosch, Peter J.; Gruber, Monica A. M.; Kapp, Eugene A.; Peng, Lifeng; Brenton-Rule, Evan C.; Buchanan, Joe; Stanislawek, Wlodek L.; Archer, Michael; Corley, Juan C.; Masciocchi, Maite; Van Oystaeyen, Annette; Wenseleers, Tom			No Evidence of Enemy Release in Pathogen and Microbial Communities of Common Wasps (Vespula vulgaris) in Their Native and Introduced Range	PLOS ONE			English	Article							DEFORMED WING VIRUS; HONEY-BEE; SOCIAL WASPS; BIOLOGICAL WEAPONS; STATISTICAL-MODEL; PARALYSIS VIRUS; HYMENOPTERA; TRANSMISSION; PROTEOMICS; VESPIDAE	When invasive species move to new environments they typically experience population bottlenecks that limit the probability that pathogens and parasites are also moved. The invasive species may thus be released from biotic interactions that can be a major source of density-dependent mortality, referred to as enemy release. We examined for evidence of enemy release in populations of the common wasp (Vespula vulgaris), which attains high densities and represents a major threat to biodiversity in its invaded range. Mass spectrometry proteomic methods were used to compare the microbial communities in wasp populations in the native (Belgium and England) and invaded range (Argentina and New Zealand). We found no evidence of enemy release, as the number of microbial taxa was similar in both the introduced and native range. However, some evidence of distinctiveness in the microbial communities was observed between countries. The pathogens observed were similar to a variety of taxa observed in honey bees. These taxa included Nosema, Paenibacillus, and Yersina spp. Genomic methods confirmed a diversity of Nosema spp., Actinobacteria, and the Deformed wing and Kashmir bee viruses. We also analysed published records of bacteria, viruses, nematodes and fungi from both V. vulgaris and the related invader V. germanica. Thirty-three different microorganism taxa have been associated with wasps including Kashmir bee virus and entomophagous fungi such as Aspergillus flavus. There was no evidence that the presence or absence of these microorganisms was dependent on region of wasp samples (i.e. their native or invaded range). Given the similarity of the wasp pathogen fauna to that from honey bees, the lack of enemy release in wasp populations is probably related to spill-over or spill-back from bees and other social insects. Social insects appear to form a reservoir of generalist parasites and pathogens, which makes the management of wasp and bee disease difficult.	[Lester, Philip J.; Gruber, Monica A. M.; Brenton-Rule, Evan C.; Buchanan, Joe] Victoria Univ Wellington, Ctr Biodivers & Restorat Ecol, Wellington, New Zealand; [Bosch, Peter J.; Peng, Lifeng] Victoria Univ Wellington, Ctr Biodiscovery, Wellington, New Zealand; [Bosch, Peter J.] Univ Iowa, Dept Biol, Iowa City, IA 52242 USA; [Kapp, Eugene A.] Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia; [Kapp, Eugene A.] Univ Melbourne, Melbourne, Vic, Australia; [Stanislawek, Wlodek L.] Minist Primary Ind, Invest & Diagnost Ctr Wallaceville, Upper Hutt, New Zealand; [Archer, Michael] York St John Univ, York, N Yorkshire, England; [Corley, Juan C.; Masciocchi, Maite] Consejo Nacl Invest Cient & Tecn, RA-1033 Buenos Aires, DF, Argentina; [Corley, Juan C.; Masciocchi, Maite] INTA EEA Bariloche, Grp Ecol Poblac Insectos, San Carlos De Bariloche, Rio Negro, Argentina; [Van Oystaeyen, Annette; Wenseleers, Tom] Univ Leuven, Lab Socioecol & Social Evolut, Leuven, Belgium	Victoria University Wellington; Victoria University Wellington; University of Iowa; Walter & Eliza Hall Institute; University of Melbourne; York Saint John University; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Instituto Nacional de Tecnologia Agropecuaria (INTA); KU Leuven	Lester, PJ (corresponding author), Victoria Univ Wellington, Ctr Biodivers & Restorat Ecol, Wellington, New Zealand.	Phil.Lester@vuw.ac.nz	Lester, Phil/A-1296-2008; Wenseleers, Tom/J-3960-2013; Masciocchi, Maite/K-3378-2019; Van Oystaeyen, Annette/AEG-9300-2022	Lester, Phil/0000-0002-1801-5687; Wenseleers, Tom/0000-0002-1434-861X; Bosch, Peter/0000-0002-0480-3439; Gruber, Monica/0000-0001-6780-8838; Peng, Lifeng/0000-0002-2043-5912; Masciocchi, Maite/0000-0002-0095-2170	Victoria University of Wellington; Department of Conservation; Royal Society of New Zealand Marsden Grant [13-VUW-037]; PIP CONICET [11220090100043]	Victoria University of Wellington; Department of Conservation; Royal Society of New Zealand Marsden Grant(Royal Society of New ZealandMarsden Fund (NZ)); PIP CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	PJL, MAMG, JB, PB, and ECBR received funding from Victoria University of Wellington, the Department of Conservation, and a Royal Society of New Zealand Marsden Grant (13-VUW-037). JCC and MM were funded by a PIP 2010 CONICET Grant #11220090100043. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511; Aizenberg-Gershtein Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067556; Anderson KE, 2011, INSECT SOC, V58, P431, DOI 10.1007/s00040-011-0194-6; Anderson KE, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058425, 10.1371/journal.pone.0083125]; Archer, 1989, RES MONOGRAPH COLL R, V31, P291; ARCHER ME, 1981, ECOL ENTOMOL, V6, P1, DOI 10.1111/j.1365-2311.1981.tb00966.x; ARCHER ME, 1985, J ANIM ECOL, V54, P473, DOI 10.2307/4492; BAKER MD, 1995, J EUKARYOT MICROBIOL, V42, P564, DOI 10.1111/j.1550-7408.1995.tb05906.x; Barlow ND, 2002, J ANIM ECOL, V71, P663, DOI 10.1046/j.1365-2656.2002.00630.x; Beggs JR, 2011, BIOCONTROL, V56, P505, DOI 10.1007/s10526-011-9389-z; Beggs JR, 1998, NEW ZEAL J ECOL, V22, P55; Blehert DS, 2009, SCIENCE, V323, P227, DOI 10.1126/science.1163874; Boerjan B, 2012, CAN J ZOOL, V90, P440, DOI 10.1139/Z2012-010; Bromenshenk JJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013181; Carpenter JM, 2010, AM MUS NOVIT, P1, DOI 10.1206/706.1; Colautti RI, 2004, ECOL LETT, V7, P721, DOI 10.1111/j.1461-0248.2004.00616.x; Dvorak Libor, 2007, Acta Musei Moraviae Scientiae Biologicae, V92, P181; Evans JD, 2011, TRENDS MICROBIOL, V19, P614, DOI 10.1016/j.tim.2011.09.003; Evison SEF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030641; Fantham H. B., 1914, Annals of Tropical Medicine and Parasitology, V8; Forsgren E, 2010, APIDOLOGIE, V41, P99, DOI 10.1051/apido/2009065; Foster LJ, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006387; Francis RM, 2012, J APIC SCI, V56, P137, DOI 10.2478/v10289-012-0014-x; Fries I, 2001, APIDOLOGIE, V32, P199, DOI 10.1051/apido:2001122; Furst MA, 2014, NATURE, V506, P364, DOI 10.1038/nature12977; Gardner-Gee R, 2013, AUSTRAL ECOL, V38, P346, DOI 10.1111/j.1442-9993.2012.02412.x; Graystock P, 2013, J INVERTEBR PATHOL, V114, P114, DOI 10.1016/j.jip.2013.06.005; Gu X, 1996, P NATL ACAD SCI USA, V93, P4671, DOI 10.1073/pnas.93.10.4671; Heger T, 2014, OIKOS, V123, P741, DOI 10.1111/j.1600-0706.2013.01263.x; Jabbour RE, 2010, APPL ENVIRON MICROB, V76, P3637, DOI 10.1128/AEM.00055-10; Jacobs J, 2011, INDIVIDUAL BASED RAR; Jones CM, 2014, J ANIM ECOL, V83, P1428, DOI 10.1111/1365-2656.12235; Kanzaki N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099241; Keane RM, 2002, TRENDS ECOL EVOL, V17, P164, DOI 10.1016/S0169-5347(02)02499-0; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Knudsen GM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020873; Kristof LJ, 1879, MITTEILUNGEN NATURWI, V15, P38; Lanzi G, 2006, J VIROL, V80, P4998, DOI 10.1128/JVI.80.10.4998-5009.2006; Lester P., 2013, N SCI REV, V70, P56; Lester PJ, 2014, DIVERS DISTRIB, V20, P964, DOI 10.1111/ddi.12223; Lester PJ, 2014, NZ ENTOMOL, V37, P1; Levitt AL, 2013, VIRUS RES, V176, P232, DOI 10.1016/j.virusres.2013.06.013; Madden AA, 2013, ENVIRON ENTOMOL, V42, P703, DOI 10.1603/EN12159; MOLLER H, 1991, NEW ZEAL J ZOOL, V18, P171, DOI 10.1080/03014223.1991.10757964; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Peng LF, 2011, PROTEOMICS, V11, P4376, DOI 10.1002/pmic.201100169; R Core Team, 2021, R LANGUAGE ENV STAT; Reeson AF, 2003, INSECT MOL BIOL, V12, P85, DOI 10.1046/j.1365-2583.2003.00390.x; Rose EAF, 1999, NEW ZEAL J ZOOL, V26, P179, DOI 10.1080/03014223.1999.9518188; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Schroeder DC, 2012, VIRULENCE, V3, P589, DOI 10.4161/viru.22219; Singh R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014357; Stach JEM, 2003, ENVIRON MICROBIOL, V5, P828, DOI 10.1046/j.1462-2920.2003.00483.x; Strauss A, 2012, FUNCT ECOL, V26, P1249, DOI 10.1111/1365-2435.12011; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57; Toft RJ, 1998, ECOL ENTOMOL, V23, P90, DOI 10.1046/j.1365-2311.1998.00100.x; Torchin ME, 2003, NATURE, V421, P628, DOI 10.1038/nature01346; URDANETA-MORALES S, 1983, Revista Brasileira de Biologia, V43, P409; Vilcinskas A, 2013, SCIENCE, V340, P862, DOI 10.1126/science.1234032; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Yanez O, 2012, APIDOLOGIE, V43, P587, DOI 10.1007/s13592-012-0128-y; Yang CC, 2010, BIOL INVASIONS, V12, P3307, DOI 10.1007/s10530-010-9724-9	64	28	29	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121358	10.1371/journal.pone.0121358	http://dx.doi.org/10.1371/journal.pone.0121358			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798856	Green Published, gold, Green Submitted			2022-12-26	WOS:000351987300244
J	Modrono, C; Plata-Bello, J; Zelaya, F; Garcia, S; Galvan, I; Marcano, F; Navarrete, G; Casanova, O; Mas, M; Gonzalez-Mora, JL				Modrono, Cristian; Plata-Bello, Julio; Zelaya, Fernando; Garcia, Sofia; Galvan, Ivan; Marcano, Francisco; Navarrete, Gorka; Casanova, Oscar; Mas, Manuel; Luis Gonzalez-Mora, Jose			Enhancing Sensorimotor Activity by Controlling Virtual Objects with Gaze	PLOS ONE			English	Article							MIRROR NEURON SYSTEM; POSTERIOR PARIETAL CORTEX; EFFECTOR INFORMATION; SPATIAL ATTENTION; MOTOR PREPARATION; EYE-MOVEMENTS; STROKE; INTEGRATION; ACTIVATION; FIELDS	This fMRI work studies brain activity of healthy volunteers who manipulated a virtual object in the context of a digital game by applying two different control methods: using their right hand or using their gaze. The results show extended activations in sensorimotor areas, not only when participants played in the traditional way (using their hand) but also when they used their gaze to control the virtual object. Furthermore, with the exception of the primary motor cortex, regional motor activity was similar regardless of what the effector was: the arm or the eye. These results have a potential application in the field of the neurorehabilitation as a new approach to generate activation of the sensorimotor system to support the recovery of the motor functions.	[Modrono, Cristian; Garcia, Sofia; Galvan, Ivan; Marcano, Francisco; Casanova, Oscar; Mas, Manuel; Luis Gonzalez-Mora, Jose] Univ La Laguna, Sch Med, Dept Physiol, Santa Cruz De Tenerife, Spain; [Plata-Bello, Julio] Univ Hosp Canary Isl, Dept Neurosurg, Santa Cruz De Tenerife, Spain; [Zelaya, Fernando] Kings Coll London, Inst Psychiat, Ctr Neuroimaging Sci, London WC2R 2LS, England; [Navarrete, Gorka] Diego Portales Univ, UDP INECO Fdn Core Neurosci UIFCoN, Lab Cognit & Social Neurosci LaNCyS, Santiago, Chile	Universidad de la Laguna; University of London; King's College London	Modrono, C (corresponding author), Univ La Laguna, Sch Med, Dept Physiol, Santa Cruz De Tenerife, Spain.	cmodrono@ull.edu.es	Marcano, Francisco J/I-1723-2015; Modrono, Cristian/N-6378-2019; Coish, Elizabeth/AAU-1245-2020; Navarrete, Gorka/H-5995-2011; Plata-Bello, Julio/AAB-1613-2019; Modroño, Cristián/M-1985-2014	Marcano, Francisco J/0000-0003-3310-4722; Navarrete, Gorka/0000-0001-7678-8656; Plata-Bello, Julio/0000-0002-2643-5470; Modroño, Cristián/0000-0001-5623-8681; Gonzalez-Mora, Jose Luis/0000-0001-8920-1375; Zelaya, Fernando/0000-0002-9525-1560	Ministerio de Ciencia e Innovacion [PTA2011-4995-I, TIN2011-28146]; Ministerio de Industria, Turismo y Comercio [TSI-020100-2011-189, TSI-020100-2010-346]; Ministerio de Economia y Competitividad [IPT-2012-0961-300000]	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Ministerio de Industria, Turismo y Comercio(Spanish Government); Ministerio de Economia y Competitividad(Spanish Government)	Financial support was provided by the following national competitive programs: Ministerio de Ciencia e Innovacion [PTA2011-4995-I, TIN2011-28146]; Ministerio de Industria, Turismo y Comercio [TSI-020100-2011-189, TSI-020100-2010-346]; Ministerio de Economia y Competitividad [IPT-2012-0961-300000]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen RA, 2009, NEURON, V63, P568, DOI 10.1016/j.neuron.2009.08.028; Arroyo HA, 2002, REV NEUROLOGIA, V34, P133, DOI 10.33588/rn.3402.2001301; Astafiev SV, 2003, J NEUROSCI, V23, P4689; Beurze SM, 2007, J NEUROPHYSIOL, V97, P188, DOI 10.1152/jn.00456.2006; Beurze SM, 2009, J NEUROPHYSIOL, V101, P3053, DOI 10.1152/jn.91194.2008; Bressler DW, 2010, NEUROIMAGE, V53, P526, DOI 10.1016/j.neuroimage.2010.06.063; Buccino G, 2006, COGN BEHAV NEUROL, V19, P55, DOI 10.1097/00146965-200603000-00007; Burstin A, 2009, INT J REHABIL RES, V32, pS77, DOI 10.1097/00004356-200908001-00102; Cameirao MS, 2010, J NEUROENG REHABIL, V7, DOI 10.1186/1743-0003-7-48; Cattaneo L, 2009, ARCH NEUROL-CHICAGO, V66, P557, DOI 10.1001/archneurol.2009.41; Connolly JD, 2007, NEUROIMAGE, V34, P1209, DOI 10.1016/j.neuroimage.2006.10.001; Culham JC, 1998, J NEUROPHYSIOL, V80, P2657, DOI 10.1152/jn.1998.80.5.2657; Curtis CE, 2012, OXFORD HDB EYE MOVEM, P383; Decety J, 1996, COGNITIVE BRAIN RES, V3, P87, DOI 10.1016/0926-6410(95)00033-X; Dechaumont-Palacin S, 2008, NEUROREHAB NEURAL RE, V22, P154, DOI 10.1177/1545968307307118; Ertelt D, 2007, NEUROIMAGE, V36, pT164, DOI 10.1016/j.neuroimage.2007.03.043; Filimon F, 2010, NEUROSCIENTIST, V16, P388, DOI 10.1177/1073858410375468; Filimon F, 2009, J NEUROSCI, V29, P2961, DOI 10.1523/JNEUROSCI.3211-08.2009; Galletti C, 2003, EXP BRAIN RES, V153, P158, DOI 10.1007/s00221-003-1589-z; Garrison KA, 2010, NEUROREHAB NEURAL RE, V24, P404, DOI 10.1177/1545968309354536; GNADT JW, 1988, EXP BRAIN RES, V70, P216; Gozli DG, 2011, PERCEPTION, V40, P1309, DOI 10.1068/p7027; Grosbras MN, 2005, HUM BRAIN MAPP, V25, P140, DOI 10.1002/hbm.20145; Hagler DJ, 2007, NEUROIMAGE, V35, P1562, DOI 10.1016/j.neuroimage.2007.01.033; Henson RNA, 2003, NEUROPSYCHOLOGIA, V41, P263, DOI 10.1016/S0028-3932(02)00159-8; Johnson-Frey SH, 2004, BRAIN COGNITION, V55, P328, DOI 10.1016/j.bandc.2004.02.032; Kandel E. R., 2013, PRINCIPLES NEURAL SC; Koyama M, 2004, NEURON, V41, P795, DOI 10.1016/S0896-6273(04)00047-9; Leigh R. J., 2006, NEUROLOGY EYE MOVEME; Lemesle M, 2001, REV NEUROL-FRANCE, V157, P1255; LEMON RN, 1976, PROC R SOC SER B-BIO, V194, P313, DOI 10.1098/rspb.1976.0082; Levy I, 2007, J NEUROSCI, V27, P4687, DOI 10.1523/JNEUROSCI.0459-07.2007; Lin YT, 2013, MULTIMED TOOLS APPL, V65, P543, DOI 10.1007/s11042-012-1202-1; Medendorp WP, 2005, J NEUROPHYSIOL, V93, P954, DOI 10.1152/jn.00725.2004; Medendorp WP, 2003, J NEUROSCI, V23, P6209; Modrono C, 2013, NEUROSCI LETT, V555, P220, DOI 10.1016/j.neulet.2013.09.044; Modrono C, 2011, J NEUROSCI METH, V202, P173, DOI 10.1016/j.jneumeth.2011.05.014; Moore T, 2001, P NATL ACAD SCI USA, V98, P1273, DOI 10.1073/pnas.021549498; Moschovakis AK, 1996, CURR OPIN NEUROBIOL, V6, P811, DOI 10.1016/S0959-4388(96)80032-8; Munoz DP, 2002, PROG BRAIN RES, V140, P3; Nichols T, 2005, NEUROIMAGE, V25, P653, DOI 10.1016/j.neuroimage.2004.12.005; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Bello JP, 2014, NEUROSCIENCE, V275, P285, DOI 10.1016/j.neuroscience.2014.06.010; Bello JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074485; Platt ML, 1998, EXP BRAIN RES, V121, P65, DOI 10.1007/s002210050438; RIZZOLATTI G, 1987, NEUROPSYCHOLOGIA, V25, P31, DOI 10.1016/0028-3932(87)90041-8; Sale P, 2012, EUR J PHYS REHAB MED, V48, P313; Salvucci D.D., 2000, P 2000 S EYE TRACK R, P71, DOI [10.1145/355017.355028, DOI 10.1145/355017.355028]; Shen Y, 2013, J ELECTRON IMAGING, V22, P16; Simon SR, 2002, J NEUROPHYSIOL, V88, P2047, DOI 10.1152/jn.2002.88.4.2047; Snyder LH, 1997, NATURE, V386, P167, DOI 10.1038/386167a0; Szameitat AJ, 2012, NEUROIMAGE, V62, P266, DOI 10.1016/j.neuroimage.2012.05.009; Vosskuhler A, 2008, BEHAV RES METHODS, V40, P1150, DOI [10.3758/BRM.40.4.1150, 10.3758/BRM.40.4.U50]; Zimmermann-Schlatter A, 2008, J NEUROENG REHABIL, V5, DOI 10.1186/1743-0003-5-8	54	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121562	10.1371/journal.pone.0121562	http://dx.doi.org/10.1371/journal.pone.0121562			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799431	gold, Green Published, Green Submitted			2022-12-26	WOS:000351987300270
J	O'Hara, L; Curley, M; Ferreira, MT; Cruickshanks, L; Milne, L; Smith, LB				O'Hara, Laura; Curley, Michael; Ferreira, Maria Tedim; Cruickshanks, Lyndsey; Milne, Laura; Smith, Lee B.			Pituitary Androgen Receptor Signalling Regulates Prolactin but Not Gonadotrophins in the Male Mouse	PLOS ONE			English	Article							RAT ANTERIOR-PITUITARY; LH-BETA-SUBUNIT; MESSENGER-RNA; MALE-MICE; HYPERPROLACTINEMIC MALES; TARGETED DISRUPTION; LUTEINIZING-HORMONE; TESTOSTERONE; GENE; SECRETION	Production of the androgen testosterone is controlled by a negative feedback loop within the hypothalamic-pituitary-gonadal (HPG) axis. Stimulation of testicular Leydig cells by pituitary luteinising hormone (LH) is under the control of hypothalamic gonadotrophin releasing hormone (GnRH), while suppression of LH secretion by the pituitary is controlled by circulating testosterone. Exactly how androgens exert their feedback control of gonadotrophin secretion (and whether this is at the level of the pituitary), as well as the role of AR in other pituitary cell types remains unclear. To investigate these questions, we exploited a transgenic mouse line (Foxg1(Cre/+); AR(fl/y)) which lacks androgen receptor in the pituitary gland. Both circulating testosterone and gonadotrophins are unchanged in adulthood, demonstrating that AR signalling is dispensable in the male mouse pituitary for testosterone-dependent regulation of LH secretion. In contrast, Foxg1(Cre/+); AR(fl/y) males have a significant increase in circulating prolactin, suggesting that, rather than controlling gonadotrophins, AR-signalling in the pituitary acts to suppress aberrant prolactin production in males.	[O'Hara, Laura; Curley, Michael; Ferreira, Maria Tedim; Cruickshanks, Lyndsey; Milne, Laura; Smith, Lee B.] Univ Edinburgh, MRC, Ctr Reprod Hlth, Edinburgh, Midlothian, Scotland	University of Edinburgh	Smith, LB (corresponding author), Univ Edinburgh, MRC, Ctr Reprod Hlth, Edinburgh, Midlothian, Scotland.	Lee.Smith@ed.ac.uk		O'Hara, Laura/0000-0001-7790-9261; Smith, Lee/0000-0002-4103-3074	Medical Research Council [G1100354/1]; Society for Endocrinology Early Career Grant Award; MRC [G1100354] Funding Source: UKRI; Medical Research Council [G1100354] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Society for Endocrinology Early Career Grant Award; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by a Medical Research Council (www.mrc.ac.uk) Program Grant Award (G1100354/1) to LBS and a Society for Endocrinology (www.endocrinology.org) Early Career Grant Award to LO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMADOR AG, 1986, ENDOCRINOL EXP, V20, P349; BAGATELL CJ, 1994, J ANDROL, V15, P15; BARTKE A, 1977, ENDOCRINOLOGY, V100, P182, DOI 10.1210/endo-100-1-182; Ben-Jonathan N, 2001, ENDOCR REV, V22, P724, DOI 10.1210/er.22.6.724; Binart N, 2003, ENDOCRINOLOGY, V144, P3779, DOI 10.1210/en.2003-0409; CHANDRASHEKAR V, 1988, Steroids, V51, P559, DOI 10.1016/0039-128X(88)90052-9; CORKER CS, 1978, J STEROID BIOCHEM, V9, P373, DOI 10.1016/0022-4731(78)90634-9; De Gendt K, 2004, P NATL ACAD SCI USA, V101, P1327, DOI 10.1073/pnas.0308114100; De Rosa M, 2004, J CLIN ENDOCR METAB, V89, P621, DOI 10.1210/jc.2003-030852; De Rosa M, 1998, EUR J ENDOCRINOL, V138, P286, DOI 10.1530/eje.0.1380286; Eddy EM, 1996, ENDOCRINOLOGY, V137, P4796, DOI 10.1210/en.137.11.4796; Freeman ME, 2000, PHYSIOL REV, V80, P1523, DOI 10.1152/physrev.2000.80.4.1523; Barrado MJG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101403; GASPAR ML, 1991, P NATL ACAD SCI USA, V88, P8606, DOI 10.1073/pnas.88.19.8606; Gieske MC, 2008, ENDOCRINOLOGY, V149, P20, DOI 10.1210/en.2007-1084; Gill-Sharma MK, 2009, INT J ENDOCRINOL, V2009, DOI 10.1155/2009/687259; Gonzalez-Parra S, 1998, NEUROENDOCRINOLOGY, V68, P152, DOI 10.1159/000054361; Hayes FJ, 2000, J CLIN ENDOCR METAB, V85, P3027, DOI 10.1210/jc.85.9.3027; Hebert JM, 2000, DEV BIOL, V222, P296, DOI 10.1006/dbio.2000.9732; Hughes IA, 2012, LANCET, V380, P1419, DOI 10.1016/S0140-6736(12)60071-3; Ishaq M, 2013, J MOL ENDOCRINOL, V50, P411, DOI 10.1530/JME-12-0231; Israel JM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4285; Jorgensen JS, 2001, MOL ENDOCRINOL, V15, P1505, DOI 10.1210/me.15.9.1505; KOTSUJI F, 1988, ENDOCRINOLOGY, V123, P2683, DOI 10.1210/endo-123-6-2683; Krutskikh A, 2011, ENDOCRINOLOGY, V152, P689, DOI 10.1210/en.2010-0768; Lindzey J, 1998, ENDOCRINOLOGY, V139, P4092, DOI 10.1210/en.139.10.4092; MATSUMOTO AM, 1990, J CLIN ENDOCR METAB, V70, P282, DOI 10.1210/jcem-70-1-282; MIGEON BR, 1981, P NATL ACAD SCI-BIOL, V78, P6339, DOI 10.1073/pnas.78.10.6339; Miyamoto J, 2007, MOL CELL BIOL, V27, P4807, DOI 10.1128/MCB.02039-06; NONOMURA M, 1985, J ENDOCRINOL, V107, P71, DOI 10.1677/joe.0.1070071; O'Hara L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084541; O'Hara Laura, 2012, BMC Res Notes, V5, P16, DOI 10.1186/1756-0500-5-16; O'Hara L, 2011, ENDOCRINOLOGY, V152, P718, DOI 10.1210/en.2010-0928; Okada Y, 2003, ENDOCRINOLOGY, V144, P267, DOI 10.1210/en.2002-220770; Pitteloud N, 2008, J CLIN ENDOCR METAB, V93, P784, DOI 10.1210/jc.2007-2156; Raskin K, 2009, J NEUROSCI, V29, P4461, DOI 10.1523/JNEUROSCI.0296-09.2009; Rodriguez S, 2008, DEV BIOL, V314, P40, DOI 10.1016/j.ydbio.2007.10.056; Scheithauer BW, 2008, ENDOCR PATHOL, V19, P27, DOI 10.1007/s12022-007-9012-0; Simanainen U, 2011, AM J PHYSIOL-ENDOC M, V301, pE727, DOI 10.1152/ajpendo.00580.2010; Singh SP, 2009, BIOL REPROD, V81, P488, DOI 10.1095/biolreprod.108.075259; Smith JT, 2005, ENDOCRINOLOGY, V146, P2976, DOI 10.1210/en.2005-0323; Smith L, 2011, REPRODUCTION, V141, P151, DOI 10.1530/REP-10-0404; Smith LB, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002697; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Starzec AB, 1996, BBA-MOL CELL RES, V1310, P348, DOI 10.1016/0167-4889(95)00178-6; Steger RW, 1998, ENDOCRINOLOGY, V139, P3691, DOI 10.1210/en.139.9.3691; Temple JL, 2003, HORM BEHAV, V44, P427, DOI 10.1016/j.yhbeh.2003.09.002; Tilbrook AJ, 2001, BIOL REPROD, V64, P735, DOI 10.1095/biolreprod64.3.735; TONG Y, 1989, ENDOCRINOLOGY, V125, P1821, DOI 10.1210/endo-125-4-1821; Tyndall V, 2012, REPRODUCTION, V143, P21, DOI 10.1530/REP-11-0239; Wang YW, 2010, DEV BIOL, V348, P199, DOI 10.1016/j.ydbio.2010.09.024; Welsh M, 2009, FASEB J, V23, P4218, DOI 10.1096/fj.09-138347; Wersinger SR, 1999, ENDOCRINE, V11, P137, DOI 10.1385/ENDO:11:2:137; Wu S, 2014, MOL ENDOCRINOL; Yu IC, 2008, ENDOCRINOLOGY, V149, P2361, DOI 10.1210/en.2007-0516	55	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121657	10.1371/journal.pone.0121657	http://dx.doi.org/10.1371/journal.pone.0121657			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799562	Green Published, Green Submitted, gold			2022-12-26	WOS:000351987300282
J	Tsang, P; Bailey, AZ; Nelson, AJ				Tsang, Philemon; Bailey, Aaron Z.; Nelson, Aimee J.			Rapid-Rate Paired Associative Stimulation over the Primary Somatosensory Cortex	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; THETA-BURST-STIMULATION; MEDIAN NERVE-STIMULATION; HUMAN MOTOR CORTEX; CORTICAL PLASTICITY; EVOKED-POTENTIALS; SUSTAINED INCREASE; RECEPTIVE-FIELDS; HUMAN HAND; HUMANS	Rapid-rate paired associative stimulation (rPAS) involves repeat pairing of peripheral nerve stimulation and Transcranial magnetic stimulation (TMS) pulses at a 5 Hz frequency. RPAS over primary motor cortex (M1) operates with spike-timing dependent plasticity such that increases in corticospinal excitability occur when the nerve and TMS pulse temporally coincide in cortex. The present study investigates the effects of rPAS over primary somatosensory cortex (SI) which has not been performed to date. In a series of experiments, rPAS was delivered over SI and M1 at varying timing intervals between the nerve and TMS pulse based on the latency of the N20 somatosensory evoked potential (SEP) component within each participant (intervals for SI-rPAS: N20, N20-2.5 ms, N20+2.5 ms, intervals for M1-rPAS: N20, N20+5 ms). Changes in SI physiology were measured via SEPs (N20, P25, N20-P25) and SEP paired-pulse inhibition, and changes in M1 physiology were measured with motor evoked potentials and short-latency afferent inhibition. Measures were obtained before rPAS and at 5, 25 and 45 minutes following stimulation. Results indicate that paired-pulse inhibition and short-latency afferent inhibition were reduced only when the SI-rPAS nerve-TMS timing interval was set to N20-2.5 ms. SI-rPAS over SI also led to remote effects on motor physiology over a wider range of nerve-TMS intervals (N20-2.5 ms -N20+2.5 ms) during which motor evoked potentials were increased. M1-rPAS increased motor evoked potentials and reduced short-latency afferent inhibition as previously reported. These data provide evidence that, similar to M1, rPAS over SI is spike-timing dependent and is capable of exerting changes in SI and M1 physiology.	[Tsang, Philemon; Bailey, Aaron Z.; Nelson, Aimee J.] McMaster Univ, Dept Kinesiol, Hamilton, ON, Canada	McMaster University	Nelson, AJ (corresponding author), McMaster Univ, Dept Kinesiol, Hamilton, ON, Canada.	nelsonaj@mcmaster.ca			Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	The research was funded by the Natural Sciences and Engineering Research Council of Canada to AJN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLISON T, 1991, BRAIN, V114, P2465, DOI 10.1093/brain/114.6.2465; Asmussen MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060496; Balzamo E, 2004, CLIN NEUROPHYSIOL, V115, P1616, DOI 10.1016/j.clinph.2004.02.012; Bliem B, 2008, J COGNITIVE NEUROSCI, V20, P1517, DOI 10.1162/jocn.2008.20106; BRINKMAN J, 1985, J PHYSIOL-LONDON, V368, P611, DOI 10.1113/jphysiol.1985.sp015879; Carmen T, 2013, BRAIN STIMUL, V6, P62, DOI 10.1016/j.brs.2012.01.010; Chen LM, 2003, SCIENCE, V302, P881, DOI 10.1126/science.1087846; Di Lazzaro V, 2004, CLIN NEUROPHYSIOL, V115, P255, DOI 10.1016/j.clinph.2003.10.009; Fathi D, 2010, CLIN NEUROPHYSIOL, V121, P90, DOI 10.1016/j.clinph.2009.07.048; Friedman RM, 2008, J NEUROPHYSIOL, V100, P3185, DOI 10.1152/jn.90278.2008; GARDNER EP, 1980, J NEUROPHYSIOL, V43, P444, DOI 10.1152/jn.1980.43.2.444; GOLDRING S, 1970, ELECTROEN CLIN NEURO, V29, P537, DOI 10.1016/0013-4694(70)90096-9; Hoffken O, 2007, J PHYSIOL-LONDON, V584, P463, DOI 10.1113/jphysiol.2007.140079; Ishikawa S, 2007, CLIN NEUROPHYSIOL, V118, P1033, DOI 10.1016/j.clinph.2007.02.003; Jacobs MF, 2014, BRAIN STIMUL, V7, P269, DOI 10.1016/j.brs.2013.12.009; Jacobs MF, 2012, NEUROREPORT, V23, P927, DOI 10.1097/WNR.0b013e328358b0f3; Kozyrev V, 2014, P NATL ACAD SCI USA, V111, P13553, DOI 10.1073/pnas.1405508111; Krivanekova L, 2011, EUR J NEUROSCI, V34, P1292, DOI 10.1111/j.1460-9568.2011.07849.x; Lee KGH, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-89; Litvak V, 2007, EUR J NEUROSCI, V25, P2862, DOI 10.1111/j.1460-9568.2007.05531.x; Mao TY, 2011, NEURON, V72, P111, DOI 10.1016/j.neuron.2011.07.029; Muller-Dahlhaus F, 2010, FRONT SYNAPTIC NEURO, V2, P34, DOI DOI 10.3389/FNSYN.2010.00034; NUWER MR, 1994, ELECTROEN CLIN NEURO, V91, P1, DOI 10.1016/0013-4694(94)90011-6; Okamoto M, 2004, NEUROIMAGE, V21, P99, DOI 10.1016/j.neuroimage.2003.08.026; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; PAVLIDES C, 1993, J NEUROPHYSIOL, V70, P733, DOI 10.1152/jn.1993.70.2.733; Quartarone A, 2006, J PHYSIOL-LONDON, V575, P657, DOI 10.1113/jphysiol.2006.114025; Ragert P, 2004, NEUROSCI LETT, V356, P91, DOI 10.1016/j.neulet.2003.11.034; Ragert P, 2003, NEUROSCI LETT, V348, P105, DOI 10.1016/S0304-3940(03)00745-6; Rai N, 2012, CLIN NEUROPHYSIOL, V123, P1226, DOI 10.1016/j.clinph.2011.09.026; Ridding MC, 2010, J PHYSIOL-LONDON, V588, P2291, DOI 10.1113/jphysiol.2010.190314; Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016; Sale MV, 2010, REV NEUROSCIENCE, V21, P55; Sale MV, 2008, J NEUROSCI, V28, P8285, DOI 10.1523/JNEUROSCI.1963-08.2008; Sattler V, 2012, EXP BRAIN RES, V221, P449, DOI 10.1007/s00221-012-3187-4; Sattler V, 2014, MOVEMENT DISORD, V29, P787, DOI 10.1002/mds.25768; Siebner HR, 2003, EXP BRAIN RES, V148, P1, DOI 10.1007/s00221-002-1234-2; Sripati AP, 2006, J NEUROSCI, V26, P2101, DOI 10.1523/JNEUROSCI.3720-05.2006; Stefan K, 2004, J NEUROPHYSIOL, V92, P66, DOI 10.1152/jn.00383.2003; Tamburin S, 2001, EXP BRAIN RES, V141, P232, DOI 10.1007/s002210100859; Tokimura H, 2000, J PHYSIOL-LONDON, V523, P503, DOI 10.1111/j.1469-7793.2000.t01-1-00503.x; TOKUNO H, 1993, J COMP NEUROL, V333, P199, DOI 10.1002/cne.903330206; Tossi MAG, 2013, NEUROREPORT, V24, P451, DOI 10.1097/WNR.0b013e3283616378; Tsang P., 2014, CLIN NEUROPHYSIOL; Wolters A, 2005, J PHYSIOL-LONDON, V565, P1039, DOI 10.1113/jphysiol.2005.084954; Wolters A, 2003, J NEUROPHYSIOL, V89, P2339, DOI 10.1152/jn.00900.2002	46	14	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120731	10.1371/journal.pone.0120731	http://dx.doi.org/10.1371/journal.pone.0120731			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799422	Green Submitted, Green Published, gold			2022-12-26	WOS:000351987300169
J	Hao, J; Bao, XX; Jin, B; Wang, XJ; Mao, ZB; Li, XP; Wei, LH; Shen, DH; Wang, JL				Hao, Juan; Bao, Xiaoxia; Jin, Bo; Wang, Xiujuan; Mao, Zebin; Li, Xiaoping; Wei, Lihui; Shen, Danhua; Wang, Jian-Liu			Ca2+ channel subunit alpha 1D promotes proliferation and migration of endometrial cancer cells mediated by 17 beta-estradiol via the G protein-coupled estrogen receptor	FASEB JOURNAL			English	Article						calcium; endometrial carcinoma; Cav1.3; ERK1/2; rapid signaling effect	ELEMENT-BINDING PROTEIN; CALCIUM-CHANNELS; RESPONSE ELEMENT; PROSTATE-CANCER; SIGNALING PATHWAY; CARCINOMA-CELLS; ACTIVATION; MECHANISMS; EXPRESSION; MEMBRANE	Calcium and calcium channels are closely related to the estrogen-induced nongenomic effect of endometrial carcinoma, but the specific role of calcium channels is unknown. This study aimed to explore the expression and the biologic effect of the L-type calcium channel in endometrial carcinoma cells and to clarify the molecular mechanism of the relationship between L-type calcium channels and estrogen. The immunohistochemical results showed that Ca2+ channel subunit alpha 1D (Cav1.3) expression was high in atypical hyperplasia (1.90 +/- 0.35) and endometrial carcinoma tissues (2.05 +/- 0.82) but weak (0.80 +/- 0.15) in benign endometrial tissues (P < 0.05). Treatment with 17 beta-estradiol rapidly increased Cav1.3 expression in a dose-and time-dependent manner, and 100 nM cell-impermeable beta-estradiol-6-(O-carboxymethyl) oxime: bovine serum albumin also promoted Cav1.3 expression. Transfection with small interfering RNA against G protein-coupled estrogen receptor (GPER) suppressed estrogen-induced up-regulation of Cav1.3 compared with control cells and markedly reduced the estrogen-induced phosphorylation of ERK1/2 and CREB. Knocking down the Cav1.3 significantly suppressed estrogen-stimulated Ca2+ influx, cell proliferation, and migration in endometrial cancer cells. Taken together, Cav1.3 was overexpressed in atypical hyperplasia and endometrial carcinoma, and the estrogen-induced phosphorylation of downstream molecular ERK1/2 and CREB is the result of activation of the GPER pathway. L-type channel Cav1.3 is required for estrogen-stimulated Ca2+ influx and contributes broadly to the development of endometrial cancer. The Cav1.3 channel may be a new target for endometrial carcinoma treatment.	[Hao, Juan; Bao, Xiaoxia; Li, Xiaoping; Wei, Lihui; Wang, Jian-Liu] Peking Univ, Peoples Hosp, Dept Obstet & Gynaecol, Beijing 100044, Peoples R China; [Shen, Danhua] Peking Univ, Peoples Hosp, Dept Pathol, Beijing 100044, Peoples R China; [Jin, Bo; Wang, Xiujuan; Mao, Zebin] Peking Univ, Dept Biochem & Mol Biol, Beijing 100044, Peoples R China	Peking University; Peking University; Peking University	Wang, JL (corresponding author), Peking Univ, Peoples Hosp, Dept Obstet & Gynaecol, 11 Xi Zhi Men South St, Beijing 100044, Peoples R China.	wangjianliu@pkuph.edu.cn	wei, li/GSD-3630-2022; 黎, 伟/GXM-4040-2022	Wang, Jianliu/0000-0003-0338-0427	National Natural Science Foundation of China [30973182, 81272869]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors thank Prof. Kewei Wang and his team for technical support. This work was supported by National Natural Science Foundation of China Grants 30973182 and 81272869. The authors declare no conflicts of interest.	Albanito L, 2007, CANCER RES, V67, P1859, DOI 10.1158/0008-5472.CAN-06-2909; Bao Xiao-xia, 2012, Zhonghua Fu Chan Ke Za Zhi, V47, P212; Bao XX, 2012, CHINESE MED J-PEKING, V125, P3120, DOI 10.3760/cma.j.issn.0366-6999.2012.17.028; Berridge MJ, 2012, BIOCHEM SOC T, V40, P297, DOI 10.1042/BST20110766; Bertolesi GE, 2002, MOL PHARMACOL, V62, P210, DOI 10.1124/mol.62.2.210; Boulware MI, 2005, J NEUROSCI, V25, P5066, DOI 10.1523/JNEUROSCI.1427-05.2005; Brewer LD, 2009, J NEUROSCI, V29, P6058, DOI 10.1523/JNEUROSCI.5253-08.2009; Bulayeva NN, 2005, AM J PHYSIOL-ENDOC M, V288, pE388, DOI 10.1152/ajpendo.00349.2004; Bulayeva NN, 2004, STEROIDS, V69, P181, DOI 10.1016/j.steroids.2003.12.003; Buraei Z, 2010, PHYSIOL REV, V90, P1461, DOI 10.1152/physrev.00057.2009; Cain SM, 2011, BIOFACTORS, V37, P197, DOI 10.1002/biof.158; Chen RB, 2014, UROL ONCOL-SEMIN ORI, V32, P524, DOI 10.1016/j.urolonc.2013.05.011; Coiret G, 2005, FEBS LETT, V579, P2995, DOI 10.1016/j.febslet.2005.02.085; Doolan CM, 2000, BRIT J PHARMACOL, V129, P1375, DOI 10.1038/sj.bjp.0703193; Duan RQ, 2001, J BIOL CHEM, V276, P11590, DOI 10.1074/jbc.M005492200; Engh A, 2012, FRONT BIOSCI-LANDMRK, V17, P1613, DOI 10.2741/4007; English J, 1999, EXP CELL RES, V253, P255, DOI 10.1006/excr.1999.4687; Ferret S, 2001, MOL CELL ENDOCRINOL, V176, P77, DOI 10.1016/S0303-7207(01)00464-6; Gackiere F, 2008, J BIOL CHEM, V283, P10162, DOI 10.1074/jbc.M707159200; Gao L, 2006, J NEUROSCI, V26, P6259, DOI 10.1523/JNEUROSCI.0481-06.2006; Giordano TP, 2010, J NEUROSCI, V30, P17051, DOI 10.1523/JNEUROSCI.2255-10.2010; Guo RX, 2006, J STEROID BIOCHEM, V99, P9, DOI 10.1016/j.jsbmb.2005.11.013; Haverstick DM, 2000, CANCER RES, V60, P1002; Huang J, 2004, MOL CELL ENDOCRINOL, V218, P65, DOI 10.1016/j.mce.2003.12.005; Kunzelmann K, 2005, J MEMBRANE BIOL, V205, P159, DOI 10.1007/s00232-005-0781-4; Latour I, 2004, GLIA, V48, P112, DOI 10.1002/glia.20063; Losel RM, 2003, PHYSIOL REV, V83, P965, DOI 10.1152/physrev.00003.2003; Maggiolini M, 2004, J BIOL CHEM, V279, P27008, DOI 10.1074/jbc.M403588200; Marshall J, 2003, NEURON, V39, P625, DOI 10.1016/S0896-6273(03)00496-3; MURPHY TH, 1991, NEURON, V7, P625, DOI 10.1016/0896-6273(91)90375-A; Naguro I., 2004, SIGNAL TRANSDUCT, V4, P195; Olson SH, 2012, CANCER EPIDEM BIOMAR, V21, P753, DOI 10.1158/1055-9965.EPI-11-0735; Pedram A, 2006, MOL ENDOCRINOL, V20, P1996, DOI 10.1210/me.2005-0525; Platet N, 2004, CRIT REV ONCOL HEMAT, V51, P55, DOI 10.1016/j.critrevonc.2004.02.001; Prevarskaya N, 2011, NAT REV CANCER, V11, P609, DOI 10.1038/nrc3105; Reinbothe TM, 2013, DIABETOLOGIA, V56, P340, DOI 10.1007/s00125-012-2758-z; Saltzman BS, 2008, AM J EPIDEMIOL, V167, P607, DOI 10.1093/aje/kwm333; Sarkar SN, 2008, P NATL ACAD SCI USA, V105, P15148, DOI 10.1073/pnas.0802379105; Shapovalov G, 2013, RECENT PAT ANTI-CANC, V8, P18; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Skrzypczak M, 2013, STEROIDS, V78, P1087, DOI 10.1016/j.steroids.2013.07.007; Smith HO, 2007, AM J OBSTET GYNECOL, V196, DOI 10.1016/j.ajog.2007.01.004; Sun LF, 2013, GYNECOL OBSTET INVES, V75, P68, DOI 10.1159/000339933; Tashiro H, 2014, CURR OBSTET GYNECOL, V3, P9, DOI 10.1007/s13669-013-0074-3; Taylor JT, 2008, CANCER LETT, V267, P116, DOI 10.1016/j.canlet.2008.03.032; Tsai CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072999; Ullrich ND, 2007, BIOCHEM BIOPH RES CO, V361, P522, DOI 10.1016/j.bbrc.2007.07.054; Vivacqua A, 2006, MOL ENDOCRINOL, V20, P631, DOI 10.1210/me.2005-0280; Watson C S, 1999, Sci STKE, V1999, pPE1, DOI 10.1126/stke.1999.12.pe1; Watters JJ, 1997, ENDOCRINOLOGY, V138, P4030, DOI 10.1210/en.138.9.4030; Wu TW, 2005, NEUROSCIENCE, V135, P59, DOI 10.1016/j.neuroscience.2004.12.027; Zhang LL, 2009, J CELL BIOCHEM, V106, P553, DOI 10.1002/jcb.22017	52	50	54	2	23	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2015	29	7					2883	2893		10.1096/fj.14-265603	http://dx.doi.org/10.1096/fj.14-265603			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CL3OI	25805831				2022-12-26	WOS:000356859100018
J	Flores-Kim, J; Darwin, AJ				Flores-Kim, Josue; Darwin, Andrew J.			Activity of a Bacterial Cell Envelope Stress Response Is Controlled by the Interaction of a Protein Binding Domain with Different Partners	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHAGE-SHOCK-PROTEIN; PHOTO-CROSS-LINKING; HIGH-LEVEL EXPRESSION; INDUCED PSP OPERON; ESCHERICHIA-COLI; YERSINIA-ENTEROCOLITICA; GENE-EXPRESSION; IN-VIVO; SALMONELLA-ENTERICA; SYSTEM	The bacterial phage shock protein (Psp) system is a highly conserved cell envelope stress response required for virulence in Yersinia enterocolitica and Salmonella enterica. In non-inducing conditions the transcription factor PspF is inhibited by an interaction with PspA. In contrast, PspA associates with the cytoplasmic membrane proteins PspBC during inducing conditions. This has led to the proposal that PspBC exists in an OFF state, which cannot recruit PspA, or an ON state, which can. However, nothing was known about the difference between these two states. Here, we provide evidence that it is the C-terminal domain of Y. enterocolitica PspC (PspC(CT)) that interacts directly with PspA, both in vivo and in vitro. Site-specific photocross-linking revealed that this interaction occurred only during Psp-inducing conditions in vivo. Importantly, wehavealsodiscoveredthatPspC(CT) can interact with the C-terminal domain of PspB (PspC(CT)center dot PspB(CT)). However, the PspC(CT)center dot PspB(CT) and PspC(CT)center dot PspA interactions were mutually exclusive in vitro. Furthermore, in vivo, PspC(CT) contacted PspB(CT) in the OFF state, whereas it contacted PspA in the ON state. These findings provide the first description of the previously proposed PspBC OFF and ON states and reveal that the regulatory switch is centered on a PspC(CT) partner-switching mechanism.	[Flores-Kim, Josue; Darwin, Andrew J.] NYU, Dept Microbiol, Sch Med, New York, NY 10016 USA	New York University	Darwin, AJ (corresponding author), NYU, Dept Microbiol MSB 202, Sch Med, 550 First Ave, New York, NY 10016 USA.	andrew.darwin@med.nyu.edu	Regan, Clinton/E-6250-2012	Darwin, Andrew/0000-0002-7751-1293	National Institutes of Health [R01AI052148]; Burroughs Wellcome Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052148] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01AI052148 (NIAID; to A. J. D.).; Holds an Investigators in Pathogenesis of Infectious Disease award from the Burroughs Wellcome Fund. To whom correspondence should be addressed: Dept. of Microbiology MSB 202, New York University School of Medicine, 550 First Ave., New York, NY 10016. Tel.: 212-263-3223; Fax: 212-263-8276; E-mail: andrew.darwin@med.nyu.edu.	Adams H, 2003, J BACTERIOL, V185, P1174, DOI 10.1128/JB.185.4.1174-1180.2003; Beloin C, 2004, MOL MICROBIOL, V51, P659, DOI 10.1046/j.1365-2958.2003.03865.x; Bensing BA, 2012, J BIOL CHEM, V287, P24438, DOI 10.1074/jbc.M112.378059; BERGLER H, 1994, MICROBIOL-SGM, V140, P1937, DOI 10.1099/13500872-140-8-1937; BRISSETTE JL, 1991, J MOL BIOL, V220, P35, DOI 10.1016/0022-2836(91)90379-K; BRISSETTE JL, 1990, P NATL ACAD SCI USA, V87, P862, DOI 10.1073/pnas.87.3.862; Chin JW, 2002, CHEMBIOCHEM, V3, P1135, DOI 10.1002/1439-7633(20021104)3:11<1135::AID-CBIC1135>3.0.CO;2-M; DALE GE, 1994, PROTEIN ENG, V7, P925, DOI 10.1093/protein/7.7.925; Darwin AJ, 2005, MOL MICROBIOL, V57, P621, DOI 10.1111/j.1365-2958.2005.04694.x; Darwin AJ, 2001, MOL MICROBIOL, V39, P429, DOI 10.1046/j.1365-2958.2001.02235.x; Darwin AJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003388; Das S, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.182931; DELORENZO V, 1993, GENE, V123, P17, DOI 10.1016/0378-1119(93)90533-9; Dennis JJ, 1998, APPL ENVIRON MICROB, V64, P2710; Edwards RA, 1998, GENE, V207, P149, DOI 10.1016/S0378-1119(97)00619-7; Eriksson S, 2003, MOL MICROBIOL, V47, P103, DOI 10.1046/j.1365-2958.2003.03313.x; Flores-Kim J, 2012, J BACTERIOL, V194, P6548, DOI 10.1128/JB.01250-12; Green RC, 2004, J BACTERIOL, V186, P4910, DOI 10.1128/JB.186.15.4910-4920.2004; Gueguen E, 2011, J BACTERIOL, V193, P5747, DOI 10.1128/JB.05080-11; Gueguen E, 2009, MOL MICROBIOL, V74, P619, DOI 10.1111/j.1365-2958.2009.06885.x; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hara N, 2012, J BACTERIOL, V194, P5353, DOI 10.1128/JB.01028-12; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; Horstman NK, 2012, MOL MICROBIOL, V85, P445, DOI 10.1111/j.1365-2958.2012.08120.x; Huvet M, 2011, MOL BIOL EVOL, V28, P1141, DOI 10.1093/molbev/msq301; Joly N, 2010, FEMS MICROBIOL REV, V34, P797, DOI 10.1111/j.1574-6976.2010.00240.x; Jordan S, 2008, FEMS MICROBIOL REV, V32, P107, DOI 10.1111/j.1574-6976.2007.00091.x; Jovanovic G, 1996, J BACTERIOL, V178, P1936, DOI 10.1128/jb.178.7.1936-1945.1996; Jovanovic G, 2010, MICROBIOL-SGM, V156, P2920, DOI 10.1099/mic.0.040055-0; Karlinsey JE, 2010, MOL MICROBIOL, V78, P669, DOI 10.1111/j.1365-2958.2010.07357.x; KINDER SA, 1993, GENE, V136, P271, DOI 10.1016/0378-1119(93)90478-L; Kleerebezem M, 1996, EMBO J, V15, P162, DOI 10.1002/j.1460-2075.1996.tb00344.x; Kobayashi R, 2007, MOL MICROBIOL, V66, P100, DOI 10.1111/j.1365-2958.2007.05893.x; Korotkov KV, 2011, TRENDS BIOCHEM SCI, V36, P433, DOI 10.1016/j.tibs.2011.04.002; Lin SX, 2011, J AM CHEM SOC, V133, P20581, DOI 10.1021/ja209008w; Lloyd LJ, 2004, J BIOL CHEM, V279, P55707, DOI 10.1074/jbc.M408994200; Lucchini S, 2005, INFECT IMMUN, V73, P88, DOI 10.1128/IAI.73.1.88-102.2005; MacRitchie DM, 2008, ADV EXP MED BIOL, V631, P80, DOI 10.1007/978-0-387-78885-2_6; Maloy S. R., 1996, GENETIC ANAL PATHOGE, P493; Maxson ME, 2006, MOL MICROBIOL, V59, P1610, DOI 10.1111/j.1365-2958.2006.05047.x; Maxson ME, 2004, J BACTERIOL, V186, P4199, DOI 10.1128/JB.186.13.4199-4208.2004; Merriam JJ, 1997, INFECT IMMUN, V65, P2497, DOI 10.1128/IAI.65.6.2497-2501.1997; Miller JH., 1972, EXPT MOL GENETICS; Model P, 1997, MOL MICROBIOL, V24, P255, DOI 10.1046/j.1365-2958.1997.3481712.x; Mori H, 2006, P NATL ACAD SCI USA, V103, P16159, DOI 10.1073/pnas.0606390103; Pham ND, 2013, CURR OPIN CHEM BIOL, V17, P90, DOI 10.1016/j.cbpa.2012.10.034; Raivio TL, 2005, MOL MICROBIOL, V56, P1119, DOI 10.1111/j.1365-2958.2005.04625.x; Rowley G, 2006, NAT REV MICROBIOL, V4, P383, DOI 10.1038/nrmicro1394; Seo J, 2007, MOL MICROBIOL, V65, P714, DOI 10.1111/j.1365-2958.2007.05821.x; Singh S, 2011, J BACTERIOL, V193, P6436, DOI 10.1128/JB.05942-11; Standar K, 2008, FEBS LETT, V582, P3585, DOI 10.1016/j.febslet.2008.09.002; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Vega NM, 2012, NAT CHEM BIOL, V8, P431, DOI [10.1038/NCHEMBIO.915, 10.1038/nchembio.915]; WANG RF, 1991, GENE, V100, P195, DOI 10.1016/0378-1119(91)90366-J; WEINER L, 1991, GENE DEV, V5, P1912, DOI 10.1101/gad.5.10.1912; Yamaguchi S, 2013, MOL MICROBIOL, V87, P656, DOI 10.1111/mmi.12122; Yamaguchi S, 2010, MOL MICROBIOL, V78, P429, DOI 10.1111/j.1365-2958.2010.07344.x; Young TS, 2010, J MOL BIOL, V395, P361, DOI 10.1016/j.jmb.2009.10.030	58	17	18	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2015	290	18					11417	11430		10.1074/jbc.M114.614107	http://dx.doi.org/10.1074/jbc.M114.614107			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH0OA	25802329	hybrid, Green Published			2022-12-26	WOS:000353719400018
J	Blenkiron, C; Tsai, P; Brown, LA; Tintinger, V; Askelund, KJ; Windsor, JA; Phillips, AR				Blenkiron, Cherie; Tsai, Peter; Brown, Lisa A.; Tintinger, Vernon; Askelund, Kathryn J.; Windsor, John A.; Phillips, Anthony R.			Characterisation of the Small RNAs in the Biomedically Important Green-Bottle Blowfly Lucilia sericata	PLOS ONE			English	Article							DIPTERA CALLIPHORIDAE; WOUND DEBRIDEMENT; MICRORNA; MAGGOT; IDENTIFICATION; TRANSLATION; ANGIOGENIN; SEQUENCE; THERAPY; LARVAE	Background The green bottle fly maggot, Lucilia sericata, is a species with importance in medicine, agriculture and forensics. Improved understanding of this species' biology is of great potential benefit to many research communities. MicroRNAs (miRNA) are a short non-protein coding regulatory RNA, which directly regulate a host of protein coding genes at the translational level. They have been shown to have developmental and tissue specific distributions where they impact directly on gene regulation. In order to improve understanding of the biology of L. sericata maggots we have performed small RNA-sequencing of their secretions and tissue at different developmental stages. Results We have successfully isolated RNA from the secretions of L. sericata maggots. Illumina small RNA-sequencing of these secretions and the three tissues (crop, salivary gland, gut) revealed that the most common small RNA fragments were derived from ribosomal RNA and transfer RNAs of both insect and bacterial origins. These RNA fragments were highly specific, with the most common tRNAs, such as GlyGCC, predominantly represented by reads derived from the 5' end of the mature maggot tRNA. Each library also had a unique profile of miRNAs with a high abundance of miR-10-5p in the maggot secretions and gut and miR-8 in the food storage organ the crop and salivary glands. The pattern of small RNAs in the bioactive maggot secretions suggests they originate from a combination of saliva, foregut and hindgut tissues. Droplet digital RT-PCR validation of the RNA-sequencing data shows that not only are there differences in the tissue profiles for miRNAs and small RNA fragments but that these are also modulated through developmental stages of the insect. Conclusions We have identified the small-RNAome of the medicinal maggots L. sericata and shown that there are distinct subsets of miRNAs expressed in specific tissues that also alter during the development of the insect. Furthermore there are very specific RNA fragments derived from other non-coding RNAs present in tissues and in the secretions. This new knowledge has applicability in diverse research fields including wound healing, agriculture and forensics.	[Blenkiron, Cherie] Univ Auckland, Fac Med & Hlth Sci, Dept Mol Med & Pathol, Auckland 1, New Zealand; [Blenkiron, Cherie; Brown, Lisa A.; Askelund, Kathryn J.; Windsor, John A.; Phillips, Anthony R.] Univ Auckland, Fac Med & Hlth Sci, Dept Surg, Auckland 1, New Zealand; [Tsai, Peter] Univ Auckland, Bioinformat Inst, Auckland 1, New Zealand; [Tintinger, Vernon] Univ Auckland, Dept Anthropol, Auckland 1, New Zealand; [Blenkiron, Cherie; Windsor, John A.; Phillips, Anthony R.] Univ Auckland, Maurice Wilkins Ctr Biodiscovery, Auckland 1, New Zealand; [Phillips, Anthony R.] Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand	University of Auckland; University of Auckland; University of Auckland; University of Auckland; University of Auckland; University of Auckland	Blenkiron, C (corresponding author), Univ Auckland, Fac Med & Hlth Sci, Dept Mol Med & Pathol, Auckland 1, New Zealand.	c.blenkiron@auckland.ac.nz	Blenkiron, Cherie/H-8468-2019	Blenkiron, Cherie/0000-0002-0217-3808; Tsai, Peter/0000-0002-9930-9029; Askelund, Kathryn/0000-0001-9051-3632	University of Auckland; Maurice Wilkins Centre for Molecular Biodiscovery	University of Auckland; Maurice Wilkins Centre for Molecular Biodiscovery	Funding was received from internal University of Auckland research grants and from the Maurice Wilkins Centre for Molecular Biodiscovery (www.mauricewilkinscentre.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrero RA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-328; Berezikov E, 2011, GENOME RES, V21, P203, DOI 10.1101/gr.116657.110; Bexfield A, 2010, BRIT J DERMATOL, V162, P554, DOI 10.1111/j.1365-2133.2009.09530.x; Blake FAS, 2007, WOUND REPAIR REGEN, V15, P756, DOI 10.1111/j.1524-475X.2007.00298.x; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Brown A, 2012, MED VET ENTOMOL, V26, P432, DOI 10.1111/j.1365-2915.2012.01029.x; Cerovsky V, 2010, CELL MOL LIFE SCI, V67, P455, DOI 10.1007/s00018-009-0194-0; Chan PP, 2009, NUCLEIC ACIDS RES, V37, pD93, DOI 10.1093/nar/gkn787; Chen X, 2010, INSECT MOL BIOL, V19, P799, DOI 10.1111/j.1365-2583.2010.01039.x; Dhahbi JM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-298; Forstemann K, 2005, PLOS BIOL, V3, P1187, DOI 10.1371/journal.pbio.0030236; Galac MR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-612; Gantier MP, 2011, NUCLEIC ACIDS RES, V39, P5692, DOI 10.1093/nar/gkr148; Gebetsberger J, 2012, ARCHAEA, V2012, DOI 10.1155/2012/260909; Gong B, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-285; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Harris LG, 2013, APPL ENVIRON MICROB, V79, P1393, DOI 10.1128/AEM.03689-12; Heath ACG, 2006, VET PARASITOL, V137, P333, DOI 10.1016/j.vetpar.2006.01.006; Horobin AJ, 2005, WOUND REPAIR REGEN, V13, P422, DOI 10.1111/j.1067-1927.2005.130410.x; Huberman L, 2007, MED VET ENTOMOL, V21, P127, DOI 10.1111/j.1365-2915.2007.00668.x; Ivanov P, 2011, MOL CELL, V43, P613, DOI 10.1016/j.molcel.2011.06.022; Jagadeeswaran G, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-52; JORDAN BR, 1974, FEBS LETT, V44, P39, DOI 10.1016/0014-5793(74)80301-7; Kin T, 2007, NUCLEIC ACIDS RES, V35, pD145, DOI 10.1093/nar/gkl837; Lee SF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-406; Lerrer B, 2007, ISME J, V1, P149, DOI 10.1038/ismej.2007.20; Lewis K, 2000, MICROBIOL MOL BIOL R, V64, P503, DOI 10.1128/MMBR.64.3.503-514.2000; Marrone AK, 2012, BMC CELL BIOL, V13, DOI 10.1186/1471-2121-13-26; Mead EA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-244; Mohd Masri S., 2005, Tropical Biomedicine, V22, P185; Nelson LA, 2012, GENE, V511, P131, DOI 10.1016/j.gene.2012.09.103; Obregon-Henao A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029970; PAVLAKIS GN, 1979, NUCLEIC ACIDS RES, V7, P2213, DOI 10.1093/nar/7.8.2213; Reibe S, 2010, PARASITOL RES, V107, P9, DOI 10.1007/s00436-010-1879-x; Rose H, 2011, INT J PARASITOL, V41, P739, DOI 10.1016/j.ijpara.2011.01.012; SCHLEIN Y, 1986, J MED ENTOMOL, V23, P11, DOI 10.1093/jmedent/23.1.11; Seitz H, 2008, CURR BIOL, V18, P147, DOI 10.1016/j.cub.2007.12.049; Shi YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043727; Shomron N, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000397; Siavash M, 2011, J RES MED SCI, V16, P904; Skalsky RL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-119; Sobala A, 2013, RNA BIOL, V10, P553, DOI 10.4161/rna.24285; Stevens JR, 2008, MED VET ENTOMOL, V22, P89, DOI 10.1111/j.1365-2915.2008.00710.x; Stoffolano JG, 2013, ANNU REV ENTOMOL, V58, P205, DOI 10.1146/annurev-ento-120811-153653; Sze SH, 2012, INSECT MOL BIOL, V21, P205, DOI 10.1111/j.1365-2583.2011.01127.x; Tarone AM, 2011, J MED ENTOMOL, V48, P1062, DOI 10.1603/ME11004; Teh CH, 2013, MED VET ENTOMOL, V27, P414, DOI 10.1111/mve.12012; Telford G, 2012, Med Vet Entomol, V26, P291, DOI 10.1111/j.1365-2915.2011.01000.x; Telford G, 2012, MED VET ENTOMOL, V26, P291, DOI 10.1111/j.1365-2915.2011.01000.x; Wang SY, 2011, MED HYPOTHESES, V76, P254, DOI 10.1016/j.mehy.2010.10.013; Whitaker IS, 2007, POSTGRAD MED J, V83, P409, DOI 10.1136/pgmj.2006.055905; Yu ZM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001340; Zaidi F, 2011, J INSECT SCI, V11, DOI 10.1673/031.011.5901; Zhang Z, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-24; Zhou JL, 2013, EXP APPL ACAROL, V59, P339, DOI 10.1007/s10493-012-9604-3	55	12	12	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0122203	10.1371/journal.pone.0122203	http://dx.doi.org/10.1371/journal.pone.0122203			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803701	gold, Green Submitted, Green Published			2022-12-26	WOS:000353889600192
J	Hamada-Kawaguchi, N; Nishida, Y; Yamamoto, D				Hamada-Kawaguchi, Noriko; Nishida, Yasuyoshi; Yamamoto, Daisuke			Btk29A-Mediated Tyrosine Phosphorylation of Armadillo/beta-Catenin Promotes Ring Canal Growth in Drosophila Oogenesis	PLOS ONE			English	Article							BETA-CATENIN; TEC-FAMILY; KINASE BTK; INTERCELLULAR BRIDGES; ACTIN ORGANIZATION; ALPHA-CATENIN; E-CADHERIN; SRC64; ADHESION; LOCALIZATION	Drosophila Btk29A is the ortholog of mammalian Btk, a Tec family nonreceptor tyrosine kinase whose deficit causes X-linked agammaglobulinemia in humans. The Btk29A(ficP) mutation induces multiple abnormalities in oogenesis, including the growth arrest of ring canals, large intercellular bridges that allow the flow of cytoplasm carrying maternal products essential for embryonic development from the nurse cells to the oocyte during oogenesis. In this study, inactivation of Parcas, a negative regulator of Btk29A, was found to promote Btk29A accumulation on ring canals with a concomitant increase in the ring canal diameter, counteracting the Btk29A(ficP) mutation. This mutation markedly reduced the accumulation of phosphotyrosine on ring canals and in the regions of cell-cell contact, where adhesion-supporting proteins such as DE-cadherin and beta-catenin ortholog Armadillo (Arm) are located. Our previous in vitro and in vivo analyses revealed that Btk29A directly phosphorylates Arm, leading to its release from DE-cadherin. In the present experiments, immunohistological analysis revealed that phosphorylation at tyrosine 150 (Y150) and Y667 of Arm was diminished in Btk29A(ficP) mutant ring canals. Overexpression of an Arm mutant with unphosphorylatable Y150 inhibited ring canal growth. Thus Btk29A-induced Y150 phosphorylation is necessary for the normal growth of ring canals. We suggest that the dissociation of tyrosine-phosphorylated Arm from DE-cadherin allows dynamic actin to reorganize, leading to ring canal expansion and cell shape changes during the course of oogenesis.	[Hamada-Kawaguchi, Noriko; Yamamoto, Daisuke] Tohoku Univ, Grad Sch Life Sci, Dept Dev Biol & Neurosci, Sendai, Miyagi 980, Japan; [Nishida, Yasuyoshi] Nagoya Univ, Grad Sch Sci, Dept Biol Sci, Nagoya, Aichi 4648601, Japan	Tohoku University; Nagoya University	Yamamoto, D (corresponding author), Tohoku Univ, Grad Sch Life Sci, Dept Dev Biol & Neurosci, Sendai, Miyagi 980, Japan.	daichan@m.tohoku.ac.jp		, Daisuke/0000-0002-4623-0106	MEXT [23220007, 26113702, 26114502]; Takeda Science Foundation; Ichiro Kanehara Foundation for the Promotion of Medical Sciences and Medical Care; Scandinavia-Japan Sasakawa Foundation; Tomizawa Junichi & Keiko Fund of the Molecular Biology Society of Japan for Young Scientists; Daiichi Sankyo Foundation of Life Science; Zoological Society of Japan; Grants-in-Aid for Scientific Research [23220007] Funding Source: KAKEN	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Ichiro Kanehara Foundation for the Promotion of Medical Sciences and Medical Care; Scandinavia-Japan Sasakawa Foundation; Tomizawa Junichi & Keiko Fund of the Molecular Biology Society of Japan for Young Scientists; Daiichi Sankyo Foundation of Life Science; Zoological Society of Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research (Nos. 23220007, 26113702 and 26114502) from MEXT to DY, a Life Science Grant from the Takeda Science Foundation to DY, a grant from The Ichiro Kanehara Foundation for the Promotion of Medical Sciences and Medical Care to NHK, a grant from The Scandinavia-Japan Sasakawa Foundation to NHK, a grant from the Tomizawa Junichi & Keiko Fund of the Molecular Biology Society of Japan for Young Scientists to NHK, a grant from the Daiichi Sankyo Foundation of Life Science to NHK, and a Zoological MO Award from The Zoological Society of Japan to NHK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba K, 1999, MOL CELL BIOL, V19, P4405; Beckett K, 2006, DEV BIOL, V299, P176, DOI 10.1016/j.ydbio.2006.07.049; Brembeck FH, 2004, GENE DEV, V18, P2225, DOI 10.1101/gad.317604; Cavey M, 2008, NATURE, V453, P751, DOI 10.1038/nature06953; Chandrasekaran V, 2005, DEVELOPMENT, V132, P3515, DOI 10.1242/dev.01926; Chen KH, 2008, CANCER LETT, V267, P37, DOI 10.1016/j.canlet.2008.03.005; Conley ME, 2009, ANNU REV IMMUNOL, V27, P199, DOI 10.1146/annurev.immunol.021908.132649; Djagaeva I, 2005, DEV BIOL, V284, P143, DOI 10.1016/j.ydbio.2005.05.012; Dodson GS, 1998, DEVELOPMENT, V125, P2883; Drees F, 2005, CELL, V123, P903, DOI 10.1016/j.cell.2005.09.021; Godt D, 1998, NATURE, V395, P387, DOI 10.1038/26493; Guarnieri DJ, 1998, MOL CELL, V1, P831, DOI 10.1016/S1097-2765(00)80082-9; Guild GM, 1997, J CELL BIOL, V138, P783, DOI 10.1083/jcb.138.4.783; Hamada N, 2005, FEBS LETT, V579, P4131, DOI 10.1016/j.febslet.2005.06.042; Hamada-Kawaguchi N, 2014, SCIENCE, V343, P294, DOI 10.1126/science.1244512; Harris TJC, 2005, TRENDS CELL BIOL, V15, P234, DOI 10.1016/j.tcb.2005.03.002; Hoffmans R, 2007, MECH DEVELOP, V124, P59, DOI 10.1016/j.mod.2006.09.006; Hudson AM, 2002, J CELL BIOL, V156, P677, DOI 10.1083/jcb.200109065; Kelso RJ, 2002, J CELL BIOL, V156, P703, DOI 10.1083/jcb.200110063; Kramerova IA, 1999, DEV DYNAM, V216, P349, DOI 10.1002/(SICI)1097-0177(199912)216:4/5<349::AID-DVDY4>3.0.CO;2-X; Lee SH, 2008, J BIOL CHEM, V283, P11526, DOI 10.1074/jbc.M708935200; Li MG, 1999, J CELL BIOL, V146, P1061, DOI 10.1083/jcb.146.5.1061; Lilien J, 2005, CURR OPIN CELL BIOL, V17, P459, DOI 10.1016/j.ceb.2005.08.009; Lu N, 2004, EMBO J, V23, P1089, DOI 10.1038/sj.emboj.7600127; Maas A, 2001, Dev Immunol, V8, P171, DOI 10.1155/2001/28962; Matsushita M, 1998, BIOCHEM BIOPH RES CO, V245, P337, DOI 10.1006/bbrc.1998.8420; Mische S, 2007, MOL BIOL CELL, V18, P2254, DOI 10.1091/mbc.E06-10-0959; Mohamed AJ, 2009, IMMUNOL REV, V228, P58, DOI 10.1111/j.1600-065X.2008.00741.x; O'Reilly AM, 2006, DEVELOPMENT, V133, P2627, DOI 10.1242/dev.02423; Ortutay C, 2008, ADV GENET, V64, P51, DOI 10.1016/S0065-2660(08)00803-1; PEIFER M, 1993, DEVELOPMENT, V118, P1191; Petrella LN, 2007, DEVELOPMENT, V134, P703, DOI 10.1242/dev.02766; Piedra J, 2003, MOL CELL BIOL, V23, P2287, DOI 10.1128/MCB.23.7.2287-2297.2003; Piedra J, 2001, J BIOL CHEM, V276, P20436, DOI 10.1074/jbc.M100194200; Robinson DN, 1997, ANNU REV CELL DEV BI, V13, P147, DOI 10.1146/annurev.cellbio.13.1.147; Roulier EM, 1998, MOL CELL, V1, P819, DOI 10.1016/S1097-2765(00)80081-7; Shinohara M, 2008, CELL, V132, P794, DOI 10.1016/j.cell.2007.12.037; SIDERAS P, 1995, ADV IMMUNOL, V59, P135, DOI 10.1016/S0065-2776(08)60631-8; Sinka R, 2002, DEVELOPMENT, V129, P3469; Smith CIE, 2001, BIOESSAYS, V23, P436, DOI 10.1002/bies.1062; Sokol NS, 1999, CURR BIOL, V9, P1221, DOI 10.1016/S0960-9822(99)80502-8; Somogyi K, 2004, MECH DEVELOP, V121, P57, DOI 10.1016/j.mod.2003.10.003; Tateno M, 2000, SCIENCE, V287, P324, DOI 10.1126/science.287.5451.324; Thomas JH, 2004, DEVELOPMENT, V131, P863, DOI 10.1242/dev.00989; XUE FY, 1993, CELL, V72, P681, DOI 10.1016/0092-8674(93)90397-9	45	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0121484	10.1371/journal.pone.0121484	http://dx.doi.org/10.1371/journal.pone.0121484			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803041	Green Published, Green Submitted, gold			2022-12-26	WOS:000353889600160
J	Li, Y; Wang, XS; Vural, S; Mishra, NK; Cowan, KH; Guda, C				Li, You; Wang, Xiaosheng; Vural, Suleyman; Mishra, Nitish K.; Cowan, Kenneth H.; Guda, Chittibabu			Exome Analysis Reveals Differentially Mutated Gene Signatures of Stage, Grade and Subtype in Breast Cancers	PLOS ONE			English	Article							LYSOPHOSPHATIDIC ACID PRODUCTION; NF-KAPPA-B; PROTEIN STABILITY; SALT SENSITIVITY; PHOSPHATASE 2A; ALPHA-ADDUCIN; RECEPTOR; GROWTH; CELLS; EXPRESSION	Breast cancers exhibit highly heterogeneous molecular profiles. Although gene expression profiles have been used to predict the risks and prognostic outcomes of breast cancers, the high variability of gene expression limits its clinical application. In contrast, genetic mutation profiles would be more advantageous than gene expression profiles because genetic mutations can be stably detected and the mutational heterogeneity widely exists in breast cancer genomes. We analyzed 98 breast cancer whole exome samples that were sorted into three subtypes, two grades and two stages. The sum deleterious effect of all mutations in each gene was scored to identify differentially mutated genes (DMGs) for this case-control study. DMGs were corroborated using extensive published knowledge. Functional consequences of deleterious SNVs on protein structure and function were also investigated. Genes such as ERBB2, ESP8, PPP2R4, KIAA0922, SP4, CENPJ, PRCP and SELP that have been experimentally or clinically verified to be tightly associated with breast cancer prognosis are among the DMGs identified in this study. We also identified some genes such as ARL6IP5, RAET1E, and ANO7 that could be crucial for breast cancer development and prognosis. Further, SNVs such as rs1058808, rs2480452, rs61751507, rs79167802, rs11540666, and rs2229437 that potentially influence protein functions are observed at significantly different frequencies in different comparison groups. Protein structure modeling revealed that many non-synonymous SNVs have a deleterious effect on protein stability, structure and function. Mutational profiling at gene-and SNV-level revealed differential patterns within each breast cancer comparison group, and the gene signatures correlate with expected prognostic characteristics of breast cancer classes. Some of the genes and SNVs identified in this study show high promise and are worthy of further investigation by experimental studies.	[Li, You; Wang, Xiaosheng; Vural, Suleyman; Mishra, Nitish K.; Guda, Chittibabu] Univ Nebraska Med Ctr, Dept Genet Cell Biol & Anat, Omaha, NE 68198 USA; [Cowan, Kenneth H.; Guda, Chittibabu] Nebraska Med Ctr, Fred & Pamela Buffett Canc Ctr, Omaha, NE USA; [Cowan, Kenneth H.; Guda, Chittibabu] Nebraska Med Ctr, Eppley Inst Res Canc, Omaha, NE USA; [Guda, Chittibabu] Univ Nebraska Med Ctr, Bioinformat & Syst Biol Core, Omaha, NE USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Guda, C (corresponding author), Univ Nebraska Med Ctr, Dept Genet Cell Biol & Anat, Omaha, NE 68198 USA.	babu.guda@unmc.edu	Mishra, Nitish Kumar/D-5577-2009; Wang, Xiaosheng/AAN-6410-2020; Mishra, Nitish/AAR-3757-2021	Wang, Xiaosheng/0000-0002-7199-7093; Vural, Suleyman/0000-0002-7777-5256	University of Nebraska Medical Center (UNMC); Fred and Pamela Buffett Cancer Center, UNMC	University of Nebraska Medical Center (UNMC); Fred and Pamela Buffett Cancer Center, UNMC	Funding for this project is provided by the University of Nebraska Medical Center (UNMC) to CG and the Fred and Pamela Buffett Cancer Center, UNMC to CG.	Abdelrahim M, 2005, MOL PHARMACOL, V68, P317, DOI 10.1124/mol.105.011825; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Alaoui-Jamali MA, 2003, CANCER RES, V63, P3764; American Cancer Society, 2013, BREAST CANCER FACTS; Arndt S, 2007, MOL CELL NEUROSCI, V34, P603, DOI 10.1016/j.mcn.2007.01.002; Banerji S, 2012, NATURE, V486, P405, DOI 10.1038/nature11154; Barash I, 2012, CARCINOGENESIS, V33, P2320, DOI 10.1093/carcin/bgs362; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bose R, 2013, CANCER DISCOV, V3, P224, DOI 10.1158/2159-8290.CD-12-0349; Boucharaba A, 2004, J CLIN INVEST, V114, P1714, DOI 10.1172/JCI200422123; Braithwaite D, 2012, CANCER EPIDEM BIOMAR, V21, P1115, DOI 10.1158/1055-9965.EPI-11-1228; Breyer JP, 2009, CANCER EPIDEM BIOMAR, V18, P1252, DOI 10.1158/1055-9965.EPI-08-1202; Brinkman A, 2000, JNCI-J NATL CANCER I, V92, P112, DOI 10.1093/jnci/92.2.112; Cabodi S, 2006, CANCER RES, V66, P4672, DOI 10.1158/0008-5472.CAN-05-2909; Calin GA, 2000, ONCOGENE, V19, P1191, DOI 10.1038/sj.onc.1203389; Capriotti E, 2005, NUCLEIC ACIDS RES, V33, pW306, DOI 10.1093/nar/gki375; Chen C, 2013, ARCH MED RES, V44, P380, DOI 10.1016/j.arcmed.2013.07.001; Chen M, 2006, ARCH IMMUNOL THER EX, V54, P75, DOI 10.1007/s00005-006-0010-6; Chen N, 2010, FEBS LETT, V584, P1427, DOI 10.1016/j.febslet.2009.12.034; Chen YJ, 2008, MOL CANCER THER, V7, P1376, DOI 10.1158/1535-7163.MCT-07-2388; Clifford RJ, 2004, BIOINFORMATICS, V20, P1006, DOI 10.1093/bioinformatics/bth029; Colak D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063204; Cusi D, 1997, LANCET, V349, P1353, DOI 10.1016/S0140-6736(97)01029-5; Davis DA, 2005, BLOOD, V105, P4561, DOI 10.1182/blood-2004-12-4618; Dehouck Y, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-151; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Du J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015940; Duan L, 2011, J BIOL CHEM, V286, P2864, DOI 10.1074/jbc.M110.143271; Eisinger F, 1996, CANCER RES, V56, P471; Georgescu SP, 2005, MOL ENDOCRINOL, V19, P2491, DOI 10.1210/me.2004-0311; Gil-Bernabe AM, 2013, BRIT J HAEMATOL, V162, P433, DOI 10.1111/bjh.12381; Gonzalez-Perez A, 2011, AM J HUM GENET, V88, P440, DOI 10.1016/j.ajhg.2011.03.004; Guo W, 2011, J MOL BIOL, V412, P365, DOI 10.1016/j.jmb.2011.07.012; Hao RX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079020; Higgins KJ, 2006, ENDOCRINOLOGY, V147, P3285, DOI 10.1210/EN.2006-0081; Hornberger J, 2005, AM J MANAG CARE, V11, P313; Howe LR, 2004, CANCER BIOL THER, V3, P36, DOI 10.4161/cbt.3.1.561; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Hutchinson L, 2010, NAT REV CLIN ONCOL, V7, P669, DOI 10.1038/nrclinonc.2010.192; Jeselsohn R, 2014, CLIN CANCER RES, V20, P1757, DOI 10.1158/1078-0432.CCR-13-2332; Jutooru I, 2010, J BIOL CHEM, V285, P25332, DOI 10.1074/jbc.M109.095240; Kallberg M, 2012, NAT PROTOC, V7, P1511, DOI 10.1038/nprot.2012.085; Katsuno Y, 2008, ONCOGENE, V27, P6322, DOI 10.1038/onc.2008.232; Keen JC, 2005, J BIOL CHEM, V280, P29519, DOI 10.1074/jbc.M505317200; Kelly TN, 2009, AM J HYPERTENS, V22, P985, DOI 10.1038/ajh.2009.118; Kikuno R, 2002, NUCLEIC ACIDS RES, V30, P166, DOI 10.1093/nar/30.1.166; Kittaneh Muaiad, 2013, Biomark Cancer, V5, P61, DOI 10.4137/BIC.S9455; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Koyanagi M, 2005, J BIOL CHEM, V280, P12430, DOI 10.1074/jbc.M410420200; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Ma YX, 2007, MOL ENDOCRINOL, V21, P1905, DOI 10.1210/me.2006-0397; Maharzi N, 2013, J IMMUNOL, V190, P6187, DOI 10.4049/jimmunol.1300400; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Meijer D, 2006, MOL CANCER RES, V4, P379, DOI 10.1158/1541-7786.MCR-05-0156; Mertens-Talcott SU, 2013, MOL CARCINOGEN, V52, P591, DOI 10.1002/mc.21893; Moeller C, 2003, DEVELOPMENT, V130, P5103, DOI 10.1242/dev.00686; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Panupinthu N, 2010, BRIT J CANCER, V102, P941, DOI 10.1038/sj.bjc.6605588; Parthiban V, 2006, NUCLEIC ACIDS RES, V34, pW239, DOI 10.1093/nar/gkl190; Peng B, 2002, MOL ENDOCRINOL, V16, P2019, DOI 10.1210/me.2002-0108; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Polyak K, 2011, J CLIN INVEST, V121, P3786, DOI 10.1172/JCI60534; Prajapati SC, 2011, FEBS J, V278, P3256, DOI 10.1111/j.1742-4658.2011.08275.x; Ross JS, 2003, ONCOLOGIST, V8, P307, DOI 10.1634/theoncologist.8-4-307; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Ruediger R, 2001, ONCOGENE, V20, P10, DOI 10.1038/sj.onc.1204059; Shostak K, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2886; Simon R, 2007, CANCER INFORM, V3, P11; Smyth SS, 2003, J BIOL CHEM, V278, P43214, DOI 10.1074/jbc.M306709200; Stone EA, 2005, GENOME RES, V15, P978, DOI 10.1101/gr.3804205; Van der Auwera Geraldine A, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1201s43, 10.1002/0471250953.bi1110s43]; Tian S, 2010, BIOMARK INSIGHTS, V5, P129, DOI 10.4137/BMI.S6184; Tong SY, 2009, BJOG-INT J OBSTET GY, V116, P1046, DOI 10.1111/j.1471-0528.2009.02186.x; Tweardy D, 2011, J CLIN ONCOL, V29, P2443, DOI 10.1200/JCO.2010.34.2014; van der Flier S, 2000, JNCI-J NATL CANCER I, V92, P120, DOI 10.1093/jnci/92.2.120; Wang J, 2008, J PROTEOME RES, V7, P3879, DOI 10.1021/pr8001645; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wu D, 2009, ONCOGENE, V28, P2219, DOI 10.1038/onc.2009.96; Wu D, 2010, J BIOL CHEM, V285, P28643, DOI 10.1074/jbc.M110.107649; Yao J, 2006, CANCER RES, V66, P4065, DOI 10.1158/0008-5472.CAN-05-4083; Yoneda-Kato N, 2005, EMBO J, V24, P1739, DOI 10.1038/sj.emboj.7600656	86	19	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0119383	10.1371/journal.pone.0119383	http://dx.doi.org/10.1371/journal.pone.0119383			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803781	gold, Green Published, Green Submitted			2022-12-26	WOS:000353889600025
J	Martinez, LM; Labovsky, V; Calcagno, MD; Davies, KM; Rivello, HG; Bianchi, MS; Wernicke, A; Vallone, VBF; Chasseing, NA				Marcelo Martinez, Leandro; Labovsky, Vivian; de Lujan Calcagno, Maria; Mauro Davies, Kevin; Garcia Rivello, Hernan; Silvia Bianchi, Maria; Wernicke, Alejandra; Fernandez Vallone, Valeria Beatriz; Alejandra Chasseing, Norma			CD105 Expression on CD34-Negative Spindle-Shaped Stromal Cells of Primary Tumor Is an Unfavorable Prognostic Marker in Early Breast Cancer Patients	PLOS ONE			English	Article							INVASIVE DUCTAL CARCINOMA; REGULATORY T-CELLS; STEM-CELLS; IN-SITU; METASTASIS; FIBROBLASTS; MICROENVIRONMENT; S100A4; MYOFIBROBLASTS; HYALURONAN	Several studies have confirmed that the breast tumor microenvironment drives cancer progression and metastatic development. The aim of our research was to investigate the prognostic significance of the breast tumor microenvironment in untreated early breast cancer patients. Therefore, we analyzed the association of the expression of alpha-SMA, FSP, CD105 and CD146 in CD34-negative spindle-shaped stromal cells, not associated with the vasculature, in primary breast tumors with classical prognostic marker levels, metastatic recurrence, local relapse, disease-free survival, metastasis-free survival and the overall survival of patients. In the same way, we evaluated the association of the amount of intra-tumor stroma, fibroblasts, collagen deposition, lymphocytic infiltration and myxoid changes in these samples with the clinical-pathological data previously described. This study is the first to demonstrate the high CD105 expression in this stromal cell type as a possible independent marker of unfavorable prognosis in early breast cancer patients. Our study suggests that this new finding can be useful prognostic marker in the clinical-pathological routine.	[Marcelo Martinez, Leandro; Labovsky, Vivian; Fernandez Vallone, Valeria Beatriz; Alejandra Chasseing, Norma] Consejo Nacl Invest Cient & Tecn, Natl Council Sci & Tech Res, Expt Biol & Med Inst IBYME, Immunohematol Lab, RA-1033 Buenos Aires, DF, Argentina; [de Lujan Calcagno, Maria] Univ Buenos Aires, Fac Pharm & Biochem, Dept Biostat, Buenos Aires, DF, Argentina; [Mauro Davies, Kevin; Garcia Rivello, Hernan; Wernicke, Alejandra] Italian Hosp, Dept Pathol Anat, Buenos Aires, DF, Argentina; [Silvia Bianchi, Maria] Consejo Nacl Invest Cient & Tecn, Natl Council Sci & Tech Res, Expt Biol & Med Inst IBYME, Neuroendocrinol Lab, RA-1033 Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Institute of Biology & Experimental Medicine; University of Buenos Aires; Hospital Italiano de Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Institute of Biology & Experimental Medicine	Chasseing, NA (corresponding author), Consejo Nacl Invest Cient & Tecn, Natl Council Sci & Tech Res, Expt Biol & Med Inst IBYME, Immunohematol Lab, RA-1033 Buenos Aires, DF, Argentina.	achasseing@ibyme.conicet.gov.ar	; Fernandez Vallone, Valeria/A-8057-2017	Garcia-Rivello, hernan/0000-0003-2056-464X; Fernandez Vallone, Valeria/0000-0003-3875-9170	National Agency for Science and Technology, Argentina [PICT2006]; National Council of Scientific and Technical Research (CONICET), Argentina [PIP2011]; Roemmers Foundation, Argentina	National Agency for Science and Technology, Argentina; National Council of Scientific and Technical Research (CONICET), Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Roemmers Foundation, Argentina	Grant PICT2006 from the National Agency for Science and Technology, Argentina (NAC; http://www.agencia.mincyt.gob.ar/). Grant PIP2011 from the National Council of Scientific and Technical Research (CONICET), Argentina (NAC; http://www.conicet.gov.ar/). Grant 2006-2008, 2009-2011 and 2011-2013 from the Roemmers Foundation, Argentina (NAC; http://www.roemmers.com.ar/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn S, 2012, TUMOR BIOL, V33, P1573, DOI 10.1007/s13277-012-0411-6; Angeli F, 2009, TUMOR BIOL, V30, P109, DOI 10.1159/000218708; Auvinen P, 2000, AM J PATHOL, V156, P529, DOI 10.1016/S0002-9440(10)64757-8; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BERTRAND P, 1992, INT J CANCER, V52, P1, DOI 10.1002/ijc.2910520102; BLOOM HJG, 1957, BRIT J CANCER, V11, P359, DOI 10.1038/bjc.1957.43; Cabezon T, 2007, INT J CANCER, V121, P1433, DOI 10.1002/ijc.22850; Charpin C, 2004, CLIN CANCER RES, V10, P5815, DOI 10.1158/1078-0432.CCR-04-0021; Chauhan H, 2003, J CLIN PATHOL, V56, P271, DOI 10.1136/jcp.56.4.271; Dales JP, 2004, INT J ONCOL, V24, P1197; de Kruijf EM, 2011, BREAST CANCER RES TR, V125, P687, DOI 10.1007/s10549-010-0855-6; Ismail NI, 2008, CANCER CELL INT, V8, DOI 10.1186/1475-2867-8-12; Jalava P, 2005, ANTICANCER RES, V25, P2535; Jones DH, 2006, NATURE, V440, P692, DOI 10.1038/nature04524; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Khamis ZI, 2012, INT J BREAST CANCER, V2012, DOI 10.1155/2012/574025; Knutson KL, 2006, J IMMUNOL, V177, P84, DOI 10.4049/jimmunol.177.1.84; Kojima Y, 2010, P NATL ACAD SCI USA, V107, P20009, DOI 10.1073/pnas.1013805107; Lee WY, 2004, ONCOLOGY-BASEL, V66, P429, DOI 10.1159/000079496; Li CG, 2000, INT J CANCER, V89, P122, DOI 10.1002/(SICI)1097-0215(20000320)89:2<122::AID-IJC4>3.0.CO;2-M; Li J, 2008, CLIN CANCER RES, V14, P3319, DOI 10.1158/1078-0432.CCR-07-4054; Li WD, 2011, PATHOL RES PRACT, V207, P739, DOI 10.1016/j.prp.2011.09.009; Loibl M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/395781; Lorusso G, 2008, HISTOCHEM CELL BIOL, V130, P1091, DOI 10.1007/s00418-008-0530-8; Man YG, 2004, EXP CELL RES, V301, P103, DOI 10.1016/j.yexcr.2004.08.037; Mao Y, 2013, CANCER METAST REV, V32, P303, DOI 10.1007/s10555-012-9415-3; Mishra PJ, 2008, CANCER RES, V68, P4331, DOI 10.1158/0008-5472.CAN-08-0943; Mohammed ZMA, 2013, BRIT J CANCER, V109, P1676, DOI 10.1038/bjc.2013.493; Nayar R, 1999, Ann Diagn Pathol, V3, P165, DOI 10.1016/S1092-9134(99)80044-6; Patel SA, 2008, J ONCOL, V2008, DOI 10.1155/2008/425895; Paulsson J, 2014, SEMIN CANCER BIOL, V25, P61, DOI 10.1016/j.semcancer.2014.02.006; Paunescu V, 2011, J CELL MOL MED, V15, P635, DOI 10.1111/j.1582-4934.2010.01044.x; Pestalozzi BC, 2005, ANN ONCOL, V16, P7, DOI 10.1093/annonc/mdi825; Rau KM, 2012, EXP THER MED, V4, P231, DOI 10.3892/etm.2012.594; Reddy BY, 2012, INT J BREAST CANCER, V2012, DOI 10.1155/2012/721659; Rong GH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070960; Spaeth EL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004992; Surowiak P, 2007, ANTICANCER RES, V27, P2917; Tan W, 2011, NATURE, V470, P548, DOI 10.1038/nature09707; Tormin A, 2011, BLOOD, V117, P5067, DOI 10.1182/blood-2010-08-304287; Wernicke M, 2003, MODERN PATHOL, V16, P99, DOI 10.1097/01.MP.0000051582.75890.2D; Wernicke M, 2011, MEDICINA-BUENOS AIRE, V71, P15; Yazhou C, 2004, TUMOR BIOL, V25, P290, DOI 10.1159/000081394; Zeisberg EM, 2007, CANCER RES, V67, P10123, DOI 10.1158/0008-5472.CAN-07-3127; Zimmerlin L, 2013, CYTOM PART A, V83A, P134, DOI 10.1002/cyto.a.22227	45	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0121421	10.1371/journal.pone.0121421	http://dx.doi.org/10.1371/journal.pone.0121421			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803686	gold, Green Published, Green Submitted			2022-12-26	WOS:000353889600157
J	Wilkening, JL; Ray, C; Varner, J				Wilkening, Jennifer L.; Ray, Chris; Varner, Johanna			Relating Sub-Surface Ice Features to Physiological Stress in a Climate Sensitive Mammal, the American Pika (Ochotona princeps)	PLOS ONE			English	Article							SIERRA-NEVADA; FECAL GLUCOCORTICOIDS; PERIGLACIAL LANDFORMS; GENERALIST HERBIVORE; GREAT-BASIN; SURVIVAL; GLACIERS; STEROIDS; PATTERNS; BEHAVIOR	The American pika (Ochotona princeps) is considered a sentinel species for detecting ecological effects of climate change. Pikas are declining within a large portion of their range, and ongoing research suggests loss of sub-surface ice as a mechanism. However, no studies have demonstrated physiological responses of pikas to sub-surface ice features. Here we present the first analysis of physiological stress in pikas living in and adjacent to habitats underlain by ice. Fresh fecal samples were collected non-invasively from two adjacent sites in the Rocky Mountains (one with sub-surface ice and one without) and analyzed for glucocorticoid metabolites (GCM). We also measured sub-surface microclimates in each habitat. Results indicate lower GCM concentration in sites with sub-surface ice, suggesting that pikas are less stressed in favorable microclimates resulting from sub-surface ice features. GCM response was well predicted by habitat characteristics associated with sub-surface ice features, such as lower mean summer temperatures. These results suggest that pikas inhabiting areas without sub-surface ice features are experiencing higher levels of physiological stress and may be more susceptible to changing climates. Although post-deposition environmental effects can confound analyses based on fecal GCM, we found no evidence for such effects in this study. Sub-surface ice features are key to water cycling and storage and will likely represent an increasingly important component of water resources in a warming climate. Fecal samples collected from additional watersheds as part of current pika monitoring programs could be used to further characterize relationships between pika stress and sub-surface ice features.	[Wilkening, Jennifer L.; Ray, Chris] Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA; [Ray, Chris] Univ Colorado, Inst Arctic & Alpine Res, Boulder, CO 80309 USA; [Varner, Johanna] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; Utah System of Higher Education; University of Utah	Wilkening, JL (corresponding author), Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA.	Jennifer.Wilkening@colorado.edu	Ray, Chris/AAI-1002-2019	Ray, Chris/0000-0002-7963-9637; Wilkening, Jennifer/0000-0001-8748-4578; Varner, Johanna/0000-0001-9431-0760	Ecology and Evolutionary Biology Department at the University of Colorado, Boulder; Colorado Mountain Club Foundation; University of Colorado Boulder Libraries Open Access Fund; Division Of Environmental Biology [1027341] Funding Source: National Science Foundation	Ecology and Evolutionary Biology Department at the University of Colorado, Boulder; Colorado Mountain Club Foundation; University of Colorado Boulder Libraries Open Access Fund; Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Financial support was provided by a research grant from the Ecology and Evolutionary Biology Department at the University of Colorado, Boulder (http://ebio.colorado.edu/index.php/graduategrants-and-fellowships) and a Neal B. Kindig Fellowship from the Colorado Mountain Club Foundation (http://www.cmc.org/About/CMCFoundation.aspx) awarded to JLW. Publication of this article was funded by the University of Colorado Boulder Libraries Open Access Fund. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Barton K, 2014, PACKAGE MUMIN; Bates D, 2012, PACKAGE LME4; Beever EA, 2003, J MAMMAL, V84, P37, DOI 10.1644/1545-1542(2003)084<0037:POAEAI>2.0.CO;2; Beever EA, 2011, GLOBAL CHANGE BIOL, V17, P2054, DOI 10.1111/j.1365-2486.2010.02389.x; Beever EA, 2010, ECOL APPL, V20, P164, DOI 10.1890/08-1011.1; Beniston M, 2003, CLIMATIC CHANGE, V59, P5, DOI 10.1023/A:1024458411589; Braganza K, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019998; Briones MJI, 1997, APPL SOIL ECOL, V6, P117; Brown CR, 2005, ECOLOGY, V86, P1034, DOI 10.1890/04-0740; Buckley YM, 2003, J APPL ECOL, V40, P481, DOI 10.1046/j.1365-2664.2003.00821.x; Burger KC, 1999, GEOMORPHOLOGY, V31, P93, DOI 10.1016/S0169-555X(99)00074-4; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; CLARK DH, 1994, QUATERNARY RES, V41, P139, DOI 10.1006/qres.1994.1016; Convey P, 2003, GLOBAL CHANGE BIOL, V9, P1718, DOI 10.1046/j.1365-2486.2003.00691.x; Cyr NE, 2008, GEN COMP ENDOCR, V158, P20, DOI 10.1016/j.ygcen.2008.05.001; Davies NA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079136; Dearing MD, 1996, OECOLOGIA, V108, P467, DOI 10.1007/BF00333723; Diaz HF, 1997, CLIMATIC CHANGE, V36, P253, DOI 10.1023/A:1005335731187; Erb LP, 2011, ECOLOGY, V92, P1730, DOI 10.1890/11-0175.1; Foley CAH, 2001, CONSERV BIOL, V15, P1134, DOI 10.1046/j.1523-1739.2001.0150041134.x; Grayson DK, 2005, J BIOGEOGR, V32, P2103, DOI 10.1111/j.1365-2699.2005.01341.x; HAFNER DJ, 1993, QUATERNARY RES, V39, P373, DOI 10.1006/qres.1993.1044; HAFNER DJ, 1994, ARCTIC ALPINE RES, V26, P375, DOI 10.2307/1551799; Harper JM, 2000, PHYSIOL BIOCHEM ZOOL, V73, P12, DOI 10.1086/316721; Huber S, 2003, GEN COMP ENDOCR, V130, P48, DOI 10.1016/S0016-6480(02)00535-X; Hughes L, 2000, TRENDS ECOL EVOL, V15, P56, DOI 10.1016/S0169-5347(99)01764-4; HUNTLY NJ, 1986, J MAMMAL, V67, P139, DOI 10.2307/1381010; Intergovernmental Panel Climate Change Working Grp III, 2014, CLIMATE CHANGE 2014: MITIGATION OF CLIMATE CHANGE, P1; Ives J.D., 1973, PERMAFROST ITS RELAT, P121; Ives J.D., 1971, J GLACIOL, V10, P105, DOI [DOI 10.3189/S0022143000013034, 10.3189/S0022143000013034]; Jeffress MR, 2013, ECOL APPL, V23, P864, DOI 10.1890/12-0979.1; KARL TR, 1991, GEOPHYS RES LETT, V18, P2253, DOI 10.1029/91GL02900; Khan MZ, 2002, GEN COMP ENDOCR, V128, P57, DOI 10.1016/S0016-6480(02)00063-1; Krajick K, 2004, SCIENCE, V303, P1600, DOI 10.1126/science.303.5664.1600; Laternser M, 2003, INT J CLIMATOL, V23, P733, DOI 10.1002/joc.912; Lawlor TE, 1998, J MAMMAL, V79, P1111, DOI 10.2307/1383003; Leopold M., 2010, NOVA ACTA LEOPOLD, V112, P281; Leopold M, 2008, ARCT ANTARCT ALP RES, V40, P519, DOI 10.1657/1523-0430(06-124)[LEOPOLD]2.0.CO;2; Leopold M, 2014, Z GEOMORPHOL, V58, P137, DOI 10.1127/0372-8854/2013/S-00129; MACARTHUR RA, 1973, CAN J ZOOL, V51, P11, DOI 10.1139/z73-002; MACDONALD IA, 1983, J LIPID RES, V24, P675; Mai DH., 1995, TERTI RE VEGETATIONS; MCDONALD KA, 1992, CONSERV BIOL, V6, P409, DOI 10.1046/j.1523-1739.1992.06030409.x; Millar CI, 2008, QUATERN INT, V188, P90, DOI 10.1016/j.quaint.2007.06.004; Millar CI, 2010, ARCT ANTARCT ALP RES, V42, P76, DOI 10.1657/1938-4246-42.1.76; Millspaugh JJ, 2004, GEN COMP ENDOCR, V138, P189, DOI 10.1016/j.ygcen.2004.07.002; Millspaugh JJ, 2001, WILDLIFE SOC B, V29, P899; Molotch NP, 2008, WATER RESOUR RES, V44, DOI 10.1029/2007WR006587; Morrison SF, 2007, J ANIM ECOL, V76, P899, DOI 10.1111/j.1365-2656.2007.01276.x; Mote PW, 2005, B AM METEOROL SOC, V86, P39, DOI 10.1175/BAMS-86-1-39; Naftz DL, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD000621; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Nalini Kataria, 2006, Slovenian Veterinary Research, V43, P135; Palme R, 2005, ANN NY ACAD SCI, V1046, P75, DOI 10.1196/annals.1343.007; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Paul F, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020816; Pinheiro J, 2001, MIXED EFFECTS MODELS; Rangel-Negrin A, 2009, ANIM CONSERV, V12, P496, DOI 10.1111/j.1469-1795.2009.00280.x; Ray C., 2012, WILDLIFE CONSERVATIO, P245; Rodhouse TJ, 2010, J MAMMAL, V91, P1287, DOI 10.1644/09-MAMM-A-334.1; Rogovin K, 2003, HORM BEHAV, V43, P132, DOI 10.1016/S0018-506X(02)00028-4; Romero LM, 2001, P NATL ACAD SCI USA, V98, P7366, DOI 10.1073/pnas.131091498; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Rusterholz HP, 1998, OECOLOGIA, V113, P341, DOI 10.1007/s004420050385; Schrott L., 1996, Z GEOMORPHOL, V104, P161; Service RF, 2004, SCIENCE, V303, P1124, DOI 10.1126/science.303.5661.1124; SMITH A T, 1990, Mammalian Species, P1, DOI 10.2307/3504319; Smith A.T., 2004, SPECIES, V41, P4; SMITH AT, 1974, ECOLOGY, V55, P1368, DOI 10.2307/1935464; Smith JA, 2013, ARCT ANTARCT ALP RES, V45, P396, DOI 10.1657/1938-4246-45.3.396; SMITH RIL, 1994, OECOLOGIA, V99, P322, DOI 10.1007/BF00627745; Terio KA, 2002, ZOO BIOL, V21, P215, DOI 10.1002/zoo.10036; Touma C, 2003, GEN COMP ENDOCR, V130, P267, DOI 10.1016/S0016-6480(02)00620-2; Viviroli D, 2003, MT RES DEV, V23, P32, DOI 10.1659/0276-4741(2003)023[0032:ATHSOT]2.0.CO;2; von der Ohe CG, 2002, WILDLIFE SOC B, V30, P1215; Walther GR, 2007, GLOBAL ECOL BIOGEOGR, V16, P801, DOI 10.1111/j.1466-8238.2007.00328.x; Walther GR, 2002, FOLIA GEOBOT, V37, P129, DOI 10.1007/BF02803195; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Watt A. D., 1995, P197; Wilkening JL, 2011, QUATERN INT, V27, P1; Wilkening JL, 2013, CONSERV PHYS, V1, P1, DOI DOI 10.1093/C0NPHYS/C0T027; Wilkening JL, 2014, THESIS U COLORADO; Williams MW, 2006, PERMAFROST PERIGLAC, V17, P13, DOI 10.1002/ppp.535	84	19	21	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0119327	10.1371/journal.pone.0119327	http://dx.doi.org/10.1371/journal.pone.0119327			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803587	Green Submitted, Green Published, gold			2022-12-26	WOS:000353889600023
J	Yokoyama, R; Nozawa, T; Takeuchi, H; Taki, Y; Sekiguchi, A; Nouchi, R; Kotozaki, Y; Nakagawa, S; Miyauchi, CM; Iizuka, K; Shinada, T; Yamamoto, Y; Hanawa, S; Araki, T; Hashizume, H; Kunitoki, K; Hanihara, M; Sassa, Y; Kawashima, R				Yokoyama, Ryoichi; Nozawa, Takayuki; Takeuchi, Hikaru; Taki, Yasuyuki; Sekiguchi, Atsushi; Nouchi, Rui; Kotozaki, Yuka; Nakagawa, Seishu; Miyauchi, Carlos Makoto; Iizuka, Kunio; Shinada, Takamitsu; Yamamoto, Yuki; Hanawa, Sugiko; Araki, Tsuyoshi; Hashizume, Hiroshi; Kunitoki, Keiko; Hanihara, Mayu; Sassa, Yuko; Kawashima, Ryuta			Regional Gray Matter Density Associated with Cognitive Reflectivity-Impulsivity: Evidence from Voxel-Based Morphometry	PLOS ONE			English	Article							DECISION-MAKING; PREFRONTAL CORTEX; TEMPERAMENT; ACCOUNTS; DISTINCT; NUCLEUS; VOLUME	When faced with a problem or choice, humans can use two different strategies: "cognitive reflectivity," which involves slow responses and fewer mistakes, or " cognitive impulsivity,"which comprises of quick responses and more mistakes. Different individuals use these two strategies differently. To our knowledge, no study has directly investigated the brain regions involved in reflectivity-impulsivity; therefore, this study focused on associations between these cognitive strategies and the gray matter structure of several brain regions. In order to accomplish this, we enrolled 776 healthy, right-handed individuals (432 men and 344 women; 20.7 +/- 1.8 years) and used voxel-based morphometry with administration of a cognitive reflectivity-impulsivity questionnaire. We found that high cognitive reflectivity was associated with greater regional gray matter density in the ventral medial prefrontal cortex. Our finding suggests that this area plays an important role in defining an individual's trait associated with reflectivity and impulsivity.	[Yokoyama, Ryoichi; Sekiguchi, Atsushi; Nakagawa, Seishu; Miyauchi, Carlos Makoto; Iizuka, Kunio; Shinada, Takamitsu; Yamamoto, Yuki; Hanawa, Sugiko; Kawashima, Ryuta] Tohoku Univ, Inst Dev Aging & Canc, Dept Funct Brain Imaging, Sendai, Miyagi 980, Japan; [Yokoyama, Ryoichi] Japan Soc Promot Sci, Tokyo, Japan; [Nozawa, Takayuki; Kotozaki, Yuka; Araki, Tsuyoshi; Kawashima, Ryuta] Tohoku Univ, Inst Dev Aging & Canc, Smart Ageing Int Res Ctr, Sendai, Miyagi 980, Japan; [Takeuchi, Hikaru; Taki, Yasuyuki; Hashizume, Hiroshi; Sassa, Yuko; Kawashima, Ryuta] Tohoku Univ, Inst Dev Aging & Canc, Div Dev Cognit Neurosci, Sendai, Miyagi 980, Japan; [Taki, Yasuyuki; Sekiguchi, Atsushi] Tohoku Univ, Tohoku Med Megabank Org, Dept Community Med Supports, Div Med Neuroimaging, Sendai, Miyagi 980, Japan; [Taki, Yasuyuki] Tohoku Univ, Inst Dev Aging & Canc, Dept Nucl Med & Radiol, Sendai, Miyagi 980, Japan; [Nouchi, Rui] Tohoku Univ, Int Res Inst Disaster Sci, Human & Social Response Res Div, Sendai, Miyagi 980, Japan; [Miyauchi, Carlos Makoto] Univ Tokyo, Grad Sch Law, Bunkyo Ku, Tokyo, Japan; [Miyauchi, Carlos Makoto] Univ Tokyo, Grad Sch Polit, Bunkyo Ku, Tokyo, Japan; [Kunitoki, Keiko; Hanihara, Mayu] Tohoku Univ, Fac Med, Sendai, Miyagi 980, Japan	Tohoku University; Japan Society for the Promotion of Science; Tohoku University; Tohoku University; Tohoku University; Tohoku University; Tohoku University; University of Tokyo; University of Tokyo; Tohoku University	Yokoyama, R (corresponding author), Tohoku Univ, Inst Dev Aging & Canc, Dept Funct Brain Imaging, Sendai, Miyagi 980, Japan.	r-yokoyama@idac.tohoku.ac.jp	Nozawa, Takayuki/Y-9610-2019; Takeuchi, Hikaru/D-1057-2011; Nouchi, Rui/GQH-1608-2022; Kotozaki, Yuka/ABA-2922-2020; Kotozaki, Yuka/ABA-2267-2020; Kunitoki, Keiko/AAS-3381-2020	Nozawa, Takayuki/0000-0001-6300-4373; Kotozaki, Yuka/0000-0002-4659-1200; Nouchi, Rui/0000-0002-2078-9518; xing zhi, shi zhi/0000-0003-3289-5681; Takeuchi, Hikaru/0000-0002-8022-9694	JST/RISTEX; JST/CREST; Ministry of Education, Culture, Sports, Science, and Technology [25700012, 23700306]; Japan Society for the Promotion of Science; Tohoku University international Advanced Research and Education Organization	JST/RISTEX(Japan Science & Technology Agency (JST)); JST/CREST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Tohoku University international Advanced Research and Education Organization	This study was supported by JST/RISTEX, JST/CREST, a Grant-in-Aid for Young Scientists (B) (KAKENHI 23700306), a Grant-in-Aid for Young Scientists (A) (KAKENHI 25700012) from the Ministry of Education, Culture, Sports, Science, and Technology, the Japan Society for the Promotion of Science, and Tohoku University international Advanced Research and Education Organization. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe N, 2007, J COGNITIVE NEUROSCI, V19, P287, DOI 10.1162/jocn.2007.19.2.287; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; AULT RL, 1973, CHILD DEV, V44, P259; BARRATT ES, 1965, PSYCHOL REP, V16, P547, DOI 10.2466/pr0.1965.16.2.547; Bechara A, 2005, NAT NEUROSCI, V8, P1458, DOI 10.1038/nn1584; Bechara A, 1997, SCIENCE, V275, P1293, DOI 10.1126/science.275.5304.1293; BLOCK J, 1974, DEV PSYCHOL, V10, P611, DOI 10.1037/h0037047; CARRILLODELAPENA MT, 1993, PERCEPT MOTOR SKILL, V77, P567, DOI 10.2466/pms.1993.77.2.567; Carver CSW, 1994, VIOLENCE MENTAL DISO, P61; Clark L, 2006, BIOL PSYCHIAT, V60, P515, DOI 10.1016/j.biopsych.2005.11.007; CLONINGER CR, 1993, ARCH GEN PSYCHIAT, V50, P975, DOI 10.1001/archpsyc.1993.01820240059008; Daruna JH, 1993, NEURODEVELOPMENTAL V; DICKMAN SJ, 1988, J PERS SOC PSYCHOL, V54, P274, DOI 10.1037/0022-3514.54.2.274; Diekhof EK, 2010, J NEUROSCI, V30, P1488, DOI 10.1523/JNEUROSCI.4690-09.2010; Evans J., 1996, RATIONALITY REASONIN; Evans JSBT, 2008, ANNU REV PSYCHOL, V59, P255, DOI 10.1146/annurev.psych.59.103006.093629; Evans JST, 2003, TRENDS COGN SCI, V7, P454, DOI 10.1016/j.tics.2003.08.012; Evenden JL, 1999, PSYCHOPHARMACOLOGY, V146, P348, DOI 10.1007/PL00005481; GARGALLO B, 1993, EUR J PSYCHOL EDUC, V8, P151, DOI 10.1007/BF03173159; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Haier RJ, 2004, NEUROIMAGE, V23, P425, DOI 10.1016/j.neuroimage.2004.04.025; Hare TA, 2009, SCIENCE, V324, P646, DOI 10.1126/science.1168450; Hayasaka S, 2004, NEUROIMAGE, V22, P676, DOI 10.1016/j.neuroimage.2004.01.041; KAGAN J, 1966, J ABNORM PSYCHOL, V71, P17, DOI 10.1037/h0022886; Kagan J, 1965, IMPULSIVE REFLECTIVE, V133, P161; Kahneman D., 2011, THINKING FAST SLOW; Kanai R, 2011, NAT REV NEUROSCI, V12, P231, DOI 10.1038/nrn3000; Kijima N, 2000, PSYCHOL REP, V86, P1050, DOI 10.2466/PR0.86.3.1050-1058; Kringelbach ML, 2004, PROG NEUROBIOL, V72, P341, DOI 10.1016/j.pneurobio.2004.03.006; Lee AKW, 2011, BRAIN IMAGING BEHAV, V5, P52, DOI 10.1007/s11682-010-9112-1; Lieberman MD, 2007, ANNU REV PSYCHOL, V58, P259, DOI 10.1146/annurev.psych.58.110405.085654; Maia TV, 2004, P NATL ACAD SCI USA, V101, P16075, DOI 10.1073/pnas.0406666101; Matsuo K, 2009, HUM BRAIN MAPP, V30, P1188, DOI 10.1002/hbm.20588; Moll J, 2007, TRENDS COGN SCI, V11, P319, DOI 10.1016/j.tics.2007.06.001; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Raven J.C., 1998, ADV PROGR MATRICES; Robbins TW, 2012, TRENDS COGN SCI, V16, P81, DOI 10.1016/j.tics.2011.11.009; Sasaki H, 2005, J PSYCHOL, V139, P233, DOI 10.3200/JRLP.139.3.233-246; Silver M, 2011, NEUROIMAGE, V54, P992, DOI 10.1016/j.neuroimage.2010.08.049; Takeuchi H, HUMAN BRAIN IN PRESS; Takeuchi H, 2015, BRAIN STRUCT FUNCT, V220, P3295, DOI 10.1007/s00429-014-0857-y; Takeuchi H, 2015, CEREB CORTEX, V25, P1188, DOI 10.1093/cercor/bht315; Takeuchi H, 2013, NEUROIMAGE, V77, P222, DOI 10.1016/j.neuroimage.2013.04.004; Takeuchi H, 2013, CORTEX, V49, P1148, DOI 10.1016/j.cortex.2013.01.014; Takeuchi H, 2012, NEUROIMAGE, V63, P1119, DOI 10.1016/j.neuroimage.2012.08.037; Takeuchi H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025532; Takeuchi H, 2011, NEUROPSYCHOLOGIA, V49, P3466, DOI 10.1016/j.neuropsychologia.2011.08.022; Takeuchi H, 2011, NEUROIMAGE, V55, P681, DOI 10.1016/j.neuroimage.2010.11.052; Takeuchi H, 2010, NEUROIMAGE, V51, P578, DOI 10.1016/j.neuroimage.2010.02.078; Takeuchi H, 2010, NEUROIMAGE, V51, P11, DOI 10.1016/j.neuroimage.2010.02.035; Taki Y, 2012, NEUROIMAGE, V59, P1023, DOI 10.1016/j.neuroimage.2011.08.092; Taki Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015213; Takigiku K., 1991, P 38 ANN M JAP GROUP P 38 ANN M JAP GROUP, P39; Takigiku K, 2001, REFLECTION IMPULSIVI; Tobler PN, 2007, J NEUROPHYSIOL, V97, P1621, DOI 10.1152/jn.00745.2006; Yokoyama R, 2014, NEUROSCI LETT, V563, P28, DOI 10.1016/j.neulet.2014.01.026	56	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0122666	10.1371/journal.pone.0122666	http://dx.doi.org/10.1371/journal.pone.0122666			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH2XV	25803809	Green Published, gold, Green Submitted			2022-12-26	WOS:000353889600207
J	Garcia, LE; Sanchez-Puerta, MV				Evangelina Garcia, Laura; Virginia Sanchez-Puerta, M.			Comparative and Evolutionary Analyses of Meloidogyne spp. Based on Mitochondrial Genome Sequences	PLOS ONE			English	Article							ROOT-KNOT NEMATODES; PLANT-PARASITIC NEMATODES; PHYLOGENETIC-RELATIONSHIPS; GENE ORDER; RDNA; POPULATION; DIVERSITY; INCOGNITA; ARENARIA	Molecular taxonomy and evolution of nematodes have been recently the focus of several studies. Mitochondrial sequences were proposed as an alternative for precise identification of Meloidogyne species, to study intraspecific variability and to follow maternal lineages. We characterized the mitochondrial genomes (mtDNAs) of the root knot nematodesM. floridensis, M. hapla and M. incognita. These were AT rich (81-83%) and highly compact, encoding 12 proteins, 2 rRNAs, and 22 tRNAs. Comparisons with published mtDNAs of M. chitwoodi, M. incognita (another strain) andM. graminicola revealed that they share protein and rRNA gene order but differ in the order of tRNAs. The mtDNAs of M. floridensis andM. incognita were strikingly similar (97-100% identity for all coding regions). In contrast, M. floridensis, M. chitwoodi, M. hapla andM. graminicola showed 65-84% nucleotide identity for coding regions. Variable mitochondrial sequences are potentially useful for evolutionary and taxonomic studies. We developed a molecular taxonomic marker by sequencing a highly-variable similar to 2 kb mitochondrial region, nad5-cox1, from 36 populations of root-knot nematodes to elucidate relationships within the genus Meloidogyne. Isolates of five species formed monophyletic groups and showed little intraspecific variability. We also present a thorough analysis of the mitochondrial region cox2-rrnS. Phylogenies based on either mitochondrial region had good discrimination power but could not discriminate between M. arenaria, M. incognita and M. floridensis.	[Evangelina Garcia, Laura; Virginia Sanchez-Puerta, M.] Univ Nacl Cuyo, IBAM CONICET, RA-5500 Mendoza, Argentina; [Evangelina Garcia, Laura; Virginia Sanchez-Puerta, M.] Univ Nacl Cuyo, Fac Ciencias Agr, RA-5500 Mendoza, Argentina; [Virginia Sanchez-Puerta, M.] Univ Nacl Cuyo, Fac Ciencias Exactas & Nat, RA-5500 Mendoza, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University Nacional Cuyo Mendoza; University Nacional Cuyo Mendoza; University Nacional Cuyo Mendoza	Sanchez-Puerta, MV (corresponding author), Univ Nacl Cuyo, IBAM CONICET, RA-5500 Mendoza, Argentina.	mvsanchezpuerta@fca.uncu.edu.ar		Sanchez-Puerta, Maria Virginia/0000-0003-2511-5093; Garcia, Laura/0000-0002-9324-6872	Agencia Nacional de Promocion Cientifica y Tecnologica [PICT-2008-277]; Universidad Nacional de Cuyo [Sectyp 06/M053]	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Universidad Nacional de Cuyo	This work was supported by Agencia Nacional de Promocion Cientifica y Tecnologica, www.agencia.mincyt.gob.ar, PICT-2008-277 to MVSP and by Universidad Nacional de Cuyo, www.uncu.edu.ar, Sectyp 06/M053 to MVSP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad P, 2003, MOL PLANT PATHOL, V4, P217, DOI [10.1046/j.1364-3703.2003.00170.x, 10.1046/J.1364-3703.2003.00170.X]; Abad P, 2008, NAT BIOTECHNOL, V26, P909, DOI 10.1038/nbt.1482; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; AZEVEDO JLB, 1993, GENETICS, V133, P933; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Bernt M, 2013, MOL PHYLOGENET EVOL, V69, P352, DOI 10.1016/j.ympev.2013.05.002; Besnard G, 2014, CR BIOL, V337, P295, DOI 10.1016/j.crvi.2014.03.003; Blaxter ML, 1998, NATURE, V392, P71, DOI 10.1038/32160; Blok VC, 2002, NEMATOLOGY, V4, P773, DOI 10.1163/156854102760402559; Blok Vivian C., 2009, P98, DOI 10.1079/9781845934927.0098; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; Cameron SL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-394; Carneiro RMDG, 2014, NEMATOLOGY, V16, P289, DOI 10.1163/15685411-00002765; Castagnone-Sereno P, 2014, J EVOL BIOL IN PRESS; De Ley IT, 2002, J NEMATOL, V34, P319; De Ley P, 2004, NEMATOL MONOGR PERSP, V2, P633; Garcia LE, 2012, J NEMATOL, V44, P291; Fargette M, 2010, INFECT GENET EVOL, V10, P807, DOI 10.1016/j.meegid.2009.04.013; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Gadberry MD, 2005, BIOINFORMATICS, V21, P1263, DOI 10.1093/bioinformatics/bti134; Gibson T, 2010, GENOME BIOL, V54, P565; Gissi C, 2008, HEREDITY, V101, P301, DOI 10.1038/hdy.2008.62; Hancock L, 2010, GENOME BIOL EVOL, V2, P897, DOI 10.1093/gbe/evq075; Hazkani-Covo E, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000834; HOFFMANN RJ, 1992, GENETICS, V131, P397; Holterman M, 2009, PHYTOPATHOLOGY, V99, P227, DOI 10.1094/PHYTO-99-3-0227; Holterman M, 2006, MOL BIOL EVOL, V23, P1792, DOI 10.1093/molbev/msl044; Hu M, 2006, TRENDS PARASITOL, V22, P78, DOI 10.1016/j.pt.2005.12.003; Hu M, 2003, INT J PARASITOL, V33, P1393, DOI 10.1016/S0020-7519(03)00130-9; HUGALL A, 1994, GENETICS, V136, P903; Humphreys-Pereira DA, 2014, MOL BIOCHEM PARASIT, V194, P20, DOI 10.1016/j.molbiopara.2014.04.003; Hunt David J., 2009, P55, DOI 10.1079/9781845934927.0055; Hyman BC, 2011, GENETICA, V139, P611, DOI 10.1007/s10709-010-9531-3; Jacob JE, 2009, BMC RES NOTES; Jones JT, 2013, MOL PLANT PATHOL, V14, P946, DOI 10.1111/mpp.12057; Karssen G., 2002, THE PLANT PARASITIC; Keddie EM, 1998, MOL BIOCHEM PARASIT, V95, P111, DOI 10.1016/S0166-6851(98)00102-9; Kim KH, 2006, INT J PARASITOL, V36, P319, DOI 10.1016/j.ijpara.2005.10.004; Koonin EV, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-209; Lavrov DV, 2014, MOL LIFE SCI, P1, DOI DOI 10.1007/978-1-4614-6436-5; Li MW, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-224; Liu GH, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-414; Lunt DH, 2014, PEERJ, V2, DOI 10.7717/peerj.356; Lunt DH, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-194; Lunt DH, 1998, MOL ECOL, V7, P1441, DOI 10.1046/j.1365-294x.1998.00495.x; Madison DR, 2000, MACCLADE 4 ANALYSIS; Maleita CM, 2012, PLANT DIS, V96, P865, DOI 10.1094/PDIS-09-11-0769-RE; McClure MA, 2012, PLANT DIS, V96, P635, DOI 10.1094/PDIS-09-11-0808; McNulty SN, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-145; OKIMOTO R, 1991, NUCLEIC ACIDS RES, V19, P1619, DOI 10.1093/nar/19.7.1619; Onkendi EM, 2013, EUR J PLANT PATHOL, V136, P1, DOI 10.1007/s10658-012-0142-y; Opperman CH, 2008, P NATL ACAD SCI USA, V105, P14802, DOI 10.1073/pnas.0805946105; Parr RL, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-185; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; POWERS TO, 1993, J NEMATOL, V25, P1; POWERS TO, 1993, J NEMATOL, V25, P564; SASSER JN, 1983, ANNU REV PHYTOPATHOL, V21, P271, DOI 10.1146/annurev.py.21.090183.001415; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Skantar AM, 2008, J NEMATOL, V40, P179; Stothard P, 2000, BIOTECHNIQUES, V28, P1102, DOI 10.2144/00286ir01; Sultana T, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-12; Sun LH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098558; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tigano MS, 2005, NEMATOLOGY, V7, P851, DOI 10.1163/156854105776186325; Watanabe K, 2010, P JPN ACAD B-PHYS, V86, P11, DOI 10.2183/pjab.86.11; Wende S, 2014, BIOCHIMIE, V100, P151, DOI 10.1016/j.biochi.2013.07.034; WOLSTENHOLME DR, 1992, INT REV CYTOL, V141, P173, DOI 10.1016/S0074-7696(08)62066-5; Zwickl D. J, 2006, GENETIC ALGORITHM AP	69	15	15	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121142	10.1371/journal.pone.0121142	http://dx.doi.org/10.1371/journal.pone.0121142			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799071	Green Published, gold, Green Submitted			2022-12-26	WOS:000351987300216
J	Hao, ZQ; Fan, CY; Cheng, T; Su, Y; Wei, Q; Li, GL				Hao, Zhiqiang; Fan, Chunyan; Cheng, Tian; Su, Ya; Wei, Qiang; Li, Guanglin			Genome-Wide Identification, Characterization and Evolutionary Analysis of Long Intergenic Noncoding RNAs in Cucumber	PLOS ONE			English	Article							GENE; DOMESTICATION; TRANSCRIPTION; ANNOTATION; MECHANISMS; REPRESSION; PREDICTION; SOFTWARE; PROVIDES	Long intergenic noncoding RNAs (lincRNAs) are intergenic transcripts with a length of at least 200 nt that lack coding potential. Emerging evidence suggests that lincRNAs from animals participate in many fundamental biological processes. However, the systemic identification of lincRNAs has been undertaken in only a few plants. We chose to use cucumber (Cucumis sativus) as a model to analyze lincRNAs due to its importance as a model plant for studying sex differentiation and fruit development and the rich genomic and transcriptome data available. The application of a bioinformatics pipeline to multiple types of gene expression data resulted in the identification and characterization of 3,274 lincRNAs. Next, 10 lincRNAs targeted by 17 miRNAs were also explored. Based on co-expression analysis between lincRNAs and mRNAs, 94 lincRNAs were annotated, which may be involved in response to stimuli, multi-organism processes, reproduction, reproductive processes, and growth. Finally, examination of the evolution of lincRNAs showed that most lincRNAs are under purifying selection, while 16 lincRNAs are under natural selection. Our results provide a rich resource for further validation of cucumber lincRNAs and their function. The identification of lincRNAs targeted by miRNAs offers new clues for investigations into the role of lincRNAs in regulating gene expression. Finally, evaluation of the lincRNAs suggested that some lincRNAs are under positive and balancing selection.	[Hao, Zhiqiang; Fan, Chunyan; Cheng, Tian; Su, Ya; Wei, Qiang; Li, Guanglin] Shaanxi Normal Univ, Coll Life Sci, Xian, Peoples R China; [Hao, Zhiqiang; Li, Guanglin] Shaanxi Normal Univ, Coll Life Sci, Coinnovat Ctr Qinba Reg Sustainable Dev, Xian, Peoples R China	Shaanxi Normal University; Shaanxi Normal University	Li, GL (corresponding author), Shaanxi Normal Univ, Coll Life Sci, Xian, Peoples R China.	glli@snnu.edu.cn		Cheng, Tian/0000-0002-3540-8247; Li, Guanglin/0000-0001-7617-1824	National Natural Science Foundation of China [31070256, 31370329]; Program for New Century Excellent Talents in University of Ministry of Education of China [NCET-12-0896]; Co-Innovation Center for Qinba regions' sustainable of development (CIC-QBRSD)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University of Ministry of Education of China(Program for New Century Excellent Talents in University (NCET)); Co-Innovation Center for Qinba regions' sustainable of development (CIC-QBRSD)	This work was funded by the National Natural Science Foundation of China [No. 31070256, No. 31370329], Program for New Century Excellent Talents in University of Ministry of Education of China [NCET-12-0896] and Co-Innovation Center for Qinba regions' sustainable of development (CIC-QBRSD). The funders had no role in study, design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amaral PP, 2008, SCIENCE, V319, P1787, DOI 10.1126/science.1155472; Ando K, 2010, J AM SOC HORTIC SCI, V135, P291, DOI 10.21273/JASHS.135.4.291; Boerner S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043047; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Carpenter S, 2013, SCIENCE, V341, P789, DOI 10.1126/science.1240925; Cho JK, 2005, EUPHYTICA, V146, P271, DOI 10.1007/s10681-005-9023-1; Franco-Zorrilla JM, 2007, NAT GENET, V39, P1033, DOI 10.1038/ng2079; Gao G, 2014, GENOME RES, V24, P629, DOI 10.1101/gr.165837.113; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Griffiths-Jones S, 2003, NUCLEIC ACIDS RES, V31, P439, DOI 10.1093/nar/gkg006; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Hangauer MJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003569; Huang SW, 2009, NAT GENET, V41, P1275, DOI 10.1038/ng.475; Huang Y, 2010, BIOINFORMATICS, V26, P680, DOI 10.1093/bioinformatics/btq003; Huarte M, 2010, CELL, V142, P409, DOI 10.1016/j.cell.2010.06.040; Hutter S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-409; Juan LR, 2013, BMC MED GENOMICS, V6, DOI 10.1186/1755-8794-6-S1-S7; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Kong L, 2007, NUCLEIC ACIDS RES, V35, pW345, DOI 10.1093/nar/gkm391; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li L, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r40; Li TT, 2012, GENOMICS, V99, P292, DOI 10.1016/j.ygeno.2012.02.003; Li Z, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-540; Liao Q, 2011, NUCLEIC ACIDS RES, V39, P3864, DOI 10.1093/nar/gkq1348; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu J, 2012, PLANT CELL, V24, P4333, DOI 10.1105/tpc.112.102855; Loewer S, 2010, NAT GENET, V42, P1113, DOI 10.1038/ng.710; Mao WH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033040; MARCELIS LFM, 1993, J HORTIC SCI, V68, P665, DOI 10.1080/00221589.1993.11516398; Marques AC, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-11-r131; PAUL IJ, 1975, MOL CELL BIOCHEM, V9, P9, DOI 10.1007/BF01731728; Qi JJ, 2013, NAT GENET, V45, P1510, DOI 10.1038/ng.2801; Qi X, 2013, PLANT MOL BIOL, V83, P459, DOI 10.1007/s11103-013-0104-6; Rackham O, 2011, RNA, V17, P2085, DOI 10.1261/rna.029405.111; SALDITTGEORGIEFF M, 1982, MOL CELL BIOL, V2, P701, DOI 10.1128/MCB.2.6.701; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shuai P, 2014, J EXP BOT, V65, P4975, DOI 10.1093/jxb/eru256; Tanurdzic M, 2004, PLANT CELL, V16, pS61, DOI 10.1105/tpc.016667; Teramoto H, 1996, PLANT MOL BIOL, V32, P797, DOI 10.1007/BF00020478; van Dongen S., 1998, NEW CLUSTER ALGORITH; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; Wu HJ, 2012, NUCLEIC ACIDS RES, V40, pW22, DOI 10.1093/nar/gks554; Yanai I, 2005, BIOINFORMATICS, V21, P650, DOI 10.1093/bioinformatics/bti042; Young RS, 2012, GENOME BIOL EVOL, V4, P427, DOI 10.1093/gbe/evs020; Zhou ZY, 2014, GENOME BIOL EVOL, V6, P1387, DOI 10.1093/gbe/evu113	49	52	54	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121800	10.1371/journal.pone.0121800	http://dx.doi.org/10.1371/journal.pone.0121800			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799544	Green Submitted, Green Published, gold			2022-12-26	WOS:000351987300291
J	Kurosaka, H; Trainor, PA; Leroux-Berger, M; Iulianella, A				Kurosaka, Hiroshi; Trainor, Paul A.; Leroux-Berger, Margot; Iulianella, Angelo			Cranial Nerve Development Requires Co-Ordinated Shh and Canonical Wnt Signaling	PLOS ONE			English	Article							NEURAL CREST CELLS; BETA-CATENIN; WNT/BETA-CATENIN; HEDGEHOG; TUBE; GENE; MEDIATE; ORIGIN; PAX3; FORM	Cranial nerves govern sensory and motor information exchange between the brain and tissues of the head and neck. The cranial nerves are derived from two specialized populations of cells, cranial neural crest cells and ectodermal placode cells. Defects in either cell type can result in cranial nerve developmental defects. Although several signaling pathways are known to regulate cranial nerve formation our understanding of how intercellular signaling between neural crest cells and placode cells is coordinated during cranial ganglia morphogenesis is poorly understood. Sonic Hedgehog (Shh) signaling is one key pathway that regulates multiple aspects of craniofacial development, but whether it co-ordinates cranial neural crest cell and placodal cell interactions during cranial ganglia formation remains unclear. In this study we examined a new Patched1 (Ptch1) loss-of-function mouse mutant and characterized the role of Ptch1 in regulating Shh signaling during cranial ganglia development. Ptch1(Wig/Wig) mutants exhibit elevated Shh signaling in concert with disorganization of the trigeminal and facial nerves. Importantly, we discovered that enhanced Shh signaling suppressed canonical Wnt signaling in the cranial nerve region. This critically affected the survival and migration of cranial neural crest cells and the development of placodal cells as well as the integration between neural crest and placodes. Collectively, our findings highlight a novel and critical role for Shh signaling in cranial nerve development via the cross regulation of canonical Wnt signaling.	[Kurosaka, Hiroshi; Trainor, Paul A.; Leroux-Berger, Margot] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Kurosaka, Hiroshi] Osaka Univ, Grad Sch Dent, Dept Orthodont & Dentofacial Orthoped, Osaka, Japan; [Trainor, Paul A.] Univ Kansas, Med Ctr, Dept Anat & Cell Biol, Kansas City, KS 66103 USA; [Leroux-Berger, Margot] Univ Paris 06, Paris, France; [Iulianella, Angelo] Dalhousie Univ, Fac Med, Dept Med Neurosci, Halifax, NS, Canada	Stowers Institute for Medical Research; Osaka University; University of Kansas; University of Kansas Medical Center; UDICE-French Research Universities; Sorbonne Universite; Dalhousie University	Trainor, PA (corresponding author), Stowers Inst Med Res, Kansas City, MO 64110 USA.	PAT@stowers.org; angelo.iulianella@dal.ca		Iulianella, Angelo/0000-0003-0712-4295; Trainor, Paul/0000-0003-2774-3624; Kurosaka, Hiroshi/0000-0002-8956-5467	Stowers Institute for Medical Research; National Institute of Dental and Craniofacial Research [DE016082]; Natural Sciences and Engineering Council of Canada [386595]; Canadian Institute of Health Research (MOP) [115150]; Plum Foundation; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE016082] Funding Source: NIH RePORTER	Stowers Institute for Medical Research; National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Natural Sciences and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institute of Health Research (MOP)(Canadian Institutes of Health Research (CIHR)); Plum Foundation; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	Research in the Trainor laboratory is supported by the Stowers Institute for Medical Research and the National Institute of Dental and Craniofacial Research (DE016082). Research in the Iulianella laboratory is funded by the Natural Sciences and Engineering Council of Canada (#386595), the Canadian Institute of Health Research (MOP# 115150), and the Plum Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agren M, 2004, GENE, V330, P101, DOI 10.1016/j.gene.2004.01.010; Ahlgren SC, 2002, P NATL ACAD SCI USA, V99, P10476, DOI 10.1073/pnas.162356199; Aoto K, 2015, HUM MOL GENET, V24, P698, DOI 10.1093/hmg/ddu489; Begbie J, 2001, SCIENCE, V294, P595, DOI 10.1126/science.1062028; Bosley TM, 2013, CURR OPIN OPHTHALMOL, V24, P398, DOI 10.1097/ICU.0b013e3283645ad6; Brault V, 2001, DEVELOPMENT, V128, P1253; Canning CA, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-35; Chen MH, 2004, GENE DEV, V18, P641, DOI 10.1101/gad.1185804; Cobourne MT, 2009, DEV BIOL, V331, P38, DOI 10.1016/j.ydbio.2009.04.021; Coppola E, 2010, P NATL ACAD SCI USA, V107, P2066, DOI 10.1073/pnas.0910213107; DAMICOMARTEL A, 1983, AM J ANAT, V166, P445, DOI 10.1002/aja.1001660406; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; DasGupta R, 1999, DEVELOPMENT, V126, P4557; Dennis JF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002927; Dessaud E, 2008, DEVELOPMENT, V135, P2489, DOI 10.1242/dev.009324; Dude CM, 2009, DEV BIOL, V326, P314, DOI 10.1016/j.ydbio.2008.11.032; Fedtsova N, 2003, DEV BIOL, V261, P456, DOI 10.1016/S0012-1606(03)00316-6; Fleenor SJ, 2013, NEURAL CREST CELLS E, P153; Freter S, 2013, DEVELOPMENT, V140, P3595, DOI 10.1242/dev.091033; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Graeber CP, 2013, SEMIN OPHTHALMOL, V28, P427, DOI 10.3109/08820538.2013.825288; HAMBURGER V, 1961, J EXP ZOOL, V148, P91, DOI 10.1002/jez.1401480202; Hari L, 2002, J CELL BIOL, V159, P867, DOI 10.1083/jcb.200209039; Ikeya M, 1997, NATURE, V389, P966, DOI 10.1038/40146; Inoue T, 2004, DEV BIOL, V270, P146, DOI 10.1016/j.ydbio.2004.02.017; Jeong JH, 2004, GENE DEV, V18, P937, DOI 10.1101/gad.1190304; Kuriyama S, 2014, J CELL BIOL, V206, P113, DOI 10.1083/jcb.201402093; Kurosaka H, 2014, J CLIN INVEST, V124, P1660, DOI 10.1172/JCI72688; Lassiter RNT, 2007, DEV BIOL, V308, P392, DOI 10.1016/j.ydbio.2007.05.032; Lee CS, 2000, DEVELOPMENT, V127, P109; Lee HY, 2004, SCIENCE, V303, P1020, DOI 10.1126/science.1091611; Lwigale PY, 2001, DEV BIOL, V239, P323, DOI 10.1006/dbio.2001.0450; Ma QF, 1998, NEURON, V20, P469, DOI 10.1016/S0896-6273(00)80988-5; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Murdoch JN, 2010, BIRTH DEFECTS RES A, V88, P633, DOI 10.1002/bdra.20686; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Sandell LL, 2014, DEV BIOL, V385, P200, DOI 10.1016/j.ydbio.2013.11.009; Sandell LL, 2011, GENESIS, V49, P342, DOI 10.1002/dvg.20727; Schlosser G, 2010, INT REV CEL MOL BIO, V283, P129, DOI 10.1016/S1937-6448(10)83004-7; Schroder JC, 2013, BEHAV BRAIN FUNCT, V9, DOI 10.1186/1744-9081-9-7; Shiau CE, 2008, NAT NEUROSCI, V11, P269, DOI 10.1038/nn2051; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Stark MR, 1997, DEVELOPMENT, V124, P4287; Steventon B, 2014, DEV BIOL, V389, P28, DOI 10.1016/j.ydbio.2014.01.021; Theveneau E, 2013, NAT CELL BIOL, V15, P763, DOI 10.1038/ncb2772; Vacik T, 2012, GENE DEV, V26, P414; Verzijl HTFM, 2003, NEUROLOGY, V61, P327, DOI 10.1212/01.WNL.0000076484.91275.CD; Wu CY, 2014, DEV BIOL, V392, P295, DOI 10.1016/j.ydbio.2014.05.016; Zhao TY, 2014, DEVELOPMENT, V141, P148, DOI 10.1242/dev.101550	49	27	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120821	10.1371/journal.pone.0120821	http://dx.doi.org/10.1371/journal.pone.0120821			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799573	Green Published, Green Submitted, gold			2022-12-26	WOS:000351987300181
J	Parviainen, S; Autio, K; Vaha-Koskela, M; Guse, K; Pesonen, S; Rosol, TJ; Zhao, F; Hemminki, A				Parviainen, Suvi; Autio, Karoliina; Vaha-Koskela, Markus; Guse, Kilian; Pesonen, Sari; Rosol, Thomas J.; Zhao, Fang; Hemminki, Akseli			Incomplete but Infectious Vaccinia Virions Are Produced in the Absence of Oncolysis in Feline SCCF1 Cells	PLOS ONE			English	Article							VIRUS; MEMBRANE; SMALLPOX; PROTEIN; KINASE; ENTRY	Vaccinia virus is a large, enveloped virus of the poxvirus family. It has broad tropism and typically virus replication culminates in accumulation and lytic release of intracellular mature virus (IMV), the most abundant form of infectious virus, as well as release by budding of extracellular enveloped virus (EEV). Vaccinia viruses have been modified to replicate selectively in cancer cells and clinically tested as oncolytic agents. During preclinical screening of relevant cancer targets for a recombinant Western Reserve strain deleted for both copies of the thymidine kinase and vaccinia growth factor genes, we noticed that confluent monolayers of SCCF1 cat squamous carcinoma cells were not destroyed even after prolonged infection. Interestingly, although SCCF1 cells were not killed, they continuously secreted virus into the cell culture supernatant. To investigate this finding further, we performed detailed studies by electron microscopy. Both intracellular and secreted virions showed morphological abnormalities on ultrastructural inspection, suggesting compromised maturation and morphogenesis of vaccinia virus in SCCF1 cells. Our data suggest that SCCF1 cells produce a morphologically abnormal virus which is nevertheless infective, providing new information on the virus-host cell interactions and intracellular biology of vaccinia virus.	[Parviainen, Suvi; Autio, Karoliina; Vaha-Koskela, Markus; Guse, Kilian; Pesonen, Sari; Hemminki, Akseli] Univ Helsinki, Haartman Inst, Dept Pathol & Transplantat Lab, Canc Gene Therapy Grp, Helsinki, Finland; [Autio, Karoliina] Univ Helsinki, Fac Vet Med, Dept Equine & Small Anim Med, Helsinki, Finland; [Rosol, Thomas J.] Ohio State Univ, Coll Vet Med, Dept Vet Biosci, Columbus, OH 43210 USA; [Zhao, Fang] Univ Helsinki, Haartman Inst, Dept Pathol, Adv Microscopy Unit, Helsinki, Finland	University of Helsinki; University of Helsinki; University System of Ohio; Ohio State University; University of Helsinki	Hemminki, A (corresponding author), Univ Helsinki, Haartman Inst, Dept Pathol & Transplantat Lab, Canc Gene Therapy Grp, Helsinki, Finland.	akseli.hemminki@helsinki.fi	Rosol, Thomas/G-9585-2011	Rosol, Thomas/0000-0003-3737-1190; Vaha-Koskela, Markus/0000-0001-7764-7820	Integrative Life Sciences Doctoral Program; Aniwel Graduate School University of Helsinki; European Research Council; ASCO Foundation; HUCH Research Funds (EVO); Sigrid Juselius Foundation; Academy of Finland; Biocenter Helsinki; Finnish Cancer Organizations; Orion-Farmos Research Foundation; K. Albin Johansson Foundation; Waldemar Von Frenckell's foundation; Ida Montini's foundation; University of Helsinki	Integrative Life Sciences Doctoral Program; Aniwel Graduate School University of Helsinki; European Research Council(European Research Council (ERC)European Commission); ASCO Foundation; HUCH Research Funds (EVO); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Academy of Finland(Academy of Finland); Biocenter Helsinki; Finnish Cancer Organizations; Orion-Farmos Research Foundation; K. Albin Johansson Foundation; Waldemar Von Frenckell's foundation; Ida Montini's foundation; University of Helsinki	This study was supported by Integrative Life Sciences Doctoral Program, Aniwel Graduate School University of Helsinki, the European Research Council, ASCO Foundation, HUCH Research Funds (EVO), Sigrid Juselius Foundation, Academy of Finland, Biocenter Helsinki, Finnish Cancer Organizations, Orion-Farmos Research Foundation, K. Albin Johansson Foundation, Waldemar Von Frenckell's foundation, Ida Montini's foundation and the University of Helsinki. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansarah-Sobrinho C, 2004, J VIROL, V78, P6335, DOI 10.1128/JVI.78.12.6335-6343.2004; BENNETT M, 1989, ARCH VIROL, V104, P19, DOI 10.1007/BF01313805; BLASCO R, 1992, J VIROL, V66, P4170, DOI 10.1128/JVI.66.7.4170-4179.1992; Condit RC, 2006, ADV VIRUS RES, V66, P31, DOI 10.1016/S0065-3527(06)66002-8; Earl P L, 2001, Curr Protoc Protein Sci, VChapter 5, DOI 10.1002/0471140864.ps0512s13; Essbauer S, 2010, VET MICROBIOL, V140, P229, DOI 10.1016/j.vetmic.2009.08.026; Geddes AM, 2006, CLIN DERMATOL, V24, P152, DOI 10.1016/j.clindermatol.2005.11.009; Guse K, 2010, J VIROL, V84, P856, DOI 10.1128/JVI.00692-09; Haddad D, 2012, ANN SURG ONCOL, V19, pS665, DOI 10.1245/s10434-011-2198-x; Hawranek T, 2003, J AM ACAD DERMATOL, V49, P513, DOI 10.1067/S0190-9622(03)00762-X; Hollinshead M, 1999, J VIROL, V73, P1503, DOI 10.1128/JVI.73.2.1503-1517.1999; Liu TC, 2007, NAT CLIN PRACT ONCOL, V4, P101, DOI 10.1038/ncponc0736; MacNeill AL, 2012, RES VET SCI, V93, P1036, DOI 10.1016/j.rvsc.2011.10.016; McCart JA, 2001, CANCER RES, V61, P8751; Mercer J, 2005, J VIROL, V79, P7146, DOI 10.1128/JVI.79.11.7146-7161.2005; Moss B, 2006, VIROLOGY, V344, P48, DOI 10.1016/j.virol.2005.09.037; Moss B, 2012, VIRUSES-BASEL, V4, P688, DOI 10.3390/v4050688; Parviainen S, 2014, GENE THER, V21, P195, DOI 10.1038/gt.2013.73; Patil SS, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-3; PAYNE LG, 1980, J GEN VIROL, V50, P89, DOI 10.1099/0022-1317-50-1-89; Pfeffer M, 2002, VET REC, V150, P50, DOI 10.1136/vr.150.2.50; Punjabi A, 2005, J VIROL, V79, P2171, DOI 10.1128/JVI.79.4.2171-2190.2005; Sandvik T, 1998, J CLIN MICROBIOL, V36, P2542, DOI 10.1128/JCM.36.9.2542-2547.1998; Smith GL, 2002, J GEN VIROL, V83, P2915, DOI 10.1099/0022-1317-83-12-2915; Tannehill-Gregg S, 2001, IN VITRO CELL DEV-AN, V37, P676, DOI 10.1290/1071-2690(2001)037<0676:FHANSC>2.0.CO;2; Theves C, 2014, CLIN MICROBIOL INFEC, V20, P210, DOI 10.1111/1469-0691.12536; Upton C, 2003, J VIROL, V77, P7590, DOI 10.1128/JVI.77.13.7590-7600.2003; Vanderplasschen A, 1998, J GEN VIROL, V79, P877, DOI 10.1099/0022-1317-79-4-877; Verardi PH, 2012, HUM VACC IMMUNOTHER, V8, P961, DOI 10.4161/hv.21080; Ward BM, 2001, J VIROL, V75, P11651, DOI 10.1128/JVI.75.23.11651-11663.2001	30	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120496	10.1371/journal.pone.0120496	http://dx.doi.org/10.1371/journal.pone.0120496			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799430	Green Published, Green Submitted, gold			2022-12-26	WOS:000351987300150
J	Samal, R; Ameling, S; Dhople, V; Sappa, PK; Wenzel, K; Volker, U; Felix, SB; Hammer, E; Konemann, S				Samal, Rasmita; Ameling, Sabine; Dhople, Vishnu; Sappa, Praveen Kumar; Wenzel, Kristin; Voelker, Uwe; Felix, Stephan B.; Hammer, Elke; Koenemann, Stephanie			Brain Derived Neurotrophic Factor Contributes to the Cardiogenic Potential of Adult Resident Progenitor Cells in Failing Murine Heart	PLOS ONE			English	Article							CARDIAC STEM-CELLS; ENDOTHELIAL-CELLS; EXPRESSION; DIFFERENTIATION; MIGRATION; PROLIFERATION; ACTIVATION; PROTEOMICS; APOPTOSIS; PROTECTS	Aims Resident cardiac progenitor cells show homing properties when injected into the injured but not to the healthy myocardium. The molecular background behind this difference in behavior needs to be studied to elucidate how adult progenitor cells can restore cardiac function of the damaged myocardium. Since the brain derived neurotrophic factor (BDNF) moderates cardioprotection in injured hearts, we focused on delineating its regulatory role in the damaged myocardium. Methods and Results Comparative gene expression profiling of freshly isolated undifferentiated Sca-1 progenitor cells derived either from heart failure transgenic alpha MHC-CyclinT1/G alpha q overexpressing mice or wildtype littermates revealed transcriptional variations. Bdnf expression was up regulated 5-fold during heart failure which was verified by qRT-PCR and confirmed at protein level. The migratory capacity of Sca-1 cells from transgenic hearts was improved by 15% in the presence of 25ng/ml BDNF. Furthermore, BDNF-mediated effects on Sca-1 cells were studied via pulsed Stable Isotope Labeling of Amino acids in Cell Culture (pSILAC) proteomics approach. After BDNF treatment significant differences between newly synthesized proteins in Sca-1 cells from control and transgenic hearts were observed for CDK1, SRRT, HDGF, and MAP2K3 which are known to regulate cell cycle, survival and differentiation. Moreover BDNF repressed the proliferation of Sca-1 cells from transgenic hearts. Conclusion Comparative profiling of resident Sca-1 cells revealed elevated BDNF levels in the failing heart. Exogenous BDNF (i) stimulated migration, which might improve the homing ability of Sca-1 cells derived from the failing heart and (ii) repressed the cell cycle progression suggesting its potency to ameliorate heart failure.	[Samal, Rasmita; Wenzel, Kristin; Felix, Stephan B.; Koenemann, Stephanie] Univ Med Greifswald, Dept Internal Med B, Greifswald, Germany; [Samal, Rasmita; Ameling, Sabine; Dhople, Vishnu; Sappa, Praveen Kumar; Voelker, Uwe; Hammer, Elke] Univ Med Greifswald, Interfac Inst Genet & Funct Genom, Greifswald, Germany; [Wenzel, Kristin; Voelker, Uwe; Felix, Stephan B.; Hammer, Elke; Koenemann, Stephanie] DZHK German Ctr Cardiovasc Res Partner Site, Greifswald, Germany	Greifswald Medical School; Greifswald Medical School; German Centre for Cardiovascular Research	Hammer, E (corresponding author), Univ Med Greifswald, Interfac Inst Genet & Funct Genom, Greifswald, Germany.	hammer@uni-greifswald.de; stephanie.koenemann@uni-greifswald.de		Volker, Uwe/0000-0002-5689-3448; Hammer, Elke/0000-0002-1507-0402	Enhancement of research competitiveness in molecular imaging (EnVision) [FKZ: CSA-SA_FP/-REGPOT 2010-1, 264143]	Enhancement of research competitiveness in molecular imaging (EnVision)	Funding: This work was supported by grants from the Enhancement of research competitiveness in molecular imaging (EnVision), Framework 7 (FKZ: CSA-SA_FP/-REGPOT 2010-1, Grant Nr: 264143) to S.B.F.	[Anonymous], 2014, PLOS ONE, DOI DOI 10.1371/J0URNAL.P0NE.0115140; Anversa P, 2013, J CLIN INVEST, V123, P62, DOI 10.1172/JCI63068; Arab S, 2006, J AM COLL CARDIOL, V48, P1733, DOI 10.1016/j.jacc.2006.06.063; Bernstein HS, 2012, PEDIATR RES, V71, P491, DOI 10.1038/pr.2011.61; Boisvert FM, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.011429; Bradfute SB, 2005, EXP HEMATOL, V33, P836, DOI 10.1016/j.exphem.2005.04.001; Cai CX, 2012, J BIOL CHEM, V287, P33720, DOI 10.1074/jbc.M112.385542; Caporali A, 2009, PHYSIOL REV, V89, P279, DOI 10.1152/physrev.00007.2008; Chang HY, 2006, METHOD ENZYMOL, V420, P225, DOI 10.1016/S0076-6879(06)20010-7; Chen BY, 2013, J NEUROSCI RES, V91, P30, DOI 10.1002/jnr.23138; Dey D, 2013, CIRC RES, V112, P1253, DOI 10.1161/CIRCRESAHA.112.300779; Diril MK, 2012, P NATL ACAD SCI USA, V109, P3826, DOI 10.1073/pnas.1115201109; Duboscq-Bidot L, 2009, EUR HEART J, V30, P2128, DOI 10.1093/eurheartj/ehp225; Engel FB, 2005, GENE DEV, V19, P1175, DOI 10.1101/gad.1306705; Garbern JC, 2013, CELL STEM CELL, V12, P689, DOI 10.1016/j.stem.2013.05.008; Guo LJ, 2006, CALCIFIED TISSUE INT, V78, P285, DOI 10.1007/s00223-005-0092-x; Guo SZ, 2012, J NEUROCHEM, V123, P58, DOI 10.1111/j.1471-4159.2012.07944.x; Hadjal Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.246; Heiss C, 2008, J CELL PHYSIOL, V215, P366, DOI 10.1002/jcp.21313; Horsthuis T, 2008, CIRC RES, V102, P849, DOI 10.1161/CIRCRESAHA.107.170571; Hutchinson KR, 2010, J MOL CELL CARDIOL, V48, P564, DOI 10.1016/j.yjmcc.2009.06.001; Kermani P, 2005, J CLIN INVEST, V115, P653, DOI 10.1172/JCI200522655; Kim H, 2004, J BIOL CHEM, V279, P33538, DOI 10.1074/jbc.M404115200; Kingham PJ, 2013, STEM CELLS DEV; Ladd AN, 2005, MOL CELL BIOL, V25, P6267, DOI 10.1128/MCB.25.14.6267-6278.2005; Landsberger M, 2007, ATHEROSCLEROSIS, V190, P43, DOI 10.1016/j.atherosclerosis.2006.02.009; Lecht S, 2010, MOL CELL BIOCHEM, V339, P201, DOI 10.1007/s11010-010-0386-9; Leenen FHH, 2012, ARTERIOSCL THROM VAS, V32, P1749, DOI 10.1161/ATVBAHA.112.252627; Li GH, 2010, ATHEROSCLEROSIS, V208, P358, DOI 10.1016/j.atherosclerosis.2009.07.046; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Long HX, 2012, STEM CELLS, V30, P2309, DOI 10.1002/stem.1194; Mann M, 2006, NAT REV MOL CELL BIO, V7, P952, DOI 10.1038/nrm2067; Matsuda S, 2012, J CELL PHYSIOL, V227, P2123, DOI 10.1002/jcp.22942; Montecucco F, 2012, EUR HEART J, V33, P1964, DOI 10.1093/eurheartj/ehr127; Nemir M, 2012, EUR HEART J; Nusse R, 2008, COLD SH Q B, V73, P59, DOI 10.1101/sqb.2008.73.035; Oh H, 2003, P NATL ACAD SCI USA, V100, P12313, DOI 10.1073/pnas.2132126100; Okada S, 2012, ARTERIOSCL THROM VAS, V32, P1902, DOI 10.1161/ATVBAHA.112.248930; Ovejero-Benito MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064890; Panek AN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006743; Samal R, 2012, J PROTEOMICS, V75, P5304, DOI 10.1016/j.jprot.2012.06.010; Sano M, 2004, EMBO J, V23, P3559, DOI 10.1038/sj.emboj.7600351; Schwanhausser B, 2009, PROTEOMICS, V9, P205, DOI 10.1002/pmic.200800275; Tateishi K, 2007, J CELL SCI, V120, P1791, DOI 10.1242/jcs.006122; Tsang TY, 2008, APOPTOSIS, V13, P1135, DOI 10.1007/s10495-008-0241-6; Viljoen KS, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-14; Wang HN, 2012, ONCOL REP, V28, P311, DOI 10.3892/or.2012.1788; Weng L, 2006, BIOINFORMATICS, V22, P1111, DOI 10.1093/bioinformatics/btl045	48	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120360	10.1371/journal.pone.0120360	http://dx.doi.org/10.1371/journal.pone.0120360			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799225	Green Submitted, Green Published, gold			2022-12-26	WOS:000351987300137
J	Siddalingappa, B; Benson, HAE; Brown, DH; Batty, KT; Chen, Y				Siddalingappa, Basavaraj; Benson, Heather A. E.; Brown, David H.; Batty, Kevin T.; Chen, Yan			Stabilization of Resveratrol in Blood Circulation by Conjugation to mPEG and mPEG-PLA Polymers: Investigation of Conjugate Linker and Polymer Composition on Stability, Metabolism, Antioxidant Activity and Pharmacokinetic Profile	PLOS ONE			English	Article							IN-VITRO; POLY(ETHYLENE GLYCOL); TRANS-RESVERATROL; PEG; ABSORPTION; COPOLYMER; PRODRUGS; DESIGN; RAT; DEGRADATION	Resveratrol is naturally occurring phytochemical with diverse biological activities such as chemoprevention, anti-inflammatory, anti-cancer, anti-oxidant. But undergoes rapid metabolism in the body (half life 0.13h). Hence Polymer conjugation utilizing different chemical linkers and polymer compositions was investigated for enhanced pharmacokinetic profile of resveratrol. Ester conjugates such as alpha-methoxy-omega-carboxylic acid poly(ethylene glycol) succinylamide resveratrol (MeO-PEGN-Succ-RSV) (2 and 20 kDa); MeO-PEG succinyl ester resveratrol (MeO-PEGO-Succ-RSV) (2 kDa); alpha-methoxy poly(ethylene glycol)-co-polylactide succinyl ester resveratrol (MeO-PEG-PLAO-Succ-RSV) (2 and 6.6kDa) were prepared by carbodiimide coupling reactions. Resveratrol-PEG ethers (2 and 5 kDa) were synthesized by alkali-mediated etherification. All polymer conjugates were fully characterized in vitro and the pharmacokinetic profile of selected conjugates was characterized in rats. Buffer and plasma stability of conjugates was dependent on polymer hydrophobicity, aggregation behavior and PEG corona, with MeO-PEG-PLAO-Succ-RSV (2 kDa) showing a 3h half-life in rat plasma in vitro. Polymer conjugates irrespective of linker chemistry protected resveratrol against metabolism in vitro. MeO-PEG-PLAO-Succ-RSV (2 kDa), Resveratrol- PEG ether (2 and 5 kDa) displayed improved pharmacokinetic profiles with significantly higher plasma area under curve (AUC), slower clearance and smaller volume of distribution, compared to resveratrol.	[Siddalingappa, Basavaraj; Benson, Heather A. E.; Batty, Kevin T.; Chen, Yan] Curtin Univ, CHIRI Biosci, Sch Pharm, Perth, WA 6845, Australia; [Brown, David H.] Curtin Univ, Dept Chem, Perth, WA 6845, Australia	Curtin University; Curtin University	Siddalingappa, B (corresponding author), Western Univ Hlth Sci, Grad Coll Biomed Sci, Pomona, CA 91766 USA.	bsiddalingappa@westernu.edu	Brown, David/A-2452-2009; Batty, Kevin T/B-8070-2008	Brown, David/0000-0002-2270-9681; Batty, Kevin T/0000-0003-3850-1778	Curtin University	Curtin University	Curtin University contributed research space and equipment, and scholarship funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alla A, 2000, POLYMER, V41, P6995, DOI 10.1016/S0032-3861(00)00070-7; ANDERSON BD, 1985, J PHARM SCI, V74, P365, DOI 10.1002/jps.2600740402; Azorin-Ortuno M, 2010, J AGR FOOD CHEM, V58, P11165, DOI 10.1021/jf102799m; Basavaraj S, 2011, RAPID COMMUN MASS SP, V25, P1543, DOI 10.1002/rcm.5000; Basavaraj S, 2013, CURR PHARM ANAL, V9, P199, DOI 10.2174/1573412911309020011; BATES HS, 1980, J CHEM SOC CHEM COMM, P773, DOI 10.1039/c39800000773; Beresford AP, 2002, DRUG DISCOV TODAY, V7, P109; Biasutto L, 2008, BIOORG MED CHEM LETT, V18, P5594, DOI 10.1016/j.bmcl.2008.08.100; Biasutto L, 2009, CELL PHYSIOL BIOCHEM, V24, P557, DOI 10.1159/000257512; Boocock DJ, 2007, CANCER EPIDEM BIOMAR, V16, P1246, DOI 10.1158/1055-9965.EPI-07-0022; Cao N, 2008, BIOMATERIALS, V29, P3856, DOI 10.1016/j.biomaterials.2008.05.016; DANHAUSERRIEDL S, 1993, INVEST NEW DRUG, V11, P187, DOI 10.1007/BF00874153; Das DK, 2006, MOL INTERV, V6, P36, DOI 10.1124/mi.6.1.7; Das Samarjit, 2007, Inflammation & Allergy Drug Targets, V6, P168, DOI 10.2174/187152807781696464; Das S, 2008, PHARM RES-DORDR, V25, P2593, DOI 10.1007/s11095-008-9677-1; Ding H, 2007, J DRUG TARGET, V15, P465, DOI 10.1080/10611860701500016; Fauconneau B, 1997, LIFE SCI, V61, P2103, DOI 10.1016/S0024-3205(97)00883-7; Fee CJ, 2007, BIOTECHNOL BIOENG, V98, P725, DOI 10.1002/bit.21482; Gao XH, 2002, J NUTR, V132, P2076, DOI 10.1093/jn/132.7.2076; Greenwald RB, 2003, BIOORG MED CHEM LETT, V13, P577, DOI 10.1016/S0960-894X(02)00926-5; Greenwald RB, 1996, J MED CHEM, V39, P424, DOI 10.1021/jm950475e; Gref R, 2000, COLLOID SURFACE B, V18, P301, DOI 10.1016/S0927-7765(99)00156-3; Hubbard BP, 2013, SCIENCE, V339, P1216, DOI 10.1126/science.1231097; Jain JP, 2010, BIOMACROMOLECULES, V11, P1027, DOI 10.1021/bm1000026; Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218; Jiang YL, 2008, BIOORGAN MED CHEM, V16, P6406, DOI 10.1016/j.bmc.2008.05.002; Kapetanovic IM, 2011, CANCER CHEMOTH PHARM, V68, P593, DOI 10.1007/s00280-010-1525-4; Kuang JM, 2008, MATER LETT, V62, P4078, DOI 10.1016/j.matlet.2008.05.061; Le Corre L, 2005, MOL NUTR FOOD RES, V49, P462, DOI 10.1002/mnfr.200400094; Lee HJ, 2004, BIOORG MED CHEM LETT, V14, P463, DOI 10.1016/j.bmcl.2003.10.038; Li Y, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/5/055106; Marier JF, 2002, J PHARMACOL EXP THER, V302, P369, DOI 10.1124/jpet.102.033340; Mehvar R, 2000, J PHARM PHARM SCI, V3, P125; Monfardini C, 1998, BIOCONJUGATE CHEM, V9, P418, DOI 10.1021/bc970184f; Muzzio M, 2012, J PHARMACEUT BIOMED, V59, P201, DOI 10.1016/j.jpba.2011.10.023; Ovesna Z, 2005, NEOPLASMA, V52, P450; Pan H, 2007, PHARM RES, V24, P2270, DOI 10.1007/s11095-007-9449-3; Pan HZ, 2006, J DRUG TARGET, V14, P425, DOI 10.1080/10611860600834219; Riley T, 1999, COLLOID SURFACE B, V16, P147, DOI 10.1016/S0927-7765(99)00066-1; Sale S, 2004, BRIT J CANCER, V90, P736, DOI 10.1038/sj.bjc.6601568; Stadler A, 2001, TETRAHEDRON, V57, P3915, DOI 10.1016/S0040-4020(01)00260-5; Tessitore L, 2000, CARCINOGENESIS, V21, P1619, DOI 10.1093/carcin/21.8.1619; Veronese FM, 2005, BIOCONJUGATE CHEM, V16, P775, DOI 10.1021/bc040241m; Veronese FM, 1999, FARMACO, V54, P497, DOI 10.1016/S0014-827X(99)00066-X; Villuendas I, 1999, MACROMOLECULES, V32, P8033, DOI 10.1021/ma990407s; Voronov A, 2008, J COLLOID INTERF SCI, V323, P379, DOI 10.1016/j.jcis.2008.04.053; Walle T, 2004, DRUG METAB DISPOS, V32, P1377, DOI 10.1124/dmd.104.000885; Wenzel E, 2005, MOL NUTR FOOD RES, V49, P482, DOI 10.1002/mnfr.200500003; Xie ZG, 2007, J CONTROL RELEASE, V117, P210, DOI 10.1016/j.jconrel.2006.11.014; Yu CW, 2002, PHARM RES-DORDR, V19, P1907, DOI 10.1023/A:1021414129280; Zhang XF, 2005, BIOMATERIALS, V26, P2121, DOI 10.1016/j.biomaterials.2004.06.024; Zhou QS, 2006, CHINESE CHEM LETT, V17, P85	52	23	23	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0118824	10.1371/journal.pone.0118824	http://dx.doi.org/10.1371/journal.pone.0118824			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799413	Green Published, gold, Green Submitted			2022-12-26	WOS:000351987300019
J	Wu, ZH; Shi, JS; Xi, ML; Jiang, FX; Deng, MW; Dayanandan, S				Wu, Zhu-hua; Shi, Jisen; Xi, Meng-li; Jiang, Fu-xing; Deng, Ming-wen; Dayanandan, Selvadurai			Inter-Simple Sequence Repeat Data Reveals High Genetic Diversity in Wild Populations of the Narrowly Distributed Endemic Lilium regale in the Minjiang River Valley of China	PLOS ONE			English	Article							CLONAL PLANT; MICROSATELLITE MARKERS; CONSERVATION GENETICS; INTERSPECIFIC HYBRIDS; ASEXUAL POPULATIONS; MOLECULAR MARKERS; ISSR MARKERS; RAPD; RARE; ALLOZYME	Lilium regale E. H. Wilson is endemic to a narrow geographic area in the Minjiang River valley in southwestern China, and is considered an important germplasm for breeding commercially valuable lily varieties, due to its vigorous growth, resistance to diseases and tolerance for low moisture. We analyzed the genetic diversity of eight populations of L. regale sampled across the entire natural distribution range of the species using Inter-Simple Sequence Repeat markers. The genetic diversity (expected heterozygosity=0.3356) was higher than those reported for other narrowly distributed endemic plants. The levels of inbreeding (F-st = 0.1897) were low, and most of the genetic variability was found to be within (80.91%) than amongpopulations (19.09%). An indirect estimate of historical levels of gene flow (N-m = 1.0678) indicated high levels of gene flow among populations. The eight analyzed populations clustered into three genetically distinct groups. Based on these results, we recommend conservation of large populations representing these three genetically distinct groups.	[Wu, Zhu-hua] Nanjing Forestry Univ, Coll Landscape Architecture, Nanjing, Jiangsu, Peoples R China; [Wu, Zhu-hua; Shi, Jisen; Xi, Meng-li; Jiang, Fu-xing; Deng, Ming-wen] Nanjing Forestry Univ, Coll Forestry, Key Lab Forest Genet & Biotechnol, Minist Educ, Nanjing, Jiangsu, Peoples R China; [Wu, Zhu-hua; Dayanandan, Selvadurai] Concordia Univ, Dept Biol, Forest & Evolutionary Genom Lab, Montreal, PQ H3G 1M8, Canada; [Wu, Zhu-hua; Dayanandan, Selvadurai] Concordia Univ, Dept Biol, Ctr Struct & Funct Genom, Montreal, PQ H3G 1M8, Canada; [Wu, Zhu-hua; Dayanandan, Selvadurai] Quebec Ctr Biodivers Sci, Montreal, PQ, Canada	Nanjing Forestry University; Nanjing Forestry University; Concordia University - Canada; Concordia University - Canada	Shi, JS (corresponding author), Nanjing Forestry Univ, Coll Forestry, Key Lab Forest Genet & Biotechnol, Minist Educ, Nanjing, Jiangsu, Peoples R China.	juliawu9@gmail.com			Science and Technology Department of Jiangsu Province [BE2009319-1]; Jiangsu Agriculture Science and Technology Innovation Fund [CX(12)2018]; "948" project of State Administration of Forestry of China in China [2013-4-34]	Science and Technology Department of Jiangsu Province; Jiangsu Agriculture Science and Technology Innovation Fund; "948" project of State Administration of Forestry of China in China	This research was financially supported by BE2009319-1 grant from Science and Technology Department of Jiangsu Province, Jiangsu Agriculture Science and Technology Innovation Fund (CX(12)2018) and "948" project of State Administration of Forestry of China (2013-4-34) in China. The funders financially support researchers to complete investigation, sampling and carrying out experiments on wild populations of Lilium regale, but the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1997, MOL BIOL BIOTECHNOLO; ARMALEO D, 1995, LICHENOLOGIST, V27, P207, DOI 10.1016/S0024-2829(05)80019-2; Arzate-Fernandez AM, 2005, PLANT SPEC BIOL, V20, P57, DOI 10.1111/j.1442-1984.2005.00124.x; Ayres DR, 1999, AM J BOT, V86, P344, DOI 10.2307/2656756; BARRETT SCH, 1991, GENETICS AND CONSERVATION OF RARE PLANTS, P3; Bohonak AJ, 2002, J HERED, V93, P153, DOI 10.1093/jhered/93.2.153; Bublyk OM, 2013, BIOLOGIA, V68, P613, DOI 10.2478/s11756-013-0192-4; Cole CT, 2003, ANNU REV ECOL EVOL S, V34, P213, DOI 10.1146/annurev.ecolsys.34.030102.151717; Comber HF, 1949, R HORT SOC LILY YB, V13, P86; Culley TM, 2001, HEREDITY, V86, P545, DOI 10.1046/j.1365-2540.2001.00875.x; Delmotte F, 2002, MOL ECOL, V11, P711, DOI 10.1046/j.1365-294X.2002.01478.x; Ge D, 2013, GENE, V520, P189, DOI 10.1016/j.gene.2013.03.015; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Frankham R, 1995, ANNU REV GENET, V29, P305, DOI 10.1146/annurev.ge.29.120195.001513; Fukai S, 2004, J JPN SOC HORTIC SCI, V73, P447, DOI 10.2503/jjshs.73.447; Gardner SN, 1999, ECOLOGY, V80, P1202, DOI 10.1890/0012-9658(1999)080[1202:MIISCO]2.0.CO;2; Gaudeul M, 2007, AM J BOT, V94, P1146, DOI 10.3732/ajb.94.7.1146; Gibson JP, 2008, AM J BOT, V95, P588, DOI 10.3732/ajb.2007316; Gonzales E, 2008, AM J BOT, V95, P1254, DOI 10.3732/ajb.2007159; Gonzalez-Astorga J, 2004, ANN BOT-LONDON, V93, P521, DOI 10.1093/aob/mch070; Grativol C, 2011, MOL BIOL REP, V38, P4245, DOI 10.1007/s11033-010-0547-7; Halkett F, 2005, TRENDS ECOL EVOL, V20, P194, DOI 10.1016/j.tree.2005.01.001; Hamrick J. L., 1989, Isozymes in plant biology., P87; Hamrick J. L., 1992, New Forests, V6, P95, DOI 10.1007/BF00120641; Hamrick J. L., 1996, P281; Hamrick JL, 1996, PHILOS T ROY SOC B, V351, P1291, DOI 10.1098/rstb.1996.0112; Hedren M, 2004, BIODIVERS CONSERV, V13, P293, DOI 10.1023/B:BIOC.0000006499.20169.f9; Holsinger K. E., 2003, HICKORY PACKAGE ANAL; Holsinger KE, 2002, MOL ECOL, V11, P1157, DOI 10.1046/j.1365-294X.2002.01512.x; Honnay O, 2008, EVOL ECOL, V22, P299, DOI 10.1007/s10682-007-9202-8; Horning ME, 2003, MOL ECOL NOTES, V3, P412, DOI 10.1046/j.1471-8286.2003.00467.x; Huang YF, 2009, BIOCHEM GENET, V47, P503, DOI 10.1007/s10528-009-9258-y; Jacquemyn H, 2005, MOL ECOL, V14, P4479, DOI 10.1111/j.1365-294X.2005.02741.x; Jin L, 2012, MOLECULES, V17, P9361, DOI 10.3390/molecules17089361; Kawase D, 2010, PLANT BIOSYST, V144, P29, DOI 10.1080/11263500903342721; Kothera L, 2007, CONSERV GENET, V8, P1043, DOI 10.1007/s10592-006-9252-4; Lachapelle J, 2012, EVOLUTION, V66, P3508, DOI 10.1111/j.1558-5646.2012.01697.x; Liu DJ, 2001, LILIES; Liu Shiliang, 2004, Yingyong Shengtai Xuebao, V15, P26; Liu XiaoLi, 2012, Journal of Beijing Forestry University, V34, P85; Luan SS, 2006, ANN BOT-LONDON, V98, P583, DOI 10.1093/aob/mcl129; Maki M, 2002, CONSERV GENET, V3, P421, DOI 10.1023/A:1020546516111; MANTEL N, 1967, CANCER RES, V27, P209; Marchelli P, 2010, CONSERV GENET, V11, P951, DOI 10.1007/s10592-009-9938-5; Marshall D. R., 1975, Crop genetic resources for today and tomorrow. Genetic variation in plant populations., P53; Mattner J, 2002, BIOL CONSERV, V107, P37, DOI 10.1016/S0006-3207(02)00041-1; Munafo JP, 2010, J AGR FOOD CHEM, V58, P8806, DOI 10.1021/jf101410d; Neel MC, 2001, AM J BOT, V88, P810, DOI 10.2307/2657033; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; NEI M, 1978, GENETICS, V89, P583; Niimi Y, 1996, J JPN SOC HORTIC SCI, V64, P919, DOI 10.2503/jjshs.64.919; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Persson HA, 1998, HEREDITAS, V128, P213, DOI 10.1111/j.1601-5223.1998.00213.x; Powell W, 1996, MOL BREEDING, V2, P225, DOI 10.1007/BF00564200; Prasad ASH, 2005, J PLANT BIOCHEM BIOT, V14, P49, DOI 10.1007/BF03263225; Primmer CR, 2009, ANN NY ACAD SCI, V1162, P357, DOI 10.1111/j.1749-6632.2009.04444.x; Pritchard JK, 2000, GENETICS, V155, P945; Reed DH, 2002, CONSERV GENET, V3, P301, DOI 10.1023/A:1019948130263; Ricardo CT, 2006, EVOL ECOL, V20, P131, DOI 10.1007/s10682-005-5379-x; Savolainen O, 2000, MOL BIOL WOODY PLANT; Shannon C. E., 1949, MATH THEORY COMMUNIC; Shao JW, 2009, BIOCHEM SYST ECOL, V37, P699, DOI 10.1016/j.bse.2009.12.001; SLATKIN M, 1985, EVOLUTION, V39, P53, DOI 10.2307/2408516; Souframanien J, 2004, THEOR APPL GENET, V109, P1687, DOI 10.1007/s00122-004-1797-3; Spigler RB, 2010, PLANT SYST EVOL, V284, P131, DOI 10.1007/s00606-009-0245-x; Spongberg SA, 1990, REUNION TREES DISCOV; Suzuki H, 2001, SEX PLANT REPROD, V13, P201, DOI 10.1007/s004970000056; Szczecinska M, 2009, DENDROBIOLOGY, V62, P23; Tatikonda L, 2009, PLANT SCI, V176, P505, DOI 10.1016/j.plantsci.2009.01.006; Tero N, 2003, MOL ECOL, V12, P2073, DOI 10.1046/j.1365-294X.2003.01898.x; Thompson FL, 2004, J EVOLUTION BIOL, V17, P581, DOI 10.1111/j.1420-9101.2004.00701.x; Tian H, 2012, AQUAT BOT, V103, P48, DOI 10.1016/j.aquabot.2012.06.001; Torres-Diaz C, 2007, ANN BOT-LONDON, V100, P75, DOI 10.1093/aob/mcm073; van Creij MGM, 1998, ACTA HORTIC, V508, P267; Van Kleunen M, 2001, ECOLOGY, V82, P3309, DOI 10.1890/0012-9658(2001)082[3309:AEOPFR]2.0.CO;2; VRIJENHOEK RC, 1994, EXS, V68, P37; [王红霞 WANG Hongxia], 2008, [安徽农业科学, Journal of Anhui Agricultural Sciences], V36, P6762; Watson MA, 2008, EVOL ECOL, V22, P471, DOI 10.1007/s10682-007-9226-0; Wen CS, 2001, INT J PLANT SCI, V162, P287, DOI 10.1086/319588; Wolf AT, 2000, AM J BOT, V87, P1138, DOI 10.2307/2656650; WRIGHT S, 1951, ANN EUGENIC, V15, P323; Wu ZhuHua, 2007, Journal of Northeast Forestry University, V35, P40; Xu XL, 2008, CATENA, V75, P138, DOI 10.1016/j.catena.2008.04.016; Yamagishi M, 2002, SCI HORTIC-AMSTERDAM, V96, P225, DOI 10.1016/S0304-4238(02)00095-X; Yang Y, 2008, INT J FOOD SCI TECH, V43, P102, DOI 10.1111/j.1365-2621.2006.01398.x; Yuan SX, 2013, EUPHYTICA, V189, P393, DOI 10.1007/s10681-012-0788-8; Zeng XQ, 2012, J PLANT ECOL-UK, V5, P270, DOI 10.1093/jpe/rtr029; [张一平 Zhang Yiping], 2005, [长江流域资源与环境, Resources and Environment in the Yangtze Basin], V14, P76; Zhao YX, 2005, CLIMATIC CHANGE, V70, P73, DOI 10.1007/s10584-005-5938-8	91	6	6	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0118831	10.1371/journal.pone.0118831	http://dx.doi.org/10.1371/journal.pone.0118831			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799495	Green Published, Green Submitted, gold			2022-12-26	WOS:000351987300020
J	Zhang, H; Huang, JX; Williams, PH; Vaissiere, BE; Zhou, ZY; Gai, QB; Dong, J; An, JD				Zhang, Hong; Huang, Jiaxing; Williams, Paul H.; Vaissiere, Bernard E.; Zhou, Zhiyong; Gai, Qinbao; Dong, Jie; An, Jiandong			Managed Bumblebees Outperform Honeybees in Increasing Peach Fruit Set in China: Different Limiting Processes with Different Pollinators	PLOS ONE			English	Article							POLLEN-TUBE GROWTH; CLARKIA-UNGUICULATA ONAGRACEAE; APIS-MELLIFERA; SELF-POLLINATION; ALMOND; FERTILIZATION; PERFORMANCE; BEES; DEPOSITION; PLANTS	Peach Prunus persica (L.) Batsch is self-compatible and largely self-fertile, but under greenhouse conditions pollinators must be introduced to achieve good fruit set and quality. Because little work has been done to assess the effectiveness of different pollinators on peach trees under greenhouse conditions, we studied 'Okubo' peach in greenhouse tunnels near Beijing between 2012 and 2014. We measured pollen deposition, pollen-tube growth rates, ovary development, and initial fruit set after the flowers were visited by either of two managed pollinators: bumblebees, Bombus patagiatus Nylander, and honeybees, Apis mellifera L. The results show that B. patagiatus is more effective than A. mellifera as a pollinator of peach in greenhouses because of differences in two processes. First, B. patagiatus deposits more pollen grains on peach stigmas than A. mellifera, both during a single visit and during a whole day of open pollination. Second, there are differences in the fertilization performance of the pollen deposited. Half of the flowers visited by B. patagiatus are fertilized 9-11 days after bee visits, while for flowers visited by A. mellifera, half are fertilized 13-15 days after bee visits. Consequently, fruit development is also accelerated by bumblebees, showing that the different pollinators have not only different pollination efficiency, but also influence the subsequent time course of fertilization and fruit set. Flowers visited by B. patagiatus show faster ovary growth and ultimately these flowers produce more fruit. Our work shows that pollinators may influence fruit production beyond the amount of pollen delivered. We show that managed indigenous bumblebees significantly outperform introduced honeybees in increasing peach initial fruit set under greenhouse conditions.	[Zhang, Hong; Huang, Jiaxing; Williams, Paul H.; Zhou, Zhiyong; Gai, Qinbao; Dong, Jie; An, Jiandong] Chinese Acad Agr Sci, Inst Apicultural Res, Minist Agr, Key Lab Insect Pollinator Biol, Beijing 100193, Peoples R China; [Williams, Paul H.] Nat Hist Museum, Dept Life Sci, London SW7 5BD, England; [Vaissiere, Bernard E.] INRA, Lab Pollinisat & Ecol Abeilles, Abeilles & Environm UR406, Avignon, France	Chinese Academy of Agricultural Sciences; Institute of Apicultural Research, CAAS; Ministry of Agriculture & Rural Affairs; Natural History Museum London; INRAE	An, JD (corresponding author), Chinese Acad Agr Sci, Inst Apicultural Res, Minist Agr, Key Lab Insect Pollinator Biol, Beijing 100193, Peoples R China.	anjiandong@caas.cn			Special Fund for Agro-scientific Research in the Public Interest [201203080-4]; SAFEA High-end Foreign Experts Program [GDJ20140326002]; International Exchange and Cooperation Program in Agricultural Science [A6950]; CAAS Fundamental Research Funds [201422021]; Agricultural Science and Technology Innovation Program [CAAS-ASTIP-2015-IAR]; Natural Science Foundation of China [30901055]	Special Fund for Agro-scientific Research in the Public Interest; SAFEA High-end Foreign Experts Program; International Exchange and Cooperation Program in Agricultural Science; CAAS Fundamental Research Funds; Agricultural Science and Technology Innovation Program; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported financially by the Special Fund for Agro-scientific Research in the Public Interest (201203080-4); the SAFEA High-end Foreign Experts Program (GDJ20140326002); the International Exchange and Cooperation Program in Agricultural Science (A6950); the CAAS Fundamental Research Funds (201422021); the Agricultural Science and Technology Innovation Program (CAAS-ASTIP-2015-IAR); and the Natural Science Foundation of China (30901055).	Abak K, 1995, ACTA HORTIC, P268, DOI 10.17660/ActaHortic.1995.412.30; Allen-Wardell G, 1998, CONSERV BIOL, V12, P8; An Jian-Dong, 2007, Yingyong Shengtai Xuebao, V18, P1071; ARBELOA A, 1987, ANN BOT-LONDON, V60, P681, DOI 10.1093/oxfordjournals.aob.a087500; Artz DR, 2011, J ECON ENTOMOL, V104, P1153, DOI 10.1603/EC10431; Benedek P., 1996, Acta Horticulturae, P169; Beyhan N, 2007, SCI HORTICULTURAE, V113, P347; Borgardt SJ, 2003, AM J BOT, V90, P1567, DOI 10.3732/ajb.90.11.1567; Cousin M, 1998, SCI HORTIC-AMSTERDAM, V72, P287, DOI 10.1016/S0304-4238(97)00138-6; Delaplane KS, 2013, J APICULT RES, V52, DOI [10.3896/IBRA.1.52.1.03, 10.3896/IBRA.1.52.4.12]; Dyer AG, 2004, J EXP BIOL, V207, P1683, DOI 10.1242/jeb.00941; FAOSTATS: Food and Agricultural Organization of the United Nations, 2014, 2014 STAT DIV; Freitas BM, 1998, J APPL ECOL, V35, P109, DOI 10.1046/j.1365-2664.1998.00278.x; Gallai N, 2009, ECOL ECON, V68, P810, DOI 10.1016/j.ecolecon.2008.06.014; Garibaldi LA, 2013, SCIENCE, V339, P1608, DOI 10.1126/science.1230200; Goulson Dave, 1999, Perspectives in Plant Ecology Evolution and Systematics, V2, P185, DOI 10.1078/1433-8319-00070; Gradziel TM, 1999, HORTSCIENCE, V34, P322, DOI 10.21273/HORTSCI.34.2.322; Herrero M, 1996, SEX PLANT REPROD, V9, P343, DOI 10.1007/BF02441953; HERRERO M, 1992, PLANT GROWTH REGUL, V11, P27, DOI 10.1007/BF00024429; JOHANSEN D.A., 1940, PLANT MICROTECHNIQUE; KHO YO, 1968, EUPHYTICA, V17, P298; King C, 2013, METHODS ECOL EVOL, V4, P811, DOI 10.1111/2041-210X.12074; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Knox RB, 1984, CELLULAR INTERACTION, V17, P508; Kremen C, 2002, P NATL ACAD SCI USA, V99, P16812, DOI 10.1073/pnas.262413599; LANGRIDGE DF, 1979, AUST J EXP AGR, V19, P510, DOI 10.1071/EA9790510; LANGRIDGE DF, 1977, AUST J EXP AGR, V17, P697, DOI 10.1071/EA9770697; Layne D. R., 2008, PEACH BOT PRODUCTION; Liu JF, 2014, PLANT REPROD, V27, P145, DOI 10.1007/s00497-014-0248-9; Lord EM, 2002, ANNU REV CELL DEV BI, V18, P81, DOI 10.1146/annurev.cellbio.18.012502.083438; Ne'eman G, 2010, BIOL REV, V85, P435, DOI 10.1111/j.1469-185X.2009.00108.x; Nemeth M. Barbara, 2006, International Journal of Botany, V2, P83; Nemeth MB, 2003, INT J PLANT SCI, V164, P153, DOI 10.1086/344549; Nyeki J, 1998, ACTA HORTIC, P279, DOI 10.17660/ActaHortic.1998.465.35; Nyeki J., 2000, International Journal of Horticultural Science, V6, P123; PIMIENTA E, 1983, ANN BOT-LONDON, V51, P469, DOI 10.1093/oxfordjournals.aob.a086492; PRIMACK RB, 1975, NATURE, V255, P143, DOI 10.1038/255143a0; Sanzol J, 2001, SCI HORTIC-AMSTERDAM, V90, P1, DOI 10.1016/S0304-4238(00)00252-1; Shaheen MA, 1996, ENV ARID LAND AGR SC, V7, P99; SNOW AA, 1987, BIOTROPICA, V19, P57, DOI 10.2307/2388460; Socias I Company Rafel, 2013, Plants (Basel), V2, P50, DOI 10.3390/plants2010050; Sogo A, 2004, J PLANT RES, V117, P37, DOI 10.1007/s10265-003-0129-z; SOUTHWICK EE, 1992, J ECON ENTOMOL, V85, P621, DOI 10.1093/jee/85.3.621; Stanghellini MS, 1998, HORTSCIENCE, V33, P28, DOI 10.21273/HORTSCI.33.1.28; THOMSON JD, 1980, OECOLOGIA, V46, P68, DOI 10.1007/BF00346968; Thomson JD, 2001, J APPL ECOL, V38, P1032, DOI 10.1046/j.1365-2664.2001.00657.x; Vaissiere B.E, 2011, PROTOCOL DETECT ASSE; Velthuis HHW, 2006, APIDOLOGIE, V37, P421, DOI 10.1051/apido:2006019; WEINBAUM SA, 1986, EUPHYTICA, V35, P193, DOI 10.1007/BF00028557; WEINBAUM SA, 1983, FRUIT VARIETIES J, V37, P113; WESTERKAMP C, 1991, PLANT SYST EVOL, V177, P71, DOI 10.1007/BF00937827; Wilcock C, 2002, TRENDS PLANT SCI, V7, P270, DOI 10.1016/S1360-1385(02)02258-6; Williams PH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032992; Zhang Hong, 2013, Zhongguo Shengtai Nongye Xuebao / Chinese Journal of Eco-Agriculture, V21, P1249, DOI 10.3724/SP.J.1011.2013.01249; Zhang Y, 2010, AGR ENG TECHNOLOGY G, V8, P94	55	29	38	2	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121143	10.1371/journal.pone.0121143	http://dx.doi.org/10.1371/journal.pone.0121143			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799170	Green Published, Green Submitted, gold			2022-12-26	WOS:000351987300217
J	Zhu, Y; Yang, XQ; Han, CT; Dai, B; Zhang, HL; Shi, GH; Wang, CF; Ye, DW				Zhu, Yao; Yang, Xiao-Qun; Han, Cheng-Tao; Dai, Bo; Zhang, Hai-Liang; Shi, Guo-Hai; Wang, Chao-Fu; Ye, Ding-Wei			Pathological Features of Localized Prostate Cancer in China: A Contemporary Analysis of Radical Prostatectomy Specimens	PLOS ONE			English	Article							CLINICOPATHOLOGICAL FEATURES; TRANSITION ZONE; OUTCOMES; TUMORS; BIOPSY; STAGE	There has been a rapid increase in the incidence of prostate cancer in China, especially in areas with boosted economic development. In this study, we analyzed the pathological features of a contemporary series of radical prostatectomy cases. A total of 230 consecutive, whole-mounted radical prostatectomy specimens collected from 2012 to 2014 were reviewed. The median age of the patients was 68 years, and 64.3% of patients presented with prostate specific antigen alone. Pathological examination indicated that a high proportion (77.4%) of patients had intermediate-or high-risk disease according to the Cancer of the Prostate Risk Assessment Post-Surgical score. After surgery, only 28 patients met the criteria for active surveillance (organ-confined Gleason >= 6 disease). The Prostate Cancer Research International Active Surveillance criteria achieved a sensitivity of 57.1% and a specificity of 98.0% for identifying candidates. The probability of Gleason score upgrading was 24.8% in the entire group and 59.0% in biopsy-confirmed Gleason >= 6 disease. The predominant tumor was located in the transition zone in 14.8% of cases, while only three patients (1.3%) had a predominant tumor located in the anterior region. Patients with transition zone-predominant tumor were likely to have been referred with urinary symptoms and high prostate specific antigen levels. The results of this study highlight the contemporary pathological features of localized prostate cancer in urban China. There was an increased trend towards asymptomatic cases, though most patients had intermediate-or high-risk disease and were suitable for definitive treatment. The low prevalence of dominant cancer in the anterior region may reflect race-based pathological differences.	[Zhu, Yao; Han, Cheng-Tao; Dai, Bo; Zhang, Hai-Liang; Shi, Guo-Hai; Ye, Ding-Wei] Fudan Univ, Shanghai Canc Ctr, Dept Urol, Shanghai 200032, Peoples R China; [Zhu, Yao; Yang, Xiao-Qun; Han, Cheng-Tao; Dai, Bo; Zhang, Hai-Liang; Shi, Guo-Hai; Wang, Chao-Fu; Ye, Ding-Wei] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200032, Peoples R China; [Yang, Xiao-Qun; Wang, Chao-Fu] Fudan Univ, Shanghai Canc Ctr, Dept Pathol, Shanghai 200032, Peoples R China	Fudan University; Fudan University; Fudan University	Wang, CF (corresponding author), Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200032, Peoples R China.	wangchaofu@126.com; dwye.shca@gmail.com	Zhang, Hailiang/AAF-4937-2020; Wang, Chao/GXF-8353-2022		National Natural Science Foundation of China [81370073]; Shanghai Shen Kang Hospital Development Center Funds [SHDC12013122]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Shen Kang Hospital Development Center Funds	This project was supported by the National Natural Science Foundation of China (81370073) (www.nsfc.gov.cn) and the Shanghai Shen Kang Hospital Development Center Funds (SHDC12013122). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Ahmadie HA, 2008, AM J SURG PATHOL, V32, P229, DOI 10.1097/PAS.0b013e31812f7b27; Cheng L, 2005, MODERN PATHOL, V18, P1022, DOI 10.1038/modpathol.3800431; Cooperberg MR, 2011, CANCER-AM CANCER SOC, V117, P5039, DOI 10.1002/cncr.26169; Epstein JI, 2012, EUR UROL, V61, P1019, DOI 10.1016/j.eururo.2012.01.050; Ferlay J, 2013, GLOBOCAN 2012 V1 0 C; Hu Y, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-356; Jack GS, 2002, J UROLOGY, V168, P519, DOI 10.1016/S0022-5347(05)64671-X; Kimura T, 2012, PATHOL INT, V62, P742, DOI 10.1111/pin.12006; King CR, 2009, UROL ONCOL-SEMIN ORI, V27, P592, DOI 10.1016/j.urolonc.2008.05.009; Lee DH, 2012, JPN J CLIN ONCOL, V42, P1079, DOI 10.1093/jjco/hys147; Mygatt J, 2014, PROSTATE CANCER P D, V17, P75, DOI 10.1038/pcan.2013.54; Na R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067585; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Peyromaure M, 2005, J UROLOGY, V174, P1794, DOI 10.1097/01.ju.0000176817.46279.93; Sakai I, 2006, INT J UROL, V13, P368, DOI 10.1111/j.1442-2042.2006.01307.x; Sundi D, 2014, J UROLOGY, V191, P60, DOI 10.1016/j.juro.2013.06.021; Takahashi H, 2014, PROSTATE, V74, P321, DOI 10.1002/pros.22754; Zhu Y, 2015, ASIAN J ANDROL, V17, P48, DOI 10.4103/1008-682X.132780	18	13	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121076	10.1371/journal.pone.0121076	http://dx.doi.org/10.1371/journal.pone.0121076			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799190	Green Submitted, gold, Green Published			2022-12-26	WOS:000351987300207
J	Jang, JY; Wang, SB; Min, JH; Chae, YH; Baek, JY; Yu, DY; Chang, TS				Jang, Ji Yong; Wang, Su Bin; Min, Ji Hyun; Chae, Yun Hee; Baek, Jin Young; Yu, Dae-Yeul; Chang, Tong-Shin			Peroxiredoxin II Is an Antioxidant Enzyme That Negatively Regulates Collagen-stimulated Platelet Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE KINASE SYK; GLYCOPROTEIN-VI; LIPID RAFTS; SIGNAL-TRANSDUCTION; HYDROGEN-PEROXIDE; REDOX REGULATION; CELL-ADHESION; GAMMA-CHAIN; IN-VIVO; ACTIVATION	Collagen-induced platelet signaling is mediated by binding to the primary receptor glycoprotein VI (GPVI). Reactive oxygen species produced in response to collagen have been found to be responsible for the propagation of GPVI signaling pathways in platelets. Therefore, it has been suggested that antioxidant enzymes could down-regulate GPVI-stimulated platelet activation. Although the antioxidant enzyme peroxiredoxin II (PrxII) has emerged as having a role in negatively regulating signaling through various receptors by eliminating H2O2 generated upon receptor stimulation, the function of PrxII in collagen-stimulated platelets is not known. We tested the hypothesis that PrxII negatively regulates collagen-stimulated platelet activation. We analyzed PrxII-deficient murine platelets. PrxII deficiency enhanced GPVI-mediated platelet activation through the defective elimination of H2O2 and the impaired protection of SH2 domain-containing tyrosine phosphatase 2 (SHP-2) against oxidative inactivation, which resulted in increased tyrosine phosphorylation of key components for the GPVI signaling cascade, including Syk, Btk, and phospholipase C gamma 2. Interestingly, PrxII-mediated antioxidative protection of SHP-2 appeared to occur in the lipid rafts. PrxII-deficient platelets exhibited increased adhesion and aggregation upon collagen stimulation. Furthermore, in vivo experiments demonstrated that PrxII deficiency facilitated platelet-dependent thrombus formation in injured carotid arteries. This study reveals that PrxII functions as a protective antioxidant enzyme against collagen-stimulated platelet activation and platelet-dependent thrombosis.	[Jang, Ji Yong; Wang, Su Bin; Min, Ji Hyun; Chae, Yun Hee; Baek, Jin Young; Chang, Tong-Shin] Ewha Womans Univ, Grad Sch Pharmaceut Sci, Seoul 120750, South Korea; [Chang, Tong-Shin] Ewha Womans Univ, Coll Pharm, Seoul 120750, South Korea; [Yu, Dae-Yeul] Korea Res Inst Biosci & Biotechnol, Dis Model Res Lab, Aging Res Ctr, Taejon 605806, South Korea	Ewha Womans University; Ewha Womans University; Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Chang, TS (corresponding author), Ewha Womans Univ, Sci Bldg C,Rm 208,52 Ewhayeodae Gil, Seoul 120750, South Korea.	changts@ewha.ac.kr	Jang, Jiyong/AAA-3074-2020		National Research Foundation - Korean Ministry of Science, ICT, and Future Planning [M10642040002-07N4204-00210]; Health Technology R&D Project - Korean Ministry of Health and Welfare [HI13C1046]; Brain Korea 21 Plus Program - Korean Ministry of Education	National Research Foundation - Korean Ministry of Science, ICT, and Future Planning; Health Technology R&D Project - Korean Ministry of Health and Welfare; Brain Korea 21 Plus Program - Korean Ministry of Education	This study was supported by National Research Foundation Grant M10642040002-07N4204-00210 funded by the Korean Ministry of Science, ICT, and Future Planning; by Health Technology R&D Project Grant HI13C1046 funded by the Korean Ministry of Health and Welfare; and by the Brain Korea 21 Plus Program (to J. Y. J., S. B. W., and J. Y. B.) funded by the Korean Ministry of Education.	Anfossi G, 2001, EUR J CLIN INVEST, V31, P452, DOI 10.1046/j.1365-2362.2001.00815.x; Atkinson BT, 2003, BLOOD, V102, P3592, DOI 10.1182/blood-2003-04-1142; Bakdash N, 2008, FREE RADICAL BIO MED, V45, P158, DOI 10.1016/j.freeradbiomed.2008.03.021; Begonja AJ, 2005, BLOOD, V106, P2757, DOI 10.1182/blood-2005-03-1047; Bennett JS, 2005, J CLIN INVEST, V115, P3363, DOI 10.1172/JCI26989; Bhatt DL, 2007, NEW ENGL J MED, V357, P2078, DOI 10.1056/NEJMe0706859; Chari R, 2009, BLOOD, V114, P3056, DOI 10.1182/blood-2008-11-188516; Chen JC, 2002, AM J PATHOL, V161, P337, DOI 10.1016/S0002-9440(10)64185-5; Chiarugi P, 2003, TRENDS BIOCHEM SCI, V28, P509, DOI 10.1016/S0968-0004(03)00174-9; Choi MH, 2005, NATURE, V435, P347, DOI 10.1038/nature03587; Davi G, 2007, NEW ENGL J MED, V357, P2482, DOI 10.1056/NEJMra071014; Dutting S, 2012, TRENDS PHARMACOL SCI, V33, P583, DOI 10.1016/j.tips.2012.07.004; Farrehi PM, 1998, CIRCULATION, V97, P1002; Freedman JE, 2008, ARTERIOSCL THROM VAS, V28, pS11, DOI 10.1161/ATVBAHA.107.159178; FUJII C, 1994, EUR J BIOCHEM, V226, P243, DOI 10.1111/j.1432-1033.1994.tb20047.x; Furlong MT, 1997, BBA-MOL CELL RES, V1355, P177, DOI 10.1016/S0167-4889(96)00131-0; Gibbins J. M., 2004, PLATELETS MEGAKARYOC, P233; Gibbins JM, 2004, J CELL SCI, V117, P3415, DOI 10.1242/jcs.01325; JandrotPerrus M, 1997, J BIOL CHEM, V272, P27035, DOI 10.1074/jbc.272.43.27035; Jang JY, 2014, ANTIOXID REDOX SIGN, V20, P2528, DOI 10.1089/ars.2013.5337; Jin RC, 2011, CIRCULATION, V123, P1963, DOI 10.1161/CIRCULATIONAHA.110.000034; Kang DH, 2011, MOL CELL, V44, P545, DOI 10.1016/j.molcel.2011.08.040; Kang SW, 1998, J BIOL CHEM, V273, P6297, DOI 10.1074/jbc.273.11.6297; Krotz F, 2002, BLOOD, V100, P917, DOI 10.1182/blood.V100.3.917; Kurosaki T, 2000, IMMUNOL REV, V176, P19; KURZ KD, 1990, THROMB RES, V60, P269, DOI 10.1016/0049-3848(90)90106-M; Kwon J, 2005, EMBO J, V24, P2331, DOI 10.1038/sj.emboj.7600706; Lee FA, 2006, J BIOL CHEM, V281, P39330, DOI 10.1074/jbc.M607930200; Lee TH, 2003, BLOOD, V101, P5033, DOI 10.1182/blood-2002-08-2548; Li QA, 2006, MOL CELL BIOL, V26, P140, DOI 10.1128/MCB.26.1.140-154.2006; Li W, 2010, J CLIN INVEST, V120, P3996, DOI 10.1172/JCI42823; Lill G, 2003, FEBS LETT, V546, P265, DOI 10.1016/S0014-5793(03)00599-4; Locke D, 2002, J BIOL CHEM, V277, P18801, DOI 10.1074/jbc.M111520200; Maeda A, 1999, ONCOGENE, V18, P2291, DOI 10.1038/sj.onc.1202552; Mairhofer M, 2002, BLOOD, V100, P897, DOI 10.1182/blood.V100.3.897; Mancini F, 2007, BLOOD, V110, P1871, DOI 10.1182/blood-2007-03-081414; Monteiro HP, 2008, ANTIOXID REDOX SIGN, V10, P843, DOI 10.1089/ars.2007.1853; Morrell CN, 2008, CIRC RES, V103, P571, DOI 10.1161/CIRCRESAHA.108.184325; Murphy AJ, 2013, NAT MED, V19, P586, DOI 10.1038/nm.3150; Nieswandt B, 2003, BLOOD, V102, P449, DOI 10.1182/blood-2002-12-3882; Oakley FD, 2009, ANTIOXID REDOX SIGN, V11, P1313, DOI 10.1089/ARS.2008.2363; PALABRICA T, 1992, NATURE, V359, P848, DOI 10.1038/359848a0; Park JG, 2011, CIRC RES, V109, P739, DOI 10.1161/CIRCRESAHA.111.245530; Pearce AC, 2002, BLOOD, V100, P3561, DOI 10.1182/blood.V100.10.3561; Pignatelli P, 1998, BLOOD, V91, P484, DOI 10.1182/blood.V91.2.484.484_484_490; Poole A, 1997, EMBO J, V16, P2333, DOI 10.1093/emboj/16.9.2333; Rhee SG, 2006, SCIENCE, V312, P1882, DOI 10.1126/science.1130481; Salmeen A, 2005, ANTIOXID REDOX SIGN, V7, P560, DOI 10.1089/ars.2005.7.560; Seno T, 2001, THROMB RES, V103, P399, DOI 10.1016/S0049-3848(01)00341-3; Sobotkova A, 2009, FREE RADICAL BIO MED, V47, P1707, DOI 10.1016/j.freeradbiomed.2009.09.015; Suzuki-Inoue K, 2004, BIOCHEM J, V378, P1023, DOI 10.1042/BJ20031430; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Tonks NK, 2005, CELL, V121, P667, DOI 10.1016/j.cell.2005.05.016; Tseng MT, 2006, THROMB RES, V118, P275, DOI 10.1016/j.thromres.2005.09.004; Ushio-Fukai Masuko, 2006, Sci STKE, V2006, pre8; Varga-Szabo D, 2008, ARTERIOSCL THROM VAS, V28, P403, DOI 10.1161/ATVBAHA.107.150474; Vial C, 2006, BIOCHEM BIOPH RES CO, V343, P415, DOI 10.1016/j.bbrc.2006.02.174; Wakino S, 2004, CIRC RES, V95, pE45, DOI 10.1161/01.RES.0000142313.68389.92; Watson SP, 2005, J THROMB HAEMOST, V3, P1752, DOI 10.1111/j.1538-7836.2005.01429.x; Weng Z, 2010, BLOOD, V116, P2579, DOI 10.1182/blood-2010-03-277236; Woo HA, 2010, CELL, V140, P517, DOI 10.1016/j.cell.2010.01.009	61	17	18	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2015	290	18					11432	11442		10.1074/jbc.M115.644260	http://dx.doi.org/10.1074/jbc.M115.644260			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH0OA	25802339	hybrid, Green Published			2022-12-26	WOS:000353719400020
J	Al-koshab, M; Nambiar, P; John, J				Al-koshab, May; Nambiar, Phrabhakaran; John, Jacob			Assessment of Condyle and Glenoid Fossa Morphology Using CBCT in South-East Asians	PLOS ONE			English	Article							BEAM COMPUTED-TOMOGRAPHY; TEMPOROMANDIBULAR-JOINT; MALOCCLUSION; THICKNESS; ROOF	Introduction Proper imaging allows practitioners to evaluate an asymptomatic tempormandibular joint (TMJ) for potential degenerative changes prior to surgical and orthodontic treatment. The recently developed cone-beam computed tomography (CBCT) allows measurement of TMJ bony structures with high accuracy. A study was undertaken to determine the morphology, and its variations, of the mandibular condyle and glenoid fossa among Malay and Chinese Malaysians. Methods CBCT was used to assess 200 joints in 100 subjects (mean age, 30.5 years). i-CAT CBCT software and The Mimics 16.0 software were employed to measure the volume, metrical size, position of each condyle sample and the thickness of the roof of the glenoid fossa (RGF). Results No significant gender differences were noted in thickness of the RGF and condylar length; however condylar volume, width, height and the joint spaces were significantly greater among males. With regards to comparison of both TMJs, the means of condylar volume, width and length of the right TMJ were significantly higher, while the means of the left condylar height and thickness of RGF were higher. When comparing the condylar measurements and the thickness of RGF between the two ethnic groups, we found no significant difference for all measurements with exception of condylar height, which is higher among Chinese. Conclusion The similarity in measurements for Malays and Chinese may be due to their common origin. This information can be clinically useful in establishing the diagnostic criteria for condylar volume, metrical size, and position in the Malaysian East Asians population.	[Al-koshab, May; Nambiar, Phrabhakaran; John, Jacob] Univ Malaya, Fac Dent, Dept Diagnost & Integrated Dent Practice, Kuala Lumpur, Malaysia	Universiti Malaya	Al-koshab, M (corresponding author), Univ Malaya, Fac Dent, Dept Diagnost & Integrated Dent Practice, Kuala Lumpur, Malaysia.	dr.mayameenalkoshab@yahoo.com	John, Jacob/ABD-7448-2020; JOHN, JACOB/AAU-1464-2021; JOHN, JACOB/B-8683-2010; NAMBIAR, PHRABHAKARAN K N/B-9495-2010; Al-koshab, May/AAW-8514-2020	JOHN, JACOB/0000-0001-8452-0676; JOHN, JACOB/0000-0001-8452-0676; Al-koshab, May/0000-0002-2353-6655	High Impact Research Grant by Ministry of Education Malaysia [UM.C/HIR/MOHE/DENT/19]	High Impact Research Grant by Ministry of Education Malaysia	This project was supported and funded by a High Impact Research Grant provided by the Ministry of Education Malaysia (UM.C/HIR/MOHE/DENT/19). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexiou K, 2009, DENTOMAXILLOFAC RAD, V38, P127, DOI [10.1259/dmfr/78885709, DOI 10.1259/DMFR/78885709]; Alomar X, 2007, SEMIN ULTRASOUND CT, V28, P170, DOI 10.1053/j.sult.2007.02.002; BLASCHKE DD, 1981, J DENT RES, V60, P35, DOI 10.1177/00220345810600010701; Chinea S, 2011, THESIS U SO CALIFORN; Cohlmia JT, 1996, ANGLE ORTHOD, V66, P27; Dalili Zahra, 2012, Dent Res J (Isfahan), V9, P607; Ejima K, 2014, DENTOMAXILLOFACIAL R; Hilgers ML, 2005, AM J ORTHOD DENTOFAC, V128, P803, DOI 10.1016/j.ajodo.2005.08.034; Honda K, 2005, CLIN ANAT, V18, P23, DOI 10.1002/ca.20054; Ikeda K, 2009, AM J ORTHOD DENTOFAC, V135, P495, DOI 10.1016/j.ajodo.2007.05.021; Kai Y, 2011, ORAL SURG ORAL MED O, V112, P508, DOI 10.1016/j.tripleo.2011.05.013; Kijima N, 2014, DENTOMAXILLOFAC RAD, V36, P249; Kinniburgh RD, 2000, ANGLE ORTHOD, V70, P70; MARMARY Y, 1979, ANGLE ORTHOD, V49, P263; Rodrigues AF, 2009, AM J ORTHOD DENTOFAC, V136, P199, DOI 10.1016/j.ajodo.2007.07.033; TADEJ G, 1989, ANGLE ORTHOD, V59, P187; Tecco Simona, 2010, BMC Med Imaging, V10, P28, DOI 10.1186/1471-2342-10-28; Wang Rui-yong, 2007, Beijing Da Xue Xue Bao Yi Xue Ban, V39, P503	18	51	55	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0121682	10.1371/journal.pone.0121682	http://dx.doi.org/10.1371/journal.pone.0121682			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803868	Green Submitted, Green Published, gold			2022-12-26	WOS:000353889600173
J	Carrillo, J; Molinos-Albert, LM; de la Concepcion, MLR; Marfil, S; Garcia, E; Derking, R; Sanders, RW; Clotet, B; Blanco, J				Carrillo, Jorge; Manuel Molinos-Albert, Luis; Luisa Rodriguez de la Concepcion, Maria; Marfil, Silvia; Garcia, Elisabet; Derking, Ronald; Sanders, Rogier W.; Clotet, Bonaventura; Blanco, Julia			Gp120/CD4 Blocking Antibodies Are Frequently Elicited in ART-Naive Chronically HIV-1 Infected Individuals	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; BROADLY NEUTRALIZING ANTIBODIES; HIV-1/SIV CHIMERIC VIRUS; CD4 BINDING-SITE; MONOCLONAL-ANTIBODIES; ENVELOPE GLYCOPROTEIN; MACAQUE MONKEYS; HIV; INFECTION; CELLS	Antibodies with the ability to block the interaction of HIV-1 envelope glycoprotein (Env) gp120 with CD4, including those overlapping the CD4 binding site (CD4bs antibodies), can protect from infection by HIV-1, and their elicitation may be an interesting goal for any vaccination strategy. To identify gp120/CD4 blocking antibodies in plasma samples from HIV-1 infected individuals we have developed a competitive flow cytometry-based functional assay. In a cohort of treatment-naive chronically infected patients, we showed that gp120/CD4 blocking antibodies were frequently elicited (detected in 97% plasma samples) and correlated with binding to trimeric HIV-1 envelope glycoproteins. However, no correlation was observed between functional CD4 binding blockade data and titer of CD4bs antibodies determined by ELISA using resurfaced gp120 proteins. Consistently, plasma samples lacking CD4bs antibodies were able to block the interaction between gp120 and its receptor, indicating that antibodies recognizing other epitopes, such as PGT126 and PG16, can also play the same role. Antibodies blocking CD4 binding increased over time and correlated positively with the capacity of plasma samples to neutralize the laboratory-adapted NL4.3 and BaL virus isolates, suggesting their potential contribution to the neutralizing workforce of plasma in vivo. Determining whether this response can be boosted to achieve broadly neutralizing antibodies may provide valuable information for the design of new strategies aimed to improve the anti-HIV-1 humoral response and to develop a successful HIV1 vaccine.	[Carrillo, Jorge; Manuel Molinos-Albert, Luis; Luisa Rodriguez de la Concepcion, Maria; Marfil, Silvia; Garcia, Elisabet; Clotet, Bonaventura; Blanco, Julia] Inst Recerca SIDA IrsiCaixa HIVACAT, Barcelona, Spain; [Manuel Molinos-Albert, Luis; Blanco, Julia] Hosp Badalona Germans Trias & Pujol, Inst Recerca Ciencies Salut Germans Trias & Pujol, Barcelona, Spain; [Derking, Ronald; Sanders, Rogier W.] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, NL-1105 AZ Amsterdam, Netherlands; [Sanders, Rogier W.] Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, New York, NY 10021 USA; [Clotet, Bonaventura; Blanco, Julia] Univ Autonoma Barcelona, E-08193 Barcelona, Spain; [Clotet, Bonaventura; Blanco, Julia] Univ Vic Cent Catalunya, UVIC UCC, Barcelona, Spain; [Clotet, Bonaventura] Fdn Lluita SIDA, Barcelona, Spain	Institut de Recerca de la Sida - IrsiCaixa; Hospital Germans Trias i Pujol; University of Amsterdam; Academic Medical Center Amsterdam; Cornell University; Autonomous University of Barcelona; Universitat de Vic - Universitat Central de Catalunya (UVic-UCC)	Carrillo, J (corresponding author), Ctr Recerca Salut Int Barcelona CRESIB, Barcelona, Spain.	jcarrillo@irsicaixa.es	Blanco, Julià/A-5347-2008; Carrillo, Jorge/AAL-9481-2021	Blanco, Julià/0000-0002-2225-0217; Carrillo, Jorge/0000-0003-0221-5948; Molinos-Albert, Luis M/0000-0001-5447-6803; Rodriguez de la Concepcion/0000-0002-6944-3462	HIVACAT Program and the Spanish AIDS network 'Red Tematica Cooperativa de Investigacion en SIDA [RD06/0006]; Fondo de Investigaciones Sanitarias [PI1102089]; Fundacio Institut de Recerca en Ciencies de la Salut Germans Trias i Pujol; ISCIII; Health Department of the Catalan Government (Generalitat de Catalunya); Spanish Health Institute 'ISCIII'; Generalitat de Catalunya and European Social Fund	HIVACAT Program and the Spanish AIDS network 'Red Tematica Cooperativa de Investigacion en SIDA; Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Fundacio Institut de Recerca en Ciencies de la Salut Germans Trias i Pujol; ISCIII(Instituto de Salud Carlos III); Health Department of the Catalan Government (Generalitat de Catalunya)(Generalitat de Catalunya); Spanish Health Institute 'ISCIII'; Generalitat de Catalunya and European Social Fund	This work was supported by the HIVACAT Program and the Spanish AIDS network 'Red Tematica Cooperativa de Investigacion en SIDA (RD06/0006)' and Fondo de Investigaciones Sanitarias (grant number PI1102089). J.B. is a researcher from Fundacio Institut de Recerca en Ciencies de la Salut Germans Trias i Pujol supported by the ISCIII and the Health Department of the Catalan Government (Generalitat de Catalunya). J. C. is supported by a 'Sara Borrell' grant from the Spanish Health Institute 'ISCIII'. LMM-A. is supported by a predoctoral grant from Generalitat de Catalunya and European Social Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba TW, 2000, NAT MED, V6, P200, DOI 10.1038/72309; BARBAS CF, 1992, P NATL ACAD SCI USA, V89, P9339, DOI 10.1073/pnas.89.19.9339; Blanco J, 2004, J LEUKOCYTE BIOL, V76, P804, DOI 10.1189/jlb.0204100; Carrillo J, 2013, AIDS, V27, P1375, DOI 10.1097/QAD.0b013e32835fac08; Hessell AJ, 2007, NATURE, V449, P101, DOI 10.1038/nature06106; Hessell AJ, 2009, NAT MED, V15, P951, DOI 10.1038/nm.1974; Hessell AJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000433; Huang JH, 2012, NATURE, V491, P406, DOI 10.1038/nature11544; Huang KHG, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1100; Julien JP, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003342; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Kwong PD, 2002, NATURE, V420, P678, DOI 10.1038/nature01188; Kwong PD, 2013, NAT REV IMMUNOL, V13, P693, DOI 10.1038/nri3516; Li YX, 2007, NAT MED, V13, P1032, DOI 10.1038/nm1624; Lynch RM, 2012, J VIROL, V86, P7588, DOI 10.1128/JVI.00734-12; Mascola JR, 2010, ANNU REV IMMUNOL, V28, P413, DOI 10.1146/annurev-immunol-030409-101256; Mascola JR, 2000, NAT MED, V6, P207, DOI 10.1038/72318; Montefiori DC., 2005, CURR PROTOC IMMUNOL, VChapter 12:12.11.11-12.11.15, DOI [10.1002/0471142735.im1211s64, DOI 10.1002/0471142735.IM1211S64]; Moulard M, 2002, P NATL ACAD SCI USA, V99, P6913, DOI 10.1073/pnas.102562599; MUSTER T, 1993, J VIROL, V67, P6642, DOI 10.1128/JVI.67.11.6642-6647.1993; Pantophlet R, 2003, J VIROL, V77, P642, DOI 10.1128/JVI.77.1.642-658.2003; Pietzsch J, 2010, J EXP MED, V207, P1995, DOI 10.1084/jem.20101176; Richman DD, 2003, P NATL ACAD SCI USA, V100, P4144, DOI 10.1073/pnas.0630530100; Sanchez-Palomino S, 2011, VACCINE, V29, P5250, DOI 10.1016/j.vaccine.2011.05.016; Sanders RW, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003618; Scanlan CN, 2002, J VIROL, V76, P7306, DOI 10.1128/JVI.76.14.7306-7321.2002; Shibata R, 1999, NAT MED, V5, P204, DOI 10.1038/5568; Titanji K, 2006, BLOOD, V108, P1580, DOI 10.1182/blood-2005-11-013383; Tomaras GD, 2008, J VIROL, V82, P12449, DOI 10.1128/JVI.01708-08; Ugolini S, 1997, J EXP MED, V186, P1287, DOI 10.1084/jem.186.8.1287; Valenzuela A, 1997, J VIROL, V71, P8289, DOI 10.1128/JVI.71.11.8289-8298.1997; Veazey RS, 2003, NAT MED, V9, P343, DOI 10.1038/nm833; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; West AP, 2014, CELL, V156, P633, DOI 10.1016/j.cell.2014.01.052; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Zwick MB, 2001, J VIROL, V75, P10892, DOI 10.1128/JVI.75.22.10892-10905.2001	38	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0120648	10.1371/journal.pone.0120648	http://dx.doi.org/10.1371/journal.pone.0120648			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803681	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000353889600087
J	Ulloa, F; Gonzalez-Junca, A; Meffre, D; Barrecheguren, PJ; Martinez-Marmol, R; Pazos, I; Olive, N; Cotrufo, T; Seoane, J; Soriano, E				Ulloa, Fausto; Gonzalez-Junca, Alba; Meffre, Delphine; Barrecheguren, Pablo Jose; Martinez-Marmol, Ramon; Pazos, Irene; Olive, Nuria; Cotrufo, Tiziana; Seoane, Joan; Soriano, Eduardo			Blockade of the SNARE Protein Syntaxin 1 Inhibits Glioblastoma Tumor Growth	PLOS ONE			English	Article							EXOCYTOSIS; EXPRESSION; GLIOMA; CHEMOATTRACTION; SIGNATURE; CARCINOMA; NEURONS	Glioblastoma (GBM) is the most prevalent adult brain tumor, with virtually no cure, and with a median overall survival of 15 months from diagnosis despite of the treatment. SNARE proteins mediate membrane fusion events in cells and are essential for many cellular processes including exocytosis and neurotransmission, intracellular trafficking and cell migration. Here we show that the blockade of the SNARE protein Syntaxin 1 (Stx1) function impairs GBM cell proliferation. We show that Stx1 loss-of-function in GBM cells, through ShRNA lentiviral transduction, a Stx1 dominant negative and botulinum toxins, dramatically reduces the growth of GBM after grafting U373 cells into the brain of immune compromised mice. Interestingly, Stx1 role on GBM progression may not be restricted just to cell proliferation since the blockade of Stx1 also reduces in vitro GBM cell invasiveness suggesting a role in several processes relevant for tumor progression. Altogether, our findings indicate that the blockade of SNARE proteins may represent a novel therapeutic tool against GBM.	[Ulloa, Fausto; Meffre, Delphine; Barrecheguren, Pablo Jose; Martinez-Marmol, Ramon; Pazos, Irene; Olive, Nuria; Cotrufo, Tiziana; Soriano, Eduardo] Univ Barcelona, Dept Cell Biol, E-08028 Barcelona, Spain; [Ulloa, Fausto; Martinez-Marmol, Ramon; Cotrufo, Tiziana; Soriano, Eduardo] ISCIII, CIBERNED, Madrid 28031, Spain; [Gonzalez-Junca, Alba; Seoane, Joan] Vall dHebron Univ Hosp, VHIO, Translat Res Program, Barcelona, Spain; [Gonzalez-Junca, Alba; Seoane, Joan] Univ Autonoma Barcelona, Cerdanyola Del Valles 08193, Spain; [Barrecheguren, Pablo Jose] IRB, Cell & Dev Biol Program, Barcelona 08028, Spain; [Soriano, Eduardo] VHIR, Barcelona 08035, Spain; [Seoane, Joan; Soriano, Eduardo] ICREA, Barcelona 08010, Spain	University of Barcelona; CIBERNED; Instituto de Salud Carlos III; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut d'Oncologia (VHIO); Autonomous University of Barcelona; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); ICREA	Ulloa, F (corresponding author), Univ Barcelona, Dept Cell Biol, Parc Cientific Barcelona, E-08028 Barcelona, Spain.	fausto.ulloa@ub.edu	Seoane, Joan/AAG-9173-2019; Martínez-Mármol, Ramón/D-2821-2018; Ulloa, Fausto/AAB-2787-2019; Soriano, Eduardo/AAB-3216-2019; Cotrufo, Tiziana/H-8784-2015	Seoane, Joan/0000-0002-6541-5974; Martínez-Mármol, Ramón/0000-0003-0929-8627; Soriano, Eduardo/0000-0002-3204-9285; MEFFRE, Delphine/0000-0002-9204-2245; Cotrufo, Tiziana/0000-0002-1671-3051	Ministerio de Economia y Competitividad (MINECO) [BFU2010-21507, SAF2013-42445-R, BFU2008-3870]; Instituto de Salud Carlos III (ISCIII) [FIS PI13/02661]; Asociacion Espanola Contra el Cancer (AECC); Fundacion Steiner; ICREA Funding Source: Custom	Ministerio de Economia y Competitividad (MINECO); Instituto de Salud Carlos III (ISCIII)(Instituto de Salud Carlos IIIEuropean Commission); Asociacion Espanola Contra el Cancer (AECC); Fundacion Steiner; ICREA(ICREA)	FU was supported by: BFU2010-21507 (Ministerio de Economia y Competitividad (MINECO)) (www.mineco.gob.es). ES was supported by: SAF2013-42445-R (Ministerio de Economia y Competitividad (MINECO)) (www.mineco.gob.es); BFU2008-3870 (Ministerio de Economia y Competitividad (MINECO)) (www.mineco.gob.es). JS was supported by: FIS PI13/02661 (Instituto de Salud Carlos III (ISCIII)) (www.isciii.es); Asociacion Espanola Contra el Cancer (AECC) (www.aecc.es); and Fundacion Steiner. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anido J, 2010, CANCER CELL, V18, P655, DOI 10.1016/j.ccr.2010.10.023; Binz T, 2013, CURR TOP MICROBIOL, V364, P139, DOI 10.1007/978-3-642-33570-9_7; BLASI J, 1993, EMBO J, V12, P4821, DOI 10.1002/j.1460-2075.1993.tb06171.x; Cotrufo T, 2012, EUR J NEUROSCI, V36, P3152, DOI 10.1111/j.1460-9568.2012.08259.x; Cotrufo T, 2011, J NEUROSCI, V31, P14463, DOI 10.1523/JNEUROSCI.3018-11.2011; Friedl P, 2011, CELL, V147, P992, DOI 10.1016/j.cell.2011.11.016; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Grabowski P, 2002, VIRCHOWS ARCH, V441, P256, DOI 10.1007/s00428-002-0650-9; Graff L, 2001, CANCER RES, V61, P2138; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Jahn R, 2012, NATURE, V490, P201, DOI 10.1038/nature11320; Jankovic J, 2009, BOTULINUM TOXIN THER; Kasai H, 2012, PHYSIOL REV, V92, P1915, DOI 10.1152/physrev.00007.2012; Kean MJ, 2009, J CELL SCI, V122, P4089, DOI 10.1242/jcs.052761; Low SH, 2003, DEV CELL, V4, P753, DOI 10.1016/S1534-5807(03)00122-9; Neto H, 2013, MOL BIOL CELL, V24, P3663, DOI 10.1091/mbc.E13-06-0302; OConnor V, 1997, P NATL ACAD SCI USA, V94, P12186, DOI 10.1073/pnas.94.22.12186; RuizMontasell B, 1996, EUR J NEUROSCI, V8, P2544, DOI 10.1111/j.1460-9568.1996.tb01548.x; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Tojima T, 2007, NAT NEUROSCI, V10, P58, DOI 10.1038/nn1814; Vezdrevanis K, 2011, UROL J, V8, P239; Volknandt W, 2002, CELL MOL NEUROBIOL, V22, P153, DOI 10.1023/A:1019809704322; Wang Y, 2006, MOL MEMBR BIOL, V23, P377, DOI 10.1080/09687860600776734; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Zhao CM, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009569; Zylbersztejn K, 2011, FEBS J, V278, P4497, DOI 10.1111/j.1742-4658.2011.08168.x	26	22	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0119707	10.1371/journal.pone.0119707	http://dx.doi.org/10.1371/journal.pone.0119707			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803850	Green Published, Green Submitted, gold			2022-12-26	WOS:000353889600040
J	Zhao, S; Yao, DS; Chen, JY; Ding, N; Ren, F				Zhao, Shan; Yao, Desheng; Chen, Junying; Ding, Nan; Ren, Fei			MiR-20a Promotes Cervical Cancer Proliferation and Metastasis In Vitro and In Vivo	PLOS ONE			English	Article							MICRORNA; GENE	MicroRNAs (miRNAs) are small, non-coding RNAs that are critical regulators of various diseases. MicroRNA-20a (miR-20a) has previously significantly altered in a range of cancers. In this study, we detected the relationship between miR-20a and the development of cervical cancer by qRT-PCR, we found that the expression level of miR-20a was significantly higher in cervical cancer patients than in normal controls, the aberrant expression of miR-20a was correlated with lymph node metastasis, histological grade and tumor diameter. Then we successfully established the stable anti-miR-20a cervical cancer cell lines by lentivirus. Inhibited miR-20a prevented tumor progression by modulating cell cycle, apoptosis, and metastasis in vitro and in vivo. TIMP2 and ATG7 were proved to be direct targets of miR-20a, using luciferase assay and western blot. These results indicate that miR-20a suppresses the proliferation, migration and invasion of cervical cancer cell through targeting ATG7 and TIMP2. Our results support the involvement of miR-20a in cervical tumorigenesis, especially lymph node metastasis. We propose that miRNAs might be used as therapeutic agent for cervical cancer.	[Zhao, Shan; Yao, Desheng; Chen, Junying; Ding, Nan; Ren, Fei] Guangxi Med Univ, Affiliated Tumor Hosp, Dept Gynecol Oncol, Nanning, Peoples R China; [Zhao, Shan] Shandong Univ, Qianfoshan Hosp, Dept Gynecol, Jinan 250100, Peoples R China	Guangxi Medical University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University	Yao, DS (corresponding author), Guangxi Med Univ, Affiliated Tumor Hosp, Dept Gynecol Oncol, Nanning, Peoples R China.	yaodesheng2012@163.com			Guangxi Natural Science Foundation [2011GXNSFA018184, 2013GXNSFBA019132]; National Natural Science Foundation of China [81460398]; Guangxi Health Department [Z2013018]	Guangxi Natural Science Foundation(National Natural Science Foundation of Guangxi Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangxi Health Department	This work was supported by Guangxi Natural Science Foundation (No. 2011GXNSFA018184 and 2013GXNSFBA019132), National Natural Science Foundation of China (No. 81460398), and supported by Guangxi Health Department (No. Z2013018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chang YX, 2013, J HEPATOL, V59, P518, DOI 10.1016/j.jhep.2013.04.034; Davies KJ, 2014, INT J BREAST CANCER, V2014, DOI 10.1155/2014/839094; Galluzzi L, 2012, CELL DEATH DIFFER, V19, P107, DOI 10.1038/cdd.2011.96; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Ili CG, 2011, J MED VIROL, V83, P833, DOI 10.1002/jmv.22057; Inami Y, 2011, J CELL BIOL, V193, P275, DOI 10.1083/jcb.201102031; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Ota A, 2004, CANCER RES, V64, P3087, DOI 10.1158/0008-5472.CAN-03-3773; Tanzer A, 2004, J MOL BIOL, V339, P327, DOI 10.1016/j.jmb.2004.03.065; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Weidberg H, 2011, ANNU REV BIOCHEM, V80, P125, DOI 10.1146/annurev-biochem-052709-094552; Wen SY, 2015, ONCOGENE, P34717; Yonekawa T, 2013, ESSAYS BIOCHEM, V55, P105, DOI [10.1042/BSE0550105, 10.1042/bse0550105]; Zhang JX, 2013, LANCET ONCOL, V14, P1295, DOI 10.1016/S1470-2045(13)70491-1; Zhang J, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-155; Zhao Y, 2007, TRENDS BIOCHEM SCI, V32, P189, DOI 10.1016/j.tibs.2007.02.006	16	73	77	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0120905	10.1371/journal.pone.0120905	http://dx.doi.org/10.1371/journal.pone.0120905			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803820	gold, Green Submitted, Green Published			2022-12-26	WOS:000353889600109
J	Gaillard, C; Strauss, F				Gaillard, Claire; Strauss, Francois			Construction of DNA Hemicatenanes from Two Small Circular DNA Molecules	PLOS ONE			English	Article							SINGLE-STRANDED-DNA; HOLLIDAY-JUNCTION; SV40 DNA; REPLICATION; COMPLEMENTARY; CATENANES; PROTEIN; GENOME; FORM; MINICHROMOSOMES	DNA hemicatenanes, one of the simplest possible junctions between two double stranded DNA molecules, have frequently been mentioned in the literature for their possible function in DNA replication, recombination, repair, and organization in chromosomes. They have been little studied experimentally, however, due to the lack of an appropriate method for their preparation. Here we have designed a method to build hemicatenanes from two small circular DNA molecules. The method involves, first, the assembly of two linear single strands and their circularization to form a catenane of two single stranded circles, and, second, the addition and base-pairing of the two single stranded circles complementary to the first ones, followed by their annealing using DNA topoisomerase I. The product was purified by gel electrophoresis and characterized. The arrangement of strands was as expected for a hemicatenane and clearly distinct from a full catenane. In addition, each circle was unwound by an average of half a double helical turn, also in excellent agreement with the structure of a hemicatenane. It was also observed that hemicatenanes are quickly destabilized by a single cut on either of the two strands passing inside the junction, strongly suggesting that DNA strands are able to slide easily inside the hemicatenane. This method should make it possible to study the biochemical properties of hemicatenanes and to test some of the hypotheses that have been proposed about their function, including a possible role for this structure in the organization of complex genomes in loops and chromosomal domains.	[Gaillard, Claire; Strauss, Francois] Museum Natl Hist Nat, F-75231 Paris, France	Museum National d'Histoire Naturelle (MNHN)	Strauss, F (corresponding author), Museum Natl Hist Nat, F-75231 Paris, France.	strauss@mnhn.fr		Strauss, Francois/0000-0003-4327-6827				Bocquet N, 2014, NAT STRUCT MOL BIOL, V21, P261, DOI 10.1038/nsmb.2775; BOREK D, 2008, NATURE PRECEDINGS; Bucka A, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.6.e24; Cejka P, 2012, MOL CELL, V47, P886, DOI 10.1016/j.molcel.2012.06.032; CHAMPOUX JJ, 1977, P NATL ACAD SCI USA, V74, P5328, DOI 10.1073/pnas.74.12.5328; Chen SH, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1343; Cheok CF, 2005, BIOCHEM SOC T, V33, P1456, DOI 10.1042/BST0331456; COLS P, 1988, RADIAT ENVIRON BIOPH, V27, P261, DOI 10.1007/BF01209755; GAILLARD C, 1990, NUCLEIC ACIDS RES, V18, P378, DOI 10.1093/nar/18.2.378; Gaillard Claire, 2000, BMC Biochemistry, V1, P1; Gaillard C, 2006, J THEOR BIOL, V243, P604, DOI 10.1016/j.jtbi.2006.07.001; HAGERMAN PJ, 1988, ANNU REV BIOPHYS BIO, V17, P265; Hartung F, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000285; Jaouen S, 2005, J MOL BIOL, V353, P822, DOI 10.1016/j.jmb.2005.08.073; Khuu PA, 2006, J MOL RECOGNIT, V19, P234, DOI 10.1002/jmr.765; KIRKEGAARD K, 1978, NUCLEIC ACIDS RES, V5, P3811, DOI 10.1093/nar/5.10.3811; Laurie B, 1998, BIOPHYS J, V74, P2815, DOI 10.1016/S0006-3495(98)77988-3; Lee JY, 2007, PLOS BIOL, V5, P1334, DOI 10.1371/journal.pbio.0050160; Lee SH, 2013, P NATL ACAD SCI USA, V110, pE3587, DOI 10.1073/pnas.1304103110; LIU LF, 1976, J MOL BIOL, V106, P439, DOI 10.1016/0022-2836(76)90095-4; Lucas I, 2000, NUCLEIC ACIDS RES, V28, P2187, DOI 10.1093/nar/28.10.2187; Manthei KA, 2013, CELL MOL LIFE SCI, V70, P4067, DOI 10.1007/s00018-013-1325-1; PANYUTIN IG, 1994, P NATL ACAD SCI USA, V91, P2021, DOI 10.1073/pnas.91.6.2021; Plank JL, 2006, J BIOL CHEM, V281, P17510, DOI 10.1074/jbc.M602933200; POUWELS PH, 1968, J MOL BIOL, V32, P169, DOI 10.1016/0022-2836(68)90002-8; Prunell A, 1999, METH MOL B, V119, P79; Seeman NC, 2010, ANNU REV BIOCHEM, V79, P65, DOI 10.1146/annurev-biochem-060308-102244; SHURE M, 1976, CELL, V8, P215, DOI 10.1016/0092-8674(76)90005-2; SOGO JM, 1986, J MOL BIOL, V189, P189, DOI 10.1016/0022-2836(86)90390-6; STETTLER UH, 1979, J MOL BIOL, V131, P21, DOI 10.1016/0022-2836(79)90299-7; SUNDIN O, 1980, CELL, V21, P103, DOI 10.1016/0092-8674(80)90118-X; Wellinger RE, 2003, MOL CELL BIOL, V23, P6363, DOI 10.1128/MCB.23.18.6363-6372.2003; WHITE JH, 1984, P NATL ACAD SCI-BIOL, V81, P3322, DOI 10.1073/pnas.81.11.3322	33	6	6	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0119368	10.1371/journal.pone.0119368	http://dx.doi.org/10.1371/journal.pone.0119368			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799010	Green Submitted, Green Published, gold			2022-12-26	WOS:000351987300045
J	Gupta, KK; Donahue, DL; Sandoval-Cooper, MJ; Castellino, FJ; Ploplis, VA				Gupta, Kamlesh K.; Donahue, Deborah L.; Sandoval-Cooper, Mayra J.; Castellino, Francis J.; Ploplis, Victoria A.			Abrogation of Plasminogen Activator Inhibitor-1-Vitronectin Interaction Ameliorates Acute Kidney Injury in Murine Endotoxemia	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; GENE DEFICIENT MICE; ACUTE-RENAL-FAILURE; PROTEIN-C; INHIBITOR TYPE-1; SEPSIS; LIPOPOLYSACCHARIDE; MECHANISMS; FIBRINOLYSIS; PAI-1	Sepsis-induced acute kidney injury (AKI) contributes to the high mortality and morbidity in patients. Although the pathogenesis of AKI during sepsis is poorly understood, it is well accepted that plasminogen activator inhibitor-1 (PAI-1) and vitronectin (Vn) are involved in AKI. However, the functional cooperation between PAI-1 and Vn in septic AKI has not been completely elucidated. To address this issue, mice were utilized lacking either PAI-1 (PAI-1(-/-)) or expressing a PAI-1-mutant (PAI-1(R101A/Q123K)) in which the interaction between PAI-1 and Vn is abrogated, while other functions of PAI-1 are retained. It was found that both PAI-1(-/-) and PAI-1(R101A/Q123K) mice are associated with decreased renal dysfunction, apoptosis, inflammation, and ERK activation as compared to wild-type (WT) mice after LPS challenge. Also, PAI-1(-/-)mice showed attenuated fibrin deposition in the kidneys. Furthermore, a lack of PAI-1 or PAI-1-Vn interaction was found to be associated with an increase in activated Protein C (aPC) in plasma. These results demonstrate that PAI-1, through its interaction with Vn, exerts multiple deleterious mechanisms to induce AKI. Therefore, targeting of the PAI-1-Vn interaction in kidney represents an appealing therapeutic strategy for the treatment of septic AKI by not only altering the fibrinolytic capacity but also regulating PC activity.	[Gupta, Kamlesh K.; Donahue, Deborah L.; Sandoval-Cooper, Mayra J.; Castellino, Francis J.; Ploplis, Victoria A.] Univ Notre Dame, WM Keck Ctr Transgene Res, Notre Dame, IN 46556 USA; [Castellino, Francis J.; Ploplis, Victoria A.] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA	University of Notre Dame; University of Notre Dame	Ploplis, VA (corresponding author), Univ Notre Dame, WM Keck Ctr Transgene Res, Notre Dame, IN 46556 USA.	vploplis@nd.edu			National Institutes of Health (National Heart Lung Blood Institute) [HL13423]; American Heart Association [12GRNT12070118]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL013423, R01HL013423] Funding Source: NIH RePORTER	National Institutes of Health (National Heart Lung Blood Institute)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health (National Heart Lung Blood Institute) grant # HL13423 (FJC), www.nih.gov; American Heart Association grant# 12GRNT12070118 (VAP), www.heart.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akcay A, 2009, MEDIAT INFLAMM, V2009, DOI 10.1155/2009/137072; CARMELIET P, 1993, J CLIN INVEST, V92, P2756, DOI 10.1172/JCI116893; CARMELIET P, 1993, J CLIN INVEST, V92, P2746, DOI 10.1172/JCI116892; Cunningham PN, 2002, J IMMUNOL, V168, P5817, DOI 10.4049/jimmunol.168.11.5817; Dellas C, 2005, THROMB HAEMOSTASIS, V93, P631, DOI 10.1160/TH05-01-0033; Eadon MT, 2012, AM J PHYSIOL-RENAL, V303, pF821, DOI 10.1152/ajprenal.00023.2012; Eddy AA, 2002, AM J PHYSIOL-RENAL, V283, pF209, DOI 10.1152/ajprenal.00032.2002; Eddy AA, 2006, J AM SOC NEPHROL, V17, P2999, DOI 10.1681/ASN.2006050503; Feliers Denis, 2011, J Signal Transduct, V2011, P768512, DOI 10.1155/2011/768512; FOUQUERAY B, 1993, J AM SOC NEPHROL, V3, P1783; Gando S, 2013, SEMIN THROMB HEMOST, V39, P392, DOI 10.1055/s-0033-1334140; Ghosh AK, 2012, J CELL PHYSIOL, V227, P493, DOI 10.1002/jcp.22783; GRINNELL BW, 1991, J BIOL CHEM, V266, P9778; Gupta A, 2009, FORM METHOD SYST DES, V35, P1, DOI 10.1007/s10703-009-0072-2; Gupta A, 2009, J AM SOC NEPHROL, V20, P267, DOI 10.1681/ASN.2008030294; Hertig A, 2004, J AM SOC NEPHROL, V15, P844, DOI 10.1097/01.ASN.0000115400.52705.83; HILLEGASS LM, 1990, J PHARMACOL METHOD, V24, P285, DOI 10.1016/0160-5402(90)90013-B; Huang YF, 2003, J CLIN INVEST, V112, P379, DOI 10.1172/JCI200318038; Huang YF, 2009, AM J PHYSIOL-RENAL, V297, pF1045, DOI 10.1152/ajprenal.00024.2009; Inoue KI, 2005, MOL PHARMACOL, V67, P673, DOI 10.1124/mol.104.005967; JEVNIKAR AM, 1991, KIDNEY INT, V40, P203, DOI 10.1038/ki.1991.201; KANG YH, 1995, SHOCK, V4, P441; KITA T, 1993, INT J EXP PATHOL, V74, P471; Kitching AR, 2003, J AM SOC NEPHROL, V14, P1487, DOI 10.1097/01.ASN.0000065550.13931.00; Kockara A, 2013, RENAL FAILURE, V35, P291, DOI 10.3109/0886022X.2012.744040; Komissarov AA, 2008, THROMB RES, V122, P397, DOI 10.1016/j.thromres.2007.10.012; Krisinger MJ, 2009, FEBS J, V276, P6586, DOI 10.1111/j.1742-4658.2009.07371.x; Lafrance JP, 2010, J AM SOC NEPHROL, V21, P345, DOI 10.1681/ASN.2009060636; Lay AJ, 2007, BLOOD, V109, P1984, DOI 10.1182/blood-2006-07-037945; Madoiwa S, 2006, INT J HEMATOL, V84, P398, DOI 10.1532/IJH97.05190; Majumdar A, 2010, INDIAN J CRIT CARE M, V14, P14, DOI 10.4103/0972-5229.63031; Matsuno N, 2001, THER APHER, V5, P36, DOI 10.1046/j.1526-0968.2001.005001036.x; Mesnard L, 2011, FASEB J, V25, P3543, DOI 10.1096/fj.11-180752; Montes R, 2000, THROMB HAEMOSTASIS, V84, P65, DOI 10.1055/s-0037-1613969; Narasaki R, 2012, J THROMB HAEMOST, V10, P2618, DOI 10.1111/jth.12032; Nimah M, 2003, CRIT CARE CLIN, V19, P441, DOI 10.1016/S0749-0704(03)00008-3; Pernerstorfer T, 1999, CIRCULATION, V100, P2485, DOI 10.1161/01.CIR.100.25.2485; PRALONG G, 1989, THROMB HAEMOSTASIS, V61, P459; Rerolle JP, 2000, KIDNEY INT, V58, P1841, DOI 10.1046/j.1523-1755.2000.00355.x; Rezaie AR, 2001, J BIOL CHEM, V276, P15567, DOI 10.1074/jbc.C100123200; Rittirsch D, 2008, NAT REV IMMUNOL, V8, P776, DOI 10.1038/nri2402; SAKATA Y, 1985, P NATL ACAD SCI USA, V82, P1121, DOI 10.1073/pnas.82.4.1121; SAWDEY MS, 1991, J CLIN INVEST, V88, P1346, DOI 10.1172/JCI115440; Schrier RW, 2004, NEW ENGL J MED, V351, P159, DOI 10.1056/NEJMra032401; Sevastos J, 2007, BLOOD, V109, P577, DOI 10.1182/blood-2006-03-008870; Shorr AF, 2006, CRIT CARE, V10, DOI 10.1186/cc4946; Song DM, 2009, BLOOD, V114, P2521, DOI 10.1182/blood-2009-02-205914; Song S, 2009, NEPHROL DIAL TRANSPL, V24, P1157, DOI 10.1093/ndt/gfn626; Takahashi K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030134; Tani T, 2001, WORLD J SURG, V25, P660, DOI 10.1007/s002680020028; Wang YP, 2013, CLIN VACCINE IMMUNOL, V20, P1008, DOI 10.1128/CVI.00674-12; Watts BA, 2013, AM J PHYSIOL-RENAL, V304, pF863, DOI 10.1152/ajprenal.00608.2012; Wu XY, 2007, AM J PHYSIOL-RENAL, V293, pF1262, DOI 10.1152/ajprenal.00445.2006; Yamamoto K, 2002, AM J PATHOL, V161, P1805, DOI 10.1016/S0002-9440(10)64457-4; Zarjou A, 2011, J AM SOC NEPHROL, V22, P999, DOI 10.1681/ASN.2010050484; Zhang DS, 2013, J PHARMACOL EXP THER, V345, P69, DOI 10.1124/jpet.112.202481; Zhou AW, 2003, NAT STRUCT BIOL, V10, P541, DOI 10.1038/nsb943	57	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120728	10.1371/journal.pone.0120728	http://dx.doi.org/10.1371/journal.pone.0120728			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799354	Green Submitted, gold, Green Published			2022-12-26	WOS:000351987300168
J	Hegde, S; Rosengarten, R; Chopra-Dewasthaly, R				Hegde, Shivanand; Rosengarten, Renate; Chopra-Dewasthaly, Rohini			Disruption of the pdhB Pyruvate Dehyrogenase Gene Affects Colony Morphology, In Vitro Growth and Cell Invasiveness of Mycoplasma agalactiae	PLOS ONE			English	Article							HOST-PATHOGEN INTERACTIONS; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; HOMOLOGOUS RECOMBINATION; BINDING PROTEINS; ALPHA-ENOLASE; GALLISEPTICUM; MUTANTS; VIRULENCE; INVASION; PLASMID	The utilization of available substrates, the metabolic potential and the growth rates of bacteria can play significant roles in their pathogenicity. This study concentrates on Mycoplasma agalactiae, which causes significant economic losses through its contribution to contagious agalactia in small ruminants by as yet unknown mechanisms. This lack of knowledge is primarily due to its fastidious growth requirements and the scarcity of genetic tools available for its manipulation and analysis. Transposon mutagenesis of M. agalactiae type strain PG2 resulted in several disruptions throughout the genome. A mutant defective in growth in vitro was found to have a transposon insertion in the pdhB gene, which encodes a component of the pyruvate dehydrogenase complex. This growth difference was quite significant during the actively dividing logarithmic phase but a gradual recovery was observed as the cells approached stationary phase. The mutant also exhibited a different and smaller colony morphology compared to the wild type strain PG2. For complementation, pdhAB was cloned downstream of a strong vpma promoter and upstream of a lacZ reporter gene in a newly constructed complementation vector. When transformed with this vector the pdhBmutant recovered its normal growth and colony morphology. Interestingly, the pdhB mutant also had significantly reduced invasiveness in HeLa cells, as revealed by double immunofluorescence staining. This deficiency was recovered in the complemented strain, which had invasiveness comparable to that of PG2. Taken together, these data indicate that pyruvate dehydrogenase might be an important player in infection with and colonization by M. agalactiae.	[Hegde, Shivanand; Rosengarten, Renate; Chopra-Dewasthaly, Rohini] Univ Vet Med Vienna, Div Clin Microbiol & Infect Biol, Dept Pathobiol, Inst Bacteriol Mycol & Hyg, Vienna, Austria	University of Veterinary Medicine Vienna	Chopra-Dewasthaly, R (corresponding author), Univ Vet Med Vienna, Inst Microbiol, Dept Pathobiol, Vienna, Austria.	Rohini.Chopra-Dewasthaly@vetmeduni.ac.at	chopra-dewasthaly, rohini/GNH-3258-2022; Hegde, Shivanand/L-4999-2019	hegde, shivanand/0000-0001-7249-6795	Austrian Science Fund (FWF) [P21796-20]; Austrian Science Fund (FWF) [P 21796] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by grant P21796-20 (to RCD, Joachim Spergser and RR) of the Austrian Science Fund (FWF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez RA, 2003, MOL MICROBIOL, V48, P1417, DOI 10.1046/j.1365-2958.2003.03518.x; Casadevall A, 1999, INFECT IMMUN, V67, P3703, DOI 10.1128/IAI.67.8.3703-3713.1999; Chambaud I, 1999, TRENDS MICROBIOL, V7, P493, DOI 10.1016/S0966-842X(99)01641-8; Chang J, 2008, FEMS IMMUNOL MED MIC, V53, P26, DOI 10.1111/j.1574-695X.2008.00394.x; Chen HJ, 2011, MICROB PATHOGENESIS, V51, P285, DOI 10.1016/j.micpath.2011.03.012; Chopra-Dewasthaly R, 2005, FEMS MICROBIOL LETT, V253, P89, DOI 10.1016/j.femsle.2005.09.021; Chopra-Dewasthaly R, 2005, INT J MED MICROBIOL, V294, P447, DOI 10.1016/j.ijmm.2004.09.010; Chopra-Dewasthaly R, 2008, MOL MICROBIOL, V67, P1196, DOI 10.1111/j.1365-2958.2007.06103.x; Chopra-Dewasthaly R, 2012, FEMS IMMUNOL MED MIC, V66, P307, DOI 10.1111/j.1574-695X.2012.01010.x; Cieri MV, 2002, INFECT IMMUN, V70, P1081, DOI 10.1128/IAI.70.3.1081-1086.2002; Corrales JC, 2007, SMALL RUMINANT RES, V68, P154, DOI 10.1016/j.smallrumres.2006.09.010; Czurda S, 2010, J BACTERIOL, V192, P4462, DOI 10.1128/JB.01537-09; Dallo SF, 2002, MOL MICROBIOL, V46, P1041, DOI 10.1046/j.1365-2958.2002.03207.x; DAMASSA AJ, 1992, J VET DIAGN INVEST, V4, P101, DOI 10.1177/104063879200400126; Dumke R, 2011, MICROBIOL-SGM, V157, P2328, DOI 10.1099/mic.0.048298-0; Dybvig K, 2007, J BACTERIOL, V189, P2197, DOI 10.1128/JB.01669-06; Fleury B, 2002, INFECT IMMUN, V70, P5612, DOI 10.1128/IAI.70.10.5612-5621.2002; Glew MD, 2000, INFECT IMMUN, V68, P4539, DOI 10.1128/IAI.68.8.4539-4548.2000; Halbedel S, 2007, INT J MED MICROBIOL, V297, P37, DOI 10.1016/j.ijmm.2006.11.001; Hasselbring BA, 2006, J BACTERIOL, V188, P6335, DOI 10.1128/JB.00698-06; Hegde S, 2011, INT J MED MICROBIOL, V301, P87; Hegde S, 2014, INT J MED MICROBIOL, V304, P1024, DOI 10.1016/j.ijmm.2014.07.011; KNUDTSON KL, 1993, GENE, V137, P217, DOI 10.1016/0378-1119(93)90009-R; Lee SW, 2008, MICROBIOL-SGM, V154, P2571, DOI 10.1099/mic.0.2008/019208-0; Li JH, 2015, J MICROBIOL METH, V108, P12, DOI 10.1016/j.mimet.2014.11.005; Maglennon GA, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-63; McAuliffe L, 2006, MICROBIOL-SGM, V152, P913, DOI 10.1099/mic.0.28604-0; MELONI GA, 1980, J GEN MICROBIOL, V116, P435; MILES RJ, 1988, LETT APPL MICROBIOL, V7, P149, DOI 10.1111/j.1472-765X.1988.tb01266.x; Much P, 2002, FEMS IMMUNOL MED MIC, V34, P181, DOI 10.1111/j.1574-695X.2002.tb00622.x; Mudahi-Orenstein S, 2003, INFECT IMMUN, V71, P3812, DOI 10.1128/IAI.71.7.3812-3820.2003; Pang E, 2011, FEMS IMMUNOL MED MIC, V63, P108, DOI 10.1111/j.1574-695X.2011.00834.x; Peterson SN, 2001, GENOME BIOL, V2; Pilo P, 2005, J BACTERIOL, V187, P6824, DOI 10.1128/JB.187.19.6824-6831.2005; Pollack JD, 1997, CRIT REV MICROBIOL, V23, P269, DOI 10.3109/10408419709115140; Razin S, 1998, MICROBIOL MOL BIOL R, V62, P1094, DOI 10.1128/MMBR.62.4.1094-1156.1998; Rohmer L, 2011, TRENDS MICROBIOL, V19, P341, DOI 10.1016/j.tim.2011.04.003; Rosengarten R, 2000, INT J MED MICROBIOL, V290, P15; Sambrook J., 2001, MOL CLONING LAB MANU; Schreiner SA, 2012, VET MICROBIOL, V156, P88, DOI 10.1016/j.vetmic.2011.10.010; Sharma VM, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.17.e86; Sirand-Pugnet P, 2007, PLOS GENET, V3, P744, DOI 10.1371/journal.pgen.0030075; Skapski A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025291; Solsona M, 1996, VET MICROBIOL, V50, P45, DOI 10.1016/0378-1135(95)00200-6; Song ZQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038836; Sun ZH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088328; Thomas C, 2013, MICROBIOL-SGM, V159, P352, DOI 10.1099/mic.0.061184-0; WEISBURG WG, 1989, J BACTERIOL, V171, P6455, DOI 10.1128/jb.171.12.6455-6467.1989; Winner F, 2000, INFECT IMMUN, V68, P4238, DOI 10.1128/IAI.68.7.4238-4244.2000	49	10	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0119706	10.1371/journal.pone.0119706	http://dx.doi.org/10.1371/journal.pone.0119706			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799063	gold, Green Published			2022-12-26	WOS:000351987300076
J	Li, LP; Wu, XC				Li, Liping; Wu, Xinchun			Effects of Metalinguistic Awareness on Reading Comprehension and the Mediator Role of Reading Fluency from Grades 2 to 4	PLOS ONE			English	Article							MORPHOLOGICAL AWARENESS; PHONOLOGICAL AWARENESS; WORD IDENTIFICATION; CHARACTER; SKILLS; RECOGNITION; MODEL; INSTRUCTION; ACQUISITION; VOCABULARY	Purpose This study examined the contribution of metalinguistic awareness including morphological awareness, phonological awareness and orthographical awareness to reading comprehension, and the role of reading fluency as a mediator of the effects of metalinguistic awareness on reading comprehension from grades 2 to 4. Methods Four hundred and fifteen elementary students in China mainland were administered a test battery that included measures of morphological awareness, phonological awareness, orthographical awareness, reading fluency, reading comprehension and IQ. Hierarchical regression and structural equation models (SEM) were used to analyze the data. Results Morphological awareness uniquely explained 9%, 10% and 13% variance of reading comprehension respectively from grade 2 to grade 4, however, phonological awareness and orthographical awareness did not contribute to reading comprehension; Reading fluency partially mediated the effect of morphological awareness on reading comprehension in grades 2-4. Conclusions These findings indicated that reading fluency and morphological awareness should be facilitated in the Chinese instruction. Morphological awareness played an important role in Chinese reading and affected reading comprehension in grades 2 to 4; Reading fluency was a significant link between morphological awareness and reading comprehension in grades 2-4.	[Li, Liping; Wu, Xinchun] Beijing Normal Univ, Sch Psychol, Beijing 100875, Peoples R China; [Li, Liping] Shanxi Normal Univ, Sch Teachers Educ, Linfen, Peoples R China	Beijing Normal University; Shanxi Normal University	Wu, XC (corresponding author), Beijing Normal Univ, Sch Psychol, Beijing 100875, Peoples R China.	xcwu@bnu.edu.cn			Plan Supporting the New Century Excellent Talents of the Ministry of Education of P.R.C [NCET-10-0246]; Major Project for Philosophy and Social Science Research of the Ministry of Education of P.R.C [11JZD041]	Plan Supporting the New Century Excellent Talents of the Ministry of Education of P.R.C(Program for New Century Excellent Talents in University (NCET)); Major Project for Philosophy and Social Science Research of the Ministry of Education of P.R.C	The present study was supported by a grant (NCET-10-0246) from the Plan Supporting the New Century Excellent Talents of the Ministry of Education of P.R.C. to the corresponding author and a grant (11JZD041) from the Major Project for Philosophy and Social Science Research of the Ministry of Education of P.R.C.	Adlof SM, 2006, READ WRIT, V19, P933, DOI 10.1007/s11145-006-9024-z; Ashby J, 2013, SCHOOL PSYCHOL REV, V42, P157; Bashir AS, 2009, LANG SPEECH HEAR SER, V40, P196, DOI 10.1044/0161-1461(2008/08-0074); Berends IE, 2006, APPL PSYCHOLINGUIST, V27, P247, DOI 10.1017/S0142716406060279; Berends IE, 2007, J RES READ, V30, P129, DOI 10.1111/j.1467-9817.2006.00324.x; Berninger VW, 2010, J PSYCHOLINGUIST RES, V39, P141, DOI 10.1007/s10936-009-9130-6; Berninger VW, 1991, LEARN INDIVID DIFFER, V3, P323, DOI DOI 10.1016/1041-6080(91)90019-W; Burke MD, 2009, REM SPEC EDUC, V30, P84, DOI 10.1177/0741932508315047; Cheung H, 2010, J EDUC PSYCHOL, V102, P367, DOI 10.1037/a0017850; Chung WL, 2007, READ WRIT, V20, P441, DOI 10.1007/s11145-006-9037-7; Cohen-Mimran R, 2009, J CHILD LANG, V36, P657, DOI 10.1017/S0305000908009148; Deacon SH, 2013, DEV PSYCHOL, V49, P1113, DOI 10.1037/a0029474; Ehri L. C., 1995, J RES READ, V18, P116, DOI [10.1111/j.14679817.1995.tb00077.x, DOI 10.1111/J.14679817.1995.TB00077.X, 10.1111/j.1467-9817.1995.tb00077.x, DOI 10.1111/J.1467-9817.1995.TB00077.X]; Eldredge JL, 2005, READ PSYCHOL, V26, P161, DOI 10.1080/02702710590930519; Erbeli F., 2012, CEPS J, V2, P119; FROST R, 1987, J EXP PSYCHOL HUMAN, V13, P104, DOI 10.1037/0096-1523.13.1.104; Fuchs L. S., 2001, IN ROLE FLUENCY READ, V5, P239, DOI [10.1207/S1532799XSSR0503_3, 10.1207/s1532799xssr0503_3]; Griffith LW, 2004, READ TEACH, V58, P126, DOI 10.1598/RT.58.2.1; Ho CSH, 2000, READ WRIT, V13, P57, DOI 10.1023/A:1008040922662; Holland J, 2004, J PSYCHOEDUC ASSESS, V22, P233, DOI 10.1177/073428290402200304; Hu LT, 1998, PSYCHOL METHODS, V3, P424, DOI 10.1037/1082-989X.3.4.424; Huang HS, 1997, INT J BEHAV DEV, V20, P249, DOI 10.1080/016502597385324; Hudson RF., 2009, READING WRITING Q, V25, P4, DOI [DOI 10.1080/10573560802491208, 10.1080/10573560802491208]; Katzir T, 2006, ANN DYSLEXIA, V56, P51, DOI 10.1007/s11881-006-0003-5; Kieffer MJ, 2013, APPL PSYCHOLINGUIST, V34, P697, DOI 10.1017/S0142716411000920; Kim YS, 2012, J EXP CHILD PSYCHOL, V113, P93, DOI 10.1016/j.jecp.2012.03.002; Kim YS, 2011, SCI STUD READ, V15, P338, DOI 10.1080/10888438.2010.493964; Kim YS, 2010, J EDUC PSYCHOL, V102, P652, DOI 10.1037/a0019643; Kuhn M., 2010, READ RES QUART, V45, P230, DOI [10.1598/RRQ.45.2.4, DOI 10.1598/RRQ.45.2.4]; Kuo LJ, 2006, EDUC PSYCHOL-US, V41, P161, DOI 10.1207/s15326985ep4103_3; LABERGE D, 1974, COGNITIVE PSYCHOL, V6, P293, DOI 10.1016/0010-0285(74)90015-2; Li H., 2006, PSYCHOL DEV ED, V22, P35, DOI [10. 16187/j.cnki.issn1001-4918.2006.01.007, DOI 10.16187/J.CNKI.ISSN1001-4918.2006.01.007]; Li H, 2012, J RES READ, V35, P287, DOI 10.1111/j.1467-9817.2010.01460.x; Liu PD, 2013, APPL PSYCHOLINGUIST, V34, P755, DOI 10.1017/S014271641200001X; Liu PD, 2010, APPL PSYCHOLINGUIST, V31, P605, DOI 10.1017/S0142716410000159; Liu PD, 2010, J EDUC PSYCHOL, V102, P62, DOI 10.1037/a0016933; McBride-Chang C, 2003, J EDUC PSYCHOL, V95, P743, DOI 10.1037/0022-0663.95.4.743; Packard JL, 2006, READ WRIT, V19, P457, DOI 10.1007/s11145-006-9003-4; Paterson KB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041766; Paterson KB, 2011, LANG COGNITIVE PROC, V26, P600, DOI 10.1080/01690965.2010.485392; Paterson KB, 2010, MEM COGNITION, V38, P502, DOI 10.3758/MC.38.4.502; Perfetti C, 2007, SCI STUD READ, V11, P357, DOI 10.1080/10888430701530730; Pikulski JJ, 2005, READ TEACH, V58, P510, DOI 10.1598/RT.58.6.2; Plaut DC, 1996, PSYCHOL REV, V103, P56, DOI 10.1037/0033-295X.103.1.56; Roth FP, 1996, J SPEC EDUC, V30, P257, DOI 10.1177/002246699603000303; Saiegh-Haddad E., 2005, READ WRIT, V18, P559, DOI [DOI 10.1007/S11145-005-3180-4, 10.1007/s11145-005-3180-4]; SEIDENBERG MS, 1989, PSYCHOL REV, V96, P523, DOI 10.1037/0033-295X.96.4.523; Shu H, 1997, READ RES QUART, V32, P78, DOI 10.1598/RRQ.32.1.5; Shu H, 2006, J EDUC PSYCHOL, V98, P122, DOI 10.1037/0022-0663.98.1.122; Siok WT, 2001, DEV PSYCHOL, V37, P886, DOI 10.1037//0012-1649.37.6.886; Swain K., 2013, READING IMPROVEMENT, V50, P12; Taub GE, 2012, J RES CHILD EDUC, V26, P359, DOI 10.1080/02568543.2012.712084; Tong XL, 2011, J EDUC PSYCHOL, V103, P523, DOI 10.1037/a0023495; Tong XL, 2010, DEV PSYCHOL, V46, P1662, DOI 10.1037/a0020611; Tong XL, 2009, SCI STUD READ, V13, P426, DOI 10.1080/10888430903162910; Vaessen A, 2010, J EDUC PSYCHOL, V102, P827, DOI 10.1037/a0019465; Wang M, 2006, J EDUC PSYCHOL, V98, P542, DOI 10.1037/0022-0663.98.3.542; Wang M, 2009, APPL PSYCHOLINGUIST, V30, P291, DOI 10.1017/S0142716409090122; Wolf M., 2001, SCIENT STUD READ, V5, P211, DOI DOI 10.1207/S1532799XSSR0503_2; Xue J, 2013, J PSYCHOLINGUIST RES, V42, P433, DOI 10.1007/s10936-012-9228-0; Yesil-Dagli U, 2011, EARLY CHILD RES Q, V26, P15, DOI 10.1016/j.ecresq.2010.06.001; Yeung PS, 2013, LEARN INDIVID DIFFER, V25, P55, DOI 10.1016/j.lindif.2013.03.004; Yeung PS, 2011, SCI STUD READ, V15, P285, DOI 10.1080/10888438.2010.482149; Zhang H., 1985, Chinese Journal of Animal Science (Zhongguo Xumu Zazhi), P1; Zhang J, 2012, READ WRIT, V25, P2183, DOI 10.1007/s11145-011-9353-4; Zipke M, 2009, READ RES QUART, V44, P300, DOI 10.1598/RRQ.44.3.4	66	24	29	8	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0114417	10.1371/journal.pone.0114417	http://dx.doi.org/10.1371/journal.pone.0114417			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE6ZS	25799530	Green Published, Green Submitted, gold			2022-12-26	WOS:000351987300001
J	Liu, M; Li, DQ; Qin, PJ; Liu, CR; Wang, HJ; Wang, FL				Liu, Meng; Li, Daqing; Qin, Pengju; Liu, Chaoran; Wang, Huijuan; Wang, Feilong			Epidemics in Interconnected Small-World Networks	PLOS ONE			English	Article							WEIGHT RANDOMIZATION; PERCOLATION	Networks can be used to describe the interconnections among individuals, which play an important role in the spread of disease. Although the small-world effect has been found to have a significant impact on epidemics in single networks, the small-world effect on epidemics in interconnected networks has rarely been considered. Here, we study the susceptible-infected-susceptible (SIS) model of epidemic spreading in a system comprising two interconnected small-world networks. We find that the epidemic threshold in such networks decreases when the rewiring probability of the component small-world networks increases. When the infection rate is low, the rewiring probability affects the global steady-state infection density, whereas when the infection rate is high, the infection density is insensitive to the rewiring probability. Moreover, epidemics in interconnected small-world networks are found to spread at different velocities that depend on the rewiring probability.	[Liu, Meng; Li, Daqing; Qin, Pengju; Liu, Chaoran; Wang, Feilong] Beihang Univ, Sch Reliabil & Syst Engn, Beijing 100191, Peoples R China; [Liu, Meng; Li, Daqing; Qin, Pengju; Liu, Chaoran; Wang, Feilong] Sci & Technol Reliabil & Environm Engn Lab, Beijing, Peoples R China; [Wang, Huijuan] Delft Univ Technol, Fac Elect Engn Math & Comp Sci, Delft, Netherlands	Beihang University; Delft University of Technology	Li, DQ (corresponding author), Beihang Univ, Sch Reliabil & Syst Engn, Beijing 100191, Peoples R China.	daqingl@buaa.edu.cn	wang, hui/GRS-4730-2022; wang, huimin/HDM-8421-2022		National Natural Science Foundation of China [61104144]; European Commission [FP7-ICT-2011-8-317672]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); European Commission(European CommissionEuropean Commission Joint Research Centre)	This work is supported by National Natural Science Foundation of China (Grant No. 61104144). Huijuan Wang is partially supported by the European Commission within the framework of the CONGAS project FP7-ICT-2011-8-317672. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Zuzek LG, 2014, ARXIV14121430; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Boccaletti S, 2014, PHYS REP, V544, P1, DOI 10.1016/j.physrep.2014.07.001; Buono C, 2014, ARXIV14123139; Buono C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092200; Cohen R., 2010, COMPLEX NETWORKS STR; Dickison M, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.066109; ERDOS P, 1960, B INT STATIST INST, V38, P343; Gomez S, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.028701; Jin Q, 2014, SCI REP-UK, V4, DOI 10.1038/srep04095; Li D, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.168701; Li DQ, 2007, EUR PHYS J B, V57, P423, DOI 10.1140/epjb/e2007-00189-0; Li DQ, 2014, EPL-EUROPHYS LETT, V105, DOI 10.1209/0295-5075/105/68004; Li DQ, 2011, NAT PHYS, V7, P481, DOI [10.1038/NPHYS1932, 10.1038/nphys1932]; Li DQ, 2011, EPL-EUROPHYS LETT, V93, DOI 10.1209/0295-5075/93/68004; Li MH, 2007, PHYS LETT A, V364, P488, DOI 10.1016/j.physleta.2006.12.040; Li W, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.228702; Liu C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097822; Moore C, 2000, PHYS REV E, V61, P5678, DOI 10.1103/PhysRevE.61.5678; Newman MEJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071321; Newman M.E.J., 2010, NETWORKS INTRO; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200; Saumell-Mendiola A, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.026106; Wang HJ, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.022801; Wang Y, 2012, PHYS LETT A, V376, P2689, DOI 10.1016/j.physleta.2012.07.037; Wang YB, 2009, PHYSICA A, V388, P2535, DOI 10.1016/j.physa.2009.02.036; Wang Z, 2013, SCI REP-UK, V3, DOI 10.1038/srep01183; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Zhao S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108000	30	17	17	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120701	10.1371/journal.pone.0120701	http://dx.doi.org/10.1371/journal.pone.0120701			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799143	Green Published, Green Submitted, gold			2022-12-26	WOS:000351987300166
J	Malisauskas, R; Botyriute, A; Cannon, JG; Smirnovas, V				Malisauskas, Ricardas; Botyriute, Akvile; Cannon, Jonathan G.; Smirnovas, Vytautas			Flavone Derivatives as Inhibitors of Insulin Amyloid-Like Fibril Formation	PLOS ONE			English	Article							T FLUORESCENCE ASSAY; LOCALIZED AMYLOIDOSIS; ALZHEIMERS-DISEASE; POTENT INHIBITOR; BETA-PROTEIN; INJECTION; MECHANISM; STRAINS; OCCURS	Several natural and synthetic flavone derivatives have been reported to inhibit formation of amyloid fibrils or to remodel existing fibrils. These studies suggest that the numbers and positions of hydroxyl groups on the flavone rings determine their effectiveness as amyloid inhibitors. In many studies the primary method for determining the effectiveness of inhibition is measuring Thioflavin T (ThT) fluorescence. This method demonstrably results in a number of false positives for inhibition. We studied the effects of 265 commercially available flavone derivatives on insulin fibril formation. We enhanced the effectiveness of ThT fluorescence measurements by fitting kinetic curves to obtain halftime of aggregation (t(50)). Maximal values of ThT fluorescence varied two fold or more in one third of all cases, but this did not correlate with changes in t(50). Changes in t(50) values were more accurate measures of inhibition of amyloid formation. We showed that without a change in an assay, but just by observing complete kinetic curves it is possible to eliminate numbers of false positive and sometimes even false negative results. Examining the data from all 265 flavones we confirmed previous observations that identified the importance of hydroxyl groups for inhibition. Our evidence suggests the importance of hydroxyl groups at locations 5, 6, 7, and 4', and the absence of a hydroxyl group at location 3, for inhibiting amyloid formation. However, the main conclusion is that the positions are not additive. The structures and their effects must be thought of in the context of the whole molecule.	[Malisauskas, Ricardas; Botyriute, Akvile; Smirnovas, Vytautas] Vilnius Univ, Inst Biotechnol, Dept Biothermodynam & Drug Design, Vilnius, Lithuania; [Malisauskas, Ricardas] Vilnius Gediminas Tech Univ, Dept Chem & Bioengn, Vilnius, Lithuania; [Cannon, Jonathan G.] Middle Georgia State Coll, Dept Nat Sci & Engn, Cochran, GA USA	Vilnius University; Vilnius Gediminas Technical University	Smirnovas, V (corresponding author), Vilnius Univ, Inst Biotechnol, Dept Biothermodynam & Drug Design, Vilnius, Lithuania.	vytautas.smirnovas@bti.vu.lt	Smirnovas, Vytautas/O-6270-2018	Smirnovas, Vytautas/0000-0002-1829-5455	European Social Fund under the Global Grant Measure [VP1-3.1-SMM-07-K-02-020]; European Social Fund [VP1-3.1-SMM-01-V-03-001]	European Social Fund under the Global Grant Measure; European Social Fund(European Social Fund (ESF))	This research was funded by the European Social Fund under the Global Grant Measure, project number VP1-3.1-SMM-07-K-02-020. RM was supported by a PhD fellowship from the European Social Fund, project number VP1-3.1-SMM-01-V-03-001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaishi T, 2008, NEUROSCI LETT, V444, P280, DOI 10.1016/j.neulet.2008.08.052; Bieschke J, 2013, NEUROTHERAPEUTICS, V10, P429, DOI 10.1007/s13311-013-0192-7; Bieschke J, 2010, P NATL ACAD SCI USA, V107, P7710, DOI 10.1073/pnas.0910723107; Borana MS, 2014, BBA-PROTEINS PROTEOM, V1844, P670, DOI 10.1016/j.bbapap.2014.01.009; Cohen SIA, 2013, P NATL ACAD SCI USA, V110, P9758, DOI 10.1073/pnas.1218402110; Dzwolak W, 2005, BIOCHEMISTRY-US, V44, P8948, DOI 10.1021/bi050281t; Fodera V, 2008, J PHYS CHEM B, V112, P15174, DOI 10.1021/jp805560c; Green NS, 2005, P NATL ACAD SCI USA, V102, P14545, DOI 10.1073/pnas.0501609102; Hellstrand E, 2010, ACS CHEM NEUROSCI, V1, P13, DOI 10.1021/cn900015v; Hudson SA, 2009, FEBS J, V276, P5960, DOI 10.1111/j.1742-4658.2009.07307.x; Kim H, 2005, J AGR FOOD CHEM, V53, P8537, DOI 10.1021/jf051985c; Kocisko DA, 2005, NEUROSCI LETT, V388, P106, DOI 10.1016/j.neulet.2005.06.053; Milto K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094469; Milto K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068684; Nielsen L, 2001, BIOCHEMISTRY-US, V40, P6036, DOI 10.1021/bi002555c; Noori  H., 2012, PROTEIN SCI, P1; Noormai A, 2012, J PEPT SCI, V18, P59, DOI 10.1002/psc.1416; Ono K, 2003, J NEUROCHEM, V87, P172, DOI 10.1046/j.1471-4159.2003.01976.x; Park SY, 2010, ARCH PHARM RES, V33, P1589, DOI 10.1007/s12272-010-1010-y; Sharoar MG, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-104; Shikama Y, 2010, INTERNAL MED, V49, P397, DOI 10.2169/internalmedicine.49.2633; Smirnovas V, 2008, BIOPHYS J, V94, P3241, DOI 10.1529/biophysj.107.123133; Swift B, 2002, DIABETIC MED, V19, P881, DOI 10.1046/j.1464-5491.2002.07581.x; Trivella DBB, 2012, J STRUCT BIOL, V180, P143, DOI 10.1016/j.jsb.2012.07.008; Ushikubo H, 2012, NEUROSCI LETT, V513, P51, DOI 10.1016/j.neulet.2012.02.006; Wang JB, 2011, BIOCHEM BIOPH RES CO, V415, P675, DOI 10.1016/j.bbrc.2011.10.135; Yumlu S, 2009, HUM PATHOL, V40, P1655, DOI 10.1016/j.humpath.2009.02.019	27	28	28	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121231	10.1371/journal.pone.0121231	http://dx.doi.org/10.1371/journal.pone.0121231			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799281	Green Published, Green Submitted, gold			2022-12-26	WOS:000351987300228
J	Li, JB; Matye, DJ; Li, TG				Li, Jibiao; Matye, David J.; Li, Tiangang			Insulin Resistance Induces Posttranslational Hepatic Sortilin 1 Degradation in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOLIPOPROTEIN-B; CYTOPLASMIC TAIL; ACID SYNTHESIS; VHS DOMAIN; CHOLESTEROL; ACTIVATION; RECEPTORS; SECRETION; SIGNALS; MTORC1	Insulin promotes hepatic apolipoprotein B100 (apoB100) degradation, whereas insulin resistance is a major cause of hepatic apoB100/triglyceride overproduction in type 2 diabetes. The cellular trafficking receptor sortilin 1 (Sort1) was recently identified to transport apoB100 to the lysosome for degradation in the liver and thus regulate plasma cholesterol and triglyceride levels. Genetic variation of SORT1 was strongly associated with cardiovascular disease risk in humans. The major goal of this study is to investigate the effect and molecular mechanism of insulin regulation of Sort1. Results showed that insulin induced Sort1 protein, but not mRNA, in AML12 cells. Treatment of PI3K or AKT inhibitors decreased Sort1 protein, whereas expression of constitutively active AKT induced Sort1 protein in AML12 cells. Consistently, hepatic Sort1 was down-regulated in diabetic mice, which was partially restored after the administration of the insulin sensitizer metformin. LC-MS/MS analysis further revealed that serine phosphorylation of Sort1 protein was required for insulin induction of Sort1 in a casein kinase 2-dependent manner and that inhibition of PI3K signaling or prevention of Sort1 phosphorylation accelerated proteasome-dependent Sort1 degradation. Administration of a PI3K inhibitor to mice decreased hepatic Sort1 protein and increased plasma cholesterol and triglyceride levels. Adenovirus-mediated overexpression of Sort1 in the liver prevented PI3K inhibitor-induced Sort1 down-regulation and decreased plasma triglyceride but had no effect on plasma cholesterol in mice. This study identified Sort1 as a novel target of insulin signaling and suggests that Sort1 may play a role in altered hepatic apoB100 metabolism in insulin-resistant conditions.	[Li, Jibiao; Matye, David J.; Li, Tiangang] Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66160 USA	University of Kansas; University of Kansas Medical Center	Li, TG (corresponding author), Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, 3901 Rainbow Blvd, Kansas City, KS 66160 USA.	tli@kumc.edu	Regan, Clinton/E-6250-2012; Li, Jibiao/A-5627-2017	Matye, David/0000-0001-6655-803X	National Institutes of Health [U24 DK059630]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021940] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK102487, U24DK059630] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103549] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Mouse Metabolic Phenotyping Center at the University of Cincinnati (supported by National Institutes of Health Grant U24 DK059630) for the FPLC analysis of the plasma lipoprotein profile.	Ai D, 2012, J CLIN INVEST, V122, P1677, DOI 10.1172/JCI61248; Ai D, 2012, J CLIN INVEST, V122, P1262, DOI 10.1172/JCI61919; Bi LP, 2013, J LIPID RES, V54, P2754, DOI 10.1194/jlr.M039347; Biddinger SB, 2008, CELL METAB, V7, P125, DOI 10.1016/j.cmet.2007.11.013; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Chamberlain JM, 2013, BIOCHEM BIOPH RES CO, V430, P66, DOI 10.1016/j.bbrc.2012.11.022; Chirieac DV, 2006, AM J PHYSIOL-GASTR L, V291, pG382, DOI 10.1152/ajpgi.00472.2005; Choi SH, 2011, TRENDS ENDOCRIN MET, V22, P353, DOI 10.1016/j.tem.2011.04.007; Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265; Crooke RM, 2005, J LIPID RES, V46, P872, DOI 10.1194/jlr.M400492-JLR200; Dumaresq-Doiron K, 2013, BIOCHEM BIOPH RES CO, V433, P90, DOI 10.1016/j.bbrc.2013.02.059; Fisher EA, 2012, BBA-MOL CELL BIOL L, V1821, P778, DOI 10.1016/j.bbalip.2012.02.001; Fullerton MD, 2013, NAT MED, V19, P1649, DOI 10.1038/nm.3372; Hermey G, 2009, CELL MOL LIFE SCI, V66, P2677, DOI 10.1007/s00018-009-0043-1; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Ihle NT, 2004, MOL CANCER THER, V3, P763; JOHNSON KF, 1992, J CELL BIOL, V119, P249, DOI 10.1083/jcb.119.2.249; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327; Kato Y, 2002, NAT STRUCT BIOL, V9, P532, DOI 10.1038/nsb807; Kjolby M, 2010, CELL METAB, V12, P213, DOI 10.1016/j.cmet.2010.08.006; Lee RG, 2013, J LIPID RES, V54, P602, DOI 10.1194/jlr.M029215; Li JB, 2014, J BIOL CHEM, V289, P22437, DOI 10.1074/jbc.M114.548933; Li TG, 2012, J BIOL CHEM, V287, P1861, DOI 10.1074/jbc.M111.305789; Linsel-Nitschke P, 2010, ATHEROSCLEROSIS, V208, P183, DOI 10.1016/j.atherosclerosis.2009.06.034; MARTOS C, 1985, BIOCHEM J, V225, P321, DOI 10.1042/bj2250321; McCormick PJ, 2008, TRAFFIC, V9, P1984, DOI 10.1111/j.1600-0854.2008.00814.x; Mullick AE, 2011, J LIPID RES, V52, P885, DOI 10.1194/jlr.M011791; Musunuru K, 2010, NATURE, V466, P714, DOI 10.1038/nature09266; Nielsen MS, 2001, EMBO J, V20, P2180, DOI 10.1093/emboj/20.9.2180; Owen JL, 2012, P NATL ACAD SCI USA, V109, P16184, DOI 10.1073/pnas.1213343109; Puertollano R, 2001, SCIENCE, V292, P1712, DOI 10.1126/science.1060750; Reaven GM, 2002, DIABETES OBES METAB, V4, pS13, DOI 10.1046/j.1462-8902.2001.00037.x; SOMMERCORN J, 1987, P NATL ACAD SCI USA, V84, P8834, DOI 10.1073/pnas.84.24.8834; Strong A, 2012, J CLIN INVEST, V122, P2807, DOI 10.1172/JCI63563; Verges B, 2010, ATHEROSCLEROSIS, V211, P353, DOI 10.1016/j.atherosclerosis.2010.01.028; Zhu YX, 2001, SCIENCE, V292, P1716, DOI 10.1126/science.1060896	37	35	35	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2015	290	18					11526	11536		10.1074/jbc.M115.641225	http://dx.doi.org/10.1074/jbc.M115.641225			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH0OA	25805502	Green Published, hybrid			2022-12-26	WOS:000353719400028
J	Li, L; Li, X; The, E; Wang, LJ; Yuan, TY; Wang, SY; Feng, J; Wang, J; Liu, Y; Wu, YH; Ma, XE; Ge, J; Cui, YY; Jiang, XY				Li, Li; Li, Xiang; The, Erlinda; Wang, Li-Jie; Yuan, Tian-You; Wang, Shi-Yi; Feng, Jing; Wang, Jing; Liu, Yuan; Wu, Ya-Han; Ma, Xiu-E; Ge, Jin; Cui, Ying-Yu; Jiang, Xiao-Yan			Low Expression of lncRNA-GAS5 Is Implicated in Human Primary Varicose Great Saphenous Veins	PLOS ONE			English	Article							VASCULAR SMOOTH-MUSCLE; ANNEXIN-II EXPRESSION; NONCODING RNA GAS5; GROWTH-ARREST; CELL-PROLIFERATION; APOPTOSIS; CANCER; PATHOGENESIS; DYSFUNCTION; MECHANISMS	The cellular mechanisms of primary varicose great saphenous veins (GSVs) involve inflammation, apoptosis, and proliferation of local cells and extracellular matrix degradation. Long non-coding RNAs (lncRNAs) play important roles in these cellular processes; however, which and how lncRNAs related to these mechanisms take effect on GSVs remain unclear. By screening lncRNAs that might experience changes in GSV varicosities, we selected the lower expressed lncRNA-GAS5 (growth arrest specific transcript 5) for functional assessments. Silencing of lncRNA-GAS5 promoted cell proliferation and migration, and cell cycle of the human saphenous vein smooth muscle cells (HSVSMCs), whereas overexpressing it inhibited these cellular behaviors and reduced apoptosis of HSVSMCs. RNA pull-down experiment revealed a direct bind of lncRNA-GAS5 to a Ca2+-dependent RNA-binding protein, Annexin A2. Further experiments showed that silencing of Annexin A2 reduced the HSVSMCs proliferation and vice versa. In the context of lncRNA-GAS5 knockdown, silencing of Annexin A2 reduced the proliferation of HSVSMCs while overexpression of Annexin A2 increased the proliferation. Thus, the low expression of lncRNA-GAS5 may facilitate HSVSMCs proliferation and migration through Annexin A2 and thereby the pathogenesis of GSV varicosities.	[Li, Li; The, Erlinda; Wang, Li-Jie; Yuan, Tian-You; Wang, Shi-Yi; Liu, Yuan; Wu, Ya-Han; Ma, Xiu-E] Tongji Univ, Sch Med, East Hosp, Res Ctr Translat Med, Shanghai 200120, Peoples R China; [Li, Li; The, Erlinda; Wu, Ya-Han; Cui, Ying-Yu; Jiang, Xiao-Yan] Tongji Univ, Sch Med, Minist Educ China, Key Lab Arrhythmias, Shanghai 200092, Peoples R China; [Li, Li; Cui, Ying-Yu; Jiang, Xiao-Yan] Tongji Univ, Inst Med Genet, Shanghai 200092, Peoples R China; [Li, Li; Cui, Ying-Yu; Jiang, Xiao-Yan] Tongji Univ, Sch Med, Dept Pathol & Pathophysiol, Shanghai 200092, Peoples R China; [Li, Xiang] Chongqing Med Univ, Affiliated Hosp 1, Dept Cardiol, Chongqing 400016, Peoples R China; [The, Erlinda; Wang, Li-Jie; Yuan, Tian-You; Wang, Shi-Yi; Feng, Jing; Wang, Jing; Liu, Yuan; Wu, Ya-Han; Ma, Xiu-E] Tongji Univ, Sch Med, East Hosp, Dept Cardiol, Shanghai 200120, Peoples R China; [Ge, Jin] Tongji Univ, Sch Med, East Hosp, Dept Vasc Surg, Shanghai 200120, Peoples R China	Tongji University; Ministry of Education, China; Tongji University; Tongji University; Tongji University; Chongqing Medical University; Tongji University; Tongji University	Jiang, XY (corresponding author), Tongji Univ, Sch Med, Minist Educ China, Key Lab Arrhythmias, Shanghai 200092, Peoples R China.	yycui@tongji.edu.cn; xiaoyanjiang001@163.com	Cui, Ying-Yu/G-6386-2011	Cui, Ying-Yu/0000-0002-6324-0795	General Program of National Natural Science Foundation of China [81100551, 81270231]; Fundamental Research Funds for the Central Universities [1500219042]	General Program of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the General Program of National Natural Science Foundation of China (81100551, to Xiao-Yan Jiang; 81270231, to Li Li), and the Fundamental Research Funds for the Central Universities (1500219042, to Xiao-Yan Jiang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral PP, 2011, NUCLEIC ACIDS RES, V39, pD146, DOI 10.1093/nar/gkq1138; [Anonymous], 2014, PLOS ONE; [Anonymous], 2010, MOL PHARM, DOI DOI 10.1124/3161110.064055; Ascher E, 2001, J VASC SURG, V33, P1080, DOI 10.1067/mva.2001.113976; Barber MRW, 2010, P NATL ACAD SCI USA, V107, P5913, DOI 10.1073/pnas.1001755107; Bergan JJ, 2006, NEW ENGL J MED, V355, P488, DOI 10.1056/NEJMra055289; Cao X, 2010, BRAIN RES, V1347, P142, DOI 10.1016/j.brainres.2010.05.072; Chiang YP, 1999, MOL CELL BIOCHEM, V199, P139, DOI 10.1023/A:1006942128672; CHIANG YP, 1993, CANCER RES, V53, P6017; Filipenko NR, 2004, J BIOL CHEM, V279, P8723, DOI 10.1074/jbc.M311951200; Fowkes FGR, 2001, INT J EPIDEMIOL, V30, P846, DOI 10.1093/ije/30.4.846; Huang Y, 2008, MOL CELL BIOCHEM, V309, P117, DOI 10.1007/s11010-007-9649-5; Kino T, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000568; KUMBLE KD, 1992, CANCER RES, V52, P163; Lee JD, 2012, PHLEBOLOGY, V27, P409, DOI 10.1258/phleb.2011.011051; Li Y, 2012, BIOCHEM BIOPH RES CO, V423, P373, DOI 10.1016/j.bbrc.2012.05.133; Lim CS, 2009, BRIT J SURG, V96, P1231, DOI 10.1002/bjs.6798; Luo M, 2010, CHEM-BIOL INTERACT, V188, P151, DOI 10.1016/j.cbi.2010.07.009; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Marks AR, 2003, TRANSPLANT P, V35, p231S, DOI 10.1016/S0041-1345(03)00243-4; Meissner MH, 2007, J VASC SURG, V46, p54S, DOI 10.1016/j.jvs.2007.08.038; Mourtada-Maarabouni M, 2009, ONCOGENE, V28, P195, DOI 10.1038/onc.2008.373; Mourtada-Maarabouni M, 2008, J CELL SCI, V121, P939, DOI 10.1242/jcs.024646; Raffetto JD, 2008, PHLEBOLOGY, V23, P85, DOI 10.1258/phleb.2007.007027; Ren F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035375; Sprague AH, 2009, BIOCHEM PHARMACOL, V78, P539, DOI 10.1016/j.bcp.2009.04.029; Takase S, 2000, ANN VASC SURG, V14, P427, DOI 10.1007/s100169910092; Tanner FC, 2000, CIRCULATION, V101, P2022, DOI 10.1161/01.CIR.101.17.2022; van Groenendael L, 2009, J VASC SURG, V50, P1106, DOI 10.1016/j.jvs.2009.06.057; Williams GT, 2011, BIOCHEM SOC T, V39, P482, DOI 10.1042/BST0390482; Wilusz JE, 2009, GENE DEV, V23, P1494, DOI 10.1101/gad.1800909; Yang F, 2011, HEPATOLOGY, V54, P1679, DOI 10.1002/hep.24563; Yin JL, 2000, ELECTROPHORESIS, V21, P3851, DOI 10.1002/1522-2683(200011)21:17<3851::AID-ELPS3851>3.3.CO;2-H; Zeng Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029518	34	30	36	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0120550	10.1371/journal.pone.0120550	http://dx.doi.org/10.1371/journal.pone.0120550			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25806802	Green Submitted, Green Published, gold			2022-12-26	WOS:000351880000084
J	Villa-Osaba, A; Gahete, MD; Cordoba-Chacon, J; de Lecea, L; Pozo-Salas, AI; Delgado-Lista, FJ; Alvarez-Benito, M; Lopez-Miranda, J; Luque, RM; Castanno, JP				Villa-Osaba, Alicia; Gahete, Manuel D.; Cordoba-Chacon, Jose; de Lecea, Luis; Pozo-Salas, Ana I.; Javier Delgado-Lista, Francisco; Alvarez-Benito, Marina; Lopez-Miranda, Jose; Luque, Raul M.; Castano, Justo P.			Obesity Alters Gene Expression for GH/IGF-I Axis in Mouse Mammary Fat Pads: Differential Role of Cortistatin and Somatostatin	PLOS ONE			English	Article							GROWTH-FACTOR-I; MESSENGER-RNA EXPRESSION; IGF-BINDING PROTEIN-3; BREAST-CANCER; FACTOR (IGF)-I; FACTOR SYSTEM; HORMONE; GHRELIN; RECEPTOR; GLAND	Locally produced growth hormone (GH) and IGF-I are key factors in the regulation of mammary gland (MG) development and may be important in breast cancer development/progression. Somatostatin (SST) and cortistatin (CORT) regulate GH/IGF-I axis at various levels, but their role in regulating GH/IGF-I in MGs remains unknown. Since obesity alters the expression of these systems in different tissues and is associated to MG (patho) physiology, we sought to investigate the role of SST/CORT in regulating GH/IGF-I system in the MGs of lean and obese mice. Therefore, we analyzed GH/IGF-I as well as SST/CORT and ghrelin systems expression in the mammary fat pads (MFPs) of SST- or CORT-knockout (KO) mice and their respective littermate-controls fed a low-fat (LF) or a high-fat (HF) diet for 16wks. Our results demonstrate that the majority of the components of GH/IGF-I, SST/CORT and ghrelin systems are locally expressed in mouse MFP. Expression of elements of the GH/IGF-I axis was significantly increased in MFPs of HF-fed control mice while lack of endogenous SST partially suppressed, and lack of CORT completely blunted, the up-regulation observed in obese WT-controls. Since SST/CORT are known to exert an inhibitory role on the GH/IGFI axis, the increase in SST/CORT-receptor sst2 expression in MFPs of HF-fed CORT- and SST-KOs together with an elevation on circulating SST in CORT-KOs could explain the differences observed. These results offer new information on the factors (GH/IGF-I axis) involved in the endocrine/metabolic dysregulation of MFPs in obesity, and suggest that CORT is not a mere SST sibling in regulating MG physiology.	[Villa-Osaba, Alicia; Gahete, Manuel D.; Cordoba-Chacon, Jose; Pozo-Salas, Ana I.; Luque, Raul M.; Castano, Justo P.] Univ Cordoba, Dept Cell Biol Physiol & Immunol, Cordoba, Spain; [Villa-Osaba, Alicia; Gahete, Manuel D.; Cordoba-Chacon, Jose; Pozo-Salas, Ana I.; Javier Delgado-Lista, Francisco; Alvarez-Benito, Marina; Lopez-Miranda, Jose; Luque, Raul M.; Castano, Justo P.] Reina Sofia Univ Hosp, Inst Maimonides Invest Biomed Cordoba IMIBIC, Cordoba, Spain; [Villa-Osaba, Alicia; Gahete, Manuel D.; Cordoba-Chacon, Jose; Lopez-Miranda, Jose; Luque, Raul M.; Castano, Justo P.] CIBER Fisiopatol Obesidad & Nutr CIBERobn, Cordoba, Spain; [Cordoba-Chacon, Jose] Univ Illinois, Dept Med, Chicago, IL USA; [Cordoba-Chacon, Jose] Jesse Brown Vet Affairs Med Ctr, Div Res & Dev, Chicago, IL USA; [de Lecea, Luis] Stanford Univ, Dept Psychiat & Behav Sci, Sch Med, Stanford, CA 94305 USA; [Javier Delgado-Lista, Francisco; Lopez-Miranda, Jose] Reina Sofia Univ Hosp, Dept Med, Lipids & Atherosclerosis Unit, Cordoba, Spain; [Alvarez-Benito, Marina] Reina Sofia Univ Hosp, Mammary Gland Unit, Cordoba, Spain	Universidad de Cordoba; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center; Stanford University	Luque, RM (corresponding author), Univ Cordoba, Dept Cell Biol Physiol & Immunol, Cordoba, Spain.	raul.luque@uco.es; justo@uco.es	Cordoba-Chacon, Jose/AAH-5753-2019; Castaño, Justo P/A-7124-2010; de Lecea, Luis/ABE-4005-2021; Gahete, Manuel D./C-4969-2009; Lopez-Miranda, Jose/Y-8306-2019; Raul, Luque Huertas/M-6948-2018	Cordoba-Chacon, Jose/0000-0001-8787-2706; Castaño, Justo P/0000-0002-3145-7287; de Lecea, Luis/0000-0002-8921-5942; Gahete, Manuel D./0000-0002-4578-2179; Lopez-Miranda, Jose/0000-0002-8844-0718; Delgado Lista, Francisco Javier/0000-0002-2982-2716; Luque, Raul M./0000-0002-7585-1913; Alvarez-Benito, Marina/0000-0002-0273-3393	CIBERobn [BFU2010-19300, PI-0369-2012, BIO-0139, PI13/00651]; "Sara Borrell" program [CD11/00276]	CIBERobn; "Sara Borrell" program	This work has been funded by the following grants: BFU2010-19300, PI-0369-2012, BIO-0139, PI13/00651, CIBERobn (to RML and JPC), and "Sara Borrell" program CD11/00276 (to MDG). Ciber is an initiative of Instituto de Salud Carlos III, Ministerio de Sanidad, Servicios Sociales e Igualdad, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn J, 2007, ARCH INTERN MED, V167, P2091, DOI 10.1001/archinte.167.19.2091; Bohlke K, 1998, EPIDEMIOLOGY, V9, P570, DOI 10.1097/00001648-199809000-00018; Boutinaud M, 2004, J MOL ENDOCRINOL, V33, P195, DOI 10.1677/jme.0.0330195; BRAZEAU P, 1973, SCIENCE, V179, P77, DOI 10.1126/science.179.4068.77; Broglio F, 2008, MOL CELL ENDOCRINOL, V286, P123, DOI 10.1016/j.mce.2007.12.012; Brown Kristy A, 2012, Front Biosci (Elite Ed), V4, P2515; BRUNING PF, 1995, INT J CANCER, V62, P266, DOI 10.1002/ijc.2910620306; Cannata D, 2010, ENDOCRINOLOGY, V151, P5751, DOI 10.1210/en.2010-0792; Chen A, 1999, ENDOCRINOLOGY, V140, P5915, DOI 10.1210/en.140.12.5915; Cleary MP, 2009, ENDOCRINOLOGY, V150, P2537, DOI 10.1210/en.2009-0070; Cordoba-Chacon J, 2012, AM J PHYSIOL-ENDOC M, V303, pE1151, DOI 10.1152/ajpendo.00340.2012; Cordoba-Chacon J, 2011, ENDOCRINOLOGY, V152, P4800, DOI 10.1210/en.2011-1542; Cordoba-Chacon J, 2010, CELL MOL LIFE SCI, V67, P1147, DOI 10.1007/s00018-009-0240-y; Cuttler L., 2006, ENDOCRINOLOGY, P697; Deghenghi R, 2001, J ENDOCRINOL INVEST, V24, pRC1, DOI 10.1007/BF03343800; deLecea L, 1996, NATURE, V381, P242, DOI 10.1038/381242a0; EMERMAN JT, 1985, HORM METAB RES, V17, P421, DOI 10.1055/s-2007-1013563; Evans AA, 1997, BRIT J CANCER, V75, P798, DOI 10.1038/bjc.1997.143; Fletcher O, 2005, CANCER EPIDEM BIOMAR, V14, P2; Gahete MD, 2008, MOL CELL ENDOCRINOL, V286, P128, DOI 10.1016/j.mce.2007.11.013; Gahete MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023302; Gahete MD, 2010, MOL CELL ENDOCRINOL, V317, P154, DOI 10.1016/j.mce.2009.12.023; Gahete MD, 2009, ANN NY ACAD SCI, V1163, P137, DOI 10.1111/j.1749-6632.2008.03660.x; Gronberg M, 2008, J HISTOCHEM CYTOCHEM, V56, P793, DOI 10.1369/jhc.2008.951145; Gutierrez JA, 2008, P NATL ACAD SCI USA, V105, P6320, DOI 10.1073/pnas.0800708105; Hagemeister AL, 2008, AM J PHYSIOL-REG I, V295, pR490, DOI 10.1152/ajpregu.00099.2008; Hankinson SE, 1998, LANCET, V351, P1393, DOI 10.1016/S0140-6736(97)10384-1; Hatzoglou A, 2002, BIOLOGY OF THE MAMMA, P55; Horseman ND, 1999, J MAMMARY GLAND BIOL, V4, P79, DOI 10.1023/A:1018708704335; Jeffery PL, 2005, ENDOCR-RELAT CANCER, V12, P839, DOI 10.1677/erc.1.00984; Kineman RD, 2007, J MOL ENDOCRINOL, V38, P511, DOI 10.1677/JME-06-0026; Kleinberg DL, 1997, J MAMMARY GLAND BIOL, V2, P49, DOI 10.1023/A:1026373513521; Kleinberg DL, 2009, ENDOCR REV, V30, P51, DOI 10.1210/er.2008-0022; Kleinberg DL, 1998, BREAST CANCER RES TR, V47, P201, DOI 10.1023/A:1005998832636; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Kreitschmann-Andermahr I, 2010, HORM RES PAEDIAT, V73, P153, DOI 10.1159/000284355; La Vecchia C, 2011, ONCOLOGIST, V16, P726, DOI 10.1634/theoncologist.2011-0050; Laban C, 2003, TRENDS ENDOCRIN MET, V14, P28, DOI 10.1016/S1043-2760(02)00003-6; Leroith Derek, 1995, Progress in Growth Factor Research, V6, P433, DOI 10.1016/0955-2235(96)00009-9; Li BDL, 2001, INT J CANCER, V91, P736, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1111>3.0.CO;2-#; Lim CT, 2011, ENDOCR J, V58, P707, DOI 10.1507/endocrj.K11E-117; Loladze AV, 2006, ENDOCRINOLOGY, V147, P5412, DOI 10.1210/en.2006-0427; Luque RM, 2006, J MOL ENDOCRINOL, V36, P547, DOI 10.1677/jme.1.01980; Luque RM, 2007, ENDOCRINOLOGY, V148, P5998, DOI 10.1210/en.2007-0946; Luque RM, 2011, ANN NY ACAD SCI, V1220, P82, DOI 10.1111/j.1749-6632.2010.05913.x; MOL JA, 1995, J CLIN ENDOCR METAB, V80, P3094, DOI 10.1210/jc.80.10.3094; Mukhina S, 2006, ENDOCRINOLOGY, V147, P1819, DOI 10.1210/en.2005-1082; Murray RD, 2004, J CLIN INVEST, V114, P349, DOI 10.1172/jci200419933; Orlando C, 2004, ENDOCR-RELAT CANCER, V11, P323, DOI 10.1677/erc.0.0110323; Papotti M, 2000, J CLIN ENDOCR METAB, V85, P3803, DOI 10.1210/jc.85.10.3803; PEYRAT JP, 1993, EUR J CANCER, V29A, P492, DOI 10.1016/S0959-8049(05)80137-6; Ray A, 2007, CANCER LETT, V253, P291, DOI 10.1016/j.canlet.2007.02.005; Reindl KM, 2012, COMP BIOCHEM PHYS A, V163, P231, DOI 10.1016/j.cbpa.2012.08.003; Renehan AG, 2004, LANCET, V363, P1346, DOI 10.1016/S0140-6736(04)16044-3; Renehan AG, 2006, TRENDS ENDOCRIN MET, V17, P328, DOI 10.1016/j.tem.2006.08.006; Richards RG, 2004, ENDOCRINOLOGY, V145, P3106, DOI 10.1210/en.2003-1112; Richert MM, 1999, ENDOCRINOLOGY, V140, P454, DOI 10.1210/en.140.1.454; Ruan WF, 1999, ENDOCRINOLOGY, V140, P5075, DOI 10.1210/en.140.11.5075; Sall JW, 2004, EXP EYE RES, V79, P465, DOI 10.1016/j.exer.2004.06.007; Shi RH, 2004, INT J CANCER, V111, P418, DOI 10.1002/ijc.20233; Suga K, 2001, JPN J CANCER RES, V92, P127, DOI 10.1111/j.1349-7006.2001.tb01074.x; Sugumar A, 2004, INT J CANCER, V111, P293, DOI 10.1002/ijc.20253; Toniolo P, 2000, INT J CANCER, V88, P828, DOI 10.1002/1097-0215(20001201)88:5<828::AID-IJC22>3.0.CO;2-8; Walden PD, 1998, ENDOCRINOLOGY, V139, P659, DOI 10.1210/en.139.2.659; WALLIS M, 1992, J MOL ENDOCRINOL, V9, P185, DOI 10.1677/jme.0.0090185; Wood TL, 2000, J MAMMARY GLAND BIOL, V5, P31, DOI 10.1023/A:1009511131541; Yang J, 2008, CELL, V132, P387, DOI 10.1016/j.cell.2008.01.017; YEE D, 1989, MOL ENDOCRINOL, V3, P509, DOI 10.1210/mend-3-3-509	68	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0120955	10.1371/journal.pone.0120955	http://dx.doi.org/10.1371/journal.pone.0120955			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25806796	Green Published, Green Submitted, gold			2022-12-26	WOS:000351880000116
J	Banerjee, J; Das Ghatak, P; Roy, S; Khanna, S; Hemann, C; Deng, BB; Das, A; Zweier, JL; Wozniak, D; Sen, CK				Banerjee, Jaideep; Das Ghatak, Piya; Roy, Sashwati; Khanna, Savita; Hemann, Craig; Deng, Binbin; Das, Amitava; Zweier, Jay L.; Wozniak, Daniel; Sen, Chandan K.			Silver-Zinc Redox-Coupled Electroceutical Wound Dressing Disrupts Bacterial Biofilm	PLOS ONE			English	Article							MULTIDRUG EFFLUX SYSTEM; PSEUDOMONAS-AERUGINOSA; GENE-EXPRESSION; IN-VITRO; QUANTITATIVE MEASUREMENT; ELECTRICAL-STIMULATION; ANTIBIOTIC-RESISTANCE; SUPEROXIDE GENERATION; GROWTH-INHIBITION; FIELDS	Pseudomonas aeruginosa biofilm is commonly associated with chronic wound infection. A FDA approved wireless electroceutical dressing (WED), which in the presence of conductive wound exudate gets activated to generate electric field (0.3-0.9V), was investigated for its anti-biofilm properties. Growth of pathogenic P. aeruginosa strain PAO1 in LB media was markedly arrested in the presence of the WED. Scanning electron microscopy demonstrated that WED markedly disrupted biofilm integrity in a setting where silver dressing was ineffective. Biofilm thickness and number of live bacterial cells were decreased in the presence of WED. Quorum sensing genes lasR and rhlR and activity of electric field sensitive enzyme, glycerol-3-phosphate dehydrogenase was also repressed by WED. This work provides first electron paramagnetic resonance spectroscopy evidence demonstrating that WED serves as a spontaneous source of reactive oxygen species. Redox-sensitive multidrug efflux systems mexAB and mexEF were repressed by WED. Taken together, these observations provide first evidence supporting the anti-biofilm properties of WED.	[Banerjee, Jaideep; Das Ghatak, Piya; Roy, Sashwati; Khanna, Savita; Hemann, Craig; Deng, Binbin; Das, Amitava; Zweier, Jay L.; Wozniak, Daniel; Sen, Chandan K.] Ohio State Univ, Wexner Med Ctr, Davis Heart & Lung Res Inst, Comprehens Wound Ctr, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Sen, CK (corresponding author), Ohio State Univ, Wexner Med Ctr, Davis Heart & Lung Res Inst, Comprehens Wound Ctr, Columbus, OH 43210 USA.	Chandan.sen@osumc.edu	Roy, sashwati/E-3990-2011; Das, Amitava/AAJ-5682-2020	Banerjee, Jaideep/0000-0002-8688-7137	Vomaris Innovations, Inc.; National Institute of Health (NIH) [GM077185, GM069589, NR013898, DK076566, R01AI097511]; Department of Defense (DOD) [W81XWH-11-2-0142]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI097511] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076566] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077185, R01GM069589] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR013898] Funding Source: NIH RePORTER	Vomaris Innovations, Inc.; National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense (DOD)(United States Department of Defense); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	This work was partly supported by research funding from Vomaris Innovations, Inc. by means of an unrestricted gift to The Ohio State University and the remaining part supported by the National Institute of Health (NIH; Grant Nos GM077185, GM069589 to CKS, NR013898 to CKS and DJW, DK076566 to SR and R01AI097511 to DJW) and Department of Defense (DOD; W81XWH-11-2-0142 to CKS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anwar N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106095; Asadi MR, 2014, ADV WOUND CARE, V3, P91, DOI 10.1089/wound.2012.0410; Banerjee J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089239; Bender H S, 1983, Vet Clin Pathol, V12, P7, DOI 10.1111/j.1939-165X.1983.tb00615.x; Bjarnsholt T, 2007, APMIS, V115, P921, DOI 10.1111/j.1600-0463.2007.apm_646.x; Branda SS, 2005, TRENDS MICROBIOL, V13, P20, DOI 10.1016/j.tim.2004.11.006; Brighton CT, 2008, J BONE JOINT SURG AM, V90A, P833, DOI 10.2106/JBJS.F.01437; Britigan BE, 1999, INFECT IMMUN, V67, P1207, DOI 10.1128/IAI.67.3.1207-1212.1999; Brosenitsch TA, 2001, J NEUROSCI, V21, P2571, DOI 10.1523/JNEUROSCI.21-08-02571.2001; Caputo M, 2014, ELECTROMAGN BIOL MED, V33, P289, DOI 10.3109/15368378.2013.822387; Chen H, 2008, P NATL ACAD SCI USA, V105, P13586, DOI 10.1073/pnas.0803391105; Collard JF, 2011, BIOELECTROMAGNETICS, V32, P28, DOI 10.1002/bem.20608; Cos P, 2010, CURR PHARM DESIGN, V16, P2279, DOI 10.2174/138161210791792868; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Das A, 2014, J IMMUNOL, V192, P1120, DOI 10.4049/jimmunol.1300613; Das T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058299; Das T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046718; Dasgupta MK, 1996, J AM SOC NEPHROL, V7, P877; Davies D, 2003, NAT REV DRUG DISCOV, V2, P114, DOI 10.1038/nrd1008; Davies DG, 1998, SCIENCE, V280, P295, DOI 10.1126/science.280.5361.295; de la Fuente-Nunez C, 2013, CURR OPIN MICROBIOL, V16, P580, DOI 10.1016/j.mib.2013.06.013; del Pozo JL, 2007, CLIN PHARMACOL THER, V82, P204, DOI 10.1038/sj.clpt.6100247; Dietrich LEP, 2006, MOL MICROBIOL, V61, P1308, DOI 10.1111/j.1365-2958.2006.05306.x; Elgharably H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070360; Famm K, 2013, NATURE, V496, P159, DOI 10.1038/496159a; Fargier E, 2012, J BACTERIOL, V194, P3502, DOI 10.1128/JB.06632-11; FREJAVILLE C, 1995, J MED CHEM, V38, P258, DOI 10.1021/jm00002a007; Garcia-Contreras R, 2013, APPL ENVIRON MICROB, V79, P6840, DOI 10.1128/AEM.02378-13; Giladi M, 2008, ANTIMICROB AGENTS CH, V52, P3517, DOI 10.1128/AAC.00673-08; Gjodsbol Kristine, 2006, Int Wound J, V3, P225, DOI 10.1111/j.1742-481X.2006.00159.x; Gottrup F, 2004, AM J SURG, V187, p38S, DOI 10.1016/S0002-9610(03)00303-9; Gottrup F, 2001, ARCH SURG-CHICAGO, V136, P765, DOI 10.1001/archsurg.136.7.765; GRAVELAND A, 1980, BIOCHEM BIOPH RES CO, V93, P1189, DOI 10.1016/0006-291X(80)90615-4; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Hall-Stoodley L, 2009, CELL MICROBIOL, V11, P1034, DOI 10.1111/j.1462-5822.2009.01323.x; Hill KE, 2010, J ANTIMICROB CHEMOTH, V65, P1195, DOI 10.1093/jac/dkq105; Hogsberg T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020492; JENSEN ET, 1993, MICROB PATHOGENESIS, V15, P377, DOI 10.1006/mpat.1993.1087; Kaufmann GF, 2008, EXPERT OPIN BIOL TH, V8, P719, DOI 10.1517/14712598.8.6.719 ; Kohler T, 1999, J BACTERIOL, V181, P6300; Kohler T, 2001, J BACTERIOL, V183, P5213, DOI 10.1128/JB.183.18.5213-5222.2001; Lewis K, 2005, BIOCHEMISTRY-MOSCOW+, V70, P267, DOI 10.1007/s10541-005-0111-6; Lewis K, 2010, ANNU REV MICROBIOL, V64, P357, DOI 10.1146/annurev.micro.112408.134306; Llucia-Valldeperas A, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt482; Mah TF, 2012, FUTURE MICROBIOL, V7, P1061, DOI [10.2217/FMB.12.76, 10.2217/fmb.12.76]; MELULENI GJ, 1995, J IMMUNOL, V155, P2029; Merriman HL, 2004, J REHABIL RES DEV, V41, P139, DOI 10.1682/JRRD.2004.02.0139; Messerli MA, 2011, BIOL BULL-US, V221, P79, DOI 10.1086/BBLv221n1p79; Miller MB, 2001, ANNU REV MICROBIOL, V55, P165, DOI 10.1146/annurev.micro.55.1.165; Nikaido H, 2009, ANNU REV BIOCHEM, V78, P119, DOI 10.1146/annurev.biochem.78.082907.145923; Obermeier A, 2009, BIOELECTROMAGNETICS, V30, P270, DOI 10.1002/bem.20479; Parsek MR, 2000, P NATL ACAD SCI USA, V97, P8789, DOI 10.1073/pnas.97.16.8789; Parsek MR, 2003, ANNU REV MICROBIOL, V57, P677, DOI 10.1146/annurev.micro.57.030502.090720; Percival SL, 2005, J HOSP INFECT, V60, P1, DOI 10.1016/j.jhin.2004.11.014; Pesci EC, 1997, J BACTERIOL, V179, P3127, DOI 10.1128/jb.179.10.3127-3132.1997; PETERSON DA, 1994, BIOCHEM BIOPH RES CO, V200, P1586, DOI 10.1006/bbrc.1994.1632; Ramadhinara A, 2013, ADV SKIN WOUND CARE, V26, P1, DOI 10.1097/01.ASW.0000425942.32993.e9; Reardon S, 2014, NATURE, V511, P18, DOI 10.1038/511018a; Reszka KJ, 2004, FREE RADICAL BIO MED, V36, P1448, DOI 10.1016/j.freeradbiomed.2004.03.011; Rickard AH, 2004, J APPL MICROBIOL, V96, P1367, DOI 10.1111/j.1365-2672.2004.02297.x; Rickard AH, 2003, FEMS MICROBIOL LETT, V220, P133, DOI 10.1016/S0378-1097(03)00094-6; Rickard AH, 2000, APPL ENVIRON MICROB, V66, P431, DOI 10.1128/AEM.66.1.431-434.2000; ROBERTSON B, 1990, BIOPHYS J, V58, P969, DOI 10.1016/S0006-3495(90)82441-3; RODGERS J, 1994, FEMS IMMUNOL MED MIC, V9, P109, DOI 10.1016/0928-8244(94)90063-9; ROSENBERG B, 1965, NATURE, V205, P698, DOI 10.1038/205698a0; Roubaud V, 1997, ANAL BIOCHEM, V247, P404, DOI 10.1006/abio.1997.2067; Roubaud V, 1998, ANAL BIOCHEM, V257, P210, DOI 10.1006/abio.1997.2542; Roy S, 2014, J PATHOL, V233, P331, DOI 10.1002/path.4360; Savli H, 2003, J MED MICROBIOL, V52, P403, DOI 10.1099/jmm.0.05132-0; Sen CK, 2009, WOUND REPAIR REGEN, V17, P763, DOI 10.1111/j.1524-475X.2009.00543.x; Soto SM, 2013, VIRULENCE, V4, P223, DOI 10.4161/viru.23724; SPADARO JA, 1974, ANTIMICROB AGENTS CH, V6, P637, DOI 10.1128/AAC.6.5.637; Spoering AL, 2006, J BACTERIOL, V188, P5136, DOI 10.1128/JB.00369-06; Stepanovic S, 2000, J MICROBIOL METH, V40, P175, DOI 10.1016/S0167-7012(00)00122-6; Stepanovic S, 2004, LETT APPL MICROBIOL, V38, P428, DOI 10.1111/j.1472-765X.2004.01513.x; Timofeeff MN, 2000, CHEM GEOL, V164, P171, DOI 10.1016/S0009-2541(99)00153-9; Valle A, 2007, J APPL MICROBIOL, V103, P1376, DOI 10.1111/j.1365-2672.2007.03374.x; van der Borden AJ, 2005, BIOMATERIALS, V26, P6731, DOI 10.1016/j.biomaterials.2004.04.052; Wirsing PG, 2013, INT WOUND J; Wurtzel O, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002945; Yeh JI, 2008, P NATL ACAD SCI USA, V105, P3280, DOI 10.1073/pnas.0712331105	81	41	41	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0119531	10.1371/journal.pone.0119531	http://dx.doi.org/10.1371/journal.pone.0119531			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803639	Green Submitted, gold, Green Published			2022-12-26	WOS:000353889600030
J	Lee, JS; Lee, DC; Ha, DH; Kim, SW; Cho, DW				Lee, Jung-Seob; Lee, Dong Chang; Ha, Dong Heon; Kim, Sung Won; Cho, Dong-Woo			Redefining the Septal L-Strut in Septal Surgery	PLOS ONE			English	Article							CARTILAGE; BIOMECHANICS; TRAUMA	In septal surgery, the surgeon preserves the L-strut, the portion anterior to a vertical line drawn from the rhinion to the anterior nasal spine (ANS) and at least a 1-cm width of the dorsal and caudal septal segment, to decrease the potential for loss of the tip and dorsal nasal support. However, nasal tip collapse and saddle deformities occur occasionally. We utilized a mechanical approach to determine the safe width size for the L-strut in contact with the maxillary crest. Five L-strut models were designed based on computed tomography data (80 patients) and previous studies (55 patients). All L-strut models connected the perpendicular plate of the ethmoid bone (PPE) and the maxillary crest and were assumed to be fixed to the PPE and maxillary crest. An approximated daily load was applied to the dorsal portion of the L-strut. Finite element analyses were performed to compare the stress, strain, and displacement distribution of all L-strut models. According to the differences in the contact area between the caudal L-strut and maxillary crest, there are significant differences in terms of the stress, strain, and displacement distribution in the L-strut. High stresses occurred at the inner corner of the L-strut when 60 - 100% of the strut was in contact with the maxillary crest. High stresses also occurred at the inferior portion of the caudal L-strut when 20 - 40% of the caudal strut was in contact with maxillary crest. We conclude that it is important to preserve the 1-cm width L-strut caudal segment, which corresponds to the portion posterior to a vertical line drawn from the rhinion to the ANS. In particular, we must maintain more than 40% of the contact area between the L-strut and the maxillary crest when the septal cartilage in the caudal portion of the L-strut is harvested.	[Lee, Jung-Seob; Ha, Dong Heon; Cho, Dong-Woo] Postech, Dept Mech Engn, Pohang, South Korea; [Lee, Dong Chang; Kim, Sung Won] Catholic Univ Korea, Dept Otolaryngol Head & Neck Surg, Seoul, South Korea	Pohang University of Science & Technology (POSTECH); Catholic University of Korea	Kim, SW (corresponding author), Catholic Univ Korea, Dept Otolaryngol Head & Neck Surg, Seoul, South Korea.	kswent@catholic.ac.kr; dwcho@postech.ac.kr			National Research Foundation of Korea (NRF) grant - Ministry of Science, ICT and Future Planning [2010-0018294, 2014R1A2A2A01004325]; Korea Health Industry Development Institute - Ministry of Health and Welfare [HI14C3228]	National Research Foundation of Korea (NRF) grant - Ministry of Science, ICT and Future Planning; Korea Health Industry Development Institute - Ministry of Health and Welfare	National Research Foundation of Korea (NRF) grant funded by the Ministry of Science, ICT and Future Planning (No. 2010-0018294, No. 2014R1A2A2A01004325) and the Korea Health Industry Development Institute funded by the Ministry of Health and Welfare (HI14C3228). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boulenouar A, 2013, THEOR APPL FRACT MEC, V67-68, P29, DOI 10.1016/j.tafmec.2013.11.001; Holt GR, 1999, OTOLARYNG CLIN N AM, V32, P615, DOI 10.1016/S0030-6665(05)70159-6; Jang YJ, 2009, ARCH OTOLARYNGOL, V135, P1256, DOI 10.1001/archoto.2009.171; Joo YH, 2013, TISSUE ENG REGEN MED, V10, P65, DOI 10.1007/s13770-013-0358-8; Jovanovic DB., 2002, AUTOMATIC CONTROL RO, V3, P443; Jung JW, 2012, INT J PRECIS ENG MAN, V13, P445, DOI 10.1007/s12541-012-0057-8; Kim David W, 2006, Facial Plast Surg, V22, P9, DOI 10.1055/s-2006-939948; Kim DS., 2005, KOREAN OPHTHALMIC OP, V10, P273; Kim DW, 2005, LARYNGOSCOPE, V115, P1451, DOI 10.1097/01.mlg.0000168579.94187.f6; Kim JS, 2010, ANN PLAS SURG, V65, P519, DOI 10.1097/SAP.0b013e3181d59f95; Lee SJ, 2010, LARYNGOSCOPE, V120, P1931, DOI 10.1002/lary.21072; Lee SJ, 2010, LARYNGOSCOPE, V120, P1508, DOI 10.1002/lary.20976; Mark JG, 1998, OTOLARYNGOL HEAD NEC, V99, P374; Mau T, 2007, LARYNGOSCOPE, V117, P1902, DOI 10.1097/MLG.0b013e3181255ec4; Park IY, 2001, SURG ANATOMY NOSE; Planas J, 1977, Clin Plast Surg, V4, P55; Richmon JD, 2005, AM J RHINOL, V19, P617, DOI 10.1177/194589240501900616; Seol YJ, 2012, SOFT MATTER, V8, P1730, DOI 10.1039/c1sm06863f; Tardy Jr ME, 1997, RHINOPLASTY ART SCI	19	14	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0119996	10.1371/journal.pone.0119996	http://dx.doi.org/10.1371/journal.pone.0119996			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803842	gold, Green Submitted, Green Published			2022-12-26	WOS:000353889600053
J	Osterndorff-Kahanek, EA; Becker, HC; Lopez, MF; Farris, SP; Tiwari, GR; Nunez, YO; Harris, RA; Mayfield, RD				Osterndorff-Kahanek, Elizabeth A.; Becker, Howard C.; Lopez, Marcelo F.; Farris, Sean P.; Tiwari, Gayatri R.; Nunez, Yury O.; Harris, R. Adron; Mayfield, R. Dayne			Chronic Ethanol Exposure Produces Time-and Brain Region-Dependent Changes in Gene Coexpression Networks	PLOS ONE			English	Article							EXCESSIVE ALCOHOL-CONSUMPTION; MESSENGER-RNAS; ANIMAL-MODELS; RAT MODEL; DRINKING; EXPRESSION; WITHDRAWAL; BDNF; TRANSCRIPTOME; GLUTAMATE	Repeated ethanol exposure and withdrawal in mice increases voluntary drinking and represents an animal model of physical dependence. We examined time- and brain region-dependent changes in gene coexpression networks in amygdala (AMY), nucleus accumbens (NAC), prefrontal cortex (PFC), and liver after four weekly cycles of chronic intermittent ethanol (CIE) vapor exposure in C57BL/6J mice. Microarrays were used to compare gene expression profiles at 0-, 8-, and 120-hours following the last ethanol exposure. Each brain region exhibited a large number of differentially expressed genes (2,000-3,000) at the 0-and 8-hour time points, but fewer changes were detected at the 120-hour time point (400-600). Within each region, there was little gene overlap across time (similar to 20%). All brain regions were significantly enriched with differentially expressed immune-related genes at the 8-hour time point. Weighted gene correlation network analysis identified modules that were highly enriched with differentially expressed genes at the 0- and 8-hour time points with virtually no enrichment at 120 hours. Modules enriched for both ethanol-responsive and cell-specific genes were identified in each brain region. These results indicate that chronic alcohol exposure causes global 'rewiring' of coexpression systems involving glial and immune signaling as well as neuronal genes.	[Osterndorff-Kahanek, Elizabeth A.; Farris, Sean P.; Tiwari, Gayatri R.; Harris, R. Adron; Mayfield, R. Dayne] Univ Texas Austin, Waggoner Ctr Alcohol & Addict Res, Austin, TX 78712 USA; [Nunez, Yury O.] Univ Texas Austin, Coll Pharm, Pharmacotherapy Educ & Res Ctr, Austin, TX 78712 USA; [Becker, Howard C.; Lopez, Marcelo F.] Med Univ S Carolina, Charleston Alcohol Res Ctr, Dept Psychiat & Behav Sci, Charleston, SC 29425 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; Medical University of South Carolina	Mayfield, RD (corresponding author), Univ Texas Austin, Waggoner Ctr Alcohol & Addict Res, Austin, TX 78712 USA.	dayne.mayfield@austin.utexas.edu	Lopez, Yury O. Nunez/B-9382-2019	Lopez, Yury O. Nunez/0000-0003-0382-9124; Farris, Sean/0000-0002-9158-1984	National Institute on Alcohol Abuse and Alcoholism (NIAAA) [AA016648, AA012404, U01 AA014095, U01 AA020929, P50 AA010761]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U01AA016648, P01AA020683, T32AA007471, P50AA010761, U01AA020929, R01AA012404, U01AA014095] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000813] Funding Source: NIH RePORTER	National Institute on Alcohol Abuse and Alcoholism (NIAAA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by National Institute on Alcohol Abuse and Alcoholism (NIAAA) grants AA016648, AA012404, U01 AA014095, U01 AA020929, and P50 AA010761. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal RG, 2014, ALCOHOL CLIN EXP RES, V38, P428, DOI 10.1111/acer.12288; Barkley-Levenson AM, 2014, ALCOHOL, V48, P217, DOI 10.1016/j.alcohol.2013.10.007; BECKER HC, 1993, ALCOHOL CLIN EXP RES, V17, P94, DOI 10.1111/j.1530-0277.1993.tb00731.x; Becker HC, 2004, ALCOHOL CLIN EXP RES, V28, P1829, DOI 10.1097/01.ALC.0000149977.95306.3A; Becker HC, 2014, ALCOHOL, V48, P205, DOI 10.1016/j.alcohol.2014.04.001; Becker HC, 2012, ALCOHOL RES-CURR REV, V34, P448; Becker HC, 2013, CURR TOP BEHAV NEURO, V13, P355, DOI 10.1007/7854_2012_203; Blednov YA, 2012, ADDICT BIOL, V17, P108, DOI 10.1111/j.1369-1600.2010.00284.x; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Conesa A, 2006, BIOINFORMATICS, V22, P1096, DOI 10.1093/bioinformatics/btl056; Crews FT, 2013, BIOL PSYCHIAT, V73, P602, DOI 10.1016/j.biopsych.2012.09.030; Crews FT, 2012, ALCOHOL RES-CURR REV, V34, P355; Farris SP, 2014, INT REV NEUROBIOL, V116, P275, DOI 10.1016/B978-0-12-801105-8.00011-4; Farris SP, 2010, INT REV NEUROBIOL, V91, P95, DOI 10.1016/S0074-7742(10)91004-0; Freeman K, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-97; Griffin WC, 2014, NEUROPSYCHOPHARMACOL, V39, P707, DOI 10.1038/npp.2013.256; Griffin WC, 2009, ALCOHOL CLIN EXP RES, V33, P1893, DOI 10.1111/j.1530-0277.2009.01027.x; Harris RA, 2011, NEUROSCI LETT, V488, P31, DOI 10.1016/j.neulet.2010.10.075; Hensler JG, 2003, J NEUROCHEM, V85, P1139, DOI 10.1046/j.1471-4159.2003.01748.x; Hopf FW, 2014, ALCOHOL, V48, P253, DOI 10.1016/j.alcohol.2014.03.001; Hopf FW, 2011, BIOL PSYCHIAT, V69, P618, DOI 10.1016/j.biopsych.2010.11.011; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Iancu OD, 2013, ALCOHOL CLIN EXP RES, V37, P1295, DOI 10.1111/acer.12100; Im HI, 2010, NAT NEUROSCI, V13, P1120, DOI 10.1038/nn.2615; Jeanblanc J, 2009, J NEUROSCI, V29, P13494, DOI 10.1523/JNEUROSCI.2243-09.2009; Kimpel MW, 2007, ALCOHOL, V41, P95, DOI 10.1016/j.alcohol.2007.03.003; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lin SM, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1075; Liu JW, 2006, NEUROPSYCHOPHARMACOL, V31, P1574, DOI 10.1038/sj.npp.1300947; Lobo MK, 2010, SCIENCE, V330, P385, DOI 10.1126/science.1188472; Lopez MF, 2014, ALCOHOL, V48, P295, DOI 10.1016/j.alcohol.2014.02.002; Lopez MF, 2005, PSYCHOPHARMACOLOGY, V181, P688, DOI 10.1007/s00213-005-0026-3; Lopez-Redondo F, 2000, MOL BRAIN RES, V76, P429, DOI 10.1016/S0169-328X(00)00022-X; Mayfield J, 2013, CURR OPIN NEUROBIOL, V23, P513, DOI 10.1016/j.conb.2013.01.024; Mayfield RD, 2008, BRIT J PHARMACOL, V154, P275, DOI 10.1038/bjp.2008.88; McGough NNH, 2004, J NEUROSCI, V24, P10542, DOI 10.1523/JNEUROSCI.3714-04.2004; Melendez RI, 2012, ADDICT BIOL, V17, P351, DOI 10.1111/j.1369-1600.2011.00357.x; Most D, 2015, PHARMACOGENOMICS J, V15, P177, DOI 10.1038/tpj.2014.43; Muller MM, 2006, P NATL ACAD SCI USA, V103, P14250, DOI 10.1073/pnas.0606668103; Mulligan MK, 2011, ALCOHOL CLIN EXP RES, V35, P659, DOI 10.1111/j.1530-0277.2010.01384.x; Nakagawa T, 2004, ANN NY ACAD SCI, V1025, P383, DOI 10.1196/annals.1307.047; Nestler EJ, 2000, NAT GENET, V26, P277, DOI 10.1038/81570; Oldham MC, 2008, NAT NEUROSCI, V11, P1271, DOI 10.1038/nn.2207; Osterndorff-Kahanek E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059870; Piechota M, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r48; Ponomarev I, 2006, J NEUROSCI, V26, P5673, DOI 10.1523/JNEUROSCI.0860-06.2006; Ponomarev I, 2012, J NEUROSCI, V32, P1884, DOI 10.1523/JNEUROSCI.3136-11.2012; Ponomarev I, 2010, NEUROPSYCHOPHARMACOL, V35, P1402, DOI 10.1038/npp.2010.10; Robison AJ, 2011, NAT REV NEUROSCI, V12, P623, DOI 10.1038/nrn3111; Sander T, 2000, PSYCHIATR GENET, V10, P103, DOI 10.1097/00041444-200010030-00001; Schratt GM, 2004, J NEUROSCI, V24, P7366, DOI 10.1523/JNEUROSCI.1739-04.2004; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Spanagel R, 2005, ALCOHOL CLIN EXP RES, V29, P1550, DOI 10.1097/01.alc.0000175074.70807.fd; Sugino K, 2006, NAT NEUROSCI, V9, P99, DOI 10.1038/nn1618; Tapocik JD, 2013, PHARMACOGENOMICS J, V13, P286, DOI 10.1038/tpj.2012.17; Thal DR, 2002, BRAIN PATHOL, V12, P405; Thiele TE, 2001, SIMPLE MOUSE MODEL B, DOI [10.1002/0471142301.ns0949s68, DOI 10.1002/0471142301.NS0949S68]; Wahlsten D, 2006, P NATL ACAD SCI USA, V103, P16364, DOI 10.1073/pnas.0605342103; Zou JY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087915	61	59	59	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0121522	10.1371/journal.pone.0121522	http://dx.doi.org/10.1371/journal.pone.0121522			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803291	Green Published, Green Submitted, gold			2022-12-26	WOS:000353889600161
J	Spigoni, V; Cito, M; Alinovi, R; Pinelli, S; Passeri, G; Zavaroni, I; Goldoni, M; Campanini, M; Aliatis, I; Mutti, A; Bonadonna, RC; Dei Cas, A				Spigoni, Valentina; Cito, Monia; Alinovi, Rossella; Pinelli, Silvana; Passeri, Giovanni; Zavaroni, Ivana; Goldoni, Matteo; Campanini, Marco; Aliatis, Irene; Mutti, Antonio; Bonadonna, Riccardo C.; Dei Cas, Alessandra			Effects of TiO2 and Co3O4 Nanoparticles on Circulating Angiogenic Cells	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; TITANIUM-DIOXIDE NANOPARTICLES; OXIDATIVE STRESS; INTRATRACHEAL INSTILLATION; AIR-POLLUTION; COBALT OXIDE; IN-VIVO; INFLAMMATORY RESPONSE; ULTRAFINE PARTICLES; NANOSIZED TIO2	Background and Aim Sparse evidence suggests a possible link between exposure to airborne nanoparticles (NPs) and cardiovascular (CV) risk, perhaps through mechanisms involving oxidative stress and inflammation. We assessed the effects of TiO2 and Co3O4 NPs in human circulating angiogenic cells (CACs), which take part in vascular endothelium repair/replacement. Methods CACs were isolated from healthy donors' buffy coats after culturing lymphomonocytes on fibronectin-coated dishes in endothelial medium for 7 days. CACs were pre-incubated with increasing concentration of TiO2 and Co3O4 (from 1 to 100 mu g/ml) to test the effects of NP characterized by Transmission Electron Microscopy -on CAC viability, apoptosis (caspase 3/7 activation), function (fibronectin adhesion assay), oxidative stress and inflammatory cytokine gene expression. Results Neither oxidative stress nor cell death were associated with exposure to TiO2 NP (except at the highest concentration tested), which, however, induced a higher pro-inflammatory effect compared to Co3O4 NPs (p<0.01). Exposure to Co3O4 NPs significantly reduced cell viability (p<0.01) and increased caspase activity (p<0.01), lipid peroxidation end-products (p<0.05) and pro-inflammatory cytokine gene expression (p<0.05 or lower). Notably, CAC functional activity was impaired after exposure to both TiO2 (p<0.05 or lower) and Co3O4 (p<0.01) NPs. Conclusions In vitro exposure to TiO2 and Co3O4 NPs exerts detrimental effects on CAC viability and function, possibly mediated by accelerated apoptosis, increased oxidant stress (Co3O4 NPs only) and enhancement of inflammatory pathways (both TiO2 and Co3O4 NPs). Such adverse effects may be relevant for a potential role of exposure to TiO2 and Co3O4 NPs in enhancing CV risk in humans.	[Spigoni, Valentina; Cito, Monia; Bonadonna, Riccardo C.; Dei Cas, Alessandra] Univ Parma, Dept Clin & Expt Med, Div Endocrinol, I-43100 Parma, Italy; [Spigoni, Valentina; Cito, Monia; Bonadonna, Riccardo C.; Dei Cas, Alessandra] Azienda Osped Univ Parma, Parma, Italy; [Alinovi, Rossella; Pinelli, Silvana; Goldoni, Matteo; Mutti, Antonio] Univ Parma, Dept Clin & Expt Med, Unit Occupat & Environm Med, I-43100 Parma, Italy; [Passeri, Giovanni] Univ Parma, Dept Clin & Expt Med, Unit Androl Metab Bone Dis & Endocrinol, I-43100 Parma, Italy; [Zavaroni, Ivana] Univ Parma, Dept Clin & Expt Med, Unit Diabet & Prevent Associated Dis, I-43100 Parma, Italy; [Campanini, Marco] IMEM CNR Ist Mat Elettron & Magnetismo Consiglio, Parma, Italy; [Aliatis, Irene] Univ Parma, Dept Phys & Earth Sci, I-43100 Parma, Italy	University of Parma; University Hospital of Parma; University of Parma; University Hospital of Parma; University of Parma; University Hospital of Parma; University of Parma; University Hospital of Parma; University of Parma; University Hospital of Parma; Consiglio Nazionale delle Ricerche (CNR); Istituto dei Materiali per l'Elettronica ed il Magnetismo (IMEM-CNR); University of Parma	Dei Cas, A (corresponding author), Univ Parma, Dept Clin & Expt Med, Div Endocrinol, I-43100 Parma, Italy.	alessandra.deicas@unipr.it	Goldoni, Matteo/E-9153-2011; Campanini, Marco/A-7428-2018; Mutti, Antonio/AAB-9037-2020; Mutti, Antonio/ABE-3833-2021; Mutti, Antonio/C-1095-2011	Goldoni, Matteo/0000-0002-1342-3921; Campanini, Marco/0000-0003-4312-4794; Mutti, Antonio/0000-0003-2189-3808; Mutti, Antonio/0000-0003-2189-3808; Bonadonna, Riccardo/0000-0002-9809-1005; Dei Cas, Alessandra/0000-0002-8666-4849; Spigoni, Valentina/0000-0001-5716-1671; Passeri, Giovanni/0000-0002-4039-1160	Ministero della Salute, Ricerca Finalizzata [RF-2009-1472550]	Ministero della Salute, Ricerca Finalizzata(Ministry of Health, Italy)	This work was supported by Ministero della Salute, Ricerca Finalizzata 2009 (Project title: Integrated approach to evaluate biological effects on lung, cardiovascular system and skin of occupational exposure to nanomaterials; RF-2009-1472550). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarifi S, 2013, INT J NANOMED, V8, P189, DOI 10.2147/IJN.S37924; Alinovi R, 2015, TOXICOL IN VITRO, V29, P426, DOI 10.1016/j.tiv.2014.12.007; Bae ON, 2013, ARTERIOSCL THROM VAS, V33, P1920, DOI 10.1161/ATVBAHA.113.301609; Baisch BL, 2014, PART FIBRE TOXICOL, V11, DOI 10.1186/1743-8977-11-5; Bihari P, 2008, PART FIBRE TOXICOL, V5, DOI 10.1186/1743-8977-5-14; Bisceglie F, 2012, J INORG BIOCHEM, V116, P195, DOI 10.1016/j.jinorgbio.2012.07.006; Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1; Caiado F, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-4; Chen T, 2013, J NANOSCI NANOTECHNO, V13, P3214, DOI 10.1166/jnn.2013.7147; Cho WS, 2012, EUR RESPIR J, V39, P546, DOI 10.1183/09031936.00047111; Deanfield JE, 2007, CIRCULATION, V115, P1285, DOI 10.1161/CIRCULATIONAHA.106.652859; Derlindati E, 2012, FOOD FUNCT, V3, P1144, DOI 10.1039/c2fo30127j; Djaoued Y, 2002, J SOL-GEL SCI TECHN, V24, P255, DOI 10.1023/A:1015357313003; Dominici F, 2006, JAMA-J AM MED ASSOC, V295, P1127, DOI 10.1001/jama.295.10.1127; Fadini GP, 2012, CIRC RES, V110, P624, DOI 10.1161/CIRCRESAHA.111.243386; Geiser M, 2005, ENVIRON HEALTH PERSP, V113, P1555, DOI 10.1289/ehp.8006; Goncalves DM, 2011, INT IMMUNOPHARMACOL, V11, P1109, DOI 10.1016/j.intimp.2011.03.007; Hafner A, 2014, INT J NANOMED, V9, P1005, DOI 10.2147/IJN.S55359; Han SG, 2013, TOXICOLOGY, V306, P1, DOI 10.1016/j.tox.2013.01.014; Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287; Leonard S, 1998, J INORG BIOCHEM, V70, P239, DOI 10.1016/S0162-0134(98)10022-3; Lindberg HK, 2012, MUTAT RES-GEN TOX EN, V745, P58, DOI 10.1016/j.mrgentox.2011.10.011; Liu JW, 2010, J VASC RES, V47, P157, DOI 10.1159/000250094; Liu R, 2009, PROG NAT SCI-MATER, V19, P573, DOI 10.1016/j.pnsc.2008.06.020; McIntyre Robin A., 2012, Science Progress, V95, P1, DOI 10.3184/003685012X13294715456431; Mikkelsen L, 2011, PART FIBRE TOXICOL, V8, DOI 10.1186/1743-8977-8-32; Montiel-Davalos A, 2012, CHEM RES TOXICOL, V25, P920, DOI 10.1021/tx200551u; Naya M, 2012, REGUL TOXICOL PHARM, V62, P1, DOI 10.1016/j.yrtph.2011.12.002; Nemmar A, 2001, AM J RESP CRIT CARE, V164, P1665, DOI 10.1164/ajrccm.164.9.2101036; Oberdorster C, 2005, PART FIBRE TOXICOL, V2, DOI 10.1186/1743-8977-2-8; Ortega R, 2014, PART FIBRE TOXICOL, V11, DOI 10.1186/1743-8977-11-14; Papis E, 2009, TOXICOL LETT, V189, P253, DOI 10.1016/j.toxlet.2009.06.851; Peters K, 2007, INT J IMMUNOPATH PH, V20, P685, DOI 10.1177/039463200702000404; Rajan S, 2008, J CELL BIOCHEM, V105, P477, DOI 10.1002/jcb.21845; Sadiq R, 2012, MUTAT RES-GEN TOX EN, V745, P65, DOI 10.1016/j.mrgentox.2012.02.002; Sager TM, 2008, PART FIBRE TOXICOL, V5, DOI 10.1186/1743-8977-5-17; Schilling K, 2010, PHOTOCH PHOTOBIO SCI, V9, P495, DOI 10.1039/b9pp00180h; Simkhovich BZ, 2008, J AM COLL CARDIOL, V52, P719, DOI 10.1016/j.jacc.2008.05.029; Sohaebuddin SK, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-22; Spigoni V, 2014, FOOD FUNCT, V5, P1881, DOI [10.1039/C3FO60641D, 10.1039/c3fo60641d]; Spigoni V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048283; Suh W, 2004, BIOCHEM BIOPH RES CO, V321, P65, DOI 10.1016/j.bbrc.2004.06.107; Ursini CL, 2014, J APPL TOXICOL, V34, P1209, DOI 10.1002/jat.3038; Valko M, 2005, CURR MED CHEM, V12, P1161, DOI 10.2174/0929867053764635; Vasa M, 2001, CIRC RES, V89, pE1, DOI 10.1161/hh1301.093953; Wang JX, 2007, TOXICOL LETT, V168, P176, DOI 10.1016/j.toxlet.2006.12.001; Werner N, 2005, NEW ENGL J MED, V353, P999, DOI 10.1056/NEJMoa043814; Wu Y, 2013, CLIN EXP PHARMACOL P, V40, P626, DOI 10.1111/1440-1681.12141; Xiong SJ, 2013, TOXICOLOGY, V304, P132, DOI 10.1016/j.tox.2012.12.015; Yang L, 2012, INFLAMMATION, V35, P1242, DOI 10.1007/s10753-012-9434-9; Zoroddu MA, 2014, CURR MED CHEM, V21, P3837, DOI 10.2174/0929867321666140601162314	51	18	18	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0119310	10.1371/journal.pone.0119310	http://dx.doi.org/10.1371/journal.pone.0119310			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803285	Green Submitted, Green Published, gold			2022-12-26	WOS:000353889600021
J	Stegen, S; Everaert, I; Deldicque, L; Vallova, S; de Courten, B; Ukropcova, B; Ukropec, J; Derave, W				Stegen, Sanne; Everaert, Inge; Deldicque, Louise; Vallova, Silvia; de Courten, Barbora; Ukropcova, Barbara; Ukropec, Jozef; Derave, Wim			Muscle Histidine-Containing Dipeptides Are Elevated by Glucose Intolerance in Both Rodents and Men	PLOS ONE			English	Article							HUMAN SKELETAL-MUSCLE; BETA-ALANINE; CARNOSINE CONTENT; GENE-EXPRESSION; IN-VIVO; SUPPLEMENTATION; EXERCISE; AGE; METABOLISM; ADDUCTS	Objective Muscle carnosine and its methylated form anserine are histidine-containing dipeptides. Both dipeptides have the ability to quench reactive carbonyl species and previous studies have shown that endogenous tissue levels are decreased in chronic diseases, such as diabetes. Design and Methods Rodent study: Skeletal muscles of rats and mice were collected from 4 different diet-intervention studies, aiming to induce various degrees of glucose intolerance: 45% high-fat feeding (male rats), 60% high-fat feeding (male rats), cafeteria feeding (male rats), 70% high-fat feeding (female mice). Body weight, glucose-tolerance and muscle histidine-containing dipeptides were assessed. Human study: Muscle biopsies were taken from m. vastus lateralis in 35 males (9 lean, 8 obese, 9 prediabetic and 9 newly diagnosed type 2 diabetic patients) and muscle carnosine and gene expression of muscle fiber type markers were measured. Results Diet interventions in rodents (cafeteria and 70% high-fat feeding) induced increases in body weight, glucose intolerance and levels of histidine-containing dipeptides in muscle. In humans, obese, prediabetic and diabetic men had increased muscle carnosine content compared to the lean (+21% (p>0.1), +30% (p<0.05) and +39% (p<0.05), respectively). The gene expression of fast-oxidative type 2A myosin heavy chain was increased in the prediabetic (1.8-fold, p<0.05) and tended to increase in the diabetic men (1.6-fold, p = 0.07), compared to healthy lean subjects. Conclusion Muscle histidine-containing dipeptides increases with progressive glucose intolerance, in male individuals (cross-sectional). In addition, high-fat diet-induced glucose intolerance was associated with increased muscle histidine-containing dipeptides in female mice (interventional). Increased muscle carnosine content might reflect fiber type composition and/or act as a compensatory mechanism aimed at preventing cell damage in states of impaired glucose tolerance.	[Stegen, Sanne; Everaert, Inge; Derave, Wim] Univ Ghent, Dept Movement & Sport Sci, B-9000 Ghent, Belgium; [Deldicque, Louise] Katholieke Univ Leuven, Exercise Physiol Res Ctr, Dept Kinesiol, Heverlee, Belgium; [Vallova, Silvia; Ukropcova, Barbara] Comenius Univ, Fac Med, Dept Pathophysiol, Bratislava, Slovakia; [de Courten, Barbora] Monash Ctr Hlth Res & Implementat, Fac Med Nursing & Hlth Sci, Melbourne, Vic, Australia; [Ukropcova, Barbara; Ukropec, Jozef] Slovak Acad Sci, Inst Expt Endocrinol, Bratislava, Slovakia	Ghent University; KU Leuven; Comenius University Bratislava; Slovak Academy of Sciences	Derave, W (corresponding author), Univ Ghent, Dept Movement & Sport Sci, B-9000 Ghent, Belgium.	wim.derave@ugent.be	Ukropec, Jozef/AAI-5590-2020; Ukropcova, Barbara/ABE-6186-2020; Derave, Wim/B-2554-2014; Ukropcova, Barbara/E-7644-2018; Ukropec, Jozef/D-5960-2018; de Courten, Barbora/B-3308-2012	Ukropcova, Barbara/0000-0002-3309-7713; Derave, Wim/0000-0002-2225-5587; Ukropec, Jozef/0000-0001-8401-6621; Deldicque, Louise/0000-0003-3393-5278; de Courten, Barbora/0000-0001-8760-2511	Research Foundation- Flanders (FWO) [G035213N, G024311]; Scientific Grant Agency of the Slovak Academy of Sciences (VEGA) [2/0192/14, 2/0174/12]; EFSD New Horizons Collaborative Research Initiative	Research Foundation- Flanders (FWO)(FWO); Scientific Grant Agency of the Slovak Academy of Sciences (VEGA); EFSD New Horizons Collaborative Research Initiative	This work was supported by: 1) The Research Foundation- Flanders (FWO G035213N and G024311: http://www.fwo.be/en/), Wim Derave; 2) Grants from the Scientific Grant Agency of the Slovak Academy of Sciences (VEGA 2/0192/14 and 2/0174/12: http://erawatch.jrc.ec.europa.eu), Barbara Ukropcova and Jozef Ukropec; and 3) EFSD New Horizons Collaborative Research Initiative 2010, Barbara Ukropcova and Jozef Ukropec. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldini G, 2011, J CELL MOL MED, V15, P1339, DOI 10.1111/j.1582-4934.2010.01101.x; Amer Diabet Assoc, 2006, DIABETES CARE, V29, pS43; Baba SP, 2013, J BIOL CHEM, V288, P28163, DOI 10.1074/jbc.M113.504753; Baguet A, 2012, AMINO ACIDS, V43, P13, DOI 10.1007/s00726-011-1197-3; BOLDYREV AA, 1990, ADV ENZYME REGUL, V30, P175; Boldyrev AA, 2013, PHYSIOL REV, V93, P1803, DOI 10.1152/physrev.00039.2012; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; BUSE MG, 1980, METABOLISM, V29, P605, DOI 10.1016/0026-0495(80)90104-3; Carini M, 2003, J MASS SPECTROM, V38, P996, DOI 10.1002/jms.517; Decker EA, 2000, BIOCHEMISTRY-MOSCOW+, V65, P766; del Favero S, 2012, AMINO ACIDS, V43, P49, DOI 10.1007/s00726-011-1190-x; Deldicque L, 2013, J PHYSIOL BIOCHEM, V69, P215, DOI 10.1007/s13105-012-0204-9; Delp MD, 1996, J APPL PHYSIOL, V80, P261, DOI 10.1152/jappl.1996.80.1.261; Derave W, 2008, REJUV RES, V11, P641, DOI 10.1089/rej.2008.0699; Everaert I, 2013, EUR J APPL PHYSIOL, V113, P1169, DOI 10.1007/s00421-012-2540-4; Everaert I, 2013, MED SCI SPORT EXER, V45, P43, DOI 10.1249/MSS.0b013e31826cdb68; Everaert I, 2011, AMINO ACIDS, V40, P1221, DOI 10.1007/s00726-010-0749-2; Gualano B, 2012, AMINO ACIDS, V43, P21, DOI 10.1007/s00726-011-1165-y; Harris RC, 1998, J SPORT SCI, V16, P639; Harris RC, 2006, AMINO ACIDS, V30, P279, DOI 10.1007/s00726-006-0299-9; Hipkiss AR, 2002, ANN NY ACAD SCI, V959, P285, DOI 10.1111/j.1749-6632.2002.tb02100.x; Kamal MA, 2009, AM J PHYSIOL-REG I, V296, pR986, DOI 10.1152/ajpregu.90744.2008; Kendrick IP, 2009, EUR J APPL PHYSIOL, V106, P131, DOI 10.1007/s00421-009-0998-5; Kiens B, 2006, PHYSIOL REV, V86, P205, DOI 10.1152/physrev.00023.2004; Kurdiova T, 2014, J PHYSIOL-LONDON, V592, P1091, DOI 10.1113/jphysiol.2013.264655; Mineo P, 2002, RAPID COMMUN MASS SP, V16, P722, DOI 10.1002/rcm.633; Miyaji T, 2012, J INT SOC SPORT NUTR, V9, DOI 10.1186/1550-2783-9-15; Mong MC, 2011, EUR J PHARMACOL, V653, P82, DOI 10.1016/j.ejphar.2010.12.001; Orioli M, 2005, J CHROMATOGR B, V827, P109, DOI 10.1016/j.jchromb.2005.04.025; Penafiel R, 2004, AMINO ACIDS, V26, P53, DOI 10.1007/s00726-003-0034-8; Peters V, 2012, AMINO ACIDS, V42, P2411, DOI 10.1007/s00726-011-1046-4; Peters V, 2010, AMINO ACIDS, V38, P1607, DOI 10.1007/s00726-009-0367-z; Pfister F, 2011, CELL PHYSIOL BIOCHEM, V28, P125, DOI 10.1159/000331721; Riedl E, 2011, CELL PHYSIOL BIOCHEM, V28, P279, DOI 10.1159/000331740; Sale C, 2013, AMINO ACIDS, V44, P1477, DOI 10.1007/s00726-013-1476-2; Samjoo IA, 2013, NUTR DIABETES, V3, DOI 10.1038/nutd.2013.30; Sauerhofer S, 2007, DIABETES, V56, P2425, DOI 10.2337/db07-0177; Soliman K. M., 2007, Journal of Applied Sciences, V7, P2252; Srikanthan P, 2012, MAGN RESON INSIGHTS, V5, P29, DOI 10.4137/MRI.S10489; Stegen S, 2014, MED SCI SPORTS EXERC; Thompson LV, 2002, J ORTHOP SPORT PHYS, V32, P44, DOI 10.2519/jospt.2002.32.2.44; Vaisy M, 2011, J NUTR BIOCHEM, V22, P1178, DOI 10.1016/j.jnutbio.2010.10.004; Yasuda K, 2002, CLIN EXP PHARMACOL P, V29, P1001, DOI 10.1046/j.1440-1681.2002.03757.x	43	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0121062	10.1371/journal.pone.0121062	http://dx.doi.org/10.1371/journal.pone.0121062			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803044	Green Published, Green Submitted, gold			2022-12-26	WOS:000353889600118
J	Zhang, LQ; Jia, RR; Palange, NJ; Satheka, AC; Togo, J; An, Y; Humphrey, M; Ban, LY; Ji, Y; Jin, HH; Feng, XC; Zheng, YW				Zhang, Luqing; Jia, Ruirui; Palange, Norberto J.; Satheka, Achim Cchitvsanzwhoh; Togo, Jacques; An, Yao; Humphrey, Mabwi; Ban, Luying; Ji, Yan; Jin, Honghong; Feng, Xuechao; Zheng, Yaowu			Large Genomic Fragment Deletions and Insertions in Mouse Using CRISPR/Cas9	PLOS ONE			English	Article							MICE; GENERATION; CAS9; GENE; RNA; ZEBRAFISH; MUTATIONS; NUCLEASE; KNOCKOUT; TALENS	ZFN, TALENs and CRISPR/Cas9 system have been used to generate point mutations and large fragment deletions and insertions in genomic modifications. CRISPR/Cas9 system is the most flexible and fast developing technology that has been extensively used to make mutations in all kinds of organisms. However, the most mutations reported up to date are small insertions and deletions. In this report, CRISPR/Cas9 system was used to make large DNA fragment deletions and insertions, including entire Dip2a gene deletion, about 65kb in size, and beta-galactosidase (lacZ) reporter gene insertion of larger than 5kb in mouse. About 11.8% (11/93) are positive for 65kb deletion from transfected and diluted ES clones. High targeting efficiencies in ES cells were also achieved with G418 selection, 46.2%(12/26) and 73.1% (19/26) for left and right arms respectively. Targeted large fragment deletion efficiency is about 21.4% of live pups or 6.0% of injected embryos. Targeted insertion of lacZ reporter with NEO cassette showed 27.1% (13/48) of targeting rate by ES cell transfection and 11.1% (2/18) by direct zygote injection. The procedures have bypassed in vitro transcription by directly co-injection of zygotes or co-transfection of embryonic stem cells with circular plasmid DNA. The methods are technically easy, time saving, and cost effective in generating mouse models and will certainly facilitate gene function studies.	[Zhang, Luqing; Jia, Ruirui; Palange, Norberto J.; Satheka, Achim Cchitvsanzwhoh; Togo, Jacques; An, Yao; Humphrey, Mabwi; Ban, Luying; Ji, Yan; Jin, Honghong; Zheng, Yaowu] NE Normal Univ, Transgen Res Ctr, Sch Life Sci, Changchun, Peoples R China; [Zhang, Luqing; Feng, Xuechao; Zheng, Yaowu] NE Normal Univ, Key Lab Mol Epigenet, Minist Educ, Changchun, Peoples R China	Northeast Normal University - China; Northeast Normal University - China	Feng, XC (corresponding author), NE Normal Univ, Key Lab Mol Epigenet, Minist Educ, Changchun, Peoples R China.	fengxc997@nenu.edu.cn; zhengyw442@nenu.edu.cn	Zhang, Luqing/A-1200-2019	Zhang, Luqing/0000-0001-7252-643X; feng, xuechao/0000-0003-2444-3757; Mabwi, Humphrey/0000-0002-5224-4870; SATHEKA [Snr.], ACHIM CCHITVSANZWHOH/0000-0002-9878-0759	National Natural Science Foundation of China [31301189, 81270953]; Fundamental Research Funds for the Central Universities [12QNJJ015, 10JCXK001]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20130043120010]; Science-Technology Foundation for Young Scientist of Jilin Province [20130522003JH]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Science-Technology Foundation for Young Scientist of Jilin Province	This work was supported, in whole or in part, by grants from the National Natural Science Foundation of China (31301189 and 81270953) http://www.nsfc.gov.cn/Portal0/default152.htm; and the Fundamental Research Funds for the Central Universities (12QNJJ015 and 10JCXK001); and the Specialized Research Fund for the Doctoral Program of Higher Education of China (20130043120010); and the Science-Technology Foundation for Young Scientist of Jilin Province (20130522003JH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Canver MC, 2014, J BIOL CHEM, V289, P21312, DOI 10.1074/jbc.M114.564625; Capecchi MR, 2001, NAT MED, V7, P1086, DOI 10.1038/nm1001-1086; Carlson DF, 2012, P NATL ACAD SCI USA, V109, P17382, DOI 10.1073/pnas.1211446109; Chang NN, 2013, CELL RES, V23, P465, DOI 10.1038/cr.2013.45; Cheah SS, 2001, MOL BIOTECHNOL, V19, P297, DOI 10.1385/MB:19:3:297; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cui XX, 2011, NAT BIOTECHNOL, V29, P64, DOI 10.1038/nbt.1731; DiCarlo JE, 2013, NUCLEIC ACIDS RES, V41, P4336, DOI 10.1093/nar/gkt135; Ding QR, 2013, CELL STEM CELL, V12, P393, DOI 10.1016/j.stem.2013.03.006; Frey UH, 2008, NAT PROTOC, V3, P1312, DOI 10.1038/nprot.2008.112; Fujii W, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt772; Geng Y, 2011, P NATL ACAD SCI USA, V108, P7058, DOI 10.1073/pnas.1007293108; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Ma YW, 2014, CELL RES, V24, P122, DOI 10.1038/cr.2013.157; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Malumbres M, 1997, BIOTECHNIQUES, V22, P1114, DOI 10.2144/97226st03; Mashiko D, 2013, SCI REP-UK, V3, DOI 10.1038/srep03355; Miller JC, 2007, NAT BIOTECHNOL, V25, P778, DOI 10.1038/nbt1319; Mizuno S, 2014, MAMM GENOME, V25, P327, DOI 10.1007/s00335-014-9524-0; Niu YY, 2014, CELL, V156, P836, DOI 10.1016/j.cell.2014.01.027; Ouchi N, 2010, J BIOL CHEM, V285, P7127, DOI 10.1074/jbc.M109.069468; Pieters T, 2012, STEM CELL REV REP, V8, P768, DOI 10.1007/s12015-011-9323-x; Ramalingam S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-2-107; Segal DJ, 2013, ELIFE, V2, DOI 10.7554/eLife.00563; Shen B, 2014, NAT METHODS, V11, P399, DOI [10.1038/nmeth.2857, 10.1038/NMETH.2857]; Tanaka M, 2010, FEBS J, V277, P4278, DOI 10.1111/j.1742-4658.2010.07816.x; Tesson L, 2011, NAT BIOTECHNOL, V29, P695, DOI 10.1038/nbt.1940; Valenzuela DM, 2003, NAT BIOTECHNOL, V21, P652, DOI 10.1038/nbt822; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Xiao A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt464; Xu JY, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0032554, 10.1371/journal.pone.0038665]; Ye SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035892	34	95	104	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0120396	10.1371/journal.pone.0120396	http://dx.doi.org/10.1371/journal.pone.0120396			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	25803037	Green Published, gold, Green Submitted			2022-12-26	WOS:000353889600076
J	Inoue-Mochita, M; Inoue, T; Fujimoto, T; Kameda, T; Awai-Kasaoka, N; Ohtsu, N; Kimoto, K; Tanihara, H				Inoue-Mochita, Miyuki; Inoue, Toshihiro; Fujimoto, Tomokazu; Kameda, Takanori; Awai-Kasaoka, Nanako; Ohtsu, Naoki; Kimoto, Kenichi; Tanihara, Hidenobu			p38 MAP Kinase Inhibitor Suppresses Transforming Growth Factor-beta 2-Induced Type 1 Collagen Production in Trabecular Meshwork Cells	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; INTRAOCULAR-PRESSURE; AQUEOUS-HUMOR; EXTRACELLULAR-MATRIX; MESENCHYMAL TRANSITION; FLUID-DYNAMICS; ROCK INHIBITOR; DEXAMETHASONE; TGF-BETA-2; CORTICOSTEROIDS	Glaucoma is an age-related neurodegenerative disease of retinal ganglion cells, and appropriate turnover of the extracellular matrix in the trabecular meshwork is important in its pathology. Here, we report the effects of Rho-associated kinase (ROCK) and p38 MAP kinase on transforming growth factor (TGF)-beta 2-induced type I collagen production in human trabecular meshwork cells. TGF-beta 2 increased RhoA activity, actin polymerization, and myosin light chain 2 phosphorylation. These effects were significantly inhibited by Y-27632, but not SB203580. TGF-beta 2 also increased promoter activity, mRNA synthesis, and protein expression of COL1A2. These effects were significantly inhibited by SB203580, but not Y-27632. Additionally, Y-27632 did not significantly inhibit TGF-beta 2-induced promoter activation, or phosphorylation or nuclear translocation of Smad2/3, whereas SB203580 partially suppressed these processes. Collectively, TGF-beta 2-induced production of type 1 collagen is suppressed by p38 inhibition and accompanied by partial inactivation of Smad2/3, in human trabecular meshwork cells.	[Inoue-Mochita, Miyuki; Inoue, Toshihiro; Fujimoto, Tomokazu; Kameda, Takanori; Awai-Kasaoka, Nanako; Ohtsu, Naoki; Tanihara, Hidenobu] Kumamoto Univ, Fac Life Sci, Dept Ophthalmol, Kumamoto, Japan; [Kameda, Takanori] Kyoto Univ, Grad Sch Med, Dept Ophthalmol & Visual Sci, Kyoto, Japan; [Kimoto, Kenichi] Oita Univ, Dept Ophthalmol, Yufu, Japan	Kumamoto University; Kyoto University; Oita University	Inoue, T (corresponding author), Kumamoto Univ, Fac Life Sci, Dept Ophthalmol, Kumamoto, Japan.	noel@da2.so-net.ne.jp		Fujimoto, Tomokazu/0000-0002-4867-1925; Inoue, Toshihiro/0000-0003-3769-7609	JSPS KAKENHI [23390403, 25861640, 23791994]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Numbers 23390403, 25861640 and 23791994. The sponsor or funding organization had no role in the design or conduct of this research.	Acott TS, 2008, EXP EYE RES, V86, P543, DOI 10.1016/j.exer.2008.01.013; [Anonymous], 2004, J HUAZHONG U SCI TEC; ARMALY MF, 1963, ARCH OPHTHALMOL-CHIC, V70, P492, DOI 10.1001/archopht.1963.00960050494011; ARMALY MF, 1963, ARCH OPHTHALMOL-CHIC, V70, P482, DOI 10.1001/archopht.1963.00960050484010; Cao Y, 2004, J HUAZHONG U SCI TEC, V24, P496; Chen SY, 2006, J BIOL CHEM, V281, P1765, DOI 10.1074/jbc.M507771200; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Fujimoto T, 2012, INVEST OPHTH VIS SCI, V53, P7097, DOI 10.1167/iovs.12-9989; Fukushima M, 2005, LIVER INT, V25, P829, DOI 10.1111/j.1478-3231.2005.01142.x; Gottanka J, 2004, INVEST OPHTH VIS SCI, V45, P153, DOI 10.1167/iovs.03-0796; Han H, 2011, INVEST OPHTH VIS SCI, V52, P2889, DOI 10.1167/iovs.10-6640; Honjo M, 2001, INVEST OPHTH VIS SCI, V42, P137; Inatani M, 2001, GRAEF ARCH CLIN EXP, V239, P109, DOI 10.1007/s004170000241; Itoh Y, 2007, EXP EYE RES, V84, P464, DOI 10.1016/j.exer.2006.10.017; Junglas B, 2009, EXP EYE RES, V88, P1065, DOI 10.1016/j.exer.2009.01.008; Kang MH, 2013, INVEST OPHTH VIS SCI, V54, P2523, DOI 10.1167/iovs.12-11474; Kimoto K, 2004, INVEST OPHTH VIS SCI, V45, P2431, DOI 10.1167/iovs.03-1276; Kopczynski C, 2013, BRIT J OPHTHALMOL, V97, P567, DOI 10.1136/bjophthalmol-2012-302466; Lee J, 2010, J BIOL CHEM, V285, P26618, DOI 10.1074/jbc.M109.073155; Mihira H, 2012, J BIOCHEM, V151, P145, DOI 10.1093/jb/mvr121; Nakamura Y, 2002, INVEST OPHTH VIS SCI, V43, P3465; Pattabiraman PP, 2014, J CELL PHYSIOL, V229, P927, DOI 10.1002/jcp.24524; Pattabiraman PP, 2010, AM J PHYSIOL-CELL PH, V298, pC749, DOI 10.1152/ajpcell.00317.2009; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Rao PV, 2001, INVEST OPHTH VIS SCI, V42, P1029; Sethi A, 2013, EXP EYE RES, V113, P117, DOI 10.1016/j.exer.2013.05.011; Takai Y, 2012, INVEST OPHTH VIS SCI, V53, P241, DOI 10.1167/iovs.11-8434; Tan JCH, 2006, CURR OPIN OPHTHALMOL, V17, P168; Tanihara H, 2008, ARCH OPHTHALMOL-CHIC, V126, P309, DOI 10.1001/archophthalmol.2007.76; Tanihara H, 2013, JAMA OPHTHALMOL, V131, P1288, DOI 10.1001/jamaophthalmol.2013.323; Tanihara H, 2013, AM J OPHTHALMOL, V156, P731, DOI 10.1016/j.ajo.2013.05.016; TRIPATHI RC, 1994, EXP EYE RES, V59, P723, DOI 10.1006/exer.1994.1158; Williams RD, 2011, AM J OPHTHALMOL, V152, P834, DOI 10.1016/j.ajo.2011.04.012; Xu T, 2012, INT J MOL MED, V30, P1119, DOI 10.3892/ijmm.2012.1107; Yue BYJT, 1996, SURV OPHTHALMOL, V40, P379	35	18	18	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120774	10.1371/journal.pone.0120774	http://dx.doi.org/10.1371/journal.pone.0120774			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799097	gold, Green Published, Green Submitted			2022-12-26	WOS:000351987300175
J	Sun, B; Liu, R; Ye, N; Xiao, ZD				Sun, Bo; Liu, Rui; Ye, Nan; Xiao, Zhong-Dang			Comprehensive Evaluation of microRNA Expression Profiling Reveals the Neural Signaling Specific Cytotoxicity of Superparamagnetic Iron Oxide Nanoparticles (SPIONs) through N-Methyl-D-Aspartate Receptor	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; CELL-DEATH; GENOTOXICITY EVALUATION; SILICA NANOPARTICLES; DISACCHARIDE MOIETY; GOLD NANOPARTICLES; TITANIUM-DIOXIDE; OXIDATIVE STRESS; AMORPHOUS SILICA; NMDA RECEPTORS	Though nanomaterials are considered as drug carriers or imaging reagents targeting the central nervous system their cytotoxicity effect on neuronal cells has not been well studied. In this study, we treated PC12 cells, a model neuronal cell line, with a nanomaterial that is widely accepted for medical use, superparamagnetic iron oxide nanoparticles (SPIONs). Our results suggest that, after treated with SPIONs, the expression pattern of the cellular miRNAs changed widely in PC12 cells. As potential miRNA targets, NMDAR, one of the candidate mRNAs that were selected using GO and KEGG pathway enrichment, was significantly down regulated by SPIONs treatment. We further illustrated that SPIONs may induce cell death through NMDAR suppression. This study revealed a NMDAR neurotoxic effect of SPIONs and provides a reliable approach for assessing the neurocytotoxic effects of nanomaterials based on the comprehensive annotation of miRNA profiling.	[Sun, Bo; Ye, Nan; Xiao, Zhong-Dang] Southeast Univ, State Key Lab Bioelect, Sch Biol Sci & Med Engn, Nanjing 210096, Jiangsu, Peoples R China; [Sun, Bo] Seoul Natl Univ, Inst Microbiol, Sch Biol Sci, Seoul, South Korea; [Liu, Rui] Seoul Natl Univ, Biophys Lab, Sch Biol Sci, Seoul, South Korea	Southeast University - China; Seoul National University (SNU); Seoul National University (SNU)	Sun, B (corresponding author), Southeast Univ, State Key Lab Bioelect, Sch Biol Sci & Med Engn, Nanjing 210096, Jiangsu, Peoples R China.	sunbo@seu.edu.cn; zdxiao@seu.edu.cn			Natural Science Foundation of Jiangsu Province [BK2012122]; National Natural Science Foundation of China (NSFC) [61071047]; Major State Basic Research Development Program of China (973 Program) [2013CB932902]	Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Major State Basic Research Development Program of China (973 Program)(National Basic Research Program of China)	This work was supported by grants from the Natural Science Foundation of Jiangsu Province (No. BK2012122), the National Natural Science Foundation of China (NSFC) (No. 61071047), and the Major State Basic Research Development Program of China (973 Program) (No. 2013CB932902). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams SM, 2004, J NEUROSCI, V24, P9441, DOI 10.1523/JNEUROSCI.3290-04.2004; Bannunah AM, 2014, MOL PHARMACEUT, V11, P4363, DOI 10.1021/mp500439c; Bigini P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032326; Borisova T, INT J BIOCH CELL BIO; Cai HAX, 2014, COLLOID SURFACE B, V123, P900, DOI 10.1016/j.colsurfb.2014.10.042; Carp SA, 2008, VALIDATION OPTICAL M, pBMD2; Chou LYT, 2012, NAT NANOTECHNOL, V7, P416, DOI 10.1038/nnano.2012.110; Creighton CJ, 2009, BRIEF BIOINFORM, V10, P490, DOI 10.1093/bib/bbp019; Drechsel DA, 2012, NEUROTOX RES, V22, P251, DOI 10.1007/s12640-012-9322-y; Du J, 2009, NEUROSCI LETT, V464, P140, DOI 10.1016/j.neulet.2009.07.032; Efimova T, 2010, CELL CYCLE, V9, P498, DOI 10.4161/cc.9.3.10541; Fang Q, 2015, J HAZARD MATER, V283, P897, DOI 10.1016/j.jhazmat.2014.10.039; Ferrari R, 2014, COLLOID SURFACE B, V123, P639, DOI 10.1016/j.colsurfb.2014.10.003; Fu J, 2012, ADV SCI LETT, V5, P294, DOI DOI 10.1166/ASL.2012.1946; Gomes T, 2014, AQUAT TOXICOL, V155, P327, DOI 10.1016/j.aquatox.2014.07.015; Grau Cristina Malagelada, 2012, Methods Mol Biol, V846, P201, DOI 10.1007/978-1-61779-536-7_18; Gu JL, 2011, SCI CHINA LIFE SCI, V54, P793, DOI 10.1007/s11427-011-4215-5; He SY, 2011, ENVIRON POLLUT, V159, P3468, DOI 10.1016/j.envpol.2011.08.024; Hu MCT, 1999, J BIOL CHEM, V274, P7095, DOI 10.1074/jbc.274.11.7095; Hu YL, 2010, INT J PHARMACEUT, V394, P115, DOI 10.1016/j.ijpharm.2010.04.026; Huang Y, 2015, BIOMATERIALS, V37, P13, DOI 10.1016/j.biomaterials.2014.10.042; Ishima T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037989; Izarra A, 2014, J TISSUE ENG REGENER; Jiang WL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037376; Johnson EM, 1996, BRAIN PATHOL, V6, P397, DOI 10.1111/j.1750-3639.1996.tb00872.x; Kawakami Z, 2011, J ETHNOPHARMACOL, V134, P74, DOI 10.1016/j.jep.2010.11.063; Khamwannah J, 2012, NANO ENERGY, V1, P411, DOI 10.1016/j.nanoen.2012.03.010; Kingwell K, 2012, NAT REV NEUROL, V8, P589, DOI [10.1038/nrneurol.2012.229, 10.1038/nrneurol.2012.128, 10.1038/nrneurol.2012.218, 10.1038/nrneurol.2012.55, 10.1038/nrneurol.2012.84]; Kircher MF, 2003, CANCER RES, V63, P8122; Kircher MF, 2012, NAT MED, V18, P829, DOI 10.1038/nm.2721; Li SC, 2011, BIOMATERIALS, V32, P9021, DOI 10.1016/j.biomaterials.2011.08.033; Liu Y, 2014, NANO LIFE, V4; Liu YR, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0110611, 10.1371/journal.pone.0087094]; Liu YR, 2014, MOL PHARMACEUT, V11, P1651, DOI 10.1021/mp5000373; Mahmood M, 2011, J CELL MOL MED, V15, P2297, DOI 10.1111/j.1582-4934.2010.01234.x; Manke A, 2014, INT J MOL SCI, V15, P7444, DOI 10.3390/ijms15057444; Mellado-Gil J, 2011, DIABETES, V60, P525, DOI 10.2337/db09-1305; Michaelis EK, 1998, PROG NEUROBIOL, V54, P369, DOI 10.1016/S0301-0082(97)00055-5; Park MVDZ, 2011, NANOTOXICOLOGY, V5, P168, DOI 10.3109/17435390.2010.506016; Park S, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/18/185101; Patel D, 2010, BIOMATERIALS, V31, P2866, DOI 10.1016/j.biomaterials.2009.12.025; Patil G, 2012, ENVIRON TOXICOL PHAR, V34, P436, DOI 10.1016/j.etap.2012.05.014; Perruisseau-Carrier C, 2011, MOL NEUROBIOL, V43, P215, DOI 10.1007/s12035-011-8179-z; Pisanic TR, 2007, BIOMATERIALS, V28, P2572, DOI 10.1016/j.biomaterials.2007.01.043; Raynal I, 2004, INVEST RADIOL, V39, P56, DOI 10.1097/01.rli.0000101027.57021.28; Rivet CJ, 2012, CHEM RES TOXICOL, V25, P153, DOI 10.1021/tx200369s; Roberson MS, 1999, ENDOCRINOLOGY, V140, P1310, DOI 10.1210/en.140.3.1310; Ruan J, 2015, NEUROREPORT, V26, P66, DOI 10.1097/WNR.0000000000000302; Saito Y, 2003, MOL BRAIN RES, V110, P159, DOI 10.1016/S0169-328X(02)00548-X; Sayed D, 2011, PHYSIOL REV, V91, P827, DOI 10.1152/physrev.00006.2010; Schroeder BR, 2014, J AM CHEM SOC, V136, P13641, DOI 10.1021/ja507255g; Siegrist KJ, 2014, PART FIBRE TOXICOL, V11, DOI 10.1186/1743-8977-11-6; Suh WH, 2009, PROG NEUROBIOL, V87, P133, DOI 10.1016/j.pneurobio.2008.09.009; Sun B, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-120; Sun J, 2014, SCI REP, V4; Sun K-T, BONE; Takadera T, 1999, J NEUROCHEM, V73, P548, DOI 10.1046/j.1471-4159.1999.0730548.x; Takadera T, 2007, NEUROCHEM RES, V32, P1336, DOI 10.1007/s11064-007-9310-4; Tavares AM, 2014, TOXICOL IN VITRO, V28, P60, DOI 10.1016/j.tiv.2013.06.009; Veiseh O, 2010, ADV DRUG DELIVER REV, V62, P284, DOI 10.1016/j.addr.2009.11.002; Wang G, 2005, FEBS LETT, V579, P4005, DOI 10.1016/j.febslet.2005.06.013; Yang H, 2010, PHARM RES-DORDR, V27, P1759, DOI 10.1007/s11095-010-0141-7; Yu MK, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/41/415102; Yu T, 2011, ACS NANO, V5, P5717, DOI 10.1021/nn2013904; Yu ZQ, 2013, J AM CHEM SOC, V135, P2883, DOI 10.1021/ja311090e; Zhang S, 2009, NANOSCALE RES LETT, V4, P70, DOI 10.1007/s11671-008-9204-7; Zhu K, 2012, INT J PHARMACEUT, V423, P378, DOI 10.1016/j.ijpharm.2011.12.030	67	15	15	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121671	10.1371/journal.pone.0121671	http://dx.doi.org/10.1371/journal.pone.0121671			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798908	Green Published, gold, Green Submitted			2022-12-26	WOS:000351987300284
J	van den Boomen, C; Jonkman, LM; Jaspers-Vlamings, PHJM; Cousijn, J; Kemner, C				van den Boomen, Carlijn; Jonkman, Lisa M.; Jaspers-Vlamings, Petra H. J. M.; Cousijn, Janna; Kemner, Chantal			Developmental Changes in ERP Responses to Spatial Frequencies	PLOS ONE			English	Article							CATEGORIZING FACIAL IDENTITIES; CONTRAST SENSITIVITY; CHILDREN; FACES; SELECTIVITY; ATTENTION; EMOTIONS	Social interaction starts with perception of other persons. One of the first steps in perception is processing of basic information such as spatial frequencies (SF), which represent details and global information. However, although behavioural perception of SF is well investigated, the developmental trajectory of the temporal characteristics of SF processing is not yet well understood. The speed of processing of this basic visual information is crucial, as it determines the speed and possibly accuracy of subsequent visual and social processes. The current study investigated developmental changes in the temporal characteristics of selective processing of high SF (HSF; details) versus low SF (LSF; global). To this end, brain activity was measured using EEG in 108 children aged 3-15 years, while HSF or LSF grating stimuli were presented. Interest was in the temporal characteristics of brain activity related to LSF and HSF processing, specifically at early (N80) or later (P1 or N2) peaks in brain activity. Analyses revealed that from 7-8 years onwards HSF but not LSF stimuli evoked an N80 peak. In younger children, aged 3-8 years, the visual manipulation mainly affected the visual N2 peak. Selective processing of HSF versus LSF thus occurs at a rather late time-point (N2 peak) in young children. Although behavioural research previously showed that 3-6 year-olds can perceive detailed information, the current results point out that selective processing of HSF versus LSF is still delayed in these children. The delayed processing in younger children could impede the use of LSF and HSF for emotional face processing. Thus, the current study is a starting point for understanding changes in basic visual processing which underlie social development.	[van den Boomen, Carlijn; Cousijn, Janna; Kemner, Chantal] Helmholtz Inst, Dept Expt Psychol, NL-3584 CS Utrecht, Netherlands; [van den Boomen, Carlijn; Kemner, Chantal] Univ Utrecht, Dept Dev Psychol, NL-3584 CS Utrecht, Netherlands; [Jonkman, Lisa M.; Jaspers-Vlamings, Petra H. J. M.] Maastricht Univ, Dept Cognit Neurosci, Sect Dev Cognit Neurosci, Fac Psychol & Neurosci, NL-6200 MD Maastricht, Netherlands; [Kemner, Chantal] Univ Med Ctr, Dept Child & Adolescent Psychiat, Brain Ctr Rudolf Magnus, NL-3584 CX Utrecht, Netherlands	Utrecht University; Maastricht University; Utrecht University; Utrecht University Medical Center	van den Boomen, C (corresponding author), Helmholtz Inst, Dept Expt Psychol, Heidelberglaan 2,Unnik Bldg Room 16-17, NL-3584 CS Utrecht, Netherlands.	C.vandenboomen@uu.nl		Cousijn, Janna/0000-0002-7699-2582	Netherlands Organisation for Scientific Research (NWO) [45307004]	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was funded by The Netherlands Organisation for Scientific Research (NWO), Grant number 45307004 awarded to CK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achenbach TM, 1991, MANUAL CHILD BEHAV C; Adams RJ, 2002, VISION RES, V42, P1205, DOI 10.1016/S0042-6989(02)00038-X; BEAZLEY LD, 1980, BRIT J OPHTHALMOL, V64, P863, DOI 10.1136/bjo.64.11.863; Boeschoten MA, 2007, CLIN NEUROPHYSIOL, V118, P2076, DOI 10.1016/j.clinph.2007.05.004; Boeschoten MA, 2005, CLIN NEUROPHYSIOL, V116, P1956, DOI 10.1016/j.clinph.2005.03.021; Braddick O, 2011, VISION RES, V51, P1588, DOI 10.1016/j.visres.2011.02.018; Dakin S, 2005, NEURON, V48, P497, DOI 10.1016/j.neuron.2005.10.018; Deruelle C, 2005, J EXP CHILD PSYCHOL, V90, P172, DOI 10.1016/j.jecp.2004.09.001; Deruelle C, 2008, BRAIN COGNITION, V66, P115, DOI 10.1016/j.bandc.2007.06.001; Dobkins KR, 2014, J VISION, V14, DOI 10.1167/14.1.1; Ellemberg D, 2001, SPATIAL VISION, V15, P99, DOI 10.1163/15685680152692042; FOSTER KH, 1985, J PHYSIOL-LONDON, V365, P331, DOI 10.1113/jphysiol.1985.sp015776; Gao XQ, 2010, J EXP CHILD PSYCHOL, V107, P67, DOI 10.1016/j.jecp.2010.05.003; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Gwiazda J, 1997, OPTOMETRY VISION SCI, V74, P785, DOI 10.1097/00006324-199710000-00017; Hawken MJ, 1997, EXP BRAIN RES, V114, P86, DOI 10.1007/PL00005626; Kenemans JL, 2000, CLIN NEUROPHYSIOL, V111, P1113, DOI 10.1016/S1388-2457(00)00270-4; Leat SJ., 2009, J OPTOM, V2(1), P19, DOI DOI 10.3921/JOPTOM.2009.19; Leonard HC, 2010, J EXP CHILD PSYCHOL, V106, P193, DOI 10.1016/j.jecp.2010.03.005; NORCIA AM, 1985, VISION RES, V25, P1399, DOI 10.1016/0042-6989(85)90217-2; Pourtois G, 2005, HUM BRAIN MAPP, V26, P65, DOI 10.1002/hbm.20130; Simmons DR, 2009, VISION RES, V49, P2705, DOI 10.1016/j.visres.2009.08.005; Spreen O, 1998, COMPENDIUM NEUROPSYC; Taylor MJ, 2004, J COGNITIVE NEUROSCI, V16, P1426, DOI 10.1162/0898929042304732; Tellegen PJ, 1998, MANUAL JUSTIFICATION; van den Boomen C, 2012, Front Psychiatry, V3, P16, DOI 10.3389/fpsyt.2012.00016; Vlamings PHJM, 2010, CHILD DEV, V81, P1304, DOI 10.1111/j.1467-8624.2010.01470.x; Vlamings PHJM, 2009, J VISION, V9, DOI 10.1167/9.5.12; Vlamings PHJM, 2010, BIOL PSYCHIAT, V68, P1107, DOI 10.1016/j.biopsych.2010.06.024; Vuilleumier P, 2003, NAT NEUROSCI, V6, P624, DOI 10.1038/nn1057; Wechsler D., 1991, WISC 3 WECHSLER INTE	31	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0122507	10.1371/journal.pone.0122507	http://dx.doi.org/10.1371/journal.pone.0122507			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE6ZS	25799038	Green Published, Green Submitted, gold			2022-12-26	WOS:000351987300335
J	Xia, H; Hu, C; Zhang, DK; Tang, S; Zhang, Z; Kou, Z; Fan, ZJ; Bente, D; Zeng, CQ; Li, TX				Xia, Han; Hu, Cheng; Zhang, Dake; Tang, Shuang; Zhang, Zhong; Kou, Zheng; Fan, Zhaojun; Bente, Dennis; Zeng, Changqing; Li, Tianxian			Metagenomic Profile of the Viral Communities in Rhipicephalus spp. Ticks from Yunnan, China	PLOS ONE			English	Article							DISEASE VIRUS; BORNE; DIVERSITY; FEVER; PHLEBOVIRUS; REVEALS; BATS	Besides mosquitoes, ticks are regarded as the primary source of vector-borne infectious diseases. Indeed, a wide variety of severe infectious human diseases, including those involving viruses, are transmitted by ticks in many parts of the world. To date, there are no published reports on the use of next-generation sequencing for studying viral diversity in ticks or discovering new viruses in these arthropods from China. Here, Ion-torrent sequencing was used to investigate the presence of viruses in three Rhipicephalus spp. tick pools (NY-11, NY-13, and MM-13) collected from the Menglian district of Yunnan, China. The sequencing run resulted in 3,641,088, 3,106,733, and 3,871,851 reads in each tick pool after trimming. Reads and assembled contiguous sequences (contigs) were subject to basic local alignment search tool analysis against the GenBank database. Large numbers of reads and contigs related to known viral sequences corresponding to a broad range of viral families were identified. Some of the sequences originated from viruses that have not been described previously in ticks. Our findings will facilitate better understanding of the tick virome, and add to our current knowledge of disease-causing viruses in ticks living under natural conditions.	[Xia, Han; Tang, Shuang; Zhang, Zhong; Kou, Zheng; Fan, Zhaojun; Li, Tianxian] Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan, Hubei, Peoples R China; [Xia, Han; Bente, Dennis] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA; [Hu, Cheng] Wuhan Univ, Int Sch Software, Wuhan, Hubei, Peoples R China; [Zhang, Dake; Zeng, Changqing] Chinese Acad Sci, Lab Genome Variat & Precis Biomed, Beijing Inst Genom, Beijing, Peoples R China	Chinese Academy of Sciences; Wuhan Institute of Virology, CAS; University of Texas System; University of Texas Medical Branch Galveston; Wuhan University; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS	Zeng, CQ (corresponding author), Chinese Acad Sci, Lab Genome Variat & Precis Biomed, Beijing Inst Genom, 1 Beichen West Rd, Beijing, Peoples R China.	czeng@big.ac.cn; litx@wh.iov.cn	XIA, HAN/AAT-7458-2020; Zhang, Dake/H-3210-2019; goletti, delia/AAM-6577-2020	XIA, HAN/0000-0001-9932-6040; Zhang, Dake/0000-0001-9508-8209; Goletti, Delia/0000-0001-8360-4376; KOU, Zheng/0000-0003-4758-2872	Ministry of Science and Technology of China [2013FY113500]; Chinese Academy of Sciences [INFOXXH12504-1-06]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Chinese Academy of Sciences(Chinese Academy of Sciences)	This research was supported by the Ministry of Science and Technology of China (grant No. 2013FY113500), Chinese Academy of Sciences (grant Nos. INFOXXH12504-1-06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreotti R, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-6; Bente DA, 2013, ANTIVIR RES, V100, P159, DOI 10.1016/j.antiviral.2013.07.006; Biagini P, 2006, J MED VIROL, V78, P298, DOI 10.1002/jmv.20539; Bzhalava D, 2013, J DATA MIN GENOM PRO, V4, P134; Chen Z, 2008, SICHUAN J ZOOL, V27, P4; Chitimia L, 2009, PARASITOL RES, V105, P907, DOI 10.1007/s00436-009-1474-1; Dacheux L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087194; Dantas-Torres F, 2012, TRENDS PARASITOL, V28, P437, DOI 10.1016/j.pt.2012.07.003; de la Fuente J, 2008, FRONT BIOSCI, V1, P9; de Villiers EM, 2011, J VIROL, V85, P7284, DOI 10.1128/JVI.02472-10; Gao XY, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000624; Ge XY, 2012, J VIROL, V86, P4620, DOI 10.1128/JVI.06671-11; Ghedin E, 2013, J GEN VIROL, V94, P2609, DOI 10.1099/vir.0.055939-0; Gibbs A, 1986, THE PLANT VIRUSES, P167; Gong ZD, 2001, CHINA J PEST CO, V2, P3; Havlikova S, 2013, ACTA VIROL, V57, P123, DOI 10.4149/av_2013_02_123; Holbrook MR, 2012, ANTIVIR RES, V96, P353, DOI 10.1016/j.antiviral.2012.10.005; Honig JE, 2004, VIROLOGY, V318, P10, DOI 10.1016/j.virol.2003.09.021; Jiang DH, 2013, ADV VIRUS RES, V86, P215, DOI 10.1016/B978-0-12-394315-6.00008-8; Karabatsos N., 1985, INTERNATIONAL CATALO; Kaufman WR, 2003, EXP PARASITOL, V104, P20, DOI 10.1016/S0014-4894(03)00113-9; Labuda M, 2004, PARASITOLOGY, V129, pS221, DOI 10.1017/S0031182004005220; Lasecka L, 2014, ARCH VIROL, V159, P1249, DOI 10.1007/s00705-013-1940-z; Liu L, 2012, J BIOMED BIOTECHNOL, V50, P2881; Lwande OW, 2013, VECTOR-BORNE ZOONOT, V13, P637, DOI 10.1089/vbz.2012.1190; Marczinke BI, 2002, VIROLOGY, V303, P146, DOI 10.1006/viro.2002.1514; McMullan LK, 2012, NEW ENGL J MED, V367, P834, DOI 10.1056/NEJMoa1203378; Nersesov V. A., 2003, Meditsinskaya Parazitologiya i Parazitarnye Bolezni, P30; Ng TFF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020579; Radford AD, 2012, J GEN VIROL, V93, P1853, DOI 10.1099/vir.0.043182-0; Savage HM, 2013, AM J TROP MED HYG, V89, P445, DOI 10.4269/ajtmh.13-0209; Steffen MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044002; Tokarz R, 2014, J VIROL, V88, P11480, DOI 10.1128/JVI.01858-14; Tokarz R, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-26; Wang JL, 2009, EMERG INFECT DIS, V15, P326, DOI 10.3201/eid1502.080979; Whon TW, 2012, J VIROL, V86, P8221, DOI 10.1128/JVI.00293-12; Wu XB, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-119; Xia H, 2011, INT J INFECT DIS, V15, pE459, DOI 10.1016/j.ijid.2011.03.013; Yu XJ, 2011, NEW ENGL J MED, V364, P1523, DOI 10.1056/NEJMoa1010095	39	82	87	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121609	10.1371/journal.pone.0121609	http://dx.doi.org/10.1371/journal.pone.0121609			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25867946	Green Published, Green Submitted, gold			2022-12-26	WOS:000351987300276
J	Xia, H; Wang, XM; Li, FB; Longuet, C; Vernet, G; Goletti, D; Zhao, YL; Lagrange, PH				Xia, Hui; Wang, Xiaomen; Li, Fabin; Longuet, Christophe; Vernet, Guy; Goletti, Delia; Zhao, Yanlin; Lagrange, Philippe H.			Diagnostic Values of the QuantiFERON-TB Gold In-Tube Assay Carried out in China for Diagnosing Pulmonary Tuberculosis	PLOS ONE			English	Article							GAMMA RELEASE ASSAYS; BLOOD INTERFERON-GAMMA; ACTIVE TUBERCULOSIS; MYCOBACTERIUM-TUBERCULOSIS; SKIN-TEST; CLINICAL UTILITY; INFECTION; LATENT; BCG; IMMUNODIAGNOSIS	Background Interferon-release assays (IGRAs) for diagnosing active pulmonary tuberculosis (PTB) are not yet fully validated, particularly in high TB-endemic areas as the People's Republic of China (PRC). The aim of this report was to assess the performance of the QuantiFERON-TB Gold In-tube (QFT-GIT) and tuberculin skin test (TST), in addition to microbiological results, as contributors for diagnosing active PTB in the PRC. Methods/Principal Findings A total of 300 PTB patients, 41 disease controls (DC) and 59 healthy community controls (HCC) were included prospectively between May 2010 and April 2011 from two provinces of the PRC (Heilongjiang and Zhejiang). The QFT-GIT and TST yielded an overall sensitivity for active TB of 80.9% and 86.2%, and a specificity of 36.6% and 26.8%, respectively. The province of origin and smear microscopy status did not significantly impact the diagnostic values for PTB. However, using the TST with a 10 mm cut-off point, a significantly higher proportion of LTBI was observed in the DC than the HCC (p=0.01). Discordant results between the QFT-GIT and TST were found among 1/3 of the PTB, HCC and DC. Two-thirds of the individuals presented TST-positive/QFT-GIT-negative discordant results. The TST-negative/QFT-GIT-positive result was not associated with age or bacillary load. Cumulative QFT-GIT and TST positive results increased the overall sensitivity (95.9%), but it was associated with a dramatic decrease of the overall specificity (24.8%) leading to a suboptimal PPV (80.1%) and a low NPV (61.1%). Conclusions/Significance The usefulness of the QFT-GIT to diagnose active TB in high TB-endemic countries remains doubtful because like the TST, the QFT-GIT cannot distinguish between LTBI and active TB. Used as single stand-alone tests, both the QFT-GIT and TST have very limited roles in the diagnosis of active PTB. However, the combined use of SM, the TST and QFT-GIT may allow for the exclusion of ATB.	[Xia, Hui; Zhao, Yanlin] Chinese Ctr Dis Control & Prevent, Natl TB Reference Lab, Beijing, Peoples R China; [Wang, Xiaomen] TB Control Ctr Heilongjiang Prov, Harbin, Heilongjiang, Peoples R China; [Li, Fabin] Zhejiang Prov Ctr Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China; [Longuet, Christophe; Vernet, Guy] Fdn Merieux, Lyon, France; [Goletti, Delia] L Spallanzani Natl Inst Infect Dis INMI, Dept Epidemiol & Preclin Res, Rome, Italy; [Lagrange, Philippe H.] Paris VII Denis Diderot Univ, Hop St Louis, AP HP, Microbiol Serv, Paris, France	Chinese Center for Disease Control & Prevention; Zhejiang Provincial Center for Disease Control & Prevention; IRCCS Lazzaro Spallanzani; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite	Zhao, YL (corresponding author), Chinese Ctr Dis Control & Prevent, Natl TB Reference Lab, Beijing, Peoples R China.	zhaoyanlin@chinatb.org; plagrange@sfr.fr	XIA, HAN/AAT-7458-2020; Zhang, Dake/H-3210-2019; goletti, delia/AAM-6577-2020	XIA, HAN/0000-0001-9932-6040; Zhang, Dake/0000-0001-9508-8209; Goletti, Delia/0000-0001-8360-4376; KOU, Zheng/0000-0003-4758-2872	Fondation Merieux	Fondation Merieux	Fondation Merieux funded the study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen P, 2000, LANCET, V356, P1099, DOI 10.1016/S0140-6736(00)02742-2; Arend SM, 2007, AM J RESP CRIT CARE, V175, P618, DOI 10.1164/rccm.200608-1099OC; Bass Jr JB, 1993, TUBERCULOSIS A COMPR; Chen XC, 2009, CLIN VACCINE IMMUNOL, V16, P879, DOI 10.1128/CVI.00044-09; CHEN ZR, 1982, CHINESE MED J-PEKING, V95, P437; Chiacchio T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027539; Chinese Ministry of Health Disease Control and Prevention Bureau Center for Disease Control and Prevention, 2008, GUIDELINES FOR IMPLE; Chinese Ministry of Health Disease Control and Prevention Bureau Center for Disease Control and Prevention China TB control program, 2009, SPUTUM SMEAR MICROSC; Dai Y, 2012, EUR J CLIN MICROBIOL, V31, P3127, DOI 10.1007/s10096-012-1674-y; Delogu G, 2014, J RHEUMATOL, V41, P11, DOI 10.3899/jrheum.140097; Dheda K, 2009, CURR OPIN PULM MED, V15, P188, DOI 10.1097/MCP.0b013e32832a0adc; Diel R, 2010, CHEST, V137, P952, DOI 10.1378/chest.09-2350; Dosanjh DPS, 2008, ANN INTERN MED, V148, P325, DOI 10.7326/0003-4819-148-5-200803040-00003; Ewer K, 2006, AM J RESP CRIT CARE, V174, P831, DOI 10.1164/rccm.200511-1783OC; Farhat M, 2006, INT J TUBERC LUNG D, V10, P1192; Feng Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032652; Goletti D, 2014, J RHEUMATOL, V41, P24, DOI 10.3899/jrheum.140099; Goletti D, 2010, J INFECTION, V61, P133, DOI 10.1016/j.jinf.2010.05.002; Harada N, 2006, INFECT CONT HOSP EP, V27, P442, DOI 10.1086/504358; Hill PC, 2005, CLIN INFECT DIS, V40, P273, DOI 10.1086/427030; Hu PL, 2014, CHINESE MED J-PEKING, V127, P3744, DOI 10.3760/cma.j.issn.0366-6999.20141004; Jafari C, 2009, AM J RESP CRIT CARE, V180, P666, DOI 10.1164/rccm.200904-0557OC; Jiang WM, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-31; Kabeer BSA, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-135; Kabeer BSA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009051; Lagrange PH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073579; Li WM, 2007, SCAND J INFECT DIS, V39, P138, DOI 10.1080/00365540600951234; Ling DI, 2011, EUR RESPIR J, V38, P649, DOI 10.1183/09031936.00181610; Lui G, 2011, J INFECTION, V62, P440, DOI 10.1016/j.jinf.2011.04.011; Mazurek GH, 2007, CLIN INFECT DIS, V45, P826, DOI 10.1086/521106; Menzies D, 2007, ANN INTERN MED, V146, P340, DOI 10.7326/0003-4819-146-5-200703060-00006; Metcalfe JZ, 2011, J INFECT DIS, V204, pS1120, DOI 10.1093/infdis/jir410; Ministry of Health People's Republic of China Joint United Nations Program on HIV/AIDS World Health Organization, 2011, 2011 ESTIMATES FOR T; Mori T, 2007, INT J TUBERC LUNG D, V11, P1021; Nahid Payam, 2006, Proc Am Thorac Soc, V3, P103, DOI 10.1513/pats.200511-119JH; Nienhaus A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002665; Ou XC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094544; Pai M, 2004, LANCET INFECT DIS, V4, P761, DOI 10.1016/S1473-3099(04)01206-X; Pai M, 2006, AM J RESP CRIT CARE, V174, P349, DOI 10.1164/rccm.200604-472OC; Pai M, 2006, EXPERT REV MOL DIAGN, V6, P413, DOI 10.1586/14737159.6.3.413; Park SY, 2009, SCAND J INFECT DIS, V41, P818, DOI 10.3109/00365540903214298; Sester M, 2011, EUR RESPIR J, V37, P100, DOI 10.1183/09031936.00114810; Small PM, 2010, NEW ENGL J MED, V363, P1070, DOI 10.1056/NEJMe1008496; Sodhi A, 1997, CLIN INFECT DIS, V25, P617, DOI 10.1086/513769; Theron G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037436; Thompson ML, 2003, BIOSTATISTICS, V4, P341, DOI 10.1093/biostatistics/4.3.341; Tsiouris SJ, 2006, J CLIN MICROBIOL, V44, P2844, DOI 10.1128/JCM.02411-05; World Health Organization [WHO], 2014, WHO REPORT 2013; Zhang M, 2010, INT J TUBERC LUNG D, V14, P1556; Zhang S, 2010, CLIN VACCINE IMMUNOL, V17, P1985, DOI 10.1128/CVI.00294-10	50	82	87	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0121021	10.1371/journal.pone.0121021	http://dx.doi.org/10.1371/journal.pone.0121021			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25867946	Green Published, gold, Green Submitted			2022-12-26	WOS:000352845100031
J	Van Dyck, D; Teychenne, M; McNaughton, SA; De Bourdeaudhuij, I; Salmon, J				Van Dyck, Delfien; Teychenne, Megan; McNaughton, Sarah A.; De Bourdeaudhuij, Ilse; Salmon, Jo			Relationship of the Perceived Social and Physical Environment with Mental Health-Related Quality of Life in Middle-Aged and Older Adults: Mediating Effects of Physical Activity	PLOS ONE			English	Article							DEPRESSIVE SYMPTOMS; NEIGHBORHOOD CHARACTERISTICS; DETERMINANTS; ASSOCIATIONS; ENGAGEMENT; MULTILEVEL; RESIDENTS; SUPPORT; ANXIETY; CRIME	Background Mental health conditions are among the leading non-fatal diseases in middle-aged and older adults in Australia. Proximal and distal social environmental factors and physical environmental factors have been associated with mental health, but the underlying mechanisms explaining these associations remain unclear. The study objective was to examine the contribution of different types of physical activity in mediating the relationship of social and physical environmental factors with mental health-related quality of life in middle-aged and older adults. Methods Baseline data from the Wellbeing, Eating and Exercise for a Long Life (WELL) study were used. WELL is a prospective cohort study, conducted in Victoria, Australia. Baseline data collection took place in 2010. In total, 3,965 middle-aged and older adults (55-65 years, 47.4% males) completed the SF-36 Health Survey, the International Physical Activity Questionnaire, and a questionnaire on socio-demographic, social and physical environmental attributes. Mediation analyses were conducted using the MacKinnon product-of-coefficients test. Results Personal safety, the neighbourhood physical activity environment, social support for physical activity from family or friends, and neighbourhood social cohesion were positively associated with mental health-related quality of life. Active transportation and leisure-time physical activity mediated 32.9% of the association between social support for physical activity from family or friends and mental health-related quality of life. These physical activity behaviours also mediated 11.0%, 3.4% and 2.3% respectively, of the relationship between the neighbourhood physical activity environment, personal safety and neighbourhood social cohesion and mental health-related quality of life. Conclusions If these results are replicated in future longitudinal studies, tailored interventions to improve mental health-related quality of life in middle-aged and older adults should use a combined strategy, focusing on increasing physical activity as well as social and physical environmental attributes.	[Van Dyck, Delfien] Res Fdn Flanders, B-1000 Brussels, Belgium; [Van Dyck, Delfien; De Bourdeaudhuij, Ilse] Univ Ghent, Dept Movement & Sports Sci, B-90000 Ghent, Belgium; [Teychenne, Megan; McNaughton, Sarah A.; Salmon, Jo] Deakin Univ, Ctr Phys Act & Nutr Res, Sch Exercise & Nutr Sci, Burwood, Vic 3125, Australia	Ghent University; Deakin University	Van Dyck, D (corresponding author), Res Fdn Flanders, Egmontstr 5, B-1000 Brussels, Belgium.	delfien.vandyck@ugent.be	Salmon, Jo/X-2630-2019; De+Bourdeaudhuij, Ilse/AAC-5528-2019; McNaughton, Sarah A/B-2075-2012; Van Dyck, Delfien/AAO-8981-2020; Salmon, Jo/C-1226-2009	Salmon, Jo/0000-0002-4734-6354; De+Bourdeaudhuij, Ilse/0000-0001-9969-7597; McNaughton, Sarah A/0000-0001-5936-9820; Salmon, Jo/0000-0002-4734-6354; Teychenne, Megan/0000-0002-7293-8255; Van Dyck, Delfien/0000-0003-1783-9075; Cardon, Greet/0000-0003-4983-6557	Research Foundation Flanders (FWO); Australian Research Council [FT100100581, DP1095595]; NHMRC [ID1026216]; Diabetes Australia Research Trust; Marie Curie Actions [FP7-PEOPLE-2009-IRSES-247630]	Research Foundation Flanders (FWO)(FWO); Australian Research Council(Australian Research Council); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Diabetes Australia Research Trust; Marie Curie Actions(European Commission)	DVD is supported by the Research Foundation Flanders (FWO; post doctoral research mandate). SAM is supported by an Australian Research Council Future Fellowship (FT100100581). JS is supported by a NHMRC Senior Research Fellowship (ID1026216). The WELL study was awarded funding from the Diabetes Australia Research Trust and the Australian Research Council (Project Grant ID: DP1095595). Analyses for the current paper were part of the MeMo International Exchange programme funded under Marie Curie Actions (FP7-PEOPLE-2009-IRSES-247630). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almedom AM, 2005, SOC SCI MED, V61, P943, DOI 10.1016/j.socscimed.2004.12.025; [Anonymous], 1978, MAIL TELEPHONE SURVE; [Anonymous], 2002, ETHNIC DIS; Asztalos M, 2009, J SCI MED SPORT, V12, P468, DOI 10.1016/j.jsams.2008.06.009; Australian Bureau of Statistics, 2003, CRIT FACT SUCC R D I, P1; Balboa-Castillo T, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-47; Beard JR, 2009, AM J PUBLIC HEALTH, V99, P1308, DOI 10.2105/AJPH.2007.125104; Berke EM, 2007, J AM GERIATR SOC, V55, P526, DOI 10.1111/j.1532-5415.2007.01108.x; Biddle SJH, 2007, PHYS ACTIVITY PSYCHO; Blazer DG, 2005, PSYCHOL MED, V35, P1421; Brown SC, 2009, J AGING HEALTH, V21, P431, DOI 10.1177/0898264308328976; Van Cauwenberg J, 2011, HEALTH PLACE, V17, P458, DOI 10.1016/j.healthplace.2010.11.010; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Croezen S, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-65; De Bourdeaudhuij I, 2005, PUBLIC HEALTH NUTR, V8, P886, DOI 10.1079/PHN2005735; De Greef K, 2011, HEALTH SOC CARE COMM, V19, P178, DOI 10.1111/j.1365-2524.2010.00958.x; DISHMAN RK, 1992, MED SCI SPORT EXER, V24, P904; Edwards R, 2007, COCHRANE DB SYST REV, V2; Friedman D, 2012, QUAL LIFE RES, V21, P123, DOI 10.1007/s11136-011-9923-6; Gebel K, 2007, AM J PREV MED, V32, P361, DOI 10.1016/j.amepre.2007.01.020; Giles-Corti B, 2003, AM J PUBLIC HEALTH, V93, P1583, DOI 10.2105/AJPH.93.9.1583; Glass TA, 2006, J AGING HEALTH, V18, P604, DOI 10.1177/0898264306291017; GREIST JH, 1979, COMPR PSYCHIAT, V20, P41, DOI 10.1016/0010-440X(79)90058-0; Henderson AS, 1997, INT J GERIATR PSYCH, V12, P145; KEENE ON, 1995, STAT MED, V14, P811, DOI 10.1002/sim.4780140810; Leach LS, 2013, SOC PSYCH PSYCH EPID, V48, P417, DOI 10.1007/s00127-012-0559-9; Li F, 2005, JIAOYU KEXUE LUNTAN, V12, P45; Lorant V, 2003, AM J EPIDEMIOL, V157, P98, DOI 10.1093/aje/kwf182; Mackinaw-Koons B, 2009, APPL PREVENTIVE PSYC, V9, P191; MacKinnon DP, 2007, ANNU REV PSYCHOL, V58, P593, DOI 10.1146/annurev.psych.58.110405.085542; MacKinnon DP, 2002, PSYCHOL METHODS, V7, P83, DOI 10.1037/1082-989X.7.1.83; Mair C, 2009, ANN EPIDEMIOL, V19, P49, DOI 10.1016/j.annepidem.2008.10.002; Mammen G, 2013, AM J PREV MED, V45, P649, DOI 10.1016/j.amepre.2013.08.001; McNaughton SA, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-109; Melchior M, 2003, SOC SCI MED, V56, P1817, DOI 10.1016/S0277-9536(02)00181-8; Modie-Moroka T, 2009, J HEALTH POPUL NUTR, V27, P462, DOI 10.3329/jhpn.v27i4.3390; Mujahid MS, 2007, AM J EPIDEMIOL, V165, P858, DOI 10.1093/aje/kwm040; Pan A, 2011, JAMA-J AM MED ASSOC, V306, P1241, DOI 10.1001/jama.2011.1282; Parra DC, 2010, SOC SCI MED, V70, P1070, DOI 10.1016/j.socscimed.2009.12.024; Piccinelli M, 2000, BRIT J PSYCHIAT, V177, P486, DOI 10.1192/bjp.177.6.486; RANSFORD CP, 1982, MED SCI SPORT EXER, V14, P1, DOI 10.1249/00005768-198201000-00001; Roux AVD, 2010, ANN NY ACAD SCI, V1186, P125, DOI 10.1111/j.1749-6632.2009.05333.x; Saelens BE, 2008, MED SCI SPORT EXER, V40, pS550, DOI 10.1249/MSS.0b013e31817c67a4; Sallis JF, 2002, PEDIATR EXERC SCI, V14, P30, DOI 10.1123/pes.14.1.30; Sallis JF, 2008, HLTH BEHAV HLTH ED, P465, DOI DOI 10.7326/0003-4819-116-4-350_; Sampson RJ, 1997, SCIENCE, V277, P918, DOI 10.1126/science.277.5328.918; Schieman S, 2004, J GERONTOL B-PSYCHOL, V59, pS89, DOI 10.1093/geronb/59.2.S89; Scott KM, 2014, CURR OPIN PSYCHIATR, V27, P289, DOI 10.1097/YCO.0000000000000067; Sniehotta FF, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-106; Stafford M, 2008, EUR J PUBLIC HEALTH, V18, P604, DOI 10.1093/eurpub/ckn091; Stafford M, 2007, AM J PUBLIC HEALTH, V97, P2076, DOI 10.2105/AJPH.2006.097154; Stafford M, 2011, AGEING SOC, V31, P893, DOI 10.1017/S0144686X10001236; Teychenne M, 2008, PREV MED, V46, P397, DOI 10.1016/j.ypmed.2008.01.009; Teychenne M, 2010, HEALTH EDUC RES, V25, P632, DOI 10.1093/her/cyq008; Trost SG, 2002, MED SCI SPORT EXER, V34, P1996, DOI 10.1097/00005768-200212000-00020; Van der Kooy K, 2007, INT J GERIATR PSYCH, V22, P613, DOI 10.1002/gps.1723; Van Dyck D, 2011, INT J BEHAV MED, V18, P235, DOI 10.1007/s12529-010-9127-4; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Wendel-Vos W, 2007, OBES REV, V8, P425, DOI 10.1111/j.1467-789X.2007.00370.x; Whitley E, 1999, BRIT MED J, V319, P1034, DOI 10.1136/bmj.319.7216.1034; World Health Organisation, 2006, HLTH TOP AG LIF COUR; Zunzunegui MV, 2003, J GERONTOL B-PSYCHOL, V58, pS93, DOI 10.1093/geronb/58.2.S93	62	63	66	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120475	10.1371/journal.pone.0120475	http://dx.doi.org/10.1371/journal.pone.0120475			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE6ZS	25799269	Green Published, Green Submitted, gold			2022-12-26	WOS:000351987300148
J	Van Dyck, D; Cardon, G; Deforche, B; De Bourdeaudhuij, I				Van Dyck, Delfien; Cardon, Greet; Deforche, Benedicte; De Bourdeaudhuij, Ilse			The Contribution of Former Work-Related Activity Levels to Predict Physical Activity and Sedentary Time during Early Retirement: Moderating Role of Educational Level and Physical Functioning	PLOS ONE			English	Article							TELEVISION VIEWING TIME; TRANSITION; BEHAVIOR	Background The transition to retirement introduces a decline in total physical activity and an increase in TV viewing time. Nonetheless, as more time becomes available, early retirement is an ideal stage to implement health interventions. Therefore, knowledge on specific determinants of physical activity and sedentary time is needed. Former work-related physical activity has been proposed as a potential determinant, but concrete evidence is lacking. The aim of this study was to examine if former work-related sitting, standing, walking or vigorous activities predict physical activity and sedentary time during early retirement. Additionally, moderating effects of educational level and physical functioning were examined. Methods In total, 392 recently retired Belgian adults (> 6 months, < 5 years) completed the International Physical Activity Questionnaire, the SF-36 Health Survey and a questionnaire on sociodemographics and former work-related activities. Generalized linear regression analyses were conducted in R. Moderating effects were examined by adding cross-products to the models. Results More former work-related sitting was predictive of more screen time during retirement. Lower levels of former work-related vigorous activities and higher levels of former work-related walking were associated with respectively more cycling for transport and more walking for transport during retirement. None of the predictors significantly explained passive transportation, cycling and walking for recreation, and leisure-time moderate-to-vigorous physical activity during retirement. Several moderating effects were found, but the direction of the interactions was not univocal. Conclusions Former-work related behaviors are of limited importance to explain physical activity during early retirement, so future studies should focus on other individual, social and environmental determinants. Nonetheless, adults who previously had a sedentary job had higher levels of screen time during retirement, so this is an important subgroup to focus on during interventions. Because of the inconsistent moderating effects of educational level and physical functioning, no clear recommendations can be formulated.	[Van Dyck, Delfien] Res Fdn Flanders, Brussels, Belgium; [Van Dyck, Delfien; Cardon, Greet; De Bourdeaudhuij, Ilse] Univ Ghent, Dept Movement & Sports Sci, B-9000 Ghent, Belgium; [Deforche, Benedicte] Univ Ghent, Dept Publ Hlth, B-9000 Ghent, Belgium	Ghent University; Ghent University	Van Dyck, D (corresponding author), Res Fdn Flanders, Brussels, Belgium.	delfien.vandyck@ugent.be	Salmon, Jo/X-2630-2019; De+Bourdeaudhuij, Ilse/AAC-5528-2019; McNaughton, Sarah A/B-2075-2012; Van Dyck, Delfien/AAO-8981-2020; Salmon, Jo/C-1226-2009	Salmon, Jo/0000-0002-4734-6354; De+Bourdeaudhuij, Ilse/0000-0001-9969-7597; McNaughton, Sarah A/0000-0001-5936-9820; Salmon, Jo/0000-0002-4734-6354; Teychenne, Megan/0000-0002-7293-8255; Van Dyck, Delfien/0000-0003-1783-9075; Cardon, Greet/0000-0003-4983-6557	Research Foundation Flanders [FWO12/PDO/158]	Research Foundation Flanders(FWO)	DVD is supported by the Research Foundation Flanders (FWO12/PDO/158; post doctoral research mandate). The funder had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Barnett I, 2011, J EPIDEMIOL COMMUN H, V65, pA34, DOI 10.1136/jech.2011.143586.76; Barnett I, 2014, J EPIDEMIOL COMMUN H, V68, P747, DOI 10.1136/jech-2013-203225; Barnett I, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-97; Barnett I, 2012, AM J PREV MED, V43, P329, DOI 10.1016/j.amepre.2012.05.026; Beck F, 2010, BRIT J HEALTH PSYCH, V15, P663, DOI 10.1348/135910709X479096; Bin Cheung Y, 2002, STAT MED, V21, P1461, DOI 10.1002/sim.1088; Chung S, 2009, AM J PREV MED, V36, P422, DOI 10.1016/j.amepre.2009.01.026; Clark BK, 2010, J PHYS ACT HEALTH, V7, P595, DOI 10.1123/jpah.7.5.595; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Evenson KR, 2002, AM J EPIDEMIOL, V155, P692, DOI 10.1093/aje/155.8.692; Giles-Corti B, 2005, EXERC SPORT SCI REV, V33, P175, DOI 10.1097/00003677-200510000-00005; Hamilton MT, 2008, CURR CARDIOVASC RISK, V2, P292, DOI 10.1007/s12170-008-0054-8; Jackman S., 2012, PSCL CLASSES METHODS; Lahti J, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-36; Landi F, 2010, BIOGERONTOLOGY, V11, P537, DOI 10.1007/s10522-010-9296-1; Lang IA, 2007, AGE AGEING, V36, P638, DOI 10.1093/ageing/afm119; Mein GK, 2005, EUR J PUBLIC HEALTH, V15, P317, DOI 10.1093/eurpub/cki087; Organization for Economic Cooperation and Development, 2006, STUD PROJ GROW PRESS; Robert S, 1996, J AGING HEALTH, V8, P359, DOI 10.1177/089826439600800304; Saelens BE, 2003, AM J PUBLIC HEALTH, V93, P1552, DOI 10.2105/AJPH.93.9.1552; Salmon J, 2003, HEALTH PSYCHOL, V22, P178, DOI 10.1037/0278-6133.22.2.178; Slingerland AS, 2007, AM J EPIDEMIOL, V165, P1356, DOI 10.1093/aje/kwm053; Touvier M, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-14; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Twisk JWR., 2006, APPL MULTILEVEL ANAL, DOI [10.1017/CBO9780511610806, DOI 10.1017/CBO9780511610806]; U.S. Department of Health and Human Services, 2008, ODPHP PUBL U; Venables WN., 2002, MODERN APPL STAT S, V4, DOI 10.1007/978-0-387-21706-2; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; World Health Organization, 2006, HLTH TOP AG LIF COUR; Zeileis A, 2008, J STAT SOFTW, V27, P1, DOI 10.18637/jss.v027.i08	30	63	66	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2015	10	3							e0122522	10.1371/journal.pone.0122522	http://dx.doi.org/10.1371/journal.pone.0122522			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE8IF	25799269	Green Submitted, Green Published, gold			2022-12-26	WOS:000352084800077
